Psyllid ID: psy12427

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350------
Protein Sequence
MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDTFKKQIKKRQYDFDETGKKIRGKADEKVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE
Secondary Structure (PSIPRED)
ccccEEEcEEEEccEEEEccccccEEEEEEEEEEcccccccccccccEEEccHHHHHHHHcccccccccccccccccccccccccccccccccccccccEEccccccccEEEEcccccccccEEEEEEEcccccEEEEEEccccccccHHHHHHHHHHHHHcccccccEEEEEEEccccEEEEEEccccccHHHHHHcccccccHHHHHcccccHHHHHHHHHHHHHHHccccccccccccEEEEccccccEEEEEccccccccccccEEEEcccccccccccccccccccccccHHHHHHHHHHHccccccccccHHHHHHHHcccEEEEcHHHHHHHcHHHHHHHHHHHHcccc
Secondary Structure Prediction (SSPRO)
cccEEEEccccccEEEEcccccccEEEEEEEEEEcccccccccccccccccccccccccccccccccccccccccccccccccHHHcccHHHHccccccccEcccHHHcEEEEEEEEEEccEEEEEEEEcccccEEEEEEEEcccHHHHHHHHHHHHHHcccccccEccEEEEEEcccEEEEEEEcccccEHHHHcccccccEcHHHHHHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccccEEEccccccEEcccccEEEEEEccHHHccHHHHcccEEcHHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHccccccHHHHccccHHHHHHHHccccccHH
Coil and Loop (DISEMBL)
msswirvgntrFTTMaitglspghqyEFRVYAEnvygrsdpsttsdlittKDTFKKQIKKRQYDfdetgkkirgkadekvsdydQYVFDIYskyvpqpvdiktssvydhyDILEEIGTGAFGVVHRcrerktgnifaakfipvshnLEKELIRKEIDIMNqlhhpklinlhdafedddEMVLIFEFLsggelferitapdykmseaevipvtlpilmtqtspavkhmhekniihldvkpenimcqtrnstnvKMIDfglatkldpnevvkistgtaefaapeiverepvgfytdMWAVGVLAYVLLSglspfagendveTLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE
Flexible Loop (DISEMBL)
msswirvgntrfttmaitglspghQYEFRVYAENVygrsdpsttsdlittkdtfkkqikkrqydfdetgkkirgkadekvsdyDQYVFDIYskyvpqpvdIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTgnifaakfipvshNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIihldvkpenIMCQTRNSTNVKMIDFGLATKLDPNEVVKIStgtaefaapeivEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEafknvseegkdFIRRLLLRNKE
Low Complexity Region (SEG)
MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDTFKKQIKKRQYDFDETGKKIRGKADEKVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE
Disordered region (IsUnstruct)
***WIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYG*****************************************KVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLL*****
Disordered Region (DISOPRED)
MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGR******************************************************KYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS******LIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRN**
Disordered Region (DISEMBL)
MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDTFKKQIKKRQYDFDETGKKIRGKADEKVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE
Disordered Region (DISPRO)
*SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGR***********************************************YVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRN**
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDTFKKQIKKRQYDFDETGKKIRGKADEKVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	356	2.2.26 [Sep-21-2011]
Q23551	7158	Twitchin OS=Caenorhabditi	no	N/A	0.960	0.047	0.573	1e-116
Q15746	1914	Myosin light chain kinase	yes	N/A	0.915	0.170	0.439	9e-79
Q6PDN3	1941	Myosin light chain kinase	yes	N/A	0.912	0.167	0.437	1e-77
P29294	1147	Myosin light chain kinase	yes	N/A	0.918	0.285	0.438	2e-77
Q28824	1176	Myosin light chain kinase	yes	N/A	0.921	0.278	0.428	3e-77
P11799	1906	Myosin light chain kinase	yes	N/A	0.918	0.171	0.417	4e-75
Q86YV6	388	Myosin light chain kinase	no	N/A	0.716	0.657	0.464	4e-67
E9PT87	786	Myosin light chain kinase	yes	N/A	0.862	0.390	0.413	6e-66
Q3UIZ8	795	Myosin light chain kinase	no	N/A	0.707	0.316	0.471	6e-65
A8C984	715	Myosin light chain kinase	no	N/A	0.727	0.362	0.461	1e-64

>sp|Q23551|UNC22_CAEEL Twitchin OS=Caenorhabditis elegans GN=unc-22 PE=1 SV=3

 Score =  417 bits (1073), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 202/352 (57%), Positives = 251/352 (71%), Gaps = 10/352 (2%)

Query: 2    SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPS-TTSDLITTKDTFKKQIKK 60
             SW     +R+T   I GL  G QYEFR+ AEN +G+S P   T+ ++   D  K+   +
Sbjct: 6156 GSWSPCAKSRYTYTTIEGLRAGKQYEFRIIAENKHGQSKPCEPTAPVLIPGDERKR---R 6212

Query: 61   RQYDFDETGKKIRGKADEKVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGA 120
            R YD DE GK +RGK     S+YD YVFDI+ +Y PQPV+IK   V DHYDI EE+GTGA
Sbjct: 6213 RGYDVDEQGKIVRGKGTVS-SNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGA 6271

Query: 121  FGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM 180
            FGVVHR  ER TGN FAAKF+   H  +KE +RKEI  M+ L HP L+NLHDAFEDD+EM
Sbjct: 6272 FGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM 6331

Query: 181  VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPE 240
            V+I+EF+SGGELFE++     KMSE E +       M Q    + HMHE N +HLD+KPE
Sbjct: 6332 VMIYEFMSGGELFEKVADEHNKMSEDEAVE-----YMRQVCKGLCHMHENNYVHLDLKPE 6386

Query: 241  NIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGV 300
            NIM  T+ S  +K+IDFGL   LDP + VK++TGTAEFAAPE+ E +PVG+YTDMW+VGV
Sbjct: 6387 NIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGV 6446

Query: 301  LAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLL 352
            L+Y+LLSGLSPF GEND ETL+NVK+CDW  D+ AF  +SE+GKDFIR+LLL
Sbjct: 6447 LSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLL 6498

Regulator of muscle contraction and relaxation. Senses mechanical strain that occurs during muscle activity by unfolding in clearly resolvable steps at differing forces.
Caenorhabditis elegans (taxid: 6239)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q15746|MYLK_HUMAN Myosin light chain kinase, smooth muscle OS=Homo sapiens GN=MYLK PE=1 SV=4

 Score =  294 bits (752), Expect = 9e-79,   Method: Compositional matrix adjust.
 Identities = 155/353 (43%), Positives = 218/353 (61%), Gaps = 27/353 (7%)

Query: 3    SWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDTFKKQIKKRQ 62
            +W  +   R T+  +  L P H+Y+FRV A NVYG S+PS  S+L T             
Sbjct: 1377 TWKELATCRSTSFNVQDLLPDHEYKFRVRAINVYGTSEPSQESELTTV------------ 1424

Query: 63   YDFDETGKKIRGKADE-KVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAF 121
                  G+K     DE +VSD D+   ++  + V    + K S   D YDI E +G+G F
Sbjct: 1425 ------GEKPEEPKDEVEVSDDDEKEPEVDYRTVTINTEQKVS---DFYDIEERLGSGKF 1475

Query: 122  GVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMV 181
            G V R  E+KT  ++A KF       EKE IR+EI IMN LHHPKL+   DAFE+   +V
Sbjct: 1476 GQVFRLVEKKTRKVWAGKFFKAYSAKEKENIRQEISIMNCLHHPKLVQCVDAFEEKANIV 1535

Query: 182  LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPEN 241
            ++ E +SGGELFERI   D++++E E I       M Q S  V+++H++ I+HLD+KPEN
Sbjct: 1536 MVLEIVSGGELFERIIDEDFELTERECIK-----YMRQISEGVEYIHKQGIVHLDLKPEN 1590

Query: 242  IMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVL 301
            IMC  +  T +K+IDFGLA +L+    +K+  GT EF APE++  EP+G+ TDMW++GV+
Sbjct: 1591 IMCVNKTGTRIKLIDFGLARRLENAGSLKVLFGTPEFVAPEVINYEPIGYATDMWSIGVI 1650

Query: 302  AYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
             Y+L+SGLSPF G+ND ETL NV +  W+FD+EAF  +S++ KDFI  LL ++
Sbjct: 1651 CYILVSGLSPFMGDNDNETLANVTSATWDFDDEAFDEISDDAKDFISNLLKKD 1703

Calcium/calmodulin-dependent myosin light chain kinase implicated in smooth muscle contraction via phosphorylation of myosin light chains (MLC). Also regulates actin-myosin interaction through a non-kinase activty. Phosphorylates PTK2B/PYK2 and myosin light-chains. Involved in the inflammatory response (e.g. apoptosis, vascular permeability, leukocyte diapedesis), cell motility and morphology, airway hyperreactivity and other activities relevant to asthma. Required for tonic airway smooth muscle contraction that is necessary for physiological and asthmatic airway resistance. Necessary for gastrointestinal motility. Implicated in the regulation of endothelial as well as vascular permeability, probably via the regulation of cytoskeletal rearrangements. In the nervous system it has been shown to control the growth initiation of astrocytic processes in culture and to participate in transmitter release at synapses formed between cultured sympathetic ganglion cells. Critical participant in signaling sequences that result in fibroblast apoptosis. Plays a role in the regulation of epithelial cell survival. Required for epithelial wound healing, especially during actomyosin ring contraction during purse-string wound closure. Mediates RhoA-dependent membrane blebbing. Triggers TRPC5 channel activity in a calcium-dependent signaling, by inducing its subcellular localization at the plasma membrane. Promotes cell migration (including tumor cells) and tumor metastasis. PTK2B/PYK2 activation by phosphorylation mediates ITGB2 activation and is thus essential to trigger neutrophil transmigration during acute lung injury (ALI). May regulate optic nerve head astrocyte migration. Probably involved in mitotic cytoskeletal regulation. Regulates tight junction probably by modulating ZO-1 exchange in the perijunctional actomyosin ring. Mediates burn-induced microvascular barrier injury; triggers endothelial contraction in the development of microvascular hyperpermeability by phosphorylating MLC. Essential for intestinal barrier dysfunction. Mediates Giardia spp.-mediated reduced epithelial barrier function during giardiasis intestinal infection via reorganization of cytoskeletal F-actin and tight junctional ZO-1. Necessary for hypotonicity-induced Ca(2+) entry and subsequent activation of volume-sensitive organic osmolyte/anion channels (VSOAC) in cervical cancer cells. Responsible for high proliferative ability of breast cancer cells through anti-apoptosis.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 8

>sp|Q6PDN3|MYLK_MOUSE Myosin light chain kinase, smooth muscle OS=Mus musculus GN=Mylk PE=1 SV=3

 Score =  290 bits (742), Expect = 1e-77,   Method: Compositional matrix adjust.
 Identities = 154/352 (43%), Positives = 216/352 (61%), Gaps = 27/352 (7%)

Query: 4    WIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDTFKKQIKKRQY 63
            W  +   R T+  +  L P  +Y+FRV A NVYG S+PS  S+L                
Sbjct: 1400 WKELATCRSTSFNVQDLLPDREYKFRVRAVNVYGTSEPSQESELTAV------------- 1446

Query: 64   DFDETGKKIRGKADE-KVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAFG 122
                 G+K     DE +VSD D+   ++  + V    + K S VYD   I E +G+G FG
Sbjct: 1447 -----GEKPEEPKDEVEVSDDDEKEPEVDYRTVTVNTEQKVSDVYD---IEERLGSGKFG 1498

Query: 123  VVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL 182
             V R  E+KTG I+A KF       EK+ IR+EI IMN LHHPKL+   DAFE+   +V+
Sbjct: 1499 QVFRLVEKKTGKIWAGKFFKAYSAKEKDNIRQEISIMNCLHHPKLVQCVDAFEEKANIVM 1558

Query: 183  IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENI 242
            + E +SGGELFERI   D++++E E I       M Q S  V+++H++ I+HLD+KPENI
Sbjct: 1559 VLEIVSGGELFERIIDEDFELTERECI-----KYMRQISEGVEYIHKQGIVHLDLKPENI 1613

Query: 243  MCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLA 302
            MC  +  T +K+IDFGLA +L+    +K+  GT EF APE++  EP+G+ TDMW++GV+ 
Sbjct: 1614 MCVNKTGTRIKLIDFGLARRLENAGSLKVLFGTPEFVAPEVINYEPIGYATDMWSIGVIC 1673

Query: 303  YVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
            Y+L+SGLSPF G+ND ETL NV +  W+FD+EAF  +S++ KDFI  LL ++
Sbjct: 1674 YILVSGLSPFMGDNDNETLANVTSATWDFDDEAFDEISDDAKDFISNLLKKD 1725

Calcium/calmodulin-dependent myosin light chain kinase implicated in smooth muscle contraction via phosphorylation of myosin light chains (MLC). Also regulates actin-myosin interaction through a non-kinase activty. Phosphorylates PTK2B/PYK2 and myosin light-chains. Involved in the inflammatory response (e.g. apoptosis, vascular permeability, leukocyte diapedesis), cell motility and morphology, airway hyperreactivity and other activities relevant to asthma. Required for tonic airway smooth muscle contraction that is necessary for physiological and asthmatic airway resistance. Necessary for gastrointestinal motility. Implicated in the regulation of endothelial as well as vascular permeability, probably via the regulation of cytoskeletal rearrangements. In the nervous system it has been shown to control the growth initiation of astrocytic processes in culture and to participate in transmitter release at synapses formed between cultured sympathetic ganglion cells. Critical participant in signaling sequences that result in fibroblast apoptosis. Plays a role in the regulation of epithelial cell survival. Required for epithelial wound healing, especially during actomyosin ring contraction during purse-string wound closure. Mediates RhoA-dependent membrane blebbing. Triggers TRPC5 channel activity in a calcium-dependent signaling, by inducing its subcellular localization at the plasma membrane. Promotes cell migration (including tumor cells) and tumor metastasis. PTK2B/PYK2 activation by phosphorylation mediates ITGB2 activation and is thus essential to trigger neutrophil transmigration during acute lung injury (ALI). May regulate optic nerve head astrocyte migration. Probably involved in mitotic cytoskeletal regulation. Regulates tight junction probably by modulating ZO-1 exchange in the perijunctional actomyosin ring. Mediates burn-induced microvascular barrier injury; triggers endothelial contraction in the development of microvascular hyperpermeability by phosphorylating MLC. Essential for intestinal barrier dysfunction. Mediates Giardia spp.-mediated reduced epithelial barrier function during giardiasis intestinal infection via reorganization of cytoskeletal F-actin and tight junctional ZO-1. Necessary for hypotonicity-induced Ca(2+) entry and subsequent activation of volume-sensitive organic osmolyte/anion channels (VSOAC) in cervical cancer cells.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 8

>sp|P29294|MYLK_RABIT Myosin light chain kinase, smooth muscle OS=Oryctolagus cuniculus GN=MYLK PE=1 SV=2

 Score =  289 bits (740), Expect = 2e-77,   Method: Compositional matrix adjust.
 Identities = 154/351 (43%), Positives = 215/351 (61%), Gaps = 24/351 (6%)

Query: 4   WIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDTFKKQIKKRQY 63
           W  +   R T+  +  L P  +Y+FRV A NVYG S+PS  S+L T  +       K + 
Sbjct: 609 WTELATCRSTSFNVRDLLPDREYKFRVRAINVYGTSEPSQESELTTVGE-------KPEE 661

Query: 64  DFDETGKKIRGKADEKVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAFGV 123
             DE          E+VSD D+   ++  + V    + K S   D YDI E +G+G FG 
Sbjct: 662 PKDEV---------EEVSDDDEKEPEVDYRTVTVNTEQKVS---DFYDIEERLGSGKFGQ 709

Query: 124 VHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI 183
           V R  E+KTG I+A KF       EKE I  EI IMN LHHPKL+   DAFE+   +V++
Sbjct: 710 VFRLVEKKTGKIWAGKFFKAYSAKEKENIPAEIGIMNCLHHPKLVQCVDAFEEKANIVMV 769

Query: 184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIM 243
            E +SGGELFERI   D++++E E I       M Q S  V+++H++ I+HLD+KPENIM
Sbjct: 770 LEIVSGGELFERIIDEDFELTERECI-----KYMRQISEGVEYIHKQGIVHLDLKPENIM 824

Query: 244 CQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAY 303
           C  +  T +K+IDFGLA +L+    +K+  GT EF APE++  EP+ + TDMW++GV+ Y
Sbjct: 825 CVNKTGTRIKLIDFGLARRLENAGSLKVLFGTPEFVAPEVINYEPISYATDMWSIGVICY 884

Query: 304 VLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
           +L+SGLSPF G+ND ETL NV +  W+FD+EAF  +S++ KDFI  LL ++
Sbjct: 885 ILVSGLSPFMGDNDNETLANVTSATWDFDDEAFDEISDDAKDFISNLLKKD 935

Calcium/calmodulin-dependent myosin light chain kinase implicated in smooth muscle contraction via phosphorylation of myosin light chains (MLC). Also regulates actin-myosin interaction through a non-kinase activty. Phosphorylates PTK2B/PYK2 and myosin light-chains. Involved in the inflammatory response (e.g. apoptosis, vascular permeability, leukocyte diapedesis), cell motility and morphology, airway hyperreactivity and other activities relevant to asthma. Required for tonic airway smooth muscle contraction that is necessary for physiological and asthmatic airway resistance. Necessary for gastrointestinal motility. Implicated in the regulation of endothelial as well as vascular permeability, probably via the regulation of cytoskeletal rearrangements. In the nervous system it has been shown to control the growth initiation of astrocytic processes in culture and to participate in transmitter release at synapses formed between cultured sympathetic ganglion cells. Critical participant in signaling sequences that result in fibroblast apoptosis. Plays a role in the regulation of epithelial cell survival. Required for epithelial wound healing, especially during actomyosin ring contraction during purse-string wound closure. Mediates RhoA-dependent membrane blebbing. Triggers TRPC5 channel activity in a calcium-dependent signaling, by inducing its subcellular localization at the plasma membrane. Promotes cell migration (including tumor cells) and tumor metastasis. PTK2B/PYK2 activation by phosphorylation mediates ITGB2 activation and is thus essential to trigger neutrophil transmigration during acute lung injury (ALI). May regulate optic nerve head astrocyte migration. Probably involved in mitotic cytoskeletal regulation. Regulates tight junction probably by modulating ZO-1 exchange in the perijunctional actomyosin ring. Mediates burn-induced microvascular barrier injury; triggers endothelial contraction in the development of microvascular hyperpermeability by phosphorylating MLC. Essential for intestinal barrier dysfunction. Mediates Giardia spp.-mediated reduced epithelial barrier function during giardiasis intestinal infection via reorganization of cytoskeletal F-actin and tight junctional ZO-1. Necessary for hypotonicity-induced Ca(2+) entry and subsequent activation of volume-sensitive organic osmolyte/anion channels (VSOAC) in cervical cancer cells.

Oryctolagus cuniculus (taxid: 9986)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 8

>sp|Q28824|MYLK_BOVIN Myosin light chain kinase, smooth muscle OS=Bos taurus GN=MYLK PE=1 SV=1

 Score =  289 bits (739), Expect = 3e-77,   Method: Compositional matrix adjust.
 Identities = 151/352 (42%), Positives = 215/352 (61%), Gaps = 24/352 (6%)

Query: 3   SWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDTFKKQIKKRQ 62
           +W  +   R T+  +  L P  +Y+FRV A NVYG S+PS  S+L    +  +++ K   
Sbjct: 637 TWKELATCRSTSFNVQDLLPDREYKFRVRAINVYGTSEPSQESELTALGEKPEEEPKDEV 696

Query: 63  YDFDETGKKIRGKADEKVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAFG 122
              D+         DEK  + D     + ++            V D YDI E +G+G FG
Sbjct: 697 EVSDD---------DEKEPEVDYRTVTVNTE----------QKVSDFYDIEERLGSGKFG 737

Query: 123 VVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL 182
            V R  E+KTG I+A KF       EKE IR+EI IMN LHHPKL+   DAFE+   +V+
Sbjct: 738 QVFRLVEKKTGKIWAGKFFKAYSAKEKENIRQEISIMNCLHHPKLVQCVDAFEEKANIVM 797

Query: 183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENI 242
           + E +SGGELFERI   D++++E E I       M Q S  V+++H++ I+HLD+KPENI
Sbjct: 798 VLEIVSGGELFERIIDEDFELTERECI-----KYMKQISEGVEYIHKQGIVHLDLKPENI 852

Query: 243 MCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLA 302
           MC  +  T +K+IDFGLA +L+    +K+  GT EF APE++  EP+G+ TDMW++GV+ 
Sbjct: 853 MCVNKTGTRIKLIDFGLARRLENAGSLKVLFGTPEFVAPEVINYEPIGYATDMWSIGVIC 912

Query: 303 YVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
           Y+L+SGLSPF G+ND ETL NV +  W+FD+EAF  +S++ KDFI  LL ++
Sbjct: 913 YILVSGLSPFMGDNDNETLANVTSATWDFDDEAFDEISDDAKDFISNLLKKD 964

Calcium/calmodulin-dependent myosin light chain kinase implicated in smooth muscle contraction via phosphorylation of myosin light chains (MLC). Also regulates actin-myosin interaction through a non-kinase activty. Phosphorylates PTK2B/PYK2 and myosin light-chains. Involved in the inflammatory response (e.g. apoptosis, vascular permeability, leukocyte diapedesis), cell motility and morphology, airway hyperreactivity and other activities relevant to asthma. Required for tonic airway smooth muscle contraction that is necessary for physiological and asthmatic airway resistance. Necessary for gastrointestinal motility. Implicated in the regulation of endothelial as well as vascular permeability, probably via the regulation of cytoskeletal rearrangements. In the nervous system it has been shown to control the growth initiation of astrocytic processes in culture and to participate in transmitter release at synapses formed between cultured sympathetic ganglion cells. Critical participant in signaling sequences that result in fibroblast apoptosis. Plays a role in the regulation of epithelial cell survival. Required for epithelial wound healing, especially during actomyosin ring contraction during purse-string wound closure. Mediates RhoA-dependent membrane blebbing. Triggers TRPC5 channel activity in a calcium-dependent signaling, by inducing its subcellular localization at the plasma membrane. Promotes cell migration (including tumor cells) and tumor metastasis. PTK2B/PYK2 activation by phosphorylation mediates ITGB2 activation and is thus essential to trigger neutrophil transmigration during acute lung injury (ALI). May regulate optic nerve head astrocyte migration. Probably involved in mitotic cytoskeletal regulation. Regulates tight junction probably by modulating ZO-1 exchange in the perijunctional actomyosin ring. Mediates burn-induced microvascular barrier injury; triggers endothelial contraction in the development of microvascular hyperpermeability by phosphorylating MLC. Essential for intestinal barrier dysfunction. Mediates Giardia spp.-mediated reduced epithelial barrier function during giardiasis intestinal infection via reorganization of cytoskeletal F-actin and tight junctional ZO-1. Necessary for hypotonicity-induced Ca(2+) entry and subsequent activation of volume-sensitive organic osmolyte/anion channels (VSOAC) in cervical cancer cells.

Bos taurus (taxid: 9913)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 8

>sp|P11799|MYLK_CHICK Myosin light chain kinase, smooth muscle OS=Gallus gallus PE=1 SV=2

 Score =  281 bits (720), Expect = 4e-75,   Method: Compositional matrix adjust.
 Identities = 147/352 (41%), Positives = 213/352 (60%), Gaps = 25/352 (7%)

Query: 4    WIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT-KDTFKKQIKKRQ 62
            W  +   R T+  +  L    +Y+FRV A NVYG S+PS  S+++   +   ++  ++  
Sbjct: 1365 WTDLTTCRSTSFNVQDLQADREYKFRVRAANVYGISEPSQESEVVKVGEKQEEELKEEEA 1424

Query: 63   YDFDETGKKIRGKADEKVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAFG 122
               D+ GK       E   +Y     +   K            V D Y+I E +G+G FG
Sbjct: 1425 ELSDDEGK-------ETEVNYRTVTINTEQK------------VSDVYNIEERLGSGKFG 1465

Query: 123  VVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL 182
             V R  E+KTG ++A KF       EKE IR EI IMN LHHPKL+   DAFE+   +V+
Sbjct: 1466 QVFRLVEKKTGKVWAGKFFKAYSAKEKENIRDEISIMNCLHHPKLVQCVDAFEEKANIVM 1525

Query: 183  IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENI 242
            + E +SGGELFERI   D++++E E I       M Q S  V+++H++ I+HLD+KPENI
Sbjct: 1526 VLEMVSGGELFERIIDEDFELTERECIK-----YMRQISEGVEYIHKQGIVHLDLKPENI 1580

Query: 243  MCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLA 302
            MC  +  T++K+IDFGLA +L+    +K+  GT EF APE++  EP+G+ TDMW++GV+ 
Sbjct: 1581 MCVNKTGTSIKLIDFGLARRLESAGSLKVLFGTPEFVAPEVINYEPIGYETDMWSIGVIC 1640

Query: 303  YVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
            Y+L+SGLSPF G+ND ETL NV +  W+FD+EAF  +S++ KDFI  LL ++
Sbjct: 1641 YILVSGLSPFMGDNDNETLANVTSATWDFDDEAFDEISDDAKDFISNLLKKD 1692

Phosphorylates a specific serine in the N-terminus of a myosin light chain, which leads to the formation of calmodulin/MLCK signal transduction complexes which allow selective transduction of calcium signals.

Gallus gallus (taxid: 9031)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 8

>sp|Q86YV6|MYLK4_HUMAN Myosin light chain kinase family member 4 OS=Homo sapiens GN=MYLK4 PE=1 SV=2

 Score =  255 bits (651), Expect = 4e-67,   Method: Compositional matrix adjust.
 Identities = 124/267 (46%), Positives = 175/267 (65%), Gaps = 12/267 (4%)

Query: 96  PQPVD-----IKTSSVYDHYDI--LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE 148
           P P D      K  +V   Y +   E +G G FG VH+C E  TG   AAK I      +
Sbjct: 85  PAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD 144

Query: 149 KELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEV 208
           KE ++ EI +MNQL H  LI L+DAFE  +++VL+ E++ GGELF+RI    Y ++E + 
Sbjct: 145 KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDT 204

Query: 209 IPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEV 268
           I     + M Q    ++HMH+  I+HLD+KPENI+C  R++  +K+IDFGLA +  P E 
Sbjct: 205 I-----LFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK 259

Query: 269 VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACD 328
           +K++ GT EF APE+V  + V F TDMW+VGV+AY+LLSGLSPF G+ND ETL N+ AC 
Sbjct: 260 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACR 319

Query: 329 WEFDEEAFKNVSEEGKDFIRRLLLRNK 355
           W+ ++E F+++SEE K+FI +LL++ K
Sbjct: 320 WDLEDEEFQDISEEAKEFISKLLIKEK 346

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|E9PT87|MYLK3_RAT Myosin light chain kinase 3 OS=Rattus norvegicus GN=Mylk3 PE=1 SV=1

 Score =  251 bits (641), Expect = 6e-66,   Method: Compositional matrix adjust.
 Identities = 137/331 (41%), Positives = 192/331 (58%), Gaps = 24/331 (7%)

Query: 38  RSDPSTTSDLITTKDTFK------KQIKKRQYDFDETGKKIRGKADEKVSDYDQYVFDIY 91
           R +P  T+DL   +D         K    +     E G+++   A+  +   D       
Sbjct: 403 RDEPVGTTDLQQGRDPGAVSPEPGKDHAAQGPGRTEAGRRVSSAAEAAIVVLDD------ 456

Query: 92  SKYVPQP-----VDIKTSSVYDHYDIL--EEIGTGAFGVVHRCRERKTGNIFAAKFIPVS 144
           S   P P     V IK + +   Y +   E +G G FG VHRC ER TG   AAK I V 
Sbjct: 457 SAAPPAPFEHRVVSIKDTLISTSYTVSQHEVLGGGRFGQVHRCTERSTGLALAAKIIKVK 516

Query: 145 HNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMS 204
           +  ++E ++ EI+IMNQL H  LI L+DAFE  +   LI E++ GGELF+RIT   Y ++
Sbjct: 517 NIKDREDVKNEINIMNQLSHVNLIQLYDAFESKNSFTLIMEYVDGGELFDRITDEKYHLT 576

Query: 205 EAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD 264
           E +V+     +   Q    V ++H+  I+HLD+KPENI+C ++    +K+IDFGLA +  
Sbjct: 577 ELDVV-----LFTRQICEGVHYLHQHYILHLDLKPENILCVSQTGHQIKIIDFGLARRYK 631

Query: 265 PNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           P E +K++ GT EF APE+V  E V F TDMW+VGV+ Y+LLSGLSPF GE D ET+  +
Sbjct: 632 PREKLKVNFGTPEFLAPEVVNYEFVSFPTDMWSVGVITYMLLSGLSPFLGETDAETMNFI 691

Query: 325 KACDWEFDEEAFKNVSEEGKDFIRRLLLRNK 355
             C W+FD + FK +SEE KDF+ RLL++ K
Sbjct: 692 VNCSWDFDADTFKGLSEEAKDFVSRLLVKEK 722

Calmodulin-dependent kinase that phosphorylates MYL2 in vitro. Promotes sarcomere formation in cardiomyocytes. Increases cardiomyocyte contractility.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 8

>sp|Q3UIZ8|MYLK3_MOUSE Myosin light chain kinase 3 OS=Mus musculus GN=Mylk3 PE=1 SV=1

 Score =  248 bits (633), Expect = 6e-65,   Method: Compositional matrix adjust.
 Identities = 122/259 (47%), Positives = 168/259 (64%), Gaps = 7/259 (2%)

Query: 99  VDIKTSSVYDHYDIL--EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEI 156
           V IK + +   Y +   E +G G FG VHRC ER TG   AAK I V +  ++E ++ E+
Sbjct: 478 VSIKDTLISAGYTVSQHEVLGGGRFGQVHRCTERSTGLALAAKIIKVKNVKDREDVKNEV 537

Query: 157 DIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPIL 216
           +IMNQL H  LI L+DAFE      LI E++ GGELF+RIT   Y ++E +V+     + 
Sbjct: 538 NIMNQLSHVNLIQLYDAFESKSSFTLIMEYVDGGELFDRITDEKYHLTELDVV-----LF 592

Query: 217 MTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA 276
             Q    V ++H+  I+HLD+KPENI+C ++    +K+IDFGLA +  P E +K++ GT 
Sbjct: 593 TRQICEGVHYLHQHYILHLDLKPENILCVSQTGHQIKIIDFGLARRYKPREKLKVNFGTP 652

Query: 277 EFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAF 336
           EF APE+V  E V F TDMW+VGV+ Y+LLSGLSPF GE D ET+  +  C W+FD + F
Sbjct: 653 EFLAPEVVNYEFVSFPTDMWSVGVITYMLLSGLSPFLGETDAETMNFIVNCSWDFDADTF 712

Query: 337 KNVSEEGKDFIRRLLLRNK 355
           K +SEE KDF+ RLL++ K
Sbjct: 713 KGLSEEAKDFVSRLLVKEK 731

May play a role in smooth muscle contraction.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 8

>sp|A8C984|MYLK3_DANRE Myosin light chain kinase 3 OS=Danio rerio GN=mylk3 PE=2 SV=1

 Score =  247 bits (630), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 125/271 (46%), Positives = 170/271 (62%), Gaps = 12/271 (4%)

Query: 92  SKYVPQPVDIKTSSV-------YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS 144
           S  +P P D +  S        Y   + +E +G G FG VH+C E  +G   AAK I V 
Sbjct: 379 SPPLPAPFDHRIVSAKQVPINSYYAVNPVEVLGGGRFGQVHKCAELSSGLTLAAKIIKVR 438

Query: 145 HNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMS 204
              E++ ++ EI +MNQL+H  LI L+DAFE    + LI E++ GGELFERI    Y+++
Sbjct: 439 GMKERDEVKNEIGVMNQLNHVNLIQLYDAFESRTNLTLIMEYVEGGELFERIIDESYQLT 498

Query: 205 EAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD 264
           E + I     +   Q    V+++H++ I+HLD+KPENI+C       +K+IDFGLA K  
Sbjct: 499 ELDAI-----VFTRQICEGVQYLHQQYILHLDLKPENILCVNSTGNQIKIIDFGLARKYR 553

Query: 265 PNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           P E +K++ GT EF APE+V  + V F TDMW+VGV+ Y+LLSGLSPF G+ND ET+ N+
Sbjct: 554 PREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVITYMLLSGLSPFMGDNDAETMNNI 613

Query: 325 KACDWEFDEEAFKNVSEEGKDFIRRLLLRNK 355
               WEFD EAF+NVSEE KDFI  LL+  K
Sbjct: 614 LHAKWEFDTEAFENVSEEAKDFISSLLVSAK 644

Kinase that phosphorylates MYL2 in vitro (By similarity). Increases cardiomyocyte contractility (By similarity). Required for sarcomere formation in the developing heart.

Danio rerio (taxid: 7955)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 8

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	356
383852204	8627	PREDICTED: twitchin-like [Megachile rotu	0.985	0.040	0.839	1e-178
350413804	8700	PREDICTED: twitchin-like [Bombus impatie	0.985	0.040	0.837	1e-177
340710318	8715	PREDICTED: twitchin-like [Bombus terrest	0.985	0.040	0.837	1e-177
380026625	8679	PREDICTED: LOW QUALITY PROTEIN: twitchin	0.985	0.040	0.834	1e-177
328789682	8619	PREDICTED: LOW QUALITY PROTEIN: twitchin	0.985	0.040	0.834	1e-177
270014673	8877	hypothetical protein TcasGA2_TC004721 [T	0.985	0.039	0.834	1e-177
189233817	8838	PREDICTED: similar to CG32019-PA [Tribol	0.985	0.039	0.834	1e-177
307200525	5935	Titin [Harpegnathos saltator]	0.985	0.059	0.828	1e-175
328710146	8645	PREDICTED: twitchin-like [Acyrthosiphon	0.985	0.040	0.820	1e-175
242010244	8829	titin, putative [Pediculus humanus corpo	0.983	0.039	0.806	1e-168

>gi|383852204|ref|XP_003701618.1| PREDICTED: twitchin-like [Megachile rotundata]

 Score =  629 bits (1621), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 299/356 (83%), Positives = 323/356 (90%), Gaps = 5/356 (1%)

Query: 1    MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDTFKKQIKK 60
            M+SWIRVGNTRF TMA+TGLSPGHQY+FRV AEN+YGRSDPS  + LITTK T K++ KK
Sbjct: 7562 MTSWIRVGNTRFCTMAVTGLSPGHQYDFRVCAENIYGRSDPSEVTPLITTKGTVKREFKK 7621

Query: 61   RQYDFDETGKKIRGKADEKVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGA 120
            ++Y  DETGKKIRG++DEK  DYDQ+VFD+YSKYVPQPV+IK  SVYD YDILEEIGTGA
Sbjct: 7622 KEYPVDETGKKIRGRSDEKPRDYDQFVFDVYSKYVPQPVEIKHISVYDRYDILEEIGTGA 7681

Query: 121  FGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM 180
            FGVVHRCRER TGNIFAAKFIPVSH +EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM
Sbjct: 7682 FGVVHRCRERATGNIFAAKFIPVSHAMEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM 7741

Query: 181  VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPE 240
            VLIFEFLSGGELFERITA  Y MSEAEVI       M Q    VKHMHEKNIIHLD+KPE
Sbjct: 7742 VLIFEFLSGGELFERITAEGYTMSEAEVI-----NYMRQICEGVKHMHEKNIIHLDIKPE 7796

Query: 241  NIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGV 300
            NIMCQTRNSTNVK+IDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWA GV
Sbjct: 7797 NIMCQTRNSTNVKLIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWACGV 7856

Query: 301  LAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE 356
            LAYVLLSGLSPFAG+ND+ETLKNVKACDW+FDEEAF++VSEEGKDFIRRLL++NKE
Sbjct: 7857 LAYVLLSGLSPFAGDNDIETLKNVKACDWDFDEEAFRDVSEEGKDFIRRLLVKNKE 7912

Source: Megachile rotundata

Species: Megachile rotundata

Genus: Megachile

Family: Megachilidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|350413804|ref|XP_003490119.1| PREDICTED: twitchin-like [Bombus impatiens]

 Score =  628 bits (1620), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 298/356 (83%), Positives = 324/356 (91%), Gaps = 5/356 (1%)

Query: 1    MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDTFKKQIKK 60
            M+SWIRVGNTRF +MA+TGLSPGHQY+FR+ AEN+YGRSDPS  + LITTK T K++ K+
Sbjct: 7639 MTSWIRVGNTRFCSMAVTGLSPGHQYDFRICAENIYGRSDPSEVTPLITTKGTIKREFKQ 7698

Query: 61   RQYDFDETGKKIRGKADEKVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGA 120
            ++Y  DETGKKIRG++DEK  DYDQ+VFDIYSKYVPQPV+IK  SVYD YDILEEIGTGA
Sbjct: 7699 KEYKVDETGKKIRGRSDEKPRDYDQFVFDIYSKYVPQPVEIKHISVYDRYDILEEIGTGA 7758

Query: 121  FGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM 180
            FGVVHRCRER TGNIFAAKFIPVSH +EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM
Sbjct: 7759 FGVVHRCRERATGNIFAAKFIPVSHAMEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM 7818

Query: 181  VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPE 240
            VLIFEFLSGGELFERITA  Y MSEAEVI       M Q   AVKHMHEKNIIHLD+KPE
Sbjct: 7819 VLIFEFLSGGELFERITAEGYTMSEAEVI-----NYMRQICEAVKHMHEKNIIHLDIKPE 7873

Query: 241  NIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGV 300
            NIMCQTRNSTNVK+IDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWA GV
Sbjct: 7874 NIMCQTRNSTNVKLIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWACGV 7933

Query: 301  LAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE 356
            LAYVLLSGLSPFAG+ND+ETLKNVKACDW+FDEEAF++VSEEGKDFIRRLL++NKE
Sbjct: 7934 LAYVLLSGLSPFAGDNDIETLKNVKACDWDFDEEAFRDVSEEGKDFIRRLLVKNKE 7989

Source: Bombus impatiens

Species: Bombus impatiens

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|340710318|ref|XP_003393739.1| PREDICTED: twitchin-like [Bombus terrestris]

 Score =  628 bits (1619), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 298/356 (83%), Positives = 324/356 (91%), Gaps = 5/356 (1%)

Query: 1    MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDTFKKQIKK 60
            M+SWIRVGNTRF +MA+TGLSPGHQY+FR+ AEN+YGRSDPS  + LITTK T K++ K+
Sbjct: 7661 MTSWIRVGNTRFCSMAVTGLSPGHQYDFRICAENIYGRSDPSEVTPLITTKGTIKREYKQ 7720

Query: 61   RQYDFDETGKKIRGKADEKVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGA 120
            ++Y  DETGKKIRG++DEK  DYDQ+VFDIYSKYVPQPV+IK  SVYD YDILEEIGTGA
Sbjct: 7721 KEYKVDETGKKIRGRSDEKPRDYDQFVFDIYSKYVPQPVEIKHISVYDRYDILEEIGTGA 7780

Query: 121  FGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM 180
            FGVVHRCRER TGNIFAAKFIPVSH +EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM
Sbjct: 7781 FGVVHRCRERATGNIFAAKFIPVSHAMEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM 7840

Query: 181  VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPE 240
            VLIFEFLSGGELFERITA  Y MSEAEVI       M Q   AVKHMHEKNIIHLD+KPE
Sbjct: 7841 VLIFEFLSGGELFERITAEGYTMSEAEVI-----NYMRQICEAVKHMHEKNIIHLDIKPE 7895

Query: 241  NIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGV 300
            NIMCQTRNSTNVK+IDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWA GV
Sbjct: 7896 NIMCQTRNSTNVKLIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWACGV 7955

Query: 301  LAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE 356
            LAYVLLSGLSPFAG+ND+ETLKNVKACDW+FDEEAF++VSEEGKDFIRRLL++NKE
Sbjct: 7956 LAYVLLSGLSPFAGDNDIETLKNVKACDWDFDEEAFRDVSEEGKDFIRRLLVKNKE 8011

Source: Bombus terrestris

Species: Bombus terrestris

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|380026625|ref|XP_003697047.1| PREDICTED: LOW QUALITY PROTEIN: twitchin-like [Apis florea]

 Score =  627 bits (1618), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 297/356 (83%), Positives = 323/356 (90%), Gaps = 5/356 (1%)

Query: 1    MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDTFKKQIKK 60
            M+SWIRVGNTRF +MA+TGLSPGHQY+FRV AEN+YGRSDPS  + LITTK T K++ K+
Sbjct: 7619 MTSWIRVGNTRFCSMAVTGLSPGHQYDFRVCAENIYGRSDPSEVTPLITTKGTVKREFKQ 7678

Query: 61   RQYDFDETGKKIRGKADEKVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGA 120
            ++Y  DETGKKIRG++DEK  DYDQ+VFD+YSKYVPQPV+IK  SVYD YDILEEIGTGA
Sbjct: 7679 KEYKVDETGKKIRGRSDEKPRDYDQFVFDVYSKYVPQPVEIKHISVYDRYDILEEIGTGA 7738

Query: 121  FGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM 180
            FGVVHRCRER TGNIFAAKFIPVSH +EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM
Sbjct: 7739 FGVVHRCRERSTGNIFAAKFIPVSHAMEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM 7798

Query: 181  VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPE 240
            VLIFEFLSGGELFERITA  Y MSEAEVI       M Q    VKHMHEKNIIHLD+KPE
Sbjct: 7799 VLIFEFLSGGELFERITAEGYTMSEAEVI-----NYMRQICEGVKHMHEKNIIHLDIKPE 7853

Query: 241  NIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGV 300
            NIMCQTRNSTNVK+IDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWA GV
Sbjct: 7854 NIMCQTRNSTNVKLIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWACGV 7913

Query: 301  LAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE 356
            LAYVLLSGLSPFAG+ND+ETLKNVKACDW+FDEEAF++VSEEGKDFIRRLL++NKE
Sbjct: 7914 LAYVLLSGLSPFAGDNDIETLKNVKACDWDFDEEAFRDVSEEGKDFIRRLLIKNKE 7969

Source: Apis florea

Species: Apis florea

Genus: Apis

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|328789682|ref|XP_003251305.1| PREDICTED: LOW QUALITY PROTEIN: twitchin [Apis mellifera]

 Score =  627 bits (1616), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 297/356 (83%), Positives = 323/356 (90%), Gaps = 5/356 (1%)

Query: 1    MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDTFKKQIKK 60
            M+SWIRVGNTRF +MA+TGLSPGHQY+FRV AEN+YGRSDPS  + LITTK T K++ K+
Sbjct: 7557 MTSWIRVGNTRFCSMAVTGLSPGHQYDFRVCAENIYGRSDPSEVTPLITTKGTVKREFKQ 7616

Query: 61   RQYDFDETGKKIRGKADEKVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGA 120
            ++Y  DETGKKIRG++DEK  DYDQ+VFD+YSKYVPQPV+IK  SVYD YDILEEIGTGA
Sbjct: 7617 KEYKVDETGKKIRGRSDEKPRDYDQFVFDVYSKYVPQPVEIKHISVYDRYDILEEIGTGA 7676

Query: 121  FGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM 180
            FGVVHRCRER TGNIFAAKFIPVSH +EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM
Sbjct: 7677 FGVVHRCRERSTGNIFAAKFIPVSHAMEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM 7736

Query: 181  VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPE 240
            VLIFEFLSGGELFERITA  Y MSEAEVI       M Q    VKHMHEKNIIHLD+KPE
Sbjct: 7737 VLIFEFLSGGELFERITAEGYTMSEAEVI-----NYMRQICEGVKHMHEKNIIHLDIKPE 7791

Query: 241  NIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGV 300
            NIMCQTRNSTNVK+IDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWA GV
Sbjct: 7792 NIMCQTRNSTNVKLIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWACGV 7851

Query: 301  LAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE 356
            LAYVLLSGLSPFAG+ND+ETLKNVKACDW+FDEEAF++VSEEGKDFIRRLL++NKE
Sbjct: 7852 LAYVLLSGLSPFAGDNDIETLKNVKACDWDFDEEAFRDVSEEGKDFIRRLLIKNKE 7907

Source: Apis mellifera

Species: Apis mellifera

Genus: Apis

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|270014673|gb|EFA11121.1| hypothetical protein TcasGA2_TC004721 [Tribolium castaneum]

 Score =  626 bits (1614), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 297/356 (83%), Positives = 321/356 (90%), Gaps = 5/356 (1%)

Query: 1    MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDTFKKQIKK 60
            +S+WIRVGNTR TTMA++GL+PGHQYEFR+YAEN+YGRSD S  S LITTKD  KK ++K
Sbjct: 7824 LSTWIRVGNTRMTTMAVSGLTPGHQYEFRIYAENIYGRSDASEVSTLITTKDAGKKAVQK 7883

Query: 61   RQYDFDETGKKIRGKADEKVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGA 120
            ++Y+ DE GKKIR    E V DYDQYVFDIYSKYVPQPV+IKT SVYD YDILEEIGTGA
Sbjct: 7884 KKYEVDENGKKIRESHKEPVKDYDQYVFDIYSKYVPQPVEIKTRSVYDDYDILEEIGTGA 7943

Query: 121  FGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM 180
            FGVVHRCRERKTGNIFAAKFIPVSH +EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM
Sbjct: 7944 FGVVHRCRERKTGNIFAAKFIPVSHAMEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM 8003

Query: 181  VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPE 240
            VLI+EFLSGGELFERITA  Y+MSEAEVI       M Q   A+KHMHE+NIIHLD+KPE
Sbjct: 8004 VLIYEFLSGGELFERITAEGYQMSEAEVI-----NYMRQICEAIKHMHERNIIHLDIKPE 8058

Query: 241  NIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGV 300
            NIMCQTR  TN+K+IDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGV
Sbjct: 8059 NIMCQTRKGTNIKLIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGV 8118

Query: 301  LAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE 356
            LAYVLLSGLSPFAGEND+ETLKNVKACDW+FDEEAF NVSEEGKDFIRRLLL+NKE
Sbjct: 8119 LAYVLLSGLSPFAGENDIETLKNVKACDWDFDEEAFANVSEEGKDFIRRLLLKNKE 8174

Source: Tribolium castaneum

Species: Tribolium castaneum

Genus: Tribolium

Family: Tenebrionidae

Order: Coleoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|189233817|ref|XP_971502.2| PREDICTED: similar to CG32019-PA [Tribolium castaneum]

 Score =  625 bits (1613), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 297/356 (83%), Positives = 321/356 (90%), Gaps = 5/356 (1%)

Query: 1    MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDTFKKQIKK 60
            +S+WIRVGNTR TTMA++GL+PGHQYEFR+YAEN+YGRSD S  S LITTKD  KK ++K
Sbjct: 7785 LSTWIRVGNTRMTTMAVSGLTPGHQYEFRIYAENIYGRSDASEVSTLITTKDAGKKAVQK 7844

Query: 61   RQYDFDETGKKIRGKADEKVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGA 120
            ++Y+ DE GKKIR    E V DYDQYVFDIYSKYVPQPV+IKT SVYD YDILEEIGTGA
Sbjct: 7845 KKYEVDENGKKIRESHKEPVKDYDQYVFDIYSKYVPQPVEIKTRSVYDDYDILEEIGTGA 7904

Query: 121  FGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM 180
            FGVVHRCRERKTGNIFAAKFIPVSH +EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM
Sbjct: 7905 FGVVHRCRERKTGNIFAAKFIPVSHAMEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM 7964

Query: 181  VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPE 240
            VLI+EFLSGGELFERITA  Y+MSEAEVI       M Q   A+KHMHE+NIIHLD+KPE
Sbjct: 7965 VLIYEFLSGGELFERITAEGYQMSEAEVI-----NYMRQICEAIKHMHERNIIHLDIKPE 8019

Query: 241  NIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGV 300
            NIMCQTR  TN+K+IDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGV
Sbjct: 8020 NIMCQTRKGTNIKLIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGV 8079

Query: 301  LAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE 356
            LAYVLLSGLSPFAGEND+ETLKNVKACDW+FDEEAF NVSEEGKDFIRRLLL+NKE
Sbjct: 8080 LAYVLLSGLSPFAGENDIETLKNVKACDWDFDEEAFANVSEEGKDFIRRLLLKNKE 8135

Source: Tribolium castaneum

Species: Tribolium castaneum

Genus: Tribolium

Family: Tenebrionidae

Order: Coleoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|307200525|gb|EFN80687.1| Titin [Harpegnathos saltator]

 Score =  621 bits (1601), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 295/356 (82%), Positives = 322/356 (90%), Gaps = 5/356 (1%)

Query: 1    MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDTFKKQIKK 60
            MS+WIR G+TRF T+A+TGLSPGHQY+FRV AENVYGRSDPS  + LITTK   K++ KK
Sbjct: 4868 MSTWIRAGHTRFCTLAVTGLSPGHQYDFRVCAENVYGRSDPSEVTPLITTKGIIKREFKK 4927

Query: 61   RQYDFDETGKKIRGKADEKVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGA 120
            ++Y+ D TGKKIRG++DEK  DYDQ+VFD+YSKYVPQPV+IK +SVYD YDILEEIGTGA
Sbjct: 4928 KEYEVDATGKKIRGRSDEKPRDYDQFVFDVYSKYVPQPVEIKHTSVYDKYDILEEIGTGA 4987

Query: 121  FGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM 180
            FGVVHRCRER TGNIFAAKFIPVSH +EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM
Sbjct: 4988 FGVVHRCRERTTGNIFAAKFIPVSHVMEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM 5047

Query: 181  VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPE 240
            VLIFEFLSGGELFERITA  Y MSEAEVI       M Q    VKHMHEKNIIHLD+KPE
Sbjct: 5048 VLIFEFLSGGELFERITAEGYTMSEAEVI-----NYMRQICEGVKHMHEKNIIHLDIKPE 5102

Query: 241  NIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGV 300
            NIMCQTRNSTNVK+IDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWA GV
Sbjct: 5103 NIMCQTRNSTNVKLIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWACGV 5162

Query: 301  LAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE 356
            LAYVLLSGLSPFAG+ND+ETLKNVKACDW+FDEEAF++VSEEGKDFIRRLL++NKE
Sbjct: 5163 LAYVLLSGLSPFAGDNDIETLKNVKACDWDFDEEAFRDVSEEGKDFIRRLLVKNKE 5218

Source: Harpegnathos saltator

Species: Harpegnathos saltator

Genus: Harpegnathos

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|328710146|ref|XP_003244179.1| PREDICTED: twitchin-like [Acyrthosiphon pisum]

 Score =  619 bits (1596), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 292/356 (82%), Positives = 321/356 (90%), Gaps = 5/356 (1%)

Query: 1    MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDTFKKQIKK 60
            MSSWIRVGNTRFT+ A+TGLSPGH+YEFRVYAENVYGRS PS  S ++ TK+  KK  K 
Sbjct: 7588 MSSWIRVGNTRFTSTAVTGLSPGHEYEFRVYAENVYGRSKPSEVSPVVKTKELLKKPPKT 7647

Query: 61   RQYDFDETGKKIRGKADEKVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGA 120
            ++Y+ DETGKKIRGKAD  + DYD YVFDIYSKY+PQPVDIKT SVYD+YDILEEIGTGA
Sbjct: 7648 KRYEVDETGKKIRGKADGNIKDYDHYVFDIYSKYIPQPVDIKTQSVYDYYDILEEIGTGA 7707

Query: 121  FGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM 180
            FGVVHRCRERKTGNIFAAKFIPV+HN+EKELI+KEIDIMNQLHHPKLINLHDAFED+DEM
Sbjct: 7708 FGVVHRCRERKTGNIFAAKFIPVAHNVEKELIKKEIDIMNQLHHPKLINLHDAFEDEDEM 7767

Query: 181  VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPE 240
            VLIFEFLSGGELFERIT+  Y MSEAEVI       M Q   A+KHMHE+NIIHLD+KPE
Sbjct: 7768 VLIFEFLSGGELFERITSEGYSMSEAEVI-----NYMRQICEAIKHMHERNIIHLDIKPE 7822

Query: 241  NIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGV 300
            NIMCQT+ S+NVK+IDFGLATKLDPNE+VKISTGTAEFAAPEIVEREPVGFYTDMWAVGV
Sbjct: 7823 NIMCQTKKSSNVKLIDFGLATKLDPNEIVKISTGTAEFAAPEIVEREPVGFYTDMWAVGV 7882

Query: 301  LAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE 356
            LAYVLLSGLSPFAGENDVETLKNVKACDW+FDE+ F  VS+EGKDFIRRLL++NKE
Sbjct: 7883 LAYVLLSGLSPFAGENDVETLKNVKACDWDFDEDTFNIVSDEGKDFIRRLLIKNKE 7938

Source: Acyrthosiphon pisum

Species: Acyrthosiphon pisum

Genus: Acyrthosiphon

Family: Aphididae

Order: Hemiptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|242010244|ref|XP_002425880.1| titin, putative [Pediculus humanus corporis] gi|212509846|gb|EEB13142.1| titin, putative [Pediculus humanus corporis]

 Score =  597 bits (1539), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 287/356 (80%), Positives = 325/356 (91%), Gaps = 6/356 (1%)

Query: 1    MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDTFKKQIKK 60
            +SSWIRVG+TRF TMA+TGL+P H+YEFRVYAEN+YG+SDP+ +S ++ TK T KK++K+
Sbjct: 7772 LSSWIRVGSTRFNTMAVTGLAPNHEYEFRVYAENIYGKSDPAVSS-VVKTKGTIKKKMKE 7830

Query: 61   RQYDFDETGKKIRGKADEKVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGA 120
            ++Y+ DETGKKIRGK D  + +YDQYVFDIYSKYVPQPVDIKT +VYD+YDILEEIGTGA
Sbjct: 7831 KKYEVDETGKKIRGKFDGPIKNYDQYVFDIYSKYVPQPVDIKTDNVYDYYDILEEIGTGA 7890

Query: 121  FGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM 180
            FGVVHRCRE+KTG+IFAAKFIP+SH +EKELIRKEIDIMN LHH KLINLHDAFEDDDEM
Sbjct: 7891 FGVVHRCREKKTGSIFAAKFIPISHVMEKELIRKEIDIMNHLHHNKLINLHDAFEDDDEM 7950

Query: 181  VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPE 240
            VLIFEFLSGGELFERITA  Y+M+EAEVI       M Q   A+KHMHEKNIIHLD+KPE
Sbjct: 7951 VLIFEFLSGGELFERITAEGYQMTEAEVI-----HYMRQICEAMKHMHEKNIIHLDIKPE 8005

Query: 241  NIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGV 300
            NIMCQTRNSTN+K+IDFGLATKL+PN+VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGV
Sbjct: 8006 NIMCQTRNSTNIKLIDFGLATKLEPNDVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGV 8065

Query: 301  LAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE 356
            LAYVLLSGLSPFAGENDVETLKNVKACDWEFDE+AF  VSEEGKDFIRRLL++++E
Sbjct: 8066 LAYVLLSGLSPFAGENDVETLKNVKACDWEFDEDAFAGVSEEGKDFIRRLLIKSQE 8121

Source: Pediculus humanus corporis

Species: Pediculus humanus

Genus: Pediculus

Family: Pediculidae

Order: Phthiraptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	356
FB|FBgn0005666	8933	bt "bent" [Drosophila melanoga	0.985	0.039	0.761	2.7e-146
WB|WBGene00006759	7158	unc-22 [Caenorhabditis elegans	0.957	0.047	0.575	3.3e-104
WB|WBGene00006436	18	ttn-1 [Caenorhabditis elegans	0.955	18.88	0.449	3.3e-73
UNIPROTKB|Q28824	1176	MYLK "Myosin light chain kinas	0.764	0.231	0.475	4.1e-73
ZFIN|ZDB-GENE-030131-8207	899	mylka "myosin, light chain kin	0.733	0.290	0.472	9.7e-72
ZFIN|ZDB-GENE-041111-150	966	mylkb "myosin light chain kina	0.780	0.287	0.452	1e-66
ZFIN|ZDB-GENE-050309-74	856	im:7148400 "im:7148400" [Danio	0.719	0.299	0.462	1.1e-66
UNIPROTKB|B4DUE3	714	MYLK "cDNA FLJ53659, highly si	0.800	0.399	0.459	9.4e-66
UNIPROTKB|F1PIF6	1960	MYLK "Uncharacterized protein"	0.803	0.145	0.464	2e-65
RGD|1310915	1942	Mylk "myosin light chain kinas	0.896	0.164	0.424	3.2e-65

FB|FBgn0005666 bt "bent" [Drosophila melanogaster (taxid:7227)]

 Score = 1451 (515.8 bits), Expect = 2.7e-146, P = 2.7e-146
 Identities = 271/356 (76%), Positives = 314/356 (88%)

Query:     1 MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDTFKKQIKK 60
             +SSWIRVGNTRFT+MA++GL+PG +Y+FR++A+NVYGRSD S TS LI TK++ KK+  +
Sbjct:  7880 LSSWIRVGNTRFTSMAVSGLTPGKEYDFRIFADNVYGRSDASDTSTLIKTKESVKKKPIE 7939

Query:    61 RQYDFDETGKKIRGKADEKVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGA 120
             R+++ D  G+K+RGKAD  V DYD YVFDIYSK+VPQPV+I   SVYD YDILEEIGTGA
Sbjct:  7940 RKWEIDANGRKLRGKADGPVKDYDSYVFDIYSKFVPQPVEISQQSVYDRYDILEEIGTGA 7999

Query:   121 FGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM 180
             FGVVHRCRER TGNIFAAKFIPVSH++EK+LIR+EIDIMNQLHH KLINLHDAFEDDDEM
Sbjct:  8000 FGVVHRCRERSTGNIFAAKFIPVSHSVEKDLIRREIDIMNQLHHQKLINLHDAFEDDDEM 8059

Query:   181 VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPE 240
             +LI EFLSGGELFERITA  Y M+EAEVI       M Q    ++HMHE+NIIHLD+KPE
Sbjct:  8060 ILILEFLSGGELFERITAEGYVMTEAEVINY-----MRQICEGIRHMHEQNIIHLDIKPE 8114

Query:   241 NIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGV 300
             NIMCQTR+STNVK+IDFGLAT+LDPNEVVKI+TGTAEFAAPEIV REPVGFYTDMWA GV
Sbjct:  8115 NIMCQTRSSTNVKLIDFGLATRLDPNEVVKITTGTAEFAAPEIVNREPVGFYTDMWATGV 8174

Query:   301 LAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE 356
             L+YVLLSGLSPFAG+NDV+TLKNVKACDW+FD E+FK +SEE KDFIR+LL+RNKE
Sbjct:  8175 LSYVLLSGLSPFAGDNDVQTLKNVKACDWDFDVESFKYISEEAKDFIRKLLVRNKE 8230

GO:0005737 "cytoplasm" evidence=ISS

GO:0004687 "myosin light chain kinase activity" evidence=NAS

GO:0005200 "structural constituent of cytoskeleton" evidence=ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;NAS

GO:0006468 "protein phosphorylation" evidence=IEA;NAS

GO:0007498 "mesoderm development" evidence=IEP

GO:0005524 "ATP binding" evidence=IEA

GO:0008307 "structural constituent of muscle" evidence=IDA

GO:0030018 "Z disc" evidence=IDA

GO:0045214 "sarcomere organization" evidence=IMP

WB|WBGene00006759 unc-22 [Caenorhabditis elegans (taxid:6239)]

 Score = 1053 (375.7 bits), Expect = 3.3e-104, P = 3.3e-104
 Identities = 202/351 (57%), Positives = 251/351 (71%)

Query:     3 SWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDP-STTSDLITTKDTFKKQIKKR 61
             SW     +R+T   I GL  G QYEFR+ AEN +G+S P   T+ ++   D  K+   +R
Sbjct:  6157 SWSPCAKSRYTYTTIEGLRAGKQYEFRIIAENKHGQSKPCEPTAPVLIPGDERKR---RR 6213

Query:    62 QYDFDETGKKIRGKADEKVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAF 121
              YD DE GK +RGK     S+YD YVFDI+ +Y PQPV+IK   V DHYDI EE+GTGAF
Sbjct:  6214 GYDVDEQGKIVRGKGTVS-SNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAF 6272

Query:   122 GVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMV 181
             GVVHR  ER TGN FAAKF+   H  +KE +RKEI  M+ L HP L+NLHDAFEDD+EMV
Sbjct:  6273 GVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 6332

Query:   182 LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPEN 241
             +I+EF+SGGELFE++     KMSE E +       M Q    + HMHE N +HLD+KPEN
Sbjct:  6333 MIYEFMSGGELFEKVADEHNKMSEDEAVEY-----MRQVCKGLCHMHENNYVHLDLKPEN 6387

Query:   242 IMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVL 301
             IM  T+ S  +K+IDFGL   LDP + VK++TGTAEFAAPE+ E +PVG+YTDMW+VGVL
Sbjct:  6388 IMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVL 6447

Query:   302 AYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLL 352
             +Y+LLSGLSPF GEND ETL+NVK+CDW  D+ AF  +SE+GKDFIR+LLL
Sbjct:  6448 SYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLL 6498

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0004812 "aminoacyl-tRNA ligase activity" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0006418 "tRNA aminoacylation for protein translation" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0003824 "catalytic activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0040011 "locomotion" evidence=IMP

GO:0000003 "reproduction" evidence=IMP

GO:0040027 "negative regulation of vulval development" evidence=IMP

GO:0040018 "positive regulation of multicellular organism growth" evidence=IMP

GO:0040015 "negative regulation of multicellular organism growth" evidence=IMP

GO:0030163 "protein catabolic process" evidence=IMP

GO:0031672 "A band" evidence=IDA

WB|WBGene00006436 ttn-1 [Caenorhabditis elegans (taxid:6239)]

 Score = 765 (274.4 bits), Expect = 3.3e-73, P = 3.3e-73
 Identities = 159/354 (44%), Positives = 228/354 (64%)

Query:     3 SWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDTFKKQIKKRQ 62
             +W +   T+   + +  L PG  Y FRV A+N +G+S+PS  S+L+  K+  +   + ++
Sbjct: 15834 TWTKAEVTKQAFITLFNLVPGESYRFRVRADNTFGQSEPSDESELVVVKNVSRVVEEPKK 15893

Query:    63 YDFDETGKKIRGKADEKVSDYDQYVFDIY-SKYVPQPVDIKTSSVYDHYDILEEIGTGAF 121
                    K+++ K  E V DY++   D   S+Y    +    + +   Y I EE+G GA+
Sbjct: 15894 -------KEVKVKEQESV-DYERVAKDSEPSEYKTIDIHRLPNDLQAKYIIHEELGKGAY 15945

Query:   122 GVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMV 181
             G V+R  E+ TG  +AAK + V   ++KE +  EI +MNQLHH KL+NLH+AF+  +EM 
Sbjct: 15946 GTVYRATEKATGKTWAAKMVQVRPGVKKENVIHEISMMNQLHHEKLLNLHEAFDMGNEMW 16005

Query:   182 LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPEN 241
             LI EF+SGGELFE+I   D  MSE EV      IL+      V HMH+  I+HLD+KPEN
Sbjct: 16006 LIEEFVSGGELFEKILEDDSLMSEEEVRDYMHQILL-----GVSHMHKNQIVHLDLKPEN 16060

Query:   242 IMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVL 301
             I+ + +NS  +K+IDFGLA KLDP + VK+  GT EF APE+V  +PVG  TDMW VGV+
Sbjct: 16061 ILLKAKNSNELKIIDFGLARKLDPKKSVKLLFGTPEFCAPEVVNYQPVGLSTDMWTVGVI 16120

Query:   302 AYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNK 355
             +YVLLSGLSPF G++D +TL NV A DW+FD+ ++ +VS+  KDFI RL++++K
Sbjct: 16121 SYVLLSGLSPFLGDSDEDTLANVSASDWDFDDPSWDDVSDLAKDFICRLMIKDK 16174

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0009792 "embryo development ending in birth or egg hatching" evidence=IMP

GO:0031674 "I band" evidence=IDA

GO:0031672 "A band" evidence=IDA

UNIPROTKB|Q28824 MYLK "Myosin light chain kinase, smooth muscle" [Bos taurus (taxid:9913)]

 Score = 673 (242.0 bits), Expect = 4.1e-73, Sum P(2) = 4.1e-73
 Identities = 133/280 (47%), Positives = 187/280 (66%)

Query:    75 KADEKVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGN 134
             K + +VSD D+   ++  + V    + K S   D YDI E +G+G FG V R  E+KTG 
Sbjct:   693 KDEVEVSDDDEKEPEVDYRTVTVNTEQKVS---DFYDIEERLGSGKFGQVFRLVEKKTGK 749

Query:   135 IFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFE 194
             I+A KF       EKE IR+EI IMN LHHPKL+   DAFE+   +V++ E +SGGELFE
Sbjct:   750 IWAGKFFKAYSAKEKENIRQEISIMNCLHHPKLVQCVDAFEEKANIVMVLEIVSGGELFE 809

Query:   195 RITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKM 254
             RI   D++++E E I       M Q S  V+++H++ I+HLD+KPENIMC  +  T +K+
Sbjct:   810 RIIDEDFELTERECIKY-----MKQISEGVEYIHKQGIVHLDLKPENIMCVNKTGTRIKL 864

Query:   255 IDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAG 314
             IDFGLA +L+    +K+  GT EF APE++  EP+G+ TDMW++GV+ Y+L+SGLSPF G
Sbjct:   865 IDFGLARRLENAGSLKVLFGTPEFVAPEVINYEPIGYATDMWSIGVICYILVSGLSPFMG 924

Query:   315 ENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
             +ND ETL NV +  W+FD+EAF  +S++ KDFI  LL ++
Sbjct:   925 DNDNETLANVTSATWDFDDEAFDEISDDAKDFISNLLKKD 964

GO:0032154 "cleavage furrow" evidence=IEA

GO:0030027 "lamellipodium" evidence=IEA

GO:0005856 "cytoskeleton" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0004687 "myosin light chain kinase activity" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005516 "calmodulin binding" evidence=IEA

GO:0003779 "actin binding" evidence=IEA

ZFIN|ZDB-GENE-030131-8207 mylka "myosin, light chain kinase a" [Danio rerio (taxid:7955)]

 Score = 649 (233.5 bits), Expect = 9.7e-72, Sum P(2) = 9.7e-72
 Identities = 127/269 (47%), Positives = 179/269 (66%)

Query:    89 DIYSKYVP--QPVDIKTS-SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH 145
             D  S+ VP  + V IKT   V D YD+ + +GTG FG V +  E+ T  ++A KFI    
Sbjct:   445 DDESEKVPDYRNVTIKTDVKVKDFYDVEDRLGTGKFGTVFKLIEKSTKKVWAGKFIKAYS 504

Query:   146 NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSE 205
               EKE +R+EI IMN LHHPKL+   DAFE   ++V++ E +SGGELF+RI   D++++E
Sbjct:   505 AKEKENVRQEIAIMNDLHHPKLVQCIDAFEGKTDIVMVLEMISGGELFDRIIDEDFELTE 564

Query:   206 AEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP 265
              EVI   L I+       V  +H+K I+HLD+KPENIMC  +  + +K+IDFGLA +L+ 
Sbjct:   565 REVIKYMLQIV-----DGVNFIHKKGIVHLDLKPENIMCVNKTGSKIKLIDFGLARRLEN 619

Query:   266 NEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVK 325
                +K+  GT EF APE++  E + + TDMW++GV+ Y+L+SGLSPF G+ND ETL NV 
Sbjct:   620 AGSLKVLFGTPEFVAPEVINYEAISYATDMWSIGVICYILVSGLSPFMGDNDNETLSNVT 679

Query:   326 ACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
             +  W+F++EAF  +SEE KDFI  LL ++
Sbjct:   680 SATWDFEDEAFDEISEEAKDFISNLLKKD 708

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0007596 "blood coagulation" evidence=IMP

ZFIN|ZDB-GENE-041111-150 mylkb "myosin light chain kinase b" [Danio rerio (taxid:7955)]

 Score = 656 (236.0 bits), Expect = 1.0e-66, Sum P(2) = 1.0e-66
 Identities = 130/287 (45%), Positives = 186/287 (64%)

Query:    68 TGKKIRGKADEKVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRC 127
             T KK   +    VSD D+     Y   V +    K  SV D YDI + +GTG FG V + 
Sbjct:   489 TEKKEEEEVGAAVSDDDEEKEPEYRDVVIK----KDCSVKDFYDIEDRLGTGKFGQVFKL 544

Query:   128 RERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFL 187
              E+ +  ++A KFI      EKE +R+EI IMN LHHPKL+   DAFE   +MV++ E +
Sbjct:   545 VEKSSKKVWAGKFIKAFSQKEKENVRQEIGIMNSLHHPKLVQCMDAFEGKSDMVMVMEMI 604

Query:   188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTR 247
             SGGELFERI   D++++E EVI   L I+       V+ +H++ I+HLD+KPENIMC  +
Sbjct:   605 SGGELFERIVDEDFELTEREVIKYMLQII-----DGVQFIHKQGIVHLDLKPENIMCINK 659

Query:   248 NSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS 307
               + +K+IDFGLA +L+ +  +K+  GT EF APE++  E + + TDMW++GV+ Y+L+S
Sbjct:   660 TGSKIKLIDFGLARRLEDSGSLKVLFGTPEFVAPEVINYEAISYPTDMWSIGVICYILVS 719

Query:   308 GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
             GLSPF G+ND ETL NV +  W+F++EAF  +S++ KDFI RLL ++
Sbjct:   720 GLSPFMGDNDNETLANVTSATWDFEDEAFDEISDQAKDFISRLLKKD 766

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0016740 "transferase activity" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

ZFIN|ZDB-GENE-050309-74 im:7148400 "im:7148400" [Danio rerio (taxid:7955)]

 Score = 623 (224.4 bits), Expect = 1.1e-66, Sum P(2) = 1.1e-66
 Identities = 122/264 (46%), Positives = 172/264 (65%)

Query:    93 KYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELI 152
             +YV   +D +   + DHY++LE++G G FG V R   + TG   A KF       ++E  
Sbjct:   418 EYVNVTIDTQ-HKLTDHYNVLEKLGVGKFGQVFRMTHKVTGRECAGKFYKSRRAKDREAA 476

Query:   153 RKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVT 212
             RKEI++MN LHHPKL+    A+++  EMV++ E+++GGELFERI    ++ +E   +   
Sbjct:   477 RKEIELMNFLHHPKLVQCLAAYDNKAEMVMVMEYVAGGELFERIVDDSFEHTEVSSVGY- 535

Query:   213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS 272
                 M Q    +K+MH++NI+HLD+KPENI+C  R  + +K+IDFGLA KLDPN  +K+ 
Sbjct:   536 ----MRQILEGIKYMHQQNILHLDLKPENIVCVDRTGSQIKIIDFGLACKLDPNTPLKVM 591

Query:   273 TGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD 332
              GT EF APE++  E V   TDMW+VGV+ Y+LLSG SPF GE+D ETL  V A  WEFD
Sbjct:   592 QGTPEFVAPEVINFEAVTLTTDMWSVGVICYILLSGESPFQGESDTETLALVTAAQWEFD 651

Query:   333 EEAFKNVSEEGKDFIRRLLLRNKE 356
             EE+F+ +++  K FI  LL  NK+
Sbjct:   652 EESFEEITDMAKGFISSLL--NKD 673

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

UNIPROTKB|B4DUE3 MYLK "cDNA FLJ53659, highly similar to Myosin light chain kinase, smooth muscle (EC2.7.11.18)" [Homo sapiens (taxid:9606)]

 Score = 669 (240.6 bits), Expect = 9.4e-66, P = 9.4e-66
 Identities = 136/296 (45%), Positives = 193/296 (65%)

Query:    61 RQYDFDETGKKIRGKADE-KVSDYDQYVFDIYSKYVPQPVDIKTSS-VYDHYDILEEIGT 118
             ++ +    G+K     DE +VSD D+   ++   Y  + V I T   V D YDI E +G+
Sbjct:   217 QESELTTVGEKPEEPKDEVEVSDDDEKEPEV--DY--RTVTINTEQKVSDFYDIEERLGS 272

Query:   119 GAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDD 178
             G FG V R  E+KT  ++A KF       EKE IR+EI IMN LHHPKL+   DAFE+  
Sbjct:   273 GKFGQVFRLVEKKTRKVWAGKFFKAYSAKEKENIRQEISIMNCLHHPKLVQCVDAFEEKA 332

Query:   179 EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVK 238
              +V++ E +SGGELFERI   D++++E E I       M Q S  V+++H++ I+HLD+K
Sbjct:   333 NIVMVLEIVSGGELFERIIDEDFELTERECIKY-----MRQISEGVEYIHKQGIVHLDLK 387

Query:   239 PENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAV 298
             PENIMC  +  T +K+IDFGLA +L+    +K+  GT EF APE++  EP+G+ TDMW++
Sbjct:   388 PENIMCVNKTGTRIKLIDFGLARRLENAGSLKVLFGTPEFVAPEVINYEPIGYATDMWSI 447

Query:   299 GVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
             GV+ Y+L+SGLSPF G+ND ETL NV +  W+FD+EAF  +S++ KDFI  LL ++
Sbjct:   448 GVICYILVSGLSPFMGDNDNETLANVTSATWDFDDEAFDEISDDAKDFISNLLKKD 503

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|F1PIF6 MYLK "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 680 (244.4 bits), Expect = 2.0e-65, P = 2.0e-65
 Identities = 137/295 (46%), Positives = 192/295 (65%)

Query:    61 RQYDFDETGKKIRGKADE-KVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTG 119
             ++ +    G+K     DE +VSD D+   ++  + V    + K S   D YDI E +G+G
Sbjct:  1461 QESELTAVGEKPEEPKDEVEVSDDDEKEPEVDYRTVTVNTEQKVS---DFYDIEERLGSG 1517

Query:   120 AFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDE 179
              FG V R  E+KTG I+A KF       EKE IR+EI IMN LHHPKL+   DAFE+   
Sbjct:  1518 KFGQVFRLVEKKTGKIWAGKFFKAYSAKEKENIRQEISIMNCLHHPKLVQCVDAFEEKAN 1577

Query:   180 MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKP 239
             +V++ E +SGGELFERI   D++++E E I       M Q S  V+++H + I+HLD+KP
Sbjct:  1578 IVMVLEIVSGGELFERIIDEDFELTERECIQY-----MRQISAGVEYIHRQGIVHLDLKP 1632

Query:   240 ENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVG 299
             ENIMC  +  T +K+IDFGLA KL+    +K+  GT EF APE++  EP+G+ TDMW++G
Sbjct:  1633 ENIMCVNKTGTRIKLIDFGLARKLENAGSLKVLFGTPEFVAPEVINYEPIGYATDMWSIG 1692

Query:   300 VLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
             V+ Y+L+SGLSPF G+ND ETL NV +  W+FD+EAF  +S++ KDFI  LL ++
Sbjct:  1693 VICYILVSGLSPFMGDNDNETLANVTSATWDFDDEAFDEISDDAKDFISNLLKKD 1747

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

RGD|1310915 Mylk "myosin light chain kinase" [Rattus norvegicus (taxid:10116)]

 Score = 678 (243.7 bits), Expect = 3.2e-65, P = 3.2e-65
 Identities = 144/339 (42%), Positives = 210/339 (61%)

Query:    27 EFRVYAENVYGRSDPSTTSDLITTKDTFKKQIK----------KRQYDFDETGKKIRGKA 76
             E +V+ E    RS      DL+  ++ +K +++           ++ +    G+K     
Sbjct:  1398 EDKVWTELATCRSTSFNVQDLLPDRE-YKFRVRAVNVYGTSEPSQESELTAVGEKPEEPK 1456

Query:    77 DE-KVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNI 135
             DE +VSD D+   ++  + V    + K S VYD   I E +G+G FG V R  E++TG I
Sbjct:  1457 DEVEVSDDDEKEPEVDYRTVTVNTEQKVSDVYD---IEERLGSGKFGQVFRLVEKRTGKI 1513

Query:   136 FAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFER 195
             +A KF       EKE IR+EI IMN LHHPKL+   DAFE+   +V++ E +SGGELFER
Sbjct:  1514 WAGKFFKAYSAKEKENIRQEISIMNCLHHPKLVQCVDAFEEKANIVMVLEIVSGGELFER 1573

Query:   196 ITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMI 255
             I   D++++E E I       M Q S  V+++H++ I+HLD+KPENIMC  +  T +K+I
Sbjct:  1574 IIDEDFELTERECIKY-----MRQISEGVEYIHKQGIVHLDLKPENIMCVNKTGTRIKLI 1628

Query:   256 DFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGE 315
             DFGLA +L+    +K+  GT EF APE++  EP+G+ TDMW++GV+ Y+L+SGLSPF G+
Sbjct:  1629 DFGLARRLENAGSLKVLFGTPEFVAPEVINYEPIGYATDMWSIGVICYILVSGLSPFMGD 1688

Query:   316 NDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
             ND ETL NV +  W+FD+EAF  +SE+ KDFI  LL ++
Sbjct:  1689 NDNETLANVTSATWDFDDEAFDEISEDAKDFISNLLKKD 1727

GO:0001725 "stress fiber" evidence=IEA

GO:0004687 "myosin light chain kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0005886 "plasma membrane" evidence=IEA

GO:0030027 "lamellipodium" evidence=IEA

GO:0030335 "positive regulation of cell migration" evidence=IEA

GO:0032060 "bleb assembly" evidence=IEA

GO:0032154 "cleavage furrow" evidence=IEA

GO:0051928 "positive regulation of calcium ion transport" evidence=IEA

GO:0060414 "aorta smooth muscle tissue morphogenesis" evidence=IEA

GO:0071476 "cellular hypotonic response" evidence=IEA

GO:0090303 "positive regulation of wound healing" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q86AD7	MYLKB_DICDI	2, ., 7, ., 1, 1, ., 1, 8	0.3436	0.6994	0.6352	yes	N/A

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	356
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-83
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-66
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-50
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-49
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-48
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-48
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-45
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-43
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	5e-42
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	7e-42
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	7e-38
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	9e-37
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-36
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-35
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-35
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-35
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	8e-34
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-32
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-32
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-32
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-32
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	6e-32
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	7e-32
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-31
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-31
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-30
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-30
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-30
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	6e-30
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-30
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-29
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-28
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-28
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-28
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-28
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-28
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-28
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-28
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-28
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	5e-28
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-28
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	6e-28
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	7e-28
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	8e-28
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	9e-28
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-27
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-27
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-27
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-27
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-27
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-27
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-27
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-27
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-27
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	5e-27
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-27
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	7e-27
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	9e-27
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-26
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-26
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-26
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-26
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-26
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-26
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-26
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-26
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	5e-26
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	7e-26
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	8e-26
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-25
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-25
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-25
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-25
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-25
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	5e-25
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-25
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	7e-25
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	9e-25
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-24
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-24
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	4e-24
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-24
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	5e-24
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	9e-24
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-23
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-23
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-23
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-23
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-23
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	6e-23
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	6e-23
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-22
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-22
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-22
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-22
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-22
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-22
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	9e-22
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-21
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-21
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-21
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-21
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-21
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-21
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-21
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	9e-21
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-20
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-20
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-20
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-20
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-20
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-20
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-20
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	4e-20
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	5e-20
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	5e-20
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	9e-20
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	9e-20
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	9e-20
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-19
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-19
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-19
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-19
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-19
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-19
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-19
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-19
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-19
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-19
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	7e-19
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	8e-19
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	9e-19
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-18
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-18
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-18
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-18
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-18
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-18
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-18
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-18
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-18
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-18
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	5e-18
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	6e-18
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	6e-18
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-17
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-17
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-17
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-17
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-17
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-17
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	5e-17
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	6e-17
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	8e-17
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	8e-17
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	9e-17
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-16
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-16
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-16
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-16
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-16
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-16
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-16
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	5e-16
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-16
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	5e-16
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	7e-16
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-15
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-15
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-15
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-15
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-15
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-15
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-15
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	5e-15
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	5e-15
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-14
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-14
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-14
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-14
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-14
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-14
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	6e-14
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	7e-14
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-13
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-13
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-13
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-13
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-13
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-13
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-13
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-13
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-13
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-13
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-13
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-13
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-12
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-12
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-12
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-12
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-12
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-12
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	6e-12
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	6e-12
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	8e-12
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-11
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-11
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-11
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-11
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-11
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-11
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-11
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-10
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-10
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-10
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-10
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-10
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-10
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	4e-10
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	5e-10
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	5e-10
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	6e-10
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	7e-10
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	7e-10
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	7e-10
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-09
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-09
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-09
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-09
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-09
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-09
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	5e-09
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	6e-09
cd00063	93	cd00063, FN3, Fibronectin type 3 domain; One of th	7e-09
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	9e-09
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-08
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-08
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-08
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-08
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-08
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-08
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-08
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	6e-08
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	9e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	9e-08
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-07
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-07
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-07
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-07
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-07
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-07
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-07
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	5e-07
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-07
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-07
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	6e-07
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	7e-07
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	8e-07
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-06
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-06
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-06
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-06
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-06
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	3e-06
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-06
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-06
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	6e-06
smart00060	83	smart00060, FN3, Fibronectin type 3 domain	8e-06
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	2e-05
pfam00041	84	pfam00041, fn3, Fibronectin type III domain	3e-05
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-05
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	4e-05
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	5e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	6e-05
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	6e-05
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	7e-05
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	7e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	8e-05
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	8e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-04
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-04
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-04
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-04
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	3e-04
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	3e-04
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-04
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	6e-04
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	7e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	8e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	0.001
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	0.001
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	0.002
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	0.003

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  252 bits (647), Expect = 3e-83
 Identities = 92/247 (37%), Positives = 147/247 (59%), Gaps = 11/247 (4%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK-ELIRKEIDIMNQLHHPKLI 168
           Y+ILE++G G+FG V+  R++KTG + A K I      +  E I +EI I+ +L HP ++
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 169 NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH 228
            L+D FED+D++ L+ E+  GG+LF+ +     ++SE E       IL      A++++H
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKK-RGRLSEDEARFYLRQILS-----ALEYLH 114

Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREP 288
            K I+H D+KPENI+       +VK+ DFGLA +LDP E +    GT E+ APE++  + 
Sbjct: 115 SKGIVHRDLKPENILLDEDG--HVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKG 172

Query: 289 VGFYTDMWAVGVLAYVLLSGLSPFAGENDV-ETLKNVKACDWEFDEEAFKNVSEEGKDFI 347
            G   D+W++GV+ Y LL+G  PF G++ + E  K +      F      ++S E KD I
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPP-EWDISPEAKDLI 231

Query: 348 RRLLLRN 354
           R+LL+++
Sbjct: 232 RKLLVKD 238

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  209 bits (535), Expect = 3e-66
 Identities = 85/249 (34%), Positives = 137/249 (55%), Gaps = 15/249 (6%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK--EIDIMNQLHHPKL 167
           Y++L ++G+G+FG V++ + + TG I A K +       K+      EI I+ +L HP +
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
           + L DAFED D + L+ E+  GG+LF+ ++     +SE E   +       Q    ++++
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSR-GGPLSEDEAKKI-----ALQILRGLEYL 114

Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEFAAPEIV-E 285
           H   IIH D+KPENI+        VK+ DFGLA KL   +  +    GT  + APE++  
Sbjct: 115 HSNGIIHRDLKPENILLDENG--VVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLG 172

Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDV---ETLKNVKACDWEFDEEAFKNVSEE 342
               G   D+W++GV+ Y LL+G  PF+GEN +   + ++ +     EFDE  + + SEE
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEE 232

Query: 343 GKDFIRRLL 351
            KD I++ L
Sbjct: 233 AKDLIKKCL 241

Length = 260

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  169 bits (430), Expect = 1e-50
 Identities = 72/246 (29%), Positives = 130/246 (52%), Gaps = 22/246 (8%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELI---RKEIDIMNQLHHPKLINLHD 172
           +G G+FG V   R++ TG ++A K +     ++++ +     E +I+++++HP ++ LH 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 173 AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPV-TLPILMTQTSPAVKHMHEKN 231
           AF+ ++++ L+ E+  GGELF         +S+              +   A++++H   
Sbjct: 61  AFQTEEKLYLVLEYAPGGELF-------SHLSKEGRFSEERARFYAAEIVLALEYLHSLG 113

Query: 232 IIHLDVKPENIM-CQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFAAPEIVEREP 288
           II+ D+KPENI+        ++K+ DFGLA K   +E  + +T  GT E+ APE++  + 
Sbjct: 114 IIYRDLKPENILLDAD---GHIKLTDFGLA-KELSSEGSRTNTFCGTPEYLAPEVLLGKG 169

Query: 289 VGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIR 348
            G   D W++GVL Y +L+G  PF  E+  E  + +      F E     +S E +D I 
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPE----FLSPEARDLIS 225

Query: 349 RLLLRN 354
            LL ++
Sbjct: 226 GLLQKD 231

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  166 bits (422), Expect = 3e-49
 Identities = 77/278 (27%), Positives = 131/278 (47%), Gaps = 49/278 (17%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK---------EIDI 158
           D +   + IG G+F  V   +E++T   +A K       L+K  + K         E ++
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKI------LDKRQLIKEKKVKYVKIEKEV 54

Query: 159 MNQL-HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM 217
           + +L  HP +I L+  F+D++ +  + E+   GEL + I      + E         IL+
Sbjct: 55  LTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIR-KYGSLDEKCTRFYAAEILL 113

Query: 218 TQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEV--------V 269
                A++++H K IIH D+KPENI+       ++K+ DFG A  LDPN           
Sbjct: 114 -----ALEYLHSKGIIHRDLKPENILLDKDM--HIKITDFGTAKVLDPNSSPESNKGDAT 166

Query: 270 KIST-------------GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN 316
            I +             GTAE+ +PE++  +P G  +D+WA+G + Y +L+G  PF G N
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226

Query: 317 DVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
           +  T + +   ++ F      +     KD I +LL+ +
Sbjct: 227 EYLTFQKILKLEYSFPPNFPPDA----KDLIEKLLVLD 260

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  164 bits (417), Expect = 1e-48
 Identities = 68/252 (26%), Positives = 133/252 (52%), Gaps = 16/252 (6%)

Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQLHHPK 166
            Y+I+++IG G+FG V+  R +  G ++  K I +S+  EKE      E+ I+ +L+HP 
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERI---TAPDYKMSEAEVIPVTLPILMTQTSPA 223
           +I  +++FE+  ++ ++ E+  GG+L ++I           E +++         Q   A
Sbjct: 61  IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQIL-----DWFVQLCLA 115

Query: 224 VKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN-EVVKISTGTAEFAAPE 282
           +K++H + I+H D+KP+NI   +     VK+ DFG++  L    ++ K   GT  + +PE
Sbjct: 116 LKYLHSRKILHRDIKPQNIFLTSNG--LVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPE 173

Query: 283 IVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEE 342
           + + +P  + +D+W++G + Y L +   PF GEN +E    +    +      +   S E
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQY---SSE 230

Query: 343 GKDFIRRLLLRN 354
            ++ +  LL ++
Sbjct: 231 LRNLVSSLLQKD 242

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  162 bits (412), Expect = 1e-48
 Identities = 61/193 (31%), Positives = 111/193 (57%), Gaps = 9/193 (4%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE-KELIRKEIDIMNQLHHPKLINLHDAF 174
           +G G FG V+  R++KTG   A K I    +    E + +EI+I+ +L+HP ++ L+  F
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
           ED++ + L+ E+  GG L + +   + K+SE E++      ++ Q    ++++H   IIH
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEIL-----RILLQILEGLEYLHSNGIIH 115

Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST-GTAEFAAPEIVEREP-VGFY 292
            D+KPENI+    ++  VK+ DFGL+  L  ++ +  +  GT  + APE++  +      
Sbjct: 116 RDLKPENILL-DSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEK 174

Query: 293 TDMWAVGVLAYVL 305
           +D+W++GV+ Y L
Sbjct: 175 SDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  155 bits (394), Expect = 2e-45
 Identities = 72/248 (29%), Positives = 132/248 (53%), Gaps = 8/248 (3%)

Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLI 168
            ++ILE+IG G FG V++ R ++TG   A K I +    +KE I  EI I+ +  HP ++
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60

Query: 169 NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH 228
             + ++   DE+ ++ EF SGG L + + + +  ++E+++  V   +L       ++++H
Sbjct: 61  KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLK-----GLEYLH 115

Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREP 288
              IIH D+K  NI+  +     VK+IDFGL+ +L   +      GT  + APE++  +P
Sbjct: 116 SNGIIHRDIKAANILLTSDGE--VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKP 173

Query: 289 VGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIR 348
             +  D+W++G+ A  L  G  P++    ++ L  +            +  S+E KDF++
Sbjct: 174 YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNP-EKWSDEFKDFLK 232

Query: 349 RLLLRNKE 356
           + L +N E
Sbjct: 233 KCLQKNPE 240

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  151 bits (384), Expect = 2e-43
 Identities = 74/258 (28%), Positives = 129/258 (50%), Gaps = 33/258 (12%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI---PVSHNLEKELIRKEIDIMNQLHH 164
           D ++ ++ +GTG+FG V   R + +G  +A K +    +    + E +  E  I+  + H
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFE------RITAPDYKMSEAEVIPVTLPILMT 218
           P L+NL+ +F+DD  + L+ E++ GGELF       R   P  +   A+V+         
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVL-------- 112

Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTA 276
               A++++H  +I++ D+KPEN++  +     +K+ DFG A ++         T  GT 
Sbjct: 113 ----ALEYLHSLDIVYRDLKPENLLLDSDGY--IKITDFGFAKRVKGR----TYTLCGTP 162

Query: 277 EFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAF 336
           E+ APEI+  +  G   D WA+G+L Y +L+G  PF  +N ++  + +      F     
Sbjct: 163 EYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFP---- 218

Query: 337 KNVSEEGKDFIRRLLLRN 354
              S + KD IR LL  +
Sbjct: 219 SFFSPDAKDLIRNLLQVD 236

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  146 bits (372), Expect = 5e-42
 Identities = 70/254 (27%), Positives = 124/254 (48%), Gaps = 24/254 (9%)

Query: 114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQLHHPKLIN-L 170
           E +G G+FG V+   ++ TG + A K + +S + E+EL  + +EI I++ L HP ++   
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 171 HDAFEDDDEMVLIF-EFLSGGELFERITAPDY-KMSEAEVIPVTLPILMTQTSPAVKHMH 228
               +++   + IF E++SGG L   +    + K+ E  +   T  IL       + ++H
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLK--KFGKLPEPVIRKYTRQILE-----GLAYLH 118

Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST---GTAEFAAPEIVE 285
              I+H D+K  NI+    +   VK+ DFG A +L   E  + +    GT  + APE++ 
Sbjct: 119 SNGIVHRDIKGANIL--VDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176

Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWE---FDEEAFKNVSEE 342
            E  G   D+W++G     + +G  P++   +            E     E    ++SEE
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPE----HLSEE 232

Query: 343 GKDFIRRLLLRNKE 356
            KDF+R+ L R+ +
Sbjct: 233 AKDFLRKCLRRDPK 246

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  146 bits (370), Expect = 7e-42
 Identities = 79/251 (31%), Positives = 133/251 (52%), Gaps = 12/251 (4%)

Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE---LIRKEIDIMNQLHHP 165
           H+++L  IG GAFG V   ++R T  +FA K++     +EK     +  E  I+ +L+HP
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            L+NL  +F+D++ M L+ + L GG+L   ++    K SE +V        + +   A++
Sbjct: 61  FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQ-KVKFSEEQV-----KFWICEIVLALE 114

Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           ++H K IIH D+KP+NI+       +V + DF +ATK+ P+ +   ++GT  + APE++ 
Sbjct: 115 YLHSKGIIHRDIKPDNILLD--EQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLC 172

Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD 345
           R+      D W++GV AY  L G  P+ G +       ++A     D       S E  D
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKRPYRG-HSRTIRDQIRAKQETADVLYPATWSTEAID 231

Query: 346 FIRRLLLRNKE 356
            I +LL R+ +
Sbjct: 232 AINKLLERDPQ 242

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  139 bits (349), Expect = 7e-38
 Identities = 79/273 (28%), Positives = 132/273 (48%), Gaps = 34/273 (12%)

Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK---ELIRKEIDIMNQLHHP 165
            Y IL ++G G+FG V+  R+RK   + A K +      +    E   +EI I+  L+HP
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRK---LVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 166 KLI-NLHDAFEDDDEMVLIFEFLSGGELFERITAPDY--KMSEAEVIPVTLPILMTQTSP 222
             I  L+D F+D+  + L+ E++ GG L + +        +SE+E +      ++ Q   
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEAL-----FILAQILS 112

Query: 223 AVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEV-------VKISTGT 275
           A++++H K IIH D+KPENI+   R+   VK+IDFGLA  L               S GT
Sbjct: 113 ALEYLHSKGIIHRDIKPENIL-LDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171

Query: 276 AEFAAPEIVE---REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD 332
             + APE++           +D+W++G+  Y LL+GL PF GE +            E  
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231

Query: 333 EEAFKN---------VSEEGKDFIRRLLLRNKE 356
             +  +         +S+   D +++LL ++ +
Sbjct: 232 TPSLASPLSPSNPELISKAASDLLKKLLAKDPK 264

Length = 384

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  133 bits (336), Expect = 9e-37
 Identities = 72/252 (28%), Positives = 127/252 (50%), Gaps = 30/252 (11%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK---ELIRKEIDIMNQLHHPKLINLHD 172
           I  GA+G V   +++ TG+I+A K I  +  + K   + +  E DI++Q   P ++ L+ 
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 173 AFEDDDEMVLIFEFLSGGELF---ERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE 229
           +F+    + L+ E+L GG+L    E + + D  ++          I + +   A++++H 
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR---------IYIAEIVLALEYLHS 111

Query: 230 KNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT----------KLDPNEVVKISTGTAEFA 279
             IIH D+KP+NI+    ++ ++K+ DFGL+             D  E  +I  GT ++ 
Sbjct: 112 NGIIHRDLKPDNILID--SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI-VGTPDYI 168

Query: 280 APEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNV 339
           APE++  +      D W++G + Y  L G+ PF GE   E  +N+     E+ E     V
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPE--DVEV 226

Query: 340 SEEGKDFIRRLL 351
           S+E  D I +LL
Sbjct: 227 SDEAIDLISKLL 238

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  133 bits (336), Expect = 3e-36
 Identities = 78/294 (26%), Positives = 129/294 (43%), Gaps = 69/294 (23%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK---------EIDI 158
            H+  ++ +G G  G V   R + TG +FA K +      +K+ + K         E +I
Sbjct: 1   KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVL------DKKEMIKRNKVKRVLTEQEI 54

Query: 159 MNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFE-RITAPDYKMSE-------AEVIP 210
           +  L HP L  L+ +F+ +  + L+ ++  GGELF      P   +SE       AEV+ 
Sbjct: 55  LATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVL- 113

Query: 211 VTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD------ 264
                       A++++H   I++ D+KPENI+     S ++ + DF L+ + D      
Sbjct: 114 -----------LALEYLHLLGIVYRDLKPENIL--LHESGHIMLSDFDLSKQSDVEPPPV 160

Query: 265 ----------------PNEVVKIST--------GTAEFAAPEIVEREPVGFYTDMWAVGV 300
                           P+E              GT E+ APE++  +  G   D W +G+
Sbjct: 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGI 220

Query: 301 LAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
           L Y +L G +PF G N  ET  N+   +  F       VS   +D IR+LL+++
Sbjct: 221 LLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSP--PVSSSARDLIRKLLVKD 272

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  130 bits (329), Expect = 1e-35
 Identities = 77/257 (29%), Positives = 134/257 (52%), Gaps = 24/257 (9%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKL 167
           + Y  LE+IG GA G V++  +R TG   A K + +     KELI  EI IM    HP +
Sbjct: 19  ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLR-KQNKELIINEILIMKDCKHPNI 77

Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
           ++ +D++   DE+ ++ E++ GG L + IT    +M+E ++  V   +L       ++++
Sbjct: 78  VDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQ-----GLEYL 132

Query: 228 HEKNIIHLDVKPENIMCQTRNST-NVKMIDFGLATKLDP-----NEVVKISTGTAEFAAP 281
           H +N+IH D+K +NI+    +   +VK+ DFG A +L       N VV    GT  + AP
Sbjct: 133 HSQNVIHRDIKSDNILL---SKDGSVKLADFGFAAQLTKEKSKRNSVV----GTPYWMAP 185

Query: 282 EIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV--KACDWEFDEEAFKNV 339
           E+++R+  G   D+W++G++   +  G  P+  E  +  L  +  K           +  
Sbjct: 186 EVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIP-PLKNP--EKW 242

Query: 340 SEEGKDFIRRLLLRNKE 356
           S E KDF+ + L+++ E
Sbjct: 243 SPEFKDFLNKCLVKDPE 259

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  129 bits (327), Expect = 2e-35
 Identities = 72/255 (28%), Positives = 120/255 (47%), Gaps = 33/255 (12%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSH----NLEKELIRKEIDIMNQLHHPKLINLH 171
           +G G FG V   + +     FA K +   H      ++  I  E +I+ + +HP ++ L+
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEH-IFSEKEILEECNHPFIVKLY 59

Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAE----VIPVTLPILMTQTSPAVKHM 227
             F+D   + ++ E+  GGEL+  +        E      +  V L         A +++
Sbjct: 60  RTFKDKKYIYMLMEYCLGGELWTILRDRG-LFDEYTARFYIACVVL---------AFEYL 109

Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVERE 287
           H + II+ D+KPEN++  +     VK++DFG A KL   +      GT E+ APEI+  +
Sbjct: 110 HNRGIIYRDLKPENLLLDSNGY--VKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNK 167

Query: 288 PVGFYTDMWAVGVLAYVLLSGLSPFAGENDV------ETLKNVKACDWEFDEEAFKNVSE 341
              F  D W++G+L Y LL+G  PF  +++       + LK       EF       + +
Sbjct: 168 GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG--KLEFP----NYIDK 221

Query: 342 EGKDFIRRLLLRNKE 356
             KD I++LL RN E
Sbjct: 222 AAKDLIKQLLRRNPE 236

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  129 bits (327), Expect = 3e-35
 Identities = 69/217 (31%), Positives = 110/217 (50%), Gaps = 13/217 (5%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE--KELIRKEIDIMNQLHHPKL 167
           Y++L  +G GA+GVV +CR + TG I A K    S + E  K+   +E+ ++ QL H  +
Sbjct: 3   YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENI 62

Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
           +NL +AF     + L+FE++    L E + A    +    V        + Q   A+ + 
Sbjct: 63  VNLKEAFRRKGRLYLVFEYV-ERTLLELLEASPGGLPPDAV-----RSYIWQLLQAIAYC 116

Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFAAPEI-V 284
           H  NIIH D+KPENI+  + +   +K+ DFG A  L       ++    T  + APE+ V
Sbjct: 117 HSHNIIHRDIKPENILV-SESGV-LKLCDFGFARALRARPASPLTDYVATRWYRAPELLV 174

Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETL 321
                G   D+WA+G +   LL G   F G++D++ L
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQL 211

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  125 bits (317), Expect = 8e-34
 Identities = 65/223 (29%), Positives = 110/223 (49%), Gaps = 26/223 (11%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR--KEIDIMNQLHHPKL 167
           Y  L +IG G +GVV++ R++ TG I A K I +    E       +EI ++ +L+HP +
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
           I L D F    ++ L+FEF+   +L++ I      + E+ +        + Q    +   
Sbjct: 61  IKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKS-----YLYQLLQGLAFC 114

Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP------NEVVKISTGTAEFAAP 281
           H   I+H D+KPEN++  T     +K+ DFGLA           + VV     T  + AP
Sbjct: 115 HSHGILHRDLKPENLLINT--EGVLKLADFGLARSFGSPVRPYTHYVV-----TRWYRAP 167

Query: 282 EIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
           E++  +    Y+   D+W+VG +   LLS    F G+++++ L
Sbjct: 168 ELLLGD--KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQL 208

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  124 bits (312), Expect = 1e-32
 Identities = 78/250 (31%), Positives = 129/250 (51%), Gaps = 20/250 (8%)

Query: 113 LEEIGTGAFGVVHRCR---ERKTGNIFAAKFIP----VSHNLEKELIRKEIDIMNQLHHP 165
           L+ +G G +G V + R      TG IFA K +     V +  +    + E +I+  + HP
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60

Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            +++L  AF+   ++ LI E+LSGGELF  +      M +      T    +++ S A++
Sbjct: 61  FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMED------TACFYLSEISLALE 114

Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK-LDPNEVVKISTGTAEFAAPEIV 284
           H+H++ II+ D+KPENI+   +   +VK+ DFGL  + +    V     GT E+ APEI+
Sbjct: 115 HLHQQGIIYRDLKPENILLDAQG--HVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEIL 172

Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
            R   G   D W++G L Y +L+G  PF  EN  +T+  +              ++ E +
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----PYLTPEAR 228

Query: 345 DFIRRLLLRN 354
           D +++LL RN
Sbjct: 229 DLLKKLLKRN 238

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  122 bits (308), Expect = 1e-32
 Identities = 63/257 (24%), Positives = 119/257 (46%), Gaps = 24/257 (9%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK-ELIRKEIDIMNQLHHPK 166
              + ++ +G G+ GVV++ R + TG I+A K I V  + E  + + +E+  +     P 
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60

Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK- 225
           ++  + AF  + E+ ++ E++ GG L   +     K+ E        P+L       +K 
Sbjct: 61  VVKCYGAFYKEGEISIVLEYMDGGSL-ADLLKKVGKIPE--------PVLAYIARQILKG 111

Query: 226 --HMH-EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS-TGTAEFAAP 281
             ++H +++IIH D+KP N++  ++    VK+ DFG++  L+       +  GT  + +P
Sbjct: 112 LDYLHTKRHIIHRDIKPSNLLINSKG--EVKIADFGISKVLENTLDQCNTFVGTVTYMSP 169

Query: 282 EIVEREPVGFYTDMWAVGVLAYVLLSGLSPF--AGENDVETLKN--VKACDWEFDEEAFK 337
           E ++ E   +  D+W++G+       G  PF   G+     L              E F 
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEF- 228

Query: 338 NVSEEGKDFIRRLLLRN 354
             S E +DFI   L ++
Sbjct: 229 --SPEFRDFISACLQKD 243

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  123 bits (312), Expect = 2e-32
 Identities = 72/278 (25%), Positives = 125/278 (44%), Gaps = 43/278 (15%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE---LIRKEIDIMNQLHH 164
           D +++++ IG GAFG V   R++ TG ++A K +  S  +++     +R E DI+     
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLP-ILMTQTSPA 223
           P ++ L+ +F+D++ + L+ E++ GG+L   +      +   +V P       + +   A
Sbjct: 61  PWIVKLYYSFQDEEHLYLVMEYMPGGDL---MNL----LIRKDVFPEETARFYIAELVLA 113

Query: 224 VKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK-----------------LDPN 266
           +  +H+   IH D+KP+NI+       ++K+ DFGL  K                 L  +
Sbjct: 114 LDSVHKLGFIHRDIKPDNILIDA--DGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171

Query: 267 EVVKIST-------------GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFA 313
            V+                 GT ++ APE++   P G   D W++GV+ Y +L G  PF 
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFY 231

Query: 314 GENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLL 351
            +   ET   +              VS E  D I RLL
Sbjct: 232 SDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLL 269

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  122 bits (307), Expect = 2e-32
 Identities = 69/249 (27%), Positives = 125/249 (50%), Gaps = 21/249 (8%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL---EKELIRKEIDIMNQLHH 164
           D  + ++ +GTG FG VH  R+R + + +A K + +   +   +++ +  E  ++ ++ H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P +I L     D   + ++ E++ GGELF       Y  +       T     ++   A+
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFS------YLRNSGRFSNSTGLFYASEIVCAL 114

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFAAPE 282
           +++H K I++ D+KPENI+       ++K+ DFG A KL      +  T  GT E+ APE
Sbjct: 115 EYLHSKEIVYRDLKPENILLDKEG--HIKLTDFGFAKKL----RDRTWTLCGTPEYLAPE 168

Query: 283 IVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEE 342
           +++ +      D WA+G+L Y +L G  PF  +N     + + A   EF     +++   
Sbjct: 169 VIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFP----RHLDLY 224

Query: 343 GKDFIRRLL 351
            KD I++LL
Sbjct: 225 AKDLIKKLL 233

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  120 bits (302), Expect = 6e-32
 Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 7/209 (3%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE--LIRKEIDIMNQLHHPKL 167
           Y+ +  +G GAFG+VH CR +    +   K IPV    + E    + E  ++  L HP +
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61

Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
           I  ++ F +D  ++++ E+  GG L E I      + + +    T+     Q   A+ H+
Sbjct: 62  IEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDED----TILHFFVQILLALHHV 117

Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVERE 287
           H K I+H D+K +NI+   ++   VK+ DFG++  L          GT  + +PE+ E +
Sbjct: 118 HTKLILHRDLKTQNILLD-KHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGK 176

Query: 288 PVGFYTDMWAVGVLAYVLLSGLSPFAGEN 316
           P    +D+WA+G + Y L S    F   N
Sbjct: 177 PYNQKSDIWALGCVLYELASLKRAFEAAN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  120 bits (304), Expect = 7e-32
 Identities = 77/282 (27%), Positives = 118/282 (41%), Gaps = 51/282 (18%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---SHNLEKELIRKEIDIMNQLHHPK 166
           Y IL  IG GA G+V + ++R+TG   A K + +      +  + +R EI  +    HP 
Sbjct: 2   YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR-EIKALQACQHPY 60

Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKH 226
           ++ L D F      VL+ E++   +L E +   +  + EA+V      +L       V +
Sbjct: 61  VVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLK-----GVAY 114

Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS--TGTAEFAAPEIV 284
           MH   I+H D+KP N++        +K+ DFGLA      E    S    T  + APE++
Sbjct: 115 MHANGIMHRDLKPANLLISADGV--LKIADFGLARLFSEEEPRLYSHQVATRWYRAPELL 172

Query: 285 EREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL-------------------- 321
                  Y    D+WAVG +   LL+G   F GEND+E L                    
Sbjct: 173 YGAR--KYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS 230

Query: 322 ---------KNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
                       K       EE F + S E  D ++ LL+ +
Sbjct: 231 LPDYNKITFPESKPIPL---EEIFPDASPEALDLLKGLLVYD 269

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  121 bits (305), Expect = 1e-31
 Identities = 77/262 (29%), Positives = 131/262 (50%), Gaps = 22/262 (8%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE---LIRKEIDIMNQLHH 164
             +D+   +G G FG V   RE+ TG+I+A K +  S  L +E      +E DI++  + 
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P +  L  AF+D D + L+ E+  GG+L   +   + +  E           + +   A+
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMA-----QFYLAELVLAI 115

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVV--KISTGTAEFAAPE 282
             +H+   +H D+KPEN++     + ++K+ DFG A +L  N++V  K+  GT ++ APE
Sbjct: 116 HSVHQMGYVHRDIKPENVLID--RTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPE 173

Query: 283 I---VEREPVGFY---TDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACD--WEFDEE 334
           +   +  +  G Y    D W++GV+AY ++ G SPF      +T  N+       +F E+
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPED 233

Query: 335 AFKNVSEEGKDFIRRLLLRNKE 356
               VS +  D I+ LL   KE
Sbjct: 234 P--KVSSDFLDLIQSLLCGQKE 253

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  117 bits (296), Expect = 4e-31
 Identities = 75/254 (29%), Positives = 124/254 (48%), Gaps = 24/254 (9%)

Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQLHHPK 166
           +Y + + IG GAFGVV++    +TG+  A K I +    E+ L  I +EID++  L HP 
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKH 226
           ++    + E  D + +I E+   G L  +I        E+ V      + + Q    + +
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSL-RQIIKKFGPFPESLVA-----VYVYQVLQGLAY 114

Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL-----DPNEVVKISTGTAEFAAP 281
           +HE+ +IH D+K  NI+  T     VK+ DFG+ATKL     D   VV    GT  + AP
Sbjct: 115 LHEQGVIHRDIKAANIL--TTKDGVVKLADFGVATKLNDVSKDDASVV----GTPYWMAP 168

Query: 282 EIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAF-KNVS 340
           E++E       +D+W++G     LL+G  P+   N +  L  +     + D     + +S
Sbjct: 169 EVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV----QDDHPPLPEGIS 224

Query: 341 EEGKDFIRRLLLRN 354
            E KDF+ +   ++
Sbjct: 225 PELKDFLMQCFQKD 238

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  116 bits (293), Expect = 1e-30
 Identities = 66/246 (26%), Positives = 115/246 (46%), Gaps = 15/246 (6%)

Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIP----VSHNLEKELIRKEIDIMNQLHHPKLI 168
           L+ I  GAFG V+  ++R TG+ FA K +     ++ N    +  +   +M Q   P + 
Sbjct: 1   LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60

Query: 169 NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH 228
            L+ +F+  D + L+ E+L+GG+    I      + E         +++      V+ +H
Sbjct: 61  KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG-LPEDWAKQYIAEVVL-----GVEDLH 114

Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREP 288
           ++ IIH D+KPEN++     + ++K+ DFGL+         K   GT ++ APE +    
Sbjct: 115 QRGIIHRDIKPENLLID--QTGHLKLTDFGLSRN---GLENKKFVGTPDYLAPETILGVG 169

Query: 289 VGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIR 348
               +D W++G + +  L G  PF  E       N+ +    + EE  +  S E  D I 
Sbjct: 170 DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLIN 229

Query: 349 RLLLRN 354
           RLL  +
Sbjct: 230 RLLCMD 235

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  116 bits (293), Expect = 2e-30
 Identities = 63/231 (27%), Positives = 108/231 (46%), Gaps = 22/231 (9%)

Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPK 166
            Y++LE IG G+FG V + R +  G I   K I   +    EK+ +  E++I+ +L HP 
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPN 60

Query: 167 LINLHDAFEDDDE--MVLIFEFLSGGEL---FERITAPDYKMSEAEVIPVTLPILMTQTS 221
           ++  +D   D     + ++ E+  GG+L    ++       + E  +  +     +TQ  
Sbjct: 61  IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRI-----LTQLL 115

Query: 222 PAVKHMH-----EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--G 274
            A+   H        ++H D+KP NI     N  NVK+ DFGLA K+  ++     T  G
Sbjct: 116 LALYECHNRSDPGNTVLHRDLKPANIFLDANN--NVKLGDFGLA-KILGHDSSFAKTYVG 172

Query: 275 TAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVK 325
           T  + +PE +        +D+W++G L Y L +   PF   N ++    +K
Sbjct: 173 TPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK 223

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  117 bits (294), Expect = 4e-30
 Identities = 70/251 (27%), Positives = 126/251 (50%), Gaps = 29/251 (11%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL---EKELIRKEIDIMNQLHHPK 166
           +++ E +GTG+FG V   + + TG  +A K +     L   + + + +E  I+ +L HP 
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79

Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERI-TAPDY-----KMSEAEVIPVTLPILMTQT 220
           ++N+  +F+D++ +  + EF+ GGELF  +  A  +     K   AE++           
Sbjct: 80  IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELV----------- 128

Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAA 280
             A +++H K+II+ D+KPEN++    N  +VK+ DFG A K+   +      GT E+ A
Sbjct: 129 -LAFEYLHSKDIIYRDLKPENLLLD--NKGHVKVTDFGFAKKV--PDRTFTLCGTPEYLA 183

Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVS 340
           PE+++ +  G   D W +GVL Y  ++G  PF  +      + + A   +F         
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFP----NWFD 239

Query: 341 EEGKDFIRRLL 351
              +D ++ LL
Sbjct: 240 GRARDLVKGLL 250

Length = 329

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  115 bits (290), Expect = 6e-30
 Identities = 71/214 (33%), Positives = 115/214 (53%), Gaps = 12/214 (5%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLIN 169
           Y   E+IG GA G V+   +  TG   A K + +    +KELI  EI +M +  HP ++N
Sbjct: 21  YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN 80

Query: 170 LHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE 229
             D++   DE+ ++ E+L+GG L + +T  +  M E ++  V    L      A++ +H 
Sbjct: 81  YLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQ-----ALEFLHS 133

Query: 230 KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFAAPEIVERE 287
             +IH D+K +NI+     S  VK+ DFG   ++ P E  K ST  GT  + APE+V R+
Sbjct: 134 NQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITP-EQSKRSTMVGTPYWMAPEVVTRK 190

Query: 288 PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETL 321
             G   D+W++G++A  ++ G  P+  EN +  L
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 224

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  115 bits (289), Expect = 6e-30
 Identities = 70/251 (27%), Positives = 122/251 (48%), Gaps = 23/251 (9%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK---------EIDIMNQLHHPK 166
           +G G FG V  C+ + TG ++A K       L+K+ ++K         E  I+ ++    
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACK------KLDKKRLKKRKGEQMALNEKKILEKVSSRF 54

Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK-MSEAEVIPVTLPILMTQTSPAVK 225
           +++L  AFE  D++ L+   ++GG+L   I         EA  I     I+       ++
Sbjct: 55  IVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIIC-----GLE 109

Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           H+H++ I++ D+KPEN++    +  NV++ D GLA +L   + +K   GT  + APE+++
Sbjct: 110 HLHQRRIVYRDLKPENVLLD--DHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQ 167

Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD 345
            E   F  D +A+G   Y +++G SPF    +    + +K    E   E     S E KD
Sbjct: 168 GEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKD 227

Query: 346 FIRRLLLRNKE 356
               LL ++ E
Sbjct: 228 LCEALLQKDPE 238

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  114 bits (288), Expect = 1e-29
 Identities = 66/242 (27%), Positives = 128/242 (52%), Gaps = 13/242 (5%)

Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           +IG G+ G+V    ++ TG   A K + +     +EL+  E+ IM    HP ++ ++ ++
Sbjct: 26  KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85

Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
              DE+ ++ EFL GG L + +T    +M+E ++  V L +L      A+  +H + +IH
Sbjct: 86  LVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIATVCLAVLK-----ALSFLHAQGVIH 138

Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFAAPEIVEREPVGFY 292
            D+K ++I+  T +   VK+ DFG   ++   EV +  +  GT  + APE++ R P G  
Sbjct: 139 RDIKSDSILL-TSDGR-VKLSDFGFCAQVS-KEVPRRKSLVGTPYWMAPEVISRLPYGTE 195

Query: 293 TDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLL 352
            D+W++G++   ++ G  P+  E  ++ +K ++       +     VS   + F+ R+L+
Sbjct: 196 VDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNL-HKVSPRLRSFLDRMLV 254

Query: 353 RN 354
           R+
Sbjct: 255 RD 256

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  112 bits (283), Expect = 1e-28
 Identities = 72/259 (27%), Positives = 121/259 (46%), Gaps = 35/259 (13%)

Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK---------EIDIM 159
            + IL ++G G +G V   +++ TG I A K       ++K L+ K         E DI+
Sbjct: 2   DFQILTQVGQGGYGQVFLAKKKDTGEIVALKR------MKKSLLFKLNEVRHVLTERDIL 55

Query: 160 NQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQ 219
                  L+ L  AF+DD+ + L  E++ GG+ F  +      +SE           M +
Sbjct: 56  TTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGD-FRTLLNNLGVLSEDHA-----RFYMAE 109

Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS---TGTA 276
              AV  +HE   IH D+KPEN +     S ++K+ DFGL+       +V  +    G+ 
Sbjct: 110 MFEAVDALHELGYIHRDLKPENFLIDA--SGHIKLTDFGLSK-----GIVTYANSVVGSP 162

Query: 277 EFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV----KACDWEFD 332
           ++ APE++  +   F  D W++G + Y  L G  PF+G    ET +N+    +       
Sbjct: 163 DYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVY 222

Query: 333 EEAFKNVSEEGKDFIRRLL 351
           ++   N+S+E  D I +L+
Sbjct: 223 DDPRFNLSDEAWDLITKLI 241

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  112 bits (280), Expect = 1e-28
 Identities = 73/214 (34%), Positives = 116/214 (54%), Gaps = 12/214 (5%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLIN 169
           Y   E+IG GA G V    +  TG   A K I +    +KELI  EI +M +L +P ++N
Sbjct: 21  YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80

Query: 170 LHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE 229
             D+F   DE+ ++ E+L+GG L + +T  +  M EA++  V    L      A++ +H 
Sbjct: 81  FLDSFLVGDELFVVMEYLAGGSLTDVVT--ETCMDEAQIAAVCRECLQ-----ALEFLHA 133

Query: 230 KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFAAPEIVERE 287
             +IH D+K +N++     S  VK+ DFG   ++ P E  K ST  GT  + APE+V R+
Sbjct: 134 NQVIHRDIKSDNVLLGMDGS--VKLTDFGFCAQITP-EQSKRSTMVGTPYWMAPEVVTRK 190

Query: 288 PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETL 321
             G   D+W++G++A  ++ G  P+  EN +  L
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 224

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  110 bits (278), Expect = 2e-28
 Identities = 57/212 (26%), Positives = 110/212 (51%), Gaps = 19/212 (8%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKL 167
           + Y++++ IG+G +G V++ R+  TG + A K I +    + E+I++EI ++ +  HP +
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62

Query: 168 INLHDAFEDDDEMVLIFEFLSGG---ELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           +    ++   D++ ++ E+  GG   ++++    P   +SE ++  V       +T   +
Sbjct: 63  VAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP---LSELQIAYVC-----RETLKGL 114

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFAAPE 282
            ++HE   IH D+K  NI+       +VK+ DFG++ +L    + K  +  GT  + APE
Sbjct: 115 AYLHETGKIHRDIKGANILLTEDG--DVKLADFGVSAQLT-ATIAKRKSFIGTPYWMAPE 171

Query: 283 IVEREPVGFYT---DMWAVGVLAYVLLSGLSP 311
           +   E  G Y    D+WA+G+ A  L     P
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  111 bits (279), Expect = 2e-28
 Identities = 77/263 (29%), Positives = 138/263 (52%), Gaps = 28/263 (10%)

Query: 110 YDILEEIGTGAFGVVHRCRER---KTGNIFAAKFIPVSHNLEK----ELIRKEIDIMNQL 162
           +++L  +GTGA+G V   R+      G ++A K +  +  ++K    E  R E  ++  +
Sbjct: 2   FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61

Query: 163 HH-PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTS 221
              P L+ LH AF+ D ++ LI ++++GGELF  +   ++  +E+EV      I++    
Sbjct: 62  RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH-FTESEVRVYIAEIVL---- 116

Query: 222 PAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFA 279
            A+ H+H+  II+ D+K ENI+  +    +V + DFGL+ +    E  +  +  GT E+ 
Sbjct: 117 -ALDHLHQLGIIYRDIKLENILLDSEG--HVVLTDFGLSKEFLAEEEERAYSFCGTIEYM 173

Query: 280 APEIVEREPVGF--YTDMWAVGVLAYVLLSGLSPFAGEND----VETLKNVKACDWEFDE 333
           APE++     G     D W++GVL + LL+G SPF  + +     E  + +      F  
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFP- 232

Query: 334 EAFKNVSEEGKDFIRRLLLRNKE 356
              K +S E +DFI++LL ++ +
Sbjct: 233 ---KTMSAEARDFIQKLLEKDPK 252

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  110 bits (277), Expect = 2e-28
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 11/213 (5%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS--HNLEKELIRKEIDIMNQLHHPKL 167
           ++IL +IG G+FGVV +   +    ++A K I +S  +  E+E    E  ++ +L    +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITA-PDYKMSEAEVIPVTLPILMTQTSPAVKH 226
           I  +++F D  ++ ++ E+   G+L + +       + E +V    + IL+      + H
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL-----GLAH 116

Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEV-VKISTGTAEFAAPEIVE 285
           +H K I+H D+K  N+     +  NVK+ D G+A  L  N        GT  + +PE+ E
Sbjct: 117 LHSKKILHRDIKSLNLFLDAYD--NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCE 174

Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDV 318
            +P    +D+WA+GV+ Y   +G  PF   N  
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHPFDANNQG 207

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  110 bits (277), Expect = 3e-28
 Identities = 67/224 (29%), Positives = 113/224 (50%), Gaps = 25/224 (11%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTG-NIFAAKFIPVSHNLEKELIRKEID----------- 157
           Y +LE +G+GAFG V++ R++  G N+ A K I V HN      ++E D           
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINV-HNPAFGKDKRERDKSIGDIVSEVT 60

Query: 158 -IMNQLHHPKLINLHDAFEDDDEMVLIFEFLSG---GELFERITAPDYKMSEAEVIPVTL 213
            I  QL HP ++  +  F ++D + ++ + + G   GE F  +     + +E  +  + +
Sbjct: 61  IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120

Query: 214 PILMTQTSPAVKHMH-EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS 272
            +++     A++++H EK I+H D+ P NIM    +   V + DFGLA +  P   +   
Sbjct: 121 QMVL-----ALRYLHKEKRIVHRDLTPNNIMLGEDD--KVTITDFGLAKQKQPESKLTSV 173

Query: 273 TGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN 316
            GT  ++ PEIV+ EP G   D+WA G + Y + +   PF   N
Sbjct: 174 VGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN 217

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  110 bits (276), Expect = 3e-28
 Identities = 62/246 (25%), Positives = 116/246 (47%), Gaps = 12/246 (4%)

Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE--LIRKEIDIMNQLHHPK 166
           HY  +  +G GAFG     R  +  ++   K + ++   EKE      EI I++ L HP 
Sbjct: 1   HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPN 60

Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKH 226
           +I  ++ F DD+ +++  E+ +GG L+++I     ++ E E++       + Q   AV +
Sbjct: 61  IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW----YLFQIVSAVSY 116

Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL-DPNEVVKISTGTAEFAAPEIVE 285
           +H+  I+H D+K  NI         +K+ DFG++  L     + +   GT  + +PE+ +
Sbjct: 117 IHKAGILHRDIKTLNIFLTKAGL--IKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQ 174

Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD 345
                F +D+WA+G + Y LL+    F   N +  +  +   ++      +   S E   
Sbjct: 175 GVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVY---SSELIS 231

Query: 346 FIRRLL 351
            +  LL
Sbjct: 232 LVHSLL 237

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score =  111 bits (280), Expect = 3e-28
 Identities = 75/258 (29%), Positives = 134/258 (51%), Gaps = 24/258 (9%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL---EKELIRKEIDIMNQLHH 164
           D ++IL+ IG GAFG V   + + TG ++A K +     L   E    R+E D++     
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
             + NLH AF+D++ + L+ ++  GG+L   ++  + ++ E           + +   A+
Sbjct: 61  RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPED-----MARFYLAEMVLAI 115

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVK--ISTGTAEFAAPE 282
             +H+   +H D+KP+N++       ++++ DFG   +L  +  V+  ++ GT ++ +PE
Sbjct: 116 DSVHQLGYVHRDIKPDNVLLDKNG--HIRLADFGSCLRLLADGTVQSNVAVGTPDYISPE 173

Query: 283 IVE--REPVGFY---TDMWAVGVLAYVLLSGLSPFAGENDVET---LKNVKAC-DWEFDE 333
           I++   +  G Y    D W++GV  Y +L G +PF  E+ VET   + N K    +  D 
Sbjct: 174 ILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDV 233

Query: 334 EAFKNVSEEGKDFIRRLL 351
               +VSEE KD IRRL+
Sbjct: 234 T---DVSEEAKDLIRRLI 248

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  111 bits (278), Expect = 5e-28
 Identities = 77/254 (30%), Positives = 129/254 (50%), Gaps = 30/254 (11%)

Query: 113 LEEIGTGAFG---VVHRCRERKTGNIFAAKFIPVSHNLEKELIR--KEIDIMNQLHHPKL 167
           L+ +G G+FG   +V +      G ++A K +  +    ++ +R   E DI+ +++HP +
Sbjct: 1   LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFI 60

Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERI------TAPDYKMSEAEVIPVTLPILMTQTS 221
           + LH AF+ + ++ LI +FL GG+LF R+      T  D K   AE+            +
Sbjct: 61  VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL------------A 108

Query: 222 PAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS-TGTAEFAA 280
            A+ H+H   II+ D+KPENI+       ++K+ DFGL+ +   +E    S  GT E+ A
Sbjct: 109 LALDHLHSLGIIYRDLKPENILLD--EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 166

Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVS 340
           PE+V R       D W+ GVL + +L+G  PF G++  ET+  +        +     +S
Sbjct: 167 PEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ----FLS 222

Query: 341 EEGKDFIRRLLLRN 354
            E +  +R L  RN
Sbjct: 223 PEAQSLLRALFKRN 236

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  110 bits (277), Expect = 5e-28
 Identities = 62/225 (27%), Positives = 114/225 (50%), Gaps = 30/225 (13%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFA-----AKFIPVSHNLEKELIRKEIDIMNQL-H 163
           Y +++++G G FG V+  R ++TG + A      KF    ++ E+ +  +E+  + +L  
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKF----YSWEECMNLREVKSLRKLNE 56

Query: 164 HPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK-MSEAEV--IPVTLPILMTQT 220
           HP ++ L + F ++DE+  +FE++  G L++ +     K  SE+ +  I       + Q 
Sbjct: 57  HPNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSI-------IYQI 108

Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAA 280
              + H+H+    H D+KPEN++        VK+ DFGLA ++           T  + A
Sbjct: 109 LQGLAHIHKHGFFHRDLKPENLLV--SGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRA 166

Query: 281 PEIVEREPVGFYT---DMWAVGVLAYVLLSGLSP-FAGENDVETL 321
           PEI+ R     Y+   D+WA+G +   L + L P F G ++++ L
Sbjct: 167 PEILLRST--SYSSPVDIWALGCIMAELYT-LRPLFPGSSEIDQL 208

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  112 bits (281), Expect = 6e-28
 Identities = 82/290 (28%), Positives = 138/290 (47%), Gaps = 58/290 (20%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL---IRKEIDIMNQLHH 164
           D ++ ++ IG GAFG V   +++ TG+I+A K +  S  LEKE    +R E DI+ +  +
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60

Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P ++ L+ +F+D++ + LI E+L GG++   +   D   +E E         + +T  A+
Sbjct: 61  PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKD-TFTEEET-----RFYIAETILAI 114

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD----------------PNEV 268
             +H+   IH D+KP+N++   +   ++K+ DFGL T L                  N +
Sbjct: 115 DSIHKLGYIHRDIKPDNLLLDAKG--HIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL 172

Query: 269 VKIST-----------------------GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVL 305
             IS                        GT ++ APE+  +       D W++GV+ Y +
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232

Query: 306 LSGLSPFAGENDVETLKNVKACDWE----FDEEAFKNVSEEGKDFIRRLL 351
           L G  PF  +N  ET +  K  +W+    F +E    +S E KD I+RL 
Sbjct: 233 LVGYPPFCSDNPQETYR--KIINWKETLQFPDEV--PLSPEAKDLIKRLC 278

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  109 bits (274), Expect = 7e-28
 Identities = 64/229 (27%), Positives = 111/229 (48%), Gaps = 12/229 (5%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR---KEIDIMNQLHH 164
            ++ I ++IG G F VV++      G + A K + +   ++ +  +   KEID++ QL H
Sbjct: 2   GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61

Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIP-VTLPILMTQTSPA 223
           P +I    +F +++E+ ++ E    G+L   I    +   +  +IP  T+     Q   A
Sbjct: 62  PNVIKYLASFIENNELNIVLELADAGDLSRMIK---HFKKQKRLIPERTIWKYFVQLCSA 118

Query: 224 VKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS-TGTAEFAAPE 282
           ++HMH K I+H D+KP N+         VK+ D GL            S  GT  + +PE
Sbjct: 119 LEHMHSKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 283 IVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGE--NDVETLKNVKACDW 329
            +      F +D+W++G L Y + +  SPF G+  N     K ++ CD+
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDY 225

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  109 bits (275), Expect = 8e-28
 Identities = 71/225 (31%), Positives = 112/225 (49%), Gaps = 18/225 (8%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAK-FIPVSHNLE-KELIRKEIDIMNQLHHPKL 167
           Y+ L  +G G++G+V +C+ ++TG I A K F+    +   K++  +EI ++ QL H  L
Sbjct: 3   YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENL 62

Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAP---DYKMSEAEVIPVTLPILMTQTSPAV 224
           +NL + F     + L+FEF+    L +    P   D                + Q    +
Sbjct: 63  VNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRK---------YLFQILRGI 113

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEFAAPEI 283
           +  H  NIIH D+KPENI+     S  VK+ DFG A  L  P EV      T  + APE+
Sbjct: 114 EFCHSHNIIHRDIKPENIL--VSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPEL 171

Query: 284 VEREP-VGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKAC 327
           +  +   G   D+WAVG L   +L+G   F G++D++ L ++  C
Sbjct: 172 LVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKC 216

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  109 bits (275), Expect = 9e-28
 Identities = 75/220 (34%), Positives = 111/220 (50%), Gaps = 16/220 (7%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK----EIDIMNQLH 163
           + Y+ L +IG G++GVV +CR R+TG I A K    S   +  +I+K    EI ++ QL 
Sbjct: 1   EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESE--DDPVIKKIALREIRMLKQLK 58

Query: 164 HPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPA 223
           HP L+NL + F    ++ L+FE+     L E    P   + E  +  +       QT  A
Sbjct: 59  HPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPR-GVPEHLIKKIIW-----QTLQA 112

Query: 224 VKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS-TGTAEFAAPE 282
           V   H+ N IH DVKPENI+  T+    +K+ DFG A  L            T  + APE
Sbjct: 113 VNFCHKHNCIHRDVKPENILI-TKQGQ-IKLCDFGFARILTGPGDDYTDYVATRWYRAPE 170

Query: 283 -IVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETL 321
            +V     G   D+WA+G +   LL+G   + G++DV+ L
Sbjct: 171 LLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQL 210

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  109 bits (274), Expect = 1e-27
 Identities = 71/257 (27%), Positives = 123/257 (47%), Gaps = 24/257 (9%)

Query: 107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK---------EID 157
           + HY +L   G G FG V  C+ R TG ++A K       LEK+ I+K         E  
Sbjct: 2   FRHYRVL---GKGGFGEVCACQVRATGKMYACK------KLEKKRIKKRKGEAMALNEKQ 52

Query: 158 IMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM 217
           I+ +++   +++L  A+E  D + L+   ++GG+L   I    Y M              
Sbjct: 53  ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHI----YNMGNPGFDEERAVFYA 108

Query: 218 TQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAE 277
            + +  ++ +H + I++ D+KPENI+       ++++ D GLA ++   E ++   GT  
Sbjct: 109 AEITCGLEDLHRERIVYRDLKPENILLDDYG--HIRISDLGLAVEIPEGETIRGRVGTVG 166

Query: 278 FAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
           + APE+V+ E   F  D W +G L Y ++ G SPF    +    + V+    E  EE  +
Sbjct: 167 YMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSE 226

Query: 338 NVSEEGKDFIRRLLLRN 354
             SE  +   R+LL ++
Sbjct: 227 KFSEAARSICRQLLTKD 243

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  110 bits (276), Expect = 1e-27
 Identities = 71/255 (27%), Positives = 128/255 (50%), Gaps = 35/255 (13%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDI---MNQLH-------HP 165
           +G G+FG V     + T  ++A K       L+K++I ++ D+   M +         HP
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKV------LKKDVILQDDDVECTMTEKRVLALAGKHP 56

Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            L  LH  F+  D +  + E+++GG+L   I     +  E         I++      ++
Sbjct: 57  FLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR-SGRFDEPRARFYAAEIVL-----GLQ 110

Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFAAPEI 283
            +HE+ II+ D+K +N++  +    ++K+ DFG+  K      V  ST  GT ++ APEI
Sbjct: 111 FLHERGIIYRDLKLDNVLLDSEG--HIKIADFGMC-KEGILGGVTTSTFCGTPDYIAPEI 167

Query: 284 VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAF--KNVSE 341
           +  +P G   D WA+GVL Y +L+G SPF G+++ E  +++       ++E    + +S+
Sbjct: 168 LSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL------EDEVRYPRWLSK 221

Query: 342 EGKDFIRRLLLRNKE 356
           E K  ++  L +N E
Sbjct: 222 EAKSILKSFLTKNPE 236

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  109 bits (274), Expect = 1e-27
 Identities = 76/244 (31%), Positives = 128/244 (52%), Gaps = 13/244 (5%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLIN 169
           Y   E+IG GA G V+   +  TG   A K + +    +KELI  EI +M +  +P ++N
Sbjct: 21  YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVN 80

Query: 170 LHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE 229
             D++   DE+ ++ E+L+GG L + +T  +  M E ++  V    L      A+  +H 
Sbjct: 81  YLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQ-----ALDFLHS 133

Query: 230 KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFAAPEIVERE 287
             +IH D+K +NI+     S  VK+ DFG   ++ P E  K ST  GT  + APE+V R+
Sbjct: 134 NQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITP-EQSKRSTMVGTPYWMAPEVVTRK 190

Query: 288 PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFI 347
             G   D+W++G++A  ++ G  P+  EN +  L  + A +   + +  + +S   +DF+
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-ATNGTPELQNPERLSAVFRDFL 249

Query: 348 RRLL 351
            R L
Sbjct: 250 NRCL 253

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  108 bits (273), Expect = 1e-27
 Identities = 64/208 (30%), Positives = 114/208 (54%), Gaps = 12/208 (5%)

Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN--LEKELIRKEIDIMNQLHHPKLINL 170
           L E+G G  GVV +   R TG I A K I +  N  ++K+++R E+DI+++ + P ++  
Sbjct: 6   LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILR-ELDILHKCNSPYIVGF 64

Query: 171 HDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEK 230
           + AF ++ ++ +  E++ GG L ++I     K  +  +    L  +       + ++HEK
Sbjct: 65  YGAFYNNGDISICMEYMDGGSL-DKI----LKEVQGRIPERILGKIAVAVLKGLTYLHEK 119

Query: 231 -NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPV 289
             IIH DVKP NI+  +R    +K+ DFG++ +L  N + K   GT+ + APE ++    
Sbjct: 120 HKIIHRDVKPSNILVNSRG--QIKLCDFGVSGQL-VNSLAKTFVGTSSYMAPERIQGNDY 176

Query: 290 GFYTDMWAVGVLAYVLLSGLSPFAGEND 317
              +D+W++G+    L +G  P+  END
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPPEND 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  109 bits (273), Expect = 2e-27
 Identities = 77/258 (29%), Positives = 139/258 (53%), Gaps = 20/258 (7%)

Query: 109 HYDILEEIGTGAFGVVHRCRE---RKTGNIFAAKFIPVSHNLEK----ELIRKEIDIMNQ 161
           ++++L+ +GTGA+G V   R+     +G ++A K +  +  ++K    E  R E  ++  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 162 LHH-PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
           +   P L+ LH AF+ D ++ LI ++++GGELF  ++  + +  E EV   +  I++   
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVL--- 116

Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--DPNEVVKISTGTAEF 278
             A++H+H+  II+ D+K ENI+  +    +V + DFGL+ +   D  E      GT E+
Sbjct: 117 --ALEHLHKLGIIYRDIKLENILLDSNG--HVVLTDFGLSKEFHEDEVERAYSFCGTIEY 172

Query: 279 AAPEIVEREPVGF--YTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAF 336
            AP+IV     G     D W++GVL Y LL+G SPF  + +  +   +     + +    
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 232

Query: 337 KNVSEEGKDFIRRLLLRN 354
           + +S   KD I+RLL+++
Sbjct: 233 QEMSALAKDIIQRLLMKD 250

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  108 bits (270), Expect = 2e-27
 Identities = 61/211 (28%), Positives = 115/211 (54%), Gaps = 10/211 (4%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL--EKELIRKEIDIMNQLHHPKL 167
           Y+I+++IG G+FG ++  + +        K I ++     EKE  +KE+ ++ ++ HP +
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61

Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKM-SEAEVIPVTLPILMTQTSPAVKH 226
           +    +F+++  + ++ E+  GG+L +RI      + SE +++         Q S  +KH
Sbjct: 62  VTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILS-----WFVQISLGLKH 116

Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL-DPNEVVKISTGTAEFAAPEIVE 285
           +H++ I+H D+K +NI   ++N    K+ DFG+A +L D  E+     GT  + +PEI +
Sbjct: 117 IHDRKILHRDIKSQNIFL-SKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQ 175

Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGEN 316
             P    TD+W++G + Y L +   PF G N
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHPFEGNN 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  109 bits (272), Expect = 2e-27
 Identities = 71/243 (29%), Positives = 128/243 (52%), Gaps = 11/243 (4%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLIN 169
           Y   E+IG GA G V+   +  TG   A + + +    +KELI  EI +M +  +P ++N
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 170 LHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE 229
             D++   DE+ ++ E+L+GG L + +T  +  M E ++  V    L      A++ +H 
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQ-----ALEFLHS 134

Query: 230 KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS-TGTAEFAAPEIVEREP 288
             +IH D+K +NI+     S  VK+ DFG   ++ P +  + +  GT  + APE+V R+ 
Sbjct: 135 NQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192

Query: 289 VGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIR 348
            G   D+W++G++A  ++ G  P+  EN +  L  + A +   + +  + +S   +DF+ 
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-ATNGTPELQNPEKLSAIFRDFLN 251

Query: 349 RLL 351
           R L
Sbjct: 252 RCL 254

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  109 bits (274), Expect = 2e-27
 Identities = 71/252 (28%), Positives = 131/252 (51%), Gaps = 29/252 (11%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIP---------VSHNL--EKELIRKEIDIMNQLHH 164
           IG G FG V++ R++ T  I+A K +          V+H +     L+R  +D       
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLD-----ES 55

Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P ++ L  +F+ D ++ L+ +++SGGELF  +   + + SE           + +   A+
Sbjct: 56  PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQK-EGRFSEDRA-----KFYIAELVLAL 109

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA-TKLDPNEVVKISTGTAEFAAPEI 283
           +H+H+ +I++ D+KPENI+     + ++ + DFGL+   L  N+      GT E+ APE+
Sbjct: 110 EHLHKYDIVYRDLKPENILLDA--TGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEV 167

Query: 284 -VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEE 342
            ++ +    + D W++GVL + +  G SPF  E+  +  +N+      F +     +S+E
Sbjct: 168 LLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNV---LSDE 224

Query: 343 GKDFIRRLLLRN 354
           G+ F++ LL RN
Sbjct: 225 GRQFVKGLLNRN 236

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  107 bits (269), Expect = 3e-27
 Identities = 62/260 (23%), Positives = 130/260 (50%), Gaps = 35/260 (13%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLIN 169
           +DILE++G G++G V++   ++TG + A K +PV  +L++  I KEI I+ Q   P ++ 
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQE--IIKEISILKQCDSPYIVK 62

Query: 170 LHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE 229
            + ++  + ++ ++ E+   G + + +   +  ++E E+  +       QT   ++++H 
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILY-----QTLKGLEYLHS 117

Query: 230 KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFAAPEIVERE 287
              IH D+K  NI+         K+ DFG++ +L  + + K +T  GT  + APE+++  
Sbjct: 118 NKKIHRDIKAGNILLNEEG--QAKLADFGVSGQLT-DTMAKRNTVIGTPFWMAPEVIQEI 174

Query: 288 PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVE-----------TLKNVKACDWEFDEEAF 336
                 D+W++G+ A  +  G  P++  + +            TL + +   W       
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPE--KW------- 225

Query: 337 KNVSEEGKDFIRRLLLRNKE 356
              S E  DF+++ L+++ E
Sbjct: 226 ---SPEFNDFVKKCLVKDPE 242

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  106 bits (267), Expect = 5e-27
 Identities = 57/202 (28%), Positives = 113/202 (55%), Gaps = 11/202 (5%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS--HNLEKELIRKEIDIMNQLHHPKL 167
           Y  +++IG G+FG     + ++ G  +  K I +S     E+E  RKE+ +++ + HP +
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61

Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPD-YKMSEAEVIPVTLPILMTQTSPAVKH 226
           +   ++FE++  + ++ ++  GG+L+++I A       E +++         Q   A+KH
Sbjct: 62  VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILD-----WFVQICLALKH 116

Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN-EVVKISTGTAEFAAPEIVE 285
           +H++ I+H D+K +NI   T++ T +K+ DFG+A  L+   E+ +   GT  + +PEI E
Sbjct: 117 VHDRKILHRDIKSQNIFL-TKDGT-IKLGDFGIARVLNSTVELARTCIGTPYYLSPEICE 174

Query: 286 REPVGFYTDMWAVGVLAYVLLS 307
             P    +D+WA+G + Y + +
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  107 bits (269), Expect = 6e-27
 Identities = 67/242 (27%), Positives = 125/242 (51%), Gaps = 32/242 (13%)

Query: 96  PQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKE 155
           P P  I        ++++E IG G +G V++ R +KTG + A K + +  + E+E I++E
Sbjct: 2   PDPTGI--------FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEE-IKEE 52

Query: 156 IDIMNQL-HHPKLINLHDAF------EDDDEMVLIFEFLSGG---ELFERITAPDYKMSE 205
            +I+ +  +HP +   + AF       +DD++ L+ E   GG   +L + +     ++ E
Sbjct: 53  YNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKE 112

Query: 206 AEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD- 264
            E I      ++ +T   + ++HE  +IH D+K +NI+  T+N+  VK++DFG++ +LD 
Sbjct: 113 -EWIAY----ILRETLRGLAYLHENKVIHRDIKGQNILL-TKNA-EVKLVDFGVSAQLDS 165

Query: 265 PNEVVKISTGTAEFAAPEIV--EREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVE 319
                    GT  + APE++  + +P   Y    D+W++G+ A  L  G  P    + + 
Sbjct: 166 TLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR 225

Query: 320 TL 321
            L
Sbjct: 226 AL 227

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  106 bits (267), Expect = 7e-27
 Identities = 72/262 (27%), Positives = 116/262 (44%), Gaps = 40/262 (15%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK--ELIRKEIDIMNQLHHPKLINLHDA 173
           IG G FG V+      TG + A K I +  N  K  + I  E+ ++  L HP L+  +  
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY-G 66

Query: 174 FEDDDEMVLIF-EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNI 232
            E   E V IF E+ SGG L E +      + E  +   TL +L       + ++H   I
Sbjct: 67  VEVHREKVYIFMEYCSGGTL-EELLEHGRILDEHVIRVYTLQLLE-----GLAYLHSHGI 120

Query: 233 IHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN-----EVVKISTGTAEFAAPEIVERE 287
           +H D+KP NI         +K+ DFG A KL  N     E V+   GT  + APE++   
Sbjct: 121 VHRDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178

Query: 288 PVGFY---TDMWAVGVLAYVLLSGLSPFAG-ENDVETLKNVKACDWEFDEEAFKN----- 338
               +    D+W++G +   + +G  P++  +N+ + + +V             +     
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHV----------GAGHKPPIP 228

Query: 339 ----VSEEGKDFIRRLLLRNKE 356
               +S EGKDF+ R L  + +
Sbjct: 229 DSLQLSPEGKDFLDRCLESDPK 250

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  106 bits (267), Expect = 9e-27
 Identities = 60/200 (30%), Positives = 108/200 (54%), Gaps = 15/200 (7%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKL 167
           D ++I+ E+G GAFG V++ + ++TG   AAK I +    E E    EIDI+++  HP +
Sbjct: 5   DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNI 64

Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
           + L++A+  ++++ ++ EF  GG L   +   +  ++E ++  V       Q   A+  +
Sbjct: 65  VGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYV-----CRQMLEALNFL 119

Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFAAPEIVE 285
           H   +IH D+K  NI+       +VK+ DFG++ K   + + K  T  GT  + APE+V 
Sbjct: 120 HSHKVIHRDLKAGNILLTLDG--DVKLADFGVSAKNK-STLQKRDTFIGTPYWMAPEVVA 176

Query: 286 RE-----PVGFYTDMWAVGV 300
            E     P  +  D+W++G+
Sbjct: 177 CETFKDNPYDYKADIWSLGI 196

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score =  106 bits (266), Expect = 1e-26
 Identities = 69/248 (27%), Positives = 121/248 (48%), Gaps = 21/248 (8%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK---------EIDIMNQLHHPK 166
           +G G FG V  C+ R TG ++A K       LEK+ I+K         E  I+ +++   
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACK------KLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKH 226
           +++L  A+E  D + L+   ++GG+L   I    Y M EA            +    ++ 
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHI----YHMGEAGFEEGRAVFYAAEICCGLED 117

Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVER 286
           +H++ I++ D+KPENI+    +  ++++ D GLA  +   + +K   GT  + APE+V+ 
Sbjct: 118 LHQERIVYRDLKPENILLD--DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN 175

Query: 287 EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDF 346
           E   F  D WA+G L Y +++G SPF         + V+    E  EE  +  S + +  
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSL 235

Query: 347 IRRLLLRN 354
            + LL ++
Sbjct: 236 CKMLLCKD 243

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score =  106 bits (266), Expect = 1e-26
 Identities = 69/251 (27%), Positives = 119/251 (47%), Gaps = 23/251 (9%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK---------EIDIMNQLHHPK 166
           +G G FG V  C+ R TG ++A K       LEK+ I+K         E  I+ +++   
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACK------RLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 167 LINLHDAFEDDDEMVLIFEFLSGGEL-FERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
           ++NL  A+E  D + L+   ++GG+L F      +    E   +     IL       ++
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILC-----GLE 116

Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
            +H +N ++ D+KPENI+    +  ++++ D GLA K+   E ++   GT  + APE++ 
Sbjct: 117 DLHRENTVYRDLKPENILLD--DYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLN 174

Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD 345
            +      D W +G L Y ++ G SPF G  +    + V     E +E      SEE K 
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKS 234

Query: 346 FIRRLLLRNKE 356
             + LL ++ +
Sbjct: 235 ICKMLLTKDPK 245

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  107 bits (268), Expect = 2e-26
 Identities = 64/226 (28%), Positives = 111/226 (49%), Gaps = 37/226 (16%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---IM-------NQLHHP 165
           IG G+FG V   + +  G  +A K       L+K+ I K+ +   IM         + HP
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKV------LQKKAILKKKEQKHIMAERNVLLKNVKHP 56

Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELF------ERITAPDYKMSEAEVIPVTLPILMTQ 219
            L+ LH +F+  D++  + ++++GGELF           P  +   AE+           
Sbjct: 57  FLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEI----------- 105

Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK-LDPNEVVKISTGTAEF 278
            + A+ ++H  NII+ D+KPENI+  ++   +V + DFGL  + ++ ++      GT E+
Sbjct: 106 -ASALGYLHSLNIIYRDLKPENILLDSQG--HVVLTDFGLCKEGIEHSKTTSTFCGTPEY 162

Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
            APE++ ++P     D W +G + Y +L GL PF   +  E   N+
Sbjct: 163 LAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI 208

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  107 bits (269), Expect = 2e-26
 Identities = 78/278 (28%), Positives = 139/278 (50%), Gaps = 35/278 (12%)

Query: 92  SKYVPQPVDIKTSSV-YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK- 149
           S+Y      I    +  + +D+++ IG GAFG V   R + +  ++A K       L K 
Sbjct: 26  SRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKL------LSKF 79

Query: 150 ELIRK--------EIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDY 201
           E+I++        E DIM   +   ++ LH AF+DD  + ++ E++ GG+L   ++  +Y
Sbjct: 80  EMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMS--NY 137

Query: 202 KMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT 261
            + E      T  +++     A+  +H    IH DVKP+N++     S ++K+ DFG   
Sbjct: 138 DIPEKWARFYTAEVVL-----ALDAIHSMGFIHRDVKPDNMLLDK--SGHLKLADFGTCM 190

Query: 262 KLDPNEVVKIST--GTAEFAAPEIVEREPV-GFY---TDMWAVGVLAYVLLSGLSPFAGE 315
           K+D N +V+  T  GT ++ +PE+++ +   G+Y    D W+VGV  Y +L G +PF  +
Sbjct: 191 KMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250

Query: 316 NDVETLKNV--KACDWEFDEEAFKNVSEEGKDFIRRLL 351
           + V T   +        F ++    +S++ KD I   L
Sbjct: 251 SLVGTYSKIMDHKNSLTFPDDI--EISKQAKDLICAFL 286

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  106 bits (266), Expect = 2e-26
 Identities = 69/279 (24%), Positives = 126/279 (45%), Gaps = 53/279 (18%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE---KELIRKEIDIMNQLHHPK 166
           Y+ LE++G G +GVV++ R++KTG I A K I + +  E      +R EI ++ +L HP 
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR-EISLLKELKHPN 59

Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKH 226
           ++ L D    + ++ L+FE+    +L + +      +S   +  +   +L       + +
Sbjct: 60  IVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLR-----GLAY 113

Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA------TKLDPNEVVKISTGTAEFAA 280
            H   I+H D+KP+NI+        +K+ DFGLA       +   +EVV     T  + A
Sbjct: 114 CHSHRILHRDLKPQNILINRDG--VLKLADFGLARAFGIPLRTYTHEVV-----TLWYRA 166

Query: 281 PEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETLK--------------- 322
           PEI+       Y+   D+W+VG +   +++G   F G+++++ L                
Sbjct: 167 PEILLGSK--HYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWP 224

Query: 323 NVKACDW---EFD-------EEAFKNVSEEGKDFIRRLL 351
            V         F        E+    +  EG D + ++L
Sbjct: 225 GVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKML 263

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  106 bits (266), Expect = 2e-26
 Identities = 75/288 (26%), Positives = 128/288 (44%), Gaps = 63/288 (21%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL--------IRKEIDIMNQ 161
           Y+  +++G G + VV++ R+++TG I A K I +     KE         +R EI ++ +
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGE--RKEAKDGINFTALR-EIKLLQE 58

Query: 162 LHHPKLINLHDAFEDDDEMVLIFEFLSG------GELFERITAPDYKMSEAEVIPVTLPI 215
           L HP +I L D F     + L+FEF+         +    +T  D K             
Sbjct: 59  LKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKS------------ 106

Query: 216 LMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTN--VKMIDFGLATKL-DPNEVVKIS 272
            M  T   ++++H   I+H D+KP N++     +++  +K+ DFGLA     PN  +   
Sbjct: 107 YMLMTLRGLEYLHSNWILHRDLKPNNLLI----ASDGVLKLADFGLARSFGSPNRKMTHQ 162

Query: 273 TGTAEFAAPEIV--EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV-KAC-- 327
             T  + APE++   R   G   DMW+VG +   LL  +    G++D++ L  + +A   
Sbjct: 163 VVTRWYRAPELLFGARH-YGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGT 221

Query: 328 ----DW----------EFDE-------EAFKNVSEEGKDFIRRLLLRN 354
               +W          EF         + F   S++  D ++RLL  N
Sbjct: 222 PTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLN 269

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  105 bits (264), Expect = 4e-26
 Identities = 66/239 (27%), Positives = 111/239 (46%), Gaps = 53/239 (22%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE-----LIRKEIDIMNQLHH 164
           Y+ + +IG G +G V++ R +KTG + A K I + +  EKE      IR EI ++ +L H
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN--EKEGFPITAIR-EIKLLQKLRH 57

Query: 165 PKLINLHDAFEDDDEMV---------LIFEF----LSGGELFERITAPDYKMSEAEVIPV 211
           P ++ L        E+V         ++FE+    L+G  L +    P+ K +E+++   
Sbjct: 58  PNIVRLK-------EIVTSKGKGSIYMVFEYMDHDLTG--LLDS---PEVKFTESQIKCY 105

Query: 212 TLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP------ 265
              +L       ++++H   I+H D+K  NI+    N   +K+ DFGLA           
Sbjct: 106 MKQLLE-----GLQYLHSNGILHRDIKGSNILIN--NDGVLKLADFGLARPYTKRNSADY 158

Query: 266 -NEVVKISTGTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLK 322
            N V+     T  +  PE++      G   DMW+VG +   L  G   F G  ++E L+
Sbjct: 159 TNRVI-----TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLE 212

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  105 bits (263), Expect = 4e-26
 Identities = 59/213 (27%), Positives = 118/213 (55%), Gaps = 12/213 (5%)

Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           +IG G+ G+V    E+ TG   A K + +     +EL+  E+ IM   HH  ++++++++
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
              DE+ ++ EFL GG L + +T    +M+E ++  V L +L      A+ ++H + +IH
Sbjct: 89  LVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIATVCLSVLR-----ALSYLHNQGVIH 141

Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFAAPEIVEREPVGFY 292
            D+K ++I+  +     +K+ DFG   ++   EV K  +  GT  + APE++ R P G  
Sbjct: 142 RDIKSDSILLTS--DGRIKLSDFGFCAQVS-KEVPKRKSLVGTPYWMAPEVISRLPYGTE 198

Query: 293 TDMWAVGVLAYVLLSGLSPFAGENDVETLKNVK 325
            D+W++G++   ++ G  P+  E  ++ ++ ++
Sbjct: 199 VDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIR 231

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  105 bits (264), Expect = 5e-26
 Identities = 62/220 (28%), Positives = 110/220 (50%), Gaps = 25/220 (11%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIP----VSHNLEKELIRKEIDIMNQLHHPKLINLH 171
           IG G+FG V   R +     +A K +     +    EK ++ +   ++  + HP L+ LH
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 172 DAFEDDDEMVLIFEFLSGGELF-----ER-ITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            +F+  D++  + ++++GGELF     ER    P  +   AE+            + A+ 
Sbjct: 63  FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEI------------ASALG 110

Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK-LDPNEVVKISTGTAEFAAPEIV 284
           ++H  NI++ D+KPENI+  ++   ++ + DFGL  + ++ N       GT E+ APE++
Sbjct: 111 YLHSLNIVYRDLKPENILLDSQG--HIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVL 168

Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
            ++P     D W +G + Y +L GL PF   N  E   N+
Sbjct: 169 HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI 208

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score =  104 bits (261), Expect = 7e-26
 Identities = 73/257 (28%), Positives = 120/257 (46%), Gaps = 24/257 (9%)

Query: 107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK---------EID 157
           + HY +L   G G FG V  C+ R TG ++A K       LEK+ I+K         E  
Sbjct: 2   FRHYRVL---GKGGFGEVCACQVRATGKMYACK------KLEKKRIKKRKGEAMALNEKR 52

Query: 158 IMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM 217
           I+ +++   +++L  A+E  D + L+   ++GG+L   I    Y M              
Sbjct: 53  ILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHI----YNMGNPGFDEQRAIFYA 108

Query: 218 TQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAE 277
            +    ++ +  + I++ D+KPENI+   R   ++++ D GLA ++   E V+   GT  
Sbjct: 109 AELCCGLEDLQRERIVYRDLKPENILLDDRG--HIRISDLGLAVQIPEGETVRGRVGTVG 166

Query: 278 FAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
           + APE++  E   F  D W +G L Y ++ G SPF    +    + V     E  EE  +
Sbjct: 167 YMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSE 226

Query: 338 NVSEEGKDFIRRLLLRN 354
             SE+ K   R LL +N
Sbjct: 227 KFSEDAKSICRMLLTKN 243

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  104 bits (261), Expect = 8e-26
 Identities = 56/212 (26%), Positives = 109/212 (51%), Gaps = 21/212 (9%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK-----ELIRKEIDIMNQLHH 164
           + +LE IG G+FG V++  +++T  + A K I    +LE+     E I++EI  ++Q   
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVI----DLEEAEDEIEDIQQEIQFLSQCRS 58

Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P +   + +F    ++ +I E+  GG   + +     K+ E  +  +   +L+      +
Sbjct: 59  PYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP--GKLDETYIAFILREVLL-----GL 111

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFAAPE 282
           +++HE+  IH D+K  NI+       +VK+ DFG++ +L    + K +T  GT  + APE
Sbjct: 112 EYLHEEGKIHRDIKAANIL--LSEEGDVKLADFGVSGQLTST-MSKRNTFVGTPFWMAPE 168

Query: 283 IVEREPVGFYTDMWAVGVLAYVLLSGLSPFAG 314
           ++++       D+W++G+ A  L  G  P + 
Sbjct: 169 VIKQSGYDEKADIWSLGITAIELAKGEPPLSD 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  103 bits (259), Expect = 3e-25
 Identities = 76/256 (29%), Positives = 137/256 (53%), Gaps = 19/256 (7%)

Query: 110 YDILEEIGTGAFGVVHRCRE---RKTGNIFAAKFIPVSHNLEK----ELIRKEIDIMNQL 162
           +++L+ +GTGA+G V   R+     TG ++A K +  +  ++K    E  R E +++  +
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61

Query: 163 HH-PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTS 221
              P L+ LH AF+ + ++ LI +++SGGE+F  +   D   SE EV   +  I++    
Sbjct: 62  RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDN-FSEDEVRFYSGEIIL---- 116

Query: 222 PAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFA 279
            A++H+H+  I++ D+K ENI+  +    +V + DFGL+ +    E  +  +  GT E+ 
Sbjct: 117 -ALEHLHKLGIVYRDIKLENILLDSEG--HVVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173

Query: 280 APEIVE-REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKN 338
           APEI+  +   G   D W++G+L + LL+G SPF  E +  T   V     + D      
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSF 233

Query: 339 VSEEGKDFIRRLLLRN 354
           +  E +D + +LL ++
Sbjct: 234 IGPEAQDLLHKLLRKD 249

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  102 bits (256), Expect = 3e-25
 Identities = 61/217 (28%), Positives = 105/217 (48%), Gaps = 20/217 (9%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK-----ELIRKEIDIMNQL 162
           D Y+++E IG GA  VV+           A K I    +LEK     + +RKE+  M+Q 
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRI----DLEKCQTSVDELRKEVQAMSQC 56

Query: 163 HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSP 222
           +HP ++  + +F   DE+ L+  +LSGG L + +           +    +  ++ +   
Sbjct: 57  NHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMK---SSYPRGGLDEAIIATVLKEVLK 113

Query: 223 AVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN-----EVVKISTGTAE 277
            ++++H    IH D+K  NI+     S  VK+ DFG++  L        +V K   GT  
Sbjct: 114 GLEYLHSNGQIHRDIKAGNILLGEDGS--VKIADFGVSASLADGGDRTRKVRKTFVGTPC 171

Query: 278 FAAPEIVE-REPVGFYTDMWAVGVLAYVLLSGLSPFA 313
           + APE++E      F  D+W+ G+ A  L +G +P++
Sbjct: 172 WMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYS 208

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  103 bits (258), Expect = 4e-25
 Identities = 76/255 (29%), Positives = 119/255 (46%), Gaps = 34/255 (13%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAK-----FIPVSHNLEKELIRKEI-DIMNQLHHPKLIN 169
           +G G FG V     +KTG ++A K      I     +E  +  K I +  N   HP L+N
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 170 LHDAFEDDDEMVLIFEFLSGGELF-----ERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           L   F+ +D +  + E+ +GG+L      +  + P      A V+              +
Sbjct: 67  LFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVL------------GL 114

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFAAPE 282
           +++HE  I++ D+K +N++  T     VK+ DFGL  K       + ST  GT EF APE
Sbjct: 115 QYLHENKIVYRDLKLDNLLLDTEG--FVKIADFGLC-KEGMGFGDRTSTFCGTPEFLAPE 171

Query: 283 IVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAF-KNVSE 341
           ++         D W +GVL Y +L G SPF G+++ E   ++       DE  + + +S 
Sbjct: 172 VLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN-----DEVRYPRFLSR 226

Query: 342 EGKDFIRRLLLRNKE 356
           E    +RRLL RN E
Sbjct: 227 EAISIMRRLLRRNPE 241

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  103 bits (257), Expect = 4e-25
 Identities = 73/247 (29%), Positives = 126/247 (51%), Gaps = 20/247 (8%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK---EIDIMNQLHHPKLINLHD 172
           IG G+FG V + R+R T  I+A K I  +H + +  +     E  ++ Q++ P ++ L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 173 AFEDDDEMVLIFEFLSGGELFERITAPD-YKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
           +F+  +++ L+  F++GGELF  +     + +S A      L         A++++H+ N
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLC-------ALENLHKFN 113

Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFAAPEIVEREPV 289
           +I+ D+KPENI+   +   ++ + DFGL  KL+  +  K +T  GT E+ APE++     
Sbjct: 114 VIYRDLKPENILLDYQG--HIALCDFGLC-KLNMKDDDKTNTFCGTPEYLAPELLLGHGY 170

Query: 290 GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRR 349
               D W +GVL Y +L+GL PF  EN  E  + +      F +        + KD +  
Sbjct: 171 TKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPD----GFDRDAKDLLIG 226

Query: 350 LLLRNKE 356
           LL R+  
Sbjct: 227 LLSRDPT 233

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  103 bits (257), Expect = 4e-25
 Identities = 62/208 (29%), Positives = 108/208 (51%), Gaps = 25/208 (12%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE----LIRKEIDIMNQLHHPKLINLH 171
           IG G+FG V   + +  G+ +A K +     L+K+    ++ +   ++  L HP L+ LH
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 172 DAFEDDDEMVLIFEFLSGGELF------ERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            +F+  +++  + ++++GGELF           P  +   AEV            + A+ 
Sbjct: 63  YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEV------------ASAIG 110

Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK-LDPNEVVKISTGTAEFAAPEIV 284
           ++H  NII+ D+KPENI+  ++   +V + DFGL  + ++P E      GT E+ APE++
Sbjct: 111 YLHSLNIIYRDLKPENILLDSQG--HVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVL 168

Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPF 312
            +EP     D W +G + Y +L GL PF
Sbjct: 169 RKEPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  102 bits (255), Expect = 5e-25
 Identities = 66/242 (27%), Positives = 127/242 (52%), Gaps = 13/242 (5%)

Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           +IG G+ G+V     + +G + A K + +     +EL+  E+ IM    H  ++ +++++
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
              DE+ ++ EFL GG L + +T    +M+E ++  V L +L      A+  +H + +IH
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLK-----ALSVLHAQGVIH 139

Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVV--KISTGTAEFAAPEIVEREPVGFY 292
            D+K ++I+    +   VK+ DFG   ++   EV   K   GT  + APE++ R P G  
Sbjct: 140 RDIKSDSILLT--HDGRVKLSDFGFCAQVS-KEVPRRKSLVGTPYWMAPELISRLPYGPE 196

Query: 293 TDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLL 352
            D+W++G++   ++ G  P+  E  ++ +K ++  +     +    VS   K F+ RLL+
Sbjct: 197 VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-NLPPKLKNLHKVSPSLKGFLDRLLV 255

Query: 353 RN 354
           R+
Sbjct: 256 RD 257

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  101 bits (254), Expect = 5e-25
 Identities = 53/224 (23%), Positives = 108/224 (48%), Gaps = 17/224 (7%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIF----AAKFIPVSHNL-EKELIRKEIDIMNQLHHPK 166
           + +++G GAFG V++ + +  G       A K +    +  + E   +E  IM +L HP 
Sbjct: 3   LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKH 226
           ++ L     +++ + ++ E++ GG+L   +     K+S ++++         Q +  +++
Sbjct: 63  VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLL-----SFALQIARGMEY 117

Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFA--APE-I 283
           +  KN IH D+   N +        VK+ DFGL+  L  ++  +   G       APE +
Sbjct: 118 LESKNFIHRDLAARNCLVGENL--VVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESL 175

Query: 284 VEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKA 326
            E +     +D+W+ GVL + + + G  P+ G ++ E L+ +K 
Sbjct: 176 KEGK-FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKN 218

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score =  102 bits (256), Expect = 7e-25
 Identities = 71/255 (27%), Positives = 130/255 (50%), Gaps = 18/255 (7%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL---EKELIRKEIDIMNQLHH 164
           + ++IL+ IG GAFG V   + +    +FA K +     L   E    R+E D++    +
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
             +  LH AF+D++ + L+ ++  GG+L   ++  + ++ E           + +   A+
Sbjct: 61  QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPED-----MARFYLAEMVIAI 115

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVK--ISTGTAEFAAPE 282
             +H+ + +H D+KP+NI+       ++++ DFG   KL  +  V+  ++ GT ++ +PE
Sbjct: 116 DSVHQLHYVHRDIKPDNILMDMNG--HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 173

Query: 283 IVE-----REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEA-F 336
           I++     +   G   D W++GV  Y +L G +PF  E+ VET   +      F   A  
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQV 233

Query: 337 KNVSEEGKDFIRRLL 351
            +VSE+ KD IRRL+
Sbjct: 234 TDVSEDAKDLIRRLI 248

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  100 bits (251), Expect = 9e-25
 Identities = 63/208 (30%), Positives = 105/208 (50%), Gaps = 14/208 (6%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVS-HNLEKELIRKEIDIMNQLHHPK 166
           Y++L  +G G+FG     +   +   +A K I  P S   +E    RKE  ++ ++ HP 
Sbjct: 2   YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDS--RKEAVLLAKMKHPN 59

Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPV-TLPILMTQTSPAVK 225
           ++   ++FE D  + ++ E+  GG+L ++I     K+   ++ P  T+     Q    V+
Sbjct: 60  IVAFKESFEADGHLYIVMEYCDGGDLMQKI-----KLQRGKLFPEDTILQWFVQMCLGVQ 114

Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL-DPNEVVKISTGTAEFAAPEIV 284
           H+HEK ++H D+K +NI   T+N   VK+ DFG A  L  P        GT  +  PEI 
Sbjct: 115 HIHEKRVLHRDIKSKNIFL-TQNG-KVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIW 172

Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPF 312
           E  P    +D+W++G + Y L +   PF
Sbjct: 173 ENMPYNNKSDIWSLGCILYELCTLKHPF 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  100 bits (252), Expect = 1e-24
 Identities = 71/258 (27%), Positives = 128/258 (49%), Gaps = 24/258 (9%)

Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN--LEKELIRKEIDIMNQLHHPKLINL 170
           L  +G GA G V +CR + TG IFA K I    N  L+K+++R E++I      P ++  
Sbjct: 6   LSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR-ELEINKSCKSPYIVKY 64

Query: 171 HDAF--EDDDEMVLIFEFLSGGEL---FERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
           + AF  E    + +  E+  GG L   ++++     ++ E  +  +   +L       + 
Sbjct: 65  YGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVL-----KGLS 119

Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           ++H + IIH D+KP NI+  TR    VK+ DFG++ +L  N +    TGT+ + APE ++
Sbjct: 120 YLHSRKIIHRDIKPSNILL-TRKG-QVKLCDFGVSGEL-VNSLAGTFTGTSFYMAPERIQ 176

Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGEND--------VETLKNVKACDWEFDEEAFK 337
            +P    +D+W++G+    +     PF  E +        +  + N+   + + +     
Sbjct: 177 GKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGI 236

Query: 338 NVSEEGKDFIRRLLLRNK 355
             SEE KDFI++ L ++ 
Sbjct: 237 KWSEEFKDFIKQCLEKDP 254

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score =  101 bits (253), Expect = 2e-24
 Identities = 69/255 (27%), Positives = 133/255 (52%), Gaps = 18/255 (7%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL---EKELIRKEIDIMNQLHH 164
           D ++I++ IG GAFG V   + + T  I+A K +     L   E    R+E +++     
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
             +  LH AF+D++ + L+ ++  GG+L   ++  + ++ E           + +   A+
Sbjct: 61  QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPED-----MARFYIAEMVLAI 115

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVK--ISTGTAEFAAPE 282
             +H+ + +H D+KP+N++       ++++ DFG   K++ +  V+  ++ GT ++ +PE
Sbjct: 116 HSIHQLHYVHRDIKPDNVLLDMNG--HIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173

Query: 283 IVE--REPVGFY---TDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD-EEAF 336
           I++   + +G Y    D W++GV  Y +L G +PF  E+ VET   +   +  F      
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHI 233

Query: 337 KNVSEEGKDFIRRLL 351
            +VSEE KD I+RL+
Sbjct: 234 TDVSEEAKDLIQRLI 248

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 99.2 bits (248), Expect = 4e-24
 Identities = 53/225 (23%), Positives = 110/225 (48%), Gaps = 18/225 (8%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIF----AAKFIPVSHNL-EKELIRKEIDIMNQLHHPK 166
           + +++G GAFG V++   +  G+      A K +    +  + E   +E  IM +L HP 
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPV-TLPILMTQTSPAVK 225
           ++ L     +++ ++++ E++ GG+L + +     + +  + + +  L     Q +  ++
Sbjct: 63  IVKLLGVCTEEEPLMIVMEYMPGGDLLDYL-----RKNRPKELSLSDLLSFALQIARGME 117

Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFA--APE- 282
           ++  KN IH D+   N +        VK+ DFGL+  L  ++  K+  G       APE 
Sbjct: 118 YLESKNFIHRDLAARNCLVGENL--VVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPES 175

Query: 283 IVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKA 326
           + E +     +D+W+ GVL + + + G  P+ G ++ E L+ +K 
Sbjct: 176 LKEGK-FTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKK 219

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 98.7 bits (246), Expect = 5e-24
 Identities = 60/247 (24%), Positives = 126/247 (51%), Gaps = 16/247 (6%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS--HNLEKELIRKEIDIMNQLHHPKL 167
           + +L+++G G++G V++ +       +A K + +      E+E    EI I+  ++HP +
Sbjct: 2   FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61

Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK---MSEAEVIPVTLPILMTQTSPAV 224
           I+  +AF D +++ ++ E+   G+L + I+    K   + E E+  + + +L       +
Sbjct: 62  ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLR-----GL 116

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           + +HE+ I+H D+K  NI+     +  VK+ D G++ K+    + K   GT  + APE+ 
Sbjct: 117 QALHEQKILHRDLKSANIL--LVANDLVKIGDLGIS-KVLKKNMAKTQIGTPHYMAPEVW 173

Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
           +  P  + +D+W++G L Y + +   PF     ++ L   K    ++        S++ +
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPPFEAR-SMQDL-RYKVQRGKYPPIPPIY-SQDLQ 230

Query: 345 DFIRRLL 351
           +FIR +L
Sbjct: 231 NFIRSML 237

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score =  100 bits (251), Expect = 5e-24
 Identities = 79/285 (27%), Positives = 130/285 (45%), Gaps = 55/285 (19%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL---IRKEIDIMNQLHH 164
           D ++ L+ IG GAFG V   +++ TG+I+A K +  +  LEKE    IR E DI+ +   
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
             ++ +  +F+D   + LI EFL GG++   +   D  +SE           + +T  A+
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKD-TLSEEAT-----QFYIAETVLAI 114

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--------------------- 263
             +H+   IH D+KP+N++   +   +VK+ DFGL T L                     
Sbjct: 115 DAIHQLGFIHRDIKPDNLLLDAKG--HVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFS 172

Query: 264 ---------------DPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSG 308
                          +  ++   + GT ++ APE+  +       D W++GV+ Y +L G
Sbjct: 173 FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Query: 309 LSPFAGENDVETLKNVKACDWE----FDEEAFKNVSEEGKDFIRR 349
             PF  E   ET +  K  +W+    F  E    +SE+ KD I R
Sbjct: 233 YPPFCSETPQETYR--KVMNWKETLVFPPEV--PISEKAKDLILR 273

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 98.4 bits (246), Expect = 9e-24
 Identities = 67/224 (29%), Positives = 104/224 (46%), Gaps = 41/224 (18%)

Query: 149 KELIRKEIDIMN---------QL--HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERIT 197
           K  ++K I   N         QL   +P  I L+ +       VLI +++  G+LF+ + 
Sbjct: 42  KLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLK 101

Query: 198 APDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDF 257
               K+SEAEV       ++ Q   A+  +H+ NIIH D+K EN++   R    + + D+
Sbjct: 102 KEG-KLSEAEVK-----KIIRQLVEALNDLHKHNIIHNDIKLENVLY-DRAKDRIYLCDY 154

Query: 258 GLATKLDPNEVVKI----ST--GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSP 311
           GL          KI    S   GT ++ +PE ++        D WAVGVL Y LL+G  P
Sbjct: 155 GL---------CKIIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHP 205

Query: 312 FAGEND----VETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLL 351
           F  + D    +E+L   +     F     KNVS+   DF++ +L
Sbjct: 206 FKEDEDEELDLESLLKRQQKKLPF----IKNVSKNANDFVQSML 245

Length = 267

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 98.9 bits (246), Expect = 1e-23
 Identities = 61/246 (24%), Positives = 126/246 (51%), Gaps = 21/246 (8%)

Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           +IG G+ G+V   RE+ +G   A K + +     +EL+  E+ IM    H  ++ ++ ++
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
              +E+ ++ EFL GG L + ++    +++E ++  V   +L      A+ ++H + +IH
Sbjct: 88  LVGEELWVLMEFLQGGALTDIVS--QTRLNEEQIATVCESVLQ-----ALCYLHSQGVIH 140

Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS-TGTAEFAAPEIVEREPVGFYT 293
            D+K ++I+        VK+ DFG   ++  +   + S  GT  + APE++ R P G   
Sbjct: 141 RDIKSDSILLTL--DGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV 198

Query: 294 DMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE-----EAFKNVSEEGKDFIR 348
           D+W++G++   ++ G  P+  ++ V+ +K ++      D      +    +S   +DF+ 
Sbjct: 199 DIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR------DSPPPKLKNAHKISPVLRDFLE 252

Query: 349 RLLLRN 354
           R+L R 
Sbjct: 253 RMLTRE 258

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 97.0 bits (242), Expect = 3e-23
 Identities = 71/222 (31%), Positives = 106/222 (47%), Gaps = 28/222 (12%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAK-FIPVSHNLEKELIRKEIDIMNQL-HHPKL 167
           Y IL +IG G F  V + + RKTG  +A K       +LE+    +EI  + +L  HP +
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI 60

Query: 168 INLHDAFEDDDE--MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
           + L +   D     + L+FE L    L+E I      + E  V        M Q   ++ 
Sbjct: 61  LRLIEVLFDRKTGRLALVFE-LMDMNLYELIKGRKRPLPEKRV-----KSYMYQLLKSLD 114

Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFG----LATKLDPNEVVKISTGTAEFAAP 281
           HMH   I H D+KPENI+        +K+ DFG    + +K    E   IS  T  + AP
Sbjct: 115 HMHRNGIFHRDIKPENILI---KDDILKLADFGSCRGIYSKPPYTEY--IS--TRWYRAP 167

Query: 282 EIVEREPVGFYT---DMWAVGVLAYVLLSGLSP-FAGENDVE 319
           E +  +  G+Y    D+WAVG + + +LS L P F G N+++
Sbjct: 168 ECLLTD--GYYGPKMDIWAVGCVFFEILS-LFPLFPGTNELD 206

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 96.8 bits (241), Expect = 3e-23
 Identities = 71/251 (28%), Positives = 125/251 (49%), Gaps = 25/251 (9%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAK---FIPVSHNLEKEL--IRKEIDIMNQLHHPKLINL 170
           +G GAFG V+ C +  TG   A K   F P S   +KE+  +  EI ++  L H +++  
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 171 HDAFEDDDEMVLIFEFLSGGELFERITAPDY-KMSEAEVIPVTLPILMTQTSPAVKHMHE 229
           +    DD+ + +  E++ GG + +++ A  Y  ++E      T  IL       V+++H 
Sbjct: 70  YGCLRDDETLSIFMEYMPGGSVKDQLKA--YGALTETVTRKYTRQIL-----EGVEYLHS 122

Query: 230 KNIIHLDVKPENIMCQTRNST-NVKMIDFGLATKLDP----NEVVKISTGTAEFAAPEIV 284
             I+H D+K  NI+   R+S  NVK+ DFG + +L         +K  TGT  + +PE++
Sbjct: 123 NMIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179

Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV-KACDWEFDEEAFKNVSEEG 343
             E  G   D+W+VG     +L+   P+A   + E +  + K      + +   +VS + 
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLTEKPPWA---EFEAMAAIFKIATQPTNPQLPSHVSPDA 236

Query: 344 KDFIRRLLLRN 354
           ++F+RR  + N
Sbjct: 237 RNFLRRTFVEN 247

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 96.9 bits (241), Expect = 3e-23
 Identities = 65/217 (29%), Positives = 106/217 (48%), Gaps = 24/217 (11%)

Query: 114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK------ELIRKEIDIMNQLHHPKL 167
           +++GTGAF   ++ R+ KTG + A K +    N         E +RKEI +M +L+HP +
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDY-KMSEAEVIPVTLPILMTQTSPAVKH 226
           I +  A  +D    L  E+++GG +   ++   Y    EA +I  T  +L       + +
Sbjct: 66  IRMLGATCEDSHFNLFVEWMAGGSVSHLLS--KYGAFKEAVIINYTEQLLR-----GLSY 118

Query: 227 MHEKNIIHLDVKPENIMCQTRNST--NVKMIDFGLATKLDPN-----EVVKISTGTAEFA 279
           +HE  IIH DVK  N++    +ST   +++ DFG A +L        E      GT  F 
Sbjct: 119 LHENQIIHRDVKGANLLI---DSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175

Query: 280 APEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN 316
           APE++  E  G   D+W+VG +   + +   P+  E 
Sbjct: 176 APEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK 212

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 96.9 bits (241), Expect = 4e-23
 Identities = 70/252 (27%), Positives = 125/252 (49%), Gaps = 24/252 (9%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK---------EIDIMNQLHHPK 166
           +G G FG V   + + TG ++A K       L+K+ ++K         E +I+ +++ P 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACK------KLDKKRLKKKSGEKMALLEKEILEKVNSPF 54

Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKH 226
           ++NL  AFE    + L+   ++GG+L   I    Y + E  +    +     Q +  + H
Sbjct: 55  IVNLAYAFESKTHLCLVMSLMNGGDLKYHI----YNVGERGLEMERVIHYSAQITCGILH 110

Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVER 286
           +H  +I++ D+KPEN++    +  N ++ D GLA +L   + +    GT  + APEI++ 
Sbjct: 111 LHSMDIVYRDMKPENVLLD--DQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKE 168

Query: 287 EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK--NVSEEGK 344
           EP  +  D +A+G   Y +++G +PF    +    + +K    E DE  F+  N +EE K
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE-DEVKFEHQNFTEESK 227

Query: 345 DFIRRLLLRNKE 356
           D  R  L +  E
Sbjct: 228 DICRLFLAKKPE 239

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 97.4 bits (242), Expect = 6e-23
 Identities = 61/220 (27%), Positives = 112/220 (50%), Gaps = 25/220 (11%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAKF----IPVSHNLEKELIRKEIDIMNQLHHPKLINLH 171
           IG G+FG V   + +  G  +A K     I ++   +K ++ +   ++  + HP L+ LH
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 172 DAFEDDDEMVLIFEFLSGGELF-----ER-ITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            +F+  +++  + +F++GGELF     ER    P  +   AE+            + A+ 
Sbjct: 63  YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEI------------ASALG 110

Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK-LDPNEVVKISTGTAEFAAPEIV 284
           ++H  NI++ D+KPENI+  ++   +V + DFGL  + +  ++      GT E+ APE++
Sbjct: 111 YLHSINIVYRDLKPENILLDSQG--HVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVI 168

Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
            ++P     D W +G + Y +L GL PF   +  E   N+
Sbjct: 169 RKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNI 208

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 97.8 bits (243), Expect = 6e-23
 Identities = 77/286 (26%), Positives = 129/286 (45%), Gaps = 55/286 (19%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL---IRKEIDIMNQLHH 164
           + ++ L+ IG GAFG V   +++ TG+++A K +  +  LEKE    IR E DI+ +   
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
             ++ +  +F+D   + LI EFL GG++   +   D    E           + +T  A+
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEET------QFYIAETVLAI 114

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT----------------------- 261
             +H+   IH D+KP+N++  ++   +VK+ DFGL T                       
Sbjct: 115 DSIHQLGFIHRDIKPDNLLLDSKG--HVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFT 172

Query: 262 -------------KLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSG 308
                        K +  ++   + GT ++ APE+  +       D W++GV+ Y +L G
Sbjct: 173 FQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Query: 309 LSPFAGENDVETLKNVKACDWE----FDEEAFKNVSEEGKDFIRRL 350
             PF  E   ET K  K  +W+    F  E    +SE+ KD I R 
Sbjct: 233 YPPFCSETPQETYK--KVMNWKETLIFPPEV--PISEKAKDLILRF 274

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 95.9 bits (238), Expect = 1e-22
 Identities = 77/256 (30%), Positives = 128/256 (50%), Gaps = 20/256 (7%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKL 167
           + ++I+ E+G GAFG V++ + ++TG + AAK I      E E    EIDI+    HP +
Sbjct: 5   EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 64

Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLP---ILMTQTSPAV 224
           + L DAF  ++ + ++ EF +GG       A D  M E E  P+T P   ++  QT  A+
Sbjct: 65  VKLLDAFYYENNLWILIEFCAGG-------AVDAVMLELER-PLTEPQIRVVCKQTLEAL 116

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS-TGTAEFAAPEI 283
            ++HE  IIH D+K  NI+       ++K+ DFG++ K       + S  GT  + APE+
Sbjct: 117 NYLHENKIIHRDLKAGNILFTL--DGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEV 174

Query: 284 VERE-----PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKN 338
           V  E     P  +  D+W++G+    +     P    N +  L  +   +     +  + 
Sbjct: 175 VMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSR- 233

Query: 339 VSEEGKDFIRRLLLRN 354
            S E KDF+++ L +N
Sbjct: 234 WSSEFKDFLKKCLEKN 249

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 95.5 bits (237), Expect = 1e-22
 Identities = 62/227 (27%), Positives = 110/227 (48%), Gaps = 10/227 (4%)

Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR---KEIDIMNQLHHP 165
           ++ I ++IG G F  V+R      G   A K + +   ++ +      KEID++ QL+HP
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            +I  + +F +D+E+ ++ E    G+L   I    +K  +  +   T+     Q   A++
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIK--HFKKQKRLIPEKTVWKYFVQLCSALE 120

Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS-TGTAEFAAPEIV 284
           HMH + ++H D+KP N+      +  VK+ D GL            S  GT  + +PE +
Sbjct: 121 HMHSRRVMHRDIKPANVFITA--TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178

Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGE--NDVETLKNVKACDW 329
                 F +D+W++G L Y + +  SPF G+  N     K ++ CD+
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY 225

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 97.2 bits (242), Expect = 1e-22
 Identities = 74/251 (29%), Positives = 120/251 (47%), Gaps = 29/251 (11%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           IG+GA G V++   R TG ++A K I  +H +  +  I +EI+I+  ++HP ++  HD F
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF 141

Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
           + + E+ ++ EF+ GG L     A      E  +  V   IL       + ++H ++I+H
Sbjct: 142 DHNGEIQVLLEFMDGGSLEGTHIA-----DEQFLADVARQIL-----SGIAYLHRRHIVH 191

Query: 235 LDVKPENIMCQTRNSTNVKMIDFG----LATKLDPNEVVKISTGTAEFAAPEIVEREPV- 289
            D+KP N++  +    NVK+ DFG    LA  +DP      S GT  + +PE +  +   
Sbjct: 192 RDIKPSNLLINSAK--NVKIADFGVSRILAQTMDP---CNSSVGTIAYMSPERINTDLNH 246

Query: 290 ----GFYTDMWAVGVLAYVLLSGLSPFA--GENDVETLKNVKACDWEFDEEAFKNVSEEG 343
               G+  D+W++GV       G  PF    + D  +L  + A       EA    S E 
Sbjct: 247 GAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASL--MCAICMSQPPEAPATASREF 304

Query: 344 KDFIRRLLLRN 354
           + FI   L R 
Sbjct: 305 RHFISCCLQRE 315

Length = 353

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 96.7 bits (240), Expect = 1e-22
 Identities = 58/203 (28%), Positives = 108/203 (53%), Gaps = 15/203 (7%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIP---VSHNLEKELIRKEIDIMNQL-HHPKLINLH 171
           IG G++  V   R +KT  I+A K +    V+ + + + ++ E  +  Q  +HP L+ LH
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT-QTSPAVKHMHEK 230
             F+ +  +  + E+++GG+L        + M     +P       + + S A+ ++HE+
Sbjct: 63  SCFQTESRLFFVIEYVNGGDLM-------FHMQRQRKLPEEHARFYSAEISLALNYLHER 115

Query: 231 NIIHLDVKPENIMCQTRNSTNVKMIDFGLATK-LDPNEVVKISTGTAEFAAPEIVEREPV 289
            II+ D+K +N++  +    ++K+ D+G+  + L P +      GT  + APEI+  E  
Sbjct: 116 GIIYRDLKLDNVLLDSEG--HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 173

Query: 290 GFYTDMWAVGVLAYVLLSGLSPF 312
           GF  D WA+GVL + +++G SPF
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 94.7 bits (235), Expect = 2e-22
 Identities = 64/227 (28%), Positives = 111/227 (48%), Gaps = 12/227 (5%)

Query: 110 YDILEEIGTGAFGVVHRCR---ERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPK 166
           + I ++IG G F  V+R     +RK   +   +   +     ++   KEID++ QL+HP 
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63

Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPV-TLPILMTQTSPAVK 225
           +I   D+F +D+E+ ++ E    G+L + I    Y   +  +IP  T+     Q   AV+
Sbjct: 64  VIKYLDSFIEDNELNIVLELADAGDLSQMIK---YFKKQKRLIPERTVWKYFVQLCSAVE 120

Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS-TGTAEFAAPEIV 284
           HMH + ++H D+KP N+      +  VK+ D GL            S  GT  + +PE +
Sbjct: 121 HMHSRRVMHRDIKPANVFITA--TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178

Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGE--NDVETLKNVKACDW 329
                 F +D+W++G L Y + +  SPF G+  N     + ++ CD+
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDY 225

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 95.9 bits (238), Expect = 3e-22
 Identities = 63/226 (27%), Positives = 120/226 (53%), Gaps = 18/226 (7%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE---LIRKEIDIMNQLHH 164
           + YD+++ IG GAFG V   R + +  ++A K +     +++       +E DIM   + 
Sbjct: 43  EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102

Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P ++ L  AF+DD  + ++ E++ GG+L   ++  +Y + E      T  +++     A+
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMS--NYDVPEKWAKFYTAEVVL-----AL 155

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFAAPE 282
             +H   +IH DVKP+N++       ++K+ DFG   K+D   +V+  T  GT ++ +PE
Sbjct: 156 DAIHSMGLIHRDVKPDNMLLDKHG--HLKLADFGTCMKMDETGMVRCDTAVGTPDYISPE 213

Query: 283 IVERE-PVGFY---TDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           +++ +   G+Y    D W+VGV  + +L G +PF  ++ V T   +
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI 259

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 93.7 bits (233), Expect = 9e-22
 Identities = 76/273 (27%), Positives = 134/273 (49%), Gaps = 42/273 (15%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL----EKELIRKEIDIMNQLH 163
           + ++ ++ I  GA+G V+  R ++T   FA K I    NL    + + +  E DI+    
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKIN-KQNLILRNQIQQVFVERDILTFAE 59

Query: 164 HPKLINLHDAFEDDDEMVLIFEFLSGGE---LFERITAPDYKMSEAEVIPVTLPIL-MTQ 219
           +P ++++  +FE    + ++ E++ GG+   L + I A          +PV +  +   +
Sbjct: 60  NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGA----------LPVDMARMYFAE 109

Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGL--------ATKL-------D 264
           T  A++++H   I+H D+KP+N++  +    ++K+ DFGL         T L       D
Sbjct: 110 TVLALEYLHNYGIVHRDLKPDNLLITSMG--HIKLTDFGLSKIGLMSLTTNLYEGHIEKD 167

Query: 265 PNEVV-KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKN 323
             E + K   GT E+ APE++ R+  G   D WA+G++ Y  L G  PF G+   E    
Sbjct: 168 TREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ 227

Query: 324 VKACD--WEFDEEAFKNVSEEGKDFIRRLLLRN 354
           V + D  W   +EA   +  + +D I RLL +N
Sbjct: 228 VISDDIEWPEGDEA---LPADAQDLISRLLRQN 257

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 93.7 bits (233), Expect = 1e-21
 Identities = 68/256 (26%), Positives = 121/256 (47%), Gaps = 42/256 (16%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELI--RKEI-------DIMNQLHHPK 166
           +G G FG V   RE+ TG  +A K       L+KE+I  + E+        ++    HP 
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKI------LKKEVIIAKDEVAHTLTESRVLQNTRHPF 56

Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELF-----ERI-TAPDYKMSEAEVIPVTLPILMTQT 220
           L  L  +F+  D +  + E+ +GGELF     ER+ +    +   AE++           
Sbjct: 57  LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS---------- 106

Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEF 278
             A+ ++H  ++++ D+K EN+M       ++K+ DFGL  K   ++   + T  GT E+
Sbjct: 107 --ALGYLHSCDVVYRDLKLENLMLD--KDGHIKITDFGLC-KEGISDGATMKTFCGTPEY 161

Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKN 338
            APE++E    G   D W +GV+ Y ++ G  PF  ++  +  + +   +  F     + 
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RT 217

Query: 339 VSEEGKDFIRRLLLRN 354
           +S E K  +  LL ++
Sbjct: 218 LSPEAKSLLAGLLKKD 233

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 92.1 bits (229), Expect = 1e-21
 Identities = 59/249 (23%), Positives = 121/249 (48%), Gaps = 16/249 (6%)

Query: 114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN--LEKELIR---KEIDIMNQLHHPKLI 168
           E +G+G+FG V+       G+ FA K + ++ +    +E ++   +EI ++++L HP ++
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 169 NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH 228
                  ++D + +  E + GG L  ++        E  +   T  IL+      ++++H
Sbjct: 66  QYLGTEREEDNLYIFLELVPGGSL-AKLLKKYGSFPEPVIRLYTRQILL-----GLEYLH 119

Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVERE- 287
           ++N +H D+K  NI+  T     VK+ DFG+A ++      K   G+  + APE++ ++ 
Sbjct: 120 DRNTVHRDIKGANILVDTNGV--VKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQG 177

Query: 288 PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFI 347
             G   D+W++G     + +G  P++    V  +  +     +       ++S+E KDFI
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRS--KELPPIPDHLSDEAKDFI 235

Query: 348 RRLLLRNKE 356
            + L R+  
Sbjct: 236 LKCLQRDPS 244

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 93.9 bits (233), Expect = 1e-21
 Identities = 68/249 (27%), Positives = 128/249 (51%), Gaps = 18/249 (7%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE---LIRKEIDIMNQLHH 164
           + Y++++ IG GAFG V   R + T  ++A K +     +++       +E DIM   + 
Sbjct: 43  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102

Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P ++ L  AF+DD  + ++ E++ GG+L   ++  +Y + E      T  +++     A+
Sbjct: 103 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS--NYDVPEKWARFYTAEVVL-----AL 155

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFAAPE 282
             +H    IH DVKP+N++     S ++K+ DFG   K++   +V+  T  GT ++ +PE
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLD--KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE 213

Query: 283 IVERE-PVGFY---TDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKN 338
           +++ +   G+Y    D W+VGV  Y +L G +PF  ++ V T   +             +
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND 273

Query: 339 VSEEGKDFI 347
           +S+E K+ I
Sbjct: 274 ISKEAKNLI 282

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 92.7 bits (230), Expect = 2e-21
 Identities = 67/258 (25%), Positives = 122/258 (47%), Gaps = 45/258 (17%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL----------HHP 165
           +G G+FG V   R +++G ++A K       L+K++I ++ D+   +          +HP
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKV------LKKDVILQDDDVECTMTEKRILSLARNHP 56

Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELF------ERITAPDYKMSEAEVIPVTLPILMTQ 219
            L  L+  F+  D +  + EF++GG+L        R      +   AE+           
Sbjct: 57  FLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITS--------- 107

Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAE 277
              A+  +H+K II+ D+K +N++    +  + K+ DFG+  K         ST  GT +
Sbjct: 108 ---ALMFLHDKGIIYRDLKLDNVLLD--HEGHCKLADFGMC-KEGIFNGKTTSTFCGTPD 161

Query: 278 FAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
           + APEI++    G   D WA+GVL Y +L G +PF  EN+ +  + +       DE  + 
Sbjct: 162 YIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN-----DEVVYP 216

Query: 338 N-VSEEGKDFIRRLLLRN 354
             +S++  D ++  + +N
Sbjct: 217 TWLSQDAVDILKAFMTKN 234

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 92.0 bits (228), Expect = 3e-21
 Identities = 66/229 (28%), Positives = 118/229 (51%), Gaps = 23/229 (10%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL-HHPK 166
           D ++I+E IG G +G V++   +K G++ A K +    ++++E I  E +I+  L +HP 
Sbjct: 22  DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEE-IEAEYNILQSLPNHPN 80

Query: 167 LINLHDAFEDDDEMV-----LIFEFLSGG---ELFERITAPDYKMSEAEVIPVTLPILMT 218
           ++  +  F   D++V     L+ E  +GG   EL + +     ++ EA +  +    L+ 
Sbjct: 81  VVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALL- 139

Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVK-ISTGTAE 277
                ++H+H   IIH DVK  NI+  T     VK++DFG++ +L    + +  S GT  
Sbjct: 140 ----GLQHLHNNRIIHRDVKGNNILLTTEGG--VKLVDFGVSAQLTSTRLRRNTSVGTPF 193

Query: 278 FAAPEIVEREPVGFYT-----DMWAVGVLAYVLLSGLSPFAGENDVETL 321
           + APE++  E    Y+     D+W++G+ A  L  G  P    + V+TL
Sbjct: 194 WMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL 242

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 92.4 bits (229), Expect = 3e-21
 Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 36/217 (16%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELI---------RKEIDIMNQLHHPK 166
           +G G FG V   RE+ TG  +A K       L KE+I           E  ++    HP 
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKI------LRKEVIIAKDEVAHTVTESRVLQNTRHPF 56

Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELF-----ERITAPDY-KMSEAEVIPVTLPILMTQT 220
           L  L  AF+  D +  + E+ +GGELF     ER+   +  +   AE++           
Sbjct: 57  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVS---------- 106

Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE-VVKISTGTAEFA 279
             A++++H +++++ D+K EN+M       ++K+ DFGL  +   +   +K   GT E+ 
Sbjct: 107 --ALEYLHSRDVVYRDIKLENLMLD--KDGHIKITDFGLCKEGISDGATMKTFCGTPEYL 162

Query: 280 APEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN 316
           APE++E    G   D W +GV+ Y ++ G  PF  ++
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 91.1 bits (226), Expect = 5e-21
 Identities = 63/210 (30%), Positives = 105/210 (50%), Gaps = 26/210 (12%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK---------EIDIMNQLHHPK 166
           +G G FG V  C+ R TG ++A K       L K+ ++K         E  I+ ++H   
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACK------KLNKKRLKKRKGYEGAMVEKRILAKVHSRF 54

Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK---MSEAEVIPVTLPILMTQTSPA 223
           +++L  AF+   ++ L+   ++GG+L   I   D +     E      T  I+       
Sbjct: 55  IVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIIS-----G 109

Query: 224 VKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL-DPNEVVKISTGTAEFAAPE 282
           ++H+H++ II+ D+KPEN++    N  NV++ D GLA +L D     K   GT  F APE
Sbjct: 110 LEHLHQRRIIYRDLKPENVLLD--NDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPE 167

Query: 283 IVEREPVGFYTDMWAVGVLAYVLLSGLSPF 312
           +++ E   F  D +A+GV  Y +++   PF
Sbjct: 168 LLQGEEYDFSVDYFALGVTLYEMIAARGPF 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 90.2 bits (224), Expect = 9e-21
 Identities = 59/213 (27%), Positives = 109/213 (51%), Gaps = 17/213 (7%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV-SHNLEKELIRKEIDIMNQLHH---P 165
           Y  LE IG GA+G V+R +   TG + A K I + + + +   I++E+ +++QL     P
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62

Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            +   + ++     + +I E+  GG +   + A         VI       + +   A+K
Sbjct: 63  NITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVI-------IREVLVALK 115

Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS-TGTAEFAAPEIV 284
           ++H+  +IH D+K  NI+    N+ NVK+ DFG+A  L+ N   + +  GT  + APE++
Sbjct: 116 YIHKVGVIHRDIKAANIL--VTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVI 173

Query: 285 EREPVGFYT--DMWAVGVLAYVLLSGLSPFAGE 315
             E   + T  D+W++G+  Y + +G  P++  
Sbjct: 174 -TEGKYYDTKADIWSLGITIYEMATGNPPYSDV 205

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 91.0 bits (226), Expect = 1e-20
 Identities = 64/216 (29%), Positives = 106/216 (49%), Gaps = 29/216 (13%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDI---MNQLH-------HP 165
           IG G++  V     +KT  I+A K I      +KEL+  + DI     + H       HP
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVI------KKELVNDDEDIDWVQTEKHVFETASNHP 56

Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVT-LPILMTQTSPAV 224
            L+ LH  F+ +  +  + EF+SGG+L        + M     +P         + S A+
Sbjct: 57  FLVGLHSCFQTESRLFFVIEFVSGGDLM-------FHMQRQRKLPEEHARFYSAEISLAL 109

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK-LDPNEVVKISTGTAEFAAPEI 283
             +HE+ II+ D+K +N++       ++K+ D+G+  + + P +      GT  + APEI
Sbjct: 110 NFLHERGIIYRDLKLDNVLLDAEG--HIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEI 167

Query: 284 VEREPVGFYTDMWAVGVLAYVLLSGLSPF--AGEND 317
           +  E  GF  D WA+GVL + +++G SPF   G +D
Sbjct: 168 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSD 203

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 89.5 bits (223), Expect = 1e-20
 Identities = 52/230 (22%), Positives = 110/230 (47%), Gaps = 28/230 (12%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV--------SHNLEKELIRKEIDIMNQLH 163
           + +++G GAFG V++   +  G         V        +   E+E   +E  IM +L 
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGDGE---GTETKVAVKTLKEGASEEEREEFLEEASIMKKLS 59

Query: 164 HPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPA 223
           HP ++ L       + + ++ E++ GG+L + +     K++  +++ + L     Q +  
Sbjct: 60  HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMAL-----QIAKG 114

Query: 224 VKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAE---FAA 280
           ++++  KN +H D+   N +  T N   VK+ DFGL+  +  ++  +   G      + A
Sbjct: 115 MEYLESKNFVHRDLAARNCLV-TENLV-VKISDFGLSRDIYEDDYYRKRGGGKLPIKWMA 172

Query: 281 PE-IVEREPVGFYT--DMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKA 326
           PE + + +   F +  D+W+ GVL + + + G  P+ G ++ E L+ ++ 
Sbjct: 173 PESLKDGK---FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLED 219

Length = 258

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 90.5 bits (224), Expect = 2e-20
 Identities = 65/249 (26%), Positives = 121/249 (48%), Gaps = 28/249 (11%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR---KEIDIMNQLHHPKLINLHD 172
           +G G FG V   RE+ +G  +A K +     + K+ +     E  ++    HP L +L  
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62

Query: 173 AFEDDDEMVLIFEFLSGGELF-----ERITAPD-YKMSEAEVIPVTLPILMTQTSPAVKH 226
           +F+  D +  + E+++GGELF     ER+ + D  +   AE++             A+ +
Sbjct: 63  SFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVS------------ALDY 110

Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK-LDPNEVVKISTGTAEFAAPEIVE 285
           +H   I++ D+K EN+M       ++K+ DFGL  + +     +K   GT E+ APE++E
Sbjct: 111 LHSGKIVYRDLKLENLMLD--KDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLE 168

Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD 345
               G   D W +GV+ Y ++ G  PF  ++  +  + +   D +F     + +S + K 
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFP----RTLSADAKS 224

Query: 346 FIRRLLLRN 354
            +  LL+++
Sbjct: 225 LLSGLLIKD 233

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 89.4 bits (221), Expect = 2e-20
 Identities = 66/254 (25%), Positives = 122/254 (48%), Gaps = 25/254 (9%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAK---FIPVSHNLEKEL--IRKEIDIMNQLHHPKLINL 170
           +G GAFG V+ C +  TG   AAK   F P S    KE+  +  EI ++  L H +++  
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 171 HDAFEDDDE--MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH 228
           +    D  E  + +  E++ GG + +++ A    ++E+     T  IL       + ++H
Sbjct: 70  YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQIL-----EGMSYLH 123

Query: 229 EKNIIHLDVKPENIMCQTRNST-NVKMIDFGLATKLD----PNEVVKISTGTAEFAAPEI 283
              I+H D+K  NI+   R+S  NVK+ DFG + +L         ++  TGT  + +PE+
Sbjct: 124 SNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180

Query: 284 VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV-KACDWEFDEEAFKNVSEE 342
           +  E  G   D+W++G     +L+   P+A   + E +  + K      + +   ++SE 
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKPPWA---EYEAMAAIFKIATQPTNPQLPSHISEH 237

Query: 343 GKDFIRRLLLRNKE 356
            +DF+  + +  + 
Sbjct: 238 ARDFLGCIFVEARH 251

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 89.6 bits (223), Expect = 2e-20
 Identities = 71/239 (29%), Positives = 117/239 (48%), Gaps = 47/239 (19%)

Query: 105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL-------IRKEID 157
           SV + Y+ L  I  G +GVV+R R++KTG I A K +     +EKE        +R EI+
Sbjct: 3   SVDE-YEKLNRIEEGTYGVVYRARDKKTGEIVALKKL----KMEKEKEGFPITSLR-EIN 56

Query: 158 IMNQLHHPKLINLHDAF--EDDDEMVLIFEF----LSGGELFERITAPDYKMSEAEVIPV 211
           I+ +L HP ++ + +     + D++ ++ E+    L    L E +  P     ++EV   
Sbjct: 57  ILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKS--LMETMKQP---FLQSEV--- 108

Query: 212 TLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL-DP----- 265
               LM Q    V H+H+  I+H D+K  N++    N   +K+ DFGLA +   P     
Sbjct: 109 --KCLMLQLLSGVAHLHDNWILHRDLKTSNLLLN--NRGILKICDFGLAREYGSPLKPYT 164

Query: 266 NEVVKISTGTAEFAAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
             VV     T  + APE++       Y+   DMW+VG +   LL+    F G+++++ L
Sbjct: 165 QLVV-----TLWYRAPELLLGAKE--YSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQL 216

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 89.2 bits (221), Expect = 2e-20
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 14/201 (6%)

Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE-KELIRKEIDIMNQLHHPKLINLH 171
            E +G G  G V++     T  I A K IP+   +E ++ I  E++I+ +   P +I  +
Sbjct: 6   QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65

Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
            AF  ++ + +  EF+ GG L      P++ +    V  V            + ++    
Sbjct: 66  GAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVAVVK----------GLTYLWSLK 115

Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGF 291
           I+H DVKP N++  TR    VK+ DFG++T+L  N + K   GT  + APE +  E  G 
Sbjct: 116 ILHRDVKPSNMLVNTRG--QVKLCDFGVSTQL-VNSIAKTYVGTNAYMAPERISGEQYGI 172

Query: 292 YTDMWAVGVLAYVLLSGLSPF 312
           ++D+W++G+    L  G  P+
Sbjct: 173 HSDVWSLGISFMELALGRFPY 193

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 89.3 bits (221), Expect = 2e-20
 Identities = 63/224 (28%), Positives = 110/224 (49%), Gaps = 16/224 (7%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFA-AKFIPVSHNLE-KELIRKEIDIMNQLHHP 165
           + +++L  +G GA+GVV +CR ++T  I A  KF     N E KE   +E+ ++  L   
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 166 KLINLHDAFEDDDEMVLIFEFLSGG--ELFERITAPDYKMSEAEVIPVTLPILMTQTSPA 223
            ++ L +AF    ++ L+FE++     EL E +           V P  +   + Q   A
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPN--------GVPPEKVRSYIYQLIKA 112

Query: 224 VKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS--TGTAEFAAP 281
           +   H+ +I+H D+KPEN++    +   +K+ DFG A  L        +    T  + +P
Sbjct: 113 IHWCHKNDIVHRDIKPENLLISHNDV--LKLCDFGFARNLSEGSNANYTEYVATRWYRSP 170

Query: 282 EIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVK 325
           E++   P G   DMW+VG +   L  G   F GE++++ L  ++
Sbjct: 171 ELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQ 214

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 90.3 bits (224), Expect = 4e-20
 Identities = 80/299 (26%), Positives = 136/299 (45%), Gaps = 67/299 (22%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL---IRKEIDIMNQLHH 164
           + +  ++ IG GAFG V   +++ TG I+A K +  S   +K+    ++ E D++ +   
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60

Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P +++L+ +F+D   + LI EFL GG+L   +   D   SE     VT    M +   A+
Sbjct: 61  PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYD-TFSE----DVT-RFYMAECVLAI 114

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT---KLDPN--------------- 266
           + +H+   IH D+KP+NI+       ++K+ DFGL+T   K   +               
Sbjct: 115 EAVHKLGFIHRDIKPDNILIDRGG--HIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNR 172

Query: 267 -----------------------------EVVKIST-GTAEFAAPEIVEREPVGFYTDMW 296
                                         ++  ST GT ++ APEI  ++  G   D W
Sbjct: 173 IDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW 232

Query: 297 AVGVLAYVLLSGLSPFAGENDVETLKNVKACDWE----FDEEAFKNVSEEGKDFIRRLL 351
           ++G + +  L G  PF  EN  ET +  K  +W     F ++   ++S E +D IRRL+
Sbjct: 233 SLGAIMFECLIGWPPFCSENSHETYR--KIINWRETLYFPDDI--HLSVEAEDLIRRLI 287

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 89.0 bits (221), Expect = 5e-20
 Identities = 66/232 (28%), Positives = 110/232 (47%), Gaps = 42/232 (18%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR----KEIDIMNQLHHP 165
           ++ L  IG G +G+V+R R+  +G I A K   V  + E++ I     +EI ++  L HP
Sbjct: 9   FEKLNRIGEGTYGIVYRARDTTSGEIVALK--KVRMDNERDGIPISSLREITLLLNLRHP 66

Query: 166 KLINLHDAFEDD--DEMVLIFEFLSG--GELFERITAPDYKMSEAEVIPVTLPILMTQTS 221
            ++ L +       D + L+ E+       L + +  P    SE++V       LM Q  
Sbjct: 67  NIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP---FSESQV-----KCLMLQLL 118

Query: 222 PAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA-------TKLDPNEVVKISTG 274
             ++++HE  IIH D+K  N++   +    +K+ DFGLA         + P  V      
Sbjct: 119 RGLQYLHENFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLPAKPMTPKVV------ 170

Query: 275 TAEFAAPEIVEREPVGF--YT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
           T  + APE++    +G   YT   DMWAVG +   LL+      G++++E L
Sbjct: 171 TLWYRAPELL----LGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQL 218

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 88.6 bits (219), Expect = 5e-20
 Identities = 57/199 (28%), Positives = 105/199 (52%), Gaps = 13/199 (6%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKL 167
           + ++I+ E+G GAFG V++ + ++TG + AAK I      E E    EI+I+   +HP +
Sbjct: 12  EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYI 71

Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
           + L  AF  D ++ ++ EF  GG +   +   D  ++E ++      ++  Q   A++++
Sbjct: 72  VKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQI-----QVICRQMLEALQYL 126

Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS-TGTAEFAAPEIVER 286
           H   IIH D+K  N++       ++K+ DFG++ K       + S  GT  + APE+V  
Sbjct: 127 HSMKIIHRDLKAGNVLLTLDG--DIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMC 184

Query: 287 E-----PVGFYTDMWAVGV 300
           E     P  +  D+W++G+
Sbjct: 185 ETMKDTPYDYKADIWSLGI 203

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 87.2 bits (217), Expect = 9e-20
 Identities = 50/224 (22%), Positives = 107/224 (47%), Gaps = 13/224 (5%)

Query: 114 EEIGTGAFGVVHRCRERKTGNIF---AAKFIPVSHNL-EKELIRKEIDIMNQLHHPKLIN 169
           +++G GAFG V++ + +         A K +    +  E++   KE  +M +L HP ++ 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 170 LHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPIL---MTQTSPAVKH 226
           L     +++ + L+ E++ GG+L + +          E   ++L  L     Q +  +++
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAE---FAAPEI 283
           +  K  +H D+   N +        VK+ DFGL+  +  ++  +  TG      + APE 
Sbjct: 121 LASKKFVHRDLAARNCLVGEDL--VVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPES 178

Query: 284 VEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKA 326
           ++       +D+W+ GVL + + + G +P+ G ++ E L+ ++ 
Sbjct: 179 LKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK 222

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 87.4 bits (216), Expect = 9e-20
 Identities = 58/218 (26%), Positives = 114/218 (52%), Gaps = 17/218 (7%)

Query: 100 DIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIM 159
           D+   +  + +++++ IG+G +G V++ R   TG + A K I +    +  ++++EI +M
Sbjct: 1   DLSRRNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMM 60

Query: 160 NQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFE--RITAPDYKMSEAEVIPVTLPILM 217
               H  ++    ++   D++ +  EF  GG L +   +T P   +SE+++  V+     
Sbjct: 61  KDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP---LSESQIAYVS----- 112

Query: 218 TQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS-TGTA 276
            +T   + ++H K  +H D+K  NI+    ++ +VK+ DFG++ ++      + S  GT 
Sbjct: 113 RETLQGLYYLHSKGKMHRDIKGANILLT--DNGHVKLADFGVSAQITATIAKRKSFIGTP 170

Query: 277 EFAAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSP 311
            + APE+   E  G Y    D+WAVG+ A + L+ L P
Sbjct: 171 YWMAPEVAAVERKGGYNQLCDIWAVGITA-IELAELQP 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 88.1 bits (218), Expect = 9e-20
 Identities = 59/220 (26%), Positives = 107/220 (48%), Gaps = 13/220 (5%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP---VSHNLEKELIRKEIDIMNQLHHPK 166
           ++ L  +G G+FG V     + T  ++A K +    V  + + E    E  ++     P 
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61

Query: 167 -LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            L  LH  F+  D +  + E+++GG+L   I     K  E + +         + S  + 
Sbjct: 62  FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVG-KFKEPQAV-----FYAAEISVGLF 115

Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK-LDPNEVVKISTGTAEFAAPEIV 284
            +H + II+ D+K +N+M  +    ++K+ DFG+  + +      +   GT ++ APEI+
Sbjct: 116 FLHRRGIIYRDLKLDNVMLDSEG--HIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEII 173

Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
             +P G   D WA GVL Y +L+G  PF GE++ E  +++
Sbjct: 174 AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI 213

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 87.3 bits (217), Expect = 1e-19
 Identities = 71/237 (29%), Positives = 105/237 (44%), Gaps = 45/237 (18%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE---KELIRKEIDIMNQL---H 163
           Y+ L EIG GA+G V++ R+  TG   A K + V  + E      +R EI ++ QL    
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLESFE 59

Query: 164 HPKLINLHDAF---EDDDEMV--LIFE--------FLSGGELFERITAPDYKMSEAEVIP 210
           HP ++ L D       D E+   L+FE        +LS             K  +  + P
Sbjct: 60  HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLS-------------KCPKPGLPP 106

Query: 211 VTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN---- 266
            T+  LM Q    V  +H   I+H D+KP+NI+  T +   VK+ DFGLA          
Sbjct: 107 ETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILV-TSDGQ-VKIADFGLARIYSFEMALT 164

Query: 267 EVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSP-FAGENDVETLK 322
            VV     T  + APE++ +       DMW+VG +   L     P F G ++ + L 
Sbjct: 165 SVVV----TLWYRAPEVLLQSSYATPVDMWSVGCIFAELFR-RRPLFRGTSEADQLD 216

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 90.3 bits (224), Expect = 1e-19
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 19/203 (9%)

Query: 132 TGNIFAAKFIPVSHNLEKEL---IRKEIDIMNQLHHPKLINLHDAFEDDDEMVL-IFEFL 187
           TG+  A K +      E+      R+E  +  +L+HP ++ L D+ E    ++  +FE++
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61

Query: 188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTR 247
            G  L E + A      +  +       LM Q   A+   H + I+H D+KP+NIM    
Sbjct: 62  PGRTLREVLAA------DGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQT 115

Query: 248 NST-NVKMIDFGLATKLDPNEVVKIST--------GTAEFAAPEIVEREPVGFYTDMWAV 298
               + K++DFG+ T L       ++T        GT  + APE +  EPV   +D++A 
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175

Query: 299 GVLAYVLLSGLSPFAGENDVETL 321
           G++    L+G     G +  E L
Sbjct: 176 GLIFLECLTGQRVVQGASVAEIL 198

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 87.2 bits (216), Expect = 1e-19
 Identities = 65/232 (28%), Positives = 113/232 (48%), Gaps = 37/232 (15%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE------LIRKEIDIMNQLH 163
           +  LE++G G +  V++ R R TG I A K I    +L+ E       IR EI +M +L 
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEI----HLDAEEGTPSTAIR-EISLMKELK 56

Query: 164 HPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPA 223
           H  ++ LHD    +++++L+FE++   +L + +   D       + P T+     Q    
Sbjct: 57  HENIVRLHDVIHTENKLMLVFEYMD-KDLKKYM---DTHGVRGALDPNTVKSFTYQLLKG 112

Query: 224 VKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD------PNEVVKISTGTAE 277
           +   HE  ++H D+KP+N++   R    +K+ DFGLA           NEVV     T  
Sbjct: 113 IAFCHENRVLHRDLKPQNLLINKRG--ELKLADFGLARAFGIPVNTFSNEVV-----TLW 165

Query: 278 FAAPEIVEREPVGFYT-----DMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           + AP+++    +G  T     D+W+VG +   +++G   F G N+ + L  +
Sbjct: 166 YRAPDVL----LGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKI 213

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 86.6 bits (214), Expect = 1e-19
 Identities = 51/199 (25%), Positives = 106/199 (53%), Gaps = 12/199 (6%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKL 167
           Y  +  +G G++G V   R R  G  +  K + + +    E++   +E  +++QL HP +
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61

Query: 168 INLHDAFEDDDEMV-LIFEFLSGGELFERITAPDYKM-SEAEVIPVTLPILMTQTSPAVK 225
           +   +++E +D ++ ++  F  GG+L+ ++     K+  E +V+   + I M     A++
Sbjct: 62  VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAM-----ALQ 116

Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEFAAPEIV 284
           ++HEK+I+H D+K +N+     N   +K+ D G+A  L+   ++     GT  + +PE+ 
Sbjct: 117 YLHEKHILHRDLKTQNVFLTRTNI--IKVGDLGIARVLENQCDMASTLIGTPYYMSPELF 174

Query: 285 EREPVGFYTDMWAVGVLAY 303
             +P  + +D+WA+G   Y
Sbjct: 175 SNKPYNYKSDVWALGCCVY 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 87.6 bits (218), Expect = 2e-19
 Identities = 77/295 (26%), Positives = 134/295 (45%), Gaps = 74/295 (25%)

Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELI---R--KEIDIMNQLH 163
            Y++L+ IG+GA+GVV    +++TG   A K I    N+  +LI   R  +EI ++  L 
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKIS---NVFDDLIDAKRILREIKLLRHLR 57

Query: 164 HPKLINLHDAF-----EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D       ED +++ ++ E +   +L + I +P   +++  +        + 
Sbjct: 58  HENIIGLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQ-PLTDDHI-----QYFLY 110

Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNST-NVKMIDFGLATKLDPNE---------V 268
           Q    +K++H  N+IH D+KP NI+    NS  ++K+ DFGLA  +DP+E         V
Sbjct: 111 QILRGLKYLHSANVIHRDLKPSNILV---NSNCDLKICDFGLARGVDPDEDEKGFLTEYV 167

Query: 269 VKISTGTAEFAAPEIVEREPVGF--YT---DMWAVGVLAYVLLSGLSPFAGENDVETLK- 322
           V     T  + APE++    +    YT   D+W+VG +   LL+    F G + ++ L  
Sbjct: 168 V-----TRWYRAPELL----LSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNL 218

Query: 323 --------NVKACDWEFDEEA------------------FKNVSEEGKDFIRRLL 351
                   + +   +   E+A                  F   S E  D + ++L
Sbjct: 219 IVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKML 273

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 87.4 bits (216), Expect = 2e-19
 Identities = 59/209 (28%), Positives = 102/209 (48%), Gaps = 27/209 (12%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDI---MNQLH-------HP 165
           IG G++  V   R +K   I+A K +      +KEL+  + DI     + H       +P
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVV------KKELVHDDEDIDWVQTEKHVFEQASSNP 56

Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVT-LPILMTQTSPAV 224
            L+ LH  F+    + L+ E+++GG+L        + M     +P         +   A+
Sbjct: 57  FLVGLHSCFQTTSRLFLVIEYVNGGDLM-------FHMQRQRKLPEEHARFYAAEICIAL 109

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK-LDPNEVVKISTGTAEFAAPEI 283
             +HE+ II+ D+K +N++       ++K+ D+G+  + L P +      GT  + APEI
Sbjct: 110 NFLHERGIIYRDLKLDNVLLDA--DGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEI 167

Query: 284 VEREPVGFYTDMWAVGVLAYVLLSGLSPF 312
           +  E  GF  D WA+GVL + +++G SPF
Sbjct: 168 LRGEEYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 86.8 bits (215), Expect = 2e-19
 Identities = 63/232 (27%), Positives = 113/232 (48%), Gaps = 38/232 (16%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE-------LIRKEIDIMN 160
           D Y+ +E+IG G +GVV++ R+R T    A K I     LE+E        IR EI ++ 
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKI----RLEQEDEGVPSTAIR-EISLLK 56

Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
           ++ H  ++ L D    +  + L+FE+L         ++PD+  +     P  +   + Q 
Sbjct: 57  EMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKN-----PRLIKTYLYQI 111

Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA------TKLDPNEVVKISTG 274
              + + H   ++H D+KP+N++   R +  +K+ DFGLA       +   +EVV     
Sbjct: 112 LRGIAYCHSHRVLHRDLKPQNLLIDRRTNA-LKLADFGLARAFGIPVRTFTHEVV----- 165

Query: 275 TAEFAAPEIV-----EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETL 321
           T  + APEI+        PV    D+W+VG +   +++    F G+++++ L
Sbjct: 166 TLWYRAPEILLGSRHYSTPV----DIWSVGCIFAEMVNQKPLFPGDSEIDEL 213

Length = 294

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 85.9 bits (212), Expect = 3e-19
 Identities = 61/217 (28%), Positives = 116/217 (53%), Gaps = 22/217 (10%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL-HHPKLI 168
           ++++E +G G +G V++ R  KTG + A K + V+ + E+E I++EI+++ +  HH  + 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIA 66

Query: 169 NLHDAFED------DDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSP 222
             + AF        DD++ L+ EF   G + + I        + E I      +  +   
Sbjct: 67  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY----ICREILR 122

Query: 223 AVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFAA 280
            + H+H+  +IH D+K +N++  T N+  VK++DFG++ +LD   V + +T  GT  + A
Sbjct: 123 GLSHLHQHKVIHRDIKGQNVLL-TENA-EVKLVDFGVSAQLD-RTVGRRNTFIGTPYWMA 179

Query: 281 PEIV--EREP---VGFYTDMWAVGVLAYVLLSGLSPF 312
           PE++  +  P     F +D+W++G+ A  +  G  P 
Sbjct: 180 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 85.9 bits (213), Expect = 4e-19
 Identities = 78/284 (27%), Positives = 129/284 (45%), Gaps = 59/284 (20%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE-------LIRKEIDIMNQL 162
           Y  +E+IG G +GVV++ R +KTG I A K I     LE E        IR EI ++ +L
Sbjct: 2   YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKI----RLESEEEGVPSTAIR-EISLLKEL 56

Query: 163 HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSP 222
            HP ++ L D    +  + LIFEFLS        + P  +  +AE++   L     Q   
Sbjct: 57  QHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYL----YQILQ 112

Query: 223 AVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA------TKLDPNEVVKISTGTA 276
            +   H + ++H D+KP+N++    N   +K+ DFGLA       ++  +EVV     T 
Sbjct: 113 GILFCHSRRVLHRDLKPQNLLID--NKGVIKLADFGLARAFGIPVRVYTHEVV-----TL 165

Query: 277 EFAAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGE------------------ 315
            + APE++   P   Y+   D+W++G +   + +    F G+                  
Sbjct: 166 WYRAPEVLLGSPR--YSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTE 223

Query: 316 ---NDVETLKNVKAC--DWEFD--EEAFKNVSEEGKDFIRRLLL 352
                V +L + K     W+      A KN+ E+G D + ++L+
Sbjct: 224 DVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLI 267

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 85.7 bits (212), Expect = 4e-19
 Identities = 61/219 (27%), Positives = 105/219 (47%), Gaps = 20/219 (9%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK-ELIRKEIDIMNQLHHPK 166
           D  ++L+E+G G +G V++   R TG   A K I +  +  K   I  E+DI+++   P 
Sbjct: 1   DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPY 60

Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKH 226
           +++ + AF  +  + +  E++  G L +++ A        E IP    +L   T   VK 
Sbjct: 61  IVDFYGAFFIEGAVYMCMEYMDAGSL-DKLYA---GGVATEGIPE--DVLRRITYAVVKG 114

Query: 227 M----HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPE 282
           +     E NIIH DVKP N++        VK+ DFG++  L  + + K + G   + APE
Sbjct: 115 LKFLKEEHNIIHRDVKPTNVLVNGNGQ--VKLCDFGVSGNLVAS-LAKTNIGCQSYMAPE 171

Query: 283 IVERE---PVGFYT---DMWAVGVLAYVLLSGLSPFAGE 315
            ++         YT   D+W++G+    +  G  P+  E
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE 210

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 85.8 bits (212), Expect = 7e-19
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 26/216 (12%)

Query: 107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS-HNLEKELI--RKEID------ 157
           Y+ ++ +  +GTG+FG V      K  +     F PV+    EK  I  +K++D      
Sbjct: 29  YEDFNFIRTLGTGSFGRVILAT-YKNED-----FPPVAIKRFEKSKIIKQKQVDHVFSER 82

Query: 158 -IMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPIL 216
            I+N ++HP  +NL+ +F+D+  + L+ EF+ GGE F  +       ++         +L
Sbjct: 83  KILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL 142

Query: 217 MTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA 276
           +       +++   NI++ D+KPEN++        +KM DFG A  +D         GT 
Sbjct: 143 I------FEYLQSLNIVYRDLKPENLLLD--KDGFIKMTDFGFAKVVDTRTYT--LCGTP 192

Query: 277 EFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPF 312
           E+ APEI+     G   D W +G+  Y +L G  PF
Sbjct: 193 EYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF 228

Length = 340

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 85.5 bits (211), Expect = 8e-19
 Identities = 70/256 (27%), Positives = 123/256 (48%), Gaps = 41/256 (16%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL---------HHPK 166
           +G G FG V   +E+ TG  +A K       L+KE+I  + ++ + L          HP 
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKI------LKKEVIVAKDEVAHTLTENRVLQNSRHPF 56

Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELF-----ERITAPDY-KMSEAEVIPVTLPILMTQT 220
           L  L  +F+  D +  + E+ +GGELF     ER+ + D  +   AE++           
Sbjct: 57  LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS---------- 106

Query: 221 SPAVKHMH-EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK-LDPNEVVKISTGTAEF 278
             A+ ++H EKN+++ D+K EN+M       ++K+ DFGL  + +     +K   GT E+
Sbjct: 107 --ALDYLHSEKNVVYRDLKLENLMLD--KDGHIKITDFGLCKEGIKDGATMKTFCGTPEY 162

Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKN 338
            APE++E    G   D W +GV+ Y ++ G  PF  ++  +  + +   +  F     + 
Sbjct: 163 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RT 218

Query: 339 VSEEGKDFIRRLLLRN 354
           +S E K  +  LL ++
Sbjct: 219 LSPEAKSLLSGLLKKD 234

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 85.4 bits (211), Expect = 9e-19
 Identities = 60/226 (26%), Positives = 112/226 (49%), Gaps = 25/226 (11%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL------- 162
           ++ L  +G G+FG V     + T  ++A K       L+K+++ ++ D+   +       
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKI------LKKDVVIQDDDVECTMVEKRVLA 55

Query: 163 ---HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQ 219
                P L  LH  F+  D +  + E+++GG+L  +I     +  E   +         +
Sbjct: 56  LSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVG-RFKEPHAV-----FYAAE 109

Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVV-KISTGTAEF 278
            +  +  +H K II+ D+K +N+M  +    ++K+ DFG+  +   + V  K   GT ++
Sbjct: 110 IAIGLFFLHSKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKENMWDGVTTKTFCGTPDY 167

Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
            APEI+  +P G   D WA GVL Y +L+G +PF GE++ E  +++
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 213

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 85.2 bits (211), Expect = 1e-18
 Identities = 70/254 (27%), Positives = 123/254 (48%), Gaps = 33/254 (12%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL----------HHP 165
           +G G+FG V     + T   FA K       L+K+++ ++ D+   +           HP
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIK------ALKKDVVLEDDDVECTMVERRVLALAWEHP 56

Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            L +L   F+  + +  + E+L+GG+L   I +   +  EA        I+       ++
Sbjct: 57  FLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQS-SGRFDEARARFYAAEIIC-----GLQ 110

Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFAAPEI 283
            +H+K II+ D+K +N++       ++K+ DFG+  K + N   K ST  GT ++ APEI
Sbjct: 111 FLHKKGIIYRDLKLDNVLLDKDG--HIKIADFGMC-KENMNGEGKASTFCGTPDYIAPEI 167

Query: 284 VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAF-KNVSEE 342
           ++ +      D W+ GVL Y +L G SPF GE++ E   ++       D   F + +S+E
Sbjct: 168 LKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN-----DRPHFPRWISKE 222

Query: 343 GKDFIRRLLLRNKE 356
            KD + +L  R+  
Sbjct: 223 AKDCLSKLFERDPT 236

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 84.7 bits (209), Expect = 1e-18
 Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 33/226 (14%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR-KEIDIMNQLHHPKLI 168
           Y  L+++G G +  V + R + T N+ A K I + H         +E+ ++  L H  ++
Sbjct: 7   YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIV 66

Query: 169 NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH 228
            LHD    +  + L+FE+L   +L + +      MS   V      I M Q    + + H
Sbjct: 67  TLHDIIHTERCLTLVFEYLD-SDLKQYLDNCGNLMSMHNV-----KIFMFQLLRGLSYCH 120

Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA------TKLDPNEVVK-------ISTGT 275
           ++ I+H D+KP+N++   +    +K+ DFGLA      TK   NEVV        +  G+
Sbjct: 121 KRKILHRDLKPQNLLINEKGE--LKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGS 178

Query: 276 AEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETL 321
            E++ P            DMW VG + Y + +G   F G    E L
Sbjct: 179 TEYSTP-----------IDMWGVGCILYEMATGRPMFPGSTVKEEL 213

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 84.5 bits (209), Expect = 1e-18
 Identities = 57/224 (25%), Positives = 112/224 (50%), Gaps = 23/224 (10%)

Query: 100 DIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAK--FIPVSHNLEKELIRKEID 157
           D++   +    + + ++G G  G V + +   TG + A K   I    ++ K+++R E+ 
Sbjct: 1   DLRNEDL----ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILR-ELQ 55

Query: 158 IMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM 217
           IM++   P +++ + AF +++ + +  EF+  G L +RI    YK    +  P+ + IL 
Sbjct: 56  IMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRI----YK----KGGPIPVEILG 106

Query: 218 TQTSPAVKHM----HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST 273
                 V+ +    +   I+H D+KP NI+  +R    +K+ DFG++ +L  N +     
Sbjct: 107 KIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG--QIKLCDFGVSGEL-INSIADTFV 163

Query: 274 GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEND 317
           GT+ + +PE ++       +D+W++G+    L  G  PFA  N 
Sbjct: 164 GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI 207

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 84.3 bits (208), Expect = 1e-18
 Identities = 65/232 (28%), Positives = 121/232 (52%), Gaps = 27/232 (11%)

Query: 99  VDIKTSSVYDH---YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKE 155
            DI  S++ D    ++++E +G G +G V++ R  KTG + A K + V+ + E+E I+ E
Sbjct: 4   DDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLE 62

Query: 156 IDIMNQL-HHPKLINLHDAF------EDDDEMVLIFEFLSGGELFERI-TAPDYKMSEAE 207
           I+++ +  HH  +   + AF        DD++ L+ EF   G + + +       + E  
Sbjct: 63  INMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW 122

Query: 208 VIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE 267
           +  +   IL       + H+H   +IH D+K +N++  T N+  VK++DFG++ +LD   
Sbjct: 123 IAYICREILR-----GLAHLHAHKVIHRDIKGQNVLL-TENA-EVKLVDFGVSAQLD-RT 174

Query: 268 VVKIST--GTAEFAAPEIV--EREPVGFY---TDMWAVGVLAYVLLSGLSPF 312
           V + +T  GT  + APE++  +  P   Y   +D+W++G+ A  +  G  P 
Sbjct: 175 VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 84.7 bits (210), Expect = 2e-18
 Identities = 81/307 (26%), Positives = 131/307 (42%), Gaps = 77/307 (25%)

Query: 104 SSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELI----RKEIDIM 159
            S    Y+IL ++G G FG V++ R+ KTG + A K I + +  EK+       +EI I+
Sbjct: 4   CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHN--EKDGFPITALREIKIL 61

Query: 160 NQLHHPKLINLHD-AFEDDDE---------MVLIF--EFLSGGELFERITAPDYKMSEAE 207
            +L HP ++ L D A E  D+         MV  +    LSG  L E    P  K++E++
Sbjct: 62  KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSG--LLEN---PSVKLTESQ 116

Query: 208 VIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD--- 264
           +        M Q    + ++HE +I+H D+K  NI+    N   +K+ DFGLA   D   
Sbjct: 117 I-----KCYMLQLLEGINYLHENHILHRDIKAANILID--NQGILKIADFGLARPYDGPP 169

Query: 265 PNEVVKISTGTAEFA---------APEIV--EREPVGFYT---DMWAVGVLAYVLLSGLS 310
           PN       GT ++           PE++  ER     YT   D+W +G +   + +   
Sbjct: 170 PNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERR----YTTAVDIWGIGCVFAEMFTRRP 225

Query: 311 PFAGENDVE---------------------TLKNVKACDWEFD-----EEAFKNVSEEGK 344
              G++D++                     +L   +      +     EE F  +  EG 
Sbjct: 226 ILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGL 285

Query: 345 DFIRRLL 351
           D + +LL
Sbjct: 286 DLLSKLL 292

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 83.9 bits (208), Expect = 2e-18
 Identities = 62/213 (29%), Positives = 105/213 (49%), Gaps = 49/213 (23%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE-------LIRKEIDIMNQL 162
           Y  +E+IG G +GVV++ R++ TG I A K I     LE E        IR EI ++ +L
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKI----RLETEDEGVPSTAIR-EISLLKEL 55

Query: 163 HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK--MSEAEVIPVTLPIL---M 217
           +HP ++ L D    ++++ L+FEFL            D K  M  + +  +  P++   +
Sbjct: 56  NHPNIVRLLDVVHSENKLYLVFEFLD----------LDLKKYMDSSPLTGLDPPLIKSYL 105

Query: 218 TQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA------TKLDPNEVVKI 271
            Q    + + H   ++H D+KP+N++        +K+ DFGLA       +   +EVV  
Sbjct: 106 YQLLQGIAYCHSHRVLHRDLKPQNLLIDREG--ALKLADFGLARAFGVPVRTYTHEVV-- 161

Query: 272 STGTAEFAAPEIVEREPVG--FYT---DMWAVG 299
              T  + APEI+    +G   Y+   D+W++G
Sbjct: 162 ---TLWYRAPEIL----LGSRQYSTPVDIWSIG 187

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 66/256 (25%), Positives = 122/256 (47%), Gaps = 29/256 (11%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHH----- 164
           ++ L  +G G+FG V     + T  ++A K       L+K++I ++ D+   +       
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKI------LKKDVIIQDDDVECTMVEKRVLA 55

Query: 165 -----PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQ 219
                P L  LH  F+  D +  + E+++GG+L   I     K  E   +         +
Sbjct: 56  LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-KFKEPHAV-----FYAAE 109

Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK-LDPNEVVKISTGTAEF 278
            +  +  +H K II+ D+K +N+M       ++K+ DFG+  + +   +  +   GT ++
Sbjct: 110 IAIGLFFLHSKGIIYRDLKLDNVMLDA--EGHIKIADFGMCKENIFGGKTTRTFCGTPDY 167

Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKN 338
            APEI+  +P G   D WA GVL Y +L+G  PF GE++ E  +++     E +    K+
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM----EHNVSYPKS 223

Query: 339 VSEEGKDFIRRLLLRN 354
           +S+E     + LL ++
Sbjct: 224 LSKEAVSICKGLLTKH 239

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 83.3 bits (206), Expect = 3e-18
 Identities = 63/227 (27%), Positives = 117/227 (51%), Gaps = 39/227 (17%)

Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE---KELIRKEIDIMNQLHHPKLIN 169
           +E+IG G +GVV++ R + TG + A K I +    E      IR EI ++ +L+HP ++ 
Sbjct: 5   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVK 63

Query: 170 LHDAFEDDDEMVLIFEFLSGGELFERITAPDYK--MSEAEVIPVTLPILMT---QTSPAV 224
           L D    ++++ L+FEFL            D K  M  + +  + LP++ +   Q    +
Sbjct: 64  LLDVIHTENKLYLVFEFLH----------QDLKKFMDASPLSGIPLPLIKSYLFQLLQGL 113

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAE-----FA 279
              H   ++H D+KP+N++  T  +  +K+ DFGLA        V + T T E     + 
Sbjct: 114 AFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFG----VPVRTYTHEVVTLWYR 167

Query: 280 APEIVEREPVG--FYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
           APEI+    +G  +Y+   D+W++G +   +++  + F G+++++ L
Sbjct: 168 APEIL----LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 210

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 82.8 bits (204), Expect = 3e-18
 Identities = 60/218 (27%), Positives = 112/218 (51%), Gaps = 17/218 (7%)

Query: 100 DIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIM 159
           DI   +    Y++++ +G+G +G V++ R   TG + A K I +    +  LI++EI ++
Sbjct: 1   DILRRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMV 60

Query: 160 NQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFE--RITAPDYKMSEAEVIPVTLPILM 217
            +  H  ++    ++   +++ +  E+  GG L +   +T P   +SE ++  V      
Sbjct: 61  KECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGP---LSELQIAYVC----- 112

Query: 218 TQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS-TGTA 276
            +T   + ++H K  +H D+K  NI+    ++ +VK+ DFG+A K+      + S  GT 
Sbjct: 113 RETLQGLAYLHSKGKMHRDIKGANILLT--DNGDVKLADFGVAAKITATIAKRKSFIGTP 170

Query: 277 EFAAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSP 311
            + APE+   E  G Y    D+WAVG+ A + L+ L P
Sbjct: 171 YWMAPEVAAVEKNGGYNQLCDIWAVGITA-IELAELQP 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 82.9 bits (205), Expect = 4e-18
 Identities = 58/227 (25%), Positives = 100/227 (44%), Gaps = 38/227 (16%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE--KELIRKEIDIMNQLHHPKL 167
           Y+ LE+IG G +G V + + R+T  I A K + +  + E       +EI ++ +L H  +
Sbjct: 2   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 61

Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKM----SEAEVIPVTLPILMTQTSPA 223
           + L+D    D ++ L+FE+             D K        ++ P  +   M Q    
Sbjct: 62  VRLYDVLHSDKKLTLVFEYCD----------QDLKKYFDSCNGDIDPEIVKSFMFQLLKG 111

Query: 224 VKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA------TKLDPNEVVKISTGTAE 277
           +   H  N++H D+KP+N++        +K+ DFGLA       +    EVV     T  
Sbjct: 112 LAFCHSHNVLHRDLKPQNLLINKNG--ELKLADFGLARAFGIPVRCYSAEVV-----TLW 164

Query: 278 FAAPEIVEREPVG--FYT---DMWAVGVLAYVLLSGLSPFAGENDVE 319
           +  P+++     G   Y+   DMW+ G +   L +   P    NDV+
Sbjct: 165 YRPPDVL----FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 207

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 83.5 bits (206), Expect = 4e-18
 Identities = 65/254 (25%), Positives = 121/254 (47%), Gaps = 33/254 (12%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAK-----FIPVSHNLEKELIRKEIDIMNQLHHPKLINL 170
           +G G+FG V     + T   FA K      + +  ++E  ++ K + +     HP L +L
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRV-LSLAWEHPFLTHL 61

Query: 171 HDAFEDDDEMVLIFEFLSGGELFERITA------PDYKMSEAEVIPVTLPILMTQTSPAV 224
           +  F+  + +  + E+L+GG+L   I +      P      AE+I              +
Sbjct: 62  YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIIC------------GL 109

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFAAPE 282
           + +H K I++ D+K +NI+  T    ++K+ DFG+  +    +  K  T  GT ++ APE
Sbjct: 110 QFLHSKGIVYRDLKLDNILLDTDG--HIKIADFGMCKENMLGDA-KTCTFCGTPDYIAPE 166

Query: 283 IVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEE 342
           I+  +      D W+ GVL Y +L G SPF G ++ E  ++++  +  +     + ++ E
Sbjct: 167 ILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYP----RWLTRE 222

Query: 343 GKDFIRRLLLRNKE 356
            KD + +L +R  E
Sbjct: 223 AKDILVKLFVREPE 236

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 83.4 bits (206), Expect = 5e-18
 Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 37/219 (16%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL----------HHP 165
           +G G+FG V     + T  ++A K       L+K++I ++ D+   +           HP
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKV------LKKDVILQDDDVDCTMTEKRILALAAKHP 56

Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERIT------APDYKMSEAEVIPVTLPILMTQ 219
            L  LH  F+  D +  + E+++GG+L  +I        P  +   AEV           
Sbjct: 57  FLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEV----------- 105

Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK-LDPNEVVKISTGTAEF 278
            + A+  +H   +I+ D+K +NI+       + K+ DFG+  + +          GT ++
Sbjct: 106 -TLALMFLHRHGVIYRDLKLDNILLDAEG--HCKLADFGMCKEGILNGVTTTTFCGTPDY 162

Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEND 317
            APEI++    G   D WA+GVL Y +++G  PF  +N+
Sbjct: 163 IAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE 201

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 83.4 bits (207), Expect = 6e-18
 Identities = 82/294 (27%), Positives = 138/294 (46%), Gaps = 69/294 (23%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAK--FIPVSHNLEKELIRKEIDIMNQL-HHP- 165
           Y+IL+++G GA+G+V +  +R+T  + A K  F    +  + +   +EI  + +L  HP 
Sbjct: 9   YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPN 68

Query: 166 --KLINLHDAFEDDDEMVLIFEFLSGGELFERITA----PDYKMSEAEVIPVTLPILMTQ 219
             KL+N+  A  D D + L+FE++   +L   I A      +K             +M Q
Sbjct: 69  IVKLLNVIKAENDKD-IYLVFEYMET-DLHAVIRANILEDVHKRY-----------IMYQ 115

Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNS-TNVKMIDFGLA---TKLDPNEVVKIST-- 273
              A+K++H  N+IH D+KP NI+    NS   VK+ DFGLA   ++L+ N    + T  
Sbjct: 116 LLKALKYIHSGNVIHRDLKPSNILL---NSDCRVKLADFGLARSLSELEENPENPVLTDY 172

Query: 274 -GTAEFAAPEIVEREPVG--FYT---DMWAVGVLAYVLLSGLSPFAGE---NDVE----- 319
             T  + APEI+    +G   YT   DMW+VG +   +L G   F G    N +E     
Sbjct: 173 VATRWYRAPEIL----LGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEV 228

Query: 320 ----TLKNVKACDWEFD---------------EEAFKNVSEEGKDFIRRLLLRN 354
               + +++++    F                +E     S++  D +++LL+ N
Sbjct: 229 IGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFN 282

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 83.2 bits (205), Expect = 6e-18
 Identities = 58/211 (27%), Positives = 109/211 (51%), Gaps = 21/211 (9%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLHHP 165
           D ++ + E+G G  GVV + + + +G I A K I   +   +  ++IR E+ ++++ + P
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIR-ELQVLHECNSP 63

Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV- 224
            ++  + AF  D E+ +  E + GG L       D  + EA+ IP     ++ + S AV 
Sbjct: 64  YIVGFYGAFYSDGEISICMEHMDGGSL-------DQVLKEAKRIPEE---ILGKVSIAVL 113

Query: 225 ---KHMHEKN-IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAA 280
               ++ EK+ I+H DVKP NI+  +R    +K+ DFG++ +L  + +     GT  + +
Sbjct: 114 RGLAYLREKHQIMHRDVKPSNILVNSRGE--IKLCDFGVSGQL-IDSMANSFVGTRSYMS 170

Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLSGLSP 311
           PE ++       +D+W++G+    L  G  P
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 82.0 bits (202), Expect = 1e-17
 Identities = 62/221 (28%), Positives = 111/221 (50%), Gaps = 23/221 (10%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLH-HPK 166
           D ++I+E IG G +G V +   +K G+  A K +   H++++E I  E +I+  L  HP 
Sbjct: 18  DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEE-IEAEYNILKALSDHPN 76

Query: 167 LINLHDAF-----EDDDEMVLIFEFLSGG---ELFERITAPDYKMSEAEVIPVTLPILMT 218
           ++  +  +     ++ D++ L+ E  +GG   +L +       +M E  +  +    LM 
Sbjct: 77  VVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALM- 135

Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVK-ISTGTAE 277
                ++H+H    IH DVK  NI+  T     VK++DFG++ +L    + +  S GT  
Sbjct: 136 ----GLQHLHVNKTIHRDVKGNNILLTTEGG--VKLVDFGVSAQLTSTRLRRNTSVGTPF 189

Query: 278 FAAPEIV--EREPVGFY---TDMWAVGVLAYVLLSGLSPFA 313
           + APE++  E++    Y    D+W++G+ A  L  G  P A
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA 230

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 81.2 bits (200), Expect = 2e-17
 Identities = 53/203 (26%), Positives = 104/203 (51%), Gaps = 11/203 (5%)

Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLH 171
           LE IG G+FG V++  + +T  + A K I +     E E I++EI +++Q   P +   +
Sbjct: 9   LERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYY 68

Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
            ++    ++ +I E+L GG   + +      + E  +  +   IL       + ++H + 
Sbjct: 69  GSYLKGTKLWIIMEYLGGGSALDLLKPG--PLEETYIATILREIL-----KGLDYLHSER 121

Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS-TGTAEFAAPEIVEREPVG 290
            IH D+K  N++   +   +VK+ DFG+A +L   ++ + +  GT  + APE++++    
Sbjct: 122 KIHRDIKAANVLLSEQG--DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 179

Query: 291 FYTDMWAVGVLAYVLLSGLSPFA 313
           F  D+W++G+ A  L  G  P +
Sbjct: 180 FKADIWSLGITAIELAKGEPPNS 202

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 80.8 bits (199), Expect = 2e-17
 Identities = 72/253 (28%), Positives = 121/253 (47%), Gaps = 25/253 (9%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAK---FIPVSHNLEKEL--IRKEIDIMNQLHHPKLINL 170
           +G GAFG V+ C +  TG   A K   F P S    KE+  +  EI ++  L H +++  
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 171 HDAFEDDDEMVL-IF-EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH 228
           +    D  E  L IF E + GG + +++ +    ++E      T  IL       V ++H
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQIL-----EGVSYLH 123

Query: 229 EKNIIHLDVKPENIMCQTRNST-NVKMIDFGLATKLD----PNEVVKISTGTAEFAAPEI 283
              I+H D+K  NI+   R+S  NVK+ DFG + +L         +K  TGT  + +PE+
Sbjct: 124 SNMIVHRDIKGANIL---RDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV 180

Query: 284 VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV-KACDWEFDEEAFKNVSEE 342
           +  E  G   D+W+VG     +L+   P+A   + E +  + K      +     +VS+ 
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEKPPWA---EFEAMAAIFKIATQPTNPVLPPHVSDH 237

Query: 343 GKDFIRRLLLRNK 355
            +DF++R+ +  K
Sbjct: 238 CRDFLKRIFVEAK 250

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 80.6 bits (199), Expect = 3e-17
 Identities = 63/238 (26%), Positives = 111/238 (46%), Gaps = 39/238 (16%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE-----LIRKEIDIMNQL 162
           D +DI+ +IG G +G V++ R++ TG + A K + + +  EKE      IR EI I+ QL
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDN--EKEGFPITAIR-EIKILRQL 63

Query: 163 HHPKLINLHDAFEDDDEMV----------LIFEFLSGGELFERITAPDYKMSEAEVIPVT 212
           +H  ++NL +   D  + +          L+FE++   +L   + +     SE  +    
Sbjct: 64  NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMD-HDLMGLLESGLVHFSEDHIKS-- 120

Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA-------TKLDP 265
               M Q    + + H+KN +H D+K  NI+    N   +K+ DFGLA       ++   
Sbjct: 121 ---FMKQLLEGLNYCHKKNFLHRDIKCSNILLN--NKGQIKLADFGLARLYNSEESRPYT 175

Query: 266 NEVVKISTGTAEFAAPE-IVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLK 322
           N+V+     T  +  PE ++  E  G   D+W+ G +   L +    F    ++  L+
Sbjct: 176 NKVI-----TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLE 228

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 80.1 bits (197), Expect = 4e-17
 Identities = 67/253 (26%), Positives = 119/253 (47%), Gaps = 25/253 (9%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAK---FIPVSHNLEKEL--IRKEIDIMNQLHHPKLINL 170
           +G GAFG V+ C +  TG   A K   F P S    KE+  +  EI ++  L H +++  
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 171 HDAFEDDDE--MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH 228
           +    D +E  + +  E++ GG + +++ A    ++E      T  IL       V ++H
Sbjct: 70  YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQ-----GVSYLH 123

Query: 229 EKNIIHLDVKPENIMCQTRNST-NVKMIDFGLATKLD----PNEVVKISTGTAEFAAPEI 283
              I+H D+K  NI+   R+S  NVK+ DFG + ++         +K  TGT  + +PE+
Sbjct: 124 SNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEV 180

Query: 284 VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV-KACDWEFDEEAFKNVSEE 342
           +  E  G   D+W+V      +L+   P+A   + E +  + K             VS+ 
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKPPWA---EYEAMAAIFKIATQPTKPMLPDGVSDA 237

Query: 343 GKDFIRRLLLRNK 355
            +DF++++ +  K
Sbjct: 238 CRDFLKQIFVEEK 250

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 80.5 bits (199), Expect = 4e-17
 Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 26/226 (11%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL-EKELIRKEIDIMNQLHH-PKLIN 169
            L EIG+G  G V++ R +KTG++ A K +  + N  E + I  ++D++ + H  P ++ 
Sbjct: 19  NLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVK 78

Query: 170 LHDAFEDDDEMVLIFEFLSG--GELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
            +  F  D ++ +  E +S    +L +RI  P   + E         IL   T   VK +
Sbjct: 79  CYGYFITDSDVFICMELMSTCLDKLLKRIQGP---IPED--------ILGKMTVAIVKAL 127

Query: 228 H----EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPE- 282
           H    +  +IH DVKP NI+       NVK+ DFG++ +L  ++    S G A + APE 
Sbjct: 128 HYLKEKHGVIHRDVKPSNILLDASG--NVKLCDFGISGRLVDSKAKTRSAGCAAYMAPER 185

Query: 283 IVEREPVGFY---TDMWAVGVLAYVLLSGLSPFAGEN-DVETLKNV 324
           I   +P   Y    D+W++G+    L +G  P+     + E L  +
Sbjct: 186 IDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI 231

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 79.4 bits (196), Expect = 5e-17
 Identities = 57/222 (25%), Positives = 103/222 (46%), Gaps = 15/222 (6%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLIN 169
           + +  ++G+G FG V     +    + A K +     L+++  +KE+  + +L H  LI+
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRV-AIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66

Query: 170 LHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM-TQTSPAVKHMH 228
           L       + + +I E +  G L   + +P     E +V+PV   I M  Q +  + ++ 
Sbjct: 67  LFAVCSVGEPVYIITELMEKGSLLAFLRSP-----EGQVLPVASLIDMACQVAEGMAYLE 121

Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA---EFAAPEIVE 285
           E+N IH D+   NI+         K+ DFGLA  +   E V +S+      ++ APE   
Sbjct: 122 EQNSIHRDLAARNIL--VGEDLVCKVADFGLARLI--KEDVYLSSDKKIPYKWTAPEAAS 177

Query: 286 REPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKA 326
                  +D+W+ G+L Y + + G  P+ G N+ E    + A
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA 219

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 79.4 bits (196), Expect = 6e-17
 Identities = 72/261 (27%), Positives = 129/261 (49%), Gaps = 27/261 (10%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL-EKELIRKEIDI-MNQLHHP 165
           D  +++EE+G GA+GVV + R   TG I A K I  + N  E++ +  ++DI M  +  P
Sbjct: 1   DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCP 60

Query: 166 KLINLHDA-FEDDDEMVLIFEFL---SGGELFERITAPDYKMSEAEVIPVTLPILMTQTS 221
             +  + A F + D  V I   +   S  + ++++      + E  +  + + I+     
Sbjct: 61  YTVTFYGALFREGD--VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVK---- 114

Query: 222 PAVKHMHEK-NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVK-ISTGTAEFA 279
            A++++H K ++IH DVKP N++        VK+ DFG++  L  + V K I  G   + 
Sbjct: 115 -ALEYLHSKLSVIHRDVKPSNVLINRNG--QVKLCDFGISGYL-VDSVAKTIDAGCKPYM 170

Query: 280 APEIV--EREPVGF--YTDMWAVGVLAYVLLSGLSPFAG-ENDVETLKN-VKACDWEFDE 333
           APE +  E    G+   +D+W++G+    L +G  P+   +   + LK  V+    +   
Sbjct: 171 APERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPA 230

Query: 334 EAFKNVSEEGKDFIRRLLLRN 354
           E F   S E +DF+ + L +N
Sbjct: 231 EKF---SPEFQDFVNKCLKKN 248

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 80.8 bits (199), Expect = 8e-17
 Identities = 60/213 (28%), Positives = 107/213 (50%), Gaps = 16/213 (7%)

Query: 118 TGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDD 177
           T AF V  R  + K   +  AKF+ ++   +    R E+  +    H  ++   D F+ D
Sbjct: 81  TAAF-VATRGSDPKEKVV--AKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSD 137

Query: 178 DEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVT---LPILMTQTSPAVKHMHEKNIIH 234
           D+++LI E+ SGG+L ++I     K    E +P     + +L  Q   A+  +H + ++H
Sbjct: 138 DKLLLIMEYGSGGDLNKQI-----KQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMH 192

Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST---GTAEFAAPEIVEREPVGF 291
            D+K  NI      +  +K+ DFG + +   +  + +++   GT  + APE+ ER+    
Sbjct: 193 RDLKSANIFLMP--TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSK 250

Query: 292 YTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
             DMW++GV+ Y LL+   PF G +  E ++ V
Sbjct: 251 KADMWSLGVILYELLTLHRPFKGPSQREIMQQV 283

Length = 478

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 80.2 bits (198), Expect = 8e-17
 Identities = 66/293 (22%), Positives = 117/293 (39%), Gaps = 63/293 (21%)

Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL---IRKEIDIMNQLHHP 165
            +  ++ IG GAFG V   R+  T  ++A K +  +  L +     ++ E DI+ +  + 
Sbjct: 2   MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNE 61

Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMS---EAEVIPVTLP-ILMTQTS 221
            ++ L+ +F+D D +  + +++ GG++          MS      +    L    + + +
Sbjct: 62  WVVKLYYSFQDKDNLYFVMDYIPGGDM----------MSLLIRLGIFEEDLARFYIAELT 111

Query: 222 PAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD----------------- 264
            A++ +H+   IH D+KP+NI+       ++K+ DFGL T                    
Sbjct: 112 CAIESVHKMGFIHRDIKPDNILID--RDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQD 169

Query: 265 ----PNEVVKIST-----------------------GTAEFAAPEIVEREPVGFYTDMWA 297
                 E  +I                         GT  + APE++ R       D W+
Sbjct: 170 SMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 229

Query: 298 VGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRL 350
           VGV+ Y +L G  PF  +   ET   V   +      +   +S E  D I RL
Sbjct: 230 VGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRL 282

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 78.7 bits (194), Expect = 9e-17
 Identities = 60/250 (24%), Positives = 111/250 (44%), Gaps = 27/250 (10%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK---------EIDIMNQLHHPK 166
           IG+G+FG V+      +G + A K + +         RK         EI ++ +L H  
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKH 226
           ++    +  D D + +  E++ GG +   +   +Y   E  ++       + Q    + +
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLN--NYGAFEETLVRN----FVRQILKGLNY 121

Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST-------GTAEFA 279
           +H + IIH D+K  NI+    N   +K+ DFG++ KL+ N +   +        G+  + 
Sbjct: 122 LHNRGIIHRDIKGANILVD--NKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179

Query: 280 APEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNV 339
           APE+V++       D+W++G L   +L+G  PF    D   L+ +         E   N+
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFP---DCTQLQAIFKIGENASPEIPSNI 236

Query: 340 SEEGKDFIRR 349
           S E  DF+ +
Sbjct: 237 SSEAIDFLEK 246

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 78.9 bits (194), Expect = 1e-16
 Identities = 59/227 (25%), Positives = 105/227 (46%), Gaps = 18/227 (7%)

Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAA-KFIPVSHNLEKELIR--KEIDIMNQLH-- 163
            Y+ + EIG GA+G V + R+ K G  F A K + V    E   +   +E+ ++  L   
Sbjct: 2   QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61

Query: 164 -HPKLINLHDA-----FEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM 217
            HP ++ L D       + + ++ L+FE +      + +T    K+ E  V   T+  +M
Sbjct: 62  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-----QDLTTYLDKVPEPGVPTETIKDMM 116

Query: 218 TQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAE 277
            Q    +  +H   ++H D+KP+NI+  +  S  +K+ DFGLA        +     T  
Sbjct: 117 FQLLRGLDFLHSHRVVHRDLKPQNILVTS--SGQIKLADFGLARIYSFQMALTSVVVTLW 174

Query: 278 FAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           + APE++ +       D+W+VG +   +      F G +DV+ L  +
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 221

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 77.8 bits (192), Expect = 2e-16
 Identities = 59/227 (25%), Positives = 98/227 (43%), Gaps = 30/227 (13%)

Query: 114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPV------SHNLEKEL--IRKEIDIMNQLHHP 165
           +++G G+FGVV R     +G     K IPV      S  L   +    KE  IM+ L H 
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGG----KVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHE 56

Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM---TQTSP 222
            LI L+        ++++ E    G L +R       + +  +    +  L     Q + 
Sbjct: 57  NLIRLYGVVLTH-PLMMVTELAPLGSLLDR-------LRKDALGHFLISTLCDYAVQIAN 108

Query: 223 AVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAE--FA- 279
            ++++  K  IH D+   NI+  + +   VK+ DFGL   L  NE   +     +  FA 
Sbjct: 109 GMRYLESKRFIHRDLAARNILLASDDK--VKIGDFGLMRALPQNEDHYVMEEHLKVPFAW 166

Query: 280 -APEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
            APE +        +D+W  GV  + + + G  P+AG +  + LK +
Sbjct: 167 CAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 79.9 bits (197), Expect = 2e-16
 Identities = 73/262 (27%), Positives = 119/262 (45%), Gaps = 34/262 (12%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK--EIDIMNQLHHPKL 167
           Y I   +G+GA G V   +    G  FA K + +    E +  R   E+  +       +
Sbjct: 34  YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSI 93

Query: 168 INLHDAFEDDDE--------MVLIFEFLSGGELFERI-----TAPDYKMSEAEVIPVTLP 214
           +  H+ F   D         + L+ ++ + G+L + I     T   ++  EA        
Sbjct: 94  VKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAG------- 146

Query: 215 ILMTQTSPAVKHMHEKNIIHLDVKPENIM-CQTRNSTNVKMIDFGLATKLDPN----EVV 269
           +L  Q   AV H+H K++IH D+K  NI+ C   ++  VK+ DFG  +K+       +V 
Sbjct: 147 LLFIQVLLAVHHVHSKHMIHRDIKSANILLC---SNGLVKLGDFGF-SKMYAATVSDDVG 202

Query: 270 KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDW 329
           +   GT  + APEI  R+P     DM+++GVL Y LL+   PF GEN  E +   K    
Sbjct: 203 RTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMH--KTLAG 260

Query: 330 EFDEEAFKNVSEEGKDFIRRLL 351
            +D     ++S E ++ +  LL
Sbjct: 261 RYDPLP-PSISPEMQEIVTALL 281

Length = 496

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 77.5 bits (191), Expect = 2e-16
 Identities = 56/218 (25%), Positives = 105/218 (48%), Gaps = 14/218 (6%)

Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHD 172
           L+E+G+G FGVVH  + R   ++ A K I      E + I +E  +M +L HP L+ L+ 
Sbjct: 9   LKELGSGQFGVVHLGKWRGKIDV-AIKMIREGAMSEDDFI-EEAKVMMKLSHPNLVQLYG 66

Query: 173 AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNI 232
                  + ++ E+++ G L   +     K+    ++ +      +    A++++     
Sbjct: 67  VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMC-----SDVCEAMEYLESNGF 121

Query: 233 IHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT---AEFAAPEIVEREPV 289
           IH D+   N +    N   VK+ DFGLA  +  ++    S GT    ++A PE+ +    
Sbjct: 122 IHRDLAARNCLVGEDNV--VKVSDFGLARYVLDDQYTS-SQGTKFPVKWAPPEVFDYSRF 178

Query: 290 GFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKA 326
              +D+W+ GVL + + S G  P+   ++ E +++V A
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA 216

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 78.2 bits (192), Expect = 2e-16
 Identities = 53/201 (26%), Positives = 101/201 (50%), Gaps = 11/201 (5%)

Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLH 171
           LE+IG G+FG V +  + +T  + A K I +     E E I++EI +++Q   P +   +
Sbjct: 9   LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68

Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
            ++  D ++ +I E+L GG   + +      + E ++  +   IL       + ++H + 
Sbjct: 69  GSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREIL-----KGLDYLHSEK 121

Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVK-ISTGTAEFAAPEIVEREPVG 290
            IH D+K  N++        VK+ DFG+A +L   ++ +    GT  + APE++++    
Sbjct: 122 KIHRDIKAANVLLSEHGE--VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 179

Query: 291 FYTDMWAVGVLAYVLLSGLSP 311
              D+W++G+ A  L  G  P
Sbjct: 180 SKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 77.3 bits (190), Expect = 4e-16
 Identities = 62/237 (26%), Positives = 103/237 (43%), Gaps = 47/237 (19%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFI---------PVSHNLEKELIRKEIDIMN 160
           Y+ + EIG GA+G V++ R+  +G+  A K +         P+S   E  L+++    + 
Sbjct: 2   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKR----LE 57

Query: 161 QLHHPKLINLHDA-----FEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI 215
              HP ++ L D       + + ++ L+FE +            D +    +V P  LP 
Sbjct: 58  AFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD----------QDLRTYLDKVPPPGLPA 107

Query: 216 -----LMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA------TKLD 264
                LM Q    +  +H   I+H D+KPENI+  +     VK+ DFGLA        L 
Sbjct: 108 ETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQ--VKLADFGLARIYSCQMALT 165

Query: 265 PNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETL 321
           P  V      T  + APE++ +       DMW+VG +   +      F G ++ + L
Sbjct: 166 PVVV------TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL 216

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 77.3 bits (190), Expect = 5e-16
 Identities = 66/256 (25%), Positives = 123/256 (48%), Gaps = 41/256 (16%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAK-----FIPVSHNLEKELIRKEIDIMNQLHHPKLINL 170
           +G G+FG V     +  G  FA K      + +  ++E  ++ K + +     +P L +L
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRV-LALAWENPFLTHL 61

Query: 171 HDAFEDDDEMVLIFEFLSGGEL---------FERITAPDYKMSEAEVIPVTLPILMTQTS 221
           +  F+  + +  + EFL+GG+L         F+   A  Y    AE++            
Sbjct: 62  YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYA---AEIVC----------- 107

Query: 222 PAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFA 279
             ++ +H K II+ D+K +N+M       ++K+ DFG+  +    +  + ST  GT ++ 
Sbjct: 108 -GLQFLHSKGIIYRDLKLDNVMLD--RDGHIKIADFGMCKENVFGDN-RASTFCGTPDYI 163

Query: 280 APEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKN- 338
           APEI++     F  D W+ GVL Y +L G SPF G+++ E  ++++      D   +   
Sbjct: 164 APEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV-----DTPHYPRW 218

Query: 339 VSEEGKDFIRRLLLRN 354
           +++E KD + +L  R+
Sbjct: 219 ITKESKDILEKLFERD 234

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 77.4 bits (190), Expect = 5e-16
 Identities = 57/230 (24%), Positives = 113/230 (49%), Gaps = 12/230 (5%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLHHP 165
           D ++ + E+G G  GVV +   + +G I A K I   +   +  ++IR E+ ++++ + P
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIR-ELQVLHECNSP 63

Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++  + AF  D E+ +  E + GG L +++     ++ E  +  V++ ++   T    K
Sbjct: 64  YIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 122

Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           H     I+H DVKP NI+  +R    +K+ DFG++ +L  + +     GT  + +PE ++
Sbjct: 123 H----KIMHRDVKPSNILVNSRGE--IKLCDFGVSGQL-IDSMANSFVGTRSYMSPERLQ 175

Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEA 335
                  +D+W++G+    +  G  P     D + L+ +  C  E D   
Sbjct: 176 GTHYSVQSDIWSMGLSLVEMAIGRYPIP-PPDAKELELMFGCPVEGDPAE 224

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 76.8 bits (189), Expect = 5e-16
 Identities = 55/202 (27%), Positives = 100/202 (49%), Gaps = 11/202 (5%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFE 175
           +G G +G+V+  R+  T    A K IP   +   + + +EI + + L H  ++    +  
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 176 DDDEMVLIFEFLSGGEL--FERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNII 233
           ++    +  E + GG L    R      K +E  +I  T  IL       +K++H+  I+
Sbjct: 76  ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL-----EGLKYLHDNQIV 130

Query: 234 HLDVKPENIMCQTRNSTNVKMIDFGLATKLDP-NEVVKISTGTAEFAAPEIVEREPVGF- 291
           H D+K +N++  T  S  VK+ DFG + +L   N   +  TGT ++ APE++++ P G+ 
Sbjct: 131 HRDIKGDNVLVNTY-SGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYG 189

Query: 292 -YTDMWAVGVLAYVLLSGLSPF 312
              D+W++G     + +G  PF
Sbjct: 190 APADIWSLGCTIVEMATGKPPF 211

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 77.3 bits (190), Expect = 5e-16
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 21/213 (9%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR-KEIDIMNQLHHPKLI 168
           Y  LE++G G +  V + R + T N+ A K I + H         +E+ ++  L H  ++
Sbjct: 8   YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 67

Query: 169 NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH 228
            LHD    D  + L+FE+L   +L + +      MS   V      I + Q    + + H
Sbjct: 68  TLHDIVHTDKSLTLVFEYLD-KDLKQYMDDCGNIMSMHNV-----KIFLYQILRGLAYCH 121

Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA------TKLDPNEVVKISTGTAEFAAPE 282
            + ++H D+KP+N++   R    +K+ DFGLA      TK   NEVV     T  +  P+
Sbjct: 122 RRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSVPTKTYSNEVV-----TLWYRPPD 174

Query: 283 I-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAG 314
           + +         DMW VG + + + SG   F G
Sbjct: 175 VLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPG 207

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 78.6 bits (193), Expect = 7e-16
 Identities = 65/249 (26%), Positives = 114/249 (45%), Gaps = 38/249 (15%)

Query: 105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS--HNLEKELIRKEIDIMNQL 162
           S  + Y+++++IG G FG V   + ++T   F  K I        EK  +  E+++M +L
Sbjct: 10  SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL 69

Query: 163 HHPKLINLHDAF--EDDDEMVLIFEFLSGGELFERITAPDYKM----SEAEVIPVTLPIL 216
            H  ++   D F  + + ++ ++ EF   G+L   I    YKM     E  ++ +T  +L
Sbjct: 70  KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKC-YKMFGKIEEHAIVDITRQLL 128

Query: 217 MTQTSPAVKHMHE-------KNIIHLDVKPENIMCQT-----------RNSTN----VKM 254
                 A+ + H        + ++H D+KP+NI   T            N+ N     K+
Sbjct: 129 H-----ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKI 183

Query: 255 IDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGF--YTDMWAVGVLAYVLLSGLSPF 312
            DFGL+  +    +     GT  + +PE++  E   +   +DMWA+G + Y L SG +PF
Sbjct: 184 GDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243

Query: 313 AGENDVETL 321
              N+   L
Sbjct: 244 HKANNFSQL 252

Length = 1021

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 75.3 bits (185), Expect = 1e-15
 Identities = 53/216 (24%), Positives = 98/216 (45%), Gaps = 28/216 (12%)

Query: 114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN----LEKEL--IRKEIDIMNQLHHPKL 167
           E +G GA+G V+ C     G + A K + +  +     EKE   +++E+D++  L H  +
Sbjct: 6   EVLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64

Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPIL---MTQTSPAV 224
           +       DD+ + +  EF+ GG +   +             P+  P+      Q    V
Sbjct: 65  VQYLGTCLDDNTISIFMEFVPGGSISSILN---------RFGPLPEPVFCKYTKQILDGV 115

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL-------DPNEVVKISTGTAE 277
            ++H   ++H D+K  N+M        +K+IDFG A +L         + ++K   GT  
Sbjct: 116 AYLHNNCVVHRDIKGNNVMLMPNGI--IKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY 173

Query: 278 FAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFA 313
           + APE++     G  +D+W++G   + + +G  P A
Sbjct: 174 WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLA 209

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 75.4 bits (185), Expect = 1e-15
 Identities = 58/223 (26%), Positives = 111/223 (49%), Gaps = 14/223 (6%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKL 167
               +++EIG+G FG+V      +   + A K I      E++ I +E  +M +L HPKL
Sbjct: 4   SELTLVQEIGSGQFGLVWLGYWLEKRKV-AIKTIREGAMSEEDFI-EEAQVMMKLSHPKL 61

Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
           + L+    +   + L+FEF+  G L + + A   K S+  ++ + L +        + ++
Sbjct: 62  VQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDV-----CEGMAYL 116

Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT---AEFAAPEIV 284
              N+IH D+   N  C    +  VK+ DFG+ T+   ++    STGT    ++++PE+ 
Sbjct: 117 ESSNVIHRDLAARN--CLVGENQVVKVSDFGM-TRFVLDDQYTSSTGTKFPVKWSSPEVF 173

Query: 285 EREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKA 326
                   +D+W+ GVL + + S G +P+   ++ E ++ + A
Sbjct: 174 SFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINA 216

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 75.5 bits (185), Expect = 1e-15
 Identities = 50/201 (24%), Positives = 102/201 (50%), Gaps = 11/201 (5%)

Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLH 171
           LE IG G+FG V +  + +T  + A K I +     E E I++EI +++Q   P +   +
Sbjct: 9   LERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68

Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
            ++    ++ +I E+L GG   + + A  +   +       +  ++ +    + ++H + 
Sbjct: 69  GSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQ-------IATMLKEILKGLDYLHSEK 121

Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS-TGTAEFAAPEIVEREPVG 290
            IH D+K  N++   +   +VK+ DFG+A +L   ++ + +  GT  + APE++++    
Sbjct: 122 KIHRDIKAANVLLSEQG--DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYD 179

Query: 291 FYTDMWAVGVLAYVLLSGLSP 311
              D+W++G+ A  L  G  P
Sbjct: 180 SKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 76/281 (27%), Positives = 125/281 (44%), Gaps = 40/281 (14%)

Query: 94  YVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKEL 151
           +  Q ++     V D Y  L  +G+GA+G V    + KTG   A K +  P    +  + 
Sbjct: 1   FYRQELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKR 60

Query: 152 IRKEIDIMNQLHHPKLINLHDAF------EDDDEMVLIFEFLSGGELFERITAPDYKMSE 205
             +E+ ++  + H  +I L D F      ED  ++ L+   + G +L   I     K+S+
Sbjct: 61  TYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQ-KLSD 117

Query: 206 AEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIM----CQTRNSTNVKMIDFGLAT 261
             +       L+ Q    +K++H   IIH D+KP NI     C+      +K++DFGLA 
Sbjct: 118 DHI-----QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE------LKILDFGLAR 166

Query: 262 KLDPNEVVKISTG---TAEFAAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGE 315
             D        TG   T  + APEI+       Y    D+W+VG +   LL+G + F G 
Sbjct: 167 HTD-----DEMTGYVATRWYRAPEIMLNW--MHYNQTVDIWSVGCIMAELLTGKTLFPGS 219

Query: 316 NDVETLKNV-KACDWEFDEEAFKNVSEEGKDFIRRLLLRNK 355
           + ++ LK +        +E   K  SE  +++I+ L    K
Sbjct: 220 DHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPK 260

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 75.0 bits (184), Expect = 2e-15
 Identities = 55/216 (25%), Positives = 111/216 (51%), Gaps = 17/216 (7%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTG---NIFAAKFIPVSHNLEKELIR--KEIDIMNQLHH 164
           Y + + +G G+FG V+  +++K      +   K IPV      E ++  +E  ++++L H
Sbjct: 2   YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61

Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGEL---FERITAPDYKMSEAEVIPVTLPILMTQTS 221
           P ++  H +F + D   +I E+  G +L    E +      +SE +V    + +L+    
Sbjct: 62  PAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL---- 117

Query: 222 PAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN-EVVKISTGTAEFAA 280
             V +MH++ I+H D+K +NI    +N+  +K+ DFG++  L  + ++    TGT  + +
Sbjct: 118 -GVHYMHQRRILHRDLKAKNIF--LKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYYMS 173

Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN 316
           PE ++ +     +D+W++G + Y +      F G+N
Sbjct: 174 PEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 74.5 bits (183), Expect = 3e-15
 Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 22/209 (10%)

Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G +G V+    +K     A K +     +E E   KE  +M ++ HP L+ L    
Sbjct: 13  KLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 71

Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
             +    +I EF++ G L + +   +      EV  V L  + TQ S A++++ +KN IH
Sbjct: 72  TREPPFYIITEFMTYGNLLDYLRECN----RQEVNAVVLLYMATQISSAMEYLEKKNFIH 127

Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA--------EFAAPEIVER 286
            D+   N  C    +  VK+ DFGL+       ++   T TA        ++ APE +  
Sbjct: 128 RDLAARN--CLVGENHLVKVADFGLS------RLMTGDTYTAHAGAKFPIKWTAPESLAY 179

Query: 287 EPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
                 +D+WA GVL + + + G+SP+ G
Sbjct: 180 NKFSIKSDVWAFGVLLWEIATYGMSPYPG 208

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 75.2 bits (185), Expect = 3e-15
 Identities = 62/222 (27%), Positives = 109/222 (49%), Gaps = 27/222 (12%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE-KELIR----KEIDIMNQL 162
           D ++ L E+G G  GVV +   R +G I A K I    +LE K  IR    +E+ ++++ 
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLI----HLEIKPAIRNQIIRELKVLHEC 56

Query: 163 HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSP 222
           + P ++  + AF  D E+ +  E + GG L       D  + +A  IP     ++ + S 
Sbjct: 57  NSPYIVGFYGAFYSDGEISICMEHMDGGSL-------DQVLKKAGRIP---ENILGKISI 106

Query: 223 AV----KHMHEK-NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAE 277
           AV     ++ EK  I+H DVKP NI+  +R    +K+ DFG++ +L  + +     GT  
Sbjct: 107 AVLRGLTYLREKHKIMHRDVKPSNILVNSRG--EIKLCDFGVSGQL-IDSMANSFVGTRS 163

Query: 278 FAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVE 319
           + +PE ++       +D+W++G+    +  G  P    +  E
Sbjct: 164 YMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE 205

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 74.3 bits (182), Expect = 5e-15
 Identities = 49/215 (22%), Positives = 103/215 (47%), Gaps = 11/215 (5%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR-KEIDIMNQLHHPK 166
           D Y+ LE++G G++  V++ + +  G + A K I +           +E  ++  L H  
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKH 226
           ++ LHD     + + L+FE++   +L + +           + P  + + + Q    + +
Sbjct: 65  IVLLHDIIHTKETLTLVFEYVH-TDLCQYMDK-----HPGGLHPENVKLFLFQLLRGLSY 118

Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA-TKLDPNEVVKISTGTAEFAAPEI-V 284
           +H++ I+H D+KP+N++    ++  +K+ DFGLA  K  P+        T  +  P++ +
Sbjct: 119 IHQRYILHRDLKPQNLLIS--DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLL 176

Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVE 319
                    DMW VG +   ++ G++ F G  D++
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ 211

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 74.6 bits (184), Expect = 5e-15
 Identities = 71/295 (24%), Positives = 123/295 (41%), Gaps = 70/295 (23%)

Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI-PVSHNLEKELIRKEIDIMNQLHH 164
           V   Y  L  IG GA+G+V     + TG   A K I P  H    +   +EI I+ +  H
Sbjct: 3   VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKH 62

Query: 165 PKLINLHD-----AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQ 219
             +I + D     +FE  +++ ++ E +   +L++ I      +S   +      IL   
Sbjct: 63  ENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQ--HLSNDHIQYFLYQILR-- 117

Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNST-NVKMIDFGLATKLDPNEVVKISTG---- 274
               +K++H  N++H D+KP N++    N+  ++K+ DFGLA   DP       TG    
Sbjct: 118 ---GLKYIHSANVLHRDLKPSNLLL---NTNCDLKICDFGLARIADPEH---DHTGFLTE 168

Query: 275 ---TAEFAAPEIV--EREPVGFYT---DMWAVGVLAYVLLSGLSPFAG------------ 314
              T  + APEI+   +     YT   D+W+VG +   +LS    F G            
Sbjct: 169 YVATRWYRAPEIMLNSKG----YTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILG 224

Query: 315 ------ENDVETLKNVKACD------------WEFDEEAFKNVSEEGKDFIRRLL 351
                 + D+  + +++A +            W    + F N   +  D + ++L
Sbjct: 225 VLGTPSQEDLNCIISLRARNYIKSLPFKPKVPW---NKLFPNADPKALDLLDKML 276

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 72.9 bits (179), Expect = 1e-14
 Identities = 67/292 (22%), Positives = 131/292 (44%), Gaps = 59/292 (20%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR----KEIDIMNQLH 163
           D Y+ LE+IG G +G V++ R++ TG + A K   +   +++E I     +EI ++  L 
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLE--MDEEGIPPTALREISLLQMLS 58

Query: 164 HP----KLINLHDAFEDDDE--MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM 217
                 +L+++    E + +  + L+FE+L      ++    + +     +   T+   M
Sbjct: 59  ESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSD--LKKFMDSNGRGPGRPLPAKTIKSFM 116

Query: 218 TQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA------TKLDPNEVVKI 271
            Q    V H H+  ++H D+KP+N++   +    +K+ D GL        K   +E+V  
Sbjct: 117 YQLLKGVAHCHKHGVMHRDLKPQNLLVD-KQKGLLKIADLGLGRAFSIPVKSYTHEIV-- 173

Query: 272 STGTAEFAAPEIV-----EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV-- 324
              T  + APE++        PV    D+W+VG +   +      F G+++++ L ++  
Sbjct: 174 ---TLWYRAPEVLLGSTHYSTPV----DIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFK 226

Query: 325 --------------KACDW-EFDE-------EAFKNVSEEGKDFIRRLLLRN 354
                         K  DW EF +        A  ++S EG D ++++L  +
Sbjct: 227 LLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYD 278

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 65/292 (22%), Positives = 123/292 (42%), Gaps = 65/292 (22%)

Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELI---RKEIDIMNQLHHPKLIN 169
           ++ +G GAFG V    +  T  ++A K +     L +  +   + E DI+ +  +  ++ 
Sbjct: 6   IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVK 65

Query: 170 LHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLP-ILMTQTSPAVKHMH 228
           L+ +F+D D +  + +++ GG++   +          EV P  L    + + + A++ +H
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLI-------RMEVFPEVLARFYIAELTLAIESVH 118

Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT--------------------KLDPNEV 268
           +   IH D+KP+NI+       ++K+ DFGL T                     ++P+++
Sbjct: 119 KMGFIHRDIKPDNILIDL--DGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDL 176

Query: 269 V----------KIST------------------GTAEFAAPEIVEREPVGFYTDMWAVGV 300
                      ++ T                  GT  + APE++ R+      D W+VGV
Sbjct: 177 WDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236

Query: 301 LAYVLLSGLSPFAGENDVETLKNVKACDWE--FDEEAFKNVSEEGKDFIRRL 350
           + + +L G  PF      ET   +K  +WE          +S E  D I +L
Sbjct: 237 ILFEMLVGQPPFLAPTPTET--QLKVINWENTLHIPPQVKLSPEAVDLITKL 286

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 23/200 (11%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS--HNLEK-ELIRKEIDIMNQLHHPK 166
           +  L EIG G+FG V+  R+ +T  + A K +  S   + EK + I KE+  + QL HP 
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 167 LINLHDAFEDDDEMVLIFEFL--SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
            I     +  +    L+ E+   S  ++ E    P   + E E+  +    L       +
Sbjct: 77  TIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKP---LQEVEIAAICHGALQ-----GL 128

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP-NEVVKISTGTAEFAAPEI 283
            ++H    IH D+K  NI+  T   T VK+ DFG A+ + P N  V    GT  + APE+
Sbjct: 129 AYLHSHERIHRDIKAGNILL-TEPGT-VKLADFGSASLVSPANSFV----GTPYWMAPEV 182

Query: 284 VEREPVGFYT---DMWAVGV 300
           +     G Y    D+W++G+
Sbjct: 183 ILAMDEGQYDGKVDVWSLGI 202

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 67/292 (22%), Positives = 122/292 (41%), Gaps = 65/292 (22%)

Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELI---RKEIDIMNQLHHPKLIN 169
           ++ +G GAFG V   R+  T  ++A K +     L +  +   + E DI+ +  +  ++ 
Sbjct: 6   IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVR 65

Query: 170 LHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLP-ILMTQTSPAVKHMH 228
           L+ +F+D D +  + +++ GG++   +     +M    + P  L    + + + AV+ +H
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLI----RMG---IFPEDLARFYIAELTCAVESVH 118

Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT--------------------------- 261
           +   IH D+KP+NI+       ++K+ DFGL T                           
Sbjct: 119 KMGFIHRDIKPDNILID--RDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE 176

Query: 262 -----------KLDPNE----------VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGV 300
                      +L P E          +     GT  + APE++ R       D W+VGV
Sbjct: 177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236

Query: 301 LAYVLLSGLSPFAGENDVETLKNVKACDWE--FDEEAFKNVSEEGKDFIRRL 350
           + Y +L G  PF  +  +ET   +K  +W+          +S E  D I +L
Sbjct: 237 ILYEMLVGQPPFLAQTPLET--QMKVINWQTSLHIPPQAKLSPEASDLIIKL 286

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 72.3 bits (177), Expect = 3e-14
 Identities = 58/221 (26%), Positives = 98/221 (44%), Gaps = 23/221 (10%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR-KEIDIMNQLHHPKLI 168
           Y  L+++G G +  V++ R + T N+ A K I + H         +E+ ++  L H  ++
Sbjct: 8   YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 67

Query: 169 NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPV-TLPILMTQTSPAVKHM 227
            LHD    +  + L+FE+L             Y       I +  + + + Q    + + 
Sbjct: 68  TLHDIIHTEKSLTLVFEYLDK-------DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYC 120

Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA------TKLDPNEVVKISTGTAEFAAP 281
           H + ++H D+KP+N++   R    +K+ DFGLA      TK   NEVV     T  +  P
Sbjct: 121 HRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTYSNEVV-----TLWYRPP 173

Query: 282 EI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETL 321
           +I +         DMW VG + Y + +G   F G    E L
Sbjct: 174 DILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL 214

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 71.5 bits (176), Expect = 5e-14
 Identities = 60/232 (25%), Positives = 106/232 (45%), Gaps = 36/232 (15%)

Query: 110 YDILEEIGTGAFGVVHRCR--ERKTGNIFAAK-FIPVSHN---LEKELIRKEIDIMNQLH 163
           Y+I   IG G +G V++ +    K G  +A K F         + +   R EI ++ +L 
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACR-EIALLRELK 60

Query: 164 HPKLINLHDAFEDDDEMV--LIFEFLSGGELFERITAPDYKMSEAEVIP-VTLPILMTQT 220
           H  +++L + F +  +    L+F++ +  +L++ I    ++ ++   IP   +  L+ Q 
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIK--FHRQAKRVSIPPSMVKSLLWQI 117

Query: 221 SPAVKHMHEKNIIHLDVKPENI--MCQTRNSTNVKMIDFGLATK--------LDPNEVVK 270
              V ++H   ++H D+KP NI  M +      VK+ D GLA           D + VV 
Sbjct: 118 LNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV 177

Query: 271 ISTGTAEFAAPEIVEREPVG--FYT---DMWAVGVLAYVLLSGLSPFAGEND 317
               T  + APE++    +G   YT   D+WA+G +   LL+    F G   
Sbjct: 178 ----TIWYRAPELL----LGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 70.7 bits (173), Expect = 6e-14
 Identities = 61/216 (28%), Positives = 108/216 (50%), Gaps = 36/216 (16%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK---EIDIMNQLHHPKLINLHD 172
           IG G FG V+ CR+  TG ++A K       L+K+ I+    E   +N+     L++  D
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKC------LDKKRIKMKQGETLALNERIMLSLVSTGD 55

Query: 173 ---------AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPA 223
                    AF   D++  I + ++GG+L   ++      SEAE+      I++      
Sbjct: 56  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV-FSEAEMRFYAAEIIL-----G 109

Query: 224 VKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA---TKLDPNEVVKISTGTAEFAA 280
           ++HMH + +++ D+KP NI+       +V++ D GLA   +K  P+     S GT  + A
Sbjct: 110 LEHMHNRFVVYRDLKPANILLD--EHGHVRISDLGLACDFSKKKPHA----SVGTHGYMA 163

Query: 281 PEIVEREPVGFYT--DMWAVGVLAYVLLSGLSPFAG 314
           PE++++  V + +  D +++G + + LL G SPF  
Sbjct: 164 PEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 71.4 bits (175), Expect = 7e-14
 Identities = 66/250 (26%), Positives = 113/250 (45%), Gaps = 15/250 (6%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLHHPKL 167
           Y  L+ +G GAFG+V   R++ TG   A K I  P S  +  +   +E+ ++  L H  +
Sbjct: 12  YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENI 71

Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
           I+L D F    E +     L G +L   +T+   +  E + I       + Q    +K++
Sbjct: 72  ISLSDIFISPLEDIYFVTELLGTDLHRLLTS---RPLEKQFIQY----FLYQILRGLKYV 124

Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEI-VER 286
           H   ++H D+KP NI+     + ++K+ DFGLA   DP     +S  T  + APEI +  
Sbjct: 125 HSAGVVHRDLKPSNIL--INENCDLKICDFGLARIQDPQMTGYVS--TRYYRAPEIMLTW 180

Query: 287 EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNV-SEEGKD 345
           +      D+W+ G +   +L G   F G++ V     +        ++    + SE    
Sbjct: 181 QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR 240

Query: 346 FIRRLLLRNK 355
           F++ L  R  
Sbjct: 241 FVQSLPKREP 250

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 73/269 (27%), Positives = 126/269 (46%), Gaps = 26/269 (9%)

Query: 94  YVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAK--FIPVSHNLEKEL 151
           Y  Q V+     V D Y  L+++G+GA+G V    +R+TG   A K  + P    L  + 
Sbjct: 1   YYRQEVNKTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKR 60

Query: 152 IRKEIDIMNQLHHPKLINLHDAFEDD------DEMVLIFEFLSGGELFERITAPDYKMSE 205
             +E+ ++  + H  +I L D F  D       +  L+  F+ G +L + +     K+SE
Sbjct: 61  AYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHE--KLSE 117

Query: 206 AEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP 265
             +       L+ Q    +K++H   IIH D+KP N+         +K++DFGLA + D 
Sbjct: 118 DRI-----QFLVYQMLKGLKYIHAAGIIHRDLKPGNL--AVNEDCELKILDFGLARQTDS 170

Query: 266 NEVVKISTGTAEFAAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETLK 322
                +   T  + APE++       YT   D+W+VG +   +L+G   F G + ++ L 
Sbjct: 171 EMTGYVV--TRWYRAPEVILNWM--HYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLM 226

Query: 323 NV-KACDWEFDEEAFKNVSEEGKDFIRRL 350
            + K       E   K  SE+ K+++++L
Sbjct: 227 EIMKVTGTPSKEFVQKLQSEDAKNYVKKL 255

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 69.1 bits (169), Expect = 2e-13
 Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 14/220 (6%)

Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLI 168
               L+E+GTG FGVV   + R   ++ A K I      E E I +E  +M +L H KL+
Sbjct: 5   DLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFI-EEAKVMMKLSHEKLV 62

Query: 169 NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH 228
            L+        + ++ E++S G L   +     +       P  L  +       + ++ 
Sbjct: 63  QLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQ-----PSQLLEMCKDVCEGMAYLE 117

Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT---AEFAAPEIVE 285
            K  IH D+   N  C   +   VK+ DFGL+  +  +E    S G+     ++ PE++ 
Sbjct: 118 SKQFIHRDLAARN--CLVDDQGCVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLL 174

Query: 286 REPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
                  +D+WA GVL + + S G  P+   N+ ET++ V
Sbjct: 175 YSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV 214

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 29/210 (13%)

Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS---HNLEKELIRKEIDIMNQL 162
           V   Y  +E IG+GA+GVV    + ++G   A K IP +     L K  +R E+ I+   
Sbjct: 3   VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR-ELKILRHF 61

Query: 163 HHPKLINLHDAF----EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
            H  +I + D       D  ++ ++ + L   +L   I   D  ++E  +        + 
Sbjct: 62  KHDNIIAIRDILRPPGADFKDVYVVMD-LMESDL-HHIIHSDQPLTEEHI-----RYFLY 114

Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNST-NVKMIDFGLATKLDPNEVVKISTGTAE 277
           Q    +K++H  N+IH D+KP N++    N    +++ DFG+A  L  +        T  
Sbjct: 115 QLLRGLKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGMARGLSSSPTEHKYFMTEY 171

Query: 278 FA-----APEIVEREPVGFYT---DMWAVG 299
            A     APE++    +  YT   DMW+VG
Sbjct: 172 VATRWYRAPELLLS--LPEYTTAIDMWSVG 199

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 68/231 (29%), Positives = 105/231 (45%), Gaps = 34/231 (14%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP--VSHNLEKELIRKEIDIMNQLHHP-- 165
           Y I E IG G++GVV    +  TG   A K I     H  +   I +EI ++  L HP  
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61

Query: 166 ---KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSP 222
              K I L  +  +  ++ ++FE L   +L + I A D      ++ P      + Q   
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVFE-LMESDLHQVIKAND------DLTPEHHQFFLYQLLR 114

Query: 223 AVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPE 282
           A+K++H  N+ H D+KP+NI+        +K+ DFGLA       V    T TA F    
Sbjct: 115 ALKYIHTANVFHRDLKPKNILANA--DCKLKICDFGLA------RVAFNDTPTAIFWTDY 166

Query: 283 IVER-----EPVG-FYT------DMWAVGVLAYVLLSGLSPFAGENDVETL 321
           +  R     E  G F++      D+W++G +   +L+G   F G+N V  L
Sbjct: 167 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 217

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 69.7 bits (170), Expect = 2e-13
 Identities = 64/225 (28%), Positives = 96/225 (42%), Gaps = 23/225 (10%)

Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL---IRKEIDIMNQLHHPKLIN 169
           L EIG G+FG V+      T  + A K +  S     E    I KE+  + QL HP  I 
Sbjct: 26  LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85

Query: 170 LHDAFEDDDEMVLIFEFL--SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
               +  +    L+ E+   S  +L E    P   + E E+  +T   L       + ++
Sbjct: 86  YKGCYLKEHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAITHGALQ-----GLAYL 137

Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP-NEVVKISTGTAEFAAPEIVER 286
           H  N+IH D+K  NI+        VK+ DFG A+K  P N  V    GT  + APE++  
Sbjct: 138 HSHNMIHRDIKAGNILLT--EPGQVKLADFGSASKSSPANSFV----GTPYWMAPEVILA 191

Query: 287 EPVGFY---TDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACD 328
              G Y    D+W++G+    L     P    N +  L ++   D
Sbjct: 192 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND 236

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 69.3 bits (170), Expect = 2e-13
 Identities = 62/235 (26%), Positives = 103/235 (43%), Gaps = 51/235 (21%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE------LIRKEIDIMNQ 161
           + Y  L+++G G++  V++ R + TG + A K I     LE E       IR E  ++  
Sbjct: 5   ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEI----RLEHEEGAPFTAIR-EASLLKD 59

Query: 162 LHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK--MSEAEVI--PVTLPILM 217
           L H  ++ LHD       + L+FE+L            D K  M +         + + +
Sbjct: 60  LKHANIVTLHDIIHTKKTLTLVFEYLD----------TDLKQYMDDCGGGLSMHNVRLFL 109

Query: 218 TQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA------TKLDPNEVVK- 270
            Q    + + H++ ++H D+KP+N++   R    +K+ DFGLA      +K   NEVV  
Sbjct: 110 FQLLRGLAYCHQRRVLHRDLKPQNLLISERGE--LKLADFGLARAKSVPSKTYSNEVVTL 167

Query: 271 ------ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVE 319
                 +  G+ E++              DMW VG + Y + +G   F G  DVE
Sbjct: 168 WYRPPDVLLGSTEYSTS-----------LDMWGVGCIFYEMATGRPLFPGSTDVE 211

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 68.9 bits (169), Expect = 2e-13
 Identities = 54/220 (24%), Positives = 98/220 (44%), Gaps = 19/220 (8%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLH 171
           +  ++G G FG V       T  + A K +     +  E   +E  IM +L H KL+ L+
Sbjct: 10  LERKLGAGQFGEVWMGTWNGTTKV-AVKTLK-PGTMSPEAFLQEAQIMKKLRHDKLVQLY 67

Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPIL---MTQTSPAVKHMH 228
               +++ + ++ E++S G L       D+ +   E   + LP L     Q +  + ++ 
Sbjct: 68  AVCSEEEPIYIVTEYMSKGSLL------DF-LKSGEGKKLRLPQLVDMAAQIAEGMAYLE 120

Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA---EFAAPEIVE 285
            +N IH D+   NI+         K+ DFGLA  ++ +E      G     ++ APE   
Sbjct: 121 SRNYIHRDLAARNILVGENL--VCKIADFGLARLIEDDEYTA-REGAKFPIKWTAPEAAN 177

Query: 286 REPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
                  +D+W+ G+L   +++ G  P+ G  + E L+ V
Sbjct: 178 YGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV 217

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 68.6 bits (168), Expect = 3e-13
 Identities = 53/220 (24%), Positives = 96/220 (43%), Gaps = 19/220 (8%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLH 171
           +L ++G G FG V       T  +      P + + +  L   E  IM +L HPKLI L+
Sbjct: 10  LLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFL--AEAQIMKKLRHPKLIQLY 67

Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM---TQTSPAVKHMH 228
                ++ + ++ E +  G L E +     +        + LP L+    Q +  + ++ 
Sbjct: 68  AVCTLEEPIYIVTELMKYGSLLEYLQGGAGRA-------LKLPQLIDMAAQVASGMAYLE 120

Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA---EFAAPEIVE 285
            +N IH D+   N++    N    K+ DFGLA  +  +   +   G     ++ APE   
Sbjct: 121 AQNYIHRDLAARNVLVGENNI--CKVADFGLARVIKEDI-YEAREGAKFPIKWTAPEAAL 177

Query: 286 REPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
                  +D+W+ G+L   +++ G  P+ G  + E L+ V
Sbjct: 178 YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV 217

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 68.9 bits (168), Expect = 3e-13
 Identities = 56/213 (26%), Positives = 105/213 (49%), Gaps = 34/213 (15%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKE------------IDIMNQLH 163
           IG G FG V+ CR+  TG ++A K       L+K+ I+ +            + +++   
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKC------LDKKRIKMKQGETLALNERIMLSLVSTGD 55

Query: 164 HPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPA 223
            P ++ +  AF   D++  I + ++GG+L   ++      SE E+      I++      
Sbjct: 56  CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV-FSEKEMRFYATEIIL-----G 109

Query: 224 VKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA---TKLDPNEVVKISTGTAEFAA 280
           ++HMH + +++ D+KP NI+       +V++ D GLA   +K  P+     S GT  + A
Sbjct: 110 LEHMHNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFSKKKPHA----SVGTHGYMA 163

Query: 281 PEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPF 312
           PE++++        D +++G + + LL G SPF
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 68.9 bits (168), Expect = 4e-13
 Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 23/221 (10%)

Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS---HNLEKELIRKEIDIMNQLHHPKLIN 169
           L EIG G+FG V+  R+ +   + A K +  S    N + + I KE+  + +L HP  I 
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79

Query: 170 LHDAFEDDDEMVLIFEFL--SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
               +  +    L+ E+   S  +L E    P   + E E+  VT   L       + ++
Sbjct: 80  YRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQ-----GLAYL 131

Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP-NEVVKISTGTAEFAAPEIVER 286
           H  N+IH DVK  NI+        VK+ DFG A+ + P N  V    GT  + APE++  
Sbjct: 132 HSHNMIHRDVKAGNILLS--EPGLVKLGDFGSASIMAPANXFV----GTPYWMAPEVILA 185

Query: 287 EPVGFY---TDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
              G Y    D+W++G+    L     P    N +  L ++
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 68.6 bits (167), Expect = 6e-13
 Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 23/221 (10%)

Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL---IRKEIDIMNQLHHPKLIN 169
           L EIG G+FG V+  R+ +T  + A K +  S     E    I KE+  + ++ HP  I 
Sbjct: 30  LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE 89

Query: 170 LHDAFEDDDEMVLIFEFL--SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
               +  +    L+ E+   S  +L E    P   + E E+  +T   L       + ++
Sbjct: 90  YKGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAITHGALQ-----GLAYL 141

Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP-NEVVKISTGTAEFAAPEIVER 286
           H  N+IH D+K  NI+        VK+ DFG A+   P N  V    GT  + APE++  
Sbjct: 142 HSHNMIHRDIKAGNILLT--EPGQVKLADFGSASIASPANSFV----GTPYWMAPEVILA 195

Query: 287 EPVGFY---TDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
              G Y    D+W++G+    L     P    N +  L ++
Sbjct: 196 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 236

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 68.2 bits (167), Expect = 6e-13
 Identities = 62/215 (28%), Positives = 97/215 (45%), Gaps = 42/215 (19%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE-----LIRKEIDIMNQLHH 164
           Y+ L +IG G FG V + R +KT  I A K + + +  EKE      +R EI I+  L H
Sbjct: 14  YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMEN--EKEGFPITALR-EIKILQLLKH 70

Query: 165 PKLINLHD-------AFEDDD-EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPIL 216
             ++NL +        +        L+FEF    +L   ++  + K + +E+  V     
Sbjct: 71  ENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKV----- 124

Query: 217 MTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA------TKLDP----N 266
           M      + ++H   I+H D+K  NI+  T++   +K+ DFGLA          P    N
Sbjct: 125 MKMLLNGLYYIHRNKILHRDMKAANILI-TKDGI-LKLADFGLARAFSLSKNSKPNRYTN 182

Query: 267 EVVKISTGTAEFAAPEIV--EREPVGFYTDMWAVG 299
            VV     T  +  PE++  ER+  G   DMW  G
Sbjct: 183 RVV-----TLWYRPPELLLGERD-YGPPIDMWGAG 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 67/263 (25%), Positives = 118/263 (44%), Gaps = 20/263 (7%)

Query: 97  QPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRK 154
           Q ++     V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +
Sbjct: 6   QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 65

Query: 155 EIDIMNQLHHPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVI 209
           E+ ++  + H  +I L D F     +     V +   L G +L   +     K+++  V 
Sbjct: 66  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV- 122

Query: 210 PVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVV 269
                 L+ Q    +K++H  +IIH D+KP N+         +K++DFGLA   D  + +
Sbjct: 123 ----QFLIYQILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLARHTD--DEM 174

Query: 270 KISTGTAEFAAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACD 328
                T  + APEI +         D+W+VG +   LL+G + F G + ++ LK +    
Sbjct: 175 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 234

Query: 329 WEFDEEAFKNV-SEEGKDFIRRL 350
                E  K + SE  +++I+ L
Sbjct: 235 GTPGAELLKKISSESARNYIQSL 257

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 67.0 bits (164), Expect = 1e-12
 Identities = 51/227 (22%), Positives = 96/227 (42%), Gaps = 26/227 (11%)

Query: 114 EEIGTGAFGVVHR--CRERKTGNI-FAAKFIPVSHNL--EKELIRKEIDIMNQLHHP--- 165
           +E+G G FG V +     +    +  A K +   H    +KE +R E  +M QL HP   
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLR-EASVMAQLDHPCIV 59

Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
           +LI +       + ++L+ E    G L        Y     E+    L  L  Q +  + 
Sbjct: 60  RLIGVCKG----EPLMLVMELAPLGPLL------KYLKKRREIPVSDLKELAHQVAMGMA 109

Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP-NEVVKISTG---TAEFAAP 281
           ++  K+ +H D+   N++   R+    K+ DFG++  L   ++  + +T      ++ AP
Sbjct: 110 YLESKHFVHRDLAARNVLLVNRH--QAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAP 167

Query: 282 EIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKAC 327
           E +        +D+W+ GV  +   S G  P+      E +  +++ 
Sbjct: 168 ECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG 214

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 64/258 (24%), Positives = 112/258 (43%), Gaps = 25/258 (9%)

Query: 109 HYDILEEIGTGAFGVVHRCR--ERKTGNIFAAKFIPVSHN---LEKELIRKEIDIMNQLH 163
            Y++++E+G GA+G+V   R  E       A K I    +   L K  +R E+ ++    
Sbjct: 1   RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR-ELKLLRHFR 59

Query: 164 -HPKLINLHD---AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQ 219
            H  +  L+D    F  +   + ++E L   +L  +I      +++A        IL   
Sbjct: 60  GHKNITCLYDMDIVFPGNFNELYLYEELMEADL-HQIIRSGQPLTDAHFQSFIYQILC-- 116

Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVV-----KISTG 274
               +K++H  N++H D+KP N++        +K+ DFGLA     N             
Sbjct: 117 ---GLKYIHSANVLHRDLKPGNLLVNA--DCELKICDFGLARGFSENPGENAGFMTEYVA 171

Query: 275 TAEFAAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE 333
           T  + APEI +  +      D+W+VG +   LL     F G++ V+ L  +       DE
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE 231

Query: 334 EAFKNV-SEEGKDFIRRL 350
           E    + S + +++IR L
Sbjct: 232 ETLSRIGSPKAQNYIRSL 249

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 65.6 bits (160), Expect = 4e-12
 Identities = 58/254 (22%), Positives = 109/254 (42%), Gaps = 29/254 (11%)

Query: 114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK----------ELIRKEIDIMNQLH 163
           E IG G +G V+      TG + A K + +   +            + +R EI+ +  L 
Sbjct: 7   ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66

Query: 164 HPKLINLHDAFEDDDEMVLIF-EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSP 222
           H  ++  +  FE  +E + IF E++ GG +   +     +  E  V   T      Q   
Sbjct: 67  HLNIVQ-YLGFETTEEYLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFT-----EQVLE 119

Query: 223 AVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD---PNEVVKISTGTAEFA 279
            + ++H K I+H D+K +N++         K+ DFG++ K D    N+      G+  + 
Sbjct: 120 GLAYLHSKGILHRDLKADNLLVDADGI--CKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177

Query: 280 APEIVEREPVGFY--TDMWAVGVLAYVLLSGLSPFAGENDVET---LKNVKACDWEFDEE 334
           APE++     G+    D+W++G +   + +G  P++ E  +     L N ++       +
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAP-PIPPD 236

Query: 335 AFKNVSEEGKDFIR 348
              N+S    DF+ 
Sbjct: 237 VSMNLSPVALDFLN 250

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 64.9 bits (158), Expect = 5e-12
 Identities = 54/219 (24%), Positives = 104/219 (47%), Gaps = 16/219 (7%)

Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHD 172
           ++E+G+G FGVVH  + R    + A K I      E++ I +E  +M +L HPKL+ L+ 
Sbjct: 9   MKELGSGQFGVVHLGKWRAQIKV-AIKAINEGAMSEEDFI-EEAKVMMKLSHPKLVQLYG 66

Query: 173 AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNI 232
                  + ++ EF+  G L   +     K+S+  ++ +   +        ++++   + 
Sbjct: 67  VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDV-----CEGMEYLERNSF 121

Query: 233 IHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF----AAPEIVEREP 288
           IH D+   N  C   ++  VK+ DFG+   +  +E    S+  A+F    + PE+     
Sbjct: 122 IHRDLAARN--CLVSSTGVVKVSDFGMTRYVLDDEYT--SSSGAKFPVKWSPPEVFNFSK 177

Query: 289 VGFYTDMWAVGVLAY-VLLSGLSPFAGENDVETLKNVKA 326
               +D+W+ GVL + V   G  PF  +++ E ++ +  
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR 216

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 65.1 bits (159), Expect = 5e-12
 Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 17/214 (7%)

Query: 114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN----LEKELIRKEIDIMNQLHHPKLIN 169
             IG G FG V++       N   A  +    N      +E   +E  IM Q  HP ++ 
Sbjct: 12  RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71

Query: 170 LHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE 229
           L     ++  + ++ E    GEL   +    Y +  A     +L +   Q S A+ ++  
Sbjct: 72  LIGVITEN-PVWIVMELAPLGELRSYLQVNKYSLDLA-----SLILYSYQLSTALAYLES 125

Query: 230 KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT--AEFAAPEIVERE 287
           K  +H D+   N++  +     VK+ DFGL+  L+     K S G    ++ APE +   
Sbjct: 126 KRFVHRDIAARNVLVSS--PDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFR 183

Query: 288 PVGFYTDMWAVGVLAYVLLS-GLSPFAG--ENDV 318
                +D+W  GV  + +L  G+ PF G   NDV
Sbjct: 184 RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV 217

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 65.6 bits (160), Expect = 6e-12
 Identities = 57/237 (24%), Positives = 109/237 (45%), Gaps = 41/237 (17%)

Query: 116 IGTGAFGVVHRCRERKTGNIFA---AKFIPVSHNLEKE------------LIRKEIDIMN 160
           +G G +G V +  +  TG I A    K I +S+++ K+             +R E+ IMN
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLR-ELKIMN 75

Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
           ++ H  ++ L D + + D + L+ + ++     +++     +++E++V       ++ Q 
Sbjct: 76  EIKHENIMGLVDVYVEGDFINLVMDIMASD--LKKVVDRKIRLTESQV-----KCILLQI 128

Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK---------------LDP 265
              +  +H+   +H D+ P NI   ++     K+ DFGLA +               +  
Sbjct: 129 LNGLNVLHKWYFMHRDLSPANIFINSKGI--CKIADFGLARRYGYPPYSDTLSKDETMQR 186

Query: 266 NEVVKISTGTAEFAAPEIV-EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETL 321
            E +     T  + APE++   E   F  DMW+VG +   LL+G   F GEN+++ L
Sbjct: 187 REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243

Length = 335

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 65.8 bits (160), Expect = 6e-12
 Identities = 57/224 (25%), Positives = 103/224 (45%), Gaps = 7/224 (3%)

Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMN 160
           T +V   Y  L+ IG+GA G+V    +   G   A K +  P  +    +   +E+ ++ 
Sbjct: 16  TFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLK 75

Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            ++H  +I+L + F     +    EF     + E + A   ++   E+    +  L+ Q 
Sbjct: 76  CVNHKNIISLLNVFTPQKSLE---EFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQM 132

Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAA 280
              +KH+H   IIH D+KP NI+   ++   +K++DFGLA     N ++     T  + A
Sbjct: 133 LCGIKHLHSAGIIHRDLKPSNIV--VKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRA 190

Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           PE++         D+W+VG +   L+ G   F G + ++    V
Sbjct: 191 PEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKV 234

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 64.3 bits (156), Expect = 8e-12
 Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 18/218 (8%)

Query: 114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDA 173
           +++G G FG V      K   +      P S ++E  L   E ++M  L H KL+ LH A
Sbjct: 12  KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFL--AEANVMKTLQHDKLVKLH-A 68

Query: 174 FEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM---TQTSPAVKHMHEK 230
               + + +I EF++ G L + +     K  E    P  LP L+    Q +  +  + ++
Sbjct: 69  VVTKEPIYIITEFMAKGSLLDFL-----KSDEGSKQP--LPKLIDFSAQIAEGMAFIEQR 121

Query: 231 NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT--AEFAAPEIVEREP 288
           N IH D++  NI+     S   K+ DFGLA  ++ NE           ++ APE +    
Sbjct: 122 NYIHRDLRAANILVSA--SLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 179

Query: 289 VGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
               +D+W+ G+L   +++ G  P+ G ++ E ++ ++
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 217

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 52/224 (23%), Positives = 107/224 (47%), Gaps = 17/224 (7%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKL 167
           +   +++++G G FG V       +  +      P + +++  L  +E ++M  L H KL
Sbjct: 6   ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFL--EEANLMKTLQHDKL 63

Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM---TQTSPAV 224
           + L+     ++ + +I E+++ G L       D+  S+ E   V LP L+    Q +  +
Sbjct: 64  VRLYAVVTKEEPIYIITEYMAKGSLL------DFLKSD-EGGKVLLPKLIDFSAQIAEGM 116

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT--AEFAAPE 282
            ++  KN IH D++  N++     S   K+ DFGLA  ++ NE           ++ APE
Sbjct: 117 AYIERKNYIHRDLRAANVL--VSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 174

Query: 283 IVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
            +        +D+W+ G+L Y +++ G  P+ G ++ + +  ++
Sbjct: 175 AINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ 218

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 63.9 bits (155), Expect = 1e-11
 Identities = 57/226 (25%), Positives = 105/226 (46%), Gaps = 22/226 (9%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKL 167
           +   +++++G G FG V          +      P + + E  L  +E  IM +L H KL
Sbjct: 6   ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFL--EEAQIMKKLRHDKL 63

Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM---TQTSPAV 224
           + L+ A   ++ + ++ E++S G L +        + + E   + LP L+    Q +  +
Sbjct: 64  VQLY-AVVSEEPIYIVTEYMSKGSLLDF-------LKDGEGRALKLPNLVDMAAQVAAGM 115

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF----AA 280
            ++   N IH D++  NI+    +    K+ DFGLA  ++ NE    +   A+F     A
Sbjct: 116 AYIERMNYIHRDLRSANIL--VGDGLVCKIADFGLARLIEDNEYT--ARQGAKFPIKWTA 171

Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
           PE          +D+W+ G+L   L++ G  P+ G N+ E L+ V+
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE 217

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 64.0 bits (156), Expect = 1e-11
 Identities = 53/235 (22%), Positives = 105/235 (44%), Gaps = 22/235 (9%)

Query: 113 LEEIGTGAFGVVHRCR-----ERKTGNIFAAKFIPVSHNLE-KELIRKEIDIMNQLHHPK 166
           LEE+G GAFG V++       ER +    A K +  +   + ++  R+E ++M+ L HP 
Sbjct: 10  LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPN 69

Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERIT--APDYKMSEAEVIPVTLPIL-------- 216
           ++ L      +    ++FE+L+ G+L E +   +P   +            L        
Sbjct: 70  IVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129

Query: 217 MTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL---DPNEVVKIST 273
             Q +  ++++   + +H D+   N +        VK+ DFGL+  +   D   V   S 
Sbjct: 130 AIQIAAGMEYLSSHHFVHRDLAARNCL--VGEGLTVKISDFGLSRDIYSADYYRVQSKSL 187

Query: 274 GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKAC 327
               +  PE +        +D+W+ GV+ + + S GL P+ G ++ E ++ +++ 
Sbjct: 188 LPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSR 242

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 65/227 (28%), Positives = 106/227 (46%), Gaps = 26/227 (11%)

Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR--KEID-IMNQL 162
             +    L EIG GAFG V++   + +G I A K I  S   EKE  R   ++D +M   
Sbjct: 2   TAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIR-STVDEKEQKRLLMDLDVVMRSS 60

Query: 163 HHPKLINLHDA-FEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLP--ILMTQ 219
             P ++  + A F + D  + +       EL + I+   +     EV+   +P  IL   
Sbjct: 61  DCPYIVKFYGALFREGDCWICM-------ELMD-ISLDKFYKYVYEVLKSVIPEEILGKI 112

Query: 220 TSPAVKHMH----EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVK-ISTG 274
               VK ++    E  IIH DVKP NI+       N+K+ DFG++ +L  + + K    G
Sbjct: 113 AVATVKALNYLKEELKIIHRDVKPSNILLDRNG--NIKLCDFGISGQLV-DSIAKTRDAG 169

Query: 275 TAEFAAPEIVE---REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDV 318
              + APE ++   R+     +D+W++G+  Y + +G  P+   N V
Sbjct: 170 CRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV 216

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 62.9 bits (153), Expect = 3e-11
 Identities = 48/185 (25%), Positives = 88/185 (47%), Gaps = 16/185 (8%)

Query: 147 LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEA 206
           +  E    E ++M QL HP+L+ L+ A    + + +I E++  G L + +     K  E 
Sbjct: 43  MSPEAFLAEANLMKQLQHPRLVRLY-AVVTQEPIYIITEYMENGSLVDFL-----KTPEG 96

Query: 207 EVIPVTLPILMT-QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP 265
             + +   I M  Q +  +  +  KN IH D++  NI+     +   K+ DFGLA  ++ 
Sbjct: 97  IKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANIL--VSETLCCKIADFGLARLIED 154

Query: 266 NEVVKISTGTAEF----AAPEIVEREPVGFYTDMWAVGV-LAYVLLSGLSPFAGENDVET 320
           NE    +   A+F     APE +        +D+W+ G+ L  ++  G  P+ G  + E 
Sbjct: 155 NEYT--AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV 212

Query: 321 LKNVK 325
           ++N++
Sbjct: 213 IQNLE 217

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 63/246 (25%), Positives = 109/246 (44%), Gaps = 21/246 (8%)

Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + +     A K +  P    +      +E+ ++  + 
Sbjct: 13  VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMK 72

Query: 164 HPKLINLHDAF------EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM 217
           H  +I L D F      E+ +E+ L+   L G +L   +     K+S+  V       L+
Sbjct: 73  HENVIGLLDVFTPATSIENFNEVYLVTN-LMGADLNNIVKCQ--KLSDEHV-----QFLI 124

Query: 218 TQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAE 277
            Q    +K++H   IIH D+KP N+         ++++DFGLA + D  + +     T  
Sbjct: 125 YQLLRGLKYIHSAGIIHRDLKPSNV--AVNEDCELRILDFGLARQAD--DEMTGYVATRW 180

Query: 278 FAAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAF 336
           + APEI +         D+W+VG +   LL G + F G + ++ LK +         E  
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVL 240

Query: 337 KNVSEE 342
           K +S E
Sbjct: 241 KKISSE 246

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 55/224 (24%), Positives = 102/224 (45%), Gaps = 7/224 (3%)

Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMN 160
           T +V   Y  L+ IG+GA G+V    +       A K +  P  +    +   +E+ +M 
Sbjct: 19  TFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMK 78

Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            ++H  +I L + F     +    EF     + E + A   ++ + E+    +  L+ Q 
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLE---EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 135

Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAA 280
              +KH+H   IIH D+KP NI+   ++   +K++DFGLA     + ++     T  + A
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIV--VKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193

Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           PE++         D+W+VG +   ++ G   F G + ++    V
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 62.9 bits (153), Expect = 4e-11
 Identities = 69/258 (26%), Positives = 125/258 (48%), Gaps = 27/258 (10%)

Query: 71  KIRGKADEKVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRE- 129
           ++R K  E ++  ++YV+   ++    P D+K     ++    + +G GAFG V      
Sbjct: 2   EVRWKVIESING-NEYVYIDPTQL---PYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAY 57

Query: 130 --RKTGNIF--AAKFI-PVSHNLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMVLI 183
              K+  +   A K + P +H+ E+E +  E+ IM+ L +H  ++NL  A      +++I
Sbjct: 58  GLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVI 117

Query: 184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH---EKNIIHLDVKPE 240
            E+   G+L       ++   + E   +TL  L++ +    K M     KN IH D+   
Sbjct: 118 TEYCCYGDLL------NFLRRKRESF-LTLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 170

Query: 241 NIMCQTRNSTNVKMIDFGLATKL--DPNEVVKISTG-TAEFAAPEIVEREPVGFYTDMWA 297
           N++    +   VK+ DFGLA  +  D N VVK +     ++ APE +      F +D+W+
Sbjct: 171 NVLLT--HGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWS 228

Query: 298 VGVLAYVLLS-GLSPFAG 314
            G+L + + S G +P+ G
Sbjct: 229 YGILLWEIFSLGSNPYPG 246

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 61.1 bits (148), Expect = 1e-10
 Identities = 55/210 (26%), Positives = 100/210 (47%), Gaps = 20/210 (9%)

Query: 115 EIGTGAFGVVHR--CRERKTGNIFAAKFIPVSHN---LEKELIRKEIDIMNQLHHPKLIN 169
           E+G+G FG V +   + +K+    A K +   +N   L+ EL+R E ++M QL +P ++ 
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLR-EANVMQQLDNPYIVR 60

Query: 170 LHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE 229
           +    E +  M L+ E    G L  +    +  ++E  +       L+ Q S  +K++ E
Sbjct: 61  MIGICEAESWM-LVMELAELGPL-NKFLQKNKHVTEKNITE-----LVHQVSMGMKYLEE 113

Query: 230 KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFA----APEIVE 285
            N +H D+   N++  T++    K+ DFGL+  L  +E    +    ++     APE + 
Sbjct: 114 TNFVHRDLAARNVLLVTQHYA--KISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMN 171

Query: 286 REPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
                  +D+W+ GVL +   S G  P+ G
Sbjct: 172 YYKFSSKSDVWSFGVLMWEAFSYGQKPYKG 201

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 51/201 (25%), Positives = 94/201 (46%), Gaps = 7/201 (3%)

Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMN 160
           T +V   Y  L+ IG+GA G+V    +       A K +  P  +    +   +E+ +M 
Sbjct: 12  TFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMK 71

Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            ++H  +I+L + F     +    EF     + E + A   ++ + E+    +  L+ Q 
Sbjct: 72  CVNHKNIISLLNVFTPQKSLE---EFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 128

Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAA 280
              +KH+H   IIH D+KP NI+   ++   +K++DFGLA     + ++     T  + A
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIV--VKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 186

Query: 281 PEIVEREPVGFYTDMWAVGVL 301
           PE++         D+W+VG +
Sbjct: 187 PEVILGMGYKENVDIWSVGCI 207

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 60/230 (26%), Positives = 106/230 (46%), Gaps = 30/230 (13%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS--HNLEKELIRKEIDIMNQLHHPKL 167
           Y  L  +G G+ G+V    +       A K I ++   ++ K  +R EI I+ +L H  +
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSV-KHALR-EIKIIRRLDHDNI 64

Query: 168 INLHDAF-----EDDDEMVLIFEFLS---GGELFE---RITAPDYKMSEAEVIPVTLPIL 216
           + +++       +  +++  + E  S     E  E           +SE         + 
Sbjct: 65  VKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHA-----RLF 119

Query: 217 MTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVK--ISTG 274
           M Q    +K++H  N++H D+KP N+   T +   +K+ DFGLA  +DP+   K  +S G
Sbjct: 120 MYQLLRGLKYIHSANVLHRDLKPANVFINTEDLV-LKIGDFGLARIVDPHYSHKGYLSEG 178

Query: 275 --TAEFAAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVE 319
             T  + +P ++   P   YT   DMWA G +   +L+G   FAG +++E
Sbjct: 179 LVTKWYRSPRLL-LSPNN-YTKAIDMWAAGCIFAEMLTGKPLFAGAHELE 226

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 57/238 (23%), Positives = 103/238 (43%), Gaps = 32/238 (13%)

Query: 114 EEIGTGAFGVVHRCRER--------------KTGNIFAAKFI--PVSHNLEKELIRKEID 157
           E++G G FG VH C                     + A K +   V+     + + KEI 
Sbjct: 11  EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFL-KEIK 69

Query: 158 IMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDY--KMSEAEVIPVT--- 212
           IM++L +P +I L      DD + +I E++  G+L + ++  +     + A  IP     
Sbjct: 70  IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIA 129

Query: 213 -LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKI 271
            L  +  Q +  +K++   N +H D+   N  C   N   +K+ DFG++  L   +  +I
Sbjct: 130 NLLYMAVQIASGMKYLASLNFVHRDLATRN--CLVGNHYTIKIADFGMSRNLYSGDYYRI 187

Query: 272 STGTA----EFAAPEIVEREPVGFYTDMWAVGVLAYVL--LSGLSPFAGENDVETLKN 323
             G A     + A E +        +D+WA GV  + +  L    P++  +D + ++N
Sbjct: 188 Q-GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIEN 244

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 59.7 bits (145), Expect = 4e-10
 Identities = 54/217 (24%), Positives = 97/217 (44%), Gaps = 25/217 (11%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPV---------SHNLEKELIRKEIDIMNQLHHPK 166
           +G+GAFG V++      G     K IPV         S    KE++  E  +M  + HP 
Sbjct: 15  LGSGAFGTVYKGVWIPEGE--KVK-IPVAIKVLREETSPKANKEILD-EAYVMASVDHPH 70

Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKH 226
           ++ L        ++ LI + +  G L + +     +  +  +    L     Q +  + +
Sbjct: 71  VVRLL-GICLSSQVQLITQLMPLGCLLDYV-----RNHKDNIGSQYLLNWCVQIAKGMSY 124

Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA---EFAAPEI 283
           + EK ++H D+   N++ +T    +VK+ DFGLA  LD +E    + G     ++ A E 
Sbjct: 125 LEEKRLVHRDLAARNVLVKTPQ--HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182

Query: 284 VEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVE 319
           +        +D+W+ GV  + L++ G  P+ G   VE
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE 219

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 59.3 bits (143), Expect = 4e-10
 Identities = 62/252 (24%), Positives = 105/252 (41%), Gaps = 33/252 (13%)

Query: 114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK---EIDIMNQLHHPKLINL 170
           E IG G FG V   R R      A K       L  +L  K   E  I+ Q  HP ++ L
Sbjct: 1   ERIGRGNFGEVFSGRLRADNTPVAVK--SCRETLPPDLKAKFLQEARILKQYSHPNIVRL 58

Query: 171 HDAFEDDDEMVLIFEFLSGGEL--FERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH 228
                    + ++ E + GG+   F R   P  K+ E       L  ++   +  ++++ 
Sbjct: 59  IGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKE-------LIQMVENAAAGMEYLE 111

Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTG-----TAEFAAPEI 283
            K+ IH D+   N +   +N   +K+ DFG++   +  + V  STG       ++ APE 
Sbjct: 112 SKHCIHRDLAARNCLVTEKNV--LKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEA 167

Query: 284 VEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFK-NVSE 341
           +        +D+W+ G+L +   S G  P+A  ++ +T         E  E+  +    E
Sbjct: 168 LNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTR--------EAIEQGVRLPCPE 219

Query: 342 EGKDFIRRLLLR 353
              D + RL+ R
Sbjct: 220 LCPDAVYRLMER 231

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 59.2 bits (143), Expect = 4e-10
 Identities = 57/208 (27%), Positives = 100/208 (48%), Gaps = 20/208 (9%)

Query: 115 EIGTGAFGVVHR--CRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINL 170
           E+G+G FG V +   + RK     A K +   +  ++  E++R E +IM+QL +P ++ +
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMR-EAEIMHQLDNPYIVRM 60

Query: 171 HDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVT-LPILMTQTSPAVKHMHE 229
               E +  M L+ E  SGG L +      +   + + I V+ +  LM Q S  +K++  
Sbjct: 61  IGVCEAEALM-LVMEMASGGPLNK------FLSGKKDEITVSNVVELMHQVSMGMKYLEG 113

Query: 230 KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--DPNEVVKISTGT--AEFAAPEIVE 285
           KN +H D+   N++    N    K+ DFGL+  L  D +     S G    ++ APE + 
Sbjct: 114 KNFVHRDLAARNVLLV--NQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECIN 171

Query: 286 REPVGFYTDMWAVGVLAYVLLS-GLSPF 312
                  +D+W+ G+  +   S G  P+
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFSYGQKPY 199

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 59.3 bits (143), Expect = 5e-10
 Identities = 52/217 (23%), Positives = 95/217 (43%), Gaps = 18/217 (8%)

Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G FG V       T  +      P +  +  E   +E  +M +L H KL+ L+ A 
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLY-AV 69

Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM---TQTSPAVKHMHEKN 231
             ++ + ++ E++S G L + +     K        + LP L+    Q +  + ++   N
Sbjct: 70  VSEEPIYIVTEYMSKGSLLDFLKGEMGKY-------LRLPQLVDMAAQIASGMAYVERMN 122

Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT--AEFAAPEIVEREPV 289
            +H D++  NI+     +   K+ DFGLA  ++ NE           ++ APE       
Sbjct: 123 YVHRDLRAANIL--VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 180

Query: 290 GFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
              +D+W+ G+L   L + G  P+ G  + E L  V+
Sbjct: 181 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 217

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 59.3 bits (144), Expect = 5e-10
 Identities = 53/212 (25%), Positives = 86/212 (40%), Gaps = 20/212 (9%)

Query: 108 DHYDILEEIGTGAFGVVHRCR----ERKTGNIFAAKFIPVS-HNLEKELIRKEIDIMNQL 162
            H   ++++G G FG V  CR       TG   A K +  S     +    +EI+I+  L
Sbjct: 4   RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL 63

Query: 163 HHPKLINLHDAFEDD--DEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT-Q 219
            H  ++      E      + LI E+L  G L       DY     + I +   +L + Q
Sbjct: 64  DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSL------RDYLQRHRDQINLKRLLLFSSQ 117

Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFA 279
               + ++  +  IH D+   NI+ +  +   VK+ DFGLA  L  ++         E  
Sbjct: 118 ICKGMDYLGSQRYIHRDLAARNILVE--SEDLVKISDFGLAKVLPEDKDYYYVKEPGESP 175

Query: 280 ----APEIVEREPVGFYTDMWAVGVLAYVLLS 307
               APE +        +D+W+ GV  Y L +
Sbjct: 176 IFWYAPECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 59.9 bits (145), Expect = 5e-10
 Identities = 58/222 (26%), Positives = 92/222 (41%), Gaps = 29/222 (13%)

Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL 162
            S V   Y+IL  +  G+ G V  C +   G+    K I  +    K   R EIDI+  +
Sbjct: 87  ASVVRMQYNILSSLTPGSEGEVFVCTKH--GDEQRKKVIVKAVTGGKTPGR-EIDILKTI 143

Query: 163 HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTS- 221
            H  +INL  A+     + ++               P YK      +  + P+ + Q   
Sbjct: 144 SHRAIINLIHAYRWKSTVCMVM--------------PKYKCDLFTYVDRSGPLPLEQAIT 189

Query: 222 ------PAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS--- 272
                  A+ ++H + IIH DVK ENI        N  + DFG A KLD +         
Sbjct: 190 IQRRLLEALAYLHGRGIIHRDVKTENIFLD--EPENAVLGDFGAACKLDAHPDTPQCYGW 247

Query: 273 TGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAG 314
           +GT E  +PE++  +P    TD+W+ G++ + +        G
Sbjct: 248 SGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG 289

Length = 392

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 59.2 bits (143), Expect = 6e-10
 Identities = 51/233 (21%), Positives = 108/233 (46%), Gaps = 22/233 (9%)

Query: 113 LEEIGTGAFGVVHRCRERKTG----NIFAAKFIPVSHNLEK-ELIRKEIDIMNQLHHPKL 167
           +EE+G  AFG +++      G     + A K +   +N ++    ++E  +M +LHHP +
Sbjct: 10  MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNI 69

Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFE----RITAPDYKMSEAEVIPVTLPI-------L 216
           + L      +  + ++FE+L+ G+L E    R    D   S  E   V   +       +
Sbjct: 70  VCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI 129

Query: 217 MTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT- 275
             Q +  ++++     +H D+   NI+   +   +VK+ D GL+ ++   +  ++   + 
Sbjct: 130 AIQIAAGMEYLSSHFFVHKDLAARNILIGEQ--LHVKISDLGLSREIYSADYYRVQPKSL 187

Query: 276 --AEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
               +  PE +        +D+W+ GV+ + + S GL P+ G ++ E ++ V+
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 60.2 bits (146), Expect = 7e-10
 Identities = 55/234 (23%), Positives = 100/234 (42%), Gaps = 35/234 (14%)

Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHN--LEKELIRKEIDIMNQLHH 164
            YDI+  IG G  G V+   +       A K I   +S N  L+K  +R E  I   L H
Sbjct: 3   RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLR-EAKIAADLIH 61

Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGEL-------FERITAPDYKMSEAEVIPVTLPILM 217
           P ++ ++    D D +     ++ G  L       +++ +    +++E   +   L I  
Sbjct: 62  PGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSK-ELAEKTSVGAFLSIFH 120

Query: 218 TQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS----- 272
              +  ++++H K ++H D+KP+NI+        V ++D+G A      E   +      
Sbjct: 121 KICA-TIEYVHSKGVLHRDLKPDNILLGL--FGEVVILDWGAAIFKKLEEEDLLDIDVDE 177

Query: 273 --------------TGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPF 312
                          GT ++ APE +   P    TD++A+GV+ Y +L+   P+
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231

Length = 932

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 58.8 bits (142), Expect = 7e-10
 Identities = 52/206 (25%), Positives = 94/206 (45%), Gaps = 18/206 (8%)

Query: 113 LEEIGTGAFGVVHRCRER----KTGNIFAAKFI-PVSHNLEKELIRKEIDIMNQLHHPKL 167
           + ++G G FG V  CR       TG   A K + P S       ++KEI+I+  L+H  +
Sbjct: 9   IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68

Query: 168 INLHDAFEDD--DEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
           +       +D  + + LI EFL  G L E +     K++  + +         Q    + 
Sbjct: 69  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYA-----VQICKGMD 123

Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE---VVKISTGTAEF-AAP 281
           ++  +  +H D+   N++ ++ +   VK+ DFGL   ++ ++    VK    +  F  AP
Sbjct: 124 YLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAP 181

Query: 282 EIVEREPVGFYTDMWAVGVLAYVLLS 307
           E + +      +D+W+ GV  Y LL+
Sbjct: 182 ECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 58.7 bits (142), Expect = 7e-10
 Identities = 55/215 (25%), Positives = 95/215 (44%), Gaps = 24/215 (11%)

Query: 112 ILEEIGTGAFGVVHRCRERKTG---NIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKL 167
           I E IG G FG V R R +  G      A K +   +   ++     E  IM Q  HP +
Sbjct: 8   IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67

Query: 168 INLHDAFEDDDEMVLIFEFLSGGEL--FERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
           I+L         +++I EF+  G L  F R        ++ +   + L  ++   +  +K
Sbjct: 68  IHLEGVVTKSRPVMIITEFMENGALDSFLR-------QNDGQFTVIQLVGMLRGIAAGMK 120

Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNV-KMIDFGLATKLDPNEVVKISTGT------AEF 278
           ++ E N +H D+   NI+    NS  V K+ DFGL+  L+ +      T +        +
Sbjct: 121 YLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW 177

Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPF 312
            APE +        +D+W+ G++ + ++S G  P+
Sbjct: 178 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 212

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 55/217 (25%), Positives = 98/217 (45%), Gaps = 18/217 (8%)

Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G FG V       T  +      P +  +  E   +E  IM +L H KL+ L+ A 
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLY-AV 69

Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM---TQTSPAVKHMHEKN 231
             ++ + ++ EF+  G L + +   D K        + LP L+    Q +  + ++   N
Sbjct: 70  VSEEPIYIVTEFMGKGSLLDFLKEGDGKY-------LKLPQLVDMAAQIADGMAYIERMN 122

Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT--AEFAAPEIVEREPV 289
            IH D++  NI+    ++   K+ DFGLA  ++ NE           ++ APE       
Sbjct: 123 YIHRDLRAANIL--VGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 180

Query: 290 GFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
              +D+W+ G+L   L++ G  P+ G  + E L+ V+
Sbjct: 181 TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE 217

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 61/222 (27%), Positives = 103/222 (46%), Gaps = 31/222 (13%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIP-VSHNLE--KELIRKEIDIMNQLHHPKLINLHD 172
           IG GAFGVV    + + G   A K +P V  NL   K + R E+ ++    H  +++  D
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNVLSALD 66

Query: 173 AFEDDD-----EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
             +        E+ ++ E +   +L + I +P   +S   V      IL       +K++
Sbjct: 67  ILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQ-PLSSDHVKVFLYQILR-----GLKYL 119

Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAE-----FAAPE 282
           H   I+H D+KP N++    ++  +K+ DFGLA   +P+E   +   T E     + APE
Sbjct: 120 HSAGILHRDIKPGNLL--VNSNCVLKICDFGLARVEEPDESKHM---TQEVVTQYYRAPE 174

Query: 283 IVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
           I+       YT   D+W+VG +   LL     F  ++ ++ L
Sbjct: 175 ILMGSR--HYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQL 214

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 58.4 bits (141), Expect = 1e-09
 Identities = 53/212 (25%), Positives = 96/212 (45%), Gaps = 17/212 (8%)

Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL----IRKEIDIMNQLHHPKLI 168
           LE++G G++  V++   R  G + A K I  S   E+ +    IR E  ++  L H  ++
Sbjct: 10  LEKLGEGSYATVYKGISRINGQLVALKVI--SMKTEEGVPFTAIR-EASLLKGLKHANIV 66

Query: 169 NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH 228
            LHD     + +  +FE++        I  P        + P  + + M Q    + ++H
Sbjct: 67  LLHDIIHTKETLTFVFEYMHTDLAQYMIQHP------GGLHPYNVRLFMFQLLRGLAYIH 120

Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA-TKLDPNEVVKISTGTAEFAAPEIV-ER 286
            ++I+H D+KP+N++        +K+ DFGLA  K  P++       T  +  P+++   
Sbjct: 121 GQHILHRDLKPQNLLISYLGE--LKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGA 178

Query: 287 EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDV 318
                  D+W  G +   +L G   F G +DV
Sbjct: 179 TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV 210

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 35/213 (16%)

Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAK-----FIPVSHNLEKELIRKEID 157
           T +V   Y  L+ IG+GA G+V    +  TG   A K     F  V+H   K   R E+ 
Sbjct: 11  TFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTH--AKRAYR-ELV 67

Query: 158 IMNQLHHPKLINLHDAF------EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPV 211
           +M  ++H  +I L + F      E+  ++ L+ E +                +  +VI +
Sbjct: 68  LMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA--------------NLCQVIQM 113

Query: 212 -----TLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN 266
                 +  L+ Q    +KH+H   IIH D+KP NI+ ++  +  +K++DFGLA     +
Sbjct: 114 DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTS 171

Query: 267 EVVKISTGTAEFAAPEIVEREPVGFYTDMWAVG 299
            ++     T  + APE++         D+W+VG
Sbjct: 172 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 204

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 57.2 bits (138), Expect = 4e-09
 Identities = 63/255 (24%), Positives = 116/255 (45%), Gaps = 43/255 (16%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK----EIDIMNQLHHP 165
           Y  L+++G+GA+G V    +++TG   A K   +S   + E+  K    E+ ++  + H 
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIK--KLSRPFQSEIFAKRAYRELTLLKHMQHE 74

Query: 166 KLINLHDAF------EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQ 219
            +I L D F      ++  +  L+  ++      ++I    + +SE +V       L+ Q
Sbjct: 75  NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMG--HPLSEDKV-----QYLVYQ 125

Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTG---TA 276
               +K++H   IIH D+KP N+         +K++DFGLA   D        TG   T 
Sbjct: 126 MLCGLKYIHSAGIIHRDLKPGNL--AVNEDCELKILDFGLARHADAE-----MTGYVVTR 178

Query: 277 EFAAPE-IVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEA 335
            + APE I+         D+W+VG +   +L+G + F G++ ++ L  +           
Sbjct: 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI----------- 227

Query: 336 FKNVSEEGKDFIRRL 350
            K     G +F+++L
Sbjct: 228 LKVTGVPGPEFVQKL 242

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 56.4 bits (136), Expect = 4e-09
 Identities = 50/214 (23%), Positives = 92/214 (42%), Gaps = 24/214 (11%)

Query: 113 LEEIGTGAFGVVHRCR----ERKTGNIFAAKFIPVSHNLE-KELIRKEIDIMNQLHHPKL 167
           +  +G G FG V           TG + A K +      +     +KEI+I+  L+H  +
Sbjct: 9   IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68

Query: 168 INLHDAFED--DDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
           +       +     + LI E++  G L + +  P +K++ A+++     +   Q    + 
Sbjct: 69  VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHKLNLAQLL-----LFAQQICEGMA 121

Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE----VVKISTGTAEFAAP 281
           ++H ++ IH D+   N++    N   VK+ DFGLA  +        V +       + A 
Sbjct: 122 YLHSQHYIHRDLAARNVLLD--NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAV 179

Query: 282 EIVEREPVGFYTDMWAVGVLAYVLL----SGLSP 311
           E ++     + +D+W+ GV  Y LL    S  SP
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP 213

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 56.3 bits (136), Expect = 5e-09
 Identities = 49/233 (21%), Positives = 105/233 (45%), Gaps = 22/233 (9%)

Query: 112 ILEEIGTGAFGVVHR--CRERKTGN---IFAAKFI--PVSHNLEKELIRKEIDIMNQLHH 164
           +  E+G GAFG V    C   +  N   + A K +    S++  K+  R E +++    H
Sbjct: 9   LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFER-EAELLTNFQH 67

Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGEL--FERITAPDYKMS---EAEVIPVTLPILM-- 217
             ++  +    + D  +++FE++  G+L  F R   PD       ++ +  +TL  L+  
Sbjct: 68  ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127

Query: 218 -TQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT- 275
             Q +  + ++  ++ +H D+   N  C       VK+ DFG++  +   +  ++   T 
Sbjct: 128 AVQIASGMVYLASQHFVHRDLATRN--CLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTM 185

Query: 276 --AEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
               +  PE +        +D+W+ GV+ + + + G  P+ G ++ E ++ + 
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT 238

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 56.0 bits (135), Expect = 6e-09
 Identities = 60/255 (23%), Positives = 109/255 (42%), Gaps = 46/255 (18%)

Query: 107 YDHYDI--LEEIGTGAFGVVHRCR-------ERKTGNIFAAKFIP--VSHNLEKELIRKE 155
           Y   +I  + +IG GAFG V + R       E  T  + A K +    S +++ +  R E
Sbjct: 2   YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFT--MVAVKMLKEEASADMQADFQR-E 58

Query: 156 IDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGEL--FERITAPDYKMSEAEV----- 208
             +M +  HP ++ L         M L+FE+++ G+L  F R  +P  + S +       
Sbjct: 59  AALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSAR 118

Query: 209 ------IPVTLPILMT---QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGL 259
                 +P++    +    Q +  + ++ E+  +H D+   N  C    +  VK+ DFGL
Sbjct: 119 KCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN--CLVGENMVVKIADFGL 176

Query: 260 AT--------KLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLS 310
           +         K   N+ + I      +  PE +        +D+WA GV+ + + S G+ 
Sbjct: 177 SRNIYSADYYKASENDAIPI-----RWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQ 231

Query: 311 PFAGENDVETLKNVK 325
           P+ G    E +  V+
Sbjct: 232 PYYGMAHEEVIYYVR 246

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|238020 cd00063, FN3, Fibronectin type 3 domain; One of three types of internal repeats found in the plasma protein fibronectin

 Score = 52.1 bits (125), Expect = 7e-09
 Identities = 21/50 (42%), Positives = 26/50 (52%), Gaps = 2/50 (4%)

Query: 2  SSWIRVGNTRF--TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLIT 49
            W  V  T    T+  +TGL PG +YEFRV A N  G S PS +  + T
Sbjct: 44 GDWKEVEVTPGSETSYTLTGLKPGTEYEFRVRAVNGGGESPPSESVTVTT 93

Its tenth fibronectin type III repeat contains an RGD cell recognition sequence in a flexible loop between 2 strands. Approximately 2% of all animal proteins contain the FN3 repeat; including extracellular and intracellular proteins, membrane spanning cytokine receptors, growth hormone receptors, tyrosine phosphatase receptors, and adhesion molecules. FN3-like domains are also found in bacterial glycosyl hydrolases. Length = 93

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 56.6 bits (136), Expect = 9e-09
 Identities = 52/253 (20%), Positives = 104/253 (41%), Gaps = 37/253 (14%)

Query: 109 HYDILEEIGTGAFGVVHRC--------RERKTGNIFAAKFIPVSHNLEKELIR------- 153
           H+ +++++  GAFG +  C         E + G     +  P    L  + ++       
Sbjct: 149 HFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAI 208

Query: 154 ---KEIDIMNQLHHPKLINLHDAFEDDDEMVLI---FEFLSGGELFERITAPDYKMSEAE 207
               EI  + +L+H  ++ + +    +    +I   ++F    +L+  +    +   +  
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEAFDWKDRP 264

Query: 208 VIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE 267
           ++  T  I M Q   AV+++H+K +IH D+K ENI         +   DFG A   +   
Sbjct: 265 LLKQTRAI-MKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLG--DFGTAMPFEKER 321

Query: 268 VVKIS--TGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG------ENDV 318
                   GT    +PEI+  +     TD+W+ G++   +LS    P         +  +
Sbjct: 322 EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381

Query: 319 ETLKNVKACDWEF 331
           + + ++  CD EF
Sbjct: 382 KIIDSLSVCDEEF 394

Length = 501

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 35/210 (16%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLIN 169
           + ILE    GA G    C + KT      K        ++     E  I+  ++HP +I 
Sbjct: 94  FSILETFTPGAEGFAFACIDNKTCEHVVIK------AGQRGGTATEAHILRAINHPSIIQ 147

Query: 170 LHDAFEDDDEMVLIFEFLSGGELFERITAPDYK------MSEAEVIPVTLPILMTQTS-- 221
           L   F  +    LI               P YK      ++    I +   IL  + S  
Sbjct: 148 LKGTFTYNKFTCLIL--------------PRYKTDLYCYLAAKRNIAIC-DILAIERSVL 192

Query: 222 PAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA---TKLDPNEVVKISTGTAEF 278
            A++++HE  IIH D+K ENI     +  +V + DFG A     ++ N+    + GT   
Sbjct: 193 RAIQYLHENRIIHRDIKAENIF--INHPGDVCLGDFGAACFPVDINANKYYGWA-GTIAT 249

Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLSG 308
            APE++ R+P G   D+W+ G++ + + + 
Sbjct: 250 NAPELLARDPYGPAVDIWSAGIVLFEMATC 279

Length = 391

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 54.4 bits (131), Expect = 1e-08
 Identities = 55/219 (25%), Positives = 100/219 (45%), Gaps = 27/219 (12%)

Query: 114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK---EIDIMNQLHHPKLINL 170
           E+IG G FG V++    K     A K    +  L  +L RK   E +I+ Q  HP ++ L
Sbjct: 1   EKIGKGNFGDVYKGV-LKGNTEVAVKTCRST--LPPDLKRKFLQEAEILKQYDHPNIVKL 57

Query: 171 HDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPA-VKHMHE 229
                    + ++ E + GG L        +   +   + V   + M+  + A ++++  
Sbjct: 58  IGVCVQKQPIYIVMELVPGGSLL------TFLRKKKNRLTVKKLLQMSLDAAAGMEYLES 111

Query: 230 KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAE----FAAPEIVE 285
           KN IH D+   N +    N   +K+ DFG++ + +   +  +S G  +    + APE + 
Sbjct: 112 KNCIHRDLAARNCLVGENNV--LKISDFGMSREEE-GGIYTVSDGLKQIPIKWTAPEALN 168

Query: 286 REPVGFYT---DMWAVGVLAYVLLS-GLSPFAGENDVET 320
               G YT   D+W+ G+L +   S G +P+ G ++ +T
Sbjct: 169 ---YGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT 204

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 25/213 (11%)

Query: 109 HYDILEEIGTGAFGVVHRCR----ERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQL 162
           H   ++++G G FG V  CR    +  TG + A K   + H+  + L    +EI+I+  L
Sbjct: 5   HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVK--KLQHSTAEHLRDFEREIEILKSL 62

Query: 163 HHPKLINLHDAF--EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIP-VTLPILMTQ 219
            H  ++             + L+ E+L  G L       DY     E +    L +  +Q
Sbjct: 63  QHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLR------DYLQKHRERLDHRKLLLYASQ 116

Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE----VVKISTGT 275
               ++++  K  +H D+   NI+ +  +   VK+ DFGL TK+ P +     V+    +
Sbjct: 117 ICKGMEYLGSKRYVHRDLATRNILVE--SENRVKIGDFGL-TKVLPQDKEYYKVREPGES 173

Query: 276 AEF-AAPEIVEREPVGFYTDMWAVGVLAYVLLS 307
             F  APE +        +D+W+ GV+ Y L +
Sbjct: 174 PIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 54.7 bits (131), Expect = 2e-08
 Identities = 47/215 (21%), Positives = 97/215 (45%), Gaps = 20/215 (9%)

Query: 115 EIGTGAFGVV------HRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLI 168
           E+G GAFG V      + C E+    +        S N  K+  R E +++  L H  ++
Sbjct: 12  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHR-EAELLTNLQHEHIV 70

Query: 169 NLHDAFEDDDEMVLIFEFLSGGEL--FERITAPD-YKMSEA----EVIPVTLPILMTQTS 221
             +    + D ++++FE++  G+L  F R   PD   M+E     E+    +  +  Q +
Sbjct: 71  KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130

Query: 222 PAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA---EF 278
             + ++  ++ +H D+   N  C    +  VK+ DFG++  +   +  ++   T     +
Sbjct: 131 AGMVYLASQHFVHRDLATRN--CLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188

Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPF 312
             PE +        +D+W++GV+ + + + G  P+
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPW 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 43/217 (19%), Positives = 97/217 (44%), Gaps = 21/217 (9%)

Query: 115 EIGTGAFGVV-----HRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLIN 169
           E+G GAFG V     +     K   + A K +       ++  ++E +++  L H  ++ 
Sbjct: 12  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71

Query: 170 LHDAFEDDDEMVLIFEFLSGGEL--FERITAPDY--------KMSEAEVIPVTLPILMTQ 219
            +    D D ++++FE++  G+L  F R   PD         + ++ E+    +  + +Q
Sbjct: 72  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131

Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA--- 276
            +  + ++  ++ +H D+   N  C    +  VK+ DFG++  +   +  ++   T    
Sbjct: 132 IASGMVYLASQHFVHRDLATRN--CLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189

Query: 277 EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPF 312
            +  PE +        +D+W+ GV+ + + + G  P+
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 53.8 bits (129), Expect = 3e-08
 Identities = 52/218 (23%), Positives = 92/218 (42%), Gaps = 16/218 (7%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFI----PVSHNLEKELIRKEIDIMNQLHHPKLINLH 171
           IG G FG V R   +  G    A  I    P     +++    E  IM Q  H  +I L 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
                    ++I E++  G L + +   D      E     L  ++   +  +K++ + N
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYLRDHD-----GEFSSYQLVGMLRGIAAGMKYLSDMN 127

Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--DPNEVVKISTGT--AEFAAPEIVERE 287
            +H D+   NI+    ++   K+ DFGL+  L  DP      S G     + APE +   
Sbjct: 128 YVHRDLAARNIL--VNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR 185

Query: 288 PVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
                +D+W+ G++ + ++S G  P+   ++ E +K +
Sbjct: 186 KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI 223

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 53.3 bits (128), Expect = 4e-08
 Identities = 54/234 (23%), Positives = 102/234 (43%), Gaps = 31/234 (13%)

Query: 116 IGTGAFGVVHRCRERKTGNIFA--AKFIPV--------SHNLEKELIRKEIDIMNQLHHP 165
           +G+GAFG V+   E    +I    +  I V        + + EK+   KE  +M+  +HP
Sbjct: 3   LGSGAFGEVY---EGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHP 59

Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERI------TAPDYKMSEAEVIPVTLPILMTQ 219
            ++ L      ++   +I E + GG+L   +            ++  E++ + L +   +
Sbjct: 60  NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDV--AK 117

Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTN---VKMIDFGLATKLDPNEVVKISTG-- 274
               ++ MH    IH D+   N +   +       VK+ DFGLA  +  ++  +      
Sbjct: 118 GCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174

Query: 275 -TAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKA 326
               + APE +        +D+W+ GVL + +L+ G  P+   N+ E L++V A
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA 228

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 54.5 bits (131), Expect = 4e-08
 Identities = 40/161 (24%), Positives = 80/161 (49%), Gaps = 29/161 (18%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL---IRKEIDIMNQLHHPKLI 168
           I++ I  GAFG V+  R++    ++A K +  +  + K +   ++ E D +     P ++
Sbjct: 8   IVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIV 67

Query: 169 NLHDAFEDDDEMVLIFEFLSGGEL---------FERITAPDYKMSEAEVIPVTLPILMTQ 219
           +L+ + +  + + L+ E+L GG++         F+   A  Y +SE  +           
Sbjct: 68  HLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKY-ISEVAL----------- 115

Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA 260
              A+ ++H   IIH D+KP+N++    N  ++K+ DFGL+
Sbjct: 116 ---ALDYLHRHGIIHRDLKPDNMLIS--NEGHIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 53.0 bits (127), Expect = 6e-08
 Identities = 54/247 (21%), Positives = 101/247 (40%), Gaps = 41/247 (16%)

Query: 114 EEIGTGAFGVVHRCR---------------ERKTGNIFAAKFI---PVSHNLEKELIRKE 155
           E++G G FG VH C                 RK   +  A  I     + N   + + KE
Sbjct: 11  EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFL-KE 69

Query: 156 IDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIP----- 210
           + I+++L  P +I L     D+D + +I E++  G+L + +++      E          
Sbjct: 70  VKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPA 129

Query: 211 -----VTLPILM---TQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK 262
                ++   L+    Q +  +K++   N +H D+   N  C    +  +K+ DFG++  
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRN--CLVGENLTIKIADFGMSRN 187

Query: 263 LDPNEVVKISTGTA----EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS--GLSPFAGEN 316
           L   +  +I  G A     + A E +        +D+WA GV  + +L      P+    
Sbjct: 188 LYAGDYYRIQ-GRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELT 246

Query: 317 DVETLKN 323
           D + ++N
Sbjct: 247 DEQVIEN 253

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 52.7 bits (127), Expect = 9e-08
 Identities = 47/218 (21%), Positives = 91/218 (41%), Gaps = 35/218 (16%)

Query: 112 ILEEIGTGAFGVVHRCR---------------ERKTG-NIFAAKFIPVSHNLE-KELIRK 154
            +E++G G FG VH C                +      + A K +    +   +E   K
Sbjct: 9   FVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLK 68

Query: 155 EIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGE----LFERITAPDYKMSEAEVIP 210
           E+ I+++L  P +  L      D  + +I E++  G+    L + +         ++ + 
Sbjct: 69  EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLS 128

Query: 211 VTLPILM-TQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVV 269
            +  + M TQ +  ++++   N +H D+   N  C    +  +K+ DFG++  L  ++  
Sbjct: 129 FSTLLYMATQIASGMRYLESLNFVHRDLATRN--CLVGKNYTIKIADFGMSRNLYSSDYY 186

Query: 270 KISTGTA----EFAAPEIVEREPVGFYT---DMWAVGV 300
           ++  G A     + A E V     G +T   D+WA GV
Sbjct: 187 RVQ-GRAPLPIRWMAWESVLL---GKFTTKSDVWAFGV 220

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 52.8 bits (127), Expect = 9e-08
 Identities = 68/287 (23%), Positives = 114/287 (39%), Gaps = 63/287 (21%)

Query: 88  FDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL 147
           F++ +KYVP    IK             IG GA+G+V   +  +T    A K I  + + 
Sbjct: 1   FEVDTKYVP----IKP------------IGRGAYGIVCSAKNSETNEKVAIKKIANAFDN 44

Query: 148 EKELIR--KEIDIMNQLHHPKLINLHD--------AFEDDDEMVLIFEFLSGGELFERIT 197
             +  R  +EI ++  L H  +I + D        AF D    V I   L   +L + I 
Sbjct: 45  RIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND----VYIVYELMDTDLHQIIR 100

Query: 198 APDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDF 257
           +      +           + Q    +K++H  N++H D+KP N++       ++K+ DF
Sbjct: 101 SSQTLSDDH------CQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC--DLKICDF 152

Query: 258 GLATKLDPNEVVKISTGTAEFAAPEIVER-----------EPVGFYTDMWAVGVLAYVLL 306
           GLA         + ++   +F    +V R                  D+W+VG +   LL
Sbjct: 153 GLA---------RTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL 203

Query: 307 SGLSPFAGENDVETLK---NVKACDWEFDEEAFKNVSEEGKDFIRRL 350
                F G++ V  LK    +     E D    +N  E+ + +IR L
Sbjct: 204 GRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN--EKARRYIRSL 248

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 44/182 (24%), Positives = 87/182 (47%), Gaps = 24/182 (13%)

Query: 155 EIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGEL-----FERITAPDYKMSEA--- 206
           E +++ Q++HP +I L+ A   D  ++LI E+   G L       R   P Y  S+    
Sbjct: 53  EFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRN 112

Query: 207 -------EVIPVTLPILMT---QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMID 256
                  +   +T+  L++   Q S  ++++ E  ++H D+   N++        +K+ D
Sbjct: 113 SSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVA--EGRKMKISD 170

Query: 257 FGLATKL-DPNEVVKISTG--TAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPF 312
           FGL+  + + +  VK S G    ++ A E +        +D+W+ GVL + +++ G +P+
Sbjct: 171 FGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 230

Query: 313 AG 314
            G
Sbjct: 231 PG 232

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 44/226 (19%), Positives = 100/226 (44%), Gaps = 20/226 (8%)

Query: 115 EIGTGAFGVV-----HRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLIN 169
           E+G GAFG V     H     +   + A K +  +    ++  ++E +++  L H  ++ 
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 170 LHDAFEDDDEMVLIFEFLSGGEL--FERITAPDYKMSE----AEVIPVTLPILM---TQT 220
            +    +   ++++FE++  G+L  F R   PD K+           +TL  ++   +Q 
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA---E 277
           +  + ++   + +H D+   N  C       VK+ DFG++  +   +  ++   T     
Sbjct: 132 ASGMVYLASLHFVHRDLATRN--CLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 278 FAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLK 322
           +  PE +        +D+W+ GV+ + + + G  P+   ++ E ++
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE 235

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 52.0 bits (124), Expect = 1e-07
 Identities = 40/192 (20%), Positives = 90/192 (46%), Gaps = 19/192 (9%)

Query: 149 KELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERI----------TA 198
           +E  + E  + ++L HP ++ L      +  + +IF + S  +L E +          + 
Sbjct: 52  REEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGST 111

Query: 199 PDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFG 258
            D K  ++ + P     ++TQ +  ++ +   +++H D+   N++    +  NVK+ D G
Sbjct: 112 DDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVL--VFDKLNVKISDLG 169

Query: 259 LATKLDPNEVVKI---STGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
           L  ++   +  K+   S     + +PE +        +D+W+ GV+ + + S GL P+ G
Sbjct: 170 LFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG 229

Query: 315 ---ENDVETLKN 323
              ++ +E ++N
Sbjct: 230 YSNQDVIEMIRN 241

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 58/238 (24%), Positives = 108/238 (45%), Gaps = 31/238 (13%)

Query: 114 EEIGTGAFGVVHRCR----ERKTGNIFAAKFIPVSHNL-EKELIR------------KEI 156
           E++G G FG VH C     E+     F+         L   +++R            KEI
Sbjct: 11  EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEI 70

Query: 157 DIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITA--PDYKMSEAEVIPV--- 211
            IM++L  P +I L       D + +I E++  G+L + ++   P     +A+V+ +   
Sbjct: 71  KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYS 130

Query: 212 TLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKI 271
           TL  + TQ +  +K++   N +H D+   N +     +  +K+ DFG++  L   +  +I
Sbjct: 131 TLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYT--IKIADFGMSRNLYSGDYYRI 188

Query: 272 STGTAEFAAPEIV-EREPVGFYT---DMWAVGVLAYVLLS--GLSPFAGENDVETLKN 323
             G A      +  E   +G +T   D+WA GV  + +L+     P++  +D + ++N
Sbjct: 189 Q-GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIEN 245

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 50.4 bits (121), Expect = 3e-07
 Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 28/210 (13%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS-HNL-----EKELIR--KEIDIMNQLH 163
           I + IG G FG V R R +  G     K I V+   L     +K+ +    E  IM Q  
Sbjct: 8   IEKVIGGGEFGEVCRGRLKLPGK----KEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD 63

Query: 164 HPKLINLHDAFEDDDEMVLIFEFLSGGEL--FERITAPDYKMSEAEVIPVTLPILMTQTS 221
           HP +I L         +++I E++  G L  F R         + +     L  ++   +
Sbjct: 64  HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREN-------DGKFTVGQLVGMLRGIA 116

Query: 222 PAVKHMHEKNIIHLDVKPENIMCQTRNSTNV-KMIDFGLATKLDPNEVVKISTG---TAE 277
             +K++ E N +H D+   NI+    NS  V K+ DFGL+ +L+ +E    + G      
Sbjct: 117 SGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIR 173

Query: 278 FAAPEIVEREPVGFYTDMWAVGVLAYVLLS 307
           + APE +        +D+W+ G++ + ++S
Sbjct: 174 WTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 50.5 bits (121), Expect = 4e-07
 Identities = 47/209 (22%), Positives = 82/209 (39%), Gaps = 20/209 (9%)

Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLI 168
              +   IG G FG V     R  G   A K +       +  +  E  +M  L HP L+
Sbjct: 7   ELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFL-AEASVMTTLRHPNLV 63

Query: 169 NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMS--EAEVIPVTLPILMTQTSPAVKH 226
            L       + + ++ E+++ G L       DY  S   A +               +++
Sbjct: 64  QLLGVVLQGNPLYIVTEYMAKGSLV------DYLRSRGRAVITLAQQLGFALDVCEGMEY 117

Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT--AEFAAPEIV 284
           + EKN +H D+   N++        V   DFGLA +          +G    ++ APE +
Sbjct: 118 LEEKNFVHRDLAARNVLVSEDLVAKVS--DFGLAKE----ASQGQDSGKLPVKWTAPEAL 171

Query: 285 EREPVGFYTDMWAVGVLAYVLLS-GLSPF 312
             +     +D+W+ G+L + + S G  P+
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVPY 200

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 50.4 bits (120), Expect = 4e-07
 Identities = 60/225 (26%), Positives = 107/225 (47%), Gaps = 26/225 (11%)

Query: 115 EIGTGAFGVVHRCRER--KTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHD 172
           ++G G +G V++ + +  K    +A K I  +  +     R EI ++ +L HP +I+L  
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT-GISMSACR-EIALLRELKHPNVISLQK 65

Query: 173 AF--EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLP-----ILMTQTSPAVK 225
            F    D ++ L+F++ +  +L+  I    ++ S+A   PV LP      L+ Q    + 
Sbjct: 66  VFLSHADRKVWLLFDY-AEHDLWHIIKF--HRASKANKKPVQLPRGMVKSLLYQILDGIH 122

Query: 226 HMHEKNIIHLDVKPENI--MCQTRNSTNVKMIDFGLA----TKLDPNEVVKISTGTAEFA 279
           ++H   ++H D+KP NI  M +      VK+ D G A    + L P   +     T  + 
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182

Query: 280 APEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPF-AGENDVET 320
           APE++       YT   D+WA+G +   LL+    F   + D++T
Sbjct: 183 APELL--LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT 225

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 50.4 bits (120), Expect = 5e-07
 Identities = 64/253 (25%), Positives = 108/253 (42%), Gaps = 28/253 (11%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAA--KFIP--VSHNLEKELIRKEIDIMNQL-HHPKLINL 170
           IG G FG V R   +K G    A  K +    S N  ++    E++++ +L HHP +INL
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFA-GELEVLCKLGHHPNIINL 68

Query: 171 HDAFEDDDEMVLIFEFLSGGELFERI-------TAPDYKMSEAEVIPVTLPILMTQTSPA 223
             A E+   + +  E+   G L + +       T P +         +T   L+   S  
Sbjct: 69  LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128

Query: 224 VKHMH---EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEV-VKISTG--TAE 277
              M    EK  IH D+   N++     +   K+ DFGL+      EV VK + G     
Sbjct: 129 ATGMQYLSEKQFIHRDLAARNVL--VGENLASKIADFGLSRG---EEVYVKKTMGRLPVR 183

Query: 278 FAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAF 336
           + A E +        +D+W+ GVL + ++S G +P+ G    E  + +      +  E  
Sbjct: 184 WMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ---GYRMEKP 240

Query: 337 KNVSEEGKDFIRR 349
           +N  +E  + +R+
Sbjct: 241 RNCDDEVYELMRQ 253

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 50.3 bits (120), Expect = 5e-07
 Identities = 58/240 (24%), Positives = 109/240 (45%), Gaps = 25/240 (10%)

Query: 98  PVDIKTSSVYDHYDILEEIGTGAFGVVHRC------RERKTGNIFAAKFIPVSHNLEKEL 151
           P+D K     D   + + +G G FG V R       + R    +  A  +   +  +K+L
Sbjct: 2   PLDPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDL 61

Query: 152 --IRKEIDIMNQL-HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITA-----PDYKM 203
             +  E+++M  +  H  +INL      +  + +I E+ + G L E + A     PDY  
Sbjct: 62  ADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTF 121

Query: 204 SEAEVI--PVTLPILMT---QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFG 258
              +V    ++   L++   Q +  ++++  +  IH D+   N++    N   +K+ DFG
Sbjct: 122 DITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNV--MKIADFG 179

Query: 259 LATKL-DPNEVVKISTG--TAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
           LA  + D +   K S G    ++ APE +        +D+W+ G+L + + + G SP+ G
Sbjct: 180 LARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG 239

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 50.4 bits (120), Expect = 5e-07
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 29/200 (14%)

Query: 148 EKEL--IRKEIDIMNQL-HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITA------ 198
           EK+L  +  E+++M  +  H  +INL  A   D  + +I E+ S G L E + A      
Sbjct: 64  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 123

Query: 199 ---------PDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNS 249
                    P+ ++S  +++         Q +  ++++  K  IH D+   N++    N 
Sbjct: 124 EYCYNPTQVPEEQLSFKDLVSCAY-----QVARGMEYLASKKCIHRDLAARNVLVTEDNV 178

Query: 250 TNVKMIDFGLATKLDPNEVVKISTG---TAEFAAPEIVEREPVGFYTDMWAVGVLAYVLL 306
             +K+ DFGLA  +   +  K +T      ++ APE +        +D+W+ GVL + + 
Sbjct: 179 --MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 236

Query: 307 S-GLSPFAGENDVETLKNVK 325
           + G SP+ G    E  K +K
Sbjct: 237 TLGGSPYPGVPVEELFKLLK 256

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 50.0 bits (119), Expect = 6e-07
 Identities = 57/245 (23%), Positives = 107/245 (43%), Gaps = 35/245 (14%)

Query: 98  PVDIKTSSVYDHYDILEEIGTGAFGVVHRC------RERKTGNIFAAKFIPVSHNLEKEL 151
           P D +     D   + + +G G FG V         +++    +  A  +      EK+L
Sbjct: 5   PEDPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDL 64

Query: 152 --IRKEIDIMNQL-HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITA---------- 198
             +  E+++M  +  H  +INL  A   D  + +I E+ S G L E + A          
Sbjct: 65  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 124

Query: 199 -----PDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVK 253
                PD +M+  +++  T      Q +  ++++  +  IH D+   N++    N   +K
Sbjct: 125 DIARVPDEQMTFKDLVSCTY-----QVARGMEYLASQKCIHRDLAARNVLVTENNV--MK 177

Query: 254 MIDFGLATKLDPNEVVKISTG---TAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GL 309
           + DFGLA  ++  +  K +T      ++ APE +        +D+W+ GVL + + + G 
Sbjct: 178 IADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 237

Query: 310 SPFAG 314
           SP+ G
Sbjct: 238 SPYPG 242

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 50.1 bits (119), Expect = 7e-07
 Identities = 59/225 (26%), Positives = 106/225 (47%), Gaps = 26/225 (11%)

Query: 115 EIGTGAFGVVHRCRER--KTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHD 172
           ++G G +G V++ + +  K    +A K I  +  +     R EI ++ +L HP +I L  
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT-GISMSACR-EIALLRELKHPNVIALQK 65

Query: 173 AF--EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLP-----ILMTQTSPAVK 225
            F    D ++ L+F++ +  +L+  I    ++ S+A   P+ LP      L+ Q    + 
Sbjct: 66  VFLSHSDRKVWLLFDY-AEHDLWHIIKF--HRASKANKKPMQLPRSMVKSLLYQILDGIH 122

Query: 226 HMHEKNIIHLDVKPENI--MCQTRNSTNVKMIDFGLA----TKLDPNEVVKISTGTAEFA 279
           ++H   ++H D+KP NI  M +      VK+ D G A    + L P   +     T  + 
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182

Query: 280 APEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPF-AGENDVET 320
           APE++       YT   D+WA+G +   LL+    F   + D++T
Sbjct: 183 APELL--LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT 225

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 49.2 bits (117), Expect = 8e-07
 Identities = 48/220 (21%), Positives = 95/220 (43%), Gaps = 20/220 (9%)

Query: 114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK---EIDIMNQLHHPKLINL 170
           E +G G FG V +   +    + A K      +L +EL  K   E  I+ Q  HP ++ L
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTPV-AVK--TCKEDLPQELKIKFLSEARILKQYDHPNIVKL 57

Query: 171 HDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEK 230
                    + ++ E + GG+    +     ++   +++   L       +  + ++  K
Sbjct: 58  IGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFAL-----DAAAGMAYLESK 112

Query: 231 NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAE----FAAPEIVER 286
           N IH D+   N  C    +  +K+ DFG++ + D    +  S+G  +    + APE +  
Sbjct: 113 NCIHRDLAARN--CLVGENNVLKISDFGMSRQEDDG--IYSSSGLKQIPIKWTAPEALNY 168

Query: 287 EPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
                 +D+W+ G+L +   S G+ P+ G  + +  + V+
Sbjct: 169 GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE 208

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 48.8 bits (116), Expect = 1e-06
 Identities = 58/222 (26%), Positives = 102/222 (45%), Gaps = 32/222 (14%)

Query: 114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINL--- 170
           E IG G FG V   +   TG   A K I    ++  +   +E  +M +LHH  L+ L   
Sbjct: 12  EIIGEGEFGAV--LQGEYTGQKVAVKNIKC--DVTAQAFLEETAVMTKLHHKNLVRLLGV 67

Query: 171 --HDAFEDDDEMVLIFEFLSGGEL--FERITAPDYKMSEAEVIPVTLPILMTQTSPAVKH 226
             H+       + ++ E +S G L  F R T     +S  +++  +L +     +  +++
Sbjct: 68  ILHNG------LYIVMELMSKGNLVNFLR-TRGRALVSVIQLLQFSLDV-----AEGMEY 115

Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVER 286
           +  K ++H D+   NI+         K+ DFGLA ++     V  S    ++ APE ++ 
Sbjct: 116 LESKKLVHRDLAARNILVSEDGVA--KVSDFGLA-RVGS-MGVDNSKLPVKWTAPEALKH 171

Query: 287 EPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKAC 327
           +     +D+W+ GVL + + S G +P+       +LK VK C
Sbjct: 172 KKFSSKSDVWSYGVLLWEVFSYGRAPYPK----MSLKEVKEC 209

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 57/229 (24%), Positives = 98/229 (42%), Gaps = 33/229 (14%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFI---PVSHNLEKELIRKEIDIMNQLHHPK 166
           Y +   IG G+FGVV+      T    A K +   P   N       +E+ IM  L+H  
Sbjct: 68  YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN-------RELLIMKNLNHIN 120

Query: 167 LINLHDAF--------EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           +I L D +        E +  + ++ EF+         T   Y M         LP+ + 
Sbjct: 121 IIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-------TVHKY-MKHYARNNHALPLFLV 172

Query: 219 -----QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST 273
                Q   A+ ++H K I H D+KP+N++      T +K+ DFG A  L   +      
Sbjct: 173 KLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHT-LKLCDFGSAKNLLAGQRSVSYI 231

Query: 274 GTAEFAAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETL 321
            +  + APE+ +       + D+W++G +   ++ G   F+G++ V+ L
Sbjct: 232 CSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQL 280

Length = 440

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 43/206 (20%), Positives = 84/206 (40%), Gaps = 29/206 (14%)

Query: 133 GNIFAAKFIPVSHNLEKELIRK---------EIDIMNQ-------LHHPKLIN-LHDAFE 175
           G IF    I      E+E+  K         ++ ++ Q       L H  ++  LH   E
Sbjct: 20  GRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIE 79

Query: 176 DDDEMVLIFEFLSGGEL--FERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNII 233
           D +   +++ +++ G L  F +        +   +    L  +  Q +  + ++H++ +I
Sbjct: 80  DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVI 139

Query: 234 HLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAE-----FAAPEIVEREP 288
           H D+   N  C       VK+ D  L+  L P +      G  E     + A E +  + 
Sbjct: 140 HKDIAARN--CVIDEELQVKITDNALSRDLFPMDYH--CLGDNENRPVKWMALESLVNKE 195

Query: 289 VGFYTDMWAVGVLAYVLLS-GLSPFA 313
               +D+W+ GVL + L++ G +P+ 
Sbjct: 196 YSSASDVWSFGVLLWELMTLGQTPYV 221

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 56/218 (25%), Positives = 99/218 (45%), Gaps = 25/218 (11%)

Query: 116 IGTGAFGVVHRCRERKTGNIF--AAKFIP--VSHNLEKELIRKEIDIMNQL-HHPKLINL 170
           IG G FG V + R +K G     A K +    S +  ++    E++++ +L HHP +INL
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA-GELEVLCKLGHHPNIINL 61

Query: 171 HDAFEDDDEMVLIFEFLSGGELFERI-------TAPDYKMSEAEVIPVTLPILMTQTSPA 223
             A E    + L  E+   G L + +       T P + ++ +    ++   L+   +  
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 224 ---VKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEV-VKISTG--TAE 277
              + ++ +K  IH D+   NI+         K+ DFGL+      EV VK + G     
Sbjct: 122 ARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRG---QEVYVKKTMGRLPVR 176

Query: 278 FAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
           + A E +        +D+W+ GVL + ++S G +P+ G
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 214

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 48.4 bits (115), Expect = 2e-06
 Identities = 56/226 (24%), Positives = 97/226 (42%), Gaps = 31/226 (13%)

Query: 116 IGTGAFGVVHRCR---ERKTGNIFAAKF----IPVSHNLEKELIRKEIDIMNQLHHP--- 165
           +G G FG V   +   E  +    A K     I  S ++E+ L  +E   M +  HP   
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFL--REAACMKEFDHPNVI 64

Query: 166 KLINLHDAFEDDDEM---VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI-----LM 217
           KLI +         +   ++I  F+  G+L   +      MS     P TLP+      M
Sbjct: 65  KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL-----MSRIGEEPFTLPLQTLVRFM 119

Query: 218 TQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVK---ISTG 274
              +  ++++  KN IH D+   N  C    +  V + DFGL+ K+   +  +    S  
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARN--CMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177

Query: 275 TAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVE 319
             ++ A E +       ++D+WA GV  + +++ G +P+AG  + E
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE 223

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 48.0 bits (114), Expect = 3e-06
 Identities = 49/220 (22%), Positives = 96/220 (43%), Gaps = 18/220 (8%)

Query: 116 IGTGAFGVVHRCRERKTGN---IFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLH 171
           IG G FG V   R +  G      A K +   +   ++     E  IM Q  HP +I+L 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
                   ++++ E++  G L   +     +  + +   + L  ++   +  +K++ +  
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDAFL-----RKHDGQFTVIQLVGMLRGIASGMKYLSDMG 126

Query: 232 IIHLDVKPENIMCQTRNSTNV-KMIDFGLATKL--DPNEVVKISTGT--AEFAAPEIVER 286
            +H D+   NI+    NS  V K+ DFGL+  L  DP        G     + APE +  
Sbjct: 127 YVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 183

Query: 287 EPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
                 +D+W+ G++ + ++S G  P+   ++ + +K ++
Sbjct: 184 RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE 223

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 47.6 bits (113), Expect = 3e-06
 Identities = 41/167 (24%), Positives = 68/167 (40%), Gaps = 33/167 (19%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFE 175
           IG G FG V+  +      I       +  NLE E I  E  + N ++    I L     
Sbjct: 20  IGCGGFGCVYETQCASDHCINNQAVAKI-ENLENETIVMETLVYNNIYDIDKIALWKNIH 78

Query: 176 DDDEM-------------------VLIFE--FLSGGELFERITAPDYKMSEAEVIPVTLP 214
           + D +                    ++ E    +  E+F+RI   + K+    +  +   
Sbjct: 79  NIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKL----IKNIMKD 134

Query: 215 ILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT 261
           +L T     ++++HE  I H D+KPENIM    N     +ID+G+A+
Sbjct: 135 MLTT-----LEYIHEHGISHGDIKPENIMVDGNNRG--YIIDYGIAS 174

Length = 294

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 45/175 (25%), Positives = 82/175 (46%), Gaps = 17/175 (9%)

Query: 155 EIDIMNQL-HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAP-----DY-----KM 203
           E+++M  +  H  +INL  A   D  + ++ E+ S G L E + A      DY     K+
Sbjct: 67  EMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKL 126

Query: 204 SEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL 263
            E ++    L     Q +  ++++  +  IH D+   N++    N   +K+ DFGLA  +
Sbjct: 127 PEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNV--MKIADFGLARDV 184

Query: 264 DPNEVVKISTG---TAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
              +  K +T      ++ APE +        +D+W+ GVL + + + G SP+ G
Sbjct: 185 HNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 47.3 bits (112), Expect = 4e-06
 Identities = 51/205 (24%), Positives = 87/205 (42%), Gaps = 18/205 (8%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLH 171
           +L+ IG G FG V     R  GN  A K I   ++   +    E  +M QL H  L+ L 
Sbjct: 10  LLQTIGKGEFGDVMLGDYR--GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLL 65

Query: 172 DAF-EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVI--PVTLPILMTQTSPAVKHMH 228
               E+   + ++ E+++ G L       DY  S    +     L         A++++ 
Sbjct: 66  GVIVEEKGGLYIVTEYMAKGSLV------DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 119

Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREP 288
             N +H D+   N++    N   V   DFGL TK + +          ++ APE +  + 
Sbjct: 120 ANNFVHRDLAARNVLVSEDNVAKVS--DFGL-TK-EASSTQDTGKLPVKWTAPEALREKK 175

Query: 289 VGFYTDMWAVGVLAYVLLS-GLSPF 312
               +D+W+ G+L + + S G  P+
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVPY 200

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 46.9 bits (111), Expect = 6e-06
 Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 23/217 (10%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK---EIDIMNQL-HHPKLINLH 171
           IG G FG V + R +K G    A    +     K+  R    E++++ +L HHP +INL 
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 172 DAFEDDDEMVLIFEFLSGGELFE-----RITAPDYKMSEAEVIPVTLP-----ILMTQTS 221
            A E    + L  E+   G L +     R+   D   + A     TL            +
Sbjct: 75  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134

Query: 222 PAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEV-VKISTG--TAEF 278
             + ++ +K  IH D+   NI+     +   K+ DFGL+      EV VK + G     +
Sbjct: 135 RGMDYLSQKQFIHRDLAARNIL--VGENYVAKIADFGLSRG---QEVYVKKTMGRLPVRW 189

Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
            A E +        +D+W+ GVL + ++S G +P+ G
Sbjct: 190 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 226

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|214495 smart00060, FN3, Fibronectin type 3 domain

 Score = 43.4 bits (102), Expect = 8e-06
 Identities = 18/39 (46%), Positives = 21/39 (53%), Gaps = 1/39 (2%)

Query: 2  SSWIRVGNTRFTTMA-ITGLSPGHQYEFRVYAENVYGRS 39
          S W  V  T  +T   +TGL PG +YEFRV A N  G  
Sbjct: 45 SEWKEVNVTPSSTSYTLTGLKPGTEYEFRVRAVNGAGEG 83

One of three types of internal repeat within the plasma protein, fibronectin. The tenth fibronectin type III repeat contains a RGD cell recognition sequence in a flexible loop between 2 strands. Type III modules are present in both extracellular and intracellular proteins. Length = 83

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 45.6 bits (108), Expect = 2e-05
 Identities = 49/225 (21%), Positives = 95/225 (42%), Gaps = 17/225 (7%)

Query: 114 EEIGTGAFGVV---HRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINL 170
           +EIG G FG V      R      +   +    +   E+ L  +E+    +L+HP ++  
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 171 HDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEK 230
                +    +L+ EF   G+L   + +    +++       L  +  + +  +  +H+ 
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQ-KDVLQRMACEVASGLLWLHQA 119

Query: 231 NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA---EFAAPEIVER- 286
           + IH D+   N  CQ     +VK+ D+GLA +  P +        A    + APE+VE  
Sbjct: 120 DFIHSDLALRN--CQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177

Query: 287 ------EPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
                 +     +++W++GV  + L +    P+   +D + LK V
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV 222

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 43.9 bits (104), Expect = 2e-05
 Identities = 28/163 (17%), Positives = 56/163 (34%), Gaps = 30/163 (18%)

Query: 111 DILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHH-----P 165
             ++ +  G    V+    +     +  K  P     +     +E+ I+  L       P
Sbjct: 1   SSIKLLKGGLTNRVYLLGTKDED--YVLKINP--SREKGADREREVAILQLLARKGLPVP 56

Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
           K++    + E D    L+ E++ G  L              EV       +  Q +  + 
Sbjct: 57  KVL---ASGESDGWSYLLMEWIEGETL-------------DEVSEEEKEDIAEQLAELLA 100

Query: 226 HMHEKNI---IHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP 265
            +H+  +    H D+ P NI+    +   + +ID+  A    P
Sbjct: 101 KLHQLPLLVLCHGDLHPGNILV--DDGKILGIIDWEYAGYGPP 141

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|200951 pfam00041, fn3, Fibronectin type III domain

 Score = 41.6 bits (98), Expect = 3e-05
 Identities = 18/39 (46%), Positives = 21/39 (53%), Gaps = 1/39 (2%)

Query: 4  WIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPS 42
           I V  T  T+  +TGL PG +YE RV A N  G   PS
Sbjct: 47 EITVPGTT-TSYTLTGLKPGTEYEVRVQAVNGAGEGPPS 84

Length = 84

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 44.5 bits (105), Expect = 3e-05
 Identities = 53/226 (23%), Positives = 96/226 (42%), Gaps = 20/226 (8%)

Query: 114 EEIGTGAFGVVHRCRERKTGNIFA---AKFIPVSHNL-EKELIRKEIDIMNQLHHPKLIN 169
           +EIG G FG V    E  T    A    K +  + +  E+    ++ D    L HP ++ 
Sbjct: 1   QEIGNGWFGKV-LLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQ 59

Query: 170 LHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE 229
                 +    +L+FE+   G+L   ++   +    ++++   L  +  + +  V HMH+
Sbjct: 60  CLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLL--LLQRMACEIAAGVTHMHK 117

Query: 230 KNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT---KLDPNEVVKISTGTAEFAAPEIVER 286
            N +H D+   N  C   +   VK+ D+G+     K D  E          + APE+V  
Sbjct: 118 HNFLHSDLALRN--CFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGE 175

Query: 287 EPVGF-------YTDMWAVGVLAYVLL-SGLSPFAGENDVETLKNV 324
              G         +++WA+GV  + L  +   P++  +D E L +V
Sbjct: 176 FHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV 221

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 44.9 bits (106), Expect = 4e-05
 Identities = 35/103 (33%), Positives = 52/103 (50%), Gaps = 12/103 (11%)

Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA--TKLDPNEVVKISTGTA 276
           Q +  +  +  KN IH D+   NI+      T  K+ DFGLA   + D N VVK   G A
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRIT--KICDFGLARDIRNDSNYVVK---GNA 276

Query: 277 ----EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
               ++ APE +      F +D+W+ G+L + + S G SP+ G
Sbjct: 277 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPG 319

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 44.6 bits (105), Expect = 4e-05
 Identities = 33/103 (32%), Positives = 52/103 (50%), Gaps = 12/103 (11%)

Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--DPNEVVKISTGTA 276
           Q +  ++ +  +  IH D+   NI+    N   VK+ DFGLA  +  DP+ V K   G A
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRK---GDA 241

Query: 277 ----EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
               ++ APE +        +D+W+ GVL + + S G SP+ G
Sbjct: 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 284

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 44.4 bits (105), Expect = 4e-05
 Identities = 56/228 (24%), Positives = 100/228 (43%), Gaps = 26/228 (11%)

Query: 116 IGTGAFGVVHR--CRERKTGNI---FAAKFIPVSHNLEKEL-IRKEIDIMNQLHHPKLIN 169
           +G GAFG V+    R R    +    A K +P S + + E     E  IM++ +H  ++ 
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73

Query: 170 LHD-AFEDDDEMVLIFEFLSGGEL--FERITAPD----YKMSEAEVIPVTLPILMTQTSP 222
           L   +FE     +L+ E ++GG+L  F R   P       ++  +++     +     + 
Sbjct: 74  LIGVSFERLPRFILL-ELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDV-----AK 127

Query: 223 AVKHMHEKNIIHLDVKPENIMCQTRNSTNV-KMIDFGLATKLDPNEVVKISTGTA----E 277
             K++ E + IH D+   N +   +    V K+ DFG+A  +      +   G A    +
Sbjct: 128 GCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG-GRAMLPIK 186

Query: 278 FAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
           +  PE          TD+W+ GVL + + S G  P+ G  + E ++ V
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV 234

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 44.6 bits (105), Expect = 5e-05
 Identities = 58/238 (24%), Positives = 98/238 (41%), Gaps = 36/238 (15%)

Query: 94  YVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL-- 151
           YV    DI  S+    + IL  +G G FG V    +RK     A K +    N+ K    
Sbjct: 117 YVVLGEDIDVST--QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIV---RNVPKYTRD 171

Query: 152 IRKEIDIMNQLHHPK------LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSE 205
            + EI  M ++          L+ +   F+++   + I     G  L       D+ M  
Sbjct: 172 AKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLL------DWIMKH 225

Query: 206 AEVIPVTLPILMTQTSPAVKHMH-EKNIIHLDVKPENIMCQTRNST-------------- 250
                  L  ++ QT  A+ + H E +++H D+KPENI+ +T ++               
Sbjct: 226 GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPC 285

Query: 251 NVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSG 308
            V++ D G       +    +S  T  + +PE+V      + TDMW++G + Y L +G
Sbjct: 286 RVRICDLGGCCDERHSRTAIVS--TRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTG 341

Length = 467

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 44.5 bits (105), Expect = 6e-05
 Identities = 21/71 (29%), Positives = 36/71 (50%), Gaps = 2/71 (2%)

Query: 274 GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV--KACDWEF 331
           GT ++ APE++  +P G   D WA+GV  +  L+G+ PF  E   +  +N+  +   W  
Sbjct: 542 GTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWPE 601

Query: 332 DEEAFKNVSEE 342
            EE     ++ 
Sbjct: 602 GEEKLSVNAQN 612

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 43.9 bits (103), Expect = 6e-05
 Identities = 50/212 (23%), Positives = 92/212 (43%), Gaps = 25/212 (11%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL--------IRKEIDIMNQLHHPKL 167
           +G+GAFG V++      G       IPV+  +  E            E  IM  + HP L
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVK---IPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 71

Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI-LMTQTSPAVKH 226
           + L         + L+ + +  G L +      Y     + I   L +    Q +  + +
Sbjct: 72  VRLLGVCLSP-TIQLVTQLMPHGCLLD------YVHEHKDNIGSQLLLNWCVQIAKGMMY 124

Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA---EFAAPEI 283
           + E+ ++H D+   N++ ++ N  +VK+ DFGLA  L+ +E    + G     ++ A E 
Sbjct: 125 LEERRLVHRDLAARNVLVKSPN--HVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182

Query: 284 VEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
           +        +D+W+ GV  + L++ G  P+ G
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 214

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 43.8 bits (103), Expect = 7e-05
 Identities = 26/100 (26%), Positives = 51/100 (51%), Gaps = 6/100 (6%)

Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA-- 276
           Q +  + ++ E  ++H D+   N++   ++  +VK+ DFGLA  LD +E    + G    
Sbjct: 117 QIAKGMSYLEEVRLVHRDLAARNVL--VKSPNHVKITDFGLARLLDIDETEYHADGGKVP 174

Query: 277 -EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
            ++ A E +        +D+W+ GV  + L++ G  P+ G
Sbjct: 175 IKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG 214

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 43.7 bits (103), Expect = 7e-05
 Identities = 28/95 (29%), Positives = 48/95 (50%), Gaps = 6/95 (6%)

Query: 215 ILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA--TKLDPNEVVKIS 272
           I+  Q    ++++H + IIH DVK ENI     +   V + D G A    + P  +    
Sbjct: 161 IIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQ--VCIGDLGAAQFPVVAPAFLG--L 216

Query: 273 TGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS 307
            GT E  APE++ R+      D+W+ G++ + +L+
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 43.7 bits (103), Expect = 8e-05
 Identities = 39/131 (29%), Positives = 63/131 (48%), Gaps = 15/131 (11%)

Query: 194 ERITAPDYKMSEAEVIPVTLPILMT---QTSPAVKHMHEKNIIHLDVKPENIMCQTRNST 250
                 D +  E    P+TL  L++   Q +  ++ +  +  IH D+   NI+    N  
Sbjct: 153 LSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNV- 211

Query: 251 NVKMIDFGLATKL--DPNEVVKISTGTA----EFAAPEIVEREPVGFYTDMWAVGVLAYV 304
            VK+ DFGLA  +  DP+ V K   G A    ++ APE +  +     +D+W+ GVL + 
Sbjct: 212 -VKICDFGLARDIYKDPDYVRK---GDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWE 267

Query: 305 LLS-GLSPFAG 314
           + S G SP+ G
Sbjct: 268 IFSLGASPYPG 278

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 43.4 bits (102), Expect = 8e-05
 Identities = 49/233 (21%), Positives = 101/233 (43%), Gaps = 20/233 (8%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQ------ 161
           +   +L E+G G+FG+V+    R      A   + V    E   +R+ I+ +N+      
Sbjct: 6   EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKG 65

Query: 162 --LHHPKLINLHDAFEDDDEMVLIFEFLSGGEL--FERITAPDYKMSEAEVIPVTLPILM 217
              HH  ++ L          +++ E ++ G+L  + R   P+ + +     P    ++ 
Sbjct: 66  FTCHH--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 123

Query: 218 --TQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL-DPNEVVKISTG 274
              + +  + +++ K  +H D+   N  C   +   VK+ DFG+   + + +   K   G
Sbjct: 124 MAAEIADGMAYLNAKKFVHRDLAARN--CMVAHDFTVKIGDFGMTRDIYETDYYRKGGKG 181

Query: 275 --TAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
                + APE ++       +DMW+ GV+ + + S    P+ G ++ + LK V
Sbjct: 182 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 234

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 33/103 (32%), Positives = 51/103 (49%), Gaps = 12/103 (11%)

Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--DPNEVVKISTGTA 276
           Q +  +  +  KN IH DV   N++    +    K+ DFGLA  +  D N VVK   G A
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLT--DGRVAKICDFGLARDIMNDSNYVVK---GNA 274

Query: 277 ----EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
               ++ APE +        +D+W+ G+L + + S G SP+ G
Sbjct: 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG 317

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 42.5 bits (100), Expect = 1e-04
 Identities = 39/166 (23%), Positives = 74/166 (44%), Gaps = 14/166 (8%)

Query: 154 KEIDIMNQLHHPKLINLHDAFEDDDEMVLI-FEFLSGGELFERITAPDYKMSEAEVIPVT 212
           KE  IM    HP +++L       +   L+   ++  G+L   I +  +  +  ++I   
Sbjct: 45  KEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFG 104

Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS 272
           L     Q +  ++++  K  +H D+   N  C    S  VK+ DFGLA  +   E   + 
Sbjct: 105 L-----QVAKGMEYLASKKFVHRDLAARN--CMLDESFTVKVADFGLARDIYDKEYYSVH 157

Query: 273 TGTA-----EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPF 312
             T      ++ A E ++ +     +D+W+ GVL + L++ G  P+
Sbjct: 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 203

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 42.1 bits (99), Expect = 2e-04
 Identities = 46/184 (25%), Positives = 82/184 (44%), Gaps = 8/184 (4%)

Query: 153 RKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGEL--FERITAP-DYKMSEAEVI 209
           R+E+D+  +L H  ++ L     + +   +I E+   G+L  F R T   D K+    + 
Sbjct: 56  RRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLS 115

Query: 210 PVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVV 269
                 L TQ +  + H+     +H D+   N +  ++    VK+    L+  +  +E  
Sbjct: 116 TKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE--VKVSLLSLSKDVYNSEYY 173

Query: 270 KISTGTA--EFAAPEIVEREPVGFYTDMWAVGVLAY-VLLSGLSPFAGENDVETLKNVKA 326
           K+        + APE V+ +     +D+W+ GVL + V   G  PF G +D E L  ++A
Sbjct: 174 KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQA 233

Query: 327 CDWE 330
              E
Sbjct: 234 GKLE 237

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 41.9 bits (98), Expect = 3e-04
 Identities = 51/223 (22%), Positives = 87/223 (39%), Gaps = 26/223 (11%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAKF----IPVSHNLEKELIRKEIDIMNQLHHPKLINLH 171
           +G G FG V   +  +  +I         I +    E E    E   M +  HP ++ L 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 172 DAFEDDDEM------VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI-----LMTQT 220
                  E       V+I  F+  G+L   +       S     P  LP       MT  
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLL-----YSRLGDCPQYLPTQMLVKFMTDI 121

Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL---DPNEVVKISTGTAE 277
           +  ++++  K+ IH D+   N  C    + NV + DFGL+ K+   D     +I+    +
Sbjct: 122 ASGMEYLSSKSFIHRDLAARN--CMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179

Query: 278 FAAPEIVEREPVGFYTDMWAVGVLAY-VLLSGLSPFAGENDVE 319
           + A E +        +D+W+ GV  + +   G +P+ G  + E
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE 222

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 41.9 bits (98), Expect = 3e-04
 Identities = 49/220 (22%), Positives = 98/220 (44%), Gaps = 28/220 (12%)

Query: 111 DILEEIGTG--AFGVVHRCRERKTGNIFAAKFIPVSHNLEK------ELIRKEIDIMNQL 162
           ++L  IG G      V+  R + TG     + I    NLE         ++ E+ +    
Sbjct: 1   ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRI----NLEACTNEMVTFLQGELHVSKLF 56

Query: 163 HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERI-TAPDYKMSEAEVIPVTLPILMTQTS 221
           +HP ++     F  D+E+ ++  F++ G   + I T     MSE  +  +   +L     
Sbjct: 57  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVL----- 111

Query: 222 PAVKHMHEKNIIHLDVKPENIM-------CQTRNSTNVKMIDFGLATKLDPNEVVKISTG 274
            A+ ++H    +H  VK  +I+         +   +N+ MI+ G   ++  ++  K S  
Sbjct: 112 KALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV-VHDFPKYSVK 170

Query: 275 TAEFAAPEIVEREPVGF--YTDMWAVGVLAYVLLSGLSPF 312
              + +PE++++   G+   +D+++VG+ A  L +G  PF
Sbjct: 171 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 210

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 41.4 bits (97), Expect = 3e-04
 Identities = 43/210 (20%), Positives = 87/210 (41%), Gaps = 24/210 (11%)

Query: 114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPV-------SHNLEKELIRKEIDIMNQLHHPK 166
           E +G G F  + +   R+ G+        V       SH    E   +   +M+QL H  
Sbjct: 1   ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60

Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI-LMTQTSPAVK 225
           L+  +      DE +++ E++  G L        Y      +I ++  + +  Q + A+ 
Sbjct: 61  LVLNYGVCVCGDESIMVQEYVKFGSL------DTYLKKNKNLINISWKLEVAKQLAWALH 114

Query: 226 HMHEKNIIHLDVKPENIMC------QTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFA 279
            + +K + H +V  +N++       +T N   +K+ D G++  + P E++        + 
Sbjct: 115 FLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEIL---LERIPWV 171

Query: 280 APEIVER-EPVGFYTDMWAVGVLAYVLLSG 308
            PE +E  + +    D W+ G   + + SG
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 41.6 bits (98), Expect = 4e-04
 Identities = 46/238 (19%), Positives = 98/238 (41%), Gaps = 34/238 (14%)

Query: 112 ILEEIGTGAFGVV-----HRCRERKTGNIFAAKFIPVSHNLEKEL-IRKEIDIMNQLHHP 165
           ++ E+G G+FG+V         + +     A K +  + ++ + +    E  +M + +  
Sbjct: 10  LIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH 69

Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDY---KMSEAEVIPVTLPI------- 215
            ++ L          +++ E ++ G+L        Y   +  EAE  P   P        
Sbjct: 70  HVVRLLGVVSTGQPTLVVMELMAKGDL------KSYLRSRRPEAENNPGLGPPTLQKFIQ 123

Query: 216 LMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT 275
           +  + +  + ++  K  +H D+   N M    + T VK+ DFG+   +   +  +     
Sbjct: 124 MAAEIADGMAYLAAKKFVHRDLAARNCMV-AEDLT-VKIGDFGMTRDIYETDYYRKGGKG 181

Query: 276 A---EFAAPEIVEREPVGFYT---DMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKA 326
                + APE ++    G +T   D+W+ GV+ + + +    P+ G ++ E LK V  
Sbjct: 182 LLPVRWMAPESLKD---GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID 236

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 40.7 bits (95), Expect = 6e-04
 Identities = 26/100 (26%), Positives = 51/100 (51%), Gaps = 6/100 (6%)

Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA-- 276
           Q +  + ++ E+ ++H D+   N++ +T    +VK+ DFGLA  L  +E    + G    
Sbjct: 117 QIAKGMNYLEERRLVHRDLAARNVLVKTPQ--HVKITDFGLAKLLGADEKEYHAEGGKVP 174

Query: 277 -EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
            ++ A E +        +D+W+ GV  + L++ G  P+ G
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 214

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 40.4 bits (95), Expect = 7e-04
 Identities = 53/221 (23%), Positives = 93/221 (42%), Gaps = 36/221 (16%)

Query: 115 EIGTGAFG--VVHRCRERKTGNIFAAKFIPVSHNLEK------ELIRKEIDIMNQLHHPK 166
            IG       +VH  + + T  + A K I    NL+       +L+++EI    QL HP 
Sbjct: 5   LIGKCFEDLMIVHLAKHKPTNTLVAVKKI----NLDSCSKEDLKLLQQEIITSRQLQHPN 60

Query: 167 LINLHDAFEDDDEMVLIFEFLSGG--ELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           ++    +F  D E+ ++   ++ G  E   +   P+  + E   I   L  ++     A+
Sbjct: 61  ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPE-GLPEL-AIAFILKDVLN----AL 114

Query: 225 KHMHEKNIIHLDVKPENIM-------CQTRNSTNVKMIDFG--LATKLDPNEVVKISTGT 275
            ++H K  IH  VK  +I+         +    +V MI  G       D     K S   
Sbjct: 115 DYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFP---KSSVKN 171

Query: 276 AEFAAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFA 313
             + +PE++++   G Y    D+++VG+ A  L +G  PF 
Sbjct: 172 LPWLSPEVLQQNLQG-YNEKSDIYSVGITACELANGHVPFK 211

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 40.6 bits (95), Expect = 8e-04
 Identities = 23/88 (26%), Positives = 43/88 (48%), Gaps = 5/88 (5%)

Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS---TGT 275
           Q   A+ ++H + IIH D+K EN++       ++ + DFG A     +          GT
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNG--PEDICLGDFGAACFARGSWSTPFHYGIAGT 325

Query: 276 AEFAAPEIVEREPVGFYTDMWAVGVLAY 303
            +  APE++  +P     D+W+ G++ +
Sbjct: 326 VDTNAPEVLAGDPYTPSVDIWSAGLVIF 353

Length = 461

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 40.5 bits (95), Expect = 0.001
 Identities = 47/212 (22%), Positives = 84/212 (39%), Gaps = 53/212 (25%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK------EIDI-MN 160
           D + + +++G GAFGVV++           A  +      E + + K       ++I MN
Sbjct: 132 DDFVLGKKLGEGAFGVVYK-----------ASLVNKQSKKEGKYVLKKATEYGAVEIWMN 180

Query: 161 ---QLHHPKLI-NLHDAF------EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVI- 209
              +   P    +    F      + +DE  L++ +     L + + + ++  +    + 
Sbjct: 181 ERVRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLL 240

Query: 210 --PVTLP-----------ILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMID 256
                LP            +M Q   A+  +H   I+H DVKP+NI+  +  S + K+ID
Sbjct: 241 GKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIF-SEGSGSFKIID 299

Query: 257 FGLATKLD------PNEVVKISTGTAEFAAPE 282
            G A  L       P E +        +AAPE
Sbjct: 300 LGAAADLRVGINYIPKEFLL----DPRYAAPE 327

Length = 566

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 40.2 bits (94), Expect = 0.001
 Identities = 49/219 (22%), Positives = 87/219 (39%), Gaps = 27/219 (12%)

Query: 116 IGTGAFGVVHRCRERKTGNIF---AAKFIPVSHNLEKEL--IRKEIDIMNQLHHPKLINL 170
           +G G FG V   +  +        A K + +  +   E+     E   M    HP ++ L
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 171 HD-AFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI-----LMTQ 219
               FE          ++I  F+  G+L   +       S    +P  LP+      M  
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLY-----SRLGGLPEKLPLQTLLKFMVD 121

Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL---DPNEVVKISTGTA 276
            +  ++++  +N IH D+   N  C  R    V + DFGL+ K+   D     +I+    
Sbjct: 122 IALGMEYLSNRNFIHRDLAARN--CMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179

Query: 277 EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
           ++ A E +        +D+WA GV  + + + G +P+ G
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG 218

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 38.7 bits (90), Expect = 0.002
 Identities = 49/233 (21%), Positives = 95/233 (40%), Gaps = 43/233 (18%)

Query: 129 ERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHH--PKLINLHDAFEDDDEMVLIFEF 186
           + +T   F  K +  S    +E  R  I     + H  P ++ LH     +D + L+ + 
Sbjct: 14  DTRTQQTFILKGLRKSSEYSRE--RLTI-----IPHCVPNMVCLHKYIVSEDSVFLVLQH 66

Query: 187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQT 246
             GG+L+  I+          +    +     +   A+  +H + I+  D+ P NI+   
Sbjct: 67  AEGGKLWSHIS------KFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDD 120

Query: 247 RNSTNVKMIDFGLATKLDP---NEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAY 303
           R   ++++  F   ++++     E V+       + APE+          D W++G + +
Sbjct: 121 RG--HIQLTYFSRWSEVEDSCDGEAVE-----NMYCAPEVGGISEETEACDWWSLGAILF 173

Query: 304 VLLSGLS-----PFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLL 351
            LL+G +     P +G N   TL N+              VSEE +  +++LL
Sbjct: 174 ELLTGKTLVECHP-SGINTHTTL-NIPEW-----------VSEEARSLLQQLL 213

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 38.9 bits (90), Expect = 0.003
 Identities = 17/48 (35%), Positives = 27/48 (56%), Gaps = 2/48 (4%)

Query: 216 LMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL 263
           +M Q    ++ +H   I+H D+KPEN++        VK+IDFG A  +
Sbjct: 314 VMRQVLTGLRKLHRIGIVHRDIKPENLLVTV--DGQVKIIDFGAAVDM 359

Length = 507

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	356
KOG0615|consensus	475		100.0
KOG0196|consensus	996		100.0
KOG0598|consensus	357		100.0
KOG0575|consensus	592		100.0
KOG0595|consensus	429		100.0
KOG0616|consensus	355		100.0
KOG0581|consensus	364		100.0
KOG0591|consensus	375		100.0
KOG0592|consensus	604		100.0
KOG0605|consensus	550		100.0
KOG0033|consensus	355		100.0
KOG0583|consensus	370		100.0
KOG0032|consensus	382		100.0
KOG0694|consensus	694		100.0
KOG0600|consensus	560		100.0
KOG0588|consensus	786		100.0
KOG0593|consensus	396		100.0
KOG0192|consensus	362		100.0
KOG0197|consensus	468		100.0
KOG0610|consensus	459		100.0
KOG0580|consensus	281		100.0
KOG0597|consensus	808		100.0
KOG0578|consensus	550		100.0
KOG0585|consensus	576		100.0
KOG0599|consensus	411		100.0
KOG0661|consensus	538		100.0
KOG0611|consensus	668		100.0
KOG0198|consensus	313		100.0
KOG0659|consensus	318		100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0201|consensus	467		100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0582|consensus	516		100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG4717|consensus	864		100.0
KOG0604|consensus	400		100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0663|consensus	419		100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0589|consensus	426		100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG1026|consensus	774		100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0658|consensus	364		100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG0607|consensus	463		100.0
KOG0594|consensus	323		100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG0660|consensus	359		100.0
KOG0690|consensus	516		100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
KOG0986|consensus	591		100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
KOG0612|consensus	1317		100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0194|consensus	474		100.0
KOG4236|consensus	888		100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0667|consensus	586		100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG4721|consensus	904		100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0193|consensus	678		100.0
KOG1095|consensus	1025		100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
KOG0579|consensus	1187		100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0696|consensus	683		100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG1989|consensus	738		100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0574|consensus	502		100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG2345|consensus	302		100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
KOG0586|consensus	596		100.0
KOG4279|consensus	1226		100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
KOG4257|consensus	974		100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG1187|consensus	361		100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG0199|consensus	1039		100.0
KOG0577|consensus	948		100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
KOG0614|consensus	732		100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG4278|consensus	1157		100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
KOG0608|consensus	1034		100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG0983|consensus	391		100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
KOG1094|consensus	807		100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG0603|consensus	612		100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG4250|consensus	732		100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG0584|consensus	632		100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG0596|consensus	677		100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG0695|consensus	593		100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG0662|consensus	292		100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG4645|consensus	1509		100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG1035|consensus	1351		100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0666|consensus	438		100.0
KOG0587|consensus	953		100.0
KOG1151|consensus	775		100.0
KOG1006|consensus	361		100.0
KOG0669|consensus	376		100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0671|consensus	415		100.0
KOG0668|consensus	338		100.0
KOG0200|consensus	609		100.0
KOG1025|consensus	1177		100.0
KOG0984|consensus	282		100.0
KOG1290|consensus	590		100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG2052|consensus	513		100.0
KOG0670|consensus	752		100.0
KOG1152|consensus	772		100.0
KOG3653|consensus	534		100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	100.0
KOG1027|consensus	903		100.0
KOG0664|consensus	449		99.98
KOG0665|consensus	369		99.98
KOG1345|consensus	378		99.98
KOG0576|consensus	829		99.97
KOG1024|consensus	563		99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1167|consensus	418		99.95
KOG1164|consensus	322		99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
KOG1163|consensus	341		99.94
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.94
KOG0195|consensus	448		99.94
KOG1165|consensus	449		99.93
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.93
KOG0603|consensus	612		99.92
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.92
KOG4158|consensus	598		99.9
KOG0590|consensus	601		99.9
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.9
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.9
KOG0606|consensus	1205		99.9
PRK12274	218	serine/threonine protein kinase; Provisional	99.9
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.89
PRK10345	210	hypothetical protein; Provisional	99.88
KOG1240|consensus	1431		99.87
KOG1166|consensus	974		99.85
PRK14879	211	serine/threonine protein kinase; Provisional	99.84
smart00090	237	RIO RIO-like kinase.	99.84
KOG1033|consensus	516		99.81
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.81
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.81
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.8
KOG1023|consensus	484		99.75
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.74
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.72
KOG0590|consensus	601		99.72
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.71
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.6
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.6
KOG0601|consensus	524		99.55
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.52
KOG0606|consensus	1205		99.51
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.48
KOG1243|consensus	690		99.47
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.4
KOG3087|consensus	229		99.35
KOG3741|consensus	655		99.34
KOG0601|consensus	524		99.31
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.28
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.14
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.13
KOG1266|consensus	458		99.13
COG4248	637	Uncharacterized protein with protein kinase and he	99.12
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.95
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.87
PRK09902	216	hypothetical protein; Provisional	98.85
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.85
KOG2137|consensus	700		98.84
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.83
KOG1235|consensus	538		98.72
KOG0576|consensus	829		98.69
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.58
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.58
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.48
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.47
PLN02876	822	acyl-CoA dehydrogenase	98.41
PF01636	239	APH: Phosphotransferase enzyme family This family	98.38
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.36
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.35
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.16
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.16
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.15
PRK10593	297	hypothetical protein; Provisional	98.01
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.99
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.9
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.82
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.75
KOG2268|consensus	465		97.67
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.65
PLN02236	344	choline kinase	97.63
PRK05231	319	homoserine kinase; Provisional	97.56
PF00041	85	fn3: Fibronectin type III domain; InterPro: IPR003	97.54
KOG1826|consensus	2724		97.53
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.42
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.33
KOG2270|consensus	520		97.28
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.24
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.17
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.08
KOG3513|consensus	1051		97.08
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.05
KOG4222|consensus	1281		97.04
cd00063	93	FN3 Fibronectin type 3 domain; One of three types	96.99
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.93
PTZ00384	383	choline kinase; Provisional	96.85
KOG1035|consensus	1351		96.81
COG2334	331	Putative homoserine kinase type II (protein kinase	96.67
PRK12396	409	5-methylribose kinase; Reviewed	96.6
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.53
PRK06148	1013	hypothetical protein; Provisional	96.49
PLN02756	418	S-methyl-5-thioribose kinase	96.4
PRK11768	325	serine/threonine protein kinase; Provisional	96.05
PTZ00296	442	choline kinase; Provisional	96.04

>KOG0615|consensus

Probab=100.00  E-value=5.7e-58  Score=406.74  Aligned_cols=246  Identities=34%  Similarity=0.593  Sum_probs=217.6

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh-------hHHHHHHHHHHHHhcCCCCceeeeeeEEeC
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL-------EKELIRKEIDIMNQLHHPKLINLHDAFEDD  177 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~-------~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  177 (356)
                      .+.+.|.+.+.||.|+||.|-+|..+.||+.||+|++......       ....+.+|++||++|+|||||+++++|+..
T Consensus       169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~  248 (475)
T KOG0615|consen  169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP  248 (475)
T ss_pred             hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence            3667899999999999999999999999999999999754211       123467999999999999999999999999


Q ss_pred             CeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeec-CCCcEEEEe
Q psy12427        178 DEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTR-NSTNVKMID  256 (356)
Q Consensus       178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~-~~~~vkl~D  256 (356)
                      ...||||||++||+|++++.+... +.+...     +.+++|++.|+.|||++||+||||||+|||+..+ ....+||+|
T Consensus       249 ds~YmVlE~v~GGeLfd~vv~nk~-l~ed~~-----K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItD  322 (475)
T KOG0615|consen  249 DSSYMVLEYVEGGELFDKVVANKY-LREDLG-----KLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITD  322 (475)
T ss_pred             CceEEEEEEecCccHHHHHHhccc-cccchh-----HHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecc
Confidence            999999999999999999976653 333333     3499999999999999999999999999999866 345789999


Q ss_pred             eeceeeeCCCCceeecCCCcCccccccccCCCCC---ccccHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHhhccccccC
Q psy12427        257 FGLATKLDPNEVVKISTGTAEFAAPEIVEREPVG---FYTDMWAVGVLAYVLLSGLSPFAGEN-DVETLKNVKACDWEFD  332 (356)
Q Consensus       257 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~sDvwSlG~il~ell~g~~Pf~~~~-~~~~~~~i~~~~~~~~  332 (356)
                      ||+|..........+.||||.|.|||++.++.+.   .+.|+||+||+||.+++|.+||.+.. +....++|..+.+.|-
T Consensus       323 FGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~  402 (475)
T KOG0615|consen  323 FGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFG  402 (475)
T ss_pred             cchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccccc
Confidence            9999999888888999999999999999877543   46799999999999999999999885 4458899999999999


Q ss_pred             hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 ~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ++.|..+|+++++||++||+.||+
T Consensus       403 p~~w~~Iseea~dlI~~mL~VdP~  426 (475)
T KOG0615|consen  403 PLQWDRISEEALDLINWMLVVDPE  426 (475)
T ss_pred             ChhhhhhhHHHHHHHHHhhEeCcc
Confidence            999999999999999999999996

>KOG0196|consensus

Probab=100.00  E-value=6.6e-58  Score=432.96  Aligned_cols=330  Identities=22%  Similarity=0.340  Sum_probs=262.2

Q ss_pred             ceEeeeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceechhhhh----------------------------
Q psy12427          4 WIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDTFK----------------------------   55 (356)
Q Consensus         4 w~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~~~~~----------------------------   55 (356)
                      =+.+.+++.|+++|+||+|+|.|+|||||++.+|+|.+|..++++|.++...                            
T Consensus       489 ~~~~~~t~~~~~ti~gL~p~t~YvfqVRarT~aG~G~~S~~~~fqT~~~~~~~~~~~~l~~i~g~~~~~v~~lll~~vv~  568 (996)
T KOG0196|consen  489 SYSTLKTKTTTATITGLKPGTVYVFQVRARTAAGYGPYSGKHEFQTLPSESSSQSGEQLPLIIGSILAGVVFLLLAAVVV  568 (996)
T ss_pred             ceeEEecccceEEeeccCCCcEEEEEEEEecccCCCCCCCceeeeecCcccccccccchhhHHHHHHHHHHHHHHHHHHH
Confidence            3566789999999999999999999999999999999999999999876210                            


Q ss_pred             HHH--hhh--hc-----cccccc-ccccC---------CCCcccCCCCceeEeeecccCCCCCCCCCCCcccceeeeccc
Q psy12427         56 KQI--KKR--QY-----DFDETG-KKIRG---------KADEKVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEI  116 (356)
Q Consensus        56 ~~~--~~~--~~-----~~~~~~-~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~l  116 (356)
                      ..+  .++  ++     ..++.. ....+         .++...++..+++.++.++.           -....+|.++|
T Consensus       569 ~~~~~~r~~~~~~~~~~~~t~~~~~~~~~~~~pG~k~YiDP~TYEDPnqAvreFakEI-----------d~s~i~Ie~VI  637 (996)
T KOG0196|consen  569 VAIVCSRKRCGYSRAEQEYTEKLQHYSNGEQLPGTKTYIDPHTYEDPNQAVREFAKEI-----------DPSCVKIEKVI  637 (996)
T ss_pred             HhheeecccccchhcccCCChhHhhhhcCCCCCCceeecCCccccCccHHHHHhhhhc-----------ChhheEEEEEE
Confidence            000  000  00     001100 00000         12233333333333332222           12457899999


Q ss_pred             cccCceEEEEEEEccCC---CEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEeccccch
Q psy12427        117 GTGAFGVVHRCRERKTG---NIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGEL  192 (356)
Q Consensus       117 g~G~fg~V~~~~~~~~~---~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L  192 (356)
                      |.|.||+||+|+.+..|   ..||||.++... +.++.+|+.|+.||.+++||||++|.|+.......+||+|||++|+|
T Consensus       638 GaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsL  717 (996)
T KOG0196|consen  638 GAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSL  717 (996)
T ss_pred             ecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcH
Confidence            99999999999999877   589999998764 56788999999999999999999999999999999999999999999


Q ss_pred             hhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCC-ce-e
Q psy12427        193 FERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE-VV-K  270 (356)
Q Consensus       193 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~-~~-~  270 (356)
                      +.+|..++     .++...++..++++|+.||+||.++|+|||||..+||||+.+-  .+|++|||+++.++.+. .. .
T Consensus       718 DsFLR~~D-----GqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnL--vCKVsDFGLSRvledd~~~~yt  790 (996)
T KOG0196|consen  718 DSFLRQND-----GQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNL--VCKVSDFGLSRVLEDDPEAAYT  790 (996)
T ss_pred             HHHHhhcC-----CceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccce--EEEeccccceeecccCCCcccc
Confidence            99997655     4455666677999999999999999999999999999997543  67999999999885443 22 2


Q ss_pred             ecCC--CcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHH
Q psy12427        271 ISTG--TAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFI  347 (356)
Q Consensus       271 ~~~g--t~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI  347 (356)
                      +..|  +.+|.|||+|.+.+++.+|||||||++|||.++ |+-||.++++++.++.|..+ +..|++  .++|..+-+|+
T Consensus       791 t~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~g-yRLPpP--mDCP~aL~qLM  867 (996)
T KOG0196|consen  791 TLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQG-YRLPPP--MDCPAALYQLM  867 (996)
T ss_pred             ccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhc-cCCCCC--CCCcHHHHHHH
Confidence            2223  789999999999999999999999999999999 99999999999999999874 334433  49999999999


Q ss_pred             HHhhhcC
Q psy12427        348 RRLLLRN  354 (356)
Q Consensus       348 ~~ll~~d  354 (356)
                      ..|||+|
T Consensus       868 ldCWqkd  874 (996)
T KOG0196|consen  868 LDCWQKD  874 (996)
T ss_pred             HHHHHHH
Confidence            9999987

>KOG0598|consensus

Probab=100.00  E-value=1.6e-55  Score=387.90  Aligned_cols=239  Identities=29%  Similarity=0.553  Sum_probs=212.9

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      .++|+++++||+|+||+||.++.+.|++.||+|+++...   ..+.+....|..||..++||.||+++-.|++...+|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            468999999999999999999999999999999997654   23456677899999999999999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      +||+.||.|+..|.+..      .+....++.++.+|+.||.|||++|||||||||+|||+|.++  +++|+|||+|...
T Consensus       104 ld~~~GGeLf~hL~~eg------~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~G--Hi~LtDFgL~k~~  175 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREG------RFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQG--HIKLTDFGLCKED  175 (357)
T ss_pred             EeccCCccHHHHHHhcC------CcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCC--cEEEeccccchhc
Confidence            99999999999887432      333444566999999999999999999999999999998665  8999999999855


Q ss_pred             -CCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHH
Q psy12427        264 -DPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEE  342 (356)
Q Consensus       264 -~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  342 (356)
                       .....+.+.+||+.|||||++.+.+|+.++|.||||+++|||++|.+||.+.+..++.++|.......++   .-+|.+
T Consensus       176 ~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p---~~ls~~  252 (357)
T KOG0598|consen  176 LKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPP---GYLSEE  252 (357)
T ss_pred             ccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCC---ccCCHH
Confidence             3445666789999999999999999999999999999999999999999999999999999998855554   248999


Q ss_pred             HHHHHHHhhhcCCC
Q psy12427        343 GKDFIRRLLLRNKE  356 (356)
Q Consensus       343 ~~~lI~~ll~~dP~  356 (356)
                      +++||+++|++||+
T Consensus       253 ardll~~LL~rdp~  266 (357)
T KOG0598|consen  253 ARDLLKKLLKRDPR  266 (357)
T ss_pred             HHHHHHHHhccCHH
Confidence            99999999999995

>KOG0575|consensus

Probab=100.00  E-value=1.8e-54  Score=402.02  Aligned_cols=237  Identities=31%  Similarity=0.551  Sum_probs=218.0

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccC---ChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS---HNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      .+|...+.||+|||+.||++++..+|..||+|++...   ....++.+.+|++|.++|+|||||+++++|++.+++|||+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4699999999999999999999999999999999763   3456788999999999999999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      |+|..++|.+++.++ ..++|.++     +.+++||+.||.|||+.+|+|||||..|+|++.+  .+|||+|||+|..+.
T Consensus        98 ELC~~~sL~el~Krr-k~ltEpEa-----ry~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~--~~VKIgDFGLAt~le  169 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRR-KPLTEPEA-----RYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNEN--MNVKIGDFGLATQLE  169 (592)
T ss_pred             EecCCccHHHHHHhc-CCCCcHHH-----HHHHHHHHHHHHHHHhcCceecccchhheeecCc--CcEEecccceeeeec
Confidence            999999999999843 35666555     4599999999999999999999999999999754  479999999999997


Q ss_pred             CC-CceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHH
Q psy12427        265 PN-EVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG  343 (356)
Q Consensus       265 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  343 (356)
                      .. +...+.||||.|.|||++.....+..+||||+|||||.||.|++||...+-.+++..|....+.+|.    .+|.++
T Consensus       170 ~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~----~ls~~A  245 (592)
T KOG0575|consen  170 YDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS----HLSAEA  245 (592)
T ss_pred             CcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc----ccCHHH
Confidence            44 6667889999999999999999999999999999999999999999999999999999999999986    899999


Q ss_pred             HHHHHHhhhcCCC
Q psy12427        344 KDFIRRLLLRNKE  356 (356)
Q Consensus       344 ~~lI~~ll~~dP~  356 (356)
                      +|||.+||+.||+
T Consensus       246 ~dLI~~lL~~~P~  258 (592)
T KOG0575|consen  246 KDLIRKLLRPNPS  258 (592)
T ss_pred             HHHHHHHhcCCcc
Confidence            9999999999995

>KOG0595|consensus

Probab=100.00  E-value=3e-54  Score=383.35  Aligned_cols=243  Identities=33%  Similarity=0.560  Sum_probs=215.4

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccC--ChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS--HNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      ..++|.+.+.||+|+||+||+|+++.++..||||.+...  .....+.+..|+.||+.++|||||++++++..++.+++|
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            456799999999999999999999999999999999877  455567778999999999999999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeec-CC---CcEEEEeeec
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTR-NS---TNVKMIDFGL  259 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~-~~---~~vkl~Dfg~  259 (356)
                      ||||+||+|.+++.... .+++..     .+.++.||+.||++||+++||||||||+|||++.. .+   ..+||+|||+
T Consensus        88 MEyC~gGDLs~yi~~~~-~l~e~t-----~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf  161 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRRG-RLPEAT-----ARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGF  161 (429)
T ss_pred             EEeCCCCCHHHHHHHcC-CCCHHH-----HHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence            99999999999998664 344444     45599999999999999999999999999999875 32   4689999999


Q ss_pred             eeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccC
Q psy12427        260 ATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNV  339 (356)
Q Consensus       260 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  339 (356)
                      |+.+.+.....+.+|+|.|||||++..+.|+-++|+||+|+|+|++++|++||...+..|.+..+..++...+ .....+
T Consensus       162 AR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~-~~~~~~  240 (429)
T KOG0595|consen  162 ARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVP-VLPAEL  240 (429)
T ss_pred             hhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccC-chhhhc
Confidence            9999988888889999999999999999999999999999999999999999999999999998877654433 333467


Q ss_pred             CHHHHHHHHHhhhcCC
Q psy12427        340 SEEGKDFIRRLLLRNK  355 (356)
Q Consensus       340 s~~~~~lI~~ll~~dP  355 (356)
                      +.+..+++..+|+.||
T Consensus       241 s~~~~~Ll~~ll~~~~  256 (429)
T KOG0595|consen  241 SNPLRELLISLLQRNP  256 (429)
T ss_pred             cCchhhhhhHHHhcCc
Confidence            8888899999988875

>KOG0616|consensus

Probab=100.00  E-value=2.1e-53  Score=363.15  Aligned_cols=234  Identities=29%  Similarity=0.582  Sum_probs=214.3

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      .++|++++.||.|+||.|.+++++.+|..+|+|++....   ..+.+...+|..+|+.+.||.++++++.|.+.+.++||
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            467999999999999999999999999999999997654   33456677899999999999999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      |||++||.|+.++.... ++++..+     +.++.||+.||+|||+++|++|||||+|||+|.++  ++||+|||.|...
T Consensus       123 meyv~GGElFS~Lrk~~-rF~e~~a-----rFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G--~iKitDFGFAK~v  194 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKSG-RFSEPHA-----RFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNG--HIKITDFGFAKRV  194 (355)
T ss_pred             EeccCCccHHHHHHhcC-CCCchhH-----HHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCC--cEEEEeccceEEe
Confidence            99999999999997643 4555544     55999999999999999999999999999998765  8999999999987


Q ss_pred             CCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHH
Q psy12427        264 DPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG  343 (356)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  343 (356)
                      ...  +.+.||||.|+|||++..+++..++|.|||||++|||+.|.+||.+.+...++++|..+...||.    -+|.++
T Consensus       195 ~~r--T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~----~fs~~~  268 (355)
T KOG0616|consen  195 SGR--TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS----YFSSDA  268 (355)
T ss_pred             cCc--EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc----ccCHHH
Confidence            643  67789999999999999999999999999999999999999999999999999999999999986    789999


Q ss_pred             HHHHHHhhhcC
Q psy12427        344 KDFIRRLLLRN  354 (356)
Q Consensus       344 ~~lI~~ll~~d  354 (356)
                      ++||+.||++|
T Consensus       269 kdLl~~LL~vD  279 (355)
T KOG0616|consen  269 KDLLKKLLQVD  279 (355)
T ss_pred             HHHHHHHHhhh
Confidence            99999999987

>KOG0581|consensus

Probab=100.00  E-value=1.7e-53  Score=375.34  Aligned_cols=238  Identities=24%  Similarity=0.432  Sum_probs=206.9

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCC-eEEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDD-EMVLIF  184 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-~~~lv~  184 (356)
                      .++.+.+..||+|+.|+||+|+++.|++.+|+|++.... ...++++.+|++|++..+||+||.+||+|..+. .+.|+|
T Consensus        78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m  157 (364)
T KOG0581|consen   78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM  157 (364)
T ss_pred             HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence            356788899999999999999999999999999996543 445678899999999999999999999999998 499999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE-KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      |||++|+|..++.... ++++..     +..++.++++||.|||+ .+||||||||.||||+..+  .|||||||.|..+
T Consensus       158 EYMDgGSLd~~~k~~g-~i~E~~-----L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG--eVKicDFGVS~~l  229 (364)
T KOG0581|consen  158 EYMDGGSLDDILKRVG-RIPEPV-----LGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKG--EVKICDFGVSGIL  229 (364)
T ss_pred             hhcCCCCHHHHHhhcC-CCCHHH-----HHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCC--CEEeccccccHHh
Confidence            9999999999987542 344444     45599999999999995 9999999999999998755  7999999999887


Q ss_pred             CCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC-----ChHHHHHHhhccccccChhhhcc
Q psy12427        264 DPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGE-----NDVETLKNVKACDWEFDEEAFKN  338 (356)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~  338 (356)
                      ... ...+.+||..|||||.+.+..|+.++||||||+.++|++.|+.||...     +..+.+..|....   |+.++.+
T Consensus       230 vnS-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p---pP~lP~~  305 (364)
T KOG0581|consen  230 VNS-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP---PPRLPEG  305 (364)
T ss_pred             hhh-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC---CCCCCcc
Confidence            644 567789999999999999999999999999999999999999999885     5566777776543   4444455


Q ss_pred             -CCHHHHHHHHHhhhcCCC
Q psy12427        339 -VSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       339 -~s~~~~~lI~~ll~~dP~  356 (356)
                       +|+|+++||..||++||+
T Consensus       306 ~fS~ef~~FV~~CL~Kdp~  324 (364)
T KOG0581|consen  306 EFSPEFRSFVSCCLRKDPS  324 (364)
T ss_pred             cCCHHHHHHHHHHhcCCcc
Confidence             999999999999999995

>KOG0591|consensus

Probab=100.00  E-value=5.9e-54  Score=364.15  Aligned_cols=244  Identities=27%  Similarity=0.447  Sum_probs=210.9

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeee-eEEeCCe-EEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHD-AFEDDDE-MVL  182 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~-~~~~~~~-~~l  182 (356)
                      ...|+++++||+|.||+||++....+|..+|.|.+....  ...++++..|+.+|++|+|||||++++ .|..+.. ++|
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni   97 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI   97 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence            356999999999999999999999999999999998543  445678889999999999999999998 6665555 899


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHH--CC--ceeccCCCCCEEEeecCCCcEEEEeee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE--KN--IIHLDVKPENIMCQTRNSTNVKMIDFG  258 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~--ivH~Dlkp~NIlv~~~~~~~vkl~Dfg  258 (356)
                      |||++.+|+|.+.+..-  +.....+.+..++.++.|++.||.++|+  ..  |+||||||.||+++.++  .|||+|||
T Consensus        98 vmE~c~~GDLsqmIk~~--K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g--vvKLGDfG  173 (375)
T KOG0591|consen   98 VMELCDAGDLSQMIKHF--KKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG--VVKLGDFG  173 (375)
T ss_pred             HHHhhcccCHHHHHHHH--HhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC--ceeeccch
Confidence            99999999999988632  1223344455566799999999999999  55  99999999999998555  79999999


Q ss_pred             ceeeeCCCCce-eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhc
Q psy12427        259 LATKLDPNEVV-KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK  337 (356)
Q Consensus       259 ~a~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  337 (356)
                      +++.+...... ...+|||.||+||.+...+|+.+|||||+||++|||+.-++||.+.+-.+...+|..+++++.+.  .
T Consensus       174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~--~  251 (375)
T KOG0591|consen  174 LGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD--E  251 (375)
T ss_pred             hHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH--H
Confidence            99998765443 45689999999999999999999999999999999999999999999999999999998763332  3


Q ss_pred             cCCHHHHHHHHHhhhcCCC
Q psy12427        338 NVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       338 ~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+|.++..+|..|+.+||+
T Consensus       252 ~YS~~l~~li~~ci~vd~~  270 (375)
T KOG0591|consen  252 HYSTDLRELINMCIAVDPE  270 (375)
T ss_pred             HhhhHHHHHHHHHccCCcc
Confidence            7899999999999999985

>KOG0592|consensus

Probab=100.00  E-value=3.4e-52  Score=381.28  Aligned_cols=238  Identities=29%  Similarity=0.569  Sum_probs=212.0

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh---hhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN---LEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l  182 (356)
                      ..+|.+.+.||+|+|++|++|+++.+++.||+|++....-   .....+..|-++|.+| .||.|++|+-.|++...+|+
T Consensus        72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF  151 (604)
T KOG0592|consen   72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF  151 (604)
T ss_pred             hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence            4689999999999999999999999999999999865532   2224466799999999 89999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      |+||+++|+|.++|..-+      .+...+.+.++.+|+.||+|||++|||||||||+|||+|.++  ++||+|||.|..
T Consensus       152 vLe~A~nGdll~~i~K~G------sfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dm--hikITDFGsAK~  223 (604)
T KOG0592|consen  152 VLEYAPNGDLLDLIKKYG------SFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDG--HIKITDFGSAKI  223 (604)
T ss_pred             EEEecCCCcHHHHHHHhC------cchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCC--cEEEeecccccc
Confidence            999999999999997542      344455677999999999999999999999999999998654  899999999988


Q ss_pred             eCCCCc--------------eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc
Q psy12427        263 LDPNEV--------------VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACD  328 (356)
Q Consensus       263 ~~~~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~  328 (356)
                      +.+...              ....+||..|.+||++.+...++++|+|+||||||.|+.|.+||.+.++.-++++|....
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~  303 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALD  303 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc
Confidence            743211              134679999999999999999999999999999999999999999999999999999999


Q ss_pred             cccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        329 WEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       329 ~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +.||+    +++++++|||+++|..||+
T Consensus       304 y~fp~----~fp~~a~dLv~KLLv~dp~  327 (604)
T KOG0592|consen  304 YEFPE----GFPEDARDLIKKLLVRDPS  327 (604)
T ss_pred             ccCCC----CCCHHHHHHHHHHHccCcc
Confidence            99996    8899999999999999995

>KOG0605|consensus

Probab=100.00  E-value=1.9e-51  Score=376.50  Aligned_cols=239  Identities=33%  Similarity=0.627  Sum_probs=207.2

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhH---HHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK---ELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      .++|+++.+||+|+||.||+|+.+.||..+|+|+++.+....+   +.++.|-+||...++|+||+|+-+|++..++|||
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi  219 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI  219 (550)
T ss_pred             cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence            4789999999999999999999999999999999998765444   4566799999999999999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      |||++||++..+|...+      .+.....+.++.+++.|+.-||+.|+|||||||+|+|||..|  |+||+|||+|..+
T Consensus       220 MEylPGGD~mTLL~~~~------~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~G--HiKLSDFGLs~gl  291 (550)
T KOG0605|consen  220 MEYLPGGDMMTLLMRKD------TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKG--HIKLSDFGLSTGL  291 (550)
T ss_pred             EEecCCccHHHHHHhcC------cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCC--CEeeccccccchh
Confidence            99999999999987544      333444566999999999999999999999999999998665  8999999999643


Q ss_pred             CCC----------------------Cc--------------------------eeecCCCcCccccccccCCCCCccccH
Q psy12427        264 DPN----------------------EV--------------------------VKISTGTAEFAAPEIVEREPVGFYTDM  295 (356)
Q Consensus       264 ~~~----------------------~~--------------------------~~~~~gt~~y~aPE~~~~~~~~~~sDv  295 (356)
                      ...                      ..                          ....+|||.|+|||++.+..|+...|.
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw  371 (550)
T KOG0605|consen  292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW  371 (550)
T ss_pred             hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence            110                      00                          011249999999999999999999999


Q ss_pred             HHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc--cccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        296 WAVGVLAYVLLSGLSPFAGENDVETLKNVKACD--WEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       296 wSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      |||||||||||.|.+||.++++.+++.+|..-.  +.+|.+  ..+|++++|||.+||. ||+
T Consensus       372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~--~~~s~eA~DLI~rll~-d~~  431 (550)
T KOG0605|consen  372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE--VDLSDEAKDLITRLLC-DPE  431 (550)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc--CcccHHHHHHHHHHhc-CHH
Confidence            999999999999999999999999999998755  556654  3789999999999998 764

>KOG0033|consensus

Probab=100.00  E-value=4.8e-53  Score=352.21  Aligned_cols=245  Identities=35%  Similarity=0.639  Sum_probs=220.8

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      +.+.|++-++||+|.|+.|+++.+..+|+.+|+|++....  ..+.+.+.+|+.|.+.|+||||++|++.+...+..++|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            4578999999999999999999999999999999885432  33567889999999999999999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCC-CcEEEEeeeceee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNS-TNVKMIDFGLATK  262 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~-~~vkl~Dfg~a~~  262 (356)
                      +|+|.|++|..-+..+ +-+++...+.     +++||++||.|+|.+||||||+||+|+|+-...+ .-+||+|||+|..
T Consensus        89 Fe~m~G~dl~~eIV~R-~~ySEa~aSH-----~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAR-EFYSEADASH-----CIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             EecccchHHHHHHHHH-HHHHHHHHHH-----HHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEE
Confidence            9999999998776554 3345555544     9999999999999999999999999999976443 4589999999999


Q ss_pred             eCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHH
Q psy12427        263 LDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEE  342 (356)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  342 (356)
                      +.........+|||.|||||+++..+|+..+|||+.|||||-|+.|++||.+.+...++++|..+.+.++.+.|..++++
T Consensus       163 l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~  242 (355)
T KOG0033|consen  163 VNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPE  242 (355)
T ss_pred             eCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHH
Confidence            98666666778999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhhhcCCC
Q psy12427        343 GKDFIRRLLLRNKE  356 (356)
Q Consensus       343 ~~~lI~~ll~~dP~  356 (356)
                      +++||++||..||.
T Consensus       243 Ak~LvrrML~~dP~  256 (355)
T KOG0033|consen  243 AKSLIRRMLTVNPK  256 (355)
T ss_pred             HHHHHHHHhccChh
Confidence            99999999999994

>KOG0583|consensus

Probab=100.00  E-value=8.8e-50  Score=370.06  Aligned_cols=240  Identities=30%  Similarity=0.577  Sum_probs=214.7

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccC----Ch-hhHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCe
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS----HN-LEKELIRKEIDIMNQLH-HPKLINLHDAFEDDDE  179 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~----~~-~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~  179 (356)
                      ..+.|.+.+.||+|+||.|++|.+..++..||+|++...    .. .....+.+|+.+++.++ ||||+++++++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            456899999999999999999999999999999977653    12 23456678999999998 9999999999999999


Q ss_pred             EEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeec
Q psy12427        180 MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGL  259 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~  259 (356)
                      +++||||+.||+|++++.. ..++.+..+     +.+++|+++|++|||++||+||||||+|||++.+. +.+||+|||+
T Consensus        95 ~~ivmEy~~gGdL~~~i~~-~g~l~E~~a-----r~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~-~~~Kl~DFG~  167 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN-KGRLKEDEA-----RKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNE-GNLKLSDFGL  167 (370)
T ss_pred             EEEEEEecCCccHHHHHHH-cCCCChHHH-----HHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCC-CCEEEecccc
Confidence            9999999999999999987 556666554     44999999999999999999999999999998763 4799999999


Q ss_pred             eeee-CCCCceeecCCCcCccccccccCCC-CC-ccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhh
Q psy12427        260 ATKL-DPNEVVKISTGTAEFAAPEIVEREP-VG-FYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAF  336 (356)
Q Consensus       260 a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  336 (356)
                      +... .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||.+.+...++..|..+.+.+|.   
T Consensus       168 s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~---  244 (370)
T KOG0583|consen  168 SAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPS---  244 (370)
T ss_pred             ccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCC---
Confidence            9988 4667778899999999999999987 75 7899999999999999999999999999999999999999886   


Q ss_pred             ccC-CHHHHHHHHHhhhcCCC
Q psy12427        337 KNV-SEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       337 ~~~-s~~~~~lI~~ll~~dP~  356 (356)
                       .+ |.++++||++||+.||.
T Consensus       245 -~~~S~~~~~Li~~mL~~~P~  264 (370)
T KOG0583|consen  245 -YLLSPEARSLIEKMLVPDPS  264 (370)
T ss_pred             -CcCCHHHHHHHHHHcCCCcc
Confidence             45 99999999999999994

>KOG0032|consensus

Probab=100.00  E-value=2.7e-49  Score=366.76  Aligned_cols=246  Identities=39%  Similarity=0.721  Sum_probs=225.4

Q ss_pred             CCcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh---hHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCe
Q psy12427        104 SSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL---EKELIRKEIDIMNQLH-HPKLINLHDAFEDDDE  179 (356)
Q Consensus       104 ~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~---~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~  179 (356)
                      ..+.+.|++.+.||+|.||.||+|+.+.+|+.+|+|++......   ..+.+.+|+.||+++. ||||+.++++|+....
T Consensus        31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~  110 (382)
T KOG0032|consen   31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS  110 (382)
T ss_pred             ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence            34556899999999999999999999999999999999766443   4568999999999998 9999999999999999


Q ss_pred             EEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCC--CcEEEEee
Q psy12427        180 MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNS--TNVKMIDF  257 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~--~~vkl~Df  257 (356)
                      +++|||++.||.|++.+...  .     ++......+++|++.|++|||+.||+||||||+|+|+.....  +.+|++||
T Consensus       111 ~~lvmEL~~GGeLfd~i~~~--~-----~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DF  183 (382)
T KOG0032|consen  111 VYLVMELCEGGELFDRIVKK--H-----YSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDF  183 (382)
T ss_pred             EEEEEEecCCchHHHHHHHc--c-----CCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeC
Confidence            99999999999999999865  1     444445559999999999999999999999999999986643  47999999


Q ss_pred             eceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhc
Q psy12427        258 GLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK  337 (356)
Q Consensus       258 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  337 (356)
                      |++............+||+.|+|||++...+|+..+||||+|+++|.|++|.+||.+.+..+...+|..+.+.|+.+.|.
T Consensus       184 Gla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~  263 (382)
T KOG0032|consen  184 GLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWD  263 (382)
T ss_pred             CCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCcc
Confidence            99999988677788899999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCHHHHHHHHHhhhcCCC
Q psy12427        338 NVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       338 ~~s~~~~~lI~~ll~~dP~  356 (356)
                      ++|+.+++||+.||..||.
T Consensus       264 ~is~~akd~i~~ll~~dp~  282 (382)
T KOG0032|consen  264 DISESAKDFIRKLLEFDPR  282 (382)
T ss_pred             ccCHHHHHHHHHhcccCcc
Confidence            9999999999999999984

>KOG0694|consensus

Probab=100.00  E-value=1.4e-49  Score=373.64  Aligned_cols=237  Identities=28%  Similarity=0.501  Sum_probs=211.8

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l  182 (356)
                      .++|.++++||+|+||+|+++..+.++..+|||++++..   ..+.+....|..|+... +||.+++++.+|+...++++
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f  446 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF  446 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence            468999999999999999999999999999999998765   33456677899998888 49999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ||||+.||++..+....       .++...++.|+..++.||+|||++||||||||.+|||+|.+|  ++||+|||+|+.
T Consensus       447 vmey~~Ggdm~~~~~~~-------~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eG--h~kiADFGlcKe  517 (694)
T KOG0694|consen  447 VMEYVAGGDLMHHIHTD-------VFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEG--HVKIADFGLCKE  517 (694)
T ss_pred             EEEecCCCcEEEEEecc-------cccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccC--cEEecccccccc
Confidence            99999999965554433       233344455999999999999999999999999999998766  899999999987


Q ss_pred             eC-CCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCH
Q psy12427        263 LD-PNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSE  341 (356)
Q Consensus       263 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  341 (356)
                      .- ....+.+.+|||.|||||++....|+.+.|.|||||+|||||.|..||.+++++|+...|......+|.    .+|.
T Consensus       518 ~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~----~ls~  593 (694)
T KOG0694|consen  518 GMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSK  593 (694)
T ss_pred             cCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC----cccH
Confidence            54 556778889999999999999999999999999999999999999999999999999999998877764    8999


Q ss_pred             HHHHHHHHhhhcCCC
Q psy12427        342 EGKDFIRRLLLRNKE  356 (356)
Q Consensus       342 ~~~~lI~~ll~~dP~  356 (356)
                      |+.+++++||.+||+
T Consensus       594 ea~~il~~ll~k~p~  608 (694)
T KOG0694|consen  594 EAIAIMRRLLRKNPE  608 (694)
T ss_pred             HHHHHHHHHhccCcc
Confidence            999999999999996

>KOG0600|consensus

Probab=100.00  E-value=7.1e-50  Score=363.28  Aligned_cols=242  Identities=25%  Similarity=0.446  Sum_probs=207.0

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh--hHHHHHHHHHHHHhcCCCCceeeeeeEEeC--CeEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL--EKELIRKEIDIMNQLHHPKLINLHDAFEDD--DEMVL  182 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~l  182 (356)
                      .+.|+.+++||+|.||.||+|++..+|+.||+|.+......  -.....+|+.||++|+||||++|.+.....  +.+||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            46799999999999999999999999999999999887633  234456899999999999999999988766  78999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      |+|||++ +|.-++....-.++     ..+++.|++||+.||+|||++||+|||||..|||||.++  .+||+|||+|+.
T Consensus       196 VFeYMdh-DL~GLl~~p~vkft-----~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G--~LKiaDFGLAr~  267 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSSPGVKFT-----EPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNG--VLKIADFGLARF  267 (560)
T ss_pred             EEecccc-hhhhhhcCCCcccC-----hHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCC--CEEeccccceee
Confidence            9999976 78777765444444     445567999999999999999999999999999998655  799999999998


Q ss_pred             eCCCC--ceeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhh---
Q psy12427        263 LDPNE--VVKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAF---  336 (356)
Q Consensus       263 ~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~---  336 (356)
                      +....  ..+..+-|..|.|||.+.+. .|+.+.|+||.||||.||+.|++.|+|.++.+.++.|.+....+.+.+|   
T Consensus       268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~  347 (560)
T KOG0600|consen  268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS  347 (560)
T ss_pred             ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence            86544  33445679999999999875 6999999999999999999999999999999999999776555444444   


Q ss_pred             ----------------------ccCCHHHHHHHHHhhhcCCC
Q psy12427        337 ----------------------KNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       337 ----------------------~~~s~~~~~lI~~ll~~dP~  356 (356)
                                            +.+|..+.+|+..||..||.
T Consensus       348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~  389 (560)
T KOG0600|consen  348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPD  389 (560)
T ss_pred             cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCcc
Confidence                                  44689999999999999995

>KOG0588|consensus

Probab=100.00  E-value=8.6e-50  Score=372.72  Aligned_cols=238  Identities=32%  Similarity=0.587  Sum_probs=218.3

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      .+-|++.+.||.|+.|.|-+|++..||+.+|||++....   ......+.+|+-||+.+.|||+++++++|++..++|+|
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv   90 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV   90 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence            345899999999999999999999999999999997652   33456788999999999999999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      +||++||.|++++...+ .+.+.+...     +++||+.|+.|||..+|+||||||+|+|+|.+++  +||+|||+|..-
T Consensus        91 lEyv~gGELFdylv~kG-~l~e~eaa~-----ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n--IKIADFGMAsLe  162 (786)
T KOG0588|consen   91 LEYVPGGELFDYLVRKG-PLPEREAAH-----FFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN--IKIADFGMASLE  162 (786)
T ss_pred             EEecCCchhHHHHHhhC-CCCCHHHHH-----HHHHHHHHHHHHhhhcceeccCCchhhhhhcccC--Eeeeccceeecc
Confidence            99999999999997655 455555544     9999999999999999999999999999998774  999999999988


Q ss_pred             CCCCceeecCCCcCccccccccCCCC-CccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHH
Q psy12427        264 DPNEVVKISTGTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEE  342 (356)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  342 (356)
                      .++....+.||+|.|.|||++.+.+| +.++||||+|||||.||+|+.||.+++....+.++..+.+..|    .++|.+
T Consensus       163 ~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP----s~Is~e  238 (786)
T KOG0588|consen  163 VPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP----SNISSE  238 (786)
T ss_pred             cCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC----CcCCHH
Confidence            88888999999999999999999998 5899999999999999999999999999999999999999888    499999


Q ss_pred             HHHHHHHhhhcCCC
Q psy12427        343 GKDFIRRLLLRNKE  356 (356)
Q Consensus       343 ~~~lI~~ll~~dP~  356 (356)
                      +++||++||.+||+
T Consensus       239 aQdLLr~ml~VDp~  252 (786)
T KOG0588|consen  239 AQDLLRRMLDVDPS  252 (786)
T ss_pred             HHHHHHHHhccCcc
Confidence            99999999999996

>KOG0593|consensus

Probab=100.00  E-value=4e-50  Score=343.98  Aligned_cols=241  Identities=28%  Similarity=0.477  Sum_probs=202.8

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh--hHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL--EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      +.|+.+.++|+|+||.|++|+++.||+.||+|.+..+.+.  -+.-..+|+.+|++|+|||+|.|+++|...+.+++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            4688899999999999999999999999999998765432  23445689999999999999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC-
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-  264 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~-  264 (356)
                      ||+.. +.+.+.....     .+....++.++.|++.|+.|+|++++|||||||+|||++.++  .+||||||+|+.+. 
T Consensus        82 ~~dhT-vL~eLe~~p~-----G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~g--vvKLCDFGFAR~L~~  153 (396)
T KOG0593|consen   82 YCDHT-VLHELERYPN-----GVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNG--VVKLCDFGFARTLSA  153 (396)
T ss_pred             ecchH-HHHHHHhccC-----CCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCC--cEEeccchhhHhhcC
Confidence            99774 4444443222     233445667999999999999999999999999999998665  79999999999987 


Q ss_pred             CCCceeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc-------------
Q psy12427        265 PNEVVKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWE-------------  330 (356)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~-------------  330 (356)
                      +++..+..+.|.+|+|||.+.+ .+|+...||||+||++.||++|.+.|+|.++.+.+..|......             
T Consensus       154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~  233 (396)
T KOG0593|consen  154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP  233 (396)
T ss_pred             CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence            6666677789999999999987 68999999999999999999999999999999988776543222             


Q ss_pred             --------------cChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        331 --------------FDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       331 --------------~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                    +.+..+.+++.-+.||++.||+.||.
T Consensus       234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~  273 (396)
T KOG0593|consen  234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPD  273 (396)
T ss_pred             ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCcc
Confidence                          11233456788999999999999994

>KOG0192|consensus

Probab=100.00  E-value=6.2e-49  Score=361.38  Aligned_cols=239  Identities=23%  Similarity=0.396  Sum_probs=201.1

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCE-EEEEEcccCChh--hHHHHHHHHHHHHhcCCCCceeeeeeEEeCC-eEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNI-FAAKFIPVSHNL--EKELIRKEIDIMNQLHHPKLINLHDAFEDDD-EMVLI  183 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~-~a~K~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-~~~lv  183 (356)
                      +...+.+.||.|+||+||++.++  |.. ||+|++......  ....|.+|+.+|.+++|||||+++|++..+. ..++|
T Consensus        41 ~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iV  118 (362)
T KOG0192|consen   41 DELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIV  118 (362)
T ss_pred             HHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEE
Confidence            45667778999999999999998  555 999999765422  2568999999999999999999999999887 79999


Q ss_pred             EEeccccchhhhhhCC-CCCCCccccccccHHHHHHHHHHHHHHHHHCC-ceeccCCCCCEEEeecCCCcEEEEeeecee
Q psy12427        184 FEFLSGGELFERITAP-DYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN-IIHLDVKPENIMCQTRNSTNVKMIDFGLAT  261 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~  261 (356)
                      ||||++|+|.+++... ...++...     +..++.||++||.|||+++ ||||||||+|||++.+. .++||+|||+++
T Consensus       119 tEy~~~GsL~~~l~~~~~~~l~~~~-----~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~-~~~KI~DFGlsr  192 (362)
T KOG0192|consen  119 TEYMPGGSLSVLLHKKRKRKLPLKV-----RLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG-KTLKIADFGLSR  192 (362)
T ss_pred             EEeCCCCcHHHHHhhcccCCCCHHH-----HHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC-CEEEECCCccce
Confidence            9999999999999863 33344333     4459999999999999999 99999999999998654 379999999999


Q ss_pred             eeCCCC-ceeecCCCcCcccccccc--CCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhcc
Q psy12427        262 KLDPNE-VVKISTGTAEFAAPEIVE--REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKN  338 (356)
Q Consensus       262 ~~~~~~-~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  338 (356)
                      ...... ......||+.|||||++.  ...++.++||||||++||||+||+.||.+.........+......++  ....
T Consensus       193 ~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~--~p~~  270 (362)
T KOG0192|consen  193 EKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP--IPKE  270 (362)
T ss_pred             eeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC--CCcc
Confidence            876542 233357999999999999  66999999999999999999999999999998777777765554433  2235


Q ss_pred             CCHHHHHHHHHhhhcCCC
Q psy12427        339 VSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       339 ~s~~~~~lI~~ll~~dP~  356 (356)
                      +++.+..+|.+||+.||+
T Consensus       271 ~~~~l~~l~~~CW~~dp~  288 (362)
T KOG0192|consen  271 CPPHLSSLMERCWLVDPS  288 (362)
T ss_pred             CCHHHHHHHHHhCCCCCC
Confidence            999999999999999995

>KOG0197|consensus

Probab=100.00  E-value=2.3e-49  Score=364.19  Aligned_cols=237  Identities=23%  Similarity=0.372  Sum_probs=203.0

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEec
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFL  187 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~  187 (356)
                      +.+++++.||+|.||+||.|.++. ...||+|.++... ...+.|.+|+++|++|+|+|||+++++|..+..++||||||
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m  283 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM  283 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence            456778999999999999999984 2478999987653 34577889999999999999999999999999999999999


Q ss_pred             cccchhhhhhC-CCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        188 SGGELFERITA-PDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       188 ~~g~L~~~l~~-~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +.|+|.++|.. ....+..     ..+..++.|||+||+||+++++|||||.++||||+.+.  .+||+|||+|+....+
T Consensus       284 ~~GsLl~yLr~~~~~~l~~-----~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~--~vKIsDFGLAr~~~d~  356 (468)
T KOG0197|consen  284 PKGSLLDYLRTREGGLLNL-----PQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDL--VVKISDFGLARLIGDD  356 (468)
T ss_pred             ccCcHHHHhhhcCCCccch-----HHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCc--eEEEcccccccccCCC
Confidence            99999999986 2223333     34455999999999999999999999999999998655  7999999999955443


Q ss_pred             CceeecC--CCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHH
Q psy12427        267 EVVKIST--GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG  343 (356)
Q Consensus       267 ~~~~~~~--gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  343 (356)
                      .......  -+..|.|||++....++.+||||||||+||||+| |+.||.+++..+.++.+.++---+.|   ..+|+++
T Consensus       357 ~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P---~~CP~~v  433 (468)
T KOG0197|consen  357 EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRP---EGCPDEV  433 (468)
T ss_pred             ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCC---CCCCHHH
Confidence            3322222  3788999999999999999999999999999999 99999999999999999886544433   4899999


Q ss_pred             HHHHHHhhhcCCC
Q psy12427        344 KDFIRRLLLRNKE  356 (356)
Q Consensus       344 ~~lI~~ll~~dP~  356 (356)
                      =++++.||..+|+
T Consensus       434 Y~lM~~CW~~~P~  446 (468)
T KOG0197|consen  434 YELMKSCWHEDPE  446 (468)
T ss_pred             HHHHHHHhhCCcc
Confidence            9999999999996

>KOG0610|consensus

Probab=100.00  E-value=2.6e-48  Score=345.60  Aligned_cols=242  Identities=29%  Similarity=0.497  Sum_probs=211.9

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhH---HHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK---ELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      .++|++++.||.|.-|+||+|+.+.++..+|+|++.......+   ..+..|.+||..++||.++.||+.|+.+...|++
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence            4689999999999999999999999999999999987654433   3455699999999999999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      ||||+||+|..+++..    +...+....++.++.+++.||+|||-+|||+|||||+||||..++  +|.|+||.++...
T Consensus       156 meyCpGGdL~~LrqkQ----p~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredG--HIMLsDFDLS~~~  229 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQ----PGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDG--HIMLSDFDLSLRC  229 (459)
T ss_pred             EecCCCccHHHHHhhC----CCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCC--cEEeeeccccccC
Confidence            9999999999888744    345566667788999999999999999999999999999998665  8999999987543


Q ss_pred             CC---------------------------------C-C-----------------------ceeecCCCcCccccccccC
Q psy12427        264 DP---------------------------------N-E-----------------------VVKISTGTAEFAAPEIVER  286 (356)
Q Consensus       264 ~~---------------------------------~-~-----------------------~~~~~~gt~~y~aPE~~~~  286 (356)
                      ..                                 . .                       .....+||-.|+|||++.+
T Consensus       230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G  309 (459)
T KOG0610|consen  230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG  309 (459)
T ss_pred             CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence            10                                 0 0                       0011248899999999999


Q ss_pred             CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        287 EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       287 ~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ...+.++|.|+|||++|||+.|..||.|.+..+++.+|......||...  .+|..++|||++||.+||+
T Consensus       310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~  377 (459)
T KOG0610|consen  310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPS  377 (459)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChh
Confidence            9999999999999999999999999999999999999999998888754  8899999999999999995

>KOG0580|consensus

Probab=100.00  E-value=3.4e-49  Score=328.16  Aligned_cols=238  Identities=32%  Similarity=0.574  Sum_probs=214.5

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      .++|.+.+.||+|.||.||+|+.++++..+|+|++-.+.   .....++++|++|-+.|+||||++++++|.+...+|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            467999999999999999999999999999999986543   22246788999999999999999999999999999999


Q ss_pred             EEeccccchhhhhhCCCC-CCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        184 FEFLSGGELFERITAPDY-KMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      +||..+|+|+..|..... ++.+.....     ++.|++.||.|+|.++|+||||||+|+|++.++  .+||+|||-+..
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~-----Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~--~lkiAdfGwsV~  173 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAAT-----YIKQLANALLYCHLKRVIHRDIKPENLLLGSAG--ELKIADFGWSVH  173 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhH-----HHHHHHHHHHHhccCCcccCCCCHHHhccCCCC--CeeccCCCceee
Confidence            999999999999985433 355555444     999999999999999999999999999998766  699999999876


Q ss_pred             eCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHH
Q psy12427        263 LDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEE  342 (356)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  342 (356)
                      -+ .+...+.+||..|.|||...+..++...|+|++|+++||++.|.+||...+..++++.|.+....+|.    .+|.+
T Consensus       174 ~p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~----~is~~  248 (281)
T KOG0580|consen  174 AP-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPS----TISGG  248 (281)
T ss_pred             cC-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCc----ccChh
Confidence            54 56677889999999999999999999999999999999999999999999999999999999998884    89999


Q ss_pred             HHHHHHHhhhcCCC
Q psy12427        343 GKDFIRRLLLRNKE  356 (356)
Q Consensus       343 ~~~lI~~ll~~dP~  356 (356)
                      ++|+|.+||.++|.
T Consensus       249 a~dlI~~ll~~~p~  262 (281)
T KOG0580|consen  249 AADLISRLLVKNPI  262 (281)
T ss_pred             HHHHHHHHhccCcc
Confidence            99999999999984

>KOG0597|consensus

Probab=100.00  E-value=3e-49  Score=362.88  Aligned_cols=236  Identities=30%  Similarity=0.543  Sum_probs=209.9

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh--hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN--LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      ++|.+.+.||+|.||.||+|+.+.+.+.||+|++.+...  .+...+++|++|++.++||||+.++++|+...++++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            468899999999999999999999999999999977654  345678999999999999999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |+.| +|+.++.... .+++..+     +.++.+++.||.|||+.+|+|||+||.|||+...  +.+|+||||+|+.+..
T Consensus        82 ~a~g-~L~~il~~d~-~lpEe~v-----~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~--~~~KlcdFg~Ar~m~~  152 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDG-KLPEEQV-----RAIAYDLVSALYYLHSNRILHRDMKPQNILLEKG--GTLKLCDFGLARAMST  152 (808)
T ss_pred             hhhh-hHHHHHHhcc-CCCHHHH-----HHHHHHHHHHHHHHHhcCcccccCCcceeeecCC--Cceeechhhhhhhccc
Confidence            9976 9999997543 4555554     4499999999999999999999999999999754  4799999999999877


Q ss_pred             CCceeec-CCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHH
Q psy12427        266 NEVVKIS-TGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK  344 (356)
Q Consensus       266 ~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  344 (356)
                      +....+. .|||.|||||...+++|+..+|+||+|||+||+++|++||...+..+..+.|......+|.    ..|.+..
T Consensus       153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~----~~S~~f~  228 (808)
T KOG0597|consen  153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS----TASSSFV  228 (808)
T ss_pred             CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc----cccHHHH
Confidence            6655444 5999999999999999999999999999999999999999999888888888876665554    8899999


Q ss_pred             HHHHHhhhcCCC
Q psy12427        345 DFIRRLLLRNKE  356 (356)
Q Consensus       345 ~lI~~ll~~dP~  356 (356)
                      +|++.+|++||.
T Consensus       229 nfl~gLL~kdP~  240 (808)
T KOG0597|consen  229 NFLQGLLIKDPA  240 (808)
T ss_pred             HHHHHHhhcChh
Confidence            999999999993

>KOG0578|consensus

Probab=100.00  E-value=2.9e-48  Score=357.95  Aligned_cols=240  Identities=30%  Similarity=0.529  Sum_probs=212.3

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      ...|...++||+|+.|.||.++...+++.||+|.+.......++.+.+|+.+|+..+|+|||++++.|...+.+++||||
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            45688899999999999999999999999999999998888889999999999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      |+||+|.+.+....  +++.+     +..++++++.||+|||.+||+|||||.+|||+..++  .+||+|||+|..+...
T Consensus       352 m~ggsLTDvVt~~~--~~E~q-----IA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g--~vKltDFGFcaqi~~~  422 (550)
T KOG0578|consen  352 MEGGSLTDVVTKTR--MTEGQ-----IAAICREILQGLKFLHARGIIHRDIKSDNILLTMDG--SVKLTDFGFCAQISEE  422 (550)
T ss_pred             cCCCchhhhhhccc--ccHHH-----HHHHHHHHHHHHHHHHhcceeeeccccceeEeccCC--cEEEeeeeeeeccccc
Confidence            99999999887543  44444     455999999999999999999999999999998766  5999999999988765


Q ss_pred             C-ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHH
Q psy12427        267 E-VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD  345 (356)
Q Consensus       267 ~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  345 (356)
                      . ...+.+|||+|||||++....|+++.||||||++++||+-|++||-..++-..+..|.. +..+.-..+..+|.+++|
T Consensus       423 ~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-ng~P~lk~~~klS~~~kd  501 (550)
T KOG0578|consen  423 QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPKLKNPEKLSPELKD  501 (550)
T ss_pred             cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-cCCCCcCCccccCHHHHH
Confidence            5 45667899999999999999999999999999999999999999998877766666644 333333344579999999


Q ss_pred             HHHHhhhcCCC
Q psy12427        346 FIRRLLLRNKE  356 (356)
Q Consensus       346 lI~~ll~~dP~  356 (356)
                      |+.+||+.||+
T Consensus       502 FL~~cL~~dv~  512 (550)
T KOG0578|consen  502 FLDRCLVVDVE  512 (550)
T ss_pred             HHHHHhhcchh
Confidence            99999999985

>KOG0585|consensus

Probab=100.00  E-value=7.9e-48  Score=347.40  Aligned_cols=242  Identities=31%  Similarity=0.593  Sum_probs=204.7

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh--------------hhHHHHHHHHHHHHhcCCCCceee
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN--------------LEKELIRKEIDIMNQLHHPKLINL  170 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~--------------~~~~~~~~E~~il~~l~hpnIv~l  170 (356)
                      ...++|++++.||+|.||.|-+|++..+++.||+|++.....              ...+.+++|+.||++++|||||+|
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            456789999999999999999999999999999999965321              123678899999999999999999


Q ss_pred             eeeEEe--CCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecC
Q psy12427        171 HDAFED--DDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN  248 (356)
Q Consensus       171 ~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~  248 (356)
                      +++..+  ...+|||+|||..|.+...-.      ....+...+.+.|+++++.||+|||.+|||||||||.|+|++.++
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p~------d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCPP------DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCCC------CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC
Confidence            999875  478999999999887743211      111255666777999999999999999999999999999998764


Q ss_pred             CCcEEEEeeeceeeeCC------CCceeecCCCcCccccccccCCC----CCccccHHHHHHHHHHHHcCCCCCCCCChH
Q psy12427        249 STNVKMIDFGLATKLDP------NEVVKISTGTAEFAAPEIVEREP----VGFYTDMWAVGVLAYVLLSGLSPFAGENDV  318 (356)
Q Consensus       249 ~~~vkl~Dfg~a~~~~~------~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlG~il~ell~g~~Pf~~~~~~  318 (356)
                        +|||+|||.+.....      .......+|||.|+|||.+..+.    .+.+.||||+||+||.|+.|+.||.++...
T Consensus       248 --~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~  325 (576)
T KOG0585|consen  248 --TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL  325 (576)
T ss_pred             --cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence              899999999987622      22233357999999999997632    357889999999999999999999999999


Q ss_pred             HHHHHhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        319 ETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       319 ~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ++..+|......||..  +.+.++++|+|++||.+||+
T Consensus       326 ~l~~KIvn~pL~fP~~--pe~~e~~kDli~~lL~KdP~  361 (576)
T KOG0585|consen  326 ELFDKIVNDPLEFPEN--PEINEDLKDLIKRLLEKDPE  361 (576)
T ss_pred             HHHHHHhcCcccCCCc--ccccHHHHHHHHHHhhcChh
Confidence            9999999988888763  37899999999999999996

>KOG0599|consensus

Probab=100.00  E-value=4e-49  Score=333.54  Aligned_cols=243  Identities=35%  Similarity=0.619  Sum_probs=216.3

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh-----h---hHHHHHHHHHHHHhc-CCCCceeeeeeEEe
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN-----L---EKELIRKEIDIMNQL-HHPKLINLHDAFED  176 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~-----~---~~~~~~~E~~il~~l-~hpnIv~l~~~~~~  176 (356)
                      +++.|.-.+.||+|..+.|-++.++.+|..+|+|++.....     .   -.+.-++|+.||+++ .||+|+.++++|+.
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            44567778899999999999999999999999999864321     1   123445799999998 69999999999999


Q ss_pred             CCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEe
Q psy12427        177 DDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMID  256 (356)
Q Consensus       177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~D  256 (356)
                      +.-+++|+|.|+.|.|+++++..- .+++..     .+.+++|+++|+.|||.++||||||||+|||++.+-  ++||+|
T Consensus        95 ~sF~FlVFdl~prGELFDyLts~V-tlSEK~-----tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~--~i~isD  166 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLTSKV-TLSEKE-----TRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNM--NIKISD  166 (411)
T ss_pred             cchhhhhhhhcccchHHHHhhhhe-eecHHH-----HHHHHHHHHHHHHHHHHhhhhhcccChhheeecccc--ceEEec
Confidence            999999999999999999997543 344444     455999999999999999999999999999998544  799999


Q ss_pred             eeceeeeCCCCceeecCCCcCcccccccc------CCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc
Q psy12427        257 FGLATKLDPNEVVKISTGTAEFAAPEIVE------REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWE  330 (356)
Q Consensus       257 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~  330 (356)
                      ||+|+.+.+.+.....||||+|+|||.+.      ...|+...|+|++|||||-|+.|.+||....+.-++..|..++++
T Consensus       167 FGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyq  246 (411)
T KOG0599|consen  167 FGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQ  246 (411)
T ss_pred             cceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccc
Confidence            99999999998888899999999999985      346788899999999999999999999999999999999999999


Q ss_pred             cChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        331 FDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       331 ~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      |..+.|.++|.+++|||++||++||+
T Consensus       247 F~speWadis~~~KdLIsrlLqVdp~  272 (411)
T KOG0599|consen  247 FRSPEWADISATVKDLISRLLQVDPT  272 (411)
T ss_pred             cCCcchhhccccHHHHHHHHHeeCch
Confidence            99999999999999999999999995

>KOG0661|consensus

Probab=100.00  E-value=5.4e-49  Score=355.19  Aligned_cols=244  Identities=27%  Similarity=0.483  Sum_probs=209.5

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh-hHHHHHHHHHHHHhcC-CCCceeeeeeEEeCC-eEE
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL-EKELIRKEIDIMNQLH-HPKLINLHDAFEDDD-EMV  181 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~-~~~  181 (356)
                      .+-++|.++++||.|.||.||+|..+.+|..||+|.++..... +.-.-.+|+..|++|. ||||++|.+++.+.. .++
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            3457899999999999999999999999999999999765432 1222347999999998 999999999998777 999


Q ss_pred             EEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeecee
Q psy12427        182 LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT  261 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~  261 (356)
                      +|||||+ .+|++++.+++..+++..+     +.|+.||++||+|+|.+|+.|||+||+||||..+.  .+||+|||+||
T Consensus        87 fVfE~Md-~NLYqLmK~R~r~fse~~i-----rnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~--~iKiaDFGLAR  158 (538)
T KOG0661|consen   87 FVFEFMD-CNLYQLMKDRNRLFSESDI-----RNIMYQILQGLAHIHKHGFFHRDLKPENILISGND--VIKIADFGLAR  158 (538)
T ss_pred             eeHHhhh-hhHHHHHhhcCCcCCHHHH-----HHHHHHHHHHHHHHHhcCcccccCChhheEecccc--eeEeccccccc
Confidence            9999994 6999999987666665554     55999999999999999999999999999997433  69999999999


Q ss_pred             eeCCCCceeecCCCcCcccccccc-CCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc----------
Q psy12427        262 KLDPNEVVKISTGTAEFAAPEIVE-REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWE----------  330 (356)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~----------  330 (356)
                      ........+..+.|.+|+|||++. ...|+.+.|||++|||++|+.+-++.|.|.++.+.+.+|+...+.          
T Consensus       159 ev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~  238 (538)
T KOG0661|consen  159 EVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY  238 (538)
T ss_pred             ccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence            998888888889999999999885 567899999999999999999999999999999998888654332          


Q ss_pred             ---------cC-------hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        331 ---------FD-------EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       331 ---------~~-------~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                               +|       .....+.+.++.++|.+||..||.
T Consensus       239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~  280 (538)
T KOG0661|consen  239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPD  280 (538)
T ss_pred             HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCc
Confidence                     22       233345799999999999999995

>KOG0611|consensus

Probab=100.00  E-value=1.8e-48  Score=345.46  Aligned_cols=238  Identities=33%  Similarity=0.604  Sum_probs=215.9

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      +.-+|++.+.||+|.||.|-+|.....|+.||+|.++.+.   ..+.-.+++|++||..|+||||+.++++|++.+.++|
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi  130 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI  130 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence            4457999999999999999999999999999999997654   3344567899999999999999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ||||..+|.|++++..+. .+++.+.     +.+++||.+|+.|+|.++++|||||.+|||+|.++  .+||+|||++..
T Consensus       131 vMEYaS~GeLYDYiSer~-~LsErEa-----RhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~--NiKIADFGLSNl  202 (668)
T KOG0611|consen  131 VMEYASGGELYDYISERG-SLSEREA-----RHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNN--NIKIADFGLSNL  202 (668)
T ss_pred             EEEecCCccHHHHHHHhc-cccHHHH-----HHHHHHHHHHHHHHhhccceecccchhheeecCCC--Ceeeeccchhhh
Confidence            999999999999998654 4555444     55999999999999999999999999999998766  699999999999


Q ss_pred             eCCCCceeecCCCcCccccccccCCCC-CccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCH
Q psy12427        263 LDPNEVVKISTGTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSE  341 (356)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  341 (356)
                      +...+...+.||+|-|.+||++.+.+| ++..|-||||++||-|+.|..||+|.+...++.+|..+.+.-|     .-+.
T Consensus       203 y~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP-----~~PS  277 (668)
T KOG0611|consen  203 YADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREP-----ETPS  277 (668)
T ss_pred             hccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCC-----CCCc
Confidence            988888899999999999999999998 5789999999999999999999999999999999999988765     3467


Q ss_pred             HHHHHHHHhhhcCCC
Q psy12427        342 EGKDFIRRLLLRNKE  356 (356)
Q Consensus       342 ~~~~lI~~ll~~dP~  356 (356)
                      ++.-||+.||.+||+
T Consensus       278 dA~gLIRwmLmVNP~  292 (668)
T KOG0611|consen  278 DASGLIRWMLMVNPE  292 (668)
T ss_pred             hHHHHHHHHHhcCcc
Confidence            899999999999996

>KOG0198|consensus

Probab=100.00  E-value=8.7e-48  Score=343.92  Aligned_cols=240  Identities=28%  Similarity=0.487  Sum_probs=197.6

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCC--eEEEEEEe
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDD--EMVLIFEF  186 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--~~~lv~e~  186 (356)
                      ++...+.||+|+||.||++.+.++|...|+|.+...+....+.+.+|+.+|.+++|||||+++|......  .++++|||
T Consensus        18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy   97 (313)
T KOG0198|consen   18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY   97 (313)
T ss_pred             hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence            5788899999999999999999999999999988765444677889999999999999999999754433  69999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC-
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP-  265 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~-  265 (356)
                      +++|+|.+++......+++..     ++.+.+||++||+|||++|||||||||+|||++.. ++.+||+|||++..... 
T Consensus        98 ~~~GsL~~~~~~~g~~l~E~~-----v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~-~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen   98 APGGSLSDLIKRYGGKLPEPL-----VRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPS-NGDVKLADFGLAKKLESK  171 (313)
T ss_pred             cCCCcHHHHHHHcCCCCCHHH-----HHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCC-CCeEEeccCccccccccc
Confidence            999999999986543444444     45599999999999999999999999999999873 24799999999987763 


Q ss_pred             ---CCceeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCC-CChHHHHHHhhccccccChhhhccCC
Q psy12427        266 ---NEVVKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAG-ENDVETLKNVKACDWEFDEEAFKNVS  340 (356)
Q Consensus       266 ---~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s  340 (356)
                         ........||+.|||||++.++ ..+.++|||||||++.||+||..||.. ....+.+..+-....  .++.+..+|
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~--~P~ip~~ls  249 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDS--LPEIPDSLS  249 (313)
T ss_pred             cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCC--CCCCCcccC
Confidence               1222345799999999999963 344599999999999999999999988 455554555544331  124556899


Q ss_pred             HHHHHHHHHhhhcCCC
Q psy12427        341 EEGKDFIRRLLLRNKE  356 (356)
Q Consensus       341 ~~~~~lI~~ll~~dP~  356 (356)
                      .++++||.+||++||+
T Consensus       250 ~~a~~Fl~~C~~~~p~  265 (313)
T KOG0198|consen  250 DEAKDFLRKCFKRDPE  265 (313)
T ss_pred             HHHHHHHHHHhhcCcc
Confidence            9999999999999995

>KOG0659|consensus

Probab=100.00  E-value=2.7e-47  Score=321.31  Aligned_cols=241  Identities=29%  Similarity=0.482  Sum_probs=204.5

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhh--HHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE--KELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~--~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      ++|..+++||+|.||.||+|++..+|+.||+|.++.....+  .....+|+..|+.++||||+.++++|-..+.+.+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            46889999999999999999999999999999998765432  2445689999999999999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      ||+ .+|..++.+..-.++..     .++.|+.++++||+|||++.|+||||||.|+|++.++  .+||+|||+|+.+.+
T Consensus        82 fm~-tdLe~vIkd~~i~l~pa-----~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g--~lKiADFGLAr~f~~  153 (318)
T KOG0659|consen   82 FMP-TDLEVVIKDKNIILSPA-----DIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDG--QLKIADFGLARFFGS  153 (318)
T ss_pred             ecc-ccHHHHhcccccccCHH-----HHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCC--cEEeecccchhccCC
Confidence            996 48988887765544444     4566999999999999999999999999999998766  799999999999864


Q ss_pred             CCc-eeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChh---------
Q psy12427        266 NEV-VKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEE---------  334 (356)
Q Consensus       266 ~~~-~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~---------  334 (356)
                      ... ....+.|..|.|||.+.+ ..|+...||||.|||+.||+-|.+-|.|.++-+++..|-.....+.++         
T Consensus       154 p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp  233 (318)
T KOG0659|consen  154 PNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP  233 (318)
T ss_pred             CCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence            433 344478999999998865 569999999999999999999999999999999988876543333222         


Q ss_pred             ---------------hhccCCHHHHHHHHHhhhcCCC
Q psy12427        335 ---------------AFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       335 ---------------~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                     .+...|+++.||+.+||..||.
T Consensus       234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~  270 (318)
T KOG0659|consen  234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPK  270 (318)
T ss_pred             cHHHHhcCCCCccccccccccHHHHHHHHhhhccCch
Confidence                           3445688999999999999983

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-46  Score=341.59  Aligned_cols=235  Identities=29%  Similarity=0.541  Sum_probs=203.7

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      ++|++.+.||+|+||.||+|.++.+++.+|+|++....   ......+.+|+.+++.++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36899999999999999999999999999999986543   223456788999999999999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      ||+.+|+|.+++.... .+++     ..+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||++....
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~-----~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~--~~kl~Dfg~~~~~~  152 (291)
T cd05612          81 EYVPGGELFSYLRNSG-RFSN-----STGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEG--HIKLTDFGFAKKLR  152 (291)
T ss_pred             eCCCCCCHHHHHHHcC-CCCH-----HHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC--CEEEEecCcchhcc
Confidence            9999999999986543 2333     33445899999999999999999999999999997554  79999999998764


Q ss_pred             CCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHH
Q psy12427        265 PNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK  344 (356)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  344 (356)
                      ..  .....|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+..+.+......++.    .++.+++
T Consensus       153 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~  226 (291)
T cd05612         153 DR--TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR----HLDLYAK  226 (291)
T ss_pred             CC--cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCc----cCCHHHH
Confidence            32  23356899999999999999999999999999999999999999999998989988887766653    6799999


Q ss_pred             HHHHHhhhcCCC
Q psy12427        345 DFIRRLLLRNKE  356 (356)
Q Consensus       345 ~lI~~ll~~dP~  356 (356)
                      +||++||+.||+
T Consensus       227 ~li~~~l~~dp~  238 (291)
T cd05612         227 DLIKKLLVVDRT  238 (291)
T ss_pred             HHHHHHcCCCHH
Confidence            999999999984

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3e-46  Score=345.54  Aligned_cols=236  Identities=27%  Similarity=0.536  Sum_probs=205.2

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      .++|++.+.||+|+||.||+|+++.+++.+|+|++....   ......+.+|+.+|++++||||+++++++..++..++|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            467999999999999999999999999999999986542   22345678899999999999999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      |||+.+|+|.+++.... .++     ...+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||++...
T Consensus        97 ~e~~~~~~L~~~l~~~~-~~~-----~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~--~~kl~Dfg~~~~~  168 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAG-RFP-----NDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKG--HVKVTDFGFAKKV  168 (329)
T ss_pred             EcCCCCChHHHHHHHcC-CCC-----HHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCC--CEEEeeccCceEc
Confidence            99999999999886532 223     233455889999999999999999999999999998654  7999999999876


Q ss_pred             CCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHH
Q psy12427        264 DPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG  343 (356)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  343 (356)
                      ....  ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+......+|.    .++.++
T Consensus       169 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~  242 (329)
T PTZ00263        169 PDRT--FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN----WFDGRA  242 (329)
T ss_pred             CCCc--ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCC----CCCHHH
Confidence            5432  3357899999999999999999999999999999999999999999988888888887765553    689999


Q ss_pred             HHHHHHhhhcCCC
Q psy12427        344 KDFIRRLLLRNKE  356 (356)
Q Consensus       344 ~~lI~~ll~~dP~  356 (356)
                      ++||++||+.||+
T Consensus       243 ~~li~~~L~~dP~  255 (329)
T PTZ00263        243 RDLVKGLLQTDHT  255 (329)
T ss_pred             HHHHHHHhhcCHH
Confidence            9999999999995

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=7e-46  Score=336.26  Aligned_cols=241  Identities=26%  Similarity=0.452  Sum_probs=196.0

Q ss_pred             eeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh---hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN---LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       110 y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      |++.+.||+|+||+||+|.++.+|+.||+|.+.....   .....+.+|+.+|++++|+||+++++++...+..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            7788999999999999999999999999999865432   2234567899999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +++|+|.+.+.....    ..+....+..++.|++.||+|||++||+||||||+|||++.++  .++|+|||++......
T Consensus        82 ~~~g~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~--~~kl~Dfg~~~~~~~~  155 (285)
T cd05631          82 MNGGDLKFHIYNMGN----PGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRG--HIRISDLGLAVQIPEG  155 (285)
T ss_pred             cCCCcHHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC--CEEEeeCCCcEEcCCC
Confidence            999999887754321    1233344556899999999999999999999999999997554  7999999999876544


Q ss_pred             CceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHH
Q psy12427        267 EVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDF  346 (356)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  346 (356)
                      .......|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+..............+|.++++|
T Consensus       156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  235 (285)
T cd05631         156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSI  235 (285)
T ss_pred             CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHH
Confidence            44445578999999999999999999999999999999999999998775433222222211112223345789999999


Q ss_pred             HHHhhhcCCC
Q psy12427        347 IRRLLLRNKE  356 (356)
Q Consensus       347 I~~ll~~dP~  356 (356)
                      |++||+.||+
T Consensus       236 i~~~l~~~P~  245 (285)
T cd05631         236 CRMLLTKNPK  245 (285)
T ss_pred             HHHHhhcCHH
Confidence            9999999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0201|consensus

Probab=100.00  E-value=2.5e-47  Score=341.72  Aligned_cols=237  Identities=26%  Similarity=0.429  Sum_probs=209.3

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh-hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEec
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN-LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFL  187 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~  187 (356)
                      .|+.++.||+|.||.||+|.+..+++.||+|++..... .+.+++.+|+.+|.+++++||.++|+.+..+..++++||||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~   93 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC   93 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence            57788999999999999999999999999999987654 45688999999999999999999999999999999999999


Q ss_pred             cccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCC
Q psy12427        188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE  267 (356)
Q Consensus       188 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~  267 (356)
                      .||++.+.+..... +.+..+..     ++++++.||.|||.++.+|||||+.|||+..++  .+||+|||.+..+....
T Consensus        94 ~gGsv~~lL~~~~~-~~E~~i~~-----ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g--~vkl~DfgVa~ql~~~~  165 (467)
T KOG0201|consen   94 GGGSVLDLLKSGNI-LDEFEIAV-----ILREVLKGLDYLHSEKKIHRDIKAANILLSESG--DVKLADFGVAGQLTNTV  165 (467)
T ss_pred             cCcchhhhhccCCC-Cccceeee-----ehHHHHHHhhhhhhcceecccccccceeEeccC--cEEEEecceeeeeechh
Confidence            99999999976543 34555444     899999999999999999999999999998764  79999999998886544


Q ss_pred             ce-eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHH
Q psy12427        268 VV-KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDF  346 (356)
Q Consensus       268 ~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  346 (356)
                      .. .+.+|||.|||||++....|+.++||||||++.+||++|.+||....++..+..|-+..   ||.+-.++|+.+++|
T Consensus       166 ~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~---PP~L~~~~S~~~kEF  242 (467)
T KOG0201|consen  166 KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSA---PPRLDGDFSPPFKEF  242 (467)
T ss_pred             hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCC---CCccccccCHHHHHH
Confidence            33 66789999999999998899999999999999999999999999999977777776544   333334899999999


Q ss_pred             HHHhhhcCCC
Q psy12427        347 IRRLLLRNKE  356 (356)
Q Consensus       347 I~~ll~~dP~  356 (356)
                      |..||++||+
T Consensus       243 V~~CL~k~P~  252 (467)
T KOG0201|consen  243 VEACLDKNPE  252 (467)
T ss_pred             HHHHhhcCcc
Confidence            9999999996

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=6.3e-46  Score=342.55  Aligned_cols=231  Identities=27%  Similarity=0.471  Sum_probs=197.7

Q ss_pred             ccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEecccc
Q psy12427        114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGG  190 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g  190 (356)
                      +.||+|+||.||+|.++.+|+.||+|+++...   ......+.+|+.+|+.++||||+++++++......++||||+.+|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999987542   223355678999999999999999999999999999999999999


Q ss_pred             chhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC-CCce
Q psy12427        191 ELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP-NEVV  269 (356)
Q Consensus       191 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~-~~~~  269 (356)
                      +|.+++.... .+++     ..+..++.||+.||+|||+.||+||||||+|||++.++  .+||+|||+++.... ....
T Consensus        81 ~L~~~l~~~~-~~~~-----~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~--~~kl~DfG~a~~~~~~~~~~  152 (323)
T cd05571          81 ELFFHLSRER-VFSE-----DRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDG--HIKITDFGLCKEGISDGATM  152 (323)
T ss_pred             cHHHHHHHcC-CCCH-----HHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC--CEEEeeCCCCcccccCCCcc
Confidence            9998886432 2333     34455899999999999999999999999999997654  799999999876422 2223


Q ss_pred             eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHHH
Q psy12427        270 KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRR  349 (356)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~  349 (356)
                      ....||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+......++    ..++.++++||++
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~  228 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLAG  228 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHH
Confidence            345699999999999999999999999999999999999999999888888888877766655    3789999999999


Q ss_pred             hhhcCCC
Q psy12427        350 LLLRNKE  356 (356)
Q Consensus       350 ll~~dP~  356 (356)
                      ||+.||+
T Consensus       229 ~L~~dP~  235 (323)
T cd05571         229 LLKKDPK  235 (323)
T ss_pred             HccCCHH
Confidence            9999995

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0582|consensus

Probab=100.00  E-value=2e-45  Score=329.86  Aligned_cols=244  Identities=26%  Similarity=0.434  Sum_probs=208.3

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh-hHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL-EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      .++|++.++||.|..++||+|+...++..||||++..+.-. +.+.+++|+..|+.++||||++++.+|..++.+++||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            46899999999999999999999999999999999766533 35889999999999999999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      ||.+|++.+++...-   . ..+.+..+..++++++.||.|||++|.||||||+.|||++.++  .|||+|||.+..+-.
T Consensus       105 fMa~GS~ldIik~~~---~-~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG--~VkLadFgvsa~l~~  178 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYY---P-DGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDG--TVKLADFGVSASLFD  178 (516)
T ss_pred             hhcCCcHHHHHHHHc---c-ccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCC--cEEEcCceeeeeecc
Confidence            999999999997532   1 1245556677999999999999999999999999999998766  799999998776532


Q ss_pred             CCc----e-eecCCCcCccccccccC--CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc------cC
Q psy12427        266 NEV----V-KISTGTAEFAAPEIVER--EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWE------FD  332 (356)
Q Consensus       266 ~~~----~-~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~------~~  332 (356)
                      ...    . .+.+||++|||||++..  ..|+.++||||||++..||.+|..||....+.+++..-..+..+      ++
T Consensus       179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~  258 (516)
T KOG0582|consen  179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLD  258 (516)
T ss_pred             cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCC
Confidence            211    1 45579999999999754  46899999999999999999999999999988887666555543      34


Q ss_pred             hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 ~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+..+.++...+.+|..||++||+
T Consensus       259 ~d~~k~~~ksf~e~i~~CL~kDP~  282 (516)
T KOG0582|consen  259 KDEDKKFSKSFREMIALCLVKDPS  282 (516)
T ss_pred             hHHhhhhcHHHHHHHHHHhhcCcc
Confidence            555566889999999999999995

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1e-45  Score=343.17  Aligned_cols=237  Identities=26%  Similarity=0.442  Sum_probs=203.7

Q ss_pred             cccceeeeccccccCceEEEEEEEccCC-CEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTG-NIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMV  181 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~-~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  181 (356)
                      ..++|++.+.||+|+||.||+|.++.++ ..+|+|.+....   ......+.+|+.+++.++||||+++++++...+..+
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~  107 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY  107 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence            3467999999999999999999987665 689999886432   233456778999999999999999999999999999


Q ss_pred             EEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeecee
Q psy12427        182 LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT  261 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~  261 (356)
                      +||||+.+|+|.+++.... .++     ...+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||++.
T Consensus       108 lv~Ey~~~g~L~~~i~~~~-~~~-----~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~--~ikL~DFG~a~  179 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLRRNK-RFP-----NDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDG--FIKMTDFGFAK  179 (340)
T ss_pred             EEEeCCCCCcHHHHHHHcC-CCC-----HHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC--CEEEecCCCCe
Confidence            9999999999999986543 233     334455999999999999999999999999999997544  79999999998


Q ss_pred             eeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCH
Q psy12427        262 KLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSE  341 (356)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  341 (356)
                      .....  .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.....+.+......+|.    .+++
T Consensus       180 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~  253 (340)
T PTZ00426        180 VVDTR--TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK----FLDN  253 (340)
T ss_pred             ecCCC--cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCH
Confidence            76432  23457999999999999988999999999999999999999999999988888988887766653    6899


Q ss_pred             HHHHHHHHhhhcCCC
Q psy12427        342 EGKDFIRRLLLRNKE  356 (356)
Q Consensus       342 ~~~~lI~~ll~~dP~  356 (356)
                      +++++|++||+.||+
T Consensus       254 ~~~~li~~~l~~dp~  268 (340)
T PTZ00426        254 NCKHLMKKLLSHDLT  268 (340)
T ss_pred             HHHHHHHHHcccCHH
Confidence            999999999999985

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.3e-45  Score=345.90  Aligned_cols=235  Identities=30%  Similarity=0.551  Sum_probs=197.5

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      ++|++.+.||+|+||+||+|.++.+++.||+|++....   ......+.+|+.++..++||||+++++.+.....+++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            36899999999999999999999999999999987543   223356778999999999999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      ||++||+|.+++.... .++     ...+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||++....
T Consensus        81 E~~~gg~L~~~l~~~~-~l~-----~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~--~vkL~DFGla~~~~  152 (363)
T cd05628          81 EFLPGGDMMTLLMKKD-TLT-----EEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKG--HVKLSDFGLCTGLK  152 (363)
T ss_pred             cCCCCCcHHHHHHhcC-CCC-----HHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC--CEEEeeccCccccc
Confidence            9999999999986532 233     334455999999999999999999999999999997654  79999999987543


Q ss_pred             CCC------------------------------------ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcC
Q psy12427        265 PNE------------------------------------VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSG  308 (356)
Q Consensus       265 ~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g  308 (356)
                      ...                                    .....+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G  232 (363)
T cd05628         153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG  232 (363)
T ss_pred             ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhC
Confidence            211                                    01234699999999999999999999999999999999999


Q ss_pred             CCCCCCCChHHHHHHhhccc--cccChhhhccCCHHHHHHHHHhhh
Q psy12427        309 LSPFAGENDVETLKNVKACD--WEFDEEAFKNVSEEGKDFIRRLLL  352 (356)
Q Consensus       309 ~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~s~~~~~lI~~ll~  352 (356)
                      ..||.+.+..+.+.++....  ..+|+.  ..+|+++++||.+|+.
T Consensus       233 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~--~~~s~~~~~li~~l~~  276 (363)
T cd05628         233 YPPFCSETPQETYKKVMNWKETLIFPPE--VPISEKAKDLILRFCC  276 (363)
T ss_pred             CCCCCCCCHHHHHHHHHcCcCcccCCCc--CCCCHHHHHHHHHHcC
Confidence            99999999988888887633  334432  3589999999999765

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.2e-45  Score=338.92  Aligned_cols=231  Identities=26%  Similarity=0.472  Sum_probs=197.1

Q ss_pred             ccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEecccc
Q psy12427        114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGG  190 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g  190 (356)
                      +.||+|+||.||+++++.+|..||+|+++...   ......+.+|+.+++.++||||+++++++.....+++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999999999999999987542   223455678999999999999999999999999999999999999


Q ss_pred             chhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC-CCce
Q psy12427        191 ELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP-NEVV  269 (356)
Q Consensus       191 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~-~~~~  269 (356)
                      +|..++.... .+     ....+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||++..... ....
T Consensus        81 ~L~~~l~~~~-~~-----~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~Dfg~~~~~~~~~~~~  152 (323)
T cd05595          81 ELFFHLSRER-VF-----TEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGATM  152 (323)
T ss_pred             cHHHHHHHcC-CC-----CHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCC--CEEecccHHhccccCCCCcc
Confidence            9988876432 23     3344455899999999999999999999999999997654  799999999875422 2222


Q ss_pred             eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHHH
Q psy12427        270 KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRR  349 (356)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~  349 (356)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+......++.    .+++++++||++
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~----~~~~~~~~li~~  228 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAG  228 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHH
Confidence            3456899999999999999999999999999999999999999999888888888777666553    789999999999


Q ss_pred             hhhcCCC
Q psy12427        350 LLLRNKE  356 (356)
Q Consensus       350 ll~~dP~  356 (356)
                      ||++||+
T Consensus       229 ~L~~dP~  235 (323)
T cd05595         229 LLKKDPK  235 (323)
T ss_pred             HccCCHH
Confidence            9999984

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-45  Score=345.91  Aligned_cols=240  Identities=29%  Similarity=0.534  Sum_probs=199.8

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      ++|++.+.||.|+||+||+|+++.+++.||+|++....   ......+.+|+.+|..++||||+++++++..+..+++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            36899999999999999999999999999999997542   223456778999999999999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      ||+.||+|.+++.... .     +....+..++.|++.||+|||++||+||||||+|||++.++  .++|+|||++..+.
T Consensus        81 E~~~~g~L~~~l~~~~-~-----l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~--~~kl~Dfg~~~~~~  152 (364)
T cd05599          81 EYLPGGDMMTLLMKKD-T-----FTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKG--HIKLSDFGLCTGLK  152 (364)
T ss_pred             CCCCCcHHHHHHHHcC-C-----CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC--CEEEeecccceecc
Confidence            9999999999986533 2     33344556999999999999999999999999999997655  79999999987643


Q ss_pred             CCC---------------------------------------ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHH
Q psy12427        265 PNE---------------------------------------VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVL  305 (356)
Q Consensus       265 ~~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~el  305 (356)
                      ...                                       .....+||+.|+|||++....++.++|||||||++|+|
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el  232 (364)
T cd05599         153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM  232 (364)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHh
Confidence            211                                       01123589999999999999999999999999999999


Q ss_pred             HcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        306 LSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       306 l~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ++|..||.+.+..+.+..+......+..+....+|+++++||++||. ||+
T Consensus       233 ~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~  282 (364)
T cd05599         233 LVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAE  282 (364)
T ss_pred             hcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHh
Confidence            99999999999888888776644332222223689999999999996 663

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG4717|consensus

Probab=100.00  E-value=6.4e-46  Score=337.66  Aligned_cols=244  Identities=29%  Similarity=0.539  Sum_probs=221.0

Q ss_pred             CCCcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh--hHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeE
Q psy12427        103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL--EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM  180 (356)
Q Consensus       103 ~~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  180 (356)
                      .+.+.+-|.+.+.||+|.|+.|-+|++.-||..||+|++......  ....+.+|+..|+.++|||||+||++......+
T Consensus        13 DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKl   92 (864)
T KOG4717|consen   13 DGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKL   92 (864)
T ss_pred             ccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceE
Confidence            344556799999999999999999999999999999999776543  345677899999999999999999999999999


Q ss_pred             EEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeece
Q psy12427        181 VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA  260 (356)
Q Consensus       181 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a  260 (356)
                      |+|+|.=++|+|+++|..+...+.+.-     .+.|+.||+.|+.|+|+..+|||||||+||.+...- +.|||.|||++
T Consensus        93 yLiLELGD~GDl~DyImKHe~Gl~E~L-----a~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKl-GlVKLTDFGFS  166 (864)
T KOG4717|consen   93 YLILELGDGGDLFDYIMKHEEGLNEDL-----AKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKL-GLVKLTDFGFS  166 (864)
T ss_pred             EEEEEecCCchHHHHHHhhhccccHHH-----HHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeec-CceEeeecccc
Confidence            999999999999999987655555444     455999999999999999999999999999987654 57999999999


Q ss_pred             eeeCCCCceeecCCCcCccccccccCCCCC-ccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccC
Q psy12427        261 TKLDPNEVVKISTGTAEFAAPEIVEREPVG-FYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNV  339 (356)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  339 (356)
                      ..+.+.....+.+|+..|.|||++.+..|+ ++.||||||||||-|++|++||+..++.|++-.|..+.+..|.    .+
T Consensus       167 Nkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPs----hv  242 (864)
T KOG4717|consen  167 NKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPS----HV  242 (864)
T ss_pred             ccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCch----hh
Confidence            999999999999999999999999999886 6889999999999999999999999999999999999999885    89


Q ss_pred             CHHHHHHHHHhhhcCCC
Q psy12427        340 SEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       340 s~~~~~lI~~ll~~dP~  356 (356)
                      |.+++|||..||+.||.
T Consensus       243 S~eCrdLI~sMLvRdPk  259 (864)
T KOG4717|consen  243 SKECRDLIQSMLVRDPK  259 (864)
T ss_pred             hHHHHHHHHHHHhcCch
Confidence            99999999999999994

>KOG0604|consensus

Probab=100.00  E-value=1.6e-46  Score=321.36  Aligned_cols=245  Identities=31%  Similarity=0.553  Sum_probs=210.5

Q ss_pred             CCCCcccceeee-ccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhc-CCCCceeeeeeEE----
Q psy12427        102 KTSSVYDHYDIL-EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL-HHPKLINLHDAFE----  175 (356)
Q Consensus       102 ~~~~~~~~y~~~-~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~----  175 (356)
                      +...+.++|++. ++||-|-.|.|-.|.++.||..+|+|++..+     ...++|++.--.. .|||||.++++|+    
T Consensus        55 k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~  129 (400)
T KOG0604|consen   55 KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQ  129 (400)
T ss_pred             hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence            344566778774 6899999999999999999999999987533     3445777765544 6999999999886    


Q ss_pred             eCCeEEEEEEeccccchhhhhhCCCC-CCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecC-CCcEE
Q psy12427        176 DDDEMVLIFEFLSGGELFERITAPDY-KMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN-STNVK  253 (356)
Q Consensus       176 ~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~-~~~vk  253 (356)
                      ...++.+|||.|+||.|+.++.++.. .+++.++     ..|++||+.|+.|||+.+|.||||||+|+|+..+. +..+|
T Consensus       130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea-----~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lK  204 (400)
T KOG0604|consen  130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREA-----SEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLK  204 (400)
T ss_pred             CceeeEeeeecccchHHHHHHHHcccccchHHHH-----HHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceE
Confidence            45788999999999999999986543 3455554     45999999999999999999999999999997543 34679


Q ss_pred             EEeeeceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC----hHHHHHHhhcccc
Q psy12427        254 MIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN----DVETLKNVKACDW  329 (356)
Q Consensus       254 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~----~~~~~~~i~~~~~  329 (356)
                      |+|||+|..........+.+-||.|.|||++..+.|+...|+||+||+||-|++|.+||....    ...+-.+|..+.+
T Consensus       205 LtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy  284 (400)
T KOG0604|consen  205 LTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQY  284 (400)
T ss_pred             ecccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCc
Confidence            999999998776667777889999999999999999999999999999999999999998775    3456788999999


Q ss_pred             ccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        330 EFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       330 ~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .||.+-|..+|++++|+|+.||..||+
T Consensus       285 ~FP~pEWs~VSe~aKdlIR~LLkt~Pt  311 (400)
T KOG0604|consen  285 EFPEPEWSCVSEAAKDLIRKLLKTEPT  311 (400)
T ss_pred             cCCChhHhHHHHHHHHHHHHHhcCCch
Confidence            999999999999999999999999995

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-45  Score=346.30  Aligned_cols=239  Identities=30%  Similarity=0.507  Sum_probs=195.7

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      ++|++.+.||.|+||+||+|.++.+++.||+|++....   ......+.+|++++++++||||+++++++......++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            36899999999999999999999999999999986532   223456778999999999999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      ||++||+|.+++.... .++     ...++.++.|++.||+|||++||+||||||+|||++.++  .+||+|||+++.+.
T Consensus        81 E~~~gg~L~~~l~~~~-~~~-----~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~--~~kl~DfGla~~~~  152 (377)
T cd05629          81 EFLPGGDLMTMLIKYD-TFS-----EDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGG--HIKLSDFGLSTGFH  152 (377)
T ss_pred             eCCCCCcHHHHHHhcC-CCC-----HHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC--CEEEeecccccccc
Confidence            9999999999886432 233     334455899999999999999999999999999997654  79999999986432


Q ss_pred             CCCc------------------------------------------------eeecCCCcCccccccccCCCCCccccHH
Q psy12427        265 PNEV------------------------------------------------VKISTGTAEFAAPEIVEREPVGFYTDMW  296 (356)
Q Consensus       265 ~~~~------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~sDvw  296 (356)
                      ....                                                ....+||+.|+|||++.+..++.++|||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw  232 (377)
T cd05629         153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW  232 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeE
Confidence            1000                                                0023589999999999999999999999


Q ss_pred             HHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHHHhhhcCC
Q psy12427        297 AVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNK  355 (356)
Q Consensus       297 SlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP  355 (356)
                      ||||++|||++|..||.+.+..+.+..+......+.-+....+|.++++||++||+ +|
T Consensus       233 SlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~  290 (377)
T cd05629         233 SLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NA  290 (377)
T ss_pred             ecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CH
Confidence            99999999999999999988888877776532222211223689999999999997 54

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-45  Score=339.61  Aligned_cols=239  Identities=28%  Similarity=0.504  Sum_probs=200.3

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      ++|++.+.||+|+||.||+|+++.++..||+|+++...   ......+.+|+.++..++||||+++++++......++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36999999999999999999999999999999987542   223456778999999999999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      ||++||+|.+++.... .+.     ...+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||++....
T Consensus        81 e~~~g~~L~~~l~~~~-~l~-----~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~kL~Dfg~a~~~~  152 (333)
T cd05600          81 EYVPGGDFRTLLNNLG-VLS-----EDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASG--HIKLTDFGLSKGIV  152 (333)
T ss_pred             eCCCCCCHHHHHHHcC-CCC-----HHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC--CEEEEeCcCCcccc
Confidence            9999999999986432 233     334455899999999999999999999999999997654  79999999997654


Q ss_pred             CCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhh----ccCC
Q psy12427        265 PNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAF----KNVS  340 (356)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~----~~~s  340 (356)
                      .  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+......+..+..    ..+|
T Consensus       153 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s  230 (333)
T cd05600         153 T--YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLS  230 (333)
T ss_pred             c--ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccC
Confidence            3  233456899999999999999999999999999999999999999999888887777553322221111    2679


Q ss_pred             HHHHHHHHHhhhcCCC
Q psy12427        341 EEGKDFIRRLLLRNKE  356 (356)
Q Consensus       341 ~~~~~lI~~ll~~dP~  356 (356)
                      +++.+||++||+.+|+
T Consensus       231 ~~~~~li~~~l~~~~~  246 (333)
T cd05600         231 DEAWDLITKLINDPSR  246 (333)
T ss_pred             HHHHHHHHHHhhChhh
Confidence            9999999999987763

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0663|consensus

Probab=100.00  E-value=9.7e-46  Score=320.89  Aligned_cols=242  Identities=25%  Similarity=0.433  Sum_probs=199.0

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhH--HHHHHHHHHHHhcCCCCceeeeeeEE--eCCeEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK--ELIRKEIDIMNQLHHPKLINLHDAFE--DDDEMVL  182 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~--~~~~~E~~il~~l~hpnIv~l~~~~~--~~~~~~l  182 (356)
                      .+.|+.+..|++|.||.||+|+++.|+..||+|.++...+.+-  -.-.+|+.+|.+++|||||.+-.+..  +-+.+|+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            4679999999999999999999999999999999987654321  23357999999999999999998875  4467999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      |||||+. +|..++..-..++     ....++.++.|+++|++|||...|+||||||+|+|++..+  .+||+|||+|+.
T Consensus       155 VMe~~Eh-DLksl~d~m~q~F-----~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G--~lKiaDFGLAR~  226 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMKQPF-----LPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKG--ILKIADFGLARE  226 (419)
T ss_pred             eHHHHHh-hHHHHHHhccCCC-----chHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCC--cEEecccchhhh
Confidence            9999976 7888887554333     3444566999999999999999999999999999997655  799999999999


Q ss_pred             eCCC-CceeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhh----
Q psy12427        263 LDPN-EVVKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAF----  336 (356)
Q Consensus       263 ~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~----  336 (356)
                      +... ...+..+-|..|.|||.+.+. .|+++.|+||+|||+.||+++++.|.|.+..+.+.+|......+.+..|    
T Consensus       227 ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~  306 (419)
T KOG0663|consen  227 YGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS  306 (419)
T ss_pred             hcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence            8643 334455679999999999765 5999999999999999999999999999999999887543222211111    


Q ss_pred             ----------------------c--cCCHHHHHHHHHhhhcCCC
Q psy12427        337 ----------------------K--NVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       337 ----------------------~--~~s~~~~~lI~~ll~~dP~  356 (356)
                                            .  .+|+...+|++.+|..||+
T Consensus       307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~  350 (419)
T KOG0663|consen  307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPG  350 (419)
T ss_pred             ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCcc
Confidence                                  1  1568999999999999995

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=4.5e-45  Score=337.49  Aligned_cols=231  Identities=26%  Similarity=0.483  Sum_probs=196.7

Q ss_pred             ccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEecccc
Q psy12427        114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGG  190 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g  190 (356)
                      +.||+|+||.||++.++.+++.||+|++....   ......+.+|+.+|+.++||||+++++++......++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            36999999999999999999999999987542   233456778999999999999999999999999999999999999


Q ss_pred             chhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC-CCce
Q psy12427        191 ELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP-NEVV  269 (356)
Q Consensus       191 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~-~~~~  269 (356)
                      +|..++.... .+.     ...+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||++..... ....
T Consensus        81 ~L~~~l~~~~-~l~-----~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~--~~kL~DfG~~~~~~~~~~~~  152 (328)
T cd05593          81 ELFFHLSRER-VFS-----EDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDG--HIKITDFGLCKEGITDAATM  152 (328)
T ss_pred             CHHHHHHhcC-CCC-----HHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCC--cEEEecCcCCccCCCccccc
Confidence            9988876432 233     334455899999999999999999999999999997654  799999999876432 2222


Q ss_pred             eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHHH
Q psy12427        270 KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRR  349 (356)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~  349 (356)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+......+|    ..++.++.+||++
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~  228 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFP----RTLSADAKSLLSG  228 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCC----CCCCHHHHHHHHH
Confidence            345689999999999999999999999999999999999999999888888888777666555    3789999999999


Q ss_pred             hhhcCCC
Q psy12427        350 LLLRNKE  356 (356)
Q Consensus       350 ll~~dP~  356 (356)
                      ||++||+
T Consensus       229 ~L~~dP~  235 (328)
T cd05593         229 LLIKDPN  235 (328)
T ss_pred             HcCCCHH
Confidence            9999985

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-45  Score=335.51  Aligned_cols=229  Identities=29%  Similarity=0.497  Sum_probs=196.4

Q ss_pred             ccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEeccccch
Q psy12427        116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGEL  192 (356)
Q Consensus       116 lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L  192 (356)
                      ||+|+||.||+|+++.+++.||+|++....   ......+.+|+.+|.+++||||+++++++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999999999999999986432   23345677899999999999999999999999999999999999999


Q ss_pred             hhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC-CCceee
Q psy12427        193 FERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP-NEVVKI  271 (356)
Q Consensus       193 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~-~~~~~~  271 (356)
                      .+++.... .+     ....+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||+++.... ......
T Consensus        81 ~~~l~~~~-~~-----~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~--~~kl~Dfg~~~~~~~~~~~~~~  152 (312)
T cd05585          81 FHHLQREG-RF-----DLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQG--HIALCDFGLCKLNMKDDDKTNT  152 (312)
T ss_pred             HHHHHhcC-CC-----CHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCC--cEEEEECcccccCccCCCcccc
Confidence            99886432 23     3334455899999999999999999999999999997654  799999999875432 222334


Q ss_pred             cCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHHHhh
Q psy12427        272 STGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLL  351 (356)
Q Consensus       272 ~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll  351 (356)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+......++    ..+++++++||.+||
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L  228 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP----DGFDRDAKDLLIGLL  228 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHc
Confidence            5689999999999999999999999999999999999999999988888888877665555    378999999999999


Q ss_pred             hcCCC
Q psy12427        352 LRNKE  356 (356)
Q Consensus       352 ~~dP~  356 (356)
                      +.||+
T Consensus       229 ~~dp~  233 (312)
T cd05585         229 SRDPT  233 (312)
T ss_pred             CCCHH
Confidence            99995

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.1e-45  Score=345.61  Aligned_cols=239  Identities=25%  Similarity=0.438  Sum_probs=197.7

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      .|+++++||+|+||+||+|+++.+++.+|+|++....   ......+.+|+.++++++||||+++++++.....+++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5889999999999999999999999999999986543   2234567889999999999999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |+++|+|.+++.... .     +....++.++.||+.||+|||++||+||||||+|||++.++  .+||+|||++..+..
T Consensus        82 ~~~gg~L~~~l~~~~-~-----~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g--~~kL~DFGla~~~~~  153 (382)
T cd05625          82 YIPGGDMMSLLIRMG-I-----FPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDG--HIKLTDFGLCTGFRW  153 (382)
T ss_pred             CCCCCcHHHHHHhcC-C-----CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC--CEEEeECCCCccccc
Confidence            999999999886532 2     23334556899999999999999999999999999998654  799999999753310


Q ss_pred             C------------------------------------------------CceeecCCCcCccccccccCCCCCccccHHH
Q psy12427        266 N------------------------------------------------EVVKISTGTAEFAAPEIVEREPVGFYTDMWA  297 (356)
Q Consensus       266 ~------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS  297 (356)
                      .                                                ......+||+.|+|||++.+..++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS  233 (382)
T cd05625         154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS  233 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEe
Confidence            0                                                0011236899999999999999999999999


Q ss_pred             HHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        298 VGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       298 lG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      |||++|||++|+.||.+.+..+....+.........+....+|++++++|.+|+. ||+
T Consensus       234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~  291 (382)
T cd05625         234 VGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCR-GPE  291 (382)
T ss_pred             chHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHcc-CHh
Confidence            9999999999999999998888777776544333333345789999999999874 664

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.1e-44  Score=334.32  Aligned_cols=236  Identities=27%  Similarity=0.498  Sum_probs=200.9

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCC-CceeeeeeEEeCCeEEEEE
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHP-KLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hp-nIv~l~~~~~~~~~~~lv~  184 (356)
                      +|++.+.||+|+||.||+|.++.+++.||+|++....   ....+.+..|+.++..++|+ +|+++++++.....+++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4889999999999999999999999999999987532   23345677899999999765 5888999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      ||+++|+|.+++.... .+.+     ..+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||++....
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~-----~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~--~~kL~Dfg~~~~~~  152 (324)
T cd05587          81 EYVNGGDLMYHIQQVG-KFKE-----PHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEG--HIKIADFGMCKENI  152 (324)
T ss_pred             cCCCCCcHHHHHHHcC-CCCH-----HHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCC--CEEEeecCcceecC
Confidence            9999999998886432 2333     34455899999999999999999999999999998654  79999999987542


Q ss_pred             -CCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHH
Q psy12427        265 -PNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG  343 (356)
Q Consensus       265 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  343 (356)
                       .........||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+.+..+......++    ..++.++
T Consensus       153 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~  228 (324)
T cd05587         153 FGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEA  228 (324)
T ss_pred             CCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHH
Confidence             22333455799999999999999999999999999999999999999999999999998888766555    3789999


Q ss_pred             HHHHHHhhhcCCC
Q psy12427        344 KDFIRRLLLRNKE  356 (356)
Q Consensus       344 ~~lI~~ll~~dP~  356 (356)
                      +++|++||++||+
T Consensus       229 ~~li~~~l~~~P~  241 (324)
T cd05587         229 VSICKGLLTKHPA  241 (324)
T ss_pred             HHHHHHHhhcCHH
Confidence            9999999999985

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0589|consensus

Probab=100.00  E-value=5.3e-46  Score=340.72  Aligned_cols=240  Identities=26%  Similarity=0.483  Sum_probs=215.0

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCe-EEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDE-MVLIF  184 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-~~lv~  184 (356)
                      ++|..++.+|+|+||.++.++++.+++.+++|.+....  ...++...+|+.++++++|||||.+.+.|..++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            57999999999999999999999999999999987665  3445677899999999999999999999998888 99999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      +|++||+|.+.+...+    ...+....+..|+.|++.|+.|||+++|+|||||+.||++..++  .|||+|||+|+.+.
T Consensus        84 ~Y~eGg~l~~~i~~~k----~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~--~VkLgDfGlaK~l~  157 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK----GVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDK--KVKLGDFGLAKILN  157 (426)
T ss_pred             eecCCCCHHHHHHHHh----hccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccC--ceeecchhhhhhcC
Confidence            9999999999998665    22333444556999999999999999999999999999998766  68999999999998


Q ss_pred             CCC-ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHH
Q psy12427        265 PNE-VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG  343 (356)
Q Consensus       265 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  343 (356)
                      +.. ...+.+||+.|+.||.+.+.+|..++|||||||++|||++-+++|.+.+......+|....+.+.+   ..+|.++
T Consensus       158 ~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp---~~ys~el  234 (426)
T KOG0589|consen  158 PEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP---SMYSSEL  234 (426)
T ss_pred             CchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC---ccccHHH
Confidence            766 667778999999999999999999999999999999999999999999999999999998855444   4789999


Q ss_pred             HHHHHHhhhcCCC
Q psy12427        344 KDFIRRLLLRNKE  356 (356)
Q Consensus       344 ~~lI~~ll~~dP~  356 (356)
                      +.+|+.||+++|+
T Consensus       235 ~~lv~~~l~~~P~  247 (426)
T KOG0589|consen  235 RSLVKSMLRKNPE  247 (426)
T ss_pred             HHHHHHHhhcCCc
Confidence            9999999999996

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=8.5e-45  Score=329.67  Aligned_cols=241  Identities=25%  Similarity=0.426  Sum_probs=195.9

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh-hHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL-EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      ++|++.++||.|+||.||+|.++.++..||+|.++..... ....+.+|+.++++++||||+++++++......++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            5699999999999999999999999999999998754322 234667899999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +.+ +|.+++......++.     ..+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+++.....
T Consensus        85 ~~~-~l~~~l~~~~~~~~~-----~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~--~~kl~DfG~~~~~~~~  156 (288)
T cd07871          85 LDS-DLKQYLDNCGNLMSM-----HNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKG--ELKLADFGLARAKSVP  156 (288)
T ss_pred             CCc-CHHHHHHhcCCCCCH-----HHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC--CEEECcCcceeeccCC
Confidence            975 888887654332332     34455899999999999999999999999999997654  7999999999765422


Q ss_pred             C-ceeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhh---------
Q psy12427        267 E-VVKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEA---------  335 (356)
Q Consensus       267 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~---------  335 (356)
                      . ......+++.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+..+.+..+......++++.         
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07871         157 TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE  236 (288)
T ss_pred             CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence            2 2233467999999999865 5689999999999999999999999999888777766544322221111         


Q ss_pred             -----------------hccCCHHHHHHHHHhhhcCCC
Q psy12427        336 -----------------FKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       336 -----------------~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                       ...++.++++||++||+.||+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~  274 (288)
T cd07871         237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETK  274 (288)
T ss_pred             hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcc
Confidence                             124688999999999999995

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=9.8e-45  Score=334.59  Aligned_cols=236  Identities=26%  Similarity=0.487  Sum_probs=200.8

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEEEEE
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      +|.+.+.||+|+||.||+|.++.++..+|+|++....   ......+..|..++..+ +||+|+++++++...+.+++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4788999999999999999999999999999987542   22234456788888887 5899999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      ||+++|+|.+++.... .+++     ..+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||++....
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~-----~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~--~~kL~DfG~~~~~~  152 (323)
T cd05616          81 EYVNGGDLMYQIQQVG-RFKE-----PHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKENM  152 (323)
T ss_pred             cCCCCCCHHHHHHHcC-CCCH-----HHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCC--cEEEccCCCceecC
Confidence            9999999998886432 2333     34455999999999999999999999999999998655  79999999997643


Q ss_pred             C-CCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHH
Q psy12427        265 P-NEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG  343 (356)
Q Consensus       265 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  343 (356)
                      . ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.++.+......+|.    .++.++
T Consensus       153 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~  228 (323)
T cd05616         153 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEA  228 (323)
T ss_pred             CCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----cCCHHH
Confidence            2 22233456899999999999999999999999999999999999999999999999998887766653    789999


Q ss_pred             HHHHHHhhhcCCC
Q psy12427        344 KDFIRRLLLRNKE  356 (356)
Q Consensus       344 ~~lI~~ll~~dP~  356 (356)
                      +++|++||++||+
T Consensus       229 ~~li~~~l~~~p~  241 (323)
T cd05616         229 VAICKGLMTKHPG  241 (323)
T ss_pred             HHHHHHHcccCHH
Confidence            9999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=6.1e-45  Score=341.87  Aligned_cols=241  Identities=27%  Similarity=0.504  Sum_probs=200.5

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      .++|++.+.||+|+||.||+|.++.++..||+|++....   ......+.+|+.+++.++||||+++++++..+...++|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            357999999999999999999999999999999986432   22335577899999999999999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      |||++||+|.+++....  ++     ...+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||++...
T Consensus       122 ~Ey~~gg~L~~~l~~~~--l~-----~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~--~~kL~DfG~~~~~  192 (370)
T cd05596         122 MEYMPGGDLVNLMSNYD--IP-----EKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG--HLKLADFGTCMKM  192 (370)
T ss_pred             EcCCCCCcHHHHHHhcC--CC-----HHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCC--CEEEEeccceeec
Confidence            99999999999886432  22     233455889999999999999999999999999998654  7999999999876


Q ss_pred             CCCCc--eeecCCCcCccccccccCC----CCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhc
Q psy12427        264 DPNEV--VKISTGTAEFAAPEIVERE----PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK  337 (356)
Q Consensus       264 ~~~~~--~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  337 (356)
                      .....  .....||+.|+|||++.+.    .++.++|||||||++|+|++|..||.+.+....+.++......+..+...
T Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  272 (370)
T cd05596         193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDI  272 (370)
T ss_pred             cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcC
Confidence            54322  2345699999999998654    37889999999999999999999999999888888887644332222234


Q ss_pred             cCCHHHHHHHHHhhhcCCC
Q psy12427        338 NVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       338 ~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+|.++++||++||+.+|+
T Consensus       273 ~~s~~~~~li~~~L~~~p~  291 (370)
T cd05596         273 EISKQAKDLICAFLTDREV  291 (370)
T ss_pred             CCCHHHHHHHHHHccChhh
Confidence            6899999999999998773

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=6.7e-45  Score=343.10  Aligned_cols=238  Identities=24%  Similarity=0.435  Sum_probs=195.0

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      .|++++.||+|+||+||+|+++.++..||+|++....   ......+.+|+.+|+.++||||+++++++.....+++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5889999999999999999999999999999997543   2334567889999999999999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |++||+|.+++.... .     +....++.++.||+.||+|||+.||+||||||+|||++.++  ++||+|||++..+..
T Consensus        82 ~~~gg~L~~~l~~~~-~-----~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~--~~kL~DFGl~~~~~~  153 (381)
T cd05626          82 YIPGGDMMSLLIRME-V-----FPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG--HIKLTDFGLCTGFRW  153 (381)
T ss_pred             cCCCCcHHHHHHhcC-C-----CCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCC--CEEEeeCcCCccccc
Confidence            999999999986532 2     23334456899999999999999999999999999997654  799999999754310


Q ss_pred             CC------------------------------------------------ceeecCCCcCccccccccCCCCCccccHHH
Q psy12427        266 NE------------------------------------------------VVKISTGTAEFAAPEIVEREPVGFYTDMWA  297 (356)
Q Consensus       266 ~~------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS  297 (356)
                      ..                                                .....+||+.|+|||++.+..++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS  233 (381)
T cd05626         154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS  233 (381)
T ss_pred             ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceee
Confidence            00                                                011246899999999999999999999999


Q ss_pred             HHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHHHhhhcC
Q psy12427        298 VGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRN  354 (356)
Q Consensus       298 lG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~d  354 (356)
                      |||++|||++|..||...+..+....+......+..+....+|.++++||.+||..+
T Consensus       234 lG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~  290 (381)
T cd05626         234 VGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSA  290 (381)
T ss_pred             hhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCc
Confidence            999999999999999998877776666543322222223468999999999976543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG1026|consensus

Probab=100.00  E-value=1.4e-45  Score=354.85  Aligned_cols=244  Identities=21%  Similarity=0.383  Sum_probs=209.9

Q ss_pred             cceeeeccccccCceEEEEEEEcc-----CCCEEEEEEcccCChh-hHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERK-----TGNIFAAKFIPVSHNL-EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMV  181 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~-----~~~~~a~K~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  181 (356)
                      .+....++||+|+||+||+|+...     +...||||.++..... .+.+|++|+++|..|+|||||+|+|+|..++.++
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~  565 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC  565 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence            456788999999999999998653     3468999999887765 7889999999999999999999999999999999


Q ss_pred             EEEEeccccchhhhhhCCCCCCC--------ccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEE
Q psy12427        182 LIFEFLSGGELFERITAPDYKMS--------EAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVK  253 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vk  253 (356)
                      +|+|||..|+|.++|..+.....        ..++.......|+.|||.||.||-++.+|||||..+|+||..+  ..||
T Consensus       566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~--l~VK  643 (774)
T KOG1026|consen  566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGEN--LVVK  643 (774)
T ss_pred             EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccc--eEEE
Confidence            99999999999999975543211        1124444566699999999999999999999999999999643  4799


Q ss_pred             EEeeeceeeeCCCCceeec---CCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccc
Q psy12427        254 MIDFGLATKLDPNEVVKIS---TGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDW  329 (356)
Q Consensus       254 l~Dfg~a~~~~~~~~~~~~---~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~  329 (356)
                      |+|||+++..-..+..+..   .-+.+|||||.|.+++++++||||||||+|||+++ |+.||.+.+++|.++-|.+++.
T Consensus       644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l  723 (774)
T KOG1026|consen  644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL  723 (774)
T ss_pred             ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc
Confidence            9999999987655544433   23689999999999999999999999999999999 9999999999999999999886


Q ss_pred             ccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        330 EFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       330 ~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                       .+  .+.++|.++-+|+..||+.+|+
T Consensus       724 -L~--~Pe~CP~~vY~LM~~CW~~~P~  747 (774)
T KOG1026|consen  724 -LS--CPENCPTEVYSLMLECWNENPK  747 (774)
T ss_pred             -cc--CCCCCCHHHHHHHHHHhhcCcc
Confidence             33  3459999999999999999985

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.3e-44  Score=333.84  Aligned_cols=234  Identities=30%  Similarity=0.493  Sum_probs=197.6

Q ss_pred             eeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHH---HhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIM---NQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       110 y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il---~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      |++.+.||+|+||.||+|.++.+++.||+|+++...   ....+.+.+|+.++   +.++||||+++++++......++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            678899999999999999999999999999987542   22335566676665   456799999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      |||+++++|...+...  .+     ....+..++.||+.||+|||++|++||||||+|||++.++  .+||+|||++...
T Consensus        81 ~E~~~~~~L~~~~~~~--~l-----~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~--~~kL~Dfg~~~~~  151 (324)
T cd05589          81 MEYAAGGDLMMHIHTD--VF-----SEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEG--FVKIADFGLCKEG  151 (324)
T ss_pred             EcCCCCCcHHHHhhcC--CC-----CHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC--cEEeCcccCCccC
Confidence            9999999998877532  23     3334455999999999999999999999999999998655  7999999998754


Q ss_pred             CC-CCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHH
Q psy12427        264 DP-NEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEE  342 (356)
Q Consensus       264 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  342 (356)
                      .. ........|++.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..+.+..+......++.    .+|.+
T Consensus       152 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~  227 (324)
T cd05589         152 MGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSRE  227 (324)
T ss_pred             CCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHH
Confidence            32 22233456899999999999999999999999999999999999999999988888888877665553    78999


Q ss_pred             HHHHHHHhhhcCCC
Q psy12427        343 GKDFIRRLLLRNKE  356 (356)
Q Consensus       343 ~~~lI~~ll~~dP~  356 (356)
                      +.+||++||+.||+
T Consensus       228 ~~~li~~~L~~dP~  241 (324)
T cd05589         228 AISIMRRLLRRNPE  241 (324)
T ss_pred             HHHHHHHHhhcCHh
Confidence            99999999999985

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=6.1e-45  Score=342.88  Aligned_cols=239  Identities=26%  Similarity=0.456  Sum_probs=196.9

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      +|++++.||+|+||+||+|+++.+++.||+|++....   ......+.+|+.+|+.++||||+++++.+..++.+++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            6899999999999999999999999999999986432   2234567789999999999999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |+++|+|.+++.... .+.     ...++.++.||+.||+|||++||+||||||+|||++.++  .+||+|||+|..+..
T Consensus        82 ~~~~g~L~~~i~~~~-~~~-----~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~--~ikL~DFG~a~~~~~  153 (376)
T cd05598          82 YIPGGDMMSLLIRLG-IFE-----EDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG--HIKLTDFGLCTGFRW  153 (376)
T ss_pred             CCCCCcHHHHHHhcC-CCC-----HHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCC--CEEEEeCCCCccccc
Confidence            999999999986532 222     333455889999999999999999999999999998654  799999999753210


Q ss_pred             C--------------------------------------------CceeecCCCcCccccccccCCCCCccccHHHHHHH
Q psy12427        266 N--------------------------------------------EVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVL  301 (356)
Q Consensus       266 ~--------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~i  301 (356)
                      .                                            ......+||+.|+|||++.+..++.++|||||||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  233 (376)
T cd05598         154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  233 (376)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence            0                                            00012368999999999999999999999999999


Q ss_pred             HHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        302 AYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       302 l~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +|+|++|+.||.+.+..+....+.........+....+|.+++++|.+|+ .+|+
T Consensus       234 lyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~  287 (376)
T cd05598         234 LYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAE  287 (376)
T ss_pred             eeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHh
Confidence            99999999999999888877776654333333334578999999999976 4763

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0658|consensus

Probab=100.00  E-value=5.1e-45  Score=320.97  Aligned_cols=240  Identities=24%  Similarity=0.389  Sum_probs=196.9

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeC--C---eEEEE
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDD--D---EMVLI  183 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~---~~~lv  183 (356)
                      .|.-.+++|.|+||.||+|....++..+|+|.+..+...    -.+|+.||+.++|||||+|.-+|...  .   +..+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            478889999999999999999999999999988655431    12699999999999999999888632  2   45689


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      ||||+ .+|.+++..-  ......+....++.+..||++||+|||+.||+||||||.|||+|.+. +.+||||||+|+.+
T Consensus       101 leymP-~tL~~~~r~~--~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~t-g~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMP-ETLYRVIRHY--TRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDT-GVLKICDFGSAKVL  176 (364)
T ss_pred             HHhch-HHHHHHHHHH--hhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCC-CeEEeccCCcceee
Confidence            99996 5898888631  11223334445566999999999999999999999999999998764 58999999999999


Q ss_pred             CCCCceeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC----------
Q psy12427        264 DPNEVVKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD----------  332 (356)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~----------  332 (356)
                      .+++......-|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++.|.|.+..+++..|.+.-+.+.          
T Consensus       177 ~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~  256 (364)
T KOG0658|consen  177 VKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN  256 (364)
T ss_pred             ccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc
Confidence            87777766677999999998865 5699999999999999999999999999999988888754322211          


Q ss_pred             ----------h-----hhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 ----------E-----EAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 ----------~-----~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                .     -..+.+++++.+|+.++|+.+|+
T Consensus       257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~  295 (364)
T KOG0658|consen  257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPS  295 (364)
T ss_pred             cccccCcccccccceeecccCCCHHHHHHHHHHhccChh
Confidence                      1     13345799999999999999985

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.7e-44  Score=338.79  Aligned_cols=238  Identities=26%  Similarity=0.508  Sum_probs=199.4

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      ++|++.+.||+|+||.||+|+++.+++.+|+|++....   ......+.+|+.+++.++||||+++++++..+...++||
T Consensus        43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~  122 (371)
T cd05622          43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM  122 (371)
T ss_pred             hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            67999999999999999999999999999999986432   223455778999999999999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      ||++||+|.+++....  ++     ...+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||++....
T Consensus       123 Ey~~gg~L~~~~~~~~--~~-----~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~--~ikL~DfG~a~~~~  193 (371)
T cd05622         123 EYMPGGDLVNLMSNYD--VP-----EKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMN  193 (371)
T ss_pred             cCCCCCcHHHHHHhcC--CC-----HHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCC--CEEEEeCCceeEcC
Confidence            9999999999886432  22     233455899999999999999999999999999997654  79999999998765


Q ss_pred             CCCc--eeecCCCcCccccccccCCC----CCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhcc
Q psy12427        265 PNEV--VKISTGTAEFAAPEIVEREP----VGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKN  338 (356)
Q Consensus       265 ~~~~--~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  338 (356)
                      ....  .....||+.|+|||++....    ++.++|||||||++|+|++|..||.+.+....+.++......++.+....
T Consensus       194 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  273 (371)
T cd05622         194 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND  273 (371)
T ss_pred             cCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCC
Confidence            3322  23456999999999997543    78899999999999999999999999998888888876543333333457


Q ss_pred             CCHHHHHHHHHhhhcC
Q psy12427        339 VSEEGKDFIRRLLLRN  354 (356)
Q Consensus       339 ~s~~~~~lI~~ll~~d  354 (356)
                      +|.+++++|..||+.+
T Consensus       274 ~s~~~~~li~~~L~~~  289 (371)
T cd05622         274 ISKEAKNLICAFLTDR  289 (371)
T ss_pred             CCHHHHHHHHHHcCCh
Confidence            9999999999999743

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.2e-44  Score=339.55  Aligned_cols=240  Identities=26%  Similarity=0.506  Sum_probs=199.5

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccC---ChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS---HNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      .++|++.+.||+|+||.||+|+++.+++.+|+|++...   .......+.+|+.+++.++||||+++++++..+...++|
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv  121 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV  121 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            35799999999999999999999999999999998642   222345677899999999999999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      |||++||+|.+++....  +.     ...+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+|...
T Consensus       122 ~Ey~~gg~L~~~l~~~~--~~-----~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~--~~kL~DFG~a~~~  192 (370)
T cd05621         122 MEYMPGGDLVNLMSNYD--VP-----EKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHG--HLKLADFGTCMKM  192 (370)
T ss_pred             EcCCCCCcHHHHHHhcC--CC-----HHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC--CEEEEecccceec
Confidence            99999999999886432  22     334455899999999999999999999999999997654  7999999999876


Q ss_pred             CCCCce--eecCCCcCccccccccCCC----CCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhc
Q psy12427        264 DPNEVV--KISTGTAEFAAPEIVEREP----VGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK  337 (356)
Q Consensus       264 ~~~~~~--~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  337 (356)
                      ......  ....||+.|+|||++....    ++.++|+||+||++|+|++|+.||.+.+..+.+.++......+..+...
T Consensus       193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  272 (370)
T cd05621         193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDV  272 (370)
T ss_pred             ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcc
Confidence            543322  3456999999999997643    7789999999999999999999999999888888887644332222224


Q ss_pred             cCCHHHHHHHHHhhhcCC
Q psy12427        338 NVSEEGKDFIRRLLLRNK  355 (356)
Q Consensus       338 ~~s~~~~~lI~~ll~~dP  355 (356)
                      .+|.+++++|..||+.+|
T Consensus       273 ~~s~~~~~li~~~L~~~~  290 (370)
T cd05621         273 EISKHAKNLICAFLTDRE  290 (370)
T ss_pred             cCCHHHHHHHHHHccCch
Confidence            689999999999997544

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0607|consensus

Probab=100.00  E-value=2.3e-45  Score=316.73  Aligned_cols=247  Identities=32%  Similarity=0.610  Sum_probs=210.5

Q ss_pred             CCCcccceeee-ccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeE
Q psy12427        103 TSSVYDHYDIL-EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEM  180 (356)
Q Consensus       103 ~~~~~~~y~~~-~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~  180 (356)
                      .+.+.+-|++. +.||+|+++.|--|..-.+|..||+|++.....-.+..+.+|++++.+. .|+||++|+++|+++..+
T Consensus        72 ~g~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~F  151 (463)
T KOG0607|consen   72 SGKFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRF  151 (463)
T ss_pred             cchHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceE
Confidence            44455566664 6899999999999999999999999999887666778888999999998 599999999999999999


Q ss_pred             EEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCC-CcEEEEeeec
Q psy12427        181 VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNS-TNVKMIDFGL  259 (356)
Q Consensus       181 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~-~~vkl~Dfg~  259 (356)
                      |+|||-|.||+|...|..+. .+++.+++.     ++++|+.||.+||.+||.||||||+|||+...+. .-||||||.+
T Consensus       152 YLVfEKm~GGplLshI~~~~-~F~E~EAs~-----vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDL  225 (463)
T KOG0607|consen  152 YLVFEKMRGGPLLSHIQKRK-HFNEREASR-----VVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDL  225 (463)
T ss_pred             EEEEecccCchHHHHHHHhh-hccHHHHHH-----HHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccc
Confidence            99999999999999987665 355555544     9999999999999999999999999999975443 2479999998


Q ss_pred             eeeeCCCC--------ceeecCCCcCcccccccc-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCCh---------
Q psy12427        260 ATKLDPNE--------VVKISTGTAEFAAPEIVE-----REPVGFYTDMWAVGVLAYVLLSGLSPFAGEND---------  317 (356)
Q Consensus       260 a~~~~~~~--------~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~---------  317 (356)
                      ......+.        ...+.+|+..|||||+..     ..-|+.+.|.||||||||-|++|++||.|...         
T Consensus       226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe  305 (463)
T KOG0607|consen  226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGE  305 (463)
T ss_pred             ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCC
Confidence            76653211        123457899999999773     33578899999999999999999999998753         


Q ss_pred             ------HHHHHHhhccccccChhhhccCCHHHHHHHHHhhhcCC
Q psy12427        318 ------VETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNK  355 (356)
Q Consensus       318 ------~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP  355 (356)
                            ...+..|..+.++||+..|..+|.+++|+|+.+|..||
T Consensus       306 ~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda  349 (463)
T KOG0607|consen  306 VCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDA  349 (463)
T ss_pred             ccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccH
Confidence                  46778899999999999999999999999999999886

>KOG0594|consensus

Probab=100.00  E-value=1.5e-44  Score=318.24  Aligned_cols=244  Identities=24%  Similarity=0.455  Sum_probs=200.8

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh--hHHHHHHHHHHHHhcCCCC-ceeeeeeEEeCC------
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL--EKELIRKEIDIMNQLHHPK-LINLHDAFEDDD------  178 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~------  178 (356)
                      ..|..+++||+|.||+||+|+.+.+|+.||+|.+......  -.....+|+.+|+.++|+| |++|++++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            4588889999999999999999999999999999876543  2344568999999999999 999999998777      


Q ss_pred             eEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeee
Q psy12427        179 EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFG  258 (356)
Q Consensus       179 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg  258 (356)
                      .+++|+||++ -+|..++.......  .......++.+++||+.||+|||+++|+||||||.|||++.++  .+||+|||
T Consensus        91 ~l~lvfe~~d-~DL~~ymd~~~~~~--~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G--~lKlaDFG  165 (323)
T KOG0594|consen   91 KLYLVFEFLD-RDLKKYMDSLPKKP--QGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSG--VLKLADFG  165 (323)
T ss_pred             eEEEEEEeec-ccHHHHHHhccccc--cCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCC--cEeeeccc
Confidence            8999999995 58988887654211  2222356788999999999999999999999999999998744  79999999


Q ss_pred             ceeeeC-CCCceeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhh
Q psy12427        259 LATKLD-PNEVVKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAF  336 (356)
Q Consensus       259 ~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  336 (356)
                      +|+.+. +.......++|..|+|||++.+. .|+...||||+|||++||+++++.|.+.++.+.+..|-.....+.+..|
T Consensus       166 lAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W  245 (323)
T KOG0594|consen  166 LARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW  245 (323)
T ss_pred             hHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence            999776 44445566789999999999876 6999999999999999999999999999999888887543222211111


Q ss_pred             --------------------------ccCCHHHHHHHHHhhhcCCC
Q psy12427        337 --------------------------KNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       337 --------------------------~~~s~~~~~lI~~ll~~dP~  356 (356)
                                                ++.+.+..+++..||+.||.
T Consensus       246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~  291 (323)
T KOG0594|consen  246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPA  291 (323)
T ss_pred             CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcc
Confidence                                      22345899999999999984

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.2e-44  Score=332.24  Aligned_cols=231  Identities=33%  Similarity=0.585  Sum_probs=195.5

Q ss_pred             ccccccCceEEEEEEEc---cCCCEEEEEEcccCC----hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        114 EEIGTGAFGVVHRCRER---KTGNIFAAKFIPVSH----NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~---~~~~~~a~K~~~~~~----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      +.||+|+||.||+++..   .+++.||+|+++...    ......+.+|+.+|+.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            67999999999999874   468899999987532    22335567899999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC-
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP-  265 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~-  265 (356)
                      +.+++|.+++.... .+.+     ..+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||+++.... 
T Consensus        82 ~~~~~L~~~~~~~~-~~~~-----~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~  153 (323)
T cd05584          82 LSGGELFMHLEREG-IFME-----DTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQG--HVKLTDFGLCKESIHE  153 (323)
T ss_pred             CCCchHHHHHHHcC-CCCH-----HHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC--CEEEeeCcCCeecccC
Confidence            99999999886433 2222     33445889999999999999999999999999997654  799999999875432 


Q ss_pred             CCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHH
Q psy12427        266 NEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD  345 (356)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  345 (356)
                      ........|++.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......+++    .+++++.+
T Consensus       154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~  229 (323)
T cd05584         154 GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPP----YLTPEARD  229 (323)
T ss_pred             CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHH
Confidence            22233456899999999999988999999999999999999999999999988888888877765553    68999999


Q ss_pred             HHHHhhhcCCC
Q psy12427        346 FIRRLLLRNKE  356 (356)
Q Consensus       346 lI~~ll~~dP~  356 (356)
                      ||++||++||+
T Consensus       230 li~~~l~~~p~  240 (323)
T cd05584         230 LLKKLLKRNPS  240 (323)
T ss_pred             HHHHHcccCHh
Confidence            99999999985

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.9e-44  Score=332.37  Aligned_cols=231  Identities=24%  Similarity=0.452  Sum_probs=196.5

Q ss_pred             ccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEEEEEEeccc
Q psy12427        114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMVLIFEFLSG  189 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~  189 (356)
                      +.||+|+||.||+|.++.++..||+|+++...   ......+..|..++..+ +||||+++++++.....+++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999999999999999987542   22345566789999876 799999999999999999999999999


Q ss_pred             cchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC-CCc
Q psy12427        190 GELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP-NEV  268 (356)
Q Consensus       190 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~-~~~  268 (356)
                      |+|..++.... .++     ...+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||++..... ...
T Consensus        81 ~~L~~~l~~~~-~~~-----~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~--~~kL~Dfg~~~~~~~~~~~  152 (321)
T cd05591          81 GDLMFQIQRSR-KFD-----EPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEG--HCKLADFGMCKEGILNGVT  152 (321)
T ss_pred             CcHHHHHHHcC-CCC-----HHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC--CEEEeecccceecccCCcc
Confidence            99998886432 233     334455899999999999999999999999999998654  799999999876432 222


Q ss_pred             eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHH
Q psy12427        269 VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIR  348 (356)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  348 (356)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+......+|.    .++.++.++|+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~ll~  228 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV----WLSKEAVSILK  228 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHH
Confidence            33456899999999999999999999999999999999999999999999999998887765553    68999999999


Q ss_pred             HhhhcCCC
Q psy12427        349 RLLLRNKE  356 (356)
Q Consensus       349 ~ll~~dP~  356 (356)
                      +||++||+
T Consensus       229 ~~L~~dp~  236 (321)
T cd05591         229 AFMTKNPN  236 (321)
T ss_pred             HHhccCHH
Confidence            99999985

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.4e-44  Score=331.52  Aligned_cols=231  Identities=26%  Similarity=0.485  Sum_probs=196.2

Q ss_pred             ccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEEEEEEeccc
Q psy12427        114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMVLIFEFLSG  189 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~  189 (356)
                      +.||+|+||+||+|.++.+++.||+|++....   ......+..|..++..+ +||||+++++++.....+++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999987532   22345566788888877 699999999999999999999999999


Q ss_pred             cchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC-CCc
Q psy12427        190 GELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP-NEV  268 (356)
Q Consensus       190 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~-~~~  268 (356)
                      |+|.+++.... .+++     ..+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||++..... ...
T Consensus        81 g~L~~~i~~~~-~l~~-----~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~--~~kL~DfG~~~~~~~~~~~  152 (320)
T cd05590          81 GDLMFHIQKSR-RFDE-----ARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEG--HCKLADFGMCKEGIFNGKT  152 (320)
T ss_pred             chHHHHHHHcC-CCCH-----HHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC--cEEEeeCCCCeecCcCCCc
Confidence            99998886432 2333     34455899999999999999999999999999997654  799999999876432 222


Q ss_pred             eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHH
Q psy12427        269 VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIR  348 (356)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  348 (356)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+......++.    .++.++++||+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~  228 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLSQDAVDILK  228 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHH
Confidence            33456899999999999999999999999999999999999999999999999888877665543    68999999999


Q ss_pred             HhhhcCCC
Q psy12427        349 RLLLRNKE  356 (356)
Q Consensus       349 ~ll~~dP~  356 (356)
                      +||+.||+
T Consensus       229 ~~L~~dP~  236 (320)
T cd05590         229 AFMTKNPT  236 (320)
T ss_pred             HHcccCHH
Confidence            99999985

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.1e-44  Score=334.53  Aligned_cols=231  Identities=27%  Similarity=0.468  Sum_probs=196.4

Q ss_pred             ccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEecccc
Q psy12427        114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGG  190 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g  190 (356)
                      +.||+|+||.||+|.++.+|..+|+|+++...   ......+.+|+.++..++||||+++++++.....+++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999987532   223455678999999999999999999999999999999999999


Q ss_pred             chhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC-CCc
Q psy12427        191 ELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE-KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP-NEV  268 (356)
Q Consensus       191 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~-~~~  268 (356)
                      +|..++.... .++     ...+..++.||+.||+|||+ .||+||||||+|||++.++  .+||+|||++..... ...
T Consensus        81 ~L~~~l~~~~-~l~-----~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~--~~kL~Dfg~~~~~~~~~~~  152 (325)
T cd05594          81 ELFFHLSRER-VFS-----EDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG--HIKITDFGLCKEGIKDGAT  152 (325)
T ss_pred             cHHHHHHhcC-CCC-----HHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCC--CEEEecCCCCeecCCCCcc
Confidence            9988876432 233     33445589999999999997 7999999999999997654  799999999876432 222


Q ss_pred             eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHH
Q psy12427        269 VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIR  348 (356)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  348 (356)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......++.    .+++++.+||+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~  228 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLS  228 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHH
Confidence            33456999999999999999999999999999999999999999999888888888776666553    68999999999


Q ss_pred             HhhhcCCC
Q psy12427        349 RLLLRNKE  356 (356)
Q Consensus       349 ~ll~~dP~  356 (356)
                      +||++||+
T Consensus       229 ~~L~~dP~  236 (325)
T cd05594         229 GLLKKDPK  236 (325)
T ss_pred             HHhhcCHH
Confidence            99999985

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0660|consensus

Probab=100.00  E-value=1e-44  Score=318.44  Aligned_cols=241  Identities=26%  Similarity=0.459  Sum_probs=199.4

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcc--cCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEe-----CCe
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP--VSHNLEKELIRKEIDIMNQLHHPKLINLHDAFED-----DDE  179 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~--~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-----~~~  179 (356)
                      ...|..++.||+|+||.|+.+.++.+|..||+|.+.  ..+........+|+.+|+.++|+||+.+.+++..     -+.
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            345667899999999999999999999999999987  4555566677789999999999999999998864     467


Q ss_pred             EEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeec
Q psy12427        180 MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGL  259 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~  259 (356)
                      +|+|+|+| +.+|.+.+.... .+++     .....++.||+.||+|+|+.+|+||||||.|+|++.+  ..+||+|||+
T Consensus       101 vYiV~elM-etDL~~iik~~~-~L~d-----~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~--c~lKI~DFGL  171 (359)
T KOG0660|consen  101 VYLVFELM-ETDLHQIIKSQQ-DLTD-----DHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNAD--CDLKICDFGL  171 (359)
T ss_pred             eEEehhHH-hhHHHHHHHcCc-cccH-----HHHHHHHHHHHHhcchhhcccccccccchhheeeccC--CCEEeccccc
Confidence            89999999 568888887543 2333     3345599999999999999999999999999999754  3689999999


Q ss_pred             eeeeCC---CCceeecCCCcCcccccccc-CCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC---
Q psy12427        260 ATKLDP---NEVVKISTGTAEFAAPEIVE-REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD---  332 (356)
Q Consensus       260 a~~~~~---~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~---  332 (356)
                      |+..+.   ....+..+.|..|.|||++. ...|+.+.||||+|||+.||++|++.|.|.+..+.++.|....+.++   
T Consensus       172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~  251 (359)
T KOG0660|consen  172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED  251 (359)
T ss_pred             eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence            999864   33334556799999999875 56799999999999999999999999999998887777654322221   


Q ss_pred             ------------------------hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 ------------------------EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 ------------------------~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                              ...+++.++++.||+++||..||.
T Consensus       252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~  299 (359)
T KOG0660|consen  252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPK  299 (359)
T ss_pred             HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCcc
Confidence                                    234456889999999999999995

>KOG0690|consensus

Probab=100.00  E-value=8.2e-45  Score=314.12  Aligned_cols=239  Identities=28%  Similarity=0.515  Sum_probs=211.2

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHH---HHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL---IRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~---~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      .-++|..+++||+|.||.|.+|+.+.+++.||+|+++..--..+..   -..|-.+|...+||.+..|--.|+...++|+
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            3478999999999999999999999999999999998764333333   3468999999999999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ||||..||.|+-.+...      ..++....+.+..+|+.||.|||+++||+||||.+|+|+|.++  ++||+|||+|..
T Consensus       246 VMeyanGGeLf~HLsre------r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDG--HIKitDFGLCKE  317 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSRE------RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDG--HIKITDFGLCKE  317 (516)
T ss_pred             EEEEccCceEeeehhhh------hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCC--ceEeeecccchh
Confidence            99999999998777542      2333444455999999999999999999999999999998766  899999999976


Q ss_pred             e-CCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCH
Q psy12427        263 L-DPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSE  341 (356)
Q Consensus       263 ~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  341 (356)
                      - .......+.||||.|+|||++....|+.+.|.|.+||+||||++|+.||...+.......|..+...||.    .+|+
T Consensus       318 ~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr----~ls~  393 (516)
T KOG0690|consen  318 EIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPR----TLSP  393 (516)
T ss_pred             cccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCc----cCCH
Confidence            4 3445667889999999999999999999999999999999999999999999999999999999988885    8999


Q ss_pred             HHHHHHHHhhhcCCC
Q psy12427        342 EGKDFIRRLLLRNKE  356 (356)
Q Consensus       342 ~~~~lI~~ll~~dP~  356 (356)
                      +++.|+..+|.+||.
T Consensus       394 eAktLLsGLL~kdP~  408 (516)
T KOG0690|consen  394 EAKTLLSGLLKKDPK  408 (516)
T ss_pred             HHHHHHHHHhhcChH
Confidence            999999999999994

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.7e-44  Score=332.79  Aligned_cols=241  Identities=28%  Similarity=0.539  Sum_probs=199.7

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      ++|++.+.||+|+||+||+++++.+++.||+|++....   ......+.+|..++..++|+||+++++++...+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46999999999999999999999999999999986532   223455778999999999999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      ||+.||+|.+++......+.+     ..+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||++....
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~-----~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~--~~kl~DfG~a~~~~  153 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPE-----DMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNG--HIRLADFGSCLKMN  153 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCH-----HHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCC--CEEEEeccceeecc
Confidence            999999999999753333333     33455899999999999999999999999999997554  79999999998765


Q ss_pred             CCCce--eecCCCcCccccccccC-----CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC-hhhh
Q psy12427        265 PNEVV--KISTGTAEFAAPEIVER-----EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD-EEAF  336 (356)
Q Consensus       265 ~~~~~--~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~  336 (356)
                      .....  ....|++.|+|||++.+     ..++.++|||||||++|+|++|+.||.+.+..+.+..+......++ +...
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  233 (331)
T cd05624         154 QDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHI  233 (331)
T ss_pred             CCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCcc
Confidence            43322  23468999999999875     4678899999999999999999999999988888888766443222 2333


Q ss_pred             ccCCHHHHHHHHHhhhcCC
Q psy12427        337 KNVSEEGKDFIRRLLLRNK  355 (356)
Q Consensus       337 ~~~s~~~~~lI~~ll~~dP  355 (356)
                      .++|++++++|.+||..+|
T Consensus       234 ~~~~~~~~~li~~ll~~~~  252 (331)
T cd05624         234 TDVSEEAKDLIQRLICSRE  252 (331)
T ss_pred             ccCCHHHHHHHHHHccCch
Confidence            5689999999999998654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.2e-44  Score=338.89  Aligned_cols=238  Identities=31%  Similarity=0.561  Sum_probs=197.8

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      ++|++.+.||+|+||+||+|.++.+++.||+|++....   ......+.+|+.++..++||||+++++.+......++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36889999999999999999999999999999986432   223456778999999999999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      ||++||+|.+++.... .+     ....+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||++....
T Consensus        81 E~~~gg~L~~~l~~~~-~l-----~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~--~vkL~DfG~~~~~~  152 (360)
T cd05627          81 EFLPGGDMMTLLMKKD-TL-----SEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKG--HVKLSDFGLCTGLK  152 (360)
T ss_pred             eCCCCccHHHHHHhcC-CC-----CHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC--CEEEeeccCCcccc
Confidence            9999999999986432 23     3334455999999999999999999999999999997654  79999999987542


Q ss_pred             CCC------------------------------------ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcC
Q psy12427        265 PNE------------------------------------VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSG  308 (356)
Q Consensus       265 ~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g  308 (356)
                      ...                                    .....+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG  232 (360)
T cd05627         153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG  232 (360)
T ss_pred             cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccC
Confidence            110                                    01124689999999999999999999999999999999999


Q ss_pred             CCCCCCCChHHHHHHhhccc--cccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        309 LSPFAGENDVETLKNVKACD--WEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       309 ~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +.||.+.+..+.+.++....  ..+|+.  ..+|+++++||.+|+. ||+
T Consensus       233 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~--~~~s~~~~~li~~l~~-~p~  279 (360)
T cd05627         233 YPPFCSETPQETYRKVMNWKETLVFPPE--VPISEKAKDLILRFCT-DSE  279 (360)
T ss_pred             CCCCCCCCHHHHHHHHHcCCCceecCCC--CCCCHHHHHHHHHhcc-Chh
Confidence            99999999888888876533  333332  3589999999999874 663

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-45  Score=338.18  Aligned_cols=238  Identities=30%  Similarity=0.570  Sum_probs=201.9

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      ++|.+.+.||+|+||+||+|+++.+++.||+|+++...   ......+.+|+.++..++||||+++++++......++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            36899999999999999999999999999999987542   233456788999999999999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      ||+.+++|.+++... ..+     ....+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||++....
T Consensus        81 e~~~~~~L~~~l~~~-~~l-----~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~--~~kL~Dfg~~~~~~  152 (350)
T cd05573          81 EYMPGGDLMNLLIRK-DVF-----PEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADG--HIKLADFGLCKKMN  152 (350)
T ss_pred             cCCCCCCHHHHHHHc-CCC-----CHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC--CEEeecCCCCccCc
Confidence            999999999998754 223     3344455899999999999999999999999999998655  79999999998764


Q ss_pred             CCC------------------------------ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q psy12427        265 PNE------------------------------VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAG  314 (356)
Q Consensus       265 ~~~------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~  314 (356)
                      ...                              ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~  232 (350)
T cd05573         153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS  232 (350)
T ss_pred             ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence            332                              12334689999999999999999999999999999999999999999


Q ss_pred             CChHHHHHHhhc--cccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        315 ENDVETLKNVKA--CDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       315 ~~~~~~~~~i~~--~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+..+...++..  ....++.  ...+|+++++||++||+ ||+
T Consensus       233 ~~~~~~~~~i~~~~~~~~~p~--~~~~~~~~~~li~~ll~-dp~  273 (350)
T cd05573         233 DTLQETYNKIINWKESLRFPP--DPPVSPEAIDLICRLLC-DPE  273 (350)
T ss_pred             CCHHHHHHHHhccCCcccCCC--CCCCCHHHHHHHHHHcc-Chh
Confidence            998888888776  3333333  23589999999999997 874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.9e-44  Score=328.94  Aligned_cols=231  Identities=26%  Similarity=0.462  Sum_probs=193.4

Q ss_pred             ccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEEEEEEeccc
Q psy12427        114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMVLIFEFLSG  189 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~  189 (356)
                      +.||+|+||.||+|.++.++..||+|+++...   ......+..|..++..+ +||||+++++++......++||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999999999999999987542   22334455677777654 899999999999999999999999999


Q ss_pred             cchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC-Cc
Q psy12427        190 GELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN-EV  268 (356)
Q Consensus       190 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~-~~  268 (356)
                      |+|.+++.... .++     ...+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||++...... ..
T Consensus        81 g~L~~~~~~~~-~~~-----~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~--~~kL~Dfg~a~~~~~~~~~  152 (316)
T cd05592          81 GDLMFHIQSSG-RFD-----EARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDG--HIKIADFGMCKENMNGEGK  152 (316)
T ss_pred             CcHHHHHHHcC-CCC-----HHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCC--CEEEccCcCCeECCCCCCc
Confidence            99998886432 233     334455899999999999999999999999999997654  7999999999765322 23


Q ss_pred             eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHH
Q psy12427        269 VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIR  348 (356)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  348 (356)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+......++    ..++.++.+||+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~ll~  228 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFP----RWISKEAKDCLS  228 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Confidence            3345689999999999999999999999999999999999999999998888888876554444    368999999999


Q ss_pred             HhhhcCCC
Q psy12427        349 RLLLRNKE  356 (356)
Q Consensus       349 ~ll~~dP~  356 (356)
                      +||+.||+
T Consensus       229 ~~l~~~P~  236 (316)
T cd05592         229 KLFERDPT  236 (316)
T ss_pred             HHccCCHH
Confidence            99999984

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=6e-44  Score=323.65  Aligned_cols=241  Identities=27%  Similarity=0.445  Sum_probs=195.0

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      ++|++.+.||+|+||.||+|+++.++..+|+|++....  ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            36999999999999999999999999999999987543  2234567789999999999999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |+.++.+..+... ...     +....+..++.|++.||+|||+.||+||||||+||+++.++  .+||+|||++.....
T Consensus        81 ~~~~~~l~~~~~~-~~~-----~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~  152 (287)
T cd07848          81 YVEKNMLELLEEM-PNG-----VPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHND--VLKLCDFGFARNLSE  152 (287)
T ss_pred             cCCCCHHHHHHhc-CCC-----CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC--cEEEeeccCcccccc
Confidence            9998766554332 222     33334556999999999999999999999999999997554  799999999987643


Q ss_pred             CCc--eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCh----------
Q psy12427        266 NEV--VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE----------  333 (356)
Q Consensus       266 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~----------  333 (356)
                      ...  .....|++.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+..+.......+.          
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07848         153 GSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP  232 (287)
T ss_pred             cccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence            221  22346899999999999989999999999999999999999999988776665554332221111          


Q ss_pred             ------------------hhhccCCHHHHHHHHHhhhcCCC
Q psy12427        334 ------------------EAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       334 ------------------~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                        .....+|.++++||++||+.||+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~  273 (287)
T cd07848         233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPT  273 (287)
T ss_pred             hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcc
Confidence                              11224789999999999999995

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-44  Score=322.81  Aligned_cols=241  Identities=25%  Similarity=0.451  Sum_probs=197.0

Q ss_pred             eeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh---hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN---LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       110 y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      |++.++||+|+||+||++.+..+++.||+|.+.....   .....+.+|+.+++.++||||+++++++..+...++||||
T Consensus         2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence            7888999999999999999999999999999865432   2234567899999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +.+|+|.+++.....    ..+....+..++.|++.||.|||+.|++||||||+||+++.++  .++|+|||++......
T Consensus        82 ~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          82 MNGGDLKFHIYNMGN----PGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYG--HIRISDLGLAVEIPEG  155 (285)
T ss_pred             cCCCcHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCC--CEEEeeCCCceecCCC
Confidence            999999888754321    1233444556899999999999999999999999999997544  7999999999876544


Q ss_pred             CceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHH
Q psy12427        267 EVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDF  346 (356)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  346 (356)
                      .......|++.|+|||++.+..++.++||||+||++|+|++|..||.+.+.......+.......+...+..++..+++|
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  235 (285)
T cd05605         156 ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSI  235 (285)
T ss_pred             CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHH
Confidence            44444578999999999999899999999999999999999999999876644433332221122223334689999999


Q ss_pred             HHHhhhcCCC
Q psy12427        347 IRRLLLRNKE  356 (356)
Q Consensus       347 I~~ll~~dP~  356 (356)
                      |++||+.||+
T Consensus       236 i~~~l~~~P~  245 (285)
T cd05605         236 CRQLLTKDPG  245 (285)
T ss_pred             HHHHccCCHH
Confidence            9999999984

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.2e-43  Score=343.42  Aligned_cols=242  Identities=24%  Similarity=0.374  Sum_probs=204.7

Q ss_pred             cceeeeccccccCceEEEEEEEccC-CCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKT-GNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~-~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      ..|.+.+.||+|+||.||+|....+ +..+|+|.+..........+++|+.+|+.++||||+++++++...+..++||||
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~  146 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY  146 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence            4599999999999999999998887 788999988766665666788899999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      ++||+|.+++.....  ....+....+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||++..+...
T Consensus       147 ~~gg~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~--~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        147 GSGGDLNKQIKQRLK--EHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG--IIKLGDFGFSKQYSDS  222 (478)
T ss_pred             CCCCCHHHHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCC--cEEEEeCcCceecCCc
Confidence            999999988753211  111233334555899999999999999999999999999998654  7999999999876533


Q ss_pred             Cc---eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHH
Q psy12427        267 EV---VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG  343 (356)
Q Consensus       267 ~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  343 (356)
                      ..   ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+..+.....   ...++.++
T Consensus       223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~s~~~  299 (478)
T PTZ00267        223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF---PCPVSSGM  299 (478)
T ss_pred             cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---CccCCHHH
Confidence            21   2334689999999999999999999999999999999999999999988888888877654422   24789999


Q ss_pred             HHHHHHhhhcCCC
Q psy12427        344 KDFIRRLLLRNKE  356 (356)
Q Consensus       344 ~~lI~~ll~~dP~  356 (356)
                      ++||.+||++||+
T Consensus       300 ~~li~~~L~~dP~  312 (478)
T PTZ00267        300 KALLDPLLSKNPA  312 (478)
T ss_pred             HHHHHHHhccChh
Confidence            9999999999995

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=7.1e-44  Score=328.82  Aligned_cols=235  Identities=26%  Similarity=0.498  Sum_probs=199.0

Q ss_pred             eeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCeEEEEEE
Q psy12427        110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLH-HPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       110 y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      |++.+.||+|+||+||+|.++.+|+.||+|++....   ......+..|+.++..+. |++|+++++++.....+++|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME   81 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence            678899999999999999999999999999987532   223345667899998886 5778889999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |++||+|.+++.... .++     ...+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||++.....
T Consensus        82 y~~~g~L~~~i~~~~-~l~-----~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~--~ikL~Dfg~~~~~~~  153 (323)
T cd05615          82 YVNGGDLMYHIQQVG-KFK-----EPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEG--HIKIADFGMCKEHMV  153 (323)
T ss_pred             CCCCCcHHHHHHHcC-CCC-----HHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC--CEEEeccccccccCC
Confidence            999999998886432 233     334556999999999999999999999999999998654  799999999876432


Q ss_pred             CC-ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHH
Q psy12427        266 NE-VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK  344 (356)
Q Consensus       266 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  344 (356)
                      .. ......||+.|+|||++.+..++.++|+||+||++|+|++|+.||.+.+..+.++.+......+|    ..++.+++
T Consensus       154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~  229 (323)
T cd05615         154 DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAV  229 (323)
T ss_pred             CCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHH
Confidence            22 22334689999999999999999999999999999999999999999999888888888776655    37899999


Q ss_pred             HHHHHhhhcCCC
Q psy12427        345 DFIRRLLLRNKE  356 (356)
Q Consensus       345 ~lI~~ll~~dP~  356 (356)
                      ++|++||++||+
T Consensus       230 ~li~~~l~~~p~  241 (323)
T cd05615         230 SICKGLMTKHPS  241 (323)
T ss_pred             HHHHHHcccCHh
Confidence            999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG0986|consensus

Probab=100.00  E-value=8e-45  Score=326.17  Aligned_cols=243  Identities=26%  Similarity=0.474  Sum_probs=208.2

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh---hHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL---EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      +.|..-++||+|+||+||-|.-+.||+.||+|.+....-.   ......+|..||.+++.+.||.+--+|+....+++|+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            4578889999999999999999999999999987543322   2345668999999999999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      ..|+||+|.-.|....    ...+....+..++.+|+.||+|||+.+||+|||||+|||+|..+  ++.|+|+|+|..+.
T Consensus       265 tlMNGGDLkfHiyn~g----~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~G--hvRISDLGLAvei~  338 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHG----NPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHG--HVRISDLGLAVEIP  338 (591)
T ss_pred             EeecCCceeEEeeccC----CCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCC--CeEeeccceEEecC
Confidence            9999999977665433    23444555566999999999999999999999999999998655  89999999999998


Q ss_pred             CCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHH
Q psy12427        265 PNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK  344 (356)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  344 (356)
                      ........+||.+|||||++..+.|+...|.|||||+||||+.|+.||.......--..+.+....-+.++...+|++++
T Consensus       339 ~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eak  418 (591)
T KOG0986|consen  339 EGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAK  418 (591)
T ss_pred             CCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHH
Confidence            88888888999999999999999999999999999999999999999987755444444444444455666668999999


Q ss_pred             HHHHHhhhcCCC
Q psy12427        345 DFIRRLLLRNKE  356 (356)
Q Consensus       345 ~lI~~ll~~dP~  356 (356)
                      ++++.+|++||+
T Consensus       419 slc~~LL~Kdp~  430 (591)
T KOG0986|consen  419 SLCEGLLTKDPE  430 (591)
T ss_pred             HHHHHHHccCHH
Confidence            999999999995

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=5.6e-44  Score=329.81  Aligned_cols=231  Identities=26%  Similarity=0.514  Sum_probs=191.7

Q ss_pred             ccccccCceEEEEEEEccCCCEEEEEEcccCCh---hhHHHHHHHH-HHHHhcCCCCceeeeeeEEeCCeEEEEEEeccc
Q psy12427        114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN---LEKELIRKEI-DIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSG  189 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~-~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  189 (356)
                      +.||+|+||+||+|+++.+++.+|+|++.....   .....+..|. .+++.++||||+++++++...+..++||||+.+
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            469999999999999999999999999865321   1222333444 456788999999999999999999999999999


Q ss_pred             cchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC-CCCc
Q psy12427        190 GELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEV  268 (356)
Q Consensus       190 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~-~~~~  268 (356)
                      |+|.+++.... .+.     ...+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+++... ....
T Consensus        81 ~~L~~~~~~~~-~~~-----~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~--~~kl~DfG~a~~~~~~~~~  152 (325)
T cd05602          81 GELFYHLQRER-CFL-----EPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG--HIVLTDFGLCKENIEHNGT  152 (325)
T ss_pred             CcHHHHHHhcC-CCC-----HHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC--CEEEccCCCCcccccCCCC
Confidence            99999886432 222     334455899999999999999999999999999997654  79999999987542 2223


Q ss_pred             eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHH
Q psy12427        269 VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIR  348 (356)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  348 (356)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+.++......++    .+++.+++++|+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~  228 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLE  228 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCC----CCCCHHHHHHHH
Confidence            3445699999999999999999999999999999999999999999998888888876554443    378999999999


Q ss_pred             HhhhcCCC
Q psy12427        349 RLLLRNKE  356 (356)
Q Consensus       349 ~ll~~dP~  356 (356)
                      +||++||+
T Consensus       229 ~~l~~~p~  236 (325)
T cd05602         229 GLLQKDRT  236 (325)
T ss_pred             HHcccCHH
Confidence            99999984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=8.1e-44  Score=327.45  Aligned_cols=231  Identities=26%  Similarity=0.470  Sum_probs=194.1

Q ss_pred             ccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEEEEEEeccc
Q psy12427        114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMVLIFEFLSG  189 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~  189 (356)
                      +.||+|+||.||+|.++.+|..||+|.++...   ......+..|..++..+ +||||+++++++...+..++||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999999999999999987542   22344566788888765 899999999999999999999999999


Q ss_pred             cchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC-CCc
Q psy12427        190 GELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP-NEV  268 (356)
Q Consensus       190 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~-~~~  268 (356)
                      |+|..++.... .++     ...+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||+++.... ...
T Consensus        81 g~L~~~i~~~~-~~~-----~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~  152 (316)
T cd05620          81 GDLMFHIQDKG-RFD-----LYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDG--HIKIADFGMCKENVFGDNR  152 (316)
T ss_pred             CcHHHHHHHcC-CCC-----HHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC--CEEeCccCCCeecccCCCc
Confidence            99998886432 222     334455899999999999999999999999999998654  799999999875422 223


Q ss_pred             eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHH
Q psy12427        269 VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIR  348 (356)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  348 (356)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+......++    ..++.++++||+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~  228 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYP----RWITKESKDILE  228 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHHHH
Confidence            3445789999999999999999999999999999999999999999988888888776554444    368999999999


Q ss_pred             HhhhcCCC
Q psy12427        349 RLLLRNKE  356 (356)
Q Consensus       349 ~ll~~dP~  356 (356)
                      +||+.||+
T Consensus       229 ~~l~~dP~  236 (316)
T cd05620         229 KLFERDPT  236 (316)
T ss_pred             HHccCCHH
Confidence            99999995

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0612|consensus

Probab=100.00  E-value=2.7e-45  Score=359.44  Aligned_cols=236  Identities=31%  Similarity=0.569  Sum_probs=208.1

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccC---ChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS---HNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      .++|.++++||+|+||.|..++++.+++.||+|++...   ...+...|+.|-+||..-+.+.|++++-+|+++.++|+|
T Consensus        74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV  153 (1317)
T KOG0612|consen   74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV  153 (1317)
T ss_pred             HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence            36799999999999999999999999999999999763   334557789999999999999999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      ||||+||+|..++..-. ++++.     ..++|+..|+.||.-||+.|+|||||||+|||+|..|  ++||+|||.|-.+
T Consensus       154 MdY~pGGDlltLlSk~~-~~pE~-----~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~G--HikLADFGsClkm  225 (1317)
T KOG0612|consen  154 MDYMPGGDLLTLLSKFD-RLPED-----WARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSG--HIKLADFGSCLKM  225 (1317)
T ss_pred             EecccCchHHHHHhhcC-CChHH-----HHHHHHHHHHHHHHHHHhccceeccCCcceeEecccC--cEeeccchhHHhc
Confidence            99999999999997544 34443     4456999999999999999999999999999998665  8999999999888


Q ss_pred             CCCCce--eecCCCcCcccccccc----C-CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc--ccccChh
Q psy12427        264 DPNEVV--KISTGTAEFAAPEIVE----R-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKAC--DWEFDEE  334 (356)
Q Consensus       264 ~~~~~~--~~~~gt~~y~aPE~~~----~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~  334 (356)
                      +.+...  ...+|||.|.|||++.    + +.|+...|.||+||++|||+.|..||..++-.+++.+|...  .+.||++
T Consensus       226 ~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~  305 (1317)
T KOG0612|consen  226 DADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDE  305 (1317)
T ss_pred             CCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcc
Confidence            755544  3457999999999995    3 56889999999999999999999999999999999999887  6777744


Q ss_pred             hhccCCHHHHHHHHHhhh
Q psy12427        335 AFKNVSEEGKDFIRRLLL  352 (356)
Q Consensus       335 ~~~~~s~~~~~lI~~ll~  352 (356)
                        .++|+++++||.+++.
T Consensus       306 --~~VSeeakdLI~~ll~  321 (1317)
T KOG0612|consen  306 --TDVSEEAKDLIEALLC  321 (1317)
T ss_pred             --cccCHHHHHHHHHHhc
Confidence              3699999999999986

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.7e-44  Score=332.67  Aligned_cols=241  Identities=29%  Similarity=0.534  Sum_probs=199.8

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh---hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN---LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      ++|++.+.||+|+||+||+|.++.+|+.+|+|+++....   .....+.+|+.+++.++||||+++++++......++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            368999999999999999999999999999999875432   23456778999999999999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      ||+++|+|.+++......+++.     .+..++.|++.||+|||+.||+||||||+|||++.++  .+||+|||++....
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~-----~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~--~~kL~Dfg~a~~~~  153 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDED-----MAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTG--HIKLADFGSAARLT  153 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHH-----HHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCC--CEEeccCCCCeECC
Confidence            9999999999987653334333     3455899999999999999999999999999998654  79999999998775


Q ss_pred             CCCce--eecCCCcCcccccccc------CCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhh
Q psy12427        265 PNEVV--KISTGTAEFAAPEIVE------REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAF  336 (356)
Q Consensus       265 ~~~~~--~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  336 (356)
                      .....  ....||+.|+|||++.      ...++.++|||||||++|+|++|..||...+..+.+.++.........+..
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  233 (330)
T cd05601         154 ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPED  233 (330)
T ss_pred             CCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCC
Confidence            43322  2346899999999986      456788999999999999999999999998888888877654322111112


Q ss_pred             ccCCHHHHHHHHHhhhcCCC
Q psy12427        337 KNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       337 ~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ..++.++++||+.||+ ||+
T Consensus       234 ~~~~~~~~~li~~ll~-~p~  252 (330)
T cd05601         234 PKVSSDFLDLIQSLLC-GQK  252 (330)
T ss_pred             CCCCHHHHHHHHHHcc-Chh
Confidence            3689999999999997 874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=7.4e-44  Score=328.76  Aligned_cols=231  Identities=27%  Similarity=0.527  Sum_probs=192.2

Q ss_pred             ccccccCceEEEEEEEccCCCEEEEEEcccCCh---hhHHHHHHHHH-HHHhcCCCCceeeeeeEEeCCeEEEEEEeccc
Q psy12427        114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN---LEKELIRKEID-IMNQLHHPKLINLHDAFEDDDEMVLIFEFLSG  189 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  189 (356)
                      +.||+|+||+||+|.++.+|+.||+|++.....   .....+..|.. +++.++||||+++++++......++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            469999999999999999999999999865321   12233444544 56789999999999999999999999999999


Q ss_pred             cchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC-CCCc
Q psy12427        190 GELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEV  268 (356)
Q Consensus       190 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~-~~~~  268 (356)
                      |+|.+++.... .+.     ...+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||++.... ....
T Consensus        81 g~L~~~l~~~~-~~~-----~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~--~~kl~Dfg~~~~~~~~~~~  152 (323)
T cd05575          81 GELFFHLQRER-SFP-----EPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQG--HVVLTDFGLCKEGIEHSKT  152 (323)
T ss_pred             CCHHHHHHhcC-CCC-----HHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC--cEEEeccCCCcccccCCCc
Confidence            99998886432 233     334455899999999999999999999999999997654  79999999987542 2223


Q ss_pred             eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHH
Q psy12427        269 VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIR  348 (356)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  348 (356)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+...++.......+    ..++.++.++|+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~  228 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLE  228 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Confidence            3345689999999999999999999999999999999999999999988888888877655444    368999999999


Q ss_pred             HhhhcCCC
Q psy12427        349 RLLLRNKE  356 (356)
Q Consensus       349 ~ll~~dP~  356 (356)
                      +||++||+
T Consensus       229 ~~l~~~p~  236 (323)
T cd05575         229 GLLQKDRT  236 (323)
T ss_pred             HHhhcCHH
Confidence            99999984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-43  Score=328.18  Aligned_cols=240  Identities=30%  Similarity=0.573  Sum_probs=197.5

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      ++|++.+.||+|+||+||+++++.+++.||+|++....   ......+.+|+.++..++||||+++++++..+..+++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46999999999999999999999999999999986422   223456788999999999999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      ||+.||+|.+++......+++     ..+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||++....
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~-----~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~--~~kl~Dfg~~~~~~  153 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPE-----DMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNG--HIRLADFGSCLRLL  153 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCH-----HHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCC--CEEEEECCceeecC
Confidence            999999999998653333333     33455899999999999999999999999999997554  79999999997764


Q ss_pred             CCCce--eecCCCcCccccccccC-----CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc--cccChhh
Q psy12427        265 PNEVV--KISTGTAEFAAPEIVER-----EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACD--WEFDEEA  335 (356)
Q Consensus       265 ~~~~~--~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~  335 (356)
                      .....  ....||+.|+|||++..     ..++.++||||+||++|+|++|+.||.+.+..+.+..+....  +.+++. 
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~-  232 (331)
T cd05597         154 ADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPD-  232 (331)
T ss_pred             CCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCc-
Confidence            33222  23468999999999863     457889999999999999999999999988888777775533  333322 


Q ss_pred             hccCCHHHHHHHHHhhhcCC
Q psy12427        336 FKNVSEEGKDFIRRLLLRNK  355 (356)
Q Consensus       336 ~~~~s~~~~~lI~~ll~~dP  355 (356)
                      ...+|+++++||++||..++
T Consensus       233 ~~~~~~~~~~li~~ll~~~~  252 (331)
T cd05597         233 VTDVSEEAKDLIRRLICSPE  252 (331)
T ss_pred             cCCCCHHHHHHHHHHccCcc
Confidence            34589999999999997543

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.6e-43  Score=325.46  Aligned_cols=231  Identities=26%  Similarity=0.458  Sum_probs=193.6

Q ss_pred             ccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEEEEEEeccc
Q psy12427        114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMVLIFEFLSG  189 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~  189 (356)
                      +.||+|+||+||+|.++.++..||+|+++...   ......+..|..++..+ +||||+++++++.....+++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999987542   22334556688888764 899999999999999999999999999


Q ss_pred             cchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC-CCc
Q psy12427        190 GELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP-NEV  268 (356)
Q Consensus       190 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~-~~~  268 (356)
                      |+|.+++.... .+++     ..+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||++..... ...
T Consensus        81 g~L~~~l~~~~-~~~~-----~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~  152 (316)
T cd05619          81 GDLMFHIQSCH-KFDL-----PRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDG--HIKIADFGMCKENMLGDAK  152 (316)
T ss_pred             CcHHHHHHHcC-CCCH-----HHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC--CEEEccCCcceECCCCCCc
Confidence            99999886432 2333     33445899999999999999999999999999998654  799999999876422 223


Q ss_pred             eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHH
Q psy12427        269 VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIR  348 (356)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  348 (356)
                      .....||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+..+.++.+......++    ..++.++++||.
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~  228 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYP----RWLTREAKDILV  228 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHH
Confidence            3445689999999999999999999999999999999999999999988888888876554444    368999999999


Q ss_pred             HhhhcCCC
Q psy12427        349 RLLLRNKE  356 (356)
Q Consensus       349 ~ll~~dP~  356 (356)
                      +||+.||+
T Consensus       229 ~~l~~~P~  236 (316)
T cd05619         229 KLFVREPE  236 (316)
T ss_pred             HHhccCHh
Confidence            99999995

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.5e-43  Score=320.00  Aligned_cols=241  Identities=26%  Similarity=0.427  Sum_probs=193.1

Q ss_pred             ceeeeccccccCceEEEEEEEcc-CCCEEEEEEcccCChh--hHHHHHHHHHHHHhc---CCCCceeeeeeEE-----eC
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERK-TGNIFAAKFIPVSHNL--EKELIRKEIDIMNQL---HHPKLINLHDAFE-----DD  177 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~-~~~~~a~K~~~~~~~~--~~~~~~~E~~il~~l---~hpnIv~l~~~~~-----~~  177 (356)
                      +|++.+.||+|+||.||+|++.. +++.+|+|.++.....  ....+.+|+.+++.+   +||||+++++++.     ..
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            68999999999999999999864 4688999988754322  234455788877766   6999999999885     34


Q ss_pred             CeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEee
Q psy12427        178 DEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDF  257 (356)
Q Consensus       178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Df  257 (356)
                      ..+++||||+. ++|.+++....    ...+....+..++.|++.||+|||++||+||||||+|||++.++  .+||+||
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~--~~kl~Df  154 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVP----EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG--QIKLADF  154 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCC--CEEEccc
Confidence            56899999996 58888876432    12233445566999999999999999999999999999997654  7999999


Q ss_pred             eceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC-----
Q psy12427        258 GLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD-----  332 (356)
Q Consensus       258 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-----  332 (356)
                      |++.............|++.|+|||++.+..++.++|||||||++|+|++|.+||.+.++.+.+..+......+.     
T Consensus       155 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  234 (290)
T cd07862         155 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  234 (290)
T ss_pred             cceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence            999876554444455689999999999988999999999999999999999999999988888777754322111     


Q ss_pred             ------------------hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 ------------------EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 ------------------~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                        ......+++++++||.+||+.||+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~  276 (290)
T cd07862         235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPA  276 (290)
T ss_pred             hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCch
Confidence                              122246789999999999999995

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.3e-43  Score=328.39  Aligned_cols=241  Identities=29%  Similarity=0.548  Sum_probs=198.6

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      ++|++.++||+|+||+||+++++.+++.+|+|++....   ......+.+|+.++..++|+||+++++++.....+++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            36899999999999999999999999999999986422   223345778999999999999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      ||+.+|+|.+++......+++     ..+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||++....
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~-----~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~--~~kL~DfG~a~~~~  153 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPE-----DMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG--HIRLADFGSCLKLM  153 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCH-----HHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC--CEEEeecchheecc
Confidence            999999999999753333333     33455899999999999999999999999999997554  79999999987654


Q ss_pred             CCCce--eecCCCcCcccccccc-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC-hhhh
Q psy12427        265 PNEVV--KISTGTAEFAAPEIVE-----REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD-EEAF  336 (356)
Q Consensus       265 ~~~~~--~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~  336 (356)
                      .....  ....||+.|+|||++.     ...++.++|||||||++|||++|+.||.+.+..+.+.++......++ +...
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  233 (332)
T cd05623         154 EDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQV  233 (332)
T ss_pred             cCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCcc
Confidence            32222  2346899999999986     34678899999999999999999999999998888888866443221 2223


Q ss_pred             ccCCHHHHHHHHHhhhcCC
Q psy12427        337 KNVSEEGKDFIRRLLLRNK  355 (356)
Q Consensus       337 ~~~s~~~~~lI~~ll~~dP  355 (356)
                      ..+|.++++||++||..+|
T Consensus       234 ~~~s~~~~~li~~ll~~~~  252 (332)
T cd05623         234 TDVSEDAKDLIRRLICSRE  252 (332)
T ss_pred             ccCCHHHHHHHHHHccChh
Confidence            5789999999999997654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.4e-43  Score=326.24  Aligned_cols=231  Identities=27%  Similarity=0.521  Sum_probs=196.0

Q ss_pred             ccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEEEEEEeccc
Q psy12427        114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMVLIFEFLSG  189 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~  189 (356)
                      +.||+|+||+||+|.++.++..||+|+++...   ......+.+|..++..+ +||||+++++++.....+++||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999987542   23345567899999888 699999999999999999999999999


Q ss_pred             cchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC-CCc
Q psy12427        190 GELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP-NEV  268 (356)
Q Consensus       190 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~-~~~  268 (356)
                      |+|..++.... .+++     ..+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||+++.... ...
T Consensus        81 ~~L~~~~~~~~-~l~~-----~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~~  152 (318)
T cd05570          81 GDLMFHIQRSG-RFDE-----PRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEG--HIKIADFGMCKEGILGGVT  152 (318)
T ss_pred             CCHHHHHHHcC-CCCH-----HHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCC--cEEecccCCCeecCcCCCc
Confidence            99988886432 2333     34455899999999999999999999999999997654  799999999875422 222


Q ss_pred             eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHH
Q psy12427        269 VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIR  348 (356)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  348 (356)
                      .....|++.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..+....+......++    ..++.++++||+
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~  228 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYP----RWLSKEAKSILK  228 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHH
Confidence            3344689999999999999999999999999999999999999999998888888877665554    368999999999


Q ss_pred             HhhhcCCC
Q psy12427        349 RLLLRNKE  356 (356)
Q Consensus       349 ~ll~~dP~  356 (356)
                      +||+.||+
T Consensus       229 ~~l~~dP~  236 (318)
T cd05570         229 SFLTKNPE  236 (318)
T ss_pred             HHccCCHH
Confidence            99999995

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.3e-43  Score=327.50  Aligned_cols=244  Identities=23%  Similarity=0.310  Sum_probs=190.0

Q ss_pred             cceeeeccccccCceEEEEEEEc-----cCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeC-Ce
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRER-----KTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQL-HHPKLINLHDAFEDD-DE  179 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~-----~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~-~~  179 (356)
                      ++|++.++||.|+||.||+|.+.     .++..||+|.++... ......+.+|+.+|..+ +||||+++++++... ..
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (338)
T cd05102           7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP   86 (338)
T ss_pred             hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence            57999999999999999999853     345789999987543 23346688999999999 899999999988754 46


Q ss_pred             EEEEEEeccccchhhhhhCCCCCCC-------------------------------------------------------
Q psy12427        180 MVLIFEFLSGGELFERITAPDYKMS-------------------------------------------------------  204 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~~~~-------------------------------------------------------  204 (356)
                      ++++|||+++|+|.+++........                                                       
T Consensus        87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (338)
T cd05102          87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL  166 (338)
T ss_pred             eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence            8999999999999998865321100                                                       


Q ss_pred             -ccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCc---eeecCCCcCccc
Q psy12427        205 -EAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEV---VKISTGTAEFAA  280 (356)
Q Consensus       205 -~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~a  280 (356)
                       ...+....+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+++.......   .....+++.|+|
T Consensus       167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~--~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  244 (338)
T cd05102         167 WKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENN--VVKICDFGLARDIYKDPDYVRKGSARLPLKWMA  244 (338)
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCC--cEEEeecccccccccCcchhcccCCCCCccccC
Confidence             01123334556889999999999999999999999999997654  799999999986532211   112235688999


Q ss_pred             cccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHH-HHHHhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        281 PEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVE-TLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       281 PE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ||++.+..++.++|||||||++|||++ |..||.+....+ ....+.......   ....+++++.++|.+||+.||+
T Consensus       245 PE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~  319 (338)
T cd05102         245 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR---APENATPEIYRIMLACWQGDPK  319 (338)
T ss_pred             cHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHccCChh
Confidence            999999999999999999999999997 999998865433 334443332211   1247899999999999999995

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.5e-43  Score=327.48  Aligned_cols=231  Identities=25%  Similarity=0.493  Sum_probs=189.8

Q ss_pred             ccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEEEEEEeccc
Q psy12427        114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMVLIFEFLSG  189 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~  189 (356)
                      +.||+|+||.||+|.++.+++.||+|+++...   ......+.+|..++..+ +||||+++++++.....+++||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999999999999999997542   22345677899999998 799999999999999999999999999


Q ss_pred             cchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee-CCCCc
Q psy12427        190 GELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL-DPNEV  268 (356)
Q Consensus       190 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~-~~~~~  268 (356)
                      |+|.+++.... .++     ...+..++.|++.||+|||++|++||||||+|||++.++  .+||+|||++... .....
T Consensus        81 g~L~~~~~~~~-~l~-----~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~--~~kL~Dfg~~~~~~~~~~~  152 (329)
T cd05588          81 GDLMFHMQRQR-KLP-----EEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEG--HIKLTDYGMCKEGIRPGDT  152 (329)
T ss_pred             CCHHHHHHHcC-CCC-----HHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC--CEEECcCccccccccCCCc
Confidence            99988875432 233     344455999999999999999999999999999997654  7999999998753 22333


Q ss_pred             eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC---------hHHHHHHhhccccccChhhhccC
Q psy12427        269 VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN---------DVETLKNVKACDWEFDEEAFKNV  339 (356)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~---------~~~~~~~i~~~~~~~~~~~~~~~  339 (356)
                      .....||+.|+|||++.+..++.++|+|||||++|+|++|+.||....         .....+.+......+|    ..+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~  228 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP----RSL  228 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC----CCC
Confidence            344579999999999999999999999999999999999999996321         1223444555554444    368


Q ss_pred             CHHHHHHHHHhhhcCCC
Q psy12427        340 SEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       340 s~~~~~lI~~ll~~dP~  356 (356)
                      +.+++++|++||+.||+
T Consensus       229 ~~~~~~li~~~L~~dP~  245 (329)
T cd05588         229 SVKASSVLKGFLNKDPK  245 (329)
T ss_pred             CHHHHHHHHHHhccCHH
Confidence            99999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.3e-43  Score=326.80  Aligned_cols=231  Identities=27%  Similarity=0.522  Sum_probs=191.6

Q ss_pred             ccccccCceEEEEEEEccCCCEEEEEEcccCCh---hhHHHHHHHH-HHHHhcCCCCceeeeeeEEeCCeEEEEEEeccc
Q psy12427        114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN---LEKELIRKEI-DIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSG  189 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~-~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  189 (356)
                      +.||+|+||.||+|+++.++..+|+|++.....   .....+..|. .+++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            469999999999999999999999999865321   2223344454 467889999999999999999999999999999


Q ss_pred             cchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee-CCCCc
Q psy12427        190 GELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL-DPNEV  268 (356)
Q Consensus       190 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~-~~~~~  268 (356)
                      ++|...+.... .+     ....+..++.||+.||+|||+.||+||||||+|||++.++  .+||+|||+++.. .....
T Consensus        81 ~~L~~~l~~~~-~~-----~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~~~~~~~~~~~  152 (321)
T cd05603          81 GELFFHLQRER-CF-----LEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQG--HVVLTDFGLCKEGVEPEET  152 (321)
T ss_pred             CCHHHHHHHcC-CC-----CHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC--CEEEccCCCCccCCCCCCc
Confidence            99988775432 22     2334455899999999999999999999999999998655  7999999998753 22223


Q ss_pred             eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHH
Q psy12427        269 VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIR  348 (356)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  348 (356)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......++    ...+.++.++|.
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~  228 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLV  228 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHH
Confidence            3445689999999999999999999999999999999999999999988888888876655444    367899999999


Q ss_pred             HhhhcCCC
Q psy12427        349 RLLLRNKE  356 (356)
Q Consensus       349 ~ll~~dP~  356 (356)
                      +||++||+
T Consensus       229 ~~l~~~p~  236 (321)
T cd05603         229 GLLHKDQR  236 (321)
T ss_pred             HHccCCHh
Confidence            99999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.4e-44  Score=329.52  Aligned_cols=231  Identities=30%  Similarity=0.553  Sum_probs=196.6

Q ss_pred             ccccccCceEEEEEEEc---cCCCEEEEEEcccCCh--hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEecc
Q psy12427        114 EEIGTGAFGVVHRCRER---KTGNIFAAKFIPVSHN--LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLS  188 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~---~~~~~~a~K~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  188 (356)
                      +.||+|+||.||++++.   .+|..+|+|++.....  .+...+.+|+++|++++||||+++++++..+..+++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            57999999999998863   5789999999875432  233456689999999999999999999999999999999999


Q ss_pred             ccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC-C
Q psy12427        189 GGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN-E  267 (356)
Q Consensus       189 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~-~  267 (356)
                      +|+|.+++.... .+     ....+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||++...... .
T Consensus        82 ~~~L~~~l~~~~-~l-----~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kL~Dfg~~~~~~~~~~  153 (318)
T cd05582          82 GGDLFTRLSKEV-MF-----TEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG--HIKLTDFGLSKESIDHEK  153 (318)
T ss_pred             CCcHHHHHHHcC-CC-----CHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCC--cEEEeeccCCcccCCCCC
Confidence            999999886432 23     3344556999999999999999999999999999997654  7999999998765433 2


Q ss_pred             ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHH
Q psy12427        268 VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFI  347 (356)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI  347 (356)
                      ......|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+......++.    .+++++++||
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li  229 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQSLL  229 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHH
Confidence            333457899999999999988999999999999999999999999999988888888877766553    6899999999


Q ss_pred             HHhhhcCCC
Q psy12427        348 RRLLLRNKE  356 (356)
Q Consensus       348 ~~ll~~dP~  356 (356)
                      ++||++||+
T Consensus       230 ~~~l~~~P~  238 (318)
T cd05582         230 RALFKRNPA  238 (318)
T ss_pred             HHHhhcCHh
Confidence            999999995

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.3e-43  Score=321.49  Aligned_cols=241  Identities=22%  Similarity=0.419  Sum_probs=188.5

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh-hHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL-EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      ++|++.+.||+|+||.||+|+++.+++.+|+|++...... ....+.+|+.+++.++||||+++++++......++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY   84 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence            5799999999999999999999999999999998754322 234567899999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +. ++|.+++......+.     ...+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||++......
T Consensus        85 ~~-~~l~~~~~~~~~~~~-----~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~  156 (303)
T cd07869          85 VH-TDLCQYMDKHPGGLH-----PENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTG--ELKLADFGLARAKSVP  156 (303)
T ss_pred             CC-cCHHHHHHhCCCCCC-----HHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC--CEEECCCCcceeccCC
Confidence            95 577777764433333     334556999999999999999999999999999997654  7999999998765322


Q ss_pred             -CceeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHhhcccccc------------
Q psy12427        267 -EVVKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGEND-VETLKNVKACDWEF------------  331 (356)
Q Consensus       267 -~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~-~~~~~~i~~~~~~~------------  331 (356)
                       .......|++.|+|||++.+ ..++.++||||+||++|+|++|..||.+..+ .+.+..+......+            
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T cd07869         157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP  236 (303)
T ss_pred             CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence             22233568999999999865 4578899999999999999999999987643 23333332110000            


Q ss_pred             --Ch------------hhhc--cCCHHHHHHHHHhhhcCCC
Q psy12427        332 --DE------------EAFK--NVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       332 --~~------------~~~~--~~s~~~~~lI~~ll~~dP~  356 (356)
                        .+            ..+.  .++.++++||++||+.||+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~  277 (303)
T cd07869         237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPK  277 (303)
T ss_pred             ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCch
Confidence              00            0011  2467899999999999995

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0194|consensus

Probab=100.00  E-value=3.9e-44  Score=334.34  Aligned_cols=240  Identities=22%  Similarity=0.383  Sum_probs=201.7

Q ss_pred             cceeeeccccccCceEEEEEEEccCCC---E-EEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGN---I-FAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM  180 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~---~-~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  180 (356)
                      ++..+.++||+|+||+||+|+.+..+.   . ||+|..+...   ..+...+.+|+++|++++|||||+++|++.....+
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl  236 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL  236 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence            345667999999999999999886532   3 8999988633   55667788999999999999999999999999999


Q ss_pred             EEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeece
Q psy12427        181 VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA  260 (356)
Q Consensus       181 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a  260 (356)
                      ++|||+|.||+|.++|......++..+     ...++.+++.||+|||++++|||||..+|+|++.++  .+||+|||++
T Consensus       237 ~ivmEl~~gGsL~~~L~k~~~~v~~~e-----k~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~--~vKISDFGLs  309 (474)
T KOG0194|consen  237 MLVMELCNGGSLDDYLKKNKKSLPTLE-----KLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKG--VVKISDFGLS  309 (474)
T ss_pred             EEEEEecCCCcHHHHHHhCCCCCCHHH-----HHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCC--eEEeCccccc
Confidence            999999999999999986553333333     344999999999999999999999999999997654  5799999999


Q ss_pred             eeeCCCCcee-ecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhcc
Q psy12427        261 TKLDPNEVVK-ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKN  338 (356)
Q Consensus       261 ~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  338 (356)
                      +.-....... ...-+.+|+|||.+....++++||||||||++||+++ |..||.+....++...|....+..+.+  ..
T Consensus       310 ~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~--~~  387 (474)
T KOG0194|consen  310 RAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIP--SK  387 (474)
T ss_pred             cCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCC--CC
Confidence            7654222222 1224789999999999999999999999999999999 899999999999999997766554433  37


Q ss_pred             CCHHHHHHHHHhhhcCCC
Q psy12427        339 VSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       339 ~s~~~~~lI~~ll~~dP~  356 (356)
                      .|.++..++.+||+.||+
T Consensus       388 ~p~~~~~~~~~c~~~~p~  405 (474)
T KOG0194|consen  388 TPKELAKVMKQCWKKDPE  405 (474)
T ss_pred             CHHHHHHHHHHhccCChh
Confidence            899999999999999995

>KOG4236|consensus

Probab=100.00  E-value=1e-44  Score=330.59  Aligned_cols=237  Identities=32%  Similarity=0.549  Sum_probs=207.0

Q ss_pred             eee--eccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        110 YDI--LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       110 y~~--~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      |+|  .++||.|-||+||-|+++++|+.||+|++.+..  ..+...+++|+.||.+++||.||.+.-.|+....+++|||
T Consensus       564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVME  643 (888)
T KOG4236|consen  564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVME  643 (888)
T ss_pred             HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEeh
Confidence            444  479999999999999999999999999997643  3344778899999999999999999999999999999999


Q ss_pred             eccccchhhhh-hCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecC-CCcEEEEeeeceeee
Q psy12427        186 FLSGGELFERI-TAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN-STNVKMIDFGLATKL  263 (356)
Q Consensus       186 ~~~~g~L~~~l-~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~-~~~vkl~Dfg~a~~~  263 (356)
                      -+.| +..+.+ .....++     .....+.++.||+.||.|||.++|+|+||||+|||+.... -..+||||||.|+.+
T Consensus       644 Kl~G-DMLEMILSsEkgRL-----~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiI  717 (888)
T KOG4236|consen  644 KLHG-DMLEMILSSEKGRL-----PERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARII  717 (888)
T ss_pred             hhcc-hHHHHHHHhhcccc-----hHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeec
Confidence            9954 555555 3333333     3444566999999999999999999999999999997543 357999999999999


Q ss_pred             CCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHH
Q psy12427        264 DPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG  343 (356)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  343 (356)
                      ........-+|||.|+|||++..+.|...-|+||+|||+|.-++|..||..+  +++-.+|.+..+.+|+..|+.+|.++
T Consensus       718 gEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW~eis~~A  795 (888)
T KOG4236|consen  718 GEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPWSEISPEA  795 (888)
T ss_pred             chhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCchhhcCHHH
Confidence            8888888889999999999999999999999999999999999999999554  66778888999999999999999999


Q ss_pred             HHHHHHhhhcC
Q psy12427        344 KDFIRRLLLRN  354 (356)
Q Consensus       344 ~~lI~~ll~~d  354 (356)
                      .|||+.+||+.
T Consensus       796 idlIn~LLqVk  806 (888)
T KOG4236|consen  796 IDLINNLLQVK  806 (888)
T ss_pred             HHHHHHHHHHH
Confidence            99999999864

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.2e-43  Score=318.01  Aligned_cols=233  Identities=27%  Similarity=0.448  Sum_probs=188.4

Q ss_pred             ccccCceEEEEEEEccCCCEEEEEEcccCChh---hHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEeccccch
Q psy12427        116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL---EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGEL  192 (356)
Q Consensus       116 lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L  192 (356)
                      ||+|+||+||+|.++.+++.+|+|.+......   ....+..|+.+++.++||||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            79999999999999999999999998654322   234567899999999999999999999999999999999999999


Q ss_pred             hhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCc-eee
Q psy12427        193 FERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEV-VKI  271 (356)
Q Consensus       193 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~-~~~  271 (356)
                      .+.+.....  ....+....+..++.||+.||+|||++||+||||||+||+++.++  .++|+|||++........ ...
T Consensus        81 ~~~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~~l~dfg~~~~~~~~~~~~~~  156 (280)
T cd05608          81 RYHIYNVDE--ENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG--NVRISDLGLAVELKDGQSKTKG  156 (280)
T ss_pred             HHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEeeCccceecCCCCccccc
Confidence            887753211  122344455566999999999999999999999999999997544  799999999987643322 233


Q ss_pred             cCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChH----HHHHHhhccccccChhhhccCCHHHHHHH
Q psy12427        272 STGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDV----ETLKNVKACDWEFDEEAFKNVSEEGKDFI  347 (356)
Q Consensus       272 ~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~s~~~~~lI  347 (356)
                      ..|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+..    +....+.....    .....+|.+++++|
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li  232 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSV----TYPDKFSPASKSFC  232 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCC----CCcccCCHHHHHHH
Confidence            46899999999999999999999999999999999999999876432    22333322222    22347899999999


Q ss_pred             HHhhhcCCC
Q psy12427        348 RRLLLRNKE  356 (356)
Q Consensus       348 ~~ll~~dP~  356 (356)
                      .+||+.||+
T Consensus       233 ~~~l~~~P~  241 (280)
T cd05608         233 EALLAKDPE  241 (280)
T ss_pred             HHHhcCCHH
Confidence            999999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.6e-43  Score=325.88  Aligned_cols=231  Identities=25%  Similarity=0.487  Sum_probs=189.2

Q ss_pred             ccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEEEEEEeccc
Q psy12427        114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMVLIFEFLSG  189 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~  189 (356)
                      +.||+|+||+||+|+++.+++.+|+|+++...   ......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999987542   23345677899998887 799999999999999999999999999


Q ss_pred             cchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC-CCCc
Q psy12427        190 GELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEV  268 (356)
Q Consensus       190 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~-~~~~  268 (356)
                      |+|..++.... .+     ....+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||+++... ....
T Consensus        81 ~~L~~~~~~~~-~l-----~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~--~~kL~DfG~~~~~~~~~~~  152 (329)
T cd05618          81 GDLMFHMQRQR-KL-----PEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG--HIKLTDYGMCKEGLRPGDT  152 (329)
T ss_pred             CCHHHHHHHcC-CC-----CHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC--CEEEeeCCccccccCCCCc
Confidence            99988875432 23     3334455899999999999999999999999999998654  79999999987542 2223


Q ss_pred             eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC---------ChHHHHHHhhccccccChhhhccC
Q psy12427        269 VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGE---------NDVETLKNVKACDWEFDEEAFKNV  339 (356)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~~  339 (356)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||...         ......+.+......+|    ..+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~~~  228 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RSL  228 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC----CCC
Confidence            34457899999999999999999999999999999999999999521         12233444555555444    378


Q ss_pred             CHHHHHHHHHhhhcCCC
Q psy12427        340 SEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       340 s~~~~~lI~~ll~~dP~  356 (356)
                      +.++++||++||+.||+
T Consensus       229 ~~~~~~ll~~~L~~dP~  245 (329)
T cd05618         229 SVKAASVLKSFLNKDPK  245 (329)
T ss_pred             CHHHHHHHHHHhcCCHH
Confidence            99999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0667|consensus

Probab=100.00  E-value=1.3e-43  Score=332.91  Aligned_cols=220  Identities=27%  Similarity=0.452  Sum_probs=192.1

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcC-C-----CCceeeeeeEEeCCeEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLH-H-----PKLINLHDAFEDDDEMV  181 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~-h-----pnIv~l~~~~~~~~~~~  181 (356)
                      -+|.+++.||+|.||.|.+|.+.+|+..||||+++....- .++...|+.||..|+ |     -|+|+++++|...++.|
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f-~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc  264 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF-LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC  264 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH-HHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence            3789999999999999999999999999999999876443 234456999999997 4     38999999999999999


Q ss_pred             EEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeecee
Q psy12427        182 LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT  261 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~  261 (356)
                      ||+|.+ .-+|++++....+.    .++...++.++.||+.||.+||+.||||+||||+|||+...+...|||+|||+|+
T Consensus       265 iVfELL-~~NLYellK~n~f~----Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc  339 (586)
T KOG0667|consen  265 IVFELL-STNLYELLKNNKFR----GLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSC  339 (586)
T ss_pred             eeehhh-hhhHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccc
Confidence            999998 56999999876543    3555667779999999999999999999999999999987777789999999998


Q ss_pred             eeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhh
Q psy12427        262 KLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEA  335 (356)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  335 (356)
                      .....  ..+.+.+..|+|||++.+.+|+.+.||||||||++||++|.+.|.|+++.+.+..|.+....+|+..
T Consensus       340 ~~~q~--vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~m  411 (586)
T KOG0667|consen  340 FESQR--VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKM  411 (586)
T ss_pred             ccCCc--ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHH
Confidence            86543  3367789999999999999999999999999999999999999999999999999887666555443

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=9.8e-43  Score=322.35  Aligned_cols=205  Identities=25%  Similarity=0.463  Sum_probs=176.0

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      ++|++.+.||+|+||.||++.++.++..+|+|.+.... ......+.+|+++|++++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence            57999999999999999999999999999999987653 23356788999999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEK-NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      +++++|.+++.... .     +....+..++.|++.||.|||++ +|+||||||+|||++.++  .+||+|||++.....
T Consensus        85 ~~~~~L~~~l~~~~-~-----~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~  156 (331)
T cd06649          85 MDGGSLDQVLKEAK-R-----IPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG--EIKLCDFGVSGQLID  156 (331)
T ss_pred             CCCCcHHHHHHHcC-C-----CCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC--cEEEccCcccccccc
Confidence            99999999986532 2     23334556899999999999986 699999999999998654  799999999876643


Q ss_pred             CCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHH
Q psy12427        266 NEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETL  321 (356)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~  321 (356)
                      . ......|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..+..
T Consensus       157 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~  211 (331)
T cd06649         157 S-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE  211 (331)
T ss_pred             c-ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            2 223456899999999999999999999999999999999999999877655543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.6e-43  Score=336.54  Aligned_cols=242  Identities=22%  Similarity=0.313  Sum_probs=189.5

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeC--------C
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDD--------D  178 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--------~  178 (356)
                      .++|++.+.||+|+||.||+|.+..++..||+|.+....    ....+|+.+|+.++||||+++++++...        .
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            357999999999999999999999999999999885432    2334799999999999999999877432        2


Q ss_pred             eEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeee
Q psy12427        179 EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFG  258 (356)
Q Consensus       179 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg  258 (356)
                      .+++||||+++ +|.+++....  .....+....+..++.||+.||+|||++||+||||||+|||++.++ ..+||+|||
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~--~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~-~~vkL~DFG  216 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYA--RNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNT-HTLKLCDFG  216 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCC-Cceeeeccc
Confidence            46799999975 6766654211  1112233344566899999999999999999999999999997543 369999999


Q ss_pred             ceeeeCCCCceeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCh----
Q psy12427        259 LATKLDPNEVVKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE----  333 (356)
Q Consensus       259 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~----  333 (356)
                      +|+.+..........||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+.+..+......++.    
T Consensus       217 la~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~  296 (440)
T PTZ00036        217 SAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK  296 (440)
T ss_pred             cchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            99877554444456789999999998764 6899999999999999999999999999887777666542221111    


Q ss_pred             ---------------------hhhccCCHHHHHHHHHhhhcCCC
Q psy12427        334 ---------------------EAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       334 ---------------------~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                           ......|+++++||++||++||+
T Consensus       297 ~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~  340 (440)
T PTZ00036        297 EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPL  340 (440)
T ss_pred             HhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChh
Confidence                                 01124688999999999999995

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.5e-43  Score=327.96  Aligned_cols=236  Identities=31%  Similarity=0.570  Sum_probs=190.7

Q ss_pred             ceeeeccccccCceEEEEEEEc---cCCCEEEEEEcccCC----hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeE
Q psy12427        109 HYDILEEIGTGAFGVVHRCRER---KTGNIFAAKFIPVSH----NLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEM  180 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~---~~~~~~a~K~~~~~~----~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~  180 (356)
                      +|++.+.||+|+||.||+|+..   .+++.+|+|++....    ......+.+|+.++..+ +||||+++++++......
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            3889999999999999999874   468999999986432    22335577899999999 589999999999999999


Q ss_pred             EEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeece
Q psy12427        181 VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA  260 (356)
Q Consensus       181 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a  260 (356)
                      ++||||+.+|+|.+++.... .++     ...+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||++
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~-~~~-----~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~--~~kl~DfG~~  152 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD-NFS-----EDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEG--HVVLTDFGLS  152 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCC-----HHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCC--CEEEeeCcCC
Confidence            99999999999999886432 233     334556899999999999999999999999999998654  7999999999


Q ss_pred             eeeCCCC--ceeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCC----hHHHHHHhhccccccCh
Q psy12427        261 TKLDPNE--VVKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGEN----DVETLKNVKACDWEFDE  333 (356)
Q Consensus       261 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~----~~~~~~~i~~~~~~~~~  333 (356)
                      +......  ......||+.|+|||++.+. .++.++|||||||++|+|++|..||....    ..+....+......++ 
T Consensus       153 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-  231 (332)
T cd05614         153 KEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP-  231 (332)
T ss_pred             ccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCC-
Confidence            8653322  22335689999999999865 47889999999999999999999997543    3334444444443333 


Q ss_pred             hhhccCCHHHHHHHHHhhhcCCC
Q psy12427        334 EAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       334 ~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                         ..++.++++||++||+.||+
T Consensus       232 ---~~~~~~~~~li~~~l~~dp~  251 (332)
T cd05614         232 ---SFIGPEAQDLLHKLLRKDPK  251 (332)
T ss_pred             ---CCCCHHHHHHHHHHcCCCHH
Confidence               47899999999999999985

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.7e-42  Score=312.88  Aligned_cols=232  Identities=27%  Similarity=0.489  Sum_probs=188.7

Q ss_pred             ccccCceEEEEEEEccCCCEEEEEEcccCCh---hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEeccccch
Q psy12427        116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHN---LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGEL  192 (356)
Q Consensus       116 lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L  192 (356)
                      ||+|+||+||++..+.+|+.+|+|.+.....   .....+..|++++++++||||+++++++..+...++||||++|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            7999999999999999999999999864321   1233455699999999999999999999999999999999999999


Q ss_pred             hhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCceeec
Q psy12427        193 FERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS  272 (356)
Q Consensus       193 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~~~~~  272 (356)
                      .+++.....    .......+..++.|++.||+|||+.|++||||||+||+++.++  .++|+|||++............
T Consensus        81 ~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~--~~~l~Dfg~~~~~~~~~~~~~~  154 (277)
T cd05607          81 KYHIYNVGE----RGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQG--NCRLSDLGLAVELKDGKTITQR  154 (277)
T ss_pred             HHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCC--CEEEeeceeeeecCCCceeecc
Confidence            888754321    1123334455889999999999999999999999999997654  6999999999877654444455


Q ss_pred             CCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHhhccccccChhhhccCCHHHHHHHH
Q psy12427        273 TGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEND----VETLKNVKACDWEFDEEAFKNVSEEGKDFIR  348 (356)
Q Consensus       273 ~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  348 (356)
                      .|++.|+|||++.+..++.++||||+||++|+|++|..||.+...    .+...........++   ...++.+++++|+
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~  231 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE---HQNFTEESKDICR  231 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc---cccCCHHHHHHHH
Confidence            789999999999998999999999999999999999999976533    233344333333222   2468999999999


Q ss_pred             HhhhcCCC
Q psy12427        349 RLLLRNKE  356 (356)
Q Consensus       349 ~ll~~dP~  356 (356)
                      +||++||+
T Consensus       232 ~~L~~~P~  239 (277)
T cd05607         232 LFLAKKPE  239 (277)
T ss_pred             HHhccCHh
Confidence            99999995

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2e-43  Score=326.17  Aligned_cols=231  Identities=26%  Similarity=0.493  Sum_probs=192.0

Q ss_pred             ccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHH-HHHhcCCCCceeeeeeEEeCCeEEEEEEeccc
Q psy12427        114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEID-IMNQLHHPKLINLHDAFEDDDEMVLIFEFLSG  189 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  189 (356)
                      +.||+|+||+||+|.++.+|+.+|+|++....   ......+..|.. +++.++||||+++++++......++||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999999999999999986542   222334445554 56778999999999999999999999999999


Q ss_pred             cchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC-CCCc
Q psy12427        190 GELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEV  268 (356)
Q Consensus       190 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~-~~~~  268 (356)
                      |+|..++.... .+     ....+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||++.... ....
T Consensus        81 ~~L~~~l~~~~-~~-----~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~--~~kL~DfG~~~~~~~~~~~  152 (325)
T cd05604          81 GELFFHLQRER-SF-----PEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQG--HVVLTDFGLCKEGIAQSDT  152 (325)
T ss_pred             CCHHHHHHHcC-CC-----CHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC--CEEEeecCCcccCCCCCCC
Confidence            99988875432 23     3334455899999999999999999999999999997655  79999999987542 2222


Q ss_pred             eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHH
Q psy12427        269 VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIR  348 (356)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  348 (356)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.......++    .++.++.++|+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ll~  228 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRP----GASLTAWSILE  228 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCC----CCCHHHHHHHH
Confidence            33456899999999999999999999999999999999999999999888888888776554443    68999999999


Q ss_pred             HhhhcCCC
Q psy12427        349 RLLLRNKE  356 (356)
Q Consensus       349 ~ll~~dP~  356 (356)
                      +||++||+
T Consensus       229 ~ll~~~p~  236 (325)
T cd05604         229 ELLEKDRQ  236 (325)
T ss_pred             HHhccCHH
Confidence            99999984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=5.3e-43  Score=323.55  Aligned_cols=231  Identities=24%  Similarity=0.469  Sum_probs=189.7

Q ss_pred             ccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEEEEEEeccc
Q psy12427        114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMVLIFEFLSG  189 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~  189 (356)
                      +.||+|+||+||+|.++.+++.+|+|+++...   ......+.+|+.++.++ +||||+++++++.....+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999997543   23345677899999988 699999999999999999999999999


Q ss_pred             cchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee-CCCCc
Q psy12427        190 GELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL-DPNEV  268 (356)
Q Consensus       190 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~-~~~~~  268 (356)
                      |+|..++.... .     +....+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||++... .....
T Consensus        81 ~~L~~~~~~~~-~-----l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~--~~kl~Dfg~~~~~~~~~~~  152 (327)
T cd05617          81 GDLMFHMQRQR-K-----LPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADG--HIKLTDYGMCKEGLGPGDT  152 (327)
T ss_pred             CcHHHHHHHcC-C-----CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCC--CEEEeccccceeccCCCCc
Confidence            99988876432 2     33344556999999999999999999999999999998655  6999999998753 22333


Q ss_pred             eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC-------hHHHHHHhhccccccChhhhccCCH
Q psy12427        269 VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN-------DVETLKNVKACDWEFDEEAFKNVSE  341 (356)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~~s~  341 (356)
                      ....+||+.|+|||++.+..++.++|||||||++|+|++|..||....       .....+.+......+|    ..+|.
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~~  228 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP----RFLSV  228 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCC----CCCCH
Confidence            445679999999999999999999999999999999999999996421       2233444444433333    47899


Q ss_pred             HHHHHHHHhhhcCCC
Q psy12427        342 EGKDFIRRLLLRNKE  356 (356)
Q Consensus       342 ~~~~lI~~ll~~dP~  356 (356)
                      .++++|++||++||+
T Consensus       229 ~~~~li~~~L~~dP~  243 (327)
T cd05617         229 KASHVLKGFLNKDPK  243 (327)
T ss_pred             HHHHHHHHHhccCHH
Confidence            999999999999995

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.5e-42  Score=314.43  Aligned_cols=241  Identities=25%  Similarity=0.452  Sum_probs=198.2

Q ss_pred             eeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh---hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN---LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       110 y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      |+..+.||.|+||+||++.+..+++.+|+|.+.....   .....+.+|+++|+.++|+||+++++.+..++..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            6778899999999999999999999999999865432   2234567899999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +.+++|.+.+.....    ..+....+..++.|++.||.|||+.||+||||||+||+++.++  .++|+|||++......
T Consensus        82 ~~~~~L~~~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~--~~kl~Dfg~~~~~~~~  155 (285)
T cd05632          82 MNGGDLKFHIYNMGN----PGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYG--HIRISDLGLAVKIPEG  155 (285)
T ss_pred             ccCccHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCC--CEEEecCCcceecCCC
Confidence            999999888754321    1234444556999999999999999999999999999997654  7999999999776544


Q ss_pred             CceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHH
Q psy12427        267 EVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDF  346 (356)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  346 (356)
                      .......|++.|+|||++.+..++.++|+||+||++|+|++|..||.+..+......+..............++.++.+|
T Consensus       156 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  235 (285)
T cd05632         156 ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSI  235 (285)
T ss_pred             CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHH
Confidence            33344578999999999999999999999999999999999999999887655544443332222333445789999999


Q ss_pred             HHHhhhcCCC
Q psy12427        347 IRRLLLRNKE  356 (356)
Q Consensus       347 I~~ll~~dP~  356 (356)
                      |..||+.||+
T Consensus       236 i~~~l~~~P~  245 (285)
T cd05632         236 CKMLLTKDPK  245 (285)
T ss_pred             HHHHccCCHh
Confidence            9999999995

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.3e-42  Score=336.83  Aligned_cols=243  Identities=27%  Similarity=0.424  Sum_probs=202.6

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCC------
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDD------  178 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~------  178 (356)
                      .++|++.+.||+|+||+||+|++..+|+.||+|++....  ..+...+.+|+.++..++|+||+++++.+....      
T Consensus        31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~  110 (496)
T PTZ00283         31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN  110 (496)
T ss_pred             CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence            468999999999999999999999999999999987543  344566788999999999999999998775432      


Q ss_pred             --eEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEe
Q psy12427        179 --EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMID  256 (356)
Q Consensus       179 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~D  256 (356)
                        .+++||||+++|+|.+++.....  ....+....+..++.|++.||+|||++||+||||||+|||++.++  .+||+|
T Consensus       111 ~~~i~lV~Ey~~~gsL~~~l~~~~~--~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~--~vkL~D  186 (496)
T PTZ00283        111 VLMIALVLDYANAGDLRQEIKSRAK--TNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNG--LVKLGD  186 (496)
T ss_pred             ceEEEEEEeCCCCCcHHHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCC--CEEEEe
Confidence              36899999999999998864321  122334444566999999999999999999999999999998654  799999


Q ss_pred             eeceeeeCCC---CceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCh
Q psy12427        257 FGLATKLDPN---EVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE  333 (356)
Q Consensus       257 fg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~  333 (356)
                      ||+++.+...   .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+.......  
T Consensus       187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~--  264 (496)
T PTZ00283        187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP--  264 (496)
T ss_pred             cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC--
Confidence            9999876432   22234568999999999999999999999999999999999999999999888888877665432  


Q ss_pred             hhhccCCHHHHHHHHHhhhcCCC
Q psy12427        334 EAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       334 ~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                       ....++++++++|.+||+.||+
T Consensus       265 -~~~~~~~~l~~li~~~L~~dP~  286 (496)
T PTZ00283        265 -LPPSISPEMQEIVTALLSSDPK  286 (496)
T ss_pred             -CCCCCCHHHHHHHHHHcccChh
Confidence             2347899999999999999985

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.2e-42  Score=311.85  Aligned_cols=239  Identities=16%  Similarity=0.250  Sum_probs=197.5

Q ss_pred             cceeeeccccccCceEEEEEEEc---cCCCEEEEEEcccCCh-hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRER---KTGNIFAAKFIPVSHN-LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~---~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      ++|++.+.||+|+||.||+|.++   ..+..+|+|.++.... .....+.+|+.++.+++||||+++++++......++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            46999999999999999999876   3457899999876532 3345688999999999999999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      |||+++|+|.+++......++     ...+..++.|++.||+|||++|++||||||+|||++.++  .++++|||.+...
T Consensus        85 ~e~~~~~~L~~~l~~~~~~l~-----~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~--~~~l~dfg~~~~~  157 (266)
T cd05064          85 TEYMSNGALDSFLRKHEGQLV-----AGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDL--VCKISGFRRLQED  157 (266)
T ss_pred             EEeCCCCcHHHHHHhCCCCCC-----HHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCC--cEEECCCcccccc
Confidence            999999999999875433333     344556999999999999999999999999999997654  7999999987654


Q ss_pred             CCCCcee--ecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCC
Q psy12427        264 DPNEVVK--ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVS  340 (356)
Q Consensus       264 ~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  340 (356)
                      .......  ...++..|+|||.+.+..++.++|||||||++||+++ |..||.+.+..+.+..+.......   .+..++
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~  234 (266)
T cd05064         158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLP---APRNCP  234 (266)
T ss_pred             cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC---CCCCCC
Confidence            3222111  2234678999999999999999999999999999875 999999999888888876653222   235789


Q ss_pred             HHHHHHHHHhhhcCCC
Q psy12427        341 EEGKDFIRRLLLRNKE  356 (356)
Q Consensus       341 ~~~~~lI~~ll~~dP~  356 (356)
                      ..+.++|.+||+.||+
T Consensus       235 ~~~~~li~~c~~~~p~  250 (266)
T cd05064         235 NLLHQLMLDCWQKERG  250 (266)
T ss_pred             HHHHHHHHHHcCCCch
Confidence            9999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=7.8e-43  Score=325.82  Aligned_cols=239  Identities=28%  Similarity=0.451  Sum_probs=189.5

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh-hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN-LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      ..++|++.++||+|+||+||+|.++.+++.||+|++..... .....+.+|+++|+.++|+||+++++++...+.+++||
T Consensus        72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  151 (353)
T PLN00034         72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL  151 (353)
T ss_pred             CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence            34678999999999999999999999999999999865432 33567889999999999999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      ||+++|+|.+..     ...+     ..+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||++....
T Consensus       152 e~~~~~~L~~~~-----~~~~-----~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~--~~kL~DfG~~~~~~  219 (353)
T PLN00034        152 EFMDGGSLEGTH-----IADE-----QFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAK--NVKIADFGVSRILA  219 (353)
T ss_pred             ecCCCCcccccc-----cCCH-----HHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC--CEEEcccccceecc
Confidence            999999985432     1122     23455899999999999999999999999999997654  79999999998764


Q ss_pred             CCC-ceeecCCCcCccccccccC-----CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhcc
Q psy12427        265 PNE-VVKISTGTAEFAAPEIVER-----EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKN  338 (356)
Q Consensus       265 ~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  338 (356)
                      ... ......||..|+|||++..     ...+.++|||||||++|||++|+.||......+....+.......+......
T Consensus       220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (353)
T PLN00034        220 QTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPAT  299 (353)
T ss_pred             cccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCc
Confidence            322 2234578999999998853     2345689999999999999999999985443332222221112222333457


Q ss_pred             CCHHHHHHHHHhhhcCCC
Q psy12427        339 VSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       339 ~s~~~~~lI~~ll~~dP~  356 (356)
                      ++.++++||.+||+.||+
T Consensus       300 ~~~~l~~li~~~l~~~P~  317 (353)
T PLN00034        300 ASREFRHFISCCLQREPA  317 (353)
T ss_pred             cCHHHHHHHHHHccCChh
Confidence            899999999999999985

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.2e-42  Score=314.98  Aligned_cols=238  Identities=26%  Similarity=0.478  Sum_probs=193.7

Q ss_pred             eeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh---hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN---LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       110 y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      |++.+.||+|+||+||++.++.+++.+|+|.+.....   .....+.+|+.++++++|+||+++++.+......++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            6778899999999999999999999999998865432   2234567899999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +.|++|.+++.....    ..+....+..++.|++.||.|||+.||+||||||+||+++.++  .++|+|||++......
T Consensus        82 ~~g~~L~~~l~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~--~~~l~Dfg~~~~~~~~  155 (285)
T cd05630          82 MNGGDLKFHIYHMGE----AGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHG--HIRISDLGLAVHVPEG  155 (285)
T ss_pred             cCCCcHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC--CEEEeeccceeecCCC
Confidence            999999988854221    1233444566899999999999999999999999999997654  6999999999776544


Q ss_pred             CceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChH---HHHHHhhccccccChhhhccCCHHH
Q psy12427        267 EVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDV---ETLKNVKACDWEFDEEAFKNVSEEG  343 (356)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~s~~~  343 (356)
                      .......|++.|+|||++.+..++.++|+||+||++|+|++|+.||......   +....+..   ..+......++.++
T Consensus       156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~  232 (285)
T cd05630         156 QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK---EVQEEYSEKFSPDA  232 (285)
T ss_pred             ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhh---hhhhhcCccCCHHH
Confidence            4334457899999999999999999999999999999999999999876432   22222211   11223345789999


Q ss_pred             HHHHHHhhhcCCC
Q psy12427        344 KDFIRRLLLRNKE  356 (356)
Q Consensus       344 ~~lI~~ll~~dP~  356 (356)
                      ++||++||+.||+
T Consensus       233 ~~li~~~l~~~p~  245 (285)
T cd05630         233 RSLCKMLLCKDPK  245 (285)
T ss_pred             HHHHHHHhhcCHH
Confidence            9999999999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.1e-42  Score=318.93  Aligned_cols=241  Identities=24%  Similarity=0.412  Sum_probs=194.1

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh-hHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL-EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      ++|.+.+.||+|+||+||+|+++.++..+|+|.++..... ....+.+|+.+++.++||||+++++++..+...++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            5799999999999999999999999999999998754322 234567899999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +.+ +|.+++......++     ...+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||++......
T Consensus        86 ~~~-~l~~~~~~~~~~~~-----~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~  157 (309)
T cd07872          86 LDK-DLKQYMDDCGNIMS-----MHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERG--ELKLADFGLARAKSVP  157 (309)
T ss_pred             CCC-CHHHHHHhcCCCCC-----HHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC--CEEECccccceecCCC
Confidence            975 78877765432233     334455899999999999999999999999999997654  7999999999765322


Q ss_pred             C-ceeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCh-----------
Q psy12427        267 E-VVKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE-----------  333 (356)
Q Consensus       267 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~-----------  333 (356)
                      . ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+......+++           
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07872         158 TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE  237 (309)
T ss_pred             ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence            2 2233467899999998865 46889999999999999999999999988877666655432211111           


Q ss_pred             ---------------hhhccCCHHHHHHHHHhhhcCCC
Q psy12427        334 ---------------EAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       334 ---------------~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                     .....+++++++||++||+.||+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~  275 (309)
T cd07872         238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESK  275 (309)
T ss_pred             hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChh
Confidence                           11235789999999999999995

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.6e-42  Score=324.44  Aligned_cols=241  Identities=24%  Similarity=0.397  Sum_probs=191.2

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCC----
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDD----  178 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----  178 (356)
                      .+.++|++.+.||+|+||.||+|.++.+|..+|+|.+....  ......+.+|+.+++.++||||+++++++....    
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            35678999999999999999999999999999999986542  333456778999999999999999999986443    


Q ss_pred             --eEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEe
Q psy12427        179 --EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMID  256 (356)
Q Consensus       179 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~D  256 (356)
                        ..++||||+.+ +|.+.+..   .++     ...+..++.|++.||+|||++||+||||||+|||++.++  .+||+|
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~~---~~~-----~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~--~~kl~D  166 (359)
T cd07876          98 FQDVYLVMELMDA-NLCQVIHM---ELD-----HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILD  166 (359)
T ss_pred             cceeEEEEeCCCc-CHHHHHhc---cCC-----HHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC--CEEEec
Confidence              57999999965 56555532   122     233455899999999999999999999999999997654  799999


Q ss_pred             eeceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC----
Q psy12427        257 FGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD----  332 (356)
Q Consensus       257 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~----  332 (356)
                      ||+++............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+......++    
T Consensus       167 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  246 (359)
T cd07876         167 FGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM  246 (359)
T ss_pred             CCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence            9999876544444445789999999999999999999999999999999999999998876555443322111100    


Q ss_pred             ----------------------------------hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 ----------------------------------EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 ----------------------------------~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                                        .......++++++||.+||+.||+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~  304 (359)
T cd07876         247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPD  304 (359)
T ss_pred             HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcc
Confidence                                              001112467899999999999996

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.3e-42  Score=322.22  Aligned_cols=239  Identities=26%  Similarity=0.411  Sum_probs=188.7

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeC-----CeEE
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDD-----DEMV  181 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~~~  181 (356)
                      +|++.+.||+|+||.||+|+++.++..||+|.+....  ......+.+|+.+++.++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4889999999999999999999999999999986432  23345678899999999999999999988543     3589


Q ss_pred             EEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeecee
Q psy12427        182 LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT  261 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~  261 (356)
                      +||||+. ++|.+++.... .     +....+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+++
T Consensus        81 lv~e~~~-~~L~~~l~~~~-~-----~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~--~~kL~Dfg~~~  151 (338)
T cd07859          81 VVFELME-SDLHQVIKAND-D-----LTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADC--KLKICDFGLAR  151 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc-c-----CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC--cEEEccCcccc
Confidence            9999995 68888876432 2     33344556999999999999999999999999999997654  79999999997


Q ss_pred             eeCCCC----ceeecCCCcCccccccccC--CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc-----
Q psy12427        262 KLDPNE----VVKISTGTAEFAAPEIVER--EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWE-----  330 (356)
Q Consensus       262 ~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~-----  330 (356)
                      ......    ......||+.|+|||++.+  ..++.++|||||||++|+|++|++||.+.+....+..+......     
T Consensus       152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  231 (338)
T cd07859         152 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET  231 (338)
T ss_pred             ccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            643211    1123468999999999876  67889999999999999999999999887765544333221111     


Q ss_pred             ----------------------cChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        331 ----------------------FDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       331 ----------------------~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                            .....+..+++++.++|.+||+.||+
T Consensus       232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~  279 (338)
T cd07859         232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPK  279 (338)
T ss_pred             HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcc
Confidence                                  11223346788999999999999995

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG4721|consensus

Probab=100.00  E-value=3e-44  Score=330.06  Aligned_cols=231  Identities=23%  Similarity=0.389  Sum_probs=196.6

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      ++...-++=||.|+.|-||+|+.+  +..||||.++.-.       ..++.-|++|+||||+.+.|+|....++||||||
T Consensus       123 Fe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEf  193 (904)
T KOG4721|consen  123 FEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEF  193 (904)
T ss_pred             HHHhhhhhhhccCcccceeeeecc--CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeec
Confidence            445566788999999999999988  7899999764322       2478889999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      |..|.|.++|....      .+....+..|.++|+.||+|||...|||||||.-||||..++  .|||+|||.++.....
T Consensus       194 Ca~GqL~~VLka~~------~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d--~VKIsDFGTS~e~~~~  265 (904)
T KOG4721|consen  194 CAQGQLYEVLKAGR------PITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDD--VVKISDFGTSKELSDK  265 (904)
T ss_pred             cccccHHHHHhccC------ccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccc--eEEeccccchHhhhhh
Confidence            99999999998654      333444566999999999999999999999999999998766  6999999999988765


Q ss_pred             CceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHH
Q psy12427        267 EVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDF  346 (356)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  346 (356)
                      ...-..+||..|||||+|+.++.+.++|||||||||||||||..||.+.+...++--+-......|-  +..+|+-++-|
T Consensus       266 STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~Lpv--PstcP~GfklL  343 (904)
T KOG4721|consen  266 STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPV--PSTCPDGFKLL  343 (904)
T ss_pred             hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccC--cccCchHHHHH
Confidence            5555678999999999999999999999999999999999999999998877666555443333332  24789999999


Q ss_pred             HHHhhhcCCC
Q psy12427        347 IRRLLLRNKE  356 (356)
Q Consensus       347 I~~ll~~dP~  356 (356)
                      |++||+..|+
T Consensus       344 ~Kqcw~sKpR  353 (904)
T KOG4721|consen  344 LKQCWNSKPR  353 (904)
T ss_pred             HHHHHhcCCC
Confidence            9999998875

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=5.9e-42  Score=313.32  Aligned_cols=247  Identities=19%  Similarity=0.302  Sum_probs=194.2

Q ss_pred             cceeeeccccccCceEEEEEEEcc----------------CCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceee
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERK----------------TGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINL  170 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~----------------~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l  170 (356)
                      ++|.+.++||+|+||.||+|.++.                ++..||+|.+.... ......+.+|+.+|.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            579999999999999999998643                33479999987653 3345678899999999999999999


Q ss_pred             eeeEEeCCeEEEEEEeccccchhhhhhCCCCCCC-------------ccccccccHHHHHHHHHHHHHHHHHCCceeccC
Q psy12427        171 HDAFEDDDEMVLIFEFLSGGELFERITAPDYKMS-------------EAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDV  237 (356)
Q Consensus       171 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dl  237 (356)
                      ++++......+++|||+.+|+|.+++........             ...+....+..++.||+.||+|||+.||+||||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dl  164 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDL  164 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCc
Confidence            9999999999999999999999998864321110             012233445669999999999999999999999


Q ss_pred             CCCCEEEeecCCCcEEEEeeeceeeeCCCCcee---ecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc--CCCCC
Q psy12427        238 KPENIMCQTRNSTNVKMIDFGLATKLDPNEVVK---ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS--GLSPF  312 (356)
Q Consensus       238 kp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~--g~~Pf  312 (356)
                      ||+|||++.++  .+||+|||+++.........   ...++..|+|||++....++.++|||||||++|+|++  +..||
T Consensus       165 kp~Nill~~~~--~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~  242 (304)
T cd05096         165 ATRNCLVGENL--TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY  242 (304)
T ss_pred             chhheEEcCCc--cEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCC
Confidence            99999998654  79999999998764333221   2235788999999998899999999999999999986  67899


Q ss_pred             CCCChHHHHHHhhcc----ccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        313 AGENDVETLKNVKAC----DWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       313 ~~~~~~~~~~~i~~~----~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+.+..+.+.++...    ...........++..+.+||.+||+.||+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~  290 (304)
T cd05096         243 GELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCR  290 (304)
T ss_pred             CcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCch
Confidence            888777766554321    01111111236789999999999999995

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0193|consensus

Probab=100.00  E-value=1.7e-43  Score=327.88  Aligned_cols=240  Identities=25%  Similarity=0.352  Sum_probs=200.2

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      ..++..+.+.||+|+||+||+|+|..   .||||++....  ..+.+.|++|+.++++-+|.||+-+.|+|..+.. .||
T Consensus       390 p~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIi  465 (678)
T KOG0193|consen  390 PPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AII  465 (678)
T ss_pred             CHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eee
Confidence            34567889999999999999999984   59999998764  4466889999999999999999999999999887 999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      +.||+|.+|+.+++.....+     ...++..|++||++||.|||.++|||||||..||++..++  .|||+|||++..-
T Consensus       466 TqwCeGsSLY~hlHv~etkf-----dm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~--kVkIgDFGLatvk  538 (678)
T KOG0193|consen  466 TQWCEGSSLYTHLHVQETKF-----DMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDL--KVKIGDFGLATVK  538 (678)
T ss_pred             ehhccCchhhhhccchhhhh-----hHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCC--cEEEecccceeee
Confidence            99999999999997654333     3344455999999999999999999999999999997654  7999999998754


Q ss_pred             C---CCCceeecCCCcCccccccccC---CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChh-hh
Q psy12427        264 D---PNEVVKISTGTAEFAAPEIVER---EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEE-AF  336 (356)
Q Consensus       264 ~---~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~  336 (356)
                      .   .........|...|||||+++.   .+|++.+||||||+++|||++|..||...+...++..+-++-..++.. ..
T Consensus       539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~  618 (678)
T KOG0193|consen  539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIR  618 (678)
T ss_pred             eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhh
Confidence            2   2333444568999999999964   478999999999999999999999999777777777776664444322 23


Q ss_pred             ccCCHHHHHHHHHhhhcCCC
Q psy12427        337 KNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       337 ~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+++.++++|+..||+++|+
T Consensus       619 s~~pk~mk~Ll~~C~~~~~~  638 (678)
T KOG0193|consen  619 SNCPKAMKRLLSDCWKFDRE  638 (678)
T ss_pred             ccCHHHHHHHHHHHHhcCcc
Confidence            46888999999999999985

>KOG1095|consensus

Probab=100.00  E-value=9.2e-43  Score=346.57  Aligned_cols=244  Identities=20%  Similarity=0.347  Sum_probs=204.4

Q ss_pred             cceeeeccccccCceEEEEEEEccCC-----CEEEEEEcccC-ChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTG-----NIFAAKFIPVS-HNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMV  181 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~-----~~~a~K~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  181 (356)
                      ...++.+.||+|+||.||+|....-.     ..||+|.++.. +..+..+|.+|+.+|+.++|||||+++|++......+
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            45788899999999999999877542     34899988754 4556788999999999999999999999999999999


Q ss_pred             EEEEeccccchhhhhhCCCC-CCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeece
Q psy12427        182 LIFEFLSGGELFERITAPDY-KMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA  260 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a  260 (356)
                      +++|||+||+|..+|.+.+. ......+....+..++.|||+|++||+++++|||||..+|+|++..  ..|||+|||+|
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~--r~VKIaDFGlA  849 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDER--RVVKIADFGLA  849 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeeccc--CcEEEcccchh
Confidence            99999999999999986532 2333444445566699999999999999999999999999999866  47999999999


Q ss_pred             eeeCCCCceeec---CCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhh
Q psy12427        261 TKLDPNEVVKIS---TGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAF  336 (356)
Q Consensus       261 ~~~~~~~~~~~~---~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  336 (356)
                      +.+...+.....   .-+..|||||.+..+.++.+||||||||+|||++| |..||.+.++.+++.-+..+. ..+++  
T Consensus       850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL~~P--  926 (1025)
T KOG1095|consen  850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RLDPP--  926 (1025)
T ss_pred             HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-ccCCC--
Confidence            965443333221   22579999999999999999999999999999999 999999999999998665544 33222  


Q ss_pred             ccCCHHHHHHHHHhhhcCCC
Q psy12427        337 KNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       337 ~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ..+|+.+-++|.+||+.+|+
T Consensus       927 ~~CP~~ly~lM~~CW~~~pe  946 (1025)
T KOG1095|consen  927 SYCPEKLYQLMLQCWKHDPE  946 (1025)
T ss_pred             CCCChHHHHHHHHHccCChh
Confidence            48999999999999999996

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-43  Score=324.24  Aligned_cols=230  Identities=29%  Similarity=0.526  Sum_probs=191.1

Q ss_pred             ccccCceEEEEEEEccCCCEEEEEEcccCCh---hhHHHHHHHHHHHHhc---CCCCceeeeeeEEeCCeEEEEEEeccc
Q psy12427        116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHN---LEKELIRKEIDIMNQL---HHPKLINLHDAFEDDDEMVLIFEFLSG  189 (356)
Q Consensus       116 lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~~~~~~lv~e~~~~  189 (356)
                      ||+|+||+||+|+++.+++.||+|++.....   ........|..++..+   +||||+++++++......++||||+.+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            7999999999999999999999999864322   1223344577777665   699999999999999999999999999


Q ss_pred             cchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC-CCc
Q psy12427        190 GELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP-NEV  268 (356)
Q Consensus       190 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~-~~~  268 (356)
                      |+|.+++.... .+     ....+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||++..... ...
T Consensus        81 g~L~~~l~~~~-~~-----~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~--~~kl~Dfg~a~~~~~~~~~  152 (330)
T cd05586          81 GELFWHLQKEG-RF-----SEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATG--HIALCDFGLSKANLTDNKT  152 (330)
T ss_pred             ChHHHHHHhcC-CC-----CHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC--CEEEecCCcCcCCCCCCCC
Confidence            99998886432 23     3344556999999999999999999999999999997654  799999999875432 223


Q ss_pred             eeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHH
Q psy12427        269 VKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFI  347 (356)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI  347 (356)
                      .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.++++......++.   ..+++++++||
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~~li  229 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK---NVLSDEGRQFV  229 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCC---ccCCHHHHHHH
Confidence            3445699999999998764 4789999999999999999999999999988888888877766654   25899999999


Q ss_pred             HHhhhcCCC
Q psy12427        348 RRLLLRNKE  356 (356)
Q Consensus       348 ~~ll~~dP~  356 (356)
                      ++||+.||+
T Consensus       230 ~~~L~~~P~  238 (330)
T cd05586         230 KGLLNRNPQ  238 (330)
T ss_pred             HHHcCCCHH
Confidence            999999984

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.9e-42  Score=311.41  Aligned_cols=229  Identities=12%  Similarity=0.122  Sum_probs=190.1

Q ss_pred             ccccccCceEEEEEEEccCCCEEEEEEcccCChhh---HHHHHHHHHHHHhcCCCCceeeeeeEEe----CCeEEEEEEe
Q psy12427        114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE---KELIRKEIDIMNQLHHPKLINLHDAFED----DDEMVLIFEF  186 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~---~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~~~lv~e~  186 (356)
                      ..||+|++|.||+|..  +|+.||+|.++......   .+.+.+|+.+|.+++||||+++++++.+    ....++||||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            4689999999999988  48899999997654333   3667799999999999999999999876    4578999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEK-NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      +++|+|.+++.... .+     .......++.+++.||.|||+. +++||||||+|||++.++  .+||+|||+++....
T Consensus       104 ~~~g~L~~~l~~~~-~~-----~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~--~~kl~dfg~~~~~~~  175 (283)
T PHA02988        104 CTRGYLREVLDKEK-DL-----SFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY--KLKIICHGLEKILSS  175 (283)
T ss_pred             CCCCcHHHHHhhCC-CC-----ChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC--cEEEcccchHhhhcc
Confidence            99999999987532 22     2333455899999999999984 999999999999998654  799999999876543


Q ss_pred             CCceeecCCCcCccccccccC--CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHH
Q psy12427        266 NEVVKISTGTAEFAAPEIVER--EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG  343 (356)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  343 (356)
                      ..  ....|+..|+|||++.+  ..++.++|||||||++|||++|..||.+.+..+.+..+......++  ....+|+++
T Consensus       176 ~~--~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~~l  251 (283)
T PHA02988        176 PP--FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK--LPLDCPLEI  251 (283)
T ss_pred             cc--ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC--CCCcCcHHH
Confidence            22  23468899999999976  6899999999999999999999999999988888888765544433  223689999


Q ss_pred             HHHHHHhhhcCCC
Q psy12427        344 KDFIRRLLLRNKE  356 (356)
Q Consensus       344 ~~lI~~ll~~dP~  356 (356)
                      ++||.+||+.||+
T Consensus       252 ~~li~~cl~~dp~  264 (283)
T PHA02988        252 KCIVEACTSHDSI  264 (283)
T ss_pred             HHHHHHHhcCCcc
Confidence            9999999999995

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=5e-42  Score=311.10  Aligned_cols=241  Identities=25%  Similarity=0.404  Sum_probs=191.3

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh--hHHHHHHHHHHHHhc---CCCCceeeeeeEEe-----CC
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL--EKELIRKEIDIMNQL---HHPKLINLHDAFED-----DD  178 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~E~~il~~l---~hpnIv~l~~~~~~-----~~  178 (356)
                      +|++.+.||+|+||+||+|.++.+++.+|+|.++.....  ....+.+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            488999999999999999999999999999998754321  223455677777665   79999999998864     35


Q ss_pred             eEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeee
Q psy12427        179 EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFG  258 (356)
Q Consensus       179 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg  258 (356)
                      ..+++|||+.+ +|.+++.....    ..+....+..++.|++.||+|||++|++||||||+|||++.++  .+||+|||
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~--~~kl~dfg  153 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPP----PGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG--QVKLADFG  153 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC--CEEECccC
Confidence            58999999974 78887764321    2234445566999999999999999999999999999997654  79999999


Q ss_pred             ceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc--------
Q psy12427        259 LATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWE--------  330 (356)
Q Consensus       259 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~--------  330 (356)
                      +++............|++.|+|||++.+..++.++||||+||++|+|++|.+||.+....+.+.++......        
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07863         154 LARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR  233 (288)
T ss_pred             ccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence            998765443334456899999999999989999999999999999999999999988777666655431110        


Q ss_pred             ---------------cChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        331 ---------------FDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       331 ---------------~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                     ........++++++++|.+||+.||+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  274 (288)
T cd07863         234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPH  274 (288)
T ss_pred             cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcc
Confidence                           11123346789999999999999995

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG0579|consensus

Probab=100.00  E-value=6.1e-44  Score=331.43  Aligned_cols=241  Identities=26%  Similarity=0.430  Sum_probs=213.0

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEec
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFL  187 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~  187 (356)
                      +.|.|+..||.|+||.||+|..+.++...|.|++......+.+++.-|++||..++||+||+|++.|-.++.++|+.|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            57899999999999999999999999999999999988888999999999999999999999999999999999999999


Q ss_pred             cccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC-C
Q psy12427        188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP-N  266 (356)
Q Consensus       188 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~-~  266 (356)
                      .||....++......+.+.++.     .+++|++.||.|||+++|||||||..|||+..+|  .++|+|||.+..... .
T Consensus       112 ~GGAVDaimlEL~r~LtE~QIq-----vvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldG--dirLADFGVSAKn~~t~  184 (1187)
T KOG0579|consen  112 GGGAVDAIMLELGRVLTEDQIQ-----VVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDG--DIRLADFGVSAKNKSTR  184 (1187)
T ss_pred             CCchHhHHHHHhccccchHHHH-----HHHHHHHHHHHHHhhcchhhhhccccceEEEecC--cEeeecccccccchhHH
Confidence            9999999888776667666654     4999999999999999999999999999999877  699999999876432 2


Q ss_pred             CceeecCCCcCcccccccc-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCH
Q psy12427        267 EVVKISTGTAEFAAPEIVE-----REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSE  341 (356)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  341 (356)
                      .......|||+|||||+..     ..+|++++||||||+.|.||..+.+|...-+++-.+-+|.+...+.. ..+..+|.
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTL-lqPS~Ws~  263 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL-LQPSHWSR  263 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcc-cCcchhhh
Confidence            2334568999999999874     56899999999999999999999999999999999988877653321 12347999


Q ss_pred             HHHHHHHHhhhcCCC
Q psy12427        342 EGKDFIRRLLLRNKE  356 (356)
Q Consensus       342 ~~~~lI~~ll~~dP~  356 (356)
                      ..+||+++||.+||+
T Consensus       264 ~F~DfLk~cL~Knp~  278 (1187)
T KOG0579|consen  264 SFSDFLKRCLVKNPR  278 (1187)
T ss_pred             HHHHHHHHHHhcCCc
Confidence            999999999999995

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=5.6e-42  Score=322.16  Aligned_cols=246  Identities=21%  Similarity=0.298  Sum_probs=194.6

Q ss_pred             ccceeeeccccccCceEEEEEEEccCC-----CEEEEEEcccCC-hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCe
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTG-----NIFAAKFIPVSH-NLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDE  179 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~-----~~~a~K~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  179 (356)
                      .++|++.+.||+|+||.||+|++..+|     ..||+|.++... ......+.+|+.+++.+ +||||+++++++.....
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            457999999999999999999975443     579999997654 33456688999999999 89999999999999999


Q ss_pred             EEEEEEeccccchhhhhhCCCCCC--------------------------------------------------------
Q psy12427        180 MVLIFEFLSGGELFERITAPDYKM--------------------------------------------------------  203 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~~~--------------------------------------------------------  203 (356)
                      .++||||+.+|+|.+++.......                                                        
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            999999999999999885422100                                                        


Q ss_pred             --------CccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCcee---ec
Q psy12427        204 --------SEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVK---IS  272 (356)
Q Consensus       204 --------~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~~~---~~  272 (356)
                              ....+....+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+++.........   ..
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~--~~kL~DfGla~~~~~~~~~~~~~~~  274 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR--VAKICDFGLARDIMNDSNYVVKGNA  274 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCC--eEEEeeceeeeeccCCcceeeccCC
Confidence                    001123334567899999999999999999999999999997544  79999999998764332211   12


Q ss_pred             CCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHHHhh
Q psy12427        273 TGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLL  351 (356)
Q Consensus       273 ~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll  351 (356)
                      .+++.|+|||++....++.++|||||||++|+|++ |+.||........+..+.......+  ....+|.+++++|.+||
T Consensus       275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl  352 (374)
T cd05106         275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMS--RPDFAPPEIYSIMKMCW  352 (374)
T ss_pred             CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCcc--CCCCCCHHHHHHHHHHc
Confidence            34668999999999999999999999999999997 9999988765554444444333222  22357899999999999


Q ss_pred             hcCCC
Q psy12427        352 LRNKE  356 (356)
Q Consensus       352 ~~dP~  356 (356)
                      +.||+
T Consensus       353 ~~dp~  357 (374)
T cd05106         353 NLEPT  357 (374)
T ss_pred             CCChh
Confidence            99995

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0696|consensus

Probab=100.00  E-value=3.2e-43  Score=312.67  Aligned_cols=237  Identities=27%  Similarity=0.499  Sum_probs=206.4

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhh---HHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE---KELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~---~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      .+|.++.+||+|+||.|-++..+.+...+|+|+++.+--.+   .+--..|..+|... +-|.+++++.+|+.-+.+|+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            46889999999999999999999999999999998754222   22223577777776 457899999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      |||+.||+|.-.+.+-. ++.+..+..     ++.+|+.||-+||++|||+||||.+|||++.++  ++||+|||++..-
T Consensus       429 MEyvnGGDLMyhiQQ~G-kFKEp~AvF-----YAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eG--HiKi~DFGmcKEn  500 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQVG-KFKEPVAVF-----YAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKEN  500 (683)
T ss_pred             EEEecCchhhhHHHHhc-ccCCchhhh-----hhHHHHHHhhhhhcCCeeeeeccccceEeccCC--ceEeeeccccccc
Confidence            99999999988876543 455555544     999999999999999999999999999998665  8999999999764


Q ss_pred             C-CCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHH
Q psy12427        264 D-PNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEE  342 (356)
Q Consensus       264 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  342 (356)
                      - ....+.+.+|||.|+|||++.+++|+.+.|.||+||+||||+.|++||.+.++.+..++|...+..+|    +.+|.|
T Consensus       501 i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyP----KslSkE  576 (683)
T KOG0696|consen  501 IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYP----KSLSKE  576 (683)
T ss_pred             ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCc----ccccHH
Confidence            2 34556778999999999999999999999999999999999999999999999999999999998887    489999


Q ss_pred             HHHHHHHhhhcCCC
Q psy12427        343 GKDFIRRLLLRNKE  356 (356)
Q Consensus       343 ~~~lI~~ll~~dP~  356 (356)
                      +.++++.+|.+.|.
T Consensus       577 Av~ickg~ltK~P~  590 (683)
T KOG0696|consen  577 AVAICKGLLTKHPG  590 (683)
T ss_pred             HHHHHHHHhhcCCc
Confidence            99999999999984

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=8.3e-42  Score=308.29  Aligned_cols=244  Identities=17%  Similarity=0.307  Sum_probs=202.7

Q ss_pred             cceeeeccccccCceEEEEEEEcc-----CCCEEEEEEcccCChh-hHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERK-----TGNIFAAKFIPVSHNL-EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMV  181 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~-----~~~~~a~K~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  181 (356)
                      ++|.+.+.||+|+||.||+|.+..     ++..+|+|.++..... ....+.+|+++|+.++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            468999999999999999998753     3578999998765544 4568889999999999999999999999999999


Q ss_pred             EEEEeccccchhhhhhCCCCC--------CCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEE
Q psy12427        182 LIFEFLSGGELFERITAPDYK--------MSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVK  253 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~--------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vk  253 (356)
                      ++|||+++++|.+++......        .....+....+..++.|++.||+|||++|++||||||+||+++.++  .++
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~--~~k  162 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL--VVK  162 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC--eEE
Confidence            999999999999998754321        1122334445666899999999999999999999999999998654  799


Q ss_pred             EEeeeceeeeCCCCce---eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccc
Q psy12427        254 MIDFGLATKLDPNEVV---KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDW  329 (356)
Q Consensus       254 l~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~  329 (356)
                      |+|||++.........   ....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus       163 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~  242 (280)
T cd05049         163 IGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRL  242 (280)
T ss_pred             ECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCc
Confidence            9999999765332221   12235788999999999999999999999999999998 9999998888888888776554


Q ss_pred             ccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        330 EFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       330 ~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ..++   ..++.+++++|++||+.||+
T Consensus       243 ~~~~---~~~~~~~~~li~~~l~~~p~  266 (280)
T cd05049         243 LQRP---RTCPSEVYDIMLGCWKRDPQ  266 (280)
T ss_pred             CCCC---CCCCHHHHHHHHHHcCCCcc
Confidence            4333   47899999999999999995

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=6.1e-42  Score=321.11  Aligned_cols=240  Identities=23%  Similarity=0.379  Sum_probs=193.4

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeC------
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDD------  177 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------  177 (356)
                      +.++|++.+.||+|+||.||+|.+..+++.+|+|.+....  ......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            4578999999999999999999999999999999987532  33345677899999999999999999987543      


Q ss_pred             CeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEee
Q psy12427        178 DEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDF  257 (356)
Q Consensus       178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Df  257 (356)
                      ...++||||+.+ +|.+.+..   .++     ...+..++.|++.||+|||++||+||||||+|||++.++  .+||+||
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~---~~~-----~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~Df  170 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM---ELD-----HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDF  170 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh---cCC-----HHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCC--cEEEEeC
Confidence            457999999965 66666542   122     233455999999999999999999999999999997654  7999999


Q ss_pred             eceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChh---
Q psy12427        258 GLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEE---  334 (356)
Q Consensus       258 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~---  334 (356)
                      |+++............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+.++......+.++   
T Consensus       171 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  250 (364)
T cd07875         171 GLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK  250 (364)
T ss_pred             CCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            99987655444445678999999999999999999999999999999999999999988877766654322111111   


Q ss_pred             -----------------------------------hhccCCHHHHHHHHHhhhcCCC
Q psy12427        335 -----------------------------------AFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       335 -----------------------------------~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                                         .....+.++++||.+||+.||+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~  307 (364)
T cd07875         251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS  307 (364)
T ss_pred             hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcc
Confidence                                               1112356899999999999995

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=8.5e-42  Score=321.14  Aligned_cols=246  Identities=21%  Similarity=0.301  Sum_probs=193.0

Q ss_pred             ccceeeeccccccCceEEEEEEE-----ccCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCe
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRE-----RKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDE  179 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~-----~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  179 (356)
                      .++|++.+.||+|+||.||+|.+     ..++..||+|+++... ......+.+|+.+|..+ +||||+++++++.....
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            45799999999999999999974     3456789999987543 33456788999999999 89999999999999999


Q ss_pred             EEEEEEeccccchhhhhhCCCCCCC-------------------------------------------------------
Q psy12427        180 MVLIFEFLSGGELFERITAPDYKMS-------------------------------------------------------  204 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~~~~-------------------------------------------------------  204 (356)
                      .++||||+++|+|.+++........                                                       
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            9999999999999999865321100                                                       


Q ss_pred             --------------ccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCcee
Q psy12427        205 --------------EAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVK  270 (356)
Q Consensus       205 --------------~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~~~  270 (356)
                                    ...+....+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+++.........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~--~~kl~DfG~a~~~~~~~~~~  271 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR--ITKICDFGLARDIRNDSNYV  271 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCC--cEEEecCccceeccCccccc
Confidence                          01123334566899999999999999999999999999997543  79999999998764332211


Q ss_pred             ---ecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHH
Q psy12427        271 ---ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDF  346 (356)
Q Consensus       271 ---~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  346 (356)
                         ...++..|+|||++.+..++.++|||||||++|+|++ |..||.+......+.+.........  .+...+.++++|
T Consensus       272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l  349 (375)
T cd05104         272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML--SPECAPSEMYDI  349 (375)
T ss_pred             ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC--CCCCCCHHHHHH
Confidence               1234678999999999999999999999999999998 9999987754443333333222221  223578999999


Q ss_pred             HHHhhhcCCC
Q psy12427        347 IRRLLLRNKE  356 (356)
Q Consensus       347 I~~ll~~dP~  356 (356)
                      |.+||+.||+
T Consensus       350 i~~cl~~dP~  359 (375)
T cd05104         350 MKSCWDADPL  359 (375)
T ss_pred             HHHHccCChh
Confidence            9999999995

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1e-41  Score=315.75  Aligned_cols=204  Identities=25%  Similarity=0.466  Sum_probs=173.7

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      ++|++.++||.|+||.||++.++.++..+|+|.+.... ......+.+|++++++++||||++++++|...+..++||||
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence            57999999999999999999999999999999987653 33446788999999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEK-NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      +.+++|.+++.... .+     ....+..++.+++.||.|||+. +++|+||||+|||++.++  .+||+|||++.....
T Consensus        85 ~~~~~L~~~l~~~~-~~-----~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~--~~kL~Dfg~~~~~~~  156 (333)
T cd06650          85 MDGGSLDQVLKKAG-RI-----PEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG--EIKLCDFGVSGQLID  156 (333)
T ss_pred             CCCCcHHHHHHHcC-CC-----CHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCC--CEEEeeCCcchhhhh
Confidence            99999999986432 22     2334455899999999999985 799999999999997654  699999999876532


Q ss_pred             CCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHH
Q psy12427        266 NEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVET  320 (356)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~  320 (356)
                      . ......|++.|+|||++.+..++.++|+|||||++|+|++|+.||......+.
T Consensus       157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~  210 (333)
T cd06650         157 S-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL  210 (333)
T ss_pred             h-ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHH
Confidence            2 22334689999999999998999999999999999999999999987654433

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG1989|consensus

Probab=100.00  E-value=1.2e-42  Score=335.98  Aligned_cols=235  Identities=28%  Similarity=0.426  Sum_probs=197.2

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcC-CCCceeeeee-EEe------CCeE
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLH-HPKLINLHDA-FED------DDEM  180 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~-~~~------~~~~  180 (356)
                      +++|.+.|.+|||+.||+|.+...|..||+|++-..++...+.+.+|+++|++|+ |+|||.+++. ...      .-.+
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev  117 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV  117 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence            5789999999999999999999988999999998888888899999999999996 9999999993 321      1357


Q ss_pred             EEEEEeccccchhhhhhCCC-CCCCccccccccHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEEeecCCCcEEEEee
Q psy12427        181 VLIFEFLSGGELFERITAPD-YKMSEAEVIPVTLPILMTQTSPAVKHMHEKN--IIHLDVKPENIMCQTRNSTNVKMIDF  257 (356)
Q Consensus       181 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~Dlkp~NIlv~~~~~~~vkl~Df  257 (356)
                      +|+||||.||+|.+++..+. ..+++.+     +..|+.++++|+++||..+  |||||||-+|||++.++  +.|||||
T Consensus       118 llLmEyC~gg~Lvd~mn~Rlq~~lte~e-----VLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g--~~KLCDF  190 (738)
T KOG1989|consen  118 LLLMEYCKGGSLVDFMNTRLQTRLTEDE-----VLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADG--NYKLCDF  190 (738)
T ss_pred             EeehhhccCCcHHHHHHHHHhccCChHH-----HHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCC--CEEeCcc
Confidence            89999999999999997432 2244444     4559999999999999987  99999999999998665  7999999


Q ss_pred             eceeeeCCCCcee----------ecCCCcCccccccc---cCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHh
Q psy12427        258 GLATKLDPNEVVK----------ISTGTAEFAAPEIV---EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV  324 (356)
Q Consensus       258 g~a~~~~~~~~~~----------~~~gt~~y~aPE~~---~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i  324 (356)
                      |.+...-......          ...-|+.|+|||++   .+.+++.++|||+|||+||-|+....||.+...    ..|
T Consensus       191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----laI  266 (738)
T KOG1989|consen  191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----LAI  266 (738)
T ss_pred             cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----eeE
Confidence            9987643221100          01258999999987   577899999999999999999999999977644    567


Q ss_pred             hccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        325 KACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       325 ~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ..+++.||+.  ..+|+.+++||+.||+.||+
T Consensus       267 lng~Y~~P~~--p~ys~~l~~LI~~mL~~nP~  296 (738)
T KOG1989|consen  267 LNGNYSFPPF--PNYSDRLKDLIRTMLQPNPD  296 (738)
T ss_pred             EeccccCCCC--ccHHHHHHHHHHHHhccCcc
Confidence            8889888874  58999999999999999995

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.2e-41  Score=301.36  Aligned_cols=239  Identities=25%  Similarity=0.427  Sum_probs=201.9

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccC--ChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS--HNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      +|++.+.||+|++|.||+|.++.++..+++|.+...  .......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            378889999999999999999999999999998654  234556788999999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +++++|.+++....    ........+..++.|++.||.|||+.|++|+||+|+||+++.++  .++|+|||++......
T Consensus        81 ~~~~~L~~~l~~~~----~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~--~~~l~df~~~~~~~~~  154 (256)
T cd08529          81 AENGDLHKLLKMQR----GRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYD--NVKIGDLGVAKLLSDN  154 (256)
T ss_pred             CCCCcHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCC--CEEEcccccceeccCc
Confidence            99999999987531    12233344455899999999999999999999999999998654  7999999998876543


Q ss_pred             Cc-eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHH
Q psy12427        267 EV-VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD  345 (356)
Q Consensus       267 ~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  345 (356)
                      .. .....|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+..+....+........+   ..++.++.+
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  231 (256)
T cd08529         155 TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVS---QMYSQQLAQ  231 (256)
T ss_pred             cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc---cccCHHHHH
Confidence            22 23346889999999999999999999999999999999999999988887777777665433222   368899999


Q ss_pred             HHHHhhhcCCC
Q psy12427        346 FIRRLLLRNKE  356 (356)
Q Consensus       346 lI~~ll~~dP~  356 (356)
                      +|.+||+.+|+
T Consensus       232 ~i~~~l~~~p~  242 (256)
T cd08529         232 LIDQCLTKDYR  242 (256)
T ss_pred             HHHHHccCCcc
Confidence            99999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.3e-41  Score=307.67  Aligned_cols=240  Identities=28%  Similarity=0.452  Sum_probs=199.1

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEecc
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLS  188 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  188 (356)
                      .|++.+.||.|+||.||++.+..++..+++|.+..........+.+|+++++.++||||+++++++......++|+||++
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            47889999999999999999999999999999977666666778899999999999999999999999999999999999


Q ss_pred             ccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCC-
Q psy12427        189 GGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE-  267 (356)
Q Consensus       189 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~-  267 (356)
                      +++|..++......+++     ..+..++.|++.||+|||+.|++||||+|+|||++.++  .++|+|||++....... 
T Consensus        86 ~~~l~~~~~~~~~~l~~-----~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~--~~kl~dfg~~~~~~~~~~  158 (282)
T cd06643          86 GGAVDAVMLELERPLTE-----PQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDG--DIKLADFGVSAKNTRTIQ  158 (282)
T ss_pred             CCcHHHHHHhcCCCCCH-----HHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCC--CEEEcccccccccccccc
Confidence            99998887643333333     34455999999999999999999999999999997654  79999999987653221 


Q ss_pred             ceeecCCCcCcccccccc-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHH
Q psy12427        268 VVKISTGTAEFAAPEIVE-----REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEE  342 (356)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  342 (356)
                      ......+++.|+|||++.     ...++.++|+||+||++|+|++|.+||...+..+...++....... ......++.+
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  237 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT-LAQPSRWSSE  237 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC-CCCccccCHH
Confidence            223346899999999984     4457789999999999999999999999888777766665543321 1223468999


Q ss_pred             HHHHHHHhhhcCCC
Q psy12427        343 GKDFIRRLLLRNKE  356 (356)
Q Consensus       343 ~~~lI~~ll~~dP~  356 (356)
                      +++||++||++||+
T Consensus       238 ~~~li~~~l~~~p~  251 (282)
T cd06643         238 FKDFLKKCLEKNVD  251 (282)
T ss_pred             HHHHHHHHccCChh
Confidence            99999999999985

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8.5e-42  Score=342.94  Aligned_cols=247  Identities=26%  Similarity=0.418  Sum_probs=197.3

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEe--CCeE
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFED--DDEM  180 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~  180 (356)
                      ...++|.+++.||.|+||+||+|.++.++..+|+|++....  ......+..|+.+|.+|+||||++++++|..  ...+
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            34578999999999999999999999999999999987543  3345678899999999999999999998854  4578


Q ss_pred             EEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHC-------CceeccCCCCCEEEeec------
Q psy12427        181 VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEK-------NIIHLDVKPENIMCQTR------  247 (356)
Q Consensus       181 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-------~ivH~Dlkp~NIlv~~~------  247 (356)
                      ++||||+.+|+|.++|.....  ....+....++.|+.||+.||+|||+.       +||||||||+|||++.+      
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~--~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~  167 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYK--MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK  167 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence            999999999999998864211  112344455666999999999999984       49999999999999642      


Q ss_pred             ---------CCCcEEEEeeeceeeeCCCCceeecCCCcCccccccccC--CCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q psy12427        248 ---------NSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVER--EPVGFYTDMWAVGVLAYVLLSGLSPFAGEN  316 (356)
Q Consensus       248 ---------~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~ell~g~~Pf~~~~  316 (356)
                               +...+||+|||++.............||+.|+|||++.+  ..++.++||||||||||+|++|..||...+
T Consensus       168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        168 ITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             ccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                     233589999999987654444445579999999999864  458899999999999999999999998776


Q ss_pred             hHHHHHHhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        317 DVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       317 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ....+.........++   ...++.++.+||..||+.||+
T Consensus       248 ~~~qli~~lk~~p~lp---i~~~S~eL~dLI~~~L~~dPe  284 (1021)
T PTZ00266        248 NFSQLISELKRGPDLP---IKGKSKELNILIKNLLNLSAK  284 (1021)
T ss_pred             cHHHHHHHHhcCCCCC---cCCCCHHHHHHHHHHhcCChh
Confidence            5544433333222222   246799999999999999985

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.3e-41  Score=308.90  Aligned_cols=235  Identities=30%  Similarity=0.567  Sum_probs=202.0

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      ++|++.+.||+|+||.||++.+..+++.+|+|++....   ......+.+|+++|++++||||+++++++..+...+++|
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            36899999999999999999999999999999986532   233466788999999999999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      ||+++++|.+++.... .+     ....+..++.|++.||+|||+.|++|+||+|+|||++.++  .+||+|||++....
T Consensus        81 e~~~~~~L~~~~~~~~-~l-----~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~--~~kl~dfg~~~~~~  152 (290)
T cd05580          81 EYVPGGELFSHLRKSG-RF-----PEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDG--YIKITDFGFAKRVK  152 (290)
T ss_pred             ecCCCCCHHHHHHHcC-CC-----CHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC--CEEEeeCCCccccC
Confidence            9999999999986542 23     3334455899999999999999999999999999997654  79999999998765


Q ss_pred             CCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHH
Q psy12427        265 PNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK  344 (356)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  344 (356)
                      ..  .....+++.|+|||.+.+...+.++|+||||+++|+|++|..||...+..+..+++......++    ..++..++
T Consensus       153 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~  226 (290)
T cd05580         153 GR--TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFP----SFFSPDAK  226 (290)
T ss_pred             CC--CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCC----ccCCHHHH
Confidence            43  2334689999999999888899999999999999999999999998887777887776665554    36799999


Q ss_pred             HHHHHhhhcCCC
Q psy12427        345 DFIRRLLLRNKE  356 (356)
Q Consensus       345 ~lI~~ll~~dP~  356 (356)
                      ++|++||+.||+
T Consensus       227 ~li~~~l~~~p~  238 (290)
T cd05580         227 DLIRNLLQVDLT  238 (290)
T ss_pred             HHHHHHccCCHH
Confidence            999999999984

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8e-42  Score=322.47  Aligned_cols=193  Identities=25%  Similarity=0.371  Sum_probs=164.1

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      .++|++.+.||+|+||.||+|.++.+++.||+|...      ...+.+|+++|++++||||++++++|......++++|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            457999999999999999999999999999999643      23467899999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +. ++|..++.... .++     ...+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+++.....
T Consensus       165 ~~-~~L~~~l~~~~-~l~-----~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~--~vkL~DFG~a~~~~~~  235 (391)
T PHA03212        165 YK-TDLYCYLAAKR-NIA-----ICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPG--DVCLGDFGAACFPVDI  235 (391)
T ss_pred             CC-CCHHHHHHhcC-CCC-----HHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCC--CEEEEeCCcccccccc
Confidence            95 68888775432 222     334456999999999999999999999999999997654  7999999998754221


Q ss_pred             --CceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q psy12427        267 --EVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAG  314 (356)
Q Consensus       267 --~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~  314 (356)
                        .......||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~  285 (391)
T PHA03212        236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE  285 (391)
T ss_pred             cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence              222345799999999999999999999999999999999999988754

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.8e-41  Score=306.62  Aligned_cols=244  Identities=19%  Similarity=0.328  Sum_probs=201.3

Q ss_pred             cceeeeccccccCceEEEEEEEccCC-----CEEEEEEcccCCh-hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTG-----NIFAAKFIPVSHN-LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMV  181 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~-----~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  181 (356)
                      ++|++.+.||+|+||.||+|.....+     ..+|+|.+..... .....+.+|+.++..++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            47899999999999999999987655     6899999875433 34567889999999999999999999999999999


Q ss_pred             EEEEeccccchhhhhhCCCCCCC----------ccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCc
Q psy12427        182 LIFEFLSGGELFERITAPDYKMS----------EAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTN  251 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~  251 (356)
                      ++|||+++++|.+++........          ...+....+..++.|++.||+|||+.|++|+||||+||+++.++  .
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~--~  162 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL--T  162 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC--c
Confidence            99999999999999865432110          02334445566999999999999999999999999999997654  7


Q ss_pred             EEEEeeeceeeeCCCCc---eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcc
Q psy12427        252 VKMIDFGLATKLDPNEV---VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKAC  327 (356)
Q Consensus       252 vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~  327 (356)
                      ++|+|||++........   .....+++.|+|||.+....++.++|||||||++|||++ |..||.+.+..+....+...
T Consensus       163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~  242 (283)
T cd05048         163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSR  242 (283)
T ss_pred             EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            99999999986543221   122346788999999998899999999999999999998 99999999888888887765


Q ss_pred             ccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        328 DWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       328 ~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ....   ....+|+++.+||++||+.||+
T Consensus       243 ~~~~---~~~~~~~~~~~l~~~c~~~~p~  268 (283)
T cd05048         243 QLLP---CPEDCPARVYALMIECWNEIPA  268 (283)
T ss_pred             CcCC---CcccCCHHHHHHHHHHccCChh
Confidence            4332   2347899999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=9.2e-42  Score=318.85  Aligned_cols=240  Identities=23%  Similarity=0.380  Sum_probs=191.5

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeC------
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDD------  177 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------  177 (356)
                      +.++|++.+.||+|+||.||+|.+..+++.+|+|.+....  ......+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            5678999999999999999999999999999999987543  23345677899999999999999999988643      


Q ss_pred             CeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEee
Q psy12427        178 DEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDF  257 (356)
Q Consensus       178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Df  257 (356)
                      ...++||||+++ +|.+.+..   .++     ...+..++.|++.||+|||++||+||||||+|||++.++  .+||+||
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~---~l~-----~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~--~~kl~Df  163 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM---ELD-----HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDF  163 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh---cCC-----HHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCC--CEEEeeC
Confidence            357999999965 56665542   122     233455899999999999999999999999999997654  7999999


Q ss_pred             eceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc------
Q psy12427        258 GLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEF------  331 (356)
Q Consensus       258 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~------  331 (356)
                      |+++............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+......+      
T Consensus       164 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (355)
T cd07874         164 GLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  243 (355)
T ss_pred             cccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            99987654444445678999999999999999999999999999999999999999887665544432211110      


Q ss_pred             --------------------------------ChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        332 --------------------------------DEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       332 --------------------------------~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                                      ........+.++++||.+||+.||+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~  300 (355)
T cd07874         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA  300 (355)
T ss_pred             hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCch
Confidence                                            0111123467899999999999995

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.6e-41  Score=300.99  Aligned_cols=239  Identities=26%  Similarity=0.443  Sum_probs=201.5

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEec
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFL  187 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~  187 (356)
                      +|++.+.||.|+||.||++.++.++..+|+|.++... ....+.+.+|+.+++.++||||+++++.+.....++++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4789999999999999999999999999999986533 334567788999999999999999999999999999999999


Q ss_pred             cccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCC
Q psy12427        188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE  267 (356)
Q Consensus       188 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~  267 (356)
                      ++++|.+++.....    ..+....+..++.|++.||.|||++|++|+||+|+||+++.++  .++|+|||++.......
T Consensus        81 ~~~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~--~~~l~dfg~~~~~~~~~  154 (255)
T cd08219          81 DGGDLMQKIKLQRG----KLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNG--KVKLGDFGSARLLTSPG  154 (255)
T ss_pred             CCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCC--cEEEcccCcceeecccc
Confidence            99999988864221    1223344556899999999999999999999999999997654  79999999998764322


Q ss_pred             c-eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHH
Q psy12427        268 V-VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDF  346 (356)
Q Consensus       268 ~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  346 (356)
                      . .....|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+........+   ..++.++++|
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l  231 (255)
T cd08219         155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLP---SHYSYELRSL  231 (255)
T ss_pred             cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCC---cccCHHHHHH
Confidence            2 23346889999999999989999999999999999999999999988887777777665544322   4689999999


Q ss_pred             HHHhhhcCCC
Q psy12427        347 IRRLLLRNKE  356 (356)
Q Consensus       347 I~~ll~~dP~  356 (356)
                      |++||++||+
T Consensus       232 i~~~l~~~P~  241 (255)
T cd08219         232 IKQMFKRNPR  241 (255)
T ss_pred             HHHHHhCCcc
Confidence            9999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.1e-41  Score=305.44  Aligned_cols=241  Identities=23%  Similarity=0.403  Sum_probs=196.9

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEec
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFL  187 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~  187 (356)
                      ++|++.+.||+|+||.||+|.++.++..+|+|++..........+.+|+.++++++||||+++++++......++||||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            47999999999999999999999999999999997665555567889999999999999999999999999999999999


Q ss_pred             cccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCC
Q psy12427        188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE  267 (356)
Q Consensus       188 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~  267 (356)
                      .+++|.+++.... .++     ...+..++.|++.||+|||+.||+||||+|+||+++.++  .++|+|||++.......
T Consensus        89 ~~~~L~~~~~~~~-~~~-----~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~--~~~l~dfg~~~~~~~~~  160 (267)
T cd06646          89 GGGSLQDIYHVTG-PLS-----ELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNG--DVKLADFGVAAKITATI  160 (267)
T ss_pred             CCCcHHHHHHhcC-CCC-----HHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC--CEEECcCccceeecccc
Confidence            9999999886432 233     334455899999999999999999999999999997544  69999999998764322


Q ss_pred             -ceeecCCCcCcccccccc---CCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCh-hhhccCCHH
Q psy12427        268 -VVKISTGTAEFAAPEIVE---REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE-EAFKNVSEE  342 (356)
Q Consensus       268 -~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~s~~  342 (356)
                       ......|++.|+|||.+.   ...++.++|+||+||++|+|++|+.||....+.+....+....+..+. .....+|.+
T Consensus       161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (267)
T cd06646         161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSST  240 (267)
T ss_pred             cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHH
Confidence             123346889999999884   445788999999999999999999999777665555444444433221 112357899


Q ss_pred             HHHHHHHhhhcCCC
Q psy12427        343 GKDFIRRLLLRNKE  356 (356)
Q Consensus       343 ~~~lI~~ll~~dP~  356 (356)
                      +.+||++||+.||+
T Consensus       241 ~~~li~~~l~~~P~  254 (267)
T cd06646         241 FHNFVKISLTKNPK  254 (267)
T ss_pred             HHHHHHHHhhCChh
Confidence            99999999999995

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.7e-41  Score=304.34  Aligned_cols=242  Identities=22%  Similarity=0.387  Sum_probs=198.7

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|.++.........+.+|+.+++.++||||+++++++......+++|||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            35799999999999999999999999999999999876655556778899999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +++++|.+++.... .+     ....+..++.|++.||+|||+.|++|+||||+||+++.++  .++|+|||++......
T Consensus        88 ~~~~~L~~~~~~~~-~~-----~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~--~~~l~dfg~~~~~~~~  159 (267)
T cd06645          88 CGGGSLQDIYHVTG-PL-----SESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNG--HVKLADFGVSAQITAT  159 (267)
T ss_pred             cCCCcHHHHHHhcC-CC-----CHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC--CEEECcceeeeEccCc
Confidence            99999999886432 23     3344556999999999999999999999999999997554  7999999998765432


Q ss_pred             C-ceeecCCCcCcccccccc---CCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChh-hhccCCH
Q psy12427        267 E-VVKISTGTAEFAAPEIVE---REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEE-AFKNVSE  341 (356)
Q Consensus       267 ~-~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~s~  341 (356)
                      . ......|++.|+|||++.   ...++.++|+|||||++|+|++|..||........+.........++.. ....++.
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd06645         160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSN  239 (267)
T ss_pred             ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCH
Confidence            2 123346899999999974   4568889999999999999999999998776655555544444332211 1125789


Q ss_pred             HHHHHHHHhhhcCCC
Q psy12427        342 EGKDFIRRLLLRNKE  356 (356)
Q Consensus       342 ~~~~lI~~ll~~dP~  356 (356)
                      .+.+||++||+.||+
T Consensus       240 ~~~~li~~~l~~~P~  254 (267)
T cd06645         240 SFHHFVKMALTKNPK  254 (267)
T ss_pred             HHHHHHHHHccCCch
Confidence            999999999999995

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.6e-41  Score=306.30  Aligned_cols=242  Identities=26%  Similarity=0.422  Sum_probs=200.1

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      .+.|++.++||.|+||.||+|.++.++..+++|.+..........+.+|+.+++.++||||+++++++..++..++||||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            35799999999999999999999999999999999877666677888999999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +++++|..++......+++     ..+..++.|++.||+|||+.|++||||+|+||+++.++  .++|+|||++......
T Consensus        91 ~~~~~l~~~~~~~~~~l~~-----~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~kl~dfg~~~~~~~~  163 (292)
T cd06644          91 CPGGAVDAIMLELDRGLTE-----PQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDG--DIKLADFGVSAKNVKT  163 (292)
T ss_pred             CCCCcHHHHHHhhcCCCCH-----HHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCC--CEEEccCccceecccc
Confidence            9999998877644333333     34455999999999999999999999999999997544  7999999998764322


Q ss_pred             -CceeecCCCcCcccccccc-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCC
Q psy12427        267 -EVVKISTGTAEFAAPEIVE-----REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVS  340 (356)
Q Consensus       267 -~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  340 (356)
                       .......+++.|+|||++.     ...++.++|+|||||++|+|++|..||...+..+.+.++.....+ .......++
T Consensus       164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  242 (292)
T cd06644         164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP-TLSQPSKWS  242 (292)
T ss_pred             ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCc-cCCCCcccC
Confidence             1223446889999999984     345678999999999999999999999888776666665543322 112234688


Q ss_pred             HHHHHHHHHhhhcCCC
Q psy12427        341 EEGKDFIRRLLLRNKE  356 (356)
Q Consensus       341 ~~~~~lI~~ll~~dP~  356 (356)
                      .++.++|++||+.||+
T Consensus       243 ~~~~~li~~~l~~~p~  258 (292)
T cd06644         243 MEFRDFLKTALDKHPE  258 (292)
T ss_pred             HHHHHHHHHHhcCCcc
Confidence            9999999999999995

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.9e-41  Score=339.07  Aligned_cols=246  Identities=21%  Similarity=0.304  Sum_probs=195.1

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      ++|++.++||+|+||.||+|.+..+|+.||+|++....   ......+.+|+.++++++||||+++++++...+..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57999999999999999999999999999999987532   223456889999999999999999999999999999999


Q ss_pred             EeccccchhhhhhCCCC--CCCc---cccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeec
Q psy12427        185 EFLSGGELFERITAPDY--KMSE---AEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGL  259 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~--~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~  259 (356)
                      ||++||+|.+++.....  ....   .......+..++.||+.||+|||++||+||||||+|||++.++  .++|+|||+
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg--~vKLiDFGL  159 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFG--EVVILDWGA  159 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCC--CEEEEecCc
Confidence            99999999998864211  1111   1122234456889999999999999999999999999998655  699999999


Q ss_pred             eeeeCCCC-------------------ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHH
Q psy12427        260 ATKLDPNE-------------------VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVET  320 (356)
Q Consensus       260 a~~~~~~~-------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~  320 (356)
                      +.......                   .....+||+.|+|||++.+..++.++|||||||++|||++|..||......+.
T Consensus       160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki  239 (932)
T PRK13184        160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI  239 (932)
T ss_pred             ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence            98662110                   01123589999999999999999999999999999999999999988665544


Q ss_pred             HHHhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        321 LKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       321 ~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ........ +.....+..+|+.+.+++.+||+.||+
T Consensus       240 ~~~~~i~~-P~~~~p~~~iP~~L~~LI~rcL~~DP~  274 (932)
T PRK13184        240 SYRDVILS-PIEVAPYREIPPFLSQIAMKALAVDPA  274 (932)
T ss_pred             hhhhhccC-hhhccccccCCHHHHHHHHHHccCChh
Confidence            33211111 111111347899999999999999995

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.7e-41  Score=309.87  Aligned_cols=242  Identities=22%  Similarity=0.399  Sum_probs=193.8

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh-hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN-LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      .++|++.+.||.|+||.||+|.++.++..||+|.+..... .....+.+|+.+++.++||||+++++++..+...++|||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            3579999999999999999999999999999999875432 233456789999999999999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |+. ++|.+++......+.     ...+..++.|++.||+|||+.|++|+||||+|||++.++  .++|+|||++.....
T Consensus        85 ~~~-~~l~~~l~~~~~~~~-----~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~dfg~~~~~~~  156 (301)
T cd07873          85 YLD-KDLKQYLDDCGNSIN-----MHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERG--ELKLADFGLARAKSI  156 (301)
T ss_pred             ccc-cCHHHHHHhcCCCCC-----HHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCC--cEEECcCcchhccCC
Confidence            996 588888765433333     334555899999999999999999999999999997654  799999999876532


Q ss_pred             CC-ceeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc------------
Q psy12427        266 NE-VVKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEF------------  331 (356)
Q Consensus       266 ~~-~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~------------  331 (356)
                      .. ......+++.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+......+            
T Consensus       157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (301)
T cd07873         157 PTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE  236 (301)
T ss_pred             CCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence            22 22234568999999988654 57889999999999999999999999888766655443221111            


Q ss_pred             -------C-------hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        332 -------D-------EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       332 -------~-------~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                             +       ......+++++++||.+||+.||+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~  275 (301)
T cd07873         237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGR  275 (301)
T ss_pred             cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcc
Confidence                   0       111235789999999999999995

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0574|consensus

Probab=100.00  E-value=1.4e-44  Score=309.73  Aligned_cols=235  Identities=26%  Similarity=0.481  Sum_probs=203.8

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEecc
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLS  188 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  188 (356)
                      -|.++++||+|+||.||++.++.+|..+|+|.+....  +.+.+.+|+.||.+++.|++|++||.+-....+++|||||.
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            4789999999999999999999999999999987754  46778899999999999999999999999999999999999


Q ss_pred             ccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC-C
Q psy12427        189 GGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN-E  267 (356)
Q Consensus       189 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~-~  267 (356)
                      .|++.+.+..++..+.+.++..     +++.-+.||+|||...-||||||..|||++.++  +.||+|||.|..+... .
T Consensus       112 AGSiSDI~R~R~K~L~E~EIs~-----iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G--~AKLADFGVAGQLTDTMA  184 (502)
T KOG0574|consen  112 AGSISDIMRARRKPLSEQEISA-----VLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDG--IAKLADFGVAGQLTDTMA  184 (502)
T ss_pred             CCcHHHHHHHhcCCccHHHHHH-----HHHHHHhHHHHHHHHHHHHhhcccccEEEcccc--hhhhhhccccchhhhhHH
Confidence            9999999987776666666654     999999999999999999999999999997655  7999999999887432 2


Q ss_pred             ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhh---ccCCHHHH
Q psy12427        268 VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAF---KNVSEEGK  344 (356)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~---~~~s~~~~  344 (356)
                      ..++-.|||.|||||++..-.|.+.+||||||+...||..|++||.+..++..+.-|-.    -|++.|   ..+|.+..
T Consensus       185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT----~PPPTF~KPE~WS~~F~  260 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPT----KPPPTFKKPEEWSSEFN  260 (502)
T ss_pred             hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccC----CCCCCCCChHhhhhHHH
Confidence            33556799999999999999999999999999999999999999999988655443322    122222   35899999


Q ss_pred             HHHHHhhhcCCC
Q psy12427        345 DFIRRLLLRNKE  356 (356)
Q Consensus       345 ~lI~~ll~~dP~  356 (356)
                      |||+.||.+.||
T Consensus       261 DFi~~CLiK~PE  272 (502)
T KOG0574|consen  261 DFIRSCLIKKPE  272 (502)
T ss_pred             HHHHHHhcCCHH
Confidence            999999999986

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-41  Score=301.67  Aligned_cols=242  Identities=25%  Similarity=0.437  Sum_probs=202.5

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEec
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFL  187 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~  187 (356)
                      ++|++.+.||.|+||.||+|.++.++..+++|++..........+.+|+.++++++||||+++++++.....++++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            47999999999999999999999999999999998776666778889999999999999999999999999999999999


Q ss_pred             cccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCC
Q psy12427        188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE  267 (356)
Q Consensus       188 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~  267 (356)
                      .+++|.+++......+++.     .+..++.|++.||+|||+.|++|+||+|+||+++.++  .++|+|||++.......
T Consensus        83 ~~~~l~~~~~~~~~~l~~~-----~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~--~~~l~d~g~~~~~~~~~  155 (262)
T cd06613          83 GGGSLQDIYQVTRGPLSEL-----QIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDG--DVKLADFGVSAQLTATI  155 (262)
T ss_pred             CCCcHHHHHHhhccCCCHH-----HHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCC--CEEECccccchhhhhhh
Confidence            9999999887543344433     3455999999999999999999999999999998654  69999999987654322


Q ss_pred             -ceeecCCCcCccccccccCC---CCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCh-hhhccCCHH
Q psy12427        268 -VVKISTGTAEFAAPEIVERE---PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE-EAFKNVSEE  342 (356)
Q Consensus       268 -~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~s~~  342 (356)
                       ......++..|+|||.+...   .++.++|+||||+++|+|++|..||.+.+..+....+.......+. .....++.+
T Consensus       156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (262)
T cd06613         156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPV  235 (262)
T ss_pred             hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHH
Confidence             22334678899999999877   8889999999999999999999999988777666655554332211 112357889


Q ss_pred             HHHHHHHhhhcCCC
Q psy12427        343 GKDFIRRLLLRNKE  356 (356)
Q Consensus       343 ~~~lI~~ll~~dP~  356 (356)
                      +++||++||+.||+
T Consensus       236 ~~~li~~~l~~~p~  249 (262)
T cd06613         236 FHDFIKKCLTKDPK  249 (262)
T ss_pred             HHHHHHHHcCCChh
Confidence            99999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-41  Score=300.64  Aligned_cols=239  Identities=25%  Similarity=0.452  Sum_probs=198.2

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh-----hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN-----LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      +.|.+.+.||.|++|.||+|.+..++..+|+|.+.....     .....+.+|++++++++||||+++++++......++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            358899999999999999999999999999999865431     123567889999999999999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ++||+++++|.+++....      .+....+..++.|++.||+|||+.|++|+||+|+||+++.++  .++|+|||++..
T Consensus        82 v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~--~~~l~dfg~~~~  153 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG------ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAG--NVKLGDFGASKR  153 (263)
T ss_pred             EEEECCCCcHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEeeccccee
Confidence            999999999999886432      223344456899999999999999999999999999997544  799999999976


Q ss_pred             eCCCCce----eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhcc
Q psy12427        263 LDPNEVV----KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKN  338 (356)
Q Consensus       263 ~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  338 (356)
                      .......    ....|+..|+|||++.+..++.++||||+|+++|+|++|+.||...+..+...++......  ......
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~  231 (263)
T cd06625         154 LQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN--PQLPSH  231 (263)
T ss_pred             ccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCC--CCCCcc
Confidence            6432211    2235788999999999999999999999999999999999999887776666665543322  233357


Q ss_pred             CCHHHHHHHHHhhhcCCC
Q psy12427        339 VSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       339 ~s~~~~~lI~~ll~~dP~  356 (356)
                      ++.++.+||++||++||+
T Consensus       232 ~~~~~~~li~~~l~~~p~  249 (263)
T cd06625         232 VSPDARNFLRRTFVENAK  249 (263)
T ss_pred             CCHHHHHHHHHHhhcCcc
Confidence            899999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.9e-41  Score=304.89  Aligned_cols=244  Identities=17%  Similarity=0.302  Sum_probs=201.2

Q ss_pred             cceeeeccccccCceEEEEEEEc-----cCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRER-----KTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~-----~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      +.|.+.+.||+|+||.||++...     .++..+|+|.+..........+.+|+.++.+++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            46899999999999999999863     3456799999877666666788899999999999999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCC-------CCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEE
Q psy12427        183 IFEFLSGGELFERITAPDYK-------MSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMI  255 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~-------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~  255 (356)
                      +|||+++++|.+++......       .....+....+..++.|++.||+|||++|++||||||+|||++.++  .++|+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~--~~kl~  162 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL--LVKIG  162 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC--cEEec
Confidence            99999999999998643311       0112244455667999999999999999999999999999997654  79999


Q ss_pred             eeeceeeeCCCCce---eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccc
Q psy12427        256 DFGLATKLDPNEVV---KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEF  331 (356)
Q Consensus       256 Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~  331 (356)
                      |||++.........   ....++..|+|||.+.+..++.++|+|||||++|+|++ |.+||...+..+.+..+.......
T Consensus       163 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~~  242 (288)
T cd05093         163 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQ  242 (288)
T ss_pred             cCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence            99999865432211   12234778999999999999999999999999999998 999999988888888887755332


Q ss_pred             ChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        332 DEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       332 ~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .   ...++.++.+||.+||+.||+
T Consensus       243 ~---~~~~~~~l~~li~~~l~~~p~  264 (288)
T cd05093         243 R---PRTCPKEVYDLMLGCWQREPH  264 (288)
T ss_pred             C---CCCCCHHHHHHHHHHccCChh
Confidence            2   236889999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.8e-41  Score=318.88  Aligned_cols=239  Identities=22%  Similarity=0.369  Sum_probs=191.2

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCC-----eEE
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDD-----EMV  181 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----~~~  181 (356)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+....  ......+.+|+.+|+.++||||+++++++....     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            3778899999999999999999999999999986532  233456778999999999999999999998776     789


Q ss_pred             EEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeecee
Q psy12427        182 LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT  261 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~  261 (356)
                      +||||+. ++|.+++....      .+....+..++.||+.||+|||++|++||||||+|||++.++  .+||+|||+++
T Consensus        81 lv~e~~~-~~l~~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~--~~kL~Dfg~a~  151 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQ------PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNC--VLKICDFGLAR  151 (372)
T ss_pred             EEeeccc-cCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCC--CEEecccccee
Confidence            9999996 57777765322      233344566999999999999999999999999999997654  79999999998


Q ss_pred             eeCCCCc--eeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc-------
Q psy12427        262 KLDPNEV--VKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEF-------  331 (356)
Q Consensus       262 ~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-------  331 (356)
                      .......  .....+++.|+|||++.+. .++.++||||+||++|||++|+.||.+.+..+.+..+.......       
T Consensus       152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~  231 (372)
T cd07853         152 VEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS  231 (372)
T ss_pred             ecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence            7543221  2234578999999998874 47899999999999999999999999988777766654321111       


Q ss_pred             ----------------Ch-----hhhccCCHHHHHHHHHhhhcCCC
Q psy12427        332 ----------------DE-----EAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       332 ----------------~~-----~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                      +.     ......++++.+||.+||+.||+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~  277 (372)
T cd07853         232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPD  277 (372)
T ss_pred             hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChh
Confidence                            10     11234689999999999999995

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=7.7e-41  Score=298.06  Aligned_cols=239  Identities=25%  Similarity=0.417  Sum_probs=203.7

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      +|++.+.||.|+||.||.+++..++..+++|.+....  ......+.+|++++++++|+||+++++++......+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            5889999999999999999999999999999886543  34456678999999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +++++|.+++....    ...+....+..++.|++.||.|||+.|++|+||+|+||+++.++  .+||+|||++......
T Consensus        81 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~--~~kl~d~~~~~~~~~~  154 (256)
T cd08221          81 ANGGTLYDKIVRQK----GQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAG--LIKLGDFGISKILGSE  154 (256)
T ss_pred             cCCCcHHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCC--CEEECcCcceEEcccc
Confidence            99999999987542    11233334455899999999999999999999999999998654  6999999999876443


Q ss_pred             C-ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHH
Q psy12427        267 E-VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD  345 (356)
Q Consensus       267 ~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  345 (356)
                      . ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+..+.+...+   ..++.++++
T Consensus       155 ~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  231 (256)
T cd08221         155 YSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVV---SVYSSELIS  231 (256)
T ss_pred             cccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc---cccCHHHHH
Confidence            3 223446899999999999888999999999999999999999999998888888888776654332   578999999


Q ss_pred             HHHHhhhcCCC
Q psy12427        346 FIRRLLLRNKE  356 (356)
Q Consensus       346 lI~~ll~~dP~  356 (356)
                      +|.+||+.||+
T Consensus       232 ~i~~~l~~~p~  242 (256)
T cd08221         232 LVHSLLQQDPE  242 (256)
T ss_pred             HHHHHcccCcc
Confidence            99999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=4.8e-41  Score=299.59  Aligned_cols=237  Identities=22%  Similarity=0.344  Sum_probs=196.4

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEec
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFL  187 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~  187 (356)
                      ++|++.+.||+|+||.||++.++. +..+|+|.+.... .....+.+|+.+|+.++||||+++++++......+++|||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   81 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM   81 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence            468899999999999999998764 5679999876433 23467888999999999999999999999999999999999


Q ss_pred             cccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCC
Q psy12427        188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE  267 (356)
Q Consensus       188 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~  267 (356)
                      ++|+|.+++......     +....+..++.|++.||+|||++|++|+||+|+||+++.++  .+||+|||.++......
T Consensus        82 ~~~~L~~~~~~~~~~-----~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~--~~kl~d~g~~~~~~~~~  154 (256)
T cd05114          82 ENGCLLNYLRQRQGK-----LSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTG--VVKVSDFGMTRYVLDDE  154 (256)
T ss_pred             CCCcHHHHHHhCccC-----CCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCC--eEEECCCCCccccCCCc
Confidence            999999988654322     23344556999999999999999999999999999997544  79999999987653322


Q ss_pred             cee--ecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHHH
Q psy12427        268 VVK--ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK  344 (356)
Q Consensus       268 ~~~--~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  344 (356)
                      ...  ...++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+.+..+........+   ...+.++.
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~  231 (256)
T cd05114         155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP---KLASMTVY  231 (256)
T ss_pred             eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC---CCCCHHHH
Confidence            221  1234668999999998899999999999999999999 99999999988888888775543222   35788999


Q ss_pred             HHHHHhhhcCCC
Q psy12427        345 DFIRRLLLRNKE  356 (356)
Q Consensus       345 ~lI~~ll~~dP~  356 (356)
                      ++|.+||+.||+
T Consensus       232 ~li~~c~~~~p~  243 (256)
T cd05114         232 EVMYSCWHEKPE  243 (256)
T ss_pred             HHHHHHccCCcc
Confidence            999999999995

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=5.4e-41  Score=300.54  Aligned_cols=239  Identities=24%  Similarity=0.369  Sum_probs=198.5

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEec
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFL  187 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~  187 (356)
                      .+|.+.+.||+|+||.||+|.++.++..+|+|.+.... .....+.+|+++++.++||||+++++++.....++++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            46889999999999999999999999999999987543 33566788999999999999999999999999999999999


Q ss_pred             cccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCC
Q psy12427        188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE  267 (356)
Q Consensus       188 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~  267 (356)
                      ++++|.+++.....    ..+....+..++.|++.||+|||++|++||||||+||+++.++  .+||+|||++.......
T Consensus        85 ~~~~L~~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~--~~kl~df~~~~~~~~~~  158 (263)
T cd05052          85 TYGNLLDYLRECNR----QEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSRLMTGDT  158 (263)
T ss_pred             CCCcHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC--cEEeCCCccccccccce
Confidence            99999998864321    2233344556899999999999999999999999999997554  79999999998764332


Q ss_pred             ceee--cCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHHH
Q psy12427        268 VVKI--STGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK  344 (356)
Q Consensus       268 ~~~~--~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  344 (356)
                      ....  ..++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+....+....   ..+....+|.++.
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  235 (263)
T cd05052         159 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY---RMERPEGCPPKVY  235 (263)
T ss_pred             eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC---CCCCCCCCCHHHH
Confidence            2111  123568999999999999999999999999999998 999999988877777765532   1223357899999


Q ss_pred             HHHHHhhhcCCC
Q psy12427        345 DFIRRLLLRNKE  356 (356)
Q Consensus       345 ~lI~~ll~~dP~  356 (356)
                      ++|++||+.||+
T Consensus       236 ~li~~cl~~~p~  247 (263)
T cd05052         236 ELMRACWQWNPS  247 (263)
T ss_pred             HHHHHHccCCcc
Confidence            999999999995

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.9e-41  Score=306.82  Aligned_cols=241  Identities=28%  Similarity=0.491  Sum_probs=200.5

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      ...+|++.+.||.|+||.||+|.++.++..+|+|.+..........+.+|+.+++.++||||+++++.+......++|||
T Consensus        18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e   97 (296)
T cd06654          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (296)
T ss_pred             cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence            34679999999999999999999999999999999987666566778899999999999999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |+++++|.+++....  +.+     ..+..++.|++.||+|||+.||+|+||||+|||++.++  .++|+|||++.....
T Consensus        98 ~~~~~~L~~~~~~~~--~~~-----~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~--~~kl~dfg~~~~~~~  168 (296)
T cd06654          98 YLAGGSLTDVVTETC--MDE-----GQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG--SVKLTDFGFCAQITP  168 (296)
T ss_pred             ccCCCCHHHHHHhcC--CCH-----HHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC--CEEECccccchhccc
Confidence            999999999886432  233     33455999999999999999999999999999997654  799999999876543


Q ss_pred             CCc-eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHH
Q psy12427        266 NEV-VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK  344 (356)
Q Consensus       266 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  344 (356)
                      ... .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+....+..+.... ..+......++..+.
T Consensus       169 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~  247 (296)
T cd06654         169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFR  247 (296)
T ss_pred             cccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCC-CCCCCCccccCHHHH
Confidence            322 223468899999999998889999999999999999999999998887655544433322 112222346899999


Q ss_pred             HHHHHhhhcCCC
Q psy12427        345 DFIRRLLLRNKE  356 (356)
Q Consensus       345 ~lI~~ll~~dP~  356 (356)
                      ++|++||++||+
T Consensus       248 ~li~~~l~~~p~  259 (296)
T cd06654         248 DFLNRCLDMDVE  259 (296)
T ss_pred             HHHHHHCcCCcc
Confidence            999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=5.4e-41  Score=302.81  Aligned_cols=245  Identities=17%  Similarity=0.278  Sum_probs=197.7

Q ss_pred             ccceeeeccccccCceEEEEEEEcc-----CCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERK-----TGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM  180 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~-----~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  180 (356)
                      .++|++.+.||+|+||.||+|.++.     ++..+|+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~   84 (277)
T cd05062           5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   84 (277)
T ss_pred             HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCe
Confidence            3579999999999999999998752     35689999886433 23455678999999999999999999999999999


Q ss_pred             EEEEEeccccchhhhhhCCCCCCCc----cccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEe
Q psy12427        181 VLIFEFLSGGELFERITAPDYKMSE----AEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMID  256 (356)
Q Consensus       181 ~lv~e~~~~g~L~~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~D  256 (356)
                      ++||||+.+++|.+++.........    .......+..++.|++.||+|||+.|++|+||||+||+++.++  .++|+|
T Consensus        85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~--~~~l~d  162 (277)
T cd05062          85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF--TVKIGD  162 (277)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCC--CEEECC
Confidence            9999999999999998653321111    1122334556889999999999999999999999999998644  799999


Q ss_pred             eeceeeeCCCCcee---ecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccC
Q psy12427        257 FGLATKLDPNEVVK---ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFD  332 (356)
Q Consensus       257 fg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~  332 (356)
                      ||++..........   ...+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+.+..+........
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~  242 (277)
T cd05062         163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDK  242 (277)
T ss_pred             CCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence            99987654322211   1235778999999999899999999999999999999 7999999988888877766543322


Q ss_pred             hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 ~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                         ...++.+++++|.+||+.||+
T Consensus       243 ---~~~~~~~~~~li~~~l~~~p~  263 (277)
T cd05062         243 ---PDNCPDMLFELMRMCWQYNPK  263 (277)
T ss_pred             ---CCCCCHHHHHHHHHHcCCChh
Confidence               246889999999999999985

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-41  Score=304.74  Aligned_cols=241  Identities=27%  Similarity=0.448  Sum_probs=201.5

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEec
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFL  187 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~  187 (356)
                      ++|++.+.||.|+||.||++.++.++..+|+|.+..........+.+|+.++++++||||+++++.+..+...++||||+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC   84 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence            57999999999999999999999899999999998776666678889999999999999999999999999999999999


Q ss_pred             cccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCC
Q psy12427        188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE  267 (356)
Q Consensus       188 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~  267 (356)
                      ++++|.+++......+++     ..+..++.|++.||.|||++|++|+||+|+||+++.++  .++|+|||++.......
T Consensus        85 ~~~~L~~~~~~~~~~l~~-----~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~--~~~l~d~g~~~~~~~~~  157 (280)
T cd06611          85 DGGALDSIMLELERGLTE-----PQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDG--DVKLADFGVSAKNKSTL  157 (280)
T ss_pred             CCCcHHHHHHHhcCCCCH-----HHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCC--CEEEccCccchhhcccc
Confidence            999999988754333333     34455999999999999999999999999999997654  79999999886653222


Q ss_pred             -ceeecCCCcCcccccccc-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCH
Q psy12427        268 -VVKISTGTAEFAAPEIVE-----REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSE  341 (356)
Q Consensus       268 -~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  341 (356)
                       ......+++.|+|||.+.     ...++.++|+||||+++|+|++|+.||...+..+.+.++........ .....++.
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  236 (280)
T cd06611         158 QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTL-DQPSKWSS  236 (280)
T ss_pred             cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCc-CCcccCCH
Confidence             223346899999999975     34577899999999999999999999998887777766655433211 12246899


Q ss_pred             HHHHHHHHhhhcCCC
Q psy12427        342 EGKDFIRRLLLRNKE  356 (356)
Q Consensus       342 ~~~~lI~~ll~~dP~  356 (356)
                      ++.++|.+||+.||+
T Consensus       237 ~~~~li~~~l~~~p~  251 (280)
T cd06611         237 SFNDFLKSCLVKDPD  251 (280)
T ss_pred             HHHHHHHHHhccChh
Confidence            999999999999985

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3.2e-41  Score=308.43  Aligned_cols=245  Identities=22%  Similarity=0.331  Sum_probs=195.0

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCE--EEEEEcccC-ChhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNI--FAAKFIPVS-HNLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~--~a~K~~~~~-~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l  182 (356)
                      .++|++.+.||+|+||.||+|.++.++..  +|+|.++.. .......+.+|+.++.++ +||||+++++++...+.+++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            35799999999999999999999887764  466666543 233456788899999999 89999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCCC----------CccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcE
Q psy12427        183 IFEFLSGGELFERITAPDYKM----------SEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNV  252 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~v  252 (356)
                      +|||+++++|.+++.......          ....+....+..++.|++.||+|||++|++||||||+|||++.++  .+
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~--~~  163 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY--VA  163 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC--cE
Confidence            999999999999986543110          111334445667999999999999999999999999999997654  79


Q ss_pred             EEEeeeceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccc
Q psy12427        253 KMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEF  331 (356)
Q Consensus       253 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~  331 (356)
                      ||+|||++.............++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+....+....   
T Consensus       164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~---  240 (303)
T cd05088         164 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY---  240 (303)
T ss_pred             EeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC---
Confidence            9999999864322111122234678999999988889999999999999999998 999999888777776664431   


Q ss_pred             ChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        332 DEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       332 ~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ..+....++.++.+||.+||+.||+
T Consensus       241 ~~~~~~~~~~~~~~li~~~l~~~p~  265 (303)
T cd05088         241 RLEKPLNCDDEVYDLMRQCWREKPY  265 (303)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCChh
Confidence            1122246889999999999999985

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=4.2e-41  Score=309.41  Aligned_cols=238  Identities=19%  Similarity=0.287  Sum_probs=191.8

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCE----EEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNI----FAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~----~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      .+|++.+.||+|+||.||+|.+..++..    ||+|.++... ......+.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            4699999999999999999998766654    8999987543 33456788999999999999999999998764 5679


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ++||+.+|+|.+++......+..     ..+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+++.
T Consensus        86 v~e~~~~g~l~~~l~~~~~~~~~-----~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~--~~kl~DfG~a~~  158 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKDNIGS-----QYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQ--HVKITDFGLAKL  158 (316)
T ss_pred             eeecCCCCCHHHHHHhccccCCH-----HHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCC--cEEEcccccccc
Confidence            99999999999998764433333     33455889999999999999999999999999997654  699999999987


Q ss_pred             eCCCCceee---cCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhcc
Q psy12427        263 LDPNEVVKI---STGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKN  338 (356)
Q Consensus       263 ~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  338 (356)
                      .........   ..++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+.... .++.  ...
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~  235 (316)
T cd05108         159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-RLPQ--PPI  235 (316)
T ss_pred             ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCC-CCCC--CCC
Confidence            653332211   224678999999999999999999999999999998 999999887766554443332 2222  236


Q ss_pred             CCHHHHHHHHHhhhcCCC
Q psy12427        339 VSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       339 ~s~~~~~lI~~ll~~dP~  356 (356)
                      ++.++.++|.+||+.||+
T Consensus       236 ~~~~~~~li~~cl~~~p~  253 (316)
T cd05108         236 CTIDVYMIMVKCWMIDAD  253 (316)
T ss_pred             CCHHHHHHHHHHccCChh
Confidence            789999999999999985

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=6.3e-41  Score=305.58  Aligned_cols=244  Identities=21%  Similarity=0.330  Sum_probs=195.4

Q ss_pred             cceeeeccccccCceEEEEEEEccCCC--EEEEEEcccC-ChhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGN--IFAAKFIPVS-HNLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~--~~a~K~~~~~-~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      ++|++.+.||+|+||.||+|..+.++.  .+++|.++.. .......+.+|+.++.++ +||||+++++++......+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            579999999999999999999987764  4688887743 333456788899999999 799999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCC----------CccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEE
Q psy12427        184 FEFLSGGELFERITAPDYKM----------SEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVK  253 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vk  253 (356)
                      +||+++++|.+++.......          ....+....+..++.|++.||+|||+.|++||||||+|||++.++  .+|
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~--~~k  159 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL--ASK  159 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC--eEE
Confidence            99999999999986532110          111233445666999999999999999999999999999997644  799


Q ss_pred             EEeeeceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccC
Q psy12427        254 MIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFD  332 (356)
Q Consensus       254 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~  332 (356)
                      |+|||++..............+..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+.....   
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~---  236 (297)
T cd05089         160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR---  236 (297)
T ss_pred             ECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC---
Confidence            999999864322111111223567999999999999999999999999999998 9999999888887777655321   


Q ss_pred             hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 ~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+....++.++.+||.+||+.||+
T Consensus       237 ~~~~~~~~~~~~~li~~~l~~~p~  260 (297)
T cd05089         237 MEKPRNCDDEVYELMRQCWRDRPY  260 (297)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChh
Confidence            112246899999999999999985

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.6e-41  Score=306.14  Aligned_cols=243  Identities=23%  Similarity=0.380  Sum_probs=196.2

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      ++|++.+.||+|+||.||+|.++.++..+|+|.++... ......+.+|+.++++++||||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            36889999999999999999999999999999887542 33456788999999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE-KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      +++++|..++.....   ...+....+..++.|++.||.|||+ .|++|+||+|+||+++.++  .++|+|||++..+..
T Consensus        81 ~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~  155 (286)
T cd06622          81 MDAGSLDKLYAGGVA---TEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG--QVKLCDFGVSGNLVA  155 (286)
T ss_pred             cCCCCHHHHHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC--CEEEeecCCcccccC
Confidence            999999888864311   1233344556699999999999997 5999999999999998644  799999999876532


Q ss_pred             CCceeecCCCcCccccccccCCC------CCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccC
Q psy12427        266 NEVVKISTGTAEFAAPEIVEREP------VGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNV  339 (356)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  339 (356)
                      . ......+++.|+|||.+.+..      ++.++|+|||||++|+|++|..||...........+.......++..+..+
T Consensus       156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd06622         156 S-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY  234 (286)
T ss_pred             C-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCccc
Confidence            2 223446888999999986543      478999999999999999999999877665554443332222233344568


Q ss_pred             CHHHHHHHHHhhhcCCC
Q psy12427        340 SEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       340 s~~~~~lI~~ll~~dP~  356 (356)
                      +.++.+||++||+.||+
T Consensus       235 ~~~~~~li~~~l~~~p~  251 (286)
T cd06622         235 SDDAQDFVAKCLNKIPN  251 (286)
T ss_pred             CHHHHHHHHHHcccCcc
Confidence            99999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.2e-40  Score=301.43  Aligned_cols=244  Identities=19%  Similarity=0.326  Sum_probs=197.8

Q ss_pred             cceeeeccccccCceEEEEEEEc----cCCCEEEEEEcccCCh-hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRER----KTGNIFAAKFIPVSHN-LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~----~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      +.|++.+.||+|+||.||+|.+.    .++..+|+|.+..... .....+.+|+.+++.++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            46899999999999999999863    3457899999875433 334678889999999999999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCCC-----------CccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCc
Q psy12427        183 IFEFLSGGELFERITAPDYKM-----------SEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTN  251 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~  251 (356)
                      +|||+.+++|.+++.......           ....+....+..++.|++.||+|||++|++||||||+|||++.++  .
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~--~  162 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL--H  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC--c
Confidence            999999999999885432110           011233444566899999999999999999999999999998654  6


Q ss_pred             EEEEeeeceeeeCCCCc---eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcc
Q psy12427        252 VKMIDFGLATKLDPNEV---VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKAC  327 (356)
Q Consensus       252 vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~  327 (356)
                      +||+|||++........   .....++..|+|||++.+..++.++|+|||||++|+|++ |..||.+.+..+....+...
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  242 (283)
T cd05090         163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKR  242 (283)
T ss_pred             EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            99999999987643322   122335678999999998889999999999999999998 99999988887777777654


Q ss_pred             ccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        328 DWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       328 ~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ....   ....++.+++++|.+||+.||+
T Consensus       243 ~~~~---~~~~~~~~~~~li~~cl~~~p~  268 (283)
T cd05090         243 QLLP---CSEDCPPRMYSLMTECWQEGPS  268 (283)
T ss_pred             CcCC---CCCCCCHHHHHHHHHHcccCcc
Confidence            4322   2347899999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG2345|consensus

Probab=100.00  E-value=1.1e-42  Score=290.60  Aligned_cols=244  Identities=23%  Similarity=0.339  Sum_probs=198.7

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeC-----CeEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDD-----DEMV  181 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~~~  181 (356)
                      .++|.+.+.||+|||+-||++..-.++..||+|.+.+....+.+...+|++.-++++|||+++++++...+     ...|
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            36899999999999999999999999999999999999888888899999999999999999999876533     4489


Q ss_pred             EEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEEeecCCCcEEEEeeec
Q psy12427        182 LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN--IIHLDVKPENIMCQTRNSTNVKMIDFGL  259 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~  259 (356)
                      ++++|...|+|.+.+.....  ....++...+..|+.++++||++||+..  ++||||||.|||+...  +.++|.|||.
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~--kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~--~~~vl~D~GS  175 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKI--KGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDS--GLPVLMDLGS  175 (302)
T ss_pred             EEeehhccccHHHHHHHHhh--cCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCC--CceEEEeccC
Confidence            99999999999998875432  2234455556669999999999999998  9999999999999753  4799999999


Q ss_pred             eeeeCCCCcee----------ecCCCcCcccccccc---CCCCCccccHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHh
Q psy12427        260 ATKLDPNEVVK----------ISTGTAEFAAPEIVE---REPVGFYTDMWAVGVLAYVLLSGLSPFAGEND--VETLKNV  324 (356)
Q Consensus       260 a~~~~~~~~~~----------~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~--~~~~~~i  324 (356)
                      ++...-.-...          ...-|..|+|||.+.   +...+.++|||||||+||+|+.|..||...-.  ....-.+
T Consensus       176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv  255 (302)
T KOG2345|consen  176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAV  255 (302)
T ss_pred             ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEee
Confidence            87653110000          012488999999885   55678999999999999999999999964422  1223345


Q ss_pred             hccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        325 KACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       325 ~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ..+++.+|...  -+|+.+.+||+.||++||.
T Consensus       256 ~n~q~s~P~~~--~yse~l~~lik~mlqvdP~  285 (302)
T KOG2345|consen  256 QNAQISIPNSS--RYSEALHQLIKSMLQVDPN  285 (302)
T ss_pred             eccccccCCCC--CccHHHHHHHHHHhcCCcc
Confidence            56677777654  3999999999999999994

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=7.9e-41  Score=297.40  Aligned_cols=233  Identities=19%  Similarity=0.327  Sum_probs=190.4

Q ss_pred             ccccccCceEEEEEEEccCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEeccccch
Q psy12427        114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGEL  192 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L  192 (356)
                      +.||+|+||.||+|.++.++..+|+|.+.... ......+.+|++++++++||||+++++++......++||||+.+++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46999999999999999999999999886543 33446788999999999999999999999999999999999999999


Q ss_pred             hhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCcee--
Q psy12427        193 FERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVK--  270 (356)
Q Consensus       193 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~~~--  270 (356)
                      .+++......+.+     ..+..++.|++.||.|||++|++|+||+|+|||++.++  .+||+|||++..........  
T Consensus        81 ~~~~~~~~~~~~~-----~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~  153 (252)
T cd05084          81 LTFLRTEGPRLKV-----KELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKN--VLKISDFGMSREEEDGVYASTG  153 (252)
T ss_pred             HHHHHhCCCCCCH-----HHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCC--cEEECccccCcccccccccccC
Confidence            9998654333333     34455999999999999999999999999999997554  79999999987654221111  


Q ss_pred             -ecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHH
Q psy12427        271 -ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIR  348 (356)
Q Consensus       271 -~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  348 (356)
                       ....+..|+|||.+.+..++.++|+|||||++|+|++ |..||...+..+....+.....   ......+|..+.+||+
T Consensus       154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~  230 (252)
T cd05084         154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR---LPCPELCPDAVYRLME  230 (252)
T ss_pred             CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC---CCCcccCCHHHHHHHH
Confidence             1122457999999999999999999999999999998 9999988877766666654321   1223468999999999


Q ss_pred             HhhhcCCC
Q psy12427        349 RLLLRNKE  356 (356)
Q Consensus       349 ~ll~~dP~  356 (356)
                      +||+.||+
T Consensus       231 ~~l~~~p~  238 (252)
T cd05084         231 RCWEYDPG  238 (252)
T ss_pred             HHcCCChh
Confidence            99999995

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=8.9e-41  Score=304.48  Aligned_cols=240  Identities=30%  Similarity=0.515  Sum_probs=201.6

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      ..+|++.+.||.|++|.||+|.+..+++.+|+|.+..........+.+|+.+++.++||||+++++.+......++|+||
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            35799999999999999999999999999999998766555567788999999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +.+++|.+++...  .+++     ..+..++.+++.||+|||+.|++|+||+|+||+++.++  .++|+|||++......
T Consensus        98 ~~~~~L~~~~~~~--~l~~-----~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~--~~kl~dfg~~~~~~~~  168 (296)
T cd06655          98 LAGGSLTDVVTET--CMDE-----AQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDG--SVKLTDFGFCAQITPE  168 (296)
T ss_pred             cCCCcHHHHHHhc--CCCH-----HHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEccCccchhcccc
Confidence            9999999988643  2233     34455999999999999999999999999999997654  7999999998766443


Q ss_pred             Cc-eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHH
Q psy12427        267 EV-VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD  345 (356)
Q Consensus       267 ~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  345 (356)
                      .. .....+++.|+|||.+.+..++.++|+|||||++|+|++|+.||.+.+..+....+..... .+......++.++++
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  247 (296)
T cd06655         169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSPIFRD  247 (296)
T ss_pred             cccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-cccCCcccCCHHHHH
Confidence            22 2234688999999999998899999999999999999999999998887666555543322 112233578999999


Q ss_pred             HHHHhhhcCCC
Q psy12427        346 FIRRLLLRNKE  356 (356)
Q Consensus       346 lI~~ll~~dP~  356 (356)
                      ||++||+.||+
T Consensus       248 li~~~l~~dp~  258 (296)
T cd06655         248 FLNRCLEMDVE  258 (296)
T ss_pred             HHHHHhhcChh
Confidence            99999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0586|consensus

Probab=100.00  E-value=8.8e-42  Score=317.76  Aligned_cols=238  Identities=32%  Similarity=0.548  Sum_probs=213.6

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh--hHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL--EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      ...|.+...||.|.|+.|.++++..++..||+|.+......  ..+.+.+|+++|..++|||||+++.+.+....+|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            45699999999999999999999999999999999876433  3356789999999999999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      ||..+|.+++++.... +..+...     +.++.|+.+|++|||+++|+|||||++|||++.+-  .+||+|||++..+.
T Consensus       135 eya~~ge~~~yl~~~g-r~~e~~a-----r~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~m--nikIaDfgfS~~~~  206 (596)
T KOG0586|consen  135 EYASGGELFDYLVKHG-RMKEKEA-----RAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENM--NIKIADFGFSTFFD  206 (596)
T ss_pred             EeccCchhHHHHHhcc-cchhhhh-----hhhhHHHHHHHHHHhhcceeccccchhhccccccc--ceeeeccccceeec
Confidence            9999999999998765 3333333     34899999999999999999999999999998654  59999999999999


Q ss_pred             CCCceeecCCCcCccccccccCCCC-CccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHH
Q psy12427        265 PNEVVKISTGTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG  343 (356)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  343 (356)
                      ......+.+|++.|.|||++.+..+ ++.+|+||+|+++|.|+.|..||.+.+-.+.-..+..+.+..|.    -+|.++
T Consensus       207 ~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~----~ms~dc  282 (596)
T KOG0586|consen  207 YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPF----YMSCDC  282 (596)
T ss_pred             ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccc----eeechh
Confidence            8888899999999999999998876 58899999999999999999999999998888888888888775    689999


Q ss_pred             HHHHHHhhhcCCC
Q psy12427        344 KDFIRRLLLRNKE  356 (356)
Q Consensus       344 ~~lI~~ll~~dP~  356 (356)
                      +++|+++|..+|.
T Consensus       283 e~lLrk~lvl~Ps  295 (596)
T KOG0586|consen  283 EDLLRKFLVLNPS  295 (596)
T ss_pred             HHHHHHhhccCcc
Confidence            9999999999985

>KOG4279|consensus

Probab=100.00  E-value=1.2e-42  Score=325.65  Aligned_cols=236  Identities=24%  Similarity=0.398  Sum_probs=200.4

Q ss_pred             cccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEeccccchhh
Q psy12427        115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFE  194 (356)
Q Consensus       115 ~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~  194 (356)
                      +||+|.||+||-|++..|....|+|.+........+-+..|+..-++|+|.|||+++|++..++.+-|.||-++||+|..
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            79999999999999999999999999988887778888999999999999999999999999999999999999999999


Q ss_pred             hhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC-CCCceeecC
Q psy12427        195 RITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKIST  273 (356)
Q Consensus       195 ~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~  273 (356)
                      ++...=.++.+.   +.++..+.+||++||+|||++.|||||||-+||||+. -++.+||+|||.+..+- -+..+.+..
T Consensus       662 LLrskWGPlKDN---Estm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNT-ySGvlKISDFGTsKRLAginP~TETFT  737 (1226)
T KOG4279|consen  662 LLRSKWGPLKDN---ESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNT-YSGVLKISDFGTSKRLAGINPCTETFT  737 (1226)
T ss_pred             HHHhccCCCccc---hhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEee-ccceEEecccccchhhccCCccccccc
Confidence            997544444222   2344569999999999999999999999999999965 45689999999998763 344556778


Q ss_pred             CCcCccccccccCC--CCCccccHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHhhccccccChhhhccCCHHHHHHHHHh
Q psy12427        274 GTAEFAAPEIVERE--PVGFYTDMWAVGVLAYVLLSGLSPFAGEN-DVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRL  350 (356)
Q Consensus       274 gt~~y~aPE~~~~~--~~~~~sDvwSlG~il~ell~g~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~l  350 (356)
                      ||.-|||||++..+  .|+.++|||||||++.||.||++||-... +...+.++  +-+...++.+..+|.+++.||.+|
T Consensus       738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV--GmyKvHP~iPeelsaeak~Filrc  815 (1226)
T KOG4279|consen  738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV--GMYKVHPPIPEELSAEAKNFILRC  815 (1226)
T ss_pred             cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh--cceecCCCCcHHHHHHHHHHHHHH
Confidence            99999999999765  48899999999999999999999997664 33444444  333344555568999999999999


Q ss_pred             hhcCCC
Q psy12427        351 LLRNKE  356 (356)
Q Consensus       351 l~~dP~  356 (356)
                      +..||.
T Consensus       816 Fepd~~  821 (1226)
T KOG4279|consen  816 FEPDPC  821 (1226)
T ss_pred             cCCCcc
Confidence            999983

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.9e-41  Score=325.54  Aligned_cols=240  Identities=23%  Similarity=0.350  Sum_probs=188.1

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCC------CCceeeeeeEEeC-Ce
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHH------PKLINLHDAFEDD-DE  179 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~h------pnIv~l~~~~~~~-~~  179 (356)
                      .++|++.++||+|+||+||+|.+..++..||+|+++.... ....+..|+.++..++|      ++++.++++|... .+
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~  206 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH  206 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence            3679999999999999999999999999999999864322 23345668888887755      4588899988754 57


Q ss_pred             EEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEeecCC---------
Q psy12427        180 MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE-KNIIHLDVKPENIMCQTRNS---------  249 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~Dlkp~NIlv~~~~~---------  249 (356)
                      .++|||++ |++|.+++.... .     +....+..++.||+.||+|||+ .|||||||||+|||++.++.         
T Consensus       207 ~~iv~~~~-g~~l~~~l~~~~-~-----l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~  279 (467)
T PTZ00284        207 MCIVMPKY-GPCLLDWIMKHG-P-----FSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA  279 (467)
T ss_pred             EEEEEecc-CCCHHHHHHHcC-C-----CCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence            89999988 778888876432 2     3333455699999999999998 59999999999999976542         


Q ss_pred             -----CcEEEEeeeceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHh
Q psy12427        250 -----TNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV  324 (356)
Q Consensus       250 -----~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i  324 (356)
                           ..+||+|||.+.....  .....+||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+.+..+
T Consensus       280 ~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i  357 (467)
T PTZ00284        280 LPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM  357 (467)
T ss_pred             cCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence                 2499999998865322  223457899999999999999999999999999999999999999998887777766


Q ss_pred             hccccccChhhhc--------------------------------------cCCHHHHHHHHHhhhcCCC
Q psy12427        325 KACDWEFDEEAFK--------------------------------------NVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       325 ~~~~~~~~~~~~~--------------------------------------~~s~~~~~lI~~ll~~dP~  356 (356)
                      ......+|.....                                      ..++.+.|||.+||+.||+
T Consensus       358 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~  427 (467)
T PTZ00284        358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQ  427 (467)
T ss_pred             HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChh
Confidence            5543333322110                                      0135678999999999995

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=9.4e-41  Score=315.57  Aligned_cols=246  Identities=22%  Similarity=0.304  Sum_probs=192.9

Q ss_pred             ccceeeeccccccCceEEEEEEEccC-----CCEEEEEEcccCC-hhhHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCe
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKT-----GNIFAAKFIPVSH-NLEKELIRKEIDIMNQLH-HPKLINLHDAFEDDDE  179 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~-----~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~  179 (356)
                      .++|.+.+.||+|+||.||+|.+...     +..||+|+++... ....+.+.+|+++|..++ ||||+++++++.....
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            45799999999999999999987533     3469999997543 334567889999999996 9999999999999999


Q ss_pred             EEEEEEeccccchhhhhhCCCCCCC-------------------------------------------------------
Q psy12427        180 MVLIFEFLSGGELFERITAPDYKMS-------------------------------------------------------  204 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~~~~-------------------------------------------------------  204 (356)
                      .++||||+++|+|.+++........                                                       
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            9999999999999988864321000                                                       


Q ss_pred             -----------------------------------ccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCC
Q psy12427        205 -----------------------------------EAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNS  249 (356)
Q Consensus       205 -----------------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~  249 (356)
                                                         ...+....+..++.|++.||+|||+.+|+||||||+|||++.++ 
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~-  274 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGK-  274 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCC-
Confidence                                               01123334566899999999999999999999999999997644 


Q ss_pred             CcEEEEeeeceeeeCCCCce---eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhh
Q psy12427        250 TNVKMIDFGLATKLDPNEVV---KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK  325 (356)
Q Consensus       250 ~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~  325 (356)
                       .+||+|||+++........   ....+++.|+|||.+.+..++.++|||||||++|+|++ |..||......+.+....
T Consensus       275 -~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~  353 (400)
T cd05105         275 -IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKI  353 (400)
T ss_pred             -EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHH
Confidence             7999999999876432211   12346788999999999999999999999999999997 999998775444333333


Q ss_pred             ccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        326 ACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       326 ~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .....++  ....++.++.++|.+||+.||+
T Consensus       354 ~~~~~~~--~~~~~~~~l~~li~~cl~~dP~  382 (400)
T cd05105         354 KSGYRMA--KPDHATQEVYDIMVKCWNSEPE  382 (400)
T ss_pred             hcCCCCC--CCccCCHHHHHHHHHHCccCHh
Confidence            3222222  2247899999999999999985

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-41  Score=306.97  Aligned_cols=240  Identities=28%  Similarity=0.498  Sum_probs=201.1

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh---hHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL---EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      +|++.+.||.|+||.||+|.+..+++.+|+|.+......   ....+.+|+++++.++||||+++++.+......+++||
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   81 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD   81 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence            689999999999999999999999999999998765432   34567889999999999999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |+.+++|.+++....    ...+....+..++.|++.||+|||+.|++|+||||+||+++.++  .++|+|||++.....
T Consensus        82 ~~~~~~L~~~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~~l~dfg~~~~~~~  155 (316)
T cd05574          82 YCPGGELFRLLQRQP----GKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESG--HIMLSDFDLSKQSDV  155 (316)
T ss_pred             ecCCCCHHHHHHhCC----CCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCC--CEEEeecchhhcccc
Confidence            999999999886432    12233344556899999999999999999999999999998654  799999999876532


Q ss_pred             CCc------------------------------eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q psy12427        266 NEV------------------------------VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGE  315 (356)
Q Consensus       266 ~~~------------------------------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~  315 (356)
                      ...                              .....|+..|+|||++.+..++.++||||||+++|+|++|..||.+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence            211                              01235788999999999988999999999999999999999999999


Q ss_pred             ChHHHHHHhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        316 NDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       316 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +..+.+.++......++..  ..++.++++||++||+.||+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~  274 (316)
T cd05574         236 NRDETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPS  274 (316)
T ss_pred             chHHHHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCHh
Confidence            8888887777655554432  23799999999999999985

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-40  Score=298.99  Aligned_cols=242  Identities=19%  Similarity=0.287  Sum_probs=195.5

Q ss_pred             eeeeccccccCceEEEEEEEccC---CCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCe-----
Q psy12427        110 YDILEEIGTGAFGVVHRCRERKT---GNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDE-----  179 (356)
Q Consensus       110 y~~~~~lg~G~fg~V~~~~~~~~---~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-----  179 (356)
                      |++.+.||+|+||.||+|....+   +..+|+|.++...  ......+.+|+.+++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            56788999999999999998754   4789999987543  3344678899999999999999999998865544     


Q ss_pred             -EEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeee
Q psy12427        180 -MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFG  258 (356)
Q Consensus       180 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg  258 (356)
                       .++++||+++|+|..++...........+....+..++.|++.||.|||+++++||||||+||+++.++  .+||+|||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~dfg  158 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDM--TVCVADFG  158 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCC--eEEECCcc
Confidence             799999999999998885443222223344455666999999999999999999999999999997654  79999999


Q ss_pred             ceeeeCCCCce---eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChh
Q psy12427        259 LATKLDPNEVV---KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEE  334 (356)
Q Consensus       259 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~  334 (356)
                      +++........   ....++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+.+..+......   .
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~  235 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRL---K  235 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---C
Confidence            99876433221   11234678999999998999999999999999999999 99999998888888777664322   2


Q ss_pred             hhccCCHHHHHHHHHhhhcCCC
Q psy12427        335 AFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       335 ~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ....++.++.++|.+||+.||+
T Consensus       236 ~~~~~~~~~~~li~~~l~~~p~  257 (273)
T cd05035         236 QPEDCLDELYDLMYSCWRADPK  257 (273)
T ss_pred             CCcCCCHHHHHHHHHHcCCChh
Confidence            2347899999999999999995

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=8.9e-41  Score=299.50  Aligned_cols=243  Identities=25%  Similarity=0.443  Sum_probs=197.4

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      ++|++.+.||+|+||.||+|+++.++..+|+|.+....   ......+.+|+.+++.++||||+++++++...+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            46999999999999999999999999999999876432   333456788999999999999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      ||+++++|.+++.....  ....+....+..++.|++.||+|||++|++|+||+|+||+++.++  .++|+|||++....
T Consensus        82 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~--~~~l~d~g~~~~~~  157 (267)
T cd08228          82 ELADAGDLSQMIKYFKK--QKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATG--VVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCcHHHHHHHhhh--ccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCC--CEEECccccceecc
Confidence            99999999888753211  112233445566999999999999999999999999999997654  69999999988765


Q ss_pred             CCCc-eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC--hHHHHHHhhccccccChhhhccCCH
Q psy12427        265 PNEV-VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN--DVETLKNVKACDWEFDEEAFKNVSE  341 (356)
Q Consensus       265 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~  341 (356)
                      .... .....|++.|+|||.+.+..++.++|+||+|+++|+|++|+.||....  ..+....+....  +++.....++.
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  235 (267)
T cd08228         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD--YPPLPTEHYSE  235 (267)
T ss_pred             chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC--CCCCChhhcCH
Confidence            3222 223468899999999998889999999999999999999999997653  344555554433  33333346889


Q ss_pred             HHHHHHHHhhhcCCC
Q psy12427        342 EGKDFIRRLLLRNKE  356 (356)
Q Consensus       342 ~~~~lI~~ll~~dP~  356 (356)
                      ++.++|++||+.||+
T Consensus       236 ~~~~li~~cl~~~p~  250 (267)
T cd08228         236 KLRELVSMCIYPDPD  250 (267)
T ss_pred             HHHHHHHHHCCCCcc
Confidence            999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2e-41  Score=302.12  Aligned_cols=239  Identities=31%  Similarity=0.570  Sum_probs=193.9

Q ss_pred             eeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHH--HHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEec
Q psy12427        110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE--LIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFL  187 (356)
Q Consensus       110 y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~--~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~  187 (356)
                      |++.+.||+|+||+||++++..++..+|+|++.........  ...+|+.++++++||||+++++++......+++||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            78899999999999999999999999999999887654433  3456999999999999999999999999999999999


Q ss_pred             cccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee-CCC
Q psy12427        188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL-DPN  266 (356)
Q Consensus       188 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~-~~~  266 (356)
                      .+++|.+++..      ...+....+..++.|++.||++||+.|++|+||||+||+++.++  .++|+|||.+... ...
T Consensus        81 ~~~~L~~~l~~------~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~--~~~l~Dfg~~~~~~~~~  152 (260)
T PF00069_consen   81 PGGSLQDYLQK------NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENG--EVKLIDFGSSVKLSENN  152 (260)
T ss_dssp             TTEBHHHHHHH------HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTS--EEEESSGTTTEESTSTT
T ss_pred             ccccccccccc------cccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccc
Confidence            99999999871      22234445566999999999999999999999999999998444  7999999999864 233


Q ss_pred             CceeecCCCcCcccccccc-CCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHH---HHHhhccccccChhhhccCCHH
Q psy12427        267 EVVKISTGTAEFAAPEIVE-REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVET---LKNVKACDWEFDEEAFKNVSEE  342 (356)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~s~~  342 (356)
                      .......++..|+|||++. +...+.++|+||+|+++|+|++|..||......+.   +..................+.+
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEE  232 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHH
Confidence            3444567899999999998 88899999999999999999999999998843333   3333322222111111123489


Q ss_pred             HHHHHHHhhhcCCC
Q psy12427        343 GKDFIRRLLLRNKE  356 (356)
Q Consensus       343 ~~~lI~~ll~~dP~  356 (356)
                      +.++|++||+.||+
T Consensus       233 l~~li~~~l~~~p~  246 (260)
T PF00069_consen  233 LRDLIKKMLSKDPE  246 (260)
T ss_dssp             HHHHHHHHSSSSGG
T ss_pred             HHHHHHHHccCChh
Confidence            99999999999995

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.7e-40  Score=299.64  Aligned_cols=246  Identities=20%  Similarity=0.298  Sum_probs=199.2

Q ss_pred             cceeeeccccccCceEEEEEEEcc-----CCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERK-----TGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMV  181 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~-----~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  181 (356)
                      +.|++.+.||+|+||.||+|.++.     ++..+|+|.+.... ......+.+|+.+++.++||||+++++++......+
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF   85 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence            569999999999999999999987     67899999887543 333456888999999999999999999999999999


Q ss_pred             EEEEeccccchhhhhhCCCCCC-CccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCC-CcEEEEeeec
Q psy12427        182 LIFEFLSGGELFERITAPDYKM-SEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNS-TNVKMIDFGL  259 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~-~~vkl~Dfg~  259 (356)
                      ++|||+.|++|.+++....... ....+....+..++.||+.||+|||+++++|+||||+|||++.++. ..+||+|||+
T Consensus        86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~  165 (277)
T cd05036          86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGM  165 (277)
T ss_pred             EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCcc
Confidence            9999999999999986543211 1123444455669999999999999999999999999999986542 3589999999


Q ss_pred             eeeeCCCCcee---ecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhh
Q psy12427        260 ATKLDPNEVVK---ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEA  335 (356)
Q Consensus       260 a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  335 (356)
                      ++.........   ....+..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+......   ..
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~---~~  242 (277)
T cd05036         166 ARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL---DP  242 (277)
T ss_pred             ccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC---CC
Confidence            98763322211   1123568999999998899999999999999999997 99999998887777666543211   22


Q ss_pred             hccCCHHHHHHHHHhhhcCCC
Q psy12427        336 FKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       336 ~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ...+|.++.+||++||+.||+
T Consensus       243 ~~~~~~~~~~~i~~cl~~~p~  263 (277)
T cd05036         243 PKGCPGPVYRIMTDCWQHTPE  263 (277)
T ss_pred             CCCCCHHHHHHHHHHcCCCcc
Confidence            347899999999999999995

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.4e-40  Score=299.04  Aligned_cols=241  Identities=20%  Similarity=0.293  Sum_probs=193.3

Q ss_pred             eeeccccccCceEEEEEEEccCCC--EEEEEEcccC--ChhhHHHHHHHHHHHHhcCCCCceeeeeeEEe------CCeE
Q psy12427        111 DILEEIGTGAFGVVHRCRERKTGN--IFAAKFIPVS--HNLEKELIRKEIDIMNQLHHPKLINLHDAFED------DDEM  180 (356)
Q Consensus       111 ~~~~~lg~G~fg~V~~~~~~~~~~--~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~~~  180 (356)
                      .+.+.||+|+||.||+|.+..++.  .+|+|.++..  .....+.+.+|+.+++.++||||+++++.+..      ....
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            467899999999999999987765  6899988754  24445678889999999999999999998743      2357


Q ss_pred             EEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeece
Q psy12427        181 VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA  260 (356)
Q Consensus       181 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a  260 (356)
                      +++|||+.+|+|.+++...........+....+..++.|++.||+|||+++|+||||||+|||++.++  .+||+|||++
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~  159 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENM--NVCVADFGLS  159 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCC--CEEECCCCcc
Confidence            89999999999988875332222222344455566999999999999999999999999999997544  7999999999


Q ss_pred             eeeCCCCce---eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhh
Q psy12427        261 TKLDPNEVV---KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAF  336 (356)
Q Consensus       261 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  336 (356)
                      +........   ....+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+....+....+.......   ..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~  236 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLK---QP  236 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC---CC
Confidence            876433221   12235778999999999999999999999999999999 899999988888877776654322   12


Q ss_pred             ccCCHHHHHHHHHhhhcCCC
Q psy12427        337 KNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       337 ~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ..+++.++++|.+||+.||+
T Consensus       237 ~~~~~~~~~li~~~l~~~p~  256 (272)
T cd05075         237 PDCLDGLYSLMSSCWLLNPK  256 (272)
T ss_pred             CCCCHHHHHHHHHHcCCCcc
Confidence            37899999999999999995

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.9e-41  Score=313.18  Aligned_cols=239  Identities=24%  Similarity=0.438  Sum_probs=191.3

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh--hhHHHHHHHHHHHHhcCCCCceeeeeeEEeC------
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN--LEKELIRKEIDIMNQLHHPKLINLHDAFEDD------  177 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------  177 (356)
                      +.++|++.+.||.|+||+||+|.+..++..||+|.+.....  .....+.+|+.+|++++||||+++++++...      
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            45689999999999999999999999999999999875432  2335567899999999999999999988543      


Q ss_pred             CeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEee
Q psy12427        178 DEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDF  257 (356)
Q Consensus       178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Df  257 (356)
                      ...+++++++ +++|.+++...  .     +....+..++.||+.||+|||++||+||||||+|||++.++  .+||+||
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~~~--~-----l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~--~~kl~Df  162 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVKCQ--K-----LSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDC--ELRILDF  162 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHhcC--C-----CCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCC--CEEEcCC
Confidence            4578999988 78888877532  2     33344566999999999999999999999999999997654  7999999


Q ss_pred             eceeeeCCCCceeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCh---
Q psy12427        258 GLATKLDPNEVVKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE---  333 (356)
Q Consensus       258 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~---  333 (356)
                      |++......  .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.......++   
T Consensus       163 g~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  240 (343)
T cd07878         163 GLARQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVL  240 (343)
T ss_pred             ccceecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            999876432  234468999999999876 56889999999999999999999999988776666555432211111   


Q ss_pred             ------------------------hhhccCCHHHHHHHHHhhhcCCC
Q psy12427        334 ------------------------EAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       334 ------------------------~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                              ..+...++.+.+||++||+.||+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~  287 (343)
T cd07878         241 KKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSD  287 (343)
T ss_pred             HhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChh
Confidence                                    11234677899999999999995

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.3e-40  Score=304.74  Aligned_cols=239  Identities=27%  Similarity=0.461  Sum_probs=199.1

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      +|++.+.||.|+||.||++.++.+++.||+|.+....   ......+.+|+++++.++||||+++++.+..+..++++||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME   81 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence            6899999999999999999999999999999987543   2234567789999999999999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |++|++|.+++.... .+     ....+..++.|++.||+|||+.|++||||+|+||+++.++  .++|+|||+++....
T Consensus        82 ~~~g~~L~~~l~~~~-~~-----~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~--~~~l~dfg~~~~~~~  153 (305)
T cd05609          82 YVEGGDCATLLKNIG-AL-----PVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMG--HIKLTDFGLSKIGLM  153 (305)
T ss_pred             cCCCCcHHHHHHHcC-CC-----CHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCC--CEEEeeCCCccccCc
Confidence            999999999986432 22     3333445889999999999999999999999999997544  799999998864211


Q ss_pred             CC----------------ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc
Q psy12427        266 NE----------------VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDW  329 (356)
Q Consensus       266 ~~----------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~  329 (356)
                      ..                ......++..|+|||.+....++.++|+|||||++|+|++|..||.+.+..+.+..+.....
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~  233 (305)
T cd05609         154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI  233 (305)
T ss_pred             CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Confidence            00                00113468899999999988899999999999999999999999999888888888777655


Q ss_pred             ccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        330 EFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       330 ~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ..+... ..+|.+++++|++||++||+
T Consensus       234 ~~~~~~-~~~~~~~~~li~~~l~~~P~  259 (305)
T cd05609         234 EWPEGD-EALPADAQDLISRLLRQNPL  259 (305)
T ss_pred             CCCCcc-ccCCHHHHHHHHHHhccChh
Confidence            444332 26899999999999999995

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.6e-40  Score=301.93  Aligned_cols=244  Identities=17%  Similarity=0.295  Sum_probs=202.0

Q ss_pred             cceeeeccccccCceEEEEEEEcc-----CCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERK-----TGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~-----~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      .+|.+.+.||+|+||.||+|.+..     ++..+++|.+..........+.+|+.+++.++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            468999999999999999998643     456799999877666666778899999999999999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCC----------CCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcE
Q psy12427        183 IFEFLSGGELFERITAPDYK----------MSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNV  252 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~----------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~v  252 (356)
                      ||||+++++|.+++......          .....+....+..++.||+.||+|||++|++||||||+|||++.++  .+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~--~~  162 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL--LV  162 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC--cE
Confidence            99999999999998654321          1122344455667999999999999999999999999999998654  79


Q ss_pred             EEEeeeceeeeCCCCce---eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccc
Q psy12427        253 KMIDFGLATKLDPNEVV---KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACD  328 (356)
Q Consensus       253 kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~  328 (356)
                      +|+|||++.........   ....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+.++.+....
T Consensus       163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~  242 (291)
T cd05094         163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR  242 (291)
T ss_pred             EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCC
Confidence            99999999765432221   22345788999999999999999999999999999998 999999888888887776655


Q ss_pred             cccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        329 WEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       329 ~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ....   ...+|.++.++|.+||++||+
T Consensus       243 ~~~~---~~~~~~~~~~li~~~l~~~P~  267 (291)
T cd05094         243 VLER---PRVCPKEVYDIMLGCWQREPQ  267 (291)
T ss_pred             CCCC---CccCCHHHHHHHHHHcccChh
Confidence            4322   246789999999999999995

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.4e-40  Score=297.30  Aligned_cols=239  Identities=21%  Similarity=0.390  Sum_probs=197.0

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      .++|++.++||+|+||.||+|... ++..+|+|.+..... ..+.+.+|+.+++.++||||+++++++...+..+++|||
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY   82 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence            357999999999999999999865 467799998765432 356788999999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +++++|.+++.....    .......+..++.|++.||+|||+.+++|+||+|+||+++.++  .++|+|||++......
T Consensus        83 ~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~--~~~l~dfg~~~~~~~~  156 (261)
T cd05072          83 MAKGSLLDFLKSDEG----GKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESL--MCKIADFGLARVIEDN  156 (261)
T ss_pred             CCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCC--cEEECCCccceecCCC
Confidence            999999998864321    1222334455889999999999999999999999999998654  7999999999876533


Q ss_pred             Cce--eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHH
Q psy12427        267 EVV--KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG  343 (356)
Q Consensus       267 ~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  343 (356)
                      ...  ....++..|+|||++....++.++|||||||++|+|++ |..||.+....+....+.... .+  +....++.++
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~  233 (261)
T cd05072         157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY-RM--PRMENCPDEL  233 (261)
T ss_pred             ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC-CC--CCCCCCCHHH
Confidence            221  12235678999999998889999999999999999998 999999988888777776543 22  2234789999


Q ss_pred             HHHHHHhhhcCCC
Q psy12427        344 KDFIRRLLLRNKE  356 (356)
Q Consensus       344 ~~lI~~ll~~dP~  356 (356)
                      .++|.+||+.||+
T Consensus       234 ~~li~~~l~~~p~  246 (261)
T cd05072         234 YDIMKTCWKEKAE  246 (261)
T ss_pred             HHHHHHHccCCcc
Confidence            9999999999995

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-40  Score=300.14  Aligned_cols=238  Identities=24%  Similarity=0.421  Sum_probs=200.3

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      ++|++.+.||.|++|.||+|.+..++..+|+|.+.... ......+.+|+++++.++||||+++++++..+...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36889999999999999999999999999999987654 33446678899999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +.+++|.+++...  .     +....+..++.|++.||.|||+++++|+||+|+||+++.++  .++|+|||++......
T Consensus        81 ~~~~~L~~~~~~~--~-----~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~--~~~l~d~g~~~~~~~~  151 (274)
T cd06609          81 CGGGSCLDLLKPG--K-----LDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEG--DVKLADFGVSGQLTST  151 (274)
T ss_pred             eCCCcHHHHHhhc--C-----CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC--CEEEcccccceeeccc
Confidence            9999999998753  2     23344556999999999999999999999999999998654  7999999999887543


Q ss_pred             -CceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHH
Q psy12427        267 -EVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD  345 (356)
Q Consensus       267 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  345 (356)
                       .......+++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+.....+....  ..++.++.+
T Consensus       152 ~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  229 (274)
T cd06609         152 MSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEG--NKFSKPFKD  229 (274)
T ss_pred             ccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcc--cccCHHHHH
Confidence             22234468889999999999889999999999999999999999998887776666665543222111  128999999


Q ss_pred             HHHHhhhcCCC
Q psy12427        346 FIRRLLLRNKE  356 (356)
Q Consensus       346 lI~~ll~~dP~  356 (356)
                      +|.+||..||+
T Consensus       230 ~l~~~l~~~p~  240 (274)
T cd06609         230 FVSLCLNKDPK  240 (274)
T ss_pred             HHHHHhhCChh
Confidence            99999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.1e-40  Score=299.57  Aligned_cols=244  Identities=15%  Similarity=0.292  Sum_probs=200.8

Q ss_pred             cceeeeccccccCceEEEEEEEc-----cCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRER-----KTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~-----~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      .+|.+.++||+|+||.||++...     .++..+|+|.+..........+.+|+++++.++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            46888999999999999999753     3467899999887766667789999999999999999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCC---------CCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEE
Q psy12427        183 IFEFLSGGELFERITAPDYK---------MSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVK  253 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~---------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vk  253 (356)
                      +|||+.+++|.+++......         .....+....+..++.|++.||+|||+.|++|+||||+|||++.++  .+|
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~--~~k  162 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL--VVK  162 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC--CEE
Confidence            99999999999998654321         1112344455677999999999999999999999999999997544  799


Q ss_pred             EEeeeceeeeCCCCcee---ecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccc
Q psy12427        254 MIDFGLATKLDPNEVVK---ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDW  329 (356)
Q Consensus       254 l~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~  329 (356)
                      |+|||++..........   ...+++.|+|||.+.+..++.++|||||||++|+|++ |.+||......+.+..+.....
T Consensus       163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~  242 (280)
T cd05092         163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRE  242 (280)
T ss_pred             ECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCcc
Confidence            99999998664332211   1234678999999999999999999999999999998 9999998888887777765432


Q ss_pred             ccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        330 EFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       330 ~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .   .....+|..+.+||.+||+.||+
T Consensus       243 ~---~~~~~~~~~~~~li~~cl~~~P~  266 (280)
T cd05092         243 L---ERPRTCPPEVYAIMQGCWQREPQ  266 (280)
T ss_pred             C---CCCCCCCHHHHHHHHHHccCChh
Confidence            2   12247899999999999999995

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1e-40  Score=301.81  Aligned_cols=244  Identities=18%  Similarity=0.301  Sum_probs=199.2

Q ss_pred             cceeeeccccccCceEEEEEEEccC-----CCEEEEEEcccCCh-hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKT-----GNIFAAKFIPVSHN-LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMV  181 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~-----~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  181 (356)
                      .+|.+.++||.|+||.||+|.+..+     +..+|+|.++.... ...+.+.+|+.++..++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            4688999999999999999987543     57899999975543 23466888999999999999999999999999999


Q ss_pred             EEEEeccccchhhhhhCCCCCC----------CccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCc
Q psy12427        182 LIFEFLSGGELFERITAPDYKM----------SEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTN  251 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~  251 (356)
                      +++||+.+++|.+++.......          ....+....+..++.|++.||+|||++|++||||||+|||++.++  .
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~--~  162 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL--N  162 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC--c
Confidence            9999999999999885322110          011233344566899999999999999999999999999997544  6


Q ss_pred             EEEEeeeceeeeCCCCce---eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcc
Q psy12427        252 VKMIDFGLATKLDPNEVV---KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKAC  327 (356)
Q Consensus       252 vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~  327 (356)
                      +||+|||+++........   ....+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+.+..+...
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~  242 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNR  242 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            999999998865433221   22345789999999998889999999999999999998 99999999888888888776


Q ss_pred             ccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        328 DWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       328 ~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .....   ..+++.++.+||.+||+.||+
T Consensus       243 ~~~~~---~~~~~~~~~~li~~cl~~~p~  268 (283)
T cd05091         243 QVLPC---PDDCPAWVYTLMLECWNEFPS  268 (283)
T ss_pred             CcCCC---CCCCCHHHHHHHHHHhCCCcc
Confidence            54332   247899999999999999995

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.7e-40  Score=295.52  Aligned_cols=240  Identities=27%  Similarity=0.451  Sum_probs=202.6

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      +|++.+.||+|+||.||+|.+..++..+|+|.+....  ......+.+|++++++++||||+++++.+......++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4889999999999999999999999999999987543  33456788999999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +++++|.+++.....    .......+..++.+++.||+|||++|++|+||+|+||+++.++ ..++|+|||++......
T Consensus        81 ~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~-~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          81 APGGTLAEYIQKRCN----SLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHK-MVVKIGDFGISKILSSK  155 (256)
T ss_pred             CCCCCHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEEccCCCceecCCC
Confidence            999999999875321    1223344556899999999999999999999999999997544 36899999999877654


Q ss_pred             CceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHH
Q psy12427        267 EVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDF  346 (356)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  346 (356)
                      .......++..|+|||.+.+..++.++||||||+++|+|++|+.||.+.+.......+.......   ....++.+++++
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~l  232 (256)
T cd08220         156 SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP---ISDRYSPDLRQL  232 (256)
T ss_pred             ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCC---CCCCcCHHHHHH
Confidence            44444568999999999999889999999999999999999999999888777777766544322   223689999999


Q ss_pred             HHHhhhcCCC
Q psy12427        347 IRRLLLRNKE  356 (356)
Q Consensus       347 I~~ll~~dP~  356 (356)
                      |.+||+.||+
T Consensus       233 i~~~l~~~p~  242 (256)
T cd08220         233 ILSMLNLDPS  242 (256)
T ss_pred             HHHHccCChh
Confidence            9999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=8.4e-41  Score=298.65  Aligned_cols=239  Identities=21%  Similarity=0.353  Sum_probs=201.2

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEec
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFL  187 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~  187 (356)
                      .+|++.++||.|+||.||+|.++. +..+|+|.+..........+.+|+.+++.++||||+++++++......+++|||+
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            468999999999999999999988 8999999998776656778889999999999999999999999999999999999


Q ss_pred             cccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCC
Q psy12427        188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE  267 (356)
Q Consensus       188 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~  267 (356)
                      ++++|.+++.....    .......+..++.|++.||+|||+.|++|+||+|+||+++.++  .+||+|||.+.......
T Consensus        85 ~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~--~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          85 EKGSLLAFLRSPEG----QVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDL--VCKVADFGLARLIKEDV  158 (261)
T ss_pred             ccCCHHHHHhcCCC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCc--eEEEccccchhhcCCcc
Confidence            99999999875321    1223344556999999999999999999999999999997654  79999999997664322


Q ss_pred             ce-eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHH
Q psy12427        268 VV-KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD  345 (356)
Q Consensus       268 ~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  345 (356)
                      .. ....++..|+|||.+....++.++|+||||+++|+|++ |+.||.+.+..+.+..+.... ..  .....+++++.+
T Consensus       159 ~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~  235 (261)
T cd05148         159 YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGY-RM--PCPAKCPQEIYK  235 (261)
T ss_pred             ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCC-cC--CCCCCCCHHHHH
Confidence            21 12235678999999998899999999999999999998 899999988888888776532 22  223478999999


Q ss_pred             HHHHhhhcCCC
Q psy12427        346 FIRRLLLRNKE  356 (356)
Q Consensus       346 lI~~ll~~dP~  356 (356)
                      +|.+||+.||+
T Consensus       236 ~i~~~l~~~p~  246 (261)
T cd05148         236 IMLECWAAEPE  246 (261)
T ss_pred             HHHHHcCCCch
Confidence            99999999995

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-40  Score=297.15  Aligned_cols=239  Identities=21%  Similarity=0.326  Sum_probs=197.8

Q ss_pred             cceeeeccccccCceEEEEEEEccC---CCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKT---GNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~---~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      ++|++.+.||+|+||.||+|.++.+   ...+|+|.++... ......+.+|+.++++++||||+++++.+......+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            5689999999999999999998754   4589999987543 33456788899999999999999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      |||+++++|.+++......++     ...+..++.|++.||+|||+++|+|+||+|+|||++.++  .++|+|||++...
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~-----~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~--~~~l~dfg~~~~~  156 (266)
T cd05033          84 TEYMENGSLDKFLRENDGKFT-----VGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNL--VCKVSDFGLSRRL  156 (266)
T ss_pred             EEcCCCCCHHHHHHhccCCCC-----HHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC--CEEECccchhhcc
Confidence            999999999999875443333     334455999999999999999999999999999997654  7999999999877


Q ss_pred             CC-CCceee--cCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccC
Q psy12427        264 DP-NEVVKI--STGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNV  339 (356)
Q Consensus       264 ~~-~~~~~~--~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  339 (356)
                      .. ......  ..+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+...... +.  ...+
T Consensus       157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-~~--~~~~  233 (266)
T cd05033         157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL-PP--PMDC  233 (266)
T ss_pred             cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC-CC--CCCC
Confidence            42 221121  234678999999999999999999999999999998 99999888888877777654322 21  2478


Q ss_pred             CHHHHHHHHHhhhcCCC
Q psy12427        340 SEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       340 s~~~~~lI~~ll~~dP~  356 (356)
                      ++.+.++|.+||+.||+
T Consensus       234 ~~~l~~li~~cl~~~p~  250 (266)
T cd05033         234 PSALYQLMLDCWQKDRN  250 (266)
T ss_pred             CHHHHHHHHHHcCCCcc
Confidence            99999999999999995

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.7e-40  Score=300.57  Aligned_cols=241  Identities=32%  Similarity=0.516  Sum_probs=194.7

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh--hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN--LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      ++|++.+.||+|+||.||+|+++.+|+.+|+|.+.....  .....+.+|+.++++++||||+++++++......+++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            368999999999999999999999999999998865432  223557789999999999999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |++++.|..++.... .+     ....+..++.|++.||+|||+.|++|+||+|+||+++.++  .++|+|||++.....
T Consensus        81 ~~~~~~l~~~~~~~~-~~-----~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~  152 (286)
T cd07847          81 YCDHTVLNELEKNPR-GV-----PEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQG--QIKLCDFGFARILTG  152 (286)
T ss_pred             ccCccHHHHHHhCCC-CC-----CHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCC--cEEECccccceecCC
Confidence            999988877664322 23     3344556999999999999999999999999999997654  799999999987754


Q ss_pred             CC-ceeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc-------------
Q psy12427        266 NE-VVKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWE-------------  330 (356)
Q Consensus       266 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~-------------  330 (356)
                      .. ......++..|+|||++.+ ..++.++|+||||+++|+|++|.+||.+.+..+.+..+......             
T Consensus       153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07847         153 PGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ  232 (286)
T ss_pred             CcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence            33 2233457889999999876 45788999999999999999999999988776655544321100             


Q ss_pred             ------cC--------hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        331 ------FD--------EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       331 ------~~--------~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                            .+        ...+.+++.++.+||.+||+.||+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  272 (286)
T cd07847         233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPT  272 (286)
T ss_pred             ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCcc
Confidence                  01        122356899999999999999995

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.2e-40  Score=299.12  Aligned_cols=238  Identities=19%  Similarity=0.270  Sum_probs=193.1

Q ss_pred             cceeeeccccccCceEEEEEEEccCCC----EEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGN----IFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~----~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      ++|++.+.||.|+||+||+|.+..++.    .||+|.++... ......+.+|+.++..++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence            578999999999999999999887776    48999987543 33456788899999999999999999998754 5678


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ++||+++|+|.+++......+++     ..+..++.|++.||+|||+++|+||||||+|||++.++  .+||+|||+++.
T Consensus        86 ~~~~~~~g~l~~~l~~~~~~~~~-----~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~--~~kL~dfG~~~~  158 (279)
T cd05109          86 VTQLMPYGCLLDYVRENKDRIGS-----QDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPN--HVKITDFGLARL  158 (279)
T ss_pred             EEEcCCCCCHHHHHhhccCCCCH-----HHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC--cEEECCCCceee
Confidence            99999999999998754333333     34455899999999999999999999999999997544  699999999987


Q ss_pred             eCCCCceee---cCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhcc
Q psy12427        263 LDPNEVVKI---STGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKN  338 (356)
Q Consensus       263 ~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  338 (356)
                      .........   ..+++.|+|||.+.+..++.++|||||||++|||++ |..||......+....+........   ...
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~  235 (279)
T cd05109         159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQ---PPI  235 (279)
T ss_pred             cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC---Ccc
Confidence            653322211   234678999999999999999999999999999998 9999988877776665555432211   247


Q ss_pred             CCHHHHHHHHHhhhcCCC
Q psy12427        339 VSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       339 ~s~~~~~lI~~ll~~dP~  356 (356)
                      ++.++.++|.+||+.||+
T Consensus       236 ~~~~~~~li~~~l~~dp~  253 (279)
T cd05109         236 CTIDVYMIMVKCWMIDSE  253 (279)
T ss_pred             CCHHHHHHHHHHcCCChh
Confidence            899999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG4257|consensus

Probab=100.00  E-value=1.8e-41  Score=314.65  Aligned_cols=237  Identities=22%  Similarity=0.335  Sum_probs=205.7

Q ss_pred             ceeeeccccccCceEEEEEEEccC----CCEEEEEEcccC-ChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKT----GNIFAAKFIPVS-HNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~----~~~~a~K~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      .....++||.|-||.||+|.....    .-.||+|..+.+ ...+.+.|..|+.+|+.++||||++|+|+|.. ...+||
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv  468 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV  468 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence            456678999999999999986543    346888988764 45567889999999999999999999999876 578999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      ||.++-|.|..++...+..++...+..     ++.||+.||+|||+.++|||||..+||||....  .|||+|||+++.+
T Consensus       469 mEL~~~GELr~yLq~nk~sL~l~tL~l-----y~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~--CVKLaDFGLSR~~  541 (974)
T KOG4257|consen  469 MELAPLGELREYLQQNKDSLPLRTLTL-----YCYQICTALAYLESKRFVHRDIAARNILVSSPQ--CVKLADFGLSRYL  541 (974)
T ss_pred             EecccchhHHHHHHhccccchHHHHHH-----HHHHHHHHHHHHHhhchhhhhhhhhheeecCcc--eeeecccchhhhc
Confidence            999999999999998776666555544     999999999999999999999999999998765  5999999999999


Q ss_pred             CCCCceeecCC--CcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCC
Q psy12427        264 DPNEVVKISTG--TAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVS  340 (356)
Q Consensus       264 ~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  340 (356)
                      +.....+...|  +.-|||||.+....++.+||||-|||+|||+++ |..||.+-.+.+.+-.+.++.--+   .+.++|
T Consensus       542 ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP---~P~nCP  618 (974)
T KOG4257|consen  542 EDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLP---CPPNCP  618 (974)
T ss_pred             cccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCC---CCCCCC
Confidence            87666655555  678999999999999999999999999999998 999999999999988888866432   335999


Q ss_pred             HHHHHHHHHhhhcCCC
Q psy12427        341 EEGKDFIRRLLLRNKE  356 (356)
Q Consensus       341 ~~~~~lI~~ll~~dP~  356 (356)
                      +.+=.++.+||..||.
T Consensus       619 p~LYslmskcWayeP~  634 (974)
T KOG4257|consen  619 PALYSLMSKCWAYEPS  634 (974)
T ss_pred             hHHHHHHHHHhccCcc
Confidence            9999999999999994

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.3e-40  Score=299.17  Aligned_cols=233  Identities=27%  Similarity=0.394  Sum_probs=188.5

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEec
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFL  187 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~  187 (356)
                      +|++.+.||+|+||.||+|.+..++..+|+|.+.... ......+.+|++++.+++||||+++++.+......++||||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            5788999999999999999999999999999986543 333456889999999999999999999999999999999999


Q ss_pred             cccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCC
Q psy12427        188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE  267 (356)
Q Consensus       188 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~  267 (356)
                      ++++|..+.     .+++     ..+..++.|++.||+|||+.||+|+||||+|||++.++  .++|+|||++...... 
T Consensus        82 ~~~~l~~~~-----~~~~-----~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~--~~~l~dfg~~~~~~~~-  148 (279)
T cd06619          82 DGGSLDVYR-----KIPE-----HVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRG--QVKLCDFGVSTQLVNS-  148 (279)
T ss_pred             CCCChHHhh-----cCCH-----HHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCC--CEEEeeCCcceecccc-
Confidence            999886442     1222     23445999999999999999999999999999998654  7999999999766432 


Q ss_pred             ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChH-------HHHHHhhccccccChhhhccCC
Q psy12427        268 VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDV-------ETLKNVKACDWEFDEEAFKNVS  340 (356)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~s  340 (356)
                      ......|+..|+|||++.+..++.++|+|||||++|+|++|..||......       +....+....  .+......++
T Consensus       149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  226 (279)
T cd06619         149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED--PPVLPVGQFS  226 (279)
T ss_pred             cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC--CCCCCCCcCC
Confidence            223457899999999999999999999999999999999999999754321       2222222211  1111123578


Q ss_pred             HHHHHHHHHhhhcCCC
Q psy12427        341 EEGKDFIRRLLLRNKE  356 (356)
Q Consensus       341 ~~~~~lI~~ll~~dP~  356 (356)
                      .++++||.+||+.||+
T Consensus       227 ~~~~~li~~~l~~~P~  242 (279)
T cd06619         227 EKFVHFITQCMRKQPK  242 (279)
T ss_pred             HHHHHHHHHHhhCChh
Confidence            9999999999999995

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1e-40  Score=304.30  Aligned_cols=242  Identities=28%  Similarity=0.488  Sum_probs=200.6

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      ....+|++.+.||.|+||.||+|.+..++..||+|.+........+.+.+|+.+++.++||||+++++++......++||
T Consensus        16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   95 (297)
T cd06656          16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   95 (297)
T ss_pred             ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence            34568999999999999999999999999999999998766556677889999999999999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      ||+++++|.+++....  +++     ..+..++.|++.||.|||+.|++||||+|+|||++.++  .++|+|||++....
T Consensus        96 e~~~~~~L~~~~~~~~--~~~-----~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~--~~~l~Dfg~~~~~~  166 (297)
T cd06656          96 EYLAGGSLTDVVTETC--MDE-----GQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDG--SVKLTDFGFCAQIT  166 (297)
T ss_pred             cccCCCCHHHHHHhCC--CCH-----HHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEECcCccceEcc
Confidence            9999999999886432  222     33455899999999999999999999999999997654  79999999988764


Q ss_pred             CCCc-eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHH
Q psy12427        265 PNEV-VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG  343 (356)
Q Consensus       265 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  343 (356)
                      .... .....+++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+....+..+.... ..+......++..+
T Consensus       167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  245 (297)
T cd06656         167 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPERLSAVF  245 (297)
T ss_pred             CCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCC-CCCCCCccccCHHH
Confidence            4332 223468899999999999889999999999999999999999998876654443333221 12222334688999


Q ss_pred             HHHHHHhhhcCCC
Q psy12427        344 KDFIRRLLLRNKE  356 (356)
Q Consensus       344 ~~lI~~ll~~dP~  356 (356)
                      ++||.+||+.||+
T Consensus       246 ~~li~~~l~~~p~  258 (297)
T cd06656         246 RDFLNRCLEMDVD  258 (297)
T ss_pred             HHHHHHHccCChh
Confidence            9999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.6e-40  Score=300.65  Aligned_cols=242  Identities=26%  Similarity=0.438  Sum_probs=191.8

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh--hHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL--EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      +|++.+.||.|++|.||+|.++.++..||+|.++.....  ....+.+|+.+++.++||||+++++++..+...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            478899999999999999999999999999998754322  235677899999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +. ++|.+++.....   ...+....+..++.|++.||+|||+.|++|+||+|+||+++.++  .++|+|||++......
T Consensus        81 ~~-~~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~~  154 (285)
T cd07861          81 LS-MDLKKYLDSLPK---GQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKG--VIKLADFGLARAFGIP  154 (285)
T ss_pred             CC-CCHHHHHhcCCC---CCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCC--cEEECcccceeecCCC
Confidence            97 578877754321   12344455566999999999999999999999999999998654  7999999999765432


Q ss_pred             C-ceeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc--------------
Q psy12427        267 E-VVKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWE--------------  330 (356)
Q Consensus       267 ~-~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~--------------  330 (356)
                      . ......+++.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+......              
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence            2 12234578999999988654 4788999999999999999999999987765444332211100              


Q ss_pred             -----------cChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        331 -----------FDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       331 -----------~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                 ........+|+++++||++||+.||+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  271 (285)
T cd07861         235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPA  271 (285)
T ss_pred             HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChh
Confidence                       11122345899999999999999995

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG1187|consensus

Probab=100.00  E-value=3.5e-41  Score=311.94  Aligned_cols=201  Identities=23%  Similarity=0.371  Sum_probs=170.6

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCC-eEEEEEEe
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDD-EMVLIFEF  186 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-~~~lv~e~  186 (356)
                      +.|.-...||+|+||.||+|..... ..||+|.+.........+|.+|+++|.+++|||+|+|+|+|.+.+ ..++|+||
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEy  153 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEY  153 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEc
Confidence            4677778999999999999998754 899999887655431344999999999999999999999999988 59999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCC---ceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN---IIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      |++|+|.+.+......    .+.+..+..|+.++|.||+|||+..   ||||||||.|||+|.+  ...||+|||+|+..
T Consensus       154 m~nGsL~d~L~~~~~~----~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~--~~aKlsDFGLa~~~  227 (361)
T KOG1187|consen  154 MPNGSLEDHLHGKKGE----PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED--FNAKLSDFGLAKLG  227 (361)
T ss_pred             cCCCCHHHHhCCCCCC----CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC--CCEEccCccCcccC
Confidence            9999999999875541    3344455569999999999999853   9999999999999854  47999999999766


Q ss_pred             CC-CCceeec-CCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q psy12427        264 DP-NEVVKIS-TGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGE  315 (356)
Q Consensus       264 ~~-~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~  315 (356)
                      .. ....... .||..|+|||++..+..+.++|||||||+|.||++|+.|.+..
T Consensus       228 ~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~  281 (361)
T KOG1187|consen  228 PEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS  281 (361)
T ss_pred             CccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence            54 4433334 8999999999999999999999999999999999999988754

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-40  Score=299.05  Aligned_cols=244  Identities=17%  Similarity=0.272  Sum_probs=199.3

Q ss_pred             cceeeeccccccCceEEEEEEEccC-----CCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKT-----GNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMV  181 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~-----~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  181 (356)
                      ++|++.+.||+|+||.||+|.++..     +..+|+|.+.... ......+.+|+.+|..++||||+++++++......+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL   85 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence            5799999999999999999998754     3789999986553 334567889999999999999999999999999999


Q ss_pred             EEEEeccccchhhhhhCCCCCC----CccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEee
Q psy12427        182 LIFEFLSGGELFERITAPDYKM----SEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDF  257 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Df  257 (356)
                      +||||+++|+|.+++.......    .........+..++.|++.||.|||+.+++||||||+|||++.++  .+||+||
T Consensus        86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~--~~kl~df  163 (277)
T cd05032          86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL--TVKIGDF  163 (277)
T ss_pred             EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCC--CEEECCc
Confidence            9999999999999986533211    111233344566899999999999999999999999999998655  7999999


Q ss_pred             eceeeeCCCCc---eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCh
Q psy12427        258 GLATKLDPNEV---VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDE  333 (356)
Q Consensus       258 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~  333 (356)
                      |+++.......   .....++..|+|||.+....++.++|||||||++|+|++ |..||.+.+..+..+.+......   
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~---  240 (277)
T cd05032         164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL---  240 (277)
T ss_pred             ccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCC---
Confidence            99876543322   123346789999999998889999999999999999998 99999998888888777644322   


Q ss_pred             hhhccCCHHHHHHHHHhhhcCCC
Q psy12427        334 EAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       334 ~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .....++.++.++|.+||+.||+
T Consensus       241 ~~~~~~~~~~~~li~~~l~~~p~  263 (277)
T cd05032         241 DLPENCPDKLLELMRMCWQYNPK  263 (277)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChh
Confidence            12236799999999999999985

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2e-40  Score=295.78  Aligned_cols=237  Identities=24%  Similarity=0.353  Sum_probs=195.7

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEec
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFL  187 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~  187 (356)
                      ++|++.+.||+|+||.||++.++. +..+|+|.+..... ....+.+|+.++.+++||||+++++++......+++|||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM   81 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence            468999999999999999998764 45699998875432 3456889999999999999999999999999999999999


Q ss_pred             cccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCC
Q psy12427        188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE  267 (356)
Q Consensus       188 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~  267 (356)
                      .+|+|.+++......+     ....+..++.|++.||+|||+.|++|+||+|+||+++.++  .+||+|||+++......
T Consensus        82 ~~~~l~~~i~~~~~~~-----~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~--~~kl~d~g~~~~~~~~~  154 (256)
T cd05113          82 SNGCLLNYLREHGKRF-----QPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQG--CVKVSDFGLSRYVLDDE  154 (256)
T ss_pred             CCCcHHHHHHhcCCCC-----CHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC--CEEECCCccceecCCCc
Confidence            9999999886543233     3344456999999999999999999999999999997544  79999999987664332


Q ss_pred             cee--ecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHHH
Q psy12427        268 VVK--ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK  344 (356)
Q Consensus       268 ~~~--~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  344 (356)
                      ...  ...++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+......+.+   ...+..++
T Consensus       155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  231 (256)
T cd05113         155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRP---HLASEKVY  231 (256)
T ss_pred             eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCC---CCCCHHHH
Confidence            211  1234678999999998889999999999999999998 99999988888777777665443322   35789999


Q ss_pred             HHHHHhhhcCCC
Q psy12427        345 DFIRRLLLRNKE  356 (356)
Q Consensus       345 ~lI~~ll~~dP~  356 (356)
                      ++|.+||+.||+
T Consensus       232 ~li~~cl~~~p~  243 (256)
T cd05113         232 AIMYSCWHEKAE  243 (256)
T ss_pred             HHHHHHcCCCcc
Confidence            999999999985

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.9e-40  Score=305.06  Aligned_cols=201  Identities=23%  Similarity=0.359  Sum_probs=159.2

Q ss_pred             eccccccCceEEEEEEEc--cCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEe--CCeEEEEEEecc
Q psy12427        113 LEEIGTGAFGVVHRCRER--KTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFED--DDEMVLIFEFLS  188 (356)
Q Consensus       113 ~~~lg~G~fg~V~~~~~~--~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~lv~e~~~  188 (356)
                      .++||+|+||+||+|+++  .+++.+|+|.+.....  ...+.+|+.+|+.++||||+++++++..  ....+++|||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            368999999999999976  4678999999865432  3456789999999999999999999854  567899999985


Q ss_pred             ccchhhhhhCCCCCC---CccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeec--CCCcEEEEeeeceeee
Q psy12427        189 GGELFERITAPDYKM---SEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTR--NSTNVKMIDFGLATKL  263 (356)
Q Consensus       189 ~g~L~~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~--~~~~vkl~Dfg~a~~~  263 (356)
                       ++|.+++.......   ....+....++.++.||+.||+|||++||+||||||+|||++.+  ..+.+||+|||+|+..
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~  162 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF  162 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence             57877765332111   11234445567799999999999999999999999999999643  2357999999999876


Q ss_pred             CCCC----ceeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCC
Q psy12427        264 DPNE----VVKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGEN  316 (356)
Q Consensus       264 ~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~  316 (356)
                      ....    ......||+.|+|||++.+. .++.++||||+||++|+|++|++||.+..
T Consensus       163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             CCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            4322    12234689999999999764 58899999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=9.7e-41  Score=299.26  Aligned_cols=243  Identities=26%  Similarity=0.435  Sum_probs=197.7

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      ++|++.+.||.|+||.||+|.++.++..+|+|.+....   ......+.+|+.+++.++||||+++++++..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            46889999999999999999999999999999876532   233467788999999999999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      ||+++++|.+++....  .....+....+..++.|++.||+|||++|++|+||+|+||+++.++  .++|+|||++....
T Consensus        82 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~--~~~l~dfg~~~~~~  157 (267)
T cd08229          82 ELADAGDLSRMIKHFK--KQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG--VVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCCHHHHHHHhh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC--CEEECcchhhhccc
Confidence            9999999998886321  1122334445566899999999999999999999999999997654  79999999987764


Q ss_pred             CCCc-eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHhhccccccChhhhccCCH
Q psy12427        265 PNEV-VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEND--VETLKNVKACDWEFDEEAFKNVSE  341 (356)
Q Consensus       265 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~s~  341 (356)
                      .... .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||.+...  .+....+....  +++.....+++
T Consensus       158 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  235 (267)
T cd08229         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--YPPLPSDHYSE  235 (267)
T ss_pred             cCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCC--CCCCCcccccH
Confidence            3222 2334688999999999998999999999999999999999999976643  34444444433  22223346899


Q ss_pred             HHHHHHHHhhhcCCC
Q psy12427        342 EGKDFIRRLLLRNKE  356 (356)
Q Consensus       342 ~~~~lI~~ll~~dP~  356 (356)
                      +++++|.+||+.||+
T Consensus       236 ~~~~li~~~l~~~p~  250 (267)
T cd08229         236 ELRQLVNMCINPDPE  250 (267)
T ss_pred             HHHHHHHHhcCCCcc
Confidence            999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.7e-40  Score=295.67  Aligned_cols=239  Identities=23%  Similarity=0.448  Sum_probs=199.1

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEec
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFL  187 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~  187 (356)
                      ++|++.+.||.|+||.||+|.++.++..+++|.+.....  ...+.+|++++++++||||+++++.+......++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            579999999999999999999999899999999875533  678889999999999999999999999999999999999


Q ss_pred             cccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCC
Q psy12427        188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE  267 (356)
Q Consensus       188 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~  267 (356)
                      .+++|.+++......+++     ..+..++.|++.||.|||+.+++|+||+|+||+++.++  .++|+|||++.......
T Consensus        81 ~~~~L~~~l~~~~~~l~~-----~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~--~~~l~dfg~~~~~~~~~  153 (256)
T cd06612          81 GAGSVSDIMKITNKTLTE-----EEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEG--QAKLADFGVSGQLTDTM  153 (256)
T ss_pred             CCCcHHHHHHhCccCCCH-----HHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCC--cEEEcccccchhcccCc
Confidence            999999998654433333     34455999999999999999999999999999998654  79999999988765433


Q ss_pred             -ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHH
Q psy12427        268 -VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDF  346 (356)
Q Consensus       268 -~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  346 (356)
                       ......++..|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+...... .......++.++.+|
T Consensus       154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  232 (256)
T cd06612         154 AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPP-TLSDPEKWSPEFNDF  232 (256)
T ss_pred             cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCC-CCCchhhcCHHHHHH
Confidence             223345789999999999999999999999999999999999999887766555444332211 111223678999999


Q ss_pred             HHHhhhcCCC
Q psy12427        347 IRRLLLRNKE  356 (356)
Q Consensus       347 I~~ll~~dP~  356 (356)
                      |.+||+.||+
T Consensus       233 i~~~l~~~P~  242 (256)
T cd06612         233 VKKCLVKDPE  242 (256)
T ss_pred             HHHHHhcChh
Confidence            9999999995

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.8e-40  Score=302.93  Aligned_cols=239  Identities=24%  Similarity=0.396  Sum_probs=192.4

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEec
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFL  187 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~  187 (356)
                      +|++.+.||+|+||.||++.+..++..+|+|.+.... ......+.+|++++.+++||||+++++++..++..+++|||+
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~   81 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM   81 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence            6899999999999999999999999999999987553 333456788999999999999999999999999999999999


Q ss_pred             cccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE-KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       188 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      ++++|.+++.... .+     ....+..++.|++.||.|||+ .+++|+||+|+|||++.++  .++|+|||++......
T Consensus        82 ~~~~L~~~l~~~~-~~-----~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~~  153 (308)
T cd06615          82 DGGSLDQVLKKAG-RI-----PENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG--EIKLCDFGVSGQLIDS  153 (308)
T ss_pred             CCCcHHHHHHhcC-CC-----CHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCC--cEEEccCCCccccccc
Confidence            9999999986532 22     333445699999999999997 5999999999999998654  6999999998765322


Q ss_pred             CceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc---------------
Q psy12427        267 EVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEF---------------  331 (356)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~---------------  331 (356)
                       ......|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+.......               
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (308)
T cd06615         154 -MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPD  232 (308)
T ss_pred             -ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCC
Confidence             2234568999999999988889999999999999999999999998766444332221110000               


Q ss_pred             ------------------Chh-hhccCCHHHHHHHHHhhhcCCC
Q psy12427        332 ------------------DEE-AFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       332 ------------------~~~-~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                        ++. ....++.++++||.+||+.||+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~  276 (308)
T cd06615         233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPK  276 (308)
T ss_pred             ccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChh
Confidence                              000 0113788999999999999985

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=8.5e-41  Score=298.81  Aligned_cols=237  Identities=24%  Similarity=0.411  Sum_probs=192.2

Q ss_pred             eeeccccccCceEEEEEEEc----cCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        111 DILEEIGTGAFGVVHRCRER----KTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       111 ~~~~~lg~G~fg~V~~~~~~----~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      ++.+.||.|.||.||+|.++    ..+..|++|.++... ......+.+|++++++++||||++++|++......++|+|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e   81 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME   81 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence            46789999999999999998    345789999996643 3346788999999999999999999999998888999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |+++|+|.+++...    ....+....+..++.||+.||+|||+++++|+||+|+||+++.++  .+||+|||++.....
T Consensus        82 ~~~~g~L~~~L~~~----~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~--~~Kl~~f~~~~~~~~  155 (259)
T PF07714_consen   82 YCPGGSLDDYLKSK----NKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNG--QVKLSDFGLSRPISE  155 (259)
T ss_dssp             --TTEBHHHHHHHT----CTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTT--EEEEESTTTGEETTT
T ss_pred             cccccccccccccc----ccccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccc
Confidence            99999999999865    112233344566999999999999999999999999999998655  799999999987733


Q ss_pred             CCceee---cCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCH
Q psy12427        266 NEVVKI---STGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSE  341 (356)
Q Consensus       266 ~~~~~~---~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  341 (356)
                      ......   ......|+|||.+....++.++||||||+++|||++ |+.||...+..+....+........   ...++.
T Consensus       156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~  232 (259)
T PF07714_consen  156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPI---PDNCPK  232 (259)
T ss_dssp             SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTS---BTTSBH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccee---ccchhH
Confidence            222221   235778999999999989999999999999999999 7899999999888888865543222   247899


Q ss_pred             HHHHHHHHhhhcCCC
Q psy12427        342 EGKDFIRRLLLRNKE  356 (356)
Q Consensus       342 ~~~~lI~~ll~~dP~  356 (356)
                      .+.++|.+||..||+
T Consensus       233 ~~~~li~~C~~~~p~  247 (259)
T PF07714_consen  233 DIYSLIQQCWSHDPE  247 (259)
T ss_dssp             HHHHHHHHHT-SSGG
T ss_pred             HHHHHHHHHcCCChh
Confidence            999999999999985

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-40  Score=295.84  Aligned_cols=237  Identities=23%  Similarity=0.331  Sum_probs=193.8

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEec
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFL  187 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~  187 (356)
                      .+|++.+.||+|+||.||+|.++ ++..+|+|.+..... ....+.+|+++++.++||||+++++++...+..++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM   81 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence            35889999999999999999886 467899998864332 3456778999999999999999999999999999999999


Q ss_pred             cccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCC
Q psy12427        188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE  267 (356)
Q Consensus       188 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~  267 (356)
                      ++++|.+++......+     ....+..++.|++.||+|||+.|++||||||+||+++.++  .+||+|||+++......
T Consensus        82 ~~~~L~~~l~~~~~~~-----~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~--~~kl~dfg~~~~~~~~~  154 (256)
T cd05059          82 ANGCLLNYLRERKGKL-----GTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDN--VVKVSDFGLARYVLDDQ  154 (256)
T ss_pred             CCCCHHHHHHhcccCC-----CHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCC--cEEECCcccceeccccc
Confidence            9999999987543333     3334455999999999999999999999999999998654  79999999987654322


Q ss_pred             cee--ecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHHH
Q psy12427        268 VVK--ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK  344 (356)
Q Consensus       268 ~~~--~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  344 (356)
                      ...  ...++..|+|||.+.+..++.++|+||||+++|+|++ |..||...++.+....+.....   ......+|.++.
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  231 (256)
T cd05059         155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR---LYRPKLAPTEVY  231 (256)
T ss_pred             ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc---CCCCCCCCHHHH
Confidence            111  1123457999999999999999999999999999999 8999998888887777765321   122246899999


Q ss_pred             HHHHHhhhcCCC
Q psy12427        345 DFIRRLLLRNKE  356 (356)
Q Consensus       345 ~lI~~ll~~dP~  356 (356)
                      ++|.+||+.+|+
T Consensus       232 ~li~~cl~~~p~  243 (256)
T cd05059         232 TIMYSCWHEKPE  243 (256)
T ss_pred             HHHHHHhcCChh
Confidence            999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.9e-40  Score=298.99  Aligned_cols=240  Identities=30%  Similarity=0.469  Sum_probs=196.8

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      +|++.+.||.|+||.||+|.+..+|..+|+|.+....  ......+.+|+.++++++||||+++++++..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4889999999999999999999999999999987654  23346788999999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      + +++|.+++......+.+     ..+..++.||+.||+|||+.|++|+||+|+||+++.++  .++|+|||++......
T Consensus        81 ~-~~~L~~~~~~~~~~~~~-----~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~--~~~l~dfg~~~~~~~~  152 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPE-----AQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADG--VLKIADFGLARLFSEE  152 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCH-----HHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCC--cEEEeeeeecccccCC
Confidence            9 99999988654433333     34555999999999999999999999999999998644  7999999999876543


Q ss_pred             C--ceeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc------------
Q psy12427        267 E--VVKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEF------------  331 (356)
Q Consensus       267 ~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~------------  331 (356)
                      .  ......|+..|+|||.+.+. .++.++||||+||++|+|++|.+||.+.++.+.+..+.......            
T Consensus       153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07832         153 EPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP  232 (286)
T ss_pred             CCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence            2  13345689999999998654 46899999999999999999999998888776665544321110            


Q ss_pred             --------------ChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        332 --------------DEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       332 --------------~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                    ....+.+.+.++.+||++||+.||+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  271 (286)
T cd07832         233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPS  271 (286)
T ss_pred             hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChh
Confidence                          0122346789999999999999995

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=6.3e-40  Score=292.23  Aligned_cols=239  Identities=23%  Similarity=0.440  Sum_probs=197.2

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEe-CCeEEEEEE
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFED-DDEMVLIFE  185 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~lv~e  185 (356)
                      .|++.+.||.|++|.||++.++.+++.+|+|.+....  ......+.+|++++++++|||++++++.+.. ...++++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            3889999999999999999999999999999986543  2344567889999999999999999998864 456899999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |+++++|.+++.....    ..+....+..++.+++.||++||++|++|+||+|+||+++.++  .++|+|||++.....
T Consensus        81 ~~~~~~l~~~l~~~~~----~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~--~~~l~df~~~~~~~~  154 (257)
T cd08223          81 FCEGGDLYHKLKEQKG----KLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTN--IIKVGDLGIARVLEN  154 (257)
T ss_pred             ccCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCC--cEEEecccceEEecc
Confidence            9999999998875321    1223344556999999999999999999999999999997654  799999999987643


Q ss_pred             C-CceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHH
Q psy12427        266 N-EVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK  344 (356)
Q Consensus       266 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  344 (356)
                      . .......+++.|+|||++.+..++.++|+||+|+++|+|++|+.||...+.......+..+....   ....++.++.
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  231 (257)
T cd08223         155 QCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP---MPKDYSPELG  231 (257)
T ss_pred             cCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC---CccccCHHHH
Confidence            2 22233468999999999999999999999999999999999999999888777666665544321   2247899999


Q ss_pred             HHHHHhhhcCCC
Q psy12427        345 DFIRRLLLRNKE  356 (356)
Q Consensus       345 ~lI~~ll~~dP~  356 (356)
                      +||.+||+.||+
T Consensus       232 ~li~~~l~~~p~  243 (257)
T cd08223         232 ELIATMLSKRPE  243 (257)
T ss_pred             HHHHHHhccCcc
Confidence            999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=4e-40  Score=294.08  Aligned_cols=231  Identities=22%  Similarity=0.376  Sum_probs=187.1

Q ss_pred             cccccCceEEEEEEEc--cCCCEEEEEEcccCCh-hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEeccccc
Q psy12427        115 EIGTGAFGVVHRCRER--KTGNIFAAKFIPVSHN-LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGE  191 (356)
Q Consensus       115 ~lg~G~fg~V~~~~~~--~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~  191 (356)
                      .||+|+||.||+|.++  .++..+|+|++..... .....+.+|+.++++++||||+++++++.. ...++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            4899999999999875  4456799999876543 234668899999999999999999998864 57899999999999


Q ss_pred             hhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCce-e
Q psy12427        192 LFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVV-K  270 (356)
Q Consensus       192 L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~~-~  270 (356)
                      |.+++......+++     ..+..++.|++.||+|||++|++||||||+|||++.++  .+||+|||++......... .
T Consensus        81 L~~~l~~~~~~~~~-----~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~--~~kl~dfg~~~~~~~~~~~~~  153 (257)
T cd05115          81 LNKFLSGKKDEITV-----SNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQH--YAKISDFGLSKALGADDSYYK  153 (257)
T ss_pred             HHHHHHhCCCCCCH-----HHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCC--cEEeccCCccccccCCcccee
Confidence            99988654333333     44455999999999999999999999999999997544  7999999999765433221 1


Q ss_pred             ---ecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHH
Q psy12427        271 ---ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDF  346 (356)
Q Consensus       271 ---~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  346 (356)
                         ...++..|+|||.+....++.++|||||||++|++++ |..||.+....+....+..+...   .....+++++.++
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~l  230 (257)
T cd05115         154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRL---DCPAECPPEMYAL  230 (257)
T ss_pred             ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC---CCCCCCCHHHHHH
Confidence               1123578999999998889999999999999999996 99999999888877777654422   2224789999999


Q ss_pred             HHHhhhcCCC
Q psy12427        347 IRRLLLRNKE  356 (356)
Q Consensus       347 I~~ll~~dP~  356 (356)
                      |.+||+.||+
T Consensus       231 i~~c~~~~~~  240 (257)
T cd05115         231 MKDCWIYKWE  240 (257)
T ss_pred             HHHHcCCChh
Confidence            9999999985

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.5e-40  Score=296.57  Aligned_cols=237  Identities=22%  Similarity=0.422  Sum_probs=194.7

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh---------hHHHHHHHHHHHHhcCCCCceeeeeeEEeCCe
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL---------EKELIRKEIDIMNQLHHPKLINLHDAFEDDDE  179 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~---------~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  179 (356)
                      +|.+...||.|+||.||+|.+..++..+|+|.+......         ....+.+|+.++++++||||+++++++.....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            367888999999999999999999999999988654321         12467789999999999999999999999999


Q ss_pred             EEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeec
Q psy12427        180 MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGL  259 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~  259 (356)
                      .+++|||+++++|.+++.... .+     ....+..++.|++.||+|||+.|++|+||+|+||+++.++  .++|+|||.
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~-~l-----~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~--~~~l~dfg~  152 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG-AF-----EETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKG--GIKISDFGI  152 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc-Cc-----cHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCC--CEEecccCC
Confidence            999999999999999986432 22     2334455899999999999999999999999999997544  799999999


Q ss_pred             eeeeCCCCc-------eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC
Q psy12427        260 ATKLDPNEV-------VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD  332 (356)
Q Consensus       260 a~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~  332 (356)
                      ++.......       .....|+..|+|||.+.+..++.++|+||+||++|+|++|+.||.+.+....+.++.....   
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---  229 (267)
T cd06628         153 SKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENAS---  229 (267)
T ss_pred             CcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCC---
Confidence            887642211       1123478899999999998899999999999999999999999988776666655544321   


Q ss_pred             hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 ~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +.....++.++.++|++||+.||+
T Consensus       230 ~~~~~~~~~~~~~li~~~l~~~p~  253 (267)
T cd06628         230 PEIPSNISSEAIDFLEKTFEIDHN  253 (267)
T ss_pred             CcCCcccCHHHHHHHHHHccCCch
Confidence            222347899999999999999984

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.9e-40  Score=292.94  Aligned_cols=238  Identities=21%  Similarity=0.331  Sum_probs=196.1

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEec
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFL  187 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~  187 (356)
                      ++|++.+.||+|++|.||+|.+.. +..+|+|.++.... ....+.+|+.++++++||||+++++++...+..+++|||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            469999999999999999998764 57899999875442 3466888999999999999999999999999999999999


Q ss_pred             cccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCC
Q psy12427        188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE  267 (356)
Q Consensus       188 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~  267 (356)
                      .+++|.+++....    ........+..++.|++.||.+||++|++|+||||+||+++.++  .++|+|||++.......
T Consensus        84 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~~l~dfg~~~~~~~~~  157 (261)
T cd05068          84 KYGSLLEYLQGGA----GRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENN--ICKVADFGLARVIKEDI  157 (261)
T ss_pred             cCCcHHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCC--CEEECCcceEEEccCCc
Confidence            9999999986533    11233344556999999999999999999999999999998654  69999999998765322


Q ss_pred             ceee--cCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHHH
Q psy12427        268 VVKI--STGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK  344 (356)
Q Consensus       268 ~~~~--~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  344 (356)
                      ....  ...+..|+|||++.+..++.++|+||||+++|+|++ |+.||.+.+..+.+..+.... ..+  ....++.++.
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~  234 (261)
T cd05068         158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGY-RMP--CPPGCPKELY  234 (261)
T ss_pred             ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCC--CCCcCCHHHH
Confidence            1111  112457999999999999999999999999999999 999999988888887775542 221  2247899999


Q ss_pred             HHHHHhhhcCCC
Q psy12427        345 DFIRRLLLRNKE  356 (356)
Q Consensus       345 ~lI~~ll~~dP~  356 (356)
                      ++|.+||+.||+
T Consensus       235 ~li~~~l~~~P~  246 (261)
T cd05068         235 DIMLDCWKEDPD  246 (261)
T ss_pred             HHHHHHhhcCcc
Confidence            999999999995

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3.8e-40  Score=294.00  Aligned_cols=230  Identities=23%  Similarity=0.388  Sum_probs=187.7

Q ss_pred             cccccCceEEEEEEE--ccCCCEEEEEEcccCCh--hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEecccc
Q psy12427        115 EIGTGAFGVVHRCRE--RKTGNIFAAKFIPVSHN--LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGG  190 (356)
Q Consensus       115 ~lg~G~fg~V~~~~~--~~~~~~~a~K~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g  190 (356)
                      +||+|+||.||+|.+  +.++..+|+|+++....  ...+.+.+|+.+++.++||||+++++++. ....++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            699999999999965  45678999999875432  23467888999999999999999999876 45678999999999


Q ss_pred             chhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCce-
Q psy12427        191 ELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVV-  269 (356)
Q Consensus       191 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~~-  269 (356)
                      +|.+++.... .+     ....+..++.|++.||+|||++|++||||||.|||++.++  .+||+|||++......... 
T Consensus        81 ~L~~~l~~~~-~~-----~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~--~~kl~Dfg~~~~~~~~~~~~  152 (257)
T cd05116          81 PLNKFLQKNK-HV-----TEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH--YAKISDFGLSKALGADENYY  152 (257)
T ss_pred             cHHHHHHhcC-CC-----CHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCC--eEEECCCccccccCCCCCee
Confidence            9999886432 23     3344555999999999999999999999999999998644  7999999999876433221 


Q ss_pred             ---eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHH
Q psy12427        270 ---KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD  345 (356)
Q Consensus       270 ---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  345 (356)
                         ....++..|+|||.+....++.++|+|||||++|||++ |..||.+.+..+....+......   +....+|.++++
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~---~~~~~~~~~l~~  229 (257)
T cd05116         153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERM---ECPQRCPPEMYD  229 (257)
T ss_pred             eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCC---CCCCCCCHHHHH
Confidence               11224578999999988889999999999999999998 99999988888887777765432   122478999999


Q ss_pred             HHHHhhhcCCC
Q psy12427        346 FIRRLLLRNKE  356 (356)
Q Consensus       346 lI~~ll~~dP~  356 (356)
                      +|++||+.||+
T Consensus       230 li~~~~~~~p~  240 (257)
T cd05116         230 LMKLCWTYGVD  240 (257)
T ss_pred             HHHHHhccCch
Confidence            99999999985

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.1e-40  Score=301.81  Aligned_cols=240  Identities=23%  Similarity=0.411  Sum_probs=188.5

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh--hHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL--EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      +|++.+.||.|+||.||+|+++.+|..+|+|.++.....  ....+.+|+.++++++||||+++++++......++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            488899999999999999999999999999998754322  234567899999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +. ++|.+++......++     ...+..++.||+.||.|||++|++||||||+||+++.++  .++|+|||++......
T Consensus        81 ~~-~~l~~~~~~~~~~~~-----~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~--~~~l~dfg~~~~~~~~  152 (284)
T cd07839          81 CD-QDLKKYFDSCNGDID-----PEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNG--ELKLADFGLARAFGIP  152 (284)
T ss_pred             CC-CCHHHHHHhcCCCCC-----HHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCC--cEEECccchhhccCCC
Confidence            96 478777654333333     344456999999999999999999999999999998654  7999999999765432


Q ss_pred             C-ceeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCC-CCCChHHHHHHhhccccccC-----------
Q psy12427        267 E-VVKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPF-AGENDVETLKNVKACDWEFD-----------  332 (356)
Q Consensus       267 ~-~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf-~~~~~~~~~~~i~~~~~~~~-----------  332 (356)
                      . ......+++.|+|||++.+. .++.++|||||||++|+|++|..|| .+.+..+.+..+.......+           
T Consensus       153 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07839         153 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP  232 (284)
T ss_pred             CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence            2 22234578999999998765 4689999999999999999988875 55555555544432111100           


Q ss_pred             --------------hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 --------------EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 --------------~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                    ......+|+++++||++||+.||+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~  270 (284)
T cd07839         233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPV  270 (284)
T ss_pred             cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChh
Confidence                          112235789999999999999995

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=4e-40  Score=295.76  Aligned_cols=239  Identities=21%  Similarity=0.366  Sum_probs=196.0

Q ss_pred             cceeeeccccccCceEEEEEEEccCCC---EEEEEEcccC-ChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGN---IFAAKFIPVS-HNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~---~~a~K~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      ++|++.+.||+|+||.||+|.++.+++   .||+|.++.. .......+.+|+.++++++||||+++++++..+...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            468999999999999999999987765   6999998765 344456788999999999999999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      |||+.+++|.+++......     +....+..++.|++.||+|||++|++|+||+|+||+++.+  ..+||+|||++...
T Consensus        84 ~e~~~~~~L~~~l~~~~~~-----~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~--~~~kl~dfg~~~~~  156 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQ-----FTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSN--LVCKVSDFGLSRFL  156 (269)
T ss_pred             EecCCCCcHHHHHhhCCCC-----CCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCC--CcEEECCCcccccc
Confidence            9999999999988654322     3334455689999999999999999999999999999754  47999999998765


Q ss_pred             CCCCceee---cC---CCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhh
Q psy12427        264 DPNEVVKI---ST---GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAF  336 (356)
Q Consensus       264 ~~~~~~~~---~~---gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  336 (356)
                      ........   ..   .+..|+|||.+.+..++.++|||||||++||+++ |..||...+..+....+... ...+.  .
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~-~~~~~--~  233 (269)
T cd05065         157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD-YRLPP--P  233 (269)
T ss_pred             ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-CcCCC--c
Confidence            43221111   11   2457999999999999999999999999999887 99999988888877777543 22222  2


Q ss_pred             ccCCHHHHHHHHHhhhcCCC
Q psy12427        337 KNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       337 ~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+++.++.++|.+||+.||+
T Consensus       234 ~~~~~~~~~li~~~l~~~p~  253 (269)
T cd05065         234 MDCPTALHQLMLDCWQKDRN  253 (269)
T ss_pred             ccCCHHHHHHHHHHcCCChh
Confidence            47899999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.1e-40  Score=297.54  Aligned_cols=236  Identities=31%  Similarity=0.558  Sum_probs=198.2

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh---hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN---LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      +|++.+.||.|+||.||+|.++.++..+|+|++.....   .....+.+|++++++++||||+++++.+..+...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            48899999999999999999999999999999875432   234678889999999999999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |+.|++|.+++... ..+.     ...+..++.|++.||.|||++|++|+||+|+||+++.++  .++|+|||++.....
T Consensus        81 ~~~~~~L~~~l~~~-~~l~-----~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~--~~~l~d~~~~~~~~~  152 (258)
T cd05578          81 LLLGGDLRYHLSQK-VKFS-----EEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQG--HVHITDFNIATKVTP  152 (258)
T ss_pred             CCCCCCHHHHHHhc-CCcC-----HHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCC--CEEEeecccccccCC
Confidence            99999999988654 2233     334556999999999999999999999999999998654  799999999987755


Q ss_pred             CCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHhhccccccChhhhccCCHH
Q psy12427        266 NEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEND---VETLKNVKACDWEFDEEAFKNVSEE  342 (356)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~s~~  342 (356)
                      ........|+..|+|||.+....++.++|+||||+++|+|++|..||...+.   ....+........++    ..++.+
T Consensus       153 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~  228 (258)
T cd05578         153 DTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYP----ATWSTE  228 (258)
T ss_pred             CccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCc----ccCcHH
Confidence            4444455688999999999988899999999999999999999999998773   444433333333333    468899


Q ss_pred             HHHHHHHhhhcCCC
Q psy12427        343 GKDFIRRLLLRNKE  356 (356)
Q Consensus       343 ~~~lI~~ll~~dP~  356 (356)
                      +.++|++||+.||+
T Consensus       229 ~~~~i~~~l~~~p~  242 (258)
T cd05578         229 AIDAINKLLERDPQ  242 (258)
T ss_pred             HHHHHHHHccCChh
Confidence            99999999999984

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=6.8e-40  Score=293.37  Aligned_cols=238  Identities=22%  Similarity=0.313  Sum_probs=193.1

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      .++|++.++||+|+||.||+|.+..+ ..+|+|.++.... ....+.+|+++++.++||||+++++.+. ....++||||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY   81 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence            35799999999999999999988765 4699999875433 3456788999999999999999999875 4568999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +.+|+|.+++.....    .......+..++.|++.||+|||+.+++|+||+|+||+++.++  .++|+|||.+......
T Consensus        82 ~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~--~~~L~dfg~~~~~~~~  155 (262)
T cd05071          82 MSKGSLLDFLKGEMG----KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL--VCKVADFGLARLIEDN  155 (262)
T ss_pred             CCCCcHHHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCC--cEEeccCCceeecccc
Confidence            999999999864321    1223334455899999999999999999999999999997644  7999999999876533


Q ss_pred             Ccee--ecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHH
Q psy12427        267 EVVK--ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG  343 (356)
Q Consensus       267 ~~~~--~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  343 (356)
                      ....  ...++..|+|||++.+..++.++|+|||||++|+|++ |..||.+....+.+..+..... .  .....++.++
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~l  232 (262)
T cd05071         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-M--PCPPECPESL  232 (262)
T ss_pred             ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC-C--CCccccCHHH
Confidence            3221  2235678999999998899999999999999999999 8999998888777776654321 1  1234789999


Q ss_pred             HHHHHHhhhcCCC
Q psy12427        344 KDFIRRLLLRNKE  356 (356)
Q Consensus       344 ~~lI~~ll~~dP~  356 (356)
                      .++|.+||++||+
T Consensus       233 ~~li~~~l~~~p~  245 (262)
T cd05071         233 HDLMCQCWRKEPE  245 (262)
T ss_pred             HHHHHHHccCCcc
Confidence            9999999999985

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG0199|consensus

Probab=100.00  E-value=2.1e-41  Score=317.56  Aligned_cols=240  Identities=25%  Similarity=0.377  Sum_probs=207.1

Q ss_pred             ccceeeeccccccCceEEEEEEEccCC---CEEEEEEcccCChh-hHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTG---NIFAAKFIPVSHNL-EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~---~~~a~K~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      .++..+.++||+|+||.|++|.|+..+   ..||+|+++..... ...+|.+|+.+|.+|+|||+++|||+..+ ..++|
T Consensus       109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM  187 (1039)
T KOG0199|consen  109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM  187 (1039)
T ss_pred             HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence            356788899999999999999998643   57999999876654 56889999999999999999999999988 78899


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      |||.++.|+|.+.|.+.    ....+..-.+..|+.||+.||.||.++++|||||..+|||+-...  .|||+|||+.+.
T Consensus       188 V~ELaplGSLldrLrka----~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllaspr--tVKI~DFGLmRa  261 (1039)
T KOG0199|consen  188 VFELAPLGSLLDRLRKA----KKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPR--TVKICDFGLMRA  261 (1039)
T ss_pred             HhhhcccchHHHHHhhc----cccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccc--eeeeecccceec
Confidence            99999999999999862    223344455666999999999999999999999999999997644  799999999999


Q ss_pred             eCCCCceeecCC----CcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhc
Q psy12427        263 LDPNEVVKISTG----TAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFK  337 (356)
Q Consensus       263 ~~~~~~~~~~~g----t~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  337 (356)
                      +..++......+    ...|+|||.++...++.+||||+|||++|||++ |+.||.|-....++++|.++..-..   .+
T Consensus       262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpR---Pk  338 (1039)
T KOG0199|consen  262 LGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPR---PK  338 (1039)
T ss_pred             cCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCC---CC
Confidence            977766655443    578999999999999999999999999999999 9999999999999999986443222   35


Q ss_pred             cCCHHHHHHHHHhhhcCCC
Q psy12427        338 NVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       338 ~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+|+++=++++.||..+|.
T Consensus       339 ~csedIY~imk~cWah~pa  357 (1039)
T KOG0199|consen  339 YCSEDIYQIMKNCWAHNPA  357 (1039)
T ss_pred             CChHHHHHHHHHhccCCcc
Confidence            8999999999999999884

>KOG0577|consensus

Probab=100.00  E-value=4.5e-42  Score=316.96  Aligned_cols=235  Identities=23%  Similarity=0.361  Sum_probs=201.8

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh---hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN---LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      .|.-++.||.|+||-||-|++..+...||||.+..+..   ..-+++.+|+.+|+++.|||++.+-|+|..+...++|||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            47778999999999999999999999999999987643   334789999999999999999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      ||- |+-.+++.-.+-.+.+..+     .-|+.+.+.||+|||+.+.||||||..|||++..+  .|||+|||.|....+
T Consensus       107 YCl-GSAsDlleVhkKplqEvEI-----AAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g--~VKLaDFGSAsi~~P  178 (948)
T KOG0577|consen  107 YCL-GSASDLLEVHKKPLQEVEI-----AAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPG--LVKLADFGSASIMAP  178 (948)
T ss_pred             HHh-ccHHHHHHHHhccchHHHH-----HHHHHHHHHHHHHHHHhhHHhhhccccceEecCCC--eeeeccccchhhcCc
Confidence            995 5777777654444555444     44999999999999999999999999999997654  799999999988765


Q ss_pred             CCceeecCCCcCcccccccc---CCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHH
Q psy12427        266 NEVVKISTGTAEFAAPEIVE---REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEE  342 (356)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  342 (356)
                      .   ...+|||.|||||++.   .+.|+-++||||||+++.||.-.++|+..++.+..+--|.....+..  .-..+|+.
T Consensus       179 A---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtL--qs~eWS~~  253 (948)
T KOG0577|consen  179 A---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL--QSNEWSDY  253 (948)
T ss_pred             h---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCC--CCchhHHH
Confidence            4   4578999999999985   46799999999999999999999999999999888888876554332  23579999


Q ss_pred             HHHHHHHhhhcCCC
Q psy12427        343 GKDFIRRLLLRNKE  356 (356)
Q Consensus       343 ~~~lI~~ll~~dP~  356 (356)
                      .++||..||++-|.
T Consensus       254 F~~Fvd~CLqKipq  267 (948)
T KOG0577|consen  254 FRNFVDSCLQKIPQ  267 (948)
T ss_pred             HHHHHHHHHhhCcc
Confidence            99999999998774

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=5.1e-40  Score=300.36  Aligned_cols=246  Identities=21%  Similarity=0.296  Sum_probs=196.6

Q ss_pred             CCCcccceeeeccccccCceEEEEEEEc-----cCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhc-CCCCceeeeeeEE
Q psy12427        103 TSSVYDHYDILEEIGTGAFGVVHRCRER-----KTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQL-HHPKLINLHDAFE  175 (356)
Q Consensus       103 ~~~~~~~y~~~~~lg~G~fg~V~~~~~~-----~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~  175 (356)
                      .....++|.+.+.||+|+||.||++.+.     .++..+|+|.++... ....+.+.+|+.+++++ +||||+++++++.
T Consensus        30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  109 (302)
T cd05055          30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT  109 (302)
T ss_pred             ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence            3344568999999999999999999863     345689999987653 33446788999999999 7999999999999


Q ss_pred             eCCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEE
Q psy12427        176 DDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMI  255 (356)
Q Consensus       176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~  255 (356)
                      ..+..+++|||+.+|+|.+++......    .+....+..++.|++.||+|||+++++|+||||+|||++.++  .++|+
T Consensus       110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~----~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~~l~  183 (302)
T cd05055         110 IGGPILVITEYCCYGDLLNFLRRKRES----FLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK--IVKIC  183 (302)
T ss_pred             cCCceEEEEEcCCCCcHHHHHHhCCCC----CCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCC--eEEEC
Confidence            999999999999999999998643211    133344555899999999999999999999999999997543  79999


Q ss_pred             eeeceeeeCCCCce---eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccc
Q psy12427        256 DFGLATKLDPNEVV---KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEF  331 (356)
Q Consensus       256 Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~  331 (356)
                      |||++.........   ....++..|+|||.+....++.++||||+||++|+|++ |..||.+....+............
T Consensus       184 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~  263 (302)
T cd05055         184 DFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM  263 (302)
T ss_pred             CCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC
Confidence            99999866432211   11235778999999999999999999999999999998 999998887665554444433322


Q ss_pred             ChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        332 DEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       332 ~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +  .....++++.+||.+||+.||+
T Consensus       264 ~--~~~~~~~~~~~li~~cl~~~p~  286 (302)
T cd05055         264 A--QPEHAPAEIYDIMKTCWDADPL  286 (302)
T ss_pred             C--CCCCCCHHHHHHHHHHcCCCch
Confidence            2  2246789999999999999985

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.6e-40  Score=298.38  Aligned_cols=235  Identities=27%  Similarity=0.474  Sum_probs=189.7

Q ss_pred             ccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEeccccch
Q psy12427        116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGEL  192 (356)
Q Consensus       116 lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L  192 (356)
                      ||.|+||+||+|.++.+|+.+|+|.+....   ......+.+|+.+|++++||||+++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999999999999999986532   22334567899999999999999999999999999999999999999


Q ss_pred             hhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCceeec
Q psy12427        193 FERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS  272 (356)
Q Consensus       193 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~~~~~  272 (356)
                      .+++.....    ..+....+..++.|++.||.|||+.|++|+||+|+||+++.++  .++|+|||.+............
T Consensus        81 ~~~l~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~  154 (277)
T cd05577          81 KYHIYNVGE----PGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHG--NVRISDLGLAVELKGGKKIKGR  154 (277)
T ss_pred             HHHHHHcCc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC--CEEEccCcchhhhccCCccccc
Confidence            998865432    1233444555899999999999999999999999999997654  7999999998766543333445


Q ss_pred             CCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHHHhhh
Q psy12427        273 TGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLL  352 (356)
Q Consensus       273 ~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~  352 (356)
                      .++..|+|||++.+..++.++|+||+||++|+|++|+.||...........+.......+......+++++.++|++||+
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  234 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQ  234 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHcc
Confidence            67889999999988889999999999999999999999998765422222222222222333445789999999999999


Q ss_pred             cCCC
Q psy12427        353 RNKE  356 (356)
Q Consensus       353 ~dP~  356 (356)
                      .||+
T Consensus       235 ~~p~  238 (277)
T cd05577         235 KDPE  238 (277)
T ss_pred             CChh
Confidence            9985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=6.3e-40  Score=296.33  Aligned_cols=238  Identities=18%  Similarity=0.268  Sum_probs=190.7

Q ss_pred             cceeeeccccccCceEEEEEEEccCCC----EEEEEEcccCCh-hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGN----IFAAKFIPVSHN-LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~----~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      ++|++.+.||+|+||+||+|.+..++.    .+++|.+..... .....+..|+.++..++||||+++++++. ....++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            468899999999999999999987776    467777654322 22356677888999999999999999875 456788


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ++||+.+|+|.+++......+++     ..+..++.|++.||+|||++|++||||||+|||++.++  .+||+|||+++.
T Consensus        86 i~e~~~~gsL~~~l~~~~~~~~~-----~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~--~~kl~Dfg~~~~  158 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRDSLDP-----QRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDS--IVQIADFGVADL  158 (279)
T ss_pred             EEEeCCCCcHHHHHHhcccCCCH-----HHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC--cEEEcCCcccee
Confidence            99999999999999754433333     34455999999999999999999999999999997544  799999999987


Q ss_pred             eCCCCce---eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhcc
Q psy12427        263 LDPNEVV---KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKN  338 (356)
Q Consensus       263 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  338 (356)
                      .......   ....++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+..+.....   ...
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~  235 (279)
T cd05111         159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQ---PQI  235 (279)
T ss_pred             ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC---CCC
Confidence            6433221   22346778999999998899999999999999999998 9999998887776665554443222   235


Q ss_pred             CCHHHHHHHHHhhhcCCC
Q psy12427        339 VSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       339 ~s~~~~~lI~~ll~~dP~  356 (356)
                      ++.++.++|.+||..||+
T Consensus       236 ~~~~~~~li~~c~~~~p~  253 (279)
T cd05111         236 CTIDVYMVMVKCWMIDEN  253 (279)
T ss_pred             CCHHHHHHHHHHcCCCcc
Confidence            788999999999999995

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=5.6e-40  Score=294.59  Aligned_cols=239  Identities=19%  Similarity=0.338  Sum_probs=195.8

Q ss_pred             cceeeeccccccCceEEEEEEEccCC---CEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTG---NIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~---~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      ++|++.+.||+|+||.||+|.++.++   ..+|+|.++... ......+.+|+.++.+++||||+++++++......+++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            47899999999999999999987554   379999987543 33456788999999999999999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      |||+++++|.+++......     +....+..++.|++.||+|||++|++||||||+|||++.++  .++|+|||++...
T Consensus        84 ~e~~~~~~L~~~~~~~~~~-----~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~--~~~l~dfg~~~~~  156 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQ-----FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNL--VCKVSDFGLSRVL  156 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCC-----CCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCC--eEEeCCCCccccc
Confidence            9999999999998754322     33344456899999999999999999999999999997544  7999999999876


Q ss_pred             CCCCce--ee--cCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhcc
Q psy12427        264 DPNEVV--KI--STGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKN  338 (356)
Q Consensus       264 ~~~~~~--~~--~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  338 (356)
                      ......  ..  ..++..|+|||.+.+..++.++|+|||||++|++++ |..||.+.+..+....+.... .++  ....
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~  233 (267)
T cd05066         157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY-RLP--APMD  233 (267)
T ss_pred             ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC-cCC--CCCC
Confidence            432211  11  123568999999999899999999999999999887 999999888777777776542 222  2246


Q ss_pred             CCHHHHHHHHHhhhcCCC
Q psy12427        339 VSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       339 ~s~~~~~lI~~ll~~dP~  356 (356)
                      ++.++.+++.+||+++|+
T Consensus       234 ~~~~~~~li~~~l~~~p~  251 (267)
T cd05066         234 CPAALHQLMLDCWQKDRN  251 (267)
T ss_pred             CCHHHHHHHHHHcccCch
Confidence            899999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=6.4e-40  Score=298.44  Aligned_cols=247  Identities=20%  Similarity=0.327  Sum_probs=198.7

Q ss_pred             cceeeeccccccCceEEEEEEEccCC----------------CEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceee
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTG----------------NIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINL  170 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~----------------~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l  170 (356)
                      ++|++.+.||+|+||.||+|.+..++                ..+|+|.+.... ......+.+|++++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            47999999999999999999877544                568999987654 3345678899999999999999999


Q ss_pred             eeeEEeCCeEEEEEEeccccchhhhhhCCCCC-----CCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEe
Q psy12427        171 HDAFEDDDEMVLIFEFLSGGELFERITAPDYK-----MSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQ  245 (356)
Q Consensus       171 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-----~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~  245 (356)
                      ++++..+...+++||++.+++|.+++......     .....+....+..++.|++.||+|||+.|++|+||||+||+++
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~  164 (296)
T cd05051          85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG  164 (296)
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeec
Confidence            99999999999999999999999998654311     0112344455667999999999999999999999999999998


Q ss_pred             ecCCCcEEEEeeeceeeeCCCCce---eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc--CCCCCCCCChHHH
Q psy12427        246 TRNSTNVKMIDFGLATKLDPNEVV---KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS--GLSPFAGENDVET  320 (356)
Q Consensus       246 ~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~--g~~Pf~~~~~~~~  320 (356)
                      .++  .++|+|||+++........   ....+++.|+|||.+.+..++.++|||||||++|+|++  |..||...+..+.
T Consensus       165 ~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~  242 (296)
T cd05051         165 KNY--TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQV  242 (296)
T ss_pred             CCC--ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHH
Confidence            654  7999999999865433221   22345778999999998889999999999999999998  7889988888887


Q ss_pred             HHHhhcc----ccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        321 LKNVKAC----DWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       321 ~~~i~~~----~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +.++...    ......+....+|.++.++|.+||+.||+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~  282 (296)
T cd05051         243 IENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEE  282 (296)
T ss_pred             HHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChh
Confidence            7776543    11111122346789999999999999985

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=7.8e-40  Score=293.66  Aligned_cols=239  Identities=21%  Similarity=0.331  Sum_probs=196.4

Q ss_pred             cceeeeccccccCceEEEEEEEccCCC---EEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGN---IFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~---~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      ++|+..+.||+|+||.||+|.++.++.   .+|+|.++... ....+.+.+|++++++++||||+++.+++......+++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            468889999999999999999986654   79999887553 34456788999999999999999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      |||+++++|.+++......+++     ..+..++.|++.||+|||+.|++|+||||+||+++.++  .+||+|||++...
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~-----~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~--~~kl~dfg~~~~~  157 (268)
T cd05063          85 TEYMENGALDKYLRDHDGEFSS-----YQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNL--ECKVSDFGLSRVL  157 (268)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCH-----HHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCC--cEEECCCccceec
Confidence            9999999999998654333333     34455899999999999999999999999999997544  7999999999866


Q ss_pred             CCCCce--ee--cCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhcc
Q psy12427        264 DPNEVV--KI--STGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKN  338 (356)
Q Consensus       264 ~~~~~~--~~--~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  338 (356)
                      ......  ..  ...+..|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+.... ..+  ...+
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~-~~~--~~~~  234 (268)
T cd05063         158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF-RLP--APMD  234 (268)
T ss_pred             ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC-CCC--CCCC
Confidence            432211  11  123457999999998889999999999999999997 999999888888888776543 222  2246


Q ss_pred             CCHHHHHHHHHhhhcCCC
Q psy12427        339 VSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       339 ~s~~~~~lI~~ll~~dP~  356 (356)
                      ++.++.++|.+||+.||+
T Consensus       235 ~~~~~~~li~~c~~~~p~  252 (268)
T cd05063         235 CPSAVYQLMLQCWQQDRA  252 (268)
T ss_pred             CCHHHHHHHHHHcCCCcc
Confidence            899999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.1e-39  Score=299.82  Aligned_cols=245  Identities=21%  Similarity=0.314  Sum_probs=197.2

Q ss_pred             ccceeeeccccccCceEEEEEEEcc-------CCCEEEEEEcccCC-hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeC
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERK-------TGNIFAAKFIPVSH-NLEKELIRKEIDIMNQL-HHPKLINLHDAFEDD  177 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~-------~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  177 (356)
                      .++|.+.+.||+|+||.||+|.+..       ....+|+|.++... ......+.+|+.+++++ +||||+++++++...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            3679999999999999999998642       34579999987543 33456678899999999 699999999999999


Q ss_pred             CeEEEEEEeccccchhhhhhCCCC----------CCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeec
Q psy12427        178 DEMVLIFEFLSGGELFERITAPDY----------KMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTR  247 (356)
Q Consensus       178 ~~~~lv~e~~~~g~L~~~l~~~~~----------~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~  247 (356)
                      +..+++|||+.+|+|.+++.....          ......+....+..++.|++.||.|||++|++||||||+|||++.+
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~  170 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTED  170 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCC
Confidence            999999999999999999865321          1122334444566689999999999999999999999999999765


Q ss_pred             CCCcEEEEeeeceeeeCCCCc---eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHH
Q psy12427        248 NSTNVKMIDFGLATKLDPNEV---VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKN  323 (356)
Q Consensus       248 ~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~  323 (356)
                      +  .+||+|||+++.......   .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+....
T Consensus       171 ~--~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~  248 (314)
T cd05099         171 N--VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL  248 (314)
T ss_pred             C--cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            4  799999999976543211   112234568999999999899999999999999999999 9999998888887777


Q ss_pred             hhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        324 VKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       324 i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +......   .....++.+++++|.+||+.||+
T Consensus       249 ~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~  278 (314)
T cd05099         249 LREGHRM---DKPSNCTHELYMLMRECWHAVPT  278 (314)
T ss_pred             HHcCCCC---CCCCCCCHHHHHHHHHHcCCCcc
Confidence            6654321   12247889999999999999985

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=6.1e-40  Score=292.40  Aligned_cols=238  Identities=20%  Similarity=0.348  Sum_probs=198.6

Q ss_pred             ccccccCceEEEEEEEccC---CCEEEEEEcccCChhh-HHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEeccc
Q psy12427        114 EEIGTGAFGVVHRCRERKT---GNIFAAKFIPVSHNLE-KELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSG  189 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~---~~~~a~K~~~~~~~~~-~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  189 (356)
                      +.||+|+||.||+|.+...   +..+|+|.+....... ...+.+|++++..++|+||+++++++......+++|||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            4699999999999999876   8999999998765433 67788999999999999999999999999999999999999


Q ss_pred             cchhhhhhCCCCC---CCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        190 GELFERITAPDYK---MSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       190 g~L~~~l~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      ++|.+++......   .....+....+..++.|++.||+|||++|++|+||+|+||+++.++  .++|+|||.+......
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~--~~~l~dfg~~~~~~~~  158 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDL--VVKISDFGLSRDVYDD  158 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCC--cEEEcccccccccccc
Confidence            9999998764210   0122344445566999999999999999999999999999998654  7999999999877543


Q ss_pred             C---ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHH
Q psy12427        267 E---VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEE  342 (356)
Q Consensus       267 ~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  342 (356)
                      .   ......+++.|+|||.+....++.++||||+|+++|+|++ |..||...+..+....+.....   ......+|.+
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  235 (262)
T cd00192         159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYR---LPKPEYCPDE  235 (262)
T ss_pred             cccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---CCCCccCChH
Confidence            2   1223457889999999998899999999999999999999 6999999988888888876332   2223477999


Q ss_pred             HHHHHHHhhhcCCC
Q psy12427        343 GKDFIRRLLLRNKE  356 (356)
Q Consensus       343 ~~~lI~~ll~~dP~  356 (356)
                      +.++|.+||+.||+
T Consensus       236 ~~~li~~~l~~~p~  249 (262)
T cd00192         236 LYELMLSCWQLDPE  249 (262)
T ss_pred             HHHHHHHHccCCcc
Confidence            99999999999985

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=7.6e-40  Score=292.51  Aligned_cols=238  Identities=22%  Similarity=0.344  Sum_probs=194.0

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      .++|++.++||+|+||.||+|.++ ++..+|+|.+..... ....+.+|+.++++++||||+++++++. ....+++|||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY   81 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence            357999999999999999999876 456799998875433 3456889999999999999999999875 4568999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +.+++|.+++.....    ..+....+..++.+++.||+|||+.|++||||+|+||+++.++  .++|+|||++......
T Consensus        82 ~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~--~~~l~dfg~~~~~~~~  155 (260)
T cd05070          82 MSKGSLLDFLKDGEG----RALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGL--VCKIADFGLARLIEDN  155 (260)
T ss_pred             cCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCc--eEEeCCceeeeeccCc
Confidence            999999999865321    1233344566999999999999999999999999999997644  7999999999876433


Q ss_pred             Ccee--ecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHH
Q psy12427        267 EVVK--ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG  343 (356)
Q Consensus       267 ~~~~--~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  343 (356)
                      ....  ...++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+....+.... .  .+.....+.++
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~  232 (260)
T cd05070         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY-R--MPCPQDCPISL  232 (260)
T ss_pred             ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-C--CCCCCcCCHHH
Confidence            2211  1234668999999998889999999999999999999 999999988888877776532 2  22235789999


Q ss_pred             HHHHHHhhhcCCC
Q psy12427        344 KDFIRRLLLRNKE  356 (356)
Q Consensus       344 ~~lI~~ll~~dP~  356 (356)
                      ++||.+||++||+
T Consensus       233 ~~li~~~l~~~p~  245 (260)
T cd05070         233 HELMLQCWKKDPE  245 (260)
T ss_pred             HHHHHHHcccCcc
Confidence            9999999999995

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=9.4e-40  Score=296.47  Aligned_cols=245  Identities=19%  Similarity=0.297  Sum_probs=195.2

Q ss_pred             ccceeeeccccccCceEEEEEEEcc-----CCCEEEEEEcccCCh-hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERK-----TGNIFAAKFIPVSHN-LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM  180 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~-----~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  180 (356)
                      .++|++.+.||+|+||.||+|..+.     .+..+|+|.+..... .....+.+|+.+++.++||||+++++++......
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT   84 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence            4689999999999999999997653     346899998865432 2345577899999999999999999999999999


Q ss_pred             EEEEEeccccchhhhhhCCCCCCC----ccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEe
Q psy12427        181 VLIFEFLSGGELFERITAPDYKMS----EAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMID  256 (356)
Q Consensus       181 ~lv~e~~~~g~L~~~l~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~D  256 (356)
                      +++|||+.+|+|.+++........    ........+..++.|++.||.|||+++|+||||||+|||++.++  .++|+|
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~--~~~L~D  162 (288)
T cd05061          85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF--TVKIGD  162 (288)
T ss_pred             EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCC--cEEECc
Confidence            999999999999999965321111    01112223456889999999999999999999999999998644  799999


Q ss_pred             eeceeeeCCCCce---eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccC
Q psy12427        257 FGLATKLDPNEVV---KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFD  332 (356)
Q Consensus       257 fg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~  332 (356)
                      ||+++........   ....++..|+|||.+.+..++.++|+|||||++|||++ |..||.+.+..+....+........
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~  242 (288)
T cd05061         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ  242 (288)
T ss_pred             CCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            9998765332211   11234678999999999899999999999999999998 8999999888887777655433221


Q ss_pred             hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 ~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                         ...++++++++|.+||+.||+
T Consensus       243 ---~~~~~~~~~~li~~~l~~~p~  263 (288)
T cd05061         243 ---PDNCPERVTDLMRMCWQFNPK  263 (288)
T ss_pred             ---CCCCCHHHHHHHHHHcCCChh
Confidence               236789999999999999985

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.1e-39  Score=298.88  Aligned_cols=245  Identities=23%  Similarity=0.310  Sum_probs=196.9

Q ss_pred             ccceeeeccccccCceEEEEEEEcc-------CCCEEEEEEcccCC-hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeC
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERK-------TGNIFAAKFIPVSH-NLEKELIRKEIDIMNQL-HHPKLINLHDAFEDD  177 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~-------~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  177 (356)
                      .++|.+.+.||+|+||.||++++..       +...+|+|.++... ......+.+|++++..+ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            4679999999999999999998753       23579999987643 33456678899999999 799999999999999


Q ss_pred             CeEEEEEEeccccchhhhhhCCCCC----------CCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeec
Q psy12427        178 DEMVLIFEFLSGGELFERITAPDYK----------MSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTR  247 (356)
Q Consensus       178 ~~~~lv~e~~~~g~L~~~l~~~~~~----------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~  247 (356)
                      ...++||||+.+|+|.+++......          .....+....+..++.|++.||+|||++|++||||||+|||++.+
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~  176 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED  176 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCC
Confidence            9999999999999999999754321          122234444566789999999999999999999999999999765


Q ss_pred             CCCcEEEEeeeceeeeCCCCce---eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHH
Q psy12427        248 NSTNVKMIDFGLATKLDPNEVV---KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKN  323 (356)
Q Consensus       248 ~~~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~  323 (356)
                      +  .+||+|||++.........   ....+++.|+|||++.+..++.++|+|||||++|+|++ |..||.+....+....
T Consensus       177 ~--~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~  254 (307)
T cd05098         177 N--VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL  254 (307)
T ss_pred             C--cEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence            4  7999999998765432211   11234578999999999889999999999999999998 9999988877676666


Q ss_pred             hhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        324 VKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       324 i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +.....   .+....++.+++++|.+||+.+|+
T Consensus       255 ~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~  284 (307)
T cd05098         255 LKEGHR---MDKPSNCTNELYMMMRDCWHAVPS  284 (307)
T ss_pred             HHcCCC---CCCCCcCCHHHHHHHHHHcccChh
Confidence            654332   122347899999999999999984

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1e-39  Score=296.45  Aligned_cols=243  Identities=20%  Similarity=0.303  Sum_probs=195.1

Q ss_pred             ceeeeccccccCceEEEEEEEcc-----CCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERK-----TGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~-----~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      +|++.+.||+|+||.||+|.+..     ....+|+|.+.... ......+.+|+.+++.++||||+++++.+......++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            37788999999999999998753     23578888886543 3344678899999999999999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCC------------------CCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEE
Q psy12427        183 IFEFLSGGELFERITAPDYK------------------MSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMC  244 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~------------------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv  244 (356)
                      ++||+.+++|.+++......                  .....+....+..++.|++.||+|||+.+++||||||+|||+
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill  160 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV  160 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence            99999999999988643211                  011223445566799999999999999999999999999999


Q ss_pred             eecCCCcEEEEeeeceeeeCCCCc---eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHH
Q psy12427        245 QTRNSTNVKMIDFGLATKLDPNEV---VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVET  320 (356)
Q Consensus       245 ~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~  320 (356)
                      +.++  .+||+|||+++.......   .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+.
T Consensus       161 ~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~  238 (290)
T cd05045         161 AEGR--KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL  238 (290)
T ss_pred             cCCC--cEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence            7544  799999999976532221   122245778999999998889999999999999999998 9999998888877


Q ss_pred             HHHhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        321 LKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       321 ~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+.+.... ..+  ....++.++.+||.+||+.||+
T Consensus       239 ~~~~~~~~-~~~--~~~~~~~~~~~~i~~cl~~~P~  271 (290)
T cd05045         239 FNLLKTGY-RME--RPENCSEEMYNLMLTCWKQEPD  271 (290)
T ss_pred             HHHHhCCC-CCC--CCCCCCHHHHHHHHHHccCCcc
Confidence            76665432 222  2247899999999999999995

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=9.3e-40  Score=292.51  Aligned_cols=244  Identities=26%  Similarity=0.409  Sum_probs=199.8

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      ++|++.+.||.|+||+||+|....++..+|+|++.... ......+.+|+.+++.++|+||+++++.+......++++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            36899999999999999999999899999999987543 23557788999999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +++++|.+++.....   ...+....+..++.|++.||++||+.|++|+||+|+||+++.++  .++|+|||++..+...
T Consensus        81 ~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~--~~~l~df~~~~~~~~~  155 (267)
T cd06610          81 LSGGSLLDIMKSSYP---RGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDG--SVKIADFGVSASLADG  155 (267)
T ss_pred             cCCCcHHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC--CEEEcccchHHHhccC
Confidence            999999999865321   12233344556999999999999999999999999999998654  6999999998766432


Q ss_pred             Cce-----eecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChh--hhcc
Q psy12427        267 EVV-----KISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEE--AFKN  338 (356)
Q Consensus       267 ~~~-----~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~  338 (356)
                      ...     ....|+..|+|||++... .++.++|+|||||++|+|++|+.||...+..+.+..+..........  .+..
T Consensus       156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (267)
T cd06610         156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKK  235 (267)
T ss_pred             ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCcccccc
Confidence            221     233588999999998877 78999999999999999999999998887776666655443221111  1246


Q ss_pred             CCHHHHHHHHHhhhcCCC
Q psy12427        339 VSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       339 ~s~~~~~lI~~ll~~dP~  356 (356)
                      ++.++.+||.+||+.||+
T Consensus       236 ~~~~~~~li~~~l~~~p~  253 (267)
T cd06610         236 YSKSFRKMISLCLQKDPS  253 (267)
T ss_pred             ccHHHHHHHHHHcCCChh
Confidence            889999999999999995

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=5.9e-40  Score=294.95  Aligned_cols=240  Identities=25%  Similarity=0.465  Sum_probs=193.1

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeC------CeE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL-HHPKLINLHDAFEDD------DEM  180 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~------~~~  180 (356)
                      +.|++.+.||+|+||.||+|.++.++..+|+|.+..... ....+.+|+.++.++ +||||+++++++...      ...
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   84 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL   84 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence            568899999999999999999999999999999876543 345678899999998 699999999998753      468


Q ss_pred             EEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeece
Q psy12427        181 VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA  260 (356)
Q Consensus       181 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a  260 (356)
                      +++|||+.+++|.+++.....    ..+....+..++.|++.||+|||+++++|+||+|+||+++.++  .++|+|||++
T Consensus        85 ~iv~e~~~~~~L~~~l~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~--~~~l~Dfg~~  158 (272)
T cd06637          85 WLVMEFCGAGSVTDLIKNTKG----NTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA--EVKLVDFGVS  158 (272)
T ss_pred             EEEEEcCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCC--CEEEccCCCc
Confidence            999999999999998875321    1233344556899999999999999999999999999998654  6999999999


Q ss_pred             eeeCCCC-ceeecCCCcCcccccccc-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChh
Q psy12427        261 TKLDPNE-VVKISTGTAEFAAPEIVE-----REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEE  334 (356)
Q Consensus       261 ~~~~~~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  334 (356)
                      ....... ......|++.|+|||++.     ...++.++|+||+||++|+|++|..||...........+.....  +..
T Consensus       159 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~  236 (272)
T cd06637         159 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA--PRL  236 (272)
T ss_pred             eecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCC--CCC
Confidence            8764322 223456899999999986     34578899999999999999999999987766555554433221  122


Q ss_pred             hhccCCHHHHHHHHHhhhcCCC
Q psy12427        335 AFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       335 ~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ....++.++.+||.+||+.||+
T Consensus       237 ~~~~~~~~~~~li~~~l~~~p~  258 (272)
T cd06637         237 KSKKWSKKFQSFIESCLVKNHS  258 (272)
T ss_pred             CCCCcCHHHHHHHHHHcCCChh
Confidence            2246889999999999999985

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.3e-39  Score=296.00  Aligned_cols=245  Identities=21%  Similarity=0.325  Sum_probs=198.4

Q ss_pred             ccceeeeccccccCceEEEEEEEccC-----CCEEEEEEcccCC-hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCe
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKT-----GNIFAAKFIPVSH-NLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDE  179 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~-----~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  179 (356)
                      .++|++.+.||+|+||.||++.++..     ...+|+|.+.... ......+.+|++++.++ +||||+++++++...+.
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~   90 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP   90 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence            35799999999999999999998743     3789999987543 33445678899999999 89999999999999999


Q ss_pred             EEEEEEeccccchhhhhhCCCCC----------CCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCC
Q psy12427        180 MVLIFEFLSGGELFERITAPDYK----------MSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNS  249 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~~----------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~  249 (356)
                      ++++|||+.+|+|..++......          .....+....+..++.|++.||+|||+.||+||||||+|||++.++ 
T Consensus        91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~-  169 (293)
T cd05053          91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH-  169 (293)
T ss_pred             eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCC-
Confidence            99999999999999998643210          1223344455667999999999999999999999999999997654 


Q ss_pred             CcEEEEeeeceeeeCCCCcee---ecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhh
Q psy12427        250 TNVKMIDFGLATKLDPNEVVK---ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK  325 (356)
Q Consensus       250 ~~vkl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~  325 (356)
                       .+||+|||+++.........   ...++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+.
T Consensus       170 -~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  248 (293)
T cd05053         170 -VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK  248 (293)
T ss_pred             -eEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence             79999999998765332211   1234678999999999999999999999999999998 999999888877777665


Q ss_pred             ccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        326 ACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       326 ~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .....   .....++.++.+||.+||+.||+
T Consensus       249 ~~~~~---~~~~~~~~~~~~li~~~l~~~p~  276 (293)
T cd05053         249 EGYRM---EKPQNCTQELYHLMRDCWHEVPS  276 (293)
T ss_pred             cCCcC---CCCCCCCHHHHHHHHHHcccCcc
Confidence            54321   12236789999999999999985

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.1e-39  Score=296.71  Aligned_cols=243  Identities=23%  Similarity=0.418  Sum_probs=192.3

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh--hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN--LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      ++|++.+.||.|++|+||+|.++.+|+.+|+|.+.....  .....+.+|++++++++||||+++++++......++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            469999999999999999999999999999999865432  223567789999999999999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |+. ++|.+.+......    ......+..++.||+.||+|||++|++|+||+|+||+++.++ ..+||+|||++.....
T Consensus        82 ~~~-~~l~~~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~-~~~kl~dfg~~~~~~~  155 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDF----AKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT-NALKLADFGLARAFGI  155 (294)
T ss_pred             ccc-ccHHHHHHhCCCC----CcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCC-CEEEEcccccccccCC
Confidence            996 5777776533211    122334455889999999999999999999999999997544 3689999999976532


Q ss_pred             C-CceeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCh----------
Q psy12427        266 N-EVVKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE----------  333 (356)
Q Consensus       266 ~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~----------  333 (356)
                      . .......+++.|+|||++.+. .++.++||||+||++|+|++|.+||...++.+.+.++.........          
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (294)
T PLN00009        156 PVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP  235 (294)
T ss_pred             CccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch
Confidence            2 122334578899999988664 5788999999999999999999999988777666654332111111          


Q ss_pred             ---------------hhhccCCHHHHHHHHHhhhcCCC
Q psy12427        334 ---------------EAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       334 ---------------~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                     .....+++++.+||.+||+.||+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~  273 (294)
T PLN00009        236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPS  273 (294)
T ss_pred             hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChh
Confidence                           11235789999999999999985

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.5e-40  Score=307.53  Aligned_cols=191  Identities=21%  Similarity=0.317  Sum_probs=161.1

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEec
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFL  187 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~  187 (356)
                      ..|++.+.||+|+||.||+|.+..++..||+|+....      ....|+.++++++||||+++++++......++|||++
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  139 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY  139 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence            4699999999999999999999999999999985432      2346999999999999999999999999999999999


Q ss_pred             cccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCC
Q psy12427        188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE  267 (356)
Q Consensus       188 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~  267 (356)
                      . ++|.+++......+++     ..+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+++......
T Consensus       140 ~-~~l~~~l~~~~~~~~~-----~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~--~~kl~DfG~a~~~~~~~  211 (357)
T PHA03209        140 S-SDLYTYLTKRSRPLPI-----DQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVD--QVCIGDLGAAQFPVVAP  211 (357)
T ss_pred             C-CcHHHHHHhccCCCCH-----HHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC--CEEEecCccccccccCc
Confidence            5 6888887654333333     34455999999999999999999999999999997654  69999999997644333


Q ss_pred             ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCC
Q psy12427        268 VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPF  312 (356)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf  312 (356)
                      ......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            334456899999999999999999999999999999999855444

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.9e-39  Score=290.67  Aligned_cols=243  Identities=27%  Similarity=0.463  Sum_probs=197.9

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      ++|++.+.||.|+||.||+|.+..+|+.+|+|.++...   ......+.+|+.++++++|+||+++++++...+..+++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            47999999999999999999999999999999886432   233567889999999999999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      ||+++++|.+++....  .....+....+..++.+++.||.|||+.|++|+||+|+||+++.++  .++|+|||++....
T Consensus        82 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~--~~~l~d~~~~~~~~  157 (267)
T cd08224          82 ELADAGDLSRMIKHFK--KQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATG--VVKLGDLGLGRFFS  157 (267)
T ss_pred             ecCCCCCHHHHHHHhc--ccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCC--cEEEeccceeeecc
Confidence            9999999998886421  1122234455667999999999999999999999999999998654  69999999988764


Q ss_pred             CCC-ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC--hHHHHHHhhccccccChhhhccCCH
Q psy12427        265 PNE-VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN--DVETLKNVKACDWEFDEEAFKNVSE  341 (356)
Q Consensus       265 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~  341 (356)
                      ... ......+++.|+|||.+.+..++.++|+|||||++|+|++|..||....  ..+....+..+...  +.....++.
T Consensus       158 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  235 (267)
T cd08224         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYP--PLPADHYSE  235 (267)
T ss_pred             CCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCC--CCChhhcCH
Confidence            332 2233468899999999999889999999999999999999999996553  33444554443332  111236889


Q ss_pred             HHHHHHHHhhhcCCC
Q psy12427        342 EGKDFIRRLLLRNKE  356 (356)
Q Consensus       342 ~~~~lI~~ll~~dP~  356 (356)
                      +++++|.+||+.||+
T Consensus       236 ~~~~~i~~cl~~~p~  250 (267)
T cd08224         236 ELRDLVSRCINPDPE  250 (267)
T ss_pred             HHHHHHHHHcCCCcc
Confidence            999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.5e-39  Score=297.51  Aligned_cols=245  Identities=22%  Similarity=0.311  Sum_probs=198.3

Q ss_pred             ccceeeeccccccCceEEEEEEEc-------cCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeC
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRER-------KTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQL-HHPKLINLHDAFEDD  177 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~-------~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~  177 (356)
                      .++|.+.+.||+|+||.||+|++.       .++..+|+|.+.... ......+.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            467999999999999999999753       234579999887543 33456788999999999 899999999999999


Q ss_pred             CeEEEEEEeccccchhhhhhCCCCC----------CCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeec
Q psy12427        178 DEMVLIFEFLSGGELFERITAPDYK----------MSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTR  247 (356)
Q Consensus       178 ~~~~lv~e~~~~g~L~~~l~~~~~~----------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~  247 (356)
                      ...+++|||+.+|+|.+++......          .....+....+..++.||+.||+|||++|++||||||+|||++.+
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~  173 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTEN  173 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCC
Confidence            9999999999999999998754221          112233444566689999999999999999999999999999754


Q ss_pred             CCCcEEEEeeeceeeeCCCCce---eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHH
Q psy12427        248 NSTNVKMIDFGLATKLDPNEVV---KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKN  323 (356)
Q Consensus       248 ~~~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~  323 (356)
                      +  .+||+|||+++........   ....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....
T Consensus       174 ~--~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~  251 (304)
T cd05101         174 N--VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL  251 (304)
T ss_pred             C--cEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH
Confidence            4  7999999999876432221   22335678999999998889999999999999999998 8999999888888777


Q ss_pred             hhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        324 VKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       324 i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +.......   ....++.++++||.+||+.+|+
T Consensus       252 ~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~  281 (304)
T cd05101         252 LKEGHRMD---KPANCTNELYMMMRDCWHAIPS  281 (304)
T ss_pred             HHcCCcCC---CCCCCCHHHHHHHHHHcccChh
Confidence            76543221   2247899999999999999985

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=8e-40  Score=302.38  Aligned_cols=239  Identities=18%  Similarity=0.296  Sum_probs=185.8

Q ss_pred             eecccccc--CceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEec
Q psy12427        112 ILEEIGTG--AFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFL  187 (356)
Q Consensus       112 ~~~~lg~G--~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~  187 (356)
                      ++++||+|  +|++||++.++.+|..||+|.+....  ......+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            56789999  78999999999999999999987643  233456778999999999999999999999999999999999


Q ss_pred             cccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCC
Q psy12427        188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE  267 (356)
Q Consensus       188 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~  267 (356)
                      ++|+|.+++.....    ..+....+..++.|++.||+|||++||+||||||+|||++.++  .++++||+.+.......
T Consensus        82 ~~~~l~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~--~~~l~~~~~~~~~~~~~  155 (327)
T cd08227          82 AYGSAKDLICTHFM----DGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG--KVYLSGLRSNLSMINHG  155 (327)
T ss_pred             CCCcHHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCC--cEEEcccchhhcccccc
Confidence            99999999864321    1233444566999999999999999999999999999998655  69999998654332110


Q ss_pred             --------ceeecCCCcCccccccccC--CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc------
Q psy12427        268 --------VVKISTGTAEFAAPEIVER--EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEF------  331 (356)
Q Consensus       268 --------~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~------  331 (356)
                              ......++..|+|||++.+  ..++.++|||||||++|+|++|+.||.................+.      
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (327)
T cd08227         156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTT  235 (327)
T ss_pred             ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccc
Confidence                    1112346778999999976  468899999999999999999999998765544333322211100      


Q ss_pred             ------------------------------------ChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        332 ------------------------------------DEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       332 ------------------------------------~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                                          ..+....+++++++||++||+.||+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  296 (327)
T cd08227         236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPD  296 (327)
T ss_pred             hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCch
Confidence                                                0011224678999999999999995

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.1e-39  Score=294.34  Aligned_cols=237  Identities=24%  Similarity=0.433  Sum_probs=198.6

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      ..|+..+.||.|+||.||+|.++.++..+|+|.+.... ......+.+|+.+++.++||||+++++++..+...++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            35888899999999999999999999999999987543 34456788999999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      ++|++|.+++...  .+.     ...+..++.|++.||+|||+.+++|+||+|+||+++.++  .++|+|||++......
T Consensus        84 ~~~~~L~~~i~~~--~l~-----~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~--~~~l~dfg~~~~~~~~  154 (277)
T cd06640          84 LGGGSALDLLRAG--PFD-----EFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQG--DVKLADFGVAGQLTDT  154 (277)
T ss_pred             CCCCcHHHHHhcC--CCC-----HHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCC--CEEEcccccceeccCC
Confidence            9999999988643  222     334455899999999999999999999999999998654  7999999999776543


Q ss_pred             Cc-eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHH
Q psy12427        267 EV-VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD  345 (356)
Q Consensus       267 ~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  345 (356)
                      .. .....++..|+|||++.+..++.++|+|||||++|+|++|..||...+.......+....   ++.....++.++.+
T Consensus       155 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~  231 (277)
T cd06640         155 QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN---PPTLTGEFSKPFKE  231 (277)
T ss_pred             ccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCC---CCCCchhhhHHHHH
Confidence            32 223357889999999998889999999999999999999999999887776666553332   22333467899999


Q ss_pred             HHHHhhhcCCC
Q psy12427        346 FIRRLLLRNKE  356 (356)
Q Consensus       346 lI~~ll~~dP~  356 (356)
                      +|++||+.||+
T Consensus       232 li~~~l~~~p~  242 (277)
T cd06640         232 FIDACLNKDPS  242 (277)
T ss_pred             HHHHHcccCcc
Confidence            99999999995

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9e-40  Score=309.22  Aligned_cols=237  Identities=23%  Similarity=0.351  Sum_probs=184.7

Q ss_pred             cccceeeeccccccCceEEEEEEEcc--CCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERK--TGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~--~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      ...+|.+.+.||.|+||.||+|....  ++..+|+|.+....     ...+|+++|++++||||+++++++......+++
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-----~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv  164 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-----TPGREIDILKTISHRAIINLIHAYRWKSTVCMV  164 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-----cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence            34579999999999999999997653  46789999876432     345799999999999999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      ||++. ++|.+++... ..+++     ..+..++.||+.||+|||++||+||||||+|||++.++  .++|+|||+++..
T Consensus       165 ~e~~~-~~l~~~l~~~-~~l~~-----~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~--~~~l~DfG~a~~~  235 (392)
T PHA03207        165 MPKYK-CDLFTYVDRS-GPLPL-----EQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPE--NAVLGDFGAACKL  235 (392)
T ss_pred             ehhcC-CCHHHHHHhc-CCCCH-----HHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC--CEEEccCcccccc
Confidence            99995 6888887422 23333     34455999999999999999999999999999997654  7999999999766


Q ss_pred             CCCCc---eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHhhccc---------
Q psy12427        264 DPNEV---VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEND---VETLKNVKACD---------  328 (356)
Q Consensus       264 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~---~~~~~~i~~~~---------  328 (356)
                      .....   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+...   ...+..+....         
T Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~  315 (392)
T PHA03207        236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ  315 (392)
T ss_pred             CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence            43222   1234689999999999999999999999999999999999999977542   22222222110         


Q ss_pred             --------------------cccChhh-hccCCHHHHHHHHHhhhcCCC
Q psy12427        329 --------------------WEFDEEA-FKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       329 --------------------~~~~~~~-~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                          +..+... ...++.++.+||++||+.||+
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~  364 (392)
T PHA03207        316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQE  364 (392)
T ss_pred             ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChh
Confidence                                0011000 023578899999999999995

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-39  Score=296.74  Aligned_cols=247  Identities=20%  Similarity=0.331  Sum_probs=193.6

Q ss_pred             cceeeeccccccCceEEEEEEEccC--------------CCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeee
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKT--------------GNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHD  172 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~--------------~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~  172 (356)
                      ++|++.+.||+|+||.||+|.+..+              ...||+|.++... ......+.+|+++|++++||||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            4799999999999999999987543              2358999987643 334567889999999999999999999


Q ss_pred             eEEeCCeEEEEEEeccccchhhhhhCCCCCC------CccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEee
Q psy12427        173 AFEDDDEMVLIFEFLSGGELFERITAPDYKM------SEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQT  246 (356)
Q Consensus       173 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~------~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~  246 (356)
                      ++......++||||+.+++|.+++.......      .........+..++.|++.||+|||+.|++|+||||+||+++.
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~  164 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN  164 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcC
Confidence            9999999999999999999999886432110      0112333455668999999999999999999999999999975


Q ss_pred             cCCCcEEEEeeeceeeeCCCCcee---ecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc--CCCCCCCCChHHHH
Q psy12427        247 RNSTNVKMIDFGLATKLDPNEVVK---ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS--GLSPFAGENDVETL  321 (356)
Q Consensus       247 ~~~~~vkl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~--g~~Pf~~~~~~~~~  321 (356)
                      ++  .+||+|||++..........   ...++..|+|||++....++.++|+|||||++|+|++  |..||...+..+.+
T Consensus       165 ~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~  242 (295)
T cd05097         165 HY--TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVI  242 (295)
T ss_pred             CC--cEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHH
Confidence            44  69999999997654332211   1234678999999998899999999999999999988  77899988877766


Q ss_pred             HHhhcc----ccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        322 KNVKAC----DWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       322 ~~i~~~----~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ..+...    ...........+|..+++||.+||+.||+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  281 (295)
T cd05097         243 ENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIK  281 (295)
T ss_pred             HHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCch
Confidence            654321    00011112235789999999999999985

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.4e-39  Score=289.95  Aligned_cols=239  Identities=25%  Similarity=0.482  Sum_probs=200.3

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      +|++.+.||.|+||.||++.+..+|+.+|+|.+....  ......+.+|+.++++++||||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4889999999999999999999999999999986542  33446788999999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +.+++|.+.+.....    .......+..++.|++.||.|||++|++|+||+|+|||++.++  .++|+|||++......
T Consensus        81 ~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~--~~~l~d~~~~~~~~~~  154 (256)
T cd08218          81 CEGGDLYKKINAQRG----VLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG--TIKLGDFGIARVLNST  154 (256)
T ss_pred             CCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC--CEEEeeccceeecCcc
Confidence            999999998864321    1122334455899999999999999999999999999997654  6999999999876433


Q ss_pred             Cc-eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHH
Q psy12427        267 EV-VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD  345 (356)
Q Consensus       267 ~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  345 (356)
                      .. .....|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+....+........   ...++.++.+
T Consensus       155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  231 (256)
T cd08218         155 VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPV---SSHYSYDLRN  231 (256)
T ss_pred             hhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCC---cccCCHHHHH
Confidence            22 1234578899999999999999999999999999999999999998888888777766554322   2478999999


Q ss_pred             HHHHhhhcCCC
Q psy12427        346 FIRRLLLRNKE  356 (356)
Q Consensus       346 lI~~ll~~dP~  356 (356)
                      +|.+||+.+|+
T Consensus       232 li~~~l~~~p~  242 (256)
T cd08218         232 LVSQLFKRNPR  242 (256)
T ss_pred             HHHHHhhCChh
Confidence            99999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=8.2e-40  Score=298.11  Aligned_cols=240  Identities=27%  Similarity=0.460  Sum_probs=193.8

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh-----hHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL-----EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~-----~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      +|++.+.||.|+||.||+|.++.++..||+|.++.....     ....+.+|+++++.++||||+++++++......++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            478889999999999999999999999999999765432     234566899999999999999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      |||+ +++|.+++......     +....+..++.||+.||+|||++|++|+||+|+||+++.++  .++|+|||++...
T Consensus        81 ~e~~-~~~L~~~i~~~~~~-----~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~--~~~l~dfg~~~~~  152 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIV-----LTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDG--VLKLADFGLARSF  152 (298)
T ss_pred             Eccc-CCCHHHHHhccCCC-----CCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCC--CEEEccceeeeec
Confidence            9999 89999998654322     33344556999999999999999999999999999998654  7999999999876


Q ss_pred             CCCC-ceeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc----------
Q psy12427        264 DPNE-VVKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEF----------  331 (356)
Q Consensus       264 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~----------  331 (356)
                      .... ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+.++.+.+.++......+          
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (298)
T cd07841         153 GSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS  232 (298)
T ss_pred             cCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccc
Confidence            5332 2233456888999998854 457889999999999999999999999888776665554321111          


Q ss_pred             --------------ChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        332 --------------DEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       332 --------------~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                    ....+..++.++.+||.+||+.||+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~  271 (298)
T cd07841         233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPN  271 (298)
T ss_pred             ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcc
Confidence                          1122345689999999999999995

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=8.1e-40  Score=305.47  Aligned_cols=240  Identities=24%  Similarity=0.410  Sum_probs=191.9

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccC--ChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeC------
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS--HNLEKELIRKEIDIMNQLHHPKLINLHDAFEDD------  177 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------  177 (356)
                      +.++|++.+.||+|+||.||+|.+..+++.+|+|.+...  .......+.+|+.+++.++||||++++++|...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            457899999999999999999999999999999998643  223345667899999999999999999988643      


Q ss_pred             CeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEee
Q psy12427        178 DEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDF  257 (356)
Q Consensus       178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Df  257 (356)
                      ...++||||+. ++|.+.+...   ++     ...+..++.|++.||+|||++|++||||||+||+++.++  .+||+||
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~~---l~-----~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~--~~kL~Df  162 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQMD---LD-----HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDF  162 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhhc---CC-----HHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC--CEEEccC
Confidence            35799999995 5787776532   22     334455899999999999999999999999999997654  7999999


Q ss_pred             eceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhh--
Q psy12427        258 GLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEA--  335 (356)
Q Consensus       258 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~--  335 (356)
                      |+++............+++.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+.+..+......++++.  
T Consensus       163 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
T cd07850         163 GLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS  242 (353)
T ss_pred             ccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            999876544433445688999999999999999999999999999999999999998876655555433211111100  


Q ss_pred             -------------------------------------hccCCHHHHHHHHHhhhcCCC
Q psy12427        336 -------------------------------------FKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       336 -------------------------------------~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                                           ....++++++||++||+.||+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  300 (353)
T cd07850         243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPE  300 (353)
T ss_pred             HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChh
Confidence                                                 113467799999999999995

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-39  Score=293.08  Aligned_cols=238  Identities=21%  Similarity=0.302  Sum_probs=195.8

Q ss_pred             cceeeeccccccCceEEEEEEEccCCC----EEEEEEcccCCh-hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGN----IFAAKFIPVSHN-LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~----~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      ++|++.+.||+|+||.||+|.++.+|.    .+|+|.+..... .....+.+|+.++..++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            578999999999999999999887764    689998876543 344678899999999999999999999887 78999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      +|||+.+|+|.+++......+++     ..+..++.|++.||+|||+.|++|+||+|+|||++.++  .+||+|||+++.
T Consensus        86 v~e~~~~g~L~~~l~~~~~~~~~-----~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~--~~kL~dfg~~~~  158 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKDNIGS-----QYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQ--HVKITDFGLAKL  158 (279)
T ss_pred             EEecCCCCcHHHHHHhccCCCCH-----HHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCC--eEEECCCccccc
Confidence            99999999999998754433333     34455999999999999999999999999999997554  699999999987


Q ss_pred             eCCCCceee---cCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhcc
Q psy12427        263 LDPNEVVKI---STGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKN  338 (356)
Q Consensus       263 ~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  338 (356)
                      .........   ..++..|+|||.+....++.++|+||||+++||+++ |..||.+....+..+.+........   ...
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~  235 (279)
T cd05057         159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQ---PPI  235 (279)
T ss_pred             ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCC---CCC
Confidence            653322111   123578999999988899999999999999999998 9999999988887777765432222   135


Q ss_pred             CCHHHHHHHHHhhhcCCC
Q psy12427        339 VSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       339 ~s~~~~~lI~~ll~~dP~  356 (356)
                      ++.++.+++.+||..||+
T Consensus       236 ~~~~~~~~~~~~l~~~p~  253 (279)
T cd05057         236 CTIDVYMVLVKCWMIDAE  253 (279)
T ss_pred             CCHHHHHHHHHHcCCChh
Confidence            789999999999999984

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2e-39  Score=291.45  Aligned_cols=238  Identities=21%  Similarity=0.314  Sum_probs=195.0

Q ss_pred             cceeeeccccccCceEEEEEEEccC---CCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKT---GNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~---~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      ++|.+.+.||+|+||.||+|.+...   ...+|+|...... ....+.+.+|+.+++.++||||+++++++.. ...++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            4688999999999999999987654   3578999887655 4455678899999999999999999998875 557899


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      |||+++++|.+++......+     ....+..++.+++.||+|||+.|++|+||||+|||++.++  .++|+|||++...
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~-----~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~--~~~l~d~g~~~~~  157 (270)
T cd05056          85 MELAPLGELRSYLQVNKYSL-----DLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD--CVKLGDFGLSRYL  157 (270)
T ss_pred             EEcCCCCcHHHHHHhCCCCC-----CHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCC--CeEEccCceeeec
Confidence            99999999999987543223     3344555899999999999999999999999999998654  7999999999876


Q ss_pred             CCCCceee--cCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCC
Q psy12427        264 DPNEVVKI--STGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVS  340 (356)
Q Consensus       264 ~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  340 (356)
                      ........  ..++..|+|||.+....++.++||||||+++|+|++ |..||.+.+..+.+..+.......   .+..+|
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~  234 (270)
T cd05056         158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLP---MPPNCP  234 (270)
T ss_pred             ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCC---CCCCCC
Confidence            54322221  224568999999998889999999999999999986 999999998888777776654322   224789


Q ss_pred             HHHHHHHHHhhhcCCC
Q psy12427        341 EEGKDFIRRLLLRNKE  356 (356)
Q Consensus       341 ~~~~~lI~~ll~~dP~  356 (356)
                      .++.++|.+||..||+
T Consensus       235 ~~~~~li~~~l~~~P~  250 (270)
T cd05056         235 PTLYSLMTKCWAYDPS  250 (270)
T ss_pred             HHHHHHHHHHcCCChh
Confidence            9999999999999985

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.2e-39  Score=295.57  Aligned_cols=244  Identities=20%  Similarity=0.329  Sum_probs=199.2

Q ss_pred             cceeeeccccccCceEEEEEEEcc-----CCCEEEEEEcccCCh-hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERK-----TGNIFAAKFIPVSHN-LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMV  181 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~-----~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  181 (356)
                      ++|++.+.||+|+||.||+|.++.     ++..+|+|.+..... .....+.+|+.+++.++||||+++++++..+...+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~   84 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC   84 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence            578999999999999999998753     578999999876543 33466888999999999999999999999999999


Q ss_pred             EEEEeccccchhhhhhCCCCCC----------------CccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEe
Q psy12427        182 LIFEFLSGGELFERITAPDYKM----------------SEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQ  245 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~----------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~  245 (356)
                      ++|||+++|+|.+++.......                ....+....+..++.|++.||+|||+++++||||+|+||+++
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~  164 (288)
T cd05050          85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG  164 (288)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEec
Confidence            9999999999999986433211                111233445567999999999999999999999999999997


Q ss_pred             ecCCCcEEEEeeeceeeeCCCCce---eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q psy12427        246 TRNSTNVKMIDFGLATKLDPNEVV---KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETL  321 (356)
Q Consensus       246 ~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~  321 (356)
                      .++  .++|+|||++.........   .....+..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+..
T Consensus       165 ~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~  242 (288)
T cd05050         165 ENM--VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVI  242 (288)
T ss_pred             CCC--ceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            554  7999999998765432211   12234677999999999999999999999999999997 88999988888888


Q ss_pred             HHhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        322 KNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       322 ~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ..+.......   ....++.++.+||.+||+.||+
T Consensus       243 ~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~  274 (288)
T cd05050         243 YYVRDGNVLS---CPDNCPLELYNLMRLCWSKLPS  274 (288)
T ss_pred             HHHhcCCCCC---CCCCCCHHHHHHHHHHcccCcc
Confidence            8777655432   1246899999999999999995

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=7.2e-40  Score=303.76  Aligned_cols=246  Identities=22%  Similarity=0.289  Sum_probs=190.3

Q ss_pred             ccceeeeccccccCceEEEEEEEcc-----CCCEEEEEEcccCCh-hhHHHHHHHHHHHHhc-CCCCceeeeeeEEe-CC
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERK-----TGNIFAAKFIPVSHN-LEKELIRKEIDIMNQL-HHPKLINLHDAFED-DD  178 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~-----~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~-~~  178 (356)
                      .++|++.+.||+|+||.||+|.+..     +++.||+|.++.... .....+.+|+.++.++ +||||+++++++.. +.
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            3579999999999999999997543     457899999875432 2345677899999999 89999999998864 46


Q ss_pred             eEEEEEEeccccchhhhhhCCCCCC-------------------------------------------------------
Q psy12427        179 EMVLIFEFLSGGELFERITAPDYKM-------------------------------------------------------  203 (356)
Q Consensus       179 ~~~lv~e~~~~g~L~~~l~~~~~~~-------------------------------------------------------  203 (356)
                      .++++|||+++++|.+++.......                                                       
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            7889999999999999885432110                                                       


Q ss_pred             CccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCc---eeecCCCcCccc
Q psy12427        204 SEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEV---VKISTGTAEFAA  280 (356)
Q Consensus       204 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~a  280 (356)
                      ....+....+..++.||+.||+|||++||+||||||+|||++.++  .++|+|||++..+.....   .....++..|+|
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~--~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN--VVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCC--cEEEeccccchhcccCcchhhccCCCCCccccC
Confidence            011334445667899999999999999999999999999998654  799999999987643221   112345678999


Q ss_pred             cccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        281 PEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       281 PE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ||++.+..++.++|||||||++|+|++ |..||.+....+.+...........  ....+++++.+++.+||+.+|+
T Consensus       244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~cl~~~p~  318 (337)
T cd05054         244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMR--APEYATPEIYSIMLDCWHNNPE  318 (337)
T ss_pred             cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCC--CCccCCHHHHHHHHHHccCChh
Confidence            999999999999999999999999998 9999987654444333322221111  1236789999999999999985

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=8.8e-40  Score=299.65  Aligned_cols=242  Identities=25%  Similarity=0.403  Sum_probs=192.5

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhh--HHHHHHHHHHHHhcCCCCceeeeeeEEeC--CeEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE--KELIRKEIDIMNQLHHPKLINLHDAFEDD--DEMVL  182 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~--~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~l  182 (356)
                      .++|++.+.||+|+||.||+|.++.+|..||+|.++......  ...+.+|+.++++++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            357999999999999999999999999999999987543221  23456799999999999999999998754  56899


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ||||+.+ +|.+++......+     ....+..++.|++.||+|||+.|++||||+|+||+++.++  .+||+|||++..
T Consensus        86 v~e~~~~-~l~~~l~~~~~~l-----~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~--~~kL~dfg~~~~  157 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMPTPF-----SESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKG--CLKIADFGLART  157 (309)
T ss_pred             EEecCCC-CHHHHHHhcccCC-----CHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC--CEEECccceeee
Confidence            9999964 7877776533233     3344555999999999999999999999999999997654  799999999987


Q ss_pred             eCCCC-ceeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCh-------
Q psy12427        263 LDPNE-VVKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE-------  333 (356)
Q Consensus       263 ~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~-------  333 (356)
                      ..... ......+++.|+|||.+.+ ..++.++||||+||++|+|++|.+||.+.+..+.+..+.........       
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07845         158 YGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS  237 (309)
T ss_pred             cCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence            65332 2222345788999999865 55789999999999999999999999999888877766542211110       


Q ss_pred             -------------------hhhccCCHHHHHHHHHhhhcCCC
Q psy12427        334 -------------------EAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       334 -------------------~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                         ..+..+++++.+||++||+.||+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~  279 (309)
T cd07845         238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPK  279 (309)
T ss_pred             cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChh
Confidence                               11123689999999999999995

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=7.4e-40  Score=296.47  Aligned_cols=241  Identities=30%  Similarity=0.503  Sum_probs=193.2

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh--hHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL--EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      ++|++.+.||+|+||.||+|.++.+++.+|+|.+......  ....+.+|+++++.++||||+++++++..+...++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            3689999999999999999999999999999988654322  34567789999999999999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |+++++|.++..... .+     ....+..++.|++.||+|||+.|++|+||+|+||+++.++  .++|+|||++.....
T Consensus        81 ~~~~~~l~~~~~~~~-~~-----~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~--~~~l~dfg~~~~~~~  152 (286)
T cd07846          81 FVDHTVLDDLEKYPN-GL-----DESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSG--VVKLCDFGFARTLAA  152 (286)
T ss_pred             cCCccHHHHHHhccC-CC-----CHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC--cEEEEeeeeeeeccC
Confidence            999988877664322 22     3344556999999999999999999999999999997654  799999999987643


Q ss_pred             CC-ceeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC-----------
Q psy12427        266 NE-VVKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD-----------  332 (356)
Q Consensus       266 ~~-~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-----------  332 (356)
                      .. ......++..|+|||++.+. .++.++||||||+++|+|++|++||.+.+..+.+..+......+.           
T Consensus       153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07846         153 PGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP  232 (286)
T ss_pred             CccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence            32 22234578899999998753 478899999999999999999999988776655444432111110           


Q ss_pred             ----------------hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 ----------------EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 ----------------~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                      ...++.++.++.+||++||+.||+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~  272 (286)
T cd07846         233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPD  272 (286)
T ss_pred             HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcc
Confidence                            112346789999999999999995

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.7e-39  Score=292.12  Aligned_cols=240  Identities=20%  Similarity=0.354  Sum_probs=195.2

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh----------hHHHHHHHHHHHHhcCCCCceeeeeeEEeCC
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL----------EKELIRKEIDIMNQLHHPKLINLHDAFEDDD  178 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~----------~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  178 (356)
                      +|.+.+.||.|+||.||+|....+|..+|+|.++.....          ..+.+.+|+.+++.++||||+++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            478889999999999999999999999999988643211          1245778999999999999999999999999


Q ss_pred             eEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeee
Q psy12427        179 EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFG  258 (356)
Q Consensus       179 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg  258 (356)
                      ..++||||+.+++|.+++.... .     +....+..++.|++.||.|||+++++|+||+|+||+++.++  .++|+|||
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~-~-----l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~--~~~l~d~~  153 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG-R-----FEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADG--ICKISDFG  153 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc-C-----CCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCC--eEEEeecc
Confidence            9999999999999999886542 2     23334556899999999999999999999999999997544  79999999


Q ss_pred             ceeeeCCCC---ceeecCCCcCccccccccCCC--CCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc--cccc
Q psy12427        259 LATKLDPNE---VVKISTGTAEFAAPEIVEREP--VGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKAC--DWEF  331 (356)
Q Consensus       259 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~  331 (356)
                      ++.......   ......|+..|+|||.+....  ++.++|+||||+++|++++|..||......+.+..+...  ...+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  233 (272)
T cd06629         154 ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPI  233 (272)
T ss_pred             ccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcC
Confidence            987653211   122345789999999987654  889999999999999999999999877666555544332  3334


Q ss_pred             ChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        332 DEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       332 ~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +......++.++++||.+||++||+
T Consensus       234 ~~~~~~~~~~~~~~li~~~l~~~p~  258 (272)
T cd06629         234 PPDVSMNLSPVALDFLNACFTINPD  258 (272)
T ss_pred             CccccccCCHHHHHHHHHHhcCChh
Confidence            4555567899999999999999995

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.7e-39  Score=293.47  Aligned_cols=238  Identities=29%  Similarity=0.493  Sum_probs=189.3

Q ss_pred             eeeeccccccCceEEEEEEEccCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcC-CCCceeeeeeEEeC--CeEEEEEE
Q psy12427        110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLH-HPKLINLHDAFEDD--DEMVLIFE  185 (356)
Q Consensus       110 y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~--~~~~lv~e  185 (356)
                      |++.++||+|+||.||+|.++.++..+|+|.++... ........+|+.++.++. ||||+++++++...  +.+++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            678899999999999999999999999999987542 222223447899999985 99999999999987  89999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |+. ++|.+.+......++     ...+..++.|++.||+|||+.|++||||+|+||+++.   +.+||+|||++.....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~-----~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~---~~~kl~dfg~~~~~~~  151 (282)
T cd07831          81 LMD-MNLYELIKGRKRPLP-----EKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD---DILKLADFGSCRGIYS  151 (282)
T ss_pred             cCC-ccHHHHHHhccCCCC-----HHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC---CCeEEEeccccccccc
Confidence            996 578777765432333     3445559999999999999999999999999999986   4799999999987654


Q ss_pred             CCceeecCCCcCcccccccc-CCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc--------------
Q psy12427        266 NEVVKISTGTAEFAAPEIVE-REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWE--------------  330 (356)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~--------------  330 (356)
                      ........++..|+|||.+. +..++.++|+||+||++|+|++|.+||.+.+..+.+..+......              
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07831         152 KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH  231 (282)
T ss_pred             CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence            43334456789999999765 455788999999999999999999999988876665555332111              


Q ss_pred             ----cCh-------hhhccCCHHHHHHHHHhhhcCCC
Q psy12427        331 ----FDE-------EAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       331 ----~~~-------~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                          ++.       .....+|.++.++|.+||++||+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~  268 (282)
T cd07831         232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPD  268 (282)
T ss_pred             ccccCcccccccHHHHcccccHHHHHHHHHHhccCcc
Confidence                111       12246789999999999999995

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.4e-39  Score=289.91  Aligned_cols=238  Identities=23%  Similarity=0.441  Sum_probs=196.6

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC-----hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-----NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      +|+..+.||+|+||.||+|....++..+++|.+....     ......+.+|+.+++.++||||+++++++......+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            3677889999999999999999899999999986543     22345678899999999999999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      +||+++++|.+++.... .     +....+..++.|++.||+|||+.|++|+||+|+||+++.++  .+||+|||++...
T Consensus        81 ~e~~~~~~L~~~~~~~~-~-----~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~--~~kl~d~~~~~~~  152 (258)
T cd06632          81 LELVPGGSLAKLLKKYG-S-----FPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNG--VVKLADFGMAKQV  152 (258)
T ss_pred             EEecCCCcHHHHHHhcC-C-----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEccCccceec
Confidence            99999999999986432 2     23334455899999999999999999999999999997654  7999999998876


Q ss_pred             CCCCceeecCCCcCccccccccCCC-CCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHH
Q psy12427        264 DPNEVVKISTGTAEFAAPEIVEREP-VGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEE  342 (356)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  342 (356)
                      ..........|+..|+|||.+.... ++.++|+||||+++|+|++|..||......+....+....  ..+.....++++
T Consensus       153 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  230 (258)
T cd06632         153 VEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK--ELPPIPDHLSDE  230 (258)
T ss_pred             cccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc--cCCCcCCCcCHH
Confidence            5444344556899999999998776 8999999999999999999999998877666555544311  112233468999


Q ss_pred             HHHHHHHhhhcCCC
Q psy12427        343 GKDFIRRLLLRNKE  356 (356)
Q Consensus       343 ~~~lI~~ll~~dP~  356 (356)
                      +++||++||+.||+
T Consensus       231 ~~~li~~~l~~~p~  244 (258)
T cd06632         231 AKDFILKCLQRDPS  244 (258)
T ss_pred             HHHHHHHHhhcCcc
Confidence            99999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-39  Score=291.93  Aligned_cols=238  Identities=23%  Similarity=0.338  Sum_probs=189.6

Q ss_pred             ccccccCceEEEEEEEccCCC--EEEEEEcccCC-hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEEEEEEeccc
Q psy12427        114 EEIGTGAFGVVHRCRERKTGN--IFAAKFIPVSH-NLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMVLIFEFLSG  189 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~~~--~~a~K~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~  189 (356)
                      +.||+|+||.||+|.++.++.  .+++|.++... ......+.+|++++.++ +||||+++++++...+..+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            369999999999999988875  46888876433 33456788999999999 799999999999999999999999999


Q ss_pred             cchhhhhhCCCCC----------CCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeec
Q psy12427        190 GELFERITAPDYK----------MSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGL  259 (356)
Q Consensus       190 g~L~~~l~~~~~~----------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~  259 (356)
                      |+|.+++......          .....+....+..++.|++.||+|||+.|++||||||+|||++.++  .+||+|||+
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~--~~kl~dfgl  158 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY--VAKIADFGL  158 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCC--eEEECCCCC
Confidence            9999998653311          0112234455667999999999999999999999999999997654  799999999


Q ss_pred             eeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhcc
Q psy12427        260 ATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKN  338 (356)
Q Consensus       260 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  338 (356)
                      +..............+..|+|||++....++.++|+|||||++|+|++ |..||.+.+..+....+.... ..  +....
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~~--~~~~~  235 (270)
T cd05047         159 SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-RL--EKPLN  235 (270)
T ss_pred             ccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC-CC--CCCCc
Confidence            864332111112234667999999998899999999999999999997 999999888877777665432 11  12246


Q ss_pred             CCHHHHHHHHHhhhcCCC
Q psy12427        339 VSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       339 ~s~~~~~lI~~ll~~dP~  356 (356)
                      ++.++.++|.+||+.||+
T Consensus       236 ~~~~~~~li~~~l~~~p~  253 (270)
T cd05047         236 CDDEVYDLMRQCWREKPY  253 (270)
T ss_pred             CCHHHHHHHHHHcccChh
Confidence            889999999999999984

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2e-39  Score=290.03  Aligned_cols=239  Identities=26%  Similarity=0.434  Sum_probs=194.1

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh--hHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL--EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      +|++.+.||+|+||.||+|.+..+++.+|+|.++.....  ....+.+|+.+++.++|+||+++++.+......++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            488899999999999999999999999999998766543  567788999999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +++++|.+++.... ...     ...+..++.+++.||+|||+.|++|+||+|+||+++.++  .+||+|||++......
T Consensus        81 ~~~~~L~~~~~~~~-~~~-----~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~--~~kl~d~g~~~~~~~~  152 (264)
T cd06626          81 CSGGTLEELLEHGR-ILD-----EHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNG--VIKLGDFGCAVKLKNN  152 (264)
T ss_pred             CCCCcHHHHHhhcC-CCC-----hHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEcccccccccCCC
Confidence            99999999986532 122     233455899999999999999999999999999998644  7999999998876433


Q ss_pred             Cce-----eecCCCcCccccccccCCC---CCccccHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHhhccccccChhhhc
Q psy12427        267 EVV-----KISTGTAEFAAPEIVEREP---VGFYTDMWAVGVLAYVLLSGLSPFAGEN-DVETLKNVKACDWEFDEEAFK  337 (356)
Q Consensus       267 ~~~-----~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlG~il~ell~g~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~  337 (356)
                      ...     ....+++.|+|||++....   ++.++||||||+++|++++|..||.... .......+.... ...-+...
T Consensus       153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~  231 (264)
T cd06626         153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGH-KPPIPDSL  231 (264)
T ss_pred             CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCC-CCCCCccc
Confidence            221     1245788999999998766   8899999999999999999999997663 333333333321 11112223


Q ss_pred             cCCHHHHHHHHHhhhcCCC
Q psy12427        338 NVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       338 ~~s~~~~~lI~~ll~~dP~  356 (356)
                      .++..+.+||++||+.||+
T Consensus       232 ~~~~~~~~li~~~l~~~p~  250 (264)
T cd06626         232 QLSPEGKDFLDRCLESDPK  250 (264)
T ss_pred             ccCHHHHHHHHHHccCCcc
Confidence            5699999999999999995

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.6e-39  Score=287.16  Aligned_cols=232  Identities=19%  Similarity=0.328  Sum_probs=189.7

Q ss_pred             ccccccCceEEEEEEEccCCCEEEEEEcccCCh-hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEeccccch
Q psy12427        114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN-LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGEL  192 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L  192 (356)
                      +.||.|+||.||+|... ++..+|+|.+..... .....+.+|+++++.++||||+++++++......++||||+++++|
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            46999999999999865 688999999876543 2345688899999999999999999999999999999999999999


Q ss_pred             hhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCcee--
Q psy12427        193 FERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVK--  270 (356)
Q Consensus       193 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~~~--  270 (356)
                      .+++......+.     ...+..++.|++.||.|||+.|++|+||+|+||+++.++  .+||+|||++..........  
T Consensus        80 ~~~~~~~~~~~~-----~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~--~~~l~d~g~~~~~~~~~~~~~~  152 (250)
T cd05085          80 LSFLRKKKDELK-----TKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENN--VLKISDFGMSRQEDDGIYSSSG  152 (250)
T ss_pred             HHHHHhcCCCCC-----HHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCC--eEEECCCccceeccccccccCC
Confidence            998865433333     334455899999999999999999999999999997554  79999999987654322211  


Q ss_pred             ecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHHH
Q psy12427        271 ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRR  349 (356)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~  349 (356)
                      ...++..|+|||++.+..++.++||||||+++|++++ |..||.+.........+.....   ......++.++.+||.+
T Consensus       153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~  229 (250)
T cd05085         153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR---MSCPQKCPDDVYKVMQR  229 (250)
T ss_pred             CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCCHHHHHHHHH
Confidence            1234678999999998889999999999999999998 9999998888777776654321   12234689999999999


Q ss_pred             hhhcCCC
Q psy12427        350 LLLRNKE  356 (356)
Q Consensus       350 ll~~dP~  356 (356)
                      ||+.||+
T Consensus       230 ~l~~~p~  236 (250)
T cd05085         230 CWDYKPE  236 (250)
T ss_pred             HcccCcc
Confidence            9999995

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.2e-39  Score=289.58  Aligned_cols=237  Identities=22%  Similarity=0.331  Sum_probs=192.3

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEec
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFL  187 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~  187 (356)
                      ++|.+.+.||+|++|.||+|.+..+ ..+|+|.+..... ..+.+.+|+.+++.++|||++++++++. ....+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM   82 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence            5799999999999999999988754 4689998765432 3466788999999999999999999875 45688999999


Q ss_pred             cccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCC
Q psy12427        188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE  267 (356)
Q Consensus       188 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~  267 (356)
                      .+++|.+++.....    .......+..++.|++.||.|||+.|++|+||+|+||+++.++  .++|+|||++.......
T Consensus        83 ~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~--~~~l~dfg~~~~~~~~~  156 (260)
T cd05069          83 GKGSLLDFLKEGDG----KYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNL--VCKIADFGLARLIEDNE  156 (260)
T ss_pred             CCCCHHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC--eEEECCCccceEccCCc
Confidence            99999999864321    1223334455899999999999999999999999999997654  79999999998764332


Q ss_pred             ce--eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHHH
Q psy12427        268 VV--KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK  344 (356)
Q Consensus       268 ~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  344 (356)
                      ..  ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+..+.+....+.... .  .....+++..++
T Consensus       157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~  233 (260)
T cd05069         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY-R--MPCPQGCPESLH  233 (260)
T ss_pred             ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-C--CCCCcccCHHHH
Confidence            21  12235678999999998899999999999999999999 999999988888777765532 2  222357899999


Q ss_pred             HHHHHhhhcCCC
Q psy12427        345 DFIRRLLLRNKE  356 (356)
Q Consensus       345 ~lI~~ll~~dP~  356 (356)
                      ++|++||++||+
T Consensus       234 ~li~~~l~~~p~  245 (260)
T cd05069         234 ELMKLCWKKDPD  245 (260)
T ss_pred             HHHHHHccCCcc
Confidence            999999999995

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.6e-39  Score=289.77  Aligned_cols=234  Identities=21%  Similarity=0.351  Sum_probs=192.0

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeE-EeCCeEEEEEEe
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF-EDDDEMVLIFEF  186 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-~~~~~~~lv~e~  186 (356)
                      ++|++.+.||+|+||.||++...  |..+|+|.++...  ....+.+|+.++++++|+|++++++++ ......+++|||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            46899999999999999999765  7889999986543  345678999999999999999999975 455778999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +++++|.+++......    ......+..++.|++.||+|||++|++||||||+||+++.++  .+||+|||++......
T Consensus        82 ~~~~~L~~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~--~~kl~dfg~~~~~~~~  155 (256)
T cd05082          82 MAKGSLVDYLRSRGRS----VLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDN--VAKVSDFGLTKEASST  155 (256)
T ss_pred             CCCCcHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCC--cEEecCCccceecccc
Confidence            9999999998754321    223334455899999999999999999999999999997654  7999999998765432


Q ss_pred             CceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHH
Q psy12427        267 EVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD  345 (356)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  345 (356)
                      .  ....++..|+|||++....++.++|||||||++|+|++ |+.||...+..+....+....   .......++.++.+
T Consensus       156 ~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~  230 (256)
T cd05082         156 Q--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---KMDAPDGCPPVVYD  230 (256)
T ss_pred             C--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC---CCCCCCCCCHHHHH
Confidence            2  22334678999999999899999999999999999997 999999888877777765542   12233578999999


Q ss_pred             HHHHhhhcCCC
Q psy12427        346 FIRRLLLRNKE  356 (356)
Q Consensus       346 lI~~ll~~dP~  356 (356)
                      +|.+||+.||+
T Consensus       231 li~~~l~~~p~  241 (256)
T cd05082         231 VMKQCWHLDAA  241 (256)
T ss_pred             HHHHHhcCChh
Confidence            99999999995

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=6.7e-40  Score=298.84  Aligned_cols=237  Identities=24%  Similarity=0.490  Sum_probs=197.8

Q ss_pred             eeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEeccc
Q psy12427        110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSG  189 (356)
Q Consensus       110 y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  189 (356)
                      |.....||+|+||.||++.++.++..+|+|.+..........+.+|+.++..++||||+++++.+..+...++++||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            44556899999999999999999999999998765555566788999999999999999999999999999999999999


Q ss_pred             cchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCc-
Q psy12427        190 GELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEV-  268 (356)
Q Consensus       190 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~-  268 (356)
                      ++|.+++...  .+     ....+..++.|++.||+|||++|++|+||+|+||+++.++  .++|+|||++........ 
T Consensus       103 ~~L~~~~~~~--~~-----~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~--~~kL~dfg~~~~~~~~~~~  173 (297)
T cd06659         103 GALTDIVSQT--RL-----NEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDG--RVKLSDFGFCAQISKDVPK  173 (297)
T ss_pred             CCHHHHHhhc--CC-----CHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCC--cEEEeechhHhhccccccc
Confidence            9998877532  22     3334556999999999999999999999999999997654  799999999876543221 


Q ss_pred             eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHH
Q psy12427        269 VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIR  348 (356)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  348 (356)
                      .....|+..|+|||++.+..++.++|||||||++|+|++|+.||...+..+.+..+....... ......++.++.+||+
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~i~  252 (297)
T cd06659         174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK-LKNAHKISPVLRDFLE  252 (297)
T ss_pred             ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCC-ccccCCCCHHHHHHHH
Confidence            233468999999999998889999999999999999999999999888777777665433222 2233468999999999


Q ss_pred             HhhhcCCC
Q psy12427        349 RLLLRNKE  356 (356)
Q Consensus       349 ~ll~~dP~  356 (356)
                      +||+.||+
T Consensus       253 ~~l~~~P~  260 (297)
T cd06659         253 RMLTREPQ  260 (297)
T ss_pred             HHhcCCcc
Confidence            99999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-39  Score=294.68  Aligned_cols=241  Identities=29%  Similarity=0.485  Sum_probs=193.5

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      ++|++.+.||+|+||.||+|.++.+++.||+|.++...  ......+.+|++++++++||||+++++++...+..+++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36899999999999999999999999999999886543  2234678899999999999999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |+.++.+..+... ...+     ....+..++.|++.||+|||+.+++|+||+|+||+++.++  .+||+|||++.....
T Consensus        81 ~~~~~~l~~~~~~-~~~~-----~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~--~~kl~d~g~~~~~~~  152 (288)
T cd07833          81 YVERTLLELLEAS-PGGL-----PPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESG--VLKLCDFGFARALRA  152 (288)
T ss_pred             cCCCCHHHHHHhc-CCCC-----CHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC--CEEEEeeecccccCC
Confidence            9988666555432 2223     3344455899999999999999999999999999998644  799999999887654


Q ss_pred             CC--ceeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC----------
Q psy12427        266 NE--VVKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD----------  332 (356)
Q Consensus       266 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~----------  332 (356)
                      ..  ......++..|+|||++.+. .++.++|+||||+++|+|++|++||.+.+..+.+..+......++          
T Consensus       153 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07833         153 RPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN  232 (288)
T ss_pred             CccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence            33  22334678999999999888 789999999999999999999999998876665544332111111          


Q ss_pred             ------------------hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 ------------------EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 ------------------~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                        ......+|.++++||++||+.||+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  274 (288)
T cd07833         233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPK  274 (288)
T ss_pred             ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCch
Confidence                              011223589999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-39  Score=289.81  Aligned_cols=239  Identities=22%  Similarity=0.344  Sum_probs=196.7

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      .++|.+.+.||+|+||.||+|.++ .+..+|+|.+..... ....+.+|+.++++++||||+++++++......+++|||
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            357999999999999999999976 457899999875433 346788999999999999999999999998999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +++++|.+++.....    ..+....+..++.+++.||.|||++|++|+||+|+||+++.++  .++|+|||++......
T Consensus        83 ~~~~~L~~~i~~~~~----~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~--~~~l~d~g~~~~~~~~  156 (261)
T cd05034          83 MSKGSLLDFLKSGEG----KKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENL--VCKIADFGLARLIEDD  156 (261)
T ss_pred             cCCCCHHHHHhcccc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCC--CEEECccccceeccch
Confidence            999999999875431    1223334455999999999999999999999999999998654  7999999998876432


Q ss_pred             Cce--eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHH
Q psy12427        267 EVV--KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG  343 (356)
Q Consensus       267 ~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  343 (356)
                      ...  ....++..|+|||.+.+..++.++|+||+|+++|+|++ |+.||.+.+..+.+.++......   .....++.++
T Consensus       157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  233 (261)
T cd05034         157 EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM---PRPPNCPEEL  233 (261)
T ss_pred             hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHH
Confidence            211  11224678999999999899999999999999999998 99999998888888887654221   1123678999


Q ss_pred             HHHHHHhhhcCCC
Q psy12427        344 KDFIRRLLLRNKE  356 (356)
Q Consensus       344 ~~lI~~ll~~dP~  356 (356)
                      .++|.+||+.||+
T Consensus       234 ~~~i~~~l~~~p~  246 (261)
T cd05034         234 YDLMLQCWDKDPE  246 (261)
T ss_pred             HHHHHHHcccCcc
Confidence            9999999999985

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.4e-39  Score=299.02  Aligned_cols=244  Identities=22%  Similarity=0.313  Sum_probs=197.0

Q ss_pred             cceeeeccccccCceEEEEEEEccC-------CCEEEEEEcccCC-hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCC
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKT-------GNIFAAKFIPVSH-NLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDD  178 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~-------~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  178 (356)
                      .+|++.+.||+|+||.||+|.+...       +..+|+|.++... ......+.+|+++++++ +||||+++++++....
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            4799999999999999999986432       2378999887543 33456788999999999 7999999999999999


Q ss_pred             eEEEEEEeccccchhhhhhCCCC----------CCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecC
Q psy12427        179 EMVLIFEFLSGGELFERITAPDY----------KMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN  248 (356)
Q Consensus       179 ~~~lv~e~~~~g~L~~~l~~~~~----------~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~  248 (356)
                      ..++++||+.+|+|.+++.....          ...+..+....+..++.|++.||+|||++|++||||||+|||++.++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~  171 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDN  171 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC
Confidence            99999999999999999875321          12233444445566899999999999999999999999999997654


Q ss_pred             CCcEEEEeeeceeeeCCCCce---eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHh
Q psy12427        249 STNVKMIDFGLATKLDPNEVV---KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV  324 (356)
Q Consensus       249 ~~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i  324 (356)
                        .+||+|||+++........   ....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+
T Consensus       172 --~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  249 (334)
T cd05100         172 --VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL  249 (334)
T ss_pred             --cEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence              7999999999876432211   11234567999999999999999999999999999998 89999998888877776


Q ss_pred             hccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        325 KACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       325 ~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ......   +....++.++.++|.+||+.+|+
T Consensus       250 ~~~~~~---~~~~~~~~~l~~li~~cl~~~p~  278 (334)
T cd05100         250 KEGHRM---DKPANCTHELYMIMRECWHAVPS  278 (334)
T ss_pred             HcCCCC---CCCCCCCHHHHHHHHHHcccChh
Confidence            554321   22247889999999999999985

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=6.4e-40  Score=298.28  Aligned_cols=240  Identities=25%  Similarity=0.481  Sum_probs=198.8

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      .+.|.....||.|+||.||++.+..++..+|+|.+..........+.+|+.+++.++||||+++++.+......++||||
T Consensus        21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~  100 (292)
T cd06658          21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF  100 (292)
T ss_pred             HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence            34566678899999999999999999999999998776666667788999999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +++++|.+++...  .+.     ...+..++.||+.||+|||++|++||||+|+||+++.++  .++|+|||++......
T Consensus       101 ~~~~~L~~~~~~~--~l~-----~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~--~~kL~dfg~~~~~~~~  171 (292)
T cd06658         101 LEGGALTDIVTHT--RMN-----EEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDG--RIKLSDFGFCAQVSKE  171 (292)
T ss_pred             CCCCcHHHHHhcC--CCC-----HHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC--CEEEccCcchhhcccc
Confidence            9999999887542  223     334456999999999999999999999999999997654  7999999998755322


Q ss_pred             C-ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHH
Q psy12427        267 E-VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD  345 (356)
Q Consensus       267 ~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  345 (356)
                      . ......|+..|+|||.+.+..++.++|+||||+++|||++|+.||.+.+..+.+..+...... .......++..+++
T Consensus       172 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  250 (292)
T cd06658         172 VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPP-RVKDSHKVSSVLRG  250 (292)
T ss_pred             cccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-ccccccccCHHHHH
Confidence            2 123346899999999999888999999999999999999999999988877766665443211 11122357899999


Q ss_pred             HHHHhhhcCCC
Q psy12427        346 FIRRLLLRNKE  356 (356)
Q Consensus       346 lI~~ll~~dP~  356 (356)
                      ||.+||+.||+
T Consensus       251 li~~~l~~~P~  261 (292)
T cd06658         251 FLDLMLVREPS  261 (292)
T ss_pred             HHHHHccCChh
Confidence            99999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-39  Score=295.25  Aligned_cols=241  Identities=22%  Similarity=0.387  Sum_probs=187.8

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh-hHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL-EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      +.|++.+.||.|++|.||+|.++.+++.||+|.+...... ....+.+|++++++++||||+++++++......++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            5799999999999999999999999999999998754322 224466899999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +.+ +|.+++......+.     ...+..++.|++.||.|||++|++||||+|+||+++.++  .+||+|||+++.....
T Consensus        85 ~~~-~L~~~~~~~~~~~~-----~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~~~~~~  156 (291)
T cd07844          85 LDT-DLKQYMDDCGGGLS-----MHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERG--ELKLADFGLARAKSVP  156 (291)
T ss_pred             CCC-CHHHHHHhCCCCCC-----HHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCC--CEEECccccccccCCC
Confidence            975 89888765433333     334556899999999999999999999999999998655  6999999998764321


Q ss_pred             C-ceeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHhhcccccc------------
Q psy12427        267 E-VVKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGEN-DVETLKNVKACDWEF------------  331 (356)
Q Consensus       267 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~-~~~~~~~i~~~~~~~------------  331 (356)
                      . ......++..|+|||++.+ ..++.++||||+|+++|+|++|+.||.+.. ..+.+..+.......            
T Consensus       157 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07844         157 SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP  236 (291)
T ss_pred             CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence            1 1122346889999999875 457889999999999999999999998765 333333322110000            


Q ss_pred             --------------ChhhhccCC--HHHHHHHHHhhhcCCC
Q psy12427        332 --------------DEEAFKNVS--EEGKDFIRRLLLRNKE  356 (356)
Q Consensus       332 --------------~~~~~~~~s--~~~~~lI~~ll~~dP~  356 (356)
                                    .......++  .++.++|.+||+.||+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~  277 (291)
T cd07844         237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPK  277 (291)
T ss_pred             ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcc
Confidence                          011112344  8899999999999995

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.8e-39  Score=288.87  Aligned_cols=238  Identities=23%  Similarity=0.383  Sum_probs=194.2

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      .+.|++.++||+|+||.||+|..+ ++..+|+|.+..... ....+.+|+.+++.++||||+++++++. ....+++|||
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY   81 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence            357999999999999999999865 578899998875433 3567889999999999999999999874 4578999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +.+++|.+++.....    .......+..++.|++.||+|||+.|++|+||+|+||+++.++  .++|+|||++......
T Consensus        82 ~~~~~L~~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~--~~~l~dfg~~~~~~~~  155 (260)
T cd05067          82 MENGSLVDFLKTPEG----IKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETL--CCKIADFGLARLIEDN  155 (260)
T ss_pred             CCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCC--CEEEccCcceeecCCC
Confidence            999999998864321    1233334555899999999999999999999999999998654  6999999999876532


Q ss_pred             Cce--eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHH
Q psy12427        267 EVV--KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG  343 (356)
Q Consensus       267 ~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  343 (356)
                      ...  ....++..|+|||++....++.++||||||+++|+|++ |+.||.+.+..+....+.....   .+....++.++
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  232 (260)
T cd05067         156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYR---MPRPDNCPEEL  232 (260)
T ss_pred             CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC---CCCCCCCCHHH
Confidence            221  12235678999999999899999999999999999999 9999998888887777655422   12334688999


Q ss_pred             HHHHHHhhhcCCC
Q psy12427        344 KDFIRRLLLRNKE  356 (356)
Q Consensus       344 ~~lI~~ll~~dP~  356 (356)
                      .++|++||+.||+
T Consensus       233 ~~li~~~l~~~p~  245 (260)
T cd05067         233 YELMRLCWKEKPE  245 (260)
T ss_pred             HHHHHHHccCChh
Confidence            9999999999995

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.8e-40  Score=293.10  Aligned_cols=230  Identities=19%  Similarity=0.273  Sum_probs=183.3

Q ss_pred             ccccccCceEEEEEEEccCCC-------EEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        114 EEIGTGAFGVVHRCRERKTGN-------IFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~~~-------~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      +.||.|+||.||+|.++.++.       .+|+|.+........+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999999876543       4888887655555556788899999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCC------cEEEEeeece
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNST------NVKMIDFGLA  260 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~------~vkl~Dfg~a  260 (356)
                      +.+|+|.+++......+++     ..+..++.||+.||+|||++||+||||||+|||++.++..      .++++|||.+
T Consensus        81 ~~~g~L~~~l~~~~~~~~~-----~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINI-----SWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCH-----HHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence            9999999998765433333     3345589999999999999999999999999999866531      3799999998


Q ss_pred             eeeCCCCceeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcC-CCCCCCCChHHHHHHhhccccccChhhhcc
Q psy12427        261 TKLDPNEVVKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSG-LSPFAGENDVETLKNVKACDWEFDEEAFKN  338 (356)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  338 (356)
                      ......   ....+++.|+|||++.+ ..++.++|||||||++|+|++| .+||...+....... ......++.    .
T Consensus       156 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-~~~~~~~~~----~  227 (258)
T cd05078         156 ITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-YEDRHQLPA----P  227 (258)
T ss_pred             cccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-HHccccCCC----C
Confidence            765432   22457889999999986 4578999999999999999998 577776665554332 222333332    5


Q ss_pred             CCHHHHHHHHHhhhcCCC
Q psy12427        339 VSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       339 ~s~~~~~lI~~ll~~dP~  356 (356)
                      .+.++.++|++||+.||+
T Consensus       228 ~~~~~~~li~~~l~~~p~  245 (258)
T cd05078         228 KWTELANLINQCMDYEPD  245 (258)
T ss_pred             CcHHHHHHHHHHhccChh
Confidence            678899999999999995

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3e-39  Score=305.26  Aligned_cols=246  Identities=21%  Similarity=0.317  Sum_probs=193.4

Q ss_pred             ccceeeeccccccCceEEEEEEEc-----cCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCe
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRER-----KTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLH-HPKLINLHDAFEDDDE  179 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~-----~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~  179 (356)
                      .++|.+.+.||+|+||.||+|+++     .++..||+|+++... ......+.+|+.+|.++. ||||+++++++...+.
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~  115 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP  115 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence            457889999999999999999965     345689999997653 233456789999999997 9999999999999999


Q ss_pred             EEEEEEeccccchhhhhhCCCCCC--------------------------------------------------------
Q psy12427        180 MVLIFEFLSGGELFERITAPDYKM--------------------------------------------------------  203 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~~~--------------------------------------------------------  203 (356)
                      .++||||+.+|+|.+++.......                                                        
T Consensus       116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (401)
T cd05107         116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM  195 (401)
T ss_pred             cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence            999999999999999986432100                                                        


Q ss_pred             ------------------------------------CccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeec
Q psy12427        204 ------------------------------------SEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTR  247 (356)
Q Consensus       204 ------------------------------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~  247 (356)
                                                          ....+....+..++.||+.||+|||+.+++||||||+|||++.+
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~  275 (401)
T cd05107         196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEG  275 (401)
T ss_pred             hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCC
Confidence                                                00011122345588899999999999999999999999999754


Q ss_pred             CCCcEEEEeeeceeeeCCCCc---eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHH
Q psy12427        248 NSTNVKMIDFGLATKLDPNEV---VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKN  323 (356)
Q Consensus       248 ~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~  323 (356)
                      +  .+||+|||+++.......   .....+++.|+|||.+.+..++.++|||||||++|||++ |..||......+.+..
T Consensus       276 ~--~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~  353 (401)
T cd05107         276 K--LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYN  353 (401)
T ss_pred             C--EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHH
Confidence            3  799999999986532211   112346788999999998889999999999999999998 8999988766665544


Q ss_pred             hhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        324 VKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       324 i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .......++  .+..++.++.+||++||+.||+
T Consensus       354 ~~~~~~~~~--~p~~~~~~l~~li~~cl~~~P~  384 (401)
T cd05107         354 AIKRGYRMA--KPAHASDEIYEIMQKCWEEKFE  384 (401)
T ss_pred             HHHcCCCCC--CCCCCCHHHHHHHHHHcCCChh
Confidence            433332222  2347899999999999999985

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.2e-39  Score=290.19  Aligned_cols=238  Identities=23%  Similarity=0.414  Sum_probs=192.8

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC------hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH------NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~------~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      +|++.+.||.|+||+||+|.. .++..+|+|.+....      ......+.+|+++++.++|+||+++++++......++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            477889999999999999976 468899999886542      1223567889999999999999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ++||+++++|.+++.... .     +....+..++.|++.||+|||+.+++|+||+|+||+++.++  .++|+|||++..
T Consensus        80 v~e~~~~~~L~~~l~~~~-~-----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~  151 (265)
T cd06631          80 FMEFVPGGSISSILNRFG-P-----LPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNG--IIKLIDFGCARR  151 (265)
T ss_pred             EEecCCCCcHHHHHHhcC-C-----CCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCC--eEEeccchhhHh
Confidence            999999999999986432 2     23344455899999999999999999999999999997554  799999999876


Q ss_pred             eCC-------CCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhh
Q psy12427        263 LDP-------NEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEA  335 (356)
Q Consensus       263 ~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  335 (356)
                      ...       ........|+..|+|||++.+..++.++|+|||||++|+|++|..||...+..+....+....... +..
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~  230 (265)
T cd06631         152 LAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLM-PRL  230 (265)
T ss_pred             hhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCC-CCC
Confidence            421       111223458899999999999999999999999999999999999998877665554444332222 223


Q ss_pred             hccCCHHHHHHHHHhhhcCCC
Q psy12427        336 FKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       336 ~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ...++.++.+||++||+.||+
T Consensus       231 ~~~~~~~~~~~i~~~l~~~p~  251 (265)
T cd06631         231 PDSFSAAAIDFVTSCLTRDQH  251 (265)
T ss_pred             CCCCCHHHHHHHHHHhcCCcc
Confidence            357899999999999999985

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.4e-39  Score=293.27  Aligned_cols=245  Identities=26%  Similarity=0.437  Sum_probs=193.0

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhc-CCCCceeeeeeEE-----eCCe
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL-HHPKLINLHDAFE-----DDDE  179 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~-----~~~~  179 (356)
                      ..++|++.+.||+|+||.||+|.++.+++.+|+|++..... ....+.+|+.+++.+ +||||+++++++.     .+..
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   94 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQ   94 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCe
Confidence            34689999999999999999999999999999998765332 235677899999999 6999999999874     4467


Q ss_pred             EEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeec
Q psy12427        180 MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGL  259 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~  259 (356)
                      ++++|||+++++|.+++....  .....+....+..++.|++.||.|||+.+++||||||+||+++.++  .++|+|||+
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~--~~kl~dfg~  170 (286)
T cd06638          95 LWLVLELCNGGSVTDLVKGFL--KRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEG--GVKLVDFGV  170 (286)
T ss_pred             EEEEEeecCCCCHHHHHHHhh--ccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCC--CEEEccCCc
Confidence            899999999999998875321  1122333444566999999999999999999999999999998654  699999999


Q ss_pred             eeeeCCCC-ceeecCCCcCccccccccC-----CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCh
Q psy12427        260 ATKLDPNE-VVKISTGTAEFAAPEIVER-----EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE  333 (356)
Q Consensus       260 a~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~  333 (356)
                      +....... ......|++.|+|||++..     ..++.++||||+||++|+|++|+.||......+.+.++...... ..
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~  249 (286)
T cd06638         171 SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPP-TL  249 (286)
T ss_pred             eeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCC-cc
Confidence            98765332 2233468999999999853     45788999999999999999999999887765555444332211 11


Q ss_pred             hhhccCCHHHHHHHHHhhhcCCC
Q psy12427        334 EAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       334 ~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .....++.++++||.+||+.||+
T Consensus       250 ~~~~~~~~~~~~li~~~l~~~p~  272 (286)
T cd06638         250 HQPELWSNEFNDFIRKCLTKDYE  272 (286)
T ss_pred             cCCCCcCHHHHHHHHHHccCCcc
Confidence            11234688999999999999995

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-39  Score=287.56  Aligned_cols=235  Identities=20%  Similarity=0.324  Sum_probs=196.6

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEec
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFL  187 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~  187 (356)
                      ++|++.+.||.|+||.||+|...  |+.+|+|.+..... ....+.+|+.+++.++|+||+++++++......++||||+
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            46899999999999999999876  78999999976654 4567888999999999999999999999999999999999


Q ss_pred             cccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCC
Q psy12427        188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE  267 (356)
Q Consensus       188 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~  267 (356)
                      ++++|.+++.....    .......+..++.|++.||.|||+.|++|+||||+||+++.++  .++|+|||.++......
T Consensus        83 ~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~--~~~l~d~g~~~~~~~~~  156 (256)
T cd05039          83 AKGSLVDYLRSRGR----AVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDL--VAKVSDFGLAKEASQGQ  156 (256)
T ss_pred             CCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCC--CEEEccccccccccccc
Confidence            99999999865431    1234455566999999999999999999999999999998654  69999999998763222


Q ss_pred             ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHH
Q psy12427        268 VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDF  346 (356)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  346 (356)
                        ....++..|+|||.+....++.++|+||||+++|+|++ |..||...+..+....+.....   ......+|+++.++
T Consensus       157 --~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l  231 (256)
T cd05039         157 --DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR---MEAPEGCPPEVYKV  231 (256)
T ss_pred             --ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC---CCCccCCCHHHHHH
Confidence              12345678999999998889999999999999999997 9999998887777666654321   12234689999999


Q ss_pred             HHHhhhcCCC
Q psy12427        347 IRRLLLRNKE  356 (356)
Q Consensus       347 I~~ll~~dP~  356 (356)
                      |++||+.+|+
T Consensus       232 i~~~l~~~p~  241 (256)
T cd05039         232 MKDCWELDPA  241 (256)
T ss_pred             HHHHhccChh
Confidence            9999999985

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.4e-39  Score=289.18  Aligned_cols=241  Identities=27%  Similarity=0.471  Sum_probs=200.2

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEE--eCCeEEEEE
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFE--DDDEMVLIF  184 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~~~~lv~  184 (356)
                      +|++.+.||.|+||.||++.+..++..+|+|.+....  ......+.+|+++++.++||||+++++.+.  .....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4788999999999999999999999999999987543  334567888999999999999999999875  345689999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHH-----HCCceeccCCCCCEEEeecCCCcEEEEeeec
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH-----EKNIIHLDVKPENIMCQTRNSTNVKMIDFGL  259 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH-----~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~  259 (356)
                      ||+++++|.+++.....  ....+....+..++.||+.||+|||     +.+++|+||+|+||+++.++  .+||+|||+
T Consensus        81 e~~~~~~L~~~l~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~--~~kl~d~g~  156 (265)
T cd08217          81 EYCEGGDLAQLIQKCKK--ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN--NVKLGDFGL  156 (265)
T ss_pred             hhccCCCHHHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCC--CEEEecccc
Confidence            99999999998864311  1122333445669999999999999     89999999999999998654  799999999


Q ss_pred             eeeeCCCCc-eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhcc
Q psy12427        260 ATKLDPNEV-VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKN  338 (356)
Q Consensus       260 a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  338 (356)
                      +........ .....+++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+.......   ....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~  233 (265)
T cd08217         157 AKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRR---IPYR  233 (265)
T ss_pred             cccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCC---Cccc
Confidence            988765443 334568999999999999889999999999999999999999999988777777776654332   2347


Q ss_pred             CCHHHHHHHHHhhhcCCC
Q psy12427        339 VSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       339 ~s~~~~~lI~~ll~~dP~  356 (356)
                      ++.++.+++.+||+.||+
T Consensus       234 ~~~~~~~l~~~~l~~~p~  251 (265)
T cd08217         234 YSSELNEVIKSMLNVDPD  251 (265)
T ss_pred             cCHHHHHHHHHHccCCcc
Confidence            899999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.6e-39  Score=289.23  Aligned_cols=229  Identities=31%  Similarity=0.547  Sum_probs=192.7

Q ss_pred             ccccCceEEEEEEEccCCCEEEEEEcccCCh---hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEeccccch
Q psy12427        116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHN---LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGEL  192 (356)
Q Consensus       116 lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L  192 (356)
                      ||.|+||.||+|.++.++..+|+|++.....   .....+.+|+.+++.++||||+++++.+..+...++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            7999999999999999999999999865432   2346788999999999999999999999999999999999999999


Q ss_pred             hhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCceeec
Q psy12427        193 FERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS  272 (356)
Q Consensus       193 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~~~~~  272 (356)
                      .+++.... .     +....+..++.|++.||+|||++|++|+||+|+||+++.++  .++|+|||++............
T Consensus        81 ~~~l~~~~-~-----l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~--~~~l~df~~~~~~~~~~~~~~~  152 (262)
T cd05572          81 WTILRDRG-L-----FDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNG--YVKLVDFGFAKKLKSGQKTWTF  152 (262)
T ss_pred             HHHHhhcC-C-----CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCC--CEEEeeCCcccccCcccccccc
Confidence            99986532 2     23344555899999999999999999999999999998654  7999999999877544333345


Q ss_pred             CCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC--hHHHHHHhhc--cccccChhhhccCCHHHHHHHH
Q psy12427        273 TGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN--DVETLKNVKA--CDWEFDEEAFKNVSEEGKDFIR  348 (356)
Q Consensus       273 ~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~--~~~~~~~i~~--~~~~~~~~~~~~~s~~~~~lI~  348 (356)
                      .+++.|+|||.+....++.++|+||+|+++|+|++|..||....  ..+.+.++..  ....+|    ..+++++++||+
T Consensus       153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~i~  228 (262)
T cd05572         153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFP----NYIDKAAKDLIK  228 (262)
T ss_pred             cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCC----cccCHHHHHHHH
Confidence            68999999999988889999999999999999999999998877  6666676663  233333    255899999999


Q ss_pred             HhhhcCCC
Q psy12427        349 RLLLRNKE  356 (356)
Q Consensus       349 ~ll~~dP~  356 (356)
                      +||+.||+
T Consensus       229 ~~l~~~p~  236 (262)
T cd05572         229 QLLRRNPE  236 (262)
T ss_pred             HHccCChh
Confidence            99999985

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.5e-39  Score=288.16  Aligned_cols=237  Identities=24%  Similarity=0.379  Sum_probs=199.4

Q ss_pred             eeeccccccCceEEEEEEEccCC----CEEEEEEcccCChh-hHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        111 DILEEIGTGAFGVVHRCRERKTG----NIFAAKFIPVSHNL-EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       111 ~~~~~lg~G~fg~V~~~~~~~~~----~~~a~K~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      ++.+.||.|+||.||++.+...+    ..+|+|.+...... ....+.+|+.++..++||||+++++++...+..+++||
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e   81 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME   81 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence            56789999999999999998766    89999999766543 56778899999999999999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |+++++|.+++......    .+....+..++.|++.||++||+.|++|+||+|+||+++.++  .++|+|||++.....
T Consensus        82 ~~~~~~l~~~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~--~~~l~dfg~~~~~~~  155 (258)
T smart00219       82 YMEGGDLLDYLRKNRPK----ELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL--VVKISDFGLSRDLYD  155 (258)
T ss_pred             ccCCCCHHHHHHhhhhc----cCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCC--eEEEcccCCceeccc
Confidence            99999999998754322    133444556999999999999999999999999999998655  799999999987654


Q ss_pred             CCceee--cCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHH
Q psy12427        266 NEVVKI--STGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEE  342 (356)
Q Consensus       266 ~~~~~~--~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  342 (356)
                      ......  ..+++.|+|||.+....++.++|+||+|+++|+|++ |.+||...+..+..+.+........   ...+|.+
T Consensus       156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  232 (258)
T smart00219      156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPK---PENCPPE  232 (258)
T ss_pred             ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC---CCcCCHH
Confidence            322222  236789999999988889999999999999999998 8999999888888888776553322   2358999


Q ss_pred             HHHHHHHhhhcCCC
Q psy12427        343 GKDFIRRLLLRNKE  356 (356)
Q Consensus       343 ~~~lI~~ll~~dP~  356 (356)
                      +.++|.+||+.||+
T Consensus       233 ~~~~i~~~l~~~p~  246 (258)
T smart00219      233 IYKLMLQCWAEDPE  246 (258)
T ss_pred             HHHHHHHHCcCChh
Confidence            99999999999995

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.1e-39  Score=295.39  Aligned_cols=247  Identities=20%  Similarity=0.316  Sum_probs=193.1

Q ss_pred             cceeeeccccccCceEEEEEEEcc----------------CCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceee
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERK----------------TGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINL  170 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~----------------~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l  170 (356)
                      ++|++.+.||+|+||.||++.+..                ++..+|+|.+.... ......+.+|+.+|+.++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            469999999999999999986543                34579999987543 3345678899999999999999999


Q ss_pred             eeeEEeCCeEEEEEEeccccchhhhhhCCCCCC-----CccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEe
Q psy12427        171 HDAFEDDDEMVLIFEFLSGGELFERITAPDYKM-----SEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQ  245 (356)
Q Consensus       171 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~  245 (356)
                      ++++......+++|||+.+++|.+++.......     ....+....+..++.|++.||+|||+.|++|+||||+|||++
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~  164 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVG  164 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEc
Confidence            999999999999999999999999987543211     111233345677999999999999999999999999999997


Q ss_pred             ecCCCcEEEEeeeceeeeCCCCce---eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc--CCCCCCCCChHHH
Q psy12427        246 TRNSTNVKMIDFGLATKLDPNEVV---KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS--GLSPFAGENDVET  320 (356)
Q Consensus       246 ~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~--g~~Pf~~~~~~~~  320 (356)
                      .++  .++|+|||++..+......   ....+++.|+|||......++.++|+|||||++|||++  |..||...+..+.
T Consensus       165 ~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~  242 (296)
T cd05095         165 KNY--TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV  242 (296)
T ss_pred             CCC--CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH
Confidence            544  7999999999865433221   11234678999999888889999999999999999998  7899988777666


Q ss_pred             HHHhhcc----ccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        321 LKNVKAC----DWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       321 ~~~i~~~----~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +.+....    ......+....++..+.+||.+||+.||+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~  282 (296)
T cd05095         243 IENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAK  282 (296)
T ss_pred             HHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcc
Confidence            5544210    00000111236789999999999999995

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.5e-39  Score=295.77  Aligned_cols=241  Identities=27%  Similarity=0.459  Sum_probs=193.0

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhh--HHHHHHHHHHHHhcCCCCceeeeeeEEeC--CeEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE--KELIRKEIDIMNQLHHPKLINLHDAFEDD--DEMVLI  183 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~--~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~lv  183 (356)
                      +.|++.+.||.|+||.||+|.++.+++.+|+|.++.....+  ...+.+|+.++++++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46999999999999999999999999999999997554322  23566899999999999999999999877  899999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      +||+. ++|.+++......     +....+..++.|++.||+|||++|++|+||+|+||+++.++  .++|+|||++...
T Consensus        85 ~e~~~-~~L~~~~~~~~~~-----l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~--~~~l~d~g~~~~~  156 (293)
T cd07843          85 MEYVE-HDLKSLMETMKQP-----FLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRG--ILKICDFGLAREY  156 (293)
T ss_pred             ehhcC-cCHHHHHHhccCC-----CCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC--cEEEeecCceeec
Confidence            99997 4888888654332     33444556999999999999999999999999999998654  7999999999876


Q ss_pred             CCC-CceeecCCCcCccccccccCCC-CCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC---------
Q psy12427        264 DPN-EVVKISTGTAEFAAPEIVEREP-VGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD---------  332 (356)
Q Consensus       264 ~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~---------  332 (356)
                      ... .......+++.|+|||.+.+.. ++.++|+||+|+++|+|++|.+||...+..+.+.++......+.         
T Consensus       157 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
T cd07843         157 GSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE  236 (293)
T ss_pred             cCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence            543 2223345788999999987654 68899999999999999999999998887766665533211100         


Q ss_pred             -----------------hhhhcc--CCHHHHHHHHHhhhcCCC
Q psy12427        333 -----------------EEAFKN--VSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 -----------------~~~~~~--~s~~~~~lI~~ll~~dP~  356 (356)
                                       ...+..  +++.++++|++||+.||+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  279 (293)
T cd07843         237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPA  279 (293)
T ss_pred             cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCcc
Confidence                             111122  588999999999999996

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.1e-39  Score=292.39  Aligned_cols=239  Identities=26%  Similarity=0.417  Sum_probs=192.1

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh------hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN------LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~------~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      +|+..+.||+|++|.||++.++.++..+|+|++.....      .....+.+|+.+++.++||||+++++++......++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            37788999999999999999999999999999875431      124567889999999999999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      |+||+.+++|.+++.... .++     ...+..++.|++.||+|||++|++|+||+|+||+++.++ ..++|+|||.+..
T Consensus        81 v~e~~~~~~L~~~l~~~~-~~~-----~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~-~~~~l~dfg~~~~  153 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG-AFK-----EAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTG-QRLRIADFGAAAR  153 (268)
T ss_pred             EEeccCCCcHHHHHHHhC-CCC-----HHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEEcccccccc
Confidence            999999999999886432 222     334455899999999999999999999999999997544 3589999999877


Q ss_pred             eCCCCc-----eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHH---HHHhhccccccChh
Q psy12427        263 LDPNEV-----VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVET---LKNVKACDWEFDEE  334 (356)
Q Consensus       263 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~---~~~i~~~~~~~~~~  334 (356)
                      ......     .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||........   ...+....  ..+.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~  231 (268)
T cd06630         154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT--TAPS  231 (268)
T ss_pred             cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccC--CCCC
Confidence            643211     1223578899999999988899999999999999999999999975543222   22222222  1222


Q ss_pred             hhccCCHHHHHHHHHhhhcCCC
Q psy12427        335 AFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       335 ~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ....++.+++++|.+||+.||+
T Consensus       232 ~~~~~~~~~~~~i~~~l~~~p~  253 (268)
T cd06630         232 IPEHLSPGLRDVTLRCLELQPE  253 (268)
T ss_pred             CchhhCHHHHHHHHHHcCCCcc
Confidence            3346899999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG0614|consensus

Probab=100.00  E-value=1.9e-41  Score=308.03  Aligned_cols=239  Identities=26%  Similarity=0.441  Sum_probs=211.6

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      .+++++..||-|+||.|-++..+.....+|+|+++..+   ..+.+.+..|-+||...+.|.||++|..|.+...+|++|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            46788899999999999999998777779999887643   445567788999999999999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      |-|-||.|+..+.++. .+.+..     .+.++..+++|++|||++|||+|||||+|+|++.++  .+||.|||+|..+.
T Consensus       500 EaClGGElWTiLrdRg-~Fdd~t-----arF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~G--y~KLVDFGFAKki~  571 (732)
T KOG0614|consen  500 EACLGGELWTILRDRG-SFDDYT-----ARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRG--YLKLVDFGFAKKIG  571 (732)
T ss_pred             HhhcCchhhhhhhhcC-Ccccch-----hhhhHHHHHHHHHHHHhcCceeccCChhheeeccCC--ceEEeehhhHHHhc
Confidence            9999999999997654 344433     345999999999999999999999999999998655  89999999999999


Q ss_pred             CCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHH
Q psy12427        265 PNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK  344 (356)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  344 (356)
                      .+..+-+.+|||.|.|||++..+..+.++|.||||+++|||++|.+||.+.+++.+++.|.++.-...  .+..++..+.
T Consensus       572 ~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~--~Pr~I~k~a~  649 (732)
T KOG0614|consen  572 SGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIE--FPRRITKTAT  649 (732)
T ss_pred             cCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhh--cccccchhHH
Confidence            88889999999999999999999999999999999999999999999999999999999988643322  2258999999


Q ss_pred             HHHHHhhhcCCC
Q psy12427        345 DFIRRLLLRNKE  356 (356)
Q Consensus       345 ~lI~~ll~~dP~  356 (356)
                      ++|++++..+|.
T Consensus       650 ~Lik~LCr~~P~  661 (732)
T KOG0614|consen  650 DLIKKLCRDNPT  661 (732)
T ss_pred             HHHHHHHhcCcH
Confidence            999999999883

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.5e-39  Score=287.03  Aligned_cols=231  Identities=20%  Similarity=0.314  Sum_probs=189.0

Q ss_pred             ccccccCceEEEEEEEccCC---CEEEEEEcccCCh-hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEeccc
Q psy12427        114 EEIGTGAFGVVHRCRERKTG---NIFAAKFIPVSHN-LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSG  189 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~~---~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  189 (356)
                      ++||+|+||.||+|....++   ..+|+|.+..... .....+.+|+.+++.++||||+++++++. ....+++|||+.+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            47999999999999876654   7999999876554 24467888999999999999999999876 4568999999999


Q ss_pred             cchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCce
Q psy12427        190 GELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVV  269 (356)
Q Consensus       190 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~~  269 (356)
                      ++|.+++.... .+     ....+..++.|++.||+|||+.+++|+||||+|||++.++  .+||+|||+++........
T Consensus        80 ~~L~~~l~~~~-~~-----~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~--~~kl~df~~~~~~~~~~~~  151 (257)
T cd05060          80 GPLLKYLKKRR-EI-----PVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRH--QAKISDFGMSRALGAGSDY  151 (257)
T ss_pred             CcHHHHHHhCC-CC-----CHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCC--cEEeccccccceeecCCcc
Confidence            99999987543 23     3344556999999999999999999999999999997654  7999999999876433321


Q ss_pred             e----ecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHHH
Q psy12427        270 K----ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK  344 (356)
Q Consensus       270 ~----~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  344 (356)
                      .    ...++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+......   +....++..++
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~  228 (257)
T cd05060         152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL---PRPEECPQEIY  228 (257)
T ss_pred             cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC---CCCCCCCHHHH
Confidence            1    1123568999999999999999999999999999998 99999988887777776654322   22347899999


Q ss_pred             HHHHHhhhcCCC
Q psy12427        345 DFIRRLLLRNKE  356 (356)
Q Consensus       345 ~lI~~ll~~dP~  356 (356)
                      ++|.+||+.||+
T Consensus       229 ~li~~cl~~~p~  240 (257)
T cd05060         229 SIMLSCWKYRPE  240 (257)
T ss_pred             HHHHHHhcCChh
Confidence            999999999995

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.7e-39  Score=288.23  Aligned_cols=234  Identities=24%  Similarity=0.352  Sum_probs=193.6

Q ss_pred             ccccccCceEEEEEEEccC-C--CEEEEEEcccCCh-hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEeccc
Q psy12427        114 EEIGTGAFGVVHRCRERKT-G--NIFAAKFIPVSHN-LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSG  189 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~-~--~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  189 (356)
                      +.||+|++|.||+|.+..+ +  ..+|+|.+..... .....+.+|+.++++++||||+++++.+.. ...+++|||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            4689999999999998763 3  3699999987665 556778899999999999999999999988 899999999999


Q ss_pred             cchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCce
Q psy12427        190 GELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVV  269 (356)
Q Consensus       190 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~~  269 (356)
                      ++|.+++.....    .......+..++.|++.||+|||++|++|+||+|+||+++.++  .+||+|||++.........
T Consensus        80 ~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~--~~kl~dfg~~~~~~~~~~~  153 (257)
T cd05040          80 GSLLDRLRKDAL----GHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD--KVKIGDFGLMRALPQNEDH  153 (257)
T ss_pred             CcHHHHHHhccc----ccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCC--EEEeccccccccccccccc
Confidence            999999876431    2334445566899999999999999999999999999998764  7999999999876432211


Q ss_pred             ----eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHHH
Q psy12427        270 ----KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK  344 (356)
Q Consensus       270 ----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  344 (356)
                          ....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+.......+  ....+|.++.
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  231 (257)
T cd05040         154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLE--RPEACPQDIY  231 (257)
T ss_pred             eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCC--CCccCCHHHH
Confidence                12346788999999999999999999999999999998 9999998888887777765332222  2236789999


Q ss_pred             HHHHHhhhcCCC
Q psy12427        345 DFIRRLLLRNKE  356 (356)
Q Consensus       345 ~lI~~ll~~dP~  356 (356)
                      ++|.+||+.+|+
T Consensus       232 ~li~~~l~~~p~  243 (257)
T cd05040         232 NVMLQCWAHNPA  243 (257)
T ss_pred             HHHHHHCCCCcc
Confidence            999999999995

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.1e-39  Score=310.30  Aligned_cols=236  Identities=18%  Similarity=0.241  Sum_probs=184.8

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      ...|.+.+.||+|+||.||+|.+..+++.||+|....      ..+.+|+++|++++||||+++++++...+..+++||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            3479999999999999999999999999999996432      2346799999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +. ++|.+++......+     ....+..++.|++.||.|||++||+||||||+|||++.++  .+||+|||+++.....
T Consensus       242 ~~-~~L~~~l~~~~~~l-----~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~--~vkL~DFGla~~~~~~  313 (461)
T PHA03211        242 YR-SDLYTYLGARLRPL-----GLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE--DICLGDFGAACFARGS  313 (461)
T ss_pred             cC-CCHHHHHHhcCCCC-----CHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCC--CEEEcccCCceecccc
Confidence            95 68888876543333     3344556999999999999999999999999999997554  6999999999876432


Q ss_pred             Cc---eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC--------hHHHHHHhhccccc---cC
Q psy12427        267 EV---VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN--------DVETLKNVKACDWE---FD  332 (356)
Q Consensus       267 ~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~~~~---~~  332 (356)
                      ..   .....||+.|+|||++.+..++.++|||||||+||||++|..|+....        ..++.+.+......   ++
T Consensus       314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~  393 (461)
T PHA03211        314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP  393 (461)
T ss_pred             cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence            21   123468999999999999999999999999999999999876543221        22333333322211   11


Q ss_pred             ------------------------hhhh---ccCCHHHHHHHHHhhhcCCC
Q psy12427        333 ------------------------EEAF---KNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 ------------------------~~~~---~~~s~~~~~lI~~ll~~dP~  356 (356)
                                              ...|   ..++.++.+||.+||+.||+
T Consensus       394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~  444 (461)
T PHA03211        394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGA  444 (461)
T ss_pred             CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChh
Confidence                                    0111   24677999999999999995

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.2e-39  Score=296.53  Aligned_cols=240  Identities=29%  Similarity=0.503  Sum_probs=198.1

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      .++|.+.+.||.|+||.||++.+..++..+|+|.+........+.+.+|+.+++.++||||+++++.+......++|+||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            46799999999999999999999989999999998766555567788999999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +++++|.+++....  +++     ..+..++.|++.||.|||++|++|+||+|+||+++.++  .++|+|||++......
T Consensus        98 ~~~~~L~~~~~~~~--l~~-----~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~--~~kL~dfg~~~~~~~~  168 (293)
T cd06647          98 LAGGSLTDVVTETC--MDE-----GQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG--SVKLTDFGFCAQITPE  168 (293)
T ss_pred             CCCCcHHHHHhhcC--CCH-----HHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCC--CEEEccCcceeccccc
Confidence            99999999886432  222     33455899999999999999999999999999997654  7999999998766433


Q ss_pred             Cc-eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHH
Q psy12427        267 EV-VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD  345 (356)
Q Consensus       267 ~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  345 (356)
                      .. .....|++.|+|||.+....++.++|+||||+++|++++|+.||...+..+.+..+.... .........++.++++
T Consensus       169 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~  247 (293)
T cd06647         169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRD  247 (293)
T ss_pred             ccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCC-CCCCCCccccCHHHHH
Confidence            22 233468899999999998889999999999999999999999998876655444333221 1111123457899999


Q ss_pred             HHHHhhhcCCC
Q psy12427        346 FIRRLLLRNKE  356 (356)
Q Consensus       346 lI~~ll~~dP~  356 (356)
                      +|++||+.||+
T Consensus       248 li~~~l~~~p~  258 (293)
T cd06647         248 FLNRCLEMDVE  258 (293)
T ss_pred             HHHHHccCChh
Confidence            99999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=3.4e-39  Score=292.45  Aligned_cols=238  Identities=26%  Similarity=0.492  Sum_probs=197.9

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEecc
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLS  188 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  188 (356)
                      .|...+.||.|++|.||++.++.++..+++|.+..........+.+|+.+++.++||||+++++++......++++||+.
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            35556799999999999999999999999999876655556678899999999999999999999999999999999999


Q ss_pred             ccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCC-
Q psy12427        189 GGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE-  267 (356)
Q Consensus       189 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~-  267 (356)
                      +++|.+++...  .+     ....+..++.|++.||+|||++|++||||+|+||+++.++  .++|+|||.+....... 
T Consensus       100 ~~~L~~~~~~~--~~-----~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~~l~d~g~~~~~~~~~~  170 (285)
T cd06648         100 GGALTDIVTHT--RM-----NEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDG--RVKLSDFGFCAQVSKEVP  170 (285)
T ss_pred             CCCHHHHHHhC--CC-----CHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCC--cEEEcccccchhhccCCc
Confidence            99999988652  22     2334455999999999999999999999999999997654  79999999886553222 


Q ss_pred             ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHH
Q psy12427        268 VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFI  347 (356)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI  347 (356)
                      ......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+.+.++........ .....++.++.+||
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li  249 (285)
T cd06648         171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKL-KNLHKVSPRLRSFL  249 (285)
T ss_pred             ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCC-cccccCCHHHHHHH
Confidence            12234589999999999988899999999999999999999999998888777777765532221 11234889999999


Q ss_pred             HHhhhcCCC
Q psy12427        348 RRLLLRNKE  356 (356)
Q Consensus       348 ~~ll~~dP~  356 (356)
                      ++||+.||+
T Consensus       250 ~~~l~~~p~  258 (285)
T cd06648         250 DRMLVRDPA  258 (285)
T ss_pred             HHHcccChh
Confidence            999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3.5e-39  Score=289.06  Aligned_cols=238  Identities=24%  Similarity=0.426  Sum_probs=190.4

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC-----hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeC--CeE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-----NLEKELIRKEIDIMNQLHHPKLINLHDAFEDD--DEM  180 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~  180 (356)
                      ..|++.+.||+|+||.||++.++.++..||+|.+....     ......+.+|+.++++++||||+++++++...  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            36889999999999999999999999999999886432     22345778899999999999999999998763  568


Q ss_pred             EEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeece
Q psy12427        181 VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA  260 (356)
Q Consensus       181 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a  260 (356)
                      +++|||+++++|.+++.... .+++     .....++.|++.||+|||+++++|+||+|+||+++.++  .++|+|||++
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~-~~~~-----~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~--~~~l~Dfg~~  153 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG-ALTE-----NVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVG--NVKLGDFGAS  153 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC-CCCH-----HHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCC--CEEECcCccc
Confidence            89999999999999886432 2222     33445899999999999999999999999999997544  7999999998


Q ss_pred             eeeCCCC----ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhh
Q psy12427        261 TKLDPNE----VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAF  336 (356)
Q Consensus       261 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  336 (356)
                      +......    ......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||...........+.....  .+...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~  231 (265)
T cd06652         154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT--NPVLP  231 (265)
T ss_pred             cccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCC--CCCCc
Confidence            7653211    12223588899999999988899999999999999999999999988766655554443221  12233


Q ss_pred             ccCCHHHHHHHHHhhhcCCC
Q psy12427        337 KNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       337 ~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ..++..+.++|++||. +|+
T Consensus       232 ~~~~~~~~~~i~~~l~-~p~  250 (265)
T cd06652         232 PHVSDHCRDFLKRIFV-EAK  250 (265)
T ss_pred             hhhCHHHHHHHHHHhc-Chh
Confidence            4678999999999995 663

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.1e-39  Score=294.25  Aligned_cols=237  Identities=23%  Similarity=0.419  Sum_probs=196.7

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      +.|+..+.||.|+||.||+|.+..++..+|+|.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            45888899999999999999999999999999987543 33456788999999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +++++|.+++...  .     .....+..++.|++.||.|||++|++|+||+|+||+++.++  .++|+|||++......
T Consensus        84 ~~~~~L~~~~~~~--~-----~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~--~~~l~dfg~~~~~~~~  154 (277)
T cd06642          84 LGGGSALDLLKPG--P-----LEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQG--DVKLADFGVAGQLTDT  154 (277)
T ss_pred             cCCCcHHHHhhcC--C-----CCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCC--CEEEccccccccccCc
Confidence            9999999887542  2     23334556899999999999999999999999999997654  6999999998766433


Q ss_pred             Cc-eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHH
Q psy12427        267 EV-VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD  345 (356)
Q Consensus       267 ~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  345 (356)
                      .. .....|+..|+|||++.+..++.++|+|||||++|+|++|..||......+....+.....   +.....++.++.+
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  231 (277)
T cd06642         155 QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP---PTLEGQYSKPFKE  231 (277)
T ss_pred             chhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCC---CCCCcccCHHHHH
Confidence            22 2234578899999999999999999999999999999999999987776666555443321   1222367899999


Q ss_pred             HHHHhhhcCCC
Q psy12427        346 FIRRLLLRNKE  356 (356)
Q Consensus       346 lI~~ll~~dP~  356 (356)
                      +|.+||+.+|+
T Consensus       232 li~~~l~~~p~  242 (277)
T cd06642         232 FVEACLNKDPR  242 (277)
T ss_pred             HHHHHccCCcc
Confidence            99999999985

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-39  Score=285.31  Aligned_cols=232  Identities=21%  Similarity=0.338  Sum_probs=190.5

Q ss_pred             ccccccCceEEEEEEEccCCCEEEEEEcccCChh-hHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEeccccch
Q psy12427        114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL-EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGEL  192 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L  192 (356)
                      ++||.|+||.||+|.+.. ++.+|+|.+...... ....+.+|++++++++||||+++++++......++||||+.+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            479999999999999988 999999998765443 456788999999999999999999999999999999999999999


Q ss_pred             hhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCcee--
Q psy12427        193 FERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVK--  270 (356)
Q Consensus       193 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~~~--  270 (356)
                      .+++......++     ...+..++.+++.||+|||+++++||||+|+|||++.++  .++|+|||++..........  
T Consensus        80 ~~~l~~~~~~~~-----~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~--~~~l~d~g~~~~~~~~~~~~~~  152 (251)
T cd05041          80 LTFLRKKKNRLT-----VKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN--VLKISDFGMSREEEGGIYTVSD  152 (251)
T ss_pred             HHHHHhcCCCCC-----HHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCC--cEEEeeccccccccCCcceecc
Confidence            999865432233     333445889999999999999999999999999997654  79999999987654222111  


Q ss_pred             -ecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHH
Q psy12427        271 -ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIR  348 (356)
Q Consensus       271 -~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  348 (356)
                       ...++..|+|||.+.+..++.++|+|||||++|+|++ |..||...........+.... .++  ....++.++.++|.
T Consensus       153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~li~  229 (251)
T cd05041         153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY-RMP--APQLCPEEIYRLML  229 (251)
T ss_pred             ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC-CCC--CCccCCHHHHHHHH
Confidence             1223567999999998899999999999999999999 899999888777666665432 211  22478999999999


Q ss_pred             HhhhcCCC
Q psy12427        349 RLLLRNKE  356 (356)
Q Consensus       349 ~ll~~dP~  356 (356)
                      +||+.+|+
T Consensus       230 ~~l~~~p~  237 (251)
T cd05041         230 QCWAYDPE  237 (251)
T ss_pred             HHhccChh
Confidence            99999985

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=4.1e-39  Score=289.04  Aligned_cols=238  Identities=24%  Similarity=0.391  Sum_probs=189.2

Q ss_pred             eccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEeccccch
Q psy12427        113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGEL  192 (356)
Q Consensus       113 ~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L  192 (356)
                      ...||+|+||.||+|.+..++..+|+|.+..........+.+|+.+++.++||||+++++++..+...++++||+++++|
T Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L   92 (268)
T cd06624          13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSL   92 (268)
T ss_pred             eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCH
Confidence            35799999999999999999999999998877666677888999999999999999999999999999999999999999


Q ss_pred             hhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCc-eee
Q psy12427        193 FERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEV-VKI  271 (356)
Q Consensus       193 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~-~~~  271 (356)
                      .+++........   .....+..++.||+.||+|||++||+||||||+||+++.+. ..++|+|||++........ ...
T Consensus        93 ~~~l~~~~~~~~---~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~-~~~~l~dfg~~~~~~~~~~~~~~  168 (268)
T cd06624          93 SALLRSKWGPLK---DNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYS-GVVKISDFGTSKRLAGINPCTET  168 (268)
T ss_pred             HHHHHHhcccCC---CcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CeEEEecchhheecccCCCcccc
Confidence            999875322221   12233455889999999999999999999999999997533 3799999999876543222 223


Q ss_pred             cCCCcCccccccccCCC--CCccccHHHHHHHHHHHHcCCCCCCCCChHHH-HHHhhccccccChhhhccCCHHHHHHHH
Q psy12427        272 STGTAEFAAPEIVEREP--VGFYTDMWAVGVLAYVLLSGLSPFAGENDVET-LKNVKACDWEFDEEAFKNVSEEGKDFIR  348 (356)
Q Consensus       272 ~~gt~~y~aPE~~~~~~--~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~~~~~lI~  348 (356)
                      ..|++.|+|||++....  ++.++|+||+|+++|+|++|+.||........ ...+..  ....+.....+++++++||+
T Consensus       169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~  246 (268)
T cd06624         169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGM--FKIHPEIPESLSAEAKNFIL  246 (268)
T ss_pred             CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhh--hccCCCCCcccCHHHHHHHH
Confidence            45789999999986643  78899999999999999999999976543222 211111  11122233478999999999


Q ss_pred             HhhhcCCC
Q psy12427        349 RLLLRNKE  356 (356)
Q Consensus       349 ~ll~~dP~  356 (356)
                      +||+.+|+
T Consensus       247 ~~l~~~p~  254 (268)
T cd06624         247 RCFEPDPD  254 (268)
T ss_pred             HHcCCCch
Confidence            99999985

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-39  Score=288.06  Aligned_cols=232  Identities=28%  Similarity=0.444  Sum_probs=192.2

Q ss_pred             ccccccCceEEEEEEEccCCCEEEEEEcccCChh---hHHHHHHHHHHH-HhcCCCCceeeeeeEEeCCeEEEEEEeccc
Q psy12427        114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL---EKELIRKEIDIM-NQLHHPKLINLHDAFEDDDEMVLIFEFLSG  189 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~---~~~~~~~E~~il-~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  189 (356)
                      +.||.|+||.||+|.++.+++.+|+|++......   ....+..|..++ ...+||||+++++++.....+++++||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5699999999999999999999999998654322   122334455444 445899999999999999999999999999


Q ss_pred             cchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCce
Q psy12427        190 GELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVV  269 (356)
Q Consensus       190 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~~  269 (356)
                      ++|.+++....      ......+..++.|++.||.|||+.+++|+||+|+||+++.++  .++|+|||++.....   .
T Consensus        82 ~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~---~  150 (260)
T cd05611          82 GDCASLIKTLG------GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTG--HLKLTDFGLSRNGLE---N  150 (260)
T ss_pred             CCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC--cEEEeecccceeccc---c
Confidence            99999886432      233344556999999999999999999999999999997654  799999999876432   2


Q ss_pred             eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHHH
Q psy12427        270 KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRR  349 (356)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~  349 (356)
                      ....+++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+......++......++.++.++|++
T Consensus       151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  230 (260)
T cd05611         151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINR  230 (260)
T ss_pred             ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHH
Confidence            23458899999999998888999999999999999999999999998888888877766666655555789999999999


Q ss_pred             hhhcCCC
Q psy12427        350 LLLRNKE  356 (356)
Q Consensus       350 ll~~dP~  356 (356)
                      ||+.||+
T Consensus       231 ~l~~~p~  237 (260)
T cd05611         231 LLCMDPA  237 (260)
T ss_pred             HccCCHH
Confidence            9999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4.4e-39  Score=292.79  Aligned_cols=246  Identities=23%  Similarity=0.374  Sum_probs=192.1

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh--hHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCe-----
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL--EKELIRKEIDIMNQLH-HPKLINLHDAFEDDDE-----  179 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~-----  179 (356)
                      ++|++.+.||.|+||.||+|.+..+++.||+|.+......  ....+.+|+.+++.++ ||||+++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            3689999999999999999999999999999988654322  2356778999999995 6999999999987665     


Q ss_pred             EEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeec
Q psy12427        180 MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGL  259 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~  259 (356)
                      .+++|||+.+ +|.+++...... ....+....+..++.||+.||.|||++|++||||+|+||+++.+ ++.+||+|||+
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~-~~~~kl~dfg~  157 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRG-PGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQ-KGLLKIADLGL  157 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecC-CCeEEEeeccc
Confidence            8999999985 788887643211 12234555667799999999999999999999999999999862 24799999999


Q ss_pred             eeeeCCC-CceeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc-------
Q psy12427        260 ATKLDPN-EVVKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWE-------  330 (356)
Q Consensus       260 a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~-------  330 (356)
                      +..+... .......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||.+.++.+.+..+......       
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (295)
T cd07837         158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP  237 (295)
T ss_pred             ceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCc
Confidence            8865322 11222356889999998865 45789999999999999999999999988777665554331110       


Q ss_pred             -----------------cChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        331 -----------------FDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       331 -----------------~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                       .+......++.++.+||.+||++||+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~  280 (295)
T cd07837         238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPA  280 (295)
T ss_pred             chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChh
Confidence                             01112245899999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=5.6e-39  Score=286.05  Aligned_cols=237  Identities=23%  Similarity=0.362  Sum_probs=194.9

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEec
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFL  187 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~  187 (356)
                      .+|++.+.||.|+||.||++.+.. +..+|+|.+..... ....+.+|++++++++||||+++++++......+++|||+
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM   81 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence            368899999999999999998864 67899998865432 3456788999999999999999999999999999999999


Q ss_pred             cccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCC
Q psy12427        188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE  267 (356)
Q Consensus       188 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~  267 (356)
                      .+++|.+++......+.     ...+..++.+++.||++||+.+++|+||+|+||+++.++  .++|+|||+++......
T Consensus        82 ~~~~L~~~~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~--~~~l~d~g~~~~~~~~~  154 (256)
T cd05112          82 EHGCLSDYLRAQRGKFS-----QETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ--VVKVSDFGMTRFVLDDQ  154 (256)
T ss_pred             CCCcHHHHHHhCccCCC-----HHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCC--eEEECCCcceeecccCc
Confidence            99999998865433333     333455889999999999999999999999999997544  79999999987654322


Q ss_pred             ce--eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHHH
Q psy12427        268 VV--KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK  344 (356)
Q Consensus       268 ~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  344 (356)
                      ..  ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+....+......+.+   ...++++.
T Consensus       155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  231 (256)
T cd05112         155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKP---RLASQSVY  231 (256)
T ss_pred             ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCC---CCCCHHHH
Confidence            11  11234678999999998899999999999999999998 99999988888888877664332222   34689999


Q ss_pred             HHHHHhhhcCCC
Q psy12427        345 DFIRRLLLRNKE  356 (356)
Q Consensus       345 ~lI~~ll~~dP~  356 (356)
                      +|+.+||+.+|+
T Consensus       232 ~l~~~~l~~~p~  243 (256)
T cd05112         232 ELMQHCWKERPE  243 (256)
T ss_pred             HHHHHHcccChh
Confidence            999999999985

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-39  Score=290.99  Aligned_cols=236  Identities=24%  Similarity=0.442  Sum_probs=193.5

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcC---CCCceeeeeeEEeCCeEEEEE
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLH---HPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      .|++.+.||.|+||.||+|.+..++..+|+|.+.... ......+.+|+.+++.++   |||++++++++......+++|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            4788899999999999999999999999999987543 334567888999999996   999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      ||+++++|.+++...  .+     ....+..++.|++.||.|||+.|++|+||+|+||+++.++  .++|+|||++....
T Consensus        82 e~~~~~~L~~~~~~~--~l-----~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~--~~~l~dfg~~~~~~  152 (277)
T cd06917          82 EYAEGGSVRTLMKAG--PI-----AEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTG--NVKLCDFGVAALLN  152 (277)
T ss_pred             ecCCCCcHHHHHHcc--CC-----CHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCC--CEEEccCCceeecC
Confidence            999999999888643  22     3344455999999999999999999999999999998644  79999999998765


Q ss_pred             CCCc-eeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhc-cCCH
Q psy12427        265 PNEV-VKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK-NVSE  341 (356)
Q Consensus       265 ~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~-~~s~  341 (356)
                      .... .....|+..|+|||.+.. ..++.++|+|||||++|+|++|..||.+.........+....   ++.... .++.
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  229 (277)
T cd06917         153 QNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK---PPRLEDNGYSK  229 (277)
T ss_pred             CCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCC---CCCCCcccCCH
Confidence            4332 233468899999998865 456889999999999999999999998887665554443321   122222 3889


Q ss_pred             HHHHHHHHhhhcCCC
Q psy12427        342 EGKDFIRRLLLRNKE  356 (356)
Q Consensus       342 ~~~~lI~~ll~~dP~  356 (356)
                      ++.+||.+||+.||+
T Consensus       230 ~~~~~i~~~l~~~p~  244 (277)
T cd06917         230 LLREFVAACLDEEPK  244 (277)
T ss_pred             HHHHHHHHHcCCCcc
Confidence            999999999999995

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.6e-39  Score=288.07  Aligned_cols=230  Identities=17%  Similarity=0.192  Sum_probs=180.8

Q ss_pred             ccccccCceEEEEEEEccC------------CCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEE
Q psy12427        114 EEIGTGAFGVVHRCRERKT------------GNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMV  181 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~------------~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  181 (356)
                      +.||+|+||.||+|.....            ...+++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            4699999999999986432            2368889877665555567888999999999999999999999999999


Q ss_pred             EEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCC-----CcEEEEe
Q psy12427        182 LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNS-----TNVKMID  256 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~-----~~vkl~D  256 (356)
                      ++|||+++++|..++......+++     ..+..++.||+.||+|||++||+||||||+|||++.++.     ..++++|
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~-----~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTT-----PWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCH-----HHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            999999999998887644333333     334559999999999999999999999999999975442     1389999


Q ss_pred             eeceeeeCCCCceeecCCCcCcccccccc-CCCCCccccHHHHHHHHHHHH-cCCCCCCCCChHHHHHHhhccccccChh
Q psy12427        257 FGLATKLDPNEVVKISTGTAEFAAPEIVE-REPVGFYTDMWAVGVLAYVLL-SGLSPFAGENDVETLKNVKACDWEFDEE  334 (356)
Q Consensus       257 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~il~ell-~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  334 (356)
                      ||++......   ....++..|+|||.+. +..++.++|||||||++|+|+ +|..||......+... .........  
T Consensus       156 ~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~~~~--  229 (262)
T cd05077         156 PGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQCMLV--  229 (262)
T ss_pred             CCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCccCC--
Confidence            9998665322   2345788999999887 567899999999999999998 5999998776554432 222222221  


Q ss_pred             hhccCCHHHHHHHHHhhhcCCC
Q psy12427        335 AFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       335 ~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                        ...++++.+||.+||+.||+
T Consensus       230 --~~~~~~~~~li~~cl~~dp~  249 (262)
T cd05077         230 --TPSCKELADLMTHCMNYDPN  249 (262)
T ss_pred             --CCChHHHHHHHHHHcCCChh
Confidence              23467899999999999995

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.9e-39  Score=292.14  Aligned_cols=240  Identities=25%  Similarity=0.456  Sum_probs=191.7

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhc-CCCCceeeeeeEE------eCCeE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL-HHPKLINLHDAFE------DDDEM  180 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~------~~~~~  180 (356)
                      +.|++.+.||.|+||.||+|.++.++..+|+|++..... ....+..|+.++.++ +||||+++++++.      .....
T Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   94 (282)
T cd06636          16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL   94 (282)
T ss_pred             hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence            579999999999999999999999999999999865433 345678899999998 6999999999985      34678


Q ss_pred             EEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeece
Q psy12427        181 VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA  260 (356)
Q Consensus       181 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a  260 (356)
                      +++|||+.+|+|.+++.....    .......+..++.|++.||+|||+.|++|+||+|+||+++.++  .++|+|||++
T Consensus        95 ~iv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~--~~~l~dfg~~  168 (282)
T cd06636          95 WLVMEFCGAGSVTDLVKNTKG----NALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENA--EVKLVDFGVS  168 (282)
T ss_pred             EEEEEeCCCCcHHHHHHHccC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEeeCcch
Confidence            999999999999998865321    1122334556889999999999999999999999999998654  6999999998


Q ss_pred             eeeCCC-CceeecCCCcCcccccccc-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChh
Q psy12427        261 TKLDPN-EVVKISTGTAEFAAPEIVE-----REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEE  334 (356)
Q Consensus       261 ~~~~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  334 (356)
                      ...... .......|++.|+|||.+.     ...++.++|+|||||++|+|++|..||....+.+....+....  .+..
T Consensus       169 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~  246 (282)
T cd06636         169 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--PPKL  246 (282)
T ss_pred             hhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCC--CCCC
Confidence            765422 1223346899999999986     3467889999999999999999999998776655554443322  1122


Q ss_pred             hhccCCHHHHHHHHHhhhcCCC
Q psy12427        335 AFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       335 ~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ....+|.++.+||++||+.||+
T Consensus       247 ~~~~~~~~~~~li~~cl~~~p~  268 (282)
T cd06636         247 KSKKWSKKFIDFIEGCLVKNYL  268 (282)
T ss_pred             cccccCHHHHHHHHHHhCCChh
Confidence            2246899999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=7.4e-39  Score=293.30  Aligned_cols=237  Identities=24%  Similarity=0.362  Sum_probs=192.4

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      ...|++.+.||+|+||+||+|.+..++..||+|.+....   ......+.+|+.+++.++||||+++++++......++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            356999999999999999999999999999999886432   23345678999999999999999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      +||+. |+|.+.+......+     ....+..++.|++.||.|||+.|++|+||+|+||+++.++  .++|+|||++...
T Consensus        94 ~e~~~-g~l~~~~~~~~~~l-----~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~--~~kL~dfg~~~~~  165 (307)
T cd06607          94 MEYCL-GSASDILEVHKKPL-----QEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPG--TVKLADFGSASLV  165 (307)
T ss_pred             HHhhC-CCHHHHHHHcccCC-----CHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCC--CEEEeecCcceec
Confidence            99996 56766665333223     3344556999999999999999999999999999997654  7999999998765


Q ss_pred             CCCCceeecCCCcCcccccccc---CCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCC
Q psy12427        264 DPNEVVKISTGTAEFAAPEIVE---REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVS  340 (356)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  340 (356)
                      ...   ....+++.|+|||++.   ...++.++||||||+++|+|++|..||.+.+.......+.....  +......++
T Consensus       166 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~  240 (307)
T cd06607         166 SPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PTLSSNDWS  240 (307)
T ss_pred             CCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC--CCCCchhhC
Confidence            433   2346788999999884   45688899999999999999999999998887776665544321  111123578


Q ss_pred             HHHHHHHHHhhhcCCC
Q psy12427        341 EEGKDFIRRLLLRNKE  356 (356)
Q Consensus       341 ~~~~~lI~~ll~~dP~  356 (356)
                      .+++++|.+||+.||+
T Consensus       241 ~~~~~li~~~l~~~p~  256 (307)
T cd06607         241 DYFRNFVDSCLQKIPQ  256 (307)
T ss_pred             HHHHHHHHHHhcCChh
Confidence            9999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG4278|consensus

Probab=100.00  E-value=6.6e-40  Score=304.10  Aligned_cols=238  Identities=23%  Similarity=0.358  Sum_probs=205.4

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEecc
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLS  188 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  188 (356)
                      +.....+||.|-||.||.|.|++-...||+|.++.+.. +.+.|..|+.+|+.++|||+|+|+|+|..+..+|||+|||.
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~  346 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC  346 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence            45667899999999999999999999999999976544 56788999999999999999999999999999999999999


Q ss_pred             ccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCc
Q psy12427        189 GGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEV  268 (356)
Q Consensus       189 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~  268 (356)
                      .|+|.++|.+.+.    ..+....+..++.||.+||+||..+++|||||..+|.||..+.  .||++|||+++.+..+..
T Consensus       347 yGNLLdYLRecnr----~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnh--iVKvADFGLsRlMtgDTY  420 (1157)
T KOG4278|consen  347 YGNLLDYLRECNR----SEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH--IVKVADFGLSRLMTGDTY  420 (1157)
T ss_pred             CccHHHHHHHhch----hhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccc--eEEeeccchhhhhcCCce
Confidence            9999999987653    3444556677999999999999999999999999999997544  689999999999865443


Q ss_pred             eeec--CCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHH
Q psy12427        269 VKIS--TGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD  345 (356)
Q Consensus       269 ~~~~--~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  345 (356)
                      +...  ..+.-|.|||-+.+..++.++|||+|||+|||+.| |-.||.+.+-...+..+.++- .  -+.+..|++.+-.
T Consensus       421 TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy-R--M~~PeGCPpkVYe  497 (1157)
T KOG4278|consen  421 TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY-R--MDGPEGCPPKVYE  497 (1157)
T ss_pred             ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc-c--ccCCCCCCHHHHH
Confidence            3221  23788999999999999999999999999999999 999999999888877776542 2  2233589999999


Q ss_pred             HHHHhhhcCCC
Q psy12427        346 FIRRLLLRNKE  356 (356)
Q Consensus       346 lI~~ll~~dP~  356 (356)
                      |++.||+..|.
T Consensus       498 LMraCW~WsPs  508 (1157)
T KOG4278|consen  498 LMRACWNWSPS  508 (1157)
T ss_pred             HHHHHhcCCcc
Confidence            99999999884

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.7e-39  Score=294.15  Aligned_cols=238  Identities=22%  Similarity=0.410  Sum_probs=192.9

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      ++|++.+.||+|+||+||++.+..++..+|+|++.... ......+.+|+++++.++||||+++++++......++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            57999999999999999999999999999999886543 33456788999999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE-KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      +++++|.+++.... .     +....+..++.+++.||.|||+ .+++|+||+|+||+++.++  .++|+|||++.....
T Consensus        85 ~~~~~L~~~~~~~~-~-----~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~--~~~l~d~gl~~~~~~  156 (284)
T cd06620          85 MDCGSLDRIYKKGG-P-----IPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG--QIKLCDFGVSGELIN  156 (284)
T ss_pred             CCCCCHHHHHHhcc-C-----CCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC--cEEEccCCcccchhh
Confidence            99999998876432 2     2333445689999999999997 6999999999999997544  799999999875532


Q ss_pred             CCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChH-----------HHHHHhhccccccChh
Q psy12427        266 NEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDV-----------ETLKNVKACDWEFDEE  334 (356)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~-----------~~~~~i~~~~~~~~~~  334 (356)
                      . ......|+..|+|||++.+..++.++|+|||||++|+|++|..||......           +.++.+......  ..
T Consensus       157 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~  233 (284)
T cd06620         157 S-IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP--RL  233 (284)
T ss_pred             h-ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCC--CC
Confidence            2 223346899999999998888999999999999999999999999876542           233333322211  11


Q ss_pred             hhccCCHHHHHHHHHhhhcCCC
Q psy12427        335 AFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       335 ~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ....++.++.+||++||++||+
T Consensus       234 ~~~~~~~~~~~li~~~l~~dp~  255 (284)
T cd06620         234 PSSDFPEDLRDFVDACLLKDPT  255 (284)
T ss_pred             CchhcCHHHHHHHHHHhcCCcc
Confidence            1124789999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0608|consensus

Probab=100.00  E-value=1.7e-40  Score=308.55  Aligned_cols=236  Identities=26%  Similarity=0.470  Sum_probs=197.5

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhH---HHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK---ELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      .|..++.||-|+||+|++++..+|...||+|.+...+-..+   ..++.|-+||..-+.+.||+|+-.|++..++|+||+
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            47889999999999999999999999999999977654444   345679999999999999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC-
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-  264 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~-  264 (356)
                      |++||++..+|.... .+.+     ...+.++.++..|+++.|.+|+|||||||+|||||.++  ++||+|||+|..+. 
T Consensus       710 YIPGGDmMSLLIrmg-IFeE-----~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdG--HIKLTDFGLCTGfRW  781 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIRMG-IFEE-----DLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG--HIKLTDFGLCTGFRW  781 (1034)
T ss_pred             ccCCccHHHHHHHhc-cCHH-----HHHHHHHHHHHHHHHHHHhccceecccCccceEEccCC--ceeeeecccccccee
Confidence            999999999887543 2222     23455999999999999999999999999999999876  89999999997541 


Q ss_pred             --------CCC----------------------------------ceeecCCCcCccccccccCCCCCccccHHHHHHHH
Q psy12427        265 --------PNE----------------------------------VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLA  302 (356)
Q Consensus       265 --------~~~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il  302 (356)
                              .++                                  .....+||+.|+|||++....++...|.||.||||
T Consensus       782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil  861 (1034)
T KOG0608|consen  782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL  861 (1034)
T ss_pred             ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence                    000                                  01123489999999999999999999999999999


Q ss_pred             HHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHHHhhh
Q psy12427        303 YVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLL  352 (356)
Q Consensus       303 ~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~  352 (356)
                      |||+.|++||-..++.++-.+|..=.-...-.+..++|.|+.++|.+|+.
T Consensus       862 ~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~  911 (1034)
T KOG0608|consen  862 YEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC  911 (1034)
T ss_pred             HHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc
Confidence            99999999999999888877776533333344446899999999998864

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1e-38  Score=285.25  Aligned_cols=238  Identities=23%  Similarity=0.378  Sum_probs=193.6

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      .++|++.+.||+|+||.||++.+.. +..+|+|.+.... .....+.+|+.+++.++|+||+++++.+.. ...+++|||
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecC-CccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            3579999999999999999998654 5679999887543 245678889999999999999999999887 788999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +++++|.+++.....    .......+..++.|++.||.|||+.|++|+||+|+||+++.++  .+||+|||.+......
T Consensus        82 ~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~  155 (260)
T cd05073          82 MAKGSLLDFLKSDEG----SKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL--VCKIADFGLARVIEDN  155 (260)
T ss_pred             CCCCcHHHHHHhCCc----cccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC--cEEECCCcceeeccCC
Confidence            999999999865321    1222334555899999999999999999999999999997544  7999999999876432


Q ss_pred             Cce--eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHH
Q psy12427        267 EVV--KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG  343 (356)
Q Consensus       267 ~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  343 (356)
                      ...  ....++..|+|||++....++.++|+|||||++|++++ |..||.+.+..+....+.....   .+....++.++
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  232 (260)
T cd05073         156 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR---MPRPENCPEEL  232 (260)
T ss_pred             CcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC---CCCcccCCHHH
Confidence            221  12235678999999998889999999999999999998 9999999888777776655422   12235789999


Q ss_pred             HHHHHHhhhcCCC
Q psy12427        344 KDFIRRLLLRNKE  356 (356)
Q Consensus       344 ~~lI~~ll~~dP~  356 (356)
                      .++|.+||++||+
T Consensus       233 ~~~i~~~l~~~p~  245 (260)
T cd05073         233 YNIMMRCWKNRPE  245 (260)
T ss_pred             HHHHHHHcccCcc
Confidence            9999999999995

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=4.3e-39  Score=294.73  Aligned_cols=244  Identities=23%  Similarity=0.356  Sum_probs=189.6

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh--hHHHHHHHHHHHHhcCCCCceeeeeeEEeCC----
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL--EKELIRKEIDIMNQLHHPKLINLHDAFEDDD----  178 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----  178 (356)
                      ...++|++.++||+|+||.||+|.++.++..+|+|.+......  ....+.+|+.++++++||||+++++++....    
T Consensus         9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (310)
T cd07865           9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN   88 (310)
T ss_pred             chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence            3456799999999999999999999999999999988654322  2334567999999999999999999987543    


Q ss_pred             ----eEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEE
Q psy12427        179 ----EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKM  254 (356)
Q Consensus       179 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl  254 (356)
                          ..++||||+. ++|.+.+......+     ....+..++.|++.||+|||+.|++|+||+|+||+++.++  .+||
T Consensus        89 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~-----~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~--~~kl  160 (310)
T cd07865          89 RYKGSFYLVFEFCE-HDLAGLLSNKNVKF-----TLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDG--ILKL  160 (310)
T ss_pred             CCCceEEEEEcCCC-cCHHHHHHhcccCC-----CHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCC--cEEE
Confidence                4599999996 47877776443233     3344556999999999999999999999999999997554  7999


Q ss_pred             EeeeceeeeCCCCc-----eeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc
Q psy12427        255 IDFGLATKLDPNEV-----VKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACD  328 (356)
Q Consensus       255 ~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~  328 (356)
                      +|||++........     .....++..|+|||.+.+. .++.++|+||||+++|+|++|.+||.+.+....+..+....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~  240 (310)
T cd07865         161 ADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLC  240 (310)
T ss_pred             CcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            99999976643221     1233568899999988664 47889999999999999999999999888766655554433


Q ss_pred             cccChhhhc----------------------------cCCHHHHHHHHHhhhcCCC
Q psy12427        329 WEFDEEAFK----------------------------NVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       329 ~~~~~~~~~----------------------------~~s~~~~~lI~~ll~~dP~  356 (356)
                      ..++++.++                            ..+..+++||.+||+.||+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~  296 (310)
T cd07865         241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPA  296 (310)
T ss_pred             CCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChh
Confidence            222222111                            1357788999999999995

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=5.3e-39  Score=290.43  Aligned_cols=241  Identities=26%  Similarity=0.416  Sum_probs=186.9

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh-hhHHHHHHHHHH-HHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN-LEKELIRKEIDI-MNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~i-l~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      ++|++.+.||+|+||.||+|.++.+|..||+|.++.... .....+..|+.+ ++.++||||+++++++..++..+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            368999999999999999999999999999999876532 223344456665 666789999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEK-NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      |++ |+|.+++.....  ....+....+..++.|++.||+|||++ +++||||||+||+++.++  .+||+|||++....
T Consensus        81 ~~~-~~l~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~--~~kl~dfg~~~~~~  155 (283)
T cd06617          81 VMD-TSLDKFYKKVYD--KGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG--QVKLCDFGISGYLV  155 (283)
T ss_pred             hhc-ccHHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC--CEEEeecccccccc
Confidence            996 678777653211  112344445566999999999999997 999999999999997654  79999999998764


Q ss_pred             CCCceeecCCCcCccccccccC----CCCCccccHHHHHHHHHHHHcCCCCCCCC-ChHHHHHHhhcc-ccccChhhhcc
Q psy12427        265 PNEVVKISTGTAEFAAPEIVER----EPVGFYTDMWAVGVLAYVLLSGLSPFAGE-NDVETLKNVKAC-DWEFDEEAFKN  338 (356)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlG~il~ell~g~~Pf~~~-~~~~~~~~i~~~-~~~~~~~~~~~  338 (356)
                      .........++..|+|||.+.+    ..++.++|+|||||++|+|++|..||... ...+.+..+... ...++.   ..
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~  232 (283)
T cd06617         156 DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPA---EK  232 (283)
T ss_pred             cccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCc---cc
Confidence            3333333568899999998865    45688999999999999999999999753 333444444332 222221   35


Q ss_pred             CCHHHHHHHHHhhhcCCC
Q psy12427        339 VSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       339 ~s~~~~~lI~~ll~~dP~  356 (356)
                      +|.++++||.+||+.||+
T Consensus       233 ~~~~l~~li~~~l~~~p~  250 (283)
T cd06617         233 FSPEFQDFVNKCLKKNYK  250 (283)
T ss_pred             cCHHHHHHHHHHccCChh
Confidence            899999999999999985

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.1e-39  Score=291.40  Aligned_cols=241  Identities=24%  Similarity=0.436  Sum_probs=191.8

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh--hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN--LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      .|++.+.||.|++|.||+|.++.++..+|+|.+.....  .....+.+|++++++++||||+++++++......+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            37889999999999999999999999999999875432  2335678899999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +. ++|.+++....    ...+....+..++.|++.||+|||+.+++|+||+|+||+++.++  .+||+|||++......
T Consensus        81 ~~-~~l~~~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~--~~~l~dfg~~~~~~~~  153 (284)
T cd07860          81 LH-QDLKKFMDASP----LSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG--AIKLADFGLARAFGVP  153 (284)
T ss_pred             cc-cCHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC--CEEEeeccchhhcccC
Confidence            96 57888775432    12233344566999999999999999999999999999998655  7999999998765432


Q ss_pred             C-ceeecCCCcCccccccccCCC-CCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC------------
Q psy12427        267 E-VVKISTGTAEFAAPEIVEREP-VGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD------------  332 (356)
Q Consensus       267 ~-~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~------------  332 (356)
                      . ......+++.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+.++.+.+.++.......+            
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07860         154 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD  233 (284)
T ss_pred             ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence            2 222335688999999887644 58889999999999999999999998877665555433211111            


Q ss_pred             -------------hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 -------------EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 -------------~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                   ......++.+++++|.+||+.||+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~  270 (284)
T cd07860         234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPN  270 (284)
T ss_pred             HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcc
Confidence                         111235789999999999999995

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-39  Score=289.28  Aligned_cols=244  Identities=25%  Similarity=0.465  Sum_probs=194.8

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCC------e
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDD------E  179 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~------~  179 (356)
                      .++|++.+.||.|+||.||+|.++.++..+++|++..... ....+.+|+.+++++ +||||+++++++....      .
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ   83 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence            3689999999999999999999999999999999876554 346788999999999 7999999999997654      4


Q ss_pred             EEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeec
Q psy12427        180 MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGL  259 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~  259 (356)
                      .++||||+++++|.+++....  .....+....+..++.|++.||+|||+.|++|+||+|+||+++.++  .++|+|||+
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~--~~~l~d~~~  159 (275)
T cd06608          84 LWLVMELCGGGSVTDLVKGLR--KKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNA--EVKLVDFGV  159 (275)
T ss_pred             EEEEEEcCCCCcHHHHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCC--eEEECCCcc
Confidence            899999999999998876422  0112233444566999999999999999999999999999998654  799999999


Q ss_pred             eeeeCCCC-ceeecCCCcCccccccccC-----CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCh
Q psy12427        260 ATKLDPNE-VVKISTGTAEFAAPEIVER-----EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE  333 (356)
Q Consensus       260 a~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~  333 (356)
                      +....... ......|++.|+|||++..     ..++.++|||||||+||+|++|..||........+..+....... -
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~  238 (275)
T cd06608         160 SAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPT-L  238 (275)
T ss_pred             ceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCC-C
Confidence            87654322 2233458899999998853     346788999999999999999999998777666666655432211 1


Q ss_pred             hhhccCCHHHHHHHHHhhhcCCC
Q psy12427        334 EAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       334 ~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .....+++++++||++||..||+
T Consensus       239 ~~~~~~~~~~~~li~~~l~~dp~  261 (275)
T cd06608         239 KSPENWSKKFNDFISECLIKNYE  261 (275)
T ss_pred             CchhhcCHHHHHHHHHHhhcChh
Confidence            11124789999999999999995

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=4.5e-39  Score=288.91  Aligned_cols=233  Identities=27%  Similarity=0.472  Sum_probs=183.3

Q ss_pred             cceeeeccc--cccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEEEEE
Q psy12427        108 DHYDILEEI--GTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       108 ~~y~~~~~l--g~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      +.|.+.+.+  |.|+||.||++..+.++..+|+|.+........     |+.+...+ +||||+++++.+...+..++||
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~   88 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIM   88 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEE
Confidence            456666665  999999999999999999999999865432211     22222222 7999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      ||+++++|.+++.... .+.     ...+..++.|++.||+|||+.|++||||+|+||+++.++ ..++|+|||++....
T Consensus        89 e~~~~~~L~~~l~~~~-~l~-----~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~~~l~dfg~~~~~~  161 (267)
T PHA03390         89 DYIKDGDLFDLLKKEG-KLS-----EAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAK-DRIYLCDYGLCKIIG  161 (267)
T ss_pred             EcCCCCcHHHHHHhcC-CCC-----HHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCC-CeEEEecCccceecC
Confidence            9999999999987543 333     344556999999999999999999999999999997654 269999999988764


Q ss_pred             CCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHH-HHHhhccccccChhhhccCCHHH
Q psy12427        265 PNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVET-LKNVKACDWEFDEEAFKNVSEEG  343 (356)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~~~  343 (356)
                      ..   ....++..|+|||++.+..++.++|+||+|+++|+|++|..||......+. ...+.... ..+...++.+|..+
T Consensus       162 ~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  237 (267)
T PHA03390        162 TP---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVSKNA  237 (267)
T ss_pred             CC---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccCHHH
Confidence            32   224588999999999999999999999999999999999999986654332 11111111 22233445799999


Q ss_pred             HHHHHHhhhcCCC
Q psy12427        344 KDFIRRLLLRNKE  356 (356)
Q Consensus       344 ~~lI~~ll~~dP~  356 (356)
                      ++||.+||+.||+
T Consensus       238 ~~li~~~l~~~p~  250 (267)
T PHA03390        238 NDFVQSMLKYNIN  250 (267)
T ss_pred             HHHHHHHhccChh
Confidence            9999999999985

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.1e-39  Score=289.65  Aligned_cols=229  Identities=19%  Similarity=0.211  Sum_probs=180.2

Q ss_pred             cccccCceEEEEEEEccC------------------------CCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceee
Q psy12427        115 EIGTGAFGVVHRCRERKT------------------------GNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINL  170 (356)
Q Consensus       115 ~lg~G~fg~V~~~~~~~~------------------------~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l  170 (356)
                      +||+|+||.||+|....+                        ...+|+|++..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            699999999999985422                        24688898876554445677889999999999999999


Q ss_pred             eeeEEeCCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecC--
Q psy12427        171 HDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN--  248 (356)
Q Consensus       171 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~--  248 (356)
                      ++++......++||||+++|+|..++......+++.     .+..++.|++.||+|||++||+||||||+|||++..+  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~-----~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVA-----WKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHH-----HHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcc
Confidence            999999999999999999999998886543333333     3445899999999999999999999999999997543  


Q ss_pred             ---CCcEEEEeeeceeeeCCCCceeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHH-cCCCCCCCCChHHHHHH
Q psy12427        249 ---STNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLL-SGLSPFAGENDVETLKN  323 (356)
Q Consensus       249 ---~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell-~g~~Pf~~~~~~~~~~~  323 (356)
                         ...+|++|||++......   ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||.+....+....
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~  233 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF  233 (274)
T ss_pred             cCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence               224799999988654321   22357888999998865 56889999999999999995 69999988776554333


Q ss_pred             hhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        324 VKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       324 i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .. ....++.    ..+.++.++|.+||+.||+
T Consensus       234 ~~-~~~~~~~----~~~~~~~~li~~cl~~~p~  261 (274)
T cd05076         234 YE-KKHRLPE----PSCKELATLISQCLTYEPT  261 (274)
T ss_pred             HH-hccCCCC----CCChHHHHHHHHHcccChh
Confidence            22 2222332    4567899999999999995

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=7.5e-39  Score=288.35  Aligned_cols=245  Identities=20%  Similarity=0.341  Sum_probs=199.3

Q ss_pred             cceeeeccccccCceEEEEEEEccC-----CCEEEEEEcccCChh-hHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKT-----GNIFAAKFIPVSHNL-EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMV  181 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~-----~~~~a~K~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  181 (356)
                      ++|++.+.||.|+||+||+|+.+.+     ...+++|.+...... ....+.+|+.++++++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            4689999999999999999997643     468999988665433 4567889999999999999999999999999999


Q ss_pred             EEEEeccccchhhhhhCCCCCC---CccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeee
Q psy12427        182 LIFEFLSGGELFERITAPDYKM---SEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFG  258 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg  258 (356)
                      +||||+++|+|.+++.......   ....+....+..++.|++.||+|||+.+|+||||||+||+++.++  .++|+|||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~--~~~l~~~~  162 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQR--EVKVSLLS  162 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCC--cEEEcccc
Confidence            9999999999999986543111   011344455666999999999999999999999999999997655  69999999


Q ss_pred             ceeeeCCCCc--eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhh
Q psy12427        259 LATKLDPNEV--VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEA  335 (356)
Q Consensus       259 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  335 (356)
                      ++........  .....++..|+|||.+.+...+.++||||||+++|+|++ |..||........+..+......++.  
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~--  240 (275)
T cd05046         163 LSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV--  240 (275)
T ss_pred             cccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCC--
Confidence            9865432211  122245778999999988888999999999999999999 88999888888888887765544332  


Q ss_pred             hccCCHHHHHHHHHhhhcCCC
Q psy12427        336 FKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       336 ~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ...++..+.++|.+||+.||+
T Consensus       241 ~~~~~~~l~~~i~~~l~~~p~  261 (275)
T cd05046         241 PEGCPSRLYKLMTRCWAVNPK  261 (275)
T ss_pred             CCCCCHHHHHHHHHHcCCCcc
Confidence            246899999999999999995

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.1e-39  Score=290.18  Aligned_cols=237  Identities=27%  Similarity=0.455  Sum_probs=193.8

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh-hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEec
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN-LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFL  187 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~  187 (356)
                      +|++.+.||.|++|.||+|.++.+++.+|+|.+..... .....+.+|++++++++||||+++++.+......++++||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            57888999999999999999999999999999876543 34466888999999999999999999999999999999999


Q ss_pred             cccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE-KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       188 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      .+++|.+++......     +....+..++.|++.||+|||+ .|++|+||+|+||+++.++  .++|+|||.+......
T Consensus        82 ~~~~L~~~~~~~~~~-----~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~--~~~l~d~g~~~~~~~~  154 (265)
T cd06605          82 DGGSLDKILKEVQGR-----IPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG--QIKLCDFGVSGQLVNS  154 (265)
T ss_pred             CCCcHHHHHHHccCC-----CCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCC--CEEEeecccchhhHHH
Confidence            999999998754322     3333445599999999999999 9999999999999998644  7999999998765322


Q ss_pred             CceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC-----ChHHHHHHhhccccccChhhhcc-CC
Q psy12427        267 EVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGE-----NDVETLKNVKACDWEFDEEAFKN-VS  340 (356)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~-~s  340 (356)
                      .. ....++..|+|||.+.+..++.++|+||||+++|+|++|..||...     ...+.++.+.....   +..... ++
T Consensus       155 ~~-~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  230 (265)
T cd06605         155 LA-KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP---PRLPSGKFS  230 (265)
T ss_pred             Hh-hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC---CCCChhhcC
Confidence            21 1256889999999999999999999999999999999999999765     22333333333221   111222 89


Q ss_pred             HHHHHHHHHhhhcCCC
Q psy12427        341 EEGKDFIRRLLLRNKE  356 (356)
Q Consensus       341 ~~~~~lI~~ll~~dP~  356 (356)
                      .++++||.+||..||+
T Consensus       231 ~~~~~li~~~l~~~p~  246 (265)
T cd06605         231 PDFQDFVNLCLIKDPR  246 (265)
T ss_pred             HHHHHHHHHHcCCCch
Confidence            9999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.1e-38  Score=282.44  Aligned_cols=240  Identities=29%  Similarity=0.524  Sum_probs=199.9

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEecc
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLS  188 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  188 (356)
                      .|++.+.||.|++|.||++.++.++..+++|.+..........+.+|+.++++++|||++++++.+......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            37788999999999999999999999999999987665556788899999999999999999999999999999999999


Q ss_pred             ccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCc
Q psy12427        189 GGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEV  268 (356)
Q Consensus       189 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~  268 (356)
                      +++|.+++......+     ....+..++.|++.||++||+.|++|+||+|+||+++.++  .++|+|||.+........
T Consensus        81 ~~~L~~~~~~~~~~~-----~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~  153 (253)
T cd05122          81 GGSLKDLLKSTNQTL-----TESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDG--EVKLIDFGLSAQLSDTKA  153 (253)
T ss_pred             CCcHHHHHhhcCCCC-----CHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCC--eEEEeecccccccccccc
Confidence            999999987643233     3334455999999999999999999999999999998644  799999999987765432


Q ss_pred             eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHH
Q psy12427        269 VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIR  348 (356)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  348 (356)
                      .....++..|+|||.+....++.++|+||||+++|+|++|..||...+..+....+......... ....++.++.++|.
T Consensus       154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~  232 (253)
T cd05122         154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLR-NPEKWSDEFKDFLK  232 (253)
T ss_pred             ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcC-cccccCHHHHHHHH
Confidence            34456889999999999888999999999999999999999999888665555554442222111 11235899999999


Q ss_pred             HhhhcCCC
Q psy12427        349 RLLLRNKE  356 (356)
Q Consensus       349 ~ll~~dP~  356 (356)
                      +||+.||+
T Consensus       233 ~~l~~~p~  240 (253)
T cd05122         233 KCLQKNPE  240 (253)
T ss_pred             HHccCChh
Confidence            99999985

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.3e-39  Score=290.27  Aligned_cols=239  Identities=21%  Similarity=0.355  Sum_probs=186.3

Q ss_pred             cceeeeccccccCceEEEEEEE----ccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEe--CCeEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRE----RKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFED--DDEMV  181 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~----~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~  181 (356)
                      ++|++.+.||+|+||.||+|..    ..++..||+|.+..........+.+|++++++++||||+++++++..  ...++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            4789999999999999999984    45688999999987766666788899999999999999999998753  35689


Q ss_pred             EEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeecee
Q psy12427        182 LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT  261 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~  261 (356)
                      +|+||+++++|.+++......++     ...+..++.|++.||+|||++|++||||||+||+++.++  .+||+|||++.
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~l~-----~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~--~~~l~dfg~~~  156 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRERLD-----HRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESEN--RVKIGDFGLTK  156 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCcCCC-----HHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCC--eEEECCCcccc
Confidence            99999999999999865432233     334455899999999999999999999999999997654  79999999998


Q ss_pred             eeCCCCcee----ecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHH---------------
Q psy12427        262 KLDPNEVVK----ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLK---------------  322 (356)
Q Consensus       262 ~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~---------------  322 (356)
                      .........    ...++..|+|||++.+..++.++|+|||||++|||++|..|+..... +...               
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  235 (284)
T cd05081         157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA-EFMRMMGNDKQGQMIVYHL  235 (284)
T ss_pred             cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch-hhhhhcccccccccchHHH
Confidence            764322211    11234569999999988899999999999999999998777643321 1111               


Q ss_pred             -HhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        323 -NVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       323 -~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                       .+......++  ....++.++.+||.+||+.||+
T Consensus       236 ~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~  268 (284)
T cd05081         236 IELLKNNGRLP--APPGCPAEIYAIMKECWNNDPS  268 (284)
T ss_pred             HHHHhcCCcCC--CCCCCCHHHHHHHHHHccCChh
Confidence             1111111111  2246899999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=8.3e-39  Score=285.93  Aligned_cols=233  Identities=20%  Similarity=0.249  Sum_probs=184.4

Q ss_pred             ccccccCceEEEEEEEcc---CCCEEEEEEcccC-ChhhHHHHHHHHHHHHhcCCCCceeeeeeEE-eCCeEEEEEEecc
Q psy12427        114 EEIGTGAFGVVHRCRERK---TGNIFAAKFIPVS-HNLEKELIRKEIDIMNQLHHPKLINLHDAFE-DDDEMVLIFEFLS  188 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~---~~~~~a~K~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~~lv~e~~~  188 (356)
                      +.||+|+||.||+|.+..   .+..+|+|.+... .......+.+|+.+++.++||||+++++++. .++..+++|||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998754   3457999988543 3344567788999999999999999999765 4566899999999


Q ss_pred             ccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCc
Q psy12427        189 GGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEV  268 (356)
Q Consensus       189 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~  268 (356)
                      +|+|.+++.........     ..+..++.|++.||+|||+.+++||||||+|||++.++  .+||+|||+++.......
T Consensus        81 ~~~L~~~~~~~~~~~~~-----~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~--~~kl~dfg~~~~~~~~~~  153 (262)
T cd05058          81 HGDLRNFIRSETHNPTV-----KDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESF--TVKVADFGLARDIYDKEY  153 (262)
T ss_pred             CCCHHHHHHhcCCCCCH-----HHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC--cEEECCccccccccCCcc
Confidence            99999998654322222     23345888999999999999999999999999997654  799999999976543211


Q ss_pred             e-----eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHH
Q psy12427        269 V-----KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEE  342 (356)
Q Consensus       269 ~-----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  342 (356)
                      .     ....++..|+|||.+.+..++.++|||||||++|||++ |.+||...+..+....+........   ...+|+.
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  230 (262)
T cd05058         154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQ---PEYCPDP  230 (262)
T ss_pred             eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCC---CCcCCHH
Confidence            1     12235778999999998899999999999999999999 6778888887777776655432221   2357899


Q ss_pred             HHHHHHHhhhcCCC
Q psy12427        343 GKDFIRRLLLRNKE  356 (356)
Q Consensus       343 ~~~lI~~ll~~dP~  356 (356)
                      +.++|.+||+.||+
T Consensus       231 ~~~li~~cl~~~p~  244 (262)
T cd05058         231 LYEVMLSCWHPKPE  244 (262)
T ss_pred             HHHHHHHHcCCChh
Confidence            99999999999985

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG0983|consensus

Probab=100.00  E-value=5.3e-40  Score=278.26  Aligned_cols=240  Identities=24%  Similarity=0.395  Sum_probs=194.9

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      ++.+.+..||.|..|.|++++.+.+|...|+|.+.... .++...+...++++... +.|+||+.+|+|..+...++.||
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            45678889999999999999999999999999997654 44556677788887776 48999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEK-NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      .|.- -+..++..-...+     .+..+..+...++.||.||.++ ||+|||+||.|||+|..+  .+||||||.+..+-
T Consensus       172 lMs~-C~ekLlkrik~pi-----PE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~G--niKlCDFGIsGrlv  243 (391)
T KOG0983|consen  172 LMST-CAEKLLKRIKGPI-----PERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG--NIKLCDFGISGRLV  243 (391)
T ss_pred             HHHH-HHHHHHHHhcCCc-----hHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCC--CEEeecccccceee
Confidence            9843 3344444333333     3333444778899999999865 899999999999998665  69999999998887


Q ss_pred             CCCceeecCCCcCccccccccCC---CCCccccHHHHHHHHHHHHcCCCCCCCC-ChHHHHHHhhccccccChhhhccCC
Q psy12427        265 PNEVVKISTGTAEFAAPEIVERE---PVGFYTDMWAVGVLAYVLLSGLSPFAGE-NDVETLKNVKACDWEFDEEAFKNVS  340 (356)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlG~il~ell~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s  340 (356)
                      .........|.+.|||||.+...   .|+-++||||||+.++||.||+.||.+- .+.+++-+|.....+-. +....+|
T Consensus       244 dSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L-~~~~gFS  322 (391)
T KOG0983|consen  244 DSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLL-PGHMGFS  322 (391)
T ss_pred             cccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCC-CcccCcC
Confidence            66666778899999999999654   5888999999999999999999999974 67788888877443222 2224599


Q ss_pred             HHHHHHHHHhhhcCCC
Q psy12427        341 EEGKDFIRRLLLRNKE  356 (356)
Q Consensus       341 ~~~~~lI~~ll~~dP~  356 (356)
                      ++..+|+..||++|++
T Consensus       323 p~F~~fv~~CL~kd~r  338 (391)
T KOG0983|consen  323 PDFQSFVKDCLTKDHR  338 (391)
T ss_pred             HHHHHHHHHHhhcCcc
Confidence            9999999999999974

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=7e-39  Score=287.30  Aligned_cols=237  Identities=23%  Similarity=0.430  Sum_probs=190.5

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC-----hhhHHHHHHHHHHHHhcCCCCceeeeeeEEe--CCeEE
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-----NLEKELIRKEIDIMNQLHHPKLINLHDAFED--DDEMV  181 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~  181 (356)
                      .|++.+.||+|+||.||+|.+..++..+|+|.+....     ......+.+|+.++++++||||+++++++..  ....+
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            5888999999999999999999999999999886432     1234567889999999999999999998875  46788


Q ss_pred             EEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeecee
Q psy12427        182 LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT  261 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~  261 (356)
                      +++||+++++|.+++.... .++     ......++.|++.||+|||+.+++|+||+|+||+++.++  .++|+|||++.
T Consensus        83 l~~e~~~~~~L~~~l~~~~-~l~-----~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~--~~~l~dfg~~~  154 (266)
T cd06651          83 IFMEYMPGGSVKDQLKAYG-ALT-----ESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAG--NVKLGDFGASK  154 (266)
T ss_pred             EEEeCCCCCcHHHHHHHcC-CCC-----HHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC--CEEEccCCCcc
Confidence            9999999999999886432 222     333455899999999999999999999999999997544  79999999987


Q ss_pred             eeCCC----CceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhc
Q psy12427        262 KLDPN----EVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK  337 (356)
Q Consensus       262 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  337 (356)
                      .....    .......++..|+|||.+.+..++.++|+||+||++|+|++|+.||......+....+.....  .+....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~  232 (266)
T cd06651         155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPT--NPQLPS  232 (266)
T ss_pred             ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCC--CCCCch
Confidence            65321    111224578899999999998899999999999999999999999988766665555443221  222234


Q ss_pred             cCCHHHHHHHHHhhhcCCC
Q psy12427        338 NVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       338 ~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+++.++++| +||..||+
T Consensus       233 ~~~~~~~~li-~~~~~~p~  250 (266)
T cd06651         233 HISEHARDFL-GCIFVEAR  250 (266)
T ss_pred             hcCHHHHHHH-HHhcCChh
Confidence            6889999999 67778885

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-38  Score=285.93  Aligned_cols=236  Identities=23%  Similarity=0.435  Sum_probs=191.4

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC-----hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeC--CeE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-----NLEKELIRKEIDIMNQLHHPKLINLHDAFEDD--DEM  180 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~  180 (356)
                      ..|.+.+.||+|+||.||+|.++.++..+|+|.+....     ......+.+|+.++++++||||+++++++...  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            36899999999999999999999999999999875421     22345788899999999999999999998754  568


Q ss_pred             EEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeece
Q psy12427        181 VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA  260 (356)
Q Consensus       181 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a  260 (356)
                      ++++||+++++|.+++.... .+.     ...+..++.|++.||.|||+.|++|+||+|+||+++.++  .++|+|||++
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~-~l~-----~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~--~~~l~dfg~~  153 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG-ALT-----ENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAG--NVKLGDFGAS  153 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC-CCC-----HHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC--CEEECccccc
Confidence            89999999999999886432 222     233455899999999999999999999999999997644  6999999999


Q ss_pred             eeeCCC----CceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhh
Q psy12427        261 TKLDPN----EVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAF  336 (356)
Q Consensus       261 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  336 (356)
                      +.....    .......++..|+|||.+.+..++.++|+|||||++|+|++|+.||......+...++....  .++..+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~p  231 (264)
T cd06653         154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQP--TKPMLP  231 (264)
T ss_pred             cccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCC--CCCCCC
Confidence            865321    11123457899999999999889999999999999999999999998877666655554322  223334


Q ss_pred             ccCCHHHHHHHHHhhhc
Q psy12427        337 KNVSEEGKDFIRRLLLR  353 (356)
Q Consensus       337 ~~~s~~~~~lI~~ll~~  353 (356)
                      ..+++++++||++||+.
T Consensus       232 ~~~~~~~~~~i~~~l~~  248 (264)
T cd06653         232 DGVSDACRDFLKQIFVE  248 (264)
T ss_pred             cccCHHHHHHHHHHhcC
Confidence            57899999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=6.2e-39  Score=286.67  Aligned_cols=237  Identities=24%  Similarity=0.429  Sum_probs=198.8

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh-hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEec
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN-LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFL  187 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~  187 (356)
                      +|++.+.||.|++|.||+|.++.+++.+++|.+..... .....+.+|+.++..++||||+++++++......+++|||+
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM   81 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence            58899999999999999999999999999999877654 34567889999999999999999999999999999999999


Q ss_pred             cccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE-KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       188 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      ++++|.+++...      ..+....+..++.|++.||+|||+ .+++|+||+|+||+++.++  .++|+|||.+......
T Consensus        82 ~~~~L~~~l~~~------~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~--~~~l~df~~~~~~~~~  153 (264)
T cd06623          82 DGGSLADLLKKV------GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKG--EVKIADFGISKVLENT  153 (264)
T ss_pred             CCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCC--CEEEccCccceecccC
Confidence            999999998754      223334445699999999999999 9999999999999997654  7999999999876543


Q ss_pred             Cce-eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC---ChHHHHHHhhccccccChhhhcc-CCH
Q psy12427        267 EVV-KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGE---NDVETLKNVKACDWEFDEEAFKN-VSE  341 (356)
Q Consensus       267 ~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~---~~~~~~~~i~~~~~~~~~~~~~~-~s~  341 (356)
                      ... ....++..|+|||.+....++.++|+||||+++|+|++|..||...   ...+....+......   ..... +|.
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  230 (264)
T cd06623         154 LDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPP---SLPAEEFSP  230 (264)
T ss_pred             CCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCC---CCCcccCCH
Confidence            332 2445789999999999999999999999999999999999999877   445555555543222   12234 899


Q ss_pred             HHHHHHHHhhhcCCC
Q psy12427        342 EGKDFIRRLLLRNKE  356 (356)
Q Consensus       342 ~~~~lI~~ll~~dP~  356 (356)
                      .+.++|++||+.+|+
T Consensus       231 ~l~~li~~~l~~~p~  245 (264)
T cd06623         231 EFRDFISACLQKDPK  245 (264)
T ss_pred             HHHHHHHHHccCChh
Confidence            999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.4e-38  Score=289.01  Aligned_cols=244  Identities=26%  Similarity=0.437  Sum_probs=193.5

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeC-----CeE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL-HHPKLINLHDAFEDD-----DEM  180 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~-----~~~  180 (356)
                      .++|++.+.||.|+||.||+|..+.+++.+|+|++..... ....+.+|+.++.++ +|||++++++++...     ...
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~   99 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL   99 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence            4679999999999999999999999999999999865432 235677899999999 899999999998743     468


Q ss_pred             EEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeece
Q psy12427        181 VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA  260 (356)
Q Consensus       181 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a  260 (356)
                      ++||||+++++|.+++....  .....+....+..++.|++.||+|||+.|++|+||||+||+++.++  .+||+|||++
T Consensus       100 ~lv~ey~~~~sL~~~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~--~~kl~dfg~~  175 (291)
T cd06639         100 WLVLELCNGGSVTELVKGLL--ICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEG--GVKLVDFGVS  175 (291)
T ss_pred             EEEEEECCCCcHHHHHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC--CEEEeecccc
Confidence            99999999999998875321  1112233445566999999999999999999999999999997654  6999999998


Q ss_pred             eeeCCCCc-eeecCCCcCccccccccCCC-----CCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChh
Q psy12427        261 TKLDPNEV-VKISTGTAEFAAPEIVEREP-----VGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEE  334 (356)
Q Consensus       261 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~-----~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  334 (356)
                      ........ .....|+..|+|||.+....     ++.++|+|||||++|+|++|+.||...+..+.+..+....... ..
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~  254 (291)
T cd06639         176 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPT-LL  254 (291)
T ss_pred             hhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCC-CC
Confidence            76543222 23346889999999986543     6789999999999999999999999887766666654432111 11


Q ss_pred             hhccCCHHHHHHHHHhhhcCCC
Q psy12427        335 AFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       335 ~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ....++.++++||.+||+.||+
T Consensus       255 ~~~~~~~~l~~li~~~l~~~p~  276 (291)
T cd06639         255 HPEKWCRSFNHFISQCLIKDFE  276 (291)
T ss_pred             cccccCHHHHHHHHHHhhcChh
Confidence            1235788999999999999985

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.2e-38  Score=283.44  Aligned_cols=241  Identities=28%  Similarity=0.524  Sum_probs=204.3

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh--hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN--LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      +|.+.+.||.|+||.||++.+..++..+|+|.+.....  .....+.+|+++++.++|||++++.+.+......++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            48889999999999999999999999999999976543  4556788999999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +++++|.+++.....  ....+....+..++.+++.||.+||+.|++|+||+|+||+++.++  .++|+|||.+......
T Consensus        81 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~--~~~l~d~~~~~~~~~~  156 (258)
T cd08215          81 ADGGDLSQKIKKQKK--EGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNG--LVKLGDFGISKVLSST  156 (258)
T ss_pred             cCCCcHHHHHHHhhc--cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCC--cEEECCccceeecccC
Confidence            999999998875421  112344445566999999999999999999999999999998644  7999999999876544


Q ss_pred             C-ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHH
Q psy12427        267 E-VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD  345 (356)
Q Consensus       267 ~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  345 (356)
                      . ......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+..+....+........   ...++.++.+
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  233 (258)
T cd08215         157 VDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPI---PSQYSSELRN  233 (258)
T ss_pred             cceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCC---CCCCCHHHHH
Confidence            3 23344688999999999999999999999999999999999999998888777777766543322   2378999999


Q ss_pred             HHHHhhhcCCC
Q psy12427        346 FIRRLLLRNKE  356 (356)
Q Consensus       346 lI~~ll~~dP~  356 (356)
                      +|++||+.||+
T Consensus       234 ~i~~~l~~~p~  244 (258)
T cd08215         234 LVSSLLQKDPE  244 (258)
T ss_pred             HHHHHcCCChh
Confidence            99999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=5.9e-39  Score=285.81  Aligned_cols=240  Identities=25%  Similarity=0.475  Sum_probs=199.5

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      +|++.+.||.|+||.||+|.++.+|..+|+|.+....  ..+...+.+|+.+++.++||||+++++.+......++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4788999999999999999999999999999986542  23446778999999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +.+++|.+++.....    .......+..++.|++.||.|||+.+++|+||+|+||+++.++ ..++|+|||.+......
T Consensus        81 ~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~-~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          81 CDGGDLMKRINRQRG----VLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNG-MVAKLGDFGIARQLNDS  155 (257)
T ss_pred             CCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCC-CeEEecccccchhccCC
Confidence            999999998865321    1223344566899999999999999999999999999997654 35799999998776433


Q ss_pred             C-ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHH
Q psy12427        267 E-VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD  345 (356)
Q Consensus       267 ~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  345 (356)
                      . ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+.......   ....++.++++
T Consensus       156 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  232 (257)
T cd08225         156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAP---ISPNFSRDLRS  232 (257)
T ss_pred             cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCC---CCCCCCHHHHH
Confidence            2 2233458999999999998889999999999999999999999999888777766665544322   22468899999


Q ss_pred             HHHHhhhcCCC
Q psy12427        346 FIRRLLLRNKE  356 (356)
Q Consensus       346 lI~~ll~~dP~  356 (356)
                      +|++||+.+|+
T Consensus       233 ~i~~~l~~~p~  243 (257)
T cd08225         233 LISQLFKVSPR  243 (257)
T ss_pred             HHHHHhccChh
Confidence            99999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=5.5e-39  Score=290.47  Aligned_cols=242  Identities=26%  Similarity=0.462  Sum_probs=192.8

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh-hHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEec
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL-EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFL  187 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~  187 (356)
                      +|++.+.||.|++|.||+|.++.+|..+|+|.++..... ....+.+|+.++++++||||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            488999999999999999999999999999998765432 3456678999999999999999999999999999999999


Q ss_pred             cccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCC
Q psy12427        188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE  267 (356)
Q Consensus       188 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~  267 (356)
                      .+ +|.+++.....   ...+....+..++.|++.||+|||++|++|+||+|+||+++.++  .++|+|||++.......
T Consensus        81 ~~-~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~--~~~l~d~g~~~~~~~~~  154 (284)
T cd07836          81 DK-DLKKYMDTHGV---RGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRG--ELKLADFGLARAFGIPV  154 (284)
T ss_pred             Cc-cHHHHHHhcCC---CCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC--cEEEeecchhhhhcCCc
Confidence            75 78887764331   12234445566999999999999999999999999999997554  79999999997653221


Q ss_pred             -ceeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC-------------
Q psy12427        268 -VVKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD-------------  332 (356)
Q Consensus       268 -~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-------------  332 (356)
                       ......+++.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+..+.+..+......+.             
T Consensus       155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07836         155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY  234 (284)
T ss_pred             cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence             12234568899999988654 568899999999999999999999998887766655432211100             


Q ss_pred             ------------hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 ------------EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 ------------~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                  ......++.+++++|.+||+.||+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~  270 (284)
T cd07836         235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPE  270 (284)
T ss_pred             cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcc
Confidence                        111235689999999999999995

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=4.7e-39  Score=288.62  Aligned_cols=240  Identities=21%  Similarity=0.322  Sum_probs=191.7

Q ss_pred             ccccccCceEEEEEEEccCC------CEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        114 EEIGTGAFGVVHRCRERKTG------NIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~~------~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      +.||.|+||.||+|.++...      ..+|+|.+.... ......+.+|+.+++.++||||+++++++......+++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            36999999999999987543      689999876543 23456788899999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCC-CccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecC---CCcEEEEeeeceee
Q psy12427        187 LSGGELFERITAPDYKM-SEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN---STNVKMIDFGLATK  262 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~---~~~vkl~Dfg~a~~  262 (356)
                      +++++|.+++....... ....+....+..++.|++.||+|||+++++|+||+|+||+++.++   ...++|+|||++..
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~  160 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD  160 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence            99999999986532111 222233445566899999999999999999999999999998654   22689999999876


Q ss_pred             eCCCCce---eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhcc
Q psy12427        263 LDPNEVV---KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKN  338 (356)
Q Consensus       263 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  338 (356)
                      .......   ....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+......   .....
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~  237 (269)
T cd05044         161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRL---QKPEN  237 (269)
T ss_pred             cccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCcc---CCccc
Confidence            5322211   12245788999999999999999999999999999998 99999988887777776543211   22246


Q ss_pred             CCHHHHHHHHHhhhcCCC
Q psy12427        339 VSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       339 ~s~~~~~lI~~ll~~dP~  356 (356)
                      +|.++.+||.+||+++|+
T Consensus       238 ~~~~~~~li~~~l~~~p~  255 (269)
T cd05044         238 CPDKIYQLMTNCWAQDPS  255 (269)
T ss_pred             chHHHHHHHHHHcCCCcc
Confidence            899999999999999995

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.1e-38  Score=287.81  Aligned_cols=236  Identities=24%  Similarity=0.423  Sum_probs=196.6

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEec
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFL  187 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~  187 (356)
                      -|++.+.||.|+||.||+|.++.++..+|+|.+.... ......+.+|+.++++++||||+++++++..+...++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            4788899999999999999999999999999886543 233467888999999999999999999999999999999999


Q ss_pred             cccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCC
Q psy12427        188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE  267 (356)
Q Consensus       188 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~  267 (356)
                      .+++|.+++...  .+     ....+..++.|++.|+.+||+.|++|+||+|+||+++.++  .++|+|||++.......
T Consensus        85 ~~~~l~~~i~~~--~~-----~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~--~~~l~dfg~~~~~~~~~  155 (277)
T cd06641          85 GGGSALDLLEPG--PL-----DETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG--EVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             CCCcHHHHHhcC--CC-----CHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCC--CEEEeecccceecccch
Confidence            999999888643  22     2334455999999999999999999999999999997554  79999999987764332


Q ss_pred             c-eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHH
Q psy12427        268 V-VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDF  346 (356)
Q Consensus       268 ~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  346 (356)
                      . .....++..|+|||.+....++.++|+|||||++|+|++|..||...........+.....   +.....++.++.++
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~  232 (277)
T cd06641         156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP---PTLEGNYSKPLKEF  232 (277)
T ss_pred             hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCC---CCCCcccCHHHHHH
Confidence            1 2234578899999999988899999999999999999999999988877666666544332   22234689999999


Q ss_pred             HHHhhhcCCC
Q psy12427        347 IRRLLLRNKE  356 (356)
Q Consensus       347 I~~ll~~dP~  356 (356)
                      |.+||+.||+
T Consensus       233 i~~~l~~~p~  242 (277)
T cd06641         233 VEACLNKEPS  242 (277)
T ss_pred             HHHHccCChh
Confidence            9999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.2e-38  Score=287.80  Aligned_cols=245  Identities=16%  Similarity=0.223  Sum_probs=197.1

Q ss_pred             ccceeeeccccccCceEEEEEEEcc----CCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEe-CCeE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERK----TGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFED-DDEM  180 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~----~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~  180 (356)
                      .++|++.+.||+|+||.||+|.+..    .+..+++|.+.... ......+.+|+.+++.++||||+++++++.. +...
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            3579999999999999999999886    35789999886543 3445678899999999999999999998765 5778


Q ss_pred             EEEEEeccccchhhhhhCCCCC--CCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeee
Q psy12427        181 VLIFEFLSGGELFERITAPDYK--MSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFG  258 (356)
Q Consensus       181 ~lv~e~~~~g~L~~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg  258 (356)
                      ++++||+.+++|.+++......  .....+....+..++.|++.||+|||+.+++|+||+|+||+++.++  .+||+|||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~--~~kl~d~g  162 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEEL--QVKITDNA  162 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCC--cEEECCCC
Confidence            9999999999999998653211  0112344455666999999999999999999999999999997554  79999999


Q ss_pred             ceeeeCCCCcee---ecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChh
Q psy12427        259 LATKLDPNEVVK---ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEE  334 (356)
Q Consensus       259 ~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~  334 (356)
                      +++.+.......   ...++..|+|||++.+..++.++|||||||++|++++ |+.||...+..+....+.... .++  
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~--  239 (280)
T cd05043         163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY-RLA--  239 (280)
T ss_pred             CcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC-CCC--
Confidence            998664333221   1235678999999999899999999999999999999 999999888877766665532 222  


Q ss_pred             hhccCCHHHHHHHHHhhhcCCC
Q psy12427        335 AFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       335 ~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ....+++++.++|.+||+.||+
T Consensus       240 ~~~~~~~~~~~li~~~l~~~p~  261 (280)
T cd05043         240 QPINCPDELFAVMACCWALDPE  261 (280)
T ss_pred             CCCcCCHHHHHHHHHHcCCChh
Confidence            2346799999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG1094|consensus

Probab=100.00  E-value=1.2e-39  Score=300.64  Aligned_cols=241  Identities=20%  Similarity=0.321  Sum_probs=200.9

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh-hHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL-EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      +...+.++||+|-||+|.+|.... +..||+|.++..... .+.+|.+|+++|.+|+||||+.|+|+|..++.+++++||
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            457889999999999999998764 689999999877654 458899999999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      |++|+|.+++.++....    +.......|+.||++||+||.+.++|||||.++|+|++.  +.++||+|||+++.+-..
T Consensus       617 mEnGDLnqFl~aheapt----~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~--e~~iKiadfgmsR~lysg  690 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELPT----AETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDG--EFTIKIADFGMSRNLYSG  690 (807)
T ss_pred             HhcCcHHHHHHhccCcc----cccchhHHHHHHHHHHHHHHHhhchhhccccccceeecC--cccEEecCcccccccccC
Confidence            99999999998764332    122223449999999999999999999999999999984  458999999999977555


Q ss_pred             Cceeec---CCCcCccccccccCCCCCccccHHHHHHHHHHHHc--CCCCCCCCChHHHHHHhhccccccC----hhhhc
Q psy12427        267 EVVKIS---TGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS--GLSPFAGENDVETLKNVKACDWEFD----EEAFK  337 (356)
Q Consensus       267 ~~~~~~---~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~--g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~  337 (356)
                      ......   +-+.+|||||.+.-++++++||+|+||++|||+++  ...||...++++...+........+    ...+.
T Consensus       691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~  770 (807)
T KOG1094|consen  691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPP  770 (807)
T ss_pred             CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCC
Confidence            544433   34789999999999999999999999999999876  8999999999988887654322211    12234


Q ss_pred             cCCHHHHHHHHHhhhcCC
Q psy12427        338 NVSEEGKDFIRRLLLRNK  355 (356)
Q Consensus       338 ~~s~~~~~lI~~ll~~dP  355 (356)
                      -++..+-++|-+||..|-
T Consensus       771 ~cp~~lyelml~Cw~~es  788 (807)
T KOG1094|consen  771 ACPQGLYELMLRCWRRES  788 (807)
T ss_pred             cCcHHHHHHHHHHhchhh
Confidence            689999999999998763

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=8.5e-39  Score=293.96  Aligned_cols=200  Identities=23%  Similarity=0.367  Sum_probs=157.6

Q ss_pred             ccccccCceEEEEEEEcc--CCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEE--eCCeEEEEEEeccc
Q psy12427        114 EEIGTGAFGVVHRCRERK--TGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFE--DDDEMVLIFEFLSG  189 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~--~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~~~~lv~e~~~~  189 (356)
                      .+||+|+||+||+|..+.  ++..+|+|.+.....  ...+.+|+.+|+.++||||+++++++.  .....+++|||+. 
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-   83 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-   83 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence            579999999999999764  568999998865432  345678999999999999999999885  4567899999986 


Q ss_pred             cchhhhhhCCCCC---CCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeec--CCCcEEEEeeeceeeeC
Q psy12427        190 GELFERITAPDYK---MSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTR--NSTNVKMIDFGLATKLD  264 (356)
Q Consensus       190 g~L~~~l~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~--~~~~vkl~Dfg~a~~~~  264 (356)
                      ++|.+++......   .....+....+..++.||+.||+|||++||+||||||+|||+..+  .++.+||+|||+++...
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~  163 (317)
T cd07867          84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN  163 (317)
T ss_pred             CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccC
Confidence            4777776432111   112234445567799999999999999999999999999999533  23479999999998764


Q ss_pred             CCCc----eeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCC
Q psy12427        265 PNEV----VKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGEN  316 (356)
Q Consensus       265 ~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~  316 (356)
                      ....    .....||+.|+|||++.+. .++.++|||||||++|||++|++||....
T Consensus       164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             CCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence            3221    2234579999999998764 57899999999999999999999997553

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=4.7e-39  Score=290.64  Aligned_cols=230  Identities=25%  Similarity=0.443  Sum_probs=178.6

Q ss_pred             cccccCceEEEEEEEccCCCEEEEEEcccCCh---hhHHHHHHHHHHHH---hcCCCCceeeeeeEEeCCeEEEEEEecc
Q psy12427        115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN---LEKELIRKEIDIMN---QLHHPKLINLHDAFEDDDEMVLIFEFLS  188 (356)
Q Consensus       115 ~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~---~l~hpnIv~l~~~~~~~~~~~lv~e~~~  188 (356)
                      .||+|+||.||++.+..++..+|+|.+.....   .....+.+|..+++   ..+||||+.+++++...+..++||||+.
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            48999999999999999999999998865421   11223344544443   3479999999999999999999999999


Q ss_pred             ccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCc
Q psy12427        189 GGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEV  268 (356)
Q Consensus       189 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~  268 (356)
                      +++|.+++.... .     +....+..++.|++.||+|||+.+++||||||+|||++.++  .++|+|||++....... 
T Consensus        81 ~~~L~~~i~~~~-~-----l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~--~~~l~dfg~~~~~~~~~-  151 (279)
T cd05633          81 GGDLHYHLSQHG-V-----FSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFSKKK-  151 (279)
T ss_pred             CCCHHHHHHhcC-C-----CCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCC--CEEEccCCcceeccccC-
Confidence            999998886432 2     33344455999999999999999999999999999997654  79999999987654322 


Q ss_pred             eeecCCCcCcccccccc-CCCCCccccHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHhhccccccChhhhccCCHHHHH
Q psy12427        269 VKISTGTAEFAAPEIVE-REPVGFYTDMWAVGVLAYVLLSGLSPFAGEND--VETLKNVKACDWEFDEEAFKNVSEEGKD  345 (356)
Q Consensus       269 ~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~s~~~~~  345 (356)
                      .....|++.|+|||.+. +..++.++|+||+||++|+|++|..||.....  .+.+....   ...+...+..++.++++
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~  228 (279)
T cd05633         152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---LTVNVELPDSFSPELKS  228 (279)
T ss_pred             ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh---hcCCcCCccccCHHHHH
Confidence            23346899999999986 45688999999999999999999999976532  22222221   11222333578999999


Q ss_pred             HHHHhhhcCCC
Q psy12427        346 FIRRLLLRNKE  356 (356)
Q Consensus       346 lI~~ll~~dP~  356 (356)
                      ||++||+.||+
T Consensus       229 li~~~l~~~p~  239 (279)
T cd05633         229 LLEGLLQRDVS  239 (279)
T ss_pred             HHHHHhcCCHH
Confidence            99999999984

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0603|consensus

Probab=100.00  E-value=5.5e-40  Score=307.28  Aligned_cols=232  Identities=28%  Similarity=0.500  Sum_probs=195.0

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEEEE
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      .+.+.|.+...+|.|+|+.|..+.+..+++..++|++.....    +..+|+.++... +||||+++++++.++.+.++|
T Consensus       319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v  394 (612)
T KOG0603|consen  319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV  394 (612)
T ss_pred             CcchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeee
Confidence            467889999999999999999999999999999999976622    223577666665 799999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      ||.+.|+.|.+.+.....      .. ..+..|+.+|+.|+.|||++|||||||||+|||++ ++.++++|+|||.++..
T Consensus       395 ~e~l~g~ell~ri~~~~~------~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~-~~~g~lrltyFG~a~~~  466 (612)
T KOG0603|consen  395 MELLDGGELLRRIRSKPE------FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD-GSAGHLRLTYFGFWSEL  466 (612)
T ss_pred             ehhccccHHHHHHHhcch------hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec-CCCCcEEEEEechhhhC
Confidence            999999998887754321      11 33445999999999999999999999999999996 33457999999999887


Q ss_pred             CCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHhhccccccChhhhccCCHH
Q psy12427        264 DPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDV-ETLKNVKACDWEFDEEAFKNVSEE  342 (356)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~  342 (356)
                      +..  ..+.+-|..|.|||++....|+.++|+||||++||+|++|+.||...... ++...+..+.+.      ..+|++
T Consensus       467 ~~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s------~~vS~~  538 (612)
T KOG0603|consen  467 ERS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS------ECVSDE  538 (612)
T ss_pred             chh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc------cccCHH
Confidence            654  33446689999999999999999999999999999999999999877555 666666554432      589999


Q ss_pred             HHHHHHHhhhcCCC
Q psy12427        343 GKDFIRRLLLRNKE  356 (356)
Q Consensus       343 ~~~lI~~ll~~dP~  356 (356)
                      ++|||++||+.||.
T Consensus       539 AKdLl~~LL~~dP~  552 (612)
T KOG0603|consen  539 AKDLLQQLLQVDPA  552 (612)
T ss_pred             HHHHHHHhccCChh
Confidence            99999999999994

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=9.4e-39  Score=290.22  Aligned_cols=241  Identities=22%  Similarity=0.380  Sum_probs=185.0

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh-hHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL-EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      +.|.+.+.||+|+||.||+|.++.+|..+|+|.+...... ....+.+|+.+++.++|+||+++++++..+...++||||
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY   84 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence            4799999999999999999999999999999998755322 234567899999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +. ++|.+.+......+.     ...+..++.|++.||+|||+.||+|+||||+|||++.++  .++|+|||+++.....
T Consensus        85 ~~-~~l~~~~~~~~~~~~-----~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~--~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          85 MH-TDLAQYMIQHPGGLH-----PYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLG--ELKLADFGLARAKSIP  156 (291)
T ss_pred             cc-CCHHHHHHhCCCCCC-----HHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCC--cEEEeccccccccCCC
Confidence            95 677666654322222     233455899999999999999999999999999997654  7999999998764322


Q ss_pred             C-ceeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHhhcccccc------------
Q psy12427        267 E-VVKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGENDV-ETLKNVKACDWEF------------  331 (356)
Q Consensus       267 ~-~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~-~~~~~i~~~~~~~------------  331 (356)
                      . ......+++.|+|||.+.+. .++.++|||||||++|+|++|..||.+.+.. +.+..+......+            
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07870         157 SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP  236 (291)
T ss_pred             CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence            1 12234578999999998764 5788999999999999999999999866532 3332221110000            


Q ss_pred             -----------C---hhhhc--cCCHHHHHHHHHhhhcCCC
Q psy12427        332 -----------D---EEAFK--NVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       332 -----------~---~~~~~--~~s~~~~~lI~~ll~~dP~  356 (356)
                                 +   ...+.  ..+.++.++|.+||+.||+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~  277 (291)
T cd07870         237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPK  277 (291)
T ss_pred             cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcc
Confidence                       0   00011  1367899999999999995

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.3e-39  Score=290.71  Aligned_cols=238  Identities=20%  Similarity=0.318  Sum_probs=183.7

Q ss_pred             cce-eeeccccccCceEEEEEE----EccCCCEEEEEEcccCCh-hhHHHHHHHHHHHHhcCCCCceeeeeeEEe--CCe
Q psy12427        108 DHY-DILEEIGTGAFGVVHRCR----ERKTGNIFAAKFIPVSHN-LEKELIRKEIDIMNQLHHPKLINLHDAFED--DDE  179 (356)
Q Consensus       108 ~~y-~~~~~lg~G~fg~V~~~~----~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~  179 (356)
                      ++| ++.+.||+|+||+||++.    ...++..+|+|.++.... .....+.+|+++|+.++||||+++++++..  ...
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            345 899999999999998865    335678999999876532 345677889999999999999999998865  346


Q ss_pred             EEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeec
Q psy12427        180 MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGL  259 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~  259 (356)
                      .+++|||+++++|.+++....       +....+..++.|++.||+|||++|++||||||+|||++.++  .++|+|||+
T Consensus        83 ~~lv~e~~~~~~l~~~~~~~~-------l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~~l~dfg~  153 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPKHK-------LNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR--LVKIGDFGL  153 (283)
T ss_pred             EEEEecCCCCCCHHHHHHHcC-------CCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCC--cEEEeeccc
Confidence            899999999999999886432       33344556999999999999999999999999999997654  799999999


Q ss_pred             eeeeCCCCc----eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChH--HHH------------
Q psy12427        260 ATKLDPNEV----VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDV--ETL------------  321 (356)
Q Consensus       260 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~--~~~------------  321 (356)
                      +........    .....++..|+|||.+....++.++||||||+++|+|++|..||......  +.+            
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd05080         154 AKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRL  233 (283)
T ss_pred             ccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhh
Confidence            987643221    11223567799999999888999999999999999999999998654321  111            


Q ss_pred             HHhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        322 KNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       322 ~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ..........  +....++.++.+++.+||+.||+
T Consensus       234 ~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~  266 (283)
T cd05080         234 IELLERGMRL--PCPKNCPQEVYILMKNCWETEAK  266 (283)
T ss_pred             hhhhhcCCCC--CCCCCCCHHHHHHHHHHhccChh
Confidence            1111111111  12246789999999999999995

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=9e-39  Score=289.13  Aligned_cols=239  Identities=25%  Similarity=0.453  Sum_probs=192.6

Q ss_pred             eeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeC--CeEEEEEE
Q psy12427        110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDD--DEMVLIFE  185 (356)
Q Consensus       110 y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~lv~e  185 (356)
                      |++.+.||.|+||.||+|.++.+++.+|+|.+....  ......+.+|+.++++++|||++++++++...  ...++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            678899999999999999999999999999998763  33345677899999999999999999999988  89999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |+++ +|.+++......++     ...+..++.|++.||+|||+.|++|+||+|+||+++.++  .++|+|||++.....
T Consensus        81 ~~~~-~l~~~~~~~~~~~~-----~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~--~~~l~d~g~~~~~~~  152 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFT-----ESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDG--VLKLADFGLARPYTK  152 (287)
T ss_pred             cccc-cHHHHHhccCCCCC-----HHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCC--CEEEccccceeeccC
Confidence            9974 88888765432333     334455999999999999999999999999999998654  799999999987754


Q ss_pred             CC--ceeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCh---------
Q psy12427        266 NE--VVKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE---------  333 (356)
Q Consensus       266 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~---------  333 (356)
                      ..  ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..+.+..+......+..         
T Consensus       153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07840         153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL  232 (287)
T ss_pred             CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence            33  1223456889999998765 45789999999999999999999999988877766665442211111         


Q ss_pred             -----------------hhhcc-CCHHHHHHHHHhhhcCCC
Q psy12427        334 -----------------EAFKN-VSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       334 -----------------~~~~~-~s~~~~~lI~~ll~~dP~  356 (356)
                                       +.+.. ++.++.++|++||+.||+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~  273 (287)
T cd07840         233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPK  273 (287)
T ss_pred             hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChh
Confidence                             11223 389999999999999995

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1e-38  Score=286.60  Aligned_cols=242  Identities=28%  Similarity=0.477  Sum_probs=197.2

Q ss_pred             ceeeeccccccCceEEEEEEEcc-CCCEEEEEEcccCC----------hhhHHHHHHHHHHHHh-cCCCCceeeeeeEEe
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERK-TGNIFAAKFIPVSH----------NLEKELIRKEIDIMNQ-LHHPKLINLHDAFED  176 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~-~~~~~a~K~~~~~~----------~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~  176 (356)
                      .|++.+.||+|+||.||+|.++. ++..+|+|.+....          ......+.+|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            37888999999999999999987 67899999875432          2223456678888875 799999999999999


Q ss_pred             CCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEeecCCCcEEEE
Q psy12427        177 DDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE-KNIIHLDVKPENIMCQTRNSTNVKMI  255 (356)
Q Consensus       177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~Dlkp~NIlv~~~~~~~vkl~  255 (356)
                      .+..+++|||+++++|.+++.....  ....+....+..++.|++.||.|||+ .+++|+||+|+||+++.++  .++|+
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~--~~~l~  156 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKE--KKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD--KVTIT  156 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC--cEEEe
Confidence            9999999999999999888743110  11223334556699999999999996 7899999999999997654  79999


Q ss_pred             eeeceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhh
Q psy12427        256 DFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEA  335 (356)
Q Consensus       256 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  335 (356)
                      |||.+.............|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+....+....  
T Consensus       157 dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--  234 (269)
T cd08528         157 DFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLP--  234 (269)
T ss_pred             cccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCC--
Confidence            999998765544344556899999999999988999999999999999999999999888877777777665544322  


Q ss_pred             hccCCHHHHHHHHHhhhcCCC
Q psy12427        336 FKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       336 ~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ...++.++.++|++||+.||+
T Consensus       235 ~~~~~~~l~~li~~cl~~~p~  255 (269)
T cd08528         235 EGMYSEDVTDVITSCLTPDAE  255 (269)
T ss_pred             cccCCHHHHHHHHHHCCCCCc
Confidence            235789999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=6.5e-39  Score=285.88  Aligned_cols=228  Identities=18%  Similarity=0.219  Sum_probs=180.8

Q ss_pred             ccccccCceEEEEEEEccCC----------CEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        114 EEIGTGAFGVVHRCRERKTG----------NIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~~----------~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      +.||+|+||.||+|.++.++          ..+++|.+...... ...+.+|+.+|+.++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46999999999999998776          35788877655433 5678899999999999999999999988 778999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCC-----cEEEEeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNST-----NVKMIDFG  258 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~-----~vkl~Dfg  258 (356)
                      |||+.+|+|.+++......++     ...+..++.||+.||+|||++||+||||||+|||++.++..     .+||+|||
T Consensus        79 ~e~~~~~~L~~~l~~~~~~~~-----~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          79 EEYVKFGPLDVFLHREKNNVS-----LHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEcCCCCcHHHHHHhhccCCC-----HHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence            999999999999875432233     33345589999999999999999999999999999865522     59999999


Q ss_pred             ceeeeCCCCceeecCCCcCccccccccCC--CCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhh
Q psy12427        259 LATKLDPNEVVKISTGTAEFAAPEIVERE--PVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEA  335 (356)
Q Consensus       259 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  335 (356)
                      ++.....   .....++..|+|||++...  .++.++|||||||++|+|++ |..||...+..+......... ..+.  
T Consensus       154 ~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~-~~~~--  227 (259)
T cd05037         154 IPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH-RLPM--  227 (259)
T ss_pred             ccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCC-CCCC--
Confidence            9887543   2234567889999999877  78999999999999999999 688887776544433332211 1111  


Q ss_pred             hccCCHHHHHHHHHhhhcCCC
Q psy12427        336 FKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       336 ~~~~s~~~~~lI~~ll~~dP~  356 (356)
                        ..+.++.++|.+||+.||+
T Consensus       228 --~~~~~~~~li~~~l~~~p~  246 (259)
T cd05037         228 --PDCAELANLINQCWTYDPT  246 (259)
T ss_pred             --CCchHHHHHHHHHhccChh
Confidence              2238999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-39  Score=289.17  Aligned_cols=240  Identities=24%  Similarity=0.444  Sum_probs=191.6

Q ss_pred             eeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh--hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEec
Q psy12427        110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN--LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFL  187 (356)
Q Consensus       110 y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~  187 (356)
                      |++.+.||.|++|.||+|.++.+|..+|+|++.....  .....+.+|+++++.++||||+++++++......+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            5678899999999999999999999999999875532  22356778999999999999999999999999999999999


Q ss_pred             cccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCC
Q psy12427        188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE  267 (356)
Q Consensus       188 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~  267 (356)
                      + ++|.+++.....    ..+....+..++.|++.||+|||+++++|+||+|+||+++.++  .++|+|||++.......
T Consensus        81 ~-~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~--~~~l~df~~~~~~~~~~  153 (283)
T cd07835          81 D-LDLKKYMDSSPL----TGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG--ALKLADFGLARAFGVPV  153 (283)
T ss_pred             C-cCHHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC--cEEEeecccccccCCCc
Confidence            5 689888864331    2234445566999999999999999999999999999998644  79999999997654222


Q ss_pred             -ceeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc----------------
Q psy12427        268 -VVKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDW----------------  329 (356)
Q Consensus       268 -~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~----------------  329 (356)
                       ......+++.|+|||++.+. .++.++|+||||+++|+|++|++||...++.+.+.++.....                
T Consensus       154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence             12233568899999988764 468899999999999999999999988876655544332111                


Q ss_pred             ---------ccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        330 ---------EFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       330 ---------~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                               .........++.++.++|.+||+.||+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~  269 (283)
T cd07835         234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPA  269 (283)
T ss_pred             hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChh
Confidence                     111222346789999999999999995

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=8.8e-39  Score=289.47  Aligned_cols=238  Identities=21%  Similarity=0.338  Sum_probs=185.1

Q ss_pred             ceeeeccccccCceEEEEEEE----ccCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeC--CeEE
Q psy12427        109 HYDILEEIGTGAFGVVHRCRE----RKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDD--DEMV  181 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~----~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~  181 (356)
                      .|++.+.||+|+||.||+|+.    +.++..+|+|.++... ......+.+|+.++++++||||+++++++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            478999999999999999984    4568899999987553 33346788999999999999999999998765  6789


Q ss_pred             EEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeecee
Q psy12427        182 LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT  261 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~  261 (356)
                      +||||++|++|.+++......     .....+..++.|++.||+|||++|++||||||+||+++.++  .++|+|||+++
T Consensus        85 lv~e~~~g~~L~~~l~~~~~~-----~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~--~~~l~dfg~~~  157 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNKNK-----INLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH--QVKIGDFGLTK  157 (284)
T ss_pred             EEEEccCCCCHHHHHHhccCC-----CCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCC--CEEECCCcccc
Confidence            999999999999998643322     23334455999999999999999999999999999997654  69999999998


Q ss_pred             eeCCCCce----eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC---------------hHHHHH
Q psy12427        262 KLDPNEVV----KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN---------------DVETLK  322 (356)
Q Consensus       262 ~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~---------------~~~~~~  322 (356)
                      ........    ....++..|+|||++.+..++.++|||||||++|+|+++..|+....               ......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR  237 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence            76433221    22346778999999998889999999999999999999877653211               011111


Q ss_pred             HhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        323 NVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       323 ~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+.... ..  +.+..++.++.+||.+||+.||+
T Consensus       238 ~~~~~~-~~--~~~~~~~~~~~~li~~~l~~~p~  268 (284)
T cd05079         238 VLEEGK-RL--PRPPNCPEEVYQLMRKCWEFQPS  268 (284)
T ss_pred             HHHcCc-cC--CCCCCCCHHHHHHHHHHccCCcc
Confidence            121211 11  12346899999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG4250|consensus

Probab=100.00  E-value=6.1e-40  Score=309.53  Aligned_cols=202  Identities=34%  Similarity=0.576  Sum_probs=173.0

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEe------CCeEE
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFED------DDEMV  181 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~~~~  181 (356)
                      -+...+.||+|+||.||+++++.+|+.+|+|.+.... ...++..-+|+++|++|+|||||++.++=+.      ....+
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            3566789999999999999999999999999987644 3344555689999999999999999997553      34678


Q ss_pred             EEEEeccccchhhhhhCCC--CCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCC-c-EEEEee
Q psy12427        182 LIFEFLSGGELFERITAPD--YKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNST-N-VKMIDF  257 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~-~-vkl~Df  257 (356)
                      ++||||.||+|..++....  +.+++.++     ..++.+++.||.|||++||+||||||.||++.....+ . -||+||
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~-----l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDf  168 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEF-----LDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDF  168 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHH-----HHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecc
Confidence            9999999999999997543  23444444     4499999999999999999999999999999765433 3 399999


Q ss_pred             eceeeeCCCCceeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q psy12427        258 GLATKLDPNEVVKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGE  315 (356)
Q Consensus       258 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~  315 (356)
                      |.|+.++.+......+||+.|.+||.+.. +.|+...|.|||||++|+.+||..||-..
T Consensus       169 G~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~  227 (732)
T KOG4250|consen  169 GAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF  227 (732)
T ss_pred             cccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence            99999999888888899999999999985 78888999999999999999999999755

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.6e-38  Score=288.06  Aligned_cols=241  Identities=29%  Similarity=0.505  Sum_probs=199.8

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      .+.|++.+.||.|++|.||+|.++.++..+++|++..... ....+.+|+++++.++|+||+++++++......++++||
T Consensus        18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   96 (286)
T cd06614          18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY   96 (286)
T ss_pred             cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence            4568899999999999999999998999999999976554 456778899999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +++++|.+++......++.     ..+..++.|++.||+|||+.|++|+||+|+||+++.++  .++|+|||++......
T Consensus        97 ~~~~~L~~~l~~~~~~l~~-----~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~  169 (286)
T cd06614          97 MDGGSLTDIITQNFVRMNE-----PQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDG--SVKLADFGFAAQLTKE  169 (286)
T ss_pred             cCCCcHHHHHHHhccCCCH-----HHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCC--CEEECccchhhhhccc
Confidence            9999999999765422333     34455999999999999999999999999999998554  7999999988655432


Q ss_pred             C-ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHH
Q psy12427        267 E-VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD  345 (356)
Q Consensus       267 ~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  345 (356)
                      . ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+...... +......++.++++
T Consensus       170 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~  248 (286)
T cd06614         170 KSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIP-PLKNPEKWSPEFKD  248 (286)
T ss_pred             hhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCcchhhCCHHHHH
Confidence            2 122335788999999999888999999999999999999999999988776665555443322 11222358999999


Q ss_pred             HHHHhhhcCCC
Q psy12427        346 FIRRLLLRNKE  356 (356)
Q Consensus       346 lI~~ll~~dP~  356 (356)
                      ||++||+.||.
T Consensus       249 li~~~l~~~p~  259 (286)
T cd06614         249 FLNKCLVKDPE  259 (286)
T ss_pred             HHHHHhccChh
Confidence            99999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.1e-38  Score=296.68  Aligned_cols=245  Identities=22%  Similarity=0.296  Sum_probs=187.8

Q ss_pred             ccceeeeccccccCceEEEEEEEc-----cCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEe-CC
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRER-----KTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQL-HHPKLINLHDAFED-DD  178 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~-----~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~-~~  178 (356)
                      .++|++.+.||+|+||.||+|.+.     .+++.||+|.++... ......+.+|+.+|.++ +||||+++++++.. +.
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            357999999999999999999853     457899999997643 23345677899999999 68999999998864 45


Q ss_pred             eEEEEEEeccccchhhhhhCCCCCCC------------------------------------------------------
Q psy12427        179 EMVLIFEFLSGGELFERITAPDYKMS------------------------------------------------------  204 (356)
Q Consensus       179 ~~~lv~e~~~~g~L~~~l~~~~~~~~------------------------------------------------------  204 (356)
                      ..+++|||+++|+|.+++........                                                      
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            68999999999999998864321000                                                      


Q ss_pred             -------ccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCc---eeecCC
Q psy12427        205 -------EAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEV---VKISTG  274 (356)
Q Consensus       205 -------~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~g  274 (356)
                             ...+....+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||++........   .....+
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENN--VVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCC--cEEEEecccccccccCcchhhcCCCCC
Confidence                   01122334456889999999999999999999999999998554  799999999876532211   111234


Q ss_pred             CcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChH-HHHHHhhccccccChhhhccCCHHHHHHHHHhhh
Q psy12427        275 TAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDV-ETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLL  352 (356)
Q Consensus       275 t~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~  352 (356)
                      +..|+|||.+.+..++.++||||||+++|+|++ |..||.+.... +....+........   ...+++++.+++.+||+
T Consensus       244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~cl~  320 (343)
T cd05103         244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA---PDYTTPEMYQTMLDCWH  320 (343)
T ss_pred             CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCC---CCCCCHHHHHHHHHHcc
Confidence            678999999999899999999999999999997 99999876543 33333333322111   13578899999999999


Q ss_pred             cCCC
Q psy12427        353 RNKE  356 (356)
Q Consensus       353 ~dP~  356 (356)
                      .||+
T Consensus       321 ~~p~  324 (343)
T cd05103         321 GEPS  324 (343)
T ss_pred             CChh
Confidence            9985

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=6.7e-39  Score=286.31  Aligned_cols=231  Identities=29%  Similarity=0.520  Sum_probs=195.4

Q ss_pred             ccccCceEEEEEEEccCCCEEEEEEcccCCh---hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEeccccch
Q psy12427        116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHN---LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGEL  192 (356)
Q Consensus       116 lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L  192 (356)
                      ||.|+||.||++.+..+|+.+++|.+.....   .....+.+|++++++++||||+++++.+......++++||+.+++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999999999999999875543   3456778899999999999999999999999999999999999999


Q ss_pred             hhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCC-----
Q psy12427        193 FERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE-----  267 (356)
Q Consensus       193 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~-----  267 (356)
                      .+++....      .+....+..++.|++.||+|||+.|++|+||+|+||+++.++  .++|+|||++.......     
T Consensus        81 ~~~l~~~~------~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~  152 (265)
T cd05579          81 ASLLENVG------SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNG--HLKLTDFGLSKVGLVRRQINLN  152 (265)
T ss_pred             HHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCC--CEEEEecccchhcccCcccccc
Confidence            99886533      233344556999999999999999999999999999998655  79999999987653321     


Q ss_pred             ----ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHH
Q psy12427        268 ----VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG  343 (356)
Q Consensus       268 ----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  343 (356)
                          ......++..|+|||.+.....+.++|+||||+++|+|++|..||......+....+......++..  ..++.++
T Consensus       153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  230 (265)
T cd05579         153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEA  230 (265)
T ss_pred             cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCcc--ccCCHHH
Confidence                1223357889999999988889999999999999999999999999999888888887766555432  2369999


Q ss_pred             HHHHHHhhhcCCC
Q psy12427        344 KDFIRRLLLRNKE  356 (356)
Q Consensus       344 ~~lI~~ll~~dP~  356 (356)
                      .+||++||+.||+
T Consensus       231 ~~~i~~~l~~~p~  243 (265)
T cd05579         231 IDLISKLLVPDPE  243 (265)
T ss_pred             HHHHHHHhcCCHh
Confidence            9999999999984

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.1e-38  Score=291.57  Aligned_cols=238  Identities=19%  Similarity=0.304  Sum_probs=189.7

Q ss_pred             cceeeeccccccCceEEEEEEEccCCC----EEEEEEcccCCh-hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGN----IFAAKFIPVSHN-LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~----~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      ++|++.+.||+|+||.||+|.+..++.    .+|+|.+..... .....+.+|+.+++.++||||+++++.+... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            468899999999999999999987775    468888765433 2334678899999999999999999998754 4678


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ++||+++|+|.+++......+.+.     .+..++.|++.||+|||++||+|+||||+||+++.++  .+||+|||+++.
T Consensus        86 v~e~~~~g~l~~~~~~~~~~~~~~-----~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~--~~kL~Dfg~~~~  158 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHKDNIGSQ-----LLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPN--HVKITDFGLARL  158 (303)
T ss_pred             eehhcCCCCHHHHHHhcccCCCHH-----HHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCC--ceEEcccccccc
Confidence            999999999999987543333333     3455899999999999999999999999999997544  699999999987


Q ss_pred             eCCCCce---eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhcc
Q psy12427        263 LDPNEVV---KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKN  338 (356)
Q Consensus       263 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  338 (356)
                      .......   ....++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+.... .++.  ...
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~  235 (303)
T cd05110         159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE-RLPQ--PPI  235 (303)
T ss_pred             ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC-CCCC--CCC
Confidence            6433221   12234678999999999999999999999999999997 999998877666554444332 2222  246


Q ss_pred             CCHHHHHHHHHhhhcCCC
Q psy12427        339 VSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       339 ~s~~~~~lI~~ll~~dP~  356 (356)
                      ++.++.++|.+||..||+
T Consensus       236 ~~~~~~~li~~c~~~~p~  253 (303)
T cd05110         236 CTIDVYMVMVKCWMIDAD  253 (303)
T ss_pred             CCHHHHHHHHHHcCCChh
Confidence            789999999999999985

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.1e-38  Score=287.54  Aligned_cols=244  Identities=27%  Similarity=0.404  Sum_probs=191.2

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh-hhHHHHHHHHHHHHhcCCCCceeeeeeEEe--CCeEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN-LEKELIRKEIDIMNQLHHPKLINLHDAFED--DDEMVLIF  184 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~lv~  184 (356)
                      ++|...+.||.|++|.||+|.++.++..+|+|.+..... .....+.+|++++++++||||++++++|..  ...+++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            368899999999999999999999999999999875433 344668899999999999999999998864  44789999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      ||+++++|.+++.....  ....+....+..++.|++.||+|||+.|++|+||+|+||+++.++  .++|+|||++....
T Consensus        81 e~~~~~~L~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~--~~~l~dfg~~~~~~  156 (287)
T cd06621          81 EYCEGGSLDSIYKKVKK--RGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKG--QVKLCDFGVSGELV  156 (287)
T ss_pred             EecCCCCHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCC--eEEEeecccccccc
Confidence            99999999887653211  112233344566999999999999999999999999999998654  69999999987553


Q ss_pred             CCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC-----ChHHHHHHhhccccccChhhh---
Q psy12427        265 PNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGE-----NDVETLKNVKACDWEFDEEAF---  336 (356)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~-----~~~~~~~~i~~~~~~~~~~~~---  336 (356)
                      ... .....++..|+|||.+.+..++.++|||||||++|+|++|..||...     ...+....+........+...   
T Consensus       157 ~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd06621         157 NSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNG  235 (287)
T ss_pred             ccc-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCC
Confidence            222 12345788999999999999999999999999999999999999866     233444444432221111111   


Q ss_pred             ccCCHHHHHHHHHhhhcCCC
Q psy12427        337 KNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       337 ~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ..+++++.+||.+||+.||+
T Consensus       236 ~~~~~~~~~li~~~l~~~p~  255 (287)
T cd06621         236 IKWSEEFKDFIKQCLEKDPT  255 (287)
T ss_pred             CchHHHHHHHHHHHcCCCcc
Confidence            23578999999999999985

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.6e-38  Score=291.02  Aligned_cols=235  Identities=23%  Similarity=0.365  Sum_probs=192.1

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      .|...+.||+|+||.||++.+..++..+|+|.+....   ......+.+|+++++.++|||++++++++..+...++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            4788899999999999999999999999999986542   2233567889999999999999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |+.| +|.+.+......++     ...+..++.|++.||.|||+.|++|+||+|+||+++.++  .++|+|||++.....
T Consensus       106 ~~~g-~l~~~~~~~~~~l~-----~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~--~~kl~dfg~~~~~~~  177 (317)
T cd06635         106 YCLG-SASDLLEVHKKPLQ-----EVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG--QVKLADFGSASIASP  177 (317)
T ss_pred             CCCC-CHHHHHHHhcCCCC-----HHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCC--CEEEecCCCccccCC
Confidence            9964 77777654333333     334455899999999999999999999999999997544  799999999875443


Q ss_pred             CCceeecCCCcCcccccccc---CCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHH
Q psy12427        266 NEVVKISTGTAEFAAPEIVE---REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEE  342 (356)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  342 (356)
                      .   ....|++.|+|||.+.   .+.++.++|+|||||++|+|++|..||...+..+.+..+........  ....+++.
T Consensus       178 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  252 (317)
T cd06635         178 A---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL--QSNEWSDY  252 (317)
T ss_pred             c---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCC--CCccccHH
Confidence            2   2346889999999973   45688999999999999999999999988877777766655443222  12368899


Q ss_pred             HHHHHHHhhhcCCC
Q psy12427        343 GKDFIRRLLLRNKE  356 (356)
Q Consensus       343 ~~~lI~~ll~~dP~  356 (356)
                      +++||.+||+.||+
T Consensus       253 l~~li~~~l~~~p~  266 (317)
T cd06635         253 FRNFVDSCLQKIPQ  266 (317)
T ss_pred             HHHHHHHHccCCcc
Confidence            99999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=7.5e-39  Score=290.35  Aligned_cols=245  Identities=23%  Similarity=0.375  Sum_probs=187.6

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCeEEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLH-HPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      ++|...++||+|+||.||++.++.++..+|+|.+.... ......+.+|+.++.++. ||||+++++++..+...+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            35778899999999999999999999999999987543 334566788999999996 9999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEK-NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      |+.. ++.++..... ......+....+..++.+++.||+|||+. +++||||||+||+++.++  .++|+|||++....
T Consensus        84 ~~~~-~l~~l~~~~~-~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~--~~kl~dfg~~~~~~  159 (288)
T cd06616          84 LMDI-SLDKFYKYVY-EVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG--NIKLCDFGISGQLV  159 (288)
T ss_pred             cccC-CHHHHHHHHH-HhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC--cEEEeecchhHHhc
Confidence            9854 4443321100 00112233444566999999999999975 999999999999998654  69999999997654


Q ss_pred             CCCceeecCCCcCccccccccCC---CCCccccHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHhhcccc-ccChhhhccC
Q psy12427        265 PNEVVKISTGTAEFAAPEIVERE---PVGFYTDMWAVGVLAYVLLSGLSPFAGEND-VETLKNVKACDW-EFDEEAFKNV  339 (356)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlG~il~ell~g~~Pf~~~~~-~~~~~~i~~~~~-~~~~~~~~~~  339 (356)
                      .........|++.|+|||++...   .++.++||||+||++|+|++|+.||..... .+.+.++..... ..+......+
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd06616         160 DSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREF  239 (288)
T ss_pred             cCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCcc
Confidence            43333444689999999999776   688999999999999999999999976542 223333322221 1222222458


Q ss_pred             CHHHHHHHHHhhhcCCC
Q psy12427        340 SEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       340 s~~~~~lI~~ll~~dP~  356 (356)
                      +.++.+||++||++||+
T Consensus       240 ~~~l~~li~~~l~~~p~  256 (288)
T cd06616         240 SPSFVNFINLCLIKDES  256 (288)
T ss_pred             CHHHHHHHHHHccCChh
Confidence            99999999999999995

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=6.5e-39  Score=297.16  Aligned_cols=240  Identities=24%  Similarity=0.419  Sum_probs=190.5

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh--hhHHHHHHHHHHHHhcCCCCceeeeeeEEe----CCeEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN--LEKELIRKEIDIMNQLHHPKLINLHDAFED----DDEMV  181 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~~~  181 (356)
                      ++|++.+.||.|+||.||+|.++.+|..||+|.+.....  .....+.+|+.+|+.++||||+++++++..    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            579999999999999999999999999999999875432  234566789999999999999999998863    45789


Q ss_pred             EEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeecee
Q psy12427        182 LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT  261 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~  261 (356)
                      +||||+. ++|.+++.... .     +....+..++.|++.||+|||+.|++||||||+||+++.++  .+||+|||++.
T Consensus        85 lv~e~~~-~~l~~~~~~~~-~-----~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~--~~kl~dfg~~~  155 (334)
T cd07855          85 VVMDLME-SDLHHIIHSDQ-P-----LTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDC--ELRIGDFGMAR  155 (334)
T ss_pred             EEEehhh-hhHHHHhccCC-C-----CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC--cEEecccccce
Confidence            9999995 68888875432 2     33344566999999999999999999999999999998654  79999999997


Q ss_pred             eeCCCCc-----eeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC---
Q psy12427        262 KLDPNEV-----VKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD---  332 (356)
Q Consensus       262 ~~~~~~~-----~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~---  332 (356)
                      .......     .....|+..|+|||.+.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.......+   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~  235 (334)
T cd07855         156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV  235 (334)
T ss_pred             eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence            7643221     123468899999999865 4588999999999999999999999988876555444333211111   


Q ss_pred             ------------------------hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 ------------------------EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 ------------------------~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                              ......+++++++||++||+.||+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~  283 (334)
T cd07855         236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPE  283 (334)
T ss_pred             hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChh
Confidence                                    112245789999999999999995

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-38  Score=295.59  Aligned_cols=241  Identities=25%  Similarity=0.383  Sum_probs=186.7

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeC-----Ce
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDD-----DE  179 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~  179 (356)
                      +.++|++.+.||+|+||.||+|.++.+|..||+|.+.... ......+.+|+.++++++||||+++++++...     ..
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            3468999999999999999999999999999999986432 22345577899999999999999999987543     45


Q ss_pred             EEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeec
Q psy12427        180 MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGL  259 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~  259 (356)
                      .++++||+. ++|.+.+...  .     +....+..++.|++.||+|||+.||+||||||+|||++.++  .+||+|||+
T Consensus        83 ~~lv~e~~~-~~l~~~~~~~--~-----l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~--~~kl~dfg~  152 (336)
T cd07849          83 VYIVQELME-TDLYKLIKTQ--H-----LSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNC--DLKICDFGL  152 (336)
T ss_pred             EEEEehhcc-cCHHHHHhcC--C-----CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC--CEEECcccc
Confidence            899999996 4777776532  2     33334556999999999999999999999999999997654  799999999


Q ss_pred             eeeeCCCCce----eecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc---
Q psy12427        260 ATKLDPNEVV----KISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEF---  331 (356)
Q Consensus       260 a~~~~~~~~~----~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~---  331 (356)
                      +.........    ....|++.|+|||.+.+ ..++.++||||+||++|+|++|++||.+.+....+..+.......   
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~  232 (336)
T cd07849         153 ARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQE  232 (336)
T ss_pred             eeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence            9776432211    22357899999998754 568899999999999999999999998776544433322111000   


Q ss_pred             ------------------------ChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        332 ------------------------DEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       332 ------------------------~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                              .......++.++.+||++||+.||+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  281 (336)
T cd07849         233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPH  281 (336)
T ss_pred             HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChh
Confidence                                    0112235789999999999999985

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.3e-38  Score=283.33  Aligned_cols=240  Identities=24%  Similarity=0.452  Sum_probs=202.0

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      +|++.+.||+|+||.||++.++.++..+|+|.+....  ......+.+|+.+++.++||||+++++++......++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4889999999999999999999999999999987543  33456677899999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +++++|.+++.....  ....+....+..++.|++.||+|||+.|++|+||+|+||+++.++  .+||+|||++......
T Consensus        81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~--~~kl~d~g~~~~~~~~  156 (256)
T cd08530          81 APFGDLSKAISKRKK--KRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAND--LVKIGDLGISKVLKKN  156 (256)
T ss_pred             cCCCCHHHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCC--cEEEeeccchhhhccC
Confidence            999999998865221  112233444566999999999999999999999999999998644  7999999998776544


Q ss_pred             CceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHH
Q psy12427        267 EVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDF  346 (356)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  346 (356)
                       ......+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||...+..+....+....+...+   ..++.+++++
T Consensus       157 -~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l  232 (256)
T cd08530         157 -MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIP---PIYSQDLQNF  232 (256)
T ss_pred             -CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCc---hhhCHHHHHH
Confidence             333456889999999999999999999999999999999999999999887777777665543322   3789999999


Q ss_pred             HHHhhhcCCC
Q psy12427        347 IRRLLLRNKE  356 (356)
Q Consensus       347 I~~ll~~dP~  356 (356)
                      |.+||+.||+
T Consensus       233 i~~~l~~~p~  242 (256)
T cd08530         233 IRSMLQVKPK  242 (256)
T ss_pred             HHHHcCCCcc
Confidence            9999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG0584|consensus

Probab=100.00  E-value=1.2e-39  Score=303.89  Aligned_cols=232  Identities=27%  Similarity=0.367  Sum_probs=195.1

Q ss_pred             eeeccccccCceEEEEEEEccCCCEEEEEEcccC----ChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCe--EEEEE
Q psy12427        111 DILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS----HNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDE--MVLIF  184 (356)
Q Consensus       111 ~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~--~~lv~  184 (356)
                      +..++||+|+|-+||+|.+..+|..||--.++..    ...+.+.|..|+.+|+.|+||||++++++|.+...  +.+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            4567899999999999999999999887555432    34455889999999999999999999999986554  88999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHC--CceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEK--NIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      |.|..|+|..++.+.+      .....+++.|++||+.||.|||++  .|||||||.+||+|+.+ .+.|||+|+|+|..
T Consensus       123 EL~TSGtLr~Y~kk~~------~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~-~G~VKIGDLGLAtl  195 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHR------RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGN-LGEVKIGDLGLATL  195 (632)
T ss_pred             ecccCCcHHHHHHHhc------cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCC-cCceeecchhHHHH
Confidence            9999999999987544      223346788999999999999987  59999999999999654 46899999999988


Q ss_pred             eCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCC-CCChHHHHHHhhccccccChhhhccCCH
Q psy12427        263 LDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFA-GENDVETLKNVKACDWEFDEEAFKNVSE  341 (356)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~s~  341 (356)
                      ...... ..-.|||.|||||++. ..|....||||||++|+||+|+..||. ..++..+++++..+..  |..+.+--.+
T Consensus       196 ~r~s~a-ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiK--P~sl~kV~dP  271 (632)
T KOG0584|consen  196 LRKSHA-KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIK--PAALSKVKDP  271 (632)
T ss_pred             hhcccc-ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCC--HHHhhccCCH
Confidence            765433 3368999999999998 789999999999999999999999996 6688899999988773  3333334478


Q ss_pred             HHHHHHHHhhhc
Q psy12427        342 EGKDFIRRLLLR  353 (356)
Q Consensus       342 ~~~~lI~~ll~~  353 (356)
                      ++++||.+||..
T Consensus       272 evr~fIekCl~~  283 (632)
T KOG0584|consen  272 EVREFIEKCLAT  283 (632)
T ss_pred             HHHHHHHHHhcC
Confidence            999999999975

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.6e-38  Score=283.08  Aligned_cols=239  Identities=21%  Similarity=0.293  Sum_probs=183.8

Q ss_pred             ccccccCceEEEEEEEcc--CCCEEEEEEcccCCh-hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEecccc
Q psy12427        114 EEIGTGAFGVVHRCRERK--TGNIFAAKFIPVSHN-LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGG  190 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~--~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g  190 (356)
                      ++||+|+||.||+|....  ....+|+|.+..... .....+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            369999999999997543  345788887765432 33456778999999999999999999999999999999999999


Q ss_pred             chhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCce-
Q psy12427        191 ELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVV-  269 (356)
Q Consensus       191 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~~-  269 (356)
                      +|.+++....... ........+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||++......... 
T Consensus        81 ~L~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~--~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMV-AQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADL--SVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccc-cccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCC--cEEEeccccccccccchhee
Confidence            9999987543211 11222334556899999999999999999999999999998654  7999999998754332211 


Q ss_pred             --eecCCCcCccccccccC-------CCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccc-cccCh-hhhc
Q psy12427        270 --KISTGTAEFAAPEIVER-------EPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACD-WEFDE-EAFK  337 (356)
Q Consensus       270 --~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~-~~~~  337 (356)
                        ....+++.|+|||++..       ..++.++|||||||++|+|++ |..||....+.+.+..+.... ..++. ....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDL  237 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccc
Confidence              12235678999998743       456789999999999999999 889999888777766654432 22222 2234


Q ss_pred             cCCHHHHHHHHHhhhcCCC
Q psy12427        338 NVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       338 ~~s~~~~~lI~~ll~~dP~  356 (356)
                      .++..+++++..|+ .||+
T Consensus       238 ~~~~~~~~~~~~~~-~dp~  255 (269)
T cd05042         238 KYSDRWYEVMQFCW-LDPE  255 (269)
T ss_pred             cCCHHHHHHHHHHh-cCcc
Confidence            68999999999998 4875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.4e-38  Score=288.95  Aligned_cols=236  Identities=31%  Similarity=0.580  Sum_probs=189.0

Q ss_pred             ceeeeccccccCceEEEEEEEc---cCCCEEEEEEcccCCh----hhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeE
Q psy12427        109 HYDILEEIGTGAFGVVHRCRER---KTGNIFAAKFIPVSHN----LEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEM  180 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~---~~~~~~a~K~~~~~~~----~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~  180 (356)
                      .|++.+.||.|+||.||+|.+.   .+|..||+|+++....    ...+.+.+|+.++.++ +||||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            3788999999999999999885   4789999999875322    2235677899999999 589999999999999999


Q ss_pred             EEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeece
Q psy12427        181 VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA  260 (356)
Q Consensus       181 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a  260 (356)
                      ++|+||+++++|.+++.... .+.     ...+..++.|++.||.|||+.|++||||+|+|||++.++  .+||+|||++
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~-~l~-----~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~  152 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE-RFK-----EQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNG--HVVLTDFGLS  152 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC-CCC-----HHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCC--CEEEeeCccc
Confidence            99999999999999986532 222     334455888999999999999999999999999998654  7999999999


Q ss_pred             eeeCCCCc--eeecCCCcCccccccccCC--CCCccccHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHhhccccccC
Q psy12427        261 TKLDPNEV--VKISTGTAEFAAPEIVERE--PVGFYTDMWAVGVLAYVLLSGLSPFAGEND----VETLKNVKACDWEFD  332 (356)
Q Consensus       261 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~il~ell~g~~Pf~~~~~----~~~~~~i~~~~~~~~  332 (356)
                      ........  .....|+..|+|||.+...  .++.++||||||+++|+|++|..||.....    .+....+......+ 
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-  231 (290)
T cd05613         153 KEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY-  231 (290)
T ss_pred             eecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCC-
Confidence            87643221  2234588999999998753  467889999999999999999999975432    33444444433333 


Q ss_pred             hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 ~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                         ...++..+.+++++||+.||+
T Consensus       232 ---~~~~~~~~~~ll~~~l~~~p~  252 (290)
T cd05613         232 ---PQEMSALAKDIIQRLLMKDPK  252 (290)
T ss_pred             ---CccCCHHHHHHHHHHhcCCHH
Confidence               246899999999999999984

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2e-38  Score=282.32  Aligned_cols=233  Identities=22%  Similarity=0.338  Sum_probs=190.4

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEec
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFL  187 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~  187 (356)
                      ++|++.+.||+|+||.||++..  +++.+|+|.++...  ....+.+|+.+++.++||||+++++++... ..+++|||+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~   80 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM   80 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence            5699999999999999999864  57899999986543  345778899999999999999999998764 479999999


Q ss_pred             cccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCC
Q psy12427        188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE  267 (356)
Q Consensus       188 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~  267 (356)
                      .+++|.+++.....    .......+..++.|++.||.|||+.|++||||||+||+++.++  .++|+|||++...... 
T Consensus        81 ~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~--~~kl~Dfg~~~~~~~~-  153 (254)
T cd05083          81 SKGNLVNFLRTRGR----ALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDG--VAKVSDFGLARVGSMG-  153 (254)
T ss_pred             CCCCHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC--cEEECCCccceecccc-
Confidence            99999999865321    1223334455899999999999999999999999999997654  7999999998764321 


Q ss_pred             ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHH
Q psy12427        268 VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDF  346 (356)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  346 (356)
                       ......+..|+|||.+.+..++.++|+|||||++|+|++ |..||...+..+....+.... .++  ....+|.++.++
T Consensus       154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~l  229 (254)
T cd05083         154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY-RME--PPEGCPADVYVL  229 (254)
T ss_pred             -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC-CCC--CCCcCCHHHHHH
Confidence             122234678999999998899999999999999999998 999999988887777766542 222  234789999999


Q ss_pred             HHHhhhcCCC
Q psy12427        347 IRRLLLRNKE  356 (356)
Q Consensus       347 I~~ll~~dP~  356 (356)
                      |++||+.+|+
T Consensus       230 i~~~l~~~p~  239 (254)
T cd05083         230 MTSCWETEPK  239 (254)
T ss_pred             HHHHcCCChh
Confidence            9999999984

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.1e-38  Score=285.09  Aligned_cols=242  Identities=20%  Similarity=0.294  Sum_probs=190.3

Q ss_pred             eeeeccccccCceEEEEEEEcc---CCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCC------
Q psy12427        110 YDILEEIGTGAFGVVHRCRERK---TGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDD------  178 (356)
Q Consensus       110 y~~~~~lg~G~fg~V~~~~~~~---~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~------  178 (356)
                      |.+.+.||+|+||.||+|.++.   ++..+|+|++....  ....+.+.+|+.+++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            5677899999999999998754   56899999987542  334567888999999999999999999886432      


Q ss_pred             eEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeee
Q psy12427        179 EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFG  258 (356)
Q Consensus       179 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg  258 (356)
                      ..++++||+.+|+|.+++................+..++.|++.||+|||+.||+||||||+||+++.+  ..+||+|||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~--~~~kl~dfg  158 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNEN--MTVCVADFG  158 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCC--CCEEECccc
Confidence            347889999999998877533211111223444566799999999999999999999999999999754  479999999


Q ss_pred             ceeeeCCCCce---eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChh
Q psy12427        259 LATKLDPNEVV---KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEE  334 (356)
Q Consensus       259 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~  334 (356)
                      +++........   ....+++.|++||.+....++.++|||||||++|+|++ |.+||.+.+..+....+........  
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~--  236 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQ--  236 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCC--
Confidence            98866432211   12235678999999999889999999999999999999 9999998888777776665432111  


Q ss_pred             hhccCCHHHHHHHHHhhhcCCC
Q psy12427        335 AFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       335 ~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                       ...++.++.+++.+||+.+|+
T Consensus       237 -~~~~~~~~~~l~~~~l~~~p~  257 (273)
T cd05074         237 -PPDCLEDVYELMCQCWSPEPK  257 (273)
T ss_pred             -CCCCCHHHHHHHHHHcCCChh
Confidence             136789999999999999985

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-38  Score=294.71  Aligned_cols=239  Identities=28%  Similarity=0.490  Sum_probs=196.5

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCC-----eEE
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDD-----EMV  181 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----~~~  181 (356)
                      +|++.+.||.|+||.||+|.+..++..+|+|.+....  ......+.+|+.+++.++||||+++++++....     .++
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4889999999999999999999999999999987643  334467888999999999999999999988765     789


Q ss_pred             EEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeecee
Q psy12427        182 LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT  261 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~  261 (356)
                      ++|||+. ++|.+++.... .++     ...+..++.|++.||+|||+.|++|+||||+|||++.+  +.++|+|||++.
T Consensus        81 lv~e~~~-~~l~~~l~~~~-~l~-----~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~--~~~~L~dfg~~~  151 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ-PLT-----DDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSN--CDLKICDFGLAR  151 (330)
T ss_pred             EEecchh-hhHHHHHhCCC-CCC-----HHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC--CCEEEcccCceE
Confidence            9999997 57888876432 333     34445599999999999999999999999999999865  479999999998


Q ss_pred             eeCCCC----ceeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChh--
Q psy12427        262 KLDPNE----VVKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEE--  334 (356)
Q Consensus       262 ~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--  334 (356)
                      ......    ......+++.|+|||++.+. .++.++|+||||+++|+|++|.+||.+.+..+.+..+......+++.  
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  231 (330)
T cd07834         152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDL  231 (330)
T ss_pred             eecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHh
Confidence            775432    22334578999999999888 78999999999999999999999999998877777665533222211  


Q ss_pred             -------------------------hhccCCHHHHHHHHHhhhcCCC
Q psy12427        335 -------------------------AFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       335 -------------------------~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                               ....++.++.+||++||++||+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~  278 (330)
T cd07834         232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPK  278 (330)
T ss_pred             hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChh
Confidence                                     1234789999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.9e-38  Score=295.01  Aligned_cols=241  Identities=22%  Similarity=0.359  Sum_probs=191.1

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeC---------
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDD---------  177 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~---------  177 (356)
                      ..+|.+.+.||.|+||.||+|.++.+|..||+|.+..........+.+|+++++.++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            46899999999999999999999999999999998776665567788999999999999999999876543         


Q ss_pred             -----CeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcE
Q psy12427        178 -----DEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNV  252 (356)
Q Consensus       178 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~v  252 (356)
                           ...+++|||+. ++|.+++...  .     +....+..++.||+.||.|||+.|++||||||+||+++.++ ..+
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~-----l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~-~~~  154 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQG--P-----LSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTED-LVL  154 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHcC--C-----CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC-ceE
Confidence                 35799999996 5888777532  2     33344556999999999999999999999999999997543 368


Q ss_pred             EEEeeeceeeeCCCCc----eeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc
Q psy12427        253 KMIDFGLATKLDPNEV----VKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKAC  327 (356)
Q Consensus       253 kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~  327 (356)
                      +|+|||++........    .....++..|+|||.+.. ..++.++|||||||++|+|++|+.||.+.++.+....+...
T Consensus       155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~  234 (342)
T cd07854         155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES  234 (342)
T ss_pred             EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            9999999986542211    122357889999998754 56788999999999999999999999888766655544321


Q ss_pred             cc--------------------------ccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        328 DW--------------------------EFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       328 ~~--------------------------~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ..                          .........++.++++||++||+.||+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  289 (342)
T cd07854         235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPM  289 (342)
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCch
Confidence            10                          011122346889999999999999995

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.4e-38  Score=286.81  Aligned_cols=237  Identities=30%  Similarity=0.588  Sum_probs=201.5

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCeEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLH-HPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lv  183 (356)
                      ++|.+.+.||.|+||.||+|.++.++..+|+|++....   ......+.+|++++.+++ ||||+++++++......+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            36899999999999999999999999999999986532   233456778999999998 99999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      |||+.+++|.+++....      .+....+..++.|++.||.+||+.|++|+||+|+||+++.++  .++|+|||++...
T Consensus        81 ~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~--~~~l~df~~~~~~  152 (280)
T cd05581          81 LEYAPNGELLQYIRKYG------SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDM--HIKITDFGTAKVL  152 (280)
T ss_pred             EcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC--CEEecCCcccccc
Confidence            99999999999987543      233444566999999999999999999999999999997654  7999999998765


Q ss_pred             CCCCc---------------------eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q psy12427        264 DPNEV---------------------VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLK  322 (356)
Q Consensus       264 ~~~~~---------------------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~  322 (356)
                      .....                     .....++..|+|||.+....++.++|+||||+++|++++|..||...+....++
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~  232 (280)
T cd05581         153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQ  232 (280)
T ss_pred             CCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence            43221                     122346889999999998889999999999999999999999999888877777


Q ss_pred             HhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        323 NVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       323 ~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+....+.++.    .+++++.+||++||+.||+
T Consensus       233 ~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~  262 (280)
T cd05581         233 KILKLEYSFPP----NFPPDAKDLIEKLLVLDPQ  262 (280)
T ss_pred             HHHhcCCCCCC----ccCHHHHHHHHHHhcCCHh
Confidence            77766666554    6799999999999999985

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=4.6e-38  Score=282.47  Aligned_cols=239  Identities=21%  Similarity=0.267  Sum_probs=182.1

Q ss_pred             ccccccCceEEEEEEEcc--CCCEEEEEEcccCCh-hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEecccc
Q psy12427        114 EEIGTGAFGVVHRCRERK--TGNIFAAKFIPVSHN-LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGG  190 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~--~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g  190 (356)
                      +.||+|+||.||+|....  ++..+|+|.++.... .....+.+|+.++++++||||+++++++......++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            369999999999998653  456899998876543 23456788999999999999999999999999999999999999


Q ss_pred             chhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCce-
Q psy12427        191 ELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVV-  269 (356)
Q Consensus       191 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~~-  269 (356)
                      +|.+++...... .........+..++.|++.||+|||+.+++|+||||+||+++.++  .+||+|||++......... 
T Consensus        81 ~L~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~--~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKA-ELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADL--TVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC--cEEECCccccccccCcceee
Confidence            999998643211 111222233455889999999999999999999999999997644  7999999998754332221 


Q ss_pred             --eecCCCcCccccccccCC-------CCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhh-ccccccChhh-hc
Q psy12427        270 --KISTGTAEFAAPEIVERE-------PVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK-ACDWEFDEEA-FK  337 (356)
Q Consensus       270 --~~~~gt~~y~aPE~~~~~-------~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~-~~~~~~~~~~-~~  337 (356)
                        ....++..|+|||++...       .++.++|+||||+++|+|++ |..||......+...... .....++.+. ..
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKL  237 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCC
Confidence              123467889999998643       35789999999999999996 999998877666544332 2223233222 23


Q ss_pred             cCCHHHHHHHHHhhhcCCC
Q psy12427        338 NVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       338 ~~s~~~~~lI~~ll~~dP~  356 (356)
                      ..++.+.++++.|+ .||+
T Consensus       238 ~~~~~~~~l~~~c~-~~P~  255 (269)
T cd05087         238 PLSDRWYEVMQFCW-LQPE  255 (269)
T ss_pred             CCChHHHHHHHHHh-cCcc
Confidence            57899999999998 5774

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.6e-38  Score=287.64  Aligned_cols=237  Identities=26%  Similarity=0.487  Sum_probs=195.6

Q ss_pred             eeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEeccc
Q psy12427        110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSG  189 (356)
Q Consensus       110 y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  189 (356)
                      |....+||+|+||.||++..+.++..+|+|.+..........+.+|+.+++.++||||+++++.+......+++|||+++
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  101 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  101 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence            44457899999999999999999999999998765555567788999999999999999999999999999999999999


Q ss_pred             cchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCC-c
Q psy12427        190 GELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE-V  268 (356)
Q Consensus       190 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~-~  268 (356)
                      ++|.+++...  .+++     ..+..++.|++.||+|||+.|++|+||+|+||+++.++  .++|+|||++....... .
T Consensus       102 ~~L~~~~~~~--~~~~-----~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~--~~~l~dfg~~~~~~~~~~~  172 (292)
T cd06657         102 GALTDIVTHT--RMNE-----EQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDG--RVKLSDFGFCAQVSKEVPR  172 (292)
T ss_pred             CcHHHHHhcC--CCCH-----HHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC--CEEEcccccceeccccccc
Confidence            9999887543  2233     33455899999999999999999999999999998654  69999999987654322 1


Q ss_pred             eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHH
Q psy12427        269 VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIR  348 (356)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  348 (356)
                      .....|++.|+|||.+.+..++.++|+||+|+++|+|++|..||.+....+....+....... ......++.++.++|.
T Consensus       173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~  251 (292)
T cd06657         173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPK-LKNLHKVSPSLKGFLD  251 (292)
T ss_pred             ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcc-cCCcccCCHHHHHHHH
Confidence            233457899999999988889999999999999999999999999887776666554432211 1122468999999999


Q ss_pred             HhhhcCCC
Q psy12427        349 RLLLRNKE  356 (356)
Q Consensus       349 ~ll~~dP~  356 (356)
                      +||+.||.
T Consensus       252 ~~l~~~P~  259 (292)
T cd06657         252 RLLVRDPA  259 (292)
T ss_pred             HHHhCCcc
Confidence            99999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0596|consensus

Probab=100.00  E-value=4.4e-39  Score=295.49  Aligned_cols=236  Identities=26%  Similarity=0.434  Sum_probs=186.3

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccC--ChhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS--HNLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      ..|++++.||.||.+.||++..... ..||+|.+...  +......+.+|+..|.+| .|.+||+|+++=..++.+||||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            4699999999999999999987654 55666655433  333457789999999999 4899999999998999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      |+= ..+|..+|.........     ..++.+..|++.|++++|+.||||.||||.|.|+..   +.+||+|||.|..+.
T Consensus       440 E~G-d~DL~kiL~k~~~~~~~-----~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk---G~LKLIDFGIA~aI~  510 (677)
T KOG0596|consen  440 ECG-DIDLNKILKKKKSIDPD-----WFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK---GRLKLIDFGIANAIQ  510 (677)
T ss_pred             ecc-cccHHHHHHhccCCCch-----HHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe---eeEEeeeechhcccC
Confidence            964 56899998765432221     256779999999999999999999999999999963   379999999998886


Q ss_pred             CCCc---eeecCCCcCccccccccCC-----------CCCccccHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHhhcccc
Q psy12427        265 PNEV---VKISTGTAEFAAPEIVERE-----------PVGFYTDMWAVGVLAYVLLSGLSPFAGEN-DVETLKNVKACDW  329 (356)
Q Consensus       265 ~~~~---~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwSlG~il~ell~g~~Pf~~~~-~~~~~~~i~~~~~  329 (356)
                      +...   ....+||+.|||||++...           +.+++|||||||||||+|+.|++||.... ...-+..|...+-
T Consensus       511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~  590 (677)
T KOG0596|consen  511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNH  590 (677)
T ss_pred             ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCc
Confidence            5433   2446899999999999532           25688999999999999999999997663 4455666665533


Q ss_pred             --ccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        330 --EFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       330 --~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                        +||.-   .-..++.++++.||+.||.
T Consensus       591 ~Iefp~~---~~~~~li~~mK~CL~rdPk  616 (677)
T KOG0596|consen  591 EIEFPDI---PENDELIDVMKCCLARDPK  616 (677)
T ss_pred             cccccCC---CCchHHHHHHHHHHhcCcc
Confidence              34321   1123499999999999995

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.7e-38  Score=294.72  Aligned_cols=241  Identities=22%  Similarity=0.400  Sum_probs=189.6

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeC-----Ce
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDD-----DE  179 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~  179 (356)
                      .++|.+.+.||+|+||+||+|.+..++..||+|.+....  ......+.+|+.+++.++||||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            457999999999999999999999999999999986532  22334566899999999999999999988644     35


Q ss_pred             EEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeec
Q psy12427        180 MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGL  259 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~  259 (356)
                      .++++||+. ++|.+++.... .+++     ..+..++.|++.||.|||+++++|+||||+||+++.++  .+||+|||+
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~-~l~~-----~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~--~~kL~Dfg~  154 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQ-TLSD-----DHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC--DLKICDFGL  154 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCC-CCCH-----HHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC--CEEECcCcc
Confidence            899999995 68888876432 2333     34455999999999999999999999999999997654  799999999


Q ss_pred             eeeeCCC-CceeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc--------
Q psy12427        260 ATKLDPN-EVVKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDW--------  329 (356)
Q Consensus       260 a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--------  329 (356)
                      +...... .......++..|+|||.+.. ..++.++|+|||||++|+|++|++||.+.+..+.+..+.....        
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07858         155 ARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG  234 (337)
T ss_pred             ccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence            9876433 22233467899999998865 4688999999999999999999999988765444433322110        


Q ss_pred             -------------------ccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        330 -------------------EFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       330 -------------------~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                         ........++++++++||++||+.||+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~  280 (337)
T cd07858         235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPS  280 (337)
T ss_pred             hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChh
Confidence                               001123357899999999999999995

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.1e-38  Score=285.10  Aligned_cols=229  Identities=24%  Similarity=0.439  Sum_probs=179.7

Q ss_pred             cccccCceEEEEEEEccCCCEEEEEEcccCChh---hHHHHHHHH---HHHHhcCCCCceeeeeeEEeCCeEEEEEEecc
Q psy12427        115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL---EKELIRKEI---DIMNQLHHPKLINLHDAFEDDDEMVLIFEFLS  188 (356)
Q Consensus       115 ~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~---~~~~~~~E~---~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  188 (356)
                      .||+|+||.||+|.+..+++.||+|.+......   ....+..|.   ..++...||+|+.+++++......++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999999999999999998654211   112233343   34445679999999999999999999999999


Q ss_pred             ccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCc
Q psy12427        189 GGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEV  268 (356)
Q Consensus       189 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~  268 (356)
                      |++|.+++.... .     +....+..++.|++.||+|||+.+++||||+|+||+++.++  .++|+|||++....... 
T Consensus        81 g~~L~~~l~~~~-~-----l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~--~~kl~dfg~~~~~~~~~-  151 (278)
T cd05606          81 GGDLHYHLSQHG-V-----FSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFSKKK-  151 (278)
T ss_pred             CCcHHHHHHhcC-C-----CCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCC--CEEEccCcCccccCccC-
Confidence            999998886432 2     33444566999999999999999999999999999997654  79999999987654322 


Q ss_pred             eeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCC---ChHHHHHHhhccccccChhhhccCCHHHH
Q psy12427        269 VKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGE---NDVETLKNVKACDWEFDEEAFKNVSEEGK  344 (356)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  344 (356)
                      .....|+..|+|||.+.+. .++.++|+||+||++|+|++|+.||.+.   ...+...........    .+..+|.++.
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~s~~~~  227 (278)
T cd05606         152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE----LPDSFSPELR  227 (278)
T ss_pred             CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCC----CCCcCCHHHH
Confidence            2345689999999999754 6889999999999999999999999876   333333333332322    2346799999


Q ss_pred             HHHHHhhhcCCC
Q psy12427        345 DFIRRLLLRNKE  356 (356)
Q Consensus       345 ~lI~~ll~~dP~  356 (356)
                      ++|.+||+.||+
T Consensus       228 ~li~~~l~~~p~  239 (278)
T cd05606         228 SLLEGLLQRDVN  239 (278)
T ss_pred             HHHHHHhhcCHH
Confidence            999999999984

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-38  Score=278.16  Aligned_cols=237  Identities=28%  Similarity=0.454  Sum_probs=198.8

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh--hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN--LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      +|++.+.||.|++|.||++.++.+++.+++|.+.....  .....+.+|++++.+++|||++++++++......+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            47889999999999999999999999999999976654  4557788999999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +++++|.+++.... .     .....+..++.|++.||.+||+.|++|+||+|+||+++.++  .++|+|||.+......
T Consensus        81 ~~~~~L~~~~~~~~-~-----l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~  152 (254)
T cd06627          81 AENGSLRQIIKKFG-P-----FPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDG--VVKLADFGVATKLNDV  152 (254)
T ss_pred             CCCCcHHHHHHhcc-C-----CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCC--CEEEeccccceecCCC
Confidence            99999999886542 2     33344455999999999999999999999999999998644  7999999999877543


Q ss_pred             Cc-eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHH
Q psy12427        267 EV-VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD  345 (356)
Q Consensus       267 ~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  345 (356)
                      .. .....++..|+|||.+....++.++|+||+|+++|+|++|..||...+......++......   .....+++++++
T Consensus       153 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  229 (254)
T cd06627         153 SKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHP---PLPEGISPELKD  229 (254)
T ss_pred             cccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCC---CCCCCCCHHHHH
Confidence            33 23345789999999998888899999999999999999999999877766555555432221   223478999999


Q ss_pred             HHHHhhhcCCC
Q psy12427        346 FIRRLLLRNKE  356 (356)
Q Consensus       346 lI~~ll~~dP~  356 (356)
                      +|.+||+.||+
T Consensus       230 ~i~~~l~~~p~  240 (254)
T cd06627         230 FLMQCFQKDPN  240 (254)
T ss_pred             HHHHHHhCChh
Confidence            99999999985

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0695|consensus

Probab=100.00  E-value=3.4e-39  Score=280.51  Aligned_cols=239  Identities=25%  Similarity=0.531  Sum_probs=203.5

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccC---ChhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS---HNLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMV  181 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~  181 (356)
                      -.++|.++++||+|+|+.|.++++++|.+.||+|+++..   ..++...+..|..+..+- +||.+|.++.+|+.++.++
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf  327 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF  327 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence            347899999999999999999999999999999999864   344567778898888887 6999999999999999999


Q ss_pred             EEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeecee
Q psy12427        182 LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT  261 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~  261 (356)
                      +|.||++||+|.-.+.+.+ .+++..+     +.+-.+|+.||.|||++|||+||||.+|||+|..+  ++||+|+|++.
T Consensus       328 fvieyv~ggdlmfhmqrqr-klpeeha-----rfys~ei~lal~flh~rgiiyrdlkldnvlldaeg--hikltdygmck  399 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHMQRQR-KLPEEHA-----RFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEG--HIKLTDYGMCK  399 (593)
T ss_pred             EEEEEecCcceeeehhhhh-cCcHHHh-----hhhhHHHHHHHHHHhhcCeeeeeccccceEEccCC--ceeecccchhh
Confidence            9999999999976665432 3444444     44889999999999999999999999999998665  89999999997


Q ss_pred             ee-CCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCC--CC-----ChHH-HHHHhhccccccC
Q psy12427        262 KL-DPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFA--GE-----NDVE-TLKNVKACDWEFD  332 (356)
Q Consensus       262 ~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~--~~-----~~~~-~~~~i~~~~~~~~  332 (356)
                      .- .+.+.+.+.+|||.|.|||++++..|+.+.|.|+|||+|+||+.|+.||.  ++     +-++ ..+-|.+.++.+|
T Consensus       400 e~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqirip  479 (593)
T KOG0695|consen  400 EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIP  479 (593)
T ss_pred             cCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccccc
Confidence            63 56777888999999999999999999999999999999999999999996  22     2223 3444556677676


Q ss_pred             hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 ~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .    .+|-.+..+++..|++||.
T Consensus       480 r----slsvkas~vlkgflnkdp~  499 (593)
T KOG0695|consen  480 R----SLSVKASHVLKGFLNKDPK  499 (593)
T ss_pred             c----eeehhhHHHHHHhhcCCcH
Confidence            4    7888999999999999994

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.1e-38  Score=289.32  Aligned_cols=242  Identities=24%  Similarity=0.405  Sum_probs=191.8

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh--hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCC------
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN--LEKELIRKEIDIMNQLHHPKLINLHDAFEDDD------  178 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~------  178 (356)
                      .++|++.+.||.|+||.||+|.++.+|..+|+|.++....  .....+.+|+.+++.++||||+++++++....      
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~   85 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK   85 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence            4679999999999999999999999999999999875432  23356678999999999999999999987654      


Q ss_pred             ----eEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEE
Q psy12427        179 ----EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKM  254 (356)
Q Consensus       179 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl  254 (356)
                          .+++++||+++ ++...+......+     ....+..++.|++.||+|||+.||+|+||+|+||+++.++  .+||
T Consensus        86 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~-----~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~--~~kl  157 (302)
T cd07864          86 KDKGAFYLVFEYMDH-DLMGLLESGLVHF-----SEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG--QIKL  157 (302)
T ss_pred             ccCCcEEEEEcccCc-cHHHHHhcCCCCC-----CHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC--cEEe
Confidence                78999999976 6666665432223     3344556999999999999999999999999999997554  7999


Q ss_pred             EeeeceeeeCCCCc--eeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc
Q psy12427        255 IDFGLATKLDPNEV--VKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEF  331 (356)
Q Consensus       255 ~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~  331 (356)
                      +|||++........  .....++..|+|||.+.+. .++.++|||||||++|+|++|++||...+..+.+..+.......
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~  237 (302)
T cd07864         158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP  237 (302)
T ss_pred             CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            99999987643332  1223457889999988653 57889999999999999999999999887777666654432111


Q ss_pred             Ch--------------------------hhhccCCHHHHHHHHHhhhcCCC
Q psy12427        332 DE--------------------------EAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       332 ~~--------------------------~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ++                          ..+..+|..+.++|.+||+.||+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~  288 (302)
T cd07864         238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPS  288 (302)
T ss_pred             ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChh
Confidence            11                          12335789999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2e-38  Score=286.42  Aligned_cols=239  Identities=27%  Similarity=0.453  Sum_probs=193.8

Q ss_pred             eeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh--hHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEec
Q psy12427        110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL--EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFL  187 (356)
Q Consensus       110 y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~  187 (356)
                      |++.+.||.|++|.||+|.++.++..+++|.+......  ....+.+|+.++++++||||+++++++..+...++++||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            56778999999999999999999999999998755332  3466778999999999999999999999999999999999


Q ss_pred             cccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCC
Q psy12427        188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE  267 (356)
Q Consensus       188 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~  267 (356)
                      .+ +|.+++......+     ....+..++.|++.||.|||+.+++|+||+|+||+++.++  .++|+|||.+.......
T Consensus        81 ~~-~l~~~l~~~~~~~-----~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~--~~~l~df~~~~~~~~~~  152 (283)
T cd05118          81 DT-DLYKLIKDRQRGL-----PESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEG--VLKLADFGLARSFGSPV  152 (283)
T ss_pred             CC-CHHHHHHhhcccC-----CHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCC--cEEEeeeeeeEecCCCc
Confidence            75 8888776543333     3344455999999999999999999999999999997544  79999999998775543


Q ss_pred             -ceeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc--------------
Q psy12427        268 -VVKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEF--------------  331 (356)
Q Consensus       268 -~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~--------------  331 (356)
                       ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.+..+.+..+.......              
T Consensus       153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd05118         153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN  232 (283)
T ss_pred             ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhh
Confidence             22334578899999999876 78999999999999999999999999888766655543221110              


Q ss_pred             ------------ChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        332 ------------DEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       332 ------------~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                  .......++.++++||.+||++||+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~  269 (283)
T cd05118         233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPH  269 (283)
T ss_pred             hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcc
Confidence                        1123345789999999999999995

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=6.7e-38  Score=278.50  Aligned_cols=238  Identities=27%  Similarity=0.470  Sum_probs=197.7

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh--hhHHHHHHHHHHHHhcCCCCceeeeeeEEeC--CeEEEEE
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN--LEKELIRKEIDIMNQLHHPKLINLHDAFEDD--DEMVLIF  184 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~lv~  184 (356)
                      +|++.+.||+|++|.||+|.++.++..+++|++.....  .....+.+|+.++++++||||+++++.+...  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            37788999999999999999999999999999876543  4457788999999999999999999999988  8999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      ||+++++|.+++.... .+     ....+..++.|++.||+|||+.|++|+||+|+||+++.++  .++|+|||.+....
T Consensus        81 e~~~~~~L~~~~~~~~-~~-----~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~--~~~l~d~~~~~~~~  152 (260)
T cd06606          81 EYVSGGSLSSLLKKFG-KL-----PEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDG--VVKLADFGCAKRLG  152 (260)
T ss_pred             EecCCCcHHHHHHHcC-CC-----CHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC--CEEEcccccEEecc
Confidence            9999999999987543 33     3344455999999999999999999999999999998644  79999999998876


Q ss_pred             CCCc---eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHhhccccccChhhhccCC
Q psy12427        265 PNEV---VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN-DVETLKNVKACDWEFDEEAFKNVS  340 (356)
Q Consensus       265 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s  340 (356)
                      ....   .....++..|+|||.+.....+.++|+||||+++|+|++|..||.... .......+...  .........++
T Consensus       153 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  230 (260)
T cd06606         153 DIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSS--GEPPEIPEHLS  230 (260)
T ss_pred             cccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhcccc--CCCcCCCcccC
Confidence            5543   344568999999999998889999999999999999999999998876 33333333321  11222334679


Q ss_pred             HHHHHHHHHhhhcCCC
Q psy12427        341 EEGKDFIRRLLLRNKE  356 (356)
Q Consensus       341 ~~~~~lI~~ll~~dP~  356 (356)
                      .++++||.+||+.||+
T Consensus       231 ~~l~~~i~~~l~~~p~  246 (260)
T cd06606         231 EEAKDFLRKCLRRDPK  246 (260)
T ss_pred             HHHHHHHHHhCcCChh
Confidence            9999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-38  Score=283.99  Aligned_cols=240  Identities=28%  Similarity=0.430  Sum_probs=192.6

Q ss_pred             eeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh--hHHHHHHHHHHHHhc---CCCCceeeeeeEEeCCe-----
Q psy12427        110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL--EKELIRKEIDIMNQL---HHPKLINLHDAFEDDDE-----  179 (356)
Q Consensus       110 y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~E~~il~~l---~hpnIv~l~~~~~~~~~-----  179 (356)
                      |++.+.||.|+||.||+|.++.++..+|+|.++.....  ....+.+|+.+++++   +||||+++++++.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            67889999999999999999988999999999754322  234566788887776   59999999999987776     


Q ss_pred             EEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeec
Q psy12427        180 MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGL  259 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~  259 (356)
                      .+++|||+.+ +|.+++.....    ..+....+..++.|++.||+|||+.+++|+||+|+||+++.++  .++|+|||+
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~--~~~l~dfg~  153 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPK----PGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG--QVKIADFGL  153 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCC--CEEEeccCc
Confidence            9999999964 78887764321    1233445566999999999999999999999999999998664  799999999


Q ss_pred             eeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc---------
Q psy12427        260 ATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWE---------  330 (356)
Q Consensus       260 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~---------  330 (356)
                      +.............++..|+|||++.+..++.++|+|||||++|+|++|.+||.+.+..+.+.++......         
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07838         154 ARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN  233 (287)
T ss_pred             ceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCC
Confidence            98875444334445788999999999999999999999999999999999999999888777766432110         


Q ss_pred             --------------cChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        331 --------------FDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       331 --------------~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                    ......+.++.++.+||.+||+.||+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  273 (287)
T cd07838         234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPH  273 (287)
T ss_pred             cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCc
Confidence                          00112235678999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=7.4e-38  Score=287.48  Aligned_cols=237  Identities=23%  Similarity=0.361  Sum_probs=192.3

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh---hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN---LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      .+.|...++||+|+||+||+|.+..++..+++|.+.....   .....+.+|+++++.++|||++++++++......++|
T Consensus        20 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   99 (313)
T cd06633          20 EEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLV   99 (313)
T ss_pred             HHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence            3457777889999999999999999999999999865432   2335677899999999999999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      |||+. |+|.+++......++     ...+..++.|++.||+|||++|++|+||+|+||+++.++  .++|+|||++...
T Consensus       100 ~e~~~-~~l~~~l~~~~~~l~-----~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~--~~kL~dfg~~~~~  171 (313)
T cd06633         100 MEYCL-GSASDLLEVHKKPLQ-----EVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG--QVKLADFGSASKS  171 (313)
T ss_pred             EecCC-CCHHHHHHhcCCCCC-----HHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCC--CEEEeecCCCccc
Confidence            99995 577777754433333     334455899999999999999999999999999997554  7999999988653


Q ss_pred             CCCCceeecCCCcCcccccccc---CCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCC
Q psy12427        264 DPNEVVKISTGTAEFAAPEIVE---REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVS  340 (356)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  340 (356)
                      ..   .....|+..|+|||.+.   ...++.++|||||||++|+|++|..||...+.......+.....  +......++
T Consensus       172 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~  246 (313)
T cd06633         172 SP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PTLQSNEWT  246 (313)
T ss_pred             CC---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CCCCccccC
Confidence            32   22346889999999984   45688899999999999999999999998877776666654432  222234678


Q ss_pred             HHHHHHHHHhhhcCCC
Q psy12427        341 EEGKDFIRRLLLRNKE  356 (356)
Q Consensus       341 ~~~~~lI~~ll~~dP~  356 (356)
                      ..+++||.+||+.+|+
T Consensus       247 ~~l~~li~~~l~~~P~  262 (313)
T cd06633         247 DSFRGFVDYCLQKIPQ  262 (313)
T ss_pred             HHHHHHHHHHccCChh
Confidence            8999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=4.2e-38  Score=291.81  Aligned_cols=243  Identities=25%  Similarity=0.418  Sum_probs=191.3

Q ss_pred             Ccccceee-eccccccCceEEEEEEEccCCCEEEEEEcccCChhh--------------HHHHHHHHHHHHhcCCCCcee
Q psy12427        105 SVYDHYDI-LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE--------------KELIRKEIDIMNQLHHPKLIN  169 (356)
Q Consensus       105 ~~~~~y~~-~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~--------------~~~~~~E~~il~~l~hpnIv~  169 (356)
                      ++.++|.. .+.||.|+||+||+|.++.++..||+|.++......              ...+.+|+++++.++||||++
T Consensus         5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   84 (335)
T PTZ00024          5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG   84 (335)
T ss_pred             ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence            34566764 577999999999999999999999999986543221              114668999999999999999


Q ss_pred             eeeeEEeCCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCC
Q psy12427        170 LHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNS  249 (356)
Q Consensus       170 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~  249 (356)
                      +++++......+++|||+. |+|.+++.... .+     .......++.|++.||+|||+.|++|+||+|+||+++.++ 
T Consensus        85 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~-----~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~-  156 (335)
T PTZ00024         85 LVDVYVEGDFINLVMDIMA-SDLKKVVDRKI-RL-----TESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKG-  156 (335)
T ss_pred             eeEEEecCCcEEEEEeccc-cCHHHHHHhcC-CC-----CHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCC-
Confidence            9999999999999999996 58888886432 23     3344455999999999999999999999999999997654 


Q ss_pred             CcEEEEeeeceeeeCCC---------------CceeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCC
Q psy12427        250 TNVKMIDFGLATKLDPN---------------EVVKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFA  313 (356)
Q Consensus       250 ~~vkl~Dfg~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~  313 (356)
                       .++|+|||++......               .......+++.|+|||.+.+. .++.++|+|||||++|+|++|.+||.
T Consensus       157 -~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~  235 (335)
T PTZ00024        157 -ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP  235 (335)
T ss_pred             -CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence             7999999999765411               111223467889999998764 46889999999999999999999999


Q ss_pred             CCChHHHHHHhhccccccCh------------------------hhhccCCHHHHHHHHHhhhcCCC
Q psy12427        314 GENDVETLKNVKACDWEFDE------------------------EAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       314 ~~~~~~~~~~i~~~~~~~~~------------------------~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +.++.+.+..+......+..                        ......++++.+||++||+.||+
T Consensus       236 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~  302 (335)
T PTZ00024        236 GENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPL  302 (335)
T ss_pred             CCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCch
Confidence            99887776665432111111                        11235689999999999999995

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-38  Score=288.61  Aligned_cols=207  Identities=24%  Similarity=0.386  Sum_probs=166.9

Q ss_pred             ceeeeccccccCceEEEEEEEcc--CCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeC--CeEE
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERK--TGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDD--DEMV  181 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~--~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~  181 (356)
                      +|++.++||+|+||.||+|.++.  ++..||+|.+....   ......+.+|+.++..++||||+++++++...  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            37889999999999999999998  89999999987633   33345677899999999999999999999988  8899


Q ss_pred             EEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecC--CCcEEEEeeec
Q psy12427        182 LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN--STNVKMIDFGL  259 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~--~~~vkl~Dfg~  259 (356)
                      +||||+.+ +|.+.+..... .....+....+..++.|++.||+|||+.+++||||||+|||++.++  ++.+||+|||+
T Consensus        81 lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~  158 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQ-AKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGL  158 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhcc-CCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence            99999965 66666643221 1112344455667999999999999999999999999999998621  34799999999


Q ss_pred             eeeeCCCCc----eeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCCh
Q psy12427        260 ATKLDPNEV----VKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGEND  317 (356)
Q Consensus       260 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~~  317 (356)
                      +........    .....+++.|+|||++.+. .++.++|||||||++|+|++|++||.+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~  221 (316)
T cd07842         159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA  221 (316)
T ss_pred             ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence            887643222    1223578899999988664 578999999999999999999999987654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0662|consensus

Probab=100.00  E-value=4e-39  Score=257.56  Aligned_cols=239  Identities=26%  Similarity=0.452  Sum_probs=195.2

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh--hHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL--EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      .|...++||+|.+|+||+++.+.++..||+|.++.+...  -.....+|+-+|+.++|.|||+++++...+..+.+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            477789999999999999999999999999999876543  245677899999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC-
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP-  265 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~-  265 (356)
                      |. -+|..+....+.     .+.....+.++.|+++||.++|+.++.||||||.|+|++.++  .+||+|||+++.+.- 
T Consensus        83 cd-qdlkkyfdslng-----~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ng--elkladfglarafgip  154 (292)
T KOG0662|consen   83 CD-QDLKKYFDSLNG-----DLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNG--ELKLADFGLARAFGIP  154 (292)
T ss_pred             hh-HHHHHHHHhcCC-----cCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCC--cEEecccchhhhcCCc
Confidence            95 477777654433     333444566999999999999999999999999999998655  799999999998752 


Q ss_pred             CCceeecCCCcCccccccccCCC-CCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhcc-----
Q psy12427        266 NEVVKISTGTAEFAAPEIVEREP-VGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKN-----  338 (356)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~-----  338 (356)
                      -......+-|..|.+|.++-+.. |+++.|+||.|||+.|+.. |++.|++.+-.+.+..|-.....+.++.|+.     
T Consensus       155 vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp  234 (292)
T KOG0662|consen  155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP  234 (292)
T ss_pred             eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence            22334445799999999997754 7899999999999999998 8889999998888888865444433333322     


Q ss_pred             --------------------CCHHHHHHHHHhhhcCC
Q psy12427        339 --------------------VSEEGKDFIRRLLLRNK  355 (356)
Q Consensus       339 --------------------~s~~~~~lI~~ll~~dP  355 (356)
                                          ++..-+|+++.+|.-+|
T Consensus       235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp  271 (292)
T KOG0662|consen  235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNP  271 (292)
T ss_pred             CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCc
Confidence                                34556788888887776

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=4.9e-38  Score=291.62  Aligned_cols=241  Identities=29%  Similarity=0.492  Sum_probs=190.2

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccC--ChhhHHHHHHHHHHHHhc-CCCCceeeeeeEEe--CCeE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS--HNLEKELIRKEIDIMNQL-HHPKLINLHDAFED--DDEM  180 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~--~~~~  180 (356)
                      +.++|++.+.||.|+||.||+|.++.++..+|+|.+...  .......+.+|+.+++++ +||||+++++++..  ....
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            457899999999999999999999999999999988542  223345567899999999 99999999999864  3468


Q ss_pred             EEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeece
Q psy12427        181 VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA  260 (356)
Q Consensus       181 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a  260 (356)
                      ++||||+. ++|.+++...  .+.     ......++.|++.||+|||+.||+|+||+|+||+++.++  .+||+|||++
T Consensus        85 ~lv~e~~~-~~L~~~~~~~--~~~-----~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~--~~kl~d~g~~  154 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN--ILE-----DVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDC--RVKLADFGLA  154 (337)
T ss_pred             EEEecccc-cCHHHHHhcC--CCC-----HHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC--cEEEeeccch
Confidence            99999996 5888887643  222     233445899999999999999999999999999998655  7999999999


Q ss_pred             eeeCCCC------ceeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-----
Q psy12427        261 TKLDPNE------VVKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACD-----  328 (356)
Q Consensus       261 ~~~~~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-----  328 (356)
                      .......      ......|++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+....+.+..+....     
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07852         155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA  234 (337)
T ss_pred             hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            8664322      1123457899999998865 457889999999999999999999998877665544432221     


Q ss_pred             ----------------------cccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        329 ----------------------WEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       329 ----------------------~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                            ........+.++.++.+||.+||+.||+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~  284 (337)
T cd07852         235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPN  284 (337)
T ss_pred             HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcc
Confidence                                  1122233345799999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG4645|consensus

Probab=100.00  E-value=3.1e-40  Score=327.78  Aligned_cols=239  Identities=26%  Similarity=0.408  Sum_probs=199.3

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhh--HHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE--KELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~--~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      .-+++....||.|.||.||-|.+..+|...|+|-++......  ...+.+|..+|..+.|||+|+++|+=.+....+|.|
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            345777889999999999999999999999999998765432  245778999999999999999999988999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      |||++|+|.+++.... ...+.     ..+.+..|++.|++|||+.|||||||||+||+++.++  .+|++|||.|..+.
T Consensus      1314 EyC~~GsLa~ll~~gr-i~dE~-----vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g--~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGR-IEDEM-----VTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNG--LIKYGDFGSAVKIK 1385 (1509)
T ss_pred             HHhccCcHHHHHHhcc-hhhhh-----HHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCC--cEEeecccceeEec
Confidence            9999999999886432 12222     2233889999999999999999999999999998766  79999999999886


Q ss_pred             CCCc-----eeecCCCcCccccccccCC---CCCccccHHHHHHHHHHHHcCCCCCCCC-ChHHHHHHhhccccccChhh
Q psy12427        265 PNEV-----VKISTGTAEFAAPEIVERE---PVGFYTDMWAVGVLAYVLLSGLSPFAGE-NDVETLKNVKACDWEFDEEA  335 (356)
Q Consensus       265 ~~~~-----~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlG~il~ell~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~  335 (356)
                      .+..     .....||+.|||||++.+.   ....+.||||+|||+.||+||+-||... ++..++-.+..+..+..|  
T Consensus      1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P-- 1463 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIP-- 1463 (1509)
T ss_pred             CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCc--
Confidence            4421     1234699999999999653   4667999999999999999999999765 566777777776655444  


Q ss_pred             hccCCHHHHHHHHHhhhcCCC
Q psy12427        336 FKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       336 ~~~~s~~~~~lI~~ll~~dP~  356 (356)
                       ..+|.+.+|||.+||+.||+
T Consensus      1464 -~~ls~~g~dFle~Cl~~dP~ 1483 (1509)
T KOG4645|consen 1464 -ERLSSEGRDFLEHCLEQDPK 1483 (1509)
T ss_pred             -hhhhHhHHHHHHHHHhcCch
Confidence             35999999999999999995

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.2e-38  Score=306.89  Aligned_cols=248  Identities=20%  Similarity=0.320  Sum_probs=178.7

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCC-CEEEEE--------------Eccc---CChhhHHHHHHHHHHHHhcCCCC
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTG-NIFAAK--------------FIPV---SHNLEKELIRKEIDIMNQLHHPK  166 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~-~~~a~K--------------~~~~---~~~~~~~~~~~E~~il~~l~hpn  166 (356)
                      .+.++|+++++||+|+||+||+|..+... ...+.|              .+..   ........+.+|+.+|++++|||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            34578999999999999999998765432 222222              1100   11223456788999999999999


Q ss_pred             ceeeeeeEEeCCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEee
Q psy12427        167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQT  246 (356)
Q Consensus       167 Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~  246 (356)
                      |+++++++......+++++++. ++|.+++.......... .....+..++.||+.||+|||++||+||||||+|||++.
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~-~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~  302 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDR-PLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC  302 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhcccccccc-ccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC
Confidence            9999999999999999999984 57777765443222211 112334568999999999999999999999999999976


Q ss_pred             cCCCcEEEEeeeceeeeCCCCc--eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCC-CCCCCC--hHHHH
Q psy12427        247 RNSTNVKMIDFGLATKLDPNEV--VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLS-PFAGEN--DVETL  321 (356)
Q Consensus       247 ~~~~~vkl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~-Pf~~~~--~~~~~  321 (356)
                      ++  .+||+|||++..+.....  .....||+.|+|||++.+..++.++|||||||++|||++|.. ||....  ....+
T Consensus       303 ~~--~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~  380 (501)
T PHA03210        303 DG--KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL  380 (501)
T ss_pred             CC--CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence            54  799999999987754322  223468999999999999999999999999999999999875 443322  22222


Q ss_pred             HHhhcc----ccccCh----------------------hhh--ccCCHHHHHHHHHhhhcCCC
Q psy12427        322 KNVKAC----DWEFDE----------------------EAF--KNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       322 ~~i~~~----~~~~~~----------------------~~~--~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ..+...    ...++.                      ...  ..++.++.++|.+||+.||+
T Consensus       381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~  443 (501)
T PHA03210        381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWH  443 (501)
T ss_pred             HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcc
Confidence            222111    111111                      111  13677889999999999995

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=8e-38  Score=286.62  Aligned_cols=236  Identities=24%  Similarity=0.363  Sum_probs=191.4

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccC---ChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS---HNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      +.|+..+.||.|+||.||+|+++.++..+|+|.+...   .......+.+|+++++.++|||++++++++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            4588889999999999999999999999999988643   2223456778999999999999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      ||+. |+|.+.+......+.     ...+..++.|++.||.|||+.+++||||+|+||+++.++  .++|+|||++....
T Consensus        95 e~~~-~~l~~~~~~~~~~l~-----~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~~~~  166 (308)
T cd06634          95 EYCL-GSASDLLEVHKKPLQ-----EVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG--LVKLGDFGSASIMA  166 (308)
T ss_pred             EccC-CCHHHHHHHcCCCCC-----HHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCC--cEEECCcccceeec
Confidence            9996 577777654332233     334455899999999999999999999999999997544  79999999987765


Q ss_pred             CCCceeecCCCcCcccccccc---CCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCH
Q psy12427        265 PNEVVKISTGTAEFAAPEIVE---REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSE  341 (356)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  341 (356)
                      ..   ....+++.|+|||.+.   ...++.++|||||||++|+|++|..||...+..+....+......  ......++.
T Consensus       167 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  241 (308)
T cd06634         167 PA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP--ALQSGHWSE  241 (308)
T ss_pred             Cc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCC--CcCcccccH
Confidence            33   2345789999999974   356788999999999999999999999887766666555443322  212236889


Q ss_pred             HHHHHHHHhhhcCCC
Q psy12427        342 EGKDFIRRLLLRNKE  356 (356)
Q Consensus       342 ~~~~lI~~ll~~dP~  356 (356)
                      ++++||++||+.+|+
T Consensus       242 ~~~~li~~cl~~~P~  256 (308)
T cd06634         242 YFRNFVDSCLQKIPQ  256 (308)
T ss_pred             HHHHHHHHHhhCCcc
Confidence            999999999999995

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=3.5e-38  Score=288.80  Aligned_cols=242  Identities=25%  Similarity=0.404  Sum_probs=188.2

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh--hHHHHHHHHHHHHhcCCCCceeeeeeEEeC-------
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL--EKELIRKEIDIMNQLHHPKLINLHDAFEDD-------  177 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-------  177 (356)
                      .++|++.++||.|+||.||+|.++.++..+|+|.+......  ....+.+|+++++.++||||+++++++...       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            46899999999999999999999999999999988654322  234567899999999999999999987543       


Q ss_pred             -CeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEe
Q psy12427        178 -DEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMID  256 (356)
Q Consensus       178 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~D  256 (356)
                       ..+++++||+.+ +|...+......     +....+..++.|++.||+|||++|++|+||||+||+++.++  .++|+|
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~-----~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~--~~~l~d  158 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVK-----LTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQG--ILKIAD  158 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccC-----CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC--CEEECc
Confidence             356999999964 676666543333     33444566999999999999999999999999999997654  799999


Q ss_pred             eeceeeeCCCCce------------eecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q psy12427        257 FGLATKLDPNEVV------------KISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKN  323 (356)
Q Consensus       257 fg~a~~~~~~~~~------------~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~  323 (356)
                      ||++.........            ....+++.|+|||.+.+. .++.++|||||||++|+|++|++||.+.+..+.+..
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~  238 (311)
T cd07866         159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL  238 (311)
T ss_pred             CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999765422111            112467889999988654 578899999999999999999999998887776665


Q ss_pred             hhccccccC--------------------------hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        324 VKACDWEFD--------------------------EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       324 i~~~~~~~~--------------------------~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +.......+                          ...+..+++++.+||.+||+.||+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~  297 (311)
T cd07866         239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPY  297 (311)
T ss_pred             HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcc
Confidence            543211111                          112234668899999999999995

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4e-38  Score=284.61  Aligned_cols=240  Identities=22%  Similarity=0.343  Sum_probs=189.2

Q ss_pred             cceeeeccccccCceEEEEEEEcc----CCCEEEEEEcccCChh-hHHHHHHHHHHHHhcCCCCceeeeeeEEe--CCeE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERK----TGNIFAAKFIPVSHNL-EKELIRKEIDIMNQLHHPKLINLHDAFED--DDEM  180 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~----~~~~~a~K~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~  180 (356)
                      ++|++.+.||+|+||.||+|....    ++..+|+|.+...... ....+.+|+++++.++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            468888999999999999998653    4789999999766543 45678899999999999999999999887  5678


Q ss_pred             EEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeece
Q psy12427        181 VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA  260 (356)
Q Consensus       181 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a  260 (356)
                      +++|||+++++|.+++......++     ...+..++.|++.||+|||++|++|+||+|+||+++.++  .++|+|||++
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~-----~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~  156 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQIN-----LKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESED--LVKISDFGLA  156 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccC-----HHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC--CEEEcccccc
Confidence            999999999999999875443233     334455999999999999999999999999999998654  7999999999


Q ss_pred             eeeCCCCcee----ecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHH--------------HHH
Q psy12427        261 TKLDPNEVVK----ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVE--------------TLK  322 (356)
Q Consensus       261 ~~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~--------------~~~  322 (356)
                      ..........    ...++..|+|||.+....++.++|+||||+++|+|++|..||.......              .+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05038         157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL  236 (284)
T ss_pred             cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence            8765322211    1234667999999998899999999999999999999999986543211              111


Q ss_pred             HhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        323 NVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       323 ~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ........++.  ...++.++.++|.+||+.||+
T Consensus       237 ~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~  268 (284)
T cd05038         237 ELLKEGERLPR--PPSCPDEVYDLMKLCWEAEPQ  268 (284)
T ss_pred             HHHHcCCcCCC--CccCCHHHHHHHHHHhccChh
Confidence            11111222221  236789999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-37  Score=275.85  Aligned_cols=229  Identities=31%  Similarity=0.559  Sum_probs=194.6

Q ss_pred             ccccCceEEEEEEEccCCCEEEEEEcccCCh---hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEeccccch
Q psy12427        116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHN---LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGEL  192 (356)
Q Consensus       116 lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L  192 (356)
                      ||.|+||.||++.++.++..+|+|.+.....   .....+.+|+.++++++||||+++++.+..+...+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            7999999999999998899999999875432   2345778899999999999999999999999999999999999999


Q ss_pred             hhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC-Cceee
Q psy12427        193 FERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN-EVVKI  271 (356)
Q Consensus       193 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~-~~~~~  271 (356)
                      .+++.... .     +....+..++.|++.||.|||+.+++|+||+|+||+++.++  .++|+|||++...... .....
T Consensus        81 ~~~l~~~~-~-----l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~--~~~l~d~~~~~~~~~~~~~~~~  152 (250)
T cd05123          81 FSHLSKEG-R-----FSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADG--HIKLTDFGLAKELSSEGSRTNT  152 (250)
T ss_pred             HHHHHhcC-C-----CCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCC--cEEEeecCcceecccCCCcccC
Confidence            99986543 2     23344455999999999999999999999999999997654  7999999998876443 22334


Q ss_pred             cCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHHHhh
Q psy12427        272 STGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLL  351 (356)
Q Consensus       272 ~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll  351 (356)
                      ..++..|+|||.+.+...+.++|+||||+++|+|++|..||...+..+....+......++.    .++.++.+||++||
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~~i~~~l  228 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPE----FLSPEARDLISGLL  228 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHHHh
Confidence            56789999999999888999999999999999999999999888877777777765544443    56999999999999


Q ss_pred             hcCCC
Q psy12427        352 LRNKE  356 (356)
Q Consensus       352 ~~dP~  356 (356)
                      +.||+
T Consensus       229 ~~~p~  233 (250)
T cd05123         229 QKDPT  233 (250)
T ss_pred             cCCHh
Confidence            99985

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1e-37  Score=290.32  Aligned_cols=239  Identities=25%  Similarity=0.440  Sum_probs=188.4

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeC------
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDD------  177 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------  177 (356)
                      +.++|++.+.||+|+||.||+|.+..++..||+|.+....  ......+.+|+.++++++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (345)
T cd07877          15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   94 (345)
T ss_pred             ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence            4468999999999999999999999999999999987542  22345677899999999999999999988643      


Q ss_pred             CeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEee
Q psy12427        178 DEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDF  257 (356)
Q Consensus       178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Df  257 (356)
                      ...+++++++ +++|.+++...  .++     ...+..++.|++.||+|||+.|++||||||+||+++.++  .+||+||
T Consensus        95 ~~~~lv~~~~-~~~L~~~~~~~--~l~-----~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~--~~kl~df  164 (345)
T cd07877          95 NDVYLVTHLM-GADLNNIVKCQ--KLT-----DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC--ELKILDF  164 (345)
T ss_pred             ccEEEEehhc-ccCHHHHHhcC--CCC-----HHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCC--CEEEecc
Confidence            3468888877 78888877532  223     334455999999999999999999999999999998654  7999999


Q ss_pred             eceeeeCCCCceeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCh---
Q psy12427        258 GLATKLDPNEVVKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE---  333 (356)
Q Consensus       258 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~---  333 (356)
                      |++......  .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+..+.+..+.......++   
T Consensus       165 g~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (345)
T cd07877         165 GLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL  242 (345)
T ss_pred             ccccccccc--ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            998765432  233467899999998866 56888999999999999999999999887766655544332211111   


Q ss_pred             ------------------------hhhccCCHHHHHHHHHhhhcCCC
Q psy12427        334 ------------------------EAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       334 ------------------------~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                              ..+...+.++++||.+||+.||+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~  289 (345)
T cd07877         243 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSD  289 (345)
T ss_pred             hhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChh
Confidence                                    11224688999999999999985

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.2e-37  Score=278.01  Aligned_cols=238  Identities=21%  Similarity=0.287  Sum_probs=181.7

Q ss_pred             ccccccCceEEEEEEEccC--CCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEecccc
Q psy12427        114 EEIGTGAFGVVHRCRERKT--GNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGG  190 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~--~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g  190 (356)
                      ++||+|+||.||++.....  ...+++|.+.... ......+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3699999999999976543  2456677766443 334567889999999999999999999999999999999999999


Q ss_pred             chhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCC---
Q psy12427        191 ELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE---  267 (356)
Q Consensus       191 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~---  267 (356)
                      +|.+++......  ........+..++.||+.||+|||+.+++||||||+|||++.++  .++|+|||++.......   
T Consensus        81 ~L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~--~~~l~Dfg~~~~~~~~~~~~  156 (268)
T cd05086          81 DLKSYLSQEQWH--RRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDL--TVKVGDYGIGPSRYKEDYIE  156 (268)
T ss_pred             cHHHHHHhhhcc--cccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCc--cEEecccccccccCcchhhh
Confidence            999998754322  11222334456889999999999999999999999999997544  79999999886432211   


Q ss_pred             ceeecCCCcCccccccccC-------CCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccc-cc-cChhhhc
Q psy12427        268 VVKISTGTAEFAAPEIVER-------EPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACD-WE-FDEEAFK  337 (356)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~-~~-~~~~~~~  337 (356)
                      ......++..|+|||++..       ..++.++|||||||++|||++ |..||...++.+.+..+.... .. +.+....
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (268)
T cd05086         157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLEL  236 (268)
T ss_pred             cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCC
Confidence            1123457889999999853       245778999999999999997 678998888877777654432 22 2223334


Q ss_pred             cCCHHHHHHHHHhhhcCCC
Q psy12427        338 NVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       338 ~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+++.+.+++..|| .||+
T Consensus       237 ~~~~~~~~l~~~c~-~~P~  254 (268)
T cd05086         237 PYSERWYEVLQFCW-LSPE  254 (268)
T ss_pred             CCcHHHHHHHHHHh-hCcc
Confidence            68999999999999 5674

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.1e-37  Score=288.26  Aligned_cols=238  Identities=17%  Similarity=0.236  Sum_probs=183.4

Q ss_pred             ecccccc--CceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEecc
Q psy12427        113 LEEIGTG--AFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLS  188 (356)
Q Consensus       113 ~~~lg~G--~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  188 (356)
                      ..+||+|  +||+||++.+..+|+.||+|++....  ....+.+.+|+.+++.++||||++++++|..+...++|+||+.
T Consensus         3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            3567777  99999999999999999999987543  2334678889999999999999999999999999999999999


Q ss_pred             ccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCc
Q psy12427        189 GGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEV  268 (356)
Q Consensus       189 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~  268 (356)
                      +++|.+++.....    .......+..++.|++.||+|||++|++||||||+|||++.++  .++++||+.+........
T Consensus        83 ~~~l~~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~--~~~~~~~~~~~~~~~~~~  156 (328)
T cd08226          83 YGSANSLLKTYFP----EGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDG--LVSLSGLSHLYSLVRNGQ  156 (328)
T ss_pred             CCCHHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCC--cEEEechHHHhhhhccCc
Confidence            9999998865321    1233444556999999999999999999999999999998654  799999986543321110


Q ss_pred             e--------eecCCCcCccccccccCC--CCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc-------
Q psy12427        269 V--------KISTGTAEFAAPEIVERE--PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEF-------  331 (356)
Q Consensus       269 ~--------~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-------  331 (356)
                      .        ....++..|+|||++.+.  .++.++|||||||++|+|++|..||.+....+.+..........       
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (328)
T cd08226         157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTF  236 (328)
T ss_pred             cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccccc
Confidence            0        112346679999999764  47889999999999999999999998876555443332211100       


Q ss_pred             ------------------------------------ChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        332 ------------------------------------DEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       332 ------------------------------------~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                                          ..+....++.++++||++||+.||+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  297 (328)
T cd08226         237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPE  297 (328)
T ss_pred             chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcc
Confidence                                                0111234678899999999999995

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.6e-38  Score=291.02  Aligned_cols=240  Identities=26%  Similarity=0.440  Sum_probs=191.6

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCC----
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDD----  178 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----  178 (356)
                      .+.++|++.+.||.|+||.||+|.+..++..||+|.+....  ......+.+|+.+|+.++||||+++++++....    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            35578999999999999999999999999999999986432  223456778999999999999999999987543    


Q ss_pred             --eEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEe
Q psy12427        179 --EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMID  256 (356)
Q Consensus       179 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~D  256 (356)
                        ..++||||+ +++|.+++...  .++     ...+..++.|++.||+|||+.||+||||+|+||+++.++  .++|+|
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~~~--~l~-----~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~--~~kl~d  161 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMKHE--KLS-----EDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDC--ELKILD  161 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHhcC--CCC-----HHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEee
Confidence              458999998 77888877532  223     334556999999999999999999999999999997544  799999


Q ss_pred             eeceeeeCCCCceeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC---
Q psy12427        257 FGLATKLDPNEVVKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD---  332 (356)
Q Consensus       257 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~---  332 (356)
                      ||++......  .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+....+..+.......+   
T Consensus       162 fg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07880         162 FGLARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF  239 (343)
T ss_pred             cccccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            9999865432  223457899999999876 4588899999999999999999999998876665555433222111   


Q ss_pred             ------------------------hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 ------------------------EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 ------------------------~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                              ......++.++.++|.+||+.||+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  287 (343)
T cd07880         240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAE  287 (343)
T ss_pred             HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChh
Confidence                                    122346789999999999999985

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.4e-37  Score=287.39  Aligned_cols=239  Identities=26%  Similarity=0.437  Sum_probs=188.5

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEe-CCeEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFED-DDEMVL  182 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~l  182 (356)
                      ..++|++.+.||.|+||.||+|.++.++..+|+|.+....  ......+.+|+.+++.++||||+++.++|.. ....++
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l   87 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF   87 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence            3467999999999999999999999999999999875432  2234567789999999999999999999875 567899


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ++||+ +++|.+++....       +....+..++.|++.||+|||++|++|+||+|.|||++.++  .++|+|||.+..
T Consensus        88 v~e~~-~~~L~~~~~~~~-------~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~--~~~l~dfg~~~~  157 (328)
T cd07856          88 VTELL-GTDLHRLLTSRP-------LEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENC--DLKICDFGLARI  157 (328)
T ss_pred             Eeehh-ccCHHHHHhcCC-------CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCC--CEEeCccccccc
Confidence            99998 568887775322       22233445899999999999999999999999999997544  799999999876


Q ss_pred             eCCCCceeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc-------------
Q psy12427        263 LDPNEVVKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACD-------------  328 (356)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-------------  328 (356)
                      ....  .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|++||.+.........+.+..             
T Consensus       158 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (328)
T cd07856         158 QDPQ--MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS  235 (328)
T ss_pred             cCCC--cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence            5432  223457889999998866 568899999999999999999999998876544333222111             


Q ss_pred             --------------cccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        329 --------------WEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       329 --------------~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                    .....+....+++++.++|++||+.||+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~  277 (328)
T cd07856         236 ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQ  277 (328)
T ss_pred             hhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChh
Confidence                          1111223346789999999999999995

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-37  Score=281.99  Aligned_cols=240  Identities=25%  Similarity=0.478  Sum_probs=191.6

Q ss_pred             eeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh-hhHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCeEEEEEEec
Q psy12427        110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN-LEKELIRKEIDIMNQLH-HPKLINLHDAFEDDDEMVLIFEFL  187 (356)
Q Consensus       110 y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lv~e~~  187 (356)
                      |++.+.||.|++|+||+|....++..+|+|.+..... .+.....+|+..+++++ ||||+++++++..+...++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            6788899999999999999999999999999865432 22234457999999999 999999999999999999999999


Q ss_pred             cccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCC
Q psy12427        188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE  267 (356)
Q Consensus       188 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~  267 (356)
                       +|+|.+.+....    ...+....+..++.|++.||.|||++|++|+||+|+||+++.++  .++|+|||++.......
T Consensus        81 -~~~l~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~--~~~l~d~~~~~~~~~~~  153 (283)
T cd07830          81 -EGNLYQLMKDRK----GKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPE--VVKIADFGLAREIRSRP  153 (283)
T ss_pred             -CCCHHHHHHhcc----cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC--CEEEeecccceeccCCC
Confidence             789988886543    11233444556999999999999999999999999999998644  79999999998775444


Q ss_pred             ceeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC--------------
Q psy12427        268 VVKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD--------------  332 (356)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~--------------  332 (356)
                      ......++..|+|||++.. ..++.++|+||||+++|+|++|++||...+..+.+..+......+.              
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07830         154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL  233 (283)
T ss_pred             CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence            4444568899999998854 4578999999999999999999999988877666655433211111              


Q ss_pred             ------------hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 ------------EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 ------------~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                  .......+.++++||++||+.||+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~  269 (283)
T cd07830         234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPK  269 (283)
T ss_pred             cccccccccccHHHHcccCCHHHHHHHHHhcccCcc
Confidence                        112224478999999999999995

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.4e-37  Score=283.16  Aligned_cols=236  Identities=20%  Similarity=0.179  Sum_probs=173.1

Q ss_pred             ccceeeeccccccCceEEEEEEEccC---CCEEEEEEcccCChhhH-H----------HHHHHHHHHHhcCCCCceeeee
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKT---GNIFAAKFIPVSHNLEK-E----------LIRKEIDIMNQLHHPKLINLHD  172 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~---~~~~a~K~~~~~~~~~~-~----------~~~~E~~il~~l~hpnIv~l~~  172 (356)
                      .++|++.+.||+|+||+||+|.+..+   +..+|+|+......... +          ....+...+..++|+||+++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            35799999999999999999999887   67788886544332110 0          1112334455678999999999


Q ss_pred             eEEeCC----eEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecC
Q psy12427        173 AFEDDD----EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN  248 (356)
Q Consensus       173 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~  248 (356)
                      ++....    ..+++++++. .++.+.+.... ..+     ...+..++.|++.||+|||+++|+||||||+|||++.++
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~-----~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK-CKN-----KKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNN  163 (294)
T ss_pred             eeeEecCCceEEEEEEehhc-cCHHHHHHhhc-cCC-----HHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC
Confidence            766443    3467777763 35555543221 122     233456999999999999999999999999999997544


Q ss_pred             CCcEEEEeeeceeeeCCCC--------ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCh-HH
Q psy12427        249 STNVKMIDFGLATKLDPNE--------VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEND-VE  319 (356)
Q Consensus       249 ~~~vkl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~-~~  319 (356)
                        .++|+|||+|+.+....        ......||+.|+|||++.+..++.++|||||||++|||++|..||.+... .+
T Consensus       164 --~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~  241 (294)
T PHA02882        164 --RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN  241 (294)
T ss_pred             --cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence              79999999998764221        11223589999999999999999999999999999999999999988743 22


Q ss_pred             H--------HHHhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        320 T--------LKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       320 ~--------~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .        +.++.....     ...+++.++.++++.|++.+|+
T Consensus       242 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~  281 (294)
T PHA02882        242 LIHAAKCDFIKRLHEGKI-----KIKNANKFIYDFIECVTKLSYE  281 (294)
T ss_pred             HHHHhHHHHHHHhhhhhh-----ccCCCCHHHHHHHHHHHhCCCC
Confidence            2        222322222     2246789999999999999985

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-38  Score=281.98  Aligned_cols=239  Identities=27%  Similarity=0.460  Sum_probs=193.7

Q ss_pred             eeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEec
Q psy12427        110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFL  187 (356)
Q Consensus       110 y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~  187 (356)
                      |++.+.||+|++|.||+|....++..+|+|.+....  ......+.+|+.+++.++||||+++++++......++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            567789999999999999999999999999998654  223356678999999999999999999999999999999999


Q ss_pred             cccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCC
Q psy12427        188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE  267 (356)
Q Consensus       188 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~  267 (356)
                      . ++|.+++......++     ...+..++.|++.||+|||+.|++|+||+|+||+++.++  .++|+|||++.......
T Consensus        81 ~-~~l~~~i~~~~~~~~-----~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~--~~~l~d~g~~~~~~~~~  152 (282)
T cd07829          81 D-MDLKKYLDKRPGPLS-----PNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDG--VLKLADFGLARAFGIPL  152 (282)
T ss_pred             C-cCHHHHHHhhccCCC-----HHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCC--CEEEecCCcccccCCCc
Confidence            7 589999876432333     344455999999999999999999999999999998644  79999999998764332


Q ss_pred             -ceeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC-------------
Q psy12427        268 -VVKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD-------------  332 (356)
Q Consensus       268 -~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-------------  332 (356)
                       ......++..|+|||.+... .++.++|+|||||++|+|++|.+||.+.+..+.+.++........             
T Consensus       153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07829         153 RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY  232 (282)
T ss_pred             cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence             22234467889999998776 788999999999999999999999999887776665543211111             


Q ss_pred             ------------hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 ------------EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 ------------~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                  ...++.++.++.+||++||+.||+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~  268 (282)
T cd07829         233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPA  268 (282)
T ss_pred             cccccccCccchHHhcccccHHHHHHHHHhhccCcc
Confidence                        122335688999999999999995

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9e-38  Score=290.56  Aligned_cols=240  Identities=28%  Similarity=0.466  Sum_probs=193.3

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCe---
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDE---  179 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~---  179 (356)
                      .+.++|++.+.||.|++|.||+|++..++..+|+|.+....  ......+.+|+.++++++||||+++++++.....   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            45678999999999999999999999999999999986532  2234556789999999999999999998876554   


Q ss_pred             ---EEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEe
Q psy12427        180 ---MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMID  256 (356)
Q Consensus       180 ---~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~D  256 (356)
                         .++|+||+ +++|.+++...  .++     ...+..++.|++.||+|||+.|++||||+|+||+++.++  .++|+|
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~~--~l~-----~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~--~~kL~d  161 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKCQ--KLS-----DDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC--ELKILD  161 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhcC--CCC-----HHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC--CEEEcc
Confidence               89999998 67998888642  233     334555999999999999999999999999999997654  799999


Q ss_pred             eeceeeeCCCCceeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCh--
Q psy12427        257 FGLATKLDPNEVVKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE--  333 (356)
Q Consensus       257 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~--  333 (356)
                      ||++......  .....++..|+|||.+.. ..++.++|||||||++|+|++|+.||.+.+..+.+..+.......++  
T Consensus       162 fg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  239 (343)
T cd07851         162 FGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL  239 (343)
T ss_pred             cccccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence            9999876432  233467889999999865 36788999999999999999999999988877776665443221111  


Q ss_pred             -------------------------hhhccCCHHHHHHHHHhhhcCCC
Q psy12427        334 -------------------------EAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       334 -------------------------~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                               ..+..+|+++.+||++||+.||+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~  287 (343)
T cd07851         240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPD  287 (343)
T ss_pred             HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChh
Confidence                                     12235689999999999999985

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.4e-37  Score=283.36  Aligned_cols=241  Identities=24%  Similarity=0.368  Sum_probs=187.6

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh-hhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN-LEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      .+.|++.+.||.|+||.||+|.++.+++.+|+|.++.... .....+..|+.++.+. +||||+++++++......+++|
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            4679999999999999999999999999999999875432 2334556677777666 4999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE-KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      ||+. ++|.+++......+     ....+..++.|++.||+|||+ .||+||||+|+||+++.++  .+||+|||++..+
T Consensus        94 e~~~-~~l~~l~~~~~~~l-----~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~--~~kL~dfg~~~~~  165 (296)
T cd06618          94 ELMS-TCLDKLLKRIQGPI-----PEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG--NVKLCDFGISGRL  165 (296)
T ss_pred             eccC-cCHHHHHHHhcCCC-----CHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC--CEEECccccchhc
Confidence            9985 46666665432222     333345599999999999997 5999999999999997544  7999999998766


Q ss_pred             CCCCceeecCCCcCccccccccCCC----CCccccHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHhhccccccChhhhcc
Q psy12427        264 DPNEVVKISTGTAEFAAPEIVEREP----VGFYTDMWAVGVLAYVLLSGLSPFAGEN-DVETLKNVKACDWEFDEEAFKN  338 (356)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlG~il~ell~g~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~  338 (356)
                      ..........++..|+|||.+.+..    ++.++|+||||+++|+|++|+.||.... ..+.+..+........ +....
T Consensus       166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~  244 (296)
T cd06618         166 VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL-PPNEG  244 (296)
T ss_pred             cCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCC-CCCCC
Confidence            4433333445788999999997654    7889999999999999999999997643 3455555544332211 11225


Q ss_pred             CCHHHHHHHHHhhhcCCC
Q psy12427        339 VSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       339 ~s~~~~~lI~~ll~~dP~  356 (356)
                      +++++.+||.+||+.||+
T Consensus       245 ~~~~l~~li~~~l~~~p~  262 (296)
T cd06618         245 FSPDFCSFVDLCLTKDHR  262 (296)
T ss_pred             CCHHHHHHHHHHccCChh
Confidence            799999999999999985

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG1035|consensus

Probab=100.00  E-value=1e-38  Score=315.48  Aligned_cols=241  Identities=27%  Similarity=0.445  Sum_probs=195.5

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEe--------
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFED--------  176 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--------  176 (356)
                      ...+|+.++.||+||||.||+|+++-+|+.||+|.|.... ......+.+|+..|.+|+|||||+++.+|.+        
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence            4467899999999999999999999999999999998765 2234668899999999999999999976521        


Q ss_pred             --------------------------------------------------------------------------------
Q psy12427        177 --------------------------------------------------------------------------------  176 (356)
Q Consensus       177 --------------------------------------------------------------------------------  176 (356)
                                                                                                      
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~  636 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS  636 (1351)
T ss_pred             cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence                                                                                            


Q ss_pred             -----------------------C--------CeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHH
Q psy12427        177 -----------------------D--------DEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK  225 (356)
Q Consensus       177 -----------------------~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  225 (356)
                                             +        ..+||-||||+...|.+++....+..     .....+.++++|++||+
T Consensus       637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-----~~d~~wrLFreIlEGLa  711 (1351)
T KOG1035|consen  637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-----QRDEAWRLFREILEGLA  711 (1351)
T ss_pred             CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-----hhHHHHHHHHHHHHHHH
Confidence                                   0        23688999999888877776554322     12334559999999999


Q ss_pred             HHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC------------------CCC-ceeecCCCcCccccccccC
Q psy12427        226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD------------------PNE-VVKISTGTAEFAAPEIVER  286 (356)
Q Consensus       226 ~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~------------------~~~-~~~~~~gt~~y~aPE~~~~  286 (356)
                      |+|++|+|||||||.||+++.++  .|||+|||+|....                  .+. ..+..+||.-|+|||++.+
T Consensus       712 YIH~~giIHRDLKP~NIFLd~~~--~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~  789 (1351)
T KOG1035|consen  712 YIHDQGIIHRDLKPRNIFLDSRN--SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD  789 (1351)
T ss_pred             HHHhCceeeccCCcceeEEcCCC--CeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence            99999999999999999999665  69999999998720                  011 2334579999999999976


Q ss_pred             CC---CCccccHHHHHHHHHHHHcCCCCCCC-CChHHHHHHhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        287 EP---VGFYTDMWAVGVLAYVLLSGLSPFAG-ENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       287 ~~---~~~~sDvwSlG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ..   |+.++|+||||+|++||+.   ||.. +.-..++.++..+.+++++.++.+--+..+.+|+.||+.||.
T Consensus       790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~  860 (1351)
T KOG1035|consen  790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPS  860 (1351)
T ss_pred             cccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCc
Confidence            54   9999999999999999994   5753 355678888998888888666666677889999999999995

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.6e-37  Score=277.44  Aligned_cols=240  Identities=20%  Similarity=0.345  Sum_probs=192.9

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC-----hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-----NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      +|.+.++||+|+||+||++.+..++..+++|+++...     ..+...+..|+.+++.++||||+++++++......+++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            4889999999999999999998877777777665321     22334566799999999999999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      +||+++++|.+++....  .....+....+..++.|++.||.|||+.|++|+||+|+||+++.   ..++|+|||.+...
T Consensus        81 ~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~---~~~~l~d~g~~~~~  155 (260)
T cd08222          81 TEYCEGRDLDCKLEELK--HTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN---NLLKIGDFGVSRLL  155 (260)
T ss_pred             EEeCCCCCHHHHHHHHh--hcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec---CCEeecccCceeec
Confidence            99999999988875321  11123334445669999999999999999999999999999964   25999999998776


Q ss_pred             CCCC-ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHH
Q psy12427        264 DPNE-VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEE  342 (356)
Q Consensus       264 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  342 (356)
                      .... ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+......   .....++.+
T Consensus       156 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  232 (260)
T cd08222         156 MGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTP---SLPETYSRQ  232 (260)
T ss_pred             CCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCC---CCcchhcHH
Confidence            4322 223345789999999998888899999999999999999999999888777776666554322   223478899


Q ss_pred             HHHHHHHhhhcCCC
Q psy12427        343 GKDFIRRLLLRNKE  356 (356)
Q Consensus       343 ~~~lI~~ll~~dP~  356 (356)
                      +.++|.+||+.||+
T Consensus       233 ~~~li~~~l~~~p~  246 (260)
T cd08222         233 LNSIMQSMLNKDPS  246 (260)
T ss_pred             HHHHHHHHhcCChh
Confidence            99999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.3e-37  Score=287.76  Aligned_cols=238  Identities=23%  Similarity=0.427  Sum_probs=185.9

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeC------
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDD------  177 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------  177 (356)
                      +.++|.+.+.||+|+||.||+|.++.+|..+|+|.+....  ......+.+|+.+++.++||||+++++++...      
T Consensus        13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~   92 (342)
T cd07879          13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF   92 (342)
T ss_pred             cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence            3467999999999999999999999999999999986532  22234577899999999999999999998754      


Q ss_pred             CeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEee
Q psy12427        178 DEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDF  257 (356)
Q Consensus       178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Df  257 (356)
                      ...++|+||+.. +|..++..   .++     ...+..++.|++.||+|||+.|++||||+|+|||++.++  .++|+||
T Consensus        93 ~~~~lv~e~~~~-~l~~~~~~---~~~-----~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~--~~kL~df  161 (342)
T cd07879          93 QDFYLVMPYMQT-DLQKIMGH---PLS-----EDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDC--ELKILDF  161 (342)
T ss_pred             ceEEEEeccccc-CHHHHHcC---CCC-----HHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEeeC
Confidence            346999999953 66554421   222     234455899999999999999999999999999997654  7999999


Q ss_pred             eceeeeCCCCceeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc-----
Q psy12427        258 GLATKLDPNEVVKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEF-----  331 (356)
Q Consensus       258 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-----  331 (356)
                      |++......  .....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+....+..+.......     
T Consensus       162 g~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (342)
T cd07879         162 GLARHADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV  239 (342)
T ss_pred             CCCcCCCCC--CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            998765322  223356889999999876 468889999999999999999999999887666555543321100     


Q ss_pred             ------------------C----hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        332 ------------------D----EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       332 ------------------~----~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                        +    ...+..++.++.+||++||+.||+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  286 (342)
T cd07879         240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVD  286 (342)
T ss_pred             HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChh
Confidence                              0    111235788999999999999995

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.7e-37  Score=281.49  Aligned_cols=236  Identities=30%  Similarity=0.554  Sum_probs=187.6

Q ss_pred             ceeeeccccccCceEEEEEEEc---cCCCEEEEEEcccCCh----hhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeE
Q psy12427        109 HYDILEEIGTGAFGVVHRCRER---KTGNIFAAKFIPVSHN----LEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEM  180 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~---~~~~~~a~K~~~~~~~----~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~  180 (356)
                      +|++.+.||.|++|.||++.+.   .++..+|+|.++....    .....+.+|+.++.++ +||||+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            3788999999999999999864   4578999999864322    2235577899999999 599999999999999999


Q ss_pred             EEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeece
Q psy12427        181 VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA  260 (356)
Q Consensus       181 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a  260 (356)
                      ++||||+.+++|.+++.... .     +....+..++.|++.||.|||+.+++|+||+|+||+++.++  .++|+|||++
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~-~-----~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~--~~~l~dfg~~  152 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE-H-----FTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEG--HVVLTDFGLS  152 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC-C-----cCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC--CEEEEECccc
Confidence            99999999999998886432 2     23334555889999999999999999999999999997654  7999999998


Q ss_pred             eeeCCCCc--eeecCCCcCccccccccCCC--CCccccHHHHHHHHHHHHcCCCCCCCCC----hHHHHHHhhccccccC
Q psy12427        261 TKLDPNEV--VKISTGTAEFAAPEIVEREP--VGFYTDMWAVGVLAYVLLSGLSPFAGEN----DVETLKNVKACDWEFD  332 (356)
Q Consensus       261 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlG~il~ell~g~~Pf~~~~----~~~~~~~i~~~~~~~~  332 (356)
                      +.......  .....|+..|+|||.+.+..  .+.++|+||||+++|+|++|..||....    ..+..+.+....... 
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-  231 (288)
T cd05583         153 KEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPF-  231 (288)
T ss_pred             cccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCC-
Confidence            77543322  12235789999999987665  7889999999999999999999996443    233334444333222 


Q ss_pred             hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 ~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                         ...++.+++++|.+||+.||+
T Consensus       232 ---~~~~~~~l~~li~~~l~~~p~  252 (288)
T cd05583         232 ---PKTMSAEARDFIQKLLEKDPK  252 (288)
T ss_pred             ---CcccCHHHHHHHHHHhcCCHh
Confidence               246889999999999999985

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=6e-37  Score=281.36  Aligned_cols=231  Identities=20%  Similarity=0.299  Sum_probs=176.9

Q ss_pred             CceEEEEEEEccCCCEEEEEEcccC--ChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEeccccchhhhhh
Q psy12427        120 AFGVVHRCRERKTGNIFAAKFIPVS--HNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERIT  197 (356)
Q Consensus       120 ~fg~V~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~  197 (356)
                      ++|.||.++.+.+++.+|+|.+...  .......+.+|+.+++.++||||+++++++......+++|||+.+++|.+++.
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~   91 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK   91 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence            4455666667778999999998765  33455678899999999999999999999999999999999999999999887


Q ss_pred             CCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCc--------e
Q psy12427        198 APDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEV--------V  269 (356)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~--------~  269 (356)
                      ....    ..+....+..++.|++.||+|||+++|+||||||+||+++.++  .+||+|||.+........        .
T Consensus        92 ~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~--~~kl~d~~~~~~~~~~~~~~~~~~~~~  165 (314)
T cd08216          92 THFP----EGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDG--KVVLSGLRYSVSMIKHGKRQRVVHDFP  165 (314)
T ss_pred             Hhcc----cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCC--ceEEecCccceeecccccccccccccc
Confidence            5321    1233344556999999999999999999999999999998654  799999998876532211        1


Q ss_pred             eecCCCcCccccccccC--CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc------------------
Q psy12427        270 KISTGTAEFAAPEIVER--EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDW------------------  329 (356)
Q Consensus       270 ~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~------------------  329 (356)
                      ....++..|+|||++..  ..++.++|+||+||++|+|++|..||........+.....+..                  
T Consensus       166 ~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (314)
T cd08216         166 KSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQ  245 (314)
T ss_pred             ccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCc
Confidence            22346788999999876  3578899999999999999999999987765443322111110                  


Q ss_pred             ------------ccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        330 ------------EFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       330 ------------~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                  ..+......++.++.+||.+||+.||+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~  284 (314)
T cd08216         246 SRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPE  284 (314)
T ss_pred             ccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCC
Confidence                        011111123467899999999999995

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=8.6e-37  Score=282.72  Aligned_cols=239  Identities=25%  Similarity=0.386  Sum_probs=185.6

Q ss_pred             ceeeeccccccCceEEEEEEEccC--CCEEEEEEcccCC--hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEe----CCe
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKT--GNIFAAKFIPVSH--NLEKELIRKEIDIMNQL-HHPKLINLHDAFED----DDE  179 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~--~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~----~~~  179 (356)
                      +|++.+.||+|+||.||++.+..+  +..+|+|.+....  ......+.+|+.++.++ +||||+++++.+..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            478899999999999999999988  8999999986432  22245667899999999 59999999987542    245


Q ss_pred             EEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeec
Q psy12427        180 MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGL  259 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~  259 (356)
                      .++++|++. ++|.+++.... .     +....+..++.||+.||+|||++|++||||||+|||++.++  .+||+|||+
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~-~-----~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~--~~kl~Dfg~  151 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQ-P-----LTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADC--ELKICDFGL  151 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCC-C-----CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCC--CEEeCcCCC
Confidence            788999885 68888875432 2     33344556999999999999999999999999999997654  799999999


Q ss_pred             eeeeCCCCc-----eeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC-
Q psy12427        260 ATKLDPNEV-----VKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD-  332 (356)
Q Consensus       260 a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-  332 (356)
                      +........     .....|++.|+|||.+.+ ..++.++|+||+||++|+|++|.+||.+.+..+.+..+......++ 
T Consensus       152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  231 (332)
T cd07857         152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE  231 (332)
T ss_pred             ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence            987643221     122358999999998765 4688999999999999999999999988776655554433211111 


Q ss_pred             --------------------------hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 --------------------------EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 --------------------------~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                                ......++.++++||.+||+.||+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~  281 (332)
T cd07857         232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPT  281 (332)
T ss_pred             HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcc
Confidence                                      122235688999999999999995

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.1e-36  Score=305.01  Aligned_cols=146  Identities=23%  Similarity=0.435  Sum_probs=126.8

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      ++|.+.++||.|+||+||+|.+..+++.||+|+++...   ......+.+|+.++..++||||+++++++.....+++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57999999999999999999999999999999987543   223466788999999999999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeecee
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT  261 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~  261 (356)
                      ||+.|++|.+++.... .     +....++.++.||+.||+|||++||+||||||+|||++.++  .+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~~-~-----l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g--~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIYG-Y-----FDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEG--HIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhcC-C-----CCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCC--CEEEEeCCCCc
Confidence            9999999999886432 2     22334466999999999999999999999999999997544  79999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0666|consensus

Probab=100.00  E-value=2.9e-38  Score=272.00  Aligned_cols=208  Identities=24%  Similarity=0.369  Sum_probs=171.0

Q ss_pred             ccceeeeccccccCceEEEEEEEccCC----CEEEEEEcccCChh--hHHHHHHHHHHHHhcCCCCceeeeeeEEe-CCe
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTG----NIFAAKFIPVSHNL--EKELIRKEIDIMNQLHHPKLINLHDAFED-DDE  179 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~----~~~a~K~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~  179 (356)
                      ...|++...||+|.||.||+|..+.++    +.+|+|.++.....  -....-+|+.+++.++|||++.|..+|.. +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            346899999999999999999766554    37899998765322  12445589999999999999999999987 889


Q ss_pred             EEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecC--CCcEEEEee
Q psy12427        180 MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN--STNVKMIDF  257 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~--~~~vkl~Df  257 (356)
                      +++++||.+. +|.+.+.-+..... ..+....+++++.||+.|++|||++-|+||||||.||||..++  .+.|||+||
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~-~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKA-KQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchh-ccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence            9999999976 88888875554333 4666778899999999999999999999999999999998663  258999999


Q ss_pred             eceeeeCCC-Cce---eecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCC
Q psy12427        258 GLATKLDPN-EVV---KISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGEN  316 (356)
Q Consensus       258 g~a~~~~~~-~~~---~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~  316 (356)
                      |+++.+... ...   ..-+-|..|.|||.+.+. .|+.+.||||+|||+.||++-.+.|.+..
T Consensus       181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E  244 (438)
T KOG0666|consen  181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE  244 (438)
T ss_pred             cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence            999987522 111   112358999999999875 58999999999999999999999998763

>KOG0587|consensus

Probab=100.00  E-value=8.3e-37  Score=293.63  Aligned_cols=240  Identities=25%  Similarity=0.480  Sum_probs=203.1

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhc-CCCCceeeeeeEE-----eCCeEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL-HHPKLINLHDAFE-----DDDEMV  181 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~-----~~~~~~  181 (356)
                      +.|.+.++||.|.+|.||+++.+++++.+|+|++...... .+.+..|.+||+.+ +|||++.++|+|.     .++.++
T Consensus        19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLW   97 (953)
T KOG0587|consen   19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLW   97 (953)
T ss_pred             CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEE
Confidence            4589999999999999999999999999999998766543 35667799999988 6999999999986     467899


Q ss_pred             EEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeecee
Q psy12427        182 LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT  261 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~  261 (356)
                      ||||||.||+..+++....    .....+..+..|++.++.||.|||...++|||||-.|||++.++  .|||+|||.+.
T Consensus        98 LVMEfC~gGSVTDLVKn~~----g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~--~VKLvDFGvSa  171 (953)
T KOG0587|consen   98 LVMEFCGGGSVTDLVKNTK----GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENA--EVKLVDFGVSA  171 (953)
T ss_pred             EEeeccCCccHHHHHhhhc----ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccC--cEEEeeeeeee
Confidence            9999999999999997544    34445556677999999999999999999999999999998655  79999999999


Q ss_pred             eeCCCC-ceeecCCCcCccccccccCC-----CCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhh
Q psy12427        262 KLDPNE-VVKISTGTAEFAAPEIVERE-----PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEA  335 (356)
Q Consensus       262 ~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  335 (356)
                      +++..- ...+.+|||.|||||++...     .|+..+|+||||++..||.-|.+|+.++.+.-.+..|.... ++--..
T Consensus       172 QldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNP-PPkLkr  250 (953)
T KOG0587|consen  172 QLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP-PPKLKR  250 (953)
T ss_pred             eeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCC-Cccccc
Confidence            886543 34567899999999999643     46778999999999999999999999999998888876532 122223


Q ss_pred             hccCCHHHHHHHHHhhhcCC
Q psy12427        336 FKNVSEEGKDFIRRLLLRNK  355 (356)
Q Consensus       336 ~~~~s~~~~~lI~~ll~~dP  355 (356)
                      ++.++++..+||..||.+|-
T Consensus       251 p~kWs~~FndFIs~cL~Kd~  270 (953)
T KOG0587|consen  251 PKKWSKKFNDFISTCLVKDY  270 (953)
T ss_pred             hhhHHHHHHHHHHHHHhhcc
Confidence            56899999999999999874

>KOG1151|consensus

Probab=100.00  E-value=7.2e-38  Score=280.82  Aligned_cols=242  Identities=30%  Similarity=0.486  Sum_probs=193.9

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHH----HHHHHHHHHhcCCCCceeeeeeEE-e
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKEL----IRKEIDIMNQLHHPKLINLHDAFE-D  176 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~-~  176 (356)
                      .+.++|-++..||+|||++||+|.+-..++.||+|+-....   .+.++.    .-+|..|-+.|+||.||++|++|. +
T Consensus       460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD  539 (775)
T KOG1151|consen  460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD  539 (775)
T ss_pred             chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence            45678999999999999999999999999999999875432   122222    336999999999999999999997 5


Q ss_pred             CCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHC--CceeccCCCCCEEEeec-CCCcEE
Q psy12427        177 DDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEK--NIIHLDVKPENIMCQTR-NSTNVK  253 (356)
Q Consensus       177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~ivH~Dlkp~NIlv~~~-~~~~vk  253 (356)
                      ...+|-|+|||+|.+|.-+|.... .+++.++     +.|+.||+.||.||.+.  .|||-||||.|||+... .++.+|
T Consensus       540 tdsFCTVLEYceGNDLDFYLKQhk-lmSEKEA-----RSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIK  613 (775)
T KOG1151|consen  540 TDSFCTVLEYCEGNDLDFYLKQHK-LMSEKEA-----RSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIK  613 (775)
T ss_pred             cccceeeeeecCCCchhHHHHhhh-hhhHHHH-----HHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeE
Confidence            577899999999999988887654 4555555     44999999999999976  59999999999998643 346799


Q ss_pred             EEeeeceeeeCCCC--------ceeecCCCcCcccccccc----CCCCCccccHHHHHHHHHHHHcCCCCCCCC-ChHHH
Q psy12427        254 MIDFGLATKLDPNE--------VVKISTGTAEFAAPEIVE----REPVGFYTDMWAVGVLAYVLLSGLSPFAGE-NDVET  320 (356)
Q Consensus       254 l~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~----~~~~~~~sDvwSlG~il~ell~g~~Pf~~~-~~~~~  320 (356)
                      |+|||++..++...        .+.-..||.+|++||.+.    ....+.+.||||+|||+|..+.|+.||..+ +..++
T Consensus       614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI  693 (775)
T KOG1151|consen  614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI  693 (775)
T ss_pred             eeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH
Confidence            99999999875432        223346899999999874    234789999999999999999999999866 45556


Q ss_pred             HHH---hhccccccChhhhccCCHHHHHHHHHhhhcC
Q psy12427        321 LKN---VKACDWEFDEEAFKNVSEEGKDFIRRLLLRN  354 (356)
Q Consensus       321 ~~~---i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~d  354 (356)
                      ++.   +......||+.  +.+|.++++||++||+..
T Consensus       694 LqeNTIlkAtEVqFP~K--PvVsseAkaFIRRCLaYR  728 (775)
T KOG1151|consen  694 LQENTILKATEVQFPPK--PVVSSEAKAFIRRCLAYR  728 (775)
T ss_pred             HhhhchhcceeccCCCC--CccCHHHHHHHHHHHHhh
Confidence            554   23345556654  379999999999999864

>KOG1006|consensus

Probab=100.00  E-value=3.5e-39  Score=272.21  Aligned_cols=244  Identities=24%  Similarity=0.365  Sum_probs=187.5

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh-hhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN-LEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      ++.+-+..||.|+||+|++-.++.+|+..|+|.++.... .+..+++.|.+...+- +.||||+++|++-.++..++.||
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME  143 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME  143 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence            456677899999999999999999999999999987654 4556677787765554 78999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE-KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      .|+ .||..+.. .-+......+.+..+..+.-..+.||.||.. .+|||||+||+|||++..+  .+||||||.+..+.
T Consensus       144 LMd-~SlDklYk-~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G--~vKLCDFGIcGqLv  219 (361)
T KOG1006|consen  144 LMD-ISLDKLYK-RVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG--DVKLCDFGICGQLV  219 (361)
T ss_pred             HHh-hhHHHHHH-HHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC--CEeeecccchHhHH
Confidence            994 46644332 1111222223332233355567889999985 5899999999999998766  69999999998876


Q ss_pred             CCCceeecCCCcCccccccccCC--CCCccccHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHhhccccccChhh--hccC
Q psy12427        265 PNEVVKISTGTAEFAAPEIVERE--PVGFYTDMWAVGVLAYVLLSGLSPFAGEN-DVETLKNVKACDWEFDEEA--FKNV  339 (356)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~il~ell~g~~Pf~~~~-~~~~~~~i~~~~~~~~~~~--~~~~  339 (356)
                      ..-..+...|...|||||.+...  .|+-+|||||||++|||+.||..||.+-+ ..+.+.++..+..+.....  --++
T Consensus       220 ~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~  299 (361)
T KOG1006|consen  220 DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHY  299 (361)
T ss_pred             HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccccccc
Confidence            55555667899999999999643  58899999999999999999999998775 3455666666554422111  1248


Q ss_pred             CHHHHHHHHHhhhcCC
Q psy12427        340 SEEGKDFIRRLLLRNK  355 (356)
Q Consensus       340 s~~~~~lI~~ll~~dP  355 (356)
                      |.....||..||.+|-
T Consensus       300 s~~~~~fintCl~Kd~  315 (361)
T KOG1006|consen  300 SFSMVRFINTCLIKDR  315 (361)
T ss_pred             CHHHHHHHHHHhhccc
Confidence            9999999999999874

>KOG0669|consensus

Probab=100.00  E-value=7.5e-39  Score=268.40  Aligned_cols=241  Identities=23%  Similarity=0.392  Sum_probs=194.5

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhh--HHHHHHHHHHHHhcCCCCceeeeeeEEe--------C
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE--KELIRKEIDIMNQLHHPKLINLHDAFED--------D  177 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~--~~~~~~E~~il~~l~hpnIv~l~~~~~~--------~  177 (356)
                      +.|....+||+|.||+||+|+.+.+|+.||+|.+-..++.+  .....+|+.+|..|+|+|++.+++.|..        .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            46888899999999999999999999999998775543322  2445689999999999999999998852        3


Q ss_pred             CeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEee
Q psy12427        178 DEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDF  257 (356)
Q Consensus       178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Df  257 (356)
                      ..+++||.+|+. +|.-++.....+++..     .++.++.+++.||.|+|++.|+|||+||+|+||+.++  .+||+||
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls-----~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dg--ilklADF  168 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLS-----EIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDG--ILKLADF  168 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCccccccHH-----HHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCc--eEEeecc
Confidence            458999999975 7887777655444443     4566999999999999999999999999999998655  7999999


Q ss_pred             eceeeeCCCCc-----eeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc
Q psy12427        258 GLATKLDPNEV-----VKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEF  331 (356)
Q Consensus       258 g~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~  331 (356)
                      |+++.+...+.     ....+-|..|.+||.+.+ ..++.+.|||..||||.||++|.+.|++.++...+..|......+
T Consensus       169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~  248 (376)
T KOG0669|consen  169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI  248 (376)
T ss_pred             ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence            99987742221     122345899999998876 469999999999999999999999999999999998887655554


Q ss_pred             ChhhhccC-------------------------------CHHHHHHHHHhhhcCCC
Q psy12427        332 DEEAFKNV-------------------------------SEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       332 ~~~~~~~~-------------------------------s~~~~~lI~~ll~~dP~  356 (356)
                      -++-|+++                               .+++.||+..||..||.
T Consensus       249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~  304 (376)
T KOG0669|consen  249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPT  304 (376)
T ss_pred             CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcc
Confidence            44444332                               24899999999999994

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=3.9e-36  Score=265.07  Aligned_cols=215  Identities=19%  Similarity=0.304  Sum_probs=172.2

Q ss_pred             cCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEeccccchhhhhhC
Q psy12427        119 GAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITA  198 (356)
Q Consensus       119 G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  198 (356)
                      |.+|.||+|+++.+++.+|+|.+.....     +.+|...+....||||+++++++......+++|||++||+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh-----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            8999999999999999999999876532     23455555666799999999999999999999999999999998864


Q ss_pred             CCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCceeecCCCcCc
Q psy12427        199 PDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF  278 (356)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y  278 (356)
                      .. .     +....+..++.|++.||+|||++|++||||||+||+++.++  .++++|||.+......  .....++..|
T Consensus        79 ~~-~-----l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~~l~df~~~~~~~~~--~~~~~~~~~y  148 (237)
T cd05576          79 FL-N-----IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRG--HIQLTYFSRWSEVEDS--CDGEAVENMY  148 (237)
T ss_pred             hc-C-----CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC--CEEEecccchhccccc--cccCCcCccc
Confidence            32 2     33344556999999999999999999999999999998655  6999999987665432  2233457789


Q ss_pred             cccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        279 AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       279 ~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +|||.+.+..++.++|+||+|+++|+|++|..||......  ..  .......+    ..++.++++||++||+.||+
T Consensus       149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~--~~--~~~~~~~~----~~~~~~~~~li~~~l~~dp~  218 (237)
T cd05576         149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG--IN--THTTLNIP----EWVSEEARSLLQQLLQFNPT  218 (237)
T ss_pred             cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh--cc--cccccCCc----ccCCHHHHHHHHHHccCCHH
Confidence            9999999888999999999999999999999988644221  00  01111222    36899999999999999995

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0671|consensus

Probab=100.00  E-value=6.6e-37  Score=270.39  Aligned_cols=211  Identities=27%  Similarity=0.471  Sum_probs=177.2

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCC--C----CceeeeeeEEeCCe
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHH--P----KLINLHDAFEDDDE  179 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~h--p----nIv~l~~~~~~~~~  179 (356)
                      +.++|.+...+|+|.||.|.++.++.++..||+|+++.-.. -++...-|+++|.++.+  |    -++.+.++|...++
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh  165 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH  165 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence            45789999999999999999999999999999999976433 23445569999999942  3    37888899999999


Q ss_pred             EEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeec------------
Q psy12427        180 MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTR------------  247 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~------------  247 (356)
                      .|+|+|.+ |.|+++++....+    ..+....++.+..|++.++++||+.+++|-||||+|||+...            
T Consensus       166 iCivfell-G~S~~dFlk~N~y----~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~  240 (415)
T KOG0671|consen  166 ICIVFELL-GLSTFDFLKENNY----IPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKV  240 (415)
T ss_pred             eEEEEecc-ChhHHHHhccCCc----cccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcc
Confidence            99999988 7799999986553    234445567799999999999999999999999999998432            


Q ss_pred             ------CCCcEEEEeeeceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHH
Q psy12427        248 ------NSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETL  321 (356)
Q Consensus       248 ------~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~  321 (356)
                            .+..|+|+|||.|+..+...  ...+.|..|.|||++.+-+++..+||||+||||+||.+|...|+..++.|.+
T Consensus       241 ~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL  318 (415)
T KOG0671|consen  241 CFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL  318 (415)
T ss_pred             ceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHH
Confidence                  13468999999998765433  4556799999999999999999999999999999999999999999888755


Q ss_pred             HHh
Q psy12427        322 KNV  324 (356)
Q Consensus       322 ~~i  324 (356)
                      .-+
T Consensus       319 aMM  321 (415)
T KOG0671|consen  319 AMM  321 (415)
T ss_pred             HHH
Confidence            443

>KOG0668|consensus

Probab=100.00  E-value=1.2e-36  Score=251.84  Aligned_cols=236  Identities=24%  Similarity=0.454  Sum_probs=192.6

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcC-CCCceeeeeeEEeC--CeEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLH-HPKLINLHDAFEDD--DEMVLI  183 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~--~~~~lv  183 (356)
                      .++|++.+++|+|.+++||.|+.-.++..+++|+++..   .+..+.+|+.||..|. ||||++|+++..++  ..+.++
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            46899999999999999999999999999999998754   3467889999999996 99999999998764  457899


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      +||+++.+...+..         .+....++.++.+++.||.|+|++||+|||+||.|+++|... ..++|+|+|+|.++
T Consensus       114 FE~v~n~Dfk~ly~---------tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~-rkLrlIDWGLAEFY  183 (338)
T KOG0668|consen  114 FEYVNNTDFKQLYP---------TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHEL-RKLRLIDWGLAEFY  183 (338)
T ss_pred             hhhhccccHHHHhh---------hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhh-ceeeeeecchHhhc
Confidence            99998766544332         233344566999999999999999999999999999998755 37999999999999


Q ss_pred             CCCCceeecCCCcCcccccccc-CCCCCccccHHHHHHHHHHHHcCCCCC-CCCChHHHHHHhhccc-------------
Q psy12427        264 DPNEVVKISTGTAEFAAPEIVE-REPVGFYTDMWAVGVLAYVLLSGLSPF-AGENDVETLKNVKACD-------------  328 (356)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlG~il~ell~g~~Pf-~~~~~~~~~~~i~~~~-------------  328 (356)
                      ++....+..+.+..|-.||.+. .+.|+.+-|+|||||++..|+..+.|| .|.++.+.+-+|.+..             
T Consensus       184 Hp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~  263 (338)
T KOG0668|consen  184 HPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ  263 (338)
T ss_pred             CCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence            9998888899999999999885 456899999999999999999998886 5667777666653321             


Q ss_pred             cccChh-----------hh--------c-cCCHHHHHHHHHhhhcCC
Q psy12427        329 WEFDEE-----------AF--------K-NVSEEGKDFIRRLLLRNK  355 (356)
Q Consensus       329 ~~~~~~-----------~~--------~-~~s~~~~~lI~~ll~~dP  355 (356)
                      ...++.           .|        + -+++++.||+.++|..|-
T Consensus       264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDH  310 (338)
T KOG0668|consen  264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDH  310 (338)
T ss_pred             cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhcc
Confidence            111111           11        1 157999999999998774

>KOG0200|consensus

Probab=100.00  E-value=2.6e-35  Score=291.12  Aligned_cols=244  Identities=22%  Similarity=0.356  Sum_probs=199.4

Q ss_pred             cceeeeccccccCceEEEEEEEcc-------CCCEEEEEEcccCC-hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCC
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERK-------TGNIFAAKFIPVSH-NLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDD  178 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~-------~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  178 (356)
                      +...+.+.||+|.||.|++|..+.       ....||+|.++... ..+...+..|+++|+.+ +||||+.++|++...+
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~  375 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG  375 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence            344666799999999999998541       14689999988654 35678889999999999 5999999999999999


Q ss_pred             eEEEEEEeccccchhhhhhCCC---------CCCCc-cccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecC
Q psy12427        179 EMVLIFEFLSGGELFERITAPD---------YKMSE-AEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN  248 (356)
Q Consensus       179 ~~~lv~e~~~~g~L~~~l~~~~---------~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~  248 (356)
                      .+++|+||+..|+|.+++...+         ....+ ..+....+..++.||+.||+||++.++|||||..+|||+..+.
T Consensus       376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~  455 (609)
T KOG0200|consen  376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNK  455 (609)
T ss_pred             ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCC
Confidence            9999999999999999998765         11111 1244455677999999999999999999999999999997654


Q ss_pred             CCcEEEEeeeceeeeCCCCceee--cCC--CcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCC-hHHHHH
Q psy12427        249 STNVKMIDFGLATKLDPNEVVKI--STG--TAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGEN-DVETLK  322 (356)
Q Consensus       249 ~~~vkl~Dfg~a~~~~~~~~~~~--~~g--t~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~-~~~~~~  322 (356)
                        .+||+|||+|+..........  ..|  +..|||||.+....++.+|||||||++|||+++ |..||.+.. ..+.++
T Consensus       456 --~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~  533 (609)
T KOG0200|consen  456 --VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLE  533 (609)
T ss_pred             --EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH
Confidence              689999999997655444432  233  456999999999999999999999999999999 999999976 677777


Q ss_pred             HhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        323 NVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       323 ~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+..+.-...   +..+++++-++++.||+.+|+
T Consensus       534 ~l~~G~r~~~---P~~c~~eiY~iM~~CW~~~p~  564 (609)
T KOG0200|consen  534 FLKEGNRMEQ---PEHCSDEIYDLMKSCWNADPE  564 (609)
T ss_pred             HHhcCCCCCC---CCCCCHHHHHHHHHHhCCCcc
Confidence            6766654322   247899999999999999985

>KOG1025|consensus

Probab=100.00  E-value=1.6e-36  Score=289.21  Aligned_cols=236  Identities=21%  Similarity=0.291  Sum_probs=197.6

Q ss_pred             eeeeccccccCceEEEEEEEccCC----CEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        110 YDILEEIGTGAFGVVHRCRERKTG----NIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       110 y~~~~~lg~G~fg~V~~~~~~~~~----~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      ....++||.|+||+||+|.+-..|    -+||+|++.... ......+.+|+-+|.+++|||+++|+|++.... +.||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            445679999999999999987665    478999886543 334567889999999999999999999998765 88999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      +||++|.|.+++...+..+-.     ..+..|..||++||.|||.++++||||..+||||..-+  ++|+.|||+++.+.
T Consensus       777 q~mP~G~LlDyvr~hr~~igs-----q~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~--hvkitdfgla~ll~  849 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHRDNIGS-----QDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPN--HVKITDFGLAKLLA  849 (1177)
T ss_pred             HhcccchHHHHHHHhhccccH-----HHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCC--eEEEEecchhhccC
Confidence            999999999999865544333     34455999999999999999999999999999997544  79999999999887


Q ss_pred             CCCceeec-CC--CcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCC
Q psy12427        265 PNEVVKIS-TG--TAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVS  340 (356)
Q Consensus       265 ~~~~~~~~-~g--t~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  340 (356)
                      +....... .|  .+.|||-|.+....++.++|||||||.+||++| |..||.+..-.|+-..+..+.- .++  ++.++
T Consensus       850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-Lsq--PpiCt  926 (1177)
T KOG1025|consen  850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-LSQ--PPICT  926 (1177)
T ss_pred             cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-CCC--CCCcc
Confidence            65544332 22  788999999999999999999999999999999 9999999999888877776553 222  24899


Q ss_pred             HHHHHHHHHhhhcCCC
Q psy12427        341 EEGKDFIRRLLLRNKE  356 (356)
Q Consensus       341 ~~~~~lI~~ll~~dP~  356 (356)
                      .++-.++.+||..|+.
T Consensus       927 iDVy~~mvkCwmid~~  942 (1177)
T KOG1025|consen  927 IDVYMVMVKCWMIDAD  942 (1177)
T ss_pred             HHHHHHHHHHhccCcc
Confidence            9999999999998874

>KOG0984|consensus

Probab=100.00  E-value=1.6e-35  Score=241.61  Aligned_cols=215  Identities=24%  Similarity=0.372  Sum_probs=173.1

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh-hhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN-LEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      ...-++.||+|++|.|-+.++..+|...|+|.++..-. .+.....+|+++..+. .+|.+|.++|..-.....++.||.
T Consensus        47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~  126 (282)
T KOG0984|consen   47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL  126 (282)
T ss_pred             hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence            45567899999999999999999999999999976533 2334566788876665 799999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEK-NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |+ .||..+....  ......+.+..+-.|+..+..||.|||++ .+||||+||.|||++.++  +||+||||.|..+..
T Consensus       127 M~-tSldkfy~~v--~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G--qVKiCDFGIsG~L~d  201 (282)
T KOG0984|consen  127 MD-TSLDKFYRKV--LKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG--QVKICDFGISGYLVD  201 (282)
T ss_pred             hh-hhHHHHHHHH--HhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC--cEEEcccccceeehh
Confidence            95 4775554321  01122333344555899999999999976 899999999999998766  899999999988865


Q ss_pred             CCceeecCCCcCccccccccC----CCCCccccHHHHHHHHHHHHcCCCCCCCC-ChHHHHHHhhccc
Q psy12427        266 NEVVKISTGTAEFAAPEIVER----EPVGFYTDMWAVGVLAYVLLSGLSPFAGE-NDVETLKNVKACD  328 (356)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlG~il~ell~g~~Pf~~~-~~~~~~~~i~~~~  328 (356)
                      .-..+...|...|||||.+..    ..|+-+|||||||+.+.||.+++.||..- ++.+.+.++....
T Consensus       202 SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep  269 (282)
T KOG0984|consen  202 SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEP  269 (282)
T ss_pred             hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCC
Confidence            444445779999999999854    36889999999999999999999999754 7888888887644

>KOG1290|consensus

Probab=100.00  E-value=2.4e-34  Score=260.90  Aligned_cols=235  Identities=23%  Similarity=0.360  Sum_probs=190.9

Q ss_pred             CceeEeeecccCCCCCCCCCCCcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcC
Q psy12427         84 DQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLH  163 (356)
Q Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~  163 (356)
                      .++..+-|.+.+++|+.+.......+|.+.++||.|.|++||+|-+..+.+.||+|+.+..... .+....|+.+|++++
T Consensus        54 eqE~~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhY-tEaAlDEIklL~~v~  132 (590)
T KOG1290|consen   54 EQEDPEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHY-TEAALDEIKLLQQVR  132 (590)
T ss_pred             cccChhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHH-HHHHHHHHHHHHHHH
Confidence            4455677899999999998776668999999999999999999999999999999998754332 345567999999983


Q ss_pred             -----C---CCceeeeeeEE----eCCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHH-C
Q psy12427        164 -----H---PKLINLHDAFE----DDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE-K  230 (356)
Q Consensus       164 -----h---pnIv~l~~~~~----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~  230 (356)
                           |   .+||+|++.|.    ++.++|||+|++ |.+|..+|....++    .+....++.|++|++.||.|||. .
T Consensus       133 ~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~Yr----Glpl~~VK~I~~qvL~GLdYLH~ec  207 (590)
T KOG1290|consen  133 EGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYR----GLPLSCVKEICRQVLTGLDYLHREC  207 (590)
T ss_pred             hcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCC----CCcHHHHHHHHHHHHHHHHHHHHhc
Confidence                 3   36999999997    567899999999 78999999866543    34455678899999999999995 5


Q ss_pred             CceeccCCCCCEEE------------------------------------------------------------------
Q psy12427        231 NIIHLDVKPENIMC------------------------------------------------------------------  244 (356)
Q Consensus       231 ~ivH~Dlkp~NIlv------------------------------------------------------------------  244 (356)
                      ||||-||||+|||+                                                                  
T Consensus       208 gIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~  287 (590)
T KOG1290|consen  208 GIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEAS  287 (590)
T ss_pred             CccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhh
Confidence            99999999999998                                                                  


Q ss_pred             --------------------------------------------------ee-------------------------c--
Q psy12427        245 --------------------------------------------------QT-------------------------R--  247 (356)
Q Consensus       245 --------------------------------------------------~~-------------------------~--  247 (356)
                                                                        ..                         .  
T Consensus       288 l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s  367 (590)
T KOG1290|consen  288 LAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSS  367 (590)
T ss_pred             hcccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccC
Confidence                                                              00                         0  


Q ss_pred             ---------------------CCCcEEEEeeeceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHH
Q psy12427        248 ---------------------NSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLL  306 (356)
Q Consensus       248 ---------------------~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell  306 (356)
                                           ...+|||+|||-|+..+  ..++....|..|+|||++.+..|++.+||||++|++|||+
T Consensus       368 ~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELa  445 (590)
T KOG1290|consen  368 PSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELA  445 (590)
T ss_pred             cCCccccccccccCCCCCCCccceeEEEeeccchhhhh--hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhh
Confidence                                 00147899999888764  2344456789999999999999999999999999999999


Q ss_pred             cCCCCCCCCC------hHHHHHHhhc
Q psy12427        307 SGLSPFAGEN------DVETLKNVKA  326 (356)
Q Consensus       307 ~g~~Pf~~~~------~~~~~~~i~~  326 (356)
                      ||...|...+      +++.+..|.+
T Consensus       446 TGDyLFePhsG~~Y~rDEDHiA~i~E  471 (590)
T KOG1290|consen  446 TGDYLFEPHSGENYSRDEDHIALIME  471 (590)
T ss_pred             cCceeecCCCCCCCCccHHHHHHHHH
Confidence            9999887542      4555555543

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=5.7e-34  Score=250.41  Aligned_cols=228  Identities=36%  Similarity=0.629  Sum_probs=191.6

Q ss_pred             CceEEEEEEEccCCCEEEEEEcccCChhh-HHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEeccccchhhhhhC
Q psy12427        120 AFGVVHRCRERKTGNIFAAKFIPVSHNLE-KELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITA  198 (356)
Q Consensus       120 ~fg~V~~~~~~~~~~~~a~K~~~~~~~~~-~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  198 (356)
                      +||.||+|.+..++..+|+|++....... ...+.+|+..+++++|+||+++++.+......++++||+.+++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999999999999999998765544 67888999999999999999999999999999999999999999998865


Q ss_pred             CCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCceeecCCCcCc
Q psy12427        199 PDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF  278 (356)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y  278 (356)
                      ...      .....+..++.+++.++.+||+.+++|+||+|.||+++.++  .++|+|||.+.............++..|
T Consensus        81 ~~~------~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~  152 (244)
T smart00220       81 RGR------LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDG--HVKLADFGLARQLDPGGLLTTFVGTPEY  152 (244)
T ss_pred             ccC------CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCC--cEEEccccceeeeccccccccccCCcCC
Confidence            332      33344566999999999999999999999999999998654  7999999999887655444556789999


Q ss_pred             cccccccCCCCCccccHHHHHHHHHHHHcCCCCCCC-CChHHHHHHhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        279 AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAG-ENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       279 ~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +|||.+....++.++|+||+|+++|+|++|..||.. .+.......+......+... ...++.++.++|.+||..||+
T Consensus       153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~  230 (244)
T smart00220      153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPP-EWKISPEAKDLIRKLLVKDPE  230 (244)
T ss_pred             CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccc-cccCCHHHHHHHHHHccCCch
Confidence            999999988899999999999999999999999988 55555555555544443321 122889999999999999985

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.3e-34  Score=273.23  Aligned_cols=245  Identities=18%  Similarity=0.264  Sum_probs=174.3

Q ss_pred             ccceeeeccccccCceEEEEEEEc----------------cCCCEEEEEEcccCChhhHHHHH--------------HHH
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRER----------------KTGNIFAAKFIPVSHNLEKELIR--------------KEI  156 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~----------------~~~~~~a~K~~~~~~~~~~~~~~--------------~E~  156 (356)
                      .++|.+.++||+|+||+||+|.+.                ..++.||+|.+........+.|.              .|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            568999999999999999999752                23568999998765433333332              367


Q ss_pred             HHHHhcCCCCc-----eeeeeeEEe--------CCeEEEEEEeccccchhhhhhCCCCCC------------------Cc
Q psy12427        157 DIMNQLHHPKL-----INLHDAFED--------DDEMVLIFEFLSGGELFERITAPDYKM------------------SE  205 (356)
Q Consensus       157 ~il~~l~hpnI-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~~~------------------~~  205 (356)
                      .++.+++|.++     ++++++|..        .+..++|+||+.+++|.+++......+                  ..
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            77777766544     667777653        356899999999999999886432111                  11


Q ss_pred             cccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCceee--cCCCcCcccccc
Q psy12427        206 AEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKI--STGTAEFAAPEI  283 (356)
Q Consensus       206 ~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~~~~--~~gt~~y~aPE~  283 (356)
                      .......+..++.|++.||.|||+.+|+||||||+|||++.++  .+||+|||++...........  ..+++.|+|||.
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~--~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~  381 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDG--QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE  381 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCC--cEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence            1222334667899999999999999999999999999997654  799999999976543322222  234899999998


Q ss_pred             ccCCC--------------------C--CccccHHHHHHHHHHHHcCCC-CCCCCCh-----------HHHHHHhhcccc
Q psy12427        284 VEREP--------------------V--GFYTDMWAVGVLAYVLLSGLS-PFAGEND-----------VETLKNVKACDW  329 (356)
Q Consensus       284 ~~~~~--------------------~--~~~sDvwSlG~il~ell~g~~-Pf~~~~~-----------~~~~~~i~~~~~  329 (356)
                      +....                    +  ....|+||+||++|+|++|.. ||.+...           ......+....+
T Consensus       382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~  461 (507)
T PLN03224        382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKY  461 (507)
T ss_pred             hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCC
Confidence            85432                    1  124699999999999999875 7764321           111222233343


Q ss_pred             ccChhhhccCCHHHHHHHHHhhhcCC
Q psy12427        330 EFDEEAFKNVSEEGKDFIRRLLLRNK  355 (356)
Q Consensus       330 ~~~~~~~~~~s~~~~~lI~~ll~~dP  355 (356)
                      .++  .+..++++++|||.+||.++|
T Consensus       462 ~~~--~~d~~s~~~~dLi~~LL~~~~  485 (507)
T PLN03224        462 DFS--LLDRNKEAGWDLACKLITKRD  485 (507)
T ss_pred             Ccc--cccccChHHHHHHHHHhccCC
Confidence            443  356789999999999999876

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=4.1e-34  Score=299.63  Aligned_cols=188  Identities=21%  Similarity=0.329  Sum_probs=155.5

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEec
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFL  187 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~  187 (356)
                      ..+...+.||+|+||.||+|.++.++..||+|.+.......    ..|+++|++++||||+++++++......++||||+
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~  765 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI  765 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence            45667789999999999999999999999999986443221    24688999999999999999999999999999999


Q ss_pred             cccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHH---HCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH---EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       188 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      ++|+|.+++..    +.+     ..+..++.|++.||+|||   +.+|+||||||+||+++.+.  ..++. ||.+....
T Consensus       766 ~~g~L~~~l~~----l~~-----~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~--~~~~~-~~~~~~~~  833 (968)
T PLN00113        766 EGKNLSEVLRN----LSW-----ERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD--EPHLR-LSLPGLLC  833 (968)
T ss_pred             CCCcHHHHHhc----CCH-----HHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCC--ceEEE-eccccccc
Confidence            99999999852    222     334559999999999999   67999999999999998655  34443 55544332


Q ss_pred             CCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q psy12427        265 PNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAG  314 (356)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~  314 (356)
                      ..   ....+++.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       834 ~~---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~  880 (968)
T PLN00113        834 TD---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA  880 (968)
T ss_pred             cC---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence            11   223678999999999999999999999999999999999999954

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=9.4e-34  Score=277.58  Aligned_cols=244  Identities=18%  Similarity=0.263  Sum_probs=161.6

Q ss_pred             cccceeeeccccccCceEEEEEEEccC----CCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeee------EE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKT----GNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDA------FE  175 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~----~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~------~~  175 (356)
                      ..++|.+.+.||+|+||.||+|.+..+    +..||+|.+......+  ...+|  .+....+.++..+...      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e--~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE--IWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH--HHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            457899999999999999999999998    8999999876433211  11111  1122222223222221      24


Q ss_pred             eCCeEEEEEEeccccchhhhhhCCCCCCCcc--------------ccccccHHHHHHHHHHHHHHHHHCCceeccCCCCC
Q psy12427        176 DDDEMVLIFEFLSGGELFERITAPDYKMSEA--------------EVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPEN  241 (356)
Q Consensus       176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~--------------~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~N  241 (356)
                      .....++|+||+.+++|.+++..........              ......+..++.||+.||+|||+++|+||||||+|
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~N  285 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQN  285 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHH
Confidence            5678999999999999999987543221110              11112345689999999999999999999999999


Q ss_pred             EEEeecCCCcEEEEeeeceeeeCCC--CceeecCCCcCccccccccCCC----------------------CCccccHHH
Q psy12427        242 IMCQTRNSTNVKMIDFGLATKLDPN--EVVKISTGTAEFAAPEIVEREP----------------------VGFYTDMWA  297 (356)
Q Consensus       242 Ilv~~~~~~~vkl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~----------------------~~~~sDvwS  297 (356)
                      ||++.++ +.+||+|||+|+.+...  .......+++.|+|||.+....                      ++.++||||
T Consensus       286 ILl~~~~-~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS  364 (566)
T PLN03225        286 IIFSEGS-GSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS  364 (566)
T ss_pred             EEEeCCC-CcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence            9997533 47999999999865432  2223456899999999764321                      234569999


Q ss_pred             HHHHHHHHHcCCCCCCCCChHHHHHH-hhcccccc-----------Ch------hhhccCCHHHHHHHHHhhhcCCC
Q psy12427        298 VGVLAYVLLSGLSPFAGENDVETLKN-VKACDWEF-----------DE------EAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       298 lG~il~ell~g~~Pf~~~~~~~~~~~-i~~~~~~~-----------~~------~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      |||+||||+++..|+..  ....+.. +.......           .+      +.+...+.+..+||++||++||+
T Consensus       365 lGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~  439 (566)
T PLN03225        365 AGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR  439 (566)
T ss_pred             HHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence            99999999987665432  2222222 22211110           00      00111234466999999999995

>KOG2052|consensus

Probab=100.00  E-value=5.7e-34  Score=256.05  Aligned_cols=237  Identities=21%  Similarity=0.354  Sum_probs=176.9

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHh--cCCCCceeeeeeEEeC----Ce
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQ--LHHPKLINLHDAFEDD----DE  179 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~~~~----~~  179 (356)
                      +..+..+.+.||+|.||+||+|+++  |..||+|++....+   ....+|.+|.+.  |+|+||+.++++=..+    ..
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ  283 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ  283 (513)
T ss_pred             hhheeEEEEEecCccccceeecccc--CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence            4567899999999999999999999  88999999965543   445567777765  5999999999875433    36


Q ss_pred             EEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHC--------CceeccCCCCCEEEeecCCCc
Q psy12427        180 MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEK--------NIIHLDVKPENIMCQTRNSTN  251 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--------~ivH~Dlkp~NIlv~~~~~~~  251 (356)
                      +++|++|.+.|||+|+|...  .++.....     .++..++.||+|||-.        .|.|||||+.||||..++  .
T Consensus       284 LwLvTdYHe~GSL~DyL~r~--tv~~~~ml-----~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~--~  354 (513)
T KOG2052|consen  284 LWLVTDYHEHGSLYDYLNRN--TVTTEGML-----KLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG--T  354 (513)
T ss_pred             EEEeeecccCCcHHHHHhhc--cCCHHHHH-----HHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC--c
Confidence            79999999999999999753  33333333     3899999999999953        499999999999997655  7


Q ss_pred             EEEEeeeceeeeCCCC-----ceeecCCCcCccccccccCC----CCC--ccccHHHHHHHHHHHHcC----------CC
Q psy12427        252 VKMIDFGLATKLDPNE-----VVKISTGTAEFAAPEIVERE----PVG--FYTDMWAVGVLAYVLLSG----------LS  310 (356)
Q Consensus       252 vkl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~~--~~sDvwSlG~il~ell~g----------~~  310 (356)
                      +-|+|+|+|.......     ..+..+||.+|||||++...    .+.  ..+||||||.||||++..          ++
T Consensus       355 C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~  434 (513)
T KOG2052|consen  355 CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQL  434 (513)
T ss_pred             EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcC
Confidence            9999999998765431     22456899999999999643    121  358999999999999763          57


Q ss_pred             CCCCCC----hHHHHHHh-hccccc-cChhhhccCC--HHHHHHHHHhhhcCCC
Q psy12427        311 PFAGEN----DVETLKNV-KACDWE-FDEEAFKNVS--EEGKDFIRRLLLRNKE  356 (356)
Q Consensus       311 Pf~~~~----~~~~~~~i-~~~~~~-~~~~~~~~~s--~~~~~lI~~ll~~dP~  356 (356)
                      ||.+..    ..+.+..+ .-.... .++..|++.+  .....+++.||..||.
T Consensus       435 Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~  488 (513)
T KOG2052|consen  435 PYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPA  488 (513)
T ss_pred             CcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCch
Confidence            886553    22333433 222222 2344454433  4477889999999984

>KOG0670|consensus

Probab=100.00  E-value=6.9e-35  Score=266.01  Aligned_cols=220  Identities=25%  Similarity=0.395  Sum_probs=185.8

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCC------CCceeeeeeEEeCCeE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHH------PKLINLHDAFEDDDEM  180 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~h------pnIv~l~~~~~~~~~~  180 (356)
                      -.+|.+....|+|-||+|.+|.+..-|..||||+|.......+.- +.|++||++|..      -|+++|+..|...+++
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtG-l~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHL  509 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTG-LKELEILKKLNDADPEDKFHCLRLFRHFKHKNHL  509 (752)
T ss_pred             cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhh-hHHHHHHHHhhccCchhhhHHHHHHHHhhhccee
Confidence            467999999999999999999999999999999998765443333 369999999952      4899999999999999


Q ss_pred             EEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeece
Q psy12427        181 VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA  260 (356)
Q Consensus       181 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a  260 (356)
                      |||+|-+ ..+|.++|..-..   ...+...+++.|+.|++.||.+|...||+|.||||+||||+...+ .+||||||.|
T Consensus       510 ClVFE~L-slNLRevLKKyG~---nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~-iLKLCDfGSA  584 (752)
T KOG0670|consen  510 CLVFEPL-SLNLREVLKKYGR---NVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKN-ILKLCDFGSA  584 (752)
T ss_pred             EEEehhh-hchHHHHHHHhCc---ccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcc-eeeeccCccc
Confidence            9999988 5789999875332   122333456779999999999999999999999999999976543 6899999999


Q ss_pred             eeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCh
Q psy12427        261 TKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE  333 (356)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~  333 (356)
                      .....+..++ ..-+..|.|||++.+.+|++..|+||+||+||||.||+..|+|.++.+++.....+...||.
T Consensus       585 ~~~~eneitP-YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~  656 (752)
T KOG0670|consen  585 SFASENEITP-YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPN  656 (752)
T ss_pred             cccccccccH-HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcH
Confidence            8877665443 34577899999999999999999999999999999999999999999999888776666553

>KOG1152|consensus

Probab=100.00  E-value=1.5e-34  Score=266.84  Aligned_cols=199  Identities=32%  Similarity=0.550  Sum_probs=169.4

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhH--------HHHHHHHHHHHhcC---CCCceeeeeeEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK--------ELIRKEIDIMNQLH---HPKLINLHDAFE  175 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~--------~~~~~E~~il~~l~---hpnIv~l~~~~~  175 (356)
                      ...|+.++.+|.|+||.|++|.++.....|++|.+.+..-...        ..+-.|++||..++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            3569999999999999999999999999999999976542222        22345999999997   999999999999


Q ss_pred             eCCeEEEEEEec-cccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEE
Q psy12427        176 DDDEMVLIFEFL-SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKM  254 (356)
Q Consensus       176 ~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl  254 (356)
                      +++.+|++||-. +|.+|++++.... ++.+.....     |++|++.|++|||++||||||||-+||.++.++  -+||
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~-----IFkQV~agi~hlh~~~ivhrdikdenvivd~~g--~~kl  711 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKL-----IFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNG--FVKL  711 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhccC-ccchHHHHH-----HHHHHHhccccccccCceecccccccEEEecCC--eEEE
Confidence            999999999976 3568899986443 555555544     999999999999999999999999999998665  6999


Q ss_pred             EeeeceeeeCCCCceeecCCCcCccccccccCCCC-CccccHHHHHHHHHHHHcCCCCCCC
Q psy12427        255 IDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAG  314 (356)
Q Consensus       255 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~ell~g~~Pf~~  314 (356)
                      +|||.|.... +......+||..|.|||++.+.+| +..-|||++|++||-++....||..
T Consensus       712 idfgsaa~~k-sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  712 IDFGSAAYTK-SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             eeccchhhhc-CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            9999987654 455677889999999999999887 5668999999999999999999864

>KOG3653|consensus

Probab=100.00  E-value=1.2e-33  Score=255.73  Aligned_cols=235  Identities=25%  Similarity=0.347  Sum_probs=179.1

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhc--CCCCceeeeeeEEeCC----eEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL--HHPKLINLHDAFEDDD----EMV  181 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l--~hpnIv~l~~~~~~~~----~~~  181 (356)
                      ...++.+.||+|+||.||+|...  ++.||||++..   .+++.+.+|.+|.+..  +|+||++++++-+...    .++
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc--CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            45778899999999999999887  68999999864   4567888888888764  7999999999876554    889


Q ss_pred             EEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHC---------CceeccCCCCCEEEeecCCCcE
Q psy12427        182 LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEK---------NIIHLDVKPENIMCQTRNSTNV  252 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---------~ivH~Dlkp~NIlv~~~~~~~v  252 (356)
                      +|++|.+.|+|.++|+..-  .++..     ...++..+++||+|||+.         .|+|||||+.||||..|.  ..
T Consensus       285 LVt~fh~kGsL~dyL~~nt--isw~~-----~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl--Tc  355 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYLKANT--ISWNS-----LCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL--TC  355 (534)
T ss_pred             EEeeeccCCcHHHHHHhcc--ccHHH-----HHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC--cE
Confidence            9999999999999998642  34443     445999999999999963         499999999999997655  79


Q ss_pred             EEEeeeceeeeCCCCce---eecCCCcCccccccccCCC-CC-----ccccHHHHHHHHHHHHcCCCCCC-CC-------
Q psy12427        253 KMIDFGLATKLDPNEVV---KISTGTAEFAAPEIVEREP-VG-----FYTDMWAVGVLAYVLLSGLSPFA-GE-------  315 (356)
Q Consensus       253 kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~-~~-----~~sDvwSlG~il~ell~g~~Pf~-~~-------  315 (356)
                      .|+|||+|..+.+....   ...+||.+|||||++.+.. +.     .+.||||+|.|||||+++..-+. +.       
T Consensus       356 cIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlp  435 (534)
T KOG3653|consen  356 CIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLP  435 (534)
T ss_pred             EeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCc
Confidence            99999999998754332   3367999999999997642 21     36899999999999998643332 11       


Q ss_pred             ---------ChHHHHHHh--hccccccChhhhcc-CCHHHHHHHHHhhhcCCC
Q psy12427        316 ---------NDVETLKNV--KACDWEFDEEAFKN-VSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       316 ---------~~~~~~~~i--~~~~~~~~~~~~~~-~s~~~~~lI~~ll~~dP~  356 (356)
                               +-+++-..+  .+....+|....++ -..-+++.|..||..|||
T Consensus       436 fe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDae  488 (534)
T KOG3653|consen  436 FEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAE  488 (534)
T ss_pred             hhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchh
Confidence                     112222222  23444454433333 346689999999999986

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=100.00  E-value=2.6e-32  Score=237.59  Aligned_cols=212  Identities=31%  Similarity=0.534  Sum_probs=178.2

Q ss_pred             eeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh-hHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEecc
Q psy12427        110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL-EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLS  188 (356)
Q Consensus       110 y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  188 (356)
                      |.+.+.||.|++|.||++....++..+|+|.+...... ....+.+|++.++.++|+|++++++.+......++++|++.
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            45778999999999999999988999999999876554 56788899999999999999999999999999999999999


Q ss_pred             ccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCC-
Q psy12427        189 GGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE-  267 (356)
Q Consensus       189 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~-  267 (356)
                      +++|.+++......     .....+..++.+++.++.+||+.+++|+||+|.||+++.+  ..++|+|||.+....... 
T Consensus        81 ~~~L~~~~~~~~~~-----~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~--~~~~l~d~g~~~~~~~~~~  153 (225)
T smart00221       81 GGDLFDYLRKKGGK-----LSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMD--GLVKLADFGLARFIHRDLA  153 (225)
T ss_pred             CCCHHHHHHhcccC-----CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC--CCEEEeeCceeeEecCccc
Confidence            99999998754321     2233445589999999999999999999999999999865  479999999998875443 


Q ss_pred             -ceeecCCCcCccccccc-cCCCCCccccHHHHHHHHHHHHcCCCCCCC-CChH-HHHHHhhccc
Q psy12427        268 -VVKISTGTAEFAAPEIV-EREPVGFYTDMWAVGVLAYVLLSGLSPFAG-ENDV-ETLKNVKACD  328 (356)
Q Consensus       268 -~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlG~il~ell~g~~Pf~~-~~~~-~~~~~i~~~~  328 (356)
                       ......++..|++||.+ ....++.++|+||||+++|+|++|+.||.. .++. ++.+.+..+.
T Consensus       154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~  218 (225)
T smart00221      154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV  218 (225)
T ss_pred             ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence             33445678899999998 677788899999999999999999999988 4554 5555555544

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1027|consensus

Probab=100.00  E-value=1.1e-33  Score=271.13  Aligned_cols=236  Identities=23%  Similarity=0.383  Sum_probs=182.5

Q ss_pred             eeeeccccccCceE-EEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEEEEEEec
Q psy12427        110 YDILEEIGTGAFGV-VHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMVLIFEFL  187 (356)
Q Consensus       110 y~~~~~lg~G~fg~-V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~e~~  187 (356)
                      |.-.+.+|.|+.|+ ||+|...  |+.||+|.+....   .....+|+..|+.- +|||||++++.=.+....||+.|.|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC--CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence            34457899999876 6888876  8899999875432   23456899999998 5999999999988999999999999


Q ss_pred             cccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEee---cCCCcEEEEeeeceeeeC
Q psy12427        188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQT---RNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       188 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~---~~~~~vkl~Dfg~a~~~~  264 (356)
                       ..+|.+++........  ..........+.|++.||+|||+.+||||||||.||||+.   ++..+++|+|||+|..+.
T Consensus       586 -~~sL~dlie~~~~d~~--~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  586 -ACSLQDLIESSGLDVE--MQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             -hhhHHHHHhccccchh--hcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence             4699999986411111  1111344568999999999999999999999999999987   354578999999999886


Q ss_pred             CCCc----eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccC
Q psy12427        265 PNEV----VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNV  339 (356)
Q Consensus       265 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  339 (356)
                      .+..    .....||-+|+|||++....-+.++||||+||++|+.++ |..||.+.-..+  .+|..+++....-. ..-
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L~~L~-~~~  739 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTLVHLE-PLP  739 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccceeeec-cCc
Confidence            4432    233458999999999999888889999999999999999 589997764433  45555554432111 111


Q ss_pred             CHHHHHHHHHhhhcCCC
Q psy12427        340 SEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       340 s~~~~~lI~~ll~~dP~  356 (356)
                      ..+++|||.+||+.||.
T Consensus       740 d~eA~dLI~~ml~~dP~  756 (903)
T KOG1027|consen  740 DCEAKDLISRMLNPDPQ  756 (903)
T ss_pred             hHHHHHHHHHhcCCCcc
Confidence            12999999999999994

>KOG0664|consensus

Probab=99.98  E-value=2.7e-34  Score=243.69  Aligned_cols=210  Identities=25%  Similarity=0.404  Sum_probs=167.7

Q ss_pred             eeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCC-----eEEEE
Q psy12427        111 DILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDD-----EMVLI  183 (356)
Q Consensus       111 ~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----~~~lv  183 (356)
                      +-.+.||-|+||.||.+.+..+|+.||+|.+...-  ......+.+|+.+|..++|.|++..++..+-..     .+|++
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            34478999999999999999999999999886532  223456778999999999999999988765432     35667


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      +|.|. .+|...+..      ...++...++-++.||++||+|||+.+|.||||||.|+|++.  +..+||||||+++..
T Consensus       136 TELmQ-SDLHKIIVS------PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNS--NCvLKICDFGLARve  206 (449)
T KOG0664|consen  136 TELMQ-SDLHKIIVS------PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNS--NCILKICDFGLARTW  206 (449)
T ss_pred             HHHHH-hhhhheecc------CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEecc--CceEEeccccccccc
Confidence            77773 466665543      333444445569999999999999999999999999999964  347899999999987


Q ss_pred             CCCCce--eecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc
Q psy12427        264 DPNEVV--KISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDW  329 (356)
Q Consensus       264 ~~~~~~--~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~  329 (356)
                      +.....  ...+-|-+|.|||++.+. .|+.+.||||.|||+.||+..+..|...++.+.++.|.....
T Consensus       207 e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLG  275 (449)
T KOG0664|consen  207 DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLG  275 (449)
T ss_pred             chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhC
Confidence            654433  223468899999999875 589999999999999999999999999999888888765433

>KOG0665|consensus

Probab=99.98  E-value=4.5e-33  Score=240.99  Aligned_cols=210  Identities=26%  Similarity=0.426  Sum_probs=174.9

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeC------
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDD------  177 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------  177 (356)
                      +..+|.-+..+|.|.- .|..+.+.-.+++||+|.+....  ........+|...|..+.|+||++++.+|.-.      
T Consensus        15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~   93 (369)
T KOG0665|consen   15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF   93 (369)
T ss_pred             eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence            3457888899999999 89999999999999999875432  22234456899999999999999999999633      


Q ss_pred             CeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEee
Q psy12427        178 DEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDF  257 (356)
Q Consensus       178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Df  257 (356)
                      ...|+|||+|. .+|.+.+..        +.....++.++.|++.|++|||+.||+||||||+||++..+.  .+||.||
T Consensus        94 ~e~y~v~e~m~-~nl~~vi~~--------elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~--~lKi~df  162 (369)
T KOG0665|consen   94 QEVYLVMELMD-ANLCQVILM--------ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDC--TLKILDF  162 (369)
T ss_pred             HhHHHHHHhhh-hHHHHHHHH--------hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchh--heeeccc
Confidence            46799999994 588887751        233345566999999999999999999999999999996543  7999999


Q ss_pred             eceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc
Q psy12427        258 GLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKAC  327 (356)
Q Consensus       258 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~  327 (356)
                      |+|+.-+..-..+..+.|..|.|||++.+..+...+||||+||++.||++|+..|.|.+.-+.+.++...
T Consensus       163 g~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~  232 (369)
T KOG0665|consen  163 GLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQ  232 (369)
T ss_pred             hhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHH
Confidence            9999876664456667899999999999999999999999999999999999999999887777666543

>KOG1345|consensus

Probab=99.98  E-value=3.2e-33  Score=236.87  Aligned_cols=242  Identities=25%  Similarity=0.383  Sum_probs=186.8

Q ss_pred             CCcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhc-CCCCceeeee-eEEeCCeEE
Q psy12427        104 SSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL-HHPKLINLHD-AFEDDDEMV  181 (356)
Q Consensus       104 ~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~-~~~~~~~~~  181 (356)
                      -.+.+.|.|.+.||+|.||.+-+|+++.++..+++|.+..... ...+|.+|...--.| .|.||+.-++ +|+..+.++
T Consensus        20 v~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv   98 (378)
T KOG1345|consen   20 VDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV   98 (378)
T ss_pred             cchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence            3456789999999999999999999999999999999876543 356677777665556 4899998665 678888999


Q ss_pred             EEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeecee
Q psy12427        182 LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT  261 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~  261 (356)
                      +++||++.|+|..-+...+       +-+...+.++.|+++|+.|||++++||||||.+||||-..+..+|||||||..+
T Consensus        99 F~qE~aP~gdL~snv~~~G-------igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~  171 (378)
T KOG1345|consen   99 FVQEFAPRGDLRSNVEAAG-------IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTR  171 (378)
T ss_pred             EeeccCccchhhhhcCccc-------ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccc
Confidence            9999999999987665432       223334559999999999999999999999999999987777799999999987


Q ss_pred             eeCCCCceeecCCCcCccccccccCC-----CCCccccHHHHHHHHHHHHcCCCCCCCCC-----hHHHHHHhhcccccc
Q psy12427        262 KLDPNEVVKISTGTAEFAAPEIVERE-----PVGFYTDMWAVGVLAYVLLSGLSPFAGEN-----DVETLKNVKACDWEF  331 (356)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlG~il~ell~g~~Pf~~~~-----~~~~~~~i~~~~~~~  331 (356)
                      ....  .....--+..|.|||...-.     ...+.+|+|.||+++|..++|.+||+...     ..+.++-...... -
T Consensus       172 k~g~--tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~-~  248 (378)
T KOG1345|consen  172 KVGT--TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP-A  248 (378)
T ss_pred             ccCc--eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc-c
Confidence            6432  12222246778999977432     35678999999999999999999998442     1222333333332 2


Q ss_pred             ChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        332 DEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       332 ~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+..|.-+|+.+..+.++-|..+|+
T Consensus       249 ~P~~F~~fs~~a~r~Fkk~lt~~~~  273 (378)
T KOG1345|consen  249 LPKKFNPFSEKALRLFKKSLTPRFK  273 (378)
T ss_pred             CchhhcccCHHHHHHHHHhcCCccc
Confidence            3456677899999999999888764

>KOG0576|consensus

Probab=99.97  E-value=1.1e-32  Score=258.10  Aligned_cols=242  Identities=23%  Similarity=0.426  Sum_probs=208.5

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      .++|.++..+|.|.+|.||+++++.++...|+|+++.....+...+.+|+-+++..+||||+.++|.+.....++++|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            35799999999999999999999999999999999998888888888999999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      |.||+|-+...... .+++     .++...++..+.||+|||++|-+|||||-.|||++..+  .+|++|||.+..+...
T Consensus        94 cgggslQdiy~~Tg-plse-----lqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~g--DvklaDfgvsaqitat  165 (829)
T KOG0576|consen   94 CGGGSLQDIYHVTG-PLSE-----LQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEG--DVKLADFGVSAQITAT  165 (829)
T ss_pred             cCCCcccceeeecc-cchh-----HHHHHHHhhhhccchhhhcCCcccccccccceeecccC--ceeecccCchhhhhhh
Confidence            99999977655432 3344     34455899999999999999999999999999997655  7999999998876432


Q ss_pred             -CceeecCCCcCccccccc---cCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhh-hccCCH
Q psy12427        267 -EVVKISTGTAEFAAPEIV---EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEA-FKNVSE  341 (356)
Q Consensus       267 -~~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~s~  341 (356)
                       .......||+.|||||+-   +.+.|...+|||++|+...|+---++|-....++..+....+..+.+|..- ...+++
T Consensus       166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~  245 (829)
T KOG0576|consen  166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSE  245 (829)
T ss_pred             hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchH
Confidence             223456799999999976   466788999999999999999999999888888888888888887765322 124899


Q ss_pred             HHHHHHHHhhhcCCC
Q psy12427        342 EGKDFIRRLLLRNKE  356 (356)
Q Consensus       342 ~~~~lI~~ll~~dP~  356 (356)
                      -+-+||+.+|.++|.
T Consensus       246 ~fh~fvK~altknpK  260 (829)
T KOG0576|consen  246 FFHNFVKGALTKNPK  260 (829)
T ss_pred             HHHHHHHHHhcCCCc
Confidence            999999999999985

>KOG1024|consensus

Probab=99.97  E-value=7.7e-31  Score=232.46  Aligned_cols=244  Identities=18%  Similarity=0.250  Sum_probs=195.8

Q ss_pred             cceeeeccccccCceEEEEEEEccCC-----CEEEEEEcccC-ChhhHHHHHHHHHHHHhcCCCCceeeeeeEEe-CCeE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTG-----NIFAAKFIPVS-HNLEKELIRKEIDIMNQLHHPKLINLHDAFED-DDEM  180 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~-----~~~a~K~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~  180 (356)
                      .+++....+-+|.||.||+|.++...     +.+.+|.++.. +..+...+..|.-.+..+.|||+.++.+++.. ...+
T Consensus       284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P  363 (563)
T KOG1024|consen  284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATP  363 (563)
T ss_pred             hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcc
Confidence            45778889999999999999887532     34555655443 23455678889999999999999999998864 4667


Q ss_pred             EEEEEeccccchhhhhhCCCC--CCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeee
Q psy12427        181 VLIFEFLSGGELFERITAPDY--KMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFG  258 (356)
Q Consensus       181 ~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg  258 (356)
                      +.++.++.-|+|..++...+.  ......+...++..++.|++.||+|||+.||||.||..+|.+|+..  .++||+|=.
T Consensus       364 ~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~--LqVkltDsa  441 (563)
T KOG1024|consen  364 FVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ--LQVKLTDSA  441 (563)
T ss_pred             eEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh--eeEEeccch
Confidence            888999999999999873332  1222344445677799999999999999999999999999999854  489999999


Q ss_pred             ceeeeCCCCceeec---CCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChh
Q psy12427        259 LATKLDPNEVVKIS---TGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEE  334 (356)
Q Consensus       259 ~a~~~~~~~~~~~~---~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~  334 (356)
                      +++.+-+.+...-.   -.+..|||||.+....|+.++|+|||||+||||+| |+.||...++.|+..-+..+- ...++
T Consensus       442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy-RlaQP  520 (563)
T KOG1024|consen  442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY-RLAQP  520 (563)
T ss_pred             hccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc-eecCC
Confidence            99987654433211   24778999999999999999999999999999999 999999999999888777643 22222


Q ss_pred             hhccCCHHHHHHHHHhhhcCCC
Q psy12427        335 AFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       335 ~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                        -++|+++-.++.-||..+|+
T Consensus       521 --~NCPDeLf~vMacCWallpe  540 (563)
T KOG1024|consen  521 --FNCPDELFTVMACCWALLPE  540 (563)
T ss_pred             --CCCcHHHHHHHHHHHhcCcc
Confidence              38999999999999999986

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=1.9e-29  Score=216.27  Aligned_cols=200  Identities=33%  Similarity=0.594  Sum_probs=167.9

Q ss_pred             ccccCceEEEEEEEccCCCEEEEEEcccCChh-hHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEeccccchhh
Q psy12427        116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL-EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFE  194 (356)
Q Consensus       116 lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~  194 (356)
                      ||.|.+|.||++....++..+++|++...... ....+.+|+..++.++|++|+++++++......++++|++.+++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            68999999999999988999999998766543 34678899999999999999999999999999999999999999999


Q ss_pred             hhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCC-ceeecC
Q psy12427        195 RITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE-VVKIST  273 (356)
Q Consensus       195 ~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~  273 (356)
                      ++.....     ......+..++.+++.++++||+.|++|+||+|.||+++.. ...++|+|||.+....... ......
T Consensus        81 ~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~  154 (215)
T cd00180          81 LLKENEG-----KLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSD-NGKVKLADFGLSKLLTSDKSLLKTIV  154 (215)
T ss_pred             HHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCC-CCcEEEecCCceEEccCCcchhhccc
Confidence            9875421     22333445599999999999999999999999999999862 2379999999998765432 123345


Q ss_pred             CCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHHHhhh
Q psy12427        274 GTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLL  352 (356)
Q Consensus       274 gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~  352 (356)
                      +...|++||.+... ..+.++|+|++|+++++|                                   ..+.+++.+||+
T Consensus       155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~~l~  199 (215)
T cd00180         155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRKMLQ  199 (215)
T ss_pred             CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHHHhh
Confidence            78899999999887 788999999999999999                                   567888888888


Q ss_pred             cCCC
Q psy12427        353 RNKE  356 (356)
Q Consensus       353 ~dP~  356 (356)
                      .||+
T Consensus       200 ~~p~  203 (215)
T cd00180         200 KDPE  203 (215)
T ss_pred             CCcc
Confidence            7774

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1167|consensus

Probab=99.95  E-value=3.6e-29  Score=224.16  Aligned_cols=197  Identities=25%  Similarity=0.467  Sum_probs=162.0

Q ss_pred             ccceeeeccccccCceEEEEEEEcc---CCCEEEEEEcccCChhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERK---TGNIFAAKFIPVSHNLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l  182 (356)
                      .+.|.+..+||+|.|++||++.+..   .++.||+|.+...+.  ...+.+|+++|..+ .+.||+++.+++..++...+
T Consensus        35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~i  112 (418)
T KOG1167|consen   35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAI  112 (418)
T ss_pred             hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCeeEE
Confidence            4568899999999999999999887   688999999876554  34578999999999 58999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      |+||+++.+-.+++....         ...++.+++.++.||+++|.+|||||||||.|+|.+... ++-.|+|||+|..
T Consensus       113 vlp~~~H~~f~~l~~~l~---------~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t-~rg~LvDFgLA~~  182 (418)
T KOG1167|consen  113 VLPYFEHDRFRDLYRSLS---------LAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRT-QRGVLVDFGLAQR  182 (418)
T ss_pred             EecccCccCHHHHHhcCC---------HHHHHHHHHHHHHHhhhhhccCccccCCCcccccccccc-CCceEEechhHHH
Confidence            999999988877775322         233455999999999999999999999999999997654 4679999999972


Q ss_pred             eC-----------------C-----------------CCc-----------eeecCCCcCccccccccCC-CCCccccHH
Q psy12427        263 LD-----------------P-----------------NEV-----------VKISTGTAEFAAPEIVERE-PVGFYTDMW  296 (356)
Q Consensus       263 ~~-----------------~-----------------~~~-----------~~~~~gt~~y~aPE~~~~~-~~~~~sDvw  296 (356)
                      .+                 +                 ...           .....||++|.|||++... .-++++|||
T Consensus       183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw  262 (418)
T KOG1167|consen  183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW  262 (418)
T ss_pred             HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence            10                 0                 000           0112489999999999754 457899999


Q ss_pred             HHHHHHHHHHcCCCCCCCC
Q psy12427        297 AVGVLAYVLLSGLSPFAGE  315 (356)
Q Consensus       297 SlG~il~ell~g~~Pf~~~  315 (356)
                      |.|+|+..+++++.||-..
T Consensus       263 s~GVI~Lslls~~~PFf~a  281 (418)
T KOG1167|consen  263 SAGVILLSLLSRRYPFFKA  281 (418)
T ss_pred             eccceeehhhccccccccC
Confidence            9999999999999998544

>KOG1164|consensus

Probab=99.95  E-value=2.1e-27  Score=218.59  Aligned_cols=204  Identities=23%  Similarity=0.326  Sum_probs=166.2

Q ss_pred             ceeeeccccccCceEEEEEEEccCC-CEEEEEEcccCChhhHHHHHHHHHHHHhcCC----CCceeeeeeE-EeCCeEEE
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTG-NIFAAKFIPVSHNLEKELIRKEIDIMNQLHH----PKLINLHDAF-EDDDEMVL  182 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~-~~~a~K~~~~~~~~~~~~~~~E~~il~~l~h----pnIv~l~~~~-~~~~~~~l  182 (356)
                      +|.+.++||+|+||.||+|.+..++ ..+|+|+...........+..|..++..+..    +++..+++.. ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            7999999999999999999998775 6789998766543333367789999999873    6899999998 57888999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecC-C--CcEEEEeeec
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN-S--TNVKMIDFGL  259 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~-~--~~vkl~Dfg~  259 (356)
                      ||+.+ |.+|.++.....    ...++..+...++.|++.+|++||+.|++||||||.|+++.... .  ..+.|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~----~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP----PGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC----CCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99977 889999875433    33444445556999999999999999999999999999997653 1  4689999999


Q ss_pred             ee--eeC-CCC-------c-eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCh
Q psy12427        260 AT--KLD-PNE-------V-VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEND  317 (356)
Q Consensus       260 a~--~~~-~~~-------~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~  317 (356)
                      ++  .+- ...       . .....||.+|+++.+..+...+.+.|+||++.++.+++.|..||.+...
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~  242 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM  242 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence            98  321 111       0 1224599999999999999999999999999999999999999987764

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=2.9e-28  Score=249.72  Aligned_cols=185  Identities=17%  Similarity=0.211  Sum_probs=131.9

Q ss_pred             hcCC-CCceeeeeeE-------EeCCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCc
Q psy12427        161 QLHH-PKLINLHDAF-------EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNI  232 (356)
Q Consensus       161 ~l~h-pnIv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i  232 (356)
                      .++| +||++++++|       .....+++++|++ +++|.+++......     +....+..+++||+.||+|||++||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~-----~~~~~~~~i~~qi~~al~~lH~~gI  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRS-----VDAFECFHVFRQIVEIVNAAHSQGI  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccccc-----ccHHHHHHHHHHHHHHHHHHHhCCe
Confidence            4455 5788888877       2345678889987 66999999753322     3344455699999999999999999


Q ss_pred             eeccCCCCCEEEee-----------------cCCCcEEEEeeeceeeeCCCC-----------------ceeecCCCcCc
Q psy12427        233 IHLDVKPENIMCQT-----------------RNSTNVKMIDFGLATKLDPNE-----------------VVKISTGTAEF  278 (356)
Q Consensus       233 vH~Dlkp~NIlv~~-----------------~~~~~vkl~Dfg~a~~~~~~~-----------------~~~~~~gt~~y  278 (356)
                      +||||||+|||++.                 +....+|++|||+++......                 ......||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            99999999999953                 223457888888876432100                 00113578899


Q ss_pred             cccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        279 AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       279 ~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +|||++.+..++.++|||||||+||||++|.+|+....  ..+..+....  .++.. ..-..+..+++.+||++||+
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~L~~~P~  254 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV--LPPQI-LLNWPKEASFCLWLLHPEPS  254 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh--cChhh-hhcCHHHHHHHHHhCCCChh
Confidence            99999999999999999999999999999999875432  2233332221  12211 12345678999999999984

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=3.7e-27  Score=217.20  Aligned_cols=163  Identities=18%  Similarity=0.248  Sum_probs=126.6

Q ss_pred             cccceeeeccccccCceEEEEEEEcc-CCCEEEEEEcccC-----ChhhHHHHHHHHHHHHhcCCCCcee-eeeeEEeCC
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERK-TGNIFAAKFIPVS-----HNLEKELIRKEIDIMNQLHHPKLIN-LHDAFEDDD  178 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~-~~~~~a~K~~~~~-----~~~~~~~~~~E~~il~~l~hpnIv~-l~~~~~~~~  178 (356)
                      +.+.|.+.+.||+|+||+||+|.++. ++..+|+|.+...     .......+.+|+++|++++|+|+++ +++.    +
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~   91 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G   91 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence            45679999999999999999999886 6778899986532     1223566889999999999999985 4432    4


Q ss_pred             eEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccC-CCCCEEEeecCCCcEEEEee
Q psy12427        179 EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDV-KPENIMCQTRNSTNVKMIDF  257 (356)
Q Consensus       179 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dl-kp~NIlv~~~~~~~vkl~Df  257 (356)
                      ..++||||++|++|... ..      ...      ..++.+++.||.|||++||+|||| ||+|||++.++  .+||+||
T Consensus        92 ~~~LVmE~~~G~~L~~~-~~------~~~------~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~--~ikLiDF  156 (365)
T PRK09188         92 KDGLVRGWTEGVPLHLA-RP------HGD------PAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDG--EAAVIDF  156 (365)
T ss_pred             CcEEEEEccCCCCHHHh-Cc------cch------HHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCC--CEEEEEC
Confidence            67999999999998622 10      001      237889999999999999999999 99999997544  7999999


Q ss_pred             eceeeeCCCCce---------eecCCCcCccccccccCC
Q psy12427        258 GLATKLDPNEVV---------KISTGTAEFAAPEIVERE  287 (356)
Q Consensus       258 g~a~~~~~~~~~---------~~~~gt~~y~aPE~~~~~  287 (356)
                      |+|+.+......         ....+++.|+|||++...
T Consensus       157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            999977533211         123478889999998644

>KOG1163|consensus

Probab=99.94  E-value=5.1e-27  Score=196.17  Aligned_cols=237  Identities=21%  Similarity=0.273  Sum_probs=185.0

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCC-CCceeeeeeEEeCCeEEEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHH-PKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~~~lv~  184 (356)
                      +.+.|.++++||.|+||.+|.|..-..|..||+|+-+....  ...+.-|..+.+.|++ ..|..+..+..+...-.+||
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            45689999999999999999999999999999998654322  2345679999999976 67888888888999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecC-CCcEEEEeeeceeee
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN-STNVKMIDFGLATKL  263 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~-~~~vkl~Dfg~a~~~  263 (356)
                      +.+ |.+|.+++.-....++-..     +.-++-|++.-++|+|.+++|||||||+|.|...+. +..+.|+|||+|..+
T Consensus        91 dLL-GPsLEdLfnfC~R~ftmkT-----vLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCSRRFTMKT-----VLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             ecc-CccHHHHHHHHhhhhhHHh-----HHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence            988 8899888865444444443     344889999999999999999999999999986543 236899999999876


Q ss_pred             CCCCc--------eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHH---HHHHhhccccccC
Q psy12427        264 DPNEV--------VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVE---TLKNVKACDWEFD  332 (356)
Q Consensus       264 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~---~~~~i~~~~~~~~  332 (356)
                      .....        .....||.+|.+--+..+..-+...|+-|+|.+|..+.-|..||++.....   -+++|.+.....+
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~  244 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP  244 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence            43211        122458999999888888888899999999999999999999999886543   3444544443333


Q ss_pred             -hhhhccCCHHHHHHHHHh
Q psy12427        333 -EEAFKNVSEEGKDFIRRL  350 (356)
Q Consensus       333 -~~~~~~~s~~~~~lI~~l  350 (356)
                       +.+.+.+|.|..-.+.-|
T Consensus       245 ie~LC~G~P~EF~myl~Y~  263 (341)
T KOG1163|consen  245 IEVLCKGFPAEFAMYLNYC  263 (341)
T ss_pred             HHHHhCCCcHHHHHHHHHH
Confidence             444556787777666655

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.94  E-value=2.5e-25  Score=203.27  Aligned_cols=240  Identities=32%  Similarity=0.560  Sum_probs=189.6

Q ss_pred             eeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh---hHHHHHHHHHHHHhcCCC-CceeeeeeEEeCCeEEEEEE
Q psy12427        110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL---EKELIRKEIDIMNQLHHP-KLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       110 y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~---~~~~~~~E~~il~~l~hp-nIv~l~~~~~~~~~~~lv~e  185 (356)
                      |.+.+.||.|+||.||++.+.   ..+++|.+......   ....+.+|+.++..+.|+ +|+++.+.+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            678889999999999999988   78899998765443   356788999999999988 79999999988888899999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      ++.++++.+++......   ..........++.|++.++.|+|+.+++|||+||+||+++..+. .++++|||.++....
T Consensus        79 ~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~-~~~l~dfg~~~~~~~  154 (384)
T COG0515          79 YVDGGSLEDLLKKIGRK---GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR-VVKLIDFGLAKLLPD  154 (384)
T ss_pred             cCCCCcHHHHHHhcccc---cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC-eEEEeccCcceecCC
Confidence            99999999766544321   23333445569999999999999999999999999999976542 589999999986643


Q ss_pred             CC-------ceeecCCCcCccccccccC---CCCCccccHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHhhccccc-
Q psy12427        266 NE-------VVKISTGTAEFAAPEIVER---EPVGFYTDMWAVGVLAYVLLSGLSPFAGEND----VETLKNVKACDWE-  330 (356)
Q Consensus       266 ~~-------~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~----~~~~~~i~~~~~~-  330 (356)
                      ..       ......|+..|+|||.+.+   ...+..+|+||+|++++++++|..||.....    ......+...... 
T Consensus       155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  234 (384)
T COG0515         155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS  234 (384)
T ss_pred             CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc
Confidence            32       2355679999999999987   5788999999999999999999999887764    4555555554433 


Q ss_pred             cChhhhccC----CHHHHHHHHHhhhcCCC
Q psy12427        331 FDEEAFKNV----SEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       331 ~~~~~~~~~----s~~~~~lI~~ll~~dP~  356 (356)
                      .........    ...+.+++..++..+|.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (384)
T COG0515         235 LASPLSPSNPELISKAASDLLKKLLAKDPK  264 (384)
T ss_pred             cccccCccccchhhHHHHHHHHHHHhcCch
Confidence            222222222    26899999999988773

>KOG0195|consensus

Probab=99.94  E-value=1.1e-26  Score=197.55  Aligned_cols=264  Identities=14%  Similarity=0.206  Sum_probs=202.0

Q ss_pred             cccCCCCceeEeeecccCCCCCCCCCCCcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh--hhHHHHHHH
Q psy12427         78 EKVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN--LEKELIRKE  155 (356)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~E  155 (356)
                      ..++..+..+....++.....+...++.-..+..++.+|.+...|+.|+|+++  |..+++|++....-  .-.++|..|
T Consensus       160 nripfkdt~wkgtktr~rdatlsr~~gid~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfnee  237 (448)
T KOG0195|consen  160 NRIPFKDTTWKGTKTRTRDATLSRYTGIDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEE  237 (448)
T ss_pred             CcccccccccccccccccccccccccCcchhhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhcchhhcchhhhh
Confidence            33444445555544554444444445555667788999999999999999998  55677788766543  234678889


Q ss_pred             HHHHHhcCCCCceeeeeeEEeCCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCC--ce
Q psy12427        156 IDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN--II  233 (356)
Q Consensus       156 ~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--iv  233 (356)
                      .-.|+.+.||||++++|.|..+.++.++..||+.|+|+.++.....    -.+...+...++.++++||+|||+..  |.
T Consensus       238 fp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~----vvvd~sqav~faldiargmaflhslep~ip  313 (448)
T KOG0195|consen  238 FPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTS----VVVDHSQAVRFALDIARGMAFLHSLEPMIP  313 (448)
T ss_pred             CcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCcc----EEEecchHHHHHHHHHhhHHHHhhcchhhh
Confidence            9999999999999999999999999999999999999999985432    22223344558999999999999864  55


Q ss_pred             eccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCceeecCCCcCccccccccCCCCC---ccccHHHHHHHHHHHHcCCC
Q psy12427        234 HLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVG---FYTDMWAVGVLAYVLLSGLS  310 (356)
Q Consensus       234 H~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~sDvwSlG~il~ell~g~~  310 (356)
                      .--|.+..|++|.+-..++..+|--++.+.      ....-.|.||+||.+...+-+   .+.|+|||++++|||.|.+.
T Consensus       314 r~~lns~hvmidedltarismad~kfsfqe------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trev  387 (448)
T KOG0195|consen  314 RFYLNSKHVMIDEDLTARISMADTKFSFQE------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREV  387 (448)
T ss_pred             hhhcccceEEecchhhhheecccceeeeec------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccc
Confidence            667899999999877666677775544321      112347899999999887654   57899999999999999999


Q ss_pred             CCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHHHhhhcCC
Q psy12427        311 PFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNK  355 (356)
Q Consensus       311 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP  355 (356)
                      ||.+-+++|.-.+|.-.....  ..++.+|.....+++-|++-||
T Consensus       388 pfadlspmecgmkialeglrv--~ippgis~hm~klm~icmnedp  430 (448)
T KOG0195|consen  388 PFADLSPMECGMKIALEGLRV--HIPPGISRHMNKLMNICMNEDP  430 (448)
T ss_pred             ccccCCchhhhhhhhhccccc--cCCCCccHHHHHHHHHHhcCCC
Confidence            999999999877775443321  2224899999999999999998

>KOG1165|consensus

Probab=99.93  E-value=6.6e-26  Score=197.58  Aligned_cols=235  Identities=22%  Similarity=0.313  Sum_probs=188.7

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCeEEEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLH-HPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      +.-+|.+.++||+|+||.++.|..--++.+||||+-...+.  .-+++.|....+.|. .++|...+-+...+.+-.+|+
T Consensus        26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi  103 (449)
T KOG1165|consen   26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI  103 (449)
T ss_pred             ecccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence            34579999999999999999999999999999998655433  356778998888885 699999998888999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCC---CcEEEEeeecee
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNS---TNVKMIDFGLAT  261 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~---~~vkl~Dfg~a~  261 (356)
                      |.+ |.||.++..-...+++-..+     ..++.|++.-++++|++.+|.|||||+|.||...++   ..|-++|||+|.
T Consensus       104 dLL-GPSLEDLFD~CgR~FSvKTV-----~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK  177 (449)
T KOG1165|consen  104 DLL-GPSLEDLFDLCGRRFSVKTV-----AMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK  177 (449)
T ss_pred             hhh-CcCHHHHHHHhcCcccHHhH-----HHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence            988 88999988766655555554     449999999999999999999999999999965332   357999999999


Q ss_pred             eeCCCCc--------eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC---ChHHHHHHhhcc-cc
Q psy12427        262 KLDPNEV--------VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGE---NDVETLKNVKAC-DW  329 (356)
Q Consensus       262 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~---~~~~~~~~i~~~-~~  329 (356)
                      .+.....        .+...||.+||+--...+..-+...|+-|||=++.++|-|..||+|-   +..+-+++|-.. ..
T Consensus       178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~  257 (449)
T KOG1165|consen  178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRS  257 (449)
T ss_pred             hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccccc
Confidence            8743221        23345999999999999999999999999999999999999999876   566667777442 23


Q ss_pred             ccChhhhccCCHHHHHHHH
Q psy12427        330 EFDEEAFKNVSEEGKDFIR  348 (356)
Q Consensus       330 ~~~~~~~~~~s~~~~~lI~  348 (356)
                      ....++..++|++....++
T Consensus       258 T~i~~Lc~g~P~efa~Yl~  276 (449)
T KOG1165|consen  258 TPIEVLCEGFPEEFATYLR  276 (449)
T ss_pred             CCHHHHHhcCHHHHHHHHH
Confidence            3445555667766555443

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.93  E-value=1.6e-25  Score=188.15  Aligned_cols=148  Identities=21%  Similarity=0.247  Sum_probs=110.7

Q ss_pred             cchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCce
Q psy12427        190 GELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVV  269 (356)
Q Consensus       190 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~~  269 (356)
                      |+|.+++......+++..     +..++.|++.||+|||+++      ||+|||++.++  .+|+  ||++.......  
T Consensus         1 GsL~~~l~~~~~~l~~~~-----~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~--~~~~--fG~~~~~~~~~--   63 (176)
T smart00750        1 VSLADILEVRGRPLNEEE-----IWAVCLQCLRALRELHRQA------KSGNILLTWDG--LLKL--DGSVAFKTPEQ--   63 (176)
T ss_pred             CcHHHHHHHhCCCCCHHH-----HHHHHHHHHHHHHHHHhcC------CcccEeEcCcc--ceee--ccceEeecccc--
Confidence            678888875443444444     4559999999999999999      99999987554  6888  99998765432  


Q ss_pred             eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHhhccccccC---hhhhccCCH--HH
Q psy12427        270 KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEND-VETLKNVKACDWEFD---EEAFKNVSE--EG  343 (356)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~-~~~~~~i~~~~~~~~---~~~~~~~s~--~~  343 (356)
                        ..|++.|+|||++.+..++.++|||||||++|||++|+.||..... ...+..+........   ......++.  ++
T Consensus        64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  141 (176)
T smart00750       64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSF  141 (176)
T ss_pred             --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhH
Confidence              2689999999999999999999999999999999999999976543 233333332211110   011223454  79


Q ss_pred             HHHHHHhhhcCCC
Q psy12427        344 KDFIRRLLLRNKE  356 (356)
Q Consensus       344 ~~lI~~ll~~dP~  356 (356)
                      ++||++||+.||+
T Consensus       142 ~~~i~~cl~~~p~  154 (176)
T smart00750      142 ADFMRVCASRLPQ  154 (176)
T ss_pred             HHHHHHHHhcccc
Confidence            9999999999985

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0603|consensus

Probab=99.92  E-value=1.9e-26  Score=216.53  Aligned_cols=221  Identities=31%  Similarity=0.568  Sum_probs=182.8

Q ss_pred             cccccCceEEEEEEE---ccCCCEEEEEEcccCChhh--HHHHHHHHHHHHhcC-CCCceeeeeeEEeCCeEEEEEEecc
Q psy12427        115 EIGTGAFGVVHRCRE---RKTGNIFAAKFIPVSHNLE--KELIRKEIDIMNQLH-HPKLINLHDAFEDDDEMVLIFEFLS  188 (356)
Q Consensus       115 ~lg~G~fg~V~~~~~---~~~~~~~a~K~~~~~~~~~--~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lv~e~~~  188 (356)
                      ++|.|.||.|++++.   ...|..+|+|+.+......  +..-..|..++...+ ||.+++++-.++.+...++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            479999999998753   3457889999887654322  223335888899887 9999999999999999999999999


Q ss_pred             ccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCc
Q psy12427        189 GGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEV  268 (356)
Q Consensus       189 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~  268 (356)
                      ||.|...+....      .+.....+.+...++-|++++|+.+++|||+|++||+++.+|  ++++.|||+++..-..+.
T Consensus        81 gg~lft~l~~~~------~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~G--hi~~tdfglske~v~~~~  152 (612)
T KOG0603|consen   81 GGDLFTRLSKEV------MFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEG--HIKLTDFGLSKEAVKEKI  152 (612)
T ss_pred             cchhhhccccCC------chHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccC--ccccCCchhhhHhHhhhh
Confidence            999987775432      222233344888999999999999999999999999998766  899999999987643332


Q ss_pred             eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHH
Q psy12427        269 VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIR  348 (356)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  348 (356)
                      .   +||..|||||+++  ....+.|.||||+++++|++|..||.+    ++..+|.......|.    .++.++++++.
T Consensus       153 ~---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~----~l~~~a~~~~~  219 (612)
T KOG0603|consen  153 A---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPR----ELSAEARSLFR  219 (612)
T ss_pred             c---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCch----hhhHHHHHHHH
Confidence            2   8999999999999  567889999999999999999999988    788888888877775    67899999999


Q ss_pred             HhhhcCCC
Q psy12427        349 RLLLRNKE  356 (356)
Q Consensus       349 ~ll~~dP~  356 (356)
                      .++..+|.
T Consensus       220 ~l~~r~p~  227 (612)
T KOG0603|consen  220 QLFKRNPE  227 (612)
T ss_pred             HHHhhCHH
Confidence            99998874

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.92  E-value=5.2e-25  Score=189.36  Aligned_cols=172  Identities=12%  Similarity=0.144  Sum_probs=131.4

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHH---H------HHHHHHHHHhcCCCCceeeeeeEE
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE---L------IRKEIDIMNQLHHPKLINLHDAFE  175 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~---~------~~~E~~il~~l~hpnIv~l~~~~~  175 (356)
                      .+.++|++.+.||.|+||.||++..  ++..+|+|++.........   .      +.+|+..+.++.||+|..+.+++.
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~  105 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL  105 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence            3457899999999999999999655  4778999999754332222   2      578999999999999999988865


Q ss_pred             eC--------CeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeec
Q psy12427        176 DD--------DEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTR  247 (356)
Q Consensus       176 ~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~  247 (356)
                      ..        +..+++|||++|.+|.++..     .++         ..+.+++.+|..||+.|++|||++|.||+++.+
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~---------~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~  171 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE---------DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKN  171 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhhh-----ccH---------HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCC
Confidence            32        45899999999999977632     111         156799999999999999999999999999754


Q ss_pred             CCCcEEEEeeeceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHH
Q psy12427        248 NSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLL  306 (356)
Q Consensus       248 ~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell  306 (356)
                      +   ++|+|||.+.........           ..+.....+..++|+||||+.+.-+.
T Consensus       172 g---i~liDfg~~~~~~e~~a~-----------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        172 G---LRIIDLSGKRCTAQRKAK-----------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             C---EEEEECCCcccccchhhH-----------HHHHHHhHhcccccccceeEeehHHH
Confidence            3   999999988655322111           11334445667899999999886543

>KOG4158|consensus

Probab=99.90  E-value=6.3e-24  Score=189.32  Aligned_cols=183  Identities=23%  Similarity=0.355  Sum_probs=133.6

Q ss_pred             CCCCceeeeeeEEe---------------------------CCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHH
Q psy12427        163 HHPKLINLHDAFED---------------------------DDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI  215 (356)
Q Consensus       163 ~hpnIv~l~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~  215 (356)
                      +|||||++.++|.+                           +..+|+||...+ .+|.+++......       .....-
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~~s-------~r~~~~  345 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRHRS-------YRTGRV  345 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCCCc-------hHHHHH
Confidence            59999999998753                           345789998774 5898888654322       122233


Q ss_pred             HHHHHHHHHHHHHHCCceeccCCCCCEEEeecCC--CcEEEEeeeceeeeCCCCc-------eeecCCCcCccccccccC
Q psy12427        216 LMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNS--TNVKMIDFGLATKLDPNEV-------VKISTGTAEFAAPEIVER  286 (356)
Q Consensus       216 ~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~--~~vkl~Dfg~a~~~~~~~~-------~~~~~gt~~y~aPE~~~~  286 (356)
                      ++.|+++|+.|||++||.|||||++|||+..+++  ..+.|+|||+|...+....       .-...|...-||||+...
T Consensus       346 ~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  346 ILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            8899999999999999999999999999966544  4679999998865432111       111247888999999864


Q ss_pred             CCC------CccccHHHHHHHHHHHHcCCCCCCCCChHHHH-HHhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        287 EPV------GFYTDMWAVGVLAYVLLSGLSPFAGENDVETL-KNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       287 ~~~------~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+-      -.++|.|+.|.+.||+++...||.+...+..- ....+.+   .+.....+++.++++|..+|+.||+
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~q---LPalp~~vpp~~rqlV~~lL~r~ps  499 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQ---LPALPSRVPPVARQLVFDLLKRDPS  499 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhh---CCCCcccCChHHHHHHHHHhcCCcc
Confidence            432      24789999999999999999999885433211 1111111   2334468999999999999999995

>KOG0590|consensus

Probab=99.90  E-value=8.8e-25  Score=214.07  Aligned_cols=237  Identities=22%  Similarity=0.326  Sum_probs=177.4

Q ss_pred             eeeccccccCceEEEEEEEccCCCEEEEEEccc-----CChhhH-HHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        111 DILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV-----SHNLEK-ELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       111 ~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~-----~~~~~~-~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      .....+|.|++|.|+.+........++.|....     ....+. ..+..|+.+-..|.|||++.....+.+.....-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            456789999999888887777666666665432     111111 12566888888899999988777766655555559


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      ||+++ +|+.++.... .+...+     +..+++|++.|++|||+.|+.||||||+|+++..++  .+||+|||.+..+.
T Consensus       401 E~~~~-Dlf~~~~~~~-~~~~~e-----~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g--~lki~Dfg~~~vf~  471 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNG-KLTPLE-----ADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENG--ILKIIDFGAASVFR  471 (601)
T ss_pred             hcccH-HHHHHHhccc-ccchhh-----hhHHHHHHHHHHHHHHhcCceeccCccccEEEecCC--ceEEeecCcceeec
Confidence            99999 9999987651 222223     344999999999999999999999999999998765  79999999987764


Q ss_pred             CC-----CceeecCCCcCccccccccCCCCCc-cccHHHHHHHHHHHHcCCCCCCCCChHHHH--HHhh---ccccccCh
Q psy12427        265 PN-----EVVKISTGTAEFAAPEIVEREPVGF-YTDMWAVGVLAYVLLSGLSPFAGENDVETL--KNVK---ACDWEFDE  333 (356)
Q Consensus       265 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~-~sDvwSlG~il~ell~g~~Pf~~~~~~~~~--~~i~---~~~~~~~~  333 (356)
                      ..     ......+|+..|+|||++.+..|+. ..||||.|+++..|.+|+.||......+..  ....   .....-+.
T Consensus       472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~  551 (601)
T KOG0590|consen  472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPN  551 (601)
T ss_pred             cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChH
Confidence            22     1223456899999999999999875 579999999999999999999866544321  1111   11222345


Q ss_pred             hhhccCCHHHHHHHHHhhhcCCC
Q psy12427        334 EAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       334 ~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ..+..++.+.+.+|.+||+.||.
T Consensus       552 ~~~~~lp~~~~~~~~~~l~~~P~  574 (601)
T KOG0590|consen  552 RLLSLLPRETRIIIYRMLQLDPT  574 (601)
T ss_pred             HHHHhchhhHHHHHHHHccCChh
Confidence            55667999999999999999995

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.90  E-value=8.7e-24  Score=187.11  Aligned_cols=233  Identities=23%  Similarity=0.336  Sum_probs=147.3

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh---hHHHHHHHHHHHHhcCC----------CCceeeeeeEE
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL---EKELIRKEIDIMNQLHH----------PKLINLHDAFE  175 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~---~~~~~~~E~~il~~l~h----------pnIv~l~~~~~  175 (356)
                      .+...+.||.|+++.||.+.+..||..+|+|+.......   ..+.+++|.-....+.+          -.++-.++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            466788999999999999999999999999998654422   33455555544333322          12222222221


Q ss_pred             ---------eC---C-----eEEEEEEeccccchhhhhh---CCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceec
Q psy12427        176 ---------DD---D-----EMVLIFEFLSGGELFERIT---APDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHL  235 (356)
Q Consensus       176 ---------~~---~-----~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~  235 (356)
                               ..   .     ..+++|+-+ -++|.+++.   .....  .......+...+..|+++.+++||+.|++|+
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~--~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHg  169 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQT--HSPLAFAARLSLTVQMIRLVANLHSYGLVHG  169 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTT--SHHHHHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccc--cchhHHHHHHHHHHHHHHHHHHHhhcceEec
Confidence                     11   1     236778777 467766643   21111  2222233344466899999999999999999


Q ss_pred             cCCCCCEEEeecCCCcEEEEeeeceeeeCCCCceeecCCCcCccccccccCC--------CCCccccHHHHHHHHHHHHc
Q psy12427        236 DVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVERE--------PVGFYTDMWAVGVLAYVLLS  307 (356)
Q Consensus       236 Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~sDvwSlG~il~ell~  307 (356)
                      ||+|+|++++.++  .++|+||+.......  .......+..|.|||.....        .++.+.|.|+||+++|.|++
T Consensus       170 di~~~nfll~~~G--~v~Lg~F~~~~r~g~--~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC  245 (288)
T PF14531_consen  170 DIKPENFLLDQDG--GVFLGDFSSLVRAGT--RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC  245 (288)
T ss_dssp             T-SGGGEEE-TTS---EEE--GGGEEETTE--EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCC--CEEEcChHHHeecCc--eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence            9999999998765  799999998766432  22224557889999977432        47888999999999999999


Q ss_pred             CCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        308 GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       308 g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      |..||...........      .| ..+ .++|+.++++|++||+.||+
T Consensus       246 ~~lPf~~~~~~~~~~~------~f-~~C-~~~Pe~v~~LI~~lL~~~~~  286 (288)
T PF14531_consen  246 GRLPFGLSSPEADPEW------DF-SRC-RDMPEPVQFLIRGLLQRNPE  286 (288)
T ss_dssp             SS-STCCCGGGSTSGG------GG-TTS-S---HHHHHHHHHHT-SSGG
T ss_pred             ccCCCCCCCccccccc------cc-hhc-CCcCHHHHHHHHHHccCCcc
Confidence            9999987754322111      12 122 27899999999999999985

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.90  E-value=1.3e-23  Score=178.28  Aligned_cols=139  Identities=16%  Similarity=0.167  Sum_probs=102.9

Q ss_pred             eccccccCceEEEEEEEccCCCEEEEEEcccCChh--h------------------------HHHHHHHHHHHHhcCCCC
Q psy12427        113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL--E------------------------KELIRKEIDIMNQLHHPK  166 (356)
Q Consensus       113 ~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~--~------------------------~~~~~~E~~il~~l~hpn  166 (356)
                      .+.||+|+||.||+|.+. +|+.||+|+++.....  .                        .....+|+.+|.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            468999999999999997 8999999999754211  0                        012235999999998877


Q ss_pred             ceeeeeeEEeCCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHH-HHCCceeccCCCCCEEEe
Q psy12427        167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM-HEKNIIHLDVKPENIMCQ  245 (356)
Q Consensus       167 Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l-H~~~ivH~Dlkp~NIlv~  245 (356)
                      +.........  ..++||||++|+++....... ..+     ....+..++.|++.+|.++ |+.||+||||||+|||++
T Consensus        81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~-~~~-----~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~  152 (190)
T cd05147          81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKD-APL-----SESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH  152 (190)
T ss_pred             CCCCcEEEec--CCEEEEEEeCCCCCcchhhhc-CCC-----CHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE
Confidence            6443332222  238999999987665442211 122     2334556899999999999 799999999999999997


Q ss_pred             ecCCCcEEEEeeeceeee
Q psy12427        246 TRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       246 ~~~~~~vkl~Dfg~a~~~  263 (356)
                      .   +.++|+|||+|...
T Consensus       153 ~---~~v~LiDFG~a~~~  167 (190)
T cd05147         153 D---GKLYIIDVSQSVEH  167 (190)
T ss_pred             C---CcEEEEEccccccC
Confidence            3   36999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0606|consensus

Probab=99.90  E-value=8.3e-24  Score=208.20  Aligned_cols=202  Identities=31%  Similarity=0.511  Sum_probs=156.1

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEec
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFL  187 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~  187 (356)
                      ++|..++.|..|++|-||.++++.+.+.+|+|+-+ .+     .+.+-  |+.....|.+|                   
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~-----lilRn--ilt~a~npfvv-------------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QN-----LILRN--ILTFAGNPFVV-------------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhcccc-cc-----hhhhc--cccccCCccee-------------------
Confidence            56889999999999999999999999999995422 11     11111  33333444444                   


Q ss_pred             cccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC-
Q psy12427        188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN-  266 (356)
Q Consensus       188 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~-  266 (356)
                        |+-...+....      ..+        .+++.|++|||+.||+|||+||+|++|..-+  ++|+.|||++...-.. 
T Consensus       136 --gDc~tllk~~g------~lP--------vdmvla~Eylh~ygivhrdlkpdnllIT~mG--hiKlTDfgLsk~GLms~  197 (1205)
T KOG0606|consen  136 --GDCATLLKNIG------PLP--------VDMVLAVEYLHSYGIVHRDLKPDNLLITSMG--HIKLTDFGLSKKGLMSL  197 (1205)
T ss_pred             --chhhhhcccCC------CCc--------chhhHHhHhhccCCeecCCCCCCcceeeecc--cccccchhhhhhhhhhc
Confidence              33333332211      111        1236789999999999999999999998654  8999999998653100 


Q ss_pred             --------------Cc-eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc
Q psy12427        267 --------------EV-VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEF  331 (356)
Q Consensus       267 --------------~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~  331 (356)
                                    .. .+..+|||.|.|||++..+.|+..+|.|++|+|+||.+-|..||.++++++.+..+..-.+.+
T Consensus       198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w  277 (1205)
T KOG0606|consen  198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW  277 (1205)
T ss_pred             cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc
Confidence                          00 112369999999999999999999999999999999999999999999999999999988888


Q ss_pred             ChhhhccCCHHHHHHHHHhhhcCC
Q psy12427        332 DEEAFKNVSEEGKDFIRRLLLRNK  355 (356)
Q Consensus       332 ~~~~~~~~s~~~~~lI~~ll~~dP  355 (356)
                      +++. ..++.|++++|.+||+++|
T Consensus       278 pE~d-ea~p~Ea~dli~~LL~qnp  300 (1205)
T KOG0606|consen  278 PEED-EALPPEAQDLIEQLLRQNP  300 (1205)
T ss_pred             cccC-cCCCHHHHHHHHHHHHhCh
Confidence            8773 4689999999999999988

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=5.4e-23  Score=173.31  Aligned_cols=185  Identities=18%  Similarity=0.216  Sum_probs=137.6

Q ss_pred             eeccccccCceEEEEEEEccCCCEEEEEEcccCChh----hHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCeEEEEEEe
Q psy12427        112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL----EKELIRKEIDIMNQLH-HPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       112 ~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~----~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      +...|++|+||+|+.+..  .+..++.+.+.....-    ....+.+|+++|++|. |+++++++++    ...+++|||
T Consensus         6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            557899999999997765  4777777777655432    1235789999999995 5889999886    446999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccC-CCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDV-KPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dl-kp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      +.|.+|.+.+..       ..      ..++.|++.+|+++|+.||+|||| ||+|||++.++  .++|+|||+|...+.
T Consensus        80 I~G~~L~~~~~~-------~~------~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g--~i~LIDFG~A~~~~~  144 (218)
T PRK12274         80 LAGAAMYQRPPR-------GD------LAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDG--SPAVIDFQLAVRGNP  144 (218)
T ss_pred             ecCccHHhhhhh-------hh------HHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCC--CEEEEECCCceecCC
Confidence            999888643311       11      127789999999999999999999 79999997544  799999999986654


Q ss_pred             CCce--------------eecCCCcCccccccccCC-CCC-ccccHHHHHHHHHHHHcCCCCCCCCCh
Q psy12427        266 NEVV--------------KISTGTAEFAAPEIVERE-PVG-FYTDMWAVGVLAYVLLSGLSPFAGEND  317 (356)
Q Consensus       266 ~~~~--------------~~~~gt~~y~aPE~~~~~-~~~-~~sDvwSlG~il~ell~g~~Pf~~~~~  317 (356)
                      ....              .....++.+++|+...-- ..+ ...+.++.|+-+|.++|+..|+.++++
T Consensus       145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence            3310              011257777777644322 223 467888999999999999999876643

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.89  E-value=1.7e-22  Score=171.85  Aligned_cols=140  Identities=19%  Similarity=0.182  Sum_probs=106.0

Q ss_pred             eccccccCceEEEEEEEccCCCEEEEEEcccCChh--------------------------hHHHHHHHHHHHHhcCCCC
Q psy12427        113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL--------------------------EKELIRKEIDIMNQLHHPK  166 (356)
Q Consensus       113 ~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~--------------------------~~~~~~~E~~il~~l~hpn  166 (356)
                      .+.||+|+||.||+|.+. +|+.||+|+++.....                          ....+..|.+.+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            468999999999999987 8999999998764211                          0122357999999999998


Q ss_pred             ceeeeeeEEeCCeEEEEEEeccccchhhh-hhCCCCCCCccccccccHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEE
Q psy12427        167 LINLHDAFEDDDEMVLIFEFLSGGELFER-ITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE-KNIIHLDVKPENIMC  244 (356)
Q Consensus       167 Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~Dlkp~NIlv  244 (356)
                      +.....+....  .++||||++|+++... +..  ...     .......++.|++.+|.++|+ .||+||||||+|||+
T Consensus        81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~--~~~-----~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll  151 (190)
T cd05145          81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD--VPL-----EEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILY  151 (190)
T ss_pred             CCCceEEEecC--CEEEEEEecCCCchhhhhhh--ccC-----CHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEE
Confidence            75544443332  4899999988755433 221  122     223445589999999999999 999999999999999


Q ss_pred             eecCCCcEEEEeeeceeeeCC
Q psy12427        245 QTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       245 ~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      + +  +.++|+|||++...+.
T Consensus       152 ~-~--~~~~liDFG~a~~~~~  169 (190)
T cd05145         152 H-D--GKPYIIDVSQAVELDH  169 (190)
T ss_pred             E-C--CCEEEEEcccceecCC
Confidence            7 3  3799999999987653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10345 hypothetical protein; Provisional

Probab=99.88  E-value=7.3e-22  Score=169.24  Aligned_cols=136  Identities=18%  Similarity=0.193  Sum_probs=106.2

Q ss_pred             eccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhc-----CCCCceeeeeeEEeCC---eEE-EE
Q psy12427        113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL-----HHPKLINLHDAFEDDD---EMV-LI  183 (356)
Q Consensus       113 ~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~l~~~~~~~~---~~~-lv  183 (356)
                      .+.||+|+||.||.  +..++.. ++|++..........+.+|+.+++.+     +||||++++|+++++.   ..+ +|
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I   83 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI   83 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence            46899999999995  6666555 68988765544567789999999999     5799999999998763   433 78


Q ss_pred             EEe--ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHH-HHHHHCCceeccCCCCCEEEeecC--CCcEEEEeee
Q psy12427        184 FEF--LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV-KHMHEKNIIHLDVKPENIMCQTRN--STNVKMIDFG  258 (356)
Q Consensus       184 ~e~--~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l-~~lH~~~ivH~Dlkp~NIlv~~~~--~~~vkl~Dfg  258 (356)
                      +||  +.+++|.+++....  +.+.       ..++.+++.++ +|||+++|+||||||+|||++..+  +..++|+||+
T Consensus        84 ~e~~G~~~~tL~~~l~~~~--~~e~-------~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         84 ADFDGKPSITLTEFAEQCR--YEED-------VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             ecCCCCcchhHHHHHHccc--ccHh-------HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            999  55799999996532  2222       12677888777 899999999999999999997533  3479999944


Q ss_pred             ce
Q psy12427        259 LA  260 (356)
Q Consensus       259 ~a  260 (356)
                      -+
T Consensus       155 G~  156 (210)
T PRK10345        155 GE  156 (210)
T ss_pred             CC
Confidence            34

>KOG1240|consensus

Probab=99.87  E-value=2.8e-23  Score=204.88  Aligned_cols=232  Identities=18%  Similarity=0.329  Sum_probs=169.3

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC-hhhHHHHHH---HHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-NLEKELIRK---EIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~---E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      ++...+.||.+.|=.|.+|++.. | .+++|++-... ....+.+.+   |++ ...+++||.+++..+-......|||-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence            57778899999999999998875 4 48889876544 333344433   444 55568999999999888888889999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee-
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL-  263 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~-  263 (356)
                      +|..+ +|+|++..+.+.      .....+.|+.|++.||.-+|..||+|+|||.+||||..-+  ++.|+||...... 
T Consensus       101 qyvkh-nLyDRlSTRPFL------~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWN--W~~LtDFAsFKPtY  171 (1431)
T KOG1240|consen  101 QYVKH-NLYDRLSTRPFL------VLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWN--WLYLTDFASFKPTY  171 (1431)
T ss_pred             HHHhh-hhhhhhccchHH------HHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeec--hhhhhcccccCCcc
Confidence            99954 899998765542      2233455899999999999999999999999999999877  8999999876432 


Q ss_pred             -C---CCCc---eeecCCCcCccccccccCC----------C-CCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHh
Q psy12427        264 -D---PNEV---VKISTGTAEFAAPEIVERE----------P-VGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV  324 (356)
Q Consensus       264 -~---~~~~---~~~~~gt~~y~aPE~~~~~----------~-~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i  324 (356)
                       .   +.+.   ..+...-.+|.|||.+...          + .+++-||||+||+++||++ |++||.-.    .+-.-
T Consensus       172 LPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----QL~aY  247 (1431)
T KOG1240|consen  172 LPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----QLLAY  247 (1431)
T ss_pred             CCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----HHHhH
Confidence             1   2221   1223345789999987542          2 5678899999999999999 89999532    22333


Q ss_pred             hccccccChhhhccC-CHHHHHHHHHhhhcCCC
Q psy12427        325 KACDWEFDEEAFKNV-SEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       325 ~~~~~~~~~~~~~~~-s~~~~~lI~~ll~~dP~  356 (356)
                      ..++-..++.....+ +..++++|..|++.||+
T Consensus       248 r~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs  280 (1431)
T KOG1240|consen  248 RSGNADDPEQLLEKIEDVSLRNLILSMIQRDPS  280 (1431)
T ss_pred             hccCccCHHHHHHhCcCccHHHHHHHHHccCch
Confidence            333222222222222 44799999999999995

>KOG1166|consensus

Probab=99.85  E-value=5.4e-21  Score=191.53  Aligned_cols=194  Identities=24%  Similarity=0.359  Sum_probs=151.8

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcC---CCCceeeeeeEEeCCeEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLH---HPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~lv  183 (356)
                      .+.|.|.+.||+|+||+||+|.... |+.+|+|+-+....=+.   .--.+++.+|+   -+.|+.+..++...+.-++|
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEf---YI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv  772 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEF---YICLQVMERLKPQMLPSIMHISSAHVFQNASVLV  772 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceee---eehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence            3579999999999999999999987 99999998765542111   01123344444   24566666666677778999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeec-----CCCcEEEEeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTR-----NSTNVKMIDFG  258 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~-----~~~~vkl~Dfg  258 (356)
                      +||.+-|+|.+++...      ....+..+..+..|++..+++||..+|||+||||+|.|+...     ++.-++|+|||
T Consensus       773 ~ey~~~Gtlld~~N~~------~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG  846 (974)
T KOG1166|consen  773 SEYSPYGTLLDLINTN------KVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFG  846 (974)
T ss_pred             eeccccccHHHhhccC------CCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecc
Confidence            9999999999999732      223333344588999999999999999999999999999532     23358999999


Q ss_pred             ceeee---CCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCC
Q psy12427        259 LATKL---DPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLS  310 (356)
Q Consensus       259 ~a~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~  310 (356)
                      .|-.+   .........++|-.+--+|+..+.++++.+|.|.++.+++.||.|+.
T Consensus       847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             cceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            98765   33445566678999999999999999999999999999999999853

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.84  E-value=6.7e-20  Score=158.57  Aligned_cols=134  Identities=22%  Similarity=0.282  Sum_probs=110.3

Q ss_pred             ccccccCceEEEEEEEccCCCEEEEEEcccCCh--------hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN--------LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~--------~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      +.||+|++|.||+|.+  +|..+++|.......        .....+.+|+.++..+.|+++.....++......+++||
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            5799999999999987  577899997654321        112456789999999999999888777777788899999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      |++|++|.+.+....    .      ....++.+++.+|.++|+.|++|+|++|.|||++ +  ..++|+|||++..
T Consensus        80 ~~~G~~L~~~~~~~~----~------~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~--~~~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSNG----M------EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-G--GKIYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhcc----H------HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-C--CCEEEEECCcccC
Confidence            999999998885321    1      3445899999999999999999999999999998 3  3699999999865

>smart00090 RIO RIO-like kinase

Probab=99.84  E-value=2.2e-20  Score=163.87  Aligned_cols=143  Identities=20%  Similarity=0.141  Sum_probs=107.5

Q ss_pred             ceeeeccccccCceEEEEEE-EccCCCEEEEEEcccCChh------------------------hHHHHHHHHHHHHhcC
Q psy12427        109 HYDILEEIGTGAFGVVHRCR-ERKTGNIFAAKFIPVSHNL------------------------EKELIRKEIDIMNQLH  163 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~-~~~~~~~~a~K~~~~~~~~------------------------~~~~~~~E~~il~~l~  163 (356)
                      .|.+.+.||+|+||.||+|. +..+|..||+|+++.....                        ....+.+|+.++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47889999999999999998 6678999999998754210                        1123568999999997


Q ss_pred             CC--CceeeeeeEEeCCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCC-ceeccCCCC
Q psy12427        164 HP--KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN-IIHLDVKPE  240 (356)
Q Consensus       164 hp--nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-ivH~Dlkp~  240 (356)
                      +.  .+.++++.    ...++||||+.|++|........      .........++.|++.++++||+.| ++||||||+
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~  178 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV------EPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEY  178 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC------CcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChh
Confidence            53  33444442    23489999999988765542211      1122234558999999999999999 999999999


Q ss_pred             CEEEeecCCCcEEEEeeeceeeeC
Q psy12427        241 NIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       241 NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      ||+++ +  ..++|+|||.+....
T Consensus       179 NIli~-~--~~i~LiDFg~a~~~~  199 (237)
T smart00090      179 NILVH-D--GKVVIIDVSQSVELD  199 (237)
T ss_pred             hEEEE-C--CCEEEEEChhhhccC
Confidence            99997 3  369999999987543

>KOG1033|consensus

Probab=99.81  E-value=4.7e-21  Score=177.22  Aligned_cols=164  Identities=24%  Similarity=0.351  Sum_probs=121.2

Q ss_pred             eEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeee
Q psy12427        179 EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFG  258 (356)
Q Consensus       179 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg  258 (356)
                      +++|.|++|.-.+|.+++..+..   -..........++.|++.|++|   +|.+|+|+||.||+...+.  .+||.|||
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~---~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~--q~kIgDFg  401 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRT---GEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDD--QLKIGDFG  401 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCc---ccccchhHHHHHHHhhccchhh---ccchhhhccccccccccch--hhhhhhhh
Confidence            36788899999999999864432   1222233345589999999999   9999999999999986554  79999999


Q ss_pred             ceeeeCCCC-------ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccc
Q psy12427        259 LATKLDPNE-------VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWE  330 (356)
Q Consensus       259 ~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~  330 (356)
                      +........       ......||..||+||.+.++.|+.++||||||+||+||+. =..+|.   -..++..+..+.  
T Consensus       402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e---r~~t~~d~r~g~--  476 (516)
T KOG1033|consen  402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE---RIATLTDIRDGI--  476 (516)
T ss_pred             heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH---HHHhhhhhhcCC--
Confidence            988775444       3344579999999999999999999999999999999997 222221   112233333333  


Q ss_pred             cChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        331 FDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       331 ~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +|+..+.++|.+ .+|+.+||...|+
T Consensus       477 ip~~~~~d~p~e-~~ll~~lls~~p~  501 (516)
T KOG1033|consen  477 IPPEFLQDYPEE-YTLLQQLLSPSPE  501 (516)
T ss_pred             CChHHhhcCcHH-HHHHHHhcCCCcc
Confidence            556666666655 5788999888874

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.81  E-value=1.8e-19  Score=154.53  Aligned_cols=131  Identities=21%  Similarity=0.268  Sum_probs=105.0

Q ss_pred             cccccCceEEEEEEEccCCCEEEEEEcccCC----h----hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSH----N----LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       115 ~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~----~----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      .||+|+||.||++.+  ++..+++|......    .    .....+.+|++++..++|+++.....++......+++|||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            489999999999985  47889999864321    1    1235567899999999988766555555666778999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      ++|++|.+++.....             .++.+++.+|.+||+.|++|+|++|.||+++ +  ..++++|||++...
T Consensus        79 ~~g~~l~~~~~~~~~-------------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~--~~~~liDfg~a~~~  139 (199)
T TIGR03724        79 IEGKPLKDVIEEGND-------------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-D--DKLYLIDFGLGKYS  139 (199)
T ss_pred             ECCccHHHHHhhcHH-------------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-C--CcEEEEECCCCcCC
Confidence            999999887754211             3889999999999999999999999999997 3  37999999998653

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.81  E-value=4.6e-19  Score=151.83  Aligned_cols=137  Identities=19%  Similarity=0.239  Sum_probs=105.8

Q ss_pred             eeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh----------------------hHHHHHHHHHHHHhcCCCC-
Q psy12427        110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL----------------------EKELIRKEIDIMNQLHHPK-  166 (356)
Q Consensus       110 y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~----------------------~~~~~~~E~~il~~l~hpn-  166 (356)
                      |.+.+.||.|+||.||++... +|..+|+|++......                      .......|+.++..+.|++ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            778899999999999999875 7999999987643210                      1123567899999998774 


Q ss_pred             -ceeeeeeEEeCCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEe
Q psy12427        167 -LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQ  245 (356)
Q Consensus       167 -Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~  245 (356)
                       ++..++    ....+++|||++|++|......            .....++.+++.++.++|+.|++|+||+|+||+++
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~  159 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVD  159 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhcccc------------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEc
Confidence             444443    2455899999999988654320            12344889999999999999999999999999997


Q ss_pred             ecCCCcEEEEeeeceeeeCC
Q psy12427        246 TRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       246 ~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      .++  .++|+|||++.....
T Consensus       160 ~~~--~~~liDfg~~~~~~~  177 (198)
T cd05144         160 DDE--KIYIIDWPQMVSTDH  177 (198)
T ss_pred             CCC--cEEEEECCccccCCC
Confidence            643  799999999966543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.80  E-value=8.2e-19  Score=172.20  Aligned_cols=136  Identities=20%  Similarity=0.243  Sum_probs=107.9

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEc--ccCCh------hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeE
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHN------LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM  180 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~--~~~~~------~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  180 (356)
                      .|...+.||+|+||+||++.+...  .+++|..  +....      ...+.+.+|++++..++|++++....++......
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             ccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            456678999999999999987643  3344332  21111      1235677899999999999999888777777788


Q ss_pred             EEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeece
Q psy12427        181 VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA  260 (356)
Q Consensus       181 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a  260 (356)
                      ++||||++|++|.+++..              ...++.+++.+|.+||+.|++||||||+|||++ +  ..++|+|||++
T Consensus       412 ~lv~E~~~g~~L~~~l~~--------------~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~--~~~~liDFGla  474 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLEG--------------NPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-D--DRLYLIDFGLG  474 (535)
T ss_pred             EEEEEecCCCcHHHHHHH--------------HHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-C--CcEEEEeCccc
Confidence            999999999999888751              233889999999999999999999999999993 2  36999999999


Q ss_pred             eee
Q psy12427        261 TKL  263 (356)
Q Consensus       261 ~~~  263 (356)
                      +..
T Consensus       475 ~~~  477 (535)
T PRK09605        475 KYS  477 (535)
T ss_pred             ccC
Confidence            764

>KOG1023|consensus

Probab=99.75  E-value=2.5e-18  Score=161.86  Aligned_cols=191  Identities=23%  Similarity=0.323  Sum_probs=146.6

Q ss_pred             HHhcCCCCceeeeeeEEeCCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCc-eeccC
Q psy12427        159 MNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNI-IHLDV  237 (356)
Q Consensus       159 l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i-vH~Dl  237 (356)
                      |+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+......+.     ......++++|+.||+|||...| .|+.|
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d-----~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLD-----YFFILSFIRDISKGLAYLHNSPIGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCcc-----HHHHHHHHHHHHHHHHHHhcCcceeeeee
Confidence            4678999999999999999999999999999999999986443333     33344588999999999998765 99999


Q ss_pred             CCCCEEEeecCCCcEEEEeeeceeeeCCC---CceeecCCCcCccccccccCCC-------CCccccHHHHHHHHHHHHc
Q psy12427        238 KPENIMCQTRNSTNVKMIDFGLATKLDPN---EVVKISTGTAEFAAPEIVEREP-------VGFYTDMWAVGVLAYVLLS  307 (356)
Q Consensus       238 kp~NIlv~~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-------~~~~sDvwSlG~il~ell~  307 (356)
                      ++.|.+++.  ...+||+|||+.......   .......-..-|.|||.+....       .+.+.|+||+|++++|+++
T Consensus        76 ~s~nClvd~--~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~  153 (484)
T KOG1023|consen   76 KSSNCLVDS--RWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF  153 (484)
T ss_pred             ccccceeee--eEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence            999999974  447899999998766421   1111112356799999997641       4567899999999999999


Q ss_pred             CCCCCCCC----ChHHHHHHhhc-cccccChhhhc--cCCHHHHHHHHHhhhcCCC
Q psy12427        308 GLSPFAGE----NDVETLKNVKA-CDWEFDEEAFK--NVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       308 g~~Pf~~~----~~~~~~~~i~~-~~~~~~~~~~~--~~s~~~~~lI~~ll~~dP~  356 (356)
                      ...||...    .+.+++..+.. ....+.+..+.  .+++++..++++||.-+|+
T Consensus       154 r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~  209 (484)
T KOG1023|consen  154 RSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPE  209 (484)
T ss_pred             ccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChh
Confidence            99999864    33466666666 33333333332  4677899999999999885

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.74  E-value=2.2e-17  Score=140.04  Aligned_cols=137  Identities=20%  Similarity=0.220  Sum_probs=96.6

Q ss_pred             eccccccCceEEEEEEEccCCCEEEEEEcccCChh--hHHH----------------------HHHHHHHHHhcCCCC--
Q psy12427        113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL--EKEL----------------------IRKEIDIMNQLHHPK--  166 (356)
Q Consensus       113 ~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~--~~~~----------------------~~~E~~il~~l~hpn--  166 (356)
                      .+.||+|+||+||+|.+. ++..||+|++......  ....                      ...|...+..+.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999887 7899999998653211  1111                      135666677765432  


Q ss_pred             ceeeeeeEEeCCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEe
Q psy12427        167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE-KNIIHLDVKPENIMCQ  245 (356)
Q Consensus       167 Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~Dlkp~NIlv~  245 (356)
                      +.++++.    ...+++|||++++.+........   ..    ......++.+++.++.++|+ .||+|+||+|+||+++
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~---~~----~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~  149 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV---RL----LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD  149 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhh---hh----cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE
Confidence            4445543    24589999999865422111100   00    03345589999999999999 9999999999999998


Q ss_pred             ecCCCcEEEEeeeceeeeC
Q psy12427        246 TRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       246 ~~~~~~vkl~Dfg~a~~~~  264 (356)
                       +  +.++|+|||.+....
T Consensus       150 -~--~~~~liDfg~a~~~~  165 (187)
T cd05119         150 -D--GKVYIIDVPQAVEID  165 (187)
T ss_pred             -C--CcEEEEECccccccc
Confidence             3  379999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.72  E-value=4.8e-17  Score=142.97  Aligned_cols=134  Identities=17%  Similarity=0.228  Sum_probs=101.0

Q ss_pred             cccc-ccCceEEEEEEEccCCCEEEEEEcccCC-------------hhhHHHHHHHHHHHHhcCCCCc--eeeeeeEEeC
Q psy12427        114 EEIG-TGAFGVVHRCRERKTGNIFAAKFIPVSH-------------NLEKELIRKEIDIMNQLHHPKL--INLHDAFEDD  177 (356)
Q Consensus       114 ~~lg-~G~fg~V~~~~~~~~~~~~a~K~~~~~~-------------~~~~~~~~~E~~il~~l~hpnI--v~l~~~~~~~  177 (356)
                      ..|| .|+.|+||.+...  +..+++|.+....             ......+.+|++++..|+|++|  +..+++....
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4687 8899999988775  7788998774321             1223557789999999998875  6677664432


Q ss_pred             -C---eEEEEEEeccc-cchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcE
Q psy12427        178 -D---EMVLIFEFLSG-GELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNV  252 (356)
Q Consensus       178 -~---~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~v  252 (356)
                       .   ..++|||+++| .+|.+++...  .+++         ..+.+++.+|.+||+.||+||||||+|||++.++  .+
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~---------~~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~--~v  181 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA--PLSE---------EQWQAIGQLIARFHDAGVYHADLNAHNILLDPDG--KF  181 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC--CCCH---------HHHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC--CE
Confidence             2   23599999997 6888777532  1111         1467899999999999999999999999997654  79


Q ss_pred             EEEeeeceee
Q psy12427        253 KMIDFGLATK  262 (356)
Q Consensus       253 kl~Dfg~a~~  262 (356)
                      +|+|||.+..
T Consensus       182 ~LIDfg~~~~  191 (239)
T PRK01723        182 WLIDFDRGEL  191 (239)
T ss_pred             EEEECCCccc
Confidence            9999998865

>KOG0590|consensus

Probab=99.72  E-value=4.3e-19  Score=174.14  Aligned_cols=243  Identities=23%  Similarity=0.416  Sum_probs=185.3

Q ss_pred             cceeeeccccccCceEEEEEEEccC-CCEEEEEEcccCC--hhhHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCeEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKT-GNIFAAKFIPVSH--NLEKELIRKEIDIMNQLH-HPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~-~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lv  183 (356)
                      ..|.+.+.||+|+|+.|-.+....+ ...+|.|.+....  ......+..|..+-..+. |+|++.+++........++.
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            3588888999999999999877543 4567777766543  222344556888888886 99999999999999999999


Q ss_pred             EEeccccchhhhh-hCCCCCCCccccccccHHHHHHHHHHHHHHHH-HCCceeccCCCCCEEEeecCCCcEEEEeeecee
Q psy12427        184 FEFLSGGELFERI-TAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH-EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT  261 (356)
Q Consensus       184 ~e~~~~g~L~~~l-~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~  261 (356)
                      +++..|+++++.+ .........     .....++.|+..++.|+| ..++.||||||+|.+++..++ .++++|||+|.
T Consensus       100 ~~~s~g~~~f~~i~~~~~~~~~~-----~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~-~l~~~df~~At  173 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDSTGTSS-----SSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS-ALKIADFGLAT  173 (601)
T ss_pred             cCcccccccccccccCCccCCCC-----cchhhhhhhhccCccccCcccccccCCCCCccchhccCCC-cccCCCchhhc
Confidence            9999999998887 322112222     223349999999999999 999999999999999986654 68999999998


Q ss_pred             eeCC-CCce---eecCC-CcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCChHHH-HHHhhccccccChh
Q psy12427        262 KLDP-NEVV---KISTG-TAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVET-LKNVKACDWEFDEE  334 (356)
Q Consensus       262 ~~~~-~~~~---~~~~g-t~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~-~~~i~~~~~~~~~~  334 (356)
                      .+.. +...   ...+| ++.|+|||...+. ......|+||.|+++..+++|..|+........ +.........+-..
T Consensus       174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  253 (601)
T KOG0590|consen  174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQL  253 (601)
T ss_pred             cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccC
Confidence            8765 2222   33468 9999999999885 456789999999999999999999976654332 12222222333455


Q ss_pred             hhccCCHHHHHHHHHhhhcCCC
Q psy12427        335 AFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       335 ~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .|..++..+.+++.+++..+|+
T Consensus       254 ~~~~~~~~~~~~l~k~l~~~~~  275 (601)
T KOG0590|consen  254 PWNSISDQAHDLLHKILKENPS  275 (601)
T ss_pred             ccccCChhhhhcccccccCCch
Confidence            6778999999999999986663

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.71  E-value=8.8e-17  Score=130.72  Aligned_cols=132  Identities=18%  Similarity=0.210  Sum_probs=108.0

Q ss_pred             eeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCC--CCceeeeeeEEeCCeEEEEEEeccc
Q psy12427        112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHH--PKLINLHDAFEDDDEMVLIFEFLSG  189 (356)
Q Consensus       112 ~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~~~~~lv~e~~~~  189 (356)
                      +.+.||.|.++.||++....  ..+++|.......  ...+.+|+.++..++|  ++++++++.....+..+++|||+.|
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g   77 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG   77 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence            45689999999999999864  7899999866543  5678889999999976  5899999988888899999999998


Q ss_pred             cchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHC---CceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        190 GELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEK---NIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       190 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      +.+..+             .......++.+++.+|++||..   +++|+|++|+||+++..  ..++++|||.++.
T Consensus        78 ~~~~~~-------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~--~~~~l~Df~~~~~  138 (155)
T cd05120          78 ETLDEV-------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG--KILGIIDWEYAGY  138 (155)
T ss_pred             eecccC-------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC--cEEEEEecccccC
Confidence            877543             1122234788999999999985   69999999999999863  4799999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.60  E-value=1.4e-15  Score=146.66  Aligned_cols=152  Identities=16%  Similarity=0.281  Sum_probs=96.1

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh----------------------------------hHHH
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL----------------------------------EKEL  151 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~----------------------------------~~~~  151 (356)
                      ++..|.. +.||.|++|+||+|+.+.+|+.||+|+++..-..                                  -...
T Consensus       118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~  196 (537)
T PRK04750        118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT  196 (537)
T ss_pred             HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence            4456776 7999999999999999988999999999743110                                  0111


Q ss_pred             ------HHHHHHHHHhcC----CCCceeeeeeE-EeCCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHH
Q psy12427        152 ------IRKEIDIMNQLH----HPKLINLHDAF-EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT  220 (356)
Q Consensus       152 ------~~~E~~il~~l~----hpnIv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i  220 (356)
                            +.+|+..+.++.    +.+.+.+-.++ ...+..++||||++|+.+.++-...........+....+..+    
T Consensus       197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~----  272 (537)
T PRK04750        197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVF----  272 (537)
T ss_pred             HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHH----
Confidence                  333444444442    33333332322 224566899999999999764221111111111211112222    


Q ss_pred             HHHHHHHHHCCceeccCCCCCEEEeecC--CCcEEEEeeeceeeeCC
Q psy12427        221 SPAVKHMHEKNIIHLDVKPENIMCQTRN--STNVKMIDFGLATKLDP  265 (356)
Q Consensus       221 ~~~l~~lH~~~ivH~Dlkp~NIlv~~~~--~~~vkl~Dfg~a~~~~~  265 (356)
                         +..+...|++|+|++|.||+++.++  .++++++|||++..+++
T Consensus       273 ---~~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        273 ---FTQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             ---HHHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence               3345578999999999999998654  23799999999988754

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.60  E-value=6.7e-15  Score=140.30  Aligned_cols=141  Identities=19%  Similarity=0.295  Sum_probs=97.0

Q ss_pred             ccccccCceEEEEEEEccCCCEEEEEEcccCChhhH----------------------------------------HHHH
Q psy12427        114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK----------------------------------------ELIR  153 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~----------------------------------------~~~~  153 (356)
                      +.||.|++|.||+|+.+ +|+.||+|+.+..-....                                        -++.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            67999999999999986 689999999865321100                                        0244


Q ss_pred             HHHHHHHhcC-----CCCceeeeeeEEeCCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHH-HHHHH
Q psy12427        154 KEIDIMNQLH-----HPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSP-AVKHM  227 (356)
Q Consensus       154 ~E~~il~~l~-----hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~-~l~~l  227 (356)
                      +|+..+.++.     ++++.-..-+....+..++||||++|++|.+.........        ....++..++. .+..+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~--------~~~~ia~~~~~~~l~ql  273 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL--------DRKALAENLARSFLNQV  273 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC--------CHHHHHHHHHHHHHHHH
Confidence            5666666652     3433222222233455699999999999987764221111        12235566655 47889


Q ss_pred             HHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       228 H~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |..|++|+|++|.||+++.++  .++++|||++..+.+
T Consensus       274 ~~~g~~H~D~hPgNilv~~~g--~i~liDfG~~~~l~~  309 (437)
T TIGR01982       274 LRDGFFHADLHPGNIFVLKDG--KIIALDFGIVGRLSE  309 (437)
T ss_pred             HhCCceeCCCCcccEEECCCC--cEEEEeCCCeeECCH
Confidence            999999999999999997554  799999999988753

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601|consensus

Probab=99.55  E-value=4.3e-15  Score=140.26  Aligned_cols=235  Identities=20%  Similarity=0.293  Sum_probs=178.5

Q ss_pred             cceeeeccccc--cCceEEEEEEE--ccCCCEEEEEEcccCCh--hhHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCeE
Q psy12427        108 DHYDILEEIGT--GAFGVVHRCRE--RKTGNIFAAKFIPVSHN--LEKELIRKEIDIMNQLH-HPKLINLHDAFEDDDEM  180 (356)
Q Consensus       108 ~~y~~~~~lg~--G~fg~V~~~~~--~~~~~~~a~K~~~~~~~--~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~  180 (356)
                      ..+.+...+|.  |.+|.||.++.  ..++..+|+|.-+....  .....=.+|+....+++ |+|.++.+..++..+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            45677889999  99999999998  88899999998544322  22222235677777774 99999999999999999


Q ss_pred             EEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHH----HHHHHHHCCceeccCCCCCEEEeecCCCcEEEEe
Q psy12427        181 VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSP----AVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMID  256 (356)
Q Consensus       181 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~----~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~D  256 (356)
                      ++-+|.+ +.+|..+.......+.+..+     +..+.+...    ||.++|+.+++|.|+||+||+...+. ...+++|
T Consensus       194 fiqtE~~-~~sl~~~~~~~~~~~p~~~l-----~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~-~s~~~~d  266 (524)
T KOG0601|consen  194 FIQTELC-GESLQSYCHTPCNFLPDNLL-----WNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDW-TSCKLTD  266 (524)
T ss_pred             eeeeccc-cchhHHhhhcccccCCchhh-----hhHHhhhhhcccccccccCCCcccccccchhheeccccc-ceeecCC
Confidence            9999988 57887777655443444444     447778888    99999999999999999999987652 3689999


Q ss_pred             eeceeeeCCCCceee------cCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC--ChHHHHHHhhccc
Q psy12427        257 FGLATKLDPNEVVKI------STGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGE--NDVETLKNVKACD  328 (356)
Q Consensus       257 fg~a~~~~~~~~~~~------~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~--~~~~~~~~i~~~~  328 (356)
                      ||+...+........      ..|...|++||.+++- ++.++|++|+|.+..+...+-.++...  +....+.+.    
T Consensus       267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~----  341 (524)
T KOG0601|consen  267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG----  341 (524)
T ss_pred             cceeEEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc----
Confidence            999988865442211      2578889999987754 678899999999999999887776555  333333322    


Q ss_pred             cccChhhhccCCHHHHHHHHHhhhcCC
Q psy12427        329 WEFDEEAFKNVSEEGKDFIRRLLLRNK  355 (356)
Q Consensus       329 ~~~~~~~~~~~s~~~~~lI~~ll~~dP  355 (356)
                       ..+.++....+.++...+..|++.+|
T Consensus       342 -~ip~e~~~~~s~~l~~~~~~~~d~~~  367 (524)
T KOG0601|consen  342 -YIPLEFCEGGSSSLRSVTSQMLDEDP  367 (524)
T ss_pred             -cCchhhhcCcchhhhhHHHHhcCcch
Confidence             25566666788888889999888776

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.52  E-value=1.1e-13  Score=115.29  Aligned_cols=127  Identities=17%  Similarity=0.195  Sum_probs=94.8

Q ss_pred             ccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCce-eeeeeEEeCCeEEEEEEeccccch
Q psy12427        114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLI-NLHDAFEDDDEMVLIFEFLSGGEL  192 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv-~l~~~~~~~~~~~lv~e~~~~g~L  192 (356)
                      +.|+.|.++.||++...  +..+++|....... ....+.+|+.+++.+.+.+++ +++....  ...++||||++|.++
T Consensus         4 ~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l   78 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL   78 (170)
T ss_pred             eecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence            57899999999999865  77899998765432 123457899999998665544 4554432  335799999999877


Q ss_pred             hhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCc-----eeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        193 FERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNI-----IHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       193 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i-----vH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ...      ..        ....++.+++.+|+.||+.++     +|+|++|.||+++ ++  .++++|||.+..
T Consensus        79 ~~~------~~--------~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~--~~~liDf~~a~~  136 (170)
T cd05151          79 LTE------DF--------SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DG--RLWLIDWEYAGM  136 (170)
T ss_pred             ccc------cc--------cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CC--eEEEEecccccC
Confidence            432      00        012267899999999999985     9999999999997 33  699999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0606|consensus

Probab=99.51  E-value=6.6e-15  Score=146.11  Aligned_cols=241  Identities=22%  Similarity=0.369  Sum_probs=183.2

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhh---HHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE---KELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~---~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      -.+.+.+.+-+..|.++.++.+.-..+|...+.|+........   .+.++.+-+++-.-++|-+++..-.+......++
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            4567888889999999999999888888777777665433222   2223333344433455666666555666788899


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      +++|..+++|...++.... ......     +.++..+..++++||+..+.|+|++|.|+|...++  +.++.|||....
T Consensus       882 ~~~~~~~~~~~Skl~~~~~-~saepa-----Rs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~g--h~~l~~~~t~~~  953 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSGC-LSAEPA-----RSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDG--HRPLTDFGTLSK  953 (1205)
T ss_pred             hhHHhccCCchhhhhcCCC-cccccc-----cchhHHHHhhhhccccchhhcccccccchhhcccC--CcccCccccccc
Confidence            9999999999888876552 222222     23677888899999999999999999999986544  789999983322


Q ss_pred             eC---------------------C---------C--CceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCC
Q psy12427        263 LD---------------------P---------N--EVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLS  310 (356)
Q Consensus       263 ~~---------------------~---------~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~  310 (356)
                      ..                     .         .  .......||+.|.+||.+.+......+|.|++|++++|.++|.+
T Consensus       954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen  954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred             cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence            10                     0         0  01122347999999999999999999999999999999999999


Q ss_pred             CCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHHHhhhcCC
Q psy12427        311 PFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNK  355 (356)
Q Consensus       311 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP  355 (356)
                      ||.....+.+..++..+....+.. ....+.++++++..+|..+|
T Consensus      1034 p~na~tpq~~f~ni~~~~~~~p~g-~~~~s~~aq~~~~~ll~~~~ 1077 (1205)
T KOG0606|consen 1034 PFNAETPQQIFENILNRDIPWPEG-PEEGSYEAQDLINRLLTEEP 1077 (1205)
T ss_pred             CCCCcchhhhhhccccCCCCCCCC-ccccChhhhhhhhhhhccCc
Confidence            999999999999999988776643 34689999999999998776

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.48  E-value=7.1e-13  Score=111.83  Aligned_cols=138  Identities=18%  Similarity=0.244  Sum_probs=96.8

Q ss_pred             eccccccCceEEEEEEEcc------CCCEEEEEEcccCC----------------------hhhHHHHH----HHHHHHH
Q psy12427        113 LEEIGTGAFGVVHRCRERK------TGNIFAAKFIPVSH----------------------NLEKELIR----KEIDIMN  160 (356)
Q Consensus       113 ~~~lg~G~fg~V~~~~~~~------~~~~~a~K~~~~~~----------------------~~~~~~~~----~E~~il~  160 (356)
                      ...||.|.-+.||.|....      .+..+|+|+.+...                      ...+..+.    +|+..|.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3579999999999998654      35799999885421                      01122333    7999999


Q ss_pred             hcCC--CCceeeeeeEEeCCeEEEEEEeccccchhh-hhhCCCCCCCccccccccHHHHHHHHHHHHHHH-HHCCceecc
Q psy12427        161 QLHH--PKLINLHDAFEDDDEMVLIFEFLSGGELFE-RITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM-HEKNIIHLD  236 (356)
Q Consensus       161 ~l~h--pnIv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l-H~~~ivH~D  236 (356)
                      ++..  -++..++++    ..-++||||+.+..+.. .+...  ....     .....+..+++.+|..| |+.|+||+|
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~--~~~~-----~~~~~i~~~i~~~l~~l~H~~glVHGD  150 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA--KLND-----EEMKNAYYQVLSMMKQLYKECNLVHAD  150 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc--ccCH-----HHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            9853  456666764    45689999997654321 12111  1111     12344778999999998 899999999


Q ss_pred             CCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        237 VKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       237 lkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      |++.|||+..   +.+.|+|||.+-..+
T Consensus       151 Ls~~NIL~~~---~~v~iIDF~qav~~~  175 (197)
T cd05146         151 LSEYNMLWHD---GKVWFIDVSQSVEPT  175 (197)
T ss_pred             CCHHHEEEEC---CcEEEEECCCceeCC
Confidence            9999999963   269999999887654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1243|consensus

Probab=99.47  E-value=4.5e-13  Score=128.07  Aligned_cols=183  Identities=19%  Similarity=0.289  Sum_probs=135.4

Q ss_pred             eeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEeccc
Q psy12427        110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSG  189 (356)
Q Consensus       110 y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  189 (356)
                      |++ +..+-++.+..-.|..+.++.++.+.+.+.......+.+.+-+.-|+.++||||+++++.++..+..|+|+|.+. 
T Consensus        15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~-   92 (690)
T KOG1243|consen   15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR-   92 (690)
T ss_pred             ccc-ccccCCCcccccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc-
Confidence            444 445555555444677788899999999887776445567788899999999999999999999999999999874 


Q ss_pred             cchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHH-HCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCc
Q psy12427        190 GELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH-EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEV  268 (356)
Q Consensus       190 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~  268 (356)
                       -|..++.+..         ...+..-+.||+.||.+|| +.+++|++|.-..|+|+..+  ..||++|.++........
T Consensus        93 -Pl~~~lk~l~---------~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G--eWkLggle~v~~~~~~~~  160 (690)
T KOG1243|consen   93 -PLETVLKELG---------KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG--EWKLGGLELVSKASGFNA  160 (690)
T ss_pred             -cHHHHHHHhH---------HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC--cEEEeeeEEEeccccCCc
Confidence             4544554322         2233447889999999998 67899999999999998766  799999998876543221


Q ss_pred             -eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcC
Q psy12427        269 -VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSG  308 (356)
Q Consensus       269 -~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g  308 (356)
                       .....---.|..|+.+....  ...|.|-|||++||++.|
T Consensus       161 ~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  161 PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence             11111123456666555443  457999999999999999

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.40  E-value=4.6e-12  Score=103.63  Aligned_cols=131  Identities=21%  Similarity=0.252  Sum_probs=99.4

Q ss_pred             ccccccCceEEEEEEEccCCCEEEEEEc-ccCC--hh-----hHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        114 EEIGTGAFGVVHRCRERKTGNIFAAKFI-PVSH--NL-----EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~~~~~a~K~~-~~~~--~~-----~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      ..+++|+-+.++.+.+.  |..+++|.= ++.-  ..     .+..-.+|+.+|.++.--.|....=+..++....|+||
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            35889999999999774  555666643 2211  11     12344579999999976666665556667788899999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      |++|-.|.+.+....        .     .+++.+-.-+.-||..||+|+||.++||++..+   .+.++|||++..
T Consensus        80 ~I~G~~lkd~l~~~~--------~-----~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~---~i~~IDfGLg~~  140 (204)
T COG3642          80 YIEGELLKDALEEAR--------P-----DLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG---RIYFIDFGLGEF  140 (204)
T ss_pred             EeCChhHHHHHHhcc--------h-----HHHHHHHHHHHHHHhcCeecCCCccceEEEeCC---cEEEEECCcccc
Confidence            999988888887541        1     278888888999999999999999999999643   499999999875

>KOG3087|consensus

Probab=99.35  E-value=7.6e-12  Score=101.92  Aligned_cols=145  Identities=23%  Similarity=0.274  Sum_probs=106.9

Q ss_pred             eeccccccCceEEEEEEEccCCCEEEEEEcccC---C-----hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS---H-----NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       112 ~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~---~-----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      .+..|-+|+-+.|+++.+.  |+.+++|.=-..   .     ...+..-.+|+..|.++.--.|.-..-++.+...-.++
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            5678999999999999887  778777743211   1     11234556799999999766666665567777777899


Q ss_pred             EEeccc-cchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCC-cEEEEeeecee
Q psy12427        184 FEFLSG-GELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNST-NVKMIDFGLAT  261 (356)
Q Consensus       184 ~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~-~vkl~Dfg~a~  261 (356)
                      |||++| .++.+++........+.    ..+..+++.|-+.+.-||..+++|+||..+||++..+++. .+.++|||++.
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d----~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESED----EGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccc----hhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence            999977 36677765433222222    2223488999999999999999999999999999877653 35999999986


Q ss_pred             e
Q psy12427        262 K  262 (356)
Q Consensus       262 ~  262 (356)
                      .
T Consensus       165 ~  165 (229)
T KOG3087|consen  165 V  165 (229)
T ss_pred             c
Confidence            5

>KOG3741|consensus

Probab=99.34  E-value=4e-11  Score=111.68  Aligned_cols=208  Identities=14%  Similarity=0.208  Sum_probs=147.4

Q ss_pred             cCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEE----eCCeEEEEEEeccc-cchh
Q psy12427        119 GAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFE----DDDEMVLIFEFLSG-GELF  193 (356)
Q Consensus       119 G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~----~~~~~~lv~e~~~~-g~L~  193 (356)
                      -...+.|++..+.+|..|++|++...........-.-+++++++.|+|+|++.++|.    .+..+++|++|.++ ++|.
T Consensus       287 ~~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  287 LFSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             cccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence            366789999999999999999995543322222334578899999999999999987    45788999999875 4676


Q ss_pred             hhhhCCCC---------CCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        194 ERITAPDY---------KMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       194 ~~l~~~~~---------~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      ++.-....         ......+.+..+|.++.|+..||.++|+.|+..+-|.|.+||++.+  .+++|+..|....+.
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~--~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGK--MRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCc--ceEEEecccceeeec
Confidence            65532221         1223345556789999999999999999999999999999999744  378998888776654


Q ss_pred             CCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCC-CCCCChHHH-HHHhhccccccChhhhccCCHH
Q psy12427        265 PNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSP-FAGENDVET-LKNVKACDWEFDEEAFKNVSEE  342 (356)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~P-f~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~~  342 (356)
                      .+..             |-+..   -.+-|.=.||.+++.|.+|..- +.....++. +..|.           ..+|.+
T Consensus       445 ~d~~-------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~-----------~~yS~D  497 (655)
T KOG3741|consen  445 EDPT-------------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT-----------TTYSTD  497 (655)
T ss_pred             CCCC-------------cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-----------hhhhHH
Confidence            4331             11111   2356889999999999998553 333333332 33332           256777


Q ss_pred             HHHHHHHhhhcCC
Q psy12427        343 GKDFIRRLLLRNK  355 (356)
Q Consensus       343 ~~~lI~~ll~~dP  355 (356)
                      ++++|.-+...++
T Consensus       498 ~rn~v~yl~s~~~  510 (655)
T KOG3741|consen  498 LRNVVEYLESLNF  510 (655)
T ss_pred             HHHHHHHHHhcCc
Confidence            7877776655443

>KOG0601|consensus

Probab=99.31  E-value=1.2e-12  Score=123.97  Aligned_cols=195  Identities=23%  Similarity=0.271  Sum_probs=144.8

Q ss_pred             ccceeeeccccccCceEEEEEEEc-cCCCEEEEEEcccCChhhHHHH--HHHHHHHHhc-CCCCceeeeeeEEeCCeEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRER-KTGNIFAAKFIPVSHNLEKELI--RKEIDIMNQL-HHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~-~~~~~~a~K~~~~~~~~~~~~~--~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l  182 (356)
                      ..+|..+..||.|.|+.|+.+.-+ .++..|++|...........++  ..|+-+...+ .|.+++++...|......++
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i  343 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI  343 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence            456888999999999999998766 5678999998765543333333  2566666666 58999999999988888889


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      -.||++++++...+.. ...+.+...     +.+..|++.++.++|++.++|+|++|.||++..++ +..++.|||+...
T Consensus       344 p~e~~~~~s~~l~~~~-~~~~d~~~~-----~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~-~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  344 PLEFCEGGSSSLRSVT-SQMLDEDPR-----LRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG-FFSKLGDFGCWTR  416 (524)
T ss_pred             chhhhcCcchhhhhHH-HHhcCcchh-----hhhHHHHHhccccccchhhhcccccccceeeccch-hhhhccccccccc
Confidence            9999999988655521 112223333     33888999999999999999999999999997654 5679999998864


Q ss_pred             eCCCCceeecCCCcCcc--ccccccCCCCCccccHHHHHHHHHHHHcCCC
Q psy12427        263 LDPNEVVKISTGTAEFA--APEIVEREPVGFYTDMWAVGVLAYVLLSGLS  310 (356)
Q Consensus       263 ~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDvwSlG~il~ell~g~~  310 (356)
                      +.-  .........++.  +|+......+..+.|++|||.-+.+.+++.+
T Consensus       417 ~~~--~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~  464 (524)
T KOG0601|consen  417 LAF--SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP  464 (524)
T ss_pred             cce--ecccccccccccccchhhccccccccccccccccccccccccCcc
Confidence            221  111122333444  5555566778899999999999999998765

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.28  E-value=3.2e-11  Score=104.77  Aligned_cols=141  Identities=16%  Similarity=0.232  Sum_probs=95.9

Q ss_pred             ccccccCceEEEEEEEccCCCEEEEEEcccCCh-hhHHHHHHHHHHHHhcCC--CCceeeeeeEEeC---CeEEEEEEec
Q psy12427        114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN-LEKELIRKEIDIMNQLHH--PKLINLHDAFEDD---DEMVLIFEFL  187 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~---~~~~lv~e~~  187 (356)
                      +.|+.|.++.||++.... |..+++|+...... .....+.+|+.++..+.+  .++.+++.+....   +..++||||+
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            568999999999998754 67899998765432 134567889999999975  3456777766553   3668999999


Q ss_pred             cccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHH--------------------------------------
Q psy12427        188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE--------------------------------------  229 (356)
Q Consensus       188 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--------------------------------------  229 (356)
                      +|.++.+.+...  ..+.     .....++.+++.+|..||+                                      
T Consensus        83 ~G~~l~~~~~~~--~~~~-----~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (223)
T cd05154          83 DGRVLRDRLLRP--ELSP-----EERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP  155 (223)
T ss_pred             CCEecCCCCCCC--CCCH-----HHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence            998886543210  0111     1111244444444444442                                      


Q ss_pred             ------------------CCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        230 ------------------KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       230 ------------------~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                                        ..++|+|+.|.||+++.++...+.|+||+.+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                              347999999999999864233579999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.14  E-value=9e-10  Score=92.66  Aligned_cols=126  Identities=23%  Similarity=0.310  Sum_probs=79.4

Q ss_pred             EEEEEEEccCCCEEEEEEcccCCh--------------------------hhHHHHHHHHHHHHhcCCC--CceeeeeeE
Q psy12427        123 VVHRCRERKTGNIFAAKFIPVSHN--------------------------LEKELIRKEIDIMNQLHHP--KLINLHDAF  174 (356)
Q Consensus       123 ~V~~~~~~~~~~~~a~K~~~~~~~--------------------------~~~~~~~~E~~il~~l~hp--nIv~l~~~~  174 (356)
                      .||.|... +|..+|+|+.+....                          .......+|++.|.++..-  ++.+++++-
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            38888774 477999998854210                          0123456799999999765  466666542


Q ss_pred             EeCCeEEEEEEecc--ccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHH-HHHCCceeccCCCCCEEEeecCCCc
Q psy12427        175 EDDDEMVLIFEFLS--GGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKH-MHEKNIIHLDVKPENIMCQTRNSTN  251 (356)
Q Consensus       175 ~~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~-lH~~~ivH~Dlkp~NIlv~~~~~~~  251 (356)
                          .-++||||+.  |..+..+... .       ........++.+++..+.. +|+.|++|+||.+.|||++.+   .
T Consensus        80 ----~~~ivME~I~~~G~~~~~l~~~-~-------~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~---~  144 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPRLKDV-D-------LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG---K  144 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGCHHHC-G-------GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT---C
T ss_pred             ----CCEEEEEecCCCccchhhHHhc-c-------ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc---e
Confidence                3379999998  6555443321 1       1122234477888886655 579999999999999999754   5


Q ss_pred             EEEEeeeceeeeC
Q psy12427        252 VKMIDFGLATKLD  264 (356)
Q Consensus       252 vkl~Dfg~a~~~~  264 (356)
                      +.++|||.+....
T Consensus       145 ~~iIDf~qav~~~  157 (188)
T PF01163_consen  145 VYIIDFGQAVDSS  157 (188)
T ss_dssp             EEE--GTTEEETT
T ss_pred             EEEEecCcceecC
Confidence            9999999886643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.13  E-value=9.7e-10  Score=97.89  Aligned_cols=133  Identities=17%  Similarity=0.111  Sum_probs=90.1

Q ss_pred             EEEEEEccCCCEEEEEEcccCChhh-----------HHHHHHHHHHHHhcCCCCc--eeeeeeEEe-----CCeEEEEEE
Q psy12427        124 VHRCRERKTGNIFAAKFIPVSHNLE-----------KELIRKEIDIMNQLHHPKL--INLHDAFED-----DDEMVLIFE  185 (356)
Q Consensus       124 V~~~~~~~~~~~~a~K~~~~~~~~~-----------~~~~~~E~~il~~l~hpnI--v~l~~~~~~-----~~~~~lv~e  185 (356)
                      |.++..  .|+.+.+|.........           ...+.+|...+.+|..-+|  ++++++.+.     ....++|||
T Consensus        38 vvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte  115 (268)
T PRK15123         38 TLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE  115 (268)
T ss_pred             EEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence            556544  36788888764433211           1136689999888854333  334444442     235789999


Q ss_pred             ecccc-chhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEee-----cCCCcEEEEeeec
Q psy12427        186 FLSGG-ELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQT-----RNSTNVKMIDFGL  259 (356)
Q Consensus       186 ~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~-----~~~~~vkl~Dfg~  259 (356)
                      ++++. +|.+++....    ...........++.+++..+..||+.||+|+|+++.|||++.     ++...+.|+||+.
T Consensus       116 ~l~~~~sL~~~~~~~~----~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r  191 (268)
T PRK15123        116 DLAPTISLEDYCADWA----TNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHR  191 (268)
T ss_pred             eCCCCccHHHHHHhhc----ccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence            99876 7888774321    011112223458899999999999999999999999999985     2345799999998


Q ss_pred             eee
Q psy12427        260 ATK  262 (356)
Q Consensus       260 a~~  262 (356)
                      ++.
T Consensus       192 ~~~  194 (268)
T PRK15123        192 AQI  194 (268)
T ss_pred             ccc
Confidence            853

>KOG1266|consensus

Probab=99.13  E-value=2.4e-11  Score=107.09  Aligned_cols=151  Identities=21%  Similarity=0.258  Sum_probs=111.1

Q ss_pred             HHHHHhcCCCCceeeeeeEEe-----CCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHC
Q psy12427        156 IDIMNQLHHPKLINLHDAFED-----DDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEK  230 (356)
Q Consensus       156 ~~il~~l~hpnIv~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~  230 (356)
                      ..-|-++.|.||++++.++.+     .....+++|||..|+|..+|.+...  ....+.....+.|+.||+.||.|||+.
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~--~~~a~~~~~wkkw~tqIlsal~yLhs~  195 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK--NQKALFQKAWKKWCTQILSALSYLHSC  195 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH--hhhhhhHHHHHHHHHHHHhhhhhhhcc
Confidence            445667789999999999864     3457899999999999999976542  334444555677999999999999986


Q ss_pred             --CceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC------CCceeecCCCcCccccccccCCCCCccccHHHHHHHH
Q psy12427        231 --NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP------NEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLA  302 (356)
Q Consensus       231 --~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il  302 (356)
                        -|+|+++..+.|++..+  +.+|+. -+-.....+      ........+.++|.|||.=.-...+-++|||+||...
T Consensus       196 ~PpiihgnlTc~tifiq~n--gLIkig-~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcA  272 (458)
T KOG1266|consen  196 DPPIIHGNLTCDTIFIQHN--GLIKIG-SVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCA  272 (458)
T ss_pred             CCccccCCcchhheeecCC--ceEEec-ccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHH
Confidence              59999999999999743  345543 221111111      0111223467899999987766777899999999999


Q ss_pred             HHHHcCCCC
Q psy12427        303 YVLLSGLSP  311 (356)
Q Consensus       303 ~ell~g~~P  311 (356)
                      .+|..+..-
T Consensus       273 lemailEiq  281 (458)
T KOG1266|consen  273 LEMAILEIQ  281 (458)
T ss_pred             HHHHHheec
Confidence            999887664

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.12  E-value=1.1e-09  Score=100.03  Aligned_cols=233  Identities=15%  Similarity=0.164  Sum_probs=150.1

Q ss_pred             eeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhc-CCCCcee--------eeeeEEeCCeEE
Q psy12427        111 DILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL-HHPKLIN--------LHDAFEDDDEMV  181 (356)
Q Consensus       111 ~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~--------l~~~~~~~~~~~  181 (356)
                      ...+.||+|+.+.+|-.-.-  +.. +.|++.........+   -+..|... .||-+-.        |+|- .....+-
T Consensus        14 ~~gr~LgqGgea~ly~l~e~--~d~-VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~iG   86 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEV--RDQ-VAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGG-RRGKVIG   86 (637)
T ss_pred             CCCccccCCccceeeecchh--hch-hheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCC-CccceeE
Confidence            45578999999999975433  223 447776544322222   22333333 5654322        2222 1223367


Q ss_pred             EEEEeccccch-hhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeece
Q psy12427        182 LIFEFLSGGEL-FERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA  260 (356)
Q Consensus       182 lv~e~~~~g~L-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a  260 (356)
                      ++|..+.|..- ..++.....+.+-..+.+..+....+.++.+.+.||..|.+-+|+.++|+||+++.  .|.|.|=...
T Consensus        87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~--~V~LVdsDsf  164 (637)
T COG4248          87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDS--KVVLVDSDSF  164 (637)
T ss_pred             EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCc--eEEEEcccce
Confidence            88888877633 23332222333444555566677899999999999999999999999999998654  7999997766


Q ss_pred             eeeCCCCceeecCCCcCcccccccc-----CCCCCccccHHHHHHHHHHHHcC-CCCCCCCChH----HHHH-Hhhccc-
Q psy12427        261 TKLDPNEVVKISTGTAEFAAPEIVE-----REPVGFYTDMWAVGVLAYVLLSG-LSPFAGENDV----ETLK-NVKACD-  328 (356)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~ell~g-~~Pf~~~~~~----~~~~-~i~~~~-  328 (356)
                      ............+|.+.|++||.-.     +-.-+..+|.|.||+++++|+.| +.||.|....    ..++ .|..+. 
T Consensus       165 qi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f  244 (637)
T COG4248         165 QINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF  244 (637)
T ss_pred             eeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence            5554455556678999999999654     33456679999999999999985 9999876321    1111 222211 


Q ss_pred             ---------cccC--hhhhccCCHHHHHHHHHhhh
Q psy12427        329 ---------WEFD--EEAFKNVSEEGKDFIRRLLL  352 (356)
Q Consensus       329 ---------~~~~--~~~~~~~s~~~~~lI~~ll~  352 (356)
                               ..++  ...|.-+++++.-+..+|+.
T Consensus       245 ~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~  279 (637)
T COG4248         245 AYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFT  279 (637)
T ss_pred             eechhccCCCCCCCCCCChhhcCHHHHHHHHHHhc
Confidence                     1111  22234578889988888875

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.95  E-value=9.5e-09  Score=89.28  Aligned_cols=135  Identities=19%  Similarity=0.277  Sum_probs=99.1

Q ss_pred             eeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh----------------------hhHHHHHHHHHHHHhcCCC--
Q psy12427        110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN----------------------LEKELIRKEIDIMNQLHHP--  165 (356)
Q Consensus       110 y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~----------------------~~~~~~~~E~~il~~l~hp--  165 (356)
                      +.+..+||.|.-|.||.|.+. .|..+|+|+-+....                      ..+...++|.++|.+|.-.  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            456789999999999999887 589999997643211                      1123456799999999654  


Q ss_pred             CceeeeeeEEeCCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEe
Q psy12427        166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQ  245 (356)
Q Consensus       166 nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~  245 (356)
                      .+.+.+++    +.-.+|||+++|-.|...-      +....     ...++..|+.-+..+-..||||+|+.+-||+++
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en-----~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~  236 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRLR------LDVEN-----PDEILDKILEEVRKAYRRGIVHGDLSEFNILVT  236 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeeccc------CcccC-----HHHHHHHHHHHHHHHHHcCccccCCchheEEEe
Confidence            67777764    5568999999987664321      11112     223667777777766789999999999999998


Q ss_pred             ecCCCcEEEEeeeceee
Q psy12427        246 TRNSTNVKMIDFGLATK  262 (356)
Q Consensus       246 ~~~~~~vkl~Dfg~a~~  262 (356)
                      .++  .+.++||--+..
T Consensus       237 ~dg--~~~vIDwPQ~v~  251 (304)
T COG0478         237 EDG--DIVVIDWPQAVP  251 (304)
T ss_pred             cCC--CEEEEeCccccc
Confidence            765  599999986644

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.87  E-value=9.9e-09  Score=98.91  Aligned_cols=141  Identities=21%  Similarity=0.343  Sum_probs=96.5

Q ss_pred             ccccccCceEEEEEEEccCCCEEEEEEcccCChhh----------------------------------------HHHHH
Q psy12427        114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE----------------------------------------KELIR  153 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~----------------------------------------~~~~~  153 (356)
                      +.|+.++-|.||+|+.++ |+.||||+.+..-...                                        .-++.
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            579999999999999986 9999999986521110                                        01244


Q ss_pred             HHHHHHHhcC-----CCCceeeeeeEEeCCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHH-HHHH
Q psy12427        154 KEIDIMNQLH-----HPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPA-VKHM  227 (356)
Q Consensus       154 ~E~~il~~l~-----hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~-l~~l  227 (356)
                      +|+.-+.+++     .|++.-..=+++..+.-+++|||++|-.+.+.........+...        ++..++.+ +..+
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~--------ia~~~~~~f~~q~  281 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKE--------LAELLVRAFLRQL  281 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHH--------HHHHHHHHHHHHH
Confidence            5776676663     35544444344556677999999999999877432222222222        33333332 3444


Q ss_pred             HHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       228 H~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      =..|++|.|.+|.||+++.++  ++.+.|||+...+++
T Consensus       282 ~~dgffHaDpHpGNi~v~~~g--~i~~lDfGi~g~l~~  317 (517)
T COG0661         282 LRDGFFHADPHPGNILVRSDG--RIVLLDFGIVGRLDP  317 (517)
T ss_pred             HhcCccccCCCccceEEecCC--cEEEEcCcceecCCH
Confidence            457999999999999998764  799999999987754

>PRK09902 hypothetical protein; Provisional

Probab=98.85  E-value=5e-08  Score=82.77  Aligned_cols=140  Identities=14%  Similarity=0.141  Sum_probs=95.8

Q ss_pred             ccccCceEEEEEEEccCCCEEEEEEcccC------ChhhHHHHHHHHHHHHhcCCCC--ceeeeeeEE---e--CCeEEE
Q psy12427        116 IGTGAFGVVHRCRERKTGNIFAAKFIPVS------HNLEKELIRKEIDIMNQLHHPK--LINLHDAFE---D--DDEMVL  182 (356)
Q Consensus       116 lg~G~fg~V~~~~~~~~~~~~a~K~~~~~------~~~~~~~~~~E~~il~~l~hpn--Iv~l~~~~~---~--~~~~~l  182 (356)
                      -|+||.+.|++....  |..+-+|.....      .......|.+|...|.+|..-+  +.++. ++.   .  .-..+|
T Consensus        26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence            367999999997665  446777766411      1224567889999999985322  44444 222   1  124689


Q ss_pred             EEEeccc-cchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeecee
Q psy12427        183 IFEFLSG-GELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT  261 (356)
Q Consensus       183 v~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~  261 (356)
                      |+|-+.| -+|.+++.....    ..........++.+++..++-||+.|+.|+|+.+.|||++.++...+.++||.-++
T Consensus       103 VTe~L~g~~~L~~~l~~~~~----~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        103 VTEDMAGFISIADWYAQHAV----SPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEEeCCCCccHHHHHhcCCc----CCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            9998854 367777654221    11122223348999999999999999999999999999986664469999998765


Q ss_pred             e
Q psy12427        262 K  262 (356)
Q Consensus       262 ~  262 (356)
                      .
T Consensus       179 ~  179 (216)
T PRK09902        179 R  179 (216)
T ss_pred             h
Confidence            4

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.85  E-value=9.1e-08  Score=81.50  Aligned_cols=137  Identities=18%  Similarity=0.233  Sum_probs=90.8

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHH---------HHHHHHHHHhcCC---CCceeeeeeE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL---------IRKEIDIMNQLHH---PKLINLHDAF  174 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~---------~~~E~~il~~l~h---pnIv~l~~~~  174 (356)
                      .++|.+.+++-......|.+..-  +|..+++|..+.......+.         ..+++..+..+..   -....++.+.
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            45688888888888777777654  47889999876544322211         2234444444432   2333333333


Q ss_pred             E-----eCCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCC
Q psy12427        175 E-----DDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNS  249 (356)
Q Consensus       175 ~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~  249 (356)
                      +     .....+++|||++|..|.+...     ..+         .+...+.+++.-||+.|+.|+|..|.|++++.+  
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e---------~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~--  171 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE---------DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN--  171 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh-----cCH---------HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC--
Confidence            2     2345578999999988865432     111         155678889999999999999999999999743  


Q ss_pred             CcEEEEeeeceee
Q psy12427        250 TNVKMIDFGLATK  262 (356)
Q Consensus       250 ~~vkl~Dfg~a~~  262 (356)
                       .++++||+..+.
T Consensus       172 -~i~iID~~~k~~  183 (229)
T PF06176_consen  172 -GIRIIDTQGKRM  183 (229)
T ss_pred             -cEEEEECccccc
Confidence             399999986653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG2137|consensus

Probab=98.84  E-value=8.6e-10  Score=106.31  Aligned_cols=136  Identities=17%  Similarity=0.260  Sum_probs=97.1

Q ss_pred             HHHHHHHHHHHH-CCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCceee----------cCCCcCccccccccC
Q psy12427        218 TQTSPAVKHMHE-KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKI----------STGTAEFAAPEIVER  286 (356)
Q Consensus       218 ~~i~~~l~~lH~-~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~~~~----------~~gt~~y~aPE~~~~  286 (356)
                      .+++.||.++|. .++||+.|.|++|.++.++  ..||+.|+.+...........          ......|.|||++.+
T Consensus       106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~--~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANG--DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccCcceeecccchhheeeccCc--ceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            345589999995 5899999999999987544  689999998865543221111          123568999999999


Q ss_pred             CCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHHHhhhcCC
Q psy12427        287 EPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNK  355 (356)
Q Consensus       287 ~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP  355 (356)
                      ...+.++|++|+||++|.+.. |+.-+...+.......-....-........+++.|+++=+.+++..|+
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~  253 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDS  253 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCc
Confidence            889999999999999999994 666666664443333322211111122236789999999999988765

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.83  E-value=4.7e-08  Score=84.08  Aligned_cols=109  Identities=18%  Similarity=0.217  Sum_probs=79.1

Q ss_pred             HHHHHHHHHHHHhcCCCC--ceeeeeeEEeC----CeEEEEEEecccc-chhhhhhCCCCCCCccccccccHHHHHHHHH
Q psy12427        149 KELIRKEIDIMNQLHHPK--LINLHDAFEDD----DEMVLIFEFLSGG-ELFERITAPDYKMSEAEVIPVTLPILMTQTS  221 (356)
Q Consensus       149 ~~~~~~E~~il~~l~hpn--Iv~l~~~~~~~----~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~  221 (356)
                      .....+|...+..|..-+  .++++++.+..    ...++|+|++++. +|.+++.....      ........++.+++
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~------~~~~~~~~ll~~l~  128 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ------LDPSQRRELLRALA  128 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc------cchhhHHHHHHHHH
Confidence            345667888888875433  44555555542    3458999999874 78888764221      11122344899999


Q ss_pred             HHHHHHHHCCceeccCCCCCEEEeecC-CCcEEEEeeeceeee
Q psy12427        222 PAVKHMHEKNIIHLDVKPENIMCQTRN-STNVKMIDFGLATKL  263 (356)
Q Consensus       222 ~~l~~lH~~~ivH~Dlkp~NIlv~~~~-~~~vkl~Dfg~a~~~  263 (356)
                      ..++-||+.||+|+|++|.|||++.++ ...+.|+||+.++..
T Consensus       129 ~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  129 RLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999999999999999999999998764 346899999988753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG1235|consensus

Probab=98.72  E-value=3.4e-08  Score=94.95  Aligned_cols=141  Identities=18%  Similarity=0.269  Sum_probs=93.4

Q ss_pred             ccccccCceEEEEEEEccCCCEEEEEEcccCChhh-------------------------------------HHHHHHHH
Q psy12427        114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE-------------------------------------KELIRKEI  156 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~-------------------------------------~~~~~~E~  156 (356)
                      +.||.-+.|.||+|+.+. |..||+|+.+..-...                                     .=+|.+|+
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            689999999999999987 9999999986532111                                     00133444


Q ss_pred             HHHHhc----CCCC------ceeeeeeEEeCCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHH-H
Q psy12427        157 DIMNQL----HHPK------LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV-K  225 (356)
Q Consensus       157 ~il~~l----~hpn------Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l-~  225 (356)
                      +-..++    .|-+      |.+++-.+  ...-+++||||+|..+.+.-.-.....+...        ++..+.++. .
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~--------i~~~l~~~~~~  315 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHD--------ILNKLVEAYLE  315 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHH--------HHHHHHHHHHH
Confidence            444333    3444      44444333  3456899999999988776432222233222        444444442 2


Q ss_pred             HHHHCCceeccCCCCCEEEeec--CCCcEEEEeeeceeeeCC
Q psy12427        226 HMHEKNIIHLDVKPENIMCQTR--NSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       226 ~lH~~~ivH~Dlkp~NIlv~~~--~~~~vkl~Dfg~a~~~~~  265 (356)
                      -|=..|++|+|=.|.||++..+  ++..+.+-|||+...+.+
T Consensus       316 qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  316 QIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            3445799999999999999864  456899999999887654

>KOG0576|consensus

Probab=98.69  E-value=2.5e-09  Score=102.28  Aligned_cols=188  Identities=18%  Similarity=0.322  Sum_probs=143.0

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCC-ceeeeeeEEeCCeEEEEEEec
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPK-LINLHDAFEDDDEMVLIFEFL  187 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~~~lv~e~~  187 (356)
                      .+.....+++|+.+.++|.+...+.... .+++...     ...+-++++|.+++||| .+..++.++.+....+.++++
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~  316 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC  316 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence            4666778999999999998877654433 5555433     33445899999999999 778888888889999999999


Q ss_pred             ccc-chhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        188 SGG-ELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       188 ~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      .++ +-....     ..++..+...+...+.+.-.++++++|+.-=+|+|    ||+...   ...+..||+....+...
T Consensus       317 s~~rs~~~~~-----~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~---~~~~~~~~~v~~~L~~~  384 (829)
T KOG0576|consen  317 STGRSSALEM-----TVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE---EEVKLLDFAVPPQLTRT  384 (829)
T ss_pred             cCCccccccC-----ChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc---cccccccccCCcccCcc
Confidence            877 322221     12233333344445777788899999998778999    887643   35899999999888776


Q ss_pred             CceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q psy12427        267 EVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAG  314 (356)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~  314 (356)
                      ....+..+++.++|||+.....+....|+||+|+--.++.-|.+|-..
T Consensus       385 ~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~  432 (829)
T KOG0576|consen  385 MKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS  432 (829)
T ss_pred             cccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence            656677899999999999999999999999999876777777777543

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.58  E-value=1.7e-06  Score=74.72  Aligned_cols=138  Identities=18%  Similarity=0.197  Sum_probs=93.5

Q ss_pred             eccccccCceEEEEEEEccCCCEEEEEEcccCChhh-------------------H-----HHHHHHHHHHHhcC--CCC
Q psy12427        113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE-------------------K-----ELIRKEIDIMNQLH--HPK  166 (356)
Q Consensus       113 ~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~-------------------~-----~~~~~E~~il~~l~--hpn  166 (356)
                      ...|+.|.-+.||+|.. .++..+|+|+++.....-                   +     ....+|..-|.++.  +-.
T Consensus        53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            34788999999999876 457899999986532211                   1     12345777787774  345


Q ss_pred             ceeeeeeEEeCCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEe
Q psy12427        167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE-KNIIHLDVKPENIMCQ  245 (356)
Q Consensus       167 Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~Dlkp~NIlv~  245 (356)
                      +.+.+++.    ...+||||+... .     .....+.+..........+..++++.+.-|-. .++||+||+.=|||+.
T Consensus       132 vP~Pi~~~----~nVLvMEfIg~~-g-----~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~  201 (268)
T COG1718         132 VPEPIAFR----NNVLVMEFIGDD-G-----LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH  201 (268)
T ss_pred             CCCceeec----CCeEEEEeccCC-C-----CCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE
Confidence            55666654    347999999543 1     11223333332222334477788888887776 8999999999999997


Q ss_pred             ecCCCcEEEEeeeceeeeC
Q psy12427        246 TRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       246 ~~~~~~vkl~Dfg~a~~~~  264 (356)
                       ++  .+.++|||-|....
T Consensus       202 -~~--~p~iID~~QaV~~~  217 (268)
T COG1718         202 -DG--EPYIIDVSQAVTID  217 (268)
T ss_pred             -CC--eEEEEECccccccC
Confidence             33  69999999886654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.58  E-value=4e-07  Score=79.40  Aligned_cols=72  Identities=22%  Similarity=0.328  Sum_probs=54.8

Q ss_pred             ccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCC--ceeeeeeEEeCCeEEEEEEeccccc
Q psy12427        114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPK--LINLHDAFEDDDEMVLIFEFLSGGE  191 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~~~~~~~~~~lv~e~~~~g~  191 (356)
                      ..||.|..+.||+.    .+..+++|......  ....+.+|.++++.+..-.  +.+.+++....+...+|||+++|..
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            57899999999984    25567888876533  3455788999999986433  4677887777777889999999863

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.48  E-value=1.2e-06  Score=71.70  Aligned_cols=129  Identities=21%  Similarity=0.208  Sum_probs=93.3

Q ss_pred             eeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCce-eeeeeEEeCCeEEEEEEecc
Q psy12427        110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLI-NLHDAFEDDDEMVLIFEFLS  188 (356)
Q Consensus       110 y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv-~l~~~~~~~~~~~lv~e~~~  188 (356)
                      ..+.+.|++|.+|.||+|.+.  |..+|+|+-..++  .+..+..|+++|..+.-.++- +++.+-.    .++.|||+.
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~   95 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYID   95 (201)
T ss_pred             hhhhhhhhcccccEEEEeecc--CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhc
Confidence            356789999999999999998  6799999875544  367888999999999876654 4555432    245699999


Q ss_pred             ccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCC-CC-CEEEeecCCCcEEEEeeeceee
Q psy12427        189 GGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVK-PE-NIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       189 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlk-p~-NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      |-.|.+.-....             +.-+..++++---|-..||-|..|. |. ||++ .++  .+.|+||..|+.
T Consensus        96 G~~L~~~~~~~~-------------rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv-~~~--~~~iIDFd~At~  155 (201)
T COG2112          96 GRPLGKLEIGGD-------------RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLV-NDR--DVYIIDFDSATF  155 (201)
T ss_pred             Ccchhhhhhccc-------------HHHHHHHHHHHHHHHHhccchhhhcCCceeEEe-cCC--cEEEEEccchhh
Confidence            888865543210             1134566666556778899999997 44 6665 332  699999999874

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.47  E-value=3e-06  Score=74.85  Aligned_cols=74  Identities=16%  Similarity=0.126  Sum_probs=52.9

Q ss_pred             ccccCc-eEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCeEEEEEEeccccchh
Q psy12427        116 IGTGAF-GVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLH-HPKLINLHDAFEDDDEMVLIFEFLSGGELF  193 (356)
Q Consensus       116 lg~G~f-g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~  193 (356)
                      |..|.+ ..||++...  +..+.+|+.....   ...+.+|+.+++.+. +--+.+++++....+..++|||+++|.+|.
T Consensus         6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             cCCCCCcCeEEEEcCC--CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            444544 889998654  4678888875443   335667999998884 444667788777767789999999987765


Q ss_pred             h
Q psy12427        194 E  194 (356)
Q Consensus       194 ~  194 (356)
                      .
T Consensus        81 ~   81 (244)
T cd05150          81 A   81 (244)
T ss_pred             H
Confidence            3

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02876 acyl-CoA dehydrogenase

Probab=98.41  E-value=4.4e-06  Score=86.49  Aligned_cols=80  Identities=15%  Similarity=0.255  Sum_probs=58.1

Q ss_pred             eccccccCceEEEEEEEccCC--CEEEEEEcccCC-hhhHHHHHHHHHHHHhcC-CCCc--eeeeeeEEeC---CeEEEE
Q psy12427        113 LEEIGTGAFGVVHRCRERKTG--NIFAAKFIPVSH-NLEKELIRKEIDIMNQLH-HPKL--INLHDAFEDD---DEMVLI  183 (356)
Q Consensus       113 ~~~lg~G~fg~V~~~~~~~~~--~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~-hpnI--v~l~~~~~~~---~~~~lv  183 (356)
                      .+.|+.|.+..+|+......+  ..+++|+..... ......+.+|+.+|+.+. |+++  .+++.++.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            467899999999998765432  467777765432 223457889999999995 6665  7778877654   467899


Q ss_pred             EEeccccch
Q psy12427        184 FEFLSGGEL  192 (356)
Q Consensus       184 ~e~~~~g~L  192 (356)
                      |||++|..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999988643

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.38  E-value=5.4e-06  Score=72.22  Aligned_cols=78  Identities=18%  Similarity=0.217  Sum_probs=56.7

Q ss_pred             eccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCC--CceeeeeeEE---eCCeEEEEEEec
Q psy12427        113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHP--KLINLHDAFE---DDDEMVLIFEFL  187 (356)
Q Consensus       113 ~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hp--nIv~l~~~~~---~~~~~~lv~e~~  187 (356)
                      ++.|+.|..+.||++....  ..+++|+....  .....+.+|..+++.+...  .+.+++....   .....+++|+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence            3678999999999998775  48999986544  4456777899999988533  3456665432   344579999999


Q ss_pred             cccchhh
Q psy12427        188 SGGELFE  194 (356)
Q Consensus       188 ~~g~L~~  194 (356)
                      +|..+..
T Consensus        78 ~g~~~~~   84 (239)
T PF01636_consen   78 PGRPLDD   84 (239)
T ss_dssp             SSEEHHH
T ss_pred             ccccccc
Confidence            9987766

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.36  E-value=1.5e-05  Score=67.78  Aligned_cols=129  Identities=18%  Similarity=0.241  Sum_probs=90.6

Q ss_pred             ccccccCceEEEEEEEccCCCEEEEEEcccCC----------------hhhHHHHHHHHHHHHhcC------CCCceeee
Q psy12427        114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH----------------NLEKELIRKEIDIMNQLH------HPKLINLH  171 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~----------------~~~~~~~~~E~~il~~l~------hpnIv~l~  171 (356)
                      ..||.|+.=.||.  +. .....+||+.....                .....+..+|+.....+.      +.+|.+++
T Consensus         7 ~~i~~G~~R~cy~--HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQ--HP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEE--CC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            5799999999996  33 23456788887655                112345566776666665      78899999


Q ss_pred             eeEEeCCeEEEEEEecccc------chhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEe
Q psy12427        172 DAFEDDDEMVLIFEFLSGG------ELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQ  245 (356)
Q Consensus       172 ~~~~~~~~~~lv~e~~~~g------~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~  245 (356)
                      |..+.+..+-+|+|.+.+.      +|.+++....  ++.         .+...+-+-.++|-+.+|+.+||+|.||++.
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~--~~~---------~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG--LTE---------ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQ  152 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC--ccH---------HHHHHHHHHHHHHHHcCCeecCCCcccEEEE
Confidence            9999999999999998542      4556663321  111         1333344445688899999999999999998


Q ss_pred             ecCCC--cEEEEe
Q psy12427        246 TRNST--NVKMID  256 (356)
Q Consensus       246 ~~~~~--~vkl~D  256 (356)
                      ..+++  .+.|+|
T Consensus       153 ~~~~~~~~lvlID  165 (199)
T PF10707_consen  153 RRDSGEFRLVLID  165 (199)
T ss_pred             ecCCCceEEEEEe
Confidence            76654  477887

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.35  E-value=8.2e-06  Score=68.83  Aligned_cols=125  Identities=22%  Similarity=0.337  Sum_probs=88.8

Q ss_pred             cceeeeccccccCc-eEEEEEEEccCCCEEEEEEccc---CCh------------------hhHHHHHHHHHHHHhcC--
Q psy12427        108 DHYDILEEIGTGAF-GVVHRCRERKTGNIFAAKFIPV---SHN------------------LEKELIRKEIDIMNQLH--  163 (356)
Q Consensus       108 ~~y~~~~~lg~G~f-g~V~~~~~~~~~~~~a~K~~~~---~~~------------------~~~~~~~~E~~il~~l~--  163 (356)
                      ..++.++.||.|.. |.||++...  |+.||+|+++.   ...                  .....|..|.....+|+  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            57899999999999 999999876  78999999321   110                  11134667888888775  


Q ss_pred             -CCCc--eeeeeeEEeC------------------CeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHH
Q psy12427        164 -HPKL--INLHDAFEDD------------------DEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSP  222 (356)
Q Consensus       164 -hpnI--v~l~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~  222 (356)
                       +.++  ++++|+..-.                  ....||.||+....          .+.         ..-+.+|.+
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~---------~~~~~~~~~  175 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQ---------IRDIPQMLR  175 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccc---------hhHHHHHHH
Confidence             4566  8999987321                  12356777665422          000         114567888


Q ss_pred             HHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeece
Q psy12427        223 AVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA  260 (356)
Q Consensus       223 ~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a  260 (356)
                      -|..+|..||+-+|+++.|..    +   -||+|||.+
T Consensus       176 dl~~~~k~gI~~~Dv~~~ny~----~---G~lvDfs~~  206 (207)
T PF13095_consen  176 DLKILHKLGIVPRDVKPRNYR----G---GKLVDFSSS  206 (207)
T ss_pred             HHHHHHHCCeeeccCcccccc----C---CEEEecccC
Confidence            889999999999999999976    3   489999964

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.16  E-value=1.4e-05  Score=70.16  Aligned_cols=73  Identities=15%  Similarity=0.162  Sum_probs=46.1

Q ss_pred             ccccccCce-EEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCC---CceeeeeeEEeC---CeEEEEEEe
Q psy12427        114 EEIGTGAFG-VVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHP---KLINLHDAFEDD---DEMVLIFEF  186 (356)
Q Consensus       114 ~~lg~G~fg-~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hp---nIv~l~~~~~~~---~~~~lv~e~  186 (356)
                      +.|+.|+.. .||++     +..+++|+.+...  ....+.+|+.+|..+...   .+..+++.....   ...+++|++
T Consensus         3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           3 EPVDSGGTDNATFRL-----GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             eeccCCCcccceEEc-----CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            457766666 59986     2356778754422  245788899999988532   344455443322   245889999


Q ss_pred             ccccchh
Q psy12427        187 LSGGELF  193 (356)
Q Consensus       187 ~~~g~L~  193 (356)
                      ++|.++.
T Consensus        76 i~G~~l~   82 (235)
T cd05155          76 LEGETAT   82 (235)
T ss_pred             ecCCCCC
Confidence            9987663

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.16  E-value=2.9e-05  Score=68.10  Aligned_cols=74  Identities=18%  Similarity=0.262  Sum_probs=49.0

Q ss_pred             ccccccCceEEEEEEEcc-CCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCC-ceeeeeeEEeCCeEEEEEEeccccc
Q psy12427        114 EEIGTGAFGVVHRCRERK-TGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPK-LINLHDAFEDDDEMVLIFEFLSGGE  191 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~-~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~~~lv~e~~~~g~  191 (356)
                      +.|..|-...+|++.... .+..+++|+....... .....+|+.+++.+...+ .+++++.+. .   .++|||++|.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeCCCc
Confidence            568889999999987553 3568889976543221 123347899999985433 344554433 2   37999999876


Q ss_pred             h
Q psy12427        192 L  192 (356)
Q Consensus       192 L  192 (356)
                      +
T Consensus        79 l   79 (235)
T cd05157          79 L   79 (235)
T ss_pred             C
Confidence            5

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.15  E-value=2.2e-05  Score=69.84  Aligned_cols=138  Identities=17%  Similarity=0.134  Sum_probs=77.5

Q ss_pred             cccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCc-eeeeeeEEeCCeEEEEEEeccccchh
Q psy12427        115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKL-INLHDAFEDDDEMVLIFEFLSGGELF  193 (356)
Q Consensus       115 ~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~lv~e~~~~g~L~  193 (356)
                      .+..|-.+.+|++.  .++..+++|........-.....+|..+++.+....+ .+++....    -.+|+||++|..+.
T Consensus         3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~   76 (256)
T TIGR02721         3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT   76 (256)
T ss_pred             cCCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence            46678888999886  3467888887654322211234679999999864333 34444432    26899999987653


Q ss_pred             hh-----------------hhCCCCCCCcccccc-ccHHHHHHHH---------HHHHHHHHH--------CCceeccCC
Q psy12427        194 ER-----------------ITAPDYKMSEAEVIP-VTLPILMTQT---------SPAVKHMHE--------KNIIHLDVK  238 (356)
Q Consensus       194 ~~-----------------l~~~~~~~~~~~~~~-~~~~~~~~~i---------~~~l~~lH~--------~~ivH~Dlk  238 (356)
                      ..                 ++...  ........ ..+..+..++         ...+..+-.        ..++|+|+.
T Consensus        77 ~~~~~~~~~~~~la~~l~~lH~~~--~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~  154 (256)
T TIGR02721        77 LDQFVALDLLLELAALLHQLHSQP--RFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH  154 (256)
T ss_pred             cccccCchhHHHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence            21                 11111  00100000 0011111111         111222221        248999999


Q ss_pred             CCCEEEeecCCCcEEEEeeeceeee
Q psy12427        239 PENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       239 p~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      |.||+++.++   +.|+||+.|..-
T Consensus       155 ~~Nil~~~~~---~~lIDwE~a~~g  176 (256)
T TIGR02721       155 AYNLVVTPQG---LKLIDWEYASDG  176 (256)
T ss_pred             cCcEEEeCCC---CEEEeccccCcC
Confidence            9999997543   789999988653

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK10593 hypothetical protein; Provisional

Probab=98.01  E-value=7.3e-05  Score=68.06  Aligned_cols=77  Identities=13%  Similarity=0.119  Sum_probs=56.6

Q ss_pred             eeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCC---CCceeeeeeEEe---CCeEEEEEE
Q psy12427        112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHH---PKLINLHDAFED---DDEMVLIFE  185 (356)
Q Consensus       112 ~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~h---pnIv~l~~~~~~---~~~~~lv~e  185 (356)
                      -.+.||.|..+.||+..... + .+.+|+.+.  ......+..|+..|+.+.-   -.+.++++++..   .+..++|||
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE   93 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQ-G-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE   93 (297)
T ss_pred             eeeecCCccceeEEEEEcCC-C-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence            45679999999999986542 3 466777543  1134678899999999853   367788887754   366899999


Q ss_pred             eccccch
Q psy12427        186 FLSGGEL  192 (356)
Q Consensus       186 ~~~~g~L  192 (356)
                      +++|.++
T Consensus        94 ~i~G~~~  100 (297)
T PRK10593         94 RLRGVSV  100 (297)
T ss_pred             ccCCEec
Confidence            9998765

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.99  E-value=5.5e-05  Score=68.79  Aligned_cols=143  Identities=14%  Similarity=0.150  Sum_probs=83.3

Q ss_pred             eccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCC--Cceeeeee------EEeCCeEEEEE
Q psy12427        113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHP--KLINLHDA------FEDDDEMVLIF  184 (356)
Q Consensus       113 ~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hp--nIv~l~~~------~~~~~~~~lv~  184 (356)
                      .+.|..|....+|++...  +..+++|+...   .....+..|+.++..+.+.  .+.+++..      ....+..++++
T Consensus        19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV   93 (296)
T ss_pred             eecccCccccceEEEEeC--CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence            457888888999998643  45788898764   2345566788888888532  24444432      23345678999


Q ss_pred             Eeccccchhh--------------hhhCCCCCCCcc--c-cccccH------------HHHHHHHHHHHHHHHH------
Q psy12427        185 EFLSGGELFE--------------RITAPDYKMSEA--E-VIPVTL------------PILMTQTSPAVKHMHE------  229 (356)
Q Consensus       185 e~~~~g~L~~--------------~l~~~~~~~~~~--~-~~~~~~------------~~~~~~i~~~l~~lH~------  229 (356)
                      +|++|..+..              .++.....+...  . ......            ......+..++.++.+      
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            9998876522              011100000000  0 000000            0011223334455543      


Q ss_pred             -CCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        230 -KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       230 -~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                       .+++|+|+.|.|||++.++  .+.|+||+.+..
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~--~~~iIDfe~a~~  205 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDE--LSGVIDFYFACT  205 (296)
T ss_pred             CCcCCccCcCcccEEEeCCc--eEEEeehhhhcC
Confidence             4699999999999997532  458999998754

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.90  E-value=0.00031  Score=66.11  Aligned_cols=76  Identities=21%  Similarity=0.238  Sum_probs=53.4

Q ss_pred             ccccccCceEEEEEEEccCCCEEEEEEcccC------C-hhhHHHHHHHHHHHHhcC---CCCceeeeeeEEeCCeEEEE
Q psy12427        114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVS------H-NLEKELIRKEIDIMNQLH---HPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~------~-~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~lv  183 (356)
                      +.||.|.+..||++.....++.+++|.-...      . ....+....|.+.|..+.   -.++++++.+  +....++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            5799999999999998644358999974311      1 123456667888888873   2456677765  34557899


Q ss_pred             EEeccccc
Q psy12427        184 FEFLSGGE  191 (356)
Q Consensus       184 ~e~~~~g~  191 (356)
                      |||+++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998643

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.82  E-value=0.00015  Score=66.12  Aligned_cols=75  Identities=17%  Similarity=0.123  Sum_probs=49.5

Q ss_pred             ccccccCceEEEEEEEcc------CCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCc-eeeeeeEEeCCeEEEEEEe
Q psy12427        114 EEIGTGAFGVVHRCRERK------TGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKL-INLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~------~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~lv~e~  186 (356)
                      +.|..|-...+|++....      ++..+++|+...... ......+|+.++..+...++ .++++.+..    .+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            456777788999887543      257899998655432 22445679999998854333 455655542    358999


Q ss_pred             ccccchh
Q psy12427        187 LSGGELF  193 (356)
Q Consensus       187 ~~~g~L~  193 (356)
                      ++|..+.
T Consensus        79 i~G~~l~   85 (302)
T cd05156          79 IPSRTLT   85 (302)
T ss_pred             eCCCcCC
Confidence            9887663

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.75  E-value=0.00067  Score=62.06  Aligned_cols=145  Identities=14%  Similarity=0.149  Sum_probs=81.4

Q ss_pred             eeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCC--ceeeeeeE------EeCCeEEEE
Q psy12427        112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPK--LINLHDAF------EDDDEMVLI  183 (356)
Q Consensus       112 ~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~~~------~~~~~~~lv  183 (356)
                      .++.++.|....+|++...  +..+++|+......  ...+..|.+++..|...+  +.+++...      ...+..+++
T Consensus        26 ~i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l  101 (307)
T TIGR00938        26 SLKGIAEGVENSNYLLTTD--VGRYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACL  101 (307)
T ss_pred             eccccCCccccceEEEEeC--CCcEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEE
Confidence            3567888888999998643  34677887654321  334556778887774222  34444321      234567899


Q ss_pred             EEeccccchhh--------------hhhCCCCCCCcccc----ccc-------------cH-HHHHHHHHHHHHHHHH--
Q psy12427        184 FEFLSGGELFE--------------RITAPDYKMSEAEV----IPV-------------TL-PILMTQTSPAVKHMHE--  229 (356)
Q Consensus       184 ~e~~~~g~L~~--------------~l~~~~~~~~~~~~----~~~-------------~~-~~~~~~i~~~l~~lH~--  229 (356)
                      ++|++|..+..              .++.....+.....    ...             .+ ......+...++++..  
T Consensus       102 ~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~  181 (307)
T TIGR00938       102 VEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFW  181 (307)
T ss_pred             EEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhh
Confidence            99998854321              11111111100000    000             00 0011223344555542  


Q ss_pred             -----CCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        230 -----KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       230 -----~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                           .+++|+|+.+.||+++.++  .+.|+||+.+..
T Consensus       182 ~~~~~~~l~HgD~~~~Nvl~~~~~--~~~vIDfd~~~~  217 (307)
T TIGR00938       182 PRDLPRGVIHADLFPDNVLFDGDS--VKGVIDFYFACT  217 (307)
T ss_pred             hhcCCCccCCCCCCcCcEEEECCc--eEEEeecccccC
Confidence                 5899999999999997643  468999998743

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2268|consensus

Probab=97.67  E-value=8.4e-05  Score=66.74  Aligned_cols=134  Identities=18%  Similarity=0.245  Sum_probs=92.7

Q ss_pred             eeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh----------------------hHHHHHHHHHHHHhcC-CC-
Q psy12427        110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL----------------------EKELIRKEIDIMNQLH-HP-  165 (356)
Q Consensus       110 y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~----------------------~~~~~~~E~~il~~l~-hp-  165 (356)
                      +.+.+.||-|.-+.+|.+-+. .|++.++|+-+.....                      .+-...+|...|+.|. |. 
T Consensus        94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            678899999999999999775 4888999865331100                      1112346888888884 32 


Q ss_pred             CceeeeeeEEeCCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEe
Q psy12427        166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQ  245 (356)
Q Consensus       166 nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~  245 (356)
                      -+.+.+++    +.-++|||++.|-.|.+.-.     .....       .+...++.-+--|-..|+||+|..-=||++.
T Consensus       173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~-----v~d~~-------~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~  236 (465)
T KOG2268|consen  173 PVPKPIDH----NRHCVVMELVDGYPLRQVRH-----VEDPP-------TLYDDLMGLIVRLANHGLIHGDFNEFNIMVK  236 (465)
T ss_pred             CCCCcccc----cceeeHHHhhcccceeeeee-----cCChH-------HHHHHHHHHHHHHHHcCceecccchheeEEe
Confidence            35555554    45689999998877754321     11111       1455555666678889999999999999998


Q ss_pred             ecCCCcEEEEeeeceee
Q psy12427        246 TRNSTNVKMIDFGLATK  262 (356)
Q Consensus       246 ~~~~~~vkl~Dfg~a~~  262 (356)
                      .++  .++++||--+-.
T Consensus       237 dd~--~i~vIDFPQmvS  251 (465)
T KOG2268|consen  237 DDD--KIVVIDFPQMVS  251 (465)
T ss_pred             cCC--CEEEeechHhhc
Confidence            544  799999975543

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.65  E-value=0.00023  Score=60.16  Aligned_cols=101  Identities=14%  Similarity=0.121  Sum_probs=73.5

Q ss_pred             HHHHHHHhcCC-CCceeeeeeEEeCCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHH---
Q psy12427        154 KEIDIMNQLHH-PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE---  229 (356)
Q Consensus       154 ~E~~il~~l~h-pnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---  229 (356)
                      +|.-+|..+++ +++++++|+|-.    +++.||...+++.....   .........+..+..++.++++.+.+|+.   
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~---~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~   80 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYR---PLSQFLQSPWEQRAKIALQLLELLEELDHGPL   80 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccc---ccccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence            58888999976 699999999832    67889998776643200   00011122334455699999999999997   


Q ss_pred             CCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        230 KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       230 ~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      ..+.-.|++|+|+-++.++  ++|++|.+.....
T Consensus        81 ~~~~lcDv~~~nfgv~~~~--~lk~iDld~v~~~  112 (188)
T PF12260_consen   81 GFFYLCDVSPDNFGVNDDG--RLKLIDLDDVFVE  112 (188)
T ss_pred             CcEEEeecchHHeEEeCCC--cEEEEechhcchh
Confidence            4588999999999998554  7999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PLN02236 choline kinase

Probab=97.63  E-value=0.00081  Score=62.54  Aligned_cols=144  Identities=15%  Similarity=0.120  Sum_probs=80.7

Q ss_pred             ccccccCceEEEEEEEcc----CCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCce-eeeeeEEeCCeEEEEEEecc
Q psy12427        114 EEIGTGAFGVVHRCRERK----TGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLI-NLHDAFEDDDEMVLIFEFLS  188 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~----~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv-~l~~~~~~~~~~~lv~e~~~  188 (356)
                      +.|..|-...+|++....    .++.+++|+......... +-.+|..+++.+..-++. ++++.+..+    .|.+|++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~  116 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH  116 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence            356668888999987532    246888998755432211 225699999988644443 556665433    5799998


Q ss_pred             ccchhhh-----------------hhCCCCCCCccccccccHHHHHHH-----------------HHHHHHHH----H--
Q psy12427        189 GGELFER-----------------ITAPDYKMSEAEVIPVTLPILMTQ-----------------TSPAVKHM----H--  228 (356)
Q Consensus       189 ~g~L~~~-----------------l~~~~~~~~~~~~~~~~~~~~~~~-----------------i~~~l~~l----H--  228 (356)
                      +.+|...                 ++...............+..++.+                 +...+..|    .  
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            7665311                 111111111000001111122211                 11111122    1  


Q ss_pred             --HCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        229 --EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       229 --~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                        ...++|+|+++.|||++.++ ..+.++||..|..-
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~-~~~~lID~Eya~~~  232 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEET-RAITIIDYEYASYN  232 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCC-CcEEEEeehhcccc
Confidence              22589999999999997533 36999999988653

>PRK05231 homoserine kinase; Provisional

Probab=97.56  E-value=0.0019  Score=59.41  Aligned_cols=75  Identities=16%  Similarity=0.069  Sum_probs=46.1

Q ss_pred             eccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCC--ceeeee------eEEeCCeEEEEE
Q psy12427        113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPK--LINLHD------AFEDDDEMVLIF  184 (356)
Q Consensus       113 ~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~------~~~~~~~~~lv~  184 (356)
                      .+.|+.|....+|++...  +..+++|++. .  .....+..|+.++..|...+  +.+++.      +....+..++++
T Consensus        27 ~~~l~~G~~n~~y~v~t~--~g~~vLK~~~-~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~  101 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTT--QGEYVLTLFE-R--LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIV  101 (319)
T ss_pred             cchhccccccceEEEEeC--CCcEEEEEec-c--CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEE
Confidence            356778888899998754  3368889875 2  12334445666666663211  333332      123356678999


Q ss_pred             Eeccccch
Q psy12427        185 EFLSGGEL  192 (356)
Q Consensus       185 e~~~~g~L  192 (356)
                      +|++|..+
T Consensus       102 ~~l~G~~~  109 (319)
T PRK05231        102 TFLEGKWP  109 (319)
T ss_pred             EecCCCCC
Confidence            99988743

>PF00041 fn3: Fibronectin type III domain; InterPro: IPR003961 Fibronectins are multi-domain glycoproteins found in a soluble form in plasma, and in an insoluble form in loose connective tissue and basement membranes []

Probab=97.54  E-value=5.2e-05  Score=54.73  Aligned_cols=33  Identities=52%  Similarity=0.733  Sum_probs=28.7

Q ss_pred             eeecceeeecCccCceEEEEEEEEecCCCCCCC
Q psy12427         10 TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPS   42 (356)
Q Consensus        10 ~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s   42 (356)
                      ...+++++++|.|++.|.|||+|.|..|.|.+|
T Consensus        53 ~~~~~~~i~~L~p~t~Y~~~v~a~~~~g~g~~S   85 (85)
T PF00041_consen   53 GNETSYTITGLQPGTTYEFRVRAVNSDGEGPPS   85 (85)
T ss_dssp             TTSSEEEEESCCTTSEEEEEEEEEETTEEEEEE
T ss_pred             eeeeeeeeccCCCCCEEEEEEEEEeCCcCcCCC
Confidence            334589999999999999999999999987764

They contain multiple copies of 3 repeat regions (types I, II and III), which bind to a variety of substances including heparin, collagen, DNA, actin, fibrin and fibronectin receptors on cell surfaces. The wide variety of these substances means that fibronectins are involved in a number of important functions: e.g., wound healing; cell adhesion; blood coagulation; cell differentiation and migration; maintenance of the cellular cytoskeleton; and tumour metastasis []. The role of fibronectin in cell differentiation is demonstrated by the marked reduction in the expression of its gene when neoplastic transformation occurs. Cell attachment has been found to be mediated by the binding of the tetrapeptide RGDS to integrins on the cell surface [], although related sequences can also display cell adhesion activity. Plasma fibronectin occurs as a dimer of 2 different subunits, linked together by 2 disulphide bonds near the C terminus. The difference in the 2 chains occurs in the type III repeat region and is caused by alternative splicing of the mRNA from one gene []. The observation that, in a given protein, an individual repeat of one of the 3 types (e.g., the first FnIII repeat) shows much less similarity to its subsequent tandem repeats within that protein than to its equivalent repeat between fibronectins from other species, has suggested that the repeating structure of fibronectin arose at an early stage of evolution. It also seems to suggest that the structure is subject to high selective pressure []. The fibronectin type III repeat region is an approximately 100 amino acid domain, different tandem repeats of which contain binding sites for DNA, heparin and the cell surface []. The superfamily of sequences believed to contain FnIII repeats represents 45 different families, the majority of which are involved in cell surface binding in some manner, or are receptor protein tyrosine kinases, or cytokine receptors.; GO: 0005515 protein binding; PDB: 1UEM_A 1TDQ_A 1X5I_A 2IC2_B 2IBG_C 2IBB_A 3R8Q_A 2FNB_A 1FNH_A 2EDB_A ....

>KOG1826|consensus

Probab=97.53  E-value=5.2e-06  Score=86.99  Aligned_cols=161  Identities=15%  Similarity=0.029  Sum_probs=115.8

Q ss_pred             HHHHHHHHHHHHhcCCCCceeeeeeEE--eCCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHH-HHHHH
Q psy12427        149 KELIRKEIDIMNQLHHPKLINLHDAFE--DDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT-SPAVK  225 (356)
Q Consensus       149 ~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i-~~~l~  225 (356)
                      ++....|.+.++...|+++.....-..  .....+..++++.+|.+++.+.......+.....   ......++ ..+..
T Consensus      1273 kemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~---~v~~~~kvsvl~~~ 1349 (2724)
T KOG1826|consen 1273 KEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRS---PVHLRHKVSVLNRN 1349 (2724)
T ss_pred             HHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhc---hHHHHHHHHHhccc
Confidence            445556777777788998887765443  2345578899999999999997654332222211   12233333 56666


Q ss_pred             HHHHCC-----ceeccCCCCCEEEeecCCCcEEEEeeeceeee-CCCCceeecCCCcCccccccccCCCCCccccHHHHH
Q psy12427        226 HMHEKN-----IIHLDVKPENIMCQTRNSTNVKMIDFGLATKL-DPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVG  299 (356)
Q Consensus       226 ~lH~~~-----ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG  299 (356)
                      -+|+..     .+|++||+-|.+++.+-  .+|+.++|+.+.. +.........+++.|++|++...-.++.++|+|+.|
T Consensus      1350 ~~ls~tnlg~T~v~~~Lkf~lpmIVtny--~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s 1427 (2724)
T KOG1826|consen 1350 VILSLTNLGNTNVSKSLKFTLPMIVTNY--NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRS 1427 (2724)
T ss_pred             hhhhcccCCccchhhhhhhhccceecCC--cccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHH
Confidence            667542     79999999999998654  6999999999833 333334455678899999999888888889999999


Q ss_pred             HHHHHHHcCCCCCCC
Q psy12427        300 VLAYVLLSGLSPFAG  314 (356)
Q Consensus       300 ~il~ell~g~~Pf~~  314 (356)
                      +-+|+..-|..||-.
T Consensus      1428 ~~ly~rs~~n~~fi~ 1442 (2724)
T KOG1826|consen 1428 LSLYLRSDGNAYFIF 1442 (2724)
T ss_pred             HHHHHHhcccHHHHH
Confidence            999999888888743

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.42  E-value=0.0011  Score=61.31  Aligned_cols=74  Identities=14%  Similarity=0.238  Sum_probs=46.7

Q ss_pred             ccccccCceEEEEEEEccC---CCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCc-eeeeeeEEeCCeEEEEEEeccc
Q psy12427        114 EEIGTGAFGVVHRCRERKT---GNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKL-INLHDAFEDDDEMVLIFEFLSG  189 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~---~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~lv~e~~~~  189 (356)
                      +.|..|-...+|++.....   +..|++|+....... .-+-.+|..+++.+..-++ .++++++.. +   +|.+|++|
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~-G---~i~~fi~g   94 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFGN-G---MIQSFINA   94 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeCC-c---EeehhhcC
Confidence            4555588888999875432   347888877543321 1222468999999865555 355665532 2   48899977


Q ss_pred             cch
Q psy12427        190 GEL  192 (356)
Q Consensus       190 g~L  192 (356)
                      ..|
T Consensus        95 ~~l   97 (330)
T PLN02421         95 RTL   97 (330)
T ss_pred             CCC
Confidence            655

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.33  E-value=0.0032  Score=56.64  Aligned_cols=32  Identities=22%  Similarity=0.318  Sum_probs=25.1

Q ss_pred             CceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        231 NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       231 ~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      .++|+|++|.|||++.++ ...-|+||+.+..-
T Consensus       186 ~lvHGD~~~~Nilv~~~~-~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDEDA-RVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCCC-CEEEEECcHhcccC
Confidence            389999999999997532 23579999988653

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG2270|consensus

Probab=97.28  E-value=0.0036  Score=57.44  Aligned_cols=142  Identities=20%  Similarity=0.280  Sum_probs=90.9

Q ss_pred             eeeccccccCceEEEEEEEccCCCEEEEEEcccC----------------------ChhhH----HHHHHHHHHHHhcCC
Q psy12427        111 DILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS----------------------HNLEK----ELIRKEIDIMNQLHH  164 (356)
Q Consensus       111 ~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~----------------------~~~~~----~~~~~E~~il~~l~h  164 (356)
                      .+-..|..|.-+-||.|... +|..+|||+++.+                      ....+    .....|+.-|.++..
T Consensus       147 ~inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~  225 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN  225 (520)
T ss_pred             ecccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence            45678999999999998654 5888999988531                      01111    234467888888876


Q ss_pred             CCceeeeeeEEeCCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHH-HHCCceeccCCCCCEE
Q psy12427        165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM-HEKNIIHLDVKPENIM  243 (356)
Q Consensus       165 pnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l-H~~~ivH~Dlkp~NIl  243 (356)
                      -.|....-...  ..-+|||+|+.+... -     .+.+....+....+..+-.+++.-|.-| |..++||.||.-=|+|
T Consensus       226 aGIP~PePIlL--k~hVLVM~FlGrdgw-~-----aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~L  297 (520)
T KOG2270|consen  226 AGIPCPEPILL--KNHVLVMEFLGRDGW-A-----APKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLL  297 (520)
T ss_pred             cCCCCCCceee--ecceEeeeeccCCCC-c-----CcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhhe
Confidence            55443322222  233799999953221 1     1122233333333444666777777765 4679999999999999


Q ss_pred             EeecCCCcEEEEeeeceeeeC
Q psy12427        244 CQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       244 v~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      +..   +.+.++|-+-|...+
T Consensus       298 yhd---G~lyiIDVSQSVE~D  315 (520)
T KOG2270|consen  298 YHD---GKLYIIDVSQSVEHD  315 (520)
T ss_pred             EEC---CEEEEEEccccccCC
Confidence            953   379999998776543

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.24  E-value=0.0079  Score=54.98  Aligned_cols=30  Identities=33%  Similarity=0.476  Sum_probs=25.0

Q ss_pred             CCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        230 KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       230 ~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      .+++|+|+.+.||+++. +  .+.|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~-~--~i~lIDfd~~~~  216 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-N--EVYVIDFDYCTI  216 (313)
T ss_pred             CceEcCCCCcccEEEeC-C--cEEEEECccccc
Confidence            47899999999999975 2  589999997643

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.17  E-value=0.0054  Score=55.36  Aligned_cols=75  Identities=20%  Similarity=0.290  Sum_probs=49.2

Q ss_pred             eeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcC---CCCceeeeeeEEeCCeEEEEEEec
Q psy12427        111 DILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLH---HPKLINLHDAFEDDDEMVLIFEFL  187 (356)
Q Consensus       111 ~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~lv~e~~  187 (356)
                      +-.+.++.|....+|+..  .++..+.+|+-.   ......+..|++-|+.|.   --.+++++++....+..+++|||+
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l   94 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL   94 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence            345678999999999977  567889999865   233457788999999884   345778888888777789999999


Q ss_pred             ccc
Q psy12427        188 SGG  190 (356)
Q Consensus       188 ~~g  190 (356)
                      +.+
T Consensus        95 ~~~   97 (288)
T PF03881_consen   95 EMG   97 (288)
T ss_dssp             ---
T ss_pred             cCC
Confidence            876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.08  E-value=0.012  Score=53.65  Aligned_cols=150  Identities=16%  Similarity=0.207  Sum_probs=84.0

Q ss_pred             eeeccccccCceEEEEEEEccCCCEEEEEEccc--CChhhHHHHHHHHHHHHhcCC--CCceeeeeeEEeCC--eEEEEE
Q psy12427        111 DILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV--SHNLEKELIRKEIDIMNQLHH--PKLINLHDAFEDDD--EMVLIF  184 (356)
Q Consensus       111 ~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~--~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~~--~~~lv~  184 (356)
                      .+.+.+..|-...+|.....  ++.+++. ...  ..........+|..+|+.+.-  .-....++.|..+.  ..+.||
T Consensus        28 ~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~  104 (321)
T COG3173          28 LIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM  104 (321)
T ss_pred             ceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence            34555666666666665554  7778887 332  222334556678999988753  23444566666555  779999


Q ss_pred             Eeccccchhh------------------hhh---CC---CCCCCc--cccccccHHHHHHHH--------------HHHH
Q psy12427        185 EFLSGGELFE------------------RIT---AP---DYKMSE--AEVIPVTLPILMTQT--------------SPAV  224 (356)
Q Consensus       185 e~~~~g~L~~------------------~l~---~~---~~~~~~--~~~~~~~~~~~~~~i--------------~~~l  224 (356)
                      +|++|..+.+                  .|.   .-   ......  .......+..+..+.              ..-.
T Consensus       105 ~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~  184 (321)
T COG3173         105 EWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLI  184 (321)
T ss_pred             EEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHH
Confidence            9998843211                  110   00   000000  000111112222222              1223


Q ss_pred             HHHHHC--------CceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        225 KHMHEK--------NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       225 ~~lH~~--------~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      .+++..        .++|+|+.+.||+++.++  -+-++||+++..-++
T Consensus       185 ~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~--~~gVlDwe~~~lGDP  231 (321)
T COG3173         185 KWLEANRPPWAGPPVLVHGDYRPGNLIIDPGR--PTGVLDWELATLGDP  231 (321)
T ss_pred             HHHHhcCCCcCCCceeeeCCcccCCEEEeCCC--eeEEEeccccccCCc
Confidence            345433        389999999999998655  389999999876544

>KOG3513|consensus

Probab=97.08  E-value=0.00066  Score=69.61  Aligned_cols=52  Identities=33%  Similarity=0.549  Sum_probs=43.2

Q ss_pred             CCceEeee--eee---cceeeecCccCceEEEEEEEEecCCCCCCCCCccceechhh
Q psy12427          2 SSWIRVGN--TRF---TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDT   53 (356)
Q Consensus         2 ~~w~~~~~--~~~---~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~~~   53 (356)
                      ..|+.+..  ...   ++++|-+|+|-..|.|||.|.|..|.|+||.+|+.....+.
T Consensus       658 ~~W~~v~~vp~~~~~~~sa~vv~L~Pwv~YeFRV~AvN~iG~gePS~pS~~~rT~ea  714 (1051)
T KOG3513|consen  658 GKWKAVTTVPGNITGDESATVVNLSPWVEYEFRVVAVNSIGIGEPSPPSEKVRTPEA  714 (1051)
T ss_pred             CcceEeeECCCcccCccceeEEccCCCcceEEEEEEEcccccCCCCCCccceecCCC
Confidence            46888864  222   37889999999999999999999999999999998766544

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.05  E-value=0.0038  Score=57.74  Aligned_cols=75  Identities=20%  Similarity=0.225  Sum_probs=48.4

Q ss_pred             ccccccCceEEEEEEEccCCCEEEEEEcc----cC--C-hhhHHHHHHHHHHHHhcC--CCC-ceeeeeeEEeCCeEEEE
Q psy12427        114 EEIGTGAFGVVHRCRERKTGNIFAAKFIP----VS--H-NLEKELIRKEIDIMNQLH--HPK-LINLHDAFEDDDEMVLI  183 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~~~~~a~K~~~----~~--~-~~~~~~~~~E~~il~~l~--hpn-Iv~l~~~~~~~~~~~lv  183 (356)
                      ++||.|....||++.....++.++||.-.    ..  + ....+...-|.+.|+...  -|. +++++.  -++....+|
T Consensus         1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~v   78 (370)
T TIGR01767         1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTV   78 (370)
T ss_pred             CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--Eccccceeh
Confidence            36899999999999986434688998542    11  1 223445556888887763  353 444543  344555789


Q ss_pred             EEecccc
Q psy12427        184 FEFLSGG  190 (356)
Q Consensus       184 ~e~~~~g  190 (356)
                      ||+++..
T Consensus        79 MEdL~~~   85 (370)
T TIGR01767        79 MEDLSHH   85 (370)
T ss_pred             HhhCccc
Confidence            9998553

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG4222|consensus

Probab=97.04  E-value=0.00051  Score=70.20  Aligned_cols=50  Identities=46%  Similarity=0.636  Sum_probs=46.0

Q ss_pred             CCceEeee-eeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceech
Q psy12427          2 SSWIRVGN-TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK   51 (356)
Q Consensus         2 ~~w~~~~~-~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~   51 (356)
                      +.|.+++. .+.|+++|.||+|++.|.|-|||+|..|.|.||..|+.....
T Consensus       572 etw~~ta~~v~~t~~~I~gL~P~~sylf~vRa~n~~Gis~Ps~~S~~vrta  622 (1281)
T KOG4222|consen  572 ETWQTTAGRVKTTTYAIRGLKPNLSYLFLVRAENEQGISDPSTSSDPVRTA  622 (1281)
T ss_pred             ccccccccccccceeeecCcCccceeeeeeeccccccccCCcccCCccccC
Confidence            67998884 999999999999999999999999999999999999976654

>cd00063 FN3 Fibronectin type 3 domain; One of three types of internal repeats found in the plasma protein fibronectin

Probab=96.99  E-value=0.0014  Score=47.15  Aligned_cols=44  Identities=45%  Similarity=0.668  Sum_probs=36.1

Q ss_pred             CceEeeee--eecceeeecCccCceEEEEEEEEecCCCCCCCCCcc
Q psy12427          3 SWIRVGNT--RFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSD   46 (356)
Q Consensus         3 ~w~~~~~~--~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~   46 (356)
                      .|..+...  ..+.+.+.+|.|++.|.|+|+|.+..|.|.++....
T Consensus        45 ~~~~~~~~~~~~~~~~i~~l~p~~~Y~~~v~a~~~~~~~~~s~~~~   90 (93)
T cd00063          45 DWKEVEVTPGSETSYTLTGLKPGTEYEFRVRAVNGGGESPPSESVT   90 (93)
T ss_pred             CCEEeeccCCcccEEEEccccCCCEEEEEEEEECCCccCCCccccc
Confidence            56666654  778999999999999999999999888887766443

Its tenth fibronectin type III repeat contains an RGD cell recognition sequence in a flexible loop between 2 strands. Approximately 2% of all animal proteins contain the FN3 repeat; including extracellular and intracellular proteins, membrane spanning cytokine receptors, growth hormone receptors, tyrosine phosphatase receptors, and adhesion molecules. FN3-like domains are also found in bacterial glycosyl hydrolases.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.93  E-value=0.013  Score=53.72  Aligned_cols=30  Identities=13%  Similarity=0.207  Sum_probs=25.7

Q ss_pred             CceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        231 NIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       231 ~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      +++|+|+.++|||++.++  .+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~--~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETR--GGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCC--CEEEEEhhhccc
Confidence            699999999999997554  589999998764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PTZ00384 choline kinase; Provisional

Probab=96.85  E-value=0.0089  Score=56.29  Aligned_cols=76  Identities=14%  Similarity=0.105  Sum_probs=46.0

Q ss_pred             eccccccCceEEEEEEEccC-CC-----EEEEEEcccCChhhHHHHHHHHHHHHhcCCCCc-eeeeeeEEeCCeEEEEEE
Q psy12427        113 LEEIGTGAFGVVHRCRERKT-GN-----IFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKL-INLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       113 ~~~lg~G~fg~V~~~~~~~~-~~-----~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~lv~e  185 (356)
                      .+.|..|-...+|++..... +.     .|.++..... ....-+-.+|+.+++.+...++ .++++.+..    .++.|
T Consensus        55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~-~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e  129 (383)
T PTZ00384         55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY-NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE  129 (383)
T ss_pred             EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCC-CceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence            34566699999999975433 12     2444432111 1111122468999999976555 456666643    58999


Q ss_pred             eccccchh
Q psy12427        186 FLSGGELF  193 (356)
Q Consensus       186 ~~~~g~L~  193 (356)
                      |++|-+|.
T Consensus       130 fIeGr~l~  137 (383)
T PTZ00384        130 WVEGNTMG  137 (383)
T ss_pred             EeccccCC
Confidence            99987763

>KOG1035|consensus

Probab=96.81  E-value=0.0026  Score=65.98  Aligned_cols=152  Identities=18%  Similarity=0.150  Sum_probs=101.1

Q ss_pred             HHHHHHHHHhcCCCCceeeeeeEEeCCeE----EEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHH
Q psy12427        152 IRKEIDIMNQLHHPKLINLHDAFEDDDEM----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM  227 (356)
Q Consensus       152 ~~~E~~il~~l~hpnIv~l~~~~~~~~~~----~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l  227 (356)
                      ..-|...+.+..|+|++.++.+-......    .+..+++..-++...+....      ......++.+..++..||+++
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~------~i~~~~~r~~~~~~~~GL~~~  302 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG------SIPLETLRILHQKLLEGLAYL  302 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc------ccCHHHHHHHHHHHhhhHHHH
Confidence            33477778888999999999876543222    23345666666665554322      233344566888999999999


Q ss_pred             HHCCceeccCCCC---CEEEeecCCCcEEEE--eeeceeeeCCCCceeecCCCcCccccccccCCCCCc--cccHHHHHH
Q psy12427        228 HEKNIIHLDVKPE---NIMCQTRNSTNVKMI--DFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGF--YTDMWAVGV  300 (356)
Q Consensus       228 H~~~ivH~Dlkp~---NIlv~~~~~~~vkl~--Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~sDvwSlG~  300 (356)
                      |+....|.-|...   +-.++  +.+.+.++  ||+.+..+..........-+.-+.+||.........  ..|+|.+|.
T Consensus       303 h~~~l~~v~L~~s~~~~~~~~--~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl  380 (1351)
T KOG1035|consen  303 HSLSLEHVVLSASSSKESTVD--GEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL  380 (1351)
T ss_pred             HHhccceeEEecccccccccC--ccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHH
Confidence            9986665555444   22222  22345555  999888776555544445567788899887776554  479999999


Q ss_pred             HHHHHHcCCCC
Q psy12427        301 LAYVLLSGLSP  311 (356)
Q Consensus       301 il~ell~g~~P  311 (356)
                      ....+..|..+
T Consensus       381 l~~~~~~~~~i  391 (1351)
T KOG1035|consen  381 LLLQLSQGEDI  391 (1351)
T ss_pred             HHhhhhhcCcc
Confidence            99998887554

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.67  E-value=0.025  Score=52.11  Aligned_cols=142  Identities=21%  Similarity=0.333  Sum_probs=80.5

Q ss_pred             cccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCC---CC---ceeeee----eEEeCCeEEEEE
Q psy12427        115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHH---PK---LINLHD----AFEDDDEMVLIF  184 (356)
Q Consensus       115 ~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~h---pn---Iv~l~~----~~~~~~~~~lv~  184 (356)
                      .|.. .-..+|++.... | .+++|+....  .....+..|...|..|.-   +-   +..+=|    ....+...+-++
T Consensus        33 ~l~s-~eN~~f~~~~~~-g-~~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf  107 (331)
T COG2334          33 GLNS-EENSNFRVQTED-G-RYILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF  107 (331)
T ss_pred             cccc-ccCceEEEEecC-C-CeEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence            4444 566788876653 3 3488988765  345667778888888832   11   222212    122223778889


Q ss_pred             Eeccccchhh---------------hhh--CCCCCCCccccc---------c--------ccHHHHHHHHHHHHHHHHH-
Q psy12427        185 EFLSGGELFE---------------RIT--APDYKMSEAEVI---------P--------VTLPILMTQTSPAVKHMHE-  229 (356)
Q Consensus       185 e~~~~g~L~~---------------~l~--~~~~~~~~~~~~---------~--------~~~~~~~~~i~~~l~~lH~-  229 (356)
                      +|++|..+..               .++  ..++.+......         .        ..-.....++...+..+.+ 
T Consensus       108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~  187 (331)
T COG2334         108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR  187 (331)
T ss_pred             EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence            9999887762               111  111111010000         0        0000123344445555443 


Q ss_pred             -------CC--ceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        230 -------KN--IIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       230 -------~~--ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                             .+  +||+|+.|.||+++.++. .+.++|||.|+.
T Consensus       188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~-~~g~iDFdDa~~  228 (331)
T COG2334         188 LPAHLPALGDQIIHGDLHPDNVLFDDDTD-VSGFIDFDDAGY  228 (331)
T ss_pred             chhhCCcccceeeecCCCccceeEcCCCC-eeeEEEcccccc
Confidence                   23  999999999999986653 478999998864

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.60  E-value=0.013  Score=54.87  Aligned_cols=75  Identities=24%  Similarity=0.255  Sum_probs=49.8

Q ss_pred             eccccccCceEEEEEEEccCCCEEEEEEcc----cC-C-hhhHHHHHHHHHHHHhcC--CCC-ceeeeeeEEeCCeEEEE
Q psy12427        113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIP----VS-H-NLEKELIRKEIDIMNQLH--HPK-LINLHDAFEDDDEMVLI  183 (356)
Q Consensus       113 ~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~----~~-~-~~~~~~~~~E~~il~~l~--hpn-Iv~l~~~~~~~~~~~lv  183 (356)
                      .+.||.|.-..||++.+...++.++||.-.    .. + ....+...-|.++|+.+.  -|. +++++.+  ++....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            467999999999999985445678888532    11 1 234455666888888774  354 4445543  44455788


Q ss_pred             EEeccc
Q psy12427        184 FEFLSG  189 (356)
Q Consensus       184 ~e~~~~  189 (356)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            888854

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.53  E-value=0.0076  Score=51.86  Aligned_cols=31  Identities=35%  Similarity=0.560  Sum_probs=19.1

Q ss_pred             CceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        231 NIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       231 ~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      -+.|+||.|.|||++.. +..++|+||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~-~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNK-DGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSS-SSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccC-CCeEEEecHHHHhh
Confidence            48999999999999222 23799999998865

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK06148 hypothetical protein; Provisional

Probab=96.49  E-value=0.032  Score=59.35  Aligned_cols=33  Identities=30%  Similarity=0.539  Sum_probs=26.6

Q ss_pred             CCceeccCCCCCEEEeecCCCcE-EEEeeeceee
Q psy12427        230 KNIIHLDVKPENIMCQTRNSTNV-KMIDFGLATK  262 (356)
Q Consensus       230 ~~ivH~Dlkp~NIlv~~~~~~~v-kl~Dfg~a~~  262 (356)
                      .++||+|+.+.|||++.++..++ -|+|||.+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            47999999999999986643345 4999998754

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.40  E-value=0.032  Score=52.65  Aligned_cols=73  Identities=14%  Similarity=0.131  Sum_probs=49.6

Q ss_pred             eccccccCceEEEEEEEccCCCEEEEEEccc-----CC--hhhHHHHHHHHHHHHhcC---CCCceeeeeeEEeCCeEEE
Q psy12427        113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPV-----SH--NLEKELIRKEIDIMNQLH---HPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       113 ~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~-----~~--~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~l  182 (356)
                      .+.||.|....||++...  +..+++|.-..     ..  ......-..|++.|..+.   ..++.+++.++.+  ..++
T Consensus        37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vl  112 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALI  112 (418)
T ss_pred             EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEE
Confidence            568999999999998874  45688887641     11  012233334677777664   2477888887763  4578


Q ss_pred             EEEeccc
Q psy12427        183 IFEFLSG  189 (356)
Q Consensus       183 v~e~~~~  189 (356)
                      +||++++
T Consensus       113 vME~L~~  119 (418)
T PLN02756        113 GMRYLEP  119 (418)
T ss_pred             EEeecCC
Confidence            8999977

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.05  E-value=0.15  Score=46.95  Aligned_cols=72  Identities=15%  Similarity=0.122  Sum_probs=43.7

Q ss_pred             ccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCC--ceeee---e--eEEeCCeEEEEEEecccc
Q psy12427        118 TGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPK--LINLH---D--AFEDDDEMVLIFEFLSGG  190 (356)
Q Consensus       118 ~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~---~--~~~~~~~~~lv~e~~~~g  190 (356)
                      .+.-..||++... ++..+++|+..... -....+..|.+.+..|....  ++...   |  ....++..+.++++++|.
T Consensus        35 ~s~eN~vy~v~~~-~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~  112 (325)
T PRK11768         35 NSYENRVYQFGDE-DGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGR  112 (325)
T ss_pred             ccccceEEEEecC-CCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCC
Confidence            3455678887643 46679999875332 24566777888888773211  22211   2  223356678899999876


Q ss_pred             c
Q psy12427        191 E  191 (356)
Q Consensus       191 ~  191 (356)
                      .
T Consensus       113 ~  113 (325)
T PRK11768        113 A  113 (325)
T ss_pred             C
Confidence            4

>PTZ00296 choline kinase; Provisional

Probab=96.04  E-value=0.067  Score=51.43  Aligned_cols=76  Identities=13%  Similarity=0.128  Sum_probs=48.6

Q ss_pred             eeccccccCceEEEEEEEccC--------CCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCce-eeeeeEEeCCeEEE
Q psy12427        112 ILEEIGTGAFGVVHRCRERKT--------GNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLI-NLHDAFEDDDEMVL  182 (356)
Q Consensus       112 ~~~~lg~G~fg~V~~~~~~~~--------~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv-~l~~~~~~~~~~~l  182 (356)
                      -.+.|..|-.-.+|++.....        ++.|.+++.-.....- -.-.+|..+++.+..-+|- ++++.+..    ..
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~l-IdR~~E~~v~~~ls~~gi~P~l~~~f~g----g~  183 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDEL-YNPISEFEVYKTMSKYRIAPQLLNTFSG----GR  183 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccce-eCHHHHHHHHHHHHHCCCCCceEEEeCC----CE
Confidence            456778888889999875421        4678888875433221 1234588888888654444 45665532    45


Q ss_pred             EEEeccccch
Q psy12427        183 IFEFLSGGEL  192 (356)
Q Consensus       183 v~e~~~~g~L  192 (356)
                      +.||++|.+|
T Consensus       184 I~efi~g~~l  193 (442)
T PTZ00296        184 IEEWLYGDPL  193 (442)
T ss_pred             EEEeeCCccC
Confidence            7899988644

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	356
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-117
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-116
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-106
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-68
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-60
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		5e-60
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-59
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-56
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-56
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-56
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-56
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-56
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-56
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-56
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-56
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-56
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-56
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		4e-56
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-56
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-56
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-56
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-55
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-55
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-55
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-55
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-55
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		4e-55
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		5e-55
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		5e-42
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-40
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		8e-40
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-39
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-39
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-39
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-39
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-39
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-39
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-39
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-39
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-39
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-39
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-39
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-39
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-39
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		8e-39
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-38
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-38
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-38
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		7e-38
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		8e-38
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-37
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-37
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-37
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-37
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-37
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-37
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		6e-37
3soa_A	444	Full-Length Human Camkii Length = 444		8e-37
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		9e-37
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-36
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-36
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-36
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		5e-36
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		7e-36
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-32
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		5e-32
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		8e-32
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-31
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		5e-31
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		6e-31
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		8e-31
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		8e-31
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		6e-30
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-28
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-27
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-27
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-27
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-27
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-27
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-27
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-27
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-27
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-27
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		9e-27
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-26
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-26
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-26
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-26
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-26
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-26
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-26
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-26
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		6e-26
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		7e-26
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-25
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-25
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-25
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-25
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-25
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-25
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-25
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-25
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-25
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-25
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		5e-25
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		5e-25
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		5e-25
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-24
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-24
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-24
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-24
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-24
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-24
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-24
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-24
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-24
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-24
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-24
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-24
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-24
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-24
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-24
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-24
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-24
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-24
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-24
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-24
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-24
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-24
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-24
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-24
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-24
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-24
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-24
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-24
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		6e-24
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		6e-24
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		6e-24
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		7e-24
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		7e-24
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-24
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-24
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		7e-24
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		7e-24
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		7e-24
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-24
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-24
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-24
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		8e-24
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		8e-24
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		9e-24
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		9e-24
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-24
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		9e-24
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-23
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-23
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-23
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-23
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-23
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-23
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-23
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-23
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-23
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-23
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-23
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-23
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-23
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-23
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-23
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-23
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-23
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-23
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-23
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-23
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-23
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-23
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-23
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-23
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		3e-23
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-23
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		4e-23
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		4e-23
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		5e-23
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		6e-23
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		6e-23
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		7e-23
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		7e-23
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		7e-23
4fie_A	423	Full-Length Human Pak4 Length = 423		7e-23
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		8e-23
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		8e-23
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		8e-23
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		8e-23
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		9e-23
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		9e-23
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		9e-23
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		9e-23
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		9e-23
2oza_A	356	Structure Of P38alpha Complex Length = 356		9e-23
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		9e-23
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		9e-23
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		9e-23
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		9e-23
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-22
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-22
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-22
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-22
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-22
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-22
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-22
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-22
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		3e-22
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-22
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-22
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-22
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-22
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-22
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-22
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		4e-22
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-22
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-22
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-22
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-22
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-22
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-22
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-22
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-22
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-22
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		5e-22
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		5e-22
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		5e-22
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		5e-22
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		5e-22
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		6e-22
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		6e-22
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		6e-22
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		6e-22
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		6e-22
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		8e-22
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		8e-22
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		8e-22
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		8e-22
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		9e-22
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		9e-22
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-21
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-21
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-21
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-21
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-21
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-21
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-21
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-21
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-21
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-21
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-21
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-21
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-21
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-21
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-21
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-21
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-21
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-21
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-21
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-21
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-21
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		3e-21
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-21
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-21
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-21
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-21
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-21
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-21
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-21
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-21
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-21
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-21
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-21
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-21
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		4e-21
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-21
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-21
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-21
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-21
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		4e-21
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		4e-21
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-21
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-21
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-21
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-21
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-21
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-21
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-21
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-21
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-21
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		5e-21
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		5e-21
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		5e-21
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-21
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		5e-21
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-21
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		6e-21
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		6e-21
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		6e-21
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		9e-21
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		9e-21
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-20
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-20
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-20
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-20
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-20
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-20
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		7e-20
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-20
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		8e-20
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		9e-20
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		9e-20
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-19
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-19
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-19
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-19
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-19
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		5e-19
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		6e-19
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		6e-19
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		6e-19
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-18
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-18
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-18
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-18
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-18
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-18
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-18
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-18
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-18
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-18
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-18
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-18
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		6e-18
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		6e-18
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		6e-18
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-18
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		7e-18
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		7e-18
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-18
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		8e-18
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-18
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		9e-18
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-17
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-17
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-17
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-17
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-17
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-17
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-17
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-17
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		5e-17
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-17
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-17
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-17
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-17
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-17
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-17
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-17
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		5e-17
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-17
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		5e-17
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		6e-17
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		6e-17
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		6e-17
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		6e-17
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		6e-17
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		6e-17
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		6e-17
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		6e-17
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		6e-17
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		7e-17
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		7e-17
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		9e-17
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-16
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-16
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-16
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-16
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		4e-16
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		5e-16
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		5e-16
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-16
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-16
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-16
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		6e-16
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		6e-16
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		7e-16
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		8e-16
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-16
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		9e-16
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		9e-16
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-15
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-15
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-15
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-15
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-15
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-15
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-15
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-15
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-15
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-15
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-15
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-15
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-15
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-15
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-15
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-15
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-15
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-15
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-15
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		5e-15
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-15
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		5e-15
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		6e-15
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		6e-15
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		6e-15
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-15
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		7e-15
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		7e-15
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		8e-15
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		8e-15
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		8e-15
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		9e-15
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		9e-15
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		9e-15
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		9e-15
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		9e-15
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		9e-15
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-14
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-14
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-14
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-14
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-14
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		1e-14
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-14
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-14
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-14
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-14
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-14
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-14
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-14
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-14
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-14
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-14
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-14
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-14
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-14
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-14
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-14
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-14
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-14
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-14
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-14
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-14
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-14
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-14
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-14
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-14
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-14
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-14
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-14
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		5e-14
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-14
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		5e-14
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		5e-14
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		6e-14
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		6e-14
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		6e-14
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		6e-14
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		6e-14
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		6e-14
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		6e-14
2oza_B	366	Structure Of P38alpha Complex Length = 366		7e-14
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		7e-14
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		7e-14
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-14
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		8e-14
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		8e-14
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		9e-14
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		9e-14
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		9e-14
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-13
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-13
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-13
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-13
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-13
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-13
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-13
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-13
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-13
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-13
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-13
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-13
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		1e-13
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-13
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-13
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-13
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-13
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-13
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-13
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-13
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-13
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-13
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-13
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-13
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-13
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-13
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-13
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-13
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-13
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-13
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-13
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-13
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-13
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-13
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-13
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-13
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-13
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-13
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-13
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-13
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-13
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-13
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-13
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-13
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-13
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-13
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-13
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-13
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-13
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-13
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-13
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-13
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-13
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-13
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-13
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-13
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-13
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		4e-13
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		5e-13
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-13
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		6e-13
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-13
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		6e-13
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		6e-13
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		7e-13
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		7e-13
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		7e-13
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		7e-13
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		8e-13
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		8e-13
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		8e-13
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-12
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-12
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-12
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-12
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-12
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-12
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-12
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-12
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-12
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-12
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-12
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-12
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-12
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-12
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-12
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-12
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-12
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-12
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-12
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-12
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-12
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-12
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-12
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-12
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-12
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-12
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-12
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-12
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-12
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		5e-12
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-12
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-12
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		5e-12
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		6e-12
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		6e-12
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		6e-12
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		6e-12
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-12
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		6e-12
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		6e-12
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-12
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		6e-12
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-12
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		7e-12
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		7e-12
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		7e-12
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		7e-12
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		7e-12
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		7e-12
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		8e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		8e-12
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		9e-12
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-11
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-11
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-11
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-11
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-11
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-11
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-11
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-11
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-11
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-11
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		2e-11
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-11
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-11
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-11
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-11
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-11
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-11
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-11
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-11
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-11
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-11
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-11
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-11
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-11
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		3e-11
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-11
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-11
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-11
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-11
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		3e-11
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-11
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-11
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-11
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-11
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-11
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-11
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-11
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-11
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-11
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-11
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-11
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-11
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-11
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-11
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-11
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-11
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-11
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-11
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-11
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-11
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-11
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-11
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		4e-11
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		4e-11
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-11
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		4e-11
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-11
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-11
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		4e-11
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		5e-11
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		5e-11
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		5e-11
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		5e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		5e-11
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		5e-11
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		5e-11
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		5e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		5e-11
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		5e-11
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		5e-11
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		5e-11
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		5e-11
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-11
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		5e-11
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		6e-11
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		6e-11
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		6e-11
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		6e-11
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		6e-11
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-11
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		6e-11
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		6e-11
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		6e-11
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-11
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-11
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		7e-11
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		7e-11
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		7e-11
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		7e-11
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		7e-11
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		7e-11
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		7e-11
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		7e-11
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		7e-11
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		7e-11
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		7e-11
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		7e-11
2pl0_A	289	Lck Bound To Imatinib Length = 289		8e-11
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		8e-11
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		8e-11
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		9e-11
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-11
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		9e-11
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		9e-11
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-10
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		1e-10
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-10
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		1e-10
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-10
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		1e-10
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		1e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-10
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-10
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-10
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-10
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		2e-10
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-10
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-10
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-10
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-10
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-10
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-10
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-10
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-10
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		3e-10
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		4e-10
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-10
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-10
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		5e-10
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		5e-10
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		5e-10
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		6e-10
4exu_A	371	Mapk13, Inactive Form Length = 371		6e-10
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-10
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		9e-10
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		9e-10
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		9e-10
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-09
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		1e-09
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-09
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		1e-09
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		1e-09
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		1e-09
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		1e-09
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		1e-09
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		1e-09
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		1e-09
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		1e-09
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		1e-09
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-09
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-09
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-09
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		2e-09
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-09
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-09
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-09
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-09
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-09
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-09
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-09
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		2e-09
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-09
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-09
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-09
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-09
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-09
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-09
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-09
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-09
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		3e-09
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-09
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-09
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-09
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-09
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-09
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-09
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		4e-09
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		4e-09
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		4e-09
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-09
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		5e-09
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		6e-09
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-09
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		7e-09
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		7e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		7e-09
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		7e-09
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		7e-09
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-09
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		7e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		8e-09
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		8e-09
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		8e-09
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		9e-09
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		9e-09
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		9e-09
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		9e-09
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		9e-09
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		9e-09
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-08
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-08
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-08
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-08
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-08
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-08
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-08
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-08
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-08
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-08
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-08
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-08
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-08
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-08
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-08
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-08
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-08
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-08
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-08
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-08
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-08
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-08
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-08
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		2e-08
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-08
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-08
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-08
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-08
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		2e-08
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		2e-08
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-08
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		2e-08
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		2e-08
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		2e-08
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-08
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		2e-08
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		2e-08
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-08
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		3e-08
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		3e-08
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-08
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-08
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-08
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-08
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-08
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		4e-08
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-08
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		4e-08
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-08
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-08
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		4e-08
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-08
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		5e-08
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		5e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		5e-08
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		5e-08
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-08
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		6e-08
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		6e-08
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		6e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		7e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		7e-08
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		7e-08
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		7e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-08
1fvr_A	327	Tie2 Kinase Domain Length = 327		8e-08
4fl3_A	635	Structural And Biophysical Characterization Of The		8e-08
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		9e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-07
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-07
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-07
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-07
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-07
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		1e-07
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-07
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-07
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-07
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		1e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-07
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-07
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-07
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-07
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-07
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-07
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-07
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		2e-07
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-07
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		3e-07
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-07
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-07
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-07
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-07
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-07
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		4e-07
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-07
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-07
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-07
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		6e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		6e-07
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		7e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		8e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		8e-07
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-06
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-06
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-06
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-06
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-06
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-06
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		3e-06
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-06
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-06
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		3e-06
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-06
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-06
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-06
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-06
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		5e-06
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		5e-06
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		5e-06
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		5e-06
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-06
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		5e-06
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		5e-06
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		5e-06
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		5e-06
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		5e-06
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		5e-06
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		7e-06
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		7e-06
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		8e-06
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		8e-06
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		9e-06
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		1e-05
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-05
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-05
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-05
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-05
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-05
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-05
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-05
2csn_A	297	Binary Complex Of Casein Kinase-1 With Cki7 Length		2e-05
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-05
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-05
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-05
1eh4_A	298	Binary Complex Of Casein Kinase-1 From S. Pombe Wit		3e-05
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-05
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		3e-05
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-05
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-05
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-05
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-05
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-05
3gni_B	389	Structure Of Strad And Mo25 Length = 389		5e-05
2nzi_A	305	Crystal Structure Of Domains A168-A170 From Titin L		1e-04
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-04
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-04
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-04
2cmw_A	310	Structure Of Human Casein Kinase 1 Gamma-1 In Compl		2e-04
4hgl_A	330	Crystal Structure Of Ck1g3 With Compound 1 Length =		2e-04
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		3e-04
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-04
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		4e-04
3e7e_A	365	Structure And Substrate Recruitment Of The Human Sp		4e-04
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		5e-04
2c47_A	313	Structure Of Casein Kinase 1 Gamma 2 Length = 313		6e-04
2lav_A	361	Nmr Solution Structure Of Human Vaccinia-Related Ki		8e-04
2kty_A	368	Solution Structure Of Human Vaccinia Related Kinase		8e-04

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  416 bits (1070), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 196/286 (68%), Positives = 238/286 (83%), Gaps = 6/286 (2%)
Query: 69  GKKIRGKAD-EKVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRC 127
           G K+RGK D  K++DYD++  DI+ KYVPQPV++K  SVYD+YDILEE+G+GAFGVVHRC
Sbjct: 11  GSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRC 70
Query: 128 RERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFL 187
            E+ TG +F AKFI   + L+K  ++ EI IMNQLHHPKLINLHDAFED  EMVLI EFL
Sbjct: 71  VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130
Query: 188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTR 247
           SGGELF+RI A DYKMSEAEVI       M Q    +KHMHE +I+HLD+KPENIMC+T+
Sbjct: 131 SGGELFDRIAAEDYKMSEAEVIN-----YMRQACEGLKHMHEHSIVHLDIKPENIMCETK 185
Query: 248 NSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS 307
            +++VK+IDFGLATKL+P+E+VK++T TAEFAAPEIV+REPVGFYTDMWA+GVL YVLLS
Sbjct: 186 KASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS 245
Query: 308 GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLR 353
           GLSPFAGE+D+ETL+NVK CDWEFDE+AF +VS E KDFI+ LL +
Sbjct: 246 GLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQK 291

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  415 bits (1067), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 202/352 (57%), Positives = 251/352 (71%), Gaps = 10/352 (2%)
Query: 2   SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPS-TTSDLITTKDTFKKQIKK 60
            SW     +R+T   I GL  G QYEFR+ AEN +G+S P   T+ ++   D  K+   +
Sbjct: 54  GSWSPCAKSRYTYTTIEGLRAGKQYEFRIIAENKHGQSKPCEPTAPVLIPGDERKR---R 110
Query: 61  RQYDFDETGKKIRGKADEKVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGA 120
           R YD DE GK +RGK     S+YD YVFDI+ +Y PQPV+IK   V DHYDI EE+GTGA
Sbjct: 111 RGYDVDEQGKIVRGKGTVS-SNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGA 169
Query: 121 FGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM 180
           FGVVHR  ER TGN FAAKF+   H  +KE +RKEI  M+ L HP L+NLHDAFEDD+EM
Sbjct: 170 FGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM 229
Query: 181 VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPE 240
           V+I+EF+SGGELFE++     KMSE E +       M Q    + HMHE N +HLD+KPE
Sbjct: 230 VMIYEFMSGGELFEKVADEHNKMSEDEAVE-----YMRQVCKGLCHMHENNYVHLDLKPE 284
Query: 241 NIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGV 300
           NIM  T+ S  +K+IDFGL   LDP + VK++TGTAEFAAPE+ E +PVG+YTDMW+VGV
Sbjct: 285 NIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGV 344
Query: 301 LAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLL 352
           L+Y+LLSGLSPF GEND ETL+NVK+CDW  D+ AF  +SE+GKDFIR+LLL
Sbjct: 345 LSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLL 396

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  381 bits (979), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 180/294 (61%), Positives = 221/294 (75%), Gaps = 6/294 (2%)
Query: 59  KKRQYDFDETGKKIRGKADEKVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGT 118
           ++R YD DE GK +RGK     S+YD YVFDI+ +Y PQPV+IK   V DHYDI EE+GT
Sbjct: 3   RRRGYDVDEQGKIVRGKGTVS-SNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGT 61
Query: 119 GAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDD 178
           GAFGVVHR  ER TGN FAAKF+   H  +KE +RKEI  M+ L HP L+NLHDAFEDD+
Sbjct: 62  GAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 121
Query: 179 EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVK 238
           EMV+I+EF+SGGELFE++     KMSE E +       M Q    + HMHE N +HLD+K
Sbjct: 122 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVE-----YMRQVCKGLCHMHENNYVHLDLK 176
Query: 239 PENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAV 298
           PENIM  T+ S  +K+IDFGL   LDP + VK++TGTAEFAAPE+ E +PVG+YTDMW+V
Sbjct: 177 PENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSV 236
Query: 299 GVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLL 352
           GVL+Y+LLSGLSPF GEND ETL+NVK+CDW  D+ AF  +SE+GKDFIR+LLL
Sbjct: 237 GVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLL 290

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  255 bits (652), Expect = 2e-68,   Method: Compositional matrix adjust.
 Identities = 124/267 (46%), Positives = 175/267 (65%), Gaps = 12/267 (4%)
Query: 96  PQPVD-----IKTSSVYDHYDI--LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE 148
           P P D      K  +V   Y +   E +G G FG VH+C E  TG   AAK I      +
Sbjct: 70  PAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD 129
Query: 149 KELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEV 208
           KE ++ EI +MNQL H  LI L+DAFE  +++VL+ E++ GGELF+RI    Y ++E + 
Sbjct: 130 KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDT 189
Query: 209 IPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEV 268
           I     + M Q    ++HMH+  I+HLD+KPENI+C  R++  +K+IDFGLA +  P E 
Sbjct: 190 I-----LFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK 244
Query: 269 VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACD 328
           +K++ GT EF APE+V  + V F TDMW+VGV+AY+LLSGLSPF G+ND ETL N+ AC 
Sbjct: 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACR 304
Query: 329 WEFDEEAFKNVSEEGKDFIRRLLLRNK 355
           W+ ++E F+++SEE K+FI +LL++ K
Sbjct: 305 WDLEDEEFQDISEEAKEFISKLLIKEK 331

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  229 bits (583), Expect = 2e-60,   Method: Compositional matrix adjust.
 Identities = 118/270 (43%), Positives = 168/270 (62%), Gaps = 20/270 (7%)
Query: 99  VDIKTSSVY------DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI------PVSHN 146
           VD+ T ++Y      DHY++ EE+G+G F +V +CR++ TG  +AAKFI           
Sbjct: 11  VDLGTENLYFQSMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRG 70
Query: 147 LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEA 206
           + +E I +E++I+ ++ HP +I LHD FE+  ++VLI E +SGGELF+   A    ++E 
Sbjct: 71  VSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFD-FLAEKESLTED 129
Query: 207 EVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTN--VKMIDFGLATKLD 264
           E         + Q    V ++H K I H D+KPENIM   +N  N  +K+IDFG+A K++
Sbjct: 130 EATQ-----FLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 184
Query: 265 PNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
                K   GT EF APEIV  EP+G   DMW++GV+ Y+LLSG SPF GE   ETL N+
Sbjct: 185 AGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI 244
Query: 325 KACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
            A +++FDEE F N SE  KDFIRRLL+++
Sbjct: 245 SAVNYDFDEEYFSNTSELAKDFIRRLLVKD 274

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  228 bits (580), Expect = 5e-60,   Method: Compositional matrix adjust.
 Identities = 116/259 (44%), Positives = 163/259 (62%), Gaps = 14/259 (5%)
Query: 104 SSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI------PVSHNLEKELIRKEID 157
           S V DHY++ EE+G+G F +V +CR++ TG  +AAKFI           + +E I +E++
Sbjct: 1   SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 158 IMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM 217
           I+ ++ HP +I LHD FE+  ++VLI E +SGGELF+   A    ++E E         +
Sbjct: 61  ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFD-FLAEKESLTEDEATQ-----FL 114
Query: 218 TQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTN--VKMIDFGLATKLDPNEVVKISTGT 275
            Q    V ++H K I H D+KPENIM   +N  N  +K+IDFG+A K++     K   GT
Sbjct: 115 KQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGT 174
Query: 276 AEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEA 335
            EF APEIV  EP+G   DMW++GV+ Y+LLSG SPF GE   ETL N+ A +++FDEE 
Sbjct: 175 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEY 234
Query: 336 FKNVSEEGKDFIRRLLLRN 354
           F N SE  KDFIRRLL+++
Sbjct: 235 FSNTSELAKDFIRRLLVKD 253

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  226 bits (577), Expect = 1e-59,   Method: Compositional matrix adjust.
 Identities = 115/261 (44%), Positives = 163/261 (62%), Gaps = 14/261 (5%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI------PVSHNLEKELIRKE 155
           +   V DHY++ EE+G+G F +V +CR++ TG  +AAKFI           + +E I +E
Sbjct: 6   RQEDVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIERE 65
Query: 156 IDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI 215
           ++I+ ++ HP +I LHD FE+  ++VLI E +SGGELF+   A    ++E E        
Sbjct: 66  VNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFD-FLAEKESLTEDEATQ----- 119
Query: 216 LMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTN--VKMIDFGLATKLDPNEVVKIST 273
            + Q    V ++H K I H D+KPENIM   +N  N  +K+IDFG+A K++     K   
Sbjct: 120 FLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF 179
Query: 274 GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE 333
           GT EF APEIV  EP+G   DMW++GV+ Y+LLSG SPF GE   ETL N+ A +++FDE
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE 239
Query: 334 EAFKNVSEEGKDFIRRLLLRN 354
           E F N SE  KDFIRRLL+++
Sbjct: 240 EYFSNTSELAKDFIRRLLVKD 260

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  216 bits (549), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 116/260 (44%), Positives = 159/260 (61%), Gaps = 14/260 (5%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN------LEKELIRKE 155
           K   V D YDI EE+G+G F +V +CRE+ TG  +AAKFI    +      + +E I +E
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIERE 65
Query: 156 IDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI 215
           + I+ Q+ HP +I LHD +E+  ++VLI E +SGGELF+   A    +SE E       I
Sbjct: 66  VSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFD-FLAQKESLSEEEATSFIKQI 124
Query: 216 LMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNST--NVKMIDFGLATKLDPNEVVKIST 273
           L       V ++H K I H D+KPENIM   +N    ++K+IDFGLA +++     K   
Sbjct: 125 L-----DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179
Query: 274 GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE 333
           GT EF APEIV  EP+G   DMW++GV+ Y+LLSG SPF G+   ETL N+ A  ++FDE
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDE 239
Query: 334 EAFKNVSEEGKDFIRRLLLR 353
           E F   SE  KDFIR+LL++
Sbjct: 240 EFFSQTSELAKDFIRKLLVK 259

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  215 bits (548), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 112/261 (42%), Positives = 159/261 (60%), Gaps = 14/261 (5%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI------PVSHNLEKELIRKE 155
           +  +V D+YD  EE+G+G F VV +CRE+ TG  +AAKFI           + +E I +E
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 156 IDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI 215
           + I+ ++ HP +I LH+ +E+  +++LI E ++GGELF+   A    ++E E        
Sbjct: 65  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKESLTEEEATE----- 118
Query: 216 LMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN--STNVKMIDFGLATKLDPNEVVKIST 273
            + Q    V ++H   I H D+KPENIM   RN     +K+IDFGLA K+D     K   
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 178
Query: 274 GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE 333
           GT EF APEIV  EP+G   DMW++GV+ Y+LLSG SPF G+   ETL NV A ++EF++
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 238
Query: 334 EAFKNVSEEGKDFIRRLLLRN 354
           E F N S   KDFIRRLL+++
Sbjct: 239 EYFSNTSALAKDFIRRLLVKD 259

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  215 bits (548), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 112/261 (42%), Positives = 159/261 (60%), Gaps = 14/261 (5%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI------PVSHNLEKELIRKE 155
           +  +V D+YD  EE+G+G F VV +CRE+ TG  +AAKFI           + +E I +E
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 156 IDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI 215
           + I+ ++ HP +I LH+ +E+  +++LI E ++GGELF+   A    ++E E        
Sbjct: 65  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKESLTEEEATE----- 118
Query: 216 LMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN--STNVKMIDFGLATKLDPNEVVKIST 273
            + Q    V ++H   I H D+KPENIM   RN     +K+IDFGLA K+D     K   
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 178
Query: 274 GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE 333
           GT EF APEIV  EP+G   DMW++GV+ Y+LLSG SPF G+   ETL NV A ++EF++
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 238
Query: 334 EAFKNVSEEGKDFIRRLLLRN 354
           E F N S   KDFIRRLL+++
Sbjct: 239 EYFSNTSALAKDFIRRLLVKD 259

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  215 bits (548), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 112/261 (42%), Positives = 159/261 (60%), Gaps = 14/261 (5%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI------PVSHNLEKELIRKE 155
           +  +V D+YD  EE+G+G F VV +CRE+ TG  +AAKFI           + +E I +E
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 156 IDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI 215
           + I+ ++ HP +I LH+ +E+  +++LI E ++GGELF+   A    ++E E        
Sbjct: 65  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKESLTEEEATE----- 118
Query: 216 LMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN--STNVKMIDFGLATKLDPNEVVKIST 273
            + Q    V ++H   I H D+KPENIM   RN     +K+IDFGLA K+D     K   
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 178
Query: 274 GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE 333
           GT EF APEIV  EP+G   DMW++GV+ Y+LLSG SPF G+   ETL NV A ++EF++
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 238
Query: 334 EAFKNVSEEGKDFIRRLLLRN 354
           E F N S   KDFIRRLL+++
Sbjct: 239 EYFSNTSALAKDFIRRLLVKD 259

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  215 bits (547), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 112/261 (42%), Positives = 160/261 (61%), Gaps = 14/261 (5%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI------PVSHNLEKELIRKE 155
           +  +V D+YD  EE+G+G F VV +CRE+ TG  +AAKFI           + +E I +E
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 156 IDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI 215
           + I+ ++ HP +I LH+ +E+  +++LI E ++GGELF+ + A    ++E E        
Sbjct: 65  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATE----- 118
Query: 216 LMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN--STNVKMIDFGLATKLDPNEVVKIST 273
            + Q    V ++H   I H D+KPENIM   RN     +K+IDFGLA K+D     K   
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 178
Query: 274 GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE 333
           GT EF APEIV  EP+G   DMW++GV+ Y+LLSG SPF G+   ETL NV A ++EF++
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 238
Query: 334 EAFKNVSEEGKDFIRRLLLRN 354
           E F N S   KDFIRRLL+++
Sbjct: 239 EYFSNTSALAKDFIRRLLVKD 259

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  215 bits (547), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 112/261 (42%), Positives = 160/261 (61%), Gaps = 14/261 (5%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI------PVSHNLEKELIRKE 155
           +  +V D+YD  EE+G+G F VV +CRE+ TG  +AAKFI           + +E I +E
Sbjct: 5   RQENVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 156 IDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI 215
           + I+ ++ HP +I LH+ +E+  +++LI E ++GGELF+ + A    ++E E        
Sbjct: 65  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATE----- 118
Query: 216 LMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN--STNVKMIDFGLATKLDPNEVVKIST 273
            + Q    V ++H   I H D+KPENIM   RN     +K+IDFGLA K+D     K   
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 178
Query: 274 GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE 333
           GT EF APEIV  EP+G   DMW++GV+ Y+LLSG SPF G+   ETL NV A ++EF++
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 238
Query: 334 EAFKNVSEEGKDFIRRLLLRN 354
           E F N S   KDFIRRLL+++
Sbjct: 239 EYFSNTSALAKDFIRRLLVKD 259

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  214 bits (546), Expect = 4e-56,   Method: Compositional matrix adjust.
 Identities = 112/261 (42%), Positives = 160/261 (61%), Gaps = 14/261 (5%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI------PVSHNLEKELIRKE 155
           +  +V D+YD  EE+G+G F VV +CRE+ TG  +AAKFI           + +E I +E
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 156 IDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI 215
           + I+ ++ HP +I LH+ +E+  +++LI E ++GGELF+ + A    ++E E        
Sbjct: 65  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATE----- 118
Query: 216 LMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN--STNVKMIDFGLATKLDPNEVVKIST 273
            + Q    V ++H   I H D+KPENIM   RN     +K+IDFGLA K+D     K   
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 178
Query: 274 GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE 333
           GT EF APEIV  EP+G   DMW++GV+ Y+LLSG SPF G+   ETL NV A ++EF++
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 238
Query: 334 EAFKNVSEEGKDFIRRLLLRN 354
           E F N S   KDFIRRLL+++
Sbjct: 239 EYFSNTSALAKDFIRRLLVKD 259

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  214 bits (546), Expect = 4e-56,   Method: Compositional matrix adjust.
 Identities = 112/261 (42%), Positives = 159/261 (60%), Gaps = 14/261 (5%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI------PVSHNLEKELIRKE 155
           +  +V D+YD  EE+G+G F VV +CRE+ TG  +AAKFI           + +E I +E
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 156 IDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI 215
           + I+ ++ HP +I LH+ +E+  +++LI E ++GGELF+   A    ++E E        
Sbjct: 65  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKESLTEEEATE----- 118
Query: 216 LMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN--STNVKMIDFGLATKLDPNEVVKIST 273
            + Q    V ++H   I H D+KPENIM   RN     +K+IDFGLA K+D     K   
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 178
Query: 274 GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE 333
           GT EF APEIV  EP+G   DMW++GV+ Y+LLSG SPF G+   ETL NV A ++EF++
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 238
Query: 334 EAFKNVSEEGKDFIRRLLLRN 354
           E F N S   KDFIRRLL+++
Sbjct: 239 EYFSNTSALAKDFIRRLLVKD 259

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  214 bits (546), Expect = 4e-56,   Method: Compositional matrix adjust.
 Identities = 112/261 (42%), Positives = 160/261 (61%), Gaps = 14/261 (5%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI------PVSHNLEKELIRKE 155
           +  +V D+YD  EE+G+G F VV +CRE+ TG  +AAKFI           + +E I +E
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 156 IDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI 215
           + I+ ++ HP +I LH+ +E+  +++LI E ++GGELF+ + A    ++E E        
Sbjct: 65  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATE----- 118
Query: 216 LMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN--STNVKMIDFGLATKLDPNEVVKIST 273
            + Q    V ++H   I H D+KPENIM   RN     +K+IDFGLA K+D     K   
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 178
Query: 274 GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE 333
           GT EF APEIV  EP+G   DMW++GV+ Y+LLSG SPF G+   ETL NV A ++EF++
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 238
Query: 334 EAFKNVSEEGKDFIRRLLLRN 354
           E F N S   KDFIRRLL+++
Sbjct: 239 EYFSNTSALAKDFIRRLLVKD 259

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  214 bits (546), Expect = 4e-56,   Method: Compositional matrix adjust.
 Identities = 112/261 (42%), Positives = 160/261 (61%), Gaps = 14/261 (5%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI------PVSHNLEKELIRKE 155
           +  +V D+YD  EE+G+G F VV +CRE+ TG  +AAKFI           + +E I +E
Sbjct: 4   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 63
Query: 156 IDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI 215
           + I+ ++ HP +I LH+ +E+  +++LI E ++GGELF+ + A    ++E E        
Sbjct: 64  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATE----- 117
Query: 216 LMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN--STNVKMIDFGLATKLDPNEVVKIST 273
            + Q    V ++H   I H D+KPENIM   RN     +K+IDFGLA K+D     K   
Sbjct: 118 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 177
Query: 274 GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE 333
           GT EF APEIV  EP+G   DMW++GV+ Y+LLSG SPF G+   ETL NV A ++EF++
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 237
Query: 334 EAFKNVSEEGKDFIRRLLLRN 354
           E F N S   KDFIRRLL+++
Sbjct: 238 EYFSNTSALAKDFIRRLLVKD 258

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score =  214 bits (546), Expect = 4e-56,   Method: Compositional matrix adjust.
 Identities = 99/251 (39%), Positives = 165/251 (65%), Gaps = 6/251 (2%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHP 165
           +Y+ Y I E++G G FG+VHRC E  +   + AKF+ V    ++ L++KEI I+N   H 
Sbjct: 3   LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHR 61
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            +++LH++FE  +E+V+IFEF+SG ++FERI    ++++E E++       + Q   A++
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVS-----YVHQVCEALQ 116
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
            +H  NI H D++PENI+ QTR S+ +K+I+FG A +L P +  ++     E+ APE+ +
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ 176
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD 345
            + V   TDMW++G L YVLLSG++PF  E + + ++N+   ++ FDEEAFK +S E  D
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236
Query: 346 FIRRLLLRNKE 356
           F+ RLL++ ++
Sbjct: 237 FVDRLLVKERK 247

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  214 bits (546), Expect = 4e-56,   Method: Compositional matrix adjust.
 Identities = 112/261 (42%), Positives = 160/261 (61%), Gaps = 14/261 (5%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI------PVSHNLEKELIRKE 155
           +  +V D+YD  EE+G+G F VV +CRE+ TG  +AAKFI           + +E I +E
Sbjct: 5   RQENVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 156 IDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI 215
           + I+ ++ HP +I LH+ +E+  +++LI E ++GGELF+ + A    ++E E        
Sbjct: 65  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATE----- 118
Query: 216 LMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN--STNVKMIDFGLATKLDPNEVVKIST 273
            + Q    V ++H   I H D+KPENIM   RN     +K+IDFGLA K+D     K   
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 178
Query: 274 GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE 333
           GT EF APEIV  EP+G   DMW++GV+ Y+LLSG SPF G+   ETL NV A ++EF++
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 238
Query: 334 EAFKNVSEEGKDFIRRLLLRN 354
           E F N S   KDFIRRLL+++
Sbjct: 239 EYFSNTSALAKDFIRRLLVKD 259

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  214 bits (546), Expect = 4e-56,   Method: Compositional matrix adjust.
 Identities = 112/261 (42%), Positives = 160/261 (61%), Gaps = 14/261 (5%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI------PVSHNLEKELIRKE 155
           +  +V D+YD  EE+G+G F VV +CRE+ TG  +AAKFI           + +E I +E
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 156 IDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI 215
           + I+ ++ HP +I LH+ +E+  +++LI E ++GGELF+ + A    ++E E        
Sbjct: 65  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATE----- 118
Query: 216 LMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN--STNVKMIDFGLATKLDPNEVVKIST 273
            + Q    V ++H   I H D+KPENIM   RN     +K+IDFGLA K+D     K   
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 178
Query: 274 GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE 333
           GT EF APEIV  EP+G   DMW++GV+ Y+LLSG SPF G+   ETL NV A ++EF++
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 238
Query: 334 EAFKNVSEEGKDFIRRLLLRN 354
           E F N S   KDFIRRLL+++
Sbjct: 239 EYFSNTSALAKDFIRRLLVKD 259

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  214 bits (546), Expect = 5e-56,   Method: Compositional matrix adjust.
 Identities = 112/261 (42%), Positives = 160/261 (61%), Gaps = 14/261 (5%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI------PVSHNLEKELIRKE 155
           +  +V D+YD  EE+G+G F VV +CRE+ TG  +AAKFI           + +E I +E
Sbjct: 4   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 63
Query: 156 IDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI 215
           + I+ ++ HP +I LH+ +E+  +++LI E ++GGELF+ + A    ++E E        
Sbjct: 64  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATE----- 117
Query: 216 LMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN--STNVKMIDFGLATKLDPNEVVKIST 273
            + Q    V ++H   I H D+KPENIM   RN     +K+IDFGLA K+D     K   
Sbjct: 118 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 177
Query: 274 GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE 333
           GT EF APEIV  EP+G   DMW++GV+ Y+LLSG SPF G+   ETL NV A ++EF++
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 237
Query: 334 EAFKNVSEEGKDFIRRLLLRN 354
           E F N S   KDFIRRLL+++
Sbjct: 238 EYFSNTSALAKDFIRRLLVKD 258

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  213 bits (543), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 111/261 (42%), Positives = 158/261 (60%), Gaps = 14/261 (5%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI------PVSHNLEKELIRKE 155
           +  +V D+YD  EE+G+G F VV +CRE+ TG  +AAKFI           + +E I +E
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 156 IDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI 215
           + I+ ++ HP +I LH+ +E+  +++LI E ++GGELF+   A    ++E E        
Sbjct: 65  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD-FLAEKESLTEEEATE----- 118
Query: 216 LMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN--STNVKMIDFGLATKLDPNEVVKIST 273
            + Q    V ++H   I H D+KPENIM   RN     +K+IDFGLA K+D     K   
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 178
Query: 274 GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE 333
           GT  F APEIV  EP+G   DMW++GV+ Y+LLSG SPF G+   ETL NV A ++EF++
Sbjct: 179 GTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 238
Query: 334 EAFKNVSEEGKDFIRRLLLRN 354
           E F N S   KDFIRRLL+++
Sbjct: 239 EYFSNTSALAKDFIRRLLVKD 259

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  213 bits (543), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 112/261 (42%), Positives = 160/261 (61%), Gaps = 14/261 (5%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI------PVSHNLEKELIRKE 155
           +  +V D+YD  EE+G+G F VV +CRE+ TG  +AAKFI           + +E I +E
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 156 IDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI 215
           + I+ ++ HP +I LH+ +E+  +++LI E ++GGELF+ + A    ++E E        
Sbjct: 65  VSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFL-AEKESLTEEEATE----- 118
Query: 216 LMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN--STNVKMIDFGLATKLDPNEVVKIST 273
            + Q    V ++H   I H D+KPENIM   RN     +K+IDFGLA K+D     K   
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 178
Query: 274 GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE 333
           GT EF APEIV  EP+G   DMW++GV+ Y+LLSG SPF G+   ETL NV A ++EF++
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 238
Query: 334 EAFKNVSEEGKDFIRRLLLRN 354
           E F N S   KDFIRRLL+++
Sbjct: 239 EYFSNTSALAKDFIRRLLVKD 259

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  213 bits (541), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 114/260 (43%), Positives = 158/260 (60%), Gaps = 14/260 (5%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN------LEKELIRKE 155
           K   V D YDI EE+G+G F +V +CRE+ TG  +AAKFI    +      + +E I +E
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 156 IDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI 215
           + I+ Q+ H  +I LHD +E+  ++VLI E +SGGELF+   A    +SE E        
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFD-FLAQKESLSEEEATS----- 119
Query: 216 LMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNST--NVKMIDFGLATKLDPNEVVKIST 273
            + Q    V ++H K I H D+KPENIM   +N    ++K+IDFGLA +++     K   
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179
Query: 274 GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE 333
           GT EF APEIV  EP+G   DMW++GV+ Y+LLSG SPF G+   ETL N+ A  ++FDE
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDE 239
Query: 334 EAFKNVSEEGKDFIRRLLLR 353
           E F   SE  KDFIR+LL++
Sbjct: 240 EFFSQTSELAKDFIRKLLVK 259

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  213 bits (541), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 114/260 (43%), Positives = 158/260 (60%), Gaps = 14/260 (5%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN------LEKELIRKE 155
           K   V D YDI EE+G+G F +V +CRE+ TG  +AAKFI    +      + +E I +E
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 156 IDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI 215
           + I+ Q+ H  +I LHD +E+  ++VLI E +SGGELF+   A    +SE E        
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFD-FLAQKESLSEEEATS----- 119
Query: 216 LMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNST--NVKMIDFGLATKLDPNEVVKIST 273
            + Q    V ++H K I H D+KPENIM   +N    ++K+IDFGLA +++     K   
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179
Query: 274 GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE 333
           GT EF APEIV  EP+G   DMW++GV+ Y+LLSG SPF G+   ETL N+ A  ++FDE
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDE 239
Query: 334 EAFKNVSEEGKDFIRRLLLR 353
           E F   SE  KDFIR+LL++
Sbjct: 240 EFFSQTSELAKDFIRKLLVK 259

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  211 bits (538), Expect = 3e-55,   Method: Compositional matrix adjust.
 Identities = 113/260 (43%), Positives = 159/260 (61%), Gaps = 14/260 (5%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN------LEKELIRKE 155
           K   V D YDI EE+G+G F +V +CRE+ TG  +AAKFI    +      + +E I +E
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 156 IDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI 215
           + I+ Q+ H  +I LHD +E+  ++VLI E +SGGELF+   A    +SE E        
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFD-FLAQKESLSEEEATS----- 119
Query: 216 LMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNST--NVKMIDFGLATKLDPNEVVKIST 273
            + Q    V ++H K I H D+KPENIM   +N    ++K+IDFGLA +++     K   
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179
Query: 274 GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE 333
           GT EF APEIV  EP+G   DMW++GV+ Y+LLSG SPF G+   ETL N+ +  ++FDE
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDE 239
Query: 334 EAFKNVSEEGKDFIRRLLLR 353
           E F + SE  KDFIR+LL++
Sbjct: 240 EFFSHTSELAKDFIRKLLVK 259

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  211 bits (538), Expect = 4e-55,   Method: Compositional matrix adjust.
 Identities = 113/260 (43%), Positives = 159/260 (61%), Gaps = 14/260 (5%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN------LEKELIRKE 155
           K   V D YDI EE+G+G F +V +CRE+ TG  +AAKFI    +      + +E I +E
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 156 IDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI 215
           + I+ Q+ H  +I LHD +E+  ++VLI E +SGGELF+   A    +SE E        
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFD-FLAQKESLSEEEATS----- 119
Query: 216 LMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNST--NVKMIDFGLATKLDPNEVVKIST 273
            + Q    V ++H K I H D+KPENIM   +N    ++K+IDFGLA +++     K   
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179
Query: 274 GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE 333
           GT EF APEIV  EP+G   DMW++GV+ Y+LLSG SPF G+   ETL N+ +  ++FDE
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDE 239
Query: 334 EAFKNVSEEGKDFIRRLLLR 353
           E F + SE  KDFIR+LL++
Sbjct: 240 EFFSHTSELAKDFIRKLLVK 259

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  211 bits (537), Expect = 5e-55,   Method: Compositional matrix adjust.
 Identities = 113/260 (43%), Positives = 159/260 (61%), Gaps = 14/260 (5%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN------LEKELIRKE 155
           K   V D YDI EE+G+G F +V +CRE+ TG  +AAKFI    +      + +E I +E
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 156 IDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI 215
           + I+ Q+ H  +I LHD +E+  ++VLI E +SGGELF+   A    +SE E        
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFD-FLAQKESLSEEEATS----- 119
Query: 216 LMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNST--NVKMIDFGLATKLDPNEVVKIST 273
            + Q    V ++H K I H D+KPENIM   +N    ++K+IDFGLA +++     K   
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179
Query: 274 GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE 333
           GT EF APEIV  EP+G   DMW++GV+ Y+LLSG SPF G+   ETL N+ +  ++FDE
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDE 239
Query: 334 EAFKNVSEEGKDFIRRLLLR 353
           E F + SE  KDFIR+LL++
Sbjct: 240 EFFSHTSELAKDFIRKLLVK 259

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score =  168 bits (425), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 96/273 (35%), Positives = 164/273 (60%), Gaps = 21/273 (7%)
Query: 99  VDIKTSSVY-------DHYDIL--EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE- 148
           VD+ T ++Y       +++ IL  +E+G G F VV +C  + TG  +AAKF+      + 
Sbjct: 11  VDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD 70
Query: 149 -KELIRKEIDIMNQLHH-PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK--MS 204
            +  I  EI ++      P++INLH+ +E+  E++LI E+ +GGE+F  +  P+    +S
Sbjct: 71  CRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFS-LCLPELAEMVS 129
Query: 205 EAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNST-NVKMIDFGLATKL 263
           E +VI      L+ Q    V ++H+ NI+HLD+KP+NI+  +     ++K++DFG++ K+
Sbjct: 130 ENDVIR-----LIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184
Query: 264 DPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKN 323
                ++   GT E+ APEI+  +P+   TDMW +G++AY+LL+  SPF GE++ ET  N
Sbjct: 185 GHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN 244
Query: 324 VKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE 356
           +   + ++ EE F +VS+   DFI+ LL++N E
Sbjct: 245 ISQVNVDYSEETFSSVSQLATDFIQSLLVKNPE 277

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 91/253 (35%), Positives = 142/253 (56%), Gaps = 12/253 (4%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV-----SHNLEKELIRKEIDIMNQL 162
           D Y++ E IG GAF VV RC  R+TG  FA K + V     S  L  E +++E  I + L
Sbjct: 24  DVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 163 HHPKLINLHDAFEDDDEMVLIFEFLSGGEL-FERITAPDYKMSEAEVIPVTLPILMTQTS 221
            HP ++ L + +  D  + ++FEF+ G +L FE +   D     +E +       M Q  
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY---MRQIL 140
Query: 222 PAVKHMHEKNIIHLDVKPENIMCQTR-NSTNVKMIDFGLATKLDPNEVVKIS-TGTAEFA 279
            A+++ H+ NIIH DVKPEN++  ++ NS  VK+ DFG+A +L  + +V     GT  F 
Sbjct: 141 EALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFM 200
Query: 280 APEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNV 339
           APE+V+REP G   D+W  GV+ ++LLSG  PF G  +    + +    ++ +   + ++
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGKYKMNPRQWSHI 259
Query: 340 SEEGKDFIRRLLL 352
           SE  KD +RR+L+
Sbjct: 260 SESAKDLVRRMLM 272

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  160 bits (406), Expect = 8e-40,   Method: Compositional matrix adjust.
 Identities = 88/256 (34%), Positives = 144/256 (56%), Gaps = 17/256 (6%)
Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP---VSHNLEKELIRKEIDIM 159
           T+   D Y     +G G+FG V  C+++ TG   A K I    V    +KE + +E+ ++
Sbjct: 27  TAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLL 86
Query: 160 NQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQ 219
            QL HP ++ L++ FED     L+ E  +GGELF+ I      +S      V    ++ Q
Sbjct: 87  KQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI------ISRKRFSEVDAARIIRQ 140
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNS-TNVKMIDFGLATKLDPNEVVKISTGTAEF 278
               + +MH+  I+H D+KPEN++ ++++   N+++IDFGL+T  + ++ +K   GTA +
Sbjct: 141 VLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYY 200
Query: 279 AAPEIVEREPVGFY---TDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEA 335
            APE++     G Y    D+W+ GV+ Y+LLSG  PF G N+ + LK V+   + F+   
Sbjct: 201 IAPEVLH----GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQ 256
Query: 336 FKNVSEEGKDFIRRLL 351
           +K VSE  KD IR++L
Sbjct: 257 WKKVSESAKDLIRKML 272

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 88/256 (34%), Positives = 144/256 (56%), Gaps = 17/256 (6%)
Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP---VSHNLEKELIRKEIDIM 159
           T+   D Y     +G G+FG V  C+++ TG   A K I    V    +KE + +E+ ++
Sbjct: 45  TAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLL 104
Query: 160 NQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQ 219
            QL HP ++ L++ FED     L+ E  +GGELF+ I      +S      V    ++ Q
Sbjct: 105 KQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI------ISRKRFSEVDAARIIRQ 158
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNS-TNVKMIDFGLATKLDPNEVVKISTGTAEF 278
               + +MH+  I+H D+KPEN++ ++++   N+++IDFGL+T  + ++ +K   GTA +
Sbjct: 159 VLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYY 218
Query: 279 AAPEIVEREPVGFY---TDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEA 335
            APE++     G Y    D+W+ GV+ Y+LLSG  PF G N+ + LK V+   + F+   
Sbjct: 219 IAPEVLH----GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQ 274
Query: 336 FKNVSEEGKDFIRRLL 351
           +K VSE  KD IR++L
Sbjct: 275 WKKVSESAKDLIRKML 290

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 88/256 (34%), Positives = 144/256 (56%), Gaps = 17/256 (6%)
Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP---VSHNLEKELIRKEIDIM 159
           T+   D Y     +G G+FG V  C+++ TG   A K I    V    +KE + +E+ ++
Sbjct: 21  TAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLL 80
Query: 160 NQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQ 219
            QL HP ++ L++ FED     L+ E  +GGELF+ I      +S      V    ++ Q
Sbjct: 81  KQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI------ISRKRFSEVDAARIIRQ 134
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNS-TNVKMIDFGLATKLDPNEVVKISTGTAEF 278
               + +MH+  I+H D+KPEN++ ++++   N+++IDFGL+T  + ++ +K   GTA +
Sbjct: 135 VLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYY 194
Query: 279 AAPEIVEREPVGFY---TDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEA 335
            APE++     G Y    D+W+ GV+ Y+LLSG  PF G N+ + LK V+   + F+   
Sbjct: 195 IAPEVLH----GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQ 250
Query: 336 FKNVSEEGKDFIRRLL 351
           +K VSE  KD IR++L
Sbjct: 251 WKKVSESAKDLIRKML 266

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 88/256 (34%), Positives = 144/256 (56%), Gaps = 17/256 (6%)
Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP---VSHNLEKELIRKEIDIM 159
           T+   D Y     +G G+FG V  C+++ TG   A K I    V    +KE + +E+ ++
Sbjct: 44  TAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLL 103
Query: 160 NQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQ 219
            QL HP ++ L++ FED     L+ E  +GGELF+ I      +S      V    ++ Q
Sbjct: 104 KQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI------ISRKRFSEVDAARIIRQ 157
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNS-TNVKMIDFGLATKLDPNEVVKISTGTAEF 278
               + +MH+  I+H D+KPEN++ ++++   N+++IDFGL+T  + ++ +K   GTA +
Sbjct: 158 VLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYY 217
Query: 279 AAPEIVEREPVGFY---TDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEA 335
            APE++     G Y    D+W+ GV+ Y+LLSG  PF G N+ + LK V+   + F+   
Sbjct: 218 IAPEVLH----GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQ 273
Query: 336 FKNVSEEGKDFIRRLL 351
           +K VSE  KD IR++L
Sbjct: 274 WKKVSESAKDLIRKML 289

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 91/264 (34%), Positives = 148/264 (56%), Gaps = 21/264 (7%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-----------NLEK- 149
           K   + + Y  + ++G+GA+G V  C+E+   +  A K I  S            N+EK 
Sbjct: 30  KEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKF 89
Query: 150 -ELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEV 208
            E I  EI ++  L HP +I L D FED     L+ EF  GGELFE+I    +K  E + 
Sbjct: 90  HEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDA 148
Query: 209 IPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNST-NVKMIDFGLATKLDPNE 267
             +     M Q    + ++H+ NI+H D+KPENI+ + +NS  N+K++DFGL++    + 
Sbjct: 149 ANI-----MKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY 203
Query: 268 VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKAC 327
            ++   GTA + APE+++++      D+W+ GV+ Y+LL G  PF G+ND + +K V+  
Sbjct: 204 KLRDRLGTAYYIAPEVLKKK-YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG 262
Query: 328 DWEFDEEAFKNVSEEGKDFIRRLL 351
            + FD   +KN+S+E K+ I+ +L
Sbjct: 263 KYYFDFNDWKNISDEAKELIKLML 286

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 83/247 (33%), Positives = 144/247 (58%), Gaps = 10/247 (4%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLHHP 165
           + Y+I+  +G G+FG V +C++R T   +A K I    + N +   I +E++++ +L HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++ L +  ED     ++ E  +GGELF+ I     + SE +   +     + Q    + 
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARI-----IKQVFSGIT 135
Query: 226 HMHEKNIIHLDVKPENIMCQTR-NSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           +MH+ NI+H D+KPENI+ +++    ++K+IDFGL+T    N  +K   GTA + APE++
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL 195
Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
            R       D+W+ GV+ Y+LLSG  PF G+N+ + LK V+   + FD   ++ +S++ K
Sbjct: 196 -RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK 254
Query: 345 DFIRRLL 351
           D IR++L
Sbjct: 255 DLIRKML 261

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  158 bits (400), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 89/254 (35%), Positives = 139/254 (54%), Gaps = 10/254 (3%)
Query: 105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS--HNLEKELIRKEIDIMNQL 162
           S+ D Y + EE+G GAF VV RC +  TG  +AAK I        + + + +E  I   L
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLL 60
Query: 163 HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSP 222
            HP ++ LHD+  ++    L+F+ ++GGELFE I A +Y  SEA+       IL      
Sbjct: 61  KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY-YSEADASHCIQQIL-----E 114
Query: 223 AVKHMHEKNIIHLDVKPENIMCQTRN-STNVKMIDFGLATKLDPNEVVKIS-TGTAEFAA 280
           +V H H   I+H D+KPEN++  +++    VK+ DFGLA ++  ++       GT  + +
Sbjct: 115 SVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLS 174
Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVS 340
           PE++ ++P G   DMWA GV+ Y+LL G  PF  E+     + +KA  ++F    +  V+
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVT 234
Query: 341 EEGKDFIRRLLLRN 354
            E KD I ++L  N
Sbjct: 235 PEAKDLINKMLTIN 248

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 142/257 (55%), Gaps = 8/257 (3%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE-LIRKEIDIMN 160
           +   + D YD  + +GTGAF  V    +++T  + A K I       KE  +  EI +++
Sbjct: 12  QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLH 71
Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
           ++ HP ++ L D +E    + LI + +SGGELF+RI    +              L+ Q 
Sbjct: 72  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER------DASRLIFQV 125
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMI-DFGLATKLDPNEVVKISTGTAEFA 279
             AVK++H+  I+H D+KPEN++  + +  +  MI DFGL+   DP  V+  + GT  + 
Sbjct: 126 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYV 185
Query: 280 APEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNV 339
           APE++ ++P     D W++GV+AY+LL G  PF  END +  + +   ++EFD   + ++
Sbjct: 186 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI 245
Query: 340 SEEGKDFIRRLLLRNKE 356
           S+  KDFIR L+ ++ E
Sbjct: 246 SDSAKDFIRHLMEKDPE 262

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 142/257 (55%), Gaps = 8/257 (3%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE-LIRKEIDIMN 160
           +   + D YD  + +GTGAF  V    +++T  + A K I       KE  +  EI +++
Sbjct: 12  QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLH 71
Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
           ++ HP ++ L D +E    + LI + +SGGELF+RI    +              L+ Q 
Sbjct: 72  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER------DASRLIFQV 125
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMI-DFGLATKLDPNEVVKISTGTAEFA 279
             AVK++H+  I+H D+KPEN++  + +  +  MI DFGL+   DP  V+  + GT  + 
Sbjct: 126 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYV 185
Query: 280 APEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNV 339
           APE++ ++P     D W++GV+AY+LL G  PF  END +  + +   ++EFD   + ++
Sbjct: 186 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI 245
Query: 340 SEEGKDFIRRLLLRNKE 356
           S+  KDFIR L+ ++ E
Sbjct: 246 SDSAKDFIRHLMEKDPE 262

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 142/257 (55%), Gaps = 8/257 (3%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE-LIRKEIDIMN 160
           +   + D YD  + +GTGAF  V    +++T  + A K I       KE  +  EI +++
Sbjct: 12  QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLH 71
Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
           ++ HP ++ L D +E    + LI + +SGGELF+RI    +              L+ Q 
Sbjct: 72  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER------DASRLIFQV 125
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMI-DFGLATKLDPNEVVKISTGTAEFA 279
             AVK++H+  I+H D+KPEN++  + +  +  MI DFGL+   DP  V+  + GT  + 
Sbjct: 126 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYV 185
Query: 280 APEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNV 339
           APE++ ++P     D W++GV+AY+LL G  PF  END +  + +   ++EFD   + ++
Sbjct: 186 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI 245
Query: 340 SEEGKDFIRRLLLRNKE 356
           S+  KDFIR L+ ++ E
Sbjct: 246 SDSAKDFIRHLMEKDPE 262

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 83/247 (33%), Positives = 144/247 (58%), Gaps = 10/247 (4%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLHHP 165
           + Y+I+  +G G+FG V +C++R T   +A K I    + N +   I +E++++ +L HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++ L +  ED     ++ E  +GGELF+ I     + SE +   +     + Q    + 
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARI-----IKQVFSGIT 135
Query: 226 HMHEKNIIHLDVKPENIMCQTR-NSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           +MH+ NI+H D+KPENI+ +++    ++K+IDFGL+T    N  +K   GTA + APE++
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL 195
Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
            R       D+W+ GV+ Y+LLSG  PF G+N+ + LK V+   + FD   ++ +S++ K
Sbjct: 196 -RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK 254
Query: 345 DFIRRLL 351
           D IR++L
Sbjct: 255 DLIRKML 261

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 85/257 (33%), Positives = 142/257 (55%), Gaps = 8/257 (3%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE-LIRKEIDIMN 160
           +   + D YD  + +GTGAF  V    +++T  + A K I       KE  +  EI +++
Sbjct: 12  QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLH 71
Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
           ++ HP ++ L D +E    + LI + +SGGELF+RI    +              L+ Q 
Sbjct: 72  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER------DASRLIFQV 125
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMI-DFGLATKLDPNEVVKISTGTAEFA 279
             AVK++H+  I+H D+KPEN++  + +  +  MI DFGL+   DP  V+  + GT  + 
Sbjct: 126 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYV 185
Query: 280 APEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNV 339
           APE++ ++P     D W++GV+AY+LL G  PF  END +  + +   ++EFD   + ++
Sbjct: 186 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI 245
Query: 340 SEEGKDFIRRLLLRNKE 356
           S+  KDFIR L+ ++ E
Sbjct: 246 SDSAKDFIRHLMEKDPE 262

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 83/247 (33%), Positives = 144/247 (58%), Gaps = 10/247 (4%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLHHP 165
           + Y+I+  +G G+FG V +C++R T   +A K I    + N +   I +E++++ +L HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++ L +  ED     ++ E  +GGELF+ I     + SE +   +     + Q    + 
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARI-----IKQVFSGIT 135
Query: 226 HMHEKNIIHLDVKPENIMCQTR-NSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           +MH+ NI+H D+KPENI+ +++    ++K+IDFGL+T    N  +K   GTA + APE++
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL 195
Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
            R       D+W+ GV+ Y+LLSG  PF G+N+ + LK V+   + FD   ++ +S++ K
Sbjct: 196 -RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK 254
Query: 345 DFIRRLL 351
           D IR++L
Sbjct: 255 DLIRKML 261

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  158 bits (399), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 89/254 (35%), Positives = 139/254 (54%), Gaps = 10/254 (3%)
Query: 105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS--HNLEKELIRKEIDIMNQL 162
           S+ D Y + EE+G GAF VV RC +  TG  +AAK I        + + + +E  I   L
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLL 60
Query: 163 HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSP 222
            HP ++ LHD+  ++    L+F+ ++GGELFE I A +Y  SEA+       IL      
Sbjct: 61  KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY-YSEADASHCIQQIL-----E 114
Query: 223 AVKHMHEKNIIHLDVKPENIMCQTRN-STNVKMIDFGLATKLDPNEVVKIS-TGTAEFAA 280
           +V H H   I+H D+KPEN++  +++    VK+ DFGLA ++  ++       GT  + +
Sbjct: 115 SVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLS 174
Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVS 340
           PE++ ++P G   DMWA GV+ Y+LL G  PF  E+     + +KA  ++F    +  V+
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVT 234
Query: 341 EEGKDFIRRLLLRN 354
            E KD I ++L  N
Sbjct: 235 PEAKDLINKMLTIN 248

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  157 bits (397), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 90/262 (34%), Positives = 142/262 (54%), Gaps = 12/262 (4%)
Query: 99  VDIKTSSVY--DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRK 154
           VD+ T ++Y    Y + EE+G GAF VV RC +   G  +AAK I        + + + +
Sbjct: 11  VDLGTENLYFQSMYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLER 70
Query: 155 EIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLP 214
           E  I   L HP ++ LHD+  ++    LIF+ ++GGELFE I A +Y  SEA+       
Sbjct: 71  EARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY-YSEADASHCIQQ 129
Query: 215 ILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTR-NSTNVKMIDFGLATKLDPNEVVKIS- 272
           IL      AV H H+  ++H D+KPEN++  ++     VK+ DFGLA +++  +      
Sbjct: 130 IL-----EAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF 184
Query: 273 TGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD 332
            GT  + +PE++ ++P G   D+WA GV+ Y+LL G  PF  E+     + +KA  ++F 
Sbjct: 185 AGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFP 244
Query: 333 EEAFKNVSEEGKDFIRRLLLRN 354
              +  V+ E KD I ++L  N
Sbjct: 245 SPEWDTVTPEAKDLINKMLTIN 266

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  156 bits (395), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 87/262 (33%), Positives = 142/262 (54%), Gaps = 13/262 (4%)
Query: 92  SKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL 151
           S +  Q  DIK       ++  E +GTGAF  V    E+ TG +FA K IP      KE 
Sbjct: 11  SSWKKQAEDIKKI-----FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKES 65
Query: 152 -IRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIP 210
            I  EI ++ ++ H  ++ L D +E  + + L+ + +SGGELF+RI    +   +     
Sbjct: 66  SIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEK----- 120
Query: 211 VTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMI-DFGLATKLDPNEVV 269
                L+ Q   AV ++H   I+H D+KPEN++  +++  +  MI DFGL+      +V+
Sbjct: 121 -DASTLIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVM 179
Query: 270 KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDW 329
             + GT  + APE++ ++P     D W++GV+AY+LL G  PF  END +  + +   ++
Sbjct: 180 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEY 239
Query: 330 EFDEEAFKNVSEEGKDFIRRLL 351
           EFD   + ++S+  KDFIR L+
Sbjct: 240 EFDSPYWDDISDSAKDFIRNLM 261

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 97/265 (36%), Positives = 147/265 (55%), Gaps = 24/265 (9%)
Query: 101 IKTSSVYDHYDI-LEE--IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID 157
           +K S  Y HYD+ L++  +G G+F +  +C  +K+   FA K I  S  +E    +KEI 
Sbjct: 1   MKDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKII--SKRMEAN-TQKEIT 57
Query: 158 IMNQLH-HPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPIL 216
            +     HP ++ LH+ F D     L+ E L+GGELFERI    +  SE E        +
Sbjct: 58  ALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKH-FSETEA-----SYI 111
Query: 217 MTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN-STNVKMIDFGLATKLDP--NEVVKIST 273
           M +   AV HMH+  ++H D+KPEN++    N +  +K+IDFG A +L P  N+ +K   
Sbjct: 112 MRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFA-RLKPPDNQPLKTPC 170
Query: 274 GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN-------DVETLKNVKA 326
            T  +AAPE++ +       D+W++GV+ Y +LSG  PF   +        VE +K +K 
Sbjct: 171 FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK 230
Query: 327 CDWEFDEEAFKNVSEEGKDFIRRLL 351
            D+ F+ EA+KNVS+E KD I+ LL
Sbjct: 231 GDFSFEGEAWKNVSQEAKDLIQGLL 255

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  154 bits (390), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 87/256 (33%), Positives = 140/256 (54%), Gaps = 17/256 (6%)
Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP---VSHNLEKELIRKEIDIM 159
           T+   D Y     +G G+FG V  C+++ TG   A K I    V    +KE + +E+ ++
Sbjct: 21  TAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLL 80
Query: 160 NQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQ 219
            QL HP +  L++ FED     L+ E  +GGELF+ I      +S      V    ++ Q
Sbjct: 81  KQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEI------ISRKRFSEVDAARIIRQ 134
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNS-TNVKMIDFGLATKLDPNEVVKISTGTAEF 278
               + + H+  I+H D+KPEN++ ++++   N+++IDFGL+T  + ++  K   GTA +
Sbjct: 135 VLSGITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYY 194
Query: 279 AAPEIVEREPVGFY---TDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEA 335
            APE++     G Y    D+W+ GV+ Y+LLSG  PF G N+ + LK V+   + F+   
Sbjct: 195 IAPEVLH----GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQ 250
Query: 336 FKNVSEEGKDFIRRLL 351
           +K VSE  KD IR+ L
Sbjct: 251 WKKVSESAKDLIRKXL 266

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  154 bits (389), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 87/253 (34%), Positives = 138/253 (54%), Gaps = 12/253 (4%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV-----SHNLEKELIRKEIDIMNQL 162
           D Y++ E IG G F VV RC  R+TG  FA K + V     S  L  E +++E  I + L
Sbjct: 26  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 85
Query: 163 HHPKLINLHDAFEDDDEMVLIFEFLSGGEL-FERITAPDYKMSEAEVIPVTLPILMTQTS 221
            HP ++ L + +  D  + ++FEF+ G +L FE +   D     +E +       M Q  
Sbjct: 86  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY---MRQIL 142
Query: 222 PAVKHMHEKNIIHLDVKPENIMCQTR-NSTNVKMIDFGLATKLDPNEVVKIS-TGTAEFA 279
            A+++ H+ NIIH DVKP  ++  ++ NS  VK+  FG+A +L  + +V     GT  F 
Sbjct: 143 EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFM 202
Query: 280 APEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNV 339
           APE+V+REP G   D+W  GV+ ++LLSG  PF G  +    + +    ++ +   + ++
Sbjct: 203 APEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGKYKMNPRQWSHI 261
Query: 340 SEEGKDFIRRLLL 352
           SE  KD +RR+L+
Sbjct: 262 SESAKDLVRRMLM 274

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  154 bits (389), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 87/253 (34%), Positives = 138/253 (54%), Gaps = 12/253 (4%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV-----SHNLEKELIRKEIDIMNQL 162
           D Y++ E IG G F VV RC  R+TG  FA K + V     S  L  E +++E  I + L
Sbjct: 24  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 163 HHPKLINLHDAFEDDDEMVLIFEFLSGGEL-FERITAPDYKMSEAEVIPVTLPILMTQTS 221
            HP ++ L + +  D  + ++FEF+ G +L FE +   D     +E +       M Q  
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY---MRQIL 140
Query: 222 PAVKHMHEKNIIHLDVKPENIMCQTR-NSTNVKMIDFGLATKLDPNEVVKIS-TGTAEFA 279
            A+++ H+ NIIH DVKP  ++  ++ NS  VK+  FG+A +L  + +V     GT  F 
Sbjct: 141 EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFM 200
Query: 280 APEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNV 339
           APE+V+REP G   D+W  GV+ ++LLSG  PF G  +    + +    ++ +   + ++
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGKYKMNPRQWSHI 259
Query: 340 SEEGKDFIRRLLL 352
           SE  KD +RR+L+
Sbjct: 260 SESAKDLVRRMLM 272

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 80/254 (31%), Positives = 142/254 (55%), Gaps = 10/254 (3%)
Query: 100 DIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIM 159
            ++T+++   +  +E +G+GAF  V   ++R TG +FA K I  S       +  EI ++
Sbjct: 1   SMQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVL 60
Query: 160 NQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPD-YKMSEAEVIPVTLPILMT 218
            ++ H  ++ L D +E      L+ + +SGGELF+RI     Y   +A ++       + 
Sbjct: 61  KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLV-------IQ 113
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQT-RNSTNVKMIDFGLATKLDPNEVVKISTGTAE 277
           Q   AVK++HE  I+H D+KPEN++  T   ++ + + DFGL +K++ N ++  + GT  
Sbjct: 114 QVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGL-SKMEQNGIMSTACGTPG 172
Query: 278 FAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
           + APE++ ++P     D W++GV+ Y+LL G  PF  E + +  + +K   +EF+   + 
Sbjct: 173 YVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWD 232
Query: 338 NVSEEGKDFIRRLL 351
           ++SE  KDFI  LL
Sbjct: 233 DISESAKDFICHLL 246

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 83/250 (33%), Positives = 138/250 (55%), Gaps = 9/250 (3%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQLHHP 165
           D+YD+ EE+G GAF VV RC  + TG  FAAK I       ++   + +E  I  +L HP
Sbjct: 29  DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 88
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++ LHD+ +++    L+F+ ++GGELFE I A ++  SEA+       IL      ++ 
Sbjct: 89  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQIL-----ESIA 142
Query: 226 HMHEKNIIHLDVKPENIMCQTR-NSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           + H   I+H ++KPEN++  ++     VK+ DFGLA +++ +E      GT  + +PE++
Sbjct: 143 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL 202
Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
           +++P     D+WA GV+ Y+LL G  PF  E+       +KA  +++    +  V+ E K
Sbjct: 203 KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 262
Query: 345 DFIRRLLLRN 354
             I  +L  N
Sbjct: 263 SLIDSMLTVN 272

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 83/250 (33%), Positives = 138/250 (55%), Gaps = 9/250 (3%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQLHHP 165
           D+YD+ EE+G GAF VV RC  + TG  FAAK I       ++   + +E  I  +L HP
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++ LHD+ +++    L+F+ ++GGELFE I A ++  SEA+       IL +     + 
Sbjct: 66  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQILES-----IA 119
Query: 226 HMHEKNIIHLDVKPENIMCQTR-NSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           + H   I+H ++KPEN++  ++     VK+ DFGLA +++ +E      GT  + +PE++
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL 179
Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
           +++P     D+WA GV+ Y+LL G  PF  E+       +KA  +++    +  V+ E K
Sbjct: 180 KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 239
Query: 345 DFIRRLLLRN 354
             I  +L  N
Sbjct: 240 SLIDSMLTVN 249

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 83/250 (33%), Positives = 138/250 (55%), Gaps = 9/250 (3%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQLHHP 165
           D+YD+ EE+G GAF VV RC  + TG  FAAK I       ++   + +E  I  +L HP
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++ LHD+ +++    L+F+ ++GGELFE I A ++  SEA+       IL +     + 
Sbjct: 66  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQILES-----IA 119
Query: 226 HMHEKNIIHLDVKPENIMCQTR-NSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           + H   I+H ++KPEN++  ++     VK+ DFGLA +++ +E      GT  + +PE++
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL 179
Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
           +++P     D+WA GV+ Y+LL G  PF  E+       +KA  +++    +  V+ E K
Sbjct: 180 KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 239
Query: 345 DFIRRLLLRN 354
             I  +L  N
Sbjct: 240 SLIDSMLTVN 249

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 83/250 (33%), Positives = 138/250 (55%), Gaps = 9/250 (3%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQLHHP 165
           D+YD+ EE+G GAF VV RC  + TG  FAAK I       ++   + +E  I  +L HP
Sbjct: 5   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 64
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++ LHD+ +++    L+F+ ++GGELFE I A ++  SEA+       IL +     + 
Sbjct: 65  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQILES-----IA 118
Query: 226 HMHEKNIIHLDVKPENIMCQTR-NSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           + H   I+H ++KPEN++  ++     VK+ DFGLA +++ +E      GT  + +PE++
Sbjct: 119 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL 178
Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
           +++P     D+WA GV+ Y+LL G  PF  E+       +KA  +++    +  V+ E K
Sbjct: 179 KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 238
Query: 345 DFIRRLLLRN 354
             I  +L  N
Sbjct: 239 SLIDSMLTVN 248

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 83/250 (33%), Positives = 140/250 (56%), Gaps = 10/250 (4%)
Query: 105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHH 164
           ++ D +++  E+G GA  +V+RC+++ T   +A K +     ++K+++R EI ++ +L H
Sbjct: 50  ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVL--KKTVDKKIVRTEIGVLLRLSH 107
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P +I L + FE   E+ L+ E ++GGELF+RI    Y  SE +       IL      AV
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGY-YSERDAADAVKQIL-----EAV 161
Query: 225 KHMHEKNIIHLDVKPENIMCQT-RNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEI 283
            ++HE  I+H D+KPEN++  T      +K+ DFGL+  ++   ++K   GT  + APEI
Sbjct: 162 AYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEI 221
Query: 284 VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGE-NDVETLKNVKACDWEFDEEAFKNVSEE 342
           +     G   DMW+VG++ Y+LL G  PF  E  D    + +  C++ F    +  VS  
Sbjct: 222 LRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLN 281
Query: 343 GKDFIRRLLL 352
            KD +R+L++
Sbjct: 282 AKDLVRKLIV 291

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  151 bits (381), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 145/271 (53%), Gaps = 21/271 (7%)
Query: 99  VDIKTSSVY-----------DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS--H 145
           VD+ T ++Y           D Y + EE+G GAF VV RC ++     +AAK I      
Sbjct: 11  VDLGTENLYFQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLS 70
Query: 146 NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSE 205
             + + + +E  I   L HP ++ LHD+  ++    L+F+ ++GGELFE I A +Y  SE
Sbjct: 71  ARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY-YSE 129
Query: 206 AEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTR-NSTNVKMIDFGLATKLD 264
           A+       IL      +V H+H+ +I+H D+KPEN++  ++     VK+ DFGLA ++ 
Sbjct: 130 ADASHCIHQIL-----ESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQ 184
Query: 265 PNEVVKIS-TGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKN 323
             +       GT  + +PE++ ++P G   D+WA GV+ Y+LL G  PF  E+  +  + 
Sbjct: 185 GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQ 244
Query: 324 VKACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
           +KA  ++F    +  V+ E K+ I ++L  N
Sbjct: 245 IKAGAYDFPSPEWDTVTPEAKNLINQMLTIN 275

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  150 bits (380), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 85/258 (32%), Positives = 137/258 (53%), Gaps = 10/258 (3%)
Query: 101 IKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS--HNLEKELIRKEIDI 158
           I  +   + Y + EE+G GAF VV RC +   G  +AA  I        + + + +E  I
Sbjct: 4   ITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARI 63
Query: 159 MNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
              L HP ++ LHD+  ++    LIF+ ++GGELFE I A +Y  SEA+       IL  
Sbjct: 64  CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY-YSEADASHCIQQIL-- 120
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTR-NSTNVKMIDFGLATKLDPNEVVKIS-TGTA 276
               AV H H+  ++H ++KPEN++  ++     VK+ DFGLA +++  +       GT 
Sbjct: 121 ---EAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTP 177
Query: 277 EFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAF 336
            + +PE++ ++P G   D+WA GV+ Y+LL G  PF  E+     + +KA  ++F    +
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEW 237
Query: 337 KNVSEEGKDFIRRLLLRN 354
             V+ E KD I ++L  N
Sbjct: 238 DTVTPEAKDLINKMLTIN 255

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  150 bits (380), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 85/254 (33%), Positives = 148/254 (58%), Gaps = 12/254 (4%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI---PVSHNLEKELIRKEIDI 158
           K   + + Y  ++++G+GA+G V  CR++ T    A K I    VS +   +L+ +E+ +
Sbjct: 31  KKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLL-EEVAV 89
Query: 159 MNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           +  L HP ++ L+D FED     L+ E   GGELF+ I    ++M   EV      +++ 
Sbjct: 90  LKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEII---HRMKFNEV---DAAVIIK 143
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTN-VKMIDFGLATKLDPNEVVKISTGTAE 277
           Q    V ++H+ NI+H D+KPEN++ +++     +K++DFGL+   +  + +K   GTA 
Sbjct: 144 QVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAY 203
Query: 278 FAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
           + APE++ R+      D+W++GV+ ++LL+G  PF G+ D E L+ V+   + FD   +K
Sbjct: 204 YIAPEVL-RKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWK 262
Query: 338 NVSEEGKDFIRRLL 351
           NVSE  KD I+++L
Sbjct: 263 NVSEGAKDLIKQML 276

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 85/254 (33%), Positives = 141/254 (55%), Gaps = 16/254 (6%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHP 165
           +  +Y +   IG G++G V    ++ T    AAK IP     + +  ++EI+IM  L HP
Sbjct: 7   INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHP 66
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPD-YKMSEAEVIPVTLPILMTQTSPAV 224
            +I L++ FED+ ++ L+ E  +GGELFER+     ++ S+A  I       M     AV
Sbjct: 67  NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-------MKDVLSAV 119
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNS-TNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEI 283
            + H+ N+ H D+KPEN +  T +  + +K+IDFGLA +  P ++++   GT  + +P++
Sbjct: 120 AYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQV 179
Query: 284 VEREPVGFY---TDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVS 340
           +E    G Y    D W+ GV+ YVLL G  PF+   D E +  ++   + F E+ + NVS
Sbjct: 180 LE----GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVS 235
Query: 341 EEGKDFIRRLLLRN 354
            + +  IRRLL ++
Sbjct: 236 PQAESLIRRLLTKS 249

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 85/254 (33%), Positives = 141/254 (55%), Gaps = 16/254 (6%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHP 165
           +  +Y +   IG G++G V    ++ T    AAK IP     + +  ++EI+IM  L HP
Sbjct: 24  INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHP 83
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPD-YKMSEAEVIPVTLPILMTQTSPAV 224
            +I L++ FED+ ++ L+ E  +GGELFER+     ++ S+A  I       M     AV
Sbjct: 84  NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-------MKDVLSAV 136
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNS-TNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEI 283
            + H+ N+ H D+KPEN +  T +  + +K+IDFGLA +  P ++++   GT  + +P++
Sbjct: 137 AYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQV 196
Query: 284 VEREPVGFY---TDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVS 340
           +E    G Y    D W+ GV+ YVLL G  PF+   D E +  ++   + F E+ + NVS
Sbjct: 197 LE----GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVS 252
Query: 341 EEGKDFIRRLLLRN 354
            + +  IRRLL ++
Sbjct: 253 PQAESLIRRLLTKS 266

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  149 bits (376), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 86/254 (33%), Positives = 139/254 (54%), Gaps = 10/254 (3%)
Query: 105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQL 162
           S+ D Y + E+IG GAF VV RC +  TG+ +AAK I        + + + +E  I   L
Sbjct: 1   SMTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLL 60
Query: 163 HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSP 222
            H  ++ LHD+  ++    L+F+ ++GGELFE I A +Y  SEA+       IL      
Sbjct: 61  KHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY-YSEADASHCIQQIL-----E 114
Query: 223 AVKHMHEKNIIHLDVKPENIMCQTR-NSTNVKMIDFGLATKLDPNEVVKIS-TGTAEFAA 280
           AV H H+  ++H D+KPEN++  ++     VK+ DFGLA ++  ++       GT  + +
Sbjct: 115 AVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLS 174
Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVS 340
           PE++ +E  G   D+WA GV+ Y+LL G  PF  E+  +  + +KA  ++F    +  V+
Sbjct: 175 PEVLRKEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVT 234
Query: 341 EEGKDFIRRLLLRN 354
            E K+ I ++L  N
Sbjct: 235 PEAKNLINQMLTIN 248

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  148 bits (373), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 82/248 (33%), Positives = 137/248 (55%), Gaps = 11/248 (4%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI---PVSHNLEKELIRKEIDIMNQLHH 164
           D Y  ++++G+GA+G V  C+++ TG   A K I    V+       +  E+ ++ QL H
Sbjct: 21  DRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDH 80
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P ++ L++ FED     L+ E   GGELF+ I     K SE     V   ++M Q     
Sbjct: 81  PNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQ-KFSE-----VDAAVIMKQVLSGT 134
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTN-VKMIDFGLATKLDPNEVVKISTGTAEFAAPEI 283
            ++H+ NI+H D+KPEN++ ++++    +K++DFGL+   +    +K   GTA + APE+
Sbjct: 135 TYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEV 194
Query: 284 VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG 343
           + R+      D+W+ GV+ Y+LL G  PF G+ D E LK V+   + FD   +  VS+E 
Sbjct: 195 L-RKKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEA 253
Query: 344 KDFIRRLL 351
           K  ++ +L
Sbjct: 254 KQLVKLML 261

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  147 bits (372), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 82/248 (33%), Positives = 137/248 (55%), Gaps = 11/248 (4%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI---PVSHNLEKELIRKEIDIMNQLHH 164
           D Y  ++++G+GA+G V  C+++ TG   A K I    V+       +  E+ ++ QL H
Sbjct: 4   DRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDH 63
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P ++ L++ FED     L+ E   GGELF+ I     K SE     V   ++M Q     
Sbjct: 64  PNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQ-KFSE-----VDAAVIMKQVLSGT 117
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTN-VKMIDFGLATKLDPNEVVKISTGTAEFAAPEI 283
            ++H+ NI+H D+KPEN++ ++++    +K++DFGL+   +    +K   GTA + APE+
Sbjct: 118 TYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEV 177
Query: 284 VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG 343
           + R+      D+W+ GV+ Y+LL G  PF G+ D E LK V+   + FD   +  VS+E 
Sbjct: 178 L-RKKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEA 236
Query: 344 KDFIRRLL 351
           K  ++ +L
Sbjct: 237 KQLVKLML 244

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  135 bits (341), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 88/260 (33%), Positives = 133/260 (51%), Gaps = 23/260 (8%)
Query: 107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS------HNLE--KELIRKEIDI 158
           Y  YD  + IG G   VV RC  R TG+ FA K + V+        LE  +E  R+E  I
Sbjct: 93  YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 159 MNQLH-HPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM 217
           + Q+  HP +I L D++E    M L+F+ +  GELF+ +T     +SE E   +   +L 
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLL- 210
Query: 218 TQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAE 277
                AV  +H  NI+H D+KPENI+    ++  +++ DFG +  L+P E ++   GT  
Sbjct: 211 ----EAVSFLHANNIVHRDLKPENILLD--DNMQIRLSDFGFSCHLEPGEKLRELCGTPG 264
Query: 278 FAAPEIV-----EREP-VGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEF 331
           + APEI+     E  P  G   D+WA GV+ + LL+G  PF     +  L+ +    ++F
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQF 324
Query: 332 DEEAFKNVSEEGKDFIRRLL 351
               + + S   KD I RLL
Sbjct: 325 SSPEWDDRSSTVKDLISRLL 344

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  134 bits (338), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 85/271 (31%), Positives = 138/271 (50%), Gaps = 24/271 (8%)
Query: 98  PVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV----SHNLE----- 148
           P    T   Y++Y+  E +G G   VV RC  + T   +A K I V    S + E     
Sbjct: 7   PGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQEL 66
Query: 149 KELIRKEIDIMNQLH-HPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAE 207
           +E   KE+DI+ ++  HP +I L D +E +    L+F+ +  GELF+ +T     +SE E
Sbjct: 67  REATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKE 125
Query: 208 VIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE 267
              +   +L       +  +H+ NI+H D+KPENI+    +  N+K+ DFG + +LDP E
Sbjct: 126 TRKIMRALL-----EVICALHKLNIVHRDLKPENILLD--DDMNIKLTDFGFSCQLDPGE 178
Query: 268 VVKISTGTAEFAAPEIVE------REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETL 321
            ++   GT  + APEI+E          G   DMW+ GV+ Y LL+G  PF     +  L
Sbjct: 179 KLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 238
Query: 322 KNVKACDWEFDEEAFKNVSEEGKDFIRRLLL 352
           + + + +++F    + + S+  KD + R L+
Sbjct: 239 RMIMSGNYQFGSPEWDDYSDTVKDLVSRFLV 269

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  134 bits (337), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 85/271 (31%), Positives = 138/271 (50%), Gaps = 24/271 (8%)
Query: 98  PVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV----SHNLE----- 148
           P    T   Y++Y+  E +G G   VV RC  + T   +A K I V    S + E     
Sbjct: 7   PGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQEL 66
Query: 149 KELIRKEIDIMNQLH-HPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAE 207
           +E   KE+DI+ ++  HP +I L D +E +    L+F+ +  GELF+ +T     +SE E
Sbjct: 67  REATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKE 125
Query: 208 VIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE 267
              +   +L       +  +H+ NI+H D+KPENI+    +  N+K+ DFG + +LDP E
Sbjct: 126 TRKIMRALL-----EVICALHKLNIVHRDLKPENILLD--DDMNIKLTDFGFSCQLDPGE 178
Query: 268 VVKISTGTAEFAAPEIVE------REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETL 321
            ++   GT  + APEI+E          G   DMW+ GV+ Y LL+G  PF     +  L
Sbjct: 179 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 238
Query: 322 KNVKACDWEFDEEAFKNVSEEGKDFIRRLLL 352
           + + + +++F    + + S+  KD + R L+
Sbjct: 239 RMIMSGNYQFGSPEWDDYSDTVKDLVSRFLV 269

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 136/262 (51%), Gaps = 24/262 (9%)
Query: 107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV----SHNLE-----KELIRKEID 157
           Y++Y+  E +G G   VV RC  + T   +A K I V    S + E     +E   KE+D
Sbjct: 3   YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 62
Query: 158 IMNQLH-HPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPIL 216
           I+ ++  HP +I L D +E +    L+F+ +  GELF+ +T     +SE E   +   +L
Sbjct: 63  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALL 121
Query: 217 MTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA 276
                  +  +H+ NI+H D+KPENI+    +  N+K+ DFG + +LDP E ++   GT 
Sbjct: 122 -----EVICALHKLNIVHRDLKPENILLD--DDMNIKLTDFGFSCQLDPGEKLREVCGTP 174
Query: 277 EFAAPEIVE------REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWE 330
            + APEI+E          G   DMW+ GV+ Y LL+G  PF     +  L+ + + +++
Sbjct: 175 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 234
Query: 331 FDEEAFKNVSEEGKDFIRRLLL 352
           F    + + S+  KD + R L+
Sbjct: 235 FGSPEWDDYSDTVKDLVSRFLV 256

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  131 bits (330), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 82/247 (33%), Positives = 134/247 (54%), Gaps = 12/247 (4%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN-LEKELIRKEIDIMNQLHHPKLINLHDA 173
           ++G+GAFG VH   ER +G     K I    + +  E I  EI+++  L HP +I + + 
Sbjct: 29  KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 174 FEDDDEMVLIFEFLSGGELFERITAPDYK---MSEAEVIPVTLPILMTQTSPAVKHMHEK 230
           FED   M ++ E   GGEL ERI +   +   +SE  V       LM Q   A+ + H +
Sbjct: 89  FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAE-----LMKQMMNALAYFHSQ 143
Query: 231 NIIHLDVKPENIMCQ-TRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPV 289
           +++H D+KPENI+ Q T   + +K+IDFGLA     +E    + GTA + APE+ +R+ V
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRD-V 202
Query: 290 GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRR 349
            F  D+W+ GV+ Y LL+G  PF G +  E  +     +  +  E  + ++ +  D +++
Sbjct: 203 TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVEC-RPLTPQAVDLLKQ 261
Query: 350 LLLRNKE 356
           +L ++ E
Sbjct: 262 MLTKDPE 268

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  131 bits (329), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 81/253 (32%), Positives = 134/253 (52%), Gaps = 20/253 (7%)
Query: 110 YDILEEIGTGAFGVVHRCRE---RKTGNIFAAKFIP----VSHNLEKELIRKEIDIMNQL 162
           +++L  +G G +G V + R+     TG IFA K +     V +  +    + E +I+ ++
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 163 HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSP 222
            HP +++L  AF+   ++ LI E+LSGGELF ++      M +      T    + + S 
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMED------TACFYLAEISM 132
Query: 223 AVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK-LDPNEVVKISTGTAEFAAP 281
           A+ H+H+K II+ D+KPENIM    +  +VK+ DFGL  + +    V     GT E+ AP
Sbjct: 133 ALGHLHQKGIIYRDLKPENIMLN--HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAP 190
Query: 282 EIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSE 341
           EI+ R       D W++G L Y +L+G  PF GEN  +T+  +  C           +++
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLTQ 246
Query: 342 EGKDFIRRLLLRN 354
           E +D +++LL RN
Sbjct: 247 EARDLLKKLLKRN 259

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  130 bits (328), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 81/253 (32%), Positives = 134/253 (52%), Gaps = 20/253 (7%)
Query: 110 YDILEEIGTGAFGVVHRCRE---RKTGNIFAAKFIP----VSHNLEKELIRKEIDIMNQL 162
           +++L  +G G +G V + R+     TG IFA K +     V +  +    + E +I+ ++
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 163 HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSP 222
            HP +++L  AF+   ++ LI E+LSGGELF ++      M +      T    + + S 
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMED------TACFYLAEISM 132
Query: 223 AVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK-LDPNEVVKISTGTAEFAAP 281
           A+ H+H+K II+ D+KPENIM    +  +VK+ DFGL  + +    V     GT E+ AP
Sbjct: 133 ALGHLHQKGIIYRDLKPENIMLN--HQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAP 190
Query: 282 EIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSE 341
           EI+ R       D W++G L Y +L+G  PF GEN  +T+  +  C           +++
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLTQ 246
Query: 342 EGKDFIRRLLLRN 354
           E +D +++LL RN
Sbjct: 247 EARDLLKKLLKRN 259

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  130 bits (328), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 80/251 (31%), Positives = 135/251 (53%), Gaps = 17/251 (6%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL-HHPK 166
           D Y++ E+IG G++ V  RC  + T   FA K I  S     E    EI+I+ +   HP 
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQHPN 77
Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKH 226
           +I L D ++D   + ++ E + GGEL ++I    +  SE E   V   I  T     V++
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF-FSEREASAVLFTITKT-----VEY 131
Query: 227 MHEKNIIHLDVKPENIMC--QTRNSTNVKMIDFGLATKLDP-NEVVKISTGTAEFAAPEI 283
           +H + ++H D+KP NI+   ++ N  ++++ DFG A +L   N ++     TA F APE+
Sbjct: 132 LHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEV 191
Query: 284 VEREPVGFYTDMWAVGVLAYVLLSGLSPFA-GENDV--ETLKNVKACDWEFDEEAFKNVS 340
           +ER+      D+W++GVL Y +L+G +PFA G +D   E L  + +  +      + +VS
Sbjct: 192 LERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVS 251
Query: 341 EEGKDFIRRLL 351
           +  KD + ++L
Sbjct: 252 DTAKDLVSKML 262

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  127 bits (320), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 80/251 (31%), Positives = 132/251 (52%), Gaps = 17/251 (6%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL-HHPK 166
           D Y++ E+IG G++ V  RC  + T   FA K I  S     E    EI+I+ +   HP 
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTE----EIEILLRYGQHPN 77
Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKH 226
           +I L D ++D   + ++ E   GGEL ++I    +  SE E   V   I  T     V++
Sbjct: 78  IITLKDVYDDGKYVYVVTELXKGGELLDKILRQKF-FSEREASAVLFTITKT-----VEY 131
Query: 227 MHEKNIIHLDVKPENIMC--QTRNSTNVKMIDFGLATKLDP-NEVVKISTGTAEFAAPEI 283
           +H + ++H D+KP NI+   ++ N  ++++ DFG A +L   N ++     TA F APE+
Sbjct: 132 LHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEV 191
Query: 284 VEREPVGFYTDMWAVGVLAYVLLSGLSPFA-GENDV--ETLKNVKACDWEFDEEAFKNVS 340
           +ER+      D+W++GVL Y  L+G +PFA G +D   E L  + +  +      + +VS
Sbjct: 192 LERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVS 251
Query: 341 EEGKDFIRRLL 351
           +  KD + + L
Sbjct: 252 DTAKDLVSKXL 262

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  121 bits (304), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 79/267 (29%), Positives = 136/267 (50%), Gaps = 24/267 (8%)
Query: 99  VDIKTSSVY-------DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL 151
           VD+ T ++Y       D Y + E IG G++    RC  + T   +A K I  S     E 
Sbjct: 11  VDLGTENLYFQSMVFSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSE- 69
Query: 152 IRKEIDIMNQL-HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIP 210
              EI+I+ +   HP +I L D ++D   + L+ E + GGEL ++I    +  SE E   
Sbjct: 70  ---EIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKF-FSEREA-- 123
Query: 211 VTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMC--QTRNSTNVKMIDFGLATKLDP-NE 267
                ++      V+++H + ++H D+KP NI+   ++ N   +++ DFG A +L   N 
Sbjct: 124 ---SFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENG 180
Query: 268 VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFA-GENDV--ETLKNV 324
           ++     TA F APE+++R+      D+W++G+L Y +L+G +PFA G +D   E L  +
Sbjct: 181 LLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRI 240
Query: 325 KACDWEFDEEAFKNVSEEGKDFIRRLL 351
            +  +      +  VSE  KD + ++L
Sbjct: 241 GSGKFTLSGGNWNTVSETAKDLVSKML 267

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 78/254 (30%), Positives = 130/254 (51%), Gaps = 29/254 (11%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP---VSHNLEKELIRKEIDIMNQLHHPK 166
           + IL  +GTG+FG VH  R R  G  +A K +    V    + E    E  +++ + HP 
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELF------ERITAPDYKMSEAEVIPVTLPILMTQT 220
           +I +   F+D  ++ +I +++ GGELF      +R   P  K   AEV            
Sbjct: 68  IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------------ 115
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAA 280
             A++++H K+II+ D+KPENI+     + ++K+ DFG A  +   +V     GT ++ A
Sbjct: 116 CLALEYLHSKDIIYRDLKPENILLD--KNGHIKITDFGFAKYVP--DVTYXLCGTPDYIA 171
Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVS 340
           PE+V  +P     D W+ G+L Y +L+G +PF   N ++T + +   +  F    F N  
Sbjct: 172 PEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF--PPFFN-- 227
Query: 341 EEGKDFIRRLLLRN 354
           E+ KD + RL+ R+
Sbjct: 228 EDVKDLLSRLITRD 241

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 133/291 (45%), Gaps = 46/291 (15%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKF-----IPVSHNLEKELIRKEIDIMNQLHH 164
           Y +   IG G++GVV    E +T  I A K      I   +  + E I+ E+ +M +LHH
Sbjct: 28  YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITA--------PDYKMSEAEVIPV----- 211
           P +  L++ +ED+  + L+ E   GG L +++              + + ++ P      
Sbjct: 88  PNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNE 147
Query: 212 ---------------------TLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNST 250
                                 +  +M Q   A+ ++H + I H D+KPEN +  T  S 
Sbjct: 148 EAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSF 207
Query: 251 NVKMIDFGLAT---KLDPNEVVKIST--GTAEFAAPEIVE--REPVGFYTDMWAVGVLAY 303
            +K++DFGL+    KL+  E   ++T  GT  F APE++    E  G   D W+ GVL +
Sbjct: 208 EIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLH 267
Query: 304 VLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
           +LL G  PF G ND +T+  V      F+   +  +S   +D +  LL RN
Sbjct: 268 LLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRN 318

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 129/251 (51%), Gaps = 17/251 (6%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL-HHPK 166
           D Y + E IG G++    RC  + T   +A K I  S     E    EI+I+ +   HP 
Sbjct: 27  DGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSE----EIEILLRYGQHPN 82
Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKH 226
           +I L D ++D   + L+ E + GGEL ++I    +  SE E        ++      V++
Sbjct: 83  IITLKDVYDDGKHVYLVTELMRGGELLDKILRQKF-FSEREA-----SFVLHTIGKTVEY 136
Query: 227 MHEKNIIHLDVKPENIMC--QTRNSTNVKMIDFGLATKLDP-NEVVKISTGTAEFAAPEI 283
           +H + ++H D+KP NI+   ++ N   +++ DFG A +L   N ++     TA F APE+
Sbjct: 137 LHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEV 196
Query: 284 VEREPVGFYTDMWAVGVLAYVLLSGLSPFA-GENDV--ETLKNVKACDWEFDEEAFKNVS 340
           ++R+      D+W++G+L Y +L+G +PFA G +D   E L  + +  +      +  VS
Sbjct: 197 LKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVS 256
Query: 341 EEGKDFIRRLL 351
           E  KD + ++L
Sbjct: 257 ETAKDLVSKML 267

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/252 (28%), Positives = 137/252 (54%), Gaps = 18/252 (7%)
Query: 109 HYDILEEIGTGAFG---VVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEI--DIMNQLH 163
           H+++L+ +G G+FG   +V +     +G+++A K +  +    ++ +R ++  DI+  ++
Sbjct: 29  HFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVN 88
Query: 164 HPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPA 223
           HP ++ LH AF+ + ++ LI +FL GG+LF R++  +   +E +V        + + +  
Sbjct: 89  HPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDV-----KFYLAELALG 142
Query: 224 VKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS-TGTAEFAAPE 282
           + H+H   II+ D+KPENI+       ++K+ DFGL+ +   +E    S  GT E+ APE
Sbjct: 143 LDHLHSLGIIYRDLKPENILLDEEG--HIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPE 200
Query: 283 IVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEE 342
           +V R+      D W+ GVL + +L+G  PF G++  ET+  +        +     +S E
Sbjct: 201 VVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQ----FLSTE 256
Query: 343 GKDFIRRLLLRN 354
            +  +R L  RN
Sbjct: 257 AQSLLRALFKRN 268

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  118 bits (296), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 76/261 (29%), Positives = 138/261 (52%), Gaps = 20/261 (7%)
Query: 105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP-------VSHNLEKEL-IRKEI 156
           ++ D Y + + +G+GA G V    ERKT    A K I         +   +  L +  EI
Sbjct: 7   ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI 66
Query: 157 DIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPIL 216
           +I+ +L+HP +I + + F+ +D  + + E + GGELF+++   + ++ EA     T  + 
Sbjct: 67  EILKKLNHPCIIKIKNFFDAEDYYI-VLELMEGGELFDKVVG-NKRLKEA-----TCKLY 119
Query: 217 MTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNS-TNVKMIDFGLATKLDPNEVVKISTGT 275
             Q   AV+++HE  IIH D+KPEN++  ++     +K+ DFG +  L    +++   GT
Sbjct: 120 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 179
Query: 276 AEFAAPEIVEREPVGFY---TDMWAVGVLAYVLLSGLSPFAGENDVETLKN-VKACDWEF 331
             + APE++       Y    D W++GV+ ++ LSG  PF+      +LK+ + +  + F
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 239
Query: 332 DEEAFKNVSEEGKDFIRRLLL 352
             E +  VSE+  D +++LL+
Sbjct: 240 IPEVWAEVSEKALDLVKKLLV 260

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  118 bits (296), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 76/261 (29%), Positives = 138/261 (52%), Gaps = 20/261 (7%)
Query: 105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP-------VSHNLEKEL-IRKEI 156
           ++ D Y + + +G+GA G V    ERKT    A K I         +   +  L +  EI
Sbjct: 7   ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI 66
Query: 157 DIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPIL 216
           +I+ +L+HP +I + + F+ +D   ++ E + GGELF+++   + ++ EA     T  + 
Sbjct: 67  EILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVG-NKRLKEA-----TCKLY 119
Query: 217 MTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNS-TNVKMIDFGLATKLDPNEVVKISTGT 275
             Q   AV+++HE  IIH D+KPEN++  ++     +K+ DFG +  L    +++   GT
Sbjct: 120 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 179
Query: 276 AEFAAPEIVEREPVGFY---TDMWAVGVLAYVLLSGLSPFAGENDVETLKN-VKACDWEF 331
             + APE++       Y    D W++GV+ ++ LSG  PF+      +LK+ + +  + F
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 239
Query: 332 DEEAFKNVSEEGKDFIRRLLL 352
             E +  VSE+  D +++LL+
Sbjct: 240 IPEVWAEVSEKALDLVKKLLV 260

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  118 bits (296), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 76/261 (29%), Positives = 138/261 (52%), Gaps = 20/261 (7%)
Query: 105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP-------VSHNLEKEL-IRKEI 156
           ++ D Y + + +G+GA G V    ERKT    A K I         +   +  L +  EI
Sbjct: 7   ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI 66
Query: 157 DIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPIL 216
           +I+ +L+HP +I + + F+ +D  + + E + GGELF+++   + ++ EA     T  + 
Sbjct: 67  EILKKLNHPCIIKIKNFFDAEDYYI-VLELMEGGELFDKVVG-NKRLKEA-----TCKLY 119
Query: 217 MTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNS-TNVKMIDFGLATKLDPNEVVKISTGT 275
             Q   AV+++HE  IIH D+KPEN++  ++     +K+ DFG +  L    +++   GT
Sbjct: 120 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 179
Query: 276 AEFAAPEIVEREPVGFY---TDMWAVGVLAYVLLSGLSPFAGENDVETLKN-VKACDWEF 331
             + APE++       Y    D W++GV+ ++ LSG  PF+      +LK+ + +  + F
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 239
Query: 332 DEEAFKNVSEEGKDFIRRLLL 352
             E +  VSE+  D +++LL+
Sbjct: 240 IPEVWAEVSEKALDLVKKLLV 260

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  118 bits (296), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 76/261 (29%), Positives = 138/261 (52%), Gaps = 20/261 (7%)
Query: 105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP-------VSHNLEKEL-IRKEI 156
           ++ D Y + + +G+GA G V    ERKT    A K I         +   +  L +  EI
Sbjct: 6   ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI 65
Query: 157 DIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPIL 216
           +I+ +L+HP +I + + F+ +D  + + E + GGELF+++   + ++ EA     T  + 
Sbjct: 66  EILKKLNHPCIIKIKNFFDAEDYYI-VLELMEGGELFDKVVG-NKRLKEA-----TCKLY 118
Query: 217 MTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNS-TNVKMIDFGLATKLDPNEVVKISTGT 275
             Q   AV+++HE  IIH D+KPEN++  ++     +K+ DFG +  L    +++   GT
Sbjct: 119 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 178
Query: 276 AEFAAPEIVEREPVGFY---TDMWAVGVLAYVLLSGLSPFAGENDVETLKN-VKACDWEF 331
             + APE++       Y    D W++GV+ ++ LSG  PF+      +LK+ + +  + F
Sbjct: 179 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 238
Query: 332 DEEAFKNVSEEGKDFIRRLLL 352
             E +  VSE+  D +++LL+
Sbjct: 239 IPEVWAEVSEKALDLVKKLLV 259

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 76/261 (29%), Positives = 138/261 (52%), Gaps = 20/261 (7%)
Query: 105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP-------VSHNLEKEL-IRKEI 156
           ++ D Y + + +G+GA G V    ERKT    A K I         +   +  L +  EI
Sbjct: 13  ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI 72
Query: 157 DIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPIL 216
           +I+ +L+HP +I + + F+ +D  + + E + GGELF+++   + ++ EA     T  + 
Sbjct: 73  EILKKLNHPCIIKIKNFFDAEDYYI-VLELMEGGELFDKVVG-NKRLKEA-----TCKLY 125
Query: 217 MTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNS-TNVKMIDFGLATKLDPNEVVKISTGT 275
             Q   AV+++HE  IIH D+KPEN++  ++     +K+ DFG +  L    +++   GT
Sbjct: 126 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 185
Query: 276 AEFAAPEIVEREPVGFY---TDMWAVGVLAYVLLSGLSPFAGENDVETLKN-VKACDWEF 331
             + APE++       Y    D W++GV+ ++ LSG  PF+      +LK+ + +  + F
Sbjct: 186 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 245
Query: 332 DEEAFKNVSEEGKDFIRRLLL 352
             E +  VSE+  D +++LL+
Sbjct: 246 IPEVWAEVSEKALDLVKKLLV 266

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  117 bits (293), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 138/261 (52%), Gaps = 20/261 (7%)
Query: 105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP-------VSHNLEKEL-IRKEI 156
           ++ D Y + + +G+GA G V    ERKT    A + I         +   +  L +  EI
Sbjct: 146 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEI 205
Query: 157 DIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPIL 216
           +I+ +L+HP +I + + F+ +D  + + E + GGELF+++   + ++ EA     T  + 
Sbjct: 206 EILKKLNHPCIIKIKNFFDAEDYYI-VLELMEGGELFDKVVG-NKRLKEA-----TCKLY 258
Query: 217 MTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNS-TNVKMIDFGLATKLDPNEVVKISTGT 275
             Q   AV+++HE  IIH D+KPEN++  ++     +K+ DFG +  L    +++   GT
Sbjct: 259 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 318
Query: 276 AEFAAPEIVEREPVGFY---TDMWAVGVLAYVLLSGLSPFAGENDVETLKN-VKACDWEF 331
             + APE++       Y    D W++GV+ ++ LSG  PF+      +LK+ + +  + F
Sbjct: 319 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 378
Query: 332 DEEAFKNVSEEGKDFIRRLLL 352
             E +  VSE+  D +++LL+
Sbjct: 379 IPEVWAEVSEKALDLVKKLLV 399

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 138/261 (52%), Gaps = 20/261 (7%)
Query: 105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP-------VSHNLEKEL-IRKEI 156
           ++ D Y + + +G+GA G V    ERKT    A + I         +   +  L +  EI
Sbjct: 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEI 191
Query: 157 DIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPIL 216
           +I+ +L+HP +I + + F+ +D  + + E + GGELF+++   + ++ EA     T  + 
Sbjct: 192 EILKKLNHPCIIKIKNFFDAEDYYI-VLELMEGGELFDKVVG-NKRLKEA-----TCKLY 244
Query: 217 MTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNS-TNVKMIDFGLATKLDPNEVVKISTGT 275
             Q   AV+++HE  IIH D+KPEN++  ++     +K+ DFG +  L    +++   GT
Sbjct: 245 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 304
Query: 276 AEFAAPEIVEREPVGFY---TDMWAVGVLAYVLLSGLSPFAGENDVETLKN-VKACDWEF 331
             + APE++       Y    D W++GV+ ++ LSG  PF+      +LK+ + +  + F
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 364
Query: 332 DEEAFKNVSEEGKDFIRRLLL 352
             E +  VSE+  D +++LL+
Sbjct: 365 IPEVWAEVSEKALDLVKKLLV 385

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 74/248 (29%), Positives = 125/248 (50%), Gaps = 18/248 (7%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE----LIRKEIDIMNQLH 163
           D +DI+  +G G FG V+  RE++   I A K +     LEKE     +R+EI+I + L 
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVL-FKSQLEKEGVEHQLRREIEIQSHLR 72
Query: 164 HPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPA 223
           HP ++ +++ F D   + L+ EF   GEL++ +     +  E           M + + A
Sbjct: 73  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG-RFDEQRSA-----TFMEELADA 126
Query: 224 VKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEI 283
           + + HE+ +IH D+KPEN++   +    +K+ DFG +    P+   +   GT ++  PE+
Sbjct: 127 LHYCHERKVIHRDIKPENLLMGYKGE--LKIADFGWSVH-APSLRRRXMCGTLDYLPPEM 183
Query: 284 VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG 343
           +E +      D+W  GVL Y  L G+ PF   +  ET + +   D +F       +S+  
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP----FLSDGS 239
Query: 344 KDFIRRLL 351
           KD I +LL
Sbjct: 240 KDLISKLL 247

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 79/250 (31%), Positives = 126/250 (50%), Gaps = 17/250 (6%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP---VSHNLEKELIRKEIDIMNQLHHP 165
           +Y I++ +G G+FG V       TG   A K I    ++ +  +  I +EI  +  L HP
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            +I L+D  +  DE++++ E+ +G ELF+ I   D KMSE E           Q   AV+
Sbjct: 74  HIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRD-KMSEQEA-----RRFFQQIISAVE 126
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           + H   I+H D+KPEN++       NVK+ DFGL+  +     +K S G+  +AAPE++ 
Sbjct: 127 YCHRHKIVHRDLKPENLLLDEH--LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIS 184
Query: 286 -REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
            +   G   D+W+ GV+ YV+L    PF  E+     KN+    +       K +S    
Sbjct: 185 GKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP----KFLSPGAA 240
Query: 345 DFIRRLLLRN 354
             I+R+L+ N
Sbjct: 241 GLIKRMLIVN 250

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 79/250 (31%), Positives = 126/250 (50%), Gaps = 17/250 (6%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP---VSHNLEKELIRKEIDIMNQLHHP 165
           +Y I++ +G G+FG V       TG   A K I    ++ +  +  I +EI  +  L HP
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            +I L+D  +  DE++++ E+ +G ELF+ I   D KMSE E           Q   AV+
Sbjct: 75  HIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRD-KMSEQEA-----RRFFQQIISAVE 127
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           + H   I+H D+KPEN++       NVK+ DFGL+  +     +K S G+  +AAPE++ 
Sbjct: 128 YCHRHKIVHRDLKPENLLLDEH--LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIS 185
Query: 286 -REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
            +   G   D+W+ GV+ YV+L    PF  E+     KN+    +       K +S    
Sbjct: 186 GKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP----KFLSPGAA 241
Query: 345 DFIRRLLLRN 354
             I+R+L+ N
Sbjct: 242 GLIKRMLIVN 251

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 79/250 (31%), Positives = 126/250 (50%), Gaps = 17/250 (6%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP---VSHNLEKELIRKEIDIMNQLHHP 165
           +Y I++ +G G+FG V       TG   A K I    ++ +  +  I +EI  +  L HP
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            +I L+D  +  DE++++ E+ +G ELF+ I   D KMSE E           Q   AV+
Sbjct: 65  HIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRD-KMSEQEA-----RRFFQQIISAVE 117
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           + H   I+H D+KPEN++       NVK+ DFGL+  +     +K S G+  +AAPE++ 
Sbjct: 118 YCHRHKIVHRDLKPENLLLDEH--LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIS 175
Query: 286 -REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
            +   G   D+W+ GV+ YV+L    PF  E+     KN+    +       K +S    
Sbjct: 176 GKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP----KFLSPGAA 231
Query: 345 DFIRRLLLRN 354
             I+R+L+ N
Sbjct: 232 GLIKRMLIVN 241

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 79/250 (31%), Positives = 126/250 (50%), Gaps = 17/250 (6%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP---VSHNLEKELIRKEIDIMNQLHHP 165
           +Y I++ +G G+FG V       TG   A K I    ++ +  +  I +EI  +  L HP
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            +I L+D  +  DE++++ E+ +G ELF+ I   D KMSE E           Q   AV+
Sbjct: 69  HIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRD-KMSEQEA-----RRFFQQIISAVE 121
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           + H   I+H D+KPEN++       NVK+ DFGL+  +     +K S G+  +AAPE++ 
Sbjct: 122 YCHRHKIVHRDLKPENLLLDEH--LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIS 179
Query: 286 -REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
            +   G   D+W+ GV+ YV+L    PF  E+     KN+    +       K +S    
Sbjct: 180 GKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP----KFLSPGAA 235
Query: 345 DFIRRLLLRN 354
             I+R+L+ N
Sbjct: 236 GLIKRMLIVN 245

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 74/248 (29%), Positives = 124/248 (50%), Gaps = 18/248 (7%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE----LIRKEIDIMNQLH 163
           D +DI   +G G FG V+  RE++   I A K +     LEKE     +R+EI+I + L 
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVL-FKSQLEKEGVEHQLRREIEIQSHLR 73
Query: 164 HPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPA 223
           HP ++ +++ F D   + L+ EF   GEL++ +     +  E           M + + A
Sbjct: 74  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG-RFDEQRSA-----TFMEELADA 127
Query: 224 VKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEI 283
           + + HE+ +IH D+KPEN++   +    +K+ DFG +    P+   +   GT ++  PE+
Sbjct: 128 LHYCHERKVIHRDIKPENLLMGYKGE--LKIADFGWSVHA-PSLRRRXMCGTLDYLPPEM 184
Query: 284 VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG 343
           +E +      D+W  GVL Y  L G+ PF   +  ET + +   D +F       +S+  
Sbjct: 185 IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP----FLSDGS 240
Query: 344 KDFIRRLL 351
           KD I +LL
Sbjct: 241 KDLISKLL 248

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  114 bits (286), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 76/261 (29%), Positives = 128/261 (49%), Gaps = 18/261 (6%)
Query: 98  PVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK----ELIR 153
           P+  K     + +DI   +G G FG V+  RER++  I A K +     LEK      +R
Sbjct: 2   PLGSKRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVL-FKTQLEKAGVEHQLR 60
Query: 154 KEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTL 213
           +E++I + L HP ++ L+  F D   + LI E+   G ++  +     K+S  +      
Sbjct: 61  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSRFDEQRTAT 116
Query: 214 PILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST 273
            I  T+ + A+ + H K +IH D+KPEN++  +  +  +K+ DFG +    P+       
Sbjct: 117 YI--TELANALSYCHSKRVIHRDIKPENLLLGS--NGELKIADFGWSVH-APSSRRTTLC 171
Query: 274 GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE 333
           GT ++  PE++E        D+W++GVL Y  L G+ PF      ET + +   ++ F +
Sbjct: 172 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPD 231
Query: 334 EAFKNVSEEGKDFIRRLLLRN 354
                V+E  +D I RLL  N
Sbjct: 232 ----FVTEGARDLISRLLKHN 248

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 76/261 (29%), Positives = 128/261 (49%), Gaps = 18/261 (6%)
Query: 98  PVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK----ELIR 153
           P+  K     + +DI   +G G FG V+  RER++  I A K +     LEK      +R
Sbjct: 2   PLGSKRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVL-FKTQLEKAGVEHQLR 60
Query: 154 KEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTL 213
           +E++I + L HP ++ L+  F D   + LI E+   G ++  +     K+S  +      
Sbjct: 61  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSRFDEQRTAT 116
Query: 214 PILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST 273
            I  T+ + A+ + H K +IH D+KPEN++  +  +  +K+ DFG +    P+       
Sbjct: 117 YI--TELANALSYCHSKRVIHRDIKPENLLLGS--NGELKIADFGWSVH-APSSRRDTLC 171
Query: 274 GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE 333
           GT ++  PE++E        D+W++GVL Y  L G+ PF      ET + +   ++ F +
Sbjct: 172 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPD 231
Query: 334 EAFKNVSEEGKDFIRRLLLRN 354
                V+E  +D I RLL  N
Sbjct: 232 ----FVTEGARDLISRLLKHN 248

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 135/278 (48%), Gaps = 37/278 (13%)
Query: 108 DHYDILEEI-GTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPK 166
           D Y +  E+ G GA+  V      + G  +A K I       +  + +E++ + Q    K
Sbjct: 12  DMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNK 71
Query: 167 -LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++ L + FEDD    L+FE L GG +   I    +  +E E   V   +     + A+ 
Sbjct: 72  NILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKH-FNEREASRVVRDV-----AAALD 125
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTN-VKMIDFGLATKLD-PNEVVKIST-------GTA 276
            +H K I H D+KPENI+C++    + VK+ DF L + +   N    I+T       G+A
Sbjct: 126 FLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSA 185
Query: 277 EFAAPEIVE--REPVGFY---TDMWAVGVLAYVLLSGLSPFAGENDVET----------- 320
           E+ APE+VE   +   FY    D+W++GV+ Y++LSG  PF G    +            
Sbjct: 186 EYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVC 245
Query: 321 ----LKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
                ++++   +EF ++ + ++S E KD I +LL+R+
Sbjct: 246 QNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRD 283

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 134/252 (53%), Gaps = 18/252 (7%)
Query: 109 HYDILEEIGTGAFG---VVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEI--DIMNQLH 163
            +++L+ +G G+FG   +V +        ++A K +  +    ++ +R ++  DI+ +++
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 84
Query: 164 HPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPA 223
           HP ++ LH AF+ + ++ LI +FL GG+LF R++  +   +E +V        + + + A
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDV-----KFYLAELALA 138
Query: 224 VKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK-LDPNEVVKISTGTAEFAAPE 282
           + H+H   II+ D+KPENI+       ++K+ DFGL+ + +D  +      GT E+ APE
Sbjct: 139 LDHLHSLGIIYRDLKPENILLDEEG--HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE 196
Query: 283 IVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEE 342
           +V R       D W+ GVL + +L+G  PF G++  ET+  +        +     +S E
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSPE 252
Query: 343 GKDFIRRLLLRN 354
            +  +R L  RN
Sbjct: 253 AQSLLRMLFKRN 264

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 75/244 (30%), Positives = 129/244 (52%), Gaps = 13/244 (5%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLIN 169
           Y   E+IG GA G V+   +  TG   A + + +    +KELI  EI +M +  +P ++N
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 170 LHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE 229
             D++   DE+ ++ E+L+GG L + +T  +  M E ++  V    L      A++ +H 
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQ-----ALEFLHS 134
Query: 230 KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFAAPEIVERE 287
             +IH D+K +NI+     S  VK+ DFG   ++ P E  K ST  GT  + APE+V R+
Sbjct: 135 NQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITP-EQSKRSTMVGTPYWMAPEVVTRK 191
Query: 288 PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFI 347
             G   D+W++G++A  ++ G  P+  EN +  L  + A +   + +  + +S   +DF+
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-ATNGTPELQNPEKLSAIFRDFL 250
Query: 348 RRLL 351
            R L
Sbjct: 251 NRCL 254

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 79/243 (32%), Positives = 120/243 (49%), Gaps = 15/243 (6%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK---EIDIMNQLHHPKLINLHD 172
           +G G+F  V+R     TG   A K I      +  ++++   E+ I  QL HP ++ L++
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 173 AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNI 232
            FED + + L+ E    GE+   +       SE E         M Q    + ++H   I
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARH-----FMHQIITGMLYLHSHGI 133
Query: 233 IHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEFAAPEIVEREPVGF 291
           +H D+   N++  TRN  N+K+ DFGLAT+L  P+E      GT  + +PEI  R   G 
Sbjct: 134 LHRDLTLSNLLL-TRN-MNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGL 191
Query: 292 YTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLL 351
            +D+W++G + Y LL G  PF  +    TL  V   D+E    +F  +S E KD I +LL
Sbjct: 192 ESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEM--PSF--LSIEAKDLIHQLL 247
Query: 352 LRN 354
            RN
Sbjct: 248 RRN 250

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 134/252 (53%), Gaps = 18/252 (7%)
Query: 109 HYDILEEIGTGAFG---VVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEI--DIMNQLH 163
            +++L+ +G G+FG   +V +        ++A K +  +    ++ +R ++  DI+ +++
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 84
Query: 164 HPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPA 223
           HP ++ LH AF+ + ++ LI +FL GG+LF R++  +   +E +V        + + + A
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDV-----KFYLAELALA 138
Query: 224 VKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK-LDPNEVVKISTGTAEFAAPE 282
           + H+H   II+ D+KPENI+       ++K+ DFGL+ + +D  +      GT E+ APE
Sbjct: 139 LDHLHSLGIIYRDLKPENILLDEEG--HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE 196
Query: 283 IVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEE 342
           +V R       D W+ GVL + +L+G  PF G++  ET+  +        +     +S E
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSPE 252
Query: 343 GKDFIRRLLLRN 354
            +  +R L  RN
Sbjct: 253 AQSLLRMLFKRN 264

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 134/252 (53%), Gaps = 18/252 (7%)
Query: 109 HYDILEEIGTGAFG---VVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEI--DIMNQLH 163
            +++L+ +G G+FG   +V +        ++A K +  +    ++ +R ++  DI+ +++
Sbjct: 26  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 85
Query: 164 HPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPA 223
           HP ++ LH AF+ + ++ LI +FL GG+LF R++  +   +E +V        + + + A
Sbjct: 86  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDV-----KFYLAELALA 139
Query: 224 VKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK-LDPNEVVKISTGTAEFAAPE 282
           + H+H   II+ D+KPENI+       ++K+ DFGL+ + +D  +      GT E+ APE
Sbjct: 140 LDHLHSLGIIYRDLKPENILLDEEG--HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE 197
Query: 283 IVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEE 342
           +V R       D W+ GVL + +L+G  PF G++  ET+  +        +     +S E
Sbjct: 198 VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSPE 253
Query: 343 GKDFIRRLLLRN 354
            +  +R L  RN
Sbjct: 254 AQSLLRMLFKRN 265

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 74/249 (29%), Positives = 126/249 (50%), Gaps = 18/249 (7%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK----ELIRKEIDIMNQLHHP 165
           ++I   +G G FG V+  RE+++  I A K +     LEK      +R+E++I + L HP
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHP 73
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++ L+  F D   + LI E+   GE+++ +     K+S+ +       I  T+ + A+ 
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPRGEVYKELQ----KLSKFDEQRTATYI--TELANALS 127
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           + H K +IH D+KPEN++  +  +  +K+ DFG +    P+       GT ++  PE++E
Sbjct: 128 YCHSKRVIHRDIKPENLLLGS--AGELKIADFGWSVH-APSSRRXXLXGTLDYLPPEMIE 184
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD 345
                   D+W++GVL Y  L G  PF      ET K +   ++ F +     V+E  +D
Sbjct: 185 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARD 240
Query: 346 FIRRLLLRN 354
            I RLL  N
Sbjct: 241 LISRLLKHN 249

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 127/243 (52%), Gaps = 11/243 (4%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLIN 169
           Y   E+IG GA G V+   +  TG   A + + +    +KELI  EI +M +  +P ++N
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 170 LHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE 229
             D++   DE+ ++ E+L+GG L + +T  +  M E ++  V    L      A++ +H 
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQ-----ALEFLHS 134
Query: 230 KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVK-ISTGTAEFAAPEIVEREP 288
             +IH D+K +NI+     S  VK+ DFG   ++ P +  +    GT  + APE+V R+ 
Sbjct: 135 NQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKA 192
Query: 289 VGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIR 348
            G   D+W++G++A  ++ G  P+  EN +  L  + A +   + +  + +S   +DF+ 
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-ATNGTPELQNPEKLSAIFRDFLN 251
Query: 349 RLL 351
           R L
Sbjct: 252 RCL 254

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 126/249 (50%), Gaps = 18/249 (7%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK----ELIRKEIDIMNQLHHP 165
           ++I   +G G FG V+  RE+++  I A K +     LEK      +R+E++I + L HP
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHP 73
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++ L+  F D   + LI E+   GE+++ +     K+S+ +         +T+ + A+ 
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPRGEVYKELQ----KLSKFDEQRTA--TYITELANALS 127
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           + H K +IH D+KPEN++  +  +  +K+ DFG +    P+       GT ++  PE++E
Sbjct: 128 YCHSKRVIHRDIKPENLLLGS--AGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIE 184
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD 345
                   D+W++GVL Y  L G  PF      ET K +   ++ F +     V+E  +D
Sbjct: 185 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARD 240
Query: 346 FIRRLLLRN 354
            I RLL  N
Sbjct: 241 LISRLLKHN 249

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 78/249 (31%), Positives = 126/249 (50%), Gaps = 21/249 (8%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE-----LIRKEIDIMNQLHH 164
           Y I E +G G+FG V      KT    A KFI  S  L K+      + +EI  +  L H
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFI--SRQLLKKSDMHMRVEREISYLKLLRH 68
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P +I L+D      ++V++ E+ +GGELF+ I     +M+E E           Q   A+
Sbjct: 69  PHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKK-RMTEDEGRR-----FFQQIICAI 121
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           ++ H   I+H D+KPEN++    ++ NVK+ DFGL+  +     +K S G+  +AAPE++
Sbjct: 122 EYCHRHKIVHRDLKPENLLLD--DNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVI 179
Query: 285 E-REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG 343
             +   G   D+W+ G++ YV+L G  PF  E      K V +C +   +     +S   
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPD----FLSPGA 235
Query: 344 KDFIRRLLL 352
           +  IRR+++
Sbjct: 236 QSLIRRMIV 244

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 127/243 (52%), Gaps = 11/243 (4%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLIN 169
           Y   E+IG GA G V+   +  TG   A + + +    +KELI  EI +M +  +P ++N
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 170 LHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE 229
             D++   DE+ ++ E+L+GG L + +T  +  M E ++  V    L      A++ +H 
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQ-----ALEFLHS 134
Query: 230 KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS-TGTAEFAAPEIVEREP 288
             +IH D+K +NI+     S  VK+ DFG   ++ P +  +    GT  + APE+V R+ 
Sbjct: 135 NQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKA 192
Query: 289 VGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIR 348
            G   D+W++G++A  ++ G  P+  EN +  L  + A +   + +  + +S   +DF+ 
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-ATNGTPELQNPEKLSAIFRDFLN 251
Query: 349 RLL 351
           R L
Sbjct: 252 RCL 254

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 127/243 (52%), Gaps = 11/243 (4%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLIN 169
           Y   E+IG GA G V+   +  TG   A + + +    +KELI  EI +M +  +P ++N
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 170 LHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE 229
             D++   DE+ ++ E+L+GG L + +T  +  M E ++  V    L      A++ +H 
Sbjct: 83  YLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQ-----ALEFLHS 135
Query: 230 KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVK-ISTGTAEFAAPEIVEREP 288
             +IH D+K +NI+     S  VK+ DFG   ++ P +  +    GT  + APE+V R+ 
Sbjct: 136 NQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKA 193
Query: 289 VGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIR 348
            G   D+W++G++A  ++ G  P+  EN +  L  + A +   + +  + +S   +DF+ 
Sbjct: 194 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-ATNGTPELQNPEKLSAIFRDFLN 252
Query: 349 RLL 351
           R L
Sbjct: 253 RCL 255

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 74/244 (30%), Positives = 129/244 (52%), Gaps = 13/244 (5%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLIN 169
           Y   E+IG GA G V+   +  TG   A + + +    +KELI  EI +M +  +P ++N
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 170 LHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE 229
             D++   DE+ ++ E+L+GG L + +T  +  M E ++  V    L      A++ +H 
Sbjct: 83  YLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQ-----ALEFLHS 135
Query: 230 KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFAAPEIVERE 287
             +IH ++K +NI+     S  VK+ DFG   ++ P E  K ST  GT  + APE+V R+
Sbjct: 136 NQVIHRNIKSDNILLGMDGS--VKLTDFGFCAQITP-EQSKRSTMVGTPYWMAPEVVTRK 192
Query: 288 PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFI 347
             G   D+W++G++A  ++ G  P+  EN +  L  + A +   + +  + +S   +DF+
Sbjct: 193 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-ATNGTPELQNPEKLSAIFRDFL 251
Query: 348 RRLL 351
            R L
Sbjct: 252 NRCL 255

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 76/251 (30%), Positives = 122/251 (48%), Gaps = 18/251 (7%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE----LIRKEIDIMNQLH 163
           D ++I   +G G FG V+  RE+K+  I A K +     +EKE     +R+EI+I   LH
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVL-FKSQIEKEGVEHQLRREIEIQAHLH 81
Query: 164 HPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPA 223
           HP ++ L++ F D   + LI E+   GEL++ +        E     +     M + + A
Sbjct: 82  HPNILRLYNYFYDRRRIYLILEYAPRGELYKELQK-SCTFDEQRTATI-----MEELADA 135
Query: 224 VKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEI 283
           + + H K +IH D+KPEN++   +    +   DFG +    P+   K   GT ++  PE+
Sbjct: 136 LMYCHGKKVIHRDIKPENLLLGLKGELKIA--DFGWSVH-APSLRRKTMCGTLDYLPPEM 192
Query: 284 VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG 343
           +E        D+W +GVL Y LL G  PF   +  ET + +   D +F      +V    
Sbjct: 193 IEGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFP----ASVPTGA 248
Query: 344 KDFIRRLLLRN 354
           +D I +LL  N
Sbjct: 249 QDLISKLLRHN 259

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 121/216 (56%), Gaps = 13/216 (6%)
Query: 99  VDIKTSSVY----DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELI 152
           VD+ T ++Y    + Y  L++IG G+FG     +  + G  +  K I +S   + E+E  
Sbjct: 11  VDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREES 70
Query: 153 RKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVT 212
           R+E+ ++  + HP ++   ++FE++  + ++ ++  GG+LF+RI A    + + + I   
Sbjct: 71  RREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILD- 129
Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN-EVVKI 271
                 Q   A+KH+H++ I+H D+K +NI   T++ T V++ DFG+A  L+   E+ + 
Sbjct: 130 ---WFVQICLALKHVHDRKILHRDIKSQNIFL-TKDGT-VQLGDFGIARVLNSTVELARA 184
Query: 272 STGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS 307
             GT  + +PEI E +P    +D+WA+G + Y L +
Sbjct: 185 CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCT 220

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 113/212 (53%), Gaps = 14/212 (6%)
Query: 107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR---KEIDIMNQLH 163
           +DH++IL  IG G+FG V   ++  T  ++A K++     +E+  +R   KE+ IM  L 
Sbjct: 14  FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE 73
Query: 164 HPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPA 223
           HP L+NL  +F+D+++M ++ + L GG+L   +    +   E      T+ + + +   A
Sbjct: 74  HPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE------TVKLFICELVMA 127
Query: 224 VKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEI 283
           + ++  + IIH D+KP+NI+       +V + DF +A  L     +    GT  + APE+
Sbjct: 128 LDYLQNQRIIHRDMKPDNILLDEHG--HVHITDFNIAAMLPRETQITTMAGTKPYMAPEM 185
Query: 284 V-EREPVG--FYTDMWAVGVLAYVLLSGLSPF 312
              R+  G  F  D W++GV AY LL G  P+
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY 217

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 125/249 (50%), Gaps = 18/249 (7%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK----ELIRKEIDIMNQLHHP 165
           ++I   +G G FG V+  RE+++  I A K +     LEK      +R+E++I + L HP
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHP 69
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++ L+  F D   + LI E+   G ++  +     K+S+ +         +T+ + A+ 
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTA--TYITELANALS 123
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           + H K +IH D+KPEN++  +  +  +K+ DFG +     +    +S GT ++  PE++E
Sbjct: 124 YCHSKRVIHRDIKPENLLLGS--AGELKIADFGWSCHAPSSRRTTLS-GTLDYLPPEMIE 180
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD 345
                   D+W++GVL Y  L G  PF      ET K +   ++ F +     V+E  +D
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARD 236
Query: 346 FIRRLLLRN 354
            I RLL  N
Sbjct: 237 LISRLLKHN 245

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 73/236 (30%), Positives = 116/236 (49%), Gaps = 14/236 (5%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL---IRKEIDIMNQLHHP 165
           HY + + +G G FG V   +   TG+  A K +        ++   IR+EI  +    HP
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            +I L+       ++ ++ E++SGGELF+ I   + ++ E E        L  Q    V 
Sbjct: 77  HIIKLYQVISTPSDIFMVMEYVSGGELFDYICK-NGRLDEKES-----RRLFQQILSGVD 130
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           + H   ++H D+KPEN++       N K+ DFGL+  +   E ++ S G+  +AAPE++ 
Sbjct: 131 YCHRHMVVHRDLKPENVLLDAH--MNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVIS 188
Query: 286 -REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVS 340
            R   G   D+W+ GV+ Y LL G  PF  ++ V TL   K CD  F    + N S
Sbjct: 189 GRLYAGPEVDIWSSGVILYALLCGTLPF-DDDHVPTLFK-KICDGIFYTPQYLNPS 242

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 112/236 (47%), Gaps = 12/236 (5%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL---IRKEIDIMNQLHHP 165
           HY + + +G G FG V     + TG+  A K +        ++   I++EI  +    HP
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            +I L+       +  ++ E++SGGELF      DY      V  +    L  Q   AV 
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELF------DYICKHGRVEEMEARRLFQQILSAVD 125
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           + H   ++H D+KPEN++       N K+ DFGL+  +   E ++ S G+  +AAPE++ 
Sbjct: 126 YCHRHMVVHRDLKPENVLLDAH--MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS 183
Query: 286 -REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVS 340
            R   G   D+W+ GV+ Y LL G  PF  E+     K ++   +   E   ++V+
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVA 239

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 121/249 (48%), Gaps = 18/249 (7%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK----ELIRKEIDIMNQLHHP 165
           ++I   +G G FG V+  RE+++  I A K +     LEK      +R+E++I + L HP
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHP 71
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++ L+  F D   + LI E+   G ++  +     K  E           +T+ + A+ 
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRT-----ATYITELANALS 125
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           + H K +IH D+KPEN++  +  +  +K+ DFG +    P+       GT ++  PE++E
Sbjct: 126 YCHSKRVIHRDIKPENLLLGS--AGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIE 182
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD 345
                   D+W++GVL Y  L G  PF      ET K +   ++ F +     V+E  +D
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARD 238
Query: 346 FIRRLLLRN 354
            I RLL  N
Sbjct: 239 LISRLLKHN 247

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 121/249 (48%), Gaps = 18/249 (7%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK----ELIRKEIDIMNQLHHP 165
           ++I   +G G FG V+  RE+++  I A K +     LEK      +R+E++I + L HP
Sbjct: 9   FEIGRPLGKGKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHP 67
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++ L+  F D   + LI E+   G ++  +     K  E           +T+ + A+ 
Sbjct: 68  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTA-----TYITELANALS 121
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           + H K +IH D+KPEN++  +  +  +K+ DFG +    P+       GT ++  PE++E
Sbjct: 122 YCHSKRVIHRDIKPENLLLGS--AGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIE 178
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD 345
                   D+W++GVL Y  L G  PF      ET K +   ++ F +     V+E  +D
Sbjct: 179 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARD 234
Query: 346 FIRRLLLRN 354
            I RLL  N
Sbjct: 235 LISRLLKHN 243

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 73/257 (28%), Positives = 123/257 (47%), Gaps = 18/257 (7%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK----ELIRKEID 157
           K     + ++I   +G G FG V+  RE+++  I A K +     LEK      +R+E++
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVE 60
Query: 158 IMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM 217
           I + L HP ++ L+  F D   + LI E+   G ++  +     K  E           +
Sbjct: 61  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTA-----TYI 114
Query: 218 TQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAE 277
           T+ + A+ + H K +IH D+KPEN++  +  +  +K+ DFG +    P+       GT +
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGS--AGELKIADFGWSVH-APSSRRAALCGTLD 171
Query: 278 FAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
           +  PE++E        D+W++GVL Y  L G  PF      ET K +   ++ F +    
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD---- 227
Query: 338 NVSEEGKDFIRRLLLRN 354
            V+E  +D I RLL  N
Sbjct: 228 FVTEGARDLISRLLKHN 244

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 121/249 (48%), Gaps = 18/249 (7%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK----ELIRKEIDIMNQLHHP 165
           ++I   +G G FG V+  RE+++  I A K +     LEK      +R+E++I + L HP
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHP 71
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++ L+  F D   + LI E+   G ++  +     K  E           +T+ + A+ 
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTA-----TYITELANALS 125
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           + H K +IH D+KPEN++  +  +  +K+ DFG +    P+       GT ++  PE++E
Sbjct: 126 YCHSKRVIHRDIKPENLLLGS--AGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIE 182
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD 345
                   D+W++GVL Y  L G  PF      ET K +   ++ F +     V+E  +D
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARD 238
Query: 346 FIRRLLLRN 354
            I RLL  N
Sbjct: 239 LISRLLKHN 247

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 121/249 (48%), Gaps = 18/249 (7%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK----ELIRKEIDIMNQLHHP 165
           ++I   +G G FG V+  RE+++  I A K +     LEK      +R+E++I + L HP
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHP 70
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++ L+  F D   + LI E+   G ++  +     K  E           +T+ + A+ 
Sbjct: 71  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTA-----TYITELANALS 124
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           + H K +IH D+KPEN++  +  +  +K+ DFG +    P+       GT ++  PE++E
Sbjct: 125 YCHSKRVIHRDIKPENLLLGS--AGELKIADFGWSVH-APSSRRXXLCGTLDYLPPEMIE 181
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD 345
                   D+W++GVL Y  L G  PF      ET K +   ++ F +     V+E  +D
Sbjct: 182 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARD 237
Query: 346 FIRRLLLRN 354
            I RLL  N
Sbjct: 238 LISRLLKHN 246

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 121/249 (48%), Gaps = 18/249 (7%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK----ELIRKEIDIMNQLHHP 165
           ++I   +G G FG V+  RE+++  I A K +     LEK      +R+E++I + L HP
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHP 68
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++ L+  F D   + LI E+   G ++  +     K  E           +T+ + A+ 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTA-----TYITELANALS 122
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           + H K +IH D+KPEN++  +  +  +K+ DFG +    P+       GT ++  PE++E
Sbjct: 123 YCHSKRVIHRDIKPENLLLGS--AGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIE 179
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD 345
                   D+W++GVL Y  L G  PF      ET K +   ++ F +     V+E  +D
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARD 235
Query: 346 FIRRLLLRN 354
            I RLL  N
Sbjct: 236 LISRLLKHN 244

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 121/249 (48%), Gaps = 18/249 (7%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK----ELIRKEIDIMNQLHHP 165
           ++I   +G G FG V+  RE+++  I A K +     LEK      +R+E++I + L HP
Sbjct: 14  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++ L+  F D   + LI E+   G ++  +     K  E           +T+ + A+ 
Sbjct: 73  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTA-----TYITELANALS 126
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           + H K +IH D+KPEN++  +  +  +K+ DFG +    P+       GT ++  PE++E
Sbjct: 127 YCHSKRVIHRDIKPENLLLGS--AGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIE 183
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD 345
                   D+W++GVL Y  L G  PF      ET K +   ++ F +     V+E  +D
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARD 239
Query: 346 FIRRLLLRN 354
            I RLL  N
Sbjct: 240 LISRLLKHN 248

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 73/257 (28%), Positives = 123/257 (47%), Gaps = 18/257 (7%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK----ELIRKEID 157
           K     + ++I   +G G FG V+  RE+++  I A K +     LEK      +R+E++
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVE 60
Query: 158 IMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM 217
           I + L HP ++ L+  F D   + LI E+   G ++  +     K  E           +
Sbjct: 61  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTA-----TYI 114
Query: 218 TQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAE 277
           T+ + A+ + H K +IH D+KPEN++  +  +  +K+ DFG +    P+       GT +
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGS--AGELKIADFGWSVH-APSSRRXXLCGTLD 171
Query: 278 FAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
           +  PE++E        D+W++GVL Y  L G  PF      ET K +   ++ F +    
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD---- 227
Query: 338 NVSEEGKDFIRRLLLRN 354
            V+E  +D I RLL  N
Sbjct: 228 FVTEGARDLISRLLKHN 244

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 124/249 (49%), Gaps = 18/249 (7%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK----ELIRKEIDIMNQLHHP 165
           ++I   +G G FG V+  RE+++  I A K +     LEK      +R+E++I + L HP
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHP 73
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++ L+  F D   + LI E+   G ++  +     K+S+ +       I  T+ + A+ 
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYI--TELANALS 127
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           + H K +IH D+KPEN++  +  +  +K+ DFG +    P+       GT ++  PE++E
Sbjct: 128 YCHSKRVIHRDIKPENLLLGS--AGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIE 184
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD 345
                   D+W++GVL Y  L G  PF      ET K +   ++ F +     V+E  +D
Sbjct: 185 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARD 240
Query: 346 FIRRLLLRN 354
            I RLL  N
Sbjct: 241 LISRLLKHN 249

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 74/257 (28%), Positives = 126/257 (49%), Gaps = 18/257 (7%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK----ELIRKEID 157
           K     + ++I   +G G FG V+  RE+++  I A K +     LEK      +R+E++
Sbjct: 5   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVE 63
Query: 158 IMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM 217
           I + L HP ++ L+  F D   + LI E+   G ++  +     K+S+ +       I  
Sbjct: 64  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYI-- 117
Query: 218 TQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAE 277
           T+ + A+ + H K +IH D+KPEN++  +  +  +K+ DFG +    P+       GT +
Sbjct: 118 TELANALSYCHSKRVIHRDIKPENLLLGS--AGELKIADFGWSVH-APSSRRXXLCGTLD 174
Query: 278 FAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
           +  PE++E        D+W++GVL Y  L G  PF      ET K +   ++ F +    
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD---- 230
Query: 338 NVSEEGKDFIRRLLLRN 354
            V+E  +D I RLL  N
Sbjct: 231 FVTEGARDLISRLLKHN 247

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 121/249 (48%), Gaps = 18/249 (7%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK----ELIRKEIDIMNQLHHP 165
           ++I   +G G FG V+  RE+++  I A K +     LEK      +R+E++I + L HP
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHP 68
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++ L+  F D   + LI E+   G ++  +     K  E           +T+ + A+ 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTA-----TYITELANALS 122
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           + H K +IH D+KPEN++  +  +  +K+ DFG +    P+       GT ++  PE++E
Sbjct: 123 YCHSKRVIHRDIKPENLLLGS--AGELKIADFGWSVH-APSSRRTXLCGTLDYLPPEMIE 179
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD 345
                   D+W++GVL Y  L G  PF      ET K +   ++ F +     V+E  +D
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARD 235
Query: 346 FIRRLLLRN 354
            I RLL  N
Sbjct: 236 LISRLLKHN 244

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 112/213 (52%), Gaps = 15/213 (7%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV----SHNLEKELIRKEIDIMNQLHH 164
           +Y +L+ IG G F  V   R   TG   A K I      S +L+K  + +E+ IM  L+H
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQK--LFREVRIMKVLNH 65
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P ++ L +  E +  + L+ E+ SGGE+F+ + A  + M E E           Q   AV
Sbjct: 66  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGW-MKEKEARAK-----FRQIVSAV 119
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           ++ H+K I+H D+K EN++       N+K+ DFG + +      +    G+  +AAPE+ 
Sbjct: 120 QYCHQKFIVHRDLKAENLLLDA--DMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELF 177
Query: 285 EREPV-GFYTDMWAVGVLAYVLLSGLSPFAGEN 316
           + +   G   D+W++GV+ Y L+SG  PF G+N
Sbjct: 178 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 210

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 124/249 (49%), Gaps = 18/249 (7%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK----ELIRKEIDIMNQLHHP 165
           ++I   +G G FG V+  RE+++  I A K +     LEK      +R+E++I + L HP
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHP 71
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++ L+  F D   + LI E+   G ++  +     K+S+ +       I  T+ + A+ 
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYI--TELANALS 125
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           + H K +IH D+KPEN++  +  +  +K+ DFG +    P+       GT ++  PE++E
Sbjct: 126 YCHSKRVIHRDIKPENLLLGS--AGELKIADFGWSVH-APSSRRAALCGTLDYLPPEMIE 182
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD 345
                   D+W++GVL Y  L G  PF      ET K +   ++ F +     V+E  +D
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARD 238
Query: 346 FIRRLLLRN 354
            I RLL  N
Sbjct: 239 LISRLLKHN 247

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 112/213 (52%), Gaps = 15/213 (7%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV----SHNLEKELIRKEIDIMNQLHH 164
           +Y +L+ IG G F  V   R   TG   A K I      S +L+K  + +E+ IM  L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQK--LFREVRIMKVLNH 72
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P ++ L +  E +  + L+ E+ SGGE+F+ + A   +M E E           Q   AV
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG-RMKEKEARAK-----FRQIVSAV 126
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           ++ H+K I+H D+K EN++       N+K+ DFG + +      +    G+  +AAPE+ 
Sbjct: 127 QYCHQKFIVHRDLKAENLLLDA--DMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELF 184
Query: 285 EREPV-GFYTDMWAVGVLAYVLLSGLSPFAGEN 316
           + +   G   D+W++GV+ Y L+SG  PF G+N
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 112/213 (52%), Gaps = 15/213 (7%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH----NLEKELIRKEIDIMNQLHH 164
           +Y +L+ IG G F  V   R   TG   A K I  +     +L+K  + +E+ IM  L+H
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQK--LFREVRIMKILNH 70
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P ++ L +  E +  + LI E+ SGGE+F+ + A   +M E E           Q   AV
Sbjct: 71  PNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSK-----FRQIVSAV 124
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           ++ H+K I+H D+K EN++       N+K+ DFG + +      +    G+  +AAPE+ 
Sbjct: 125 QYCHQKRIVHRDLKAENLLLDA--DMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELF 182
Query: 285 EREPV-GFYTDMWAVGVLAYVLLSGLSPFAGEN 316
           + +   G   D+W++GV+ Y L+SG  PF G+N
Sbjct: 183 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 215

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 112/213 (52%), Gaps = 15/213 (7%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV----SHNLEKELIRKEIDIMNQLHH 164
           +Y +L+ IG G F  V   R   TG   A K I      S +L+K  + +E+ IM  L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQK--LFREVRIMKVLNH 72
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P ++ L +  E +  + L+ E+ SGGE+F+ + A   +M E E           Q   AV
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG-RMKEKEARAK-----FRQIVSAV 126
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           ++ H+K I+H D+K EN++       N+K+ DFG + +      +    G+  +AAPE+ 
Sbjct: 127 QYCHQKFIVHRDLKAENLLLDA--DMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELF 184
Query: 285 EREPV-GFYTDMWAVGVLAYVLLSGLSPFAGEN 316
           + +   G   D+W++GV+ Y L+SG  PF G+N
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 120/249 (48%), Gaps = 18/249 (7%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK----ELIRKEIDIMNQLHHP 165
           ++I   +G G FG V+  RE+++  I A K +     LEK      +R+E++I + L HP
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHP 73
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++ L+  F D   + LI E+   G ++  +     K  E           +T+ + A+ 
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTA-----TYITELANALS 127
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           + H K +IH D+KPEN++  +  +  +K+ DFG +    P+       GT ++  PE +E
Sbjct: 128 YCHSKRVIHRDIKPENLLLGS--AGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEXIE 184
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD 345
                   D+W++GVL Y  L G  PF      ET K +   ++ F +     V+E  +D
Sbjct: 185 GRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARD 240
Query: 346 FIRRLLLRN 354
            I RLL  N
Sbjct: 241 LISRLLKHN 249

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 124/249 (49%), Gaps = 18/249 (7%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK----ELIRKEIDIMNQLHHP 165
           ++I   +G G FG V+  RE+++  I A K +     LEK      +R+E++I + L HP
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHP 69
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++ L+  F D   + LI E+   G ++  +     K+S+ +       I  T+ + A+ 
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYI--TELANALS 123
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           + H K +IH D+KPEN++  +  +  +K+ DFG +    P+       GT ++  PE++E
Sbjct: 124 YCHSKRVIHRDIKPENLLLGS--AGELKIADFGWSVH-APSSRRDTLCGTLDYLPPEMIE 180
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD 345
                   D+W++GVL Y  L G  PF      ET K +   ++ F +     V+E  +D
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARD 236
Query: 346 FIRRLLLRN 354
            I RLL  N
Sbjct: 237 LISRLLKHN 245

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 124/249 (49%), Gaps = 18/249 (7%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK----ELIRKEIDIMNQLHHP 165
           ++I   +G G FG V+  RE+++  I A K +     LEK      +R+E++I + L HP
Sbjct: 27  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHP 85
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++ L+  F D   + LI E+   G ++  +     K+S+ +         +T+ + A+ 
Sbjct: 86  NILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTA--TYITELANALS 139
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           + H K +IH D+KPEN++  +  +  +K+ DFG +    P+       GT ++  PE++E
Sbjct: 140 YCHSKRVIHRDIKPENLLLGS--AGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIE 196
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD 345
                   D+W++GVL Y  L G  PF      ET K +   ++ F +     V+E  +D
Sbjct: 197 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARD 252
Query: 346 FIRRLLLRN 354
            I RLL  N
Sbjct: 253 LISRLLKHN 261

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 124/249 (49%), Gaps = 18/249 (7%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK----ELIRKEIDIMNQLHHP 165
           ++I   +G G FG V+  RE+++  I A K +     LEK      +R+E++I + L HP
Sbjct: 36  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHP 94
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++ L+  F D   + LI E+   G ++  +     K+S+ +         +T+ + A+ 
Sbjct: 95  NILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTA--TYITELANALS 148
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           + H K +IH D+KPEN++  +  +  +K+ DFG +    P+       GT ++  PE++E
Sbjct: 149 YCHSKRVIHRDIKPENLLLGS--AGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIE 205
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD 345
                   D+W++GVL Y  L G  PF      ET K +   ++ F +     V+E  +D
Sbjct: 206 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARD 261
Query: 346 FIRRLLLRN 354
            I RLL  N
Sbjct: 262 LISRLLKHN 270

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 122/249 (48%), Gaps = 18/249 (7%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK----ELIRKEIDIMNQLHHP 165
           ++I   +G G FG V+  RE+++  I A K +     LEK      +R+E++I + L HP
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHP 68
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++ L+  F D   + LI E+   G ++  +     K  E           +T+ + A+ 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTA-----TYITELANALS 122
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           + H K +IH D+KPEN++  +  +  +K+ DFG +     +   ++  GT ++  PE++E
Sbjct: 123 YCHSKRVIHRDIKPENLLLGS--AGELKIADFGWSVHAPSSRRTEL-CGTLDYLPPEMIE 179
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD 345
                   D+W++GVL Y  L G  PF      ET K +   ++ F +     V+E  +D
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARD 235
Query: 346 FIRRLLLRN 354
            I RLL  N
Sbjct: 236 LISRLLKHN 244

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 140/259 (54%), Gaps = 20/259 (7%)
Query: 108 DHYDILEEIGTGAFGVVHRCRE---RKTGNIFAAKFIPVSHNLEK----ELIRKEIDIMN 160
           +++++L+ +GTGA+G V   R+     TG ++A K +  +  ++K    E  R E  ++ 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 161 QLHH-PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQ 219
            +   P L+ LH AF+ + ++ LI ++++GGELF  ++  + + +E EV      I + +
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-RFTEHEV-----QIYVGE 167
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--DPNEVVKISTGTAE 277
              A++H+H+  II+ D+K ENI+  +    +V + DFGL+ +   D  E      GT E
Sbjct: 168 IVLALEHLHKLGIIYRDIKLENILLDSNG--HVVLTDFGLSKEFVADETERAYDFCGTIE 225
Query: 278 FAAPEIVEREPVGF--YTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEA 335
           + AP+IV     G     D W++GVL Y LL+G SPF  + +  +   +     + +   
Sbjct: 226 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 285
Query: 336 FKNVSEEGKDFIRRLLLRN 354
            + +S   KD I+RLL+++
Sbjct: 286 PQEMSALAKDLIQRLLMKD 304

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 74/258 (28%), Positives = 127/258 (49%), Gaps = 18/258 (6%)
Query: 101 IKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK----ELIRKEI 156
           +K     + ++I   +G G FG V+  RE+++  I A K +     LEK      +R+E+
Sbjct: 1   MKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREV 59
Query: 157 DIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPIL 216
           +I + L HP ++ L+  F D   + LI E+   G ++  +     K+S+ +       I 
Sbjct: 60  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYI- 114
Query: 217 MTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA 276
            T+ + A+ + H K +IH D+KPEN++  +  +  +K+ DFG +    P+       GT 
Sbjct: 115 -TELANALSYCHSKRVIHRDIKPENLLLGS--AGELKIADFGWSVH-APSSRRTDLCGTL 170
Query: 277 EFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAF 336
           ++  PE++E        D+W++GVL Y  L G  PF      ET K +   ++ F +   
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--- 227
Query: 337 KNVSEEGKDFIRRLLLRN 354
             V+E  +D I RLL  N
Sbjct: 228 -FVTEGARDLISRLLKHN 244

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 111/213 (52%), Gaps = 15/213 (7%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH----NLEKELIRKEIDIMNQLHH 164
           +Y +L+ IG G F  V   R   TG   A K I  +     +L+K  + +E+ IM  L+H
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQK--LFREVRIMKILNH 73
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P ++ L +  E +  + LI E+ SGGE+F+ + A   +M E E           Q   AV
Sbjct: 74  PNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSK-----FRQIVSAV 127
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           ++ H+K I+H D+K EN++       N+K+ DFG + +      +    G   +AAPE+ 
Sbjct: 128 QYCHQKRIVHRDLKAENLLLDA--DMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELF 185
Query: 285 EREPV-GFYTDMWAVGVLAYVLLSGLSPFAGEN 316
           + +   G   D+W++GV+ Y L+SG  PF G+N
Sbjct: 186 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 112/236 (47%), Gaps = 12/236 (5%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL---IRKEIDIMNQLHHP 165
           HY + + +G G FG V     + TG+  A K +        ++   I++EI  +    HP
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            +I L+       +  ++ E++SGGELF      DY      V  +    L  Q   AV 
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELF------DYICKHGRVEEMEARRLFQQILSAVD 125
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           + H   ++H D+KPEN++       N K+ DFGL+  +   E ++ S G+  +AAPE++ 
Sbjct: 126 YCHRHMVVHRDLKPENVLLDAH--MNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVIS 183
Query: 286 -REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVS 340
            R   G   D+W+ GV+ Y LL G  PF  E+     K ++   +   E   ++V+
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVA 239

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  107 bits (268), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 122/243 (50%), Gaps = 18/243 (7%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE---LIRKEIDIMNQLHHPKLINLHD 172
           +G G+F  V   RE  T   +A K +   H +++     + +E D+M++L HP  + L+ 
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 96
Query: 173 AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNI 232
            F+DD+++     +   GEL + I     K+   +           +   A++++H K I
Sbjct: 97  TFQDDEKLYFGLSYAKNGELLKYIR----KIGSFD--ETCTRFYTAEIVSALEYLHGKGI 150
Query: 233 IHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP---NEVVKISTGTAEFAAPEIVEREPV 289
           IH D+KPENI+       ++++ DFG A  L P           GTA++ +PE++  +  
Sbjct: 151 IHRDLKPENILLN--EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 208
Query: 290 GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRR 349
              +D+WA+G + Y L++GL PF   N+    + +   +++F E+ F     + +D + +
Sbjct: 209 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLVEK 264
Query: 350 LLL 352
           LL+
Sbjct: 265 LLV 267

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  107 bits (268), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 111/213 (52%), Gaps = 15/213 (7%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV----SHNLEKELIRKEIDIMNQLHH 164
           +Y +L+ IG G F  V   R   TG   A K I      S +L+K  + +E+ IM  L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQK--LFREVRIMKVLNH 72
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P ++ L +  E +  + L+ E+ SGGE+F+ + A   +M E E           Q   AV
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG-RMKEKEARAK-----FRQIVSAV 126
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           ++ H+K I+H D+K EN++       N+K+ DFG + +      +    G   +AAPE+ 
Sbjct: 127 QYCHQKFIVHRDLKAENLLLDA--DMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELF 184
Query: 285 EREPV-GFYTDMWAVGVLAYVLLSGLSPFAGEN 316
           + +   G   D+W++GV+ Y L+SG  PF G+N
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  107 bits (268), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 124/249 (49%), Gaps = 18/249 (7%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK----ELIRKEIDIMNQLHHP 165
           ++I   +G G FG V+  RE+++  I A K +     LEK      +R+E++I + L HP
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHP 73
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++ L+  F D   + LI E+   G ++  +     K+S+ +       I  T+ + A+ 
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYI--TELANALS 127
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           + H K +IH D+KPEN++  +  +  +K+ DFG +     +    +  GT ++  PE++E
Sbjct: 128 YCHSKRVIHRDIKPENLLLGS--AGELKIADFGWSVHAPSSRRTDL-CGTLDYLPPEMIE 184
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD 345
                   D+W++GVL Y  L G  PF      ET K +   ++ F +     V+E  +D
Sbjct: 185 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARD 240
Query: 346 FIRRLLLRN 354
            I RLL  N
Sbjct: 241 LISRLLKHN 249

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  107 bits (268), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 122/243 (50%), Gaps = 18/243 (7%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE---LIRKEIDIMNQLHHPKLINLHD 172
           +G G+F  V   RE  T   +A K +   H +++     + +E D+M++L HP  + L+ 
Sbjct: 16  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 75
Query: 173 AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNI 232
            F+DD+++     +   GEL + I     K+   +           +   A++++H K I
Sbjct: 76  TFQDDEKLYFGLSYAKNGELLKYIR----KIGSFD--ETCTRFYTAEIVSALEYLHGKGI 129
Query: 233 IHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP---NEVVKISTGTAEFAAPEIVEREPV 289
           IH D+KPENI+       ++++ DFG A  L P           GTA++ +PE++  +  
Sbjct: 130 IHRDLKPENILLN--EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 187
Query: 290 GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRR 349
              +D+WA+G + Y L++GL PF   N+    + +   +++F E+ F     + +D + +
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLVEK 243
Query: 350 LLL 352
           LL+
Sbjct: 244 LLV 246

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  107 bits (268), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 120/249 (48%), Gaps = 18/249 (7%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK----ELIRKEIDIMNQLHHP 165
           ++I   +G G FG V+  RE++   I A K +     LEK      +R+E++I + L HP
Sbjct: 7   FEIGRPLGKGKFGNVYLAREKQRKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHP 65
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++ L+  F D   + LI E+   G ++  +     K  E           +T+ + A+ 
Sbjct: 66  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRT-----ATYITELANALS 119
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           + H K +IH D+KPEN++  +  +  +K+ DFG +    P+       GT ++  PE++E
Sbjct: 120 YCHSKRVIHRDIKPENLLLGS--AGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIE 176
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD 345
                   D+W++GVL Y  L G  PF      ET K +   ++ F +     V+E  +D
Sbjct: 177 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARD 232
Query: 346 FIRRLLLRN 354
            I RLL  N
Sbjct: 233 LISRLLKHN 241

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  107 bits (268), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 122/243 (50%), Gaps = 18/243 (7%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE---LIRKEIDIMNQLHHPKLINLHD 172
           +G G+F  V   RE  T   +A K +   H +++     + +E D+M++L HP  + L+ 
Sbjct: 15  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 74
Query: 173 AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNI 232
            F+DD+++     +   GEL + I     K+   +           +   A++++H K I
Sbjct: 75  TFQDDEKLYFGLSYAKNGELLKYIR----KIGSFD--ETCTRFYTAEIVSALEYLHGKGI 128
Query: 233 IHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP---NEVVKISTGTAEFAAPEIVEREPV 289
           IH D+KPENI+       ++++ DFG A  L P           GTA++ +PE++  +  
Sbjct: 129 IHRDLKPENILLN--EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 186
Query: 290 GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRR 349
              +D+WA+G + Y L++GL PF   N+    + +   +++F E+ F     + +D + +
Sbjct: 187 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLVEK 242
Query: 350 LLL 352
           LL+
Sbjct: 243 LLV 245

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  107 bits (268), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 122/243 (50%), Gaps = 18/243 (7%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE---LIRKEIDIMNQLHHPKLINLHD 172
           +G G+F  V   RE  T   +A K +   H +++     + +E D+M++L HP  + L+ 
Sbjct: 17  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 76
Query: 173 AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNI 232
            F+DD+++     +   GEL + I     K+   +           +   A++++H K I
Sbjct: 77  TFQDDEKLYFGLSYAKNGELLKYIR----KIGSFD--ETCTRFYTAEIVSALEYLHGKGI 130
Query: 233 IHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP---NEVVKISTGTAEFAAPEIVEREPV 289
           IH D+KPENI+       ++++ DFG A  L P           GTA++ +PE++  +  
Sbjct: 131 IHRDLKPENILLN--EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 188
Query: 290 GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRR 349
              +D+WA+G + Y L++GL PF   N+    + +   +++F E+ F     + +D + +
Sbjct: 189 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLVEK 244
Query: 350 LLL 352
           LL+
Sbjct: 245 LLV 247

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 112/213 (52%), Gaps = 15/213 (7%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV----SHNLEKELIRKEIDIMNQLHH 164
           +Y +L+ IG G F  V   R   TG   A + I      S +L+K  + +E+ IM  L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQK--LFREVRIMKVLNH 72
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P ++ L +  E +  + L+ E+ SGGE+F+ + A   +M E E           Q   AV
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG-RMKEKEARAK-----FRQIVSAV 126
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           ++ H+K I+H D+K EN++       N+K+ DFG + +      +    G+  +AAPE+ 
Sbjct: 127 QYCHQKFIVHRDLKAENLLLDA--DMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELF 184
Query: 285 EREPV-GFYTDMWAVGVLAYVLLSGLSPFAGEN 316
           + +   G   D+W++GV+ Y L+SG  PF G+N
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 121/249 (48%), Gaps = 18/249 (7%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK----ELIRKEIDIMNQLHHP 165
           ++I   +G G FG V+  RE+++  I A K +     LEK      +R+E++I + L HP
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHP 68
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++ L+  F D   + LI E+   G ++  +     K  E           +T+ + A+ 
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTA-----TYITELANALS 122
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           + H K +IH D+KPEN++  +  +  +K+ DFG +    P+       GT ++  PE++E
Sbjct: 123 YCHSKRVIHRDIKPENLLLGS--AGELKIADFGWSVH-APSSRRTDLCGTLDYLPPEMIE 179
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD 345
                   D+W++GVL Y  L G  PF      ET K +   ++ F +     V+E  +D
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARD 235
Query: 346 FIRRLLLRN 354
            I RLL  N
Sbjct: 236 LISRLLKHN 244

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 67/249 (26%), Positives = 126/249 (50%), Gaps = 30/249 (12%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE---LIRKEIDIMNQLHHPKLINLHD 172
           +G G+F  V   RE  T   +A K +   H +++     + +E D+M++L HP  + L+ 
Sbjct: 18  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 77
Query: 173 AFEDDDEMVLIFEFLSGGELFE---RITAPD---YKMSEAEVIPVTLPILMTQTSPAVKH 226
            F+DD+++     +   GEL +   +I + D    +   AE++             A+++
Sbjct: 78  TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS------------ALEY 125
Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP---NEVVKISTGTAEFAAPEI 283
           +H K IIH D+KPENI+       ++++ DFG A  L P           GTA++ +PE+
Sbjct: 126 LHGKGIIHRDLKPENILLN--EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 183
Query: 284 VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG 343
           +  +     +D+WA+G + Y L++GL PF   N+    + +   +++F E+ F     + 
Sbjct: 184 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KA 239
Query: 344 KDFIRRLLL 352
           +D + +LL+
Sbjct: 240 RDLVEKLLV 248

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 124/249 (49%), Gaps = 18/249 (7%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK----ELIRKEIDIMNQLHHP 165
           ++I   +G G FG V+  RE+++  I A K +     LEK      +R+E++I + L HP
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHP 69
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++ L+  F D   + LI E+   G ++  +     K+S+ +       I  T+ + A+ 
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYI--TELANALS 123
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           + H K +IH D+KPEN++  +  +  +K+ DFG +     +    +  GT ++  PE++E
Sbjct: 124 YCHSKRVIHRDIKPENLLLGS--AGELKIADFGWSVHAPSSRRTDL-CGTLDYLPPEMIE 180
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD 345
                   D+W++GVL Y  L G  PF      ET K +   ++ F +     V+E  +D
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARD 236
Query: 346 FIRRLLLRN 354
            I RLL  N
Sbjct: 237 LISRLLKHN 245

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 123/243 (50%), Gaps = 18/243 (7%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE---LIRKEIDIMNQLHHPKLINLHD 172
           +G G+F  V   RE  T   +A K +   H +++     + +E D+M++L HP  + L+ 
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 96
Query: 173 AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNI 232
            F+DD+++     +   GEL + I     K+   +           +   A++++H K I
Sbjct: 97  TFQDDEKLYFGLSYAKNGELLKYIR----KIGSFD--ETCTRFYTAEIVSALEYLHGKGI 150
Query: 233 IHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS---TGTAEFAAPEIVEREPV 289
           IH D+KPENI+       ++++ DFG A  L P      +    GTA++ +PE++  +  
Sbjct: 151 IHRDLKPENILLN--EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 208
Query: 290 GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRR 349
              +D+WA+G + Y L++GL PF   N+    + +   +++F E+ F     + +D + +
Sbjct: 209 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLVEK 264
Query: 350 LLL 352
           LL+
Sbjct: 265 LLV 267

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  107 bits (267), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 122/243 (50%), Gaps = 18/243 (7%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE---LIRKEIDIMNQLHHPKLINLHD 172
           +G G+F  V   RE  T   +A K +   H +++     + +E D+M++L HP  + L+ 
Sbjct: 22  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 81
Query: 173 AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNI 232
            F+DD+++     +   GEL + I     K+   +           +   A++++H K I
Sbjct: 82  TFQDDEKLYFGLSYAKNGELLKYIR----KIGSFD--ETCTRFYTAEIVSALEYLHGKGI 135
Query: 233 IHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP---NEVVKISTGTAEFAAPEIVEREPV 289
           IH D+KPENI+       ++++ DFG A  L P           GTA++ +PE++  +  
Sbjct: 136 IHRDLKPENILLN--EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 193
Query: 290 GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRR 349
              +D+WA+G + Y L++GL PF   N+    + +   +++F E+ F     + +D + +
Sbjct: 194 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLVEK 249
Query: 350 LLL 352
           LL+
Sbjct: 250 LLV 252

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  107 bits (267), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 122/243 (50%), Gaps = 18/243 (7%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE---LIRKEIDIMNQLHHPKLINLHD 172
           +G G+F  V   RE  T   +A K +   H +++     + +E D+M++L HP  + L+ 
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 173 AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNI 232
            F+DD+++     +   GEL + I     K+   +           +   A++++H K I
Sbjct: 98  TFQDDEKLYFGLSYAKNGELLKYIR----KIGSFD--ETCTRFYTAEIVSALEYLHGKGI 151
Query: 233 IHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP---NEVVKISTGTAEFAAPEIVEREPV 289
           IH D+KPENI+       ++++ DFG A  L P           GTA++ +PE++  +  
Sbjct: 152 IHRDLKPENILLN--EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 209
Query: 290 GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRR 349
              +D+WA+G + Y L++GL PF   N+    + +   +++F E+ F     + +D + +
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLVEK 265
Query: 350 LLL 352
           LL+
Sbjct: 266 LLV 268

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  107 bits (267), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 122/243 (50%), Gaps = 18/243 (7%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE---LIRKEIDIMNQLHHPKLINLHD 172
           +G G+F  V   RE  T   +A K +   H +++     + +E D+M++L HP  + L+ 
Sbjct: 45  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 104
Query: 173 AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNI 232
            F+DD+++     +   GEL + I     K+   +           +   A++++H K I
Sbjct: 105 CFQDDEKLYFGLSYAKNGELLKYIR----KIGSFD--ETCTRFYTAEIVSALEYLHGKGI 158
Query: 233 IHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP---NEVVKISTGTAEFAAPEIVEREPV 289
           IH D+KPENI+       ++++ DFG A  L P           GTA++ +PE++  +  
Sbjct: 159 IHRDLKPENILLN--EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 216
Query: 290 GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRR 349
              +D+WA+G + Y L++GL PF   N+    + +   +++F E+ F     + +D + +
Sbjct: 217 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLVEK 272
Query: 350 LLL 352
           LL+
Sbjct: 273 LLV 275

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 122/243 (50%), Gaps = 18/243 (7%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE---LIRKEIDIMNQLHHPKLINLHD 172
           +G G+F  V   RE  T   +A K +   H +++     + +E D+M++L HP  + L+ 
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 173 AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNI 232
            F+DD+++     +   GEL + I     K+   +           +   A++++H K I
Sbjct: 98  TFQDDEKLYFGLSYAKNGELLKYIR----KIGSFD--ETCTRFYTAEIVSALEYLHGKGI 151
Query: 233 IHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP---NEVVKISTGTAEFAAPEIVEREPV 289
           IH D+KPENI+       ++++ DFG A  L P           GTA++ +PE++  +  
Sbjct: 152 IHRDLKPENILLN--EDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSA 209
Query: 290 GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRR 349
              +D+WA+G + Y L++GL PF   N+    + +   +++F E+ F     + +D + +
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLVEK 265
Query: 350 LLL 352
           LL+
Sbjct: 266 LLV 268

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 122/243 (50%), Gaps = 18/243 (7%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE---LIRKEIDIMNQLHHPKLINLHD 172
           +G G+F  V   RE  T   +A K +   H +++     + +E D+M++L HP  + L+ 
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 173 AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNI 232
            F+DD+++     +   GEL + I     K+   +           +   A++++H K I
Sbjct: 98  TFQDDEKLYFGLSYAKNGELLKYIR----KIGSFD--ETCTRFYTAEIVSALEYLHGKGI 151
Query: 233 IHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP---NEVVKISTGTAEFAAPEIVEREPV 289
           IH D+KPENI+       ++++ DFG A  L P           GTA++ +PE++  +  
Sbjct: 152 IHRDLKPENILLN--EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 209
Query: 290 GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRR 349
              +D+WA+G + Y L++GL PF   N+    + +   +++F E+ F     + +D + +
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLVEK 265
Query: 350 LLL 352
           LL+
Sbjct: 266 LLV 268

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 121/249 (48%), Gaps = 18/249 (7%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK----ELIRKEIDIMNQLHHP 165
           ++I   +G G FG V+  RE+++  I A K +     LEK      +R+E++I + L HP
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHP 70
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++ L+  F D   + LI E+   G ++  +     K  E           +T+ + A+ 
Sbjct: 71  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTA-----TYITELANALS 124
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           + H K +IH D+KPEN++  +  +  +K+ +FG +    P+       GT ++  PE++E
Sbjct: 125 YCHSKRVIHRDIKPENLLLGS--AGELKIANFGWSVH-APSSRRTTLCGTLDYLPPEMIE 181
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD 345
                   D+W++GVL Y  L G  PF      ET K +   ++ F +     V+E  +D
Sbjct: 182 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARD 237
Query: 346 FIRRLLLRN 354
            I RLL  N
Sbjct: 238 LISRLLKHN 246

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 67/249 (26%), Positives = 126/249 (50%), Gaps = 30/249 (12%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE---LIRKEIDIMNQLHHPKLINLHD 172
           +G G+F  V   RE  T   +A K +   H +++     + +E D+M++L HP  + L+ 
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 100
Query: 173 AFEDDDEMVLIFEFLSGGELFE---RITAPD---YKMSEAEVIPVTLPILMTQTSPAVKH 226
            F+DD+++     +   GEL +   +I + D    +   AE++             A+++
Sbjct: 101 TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS------------ALEY 148
Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP---NEVVKISTGTAEFAAPEI 283
           +H K IIH D+KPENI+       ++++ DFG A  L P           GTA++ +PE+
Sbjct: 149 LHGKGIIHRDLKPENILLN--EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 206
Query: 284 VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG 343
           +  +     +D+WA+G + Y L++GL PF   N+    + +   +++F E+ F     + 
Sbjct: 207 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KA 262
Query: 344 KDFIRRLLL 352
           +D + +LL+
Sbjct: 263 RDLVEKLLV 271

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 122/243 (50%), Gaps = 18/243 (7%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE---LIRKEIDIMNQLHHPKLINLHD 172
           +G G+F  V   RE  T   +A K +   H +++     + +E D+M++L HP  + L+ 
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 99
Query: 173 AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNI 232
            F+DD+++     +   GEL + I     K+   +           +   A++++H K I
Sbjct: 100 TFQDDEKLYFGLSYAKNGELLKYIR----KIGSFD--ETCTRFYTAEIVSALEYLHGKGI 153
Query: 233 IHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP---NEVVKISTGTAEFAAPEIVEREPV 289
           IH D+KPENI+       ++++ DFG A  L P           GTA++ +PE++  +  
Sbjct: 154 IHRDLKPENILLN--EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 290 GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRR 349
              +D+WA+G + Y L++GL PF   N+    + +   +++F E+ F     + +D + +
Sbjct: 212 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLVEK 267
Query: 350 LLL 352
           LL+
Sbjct: 268 LLV 270

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 120/249 (48%), Gaps = 18/249 (7%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK----ELIRKEIDIMNQLHHP 165
           ++I   +G G FG V+  RE+ +  I A K +     LEK      +R+E++I + L HP
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKNSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHP 68
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++ L+  F D   + LI E+   G ++  +     K  E           +T+ + A+ 
Sbjct: 69  NILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLS-KFDEQRTA-----TYITELANALS 122
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           + H K +IH D+KPEN++  +  +  +K+ DFG +    P+       GT ++  PE++E
Sbjct: 123 YCHSKKVIHRDIKPENLLLGS--AGELKIADFGWSVH-APSSRRAALCGTLDYLPPEMIE 179
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD 345
                   D+W++GVL Y  L G  PF      +T K +   ++ F +     V+E  +D
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPD----FVTEGARD 235
Query: 346 FIRRLLLRN 354
            I RLL  N
Sbjct: 236 LISRLLKHN 244

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 124/249 (49%), Gaps = 18/249 (7%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK----ELIRKEIDIMNQLHHP 165
           ++I   +G G FG V+  RE+++  I A K +     LEK      +R+E++I + L HP
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHP 71
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++ L+  F D   + LI E+   G ++  +     K+S+ +         +T+ + A+ 
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTA--TYITELANALS 125
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           + H K +IH D+KPEN++  +  +  +K+ DFG +    P+       GT ++  PE++E
Sbjct: 126 YCHSKRVIHRDIKPENLLLGS--AGELKIADFGWSVH-APSSRRDDLCGTLDYLPPEMIE 182
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD 345
                   D+W++GVL Y  L G  PF      ET K +   ++ F +     V+E  +D
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARD 238
Query: 346 FIRRLLLRN 354
            I RLL  N
Sbjct: 239 LISRLLKHN 247

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 73/257 (28%), Positives = 126/257 (49%), Gaps = 18/257 (7%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK----ELIRKEID 157
           K     + ++I   +G G FG V+  RE+++  I A K +     LEK      +R+E++
Sbjct: 28  KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVE 86
Query: 158 IMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM 217
           I + L HP ++ L+  F D   + LI E+   G ++  +     K+S+ +         +
Sbjct: 87  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTA--TYI 140
Query: 218 TQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAE 277
           T+ + A+ + H K +IH D+KPEN++  +  +  +K+ DFG +    P+       GT +
Sbjct: 141 TELANALSYCHSKRVIHRDIKPENLLLGS--AGELKIADFGWSVHA-PSSRRDDLCGTLD 197
Query: 278 FAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
           +  PE++E        D+W++GVL Y  L G  PF      ET K +   ++ F +    
Sbjct: 198 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD---- 253
Query: 338 NVSEEGKDFIRRLLLRN 354
            V+E  +D I RLL  N
Sbjct: 254 FVTEGARDLISRLLKHN 270

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 67/249 (26%), Positives = 126/249 (50%), Gaps = 30/249 (12%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE---LIRKEIDIMNQLHHPKLINLHD 172
           +G G+F  V   RE  T   +A K +   H +++     + +E D+M++L HP  + L+ 
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 99
Query: 173 AFEDDDEMVLIFEFLSGGELFE---RITAPD---YKMSEAEVIPVTLPILMTQTSPAVKH 226
            F+DD+++     +   GEL +   +I + D    +   AE++             A+++
Sbjct: 100 TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS------------ALEY 147
Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP---NEVVKISTGTAEFAAPEI 283
           +H K IIH D+KPENI+       ++++ DFG A  L P           GTA++ +PE+
Sbjct: 148 LHGKGIIHRDLKPENILLN--EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 284 VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG 343
           +  +     +D+WA+G + Y L++GL PF   N+    + +   +++F E+ F     + 
Sbjct: 206 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KA 261
Query: 344 KDFIRRLLL 352
           +D + +LL+
Sbjct: 262 RDLVEKLLV 270

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 122/243 (50%), Gaps = 18/243 (7%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE---LIRKEIDIMNQLHHPKLINLHD 172
           +G G+F  V   RE  T   +A K +   H +++     + +E D+M++L HP  + L+ 
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 99
Query: 173 AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNI 232
            F+DD+++     +   GEL + I     K+   +           +   A++++H K I
Sbjct: 100 TFQDDEKLYFGLSYAKNGELLKYIR----KIGSFD--ETCTRFYTAEIVSALEYLHGKGI 153
Query: 233 IHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP---NEVVKISTGTAEFAAPEIVEREPV 289
           IH D+KPENI+       ++++ DFG A  L P           GTA++ +PE++  +  
Sbjct: 154 IHRDLKPENILLN--EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 290 GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRR 349
              +D+WA+G + Y L++GL PF   N+    + +   +++F E+ F     + +D + +
Sbjct: 212 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLVEK 267
Query: 350 LLL 352
           LL+
Sbjct: 268 LLV 270

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 67/249 (26%), Positives = 127/249 (51%), Gaps = 30/249 (12%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE---LIRKEIDIMNQLHHPKLINLHD 172
           +G G+F  V   RE  T   +A K +   H +++     + +E D+M++L HP  + L+ 
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 100
Query: 173 AFEDDDEMVLIFEFLSGGELFE---RITAPD---YKMSEAEVIPVTLPILMTQTSPAVKH 226
            F+DD+++     +   GEL +   +I + D    +   AE++             A+++
Sbjct: 101 TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS------------ALEY 148
Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS---TGTAEFAAPEI 283
           +H K IIH D+KPENI+       ++++ DFG A  L P      +    GTA++ +PE+
Sbjct: 149 LHGKGIIHRDLKPENILLN--EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 206
Query: 284 VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG 343
           +  +     +D+WA+G + Y L++GL PF   N+    + +   +++F E+ F     + 
Sbjct: 207 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KA 262
Query: 344 KDFIRRLLL 352
           +D + +LL+
Sbjct: 263 RDLVEKLLV 271

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 121/249 (48%), Gaps = 18/249 (7%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK----ELIRKEIDIMNQLHHP 165
           ++I   +G G FG V+  RE+++  I A K +     LEK      +R+E++I + L HP
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHP 71
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++ L+  F D   + LI E+   G ++  +     K  E           +T+ + A+ 
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTA-----TYITELANALS 125
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           + H K +IH D+KPEN++  +  +  +K+ +FG +    P+       GT ++  PE++E
Sbjct: 126 YCHSKRVIHRDIKPENLLLGS--AGELKIANFGWSVH-APSSRRTTLCGTLDYLPPEMIE 182
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD 345
                   D+W++GVL Y  L G  PF      ET K +   ++ F +     V+E  +D
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARD 238
Query: 346 FIRRLLLRN 354
            I RLL  N
Sbjct: 239 LISRLLKHN 247

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 124/262 (47%), Gaps = 12/262 (4%)
Query: 95  VPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK 154
           V  P+D+      D Y+++++IG+G FGV    R++++  + A K+I     +    +++
Sbjct: 6   VSGPMDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAAN-VKR 64
Query: 155 EIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERIT-APDYKMSEAEVIPVTL 213
           EI     L HP ++   +       + ++ E+ SGGELFERI  A  +   EA       
Sbjct: 65  EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR------ 118
Query: 214 PILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST 273
                Q    V + H   + H D+K EN +     +  +K+ DFG +     +   K + 
Sbjct: 119 -FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 177
Query: 274 GTAEFAAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV--KACDWE 330
           GT  + APE+ +++E  G   D+W+ GV  YV+L G  PF    + +  +    +  + +
Sbjct: 178 GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQ 237
Query: 331 FDEEAFKNVSEEGKDFIRRLLL 352
           +    + ++S E +  I R+ +
Sbjct: 238 YAIPDYVHISPECRHLISRIFV 259

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 112/213 (52%), Gaps = 15/213 (7%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV----SHNLEKELIRKEIDIMNQLHH 164
           +Y +L+ IG G F  V   R   TG   A + I      S +L+K  + +E+ IM  L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQK--LFREVRIMKVLNH 72
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P ++ L +  E +  + L+ E+ SGGE+F+ + A   +M E E           Q   AV
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG-RMKEKEARAK-----FRQIVSAV 126
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           ++ H+K I+H D+K EN++       N+K+ DFG + +      +    G+  +AAPE+ 
Sbjct: 127 QYCHQKFIVHRDLKAENLLLDA--DMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELF 184
Query: 285 EREPV-GFYTDMWAVGVLAYVLLSGLSPFAGEN 316
           + +   G   D+W++GV+ Y L+SG  PF G+N
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 76/242 (31%), Positives = 119/242 (49%), Gaps = 26/242 (10%)
Query: 99  VDIKTSSVY----DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN--LEKELI 152
           VD+ T ++Y    + Y+ L  +G G++G+V +CR + TG I A K    S +  + K++ 
Sbjct: 12  VDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIA 71
Query: 153 RKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF-----LSGGELFERITAPDYKMSEAE 207
            +EI ++ QL H  L+NL +  +      L+FEF     L   ELF      DY++ +  
Sbjct: 72  MREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFP--NGLDYQVVQK- 128
Query: 208 VIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL-DPN 266
                    + Q    +   H  NIIH D+KPENI+     S  VK+ DFG A  L  P 
Sbjct: 129 --------YLFQIINGIGFCHSHNIIHRDIKPENIL--VSQSGVVKLCDFGFARTLAAPG 178
Query: 267 EVVKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVK 325
           EV      T  + APE++  +   G   D+WA+G L   +  G   F G++D++ L ++ 
Sbjct: 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIM 238
Query: 326 AC 327
            C
Sbjct: 239 MC 240

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 82/273 (30%), Positives = 129/273 (47%), Gaps = 36/273 (13%)
Query: 96  PQPVDIKTSSVYDHYDILEEI-GTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK 154
           P+P   K  +V D Y + +++ G G  G V  C  R+TG   A K +      +    R+
Sbjct: 19  PEP---KKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL-----YDSPKARQ 70
Query: 155 EIDIMNQLHH------PKLINLHDAFEDDDE----MVLIFEFLSGGELFERITA-PDYKM 203
           E+D     HH      P ++ + D +E+       +++I E + GGELF RI    D   
Sbjct: 71  EVD-----HHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAF 125
Query: 204 SEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNV-KMIDFGLATK 262
           +E E   +     M     A++ +H  NI H DVKPEN++  ++    V K+ DFG A +
Sbjct: 126 TEREAAEI-----MRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180
Query: 263 LDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPF---AGENDVE 319
              N  ++    T  + APE++  E      DMW++GV+ Y+LL G  PF    G+    
Sbjct: 181 TTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP 239
Query: 320 TLK-NVKACDWEFDEEAFKNVSEEGKDFIRRLL 351
            +K  ++   + F    +  VSE+ K  IR LL
Sbjct: 240 GMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLL 272

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 76/220 (34%), Positives = 118/220 (53%), Gaps = 12/220 (5%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN--LEKELIRKEIDIMNQLHHPKL 167
           Y+ + +IG G++GVV +CR R TG I A K    S +  + K++  +EI ++ QL HP L
Sbjct: 5   YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNL 64
Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
           +NL + F     + L+FE+     L E +      + E  V  +T      QT  AV   
Sbjct: 65  VNLLEVFRRKRRLHLVFEYCDHTVLHE-LDRYQRGVPEHLVKSITW-----QTLQAVNFC 118
Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL-DPNEVVKISTGTAEFAAPE-IVE 285
           H+ N IH DVKPENI+  T++S  +K+ DFG A  L  P++       T  + +PE +V 
Sbjct: 119 HKHNCIHRDVKPENILI-TKHSV-IKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVG 176
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVK 325
               G   D+WA+G +   LLSG+  + G++DV+ L  ++
Sbjct: 177 DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIR 216

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 124/262 (47%), Gaps = 12/262 (4%)
Query: 95  VPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK 154
           V  P+D+      D Y+++++IG G FGV    R+++   + A K+I     ++ E +++
Sbjct: 6   VAGPMDLPIMHDSDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKID-ENVKR 64
Query: 155 EIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERIT-APDYKMSEAEVIPVTL 213
           EI     L HP ++   +       + ++ E+ SGGELFERI  A  +   EA       
Sbjct: 65  EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR------ 118
Query: 214 PILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST 273
                Q    V + H   + H D+K EN +     +  +K+ DFG +     +   K + 
Sbjct: 119 -FFFQQLISGVSYAHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAV 177
Query: 274 GTAEFAAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV--KACDWE 330
           GT  + APE+ +++E  G   D+W+ GV  YV+L G  PF    + +  +    +  + +
Sbjct: 178 GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQ 237
Query: 331 FDEEAFKNVSEEGKDFIRRLLL 352
           +    + ++S E +  I R+ +
Sbjct: 238 YAIPDYVHISPECRHLISRIFV 259

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 105/217 (48%), Gaps = 10/217 (4%)
Query: 98  PVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID 157
           P+D+      D YD +++IG+G FGV    R++ T  + A K+I     ++ E +++EI 
Sbjct: 10  PLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID-ENVQREII 68
Query: 158 IMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERIT-APDYKMSEAEVIPVTLPIL 216
               L HP ++   +       + +I E+ SGGEL+ERI  A  +   EA          
Sbjct: 69  NHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR-------FF 121
Query: 217 MTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA 276
             Q    V + H   I H D+K EN +     +  +K+ DFG +     +   K + GT 
Sbjct: 122 FQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 181
Query: 277 EFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPF 312
            + APE++ R+   G   D+W+ GV  YV+L G  PF
Sbjct: 182 AYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF 218

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 112/226 (49%), Gaps = 25/226 (11%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL----EKELIRKEIDIMNQLHHP 165
           +  L+ IG G+FG V   R +     +A K +     L    EK ++ +   ++  + HP
Sbjct: 40  FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERIT------APDYKMSEAEVIPVTLPILMTQ 219
            L+ LH +F+  D++  + ++++GGELF  +        P  +   AE+           
Sbjct: 100 FLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEI----------- 148
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK-LDPNEVVKISTGTAEF 278
            + A+ ++H  NI++ D+KPENI+  ++   ++ + DFGL  + ++ N       GT E+
Sbjct: 149 -ASALGYLHSLNIVYRDLKPENILLDSQG--HIVLTDFGLCKENIEHNSTTSTFCGTPEY 205
Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
            APE++ ++P     D W +G + Y +L GL PF   N  E   N+
Sbjct: 206 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI 251

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 116/213 (54%), Gaps = 12/213 (5%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           +IG G+ G+V    E+ TG   A K + +     +EL+  E+ IM   HH  +++++ ++
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
              DE+ ++ EFL GG L + +T    +M+E ++  V L +L      A+ ++H + +IH
Sbjct: 112 LVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIATVCLSVLR-----ALSYLHNQGVIH 164
Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVV--KISTGTAEFAAPEIVEREPVGFY 292
            D+K ++I+  +     +K+ DFG   ++   EV   K   GT  + APE++ R P G  
Sbjct: 165 RDIKSDSILLTS--DGRIKLSDFGFCAQVS-KEVPKRKXLVGTPYWMAPEVISRLPYGTE 221
Query: 293 TDMWAVGVLAYVLLSGLSPFAGENDVETLKNVK 325
            D+W++G++   ++ G  P+  E  ++ ++ ++
Sbjct: 222 VDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIR 254

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 111/213 (52%), Gaps = 15/213 (7%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH----NLEKELIRKEIDIMNQLHH 164
           +Y + + IG G F  V   R   TG   A K I  +     +L+K  + +E+ IM  L+H
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQK--LFREVRIMKILNH 73
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P ++ L +  E +  + L+ E+ SGGE+F+ + A   +M E E           Q   AV
Sbjct: 74  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG-RMKEKEA-----RAKFRQIVSAV 127
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           ++ H+K I+H D+K EN++       N+K+ DFG + +      +    G+  +AAPE+ 
Sbjct: 128 QYCHQKYIVHRDLKAENLLLD--GDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELF 185
Query: 285 EREPV-GFYTDMWAVGVLAYVLLSGLSPFAGEN 316
           + +   G   D+W++GV+ Y L+SG  PF G+N
Sbjct: 186 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 121/243 (49%), Gaps = 18/243 (7%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE---LIRKEIDIMNQLHHPKLINLHD 172
           +G G+F      RE  T   +A K +   H +++     + +E D+M++L HP  + L+ 
Sbjct: 38  LGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 173 AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNI 232
            F+DD+++     +   GEL + I     K+   +           +   A++++H K I
Sbjct: 98  TFQDDEKLYFGLSYAKNGELLKYIR----KIGSFD--ETCTRFYTAEIVSALEYLHGKGI 151
Query: 233 IHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP---NEVVKISTGTAEFAAPEIVEREPV 289
           IH D+KPENI+       ++++ DFG A  L P           GTA++ +PE++  +  
Sbjct: 152 IHRDLKPENILLN--EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 209
Query: 290 GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRR 349
              +D+WA+G + Y L++GL PF   N+    + +   +++F E+ F     + +D + +
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KARDLVEK 265
Query: 350 LLL 352
           LL+
Sbjct: 266 LLV 268

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 67/249 (26%), Positives = 125/249 (50%), Gaps = 30/249 (12%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE---LIRKEIDIMNQLHHPKLINLHD 172
           +G G+F  V   RE  T   +A K +   H +++     + +E D+M++L HP  + L+ 
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 99
Query: 173 AFEDDDEMVLIFEFLSGGELFE---RITAPD---YKMSEAEVIPVTLPILMTQTSPAVKH 226
            F+DD+++     +   GEL +   +I + D    +   AE++             A+++
Sbjct: 100 TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS------------ALEY 147
Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP---NEVVKISTGTAEFAAPEI 283
           +H K IIH D+KPENI+       ++++ DFG A  L P           GTA++ +PE+
Sbjct: 148 LHGKGIIHRDLKPENILLN--EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 284 VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG 343
           +  +     +D+WA+G + Y L++GL PF   N+      +   +++F E+ F     + 
Sbjct: 206 LTEKSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFP----KA 261
Query: 344 KDFIRRLLL 352
           +D + +LL+
Sbjct: 262 RDLVEKLLV 270

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 126/267 (47%), Gaps = 33/267 (12%)
Query: 102 KTSSVYDHYDILEEI-GTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMN 160
           K  +V D Y + +++ G G  G V  C  R+TG   A K +      +    R+E+D   
Sbjct: 3   KKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL-----YDSPKARQEVD--- 54
Query: 161 QLHH------PKLINLHDAFEDDDE----MVLIFEFLSGGELFERITA-PDYKMSEAEVI 209
             HH      P ++ + D +E+       +++I E + GGELF RI    D   +E E  
Sbjct: 55  --HHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA 112
Query: 210 PVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNV-KMIDFGLATKLDPNEV 268
            +     M     A++ +H  NI H DVKPEN++  ++    V K+ DFG A +   N  
Sbjct: 113 EI-----MRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-A 166
Query: 269 VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPF---AGENDVETLK-NV 324
           ++    T  + APE++  E      DMW++GV+ Y+LL G  PF    G+     +K  +
Sbjct: 167 LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRI 226
Query: 325 KACDWEFDEEAFKNVSEEGKDFIRRLL 351
           +   + F    +  VSE+ K  IR LL
Sbjct: 227 RLGQYGFPNPEWSEVSEDAKQLIRLLL 253

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 121/243 (49%), Gaps = 18/243 (7%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE---LIRKEIDIMNQLHHPKLINLHD 172
           +G G+F  V   RE  T   +A K +   H +++     + +E D+M++L HP  + L+ 
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 99
Query: 173 AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNI 232
            F+DD+++     +   GEL + I     K+   +           +   A++++H K I
Sbjct: 100 TFQDDEKLYFGLSYAKNGELLKYIR----KIGSFD--ETCTRFYTAEIVSALEYLHGKGI 153
Query: 233 IHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP---NEVVKISTGTAEFAAPEIVEREPV 289
           IH D+KPENI+       ++++ DFG A  L P           GTA++ +PE++  +  
Sbjct: 154 IHRDLKPENILLN--EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 290 GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRR 349
              +D+WA+G + Y L++GL PF   N+      +   +++F E+ F     + +D + +
Sbjct: 212 CKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFP----KARDLVEK 267
Query: 350 LLL 352
           LL+
Sbjct: 268 LLV 270

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 121/248 (48%), Gaps = 10/248 (4%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKL 167
           D Y+++++IG+G FGV    R++++  + A K+I     ++ E +++EI     L HP +
Sbjct: 18  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKID-ENVKREIINHRSLRHPNI 76
Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
           +   +       + ++ E+ SGGELFERI     + SE E           Q    V + 
Sbjct: 77  VRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEA-----RFFFQQLISGVSYC 130
Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEI-VER 286
           H   + H D+K EN +     +  +K+ DFG +     +   K + GT  + APE+ +++
Sbjct: 131 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 190
Query: 287 EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV--KACDWEFDEEAFKNVSEEGK 344
           E  G   D+W+ GV  YV+L G  PF    + +  +    +  + ++    + ++S E +
Sbjct: 191 EYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECR 250
Query: 345 DFIRRLLL 352
             I R+ +
Sbjct: 251 HLISRIFV 258

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 125/262 (47%), Gaps = 12/262 (4%)
Query: 95  VPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK 154
           V  P+D+      D Y+++++IG+G FGV    R++++  + A K+I     ++ E +++
Sbjct: 6   VSGPMDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKID-ENVKR 64
Query: 155 EIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERIT-APDYKMSEAEVIPVTL 213
           EI     L HP ++   +       + ++ E+ SGGELFERI  A  +   EA       
Sbjct: 65  EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR------ 118
Query: 214 PILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST 273
                Q    V + H   + H D+K EN +     +  +K+  FG +     +   K + 
Sbjct: 119 -FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTV 177
Query: 274 GTAEFAAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV--KACDWE 330
           GT  + APE+ +++E  G   D+W+ GV  YV+L G  PF    + +  +    +  + +
Sbjct: 178 GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQ 237
Query: 331 FDEEAFKNVSEEGKDFIRRLLL 352
           +    + ++S E +  I R+ +
Sbjct: 238 YAIPDYVHISPECRHLISRIFV 259

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 125/262 (47%), Gaps = 12/262 (4%)
Query: 95  VPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK 154
           V  P+D+      D Y+++++IG+G FGV    R++++  + A K+I     ++ E +++
Sbjct: 6   VSGPMDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKID-ENVKR 64
Query: 155 EIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERIT-APDYKMSEAEVIPVTL 213
           EI     L HP ++   +       + ++ E+ SGGELFERI  A  +   EA       
Sbjct: 65  EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR------ 118
Query: 214 PILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST 273
                Q    V + H   + H D+K EN +     +  +K+  FG +     +   K + 
Sbjct: 119 -FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTV 177
Query: 274 GTAEFAAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV--KACDWE 330
           GT  + APE+ +++E  G   D+W+ GV  YV+L G  PF    + +  +    +  + +
Sbjct: 178 GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQ 237
Query: 331 FDEEAFKNVSEEGKDFIRRLLL 352
           +    + ++S E +  I R+ +
Sbjct: 238 YAIPDYVHISPECRHLISRIFV 259

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 126/249 (50%), Gaps = 30/249 (12%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE---LIRKEIDIMNQLHHPKLINLHD 172
           +G G+F  V   RE  T   +A K +   H +++     + +E D+M++L HP  + L+ 
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 99
Query: 173 AFEDDDEMVLIFEFLSGGELFE---RITAPD---YKMSEAEVIPVTLPILMTQTSPAVKH 226
            F+DD+++     +   G L +   +I + D    +   AE++             A+++
Sbjct: 100 TFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVS------------ALEY 147
Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS---TGTAEFAAPEI 283
           +H K IIH D+KPENI+       ++++ DFG A  L P      +    GTA++ +PE+
Sbjct: 148 LHGKGIIHRDLKPENILLN--EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 205
Query: 284 VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG 343
           +  +     +D+WA+G + Y L++GL PF   N+    + +   +++F E+ F     + 
Sbjct: 206 LTEKSASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP----KA 261
Query: 344 KDFIRRLLL 352
           +D + +LL+
Sbjct: 262 RDLVEKLLV 270

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  104 bits (260), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 112/209 (53%), Gaps = 15/209 (7%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP---VSHNLEKELIRKEIDIMNQL-HHP 165
           +D+L  IG G++  V   R +KT  I+A K +    V+ + + + ++ E  +  Q  +HP
Sbjct: 22  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 81
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT-QTSPAV 224
            L+ LH  F+ +  +  + E+++GG+L        + M     +P       + + S A+
Sbjct: 82  FLVGLHSCFQTESRLFFVIEYVNGGDLM-------FHMQRQRKLPEEHARFYSAEISLAL 134
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK-LDPNEVVKISTGTAEFAAPEI 283
            ++HE+ II+ D+K +N++  +    ++K+ D+G+  + L P +      GT  + APEI
Sbjct: 135 NYLHERGIIYRDLKLDNVLLDSEG--HIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEI 192
Query: 284 VEREPVGFYTDMWAVGVLAYVLLSGLSPF 312
           +  E  GF  D WA+GVL + +++G SPF
Sbjct: 193 LRGEDYGFSVDWWALGVLMFEMMAGRSPF 221

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 138/278 (49%), Gaps = 37/278 (13%)
Query: 108 DHYDILEEI-GTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLH-HP 165
           D Y + E++ G GA   V  C    T   +A K I       +  + +E++++ Q   H 
Sbjct: 12  DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHR 71
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++ L + FE++D   L+FE + GG +   I    +  +E E       +++   + A+ 
Sbjct: 72  NVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRH-FNELEA-----SVVVQDVASALD 125
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTN-VKMIDFGLATKLDPN-EVVKIST-------GTA 276
            +H K I H D+KPENI+C+  N  + VK+ DFGL + +  N +   IST       G+A
Sbjct: 126 FLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSA 185
Query: 277 EFAAPEIVE--REPVGFY---TDMWAVGVLAYVLLSGLSPFAGENDVET----------- 320
           E+ APE+VE   E    Y    D+W++GV+ Y+LLSG  PF G    +            
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245
Query: 321 ----LKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
                ++++   +EF ++ + ++S   KD I +LL+R+
Sbjct: 246 QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRD 283

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 136/283 (48%), Gaps = 23/283 (8%)
Query: 84  DQYVFDIYSKYVPQPVDIKTSSVY-DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP 142
           D+YV D      P  V +K   +  D ++IL+ IG GAF  V   + ++TG ++A K + 
Sbjct: 36  DKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMN 95
Query: 143 VSHNLEK---ELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAP 199
               L++      R+E D++       +  LH AF+D++ + L+ E+  GG+L   ++  
Sbjct: 96  KWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLS-- 153
Query: 200 DYKMSEAEVIPVTLP-ILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFG 258
                  E IP  +    + +   A+  +H    +H D+KP+NI+       ++++ DFG
Sbjct: 154 ----KFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLD--RCGHIRLADFG 207
Query: 259 LATKLDPNEVVK--ISTGTAEFAAPEIVEREPVGFY-------TDMWAVGVLAYVLLSGL 309
              KL  +  V+  ++ GT ++ +PEI++    G          D WA+GV AY +  G 
Sbjct: 208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
Query: 310 SPFAGENDVETLKNVKACDWEFDEEAF-KNVSEEGKDFIRRLL 351
           +PF  ++  ET   +             + V EE +DFI+RLL
Sbjct: 268 TPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLL 310

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 124/249 (49%), Gaps = 30/249 (12%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE---LIRKEIDIMNQLHHPKLINLHD 172
           +G G+F  V   RE  T   +A K +   H +++     + +E D+M++L HP  + L+ 
Sbjct: 43  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 102
Query: 173 AFEDDDEMVLIFEFLSGGELFE---RITAPD---YKMSEAEVIPVTLPILMTQTSPAVKH 226
            F+DD+++     +   GEL +   +I + D    +   AE++             A+++
Sbjct: 103 TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS------------ALEY 150
Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP---NEVVKISTGTAEFAAPEI 283
           +H K IIH D+KPENI+       ++++ DFG A  L P           GTA++ +PE+
Sbjct: 151 LHGKGIIHRDLKPENILLN--EDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 208
Query: 284 VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG 343
           +  +     +D+WA+G + Y L++GL PF   N+    + +   +++F    F     + 
Sbjct: 209 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAAFFP----KA 264
Query: 344 KDFIRRLLL 352
           +D + +LL+
Sbjct: 265 RDLVEKLLV 273

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 68/248 (27%), Positives = 129/248 (52%), Gaps = 13/248 (5%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLI 168
           + D   +IG G+ G+V     R +G + A K + +     +EL+  E+ IM    H  ++
Sbjct: 152 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVV 211
Query: 169 NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH 228
            +++++   DE+ ++ EFL GG L + +T    +M+E ++  V L +L      A+  +H
Sbjct: 212 EMYNSYLVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIAAVCLAVLQ-----ALSVLH 264
Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVV--KISTGTAEFAAPEIVER 286
            + +IH D+K ++I+    +   VK+ DFG   ++   EV   K   GT  + APE++ R
Sbjct: 265 AQGVIHRDIKSDSILLT--HDGRVKLSDFGFCAQVS-KEVPRRKXLVGTPYWMAPELISR 321
Query: 287 EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDF 346
            P G   D+W++G++   ++ G  P+  E  ++ +K ++  +     +    VS   K F
Sbjct: 322 LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-NLPPRLKNLHKVSPSLKGF 380
Query: 347 IRRLLLRN 354
           + RLL+R+
Sbjct: 381 LDRLLVRD 388

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 127/242 (52%), Gaps = 13/242 (5%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           +IG G+ G+V     R +G + A K + +     +EL+  E+ IM    H  ++ +++++
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 97
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
              DE+ ++ EFL GG L + +T    +M+E ++  V L +L      A+  +H + +IH
Sbjct: 98  LVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIAAVCLAVLQ-----ALSVLHAQGVIH 150
Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVV--KISTGTAEFAAPEIVEREPVGFY 292
            D+K ++I+    +   VK+ DFG   ++   EV   K   GT  + APE++ R P G  
Sbjct: 151 RDIKSDSILLT--HDGRVKLSDFGFCAQVS-KEVPRRKXLVGTPYWMAPELISRLPYGPE 207
Query: 293 TDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLL 352
            D+W++G++   ++ G  P+  E  ++ +K ++  +     +    VS   K F+ RLL+
Sbjct: 208 VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-NLPPRLKNLHKVSPSLKGFLDRLLV 266
Query: 353 RN 354
           R+
Sbjct: 267 RD 268

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 130/270 (48%), Gaps = 22/270 (8%)
Query: 94  YVPQPVDIKTSSVYDHYDILEEI-GTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELI 152
           +V   + IK +++ D Y +  ++ G G  G V +   ++T   FA K +    +  K   
Sbjct: 17  HVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML---QDCPKA-- 71
Query: 153 RKEIDIMNQLHH-PKLINLHDAFED----DDEMVLIFEFLSGGELFERIT-APDYKMSEA 206
           R+E+++  +    P ++ + D +E+       ++++ E L GGELF RI    D   +E 
Sbjct: 72  RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 131
Query: 207 EVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIM-CQTRNSTNVKMIDFGLATKLDP 265
           E   +     M     A++++H  NI H DVKPEN++    R +  +K+ DFG A +   
Sbjct: 132 EASEI-----MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 186
Query: 266 NEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVK 325
           +  +     T  + APE++  E      DMW++GV+ Y+LL G  PF   + +     +K
Sbjct: 187 HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 246
Query: 326 A----CDWEFDEEAFKNVSEEGKDFIRRLL 351
                  +EF    +  VSEE K  IR LL
Sbjct: 247 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLL 276

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 127/242 (52%), Gaps = 13/242 (5%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           +IG G+ G+V     R +G + A K + +     +EL+  E+ IM    H  ++ +++++
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 95
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
              DE+ ++ EFL GG L + +T    +M+E ++  V L +L      A+  +H + +IH
Sbjct: 96  LVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIAAVCLAVLQ-----ALSVLHAQGVIH 148
Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVV--KISTGTAEFAAPEIVEREPVGFY 292
            D+K ++I+    +   VK+ DFG   ++   EV   K   GT  + APE++ R P G  
Sbjct: 149 RDIKSDSILLT--HDGRVKLSDFGFCAQVS-KEVPRRKXLVGTPYWMAPELISRLPYGPE 205
Query: 293 TDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLL 352
            D+W++G++   ++ G  P+  E  ++ +K ++  +     +    VS   K F+ RLL+
Sbjct: 206 VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-NLPPRLKNLHKVSPSLKGFLDRLLV 264
Query: 353 RN 354
           R+
Sbjct: 265 RD 266

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 112/209 (53%), Gaps = 15/209 (7%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP---VSHNLEKELIRKEIDIMNQL-HHP 165
           +D+L  IG G++  V   R +KT  I+A K +    V+ + + + ++ E  +  Q  +HP
Sbjct: 7   FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 66
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT-QTSPAV 224
            L+ LH  F+ +  +  + E+++GG+L        + M     +P       + + S A+
Sbjct: 67  FLVGLHSCFQTESRLFFVIEYVNGGDLM-------FHMQRQRKLPEEHARFYSAEISLAL 119
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK-LDPNEVVKISTGTAEFAAPEI 283
            ++HE+ II+ D+K +N++  +    ++K+ D+G+  + L P +      GT  + APEI
Sbjct: 120 NYLHERGIIYRDLKLDNVLLDSEG--HIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEI 177
Query: 284 VEREPVGFYTDMWAVGVLAYVLLSGLSPF 312
           +  E  GF  D WA+GVL + +++G SPF
Sbjct: 178 LRGEDYGFSVDWWALGVLMFEMMAGRSPF 206

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 127/242 (52%), Gaps = 13/242 (5%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           +IG G+ G+V     R +G + A K + +     +EL+  E+ IM    H  ++ +++++
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
              DE+ ++ EFL GG L + +T    +M+E ++  V L +L      A+  +H + +IH
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIAAVCLAVLQ-----ALSVLHAQGVIH 139
Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVV--KISTGTAEFAAPEIVEREPVGFY 292
            D+K ++I+    +   VK+ DFG   ++   EV   K   GT  + APE++ R P G  
Sbjct: 140 RDIKSDSILLT--HDGRVKLSDFGFCAQVS-KEVPRRKXLVGTPYWMAPELISRLPYGPE 196
Query: 293 TDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLL 352
            D+W++G++   ++ G  P+  E  ++ +K ++  +     +    VS   K F+ RLL+
Sbjct: 197 VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-NLPPRLKNLHKVSPSLKGFLDRLLV 255
Query: 353 RN 354
           R+
Sbjct: 256 RD 257

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 112/209 (53%), Gaps = 15/209 (7%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP---VSHNLEKELIRKEIDIMNQL-HHP 165
           +D+L  IG G++  V   R +KT  I+A K +    V+ + + + ++ E  +  Q  +HP
Sbjct: 11  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT-QTSPAV 224
            L+ LH  F+ +  +  + E+++GG+L        + M     +P       + + S A+
Sbjct: 71  FLVGLHSCFQTESRLFFVIEYVNGGDLM-------FHMQRQRKLPEEHARFYSAEISLAL 123
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK-LDPNEVVKISTGTAEFAAPEI 283
            ++HE+ II+ D+K +N++  +    ++K+ D+G+  + L P +      GT  + APEI
Sbjct: 124 NYLHERGIIYRDLKLDNVLLDSEG--HIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEI 181
Query: 284 VEREPVGFYTDMWAVGVLAYVLLSGLSPF 312
           +  E  GF  D WA+GVL + +++G SPF
Sbjct: 182 LRGEDYGFSVDWWALGVLMFEMMAGRSPF 210

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 131/270 (48%), Gaps = 22/270 (8%)
Query: 94  YVPQPVDIKTSSVYDHYDILEEI-GTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELI 152
           +V   + IK +++ D Y +  ++ G G  G V +   ++T   FA K +    +  K   
Sbjct: 9   HVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML---QDCPKA-- 63
Query: 153 RKEIDIMNQLHH-PKLINLHDAFED----DDEMVLIFEFLSGGELFERIT-APDYKMSEA 206
           R+E+++  +    P ++ + D +E+       ++++ E L GGELF RI    D   +E 
Sbjct: 64  RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 123
Query: 207 EVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQT-RNSTNVKMIDFGLATKLDP 265
           E   +     M     A++++H  NI H DVKPEN++  + R +  +K+ DFG A +   
Sbjct: 124 EASEI-----MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 178
Query: 266 NEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVK 325
           +  +     T  + APE++  E      DMW++GV+ Y+LL G  PF   + +     +K
Sbjct: 179 HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 238
Query: 326 A----CDWEFDEEAFKNVSEEGKDFIRRLL 351
                  +EF    +  VSEE K  IR LL
Sbjct: 239 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLL 268

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 131/270 (48%), Gaps = 22/270 (8%)
Query: 94  YVPQPVDIKTSSVYDHYDILEEI-GTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELI 152
           +V   + IK +++ D Y +  ++ G G  G V +   ++T   FA K +    +  K   
Sbjct: 7   HVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML---QDCPKA-- 61
Query: 153 RKEIDIMNQLHH-PKLINLHDAFED----DDEMVLIFEFLSGGELFERIT-APDYKMSEA 206
           R+E+++  +    P ++ + D +E+       ++++ E L GGELF RI    D   +E 
Sbjct: 62  RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 121
Query: 207 EVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQT-RNSTNVKMIDFGLATKLDP 265
           E   +     M     A++++H  NI H DVKPEN++  + R +  +K+ DFG A +   
Sbjct: 122 EASEI-----MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 176
Query: 266 NEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVK 325
           +  +     T  + APE++  E      DMW++GV+ Y+LL G  PF   + +     +K
Sbjct: 177 HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 236
Query: 326 A----CDWEFDEEAFKNVSEEGKDFIRRLL 351
                  +EF    +  VSEE K  IR LL
Sbjct: 237 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLL 266

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 127/242 (52%), Gaps = 13/242 (5%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           +IG G+ G+V     R +G + A K + +     +EL+  E+ IM    H  ++ +++++
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 90
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
              DE+ ++ EFL GG L + +T    +M+E ++  V L +L      A+  +H + +IH
Sbjct: 91  LVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIAAVCLAVLQ-----ALSVLHAQGVIH 143
Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVV--KISTGTAEFAAPEIVEREPVGFY 292
            D+K ++I+    +   VK+ DFG   ++   EV   K   GT  + APE++ R P G  
Sbjct: 144 RDIKSDSILLT--HDGRVKLSDFGFCAQVS-KEVPRRKXLVGTPYWMAPELISRLPYGPE 200
Query: 293 TDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLL 352
            D+W++G++   ++ G  P+  E  ++ +K ++  +     +    VS   K F+ RLL+
Sbjct: 201 VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-NLPPRLKNLHKVSPSLKGFLDRLLV 259
Query: 353 RN 354
           R+
Sbjct: 260 RD 261

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 130/270 (48%), Gaps = 22/270 (8%)
Query: 94  YVPQPVDIKTSSVYDHYDILEEI-GTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELI 152
           +V   + IK +++ D Y +  ++ G G  G V +   ++T   FA K +    +  K   
Sbjct: 3   HVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML---QDCPKA-- 57
Query: 153 RKEIDIMNQLHH-PKLINLHDAFED----DDEMVLIFEFLSGGELFERIT-APDYKMSEA 206
           R+E+++  +    P ++ + D +E+       ++++ E L GGELF RI    D   +E 
Sbjct: 58  RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 117
Query: 207 EVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIM-CQTRNSTNVKMIDFGLATKLDP 265
           E   +     M     A++++H  NI H DVKPEN++    R +  +K+ DFG A +   
Sbjct: 118 EASEI-----MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 172
Query: 266 NEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVK 325
           +  +     T  + APE++  E      DMW++GV+ Y+LL G  PF   + +     +K
Sbjct: 173 HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 232
Query: 326 A----CDWEFDEEAFKNVSEEGKDFIRRLL 351
                  +EF    +  VSEE K  IR LL
Sbjct: 233 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLL 262

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 71/253 (28%), Positives = 126/253 (49%), Gaps = 18/253 (7%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL---EKELIRKEIDIMNQLHHPK 166
           ++IL+ IG GAFG V   + +    +FA K +     L   E    R+E D++       
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKH 226
           +  LH AF+DD+ + L+ ++  GG+L   ++  + ++ E           + +   A+  
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEE-----MARFYLAEMVIAIDS 190
Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVK--ISTGTAEFAAPEIV 284
           +H+ + +H D+KP+NI+       ++++ DFG   KL  +  V+  ++ GT ++ +PEI+
Sbjct: 191 VHQLHYVHRDIKPDNILMDMNG--HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 248
Query: 285 E-----REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD-EEAFKN 338
           +     +   G   D W++GV  Y +L G +PF  E+ VET   +      F       +
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTD 308
Query: 339 VSEEGKDFIRRLL 351
           VSE  KD IRRL+
Sbjct: 309 VSENAKDLIRRLI 321

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 131/270 (48%), Gaps = 22/270 (8%)
Query: 94  YVPQPVDIKTSSVYDHYDILEEI-GTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELI 152
           +V   + IK +++ D Y +  ++ G G  G V +   ++T   FA K +    +  K   
Sbjct: 3   HVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML---QDCPKA-- 57
Query: 153 RKEIDIMNQLHH-PKLINLHDAFED----DDEMVLIFEFLSGGELFERIT-APDYKMSEA 206
           R+E+++  +    P ++ + D +E+       ++++ E L GGELF RI    D   +E 
Sbjct: 58  RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 117
Query: 207 EVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQT-RNSTNVKMIDFGLATKLDP 265
           E   +     M     A++++H  NI H DVKPEN++  + R +  +K+ DFG A +   
Sbjct: 118 EASEI-----MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 172
Query: 266 NEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVK 325
           +  +     T  + APE++  E      DMW++GV+ Y+LL G  PF   + +     +K
Sbjct: 173 HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 232
Query: 326 A----CDWEFDEEAFKNVSEEGKDFIRRLL 351
                  +EF    +  VSEE K  IR LL
Sbjct: 233 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLL 262

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 129/249 (51%), Gaps = 13/249 (5%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKL 167
            + D   +IG G+ G+V     R +G + A K + +     +EL+  E+ IM    H  +
Sbjct: 74  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 133
Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
           + +++++   DE+ ++ EFL GG L + +T    +M+E ++  V L +L      A+  +
Sbjct: 134 VEMYNSYLVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIAAVCLAVLQ-----ALSVL 186
Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVV--KISTGTAEFAAPEIVE 285
           H + +IH D+K ++I+    +   VK+ DFG   ++   EV   K   GT  + APE++ 
Sbjct: 187 HAQGVIHRDIKSDSILLT--HDGRVKLSDFGFCAQVS-KEVPRRKXLVGTPYWMAPELIS 243
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD 345
           R P G   D+W++G++   ++ G  P+  E  ++ +K ++  +     +    VS   K 
Sbjct: 244 RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-NLPPRLKNLHKVSPSLKG 302
Query: 346 FIRRLLLRN 354
           F+ RLL+R+
Sbjct: 303 FLDRLLVRD 311

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 143/280 (51%), Gaps = 19/280 (6%)
Query: 84  DQYVFDIYSKYVPQPVDIKTSSVY-DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP 142
           D+YV +      P    +K   ++ + ++I++ IG GAFG V   + + T  I+A K + 
Sbjct: 65  DKYVAEFLEWAKPFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILN 124
Query: 143 VSHNL---EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAP 199
               L   E    R+E D++       +  LH AF+D++ + L+ ++  GG+L   ++  
Sbjct: 125 KWEMLKRAETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKF 184
Query: 200 DYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGL 259
           + K+ E           + +   A+  +H+ + +H D+KP+N++       ++++ DFG 
Sbjct: 185 EDKLPED-----MARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNG--HIRLADFGS 237
Query: 260 ATKLDPNEVVK--ISTGTAEFAAPEIVE--REPVGFY---TDMWAVGVLAYVLLSGLSPF 312
             K++ +  V+  ++ GT ++ +PEI++   + +G Y    D W++GV  Y +L G +PF
Sbjct: 238 CLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 297
Query: 313 AGENDVETLKNVKACDWEFD-EEAFKNVSEEGKDFIRRLL 351
             E+ VET   +   +  F       +VSEE KD I+RL+
Sbjct: 298 YAESLVETYGKIMNHEERFQFPSHVTDVSEEAKDLIQRLI 337

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 131/270 (48%), Gaps = 22/270 (8%)
Query: 94  YVPQPVDIKTSSVYDHYDILEEI-GTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELI 152
           +V   + IK +++ D Y +  ++ G G  G V +   ++T   FA K +    +  K   
Sbjct: 8   HVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML---QDCPKA-- 62
Query: 153 RKEIDIMNQLHH-PKLINLHDAFED----DDEMVLIFEFLSGGELFERIT-APDYKMSEA 206
           R+E+++  +    P ++ + D +E+       ++++ E L GGELF RI    D   +E 
Sbjct: 63  RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 122
Query: 207 EVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQT-RNSTNVKMIDFGLATKLDP 265
           E   +     M     A++++H  NI H DVKPEN++  + R +  +K+ DFG A +   
Sbjct: 123 EASEI-----MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 177
Query: 266 NEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVK 325
           +  +     T  + APE++  E      DMW++GV+ Y+LL G  PF   + +     +K
Sbjct: 178 HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 237
Query: 326 A----CDWEFDEEAFKNVSEEGKDFIRRLL 351
                  +EF    +  VSEE K  IR LL
Sbjct: 238 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLL 267

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 143/280 (51%), Gaps = 19/280 (6%)
Query: 84  DQYVFDIYSKYVPQPVDIKTSSVY-DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP 142
           D+YV +      P    +K   ++ + ++I++ IG GAFG V   + + T  I+A K + 
Sbjct: 49  DKYVAEFLEWAKPFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILN 108
Query: 143 VSHNL---EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAP 199
               L   E    R+E D++       +  LH AF+D++ + L+ ++  GG+L   ++  
Sbjct: 109 KWEMLKRAETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKF 168
Query: 200 DYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGL 259
           + K+ E           + +   A+  +H+ + +H D+KP+N++       ++++ DFG 
Sbjct: 169 EDKLPED-----MARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNG--HIRLADFGS 221
Query: 260 ATKLDPNEVVK--ISTGTAEFAAPEIVE--REPVGFY---TDMWAVGVLAYVLLSGLSPF 312
             K++ +  V+  ++ GT ++ +PEI++   + +G Y    D W++GV  Y +L G +PF
Sbjct: 222 CLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 281
Query: 313 AGENDVETLKNVKACDWEFD-EEAFKNVSEEGKDFIRRLL 351
             E+ VET   +   +  F       +VSEE KD I+RL+
Sbjct: 282 YAESLVETYGKIMNHEERFQFPSHVTDVSEEAKDLIQRLI 321

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 112/209 (53%), Gaps = 15/209 (7%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP---VSHNLEKELIRKEIDIMNQL-HHP 165
           +D+L  IG G++  V   R +KT  I+A + +    V+ + + + ++ E  +  Q  +HP
Sbjct: 54  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT-QTSPAV 224
            L+ LH  F+ +  +  + E+++GG+L        + M     +P       + + S A+
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDLM-------FHMQRQRKLPEEHARFYSAEISLAL 166
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK-LDPNEVVKISTGTAEFAAPEI 283
            ++HE+ II+ D+K +N++  +    ++K+ D+G+  + L P +      GT  + APEI
Sbjct: 167 NYLHERGIIYRDLKLDNVLLDSEG--HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEI 224
Query: 284 VEREPVGFYTDMWAVGVLAYVLLSGLSPF 312
           +  E  GF  D WA+GVL + +++G SPF
Sbjct: 225 LRGEDYGFSVDWWALGVLMFEMMAGRSPF 253

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 131/270 (48%), Gaps = 22/270 (8%)
Query: 94  YVPQPVDIKTSSVYDHYDILEEI-GTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELI 152
           +V   + IK +++ D Y +  ++ G G  G V +   ++T   FA K +    +  K   
Sbjct: 1   HVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML---QDCPKA-- 55
Query: 153 RKEIDIMNQLHH-PKLINLHDAFED----DDEMVLIFEFLSGGELFERIT-APDYKMSEA 206
           R+E+++  +    P ++ + D +E+       ++++ E L GGELF RI    D   +E 
Sbjct: 56  RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 115
Query: 207 EVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQT-RNSTNVKMIDFGLATKLDP 265
           E   +     M     A++++H  NI H DVKPEN++  + R +  +K+ DFG A +   
Sbjct: 116 EASEI-----MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 170
Query: 266 NEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVK 325
           +  +     T  + APE++  E      DMW++GV+ Y+LL G  PF   + +     +K
Sbjct: 171 HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 230
Query: 326 A----CDWEFDEEAFKNVSEEGKDFIRRLL 351
                  +EF    +  VSEE K  IR LL
Sbjct: 231 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLL 260

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 131/270 (48%), Gaps = 22/270 (8%)
Query: 94  YVPQPVDIKTSSVYDHYDILEEI-GTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELI 152
           +V   + IK +++ D Y +  ++ G G  G V +   ++T   FA K +    +  K   
Sbjct: 2   HVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML---QDCPKA-- 56
Query: 153 RKEIDIMNQLHH-PKLINLHDAFED----DDEMVLIFEFLSGGELFERIT-APDYKMSEA 206
           R+E+++  +    P ++ + D +E+       ++++ E L GGELF RI    D   +E 
Sbjct: 57  RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 116
Query: 207 EVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQT-RNSTNVKMIDFGLATKLDP 265
           E   +     M     A++++H  NI H DVKPEN++  + R +  +K+ DFG A +   
Sbjct: 117 EASEI-----MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 171
Query: 266 NEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVK 325
           +  +     T  + APE++  E      DMW++GV+ Y+LL G  PF   + +     +K
Sbjct: 172 HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 231
Query: 326 A----CDWEFDEEAFKNVSEEGKDFIRRLL 351
                  +EF    +  VSEE K  IR LL
Sbjct: 232 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLL 261

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 128/265 (48%), Gaps = 22/265 (8%)
Query: 99  VDIKTSSVYDHYDILEEI-GTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID 157
           + IK +++ D Y +  ++ G G  G V +   ++T   FA K +    +  K   R+E++
Sbjct: 52  LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML---QDCPKA--RREVE 106
Query: 158 IMNQLHH-PKLINLHDAFED----DDEMVLIFEFLSGGELFERIT-APDYKMSEAEVIPV 211
           +  +    P ++ + D +E+       ++++ E L GGELF RI    D   +E E   +
Sbjct: 107 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 166
Query: 212 TLPILMTQTSPAVKHMHEKNIIHLDVKPENIM-CQTRNSTNVKMIDFGLATKLDPNEVVK 270
                M     A++++H  NI H DVKPEN++    R +  +K+ DFG A +   +  + 
Sbjct: 167 -----MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 221
Query: 271 ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKA---- 326
               T  + APE++  E      DMW++GV+ Y+LL G  PF   + +     +K     
Sbjct: 222 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 281
Query: 327 CDWEFDEEAFKNVSEEGKDFIRRLL 351
             +EF    +  VSEE K  IR LL
Sbjct: 282 GQYEFPNPEWSEVSEEVKMLIRNLL 306

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 128/265 (48%), Gaps = 22/265 (8%)
Query: 99  VDIKTSSVYDHYDILEEI-GTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID 157
           + IK +++ D Y +  ++ G G  G V +   ++T   FA K +    +  K   R+E++
Sbjct: 58  LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML---QDCPKA--RREVE 112
Query: 158 IMNQLHH-PKLINLHDAFED----DDEMVLIFEFLSGGELFERIT-APDYKMSEAEVIPV 211
           +  +    P ++ + D +E+       ++++ E L GGELF RI    D   +E E   +
Sbjct: 113 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 172
Query: 212 TLPILMTQTSPAVKHMHEKNIIHLDVKPENIM-CQTRNSTNVKMIDFGLATKLDPNEVVK 270
                M     A++++H  NI H DVKPEN++    R +  +K+ DFG A +   +  + 
Sbjct: 173 -----MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 227
Query: 271 ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKA---- 326
               T  + APE++  E      DMW++GV+ Y+LL G  PF   + +     +K     
Sbjct: 228 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 287
Query: 327 CDWEFDEEAFKNVSEEGKDFIRRLL 351
             +EF    +  VSEE K  IR LL
Sbjct: 288 GQYEFPNPEWSEVSEEVKMLIRNLL 312

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 107/213 (50%), Gaps = 15/213 (7%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV----SHNLEKELIRKEIDIMNQLHH 164
           +Y +L+ IG G F  V   R   TG   A K I      S +L+K  + +E+ I   L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQK--LFREVRIXKVLNH 72
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P ++ L +  E +  + L+ E+ SGGE+F      DY ++              Q   AV
Sbjct: 73  PNIVKLFEVIETEKTLYLVXEYASGGEVF------DYLVAHGRXKEKEARAKFRQIVSAV 126
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           ++ H+K I+H D+K EN++       N+K+ DFG + +      +    G   +AAPE+ 
Sbjct: 127 QYCHQKFIVHRDLKAENLLLDA--DXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELF 184
Query: 285 EREPV-GFYTDMWAVGVLAYVLLSGLSPFAGEN 316
           + +   G   D+W++GV+ Y L+SG  PF G+N
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 130/270 (48%), Gaps = 22/270 (8%)
Query: 94  YVPQPVDIKTSSVYDHYDILEEI-GTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELI 152
           +V   + IK +++ D Y +  ++ G G  G V +   ++T   FA K +    +  K   
Sbjct: 1   HVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML---QDCPKA-- 55
Query: 153 RKEIDIMNQLHH-PKLINLHDAFED----DDEMVLIFEFLSGGELFERIT-APDYKMSEA 206
           R+E+++  +    P ++ + D +E+       ++++ E L GGELF RI    D   +E 
Sbjct: 56  RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 115
Query: 207 EVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIM-CQTRNSTNVKMIDFGLATKLDP 265
           E   +     M     A++++H  NI H DVKPEN++    R +  +K+ DFG A +   
Sbjct: 116 EASEI-----MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 170
Query: 266 NEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVK 325
           +  +     T  + APE++  E      DMW++GV+ Y+LL G  PF   + +     +K
Sbjct: 171 HNSLTEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 230
Query: 326 A----CDWEFDEEAFKNVSEEGKDFIRRLL 351
                  +EF    +  VSEE K  IR LL
Sbjct: 231 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLL 260

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 130/253 (51%), Gaps = 17/253 (6%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---I 158
           + ++  D +D ++ +GTG+FG V   + +++GN +A K +     ++ + I   ++   I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 159 MNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           +  ++ P L+ L  +F+D+  + ++ E+++GGE+F  +     + SE         I++T
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLT 153
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
                 +++H  ++I+ D+KPEN++   +    +++ DFG A ++          GT E+
Sbjct: 154 -----FEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGR--TWXLCGTPEY 204
Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKN 338
            APEI+  +      D WA+GVL Y + +G  PF  +  ++  + + +    F      +
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKVRFPS----H 260
Query: 339 VSEEGKDFIRRLL 351
            S + KD +R LL
Sbjct: 261 FSSDLKDLLRNLL 273

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 130/253 (51%), Gaps = 17/253 (6%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---I 158
           + ++  D +D ++ +GTG+FG V   + +++GN +A K +     ++ + I   ++   I
Sbjct: 56  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 115
Query: 159 MNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           +  ++ P L+ L  +F+D+  + ++ E+++GGE+F  +     + SE         I++T
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLT 174
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
                 +++H  ++I+ D+KPEN++   +    +++ DFG A ++          GT E+
Sbjct: 175 -----FEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRV--KGATWTLCGTPEY 225
Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKN 338
            APEI+  +      D WA+GVL Y + +G  PF  +  ++  + + +    F      +
Sbjct: 226 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----H 281
Query: 339 VSEEGKDFIRRLL 351
            S + KD +R LL
Sbjct: 282 FSSDLKDLLRNLL 294

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 125/261 (47%), Gaps = 15/261 (5%)
Query: 97  QPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE---KELIR 153
           QPV   T + +  Y +L   G G FG V  C+ R TG ++A K +      +   + +  
Sbjct: 179 QPV---TKNTFRQYRVL---GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL 232
Query: 154 KEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTL 213
            E  I+ +++   +++L  A+E  D + L+   ++GG+L   I    Y M +A       
Sbjct: 233 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHI----YHMGQAGFPEARA 288
Query: 214 PILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST 273
                +    ++ +H + I++ D+KPENI+    +  ++++ D GLA  +   + +K   
Sbjct: 289 VFYAAEICCGLEDLHRERIVYRDLKPENIL--LDDHGHIRISDLGLAVHVPEGQTIKGRV 346
Query: 274 GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE 333
           GT  + APE+V+ E   F  D WA+G L Y +++G SPF         + V+    E  E
Sbjct: 347 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE 406
Query: 334 EAFKNVSEEGKDFIRRLLLRN 354
           E  +  S + +    +LL ++
Sbjct: 407 EYSERFSPQARSLCSQLLCKD 427

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 119/224 (53%), Gaps = 18/224 (8%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE---LIRKEIDIMNQLHHPK 166
           Y++++ IG GAFG V   R + T  ++A K +     +++       +E DIM   + P 
Sbjct: 76  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 135
Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKH 226
           ++ L  AF+DD  + ++ E++ GG+L   ++  +Y + E      T  +++     A+  
Sbjct: 136 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS--NYDVPEKWARFYTAEVVL-----ALDA 188
Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFAAPEIV 284
           +H    IH DVKP+N++     S ++K+ DFG   K++   +V+  T  GT ++ +PE++
Sbjct: 189 IHSMGFIHRDVKPDNMLLD--KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 246
Query: 285 EREPV-GFY---TDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           + +   G+Y    D W+VGV  Y +L G +PF  ++ V T   +
Sbjct: 247 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 290

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 130/253 (51%), Gaps = 17/253 (6%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---I 158
           + ++  D +D ++ +GTG+FG V   + +++GN +A K +     ++ + I   ++   I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 159 MNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           +  ++ P L+ L  +F+D+  + ++ E+++GGE+F  +     + SE         I++T
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLT 153
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
                 +++H  ++I+ D+KPEN++   +    +++ DFG A ++          GT E+
Sbjct: 154 -----FEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGR--TWXLCGTPEY 204
Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKN 338
            APEI+  +      D WA+GVL Y + +G  PF  +  ++  + + +    F      +
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----H 260
Query: 339 VSEEGKDFIRRLL 351
            S + KD +R LL
Sbjct: 261 FSSDLKDLLRNLL 273

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 130/253 (51%), Gaps = 17/253 (6%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---I 158
           + ++  D +D ++ +GTG+FG V   + +++GN +A K +     ++ + I   ++   I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 159 MNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           +  ++ P L+ L  +F+D+  + ++ E+++GGE+F  +     + SE         I++T
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLT 153
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
                 +++H  ++I+ D+KPEN++   +    +++ DFG A ++          GT E+
Sbjct: 154 -----FEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGR--TWXLAGTPEY 204
Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKN 338
            APEI+  +      D WA+GVL Y + +G  PF  +  ++  + + +    F      +
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----H 260
Query: 339 VSEEGKDFIRRLL 351
            S + KD +R LL
Sbjct: 261 FSSDLKDLLRNLL 273

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 119/224 (53%), Gaps = 18/224 (8%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE---LIRKEIDIMNQLHHPK 166
           Y++++ IG GAFG V   R + T  ++A K +     +++       +E DIM   + P 
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKH 226
           ++ L  AF+DD  + ++ E++ GG+L   ++  +Y + E      T  +++     A+  
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS--NYDVPEKWARFYTAEVVL-----ALDA 183
Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFAAPEIV 284
           +H    IH DVKP+N++     S ++K+ DFG   K++   +V+  T  GT ++ +PE++
Sbjct: 184 IHSMGFIHRDVKPDNMLLD--KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 241
Query: 285 EREPV-GFY---TDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           + +   G+Y    D W+VGV  Y +L G +PF  ++ V T   +
Sbjct: 242 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 285

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 69/251 (27%), Positives = 128/251 (50%), Gaps = 18/251 (7%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE---LIRKEIDIMNQLHHPK 166
           Y++++ IG GAFG V   R + T  ++A K +     +++       +E DIM   + P 
Sbjct: 76  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 135
Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKH 226
           ++ L  AF+DD  + ++ E++ GG+L   ++  +Y + E      T  +++     A+  
Sbjct: 136 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS--NYDVPEKWARFYTAEVVL-----ALDA 188
Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFAAPEIV 284
           +H    IH DVKP+N++     S ++K+ DFG   K++   +V+  T  GT ++ +PE++
Sbjct: 189 IHSMGFIHRDVKPDNMLLD--KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 246
Query: 285 EREPV-GFY---TDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVS 340
           + +   G+Y    D W+VGV  Y +L G +PF  ++ V T   +             ++S
Sbjct: 247 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 306
Query: 341 EEGKDFIRRLL 351
           +E K+ I   L
Sbjct: 307 KEAKNLICAFL 317

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 130/253 (51%), Gaps = 17/253 (6%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---I 158
           + ++  D +D ++ +GTG+FG V   + +++GN +A K +     ++ + I   ++   I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 159 MNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           +  ++ P L+ L  +F+D+  + ++ E+++GGE+F  +     + SE         I++T
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLT 153
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
                 +++H  ++I+ D+KPEN++   +    +++ DFG A ++          GT E+
Sbjct: 154 -----FEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGR--TWXLCGTPEY 204
Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKN 338
            APEI+  +      D WA+GVL Y + +G  PF  +  ++  + + +    F      +
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----H 260
Query: 339 VSEEGKDFIRRLL 351
            S + KD +R LL
Sbjct: 261 FSSDLKDLLRNLL 273

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 130/253 (51%), Gaps = 17/253 (6%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---I 158
           + ++  D +D ++ +GTG+FG V   + +++GN +A K +     ++ + I   ++   I
Sbjct: 36  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 159 MNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           +  ++ P L+ L  +F+D+  + ++ E+++GGE+F  +     + SE         I++T
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLT 154
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
                 +++H  ++I+ D+KPEN++   +    +++ DFG A ++          GT E+
Sbjct: 155 -----FEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGR--TWXLCGTPEY 205
Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKN 338
            APEI+  +      D WA+GVL Y + +G  PF  +  ++  + + +    F      +
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----H 261
Query: 339 VSEEGKDFIRRLL 351
            S + KD +R LL
Sbjct: 262 FSSDLKDLLRNLL 274

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 125/261 (47%), Gaps = 15/261 (5%)
Query: 97  QPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE---KELIR 153
           QPV   T + +  Y +L   G G FG V  C+ R TG ++A K +      +   + +  
Sbjct: 179 QPV---TKNTFRQYRVL---GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL 232
Query: 154 KEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTL 213
            E  I+ +++   +++L  A+E  D + L+   ++GG+L   I    Y M +A       
Sbjct: 233 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHI----YHMGQAGFPEARA 288
Query: 214 PILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST 273
                +    ++ +H + I++ D+KPENI+    +  ++++ D GLA  +   + +K   
Sbjct: 289 VFYAAEICCGLEDLHRERIVYRDLKPENIL--LDDHGHIRISDLGLAVHVPEGQTIKGRV 346
Query: 274 GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE 333
           GT  + APE+V+ E   F  D WA+G L Y +++G SPF         + V+    E  E
Sbjct: 347 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE 406
Query: 334 EAFKNVSEEGKDFIRRLLLRN 354
           E  +  S + +    +LL ++
Sbjct: 407 EYSERFSPQARSLCSQLLCKD 427

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 130/253 (51%), Gaps = 17/253 (6%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---I 158
           + ++  D +D ++ +GTG+FG V   + +++GN +A K +     ++ + I   ++   I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 159 MNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           +  ++ P L+ L  +F+D+  + ++ E+++GGE+F  +     + SE         I++T
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLT 153
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
                 +++H  ++I+ D+KPEN++   +    +++ DFG A ++          GT E+
Sbjct: 154 -----FEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGR--TWXLCGTPEY 204
Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKN 338
            APEI+  +      D WA+GVL Y + +G  PF  +  ++  + + +    F      +
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----H 260
Query: 339 VSEEGKDFIRRLL 351
            S + KD +R LL
Sbjct: 261 FSSDLKDLLRNLL 273

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 130/253 (51%), Gaps = 17/253 (6%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---I 158
           + ++  D +D ++ +GTG+FG V   + +++GN +A K +     ++ + I   ++   I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 159 MNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           +  ++ P L+ L  +F+D+  + ++ E+++GGE+F  +     + SE         I++T
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLT 153
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
                 +++H  ++I+ D+KPEN++   +    +++ DFG A ++          GT E+
Sbjct: 154 -----FEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGR--TWXLCGTPEY 204
Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKN 338
            APEI+  +      D WA+GVL Y + +G  PF  +  ++  + + +    F      +
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----H 260
Query: 339 VSEEGKDFIRRLL 351
            S + KD +R LL
Sbjct: 261 FSSDLKDLLRNLL 273

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 130/253 (51%), Gaps = 17/253 (6%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---I 158
           + ++  D +D ++ +GTG+FG V   + +++GN +A K +     ++ + I   ++   I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 159 MNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           +  ++ P L+ L  +F+D+  + ++ E+++GGE+F  +     + SE         I++T
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLT 153
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
                 +++H  ++I+ D+KPEN++   +    +++ DFG A ++          GT E+
Sbjct: 154 -----FEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGR--TWXLXGTPEY 204
Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKN 338
            APEI+  +      D WA+GVL Y + +G  PF  +  ++  + + +    F      +
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----H 260
Query: 339 VSEEGKDFIRRLL 351
            S + KD +R LL
Sbjct: 261 FSSDLKDLLRNLL 273

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 136/282 (48%), Gaps = 19/282 (6%)
Query: 73  RGKADEKVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKT 132
           +G   E V ++     + + K    P   + ++  D ++ ++ +GTG+FG V   +  +T
Sbjct: 8   KGSEQESVKEFLAKAKEDFLKKWENPA--QNTAHLDQFERIKTLGTGSFGRVMLVKHMET 65
Query: 133 GNIFAAKFI---PVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSG 189
           GN +A K +    V    E E    E  I+  ++ P L+ L  +F+D+  + ++ E+  G
Sbjct: 66  GNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPG 125
Query: 190 GELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNS 249
           GE+F  +     + SE         I++T      +++H  ++I+ D+KPEN+M   +  
Sbjct: 126 GEMFSHLRRIG-RFSEPHARFYAAQIVLT-----FEYLHSLDLIYRDLKPENLMIDQQGY 179
Query: 250 TNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGL 309
             +K+ DFGLA ++          GT E+ APEI+  +      D WA+GVL Y + +G 
Sbjct: 180 --IKVTDFGLAKRVKGR--TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
Query: 310 SPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLL 351
            PF  +  ++  + + +    F      + S + KD +R LL
Sbjct: 236 PPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 273

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 72/240 (30%), Positives = 115/240 (47%), Gaps = 16/240 (6%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL---EKELIRKEIDIMNQLHHPKLINLHD 172
           +G G F   +   +  T  +FA K +P S  L   +KE +  EI I   L +P ++  H 
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 173 AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNI 232
            FEDDD + ++ E      L E      +K  +A   P      M QT   V+++H   +
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLEL-----HKRRKAVTEPEAR-YFMRQTIQGVQYLHNNRV 163
Query: 233 IHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEFAAPEIVEREPVGF 291
           IH D+K  N+     +  +VK+ DFGLATK++   E  K   GT  + APE++ ++   F
Sbjct: 164 IHRDLKLGNLFLN--DDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKGHSF 221
Query: 292 YTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLL 351
             D+W++G + Y LL G  PF      ET   +K  ++       ++++      IRR+L
Sbjct: 222 EVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVP----RHINPVASALIRRML 277

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 130/253 (51%), Gaps = 17/253 (6%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---I 158
           + ++  D +D ++ +GTG+FG V   + +++GN +A K +     ++ + I   ++   I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 159 MNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           +  ++ P L+ L  +F+D+  + ++ E+++GGE+F  +     + SE         I++T
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLT 153
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
                 +++H  ++I+ D+KPEN++   +    +++ DFG A ++          GT E+
Sbjct: 154 -----FEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGR--TWXLCGTPEY 204
Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKN 338
            APEI+  +      D WA+GVL Y + +G  PF  +  ++  + + +    F      +
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKVRFPS----H 260
Query: 339 VSEEGKDFIRRLL 351
            S + KD +R LL
Sbjct: 261 FSSDLKDLLRNLL 273

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 125/247 (50%), Gaps = 17/247 (6%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---IMNQLHH 164
           D ++ ++ +GTG+FG V   + ++TGN +A K +     ++ + I   ++   I+  ++ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P L+ L  +F+D+  + ++ E+  GGE+F  +     + SE         I++T      
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG-RFSEPHARFYAAQIVLT-----F 155
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           +++H  ++I+ D+KPEN+M   +    +K+ DFG A ++          GT E+ APEI+
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGY--IKVTDFGFAKRVKGR--TWXLCGTPEYLAPEII 211
Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
             +      D WA+GVL Y + +G  PF  +  ++  + + +    F      + S + K
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLK 267
Query: 345 DFIRRLL 351
           D +R LL
Sbjct: 268 DLLRNLL 274

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 72/240 (30%), Positives = 115/240 (47%), Gaps = 16/240 (6%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL---EKELIRKEIDIMNQLHHPKLINLHD 172
           +G G F   +   +  T  +FA K +P S  L   +KE +  EI I   L +P ++  H 
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 173 AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNI 232
            FEDDD + ++ E      L E      +K  +A   P      M QT   V+++H   +
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLEL-----HKRRKAVTEPEAR-YFMRQTIQGVQYLHNNRV 163
Query: 233 IHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEFAAPEIVEREPVGF 291
           IH D+K  N+     +  +VK+ DFGLATK++   E  K   GT  + APE++ ++   F
Sbjct: 164 IHRDLKLGNLFLN--DDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKGHSF 221
Query: 292 YTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLL 351
             D+W++G + Y LL G  PF      ET   +K  ++       ++++      IRR+L
Sbjct: 222 EVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVP----RHINPVASALIRRML 277

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 130/253 (51%), Gaps = 17/253 (6%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---I 158
           + ++  D +D ++ +GTG+FG V   + +++GN +A K +     ++ + I   ++   I
Sbjct: 22  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 81
Query: 159 MNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           +  ++ P L+ L  +F+D+  + ++ E+++GGE+F  +     + SE         I++T
Sbjct: 82  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLT 140
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
                 +++H  ++I+ D+KPEN++   +    +++ DFG A ++          GT E+
Sbjct: 141 -----FEYLHSLDLIYRDLKPENLLIDEQGY--IQVTDFGFAKRVKGR--TWXLCGTPEY 191
Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKN 338
            APEI+  +      D WA+GVL Y + +G  PF  +  ++  + + +    F      +
Sbjct: 192 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----H 247
Query: 339 VSEEGKDFIRRLL 351
            S + KD +R LL
Sbjct: 248 FSSDLKDLLRNLL 260

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 126/247 (51%), Gaps = 17/247 (6%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---IMNQLHH 164
           D ++ ++ +GTG+FG V   + ++TGN FA K +     ++ + I   ++   I+  ++ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P L+ L  +F+D+  + ++ E++ GGE+F  +     + SE         I++T      
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLT-----F 154
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           +++H  ++I+ D+KPEN++   +    +++ DFG A ++          GT E+ APEI+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGR--TWXLCGTPEYLAPEII 210
Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
             +      D WA+GVL Y + +G  PF  +  ++  + + +    F      + S + K
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLK 266
Query: 345 DFIRRLL 351
           D +R LL
Sbjct: 267 DLLRNLL 273

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 126/247 (51%), Gaps = 17/247 (6%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---IMNQLHH 164
           D ++ ++ +GTG+FG V   + ++TGN FA K +     ++ + I   ++   I+  ++ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P L+ L  +F+D+  + ++ E++ GGE+F  +     + SE         I++T      
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLT-----F 154
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           +++H  ++I+ D+KPEN++   +    +++ DFG A ++          GT E+ APEI+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGR--TWXLCGTPEYLAPEII 210
Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
             +      D WA+GVL Y + +G  PF  +  ++  + + +    F      + S + K
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLK 266
Query: 345 DFIRRLL 351
           D +R LL
Sbjct: 267 DLLRNLL 273

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 126/247 (51%), Gaps = 17/247 (6%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---IMNQLHH 164
           D ++ ++ +GTG+FG V   + ++TGN FA K +     ++ + I   ++   I+  ++ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P L+ L  +F+D+  + ++ E++ GGE+F  +     + SE         I++T      
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLT-----F 154
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           +++H  ++I+ D+KPEN++   +    +++ DFG A ++          GT E+ APEI+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGR--TWXLCGTPEYLAPEII 210
Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
             +      D WA+GVL Y + +G  PF  +  ++  + + +    F      + S + K
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLK 266
Query: 345 DFIRRLL 351
           D +R LL
Sbjct: 267 DLLRNLL 273

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 137/278 (49%), Gaps = 37/278 (13%)
Query: 108 DHYDILEEI-GTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLH-HP 165
           D Y + E++ G GA   V  C    T   +A K I       +  + +E++++ Q   H 
Sbjct: 12  DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHR 71
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++ L + FE++D   L+FE + GG +   I    +  +E E       +++   + A+ 
Sbjct: 72  NVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRH-FNELEA-----SVVVQDVASALD 125
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTN-VKMIDFGLATKLDPN-EVVKIST-------GTA 276
            +H K I H D+KPENI+C+  N  + VK+ DF L + +  N +   IST       G+A
Sbjct: 126 FLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185
Query: 277 EFAAPEIVE--REPVGFY---TDMWAVGVLAYVLLSGLSPFAGENDVET----------- 320
           E+ APE+VE   E    Y    D+W++GV+ Y+LLSG  PF G    +            
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245
Query: 321 ----LKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
                ++++   +EF ++ + ++S   KD I +LL+R+
Sbjct: 246 QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRD 283

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 130/253 (51%), Gaps = 17/253 (6%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---I 158
           + ++  D +D ++ +GTG+FG V   + +++GN +A K +     ++ + I   ++   I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 159 MNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           +  ++ P L+ L  +F+D+  + ++ E+++GGE+F  +     + SE         I++T
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLT 153
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
                 +++H  ++I+ D+KPEN++   +    +++ DFG A ++          GT E+
Sbjct: 154 -----FEYLHSLDLIYRDLKPENLIIDQQGY--IQVTDFGFAKRVKGR--TWXLCGTPEY 204
Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKN 338
            APEI+  +      D WA+GVL Y + +G  PF  +  ++  + + +    F      +
Sbjct: 205 LAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----H 260
Query: 339 VSEEGKDFIRRLL 351
            S + KD +R LL
Sbjct: 261 FSSDLKDLLRNLL 273

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  101 bits (251), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 129/259 (49%), Gaps = 29/259 (11%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---I 158
           + ++  D +D ++ +GTG+FG V   + +++GN +A K +     ++ + I   ++   I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 159 MNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFE------RITAPDYKMSEAEVIPVT 212
           +  ++ P L+ L  +F+D+  + ++ E+++GGE+F       R   P  +   A+++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLT- 153
Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS 272
                       +++H  ++I+ D+KPEN++   +    +++ DFG A ++         
Sbjct: 154 -----------FEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGR--TWXL 198
Query: 273 TGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD 332
            GT E+ APEI+  +      D WA+GVL Y + +G  PF  +  ++  + + +    F 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP 258
Query: 333 EEAFKNVSEEGKDFIRRLL 351
                + S + KD +R LL
Sbjct: 259 S----HFSSDLKDLLRNLL 273

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 129/259 (49%), Gaps = 29/259 (11%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---I 158
           + ++  D +D ++ +GTG+FG V   + +++GN +A K +     ++ + I   ++   I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 159 MNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFE------RITAPDYKMSEAEVIPVT 212
           +  ++ P L+ L  +F+D+  + ++ E+++GGE+F       R   P  +   A+++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT- 153
Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS 272
                       +++H  ++I+ D+KPEN++   +    +++ DFG A ++         
Sbjct: 154 -----------FEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGR--TWXL 198
Query: 273 TGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD 332
            GT E+ APEI+  +      D WA+GVL Y + +G  PF  +  ++  + + +    F 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP 258
Query: 333 EEAFKNVSEEGKDFIRRLL 351
                + S + KD +R LL
Sbjct: 259 S----HFSSDLKDLLRNLL 273

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 129/259 (49%), Gaps = 29/259 (11%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---I 158
           + ++  D +D ++ +GTG+FG V   + +++GN +A K +     ++ + I   ++   I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 159 MNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFE------RITAPDYKMSEAEVIPVT 212
           +  ++ P L+ L  +F+D+  + ++ E+++GGE+F       R   P  +   A+++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT- 153
Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS 272
                       +++H  ++I+ D+KPEN++   +    +++ DFG A ++         
Sbjct: 154 -----------FEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGR--TWXL 198
Query: 273 TGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD 332
            GT E+ APEI+  +      D WA+GVL Y + +G  PF  +  ++  + + +    F 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP 258
Query: 333 EEAFKNVSEEGKDFIRRLL 351
                + S + KD +R LL
Sbjct: 259 S----HFSSDLKDLLRNLL 273

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 129/259 (49%), Gaps = 29/259 (11%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---I 158
           + ++  D +D ++ +GTG+FG V   + +++GN +A K +     ++ + I   ++   I
Sbjct: 30  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 89
Query: 159 MNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFE------RITAPDYKMSEAEVIPVT 212
           +  ++ P L+ L  +F+D+  + ++ E+++GGE+F       R   P  +   A+++   
Sbjct: 90  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT- 148
Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS 272
                       +++H  ++I+ D+KPEN++   +    +++ DFG A ++         
Sbjct: 149 -----------FEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGR--TWXL 193
Query: 273 TGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD 332
            GT E+ APEI+  +      D WA+GVL Y + +G  PF  +  ++  + + +    F 
Sbjct: 194 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP 253
Query: 333 EEAFKNVSEEGKDFIRRLL 351
                + S + KD +R LL
Sbjct: 254 S----HFSSDLKDLLRNLL 268

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  100 bits (250), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 72/240 (30%), Positives = 115/240 (47%), Gaps = 16/240 (6%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL---EKELIRKEIDIMNQLHHPKLINLHD 172
           +G G F   +   +  T  +FA K +P S  L   +KE +  EI I   L +P ++  H 
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 173 AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNI 232
            FEDDD + ++ E      L E      +K  +A   P      M QT   V+++H   +
Sbjct: 94  FFEDDDFVYVVLEICRRRSLLEL-----HKRRKAVTEPEAR-YFMRQTIQGVQYLHNNRV 147
Query: 233 IHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEFAAPEIVEREPVGF 291
           IH D+K  N+     +  +VK+ DFGLATK++   E  K   GT  + APE++ ++   F
Sbjct: 148 IHRDLKLGNLFLN--DDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSF 205
Query: 292 YTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLL 351
             D+W++G + Y LL G  PF      ET   +K  ++       ++++      IRR+L
Sbjct: 206 EVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVP----RHINPVASALIRRML 261

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 129/259 (49%), Gaps = 29/259 (11%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---I 158
           + ++  D +D ++ +GTG+FG V   + +++GN +A K +     ++ + I   ++   I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 159 MNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFE------RITAPDYKMSEAEVIPVT 212
           +  ++ P L+ L  +F+D+  + ++ E+++GGE+F       R   P  +   A+++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT- 153
Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS 272
                       +++H  ++I+ D+KPEN++   +    +++ DFG A ++         
Sbjct: 154 -----------FEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGR--TWXL 198
Query: 273 TGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD 332
            GT E+ APEI+  +      D WA+GVL Y + +G  PF  +  ++  + + +    F 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP 258
Query: 333 EEAFKNVSEEGKDFIRRLL 351
                + S + KD +R LL
Sbjct: 259 S----HFSSDLKDLLRNLL 273

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 129/259 (49%), Gaps = 29/259 (11%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---I 158
           + ++  D +D ++ +GTG+FG V   + +++GN +A K +     ++ + I   ++   I
Sbjct: 56  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 115
Query: 159 MNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFE------RITAPDYKMSEAEVIPVT 212
           +  ++ P L+ L  +F+D+  + ++ E+++GGE+F       R   P  +   A+++   
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT- 174
Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS 272
                       +++H  ++I+ D+KPEN++   +    +++ DFG A ++         
Sbjct: 175 -----------FEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGR--TWXL 219
Query: 273 TGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD 332
            GT E+ APEI+  +      D WA+GVL Y + +G  PF  +  ++  + + +    F 
Sbjct: 220 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP 279
Query: 333 EEAFKNVSEEGKDFIRRLL 351
                + S + KD +R LL
Sbjct: 280 S----HFSSDLKDLLRNLL 294

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 125/247 (50%), Gaps = 17/247 (6%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---IMNQLHH 164
           D ++ ++ IGTG+FG V   +  +TGN +A K +     ++ + I   ++   I+  ++ 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P L+ L  +F+D+  + ++ E++ GGE+F  +     + SE         I++T      
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLT-----F 154
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           +++H  ++I+ D+KPEN++   +    +K+ DFG A ++          GT E+ APEI+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGY--IKVADFGFAKRVKGR--TWXLCGTPEYLAPEII 210
Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
             +      D WA+GVL Y + +G  PF  +  ++  + + +    F      + S + K
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLK 266
Query: 345 DFIRRLL 351
           D +R LL
Sbjct: 267 DLLRNLL 273

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/240 (30%), Positives = 115/240 (47%), Gaps = 16/240 (6%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL---EKELIRKEIDIMNQLHHPKLINLHD 172
           +G G F   +   +  T  +FA K +P S  L   +KE +  EI I   L +P ++  H 
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 173 AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNI 232
            FEDDD + ++ E      L E      +K  +A   P      M QT   V+++H   +
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLEL-----HKRRKAVTEPEAR-YFMRQTIQGVQYLHNNRV 163
Query: 233 IHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEFAAPEIVEREPVGF 291
           IH D+K  N+     +  +VK+ DFGLATK++   E  K   GT  + APE++ ++   F
Sbjct: 164 IHRDLKLGNLFLN--DDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSF 221
Query: 292 YTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLL 351
             D+W++G + Y LL G  PF      ET   +K  ++       ++++      IRR+L
Sbjct: 222 EVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVP----RHINPVASALIRRML 277

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 118/224 (52%), Gaps = 18/224 (8%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE---LIRKEIDIMNQLHHPK 166
           YD+++ IG GAFG V   R + +  ++A K +     +++       +E DIM   + P 
Sbjct: 77  YDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 136
Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKH 226
           ++ L  AF+DD  + ++ E++ GG+L   ++  +Y + E      T  +++     A+  
Sbjct: 137 VVQLFCAFQDDKYLYMVMEYMPGGDLVNLMS--NYDVPEKWAKFYTAEVVL-----ALDA 189
Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFAAPEIV 284
           +H   +IH DVKP+N++       ++K+ DFG   K+D   +V   T  GT ++ +PE++
Sbjct: 190 IHSMGLIHRDVKPDNMLLDKHG--HLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVL 247
Query: 285 EREPV-GFY---TDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           + +   G+Y    D W+VGV  + +L G +PF  ++ V T   +
Sbjct: 248 KSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI 291

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 109/213 (51%), Gaps = 15/213 (7%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP---VSHNLEKELIRKEIDIMNQLHHPK 166
           +++ E +GTG FG V R   + TG   A K         N E+  +  EI IM +L+HP 
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL--EIQIMKKLNHPN 73
Query: 167 LINLHDA------FEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
           +++  +          +D  +L  E+  GG+L + +   +      E  P+    L++  
Sbjct: 74  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG-PIR--TLLSDI 130
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNV-KMIDFGLATKLDPNEVVKISTGTAEFA 279
           S A++++HE  IIH D+KPENI+ Q      + K+ID G A +LD  E+     GT ++ 
Sbjct: 131 SSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYL 190
Query: 280 APEIVEREPVGFYTDMWAVGVLAYVLLSGLSPF 312
           APE++E++      D W+ G LA+  ++G  PF
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 109/213 (51%), Gaps = 15/213 (7%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP---VSHNLEKELIRKEIDIMNQLHHPK 166
           +++ E +GTG FG V R   + TG   A K         N E+  +  EI IM +L+HP 
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL--EIQIMKKLNHPN 74
Query: 167 LINLHDA------FEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
           +++  +          +D  +L  E+  GG+L + +   +      E  P+    L++  
Sbjct: 75  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG-PIR--TLLSDI 131
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNV-KMIDFGLATKLDPNEVVKISTGTAEFA 279
           S A++++HE  IIH D+KPENI+ Q      + K+ID G A +LD  E+     GT ++ 
Sbjct: 132 SSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYL 191
Query: 280 APEIVEREPVGFYTDMWAVGVLAYVLLSGLSPF 312
           APE++E++      D W+ G LA+  ++G  PF
Sbjct: 192 APELLEQKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 123/247 (49%), Gaps = 17/247 (6%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI---PVSHNLEKELIRKEIDIMNQLHH 164
           D ++ ++ +GTG+FG V   +  +TGN +A K +    V    E E    E  I+  ++ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P L+ L  +F+D+  + ++ E+  GGE+F  +     + SE         I++T      
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG-RFSEPHARFYAAQIVLT-----F 154
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           +++H  ++I+ D+KPEN+M   +    +++ DFGLA ++          GT E+ APEI+
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGY--IQVTDFGLAKRVKGR--TWXLCGTPEYLAPEII 210
Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
             +      D WA+GVL Y + +G  PF  +  ++  + + +    F      + S + K
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLK 266
Query: 345 DFIRRLL 351
           D +R LL
Sbjct: 267 DLLRNLL 273

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 124/247 (50%), Gaps = 17/247 (6%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---IMNQLHH 164
           D ++ ++ +GTG+FG V   +  +TGN +A K +     ++ + I   ++   I+  ++ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P L+ L  +F+D+  + ++ E+  GGE+F  +     + SE         I++T      
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG-RFSEPHARFYAAQIVLT-----F 154
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           +++H  ++I+ D+KPEN+M   +    +K+ DFG A ++          GT E+ APEI+
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGY--IKVTDFGFAKRVKGR--TWXLCGTPEYLAPEII 210
Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
             +      D WA+GVL Y + +G  PF  +  ++  + + +    F      + S + K
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLK 266
Query: 345 DFIRRLL 351
           D +R LL
Sbjct: 267 DLLRNLL 273

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 126/247 (51%), Gaps = 17/247 (6%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---IMNQLHH 164
           D ++ ++ +GTG+FG V   + ++TGN +A K +     ++ + I   ++   I+  ++ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P L+ L  +F+D+  + ++ E++ GGE+F  +     + SE         I++T      
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLT-----F 155
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           +++H  ++I+ D+KPEN++   +    +++ DFG A ++          GT E+ APEI+
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGR--TWXLCGTPEYLAPEII 211
Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
             +      D WA+GVL Y + +G  PF  +  ++  + + +    F      + S + K
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLK 267
Query: 345 DFIRRLL 351
           D +R LL
Sbjct: 268 DLLRNLL 274

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 126/247 (51%), Gaps = 17/247 (6%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---IMNQLHH 164
           D ++ ++ +GTG+FG V   + ++TGN +A K +     ++ + I   ++   I+  ++ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P L+ L  +F+D+  + ++ E++ GGE+F  +     + SE         I++T      
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLT-----F 155
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           +++H  ++I+ D+KPEN++   +    +++ DFG A ++          GT E+ APEI+
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGR--TWXLCGTPEYLAPEII 211
Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
             +      D WA+GVL Y + +G  PF  +  ++  + + +    F      + S + K
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLK 267
Query: 345 DFIRRLL 351
           D +R LL
Sbjct: 268 DLLRNLL 274

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 126/247 (51%), Gaps = 17/247 (6%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---IMNQLHH 164
           D ++ ++ +GTG+FG V   + ++TGN +A K +     ++ + I   ++   I+  ++ 
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P L+ L  +F+D+  + ++ E++ GGE+F  +     + SE         I++T      
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLT-----F 147
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           +++H  ++I+ D+KPEN++   +    +++ DFG A ++          GT E+ APEI+
Sbjct: 148 EYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGR--TWXLCGTPEYLAPEII 203
Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
             +      D WA+GVL Y + +G  PF  +  ++  + + +    F      + S + K
Sbjct: 204 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLK 259
Query: 345 DFIRRLL 351
           D +R LL
Sbjct: 260 DLLRNLL 266

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 126/247 (51%), Gaps = 17/247 (6%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---IMNQLHH 164
           D ++ ++ +GTG+FG V   + ++TGN +A K +     ++ + I   ++   I+  ++ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P L+ L  +F+D+  + ++ E++ GGE+F  +     + SE         I++T      
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLT-----F 155
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           +++H  ++I+ D+KPEN++   +    +++ DFG A ++          GT E+ APEI+
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGR--TWXLCGTPEYLAPEII 211
Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
             +      D WA+GVL Y + +G  PF  +  ++  + + +    F      + S + K
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLK 267
Query: 345 DFIRRLL 351
           D +R LL
Sbjct: 268 DLLRNLL 274

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 126/247 (51%), Gaps = 17/247 (6%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---IMNQLHH 164
           D ++ ++ +GTG+FG V   + ++TGN +A K +     ++ + I   ++   I+  ++ 
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P L+ L  +F+D+  + ++ E++ GGE+F  +     + SE         I++T      
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLT-----F 175
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           +++H  ++I+ D+KPEN++   +    +++ DFG A ++          GT E+ APEI+
Sbjct: 176 EYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGR--TWXLCGTPEYLAPEII 231
Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
             +      D WA+GVL Y + +G  PF  +  ++  + + +    F      + S + K
Sbjct: 232 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLK 287
Query: 345 DFIRRLL 351
           D +R LL
Sbjct: 288 DLLRNLL 294

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 129/253 (50%), Gaps = 17/253 (6%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---I 158
           + ++  D +D ++ +GTG+FG V   + +++GN +A K +     ++ + I   ++   I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 159 MNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           +  ++ P L+ L  +F+D+  + ++ E+++GGE+F  +     + SE         I++T
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLT 153
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
                 +++H  ++I+ D+KPEN++   +    +++ DFG A ++          GT E+
Sbjct: 154 -----FEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGR--TWXLCGTPEY 204
Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKN 338
            AP I+  +      D WA+GVL Y + +G  PF  +  ++  + + +    F      +
Sbjct: 205 LAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----H 260
Query: 339 VSEEGKDFIRRLL 351
            S + KD +R LL
Sbjct: 261 FSSDLKDLLRNLL 273

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 125/247 (50%), Gaps = 17/247 (6%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---IMNQLHH 164
           D ++ ++ IGTG+FG V   +  +TGN +A K +     ++ + I   ++   I+  ++ 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P L+ L  +F+D+  + ++ E++ GG++F  +     + SE         I++T      
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIG-RFSEPHARFYAAQIVLT-----F 154
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           +++H  ++I+ D+KPEN++   +    +K+ DFG A ++          GT E+ APEI+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGY--IKVADFGFAKRVKGR--TWXLCGTPEYLAPEII 210
Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
             +      D WA+GVL Y + +G  PF  +  ++  + + +    F      + S + K
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLK 266
Query: 345 DFIRRLL 351
           D +R LL
Sbjct: 267 DLLRNLL 273

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 129/253 (50%), Gaps = 17/253 (6%)
Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---I 158
           + ++  D +D ++ +GTG+FG V   + +++GN +A K +     ++ + I   ++   I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 159 MNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           +  ++ P L+ L  +F+D+  + ++ E+++GGE+F  +     + SE         I++T
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLT 153
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
                 +++H  ++I+ D+KPEN++   +    +++ DFG A ++          GT E 
Sbjct: 154 -----FEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGR--TWXLCGTPEA 204
Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKN 338
            APEI+  +      D WA+GVL Y + +G  PF  +  ++  + + +    F      +
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----H 260
Query: 339 VSEEGKDFIRRLL 351
            S + KD +R LL
Sbjct: 261 FSSDLKDLLRNLL 273

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 127/248 (51%), Gaps = 21/248 (8%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           +IG G+ G+V   RE+ +G   A K + +     +EL+  E+ IM    H  ++ ++ ++
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
              +E+ ++ EFL GG L + ++    +++E ++  V   +L      A+ ++H + +IH
Sbjct: 112 LVGEELWVLMEFLQGGALTDIVS--QVRLNEEQIATVCEAVLQ-----ALAYLHAQGVIH 164
Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLD---PNEVVKISTGTAEFAAPEIVEREPVGF 291
            D+K ++I+        VK+ DFG   ++    P    K   GT  + APE++ R     
Sbjct: 165 RDIKSDSILLTLDG--RVKLSDFGFCAQISKDVPKR--KXLVGTPYWMAPEVISRSLYAT 220
Query: 292 YTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKN---VSEEGKDFIR 348
             D+W++G++   ++ G  P+  ++ V+ +K ++    +      KN   VS   +DF+ 
Sbjct: 221 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR----DSPPPKLKNSHKVSPVLRDFLE 276
Query: 349 RLLLRNKE 356
           R+L+R+ +
Sbjct: 277 RMLVRDPQ 284

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 124/253 (49%), Gaps = 29/253 (11%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI---------PVSHNLEKELIRKEIDI 158
           D ++ +  +GTG+FG V   + ++TGN +A K +          + H L ++ I++ ++ 
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNF 101
Query: 159 MNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
                 P L+ L  +F+D+  + ++ E+  GGE+F  +     + SE         I++T
Sbjct: 102 ------PFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIG-RFSEPHARFYAAQIVLT 154
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
                 +++H  ++I+ D+KPEN++   +    +K+ DFG A ++          GT E+
Sbjct: 155 -----FEYLHSLDLIYRDLKPENLLIDQQGY--IKVADFGFAKRVKGR--TWXLCGTPEY 205
Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKN 338
            APEI+  +      D WA+GVL Y + +G  PF  +  ++  + + +    F      +
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----H 261
Query: 339 VSEEGKDFIRRLL 351
            S + KD +R LL
Sbjct: 262 FSSDLKDLLRNLL 274

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 125/247 (50%), Gaps = 17/247 (6%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---IMNQLHH 164
           D ++ ++ IGTG+FG V   +  +TGN +A K +     ++ + I   ++   I+  ++ 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P L+ L  +F+D+  + ++ E++ GG++F  +     + SE         I++T      
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIG-RFSEPHARFYAAQIVLT-----F 154
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           +++H  ++I+ D+KPEN++   +    +K+ DFG A ++          GT E+ APEI+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGY--IKVADFGFAKRVKGR--TWXLCGTPEYLAPEII 210
Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
             +      D WA+GVL Y + +G  PF  +  ++  + + +    F      + S + K
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLK 266
Query: 345 DFIRRLL 351
           D +R LL
Sbjct: 267 DLLRNLL 273

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 126/247 (51%), Gaps = 17/247 (6%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---IMNQLHH 164
           D ++ ++ +GTG+FG V   +  +TGN +A K +     ++ + I   ++   I+  ++ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P L+ L  +F+D+  + ++ E+++GGE+F  +     + SE         I++T      
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLT-----F 154
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           +++H  ++I+ D+KPEN++   +    +++ DFG A ++          GT E+ APEI+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGR--TWXLCGTPEYLAPEII 210
Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
             +      D WA+GVL Y + +G  PF  +  ++  + + +    F      + S + K
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLK 266
Query: 345 DFIRRLL 351
           D +R LL
Sbjct: 267 DLLRNLL 273

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 110/217 (50%), Gaps = 21/217 (9%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE-KELIRKEIDIMNQLHHPKLI 168
           +D+++ +G GA+G V     R T    A K + +   ++  E I+KEI I   L+H  ++
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVV 67
Query: 169 NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH 228
             +    + +   L  E+ SGGELF+RI  PD  M E +           Q    V ++H
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDA-----QRFFHQLMAGVVYLH 121
Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN---EVVKISTGTAEFAAPEIVE 285
              I H D+KPEN++   R+  N+K+ DFGLAT    N    ++    GT  + APE+++
Sbjct: 122 GIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 286 R-----EPVGFYTDMWAVGVLAYVLLSGLSPFAGEND 317
           R     EPV    D+W+ G++   +L+G  P+   +D
Sbjct: 180 RREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 123/253 (48%), Gaps = 29/253 (11%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---IMNQLHH 164
           D ++ ++ +GTG+FG V   +  +TGN +A K +     ++ + I   ++   I+  ++ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFE------RITAPDYKMSEAEVIPVTLPILMT 218
           P L+ L  +F+D+  + ++ E+  GGE+F       R   P  +   A+++         
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLT------- 153
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
                 +++H  ++I+ D+KPEN+M   +    +K+ DFG A ++          GT E+
Sbjct: 154 -----FEYLHSLDLIYRDLKPENLMIDQQGY--IKVTDFGFAKRVKGR--TWXLCGTPEY 204
Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKN 338
            APEI+  +      D WA+GVL Y + +G  PF  +  ++  + + +    F      +
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----H 260
Query: 339 VSEEGKDFIRRLL 351
            S + KD +R LL
Sbjct: 261 FSSDLKDLLRNLL 273

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 127/265 (47%), Gaps = 22/265 (8%)
Query: 99  VDIKTSSVYDHYDILEEI-GTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID 157
           + IK +++ D Y +  ++ G G  G V +   ++T   FA K +    +  K   R+E++
Sbjct: 52  LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKXL---QDCPKA--RREVE 106
Query: 158 IMNQLHH-PKLINLHDAFED----DDEMVLIFEFLSGGELFERIT-APDYKMSEAEVIPV 211
           +  +    P ++ + D +E+       ++++ E L GGELF RI    D   +E E   +
Sbjct: 107 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEI 166
Query: 212 TLPILMTQTSPAVKHMHEKNIIHLDVKPENIM-CQTRNSTNVKMIDFGLATKLDPNEVVK 270
              I       A++++H  NI H DVKPEN++    R +  +K+ DFG A +   +  + 
Sbjct: 167 XKSI-----GEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 221
Query: 271 ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVE----TLKNVKA 326
               T  + APE++  E      D W++GV+ Y+LL G  PF   + +         ++ 
Sbjct: 222 TPCYTPYYVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRX 281
Query: 327 CDWEFDEEAFKNVSEEGKDFIRRLL 351
             +EF    +  VSEE K  IR LL
Sbjct: 282 GQYEFPNPEWSEVSEEVKXLIRNLL 306

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 124/247 (50%), Gaps = 17/247 (6%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---IMNQLHH 164
           D ++ ++ +GTG+FG V   +  +TGN +A K +     ++ + I   ++   I+  ++ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P L+ L  +F+D+  + ++ E+  GGE+F  +     + SE         I++T      
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG-RFSEPHARFYAAQIVLT-----F 154
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           +++H  ++I+ D+KPEN+M   +    +++ DFG A ++          GT E+ APEI+
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGY--IQVTDFGFAKRVKGR--TWXLCGTPEYLAPEII 210
Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
             +      D WA+GVL Y + +G  PF  +  ++  + + +    F      + S + K
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLK 266
Query: 345 DFIRRLL 351
           D +R LL
Sbjct: 267 DLLRNLL 273

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 123/247 (49%), Gaps = 17/247 (6%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---IMNQLHH 164
           D ++ ++ +GTG+FG V   +  +TGN +A K +     ++ + I   ++   I+  ++ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P L  L  +F+D+  + ++ E+  GGE+F  +     + SE         I++T      
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG-RFSEPHARFYAAQIVLT-----F 155
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           +++H  ++I+ D+KPEN+M   +    +K+ DFG A ++          GT E+ APEI+
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGY--IKVTDFGFAKRVKGR--TWXLCGTPEYLAPEII 211
Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
             +      D WA+GVL Y + +G  PF  +  ++  + + +    F      + S + K
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLK 267
Query: 345 DFIRRLL 351
           D +R LL
Sbjct: 268 DLLRNLL 274

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 125/253 (49%), Gaps = 29/253 (11%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---IMNQLHH 164
           D ++ ++ +GTG+FG V   + ++TGN +A K +     ++ + I   ++   I+  ++ 
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFE------RITAPDYKMSEAEVIPVTLPILMT 218
           P L+ L  +F+D+  + ++ E++ GGE+F       R   P  +   A+++         
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLT------- 146
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
                 +++H  ++I+ D+KPEN++   +    +++ DFG A ++          GT E+
Sbjct: 147 -----FEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGR--TWXLCGTPEY 197
Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKN 338
            APEI+  +      D WA+GVL Y + +G  PF  +  ++  + + +    F      +
Sbjct: 198 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----H 253
Query: 339 VSEEGKDFIRRLL 351
            S + KD +R LL
Sbjct: 254 FSSDLKDLLRNLL 266

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 123/247 (49%), Gaps = 17/247 (6%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---IMNQLHH 164
           D ++ ++ +GTG+FG V   +  +TGN +A K +     ++ + I   ++   I+  ++ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P L  L  +F+D+  + ++ E+  GGE+F  +     + SE         I++T      
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG-RFSEPHARFYAAQIVLT-----F 155
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           +++H  ++I+ D+KPEN+M   +    +K+ DFG A ++          GT E+ APEI+
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGY--IKVTDFGFAKRVKGR--TWXLCGTPEYLAPEII 211
Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
             +      D WA+GVL Y + +G  PF  +  ++  + + +    F      + S + K
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLK 267
Query: 345 DFIRRLL 351
           D +R LL
Sbjct: 268 DLLRNLL 274

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 110/217 (50%), Gaps = 21/217 (9%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE-KELIRKEIDIMNQLHHPKLI 168
           +D+++ +G GA+G V     R T    A K + +   ++  E I+KEI I   L+H  ++
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 169 NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH 228
             +    + +   L  E+ SGGELF+RI  PD  M E +           Q    V ++H
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDA-----QRFFHQLMAGVVYLH 122
Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN---EVVKISTGTAEFAAPEIVE 285
              I H D+KPEN++   R+  N+K+ DFGLAT    N    ++    GT  + APE+++
Sbjct: 123 GIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 286 R-----EPVGFYTDMWAVGVLAYVLLSGLSPFAGEND 317
           R     EPV    D+W+ G++   +L+G  P+   +D
Sbjct: 181 RREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 110/217 (50%), Gaps = 21/217 (9%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE-KELIRKEIDIMNQLHHPKLI 168
           +D+++ +G GA+G V     R T    A K + +   ++  E I+KEI I   L+H  ++
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 169 NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH 228
             +    + +   L  E+ SGGELF+RI  PD  M E +           Q    V ++H
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDA-----QRFFHQLMAGVVYLH 121
Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN---EVVKISTGTAEFAAPEIVE 285
              I H D+KPEN++   R+  N+K+ DFGLAT    N    ++    GT  + APE+++
Sbjct: 122 GIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 286 R-----EPVGFYTDMWAVGVLAYVLLSGLSPFAGEND 317
           R     EPV    D+W+ G++   +L+G  P+   +D
Sbjct: 180 RREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 110/217 (50%), Gaps = 21/217 (9%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE-KELIRKEIDIMNQLHHPKLI 168
           +D+++ +G GA+G V     R T    A K + +   ++  E I+KEI I   L+H  ++
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVV 67
Query: 169 NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH 228
             +    + +   L  E+ SGGELF+RI  PD  M E +           Q    V ++H
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDA-----QRFFHQLMAGVVYLH 121
Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN---EVVKISTGTAEFAAPEIVE 285
              I H D+KPEN++   R+  N+K+ DFGLAT    N    ++    GT  + APE+++
Sbjct: 122 GIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 286 R-----EPVGFYTDMWAVGVLAYVLLSGLSPFAGEND 317
           R     EPV    D+W+ G++   +L+G  P+   +D
Sbjct: 180 RREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 125/247 (50%), Gaps = 17/247 (6%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---IMNQLHH 164
           D ++ ++ +GTG+FG V   +  +TGN +A K +     ++ + I   ++   I+  ++ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P L+ L  +F+D+  + ++ E++ GGE+F  +     + SE         I++T      
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLT-----F 155
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           +++H  ++I+ D+KPEN++   +    +++ DFG A ++          GT E+ APEI+
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGRTWT--LCGTPEYLAPEII 211
Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
             +      D WA+GVL Y + +G  PF  +  ++  + + +    F      + S + K
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLK 267
Query: 345 DFIRRLL 351
           D +R LL
Sbjct: 268 DLLRNLL 274

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 125/247 (50%), Gaps = 17/247 (6%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---IMNQLHH 164
           D ++ ++ +GTG+FG V   +  +TGN +A K +     ++ + I   ++   I+  ++ 
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P L+ L  +F+D+  + ++ E++ GGE+F  +     + SE         I++T      
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLT-----F 140
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           +++H  ++I+ D+KPEN++   +    +++ DFG A ++          GT E+ APEI+
Sbjct: 141 EYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGRTWT--LCGTPEYLAPEII 196
Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
             +      D WA+GVL Y + +G  PF  +  ++  + + +    F      + S + K
Sbjct: 197 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLK 252
Query: 345 DFIRRLL 351
           D +R LL
Sbjct: 253 DLLRNLL 259

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 24/217 (11%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK---EIDIMNQLHHPK 166
           +D L+ +G G FG V   RE+ TG  +A K +     + K+ +     E  ++    HP 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELF-----ERI-TAPDYKMSEAEVIPVTLPILMTQT 220
           L  L  AF+  D +  + E+ +GGELF     ER+ T    +   AE++           
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVS---------- 116
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK-LDPNEVVKISTGTAEFA 279
             A++++H +++++ D+K EN+M       ++K+ DFGL  + +     +K   GT E+ 
Sbjct: 117 --ALEYLHSRDVVYRDIKLENLMLD--KDGHIKITDFGLCKEGISDGATMKTFCGTPEYL 172
Query: 280 APEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN 316
           APE++E    G   D W +GV+ Y ++ G  PF  ++
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 24/217 (11%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK---EIDIMNQLHHPK 166
           +D L+ +G G FG V   RE+ TG  +A K +     + K+ +     E  ++    HP 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELF-----ERI-TAPDYKMSEAEVIPVTLPILMTQT 220
           L  L  AF+  D +  + E+ +GGELF     ER+ T    +   AE++           
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVS---------- 116
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK-LDPNEVVKISTGTAEFA 279
             A++++H +++++ D+K EN+M       ++K+ DFGL  + +     +K   GT E+ 
Sbjct: 117 --ALEYLHSRDVVYRDIKLENLMLD--KDGHIKITDFGLCKEGISDGATMKTFCGTPEYL 172
Query: 280 APEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN 316
           APE++E    G   D W +GV+ Y ++ G  PF  ++
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 24/217 (11%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK---EIDIMNQLHHPK 166
           +D L+ +G G FG V   RE+ TG  +A K +     + K+ +     E  ++    HP 
Sbjct: 10  FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 69
Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELF-----ERI-TAPDYKMSEAEVIPVTLPILMTQT 220
           L  L  AF+  D +  + E+ +GGELF     ER+ T    +   AE++           
Sbjct: 70  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVS---------- 119
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK-LDPNEVVKISTGTAEFA 279
             A++++H +++++ D+K EN+M       ++K+ DFGL  + +     +K   GT E+ 
Sbjct: 120 --ALEYLHSRDVVYRDIKLENLMLD--KDGHIKITDFGLCKEGISDGATMKTFCGTPEYL 175
Query: 280 APEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN 316
           APE++E    G   D W +GV+ Y ++ G  PF  ++
Sbjct: 176 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 212

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 110/217 (50%), Gaps = 21/217 (9%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE-KELIRKEIDIMNQLHHPKLI 168
           +D+++ +G GA+G V     R T    A K + +   ++  E I+KEI I   L+H  ++
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 169 NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH 228
             +    + +   L  E+ SGGELF+RI  PD  M E +           Q    V ++H
Sbjct: 67  KFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDA-----QRFFHQLMAGVVYLH 120
Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN---EVVKISTGTAEFAAPEIVE 285
              I H D+KPEN++   R+  N+K+ DFGLAT    N    ++    GT  + APE+++
Sbjct: 121 GIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 286 R-----EPVGFYTDMWAVGVLAYVLLSGLSPFAGEND 317
           R     EPV    D+W+ G++   +L+G  P+   +D
Sbjct: 179 RREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 211

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 125/247 (50%), Gaps = 17/247 (6%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---IMNQLHH 164
           D ++ ++ +GTG+FG V   +  +TGN +A K +     ++ + I   ++   I+  ++ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P L+ L  +F+D+  + ++ E++ GGE+F  +     + SE         I++T      
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLT-----F 154
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           +++H  ++I+ D+KPEN++   +    +++ DFG A ++          GT E+ APEI+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGR--TWXLCGTPEYLAPEII 210
Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
             +      D WA+GVL Y + +G  PF  +  ++  + + +    F      + S + K
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLK 266
Query: 345 DFIRRLL 351
           D +R LL
Sbjct: 267 DLLRNLL 273

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 125/247 (50%), Gaps = 17/247 (6%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---IMNQLHH 164
           D ++ ++ +GTG+FG V   +  +TGN +A K +     ++ + I   ++   I+  ++ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P L+ L  +F+D+  + ++ E++ GGE+F  +     + SE         I++T      
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLT-----F 154
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           +++H  ++I+ D+KPEN++   +    +++ DFG A ++          GT E+ APEI+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGR--TWXLCGTPEYLAPEII 210
Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
             +      D WA+GVL Y + +G  PF  +  ++  + + +    F      + S + K
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLK 266
Query: 345 DFIRRLL 351
           D +R LL
Sbjct: 267 DLLRNLL 273

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 110/217 (50%), Gaps = 21/217 (9%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE-KELIRKEIDIMNQLHHPKLI 168
           +D+++ +G GA+G V     R T    A K + +   ++  E I+KEI I   L+H  ++
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVV 68
Query: 169 NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH 228
             +    + +   L  E+ SGGELF+RI  PD  M E +           Q    V ++H
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDA-----QRFFHQLMAGVVYLH 122
Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN---EVVKISTGTAEFAAPEIVE 285
              I H D+KPEN++   R+  N+K+ DFGLAT    N    ++    GT  + APE+++
Sbjct: 123 GIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 180
Query: 286 R-----EPVGFYTDMWAVGVLAYVLLSGLSPFAGEND 317
           R     EPV    D+W+ G++   +L+G  P+   +D
Sbjct: 181 RREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 125/247 (50%), Gaps = 17/247 (6%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---IMNQLHH 164
           D ++ ++ +GTG+FG V   +  +TGN +A K +     ++ + I   ++   I+  ++ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P L+ L  +F+D+  + ++ E++ GGE+F  +     + SE         I++T      
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLT-----F 155
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           +++H  ++I+ D+KPEN++   +    +++ DFG A ++          GT E+ APEI+
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGR--TWXLCGTPEYLAPEII 211
Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
             +      D WA+GVL Y + +G  PF  +  ++  + + +    F      + S + K
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLK 267
Query: 345 DFIRRLL 351
           D +R LL
Sbjct: 268 DLLRNLL 274

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 24/217 (11%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK---EIDIMNQLHHPK 166
           +D L+ +G G FG V   RE+ TG  +A K +     + K+ +     E  ++    HP 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELF-----ERI-TAPDYKMSEAEVIPVTLPILMTQT 220
           L  L  AF+  D +  + E+ +GGELF     ER+ T    +   AE++           
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVS---------- 116
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK-LDPNEVVKISTGTAEFA 279
             A++++H +++++ D+K EN+M       ++K+ DFGL  + +     +K   GT E+ 
Sbjct: 117 --ALEYLHSRDVVYRDIKLENLMLD--KDGHIKITDFGLCKEGISDGATMKXFCGTPEYL 172
Query: 280 APEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN 316
           APE++E    G   D W +GV+ Y ++ G  PF  ++
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 110/217 (50%), Gaps = 21/217 (9%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE-KELIRKEIDIMNQLHHPKLI 168
           +D+++ +G GA+G V     R T    A K + +   ++  E I+KEI I   L+H  ++
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 169 NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH 228
             +    + +   L  E+ SGGELF+RI  PD  M E +           Q    V ++H
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDA-----QRFFHQLMAGVVYLH 121
Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN---EVVKISTGTAEFAAPEIVE 285
              I H D+KPEN++   R+  N+K+ DFGLAT    N    ++    GT  + APE+++
Sbjct: 122 GIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 286 R-----EPVGFYTDMWAVGVLAYVLLSGLSPFAGEND 317
           R     EPV    D+W+ G++   +L+G  P+   +D
Sbjct: 180 RREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 24/217 (11%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK---EIDIMNQLHHPK 166
           +D L+ +G G FG V   RE+ TG  +A K +     + K+ +     E  ++    HP 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELF-----ERI-TAPDYKMSEAEVIPVTLPILMTQT 220
           L  L  AF+  D +  + E+ +GGELF     ER+ T    +   AE++           
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVS---------- 116
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK-LDPNEVVKISTGTAEFA 279
             A++++H +++++ D+K EN+M       ++K+ DFGL  + +     +K   GT E+ 
Sbjct: 117 --ALEYLHSRDVVYRDIKLENLMLD--KDGHIKITDFGLCKEGISDGATMKXFCGTPEYL 172
Query: 280 APEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN 316
           APE++E    G   D W +GV+ Y ++ G  PF  ++
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 110/217 (50%), Gaps = 21/217 (9%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE-KELIRKEIDIMNQLHHPKLI 168
           +D+++ +G GA+G V     R T    A K + +   ++  E I+KEI I   L+H  ++
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 169 NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH 228
             +    + +   L  E+ SGGELF+RI  PD  M E +           Q    V ++H
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDA-----QRFFHQLMAGVVYLH 122
Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN---EVVKISTGTAEFAAPEIVE 285
              I H D+KPEN++   R+  N+K+ DFGLAT    N    ++    GT  + APE+++
Sbjct: 123 GIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 286 R-----EPVGFYTDMWAVGVLAYVLLSGLSPFAGEND 317
           R     EPV    D+W+ G++   +L+G  P+   +D
Sbjct: 181 RREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 110/217 (50%), Gaps = 21/217 (9%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE-KELIRKEIDIMNQLHHPKLI 168
           +D+++ +G GA+G V     R T    A K + +   ++  E I+KEI I   L+H  ++
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 169 NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH 228
             +    + +   L  E+ SGGELF+RI  PD  M E +           Q    V ++H
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDA-----QRFFHQLMAGVVYLH 122
Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN---EVVKISTGTAEFAAPEIVE 285
              I H D+KPEN++   R+  N+K+ DFGLAT    N    ++    GT  + APE+++
Sbjct: 123 GIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 286 R-----EPVGFYTDMWAVGVLAYVLLSGLSPFAGEND 317
           R     EPV    D+W+ G++   +L+G  P+   +D
Sbjct: 181 RREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 110/217 (50%), Gaps = 21/217 (9%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE-KELIRKEIDIMNQLHHPKLI 168
           +D+++ +G GA+G V     R T    A K + +   ++  E I+KEI I   L+H  ++
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 169 NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH 228
             +    + +   L  E+ SGGELF+RI  PD  M E +           Q    V ++H
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDA-----QRFFHQLMAGVVYLH 122
Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN---EVVKISTGTAEFAAPEIVE 285
              I H D+KPEN++   R+  N+K+ DFGLAT    N    ++    GT  + APE+++
Sbjct: 123 GIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 286 R-----EPVGFYTDMWAVGVLAYVLLSGLSPFAGEND 317
           R     EPV    D+W+ G++   +L+G  P+   +D
Sbjct: 181 RREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 125/247 (50%), Gaps = 17/247 (6%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---IMNQLHH 164
           D ++ ++ +GTG+FG V   +  +TGN +A K +     ++ + I   ++   I+  ++ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P L+ L  +F+D+  + ++ E++ GGE+F  +     + SE         I++T      
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLT-----F 154
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           +++H  ++I+ D+KPEN++   +    +++ DFG A ++          GT E+ APEI+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGR--TWXLCGTPEYLAPEII 210
Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
             +      D WA+GVL Y + +G  PF  +  ++  + + +    F      + S + K
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLK 266
Query: 345 DFIRRLL 351
           D +R LL
Sbjct: 267 DLLRNLL 273

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 24/217 (11%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK---EIDIMNQLHHPK 166
           +D L+ +G G FG V   RE+ TG  +A K +     + K+ +     E  ++    HP 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELF-----ERI-TAPDYKMSEAEVIPVTLPILMTQT 220
           L  L  AF+  D +  + E+ +GGELF     ER+ T    +   AE++           
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVS---------- 116
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK-LDPNEVVKISTGTAEFA 279
             A++++H +++++ D+K EN+M       ++K+ DFGL  + +     +K   GT E+ 
Sbjct: 117 --ALEYLHSRDVVYRDIKLENLMLD--KDGHIKITDFGLCKEGISDGATMKXFCGTPEYL 172
Query: 280 APEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN 316
           APE++E    G   D W +GV+ Y ++ G  PF  ++
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 110/217 (50%), Gaps = 21/217 (9%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE-KELIRKEIDIMNQLHHPKLI 168
           +D+++ +G GA+G V     R T    A K + +   ++  E I+KEI I   L+H  ++
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 169 NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH 228
             +    + +   L  E+ SGGELF+RI  PD  M E +           Q    V ++H
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDA-----QRFFHQLMAGVVYLH 121
Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN---EVVKISTGTAEFAAPEIVE 285
              I H D+KPEN++   R+  N+K+ DFGLAT    N    ++    GT  + APE+++
Sbjct: 122 GIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 286 R-----EPVGFYTDMWAVGVLAYVLLSGLSPFAGEND 317
           R     EPV    D+W+ G++   +L+G  P+   +D
Sbjct: 180 RREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 110/217 (50%), Gaps = 21/217 (9%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE-KELIRKEIDIMNQLHHPKLI 168
           +D+++ +G GA+G V     R T    A K + +   ++  E I+KEI I   L+H  ++
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 169 NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH 228
             +    + +   L  E+ SGGELF+RI  PD  M E +           Q    V ++H
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDA-----QRFFHQLMAGVVYLH 121
Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN---EVVKISTGTAEFAAPEIVE 285
              I H D+KPEN++   R+  N+K+ DFGLAT    N    ++    GT  + APE+++
Sbjct: 122 GIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 286 R-----EPVGFYTDMWAVGVLAYVLLSGLSPFAGEND 317
           R     EPV    D+W+ G++   +L+G  P+   +D
Sbjct: 180 RREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 110/217 (50%), Gaps = 21/217 (9%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE-KELIRKEIDIMNQLHHPKLI 168
           +D+++ +G GA+G V     R T    A K + +   ++  E I+KEI I   L+H  ++
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 169 NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH 228
             +    + +   L  E+ SGGELF+RI  PD  M E +           Q    V ++H
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDA-----QRFFHQLMAGVVYLH 122
Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN---EVVKISTGTAEFAAPEIVE 285
              I H D+KPEN++   R+  N+K+ DFGLAT    N    ++    GT  + APE+++
Sbjct: 123 GIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 286 R-----EPVGFYTDMWAVGVLAYVLLSGLSPFAGEND 317
           R     EPV    D+W+ G++   +L+G  P+   +D
Sbjct: 181 RREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 110/217 (50%), Gaps = 21/217 (9%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE-KELIRKEIDIMNQLHHPKLI 168
           +D+++ +G GA+G V     R T    A K + +   ++  E I+KEI I   L+H  ++
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 169 NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH 228
             +    + +   L  E+ SGGELF+RI  PD  M E +           Q    V ++H
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDA-----QRFFHQLMAGVVYLH 121
Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN---EVVKISTGTAEFAAPEIVE 285
              I H D+KPEN++   R+  N+K+ DFGLAT    N    ++    GT  + APE+++
Sbjct: 122 GIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 286 R-----EPVGFYTDMWAVGVLAYVLLSGLSPFAGEND 317
           R     EPV    D+W+ G++   +L+G  P+   +D
Sbjct: 180 RREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 110/217 (50%), Gaps = 21/217 (9%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE-KELIRKEIDIMNQLHHPKLI 168
           +D+++ +G GA+G V     R T    A K + +   ++  E I+KEI I   L+H  ++
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 169 NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH 228
             +    + +   L  E+ SGGELF+RI  PD  M E +           Q    V ++H
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDA-----QRFFHQLMAGVVYLH 121
Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN---EVVKISTGTAEFAAPEIVE 285
              I H D+KPEN++   R+  N+K+ DFGLAT    N    ++    GT  + APE+++
Sbjct: 122 GIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 286 R-----EPVGFYTDMWAVGVLAYVLLSGLSPFAGEND 317
           R     EPV    D+W+ G++   +L+G  P+   +D
Sbjct: 180 RREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 110/217 (50%), Gaps = 21/217 (9%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE-KELIRKEIDIMNQLHHPKLI 168
           +D+++ +G GA+G V     R T    A K + +   ++  E I+KEI I   L+H  ++
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 169 NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH 228
             +    + +   L  E+ SGGELF+RI  PD  M E +           Q    V ++H
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDA-----QRFFHQLMAGVVYLH 121
Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN---EVVKISTGTAEFAAPEIVE 285
              I H D+KPEN++   R+  N+K+ DFGLAT    N    ++    GT  + APE+++
Sbjct: 122 GIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 286 R-----EPVGFYTDMWAVGVLAYVLLSGLSPFAGEND 317
           R     EPV    D+W+ G++   +L+G  P+   +D
Sbjct: 180 RREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 110/217 (50%), Gaps = 21/217 (9%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE-KELIRKEIDIMNQLHHPKLI 168
           +D+++ +G GA+G V     R T    A K + +   ++  E I+KEI I   L+H  ++
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 169 NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH 228
             +    + +   L  E+ SGGELF+RI  PD  M E +           Q    V ++H
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDA-----QRFFHQLMAGVVYLH 121
Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN---EVVKISTGTAEFAAPEIVE 285
              I H D+KPEN++   R+  N+K+ DFGLAT    N    ++    GT  + APE+++
Sbjct: 122 GIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 286 R-----EPVGFYTDMWAVGVLAYVLLSGLSPFAGEND 317
           R     EPV    D+W+ G++   +L+G  P+   +D
Sbjct: 180 RREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 24/217 (11%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK---EIDIMNQLHHPK 166
           +D L+ +G G FG V   RE+ TG  +A K +     + K+ +     E  ++    HP 
Sbjct: 12  FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 71
Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELF-----ERI-TAPDYKMSEAEVIPVTLPILMTQT 220
           L  L  AF+  D +  + E+ +GGELF     ER+ T    +   AE++           
Sbjct: 72  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVS---------- 121
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK-LDPNEVVKISTGTAEFA 279
             A++++H +++++ D+K EN+M       ++K+ DFGL  + +     +K   GT E+ 
Sbjct: 122 --ALEYLHSRDVVYRDIKLENLMLD--KDGHIKITDFGLCKEGISDGATMKXFCGTPEYL 177
Query: 280 APEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN 316
           APE++E    G   D W +GV+ Y ++ G  PF  ++
Sbjct: 178 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 214

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 98.2 bits (243), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 110/217 (50%), Gaps = 21/217 (9%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE-KELIRKEIDIMNQLHHPKLI 168
           +D+++ +G GA+G V     R T    A K + +   ++  E I+KEI I   L+H  ++
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 169 NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH 228
             +    + +   L  E+ SGGELF+RI  PD  M E +           Q    V ++H
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDA-----QRFFHQLMAGVVYLH 122
Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN---EVVKISTGTAEFAAPEIVE 285
              I H D+KPEN++   R+  N+K+ DFGLAT    N    ++    GT  + APE+++
Sbjct: 123 GIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 286 R-----EPVGFYTDMWAVGVLAYVLLSGLSPFAGEND 317
           R     EPV    D+W+ G++   +L+G  P+   +D
Sbjct: 181 RREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 110/217 (50%), Gaps = 21/217 (9%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE-KELIRKEIDIMNQLHHPKLI 168
           +D+++ +G GA+G V     R T    A K + +   ++  E I+KEI I   L+H  ++
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 169 NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH 228
             +    + +   L  E+ SGGELF+RI  PD  M E +           Q    V ++H
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDA-----QRFFHQLMAGVVYLH 121
Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN---EVVKISTGTAEFAAPEIVE 285
              I H D+KPEN++   R+  N+K+ DFGLAT    N    ++    GT  + APE+++
Sbjct: 122 GIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 286 R-----EPVGFYTDMWAVGVLAYVLLSGLSPFAGEND 317
           R     EPV    D+W+ G++   +L+G  P+   +D
Sbjct: 180 RREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 110/217 (50%), Gaps = 21/217 (9%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE-KELIRKEIDIMNQLHHPKLI 168
           +D+++ +G GA+G V     R T    A K + +   ++  E I+KEI I   L+H  ++
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVV 68
Query: 169 NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH 228
             +    + +   L  E+ SGGELF+RI  PD  M E +           Q    V ++H
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDA-----QRFFHQLMAGVVYLH 122
Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN---EVVKISTGTAEFAAPEIVE 285
              I H D+KPEN++   R+  N+K+ DFGLAT    N    ++    GT  + APE+++
Sbjct: 123 GIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 286 R-----EPVGFYTDMWAVGVLAYVLLSGLSPFAGEND 317
           R     EPV    D+W+ G++   +L+G  P+   +D
Sbjct: 181 RREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 135/288 (46%), Gaps = 31/288 (10%)
Query: 73  RGKADEKVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKT 132
           +G   E V ++     + + K    P   + ++  D ++ ++ +GTG+FG V   +  +T
Sbjct: 9   KGSEQESVKEFLAKAKEDFLKKWENPA--QNTAHLDQFERIKTLGTGSFGRVMLVKHMET 66
Query: 133 GNIFAAKFIPVSHNLEKELIRKEID---IMNQLHHPKLINLHDAFEDDDEMVLIFEFLSG 189
           GN +A K +     ++ + I   ++   I+  ++ P L  L  +F+D+  + ++ E+  G
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPG 126
Query: 190 GELFE------RITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIM 243
           GE+F       R   P  +   A+++               +++H  ++I+ D+KPEN+M
Sbjct: 127 GEMFSHLRRIGRFXEPHARFYAAQIVLT------------FEYLHSLDLIYRDLKPENLM 174
Query: 244 CQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAY 303
              +    +K+ DFG A ++          GT E+ APEI+  +      D WA+GVL Y
Sbjct: 175 IDQQGY--IKVTDFGFAKRVKGR--TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 230
Query: 304 VLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLL 351
            + +G  PF  +  ++  + + +    F      + S + KD +R LL
Sbjct: 231 EMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 274

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 97.4 bits (241), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 124/253 (49%), Gaps = 29/253 (11%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---IMNQLHH 164
           D ++ ++ +GTG+FG V   +  +TGN +A K +     ++ + I   ++   I+  ++ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFE------RITAPDYKMSEAEVIPVTLPILMT 218
           P L+ L  +F+D+  + ++ E++ GGE+F       R   P  +   A+++         
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLT------- 153
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
                 +++H  ++I+ D+KPEN++   +    +++ DFG A ++          GT E+
Sbjct: 154 -----FEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGR--TWXLCGTPEY 204
Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKN 338
            APEI+  +      D WA+GVL Y + +G  PF  +  ++  + + +    F      +
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----H 260
Query: 339 VSEEGKDFIRRLL 351
            S + KD +R LL
Sbjct: 261 FSSDLKDLLRNLL 273

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 97.4 bits (241), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 124/253 (49%), Gaps = 29/253 (11%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---IMNQLHH 164
           D ++ ++ +GTG+FG V   +  +TGN +A K +     ++ + I   ++   I+  ++ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFE------RITAPDYKMSEAEVIPVTLPILMT 218
           P L+ L  +F+D+  + ++ E++ GGE+F       R   P  +   A+++         
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLT------- 154
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
                 +++H  ++I+ D+KPEN++   +    +++ DFG A ++          GT E+
Sbjct: 155 -----FEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGR--TWXLCGTPEY 205
Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKN 338
            APEI+  +      D WA+GVL Y + +G  PF  +  ++  + + +    F      +
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----H 261
Query: 339 VSEEGKDFIRRLL 351
            S + KD +R LL
Sbjct: 262 FSSDLKDLLRNLL 274

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 124/253 (49%), Gaps = 29/253 (11%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID---IMNQLHH 164
           D ++ ++ +GTG+FG V   +  +TGN +A K +     ++ + I   ++   I+  ++ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFE------RITAPDYKMSEAEVIPVTLPILMT 218
           P L+ L  +F+D+  + ++ E++ GGE+F       R   P  +   A+++         
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLT------- 153
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
                 +++H  ++I+ D+KPEN++   +    +++ DFG A ++          GT E+
Sbjct: 154 -----FEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGR--TWXLCGTPEY 204
Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKN 338
            APEI+  +      D WA+GVL Y + +G  PF  +  ++  + + +    F      +
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----H 260
Query: 339 VSEEGKDFIRRLL 351
            S + KD +R LL
Sbjct: 261 FSSDLKDLLRNLL 273

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 109/205 (53%), Gaps = 10/205 (4%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLIN 169
           +D+LE++G G++G V++   ++TG I A K +PV  +L++  I KEI IM Q   P ++ 
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE--IIKEISIMQQCDSPHVVK 88
Query: 170 LHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE 229
            + ++  + ++ ++ E+   G + + I   +  ++E E+  +     +  T   ++++H 
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATI-----LQSTLKGLEYLHF 143
Query: 230 KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL-DPNEVVKISTGTAEFAAPEIVEREP 288
              IH D+K  NI+  T    + K+ DFG+A +L D         GT  + APE+++   
Sbjct: 144 MRKIHRDIKAGNILLNTEG--HAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIG 201
Query: 289 VGFYTDMWAVGVLAYVLLSGLSPFA 313
                D+W++G+ A  +  G  P+A
Sbjct: 202 YNCVADIWSLGITAIEMAEGKPPYA 226

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 127/259 (49%), Gaps = 31/259 (11%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKL 167
           Y++L  IGTG++G   + R +  G I   K +        EK+++  E++++ +L HP +
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 168 INLHDAFED--DDEMVLIFEFLSGGELFERITAPDYK---MSEAEVIPVTLPILMTQTSP 222
           +  +D   D  +  + ++ E+  GG+L   IT    +   + E  V+ V     MTQ + 
Sbjct: 68  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV-----MTQLTL 122
Query: 223 AVKHMHEKN-----IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE-VVKISTGTA 276
           A+K  H ++     ++H D+KP N+    +   NVK+ DFGLA  L+ +E   K   GT 
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGLARILNHDEDFAKEFVGTP 180
Query: 277 EFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAF 336
            + +PE + R      +D+W++G L Y L + + PF   +  E    ++       E  F
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-------EGKF 233
Query: 337 KNV----SEEGKDFIRRLL 351
           + +    S+E  + I R+L
Sbjct: 234 RRIPYRYSDELNEIITRML 252

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 126/259 (48%), Gaps = 31/259 (11%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKL 167
           Y++L  IGTG++G   + R +  G I   K +        EK+++  E++++ +L HP +
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 168 INLHDAFED--DDEMVLIFEFLSGGELFERITAPDYK---MSEAEVIPVTLPILMTQTSP 222
           +  +D   D  +  + ++ E+  GG+L   IT    +   + E  V+ V     MTQ + 
Sbjct: 68  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV-----MTQLTL 122
Query: 223 AVKHMHEKN-----IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN-EVVKISTGTA 276
           A+K  H ++     ++H D+KP N+    +   NVK+ DFGLA  L+ +    K   GT 
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGLARILNHDTSFAKTFVGTP 180
Query: 277 EFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAF 336
            + +PE + R      +D+W++G L Y L + + PF   +  E    ++       E  F
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-------EGKF 233
Query: 337 KNV----SEEGKDFIRRLL 351
           + +    S+E  + I R+L
Sbjct: 234 RRIPYRYSDELNEIITRML 252

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 109/217 (50%), Gaps = 21/217 (9%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE-KELIRKEIDIMNQLHHPKLI 168
           +D+++ +G GA G V     R T    A K + +   ++  E I+KEI I   L+H  ++
Sbjct: 8   WDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 169 NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH 228
             +    + +   L  E+ SGGELF+RI  PD  M E +           Q    V ++H
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDA-----QRFFHQLMAGVVYLH 121
Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN---EVVKISTGTAEFAAPEIVE 285
              I H D+KPEN++   R+  N+K+ DFGLAT    N    ++    GT  + APE+++
Sbjct: 122 GIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 286 R-----EPVGFYTDMWAVGVLAYVLLSGLSPFAGEND 317
           R     EPV    D+W+ G++   +L+G  P+   +D
Sbjct: 180 RREFHAEPV----DVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 126/259 (48%), Gaps = 31/259 (11%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKL 167
           Y++L  IGTG++G   + R +  G I   K +        EK+++  E++++ +L HP +
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 168 INLHDAFED--DDEMVLIFEFLSGGELFERITAPDYK---MSEAEVIPVTLPILMTQTSP 222
           +  +D   D  +  + ++ E+  GG+L   IT    +   + E  V+ V     MTQ + 
Sbjct: 68  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV-----MTQLTL 122
Query: 223 AVKHMHEKN-----IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN-EVVKISTGTA 276
           A+K  H ++     ++H D+KP N+    +   NVK+ DFGLA  L+ +    K   GT 
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGLARILNHDTSFAKAFVGTP 180
Query: 277 EFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAF 336
            + +PE + R      +D+W++G L Y L + + PF   +  E    ++       E  F
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-------EGKF 233
Query: 337 KNV----SEEGKDFIRRLL 351
           + +    S+E  + I R+L
Sbjct: 234 RRIPYRYSDELNEIITRML 252

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 113/227 (49%), Gaps = 37/227 (16%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL----- 162
           D+++ +  +G G+FG V   R ++TG+++A K       L+K++I ++ D+   +     
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKV------LKKDVILQDDDVECTMTEKRI 76
Query: 163 -----HHPKLINLHDAFEDDDEMVLIFEFLSGGELF------ERITAPDYKMSEAEVIPV 211
                +HP L  L   F+  D +  + EF++GG+L        R      +   AE+I  
Sbjct: 77  LSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIIS- 135
Query: 212 TLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKI 271
                      A+  +H+K II+ D+K +N++    +  + K+ DFG+  +   N V   
Sbjct: 136 -----------ALMFLHDKGIIYRDLKLDNVLLD--HEGHCKLADFGMCKEGICNGVTTA 182
Query: 272 S-TGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEND 317
           +  GT ++ APEI++    G   D WA+GVL Y +L G +PF  EN+
Sbjct: 183 TFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE 229

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 107/199 (53%), Gaps = 13/199 (6%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKL 167
           D ++I+ E+G GAFG V++ + ++T  + AAK I      E E    EIDI+    HP +
Sbjct: 37  DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 96
Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
           + L DAF  ++ + ++ EF +GG +   +   +  ++E+++      ++  QT  A+ ++
Sbjct: 97  VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQI-----QVVCKQTLDALNYL 151
Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS-TGTAEFAAPEIVER 286
           H+  IIH D+K  NI+       ++K+ DFG++ K       + S  GT  + APE+V  
Sbjct: 152 HDNKIIHRDLKAGNILFTLDG--DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 209
Query: 287 E-----PVGFYTDMWAVGV 300
           E     P  +  D+W++G+
Sbjct: 210 ETSKDRPYDYKADVWSLGI 228

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 109/200 (54%), Gaps = 15/200 (7%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKL 167
           D ++I+ E+G GAFG V++ + ++T  + AAK I      E E    EIDI+    HP +
Sbjct: 37  DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 96
Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
           + L DAF  ++ + ++ EF +GG +   +   +  ++E+++      ++  QT  A+ ++
Sbjct: 97  VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQI-----QVVCKQTLDALNYL 151
Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFAAPEIVE 285
           H+  IIH D+K  NI+       ++K+ DFG++ K +   + +  +  GT  + APE+V 
Sbjct: 152 HDNKIIHRDLKAGNILFTL--DGDIKLADFGVSAK-NTRXIQRRDSFIGTPYWMAPEVVM 208
Query: 286 RE-----PVGFYTDMWAVGV 300
            E     P  +  D+W++G+
Sbjct: 209 CETSKDRPYDYKADVWSLGI 228

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 110/226 (48%), Gaps = 37/226 (16%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP---------VSHNLEKELIRKEIDI 158
           + ++ L+ +G G FG V   +E+ TG  +A K +          V+H L       E  +
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL------TENRV 201
Query: 159 MNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELF-----ERITAPDY-KMSEAEVIPVT 212
           +    HP L  L  +F+  D +  + E+ +GGELF     ER+ + D  +   AE++   
Sbjct: 202 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS-- 259
Query: 213 LPILMTQTSPAVKHMH-EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK-LDPNEVVK 270
                     A+ ++H EKN+++ D+K EN+M       ++K+ DFGL  + +     +K
Sbjct: 260 ----------ALDYLHSEKNVVYRDLKLENLMLD--KDGHIKITDFGLCKEGIKDGATMK 307
Query: 271 ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN 316
              GT E+ APE++E    G   D W +GV+ Y ++ G  PF  ++
Sbjct: 308 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 353

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 110/226 (48%), Gaps = 37/226 (16%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP---------VSHNLEKELIRKEIDI 158
           + ++ L+ +G G FG V   +E+ TG  +A K +          V+H L       E  +
Sbjct: 151 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL------TENRV 204
Query: 159 MNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELF-----ERITAPDY-KMSEAEVIPVT 212
           +    HP L  L  +F+  D +  + E+ +GGELF     ER+ + D  +   AE++   
Sbjct: 205 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS-- 262
Query: 213 LPILMTQTSPAVKHMH-EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK-LDPNEVVK 270
                     A+ ++H EKN+++ D+K EN+M       ++K+ DFGL  + +     +K
Sbjct: 263 ----------ALDYLHSEKNVVYRDLKLENLMLD--KDGHIKITDFGLCKEGIKDGATMK 310
Query: 271 ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN 316
              GT E+ APE++E    G   D W +GV+ Y ++ G  PF  ++
Sbjct: 311 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 356

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 110/227 (48%), Gaps = 10/227 (4%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL---IRKEIDIMNQLHHP 165
           ++ I ++IG G F  V+R      G   A K + +   ++ +      KEID++ QL+HP
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            +I  + +F +D+E+ ++ E    G+L   I    +K  +  +   T+     Q   A++
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIK--HFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS-TGTAEFAAPEIV 284
           HMH + ++H D+KP N+      +  VK+ D GL            S  GT  + +PE +
Sbjct: 151 HMHSRRVMHRDIKPANVFITA--TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 208
Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGE--NDVETLKNVKACDW 329
                 F +D+W++G L Y + +  SPF G+  N     K ++ CD+
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY 255

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 108/200 (54%), Gaps = 15/200 (7%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKL 167
           D ++I+ E+G GAFG V++ + ++T  + AAK I      E E    EIDI+    HP +
Sbjct: 37  DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 96
Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
           + L DAF  ++ + ++ EF +GG +   +   +  ++E+++      ++  QT  A+ ++
Sbjct: 97  VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQI-----QVVCKQTLDALNYL 151
Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFAAPEIVE 285
           H+  IIH D+K  NI+       ++K+ DFG++ K +   + +     GT  + APE+V 
Sbjct: 152 HDNKIIHRDLKAGNILFTL--DGDIKLADFGVSAK-NTRXIQRRDXFIGTPYWMAPEVVM 208
Query: 286 RE-----PVGFYTDMWAVGV 300
            E     P  +  D+W++G+
Sbjct: 209 CETSKDRPYDYKADVWSLGI 228

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 110/226 (48%), Gaps = 37/226 (16%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP---------VSHNLEKELIRKEIDI 158
           + ++ L+ +G G FG V   +E+ TG  +A K +          V+H L       E  +
Sbjct: 8   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL------TENRV 61
Query: 159 MNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELF-----ERITAPDY-KMSEAEVIPVT 212
           +    HP L  L  +F+  D +  + E+ +GGELF     ER+ + D  +   AE++   
Sbjct: 62  LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS-- 119
Query: 213 LPILMTQTSPAVKHMH-EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK-LDPNEVVK 270
                     A+ ++H EKN+++ D+K EN+M       ++K+ DFGL  + +     +K
Sbjct: 120 ----------ALDYLHSEKNVVYRDLKLENLMLD--KDGHIKITDFGLCKEGIKDGATMK 167
Query: 271 ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN 316
              GT E+ APE++E    G   D W +GV+ Y ++ G  PF  ++
Sbjct: 168 XFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 213

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 110/226 (48%), Gaps = 37/226 (16%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP---------VSHNLEKELIRKEIDI 158
           + ++ L+ +G G FG V   +E+ TG  +A K +          V+H L       E  +
Sbjct: 10  NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL------TENRV 63
Query: 159 MNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELF-----ERITAPDY-KMSEAEVIPVT 212
           +    HP L  L  +F+  D +  + E+ +GGELF     ER+ + D  +   AE++   
Sbjct: 64  LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS-- 121
Query: 213 LPILMTQTSPAVKHMH-EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK-LDPNEVVK 270
                     A+ ++H EKN+++ D+K EN+M       ++K+ DFGL  + +     +K
Sbjct: 122 ----------ALDYLHSEKNVVYRDLKLENLMLD--KDGHIKITDFGLCKEGIKDGATMK 169
Query: 271 ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN 316
              GT E+ APE++E    G   D W +GV+ Y ++ G  PF  ++
Sbjct: 170 XFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 215

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 110/226 (48%), Gaps = 37/226 (16%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP---------VSHNLEKELIRKEIDI 158
           + ++ L+ +G G FG V   +E+ TG  +A K +          V+H L       E  +
Sbjct: 9   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL------TENRV 62
Query: 159 MNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELF-----ERITAPDY-KMSEAEVIPVT 212
           +    HP L  L  +F+  D +  + E+ +GGELF     ER+ + D  +   AE++   
Sbjct: 63  LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS-- 120
Query: 213 LPILMTQTSPAVKHMH-EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK-LDPNEVVK 270
                     A+ ++H EKN+++ D+K EN+M       ++K+ DFGL  + +     +K
Sbjct: 121 ----------ALDYLHSEKNVVYRDLKLENLMLD--KDGHIKITDFGLCKEGIKDGATMK 168
Query: 271 ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN 316
              GT E+ APE++E    G   D W +GV+ Y ++ G  PF  ++
Sbjct: 169 XFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 214

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 112/233 (48%), Gaps = 17/233 (7%)
Query: 99  VDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE-----LIR 153
           +D+K+ +    Y+ L+ +G G F  V++ R++ T  I A K I + H  E +        
Sbjct: 3   LDVKSRA--KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL 60
Query: 154 KEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTL 213
           +EI ++ +L HP +I L DAF     + L+F+F+      E I     K +   + P  +
Sbjct: 61  REIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD--LEVII----KDNSLVLTPSHI 114
Query: 214 PILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL-DPNEVVKIS 272
              M  T   ++++H+  I+H D+KP N++        +K+ DFGLA     PN      
Sbjct: 115 KAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAKSFGSPNRAYXHQ 172
Query: 273 TGTAEFAAPEIV-EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
             T  + APE++      G   DMWAVG +   LL  +    G++D++ L  +
Sbjct: 173 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI 225

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 110/240 (45%), Gaps = 16/240 (6%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL---EKELIRKEIDIMNQLHHPKLINLHD 172
           +G G F       +  T  +FA K +P S  L   ++E +  EI I   L H  ++  H 
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 173 AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNI 232
            FED+D + ++ E      L E      +K  +A   P      + Q     +++H   +
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLEL-----HKRRKALTEPEAR-YYLRQIVLGCQYLHRNRV 160
Query: 233 IHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEFAAPEIVEREPVGF 291
           IH D+K  N+         VK+ DFGLATK++   E  K+  GT  + APE++ ++   F
Sbjct: 161 IHRDLKLGNLFLN--EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF 218
Query: 292 YTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLL 351
             D+W++G + Y LL G  PF      ET   +K  ++       K+++      I+++L
Sbjct: 219 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINPVAASLIQKML 274

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 110/240 (45%), Gaps = 16/240 (6%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL---EKELIRKEIDIMNQLHHPKLINLHD 172
           +G G F       +  T  +FA K +P S  L   ++E +  EI I   L H  ++  H 
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 173 AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNI 232
            FED+D + ++ E      L E      +K  +A   P      + Q     +++H   +
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLEL-----HKRRKALTEPEAR-YYLRQIVLGCQYLHRNRV 136
Query: 233 IHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEFAAPEIVEREPVGF 291
           IH D+K  N+         VK+ DFGLATK++   E  K+  GT  + APE++ ++   F
Sbjct: 137 IHRDLKLGNLFLN--EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF 194
Query: 292 YTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLL 351
             D+W++G + Y LL G  PF      ET   +K  ++       K+++      I+++L
Sbjct: 195 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINPVAASLIQKML 250

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 110/240 (45%), Gaps = 16/240 (6%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL---EKELIRKEIDIMNQLHHPKLINLHD 172
           +G G F       +  T  +FA K +P S  L   ++E +  EI I   L H  ++  H 
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 173 AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNI 232
            FED+D + ++ E      L E      +K  +A   P      + Q     +++H   +
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLEL-----HKRRKALTEPEAR-YYLRQIVLGCQYLHRNRV 162
Query: 233 IHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEFAAPEIVEREPVGF 291
           IH D+K  N+         VK+ DFGLATK++   E  K+  GT  + APE++ ++   F
Sbjct: 163 IHRDLKLGNLFLN--EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF 220
Query: 292 YTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLL 351
             D+W++G + Y LL G  PF      ET   +K  ++       K+++      I+++L
Sbjct: 221 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINPVAASLIQKML 276

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 123/250 (49%), Gaps = 17/250 (6%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP---VSHNLEKELIRKEIDIMNQLHHPK 166
           ++ L  +G G+FG V     + T  ++A K +    V  + + E    E  ++  L  P 
Sbjct: 21  FNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPP 80
Query: 167 -LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            L  LH  F+  D +  + E+++GG+L   I     K  E + +         + S  + 
Sbjct: 81  FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVG-KFKEPQAV-----FYAAEISIGLF 134
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVV-KISTGTAEFAAPEIV 284
            +H++ II+ D+K +N+M  +    ++K+ DFG+  +   + V  +   GT ++ APEI+
Sbjct: 135 FLHKRGIIYRDLKLDNVMLDSEG--HIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEII 192
Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
             +P G   D WA GVL Y +L+G  PF GE++ E  +++     E +    K++S+E  
Sbjct: 193 AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI----MEHNVSYPKSLSKEAV 248
Query: 345 DFIRRLLLRN 354
              + L+ ++
Sbjct: 249 SICKGLMTKH 258

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 109/240 (45%), Gaps = 16/240 (6%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL---EKELIRKEIDIMNQLHHPKLINLHD 172
           +G G F       +  T  +FA K +P S  L   ++E +  EI I   L H  ++  H 
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 173 AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNI 232
            FED+D + ++ E      L E      +K  +A   P      + Q     +++H   +
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLEL-----HKRRKALTEPEAR-YYLRQIVLGCQYLHRNRV 142
Query: 233 IHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEFAAPEIVEREPVGF 291
           IH D+K  N+         VK+ DFGLATK++   E  K   GT  + APE++ ++   F
Sbjct: 143 IHRDLKLGNLFLN--EDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSF 200
Query: 292 YTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLL 351
             D+W++G + Y LL G  PF      ET   +K  ++       K+++      I+++L
Sbjct: 201 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINPVAASLIQKML 256

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 109/240 (45%), Gaps = 16/240 (6%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL---EKELIRKEIDIMNQLHHPKLINLHD 172
           +G G F       +  T  +FA K +P S  L   ++E +  EI I   L H  ++  H 
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 173 AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNI 232
            FED+D + ++ E      L E      +K  +A   P      + Q     +++H   +
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLEL-----HKRRKALTEPEAR-YYLRQIVLGCQYLHRNRV 138
Query: 233 IHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEFAAPEIVEREPVGF 291
           IH D+K  N+         VK+ DFGLATK++   E  K   GT  + APE++ ++   F
Sbjct: 139 IHRDLKLGNLFLN--EDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSF 196
Query: 292 YTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLL 351
             D+W++G + Y LL G  PF      ET   +K  ++       K+++      I+++L
Sbjct: 197 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINPVAASLIQKML 252

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 109/240 (45%), Gaps = 16/240 (6%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL---EKELIRKEIDIMNQLHHPKLINLHD 172
           +G G F       +  T  +FA K +P S  L   ++E +  EI I   L H  ++  H 
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 173 AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNI 232
            FED+D + ++ E      L E      +K  +A   P      + Q     +++H   +
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLEL-----HKRRKALTEPEAR-YYLRQIVLGCQYLHRNRV 138
Query: 233 IHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEFAAPEIVEREPVGF 291
           IH D+K  N+         VK+ DFGLATK++   E  K   GT  + APE++ ++   F
Sbjct: 139 IHRDLKLGNLFLN--EDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSF 196
Query: 292 YTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLL 351
             D+W++G + Y LL G  PF      ET   +K  ++       K+++      I+++L
Sbjct: 197 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINPVAASLIQKML 252

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/250 (27%), Positives = 117/250 (46%), Gaps = 18/250 (7%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSH-----NLEKELIRKEIDIMNQLHHPKLINL 170
           +G G FG V  C+ + TG ++A K +           +  ++ K+I  + ++H   +++L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI--LAKVHSRFIVSL 250
Query: 171 HDAFEDDDEMVLIFEFLSGGELFERITAPDY---KMSEAEVIPVTLPILMTQTSPAVKHM 227
             AFE   ++ L+   ++GG++   I   D       E   I  T      Q    ++H+
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT-----AQIVSGLEHL 305
Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEV-VKISTGTAEFAAPEIVER 286
           H++NII+ D+KPEN++    +  NV++ D GLA +L   +   K   GT  F APE++  
Sbjct: 306 HQRNIIYRDLKPENVLLD--DDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG 363
Query: 287 EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDF 346
           E   F  D +A+GV  Y +++   PF    +    K +K    E         S   KDF
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDF 423
Query: 347 IRRLLLRNKE 356
              LL ++ E
Sbjct: 424 CEALLQKDPE 433

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/250 (27%), Positives = 117/250 (46%), Gaps = 18/250 (7%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSH-----NLEKELIRKEIDIMNQLHHPKLINL 170
           +G G FG V  C+ + TG ++A K +           +  ++ K+I  + ++H   +++L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI--LAKVHSRFIVSL 250
Query: 171 HDAFEDDDEMVLIFEFLSGGELFERITAPDY---KMSEAEVIPVTLPILMTQTSPAVKHM 227
             AFE   ++ L+   ++GG++   I   D       E   I  T      Q    ++H+
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT-----AQIVSGLEHL 305
Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEV-VKISTGTAEFAAPEIVER 286
           H++NII+ D+KPEN++    +  NV++ D GLA +L   +   K   GT  F APE++  
Sbjct: 306 HQRNIIYRDLKPENVLLD--DDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG 363
Query: 287 EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDF 346
           E   F  D +A+GV  Y +++   PF    +    K +K    E         S   KDF
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDF 423
Query: 347 IRRLLLRNKE 356
              LL ++ E
Sbjct: 424 CEALLQKDPE 433

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/250 (27%), Positives = 117/250 (46%), Gaps = 18/250 (7%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSH-----NLEKELIRKEIDIMNQLHHPKLINL 170
           +G G FG V  C+ + TG ++A K +           +  ++ K+I  + ++H   +++L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI--LAKVHSRFIVSL 250
Query: 171 HDAFEDDDEMVLIFEFLSGGELFERITAPDY---KMSEAEVIPVTLPILMTQTSPAVKHM 227
             AFE   ++ L+   ++GG++   I   D       E   I  T      Q    ++H+
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT-----AQIVSGLEHL 305
Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEV-VKISTGTAEFAAPEIVER 286
           H++NII+ D+KPEN++    +  NV++ D GLA +L   +   K   GT  F APE++  
Sbjct: 306 HQRNIIYRDLKPENVLLD--DDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG 363
Query: 287 EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDF 346
           E   F  D +A+GV  Y +++   PF    +    K +K    E         S   KDF
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDF 423
Query: 347 IRRLLLRNKE 356
              LL ++ E
Sbjct: 424 CEALLQKDPE 433

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/250 (27%), Positives = 117/250 (46%), Gaps = 18/250 (7%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSH-----NLEKELIRKEIDIMNQLHHPKLINL 170
           +G G FG V  C+ + TG ++A K +           +  ++ K+I  + ++H   +++L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI--LAKVHSRFIVSL 250
Query: 171 HDAFEDDDEMVLIFEFLSGGELFERITAPDY---KMSEAEVIPVTLPILMTQTSPAVKHM 227
             AFE   ++ L+   ++GG++   I   D       E   I  T      Q    ++H+
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT-----AQIVSGLEHL 305
Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEV-VKISTGTAEFAAPEIVER 286
           H++NII+ D+KPEN++    +  NV++ D GLA +L   +   K   GT  F APE++  
Sbjct: 306 HQRNIIYRDLKPENVLLD--DDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG 363
Query: 287 EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDF 346
           E   F  D +A+GV  Y +++   PF    +    K +K    E         S   KDF
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDF 423
Query: 347 IRRLLLRNKE 356
              LL ++ E
Sbjct: 424 CEALLQKDPE 433

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 70/257 (27%), Positives = 127/257 (49%), Gaps = 16/257 (6%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAK--FIPVSHNLEKELIRKEIDIMN--Q 161
           + + Y I++++G G    V+   +       A K  FIP     E+ L R E ++ N  Q
Sbjct: 9   INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREK-EETLKRFEREVHNSSQ 67
Query: 162 LHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTS 221
           L H  ++++ D  E+DD   L+ E++ G  L E I +    +S    I  T  IL     
Sbjct: 68  LSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQIL----- 121
Query: 222 PAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS--TGTAEFA 279
             +KH H+  I+H D+KP+NI+  +  +  +K+ DFG+A  L    + + +   GT ++ 
Sbjct: 122 DGIKHAHDMRIVHRDIKPQNILIDSNKT--LKIFDFGIAKALSETSLTQTNHVLGTVQYF 179
Query: 280 APEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVE-TLKNVKACDWEFDEEAFKN 338
           +PE  + E     TD++++G++ Y +L G  PF GE  V   +K+++        +  K+
Sbjct: 180 SPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKD 239
Query: 339 VSEEGKDFIRRLLLRNK 355
           + +   + I R   ++K
Sbjct: 240 IPQSLSNVILRATEKDK 256

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 110/220 (50%), Gaps = 22/220 (10%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK------ELIRKEIDIMNQ 161
           D Y++ E IG+GA  VV            A K I    NLEK      EL+ KEI  M+Q
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI----NLEKCQTSMDELL-KEIQAMSQ 69
Query: 162 LHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVI--PVTLPILMTQ 219
            HHP +++ + +F   DE+ L+ + LSGG + + I     K      +    T+  ++ +
Sbjct: 70  CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 129
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFG----LATKLD--PNEVVKIST 273
               ++++H+   IH DVK  NI+     S  V++ DFG    LAT  D   N+V K   
Sbjct: 130 VLEGLEYLHKNGQIHRDVKAGNILLGEDGS--VQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 274 GTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPF 312
           GT  + APE++E+     F  D+W+ G+ A  L +G +P+
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY 227

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 113/229 (49%), Gaps = 23/229 (10%)
Query: 101 IKTSSVYDHYDILEEI-GTGAFGVVHRCRERKTGNIFAAK-FIPVSHNLEKELIRKEIDI 158
           + + S  +H  +L +I G GA   V R R +KTG++FA K F  +S     ++  +E ++
Sbjct: 1   MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEV 60
Query: 159 MNQLHHPKLINLHDAFEDDD---EMVLIFEFLSGGELFERITAPD--YKMSEAEVIPVTL 213
           + +L+H  ++ L  A E++      VLI EF   G L+  +  P   Y + E+E +    
Sbjct: 61  LKKLNHKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL---- 115
Query: 214 PILMTQTSPAVKHMHEKNIIHLDVKPENIM--CQTRNSTNVKMIDFGLATKLDPNEVVKI 271
            I++      + H+ E  I+H ++KP NIM        +  K+ DFG A +L+ +E    
Sbjct: 116 -IVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVX 174
Query: 272 STGTAEFAAPEIVEREPV--------GFYTDMWAVGVLAYVLLSGLSPF 312
             GT E+  P++ ER  +        G   D+W++GV  Y   +G  PF
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 110/220 (50%), Gaps = 22/220 (10%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK------ELIRKEIDIMNQ 161
           D Y++ E IG+GA  VV            A K I    NLEK      EL+ KEI  M+Q
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI----NLEKCQTSMDELL-KEIQAMSQ 64
Query: 162 LHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVI--PVTLPILMTQ 219
            HHP +++ + +F   DE+ L+ + LSGG + + I     K      +    T+  ++ +
Sbjct: 65  CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 124
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFG----LATKLD--PNEVVKIST 273
               ++++H+   IH DVK  NI+     S  V++ DFG    LAT  D   N+V K   
Sbjct: 125 VLEGLEYLHKNGQIHRDVKAGNILLGEDGS--VQIADFGVSAFLATGGDITRNKVRKTFV 182
Query: 274 GTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPF 312
           GT  + APE++E+     F  D+W+ G+ A  L +G +P+
Sbjct: 183 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY 222

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 108/221 (48%), Gaps = 15/221 (6%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP-----VSHNLEKELIRKEIDIMNQLHH 164
           ++ L  +G G+FG V     + T  ++A K +         ++E  ++ K +  +     
Sbjct: 22  FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG-KP 80
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P L  LH  F+  D +  + E+++GG+L   I     +  E   +         + +  +
Sbjct: 81  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAV-----FYAAEIAIGL 134
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVV-KISTGTAEFAAPEI 283
             +  K II+ D+K +N+M  +    ++K+ DFG+  +   + V  K   GT ++ APEI
Sbjct: 135 FFLQSKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEI 192
Query: 284 VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           +  +P G   D WA GVL Y +L+G +PF GE++ E  +++
Sbjct: 193 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 233

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 76/270 (28%), Positives = 124/270 (45%), Gaps = 43/270 (15%)
Query: 94  YVPQPVDIKTSSVYDHYDILEEI-GTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELI 152
           +V   + IK +++ D Y +  ++ G G  G V +   ++T   FA K +    +  K   
Sbjct: 3   HVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML---QDCPKA-- 57
Query: 153 RKEIDIMNQLHH-PKLINLHDAFED----DDEMVLIFEFLSGGELFERIT-APDYKMSEA 206
           R+E+++  +    P ++ + D +E+       ++++ E L GGELF RI    D   +E 
Sbjct: 58  RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 117
Query: 207 EVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIM-CQTRNSTNVKMIDFGLATKLDP 265
           E   +     M     A++++H  NI H DVKPEN++    R +  +K+ DFG A     
Sbjct: 118 EASEI-----MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA----- 167
Query: 266 NEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVK 325
               K +TG            E      DMW++GV+ Y+LL G  PF   + +     +K
Sbjct: 168 ----KETTG------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 211
Query: 326 A----CDWEFDEEAFKNVSEEGKDFIRRLL 351
                  +EF    +  VSEE K  IR LL
Sbjct: 212 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLL 241

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 120/227 (52%), Gaps = 24/227 (10%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL-HHPKLI 168
           ++++E +G G +G V++ R  KTG + A K + V+ + E+E I++EI+++ +  HH  + 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIA 84
Query: 169 NLHDAFED------DDEMVLIFEFLSGGELFERI-TAPDYKMSEAEVIPVTLPILMTQTS 221
             + AF        DD++ L+ EF   G + + I       + E  +  +   IL     
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR---- 140
Query: 222 PAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFA 279
             + H+H+  +IH D+K +N++  T N+  VK++DFG++ +LD   V + +T  GT  + 
Sbjct: 141 -GLSHLHQHKVIHRDIKGQNVLL-TENA-EVKLVDFGVSAQLD-RTVGRRNTFIGTPYWM 196
Query: 280 APEIV--EREPVGFY---TDMWAVGVLAYVLLSGLSPFAGENDVETL 321
           APE++  +  P   Y   +D+W++G+ A  +  G  P    + +  L
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL 243

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 117/226 (51%), Gaps = 27/226 (11%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---SHNLEKELIRKEIDIMNQLHH 164
           +++  +E+IG G +GVV++ R + TG + A K I +   +  +    IR EI ++ +L+H
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 62
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK--MSEAEVIPVTLPIL---MTQ 219
           P ++ L D    ++++ L+FEFLS           D K  M  + +  + LP++   + Q
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLSM----------DLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEF 278
               +   H   ++H D+KPEN++  T  +  +K+ DFGLA     P         T  +
Sbjct: 113 LLQGLAFCHSHRVLHRDLKPENLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWY 170
Query: 279 AAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
            APEI+      +Y+   D+W++G +   +++  + F G+++++ L
Sbjct: 171 RAPEILLG--CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 214

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 110/226 (48%), Gaps = 25/226 (11%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL------- 162
           ++ L  +G G+FG V     + T  ++A K       L+K+++ ++ D+   +       
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKI------LKKDVVIQDDDVECTMVEKRVLA 396
Query: 163 ---HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQ 219
                P L  LH  F+  D +  + E+++GG+L   I     +  E   +         +
Sbjct: 397 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAV-----FYAAE 450
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVV-KISTGTAEF 278
            +  +  +  K II+ D+K +N+M  +    ++K+ DFG+  +   + V  K   GT ++
Sbjct: 451 IAIGLFFLQSKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKENIWDGVTTKXFCGTPDY 508
Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
            APEI+  +P G   D WA GVL Y +L+G +PF GE++ E  +++
Sbjct: 509 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 554

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 113/229 (49%), Gaps = 23/229 (10%)
Query: 101 IKTSSVYDHYDILEEI-GTGAFGVVHRCRERKTGNIFAAK-FIPVSHNLEKELIRKEIDI 158
           + + S  +H  +L +I G GA   V R R +KTG++FA K F  +S     ++  +E ++
Sbjct: 1   MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEV 60
Query: 159 MNQLHHPKLINLHDAFEDDD---EMVLIFEFLSGGELFERITAPD--YKMSEAEVIPVTL 213
           + +L+H  ++ L  A E++      VLI EF   G L+  +  P   Y + E+E +    
Sbjct: 61  LKKLNHKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL---- 115
Query: 214 PILMTQTSPAVKHMHEKNIIHLDVKPENIM--CQTRNSTNVKMIDFGLATKLDPNEVVKI 271
            I++      + H+ E  I+H ++KP NIM        +  K+ DFG A +L+ +E    
Sbjct: 116 -IVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS 174
Query: 272 STGTAEFAAPEIVEREPV--------GFYTDMWAVGVLAYVLLSGLSPF 312
             GT E+  P++ ER  +        G   D+W++GV  Y   +G  PF
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 117/226 (51%), Gaps = 27/226 (11%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---SHNLEKELIRKEIDIMNQLHH 164
           +++  +E+IG G +GVV++ R + TG + A K I +   +  +    IR EI ++ +L+H
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 64
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK--MSEAEVIPVTLPIL---MTQ 219
           P ++ L D    ++++ L+FEFLS           D K  M  + +  + LP++   + Q
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLSM----------DLKKFMDASALTGIPLPLIKSYLFQ 114
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEF 278
               +   H   ++H D+KPEN++  T  +  +K+ DFGLA     P         T  +
Sbjct: 115 LLQGLAFCHSHRVLHRDLKPENLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWY 172
Query: 279 AAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
            APEI+      +Y+   D+W++G +   +++  + F G+++++ L
Sbjct: 173 RAPEILLG--CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 216

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 102/197 (51%), Gaps = 13/197 (6%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLIN 169
           ++I+ E+G GAFG V++ + ++TG + AAK I      E E    EI+I+    HP ++ 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 170 LHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE 229
           L  A+  D ++ ++ EF  GG +   +   D  ++E ++      ++  Q   A+  +H 
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQI-----QVVCRQMLEALNFLHS 135
Query: 230 KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK-LDPNEVVKISTGTAEFAAPEIVERE- 287
           K IIH D+K  N++       ++++ DFG++ K L   +      GT  + APE+V  E 
Sbjct: 136 KRIIHRDLKAGNVLMTLEG--DIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCET 193
Query: 288 ----PVGFYTDMWAVGV 300
               P  +  D+W++G+
Sbjct: 194 MKDTPYDYKADIWSLGI 210

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 116/223 (52%), Gaps = 21/223 (9%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE--KELIRKEIDIMNQLHHP 165
           +++  +E+IG G +GVV++ R + TG + A K I +    E       +EI ++ +L+HP
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPIL---MTQTSP 222
            ++ L D    ++++ L+FEFLS       +   D+ M  + +  + LP++   + Q   
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLS-------MDLKDF-MDASALTGIPLPLIKSYLFQLLQ 116
Query: 223 AVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEFAAP 281
            +   H   ++H D+KP+N++  T  +  +K+ DFGLA     P         T  + AP
Sbjct: 117 GLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAP 174
Query: 282 EIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
           EI+      +Y+   D+W++G +   +++  + F G+++++ L
Sbjct: 175 EILLG--CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 215

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 102/197 (51%), Gaps = 13/197 (6%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLIN 169
           ++I+ E+G GAFG V++ + ++TG + AAK I      E E    EI+I+    HP ++ 
Sbjct: 13  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 72
Query: 170 LHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE 229
           L  A+  D ++ ++ EF  GG +   +   D  ++E ++      ++  Q   A+  +H 
Sbjct: 73  LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQI-----QVVCRQMLEALNFLHS 127
Query: 230 KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK-LDPNEVVKISTGTAEFAAPEIVERE- 287
           K IIH D+K  N++       ++++ DFG++ K L   +      GT  + APE+V  E 
Sbjct: 128 KRIIHRDLKAGNVLMTLEG--DIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCET 185
Query: 288 ----PVGFYTDMWAVGV 300
               P  +  D+W++G+
Sbjct: 186 MKDTPYDYKADIWSLGI 202

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 118/224 (52%), Gaps = 23/224 (10%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---SHNLEKELIRKEIDIMNQLHH 164
           +++  +E+IG G +GVV++ R + TG + A K I +   +  +    IR EI ++ +L+H
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 64
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPIL---MTQTS 221
           P ++ L D    ++++ L+FEFLS       +   D+ M  + +  + LP++   + Q  
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLS-------MDLKDF-MDASALTGIPLPLIKSYLFQLL 116
Query: 222 PAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEFAA 280
             +   H   ++H D+KP+N++  T  +  +K+ DFGLA     P         T  + A
Sbjct: 117 QGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 281 PEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
           PEI+      +Y+   D+W++G +   +++  + F G+++++ L
Sbjct: 175 PEILLG--CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 216

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 129/286 (45%), Gaps = 53/286 (18%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK------------- 154
           + Y + +EIG G++GVV           +A K +      +K+LIR+             
Sbjct: 13  NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLS-----KKKLIRQAGFPRRPPPRGTR 67
Query: 155 ------------------EIDIMNQLHHPKLINLHDAFED--DDEMVLIFEFLSGGELFE 194
                             EI I+ +L HP ++ L +  +D  +D + ++FE ++ G + E
Sbjct: 68  PAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME 127
Query: 195 RITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKM 254
             T       +A                 ++++H + IIH D+KP N++       ++K+
Sbjct: 128 VPTLKPLSEDQAR-------FYFQDLIKGIEYLHYQKIIHRDIKPSNLL--VGEDGHIKI 178
Query: 255 IDFGLATKLDPNEVVKIST-GTAEFAAPE-IVEREPV--GFYTDMWAVGVLAYVLLSGLS 310
            DFG++ +   ++ +  +T GT  F APE + E   +  G   D+WA+GV  Y  + G  
Sbjct: 179 ADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238
Query: 311 PFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE 356
           PF  E  +     +K+   EF ++   +++E+ KD I R+L +N E
Sbjct: 239 PFMDERIMCLHSKIKSQALEFPDQP--DIAEDLKDLITRMLDKNPE 282

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 116/226 (51%), Gaps = 27/226 (11%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---SHNLEKELIRKEIDIMNQLHH 164
           +++  +E+IG G +GVV++ R + TG + A K I +   +  +    IR EI ++ +L+H
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 63
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK--MSEAEVIPVTLPIL---MTQ 219
           P ++ L D    ++++ L+FEFL            D K  M  + +  + LP++   + Q
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLHQ----------DLKKFMDASALTGIPLPLIKSYLFQ 113
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEF 278
               +   H   ++H D+KPEN++  T  +  +K+ DFGLA     P         T  +
Sbjct: 114 LLQGLAFCHSHRVLHRDLKPENLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWY 171
Query: 279 AAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
            APEI+      +Y+   D+W++G +   +++  + F G+++++ L
Sbjct: 172 RAPEILLG--CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 215

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 116/226 (51%), Gaps = 27/226 (11%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---SHNLEKELIRKEIDIMNQLHH 164
           +++  +E+IG G +GVV++ R + TG + A K I +   +  +    IR EI ++ +L+H
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 62
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK--MSEAEVIPVTLPIL---MTQ 219
           P ++ L D    ++++ L+FEFL            D K  M  + +  + LP++   + Q
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQ----------DLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEF 278
               +   H   ++H D+KPEN++  T  +  +K+ DFGLA     P         T  +
Sbjct: 113 LLQGLAFCHSHRVLHRDLKPENLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWY 170
Query: 279 AAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
            APEI+      +Y+   D+W++G +   +++  + F G+++++ L
Sbjct: 171 RAPEILLG--CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 214

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 114/225 (50%), Gaps = 25/225 (11%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE--KELIRKEIDIMNQLHHP 165
           +++  +E+IG G +GVV++ R + TG + A K I +    E       +EI ++ +L+HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK--MSEAEVIPVTLPIL---MTQT 220
            ++ L D    ++++ L+FEFL            D K  M  + +  + LP++   + Q 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ----------DLKDFMDASALTGIPLPLIKSYLFQL 112
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEFA 279
              +   H   ++H D+KPEN++  T  +  +K+ DFGLA     P         T  + 
Sbjct: 113 LQGLAFCHSHRVLHRDLKPENLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYR 170
Query: 280 APEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
           APEI+      +Y+   D+W++G +   +++  + F G+++++ L
Sbjct: 171 APEILLG--CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 116/226 (51%), Gaps = 27/226 (11%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---SHNLEKELIRKEIDIMNQLHH 164
           +++  +E+IG G +GVV++ R + TG + A K I +   +  +    IR EI ++ +L+H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 61
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK--MSEAEVIPVTLPIL---MTQ 219
           P ++ L D    ++++ L+FEFL            D K  M  + +  + LP++   + Q
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ----------DLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEF 278
               +   H   ++H D+KP+N++  T  +  +K+ DFGLA     P         T  +
Sbjct: 112 LLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWY 169
Query: 279 AAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
            APEI+      +Y+   D+W++G +   +++  + F G+++++ L
Sbjct: 170 RAPEILLG--CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 116/226 (51%), Gaps = 27/226 (11%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---SHNLEKELIRKEIDIMNQLHH 164
           +++  +E+IG G +GVV++ R + TG + A K I +   +  +    IR EI ++ +L+H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 61
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK--MSEAEVIPVTLPIL---MTQ 219
           P ++ L D    ++++ L+FEFL            D K  M  + +  + LP++   + Q
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ----------DLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEF 278
               +   H   ++H D+KP+N++  T  +  +K+ DFGLA     P         T  +
Sbjct: 112 LLQGLSFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWY 169
Query: 279 AAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
            APEI+      +Y+   D+W++G +   +++  + F G+++++ L
Sbjct: 170 RAPEILLG--CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 116/226 (51%), Gaps = 27/226 (11%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---SHNLEKELIRKEIDIMNQLHH 164
           +++  +E+IG G +GVV++ R + TG + A K I +   +  +    IR EI ++ +L+H
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 62
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK--MSEAEVIPVTLPIL---MTQ 219
           P ++ L D    ++++ L+FEFL            D K  M  + +  + LP++   + Q
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQ----------DLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEF 278
               +   H   ++H D+KP+N++  T  +  +K+ DFGLA     P         T  +
Sbjct: 113 LLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWY 170
Query: 279 AAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
            APEI+      +Y+   D+W++G +   +++  + F G+++++ L
Sbjct: 171 RAPEILLG--CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 214

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 116/226 (51%), Gaps = 27/226 (11%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---SHNLEKELIRKEIDIMNQLHH 164
           +++  +E+IG G +GVV++ R + TG + A K I +   +  +    IR EI ++ +L+H
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 63
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK--MSEAEVIPVTLPIL---MTQ 219
           P ++ L D    ++++ L+FEFL            D K  M  + +  + LP++   + Q
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLHQ----------DLKKFMDASALTGIPLPLIKSYLFQ 113
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEF 278
               +   H   ++H D+KP+N++  T  +  +K+ DFGLA     P         T  +
Sbjct: 114 LLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWY 171
Query: 279 AAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
            APEI+      +Y+   D+W++G +   +++  + F G+++++ L
Sbjct: 172 RAPEILLG--CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 215

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 116/226 (51%), Gaps = 27/226 (11%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---SHNLEKELIRKEIDIMNQLHH 164
           +++  +E+IG G +GVV++ R + TG + A K I +   +  +    IR EI ++ +L+H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 61
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK--MSEAEVIPVTLPIL---MTQ 219
           P ++ L D    ++++ L+FEFL            D K  M  + +  + LP++   + Q
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ----------DLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEF 278
               +   H   ++H D+KP+N++  T  +  +K+ DFGLA     P         T  +
Sbjct: 112 LLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWY 169
Query: 279 AAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
            APEI+      +Y+   D+W++G +   +++  + F G+++++ L
Sbjct: 170 RAPEILLG--CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 116/226 (51%), Gaps = 27/226 (11%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---SHNLEKELIRKEIDIMNQLHH 164
           +++  +E+IG G +GVV++ R + TG + A K I +   +  +    IR EI ++ +L+H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 61
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK--MSEAEVIPVTLPIL---MTQ 219
           P ++ L D    ++++ L+FEFL            D K  M  + +  + LP++   + Q
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ----------DLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEF 278
               +   H   ++H D+KP+N++  T  +  +K+ DFGLA     P         T  +
Sbjct: 112 LLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWY 169
Query: 279 AAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
            APEI+      +Y+   D+W++G +   +++  + F G+++++ L
Sbjct: 170 RAPEILLG--CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 116/226 (51%), Gaps = 27/226 (11%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---SHNLEKELIRKEIDIMNQLHH 164
           +++  +E+IG G +GVV++ R + TG + A K I +   +  +    IR EI ++ +L+H
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 62
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK--MSEAEVIPVTLPIL---MTQ 219
           P ++ L D    ++++ L+FEFL            D K  M  + +  + LP++   + Q
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQ----------DLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEF 278
               +   H   ++H D+KP+N++  T  +  +K+ DFGLA     P         T  +
Sbjct: 113 LLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWY 170
Query: 279 AAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
            APEI+      +Y+   D+W++G +   +++  + F G+++++ L
Sbjct: 171 RAPEILLG--CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 214

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 116/226 (51%), Gaps = 27/226 (11%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---SHNLEKELIRKEIDIMNQLHH 164
           +++  +E+IG G +GVV++ R + TG + A K I +   +  +    IR EI ++ +L+H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 60
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK--MSEAEVIPVTLPIL---MTQ 219
           P ++ L D    ++++ L+FEFL            D K  M  + +  + LP++   + Q
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQ----------DLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEF 278
               +   H   ++H D+KP+N++  T  +  +K+ DFGLA     P         T  +
Sbjct: 111 LLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWY 168
Query: 279 AAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
            APEI+      +Y+   D+W++G +   +++  + F G+++++ L
Sbjct: 169 RAPEILLG--CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 212

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 116/226 (51%), Gaps = 27/226 (11%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---SHNLEKELIRKEIDIMNQLHH 164
           +++  +E+IG G +GVV++ R + TG + A K I +   +  +    IR EI ++ +L+H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 61
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK--MSEAEVIPVTLPIL---MTQ 219
           P ++ L D    ++++ L+FEFL            D K  M  + +  + LP++   + Q
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ----------DLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEF 278
               +   H   ++H D+KP+N++  T  +  +K+ DFGLA     P         T  +
Sbjct: 112 LLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWY 169
Query: 279 AAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
            APEI+      +Y+   D+W++G +   +++  + F G+++++ L
Sbjct: 170 RAPEILLG--CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 116/226 (51%), Gaps = 27/226 (11%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---SHNLEKELIRKEIDIMNQLHH 164
           +++  +E+IG G +GVV++ R + TG + A K I +   +  +    IR EI ++ +L+H
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 64
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK--MSEAEVIPVTLPIL---MTQ 219
           P ++ L D    ++++ L+FEFL            D K  M  + +  + LP++   + Q
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLHQ----------DLKKFMDASALTGIPLPLIKSYLFQ 114
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEF 278
               +   H   ++H D+KP+N++  T  +  +K+ DFGLA     P         T  +
Sbjct: 115 LLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWY 172
Query: 279 AAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
            APEI+      +Y+   D+W++G +   +++  + F G+++++ L
Sbjct: 173 RAPEILLG--CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 216

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 116/226 (51%), Gaps = 27/226 (11%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---SHNLEKELIRKEIDIMNQLHH 164
           +++  +E+IG G +GVV++ R + TG + A K I +   +  +    IR EI ++ +L+H
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 63
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK--MSEAEVIPVTLPIL---MTQ 219
           P ++ L D    ++++ L+FEFL            D K  M  + +  + LP++   + Q
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLHQ----------DLKKFMDASALTGIPLPLIKSYLFQ 113
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEF 278
               +   H   ++H D+KP+N++  T  +  +K+ DFGLA     P         T  +
Sbjct: 114 LLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWY 171
Query: 279 AAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
            APEI+      +Y+   D+W++G +   +++  + F G+++++ L
Sbjct: 172 RAPEILLG--CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 215

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 116/226 (51%), Gaps = 27/226 (11%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---SHNLEKELIRKEIDIMNQLHH 164
           +++  +E+IG G +GVV++ R + TG + A K I +   +  +    IR EI ++ +L+H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 61
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK--MSEAEVIPVTLPIL---MTQ 219
           P ++ L D    ++++ L+FEFL            D K  M  + +  + LP++   + Q
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ----------DLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEF 278
               +   H   ++H D+KP+N++  T  +  +K+ DFGLA     P         T  +
Sbjct: 112 LLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWY 169
Query: 279 AAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
            APEI+      +Y+   D+W++G +   +++  + F G+++++ L
Sbjct: 170 RAPEILLG--CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 116/226 (51%), Gaps = 27/226 (11%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---SHNLEKELIRKEIDIMNQLHH 164
           +++  +E+IG G +GVV++ R + TG + A K I +   +  +    IR EI ++ +L+H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 60
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK--MSEAEVIPVTLPIL---MTQ 219
           P ++ L D    ++++ L+FEFL            D K  M  + +  + LP++   + Q
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQ----------DLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEF 278
               +   H   ++H D+KP+N++  T  +  +K+ DFGLA     P         T  +
Sbjct: 111 LLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWY 168
Query: 279 AAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
            APEI+      +Y+   D+W++G +   +++  + F G+++++ L
Sbjct: 169 RAPEILLG--CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 212

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 116/226 (51%), Gaps = 27/226 (11%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---SHNLEKELIRKEIDIMNQLHH 164
           +++  +E+IG G +GVV++ R + TG + A K I +   +  +    IR EI ++ +L+H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 60
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK--MSEAEVIPVTLPIL---MTQ 219
           P ++ L D    ++++ L+FEFL            D K  M  + +  + LP++   + Q
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQ----------DLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEF 278
               +   H   ++H D+KP+N++  T  +  +K+ DFGLA     P         T  +
Sbjct: 111 LLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWY 168
Query: 279 AAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
            APEI+      +Y+   D+W++G +   +++  + F G+++++ L
Sbjct: 169 RAPEILLG--CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 212

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 116/226 (51%), Gaps = 27/226 (11%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---SHNLEKELIRKEIDIMNQLHH 164
           +++  +E+IG G +GVV++ R + TG + A K I +   +  +    IR EI ++ +L+H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 60
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK--MSEAEVIPVTLPIL---MTQ 219
           P ++ L D    ++++ L+FEFL            D K  M  + +  + LP++   + Q
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQ----------DLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEF 278
               +   H   ++H D+KP+N++  T  +  +K+ DFGLA     P         T  +
Sbjct: 111 LLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWY 168
Query: 279 AAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
            APEI+      +Y+   D+W++G +   +++  + F G+++++ L
Sbjct: 169 RAPEILLG--CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 212

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 116/226 (51%), Gaps = 27/226 (11%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---SHNLEKELIRKEIDIMNQLHH 164
           +++  +E+IG G +GVV++ R + TG + A K I +   +  +    IR EI ++ +L+H
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 65
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK--MSEAEVIPVTLPIL---MTQ 219
           P ++ L D    ++++ L+FEFL            D K  M  + +  + LP++   + Q
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLHQ----------DLKKFMDASALTGIPLPLIKSYLFQ 115
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEF 278
               +   H   ++H D+KP+N++  T  +  +K+ DFGLA     P         T  +
Sbjct: 116 LLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWY 173
Query: 279 AAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
            APEI+      +Y+   D+W++G +   +++  + F G+++++ L
Sbjct: 174 RAPEILLG--CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 217

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 116/226 (51%), Gaps = 27/226 (11%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---SHNLEKELIRKEIDIMNQLHH 164
           +++  +E+IG G +GVV++ R + TG + A K I +   +  +    IR EI ++ +L+H
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 64
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK--MSEAEVIPVTLPIL---MTQ 219
           P ++ L D    ++++ L+FEFL            D K  M  + +  + LP++   + Q
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLHQ----------DLKKFMDASALTGIPLPLIKSYLFQ 114
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEF 278
               +   H   ++H D+KP+N++  T  +  +K+ DFGLA     P         T  +
Sbjct: 115 LLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWY 172
Query: 279 AAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
            APEI+      +Y+   D+W++G +   +++  + F G+++++ L
Sbjct: 173 RAPEILLG--CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 216

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 116/226 (51%), Gaps = 27/226 (11%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---SHNLEKELIRKEIDIMNQLHH 164
           +++  +E+IG G +GVV++ R + TG + A K I +   +  +    IR EI ++ +L+H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 61
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK--MSEAEVIPVTLPIL---MTQ 219
           P ++ L D    ++++ L+FEFL            D K  M  + +  + LP++   + Q
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ----------DLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEF 278
               +   H   ++H D+KP+N++  T  +  +K+ DFGLA     P         T  +
Sbjct: 112 LLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWY 169
Query: 279 AAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
            APEI+      +Y+   D+W++G +   +++  + F G+++++ L
Sbjct: 170 RAPEILLG--CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 116/226 (51%), Gaps = 27/226 (11%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---SHNLEKELIRKEIDIMNQLHH 164
           +++  +E+IG G +GVV++ R + TG + A K I +   +  +    IR EI ++ +L+H
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 68
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK--MSEAEVIPVTLPIL---MTQ 219
           P ++ L D    ++++ L+FEFL            D K  M  + +  + LP++   + Q
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLHQ----------DLKKFMDASALTGIPLPLIKSYLFQ 118
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEF 278
               +   H   ++H D+KP+N++  T  +  +K+ DFGLA     P         T  +
Sbjct: 119 LLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWY 176
Query: 279 AAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
            APEI+      +Y+   D+W++G +   +++  + F G+++++ L
Sbjct: 177 RAPEILLG--CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 220

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 116/226 (51%), Gaps = 27/226 (11%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---SHNLEKELIRKEIDIMNQLHH 164
           +++  +E+IG G +GVV++ R + TG + A K I +   +  +    IR EI ++ +L+H
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 64
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK--MSEAEVIPVTLPIL---MTQ 219
           P ++ L D    ++++ L+FEFL            D K  M  + +  + LP++   + Q
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLHQ----------DLKTFMDASALTGIPLPLIKSYLFQ 114
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEF 278
               +   H   ++H D+KP+N++  T  +  +K+ DFGLA     P         T  +
Sbjct: 115 LLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWY 172
Query: 279 AAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
            APEI+      +Y+   D+W++G +   +++  + F G+++++ L
Sbjct: 173 RAPEILLG--CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 216

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 116/226 (51%), Gaps = 27/226 (11%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---SHNLEKELIRKEIDIMNQLHH 164
           +++  +E+IG G +GVV++ R + TG + A K I +   +  +    IR EI ++ +L+H
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 62
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK--MSEAEVIPVTLPIL---MTQ 219
           P ++ L D    ++++ L+FEFL            D K  M  + +  + LP++   + Q
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQ----------DLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEF 278
               +   H   ++H D+KP+N++  T  +  +K+ DFGLA     P         T  +
Sbjct: 113 LLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWY 170
Query: 279 AAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
            APEI+      +Y+   D+W++G +   +++  + F G+++++ L
Sbjct: 171 RAPEILLG--CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 214

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 116/226 (51%), Gaps = 27/226 (11%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---SHNLEKELIRKEIDIMNQLHH 164
           +++  +E+IG G +GVV++ R + TG + A K I +   +  +    IR EI ++ +L+H
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 65
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK--MSEAEVIPVTLPIL---MTQ 219
           P ++ L D    ++++ L+FEFL            D K  M  + +  + LP++   + Q
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLHQ----------DLKKFMDASALTGIPLPLIKSYLFQ 115
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEF 278
               +   H   ++H D+KP+N++  T  +  +K+ DFGLA     P         T  +
Sbjct: 116 LLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWY 173
Query: 279 AAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
            APEI+      +Y+   D+W++G +   +++  + F G+++++ L
Sbjct: 174 RAPEILLG--CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 217

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 116/226 (51%), Gaps = 27/226 (11%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---SHNLEKELIRKEIDIMNQLHH 164
           +++  +E+IG G +GVV++ R + TG + A K I +   +  +    IR EI ++ +L+H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 61
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK--MSEAEVIPVTLPIL---MTQ 219
           P ++ L D    ++++ L+FEFL            D K  M  + +  + LP++   + Q
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ----------DLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEF 278
               +   H   ++H D+KP+N++  T  +  +K+ DFGLA     P         T  +
Sbjct: 112 LLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWY 169
Query: 279 AAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
            APEI+      +Y+   D+W++G +   +++  + F G+++++ L
Sbjct: 170 RAPEILLGX--KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 116/226 (51%), Gaps = 27/226 (11%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---SHNLEKELIRKEIDIMNQLHH 164
           +++  +E+IG G +GVV++ R + TG + A K I +   +  +    IR EI ++ +L+H
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 68
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK--MSEAEVIPVTLPIL---MTQ 219
           P ++ L D    ++++ L+FEFL            D K  M  + +  + LP++   + Q
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLHQ----------DLKKFMDASALTGIPLPLIKSYLFQ 118
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEF 278
               +   H   ++H D+KP+N++  T  +  +K+ DFGLA     P         T  +
Sbjct: 119 LLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWY 176
Query: 279 AAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
            APEI+      +Y+   D+W++G +   +++  + F G+++++ L
Sbjct: 177 RAPEILLGX--KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 220

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 61/249 (24%), Positives = 120/249 (48%), Gaps = 23/249 (9%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAK-----FIPVSHNLEKELIRKEIDIMNQLHHPKLINL 170
           +G G+FG V     +KT   FA K      + +  ++E  ++ K + +     HP L ++
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV-LSLAWEHPFLTHM 83
Query: 171 HDAFEDDDEMVLIFEFLSGGELFERI-TAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE 229
              F+  + +  + E+L+GG+L   I +   + +S A      + +        ++ +H 
Sbjct: 84  FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL-------GLQFLHS 136
Query: 230 KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK-LDPNEVVKISTGTAEFAAPEIVEREP 288
           K I++ D+K +NI+       ++K+ DFG+  + +  +       GT ++ APEI+  + 
Sbjct: 137 KGIVYRDLKLDNILLD--KDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQK 194
Query: 289 VGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAF-KNVSEEGKDFI 347
                D W+ GVL Y +L G SPF G+++ E   +++      D   + + + +E KD +
Sbjct: 195 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM-----DNPFYPRWLEKEAKDLL 249
Query: 348 RRLLLRNKE 356
            +L +R  E
Sbjct: 250 VKLFVREPE 258

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 109/214 (50%), Gaps = 25/214 (11%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLHHP 165
           D ++ + E+G G  GVV + + R +G I A K I   +   +  ++IR E+ ++++ + P
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIR-ELQVLHECNSP 74
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIP------VTLPILMTQ 219
            ++  + AF  D E+ +  E + GG L       D  + EA+ IP      V++ +L   
Sbjct: 75  YIVGFYGAFYSDGEISICMEHMDGGSL-------DQVLKEAKRIPEEILGKVSIAVLR-- 125
Query: 220 TSPAVKHMHEKN-IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
               + ++ EK+ I+H DVKP NI+  +R    +K+ DFG++ +L  + +     GT  +
Sbjct: 126 ---GLAYLREKHQIMHRDVKPSNILVNSRG--EIKLCDFGVSGQLI-DSMANSFVGTRSY 179
Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPF 312
            APE ++       +D+W++G+    L  G  P 
Sbjct: 180 MAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 124/255 (48%), Gaps = 23/255 (9%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAK-----FIPVSHNLEKELIRKEIDIMNQLHH 164
           +++ + +G G+FG V     +KT   FA K      + +  ++E  ++ K + +     H
Sbjct: 20  FELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV-LSLAWEH 78
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERI-TAPDYKMSEAEVIPVTLPILMTQTSPA 223
           P L ++   F+  + +  + E+L+GG+L   I +   + +S A      + +        
Sbjct: 79  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL-------G 131
Query: 224 VKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK-LDPNEVVKISTGTAEFAAPE 282
           ++ +H K I++ D+K +NI+       ++K+ DFG+  + +  +       GT ++ APE
Sbjct: 132 LQFLHSKGIVYRDLKLDNILLD--KDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPE 189
Query: 283 IVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAF-KNVSE 341
           I+  +      D W+ GVL Y +L G SPF G+++ E   +++      D   + + + +
Sbjct: 190 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM-----DNPFYPRWLEK 244
Query: 342 EGKDFIRRLLLRNKE 356
           E KD + +L +R  E
Sbjct: 245 EAKDLLVKLFVREPE 259

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 115/226 (50%), Gaps = 27/226 (11%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---SHNLEKELIRKEIDIMNQLHH 164
           +++  +E+IG G +GVV++ R + TG + A   I +   +  +    IR EI ++ +L+H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-EISLLKELNH 61
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK--MSEAEVIPVTLPIL---MTQ 219
           P ++ L D    ++++ L+FEFL            D K  M  + +  + LP++   + Q
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ----------DLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEF 278
               +   H   ++H D+KP+N++  T  +  +K+ DFGLA     P         T  +
Sbjct: 112 LLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWY 169
Query: 279 AAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
            APEI+      +Y+   D+W++G +   +++  + F G+++++ L
Sbjct: 170 RAPEILLG--CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 115/226 (50%), Gaps = 27/226 (11%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---SHNLEKELIRKEIDIMNQLHH 164
           +++  +E+IG G +GVV++ R + TG + A   I +   +  +    IR EI ++ +L+H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-EISLLKELNH 60
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK--MSEAEVIPVTLPIL---MTQ 219
           P ++ L D    ++++ L+FEFL            D K  M  + +  + LP++   + Q
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQ----------DLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEF 278
               +   H   ++H D+KP+N++  T  +  +K+ DFGLA     P         T  +
Sbjct: 111 LLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWY 168
Query: 279 AAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
            APEI+      +Y+   D+W++G +   +++  + F G+++++ L
Sbjct: 169 RAPEILLG--CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 212

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 112/236 (47%), Gaps = 20/236 (8%)
Query: 95  VPQPVDIKTSS-VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL-- 151
           VP+   + T S + D Y++ E +G G    VH  R+ +     A K +      +     
Sbjct: 15  VPRGSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYL 74
Query: 152 -IRKEIDIMNQLHHPKLINLHDAFEDDDEM----VLIFEFLSGGELFERITAPDYKMSEA 206
             R+E      L+HP ++ ++D  E +        ++ E++ G      +T  D   +E 
Sbjct: 75  RFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDG------VTLRDIVHTEG 128
Query: 207 EVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--D 264
            + P     ++     A+   H+  IIH DVKP NIM    N+  VK++DFG+A  +   
Sbjct: 129 PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADS 186
Query: 265 PNEVVKIST--GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDV 318
            N V + +   GTA++ +PE    + V   +D++++G + Y +L+G  PF G++ V
Sbjct: 187 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 242

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 107/226 (47%), Gaps = 19/226 (8%)
Query: 104 SSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL---IRKEIDIMN 160
           S + D Y++ E +G G    VH  R+ +     A K +      +       R+E     
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 67
Query: 161 QLHHPKLINLHDAFEDDDEM----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPIL 216
            L+HP ++ ++D  E +        ++ E++ G      +T  D   +E  + P     +
Sbjct: 68  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDG------VTLRDIVHTEGPMTPKRAIEV 121
Query: 217 MTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--DPNEVVKIST- 273
           +     A+   H+  IIH DVKP NIM    N+  VK++DFG+A  +    N V + +  
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQTAAV 179
Query: 274 -GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDV 318
            GTA++ +PE    + V   +D++++G + Y +L+G  PF G++ V
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 107/226 (47%), Gaps = 19/226 (8%)
Query: 104 SSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL---IRKEIDIMN 160
           S + D Y++ E +G G    VH  R+ +     A K +      +       R+E     
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAA 67
Query: 161 QLHHPKLINLHDAFEDDDEM----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPIL 216
            L+HP ++ ++D  E +        ++ E++ G      +T  D   +E  + P     +
Sbjct: 68  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDG------VTLRDIVHTEGPMTPKRAIEV 121
Query: 217 MTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--DPNEVVKIST- 273
           +     A+   H+  IIH DVKP NIM    N+  VK++DFG+A  +    N V + +  
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQTAAV 179
Query: 274 -GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDV 318
            GTA++ +PE    + V   +D++++G + Y +L+G  PF G++ V
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 114/241 (47%), Gaps = 12/241 (4%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFE 175
           +G G +G+V+  R+       A K IP   +   + + +EI +   L H  ++    +F 
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 176 DDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHL 235
           ++  + +  E + GG L   + +    + + E    T+     Q    +K++H+  I+H 
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNE---QTIGFYTKQILEGLKYLHDNQIVHR 146
Query: 236 DVKPENIMCQTRNSTNVKMIDFGLATKLDP-NEVVKISTGTAEFAAPEIVEREPVGF--Y 292
           D+K +N++  T +   +K+ DFG + +L   N   +  TGT ++ APEI+++ P G+   
Sbjct: 147 DIKGDNVLINTYSGV-LKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKA 205
Query: 293 TDMWAVGVLAYVLLSGLSPF--AGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRL 350
            D+W++G     + +G  PF   GE         K   ++   E  +++S E K FI + 
Sbjct: 206 ADIWSLGCTIIEMATGKPPFYELGEPQAAMF---KVGMFKVHPEIPESMSAEAKAFILKC 262
Query: 351 L 351
Sbjct: 263 F 263

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 112/225 (49%), Gaps = 15/225 (6%)
Query: 105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS---HNLEKELIRKEIDIMNQ 161
            + + Y  LE++G G +GVV++ ++ + G I A K I +      +    IR EI ++ +
Sbjct: 18  GLMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIR-EISLLKE 75
Query: 162 LHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTS 221
           LHHP +++L D    +  + L+FEF+   +L + +      + ++++      I + Q  
Sbjct: 76  LHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQI-----KIYLYQLL 129
Query: 222 PAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEFAA 280
             V H H+  I+H D+KP+N++  +  +  +K+ DFGLA     P         T  + A
Sbjct: 130 RGVAHCHQHRILHRDLKPQNLLINSDGA--LKLADFGLARAFGIPVRSYTHEVVTLWYRA 187
Query: 281 PEIV-EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           P+++   +      D+W++G +   +++G   F G  D + L  +
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKI 232

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 112/226 (49%), Gaps = 15/226 (6%)
Query: 104 SSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS---HNLEKELIRKEIDIMN 160
             + + Y  LE++G G +GVV++ ++ + G I A K I +      +    IR EI ++ 
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIR-EISLLK 74
Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
           +LHHP +++L D    +  + L+FEF+   +L + +      + ++++      I + Q 
Sbjct: 75  ELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQI-----KIYLYQL 128
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEFA 279
              V H H+  I+H D+KP+N++  +  +  +K+ DFGLA     P         T  + 
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLLINSDGA--LKLADFGLARAFGIPVRSYTHEVVTLWYR 186
Query: 280 APEIV-EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           AP+++   +      D+W++G +   +++G   F G  D + L  +
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKI 232

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 114/241 (47%), Gaps = 12/241 (4%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFE 175
           +G G +G+V+  R+       A K IP   +   + + +EI +   L H  ++    +F 
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 176 DDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHL 235
           ++  + +  E + GG L   + +    + + E    T+     Q    +K++H+  I+H 
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNE---QTIGFYTKQILEGLKYLHDNQIVHR 132
Query: 236 DVKPENIMCQTRNSTNVKMIDFGLATKLDP-NEVVKISTGTAEFAAPEIVEREPVGF--Y 292
           D+K +N++  T +   +K+ DFG + +L   N   +  TGT ++ APEI+++ P G+   
Sbjct: 133 DIKGDNVLINTYSGV-LKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKA 191
Query: 293 TDMWAVGVLAYVLLSGLSPF--AGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRL 350
            D+W++G     + +G  PF   GE         K   ++   E  +++S E K FI + 
Sbjct: 192 ADIWSLGCTIIEMATGKPPFYELGEPQAAMF---KVGMFKVHPEIPESMSAEAKAFILKC 248
Query: 351 L 351
Sbjct: 249 F 249

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 109/211 (51%), Gaps = 19/211 (9%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQLHHPKLINLHD 172
            IG+G+FG V++ +    G++ A K + V     ++    R E+ ++ +  H  ++ L  
Sbjct: 43  RIGSGSFGTVYKGKWH--GDV-AVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNIL-LFM 98
Query: 173 AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNI 232
            +   D + ++ ++  G  L++ +   + K    ++I +       QT+  + ++H KNI
Sbjct: 99  GYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIA-----RQTAQGMDYLHAKNI 153
Query: 233 IHLDVKPENIMCQTRNSTNVKMIDFGLAT---KLDPNEVVKISTGTAEFAAPEIVERE-- 287
           IH D+K  NI         VK+ DFGLAT   +   ++ V+  TG+  + APE++  +  
Sbjct: 154 IHRDMKSNNIFLH--EGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDN 211
Query: 288 -PVGFYTDMWAVGVLAYVLLSGLSPFAGEND 317
            P  F +D+++ G++ Y L++G  P++  N+
Sbjct: 212 NPFSFQSDVYSYGIVLYELMTGELPYSHINN 242

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/253 (23%), Positives = 125/253 (49%), Gaps = 17/253 (6%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLHHP 165
           D ++ + E+G G  GVV +   + +G + A K I   +   +  ++IR E+ ++++ + P
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR-ELQVLHECNSP 83
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++  + AF  D E+ +  E + GG L +++     ++ E  +  V++ ++   T    K
Sbjct: 84  YIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 142
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           H     I+H DVKP NI+  +R    +K+ DFG++ +L  + +     GT  + +PE ++
Sbjct: 143 H----KIMHRDVKPSNILVNSRG--EIKLCDFGVSGQL-IDSMANSFVGTRSYMSPERLQ 195
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK----NVSE 341
                  +D+W++G+    +  G  P    +   ++   +  D+  +E   K      S 
Sbjct: 196 GTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSG--SMAIFELLDYIVNEPPPKLPSGVFSL 253
Query: 342 EGKDFIRRLLLRN 354
           E +DF+ + L++N
Sbjct: 254 EFQDFVNKCLIKN 266

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 126/257 (49%), Gaps = 19/257 (7%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLHHP 165
           D ++ + E+G G  GVV +   + +G + A K I   +   +  ++IR E+ ++++ + P
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR-ELQVLHECNSP 64
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++  + AF  D E+ +  E + GG L +++     ++ E  +  V++ ++   T    K
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           H     I+H DVKP NI+  +R    +K+ DFG++ +L  + +     GT  + +PE ++
Sbjct: 124 H----KIMHRDVKPSNILVNSRG--EIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQ 176
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPF----AGENDVETLKNVKACDWEFDEEAFK---- 337
                  +D+W++G+    +  G  P     A E+    +   +  D+  +E   K    
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSG 236
Query: 338 NVSEEGKDFIRRLLLRN 354
             S E +DF+ + L++N
Sbjct: 237 VFSLEFQDFVNKCLIKN 253

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 112/212 (52%), Gaps = 19/212 (8%)
Query: 114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQLHHPKLINLH 171
           + IG+G+FG V++ +    G++ A K + V+    ++L   + E+ ++ +  H  ++ L 
Sbjct: 30  QRIGSGSFGTVYKGKWH--GDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LF 85
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
             +    ++ ++ ++  G  L+  + A + K    ++I +       QT+  + ++H K+
Sbjct: 86  MGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIA-----RQTARGMDYLHAKS 140
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLAT---KLDPNEVVKISTGTAEFAAPEIVERE- 287
           IIH D+K  NI     N+  VK+ DFGLAT   +   +   +  +G+  + APE++  + 
Sbjct: 141 IIHRDLKSNNIFLHEDNT--VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 288 --PVGFYTDMWAVGVLAYVLLSGLSPFAGEND 317
             P  F +D++A G++ Y L++G  P++  N+
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 230

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 106/224 (47%), Gaps = 19/224 (8%)
Query: 104 SSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL---IRKEIDIMN 160
           S + D Y++ E +G G    VH  R+ +     A K +      +       R+E     
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAA 67
Query: 161 QLHHPKLINLHDAFEDDDEM----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPIL 216
            L+HP ++ ++D  E +        ++ E++ G      +T  D   +E  + P     +
Sbjct: 68  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDG------VTLRDIVHTEGPMTPKRAIEV 121
Query: 217 MTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--DPNEVVKIST- 273
           +     A+   H+  IIH DVKP NIM    N+  VK++DFG+A  +    N V + +  
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQTAAV 179
Query: 274 -GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN 316
            GTA++ +PE    + V   +D++++G + Y +L+G  PF G++
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 112/212 (52%), Gaps = 19/212 (8%)
Query: 114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQLHHPKLINLH 171
           + IG+G+FG V++ +    G++ A K + V+    ++L   + E+ ++ +  H  ++ L 
Sbjct: 18  QRIGSGSFGTVYKGKWH--GDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LF 73
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
             +    ++ ++ ++  G  L+  + A + K    ++I +       QT+  + ++H K+
Sbjct: 74  MGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIA-----RQTARGMDYLHAKS 128
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLAT---KLDPNEVVKISTGTAEFAAPEIVERE- 287
           IIH D+K  NI     N+  VK+ DFGLAT   +   +   +  +G+  + APE++  + 
Sbjct: 129 IIHRDLKSNNIFLHEDNT--VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 186
Query: 288 --PVGFYTDMWAVGVLAYVLLSGLSPFAGEND 317
             P  F +D++A G++ Y L++G  P++  N+
Sbjct: 187 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 218

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 107/226 (47%), Gaps = 19/226 (8%)
Query: 104 SSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL---IRKEIDIMN 160
           S + D Y++ E +G G    VH  R+ +     A K +      +       R+E     
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAA 67
Query: 161 QLHHPKLINLHDAFEDDDEM----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPIL 216
            L+HP ++ ++D  E +        ++ E++ G      +T  D   +E  + P     +
Sbjct: 68  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDG------VTLRDIVHTEGPMTPKRAIEV 121
Query: 217 MTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--DPNEVVKIST- 273
           +     A+   H+  IIH DVKP NI+    N+  VK++DFG+A  +    N V + +  
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANILISATNA--VKVVDFGIARAIADSGNSVXQTAAV 179
Query: 274 -GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDV 318
            GTA++ +PE    + V   +D++++G + Y +L+G  PF G++ V
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 115/226 (50%), Gaps = 27/226 (11%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---SHNLEKELIRKEIDIMNQLHH 164
           +++  +E+IG G +GVV++ R + TG + A K I +   +  +    IR EI ++ +L+H
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 64
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK--MSEAEVIPVTLPIL---MTQ 219
           P ++ L D    ++++ L+FE +            D K  M  + +  + LP++   + Q
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEHVDQ----------DLKKFMDASALTGIPLPLIKSYLFQ 114
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEF 278
               +   H   ++H D+KP+N++  T  +  +K+ DFGLA     P         T  +
Sbjct: 115 LLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWY 172
Query: 279 AAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
            APEI+      +Y+   D+W++G +   +++  + F G+++++ L
Sbjct: 173 RAPEILLG--CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 216

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 115/226 (50%), Gaps = 27/226 (11%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---SHNLEKELIRKEIDIMNQLHH 164
           +++  +E+IG G +GVV++ R + TG + A K I +   +  +    IR EI ++ +L+H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 60
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK--MSEAEVIPVTLPIL---MTQ 219
           P ++ L D    ++++ L+FE +            D K  M  + +  + LP++   + Q
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEHVHQ----------DLKTFMDASALTGIPLPLIKSYLFQ 110
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEF 278
               +   H   ++H D+KP+N++  T  +  +K+ DFGLA     P         T  +
Sbjct: 111 LLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWY 168
Query: 279 AAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
            APEI+      +Y+   D+W++G +   +++  + F G+++++ L
Sbjct: 169 RAPEILLG--CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 212

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 112/212 (52%), Gaps = 19/212 (8%)
Query: 114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQLHHPKLINLH 171
           + IG+G+FG V++ +    G++ A K + V+    ++L   + E+ ++ +  H  ++ L 
Sbjct: 30  QRIGSGSFGTVYKGKWH--GDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LF 85
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
             +    ++ ++ ++  G  L+  + A + K    ++I +       QT+  + ++H K+
Sbjct: 86  MGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIA-----RQTARGMDYLHAKS 140
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLAT---KLDPNEVVKISTGTAEFAAPEIVERE- 287
           IIH D+K  NI     N+  VK+ DFGLAT   +   +   +  +G+  + APE++  + 
Sbjct: 141 IIHRDLKSNNIFLHEDNT--VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 288 --PVGFYTDMWAVGVLAYVLLSGLSPFAGEND 317
             P  F +D++A G++ Y L++G  P++  N+
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 230

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 124/253 (49%), Gaps = 21/253 (8%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLHHP 165
           D ++ + E+G G  GVV +   + +G + A K I   +   +  ++IR E+ ++++ + P
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR-ELQVLHECNSP 67
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++  + AF  D E+ +  E + GG L +++     ++ E  +  V++ ++   T    K
Sbjct: 68  YIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 126
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           H     I+H DVKP NI+  +R    +K+ DFG++ +L  +E+     GT  + +PE ++
Sbjct: 127 H----KIMHRDVKPSNILVNSRG--EIKLCDFGVSGQLI-DEMANEFVGTRSYMSPERLQ 179
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSE---- 341
                  +D+W++G+    +  G  P       E L      D+  +E   K  S     
Sbjct: 180 GTHYSVQSDIWSMGLSLVEMAVGRYPRPPMAIFELL------DYIVNEPPPKLPSAVFSL 233
Query: 342 EGKDFIRRLLLRN 354
           E +DF+ + L++N
Sbjct: 234 EFQDFVNKCLIKN 246

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 12/214 (5%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE--KELIRKEIDIMNQLHHPKL 167
           Y+ LE+IG G +G V + + R+T  I A K + +  + E       +EI ++ +L H  +
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
           + LHD    D ++ L+FEF       ++     +     ++ P  +   + Q    +   
Sbjct: 64  VRLHDVLHSDKKLTLVFEFC------DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEFAAPEIVER 286
           H +N++H D+KP+N++   RN   +K+ DFGLA     P         T  +  P+++  
Sbjct: 118 HSRNVLHRDLKPQNLLI-NRNG-ELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 287 EPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDVE 319
             +     DMW+ G +   L +   P    NDV+
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAARPLFPGNDVD 209

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 113/227 (49%), Gaps = 12/227 (5%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLHHP 165
           D ++ + E+G G  GVV +   + +G + A K I   +   +  ++IR E+ ++++ + P
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR-ELQVLHECNSP 126
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++  + AF  D E+ +  E + GG L +++     ++ E  +  V++ ++   T    K
Sbjct: 127 YIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 185
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           H     I+H DVKP NI+  +R    +K+ DFG++ +L  + +     GT  + +PE ++
Sbjct: 186 H----KIMHRDVKPSNILVNSRG--EIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQ 238
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD 332
                  +D+W++G+    +  G  P     D + L+ +  C  E D
Sbjct: 239 GTHYSVQSDIWSMGLSLVEMAVGRYPIP-PPDAKELELMFGCQVEGD 284

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 113/227 (49%), Gaps = 12/227 (5%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLHHP 165
           D ++ + E+G G  GVV +   + +G + A K I   +   +  ++IR E+ ++++ + P
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR-ELQVLHECNSP 91
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++  + AF  D E+ +  E + GG L +++     ++ E  +  V++ ++   T    K
Sbjct: 92  YIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 150
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           H     I+H DVKP NI+  +R    +K+ DFG++ +L  + +     GT  + +PE ++
Sbjct: 151 H----KIMHRDVKPSNILVNSRG--EIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQ 203
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD 332
                  +D+W++G+    +  G  P     D + L+ +  C  E D
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGRYPIP-PPDAKELELMFGCQVEGD 249

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 113/227 (49%), Gaps = 12/227 (5%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLHHP 165
           D ++ + E+G G  GVV +   + +G + A K I   +   +  ++IR E+ ++++ + P
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR-ELQVLHECNSP 64
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++  + AF  D E+ +  E + GG L +++     ++ E  +  V++ ++   T    K
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           H     I+H DVKP NI+  +R    +K+ DFG++ +L  + +     GT  + +PE ++
Sbjct: 124 H----KIMHRDVKPSNILVNSRG--EIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQ 176
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD 332
                  +D+W++G+    +  G  P     D + L+ +  C  E D
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIP-PPDAKELELMFGCQVEGD 222

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 113/227 (49%), Gaps = 12/227 (5%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLHHP 165
           D ++ + E+G G  GVV +   + +G + A K I   +   +  ++IR E+ ++++ + P
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR-ELQVLHECNSP 64
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++  + AF  D E+ +  E + GG L +++     ++ E  +  V++ ++   T    K
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           H     I+H DVKP NI+  +R    +K+ DFG++ +L  + +     GT  + +PE ++
Sbjct: 124 H----KIMHRDVKPSNILVNSRG--EIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQ 176
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD 332
                  +D+W++G+    +  G  P     D + L+ +  C  E D
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIP-PPDAKELELMFGCQVEGD 222

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 113/227 (49%), Gaps = 12/227 (5%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLHHP 165
           D ++ + E+G G  GVV +   + +G + A K I   +   +  ++IR E+ ++++ + P
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR-ELQVLHECNSP 64
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++  + AF  D E+ +  E + GG L +++     ++ E  +  V++ ++   T    K
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           H     I+H DVKP NI+  +R    +K+ DFG++ +L  + +     GT  + +PE ++
Sbjct: 124 H----KIMHRDVKPSNILVNSRG--EIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQ 176
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD 332
                  +D+W++G+    +  G  P     D + L+ +  C  E D
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIP-PPDAKELELMFGCQVEGD 222

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 113/227 (49%), Gaps = 12/227 (5%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLHHP 165
           D ++ + E+G G  GVV +   + +G + A K I   +   +  ++IR E+ ++++ + P
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR-ELQVLHECNSP 64
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++  + AF  D E+ +  E + GG L +++     ++ E  +  V++ ++   T    K
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           H     I+H DVKP NI+  +R    +K+ DFG++ +L  + +     GT  + +PE ++
Sbjct: 124 H----KIMHRDVKPSNILVNSRG--EIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQ 176
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD 332
                  +D+W++G+    +  G  P     D + L+ +  C  E D
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIP-PPDAKELELMFGCQVEGD 222

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK--------EIDIMNQ 161
           Y  +  +G+GAFG V    +++       KFI     LE   I          EI I+++
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 162 LHHPKLINLHDAFEDDDEMVLIFE-FLSGGELFERITA-PDYKMSEAEVIPVTLPILMTQ 219
           + H  +I + D FE+     L+ E   SG +LF  I   P      A  I         Q
Sbjct: 86  VEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYI-------FRQ 138
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFA 279
              AV ++  K+IIH D+K ENI+        +K+IDFG A  L+  ++     GT E+ 
Sbjct: 139 LVSAVGYLRLKDIIHRDIKDENIV--IAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYC 196
Query: 280 APEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFA 313
           APE++   P  G   +MW++GV  Y L+   +PF 
Sbjct: 197 APEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 12/204 (5%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G FG V+    +K     A K +     +E E   KE  +M ++ HP L+ L    
Sbjct: 18  KLGGGQFGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
             +    +I EF++ G L + +     + +  EV  V L  + TQ S A++++ +KN IH
Sbjct: 77  TREPPFYIITEFMTYGNLLDYLR----ECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 132
Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA---EFAAPEIVEREPVGF 291
            D+   N  C    +  VK+ DFGL ++L   +      G     ++ APE +       
Sbjct: 133 RDLAARN--CLVGENHLVKVADFGL-SRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 292 YTDMWAVGVLAYVLLS-GLSPFAG 314
            +D+WA GVL + + + G+SP+ G
Sbjct: 190 KSDVWAFGVLLWEIATYGMSPYPG 213

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 12/204 (5%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G +G V+    +K     A K +     +E E   KE  +M ++ HP L+ L    
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
             +    +I EF++ G L + +     + +  EV  V L  + TQ S A++++ +KN IH
Sbjct: 79  TREPPFYIIIEFMTYGNLLDYLR----ECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA---EFAAPEIVEREPVGF 291
            D+   N  C    +  VK+ DFGL ++L   +      G     ++ APE +       
Sbjct: 135 RDLAARN--CLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 292 YTDMWAVGVLAYVLLS-GLSPFAG 314
            +D+WA GVL + + + G+SP+ G
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPG 215

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 12/204 (5%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G +G V+    +K     A K +     +E E   KE  +M ++ HP L+ L    
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
             +    +I EF++ G L + +     + +  EV  V L  + TQ S A++++ +KN IH
Sbjct: 79  TREPPFYIIIEFMTYGNLLDYLR----ECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA---EFAAPEIVEREPVGF 291
            D+   N  C    +  VK+ DFGL ++L   +      G     ++ APE +       
Sbjct: 135 RDLAARN--CLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 292 YTDMWAVGVLAYVLLS-GLSPFAG 314
            +D+WA GVL + + + G+SP+ G
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPG 215

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 106/226 (46%), Gaps = 19/226 (8%)
Query: 104 SSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL---IRKEIDIMN 160
           S + D Y++ E +G G    VH  R+ +     A K +      +       R+E     
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 67
Query: 161 QLHHPKLINLHDAFEDDDEM----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPIL 216
            L+HP ++ ++   E +        ++ E++ G      +T  D   +E  + P     +
Sbjct: 68  ALNHPAIVAVYATGEAETPAGPLPYIVMEYVDG------VTLRDIVHTEGPMTPKRAIEV 121
Query: 217 MTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--DPNEVVKIST- 273
           +     A+   H+  IIH DVKP NIM    N+  VK++DFG+A  +    N V + +  
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQTAAV 179
Query: 274 -GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDV 318
            GTA++ +PE    + V   +D++++G + Y +L+G  PF G++ V
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 12/204 (5%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G +G V+    +K     A K +     +E E   KE  +M ++ HP L+ L    
Sbjct: 18  KLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
             +    +I EF++ G L + +     + +  EV  V L  + TQ S A++++ +KN IH
Sbjct: 77  TREPPFYIIIEFMTYGNLLDYLR----ECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 132
Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA---EFAAPEIVEREPVGF 291
            D+   N  C    +  VK+ DFGL ++L   +      G     ++ APE +       
Sbjct: 133 RDLAARN--CLVGENHLVKVADFGL-SRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 292 YTDMWAVGVLAYVLLS-GLSPFAG 314
            +D+WA GVL + + + G+SP+ G
Sbjct: 190 KSDVWAFGVLLWEIATYGMSPYPG 213

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 111/222 (50%), Gaps = 18/222 (8%)
Query: 111 DILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR---KEIDIMNQLHHPKL 167
           +I E+IG G+FG VHR      G+  A K + +  +   E +    +E+ IM +L HP +
Sbjct: 40  NIKEKIGAGSFGTVHRAEWH--GSDVAVKIL-MEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT-QTSPAVKH 226
           +    A      + ++ E+LS G L+  +    +K    E +     + M    +  + +
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLL----HKSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 227 MHEKN--IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVV--KISTGTAEFAAPE 282
           +H +N  I+H D+K  N++   + +  VK+ DFGL ++L  +  +  K + GT E+ APE
Sbjct: 153 LHNRNPPIVHRDLKSPNLLVDKKYT--VKVCDFGL-SRLKASXFLXSKXAAGTPEWMAPE 209
Query: 283 IVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           ++  EP    +D+++ GV+ + L +   P+   N  + +  V
Sbjct: 210 VLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV 251

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 12/204 (5%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G +G V+    +K     A K +     +E E   KE  +M ++ HP L+ L    
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
             +    +I EF++ G L + +     + +  EV  V L  + TQ S A++++ +KN IH
Sbjct: 84  TREPPFYIIIEFMTYGNLLDYLR----ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 139
Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA---EFAAPEIVEREPVGF 291
            D+   N  C    +  VK+ DFGL ++L   +      G     ++ APE +       
Sbjct: 140 RDLAARN--CLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 292 YTDMWAVGVLAYVLLS-GLSPFAG 314
            +D+WA GVL + + + G+SP+ G
Sbjct: 197 KSDVWAFGVLLWEIATYGMSPYPG 220

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 90/182 (49%), Gaps = 18/182 (9%)
Query: 152 IRKEIDIMNQLHHPKLINLHDAF--EDDDEMVLIFEFLSGG--ELFERITAPDYKMSEAE 207
           ++KEI ++ +L H  +I L D    E+  +M ++ E+   G  E+ + +    + + +A 
Sbjct: 53  VKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAH 112
Query: 208 VIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP-- 265
                      Q    ++++H + I+H D+KP N++  T  +  +K+   G+A  L P  
Sbjct: 113 G-------YFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT--LKISALGVAEALHPFA 163
Query: 266 -NEVVKISTGTAEFAAPEIVEREPV--GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLK 322
            ++  + S G+  F  PEI        GF  D+W+ GV  Y + +GL PF G+N  +  +
Sbjct: 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFE 223
Query: 323 NV 324
           N+
Sbjct: 224 NI 225

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 12/204 (5%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G +G V+    +K     A K +     +E E   KE  +M ++ HP L+ L    
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
             +    +I EF++ G L + +     + +  EV  V L  + TQ S A++++ +KN IH
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLR----ECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA---EFAAPEIVEREPVGF 291
            D+   N  C    +  VK+ DFGL ++L   +      G     ++ APE +       
Sbjct: 135 RDLAARN--CLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 292 YTDMWAVGVLAYVLLS-GLSPFAG 314
            +D+WA GVL + + + G+SP+ G
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPG 215

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 12/204 (5%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G +G V+    +K     A K +     +E E   KE  +M ++ HP L+ L    
Sbjct: 21  KLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 79
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
             +    +I EF++ G L + +     + +  EV  V L  + TQ S A++++ +KN IH
Sbjct: 80  TREPPFYIIIEFMTYGNLLDYLR----ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 135
Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA---EFAAPEIVEREPVGF 291
            D+   N  C    +  VK+ DFGL ++L   +      G     ++ APE +       
Sbjct: 136 RDLAARN--CLVGENHLVKVADFGL-SRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSI 192
Query: 292 YTDMWAVGVLAYVLLS-GLSPFAG 314
            +D+WA GVL + + + G+SP+ G
Sbjct: 193 KSDVWAFGVLLWEIATYGMSPYPG 216

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 12/204 (5%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G +G V+    +K     A K +     +E E   KE  +M ++ HP L+ L    
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
             +    +I EF++ G L + +     + +  EV  V L  + TQ S A++++ +KN IH
Sbjct: 84  TREPPFYIITEFMTYGNLLDYLR----ECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 139
Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA---EFAAPEIVEREPVGF 291
            D+   N  C    +  VK+ DFGL ++L   +      G     ++ APE +       
Sbjct: 140 RDLAARN--CLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 292 YTDMWAVGVLAYVLLS-GLSPFAG 314
            +D+WA GVL + + + G+SP+ G
Sbjct: 197 KSDVWAFGVLLWEIATYGMSPYPG 220

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 12/204 (5%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G +G V+    +K     A K +     +E E   KE  +M ++ HP L+ L    
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
             +    +I EF++ G L + +     + +  EV  V L  + TQ S A++++ +KN IH
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLR----ECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA---EFAAPEIVEREPVGF 291
            D+   N  C    +  VK+ DFGL ++L   +      G     ++ APE +       
Sbjct: 135 RDLAARN--CLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 292 YTDMWAVGVLAYVLLS-GLSPFAG 314
            +D+WA GVL + + + G+SP+ G
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPG 215

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 12/204 (5%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G +G V+    +K     A K +     +E E   KE  +M ++ HP L+ L    
Sbjct: 18  KLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
             +    +I EF++ G L + +     + +  EV  V L  + TQ S A++++ +KN IH
Sbjct: 77  TREPPFYIITEFMTYGNLLDYLR----ECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 132
Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA---EFAAPEIVEREPVGF 291
            D+   N  C    +  VK+ DFGL ++L   +      G     ++ APE +       
Sbjct: 133 RDLAARN--CLVGENHLVKVADFGL-SRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 292 YTDMWAVGVLAYVLLS-GLSPFAG 314
            +D+WA GVL + + + G+SP+ G
Sbjct: 190 KSDVWAFGVLLWEIATYGMSPYPG 213

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 110/222 (49%), Gaps = 18/222 (8%)
Query: 99  VDIKTSSVY-------DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL 151
           VD+ T ++Y       + +  LE+IG G+FG V +  + +T  + A K I +    ++  
Sbjct: 11  VDLGTENLYFQSMDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE 70
Query: 152 I-RKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIP 210
             ++EI +++Q   P +   + ++  D ++ +I E+L GG   + +      + E ++  
Sbjct: 71  DIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIAT 128
Query: 211 VTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVK 270
           +   IL       + ++H +  IH D+K  N++        VK+ DFG+A +L   ++ +
Sbjct: 129 ILREILK-----GLDYLHSEKKIHRDIKAANVLLSEHG--EVKLADFGVAGQLTDTQIKR 181
Query: 271 IS-TGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSP 311
            +  GT  + APE++++       D+W++G+ A  L  G  P
Sbjct: 182 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 223

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 12/204 (5%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G +G V+    +K     A K +     +E E   KE  +M ++ HP L+ L    
Sbjct: 33  KLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 91
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
             +    +I EF++ G L + +     + +  EV  V L  + TQ S A++++ +KN IH
Sbjct: 92  TREPPFYIITEFMTYGNLLDYLR----ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 147
Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA---EFAAPEIVEREPVGF 291
            D+   N  C    +  VK+ DFGL ++L   +      G     ++ APE +       
Sbjct: 148 RDLAARN--CLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 204
Query: 292 YTDMWAVGVLAYVLLS-GLSPFAG 314
            +D+WA GVL + + + G+SP+ G
Sbjct: 205 KSDVWAFGVLLWEIATYGMSPYPG 228

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 12/204 (5%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G +G V+    +K     A K +     +E E   KE  +M ++ HP L+ L    
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
             +    +I EF++ G L + +     + +  EV  V L  + TQ S A++++ +KN IH
Sbjct: 81  TREPPFYIITEFMTYGNLLDYLR----ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 136
Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA---EFAAPEIVEREPVGF 291
            D+   N  C    +  VK+ DFGL ++L   +      G     ++ APE +       
Sbjct: 137 RDLAARN--CLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 193
Query: 292 YTDMWAVGVLAYVLLS-GLSPFAG 314
            +D+WA GVL + + + G+SP+ G
Sbjct: 194 KSDVWAFGVLLWEIATYGMSPYPG 217

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 12/204 (5%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G +G V+    +K     A K +     +E E   KE  +M ++ HP L+ L    
Sbjct: 21  KLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 79
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
             +    +I EF++ G L + +     + +  EV  V L  + TQ S A++++ +KN IH
Sbjct: 80  TREPPFYIITEFMTYGNLLDYLR----ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 135
Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA---EFAAPEIVEREPVGF 291
            D+   N  C    +  VK+ DFGL ++L   +      G     ++ APE +       
Sbjct: 136 RDLAARN--CLVGENHLVKVADFGL-SRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSI 192
Query: 292 YTDMWAVGVLAYVLLS-GLSPFAG 314
            +D+WA GVL + + + G+SP+ G
Sbjct: 193 KSDVWAFGVLLWEIATYGMSPYPG 216

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 12/204 (5%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G +G V+    +K     A K +     +E E   KE  +M ++ HP L+ L    
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
             +    +I EF++ G L + +     + +  EV  V L  + TQ S A++++ +KN IH
Sbjct: 81  TREPPFYIITEFMTYGNLLDYLR----ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 136
Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA---EFAAPEIVEREPVGF 291
            D+   N  C    +  VK+ DFGL ++L   +      G     ++ APE +       
Sbjct: 137 RDLAARN--CLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 193
Query: 292 YTDMWAVGVLAYVLLS-GLSPFAG 314
            +D+WA GVL + + + G+SP+ G
Sbjct: 194 KSDVWAFGVLLWEIATYGMSPYPG 217

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 12/204 (5%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G +G V+    +K     A K +     +E E   KE  +M ++ HP L+ L    
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
             +    +I EF++ G L + +     + +  EV  V L  + TQ S A++++ +KN IH
Sbjct: 84  TREPPFYIITEFMTYGNLLDYLR----ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 139
Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA---EFAAPEIVEREPVGF 291
            D+   N  C    +  VK+ DFGL ++L   +      G     ++ APE +       
Sbjct: 140 RDLAARN--CLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 292 YTDMWAVGVLAYVLLS-GLSPFAG 314
            +D+WA GVL + + + G+SP+ G
Sbjct: 197 KSDVWAFGVLLWEIATYGMSPYPG 220

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 12/204 (5%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G +G V+    +K     A K +     +E E   KE  +M ++ HP L+ L    
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
             +    +I EF++ G L + +     + +  EV  V L  + TQ S A++++ +KN IH
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLR----ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA---EFAAPEIVEREPVGF 291
            D+   N  C    +  VK+ DFGL ++L   +      G     ++ APE +       
Sbjct: 135 RDLAARN--CLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 292 YTDMWAVGVLAYVLLS-GLSPFAG 314
            +D+WA GVL + + + G+SP+ G
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPG 215

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 12/204 (5%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G +G V+    +K     A K +     +E E   KE  +M ++ HP L+ L    
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
             +    +I EF++ G L + +     + +  EV  V L  + TQ S A++++ +KN IH
Sbjct: 84  TREPPFYIITEFMTYGNLLDYLR----ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 139
Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA---EFAAPEIVEREPVGF 291
            D+   N  C    +  VK+ DFGL ++L   +      G     ++ APE +       
Sbjct: 140 RDLAARN--CLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 292 YTDMWAVGVLAYVLLS-GLSPFAG 314
            +D+WA GVL + + + G+SP+ G
Sbjct: 197 KSDVWAFGVLLWEIATYGMSPYPG 220

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 12/204 (5%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G +G V+    +K     A K +     +E E   KE  +M ++ HP L+ L    
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
             +    +I EF++ G L + +     + +  EV  V L  + TQ S A++++ +KN IH
Sbjct: 81  TREPPFYIITEFMTYGNLLDYLR----ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 136
Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA---EFAAPEIVEREPVGF 291
            D+   N  C    +  VK+ DFGL ++L   +      G     ++ APE +       
Sbjct: 137 RDLAARN--CLVGENHLVKVADFGL-SRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSI 193
Query: 292 YTDMWAVGVLAYVLLS-GLSPFAG 314
            +D+WA GVL + + + G+SP+ G
Sbjct: 194 KSDVWAFGVLLWEIATYGMSPYPG 217

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 12/204 (5%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G +G V+    +K     A K +     +E E   KE  +M ++ HP L+ L    
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
             +    +I EF++ G L + +     + +  EV  V L  + TQ S A++++ +KN IH
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLR----ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA---EFAAPEIVEREPVGF 291
            D+   N  C    +  VK+ DFGL ++L   +      G     ++ APE +       
Sbjct: 135 RDLAARN--CLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 292 YTDMWAVGVLAYVLLS-GLSPFAG 314
            +D+WA GVL + + + G+SP+ G
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPG 215

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 12/204 (5%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G +G V+    +K     A K +     +E E   KE  +M ++ HP L+ L    
Sbjct: 24  KLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 82
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
             +    +I EF++ G L + +     + +  EV  V L  + TQ S A++++ +KN IH
Sbjct: 83  TREPPFYIITEFMTYGNLLDYLR----ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 138
Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA---EFAAPEIVEREPVGF 291
            D+   N  C    +  VK+ DFGL ++L   +      G     ++ APE +       
Sbjct: 139 RDLAARN--CLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 195
Query: 292 YTDMWAVGVLAYVLLS-GLSPFAG 314
            +D+WA GVL + + + G+SP+ G
Sbjct: 196 KSDVWAFGVLLWEIATYGMSPYPG 219

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 12/204 (5%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G +G V+    +K     A K +     +E E   KE  +M ++ HP L+ L    
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
             +    +I EF++ G L + +     + +  EV  V L  + TQ S A++++ +KN IH
Sbjct: 84  TREPPFYIITEFMTYGNLLDYLR----ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 139
Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA---EFAAPEIVEREPVGF 291
            D+   N  C    +  VK+ DFGL ++L   +      G     ++ APE +       
Sbjct: 140 RDLAARN--CLVGENHLVKVADFGL-SRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 292 YTDMWAVGVLAYVLLS-GLSPFAG 314
            +D+WA GVL + + + G+SP+ G
Sbjct: 197 KSDVWAFGVLLWEIATYGMSPYPG 220

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 99/214 (46%), Gaps = 12/214 (5%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE--KELIRKEIDIMNQLHHPKL 167
           Y+ LE+IG G +G V + + R+T  I A K + +  + E       +EI ++ +L H  +
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
           + LHD    D ++ L+FEF       ++     +     ++ P  +   + Q    +   
Sbjct: 64  VRLHDVLHSDKKLTLVFEFC------DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEFAAPEIVER 286
           H +N++H D+KP+N++   RN   +K+ +FGLA     P         T  +  P+++  
Sbjct: 118 HSRNVLHRDLKPQNLLI-NRNG-ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 287 EPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDVE 319
             +     DMW+ G +   L +   P    NDV+
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 209

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 102/203 (50%), Gaps = 11/203 (5%)
Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELI-RKEIDIMNQLHHPKLINLH 171
           LE+IG G+FG V +  + +T  + A K I +    ++    ++EI +++Q   P +   +
Sbjct: 12  LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 71
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
            ++  D ++ +I E+L GG   + +      + E ++  +   IL       + ++H + 
Sbjct: 72  GSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILK-----GLDYLHSEK 124
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS-TGTAEFAAPEIVEREPVG 290
            IH D+K  N++        VK+ DFG+A +L   ++ + +  GT  + APE++++    
Sbjct: 125 KIHRDIKAANVLLSEHG--EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 182
Query: 291 FYTDMWAVGVLAYVLLSGLSPFA 313
              D+W++G+ A  L  G  P +
Sbjct: 183 SKADIWSLGITAIELARGEPPHS 205

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 105/227 (46%), Gaps = 18/227 (7%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAA-KFIPVSHNLEKELIR--KEIDIMNQL--- 162
            Y+ + EIG GA+G V + R+ K G  F A K + V    E   +   +E+ ++  L   
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71
Query: 163 HHPKLINLHDAF-----EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM 217
            HP ++ L D       + + ++ L+FE +      + +T    K+ E  V   T+  +M
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-----QDLTTYLDKVPEPGVPTETIKDMM 126
Query: 218 TQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAE 277
            Q    +  +H   ++H D+KP+NI+    +S  +K+ DFGLA        +     T  
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNIL--VTSSGQIKLADFGLARIYSFQMALTSVVVTLW 184
Query: 278 FAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           + APE++ +       D+W+VG +   +      F G +DV+ L  +
Sbjct: 185 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 231

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 100/213 (46%), Gaps = 11/213 (5%)
Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLHHPKLINL 170
           L EIG GA+G V++   + +G I A K I   V    +K+L+     +M     P ++  
Sbjct: 27  LGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQF 86
Query: 171 HDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEK 230
           + A   + +  +  E +S    F++     Y + +  +    L  +   T  A+ H+ E 
Sbjct: 87  YGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144
Query: 231 -NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE---- 285
             IIH D+KP NI+     S N+K+ DFG++ +L  +       G   + APE ++    
Sbjct: 145 LKIIHRDIKPSNILLD--RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSAS 202
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDV 318
           R+     +D+W++G+  Y L +G  P+   N V
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFPYPKWNSV 235

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 119/261 (45%), Gaps = 27/261 (10%)
Query: 99  VDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDI 158
           V +    V   Y++L+ IG G+FG V +  + K     A K +       ++   +EI I
Sbjct: 88  VQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAA-EEIRI 146
Query: 159 MNQLHHP------KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVT 212
           +  L          +I++ + F   + + + FE LS   L+E I    ++         +
Sbjct: 147 LEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQ-------GFS 198
Query: 213 LPILMTQTSPAVK---HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVV 269
           LP++       ++    +H+  IIH D+KPENI+ + +  + +K+IDFG  +    ++ V
Sbjct: 199 LPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRV 256
Query: 270 KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDW 329
                +  + APE++     G   DMW++G +   LL+G     GE++ + L    AC  
Sbjct: 257 YTXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQL----ACMI 312
Query: 330 EF---DEEAFKNVSEEGKDFI 347
           E      +   + S+  K+F+
Sbjct: 313 ELLGMPSQKLLDASKRAKNFV 333

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/284 (23%), Positives = 119/284 (41%), Gaps = 49/284 (17%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAA----------KFIPVSHNLEKELIRKEIDI 158
            Y+ + EIG GA+G V + R+ K G  F A          + +P+S   E  ++R     
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH---- 67
Query: 159 MNQLHHPKLINLHDAF-----EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTL 213
           +    HP ++ L D       + + ++ L+FE +      + +T    K+ E  V   T+
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-----QDLTTYLDKVPEPGVPTETI 122
Query: 214 PILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST 273
             +M Q    +  +H   ++H D+KP+NI+  +  S  +K+ DFGLA        +    
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS--SGQIKLADFGLARIYSFQMALTSVV 180
Query: 274 GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKAC------ 327
            T  + APE++ +       D+W+VG +   +      F G +DV+ L  +         
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240
Query: 328 -DWEFD----------------EEAFKNVSEEGKDFIRRLLLRN 354
            DW  D                E+   ++ E GKD + + L  N
Sbjct: 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFN 284

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 119/261 (45%), Gaps = 27/261 (10%)
Query: 99  VDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDI 158
           V +    V   Y++L+ IG G+FG V +  + K     A K +       ++   +EI I
Sbjct: 88  VQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAA-EEIRI 146
Query: 159 MNQLHHP------KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVT 212
           +  L          +I++ + F   + + + FE LS   L+E I    ++         +
Sbjct: 147 LEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQ-------GFS 198
Query: 213 LPILMTQTSPAVK---HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVV 269
           LP++       ++    +H+  IIH D+KPENI+ + +  + +K+IDFG  +    ++ V
Sbjct: 199 LPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRV 256
Query: 270 KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDW 329
                +  + APE++     G   DMW++G +   LL+G     GE++ + L    AC  
Sbjct: 257 YTXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQL----ACMI 312
Query: 330 EF---DEEAFKNVSEEGKDFI 347
           E      +   + S+  K+F+
Sbjct: 313 ELLGMPSQKLLDASKRAKNFV 333

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 111/222 (50%), Gaps = 18/222 (8%)
Query: 111 DILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR---KEIDIMNQLHHPKL 167
           +I E+IG G+FG VHR      G+  A K + +  +   E +    +E+ IM +L HP +
Sbjct: 40  NIKEKIGAGSFGTVHRAEWH--GSDVAVKIL-MEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT-QTSPAVKH 226
           +    A      + ++ E+LS G L+  +    +K    E +     + M    +  + +
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLL----HKSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 227 MHEKN--IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVV--KISTGTAEFAAPE 282
           +H +N  I+H ++K  N++   + +  VK+ DFGL ++L  +  +  K + GT E+ APE
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVDKKYT--VKVCDFGL-SRLKASTFLSSKSAAGTPEWMAPE 209
Query: 283 IVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           ++  EP    +D+++ GV+ + L +   P+   N  + +  V
Sbjct: 210 VLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV 251

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 110/212 (51%), Gaps = 19/212 (8%)
Query: 114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQLHHPKLINLH 171
           + IG+G+FG V++ +    G++ A K + V+    ++L   + E+ ++ +  H  ++ L 
Sbjct: 42  QRIGSGSFGTVYKGKWH--GDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LF 97
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
             +    ++ ++ ++  G  L+  +   + K    ++I +       QT+  + ++H K+
Sbjct: 98  MGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA-----RQTAQGMDYLHAKS 152
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLAT---KLDPNEVVKISTGTAEFAAPEIV---E 285
           IIH D+K  NI         VK+ DFGLAT   +   +   +  +G+  + APE++   +
Sbjct: 153 IIHRDLKSNNIFLH--EDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 210
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGEND 317
           + P  F +D++A G++ Y L++G  P++  N+
Sbjct: 211 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 242

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 110/212 (51%), Gaps = 19/212 (8%)
Query: 114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQLHHPKLINLH 171
           + IG+G+FG V++ +    G++ A K + V+    ++L   + E+ ++ +  H  ++ L 
Sbjct: 19  QRIGSGSFGTVYKGKWH--GDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LF 74
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
             +    ++ ++ ++  G  L+  +   + K    ++I +       QT+  + ++H K+
Sbjct: 75  MGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA-----RQTAQGMDYLHAKS 129
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLAT---KLDPNEVVKISTGTAEFAAPEIV---E 285
           IIH D+K  NI         VK+ DFGLAT   +   +   +  +G+  + APE++   +
Sbjct: 130 IIHRDLKSNNIFLH--EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGEND 317
           + P  F +D++A G++ Y L++G  P++  N+
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 219

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 110/212 (51%), Gaps = 19/212 (8%)
Query: 114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQLHHPKLINLH 171
           + IG+G+FG V++ +    G++ A K + V+    ++L   + E+ ++ +  H  ++ L 
Sbjct: 34  QRIGSGSFGTVYKGKWH--GDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LF 89
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
             +    ++ ++ ++  G  L+  +   + K    ++I +       QT+  + ++H K+
Sbjct: 90  MGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA-----RQTAQGMDYLHAKS 144
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLAT---KLDPNEVVKISTGTAEFAAPEIV---E 285
           IIH D+K  NI         VK+ DFGLAT   +   +   +  +G+  + APE++   +
Sbjct: 145 IIHRDLKSNNIFLH--EDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 202
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGEND 317
           + P  F +D++A G++ Y L++G  P++  N+
Sbjct: 203 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 234

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 120/280 (42%), Gaps = 41/280 (14%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAA-KFIPVSHNLEKELIR--KEIDIMNQL--- 162
            Y+ + EIG GA+G V + R+ K G  F A K + V    E   +   +E+ ++  L   
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71
Query: 163 HHPKLINLHDAF-----EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM 217
            HP ++ L D       + + ++ L+FE +      + +T    K+ E  V   T+  +M
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-----QDLTTYLDKVPEPGVPTETIKDMM 126
Query: 218 TQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAE 277
            Q    +  +H   ++H D+KP+NI+  +  S  +K+ DFGLA        +     T  
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTS--SGQIKLADFGLARIYSFQMALTSVVVTLW 184
Query: 278 FAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKAC-------DWE 330
           + APE++ +       D+W+VG +   +      F G +DV+ L  +          DW 
Sbjct: 185 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 244
Query: 331 FD----------------EEAFKNVSEEGKDFIRRLLLRN 354
            D                E+   ++ E GKD + + L  N
Sbjct: 245 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFN 284

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 110/212 (51%), Gaps = 19/212 (8%)
Query: 114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQLHHPKLINLH 171
           + IG+G+FG V++ +    G++ A K + V+    ++L   + E+ ++ +  H  ++ L 
Sbjct: 42  QRIGSGSFGTVYKGKWH--GDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LF 97
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
             +    ++ ++ ++  G  L+  +   + K    ++I +       QT+  + ++H K+
Sbjct: 98  MGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA-----RQTAQGMDYLHAKS 152
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLAT---KLDPNEVVKISTGTAEFAAPEIV---E 285
           IIH D+K  NI         VK+ DFGLAT   +   +   +  +G+  + APE++   +
Sbjct: 153 IIHRDLKSNNIFLH--EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 210
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGEND 317
           + P  F +D++A G++ Y L++G  P++  N+
Sbjct: 211 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 242

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 110/212 (51%), Gaps = 19/212 (8%)
Query: 114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQLHHPKLINLH 171
           + IG+G+FG V++ +    G++ A K + V+    ++L   + E+ ++ +  H  ++ L 
Sbjct: 16  QRIGSGSFGTVYKGKWH--GDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LF 71
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
             +    ++ ++ ++  G  L+  +   + K    ++I +       QT+  + ++H K+
Sbjct: 72  MGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA-----RQTAQGMDYLHAKS 126
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLAT---KLDPNEVVKISTGTAEFAAPEIV---E 285
           IIH D+K  NI         VK+ DFGLAT   +   +   +  +G+  + APE++   +
Sbjct: 127 IIHRDLKSNNIFLH--EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 184
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGEND 317
           + P  F +D++A G++ Y L++G  P++  N+
Sbjct: 185 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 216

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 110/212 (51%), Gaps = 19/212 (8%)
Query: 114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQLHHPKLINLH 171
           + IG+G+FG V++ +    G++ A K + V+    ++L   + E+ ++ +  H  ++ L 
Sbjct: 41  QRIGSGSFGTVYKGKWH--GDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LF 96
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
             +    ++ ++ ++  G  L+  +   + K    ++I +       QT+  + ++H K+
Sbjct: 97  MGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA-----RQTAQGMDYLHAKS 151
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLAT---KLDPNEVVKISTGTAEFAAPEIV---E 285
           IIH D+K  NI         VK+ DFGLAT   +   +   +  +G+  + APE++   +
Sbjct: 152 IIHRDLKSNNIFLH--EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 209
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGEND 317
           + P  F +D++A G++ Y L++G  P++  N+
Sbjct: 210 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 241

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 110/212 (51%), Gaps = 19/212 (8%)
Query: 114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQLHHPKLINLH 171
           + IG+G+FG V++ +    G++ A K + V+    ++L   + E+ ++ +  H  ++ L 
Sbjct: 19  QRIGSGSFGTVYKGKWH--GDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LF 74
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
             +    ++ ++ ++  G  L+  +   + K    ++I +       QT+  + ++H K+
Sbjct: 75  MGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA-----RQTAQGMDYLHAKS 129
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLAT---KLDPNEVVKISTGTAEFAAPEIV---E 285
           IIH D+K  NI         VK+ DFGLAT   +   +   +  +G+  + APE++   +
Sbjct: 130 IIHRDLKSNNIFLH--EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGEND 317
           + P  F +D++A G++ Y L++G  P++  N+
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 219

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 101/203 (49%), Gaps = 11/203 (5%)
Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELI-RKEIDIMNQLHHPKLINLH 171
           LE+IG G+FG V +  + +T  + A K I +    ++    ++EI +++Q   P +   +
Sbjct: 12  LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 71
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
            ++  D ++ +I E+L GG   + +      + E ++  +   IL       + ++H + 
Sbjct: 72  GSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILK-----GLDYLHSEK 124
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVK-ISTGTAEFAAPEIVEREPVG 290
            IH D+K  N++        VK+ DFG+A +L   ++ +    GT  + APE++++    
Sbjct: 125 KIHRDIKAANVLLSEHG--EVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYD 182
Query: 291 FYTDMWAVGVLAYVLLSGLSPFA 313
              D+W++G+ A  L  G  P +
Sbjct: 183 SKADIWSLGITAIELARGEPPHS 205

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 110/212 (51%), Gaps = 19/212 (8%)
Query: 114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQLHHPKLINLH 171
           + IG+G+FG V++ +    G++ A K + V+    ++L   + E+ ++ +  H  ++ L 
Sbjct: 14  QRIGSGSFGTVYKGKWH--GDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LF 69
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
             +    ++ ++ ++  G  L+  +   + K    ++I +       QT+  + ++H K+
Sbjct: 70  MGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA-----RQTAQGMDYLHAKS 124
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLAT---KLDPNEVVKISTGTAEFAAPEIV---E 285
           IIH D+K  NI         VK+ DFGLAT   +   +   +  +G+  + APE++   +
Sbjct: 125 IIHRDLKSNNIFLH--EDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGEND 317
           + P  F +D++A G++ Y L++G  P++  N+
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 110/212 (51%), Gaps = 19/212 (8%)
Query: 114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQLHHPKLINLH 171
           + IG+G+FG V++ +    G++ A K + V+    ++L   + E+ ++ +  H  ++ L 
Sbjct: 14  QRIGSGSFGTVYKGKWH--GDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LF 69
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
             +    ++ ++ ++  G  L+  +   + K    ++I +       QT+  + ++H K+
Sbjct: 70  MGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA-----RQTAQGMDYLHAKS 124
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLAT---KLDPNEVVKISTGTAEFAAPEIV---E 285
           IIH D+K  NI         VK+ DFGLAT   +   +   +  +G+  + APE++   +
Sbjct: 125 IIHRDLKSNNIFLH--EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGEND 317
           + P  F +D++A G++ Y L++G  P++  N+
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 101/203 (49%), Gaps = 11/203 (5%)
Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELI-RKEIDIMNQLHHPKLINLH 171
           LE+IG G+FG V +  + +T  + A K I +    ++    ++EI +++Q   P +   +
Sbjct: 27  LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 86
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
            ++  D ++ +I E+L GG   + +      + E ++  +   IL       + ++H + 
Sbjct: 87  GSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILK-----GLDYLHSEK 139
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVK-ISTGTAEFAAPEIVEREPVG 290
            IH D+K  N++        VK+ DFG+A +L   ++ +    GT  + APE++++    
Sbjct: 140 KIHRDIKAANVLLSEHG--EVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYD 197
Query: 291 FYTDMWAVGVLAYVLLSGLSPFA 313
              D+W++G+ A  L  G  P +
Sbjct: 198 SKADIWSLGITAIELARGEPPHS 220

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 110/212 (51%), Gaps = 19/212 (8%)
Query: 114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQLHHPKLINLH 171
           + IG+G+FG V++ +    G++ A K + V+    ++L   + E+ ++ +  H  ++ L 
Sbjct: 14  QRIGSGSFGTVYKGKWH--GDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LF 69
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
             +    ++ ++ ++  G  L+  +   + K    ++I +       QT+  + ++H K+
Sbjct: 70  MGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA-----RQTAQGMDYLHAKS 124
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLAT---KLDPNEVVKISTGTAEFAAPEIV---E 285
           IIH D+K  NI         VK+ DFGLAT   +   +   +  +G+  + APE++   +
Sbjct: 125 IIHRDLKSNNIFLH--EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGEND 317
           + P  F +D++A G++ Y L++G  P++  N+
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 12/204 (5%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G +G V+    +K     A K +     +E E   KE  +M ++ HP L+ L    
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
             +    +I EF++ G L + +     + +  EV  V L  + TQ S A++++ +KN IH
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLR----ECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 341
Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA---EFAAPEIVEREPVGF 291
            ++   N  C    +  VK+ DFGL ++L   +      G     ++ APE +       
Sbjct: 342 RNLAARN--CLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 292 YTDMWAVGVLAYVLLS-GLSPFAG 314
            +D+WA GVL + + + G+SP+ G
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYPG 422

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 118/261 (45%), Gaps = 27/261 (10%)
Query: 99  VDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDI 158
           V +    V   Y++L+ IG G FG V +  + K     A K +       ++   +EI I
Sbjct: 88  VQVPHDHVAYRYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAA-EEIRI 146
Query: 159 MNQLHHP------KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVT 212
           +  L          +I++ + F   + + + FE LS   L+E I    ++         +
Sbjct: 147 LEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQ-------GFS 198
Query: 213 LPILMTQTSPAVK---HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVV 269
           LP++       ++    +H+  IIH D+KPENI+ + +  + +K+IDFG  +    ++ V
Sbjct: 199 LPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRV 256
Query: 270 KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDW 329
                +  + APE++     G   DMW++G +   LL+G     GE++ + L    AC  
Sbjct: 257 YXXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQL----ACMI 312
Query: 330 EF---DEEAFKNVSEEGKDFI 347
           E      +   + S+  K+F+
Sbjct: 313 ELLGMPXQKLLDASKRAKNFV 333

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 116/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG+  A K +  P    +  +   +E+ ++  + 
Sbjct: 16  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 75
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCA--KLTDDHV-----QFLIY 128
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D      ++T    +
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLARHTDDEMTGYVATRW--Y 184
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 245 KISSESARNYIQSL 258

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 117/254 (46%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG+  A K +  P    +  +   +E+ ++  + 
Sbjct: 16  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 75
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 128
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D +E+      T  +
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLARHTD-DEMAGF-VATRWY 184
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 245 KISSESARNYIQSL 258

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/261 (23%), Positives = 127/261 (48%), Gaps = 34/261 (13%)
Query: 66  DETGKKIRGKADEKVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVH 125
           +E  + +RG   +K  + D+  F  + ++  + V++      + + +   IG G FG V+
Sbjct: 151 EEICQNLRGDVFQKFIESDK--FTRFCQW--KNVELNIHLTMNDFSVHRIIGRGGFGEVY 206
Query: 126 RCRERKTGNIFAAKFIPVSHNLEKELIRKE------------IDIMNQLHHPKLINLHDA 173
            CR+  TG ++A K       L+K+ I+ +            + +++    P ++ +  A
Sbjct: 207 GCRKADTGKMYAMK------CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA 260
Query: 174 FEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNII 233
           F   D++  I + ++GG+L   ++      SEA++      I++      ++HMH + ++
Sbjct: 261 FHTPDKLSFILDLMNGGDLHYHLSQHGV-FSEADMRFYAAEIIL-----GLEHMHNRFVV 314
Query: 234 HLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGF-- 291
           + D+KP NI+       +V++ D GLA      +    S GT  + APE++++  V +  
Sbjct: 315 YRDLKPANILLDEHG--HVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQK-GVAYDS 370
Query: 292 YTDMWAVGVLAYVLLSGLSPF 312
             D +++G + + LL G SPF
Sbjct: 371 SADWFSLGCMLFKLLRGHSPF 391

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/261 (23%), Positives = 127/261 (48%), Gaps = 34/261 (13%)
Query: 66  DETGKKIRGKADEKVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVH 125
           +E  + +RG   +K  + D+  F  + ++  + V++      + + +   IG G FG V+
Sbjct: 151 EEICQNLRGDVFQKFIESDK--FTRFCQW--KNVELNIHLTMNDFSVHRIIGRGGFGEVY 206
Query: 126 RCRERKTGNIFAAKFIPVSHNLEKELIRKE------------IDIMNQLHHPKLINLHDA 173
            CR+  TG ++A K       L+K+ I+ +            + +++    P ++ +  A
Sbjct: 207 GCRKADTGKMYAMK------CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA 260
Query: 174 FEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNII 233
           F   D++  I + ++GG+L   ++      SEA++      I++      ++HMH + ++
Sbjct: 261 FHTPDKLSFILDLMNGGDLHYHLSQHGV-FSEADMRFYAAEIIL-----GLEHMHNRFVV 314
Query: 234 HLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGF-- 291
           + D+KP NI+       +V++ D GLA      +    S GT  + APE++++  V +  
Sbjct: 315 YRDLKPANILLDEHG--HVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQK-GVAYDS 370
Query: 292 YTDMWAVGVLAYVLLSGLSPF 312
             D +++G + + LL G SPF
Sbjct: 371 SADWFSLGCMLFKLLRGHSPF 391

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/261 (23%), Positives = 127/261 (48%), Gaps = 34/261 (13%)
Query: 66  DETGKKIRGKADEKVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVH 125
           +E  + +RG   +K  + D+  F  + ++  + V++      + + +   IG G FG V+
Sbjct: 151 EEICQNLRGDVFQKFIESDK--FTRFCQW--KNVELNIHLTMNDFSVHRIIGRGGFGEVY 206
Query: 126 RCRERKTGNIFAAKFIPVSHNLEKELIRKE------------IDIMNQLHHPKLINLHDA 173
            CR+  TG ++A K       L+K+ I+ +            + +++    P ++ +  A
Sbjct: 207 GCRKADTGKMYAMK------CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA 260
Query: 174 FEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNII 233
           F   D++  I + ++GG+L   ++      SEA++      I++      ++HMH + ++
Sbjct: 261 FHTPDKLSFILDLMNGGDLHYHLSQHGV-FSEADMRFYAAEIIL-----GLEHMHNRFVV 314
Query: 234 HLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGF-- 291
           + D+KP NI+       +V++ D GLA      +    S GT  + APE++++  V +  
Sbjct: 315 YRDLKPANILLDEHG--HVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQK-GVAYDS 370
Query: 292 YTDMWAVGVLAYVLLSGLSPF 312
             D +++G + + LL G SPF
Sbjct: 371 SADWFSLGCMLFKLLRGHSPF 391

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/261 (23%), Positives = 127/261 (48%), Gaps = 34/261 (13%)
Query: 66  DETGKKIRGKADEKVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVH 125
           +E  + +RG   +K  + D+  F  + ++  + V++      + + +   IG G FG V+
Sbjct: 150 EEICQNLRGDVFQKFIESDK--FTRFCQW--KNVELNIHLTMNDFSVHRIIGRGGFGEVY 205
Query: 126 RCRERKTGNIFAAKFIPVSHNLEKELIRKE------------IDIMNQLHHPKLINLHDA 173
            CR+  TG ++A K       L+K+ I+ +            + +++    P ++ +  A
Sbjct: 206 GCRKADTGKMYAMK------CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA 259
Query: 174 FEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNII 233
           F   D++  I + ++GG+L   ++      SEA++      I++      ++HMH + ++
Sbjct: 260 FHTPDKLSFILDLMNGGDLHYHLSQHGV-FSEADMRFYAAEIIL-----GLEHMHNRFVV 313
Query: 234 HLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGF-- 291
           + D+KP NI+       +V++ D GLA      +    S GT  + APE++++  V +  
Sbjct: 314 YRDLKPANILLDEHG--HVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQK-GVAYDS 369
Query: 292 YTDMWAVGVLAYVLLSGLSPF 312
             D +++G + + LL G SPF
Sbjct: 370 SADWFSLGCMLFKLLRGHSPF 390

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 116/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG+  A K +  P    +  +   +E+ ++  + 
Sbjct: 16  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 75
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 128
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D      ++  T  +
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLARHTDDEMTGYVA--TRWY 184
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 245 KISSESARNYIQSL 258

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 99/201 (49%), Gaps = 11/201 (5%)
Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELI-RKEIDIMNQLHHPKLINLH 171
           L+ IG G+FG V++  +  T  + A K I +    ++    ++EI +++Q   P +    
Sbjct: 24  LDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYF 83
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
            ++    ++ +I E+L GG   + +      + E  +  +   IL       + ++H + 
Sbjct: 84  GSYLKSTKLWIIMEYLGGGSALDLLKPGP--LEETYIATILREILK-----GLDYLHSER 136
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVK-ISTGTAEFAAPEIVEREPVG 290
            IH D+K  N++   +   +VK+ DFG+A +L   ++ +    GT  + APE++++    
Sbjct: 137 KIHRDIKAANVLLSEQG--DVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYD 194
Query: 291 FYTDMWAVGVLAYVLLSGLSP 311
           F  D+W++G+ A  L  G  P
Sbjct: 195 FKADIWSLGITAIELAKGEPP 215

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 117/254 (46%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG+  A K +  P    +  +   +E+ ++  + 
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 132
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D +E+      T  +
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLARHTD-DEMAGF-VATRWY 188
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 249 KISSESARNYIQSL 262

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 106/229 (46%), Gaps = 19/229 (8%)
Query: 97  QPVDIKTSSVYDHYDI-------LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK 149
           +P     S  YD +++         ++G G +G V+    +K     A K +     +E 
Sbjct: 241 KPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEV 299
Query: 150 ELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVI 209
           E   KE  +M ++ HP L+ L      +    +I EF++ G L + +     + +  EV 
Sbjct: 300 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR----ECNRQEVN 355
Query: 210 PVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVV 269
            V L  + TQ S A++++ +KN IH ++   N  C    +  VK+ DFGL ++L   +  
Sbjct: 356 AVVLLYMATQISSAMEYLEKKNFIHRNLAARN--CLVGENHLVKVADFGL-SRLMTGDTY 412
Query: 270 KISTGTA---EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
               G     ++ APE +        +D+WA GVL + + + G+SP+ G
Sbjct: 413 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 461

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 117/254 (46%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG+  A K +  P    +  +   +E+ ++  + 
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 132
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D +E+      T  +
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLARHTD-DEMAGF-VATRWY 188
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 249 KISSESARNYIQSL 262

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 116/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG+  A K +  P    +  +   +E+ ++  + 
Sbjct: 40  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 99
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 100 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 152
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D      ++  T  +
Sbjct: 153 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLARHTDDEMTGYVA--TRWY 208
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 268
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 269 KISSESARNYIQSL 282

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 108/217 (49%), Gaps = 16/217 (7%)
Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHD 172
           ++EIG+G FG+VH         + A K I      E++ I +E ++M +L HPKL+ L+ 
Sbjct: 12  VQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEEDFI-EEAEVMMKLSHPKLVQLYG 69
Query: 173 AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPV-TLPILMTQTSPAVKHMHEKN 231
              +   + L+FEF+  G L       DY  ++  +    TL  +       + ++ E +
Sbjct: 70  VCLEQAPICLVFEFMEHGCL------SDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAS 123
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT---AEFAAPEIVEREP 288
           +IH D+   N  C    +  +K+ DFG+ T+   ++    STGT    ++A+PE+     
Sbjct: 124 VIHRDLAARN--CLVGENQVIKVSDFGM-TRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 180
Query: 289 VGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
               +D+W+ GVL + + S G  P+   ++ E ++++
Sbjct: 181 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 217

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 116/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG+  A K +  P    +  +   +E+ ++  + 
Sbjct: 40  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 99
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 100 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV-----QFLIY 152
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D  + +     T  +
Sbjct: 153 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLARHTD--DEMXGXVATRWY 208
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 268
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 269 KISSESARNYIQSL 282

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 116/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG+  A K +  P    +  +   +E+ ++  + 
Sbjct: 39  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 98
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 99  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 151
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D      ++  T  +
Sbjct: 152 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLARHTDDEMTGYVA--TRWY 207
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 208 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 267
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 268 KISSESARNYIQSL 281

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 103/224 (45%), Gaps = 7/224 (3%)
Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMN 160
           T +V   Y  L+ IG+GA G+V    +   G   A K +  P  +    +   +E+ ++ 
Sbjct: 19  TFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLK 78
Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            ++H  +I+L + F     +    EF     + E + A   ++   E+    +  L+ Q 
Sbjct: 79  CVNHKNIISLLNVFTPQKTLE---EFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQM 135
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAA 280
              +KH+H   IIH D+KP NI+   ++   +K++DFGLA     N ++     T  + A
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIV--VKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRA 193
Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           PE++         D+W+VG +   L+ G   F G + ++    V
Sbjct: 194 PEVILGMGYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKV 237

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 71/235 (30%), Positives = 112/235 (47%), Gaps = 25/235 (10%)
Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP----VSHNLEKELIRKEIDI 158
           T  V D Y+I+E IG GA+GVV   R R TG   A K IP    V  N ++ L  +E+ I
Sbjct: 49  TFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTL--RELKI 106
Query: 159 MNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLP---I 215
           +    H  +I + D        V   EF S   + + + +  +++  +   P+TL     
Sbjct: 107 LKHFKHDNIIAIKDILRP---TVPYGEFKSVYVVLDLMESDLHQIIHSSQ-PLTLEHVRY 162
Query: 216 LMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--DPNEVVKIST 273
            + Q    +K+MH   +IH D+KP N++     +  +K+ DFG+A  L   P E     T
Sbjct: 163 FLYQLLRGLKYMHSAQVIHRDLKPSNLLVN--ENCELKIGDFGMARGLCTSPAEHQYFMT 220
Query: 274 ---GTAEFAAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETLK 322
               T  + APE++    +  YT   D+W+VG +   +L+    F G+N V  L+
Sbjct: 221 EYVATRWYRAPELMLS--LHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQ 273

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 116/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG+  A K +  P    +  +   +E+ ++  + 
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 132
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D      ++T    +
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLARHTDDEMTGYVATRW--Y 188
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 249 KISSESARNYIQSL 262

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 99/221 (44%), Gaps = 23/221 (10%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR-KEIDIMNQLHHPKLI 168
           Y  L+++G G +  V++ + + T N+ A K I + H         +E+ ++  L H  ++
Sbjct: 4   YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 63
Query: 169 NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPV-TLPILMTQTSPAVKHM 227
            LHD    +  + L+FE+L             Y      +I +  + + + Q    + + 
Sbjct: 64  TLHDIIHTEKSLTLVFEYLDKD-------LKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA------TKLDPNEVVKISTGTAEFAAP 281
           H + ++H D+KP+N++   R    +K+ DFGLA      TK   NEVV     T  +  P
Sbjct: 117 HRQKVLHRDLKPQNLLINERG--ELKLADFGLARAKSIPTKTYDNEVV-----TLWYRPP 169
Query: 282 EI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETL 321
           +I +         DMW VG + Y + +G   F G    E L
Sbjct: 170 DILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQL 210

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 116/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG+  A K +  P    +  +   +E+ ++  + 
Sbjct: 26  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 85
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 86  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 138
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D      ++T    +
Sbjct: 139 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLARHTDDEMTGYVATRW--Y 194
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 254
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 255 KISSESARNYIQSL 268

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 116/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG+  A K +  P    +  +   +E+ ++  + 
Sbjct: 30  VPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 89
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 90  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 142
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D      ++T    +
Sbjct: 143 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLARHTDDEMTGYVATRW--Y 198
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 199 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 258
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 259 KISSESARNYIQSL 272

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 46/201 (22%), Positives = 100/201 (49%), Gaps = 11/201 (5%)
Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELI-RKEIDIMNQLHHPKLINLH 171
           LE IG G+FG V +  + +T  + A K I +    ++    ++EI +++Q     +   +
Sbjct: 28  LERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYY 87
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
            ++    ++ +I E+L GG   + + A  +   +       +  ++ +    + ++H + 
Sbjct: 88  GSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQ-------IATMLKEILKGLDYLHSEK 140
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS-TGTAEFAAPEIVEREPVG 290
            IH D+K  N++   +   +VK+ DFG+A +L   ++ + +  GT  + APE++++    
Sbjct: 141 KIHRDIKAANVLLSEQG--DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYD 198
Query: 291 FYTDMWAVGVLAYVLLSGLSP 311
              D+W++G+ A  L  G  P
Sbjct: 199 SKADIWSLGITAIELAKGEPP 219

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR-KEIDIMNQLHHPKLINLHDAF 174
           +G G+FG VHR ++++TG   A K + +      E+ R +E+     L  P+++ L+ A 
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRL------EVFRVEELVACAGLSSPRIVPLYGAV 119
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI-LMTQTSPAVKHMHEKNII 233
            +   + +  E L GG L + I        +   +P    +  + Q    ++++H + I+
Sbjct: 120 REGPWVNIFMELLEGGSLGQLI-------KQMGCLPEDRALYYLGQALEGLEYLHTRRIL 172
Query: 234 HLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVK------ISTGTAEFAAPEIVERE 287
           H DVK +N++  + + +   + DFG A  L P+ + K         GT    APE+V  +
Sbjct: 173 HGDVKADNVLLSS-DGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 288 PVGFYTDMWAVGVLAYVLLSGLSPF 312
           P     D+W+   +   +L+G  P+
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGCHPW 256

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 111/242 (45%), Gaps = 21/242 (8%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE------LIRKEIDIMNQ 161
           + Y  LE+IG G +GVV++  +   G  FA K I     LEKE         +EI I+ +
Sbjct: 2   EKYHGLEKIGEGTYGVVYKA-QNNYGETFALKKI----RLEKEDEGIPSTTIREISILKE 56
Query: 162 LHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTS 221
           L H  ++ L+D       +VL+FE L      ++       + E  +  VT    + Q  
Sbjct: 57  LKHSNIVKLYDVIHTKKRLVLVFEHL------DQDLKKLLDVCEGGLESVTAKSFLLQLL 110
Query: 222 PAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEFAA 280
             + + H++ ++H D+KP+N++        +K+ DFGLA     P         T  + A
Sbjct: 111 NGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKYTHEVVTLWYRA 168
Query: 281 PEIV-EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNV 339
           P+++   +      D+W+VG +   +++G   F G ++ + L  +       + + + NV
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228
Query: 340 SE 341
           +E
Sbjct: 229 TE 230

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 71/235 (30%), Positives = 112/235 (47%), Gaps = 25/235 (10%)
Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP----VSHNLEKELIRKEIDI 158
           T  V D Y+I+E IG GA+GVV   R R TG   A K IP    V  N ++ L  +E+ I
Sbjct: 50  TFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTL--RELKI 107
Query: 159 MNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLP---I 215
           +    H  +I + D        V   EF S   + + + +  +++  +   P+TL     
Sbjct: 108 LKHFKHDNIIAIKDILR---PTVPYGEFKSVYVVLDLMESDLHQIIHSSQ-PLTLEHVRY 163
Query: 216 LMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--DPNEVVKIST 273
            + Q    +K+MH   +IH D+KP N++     +  +K+ DFG+A  L   P E     T
Sbjct: 164 FLYQLLRGLKYMHSAQVIHRDLKPSNLL--VNENCELKIGDFGMARGLCTSPAEHQYFMT 221
Query: 274 ---GTAEFAAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETLK 322
               T  + APE++    +  YT   D+W+VG +   +L+    F G+N V  L+
Sbjct: 222 EYVATRWYRAPELMLS--LHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQ 274

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 111/242 (45%), Gaps = 21/242 (8%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE------LIRKEIDIMNQ 161
           + Y  LE+IG G +GVV++  +   G  FA K I     LEKE         +EI I+ +
Sbjct: 2   EKYHGLEKIGEGTYGVVYKA-QNNYGETFALKKI----RLEKEDEGIPSTTIREISILKE 56
Query: 162 LHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTS 221
           L H  ++ L+D       +VL+FE L      ++       + E  +  VT    + Q  
Sbjct: 57  LKHSNIVKLYDVIHTKKRLVLVFEHL------DQDLKKLLDVCEGGLESVTAKSFLLQLL 110
Query: 222 PAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEFAA 280
             + + H++ ++H D+KP+N++        +K+ DFGLA     P         T  + A
Sbjct: 111 NGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKYTHEVVTLWYRA 168
Query: 281 PEIV-EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNV 339
           P+++   +      D+W+VG +   +++G   F G ++ + L  +       + + + NV
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228
Query: 340 SE 341
           +E
Sbjct: 229 TE 230

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 107/217 (49%), Gaps = 16/217 (7%)
Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHD 172
           ++EIG+G FG+VH         + A K I      E++ I +E ++M +L HPKL+ L+ 
Sbjct: 15  VQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEEDFI-EEAEVMMKLSHPKLVQLYG 72
Query: 173 AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPV-TLPILMTQTSPAVKHMHEKN 231
              +   + L+FEF+  G L       DY  ++  +    TL  +       + ++ E  
Sbjct: 73  VCLEQAPICLVFEFMEHGCL------SDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 126
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT---AEFAAPEIVEREP 288
           +IH D+   N  C    +  +K+ DFG+ T+   ++    STGT    ++A+PE+     
Sbjct: 127 VIHRDLAARN--CLVGENQVIKVSDFGM-TRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 183
Query: 289 VGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
               +D+W+ GVL + + S G  P+   ++ E ++++
Sbjct: 184 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 220

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 12/204 (5%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G +G V+    +K     A K +     +E E   KE  +M ++ HP L+ L    
Sbjct: 39  KLGGGQYGEVYVGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 97
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
             +    ++ E++  G L + +     + +  EV  V L  + TQ S A++++ +KN IH
Sbjct: 98  TLEPPFYIVTEYMPYGNLLDYLR----ECNREEVTAVVLLYMATQISSAMEYLEKKNFIH 153
Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA---EFAAPEIVEREPVGF 291
            D+   N  C    +  VK+ DFGL ++L   +      G     ++ APE +       
Sbjct: 154 RDLAARN--CLVGENHVVKVADFGL-SRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSI 210
Query: 292 YTDMWAVGVLAYVLLS-GLSPFAG 314
            +D+WA GVL + + + G+SP+ G
Sbjct: 211 KSDVWAFGVLLWEIATYGMSPYPG 234

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR-KEIDIMNQLHHPKLINLHDAF 174
           +G G+FG VHR ++++TG   A K + +      E+ R +E+     L  P+++ L+ A 
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRL------EVFRVEELVACAGLSSPRIVPLYGAV 133
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI-LMTQTSPAVKHMHEKNII 233
            +   + +  E L GG L + I        +   +P    +  + Q    ++++H + I+
Sbjct: 134 REGPWVNIFMELLEGGSLGQLI-------KQMGCLPEDRALYYLGQALEGLEYLHTRRIL 186
Query: 234 HLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVK------ISTGTAEFAAPEIVERE 287
           H DVK +N++  + + +   + DFG A  L P+ + K         GT    APE+V  +
Sbjct: 187 HGDVKADNVLLSS-DGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 245
Query: 288 PVGFYTDMWAVGVLAYVLLSGLSPF 312
           P     D+W+   +   +L+G  P+
Sbjct: 246 PCDAKVDIWSSCCMMLHMLNGCHPW 270

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 107/217 (49%), Gaps = 16/217 (7%)
Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHD 172
           ++EIG+G FG+VH         + A K I      E++ I +E ++M +L HPKL+ L+ 
Sbjct: 12  VQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEEDFI-EEAEVMMKLSHPKLVQLYG 69
Query: 173 AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPV-TLPILMTQTSPAVKHMHEKN 231
              +   + L+FEF+  G L       DY  ++  +    TL  +       + ++ E  
Sbjct: 70  VCLEQAPICLVFEFMEHGCL------SDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 123
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT---AEFAAPEIVEREP 288
           +IH D+   N  C    +  +K+ DFG+ T+   ++    STGT    ++A+PE+     
Sbjct: 124 VIHRDLAARN--CLVGENQVIKVSDFGM-TRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 180
Query: 289 VGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
               +D+W+ GVL + + S G  P+   ++ E ++++
Sbjct: 181 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 217

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 116/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 22  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 81
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 82  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 134
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+       + +K++DFGLA   D      ++T    +
Sbjct: 135 QILRGLKYIHSADIIHRDLKPSNLAVN--EDSELKILDFGLARHTDDEMTGYVATRW--Y 190
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 250
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 251 KISSESARNYIQSL 264

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 132
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D      ++T    +
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLARHTDDEMTGXVATRW--Y 188
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 249 KISSESARNYIQSL 262

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 107/217 (49%), Gaps = 16/217 (7%)
Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHD 172
           ++EIG+G FG+VH         + A K I      E++ I +E ++M +L HPKL+ L+ 
Sbjct: 10  VQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEEDFI-EEAEVMMKLSHPKLVQLYG 67
Query: 173 AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPV-TLPILMTQTSPAVKHMHEKN 231
              +   + L+FEF+  G L       DY  ++  +    TL  +       + ++ E  
Sbjct: 68  VCLEQAPICLVFEFMEHGCL------SDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT---AEFAAPEIVEREP 288
           +IH D+   N  C    +  +K+ DFG+ T+   ++    STGT    ++A+PE+     
Sbjct: 122 VIHRDLAARN--CLVGENQVIKVSDFGM-TRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 289 VGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
               +D+W+ GVL + + S G  P+   ++ E ++++
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 215

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 111/242 (45%), Gaps = 21/242 (8%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE------LIRKEIDIMNQ 161
           + Y  LE+IG G +GVV++  +   G  FA K I     LEKE         +EI I+ +
Sbjct: 2   EKYHGLEKIGEGTYGVVYKA-QNNYGETFALKKI----RLEKEDEGIPSTTIREISILKE 56
Query: 162 LHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTS 221
           L H  ++ L+D       +VL+FE L      ++       + E  +  VT    + Q  
Sbjct: 57  LKHSNIVKLYDVIHTKKRLVLVFEHL------DQDLKKLLDVCEGGLESVTAKSFLLQLL 110
Query: 222 PAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEFAA 280
             + + H++ ++H D+KP+N++        +K+ DFGLA     P         T  + A
Sbjct: 111 NGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKYTHEIVTLWYRA 168
Query: 281 PEIV-EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNV 339
           P+++   +      D+W+VG +   +++G   F G ++ + L  +       + + + NV
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228
Query: 340 SE 341
           +E
Sbjct: 229 TE 230

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR-KEIDIMNQLHHPKLINLHDAF 174
           +G G+FG VHR ++++TG   A K + +      E+ R +E+     L  P+++ L+ A 
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRL------EVFRVEELVACAGLSSPRIVPLYGAV 135
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI-LMTQTSPAVKHMHEKNII 233
            +   + +  E L GG L + I        +   +P    +  + Q    ++++H + I+
Sbjct: 136 REGPWVNIFMELLEGGSLGQLI-------KQMGCLPEDRALYYLGQALEGLEYLHTRRIL 188
Query: 234 HLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVK------ISTGTAEFAAPEIVERE 287
           H DVK +N++  + + +   + DFG A  L P+ + K         GT    APE+V  +
Sbjct: 189 HGDVKADNVLLSS-DGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 247
Query: 288 PVGFYTDMWAVGVLAYVLLSGLSPF 312
           P     D+W+   +   +L+G  P+
Sbjct: 248 PCDAKVDIWSSCCMMLHMLNGCHPW 272

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 18  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 77
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 78  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 130
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D      ++  T  +
Sbjct: 131 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLARHTDDEMTGYVA--TRWY 186
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 187 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 246
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 247 KISSESARNYIQSL 260

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 116/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 26  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 85
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 86  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 138
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+       + +K++DFGLA   D      ++T    +
Sbjct: 139 QILRGLKYIHSADIIHRDLKPSNLAVN--EDSELKILDFGLARHTDDEMTGYVATRW--Y 194
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 254
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 255 KISSESARNYIQSL 268

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 104/230 (45%), Gaps = 27/230 (11%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR--KEIDIMNQL---HH 164
           Y+ + EIG GA+G V++ R+  +G+  A K + V +  E   I   +E+ ++ +L    H
Sbjct: 6   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEH 65
Query: 165 PKLINLHDAF-----EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI---- 215
           P ++ L D       + + ++ L+FE +            D +    +  P  LP     
Sbjct: 66  PNVVRLMDVCATSRTDREIKVTLVFEHVDQ----------DLRTYLDKAPPPGLPAETIK 115
Query: 216 -LMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTG 274
            LM Q    +  +H   I+H D+KPENI+  +  +  VK+ DFGLA        +     
Sbjct: 116 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT--VKLADFGLARIYSYQMALAPVVV 173
Query: 275 TAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           T  + APE++ +       DMW+VG +   +      F G ++ + L  +
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 223

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 17  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 76
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 77  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 129
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D      ++  T  +
Sbjct: 130 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLARHTDDEMTGYVA--TRWY 185
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 186 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 245
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 246 KISSESARNYIQSL 259

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 132
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D      ++T    +
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLARHTDDEMTGYVATRW--Y 188
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 189 RAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 249 KISSESARNYIQSL 262

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 91/194 (46%), Gaps = 12/194 (6%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQ---LHHPK 166
           +  L  +G G++G V + R ++ G ++A K         K+  RK  ++ +      HP 
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKH 226
            + L  A+E+   + L  E L G  L +   A    + EA+V       L+     A+ H
Sbjct: 119 CVRLEQAWEEGGILYLQTE-LCGPSLQQHCEAWGASLPEAQVWGYLRDTLL-----ALAH 172
Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVER 286
           +H + ++HLDVKP NI    R     K+ DFGL  +L      ++  G   + APE+++ 
Sbjct: 173 LHSQGLVHLDVKPANIFLGPRG--RCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG 230
Query: 287 EPVGFYTDMWAVGV 300
              G   D++++G+
Sbjct: 231 S-YGTAADVFSLGL 243

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 132
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D      ++T    +
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLARHTDDEMTGYVATRW--Y 188
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 249 KISSESARNYIQSL 262

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 115/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  IG+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 25  VPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 84
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 85  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 137
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D      ++T    +
Sbjct: 138 QILRGLKYIHSADIIHRDLKPSNLAVN--EDXELKILDFGLARHTDDEMTGYVATRW--Y 193
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 253
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 254 KISSESARNYIQSL 267

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 17  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 76
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 77  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 129
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D      ++  T  +
Sbjct: 130 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLARHTDDEMTGYVA--TRWY 185
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 186 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 245
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 246 KISSESARNYIQSL 259

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 32  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMK 91
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 92  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 144
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D      ++  T  +
Sbjct: 145 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLARHTDDEMTGYVA--TRWY 200
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 201 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 260
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 261 KISSESARNYIQSL 274

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 100/221 (45%), Gaps = 6/221 (2%)
Query: 105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV-SHNLEKELIRKEIDIMNQLH 163
           S    +  LE++G G +  V++   + TG   A K + + S         +EI +M +L 
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 164 HPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPA 223
           H  ++ L+D    ++++ L+FEF+   +L + + +     +   +    +     Q    
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 224 VKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEFAAPE 282
           +   HE  I+H D+KP+N++   R    +K+ DFGLA     P         T  + AP+
Sbjct: 121 LAFCHENKILHRDLKPQNLLINKRGQ--LKLGDFGLARAFGIPVNTFSSEVVTLWYRAPD 178
Query: 283 IV-EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLK 322
           ++          D+W+ G +   +++G   F G ND E LK
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLK 219

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 16  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 75
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 128
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D      ++  T  +
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLARHTDDEMTGYVA--TRWY 184
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 245 KISSESARNYIQSL 258

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 32  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 91
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 92  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 144
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D      ++T    +
Sbjct: 145 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLARHTDDEMTGYVATRW--Y 200
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 201 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 260
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 261 KISSESARNYIQSL 274

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 132
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D      ++T    +
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLARHTDDEMTGYVATRW--Y 188
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 249 KISSESARNYIQSL 262

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 104/230 (45%), Gaps = 27/230 (11%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR--KEIDIMNQL---HH 164
           Y+ + EIG GA+G V++ R+  +G+  A K + V +  E   I   +E+ ++ +L    H
Sbjct: 6   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEH 65
Query: 165 PKLINLHDAF-----EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI---- 215
           P ++ L D       + + ++ L+FE +            D +    +  P  LP     
Sbjct: 66  PNVVRLMDVCATSRTDREIKVTLVFEHVDQ----------DLRTYLDKAPPPGLPAETIK 115
Query: 216 -LMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTG 274
            LM Q    +  +H   I+H D+KPENI+  +  +  VK+ DFGLA        +     
Sbjct: 116 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT--VKLADFGLARIYSYQMALDPVVV 173
Query: 275 TAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           T  + APE++ +       DMW+VG +   +      F G ++ + L  +
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 223

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 32  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 91
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 92  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 144
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D      ++T    +
Sbjct: 145 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLARHTDDEMTGYVATRW--Y 200
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 201 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 260
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 261 KISSESARNYIQSL 274

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 22  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 81
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 82  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 134
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D      ++T    +
Sbjct: 135 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLARHTDDEMTGYVATRW--Y 190
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 250
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 251 KISSESARNYIQSL 264

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 31  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 90
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 91  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 143
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D      ++T    +
Sbjct: 144 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLARHTDDEMTGYVATRW--Y 199
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 200 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 259
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 260 KISSESARNYIQSL 273

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 39  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 98
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 99  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 151
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D      ++  T  +
Sbjct: 152 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLARHTDDEMTGYVA--TRWY 207
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 208 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 267
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 268 KISSESARNYIQSL 281

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 43  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 102
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 103 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 155
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D      ++  T  +
Sbjct: 156 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLARHTDDEMTGYVA--TRWY 211
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 212 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 271
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 272 KISSESARNYIQSL 285

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 22  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 81
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 82  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 134
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D      ++T    +
Sbjct: 135 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLARHTDDEMTGYVATRW--Y 190
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 250
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 251 KISSESARNYIQSL 264

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 113/223 (50%), Gaps = 21/223 (9%)
Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK-ELIRKEIDIMNQLHH-PKLINL 170
           L E+G+G  G V + R RKTG++ A K +  S N E+ + I  ++D++ + H  P ++  
Sbjct: 30  LGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQC 89
Query: 171 HDAFEDDDEMVLIFEFLS--GGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH 228
              F  + ++ +  E +     +L +R+  P   + E  +  +T+ I+      A+ ++ 
Sbjct: 90  FGTFITNTDVFIAMELMGTCAEKLKKRMQGP---IPERILGKMTVAIVK-----ALYYLK 141
Query: 229 EKN-IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE-- 285
           EK+ +IH DVKP NI+   R    +K+ DFG++ +L  ++    S G A + APE ++  
Sbjct: 142 EKHGVIHRDVKPSNILLDERG--QIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPP 199
Query: 286 ---REPVGFYTDMWAVGVLAYVLLSGLSPFAG-ENDVETLKNV 324
              +       D+W++G+    L +G  P+   + D E L  V
Sbjct: 200 DPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV 242

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 25  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 84
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 85  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 137
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D      ++T    +
Sbjct: 138 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLARHTDDEMTGYVATRW--Y 193
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 253
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 254 KISSESARNYIQSL 267

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 19  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 78
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 79  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 131
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D      ++T    +
Sbjct: 132 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLARHTDDEMTGYVATRW--Y 187
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 188 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 247
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 248 KISSESARNYIQSL 261

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 22  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 81
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 82  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 134
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D      ++T    +
Sbjct: 135 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLARHTDDEMTGYVATRW--Y 190
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 250
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 251 KISSESARNYIQSL 264

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 25  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 84
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 85  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 137
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D      ++T    +
Sbjct: 138 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLARHTDDEMTGYVATRW--Y 193
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 253
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 254 KISSESARNYIQSL 267

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 40  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 99
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 100 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 152
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D      ++  T  +
Sbjct: 153 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLARHTDDEMTGYVA--TRWY 208
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 268
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 269 KISSESARNYIQSL 282

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 27  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 86
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 139
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D      ++T    +
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLARHTDDEMTGYVATRW--Y 195
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 256 KISSESARNYIQSL 269

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 106/217 (48%), Gaps = 16/217 (7%)
Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHD 172
           ++EIG+G FG+VH         + A K I      E + I +E ++M +L HPKL+ L+ 
Sbjct: 32  VQEIGSGQFGLVHLGYWLNKDKV-AIKTIKEGSMSEDDFI-EEAEVMMKLSHPKLVQLYG 89
Query: 173 AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPV-TLPILMTQTSPAVKHMHEKN 231
              +   + L+FEF+  G L       DY  ++  +    TL  +       + ++ E  
Sbjct: 90  VCLEQAPICLVFEFMEHGCL------SDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 143
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT---AEFAAPEIVEREP 288
           +IH D+   N  C    +  +K+ DFG+ T+   ++    STGT    ++A+PE+     
Sbjct: 144 VIHRDLAARN--CLVGENQVIKVSDFGM-TRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 200
Query: 289 VGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
               +D+W+ GVL + + S G  P+   ++ E ++++
Sbjct: 201 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 237

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 132
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D      ++T    +
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLARHTDDEMTGYVATRW--Y 188
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 249 KISSESARNYIQSL 262

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 132
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D      ++T    +
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLARHTDDEMTGYVATRW--Y 188
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 249 KISSESARNYIQSL 262

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 26  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 85
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 86  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 138
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D      ++T    +
Sbjct: 139 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLARHTDDEMTGYVATRW--Y 194
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 254
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 255 KISSESARNYIQSL 268

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 31  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 90
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 91  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 143
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D      ++  T  +
Sbjct: 144 QILRGLKYIHSADIIHRDLKPSNLAVN--EDXELKILDFGLARHTDDEMTGYVA--TRWY 199
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 200 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 259
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 260 KISSESARNYIQSL 273

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 43  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 102
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 103 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 155
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D  + +     T  +
Sbjct: 156 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLARHTD--DEMXGYVATRWY 211
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 212 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 271
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 272 KISSESARNYIQSL 285

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 132
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D      ++T    +
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLARHTDDEMTGYVATRW--Y 188
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 249 KISSESARNYIQSL 262

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 25  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 84
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 85  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 137
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D      ++T    +
Sbjct: 138 QILRGLKYIHSADIIHRDLKPSNLAVN--EDXELKILDFGLARHTDDEMTGYVATRW--Y 193
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 253
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 254 KISSESARNYIQSL 267

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 132
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D      ++T    +
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLARHTDDEMTGYVATRW--Y 188
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 249 KISSESARNYIQSL 262

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 132
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D      ++T    +
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLARHTDDEMTGYVATRW--Y 188
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 249 KISSESARNYIQSL 262

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 26  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 85
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 86  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 138
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D      ++T    +
Sbjct: 139 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLARHTDDEMTGYVATRW--Y 194
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 254
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 255 KISSESARNYIQSL 268

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 21/220 (9%)
Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS---HNLEKELIRKEIDIMNQLHHPKLIN 169
           L EIG G+FG V+  R+ +   + A K +  S    N + + I KE+  + +L HP  I 
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 170 LHDAFEDDDEMVLIFEFL--SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
               +  +    L+ E+   S  +L E    P   + E E+  VT   L       + ++
Sbjct: 80  YRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQ-----GLAYL 131
Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVERE 287
           H  N+IH DVK  NI+        VK+ DFG A+ + P        GT  + APE++   
Sbjct: 132 HSHNMIHRDVKAGNILLS--EPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAM 186
Query: 288 PVGFY---TDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
             G Y    D+W++G+    L     P    N +  L ++
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 104/230 (45%), Gaps = 27/230 (11%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR--KEIDIMNQL---HH 164
           Y+ + EIG GA+G V++ R+  +G+  A K + V +  E   I   +E+ ++ +L    H
Sbjct: 6   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEH 65
Query: 165 PKLINLHDAF-----EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI---- 215
           P ++ L D       + + ++ L+FE +            D +    +  P  LP     
Sbjct: 66  PNVVRLMDVCATSRTDREIKVTLVFEHVDQ----------DLRTYLDKAPPPGLPAETIK 115
Query: 216 -LMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTG 274
            LM Q    +  +H   I+H D+KPENI+  +  +  VK+ DFGLA        +     
Sbjct: 116 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT--VKLADFGLARIYSYQMALFPVVV 173
Query: 275 TAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           T  + APE++ +       DMW+VG +   +      F G ++ + L  +
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 223

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQ--KLTDDHV-----QFLIY 132
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D      ++T    +
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVN--EDCELKILDFGLARHTDDEMTGYVATRW--Y 188
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 249 KISSESARNYIQSL 262

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQ--KLTDDHV-----QFLIY 132
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D      ++T    +
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVN--EDXELKILDFGLARHTDDEMTGYVATRW--Y 188
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 249 KISSESARNYIQSL 262

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 116/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   + +   K+++  V       L+ 
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQ--KLTDDHV-----QFLIY 132
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+       + +K++DFGL    D      ++T    +
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNLAVN--EDSELKILDFGLCRHTDDEMTGYVATRW--Y 188
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 249 KISSESARNYIQSL 262

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 103/224 (45%), Gaps = 7/224 (3%)
Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMN 160
           T +V   Y  L+ IG+GA G+V    +   G   A K +  P  +    +   +E+ ++ 
Sbjct: 17  TFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLK 76
Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            ++H  +I+L + F     +    EF     + E + A   ++   E+    +  L+ Q 
Sbjct: 77  CVNHKNIISLLNVFTPQKTLE---EFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQM 133
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAA 280
              +KH+H   IIH D+KP NI+   ++   +K++DFGLA     N ++     T  + A
Sbjct: 134 LCGIKHLHSAGIIHRDLKPSNIV--VKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRA 191
Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           PE++         D+W+VG +   L+ G   F G + ++    V
Sbjct: 192 PEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKV 235

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 103/243 (42%), Gaps = 38/243 (15%)
Query: 104 SSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAK------------FIPVSHNLEKEL 151
           S     Y+ + EIG GA+G V++ R+  +G+  A K             +P+S   E  L
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 152 IRKEIDIMNQLHHPKLINLHDAF-----EDDDEMVLIFEFLSGGELFERITAPDYKMSEA 206
           +R+    +    HP ++ L D       + + ++ L+FE +            D +    
Sbjct: 65  LRR----LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ----------DLRTYLD 110
Query: 207 EVIPVTLPI-----LMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT 261
           +  P  LP      LM Q    +  +H   I+H D+KPENI+  +  +  VK+ DFGLA 
Sbjct: 111 KAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT--VKLADFGLAR 168
Query: 262 KLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETL 321
                  +     T  + APE++ +       DMW+VG +   +      F G ++ + L
Sbjct: 169 IYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL 228
Query: 322 KNV 324
             +
Sbjct: 229 GKI 231

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 21/220 (9%)
Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS---HNLEKELIRKEIDIMNQLHHPKLIN 169
           L EIG G+FG V+  R+ +   + A K +  S    N + + I KE+  + +L HP  I 
Sbjct: 59  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 118
Query: 170 LHDAFEDDDEMVLIFEFL--SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
               +  +    L+ E+   S  +L E    P   + E E+  VT   L       + ++
Sbjct: 119 YRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQ-----GLAYL 170
Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVERE 287
           H  N+IH DVK  NI+        VK+ DFG A+ + P        GT  + APE++   
Sbjct: 171 HSHNMIHRDVKAGNILLS--EPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAM 225
Query: 288 PVGFY---TDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
             G Y    D+W++G+    L     P    N +  L ++
Sbjct: 226 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 265

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 108/216 (50%), Gaps = 29/216 (13%)
Query: 114 EEIGTGAFGVVHRCRERKTGNIFAAK-FIPVSHNLEKELIRK------EIDIMNQLHHPK 166
           ++IG G FG+VH+ R  K  ++ A K  I      E E+I K      E+ IM+ L+HP 
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI-LMTQTSPAVK 225
           ++ L+    +   MV+  EF+  G+L+ R+      + +A  I  ++ + LM   +  ++
Sbjct: 85  IVKLYGLMHNPPRMVM--EFVPCGDLYHRL------LDKAHPIKWSVKLRLMLDIALGIE 136
Query: 226 HMHEKN--IIHLDVKPENIMCQTRNSTN---VKMIDFGLATKLDPNEVVKIS--TGTAEF 278
           +M  +N  I+H D++  NI  Q+ +       K+ DFGL+ +     V  +S   G  ++
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQW 192
Query: 279 AAPEIV--EREPVGFYTDMWAVGVLAYVLLSGLSPF 312
            APE +  E E      D ++  ++ Y +L+G  PF
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 117/253 (46%), Gaps = 26/253 (10%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAK--FIPVSHNLEKELIRKEIDIMNQLHHPKL 167
           Y  L+ +G+GA+G V    + +TG   A K  + P    L  +   +E+ ++  + H  +
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86
Query: 168 INLHDAFEDDDEM------VLIFEFLSG--GELFERITAPDYKMSEAEVIPVTLPILMTQ 219
           I L D F  D+ +       L+  F+    G+L +       K+ E  +       L+ Q
Sbjct: 87  IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-----EKLGEDRI-----QFLVYQ 136
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFA 279
               ++++H   IIH D+KP N+         +K++DFGLA + D      + T    + 
Sbjct: 137 MLKGLRYIHAAGIIHRDLKPGNLAVN--EDCELKILDFGLARQADSEMXGXVVT--RWYR 192
Query: 280 APEIVEREPVGFYT-DMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKN 338
           APE++        T D+W+VG +   +++G + F G + ++ LK +         E  + 
Sbjct: 193 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 252
Query: 339 V-SEEGKDFIRRL 350
           + S+E K++++ L
Sbjct: 253 LQSDEAKNYMKGL 265

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 115/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 132
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++D+GLA   D      ++T    +
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDYGLARHTDDEMTGYVATRW--Y 188
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 249 KISSESARNYIQSL 262

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 104/219 (47%), Gaps = 30/219 (13%)
Query: 113 LEEI-GTGAFGVVHRCRERKTGN---IFAAKFIP---VSHNLEKELIRKEIDIMNQLHHP 165
           LEEI G G FG V+R      G+   + AA+  P   +S  +E   +R+E  +   L HP
Sbjct: 11  LEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIEN--VRQEAKLFAMLKHP 66
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            +I L      +  + L+ EF  GG L       +  +S   + P  L     Q +  + 
Sbjct: 67  NIIALRGVCLKEPNLCLVMEFARGGPL-------NRVLSGKRIPPDILVNWAVQIARGMN 119
Query: 226 HMHEKNI---IHLDVKPENIMCQTR------NSTNVKMIDFGLATKLDPNEVVKIST-GT 275
           ++H++ I   IH D+K  NI+   +      ++  +K+ DFGLA +   +   K+S  G 
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMSAAGA 177
Query: 276 AEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAG 314
             + APE++        +D+W+ GVL + LL+G  PF G
Sbjct: 178 YAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG 216

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/239 (23%), Positives = 104/239 (43%), Gaps = 21/239 (8%)
Query: 99  VDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI---PVSHNLEKELIRKE 155
            D ++    D + +    G G FG V   +E+ TG   A K +   P   N E ++++  
Sbjct: 14  ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQD- 72
Query: 156 IDIMNQLHHPKLINLHDAF-------EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEV 208
              +  LHHP ++ L   F         D  + ++ E++   +   R    +Y   +   
Sbjct: 73  ---LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP--DTLHRCCR-NYYRRQVAP 126
Query: 209 IPVTLPILMTQT--SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN 266
            P+ + + + Q   S    H+   N+ H D+KP N++    + T +K+ DFG A KL P+
Sbjct: 127 PPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGT-LKLCDFGSAKKLSPS 185
Query: 267 EVVKISTGTAEFAAPEIV-EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           E       +  + APE++   +      D+W+VG +   ++ G   F G+N    L  +
Sbjct: 186 EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI 244

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 17/212 (8%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR----KEIDIMNQLHHPKLINLH 171
           IG G FG VH+       N   A  I    N   + +R    +E   M Q  HP ++ L 
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
                ++ + +I E  + GEL   +    Y +  A +I     +   Q S A+ ++  K 
Sbjct: 81  GVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLI-----LYAYQLSTALAYLESKR 134
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA--EFAAPEIVEREPV 289
            +H D+   N++  + +   VK+ DFGL+  ++ +   K S G    ++ APE +     
Sbjct: 135 FVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 192
Query: 290 GFYTDMWAVGVLAY-VLLSGLSPFAG--ENDV 318
              +D+W  GV  + +L+ G+ PF G   NDV
Sbjct: 193 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 224

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 19/227 (8%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + K+G   A K +  P    +  +   +E+ ++  + 
Sbjct: 49  VPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMK 108
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 109 HENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 161
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D      ++T    +
Sbjct: 162 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLARHTDDEMTGYVATRW--Y 217
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
            APEI +         D+W+VG +   LL+G + F G + +  L+ +
Sbjct: 218 RAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQI 264

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 17/212 (8%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR----KEIDIMNQLHHPKLINLH 171
           IG G FG VH+       N   A  I    N   + +R    +E   M Q  HP ++ L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
                ++ + +I E  + GEL   +    Y +  A +I     +   Q S A+ ++  K 
Sbjct: 78  GVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLI-----LYAYQLSTALAYLESKR 131
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA--EFAAPEIVEREPV 289
            +H D+   N++  + +   VK+ DFGL+  ++ +   K S G    ++ APE +     
Sbjct: 132 FVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 290 GFYTDMWAVGVLAY-VLLSGLSPFAG--ENDV 318
              +D+W  GV  + +L+ G+ PF G   NDV
Sbjct: 190 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 221

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 17/212 (8%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR----KEIDIMNQLHHPKLINLH 171
           IG G FG VH+       N   A  I    N   + +R    +E   M Q  HP ++ L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
                ++ + +I E  + GEL   +    Y +  A +I     +   Q S A+ ++  K 
Sbjct: 78  GVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLI-----LYAYQLSTALAYLESKR 131
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA--EFAAPEIVEREPV 289
            +H D+   N++  + +   VK+ DFGL+  ++ +   K S G    ++ APE +     
Sbjct: 132 FVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 290 GFYTDMWAVGVLAY-VLLSGLSPFAG--ENDV 318
              +D+W  GV  + +L+ G+ PF G   NDV
Sbjct: 190 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 221

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 17/212 (8%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR----KEIDIMNQLHHPKLINLH 171
           IG G FG VH+       N   A  I    N   + +R    +E   M Q  HP ++ L 
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
                ++ + +I E  + GEL   +    Y +  A +I     +   Q S A+ ++  K 
Sbjct: 106 GVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLI-----LYAYQLSTALAYLESKR 159
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA--EFAAPEIVEREPV 289
            +H D+   N++  + +   VK+ DFGL+  ++ +   K S G    ++ APE +     
Sbjct: 160 FVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 217
Query: 290 GFYTDMWAVGVLAY-VLLSGLSPFAG--ENDV 318
              +D+W  GV  + +L+ G+ PF G   NDV
Sbjct: 218 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 249

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 17/212 (8%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR----KEIDIMNQLHHPKLINLH 171
           IG G FG VH+       N   A  I    N   + +R    +E   M Q  HP ++ L 
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
                ++ + +I E  + GEL   +    Y +  A +I     +   Q S A+ ++  K 
Sbjct: 80  GVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLI-----LYAYQLSTALAYLESKR 133
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA--EFAAPEIVEREPV 289
            +H D+   N++  + +   VK+ DFGL+  ++ +   K S G    ++ APE +     
Sbjct: 134 FVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 191
Query: 290 GFYTDMWAVGVLAY-VLLSGLSPFAG--ENDV 318
              +D+W  GV  + +L+ G+ PF G   NDV
Sbjct: 192 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 223

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 115/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG+  A K +  P    +  +   +E+ ++  + 
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 132
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DF LA   D      ++T    +
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFYLARHTDDEMTGYVATRW--Y 188
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 249 KISSESARNYIQSL 262

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 17/212 (8%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR----KEIDIMNQLHHPKLINLH 171
           IG G FG VH+       N   A  I    N   + +R    +E   M Q  HP ++ L 
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
                ++ + +I E  + GEL   +    Y +  A +I     +   Q S A+ ++  K 
Sbjct: 75  GVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLI-----LYAYQLSTALAYLESKR 128
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA--EFAAPEIVEREPV 289
            +H D+   N++  + +   VK+ DFGL+  ++ +   K S G    ++ APE +     
Sbjct: 129 FVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 290 GFYTDMWAVGVLAY-VLLSGLSPFAG--ENDV 318
              +D+W  GV  + +L+ G+ PF G   NDV
Sbjct: 187 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 218

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 17/212 (8%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR----KEIDIMNQLHHPKLINLH 171
           IG G FG VH+       N   A  I    N   + +R    +E   M Q  HP ++ L 
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
                ++ + +I E  + GEL   +    Y +  A +I     +   Q S A+ ++  K 
Sbjct: 83  GVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLI-----LYAYQLSTALAYLESKR 136
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA--EFAAPEIVEREPV 289
            +H D+   N++  + +   VK+ DFGL+  ++ +   K S G    ++ APE +     
Sbjct: 137 FVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 290 GFYTDMWAVGVLAY-VLLSGLSPFAG--ENDV 318
              +D+W  GV  + +L+ G+ PF G   NDV
Sbjct: 195 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 226

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 116/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 27  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 86
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 139
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA +   +E+      T  +
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLA-RHTADEMTGY-VATRWY 195
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 256 KISSESARNYIQSL 269

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 116/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 27  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 86
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 139
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA +   +E+      T  +
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLA-RHTADEMTGY-VATRWY 195
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 256 KISSESARNYIQSL 269

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 116/254 (45%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 27  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 86
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 139
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA +   +E+      T  +
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDFGLA-RHTADEMTGY-VATRWY 195
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 256 KISSESARNYIQSL 269

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 28/211 (13%)
Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLH- 171
           +E IG+G FG V + + R  G  +  K   V +N EK    +E+  + +L H  +++ + 
Sbjct: 16  IELIGSGGFGQVFKAKHRIDGKTYVIK--RVKYNNEK--AEREVKALAKLDHVNIVHYNG 71
Query: 172 --DAFEDDDE-------------MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI- 215
             D F+ D E             + +  EF   G L + I     +    E +   L + 
Sbjct: 72  CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-----EKRRGEKLDKVLALE 126
Query: 216 LMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT 275
           L  Q +  V ++H K +I+ D+KP NI     ++  VK+ DFGL T L  +     S GT
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLV--DTKQVKIGDFGLVTSLKNDGKRXRSKGT 184
Query: 276 AEFAAPEIVEREPVGFYTDMWAVGVLAYVLL 306
             + +PE +  +  G   D++A+G++   LL
Sbjct: 185 LRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 106/217 (48%), Gaps = 16/217 (7%)
Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHD 172
           ++EIG+G FG+VH         + A K I      E++ I +E ++M +L HPKL+ L+ 
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEEDFI-EEAEVMMKLSHPKLVQLYG 70
Query: 173 AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPV-TLPILMTQTSPAVKHMHEKN 231
              +   + L+ EF+  G L       DY  ++  +    TL  +       + ++ E  
Sbjct: 71  VCLEQAPICLVTEFMEHGCL------SDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 124
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT---AEFAAPEIVEREP 288
           +IH D+   N  C    +  +K+ DFG+ T+   ++    STGT    ++A+PE+     
Sbjct: 125 VIHRDLAARN--CLVGENQVIKVSDFGM-TRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 181
Query: 289 VGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
               +D+W+ GVL + + S G  P+   ++ E ++++
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 114/254 (44%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 132
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++ FGLA   D      ++T    +
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILGFGLARHTDDEMTGYVATRW--Y 188
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 249 KISSESARNYIQSL 262

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 104/214 (48%), Gaps = 25/214 (11%)
Query: 114 EEIGTGAFGVVHRCRERKTGNIFAAK-FIPVSHNLEKELIRK------EIDIMNQLHHPK 166
           ++IG G FG+VH+ R  K  ++ A K  I      E E+I K      E+ IM+ L+HP 
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI-LMTQTSPAVK 225
           ++ L+    +   MV+  EF+  G+L+ R+      + +A  I  ++ + LM   +  ++
Sbjct: 85  IVKLYGLMHNPPRMVM--EFVPCGDLYHRL------LDKAHPIKWSVKLRLMLDIALGIE 136
Query: 226 HMHEKN--IIHLDVKPENIMCQTRNSTN---VKMIDFGLATKLDPNEVVKISTGTAEFAA 280
           +M  +N  I+H D++  NI  Q+ +       K+ DFG  T       V    G  ++ A
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG--TSQQSVHSVSGLLGNFQWMA 194
Query: 281 PEIV--EREPVGFYTDMWAVGVLAYVLLSGLSPF 312
           PE +  E E      D ++  ++ Y +L+G  PF
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 101/217 (46%), Gaps = 14/217 (6%)
Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLH 171
            L+E+GTG FGVV   + R   ++ A K I      E E I +E  +M  L H KL+ L+
Sbjct: 13  FLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFI-EEAKVMMNLSHEKLVQLY 70
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
                   + +I E+++ G L   +    ++    +++ +           A++++  K 
Sbjct: 71  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC-----KDVCEAMEYLESKQ 125
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT---AEFAAPEIVEREP 288
            +H D+   N  C   +   VK+ DFGL+  +  +E    S G+     ++ PE++    
Sbjct: 126 FLHRDLAARN--CLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMYSK 182
Query: 289 VGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
               +D+WA GVL + + S G  P+    + ET +++
Sbjct: 183 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 219

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 100/216 (46%), Gaps = 12/216 (5%)
Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLH 171
            L+E+GTG FGVV   + R   ++ A K I      E E I +E  +M  L H KL+ L+
Sbjct: 28  FLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFI-EEAKVMMNLSHEKLVQLY 85
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
                   + +I E+++ G L   +    ++    +++      +      A++++  K 
Sbjct: 86  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE-----MCKDVCEAMEYLESKQ 140
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATK-LDPNEVVKI-STGTAEFAAPEIVEREPV 289
            +H D+   N  C   +   VK+ DFGL+   LD  E   + S     ++ PE++     
Sbjct: 141 FLHRDLAARN--CLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKF 198
Query: 290 GFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
              +D+WA GVL + + S G  P+    + ET +++
Sbjct: 199 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 234

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 101/217 (46%), Gaps = 14/217 (6%)
Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLH 171
            L+E+GTG FGVV   + R   ++ A K I      E E I +E  +M  L H KL+ L+
Sbjct: 19  FLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFI-EEAKVMMNLSHEKLVQLY 76
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
                   + +I E+++ G L   +    ++    +++      +      A++++  K 
Sbjct: 77  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE-----MCKDVCEAMEYLESKQ 131
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT---AEFAAPEIVEREP 288
            +H D+   N  C   +   VK+ DFGL+  +  +E    S G+     ++ PE++    
Sbjct: 132 FLHRDLAARN--CLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMYSK 188
Query: 289 VGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
               +D+WA GVL + + S G  P+    + ET +++
Sbjct: 189 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 225

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 101/217 (46%), Gaps = 14/217 (6%)
Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLH 171
            L+E+GTG FGVV   + R   ++ A K I      E E I +E  +M  L H KL+ L+
Sbjct: 12  FLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFI-EEAKVMMNLSHEKLVQLY 69
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
                   + +I E+++ G L   +    ++    +++ +           A++++  K 
Sbjct: 70  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC-----KDVCEAMEYLESKQ 124
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT---AEFAAPEIVEREP 288
            +H D+   N  C   +   VK+ DFGL+  +  +E    S G+     ++ PE++    
Sbjct: 125 FLHRDLAARN--CLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMYSK 181
Query: 289 VGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
               +D+WA GVL + + S G  P+    + ET +++
Sbjct: 182 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 218

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 101/216 (46%), Gaps = 14/216 (6%)
Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHD 172
           L+E+GTG FGVV   + R   ++ A K I      E E I +E  +M  L H KL+ L+ 
Sbjct: 9   LKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFI-EEAKVMMNLSHEKLVQLYG 66
Query: 173 AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNI 232
                  + +I E+++ G L   +    ++    +++ +           A++++  K  
Sbjct: 67  VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC-----KDVCEAMEYLESKQF 121
Query: 233 IHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT---AEFAAPEIVEREPV 289
           +H D+   N  C   +   VK+ DFGL+  +  +E    S G+     ++ PE++     
Sbjct: 122 LHRDLAARN--CLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMYSKF 178
Query: 290 GFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
              +D+WA GVL + + S G  P+    + ET +++
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 214

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 114/254 (44%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 132
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++D GLA   D      ++T    +
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDAGLARHTDDEMTGYVATRW--Y 188
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 249 KISSESARNYIQSL 262

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 17/212 (8%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR----KEIDIMNQLHHPKLINLH 171
           IG G FG VH+       N   A  I    N   + +R    +E   M Q  HP ++ L 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
                ++ + +I E  + GEL   +    + +  A +I     +   Q S A+ ++  K 
Sbjct: 458 GVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLI-----LYAYQLSTALAYLESKR 511
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA--EFAAPEIVEREPV 289
            +H D+   N++  + +   VK+ DFGL+  ++ +   K S G    ++ APE +     
Sbjct: 512 FVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 290 GFYTDMWAVGVLAY-VLLSGLSPFAG--ENDV 318
              +D+W  GV  + +L+ G+ PF G   NDV
Sbjct: 570 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 601

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 114/254 (44%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 132
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++D GLA   D      ++T    +
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDRGLARHTDDEMTGYVATRW--Y 188
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 249 KISSESARNYIQSL 262

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 107/216 (49%), Gaps = 29/216 (13%)
Query: 114 EEIGTGAFGVVHRCRERKTGNIFAAK-FIPVSHNLEKELIRK------EIDIMNQLHHPK 166
           ++IG G FG+VH+ R  K  ++ A K  I      E E+I K      E+ IM+ L+HP 
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI-LMTQTSPAVK 225
           ++ L+    +   MV+  EF+  G+L+ R+      + +A  I  ++ + LM   +  ++
Sbjct: 85  IVKLYGLMHNPPRMVM--EFVPCGDLYHRL------LDKAHPIKWSVKLRLMLDIALGIE 136
Query: 226 HMHEKN--IIHLDVKPENIMCQTRNSTN---VKMIDFGLATKLDPNEVVKIS--TGTAEF 278
           +M  +N  I+H D++  NI  Q+ +       K+ DF L+ +     V  +S   G  ++
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQ----SVHSVSGLLGNFQW 192
Query: 279 AAPEIV--EREPVGFYTDMWAVGVLAYVLLSGLSPF 312
            APE +  E E      D ++  ++ Y +L+G  PF
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 101/217 (46%), Gaps = 14/217 (6%)
Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLH 171
            L+E+GTG FGVV   + R   ++ A K I      E E I +E  +M  L H KL+ L+
Sbjct: 13  FLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFI-EEAKVMMNLSHEKLVQLY 70
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
                   + +I E+++ G L   +    ++    +++ +           A++++  K 
Sbjct: 71  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC-----KDVCEAMEYLESKQ 125
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT---AEFAAPEIVEREP 288
            +H D+   N  C   +   VK+ DFGL+  +  +E    S G+     ++ PE++    
Sbjct: 126 FLHRDLAARN--CLVNDQGVVKVSDFGLSRYVLDDEYTS-SRGSKFPVRWSPPEVLMYSK 182
Query: 289 VGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
               +D+WA GVL + + S G  P+    + ET +++
Sbjct: 183 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 219

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 17/212 (8%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR----KEIDIMNQLHHPKLINLH 171
           IG G FG VH+       N   A  I    N   + +R    +E   M Q  HP ++ L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
                ++ + +I E  + GEL   +    + +  A +I     +   Q S A+ ++  K 
Sbjct: 78  GVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLI-----LYAYQLSTALAYLESKR 131
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA--EFAAPEIVEREPV 289
            +H D+   N++  + +   VK+ DFGL+  ++ +   K S G    ++ APE +     
Sbjct: 132 FVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRRF 189
Query: 290 GFYTDMWAVGVLAY-VLLSGLSPFAG--ENDV 318
              +D+W  GV  + +L+ G+ PF G   NDV
Sbjct: 190 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 221

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 101/217 (46%), Gaps = 14/217 (6%)
Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLH 171
            L+E+GTG FGVV   + R   ++ A K I      E E I +E  +M  L H KL+ L+
Sbjct: 28  FLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFI-EEAKVMMNLSHEKLVQLY 85
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
                   + +I E+++ G L   +    ++    +++      +      A++++  K 
Sbjct: 86  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE-----MCKDVCEAMEYLESKQ 140
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT---AEFAAPEIVEREP 288
            +H D+   N  C   +   VK+ DFGL+  +  +E    S G+     ++ PE++    
Sbjct: 141 FLHRDLAARN--CLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMYSK 197
Query: 289 VGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
               +D+WA GVL + + S G  P+    + ET +++
Sbjct: 198 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 234

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 114/254 (44%), Gaps = 20/254 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 20  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 79
Query: 164 HPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F     +     V +   L G +L   +     K+++  V       L+ 
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHV-----QFLIY 132
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++D GLA   D      ++T    +
Sbjct: 133 QILRGLKYIHSADIIHRDLKPSNL--AVNEDCELKILDGGLARHTDDEMTGYVATRW--Y 188
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
            APEI +         D+W+VG +   LL+G + F G + ++ LK +         E  K
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 338 NV-SEEGKDFIRRL 350
            + SE  +++I+ L
Sbjct: 249 KISSESARNYIQSL 262

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 7/224 (3%)
Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMN 160
           T +V   Y  L+ IG+GA G+V    +       A K +  P  +    +   +E+ +M 
Sbjct: 19  TFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            ++H  +I L + F     +    EF     + E + A   ++ + E+    +  L+ Q 
Sbjct: 79  VVNHKNIIGLLNVFTPQKSLE---EFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAA 280
              +KH+H   IIH D+KP NI+   ++   +K++DFGLA     + ++     T  + A
Sbjct: 136 LVGIKHLHSAGIIHRDLKPSNIVV--KSDATLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           PE++         D+W+VGV+   ++ G   F G + ++    V
Sbjct: 194 PEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKV 237

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 17/212 (8%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR----KEIDIMNQLHHPKLINLH 171
           IG G FG VH+       N   A  I    N   + +R    +E   M Q  HP ++ L 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
                ++ + +I E  + GEL   +    + +  A +I     +   Q S A+ ++  K 
Sbjct: 458 GVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLI-----LYAYQLSTALAYLESKR 511
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA--EFAAPEIVEREPV 289
            +H D+   N++    +   VK+ DFGL+  ++ +   K S G    ++ APE +     
Sbjct: 512 FVHRDIAARNVLVSATDC--VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 290 GFYTDMWAVGVLAY-VLLSGLSPFAG--ENDV 318
              +D+W  GV  + +L+ G+ PF G   NDV
Sbjct: 570 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 601

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 102/224 (45%), Gaps = 7/224 (3%)
Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMN 160
           T +V   Y  L+ IG+GA G+V    +       A K +  P  +    +   +E+ +M 
Sbjct: 19  TFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            ++H  +I L + F     +    EF     + E + A   ++ + E+    +  L+ Q 
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLE---EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAA 280
              +KH+H   IIH D+KP NI+   ++   +K++DFGLA     + ++     T  + A
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIV--VKSDCTLKILDFGLARTAGTSFMMTPEVVTRYYRA 193
Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           PE++         D+W+VG +   ++ G   F G + ++    V
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 102/224 (45%), Gaps = 7/224 (3%)
Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMN 160
           T +V   Y  L+ IG+GA G+V    +       A K +  P  +    +   +E+ +M 
Sbjct: 19  TFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            ++H  +I L + F     +    EF     + E + A   ++ + E+    +  L+ Q 
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLE---EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAA 280
              +KH+H   IIH D+KP NI+   ++   +K++DFGLA     + ++     T  + A
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIV--VKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           PE++         D+W+VG +   ++ G   F G + ++    V
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 96/205 (46%), Gaps = 22/205 (10%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR-KEIDIMNQLHHPKLINLHDAF 174
           +G G+FG VHR  +++TG   A K + +      E+ R +E+     L  P+++ L+ A 
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVRL------EVFRAEELMACAGLTSPRIVPLYGAV 135
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI-LMTQTSPAVKHMHEKNII 233
            +   + +  E L GG L + +        E   +P    +  + Q    ++++H + I+
Sbjct: 136 REGPWVNIFMELLEGGSLGQLV-------KEQGCLPEDRALYYLGQALEGLEYLHSRRIL 188
Query: 234 HLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVK------ISTGTAEFAAPEIVERE 287
           H DVK +N++  + + ++  + DFG A  L P+ + K         GT    APE+V   
Sbjct: 189 HGDVKADNVLLSS-DGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGR 247
Query: 288 PVGFYTDMWAVGVLAYVLLSGLSPF 312
                 D+W+   +   +L+G  P+
Sbjct: 248 SCDAKVDVWSSCCMMLHMLNGCHPW 272

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 118/251 (47%), Gaps = 46/251 (18%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAK--FIPVSHNLEKELIRKEIDIMNQLH 163
           V   Y++++++G GA+G+V +  +R+TG + A K  F    ++ + +   +EI I+ +L 
Sbjct: 7   VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELS 66
Query: 164 -HPKLINLHDAF--EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            H  ++NL +    ++D ++ L+F+++   +L   I A   +       PV    ++ Q 
Sbjct: 67  GHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRANILE-------PVHKQYVVYQL 118
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL----------------- 263
              +K++H   ++H D+KP NI+       +VK+ DFGL+                    
Sbjct: 119 IKVIKYLHSGGLLHRDMKPSNILLNA--ECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 264 -----DPNEVVKISTGTAEFAAPEIVEREPVGF--YT---DMWAVGVLAYVLLSGLSPFA 313
                D   ++     T  + APEI+    +G   YT   DMW++G +   +L G   F 
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEIL----LGSTKYTKGIDMWSLGCILGEILCGKPIFP 232
Query: 314 GENDVETLKNV 324
           G + +  L+ +
Sbjct: 233 GSSTMNQLERI 243

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 102/216 (47%), Gaps = 17/216 (7%)
Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLH 171
           +++ +G G FG V       +  +      P + +++  L  +E ++M  L H KL+ L+
Sbjct: 17  LVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFL--EEANLMKTLQHDKLVRLY 74
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM---TQTSPAVKHMH 228
                ++ + +I E+++ G L       D+  S+ E   V LP L+    Q +  + ++ 
Sbjct: 75  AVVTREEPIYIITEYMAKGSLL------DFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIE 127
Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT--AEFAAPEIVER 286
            KN IH D++  N++     S   K+ DFGLA  ++ NE           ++ APE +  
Sbjct: 128 RKNYIHRDLRAANVL--VSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF 185
Query: 287 EPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETL 321
                 +D+W+ G+L Y +++ G  P+ G  + + +
Sbjct: 186 GCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVM 221

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 96/205 (46%), Gaps = 22/205 (10%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR-KEIDIMNQLHHPKLINLHDAF 174
           +G G+FG VHR  +++TG   A K + +      E+ R +E+     L  P+++ L+ A 
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVRL------EVFRAEELMACAGLTSPRIVPLYGAV 154
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI-LMTQTSPAVKHMHEKNII 233
            +   + +  E L GG L + +        E   +P    +  + Q    ++++H + I+
Sbjct: 155 REGPWVNIFMELLEGGSLGQLV-------KEQGCLPEDRALYYLGQALEGLEYLHSRRIL 207
Query: 234 HLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVK------ISTGTAEFAAPEIVERE 287
           H DVK +N++  + + ++  + DFG A  L P+ + K         GT    APE+V   
Sbjct: 208 HGDVKADNVLLSS-DGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGR 266
Query: 288 PVGFYTDMWAVGVLAYVLLSGLSPF 312
                 D+W+   +   +L+G  P+
Sbjct: 267 SCDAKVDVWSSCCMMLHMLNGCHPW 291

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 7/224 (3%)
Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMN 160
           T +V   Y  L+ IG+GA G+V    +       A K +  P  +    +   +E+ +M 
Sbjct: 19  TFTVLKRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            ++H  +I L + F     +    EF     + E + A   ++ + E+    +  L+ Q 
Sbjct: 79  VVNHKNIIGLLNVFTPQKSLE---EFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAA 280
              +KH+H   IIH D+KP NI+   ++   +K++DFGLA     + ++     T  + A
Sbjct: 136 LVGIKHLHSAGIIHRDLKPSNIVV--KSDATLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           PE++         D+W+VGV+   ++ G   F G + ++    V
Sbjct: 194 PEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKV 237

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 102/224 (45%), Gaps = 7/224 (3%)
Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMN 160
           T +V   Y  L+ IG+GA G+V    +       A K +  P  +    +   +E+ +M 
Sbjct: 20  TFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMK 79
Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            ++H  +I L + F     +    EF     + E + A   ++ + E+    +  L+ Q 
Sbjct: 80  CVNHKNIIGLLNVFTPQKSLE---EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 136
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAA 280
              +KH+H   IIH D+KP NI+   ++   +K++DFGLA     + ++     T  + A
Sbjct: 137 LCGIKHLHSAGIIHRDLKPSNIV--VKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194
Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           PE++         D+W+VG +   ++ G   F G + ++    V
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 238

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 17/212 (8%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR----KEIDIMNQLHHPKLINLH 171
           IG G FG VH+       N   A  I    N   + +R    +E   M Q  HP ++ L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
                ++ + +I E  + GEL   +    + +  A +I     +   Q S A+ ++  K 
Sbjct: 78  GVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLI-----LYAYQLSTALAYLESKR 131
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA--EFAAPEIVEREPV 289
            +H D+   N++    +   VK+ DFGL+  ++ +   K S G    ++ APE +     
Sbjct: 132 FVHRDIAARNVLVSATDC--VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 290 GFYTDMWAVGVLAY-VLLSGLSPFAG--ENDV 318
              +D+W  GV  + +L+ G+ PF G   NDV
Sbjct: 190 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 221

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 102/224 (45%), Gaps = 7/224 (3%)
Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMN 160
           T +V   Y  L+ IG+GA G+V    +       A K +  P  +    +   +E+ +M 
Sbjct: 19  TFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            ++H  +I L + F     +    EF     + E + A   ++ + E+    +  L+ Q 
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLE---EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAA 280
              +KH+H   IIH D+KP NI+   ++   +K++DFGLA     + ++     T  + A
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIV--VKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           PE++         D+W+VG +   ++ G   F G + ++    V
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 103/216 (47%), Gaps = 17/216 (7%)
Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLH 171
           +++++G G FG V       +  +      P + +++  L  +E ++M  L H KL+ L+
Sbjct: 16  LVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFL--EEANLMKTLQHDKLVRLY 73
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM---TQTSPAVKHMH 228
                ++ + +I EF++ G L       D+  S+ E   V LP L+    Q +  + ++ 
Sbjct: 74  AVVTKEEPIYIITEFMAKGSLL------DFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIE 126
Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT--AEFAAPEIVER 286
            KN IH D++  N++     S   K+ DFGLA  ++ NE           ++ APE +  
Sbjct: 127 RKNYIHRDLRAANVL--VSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF 184
Query: 287 EPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETL 321
                 +++W+ G+L Y +++ G  P+ G  + + +
Sbjct: 185 GCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVM 220

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 18/218 (8%)
Query: 114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDA 173
           +++G G FG V      K   +      P S ++E  L   E ++M  L H KL+ LH A
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFL--AEANVMKTLQHDKLVKLH-A 250
Query: 174 FEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM---TQTSPAVKHMHEK 230
               + + +I EF++ G L + +     K  E    P  LP L+    Q +  +  + ++
Sbjct: 251 VVTKEPIYIITEFMAKGSLLDFL-----KSDEGSKQP--LPKLIDFSAQIAEGMAFIEQR 303
Query: 231 NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT--AEFAAPEIVEREP 288
           N IH D++  NI+     S   K+ DFGLA  ++ NE           ++ APE +    
Sbjct: 304 NYIHRDLRAANILVSA--SLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 361
Query: 289 VGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
               +D+W+ G+L   +++ G  P+ G ++ E ++ ++
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 102/224 (45%), Gaps = 7/224 (3%)
Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMN 160
           T +V   Y  L+ IG+GA G+V    +       A K +  P  +    +   +E+ +M 
Sbjct: 19  TFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            ++H  +I L + F     +    EF     + E + A   ++ + E+    +  L+ Q 
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLE---EFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAA 280
              +KH+H   IIH D+KP NI+   ++   +K++DFGLA     + ++     T  + A
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIV--VKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           PE++         D+W+VG +   ++ G   F G + ++    V
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 33/229 (14%)
Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQL-HHPKLIN 169
           LE+IG+G FG V +C +R  G I+A K    P++ +++++   +E+     L  H  ++ 
Sbjct: 16  LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR 75
Query: 170 LHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMS---EAEVIPVTLPILMTQTSPAVKH 226
              A+ +DD M++  E+ +GG L + I+     MS   EAE     L  L+ Q    +++
Sbjct: 76  YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAE-----LKDLLLQVGRGLRY 130
Query: 227 MHEKNIIHLDVKPENIMCQ-----------------TRNSTNVKMIDFGLATKLDPNEVV 269
           +H  +++H+D+KP NI                      N    K+ D G  T++   +V 
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV- 189
Query: 270 KISTGTAEFAAPEIVEREPVGF-YTDMWAVGVLAYVLLSGLSPFAGEND 317
               G + F A E+++         D++A+  L  V  +G  P     D
Sbjct: 190 --EEGDSRFLANEVLQENYTHLPKADIFALA-LTVVCAAGAEPLPRNGD 235

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/244 (24%), Positives = 108/244 (44%), Gaps = 44/244 (18%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE--KELIRKEIDIMNQLHHP 165
           + Y+I+  +G G FG V +C + + G    A  + +  N+E  KE  R EI+++ +++  
Sbjct: 33  ERYEIVSTLGEGTFGRVVQCVDHRRGGARVA--LKIIKNVEKYKEAARLEINVLEKINEK 90
Query: 166 K------LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI---- 215
                   + + D F+    M + FE L G   F+ +   +Y         +  PI    
Sbjct: 91  DPDNKNLCVQMFDWFDYHGHMCISFELL-GLSTFDFLKDNNY---------LPYPIHQVR 140
Query: 216 -LMTQTSPAVKHMHEKNIIHLDVKPENIMC-----------------QTRNSTNVKMIDF 257
            +  Q   AVK +H+  + H D+KPENI+                  ++  ST V+++DF
Sbjct: 141 HMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDF 200
Query: 258 GLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEND 317
           G AT    +    +S  T  + APE++         D+W++G + +    G + F   ++
Sbjct: 201 GSATFDHEHHSTIVS--TRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDN 258
Query: 318 VETL 321
            E L
Sbjct: 259 REHL 262

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 33/229 (14%)
Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQL-HHPKLIN 169
           LE+IG+G FG V +C +R  G I+A K    P++ +++++   +E+     L  H  ++ 
Sbjct: 14  LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR 73
Query: 170 LHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMS---EAEVIPVTLPILMTQTSPAVKH 226
              A+ +DD M++  E+ +GG L + I+     MS   EAE     L  L+ Q    +++
Sbjct: 74  YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAE-----LKDLLLQVGRGLRY 128
Query: 227 MHEKNIIHLDVKPENIMCQ-----------------TRNSTNVKMIDFGLATKLDPNEVV 269
           +H  +++H+D+KP NI                      N    K+ D G  T++   +V 
Sbjct: 129 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV- 187
Query: 270 KISTGTAEFAAPEIVEREPVGF-YTDMWAVGVLAYVLLSGLSPFAGEND 317
               G + F A E+++         D++A+  L  V  +G  P     D
Sbjct: 188 --EEGDSRFLANEVLQENYTHLPKADIFALA-LTVVCAAGAEPLPRNGD 233

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 114/245 (46%), Gaps = 26/245 (10%)
Query: 95  VPQPVDIKTSSVYD---HYDILEEIGTGAFGVVHRCRE--RKTGNIFAAKFIPVSHNLEK 149
           VP  V++     +D    Y  L+ IG GA+G+V    +  RKT  +   K  P  H    
Sbjct: 27  VPGEVEMVKGQPFDVGPRYTQLQYIGEGAYGMVSSAYDHVRKT-RVAIKKISPFEHQTYC 85
Query: 150 ELIRKEIDIMNQLHHPKLINLHDAFEDD--DEM--VLIFEFLSGGELFERITAPDYKMSE 205
           +   +EI I+ +  H  +I + D       + M  V I + L   +L++ + +   ++S 
Sbjct: 86  QRTLREIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKS--QQLSN 143
Query: 206 AEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP 265
             +        + Q    +K++H  N++H D+KP N++  T  + ++K+ DFGLA   DP
Sbjct: 144 DHIC-----YFLYQILRGLKYIHSANVLHRDLKPSNLLINT--TCDLKICDFGLARIADP 196
Query: 266 NE----VVKISTGTAEFAAPEIVEREPVGF--YTDMWAVGVLAYVLLSGLSPFAGENDVE 319
                  +     T  + APEI+     G+    D+W+VG +   +LS    F G++ ++
Sbjct: 197 EHDHTGFLTEXVATRWYRAPEIMLNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 255
Query: 320 TLKNV 324
            L ++
Sbjct: 256 QLNHI 260

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 33/229 (14%)
Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQL-HHPKLIN 169
           LE+IG+G FG V +C +R  G I+A K    P++ +++++   +E+     L  H  ++ 
Sbjct: 14  LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR 73
Query: 170 LHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMS---EAEVIPVTLPILMTQTSPAVKH 226
              A+ +DD M++  E+ +GG L + I+     MS   EAE     L  L+ Q    +++
Sbjct: 74  YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAE-----LKDLLLQVGRGLRY 128
Query: 227 MHEKNIIHLDVKPENIMCQ-----------------TRNSTNVKMIDFGLATKLDPNEVV 269
           +H  +++H+D+KP NI                      N    K+ D G  T++   +V 
Sbjct: 129 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV- 187
Query: 270 KISTGTAEFAAPEIVEREPVGF-YTDMWAVGVLAYVLLSGLSPFAGEND 317
               G + F A E+++         D++A+  L  V  +G  P     D
Sbjct: 188 --EEGDSRFLANEVLQENYTHLPKADIFALA-LTVVCAAGAEPLPRNGD 233

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPK 166
           Y   ++ E +G GAFGVV  C+ +      A K I      E++    E+  +++++HP 
Sbjct: 7   YKEIEVEEVVGRGAFGVV--CKAKWRAKDVAIKQI--ESESERKAFIVELRQLSRVNHPN 62
Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITA----PDYKMSEAEVIPVTLPILMTQTSP 222
           ++ L+ A  +   + L+ E+  GG L+  +      P Y  + A    ++  +  +Q   
Sbjct: 63  IVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHA----MSWCLQCSQGVA 116
Query: 223 AVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPE 282
            +  M  K +IH D+KP N++      T +K+ DFG A  +  +  +  + G+A + APE
Sbjct: 117 YLHSMQPKALIHRDLKPPNLL-LVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPE 173
Query: 283 IVEREPVGFYTDMWAVGVLAYVLLSGLSPF 312
           + E        D+++ G++ + +++   PF
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKPF 203

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 102/224 (45%), Gaps = 7/224 (3%)
Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMN 160
           T +V   Y  L+ IG+GA G+V    +       A K +  P  +    +   +E+ +M 
Sbjct: 19  TFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            ++H  +I L + F     +    EF     + E + A   ++ + E+    +  L+ Q 
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLE---EFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAA 280
              +KH+H   IIH D+KP NI+   ++   +K++DFGLA     + ++     T  + A
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIV--VKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           PE++         D+W+VG +   ++ G   F G + ++    V
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 100/207 (48%), Gaps = 18/207 (8%)
Query: 115 EIGTGAFGVVHRC--RERKTGNIFAAKFIPV-SHNLEKELIRKEIDIMNQLHHPKLINLH 171
           E+G G FG V +   R RK     A K +   +   + E + +E  IM+QL +P ++ L 
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVT-LPILMTQTSPAVKHMHEK 230
              + +  ++L+ E   GG L +      + + + E IPV+ +  L+ Q S  +K++ EK
Sbjct: 77  GVCQAE-ALMLVMEMAGGGPLHK------FLVGKREEIPVSNVAELLHQVSMGMKYLEEK 129
Query: 231 NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFA----APEIVER 286
           N +H D+   N++   R+    K+ DFGL+  L  ++    +    ++     APE +  
Sbjct: 130 NFVHRDLAARNVLLVNRHYA--KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 187
Query: 287 EPVGFYTDMWAVGVLAYVLLS-GLSPF 312
                 +D+W+ GV  +  LS G  P+
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKPY 214

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 102/224 (45%), Gaps = 7/224 (3%)
Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMN 160
           T +V   Y  L+ IG+GA G+V    +       A K +  P  +    +   +E+ +M 
Sbjct: 19  TFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            ++H  +I L + F     +    EF     + E + A   ++ + E+    +  L+ Q 
Sbjct: 79  VVNHKNIIGLLNVFTPQKSLE---EFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAA 280
              +KH+H   IIH D+KP NI+   ++   +K++DFGLA     + ++     T  + A
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIV--VKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           PE++         D+W+VG +   ++ G   F G + ++    V
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 102/224 (45%), Gaps = 7/224 (3%)
Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMN 160
           T +V   Y  L+ IG+GA G+V    +       A K +  P  +    +   +E+ +M 
Sbjct: 21  TFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMK 80
Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            ++H  +I L + F     +    EF     + E + A   ++ + E+    +  L+ Q 
Sbjct: 81  CVNHKNIIGLLNVFTPQKSLE---EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 137
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAA 280
              +KH+H   IIH D+KP NI+   ++   +K++DFGLA     + ++     T  + A
Sbjct: 138 LCGIKHLHSAGIIHRDLKPSNIV--VKSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRA 195
Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           PE++         D+W+VG +   ++ G   F G + ++    V
Sbjct: 196 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 239

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPK 166
           Y   ++ E +G GAFGVV  C+ +      A K I      E++    E+  +++++HP 
Sbjct: 8   YKEIEVEEVVGRGAFGVV--CKAKWRAKDVAIKQI--ESESERKAFIVELRQLSRVNHPN 63
Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITA----PDYKMSEAEVIPVTLPILMTQTSP 222
           ++ L+ A  +   + L+ E+  GG L+  +      P Y  + A    ++  +  +Q   
Sbjct: 64  IVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHA----MSWCLQCSQGVA 117
Query: 223 AVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPE 282
            +  M  K +IH D+KP N++      T +K+ DFG A  +  +  +  + G+A + APE
Sbjct: 118 YLHSMQPKALIHRDLKPPNLL-LVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPE 174
Query: 283 IVEREPVGFYTDMWAVGVLAYVLLSGLSPF 312
           + E        D+++ G++ + +++   PF
Sbjct: 175 VFEGSNYSEKCDVFSWGIILWEVITRRKPF 204

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 25/213 (11%)
Query: 109 HYDILEEIGTGAFGVVHRCR----ERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQL 162
           H   L+++G G FG V  CR    +  TG + A K   + H+ E+ L    +EI+I+  L
Sbjct: 14  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK--KLQHSTEEHLRDFEREIEILKSL 71
Query: 163 HHPKLINLHDAF--EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIP-VTLPILMTQ 219
            H  ++             + LI E+L  G L       DY  + AE I  + L    +Q
Sbjct: 72  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL------RDYLQAHAERIDHIKLLQYTSQ 125
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE-----VVKISTG 274
               ++++  K  IH D+   NI+ +  N   VK+ DFGL TK+ P +     V +    
Sbjct: 126 ICKGMEYLGTKRYIHRDLATRNILVE--NENRVKIGDFGL-TKVLPQDKEXXKVKEPGES 182
Query: 275 TAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS 307
              + APE +        +D+W+ GV+ Y L +
Sbjct: 183 PIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 33/229 (14%)
Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQL-HHPKLIN 169
           LE+IG+G FG V +C +R  G I+A K    P++ +++++   +E+     L  H  ++ 
Sbjct: 12  LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR 71
Query: 170 LHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMS---EAEVIPVTLPILMTQTSPAVKH 226
              A+ +DD M++  E+ +GG L + I+     MS   EAE     L  L+ Q    +++
Sbjct: 72  YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAE-----LKDLLLQVGRGLRY 126
Query: 227 MHEKNIIHLDVKPENIMCQ-----------------TRNSTNVKMIDFGLATKLDPNEVV 269
           +H  +++H+D+KP NI                      N    K+ D G  T++   +V 
Sbjct: 127 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV- 185
Query: 270 KISTGTAEFAAPEIVEREPVGF-YTDMWAVGVLAYVLLSGLSPFAGEND 317
               G + F A E+++         D++A+  L  V  +G  P     D
Sbjct: 186 --EEGDSRFLANEVLQENYTHLPKADIFALA-LTVVXAAGAEPLPRNGD 231

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 23/212 (10%)
Query: 109 HYDILEEIGTGAFGVVHRCR----ERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQL 162
           H   L ++G G FG V  CR    +  TG + A K   + H+ E+ L    +EI+I+  L
Sbjct: 14  HLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVK--KLQHSTEEHLRDFEREIEILKSL 71
Query: 163 HHPKLINLHDAF--EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            H  ++             + LI EFL  G L E +     ++   +++  T     +Q 
Sbjct: 72  QHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYT-----SQI 126
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE-----VVKISTGT 275
              ++++  K  IH D+   NI+ +  N   VK+ DFGL TK+ P +     V +     
Sbjct: 127 CKGMEYLGTKRYIHRDLATRNILVE--NENRVKIGDFGL-TKVLPQDKEXXKVKEPGESP 183
Query: 276 AEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS 307
             + APE +        +D+W+ GV+ Y L +
Sbjct: 184 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 110/242 (45%), Gaps = 25/242 (10%)
Query: 96  PQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGN---IFAAKFIPVSHNLEKELI 152
           P+ V  +   V   Y  L  IG GA+G+V  C      N   +   K  P  H    +  
Sbjct: 31  PEMVRGQVFDVGPRYTNLSYIGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRT 88
Query: 153 RKEIDIMNQLHHPKLINLHDAFEDD--DEM--VLIFEFLSGGELFERITAPDYKMSEAEV 208
            +EI I+ +  H  +I ++D       ++M  V +   L G +L++ +      +S   +
Sbjct: 89  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHI 146
Query: 209 IPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE- 267
                   + Q    +K++H  N++H D+KP N++  T  + ++K+ DFGLA   DP+  
Sbjct: 147 C-----YFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--TXDLKICDFGLARVADPDHD 199
Query: 268 ---VVKISTGTAEFAAPEIVEREPVGF--YTDMWAVGVLAYVLLSGLSPFAGENDVETLK 322
               +     T  + APEI+     G+    D+W+VG +   +LS    F G++ ++ L 
Sbjct: 200 HTGFLTEYVATRWYRAPEIMLNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 258
Query: 323 NV 324
           ++
Sbjct: 259 HI 260

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 110/248 (44%), Gaps = 22/248 (8%)
Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLHHPKLINL 170
           L  +G+GA+G V    + +     A K +  P    +      +E+ ++  L H  +I L
Sbjct: 33  LRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 171 HDAF------EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
            D F      ED  E+ L+   + G +L   + +    +S+  V       L+ Q    +
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLM-GADLNNIVKSQ--ALSDEHV-----QFLVYQLLRGL 144
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEI- 283
           K++H   IIH D+KP N+       + ++++DFGLA + D  E +     T  + APEI 
Sbjct: 145 KYIHSAGIIHRDLKPSNVAVN--EDSELRILDFGLARQAD--EEMTGYVATRWYRAPEIM 200
Query: 284 VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNV-SEE 342
           +         D+W+VG +   LL G + F G + ++ LK +         E    + SE 
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEH 260
Query: 343 GKDFIRRL 350
            + +I+ L
Sbjct: 261 ARTYIQSL 268

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 102/224 (45%), Gaps = 7/224 (3%)
Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMN 160
           T +V   Y  L+ IG+GA G+V    +       A K +  P  +    +   +E+ +M 
Sbjct: 19  TFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            ++H  +I L + F     +    EF     + E + A   ++ + E+    +  L+ Q 
Sbjct: 79  VVNHKNIIGLLNVFTPQKSLE---EFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAA 280
              +KH+H   IIH D+KP NI+   ++   +K++DFGLA     + ++     T  + A
Sbjct: 136 LVGIKHLHSAGIIHRDLKPSNIVV--KSDATLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           PE++         D+W+VG +   ++ G   F G + ++    V
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 108/260 (41%), Gaps = 42/260 (16%)
Query: 110 YDILEEIGTGAFGVV---HRCRERKTGNIFAAKFIP-------------VSHNLEKELIR 153
           Y +   +G G FG V   HR  +R      A K IP             V+  LE  L+ 
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQ---VAIKVIPRNRVLGWSPLSDSVTCPLEVALLW 89
Query: 154 KEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF-LSGGELFERITAPDYKMSEAEVIPVT 212
           K   +     HP +I L D FE  +  +L+ E  L   +LF+ IT     + E       
Sbjct: 90  K---VGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSR--- 142
Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS 272
                 Q   A++H H + ++H D+K ENI+   R     K+IDFG    L  +E     
Sbjct: 143 --CFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGC-AKLIDFGSGALLH-DEPYTDF 198
Query: 273 TGTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEF 331
            GT  ++ PE + R         +W++G+L Y ++ G  PF  E D E L        E 
Sbjct: 199 DGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPF--ERDQEIL--------EA 248
Query: 332 DEEAFKNVSEEGKDFIRRLL 351
           +     +VS +    IRR L
Sbjct: 249 ELHFPAHVSPDCCALIRRCL 268

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 98/224 (43%), Gaps = 41/224 (18%)
Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLH- 171
           +E IG+G FG V + + R  G  +  +   V +N EK    +E+  + +L H  +++ + 
Sbjct: 17  IELIGSGGFGQVFKAKHRIDGKTYVIR--RVKYNNEK--AEREVKALAKLDHVNIVHYNG 72
Query: 172 --DAFEDDDE--------------------------MVLIFEFLSGGELFERITAPDYKM 203
             D F+ D E                          + +  EF   G L + I     + 
Sbjct: 73  CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWI-----EK 127
Query: 204 SEAEVIPVTLPI-LMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK 262
              E +   L + L  Q +  V ++H K +IH D+KP NI     ++  VK+ DFGL T 
Sbjct: 128 RRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLV--DTKQVKIGDFGLVTS 185
Query: 263 LDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLL 306
           L  +     S GT  + +PE +  +  G   D++A+G++   LL
Sbjct: 186 LKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 109/248 (43%), Gaps = 22/248 (8%)
Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLHHPKLINL 170
           L  +G+GA+G V    + +     A K +  P    +      +E+ ++  L H  +I L
Sbjct: 33  LRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 171 HDAF------EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
            D F      ED  E+ L+   + G +L   +      +S+  V       L+ Q    +
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLM-GADLNNIVKCQ--ALSDEHV-----QFLVYQLLRGL 144
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEI- 283
           K++H   IIH D+KP N+       + ++++DFGLA + D  E +     T  + APEI 
Sbjct: 145 KYIHSAGIIHRDLKPSNVAVN--EDSELRILDFGLARQAD--EEMTGYVATRWYRAPEIM 200
Query: 284 VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNV-SEE 342
           +         D+W+VG +   LL G + F G + ++ LK +         E    + SE 
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEH 260
Query: 343 GKDFIRRL 350
            + +I+ L
Sbjct: 261 ARTYIQSL 268

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 100/221 (45%), Gaps = 27/221 (12%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPV------SHNLEKELIRKEIDIMNQL-HHPKLI 168
           +G GAFG V        G   A   + V      +H  EKE +  E+ IM+ L  H  ++
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 169 NLHDAFEDDDEMVLIFEFLSGGELFERI--------TAPDYKMSEAEVIPVTLPILMTQT 220
           NL  A      +++I E+   G+L   +        T P + ++ + +    L    +Q 
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQV 173
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--DPNEVVKISTGTA-- 276
           +  +  +  KN IH DV   N++    N    K+ DFGLA  +  D N +VK   G A  
Sbjct: 174 AQGMAFLASKNCIHRDVAARNVL--LTNGHVAKIGDFGLARDIMNDSNYIVK---GNARL 228
Query: 277 --EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
             ++ APE +        +D+W+ G+L + + S GL+P+ G
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG 269

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 108/248 (43%), Gaps = 22/248 (8%)
Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLHHPKLINL 170
           L  +G+GA+G V    + +     A K +  P    +      +E+ ++  L H  +I L
Sbjct: 25  LRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGL 84
Query: 171 HDAF------EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
            D F      ED  E+ L+   + G +L   +      +S+  V       L+ Q    +
Sbjct: 85  LDVFTPATSIEDFSEVYLVTTLM-GADLNNIVKCQ--ALSDEHV-----QFLVYQLLRGL 136
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEI- 283
           K++H   IIH D+KP N+         ++++DFGLA + D  E +     T  + APEI 
Sbjct: 137 KYIHSAGIIHRDLKPSNVAVN--EDCELRILDFGLARQAD--EEMTGYVATRWYRAPEIM 192
Query: 284 VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEE- 342
           +         D+W+VG +   LL G + F G + ++ LK +         E    +S E 
Sbjct: 193 LNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEH 252
Query: 343 GKDFIRRL 350
            + +I+ L
Sbjct: 253 ARTYIQSL 260

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 27/221 (12%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPV------SHNLEKELIRKEIDIMNQL-HHPKLI 168
           +G GAFG V        G   A   + V      +H  EKE +  E+ IM+ L  H  ++
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 169 NLHDAFEDDDEMVLIFEFLSGGELFERI--------TAPDYKMSEAEVIPVTLPILMTQT 220
           NL  A      +++I E+   G+L   +        T P + ++ +      L    +Q 
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--DPNEVVKISTGTA-- 276
           +  +  +  KN IH DV   N++    N    K+ DFGLA  +  D N +VK   G A  
Sbjct: 174 AQGMAFLASKNCIHRDVAARNVL--LTNGHVAKIGDFGLARDIMNDSNYIVK---GNARL 228
Query: 277 --EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
             ++ APE +        +D+W+ G+L + + S GL+P+ G
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG 269

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 15/213 (7%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF- 174
           IG G+FGVV++ +   +G + A K +      +K    +E+ IM +L H  ++ L   F 
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 95
Query: 175 ---EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
              E  DE+ L        E   R+ A  Y  ++  +  + + + M Q   ++ ++H   
Sbjct: 96  SSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 154
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGF 291
           I H D+KP+N++    ++  +K+ DFG A +L   E       +  + APE++       
Sbjct: 155 ICHRDIKPQNLLLDP-DTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG--ATD 211
Query: 292 YT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
           YT   D+W+ G +   LL G   F G++ V+ L
Sbjct: 212 YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 244

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 18/218 (8%)
Query: 114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDA 173
           +++G G FG V      K   +      P S ++E  L   E ++M  L H KL+ LH A
Sbjct: 21  KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFL--AEANVMKTLQHDKLVKLH-A 77
Query: 174 FEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM---TQTSPAVKHMHEK 230
               + + +I EF++ G L + +     K  E    P  LP L+    Q +  +  + ++
Sbjct: 78  VVTKEPIYIITEFMAKGSLLDFL-----KSDEGSKQP--LPKLIDFSAQIAEGMAFIEQR 130
Query: 231 NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTG--TAEFAAPEIVEREP 288
           N IH D++  NI+     S   K+ DFGLA  ++ NE           ++ APE +    
Sbjct: 131 NYIHRDLRAANILVSA--SLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 188
Query: 289 VGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
               +D+W+ G+L   +++ G  P+ G ++ E ++ ++
Sbjct: 189 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 226

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 102/224 (45%), Gaps = 7/224 (3%)
Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMN 160
           T +V   Y  L+ IG+GA G+V    +       A K +  P  +    +   +E+ +M 
Sbjct: 19  TFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            ++H  +I L + F     +    EF     + E + A   ++ + E+    +  L+ Q 
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLE---EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAA 280
              +KH+H   IIH D+KP NI+   ++   +K++DFGLA     + +++    T  + A
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIV--VKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRA 193
Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           PE++         D+W+VG +   ++     F G + ++    V
Sbjct: 194 PEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKV 237

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 19/215 (8%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF- 174
           IG G+FGVV++ +   +G + A K +      +K    +E+ IM +L H  ++ L   F 
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 102
Query: 175 ---EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
              E  DE+ L        E   R+ A  Y  ++  +  + + + M Q   ++ ++H   
Sbjct: 103 SSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 161
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGF 291
           I H D+KP+N++    ++  +K+ DFG A +L   E       +  + APE++     G 
Sbjct: 162 ICHRDIKPQNLLLDP-DTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELI----FGA 216
Query: 292 --YT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
             YT   D+W+ G +   LL G   F G++ V+ L
Sbjct: 217 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 251

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 19/215 (8%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF- 174
           IG G+FGVV++ +   +G + A K +      +K    +E+ IM +L H  ++ L   F 
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 91
Query: 175 ---EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
              E  DE+ L        E   R+ A  Y  ++  +  + + + M Q   ++ ++H   
Sbjct: 92  SSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 150
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGF 291
           I H D+KP+N++    ++  +K+ DFG A +L   E       +  + APE++     G 
Sbjct: 151 ICHRDIKPQNLLLDP-DTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELI----FGA 205
Query: 292 --YT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
             YT   D+W+ G +   LL G   F G++ V+ L
Sbjct: 206 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 240

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 99/203 (48%), Gaps = 18/203 (8%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN-LEKELIRKEIDI-MNQLHHP 165
           D  + + E+G GA+GVV + R   +G I A K I  + N  E++ +  ++DI M  +  P
Sbjct: 51  DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 110
Query: 166 KLINLHDAFEDDDEMVLIFEFL--SGGELFERITAPDYKMSEAEVIPV-TLPILMTQTSP 222
             +  + A   + ++ +  E +  S  + ++++      + + + IP   L  +      
Sbjct: 111 FTVTFYGALFREGDVWICMELMDTSLDKFYKQV------IDKGQTIPEDILGKIAVSIVK 164
Query: 223 AVKHMHEK-NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAP 281
           A++H+H K ++IH DVKP N++        VKM DFG++  L  +    I  G   + AP
Sbjct: 165 ALEHLHSKLSVIHRDVKPSNVLINALG--QVKMCDFGISGYLVDSVAKTIDAGCKPYMAP 222
Query: 282 EIVERE----PVGFYTDMWAVGV 300
           E +  E         +D+W++G+
Sbjct: 223 ERINPELNQKGYSVKSDIWSLGI 245

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 15/213 (7%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF- 174
           IG G+FGVV++ +   +G + A K +      +K    +E+ IM +L H  ++ L   F 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 175 ---EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
              E  DE+ L        E   R+ A  Y  ++  +  + + + M Q   ++ ++H   
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGF 291
           I H D+KP+N++    ++  +K+ DFG A +L   E       +  + APE++       
Sbjct: 143 ICHRDIKPQNLLLDP-DTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG--ATD 199
Query: 292 YT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
           YT   D+W+ G +   LL G   F G++ V+ L
Sbjct: 200 YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 232

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 92/213 (43%), Gaps = 15/213 (7%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI-PVSHNLEKELIRKEIDIMNQLHH-P 165
           D Y ++ ++G G +  V              K + PV    +K  I++EI I+  L   P
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKNKIKREIKILENLRGGP 92
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            +I L D  +D           +   +FE +   D+K     +    +   M +   A+ 
Sbjct: 93  NIITLADIVKDPVSR-------TPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALD 145
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPE-IV 284
           + H   I+H DVKP N+M    +   +++ID+GLA    P +   +   +  F  PE +V
Sbjct: 146 YCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 204
Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGEND 317
           + +   +  DMW++G +   ++    PF   +D
Sbjct: 205 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 237

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 19/215 (8%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF- 174
           IG G+FGVV++ +   +G + A K +      +K    +E+ IM +L H  ++ L   F 
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 95
Query: 175 ---EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
              E  DE+ L        E   R+ A  Y  ++  +  + + + M Q   ++ ++H   
Sbjct: 96  SSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 154
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGF 291
           I H D+KP+N++    ++  +K+ DFG A +L   E       +  + APE++     G 
Sbjct: 155 ICHRDIKPQNLLLDP-DTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELI----FGA 209
Query: 292 --YT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
             YT   D+W+ G +   LL G   F G++ V+ L
Sbjct: 210 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 244

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 99/203 (48%), Gaps = 18/203 (8%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN-LEKELIRKEIDI-MNQLHHP 165
           D  + + E+G GA+GVV + R   +G I A K I  + N  E++ +  ++DI M  +  P
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 166 KLINLHDAFEDDDEMVLIFEFL--SGGELFERITAPDYKMSEAEVIPV-TLPILMTQTSP 222
             +  + A   + ++ +  E +  S  + ++++      + + + IP   L  +      
Sbjct: 67  FTVTFYGALFREGDVWICMELMDTSLDKFYKQV------IDKGQTIPEDILGKIAVSIVK 120
Query: 223 AVKHMHEK-NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAP 281
           A++H+H K ++IH DVKP N++        VKM DFG++  L  +    I  G   + AP
Sbjct: 121 ALEHLHSKLSVIHRDVKPSNVLINALG--QVKMCDFGISGYLVDDVAKDIDAGCKPYMAP 178
Query: 282 EIVERE----PVGFYTDMWAVGV 300
           E +  E         +D+W++G+
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGI 201

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 19/215 (8%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF- 174
           IG G+FGVV++ +   +G + A K +      +K    +E+ IM +L H  ++ L   F 
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 84
Query: 175 ---EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
              E  DE+ L        E   R+ A  Y  ++  +  + + + M Q   ++ ++H   
Sbjct: 85  SSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 143
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGF 291
           I H D+KP+N++    ++  +K+ DFG A +L   E       +  + APE++     G 
Sbjct: 144 ICHRDIKPQNLLLDP-DTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELI----FGA 198
Query: 292 --YT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
             YT   D+W+ G +   LL G   F G++ V+ L
Sbjct: 199 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 233

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 19/215 (8%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF- 174
           IG G+FGVV++ +   +G + A K +      +K    +E+ IM +L H  ++ L   F 
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 87
Query: 175 ---EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
              E  DE+ L        E   R+ A  Y  ++  +  + + + M Q   ++ ++H   
Sbjct: 88  SSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 146
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGF 291
           I H D+KP+N++    ++  +K+ DFG A +L   E       +  + APE++     G 
Sbjct: 147 ICHRDIKPQNLLLDP-DTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELI----FGA 201
Query: 292 --YT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
             YT   D+W+ G +   LL G   F G++ V+ L
Sbjct: 202 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 236

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 19/215 (8%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF- 174
           IG G+FGVV++ +   +G + A K +      +K    +E+ IM +L H  ++ L   F 
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 117
Query: 175 ---EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
              E  DE+ L        E   R+ A  Y  ++  +  + + + M Q   ++ ++H   
Sbjct: 118 SSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 176
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGF 291
           I H D+KP+N++    ++  +K+ DFG A +L   E       +  + APE++     G 
Sbjct: 177 ICHRDIKPQNLLLDP-DTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELI----FGA 231
Query: 292 --YT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
             YT   D+W+ G +   LL G   F G++ V+ L
Sbjct: 232 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 266

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 19/215 (8%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF- 174
           IG G+FGVV++ +   +G + A K +      +K    +E+ IM +L H  ++ L   F 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 175 ---EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
              E  DE+ L        E   R+ A  Y  ++  +  + + + M Q   ++ ++H   
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGF 291
           I H D+KP+N++    ++  +K+ DFG A +L   E       +  + APE++     G 
Sbjct: 143 ICHRDIKPQNLLLDP-DTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELI----FGA 197
Query: 292 --YT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
             YT   D+W+ G +   LL G   F G++ V+ L
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 232

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 109 HYDILEEIGTGAFGVVHRCR----ERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQL 162
           H   L+++G G FG V  CR    +  TG + A K   + H+ E+ L    +EI+I+  L
Sbjct: 18  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK--KLQHSTEEHLRDFEREIEILKSL 75
Query: 163 HHPKLINLHDAF--EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            H  ++             + LI E+L  G L + +     ++   +++  T     +Q 
Sbjct: 76  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT-----SQI 130
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE-----VVKISTGT 275
              ++++  K  IH D+   NI+ +  N   VK+ DFGL TK+ P +     V +     
Sbjct: 131 CKGMEYLGTKRYIHRDLATRNILVE--NENRVKIGDFGL-TKVLPQDKEXXKVKEPGESP 187
Query: 276 AEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS 307
             + APE +        +D+W+ GV+ Y L +
Sbjct: 188 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 15/213 (7%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF- 174
           IG G+FGVV++ +   +G + A K +      +K    +E+ IM +L H  ++ L   F 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 175 ---EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
              E  DE+ L        E   R+ A  Y  ++  +  + + + M Q   ++ ++H   
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGF 291
           I H D+KP+N++    ++  +K+ DFG A +L   E       +  + APE++       
Sbjct: 143 ICHRDIKPQNLLLDP-DTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG--ATD 199
Query: 292 YT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
           YT   D+W+ G +   LL G   F G++ V+ L
Sbjct: 200 YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 232

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 102/224 (45%), Gaps = 7/224 (3%)
Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMN 160
           T +V   Y  L+ IG+GA G+V    +       A K +  P  +    +   +E+ +M 
Sbjct: 19  TFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            ++H  +I L + F     +    EF     + E + A   ++ + E+    +  L+ Q 
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLE---EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAA 280
              +KH+H   IIH D+KP NI+   ++   +K++DFGLA     + +++    T  + A
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIV--VKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRA 193
Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           PE++         D+W+VG +   ++     F G + ++    V
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKV 237

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 109 HYDILEEIGTGAFGVVHRCR----ERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQL 162
           H   L+++G G FG V  CR    +  TG + A K   + H+ E+ L    +EI+I+  L
Sbjct: 42  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK--KLQHSTEEHLRDFEREIEILKSL 99
Query: 163 HHPKLINLHDAF--EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            H  ++             + LI E+L  G L + +     ++   +++  T     +Q 
Sbjct: 100 QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT-----SQI 154
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE-----VVKISTGT 275
              ++++  K  IH D+   NI+ +  N   VK+ DFGL TK+ P +     V +     
Sbjct: 155 CKGMEYLGTKRYIHRDLATRNILVE--NENRVKIGDFGL-TKVLPQDKEXXKVKEPGESP 211
Query: 276 AEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS 307
             + APE +        +D+W+ GV+ Y L +
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 109 HYDILEEIGTGAFGVVHRCR----ERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQL 162
           H   L+++G G FG V  CR    +  TG + A K   + H+ E+ L    +EI+I+  L
Sbjct: 14  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK--KLQHSTEEHLRDFEREIEILKSL 71
Query: 163 HHPKLINLHDAF--EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            H  ++             + LI E+L  G L + +     ++   +++  T     +Q 
Sbjct: 72  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT-----SQI 126
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE-----VVKISTGT 275
              ++++  K  IH D+   NI+ +  N   VK+ DFGL TK+ P +     V +     
Sbjct: 127 CKGMEYLGTKRYIHRDLATRNILVE--NENRVKIGDFGL-TKVLPQDKEXXKVKEPGESP 183
Query: 276 AEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS 307
             + APE +        +D+W+ GV+ Y L +
Sbjct: 184 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 109 HYDILEEIGTGAFGVVHRCR----ERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQL 162
           H   L+++G G FG V  CR    +  TG + A K   + H+ E+ L    +EI+I+  L
Sbjct: 11  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK--KLQHSTEEHLRDFEREIEILKSL 68
Query: 163 HHPKLINLHDAF--EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            H  ++             + LI E+L  G L + +     ++   +++  T     +Q 
Sbjct: 69  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT-----SQI 123
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN--EVVKISTGTAE- 277
              ++++  K  IH D+   NI+ +  N   VK+ DFGL TK+ P   E  K+       
Sbjct: 124 CKGMEYLGTKRYIHRDLATRNILVE--NENRVKIGDFGL-TKVLPQDKEFFKVKEPGESP 180
Query: 278 --FAAPEIVEREPVGFYTDMWAVGVLAYVLLS 307
             + APE +        +D+W+ GV+ Y L +
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 102/224 (45%), Gaps = 7/224 (3%)
Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMN 160
           T +V   Y  L+ IG+GA G+V    +       A K +  P  +    +   +E+ +M 
Sbjct: 19  TFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            ++H  +I+L + F     +    EF     + E + A   ++ + E+    +  L+ Q 
Sbjct: 79  XVNHKNIISLLNVFTPQKTLE---EFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAA 280
              +KH+H   IIH D+KP NI+   ++   +K++DFGLA     + ++     T  + A
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIV--VKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           PE++         D+W+VG +   ++     F G + ++    V
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 237

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 107/230 (46%), Gaps = 26/230 (11%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL--EKELIRKEIDIMNQLHHP 165
           D Y+I   IG G+FG V +  +R      A K I        + ++  + +++MN+ H  
Sbjct: 35  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNK-HDT 93
Query: 166 KL----INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSE-------AEVIPVTLP 214
           ++    ++L   F   + + L+FE LS   L++ +   +++          A+ +   L 
Sbjct: 94  EMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALL 152
Query: 215 ILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTG 274
            L T          E +IIH D+KPENI+      + +K++DFG + +L       I + 
Sbjct: 153 FLATP---------ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQXIQSR 203
Query: 275 TAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
              + +PE++   P     DMW++G +   + +G   F+G N+V+ +  +
Sbjct: 204 F--YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKI 251

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 109 HYDILEEIGTGAFGVVHRCR----ERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQL 162
           H   L+++G G FG V  CR    +  TG + A K   + H+ E+ L    +EI+I+  L
Sbjct: 9   HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK--KLQHSTEEHLRDFEREIEILKSL 66
Query: 163 HHPKLINLHDAF--EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            H  ++             + LI E+L  G L + +     ++   +++  T     +Q 
Sbjct: 67  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT-----SQI 121
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE-----VVKISTGT 275
              ++++  K  IH D+   NI+ +  N   VK+ DFGL TK+ P +     V +     
Sbjct: 122 CKGMEYLGTKRYIHRDLATRNILVE--NENRVKIGDFGL-TKVLPQDKEXXKVKEPGESP 178
Query: 276 AEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS 307
             + APE +        +D+W+ GV+ Y L +
Sbjct: 179 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 109 HYDILEEIGTGAFGVVHRCR----ERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQL 162
           H   L+++G G FG V  CR    +  TG + A K   + H+ E+ L    +EI+I+  L
Sbjct: 16  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK--KLQHSTEEHLRDFEREIEILKSL 73
Query: 163 HHPKLINLHDAF--EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            H  ++             + LI E+L  G L + +     ++   +++  T     +Q 
Sbjct: 74  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT-----SQI 128
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE-----VVKISTGT 275
              ++++  K  IH D+   NI+ +  N   VK+ DFGL TK+ P +     V +     
Sbjct: 129 CKGMEYLGTKRYIHRDLATRNILVE--NENRVKIGDFGL-TKVLPQDKEXXKVKEPGESP 185
Query: 276 AEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS 307
             + APE +        +D+W+ GV+ Y L +
Sbjct: 186 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 109 HYDILEEIGTGAFGVVHRCR----ERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQL 162
           H   L+++G G FG V  CR    +  TG + A K   + H+ E+ L    +EI+I+  L
Sbjct: 17  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK--KLQHSTEEHLRDFEREIEILKSL 74
Query: 163 HHPKLINLHDAF--EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            H  ++             + LI E+L  G L + +     ++   +++  T     +Q 
Sbjct: 75  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT-----SQI 129
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE-----VVKISTGT 275
              ++++  K  IH D+   NI+ +  N   VK+ DFGL TK+ P +     V +     
Sbjct: 130 CKGMEYLGTKRYIHRDLATRNILVE--NENRVKIGDFGL-TKVLPQDKEXXKVKEPGESP 186
Query: 276 AEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS 307
             + APE +        +D+W+ GV+ Y L +
Sbjct: 187 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 109 HYDILEEIGTGAFGVVHRCR----ERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQL 162
           H   L+++G G FG V  CR    +  TG + A K   + H+ E+ L    +EI+I+  L
Sbjct: 11  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK--KLQHSTEEHLRDFEREIEILKSL 68
Query: 163 HHPKLINLHDAF--EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            H  ++             + LI E+L  G L + +     ++   +++  T     +Q 
Sbjct: 69  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT-----SQI 123
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE-----VVKISTGT 275
              ++++  K  IH D+   NI+ +  N   VK+ DFGL TK+ P +     V +     
Sbjct: 124 CKGMEYLGTKRYIHRDLATRNILVE--NENRVKIGDFGL-TKVLPQDKEXXKVKEPGESP 180
Query: 276 AEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS 307
             + APE +        +D+W+ GV+ Y L +
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 117/269 (43%), Gaps = 47/269 (17%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK-ELIRKEIDIMNQLHHPKLINLHDAF 174
           +G GAFG V + R       +A K   + H  EK   I  E+ ++  L+H  ++  + A+
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIK--KIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 175 EDDDEMV-------------LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTS 221
            +    V             +  E+   G L++ I + +      E        L  Q  
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR-----LFRQIL 126
Query: 222 PAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA---------TKLDPNEV---- 268
            A+ ++H + IIH D+KP NI      S NVK+ DFGLA          KLD   +    
Sbjct: 127 EALSYIHSQGIIHRDLKPMNIFID--ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 269 --VKISTGTAEFAAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFA-GENDVETLK 322
             +  + GTA + A E++  +  G Y    DM+++G++ + +   + PF+ G   V  LK
Sbjct: 185 DNLTSAIGTAMYVATEVL--DGTGHYNEKIDMYSLGIIFFEM---IYPFSTGMERVNILK 239
Query: 323 NVKACDWEFDEEAFKNVSEEGKDFIRRLL 351
            +++   EF  +   N  +  K  IR L+
Sbjct: 240 KLRSVSIEFPPDFDDNKMKVEKKIIRLLI 268

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 107/230 (46%), Gaps = 26/230 (11%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL--EKELIRKEIDIMNQLHHP 165
           D Y+I   IG G+FG V +  +R      A K I        + ++  + +++MN+ H  
Sbjct: 54  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNK-HDT 112
Query: 166 KL----INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSE-------AEVIPVTLP 214
           ++    ++L   F   + + L+FE LS   L++ +   +++          A+ +   L 
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALL 171
Query: 215 ILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTG 274
            L T          E +IIH D+KPENI+      + +K++DFG + +L       I + 
Sbjct: 172 FLATP---------ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQXIQSR 222
Query: 275 TAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
              + +PE++   P     DMW++G +   + +G   F+G N+V+ +  +
Sbjct: 223 F--YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKI 270

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 19/215 (8%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF- 174
           IG G+FGVV++ +   +G + A K +      +K    +E+ IM +L H  ++ L   F 
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 96
Query: 175 ---EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
              E  DE+ L        E   R+ A  Y  ++  +  + + + M Q   ++ ++H   
Sbjct: 97  SSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 155
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGF 291
           I H D+KP+N++    ++  +K+ DFG A +L   E       +  + APE++     G 
Sbjct: 156 ICHRDIKPQNLLLDP-DTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI----FGA 210
Query: 292 --YT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
             YT   D+W+ G +   LL G   F G++ V+ L
Sbjct: 211 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 245

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 109 HYDILEEIGTGAFGVVHRCR----ERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQL 162
           H   L+++G G FG V  CR    +  TG + A K   + H+ E+ L    +EI+I+  L
Sbjct: 11  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK--KLQHSTEEHLRDFEREIEILKSL 68
Query: 163 HHPKLINLHDAF--EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            H  ++             + LI E+L  G L + +     ++   +++  T     +Q 
Sbjct: 69  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT-----SQI 123
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE-----VVKISTGT 275
              ++++  K  IH D+   NI+ +  N   VK+ DFGL TK+ P +     V +     
Sbjct: 124 CKGMEYLGTKRYIHRDLATRNILVE--NENRVKIGDFGL-TKVLPQDKEXXKVKEPGESP 180
Query: 276 AEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS 307
             + APE +        +D+W+ GV+ Y L +
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 102/224 (45%), Gaps = 7/224 (3%)
Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMN 160
           T +V   Y  L+ IG+GA G+V    +       A K +  P  +    +   +E+ +M 
Sbjct: 19  TFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            ++H  +I+L + F     +    EF     + E + A   ++ + E+    +  L+ Q 
Sbjct: 79  XVNHKNIISLLNVFTPQKTLE---EFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQM 135
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAA 280
              +KH+H   IIH D+KP NI+   ++   +K++DFGLA     + ++     T  + A
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIV--VKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           PE++         D+W+VG +   ++     F G + ++    V
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 237

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 109 HYDILEEIGTGAFGVVHRCR----ERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQL 162
           H   L+++G G FG V  CR    +  TG + A K   + H+ E+ L    +EI+I+  L
Sbjct: 10  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK--KLQHSTEEHLRDFEREIEILKSL 67
Query: 163 HHPKLINLHDAF--EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            H  ++             + LI E+L  G L + +     ++   +++  T     +Q 
Sbjct: 68  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT-----SQI 122
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE-----VVKISTGT 275
              ++++  K  IH D+   NI+ +  N   VK+ DFGL TK+ P +     V +     
Sbjct: 123 CKGMEYLGTKRYIHRDLATRNILVE--NENRVKIGDFGL-TKVLPQDKEXXKVKEPGESP 179
Query: 276 AEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS 307
             + APE +        +D+W+ GV+ Y L +
Sbjct: 180 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 101/224 (45%), Gaps = 7/224 (3%)
Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMN 160
           T +V   Y  L+ IG+GA G+V    +       A K +  P  +    +   +E+ +M 
Sbjct: 13  TFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMK 72
Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            ++H  +I L + F     +    EF     + E + A   ++ + E+    +  L+ Q 
Sbjct: 73  CVNHKNIIGLLNVFTPQKSLE---EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 129
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAA 280
              +KH+H   IIH D+KP NI+   ++   +K++DFGLA     + ++     T  + A
Sbjct: 130 LCGIKHLHSAGIIHRDLKPSNIV--VKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 187
Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           PE++         D+W+VG +   ++     F G + ++    V
Sbjct: 188 PEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKV 231

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 19/215 (8%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF- 174
           IG G+FGVV++ +   +G + A K +      +K    +E+ IM +L H  ++ L   F 
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 111
Query: 175 ---EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
              E  DE+ L        E   R+ A  Y  ++  +  + + + M Q   ++ ++H   
Sbjct: 112 SSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 170
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGF 291
           I H D+KP+N++    ++  +K+ DFG A +L   E       +  + APE++     G 
Sbjct: 171 ICHRDIKPQNLLLDP-DTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI----FGA 225
Query: 292 --YT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
             YT   D+W+ G +   LL G   F G++ V+ L
Sbjct: 226 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 260

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 109 HYDILEEIGTGAFGVVHRCR----ERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQL 162
           H   L+++G G FG V  CR    +  TG + A K   + H+ E+ L    +EI+I+  L
Sbjct: 15  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK--KLQHSTEEHLRDFEREIEILKSL 72
Query: 163 HHPKLINLHDAF--EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            H  ++             + LI E+L  G L + +     ++   +++  T     +Q 
Sbjct: 73  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT-----SQI 127
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE-----VVKISTGT 275
              ++++  K  IH D+   NI+ +  N   VK+ DFGL TK+ P +     V +     
Sbjct: 128 CKGMEYLGTKRYIHRDLATRNILVE--NENRVKIGDFGL-TKVLPQDKEXXKVKEPGESP 184
Query: 276 AEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS 307
             + APE +        +D+W+ GV+ Y L +
Sbjct: 185 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 109 HYDILEEIGTGAFGVVHRCR----ERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQL 162
           H   L+++G G FG V  CR    +  TG + A K   + H+ E+ L    +EI+I+  L
Sbjct: 29  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK--KLQHSTEEHLRDFEREIEILKSL 86
Query: 163 HHPKLINLHDAF--EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            H  ++             + LI E+L  G L + +     ++   +++  T     +Q 
Sbjct: 87  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT-----SQI 141
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE-----VVKISTGT 275
              ++++  K  IH D+   NI+ +  N   VK+ DFGL TK+ P +     V +     
Sbjct: 142 CKGMEYLGTKRYIHRDLATRNILVE--NENRVKIGDFGL-TKVLPQDKEXXKVKEPGESP 198
Query: 276 AEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS 307
             + APE +        +D+W+ GV+ Y L +
Sbjct: 199 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 19/215 (8%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF- 174
           IG G+FGVV++ +   +G + A K +      +K    +E+ IM +L H  ++ L   F 
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 117
Query: 175 ---EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
              E  DE+ L        E   R+ A  Y  ++  +  + + + M Q   ++ ++H   
Sbjct: 118 SSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 176
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGF 291
           I H D+KP+N++    ++  +K+ DFG A +L   E       +  + APE++     G 
Sbjct: 177 ICHRDIKPQNLLLDP-DTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI----FGA 231
Query: 292 --YT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
             YT   D+W+ G +   LL G   F G++ V+ L
Sbjct: 232 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 266

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 101/224 (45%), Gaps = 7/224 (3%)
Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMN 160
           T +V   Y  L+ IG+GA G+V    +       A K +  P  +    +   +E+ +M 
Sbjct: 24  TFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMK 83
Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            ++H  +I L + F     +    EF     + E + A   ++ + E+    +  L+ Q 
Sbjct: 84  CVNHKNIIGLLNVFTPQKSLE---EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 140
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAA 280
              +KH+H   IIH D+KP NI+   ++   +K++DFGLA     + ++     T  + A
Sbjct: 141 LCGIKHLHSAGIIHRDLKPSNIV--VKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 198
Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           PE++         D+W+VG +   ++     F G + ++    V
Sbjct: 199 PEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKV 242

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 122/283 (43%), Gaps = 56/283 (19%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFI-PVSHNLEKELIRKEIDIMNQLHHPKLINLH--- 171
           +G GA+GVV     + TG I A K I P    L      +EI I+    H  +I +    
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78
Query: 172 --DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE 229
             D+FE+ +E+ +I E +       R+ +    +S+  +        + QT  AVK +H 
Sbjct: 79  RPDSFENFNEVYIIQELMQTD--LHRVISTQM-LSDDHI-----QYFIYQTLRAVKVLHG 130
Query: 230 KNIIHLDVKPENIMCQTRNSTNVKMIDFGLA-----TKLDPNEVVKISTGTAEFA----- 279
            N+IH D+KP N++  +  + ++K+ DFGLA     +  D +E     +G  EF      
Sbjct: 131 SNVIHRDLKPSNLLINS--NCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWY 188
Query: 280 -APEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAG-------------------ENDV 318
            APE+ +         D+W+ G +   L      F G                   +ND+
Sbjct: 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDL 248
Query: 319 ETLKNVKACDWEFD---------EEAFKNVSEEGKDFIRRLLL 352
             +++ +A ++            E+ F  V+ +G D ++R+L+
Sbjct: 249 RCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLV 291

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 19/215 (8%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF- 174
           IG G+FGVV++ +   +G + A K +      +K    +E+ IM +L H  ++ L   F 
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 121
Query: 175 ---EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
              E  DE+ L        E   R+ A  Y  ++  +  + + + M Q   ++ ++H   
Sbjct: 122 SSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 180
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGF 291
           I H D+KP+N++    ++  +K+ DFG A +L   E       +  + APE++     G 
Sbjct: 181 ICHRDIKPQNLLLDP-DTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI----FGA 235
Query: 292 --YT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
             YT   D+W+ G +   LL G   F G++ V+ L
Sbjct: 236 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 270

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 102/224 (45%), Gaps = 7/224 (3%)
Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMN 160
           T +V   Y  L+ IG+GA G+V    +       A K +  P  +    +   +E+ +M 
Sbjct: 18  TFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMK 77
Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            ++H  +I+L + F     +    EF     + E + A   ++ + E+    +  L+ Q 
Sbjct: 78  CVNHKNIISLLNVFTPQKTLE---EFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 134
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAA 280
              +KH+H   IIH D+KP NI+   ++   +K++DFGLA     + ++     T  + A
Sbjct: 135 LCGIKHLHSAGIIHRDLKPSNIV--VKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 192
Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           PE++         D+W+VG +   ++     F G + ++    V
Sbjct: 193 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 236

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 102/224 (45%), Gaps = 7/224 (3%)
Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMN 160
           T +V   Y  L+ IG+GA G+V    +       A K +  P  +    +   +E+ +M 
Sbjct: 13  TFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMK 72
Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            ++H  +I+L + F     +    EF     + E + A   ++ + E+    +  L+ Q 
Sbjct: 73  CVNHKNIISLLNVFTPQKTLE---EFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 129
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAA 280
              +KH+H   IIH D+KP NI+   ++   +K++DFGLA     + ++     T  + A
Sbjct: 130 LCGIKHLHSAGIIHRDLKPSNIV--VKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 187
Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           PE++         D+W+VG +   ++     F G + ++    V
Sbjct: 188 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 231

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 102/224 (45%), Gaps = 7/224 (3%)
Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMN 160
           T +V   Y  L+ IG+GA G+V    +       A K +  P  +    +   +E+ +M 
Sbjct: 19  TFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            ++H  +I+L + F     +    EF     + E + A   ++ + E+    +  L+ Q 
Sbjct: 79  CVNHKNIISLLNVFTPQKTLE---EFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAA 280
              +KH+H   IIH D+KP NI+   ++   +K++DFGLA     + ++     T  + A
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIV--VKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           PE++         D+W+VG +   ++     F G + ++    V
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 237

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 102/224 (45%), Gaps = 7/224 (3%)
Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMN 160
           T +V   Y  L+ IG+GA G+V    +       A K +  P  +    +   +E+ +M 
Sbjct: 19  TFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            ++H  +I+L + F     +    EF     + E + A   ++ + E+    +  L+ Q 
Sbjct: 79  CVNHKNIISLLNVFTPQKTLE---EFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 135
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAA 280
              +KH+H   IIH D+KP NI+   ++   +K++DFGLA     + ++     T  + A
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIV--VKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           PE++         D+W+VG +   ++     F G + ++    V
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 237

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 15/213 (7%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF- 174
           IG G+FGVV++ +   +G + A K +      +K    +E+ IM +L H  ++ L   F 
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 88
Query: 175 ---EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
              E  DE+ L        E   R+ A  Y  ++  +  + + + M Q   ++ ++H   
Sbjct: 89  SSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 147
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGF 291
           I H D+KP+N++    ++  +K+ DFG A +L   E       +  + APE++       
Sbjct: 148 ICHRDIKPQNLLLDP-DTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG--ATD 204
Query: 292 YT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
           YT   D+W+ G +   LL G   F G++ V+ L
Sbjct: 205 YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 237

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 109 HYDILEEIGTGAFGVVHRCR----ERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQL 162
           H   L+++G G FG V  CR    +  TG + A K   + H+ E+ L    +EI+I+  L
Sbjct: 29  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK--KLQHSTEEHLRDFEREIEILKSL 86
Query: 163 HHPKLINLHDAF--EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            H  ++             + LI E+L  G L + +     ++   +++  T     +Q 
Sbjct: 87  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT-----SQI 141
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE-----VVKISTGT 275
              ++++  K  IH D+   NI+ +  N   VK+ DFGL TK+ P +     V +     
Sbjct: 142 CKGMEYLGTKRYIHRDLATRNILVE--NENRVKIGDFGL-TKVLPQDKEXXKVKEPGESP 198
Query: 276 AEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS 307
             + APE +        +D+W+ GV+ Y L +
Sbjct: 199 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 102/224 (45%), Gaps = 7/224 (3%)
Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMN 160
           T +V   Y  L+ IG+GA G+V    +       A K +  P  +    +   +E+ +M 
Sbjct: 57  TFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMK 116
Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            ++H  +I+L + F     +    EF     + E + A   ++ + E+    +  L+ Q 
Sbjct: 117 CVNHKNIISLLNVFTPQKTLE---EFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 173
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAA 280
              +KH+H   IIH D+KP NI+   ++   +K++DFGLA     + ++     T  + A
Sbjct: 174 LCGIKHLHSAGIIHRDLKPSNIV--VKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 231
Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           PE++         D+W+VG +   ++     F G + ++    V
Sbjct: 232 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 275

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 102/224 (45%), Gaps = 7/224 (3%)
Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMN 160
           T +V   Y  L+ IG+GA G+V    +       A K +  P  +    +   +E+ +M 
Sbjct: 20  TFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMK 79
Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            ++H  +I+L + F     +    EF     + E + A   ++ + E+    +  L+ Q 
Sbjct: 80  CVNHKNIISLLNVFTPQKTLE---EFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 136
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAA 280
              +KH+H   IIH D+KP NI+   ++   +K++DFGLA     + ++     T  + A
Sbjct: 137 LCGIKHLHSAGIIHRDLKPSNIV--VKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194
Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           PE++         D+W+VG +   ++     F G + ++    V
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 238

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 102/224 (45%), Gaps = 7/224 (3%)
Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMN 160
           T +V   Y  L+ IG+GA G+V    +       A K +  P  +    +   +E+ +M 
Sbjct: 20  TFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMK 79
Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            ++H  +I+L + F     +    EF     + E + A   ++ + E+    +  L+ Q 
Sbjct: 80  CVNHKNIISLLNVFTPQKTLE---EFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 136
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAA 280
              +KH+H   IIH D+KP NI+   ++   +K++DFGLA     + ++     T  + A
Sbjct: 137 LCGIKHLHSAGIIHRDLKPSNIV--VKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194
Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           PE++         D+W+VG +   ++     F G + ++    V
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 238

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 19/215 (8%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF- 174
           IG G+FGVV++ +   +G + A K +      +K    +E+ IM +L H  ++ L   F 
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 119
Query: 175 ---EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
              E  DE+ L        E   R+ A  Y  ++  +  + + + M Q   ++ ++H   
Sbjct: 120 SSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 178
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGF 291
           I H D+KP+N++    ++  +K+ DFG A +L   E       +  + APE++     G 
Sbjct: 179 ICHRDIKPQNLLLDP-DTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI----FGA 233
Query: 292 --YT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
             YT   D+W+ G +   LL G   F G++ V+ L
Sbjct: 234 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 268

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 102/224 (45%), Gaps = 7/224 (3%)
Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMN 160
           T +V   Y  L+ IG+GA G+V    +       A K +  P  +    +   +E+ +M 
Sbjct: 12  TFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMK 71
Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            ++H  +I+L + F     +    EF     + E + A   ++ + E+    +  L+ Q 
Sbjct: 72  CVNHKNIISLLNVFTPQKTLE---EFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 128
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAA 280
              +KH+H   IIH D+KP NI+   ++   +K++DFGLA     + ++     T  + A
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIV--VKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 186
Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           PE++         D+W+VG +   ++     F G + ++    V
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 94/201 (46%), Gaps = 7/201 (3%)
Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMN 160
           T +V   Y  L+ IG+GA G+V    +       A K +  P  +    +   +E+ +M 
Sbjct: 57  TFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMK 116
Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            ++H  +I+L + F     +    EF     + E + A   ++ + E+    +  L+ Q 
Sbjct: 117 CVNHKNIISLLNVFTPQKTLE---EFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 173
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAA 280
              +KH+H   IIH D+KP NI+   ++   +K++DFGLA     + ++     T  + A
Sbjct: 174 LCGIKHLHSAGIIHRDLKPSNIV--VKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 231
Query: 281 PEIVEREPVGFYTDMWAVGVL 301
           PE++         D+W+VG +
Sbjct: 232 PEVILGMGYKENVDIWSVGCI 252

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 102/224 (45%), Gaps = 7/224 (3%)
Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMN 160
           T +V   Y  L+ IG+GA G+V    +       A K +  P  +    +   +E+ +M 
Sbjct: 19  TFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            ++H  +I+L + F     +    EF     + E + A   ++ + E+    +  L+ Q 
Sbjct: 79  XVNHKNIISLLNVFTPQKTLE---EFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQM 135
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAA 280
              +KH+H   IIH D+KP NI+   ++   +K++DFGLA     + ++     T  + A
Sbjct: 136 LXGIKHLHSAGIIHRDLKPSNIV--VKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           PE++         D+W+VG +   ++     F G + ++    V
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 237

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/240 (23%), Positives = 104/240 (43%), Gaps = 40/240 (16%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK--ELIRKEIDIMNQLHHP-- 165
           Y+I++ +G GAFG V  C + K G    A  + +  N+++  E  R EI ++  L+    
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVA--VKIVKNVDRYCEAARSEIQVLEHLNTTDP 73
Query: 166 ----KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLP---ILMT 218
               + + + + FE    + ++FE L        ++  D+ + E   +P  L     +  
Sbjct: 74  NSTFRCVQMLEWFEHHGHICIVFELLG-------LSTYDF-IKENGFLPFRLDHIRKMAY 125
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNST-----------------NVKMIDFGLAT 261
           Q   +V  +H   + H D+KPENI+    + T                 ++K++DFG AT
Sbjct: 126 QICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSAT 185
Query: 262 KLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETL 321
             D +    +S  T  + APE++         D+W++G +      G + F   +  E L
Sbjct: 186 YDDEHHSTLVS--TRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 102/224 (45%), Gaps = 7/224 (3%)
Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMN 160
           T +V   Y  L+ IG+GA G+V    +       A K +  P  +    +   +E+ +M 
Sbjct: 13  TFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMK 72
Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            ++H  +I+L + F     +    EF     + E + A   ++ + E+    +  L+ Q 
Sbjct: 73  CVNHKNIISLLNVFTPQKTLE---EFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 129
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAA 280
              +KH+H   IIH D+KP NI+   ++   +K++DFGLA     + ++     T  + A
Sbjct: 130 LCGIKHLHSAGIIHRDLKPSNIV--VKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 187
Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           PE++         D+W+VG +   ++     F G + ++    V
Sbjct: 188 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 231

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 110/242 (45%), Gaps = 25/242 (10%)
Query: 96  PQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGN---IFAAKFIPVSHNLEKELI 152
           P+ V  +   V   Y  L  IG GA+G+V  C      N   +   K  P  H    +  
Sbjct: 15  PEMVRGQVFDVGPRYTNLSYIGEGAYGMV--CSAYDNLNKVRVAIKKISPFEHQTYCQRT 72
Query: 153 RKEIDIMNQLHHPKLINLHDAFEDD--DEM--VLIFEFLSGGELFERITAPDYKMSEAEV 208
            +EI I+ +  H  +I ++D       ++M  V I + L   +L++ +      +S   +
Sbjct: 73  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQ--HLSNDHI 130
Query: 209 IPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE- 267
                   + Q    +K++H  N++H D+KP N++  T  + ++K+ DFGLA   DP+  
Sbjct: 131 C-----YFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--TCDLKICDFGLARVADPDHD 183
Query: 268 ---VVKISTGTAEFAAPEIVEREPVGF--YTDMWAVGVLAYVLLSGLSPFAGENDVETLK 322
               +     T  + APEI+     G+    D+W+VG +   +LS    F G++ ++ L 
Sbjct: 184 HTGFLTEYVATRWYRAPEIMLNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242
Query: 323 NV 324
           ++
Sbjct: 243 HI 244

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 19/215 (8%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF- 174
           IG G+FGVV++ +   +G + A K +      +K    +E+ IM +L H  ++ L   F 
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 162
Query: 175 ---EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
              E  DE+ L        E   R+ A  Y  ++  +  + + + M Q   ++ ++H   
Sbjct: 163 SSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 221
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGF 291
           I H D+KP+N++    ++  +K+ DFG A +L   E       +  + APE++     G 
Sbjct: 222 ICHRDIKPQNLLLDP-DTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI----FGA 276
Query: 292 --YT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
             YT   D+W+ G +   LL G   F G++ V+ L
Sbjct: 277 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 311

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 106/230 (46%), Gaps = 26/230 (11%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL--EKELIRKEIDIMNQLHHP 165
           D Y+I   IG G+FG V +  +R      A K I        + ++  + +++MN+ H  
Sbjct: 54  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNK-HDT 112
Query: 166 KL----INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSE-------AEVIPVTLP 214
           ++    ++L   F   + + L+FE LS   L++ +   +++          A+ +   L 
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALL 171
Query: 215 ILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTG 274
            L T          E +IIH D+KPENI+        +K++DFG + +L       I + 
Sbjct: 172 FLATP---------ELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQRIYQXIQSR 222
Query: 275 TAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
              + +PE++   P     DMW++G +   + +G   F+G N+V+ +  +
Sbjct: 223 F--YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKI 270

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 102/224 (45%), Gaps = 7/224 (3%)
Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMN 160
           T +V   Y  L+ IG+GA G+V    +       A K +  P  +    +   +E+ +M 
Sbjct: 12  TFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMK 71
Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            ++H  +I+L + F     +    EF     + E + A   ++ + E+    +  L+ Q 
Sbjct: 72  CVNHKNIISLLNVFTPQKTLE---EFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQM 128
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAA 280
              +KH+H   IIH D+KP NI+   ++   +K++DFGLA     + ++     T  + A
Sbjct: 129 LXGIKHLHSAGIIHRDLKPSNIV--VKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRA 186
Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           PE++         D+W+VG +   ++     F G + ++    V
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 102/224 (45%), Gaps = 7/224 (3%)
Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMN 160
           T +V   Y  L+ IG+GA G+V    +       A K +  P  +    +   +E+ +M 
Sbjct: 19  TFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            ++H  +I+L + F     +    EF     + E + A   ++ + E+    +  L+ Q 
Sbjct: 79  CVNHKNIISLLNVFTPQKTLE---EFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQM 135
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAA 280
              +KH+H   IIH D+KP NI+   ++   +K++DFGLA     + ++     T  + A
Sbjct: 136 LXGIKHLHSAGIIHRDLKPSNIV--VKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
           PE++         D+W+VG +   ++     F G + ++    V
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 237

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 110/242 (45%), Gaps = 25/242 (10%)
Query: 96  PQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGN---IFAAKFIPVSHNLEKELI 152
           P+ V  +   V   Y  L  IG GA+G+V  C      N   +   K  P  H    +  
Sbjct: 15  PEMVRGQVFDVGPRYTNLSYIGEGAYGMV--CSAYDNLNKVRVAIKKISPFEHQTYCQRT 72
Query: 153 RKEIDIMNQLHHPKLINLHDAFEDD--DEM--VLIFEFLSGGELFERITAPDYKMSEAEV 208
            +EI I+ +  H  +I ++D       ++M  V I + L   +L++ +      +S   +
Sbjct: 73  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ--HLSNDHI 130
Query: 209 IPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE- 267
                   + Q    +K++H  N++H D+KP N++  T  + ++K+ DFGLA   DP+  
Sbjct: 131 C-----YFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--TCDLKICDFGLARVADPDHD 183
Query: 268 ---VVKISTGTAEFAAPEIVEREPVGF--YTDMWAVGVLAYVLLSGLSPFAGENDVETLK 322
               +     T  + APEI+     G+    D+W+VG +   +LS    F G++ ++ L 
Sbjct: 184 HTGFLXEXVATRWYRAPEIMLNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242
Query: 323 NV 324
           ++
Sbjct: 243 HI 244

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 19/215 (8%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPV------SHNLEKELIRKEIDIMNQL-HHPKLI 168
           +G GAFG V        G   A   + V      +H  EKE +  E+ IM+ L  H  ++
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 169 NLHDAFEDDDEMVLIFEFLSGGEL--FERITAPDYKMSEAEVIPVTLPILM---TQTSPA 223
           NL  A      +++I E+   G+L  F R  A +  + + +  P+ L  L+   +Q +  
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKA-EADLDKEDGRPLELRDLLHFSSQVAQG 172
Query: 224 VKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--DPNEVVKISTGT-AEFAA 280
           +  +  KN IH DV   N++    N    K+ DFGLA  +  D N +VK +     ++ A
Sbjct: 173 MAFLASKNCIHRDVAARNVL--LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMA 230
Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
           PE +        +D+W+ G+L + + S GL+P+ G
Sbjct: 231 PESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG 265

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 110/242 (45%), Gaps = 25/242 (10%)
Query: 96  PQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGN---IFAAKFIPVSHNLEKELI 152
           P+ V  +   V   Y  L  IG GA+G+V  C      N   +   K  P  H    +  
Sbjct: 16  PEMVRGQVFDVGPRYTNLSYIGEGAYGMV--CSAYDNLNKVRVAIKKISPFEHQTYCQRT 73
Query: 153 RKEIDIMNQLHHPKLINLHDAFEDD--DEM--VLIFEFLSGGELFERITAPDYKMSEAEV 208
            +EI I+ +  H  +I ++D       ++M  V I + L   +L++ +      +S   +
Sbjct: 74  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ--HLSNDHI 131
Query: 209 IPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE- 267
                   + Q    +K++H  N++H D+KP N++  T  + ++K+ DFGLA   DP+  
Sbjct: 132 C-----YFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--TCDLKICDFGLARVADPDHD 184
Query: 268 ---VVKISTGTAEFAAPEIVEREPVGF--YTDMWAVGVLAYVLLSGLSPFAGENDVETLK 322
               +     T  + APEI+     G+    D+W+VG +   +LS    F G++ ++ L 
Sbjct: 185 HTGFLXEXVATRWYRAPEIMLNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 243
Query: 323 NV 324
           ++
Sbjct: 244 HI 245

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 110/242 (45%), Gaps = 25/242 (10%)
Query: 96  PQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGN---IFAAKFIPVSHNLEKELI 152
           P+ V  +   V   Y  L  IG GA+G+V  C      N   +   K  P  H    +  
Sbjct: 11  PEMVRGQVFDVGPRYTNLSYIGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRT 68
Query: 153 RKEIDIMNQLHHPKLINLHDAFEDD--DEM--VLIFEFLSGGELFERITAPDYKMSEAEV 208
            +EI I+ +  H  +I ++D       ++M  V I + L   +L++ +      +S   +
Sbjct: 69  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ--HLSNDHI 126
Query: 209 IPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE- 267
                   + Q    +K++H  N++H D+KP N++  T  + ++K+ DFGLA   DP+  
Sbjct: 127 C-----YFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--TCDLKICDFGLARVADPDHD 179
Query: 268 ---VVKISTGTAEFAAPEIVEREPVGF--YTDMWAVGVLAYVLLSGLSPFAGENDVETLK 322
               +     T  + APEI+     G+    D+W+VG +   +LS    F G++ ++ L 
Sbjct: 180 HTGFLTEYVATRWYRAPEIMLNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 238
Query: 323 NV 324
           ++
Sbjct: 239 HI 240

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 110/242 (45%), Gaps = 25/242 (10%)
Query: 96  PQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGN---IFAAKFIPVSHNLEKELI 152
           P+ V  +   V   Y  L  IG GA+G+V  C      N   +   K  P  H    +  
Sbjct: 15  PEMVRGQVFDVGPRYTNLSYIGEGAYGMV--CSAYDNLNKVRVAIKKISPFEHQTYXQRT 72
Query: 153 RKEIDIMNQLHHPKLINLHDAFEDD--DEM--VLIFEFLSGGELFERITAPDYKMSEAEV 208
            +EI I+ +  H  +I ++D       ++M  V I + L   +L++ +      +S   +
Sbjct: 73  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ--HLSNDHI 130
Query: 209 IPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE- 267
                   + Q    +K++H  N++H D+KP N++  T  + ++K+ DFGLA   DP+  
Sbjct: 131 C-----YFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--TXDLKICDFGLARVADPDHD 183
Query: 268 ---VVKISTGTAEFAAPEIVEREPVGF--YTDMWAVGVLAYVLLSGLSPFAGENDVETLK 322
               +     T  + APEI+     G+    D+W+VG +   +LS    F G++ ++ L 
Sbjct: 184 HTGFLTEYVATRWYRAPEIMLNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242
Query: 323 NV 324
           ++
Sbjct: 243 HI 244

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 100/207 (48%), Gaps = 18/207 (8%)
Query: 115 EIGTGAFGVVHRC--RERKTGNIFAAKFIPV-SHNLEKELIRKEIDIMNQLHHPKLINLH 171
           E+G G FG V +   R RK     A K +   +   + E + +E  IM+QL +P ++ L 
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVT-LPILMTQTSPAVKHMHEK 230
              + +  ++L+ E   GG L +      + + + E IPV+ +  L+ Q S  +K++ EK
Sbjct: 403 GVCQAE-ALMLVMEMAGGGPLHK------FLVGKREEIPVSNVAELLHQVSMGMKYLEEK 455
Query: 231 NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFA----APEIVER 286
           N +H ++   N++   R+    K+ DFGL+  L  ++    +    ++     APE +  
Sbjct: 456 NFVHRNLAARNVLLVNRH--YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 513
Query: 287 EPVGFYTDMWAVGVLAYVLLS-GLSPF 312
                 +D+W+ GV  +  LS G  P+
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQKPY 540

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 110/242 (45%), Gaps = 25/242 (10%)
Query: 96  PQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGN---IFAAKFIPVSHNLEKELI 152
           P+ V  +   V   Y  L  IG GA+G+V  C      N   +   K  P  H    +  
Sbjct: 16  PEMVRGQVFDVGPRYTNLSYIGEGAYGMV--CSAYDNLNKVRVAIKKISPFEHQTYCQRT 73
Query: 153 RKEIDIMNQLHHPKLINLHDAFEDD--DEM--VLIFEFLSGGELFERITAPDYKMSEAEV 208
            +EI I+ +  H  +I ++D       ++M  V I + L   +L++ +      +S   +
Sbjct: 74  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ--HLSNDHI 131
Query: 209 IPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE- 267
                   + Q    +K++H  N++H D+KP N++  T  + ++K+ DFGLA   DP+  
Sbjct: 132 C-----YFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--TCDLKICDFGLARVADPDHD 184
Query: 268 ---VVKISTGTAEFAAPEIVEREPVGF--YTDMWAVGVLAYVLLSGLSPFAGENDVETLK 322
               +     T  + APEI+     G+    D+W+VG +   +LS    F G++ ++ L 
Sbjct: 185 HTGFLTEYVATRWYRAPEIMLNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 243
Query: 323 NV 324
           ++
Sbjct: 244 HI 245

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 110/242 (45%), Gaps = 25/242 (10%)
Query: 96  PQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGN---IFAAKFIPVSHNLEKELI 152
           P+ V  +   V   Y  L  IG GA+G+V  C      N   +   K  P  H    +  
Sbjct: 17  PEMVRGQVFDVGPRYTNLSYIGEGAYGMV--CSAYDNLNKVRVAIKKISPFEHQTYCQRT 74
Query: 153 RKEIDIMNQLHHPKLINLHDAFEDD--DEM--VLIFEFLSGGELFERITAPDYKMSEAEV 208
            +EI I+ +  H  +I ++D       ++M  V I + L   +L++ +      +S   +
Sbjct: 75  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ--HLSNDHI 132
Query: 209 IPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE- 267
                   + Q    +K++H  N++H D+KP N++  T  + ++K+ DFGLA   DP+  
Sbjct: 133 C-----YFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--TCDLKICDFGLARVADPDHD 185
Query: 268 ---VVKISTGTAEFAAPEIVEREPVGF--YTDMWAVGVLAYVLLSGLSPFAGENDVETLK 322
               +     T  + APEI+     G+    D+W+VG +   +LS    F G++ ++ L 
Sbjct: 186 HTGFLTEYVATRWYRAPEIMLNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 244
Query: 323 NV 324
           ++
Sbjct: 245 HI 246

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 110/242 (45%), Gaps = 25/242 (10%)
Query: 96  PQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGN---IFAAKFIPVSHNLEKELI 152
           P+ V  +   V   Y  L  IG GA+G+V  C      N   +   K  P  H    +  
Sbjct: 8   PEMVRGQVFDVGPRYTNLSYIGEGAYGMV--CSAYDNLNKVRVAIKKISPFEHQTYCQRT 65
Query: 153 RKEIDIMNQLHHPKLINLHDAFEDD--DEM--VLIFEFLSGGELFERITAPDYKMSEAEV 208
            +EI I+ +  H  +I ++D       ++M  V I + L   +L++ +      +S   +
Sbjct: 66  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ--HLSNDHI 123
Query: 209 IPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE- 267
                   + Q    +K++H  N++H D+KP N++  T  + ++K+ DFGLA   DP+  
Sbjct: 124 C-----YFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--TCDLKICDFGLARVADPDHD 176
Query: 268 ---VVKISTGTAEFAAPEIVEREPVGF--YTDMWAVGVLAYVLLSGLSPFAGENDVETLK 322
               +     T  + APEI+     G+    D+W+VG +   +LS    F G++ ++ L 
Sbjct: 177 HTGFLTEYVATRWYRAPEIMLNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 235
Query: 323 NV 324
           ++
Sbjct: 236 HI 237

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 110/242 (45%), Gaps = 25/242 (10%)
Query: 96  PQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGN---IFAAKFIPVSHNLEKELI 152
           P+ V  +   V   Y  L  IG GA+G+V  C      N   +   K  P  H    +  
Sbjct: 15  PEMVRGQVFDVGPRYTNLSYIGEGAYGMV--CSAYDNLNKVRVAIKKISPFEHQTYCQRT 72
Query: 153 RKEIDIMNQLHHPKLINLHDAFEDD--DEM--VLIFEFLSGGELFERITAPDYKMSEAEV 208
            +EI I+ +  H  +I ++D       ++M  V I + L   +L++ +      +S   +
Sbjct: 73  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ--HLSNDHI 130
Query: 209 IPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE- 267
                   + Q    +K++H  N++H D+KP N++  T  + ++K+ DFGLA   DP+  
Sbjct: 131 C-----YFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--TCDLKICDFGLARVADPDHD 183
Query: 268 ---VVKISTGTAEFAAPEIVEREPVGF--YTDMWAVGVLAYVLLSGLSPFAGENDVETLK 322
               +     T  + APEI+     G+    D+W+VG +   +LS    F G++ ++ L 
Sbjct: 184 HTGFLTEYVATRWYRAPEIMLNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242
Query: 323 NV 324
           ++
Sbjct: 243 HI 244

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 110/242 (45%), Gaps = 25/242 (10%)
Query: 96  PQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGN---IFAAKFIPVSHNLEKELI 152
           P+ V  +   V   Y  L  IG GA+G+V  C      N   +   K  P  H    +  
Sbjct: 13  PEMVRGQVFDVGPRYTNLSYIGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRT 70
Query: 153 RKEIDIMNQLHHPKLINLHDAFEDD--DEM--VLIFEFLSGGELFERITAPDYKMSEAEV 208
            +EI I+ +  H  +I ++D       ++M  V I + L   +L++ +      +S   +
Sbjct: 71  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ--HLSNDHI 128
Query: 209 IPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE- 267
                   + Q    +K++H  N++H D+KP N++  T  + ++K+ DFGLA   DP+  
Sbjct: 129 C-----YFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--TCDLKICDFGLARVADPDHD 181
Query: 268 ---VVKISTGTAEFAAPEIVEREPVGF--YTDMWAVGVLAYVLLSGLSPFAGENDVETLK 322
               +     T  + APEI+     G+    D+W+VG +   +LS    F G++ ++ L 
Sbjct: 182 HTGFLTEYVATRWYRAPEIMLNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 240
Query: 323 NV 324
           ++
Sbjct: 241 HI 242

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 103/215 (47%), Gaps = 19/215 (8%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFE 175
           IG G+FGVV++ +   +G + A K +      +K    +E+ IM +L H  ++ L   F 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 176 DDDE------MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE 229
              E      + L+ +++   E   R+ A  Y  ++  +  + + + M Q   ++ ++H 
Sbjct: 84  SSGEKKDVVYLNLVLDYVP--ETVYRV-ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 230 KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPV 289
             I H D+KP+N++    ++  +K+ DFG A +L   E       +  + APE++     
Sbjct: 141 FGICHRDIKPQNLLLDP-DTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG--A 197
Query: 290 GFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
             YT   D+W+ G +   LL G   F G++ V+ L
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 232

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 110/242 (45%), Gaps = 25/242 (10%)
Query: 96  PQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGN---IFAAKFIPVSHNLEKELI 152
           P+ V  +   V   Y  L  IG GA+G+V  C      N   +   K  P  H    +  
Sbjct: 9   PEMVRGQVFDVGPRYTNLSYIGEGAYGMV--CSAYDNLNKVRVAIKKISPFEHQTYCQRT 66
Query: 153 RKEIDIMNQLHHPKLINLHDAFEDD--DEM--VLIFEFLSGGELFERITAPDYKMSEAEV 208
            +EI I+ +  H  +I ++D       ++M  V I + L   +L++ +      +S   +
Sbjct: 67  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ--HLSNDHI 124
Query: 209 IPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE- 267
                   + Q    +K++H  N++H D+KP N++  T  + ++K+ DFGLA   DP+  
Sbjct: 125 C-----YFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--TCDLKICDFGLARVADPDHD 177
Query: 268 ---VVKISTGTAEFAAPEIVEREPVGF--YTDMWAVGVLAYVLLSGLSPFAGENDVETLK 322
               +     T  + APEI+     G+    D+W+VG +   +LS    F G++ ++ L 
Sbjct: 178 HTGFLTEYVATRWYRAPEIMLNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 236
Query: 323 NV 324
           ++
Sbjct: 237 HI 238

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 110/242 (45%), Gaps = 25/242 (10%)
Query: 96  PQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGN---IFAAKFIPVSHNLEKELI 152
           P+ V  +   V   Y  L  IG GA+G+V  C      N   +   K  P  H    +  
Sbjct: 9   PEMVRGQVFDVGPRYTNLSYIGEGAYGMV--CSAYDNLNKVRVAIKKISPFEHQTYCQRT 66
Query: 153 RKEIDIMNQLHHPKLINLHDAFEDD--DEM--VLIFEFLSGGELFERITAPDYKMSEAEV 208
            +EI I+ +  H  +I ++D       ++M  V I + L   +L++ +      +S   +
Sbjct: 67  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ--HLSNDHI 124
Query: 209 IPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE- 267
                   + Q    +K++H  N++H D+KP N++  T  + ++K+ DFGLA   DP+  
Sbjct: 125 C-----YFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--TCDLKICDFGLARVADPDHD 177
Query: 268 ---VVKISTGTAEFAAPEIVEREPVGF--YTDMWAVGVLAYVLLSGLSPFAGENDVETLK 322
               +     T  + APEI+     G+    D+W+VG +   +LS    F G++ ++ L 
Sbjct: 178 HTGFLTEYVATRWYRAPEIMLNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 236
Query: 323 NV 324
           ++
Sbjct: 237 HI 238

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 110/242 (45%), Gaps = 25/242 (10%)
Query: 96  PQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGN---IFAAKFIPVSHNLEKELI 152
           P+ V  +   V   Y  L  IG GA+G+V  C      N   +   K  P  H    +  
Sbjct: 19  PEMVRGQVFDVGPRYTNLSYIGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRT 76
Query: 153 RKEIDIMNQLHHPKLINLHDAFEDD--DEM--VLIFEFLSGGELFERITAPDYKMSEAEV 208
            +EI I+ +  H  +I ++D       ++M  V I + L   +L++ +      +S   +
Sbjct: 77  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ--HLSNDHI 134
Query: 209 IPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE- 267
                   + Q    +K++H  N++H D+KP N++  T  + ++K+ DFGLA   DP+  
Sbjct: 135 C-----YFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--TCDLKICDFGLARVADPDHD 187
Query: 268 ---VVKISTGTAEFAAPEIVEREPVGF--YTDMWAVGVLAYVLLSGLSPFAGENDVETLK 322
               +     T  + APEI+     G+    D+W+VG +   +LS    F G++ ++ L 
Sbjct: 188 HTGFLTEYVATRWYRAPEIMLNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 246
Query: 323 NV 324
           ++
Sbjct: 247 HI 248

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 110/242 (45%), Gaps = 25/242 (10%)
Query: 96  PQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGN---IFAAKFIPVSHNLEKELI 152
           P+ V  +   V   Y  L  IG GA+G+V  C      N   +   K  P  H    +  
Sbjct: 11  PEMVRGQVFDVGPRYTNLSYIGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRT 68
Query: 153 RKEIDIMNQLHHPKLINLHDAFEDD--DEM--VLIFEFLSGGELFERITAPDYKMSEAEV 208
            +EI I+ +  H  +I ++D       ++M  V I + L   +L++ +      +S   +
Sbjct: 69  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ--HLSNDHI 126
Query: 209 IPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE- 267
                   + Q    +K++H  N++H D+KP N++  T  + ++K+ DFGLA   DP+  
Sbjct: 127 C-----YFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--TCDLKICDFGLARVADPDHD 179
Query: 268 ---VVKISTGTAEFAAPEIVEREPVGF--YTDMWAVGVLAYVLLSGLSPFAGENDVETLK 322
               +     T  + APEI+     G+    D+W+VG +   +LS    F G++ ++ L 
Sbjct: 180 HTGFLTEYVATRWYRAPEIMLNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 238
Query: 323 NV 324
           ++
Sbjct: 239 HI 240

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 110/242 (45%), Gaps = 25/242 (10%)
Query: 96  PQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGN---IFAAKFIPVSHNLEKELI 152
           P+ V  +   V   Y  L  IG GA+G+V  C      N   +   K  P  H    +  
Sbjct: 31  PEMVRGQVFDVGPRYTNLSYIGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRT 88
Query: 153 RKEIDIMNQLHHPKLINLHDAFEDD--DEM--VLIFEFLSGGELFERITAPDYKMSEAEV 208
            +EI I+ +  H  +I ++D       ++M  V I + L   +L++ +      +S   +
Sbjct: 89  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ--HLSNDHI 146
Query: 209 IPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE- 267
                   + Q    +K++H  N++H D+KP N++  T  + ++K+ DFGLA   DP+  
Sbjct: 147 C-----YFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--TCDLKICDFGLARVADPDHD 199
Query: 268 ---VVKISTGTAEFAAPEIVEREPVGF--YTDMWAVGVLAYVLLSGLSPFAGENDVETLK 322
               +     T  + APEI+     G+    D+W+VG +   +LS    F G++ ++ L 
Sbjct: 200 HTGFLTEYVATRWYRAPEIMLNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 258
Query: 323 NV 324
           ++
Sbjct: 259 HI 260

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 110/242 (45%), Gaps = 25/242 (10%)
Query: 96  PQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGN---IFAAKFIPVSHNLEKELI 152
           P+ V  +   V   Y  L  IG GA+G+V  C      N   +   K  P  H    +  
Sbjct: 11  PEMVRGQVFDVGPRYTNLSYIGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRT 68
Query: 153 RKEIDIMNQLHHPKLINLHDAFEDD--DEM--VLIFEFLSGGELFERITAPDYKMSEAEV 208
            +EI I+ +  H  +I ++D       ++M  V I + L   +L++ +      +S   +
Sbjct: 69  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ--HLSNDHI 126
Query: 209 IPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE- 267
                   + Q    +K++H  N++H D+KP N++  T  + ++K+ DFGLA   DP+  
Sbjct: 127 C-----YFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--TXDLKICDFGLARVADPDHD 179
Query: 268 ---VVKISTGTAEFAAPEIVEREPVGF--YTDMWAVGVLAYVLLSGLSPFAGENDVETLK 322
               +     T  + APEI+     G+    D+W+VG +   +LS    F G++ ++ L 
Sbjct: 180 HTGFLTEYVATRWYRAPEIMLNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 238
Query: 323 NV 324
           ++
Sbjct: 239 HI 240

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 101/217 (46%), Gaps = 12/217 (5%)
Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLH 171
           ++E +G G FG V        G+   A       ++  +    E ++M QL H +L+ L+
Sbjct: 25  LVERLGAGQFGEVWMGY--YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 82
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
            A    + + +I E++  G L + +  P    S  ++    L  +  Q +  +  + E+N
Sbjct: 83  -AVVTQEPIYIITEYMENGSLVDFLKTP----SGIKLTINKLLDMAAQIAEGMAFIEERN 137
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTG--TAEFAAPEIVEREPV 289
            IH D++  NI+    ++ + K+ DFGLA  ++ NE           ++ APE +     
Sbjct: 138 YIHRDLRAANILVS--DTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTF 195
Query: 290 GFYTDMWAVGV-LAYVLLSGLSPFAGENDVETLKNVK 325
              +D+W+ G+ L  ++  G  P+ G  + E ++N++
Sbjct: 196 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 232

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 17/214 (7%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE-KELIRKEIDIMNQLHHPKLINLHDAF 174
           IG G+FGVV++ +   +G + A K +     L+ K    +E+ IM +L H  ++ L   F
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKV-----LQGKAFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 175 ----EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEK 230
               E  DE+ L        E   R+ A  Y  ++  +  + + + M Q   ++ ++H  
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 231 NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVG 290
            I H D+KP+N++    ++  +K+ DFG A +L   E       +  + APE++      
Sbjct: 142 GICHRDIKPQNLLLDP-DTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG--AT 198
Query: 291 FYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
            YT   D+W+ G +   LL G   F G++ V+ L
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 232

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 110/242 (45%), Gaps = 25/242 (10%)
Query: 96  PQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGN---IFAAKFIPVSHNLEKELI 152
           P+ V  +   V   Y  L  IG GA+G+V  C      N   +   K  P  H    +  
Sbjct: 15  PEMVRGQVFDVGPRYTNLSYIGEGAYGMV--CSAYDNLNKVRVAIRKISPFEHQTYCQRT 72
Query: 153 RKEIDIMNQLHHPKLINLHDAFEDD--DEM--VLIFEFLSGGELFERITAPDYKMSEAEV 208
            +EI I+ +  H  +I ++D       ++M  V I + L   +L++ +      +S   +
Sbjct: 73  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ--HLSNDHI 130
Query: 209 IPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE- 267
                   + Q    +K++H  N++H D+KP N++  T  + ++K+ DFGLA   DP+  
Sbjct: 131 C-----YFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--TCDLKICDFGLARVADPDHD 183
Query: 268 ---VVKISTGTAEFAAPEIVEREPVGF--YTDMWAVGVLAYVLLSGLSPFAGENDVETLK 322
               +     T  + APEI+     G+    D+W+VG +   +LS    F G++ ++ L 
Sbjct: 184 HTGFLTEYVATRWYRAPEIMLNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242
Query: 323 NV 324
           ++
Sbjct: 243 HI 244

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 110/242 (45%), Gaps = 25/242 (10%)
Query: 96  PQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGN---IFAAKFIPVSHNLEKELI 152
           P+ V  +   V   Y  L  IG GA+G+V  C      N   +   K  P  H    +  
Sbjct: 13  PEMVRGQVFDVGPRYTNLSYIGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRT 70
Query: 153 RKEIDIMNQLHHPKLINLHDAFEDD--DEM--VLIFEFLSGGELFERITAPDYKMSEAEV 208
            +EI I+    H  +I ++D       ++M  V I + L   +L++ +      +S   +
Sbjct: 71  LREIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ--HLSNDHI 128
Query: 209 IPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE- 267
                   + Q    +K++H  N++H D+KP N++  T  ++++K+ DFGLA   DP+  
Sbjct: 129 C-----YFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--TSDLKICDFGLARVADPDHD 181
Query: 268 ---VVKISTGTAEFAAPEIVEREPVGF--YTDMWAVGVLAYVLLSGLSPFAGENDVETLK 322
               +     T  + APEI+     G+    D+W+VG +   +LS    F G++ ++ L 
Sbjct: 182 HTGFLTEYVATRWYRAPEIMLNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 240
Query: 323 NV 324
           ++
Sbjct: 241 HI 242

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 110/242 (45%), Gaps = 25/242 (10%)
Query: 96  PQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGN---IFAAKFIPVSHNLEKELI 152
           P+ V  +   V   Y  L  IG GA+G+V  C      N   +   K  P  H    +  
Sbjct: 11  PEMVRGQVFDVGPRYTNLSYIGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRT 68
Query: 153 RKEIDIMNQLHHPKLINLHDAFEDD--DEM--VLIFEFLSGGELFERITAPDYKMSEAEV 208
            +EI I+ +  H  +I ++D       ++M  V I + L   +L++ +      +S   +
Sbjct: 69  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ--HLSNDHI 126
Query: 209 IPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE- 267
                   + Q    +K++H  N++H D+KP N++  T  + ++K+ DFGLA   DP+  
Sbjct: 127 C-----YFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--TXDLKICDFGLARVADPDHD 179
Query: 268 ---VVKISTGTAEFAAPEIVEREPVGF--YTDMWAVGVLAYVLLSGLSPFAGENDVETLK 322
               +     T  + APEI+     G+    D+W+VG +   +LS    F G++ ++ L 
Sbjct: 180 HTGFLTEYVATRWYRAPEIMLNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 238
Query: 323 NV 324
           ++
Sbjct: 239 HI 240

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 101/217 (46%), Gaps = 12/217 (5%)
Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLH 171
           ++E +G G FG V        G+   A       ++  +    E ++M QL H +L+ L+
Sbjct: 23  LVERLGAGQFGEVWMGY--YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 80
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
            A    + + +I E++  G L + +  P    S  ++    L  +  Q +  +  + E+N
Sbjct: 81  -AVVTQEPIYIITEYMENGSLVDFLKTP----SGIKLTINKLLDMAAQIAEGMAFIEERN 135
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT--AEFAAPEIVEREPV 289
            IH D++  NI+    ++ + K+ DFGLA  ++ NE           ++ APE +     
Sbjct: 136 YIHRDLRAANILVS--DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 193
Query: 290 GFYTDMWAVGV-LAYVLLSGLSPFAGENDVETLKNVK 325
              +D+W+ G+ L  ++  G  P+ G  + E ++N++
Sbjct: 194 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 230

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 101/217 (46%), Gaps = 12/217 (5%)
Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLH 171
           ++E +G G FG V        G+   A       ++  +    E ++M QL H +L+ L+
Sbjct: 17  LVERLGAGQFGEVWMGY--YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 74
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
            A    + + +I E++  G L + +  P    S  ++    L  +  Q +  +  + E+N
Sbjct: 75  -AVVTQEPIYIITEYMENGSLVDFLKTP----SGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT--AEFAAPEIVEREPV 289
            IH D++  NI+    ++ + K+ DFGLA  ++ NE           ++ APE +     
Sbjct: 130 YIHRDLRAANILVS--DTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTF 187
Query: 290 GFYTDMWAVGV-LAYVLLSGLSPFAGENDVETLKNVK 325
              +D+W+ G+ L  ++  G  P+ G  + E ++N++
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 101/217 (46%), Gaps = 12/217 (5%)
Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLH 171
           ++E +G G FG V        G+   A       ++  +    E ++M QL H +L+ L+
Sbjct: 22  LVERLGAGQFGEVWMGY--YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 79
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
            A    + + +I E++  G L + +  P    S  ++    L  +  Q +  +  + E+N
Sbjct: 80  -AVVTQEPIYIITEYMENGSLVDFLKTP----SGIKLTINKLLDMAAQIAEGMAFIEERN 134
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT--AEFAAPEIVEREPV 289
            IH D++  NI+    ++ + K+ DFGLA  ++ NE           ++ APE +     
Sbjct: 135 YIHRDLRAANILVS--DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 192
Query: 290 GFYTDMWAVGV-LAYVLLSGLSPFAGENDVETLKNVK 325
              +D+W+ G+ L  ++  G  P+ G  + E ++N++
Sbjct: 193 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 229

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 122/283 (43%), Gaps = 56/283 (19%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFI-PVSHNLEKELIRKEIDIMNQLHHPKLINLH--- 171
           +G GA+GVV     + TG I A K I P    L      +EI I+    H  +I +    
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78
Query: 172 --DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE 229
             D+FE+ +E+ +I E +       R+ +    +S+  +        + QT  AVK +H 
Sbjct: 79  RPDSFENFNEVYIIQELMQTD--LHRVISTQM-LSDDHI-----QYFIYQTLRAVKVLHG 130
Query: 230 KNIIHLDVKPENIMCQTRNSTNVKMIDFGLA-----TKLDPNEVVKISTGTAEFA----- 279
            N+IH D+KP N++  +  + ++K+ DFGLA     +  D +E     +G  E+      
Sbjct: 131 SNVIHRDLKPSNLLINS--NCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWY 188
Query: 280 -APEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAG-------------------ENDV 318
            APE+ +         D+W+ G +   L      F G                   +ND+
Sbjct: 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDL 248
Query: 319 ETLKNVKACDWEFD---------EEAFKNVSEEGKDFIRRLLL 352
             +++ +A ++            E+ F  V+ +G D ++R+L+
Sbjct: 249 RCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLV 291

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 101/217 (46%), Gaps = 12/217 (5%)
Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLH 171
           ++E +G G FG V        G+   A       ++  +    E ++M QL H +L+ L+
Sbjct: 17  LVERLGAGQFGEVWMGY--YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 74
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
            A    + + +I E++  G L + +  P    S  ++    L  +  Q +  +  + E+N
Sbjct: 75  -AVVTQEPIYIITEYMENGSLVDFLKTP----SGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTG--TAEFAAPEIVEREPV 289
            IH D++  NI+    ++ + K+ DFGLA  ++ NE           ++ APE +     
Sbjct: 130 YIHRDLRAANILVS--DTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTF 187
Query: 290 GFYTDMWAVGV-LAYVLLSGLSPFAGENDVETLKNVK 325
              +D+W+ G+ L  ++  G  P+ G  + E ++N++
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 101/217 (46%), Gaps = 12/217 (5%)
Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLH 171
           ++E +G G FG V        G+   A       ++  +    E ++M QL H +L+ L+
Sbjct: 12  LVERLGAGQFGEVWMGY--YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 69
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
            A    + + +I E++  G L + +  P    S  ++    L  +  Q +  +  + E+N
Sbjct: 70  -AVVTQEPIYIITEYMENGSLVDFLKTP----SGIKLTINKLLDMAAQIAEGMAFIEERN 124
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT--AEFAAPEIVEREPV 289
            IH D++  NI+    ++ + K+ DFGLA  ++ NE           ++ APE +     
Sbjct: 125 YIHRDLRAANILVS--DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 182
Query: 290 GFYTDMWAVGV-LAYVLLSGLSPFAGENDVETLKNVK 325
              +D+W+ G+ L  ++  G  P+ G  + E ++N++
Sbjct: 183 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 219

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 101/217 (46%), Gaps = 12/217 (5%)
Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLH 171
           ++E +G G FG V        G+   A       ++  +    E ++M QL H +L+ L+
Sbjct: 23  LVERLGAGQFGEVWMGY--YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 80
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
            A    + + +I E++  G L + +  P    S  ++    L  +  Q +  +  + E+N
Sbjct: 81  -AVVTQEPIYIITEYMENGSLVDFLKTP----SGIKLTINKLLDMAAQIAEGMAFIEERN 135
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTG--TAEFAAPEIVEREPV 289
            IH D++  NI+    ++ + K+ DFGLA  ++ NE           ++ APE +     
Sbjct: 136 YIHRDLRAANILVS--DTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTF 193
Query: 290 GFYTDMWAVGV-LAYVLLSGLSPFAGENDVETLKNVK 325
              +D+W+ G+ L  ++  G  P+ G  + E ++N++
Sbjct: 194 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 230

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 101/217 (46%), Gaps = 12/217 (5%)
Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLH 171
           ++E +G G FG V        G+   A       ++  +    E ++M QL H +L+ L+
Sbjct: 17  LVERLGAGQFGEVWMGY--YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 74
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
            A    + + +I E++  G L + +  P    S  ++    L  +  Q +  +  + E+N
Sbjct: 75  -AVVTQEPIYIITEYMENGSLVDFLKTP----SGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT--AEFAAPEIVEREPV 289
            IH D++  NI+    ++ + K+ DFGLA  ++ NE           ++ APE +     
Sbjct: 130 YIHRDLRAANILVS--DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 187
Query: 290 GFYTDMWAVGV-LAYVLLSGLSPFAGENDVETLKNVK 325
              +D+W+ G+ L  ++  G  P+ G  + E ++N++
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 109 HYDILEEIGTGAFGVVHRCR----ERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQL 162
           H   L+++G G FG V  CR    +  TG + A K   + H+ E+ L    +EI+I+  L
Sbjct: 12  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK--KLQHSTEEHLRDFEREIEILKSL 69
Query: 163 HHPKLINLHDAFEDDDE--MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            H  ++             + LI E+L  G L + +     ++   +++  T     +Q 
Sbjct: 70  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT-----SQI 124
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE-----VVKISTGT 275
              ++++  K  IH ++   NI+ +  N   VK+ DFGL TK+ P +     V +     
Sbjct: 125 CKGMEYLGTKRYIHRNLATRNILVE--NENRVKIGDFGL-TKVLPQDKEYYKVKEPGESP 181
Query: 276 AEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS 307
             + APE +        +D+W+ GV+ Y L +
Sbjct: 182 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 110/242 (45%), Gaps = 25/242 (10%)
Query: 96  PQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGN---IFAAKFIPVSHNLEKELI 152
           P+ V  +   V   Y  L  IG GA+G+V  C      N   +   K  P  H    +  
Sbjct: 15  PEMVRGQVFDVGPRYTNLSYIGEGAYGMV--CSAYDNLNKVRVAIKKISPFEHQTYCQRT 72
Query: 153 RKEIDIMNQLHHPKLINLHDAFEDD--DEM--VLIFEFLSGGELFERITAPDYKMSEAEV 208
            +EI I+ +  H  +I ++D       ++M  V I + L   +L++ +      +S   +
Sbjct: 73  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ--HLSNDHI 130
Query: 209 IPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE- 267
                   + Q    +K++H  N++H D+KP N++  T  + ++K+ DFGLA   DP+  
Sbjct: 131 C-----YFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--TXDLKICDFGLARVADPDHD 183
Query: 268 ---VVKISTGTAEFAAPEIVEREPVGF--YTDMWAVGVLAYVLLSGLSPFAGENDVETLK 322
               +     T  + APEI+     G+    D+W+VG +   +LS    F G++ ++ L 
Sbjct: 184 HTGFLTEYVATRWYRAPEIMLNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242
Query: 323 NV 324
           ++
Sbjct: 243 HI 244

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 101/217 (46%), Gaps = 12/217 (5%)
Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLH 171
           ++E +G G FG V        G+   A       ++  +    E ++M QL H +L+ L+
Sbjct: 18  LVERLGAGQFGEVWMGY--YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 75
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
            A    + + +I E++  G L + +  P    S  ++    L  +  Q +  +  + E+N
Sbjct: 76  -AVVTQEPIYIITEYMENGSLVDFLKTP----SGIKLTINKLLDMAAQIAEGMAFIEERN 130
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT--AEFAAPEIVEREPV 289
            IH D++  NI+    ++ + K+ DFGLA  ++ NE           ++ APE +     
Sbjct: 131 YIHRDLRAANILVS--DTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTF 188
Query: 290 GFYTDMWAVGV-LAYVLLSGLSPFAGENDVETLKNVK 325
              +D+W+ G+ L  ++  G  P+ G  + E ++N++
Sbjct: 189 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 225

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 17/214 (7%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE-KELIRKEIDIMNQLHHPKLINLHDAF 174
           IG G+FGVV++ +   +G + A K +     L+ K    +E+ IM +L H  ++ L   F
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKV-----LQGKAFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 175 ----EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEK 230
               E  DE+ L        E   R+ A  Y  ++  +  + + + M Q   ++ ++H  
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 231 NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVG 290
            I H D+KP+N++    ++  +K+ DFG A +L   E       +  + APE++      
Sbjct: 142 GICHRDIKPQNLLLDP-DTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG--AT 198
Query: 291 FYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
            YT   D+W+ G +   LL G   F G++ V+ L
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 232

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 101/217 (46%), Gaps = 12/217 (5%)
Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLH 171
           ++E +G G FG V        G+   A       ++  +    E ++M QL H +L+ L+
Sbjct: 27  LVERLGAGQFGEVWMGY--YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 84
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
            A    + + +I E++  G L + +  P    S  ++    L  +  Q +  +  + E+N
Sbjct: 85  -AVVTQEPIYIITEYMENGSLVDFLKTP----SGIKLTINKLLDMAAQIAEGMAFIEERN 139
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTG--TAEFAAPEIVEREPV 289
            IH D++  NI+    ++ + K+ DFGLA  ++ NE           ++ APE +     
Sbjct: 140 YIHRDLRAANILVS--DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 197
Query: 290 GFYTDMWAVGV-LAYVLLSGLSPFAGENDVETLKNVK 325
              +D+W+ G+ L  ++  G  P+ G  + E ++N++
Sbjct: 198 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 234

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 19/215 (8%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPV------SHNLEKELIRKEIDIMNQL-HHPKLI 168
           +G GAFG V        G   A   + V      +H  EKE +  E+ IM+ L  H  ++
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 105
Query: 169 NLHDAFEDDDEMVLIFEFLSGGEL--FERITAPDYKMSEAEVIPVTLPILM---TQTSPA 223
           NL  A      +++I E+   G+L  F R  A +  + + +  P+ L  L+   +Q +  
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKA-EADLDKEDGRPLELRDLLHFSSQVAQG 164
Query: 224 VKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--DPNEVVKISTGT-AEFAA 280
           +  +  KN IH DV   N++    N    K+ DFGLA  +  D N +VK +     ++ A
Sbjct: 165 MAFLASKNCIHRDVAARNVL--LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMA 222
Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
           PE +        +D+W+ G+L + + S GL+P+ G
Sbjct: 223 PESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG 257

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 101/217 (46%), Gaps = 12/217 (5%)
Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLH 171
           ++E +G G FG V        G+   A       ++  +    E ++M QL H +L+ L+
Sbjct: 19  LVERLGAGQFGEVWMGY--YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 76
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
            A    + + +I E++  G L + +  P    S  ++    L  +  Q +  +  + E+N
Sbjct: 77  -AVVTQEPIYIITEYMENGSLVDFLKTP----SGIKLTINKLLDMAAQIAEGMAFIEERN 131
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT--AEFAAPEIVEREPV 289
            IH D++  NI+    ++ + K+ DFGLA  ++ NE           ++ APE +     
Sbjct: 132 YIHRDLRAANILVS--DTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTF 189
Query: 290 GFYTDMWAVGV-LAYVLLSGLSPFAGENDVETLKNVK 325
              +D+W+ G+ L  ++  G  P+ G  + E ++N++
Sbjct: 190 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 226

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 110/242 (45%), Gaps = 25/242 (10%)
Query: 96  PQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGN---IFAAKFIPVSHNLEKELI 152
           P+ V  +   V   Y  L  IG GA+G+V  C      N   +   K  P  H    +  
Sbjct: 11  PEMVRGQVFDVGPRYTNLSYIGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRT 68
Query: 153 RKEIDIMNQLHHPKLINLHDAFEDD--DEM--VLIFEFLSGGELFERITAPDYKMSEAEV 208
            +EI I+ +  H  +I ++D       ++M  V I + L   +L++ +      +S   +
Sbjct: 69  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ--HLSNDHI 126
Query: 209 IPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE- 267
                   + Q    +K++H  N++H D+KP N++  T  + ++K+ DFGLA   DP+  
Sbjct: 127 C-----YFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--TXDLKIXDFGLARVADPDHD 179
Query: 268 ---VVKISTGTAEFAAPEIVEREPVGF--YTDMWAVGVLAYVLLSGLSPFAGENDVETLK 322
               +     T  + APEI+     G+    D+W+VG +   +LS    F G++ ++ L 
Sbjct: 180 HTGFLTEYVATRWYRAPEIMLNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 238
Query: 323 NV 324
           ++
Sbjct: 239 HI 240

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 109/242 (45%), Gaps = 25/242 (10%)
Query: 96  PQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGN---IFAAKFIPVSHNLEKELI 152
           P+ V  +   V   Y  L  IG GA+G+V  C      N   +   K  P  H    +  
Sbjct: 13  PEMVRGQVFDVGPRYTNLSYIGEGAYGMV--CSAYDNVNKVRVAIKKISPFEHQTYCQRT 70
Query: 153 RKEIDIMNQLHHPKLINLHDAFEDD--DEM--VLIFEFLSGGELFERITAPDYKMSEAEV 208
            +EI I+    H  +I ++D       ++M  V I + L   +L++ +      +S   +
Sbjct: 71  LREIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ--HLSNDHI 128
Query: 209 IPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE- 267
                   + Q    +K++H  N++H D+KP N++  T  + ++K+ DFGLA   DP+  
Sbjct: 129 C-----YFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--TCDLKICDFGLARVADPDHD 181
Query: 268 ---VVKISTGTAEFAAPEIVEREPVGF--YTDMWAVGVLAYVLLSGLSPFAGENDVETLK 322
               +     T  + APEI+     G+    D+W+VG +   +LS    F G++ ++ L 
Sbjct: 182 HTGFLTEYVATRWYRAPEIMLNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 240
Query: 323 NV 324
           ++
Sbjct: 241 HI 242

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 101/217 (46%), Gaps = 12/217 (5%)
Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLH 171
           ++E +G G FG V        G+   A       ++  +    E ++M QL H +L+ L+
Sbjct: 26  LVERLGAGQFGEVWMGY--YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 83
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
            A    + + +I E++  G L + +  P    S  ++    L  +  Q +  +  + E+N
Sbjct: 84  -AVVTQEPIYIITEYMENGSLVDFLKTP----SGIKLTINKLLDMAAQIAEGMAFIEERN 138
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTG--TAEFAAPEIVEREPV 289
            IH D++  NI+    ++ + K+ DFGLA  ++ NE           ++ APE +     
Sbjct: 139 YIHRDLRAANILVS--DTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTF 196
Query: 290 GFYTDMWAVGV-LAYVLLSGLSPFAGENDVETLKNVK 325
              +D+W+ G+ L  ++  G  P+ G  + E ++N++
Sbjct: 197 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 233

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 29/221 (13%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV--SHNLEKELIRKEIDIMNQL--HHP 165
           Y IL++IG+G    V +    K   I+A K++ +  + N   +  R EI  +N+L  H  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
           K+I L+D    D  + ++ E          I    +   +  + P            AV 
Sbjct: 117 KIIRLYDYEITDQYIYMVMEC-------GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 169
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN--EVVKIS-TGTAEFAAPE 282
            +H+  I+H D+KP N +        +K+IDFG+A ++ P+   VVK S  GT  +  PE
Sbjct: 170 TIHQHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 226
Query: 283 IVE-----RE------PVGFYTDMWAVGVLAYVLLSGLSPF 312
            ++     RE       +   +D+W++G + Y +  G +PF
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 122/283 (43%), Gaps = 56/283 (19%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFI-PVSHNLEKELIRKEIDIMNQLHHPKLINLH--- 171
           +G GA+GVV     + TG I A K I P    L      +EI I+    H  +I +    
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78
Query: 172 --DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE 229
             D+FE+ +E+ +I E +       R+ +    +S+  +        + QT  AVK +H 
Sbjct: 79  RPDSFENFNEVYIIQELMQTD--LHRVISTQM-LSDDHI-----QYFIYQTLRAVKVLHG 130
Query: 230 KNIIHLDVKPENIMCQTRNSTNVKMIDFGLA-----TKLDPNEVVKISTGTAE------F 278
            N+IH D+KP N++  +  + ++K+ DFGLA     +  D +E     +G  E      +
Sbjct: 131 SNVIHRDLKPSNLLINS--NCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWY 188
Query: 279 AAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAG-------------------ENDV 318
            APE+ +         D+W+ G +   L      F G                   +ND+
Sbjct: 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDL 248
Query: 319 ETLKNVKACDWEFD---------EEAFKNVSEEGKDFIRRLLL 352
             +++ +A ++            E+ F  V+ +G D ++R+L+
Sbjct: 249 RCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLV 291

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 114/260 (43%), Gaps = 65/260 (25%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFI---PVSHNLEKELIRKEIDIMNQLHHPK 166
           Y + + +GTG+FG+V    + ++G  FA K +   P   N       +E+DIM  L H  
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN-------RELDIMKVLDHVN 61
Query: 167 LINLHDAF------------EDDDEMVLIFEFLSGGE----------------------- 191
           +I L D F              DD   L      GG+                       
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKL------GGKNNGVNNHHKSVIVNPSQNKYLNV 115
Query: 192 LFERITAPDYKMSEAEV-----IPVTL-PILMTQTSPAVKHMHEKNIIHLDVKPENIMCQ 245
           + E +    +K+ ++ +     IP+ L  I + Q   AV  +H   I H D+KP+N++  
Sbjct: 116 IMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVN 175
Query: 246 TRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV----EREPVGFYTDMWAVGVL 301
           ++++T +K+ DFG A KL P+E       +  + APE++    E  P     D+W++G +
Sbjct: 176 SKDNT-LKLCDFGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPS---IDLWSIGCV 231
Query: 302 AYVLLSGLSPFAGENDVETL 321
              L+ G   F+GE  ++ L
Sbjct: 232 FGELILGKPLFSGETSIDQL 251

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 29/221 (13%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV--SHNLEKELIRKEIDIMNQL--HHP 165
           Y IL++IG+G    V +    K   I+A K++ +  + N   +  R EI  +N+L  H  
Sbjct: 11  YSILKQIGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
           K+I L+D +E  D+   I+  +  G     I    +   +  + P            AV 
Sbjct: 70  KIIRLYD-YEITDQ--YIYMVMECG----NIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 122
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN--EVVKIS-TGTAEFAAPE 282
            +H+  I+H D+KP N +        +K+IDFG+A ++ P+   VVK S  GT  +  PE
Sbjct: 123 TIHQHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179
Query: 283 IVE-----RE------PVGFYTDMWAVGVLAYVLLSGLSPF 312
            ++     RE       +   +D+W++G + Y +  G +PF
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 220

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/240 (24%), Positives = 101/240 (42%), Gaps = 36/240 (15%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKL 167
           + Y+I+  +G G FG V  C +   G    A  I  +    +E  R EI+++ ++     
Sbjct: 51  ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDK 110
Query: 168 IN------LHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI---LMT 218
            N      + D F     M + FE L G   FE +   +++       P  LP    +  
Sbjct: 111 ENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQ-------PYPLPHVRHMAY 162
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIM---------------CQTRN--STNVKMIDFGLAT 261
           Q   A++ +HE  + H D+KPENI+               C+ ++  +T++++ DFG AT
Sbjct: 163 QLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 222
Query: 262 KLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETL 321
             D      I   T  +  PE++         D+W++G + +    G + F    + E L
Sbjct: 223 -FDHEHHTTI-VATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 280

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 29/221 (13%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV--SHNLEKELIRKEIDIMNQL--HHP 165
           Y IL++IG+G    V +    K   I+A K++ +  + N   +  R EI  +N+L  H  
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
           K+I L+D +E  D+   I+  +  G     I    +   +  + P            AV 
Sbjct: 89  KIIRLYD-YEITDQ--YIYMVMECG----NIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 141
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN--EVVKIS-TGTAEFAAPE 282
            +H+  I+H D+KP N +        +K+IDFG+A ++ P+   VVK S  GT  +  PE
Sbjct: 142 TIHQHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 198
Query: 283 IVE-----RE------PVGFYTDMWAVGVLAYVLLSGLSPF 312
            ++     RE       +   +D+W++G + Y +  G +PF
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 239

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 103/241 (42%), Gaps = 42/241 (17%)
Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK--ELIRKEIDIMNQLHHPKL-- 167
           ++ ++G G FG V  C+       +A K   V  N++K     + E DI+ ++ +  +  
Sbjct: 39  VIRKMGDGTFGRVLLCQHIDNKKYYAVK---VVRNIKKYTRSAKIEADILKKIQNDDINN 95
Query: 168 ---INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
              +  H  F   D M LIFE L G  L+E IT  +Y     E I     +   +   A+
Sbjct: 96  NNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIK----LYCIEILKAL 150
Query: 225 KHMHEKNIIHLDVKPENIMCQ-----------------------TRNSTNVKMIDFGLAT 261
            ++ + ++ H D+KPENI+                            ST +K+IDFG AT
Sbjct: 151 NYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCAT 210
Query: 262 -KLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVET 320
            K D +  +     T ++ APE++        +DMW+ G +   L +G   F     +E 
Sbjct: 211 FKSDYHGSI---INTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEH 267
Query: 321 L 321
           L
Sbjct: 268 L 268

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/240 (24%), Positives = 101/240 (42%), Gaps = 36/240 (15%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKL 167
           + Y+I+  +G G FG V  C +   G    A  I  +    +E  R EI+++ ++     
Sbjct: 28  ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDK 87
Query: 168 IN------LHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI---LMT 218
            N      + D F     M + FE L G   FE +   +++       P  LP    +  
Sbjct: 88  ENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQ-------PYPLPHVRHMAY 139
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIM---------------CQTRN--STNVKMIDFGLAT 261
           Q   A++ +HE  + H D+KPENI+               C+ ++  +T++++ DFG AT
Sbjct: 140 QLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 199
Query: 262 KLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETL 321
             D      I   T  +  PE++         D+W++G + +    G + F    + E L
Sbjct: 200 -FDHEHHTTI-VATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 257

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 18/224 (8%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKL 167
           +   +++ +G G FG V          +      P + + E  L  +E  IM +L H KL
Sbjct: 9   ESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFL--EEAQIMKKLKHDKL 66
Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM---TQTSPAV 224
           + L+ A   ++ + ++ E+++ G L       D+ + + E   + LP L+    Q +  +
Sbjct: 67  VQLY-AVVSEEPIYIVTEYMNKGSLL------DF-LKDGEGRALKLPNLVDMAAQVAAGM 118
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT--AEFAAPE 282
            ++   N IH D++  NI+    N    K+ DFGLA  ++ NE           ++ APE
Sbjct: 119 AYIERMNYIHRDLRSANIL--VGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPE 176
Query: 283 IVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
                     +D+W+ G+L   L++ G  P+ G N+ E L+ V+
Sbjct: 177 AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE 220

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 29/221 (13%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV--SHNLEKELIRKEIDIMNQL--HHP 165
           Y IL++IG+G    V +    K   I+A K++ +  + N   +  R EI  +N+L  H  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
           K+I L+D +E  D+   I+  +  G     I    +   +  + P            AV 
Sbjct: 117 KIIRLYD-YEITDQ--YIYMVMECG----NIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 169
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN--EVVKIS-TGTAEFAAPE 282
            +H+  I+H D+KP N +        +K+IDFG+A ++ P+   VVK S  GT  +  PE
Sbjct: 170 TIHQHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 226
Query: 283 IVE-----RE------PVGFYTDMWAVGVLAYVLLSGLSPF 312
            ++     RE       +   +D+W++G + Y +  G +PF
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 98/220 (44%), Gaps = 23/220 (10%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPV------SHNLEKELIRKEIDIMNQL-HHPKLI 168
           +G GAFG V        G   A   + V      +H  EKE +  E+ IM+ L  H  ++
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 169 NLHDAFEDDDEMVLIFEFLSGGELF---ERITAPDYKMS-------EAEVIPVTLPILMT 218
           NL  A      +++I E+   G+L     R   P  + S       E ++    L    +
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSS 173
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--DPNEVVKISTGT- 275
           Q +  +  +  KN IH DV   N++    N    K+ DFGLA  +  D N +VK +    
Sbjct: 174 QVAQGMAFLASKNCIHRDVAARNVL--LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 231
Query: 276 AEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
            ++ APE +        +D+W+ G+L + + S GL+P+ G
Sbjct: 232 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG 271

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 29/221 (13%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV--SHNLEKELIRKEIDIMNQL--HHP 165
           Y IL++IG+G    V +    K   I+A K++ +  + N   +  R EI  +N+L  H  
Sbjct: 10  YSILKQIGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 68
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
           K+I L+D +E  D+   I+  +  G     I    +   +  + P            AV 
Sbjct: 69  KIIRLYD-YEITDQ--YIYMVMECG----NIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 121
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN--EVVKIS-TGTAEFAAPE 282
            +H+  I+H D+KP N +        +K+IDFG+A ++ P+   VVK S  GT  +  PE
Sbjct: 122 TIHQHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 178
Query: 283 IVE-----RE------PVGFYTDMWAVGVLAYVLLSGLSPF 312
            ++     RE       +   +D+W++G + Y +  G +PF
Sbjct: 179 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 219

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/240 (24%), Positives = 101/240 (42%), Gaps = 36/240 (15%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKL 167
           + Y+I+  +G G FG V  C +   G    A  I  +    +E  R EI+++ ++     
Sbjct: 19  ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDK 78
Query: 168 IN------LHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI---LMT 218
            N      + D F     M + FE L G   FE +   +++       P  LP    +  
Sbjct: 79  ENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQ-------PYPLPHVRHMAY 130
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIM---------------CQTRN--STNVKMIDFGLAT 261
           Q   A++ +HE  + H D+KPENI+               C+ ++  +T++++ DFG AT
Sbjct: 131 QLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 190
Query: 262 KLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETL 321
             D      I   T  +  PE++         D+W++G + +    G + F    + E L
Sbjct: 191 -FDHEHHTTI-VATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 29/221 (13%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV--SHNLEKELIRKEIDIMNQL--HHP 165
           Y IL++IG+G    V +    K   I+A K++ +  + N   +  R EI  +N+L  H  
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
           K+I L+D +E  D+   I+  +  G     I    +   +  + P            AV 
Sbjct: 89  KIIRLYD-YEITDQ--YIYMVMECG----NIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 141
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN--EVVKIS-TGTAEFAAPE 282
            +H+  I+H D+KP N +        +K+IDFG+A ++ P+   VVK S  GT  +  PE
Sbjct: 142 TIHQHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPE 198
Query: 283 IVE-----RE------PVGFYTDMWAVGVLAYVLLSGLSPF 312
            ++     RE       +   +D+W++G + Y +  G +PF
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 239

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 29/221 (13%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV--SHNLEKELIRKEIDIMNQL--HHP 165
           Y IL++IG+G    V +    K   I+A K++ +  + N   +  R EI  +N+L  H  
Sbjct: 14  YSILKQIGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 72
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
           K+I L+D +E  D+   I+  +  G     I    +   +  + P            AV 
Sbjct: 73  KIIRLYD-YEITDQ--YIYMVMECG----NIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 125
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN--EVVKIS-TGTAEFAAPE 282
            +H+  I+H D+KP N +        +K+IDFG+A ++ P+   VVK S  GT  +  PE
Sbjct: 126 TIHQHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 182
Query: 283 IVE-----RE------PVGFYTDMWAVGVLAYVLLSGLSPF 312
            ++     RE       +   +D+W++G + Y +  G +PF
Sbjct: 183 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 223

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 106/222 (47%), Gaps = 33/222 (14%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE-KELIRKEIDIMNQLHHPKLINLHDAF 174
           IG G+FGVV++ +   +G + A K +     L+ K    +E+ IM +L H  ++ L   F
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKV-----LQGKAFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 175 ----EDDDEMVLIFEFLSGGELFERITAPDYKMSE-----AEVIPVT-LPILMTQTSPAV 224
               E  DE+ L         + + + A  Y+++       + +PV  + + M Q   ++
Sbjct: 83  YSSGEKKDEVYL-------NLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
            ++H   I H D+KP+N++    ++  +K+ DFG A +L   E       +  + APE++
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDP-DTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELI 194
Query: 285 EREPVGF--YT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
                G   YT   D+W+ G +   LL G   F G++ V+ L
Sbjct: 195 ----FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 232

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 94/205 (45%), Gaps = 14/205 (6%)
Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLH 171
           +L+E+G+G FGVV   + +   ++ A K I      E E   +E   M +L HPKL+  +
Sbjct: 12  LLKELGSGQFGVVKLGKWKGQYDV-AVKMIKEGSMSEDEFF-QEAQTMMKLSHPKLVKFY 69
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
                +  + ++ E++S G L   + +    +  ++++ +   +        +  +    
Sbjct: 70  GVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDV-----CEGMAFLESHQ 124
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT---AEFAAPEIVEREP 288
            IH D+   N  C       VK+ DFG+   +  ++ V  S GT    +++APE+     
Sbjct: 125 FIHRDLAARN--CLVDRDLCVKVSDFGMTRYVLDDQYVS-SVGTKFPVKWSAPEVFHYFK 181
Query: 289 VGFYTDMWAVGVLAYVLLS-GLSPF 312
               +D+WA G+L + + S G  P+
Sbjct: 182 YSSKSDVWAFGILMWEVFSLGKMPY 206

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 24/216 (11%)
Query: 114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDA 173
           +++G G FG V      K   +      P S ++E  L   E ++M  L H KL+ LH A
Sbjct: 188 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFL--AEANVMKTLQHDKLVKLH-A 244
Query: 174 FEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM---TQTSPAVKHMHEK 230
               + + +I EF++ G L + +     K  E    P  LP L+    Q +  +  + ++
Sbjct: 245 VVTKEPIYIITEFMAKGSLLDFL-----KSDEGSKQP--LPKLIDFSAQIAEGMAFIEQR 297
Query: 231 NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVG 290
           N IH D++  NI+     S   K+ DFGLA ++     +K       + APE +      
Sbjct: 298 NYIHRDLRAANILVSA--SLVCKIADFGLA-RVGAKFPIK-------WTAPEAINFGSFT 347
Query: 291 FYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
             +D+W+ G+L   +++ G  P+ G ++ E ++ ++
Sbjct: 348 IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 383

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 94/203 (46%), Gaps = 17/203 (8%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFA--AKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHD 172
           ++G G FGVV++     T       A  + ++    K+   +EI +M +  H  L+ L  
Sbjct: 38  KMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 173 AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI---LMTQTSPAVKHMHE 229
              D D++ L++ ++  G L +R++  D         P++  +   +    +  +  +HE
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCLD------GTPPLSWHMRCKIAQGAANGINFLHE 151
Query: 230 KNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT---KLDPNEVVKISTGTAEFAAPEIVER 286
            + IH D+K  NI+     +   K+ DFGLA    K     +     GT  + APE + R
Sbjct: 152 NHHIHRDIKSANILLD--EAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEAL-R 208
Query: 287 EPVGFYTDMWAVGVLAYVLLSGL 309
             +   +D+++ GV+   +++GL
Sbjct: 209 GEITPKSDIYSFGVVLLEIITGL 231

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 116/269 (43%), Gaps = 47/269 (17%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK-ELIRKEIDIMNQLHHPKLINLHDAF 174
           +G GAFG V + R       +A K   + H  EK   I  E+ ++  L+H  ++  + A+
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIK--KIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 175 EDDDEMV-------------LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTS 221
            +    V             +  E+     L++ I + +      E        L  Q  
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWR-----LFRQIL 126
Query: 222 PAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA---------TKLDPNEV---- 268
            A+ ++H + IIH D+KP NI      S NVK+ DFGLA          KLD   +    
Sbjct: 127 EALSYIHSQGIIHRDLKPMNIFID--ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 269 --VKISTGTAEFAAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFA-GENDVETLK 322
             +  + GTA + A E++  +  G Y    DM+++G++ + +   + PF+ G   V  LK
Sbjct: 185 DNLTSAIGTAMYVATEVL--DGTGHYNEKIDMYSLGIIFFEM---IYPFSTGMERVNILK 239
Query: 323 NVKACDWEFDEEAFKNVSEEGKDFIRRLL 351
            +++   EF  +   N  +  K  IR L+
Sbjct: 240 KLRSVSIEFPPDFDDNKMKVEKKIIRLLI 268

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 90/187 (48%), Gaps = 13/187 (6%)
Query: 153 RKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELF---ERITAPDYKMSEAEVI 209
           + E+ I+  + +   +       + DE+ +I+E++    +    E     D   +    I
Sbjct: 91  KNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLD--KNYTCFI 148
Query: 210 PV-TLPILMTQTSPAVKHMH-EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE 267
           P+  +  ++     +  ++H EKNI H DVKP NI+     +  VK+ DFG +  +  ++
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK--NGRVKLSDFGESEYM-VDK 205
Query: 268 VVKISTGTAEFAAPEIVEREPV--GFYTDMWAVGVLAYVLLSGLSPFAGE-NDVETLKNV 324
            +K S GT EF  PE    E    G   D+W++G+  YV+   + PF+ + + VE   N+
Sbjct: 206 KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI 265
Query: 325 KACDWEF 331
           +  + E+
Sbjct: 266 RTKNIEY 272

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/217 (23%), Positives = 101/217 (46%), Gaps = 12/217 (5%)
Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLH 171
           ++E +G G FG V        G+   A       ++  +    E ++M QL H +L+ L+
Sbjct: 13  LVERLGAGQFGEVWMGY--YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 70
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
            A    + + +I E++  G L + +  P    S  ++    L  +  Q +  +  + E+N
Sbjct: 71  -AVVTQEPIYIITEYMENGSLVDFLKTP----SGIKLTINKLLDMAAQIAEGMAFIEERN 125
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT--AEFAAPEIVEREPV 289
            IH +++  NI+    ++ + K+ DFGLA  ++ NE           ++ APE +     
Sbjct: 126 YIHRNLRAANILVS--DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 183
Query: 290 GFYTDMWAVGV-LAYVLLSGLSPFAGENDVETLKNVK 325
              +D+W+ G+ L  ++  G  P+ G  + E ++N++
Sbjct: 184 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 220

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 94/203 (46%), Gaps = 17/203 (8%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFA--AKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHD 172
           ++G G FGVV++     T       A  + ++    K+   +EI +M +  H  L+ L  
Sbjct: 38  KMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 173 AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI---LMTQTSPAVKHMHE 229
              D D++ L++ ++  G L +R++  D         P++  +   +    +  +  +HE
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCLD------GTPPLSWHMRCKIAQGAANGINFLHE 151
Query: 230 KNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT---KLDPNEVVKISTGTAEFAAPEIVER 286
            + IH D+K  NI+     +   K+ DFGLA    K     +     GT  + APE + R
Sbjct: 152 NHHIHRDIKSANILLD--EAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEAL-R 208
Query: 287 EPVGFYTDMWAVGVLAYVLLSGL 309
             +   +D+++ GV+   +++GL
Sbjct: 209 GEITPKSDIYSFGVVLLEIITGL 231

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 29/221 (13%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV--SHNLEKELIRKEIDIMNQL--HHP 165
           Y IL++IG+G    V +    K   I+A K++ +  + N   +  R EI  +N+L  H  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
           K+I L+D    D  + ++ E          I    +   +  + P            AV 
Sbjct: 117 KIIRLYDYEITDQYIYMVMEC-------GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 169
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN--EVVKIS-TGTAEFAAPE 282
            +H+  I+H D+KP N +        +K+IDFG+A ++ P+   VVK S  G   +  PE
Sbjct: 170 TIHQHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226
Query: 283 IVE-----RE------PVGFYTDMWAVGVLAYVLLSGLSPF 312
            ++     RE       +   +D+W++G + Y +  G +PF
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 104/225 (46%), Gaps = 35/225 (15%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLH-HPKLINLHDAF 174
           +  G F  V+  ++  +G  +A K +  +   +   I +E+  M +L  HP ++    A 
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 175 ----EDDD----EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKH 226
               E+ D    E +L+ E L  G+L E +   +   S   +   T+  +  QT  AV+H
Sbjct: 96  SIGKEESDTGQAEFLLLTE-LCKGQLVEFLKKME---SRGPLSCDTVLKIFYQTCRAVQH 151
Query: 227 MHEKN--IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD--PN------------EVVK 270
           MH +   IIH D+K EN++    N   +K+ DFG AT +   P+            E + 
Sbjct: 152 MHRQKPPIIHRDLKVENLL--LSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209
Query: 271 ISTGTAEFAAPEIVE---REPVGFYTDMWAVGVLAYVLLSGLSPF 312
            +T T  +  PEI++     P+G   D+WA+G + Y+L     PF
Sbjct: 210 RNT-TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF 253

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 94/203 (46%), Gaps = 17/203 (8%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFA--AKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHD 172
           ++G G FGVV++     T       A  + ++    K+   +EI +M +  H  L+ L  
Sbjct: 32  KMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 91
Query: 173 AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI---LMTQTSPAVKHMHE 229
              D D++ L++ ++  G L +R++  D         P++  +   +    +  +  +HE
Sbjct: 92  FSSDGDDLCLVYVYMPNGSLLDRLSCLD------GTPPLSWHMRCKIAQGAANGINFLHE 145
Query: 230 KNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT---KLDPNEVVKISTGTAEFAAPEIVER 286
            + IH D+K  NI+     +   K+ DFGLA    K     +     GT  + APE + R
Sbjct: 146 NHHIHRDIKSANILLD--EAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEAL-R 202
Query: 287 EPVGFYTDMWAVGVLAYVLLSGL 309
             +   +D+++ GV+   +++GL
Sbjct: 203 GEITPKSDIYSFGVVLLEIITGL 225

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 102/227 (44%), Gaps = 30/227 (13%)
Query: 116 IGTGAFGVVHRCRE---RKTG---NIFAAKFIPVSHNLEKELIRKEIDIMNQL-HHPKLI 168
           +G+GAFG V         KTG    +        + + E+E +  E+ +M QL  H  ++
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 169 NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEV-------------IPVT--- 212
           NL  A      + LIFE+   G+L   + +   K SE E+             + V    
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 213 -LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--DPNEVV 269
            L     Q +  ++ +  K+ +H D+   N++    +   VK+ DFGLA  +  D N VV
Sbjct: 173 DLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL--VTHGKVVKICDFGLARDIMSDSNYVV 230
Query: 270 KISTGT-AEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
           + +     ++ APE +        +D+W+ G+L + + S G++P+ G
Sbjct: 231 RGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 103/220 (46%), Gaps = 30/220 (13%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF- 174
           IG G+FGVV + +  ++  +   K +      +K    +E+ IM  + HP +++L   F 
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVL-----QDKRFKNRELQIMRIVKHPNVVDLKAFFY 102
Query: 175 -----EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPIL-----MTQTSPAV 224
                +D+  + L+ E++   E   R +    K+ +      T+P+L     M Q   ++
Sbjct: 103 SNGDKKDEVFLNLVLEYVP--ETVYRASRHYAKLKQ------TMPMLLIKLYMYQLLRSL 154
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
            ++H   I H D+KP+N++    +   +K+IDFG A  L   E       +  + APE++
Sbjct: 155 AYIHSIGICHRDIKPQNLLLDPPSGV-LKLIDFGSAKILIAGEPNVSXICSRYYRAPELI 213
Query: 285 EREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
                  YT   D+W+ G +   L+ G   F GE+ ++ L
Sbjct: 214 FG--ATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQL 251

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 65/132 (49%), Gaps = 3/132 (2%)
Query: 192 LFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTN 251
           +FE I   D+K     +    +   M +   A+ + H K I+H DVKP N+M   +    
Sbjct: 118 VFEYINNTDFKQLYQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQK-K 176
Query: 252 VKMIDFGLATKLDPNEVVKISTGTAEFAAPE-IVEREPVGFYTDMWAVGVLAYVLLSGLS 310
           +++ID+GLA    P +   +   +  F  PE +V+ +   +  DMW++G +   ++    
Sbjct: 177 LRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRRE 236
Query: 311 P-FAGENDVETL 321
           P F G+++ + L
Sbjct: 237 PFFHGQDNYDQL 248

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/240 (22%), Positives = 102/240 (42%), Gaps = 40/240 (16%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK--ELIRKEIDIMNQLHHP-- 165
           Y+I++ +G GAFG V  C + K G    A  + +  N+++  E  R EI ++  L+    
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVA--VKIVKNVDRYCEAARSEIQVLEHLNTTDP 73
Query: 166 ----KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLP---ILMT 218
               + + + + FE    + ++FE L        ++  D+ + E   +P  L     +  
Sbjct: 74  NSTFRCVQMLEWFEHHGHICIVFELLG-------LSTYDF-IKENGFLPFRLDHIRKMAY 125
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNST-----------------NVKMIDFGLAT 261
           Q   +V  +H   + H D+KPENI+    + T                 ++K++DFG AT
Sbjct: 126 QICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSAT 185
Query: 262 KLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETL 321
             D +    +      + APE++         D+W++G +      G + F   +  E L
Sbjct: 186 YDDEHHSTLVX--XRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 65/132 (49%), Gaps = 3/132 (2%)
Query: 192 LFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTN 251
           +FE I   D+K     +    +   M +   A+ + H K I+H DVKP N+M   +    
Sbjct: 113 VFEYINNTDFKQLYQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQK-K 171
Query: 252 VKMIDFGLATKLDPNEVVKISTGTAEFAAPE-IVEREPVGFYTDMWAVGVLAYVLLSGLS 310
           +++ID+GLA    P +   +   +  F  PE +V+ +   +  DMW++G +   ++    
Sbjct: 172 LRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRRE 231
Query: 311 P-FAGENDVETL 321
           P F G+++ + L
Sbjct: 232 PFFHGQDNYDQL 243

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 99/218 (45%), Gaps = 22/218 (10%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLHHPKLINLHDA 173
           +G+GA+G V    ++++G   A K +  P    +  +   +E+ ++  + H  +I L D 
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 174 FEDDDEM------VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
           F     +       L+  F+      ++I     K SE ++       L+ Q    +K++
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTD--LQKIMG--LKFSEEKI-----QYLVYQMLKGLKYI 142
Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPE-IVER 286
           H   ++H D+KP N+         +K++DFGLA   D      + T    + APE I+  
Sbjct: 143 HSAGVVHRDLKPGNLAVN--EDCELKILDFGLARHADAEMTGYVVTRW--YRAPEVILSW 198
Query: 287 EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
                  D+W+VG +   +L+G + F G++ ++ L  +
Sbjct: 199 MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI 236

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/239 (22%), Positives = 104/239 (43%), Gaps = 23/239 (9%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLHHPKLINLHDA 173
           +G+GA+G V    ++++G   A K +  P    +  +   +E+ ++  + H  +I L D 
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 174 FEDDDEMVLIFEFLSGGELFERITAPDY-KMSEAEVIPVTLPILMTQTSPAVKHMHEKNI 232
           F     +   ++F     L       D  K+   E     +  L+ Q    +K++H   +
Sbjct: 110 FTPASSLRNFYDFY----LVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGV 165
Query: 233 IHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPE-IVEREPVGF 291
           +H D+KP N+         +K++DFGLA   D      +   T  + APE I+       
Sbjct: 166 VHRDLKPGNLAVN--EDCELKILDFGLARHADAEMTGYVV--TRWYRAPEVILSWMHYNQ 221
Query: 292 YTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRL 350
             D+W+VG +   +L+G + F G++ ++ L  +            K     G +F+++L
Sbjct: 222 TVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI-----------LKVTGVPGTEFVQKL 269

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 109/266 (40%), Gaps = 41/266 (15%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK-ELIRKEIDIMNQLHHPKLINLHDAF 174
           +G GAFG V + R       +A K   + H  EK   I  E+ ++  L+H  ++  + A+
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIK--KIRHTEEKLSTILSEVXLLASLNHQYVVRYYAAW 71
Query: 175 EDDDEMV-------------LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTS 221
            +    V             +  E+     L++ I + +      E        L  Q  
Sbjct: 72  LERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWR-----LFRQIL 126
Query: 222 PAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT---------KLDPNEV---- 268
            A+ ++H + IIH ++KP NI      S NVK+ DFGLA          KLD   +    
Sbjct: 127 EALSYIHSQGIIHRNLKPXNIFID--ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 269 --VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFA-GENDVETLKNVK 325
             +  + GTA + A E++  +  G Y +      L  +    + PF+ G   V  LK ++
Sbjct: 185 DNLTSAIGTAXYVATEVL--DGTGHYNEKIDXYSLGIIFFEXIYPFSTGXERVNILKKLR 242
Query: 326 ACDWEFDEEAFKNVSEEGKDFIRRLL 351
           +   EF  +   N  +  K  IR L+
Sbjct: 243 SVSIEFPPDFDDNKXKVEKKIIRLLI 268

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 32/127 (25%), Positives = 60/127 (47%), Gaps = 2/127 (1%)
Query: 192 LFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTN 251
           +FE +   D+K     +    +   M +   A+ + H   I+H DVKP N+M    +   
Sbjct: 112 VFEHVNNTDFKQLRQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-K 170
Query: 252 VKMIDFGLATKLDPNEVVKISTGTAEFAAPE-IVEREPVGFYTDMWAVGVLAYVLLSGLS 310
           +++ID+GLA    P +   +   +  F  PE +V+ +   +  DMW++G +   ++    
Sbjct: 171 LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 230
Query: 311 PFAGEND 317
           PF   +D
Sbjct: 231 PFFHGHD 237

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 90/182 (49%), Gaps = 16/182 (8%)
Query: 97  QPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN--LEKELIRK 154
           Q   IK   V D+Y+I   IG G++G V+   ++      A K +       ++ + I +
Sbjct: 17  QGAIIKNVKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILR 76
Query: 155 EIDIMNQLHHPKLINLHDAFEDD-----DEMVLIFEFLSGGELFERITAPDYKMSEAEVI 209
           EI I+N+L    +I LHD    +     DE+ ++ E ++  +L +    P + ++E  V 
Sbjct: 77  EITILNRLKSDYIIRLHDLIIPEDLLKFDELYIVLE-IADSDLKKLFKTPIF-LTEQHVK 134
Query: 210 PVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVV 269
            +   +L+ +     K +HE  IIH D+KP N  C      +VK+ DFGLA  ++ ++ +
Sbjct: 135 TILYNLLLGE-----KFIHESGIIHRDLKPAN--CLLNQDCSVKICDFGLARTINSDKDI 187
Query: 270 KI 271
            I
Sbjct: 188 HI 189

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 101/227 (44%), Gaps = 30/227 (13%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPV------SHNLEKELIRKEIDIMNQL-HHPKLI 168
           +G GAFG V        G   A   + V      +H  EKE +  E+ IM+ L  H  ++
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 98
Query: 169 NLHDAFEDDDEMVLIFEFLSGGELF-------ERITAPDYK-------MSEAEVIPVTLP 214
           NL  A      +++I E+   G+L        E +  P          + + +  P+ L 
Sbjct: 99  NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELR 158
Query: 215 ILM---TQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--DPNEVV 269
            L+   +Q +  +  +  KN IH DV   N++    N    K+ DFGLA  +  D N +V
Sbjct: 159 DLLHFSSQVAQGMAFLASKNCIHRDVAARNVL--LTNGHVAKIGDFGLARDIMNDSNYIV 216
Query: 270 KISTGT-AEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
           K +     ++ APE +        +D+W+ G+L + + S GL+P+ G
Sbjct: 217 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG 263

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 83/203 (40%), Gaps = 22/203 (10%)
Query: 114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDA 173
           E +G G FG   +   R+TG +   K +       +    KE+ +M  L HP ++     
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 174 FEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNII 233
              D  +  I E++ GG L   I + D +   ++ +     I     +  + ++H  NII
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDI-----ASGMAYLHSMNII 130
Query: 234 HLDVKPENIMCQTRNSTNVKMIDFGLAT-----KLDPNEVVKIS----------TGTAEF 278
           H D+   N  C  R + NV + DFGLA      K  P  +  +            G   +
Sbjct: 131 HRDLNSHN--CLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 279 AAPEIVEREPVGFYTDMWAVGVL 301
            APE++         D+++ G++
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIV 211

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/127 (25%), Positives = 60/127 (47%), Gaps = 2/127 (1%)
Query: 192 LFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTN 251
           +FE +   D+K     +    +   M +   A+ + H   I+H DVKP N+M    +   
Sbjct: 110 VFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-K 168
Query: 252 VKMIDFGLATKLDPNEVVKISTGTAEFAAPE-IVEREPVGFYTDMWAVGVLAYVLLSGLS 310
           +++ID+GLA    P +   +   +  F  PE +V+ +   +  DMW++G +   ++    
Sbjct: 169 LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 228
Query: 311 PFAGEND 317
           PF   +D
Sbjct: 229 PFFHGHD 235

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/228 (23%), Positives = 104/228 (45%), Gaps = 18/228 (7%)
Query: 102 KTSSVYDHYDIL--EEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEID 157
           K   V +H D++  E+IG G FG V   R R    + A K     +  +L+ + + +E  
Sbjct: 106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFL-QEAR 164
Query: 158 IMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM 217
           I+ Q  HP ++ L         + ++ E + GG+    +     +   A +   TL  ++
Sbjct: 165 ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL-----RTEGARLRVKTLLQMV 219
Query: 218 TQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAE 277
              +  ++++  K  IH D+   N +   +N   +K+ DFG++ + + + V   S G  +
Sbjct: 220 GDAAAGMEYLESKCCIHRDLAARNCLVTEKNV--LKISDFGMSRE-EADGVXAASGGLRQ 276
Query: 278 ----FAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVET 320
               + APE +        +D+W+ G+L +   S G SP+   ++ +T
Sbjct: 277 VPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT 324

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/127 (25%), Positives = 60/127 (47%), Gaps = 2/127 (1%)
Query: 192 LFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTN 251
           +FE +   D+K     +    +   M +   A+ + H   I+H DVKP N+M    +   
Sbjct: 111 VFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-K 169
Query: 252 VKMIDFGLATKLDPNEVVKISTGTAEFAAPE-IVEREPVGFYTDMWAVGVLAYVLLSGLS 310
           +++ID+GLA    P +   +   +  F  PE +V+ +   +  DMW++G +   ++    
Sbjct: 170 LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
Query: 311 PFAGEND 317
           PF   +D
Sbjct: 230 PFFHGHD 236

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/127 (25%), Positives = 60/127 (47%), Gaps = 2/127 (1%)
Query: 192 LFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTN 251
           +FE +   D+K     +    +   M +   A+ + H   I+H DVKP N+M    +   
Sbjct: 112 VFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-K 170
Query: 252 VKMIDFGLATKLDPNEVVKISTGTAEFAAPE-IVEREPVGFYTDMWAVGVLAYVLLSGLS 310
           +++ID+GLA    P +   +   +  F  PE +V+ +   +  DMW++G +   ++    
Sbjct: 171 LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 230
Query: 311 PFAGEND 317
           PF   +D
Sbjct: 231 PFFHGHD 237

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/127 (25%), Positives = 60/127 (47%), Gaps = 2/127 (1%)
Query: 192 LFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTN 251
           +FE +   D+K     +    +   M +   A+ + H   I+H DVKP N+M    +   
Sbjct: 112 VFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-K 170
Query: 252 VKMIDFGLATKLDPNEVVKISTGTAEFAAPE-IVEREPVGFYTDMWAVGVLAYVLLSGLS 310
           +++ID+GLA    P +   +   +  F  PE +V+ +   +  DMW++G +   ++    
Sbjct: 171 LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 230
Query: 311 PFAGEND 317
           PF   +D
Sbjct: 231 PFFHGHD 237

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/127 (25%), Positives = 60/127 (47%), Gaps = 2/127 (1%)
Query: 192 LFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTN 251
           +FE +   D+K     +    +   M +   A+ + H   I+H DVKP N+M    +   
Sbjct: 112 VFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-K 170
Query: 252 VKMIDFGLATKLDPNEVVKISTGTAEFAAPE-IVEREPVGFYTDMWAVGVLAYVLLSGLS 310
           +++ID+GLA    P +   +   +  F  PE +V+ +   +  DMW++G +   ++    
Sbjct: 171 LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 230
Query: 311 PFAGEND 317
           PF   +D
Sbjct: 231 PFFHGHD 237

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/127 (25%), Positives = 60/127 (47%), Gaps = 2/127 (1%)
Query: 192 LFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTN 251
           +FE +   D+K     +    +   M +   A+ + H   I+H DVKP N+M    +   
Sbjct: 112 VFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-K 170
Query: 252 VKMIDFGLATKLDPNEVVKISTGTAEFAAPE-IVEREPVGFYTDMWAVGVLAYVLLSGLS 310
           +++ID+GLA    P +   +   +  F  PE +V+ +   +  DMW++G +   ++    
Sbjct: 171 LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 230
Query: 311 PFAGEND 317
           PF   +D
Sbjct: 231 PFFHGHD 237

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/127 (25%), Positives = 60/127 (47%), Gaps = 2/127 (1%)
Query: 192 LFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTN 251
           +FE +   D+K     +    +   M +   A+ + H   I+H DVKP N+M    +   
Sbjct: 112 VFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-K 170
Query: 252 VKMIDFGLATKLDPNEVVKISTGTAEFAAPE-IVEREPVGFYTDMWAVGVLAYVLLSGLS 310
           +++ID+GLA    P +   +   +  F  PE +V+ +   +  DMW++G +   ++    
Sbjct: 171 LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 230
Query: 311 PFAGEND 317
           PF   +D
Sbjct: 231 PFFHGHD 237

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/127 (25%), Positives = 60/127 (47%), Gaps = 2/127 (1%)
Query: 192 LFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTN 251
           +FE +   D+K     +    +   M +   A+ + H   I+H DVKP N+M    +   
Sbjct: 112 VFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-K 170
Query: 252 VKMIDFGLATKLDPNEVVKISTGTAEFAAPE-IVEREPVGFYTDMWAVGVLAYVLLSGLS 310
           +++ID+GLA    P +   +   +  F  PE +V+ +   +  DMW++G +   ++    
Sbjct: 171 LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 230
Query: 311 PFAGEND 317
           PF   +D
Sbjct: 231 PFFHGHD 237

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/127 (25%), Positives = 60/127 (47%), Gaps = 2/127 (1%)
Query: 192 LFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTN 251
           +FE +   D+K     +    +   M +   A+ + H   I+H DVKP N+M    +   
Sbjct: 111 VFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-K 169
Query: 252 VKMIDFGLATKLDPNEVVKISTGTAEFAAPE-IVEREPVGFYTDMWAVGVLAYVLLSGLS 310
           +++ID+GLA    P +   +   +  F  PE +V+ +   +  DMW++G +   ++    
Sbjct: 170 LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
Query: 311 PFAGEND 317
           PF   +D
Sbjct: 230 PFFHGHD 236

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/127 (25%), Positives = 60/127 (47%), Gaps = 2/127 (1%)
Query: 192 LFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTN 251
           +FE +   D+K     +    +   M +   A+ + H   I+H DVKP N+M    +   
Sbjct: 112 VFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-K 170
Query: 252 VKMIDFGLATKLDPNEVVKISTGTAEFAAPE-IVEREPVGFYTDMWAVGVLAYVLLSGLS 310
           +++ID+GLA    P +   +   +  F  PE +V+ +   +  DMW++G +   ++    
Sbjct: 171 LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 230
Query: 311 PFAGEND 317
           PF   +D
Sbjct: 231 PFFHGHD 237

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN-LEKELIRKEIDIMNQ-LHHP 165
           D  + + E+G GA+GVV + R   +G I A K I  + N  E++ +  ++DI  + +  P
Sbjct: 34  DDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCP 93
Query: 166 KLINLHDAFEDDDEMVLIFEFL--SGGELFERITAPDYKMSEAEVIPV-TLPILMTQTSP 222
             +  + A   + ++ +  E    S  + ++++      + + + IP   L  +      
Sbjct: 94  FTVTFYGALFREGDVWICXELXDTSLDKFYKQV------IDKGQTIPEDILGKIAVSIVK 147
Query: 223 AVKHMHEK-NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAP 281
           A++H+H K ++IH DVKP N++        VK  DFG++  L  +    I  G   + AP
Sbjct: 148 ALEHLHSKLSVIHRDVKPSNVLINALG--QVKXCDFGISGYLVDDVAKDIDAGCKPYXAP 205
Query: 282 EIVERE----PVGFYTDMWAVGV 300
           E +  E         +D+W++G+
Sbjct: 206 ERINPELNQKGYSVKSDIWSLGI 228

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/228 (23%), Positives = 104/228 (45%), Gaps = 18/228 (7%)
Query: 102 KTSSVYDHYDIL--EEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEID 157
           K   V +H D++  E+IG G FG V   R R    + A K     +  +L+ + + +E  
Sbjct: 106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFL-QEAR 164
Query: 158 IMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM 217
           I+ Q  HP ++ L         + ++ E + GG+    +     +   A +   TL  ++
Sbjct: 165 ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL-----RTEGARLRVKTLLQMV 219
Query: 218 TQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAE 277
              +  ++++  K  IH D+   N +   +N   +K+ DFG++ + + + V   S G  +
Sbjct: 220 GDAAAGMEYLESKCCIHRDLAARNCLVTEKNV--LKISDFGMSRE-EADGVYAASGGLRQ 276
Query: 278 ----FAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVET 320
               + APE +        +D+W+ G+L +   S G SP+   ++ +T
Sbjct: 277 VPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT 324

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 105/247 (42%), Gaps = 39/247 (15%)
Query: 98  PVDIKTSSVYDHYDILEEIGTGAFGVV-----HRCRERKTGNIFAAKFI-PVSHNLEKEL 151
           P D K     +     + +G GAFG V     +   +       A K + P +H  E+E 
Sbjct: 31  PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA 90
Query: 152 IRKEIDIMNQL-HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIP 210
           +  E+ +++ L +H  ++NL  A       ++I E+   G+L   +     +  ++ +  
Sbjct: 91  LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR----RKRDSFICS 146
Query: 211 VTLPILMT----------------QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKM 254
            T P +M                 Q +  +  +  KN IH D+   NI+      T  K+
Sbjct: 147 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT--KI 204
Query: 255 IDFGLA--TKLDPNEVVKISTGTA----EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS- 307
            DFGLA   K D N VVK   G A    ++ APE +      F +D+W+ G+  + L S 
Sbjct: 205 CDFGLARDIKNDSNYVVK---GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 261
Query: 308 GLSPFAG 314
           G SP+ G
Sbjct: 262 GSSPYPG 268

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 105/247 (42%), Gaps = 39/247 (15%)
Query: 98  PVDIKTSSVYDHYDILEEIGTGAFGVV-----HRCRERKTGNIFAAKFI-PVSHNLEKEL 151
           P D K     +     + +G GAFG V     +   +       A K + P +H  E+E 
Sbjct: 36  PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA 95
Query: 152 IRKEIDIMNQL-HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIP 210
           +  E+ +++ L +H  ++NL  A       ++I E+   G+L   +     +  ++ +  
Sbjct: 96  LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR----RKRDSFICS 151
Query: 211 VTLPILMT----------------QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKM 254
            T P +M                 Q +  +  +  KN IH D+   NI+      T  K+
Sbjct: 152 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT--KI 209
Query: 255 IDFGLA--TKLDPNEVVKISTGTA----EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS- 307
            DFGLA   K D N VVK   G A    ++ APE +      F +D+W+ G+  + L S 
Sbjct: 210 CDFGLARDIKNDSNYVVK---GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 266
Query: 308 GLSPFAG 314
           G SP+ G
Sbjct: 267 GSSPYPG 273

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 101/231 (43%), Gaps = 39/231 (16%)
Query: 114 EEIGTGAFGVV-----HRCRERKTGNIFAAKFI-PVSHNLEKELIRKEIDIMNQL-HHPK 166
           + +G GAFG V     +   +       A K + P +H  E+E +  E+ +++ L +H  
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT-------- 218
           ++NL  A       ++I E+   G+L   +     +  ++ +   T P +M         
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLR----RKRDSFICSKTSPAIMEDDELALDL 144
Query: 219 --------QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA--TKLDPNEV 268
                   Q +  +  +  KN IH D+   NI+      T  K+ DFGLA   K D N V
Sbjct: 145 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT--KICDFGLARDIKNDSNYV 202
Query: 269 VKISTGTA----EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
           VK   G A    ++ APE +      F +D+W+ G+  + L S G SP+ G
Sbjct: 203 VK---GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/127 (25%), Positives = 60/127 (47%), Gaps = 2/127 (1%)
Query: 192 LFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTN 251
           +FE +   D+K     +    +   M +   A+ + H   I+H DVKP N+M    +   
Sbjct: 117 VFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-K 175
Query: 252 VKMIDFGLATKLDPNEVVKISTGTAEFAAPE-IVEREPVGFYTDMWAVGVLAYVLLSGLS 310
           +++ID+GLA    P +   +   +  F  PE +V+ +   +  DMW++G +   ++    
Sbjct: 176 LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 235
Query: 311 PFAGEND 317
           PF   +D
Sbjct: 236 PFFHGHD 242

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 12/214 (5%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G FG V       T  +      P   N+  E   +E  +M +L H KL+ L+ A 
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTLKP--GNMSPEAFLQEAQVMKKLRHEKLVQLY-AV 248
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
             ++ + ++ E++S G L + +     +M +   +P  L  +  Q +  + ++   N +H
Sbjct: 249 VSEEPIYIVTEYMSKGSLLDFLKG---EMGKYLRLP-QLVDMAAQIASGMAYVERMNYVH 304
Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT--AEFAAPEIVEREPVGFY 292
            D++  NI+     +   K+ DFGL   ++ NE           ++ APE          
Sbjct: 305 RDLRAANIL--VGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 362
Query: 293 TDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
           +D+W+ G+L   L + G  P+ G  + E L  V+
Sbjct: 363 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 396

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 109 HYDILEEIGTGAFGVVHRCR----ERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHH 164
           H   + ++G G FG V  CR       TG + A K +  S   ++   ++EI I+  LH 
Sbjct: 8   HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS 67
Query: 165 PKLINLHDAF--EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSP 222
             ++            E+ L+ E+L  G L + +     ++  + ++     +  +Q   
Sbjct: 68  DFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLL-----LYSSQICK 122
Query: 223 AVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA--TKLDPNEVVKISTGTAE--F 278
            ++++  +  +H D+   NI+ ++    +VK+ DFGLA    LD +  V    G +   +
Sbjct: 123 GMEYLGSRRCVHRDLAARNILVES--EAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFW 180
Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLS 307
            APE +        +D+W+ GV+ Y L +
Sbjct: 181 YAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 94/215 (43%), Gaps = 18/215 (8%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEI----DIMNQLHH 164
           +  I E IG G FG V R R +  G   +   I        E  R+E      IM Q  H
Sbjct: 17  YVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEH 76
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P +I L     +   ++++ EF+  G L   +     ++++ +   + L  ++   +  +
Sbjct: 77  PNIIRLEGVVTNSMPVMILTEFMENGALDSFL-----RLNDGQFTVIQLVGMLRGIASGM 131
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL-----DPNEVVKISTGTA-EF 278
           +++ E + +H D+   NI+  +  +   K+ DFGL+  L     DP E   +       +
Sbjct: 132 RYLAEMSYVHRDLAARNILVNS--NLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRW 189
Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPF 312
            APE +        +D W+ G++ + ++S G  P+
Sbjct: 190 TAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPY 224

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 85/174 (48%), Gaps = 10/174 (5%)
Query: 155 EIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLP 214
           E ++M QL H +L+ L+ A    + + +I E++  G L + +  P    S  ++    L 
Sbjct: 58  EANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTP----SGIKLTINKLL 112
Query: 215 ILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTG 274
            +  Q +  +  + E+N IH D++  NI+    ++ + K+ DFGLA  ++  E       
Sbjct: 113 DMAAQIAEGMAFIEERNYIHRDLRAANILVS--DTLSCKIADFGLARLIEDAEXTAREGA 170
Query: 275 --TAEFAAPEIVEREPVGFYTDMWAVGV-LAYVLLSGLSPFAGENDVETLKNVK 325
               ++ APE +        +D+W+ G+ L  ++  G  P+ G  + E ++N++
Sbjct: 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 97/224 (43%), Gaps = 19/224 (8%)
Query: 112 ILEEIGTGAFGVVHR----CRERKTGNIFAAKFIP--VSHNLEKELIRKEIDIMNQLHHP 165
           +LE++G G+FGVV R        KT ++      P  +S     +   +E++ M+ L H 
Sbjct: 16  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 75
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            LI L+        M ++ E    G L +R+     +  +   +  TL     Q +  + 
Sbjct: 76  NLIRLYGVVL-TPPMKMVTELAPLGSLLDRL-----RKHQGHFLLGTLSRYAVQVAEGMG 129
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE--VVKISTGTAEFA--AP 281
           ++  K  IH D+   N++  TR+   VK+ DFGL   L  N+   V        FA  AP
Sbjct: 130 YLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 187
Query: 282 EIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
           E ++       +D W  GV  + + + G  P+ G N  + L  +
Sbjct: 188 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 231

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 105/247 (42%), Gaps = 39/247 (15%)
Query: 98  PVDIKTSSVYDHYDILEEIGTGAFGVV-----HRCRERKTGNIFAAKFI-PVSHNLEKEL 151
           P D K     +     + +G GAFG V     +   +       A K + P +H  E+E 
Sbjct: 29  PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA 88
Query: 152 IRKEIDIMNQL-HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIP 210
           +  E+ +++ L +H  ++NL  A       ++I E+   G+L   +     +  ++ +  
Sbjct: 89  LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR----RKRDSFICS 144
Query: 211 VTLPILMT----------------QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKM 254
            T P +M                 Q +  +  +  KN IH D+   NI+      T  K+
Sbjct: 145 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT--KI 202
Query: 255 IDFGLA--TKLDPNEVVKISTGTA----EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS- 307
            DFGLA   K D N VVK   G A    ++ APE +      F +D+W+ G+  + L S 
Sbjct: 203 CDFGLARDIKNDSNYVVK---GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 259
Query: 308 GLSPFAG 314
           G SP+ G
Sbjct: 260 GSSPYPG 266

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/192 (22%), Positives = 90/192 (46%), Gaps = 19/192 (9%)
Query: 149 KELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERI----------TA 198
           +E  R E  +  +L HP ++ L      D  + +IF + S G+L E +          + 
Sbjct: 56  REEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGST 115
Query: 199 PDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFG 258
            D +  ++ + P     L+ Q +  ++++   +++H D+   N++    +  NVK+ D G
Sbjct: 116 DDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVL--VYDKLNVKISDLG 173
Query: 259 LATKLDPNEVVKI---STGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
           L  ++   +  K+   S     + APE +        +D+W+ GV+ + + S GL P+ G
Sbjct: 174 LFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG 233
Query: 315 END---VETLKN 323
            ++   VE ++N
Sbjct: 234 YSNQDVVEMIRN 245

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 105/247 (42%), Gaps = 39/247 (15%)
Query: 98  PVDIKTSSVYDHYDILEEIGTGAFGVV-----HRCRERKTGNIFAAKFI-PVSHNLEKEL 151
           P D K     +     + +G GAFG V     +   +       A K + P +H  E+E 
Sbjct: 36  PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA 95
Query: 152 IRKEIDIMNQL-HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIP 210
           +  E+ +++ L +H  ++NL  A       ++I E+   G+L   +     +  ++ +  
Sbjct: 96  LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR----RKRDSFICS 151
Query: 211 VTLPILMT----------------QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKM 254
            T P +M                 Q +  +  +  KN IH D+   NI+      T  K+
Sbjct: 152 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT--KI 209
Query: 255 IDFGLA--TKLDPNEVVKISTGTA----EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS- 307
            DFGLA   K D N VVK   G A    ++ APE +      F +D+W+ G+  + L S 
Sbjct: 210 CDFGLARHIKNDSNYVVK---GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 266
Query: 308 GLSPFAG 314
           G SP+ G
Sbjct: 267 GSSPYPG 273

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 97/224 (43%), Gaps = 19/224 (8%)
Query: 112 ILEEIGTGAFGVVHR----CRERKTGNIFAAKFIP--VSHNLEKELIRKEIDIMNQLHHP 165
           +LE++G G+FGVV R        KT ++      P  +S     +   +E++ M+ L H 
Sbjct: 16  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 75
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            LI L+        M ++ E    G L +R+     +  +   +  TL     Q +  + 
Sbjct: 76  NLIRLYGVVL-TPPMKMVTELAPLGSLLDRL-----RKHQGHFLLGTLSRYAVQVAEGMG 129
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE--VVKISTGTAEFA--AP 281
           ++  K  IH D+   N++  TR+   VK+ DFGL   L  N+   V        FA  AP
Sbjct: 130 YLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 187
Query: 282 EIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
           E ++       +D W  GV  + + + G  P+ G N  + L  +
Sbjct: 188 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 231

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/127 (25%), Positives = 60/127 (47%), Gaps = 2/127 (1%)
Query: 192 LFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTN 251
           +FE +   D+K     +    +   M +   A+ + H   I+H DVKP N+M    +   
Sbjct: 112 VFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-K 170
Query: 252 VKMIDFGLATKLDPNEVVKISTGTAEFAAPE-IVEREPVGFYTDMWAVGVLAYVLLSGLS 310
           +++ID+GLA    P +   +   +  F  PE +V+ +   +  DMW++G +   ++    
Sbjct: 171 LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 230
Query: 311 PFAGEND 317
           PF   +D
Sbjct: 231 PFFHGHD 237

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 97/224 (43%), Gaps = 19/224 (8%)
Query: 112 ILEEIGTGAFGVVHR----CRERKTGNIFAAKFIP--VSHNLEKELIRKEIDIMNQLHHP 165
           +LE++G G+FGVV R        KT ++      P  +S     +   +E++ M+ L H 
Sbjct: 22  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            LI L+        M ++ E    G L +R+     +  +   +  TL     Q +  + 
Sbjct: 82  NLIRLYGVVL-TPPMKMVTELAPLGSLLDRL-----RKHQGHFLLGTLSRYAVQVAEGMG 135
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE--VVKISTGTAEFA--AP 281
           ++  K  IH D+   N++  TR+   VK+ DFGL   L  N+   V        FA  AP
Sbjct: 136 YLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 193
Query: 282 EIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
           E ++       +D W  GV  + + + G  P+ G N  + L  +
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 97/224 (43%), Gaps = 19/224 (8%)
Query: 112 ILEEIGTGAFGVVHR----CRERKTGNIFAAKFIP--VSHNLEKELIRKEIDIMNQLHHP 165
           +LE++G G+FGVV R        KT ++      P  +S     +   +E++ M+ L H 
Sbjct: 22  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            LI L+        M ++ E    G L +R+     +  +   +  TL     Q +  + 
Sbjct: 82  NLIRLYGVVL-TPPMKMVTELAPLGSLLDRL-----RKHQGHFLLGTLSRYAVQVAEGMG 135
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE--VVKISTGTAEFA--AP 281
           ++  K  IH D+   N++  TR+   VK+ DFGL   L  N+   V        FA  AP
Sbjct: 136 YLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAP 193
Query: 282 EIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
           E ++       +D W  GV  + + + G  P+ G N  + L  +
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 97/224 (43%), Gaps = 19/224 (8%)
Query: 112 ILEEIGTGAFGVVHR----CRERKTGNIFAAKFIP--VSHNLEKELIRKEIDIMNQLHHP 165
           +LE++G G+FGVV R        KT ++      P  +S     +   +E++ M+ L H 
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            LI L+        M ++ E    G L +R+     +  +   +  TL     Q +  + 
Sbjct: 72  NLIRLYGVVL-TPPMKMVTELAPLGSLLDRL-----RKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE--VVKISTGTAEFA--AP 281
           ++  K  IH D+   N++  TR+   VK+ DFGL   L  N+   V        FA  AP
Sbjct: 126 YLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 282 EIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
           E ++       +D W  GV  + + + G  P+ G N  + L  +
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 227

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 97/224 (43%), Gaps = 19/224 (8%)
Query: 112 ILEEIGTGAFGVVHR----CRERKTGNIFAAKFIP--VSHNLEKELIRKEIDIMNQLHHP 165
           +LE++G G+FGVV R        KT ++      P  +S     +   +E++ M+ L H 
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            LI L+        M ++ E    G L +R+     +  +   +  TL     Q +  + 
Sbjct: 72  NLIRLYGVVL-TPPMKMVTELAPLGSLLDRL-----RKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE--VVKISTGTAEFA--AP 281
           ++  K  IH D+   N++  TR+   VK+ DFGL   L  N+   V        FA  AP
Sbjct: 126 YLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 282 EIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
           E ++       +D W  GV  + + + G  P+ G N  + L  +
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 227

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 99/232 (42%), Gaps = 34/232 (14%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS-HNLEKELIRKEIDIMNQLHHP-- 165
            Y +   +G+G FG V+         I  +  +PV+  ++EK+ I    ++ N    P  
Sbjct: 9   QYQVGPLLGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 61
Query: 166 ------------KLINLHDAFEDDDEMVLIFEFLSG-GELFERITAPDYKMSEAEVIPVT 212
                        +I L D FE  D  VLI E +    +LF+ IT       E       
Sbjct: 62  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARS--- 118
Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS 272
                 Q   AV+H H   ++H D+K ENI+    N   +K+IDFG    L  + V    
Sbjct: 119 ---FFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGELKLIDFGSGALLK-DTVYTDF 173
Query: 273 TGTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKN 323
            GT  ++ PE +      G    +W++G+L Y ++ G  PF  E+D E ++ 
Sbjct: 174 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEIIRG 223

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 94/216 (43%), Gaps = 18/216 (8%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEI----DIMNQLH 163
            +  I E IG G FG V R R +  G   +   I        E  R+E      IM Q  
Sbjct: 14  SYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFE 73
Query: 164 HPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPA 223
           HP +I L     +   ++++ EF+  G L   +     ++++ +   + L  ++   +  
Sbjct: 74  HPNIIRLEGVVTNSMPVMILTEFMENGALDSFL-----RLNDGQFTVIQLVGMLRGIASG 128
Query: 224 VKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA------E 277
           ++++ E + +H D+   NI+  +  +   K+ DFGL+  L+ N      T +        
Sbjct: 129 MRYLAEMSYVHRDLAARNILVNS--NLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIR 186
Query: 278 FAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPF 312
           + APE +        +D W+ G++ + ++S G  P+
Sbjct: 187 WTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPY 222

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 97/224 (43%), Gaps = 19/224 (8%)
Query: 112 ILEEIGTGAFGVVHR----CRERKTGNIFAAKFIP--VSHNLEKELIRKEIDIMNQLHHP 165
           +LE++G G+FGVV R        KT ++      P  +S     +   +E++ M+ L H 
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            LI L+        M ++ E    G L +R+     +  +   +  TL     Q +  + 
Sbjct: 72  NLIRLYGVVL-TPPMKMVTELAPLGSLLDRL-----RKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE--VVKISTGTAEFA--AP 281
           ++  K  IH D+   N++  TR+   VK+ DFGL   L  N+   V        FA  AP
Sbjct: 126 YLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAP 183
Query: 282 EIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
           E ++       +D W  GV  + + + G  P+ G N  + L  +
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 227

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/192 (22%), Positives = 90/192 (46%), Gaps = 19/192 (9%)
Query: 149 KELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERI----------TA 198
           +E  R E  +  +L HP ++ L      D  + +IF + S G+L E +          + 
Sbjct: 73  REEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGST 132
Query: 199 PDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFG 258
            D +  ++ + P     L+ Q +  ++++   +++H D+   N++    +  NVK+ D G
Sbjct: 133 DDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVL--VYDKLNVKISDLG 190
Query: 259 LATKLDPNEVVKI---STGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
           L  ++   +  K+   S     + APE +        +D+W+ GV+ + + S GL P+ G
Sbjct: 191 LFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG 250
Query: 315 END---VETLKN 323
            ++   VE ++N
Sbjct: 251 YSNQDVVEMIRN 262

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 31/127 (24%), Positives = 60/127 (47%), Gaps = 2/127 (1%)
Query: 192 LFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTN 251
           +FE +   D+K     +    +   M +   A+ + H   I+H DVKP N++    +   
Sbjct: 112 VFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVLIDHEHR-K 170
Query: 252 VKMIDFGLATKLDPNEVVKISTGTAEFAAPE-IVEREPVGFYTDMWAVGVLAYVLLSGLS 310
           +++ID+GLA    P +   +   +  F  PE +V+ +   +  DMW++G +   ++    
Sbjct: 171 LRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 230
Query: 311 PFAGEND 317
           PF   +D
Sbjct: 231 PFFHGHD 237

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 12/214 (5%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G FG V       T  +      P    +  E   +E  +M +L H KL+ L+ A 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLY-AV 81
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
             ++ + ++ E++S G L + +     +M +   +P  L  +  Q +  + ++   N +H
Sbjct: 82  VSEEPIYIVIEYMSKGSLLDFLKG---EMGKYLRLP-QLVDMAAQIASGMAYVERMNYVH 137
Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTG--TAEFAAPEIVEREPVGFY 292
            D++  NI+     +   K+ DFGLA  ++ NE           ++ APE          
Sbjct: 138 RDLRAANIL--VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 293 TDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
           +D+W+ G+L   L + G  P+ G  + E L  V+
Sbjct: 196 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 108/235 (45%), Gaps = 40/235 (17%)
Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHD 172
           L+ +G G  G+V    +       A K I ++     +   +EI I+ +L H        
Sbjct: 16  LKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDH-------- 67
Query: 173 AFEDDDEMVLIFEFL--SGGELFERITA----------PDYKMSEAEVIPVTLPIL---- 216
                D +V +FE L  SG +L + + +           +Y  ++   +    P+L    
Sbjct: 68  -----DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHA 122
Query: 217 ---MTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVK--I 271
              M Q    +K++H  N++H D+KP N+   T +   +K+ DFGLA  +DP+   K  +
Sbjct: 123 RLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLV-LKIGDFGLARIMDPHYSHKGHL 181
Query: 272 STG--TAEFAAPEIVEREPVGF--YTDMWAVGVLAYVLLSGLSPFAGENDVETLK 322
           S G  T  + +P ++   P  +    DMWA G +   +L+G + FAG +++E ++
Sbjct: 182 SEGLVTKWYRSPRLL-LSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQ 235

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 12/214 (5%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G FG V       T  +      P    +  E   +E  +M +L H KL+ L+ A 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLY-AV 81
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
             ++ + ++ E++S G L + +     +M +   +P  L  +  Q +  + ++   N +H
Sbjct: 82  VSEEPIYIVIEYMSKGSLLDFLKG---EMGKYLRLP-QLVDMAAQIASGMAYVERMNYVH 137
Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTG--TAEFAAPEIVEREPVGFY 292
            D++  NI+     +   K+ DFGLA  ++ NE           ++ APE          
Sbjct: 138 RDLRAANIL--VGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 293 TDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
           +D+W+ G+L   L + G  P+ G  + E L  V+
Sbjct: 196 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 94/217 (43%), Gaps = 18/217 (8%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G FG V       T  +      P    +  E   +E  +M +L H KL+ L+ A 
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLY-AV 247
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM---TQTSPAVKHMHEKN 231
             ++ + ++ E++S G L + +     K        + LP L+    Q +  + ++   N
Sbjct: 248 VSEEPIYIVTEYMSKGSLLDFLKGETGKY-------LRLPQLVDMAAQIASGMAYVERMN 300
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT--AEFAAPEIVEREPV 289
            +H D++  NI+     +   K+ DFGLA  ++ NE           ++ APE       
Sbjct: 301 YVHRDLRAANIL--VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 358
Query: 290 GFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
              +D+W+ G+L   L + G  P+ G  + E L  V+
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 94/217 (43%), Gaps = 18/217 (8%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G FG V       T  +      P    +  E   +E  +M +L H KL+ L+ A 
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLY-AV 247
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM---TQTSPAVKHMHEKN 231
             ++ + ++ E++S G L + +     K        + LP L+    Q +  + ++   N
Sbjct: 248 VSEEPIYIVTEYMSKGSLLDFLKGETGKY-------LRLPQLVDMAAQIASGMAYVERMN 300
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT--AEFAAPEIVEREPV 289
            +H D++  NI+     +   K+ DFGLA  ++ NE           ++ APE       
Sbjct: 301 YVHRDLRAANIL--VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 358
Query: 290 GFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
              +D+W+ G+L   L + G  P+ G  + E L  V+
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 113 LEEIGTGAFGVVH-RCRERK---TGNIFAAKFIPVSHNLE-KELIRKEIDIMNQLHHPKL 167
           + ++G G FG V   C +     TG + A K +      + +   ++EIDI+  L+H  +
Sbjct: 19  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 168 INLHDAFEDDDE--MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
           I      ED  E  + L+ E++  G L  R   P + +  A+++     +   Q    + 
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSL--RDYLPRHSIGLAQLL-----LFAQQICEGMA 131
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL-DPNEVVKI---STGTAEFAAP 281
           ++H ++ IH ++   N++    N   VK+ DFGLA  + + +E  ++         + AP
Sbjct: 132 YLHSQHYIHRNLAARNVL--LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 189
Query: 282 EIVEREPVGFYTDMWAVGVLAYVLLS 307
           E ++     + +D+W+ GV  Y LL+
Sbjct: 190 ECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 87/180 (48%), Gaps = 26/180 (14%)
Query: 164 HPKLINLHDAFEDDDEMVLIFEF--LSGGELFERITAPDYKMS-EAEVIPVTLPILMTQT 220
           HP +I  + +   D  + +  E   L+  +L E     D  +  + E  P++L   + Q 
Sbjct: 86  HPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISL---LRQI 142
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRN---------STNVKMI--DFGLATKLDPNEV- 268
           +  V H+H   IIH D+KP+NI+  T +         + N++++  DFGL  KLD  +  
Sbjct: 143 ASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXX 202
Query: 269 ----VKISTGTAEFAAPEIVEREPVGFYT---DMWAVGVLAYVLLS-GLSPFAGENDVET 320
               +   +GT+ + APE++E       T   D++++G + Y +LS G  PF  +   E+
Sbjct: 203 FRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 262

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 12/214 (5%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G FG V       T  +      P    +  E   +E  +M +L H KL+ L+ A 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLY-AV 81
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
             ++ + ++ E++S G L + +     +M +   +P  L  +  Q +  + ++   N +H
Sbjct: 82  VSEEPIYIVCEYMSKGSLLDFLKG---EMGKYLRLP-QLVDMAAQIASGMAYVERMNYVH 137
Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTG--TAEFAAPEIVEREPVGFY 292
            D++  NI+     +   K+ DFGLA  ++ NE           ++ APE          
Sbjct: 138 RDLRAANIL--VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 293 TDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
           +D+W+ G+L   L + G  P+ G  + E L  V+
Sbjct: 196 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 87/180 (48%), Gaps = 26/180 (14%)
Query: 164 HPKLINLHDAFEDDDEMVLIFEF--LSGGELFERITAPDYKMS-EAEVIPVTLPILMTQT 220
           HP +I  + +   D  + +  E   L+  +L E     D  +  + E  P++L   + Q 
Sbjct: 86  HPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISL---LRQI 142
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRN---------STNVKMI--DFGLATKLDPNEV- 268
           +  V H+H   IIH D+KP+NI+  T +         + N++++  DFGL  KLD  +  
Sbjct: 143 ASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXX 202
Query: 269 ----VKISTGTAEFAAPEIVEREPVGFYT---DMWAVGVLAYVLLS-GLSPFAGENDVET 320
               +   +GT+ + APE++E       T   D++++G + Y +LS G  PF  +   E+
Sbjct: 203 FRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 262

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 94/217 (43%), Gaps = 18/217 (8%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G FG V       T  +      P    +  E   +E  +M +L H KL+ L+ A 
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLY-AV 247
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM---TQTSPAVKHMHEKN 231
             ++ + ++ E++S G L + +     K        + LP L+    Q +  + ++   N
Sbjct: 248 VSEEPIYIVGEYMSKGSLLDFLKGETGKY-------LRLPQLVDMAAQIASGMAYVERMN 300
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT--AEFAAPEIVEREPV 289
            +H D++  NI+     +   K+ DFGLA  ++ NE           ++ APE       
Sbjct: 301 YVHRDLRAANIL--VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 358
Query: 290 GFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
              +D+W+ G+L   L + G  P+ G  + E L  V+
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 113 LEEIGTGAFGVVH-RCRERK---TGNIFAAKFIPVSHNLE-KELIRKEIDIMNQLHHPKL 167
           + ++G G FG V   C +     TG + A K +      + +   ++EIDI+  L+H  +
Sbjct: 19  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 168 INLHDAFEDDDE--MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
           I      ED  E  + L+ E++  G L  R   P + +  A+++     +   Q    + 
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSL--RDYLPRHSIGLAQLL-----LFAQQICEGMA 131
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL-DPNEVVKI---STGTAEFAAP 281
           ++H ++ IH ++   N++    N   VK+ DFGLA  + + +E  ++         + AP
Sbjct: 132 YLHAQHYIHRNLAARNVL--LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 189
Query: 282 EIVEREPVGFYTDMWAVGVLAYVLLS 307
           E ++     + +D+W+ GV  Y LL+
Sbjct: 190 ECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 12/214 (5%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G FG V       T  +      P    +  E   +E  +M +L H KL+ L+ A 
Sbjct: 16  KLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLY-AV 72
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
             ++ + ++ E++S G L + +     +M +   +P  L  +  Q +  + ++   N +H
Sbjct: 73  VSEEPIYIVTEYMSKGSLLDFLKG---EMGKYLRLP-QLVDMAAQIASGMAYVERMNYVH 128
Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTG--TAEFAAPEIVEREPVGFY 292
            D++  NI+     +   K+ DFGLA  ++ NE           ++ APE          
Sbjct: 129 RDLRAANIL--VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 186
Query: 293 TDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
           +D+W+ G+L   L + G  P+ G  + E L  V+
Sbjct: 187 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 220

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 12/214 (5%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G FG V       T  +      P    +  E   +E  +M +L H KL+ L+ A 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLY-AV 81
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
             ++ + ++ E++S G L + +     +M +   +P  L  +  Q +  + ++   N +H
Sbjct: 82  VSEEPIYIVTEYMSKGSLLDFLKG---EMGKYLRLP-QLVDMAAQIASGMAYVERMNYVH 137
Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTG--TAEFAAPEIVEREPVGFY 292
            D++  NI+     +   K+ DFGLA  ++ NE           ++ APE          
Sbjct: 138 RDLRAANIL--VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 293 TDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
           +D+W+ G+L   L + G  P+ G  + E L  V+
Sbjct: 196 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 12/214 (5%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G FG V       T  +      P    +  E   +E  +M +L H KL+ L+ A 
Sbjct: 14  KLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLY-AV 70
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
             ++ + ++ E++S G L + +     +M +   +P  L  +  Q +  + ++   N +H
Sbjct: 71  VSEEPIYIVTEYMSKGSLLDFLKG---EMGKYLRLP-QLVDMAAQIASGMAYVERMNYVH 126
Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTG--TAEFAAPEIVEREPVGFY 292
            D++  NI+     +   K+ DFGLA  ++ NE           ++ APE          
Sbjct: 127 RDLRAANIL--VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 184
Query: 293 TDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
           +D+W+ G+L   L + G  P+ G  + E L  V+
Sbjct: 185 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 218

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 12/214 (5%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G FG V       T  +      P    +  E   +E  +M +L H KL+ L+ A 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLY-AV 81
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
             ++ + ++ E++S G L + +     +M +   +P  L  +  Q +  + ++   N +H
Sbjct: 82  VSEEPIYIVMEYMSKGCLLDFLKG---EMGKYLRLP-QLVDMAAQIASGMAYVERMNYVH 137
Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTG--TAEFAAPEIVEREPVGFY 292
            D++  NI+     +   K+ DFGLA  ++ NE           ++ APE          
Sbjct: 138 RDLRAANIL--VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 293 TDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
           +D+W+ G+L   L + G  P+ G  + E L  V+
Sbjct: 196 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 113 LEEIGTGAFGVVHRCR----ERKTGNIFAAKFI-PVSHNLEKELIRKEIDIMNQLHHPKL 167
           + ++G G FG V  CR       TG   A K + P S       ++KEI+I+  L+H  +
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 168 INLHDAFEDD--DEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
           +       +D  + + LI EFL  G L E +     K++  + +   +     Q    + 
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV-----QICKGMD 140
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE---VVKISTGTAEF-AAP 281
           ++  +  +H D+   N++ ++ +   VK+ DFGL   ++ ++    VK    +  F  AP
Sbjct: 141 YLGSRQYVHRDLAARNVLVESEH--QVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAP 198
Query: 282 EIVEREPVGFYTDMWAVGVLAYVLL----SGLSPFA 313
           E + +      +D+W+ GV  + LL    S  SP A
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA 234

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/209 (22%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 109 HYDILEEIGTGAFGVVHRCR----ERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHH 164
           H   + ++G G FG V  CR       TG + A K +  S   ++   ++EI I+  LH 
Sbjct: 11  HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS 70
Query: 165 PKLINLHDAF--EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSP 222
             ++             + L+ E+L  G L + +     ++  + ++     +  +Q   
Sbjct: 71  DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLL-----LYSSQICK 125
Query: 223 AVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT--KLDPNEVVKISTGTAE--F 278
            ++++  +  +H D+   NI+ ++    +VK+ DFGLA    LD +  V    G +   +
Sbjct: 126 GMEYLGSRRCVHRDLAARNILVES--EAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 183
Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLS 307
            APE +        +D+W+ GV+ Y L +
Sbjct: 184 YAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 95/217 (43%), Gaps = 18/217 (8%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G FG V       T  +      P +  +  E   +E  +M +L H KL+ L+ A 
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLY-AV 330
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM---TQTSPAVKHMHEKN 231
             ++ + ++ E++S G L + +     K        + LP L+    Q +  + ++   N
Sbjct: 331 VSEEPIYIVTEYMSKGSLLDFLKGETGKY-------LRLPQLVDMAAQIASGMAYVERMN 383
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTG--TAEFAAPEIVEREPV 289
            +H D++  NI+     +   K+ DFGLA  ++ NE           ++ APE       
Sbjct: 384 YVHRDLRAANIL--VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 441
Query: 290 GFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
              +D+W+ G+L   L + G  P+ G  + E L  V+
Sbjct: 442 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/209 (22%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 109 HYDILEEIGTGAFGVVHRCR----ERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHH 164
           H   + ++G G FG V  CR       TG + A K +  S   ++   ++EI I+  LH 
Sbjct: 12  HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS 71
Query: 165 PKLINLHDAF--EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSP 222
             ++             + L+ E+L  G L + +     ++  + ++     +  +Q   
Sbjct: 72  DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLL-----LYSSQICK 126
Query: 223 AVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT--KLDPNEVVKISTGTAE--F 278
            ++++  +  +H D+   NI+ ++    +VK+ DFGLA    LD +  V    G +   +
Sbjct: 127 GMEYLGSRRCVHRDLAARNILVES--EAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 184
Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLS 307
            APE +        +D+W+ GV+ Y L +
Sbjct: 185 YAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/209 (22%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 109 HYDILEEIGTGAFGVVHRCR----ERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHH 164
           H   + ++G G FG V  CR       TG + A K +  S   ++   ++EI I+  LH 
Sbjct: 24  HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS 83
Query: 165 PKLINLHDAF--EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSP 222
             ++             + L+ E+L  G L + +     ++  + ++     +  +Q   
Sbjct: 84  DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLL-----LYSSQICK 138
Query: 223 AVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT--KLDPNEVVKISTGTAE--F 278
            ++++  +  +H D+   NI+ ++    +VK+ DFGLA    LD +  V    G +   +
Sbjct: 139 GMEYLGSRRCVHRDLAARNILVES--EAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 196
Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLS 307
            APE +        +D+W+ GV+ Y L +
Sbjct: 197 YAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 113 LEEIGTGAFGVVHRCR----ERKTGNIFAAKFI-PVSHNLEKELIRKEIDIMNQLHHPKL 167
           + ++G G FG V  CR       TG   A K + P S       ++KEI+I+  L+H  +
Sbjct: 14  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 73
Query: 168 INLHDAFEDD--DEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
           +       +D  + + LI EFL  G L E +     K++  + +   +     Q    + 
Sbjct: 74  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV-----QICKGMD 128
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE---VVKISTGTAEF-AAP 281
           ++  +  +H D+   N++ ++ +   VK+ DFGL   ++ ++    VK    +  F  AP
Sbjct: 129 YLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAP 186
Query: 282 EIVEREPVGFYTDMWAVGVLAYVLL----SGLSPFA 313
           E + +      +D+W+ GV  + LL    S  SP A
Sbjct: 187 ECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA 222

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 34/232 (14%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS-HNLEKELIRKEIDIMNQLHHP-- 165
            Y +   +G+G FG V+         I  +  +PV+  ++EK+ I    ++ N    P  
Sbjct: 10  QYQVGPLLGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 62
Query: 166 ------------KLINLHDAFEDDDEMVLIFEFLSG-GELFERITAPDYKMSEAEVIPVT 212
                        +I L D FE  D  VLI E      +LF+ IT       E       
Sbjct: 63  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS--- 119
Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS 272
                 Q   AV+H H   ++H D+K ENI+    N   +K+IDFG    L  + V    
Sbjct: 120 ---FFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGELKLIDFGSGALLK-DTVYTDF 174
Query: 273 TGTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKN 323
            GT  ++ PE +      G    +W++G+L Y ++ G  PF  E+D E ++ 
Sbjct: 175 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEIIRG 224

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 34/232 (14%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS-HNLEKELIRKEIDIMNQLHHP-- 165
            Y +   +G+G FG V+         I  +  +PV+  ++EK+ I    ++ N    P  
Sbjct: 5   QYQVGPLLGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 57
Query: 166 ------------KLINLHDAFEDDDEMVLIFEFLSG-GELFERITAPDYKMSEAEVIPVT 212
                        +I L D FE  D  VLI E      +LF+ IT       E       
Sbjct: 58  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS--- 114
Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS 272
                 Q   AV+H H   ++H D+K ENI+    N   +K+IDFG    L  + V    
Sbjct: 115 ---FFWQVLEAVRHCHNXGVLHRDIKDENILIDL-NRGELKLIDFGSGALLK-DTVYTDF 169
Query: 273 TGTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKN 323
            GT  ++ PE +      G    +W++G+L Y ++ G  PF  E+D E ++ 
Sbjct: 170 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEIIRG 219

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 34/232 (14%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS-HNLEKELIRKEIDIMNQLHHP-- 165
            Y +   +G+G FG V+         I  +  +PV+  ++EK+ I    ++ N    P  
Sbjct: 9   QYQVGPLLGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 61
Query: 166 ------------KLINLHDAFEDDDEMVLIFEFLSG-GELFERITAPDYKMSEAEVIPVT 212
                        +I L D FE  D  VLI E      +LF+ IT       E       
Sbjct: 62  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS--- 118
Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS 272
                 Q   AV+H H   ++H D+K ENI+    N   +K+IDFG    L  + V    
Sbjct: 119 ---FFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGELKLIDFGSGALLK-DTVYTDF 173
Query: 273 TGTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKN 323
            GT  ++ PE +      G    +W++G+L Y ++ G  PF  E+D E ++ 
Sbjct: 174 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEIIRG 223

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/219 (21%), Positives = 101/219 (46%), Gaps = 16/219 (7%)
Query: 116 IGTGAFGVVHRCRERKTGN---IFAAKFIPVSHN-LEKELIRKEIDIMNQLHHPKLINLH 171
           IG G FG V   R +  G      A K + V +   ++     E  IM Q  HP +++L 
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
                   ++++ EF+  G L   +   D + +  +++      ++   +  ++++ +  
Sbjct: 111 GVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVG-----MLRGIAAGMRYLADMG 165
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKL-DPNEVVKISTG---TAEFAAPEIVERE 287
            +H D+   NI+  +  +   K+ DFGL+  + D  E V  +TG      + APE ++  
Sbjct: 166 YVHRDLAARNILVNS--NLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYR 223
Query: 288 PVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
                +D+W+ G++ + ++S G  P+   ++ + +K ++
Sbjct: 224 KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE 262

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 105/241 (43%), Gaps = 40/241 (16%)
Query: 101 IKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN--LEKELIRKEIDI 158
           IK   V D+Y I   IG G++G V+   ++ T    A K +       ++ + I +EI I
Sbjct: 19  IKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITI 78
Query: 159 MNQLHHPKLINLHDAFEDD-----DEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTL 213
           +N+L    +I L+D    D     DE+ ++ E ++  +L +    P + ++E  +  +  
Sbjct: 79  LNRLKSDYIIRLYDLIIPDDLLKFDELYIVLE-IADSDLKKLFKTPIF-LTEEHIKTILY 136
Query: 214 PILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST 273
            +L+ +       +HE  IIH D+KP N  C      +VK+ DFGLA  ++  +   I  
Sbjct: 137 NLLLGEN-----FIHESGIIHRDLKPAN--CLLNQDCSVKVCDFGLARTINSEKDTNIVN 189
Query: 274 GTAE-----------------------FAAPE-IVEREPVGFYTDMWAVGVLAYVLLSGL 309
              E                       + APE I+ +E      D+W+ G +   LL+ L
Sbjct: 190 DLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML 249
Query: 310 S 310
Sbjct: 250 Q 250

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 34/232 (14%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS-HNLEKELIRKEIDIMNQLHHP-- 165
            Y +   +G+G FG V+         I  +  +PV+  ++EK+ I    ++ N    P  
Sbjct: 25  QYQVGPLLGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 77
Query: 166 ------------KLINLHDAFEDDDEMVLIFEFLSG-GELFERITAPDYKMSEAEVIPVT 212
                        +I L D FE  D  VLI E      +LF+ IT       E       
Sbjct: 78  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS--- 134
Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS 272
                 Q   AV+H H   ++H D+K ENI+    N   +K+IDFG    L  + V    
Sbjct: 135 ---FFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGELKLIDFGSGALLK-DTVYTDF 189
Query: 273 TGTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKN 323
            GT  ++ PE +      G    +W++G+L Y ++ G  PF  E+D E ++ 
Sbjct: 190 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEIIRG 239

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 34/232 (14%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS-HNLEKELIRKEIDIMNQLHHP-- 165
            Y +   +G+G FG V+         I  +  +PV+  ++EK+ I    ++ N    P  
Sbjct: 10  QYQVGPLLGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 62
Query: 166 ------------KLINLHDAFEDDDEMVLIFEFLSG-GELFERITAPDYKMSEAEVIPVT 212
                        +I L D FE  D  VLI E      +LF+ IT       E       
Sbjct: 63  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS--- 119
Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS 272
                 Q   AV+H H   ++H D+K ENI+    N   +K+IDFG    L  + V    
Sbjct: 120 ---FFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGELKLIDFGSGALLK-DTVYTDF 174
Query: 273 TGTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKN 323
            GT  ++ PE +      G    +W++G+L Y ++ G  PF  E+D E ++ 
Sbjct: 175 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEIIRG 224

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 94/217 (43%), Gaps = 18/217 (8%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G FG V       T  +      P    +  E   +E  +M +L H KL+ L+ A 
Sbjct: 15  KLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLY-AV 71
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM---TQTSPAVKHMHEKN 231
             ++ + ++ E++S G L + +     K        + LP L+    Q +  + ++   N
Sbjct: 72  VSEEPIXIVTEYMSKGSLLDFLKGETGKY-------LRLPQLVDMAAQIASGMAYVERMN 124
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTG--TAEFAAPEIVEREPV 289
            +H D++  NI+     +   K+ DFGLA  ++ NE           ++ APE       
Sbjct: 125 YVHRDLRAANIL--VGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRF 182
Query: 290 GFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
              +D+W+ G+L   L + G  P+ G  + E L  V+
Sbjct: 183 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 219

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 94/217 (43%), Gaps = 18/217 (8%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G FG V       T  +      P    +  E   +E  +M +L H KL+ L+ A 
Sbjct: 18  KLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLY-AV 74
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM---TQTSPAVKHMHEKN 231
             ++ + ++ E++S G L + +     K        + LP L+    Q +  + ++   N
Sbjct: 75  VSEEPIYIVTEYMSKGSLLDFLKGETGKY-------LRLPQLVDMAAQIASGMAYVERMN 127
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTG--TAEFAAPEIVEREPV 289
            +H D++  NI+     +   K+ DFGLA  ++ NE           ++ APE       
Sbjct: 128 YVHRDLRAANIL--VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 185
Query: 290 GFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
              +D+W+ G+L   L + G  P+ G  + E L  V+
Sbjct: 186 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 222

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 34/232 (14%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS-HNLEKELIRKEIDIMNQLHHP-- 165
            Y +   +G+G FG V+         I  +  +PV+  ++EK+ I    ++ N    P  
Sbjct: 25  QYQVGPLLGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 77
Query: 166 ------------KLINLHDAFEDDDEMVLIFEFLSG-GELFERITAPDYKMSEAEVIPVT 212
                        +I L D FE  D  VLI E      +LF+ IT       E       
Sbjct: 78  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS--- 134
Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS 272
                 Q   AV+H H   ++H D+K ENI+    N   +K+IDFG    L  + V    
Sbjct: 135 ---FFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGELKLIDFGSGALLK-DTVYTDF 189
Query: 273 TGTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKN 323
            GT  ++ PE +      G    +W++G+L Y ++ G  PF  E+D E ++ 
Sbjct: 190 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEIIRG 239

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 91/205 (44%), Gaps = 25/205 (12%)
Query: 117 GTGAFGVVHRCRERKTGNIFA--AKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           G G FGVV++     T       A  + ++    K+   +EI +  +  H  L+ L    
Sbjct: 31  GEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLGFS 90
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI-------LMTQTSPAVKHM 227
            D D++ L++ +   G L +R++  D           T P+       +    +  +  +
Sbjct: 91  SDGDDLCLVYVYXPNGSLLDRLSCLDG----------TPPLSWHXRCKIAQGAANGINFL 140
Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP-NEVVKIS--TGTAEFAAPEIV 284
           HE + IH D+K  NI+     +   K+ DFGLA   +   + V  S   GT  + APE +
Sbjct: 141 HENHHIHRDIKSANILLD--EAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEAL 198
Query: 285 EREPVGFYTDMWAVGVLAYVLLSGL 309
            R  +   +D+++ GV+   +++GL
Sbjct: 199 -RGEITPKSDIYSFGVVLLEIITGL 222

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/244 (24%), Positives = 115/244 (47%), Gaps = 19/244 (7%)
Query: 75  KADEKVSDY--DQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKT 132
           KA   ++D     Y+    S  VP  VD++ ++  +++D    IG G FG V++   R  
Sbjct: 7   KATNSINDALSSSYLVPFESYRVPL-VDLEEAT--NNFDHKFLIGHGVFGKVYKGVLRDG 63
Query: 133 GNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGEL 192
             +   +  P S     E    EI+ ++   HP L++L    ++ +EM+LI++++  G L
Sbjct: 64  AKVALKRRTPESSQ-GIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122
Query: 193 FERITA---PDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNS 249
              +     P   MS  + + + +       +  + ++H + IIH DVK  NI+     +
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICI-----GAARGLHYLHTRAIIHRDVKSINILLD--EN 175
Query: 250 TNVKMIDFGLA---TKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLL 306
              K+ DFG++   T+LD   +  +  GT  +  PE   +  +   +D+++ GV+ + +L
Sbjct: 176 FVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235
Query: 307 SGLS 310
              S
Sbjct: 236 CARS 239

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 34/232 (14%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS-HNLEKELIRKEIDIMNQLHHP-- 165
            Y +   +G+G FG V+         I  +  +PV+  ++EK+ I    ++ N    P  
Sbjct: 24  QYQVGPLLGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 76
Query: 166 ------------KLINLHDAFEDDDEMVLIFEFLSG-GELFERITAPDYKMSEAEVIPVT 212
                        +I L D FE  D  VLI E      +LF+ IT       E       
Sbjct: 77  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS--- 133
Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS 272
                 Q   AV+H H   ++H D+K ENI+    N   +K+IDFG    L  + V    
Sbjct: 134 ---FFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGELKLIDFGSGALLK-DTVYTDF 188
Query: 273 TGTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKN 323
            GT  ++ PE +      G    +W++G+L Y ++ G  PF  E+D E ++ 
Sbjct: 189 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEIIRG 238

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 34/232 (14%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS-HNLEKELIRKEIDIMNQLHHP-- 165
            Y +   +G+G FG V+         I  +  +PV+  ++EK+ I    ++ N    P  
Sbjct: 25  QYQVGPLLGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 77
Query: 166 ------------KLINLHDAFEDDDEMVLIFEFLSG-GELFERITAPDYKMSEAEVIPVT 212
                        +I L D FE  D  VLI E      +LF+ IT       E       
Sbjct: 78  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS--- 134
Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS 272
                 Q   AV+H H   ++H D+K ENI+    N   +K+IDFG    L  + V    
Sbjct: 135 ---FFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGELKLIDFGSGALLK-DTVYTDF 189
Query: 273 TGTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKN 323
            GT  ++ PE +      G    +W++G+L Y ++ G  PF  E+D E ++ 
Sbjct: 190 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEIIRG 239

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 96/206 (46%), Gaps = 20/206 (9%)
Query: 113 LEEIGTGAFGVVH-RCRERK---TGNIFAAKFIPVSHNLE-KELIRKEIDIMNQLHHPKL 167
           + ++G G FG V   C +     TG + A K +      + +   ++EIDI+  L+H  +
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 168 INLHDAFEDDD--EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
           I      ED     + L+ E++  G L  R   P + +  A+++     +   Q    + 
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSL--RDYLPRHSIGLAQLL-----LFAQQICEGMA 148
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL-DPNEVVKI---STGTAEFAAP 281
           ++H ++ IH D+   N++    N   VK+ DFGLA  + + +E  ++         + AP
Sbjct: 149 YLHAQHYIHRDLAARNVLLD--NDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAP 206
Query: 282 EIVEREPVGFYTDMWAVGVLAYVLLS 307
           E ++     + +D+W+ GV  Y LL+
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 34/232 (14%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS-HNLEKELIRKEIDIMNQLHHP-- 165
            Y +   +G+G FG V+         I  +  +PV+  ++EK+ I    ++ N    P  
Sbjct: 8   QYQVGPLLGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 60
Query: 166 ------------KLINLHDAFEDDDEMVLIFEFLSG-GELFERITAPDYKMSEAEVIPVT 212
                        +I L D FE  D  VLI E      +LF+ IT       E       
Sbjct: 61  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS--- 117
Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS 272
                 Q   AV+H H   ++H D+K ENI+    N   +K+IDFG    L  + V    
Sbjct: 118 ---FFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGELKLIDFGSGALLK-DTVYTDF 172
Query: 273 TGTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKN 323
            GT  ++ PE +      G    +W++G+L Y ++ G  PF  E+D E ++ 
Sbjct: 173 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEIIRG 222

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 34/232 (14%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS-HNLEKELIRKEIDIMNQLHHP-- 165
            Y +   +G+G FG V+         I  +  +PV+  ++EK+ I    ++ N    P  
Sbjct: 10  QYQVGPLLGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 62
Query: 166 ------------KLINLHDAFEDDDEMVLIFEFLSG-GELFERITAPDYKMSEAEVIPVT 212
                        +I L D FE  D  VLI E      +LF+ IT       E       
Sbjct: 63  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS--- 119
Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS 272
                 Q   AV+H H   ++H D+K ENI+    N   +K+IDFG    L  + V    
Sbjct: 120 ---FFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGELKLIDFGSGALLK-DTVYTDF 174
Query: 273 TGTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKN 323
            GT  ++ PE +      G    +W++G+L Y ++ G  PF  E+D E ++ 
Sbjct: 175 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEIIRG 224

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 34/232 (14%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS-HNLEKELIRKEIDIMNQLHHP-- 165
            Y +   +G+G FG V+         I  +  +PV+  ++EK+ I    ++ N    P  
Sbjct: 24  QYQVGPLLGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 76
Query: 166 ------------KLINLHDAFEDDDEMVLIFEFLSG-GELFERITAPDYKMSEAEVIPVT 212
                        +I L D FE  D  VLI E      +LF+ IT       E       
Sbjct: 77  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS--- 133
Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS 272
                 Q   AV+H H   ++H D+K ENI+    N   +K+IDFG    L  + V    
Sbjct: 134 ---FFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGELKLIDFGSGALLK-DTVYTDF 188
Query: 273 TGTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKN 323
            GT  ++ PE +      G    +W++G+L Y ++ G  PF  E+D E ++ 
Sbjct: 189 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEIIRG 238

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 34/232 (14%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS-HNLEKELIRKEIDIMNQLHHP-- 165
            Y +   +G+G FG V+         I  +  +PV+  ++EK+ I    ++ N    P  
Sbjct: 5   QYQVGPLLGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 57
Query: 166 ------------KLINLHDAFEDDDEMVLIFEFLSG-GELFERITAPDYKMSEAEVIPVT 212
                        +I L D FE  D  VLI E      +LF+ IT       E       
Sbjct: 58  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS--- 114
Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS 272
                 Q   AV+H H   ++H D+K ENI+    N   +K+IDFG    L  + V    
Sbjct: 115 ---FFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGELKLIDFGSGALLK-DTVYTDF 169
Query: 273 TGTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKN 323
            GT  ++ PE +      G    +W++G+L Y ++ G  PF  E+D E ++ 
Sbjct: 170 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEIIRG 219

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 34/232 (14%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS-HNLEKELIRKEIDIMNQLHHP-- 165
            Y +   +G+G FG V+         I  +  +PV+  ++EK+ I    ++ N    P  
Sbjct: 44  QYQVGPLLGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 96
Query: 166 ------------KLINLHDAFEDDDEMVLIFEFLSG-GELFERITAPDYKMSEAEVIPVT 212
                        +I L D FE  D  VLI E      +LF+ IT       E       
Sbjct: 97  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS--- 153
Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS 272
                 Q   AV+H H   ++H D+K ENI+    N   +K+IDFG    L  + V    
Sbjct: 154 ---FFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGELKLIDFGSGALLK-DTVYTDF 208
Query: 273 TGTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKN 323
            GT  ++ PE +      G    +W++G+L Y ++ G  PF  E+D E ++ 
Sbjct: 209 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEIIRG 258

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 12/214 (5%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G FG V       T  +      P    +  E   +E  +M +L H KL+ L+ A 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLY-AV 81
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
             ++ + ++ E++S G L + +     +M +   +P  L  +  Q +  + ++   N +H
Sbjct: 82  VSEEPIYIVTEYMSKGCLLDFLKG---EMGKYLRLP-QLVDMAAQIASGMAYVERMNYVH 137
Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTG--TAEFAAPEIVEREPVGFY 292
            D++  NI+     +   K+ DFGLA  ++ NE           ++ APE          
Sbjct: 138 RDLRAANIL--VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 293 TDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
           +D+W+ G+L   L + G  P+ G  + E L  V+
Sbjct: 196 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 95/214 (44%), Gaps = 12/214 (5%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G FG V       T  +      P    +  E   +E  +M ++ H KL+ L+ A 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKIRHEKLVQLY-AV 81
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
             ++ + ++ E++S G L + +     +M +   +P  L  +  Q +  + ++   N +H
Sbjct: 82  VSEEPIYIVTEYMSKGSLLDFLKG---EMGKYLRLP-QLVDMAAQIASGMAYVERMNYVH 137
Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTG--TAEFAAPEIVEREPVGFY 292
            D++  NI+     +   K+ DFGLA  ++ NE           ++ APE          
Sbjct: 138 RDLRAANIL--VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 293 TDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
           +D+W+ G+L   L + G  P+ G  + E L  V+
Sbjct: 196 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 83/167 (49%), Gaps = 16/167 (9%)
Query: 105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFA-AKFIPVSHNL-EKELIRKEIDIMNQL 162
            + D Y+I   IGTG++G V    ++    + A  K + V  +L + + I +EI I+N+L
Sbjct: 50  QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL 109
Query: 163 HHPKLINLHDAF-----EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM 217
           +H  ++ + D       E  DE+ ++ E       F+++      ++E  +  +   +L+
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIADSD--FKKLFRTPVYLTELHIKTLLYNLLV 167
Query: 218 TQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD 264
                 VK++H   I+H D+KP N  C      +VK+ DFGLA  +D
Sbjct: 168 -----GVKYVHSAGILHRDLKPAN--CLVNQDCSVKVCDFGLARTVD 207

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 34/232 (14%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS-HNLEKELIRKEIDIMNQLHHP-- 165
            Y +   +G+G FG V+         I  +  +PV+  ++EK+ I    ++ N    P  
Sbjct: 32  QYQVGPLLGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 84
Query: 166 ------------KLINLHDAFEDDDEMVLIFEFLSG-GELFERITAPDYKMSEAEVIPVT 212
                        +I L D FE  D  VLI E      +LF+ IT       E       
Sbjct: 85  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS--- 141
Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS 272
                 Q   AV+H H   ++H D+K ENI+    N   +K+IDFG    L  + V    
Sbjct: 142 ---FFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGELKLIDFGSGALLK-DTVYTDF 196
Query: 273 TGTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKN 323
            GT  ++ PE +      G    +W++G+L Y ++ G  PF  E+D E ++ 
Sbjct: 197 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEIIRG 246

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 94/214 (43%), Gaps = 12/214 (5%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G FG V       T  +      P    +  E   +E  +M +L H KL+ L+ A 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLY-AV 81
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIH 234
             ++ + ++ E++S G L + +     +M +   +P  L  +  Q +  + ++   N +H
Sbjct: 82  VSEEPIYIVTEYMSKGSLLDFLKG---EMGKYLRLP-QLVDMAAQIASGMAYVERMNYVH 137
Query: 235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTG--TAEFAAPEIVEREPVGFY 292
            D+   NI+     +   K+ DFGLA  ++ NE           ++ APE          
Sbjct: 138 RDLAAANIL--VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 293 TDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
           +D+W+ G+L   L + G  P+ G  + E L  V+
Sbjct: 196 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 105/240 (43%), Gaps = 24/240 (10%)
Query: 89  DIYSKYVPQPVDIKTSSVYDHYDIL----EEIGTGAFGVVHRCRERKTGNIFAAKFIPVS 144
           ++Y      P +I+   VY    +L    +E+G+G FG V +   +    +       + 
Sbjct: 4   EVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILK 63
Query: 145 HN-----LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAP 199
           +      L+ EL+  E ++M QL +P ++ +    E +  M L+ E    G L +     
Sbjct: 64  NEANDPALKDELL-AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNK----- 116
Query: 200 DYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGL 259
            Y      V    +  L+ Q S  +K++ E N +H D+   N++  T++    K+ DFGL
Sbjct: 117 -YLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYA--KISDFGL 173
Query: 260 ATKLDPNE-VVKIST---GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
           +  L  +E   K  T      ++ APE +        +D+W+ GVL +   S G  P+ G
Sbjct: 174 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 233

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 105/240 (43%), Gaps = 24/240 (10%)
Query: 89  DIYSKYVPQPVDIKTSSVYDHYDIL----EEIGTGAFGVVHRCRERKTGNIFAAKFIPVS 144
           ++Y      P +I+   VY    +L    +E+G+G FG V +   +    +       + 
Sbjct: 4   EVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILK 63
Query: 145 HN-----LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAP 199
           +      L+ EL+  E ++M QL +P ++ +    E +  M L+ E    G L +     
Sbjct: 64  NEANDPALKDELL-AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNK----- 116
Query: 200 DYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGL 259
            Y      V    +  L+ Q S  +K++ E N +H D+   N++  T++    K+ DFGL
Sbjct: 117 -YLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYA--KISDFGL 173
Query: 260 ATKLDPNE-VVKIST---GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
           +  L  +E   K  T      ++ APE +        +D+W+ GVL +   S G  P+ G
Sbjct: 174 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 233

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 34/232 (14%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS-HNLEKELIRKEIDIMNQLHHP-- 165
            Y +   +G+G FG V+         I  +  +PV+  ++EK+ I    ++ N    P  
Sbjct: 52  QYQVGPLLGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 104
Query: 166 ------------KLINLHDAFEDDDEMVLIFEFLSG-GELFERITAPDYKMSEAEVIPVT 212
                        +I L D FE  D  VLI E      +LF+ IT       E       
Sbjct: 105 VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS--- 161
Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS 272
                 Q   AV+H H   ++H D+K ENI+    N   +K+IDFG    L  + V    
Sbjct: 162 ---FFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGELKLIDFGSGALLK-DTVYTDF 216
Query: 273 TGTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKN 323
            GT  ++ PE +      G    +W++G+L Y ++ G  PF  E+D E ++ 
Sbjct: 217 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEIIRG 266

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 34/232 (14%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS-HNLEKELIRKEIDIMNQLHHP-- 165
            Y +   +G+G FG V+         I  +  +PV+  ++EK+ I    ++ N    P  
Sbjct: 37  QYQVGPLLGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 89
Query: 166 ------------KLINLHDAFEDDDEMVLIFEFLSG-GELFERITAPDYKMSEAEVIPVT 212
                        +I L D FE  D  VLI E      +LF+ IT       E       
Sbjct: 90  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS--- 146
Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS 272
                 Q   AV+H H   ++H D+K ENI+    N   +K+IDFG    L  + V    
Sbjct: 147 ---FFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGELKLIDFGSGALLK-DTVYTDF 201
Query: 273 TGTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKN 323
            GT  ++ PE +      G    +W++G+L Y ++ G  PF  E+D E ++ 
Sbjct: 202 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEIIRG 251

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/226 (21%), Positives = 94/226 (41%), Gaps = 14/226 (6%)
Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE--KELIRKEIDIMN 160
           +++  D Y  + ++G G +G V++  +  T    A K I + H  E       +E+ ++ 
Sbjct: 29  SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLK 88
Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
           +L H  +I L      +  + LIFE+            PD  M         +   + Q 
Sbjct: 89  ELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMR-------VIKSFLYQL 141
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTN---VKMIDFGLATKLD-PNEVVKISTGTA 276
              V   H +  +H D+KP+N++    +++    +K+ DFGLA     P         T 
Sbjct: 142 INGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITL 201
Query: 277 EFAAPEI-VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETL 321
            +  PEI +         D+W++  +   +L     F G+++++ L
Sbjct: 202 WYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQL 247

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 98/231 (42%), Gaps = 34/231 (14%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS-HNLEKELIRKEIDIMNQLHHP--- 165
           Y +   +G+G FG V+         I  +  +PV+  ++EK+ I    ++ N    P   
Sbjct: 58  YQVGPLLGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 110
Query: 166 -----------KLINLHDAFEDDDEMVLIFEFLSG-GELFERITAPDYKMSEAEVIPVTL 213
                       +I L D FE  D  VLI E      +LF+ IT       E        
Sbjct: 111 VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS---- 166
Query: 214 PILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST 273
                Q   AV+H H   ++H D+K ENI+    N   +K+IDFG    L  + V     
Sbjct: 167 --FFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGELKLIDFGSGALLK-DTVYTDFD 222
Query: 274 GTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKN 323
           GT  ++ PE +      G    +W++G+L Y ++ G  PF  E+D E ++ 
Sbjct: 223 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEIIRG 271

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 34/232 (14%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS-HNLEKELIRKEIDIMNQLHHP-- 165
            Y +   +G+G FG V+         I  +  +PV+  ++EK+ I    ++ N    P  
Sbjct: 52  QYQVGPLLGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 104
Query: 166 ------------KLINLHDAFEDDDEMVLIFEFLSG-GELFERITAPDYKMSEAEVIPVT 212
                        +I L D FE  D  VLI E      +LF+ IT       E       
Sbjct: 105 VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS--- 161
Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS 272
                 Q   AV+H H   ++H D+K ENI+    N   +K+IDFG    L  + V    
Sbjct: 162 ---FFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGELKLIDFGSGALLK-DTVYTDF 216
Query: 273 TGTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKN 323
            GT  ++ PE +      G    +W++G+L Y ++ G  PF  E+D E ++ 
Sbjct: 217 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEIIRG 266

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/122 (24%), Positives = 59/122 (48%), Gaps = 2/122 (1%)
Query: 192 LFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTN 251
           +FE +   D+K+    +    +   + +   A+ + H + I+H DVKP N+M        
Sbjct: 108 IFEYVNNTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID-HELRK 166
Query: 252 VKMIDFGLATKLDPNEVVKISTGTAEFAAPE-IVEREPVGFYTDMWAVGVLAYVLLSGLS 310
           +++ID+GLA    P +   +   +  F  PE +V+ +   +  DMW++G +   ++    
Sbjct: 167 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 226
Query: 311 PF 312
           PF
Sbjct: 227 PF 228

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 98/222 (44%), Gaps = 23/222 (10%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL------EKELI--RKEIDIMNQLHHPKL 167
           IG G FG V++   + +      K +PV+         EK+ +    E  IM Q  H  +
Sbjct: 52  IGAGEFGEVYKGMLKTSS---GKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
           I L         M++I E++  G L + +   D + S  +++      ++   +  +K++
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVG-----MLRGIAAGMKYL 163
Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--DPNEVVKISTGT--AEFAAPEI 283
              N +H D+   NI+  +  +   K+ DFGL+  L  DP      S G     + APE 
Sbjct: 164 ANMNYVHRDLAARNILVNS--NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 221
Query: 284 VEREPVGFYTDMWAVGVLAY-VLLSGLSPFAGENDVETLKNV 324
           +        +D+W+ G++ + V+  G  P+   ++ E +K +
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 263

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 88/184 (47%), Gaps = 30/184 (16%)
Query: 164 HPKLINLHDAFEDDDEMVLIFEF--LSGGELFERITAPDYKMS-EAEVIPVTLPILMTQT 220
           HP +I  + +   D  + +  E   L+  +L E     D  +  + E  P++L   + Q 
Sbjct: 68  HPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISL---LRQI 124
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRN---------STNVKMI--DFGLATKLDPNEV- 268
           +  V H+H   IIH D+KP+NI+  T +         + N++++  DFGL  KLD  +  
Sbjct: 125 ASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXX 184
Query: 269 ----VKISTGTAEFAAPEIVE-------REPVGFYTDMWAVGVLAYVLLS-GLSPFAGEN 316
               +   +GT+ + APE++E       +  +    D++++G + Y +LS G  PF  + 
Sbjct: 185 FRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244
Query: 317 DVET 320
             E+
Sbjct: 245 SRES 248

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/245 (22%), Positives = 112/245 (45%), Gaps = 39/245 (15%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV-SHNLEKELIRKEIDIMNQLHHPKLI 168
           ++ ++ +G G FGVV   + +     +A K I + +  L +E + +E+  + +L HP ++
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 169 NLHDAFEDDD----------EMVLIFEFLSGGELFERITAPDYKMSEAEV----IPVTLP 214
              +A+ + +          ++ L  +     +L  +    D+      +      V L 
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQM----QLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 215 ILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKI--- 271
           I + Q + AV+ +H K ++H D+KP NI     +   VK+ DFGL T +D +E  +    
Sbjct: 123 IFL-QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMDQDEEEQTVLT 179
Query: 272 ----------STGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEND-VET 320
                       GT  + +PE +         D++++G++ + L   L PF+ + + V T
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL---LYPFSTQMERVRT 236
Query: 321 LKNVK 325
           L +V+
Sbjct: 237 LTDVR 241

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/122 (24%), Positives = 59/122 (48%), Gaps = 2/122 (1%)
Query: 192 LFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTN 251
           +FE +   D+K+    +    +   + +   A+ + H + I+H DVKP N+M        
Sbjct: 106 IFEYVNNTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID-HELRK 164
Query: 252 VKMIDFGLATKLDPNEVVKISTGTAEFAAPE-IVEREPVGFYTDMWAVGVLAYVLLSGLS 310
           +++ID+GLA    P +   +   +  F  PE +V+ +   +  DMW++G +   ++    
Sbjct: 165 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 224
Query: 311 PF 312
           PF
Sbjct: 225 PF 226

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/122 (24%), Positives = 59/122 (48%), Gaps = 2/122 (1%)
Query: 192 LFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTN 251
           +FE +   D+K+    +    +   + +   A+ + H + I+H DVKP N+M        
Sbjct: 106 IFEYVNNTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID-HELRK 164
Query: 252 VKMIDFGLATKLDPNEVVKISTGTAEFAAPE-IVEREPVGFYTDMWAVGVLAYVLLSGLS 310
           +++ID+GLA    P +   +   +  F  PE +V+ +   +  DMW++G +   ++    
Sbjct: 165 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 224
Query: 311 PF 312
           PF
Sbjct: 225 PF 226

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/122 (24%), Positives = 59/122 (48%), Gaps = 2/122 (1%)
Query: 192 LFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTN 251
           +FE +   D+K+    +    +   + +   A+ + H + I+H DVKP N+M        
Sbjct: 106 IFEYVNNTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID-HELRK 164
Query: 252 VKMIDFGLATKLDPNEVVKISTGTAEFAAPE-IVEREPVGFYTDMWAVGVLAYVLLSGLS 310
           +++ID+GLA    P +   +   +  F  PE +V+ +   +  DMW++G +   ++    
Sbjct: 165 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 224
Query: 311 PF 312
           PF
Sbjct: 225 PF 226

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 88/184 (47%), Gaps = 30/184 (16%)
Query: 164 HPKLINLHDAFEDDDEMVLIFEF--LSGGELFERITAPDYKMS-EAEVIPVTLPILMTQT 220
           HP +I  + +   D  + +  E   L+  +L E     D  +  + E  P++L   + Q 
Sbjct: 68  HPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISL---LRQI 124
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRN---------STNVKMI--DFGLATKLDPNEV- 268
           +  V H+H   IIH D+KP+NI+  T +         + N++++  DFGL  KLD  +  
Sbjct: 125 ASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184
Query: 269 ----VKISTGTAEFAAPEIVE-------REPVGFYTDMWAVGVLAYVLLS-GLSPFAGEN 316
               +   +GT+ + APE++E       +  +    D++++G + Y +LS G  PF  + 
Sbjct: 185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244
Query: 317 DVET 320
             E+
Sbjct: 245 SRES 248

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/122 (24%), Positives = 59/122 (48%), Gaps = 2/122 (1%)
Query: 192 LFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTN 251
           +FE +   D+K+    +    +   + +   A+ + H + I+H DVKP N+M        
Sbjct: 106 IFEYVNNTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID-HELRK 164
Query: 252 VKMIDFGLATKLDPNEVVKISTGTAEFAAPE-IVEREPVGFYTDMWAVGVLAYVLLSGLS 310
           +++ID+GLA    P +   +   +  F  PE +V+ +   +  DMW++G +   ++    
Sbjct: 165 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 224
Query: 311 PF 312
           PF
Sbjct: 225 PF 226

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/122 (24%), Positives = 59/122 (48%), Gaps = 2/122 (1%)
Query: 192 LFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTN 251
           +FE +   D+K+    +    +   + +   A+ + H + I+H DVKP N+M        
Sbjct: 106 IFEYVNNTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID-HELRK 164
Query: 252 VKMIDFGLATKLDPNEVVKISTGTAEFAAPE-IVEREPVGFYTDMWAVGVLAYVLLSGLS 310
           +++ID+GLA    P +   +   +  F  PE +V+ +   +  DMW++G +   ++    
Sbjct: 165 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 224
Query: 311 PF 312
           PF
Sbjct: 225 PF 226

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/122 (24%), Positives = 59/122 (48%), Gaps = 2/122 (1%)
Query: 192 LFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTN 251
           +FE +   D+K+    +    +   + +   A+ + H + I+H DVKP N+M        
Sbjct: 107 IFEYVNNTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID-HELRK 165
Query: 252 VKMIDFGLATKLDPNEVVKISTGTAEFAAPE-IVEREPVGFYTDMWAVGVLAYVLLSGLS 310
           +++ID+GLA    P +   +   +  F  PE +V+ +   +  DMW++G +   ++    
Sbjct: 166 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 225
Query: 311 PF 312
           PF
Sbjct: 226 PF 227

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/122 (24%), Positives = 59/122 (48%), Gaps = 2/122 (1%)
Query: 192 LFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTN 251
           +FE +   D+K+    +    +   + +   A+ + H + I+H DVKP N+M        
Sbjct: 106 IFEYVNNTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID-HELRK 164
Query: 252 VKMIDFGLATKLDPNEVVKISTGTAEFAAPE-IVEREPVGFYTDMWAVGVLAYVLLSGLS 310
           +++ID+GLA    P +   +   +  F  PE +V+ +   +  DMW++G +   ++    
Sbjct: 165 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 224
Query: 311 PF 312
           PF
Sbjct: 225 PF 226

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/122 (24%), Positives = 59/122 (48%), Gaps = 2/122 (1%)
Query: 192 LFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTN 251
           +FE +   D+K+    +    +   + +   A+ + H + I+H DVKP N+M        
Sbjct: 107 IFEYVNNTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID-HELRK 165
Query: 252 VKMIDFGLATKLDPNEVVKISTGTAEFAAPE-IVEREPVGFYTDMWAVGVLAYVLLSGLS 310
           +++ID+GLA    P +   +   +  F  PE +V+ +   +  DMW++G +   ++    
Sbjct: 166 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 225
Query: 311 PF 312
           PF
Sbjct: 226 PF 227

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 29/223 (13%)
Query: 86  YVFDIYSKYVPQ--PVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGN--IFAAKFI 141
           Y    YS ++PQ  P DI    V   Y++   I  G  G ++   +R      +     +
Sbjct: 61  YCGSPYS-FLPQLNPGDI----VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLV 115
Query: 142 PVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM-----VLIFEFLSGGELFERI 196
                  + +   E   + ++ HP ++ + +  E  D        ++ E++ GG+  +R 
Sbjct: 116 HSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYV-GGQSLKR- 173
Query: 197 TAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMID 256
            +   K+  AE I   L IL     PA+ ++H   +++ D+KPENIM        +K+ID
Sbjct: 174 -SKGQKLPVAEAIAYLLEIL-----PALSYLHSIGLVYNDLKPENIML---TEEQLKLID 224
Query: 257 FGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVG 299
            G  ++++    +    GT  F APEIV   P    TD++ VG
Sbjct: 225 LGAVSRINSFGYLY---GTPGFQAPEIVRTGPT-VATDIYTVG 263

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 109/260 (41%), Gaps = 49/260 (18%)
Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL--------IRKEIDIM 159
           ++ + + +IG GAFG V +   R  G +    F  V+  + KE          ++E  +M
Sbjct: 47  NNIEYVRDIGEGAFGRVFQ--ARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALM 104
Query: 160 NQLHHPKLINLHDAFEDDDEMVLIFEFLSGGEL--FERITAPD-------------YKMS 204
            +  +P ++ L         M L+FE+++ G+L  F R  +P               ++S
Sbjct: 105 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164
Query: 205 EAEVIPVTLP---ILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT 261
                P++      +  Q +  + ++ E+  +H D+   N  C    +  VK+ DFGL+ 
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN--CLVGENMVVKIADFGLSR 222
Query: 262 --------KLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPF 312
                   K D N+ + I      +  PE +        +D+WA GV+ + + S GL P+
Sbjct: 223 NIYSADYYKADGNDAIPI-----RWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277
Query: 313 AGENDVETL-----KNVKAC 327
            G    E +      N+ AC
Sbjct: 278 YGMAHEEVIYYVRDGNILAC 297

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 32/227 (14%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS-HNLEKELIRKEIDIMNQLHHP-- 165
            Y +   +G+G FG V+         I  +  +PV+  ++EK+ I    ++ N    P  
Sbjct: 5   QYQVGPLLGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 57
Query: 166 ------------KLINLHDAFEDDDEMVLIFEFLSG-GELFERITAPDYKMSEAEVIPVT 212
                        +I L D FE  D  VLI E      +LF+ IT       E       
Sbjct: 58  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS--- 114
Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS 272
                 Q   AV+H H   ++H D+K ENI+    N   +K+IDFG    L  + V    
Sbjct: 115 ---FFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGELKLIDFGSGALLK-DTVYTDF 169
Query: 273 TGTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDV 318
            GT  ++ PE +      G    +W++G+L Y ++ G  PF  + ++
Sbjct: 170 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 216

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 30/122 (24%), Positives = 59/122 (48%), Gaps = 2/122 (1%)
Query: 192 LFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTN 251
           +FE +   D+K+    +    +   + +   A+ + H + I+H DVKP N+M        
Sbjct: 127 IFEYVNNTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID-HELRK 185
Query: 252 VKMIDFGLATKLDPNEVVKISTGTAEFAAPE-IVEREPVGFYTDMWAVGVLAYVLLSGLS 310
           +++ID+GLA    P +   +   +  F  PE +V+ +   +  DMW++G +   ++    
Sbjct: 186 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 245
Query: 311 PF 312
           PF
Sbjct: 246 PF 247

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 94/217 (43%), Gaps = 18/217 (8%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G FG V       T  +      P    +  E   +E  +M +L H KL+ L+ A 
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLY-AV 78
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM---TQTSPAVKHMHEKN 231
             ++ + ++ E+++ G L + +     K        + LP L+    Q +  + ++   N
Sbjct: 79  VSEEPIYIVTEYMNKGSLLDFLKGETGKY-------LRLPQLVDMSAQIASGMAYVERMN 131
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTG--TAEFAAPEIVEREPV 289
            +H D++  NI+     +   K+ DFGLA  ++ NE           ++ APE       
Sbjct: 132 YVHRDLRAANIL--VGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 189
Query: 290 GFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
              +D+W+ G+L   L + G  P+ G  + E L  V+
Sbjct: 190 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 226

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/230 (19%), Positives = 103/230 (44%), Gaps = 21/230 (9%)
Query: 114 EEIGTGAFGVV-----HRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLI 168
            E+G GAFG V     +     K   + A K +       ++  ++E +++  L H  ++
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 169 NLHDAFEDDDEMVLIFEFLSGGEL--FERITAPDY--------KMSEAEVIPVTLPILMT 218
             +    D D ++++FE++  G+L  F R   PD         + ++ E+    +  + +
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA-- 276
           Q +  + ++  ++ +H D+   N  C    +  VK+ DFG++  +   +  ++   T   
Sbjct: 141 QIASGMVYLASQHFVHRDLATRN--CLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 198
Query: 277 -EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
             +  PE +        +D+W+ GV+ + + + G  P+   ++ E ++ +
Sbjct: 199 IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 248

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 94/217 (43%), Gaps = 18/217 (8%)
Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           ++G G FG V       T  +      P    +  E   +E  +M +L H KL+ L+ A 
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLY-AV 78
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM---TQTSPAVKHMHEKN 231
             ++ + ++ E+++ G L + +     K        + LP L+    Q +  + ++   N
Sbjct: 79  VSEEPIYIVTEYMNKGSLLDFLKGETGKY-------LRLPQLVDMSAQIASGMAYVERMN 131
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTG--TAEFAAPEIVEREPV 289
            +H D++  NI+     +   K+ DFGLA  ++ NE           ++ APE       
Sbjct: 132 YVHRDLRAANIL--VGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRF 189
Query: 290 GFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
              +D+W+ G+L   L + G  P+ G  + E L  V+
Sbjct: 190 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 226

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/240 (23%), Positives = 105/240 (43%), Gaps = 24/240 (10%)
Query: 89  DIYSKYVPQPVDIKTSSVYDHYDIL----EEIGTGAFGVVHRCRERKTGNIFAAKFIPVS 144
           ++Y      P +I+   VY    +L    +E+G+G FG V +   +    +       + 
Sbjct: 347 EVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILK 406
Query: 145 HN-----LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAP 199
           +      L+ EL+  E ++M QL +P ++ +    E +  M+++       E+ E     
Sbjct: 407 NEANDPALKDELL-AEANVMQQLDNPYIVRMIGICEAESWMLVM-------EMAELGPLN 458
Query: 200 DYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGL 259
            Y      V    +  L+ Q S  +K++ E N +H D+   N++  T++    K+ DFGL
Sbjct: 459 KYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGL 516
Query: 260 ATKLDPNE-VVKIST---GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
           +  L  +E   K  T      ++ APE +        +D+W+ GVL +   S G  P+ G
Sbjct: 517 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 576

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 32/227 (14%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS-HNLEKELIRKEIDIMNQLHHP-- 165
            Y +   +G+G FG V+         I  +  +PV+  ++EK+ I    ++ N    P  
Sbjct: 38  QYQVGPLLGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 90
Query: 166 ------------KLINLHDAFEDDDEMVLIFEFLSG-GELFERITAPDYKMSEAEVIPVT 212
                        +I L D FE  D  VLI E      +LF+ IT       E       
Sbjct: 91  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS--- 147
Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS 272
                 Q   AV+H H   ++H D+K ENI+    N   +K+IDFG    L  + V    
Sbjct: 148 ---FFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGELKLIDFGSGALLK-DTVYTDF 202
Query: 273 TGTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDV 318
            GT  ++ PE +      G    +W++G+L Y ++ G  PF  + ++
Sbjct: 203 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 249

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 32/227 (14%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS-HNLEKELIRKEIDIMNQLHHP-- 165
            Y +   +G+G FG V+         I  +  +PV+  ++EK+ I    ++ N    P  
Sbjct: 37  QYQVGPLLGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 89
Query: 166 ------------KLINLHDAFEDDDEMVLIFEFLSG-GELFERITAPDYKMSEAEVIPVT 212
                        +I L D FE  D  VLI E      +LF+ IT       E       
Sbjct: 90  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS--- 146
Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS 272
                 Q   AV+H H   ++H D+K ENI+    N   +K+IDFG    L  + V    
Sbjct: 147 ---FFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGELKLIDFGSGALLK-DTVYTDF 201
Query: 273 TGTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDV 318
            GT  ++ PE +      G    +W++G+L Y ++ G  PF  + ++
Sbjct: 202 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 248

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 32/227 (14%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS-HNLEKELIRKEIDIMNQLHHP-- 165
            Y +   +G+G FG V+         I  +  +PV+  ++EK+ I    ++ N    P  
Sbjct: 38  QYQVGPLLGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 90
Query: 166 ------------KLINLHDAFEDDDEMVLIFEFLSG-GELFERITAPDYKMSEAEVIPVT 212
                        +I L D FE  D  VLI E      +LF+ IT       E       
Sbjct: 91  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS--- 147
Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS 272
                 Q   AV+H H   ++H D+K ENI+    N   +K+IDFG    L  + V    
Sbjct: 148 ---FFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGELKLIDFGSGALLK-DTVYTDF 202
Query: 273 TGTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDV 318
            GT  ++ PE +      G    +W++G+L Y ++ G  PF  + ++
Sbjct: 203 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 249

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 32/227 (14%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS-HNLEKELIRKEIDIMNQLHHP-- 165
            Y +   +G+G FG V+         I  +  +PV+  ++EK+ I    ++ N    P  
Sbjct: 37  QYQVGPLLGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 89
Query: 166 ------------KLINLHDAFEDDDEMVLIFEFLSG-GELFERITAPDYKMSEAEVIPVT 212
                        +I L D FE  D  VLI E      +LF+ IT       E       
Sbjct: 90  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS--- 146
Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS 272
                 Q   AV+H H   ++H D+K ENI+    N   +K+IDFG    L  + V    
Sbjct: 147 ---FFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGELKLIDFGSGALLK-DTVYTDF 201
Query: 273 TGTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDV 318
            GT  ++ PE +      G    +W++G+L Y ++ G  PF  + ++
Sbjct: 202 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 248

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 32/227 (14%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS-HNLEKELIRKEIDIMNQLHHP-- 165
            Y +   +G+G FG V+         I  +  +PV+  ++EK+ I    ++ N    P  
Sbjct: 38  QYQVGPLLGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 90
Query: 166 ------------KLINLHDAFEDDDEMVLIFEFLSG-GELFERITAPDYKMSEAEVIPVT 212
                        +I L D FE  D  VLI E      +LF+ IT       E       
Sbjct: 91  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS--- 147
Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS 272
                 Q   AV+H H   ++H D+K ENI+    N   +K+IDFG    L  + V    
Sbjct: 148 ---FFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGELKLIDFGSGALLK-DTVYTDF 202
Query: 273 TGTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDV 318
            GT  ++ PE +      G    +W++G+L Y ++ G  PF  + ++
Sbjct: 203 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 249

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 32/227 (14%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS-HNLEKELIRKEIDIMNQLHHP-- 165
            Y +   +G+G FG V+         I  +  +PV+  ++EK+ I    ++ N    P  
Sbjct: 38  QYQVGPLLGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 90
Query: 166 ------------KLINLHDAFEDDDEMVLIFEFLSG-GELFERITAPDYKMSEAEVIPVT 212
                        +I L D FE  D  VLI E      +LF+ IT       E       
Sbjct: 91  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS--- 147
Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS 272
                 Q   AV+H H   ++H D+K ENI+    N   +K+IDFG    L  + V    
Sbjct: 148 ---FFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGELKLIDFGSGALLK-DTVYTDF 202
Query: 273 TGTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDV 318
            GT  ++ PE +      G    +W++G+L Y ++ G  PF  + ++
Sbjct: 203 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 249

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 32/227 (14%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS-HNLEKELIRKEIDIMNQLHHP-- 165
            Y +   +G+G FG V+         I  +  +PV+  ++EK+ I    ++ N    P  
Sbjct: 37  QYQVGPLLGSGGFGSVY-------SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 89
Query: 166 ------------KLINLHDAFEDDDEMVLIFEFLSG-GELFERITAPDYKMSEAEVIPVT 212
                        +I L D FE  D  VLI E      +LF+ IT       E       
Sbjct: 90  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS--- 146
Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS 272
                 Q   AV+H H   ++H D+K ENI+    N   +K+IDFG    L  + V    
Sbjct: 147 ---FFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGELKLIDFGSGALLK-DTVYTDF 201
Query: 273 TGTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDV 318
            GT  ++ PE +      G    +W++G+L Y ++ G  PF  + ++
Sbjct: 202 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 248

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 102/231 (44%), Gaps = 24/231 (10%)
Query: 98  PVDIKTSSVYDHYDIL----EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN-----LE 148
           P +I+   VY    +L    +E+G+G FG V +   +    +       + +      L+
Sbjct: 11  PEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK 70
Query: 149 KELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEV 208
            EL+  E ++M QL +P ++ +    E +  M+++       E+ E      Y      V
Sbjct: 71  DELL-AEANVMQQLDNPYIVRMIGICEAESWMLVM-------EMAELGPLNKYLQQNRHV 122
Query: 209 IPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE- 267
               +  L+ Q S  +K++ E N +H D+   N++  T++    K+ DFGL+  L  +E 
Sbjct: 123 KDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYA--KISDFGLSKALRADEN 180
Query: 268 VVKIST---GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
             K  T      ++ APE +        +D+W+ GVL +   S G  P+ G
Sbjct: 181 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 231

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 103/227 (45%), Gaps = 20/227 (8%)
Query: 115 EIGTGAFGVV------HRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLI 168
           E+G GAFG V      + C E+    +        S N  K+  R E +++  L H  ++
Sbjct: 20  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHR-EAELLTNLQHEHIV 78
Query: 169 NLHDAFEDDDEMVLIFEFLSGGEL--FERITAPD-YKMSEA----EVIPVTLPILMTQTS 221
             +    + D ++++FE++  G+L  F R   PD   M+E     E+    +  +  Q +
Sbjct: 79  KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIA 138
Query: 222 PAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA---EF 278
             + ++  ++ +H D+   N  C    +  VK+ DFG++  +   +  ++   T     +
Sbjct: 139 AGMVYLASQHFVHRDLATRN--CLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 196
Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
             PE +        +D+W++GV+ + + + G  P+   ++ E ++ +
Sbjct: 197 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 243

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 93/212 (43%), Gaps = 18/212 (8%)
Query: 112 ILEEIGTGAFGVVHRCRERKTGN--IFAAKFIPVSHNLEKEL--IRKEIDIMNQLHHPKL 167
           I + IG G FG V     +  G   IF A     S   EK+      E  IM Q  HP +
Sbjct: 37  IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNV 96
Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
           I+L         +++I EF+  G L   +     + ++ +   + L  ++   +  +K++
Sbjct: 97  IHLEGVVTKSTPVMIITEFMENGSLDSFL-----RQNDGQFTVIQLVGMLRGIAAGMKYL 151
Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL-----DPNEVVKISTGTA-EFAAP 281
            + N +H D+   NI+  +  +   K+ DFGL+  L     DP     +       + AP
Sbjct: 152 ADMNYVHRDLAARNILVNS--NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 209
Query: 282 EIVEREPVGFYTDMWAVGVLAYVLLS-GLSPF 312
           E ++       +D+W+ G++ + ++S G  P+
Sbjct: 210 EAIQYRKFTSASDVWSYGIVMWEVMSYGERPY 241

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 113/257 (43%), Gaps = 25/257 (9%)
Query: 80  VSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCR-----ERKTGN 134
           V D D+   D + + +P     K     D   + + +G GAFG V         +  T  
Sbjct: 37  VMDPDELPLDEHCERLPYDAS-KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCR 95
Query: 135 IFAAKFIP--VSHNLEKELIRKEIDIMNQLHHPKLINLHDAF-EDDDEMVLIFEFLSGGE 191
             A K +    +H+  + L+ +   +++  HH  ++NL  A  +    +++I EF   G 
Sbjct: 96  TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 155
Query: 192 LFERITAPDYKMSEAEVIP-------VTLPILMT---QTSPAVKHMHEKNIIHLDVKPEN 241
           L   + +   +    +V P       +TL  L+    Q +  ++ +  +  IH D+   N
Sbjct: 156 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 215
Query: 242 IMCQTRNSTNVKMIDFGLATKL--DPNEVVKISTGTA-EFAAPEIVEREPVGFYTDMWAV 298
           I+   +N   VK+ DFGLA  +  DP+ V K       ++ APE +        +D+W+ 
Sbjct: 216 ILLSEKNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 273
Query: 299 GVLAYVLLS-GLSPFAG 314
           GVL + + S G SP+ G
Sbjct: 274 GVLLWEIFSLGASPYPG 290

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 114/244 (46%), Gaps = 19/244 (7%)
Query: 75  KADEKVSDY--DQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKT 132
           KA   ++D     Y+    S  VP  VD++ ++  +++D    IG G FG V++   R  
Sbjct: 7   KATNSINDALSSSYLVPFESYRVPL-VDLEEAT--NNFDHKFLIGHGVFGKVYKGVLRDG 63
Query: 133 GNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGEL 192
             +   +  P S     E    EI+ ++   HP L++L    ++ +EM+LI++++  G L
Sbjct: 64  AKVALKRRTPESSQ-GIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122
Query: 193 FERITA---PDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNS 249
              +     P   MS  + + + +       +  + ++H + IIH DVK  NI+     +
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICI-----GAARGLHYLHTRAIIHRDVKSINILLD--EN 175
Query: 250 TNVKMIDFGLA---TKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLL 306
              K+ DFG++   T+L    +  +  GT  +  PE   +  +   +D+++ GV+ + +L
Sbjct: 176 FVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235
Query: 307 SGLS 310
              S
Sbjct: 236 CARS 239

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 96/219 (43%), Gaps = 16/219 (7%)
Query: 116 IGTGAFGVVHRCRERKTGN---IFAAKFIPVSHN-LEKELIRKEIDIMNQLHHPKLINLH 171
           IG G FG V   R +  G      A K + V +   ++     E  IM Q  HP +I+L 
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLE 89
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
                   ++++ E++  G L   +     K ++ +   + L  ++   S  +K++ +  
Sbjct: 90  GVVTKSKPVMIVTEYMENGSLDTFL-----KKNDGQFTVIQLVGMLRGISAGMKYLSDMG 144
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--DPNEVVKISTGT--AEFAAPEIVERE 287
            +H D+   NI+  +  +   K+ DFGL+  L  DP        G     + APE +   
Sbjct: 145 YVHRDLAARNILINS--NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFR 202
Query: 288 PVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
                +D+W+ G++ + ++S G  P+    + + +K V+
Sbjct: 203 KFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVE 241

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 24/229 (10%)
Query: 108 DHYDILEEIGTGAFGVVHRCR-----ERKTGNIFAAKFIP--VSHNLEKELIRKEIDIMN 160
           D   + + +G GAFG V         +  T    A K +    +H+  + L+ +   +++
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 161 QLHHPKLINLHDAF-EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIP-------VT 212
             HH  ++NL  A  +    +++I EF   G L   + +   +    +V P       +T
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 137
Query: 213 LPILMT---QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--DPNE 267
           L  L+    Q +  ++ +  +  IH D+   NI+   +N   VK+ DFGLA  +  DP+ 
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIXKDPDX 195
Query: 268 VVKISTGTA-EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
           V K       ++ APE +        +D+W+ GVL + + S G SP+ G
Sbjct: 196 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 244

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 72/159 (45%), Gaps = 12/159 (7%)
Query: 167 LINLHDAFEDDDEMVLIFEFLSG-GELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
           +I L D FE  D  VLI E      +LF+ IT       E             Q   AV+
Sbjct: 118 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS------FFWQVLEAVR 171
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           H H   ++H D+K ENI+    N   +K+IDFG    L  + V     GT  ++ PE + 
Sbjct: 172 HCHNCGVLHRDIKDENILIDL-NRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIR 229
Query: 286 REPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKN 323
                G    +W++G+L Y ++ G  PF  E+D E ++ 
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEIIRG 266

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/219 (21%), Positives = 97/219 (44%), Gaps = 16/219 (7%)
Query: 116 IGTGAFGVVHRCRERKTGN---IFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLH 171
           IG G FG V   R +  G      A K +   + + ++     E  IM Q  HP +I+L 
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
                   +++I E++  G L   +   D + +  +++      ++      +K++ + +
Sbjct: 82  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVG-----MLRGIGSGMKYLSDMS 136
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--DPNEVVKISTGTA--EFAAPEIVERE 287
            +H D+   NI+  +  +   K+ DFG++  L  DP        G     + APE +   
Sbjct: 137 YVHRDLAARNILVNS--NLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 194
Query: 288 PVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
                +D+W+ G++ + ++S G  P+   ++ + +K ++
Sbjct: 195 KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE 233

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/219 (21%), Positives = 97/219 (44%), Gaps = 16/219 (7%)
Query: 116 IGTGAFGVVHRCRERKTGN---IFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLH 171
           IG G FG V   R +  G      A K +   + + ++     E  IM Q  HP +I+L 
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 96
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
                   +++I E++  G L   +   D + +  +++      ++      +K++ + +
Sbjct: 97  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVG-----MLRGIGSGMKYLSDMS 151
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--DPNEVVKISTGTA--EFAAPEIVERE 287
            +H D+   NI+  +  +   K+ DFG++  L  DP        G     + APE +   
Sbjct: 152 AVHRDLAARNILVNS--NLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 209
Query: 288 PVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
                +D+W+ G++ + ++S G  P+   ++ + +K ++
Sbjct: 210 KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE 248

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 24/229 (10%)
Query: 108 DHYDILEEIGTGAFGVVHRCR-----ERKTGNIFAAKFIP--VSHNLEKELIRKEIDIMN 160
           D   + + +G GAFG V         +  T    A K +    +H+  + L+ +   +++
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 161 QLHHPKLINLHDAF-EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIP-------VT 212
             HH  ++NL  A  +    +++I EF   G L   + +   +    +V P       +T
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 213 LPILMT---QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--DPNE 267
           L  L+    Q +  ++ +  +  IH D+   NI+   +N   VK+ DFGLA  +  DP+ 
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDX 204
Query: 268 VVKISTGTA-EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
           V K       ++ APE +        +D+W+ GVL + + S G SP+ G
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 112/255 (43%), Gaps = 25/255 (9%)
Query: 82  DYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCR-----ERKTGNIF 136
           D D+   D + + +P     K     D   + + +G GAFG V         +  T    
Sbjct: 2   DPDELPLDEHCERLPYDAS-KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTV 60
Query: 137 AAKFIP--VSHNLEKELIRKEIDIMNQLHHPKLINLHDAF-EDDDEMVLIFEFLSGGELF 193
           A K +    +H+  + L+ +   +++  HH  ++NL  A  +    +++I EF   G L 
Sbjct: 61  AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS 120
Query: 194 ERITAPDYKMSEAEVIP-------VTLPILMT---QTSPAVKHMHEKNIIHLDVKPENIM 243
             + +   +    +V P       +TL  L+    Q +  ++ +  +  IH D+   NI+
Sbjct: 121 TYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 180
Query: 244 CQTRNSTNVKMIDFGLATKL--DPNEVVKISTGTA-EFAAPEIVEREPVGFYTDMWAVGV 300
              +N   VK+ DFGLA  +  DP+ V K       ++ APE +        +D+W+ GV
Sbjct: 181 LSEKNV--VKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 238
Query: 301 LAYVLLS-GLSPFAG 314
           L + + S G SP+ G
Sbjct: 239 LLWEIFSLGASPYPG 253

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 23/222 (10%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR---KEIDIMNQL-HHPKLINLH 171
           IG G FG V + R +K G    A    +     K+  R    E++++ +L HHP +INL 
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 82
Query: 172 DAFEDDDEMVLIFEFLSGGELFERI-------TAPDYKMSEAEVIPVTLPILM---TQTS 221
            A E    + L  E+   G L + +       T P + ++ +    ++   L+      +
Sbjct: 83  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 142
Query: 222 PAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEV-VKISTGT--AEF 278
             + ++ +K  IH D+   NI+     +   K+ DFGL+      EV VK + G     +
Sbjct: 143 RGMDYLSQKQFIHRDLAARNIL--VGENYVAKIADFGLSRG---QEVYVKKTMGRLPVRW 197
Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVE 319
            A E +        +D+W+ GVL + ++S G +P+ G    E
Sbjct: 198 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 239

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/219 (21%), Positives = 97/219 (44%), Gaps = 16/219 (7%)
Query: 116 IGTGAFGVVHRCRERKTGN---IFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLH 171
           IG G FG V   R +  G      A K +   + + ++     E  IM Q  HP +I+L 
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
                   +++I E++  G L   +   D + +  +++      ++      +K++ + +
Sbjct: 76  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVG-----MLRGIGSGMKYLSDMS 130
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--DPNEVVKISTGTA--EFAAPEIVERE 287
            +H D+   NI+  +  +   K+ DFG++  L  DP        G     + APE +   
Sbjct: 131 YVHRDLAARNILVNS--NLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 188
Query: 288 PVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
                +D+W+ G++ + ++S G  P+   ++ + +K ++
Sbjct: 189 KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE 227

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 24/229 (10%)
Query: 108 DHYDILEEIGTGAFGVVHRCR-----ERKTGNIFAAKFIP--VSHNLEKELIRKEIDIMN 160
           D   + + +G GAFG V         +  T    A K +    +H+  + L+ +   +++
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 161 QLHHPKLINLHDAF-EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIP-------VT 212
             HH  ++NL  A  +    +++I EF   G L   + +   +    +V P       +T
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 137
Query: 213 LPILMT---QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--DPNE 267
           L  L+    Q +  ++ +  +  IH D+   NI+   +N   VK+ DFGLA  +  DP+ 
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIXKDPDX 195
Query: 268 VVKISTGTA-EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
           V K       ++ APE +        +D+W+ GVL + + S G SP+ G
Sbjct: 196 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 244

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 23/222 (10%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR---KEIDIMNQL-HHPKLINLH 171
           IG G FG V + R +K G    A    +     K+  R    E++++ +L HHP +INL 
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 172 DAFEDDDEMVLIFEFLSGGELFERI-------TAPDYKMSEAEVIPVTLPILM---TQTS 221
            A E    + L  E+   G L + +       T P + ++ +    ++   L+      +
Sbjct: 93  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152
Query: 222 PAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEV-VKISTGT--AEF 278
             + ++ +K  IH D+   NI+     +   K+ DFGL+      EV VK + G     +
Sbjct: 153 RGMDYLSQKQFIHRDLAARNIL--VGENYVAKIADFGLSRG---QEVYVKKTMGRLPVRW 207
Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVE 319
            A E +        +D+W+ GVL + ++S G +P+ G    E
Sbjct: 208 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 249

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 102/231 (44%), Gaps = 24/231 (10%)
Query: 98  PVDIKTSSVYDHYDIL----EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN-----LE 148
           P +I+   VY    +L    +E+G+G FG V +   +    +       + +      L+
Sbjct: 355 PEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK 414
Query: 149 KELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEV 208
            EL+  E ++M QL +P ++ +    E +  M+++       E+ E      Y      V
Sbjct: 415 DELL-AEANVMQQLDNPYIVRMIGICEAESWMLVM-------EMAELGPLNKYLQQNRHV 466
Query: 209 IPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE- 267
               +  L+ Q S  +K++ E N +H D+   N++  T++    K+ DFGL+  L  +E 
Sbjct: 467 KDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADEN 524
Query: 268 VVKIST---GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
             K  T      ++ APE +        +D+W+ GVL +   S G  P+ G
Sbjct: 525 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 575

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 94/211 (44%), Gaps = 20/211 (9%)
Query: 114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN-----LEKELIRKEIDIMNQLHHPKLI 168
           +E+G+G FG V +   +    +       + +      L+ EL+  E ++M QL +P ++
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELL-AEANVMQQLDNPYIV 75
Query: 169 NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH 228
            +    E +  M+++       E+ E      Y      V    +  L+ Q S  +K++ 
Sbjct: 76  RMIGICEAESWMLVM-------EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE 128
Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGL--ATKLDPNEVVKISTGT--AEFAAPEIV 284
           E N +H D+   N++  T++    K+ DFGL  A + D N     + G    ++ APE +
Sbjct: 129 ESNFVHRDLAARNVLLVTQHYA--KISDFGLSKALRADENXYKAQTHGKWPVKWYAPECI 186
Query: 285 EREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
                   +D+W+ GVL +   S G  P+ G
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 217

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 94/211 (44%), Gaps = 20/211 (9%)
Query: 114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN-----LEKELIRKEIDIMNQLHHPKLI 168
           +E+G+G FG V +   +    +       + +      L+ EL+  E ++M QL +P ++
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELL-AEANVMQQLDNPYIV 71
Query: 169 NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH 228
            +    E +  M+++       E+ E      Y      V    +  L+ Q S  +K++ 
Sbjct: 72  RMIGICEAESWMLVM-------EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE 124
Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE-VVKIST---GTAEFAAPEIV 284
           E N +H D+   N++  T++    K+ DFGL+  L  +E   K  T      ++ APE +
Sbjct: 125 ESNFVHRDLAARNVLLVTQHYA--KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 285 EREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
                   +D+W+ GVL +   S G  P+ G
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 213

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 24/229 (10%)
Query: 108 DHYDILEEIGTGAFGVVHRCR-----ERKTGNIFAAKFIP--VSHNLEKELIRKEIDIMN 160
           D   + + +G GAFG V         +  T    A K +    +H+  + L+ +   +++
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 161 QLHHPKLINLHDAF-EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIP-------VT 212
             HH  ++NL  A  +    +++I EF   G L   + +   +    +V P       +T
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 213 LPILMT---QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--DPNE 267
           L  L+    Q +  ++ +  +  IH D+   NI+   +N   VK+ DFGLA  +  DP+ 
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDY 204
Query: 268 VVKISTGTA-EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
           V K       ++ APE +        +D+W+ GVL + + S G SP+ G
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 24/229 (10%)
Query: 108 DHYDILEEIGTGAFGVVHRCR-----ERKTGNIFAAKFIP--VSHNLEKELIRKEIDIMN 160
           D   + + +G GAFG V         +  T    A K +    +H+  + L+ +   +++
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 161 QLHHPKLINLHDAF-EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIP-------VT 212
             HH  ++NL  A  +    +++I EF   G L   + +   +    +V P       +T
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 137
Query: 213 LPILMT---QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--DPNE 267
           L  L+    Q +  ++ +  +  IH D+   NI+   +N   VK+ DFGLA  +  DP+ 
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDY 195
Query: 268 VVKISTGTA-EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
           V K       ++ APE +        +D+W+ GVL + + S G SP+ G
Sbjct: 196 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 244

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 24/229 (10%)
Query: 108 DHYDILEEIGTGAFGVVHRCR-----ERKTGNIFAAKFIP--VSHNLEKELIRKEIDIMN 160
           D   + + +G GAFG V         +  T    A K +    +H+  + L+ +   +++
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 161 QLHHPKLINLHDAF-EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIP-------VT 212
             HH  ++NL  A  +    +++I EF   G L   + +   +    +V P       +T
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 137
Query: 213 LPILMT---QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--DPNE 267
           L  L+    Q +  ++ +  +  IH D+   NI+   +N   VK+ DFGLA  +  DP+ 
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDY 195
Query: 268 VVKISTGTA-EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
           V K       ++ APE +        +D+W+ GVL + + S G SP+ G
Sbjct: 196 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 244

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 94/211 (44%), Gaps = 20/211 (9%)
Query: 114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN-----LEKELIRKEIDIMNQLHHPKLI 168
           +E+G+G FG V +   +    +       + +      L+ EL+  E ++M QL +P ++
Sbjct: 11  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELL-AEANVMQQLDNPYIV 69
Query: 169 NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH 228
            +    E +  M+++       E+ E      Y      V    +  L+ Q S  +K++ 
Sbjct: 70  RMIGICEAESWMLVM-------EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE 122
Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE-VVKIST---GTAEFAAPEIV 284
           E N +H D+   N++  T++    K+ DFGL+  L  +E   K  T      ++ APE +
Sbjct: 123 ESNFVHRDLAARNVLLVTQHYA--KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 180
Query: 285 EREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
                   +D+W+ GVL +   S G  P+ G
Sbjct: 181 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 211

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/229 (24%), Positives = 101/229 (44%), Gaps = 24/229 (10%)
Query: 100 DIKTSSVYDHYDIL----EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN-----LEKE 150
           +I+   VY    +L    +E+G+G FG V +   +    +       + +      L+ E
Sbjct: 5   EIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE 64
Query: 151 LIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIP 210
           L+  E ++M QL +P ++ +    E +  M+++       E+ E      Y      V  
Sbjct: 65  LL-AEANVMQQLDNPYIVRMIGICEAESWMLVM-------EMAELGPLNKYLQQNRHVKD 116
Query: 211 VTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE-VV 269
             +  L+ Q S  +K++ E N +H D+   N++  T++    K+ DFGL+  L  +E   
Sbjct: 117 KNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYA--KISDFGLSKALRADENYY 174
Query: 270 KIST---GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
           K  T      ++ APE +        +D+W+ GVL +   S G  P+ G
Sbjct: 175 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 223

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 94/211 (44%), Gaps = 20/211 (9%)
Query: 114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN-----LEKELIRKEIDIMNQLHHPKLI 168
           +E+G+G FG V +   +    +       + +      L+ EL+  E ++M QL +P ++
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELL-AEANVMQQLDNPYIV 75
Query: 169 NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH 228
            +    E +  M+++       E+ E      Y      V    +  L+ Q S  +K++ 
Sbjct: 76  RMIGICEAESWMLVM-------EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE 128
Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE-VVKIST---GTAEFAAPEIV 284
           E N +H D+   N++  T++    K+ DFGL+  L  +E   K  T      ++ APE +
Sbjct: 129 ESNFVHRDLAARNVLLVTQHYA--KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 186
Query: 285 EREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
                   +D+W+ GVL +   S G  P+ G
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 217

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 103/248 (41%), Gaps = 28/248 (11%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR--KEIDIMNQLHHPKL 167
           Y+ L +IG G FG V + R RKTG   A K + + +  E   I   +EI I+  L H  +
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 168 INLHDAFED--------DDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQ 219
           +NL +               + L+F+F    +L   ++    K + +E+  V     M  
Sbjct: 80  VNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRV-----MQM 133
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL------DPNEVVKIST 273
               + ++H   I+H D+K  N++  TR+   +K+ DFGLA          PN       
Sbjct: 134 LLNGLYYIHRNKILHRDMKAANVLI-TRDGV-LKLADFGLARAFSLAKNSQPNRYXN-RV 190
Query: 274 GTAEFAAPEIV--EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEF 331
            T  +  PE++  ER+  G   D+W  G +   + +      G  +   L  +       
Sbjct: 191 VTLWYRPPELLLGERD-YGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 249
Query: 332 DEEAFKNV 339
             E + NV
Sbjct: 250 TPEVWPNV 257

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/228 (19%), Positives = 100/228 (43%), Gaps = 20/228 (8%)
Query: 115 EIGTGAFGVV-----HRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLIN 169
           E+G GAFG V     H     +   + A K +  +    ++  ++E +++  L H  ++ 
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 170 LHDAFEDDDEMVLIFEFLSGGEL--FERITAPDYKMSEA--EVIPVTLPI-----LMTQT 220
                 +   ++++FE++  G+L  F R   PD K+     +V P  L +     + +Q 
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA---E 277
           +  + ++   + +H D+   N  C       VK+ DFG++  +   +  ++   T     
Sbjct: 139 AAGMVYLAGLHFVHRDLATRN--CLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 278 FAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
           +  PE +        +D+W+ GV+ + + + G  P+   ++ E +  +
Sbjct: 197 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI 244

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 89/184 (48%), Gaps = 22/184 (11%)
Query: 154 KEIDIMNQLHHPKLINLHDAF--EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPV 211
           +EI ++ +L HP +I+L   F    D ++ L+F++ +  +L+  I    ++ S+A   PV
Sbjct: 67  REIALLRELKHPNVISLQKVFLSHADRKVWLLFDY-AEHDLWHIIKF--HRASKANKKPV 123
Query: 212 TLP-----ILMTQTSPAVKHMHEKNIIHLDVKPENI--MCQTRNSTNVKMIDFGLA---- 260
            LP      L+ Q    + ++H   ++H D+KP NI  M +      VK+ D G A    
Sbjct: 124 QLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 183
Query: 261 TKLDPNEVVKISTGTAEFAAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPF-AGEN 316
           + L P   +     T  + APE++       YT   D+WA+G +   LL+    F   + 
Sbjct: 184 SPLKPLADLDPVVVTFWYRAPELLLG--ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241
Query: 317 DVET 320
           D++T
Sbjct: 242 DIKT 245

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 93/210 (44%), Gaps = 28/210 (13%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR--KEIDIMNQLHHPKL 167
           Y+ L +IG G FG V + R RKTG   A K + + +  E   I   +EI I+  L H  +
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 168 INLHDAFED--------DDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQ 219
           +NL +               + L+F+F    +L   ++    K + +E+  V     M  
Sbjct: 80  VNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRV-----MQM 133
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL------DPNEVVKIST 273
               + ++H   I+H D+K  N++  TR+   +K+ DFGLA          PN       
Sbjct: 134 LLNGLYYIHRNKILHRDMKAANVLI-TRDGV-LKLADFGLARAFSLAKNSQPNRYXN-RV 190
Query: 274 GTAEFAAPEIV--EREPVGFYTDMWAVGVL 301
            T  +  PE++  ER+  G   D+W  G +
Sbjct: 191 VTLWYRPPELLLGERD-YGPPIDLWGAGCI 219

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/228 (19%), Positives = 100/228 (43%), Gaps = 20/228 (8%)
Query: 115 EIGTGAFGVV-----HRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLIN 169
           E+G GAFG V     H     +   + A K +  +    ++  ++E +++  L H  ++ 
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 170 LHDAFEDDDEMVLIFEFLSGGEL--FERITAPDYKMSEA--EVIPVTLPI-----LMTQT 220
                 +   ++++FE++  G+L  F R   PD K+     +V P  L +     + +Q 
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA---E 277
           +  + ++   + +H D+   N  C       VK+ DFG++  +   +  ++   T     
Sbjct: 145 AAGMVYLAGLHFVHRDLATRN--CLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 278 FAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
           +  PE +        +D+W+ GV+ + + + G  P+   ++ E +  +
Sbjct: 203 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI 250

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 93/210 (44%), Gaps = 28/210 (13%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR--KEIDIMNQLHHPKL 167
           Y+ L +IG G FG V + R RKTG   A K + + +  E   I   +EI I+  L H  +
Sbjct: 19  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 78
Query: 168 INLHDAFED--------DDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQ 219
           +NL +               + L+F+F    +L   ++    K + +E+  V     M  
Sbjct: 79  VNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRV-----MQM 132
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL------DPNEVVKIST 273
               + ++H   I+H D+K  N++  TR+   +K+ DFGLA          PN       
Sbjct: 133 LLNGLYYIHRNKILHRDMKAANVLI-TRDGV-LKLADFGLARAFSLAKNSQPNRYXN-RV 189
Query: 274 GTAEFAAPEIV--EREPVGFYTDMWAVGVL 301
            T  +  PE++  ER+  G   D+W  G +
Sbjct: 190 VTLWYRPPELLLGERD-YGPPIDLWGAGCI 218

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 96/243 (39%), Gaps = 48/243 (19%)
Query: 110 YDILEEIGTGAFGVVHRCRER-KTG---NIFAAKFIPVSHNLEKELIRKEIDIMNQLH-H 164
           + I ++IG G F  V+    + + G    I     IP SH +    I  E+  +      
Sbjct: 23  FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIR---IAAELQCLTVAGGQ 79
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
             ++ +   F  +D +V+   +L      + + +    +S  EV    L +       A+
Sbjct: 80  DNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNS----LSFQEVREYMLNLF-----KAL 130
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA-----TK----------------- 262
           K +H+  I+H DVKP N +   R      ++DFGLA     TK                 
Sbjct: 131 KRIHQFGIVHRDVKPSNFL-YNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCS 189
Query: 263 -------LDPNEVVKISTGTAEFAAPEIVEREP-VGFYTDMWAVGVLAYVLLSGLSPFAG 314
                  L   + V    GT  F APE++ + P      DMW+ GV+   LLSG  PF  
Sbjct: 190 QNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249
Query: 315 END 317
            +D
Sbjct: 250 ASD 252

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 74/161 (45%), Gaps = 17/161 (10%)
Query: 164 HPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPA 223
           HP +I  +   E D +   I   L    L E +   D+     E  P+TL   + QT+  
Sbjct: 77  HPNVIR-YFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLE--PITL---LQQTTSG 130
Query: 224 VKHMHEKNIIHLDVKPENIMCQTRNS---TNVKMIDFGLATKL--DPNEVVKIS--TGTA 276
           + H+H  NI+H D+KP NI+    N+       + DFGL  KL    +   + S   GT 
Sbjct: 131 LAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190
Query: 277 EFAAPEIVE---REPVGFYTDMWAVG-VLAYVLLSGLSPFA 313
            + APE++    +E   +  D+++ G V  YV+  G  PF 
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG 231

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/228 (19%), Positives = 100/228 (43%), Gaps = 20/228 (8%)
Query: 115 EIGTGAFGVV-----HRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLIN 169
           E+G GAFG V     H     +   + A K +  +    ++  ++E +++  L H  ++ 
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 170 LHDAFEDDDEMVLIFEFLSGGEL--FERITAPDYKMSEA--EVIPVTLPI-----LMTQT 220
                 +   ++++FE++  G+L  F R   PD K+     +V P  L +     + +Q 
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA---E 277
           +  + ++   + +H D+   N  C       VK+ DFG++  +   +  ++   T     
Sbjct: 168 AAGMVYLAGLHFVHRDLATRN--CLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 278 FAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
           +  PE +        +D+W+ GV+ + + + G  P+   ++ E +  +
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI 273

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 93/210 (44%), Gaps = 28/210 (13%)
Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR--KEIDIMNQLHHPKL 167
           Y+ L +IG G FG V + R RKTG   A K + + +  E   I   +EI I+  L H  +
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 168 INLHDAFED--------DDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQ 219
           +NL +               + L+F+F    +L   ++    K + +E+  V     M  
Sbjct: 80  VNLIEICRTKASPYNRCKASIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRV-----MQM 133
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL------DPNEVVKIST 273
               + ++H   I+H D+K  N++  TR+   +K+ DFGLA          PN       
Sbjct: 134 LLNGLYYIHRNKILHRDMKAANVLI-TRDGV-LKLADFGLARAFSLAKNSQPNRYXN-RV 190
Query: 274 GTAEFAAPEIV--EREPVGFYTDMWAVGVL 301
            T  +  PE++  ER+  G   D+W  G +
Sbjct: 191 VTLWYRPPELLLGERD-YGPPIDLWGAGCI 219

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/166 (22%), Positives = 75/166 (45%), Gaps = 10/166 (6%)
Query: 153 RKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVT 212
           ++E     +L  P ++ +HD  E D ++ +    ++G +L   +        +  + P  
Sbjct: 82  QREARTAGRLQEPHVVPIHDFGEIDGQLYVDXRLINGVDLAAXL------RRQGPLAPPR 135
Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKI- 271
              ++ Q   A+   H     H DVKPENI+    +     ++DFG+A+     ++ ++ 
Sbjct: 136 AVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDF--AYLVDFGIASATTDEKLTQLG 193
Query: 272 -STGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN 316
            + GT  + APE        +  D++A+  + Y  L+G  P+ G+ 
Sbjct: 194 NTVGTLYYXAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ 239

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 88/205 (42%), Gaps = 18/205 (8%)
Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLH 171
           +L+ IG G FG V     R  GN  A K I   ++   +    E  +M QL H  L+ L 
Sbjct: 197 LLQTIGKGEFGDVMLGDYR--GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLL 252
Query: 172 DAF-EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEK 230
               E+   + ++ E+++ G L + + +    +   +     L         A++++   
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDC----LLKFSLDVCEAMEYLEGN 308
Query: 231 NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT--AEFAAPEIVEREP 288
           N +H D+   N++    N   V   DFGL  +    +     TG    ++ APE +  + 
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVS--DFGLTKEASSTQ----DTGKLPVKWTAPEALREKK 362
Query: 289 VGFYTDMWAVGVLAYVLLS-GLSPF 312
               +D+W+ G+L + + S G  P+
Sbjct: 363 FSTKSDVWSFGILLWEIYSFGRVPY 387

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 88/205 (42%), Gaps = 18/205 (8%)
Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLH 171
           +L+ IG G FG V     R  GN  A K I   ++   +    E  +M QL H  L+ L 
Sbjct: 25  LLQTIGKGEFGDVMLGDYR--GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLL 80
Query: 172 DAF-EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEK 230
               E+   + ++ E+++ G L + + +    +   +     L         A++++   
Sbjct: 81  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD----CLLKFSLDVCEAMEYLEGN 136
Query: 231 NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT--AEFAAPEIVEREP 288
           N +H D+   N++    N   V   DFGL  +    +     TG    ++ APE +  + 
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVS--DFGLTKEASSTQ----DTGKLPVKWTAPEALREKK 190
Query: 289 VGFYTDMWAVGVLAYVLLS-GLSPF 312
               +D+W+ G+L + + S G  P+
Sbjct: 191 FSTKSDVWSFGILLWEIYSFGRVPY 215

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 96/206 (46%), Gaps = 20/206 (9%)
Query: 113 LEEIGTGAFGVVH-RCRERK---TGNIFAAKFIPVSHNLE-KELIRKEIDIMNQLHHPKL 167
           + ++G G FG V   C +     TG + A K +      + +   ++EI+I+  L+H  +
Sbjct: 13  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 72
Query: 168 INLHDAFEDDDE--MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
           +      ED  E  + L+ E++  G L  R   P + +  A+++     +   Q    + 
Sbjct: 73  VKYKGCCEDQGEKSVQLVMEYVPLGSL--RDYLPRHCVGLAQLL-----LFAQQICEGMA 125
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL-DPNEVVKI---STGTAEFAAP 281
           ++H ++ IH  +   N++    N   VK+ DFGLA  + + +E  ++         + AP
Sbjct: 126 YLHAQHYIHRALAARNVL--LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 183
Query: 282 EIVEREPVGFYTDMWAVGVLAYVLLS 307
           E ++     + +D+W+ GV  Y LL+
Sbjct: 184 ECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 96/206 (46%), Gaps = 20/206 (9%)
Query: 113 LEEIGTGAFGVVH-RCRERK---TGNIFAAKFIPVSHNLE-KELIRKEIDIMNQLHHPKL 167
           + ++G G FG V   C +     TG + A K +      + +   ++EI+I+  L+H  +
Sbjct: 14  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 73
Query: 168 INLHDAFEDDDE--MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
           +      ED  E  + L+ E++  G L  R   P + +  A+++     +   Q    + 
Sbjct: 74  VKYKGCCEDQGEKSVQLVMEYVPLGSL--RDYLPRHCVGLAQLL-----LFAQQICEGMA 126
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL-DPNEVVKI---STGTAEFAAP 281
           ++H ++ IH  +   N++    N   VK+ DFGLA  + + +E  ++         + AP
Sbjct: 127 YLHAQHYIHRALAARNVL--LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 184
Query: 282 EIVEREPVGFYTDMWAVGVLAYVLLS 307
           E ++     + +D+W+ GV  Y LL+
Sbjct: 185 ECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 65/135 (48%), Gaps = 14/135 (10%)
Query: 180 MVLIFEFLSGGELFERITAPDYKMSEAEVIP-VTLPILMTQTSPAVKHMHEK-NIIHLDV 237
           +V++FE L G  L   I     K  E   IP + +  +  Q    + +MH +  IIH D+
Sbjct: 105 VVMVFEVL-GENLLALI-----KKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDI 158
Query: 238 KPENIMCQT----RNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYT 293
           KPEN++ +      N   +K+ D G A   D  E    S  T E+ +PE++   P G   
Sbjct: 159 KPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSIQTREYRSPEVLLGAPWGCGA 216
Query: 294 DMWAVGVLAYVLLSG 308
           D+W+   L + L++G
Sbjct: 217 DIWSTACLIFELITG 231

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 99/222 (44%), Gaps = 23/222 (10%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR---KEIDIMNQL-HHPKLINLH 171
           IG G FG V + R +K G    A    +     K+  R    E++++ +L HHP +INL 
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 89
Query: 172 DAFEDDDEMVLIFEFLSGGELFERI-------TAPDYKMSEAEVIPVTLPILM---TQTS 221
            A E    + L  E+   G L + +       T P + ++ +    ++   L+      +
Sbjct: 90  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 149
Query: 222 PAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEV-VKISTGT--AEF 278
             + ++ +K  IH ++   NI+     +   K+ DFGL+      EV VK + G     +
Sbjct: 150 RGMDYLSQKQFIHRNLAARNIL--VGENYVAKIADFGLSRG---QEVYVKKTMGRLPVRW 204
Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVE 319
            A E +        +D+W+ GVL + ++S G +P+ G    E
Sbjct: 205 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 246

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 65/135 (48%), Gaps = 14/135 (10%)
Query: 180 MVLIFEFLSGGELFERITAPDYKMSEAEVIP-VTLPILMTQTSPAVKHMHEK-NIIHLDV 237
           +V++FE L G  L   I     K  E   IP + +  +  Q    + +MH +  IIH D+
Sbjct: 105 VVMVFEVL-GENLLALI-----KKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDI 158
Query: 238 KPENIMCQT----RNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYT 293
           KPEN++ +      N   +K+ D G A   D  E    S  T E+ +PE++   P G   
Sbjct: 159 KPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSIQTREYRSPEVLLGAPWGCGA 216
Query: 294 DMWAVGVLAYVLLSG 308
           D+W+   L + L++G
Sbjct: 217 DIWSTACLIFELITG 231

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 88/205 (42%), Gaps = 18/205 (8%)
Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLH 171
           +L+ IG G FG V     R  GN  A K I   ++   +    E  +M QL H  L+ L 
Sbjct: 10  LLQTIGKGEFGDVMLGDYR--GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLL 65
Query: 172 DAF-EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEK 230
               E+   + ++ E+++ G L + + +    +   +     L         A++++   
Sbjct: 66  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD----CLLKFSLDVCEAMEYLEGN 121
Query: 231 NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT--AEFAAPEIVEREP 288
           N +H D+   N++    N   V   DFGL  +    +     TG    ++ APE +  + 
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVS--DFGLTKEASSTQ----DTGKLPVKWTAPEALREKK 175
Query: 289 VGFYTDMWAVGVLAYVLLS-GLSPF 312
               +D+W+ G+L + + S G  P+
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVPY 200

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 92/212 (43%), Gaps = 18/212 (8%)
Query: 112 ILEEIGTGAFGVVHRCRERKTGN--IFAAKFIPVSHNLEKEL--IRKEIDIMNQLHHPKL 167
           I + IG G FG V     +  G   IF A     S   EK+      E  IM Q  HP +
Sbjct: 11  IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNV 70
Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
           I+L         +++I EF+  G L   +     + ++ +   + L  ++   +  +K++
Sbjct: 71  IHLEGVVTKSTPVMIITEFMENGSLDSFL-----RQNDGQFTVIQLVGMLRGIAAGMKYL 125
Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL-----DPNEVVKISTGTA-EFAAP 281
            + N +H  +   NI+  +  +   K+ DFGL+  L     DP     +       + AP
Sbjct: 126 ADMNYVHRALAARNILVNS--NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 183
Query: 282 EIVEREPVGFYTDMWAVGVLAYVLLS-GLSPF 312
           E ++       +D+W+ G++ + ++S G  P+
Sbjct: 184 EAIQYRKFTSASDVWSYGIVMWEVMSYGERPY 215

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 94/218 (43%), Gaps = 16/218 (7%)
Query: 116 IGTGAFGVVHRCRER---KTGNIFAAKFIPVSHN-LEKELIRKEIDIMNQLHHPKLINLH 171
           +G G FG V   R +   K     A K + V +   ++     E  IM Q  HP +I L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
                   ++++ E++  G L   +   D     A+   + L  ++   +  +K++ +  
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHD-----AQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--DPNEVVKISTGT--AEFAAPEIVERE 287
            +H D+   NI+  +  +   K+ DFGL+  L  DP        G     + +PE +   
Sbjct: 168 FVHRDLAARNILINS--NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 288 PVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
                +D+W+ G++ + ++S G  P+   ++ + +K V
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 103/230 (44%), Gaps = 30/230 (13%)
Query: 108 DHYDILEEIGTGAFGVVHRCR-----ERKTGNIFAAKFIP--VSHNLEKELIRKEIDIMN 160
           D  ++ + +G GAFG V         +  T    A K +    +H+  + L+ +   +++
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 161 QLHHPKLINLHDAF-EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIP--------V 211
             HH  ++NL  A  +    +++I EF   G L   +     +    E +P        +
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-----RSKRNEFVPYKDLYKDFL 141
Query: 212 TLPILMT---QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--DPN 266
           TL  L+    Q +  ++ +  +  IH D+   NI+   +N   VK+ DFGLA  +  DP+
Sbjct: 142 TLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPD 199
Query: 267 EVVKISTGTA-EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
            V K       ++ APE +        +D+W+ GVL + + S G SP+ G
Sbjct: 200 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 249

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 101/242 (41%), Gaps = 22/242 (9%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL-IRKEIDIMNQLHHPKLINLHDAF 174
           +G G FG V++ R    G + A K +        EL  + E+++++   H  L+ L    
Sbjct: 46  LGRGGFGKVYKGR-LADGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFC 104
Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLP-----ILMTQTSPAVKHMH- 228
               E +L++ +++ G +     A   +       P+  P      L +    A  H H 
Sbjct: 105 MTPTERLLVYPYMANGSV-----ASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC 159
Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE--VVKISTGTAEFAAPEIVER 286
           +  IIH DVK  NI+        V   DFGLA  +D  +  V     GT    APE +  
Sbjct: 160 DPKIIHRDVKAANILLDEEFEAVVG--DFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLST 217
Query: 287 EPVGFYTDMWAVGVLAYVLLSG-----LSPFAGENDVETLKNVKACDWEFDEEAFKNVSE 341
                 TD++  GV+   L++G     L+  A ++DV  L  VK    E   EA  +V  
Sbjct: 218 GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDL 277
Query: 342 EG 343
           +G
Sbjct: 278 QG 279

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 87/205 (42%), Gaps = 18/205 (8%)
Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLH 171
           +L+ IG G FG V     R  GN  A K I   ++   +    E  +M QL H  L+ L 
Sbjct: 16  LLQTIGKGEFGDVMLGDYR--GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLL 71
Query: 172 DAF-EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEK 230
               E+   + ++ E+++ G L + + +    +   +     L         A++++   
Sbjct: 72  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD----CLLKFSLDVCEAMEYLEGN 127
Query: 231 NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT--AEFAAPEIVEREP 288
           N +H D+   N++    N   V   DFGL  +    +     TG    ++ APE +    
Sbjct: 128 NFVHRDLAARNVLVSEDNVAKVS--DFGLTKEASSTQ----DTGKLPVKWTAPEALREAA 181
Query: 289 VGFYTDMWAVGVLAYVLLS-GLSPF 312
               +D+W+ G+L + + S G  P+
Sbjct: 182 FSTKSDVWSFGILLWEIYSFGRVPY 206

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 112/259 (43%), Gaps = 34/259 (13%)
Query: 82  DYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCR-----ERKTGNIF 136
           D D+   D + + +P     K     D  ++ + +G GAFG V         +  T    
Sbjct: 3   DPDELPLDEHCERLPYDAS-KWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTV 61
Query: 137 AAKFIP--VSHNLEKELIRKEIDIMNQLHHPKLINLHDAF-EDDDEMVLIFEFLSGGELF 193
           A K +    +H+  + L+ +   +++  HH  ++NL  A  +    +++I EF   G L 
Sbjct: 62  AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS 121
Query: 194 ERITAPDYKMSEAEVIP-----------VTLPILMT---QTSPAVKHMHEKNIIHLDVKP 239
             +     +    E +P           +TL  L+    Q +  ++ +  +  IH D+  
Sbjct: 122 TYL-----RSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 176
Query: 240 ENIMCQTRNSTNVKMIDFGLATKL--DPNEVVKISTGTA-EFAAPEIVEREPVGFYTDMW 296
            NI+   +N   VK+ DFGLA  +  DP+ V K       ++ APE +        +D+W
Sbjct: 177 RNILLSEKNV--VKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVW 234
Query: 297 AVGVLAYVLLS-GLSPFAG 314
           + GVL + + S G SP+ G
Sbjct: 235 SFGVLLWEIFSLGASPYPG 253

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 93/218 (42%), Gaps = 16/218 (7%)
Query: 116 IGTGAFGVVHRCRER---KTGNIFAAKFIPVSHN-LEKELIRKEIDIMNQLHHPKLINLH 171
           +G G FG V   R +   K     A K + V +   ++     E  IM Q  HP +I L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
                   ++++ E++  G L   +   D     A+   + L  ++   +  +K++ +  
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHD-----AQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--DPNEVVKISTGT--AEFAAPEIVERE 287
            +H D+   NI+  +  +   K+ DFGL   L  DP        G     + +PE +   
Sbjct: 168 YVHRDLAARNILINS--NLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 288 PVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
                +D+W+ G++ + ++S G  P+   ++ + +K V
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 103/230 (44%), Gaps = 30/230 (13%)
Query: 108 DHYDILEEIGTGAFGVVHRCR-----ERKTGNIFAAKFIP--VSHNLEKELIRKEIDIMN 160
           D  ++ + +G GAFG V         +  T    A K +    +H+  + L+ +   +++
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 161 QLHHPKLINLHDAF-EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIP--------V 211
             HH  ++NL  A  +    +++I EF   G L   +     +    E +P        +
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-----RSKRNEFVPYKDLYKDFL 141
Query: 212 TLPILMT---QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--DPN 266
           TL  L+    Q +  ++ +  +  IH D+   NI+   +N   VK+ DFGLA  +  DP+
Sbjct: 142 TLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNV--VKIXDFGLARDIYKDPD 199
Query: 267 EVVKISTGTA-EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
            V K       ++ APE +        +D+W+ GVL + + S G SP+ G
Sbjct: 200 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 249

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 102/229 (44%), Gaps = 24/229 (10%)
Query: 108 DHYDILEEIGTGAFGVVHRCR-----ERKTGNIFAAKFIP--VSHNLEKELIRKEIDIMN 160
           D   + + +G GAFG V         +  T    A K +    +H+  + L+ +   +++
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 88
Query: 161 QLHHPKLINLHDAF-EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIP-------VT 212
             HH  ++NL  A  +    +++I EF   G L   + +   +    +  P       +T
Sbjct: 89  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLT 148
Query: 213 LPILMT---QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--DPNE 267
           L  L+    Q +  ++ +  +  IH D+   NI+   +N   VK+ DFGLA  +  DP+ 
Sbjct: 149 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDY 206
Query: 268 VVKISTGTA-EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
           V K       ++ APE +        +D+W+ GVL + + S G SP+ G
Sbjct: 207 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 255

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/231 (20%), Positives = 97/231 (41%), Gaps = 41/231 (17%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLI 168
           HY  ++++G G F  V        G+ +A K I      ++E  ++E D+    +HP ++
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 169 NL-----------HDAFEDDDEMVLIFEFLSGGELF---ERITAPDYKMSEAEVIPVTLP 214
            L           H+A+       L+  F   G L+   ER+      ++E +++ + L 
Sbjct: 90  RLVAYCLRERGAKHEAW-------LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLG 142
Query: 215 ILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL-----DPNEVV 269
           I        ++ +H K   H D+KP NI+    +     ++D G   +         + +
Sbjct: 143 I-----CRGLEAIHAKGYAHRDLKPTNIL--LGDEGQPVLMDLGSMNQACIHVEGSRQAL 195
Query: 270 KISTGTAE-----FAAPEIVEREP---VGFYTDMWAVGVLAYVLLSGLSPF 312
            +    A+     + APE+   +    +   TD+W++G + Y ++ G  P+
Sbjct: 196 TLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY 246

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 102/227 (44%), Gaps = 22/227 (9%)
Query: 108 DHYDILEEIGTGAFGVVHRCR-----ERKTGNIFAAKFIP--VSHNLEKELIRKEIDIMN 160
           D   + + +G GAFG V         +  T    A K +    +H+  + L+ +   +++
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 88
Query: 161 QLHHPKLINLHDAF-EDDDEMVLIFEFLSGGELFERITAP-----DYKMSEAEVIPVTLP 214
             HH  ++NL  A  +    +++I EF   G L   + +       YK  +     +TL 
Sbjct: 89  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLE 148
Query: 215 ILMT---QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--DPNEVV 269
            L+    Q +  ++ +  +  IH D+   NI+   +N   VK+ DFGLA  +  DP+ V 
Sbjct: 149 HLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNV--VKICDFGLARDIXKDPDXVR 206
Query: 270 KISTGTA-EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
           K       ++ APE +        +D+W+ GVL + + S G SP+ G
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 95/225 (42%), Gaps = 16/225 (7%)
Query: 131 KTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGG 190
           +T NI +  F      L K ++R EI ++N  HHP ++ L D F   +E  +   +L   
Sbjct: 62  RTVNILSDSF------LCKRVLR-EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLV-T 113
Query: 191 ELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNST 250
           EL     A         + P  +   M      +  +HE  ++H D+ P NI+    N  
Sbjct: 114 ELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN-- 171
Query: 251 NVKMIDFGLATKLDPNEVVKISTGTAE-FAAPEIVEREPVGF--YTDMWAVGVLAYVLLS 307
           ++ + DF LA + D  +  K    T   + APE+V +   GF    DMW+ G +   + +
Sbjct: 172 DITICDFNLARE-DTADANKTHYVTHRWYRAPELVMQFK-GFTKLVDMWSAGCVMAEMFN 229
Query: 308 GLSPFAGENDVETL-KNVKACDWEFDEEAFKNVSEEGKDFIRRLL 351
             + F G      L K V+       E+     S   +D++R  L
Sbjct: 230 RKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSL 274

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 95/225 (42%), Gaps = 16/225 (7%)
Query: 131 KTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGG 190
           +T NI +  F      L K ++R EI ++N  HHP ++ L D F   +E  +   +L   
Sbjct: 62  RTVNILSDSF------LCKRVLR-EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLV-T 113
Query: 191 ELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNST 250
           EL     A         + P  +   M      +  +HE  ++H D+ P NI+    N  
Sbjct: 114 ELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN-- 171
Query: 251 NVKMIDFGLATKLDPNEVVKISTGTAE-FAAPEIVEREPVGF--YTDMWAVGVLAYVLLS 307
           ++ + DF LA + D  +  K    T   + APE+V +   GF    DMW+ G +   + +
Sbjct: 172 DITICDFNLARE-DTADANKTHYVTHRWYRAPELVMQFK-GFTKLVDMWSAGCVMAEMFN 229
Query: 308 GLSPFAGENDVETL-KNVKACDWEFDEEAFKNVSEEGKDFIRRLL 351
             + F G      L K V+       E+     S   +D++R  L
Sbjct: 230 RKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSL 274

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 87/182 (47%), Gaps = 24/182 (13%)
Query: 155 EIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELF-----ERITAPDY-------- 201
           E +++ Q++HP +I L+ A   D  ++LI E+   G L       R   P Y        
Sbjct: 76  EFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 202 --KMSEAEVIPVTLPILMT---QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMID 256
              +   +   +T+  L++   Q S  ++++ E +++H D+   NI+        +K+ D
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVA--EGRKMKISD 193
Query: 257 FGLATKL-DPNEVVKISTG--TAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPF 312
           FGL+  + + +  VK S G    ++ A E +        +D+W+ GVL + +++ G +P+
Sbjct: 194 FGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253
Query: 313 AG 314
            G
Sbjct: 254 PG 255

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/249 (20%), Positives = 105/249 (42%), Gaps = 24/249 (9%)
Query: 92  SKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL 151
           S YVP   ++    +     +L E+G G+FG+V+    R      A   + V    E   
Sbjct: 5   SVYVPDEWEVSREKI----TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS 60
Query: 152 IRKEIDIMNQ--------LHHPKLINLHDAFEDDDEMVLIFEFLSGGEL--FERITAPDY 201
           +R+ I+ +N+         HH  ++ L          +++ E ++ G+L  + R   P+ 
Sbjct: 61  LRERIEFLNEASVMKGFTCHH--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEA 118
Query: 202 KMSEAEVIPVTLPI--LMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGL 259
           + +     P    +  +  + +  + +++ K  +H D+   N  C   +   VK+ DFG+
Sbjct: 119 ENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARN--CMVAHDFTVKIGDFGM 176
Query: 260 ATKLDPNEVVKISTG---TAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGE 315
              +   +  +          + APE ++       +DMW+ GV+ + + S    P+ G 
Sbjct: 177 TRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL 236
Query: 316 NDVETLKNV 324
           ++ + LK V
Sbjct: 237 SNEQVLKFV 245

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/223 (21%), Positives = 96/223 (43%), Gaps = 24/223 (10%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK----ELIRK----EIDIMNQLHHPKL 167
           IG+G  G V   R R  G     + +PV+    K    E  R+    E  IM Q  HP +
Sbjct: 57  IGSGDSGEVCYGRLRVPGQ----RDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
           I L          +++ E++  G L   +   D + +  +++      ++      ++++
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVG-----MLRGVGAGMRYL 167
Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--DPNEVVKISTGTA--EFAAPEI 283
            +   +H D+   N++  +  +   K+ DFGL+  L  DP+     + G     + APE 
Sbjct: 168 SDLGYVHRDLAARNVLVDS--NLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEA 225
Query: 284 VEREPVGFYTDMWAVGVLAY-VLLSGLSPFAGENDVETLKNVK 325
           +        +D+W+ GV+ + VL  G  P+    + + + +V+
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE 268

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 86/182 (47%), Gaps = 24/182 (13%)
Query: 155 EIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELF-----ERITAPDY-------- 201
           E +++ Q++HP +I L+ A   D  ++LI E+   G L       R   P Y        
Sbjct: 76  EFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 202 --KMSEAEVIPVTLPILMT---QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMID 256
              +   +   +T+  L++   Q S  ++++ E  ++H D+   NI+        +K+ D
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA--EGRKMKISD 193
Query: 257 FGLATKL-DPNEVVKISTG--TAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPF 312
           FGL+  + + +  VK S G    ++ A E +        +D+W+ GVL + +++ G +P+
Sbjct: 194 FGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253
Query: 313 AG 314
            G
Sbjct: 254 PG 255

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/223 (21%), Positives = 96/223 (43%), Gaps = 24/223 (10%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK----ELIRK----EIDIMNQLHHPKL 167
           IG+G  G V   R R  G     + +PV+    K    E  R+    E  IM Q  HP +
Sbjct: 57  IGSGDSGEVCYGRLRVPGQ----RDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
           I L          +++ E++  G L   +   D + +  +++      ++      ++++
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVG-----MLRGVGAGMRYL 167
Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--DPNEVVKISTGTA--EFAAPEI 283
            +   +H D+   N++  +  +   K+ DFGL+  L  DP+     + G     + APE 
Sbjct: 168 SDLGYVHRDLAARNVLVDS--NLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEA 225
Query: 284 VEREPVGFYTDMWAVGVLAY-VLLSGLSPFAGENDVETLKNVK 325
           +        +D+W+ GV+ + VL  G  P+    + + + +V+
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE 268

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 86/182 (47%), Gaps = 24/182 (13%)
Query: 155 EIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELF-----ERITAPDY-------- 201
           E +++ Q++HP +I L+ A   D  ++LI E+   G L       R   P Y        
Sbjct: 76  EFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 202 --KMSEAEVIPVTLPILMT---QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMID 256
              +   +   +T+  L++   Q S  ++++ E  ++H D+   NI+        +K+ D
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA--EGRKMKISD 193
Query: 257 FGLATKL-DPNEVVKISTG--TAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPF 312
           FGL+  + + +  VK S G    ++ A E +        +D+W+ GVL + +++ G +P+
Sbjct: 194 FGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253
Query: 313 AG 314
            G
Sbjct: 254 PG 255

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 80/184 (43%), Gaps = 16/184 (8%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHP 165
           V + Y +  +IG+G+FG ++   +   G   A K   V     +  I  +I  M Q    
Sbjct: 7   VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ-GGV 65
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            +  +     + D  V++ E L G  L +       K S   V+     +L  Q    ++
Sbjct: 66  GIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVL-----LLADQMISRIE 119
Query: 226 HMHEKNIIHLDVKPEN-IMCQTRNSTNVKMIDFGLATKLD--------PNEVVKISTGTA 276
           ++H KN IH DVKP+N +M   +    V +IDFGLA K          P    K  TGTA
Sbjct: 120 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 179
Query: 277 EFAA 280
            +A+
Sbjct: 180 RYAS 183

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/229 (20%), Positives = 98/229 (42%), Gaps = 20/229 (8%)
Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQ--------LH 163
           +L E+G G+FG+V+    R      A   + V    E   +R+ I+ +N+         H
Sbjct: 18  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 77
Query: 164 HPKLINLHDAFEDDDEMVLIFEFLSGGEL--FERITAPDYKMSEAEVIPVTLPI--LMTQ 219
           H  ++ L          +++ E ++ G+L  + R   P+ + +     P    +  +  +
Sbjct: 78  H--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 135
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTG---TA 276
            +  + +++ K  +H D+   N  C   +   VK+ DFG+   +   +  +         
Sbjct: 136 IADGMAYLNAKKFVHRDLAARN--CMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV 193
Query: 277 EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
            + APE ++       +DMW+ GV+ + + S    P+ G ++ + LK V
Sbjct: 194 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 242

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/229 (20%), Positives = 98/229 (42%), Gaps = 20/229 (8%)
Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQ--------LH 163
           +L E+G G+FG+V+    R      A   + V    E   +R+ I+ +N+         H
Sbjct: 21  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 164 HPKLINLHDAFEDDDEMVLIFEFLSGGEL--FERITAPDYKMSEAEVIPVTLPI--LMTQ 219
           H  ++ L          +++ E ++ G+L  + R   P+ + +     P    +  +  +
Sbjct: 81  H--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTG---TA 276
            +  + +++ K  +H D+   N  C   +   VK+ DFG+   +   +  +         
Sbjct: 139 IADGMAYLNAKKFVHRDLAARN--CMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV 196
Query: 277 EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
            + APE ++       +DMW+ GV+ + + S    P+ G ++ + LK V
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 245

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 80/184 (43%), Gaps = 16/184 (8%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHP 165
           V + Y +  +IG+G+FG ++   +   G   A K   V     +  I  +I  M Q    
Sbjct: 5   VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ-GGV 63
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            +  +     + D  V++ E L G  L +       K S   V+     +L  Q    ++
Sbjct: 64  GIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVL-----LLADQMISRIE 117
Query: 226 HMHEKNIIHLDVKPEN-IMCQTRNSTNVKMIDFGLATKLD--------PNEVVKISTGTA 276
           ++H KN IH DVKP+N +M   +    V +IDFGLA K          P    K  TGTA
Sbjct: 118 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 277 EFAA 280
            +A+
Sbjct: 178 RYAS 181

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/231 (21%), Positives = 98/231 (42%), Gaps = 24/231 (10%)
Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQ--------LH 163
           +L E+G G+FG+V+    R      A   + V    E   +R+ I+ +N+         H
Sbjct: 21  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 164 HPKLINLHDAFEDDDEMVLIFEFLSGGEL--FERITAPDYKMSEAEVIPVTLPI--LMTQ 219
           H  ++ L          +++ E ++ G+L  + R   P+ + +     P    +  +  +
Sbjct: 81  H--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTG----- 274
            +  + +++ K  +H D+   N  C   +   VK+ DFG+    D  E      G     
Sbjct: 139 IADGMAYLNAKKFVHRDLAARN--CMVAHDFTVKIGDFGMTR--DIYETAYYRKGGKGLL 194
Query: 275 TAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
              + APE ++       +DMW+ GV+ + + S    P+ G ++ + LK V
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 245

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 116 IGTGAFGVVH------RCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLIN 169
           IG G FGVV+      + + R    I +   I     +E  L  +E  +M  L+HP ++ 
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFL--REGLLMRGLNHPNVLA 86
Query: 170 LHDAFEDDDEMV-LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH 228
           L       + +  ++  ++  G+L + I +P    +  ++I   L     Q +  ++++ 
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGL-----QVARGMEYLA 141
Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTG-----TAEFAAPEI 283
           E+  +H D+   N  C    S  VK+ DFGLA  +   E   +          ++ A E 
Sbjct: 142 EQKFVHRDLAARN--CMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199
Query: 284 VEREPVGFYTDMWAVGVLAYVLLSGLSP 311
           ++       +D+W+ GVL + LL+  +P
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/229 (21%), Positives = 100/229 (43%), Gaps = 20/229 (8%)
Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQ--------LH 163
           +L E+G G+FG+V+    R      A   + V    E   +R+ I+ +N+         H
Sbjct: 21  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 164 HPKLINLHDAFEDDDEMVLIFEFLSGGEL--FERITAPDYKMSEAEVIPVTLPI--LMTQ 219
           H  ++ L          +++ E ++ G+L  + R   P+ + +     P    +  +  +
Sbjct: 81  H--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL-DPNEVVKISTG--TA 276
            +  + +++ K  +H D+   N  C   +   VK+ DFG+   + + +   K   G    
Sbjct: 139 IADGMAYLNAKKFVHRDLAARN--CMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 196
Query: 277 EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
            + APE ++       +DMW+ GV+ + + S    P+ G ++ + LK V
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 245

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/229 (21%), Positives = 100/229 (43%), Gaps = 20/229 (8%)
Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQ--------LH 163
           +L E+G G+FG+V+    R      A   + V    E   +R+ I+ +N+         H
Sbjct: 20  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 79
Query: 164 HPKLINLHDAFEDDDEMVLIFEFLSGGEL--FERITAPDYKMSEAEVIPVTLPI--LMTQ 219
           H  ++ L          +++ E ++ G+L  + R   P+ + +     P    +  +  +
Sbjct: 80  H--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 137
Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL-DPNEVVKISTGT--A 276
            +  + +++ K  +H D+   N  C   +   VK+ DFG+   + + +   K   G    
Sbjct: 138 IADGMAYLNAKKFVHRDLAARN--CMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 195
Query: 277 EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
            + APE ++       +DMW+ GV+ + + S    P+ G ++ + LK V
Sbjct: 196 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 244

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/249 (20%), Positives = 107/249 (42%), Gaps = 24/249 (9%)
Query: 92  SKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL 151
           S YVP   ++    +     +L E+G G+FG+V+    R      A   + V    E   
Sbjct: 6   SVYVPDEWEVSREKI----TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS 61
Query: 152 IRKEIDIMNQ--------LHHPKLINLHDAFEDDDEMVLIFEFLSGGEL--FERITAPDY 201
           +R+ I+ +N+         HH  ++ L          +++ E ++ G+L  + R   P+ 
Sbjct: 62  LRERIEFLNEASVMKGFTCHH--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEA 119
Query: 202 KMSEAEVIPVTLPI--LMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGL 259
           + +     P    +  +  + +  + +++ K  +H ++   N  C   +   VK+ DFG+
Sbjct: 120 ENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRNLAARN--CMVAHDFTVKIGDFGM 177
Query: 260 ATKL-DPNEVVKISTG--TAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGE 315
              + + +   K   G     + APE ++       +DMW+ GV+ + + S    P+ G 
Sbjct: 178 TRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL 237
Query: 316 NDVETLKNV 324
           ++ + LK V
Sbjct: 238 SNEQVLKFV 246

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 96/231 (41%), Gaps = 20/231 (8%)
Query: 97  QPVDIKTSSVYDHYDILEEIGTGAFGVVHRC----RERKTGNIFAAKFIPVSHNLEKELI 152
           Q V I  SS+  H++  E IG G FG V+       + K  +        ++   E    
Sbjct: 20  QHVVIGPSSLIVHFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF 77
Query: 153 RKEIDIMNQLHHPKLINLHD-AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPV 211
             E  IM    HP +++L       +   +++  ++  G+L   I    +  +  ++I  
Sbjct: 78  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 137
Query: 212 TLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKI 271
            L     Q +  +K++  K  +H D+   N  C       VK+ DFGLA  +   E   +
Sbjct: 138 GL-----QVAKGMKYLASKKFVHRDLAARN--CMLDEKFTVKVADFGLARDMYDKEXXSV 190
Query: 272 STGTA-----EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGEN 316
              T      ++ A E ++ +     +D+W+ GVL + L++ G  P+   N
Sbjct: 191 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 241

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 96/231 (41%), Gaps = 20/231 (8%)
Query: 97  QPVDIKTSSVYDHYDILEEIGTGAFGVVHRC----RERKTGNIFAAKFIPVSHNLEKELI 152
           Q V I  SS+  H++  E IG G FG V+       + K  +        ++   E    
Sbjct: 13  QHVVIGPSSLIVHFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF 70
Query: 153 RKEIDIMNQLHHPKLINLHD-AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPV 211
             E  IM    HP +++L       +   +++  ++  G+L   I    +  +  ++I  
Sbjct: 71  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 130
Query: 212 TLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKI 271
            L     Q +  +K++  K  +H D+   N  C       VK+ DFGLA  +   E   +
Sbjct: 131 GL-----QVAKGMKYLASKKFVHRDLAARN--CMLDEKFTVKVADFGLARDMYDKEYYSV 183
Query: 272 STGTA-----EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGEN 316
              T      ++ A E ++ +     +D+W+ GVL + L++ G  P+   N
Sbjct: 184 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 234

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 96/231 (41%), Gaps = 20/231 (8%)
Query: 97  QPVDIKTSSVYDHYDILEEIGTGAFGVVHRC----RERKTGNIFAAKFIPVSHNLEKELI 152
           Q V I  SS+  H++  E IG G FG V+       + K  +        ++   E    
Sbjct: 20  QHVVIGPSSLIVHFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF 77
Query: 153 RKEIDIMNQLHHPKLINLHD-AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPV 211
             E  IM    HP +++L       +   +++  ++  G+L   I    +  +  ++I  
Sbjct: 78  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 137
Query: 212 TLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKI 271
            L     Q +  +K++  K  +H D+   N  C       VK+ DFGLA  +   E   +
Sbjct: 138 GL-----QVAKGMKYLASKKFVHRDLAARN--CMLDEKFTVKVADFGLARDMYDKEYYSV 190
Query: 272 STGTA-----EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGEN 316
              T      ++ A E ++ +     +D+W+ GVL + L++ G  P+   N
Sbjct: 191 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 241

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 96/231 (41%), Gaps = 20/231 (8%)
Query: 97  QPVDIKTSSVYDHYDILEEIGTGAFGVVHRC----RERKTGNIFAAKFIPVSHNLEKELI 152
           Q V I  SS+  H++  E IG G FG V+       + K  +        ++   E    
Sbjct: 21  QHVVIGPSSLIVHFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF 78
Query: 153 RKEIDIMNQLHHPKLINLHD-AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPV 211
             E  IM    HP +++L       +   +++  ++  G+L   I    +  +  ++I  
Sbjct: 79  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 138
Query: 212 TLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKI 271
            L     Q +  +K++  K  +H D+   N  C       VK+ DFGLA  +   E   +
Sbjct: 139 GL-----QVAKGMKYLASKKFVHRDLAARN--CMLDEKFTVKVADFGLARDMYDKEYYSV 191
Query: 272 STGTA-----EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGEN 316
              T      ++ A E ++ +     +D+W+ GVL + L++ G  P+   N
Sbjct: 192 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 242

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 96/231 (41%), Gaps = 20/231 (8%)
Query: 97  QPVDIKTSSVYDHYDILEEIGTGAFGVVHRC----RERKTGNIFAAKFIPVSHNLEKELI 152
           Q V I  SS+  H++  E IG G FG V+       + K  +        ++   E    
Sbjct: 21  QHVVIGPSSLIVHFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF 78
Query: 153 RKEIDIMNQLHHPKLINLHD-AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPV 211
             E  IM    HP +++L       +   +++  ++  G+L   I    +  +  ++I  
Sbjct: 79  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 138
Query: 212 TLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKI 271
            L     Q +  +K++  K  +H D+   N  C       VK+ DFGLA  +   E   +
Sbjct: 139 GL-----QVAKGMKYLASKKFVHRDLAARN--CMLDEKFTVKVADFGLARDMYDKEYYSV 191
Query: 272 STGTA-----EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGEN 316
              T      ++ A E ++ +     +D+W+ GVL + L++ G  P+   N
Sbjct: 192 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 242

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 96/231 (41%), Gaps = 20/231 (8%)
Query: 97  QPVDIKTSSVYDHYDILEEIGTGAFGVVHRC----RERKTGNIFAAKFIPVSHNLEKELI 152
           Q V I  SS+  H++  E IG G FG V+       + K  +        ++   E    
Sbjct: 39  QHVVIGPSSLIVHFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF 96
Query: 153 RKEIDIMNQLHHPKLINLHD-AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPV 211
             E  IM    HP +++L       +   +++  ++  G+L   I    +  +  ++I  
Sbjct: 97  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 156
Query: 212 TLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKI 271
            L     Q +  +K++  K  +H D+   N  C       VK+ DFGLA  +   E   +
Sbjct: 157 GL-----QVAKGMKYLASKKFVHRDLAARN--CMLDEKFTVKVADFGLARDMYDKEYYSV 209
Query: 272 STGTA-----EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGEN 316
              T      ++ A E ++ +     +D+W+ GVL + L++ G  P+   N
Sbjct: 210 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 260

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 96/231 (41%), Gaps = 20/231 (8%)
Query: 97  QPVDIKTSSVYDHYDILEEIGTGAFGVVHRC----RERKTGNIFAAKFIPVSHNLEKELI 152
           Q V I  SS+  H++  E IG G FG V+       + K  +        ++   E    
Sbjct: 18  QHVVIGPSSLIVHFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF 75
Query: 153 RKEIDIMNQLHHPKLINLHD-AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPV 211
             E  IM    HP +++L       +   +++  ++  G+L   I    +  +  ++I  
Sbjct: 76  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 135
Query: 212 TLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKI 271
            L     Q +  +K++  K  +H D+   N  C       VK+ DFGLA  +   E   +
Sbjct: 136 GL-----QVAKGMKYLASKKFVHRDLAARN--CMLDEKFTVKVADFGLARDMYDKEYYSV 188
Query: 272 STGTA-----EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGEN 316
              T      ++ A E ++ +     +D+W+ GVL + L++ G  P+   N
Sbjct: 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 239

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 96/231 (41%), Gaps = 20/231 (8%)
Query: 97  QPVDIKTSSVYDHYDILEEIGTGAFGVVHRC----RERKTGNIFAAKFIPVSHNLEKELI 152
           Q V I  SS+  H++  E IG G FG V+       + K  +        ++   E    
Sbjct: 16  QHVVIGPSSLIVHFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF 73
Query: 153 RKEIDIMNQLHHPKLINLHD-AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPV 211
             E  IM    HP +++L       +   +++  ++  G+L   I    +  +  ++I  
Sbjct: 74  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 133
Query: 212 TLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKI 271
            L     Q +  +K++  K  +H D+   N  C       VK+ DFGLA  +   E   +
Sbjct: 134 GL-----QVAKGMKYLASKKFVHRDLAARN--CMLDEKFTVKVADFGLARDMYDKEYYSV 186
Query: 272 STGTA-----EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGEN 316
              T      ++ A E ++ +     +D+W+ GVL + L++ G  P+   N
Sbjct: 187 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 237

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/249 (20%), Positives = 107/249 (42%), Gaps = 24/249 (9%)
Query: 92  SKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL 151
           S YVP   ++    +     +L E+G G+FG+V+    R      A   + V    E   
Sbjct: 5   SVYVPDEWEVSREKI----TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS 60
Query: 152 IRKEIDIMNQ--------LHHPKLINLHDAFEDDDEMVLIFEFLSGGEL--FERITAPDY 201
           +R+ I+ +N+         HH  ++ L          +++ E ++ G+L  + R   P+ 
Sbjct: 61  LRERIEFLNEASVMKGFTCHH--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEA 118
Query: 202 KMSEAEVIPVTLPI--LMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGL 259
           + +     P    +  +  + +  + +++ K  +H ++   N  C   +   VK+ DFG+
Sbjct: 119 ENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRNLAARN--CMVAHDFTVKIGDFGM 176
Query: 260 ATKL-DPNEVVKISTG--TAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGE 315
              + + +   K   G     + APE ++       +DMW+ GV+ + + S    P+ G 
Sbjct: 177 TRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL 236
Query: 316 NDVETLKNV 324
           ++ + LK V
Sbjct: 237 SNEQVLKFV 245

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 96/231 (41%), Gaps = 20/231 (8%)
Query: 97  QPVDIKTSSVYDHYDILEEIGTGAFGVVHRC----RERKTGNIFAAKFIPVSHNLEKELI 152
           Q V I  SS+  H++  E IG G FG V+       + K  +        ++   E    
Sbjct: 19  QHVVIGPSSLIVHFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF 76
Query: 153 RKEIDIMNQLHHPKLINLHD-AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPV 211
             E  IM    HP +++L       +   +++  ++  G+L   I    +  +  ++I  
Sbjct: 77  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 136
Query: 212 TLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKI 271
            L     Q +  +K++  K  +H D+   N  C       VK+ DFGLA  +   E   +
Sbjct: 137 GL-----QVAKGMKYLASKKFVHRDLAARN--CMLDEKFTVKVADFGLARDMYDKEYYSV 189
Query: 272 STGTA-----EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGEN 316
              T      ++ A E ++ +     +D+W+ GVL + L++ G  P+   N
Sbjct: 190 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 240

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 96/231 (41%), Gaps = 20/231 (8%)
Query: 97  QPVDIKTSSVYDHYDILEEIGTGAFGVVHRC----RERKTGNIFAAKFIPVSHNLEKELI 152
           Q V I  SS+  H++  E IG G FG V+       + K  +        ++   E    
Sbjct: 40  QHVVIGPSSLIVHFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF 97
Query: 153 RKEIDIMNQLHHPKLINLHD-AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPV 211
             E  IM    HP +++L       +   +++  ++  G+L   I    +  +  ++I  
Sbjct: 98  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 157
Query: 212 TLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKI 271
            L     Q +  +K++  K  +H D+   N  C       VK+ DFGLA  +   E   +
Sbjct: 158 GL-----QVAKGMKYLASKKFVHRDLAARN--CMLDEKFTVKVADFGLARDMYDKEYYSV 210
Query: 272 STGTA-----EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGEN 316
              T      ++ A E ++ +     +D+W+ GVL + L++ G  P+   N
Sbjct: 211 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 261

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 74/167 (44%), Gaps = 11/167 (6%)
Query: 149 KELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEV 208
           KE    E  IM  L HP ++ L    E++   + I E    GEL   +     + ++  +
Sbjct: 53  KEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWI-IMELYPYGELGHYL-----ERNKNSL 106
Query: 209 IPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEV 268
             +TL +   Q   A+ ++   N +H D+   NI+  +     VK+ DFGL+  ++  + 
Sbjct: 107 KVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPEC--VKLGDFGLSRYIEDEDY 164
Query: 269 VKISTG--TAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPF 312
            K S      ++ +PE +        +D+W   V  + +LS G  PF
Sbjct: 165 YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 211

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 74/167 (44%), Gaps = 11/167 (6%)
Query: 149 KELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEV 208
           KE    E  IM  L HP ++ L    E++   + I E    GEL   +     + ++  +
Sbjct: 57  KEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWI-IMELYPYGELGHYL-----ERNKNSL 110
Query: 209 IPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEV 268
             +TL +   Q   A+ ++   N +H D+   NI+  +     VK+ DFGL+  ++  + 
Sbjct: 111 KVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPEC--VKLGDFGLSRYIEDEDY 168
Query: 269 VKISTG--TAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPF 312
            K S      ++ +PE +        +D+W   V  + +LS G  PF
Sbjct: 169 YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 215

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 92/218 (42%), Gaps = 16/218 (7%)
Query: 116 IGTGAFGVVHRC---RERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQLHHPKLINL 170
           +G G FG V      +E  T    A K + + ++ ++E+     E   M    HP +I L
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 171 HDAF-----EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
                    +   + ++I  F+  G+L   +     +     +   TL   M   +  ++
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL---DPNEVVKISTGTAEFAAPE 282
           ++  +N +H D+   N  C  R+   V + DFGL+ K+   D     +I+    ++ A E
Sbjct: 162 YLSNRNFLHRDLAARN--CMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIE 219
Query: 283 IVEREPVGFYTDMWAVGVLAY-VLLSGLSPFAGENDVE 319
            +        +D+WA GV  + +   G++P+ G  + E
Sbjct: 220 SLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE 257

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 74/167 (44%), Gaps = 11/167 (6%)
Query: 149 KELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEV 208
           KE    E  IM  L HP ++ L    E++   + I E    GEL   +     + ++  +
Sbjct: 69  KEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWI-IMELYPYGELGHYL-----ERNKNSL 122
Query: 209 IPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEV 268
             +TL +   Q   A+ ++   N +H D+   NI+  +     VK+ DFGL+  ++  + 
Sbjct: 123 KVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPEC--VKLGDFGLSRYIEDEDY 180
Query: 269 VKISTG--TAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPF 312
            K S      ++ +PE +        +D+W   V  + +LS G  PF
Sbjct: 181 YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 227

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 80/184 (43%), Gaps = 16/184 (8%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHP 165
           V + Y +  +IG+G+FG ++      +G   A K   V     +  I  +   M Q    
Sbjct: 7   VGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIESKFYKMMQ-GGV 65
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            + ++     + D  V++ E L G  L +       K S   V+     +L  Q    ++
Sbjct: 66  GIPSIKWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVL-----LLADQMISRIE 119
Query: 226 HMHEKNIIHLDVKPEN-IMCQTRNSTNVKMIDFGLATKLD--------PNEVVKISTGTA 276
           ++H KN IH DVKP+N +M   +    V +IDFGLA K          P    K  TGTA
Sbjct: 120 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 179
Query: 277 EFAA 280
            +A+
Sbjct: 180 RYAS 183

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 51/100 (51%), Gaps = 6/100 (6%)
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--DPNEVVKISTGTA 276
           Q +  ++ +  +  IH D+   NI+   +N   VK+ DFGLA  +  DP+ V K      
Sbjct: 199 QVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 277 -EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
            ++ APE +        +D+W+ GVL + + S G SP+ G
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 296

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 51/100 (51%), Gaps = 6/100 (6%)
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--DPNEVVKISTGTA 276
           Q +  ++ +  +  IH D+   NI+   +N   VK+ DFGLA  +  DP+ V K      
Sbjct: 206 QVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 277 -EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
            ++ APE +        +D+W+ GVL + + S G SP+ G
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 303

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/240 (24%), Positives = 104/240 (43%), Gaps = 29/240 (12%)
Query: 99  VDIKTSSVYDH---YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKE 155
           VD+ T ++Y       +LE    G FG V + +        A K  P+    +K+  + E
Sbjct: 12  VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ--LLNEYVAVKIFPIQ---DKQSWQNE 66
Query: 156 IDI--MNQLHHPKLINLHDAFED----DDEMVLIFEFLSGGELFERITAPDYKMSE---- 205
            ++  +  + H  ++    A +     D ++ LI  F   G L + + A     +E    
Sbjct: 67  YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHI 126
Query: 206 AEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP 265
           AE +   L  L  +  P +K  H+  I H D+K +N++   +N+    + DFGLA K + 
Sbjct: 127 AETMARGLAYL-HEDIPGLKDGHKPAISHRDIKSKNVL--LKNNLTACIADFGLALKFEA 183
Query: 266 NEVVKIS---TGTAEFAAPEIVE-----REPVGFYTDMWAVGVLAYVLLSGLSPFAGEND 317
            +    +    GT  + APE++E     +       DM+A+G++ + L S  +   G  D
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 51/100 (51%), Gaps = 6/100 (6%)
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--DPNEVVKISTGTA 276
           Q +  ++ +  +  IH D+   NI+   +N   VK+ DFGLA  +  DP+ V K      
Sbjct: 208 QVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 277 -EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
            ++ APE +        +D+W+ GVL + + S G SP+ G
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 305

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 51/100 (51%), Gaps = 6/100 (6%)
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--DPNEVVKISTGTA 276
           Q +  ++ +  +  IH D+   NI+   +N   VK+ DFGLA  +  DP+ V K      
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 277 -EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
            ++ APE +        +D+W+ GVL + + S G SP+ G
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 298

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/211 (22%), Positives = 92/211 (43%), Gaps = 23/211 (10%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL--------IRKEIDIMNQLHHPKL 167
           +G+GAFG V++      G       IPV+  +  E            E  IM  + HP L
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVK---IPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 79
Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
           + L         + L+ + +  G L E +      +    ++   +     Q +  + ++
Sbjct: 80  VRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCV-----QIAKGMMYL 133
Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTG---TAEFAAPEIV 284
            E+ ++H D+   N++ ++ N  +VK+ DFGLA  L+ +E    + G     ++ A E +
Sbjct: 134 EERRLVHRDLAARNVLVKSPN--HVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 191
Query: 285 EREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
                   +D+W+ GV  + L++ G  P+ G
Sbjct: 192 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 222

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 95/231 (41%), Gaps = 20/231 (8%)
Query: 97  QPVDIKTSSVYDHYDILEEIGTGAFGVVHRC----RERKTGNIFAAKFIPVSHNLEKELI 152
           Q V I  SS+  H++  E IG G FG V+       + K  +        ++   E    
Sbjct: 22  QHVVIGPSSLIVHFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF 79
Query: 153 RKEIDIMNQLHHPKLINLHD-AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPV 211
             E  IM    HP +++L       +   +++  ++  G+L   I    +  +  ++I  
Sbjct: 80  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 139
Query: 212 TLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKI 271
            L     Q +  +K +  K  +H D+   N  C       VK+ DFGLA  +   E   +
Sbjct: 140 GL-----QVAKGMKFLASKKFVHRDLAARN--CMLDEKFTVKVADFGLARDMYDKEFDSV 192
Query: 272 STGTA-----EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGEN 316
              T      ++ A E ++ +     +D+W+ GVL + L++ G  P+   N
Sbjct: 193 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 243

>pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 89/218 (40%), Gaps = 20/218 (9%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLI 168
           HY +   IG G+FGV+            A KF P   +  +  +R E      L     I
Sbjct: 10  HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ--LRDEYRTYKLLAGCTGI 67
Query: 169 -NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
            N++   ++    VL+ + L G  L + +     K S       T+ +   Q    V+ +
Sbjct: 68  PNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVK-----TVAMAAKQMLARVQSI 121
Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMI---DFGL-------ATKLD-PNEVVKISTGTA 276
           HEK++++ D+KP+N +    NS N  MI   DFG+        TK   P    K  +GTA
Sbjct: 122 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 181
Query: 277 EFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAG 314
            + +             D+ A+G +    L G  P+ G
Sbjct: 182 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 219

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 95/231 (41%), Gaps = 20/231 (8%)
Query: 97  QPVDIKTSSVYDHYDILEEIGTGAFGVVHRC----RERKTGNIFAAKFIPVSHNLEKELI 152
           Q V I  SS+  H++  E IG G FG V+       + K  +        ++   E    
Sbjct: 21  QHVVIGPSSLIVHFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF 78
Query: 153 RKEIDIMNQLHHPKLINLHD-AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPV 211
             E  IM    HP +++L       +   +++  ++  G+L   I    +  +  ++I  
Sbjct: 79  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 138
Query: 212 TLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKI 271
            L     Q +  +K +  K  +H D+   N  C       VK+ DFGLA  +   E   +
Sbjct: 139 GL-----QVAKGMKFLASKKFVHRDLAARN--CMLDEKFTVKVADFGLARDMYDKEFDSV 191
Query: 272 STGTA-----EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGEN 316
              T      ++ A E ++ +     +D+W+ GVL + L++ G  P+   N
Sbjct: 192 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 242

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 95/231 (41%), Gaps = 20/231 (8%)
Query: 97  QPVDIKTSSVYDHYDILEEIGTGAFGVVHRC----RERKTGNIFAAKFIPVSHNLEKELI 152
           Q V I  SS+  H++  E IG G FG V+       + K  +        ++   E    
Sbjct: 19  QHVVIGPSSLIVHFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF 76
Query: 153 RKEIDIMNQLHHPKLINLHD-AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPV 211
             E  IM    HP +++L       +   +++  ++  G+L   I    +  +  ++I  
Sbjct: 77  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 136
Query: 212 TLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKI 271
            L     Q +  +K +  K  +H D+   N  C       VK+ DFGLA  +   E   +
Sbjct: 137 GL-----QVAKGMKFLASKKFVHRDLAARN--CMLDEKFTVKVADFGLARDMYDKEFDSV 189
Query: 272 STGTA-----EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGEN 316
              T      ++ A E ++ +     +D+W+ GVL + L++ G  P+   N
Sbjct: 190 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 240

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/112 (30%), Positives = 59/112 (52%), Gaps = 9/112 (8%)
Query: 210 PVTLPILMT---QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL--D 264
           P+T+  L++   Q +  ++ +  +  IH D+   NI+    N   VK+ DFGLA  +  +
Sbjct: 195 PITMEDLISYSFQVARGMEFLSSRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKN 252
Query: 265 PNEVVKISTGTA-EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
           P+ V K  T    ++ APE +  +     +D+W+ GVL + + S G SP+ G
Sbjct: 253 PDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPG 304

>pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 89/218 (40%), Gaps = 20/218 (9%)
Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLI 168
           HY +   IG G+FGV+            A KF P   +  +  +R E      L     I
Sbjct: 11  HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ--LRDEYRTYKLLAGCTGI 68
Query: 169 -NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
            N++   ++    VL+ + L G  L + +     K S       T+ +   Q    V+ +
Sbjct: 69  PNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVK-----TVAMAAKQMLARVQSI 122
Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMI---DFGL-------ATKLD-PNEVVKISTGTA 276
           HEK++++ D+KP+N +    NS N  MI   DFG+        TK   P    K  +GTA
Sbjct: 123 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 182
Query: 277 EFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAG 314
            + +             D+ A+G +    L G  P+ G
Sbjct: 183 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 220

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 95/231 (41%), Gaps = 20/231 (8%)
Query: 97  QPVDIKTSSVYDHYDILEEIGTGAFGVVHRC----RERKTGNIFAAKFIPVSHNLEKELI 152
           Q V I  SS+  H++  E IG G FG V+       + K  +        ++   E    
Sbjct: 21  QHVVIGPSSLIVHFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF 78
Query: 153 RKEIDIMNQLHHPKLINLHD-AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPV 211
             E  IM    HP +++L       +   +++  ++  G+L   I    +  +  ++I  
Sbjct: 79  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 138
Query: 212 TLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKI 271
            L     Q +  +K +  K  +H D+   N  C       VK+ DFGLA  +   E   +
Sbjct: 139 GL-----QVAKGMKFLASKKFVHRDLAARN--CMLDEKFTVKVADFGLARDMYDKEFDSV 191
Query: 272 STGTA-----EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGEN 316
              T      ++ A E ++ +     +D+W+ GVL + L++ G  P+   N
Sbjct: 192 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 242

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 16/218 (7%)
Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHP 165
           V + + +  +IG+G+FG ++     +T    A K   V     + L   +I  + Q    
Sbjct: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQ-GGT 63
Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            + N+     + D  VL+ + L G  L +       K+S   V+     +L  Q    V+
Sbjct: 64  GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVL-----MLADQMINRVE 117
Query: 226 HMHEKNIIHLDVKPEN-IMCQTRNSTNVKMIDFGLATKLD--------PNEVVKISTGTA 276
            +H K+ +H D+KP+N +M   R +  V +IDFGLA K          P    K  TGTA
Sbjct: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 177
Query: 277 EFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAG 314
            +A+             D+ ++G +    L G  P+ G
Sbjct: 178 RYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 95/231 (41%), Gaps = 20/231 (8%)
Query: 97  QPVDIKTSSVYDHYDILEEIGTGAFGVVHRC----RERKTGNIFAAKFIPVSHNLEKELI 152
           Q V I  SS+  H++  E IG G FG V+       + K  +        ++   E    
Sbjct: 22  QHVVIGPSSLIVHFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF 79
Query: 153 RKEIDIMNQLHHPKLINLHD-AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPV 211
             E  IM    HP +++L       +   +++  ++  G+L   I    +  +  ++I  
Sbjct: 80  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 139
Query: 212 TLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKI 271
            L     Q +  +K +  K  +H D+   N  C       VK+ DFGLA  +   E   +
Sbjct: 140 GL-----QVAKGMKFLASKKFVHRDLAARN--CMLDEKFTVKVADFGLARDMLDKEFDSV 192
Query: 272 STGTA-----EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGEN 316
              T      ++ A E ++ +     +D+W+ GVL + L++ G  P+   N
Sbjct: 193 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 243

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 95/231 (41%), Gaps = 20/231 (8%)
Query: 97  QPVDIKTSSVYDHYDILEEIGTGAFGVVHRC----RERKTGNIFAAKFIPVSHNLEKELI 152
           Q V I  SS+  H++  E IG G FG V+       + K  +        ++   E    
Sbjct: 26  QHVVIGPSSLIVHFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF 83
Query: 153 RKEIDIMNQLHHPKLINLHD-AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPV 211
             E  IM    HP +++L       +   +++  ++  G+L   I    +  +  ++I  
Sbjct: 84  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 143
Query: 212 TLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKI 271
            L     Q +  +K +  K  +H D+   N  C       VK+ DFGLA  +   E   +
Sbjct: 144 GL-----QVAKGMKFLASKKFVHRDLAARN--CMLDEKFTVKVADFGLARDMYDKEFDSV 196
Query: 272 STGTA-----EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGEN 316
              T      ++ A E ++ +     +D+W+ GVL + L++ G  P+   N
Sbjct: 197 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 247

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 95/231 (41%), Gaps = 20/231 (8%)
Query: 97  QPVDIKTSSVYDHYDILEEIGTGAFGVVHRC----RERKTGNIFAAKFIPVSHNLEKELI 152
           Q V I  SS+  H++  E IG G FG V+       + K  +        ++   E    
Sbjct: 80  QHVVIGPSSLIVHFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF 137
Query: 153 RKEIDIMNQLHHPKLINLHD-AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPV 211
             E  IM    HP +++L       +   +++  ++  G+L   I    +  +  ++I  
Sbjct: 138 LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 197
Query: 212 TLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKI 271
            L     Q +  +K +  K  +H D+   N  C       VK+ DFGLA  +   E   +
Sbjct: 198 GL-----QVAKGMKFLASKKFVHRDLAARN--CMLDEKFTVKVADFGLARDMYDKEFDSV 250
Query: 272 STGTA-----EFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGEN 316
              T      ++ A E ++ +     +D+W+ GVL + L++ G  P+   N
Sbjct: 251 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 301

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/211 (22%), Positives = 92/211 (43%), Gaps = 23/211 (10%)
Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL--------IRKEIDIMNQLHHPKL 167
           +G+GAFG V++      G       IPV+  +  E            E  IM  + HP L
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVK---IPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 102
Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
           + L         + L+ + +  G L E +      +    ++   +     Q +  + ++
Sbjct: 103 VRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCV-----QIAKGMMYL 156
Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTG---TAEFAAPEIV 284
            E+ ++H D+   N++ ++ N  +VK+ DFGLA  L+ +E    + G     ++ A E +
Sbjct: 157 EERRLVHRDLAARNVLVKSPN--HVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 214
Query: 285 EREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
                   +D+W+ GV  + L++ G  P+ G
Sbjct: 215 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 245

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 52/240 (21%), Positives = 102/240 (42%), Gaps = 32/240 (13%)
Query: 110 YDILEEIGTGA--FGVVHRCRERKTGNIFAAKFIPVSHNLEK------ELIRKEIDIMNQ 161
           Y++L  IG G      V+  R + TG     + I    NLE         ++ E+ +   
Sbjct: 11  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI----NLEACSNEMVTFLQGELHVSKL 66
Query: 162 LHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDY-KMSEAEVIPVTLPILMTQT 220
            +HP ++     F  D+E+ ++  F++ G   + I       M+E  +  +   +L    
Sbjct: 67  FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLK--- 123
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNS-------TNVKMIDFGLATKLDPNEVVKIST 273
             A+ ++H    +H  VK  +I+             +N+ MI  G   ++  ++  K S 
Sbjct: 124 --ALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVV-HDFPKYSV 180
Query: 274 GTAEFAAPEIVEREPVGF--YTDMWAVGVLAYVLLSGLSPF----AGENDVETLKNVKAC 327
               + +PE++++   G+   +D+++VG+ A  L +G  PF    A +  +E L     C
Sbjct: 181 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 240

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 52/240 (21%), Positives = 102/240 (42%), Gaps = 32/240 (13%)
Query: 110 YDILEEIGTGA--FGVVHRCRERKTGNIFAAKFIPVSHNLEK------ELIRKEIDIMNQ 161
           Y++L  IG G      V+  R + TG     + I    NLE         ++ E+ +   
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI----NLEACSNEMVTFLQGELHVSKL 82
Query: 162 LHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDY-KMSEAEVIPVTLPILMTQT 220
            +HP ++     F  D+E+ ++  F++ G   + I       M+E  +  +   +L    
Sbjct: 83  FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLK--- 139
Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNS-------TNVKMIDFGLATKLDPNEVVKIST 273
             A+ ++H    +H  VK  +I+             +N+ MI  G   ++  ++  K S 
Sbjct: 140 --ALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVV-HDFPKYSV 196
Query: 274 GTAEFAAPEIVEREPVGF--YTDMWAVGVLAYVLLSGLSPF----AGENDVETLKNVKAC 327
               + +PE++++   G+   +D+++VG+ A  L +G  PF    A +  +E L     C
Sbjct: 197 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 256

>pdb|2NZI|A Chain A, Crystal Structure Of Domains A168-A170 From Titin Length = 305

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/64 (39%), Positives = 33/64 (51%), Gaps = 5/64 (7%)
Query: 4   WIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDTFKKQIKKRQY 63
           W+RVG  R T   +  L     Y+FRV AEN +G S PS  S+      T  K+ K R  
Sbjct: 245 WLRVGQARETRYTVINLFGKTSYQFRVIAENKFGLSKPSEPSE-----PTITKEDKTRAM 299
Query: 64  DFDE 67
           ++DE
Sbjct: 300 NYDE 303

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/210 (21%), Positives = 88/210 (41%), Gaps = 24/210 (11%)
Query: 114 EEIGTGAFGVVHRCRERKTGNI-------FAAKFIPVSHNLEKELIRKEIDIMNQLHHPK 166
           E +G G F  + +   R+ G+           K +  +H    E   +   +M++L H  
Sbjct: 14  ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKH 226
           L+  +      DE +L+ EF+  G L        Y       I +   + + +   A  H
Sbjct: 74  LVLNYGVCVCGDENILVQEFVKFGSL------DTYLKKNKNCINILWKLEVAKQLAAAMH 127
Query: 227 MHEKN-IIHLDVKPENIMC------QTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFA 279
             E+N +IH +V  +NI+       +T N   +K+ D G++  + P ++++       + 
Sbjct: 128 FLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ---ERIPWV 184
Query: 280 APEIVER-EPVGFYTDMWAVGVLAYVLLSG 308
            PE +E  + +   TD W+ G   + + SG
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/223 (21%), Positives = 94/223 (42%), Gaps = 28/223 (12%)
Query: 107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQLHH 164
           ++  +I E IG G FG V+  R    G + A + I +  + E +L   ++E+    Q  H
Sbjct: 32  FEQLEIGELIGKGRFGQVYHGRWH--GEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRH 88
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
             ++    A      + +I     G  L+  +      +   +   +   I+       +
Sbjct: 89  ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIV-----KGM 143
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT------KLDPNEVVKISTGTAEF 278
            ++H K I+H D+K +N+     ++  V + DFGL +           + ++I  G    
Sbjct: 144 GYLHAKGILHKDLKSKNVFY---DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200
Query: 279 AAPEIV---------EREPVGFYTDMWAVGVLAYVLLSGLSPF 312
            APEI+         ++ P   ++D++A+G + Y L +   PF
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF 243

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/108 (26%), Positives = 51/108 (47%), Gaps = 15/108 (13%)
Query: 216 LMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKI---- 271
           +  Q + AV+ +H K ++H D+KP NI     +   VK+ DFGL T +D +E  +     
Sbjct: 169 IFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMDQDEEEQTVLTP 226
Query: 272 ---------STGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLS 310
                      GT  + +PE +         D++++G++ + LL   S
Sbjct: 227 MPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFS 274

>pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/114 (28%), Positives = 55/114 (48%), Gaps = 11/114 (9%)
Query: 212 TLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTN---VKMIDFGLATK-LDPNE 267
           T+ ++  Q    ++++H KN+I+ DVKPEN +   + +     + +IDFGLA + +DP  
Sbjct: 98  TVLMIAIQLLSRMEYVHSKNLIYRDVKPENFLIGRQGNKKEHVIHIIDFGLAKEYIDPET 157
Query: 268 VVKIS-------TGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAG 314
              I        TGTA + +      +      D+ A+G +    L G  P+ G
Sbjct: 158 KKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQG 211

>pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 57/114 (50%), Gaps = 11/114 (9%)
Query: 212 TLPILMTQTSPAVKHMHEKNIIHLDVKPEN-IMCQTRNSTN--VKMIDFGLATK-LDPNE 267
           T+ ++  Q    ++++H KN+I+ DVKPEN ++ +  N T   + +IDFGLA + +DP  
Sbjct: 106 TVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFGLAKEYIDPET 165
Query: 268 VVKIS-------TGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAG 314
              I        TGTA + +      +      D+ A+G +    L G  P+ G
Sbjct: 166 KKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQG 219

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/210 (21%), Positives = 88/210 (41%), Gaps = 24/210 (11%)
Query: 114 EEIGTGAFGVVHRCRERKTGNI-------FAAKFIPVSHNLEKELIRKEIDIMNQLHHPK 166
           E +G G F  + +   R+ G+           K +  +H    E   +   +M++L H  
Sbjct: 14  ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI-LMTQTSPAVK 225
           L+  +      DE +L+ EF+  G L        Y       I +   + +  Q + A+ 
Sbjct: 74  LVLNYGVCFCGDENILVQEFVKFGSL------DTYLKKNKNCINILWKLEVAKQLAWAMH 127
Query: 226 HMHEKNIIHLDVKPENIMC------QTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFA 279
            + E  +IH +V  +NI+       +T N   +K+ D G++  + P ++++       + 
Sbjct: 128 FLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ---ERIPWV 184
Query: 280 APEIVER-EPVGFYTDMWAVGVLAYVLLSG 308
            PE +E  + +   TD W+ G   + + SG
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/100 (27%), Positives = 53/100 (53%), Gaps = 6/100 (6%)
Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTG---T 275
           Q +  + ++ +  ++H D+   N++ ++ N  +VK+ DFGLA  LD +E    + G    
Sbjct: 127 QIAKGMSYLEDVRLVHRDLAARNVLVKSPN--HVKITDFGLARLLDIDETEYHADGGKVP 184
Query: 276 AEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG 314
            ++ A E + R      +D+W+ GV  + L++ G  P+ G
Sbjct: 185 IKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDG 224

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/214 (21%), Positives = 90/214 (42%), Gaps = 23/214 (10%)
Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPV--------SHNLEKELIRKEIDIMNQLHH 164
           L+ +G+G FG VH+      G       IPV        S     + +   +  +  L H
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIK---IPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDH 74
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
             ++ L         + L+ ++L  G L + +     +     + P  L     Q +  +
Sbjct: 75  AHIVRLL-GLCPGSSLQLVTQYLPLGSLLDHV-----RQHRGALGPQLLLNWGVQIAKGM 128
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
            ++ E  ++H ++   N++   ++ + V++ DFG+A  L P++   + +          +
Sbjct: 129 YYLEEHGMVHRNLAARNVLL--KSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 186
Query: 285 EREPVGFYT---DMWAVGVLAYVLLS-GLSPFAG 314
           E    G YT   D+W+ GV  + L++ G  P+AG
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAG 220

>pdb|3E7E|A Chain A, Structure And Substrate Recruitment Of The Human Spindle Checkpoint Kinase Bub Length = 365

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 37/141 (26%), Positives = 61/141 (43%), Gaps = 15/141 (10%)
Query: 181 VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI-LMTQTSPAVKHMHEKNIIHLDVKP 239
           VL+ E  S G L   I    YK +  +V+P  L I    +    ++ +H+  IIH D+KP
Sbjct: 143 VLVGELYSYGTLLNAINL--YKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKP 200
Query: 240 ENIMC---------QTRNSTNVKMIDFG--LATKLDP-NEVVKISTGTAEFAAPEIVERE 287
           +N +          +   S  + +ID G  +  KL P   +      T+ F   E++  +
Sbjct: 201 DNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK 260
Query: 288 PVGFYTDMWAVGVLAYVLLSG 308
           P  +  D + V    Y +L G
Sbjct: 261 PWNYQIDYFGVAATVYCMLFG 281

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/214 (21%), Positives = 90/214 (42%), Gaps = 23/214 (10%)
Query: 113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPV--------SHNLEKELIRKEIDIMNQLHH 164
           L+ +G+G FG VH+      G       IPV        S     + +   +  +  L H
Sbjct: 36  LKVLGSGVFGTVHKGVWIPEGESIK---IPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDH 92
Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
             ++ L         + L+ ++L  G L + +     +     + P  L     Q +  +
Sbjct: 93  AHIVRLL-GLCPGSSLQLVTQYLPLGSLLDHV-----RQHRGALGPQLLLNWGVQIAKGM 146
Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
            ++ E  ++H ++   N++   ++ + V++ DFG+A  L P++   + +          +
Sbjct: 147 YYLEEHGMVHRNLAARNVLL--KSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 204
Query: 285 EREPVGFYT---DMWAVGVLAYVLLS-GLSPFAG 314
           E    G YT   D+W+ GV  + L++ G  P+AG
Sbjct: 205 ESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAG 238

>pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 32/114 (28%), Positives = 55/114 (48%), Gaps = 11/114 (9%)
Query: 212 TLPILMTQTSPAVKHMHEKNIIHLDVKPENIMC---QTRNSTNVKMIDFGLATK-LDPNE 267
           T+ ++  Q    ++++H K++I+ DVKPEN +     T+    + +IDFGLA + +DP  
Sbjct: 101 TVLMIAIQLITRMEYVHTKSLIYRDVKPENFLVGRPGTKRQHAIHIIDFGLAKEYIDPET 160
Query: 268 VVKIS-------TGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAG 314
              I        TGTA + +      +      D+ A+G +    L G  P+ G
Sbjct: 161 KKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQG 214

>pdb|2LAV|A Chain A, Nmr Solution Structure Of Human Vaccinia-Related Kinase 1 Length = 361

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 37/152 (24%), Positives = 63/152 (41%), Gaps = 24/152 (15%)
Query: 169 NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH 228
            LHD        +++  F  G +L +   A   + S   V+ ++L IL       ++++H
Sbjct: 117 GLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSLRIL-----DILEYIH 169
Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVK--------ISTGTAEF-- 278
           E   +H D+K  N++   +N   V ++D+GLA +  P  V K           GT EF  
Sbjct: 170 EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKEYKEDPKRCHDGTIEFTS 229
Query: 279 -------AAPEIVEREPVGFYTDMWAVGVLAY 303
                  A     + E +G+    W  G L +
Sbjct: 230 IDAHNGVAPSRRGDLEILGYCMIQWLTGHLPW 261

>pdb|2KTY|A Chain A, Solution Structure Of Human Vaccinia Related Kinase-1 Length = 368

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 37/152 (24%), Positives = 63/152 (41%), Gaps = 24/152 (15%)
Query: 169 NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH 228
            LHD        +++  F  G +L +   A   + S   V+ ++L IL       ++++H
Sbjct: 117 GLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSLRIL-----DILEYIH 169
Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVK--------ISTGTAEF-- 278
           E   +H D+K  N++   +N   V ++D+GLA +  P  V K           GT EF  
Sbjct: 170 EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKEYKEDPKRCHDGTIEFTS 229
Query: 279 -------AAPEIVEREPVGFYTDMWAVGVLAY 303
                  A     + E +G+    W  G L +
Sbjct: 230 IDAHNGVAPSRRGDLEILGYCMIQWLTGHLPW 261

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	356
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-163
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-144
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-135
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-132
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-126
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-125
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-124
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-124
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-121
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-91
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	9e-90
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	5e-89
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	6e-89
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-87
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-86
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-85
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	5e-84
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	9e-84
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-83
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-83
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	7e-83
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-82
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-82
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	7e-82
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	7e-81
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-79
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	8e-79
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-78
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	5e-78
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-77
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-77
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	6e-76
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	5e-68
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	8e-67
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-63
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-62
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	6e-62
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-61
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	8e-61
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-59
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	8e-59
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	9e-59
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-58
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-57
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-56
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-56
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-54
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-54
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-54
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-53
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-53
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-53
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-53
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-53
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	6e-53
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	6e-51
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	9e-51
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	9e-51
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-50
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-49
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-49
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-49
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-49
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-48
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-48
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	7e-48
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-47
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	6e-47
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	9e-47
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-46
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-46
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-46
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-45
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-45
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-45
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-45
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-45
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-44
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-44
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-44
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-43
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-43
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-43
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-42
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-42
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-42
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-42
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-42
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	5e-42
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	6e-42
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	8e-42
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-41
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-41
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	6e-41
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-40
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	7e-40
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-39
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-38
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-38
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-38
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-38
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-38
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-37
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	9e-37
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-35
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-35
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	5e-35
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-35
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-34
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-34
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	5e-34
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-33
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-32
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-32
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-32
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	5e-32
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	6e-32
3an0_A	340	Dual specificity mitogen-activated protein kinase;	6e-32
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-31
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-31
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-30
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-30
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-30
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-30
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-30
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-29
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-29
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	5e-29
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	7e-29
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-28
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-28
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	5e-28
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-27
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-27
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-27
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-27
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	6e-27
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-26
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-26
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-26
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-26
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	6e-26
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-25
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-25
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	6e-25
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	7e-25
3uqc_A	286	Probable conserved transmembrane protein; structur	9e-25
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-24
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-23
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-22
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-22
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-22
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-22
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	9e-22
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-21
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-21
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-21
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	5e-21
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	5e-21
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	8e-21
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-20
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-20
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	6e-20
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-19
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-19
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-19
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-19
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-19
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	4e-19
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-19
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-19
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-19
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	7e-19
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	7e-19
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	8e-19
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-18
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-18
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-18
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-18
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	7e-18
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	8e-18
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	8e-18
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-17
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-17
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-17
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-17
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-17
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-17
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-17
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-17
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-17
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-17
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-17
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-17
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-17
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	5e-17
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	5e-17
2nzi_A	305	Titin; IG-domain, FNIII-domain, transferase; 2.90A	8e-17
1x5y_A	111	Myosin binding protein C, fast-type; fast MYBP-C,	1e-16
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-16
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-16
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-16
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-16
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-16
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-16
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-16
4aoj_A	329	High affinity nerve growth factor receptor; transf	7e-16
2yuw_A	110	Myosin binding protein C, SLOW type; fibronectin I	8e-16
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-15
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-15
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-15
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-15
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-15
1uem_A	117	KIAA1568 protein; immunoglobulin-like beta-sandwic	2e-15
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-15
2dju_A	106	Receptor-type tyrosine-protein phosphatase F; LAR	2e-15
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-15
1x3d_A	118	Fibronectin type-III domain containing protein 3A;	2e-15
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-15
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-15
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-15
1x4z_A	121	Biregional cell adhesion molecule-related/DOWN- re	5e-15
2crz_A	110	Fibronectin type-III domain containing protein 3A;	1e-14
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-14
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-14
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-14
1bpv_A	112	Titin, A71, connectin; fibronectin type III; NMR {	2e-14
3lpw_A	197	A77-A78 domain from titin; intracellular FNIII-tan	2e-14
3lpw_A	197	A77-A78 domain from titin; intracellular FNIII-tan	1e-11
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-14
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-14
1x5x_A	109	Fibronectin type-III domain containing protein 3A;	2e-14
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-14
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-14
1wis_A	124	KIAA1514 protein; FNIII domain, sidekick-2, struct	4e-14
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	7e-14
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	7e-14
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	8e-14
1uey_A	127	KIAA0343 protein; immunoglobulin-like beta-sandwic	9e-14
2crm_A	120	Fibronectin type-III domain containing protein 3A;	9e-14
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-13
1wf5_A	121	Sidekick 2 protein; FNIII domain, structural genom	1e-13
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-13
2yux_A	120	Myosin-binding protein C, SLOW-type; fibronectin I	2e-13
2db8_A	110	Tripartite motif protein 9, isoform 2; ring finger	2e-13
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-13
1wfu_A	120	Unnamed protein product; FN3 domain, similar to 17	3e-13
1zlg_A	680	Anosmin 1; insulin-like growth factor receptor Cys	1e-12
1zlg_A	680	Anosmin 1; insulin-like growth factor receptor Cys	6e-05
1zlg_A	680	Anosmin 1; insulin-like growth factor receptor Cys	2e-04
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-12
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	5e-12
2dmk_A	127	Midline 2 isoform 2; midline defect 2, tripartite	6e-12
3mtr_A	215	N-CAM-1, NCAM-1, neural cell adhesion molecule 1;	7e-12
2haz_A	105	N-CAM 1, neural cell adhesion molecule 1; fibronec	7e-12
1x4x_A	106	Fibronectin type-III domain containing protein 3A;	1e-11
2ic2_A	115	CG9211-PA, GH03927P; IHOG, hedgehog, fibronectin t	1e-11
2ibg_A	214	CG9211-PA, GH03927P; IHOG, fibronectin type III, p	1e-11
2ibg_A	214	CG9211-PA, GH03927P; IHOG, fibronectin type III, p	8e-10
2e3v_A	122	Neural cell adhesion molecule 1, 140 kDa isoform;	1e-11
1cfb_A	205	Drosophila neuroglian; neural adhesion molecule; H	1e-11
1cfb_A	205	Drosophila neuroglian; neural adhesion molecule; H	3e-06
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-11
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-11
2kbg_A	114	N-CAM 2, neural cell adhesion molecule 2; fibronec	5e-11
1x5f_A	120	Neogenin; RGM binding, fibronectin type III domain	9e-11
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-10
2jll_A	389	NCAM2, neural cell adhesion molecule 2; immunoglob	1e-09
2jll_A	389	NCAM2, neural cell adhesion molecule 2; immunoglob	4e-08
2vkw_A	209	Neural cell adhesion molecule 1,140 kDa isoform; a	3e-09
2vkw_A	209	Neural cell adhesion molecule 1,140 kDa isoform; a	2e-08
2ed7_A	119	Netrin receptor DCC; tumor suppressor protein DCC,	4e-09
3teu_A	98	Fibcon; FN3 domain, fibronectin TPYE III domain, c	5e-09
2yrz_A	118	Integrin beta-4; GP150, CD104 antigen, structural	7e-09
3tes_A	98	Tencon; fibronectin type III domain, FN3, consensu	2e-08
3b83_A	100	Ten-D3; beta sheet, computational redesigned prote	3e-08
1v5j_A	108	KIAA1355 protein, RSGI RUH-008; FN3 domain, human	3e-08
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-08
2h41_A	95	Fibronectin; beta sandwich, cell adhesion, structu	4e-08
2dn7_A	107	Receptor-type tyrosine-protein phosphatase F; LAR	5e-08
2edd_A	123	Netrin receptor DCC; tumor suppressor protein DCC,	7e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-08
1j8k_A	94	Fibronectin; EDA, TYPEIII domain, protein binding;	8e-08
2e7h_A	109	Ephrin type-B receptor 4; FN3 domain, tyrosine- pr	1e-07
3r8q_A	290	Fibronectin; heparin, FNIII, heparin binding, cell	2e-07
3r8q_A	290	Fibronectin; heparin, FNIII, heparin binding, cell	3e-07
3r8q_A	290	Fibronectin; heparin, FNIII, heparin binding, cell	6e-07
2ee3_A	108	Collagen alpha-1(XX) chain; KIAA1510, structural g	2e-07
2rb8_A	104	Tenascin; beta sheet,loop design, alternative spli	2e-07
1x5z_A	115	Receptor-type tyrosine-protein phosphatase delta;	2e-07
2cum_A	105	Tenascin-X; hexabrachion-like, fibronectin type II	2e-07
2ekj_A	105	Collagen alpha-1(XX) chain; KIAA1510, structural g	3e-07
2gee_A	203	Hypothetical protein; fibronectin, EIIIB, cancer,	3e-07
2gee_A	203	Hypothetical protein; fibronectin, EIIIB, cancer,	3e-06
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-07
1qr4_A	186	Protein (tenascin); fibronectin type-III, heparin,	4e-07
1qr4_A	186	Protein (tenascin); fibronectin type-III, heparin,	3e-06
2dkm_A	104	Collagen alpha-1(XX) chain; FN3 domain, KIAA1510,	6e-07
1x5g_A	116	Neogenin; RGM binding, fibronectin type III domain	7e-07
1tdq_A	283	Tenascin-R; extracellular matrix, lecticans, tenas	7e-07
1tdq_A	283	Tenascin-R; extracellular matrix, lecticans, tenas	7e-07
1tdq_A	283	Tenascin-R; extracellular matrix, lecticans, tenas	1e-06
3t1w_A	375	Four-domain fibronectin fragment; human fibronecti	7e-07
3t1w_A	375	Four-domain fibronectin fragment; human fibronecti	4e-06
3t1w_A	375	Four-domain fibronectin fragment; human fibronecti	5e-06
3t1w_A	375	Four-domain fibronectin fragment; human fibronecti	9e-06
1wk0_A	137	KIAA0970 protein; fibronectin type III domain, str	9e-07
1wfo_A	130	Sidekick 2; FN3, cell adhesion, structural genomic	1e-06
2ha1_A	201	Fibronectin; beta sandwich, protein-protein comple	1e-06
2ha1_A	201	Fibronectin; beta sandwich, protein-protein comple	4e-06
2cui_A	112	Tenascin-X; fibronectin type III domain, extracell	2e-06
3t04_D	103	Monobody 7C12; engineered binding protein, antibod	2e-06
3qht_C	97	Monobody YSMB-1; fibronectin type III, yeast small	2e-06
3fl7_A	536	Ephrin receptor; ATP-binding, kinase, nucleotide-b	3e-06
3fl7_A	536	Ephrin receptor; ATP-binding, kinase, nucleotide-b	1e-05
2ed8_A	106	Netrin receptor DCC; tumor suppressor protein DCC,	3e-06
1x5j_A	113	Neogenin; RGM binding, fibronectin type III domain	3e-06
2ocf_D	121	Fibronectin; estrogen receptor, LBD, monobody, est	4e-06
1fnf_A	368	Fibronectin; RGD, extracellular matrix, cell adhes	4e-06
1fnf_A	368	Fibronectin; RGD, extracellular matrix, cell adhes	8e-06
1fnf_A	368	Fibronectin; RGD, extracellular matrix, cell adhes	2e-05
1fnf_A	368	Fibronectin; RGD, extracellular matrix, cell adhes	4e-05
3l5h_A	589	Interleukin-6 receptor subunit beta; IG-like, FNII	4e-06
3l5h_A	589	Interleukin-6 receptor subunit beta; IG-like, FNII	2e-05
3l5h_A	589	Interleukin-6 receptor subunit beta; IG-like, FNII	2e-04
2w1n_A	238	O-GLCNACASE NAGJ; hexosaminidase, glycoside hydrol	4e-06
3f7q_A	234	Integrin beta-4, GP150; hemidesmosome, cell adhesi	5e-06
3f7q_A	234	Integrin beta-4, GP150; hemidesmosome, cell adhesi	7e-05
3k2m_C	101	Monobody HA4; engineered binding protein, antibody	5e-06
2cuh_A	115	Tenascin-X; fibronectin type III domain, extracell	5e-06
2dm4_A	108	Sortilin-related receptor; beta-sandwich, sorting	5e-06
2v5y_A	731	Receptor-type tyrosine-protein phosphatase MU; mem	9e-06
3l5i_A	290	Interleukin-6 receptor subunit beta; cytokine rece	1e-05
3l5i_A	290	Interleukin-6 receptor subunit beta; cytokine rece	2e-04
2edb_A	116	Netrin receptor DCC; tumor suppressor protein DCC,	2e-05
2ede_A	114	Netrin receptor DCC; tumor suppressor protein DCC,	2e-05
1x5l_A	111	Ephrin type-A receptor 8; FN3 domain, structural g	2e-05
1x5i_A	126	Neogenin; RGM binding, fibronectin type III domain	2e-05
3p4l_A	211	Neogenin; iron homeostasis, hemojuvelin receptor,	5e-05
3s98_A	306	Interferon alpha/beta receptor 1; human, type I in	5e-05
3mpc_A	103	FN3-like protein; fibronectin, FN(III), unknown fu	5e-05
1k85_A	88	Chitinase A1; fibronectin type III domain, chitin	9e-05
2djs_A	108	Ephrin type-B receptor 1; tyrosine-protein kinase	1e-04
1x5a_A	107	Ephrin type-A receptor 1; tyrosine-protein kinase	2e-04
1wfn_A	119	Sidekick 2; FN3, cell adhesion, structural genomic	2e-04
1ujt_A	120	KIAA1568 protein; fibronectin type III domain, str	6e-04

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  468 bits (1205), Expect = e-163
 Identities = 200/356 (56%), Positives = 250/356 (70%), Gaps = 8/356 (2%)

Query: 1   MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDTFKKQIKK 60
             SW     +R+T   I GL  G QYEFR+ AEN +G+S P   +  +      +K  ++
Sbjct: 53  GGSWSPCAKSRYTYTTIEGLRAGKQYEFRIIAENKHGQSKPCEPTAPVLIPGDERK--RR 110

Query: 61  RQYDFDETGKKIRGKADEKVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGA 120
           R YD DE GK +RGK     S+YD YVFDI+ +Y PQPV+IK   V DHYDI EE+GTGA
Sbjct: 111 RGYDVDEQGKIVRGKGTVS-SNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGA 169

Query: 121 FGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM 180
           FGVVHR  ER TGN FAAKF+   H  +KE +RKEI  M+ L HP L+NLHDAFEDD+EM
Sbjct: 170 FGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM 229

Query: 181 VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPE 240
           V+I+EF+SGGELFE++     KMSE E +       M Q    + HMHE N +HLD+KPE
Sbjct: 230 VMIYEFMSGGELFEKVADEHNKMSEDEAV-----EYMRQVCKGLCHMHENNYVHLDLKPE 284

Query: 241 NIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGV 300
           NIM  T+ S  +K+IDFGL   LDP + VK++TGTAEFAAPE+ E +PVG+YTDMW+VGV
Sbjct: 285 NIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGV 344

Query: 301 LAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE 356
           L+Y+LLSGLSPF GEND ETL+NVK+CDW  D+ AF  +SE+GKDFIR+LLL +  
Sbjct: 345 LSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPN 400

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  412 bits (1061), Expect = e-144
 Identities = 196/298 (65%), Positives = 240/298 (80%), Gaps = 6/298 (2%)

Query: 60  KRQYDFDETGKKIRGKADE-KVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGT 118
           +  +     G K+RGK D  K++DYD++  DI+ KYVPQPV++K  SVYD+YDILEE+G+
Sbjct: 2   RGSHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGS 61

Query: 119 GAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDD 178
           GAFGVVHRC E+ TG +F AKFI   + L+K  ++ EI IMNQLHHPKLINLHDAFED  
Sbjct: 62  GAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 121

Query: 179 EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVK 238
           EMVLI EFLSGGELF+RI A DYKMSEAEVI       M Q    +KHMHE +I+HLD+K
Sbjct: 122 EMVLILEFLSGGELFDRIAAEDYKMSEAEVI-----NYMRQACEGLKHMHEHSIVHLDIK 176

Query: 239 PENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAV 298
           PENIMC+T+ +++VK+IDFGLATKL+P+E+VK++T TAEFAAPEIV+REPVGFYTDMWA+
Sbjct: 177 PENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAI 236

Query: 299 GVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE 356
           GVL YVLLSGLSPFAGE+D+ETL+NVK CDWEFDE+AF +VS E KDFI+ LL +   
Sbjct: 237 GVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPR 294

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  389 bits (1002), Expect = e-135
 Identities = 128/327 (39%), Positives = 187/327 (57%), Gaps = 12/327 (3%)

Query: 37  GRSDPSTTSDLITTKDTFKKQIKKRQYDFDETGKKIRGKADEKVSDYDQYVFDIYSKYVP 96
           G    +      + K++  +  +    +  E            V         +     P
Sbjct: 11  GVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPP 70

Query: 97  QP-----VDIKTSSVYDHYDI--LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK 149
            P     V  K  +V   Y +   E +G G FG VH+C E  TG   AAK I      +K
Sbjct: 71  APFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK 130

Query: 150 ELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVI 209
           E ++ EI +MNQL H  LI L+DAFE  +++VL+ E++ GGELF+RI    Y ++E + I
Sbjct: 131 EEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTI 190

Query: 210 PVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVV 269
                + M Q    ++HMH+  I+HLD+KPENI+C  R++  +K+IDFGLA +  P E +
Sbjct: 191 -----LFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL 245

Query: 270 KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDW 329
           K++ GT EF APE+V  + V F TDMW+VGV+AY+LLSGLSPF G+ND ETL N+ AC W
Sbjct: 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRW 305

Query: 330 EFDEEAFKNVSEEGKDFIRRLLLRNKE 356
           + ++E F+++SEE K+FI +LL++ K 
Sbjct: 306 DLEDEEFQDISEEAKEFISKLLIKEKS 332

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  378 bits (973), Expect = e-132
 Identities = 98/251 (39%), Positives = 164/251 (65%), Gaps = 6/251 (2%)

Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHP 165
           +Y+ Y I E++G G FG+VHRC E  +   + AKF+ V    ++ L++KEI I+N   H 
Sbjct: 3   LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHR 61

Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            +++LH++FE  +E+V+IFEF+SG ++FERI    ++++E E++     +       A++
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE-----ALQ 116

Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
            +H  NI H D++PENI+ QTR S+ +K+I+FG A +L P +  ++     E+ APE+ +
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ 176

Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD 345
            + V   TDMW++G L YVLLSG++PF  E + + ++N+   ++ FDEEAFK +S E  D
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236

Query: 346 FIRRLLLRNKE 356
           F+ RLL++ ++
Sbjct: 237 FVDRLLVKERK 247

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  363 bits (933), Expect = e-126
 Identities = 111/264 (42%), Positives = 158/264 (59%), Gaps = 14/264 (5%)

Query: 101 IKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS------HNLEKELIRK 154
            K   V D YDI EE+G+G F +V +CRE+ TG  +AAKFI           + +E I +
Sbjct: 5   FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIER 64

Query: 155 EIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLP 214
           E+ I+ Q+ H  +I LHD +E+  ++VLI E +SGGELF+ +   +  +SE E       
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES-LSEEEAT----- 118

Query: 215 ILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTR--NSTNVKMIDFGLATKLDPNEVVKIS 272
             + Q    V ++H K I H D+KPENIM   +     ++K+IDFGLA +++     K  
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178

Query: 273 TGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD 332
            GT EF APEIV  EP+G   DMW++GV+ Y+LLSG SPF G+   ETL N+ +  ++FD
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD 238

Query: 333 EEAFKNVSEEGKDFIRRLLLRNKE 356
           EE F + SE  KDFIR+LL++   
Sbjct: 239 EEFFSHTSELAKDFIRKLLVKETR 262

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  362 bits (931), Expect = e-125
 Identities = 113/264 (42%), Positives = 158/264 (59%), Gaps = 14/264 (5%)

Query: 101 IKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS------HNLEKELIRK 154
            K   V D YDI EE+G+G F +V +CRE+ TG  +AAKFI           + +E I +
Sbjct: 5   FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIER 64

Query: 155 EIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLP 214
           E+ I+ Q+ HP +I LHD +E+  ++VLI E +SGGELF+ +   +  +SE E       
Sbjct: 65  EVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES-LSEEEAT----- 118

Query: 215 ILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTR--NSTNVKMIDFGLATKLDPNEVVKIS 272
             + Q    V ++H K I H D+KPENIM   +     ++K+IDFGLA +++     K  
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178

Query: 273 TGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD 332
            GT EF APEIV  EP+G   DMW++GV+ Y+LLSG SPF G+   ETL N+ A  ++FD
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD 238

Query: 333 EEAFKNVSEEGKDFIRRLLLRNKE 356
           EE F   SE  KDFIR+LL++   
Sbjct: 239 EEFFSQTSELAKDFIRKLLVKETR 262

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  358 bits (922), Expect = e-124
 Identities = 115/261 (44%), Positives = 164/261 (62%), Gaps = 14/261 (5%)

Query: 104 SSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP------VSHNLEKELIRKEID 157
           S V DHY++ EE+G+G F +V +CR++ TG  +AAKFI           + +E I +E++
Sbjct: 1   SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60

Query: 158 IMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM 217
           I+ ++ HP +I LHD FE+  ++VLI E +SGGELF+ +      ++E E       IL 
Sbjct: 61  ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE-KESLTEDEATQFLKQILD 119

Query: 218 TQTSPAVKHMHEKNIIHLDVKPENIMCQTRN--STNVKMIDFGLATKLDPNEVVKISTGT 275
                 V ++H K I H D+KPENIM   +N  +  +K+IDFG+A K++     K   GT
Sbjct: 120 -----GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGT 174

Query: 276 AEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEA 335
            EF APEIV  EP+G   DMW++GV+ Y+LLSG SPF GE   ETL N+ A +++FDEE 
Sbjct: 175 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEY 234

Query: 336 FKNVSEEGKDFIRRLLLRNKE 356
           F N SE  KDFIRRLL+++ +
Sbjct: 235 FSNTSELAKDFIRRLLVKDPK 255

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  358 bits (921), Expect = e-124
 Identities = 112/264 (42%), Positives = 160/264 (60%), Gaps = 14/264 (5%)

Query: 101 IKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS------HNLEKELIRK 154
            +  +V D+YD  EE+G+G F VV +CRE+ TG  +AAKFI           + +E I +
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63

Query: 155 EIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLP 214
           E+ I+ ++ HP +I LH+ +E+  +++LI E ++GGELF+ +      ++E E       
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQ 122

Query: 215 ILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN--STNVKMIDFGLATKLDPNEVVKIS 272
           IL       V ++H   I H D+KPENIM   RN     +K+IDFGLA K+D     K  
Sbjct: 123 ILN-----GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177

Query: 273 TGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD 332
            GT EF APEIV  EP+G   DMW++GV+ Y+LLSG SPF G+   ETL NV A ++EF+
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 237

Query: 333 EEAFKNVSEEGKDFIRRLLLRNKE 356
           +E F N S   KDFIRRLL+++ +
Sbjct: 238 DEYFSNTSALAKDFIRRLLVKDPK 261

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  351 bits (903), Expect = e-121
 Identities = 90/261 (34%), Positives = 153/261 (58%), Gaps = 11/261 (4%)

Query: 102 KTSSVYDHYDIL-EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDI 158
              +  + Y +  +E+G G F VV +C  + TG  +AAKF+         +  I  EI +
Sbjct: 22  SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAV 81

Query: 159 MNQL-HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK-MSEAEVIPVTLPIL 216
           +      P++INLH+ +E+  E++LI E+ +GGE+F        + +SE +VI      L
Sbjct: 82  LELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVI-----RL 136

Query: 217 MTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNST-NVKMIDFGLATKLDPNEVVKISTGT 275
           + Q    V ++H+ NI+HLD+KP+NI+  +     ++K++DFG++ K+     ++   GT
Sbjct: 137 IKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGT 196

Query: 276 AEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEA 335
            E+ APEI+  +P+   TDMW +G++AY+LL+  SPF GE++ ET  N+   + ++ EE 
Sbjct: 197 PEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEET 256

Query: 336 FKNVSEEGKDFIRRLLLRNKE 356
           F +VS+   DFI+ LL++N E
Sbjct: 257 FSSVSQLATDFIQSLLVKNPE 277

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  276 bits (707), Expect = 3e-91
 Identities = 86/263 (32%), Positives = 136/263 (51%), Gaps = 16/263 (6%)

Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS-----HNLEKELIRKEI 156
                 D Y++ E IG G F VV RC  R+TG  FA K + V+       L  E +++E 
Sbjct: 18  DDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREA 77

Query: 157 DIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITA---PDYKMSEAEVIPVTL 213
            I + L HP ++ L + +  D  + ++FEF+ G +L   I       +  SEA       
Sbjct: 78  SICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVAS---- 133

Query: 214 PILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTR-NSTNVKMIDFGLATKL-DPNEVVKI 271
              M Q   A+++ H+ NIIH DVKP  ++  ++ NS  VK+  FG+A +L +   V   
Sbjct: 134 -HYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG 192

Query: 272 STGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEF 331
             GT  F APE+V+REP G   D+W  GV+ ++LLSG  PF G  +    + +    ++ 
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGKYKM 251

Query: 332 DEEAFKNVSEEGKDFIRRLLLRN 354
           +   + ++SE  KD +RR+L+ +
Sbjct: 252 NPRQWSHISESAKDLVRRMLMLD 274

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  270 bits (692), Expect = 9e-90
 Identities = 81/264 (30%), Positives = 136/264 (51%), Gaps = 12/264 (4%)

Query: 96  PQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE-KELIRK 154
            +       ++ D +    ++G+GAFG VH   ER +G     K I    +    E I  
Sbjct: 10  GRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEA 69

Query: 155 EIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKM---SEAEVIPV 211
           EI+++  L HP +I + + FED   M ++ E   GGEL ERI +   +    SE  V   
Sbjct: 70  EIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVA-- 127

Query: 212 TLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN-STNVKMIDFGLATKLDPNEVVK 270
               LM Q   A+ + H ++++H D+KPENI+ Q  +  + +K+IDFGLA     +E   
Sbjct: 128 ---ELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHST 184

Query: 271 ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWE 330
            + GTA + APE+ +R+ V F  D+W+ GV+ Y LL+G  PF G +  E  +     +  
Sbjct: 185 NAAGTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPN 243

Query: 331 FDEEAFKNVSEEGKDFIRRLLLRN 354
           +  E  + ++ +  D ++++L ++
Sbjct: 244 YAVE-CRPLTPQAVDLLKQMLTKD 266

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  268 bits (687), Expect = 5e-89
 Identities = 82/255 (32%), Positives = 140/255 (54%), Gaps = 9/255 (3%)

Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMN 160
           ++   D+YD+ EE+G GAF VV RC  + TG  FAAK I        + + + +E  I  
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
           +L HP ++ LHD+ +++    L+F+ ++GGELFE I A ++  SEA+         + Q 
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF-YSEADA-----SHCIQQI 114

Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTR-NSTNVKMIDFGLATKLDPNEVVKISTGTAEFA 279
             ++ + H   I+H ++KPEN++  ++     VK+ DFGLA +++ +E      GT  + 
Sbjct: 115 LESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYL 174

Query: 280 APEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNV 339
           +PE+++++P     D+WA GV+ Y+LL G  PF  E+       +KA  +++    +  V
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTV 234

Query: 340 SEEGKDFIRRLLLRN 354
           + E K  I  +L  N
Sbjct: 235 TPEAKSLIDSMLTVN 249

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  270 bits (693), Expect = 6e-89
 Identities = 82/256 (32%), Positives = 140/256 (54%), Gaps = 9/256 (3%)

Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIM 159
            ++   D+YD+ EE+G GAF VV RC  + TG  FAAK I        + + + +E  I 
Sbjct: 23  ASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARIC 82

Query: 160 NQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQ 219
            +L HP ++ LHD+ +++    L+F+ ++GGELFE I A ++  SEA+         + Q
Sbjct: 83  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF-YSEADAS-----HCIQQ 136

Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTR-NSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
              ++ + H   I+H ++KPEN++  ++     VK+ DFGLA +++ +E      GT  +
Sbjct: 137 ILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY 196

Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKN 338
            +PE+++++P     D+WA GV+ Y+LL G  PF  E+       +KA  +++    +  
Sbjct: 197 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDT 256

Query: 339 VSEEGKDFIRRLLLRN 354
           V+ E K  I  +L  N
Sbjct: 257 VTPEAKSLIDSMLTVN 272

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  266 bits (682), Expect = 2e-87
 Identities = 77/299 (25%), Positives = 127/299 (42%), Gaps = 46/299 (15%)

Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS-----HNLEKELIRKEI 156
               +   Y +   IG G++GVV    E +T  I A K +  +     +  + E I+ E+
Sbjct: 20  SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEV 79

Query: 157 DIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI- 215
            +M +LHHP +  L++ +ED+  + L+ E   GG L +++       +    + V     
Sbjct: 80  RLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQI 139

Query: 216 ---------------------------------LMTQTSPAVKHMHEKNIIHLDVKPENI 242
                                            +M Q   A+ ++H + I H D+KPEN 
Sbjct: 140 CPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENF 199

Query: 243 MCQTRNSTNVKMIDFGLATKLDPNEVVKIST-----GTAEFAAPEIVE--REPVGFYTDM 295
           +  T  S  +K++DFGL+ +       +        GT  F APE++    E  G   D 
Sbjct: 200 LFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259

Query: 296 WAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
           W+ GVL ++LL G  PF G ND +T+  V      F+   +  +S   +D +  LL RN
Sbjct: 260 WSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRN 318

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  262 bits (672), Expect = 1e-86
 Identities = 80/255 (31%), Positives = 142/255 (55%), Gaps = 8/255 (3%)

Query: 101 IKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMN 160
           ++T+++   +  +E +G+GAF  V   ++R TG +FA K I  S       +  EI ++ 
Sbjct: 2   MQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLK 61

Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
           ++ H  ++ L D +E      L+ + +SGGELF+RI       +E +   V   +L    
Sbjct: 62  KIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGV-YTEKDASLVIQQVLS--- 117

Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNS-TNVKMIDFGLATKLDPNEVVKISTGTAEFA 279
             AVK++HE  I+H D+KPEN++  T    + + + DFGL+ K++ N ++  + GT  + 
Sbjct: 118 --AVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLS-KMEQNGIMSTACGTPGYV 174

Query: 280 APEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNV 339
           APE++ ++P     D W++GV+ Y+LL G  PF  E + +  + +K   +EF+   + ++
Sbjct: 175 APEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDI 234

Query: 340 SEEGKDFIRRLLLRN 354
           SE  KDFI  LL ++
Sbjct: 235 SESAKDFICHLLEKD 249

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  259 bits (664), Expect = 1e-85
 Identities = 82/257 (31%), Positives = 138/257 (53%), Gaps = 14/257 (5%)

Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQ 161
               +  +Y +   IG G++G V    ++ T    AAK IP     + +  ++EI+IM  
Sbjct: 3   TKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKS 62

Query: 162 LHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTS 221
           L HP +I L++ FED+ ++ L+ E  +GGELFER+        E++        +M    
Sbjct: 63  LDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRV-FRESDA-----ARIMKDVL 116

Query: 222 PAVKHMHEKNIIHLDVKPENIMCQTRNS-TNVKMIDFGLATKLDPNEVVKISTGTAEFAA 280
            AV + H+ N+ H D+KPEN +  T +  + +K+IDFGLA +  P ++++   GT  + +
Sbjct: 117 SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVS 176

Query: 281 PEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
           P+++E      Y    D W+ GV+ YVLL G  PF+   D E +  ++   + F E+ + 
Sbjct: 177 PQVLEGL----YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWL 232

Query: 338 NVSEEGKDFIRRLLLRN 354
           NVS + +  IRRLL ++
Sbjct: 233 NVSPQAESLIRRLLTKS 249

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  255 bits (654), Expect = 5e-84
 Identities = 83/259 (32%), Positives = 145/259 (55%), Gaps = 16/259 (6%)

Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS--HNLEKELIRKEIDIM 159
              +  + Y+I+  +G G+FG V +C++R T   +A K I  +   N +   I +E++++
Sbjct: 16  FQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELL 75

Query: 160 NQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQ 219
            +L HP ++ L +  ED     ++ E  +GGELF+ I       SE +        ++ Q
Sbjct: 76  KKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDA-----ARIIKQ 129

Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRN-STNVKMIDFGLATKLDPNEVVKISTGTAEF 278
               + +MH+ NI+H D+KPENI+ +++    ++K+IDFGL+T    N  +K   GTA +
Sbjct: 130 VFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYY 189

Query: 279 AAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEA 335
            APE++       Y    D+W+ GV+ Y+LLSG  PF G+N+ + LK V+   + FD   
Sbjct: 190 IAPEVLRGT----YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQ 245

Query: 336 FKNVSEEGKDFIRRLLLRN 354
           ++ +S++ KD IR++L  +
Sbjct: 246 WRTISDDAKDLIRKMLTFH 264

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  256 bits (657), Expect = 9e-84
 Identities = 83/255 (32%), Positives = 142/255 (55%), Gaps = 10/255 (3%)

Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQ 161
              ++ D +++  E+G GA  +V+RC+++ T   +A K +  +  ++K+++R EI ++ +
Sbjct: 47  NRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLR 104

Query: 162 LHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTS 221
           L HP +I L + FE   E+ L+ E ++GGELF+RI    Y  SE +       IL     
Sbjct: 105 LSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGY-YSERDAADAVKQILE---- 159

Query: 222 PAVKHMHEKNIIHLDVKPENIMCQTRNS-TNVKMIDFGLATKLDPNEVVKISTGTAEFAA 280
            AV ++HE  I+H D+KPEN++  T      +K+ DFGL+  ++   ++K   GT  + A
Sbjct: 160 -AVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCA 218

Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGE-NDVETLKNVKACDWEFDEEAFKNV 339
           PEI+     G   DMW+VG++ Y+LL G  PF  E  D    + +  C++ F    +  V
Sbjct: 219 PEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEV 278

Query: 340 SEEGKDFIRRLLLRN 354
           S   KD +R+L++ +
Sbjct: 279 SLNAKDLVRKLIVLD 293

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  260 bits (665), Expect = 3e-83
 Identities = 87/260 (33%), Positives = 144/260 (55%), Gaps = 11/260 (4%)

Query: 99  VDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP---VSHNLEKELIRKE 155
           V   T+   D Y     +G G+FG V  C+++ TG   A K I    V    +KE + +E
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76

Query: 156 IDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI 215
           + ++ QL HP ++ L++ FED     L+ E  +GGELF+ I +     SE +   +   +
Sbjct: 77  VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR-FSEVDAARIIRQV 135

Query: 216 LMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNS-TNVKMIDFGLATKLDPNEVVKISTG 274
           L       + +MH+  I+H D+KPEN++ ++++   N+++IDFGL+T  + ++ +K   G
Sbjct: 136 LS-----GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIG 190

Query: 275 TAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEE 334
           TA + APE++         D+W+ GV+ Y+LLSG  PF G N+ + LK V+   + F+  
Sbjct: 191 TAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELP 249

Query: 335 AFKNVSEEGKDFIRRLLLRN 354
            +K VSE  KD IR++L   
Sbjct: 250 QWKKVSESAKDLIRKMLTYV 269

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  258 bits (662), Expect = 3e-83
 Identities = 84/258 (32%), Positives = 137/258 (53%), Gaps = 10/258 (3%)

Query: 101 IKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDI 158
           I  +   + Y + EE+G GAF VV RC +   G  +AA  I        + + + +E  I
Sbjct: 4   ITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARI 63

Query: 159 MNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
              L HP ++ LHD+  ++    LIF+ ++GGELFE I A +Y  SEA+         + 
Sbjct: 64  CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY-YSEADAS-----HCIQ 117

Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTR-NSTNVKMIDFGLATKLD-PNEVVKISTGTA 276
           Q   AV H H+  ++H ++KPEN++  ++     VK+ DFGLA +++   +      GT 
Sbjct: 118 QILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTP 177

Query: 277 EFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAF 336
            + +PE++ ++P G   D+WA GV+ Y+LL G  PF  E+     + +KA  ++F    +
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEW 237

Query: 337 KNVSEEGKDFIRRLLLRN 354
             V+ E KD I ++L  N
Sbjct: 238 DTVTPEAKDLINKMLTIN 255

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  259 bits (663), Expect = 7e-83
 Identities = 80/256 (31%), Positives = 142/256 (55%), Gaps = 10/256 (3%)

Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIM 159
           K   + + Y  ++++G+GA+G V  CR++ T    A K I  +         + +E+ ++
Sbjct: 31  KKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVL 90

Query: 160 NQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQ 219
             L HP ++ L+D FED     L+ E   GGELF+ I     K +E +   +   +L   
Sbjct: 91  KLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH-RMKFNEVDAAVIIKQVLS-- 147

Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNST-NVKMIDFGLATKLDPNEVVKISTGTAEF 278
               V ++H+ NI+H D+KPEN++ +++     +K++DFGL+   +  + +K   GTA +
Sbjct: 148 ---GVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYY 204

Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKN 338
            APE++ +       D+W++GV+ ++LL+G  PF G+ D E L+ V+   + FD   +KN
Sbjct: 205 IAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKN 263

Query: 339 VSEEGKDFIRRLLLRN 354
           VSE  KD I+++L  +
Sbjct: 264 VSEGAKDLIKQMLQFD 279

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  258 bits (660), Expect = 2e-82
 Identities = 82/259 (31%), Positives = 144/259 (55%), Gaps = 16/259 (6%)

Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIM 159
              +  + Y+I+  +G G+FG V +C++R T   +A K I  +   N +   I +E++++
Sbjct: 16  FQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELL 75

Query: 160 NQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQ 219
            +L HP ++ L +  ED     ++ E  +GGELF+ I       SE +   +   +    
Sbjct: 76  KKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFS-- 132

Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNST-NVKMIDFGLATKLDPNEVVKISTGTAEF 278
               + +MH+ NI+H D+KPENI+ +++    ++K+IDFGL+T    N  +K   GTA +
Sbjct: 133 ---GITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYY 189

Query: 279 AAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEA 335
            APE++       Y    D+W+ GV+ Y+LLSG  PF G+N+ + LK V+   + FD   
Sbjct: 190 IAPEVLRGT----YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQ 245

Query: 336 FKNVSEEGKDFIRRLLLRN 354
           ++ +S++ KD IR++L  +
Sbjct: 246 WRTISDDAKDLIRKMLTFH 264

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  252 bits (645), Expect = 5e-82
 Identities = 75/260 (28%), Positives = 134/260 (51%), Gaps = 17/260 (6%)

Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQ 161
            +    D Y++ E+IG G++ V  RC  + T   FA K I  S    K    +EI+I+ +
Sbjct: 16  NSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKS----KRDPTEEIEILLR 71

Query: 162 L-HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
              HP +I L D ++D   + ++ E + GGEL ++I    +  SE E        ++   
Sbjct: 72  YGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF-FSEREA-----SAVLFTI 125

Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTR--NSTNVKMIDFGLATKLDP-NEVVKISTGTAE 277
           +  V+++H + ++H D+KP NI+      N  ++++ DFG A +L   N ++     TA 
Sbjct: 126 TKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTAN 185

Query: 278 FAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAG---ENDVETLKNVKACDWEFDEE 334
           F APE++ER+      D+W++GVL Y +L+G +PFA    +   E L  + +  +     
Sbjct: 186 FVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGG 245

Query: 335 AFKNVSEEGKDFIRRLLLRN 354
            + +VS+  KD + ++L  +
Sbjct: 246 YWNSVSDTAKDLVSKMLHVD 265

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  250 bits (640), Expect = 7e-82
 Identities = 82/273 (30%), Positives = 135/273 (49%), Gaps = 24/273 (8%)

Query: 98  PVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE--------- 148
           P    T   Y++Y+  E +G G   VV RC  + T   +A K I V+             
Sbjct: 7   PGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQEL 66

Query: 149 KELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAE 207
           +E   KE+DI+ ++  HP +I L D +E +    L+F+ +  GELF+ +T     +SE E
Sbjct: 67  REATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKE 125

Query: 208 VIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE 267
                   +M      +  +H+ NI+H D+KPENI+    +  N+K+ DFG + +LDP E
Sbjct: 126 T-----RKIMRALLEVICALHKLNIVHRDLKPENILLD--DDMNIKLTDFGFSCQLDPGE 178

Query: 268 VVKISTGTAEFAAPEIVEREPVGFYT------DMWAVGVLAYVLLSGLSPFAGENDVETL 321
            ++   GT  + APEI+E      +       DMW+ GV+ Y LL+G  PF     +  L
Sbjct: 179 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 238

Query: 322 KNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
           + + + +++F    + + S+  KD + R L+  
Sbjct: 239 RMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQ 271

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  254 bits (651), Expect = 7e-81
 Identities = 87/270 (32%), Positives = 144/270 (53%), Gaps = 21/270 (7%)

Query: 99  VDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP-------------VSH 145
           V  K   + + Y  + ++G+GA+G V  C+E+   +  A K I               + 
Sbjct: 27  VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86

Query: 146 NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSE 205
               E I  EI ++  L HP +I L D FED     L+ EF  GGELFE+I        E
Sbjct: 87  EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK-FDE 145

Query: 206 AEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNS-TNVKMIDFGLATKLD 264
            +   +   IL       + ++H+ NI+H D+KPENI+ + +NS  N+K++DFGL++   
Sbjct: 146 CDAANIMKQILS-----GICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS 200

Query: 265 PNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV 324
            +  ++   GTA + APE+++++      D+W+ GV+ Y+LL G  PF G+ND + +K V
Sbjct: 201 KDYKLRDRLGTAYYIAPEVLKKK-YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV 259

Query: 325 KACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
           +   + FD   +KN+S+E K+ I+ +L  +
Sbjct: 260 EKGKYYFDFNDWKNISDEAKELIKLMLTYD 289

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  244 bits (626), Expect = 2e-79
 Identities = 93/267 (34%), Positives = 141/267 (52%), Gaps = 22/267 (8%)

Query: 101 IKTSSVYDHYDIL---EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID 157
           +K S  Y HYD+    + +G G+F +  +C  +K+   FA K I       +   +KEI 
Sbjct: 1   MKDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEIT 57

Query: 158 IMNQL-HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPIL 216
            +     HP ++ LH+ F D     L+ E L+GGELFERI    +  SE E        +
Sbjct: 58  ALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKH-FSETEA-----SYI 111

Query: 217 MTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNST-NVKMIDFGLATKLDP-NEVVKISTG 274
           M +   AV HMH+  ++H D+KPEN++    N    +K+IDFG A    P N+ +K    
Sbjct: 112 MRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF 171

Query: 275 TAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEND-------VETLKNVKAC 327
           T  +AAPE++ +       D+W++GV+ Y +LSG  PF   +        VE +K +K  
Sbjct: 172 TLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG 231

Query: 328 DWEFDEEAFKNVSEEGKDFIRRLLLRN 354
           D+ F+ EA+KNVS+E KD I+ LL  +
Sbjct: 232 DFSFEGEAWKNVSQEAKDLIQGLLTVD 258

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  245 bits (626), Expect = 8e-79
 Identities = 88/332 (26%), Positives = 144/332 (43%), Gaps = 23/332 (6%)

Query: 38  RSDPSTTSDLITTKDTFKKQIKKRQYDFDETGKKIRGKADEKVSDYDQYVFDIYSKYVPQ 97
           R      +     +  F + ++           + +   D +    +   F         
Sbjct: 24  REIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDEL 83

Query: 98  PVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS--------HNLEK 149
           P        Y  YD  + IG G   VV RC  R TG+ FA K + V+            +
Sbjct: 84  PDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVR 143

Query: 150 ELIRKEIDIMNQLH-HPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEV 208
           E  R+E  I+ Q+  HP +I L D++E    M L+F+ +  GELF+ +T     +SE E 
Sbjct: 144 EATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV-ALSEKET 202

Query: 209 IPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEV 268
                  +M     AV  +H  NI+H D+KPENI+    ++  +++ DFG +  L+P E 
Sbjct: 203 -----RSIMRSLLEAVSFLHANNIVHRDLKPENILLD--DNMQIRLSDFGFSCHLEPGEK 255

Query: 269 VKISTGTAEFAAPEIVEREPVGFYT------DMWAVGVLAYVLLSGLSPFAGENDVETLK 322
           ++   GT  + APEI++      +       D+WA GV+ + LL+G  PF     +  L+
Sbjct: 256 LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLR 315

Query: 323 NVKACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
            +    ++F    + + S   KD I RLL  +
Sbjct: 316 MIMEGQYQFSSPEWDDRSSTVKDLISRLLQVD 347

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  241 bits (617), Expect = 4e-78
 Identities = 78/286 (27%), Positives = 133/286 (46%), Gaps = 37/286 (12%)

Query: 100 DIKTSSVYDHYDILEE-IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDI 158
           D  +    D Y + E+ +G GA   V  C    T   +A K I       +  + +E+++
Sbjct: 4   DSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEM 63

Query: 159 MNQL-HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM 217
           + Q   H  ++ L + FE++D   L+FE + GG +   I    +  +E E   V   +  
Sbjct: 64  LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRH-FNELEASVVVQDVAS 122

Query: 218 TQTSPAVKHMHEKNIIHLDVKPENIMCQTRNS-TNVKMIDFGLATKLDPNEVVKIST--- 273
                A+  +H K I H D+KPENI+C+  N  + VK+ DF L + +  N      +   
Sbjct: 123 -----ALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177

Query: 274 -----GTAEFAAPEIVEREPVGF--YT---DMWAVGVLAYVLLSGLSPFAGENDVET--- 320
                G+AE+ APE+VE        Y    D+W++GV+ Y+LLSG  PF G    +    
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD 237

Query: 321 ------------LKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
                        ++++   +EF ++ + ++S   KD I +LL+R+
Sbjct: 238 RGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRD 283

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  241 bits (618), Expect = 5e-78
 Identities = 77/275 (28%), Positives = 124/275 (45%), Gaps = 23/275 (8%)

Query: 92  SKYVPQPVDIKTSSVYDHYDILEE-IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE 150
            + + Q  + K  +V D Y + ++ +G G  G V  C  R+TG   A K +      +  
Sbjct: 12  LEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY-----DSP 66

Query: 151 LIRKEIDIMNQL-HHPKLINLHDAFEDDDEMV----LIFEFLSGGELFERITA-PDYKMS 204
             R+E+D   Q    P ++ + D +E+         +I E + GGELF RI    D   +
Sbjct: 67  KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFT 126

Query: 205 EAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN-STNVKMIDFGLATKL 263
           E E        +M     A++ +H  NI H DVKPEN++  ++     +K+ DFG A + 
Sbjct: 127 EREA-----AEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181

Query: 264 DPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVET--- 320
             N +      T  + APE++  E      DMW++GV+ Y+LL G  PF           
Sbjct: 182 TQNALQTP-CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG 240

Query: 321 -LKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
             + ++   + F    +  VSE+ K  IR LL  +
Sbjct: 241 MKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTD 275

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  243 bits (621), Expect = 1e-77
 Identities = 73/268 (27%), Positives = 128/268 (47%), Gaps = 22/268 (8%)

Query: 99  VDIKTSSVYDHYDIL-EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID 157
           + IK +++ D Y +  + +G G  G V +   ++T   FA K +      +    R+E++
Sbjct: 52  LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVE 106

Query: 158 IMNQL-HHPKLINLHDAFED----DDEMVLIFEFLSGGELFERITA-PDYKMSEAEVIPV 211
           +  +    P ++ + D +E+       ++++ E L GGELF RI    D   +E E   +
Sbjct: 107 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 166

Query: 212 TLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN-STNVKMIDFGLATKLDPNEVVK 270
              I       A++++H  NI H DVKPEN++  ++  +  +K+ DFG A +   +  + 
Sbjct: 167 MKSIGE-----AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 221

Query: 271 ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVET----LKNVKA 326
               T  + APE++  E      DMW++GV+ Y+LL G  PF   + +         ++ 
Sbjct: 222 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 281

Query: 327 CDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
             +EF    +  VSEE K  IR LL   
Sbjct: 282 GQYEFPNPEWSEVSEEVKMLIRNLLKTE 309

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  242 bits (620), Expect = 3e-77
 Identities = 75/288 (26%), Positives = 140/288 (48%), Gaps = 21/288 (7%)

Query: 80  VSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAK 139
           +S     VF ++         +   ++ D Y + + +G+GA G V    ERKT    A +
Sbjct: 108 LSLSRNKVF-VFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIR 166

Query: 140 FIP--------VSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGE 191
            I                  +  EI+I+ +L+HP +I + + F+ +D   ++ E + GGE
Sbjct: 167 IISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGE 225

Query: 192 LFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTR-NST 250
           LF+++     ++ EA        +L+     AV+++HE  IIH D+KPEN++  ++    
Sbjct: 226 LFDKVVGNK-RLKEATCKLYFYQMLL-----AVQYLHENGIIHRDLKPENVLLSSQEEDC 279

Query: 251 NVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYT---DMWAVGVLAYVLLS 307
            +K+ DFG +  L    +++   GT  + APE++       Y    D W++GV+ ++ LS
Sbjct: 280 LIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 339

Query: 308 GLSPFAGENDVETL-KNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
           G  PF+      +L   + +  + F  E +  VSE+  D +++LL+ +
Sbjct: 340 GYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVD 387

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  236 bits (603), Expect = 6e-76
 Identities = 73/267 (27%), Positives = 133/267 (49%), Gaps = 20/267 (7%)

Query: 101 IKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP--------VSHNLEKELI 152
           +   ++ D Y + + +G+GA G V    ERKT    A K I                  +
Sbjct: 3   VYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNV 62

Query: 153 RKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVT 212
             EI+I+ +L+HP +I + + F+ +D   ++ E + GGELF+++     ++ EA      
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNK-RLKEATC---- 116

Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTR-NSTNVKMIDFGLATKLDPNEVVKI 271
             +   Q   AV+++HE  IIH D+KPEN++  ++     +K+ DFG +  L    +++ 
Sbjct: 117 -KLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT 175

Query: 272 STGTAEFAAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL-KNVKAC 327
             GT  + APE++       Y    D W++GV+ ++ LSG  PF+      +L   + + 
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 235

Query: 328 DWEFDEEAFKNVSEEGKDFIRRLLLRN 354
            + F  E +  VSE+  D +++LL+ +
Sbjct: 236 KYNFIPEVWAEVSEKALDLVKKLLVVD 262

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  214 bits (548), Expect = 5e-68
 Identities = 71/272 (26%), Positives = 120/272 (44%), Gaps = 43/272 (15%)

Query: 95  VPQPVDIKTSSVYDHYDIL-EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR 153
           V   + IK +++ D Y +  + +G G  G V +   ++T   FA K +      +    R
Sbjct: 4   VKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKAR 58

Query: 154 KEIDIMNQL-HHPKLINLHDAFED----DDEMVLIFEFLSGGELFERITA-PDYKMSEAE 207
           +E+++  +    P ++ + D +E+       ++++ E L GGELF RI    D   +E E
Sbjct: 59  REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE 118

Query: 208 VIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN-STNVKMIDFGLATKLDPN 266
              +   I       A++++H  NI H DVKPEN++  ++  +  +K+ DFG        
Sbjct: 119 ASEIMKSIGE-----AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF------- 166

Query: 267 EVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVET----LK 322
                        A E    E      DMW++GV+ Y+LL G  PF   + +        
Sbjct: 167 -------------AKE-TTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 212

Query: 323 NVKACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
            ++   +EF    +  VSEE K  IR LL   
Sbjct: 213 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTE 244

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  212 bits (542), Expect = 8e-67
 Identities = 67/291 (23%), Positives = 119/291 (40%), Gaps = 45/291 (15%)

Query: 104 SSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK-ELIRKEIDIMNQL 162
           S+    + + + +G GA   V R R +KTG++FA K       L   ++  +E +++ +L
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 163 HHPKLINLHDAFEDD--DEMVLIFEFLSGGELFERITAP--DYKMSEAEVIPVTLPILMT 218
           +H  ++ L    E+      VLI EF   G L+  +  P   Y + E+E +     I++ 
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL-----IVLR 119

Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTR--NSTNVKMIDFGLATKLDPNEVVKISTGTA 276
                + H+ E  I+H ++KP NIM        +  K+ DFG A +L+ +E      GT 
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTE 179

Query: 277 EFAAPEIVEREPVGFYT--------DMWAVGVLAYVLLSGLSPF----AGENDVETLKNV 324
           E+  P++ ER  +            D+W++GV  Y   +G  PF        + E +  +
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239

Query: 325 KAC-----------------DWEFDEEAFKNVS----EEGKDFIRRLLLRN 354
                               DW  D     ++S          +  +L  +
Sbjct: 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEAD 290

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  206 bits (526), Expect = 2e-63
 Identities = 63/271 (23%), Positives = 114/271 (42%), Gaps = 24/271 (8%)

Query: 104 SSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK-ELIRKEIDIMNQL 162
           S+    + + + +G GA   V R R +KTG++FA K       L   ++  +E +++ +L
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 163 HHPKLINLHDAFEDD--DEMVLIFEFLSGGELFERITAP--DYKMSEAEVIPVTLPILMT 218
           +H  ++ L    E+      VLI EF   G L+  +  P   Y + E+E +     I++ 
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL-----IVLR 119

Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTR--NSTNVKMIDFGLATKLDPNEVVKISTGTA 276
                + H+ E  I+H ++KP NIM        +  K+ DFG A +L+ +E      GT 
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTE 179

Query: 277 EFAAPEIVEREPVGFYT--------DMWAVGVLAYVLLSGLSPF----AGENDVETLKNV 324
           E+  P++ ER  +            D+W++GV  Y   +G  PF        + E +  +
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239

Query: 325 KACDWEFDEEAFKNVSEEGKDFIRRLLLRNK 355
                       +       D+   + +   
Sbjct: 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCS 270

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  201 bits (512), Expect = 1e-62
 Identities = 62/281 (22%), Positives = 114/281 (40%), Gaps = 40/281 (14%)

Query: 104 SSVY-DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL 162
           S  Y   ++ +  +G GAFG V + R       +A K I  +   +   I  E+ ++  L
Sbjct: 1   SLRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-KLSTILSEVMLLASL 59

Query: 163 HHPKLINLHDAFEDDDEMV-------------LIFEFLSGGELFERITAPDYKMSEAEVI 209
           +H  ++  + A+ +    V             +  E+   G L++ I + +      E  
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119

Query: 210 PVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVV 269
                 L  Q   A+ ++H + IIH D+KP NI     +  NVK+ DFGLA  +  +  +
Sbjct: 120 -----RLFRQILEALSYIHSQGIIHRDLKPMNIFI-DESR-NVKIGDFGLAKNVHRSLDI 172

Query: 270 KIST---------------GTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFA 313
                              GTA + A E+++         DM+++G++ + ++       
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FST 230

Query: 314 GENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
           G   V  LK +++   EF  +   N  +  K  IR L+  +
Sbjct: 231 GMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHD 271

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  198 bits (506), Expect = 6e-62
 Identities = 75/252 (29%), Positives = 116/252 (46%), Gaps = 17/252 (6%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP----VSHNLEKELIRKEIDIMNQLH 163
           + + +   +G G+F  V+R     TG   A K I         + + +   E+ I  QL 
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQN-EVKIHCQLK 69

Query: 164 HPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPA 223
           HP ++ L++ FED + + L+ E    GE+   +       SE E         M Q    
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR-----HFMHQIITG 124

Query: 224 VKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEFAAPE 282
           + ++H   I+H D+   N++       N+K+ DFGLAT+L  P+E      GT  + +PE
Sbjct: 125 MLYLHSHGILHRDLTLSNLLLTRNM--NIKIADFGLATQLKMPHEKHYTLCGTPNYISPE 182

Query: 283 IVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEE 342
           I  R   G  +D+W++G + Y LL G  PF  +    TL  V   D+E        +S E
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPS----FLSIE 238

Query: 343 GKDFIRRLLLRN 354
            KD I +LL RN
Sbjct: 239 AKDLIHQLLRRN 250

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  198 bits (505), Expect = 1e-61
 Identities = 71/251 (28%), Positives = 120/251 (47%), Gaps = 18/251 (7%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP----VSHNLEKELIRKEIDIMNQLH 163
           + ++I   +G G FG V+  RE+++  I A K +         +E +L R E++I + L 
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR-EVEIQSHLR 67

Query: 164 HPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPA 223
           HP ++ L+  F D   + LI E+   G ++  +     K  E           +T+ + A
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRT-----ATYITELANA 121

Query: 224 VKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEI 283
           + + H K +IH D+KPEN++  +     +K+ DFG +    P+       GT ++  PE+
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAG--ELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEM 178

Query: 284 VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG 343
           +E        D+W++GVL Y  L G  PF      ET K +   ++ F +     V+E  
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGA 234

Query: 344 KDFIRRLLLRN 354
           +D I RLL  N
Sbjct: 235 RDLISRLLKHN 245

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  195 bits (499), Expect = 8e-61
 Identities = 71/251 (28%), Positives = 124/251 (49%), Gaps = 18/251 (7%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP----VSHNLEKELIRKEIDIMNQLH 163
           D +DI   +G G FG V+  RE++   I A K +         +E + +R+EI+I + L 
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ-LRREIEIQSHLR 72

Query: 164 HPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPA 223
           HP ++ +++ F D   + L+ EF   GEL++ +     +  E           M + + A
Sbjct: 73  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG-RFDEQRSA-----TFMEELADA 126

Query: 224 VKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEI 283
           + + HE+ +IH D+KPEN++   +    +K+ DFG +    P+   +   GT ++  PE+
Sbjct: 127 LHYCHERKVIHRDIKPENLLMGYKG--ELKIADFGWS-VHAPSLRRRTMCGTLDYLPPEM 183

Query: 284 VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG 343
           +E +      D+W  GVL Y  L G+ PF   +  ET + +   D +F       +S+  
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP----PFLSDGS 239

Query: 344 KDFIRRLLLRN 354
           KD I +LL  +
Sbjct: 240 KDLISKLLRYH 250

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  194 bits (494), Expect = 2e-59
 Identities = 64/264 (24%), Positives = 112/264 (42%), Gaps = 18/264 (6%)

Query: 96  PQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP----VSHNLEKEL 151
             P  +        Y     +G G F       +  T  +FA K +P    +  +  +++
Sbjct: 29  EIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKM 88

Query: 152 IRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPV 211
              EI I   L H  ++  H  FED+D + ++ E      L E        ++E E    
Sbjct: 89  SM-EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK-ALTEPEAR-- 144

Query: 212 TLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVK 270
                + Q     +++H   +IH D+K  N+         VK+ DFGLATK++   E  K
Sbjct: 145 ---YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL--EVKIGDFGLATKVEYDGERKK 199

Query: 271 ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWE 330
           +  GT  + APE++ ++   F  D+W++G + Y LL G  PF      ET   +K  ++ 
Sbjct: 200 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS 259

Query: 331 FDEEAFKNVSEEGKDFIRRLLLRN 354
                 K+++      I+++L  +
Sbjct: 260 IP----KHINPVAASLIQKMLQTD 279

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  200 bits (510), Expect = 8e-59
 Identities = 65/251 (25%), Positives = 115/251 (45%), Gaps = 15/251 (5%)

Query: 104 SSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE-KELIRKEIDIMNQL 162
           +     +++ E +GTG FG V R   + TG   A K      + + +E    EI IM +L
Sbjct: 10  TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69

Query: 163 HHPKLINLHDAFED------DDEMVLIFEFLSGGELFERITAPD--YKMSEAEVIPVTLP 214
           +HP +++  +  +       +D  +L  E+  GG+L + +   +    + E  +      
Sbjct: 70  NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR----- 124

Query: 215 ILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTR-NSTNVKMIDFGLATKLDPNEVVKIST 273
            L++  S A++++HE  IIH D+KPENI+ Q        K+ID G A +LD  E+     
Sbjct: 125 TLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV 184

Query: 274 GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE 333
           GT ++ APE++E++      D W+ G LA+  ++G  PF                     
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI 244

Query: 334 EAFKNVSEEGK 344
             + +++   K
Sbjct: 245 VVYDDLTGAVK 255

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  190 bits (486), Expect = 9e-59
 Identities = 64/264 (24%), Positives = 112/264 (42%), Gaps = 18/264 (6%)

Query: 96  PQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP----VSHNLEKEL 151
             P  +        Y     +G G F       +  T  +FA K +P    +  +  +++
Sbjct: 3   EIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKM 62

Query: 152 IRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPV 211
              EI I   L H  ++  H  FED+D + ++ E      L E        ++E E    
Sbjct: 63  SM-EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK-ALTEPEAR-- 118

Query: 212 TLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVK 270
                + Q     +++H   +IH D+K  N+         VK+ DFGLATK++   E  K
Sbjct: 119 ---YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL--EVKIGDFGLATKVEYDGERKK 173

Query: 271 ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWE 330
           +  GT  + APE++ ++   F  D+W++G + Y LL G  PF      ET   +K  ++ 
Sbjct: 174 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS 233

Query: 331 FDEEAFKNVSEEGKDFIRRLLLRN 354
                 K+++      I+++L  +
Sbjct: 234 IP----KHINPVAASLIQKMLQTD 253

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  191 bits (488), Expect = 2e-58
 Identities = 61/251 (24%), Positives = 123/251 (49%), Gaps = 14/251 (5%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHP 165
           + Y  L++IG G+FG     +  + G  +  K I +S   + E+E  R+E+ ++  + HP
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERIT-APDYKMSEAEVIPVTLPILMTQTSPAV 224
            ++   ++FE++  + ++ ++  GG+LF+RI         E +++         Q   A+
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW-----FVQICLAL 138

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS-TGTAEFAAPEI 283
           KH+H++ I+H D+K +NI         V++ DFG+A  L+    +  +  GT  + +PEI
Sbjct: 139 KHVHDRKILHRDIKSQNIF--LTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEI 196

Query: 284 VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG 343
            E +P    +D+WA+G + Y L +    F   +    +  + +  +      +   S + 
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHY---SYDL 253

Query: 344 KDFIRRLLLRN 354
           +  + +L  RN
Sbjct: 254 RSLVSQLFKRN 264

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  188 bits (479), Expect = 2e-57
 Identities = 57/256 (22%), Positives = 105/256 (41%), Gaps = 17/256 (6%)

Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR--KEIDIM 159
             S     +  L  +G G++G V + R ++ G ++A K         K+  R   E+   
Sbjct: 51  PESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSH 110

Query: 160 NQL-HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
            ++  HP  + L  A+E+   + L  E   G  L +   A    + EA+V        + 
Sbjct: 111 EKVGQHPCCVRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVW-----GYLR 164

Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
            T  A+ H+H + ++HLDVKP NI          K+ DFGL  +L      ++  G   +
Sbjct: 165 DTLLALAHLHSQGLVHLDVKPANIFL-GPRG-RCKLGDFGLLVELGTAGAGEVQEGDPRY 222

Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKN 338
            APE+++    G   D++++G+    +   +    G    + L+           E    
Sbjct: 223 MAPELLQ-GSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGY-----LPPEFTAG 276

Query: 339 VSEEGKDFIRRLLLRN 354
           +S E +  +  +L  +
Sbjct: 277 LSSELRSVLVMMLEPD 292

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  184 bits (469), Expect = 2e-56
 Identities = 69/264 (26%), Positives = 126/264 (47%), Gaps = 23/264 (8%)

Query: 104 SSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQ 161
            S  + Y++L  IGTG++G   + R +  G I   K +        EK+++  E++++ +
Sbjct: 2   PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61

Query: 162 LHHPKLINLHDAFED--DDEMVLIFEFLSGGELFERITAPDYK---MSEAEVIPVTLPIL 216
           L HP ++  +D   D  +  + ++ E+  GG+L   IT    +   + E  V+ V     
Sbjct: 62  LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV----- 116

Query: 217 MTQTSPAVKHMHEKN-----IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVV-K 270
           MTQ + A+K  H ++     ++H D+KP N+    +   NVK+ DFGLA  L+ +    K
Sbjct: 117 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGLARILNHDTSFAK 174

Query: 271 ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWE 330
              GT  + +PE + R      +D+W++G L Y L + + PF   +  E    ++   + 
Sbjct: 175 TFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR 234

Query: 331 FDEEAFKNVSEEGKDFIRRLLLRN 354
                +   S+E  + I R+L   
Sbjct: 235 RIPYRY---SDELNEIITRMLNLK 255

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  188 bits (480), Expect = 3e-56
 Identities = 57/257 (22%), Positives = 100/257 (38%), Gaps = 23/257 (8%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL-HHPKLI 168
           +   + +G GA G +   R        A K I            +E+ ++ +   HP +I
Sbjct: 26  FCPKDVLGHGAEGTI-VYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVI 81

Query: 169 NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH 228
                 +D     +  E L    L E +   D+     E I      L+ QT+  + H+H
Sbjct: 82  RYFCTEKDRQFQYIAIE-LCAATLQEYVEQKDFAHLGLEPI-----TLLQQTTSGLAHLH 135

Query: 229 EKNIIHLDVKPENIMCQTRNST---NVKMIDFGLATKLDPNE----VVKISTGTAEFAAP 281
             NI+H D+KP NI+    N+       + DFGL  KL              GT  + AP
Sbjct: 136 SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195

Query: 282 EIVEREPVGFYT---DMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFK 337
           E++  +     T   D+++ G + Y ++S G  PF      +    + AC  +      K
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHP-EK 254

Query: 338 NVSEEGKDFIRRLLLRN 354
           +     ++ I +++  +
Sbjct: 255 HEDVIARELIEKMIAMD 271

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  181 bits (460), Expect = 1e-54
 Identities = 45/266 (16%), Positives = 96/266 (36%), Gaps = 28/266 (10%)

Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLI 168
           HY  ++++G G F  V        G+ +A K I      ++E  ++E D+    +HP ++
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89

Query: 169 NLHDAFEDDD----EMVLIFEFLSGGELFERITA---PDYKMSEAEVIPVTLPILMTQTS 221
            L      +     E  L+  F   G L+  I         ++E +++ +     +    
Sbjct: 90  RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWL-----LLGIC 144

Query: 222 PAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN----------EVVKI 271
             ++ +H K   H D+KP NI+          ++D G   +   +          +    
Sbjct: 145 RGLEAIHAKGYAHRDLKPTNILLGDEG--QPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202

Query: 272 STGTAEFAAPEIVE---REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACD 328
              T  + APE+        +   TD+W++G + Y ++ G  P+           +   +
Sbjct: 203 QRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN 262

Query: 329 WEFDEEAFKNVSEEGKDFIRRLLLRN 354
            +         S      +  ++  +
Sbjct: 263 -QLSIPQSPRHSSALWQLLNSMMTVD 287

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  180 bits (460), Expect = 1e-54
 Identities = 57/265 (21%), Positives = 110/265 (41%), Gaps = 32/265 (12%)

Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQLHHP- 165
            Y IL++IG+G    V +    +   I+A K++ +     + L   R EI  +N+L    
Sbjct: 29  IYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87

Query: 166 -KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
            K+I L+D    D  + ++ E     +L   +      +   E               AV
Sbjct: 88  DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERK-----SYWKNMLEAV 140

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST---GTAEFAAP 281
             +H+  I+H D+KP N +        +K+IDFG+A ++ P+    +     GT  +  P
Sbjct: 141 HTIHQHGIVHSDLKPANFLI---VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197

Query: 282 EIVEREP-----------VGFYTDMWAVGVLAYVLLSGLSPFAG-ENDVETLKNVKACDW 329
           E ++              +   +D+W++G + Y +  G +PF    N +  L  +   + 
Sbjct: 198 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 257

Query: 330 EFDEEAFKNVSEEGKDFIRRLLLRN 354
           E +        ++ +D ++  L R+
Sbjct: 258 EIEFP--DIPEKDLQDVLKCCLKRD 280

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  180 bits (458), Expect = 2e-54
 Identities = 62/267 (23%), Positives = 115/267 (43%), Gaps = 16/267 (5%)

Query: 96  PQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL---EKELI 152
                    +   ++ I ++IG G F  V+R      G   A K + +   +    +   
Sbjct: 20  KALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADC 79

Query: 153 RKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITA---PDYKMSEAEVI 209
            KEID++ QL+HP +I  + +F +D+E+ ++ E    G+L   I         + E  V 
Sbjct: 80  IKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW 139

Query: 210 PVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVV 269
              + +       A++HMH + ++H D+KP N+         VK+ D GL          
Sbjct: 140 KYFVQLCS-----ALEHMHSRRVMHRDIKPANVFITATG--VVKLGDLGLGRFFSSKTTA 192

Query: 270 KIS-TGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN-DVETLKNVKAC 327
             S  GT  + +PE +      F +D+W++G L Y + +  SPF G+  ++ +L   K  
Sbjct: 193 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK-KIE 251

Query: 328 DWEFDEEAFKNVSEEGKDFIRRLLLRN 354
             ++      + SEE +  +   +  +
Sbjct: 252 QCDYPPLPSDHYSEELRQLVNMCINPD 278

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  179 bits (455), Expect = 1e-53
 Identities = 57/265 (21%), Positives = 110/265 (41%), Gaps = 32/265 (12%)

Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHP- 165
            Y IL++IG+G    V +    +   I+A K++ +    N   +  R EI  +N+L    
Sbjct: 10  IYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 166 -KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
            K+I L+D    D  + ++ E     +L   +      +   E               AV
Sbjct: 69  DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERK-----SYWKNMLEAV 121

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST---GTAEFAAP 281
             +H+  I+H D+KP N +        +K+IDFG+A ++ P+    +     GT  +  P
Sbjct: 122 HTIHQHGIVHSDLKPANFLI---VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178

Query: 282 EIVEREP-----------VGFYTDMWAVGVLAYVLLSGLSPFAG-ENDVETLKNVKACDW 329
           E ++              +   +D+W++G + Y +  G +PF    N +  L  +   + 
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 238

Query: 330 EFDEEAFKNVSEEGKDFIRRLLLRN 354
           E +        ++ +D ++  L R+
Sbjct: 239 EIEFP--DIPEKDLQDVLKCCLKRD 261

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  178 bits (453), Expect = 2e-53
 Identities = 73/249 (29%), Positives = 125/249 (50%), Gaps = 15/249 (6%)

Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPK 166
           +Y +L+ IG G F  V   R   TG   A K I  +       + + +E+ IM  L+HP 
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75

Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKH 226
           ++ L +  E +  + LI E+ SGGE+F+ + A   +M E E           Q   AV++
Sbjct: 76  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG-RMKEKEARS-----KFRQIVSAVQY 129

Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVER 286
            H+K I+H D+K EN++       N+K+ DFG + +      +    G   +AAPE+ + 
Sbjct: 130 CHQKRIVHRDLKAENLLLDADM--NIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQG 187

Query: 287 EP-VGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD 345
           +   G   D+W++GV+ Y L+SG  PF G+N  E  + V     ++    +  +S + ++
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG--KYRIPFY--MSTDCEN 243

Query: 346 FIRRLLLRN 354
            ++R L+ N
Sbjct: 244 LLKRFLVLN 252

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  181 bits (460), Expect = 2e-53
 Identities = 61/281 (21%), Positives = 116/281 (41%), Gaps = 36/281 (12%)

Query: 103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL 162
             S+ +     + +G G+ G V   +    G   A K + +      ++   EI ++ + 
Sbjct: 10  EQSLKNLVVSEKILGYGSSGTV-VFQGSFQGRPVAVKRMLIDFC---DIALMEIKLLTES 65

Query: 163 -HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI-LMTQT 220
             HP +I  + +   D  + +  E L    L + + + +      ++     PI L+ Q 
Sbjct: 66  DDHPNVIRYYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124

Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNST-----------NVKMIDFGLATKLDPNEVV 269
           +  V H+H   IIH D+KP+NI+  T +              + + DFGL  KLD  +  
Sbjct: 125 ASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184

Query: 270 KIST-----GTAEFAAPEI----VEREPVGFYT---DMWAVGVLAYVLLS-GLSPFAGEN 316
             +      GT+ + APE+       +     T   D++++G + Y +LS G  PF  + 
Sbjct: 185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244

Query: 317 DVETLKNVKACDWEFDEEAF---KNVSEEGKDFIRRLLLRN 354
             E   N+    +  DE      +++  E  D I +++  +
Sbjct: 245 SRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHD 283

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  178 bits (452), Expect = 4e-53
 Identities = 58/286 (20%), Positives = 117/286 (40%), Gaps = 45/286 (15%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI-----------------PVSHNLEKE 150
           + Y I+  +  G F  +  C +      +A K                    +S   + +
Sbjct: 31  NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88

Query: 151 LIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIP 210
             + E+ I+  + +   +       + DE+ +I+E++    + +      + + +     
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEY-FFVLDKNYTCF 147

Query: 211 VTLPI---LMTQTSPAVKHMH-EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN 266
           + + +   ++     +  ++H EKNI H DVKP NI+        VK+ DFG + +   +
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNG--RVKLSDFGES-EYMVD 204

Query: 267 EVVKISTGTAEFAAPEIVEREPV--GFYTDMWAVGVLAYVLLSGLSPFAGE-NDVETLKN 323
           + +K S GT EF  PE    E    G   D+W++G+  YV+   + PF+ + + VE   N
Sbjct: 205 KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN 264

Query: 324 VKACDWEF---------------DEEAFKNVSEEGKDFIRRLLLRN 354
           ++  + E+                  +   +S E  DF++  L +N
Sbjct: 265 IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKN 310

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  175 bits (447), Expect = 4e-53
 Identities = 56/263 (21%), Positives = 104/263 (39%), Gaps = 38/263 (14%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLIN 169
           +  +E IG+G FG V + + R  G  +  K +        E   +E+  + +L H  +++
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNIVH 68

Query: 170 LHDAFEDDDEMV----------------LIFEFLSGGELFERI-TAPDYKMSEAEVIPVT 212
            +  ++  D                   +  EF   G L + I      K+ +   +   
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL--- 125

Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS 272
              L  Q +  V ++H K +I+ D+KP NI         VK+ DFGL T L  +     S
Sbjct: 126 --ELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK--QVKIGDFGLVTSLKNDGKRTRS 181

Query: 273 TGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSP-FAGENDVETLKNVKACDWEF 331
            GT  + +PE +  +  G   D++A+G++   LL      F        L++        
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGI-----I 236

Query: 332 DEEAFKNVSEEGKDFIRRLLLRN 354
            +       ++ K  +++LL + 
Sbjct: 237 SD----IFDKKEKTLLQKLLSKK 255

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  178 bits (454), Expect = 6e-53
 Identities = 56/265 (21%), Positives = 109/265 (41%), Gaps = 32/265 (12%)

Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQLHHP- 165
            Y IL++IG+G    V +    +   I+A K++ +     + L   R EI  +N+L    
Sbjct: 57  IYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115

Query: 166 -KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
            K+I L+D    D  + ++ E     +L   +      +   E               AV
Sbjct: 116 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERK-----SYWKNMLEAV 168

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST---GTAEFAAP 281
             +H+  I+H D+KP N +        +K+IDFG+A ++ P+    +     G   +  P
Sbjct: 169 HTIHQHGIVHSDLKPANFLI---VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225

Query: 282 EIVEREP-----------VGFYTDMWAVGVLAYVLLSGLSPFAG-ENDVETLKNVKACDW 329
           E ++              +   +D+W++G + Y +  G +PF    N +  L  +   + 
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 285

Query: 330 EFDEEAFKNVSEEGKDFIRRLLLRN 354
           E +        ++ +D ++  L R+
Sbjct: 286 EIEFP--DIPEKDLQDVLKCCLKRD 308

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  174 bits (442), Expect = 6e-51
 Identities = 72/283 (25%), Positives = 135/283 (47%), Gaps = 29/283 (10%)

Query: 84  DQYVFDIYSKYVPQPVDIKTSSV-YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP 142
           ++ + +  S+Y      I+   +  + Y++++ IG GAFG V   R + T  ++A K + 
Sbjct: 44  NKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS 103

Query: 143 VSHNLEK---ELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELF-----E 194
               +++       +E DIM   + P ++ L  AF+DD  + ++ E++ GG+L       
Sbjct: 104 KFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY 163

Query: 195 RITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKM 254
            +     +   AEV+             A+  +H    IH DVKP+N++     S ++K+
Sbjct: 164 DVPEKWARFYTAEVVL------------ALDAIHSMGFIHRDVKPDNMLLD--KSGHLKL 209

Query: 255 IDFGLATKLDPNEVVKIST--GTAEFAAPEIVEREP-VGFYT---DMWAVGVLAYVLLSG 308
            DFG   K++   +V+  T  GT ++ +PE+++ +   G+Y    D W+VGV  Y +L G
Sbjct: 210 ADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

Query: 309 LSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLL 351
            +PF  ++ V T   +             ++S+E K+ I   L
Sbjct: 270 DTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFL 312

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  172 bits (439), Expect = 9e-51
 Identities = 71/275 (25%), Positives = 125/275 (45%), Gaps = 33/275 (12%)

Query: 95  VPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK---EL 151
           +P   D      +DH++IL  IG G+FG V   ++  T  ++A K++     +E+     
Sbjct: 2   MPPVFDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRN 61

Query: 152 IRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELF------ERITAPDYKMSE 205
           + KE+ IM  L HP L+NL  +F+D+++M ++ + L GG+L               K+  
Sbjct: 62  VFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFI 121

Query: 206 AEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP 265
            E++             A+ ++  + IIH D+KP+NI+       +V + DF +A  L  
Sbjct: 122 CELV------------MALDYLQNQRIIHRDMKPDNILLDEHG--HVHITDFNIAAMLPR 167

Query: 266 NEVVKISTGTAEFAAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPF---AGENDVE 319
              +    GT  + APE+        Y+   D W++GV AY LL G  P+   +  +  E
Sbjct: 168 ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKE 227

Query: 320 TLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
            +   +     +        S+E    +++LL  N
Sbjct: 228 IVHTFETTVVTYPS----AWSQEMVSLLKKLLEPN 258

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  173 bits (441), Expect = 9e-51
 Identities = 78/289 (26%), Positives = 135/289 (46%), Gaps = 35/289 (12%)

Query: 84  DQYVFDIYSKYVPQPVDIKTSSV-YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP 142
           D+YV D      P  V +K   +  D ++IL+ IG GAF  V   + ++TG ++A K + 
Sbjct: 36  DKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMN 95

Query: 143 VSHNLEK---ELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAP 199
               L++      R+E D++       +  LH AF+D++ + L+ E+  GG+L   ++  
Sbjct: 96  KWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKF 155

Query: 200 DYKMSE-------AEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNV 252
             ++         AE++             A+  +H    +H D+KP+NI+       ++
Sbjct: 156 GERIPAEMARFYLAEIV------------MAIDSVHRLGYVHRDIKPDNILLD--RCGHI 201

Query: 253 KMIDFGLATKLDPNEVVKIST--GTAEFAAPEIVERE----PVGFYT---DMWAVGVLAY 303
           ++ DFG   KL  +  V+     GT ++ +PEI++        G Y    D WA+GV AY
Sbjct: 202 RLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAY 261

Query: 304 VLLSGLSPFAGENDVETLKNVKACDWEFDEEAF-KNVSEEGKDFIRRLL 351
            +  G +PF  ++  ET   +             + V EE +DFI+RLL
Sbjct: 262 EMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLL 310

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  172 bits (438), Expect = 3e-50
 Identities = 76/292 (26%), Positives = 139/292 (47%), Gaps = 33/292 (11%)

Query: 84  DQYVFDIYSKYVPQPVDIKTSSV-YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP 142
           ++ + +      P    +K   +  + ++IL+ IG GAFG V   + +    +FA K + 
Sbjct: 49  EKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN 108

Query: 143 VSHNLEK---ELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAP 199
               L++      R+E D++       +  LH AF+DD+ + L+ ++  GG+L   ++  
Sbjct: 109 KWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKF 168

Query: 200 DYKMSE-------AEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNV 252
           + ++ E       AE++             A+  +H+ + +H D+KP+NI+     + ++
Sbjct: 169 EDRLPEEMARFYLAEMV------------IAIDSVHQLHYVHRDIKPDNILMD--MNGHI 214

Query: 253 KMIDFGLATKLDPNEVVKIST--GTAEFAAPEIVEREPVGF--YT---DMWAVGVLAYVL 305
           ++ DFG   KL  +  V+ S   GT ++ +PEI++    G   Y    D W++GV  Y +
Sbjct: 215 RLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEM 274

Query: 306 LSGLSPFAGENDVETLKNVKACDWEFDE-EAFKNVSEEGKDFIRRLLLRNKE 356
           L G +PF  E+ VET   +      F       +VSE  KD IRRL+   + 
Sbjct: 275 LYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREH 326

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  168 bits (428), Expect = 2e-49
 Identities = 51/305 (16%), Positives = 99/305 (32%), Gaps = 39/305 (12%)

Query: 70  KKIRGKADEKVSDY-DQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCR 128
            K+     + VS Y + + +      +    + +  S      +   +G GAF  V+   
Sbjct: 28  FKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGS--KLVYVHHLLGEGAFAQVYEAT 85

Query: 129 ER-----KTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI 183
           +      K    F  K    ++  E  +  + ++ +        +  + A    +  VL+
Sbjct: 86  QGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLV 145

Query: 184 FEFLSGGELFERI----TAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKP 239
            E  S G L   I      P+  M +  VI         +    ++ +H+  IIH D+KP
Sbjct: 146 GELYSYGTLLNAINLYKNTPEKVMPQGLVI-----SFAMRMLYMIEQVHDCEIIHGDIKP 200

Query: 240 ENIMCQTR---------NSTNVKMIDFGLA---TKLDPNEVVKISTGTAEFAAPEIVERE 287
           +N +              S  + +ID G +          +      T+ F   E++  +
Sbjct: 201 DNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK 260

Query: 288 PVGFYTDMWAVGVLAYVLLSGLSPF-AGENDVETLKNVKACDWEFDEEAFKNVSEEGKDF 346
           P  +  D + V    Y +L G       E      + +       D            +F
Sbjct: 261 PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMW---------NEF 311

Query: 347 IRRLL 351
              +L
Sbjct: 312 FHVML 316

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  167 bits (426), Expect = 2e-49
 Identities = 69/269 (25%), Positives = 111/269 (41%), Gaps = 28/269 (10%)

Query: 96  PQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL---- 151
            + +          Y  +  +G+GAFG V    +++       KFI     LE       
Sbjct: 12  LEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDP 71

Query: 152 ----IRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF-LSGGELFERITAPDYKMSEA 206
               +  EI I++++ H  +I + D FE+     L+ E   SG +LF  I     ++ E 
Sbjct: 72  KLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP-RLDEP 130

Query: 207 EVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN 266
                    +  Q   AV ++  K+IIH D+K ENI+        +K+IDFG A  L+  
Sbjct: 131 LAS-----YIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDF--TIKLIDFGSAAYLERG 183

Query: 267 EVVKISTGTAEFAAPEIVEREP-VGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVK 325
           ++     GT E+ APE++   P  G   +MW++GV  Y L+   +PF        L+   
Sbjct: 184 KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF------CELEETV 237

Query: 326 ACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
                        VS+E    +  LL   
Sbjct: 238 EAAIHPP----YLVSKELMSLVSGLLQPV 262

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  167 bits (424), Expect = 2e-49
 Identities = 67/266 (25%), Positives = 123/266 (46%), Gaps = 44/266 (16%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK---------EIDI 158
           + +   + +G G+F  V   RE  T   +A K       LEK  I K         E D+
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKI------LEKRHIIKENKVPYVTRERDV 83

Query: 159 MNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELF------ERITAPDYKMSEAEVIPVT 212
           M++L HP  + L+  F+DD+++     +   GEL               +   AE++   
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS-- 141

Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS 272
                     A++++H K IIH D+KPENI+       ++++ DFG A K+   E  +  
Sbjct: 142 ----------ALEYLHGKGIIHRDLKPENILLNEDM--HIQITDFGTA-KVLSPESKQAR 188

Query: 273 T----GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACD 328
                GTA++ +PE++  +     +D+WA+G + Y L++GL PF   N+    + +   +
Sbjct: 189 ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 248

Query: 329 WEFDEEAFKNVSEEGKDFIRRLLLRN 354
           ++F     +    + +D + +LL+ +
Sbjct: 249 YDFP----EKFFPKARDLVEKLLVLD 270

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  168 bits (427), Expect = 3e-49
 Identities = 70/262 (26%), Positives = 118/262 (45%), Gaps = 14/262 (5%)

Query: 98  PVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID 157
           P+D+      D YD +++IG+G FGV    R++ T  + A K+I        E +++EI 
Sbjct: 10  PLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREII 68

Query: 158 IMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM 217
               L HP ++   +       + +I E+ SGGEL+ERI     + SE E          
Sbjct: 69  NHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAG-RFSEDEAR-----FFF 122

Query: 218 TQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAE 277
            Q    V + H   I H D+K EN +     +  +K+ DFG +     +   K + GT  
Sbjct: 123 QQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 182

Query: 278 FAAPEIVEREP-VGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKN----VKACDWEFD 332
           + APE++ R+   G   D+W+ GV  YV+L G  PF    +    +     + +  +   
Sbjct: 183 YIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIP 242

Query: 333 EEAFKNVSEEGKDFIRRLLLRN 354
           ++    +S E    I R+ + +
Sbjct: 243 DDIR--ISPECCHLISRIFVAD 262

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  164 bits (417), Expect = 1e-48
 Identities = 66/250 (26%), Positives = 115/250 (46%), Gaps = 16/250 (6%)

Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL---IRKEIDIMNQLHHP 165
           HY + + +G G FG V     + TG+  A K +        ++   I++EI  +    HP
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71

Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            +I L+       +  ++ E++SGGELF+ I     ++ E E        L  Q   AV 
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG-RVEEMEAR-----RLFQQILSAVD 125

Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           + H   ++H D+KPEN++       N K+ DFGL+  +   E ++ S G+  +AAPE++ 
Sbjct: 126 YCHRHMVVHRDLKPENVLLDAHM--NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS 183

Query: 286 REP-VGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
                G   D+W+ GV+ Y LL G  PF  E+     K ++   +       + ++    
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP----EYLNRSVA 239

Query: 345 DFIRRLLLRN 354
             +  +L  +
Sbjct: 240 TLLMHMLQVD 249

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  164 bits (416), Expect = 5e-48
 Identities = 65/291 (22%), Positives = 111/291 (38%), Gaps = 45/291 (15%)

Query: 92  SKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL 151
           S +V Q V++          +   +  G F  V+  ++  +G  +A K +  +   +   
Sbjct: 16  SDFVGQTVELGE----LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRA 71

Query: 152 IRKEIDIMNQL-HHPKLINLHDAF-------EDDDEMVLIFEFLSGGELFERI--TAPDY 201
           I +E+  M +L  HP ++    A        +      L+   L  G+L E +       
Sbjct: 72  IIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG 131

Query: 202 KMSEAEVIPVTLPILMTQTSPAVKHMHEKN--IIHLDVKPENIMCQTRNSTNVKMIDFGL 259
            +S   V+ +       QT  AV+HMH +   IIH D+K EN++   +    +K+ DFG 
Sbjct: 132 PLSCDTVLKI-----FYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG--TIKLCDFGS 184

Query: 260 ATKLDPNEVVKIST-------------GTAEFAAPEIVE---REPVGFYTDMWAVGVLAY 303
           AT +        S               T  +  PEI++     P+G   D+WA+G + Y
Sbjct: 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILY 244

Query: 304 VLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
           +L     PF        L+ V     ++               IR +L  N
Sbjct: 245 LLCFRQHPFEDGA---KLRIVNG---KYSIPPHDTQYTVFHSLIRAMLQVN 289

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  163 bits (414), Expect = 7e-48
 Identities = 61/263 (23%), Positives = 101/263 (38%), Gaps = 28/263 (10%)

Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK------ELIRKE 155
           +   +   Y +   +G+G FG V+           A K +      +         +  E
Sbjct: 37  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 96

Query: 156 IDIMNQLHH--PKLINLHDAFEDDDEMVLIFEFLSG-GELFERITAPDYKMSEAEVIPVT 212
           + ++ ++      +I L D FE  D  VLI E      +LF+ IT     + E       
Sbjct: 97  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELAR--- 152

Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS 272
                 Q   AV+H H   ++H D+K ENI+    N   +K+IDFG    L  + V    
Sbjct: 153 --SFFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGELKLIDFGSGALL-KDTVYTDF 208

Query: 273 TGTAEFAAPEIVEREP-VGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEF 331
            GT  ++ PE +      G    +W++G+L Y ++ G  PF  + ++           + 
Sbjct: 209 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------IRGQV 260

Query: 332 DEEAFKNVSEEGKDFIRRLLLRN 354
                  VS E +  IR  L   
Sbjct: 261 FFRQR--VSSECQHLIRWCLALR 281

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  162 bits (413), Expect = 1e-47
 Identities = 67/272 (24%), Positives = 107/272 (39%), Gaps = 30/272 (11%)

Query: 95  VPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK 154
            P P      +    Y +   +G G FG V            A K IP +  L    +  
Sbjct: 18  TPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSD 77

Query: 155 ------EIDIMNQLH----HPKLINLHDAFEDDDEMVLIFEF-LSGGELFERITAPDYKM 203
                 E+ ++ ++     HP +I L D FE  +  +L+ E  L   +LF+ IT     +
Sbjct: 78  SVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG-PL 136

Query: 204 SEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL 263
            E             Q   A++H H + ++H D+K ENI+   R     K+IDFG    L
Sbjct: 137 GEGPSR-----CFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRG-CAKLIDFGSGA-L 189

Query: 264 DPNEVVKISTGTAEFAAPEIVEREP-VGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLK 322
             +E      GT  ++ PE + R         +W++G+L Y ++ G  PF  + ++    
Sbjct: 190 LHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI---- 245

Query: 323 NVKACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
                + E    A   VS +    IRR L   
Sbjct: 246 ----LEAELHFPAH--VSPDCCALIRRCLAPK 271

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  160 bits (407), Expect = 6e-47
 Identities = 53/274 (19%), Positives = 113/274 (41%), Gaps = 38/274 (13%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN-LEKELIRKEIDIMNQLHHPK 166
             ++ ++ +G G FGVV   + +     +A K I + +  L +E + +E+  + +L HP 
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 167 LINLHDAFEDDDEMV------------LIFEFLSGGELFERITAPDYKMSEAEVIPVTLP 214
           ++   +A+ + +               +  +      L + +            + + + 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI- 123

Query: 215 ILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVK---- 270
               Q + AV+ +H K ++H D+KP NI     +   VK+ DFGL T +D +E  +    
Sbjct: 124 --FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD--VVKVGDFGLVTAMDQDEEEQTVLT 179

Query: 271 ---------ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEND-VET 320
                       GT  + +PE +         D++++G++ + L   L PF+ + + V T
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL---LYPFSTQMERVRT 236

Query: 321 LKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
           L +V+   +      F          ++ +L  +
Sbjct: 237 LTDVRNLKF---PPLFTQKYPCEYVMVQDMLSPS 267

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  158 bits (402), Expect = 2e-46
 Identities = 68/254 (26%), Positives = 120/254 (47%), Gaps = 18/254 (7%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE-KELIRKEIDIMNQLHHPK 166
           + +D+++ +G GA+G V     R T    A K + +   ++  E I+KEI I   L+H  
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66

Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKH 226
           ++  +    + +   L  E+ SGGELF+RI  PD  M E +           Q    V +
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQ-----RFFHQLMAGVVY 120

Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKI---STGTAEFAAPEI 283
           +H   I H D+KPEN++   R+  N+K+ DFGLAT    N   ++     GT  + APE+
Sbjct: 121 LHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178

Query: 284 VEREP-VGFYTDMWAVGVLAYVLLSGLSPF--AGENDVETLKNVKACDWEFDEEAFKNVS 340
           ++R        D+W+ G++   +L+G  P+    ++  E     +    +     +K + 
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK---KTYLNPWKKID 235

Query: 341 EEGKDFIRRLLLRN 354
                 + ++L+ N
Sbjct: 236 SAPLALLHKILVEN 249

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  160 bits (406), Expect = 2e-46
 Identities = 75/250 (30%), Positives = 123/250 (49%), Gaps = 17/250 (6%)

Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL---IRKEIDIMNQLHHP 165
            Y I E +G G+FG V      KT    A KFI      + ++   + +EI  +  L HP
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69

Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            +I L+D      ++V++ E+ +GGELF+ I     +M+E E           Q   A++
Sbjct: 70  HIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKK-RMTEDEGR-----RFFQQIICAIE 122

Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           + H   I+H D+KPEN++       NVK+ DFGL+  +     +K S G+  +AAPE++ 
Sbjct: 123 YCHRHKIVHRDLKPENLLLDDNL--NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIN 180

Query: 286 REP-VGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
            +   G   D+W+ G++ YV+L G  PF  E      K V +C +         +S   +
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMP----DFLSPGAQ 236

Query: 345 DFIRRLLLRN 354
             IRR+++ +
Sbjct: 237 SLIRRMIVAD 246

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  160 bits (407), Expect = 2e-46
 Identities = 39/302 (12%), Positives = 78/302 (25%), Gaps = 54/302 (17%)

Query: 96  PQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK---ELI 152
              VD   S       ++E +  G   VV   R+ +    FA K   +     +   E +
Sbjct: 50  ETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERL 109

Query: 153 RKEIDIMNQLHH------------------------PKLINLHDAFEDDD--EMVLIFEF 186
            +      +L                          P    L    +D      +L+   
Sbjct: 110 HEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA 169

Query: 187 LSG-----GELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPEN 241
            S          + +           +  +T  ++         ++  K ++H    P+N
Sbjct: 170 ASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIR-----LAANLQSKGLVHGHFTPDN 224

Query: 242 IMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVERE--PVGFYTDMWAVG 299
           +         + + D     K         S+    +A  E +           + W +G
Sbjct: 225 LFIMPDG--RLMLGDVSALWK--VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLG 280

Query: 300 VLAYVLLSGLSPFAGEN-------DVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLL 352
           +  Y +     PF              +L+        F       + +  K  I R L 
Sbjct: 281 LSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSC--TPLPDFVKTLIGRFLN 338

Query: 353 RN 354
            +
Sbjct: 339 FD 340

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  158 bits (402), Expect = 1e-45
 Identities = 64/258 (24%), Positives = 127/258 (49%), Gaps = 33/258 (12%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK---ELIRKEIDIMNQLHH 164
           D +D ++ +GTG+FG V   + +++GN +A K +     ++    E    E  I+  ++ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELF------ERITAPDYKMSEAEVIPVTLPILMT 218
           P L+ L  +F+D+  + ++ E+++GGE+F       R + P  +   A+++         
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL-------- 152

Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTA 276
                 +++H  ++I+ D+KPEN++   +    +++ DFG A ++      +  T  GT 
Sbjct: 153 ----TFEYLHSLDLIYRDLKPENLLIDQQG--YIQVTDFGFAKRVKG----RTWTLCGTP 202

Query: 277 EFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAF 336
           E  APEI+  +      D WA+GVL Y + +G  PF  +  ++  + + +    F     
Sbjct: 203 EALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP---- 258

Query: 337 KNVSEEGKDFIRRLLLRN 354
            + S + KD +R LL  +
Sbjct: 259 SHFSSDLKDLLRNLLQVD 276

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  161 bits (408), Expect = 2e-45
 Identities = 65/250 (26%), Positives = 115/250 (46%), Gaps = 16/250 (6%)

Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL---IRKEIDIMNQLHHP 165
           HY + + +G G FG V   +   TG+  A K +        ++   IR+EI  +    HP
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76

Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            +I L+       ++ ++ E++SGGELF+ I     ++ E E        L  Q    V 
Sbjct: 77  HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG-RLDEKESR-----RLFQQILSGVD 130

Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           + H   ++H D+KPEN++       N K+ DFGL+  +   E ++ S G+  +AAPE++ 
Sbjct: 131 YCHRHMVVHRDLKPENVLLDAHM--NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS 188

Query: 286 REP-VGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
                G   D+W+ GV+ Y LL G  PF  ++     K +    +       + ++    
Sbjct: 189 GRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP----QYLNPSVI 244

Query: 345 DFIRRLLLRN 354
             ++ +L  +
Sbjct: 245 SLLKHMLQVD 254

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  162 bits (412), Expect = 2e-45
 Identities = 68/257 (26%), Positives = 120/257 (46%), Gaps = 23/257 (8%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK---------EIDI 158
           + +     +G G FG V  C+ R TG ++A K       LEK+ I+K         E  I
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKK------LEKKRIKKRKGEAMALNEKQI 237

Query: 159 MNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERIT-APDYKMSEAEVIPVTLPILM 217
           + +++   +++L  A+E  D + L+   ++GG+L   I         EA  +     I  
Sbjct: 238 LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICC 297

Query: 218 TQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAE 277
                 ++ +H + I++ D+KPENI+       ++++ D GLA  +   + +K   GT  
Sbjct: 298 -----GLEDLHRERIVYRDLKPENILLDDHG--HIRISDLGLAVHVPEGQTIKGRVGTVG 350

Query: 278 FAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
           + APE+V+ E   F  D WA+G L Y +++G SPF         + V+    E  EE  +
Sbjct: 351 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSE 410

Query: 338 NVSEEGKDFIRRLLLRN 354
             S + +    +LL ++
Sbjct: 411 RFSPQARSLCSQLLCKD 427

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  156 bits (397), Expect = 3e-45
 Identities = 77/258 (29%), Positives = 128/258 (49%), Gaps = 33/258 (12%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK---ELIRKEIDIMNQLHH 164
             + IL  +GTG+FG VH  R R  G  +A K +     +     E    E  +++ + H
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65

Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELF------ERITAPDYKMSEAEVIPVTLPILMT 218
           P +I +   F+D  ++ +I +++ GGELF      +R   P  K   AEV          
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL-------- 117

Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTA 276
               A++++H K+II+ D+KPENI+       ++K+ DFG A K  P+      T  GT 
Sbjct: 118 ----ALEYLHSKDIIYRDLKPENILLDKNG--HIKITDFGFA-KYVPD---VTYTLCGTP 167

Query: 277 EFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAF 336
           ++ APE+V  +P     D W+ G+L Y +L+G +PF   N ++T + +   +  F     
Sbjct: 168 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP---- 223

Query: 337 KNVSEEGKDFIRRLLLRN 354
              +E+ KD + RL+ R+
Sbjct: 224 PFFNEDVKDLLSRLITRD 241

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  156 bits (396), Expect = 4e-45
 Identities = 68/254 (26%), Positives = 120/254 (47%), Gaps = 18/254 (7%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE-KELIRKEIDIMNQLHHPK 166
           + +D+++ +G GA+G V     R T    A K + +   ++  E I+KEI I   L+H  
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66

Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKH 226
           ++  +    + +   L  E+ SGGELF+RI  PD  M E +           Q    V +
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQ-----RFFHQLMAGVVY 120

Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKI---STGTAEFAAPEI 283
           +H   I H D+KPEN++   R+  N+K+ DFGLAT    N   ++     GT  + APE+
Sbjct: 121 LHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178

Query: 284 VEREP-VGFYTDMWAVGVLAYVLLSGLSPF--AGENDVETLKNVKACDWEFDEEAFKNVS 340
           ++R        D+W+ G++   +L+G  P+    ++  E     +    +     +K + 
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK---KTYLNPWKKID 235

Query: 341 EEGKDFIRRLLLRN 354
                 + ++L+ N
Sbjct: 236 SAPLALLHKILVEN 249

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  154 bits (392), Expect = 1e-44
 Identities = 66/278 (23%), Positives = 124/278 (44%), Gaps = 43/278 (15%)

Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK------------------- 149
            Y + +EIG G++GVV           +A K +     + +                   
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73

Query: 150 -------ELIRKEIDIMNQLHHPKLINLHDAFED--DDEMVLIFEFLSGGELFERITAPD 200
                  E + +EI I+ +L HP ++ L +  +D  +D + ++FE ++ G + E  T   
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK- 132

Query: 201 YKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA 260
             +SE +                ++++H + IIH D+KP N++       ++K+ DFG++
Sbjct: 133 -PLSEDQAR-----FYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDG--HIKIADFGVS 184

Query: 261 TKL-DPNEVVKISTGTAEFAAPEIV---EREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN 316
            +    + ++  + GT  F APE +    +   G   D+WA+GV  Y  + G  PF  E 
Sbjct: 185 NEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244

Query: 317 DVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
            +     +K+   EF +    +++E+ KD I R+L +N
Sbjct: 245 IMCLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKN 280

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  153 bits (389), Expect = 2e-44
 Identities = 54/275 (19%), Positives = 115/275 (41%), Gaps = 38/275 (13%)

Query: 104 SSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQ 161
           S     +  LE+IG+G FG V +C +R  G I+A K    P++ +++++   +E+     
Sbjct: 7   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 66

Query: 162 L-HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK---MSEAEVIPVTLPILM 217
           L  H  ++    A+ +DD M++  E+ +GG L + I+          EAE+  + L +  
Sbjct: 67  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126

Query: 218 TQTSPAVKHMHEKNIIHLDVKPENIM-----------------CQTRNSTNVKMIDFGLA 260
                 ++++H  +++H+D+KP NI                      N    K+ D G  
Sbjct: 127 -----GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV 181

Query: 261 TKLDPNEVVKISTGTAEFAAPEIV-EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVE 319
           T++   +V     G + F A E++ E        D++A+ +               +   
Sbjct: 182 TRISSPQVE---EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH 238

Query: 320 TLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
            ++  +           + +S+E  + ++ ++  +
Sbjct: 239 EIRQGRL------PRIPQVLSQEFTELLKVMIHPD 267

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  153 bits (389), Expect = 3e-44
 Identities = 58/259 (22%), Positives = 113/259 (43%), Gaps = 26/259 (10%)

Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP----VSHNLEKELIRKEIDIMNQLHH 164
            Y + + +G G++G V    + +T    A K +           +  ++KEI ++ +L H
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65

Query: 165 PKLINLHD--AFEDDDEMVLIFEFLSGG--ELFERITAPDYKMSEAEVIPVTLPILMTQT 220
             +I L D    E+  +M ++ E+   G  E+ + +  P+ +    +           Q 
Sbjct: 66  KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV--PEKRFPVCQAH-----GYFCQL 118

Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP---NEVVKISTGTAE 277
              ++++H + I+H D+KP N++  T     +K+   G+A  L P   ++  + S G+  
Sbjct: 119 IDGLEYLHSQGIVHKDIKPGNLLLTTGG--TLKISALGVAEALHPFAADDTCRTSQGSPA 176

Query: 278 FAAPEIV--EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEA 335
           F  PEI        GF  D+W+ GV  Y + +GL PF G+N  +  +N+    +    + 
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGD- 235

Query: 336 FKNVSEEGKDFIRRLLLRN 354
                    D ++ +L   
Sbjct: 236 ---CGPPLSDLLKGMLEYE 251

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  154 bits (389), Expect = 1e-43
 Identities = 38/295 (12%), Positives = 85/295 (28%), Gaps = 66/295 (22%)

Query: 109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK-------------- 154
                  +G           +++TG  F       +       I++              
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 155 --------------EIDIMNQLHHPKLINLHDAFEDDDEM--VLIFEFLS------GGEL 192
                           D++      K+I +     D   +    ++  +       G  L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 193 FERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNV 252
               +     +     + +TL ++       +  +H   ++H  ++P +I+   R    V
Sbjct: 194 LSHSST-HKSLVHHARLQLTLQVIR-----LLASLHHYGLVHTYLRPVDIVLDQRG--GV 245

Query: 253 KMIDFGLATKLDPNEVVKISTGTAEFAAPEIVERE-----------PVGFYTDMWAVGVL 301
            +  F    +     V   S+ +  F  PE+  R             + F  D WA+G++
Sbjct: 246 FLTGFEHLVRDGARVV---SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302

Query: 302 AYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE 356
            Y +     P   +  +   + +            KN+ +  +  +   L   KE
Sbjct: 303 IYWIWCADLPITKDAALGGSEWIFRSC--------KNIPQPVRALLEGFLRYPKE 349

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  152 bits (386), Expect = 2e-43
 Identities = 70/264 (26%), Positives = 124/264 (46%), Gaps = 42/264 (15%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELI--RKEID-------I 158
           + +D L+ +G G FG V   RE+ TG  +A K       L KE+I  + E+        +
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKI------LRKEVIIAKDEVAHTVTESRV 58

Query: 159 MNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERI------TAPDYKMSEAEVIPVT 212
           +    HP L  L  AF+  D +  + E+ +GGELF  +      T    +   AE++   
Sbjct: 59  LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVS-- 116

Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS 272
                     A++++H +++++ D+K EN+M       ++K+ DFGL  K   ++   + 
Sbjct: 117 ----------ALEYLHSRDVVYRDIKLENLMLDK--DGHIKITDFGLC-KEGISDGATMK 163

Query: 273 T--GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWE 330
           T  GT E+ APE++E    G   D W +GV+ Y ++ G  PF  ++     + +   +  
Sbjct: 164 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR 223

Query: 331 FDEEAFKNVSEEGKDFIRRLLLRN 354
           F     + +S E K  +  LL ++
Sbjct: 224 FP----RTLSPEAKSLLAGLLKKD 243

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  151 bits (384), Expect = 2e-43
 Identities = 82/263 (31%), Positives = 135/263 (51%), Gaps = 36/263 (13%)

Query: 108 DHYDILEEIGTGAFGVVHRCRE---RKTGNIFAAKFIP----VSHNLEKELIRKEIDIMN 160
           + +++L  +G G +G V + R+     TG IFA K +     V +  +    + E +I+ 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76

Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSE-------AEVIPVTL 213
           ++ HP +++L  AF+   ++ LI E+LSGGELF ++   +    E       AE+     
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISM--- 132

Query: 214 PILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST 273
                    A+ H+H+K II+ D+KPENIM   +   +VK+ DFGL  K   ++     T
Sbjct: 133 ---------ALGHLHQKGIIYRDLKPENIMLNHQG--HVKLTDFGLC-KESIHDGTVTHT 180

Query: 274 --GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEF 331
             GT E+ APEI+ R       D W++G L Y +L+G  PF GEN  +T+  +  C    
Sbjct: 181 FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL 240

Query: 332 DEEAFKNVSEEGKDFIRRLLLRN 354
                  +++E +D +++LL RN
Sbjct: 241 P----PYLTQEARDLLKKLLKRN 259

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  153 bits (389), Expect = 2e-42
 Identities = 70/266 (26%), Positives = 116/266 (43%), Gaps = 38/266 (14%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK---------EIDI 158
           D +     +G G FG V  C+ + TG ++A K       L K+ ++K         E  I
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKK------LNKKRLKKRKGYQGAMVEKKI 238

Query: 159 MNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKM---SEAEVIPVTLPI 215
           + ++H   +++L  AFE   ++ L+   ++GG++   I   D       E   I  T  I
Sbjct: 239 LAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI 298

Query: 216 LMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST-- 273
           +       ++H+H++NII+ D+KPEN++       NV++ D GLA         K     
Sbjct: 299 VS-----GLEHLHQRNIIYRDLKPENVLLDDDG--NVRISDLGLA-VELKAGQTKTKGYA 350

Query: 274 GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDV----ETLKNVKACDW 329
           GT  F APE++  E   F  D +A+GV  Y +++   PF    +     E  + V     
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL---- 406

Query: 330 EFDEEAF-KNVSEEGKDFIRRLLLRN 354
                 +    S   KDF   LL ++
Sbjct: 407 -EQAVTYPDKFSPASKDFCEALLQKD 431

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  149 bits (379), Expect = 2e-42
 Identities = 65/266 (24%), Positives = 124/266 (46%), Gaps = 45/266 (16%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELI--RKEID-IM----- 159
           + + + + +G G+FG V     +KT   FA K       L+K+++    +++  M     
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKA------LKKDVVLMDDDVECTMVEKRV 70

Query: 160 --NQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSE-------AEVIP 210
                 HP L ++   F+  + +  + E+L+GG+L   I +   K          AE+I 
Sbjct: 71  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIIL 129

Query: 211 VTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVK 270
                        ++ +H K I++ D+K +NI+       ++K+ DFG+  K +     K
Sbjct: 130 ------------GLQFLHSKGIVYRDLKLDNILLDKDG--HIKIADFGMC-KENMLGDAK 174

Query: 271 IST--GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACD 328
            +T  GT ++ APEI+  +      D W+ GVL Y +L G SPF G+++ E   +++  +
Sbjct: 175 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN 234

Query: 329 WEFDEEAFKNVSEEGKDFIRRLLLRN 354
             +     + + +E KD + +L +R 
Sbjct: 235 PFYP----RWLEKEAKDLLVKLFVRE 256

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  148 bits (377), Expect = 3e-42
 Identities = 75/260 (28%), Positives = 130/260 (50%), Gaps = 32/260 (12%)

Query: 108 DHYDILEEIGTGAFGVVHRCRE---RKTGNIFAAKFIPVSHNLEKELI--RKEIDIMNQL 162
             +++L+ +G G+FG V   ++        ++A K +  +    ++ +  + E DI+ ++
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83

Query: 163 HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERI------TAPDYKMSEAEVIPVTLPIL 216
           +HP ++ LH AF+ + ++ LI +FL GG+LF R+      T  D K   AE+        
Sbjct: 84  NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELAL------ 137

Query: 217 MTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--G 274
                 A+ H+H   II+ D+KPENI+       ++K+ DFGL+ K   +   K  +  G
Sbjct: 138 ------ALDHLHSLGIIYRDLKPENILLDEEG--HIKLTDFGLS-KESIDHEKKAYSFCG 188

Query: 275 TAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEE 334
           T E+ APE+V R       D W+ GVL + +L+G  PF G++  ET+  +          
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP-- 246

Query: 335 AFKNVSEEGKDFIRRLLLRN 354
             + +S E +  +R L  RN
Sbjct: 247 --QFLSPEAQSLLRMLFKRN 264

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  150 bits (380), Expect = 3e-42
 Identities = 69/265 (26%), Positives = 122/265 (46%), Gaps = 43/265 (16%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELI--RKEID-------- 157
             +  L+ IG G+FG V   R +     +A K       L+K+ I  +KE          
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKV------LQKKAILKKKEEKHIMSERNV 91

Query: 158 IMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERI------TAPDYKMSEAEVIPV 211
           ++  + HP L+ LH +F+  D++  + ++++GGELF  +        P  +   AE+   
Sbjct: 92  LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIAS- 150

Query: 212 TLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKI 271
                      A+ ++H  NI++ D+KPENI+  ++   ++ + DFGL  K +       
Sbjct: 151 -----------ALGYLHSLNIVYRDLKPENILLDSQG--HIVLTDFGLC-KENIEHNSTT 196

Query: 272 ST--GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDW 329
           ST  GT E+ APE++ ++P     D W +G + Y +L GL PF   N  E   N+     
Sbjct: 197 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL 256

Query: 330 EFDEEAFKNVSEEGKDFIRRLLLRN 354
           +       N++   +  +  LL ++
Sbjct: 257 QLK----PNITNSARHLLEGLLQKD 277

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  149 bits (378), Expect = 4e-42
 Identities = 66/265 (24%), Positives = 124/265 (46%), Gaps = 43/265 (16%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELI--RKEID-------- 157
           D+++ +  +G G+FG V   R ++TG+++A K       L+K++I    +++        
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKV------LKKDVILQDDDVECTMTEKRI 76

Query: 158 IMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELF------ERITAPDYKMSEAEVIPV 211
           +    +HP L  L   F+  D +  + EF++GG+L        R      +   AE+I  
Sbjct: 77  LSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIIS- 135

Query: 212 TLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKI 271
                      A+  +H+K II+ D+K +N++       + K+ DFG+  K      V  
Sbjct: 136 -----------ALMFLHDKGIIYRDLKLDNVLLDHEG--HCKLADFGMC-KEGICNGVTT 181

Query: 272 ST--GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDW 329
           +T  GT ++ APEI++    G   D WA+GVL Y +L G +PF  EN+ +  + +   + 
Sbjct: 182 ATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV 241

Query: 330 EFDEEAFKNVSEEGKDFIRRLLLRN 354
            +       + E+    ++  + +N
Sbjct: 242 VYP----TWLHEDATGILKSFMTKN 262

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  147 bits (373), Expect = 5e-42
 Identities = 74/260 (28%), Positives = 125/260 (48%), Gaps = 35/260 (13%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKL 167
             Y   E+IG GA G V+   +  TG   A + + +    +KELI  EI +M +  +P +
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79

Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
           +N  D++   DE+ ++ E+L+GG L + +T     M E ++  V    L      A++ +
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQ-----ALEFL 132

Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFAAPEIVE 285
           H   +IH D+K +NI+       +VK+ DFG   ++ P E  K ST  GT  + APE+V 
Sbjct: 133 HSNQVIHRDIKSDNILLGMDG--SVKLTDFGFCAQITP-EQSKRSTMVGTPYWMAPEVVT 189

Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGE-----------NDVETLKNVKACDWEFDEE 334
           R+  G   D+W++G++A  ++ G  P+  E           N    L+N           
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP---------- 239

Query: 335 AFKNVSEEGKDFIRRLLLRN 354
             + +S   +DF+ R L  +
Sbjct: 240 --EKLSAIFRDFLNRCLEMD 257

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  148 bits (377), Expect = 6e-42
 Identities = 65/265 (24%), Positives = 122/265 (46%), Gaps = 43/265 (16%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELI--RKEID-------- 157
             ++ L  +G G+FG V     + T  ++A K       L+K+++    +++        
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKI------LKKDVVIQDDDVECTMVEKRV 73

Query: 158 IMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELF------ERITAPDYKMSEAEVIPV 211
           +      P L  LH  F+  D +  + E+++GG+L        R   P      AE+   
Sbjct: 74  LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI- 132

Query: 212 TLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKI 271
                       +  +  K II+ D+K +N+M  +    ++K+ DFG+  K +  + V  
Sbjct: 133 -----------GLFFLQSKGIIYRDLKLDNVMLDSEG--HIKIADFGMC-KENIWDGVTT 178

Query: 272 ST--GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDW 329
            T  GT ++ APEI+  +P G   D WA GVL Y +L+G +PF GE++ E  +++   + 
Sbjct: 179 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV 238

Query: 330 EFDEEAFKNVSEEGKDFIRRLLLRN 354
            +     K++S+E     + L+ ++
Sbjct: 239 AYP----KSMSKEAVAICKGLMTKH 259

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  147 bits (373), Expect = 8e-42
 Identities = 62/262 (23%), Positives = 124/262 (47%), Gaps = 35/262 (13%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKL 167
              D   +IG G+ G+V   RE+ +G   A K + +     +EL+  E+ IM    H  +
Sbjct: 45  LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNV 104

Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
           + ++ ++   +E+ ++ EFL GG L + ++    +++E ++  V   +L      A+ ++
Sbjct: 105 VEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQ-----ALAYL 157

Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFAAPEIVE 285
           H + +IH D+K ++I+        VK+ DFG   ++   +V K  +  GT  + APE++ 
Sbjct: 158 HAQGVIHRDIKSDSILLTLDG--RVKLSDFGFCAQIS-KDVPKRKSLVGTPYWMAPEVIS 214

Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGE-----------NDVETLKNVKACDWEFDEE 334
           R       D+W++G++   ++ G  P+  +           +    LKN           
Sbjct: 215 RSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNS---------- 264

Query: 335 AFKNVSEEGKDFIRRLLLRNKE 356
               VS   +DF+ R+L+R+ +
Sbjct: 265 --HKVSPVLRDFLERMLVRDPQ 284

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  152 bits (386), Expect = 2e-41
 Identities = 67/306 (21%), Positives = 130/306 (42%), Gaps = 41/306 (13%)

Query: 66  DETGKKIRGKADEKVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVH 125
           +E  + +RG   +K  + D++      K V            + + +   IG G FG V+
Sbjct: 151 EEICQNLRGDVFQKFIESDKFTRFCQWKNVEL----NIHLTMNDFSVHRIIGRGGFGEVY 206

Query: 126 RCRERKTGNIFAAKFIPVSHNLEKELI--RKEID----------IMNQLHHPKLINLHDA 173
            CR+  TG ++A K       L+K+ I  ++             +++    P ++ +  A
Sbjct: 207 GCRKADTGKMYAMKC------LDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA 260

Query: 174 FEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNII 233
           F   D++  I + ++GG+L   ++      SEA++      I++      ++HMH + ++
Sbjct: 261 FHTPDKLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIIL-----GLEHMHNRFVV 314

Query: 234 HLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVER-EPVGFY 292
           + D+KP NI+       +V++ D GLA      +    S GT  + APE++++       
Sbjct: 315 YRDLKPANILLDEHG--HVRISDLGLA-CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSS 371

Query: 293 TDMWAVGVLAYVLLSGLSPFAGENDV---ETLKNVKACDWEFDEEAF-KNVSEEGKDFIR 348
            D +++G + + LL G SPF         E  +                + S E +  + 
Sbjct: 372 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-----TMAVELPDSFSPELRSLLE 426

Query: 349 RLLLRN 354
            LL R+
Sbjct: 427 GLLQRD 432

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  148 bits (375), Expect = 5e-41
 Identities = 68/267 (25%), Positives = 125/267 (46%), Gaps = 43/267 (16%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELI--RKEID-------I 158
           + ++ L+ +G G FG V   +E+ TG  +A K       L+KE+I  + E+        +
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKI------LKKEVIVAKDEVAHTLTENRV 201

Query: 159 MNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERI------TAPDYKMSEAEVIPVT 212
           +    HP L  L  +F+  D +  + E+ +GGELF  +      +    +   AE++   
Sbjct: 202 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS-- 259

Query: 213 LPILMTQTSPAVKHMH-EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKI 271
                     A+ ++H EKN+++ D+K EN+M       ++K+ DFGL  K    +   +
Sbjct: 260 ----------ALDYLHSEKNVVYRDLKLENLMLDKDG--HIKITDFGLC-KEGIKDGATM 306

Query: 272 ST--GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDW 329
            T  GT E+ APE++E    G   D W +GV+ Y ++ G  PF  ++  +  + +   + 
Sbjct: 307 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI 366

Query: 330 EFDEEAFKNVSEEGKDFIRRLLLRNKE 356
            F     + +  E K  +  LL ++ +
Sbjct: 367 RFP----RTLGPEAKSLLSGLLKKDPK 389

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  151 bits (382), Expect = 6e-41
 Identities = 65/265 (24%), Positives = 123/265 (46%), Gaps = 43/265 (16%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELI--RKEID-------I 158
             ++ L  +G G+FG V     + T  ++A K       L+K+++    +++       +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKI------LKKDVVIQDDDVECTMVEKRV 394

Query: 159 MNQ-LHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERI------TAPDYKMSEAEVIPV 211
           +      P L  LH  F+  D +  + E+++GG+L   I        P      AE+   
Sbjct: 395 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI- 453

Query: 212 TLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKI 271
                       +  +  K II+ D+K +N+M  +    ++K+ DFG+  K +  + V  
Sbjct: 454 -----------GLFFLQSKGIIYRDLKLDNVMLDSEG--HIKIADFGMC-KENIWDGVTT 499

Query: 272 ST--GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDW 329
            T  GT ++ APEI+  +P G   D WA GVL Y +L+G +PF GE++ E  +++   + 
Sbjct: 500 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV 559

Query: 330 EFDEEAFKNVSEEGKDFIRRLLLRN 354
            +     K++S+E     + L+ ++
Sbjct: 560 AYP----KSMSKEAVAICKGLMTKH 580

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  143 bits (363), Expect = 4e-40
 Identities = 67/275 (24%), Positives = 125/275 (45%), Gaps = 54/275 (19%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELI--RKEID-------I 158
             +D+L  IG G++  V   R +KT  I+A K       ++KEL+   ++ID       +
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKV------VKKELVNDDEDIDWVQTEKHV 62

Query: 159 MNQ-LHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSE-------AEVIP 210
             Q  +HP L+ LH  F+ +  +  + E+++GG+L   +     K+ E       AE+  
Sbjct: 63  FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISL 121

Query: 211 VTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVK 270
                       A+ ++HE+ II+ D+K +N++  +    ++K+ D+G+  K        
Sbjct: 122 ------------ALNYLHERGIIYRDLKLDNVLLDSEG--HIKLTDYGMC-KEGLRPGDT 166

Query: 271 IST--GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFA---------GENDVE 319
            ST  GT  + APEI+  E  GF  D WA+GVL + +++G SPF             +  
Sbjct: 167 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 226

Query: 320 TLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
             + +            +++S +    ++  L ++
Sbjct: 227 LFQVILEKQIRIP----RSLSVKAASVLKSFLNKD 257

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  142 bits (359), Expect = 7e-40
 Identities = 69/267 (25%), Positives = 123/267 (46%), Gaps = 38/267 (14%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKL 167
           + ++I+ E+G GAFG V++ + ++TG + AAK I      E E    EI+I+    HP +
Sbjct: 19  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYI 78

Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
           + L  A+  D ++ ++ EF  GG +   +   D  ++E ++  V   +L      A+  +
Sbjct: 79  VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLE-----ALNFL 133

Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFAAPEIVE 285
           H K IIH D+K  N++  T    ++++ DFG++ K     + K  +  GT  + APE+V 
Sbjct: 134 HSKRIIHRDLKAGNVLM-TLEG-DIRLADFGVSAKNL-KTLQKRDSFIGTPYWMAPEVVM 190

Query: 286 REPV-----GFYTDMWAVGVLAYVLLSGLSPFAGE-----------NDVETLKNVKACDW 329
            E +      +  D+W++G+    +     P               +D  TL       W
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPS--KW 248

Query: 330 EFDEEAFKNVSEEGKDFIRRLLLRNKE 356
                     S E +DF++  L +N E
Sbjct: 249 ----------SVEFRDFLKIALDKNPE 265

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  142 bits (360), Expect = 3e-39
 Identities = 64/274 (23%), Positives = 124/274 (45%), Gaps = 52/274 (18%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELI--RKEID-------I 158
             +D+L  IG G++  V   R +KT  I+A +       ++KEL+   ++ID       +
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRV------VKKELVNDDEDIDWVQTEKHV 105

Query: 159 MNQ-LHHPKLINLHDAFEDDDEMVLIFEFLSGGELF------ERITAPDYKMSEAEVIPV 211
             Q  +HP L+ LH  F+ +  +  + E+++GG+L        ++     +   AE+   
Sbjct: 106 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL- 164

Query: 212 TLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKI 271
                      A+ ++HE+ II+ D+K +N++  +    ++K+ D+G+  K         
Sbjct: 165 -----------ALNYLHERGIIYRDLKLDNVLLDSEG--HIKLTDYGMC-KEGLRPGDTT 210

Query: 272 ST--GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFA---------GENDVET 320
           ST  GT  + APEI+  E  GF  D WA+GVL + +++G SPF             +   
Sbjct: 211 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 270

Query: 321 LKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
            + +            +++S +    ++  L ++
Sbjct: 271 FQVILEKQIRIP----RSLSVKAASVLKSFLNKD 300

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  139 bits (352), Expect = 1e-38
 Identities = 54/264 (20%), Positives = 106/264 (40%), Gaps = 19/264 (7%)

Query: 97  QPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEI 156
           +PVD +             +G G+FG VHR ++++TG   A K + +     +    +E+
Sbjct: 47  KPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRL-----EVFRVEEL 101

Query: 157 DIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPIL 216
                L  P+++ L+ A  +   + +  E L GG L + I      + E   +      L
Sbjct: 102 VACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG-CLPEDRALYYLGQAL 160

Query: 217 MTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA 276
                  ++++H + I+H DVK +N++  + + +   + DFG A  L P+ + K      
Sbjct: 161 E-----GLEYLHTRRILHGDVKADNVLL-SSDGSRAALCDFGHALCLQPDGLGKSLLTGD 214

Query: 277 EFA------APEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWE 330
                    APE+V  +P     D+W+   +   +L+G  P+           + +    
Sbjct: 215 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPP 274

Query: 331 FDEEAFKNVSEEGKDFIRRLLLRN 354
             E    + +      I+  L + 
Sbjct: 275 IREIP-PSCAPLTAQAIQEGLRKE 297

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  140 bits (354), Expect = 2e-38
 Identities = 35/287 (12%), Positives = 81/287 (28%), Gaps = 51/287 (17%)

Query: 107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELI---RKEIDIMNQL- 162
                    +G           +++TG  F       +       I   ++E+  +  L 
Sbjct: 77  PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 136

Query: 163 ---------------------HHPKLINLHDAFEDDDEMVLIFEFL-------SGGELFE 194
                                  P+   +     D+ +M ++  F        +     E
Sbjct: 137 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 196

Query: 195 RITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKM 254
            + +      ++ V    L +   Q    +  +H   ++H  ++P +I+   R    V +
Sbjct: 197 VLLS-HSSTHKSLVHHARLQL-TLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG--GVFL 252

Query: 255 IDFGLATKLDPNEVVKIST--GTAEFAAPEIVEREP-----VGFYTDMWAVGVLAYVLLS 307
             F    +   + V  I       E  A  ++         + F  D W +G+  Y +  
Sbjct: 253 TGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312

Query: 308 GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
              P   +  +   + +      F      N+ +  +  +   L   
Sbjct: 313 ADLPNTDDAALGGSEWI------FRSCK--NIPQPVRALLEGFLRYP 351

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  137 bits (348), Expect = 3e-38
 Identities = 64/262 (24%), Positives = 129/262 (49%), Gaps = 35/262 (13%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKL 167
           + +D+LE++G G++G V++   ++TG I A K +PV  +L++  I KEI IM Q   P +
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE--IIKEISIMQQCDSPHV 86

Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
           +  + ++  + ++ ++ E+   G + + I   +  ++E E+  +    L       ++++
Sbjct: 87  VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLK-----GLEYL 141

Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFAAPEIVE 285
           H    IH D+K  NI+  T    + K+ DFG+A +L  + + K +T  GT  + APE+++
Sbjct: 142 HFMRKIHRDIKAGNILLNTEG--HAKLADFGVAGQLT-DTMAKRNTVIGTPFWMAPEVIQ 198

Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGE-----------NDVETLKNVKACDWEFDEE 334
                   D+W++G+ A  +  G  P+A             N   T +            
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKP---------- 248

Query: 335 AFKNVSEEGKDFIRRLLLRNKE 356
             +  S+   DF+++ L+++ E
Sbjct: 249 --ELWSDNFTDFVKQCLVKSPE 268

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  137 bits (346), Expect = 4e-38
 Identities = 68/271 (25%), Positives = 120/271 (44%), Gaps = 34/271 (12%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV-SHNLEKELIRKEIDIMNQLHHPK 166
           D Y++ E IG+GA  VV            A K I +       + + KEI  M+Q HHP 
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLP-----ILMTQTS 221
           +++ + +F   DE+ L+ + LSGG + + I    + +++ E     L       ++ +  
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIK---HIVAKGEHKSGVLDESTIATILREVL 131

Query: 222 PAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL----DPNEVVKIST--GT 275
             ++++H+   IH DVK  NI+       +V++ DFG++  L    D        T  GT
Sbjct: 132 EGLEYLHKNGQIHRDVKAGNILLGEDG--SVQIADFGVSAFLATGGDITRNKVRKTFVGT 189

Query: 276 AEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGE-----------NDVETLKN 323
             + APE++E+     F  D+W+ G+ A  L +G +P+              ND  +L+ 
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249

Query: 324 VKACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
                   D+E  K   +  +  I   L ++
Sbjct: 250 GVQ-----DKEMLKKYGKSFRKMISLCLQKD 275

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  137 bits (346), Expect = 4e-38
 Identities = 55/212 (25%), Positives = 107/212 (50%), Gaps = 13/212 (6%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV-SHNLEKELIRKEIDIMNQLHHPK 166
           + +  LE+IG G+FG V +  + +T  + A K I +     E E I++EI +++Q   P 
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81

Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKH 226
           +   + ++  D ++ +I E+L GG   + +      + E ++  +   IL       + +
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILK-----GLDY 134

Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFAAPEIV 284
           +H +  IH D+K  N++        VK+ DFG+A +L  +  +K +T  GT  + APE++
Sbjct: 135 LHSEKKIHRDIKAANVL--LSEHGEVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAPEVI 191

Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN 316
           ++       D+W++G+ A  L  G  P +  +
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGEPPHSELH 223

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  137 bits (347), Expect = 1e-37
 Identities = 75/269 (27%), Positives = 137/269 (50%), Gaps = 40/269 (14%)

Query: 108 DHYDILEEIGTGAFGVVHRCRE---RKTGNIFAAKFIP----VSHNLEKELIRKEIDIMN 160
           +++++L+ +GTGA+G V   R+     TG ++A K +     V      E  R E  ++ 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113

Query: 161 QL-HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERI------TAPDYKMSEAEVIPVTL 213
            +   P L+ LH AF+ + ++ LI ++++GGELF  +      T  + ++   E++    
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIV---- 169

Query: 214 PILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST 273
                    A++H+H+  II+ D+K ENI+    ++ +V + DFGL+ +   +E  +   
Sbjct: 170 --------LALEHLHKLGIIYRDIKLENILLD--SNGHVVLTDFGLSKEFVADETERAYD 219

Query: 274 --GTAEFAAPEIVEREPVGFYT--DMWAVGVLAYVLLSGLSPFAGEND----VETLKNVK 325
             GT E+ AP+IV     G     D W++GVL Y LL+G SPF  + +     E  + + 
Sbjct: 220 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 279

Query: 326 ACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
             +  +     + +S   KD I+RLL+++
Sbjct: 280 KSEPPYP----QEMSALAKDLIQRLLMKD 304

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  139 bits (352), Expect = 9e-37
 Identities = 53/216 (24%), Positives = 89/216 (41%), Gaps = 24/216 (11%)

Query: 108 DHYDILEEIGTGAFGVVHRCR-ERKTGNIFAAKFIPVSHNLE-KELIRKEIDIMNQLHHP 165
             Y++   I  G  G ++        G     K +  S + E + +   E   + ++ HP
Sbjct: 80  GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHP 139

Query: 166 KLINLHDAFEDDDEMV-----LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            ++ + +  E  D        ++ E++ G  L          +  AE I   L IL    
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEIL---- 192

Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEFA 279
            PA+ ++H   +++ D+KPENIM  T     +K+ID G  ++++    +     GT  F 
Sbjct: 193 -PALSYLHSIGLVYNDLKPENIM-LTEE--QLKLIDLGAVSRINSFGYLY----GTPGFQ 244

Query: 280 APEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGE 315
           APEIV   P    TD++ VG     L   L    G 
Sbjct: 245 APEIVRTGPTV-ATDIYTVGRTLAALTLDLPTRNGR 279

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  130 bits (330), Expect = 1e-35
 Identities = 81/284 (28%), Positives = 124/284 (43%), Gaps = 57/284 (20%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK----EIDIMNQLH 163
           + Y+ + +IG G++GVV +CR R TG I A K    S   +  +I+K    EI ++ QL 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE--DDPVIKKIALREIRMLKQLK 60

Query: 164 HPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPA 223
           HP L+NL + F     + L+FE+     +   +      + E  V       +  QT  A
Sbjct: 61  HPNLVNLLEVFRRKRRLHLVFEYCD-HTVLHELDRYQRGVPEHLV-----KSITWQTLQA 114

Query: 224 VKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA----TKLDP--NEVVKISTGTAE 277
           V   H+ N IH DVKPENI+    +   +K+ DFG A       D   +EV      T  
Sbjct: 115 VNFCHKHNCIHRDVKPENILITKHS--VIKLCDFGFARLLTGPSDYYDDEVA-----TRW 167

Query: 278 FAAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL------------- 321
           + +PE++  +    Y    D+WA+G +   LLSG+  + G++DV+ L             
Sbjct: 168 YRSPELLVGDT--QYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPR 225

Query: 322 -----------KNVKACDWEFD---EEAFKNVSEEGKDFIRRLL 351
                        VK  D E     E  F N+S      ++  L
Sbjct: 226 HQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCL 269

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  129 bits (326), Expect = 3e-35
 Identities = 57/251 (22%), Positives = 105/251 (41%), Gaps = 18/251 (7%)

Query: 114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQLHHPKLINLH 171
            EIG G+F  V++  + +T    A   +      + E    ++E +++  L HP ++  +
Sbjct: 32  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91

Query: 172 DAFED----DDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
           D++E        +VL+ E ++ G L   +      M    +      IL       ++ +
Sbjct: 92  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILK-----GLQFL 145

Query: 228 HEKN--IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           H +   IIH D+K +NI        +VK+ D GLAT    +   K   GT EF APE+ E
Sbjct: 146 HTRTPPIIHRDLKCDNIFITGPTG-SVKIGDLGLATLKRASF-AKAVIGTPEFMAPEMYE 203

Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD 345
            +      D++A G+    + +   P++   +   +   +           K    E K+
Sbjct: 204 EK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR-RVTSGVKPASFDKVAIPEVKE 261

Query: 346 FIRRLLLRNKE 356
            I   + +NK+
Sbjct: 262 IIEGCIRQNKD 272

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  129 bits (327), Expect = 5e-35
 Identities = 73/286 (25%), Positives = 120/286 (41%), Gaps = 61/286 (21%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK----EIDIMNQLH 163
           + Y+ L  +G G++G+V +CR + TG I A K    S   + ++++K    EI ++ QL 
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD--DDKMVKKIAMREIKLLKQLR 82

Query: 164 HPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPA 223
           H  L+NL +  +      L+FEF+    + + +      +    V        + Q    
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVD-HTILDDLELFPNGLDYQVV-----QKYLFQIING 136

Query: 224 VKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA-TKLDP-----NEVVKISTGTAE 277
           +   H  NIIH D+KPENI+        VK+ DFG A T   P     +EV      T  
Sbjct: 137 IGFCHSHNIIHRDIKPENILVSQSG--VVKLCDFGFARTLAAPGEVYDDEVA-----TRW 189

Query: 278 FAAPEIVEREPVG--FYT---DMWAVGVLAYVLLSGLSPFAGENDVETL----------- 321
           + APE++    VG   Y    D+WA+G L   +  G   F G++D++ L           
Sbjct: 190 YRAPELL----VGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLI 245

Query: 322 -------------KNVKACDWEFD---EEAFKNVSEEGKDFIRRLL 351
                          V+  + +     E  +  +SE   D  ++ L
Sbjct: 246 PRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCL 291

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  130 bits (328), Expect = 5e-35
 Identities = 64/267 (23%), Positives = 108/267 (40%), Gaps = 43/267 (16%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHH 164
             +  L EIG G+FG V+  R+ +   + A K +  S    N + + I KE+  + +L H
Sbjct: 54  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113

Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P  I     +  +    L+ E+  G    + +      + E E+  VT   L       +
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGS-ASDLLEVHKKPLQEVEIAAVTHGALQ-----GL 167

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP-NEVVKISTGTAEFAAPEI 283
            ++H  N+IH DVK  NI+        VK+ DFG A+ + P N  V    GT  + APE+
Sbjct: 168 AYLHSHNMIHRDVKAGNIL--LSEPGLVKLGDFGSASIMAPANSFV----GTPYWMAPEV 221

Query: 284 VEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGE-----------NDVETLKNVKACDW 329
           +     G Y    D+W++G+    L     P               N+   L++      
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS------ 275

Query: 330 EFDEEAFKNVSEEGKDFIRRLLLRNKE 356
                   + SE  ++F+   L +  +
Sbjct: 276 -------GHWSEYFRNFVDSCLQKIPQ 295

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  128 bits (322), Expect = 4e-34
 Identities = 50/240 (20%), Positives = 108/240 (45%), Gaps = 11/240 (4%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK-ELIRKEIDIMNQLHHPK 166
           D ++ + E+G G  GVV +   + +G + A K I +         I +E+ ++++ + P 
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92

Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKH 226
           ++  + AF  D E+ +  E + GG L +++     ++ E  +  V++ ++       + +
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIK-----GLTY 146

Query: 227 MH-EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           +  +  I+H DVKP NI+  +R    +K+ DFG++ +L  + +     GT  + +PE ++
Sbjct: 147 LREKHKIMHRDVKPSNILVNSRG--EIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQ 203

Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD 345
                  +D+W++G+    +  G  P    +  E              E        G+ 
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  127 bits (320), Expect = 4e-34
 Identities = 59/320 (18%), Positives = 111/320 (34%), Gaps = 76/320 (23%)

Query: 104 SSVY-DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN-LEKELIRKEIDIMNQ 161
           +S Y   ++ ++ +G G FGVV   + +     +A K I + +  L +E + +E+  + +
Sbjct: 1   ASRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAK 60

Query: 162 LHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSE---------------- 205
           L HP ++   +A+ +        E        E    P    S                 
Sbjct: 61  LEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFST 120

Query: 206 --------AEVIPVTLPILM------------------------------TQTSPAVKHM 227
                        V L I M                               Q + AV+ +
Sbjct: 121 KNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFL 180

Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVK-------------ISTG 274
           H K ++H D+KP NI     +   VK+ DFGL T +D +E  +                G
Sbjct: 181 HSKGLMHRDLKPSNIFFTMDD--VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238

Query: 275 TAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEE 334
           T  + +PE +         D++++G++ + LL   S       V  + +V+   +     
Sbjct: 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST--QMERVRIITDVRNLKFPLL-- 294

Query: 335 AFKNVSEEGKDFIRRLLLRN 354
            F     +    ++ +L  +
Sbjct: 295 -FTQKYPQEHMMVQDMLSPS 313

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  126 bits (318), Expect = 5e-34
 Identities = 57/257 (22%), Positives = 110/257 (42%), Gaps = 38/257 (14%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFE 175
           +G G +G+V+  R+       A K IP   +   + + +EI +   L H  ++    +F 
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 176 DDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHL 235
           ++  + +  E + GG L   + +    + + E     +     Q    +K++H+  I+H 
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT---IGFYTKQILEGLKYLHDNQIVHR 146

Query: 236 DVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS-TGTAEFAAPEIVEREPVGFYT- 293
           D+K +N++  T +   +K+ DFG + +L        + TGT ++ APEI+++ P G+   
Sbjct: 147 DIKGDNVLINTYSGV-LKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKA 205

Query: 294 -DMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEA---FK------------ 337
            D+W++G     + +G  PF                 E  E     FK            
Sbjct: 206 ADIWSLGCTIIEMATGKPPFY----------------ELGEPQAAMFKVGMFKVHPEIPE 249

Query: 338 NVSEEGKDFIRRLLLRN 354
           ++S E K FI +    +
Sbjct: 250 SMSAEAKAFILKCFEPD 266

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  124 bits (314), Expect = 3e-33
 Identities = 71/270 (26%), Positives = 136/270 (50%), Gaps = 42/270 (15%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL-HHPK 166
             ++++E +G G +G V++ R  KTG + A K + V+ + E+E I++EI+++ +  HH  
Sbjct: 24  GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRN 82

Query: 167 LINLHDAF------EDDDEMVLIFEFLSGGELFERITA-PDYKMSEAEVIPVTLPILMTQ 219
           +   + AF        DD++ L+ EF   G + + I       + E  +  +   IL   
Sbjct: 83  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR-- 140

Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAE 277
               + H+H+  +IH D+K +N++  T N+  VK++DFG++ +LD   V + +T  GT  
Sbjct: 141 ---GLSHLHQHKVIHRDIKGQNVLL-TENA-EVKLVDFGVSAQLD-RTVGRRNTFIGTPY 194

Query: 278 FAAPEIV--EREPVGFY---TDMWAVGVLAYVLLSGLSPFAGENDVETL----KN----V 324
           + APE++  +  P   Y   +D+W++G+ A  +  G  P    + +  L    +N    +
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL 254

Query: 325 KACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
           K+  W          S++ + FI   L++N
Sbjct: 255 KSKKW----------SKKFQSFIESCLVKN 274

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  121 bits (306), Expect = 2e-32
 Identities = 63/258 (24%), Positives = 117/258 (45%), Gaps = 21/258 (8%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK-ELIRKEIDI-MNQLHHP 165
           D  + + E+G GA+GVV + R   +G I A K I  + N ++ + +  ++DI M  +  P
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66

Query: 166 KLINLHDAFEDDDEMVLIFEFLSGG--ELFERITAPDYKMSEAEVIPVTLPILMTQTSPA 223
             +  + A   + ++ +  E +     + ++++      + E  +  + + I+      A
Sbjct: 67  FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK-----A 121

Query: 224 VKHMHEK-NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPE 282
           ++H+H K ++IH DVKP N++        VKM DFG++  L  +    I  G   + APE
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLINALG--QVKMCDFGISGYLVDDVAKDIDAGCKPYMAPE 179

Query: 283 -IVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAG-ENDVETLKN-VKACDWEFDEEAF 336
            I        Y+   D+W++G+    L     P+       + LK  V+    +   + F
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF 239

Query: 337 KNVSEEGKDFIRRLLLRN 354
              S E  DF  + L +N
Sbjct: 240 ---SAEFVDFTSQCLKKN 254

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  121 bits (305), Expect = 3e-32
 Identities = 60/214 (28%), Positives = 108/214 (50%), Gaps = 13/214 (6%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRK---EIDIMNQLHHPK 166
           Y I++++G G    V+   +       A K I +    ++E +++   E+   +QL H  
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72

Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKH 226
           ++++ D  E+DD   L+ E++ G  L E I +    +S    I  T  IL       +KH
Sbjct: 73  IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILD-----GIKH 126

Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFAAPEIV 284
            H+  I+H D+KP+NI+  +     +K+ DFG+A  L    + + +   GT ++ +PE  
Sbjct: 127 AHDMRIVHRDIKPQNILIDSNK--TLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQA 184

Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDV 318
           + E     TD++++G++ Y +L G  PF GE  V
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV 218

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  123 bits (309), Expect = 4e-32
 Identities = 42/221 (19%), Positives = 90/221 (40%), Gaps = 22/221 (9%)

Query: 108 DHYDILEEIGTGA--FGVVHRCRERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQLH 163
             Y++L  IG G      V+  R + TG     + I +     + +  ++ E+ +    +
Sbjct: 25  GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84

Query: 164 HPKLINLHDAFEDDDEMVLIFEFLSGGELFERITA-PDYKMSEAEVIPVTLPILMTQTSP 222
           HP ++     F  D+E+ ++  F++ G   + I       M+E  +  +   +L      
Sbjct: 85  HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLK----- 139

Query: 223 AVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN--------EVVKISTG 274
           A+ ++H    +H  VK  +I+        V +        +  +        +  K S  
Sbjct: 140 ALDYIHHMGYVHRSVKASHIL--ISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197

Query: 275 TAEFAAPEIVEREPVG--FYTDMWAVGVLAYVLLSGLSPFA 313
              + +PE++++   G    +D+++VG+ A  L +G  PF 
Sbjct: 198 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 238

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  121 bits (307), Expect = 5e-32
 Identities = 72/294 (24%), Positives = 125/294 (42%), Gaps = 59/294 (20%)

Query: 99  VDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL------I 152
           + +   S    Y+ L+ +G G F  V++ R++ T  I A K I + H  E +       +
Sbjct: 1   MALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL 60

Query: 153 RKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVT 212
           R EI ++ +L HP +I L DAF     + L+F+F+   +L   I      ++ + +    
Sbjct: 61  R-EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHI---- 114

Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA-TKLDP-----N 266
               M  T   ++++H+  I+H D+KP N++        +K+ DFGLA +   P     +
Sbjct: 115 -KAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG--VLKLADFGLAKSFGSPNRAYTH 171

Query: 267 EVVKISTGTAEFAAPEIV--EREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
           +VV     T  + APE++   R     Y    DMWAVG +   LL  +    G++D++ L
Sbjct: 172 QVV-----TRWYRAPELLFGARM----YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL 222

Query: 322 KNV-KAC------DW----------EFD-------EEAFKNVSEEGKDFIRRLL 351
             + +         W           F           F    ++  D I+ L 
Sbjct: 223 TRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLF 276

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  120 bits (304), Expect = 6e-32
 Identities = 44/217 (20%), Positives = 92/217 (42%), Gaps = 13/217 (5%)

Query: 105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELI---RKEIDIMNQ 161
           + +  Y +   +G G  G V+   +     I A K +  + + +       ++E     +
Sbjct: 31  TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGR 90

Query: 162 LHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTS 221
           L  P ++ +HD  E D ++ +    ++G +L   +      ++    + +     + Q  
Sbjct: 91  LQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRR-QGPLAPPRAVAI-----VRQIG 144

Query: 222 PAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFA 279
            A+   H     H DVKPENI+    +     ++DFG+A+     ++ ++    GT  + 
Sbjct: 145 SALDAAHAAGATHRDVKPENILVSADD--FAYLVDFGIASATTDEKLTQLGNTVGTLYYM 202

Query: 280 APEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN 316
           APE        +  D++A+  + Y  L+G  P+ G+ 
Sbjct: 203 APERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ 239

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  120 bits (302), Expect = 2e-31
 Identities = 66/287 (22%), Positives = 117/287 (40%), Gaps = 65/287 (22%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE------LIRKEIDIMNQ 161
           + Y  L+++G G +  V++ + + T N+ A K I     LE E       IR E+ ++  
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI----RLEHEEGAPCTAIR-EVSLLKD 56

Query: 162 LHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTS 221
           L H  ++ LHD    +  + L+FE+L   +L + +      ++   V      + + Q  
Sbjct: 57  LKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNV-----KLFLFQLL 110

Query: 222 PAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA-TKLDP-----NEVVKISTGT 275
             + + H + ++H D+KP+N++        +K+ DFGLA  K  P     NEVV     T
Sbjct: 111 RGLAYCHRQKVLHRDLKPQNLLI--NERGELKLADFGLARAKSIPTKTYDNEVV-----T 163

Query: 276 AEFAAPEIV--EREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL--------- 321
             +  P+I+    +    Y+   DMW VG + Y + +G   F G    E L         
Sbjct: 164 LWYRPPDILLGSTD----YSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGT 219

Query: 322 ---------------KNVKACDWEFD--EEAFKNVSEEGKDFIRRLL 351
                          K      +  +        +  +G D + +LL
Sbjct: 220 PTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLL 266

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  116 bits (293), Expect = 2e-30
 Identities = 64/286 (22%), Positives = 118/286 (41%), Gaps = 62/286 (21%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE-----LIRKEIDIMNQL 162
             Y+ LE+IG G +G V + + R+T  I A K + +    + E      +R EI ++ +L
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPSSALR-EICLLKEL 58

Query: 163 HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSP 222
            H  ++ LHD    D ++ L+FEF    +L +   + +  +    V        + Q   
Sbjct: 59  KHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIV-----KSFLFQLLK 112

Query: 223 AVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA-TKLDP-----NEVVKISTGTA 276
            +   H +N++H D+KP+N++        +K+ +FGLA     P      EVV     T 
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLINRNG--ELKLANFGLARAFGIPVRCYSAEVV-----TL 165

Query: 277 EFAAPEIV--EREPVGFYT---DMWAVGVLAYVLLSGLSP-FAGENDVETLKNV-KAC-- 327
            +  P+++   +     Y+   DMW+ G +   L +   P F G +  + LK + +    
Sbjct: 166 WYRPPDVLFGAKL----YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 221

Query: 328 ----DW----------EFD--------EEAFKNVSEEGKDFIRRLL 351
                W           +               ++  G+D ++ LL
Sbjct: 222 PTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLL 267

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  116 bits (293), Expect = 2e-30
 Identities = 63/260 (24%), Positives = 118/260 (45%), Gaps = 26/260 (10%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK-ELIRKEIDI-MNQLHHP 165
           +  + L E+G+G  G V + R RKTG++ A K +  S N E+ + I  ++D+ +     P
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84

Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++     F  + ++ +  E +      +        + E  +  +T+ I+      A+ 
Sbjct: 85  YIVQCFGTFITNTDVFIAMELMGTC-AEKLKKRMQGPIPERILGKMTVAIVK-----ALY 138

Query: 226 HMHEK-NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           ++ EK  +IH DVKP NI+   R    +K+ DFG++ +L  ++    S G A + APE +
Sbjct: 139 YLKEKHGVIHRDVKPSNILLDERG--QIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERI 196

Query: 285 EREPV--GFYT---DMWAVGVLAYVLLSGLSPFAG-ENDVETLKNVKACDWE----FDEE 334
           +        Y    D+W++G+    L +G  P+   + D E L  V     E        
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV--LQEEPPLLPGHM 254

Query: 335 AFKNVSEEGKDFIRRLLLRN 354
            F   S + + F++  L ++
Sbjct: 255 GF---SGDFQSFVKDCLTKD 271

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  116 bits (294), Expect = 3e-30
 Identities = 53/235 (22%), Positives = 101/235 (42%), Gaps = 42/235 (17%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE-----LIRKEIDIMNQL 162
           D Y  + ++G G +G V++  +  T    A K I + H  E+E      IR E+ ++ +L
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH--EEEGVPGTAIR-EVSLLKEL 90

Query: 163 HHPKLINLHDAFEDDDEMVLIFEFLSG--GELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            H  +I L      +  + LIFE+      +  ++       +S   +        + Q 
Sbjct: 91  QHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNP----DVSMRVI-----KSFLYQL 141

Query: 221 SPAVKHMHEKNIIHLDVKPENI---MCQTRNSTNVKMIDFGLA-TKLDP-----NEVVKI 271
              V   H +  +H D+KP+N+   +     +  +K+ DFGLA     P     +E++  
Sbjct: 142 INGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-- 199

Query: 272 STGTAEFAAPEIV--EREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
              T  +  PEI+   R     Y+   D+W++  +   +L     F G+++++ L
Sbjct: 200 ---TLWYRPPEILLGSRH----YSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQL 247

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  116 bits (293), Expect = 3e-30
 Identities = 60/270 (22%), Positives = 114/270 (42%), Gaps = 41/270 (15%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL-EKELIRKEIDI-MNQLHHP 165
           +    L EIG GA+G V++   + +G I A K I  + +  E++ +  ++D+ M     P
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81

Query: 166 KLINLHDAFEDDDEMVLIFEFLSGG---ELFERITAPDYKMSEAEVIPVTLPILMTQTSP 222
            ++  + A   + +  +  E +S           +  D  + E  +  +TL  +      
Sbjct: 82  YIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVK----- 136

Query: 223 AVKHMHEK-NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST-GTAEFAA 280
           A+ H+ E   IIH D+KP NI+       N+K+ DFG++ +L  + + K    G   + A
Sbjct: 137 ALNHLKENLKIIHRDIKPSNILLDRSG--NIKLCDFGISGQLV-DSIAKTRDAGCRPYMA 193

Query: 281 PEIVEREPVGF-YT---DMWAVGVLAYVLLSGLSPFAG------------ENDVETLKNV 324
           PE ++       Y    D+W++G+  Y L +G  P+              + D   L N 
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNS 253

Query: 325 KACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
           +  ++          S    +F+   L ++
Sbjct: 254 EEREF----------SPSFINFVNLCLTKD 273

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  116 bits (292), Expect = 4e-30
 Identities = 60/231 (25%), Positives = 107/231 (46%), Gaps = 34/231 (14%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE------LIRKEIDIMNQ 161
             +  LE++G G +  V++   + TG   A K +     L+ E       IR EI +M +
Sbjct: 5   SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV----KLDSEEGTPSTAIR-EISLMKE 59

Query: 162 LHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTS 221
           L H  ++ L+D    ++++ L+FEF+   +L + + +     +   +    +     Q  
Sbjct: 60  LKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118

Query: 222 PAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA-TKLDP-----NEVVKISTGT 275
             +   HE  I+H D+KP+N++   R    +K+ DFGLA     P     +EVV     T
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRG--QLKLGDFGLARAFGIPVNTFSSEVV-----T 171

Query: 276 AEFAAPEIV--EREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETL 321
             + AP+++   R     Y+   D+W+ G +   +++G   F G ND E L
Sbjct: 172 LWYRAPDVLMGSRT----YSTSIDIWSCGCILAEMITGKPLFPGTNDEEQL 218

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  114 bits (287), Expect = 2e-29
 Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 19/220 (8%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELI---RKEIDIMNQLHHPK 166
           Y++ E +G G    VH  R+ +     A K +      +       R+E      L+HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73

Query: 167 LINLHDAFEDDDEMV----LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSP 222
           ++ ++D  E +        ++ E++ G  L + +   +  M+    I V           
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQ----- 127

Query: 223 AVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST----GTAEF 278
           A+   H+  IIH DVKP NIM    N   VK++DFG+A  +  +      T    GTA++
Sbjct: 128 ALNFSHQNGIIHRDVKPANIMISATN--AVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185

Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDV 318
            +PE    + V   +D++++G + Y +L+G  PF G++ V
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  112 bits (284), Expect = 4e-29
 Identities = 65/285 (22%), Positives = 124/285 (43%), Gaps = 62/285 (21%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE-----LIRKEIDIMNQL 162
           + Y  LE+IG G +GVV++ +    G  FA K I +    E E      IR EI I+ +L
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEK--EDEGIPSTTIR-EISILKEL 57

Query: 163 HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSP 222
            H  ++ L+D       +VL+FE L   +L + +   +  +             + Q   
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTA-----KSFLLQLLN 111

Query: 223 AVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA-TKLDP-----NEVVKISTGTA 276
            + + H++ ++H D+KP+N++        +K+ DFGLA     P     +E+V     T 
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREG--ELKIADFGLARAFGIPVRKYTHEIV-----TL 164

Query: 277 EFAAPEIV--EREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETLKNV-KAC--- 327
            + AP+++   ++    Y+   D+W+VG +   +++G   F G ++ + L  + +     
Sbjct: 165 WYRAPDVLMGSKK----YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTP 220

Query: 328 ------------DWEFD---------EEAFKNVSEEGKDFIRRLL 351
                        ++ +         E   K + E G D + ++L
Sbjct: 221 NSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKML 265

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  115 bits (289), Expect = 5e-29
 Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 26/225 (11%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK--ELIRKEIDIMNQL----- 162
           Y++L+ IG G+FG V +  + K     A K +    N ++      +EI I+  L     
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMV---RNEKRFHRQAAEEIRILEHLRKQDK 155

Query: 163 ---HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK-MSEAEVIPVTLPILMT 218
               +  +I++ + F   + + + FE LS   L+E I    ++  S   V      IL  
Sbjct: 156 DNTMN--VIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQ- 211

Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
                +  +H+  IIH D+KPENI+ + +  + +K+IDFG +          I +    F
Sbjct: 212 ----CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQS---RF 264

Query: 279 -AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLK 322
             APE++     G   DMW++G +   LL+G     GE++ + L 
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLA 309

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  112 bits (283), Expect = 7e-29
 Identities = 46/227 (20%), Positives = 92/227 (40%), Gaps = 28/227 (12%)

Query: 107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQLHH 164
           ++  +I E IG G FG V+  R        A + I +  + E +L   ++E+    Q  H
Sbjct: 32  FEQLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRH 88

Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
             ++    A      + +I     G  L+  +      +   +        +  +    +
Sbjct: 89  ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTR-----QIAQEIVKGM 143

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT------KLDPNEVVKISTGTAEF 278
            ++H K I+H D+K +N+     ++  V + DFGL +           + ++I  G    
Sbjct: 144 GYLHAKGILHKDLKSKNVFY---DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200

Query: 279 AAPEIV---------EREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN 316
            APEI+         ++ P   ++D++A+G + Y L +   PF  + 
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP 247

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  112 bits (282), Expect = 1e-28
 Identities = 70/286 (24%), Positives = 127/286 (44%), Gaps = 63/286 (22%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE-----LIRKEIDIMNQL 162
           + Y  LE++G G +GVV++ ++   G I A K I +    E E      IR EI ++ +L
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDA--EDEGIPSTAIR-EISLLKEL 76

Query: 163 HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSP 222
           HHP +++L D    +  + L+FEF+   +L + +      + ++++      I + Q   
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQI-----KIYLYQLLR 130

Query: 223 AVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA-TKLDP-----NEVVKISTGTA 276
            V H H+  I+H D+KP+N++  +     +K+ DFGLA     P     +EVV     T 
Sbjct: 131 GVAHCHQHRILHRDLKPQNLLINSDG--ALKLADFGLARAFGIPVRSYTHEVV-----TL 183

Query: 277 EFAAPEIV--EREPVGFYT---DMWAVGVLAYVLLSGLSPFAGEND-------------- 317
            + AP+++   ++    Y+   D+W++G +   +++G   F G  D              
Sbjct: 184 WYRAPDVLMGSKK----YSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTP 239

Query: 318 -------VETLKNVKACD---WEFD--EEAFKNVSEEGKDFIRRLL 351
                  V+ L   K      +E            +EG D +  +L
Sbjct: 240 NPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNML 285

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  111 bits (280), Expect = 2e-28
 Identities = 51/213 (23%), Positives = 99/213 (46%), Gaps = 12/213 (5%)

Query: 107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQLHH 164
           +   +I E+IG G+FG VHR      G+  A K +       + +    +E+ IM +L H
Sbjct: 36  WCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH 93

Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P ++    A      + ++ E+LS G L+  +     +    ++       +    +  +
Sbjct: 94  PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGARE---QLDERRRLSMAYDVAKGM 150

Query: 225 KHMHEKN--IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS-TGTAEFAAP 281
            ++H +N  I+H ++K  N++   +    VK+ DFGL+       +   S  GT E+ AP
Sbjct: 151 NYLHNRNPPIVHRNLKSPNLLVDKKY--TVKVCDFGLSRLKASTFLSSKSAAGTPEWMAP 208

Query: 282 EIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAG 314
           E++  EP    +D+++ GV+ + L +   P+  
Sbjct: 209 EVLRDEPSNEKSDVYSFGVILWELATLQQPWGN 241

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  110 bits (276), Expect = 5e-28
 Identities = 50/216 (23%), Positives = 107/216 (49%), Gaps = 19/216 (8%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELI--RKEIDIMNQLHHPKLIN 169
           + + IG+G+FG V++ +        A K + V+    ++L   + E+ ++ +  H  ++ 
Sbjct: 28  VGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 84

Query: 170 LHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE 229
                    ++ ++ ++  G  L+  + A + K    ++I      +  QT+  + ++H 
Sbjct: 85  FMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLI-----DIARQTARGMDYLHA 138

Query: 230 KNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT---KLDPNEVVKISTGTAEFAAPEIVER 286
           K+IIH D+K  NI     N   VK+ DFGLAT   +   +   +  +G+  + APE++  
Sbjct: 139 KSIIHRDLKSNNIFLHEDN--TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196

Query: 287 EPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVE 319
           +    Y+   D++A G++ Y L++G  P++  N+ +
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 232

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  108 bits (273), Expect = 2e-27
 Identities = 61/288 (21%), Positives = 110/288 (38%), Gaps = 59/288 (20%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL------IRKEIDIMNQ 161
             Y+ + EIG GA+G V++ R+  +G+  A K + V +            +R E+ ++ +
Sbjct: 9   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR-EVALLRR 67

Query: 162 LH---HPKLINLHDAF-----EDDDEMVLIFEFLSG--GELFERITAPDYKMSEAEVIPV 211
           L    HP ++ L D       + + ++ L+FE +        ++   P   +    +   
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPP--GLPAETI--- 122

Query: 212 TLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP-----N 266
               LM Q    +  +H   I+H D+KPENI+  +     VK+ DFGLA           
Sbjct: 123 --KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG--TVKLADFGLARIYSYQMALTP 178

Query: 267 EVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV-K 325
            VV     T  + APE++ +       DMW+VG +   +      F G ++ + L  +  
Sbjct: 179 VVV-----TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD 233

Query: 326 AC---------------DWEFD-------EEAFKNVSEEGKDFIRRLL 351
                               F        +     + E G   +  +L
Sbjct: 234 LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEML 281

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  109 bits (274), Expect = 2e-27
 Identities = 64/292 (21%), Positives = 110/292 (37%), Gaps = 67/292 (22%)

Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI-PVSHNLEKELIRKEIDIMNQL-H 163
             D Y ++ ++G G +  V              K + PV    +K++ R EI I+  L  
Sbjct: 34  NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKR-EIKILENLRG 89

Query: 164 HPKLINLHDAFEDDDEM--VLIFEFLSGGEL---FERITAPDYKMSEAEVIPVTLPILMT 218
            P +I L D  +D       L+FE ++  +    ++ +T  D +              M 
Sbjct: 90  GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF------------YMY 137

Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           +   A+ + H   I+H DVKP N+M    +   +++ID+GLA    P +   +   +  F
Sbjct: 138 EILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYF 196

Query: 279 AAPEIVEREPVGF--YT---DMWAVGVLAYVLLSGLSP-FAGENDV-------------- 318
             PE++    V +  Y    DMW++G +   ++    P F G ++               
Sbjct: 197 KGPELL----VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 252

Query: 319 -----------------ETLKNVKACDWE--FDEEAFKNVSEEGKDFIRRLL 351
                            + L       WE     E    VS E  DF+ +LL
Sbjct: 253 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLL 304

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  108 bits (271), Expect = 2e-27
 Identities = 50/222 (22%), Positives = 101/222 (45%), Gaps = 23/222 (10%)

Query: 107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELI-------RKEIDIM 159
            +  +  ++IG G FG+VH+ R  K  ++ A K + +  +  +  +       ++E+ IM
Sbjct: 18  DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIM 77

Query: 160 NQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQ 219
           + L+HP ++ L+      +   ++ EF+  G+L+ R+    + +  +  +      LM  
Sbjct: 78  SNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKL-----RLMLD 130

Query: 220 TSPAVKHMHEKN--IIHLDVKPENI---MCQTRNSTNVKMIDFGLATKLDPNEVVKISTG 274
            +  +++M  +N  I+H D++  NI             K+ DFGL+ +      V    G
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS--VHSVSGLLG 188

Query: 275 TAEFAAPEI--VEREPVGFYTDMWAVGVLAYVLLSGLSPFAG 314
             ++ APE    E E      D ++  ++ Y +L+G  PF  
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  109 bits (274), Expect = 5e-27
 Identities = 64/286 (22%), Positives = 116/286 (40%), Gaps = 64/286 (22%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLIN 169
           Y   + IG G+FGVV++ +   +G + A K +      +K    +E+ IM +L H  ++ 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 111

Query: 170 LHDAF------EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPA 223
           L   F      +D+  + L+ +++    ++       Y  ++  +  + + + M Q   +
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVAR--HYSRAKQTLPVIYVKLYMYQLFRS 168

Query: 224 VKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFA---- 279
           + ++H   I H D+KP+N++    ++  +K+ DFG A +L   E        +       
Sbjct: 169 LAYIHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQLVRGEPN-----VSYICSRYY 222

Query: 280 -APEIVEREPVGF--YT---DMWAVG-VLAYVLLSGLSPFAGENDVETLK---------- 322
            APE++     G   YT   D+W+ G VLA  LL G   F G++ V+ L           
Sbjct: 223 RAPELI----FGATDYTSSIDVWSAGCVLAE-LLLGQPIFPGDSGVDQLVEIIKVLGTPT 277

Query: 323 -----------------NVKACDWEFDEEAFKNVSEEGKDFIRRLL 351
                             +KA  W   +        E      RLL
Sbjct: 278 REQIREMNPNYTEFKFPQIKAHPWT--KVFRPRTPPEAIALCSRLL 321

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  108 bits (271), Expect = 6e-27
 Identities = 59/254 (23%), Positives = 103/254 (40%), Gaps = 41/254 (16%)

Query: 92  SKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE- 150
           +K            V   Y+ L +IG G FG V + R RKTG   A K + + +  EKE 
Sbjct: 2   AKQYDSVECPFCDEV-SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN--EKEG 58

Query: 151 ----LIRKEIDIMNQLHHPKLINLHD--------AFEDDDEMVLIFEFLSGGELFERITA 198
                +R EI I+  L H  ++NL +               + L+F+F    +L   ++ 
Sbjct: 59  FPITALR-EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSN 116

Query: 199 PDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFG 258
              K + +E+       +M      + ++H   I+H D+K  N++        +K+ DFG
Sbjct: 117 VLVKFTLSEI-----KRVMQMLLNGLYYIHRNKILHRDMKAANVL--ITRDGVLKLADFG 169

Query: 259 LATKLDPNEVVKISTGTAE-----FAAPEIV--EREPVGFYT---DMWAVG-VLAYVLLS 307
           LA      +  + +  T       +  PE++  ER+    Y    D+W  G ++A  + +
Sbjct: 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERD----YGPPIDLWGAGCIMAE-MWT 224

Query: 308 GLSPFAGENDVETL 321
                 G  +   L
Sbjct: 225 RSPIMQGNTEQHQL 238

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  105 bits (265), Expect = 2e-26
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 19/213 (8%)

Query: 107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPK 166
           Y   ++ E +G GAFGVV + + R      A K I      E++    E+  +++++HP 
Sbjct: 7   YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQI--ESESERKAFIVELRQLSRVNHPN 62

Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERI--TAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           ++ L+ A  +   + L+ E+  GG L+  +    P    + A  +         Q S  V
Sbjct: 63  IVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAM-----SWCLQCSQGV 115

Query: 225 KHMHE---KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAP 281
            ++H    K +IH D+KP N++      T +K+ DFG A  +     +  + G+A + AP
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLL-LVAGGTVLKICDFGTACDI--QTHMTNNKGSAAWMAP 172

Query: 282 EIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAG 314
           E+ E        D+++ G++ + +++   PF  
Sbjct: 173 EVFEGSNYSEKCDVFSWGIILWEVITRRKPFDE 205

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  105 bits (263), Expect = 2e-26
 Identities = 56/222 (25%), Positives = 93/222 (41%), Gaps = 25/222 (11%)

Query: 107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELI----RKEIDIMNQL 162
           +    + E IG G FG V+R      G+  A K      + +        R+E  +   L
Sbjct: 6   FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63

Query: 163 HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM-TQTS 221
            HP +I L      +  + L+ EF  GG L   ++           IP  + +    Q +
Sbjct: 64  KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR--------IPPDILVNWAVQIA 115

Query: 222 PAVKHMHEKN---IIHLDVKPENI------MCQTRNSTNVKMIDFGLATKLDPNEVVKIS 272
             + ++H++    IIH D+K  NI           ++  +K+ DFGLA +         +
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA-REWHRTTKMSA 174

Query: 273 TGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAG 314
            G   + APE++        +D+W+ GVL + LL+G  PF G
Sbjct: 175 AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG 216

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  105 bits (265), Expect = 2e-26
 Identities = 46/223 (20%), Positives = 85/223 (38%), Gaps = 28/223 (12%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLH 171
             E +G G FG   +   R+TG +   K +       +    KE+ +M  L HP ++   
Sbjct: 14  HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73

Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN 231
                D  +  I E++ GG L   I + D +   ++ +           +  + ++H  N
Sbjct: 74  GVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRV-----SFAKDIASGMAYLHSMN 128

Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLA---------------TKLDPNEVVKISTGTA 276
           IIH D+   N +   R + NV + DFGLA                K    +      G  
Sbjct: 129 IIHRDLNSHNCL--VRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186

Query: 277 EFAAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGEN 316
            + APE++       Y    D+++ G++   ++  ++      
Sbjct: 187 YWMAPEMINGRS---YDEKVDVFSFGIVLCEIIGRVNADPDYL 226

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  106 bits (267), Expect = 4e-26
 Identities = 53/229 (23%), Positives = 103/229 (44%), Gaps = 28/229 (12%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK--ELIRKEIDIMNQL--- 162
           D Y+I   IG G+FG V +  +R      A K I    N +      + E+ ++  +   
Sbjct: 54  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII---KNKKAFLNQAQIEVRLLELMNKH 110

Query: 163 -----HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK-MSEAEVIPVTLPIL 216
                ++  +++L   F   + + L+FE LS   L++ +   +++ +S          + 
Sbjct: 111 DTEMKYY--IVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMC 167

Query: 217 MTQTSPAVKHMHEK--NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTG 274
                 A+  +     +IIH D+KPENI+      + +K++DFG + +L       I + 
Sbjct: 168 T-----ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQS- 221

Query: 275 TAEF-AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLK 322
              F  +PE++   P     DMW++G +   + +G   F+G N+V+ + 
Sbjct: 222 --RFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMN 268

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  101 bits (255), Expect = 3e-25
 Identities = 31/218 (14%), Positives = 77/218 (35%), Gaps = 23/218 (10%)

Query: 107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQLHH 164
           +   + L ++     G + + R +  GN    K + V     ++     +E   +    H
Sbjct: 9   FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66

Query: 165 PKLINLHDAFED--DDEMVLIFEFLSGGELFERI-TAPDYKMSEAEVIPVTLPILMTQTS 221
           P ++ +  A +        LI  ++  G L+  +    ++ + +++ +           +
Sbjct: 67  PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAV-----KFALDMA 121

Query: 222 PAVKHMHEKN--IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFA 279
             +  +H     I    +   ++M         ++    +      +           + 
Sbjct: 122 RGMAFLHTLEPLIPRHALNSRSVMIDEDM--TARISMADVKF----SFQSPGRMYAPAWV 175

Query: 280 APEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAG 314
           APE ++++P        DMW+  VL + L++   PFA 
Sbjct: 176 APEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  103 bits (259), Expect = 4e-25
 Identities = 63/289 (21%), Positives = 116/289 (40%), Gaps = 67/289 (23%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKL 167
             Y   + IG G+FGVV + +  ++  + A K +      +K    +E+ IM  + HP +
Sbjct: 40  IAYTNCKVIGNGSFGVVFQAKLVESDEV-AIKKVL----QDKRFKNRELQIMRIVKHPNV 94

Query: 168 INLHDAF------EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTS 221
           ++L   F      +D+  + L+ E++    ++       Y   +  +  + + + M Q  
Sbjct: 95  VDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASR--HYAKLKQTMPMLLIKLYMYQLL 151

Query: 222 PAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFA-- 279
            ++ ++H   I H D+KP+N++     S  +K+IDFG A  L   E        +     
Sbjct: 152 RSLAYIHSIGICHRDIKPQNLLL-DPPSGVLKLIDFGSAKILIAGE-----PNVSYICSR 205

Query: 280 ---APEIVEREPVGF--YT---DMWAVG-VLAYVLLSGLSPFAGENDVETLK-------- 322
              APE++     G   YT   D+W+ G V+A  L+ G   F GE+ ++ L         
Sbjct: 206 YYRAPELI----FGATNYTTNIDIWSTGCVMAE-LMQGQPLFPGESGIDQLVEIIKVLGT 260

Query: 323 -------------------NVKACDWEFDEEAF-KNVSEEGKDFIRRLL 351
                               ++   +    + F      +  D I RLL
Sbjct: 261 PSREQIKTMNPNYMEHKFPQIRPHPF---SKVFRPRTPPDAIDLISRLL 306

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  102 bits (256), Expect = 6e-25
 Identities = 64/288 (22%), Positives = 115/288 (39%), Gaps = 61/288 (21%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERK-TGNIFAAKFIPVSHNLEKE-----LIRKEIDIMNQ 161
             Y+ + EIG GA+G V + R+ K  G   A K + V     +E      IR E+ ++  
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT--GEEGMPLSTIR-EVAVLRH 67

Query: 162 LH---HPKLINLHDAF-----EDDDEMVLIFEFLSG--GELFERITAPDYKMSEAEVIPV 211
           L    HP ++ L D       + + ++ L+FE +        +++  P   +    +   
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP--GVPTETI--- 122

Query: 212 TLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA-TKLDP----N 266
               +M Q    +  +H   ++H D+KP+NI+  +     +K+ DFGLA          +
Sbjct: 123 --KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG--QIKLADFGLARIYSFQMALTS 178

Query: 267 EVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV-K 325
            VV     T  + APE++ +       D+W+VG +   +      F G +DV+ L  +  
Sbjct: 179 VVV-----TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 233

Query: 326 AC---------------DWEFD-------EEAFKNVSEEGKDFIRRLL 351
                               F        E+   ++ E GKD + + L
Sbjct: 234 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCL 281

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  103 bits (258), Expect = 7e-25
 Identities = 58/256 (22%), Positives = 104/256 (40%), Gaps = 36/256 (14%)

Query: 97  QPVDIKTSSVYDHYDIL-EEIGTGAFGVVHRCRER--KTGNIFAAKFIPVSHNLEKELIR 153
             +  +   V D ++    ++G G +G V++ + +  K    +A K I     +     R
Sbjct: 9   VKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE-GTGISMSACR 67

Query: 154 KEIDIMNQLHHPKLINLHDAFED--DDEMVLIFEFLSG--GELFERITAPDYKMSEAEVI 209
            EI ++ +L HP +I+L   F    D ++ L+F++       + +   A        ++ 
Sbjct: 68  -EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLP 126

Query: 210 PVTLPILMTQTSPAVKHMHEKNIIHLDVKPEN--IMCQTRNSTNVKMIDFGLA------- 260
              +  L+ Q    + ++H   ++H D+KP N  +M +      VK+ D G A       
Sbjct: 127 RGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 186

Query: 261 ---TKLDPNEVVKISTGTAEFAAPEIV--EREPVGFYT---DMWAVGVLAYVLLSGLSPF 312
                LDP  VV     T  + APE++   R     YT   D+WA+G +   LL+    F
Sbjct: 187 KPLADLDP-VVV-----TFWYRAPELLLGARH----YTKAIDIWAIGCIFAELLTSEPIF 236

Query: 313 AGENDVETLKNVKACD 328
               +     N    D
Sbjct: 237 HCRQEDIKTSNPYHHD 252

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  100 bits (252), Expect = 9e-25
 Identities = 27/217 (12%), Positives = 51/217 (23%), Gaps = 39/217 (17%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL---EKELIRKEIDIMNQLHH 164
             Y +L   G        +  +       A  F+     L     +        ++++  
Sbjct: 31  GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK 90

Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P +  + D        +++ E++ GG L E         S    I     +       A 
Sbjct: 91  PGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAA-----AA 142

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
              H   +      P  +        +V +         +P                   
Sbjct: 143 DAAHRAGVALSIDHPSRVR--VSIDGDVVLAYPATMPDANP------------------- 181

Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETL 321
                    D+  +G   Y LL    P         L
Sbjct: 182 -------QDDIRGIGASLYALLVNRWPLPEAGVRSGL 211

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  101 bits (254), Expect = 2e-24
 Identities = 52/237 (21%), Positives = 96/237 (40%), Gaps = 34/237 (14%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLH------ 163
           Y ++ ++G G F  V   ++       A K +     +  E    EI ++ +++      
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTK 79

Query: 164 -----HPKLINLHDAFE----DDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLP 214
                   ++ L D F     +   +V++FE L G  L   I   +++        + L 
Sbjct: 80  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHR-------GIPLI 131

Query: 215 IL---MTQTSPAVKHMHEK-NIIHLDVKPENIM----CQTRNSTNVKMIDFGLATKLDPN 266
            +     Q    + +MH +  IIH D+KPEN++        N   +K+ D G A   D +
Sbjct: 132 YVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH 191

Query: 267 EVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKN 323
               I   T E+ +PE++   P G   D+W+   L + L++G   F  +      K+
Sbjct: 192 YTNSIQ--TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  100 bits (251), Expect = 1e-23
 Identities = 56/259 (21%), Positives = 108/259 (41%), Gaps = 21/259 (8%)

Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V   Y  L+ IG+GA G+V    +       A K +  P  +    +   +E+ +M  ++
Sbjct: 60  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 119

Query: 164 HPKLINLHDAF------EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM 217
           H  +I+L + F      E+  ++ L+ E +    L         ++ + E+    +  L+
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL--------CQVIQMELDHERMSYLL 170

Query: 218 TQTSPAVKHMHEKNIIHLDVKPENIMCQTRNST-NVKMIDFGLATKLDPNEVVKISTGTA 276
            Q    +KH+H   IIH D+KP NI+     S   +K++DFGLA     + ++     T 
Sbjct: 171 YQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTR 227

Query: 277 EFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAF 336
            + APE++         D+W+VG +   ++     F G + ++    V         E  
Sbjct: 228 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 287

Query: 337 KNVSEEGKDFIRRLLLRNK 355
           K +    ++++        
Sbjct: 288 KKLQPTVRNYVENRPKYAG 306

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 95.8 bits (239), Expect = 1e-22
 Identities = 56/243 (23%), Positives = 99/243 (40%), Gaps = 44/243 (18%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAA-KFIPVSHNLEK--ELIRKEIDIMNQL---- 162
           Y+I++ +G GAFG V  C + K G    A K +    N+++  E  R EI ++  L    
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV---KNVDRYCEAARSEIQVLEHLNTTD 72

Query: 163 ----HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK-MSEAEVIPVTLPILM 217
                    + + + FE    + ++FE L G   ++ I    +       +  +   I  
Sbjct: 73  PNSTFR--CVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICK 129

Query: 218 TQTSPAVKHMHEKNIIHLDVKPENIM-----------------CQTRNSTNVKMIDFGLA 260
                +V  +H   + H D+KPENI+                  +T  + ++K++DFG A
Sbjct: 130 -----SVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184

Query: 261 TKLDPNEVVKISTGTAEF-AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVE 319
           T  D +    +ST       APE++         D+W++G +      G + F   +  E
Sbjct: 185 TYDDEHHSTLVSTR---HYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241

Query: 320 TLK 322
            L 
Sbjct: 242 HLA 244

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 96.3 bits (240), Expect = 1e-22
 Identities = 55/258 (21%), Positives = 108/258 (41%), Gaps = 19/258 (7%)

Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V   Y  L+ IG+GA G+V    +       A K +  P  +    +   +E+ +M  ++
Sbjct: 23  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 82

Query: 164 HPKLINLHDAF------EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM 217
           H  +I L + F      E+  ++ ++ E +    L         ++ + E+    +  L+
Sbjct: 83  HKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL--------CQVIQMELDHERMSYLL 133

Query: 218 TQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAE 277
            Q    +KH+H   IIH D+KP NI+   ++   +K++DFGLA     + ++     T  
Sbjct: 134 YQMLCGIKHLHSAGIIHRDLKPSNIV--VKSDCTLKILDFGLARTAGTSFMMTPYVVTRY 191

Query: 278 FAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK 337
           + APE++         D+W+VG +   ++ G   F G + ++    V         E  K
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251

Query: 338 NVSEEGKDFIRRLLLRNK 355
            +    + ++        
Sbjct: 252 KLQPTVRTYVENRPKYAG 269

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 95.1 bits (237), Expect = 3e-22
 Identities = 54/243 (22%), Positives = 98/243 (40%), Gaps = 44/243 (18%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAA-KFIPVSHNLEK--ELIRKEIDIMNQL---- 162
           Y+I+  +G G FG V  C +   G    A K I    N+ K  E  R EI+++ ++    
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKII---RNVGKYREAARLEINVLKKIKEKD 77

Query: 163 ----HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK-MSEAEVIPVTLPILM 217
                    + + D F     M + FE L G   FE +   +++      V  +   +  
Sbjct: 78  KENKFL--CVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCH 134

Query: 218 TQTSPAVKHMHEKNIIHLDVKPENIM-----------------CQTRNSTNVKMIDFGLA 260
                A++ +HE  + H D+KPENI+                  ++  +T++++ DFG A
Sbjct: 135 -----ALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189

Query: 261 TKLDPNEVVKISTGTAEF-AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVE 319
           T    +    ++T        PE++         D+W++G + +    G + F    + E
Sbjct: 190 TFDHEHHTTIVATR---HYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246

Query: 320 TLK 322
            L 
Sbjct: 247 HLV 249

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 94.6 bits (236), Expect = 3e-22
 Identities = 56/275 (20%), Positives = 115/275 (41%), Gaps = 40/275 (14%)

Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHP 165
           +   Y  L+ +G G  G+V    +       A K I ++     +   +EI I+ +L H 
Sbjct: 9   LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHD 68

Query: 166 KLINLHDAF--------------EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPV 211
            ++ + +                 + + + ++ E++   +L   +      + E      
Sbjct: 69  NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGP--LLEEHA--- 122

Query: 212 TLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTN--VKMIDFGLATKLDPNEVV 269
              + M Q    +K++H  N++H D+KP N+     N+ +  +K+ DFGLA  +DP+   
Sbjct: 123 --RLFMYQLLRGLKYIHSANVLHRDLKPANLFI---NTEDLVLKIGDFGLARIMDPHYSH 177

Query: 270 KIS-TG---TAEFAAPEIVEREPVGF--YT---DMWAVGVLAYVLLSGLSPFAGENDVET 320
           K   +    T  + +P ++    +    YT   DMWA G +   +L+G + FAG +++E 
Sbjct: 178 KGHLSEGLVTKWYRSPRLL----LSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ 233

Query: 321 LKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNK 355
           ++ +        EE  + +      +IR  +    
Sbjct: 234 MQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPH 268

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 93.9 bits (234), Expect = 9e-22
 Identities = 70/301 (23%), Positives = 122/301 (40%), Gaps = 74/301 (24%)

Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI-PVSHNLEKELIRKEIDIMNQLHH 164
           +   + +   +G GA+GVV     + TG I A K I P    L      +EI I+    H
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKH 68

Query: 165 PKLINLHDAF-----EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQ 219
             +I + +       E+ +E+ +I E +   +L   I+     +S+  +        + Q
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQM--LSDDHI-----QYFIYQ 120

Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNST-NVKMIDFGLATKLDPNEVVKISTGTAEF 278
           T  AVK +H  N+IH D+KP N++    NS  ++K+ DFGLA  +D +          + 
Sbjct: 121 TLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177

Query: 279 A-----------APEIVEREPVGF--YT---DMWAVG-VLAYVLLSGLSPFAG------- 314
                       APE++    +    Y+   D+W+ G +LA  L      F G       
Sbjct: 178 GMVEFVATRWYRAPEVM----LTSAKYSRAMDVWSCGCILAE-LFLRRPIFPGRDYRHQL 232

Query: 315 ------------ENDVETLKNVKA------------CDWEFDEEAFKNVSEEGKDFIRRL 350
                       +ND+  +++ +A                  E+ F  V+ +G D ++R+
Sbjct: 233 LLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPL---EKMFPRVNPKGIDLLQRM 289

Query: 351 L 351
           L
Sbjct: 290 L 290

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 94.5 bits (235), Expect = 2e-21
 Identities = 51/219 (23%), Positives = 102/219 (46%), Gaps = 14/219 (6%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLH 171
           +  ++G G +G V+    +K     A K +       +E + KE  +M ++ HP L+ L 
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLVQLL 282

Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDY-KMSEAEVIPVTLPILM-TQTSPAVKHMHE 229
                +    +I EF++ G L       DY +    + +   + + M TQ S A++++ +
Sbjct: 283 GVCTREPPFYIITEFMTYGNLL------DYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336

Query: 230 KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT--AEFAAPEIVERE 287
           KN IH ++   N +    +   VK+ DFGL+  +  +     +      ++ APE +   
Sbjct: 337 KNFIHRNLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 394

Query: 288 PVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
                +D+WA GVL + + + G+SP+ G +  +  + ++
Sbjct: 395 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 433

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 93.2 bits (232), Expect = 2e-21
 Identities = 59/247 (23%), Positives = 100/247 (40%), Gaps = 48/247 (19%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK--ELIRKEIDIMNQL----- 162
           + ++ ++G G FG V  C+       +A K +    N++K     + E DI+ ++     
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV---RNIKKYTRSAKIEADILKKIQNDDI 93

Query: 163 HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPIL---MTQ 219
           ++  ++  H  F   D M LIFE L G  L+E IT  +Y           +  +     +
Sbjct: 94  NNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYN-------GFHIEDIKLYCIE 145

Query: 220 TSPAVKHMHEKNIIHLDVKPENIM-----------------------CQTRNSTNVKMID 256
              A+ ++ + ++ H D+KPENI+                            ST +K+ID
Sbjct: 146 ILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205

Query: 257 FGLATKLDPNEVVKISTGTAEF-AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGE 315
           FG AT         I+T       APE++        +DMW+ G +   L +G   F   
Sbjct: 206 FGCATFKSDYHGSIINT---RQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262

Query: 316 NDVETLK 322
             +E L 
Sbjct: 263 EHMEHLA 269

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 92.7 bits (231), Expect = 2e-21
 Identities = 67/311 (21%), Positives = 114/311 (36%), Gaps = 69/311 (22%)

Query: 92  SKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL 151
           S       D ++    D + +    G G FG V   +E+ TG   A K +          
Sbjct: 7   SLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE 66

Query: 152 IRKEIDIMNQLHHPKLINLHDAF-----EDDDEM--VLIFEFLSGGELFERITAPDYKMS 204
           ++  +  +  LHHP ++ L   F      D  ++   ++ E++    L        Y   
Sbjct: 67  LQ-IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRN--YYRR 122

Query: 205 EAEVIPVTLPILMTQTSPAVKHMHEK--NIIHLDVKPENIMCQTRNSTN--VKMIDFGLA 260
           +    P+ + + + Q   ++  +H    N+ H D+KP N++    N  +  +K+ DFG A
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV---NEADGTLKLCDFGSA 179

Query: 261 TKLDPNEVVKISTGTAEFA-----APEIVEREPVGF--YT---DMWAVG-VLAYVLLSGL 309
            KL P+E        A        APE++     G   YT   D+W+VG + A  ++ G 
Sbjct: 180 KKLSPSE-----PNVAYICSRYYRAPELI----FGNQHYTTAVDIWSVGCIFAE-MMLGE 229

Query: 310 SPFAGENDV---------------------------ETLKNVKACDWE--FDEEAFKNVS 340
             F G+N                               L N K   W   F  +     +
Sbjct: 230 PIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVF-SDHSLKDA 288

Query: 341 EEGKDFIRRLL 351
           +E  D +  LL
Sbjct: 289 KEAYDLLSALL 299

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 92.1 bits (229), Expect = 5e-21
 Identities = 60/261 (22%), Positives = 96/261 (36%), Gaps = 61/261 (23%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKL 167
             Y + + +GTG+FG+V    + ++G  FA K +      +     +E+DIM  L H  +
Sbjct: 7   KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVL----QDPRYKNRELDIMKVLDHVNI 62

Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPV---------------- 211
           I L D F    +                            VI                  
Sbjct: 63  IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD 122

Query: 212 --------------TLPIL-----MTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNV 252
                         ++P+      + Q   AV  +H   I H D+KP+N++        +
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVN-SKDNTL 181

Query: 253 KMIDFGLATKLDPNEVVKISTGTAEFA-----APEIVEREPVGF--YT---DMWAVG-VL 301
           K+ DFG A KL P+E        A        APE++    +G   YT   D+W++G V 
Sbjct: 182 KLCDFGSAKKLIPSE-----PSVAYICSRFYRAPELM----LGATEYTPSIDLWSIGCVF 232

Query: 302 AYVLLSGLSPFAGENDVETLK 322
              L+ G   F+GE  ++ L 
Sbjct: 233 GE-LILGKPLFSGETSIDQLV 252

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 91.6 bits (228), Expect = 5e-21
 Identities = 58/268 (21%), Positives = 117/268 (43%), Gaps = 39/268 (14%)

Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           +   Y     +G+GA+G V    ++++G   A K +  P    +  +   +E+ ++  + 
Sbjct: 22  LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ 81

Query: 164 HPKLINLHDAF------EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM 217
           H  +I L D F       +  +  L+  F+   +L + +       SE ++       L+
Sbjct: 82  HENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLK---FSEEKIQ-----YLV 132

Query: 218 TQTSPAVKHMHEKNIIHLDVKPENIMCQTRNST-NVKMIDFGLATKLDPN---EVVKIST 273
            Q    +K++H   ++H D+KP N+     N    +K++DFGLA   D      VV    
Sbjct: 133 YQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLARHADAEMTGYVV---- 185

Query: 274 GTAEFAAPEIVEREPVGF--YT---DMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACD 328
            T  + APE++    + +  Y    D+W+VG +   +L+G + F G++ ++ L  +    
Sbjct: 186 -TRWYRAPEVI----LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 240

Query: 329 WEFDEEAFKNV-SEEGKDFIRRLLLRNK 355
                E  + +  +  K +I+ L    +
Sbjct: 241 GVPGTEFVQKLNDKAAKSYIQSLPQTPR 268

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 91.7 bits (228), Expect = 8e-21
 Identities = 57/263 (21%), Positives = 98/263 (37%), Gaps = 43/263 (16%)

Query: 92  SKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEK 149
            +       IK   V D+Y I   IG G++G V+   ++ T    A K +       ++ 
Sbjct: 10  GRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDC 69

Query: 150 ELIRKEIDIMNQLHHPKLINLHDAF-----EDDDEMVLIFEFLSGGELFERITAPDYKMS 204
           + I +EI I+N+L    +I L+D          DE+ ++ E     +L +    P + ++
Sbjct: 70  KRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIF-LT 127

Query: 205 EAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNST-NVKMIDFGLATKL 263
           E  +       ++         +HE  IIH D+KP N +    N   +VK+ DFGLA  +
Sbjct: 128 EEHIK-----TILYNLLLGENFIHESGIIHRDLKPANCLL---NQDCSVKVCDFGLARTI 179

Query: 264 DPNEVVKISTGTAEFAAPEIVEREPVGFYT------------------------DMWAVG 299
           +  +   I     E   P    +      T                        D+W+ G
Sbjct: 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG 239

Query: 300 -VLAYVLLSGLSPFAGENDVETL 321
            + A +L    S      +   L
Sbjct: 240 CIFAELLNMLQSHINDPTNRFPL 262

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 89.7 bits (223), Expect = 3e-20
 Identities = 67/281 (23%), Positives = 122/281 (43%), Gaps = 38/281 (13%)

Query: 93  KYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKE 150
            +  Q ++     V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +
Sbjct: 14  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 73

Query: 151 LIRKEIDIMNQLHHPKLINLHDAF------EDDDEMVLIFEFLSGGELFERITAPDYKMS 204
              +E+ ++  + H  +I L D F      E+ +++ L+   + G +L   +        
Sbjct: 74  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDD 132

Query: 205 EAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNST-NVKMIDFGLATKL 263
             + +       + Q    +K++H  +IIH D+KP N+     N    +K++DFGLA   
Sbjct: 133 HVQFL-------IYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHT 182

Query: 264 DPN---EVVKISTGTAEFAAPEIVEREPVGF--YT---DMWAVGVLAYVLLSGLSPFAGE 315
                  V      T  + APEI+    + +  Y    D+W+VG +   LL+G + F G 
Sbjct: 183 ADEMTGYVA-----TRWYRAPEIM----LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233

Query: 316 NDVETLKNVKACDWEFDEEAFKNV-SEEGKDFIRRLLLRNK 355
           + ++ LK +         E  K + SE  +++I+ L    K
Sbjct: 234 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 274

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 89.7 bits (223), Expect = 3e-20
 Identities = 53/313 (16%), Positives = 106/313 (33%), Gaps = 70/313 (22%)

Query: 92  SKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL 151
            +   + +  +  ++   Y +   I +G++G V    +   G   A K +  + +  + +
Sbjct: 6   GEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTV 64

Query: 152 -----------IRKEIDIMNQLHHPKLINLHDAF-----EDDDEMVLIFEFLSGGELFER 195
                      + +EI ++N  HHP ++ L D F         ++ L+ E +   +L + 
Sbjct: 65  NILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQV 123

Query: 196 ITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNST-NVKM 254
           I      +S   +        M      +  +HE  ++H D+ P NI+        ++ +
Sbjct: 124 IHDQRIVISPQHIQ-----YFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADNNDITI 175

Query: 255 IDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGF--YT---DMWAVGVLAYVLLSGL 309
            DF LA +   +           + APE+V    + F  +T   DMW+ G +   + +  
Sbjct: 176 CDFNLAREDTADANKTHYVTHRWYRAPELV----MQFKGFTKLVDMWSAGCVMAEMFNRK 231

Query: 310 SPFAGEN------------------DVETLKNVKA-------------CDWEFDEEAFKN 338
           + F G                    DV    +  A               W         
Sbjct: 232 ALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAW---TAVVPT 288

Query: 339 VSEEGKDFIRRLL 351
                 D I ++L
Sbjct: 289 ADPVALDLIAKML 301

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 88.9 bits (221), Expect = 6e-20
 Identities = 69/293 (23%), Positives = 121/293 (41%), Gaps = 66/293 (22%)

Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI-PVSHNLEKELIRKEIDIMNQLHH 164
           V   Y  L  IG GA+G+V    +       A K I P  H    +   +EI I+ +  H
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 84

Query: 165 PKLINLHDAF-----EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQ 219
             +I ++D       E   ++ ++ + +   +L++ +      +S   +        + Q
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDHIC-----YFLYQ 136

Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNST-NVKMIDFGLATKLDPNEVVKIS-TG--- 274
               +K++H  N++H D+KP N++    N+T ++K+ DFGLA   DP+       T    
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193

Query: 275 TAEFAAPEIVEREPVGF--YT---DMWAVG-VLAYVLLSGLSPFAGEN------------ 316
           T  + APEI+    +    YT   D+W+VG +LA  +LS    F G++            
Sbjct: 194 TRWYRAPEIM----LNSKGYTKSIDIWSVGCILAE-MLSNRPIFPGKHYLDQLNHILGIL 248

Query: 317 ------DVETLKNVKA------------CDWEFDEEAFKNVSEEGKDFIRRLL 351
                 D+  + N+KA              W      F N   +  D + ++L
Sbjct: 249 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWN---RLFPNADSKALDLLDKML 298

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 88.7 bits (220), Expect = 1e-19
 Identities = 52/232 (22%), Positives = 92/232 (39%), Gaps = 49/232 (21%)

Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP-VSHNLE--KELIRKEIDIMNQL 162
           + D Y+I   IGTG++G V    ++    + A K I  V  +L   K ++R EI I+N+L
Sbjct: 51  IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR-EIAILNRL 109

Query: 163 HHPKLINLHD-----AFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM 217
           +H  ++ + D       E  DE+ ++ E     +  +    P Y ++E  +       L+
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVY-LTELHI-----KTLL 162

Query: 218 TQTSPAVKHMHEKNIIHLDVKPENIMCQTRNST-NVKMIDFGLA-----TKLDPNEVVKI 271
                 VK++H   I+H D+KP N +    N   +VK+ DFGLA      +   +++   
Sbjct: 163 YNLLVGVKYVHSAGILHRDLKPANCLV---NQDCSVKVCDFGLARTVDYPENGNSQLPIS 219

Query: 272 STGTAEFAAPEIVEREPVGFYT------------------------DMWAVG 299
                         +      T                        D+W++G
Sbjct: 220 PREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG 271

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 87.0 bits (216), Expect = 1e-19
 Identities = 56/244 (22%), Positives = 93/244 (38%), Gaps = 41/244 (16%)

Query: 112 ILEEIGTGAFGVVHRCR----ERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKL 167
            L+++G G FG V  CR    +  TG + A K +  S         +EI+I+  L H  +
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73

Query: 168 INLHDAFEDDDE--MVLIFEFLSGGELFERITAPDY-KMSEAEVIPVTLPILMTQTSPAV 224
           +             + LI E+L  G L       DY +  +  +  + L    +Q    +
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLR------DYLQKHKERIDHIKLLQYTSQICKGM 127

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF----AA 280
           +++  K  IH D+   NI+ +  N   VK+ DFGL   L  ++         E      A
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENR--VKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA 185

Query: 281 PE-IVEREPVGFYT--DMWAVGVLAYVLLS----------------GLSPFAGENDVETL 321
           PE + E +   F    D+W+ GV+ Y L +                G            +
Sbjct: 186 PESLTESK---FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242

Query: 322 KNVK 325
           + +K
Sbjct: 243 ELLK 246

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 87.0 bits (216), Expect = 2e-19
 Identities = 58/271 (21%), Positives = 95/271 (35%), Gaps = 48/271 (17%)

Query: 92  SKYVPQPVDIKTSSVYDHYDI-------LEEIGTGAFGVVHRCR----ERKTGNIFAAKF 140
                Q          D           L+++G G FG V  CR    +  TG + A K 
Sbjct: 18  ENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK 77

Query: 141 IPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDE--MVLIFEFLSGGELFERITA 198
           +  S         +EI+I+  L H  ++             + LI E+L  G L      
Sbjct: 78  LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR----- 132

Query: 199 PDY-KMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDF 257
            DY +  +  +  + L    +Q    ++++  K  IH D+   NI+ +  N   VK+ DF
Sbjct: 133 -DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR--VKIGDF 189

Query: 258 GLATKLDPNEVVKISTGTAEF----AAPE-IVEREPVGFYT--DMWAVGVLAYVLLS--- 307
           GL   L  ++         E      APE + E +   F    D+W+ GV+ Y L +   
Sbjct: 190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK---FSVASDVWSFGVVLYELFTYIE 246

Query: 308 -------------GLSPFAGENDVETLKNVK 325
                        G            ++ +K
Sbjct: 247 KSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 86.1 bits (214), Expect = 3e-19
 Identities = 52/232 (22%), Positives = 94/232 (40%), Gaps = 35/232 (15%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---------SHNLEKELIRKEIDIMNQL 162
            ++ +G+GAFG V++      G       IPV         S    KE++  E  +M  +
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGE---KVKIPVAIKELREATSPKANKEILD-EAYVMASV 74

Query: 163 HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSP 222
            +P +  L         + LI + +  G L + +      +         L     Q + 
Sbjct: 75  DNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIG-----SQYLLNWCVQIAK 128

Query: 223 AVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF---- 278
            + ++ ++ ++H D+   N++ +T     VK+ DFGLA  L   E    + G  +     
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAEEKEYHAEG-GKVPIKW 185

Query: 279 AAPE-IVEREPVGFYT---DMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
            A E I+ R     YT   D+W+ GV  + L++ G  P+ G    E    ++
Sbjct: 186 MALESILHRI----YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 86.2 bits (214), Expect = 3e-19
 Identities = 48/226 (21%), Positives = 92/226 (40%), Gaps = 26/226 (11%)

Query: 112 ILEEIGTGAFGVVHRCR----ERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKL 167
            + ++G G FG V  CR       TG + A K +  S   ++   ++EI I+  LH   +
Sbjct: 27  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86

Query: 168 INLHDAFEDDDE--MVLIFEFLSGGELFERITAPDY-KMSEAEVIPVTLPILMTQTSPAV 224
           +             + L+ E+L  G L       D+ +   A +    L +  +Q    +
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLR------DFLQRHRARLDASRLLLYSSQICKGM 140

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF----AA 280
           +++  +  +H D+   NI+ ++     VK+ DFGLA  L  ++   +     +      A
Sbjct: 141 EYLGSRRCVHRDLAARNILVESEAH--VKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA 198

Query: 281 PE-IVEREPVGFYT--DMWAVGVLAYVLLS-GLSPFAGENDVETLK 322
           PE + +     F    D+W+ GV+ Y L +      +   +   + 
Sbjct: 199 PESLSDNI---FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM 241

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 85.4 bits (212), Expect = 4e-19
 Identities = 54/224 (24%), Positives = 103/224 (45%), Gaps = 24/224 (10%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLH 171
           +  ++G G +G V+    +K     A K +       +E + KE  +M ++ HP L+ L 
Sbjct: 17  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLVQLL 75

Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDY-KMSEAEVIPVTLPILM-TQTSPAVKHMHE 229
                +    +I EF++ G L       DY +    + +   + + M TQ S A++++ +
Sbjct: 76  GVCTREPPFYIITEFMTYGNLL------DYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129

Query: 230 KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF----AAPEIVE 285
           KN IH D+   N +    +   VK+ DFGL+  +  +         A+F     APE + 
Sbjct: 130 KNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTA--HAGAKFPIKWTAPESLA 185

Query: 286 REPVGFYT---DMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
                 ++   D+WA GVL + + + G+SP+ G +  +  + ++
Sbjct: 186 Y---NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 226

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 85.9 bits (213), Expect = 4e-19
 Identities = 49/235 (20%), Positives = 86/235 (36%), Gaps = 40/235 (17%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKL 167
               +LE    G FG V + +        A K  P+      +    E+  +  + H  +
Sbjct: 24  MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQ-NEYEVYSLPGMKHENI 80

Query: 168 INLHDA----FEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPA 223
           +    A       D ++ LI  F   G L + + A            V+   L       
Sbjct: 81  LQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----------VVSWNELCHIAETM 130

Query: 224 VK---HMHEK----------NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVK 270
            +   ++HE            I H D+K +N++   +N+    + DFGLA K +  +   
Sbjct: 131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVL--LKNNLTACIADFGLALKFEAGKSAG 188

Query: 271 IST---GTAEFAAPEIVEREPVGFYT-----DMWAVGVLAYVLLSGLSPFAGEND 317
            +    GT  + APE++E             DM+A+G++ + L S  +   G  D
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 85.0 bits (211), Expect = 4e-19
 Identities = 45/236 (19%), Positives = 85/236 (36%), Gaps = 39/236 (16%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV--------SHNLEKELIRKEIDIMNQLH 163
             E +G G F  + +   R+ G+        V          N  +        +M++L 
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE-AASMMSKLS 70

Query: 164 HPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM-TQTSP 222
           H  L+  +      DE +L+ EF+  G L        Y       I +   + +  Q + 
Sbjct: 71  HKHLVLNYGVCVCGDENILVQEFVKFGSLD------TYLKKNKNCINILWKLEVAKQLAA 124

Query: 223 AVKHMHEKNIIHLDVKPENIM------CQTRNSTNVKMIDFGLATKLDPNEVVKIS---T 273
           A+  + E  +IH +V  +NI+       +T N   +K+ D G++  + P ++++      
Sbjct: 125 AMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV 184

Query: 274 GTAEFAAPE-IVEREPVGFYT---DMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
                  PE I             D W+ G   + + S G  P +  +    L+  
Sbjct: 185 ------PPECIENP---KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 85.1 bits (211), Expect = 5e-19
 Identities = 40/231 (17%), Positives = 82/231 (35%), Gaps = 35/231 (15%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINL- 170
           +LE +G G +G V R   +  G   A K    S + +      E+     L H  ++   
Sbjct: 12  LLECVGKGRYGEVWRGSWQ--GENVAVKIFS-SRDEKSWFRETELYNTVMLRHENILGFI 68

Query: 171 ---HDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
                +     ++ LI  +   G L++ +      +     +      ++   +  + H+
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYLQ--LTTLDTVSCL-----RIVLSIASGLAHL 121

Query: 228 HEK--------NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVV-----KISTG 274
           H +         I H D+K +NI+   + +    + D GLA     +            G
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNIL--VKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179

Query: 275 TAEFAAPEIVEREPVGFYT------DMWAVGVLAYVLLSGLSPFAGENDVE 319
           T  + APE+++              D+WA G++ + +   +       D +
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 84.2 bits (209), Expect = 7e-19
 Identities = 54/222 (24%), Positives = 100/222 (45%), Gaps = 24/222 (10%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLH 171
            ++EIG+G FG+VH         + A K I      E++ I  E ++M +L HPKL+ L+
Sbjct: 12  FVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEEDFIE-EAEVMMKLSHPKLVQLY 69

Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDY-KMSEAEVIPVTLPILMTQTSPAVKHMHEK 230
               +   + L+ EF+  G L       DY +         TL  +       + ++ E 
Sbjct: 70  GVCLEQAPICLVTEFMEHGCLS------DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 123

Query: 231 NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF----AAPEIVER 286
            +IH D+   N +        +K+ DFG+   +  ++    S+   +F    A+PE+   
Sbjct: 124 CVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYT--SSTGTKFPVKWASPEVFSF 179

Query: 287 EPVGFYT---DMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
                Y+   D+W+ GVL + + S G  P+   ++ E ++++
Sbjct: 180 ---SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 85.8 bits (213), Expect = 7e-19
 Identities = 68/268 (25%), Positives = 125/268 (46%), Gaps = 38/268 (14%)

Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V   Y  L+ +G+GA+G V    + +TG   A K +  P    L  +   +E+ ++  + 
Sbjct: 23  VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 82

Query: 164 HPKLINLHDAF------EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM 217
           H  +I L D F      +D  +  L+  F+ G +L + +     K+ E  +       L+
Sbjct: 83  HENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQ-----FLV 134

Query: 218 TQTSPAVKHMHEKNIIHLDVKPENIMCQTRNST-NVKMIDFGLATKLDPN---EVVKIST 273
            Q    ++++H   IIH D+KP N+     N    +K++DFGLA + D      VV    
Sbjct: 135 YQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQADSEMTGYVV---- 187

Query: 274 GTAEFAAPEIVEREPVGF--YT---DMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACD 328
            T  + APE++    + +  YT   D+W+VG +   +++G + F G + ++ LK +    
Sbjct: 188 -TRWYRAPEVI----LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 242

Query: 329 WEFDEEAFKNV-SEEGKDFIRRLLLRNK 355
                E  + + S+E K++++ L    K
Sbjct: 243 GTPPAEFVQRLQSDEAKNYMKGLPELEK 270

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 86.8 bits (215), Expect = 8e-19
 Identities = 62/308 (20%), Positives = 120/308 (38%), Gaps = 36/308 (11%)

Query: 36  YGRSDPSTTSDLITTKDTFKKQIKKRQYDFDETGKKIRGKADEKVSDYDQYVF-----DI 90
           Y R     T   I       ++            K+        VS+ D Y       D 
Sbjct: 317 YCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDT 376

Query: 91  YSKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV------- 143
           Y+    +  +I+   +     +   IG G FG VH+       N      + V       
Sbjct: 377 YTMPSTRDYEIQRERIE----LGRCIGEGQFGDVHQGIYMSPEN----PAMAVAIKTCKN 428

Query: 144 --SHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDY 201
             S ++ ++ ++ E   M Q  HP ++ L     ++   + I E  + GEL        +
Sbjct: 429 CTSDSVREKFLQ-EALTMRQFDHPHIVKLIGVITENPVWI-IMELCTLGELR------SF 480

Query: 202 -KMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA 260
            ++ +  +   +L +   Q S A+ ++  K  +H D+   N++  + +   VK+ DFGL+
Sbjct: 481 LQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLS 538

Query: 261 TKLDPNEVVKISTGT--AEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGEND 317
             ++ +   K S G    ++ APE +        +D+W  GV  + +L  G+ PF G  +
Sbjct: 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 598

Query: 318 VETLKNVK 325
            + +  ++
Sbjct: 599 NDVIGRIE 606

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 84.8 bits (210), Expect = 1e-18
 Identities = 50/229 (21%), Positives = 88/229 (38%), Gaps = 35/229 (15%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLH 171
           + E IG G FG V R + R  G   A K    S          EI     L H  ++   
Sbjct: 46  LQESIGKGRFGEVWRGKWR--GEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFI 102

Query: 172 DAFEDDD----EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
            A   D+    ++ L+ ++   G LF+ +    Y ++   +I      L   T+  + H+
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMI-----KLALSTASGLAHL 155

Query: 228 HEK--------NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE-----VVKISTG 274
           H +         I H D+K +NI+   + +    + D GLA + D              G
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNIL--VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 213

Query: 275 TAEFAAPEIVEREPVGFY------TDMWAVGVLAYVLLSGLSPFAGEND 317
           T  + APE+++      +       D++A+G++ + +    S      D
Sbjct: 214 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 86.1 bits (213), Expect = 1e-18
 Identities = 50/222 (22%), Positives = 94/222 (42%), Gaps = 16/222 (7%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKL 167
           +   +  ++G G FG V       T  + A K +       +  + +E  +M +L H KL
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAFL-QEAQVMKKLRHEKL 324

Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDY-KMSEAEVIPVTLPILM-TQTSPAVK 225
           + L+    ++   + + E++S G L       D+ K    + + +   + M  Q +  + 
Sbjct: 325 VQLYAVVSEEPIYI-VTEYMSKGSLL------DFLKGETGKYLRLPQLVDMAAQIASGMA 377

Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT--AEFAAPEI 283
           ++   N +H D++  NI+         K+ DFGLA  ++ NE           ++ APE 
Sbjct: 378 YVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 435

Query: 284 VEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
                    +D+W+ G+L   L + G  P+ G  + E L  V
Sbjct: 436 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 477

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 84.0 bits (208), Expect = 5e-18
 Identities = 51/223 (22%), Positives = 94/223 (42%), Gaps = 18/223 (8%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKL 167
           +   +  ++G G FG V       T  + A K +       +  + +E  +M +L H KL
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAFL-QEAQVMKKLRHEKL 241

Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM---TQTSPAV 224
           + L+    ++   + + E++S G L + +     K        + LP L+    Q +  +
Sbjct: 242 VQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGK-------YLRLPQLVDMAAQIASGM 293

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT--AEFAAPE 282
            ++   N +H D++  NI+         K+ DFGLA  ++ NE           ++ APE
Sbjct: 294 AYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 351

Query: 283 IVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
                     +D+W+ G+L   L + G  P+ G  + E L  V
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 394

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 82.0 bits (203), Expect = 7e-18
 Identities = 50/184 (27%), Positives = 76/184 (41%), Gaps = 18/184 (9%)

Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHP 165
           V + Y +  +IG+G+FG ++   +   G   A K        +   +  E  I   +   
Sbjct: 7   VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL--ECVKTKHPQLHIESKIYKMMQGG 64

Query: 166 KLI-NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
             I  +     + D  V++ E L G  L +       K S   V+     +L  Q    +
Sbjct: 65  VGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVL-----LLADQMISRI 118

Query: 225 KHMHEKNIIHLDVKPENI-MCQTRNSTNVKMIDFGLATK-LDPNEVVKIS-------TGT 275
           +++H KN IH DVKP+N  M   +    V +IDFGLA K  D      I        TGT
Sbjct: 119 EYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 178

Query: 276 AEFA 279
           A +A
Sbjct: 179 ARYA 182

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 81.6 bits (202), Expect = 8e-18
 Identities = 48/215 (22%), Positives = 84/215 (39%), Gaps = 27/215 (12%)

Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHP 165
           V  HY +   IG G+FGV+            A KF       +   +R E      L   
Sbjct: 8   VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF--EPRRSDAPQLRDEYRTYKLLAGC 65

Query: 166 KLI-NLHDAFEDDDEMVLIFEFL--SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSP 222
             I N++   ++    VL+ + L  S  +L +       K S   V      +   Q   
Sbjct: 66  TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL---CGRKFSVKTVA-----MAAKQMLA 117

Query: 223 AVKHMHEKNIIHLDVKPENIMC---QTRNSTNVKMIDFGLATK-LDPNEVVKIS------ 272
            V+ +HEK++++ D+KP+N +     ++N+  + ++DFG+     DP     I       
Sbjct: 118 RVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN 177

Query: 273 -TGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLL 306
            +GTA + +             D+ A   L +V +
Sbjct: 178 LSGTARYMSINTHLGREQSRRDDLEA---LGHVFM 209

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 82.7 bits (205), Expect = 8e-18
 Identities = 51/223 (22%), Positives = 97/223 (43%), Gaps = 22/223 (9%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL-IRKEIDIMNQLHHPKLINL 170
           + E+IG G FG V   R R    + A K    +   + +    +E  I+ Q  HP ++ L
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177

Query: 171 HDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM-TQTSPAVKHMHE 229
                    + ++ E + GG+         +  +E   + V   + M    +  ++++  
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFL------TFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231

Query: 230 KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF----AAPEIVE 285
           K  IH D+   N +   +N   +K+ DFG++ + + + V   S G  +      APE + 
Sbjct: 232 KCCIHRDLAARNCLVTEKNV--LKISDFGMS-REEADGVYAASGGLRQVPVKWTAPEALN 288

Query: 286 REPVGFYT---DMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
               G Y+   D+W+ G+L +   S G SP+   ++ +T + V
Sbjct: 289 Y---GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV 328

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 81.1 bits (201), Expect = 1e-17
 Identities = 52/222 (23%), Positives = 97/222 (43%), Gaps = 24/222 (10%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLH 171
           +L+E+G+G FGVV   + +   ++ A K I      E E   +E   M +L HPKL+  +
Sbjct: 12  LLKELGSGQFGVVKLGKWKGQYDV-AVKMIKEGSMSEDEFF-QEAQTMMKLSHPKLVKFY 69

Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM-TQTSPAVKHMHEK 230
                +  + ++ E++S G L       +Y  S  + +  +  + M       +  +   
Sbjct: 70  GVCSKEYPIYIVTEYISNGCLL------NYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH 123

Query: 231 NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF----AAPEIVER 286
             IH D+   N +        VK+ DFG+   +  ++   +S+   +F    +APE+   
Sbjct: 124 QFIHRDLAARNCLVDRDLC--VKVSDFGMTRYVLDDQY--VSSVGTKFPVKWSAPEVFHY 179

Query: 287 EPVGFYT---DMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
                Y+   D+WA G+L + + S G  P+    + E +  V
Sbjct: 180 ---FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV 218

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 81.6 bits (202), Expect = 1e-17
 Identities = 44/230 (19%), Positives = 93/230 (40%), Gaps = 32/230 (13%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV--------SHNLEKELIRKEIDIMNQLH 163
           I + IG+G  G V   R R  G     + +PV            ++     E  IM Q  
Sbjct: 53  IEKIIGSGDSGEVCYGRLRVPGQ----RDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108

Query: 164 HPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDY-KMSEAEVIPVTLPILMTQTSP 222
           HP +I L          +++ E++  G L        + +  + +   + L  ++     
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLD------TFLRTHDGQFTIMQLVGMLRGVGA 162

Query: 223 AVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF---- 278
            ++++ +   +H D+   N++  +      K+ DFGL+  L+ +     +T   +     
Sbjct: 163 GMRYLSDLGYVHRDLAARNVLVDSNLV--CKVSDFGLSRVLEDDPDAAYTTTGGKIPIRW 220

Query: 279 AAPEIVEREPVGFYT---DMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
            APE +       ++   D+W+ GV+ + +L+ G  P+    + + + +V
Sbjct: 221 TAPEAIAF---RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 81.6 bits (202), Expect = 1e-17
 Identities = 52/232 (22%), Positives = 95/232 (40%), Gaps = 35/232 (15%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---------SHNLEKELIRKEIDIMNQL 162
            ++ +G+GAFG V++      G       IPV         S    KE++  E  +M  +
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGE---KVKIPVAIKELREATSPKANKEILD-EAYVMASV 74

Query: 163 HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSP 222
            +P +  L         + LI + +  G L + +      +         L     Q + 
Sbjct: 75  DNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIG-----SQYLLNWCVQIAK 128

Query: 223 AVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF---- 278
            + ++ ++ ++H D+   N++ +T    +VK+ DFGLA  L   E    + G  +     
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQ--HVKITDFGLAKLLGAEEKEYHAEG-GKVPIKW 185

Query: 279 AAPE-IVEREPVGFYT---DMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
            A E I+ R     YT   D+W+ GV  + L++ G  P+ G    E    ++
Sbjct: 186 MALESILHRI----YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 82.0 bits (203), Expect = 1e-17
 Identities = 54/227 (23%), Positives = 105/227 (46%), Gaps = 48/227 (21%)

Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V   Y++++++G GA+G+V +  +R+TG + A K I     ++ + +   +EI I+ +L 
Sbjct: 7   VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELS 66

Query: 164 -HPKLINLHDAF--EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            H  ++NL +    ++D ++ L+F+++   +L   I A    +            ++ Q 
Sbjct: 67  GHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRANI--LEPVHK-----QYVVYQL 118

Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNST-NVKMIDFGLATKLDPNEVVKISTGTAEFA 279
              +K++H   ++H D+KP NI+    N+  +VK+ DFGL+        V  +   +   
Sbjct: 119 IKVIKYLHSGGLLHRDMKPSNILL---NAECHVKVADFGLSRSFVNIRRVTNNIPLSINE 175

Query: 280 ----------------------APEIVEREPVGF--YT---DMWAVG 299
                                 APEI+    +G   YT   DMW++G
Sbjct: 176 NTENFDDDQPILTDYVATRWYRAPEIL----LGSTKYTKGIDMWSLG 218

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 81.6 bits (202), Expect = 1e-17
 Identities = 46/231 (19%), Positives = 96/231 (41%), Gaps = 33/231 (14%)

Query: 112 ILEEIGTGAFGVVHRCR---ERKTGNIFAA----KFIPVSHNLEKELIRKEIDIMNQLHH 164
            L+ +G+G FG VH+     E ++  I       +      + +       +  +  L H
Sbjct: 17  KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVT--DHMLAIGSLDH 74

Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDY-KMSEAEVIPVTLPILMTQTSPA 223
             ++ L         + L+ ++L  G L       D+ +     + P  L     Q +  
Sbjct: 75  AHIVRLL-GLCPGSSLQLVTQYLPLGSLL------DHVRQHRGALGPQLLLNWGVQIAKG 127

Query: 224 VKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF----A 279
           + ++ E  ++H ++   N++ ++ +   V++ DFG+A  L P++   + +  A+      
Sbjct: 128 MYYLEEHGMVHRNLAARNVLLKSPSQ--VQVADFGVADLLPPDDKQLLYSE-AKTPIKWM 184

Query: 280 APE-IVEREPVGFYT---DMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
           A E I   +    YT   D+W+ GV  + L++ G  P+AG    E    ++
Sbjct: 185 ALESIHFGK----YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 81.7 bits (202), Expect = 1e-17
 Identities = 37/231 (16%), Positives = 78/231 (33%), Gaps = 35/231 (15%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINL- 170
           ++++IG G +G V   + R  G   A K    +          EI     + H  ++   
Sbjct: 41  MVKQIGKGRYGEVWMGKWR--GEKVAVKVFF-TTEEASWFRETEIYQTVLMRHENILGFI 97

Query: 171 ---HDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
                      ++ LI ++   G L++ +      +    ++      L   +   + H+
Sbjct: 98  AADIKGTGSWTQLYLITDYHENGSLYDYLK--STTLDAKSML-----KLAYSSVSGLCHL 150

Query: 228 HEKN--------IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE-----VVKISTG 274
           H +         I H D+K +NI+   + +    + D GLA K   +            G
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNIL--VKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208

Query: 275 TAEFAAPEI------VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVE 319
           T  +  PE+                DM++ G++ + +           + +
Sbjct: 209 TKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 80.8 bits (200), Expect = 2e-17
 Identities = 49/214 (22%), Positives = 80/214 (37%), Gaps = 34/214 (15%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---------SHNLEKELIRKEIDIMNQL 162
            + ++G G FG V       T +        V                  + EIDI+  L
Sbjct: 35  KIRDLGEGHFGKVSLYCYDPTND---GTGEMVAVKALKADAGPQHRSGWKQ-EIDILRTL 90

Query: 163 HHPKLINLHDAFEDDDE--MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
           +H  +I      ED     + L+ E++  G L       DY +    +    L +   Q 
Sbjct: 91  YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLR------DY-LPRHSIGLAQLLLFAQQI 143

Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF-- 278
              + ++H ++ IH D+   N++        VK+ DFGLA  +             +   
Sbjct: 144 CEGMAYLHAQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDGDSPV 201

Query: 279 --AAPE-IVEREPVGFYT--DMWAVGVLAYVLLS 307
              APE + E +   FY   D+W+ GV  Y LL+
Sbjct: 202 FWYAPECLKEYK---FYYASDVWSFGVTLYELLT 232

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 80.3 bits (199), Expect = 2e-17
 Identities = 56/222 (25%), Positives = 99/222 (44%), Gaps = 24/222 (10%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLH 171
            L+E+GTG FGVV   + R   ++ A K I      E E I  E  +M  L H KL+ L+
Sbjct: 28  FLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIE-EAKVMMNLSHEKLVQLY 85

Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM-TQTSPAVKHMHEK 230
                   + +I E+++ G L       +Y             + M      A++++  K
Sbjct: 86  GVCTKQRPIFIITEYMANGCLL------NYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 139

Query: 231 NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF----AAPEIVER 286
             +H D+   N +   +    VK+ DFGL+  +  +E    S+  ++F    + PE++  
Sbjct: 140 QFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDDEYT--SSVGSKFPVRWSPPEVLMY 195

Query: 287 EPVGFYT---DMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
                ++   D+WA GVL + + S G  P+    + ET +++
Sbjct: 196 ---SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 234

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 80.0 bits (198), Expect = 3e-17
 Identities = 55/228 (24%), Positives = 92/228 (40%), Gaps = 27/228 (11%)

Query: 112 ILEEIGTGAFGVVHR--CRERKTGNIFAA----KFIPVSHNLEKELIRKEIDIMNQLHHP 165
           +LE++G G+FGVV R          +  A    K   +S     +   +E++ M+ L H 
Sbjct: 22  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81

Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            LI L+        M ++ E    G L +R+               TL     Q +  + 
Sbjct: 82  NLIRLY-GVVLTPPMKMVTELAPLGSLLDRLRKHQGHFL-----LGTLSRYAVQVAEGMG 135

Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF----AAP 281
           ++  K  IH D+   N++  TR+   VK+ DFGL   L  N+   +     +      AP
Sbjct: 136 YLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 193

Query: 282 E-IVEREPVGFYT---DMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
           E +  R     ++   D W  GV  + + + G  P+ G N  + L  +
Sbjct: 194 ESLKTRT----FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 80.0 bits (198), Expect = 3e-17
 Identities = 45/242 (18%), Positives = 98/242 (40%), Gaps = 37/242 (15%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV--------SHNLEKELIRKEIDIMNQLH 163
           +  E+G GAFG V                + V        +    K+  R E +++  L 
Sbjct: 19  LKRELGEGAFGKVFLAECY--NLSPTKDKMLVAVKALKDPTLAARKDFQR-EAELLTNLQ 75

Query: 164 HPKLINLHDAFEDDDEMVLIFEFLSGGEL--FERITAPDYKMSEAEVI-----PVTLPIL 216
           H  ++  +    D D ++++FE++  G+L  F R   PD  +            + L  +
Sbjct: 76  HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135

Query: 217 M---TQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST 273
           +   +Q +  + ++  ++ +H D+   N +        VK+ DFG++  +   +  ++  
Sbjct: 136 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL--VKIGDFGMSRDVYSTDYYRV-G 192

Query: 274 GTAEF----AAPE-IVEREPVGFYT---DMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
           G          PE I+       +T   D+W+ GV+ + + + G  P+   ++ E ++ +
Sbjct: 193 GHTMLPIRWMPPESIMY----RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 248

Query: 325 KA 326
             
Sbjct: 249 TQ 250

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 80.0 bits (198), Expect = 4e-17
 Identities = 46/215 (21%), Positives = 89/215 (41%), Gaps = 34/215 (15%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---------SHNLEKELIRKEIDIMNQL 162
            + ++G G FG V  CR    G+        V           N   +L + EI+I+  L
Sbjct: 25  RIRDLGEGHFGKVELCRYDPEGD---NTGEQVAVKSLKPESGGNHIADLKK-EIEILRNL 80

Query: 163 HHPKLINLHDAFEDDDE--MVLIFEFLSGGELFERITAPDY-KMSEAEVIPVTLPILMTQ 219
           +H  ++       +D    + LI EFL  G L       +Y   ++ ++          Q
Sbjct: 81  YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLK------EYLPKNKNKINLKQQLKYAVQ 134

Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF- 278
               + ++  +  +H D+   N++ ++ +   VK+ DFGL   ++ ++         +  
Sbjct: 135 ICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAIETDKEYYTVKDDRDSP 192

Query: 279 ---AAPE-IVEREPVGFYT--DMWAVGVLAYVLLS 307
               APE +++ +   FY   D+W+ GV  + LL+
Sbjct: 193 VFWYAPECLMQSK---FYIASDVWSFGVTLHELLT 224

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 80.9 bits (200), Expect = 5e-17
 Identities = 57/224 (25%), Positives = 101/224 (45%), Gaps = 26/224 (11%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLH 171
           + +++G G FG V      K   + A K +       +  +  E ++M  L H KL+ LH
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSMSVEAFL-AEANVMKTLQHDKLVKLH 249

Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDY-KMSEAEVIPVTLPILM-TQTSPAVKHMHE 229
                +   + I EF++ G L       D+ K  E    P+   I    Q +  +  + +
Sbjct: 250 AVVTKEPIYI-ITEFMAKGSLL------DFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302

Query: 230 KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFA----APEIVE 285
           +N IH D++  NI+         K+ DFGLA  ++ NE      G A+F     APE + 
Sbjct: 303 RNYIHRDLRAANILVSASL--VCKIADFGLARVIEDNEYTA-REG-AKFPIKWTAPEAIN 358

Query: 286 REPVGFYT---DMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
               G +T   D+W+ G+L   +++ G  P+ G ++ E ++ ++
Sbjct: 359 ---FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 81.5 bits (201), Expect = 5e-17
 Identities = 52/226 (23%), Positives = 96/226 (42%), Gaps = 32/226 (14%)

Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPV--------SHNLEKELIRKEIDIMNQLHHPK 166
           E+G G FG V +   R        K I V        +   + E + +E  IM+QL +P 
Sbjct: 343 ELGCGNFGSVRQGVYRMRK-----KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPY 397

Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKH 226
           ++ L       + ++L+ E   GG L + +          E+    +  L+ Q S  +K+
Sbjct: 398 IVRLI-GVCQAEALMLVMEMAGGGPLHKFL-----VGKREEIPVSNVAELLHQVSMGMKY 451

Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF----AAPE 282
           + EKN +H ++   N++   R+    K+ DFGL+  L  ++    +    ++     APE
Sbjct: 452 LEEKNFVHRNLAARNVLLVNRHY--AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 509

Query: 283 IVEREPVGFYT---DMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
            +       ++   D+W+ GV  +  LS G  P+      E +  +
Sbjct: 510 CINF---RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 552

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 80.8 bits (199), Expect = 5e-17
 Identities = 57/213 (26%), Positives = 90/213 (42%), Gaps = 25/213 (11%)

Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHP 165
           V + + +  +IG+G+FG ++     +T    A K   V    +   +  E  I   L   
Sbjct: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV--KTKHPQLLYESKIYRILQGG 62

Query: 166 KLI-NLHDAFEDDDEMVLIFEFL--SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSP 222
             I N+     + D  VL+ + L  S  +LF        K+S   V+     +L  Q   
Sbjct: 63  TGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFC---SRKLSLKTVL-----MLADQMIN 114

Query: 223 AVKHMHEKNIIHLDVKPENI-MCQTRNSTNVKMIDFGLATK-LDPNEVVKIS-------T 273
            V+ +H K+ +H D+KP+N  M   R +  V +IDFGLA K  D +    I        T
Sbjct: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174

Query: 274 GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLL 306
           GTA +A+             D+ +   L YVL+
Sbjct: 175 GTARYASVNTHLGIEQSRRDDLES---LGYVLM 204

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 79.2 bits (196), Expect = 5e-17
 Identities = 54/227 (23%), Positives = 98/227 (43%), Gaps = 34/227 (14%)

Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPV--------SHNLEKELIRKEIDIMNQLHHPK 166
           E+G G FG V +   R        K I V        +   + E + +E  IM+QL +P 
Sbjct: 17  ELGCGNFGSVRQGVYRMRK-----KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPY 71

Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKH 226
           ++ L       + ++L+ E   GG L + +     ++         +  L+ Q S  +K+
Sbjct: 72  IVRLI-GVCQAEALMLVMEMAGGGPLHKFLVGKREEIP-----VSNVAELLHQVSMGMKY 125

Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF----AAPE 282
           + EKN +H D+   N++   R+    K+ DFGL+  L  ++    +    ++     APE
Sbjct: 126 LEEKNFVHRDLAARNVLLVNRH--YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 183

Query: 283 -IVEREPVGFYT---DMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
            I  R+    ++   D+W+ GV  +  LS G  P+      E +  +
Sbjct: 184 CINFRK----FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 226

>2nzi_A Titin; IG-domain, FNIII-domain, transferase; 2.90A {Homo sapiens} Length = 305

 Score = 79.0 bits (195), Expect = 8e-17
 Identities = 21/51 (41%), Positives = 27/51 (52%)

Query: 2   SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD 52
             W+RVG  R T   +  L     Y+FRV AEN +G S PS  S+   TK+
Sbjct: 243 ERWLRVGQARETRYTVINLFGKTSYQFRVIAENKFGLSKPSEPSEPTITKE 293

>1x5y_A Myosin binding protein C, fast-type; fast MYBP-C, fibronectin type III domain containing protein, cytoskeleton, muscle contraction; NMR {Mus musculus} SCOP: b.1.2.1 Length = 111

 Score = 74.3 bits (183), Expect = 1e-16
 Identities = 13/54 (24%), Positives = 23/54 (42%), Gaps = 2/54 (3%)

Query: 2   SSWIRV--GNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDT 53
             W+             +  L  G +  FRV   N+ GRS+P+T    +T +++
Sbjct: 53  EEWVPANKEPVERCGFTVKDLPTGARILFRVVGVNIAGRSEPATLLQPVTIRES 106

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 78.0 bits (193), Expect = 1e-16
 Identities = 56/224 (25%), Positives = 100/224 (44%), Gaps = 26/224 (11%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLH 171
           ++E +G G FG V          + A K +          +  E ++M QL H +L+ L+
Sbjct: 17  LVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDAFL-AEANLMKQLQHQRLVRLY 74

Query: 172 DAFEDDDEMVLIFEFLSGGELFERITAPDY-KMSEAEVIPVTLPILM-TQTSPAVKHMHE 229
                +   + I E++  G L       D+ K      + +   + M  Q +  +  + E
Sbjct: 75  AVVTQEPIYI-ITEYMENGSLV------DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 230 KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF----AAPEIVE 285
           +N IH D++  NI+     S   K+ DFGLA  ++ NE      G A+F     APE + 
Sbjct: 128 RNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEYTA-REG-AKFPIKWTAPEAIN 183

Query: 286 REPVGFYT---DMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
               G +T   D+W+ G+L   +++ G  P+ G  + E ++N++
Sbjct: 184 Y---GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 78.6 bits (194), Expect = 1e-16
 Identities = 44/188 (23%), Positives = 74/188 (39%), Gaps = 24/188 (12%)

Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHP 165
           V  ++ + ++IG G FG +   +   T    A K            +  E     QL   
Sbjct: 7   VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL--EPMKSRAPQLHLEYRFYKQLGSG 64

Query: 166 KLI-NLHDAFEDDDEMVLIFEFL--SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSP 222
             I  ++          ++ E L  S  +LF+     D   S   V+     ++  Q   
Sbjct: 65  DGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDL---CDRTFSLKTVL-----MIAIQLIS 116

Query: 223 AVKHMHEKNIIHLDVKPENIM---CQTRNSTNVKMIDFGLATK-LDPNEVVKIS------ 272
            ++++H KN+I+ DVKPEN +      +    + +IDF LA + +DP     I       
Sbjct: 117 RMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKS 176

Query: 273 -TGTAEFA 279
            TGTA + 
Sbjct: 177 LTGTARYM 184

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 78.1 bits (193), Expect = 1e-16
 Identities = 52/229 (22%), Positives = 93/229 (40%), Gaps = 38/229 (16%)

Query: 115 EIGTGAFGVVHRCRERKTGNIFAAKFIPV----------SHNLEKELIRKEIDIMNQLHH 164
           E+G+G FG V +   +            V             L+ EL+  E ++M QL +
Sbjct: 24  ELGSGNFGTVKKGYYQMKK-----VVKTVAVKILKNEANDPALKDELLA-EANVMQQLDN 77

Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P ++ +     + +  +L+ E    G L        Y      V    +  L+ Q S  +
Sbjct: 78  PYIVRMI-GICEAESWMLVMEMAELGPLN------KYLQQNRHVKDKNIIELVHQVSMGM 130

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF----AA 280
           K++ E N +H D+   N++  T++    K+ DFGL+  L  +E    +    ++     A
Sbjct: 131 KYLEESNFVHRDLAARNVLLVTQH--YAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 188

Query: 281 PE-IVEREPVGFYT---DMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
           PE I   +    ++   D+W+ GVL +   S G  P+ G    E    +
Sbjct: 189 PECINYYK----FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 233

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 77.2 bits (191), Expect = 3e-16
 Identities = 48/242 (19%), Positives = 102/242 (42%), Gaps = 38/242 (15%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---------SHNLEKELIRKEIDIMNQL 162
            +EE+G   FG V++      G     +   V            L +E    E  +  +L
Sbjct: 13  FMEELGEDRFGKVYKGHLF--GPAPGEQTQAVAIKTLKDKAEGPLREEFRH-EAMLRARL 69

Query: 163 HHPKLINLHDAFEDDDEMVLIFEFLSGGEL--FERITAPDYKMSEAEVIPVTLPIL---- 216
            HP ++ L      D  + +IF + S G+L  F  + +P   +   +        L    
Sbjct: 70  QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129

Query: 217 ----MTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS 272
               + Q +  ++++   +++H D+   N++   + +  VK+ D GL  ++   +  K+ 
Sbjct: 130 FVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN--VKISDLGLFREVYAADYYKLL 187

Query: 273 TGTAEF----AAPE-IVEREPVGFYT---DMWAVGVLAYVLLS-GLSPFAGENDVETLKN 323
              +       APE I+     G ++   D+W+ GV+ + + S GL P+ G ++ + ++ 
Sbjct: 188 GN-SLLPIRWMAPEAIMY----GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 242

Query: 324 VK 325
           ++
Sbjct: 243 IR 244

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 76.9 bits (190), Expect = 3e-16
 Identities = 51/232 (21%), Positives = 97/232 (41%), Gaps = 39/232 (16%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---------SHNLEKELIRKEIDIMNQL 162
           +   IG G FG VH+       N      + V         S ++ ++ ++ E   M Q 
Sbjct: 19  LGRCIGEGQFGDVHQGIYMSPEN----PALAVAIKTCKNCTSDSVREKFLQ-EALTMRQF 73

Query: 163 HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDY-KMSEAEVIPVTLPILMTQTS 221
            HP ++ L     ++   + I E  + GEL        + ++ +  +   +L +   Q S
Sbjct: 74  DHPHIVKLIGVITENPVWI-IMELCTLGELR------SFLQVRKYSLDLASLILYAYQLS 126

Query: 222 PAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF--- 278
            A+ ++  K  +H D+   N++  + +   VK+ DFGL+  ++ +   K      +    
Sbjct: 127 TALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTYYK--ASKGKLPIK 182

Query: 279 -AAPE-IVEREPVGFYT---DMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
             APE I  R     +T   D+W  GV  + +L  G+ PF G  + + +  +
Sbjct: 183 WMAPESINFRR----FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 230

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 77.6 bits (191), Expect = 4e-16
 Identities = 44/247 (17%), Positives = 88/247 (35%), Gaps = 44/247 (17%)

Query: 107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR-KEIDIMNQLHHP 165
            D+  +LE IG G +G V++          A K    ++   +  I  K I  +  + H 
Sbjct: 12  LDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFAN--RQNFINEKNIYRVPLMEHD 67

Query: 166 KLINL-----HDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
            +            +   E +L+ E+   G L + ++        +  +           
Sbjct: 68  NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL-------AHSV 120

Query: 221 SPAVKHMHE---------KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKI 271
           +  + ++H            I H D+   N++   +N     + DFGL+ +L  N +V+ 
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVL--VKNDGTCVISDFGLSMRLTGNRLVRP 178

Query: 272 S---------TGTAEFAAPEIVE-------REPVGFYTDMWAVGVLAYVLLSGLSPFAGE 315
                      GT  + APE++E        E      DM+A+G++ + +    +     
Sbjct: 179 GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238

Query: 316 NDVETLK 322
             V   +
Sbjct: 239 ESVPEYQ 245

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 76.1 bits (188), Expect = 6e-16
 Identities = 51/225 (22%), Positives = 90/225 (40%), Gaps = 32/225 (14%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLH 171
           +L+ IG G FG V     R  GN  A K I      +  L   E  +M QL H  L+ L 
Sbjct: 25  LLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFL--AEASVMTQLRHSNLVQLL 80

Query: 172 DA-FEDDDEMVLIFEFLSGGELFERITAPDY-KMSEAEVIPVTLPILM-TQTSPAVKHMH 228
               E+   + ++ E+++ G L       DY +     V+     +        A++++ 
Sbjct: 81  GVIVEEKGGLYIVTEYMAKGSLV------DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 134

Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF----AAPEIV 284
             N +H D+   N++    N    K+ DFGL       +    +  T +      APE +
Sbjct: 135 GNNFVHRDLAARNVLVSEDNV--AKVSDFGLT------KEASSTQDTGKLPVKWTAPEAL 186

Query: 285 EREPVGFYT---DMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
                  ++   D+W+ G+L + + S G  P+      + +  V+
Sbjct: 187 RE---KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 228

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 76.6 bits (189), Expect = 7e-16
 Identities = 44/241 (18%), Positives = 96/241 (39%), Gaps = 36/241 (14%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV--------SHNLEKELIRKEIDIMNQLH 163
           +  E+G GAFG V          +     + V        S +  ++  R E +++  L 
Sbjct: 45  LKWELGEGAFGKVFLAECH--NLLPEQDKMLVAVKALKEASESARQDFQR-EAELLTMLQ 101

Query: 164 HPKLINLHDAFEDDDEMVLIFEFLSGGEL--FERITAPDYKMSEAEVIPVTLPILM---- 217
           H  ++       +   ++++FE++  G+L  F R   PD K+          P+ +    
Sbjct: 102 HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 161

Query: 218 ---TQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTG 274
              +Q +  + ++   + +H D+   N +        VK+ DFG++  +   +  ++  G
Sbjct: 162 AVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRDIYSTDYYRV-GG 218

Query: 275 TAEF----AAPE-IVEREPVGFYT---DMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
                     PE I+       +T   D+W+ GV+ + + + G  P+   ++ E +  + 
Sbjct: 219 RTMLPIRWMPPESILY----RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT 274

Query: 326 A 326
            
Sbjct: 275 Q 275

>2yuw_A Myosin binding protein C, SLOW type; fibronectin III domain, SLOW- type protein, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 110

 Score = 71.6 bits (176), Expect = 8e-16
 Identities = 17/54 (31%), Positives = 21/54 (38%), Gaps = 2/54 (3%)

Query: 2   SSWIRV--GNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDT 53
             WI         T   ITGL    +   RV A N  G S+P   S  I  K++
Sbjct: 52  EDWIVANKDLIDKTKFTITGLPTDAKIFVRVKAVNAAGASEPKYYSQPILVKES 105

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 75.9 bits (187), Expect = 1e-15
 Identities = 30/208 (14%), Positives = 73/208 (35%), Gaps = 39/208 (18%)

Query: 101 IKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMN 160
           +      + + + ++IG+G FG+++           A   + V +     L   E+    
Sbjct: 30  VLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFS-ELKFYQ 88

Query: 161 QLHHPKLINLHDAFEDDDEM-------------------VLIFEFL--SGGELFERITAP 199
           ++     I      +  D +                    ++ E L     ++  +    
Sbjct: 89  RVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQ---- 144

Query: 200 DYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGL 259
           +    ++ V+ + + +L       ++++HE   +H D+K  N++   +N   V + D+GL
Sbjct: 145 NGTFKKSTVLQLGIRMLD-----VLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGL 199

Query: 260 ATK-LDPNEVVKIS-------TGTAEFA 279
           + +        +          GT EF 
Sbjct: 200 SYRYCPNGNHKQYQENPRKGHNGTIEFT 227

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 75.8 bits (187), Expect = 1e-15
 Identities = 52/266 (19%), Positives = 101/266 (37%), Gaps = 40/266 (15%)

Query: 85  QYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV- 143
            Y F   +  +    ++   ++     ++  +G GAFG V+  +    G       + V 
Sbjct: 11  NYCFAGKTSSISDLKEVPRKNI----TLIRGLGHGAFGEVYEGQVS--GMPNDPSPLQVA 64

Query: 144 --------SHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGEL--F 193
                   S   E + +  E  I+++ +H  ++             ++ E ++GG+L  F
Sbjct: 65  VKTLPEVCSEQDELDFLM-EALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSF 123

Query: 194 ERITAPDYKMSEAEVIPVTLPIL---MTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNST 250
            R T P           + +  L       +   +++ E + IH D+   N +       
Sbjct: 124 LRETRPRPSQPS----SLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 179

Query: 251 N-VKMIDFGLATKLDPNEVVKISTGTAEFA----APE-IVEREPVGFYT---DMWAVGVL 301
              K+ DFG+A  +      +   G A        PE  +E    G +T   D W+ GVL
Sbjct: 180 RVAKIGDFGMARDIYRASYYR-KGGCAMLPVKWMPPEAFME----GIFTSKTDTWSFGVL 234

Query: 302 AYVLLS-GLSPFAGENDVETLKNVKA 326
            + + S G  P+  +++ E L+ V +
Sbjct: 235 LWEIFSLGYMPYPSKSNQEVLEFVTS 260

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 76.2 bits (188), Expect = 1e-15
 Identities = 48/232 (20%), Positives = 97/232 (41%), Gaps = 36/232 (15%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---------SHNLEKELIRKEIDIMNQL 162
           I + +G G FG V   R +        K I V         +    ++ +  E  IM Q 
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSK----KEISVAIKTLKVGYTEKQRRDFLG-EASIMGQF 103

Query: 163 HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDY-KMSEAEVIPVTLPILMTQTS 221
            HP +I L         ++++ E++  G L        + +  +A+   + L  ++   +
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLD------SFLRKHDAQFTVIQLVGMLRGIA 157

Query: 222 PAVKHMHEKNIIHLDVKPENIMCQTRNSTN-VKMIDFGLATKLDPNEVVKISTGTAEF-- 278
             +K++ +   +H D+   NI+    NS    K+ DFGL   L+ +     +T   +   
Sbjct: 158 SGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPI 214

Query: 279 --AAPEIVEREPVGFYT---DMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
              +PE +       +T   D+W+ G++ + ++S G  P+   ++ + +K V
Sbjct: 215 RWTSPEAIAY---RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 76.6 bits (189), Expect = 1e-15
 Identities = 51/225 (22%), Positives = 87/225 (38%), Gaps = 32/225 (14%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLH 171
           +L+ IG G FG V     R  GN  A K I      +  L   E  +M QL H  L+ L 
Sbjct: 197 LLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFL--AEASVMTQLRHSNLVQLL 252

Query: 172 DA-FEDDDEMVLIFEFLSGGELFERITAPDY--KMSEAEVIPVTLPILMTQTSPAVKHMH 228
               E+   + ++ E+++ G L       DY      + +    L         A++++ 
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLV------DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 306

Query: 229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFA----APEIV 284
             N +H D+   N++    N    K+ DFGL       E         +      APE +
Sbjct: 307 GNNFVHRDLAARNVLVSEDNV--AKVSDFGLT-----KEASSTQDT-GKLPVKWTAPEAL 358

Query: 285 EREPVGFYT---DMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
                  ++   D+W+ G+L + + S G  P+      + +  V+
Sbjct: 359 RE---KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 400

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 75.0 bits (185), Expect = 2e-15
 Identities = 43/238 (18%), Positives = 95/238 (39%), Gaps = 34/238 (14%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---------SHNLEKELIRKEIDIMNQL 162
           +  E+G G+FG+V+    +  G +       V         S     E +  E  +M + 
Sbjct: 29  MSRELGQGSFGMVYEGVAK--GVVKDEPETRVAIKTVNEAASMRERIEFLN-EASVMKEF 85

Query: 163 HHPKLINLHDAFEDDDEMVLIFEFLSGGEL--FERITAPDYKMSEAEVIPVTLPILM--- 217
           +   ++ L          ++I E ++ G+L  + R   P    +   + P +L  ++   
Sbjct: 86  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAM-ANNPVLAPPSLSKMIQMA 144

Query: 218 TQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAE 277
            + +  + +++    +H D+   N M        VK+ DFG+   +   +  +   G   
Sbjct: 145 GEIADGMAYLNANKFVHRDLAARNCMVAEDF--TVKIGDFGMTRDIYETDYYR-KGGKGL 201

Query: 278 F----AAPE-IVEREPVGFYT---DMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKA 326
                 +PE + +    G +T   D+W+ GV+ + + +    P+ G ++ + L+ V  
Sbjct: 202 LPVRWMSPESLKD----GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255

>1uem_A KIAA1568 protein; immunoglobulin-like beta-sandwich fold, fibronectin type III, structural genomics; NMR {Homo sapiens} SCOP: b.1.2.1 Length = 117

 Score = 70.9 bits (174), Expect = 2e-15
 Identities = 22/52 (42%), Positives = 27/52 (51%), Gaps = 1/52 (1%)

Query: 3   SWIRVGNT-RFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDT 53
           SW  V N  + T   + GL P   Y F V A N  G SDPS  SD + T+D+
Sbjct: 61  SWQTVANHVKTTLYTVRGLRPNTIYLFMVRAINPQGLSDPSPMSDPVRTQDS 112

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 75.1 bits (185), Expect = 2e-15
 Identities = 49/231 (21%), Positives = 96/231 (41%), Gaps = 33/231 (14%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV--------SHNLEKELIRKEIDIMNQLH 163
             + IG G FG V++   + +      K +PV            ++     E  IM Q  
Sbjct: 48  RQKVIGAGEFGEVYKGMLKTSS---GKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 104

Query: 164 HPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDY-KMSEAEVIPVTLPILMTQTSP 222
           H  +I L         M++I E++  G L        + +  + E   + L  ++   + 
Sbjct: 105 HHNIIRLEGVISKYKPMMIITEYMENGALD------KFLREKDGEFSVLQLVGMLRGIAA 158

Query: 223 AVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL-DPNEVVKISTGTAEF--- 278
            +K++   N +H D+   NI+  +      K+ DFGL+  L D  E    ++G  +    
Sbjct: 159 GMKYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEATYTTSG-GKIPIR 215

Query: 279 -AAPEIVEREPVGFYT---DMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
             APE +       +T   D+W+ G++ + +++ G  P+   ++ E +K +
Sbjct: 216 WTAPEAISY---RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 263

>2dju_A Receptor-type tyrosine-protein phosphatase F; LAR protein, leukocyte antigen related, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 106

 Score = 70.4 bits (173), Expect = 2e-15
 Identities = 18/52 (34%), Positives = 23/52 (44%)

Query: 2   SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDT 53
             +  V     T  +I GLSP  +Y FRV A N  GR  PS      T + +
Sbjct: 50  GPFQEVDGVATTRYSIGGLSPFSEYAFRVLAVNSIGRGPPSEAVRARTGEQS 101

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 75.0 bits (185), Expect = 2e-15
 Identities = 60/283 (21%), Positives = 105/283 (37%), Gaps = 55/283 (19%)

Query: 90  IYSKYVPQPVDIKTSSVYDHYD-----------ILEEIGTGAFGVVHRCRERKTGNIFAA 138
           +  +  P P+  +   + +               + +IG GAFG V + R    G +   
Sbjct: 18  LLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAP--GLLPYE 75

Query: 139 KFIPV---------SHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSG 189
            F  V         S +++ +  R E  +M +  +P ++ L         M L+FE+++ 
Sbjct: 76  PFTMVAVKMLKEEASADMQADFQR-EAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAY 134

Query: 190 GEL--FERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH----------------EKN 231
           G+L  F R  +P    S +     T   + +   P +                    E+ 
Sbjct: 135 GDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK 194

Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA---EFAAPE-IVERE 287
            +H D+   N +        VK+ DFGL+  +   +  K     A    +  PE I    
Sbjct: 195 FVHRDLATRNCLVGENM--VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-- 250

Query: 288 PVGFYT---DMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKA 326
               YT   D+WA GV+ + + S GL P+ G    E +  V+ 
Sbjct: 251 --NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD 291

>1x3d_A Fibronectin type-III domain containing protein 3A; structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: b.1.2.1 Length = 118

 Score = 70.5 bits (173), Expect = 2e-15
 Identities = 14/50 (28%), Positives = 19/50 (38%)

Query: 2   SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK 51
             + +          IT LSP    +FR+ A N YG S  S      T+ 
Sbjct: 62  GEFCQCYMGSQKQFKITKLSPAMGCKFRLSARNDYGTSGFSEEVLYYTSG 111

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 74.6 bits (184), Expect = 3e-15
 Identities = 45/233 (19%), Positives = 96/233 (41%), Gaps = 24/233 (10%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIF---AAKFIPVSHNLEKELIR--KEIDIMNQLHHPK 166
           + + +G G FG V     ++        A K + + ++ ++E+     E   M    HP 
Sbjct: 38  LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97

Query: 167 LINL-----HDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTS 221
           +I L       + +   + ++I  F+  G+L   +     +     +   TL   M   +
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157

Query: 222 PAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA---EF 278
             ++++  +N +H D+   N M +   +  V + DFGL+ K+   +  +         ++
Sbjct: 158 LGMEYLSNRNFLHRDLAARNCMLRDDMT--VCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215

Query: 279 AAPE-IVEREPVGFYT---DMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKA 326
            A E + +      YT   D+WA GV  + + + G++P+ G  + E    +  
Sbjct: 216 IAIESLAD----RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH 264

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 74.7 bits (184), Expect = 3e-15
 Identities = 52/267 (19%), Positives = 101/267 (37%), Gaps = 40/267 (14%)

Query: 84  DQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV 143
             Y F   +  +    ++   ++     ++  +G GAFG V+  +    G       + V
Sbjct: 51  PNYCFAGKTSSISDLKEVPRKNI----TLIRGLGHGAFGEVYEGQVS--GMPNDPSPLQV 104

Query: 144 ---------SHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGEL-- 192
                    S   E + +  E  I+++ +H  ++             ++ E ++GG+L  
Sbjct: 105 AVKTLPEVCSEQDELDFLM-EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKS 163

Query: 193 FERITAPDYKMSEAEVIPVTLPIL---MTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNS 249
           F R T P           + +  L       +   +++ E + IH D+   N +      
Sbjct: 164 FLRETRPRPSQPS----SLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGP 219

Query: 250 TN-VKMIDFGLATKLDPNEVVKISTGTAEFA----APE-IVEREPVGFYT---DMWAVGV 300
               K+ DFG+A  +      +   G A        PE  +E    G +T   D W+ GV
Sbjct: 220 GRVAKIGDFGMARDIYRAGYYR-KGGCAMLPVKWMPPEAFME----GIFTSKTDTWSFGV 274

Query: 301 LAYVLLS-GLSPFAGENDVETLKNVKA 326
           L + + S G  P+  +++ E L+ V +
Sbjct: 275 LLWEIFSLGYMPYPSKSNQEVLEFVTS 301

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 74.3 bits (183), Expect = 4e-15
 Identities = 48/234 (20%), Positives = 93/234 (39%), Gaps = 25/234 (10%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIF---AAKFIPVSHNLEKELIR--KEIDIMNQLHHPK 166
           +   +G G FG V   + ++    F   A K +        ++    +E   M +  HP 
Sbjct: 27  LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86

Query: 167 LINL------HDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
           +  L        A       ++I  F+  G+L   + A     +   +   TL   M   
Sbjct: 87  VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146

Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA---E 277
           +  ++++  +N IH D+   N M     +  V + DFGL+ K+   +  +    +    +
Sbjct: 147 ACGMEYLSSRNFIHRDLAARNCMLAEDMT--VCVADFGLSRKIYSGDYYRQGCASKLPVK 204

Query: 278 FAAPE-IVEREPVGFYT---DMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKA 326
           + A E + +      YT   D+WA GV  + +++ G +P+AG  + E    +  
Sbjct: 205 WLALESLAD----NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254

>1x4z_A Biregional cell adhesion molecule-related/DOWN- regulated oncogenes (CDON)binding...; fibronectin type III, FN3; NMR {Mus musculus} SCOP: b.1.2.1 Length = 121

 Score = 69.7 bits (171), Expect = 5e-15
 Identities = 18/54 (33%), Positives = 24/54 (44%), Gaps = 3/54 (5%)

Query: 2   SSWIRVGNT---RFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD 52
             WI   +       ++ ITGL  G  Y+FRV A N+ G S+PS  S       
Sbjct: 62  GDWILATSAIPPSRLSVEITGLEKGISYKFRVRALNMLGESEPSAPSRPYVVSG 115

>2crz_A Fibronectin type-III domain containing protein 3A; structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: b.1.2.1 Length = 110

 Score = 68.5 bits (168), Expect = 1e-14
 Identities = 13/52 (25%), Positives = 18/52 (34%)

Query: 2   SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDT 53
                V         ++ L PG  Y FR+ A N  G    S   D+ T   +
Sbjct: 54  DEPREVYQGSEVECTVSSLLPGKTYSFRLRAANKMGFGPFSEKCDITTAPGS 105

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 73.1 bits (180), Expect = 1e-14
 Identities = 58/241 (24%), Positives = 95/241 (39%), Gaps = 36/241 (14%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV--------SHNLEKELIRKEIDIMNQL- 162
             + +G GAFG V        G       + V        +H  EKE +  E+ IM+ L 
Sbjct: 50  FGKTLGAGAFGKVVEATAF--GLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG 107

Query: 163 HHPKLINLHDAFEDDDEMVLIFEFLSGGELFE-----RITAPDYKMSEAEVIPVTLPILM 217
            H  ++NL  A      +++I E+   G+L                        +   L+
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167

Query: 218 ---TQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTG 274
              +Q +  +  +  KN IH DV   N++    +    K+ DFGLA  +  +    +   
Sbjct: 168 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH--VAKIGDFGLARDIMNDSNYIVKGN 225

Query: 275 TAEF----AAPE-IVEREPVGFYT---DMWAVGVLAYVLLS-GLSPFAG-ENDVETLKNV 324
            A       APE I +      YT   D+W+ G+L + + S GL+P+ G   + +  K V
Sbjct: 226 -ARLPVKWMAPESIFD----CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV 280

Query: 325 K 325
           K
Sbjct: 281 K 281

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 72.3 bits (178), Expect = 2e-14
 Identities = 48/229 (20%), Positives = 90/229 (39%), Gaps = 26/229 (11%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIF---AAKFIPVSHNL-EKELIRKEIDIMNQLHHPKL 167
               IG G FGVV+              A K +     + + E   +E  +M  L+HP +
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84

Query: 168 INLHDAFEDDDEMVL-IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKH 226
           + L       + +   +  ++  G+L + I +P    +  ++I         Q +  +++
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISF-----GLQVARGMEY 139

Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT-AEF----AAP 281
           + E+  +H D+   N M     +  VK+ DFGLA  +   E   +     A       A 
Sbjct: 140 LAEQKFVHRDLAARNCMLDESFT--VKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197

Query: 282 E-IVEREPVGFYT---DMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
           E +        +T   D+W+ GVL + LL+ G  P+   +  +    + 
Sbjct: 198 ESLQT----YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA 242

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 71.8 bits (177), Expect = 2e-14
 Identities = 54/227 (23%), Positives = 90/227 (39%), Gaps = 29/227 (12%)

Query: 112 ILEEIGTGAFGVVHR--CRERKTGNIFAA-KFIPVSHNL-EKELIRKEIDIMNQLHHPKL 167
           +   +G G FG V+       K   I  A K       L  KE    E  IM  L HP +
Sbjct: 16  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75

Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDY-KMSEAEVIPVTLPILMTQTSPAVKH 226
           + L     +++   +I E    GEL        Y + ++  +  +TL +   Q   A+ +
Sbjct: 76  VKLI-GIIEEEPTWIIMELYPYGELG------HYLERNKNSLKVLTLVLYSLQICKAMAY 128

Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF----AAPE 282
           +   N +H D+   NI+  +     VK+ DFGL+  ++  +  K             +PE
Sbjct: 129 LESINCVHRDIAVRNILVASPEC--VKLGDFGLSRYIEDEDYYK--ASVTRLPIKWMSPE 184

Query: 283 -IVEREPVGFYT---DMWAVGVLAYVLLS-GLSPFAGENDVETLKNV 324
            I  R     +T   D+W   V  + +LS G  PF    + + +  +
Sbjct: 185 SINFRR----FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL 227

>1bpv_A Titin, A71, connectin; fibronectin type III; NMR {Homo sapiens} SCOP: b.1.2.1 Length = 112

 Score = 68.1 bits (167), Expect = 2e-14
 Identities = 20/57 (35%), Positives = 28/57 (49%), Gaps = 3/57 (5%)

Query: 2   SSWIRV--GNTRFTTMAITGLSPGHQYEFRVYAENVYGR-SDPSTTSDLITTKDTFK 55
             W++    N       ++GL+    YEFRV A+N  G  S PS  SD IT +D  +
Sbjct: 55  GRWLKANFSNILENEFTVSGLTEDAAYEFRVIAKNAAGAISPPSEPSDAITCRDDVE 111

>3lpw_A A77-A78 domain from titin; intracellular FNIII-tandem, structural protein; 1.65A {Homo sapiens} Length = 197

 Score = 70.1 bits (172), Expect = 2e-14
 Identities = 20/51 (39%), Positives = 24/51 (47%)

Query: 2   SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD 52
             W      + T   ITGL  G +Y FRV A+N  G SDP   S  +  KD
Sbjct: 147 DKWATCATVKVTEATITGLIQGEEYSFRVSAQNEKGISDPRQLSVPVIAKD 197

>3lpw_A A77-A78 domain from titin; intracellular FNIII-tandem, structural protein; 1.65A {Homo sapiens} Length = 197

 Score = 62.0 bits (151), Expect = 1e-11
 Identities = 15/52 (28%), Positives = 23/52 (44%), Gaps = 1/52 (1%)

Query: 2   SSWIRVGNTRFTTMA-ITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD 52
            ++  V      T   +  L  G  Y FRV AEN YG   P+ T++ +   +
Sbjct: 50  KAYSTVATNCHKTSWKVDQLQEGCSYYFRVLAENEYGIGLPAETAESVKASE 101

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 72.3 bits (178), Expect = 2e-14
 Identities = 56/249 (22%), Positives = 99/249 (39%), Gaps = 47/249 (18%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---------SHNLEKELIRKEIDIMNQL 162
           + + +G GAFG V              + + V         +     +L+  E+++M  +
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVS-EMEMMKMI 97

Query: 163 -HHPKLINLHDAFEDDDEMVLIFEFLSGGELFE-------RITAPDYKMSEAEVIPVTLP 214
             H  +INL  A   D  + +I E+ S G L E             Y ++      +T  
Sbjct: 98  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157

Query: 215 ILMT---QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKI 271
            L++   Q +  ++++  +  IH D+   N++    N   +K+ DFGLA  ++  +  K 
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN--VMKIADFGLARDINNIDYYKK 215

Query: 272 STGTAEFAAPEIVEREPV----------GFYT---DMWAVGVLAYVLLS-GLSPFAGEND 317
           +T            R PV            YT   D+W+ GVL + + + G SP+ G   
Sbjct: 216 TTNG----------RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265

Query: 318 VETLKNVKA 326
            E  K +K 
Sbjct: 266 EELFKLLKE 274

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 72.4 bits (178), Expect = 2e-14
 Identities = 55/249 (22%), Positives = 98/249 (39%), Gaps = 47/249 (18%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---------SHNLEKELIRKEIDIMNQL 162
           + + +G G FG V              + + V         +     +L+  E+++M  +
Sbjct: 85  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVS-EMEMMKMI 143

Query: 163 -HHPKLINLHDAFEDDDEMVLIFEFLSGGELFE-------RITAPDYKMSEAEVIPVTLP 214
             H  +INL  A   D  + +I E+ S G L E             Y ++      +T  
Sbjct: 144 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203

Query: 215 ILMT---QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKI 271
            L++   Q +  ++++  +  IH D+   N++    N   +K+ DFGLA  ++  +  K 
Sbjct: 204 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN--VMKIADFGLARDINNIDYYKK 261

Query: 272 STGTAEFAAPEIVEREPV----------GFYT---DMWAVGVLAYVLLS-GLSPFAGEND 317
           +T            R PV            YT   D+W+ GVL + + + G SP+ G   
Sbjct: 262 TTNG----------RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311

Query: 318 VETLKNVKA 326
            E  K +K 
Sbjct: 312 EELFKLLKE 320

>1x5x_A Fibronectin type-III domain containing protein 3A; structural genomics, KIAA0970, NPPSFA; NMR {Homo sapiens} SCOP: b.1.2.1 Length = 109

 Score = 67.4 bits (165), Expect = 2e-14
 Identities = 13/48 (27%), Positives = 23/48 (47%), Gaps = 3/48 (6%)

Query: 6   RVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDT 53
              +  +T   +  L    +Y+F+V A N  G+S+PS   +  T  D+
Sbjct: 60  DGEDLAYT---VKNLRRSTKYKFKVIAYNSEGKSNPSEVVEFTTCPDS 104

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 71.5 bits (176), Expect = 3e-14
 Identities = 60/266 (22%), Positives = 101/266 (37%), Gaps = 47/266 (17%)

Query: 91  YSKYVPQPVDIKTSSVYDHYDI--LEEIGTGAFGVVHRCRERKTGNIFAAKFIPV----- 143
           +  +     D     V D  DI   + IG G FG V + R +K G       +       
Sbjct: 6   HHHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDG-----LRMDAAIKRM 60

Query: 144 ----SHNLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMVLIFEFLSGGELFE---- 194
               S +  ++    E++++ +L HHP +INL  A E    + L  E+   G L +    
Sbjct: 61  KEYASKDDHRDFAG-ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK 119

Query: 195 -RITAPDYKMSEAEVIPVTLPIL-----MTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN 248
            R+   D   + A     TL            +  + ++ +K  IH D+   NI+     
Sbjct: 120 SRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179

Query: 249 STNVKMIDFGLATKLDPNEVVKISTGTAEF----AAPE-IVEREPVGFYT---DMWAVGV 300
               K+ DFGL+   +    V +            A E +        YT   D+W+ GV
Sbjct: 180 --VAKIADFGLSRGQE----VYVKKTMGRLPVRWMAIESLNYS----VYTTNSDVWSYGV 229

Query: 301 LAYVLLS-GLSPFAGENDVETLKNVK 325
           L + ++S G +P+ G    E  + + 
Sbjct: 230 LLWEIVSLGGTPYCGMTCAELYEKLP 255

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 71.7 bits (176), Expect = 3e-14
 Identities = 34/219 (15%), Positives = 73/219 (33%), Gaps = 37/219 (16%)

Query: 92  SKYVPQPV---DIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNI-----FAAKFIPV 143
            +++ +     +I T      + +   IG G FG ++      + ++        K  P 
Sbjct: 16  KRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPS 75

Query: 144 SH-----------NLEKELIRKEIDIMNQLHHPKLINLH----DAFEDDDEMVLIFEFLS 188
            +              K    ++     +L +  +                  +I +   
Sbjct: 76  DNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF- 134

Query: 189 GGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN 248
           G +L +   A   + S   V+      L  +    ++++HE   +H D+K  N++   +N
Sbjct: 135 GSDLQKIYEANAKRFSRKTVL-----QLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN 189

Query: 249 STNVKMIDFGLATK-LDPNEVVKIS-------TGTAEFA 279
              V ++D+GLA +          +        GT EF 
Sbjct: 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFT 228

>1wis_A KIAA1514 protein; FNIII domain, sidekick-2, structural genomics, riken structural genomics/proteomics initiative, RSGI, unknown function; NMR {Homo sapiens} SCOP: b.1.2.1 Length = 124

 Score = 67.4 bits (165), Expect = 4e-14
 Identities = 15/56 (26%), Positives = 23/56 (41%), Gaps = 4/56 (7%)

Query: 2   SSWIRVGNT----RFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDT 53
             W+ +          +M +  L+P   Y FR+   N+ G S PS  S  I T  +
Sbjct: 64  EEWLLIHQLSNEPDARSMEVPDLNPFTCYSFRMRQVNIVGTSPPSQPSRKIQTLQS 119

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 71.2 bits (175), Expect = 7e-14
 Identities = 58/248 (23%), Positives = 95/248 (38%), Gaps = 47/248 (18%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---------SHNLEKELIRKEIDIMNQL 162
           + + +G GAFG V              +   V         +     +LI  E+++M  +
Sbjct: 73  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLIS-EMEMMKMI 131

Query: 163 -HHPKLINLHDAFEDDDEMVLIFEFLSGGELFE-------RITAPDYKMSEAEVIPVTLP 214
             H  +INL  A   D  + +I E+ S G L E             Y  S      ++  
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191

Query: 215 ILM---TQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKI 271
            L+    Q +  ++++  K  IH D+   N++    N   +K+ DFGLA  +   +  K 
Sbjct: 192 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN--VMKIADFGLARDIHHIDYYKK 249

Query: 272 STGTAEFAAPEIVEREPV----------GFYT---DMWAVGVLAYVLLS-GLSPFAGEND 317
           +T            R PV            YT   D+W+ GVL + + + G SP+ G   
Sbjct: 250 TTNG----------RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299

Query: 318 VETLKNVK 325
            E  K +K
Sbjct: 300 EELFKLLK 307

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 71.1 bits (174), Expect = 7e-14
 Identities = 52/307 (16%), Positives = 105/307 (34%), Gaps = 77/307 (25%)

Query: 77  DEKVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIF 136
            E  +DY +  +     ++ +  D+        Y ++ ++G G F  V    + +     
Sbjct: 15  QEDPNDYCKGGY-----HLVKIGDL----FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFV 65

Query: 137 AAKFIPVSHNLEKELIRKEIDIMNQL-----HHP---KLINLHDAFE----DDDEMVLIF 184
           A K +  S     E    EI ++  +     + P    ++ L D F+    +   + ++F
Sbjct: 66  AMK-VVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVF 124

Query: 185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEK-NIIHLDVKPENIM 243
           E L G  L + I   +Y+      +   +  ++      + ++H K  IIH D+KPENI+
Sbjct: 125 EVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQ----GLDYLHTKCRIIHTDIKPENIL 179

Query: 244 CQTRNST-----------------------------------------------NVKMID 256
                                                                  VK+ D
Sbjct: 180 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIAD 239

Query: 257 FGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN 316
            G A  +  +    I T   ++ + E++         D+W+   +A+ L +G   F   +
Sbjct: 240 LGNACWVHKHFTEDIQTR--QYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHS 297

Query: 317 DVETLKN 323
             E  ++
Sbjct: 298 GEEYTRD 304

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 70.0 bits (172), Expect = 8e-14
 Identities = 48/229 (20%), Positives = 88/229 (38%), Gaps = 26/229 (11%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIF---AAKFIPVSHNL-EKELIRKEIDIMNQLHHPKL 167
             E IG G FG V+              A K +    ++ E      E  IM    HP +
Sbjct: 29  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 88

Query: 168 INLHDA-FEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKH 226
           ++L       +   +++  ++  G+L   I    +  +  ++I         Q +  +K+
Sbjct: 89  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF-----GLQVAKGMKY 143

Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFA-----AP 281
           +  K  +H D+   N M   + +  VK+ DFGLA  +   E   +   T         A 
Sbjct: 144 LASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 201

Query: 282 E-IVEREPVGFYT---DMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
           E +  +     +T   D+W+ GVL + L++ G  P+   N  +    + 
Sbjct: 202 ESLQTQ----KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 246

>1uey_A KIAA0343 protein; immunoglobulin-like beta-sandwich fold, NG-CAM related cell adhesion molecule, fibronectin type III domain, structural genomics; NMR {Homo sapiens} SCOP: b.1.2.1 Length = 127

 Score = 66.2 bits (162), Expect = 9e-14
 Identities = 20/50 (40%), Positives = 22/50 (44%), Gaps = 1/50 (2%)

Query: 4   WIRVGNTRFT-TMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD 52
           W        T T A   LSP   Y FRV A N  G+S PS  S+   TK 
Sbjct: 64  WHHQTEVSGTQTTAQLNLSPYVNYSFRVMAVNSIGKSLPSEASEQYLTKA 113

>2crm_A Fibronectin type-III domain containing protein 3A; structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: b.1.2.1 Length = 120

 Score = 66.3 bits (162), Expect = 9e-14
 Identities = 12/50 (24%), Positives = 20/50 (40%)

Query: 1   MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT 50
            + W  + +          L+PG  Y  RVY  +  G+S  S +  + T 
Sbjct: 63  GNKWEMIYSGATREHLCDRLNPGCFYRLRVYCISDGGQSAVSESLLVQTP 112

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 70.0 bits (172), Expect = 1e-13
 Identities = 60/245 (24%), Positives = 102/245 (41%), Gaps = 38/245 (15%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV--------SHNLEKELIRKEIDIMNQL- 162
             + +G GAFG V        G I +   + V        +H  E+E +  E+ +++ L 
Sbjct: 27  FGKTLGAGAFGKVVEATAY--GLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84

Query: 163 HHPKLINLHDAFEDDDEMVLIFEFLSGGEL--FERITAPDYKMS-------EAEVIPVTL 213
           +H  ++NL  A       ++I E+   G+L  F R     +  S       E + + + L
Sbjct: 85  NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144

Query: 214 PILMT---QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVK 270
             L++   Q +  +  +  KN IH D+   NI+         K+ DFGLA  +  +    
Sbjct: 145 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR--ITKICDFGLARDIKNDSNYV 202

Query: 271 ISTGTA---EFAAPE-IVEREPVGFYT---DMWAVGVLAYVLLS-GLSPFAG-ENDVETL 321
           +        ++ APE I        YT   D+W+ G+  + L S G SP+ G   D +  
Sbjct: 203 VKGNARLPVKWMAPESIFN----CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258

Query: 322 KNVKA 326
           K +K 
Sbjct: 259 KMIKE 263

>1wf5_A Sidekick 2 protein; FNIII domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: b.1.2.1 Length = 121

 Score = 66.2 bits (162), Expect = 1e-13
 Identities = 11/52 (21%), Positives = 27/52 (51%), Gaps = 2/52 (3%)

Query: 4   WIRVGNT--RFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDT 53
            + + +   + T++ + GL P   Y+FR+ A N  G+   S  ++ ++  ++
Sbjct: 65  TVLLASVDPKATSVTVKGLVPARSYQFRLCAVNDVGKGQFSKDTERVSLPES 116

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 70.2 bits (172), Expect = 1e-13
 Identities = 47/234 (20%), Positives = 85/234 (36%), Gaps = 36/234 (15%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---------SHNLEKELIRKEIDIMNQL 162
             E IG G FG V+             K I                 + +  E  IM   
Sbjct: 93  FNEVIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLT-EGIIMKDF 147

Query: 163 HHPKLINLHDA-FEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTS 221
            HP +++L       +   +++  ++  G+L   I    +  +  ++I         Q +
Sbjct: 148 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF-----GLQVA 202

Query: 222 PAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFA-- 279
             +K +  K  +H D+   N M   + +  VK+ DFGLA  +   E   +   T      
Sbjct: 203 KGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPV 260

Query: 280 ---APE-IVEREPVGFYT---DMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
              A E +  +     +T   D+W+ GVL + L++ G  P+   N  +    + 
Sbjct: 261 KWMALESLQTQ----KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 310

>2yux_A Myosin-binding protein C, SLOW-type; fibronectin III domain, structural genomics., NPPSFA; NMR {Homo sapiens} Length = 120

 Score = 65.5 bits (160), Expect = 2e-13
 Identities = 16/51 (31%), Positives = 26/51 (50%), Gaps = 1/51 (1%)

Query: 2   SSWIRVG-NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK 51
             W  V  +   T+  IT L  G++Y FRV++EN+ G S+ +T +      
Sbjct: 62  MEWFTVIEHYHRTSATITELVIGNEYYFRVFSENMCGLSEDATMTKESAVI 112

>2db8_A Tripartite motif protein 9, isoform 2; ring finger protein 91, TRIM9, KIAA0282, RNF91, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 110

 Score = 64.8 bits (158), Expect = 2e-13
 Identities = 15/52 (28%), Positives = 21/52 (40%)

Query: 2   SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDT 53
             +  V   + T   + GL     Y  RV A N  G S  S T  L T++ +
Sbjct: 54  GQFREVYVGKETMCTVDGLHFNSTYNARVKAFNKTGVSPYSKTLVLQTSEGS 105

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 68.8 bits (169), Expect = 2e-13
 Identities = 50/256 (19%), Positives = 98/256 (38%), Gaps = 56/256 (21%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---------SHNLEKELIRKEIDIMNQL 162
           + + +G G FG V +           A +  V         S +  ++L+  E +++ Q+
Sbjct: 27  LGKTLGEGEFGKVVKAT--AFHLKGRAGYTTVAVKMLKENASPSELRDLLS-EFNVLKQV 83

Query: 163 HHPKLINLHDAFEDDDEMVLIFEFLSGGEL---------------FERITAPDYKMSEAE 207
           +HP +I L+ A   D  ++LI E+   G L                   +     +   +
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143

Query: 208 VIPVTLPILM---TQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD 264
              +T+  L+    Q S  ++++ E  ++H D+   NI+        +K+ DFGL+  + 
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGR--KMKISDFGLSRDVY 201

Query: 265 PNEVVKISTGTAEFAAPEIVEREPV----------GFYT---DMWAVGVLAYVLLS-GLS 310
             +     +            R PV            YT   D+W+ GVL + +++ G +
Sbjct: 202 EEDSYVKRSQG----------RIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251

Query: 311 PFAGENDVETLKNVKA 326
           P+ G         +K 
Sbjct: 252 PYPGIPPERLFNLLKT 267

>1wfu_A Unnamed protein product; FN3 domain, similar to 1700007B22RIK protein, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Mus musculus} SCOP: b.1.2.1 Length = 120

 Score = 65.0 bits (158), Expect = 3e-13
 Identities = 13/52 (25%), Positives = 23/52 (44%)

Query: 1   MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD 52
           M S+  +     T   + GL P   Y+FR+   +  G  + S    + TT++
Sbjct: 63  MHSYGVIYTGYATRHVVEGLEPRTLYKFRLKVTSPSGEYEYSPVVSVATTRE 114

>1zlg_A Anosmin 1; insulin-like growth factor receptor Cys-rich fold, WHEY acidic protein fold, fibronectin type III fold, hormone- growth factor complex; NMR {Homo sapiens} Length = 680

 Score = 67.7 bits (164), Expect = 1e-12
 Identities = 14/53 (26%), Positives = 22/53 (41%)

Query: 1   MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDT 53
            + W  V  T    + +T + P   Y+FRV A NV+G    +  S    +   
Sbjct: 211 ATHWQTVAQTTDERVQLTDIRPSRWYQFRVAAVNVHGTRGFTAPSKHFRSSKD 263

>1zlg_A Anosmin 1; insulin-like growth factor receptor Cys-rich fold, WHEY acidic protein fold, fibronectin type III fold, hormone- growth factor complex; NMR {Homo sapiens} Length = 680

 Score = 43.8 bits (102), Expect = 6e-05
 Identities = 11/113 (9%), Positives = 25/113 (22%), Gaps = 3/113 (2%)

Query: 4   WIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDTFKKQIKKRQY 63
               G T    + +  LS   +Y+  V        S               K +  K   
Sbjct: 453 EASSGMTHENYIILQDLSFSCKYKVTVQPIRPKSHSKAEAVFFTTPPCSALKGKSHKPIG 512

Query: 64  DFDETGKKIRGKADEKVSDYDQYVFDIYSKYVP---QPVDIKTSSVYDHYDIL 113
              E G  +     +  +    ++    +       +            + + 
Sbjct: 513 CLGEAGHVLSKVLAKPENLSASFIVQDVNITGHFSWKMAKANLYQPMTGFQVT 565

>1zlg_A Anosmin 1; insulin-like growth factor receptor Cys-rich fold, WHEY acidic protein fold, fibronectin type III fold, hormone- growth factor complex; NMR {Homo sapiens} Length = 680

 Score = 42.3 bits (98), Expect = 2e-04
 Identities = 6/40 (15%), Positives = 11/40 (27%), Gaps = 2/40 (5%)

Query: 13  TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD 52
             + +  L P   Y   V      G    +  +    T +
Sbjct: 594 YVLTVPNLRPSTLYRLEVQVLTPGGEGPATIKT--FRTPE 631

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 65.0 bits (159), Expect = 5e-12
 Identities = 56/251 (22%), Positives = 97/251 (38%), Gaps = 51/251 (20%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV---------SHNLEKELIRKEIDIMNQL 162
           + + +G GAFG V        G    A    V         +H+  + L+  E+ I+  +
Sbjct: 31  LGKPLGRGAFGQVIEA--DAFGIDKTATCRTVAVKMLKEGATHSEHRALMS-ELKILIHI 87

Query: 163 -HHPKLINLHDA-FEDDDEMVLIFEFLSGGEL--FERITAPDYKMSEAEVIPVTLPIL-- 216
            HH  ++NL  A  +    +++I EF   G L  + R    ++   +     +    L  
Sbjct: 88  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147

Query: 217 ------MTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVK 270
                   Q +  ++ +  +  IH D+   NI+   +N   VK+ DFGLA  +  +    
Sbjct: 148 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN--VVKICDFGLARDIYKDPDYV 205

Query: 271 ISTGTAEFAAPEIVEREPV----------GFYT---DMWAVGVLAYVLLS-GLSPFAG-E 315
                          R P+            YT   D+W+ GVL + + S G SP+ G +
Sbjct: 206 RKGDA----------RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255

Query: 316 NDVETLKNVKA 326
            D E  + +K 
Sbjct: 256 IDEEFCRRLKE 266

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 65.1 bits (159), Expect = 5e-12
 Identities = 32/209 (15%), Positives = 65/209 (31%), Gaps = 36/209 (17%)

Query: 100 DIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNI--------FAAKFIPVSHNLEKEL 151
            + T      + +         G+++      T           F+ K       L  E 
Sbjct: 34  TVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQ 93

Query: 152 I-------RKEIDIMNQLHHPKLI---NLHDAFEDDDEM-VLIFEFL--SGGELFERITA 198
                     +++   +L+   L+            D+   L+   L  S     +   +
Sbjct: 94  NFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDV--S 151

Query: 199 PDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFG 258
           P + +SE  V+      +  +   A++ +HE   +H +V  ENI     + + V +  +G
Sbjct: 152 PKHVLSERSVL-----QVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYG 206

Query: 259 LATK-LDPNEVVKIS-------TGTAEFA 279
            A +     + V           G  EF 
Sbjct: 207 FAFRYCPSGKHVAYVEGSRSPHEGDLEFI 235

>2dmk_A Midline 2 isoform 2; midline defect 2, tripartite motif protein 1, midin-2, ring finger protein 60, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 127

 Score = 61.5 bits (149), Expect = 6e-12
 Identities = 14/50 (28%), Positives = 21/50 (42%)

Query: 2   SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK 51
            SW+ V N +     + GL  G +Y F V A N  G  +   T     ++
Sbjct: 69  DSWMIVPNIKQNHYTVHGLQSGTRYIFIVKAINQAGSRNSEPTRLKTNSQ 118

>3mtr_A N-CAM-1, NCAM-1, neural cell adhesion molecule 1; immunoglobulin domain, fibronectin type III repeat, CE adhesion; 1.80A {Homo sapiens} Length = 215

 Score = 63.3 bits (154), Expect = 7e-12
 Identities = 14/50 (28%), Positives = 18/50 (36%), Gaps = 1/50 (2%)

Query: 1   MSSWIRVGNTRF-TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLIT 49
            S W           + I GL P   Y  R+ A N  G  + S  S+  T
Sbjct: 160 HSKWYDAKEASMEGIVTIVGLKPETTYAVRLAALNGKGLGEISAASEFKT 209

>2haz_A N-CAM 1, neural cell adhesion molecule 1; fibronectin type III repeat, FN1, beta sandwich; 1.70A {Homo sapiens} SCOP: b.1.2.1 Length = 105

 Score = 60.5 bits (147), Expect = 7e-12
 Identities = 14/51 (27%), Positives = 19/51 (37%), Gaps = 1/51 (1%)

Query: 1   MSSWIRVG-NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT 50
            S W      +    + I GL P   Y  R+ A N  G  + S  S+  T 
Sbjct: 53  HSKWYDAKEASMEGIVTIVGLKPETTYAVRLAALNGKGLGEISAASEFKTQ 103

>1x4x_A Fibronectin type-III domain containing protein 3A; FN3, immunoglobulin-like beta- sandwich fold, KIAA0970, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.1.2.1 Length = 106

 Score = 60.0 bits (146), Expect = 1e-11
 Identities = 14/49 (28%), Positives = 17/49 (34%)

Query: 2  SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT 50
           S          +  I GLSP   Y  RV A +V G    S     +T 
Sbjct: 50 GSMQICYCGPGLSYEIKGLSPATTYYCRVQALSVVGAGPFSEVVACVTP 98

>2ic2_A CG9211-PA, GH03927P; IHOG, hedgehog, fibronectin type III, protein binding; HET: MSE; 1.30A {Drosophila melanogaster} SCOP: b.1.2.1 Length = 115

 Score = 60.3 bits (146), Expect = 1e-11
 Identities = 12/50 (24%), Positives = 18/50 (36%)

Query: 2   SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK 51
                    +  T ++T L P H Y FR+ A      +  S TS     +
Sbjct: 60  KPKWNSELGKSFTASVTDLKPQHTYRFRILAVYSNNDNKESNTSAKFYLQ 109

>2ibg_A CG9211-PA, GH03927P; IHOG, fibronectin type III, protein binding; 2.20A {Drosophila melanogaster} SCOP: b.1.2.1 b.1.2.1 PDB: 2ibb_A Length = 214

 Score = 62.5 bits (152), Expect = 1e-11
 Identities = 12/41 (29%), Positives = 17/41 (41%)

Query: 13  TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDT 53
            T ++T L P H Y FR+ A      +  S TS     +  
Sbjct: 70  FTASVTDLKPQHTYRFRILAVYSNNDNKESNTSAKFYLQPG 110

>2ibg_A CG9211-PA, GH03927P; IHOG, fibronectin type III, protein binding; 2.20A {Drosophila melanogaster} SCOP: b.1.2.1 b.1.2.1 PDB: 2ibb_A Length = 214

 Score = 57.1 bits (138), Expect = 8e-10
 Identities = 8/52 (15%), Positives = 18/52 (34%), Gaps = 2/52 (3%)

Query: 2   SSWIR--VGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK 51
             + +  +      +  I  L     YEF++ + +    S+ S      T +
Sbjct: 161 GEYFKATIEGAHARSFKIAPLETATMYEFKLQSFSAASASEFSALKQGRTQR 212

>2e3v_A Neural cell adhesion molecule 1, 140 kDa isoform; NCAM, N-CAM 1, NCAM-120, CD56 antigen, membra protein, glycoprotein, structural genomics, NPPSFA; HET: PGE BTB; 1.95A {Homo sapiens} Length = 122

 Score = 60.2 bits (146), Expect = 1e-11
 Identities = 12/38 (31%), Positives = 16/38 (42%)

Query: 13  TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT 50
             + I GL P   Y  R+ A N  G  + S  S+  T 
Sbjct: 67  GIVTIVGLKPETTYAVRLAALNGKGLGEISAASEFKTQ 104

>1cfb_A Drosophila neuroglian; neural adhesion molecule; HET: NAG; 2.00A {Drosophila melanogaster} SCOP: b.1.2.1 b.1.2.1 Length = 205

 Score = 62.0 bits (151), Expect = 1e-11
 Identities = 18/53 (33%), Positives = 23/53 (43%), Gaps = 2/53 (3%)

Query: 2   SSWIRVGNT--RFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD 52
           +SW           +  +  +SP   Y FRV A N  G S PS  SD  TT+ 
Sbjct: 49  ASWDAAYEKVPNTDSSFVVQMSPWANYTFRVIAFNKIGASPPSAHSDSCTTQP 101

>1cfb_A Drosophila neuroglian; neural adhesion molecule; HET: NAG; 2.00A {Drosophila melanogaster} SCOP: b.1.2.1 b.1.2.1 Length = 205

 Score = 46.2 bits (110), Expect = 3e-06
 Identities = 9/51 (17%), Positives = 20/51 (39%), Gaps = 2/51 (3%)

Query: 2   SSWIR--VGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT 50
           ++W    + + R   + I       +Y  +V A N  G S+ +    +  +
Sbjct: 151 AAWENNNIFDWRQNNIVIADQPTFVKYLIKVVAINDRGESNVAAEEVVGYS 201

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 63.0 bits (154), Expect = 2e-11
 Identities = 50/224 (22%), Positives = 86/224 (38%), Gaps = 55/224 (24%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAK-----FIPVSHNLEKELIRKEIDIMNQLHHPKLINL 170
           +G G FGVV++          A K         +  L+++  + EI +M +  H  L+ L
Sbjct: 39  MGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQ-EIKVMAKCQHENLVEL 95

Query: 171 HDAFEDDDEMVLIFEFLSGG----ELFERITAPDYKMSEAEVIPVTLP------ILMTQT 220
                D D++ L++ ++  G     L      P             L       I     
Sbjct: 96  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP------------PLSWHMRCKI----- 138

Query: 221 SPAV------KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST- 273
             A         +HE + IH D+K  NI+     +   K+ DFGLA   +      +++ 
Sbjct: 139 --AQGAANGINFLHENHHIHRDIKSANILLD--EAFTAKISDFGLARASEKFAQTVMTSR 194

Query: 274 --GTAEFAAPEIVEREPVGFYT---DMWAVGVLAYVLLSGLSPF 312
             GT  + APE +     G  T   D+++ GV+   +++GL   
Sbjct: 195 IVGTTAYMAPEALR----GEITPKSDIYSFGVVLLEIITGLPAV 234

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 62.3 bits (152), Expect = 5e-11
 Identities = 54/255 (21%), Positives = 96/255 (37%), Gaps = 53/255 (20%)

Query: 112 ILEEIGTGAFGVVHRCR-----ERKTGNIFAAKFIPVSHNLE--KELIRKEIDIMNQL-H 163
             + +G+GAFG V         +       A K +    +    + L+  E+ +M QL  
Sbjct: 49  FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMS-ELKMMTQLGS 107

Query: 164 HPKLINLHDAFEDDDEMVLIFEFLSGGEL--------------FERITAPDYKMSEAEVI 209
           H  ++NL  A      + LIFE+   G+L                          E ++ 
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167

Query: 210 PVTLPILMT---QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN 266
            +T   L+    Q +  ++ +  K+ +H D+   N++        VK+ DFGLA  +  +
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK--VVKICDFGLARDIMSD 225

Query: 267 EVVKISTGTAEFAAPEIVEREPV----------GFYT---DMWAVGVLAYVLLS-GLSPF 312
               +              R PV          G YT   D+W+ G+L + + S G++P+
Sbjct: 226 SNYVVRGNA----------RLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275

Query: 313 AG-ENDVETLKNVKA 326
            G   D    K ++ 
Sbjct: 276 PGIPVDANFYKLIQN 290

>2kbg_A N-CAM 2, neural cell adhesion molecule 2; fibronectin type III module, beta-sheet sandwich, cell membrane, glycoprotein, immunoglobulin domain; NMR {Homo sapiens} Length = 114

 Score = 58.3 bits (141), Expect = 5e-11
 Identities = 10/51 (19%), Positives = 18/51 (35%)

Query: 13  TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDTFKKQIKKRQY 63
             + +  L     YE ++ A N  G S+P+     +  K    K      +
Sbjct: 64  DHIILEHLQWTMGYEVQITAANRLGYSEPTVYEFSMPPKPNIIKDHHHHHH 114

>1x5f_A Neogenin; RGM binding, fibronectin type III domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: b.1.2.1 Length = 120

 Score = 57.8 bits (140), Expect = 9e-11
 Identities = 12/51 (23%), Positives = 20/51 (39%)

Query: 3   SWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDT 53
                 +     + I  L P   Y FRV A+N +G  + S    + T  ++
Sbjct: 65  RVENTSHPGEMQVTIQNLMPATVYIFRVMAQNKHGSGESSAPLRVETQPES 115

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 60.7 bits (148), Expect = 1e-10
 Identities = 46/174 (26%), Positives = 80/174 (45%), Gaps = 16/174 (9%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAK-FIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF 174
           IG G FG V++    + G   A K   P S    +E    EI+ ++   HP L++L    
Sbjct: 47  IGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEEF-ETEIETLSFCRHPHLVSLIGFC 104

Query: 175 EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK---HMHEKN 231
           ++ +EM+LI++++  G L   +   D        + ++    +     A +   ++H + 
Sbjct: 105 DERNEMILIYKYMENGNLKRHLYGSD-----LPTMSMSWEQRLEICIGAARGLHYLHTRA 159

Query: 232 IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST---GTAEFAAPE 282
           IIH DVK  NI+     +   K+ DFG++ K    +   +ST   GT  +  PE
Sbjct: 160 IIHRDVKSINILLD--ENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPE 211

>2jll_A NCAM2, neural cell adhesion molecule 2; immunoglobulin domain, immunoglobulin superfamily, transmembrane, phosphoprotein, membrane, glycoprotein; HET: NAG; 2.30A {Homo sapiens} PDB: 2xyc_A* 2jlk_A* 2doc_A Length = 389

 Score = 57.9 bits (140), Expect = 1e-09
 Identities = 15/53 (28%), Positives = 19/53 (35%), Gaps = 1/53 (1%)

Query: 2   SSWIRV-GNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDT 53
             W  V  +   T + +  L P   YE RV A N  G+ D S      T    
Sbjct: 240 EIWKIVRSHGVQTMVVLNNLEPNTTYEIRVAAVNGKGQGDYSKIEIFQTLPVR 292

>2jll_A NCAM2, neural cell adhesion molecule 2; immunoglobulin domain, immunoglobulin superfamily, transmembrane, phosphoprotein, membrane, glycoprotein; HET: NAG; 2.30A {Homo sapiens} PDB: 2xyc_A* 2jlk_A* 2doc_A Length = 389

 Score = 53.7 bits (129), Expect = 4e-08
 Identities = 9/52 (17%), Positives = 17/52 (32%), Gaps = 2/52 (3%)

Query: 2   SSWIRVGNTRF--TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK 51
                    +     + +  L     YE ++ A N  G S+P+     +  K
Sbjct: 336 EDQWLEKKVQGNKDHIILEHLQWTMGYEVQITAANRLGYSEPTVYEFSMPPK 387

>2vkw_A Neural cell adhesion molecule 1,140 kDa isoform; adhesion receptor; 2.3A {Homo sapiens} SCOP: b.1.2.1 b.1.2.1 PDB: 2vkx_A 1lwr_A Length = 209

 Score = 55.6 bits (134), Expect = 3e-09
 Identities = 13/53 (24%), Positives = 17/53 (32%), Gaps = 5/53 (9%)

Query: 2   SSWIRVGNTRF-----TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLIT 49
             W               + I GL P   Y  R+ A N  G  + S  S+  T
Sbjct: 52  EVWHSKWYDAKEASMEGIVTIVGLKPETTYAVRLAALNGKGLGEISAASEFKT 104

>2vkw_A Neural cell adhesion molecule 1,140 kDa isoform; adhesion receptor; 2.3A {Homo sapiens} SCOP: b.1.2.1 b.1.2.1 PDB: 2vkx_A 1lwr_A Length = 209

 Score = 53.3 bits (128), Expect = 2e-08
 Identities = 11/52 (21%), Positives = 16/52 (30%), Gaps = 2/52 (3%)

Query: 2   SSWIRVGNTRF--TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK 51
           S W            + +  L    +YE  V AEN  G+S  +         
Sbjct: 152 SEWKPEIRLPSGSDHVMLKSLDWNAEYEVYVVAENQQGKSKAAHFVFRTAAA 203

>2ed7_A Netrin receptor DCC; tumor suppressor protein DCC, colorectal cancer suppressor, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 119

 Score = 53.2 bits (128), Expect = 4e-09
 Identities = 11/51 (21%), Positives = 19/51 (37%)

Query: 3   SWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDT 53
             +         + +  L P   Y FRV A N +G  + S    + T  ++
Sbjct: 64  RALNTTQPGSLQLTVGNLKPEAMYTFRVVAYNEWGPGESSQPIKVATQPES 114

>3teu_A Fibcon; FN3 domain, fibronectin TPYE III domain, consensus design, S de novo protein; HET: DIO; 1.00A {Synthetic} Length = 98

 Score = 52.0 bits (125), Expect = 5e-09
 Identities = 15/53 (28%), Positives = 22/53 (41%), Gaps = 2/53 (3%)

Query: 2  SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDTF 54
             + V  +  T++ ITGL+PG +Y   VYA      S P   +   T     
Sbjct: 45 PKELTVPPSS-TSVTITGLTPGVEYVVSVYALKDNQESPPLVGT-QTTGGHHH 95

>2yrz_A Integrin beta-4; GP150, CD104 antigen, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 118

 Score = 52.4 bits (126), Expect = 7e-09
 Identities = 12/55 (21%), Positives = 18/55 (32%), Gaps = 8/55 (14%)

Query: 2   SSWIRV-----GNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK 51
               R+       T      +  L P H Y FRV A++  G          I ++
Sbjct: 60  GELHRLNIPNPAQTSVV---VEDLLPNHSYVFRVRAQSQEGWGREREGVITIESQ 111

>3tes_A Tencon; fibronectin type III domain, FN3, consensus design, de novo; 2.50A {Synthetic} Length = 98

 Score = 50.5 bits (121), Expect = 2e-08
 Identities = 13/47 (27%), Positives = 21/47 (44%), Gaps = 3/47 (6%)

Query: 4  WIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT 50
           + V  +   +  +TGL PG +Y   +Y      RS+P +     TT
Sbjct: 47 NLTVPGSE-RSYDLTGLKPGTEYTVSIYGVKGGHRSNPLSAE--FTT 90

>3b83_A Ten-D3; beta sheet, computational redesigned protein, alternative splicing, cell adhesion, coiled coil, EGF-like domain, extracellular matrix; 2.40A {Homo sapiens} Length = 100

 Score = 50.1 bits (120), Expect = 3e-08
 Identities = 14/38 (36%), Positives = 20/38 (52%), Gaps = 2/38 (5%)

Query: 13 TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT 50
          T++ +T L P   YE R+ A N    S P +T+   TT
Sbjct: 55 TSLTLTNLEPNTTYEIRIVARNGQQYSPPVSTT--FTT 90

>1v5j_A KIAA1355 protein, RSGI RUH-008; FN3 domain, human cDNA, structural genomics, riken structural genomics/proteomics initiative, cell adhesion; NMR {Homo sapiens} SCOP: b.1.2.1 Length = 108

 Score = 50.3 bits (120), Expect = 3e-08
 Identities = 14/38 (36%), Positives = 21/38 (55%)

Query: 13  TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT 50
           T + + GL     YEFR+ A      SDPS T+++ T+
Sbjct: 63  TELLVPGLIKDVLYEFRLVAFAGSFVSDPSNTANVSTS 100

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 53.4 bits (129), Expect = 3e-08
 Identities = 51/212 (24%), Positives = 88/212 (41%), Gaps = 29/212 (13%)

Query: 116 IGTGAFGVVHRCRERKTGNIFAAKFIPV--SHNLEKELIRKEIDIMNQLHHPKLINLHDA 173
           +G G FG V++ R    G + A K +    +   E +    E+++++   H  L+ L   
Sbjct: 38  LGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQT-EVEMISMAVHRNLLRLRGF 95

Query: 174 FEDDDEMVLIFEFLSGG----ELFERITAPDYKMSEAEVIPVTLPILM---TQTSPAVKH 226
                E +L++ +++ G     L ER              P+  P        ++  + +
Sbjct: 96  CMTPTERLLVYPYMANGSVASCLRER---------PESQPPLDWPKRQRIALGSARGLAY 146

Query: 227 MHEK---NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST---GTAEFAA 280
           +H+     IIH DVK  NI+          + DFGLA KL   +   ++T   GT    A
Sbjct: 147 LHDHCDPKIIHRDVKAANILLD--EEFEAVVGDFGLA-KLMDYKDTHVTTAVRGTIGHIA 203

Query: 281 PEIVEREPVGFYTDMWAVGVLAYVLLSGLSPF 312
           PE +        TD++  GV+   L++G   F
Sbjct: 204 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 235

>2h41_A Fibronectin; beta sandwich, cell adhesion, structural protein; NMR {Homo sapiens} PDB: 2h45_A Length = 95

 Score = 49.4 bits (118), Expect = 4e-08
 Identities = 11/47 (23%), Positives = 21/47 (44%), Gaps = 1/47 (2%)

Query: 3  SWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLIT 49
           ++ + +T  T++ I  L PG +Y   VY  +  G      ++   T
Sbjct: 50 QYLDLPSTA-TSVNIPDLLPGRKYIVNVYQISEDGEQSLILSTSQTT 95

>2dn7_A Receptor-type tyrosine-protein phosphatase F; LAR protein, leukocyte antigen related, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.1.2.1 Length = 107

 Score = 49.7 bits (119), Expect = 5e-08
 Identities = 12/52 (23%), Positives = 20/52 (38%), Gaps = 2/52 (3%)

Query: 2   SSWIRV-GNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD 52
           +    +          +TGL  G  Y FR+ A+N  G  +      + T +D
Sbjct: 50  ARPNTIDFGKDDQHFTVTGLHKGTTYIFRLAAKNRAGLGEEFEKE-IRTPED 100

>2edd_A Netrin receptor DCC; tumor suppressor protein DCC, colorectal cancer suppressor, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 123

 Score = 49.5 bits (118), Expect = 7e-08
 Identities = 14/51 (27%), Positives = 20/51 (39%)

Query: 2   SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD 52
           S+  +  +T   +   TGL P   YEF V        S  S T+   T + 
Sbjct: 67  SAKYKSEDTTSLSYTATGLKPNTMYEFSVMVTKNRRSSTWSMTAHATTYEA 117

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 52.6 bits (126), Expect = 7e-08
 Identities = 56/285 (19%), Positives = 97/285 (34%), Gaps = 71/285 (24%)

Query: 112 ILEEIGTGAFGVVHRCR-----ERKTGNIFAAKFIPVSHNL-EKELIRKEIDIMNQL-HH 164
           + + +G GAFG V         +  T    A K +       E   +  E+ I+  + HH
Sbjct: 26  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85

Query: 165 PKLINLHDA-FEDDDEMVLIFEFLSGGEL------------------FERITAPDYKMSE 205
             ++NL  A  +    +++I EF   G L                         DY  + 
Sbjct: 86  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145

Query: 206 AEVIPVTLPIL-MTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFG------ 258
              +   L  +  +Q+S +   + EK++  ++ +           T   +I +       
Sbjct: 146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKG 205

Query: 259 ---LATK-------------LDPNEVVKIS----------------TGTAEF----AAPE 282
              LA++             L    VVKI                  G A       APE
Sbjct: 206 MEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 265

Query: 283 IVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAG-ENDVETLKNVK 325
            +        +D+W+ GVL + + S G SP+ G + D E  + +K
Sbjct: 266 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 310

>1j8k_A Fibronectin; EDA, TYPEIII domain, protein binding; NMR {Homo sapiens} SCOP: b.1.2.1 Length = 94

 Score = 48.6 bits (116), Expect = 8e-08
 Identities = 11/38 (28%), Positives = 16/38 (42%), Gaps = 2/38 (5%)

Query: 13 TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT 50
           T  + GL PG +Y   V A +    S P   +   +T
Sbjct: 55 DTAELQGLRPGSEYTVSVVALHDDMESQPLIGT--QST 90

>2e7h_A Ephrin type-B receptor 4; FN3 domain, tyrosine- protein kinase receptor HTK, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 109

 Score = 48.6 bits (116), Expect = 1e-07
 Identities = 12/50 (24%), Positives = 16/50 (32%)

Query: 3   SWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD 52
           S +R   T      + GL  G  Y  +V A +  G           T  D
Sbjct: 54  SSVRFLKTSENRAELRGLKRGASYLVQVRARSEAGYGPFGQEHHSQTQLD 103

>3r8q_A Fibronectin; heparin, FNIII, heparin binding, cell adhesion; 2.40A {Homo sapiens} PDB: 1fnh_A Length = 290

 Score = 51.0 bits (122), Expect = 2e-07
 Identities = 9/38 (23%), Positives = 16/38 (42%)

Query: 13  TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT 50
           +++ ++GL    +YE  VYA      S P+        
Sbjct: 74  SSVVVSGLMVATKYEVSVYALKDTLTSRPAQGVVTTLE 111

>3r8q_A Fibronectin; heparin, FNIII, heparin binding, cell adhesion; 2.40A {Homo sapiens} PDB: 1fnh_A Length = 290

 Score = 50.2 bits (120), Expect = 3e-07
 Identities = 12/33 (36%), Positives = 15/33 (45%)

Query: 13  TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTS 45
            +  ITGL PG  Y+  +Y  N   RS P    
Sbjct: 165 RSYTITGLQPGTDYKIYLYTLNDNARSSPVVID 197

>3r8q_A Fibronectin; heparin, FNIII, heparin binding, cell adhesion; 2.40A {Homo sapiens} PDB: 1fnh_A Length = 290

 Score = 49.4 bits (118), Expect = 6e-07
 Identities = 13/49 (26%), Positives = 17/49 (34%), Gaps = 2/49 (4%)

Query: 2   SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT 50
              +       T   ITGL PG +Y   V A     +S+P        T
Sbjct: 244 REVVPRPRPGVTEATITGLEPGTEYTIYVIALKNNQKSEPLIGR--KKT 290

>2ee3_A Collagen alpha-1(XX) chain; KIAA1510, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 108

 Score = 48.2 bits (115), Expect = 2e-07
 Identities = 13/45 (28%), Positives = 15/45 (33%), Gaps = 4/45 (8%)

Query: 8  GNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD 52
          GN       +  LS    Y  RV      G S   T    +TTK 
Sbjct: 57 GNATSAM--LGPLSSSTTYTVRVTCLYPGGGSSTLTGR--VTTKK 97

>2rb8_A Tenascin; beta sheet,loop design, alternative splicing, cell adhesion, coiled coil, EGF-like domain, extracellular matrix, glycoprotein; 1.45A {Homo sapiens} PDB: 2rbl_A 1ten_A Length = 104

 Score = 47.8 bits (114), Expect = 2e-07
 Identities = 10/49 (20%), Positives = 19/49 (38%), Gaps = 3/49 (6%)

Query: 3  SWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK 51
          + I +        +I  L P  +YE  + +      S+P+  +   TT 
Sbjct: 47 TTIDLTEDE-NQYSIGNLKPDTEYEVSLISRRGDMSSNPAKET--FTTG 92

>1x5z_A Receptor-type tyrosine-protein phosphatase delta; fibronectin type III domain containing protein, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.1.2.1 Length = 115

 Score = 47.7 bits (114), Expect = 2e-07
 Identities = 11/52 (21%), Positives = 19/52 (36%)

Query: 2   SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDT 53
               R+     T+  + GL P   Y FR+ A +  G    +      T + +
Sbjct: 59  GEEQRITIEPGTSYRLQGLKPNSLYYFRLAARSPQGLGASTAEISARTMQSS 110

>2cum_A Tenascin-X; hexabrachion-like, fibronectin type III domain, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.1.2.1 Length = 105

 Score = 47.5 bits (113), Expect = 2e-07
 Identities = 12/38 (31%), Positives = 16/38 (42%), Gaps = 2/38 (5%)

Query: 13 TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT 50
          T+  + GL P   Y  R+ A        P +TS   TT
Sbjct: 59 TSHQLLGLFPSTSYNARLQAMWGQSLLPPVSTS--FTT 94

>2ekj_A Collagen alpha-1(XX) chain; KIAA1510, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 105

 Score = 47.4 bits (113), Expect = 3e-07
 Identities = 9/41 (21%), Positives = 17/41 (41%), Gaps = 1/41 (2%)

Query: 5  IRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTS 45
          + V   R + + +  L    +Y   V A    GRS+  + +
Sbjct: 54 VSVPGAR-SHVTLPDLQAATKYRVLVSAIYAAGRSEAVSAT 93

>2gee_A Hypothetical protein; fibronectin, EIIIB, cancer, neovascularization, cell adhesion, protein binding, oncoprotein; 2.01A {Homo sapiens} PDB: 2fnb_A Length = 203

 Score = 49.4 bits (118), Expect = 3e-07
 Identities = 12/33 (36%), Positives = 16/33 (48%)

Query: 13  TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTS 45
               +TGL PG  Y+  VY     G S P+T +
Sbjct: 77  GYYTVTGLEPGIDYDISVYTVKNGGESTPTTLT 109

>2gee_A Hypothetical protein; fibronectin, EIIIB, cancer, neovascularization, cell adhesion, protein binding, oncoprotein; 2.01A {Homo sapiens} PDB: 2fnb_A Length = 203

 Score = 46.4 bits (110), Expect = 3e-06
 Identities = 9/38 (23%), Positives = 13/38 (34%), Gaps = 2/38 (5%)

Query: 13  TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT 50
             + +T L PG +Y   V +      S P        T
Sbjct: 168 NAVVLTNLLPGTEYVVSVSSVYEQHESTPLRGR--QKT 203

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 50.3 bits (119), Expect = 3e-07
 Identities = 45/314 (14%), Positives = 88/314 (28%), Gaps = 83/314 (26%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV--------SHNLEKELIRKEIDIM 159
           +     E+IG G FG V +          A K I +        SH    E I  EI I 
Sbjct: 20  EKLQRCEKIGEGVFGEVFQT--IADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77

Query: 160 NQLH---------HPKLINLHDAF------------------------------EDDDEM 180
            +L              I L+                                   DD++
Sbjct: 78  KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137

Query: 181 VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEK-NIIHLDVKP 239
            ++ EF  GG   E++      ++ A+ I       + Q + ++          H D+  
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLSSLATAKSI-------LHQLTASLAVAEASLRFEHRDLHW 190

Query: 240 ENIMCQTRNSTN------------------VKMIDFGLATKLDPNEVVKISTGTAEFAAP 281
            N++ +  +                     V +ID+ L+       VV            
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDV----SMDE 246

Query: 282 EIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAG----ENDVETLKNVKACDWEFDEEAFK 337
           ++   +    +     +            P++         + +        + +  A K
Sbjct: 247 DLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMK 306

Query: 338 NVSEEGKDFIRRLL 351
            +  + ++F R +L
Sbjct: 307 QIKRKIQEFHRTML 320

>1qr4_A Protein (tenascin); fibronectin type-III, heparin, extracellular matrix, adhesion, fusion protein, structural protein; 2.55A {Gallus gallus} SCOP: b.1.2.1 b.1.2.1 Length = 186

 Score = 49.0 bits (117), Expect = 4e-07
 Identities = 10/33 (30%), Positives = 16/33 (48%)

Query: 13 TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTS 45
          T+  + GL  G +Y   + AE    +S P+T  
Sbjct: 58 TSFILRGLDAGTEYTISLVAEKGRHKSKPTTIK 90

>1qr4_A Protein (tenascin); fibronectin type-III, heparin, extracellular matrix, adhesion, fusion protein, structural protein; 2.55A {Gallus gallus} SCOP: b.1.2.1 b.1.2.1 Length = 186

 Score = 46.3 bits (110), Expect = 3e-06
 Identities = 8/39 (20%), Positives = 15/39 (38%), Gaps = 2/39 (5%)

Query: 13  TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK 51
           T   +  L PG  Y   + +   +  S+P +    + T 
Sbjct: 147 TRTKLVKLVPGVDYNVNIISVKGFEESEPISGI--LKTA 183

>2dkm_A Collagen alpha-1(XX) chain; FN3 domain, KIAA1510, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 104

 Score = 46.4 bits (110), Expect = 6e-07
 Identities = 10/41 (24%), Positives = 15/41 (36%), Gaps = 3/41 (7%)

Query: 5  IRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTS 45
          ++VG        + GL PG  YE  V +      S+     
Sbjct: 56 VQVGRPEVL---LDGLEPGRDYEVSVQSLRGPEGSEARGIR 93

>1x5g_A Neogenin; RGM binding, fibronectin type III domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: b.1.2.1 Length = 116

 Score = 46.6 bits (111), Expect = 7e-07
 Identities = 13/51 (25%), Positives = 19/51 (37%), Gaps = 1/51 (1%)

Query: 2   SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD 52
                V +    +  I GL    +Y FRV A N +G    +    + T  D
Sbjct: 61  DKEQDV-DVSSHSYTINGLKKYTEYSFRVVAYNKHGPGVSTPDVAVRTLSD 110

>1tdq_A Tenascin-R; extracellular matrix, lecticans, tenascins, protein-protein interactions, C-type lectin domain; 2.60A {Rattus norvegicus} SCOP: b.1.2.1 b.1.2.1 b.1.2.1 Length = 283

 Score = 49.0 bits (117), Expect = 7e-07
 Identities = 12/44 (27%), Positives = 17/44 (38%)

Query: 2   SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTS 45
            S         T+  +T L PG +Y   + AE    +S  ST  
Sbjct: 237 ISSEVTVPRDRTSYTLTDLEPGAEYIISITAERGRQQSLESTVD 280

>1tdq_A Tenascin-R; extracellular matrix, lecticans, tenascins, protein-protein interactions, C-type lectin domain; 2.60A {Rattus norvegicus} SCOP: b.1.2.1 b.1.2.1 b.1.2.1 Length = 283

 Score = 49.0 bits (117), Expect = 7e-07
 Identities = 13/50 (26%), Positives = 22/50 (44%), Gaps = 3/50 (6%)

Query: 2   SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK 51
            +  R+     +  ++  L PG +YE  + A      SD S+T    TT+
Sbjct: 58  KTTFRLQPPL-SQYSVQALRPGSRYEVSISAVRGTNESDASSTQ--FTTE 104

>1tdq_A Tenascin-R; extracellular matrix, lecticans, tenascins, protein-protein interactions, C-type lectin domain; 2.60A {Rattus norvegicus} SCOP: b.1.2.1 b.1.2.1 b.1.2.1 Length = 283

 Score = 48.3 bits (115), Expect = 1e-06
 Identities = 11/44 (25%), Positives = 18/44 (40%)

Query: 2   SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTS 45
              +  G    T   +T L PG +Y   + A     +S P+T +
Sbjct: 149 EVLVPKGIGPTTKTTLTDLVPGTEYGVGISAVMNSKQSIPATMN 192

>3t1w_A Four-domain fibronectin fragment; human fibronectin, FN type-III domain, oncofetal splice VARI extra-domain B, EIIIB, ED-B, angiogenesis, integrin; 2.40A {Homo sapiens} Length = 375

 Score = 49.4 bits (118), Expect = 7e-07
 Identities = 11/44 (25%), Positives = 19/44 (43%), Gaps = 1/44 (2%)

Query: 2   SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTS 45
               RV ++R  ++ +T L+PG +Y   + A N    S      
Sbjct: 321 PREDRVPHSR-NSITLTNLTPGTEYVVSIVALNGREESPLLIGQ 363

>3t1w_A Four-domain fibronectin fragment; human fibronectin, FN type-III domain, oncofetal splice VARI extra-domain B, EIIIB, ED-B, angiogenesis, integrin; 2.40A {Homo sapiens} Length = 375

 Score = 47.1 bits (112), Expect = 4e-06
 Identities = 11/33 (33%), Positives = 15/33 (45%)

Query: 13  TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTS 45
               +TGL PG  Y+  V      G S P+T +
Sbjct: 150 GYYTVTGLEPGIDYDISVITLINGGESAPTTLT 182

>3t1w_A Four-domain fibronectin fragment; human fibronectin, FN type-III domain, oncofetal splice VARI extra-domain B, EIIIB, ED-B, angiogenesis, integrin; 2.40A {Homo sapiens} Length = 375

 Score = 47.1 bits (112), Expect = 5e-06
 Identities = 11/43 (25%), Positives = 17/43 (39%)

Query: 2  SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTT 44
          +S   V +   ++     LSPG +Y   VY       S P + 
Sbjct: 48 NSLEEVVHADQSSCTFDNLSPGLEYNVSVYTVKDDKESVPISD 90

>3t1w_A Four-domain fibronectin fragment; human fibronectin, FN type-III domain, oncofetal splice VARI extra-domain B, EIIIB, ED-B, angiogenesis, integrin; 2.40A {Homo sapiens} Length = 375

 Score = 46.0 bits (109), Expect = 9e-06
 Identities = 8/33 (24%), Positives = 12/33 (36%)

Query: 13  TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTS 45
             + +T L PG +Y   V +      S P    
Sbjct: 241 NAVVLTNLLPGTEYVVSVSSVYEQHESTPLRGR 273

>1wk0_A KIAA0970 protein; fibronectin type III domain, structural genomics, riken structural genomics/proteomics initiative, RSGI, unknown function; NMR {Homo sapiens} SCOP: b.1.2.1 Length = 137

 Score = 46.9 bits (111), Expect = 9e-07
 Identities = 11/46 (23%), Positives = 16/46 (34%)

Query: 4   WIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLIT 49
           +  V     T + +  L P   Y  +V AE    +  PS      T
Sbjct: 73  YKSVYVGEETNITLNDLKPAMDYHAKVQAEYNSIKGTPSEAEIFTT 118

>1wfo_A Sidekick 2; FN3, cell adhesion, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: b.1.2.1 Length = 130

 Score = 46.2 bits (110), Expect = 1e-06
 Identities = 12/52 (23%), Positives = 21/52 (40%)

Query: 2   SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDT 53
           ++ + V          TGL P   Y FR+ A+   G  + +    + T K +
Sbjct: 74  TATVEVLAPSARQYTATGLKPESVYLFRITAQTRKGWGEAAEALVVTTEKRS 125

>2ha1_A Fibronectin; beta sandwich, protein-protein complex, rigid BODY docking, cell adhesion, structural protein; NMR {Homo sapiens} Length = 201

 Score = 47.3 bits (112), Expect = 1e-06
 Identities = 11/38 (28%), Positives = 17/38 (44%), Gaps = 1/38 (2%)

Query: 13  TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT 50
           T++ I  L PG +Y   VY  +  G      ++   TT
Sbjct: 165 TSVNIPDLLPGRKYIVNVYQISEDGEQSLILSTS-QTT 201

>2ha1_A Fibronectin; beta sandwich, protein-protein complex, rigid BODY docking, cell adhesion, structural protein; NMR {Homo sapiens} Length = 201

 Score = 46.2 bits (109), Expect = 4e-06
 Identities = 10/39 (25%), Positives = 17/39 (43%)

Query: 13 TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK 51
           +  I GL PG  YE ++ +   YG  + +      T+ 
Sbjct: 56 NSYTIKGLKPGVVYEGQLISIQQYGHQEVTRFDFTTTST 94

>2cui_A Tenascin-X; fibronectin type III domain, extracellular matirx, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.1.2.1 Length = 112

 Score = 45.0 bits (106), Expect = 2e-06
 Identities = 5/33 (15%), Positives = 11/33 (33%)

Query: 13  TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTS 45
            +  +  L  G  Y   +Y      ++D    +
Sbjct: 70  HSAVLRDLRSGTLYSLTLYGLRGPHKADSIQGT 102

>3t04_D Monobody 7C12; engineered binding protein, antibody mimic, protein-protein SH2 domain, ATP-binding, phosphoprotein; 2.10A {Homo sapiens} Length = 103

 Score = 44.7 bits (106), Expect = 2e-06
 Identities = 12/47 (25%), Positives = 18/47 (38%), Gaps = 1/47 (2%)

Query: 5   IRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK 51
             V     +T  I+GL PG  Y   VYA + +       +   I  +
Sbjct: 57  FTVPGYY-STATISGLKPGVDYTITVYAYDTFFPGYEPNSPISINYR 102

>3qht_C Monobody YSMB-1; fibronectin type III, yeast small ubiquitin-like modifier, S NOVO protein; 2.40A {Artificial gene} Length = 97

 Score = 44.7 bits (106), Expect = 2e-06
 Identities = 15/47 (31%), Positives = 20/47 (42%), Gaps = 1/47 (2%)

Query: 5  IRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK 51
            V  +  +T  I+GLSPG  Y   VYA   Y     S +   I  +
Sbjct: 51 FTVPGSS-STATISGLSPGVDYTITVYAYYSYYDLYYSYSPSSINYR 96

>3fl7_A Ephrin receptor; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase, glycoprotein; HET: NAG; 2.50A {Homo sapiens} PDB: 2x10_A* 2x11_A 3mx0_A* 3mbw_A* Length = 536

 Score = 48.2 bits (114), Expect = 3e-06
 Identities = 11/51 (21%), Positives = 19/51 (37%)

Query: 2   SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD 52
           S+   V  T   ++ +  L+P   Y  +V A    G+   S   +  T   
Sbjct: 484 SNSYNVRRTEGFSVTLDDLAPDTTYLVQVQALTQEGQGAGSKVHEFQTLSP 534

>3fl7_A Ephrin receptor; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase, glycoprotein; HET: NAG; 2.50A {Homo sapiens} PDB: 2x10_A* 2x11_A 3mx0_A* 3mbw_A* Length = 536

 Score = 45.9 bits (108), Expect = 1e-05
 Identities = 9/44 (20%), Positives = 15/44 (34%)

Query: 6   RVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLIT 49
                  T++ ++ L P   Y F V A N       S +    +
Sbjct: 393 PPHGLTRTSVTVSDLEPHMNYTFTVEARNGVSGLVTSRSFRTAS 436

>2ed8_A Netrin receptor DCC; tumor suppressor protein DCC, colorectal cancer suppressor, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 106

 Score = 44.6 bits (106), Expect = 3e-06
 Identities = 10/51 (19%), Positives = 17/51 (33%), Gaps = 1/51 (1%)

Query: 2   SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD 52
                +      +  + GL    +Y  R  A N YG    +    ++T  D
Sbjct: 51  GKEQNIEVDG-LSYKLEGLKKFTEYSLRFLAYNRYGPGVSTDDITVVTLSD 100

>1x5j_A Neogenin; RGM binding, fibronectin type III domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: b.1.2.1 Length = 113

 Score = 44.8 bits (106), Expect = 3e-06
 Identities = 13/52 (25%), Positives = 21/52 (40%), Gaps = 1/52 (1%)

Query: 2   SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDT 53
           + +     T  + + +TGL P   YEF V        S  S T+   T + +
Sbjct: 58  TKYKNANATTLSYL-VTGLKPNTLYEFSVMVTKGRRSSTWSMTAHGTTFELS 108

>2ocf_D Fibronectin; estrogen receptor, LBD, monobody, estradiol, hormone-growth complex; HET: CME EST; 2.95A {Homo sapiens} Length = 121

 Score = 44.5 bits (105), Expect = 4e-06
 Identities = 12/50 (24%), Positives = 18/50 (36%), Gaps = 1/50 (2%)

Query: 2   SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK 51
                V  ++ +T  I+GL PG  Y   VYA          +    I  +
Sbjct: 72  VQEFTVPGSK-STATISGLKPGVDYTITVYAVTGLRLMLAGSKPISINYR 120

>1fnf_A Fibronectin; RGD, extracellular matrix, cell adhesion protein; 2.00A {Homo sapiens} SCOP: b.1.2.1 b.1.2.1 b.1.2.1 b.1.2.1 PDB: 1mfn_A 2mfn_A 2ck2_A Length = 368

 Score = 47.1 bits (112), Expect = 4e-06
 Identities = 8/33 (24%), Positives = 12/33 (36%)

Query: 13  TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTS 45
             + +T L PG +Y   V +      S P    
Sbjct: 149 NAVVLTNLLPGTEYVVSVSSVYEQHESTPLRGR 181

>1fnf_A Fibronectin; RGD, extracellular matrix, cell adhesion protein; 2.00A {Homo sapiens} SCOP: b.1.2.1 b.1.2.1 b.1.2.1 b.1.2.1 PDB: 1mfn_A 2mfn_A 2ck2_A Length = 368

 Score = 46.4 bits (110), Expect = 8e-06
 Identities = 11/44 (25%), Positives = 18/44 (40%)

Query: 2  SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTS 45
          +S   V +   ++     LSPG +Y   VY       S P + +
Sbjct: 47 NSLEEVVHADQSSCTFDNLSPGLEYNVSVYTVKDDKESVPISDT 90

>1fnf_A Fibronectin; RGD, extracellular matrix, cell adhesion protein; 2.00A {Homo sapiens} SCOP: b.1.2.1 b.1.2.1 b.1.2.1 b.1.2.1 PDB: 1mfn_A 2mfn_A 2ck2_A Length = 368

 Score = 45.2 bits (107), Expect = 2e-05
 Identities = 14/39 (35%), Positives = 18/39 (46%)

Query: 13  TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK 51
           +T  I+GL PG  Y   VYA    G S  S+    I  +
Sbjct: 329 STATISGLKPGVDYTITVYAVTGRGDSPASSKPISINYR 367

>1fnf_A Fibronectin; RGD, extracellular matrix, cell adhesion protein; 2.00A {Homo sapiens} SCOP: b.1.2.1 b.1.2.1 b.1.2.1 b.1.2.1 PDB: 1mfn_A 2mfn_A 2ck2_A Length = 368

 Score = 44.1 bits (104), Expect = 4e-05
 Identities = 8/33 (24%), Positives = 14/33 (42%)

Query: 13  TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTS 45
            ++ +T L+PG +Y   + A N    S      
Sbjct: 239 NSITLTNLTPGTEYVVSIVALNGREESPLLIGQ 271

>3l5h_A Interleukin-6 receptor subunit beta; IG-like, FNIII, cell membrane, disulfide bond, glycoprotein, immunoglobulin domain, membrane, phosphoprotein; HET: NAG NDG BMA FUC; 3.60A {Homo sapiens} Length = 589

 Score = 47.3 bits (112), Expect = 4e-06
 Identities = 9/52 (17%), Positives = 13/52 (25%), Gaps = 2/52 (3%)

Query: 2   SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDT 53
           + W +   T   T     L+    Y   V      G   P +       K  
Sbjct: 445 TDWQQEDGTVHRTYLRGNLAESKCYLITVTPVYADGPGSPESIK--AYLKQA 494

>3l5h_A Interleukin-6 receptor subunit beta; IG-like, FNIII, cell membrane, disulfide bond, glycoprotein, immunoglobulin domain, membrane, phosphoprotein; HET: NAG NDG BMA FUC; 3.60A {Homo sapiens} Length = 589

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 8/39 (20%), Positives = 16/39 (41%)

Query: 13  TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK 51
           ++  +  L P  +Y FR+      G+   S  S+  +  
Sbjct: 259 SSFTVQDLKPFTEYVFRIRCMKEDGKGYWSDWSEEASGI 297

>3l5h_A Interleukin-6 receptor subunit beta; IG-like, FNIII, cell membrane, disulfide bond, glycoprotein, immunoglobulin domain, membrane, phosphoprotein; HET: NAG NDG BMA FUC; 3.60A {Homo sapiens} Length = 589

 Score = 41.9 bits (98), Expect = 2e-04
 Identities = 9/50 (18%), Positives = 17/50 (34%), Gaps = 1/50 (2%)

Query: 2   SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK 51
           +      ++  T   ++ L+    Y  R+ A    G  D    +   T K
Sbjct: 541 NETAVNVDSSHTEYTLSSLTSDTLYMVRMAAYTDEGGKDGPEFT-FTTPK 589

>2w1n_A O-GLCNACASE NAGJ; hexosaminidase, glycoside hydrolase, fibronectin type-III, beta-N-acetylglucosaminidase, cohesin, hydrolase; 1.80A {Clostridium perfringens} Length = 238

 Score = 46.5 bits (109), Expect = 4e-06
 Identities = 8/49 (16%), Positives = 16/49 (32%)

Query: 3   SWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK 51
             +       T+     L+    Y F++ A+   G      +  L T +
Sbjct: 190 KKVAEIGKDETSYTFKKLNRHTIYNFKIAAKYSNGEVSSKESLTLRTAR 238

>3f7q_A Integrin beta-4, GP150; hemidesmosome, cell adhesion, carcinoma, epidermolysis bullosa, alternative splicing, disease mutation, glycoprotein; HET: 1PE PG4; 1.75A {Homo sapiens} PDB: 3f7r_A 3f7p_C 1qg3_A Length = 234

 Score = 46.3 bits (110), Expect = 5e-06
 Identities = 11/51 (21%), Positives = 22/51 (43%)

Query: 2  SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD 52
           S   + +++  ++ +T L P   YE +V A    G    S+     T ++
Sbjct: 47 ESEAHLLDSKVPSVELTNLYPYCDYEMKVCAYGAQGEGPYSSLVSCRTHQE 97

>3f7q_A Integrin beta-4, GP150; hemidesmosome, cell adhesion, carcinoma, epidermolysis bullosa, alternative splicing, disease mutation, glycoprotein; HET: 1PE PG4; 1.75A {Homo sapiens} PDB: 3f7r_A 3f7p_C 1qg3_A Length = 234

 Score = 42.8 bits (101), Expect = 7e-05
 Identities = 8/39 (20%), Positives = 12/39 (30%)

Query: 13  TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK 51
             + I  L     Y + V A N  G          + T+
Sbjct: 160 RMLLIENLRESQPYRYTVKARNGAGWGPEREAIINLATQ 198

>3k2m_C Monobody HA4; engineered binding protein, antibody mimic, protein-protein SH2 domain, ATP-binding, phosphoprotein; 1.75A {Homo sapiens} PDB: 3uyo_D 1ttf_A 1ttg_A 3rzw_A 1fna_A Length = 101

 Score = 43.6 bits (103), Expect = 5e-06
 Identities = 14/49 (28%), Positives = 18/49 (36%), Gaps = 1/49 (2%)

Query: 5   IRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDT 53
             V  +  +T  I+GLSPG  Y   VYA            S +     T
Sbjct: 53  FTVPYSS-STATISGLSPGVDYTITVYAWGEDSAGYMFMYSPISINYRT 100

>2cuh_A Tenascin-X; fibronectin type III domain, extracellular matrix, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.1.2.1 Length = 115

 Score = 44.0 bits (104), Expect = 5e-06
 Identities = 6/38 (15%), Positives = 11/38 (28%), Gaps = 2/38 (5%)

Query: 13 TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT 50
              +  L     Y   V        + P++ +   TT
Sbjct: 59 VDYPLHDLVLHTNYTATVRGLRGPNLTSPASIT--FTT 94

>2dm4_A Sortilin-related receptor; beta-sandwich, sorting protein-related receptor containing LDLR class A repeats, sorla; NMR {Homo sapiens} Length = 108

 Score = 44.0 bits (104), Expect = 5e-06
 Identities = 11/48 (22%), Positives = 15/48 (31%), Gaps = 3/48 (6%)

Query: 5   IRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD 52
            R  +       I  L     Y  RV A    G  + S +  + T K 
Sbjct: 58  QRAASNFTE---IKNLLVNTLYTVRVAAVTSRGIGNWSDSKSITTIKG 102

>2v5y_A Receptor-type tyrosine-protein phosphatase MU; membrane, hydrolase, glycoprotein, receptor protei tyrosine phosphatase, cell adhesion; HET: NAG; 3.10A {Homo sapiens} Length = 731

 Score = 46.3 bits (109), Expect = 9e-06
 Identities = 12/54 (22%), Positives = 14/54 (25%), Gaps = 2/54 (3%)

Query: 2   SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENV--YGRSDPSTTSDLITTKDT 53
            SW        T+  I  L P  +YE  V        G   P       T    
Sbjct: 305 GSWNDRQPVDSTSYKIGHLDPDTEYEISVLLTRPGEGGTGSPGPALRTRTKCAD 358

>3l5i_A Interleukin-6 receptor subunit beta; cytokine receptor, fibronectin type III domain, alternative cell membrane, disulfide bond; 1.90A {Homo sapiens} PDB: 3l5j_A Length = 290

 Score = 45.2 bits (107), Expect = 1e-05
 Identities = 8/43 (18%), Positives = 11/43 (25%)

Query: 3   SWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTS 45
            W +   T   T     L+    Y   V      G   P +  
Sbjct: 147 DWQQEDGTVHRTYLRGNLAESKCYLITVTPVYADGPGSPESIK 189

>3l5i_A Interleukin-6 receptor subunit beta; cytokine receptor, fibronectin type III domain, alternative cell membrane, disulfide bond; 1.90A {Homo sapiens} PDB: 3l5j_A Length = 290

 Score = 41.3 bits (97), Expect = 2e-04
 Identities = 9/44 (20%), Positives = 16/44 (36%), Gaps = 2/44 (4%)

Query: 9  NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD 52
          N       +T      +Y   +   N+ G+SD +  +  I   D
Sbjct: 57 NYTVNATKLTVNLTNDRYLATLTVRNLVGKSDAAVLT--IPACD 98

>2edb_A Netrin receptor DCC; tumor suppressor protein DCC, colorectal cancer suppressor, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 116

 Score = 42.4 bits (100), Expect = 2e-05
 Identities = 11/44 (25%), Positives = 15/44 (34%), Gaps = 4/44 (9%)

Query: 8   GNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK 51
              R+ +  I  L     Y   + A N  G   P   S   TT+
Sbjct: 68  SKQRYYS--IERLESSSHYVISLKAFNNAGEGVPLYES--ATTR 107

>2ede_A Netrin receptor DCC; tumor suppressor protein DCC, colorectal cancer suppressor, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 114

 Score = 42.4 bits (100), Expect = 2e-05
 Identities = 14/54 (25%), Positives = 17/54 (31%), Gaps = 5/54 (9%)

Query: 2   SSWIRV---GNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD 52
             WI     G+       I  L+    Y FR+ A N  G    S      T K 
Sbjct: 57  DDWIMETISGDRLTHQ--IMDLNLDTMYYFRIQARNSKGVGPLSDPILFRTLKV 108

>1x5l_A Ephrin type-A receptor 8; FN3 domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: b.1.2.1 Length = 111

 Score = 42.0 bits (99), Expect = 2e-05
 Identities = 16/51 (31%), Positives = 24/51 (47%), Gaps = 3/51 (5%)

Query: 2   SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD 52
            S ++   TR T   ++GL PG +Y F+V A    G    S   ++ T K 
Sbjct: 58  YSTLKAVTTRAT---VSGLKPGTRYVFQVRARTSAGCGRFSQAMEVETGKP 105

>1x5i_A Neogenin; RGM binding, fibronectin type III domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: b.1.2.1 Length = 126

 Score = 42.4 bits (100), Expect = 2e-05
 Identities = 11/46 (23%), Positives = 15/46 (32%), Gaps = 2/46 (4%)

Query: 8   GNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDT 53
              R+ T  I  L P   Y   + A N  G   P   S +     +
Sbjct: 78  YKQRYYT--IENLDPSSHYVITLKAFNNVGEGIPLYESAVTRPHTS 121

>3p4l_A Neogenin; iron homeostasis, hemojuvelin receptor, FNIII domain, fibron type III, cell adhesion; 1.80A {Homo sapiens} PDB: 1x5k_A Length = 211

 Score = 42.9 bits (101), Expect = 5e-05
 Identities = 13/51 (25%), Positives = 20/51 (39%), Gaps = 1/51 (1%)

Query: 2   SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD 52
           + +     T  + + +TGL P   YEF V        S  S T+   T + 
Sbjct: 54  TKYKNANATTLSYL-VTGLKPNTLYEFSVMVTKGRRSSTWSMTAHGTTFEL 103

>3s98_A Interferon alpha/beta receptor 1; human, type I interferons, receptor chain, ifnar1, fibronect III, type I interferon receptor chain; HET: NAG; 1.90A {Homo sapiens} Length = 306

 Score = 43.4 bits (101), Expect = 5e-05
 Identities = 9/55 (16%), Positives = 15/55 (27%), Gaps = 4/55 (7%)

Query: 4   WIRVGNTRFTT----MAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDTF 54
           W ++ +         +    +     Y  RV A +    S  S      T    F
Sbjct: 251 WKQIPDCENVKTTQCVFPQNVFQKGIYLLRVQASDGNNTSFWSEEIKFDTEIQAF 305

>3mpc_A FN3-like protein; fibronectin, FN(III), unknown function; 1.60A {Clostridium thermocellum} Length = 103

 Score = 40.9 bits (96), Expect = 5e-05
 Identities = 10/43 (23%), Positives = 20/43 (46%), Gaps = 3/43 (6%)

Query: 7  VGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLIT 49
          + +T +T    TG++ G +Y + V A +    +  S  + L  
Sbjct: 54 ITSTNYT---DTGVATGTKYYYVVSAVSNGVETLNSAEAILQY 93

>1k85_A Chitinase A1; fibronectin type III domain, chitin binding domain, carbohydrase, horizontal gene transfer, hydrolase; NMR {Bacillus circulans} SCOP: b.1.2.1 Length = 88

 Score = 39.6 bits (93), Expect = 9e-05
 Identities = 12/40 (30%), Positives = 16/40 (40%), Gaps = 1/40 (2%)

Query: 6  RVGNTRFTTMAITGLSPGHQYEFRVYAENVYG-RSDPSTT 44
                 TT  I+GL+    Y F V A++  G  S  S  
Sbjct: 44 LATTVTGTTATISGLAADTSYTFTVKAKDAAGNVSAASNA 83

>2djs_A Ephrin type-B receptor 1; tyrosine-protein kinase receptor EPH-2, NET, HEK6, ELK, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.1.2.1 Length = 108

 Score = 40.1 bits (94), Expect = 1e-04
 Identities = 14/47 (29%), Positives = 18/47 (38%)

Query: 6   RVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD 52
            +  ++  T  I GL PG  Y  +V A  V G    S      T  D
Sbjct: 56  SMARSQTNTARIDGLRPGMVYVVQVRARTVAGYGKFSGKMCFQTLTD 102

>1x5a_A Ephrin type-A receptor 1; tyrosine-protein kinase receptor, ESK, fibronectin type III (FN3) domain, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: b.1.2.1 Length = 107

 Score = 39.4 bits (92), Expect = 2e-04
 Identities = 9/40 (22%), Positives = 13/40 (32%)

Query: 13  TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD 52
             + +T L P   Y  RV      G    S   +  T+  
Sbjct: 62  PRVLLTKLQPDTTYIVRVRTLTPLGPGPFSPDHEFRTSPP 101

>1wfn_A Sidekick 2; FN3, cell adhesion, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: b.1.2.1 Length = 119

 Score = 39.3 bits (92), Expect = 2e-04
 Identities = 9/48 (18%), Positives = 14/48 (29%), Gaps = 3/48 (6%)

Query: 2   SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYG---RSDPSTTSD 46
           +              +TGL+    Y   V A    G    S  + +S 
Sbjct: 63  TRVTHYLPNVTLEYRVTGLTALTTYTIEVAAMTSKGQGQVSASTISSG 110

>1ujt_A KIAA1568 protein; fibronectin type III domain, structural genomics, riken structural genomics/proteomics initiative, RSGI, unknown function; NMR {Homo sapiens} SCOP: b.1.2.1 Length = 120

 Score = 38.3 bits (89), Expect = 6e-04
 Identities = 11/54 (20%), Positives = 20/54 (37%), Gaps = 2/54 (3%)

Query: 2   SSWIR--VGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDT 53
           SSW           +  +  L  G  YE +V       +   S +  + TT+++
Sbjct: 62  SSWQNLDAKVPTERSAVLVNLKKGVTYEIKVRPYFNEFQGMDSESKTVRTTEES 115

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	356
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.94
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.88
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.79
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.5
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.38
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.24
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.1
1wfu_A	120	Unnamed protein product; FN3 domain, similar to 17	98.84
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.84
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.71
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.68
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.62
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.59
2db8_A	110	Tripartite motif protein 9, isoform 2; ring finger	98.58
2crz_A	110	Fibronectin type-III domain containing protein 3A;	98.58
1bpv_A	112	Titin, A71, connectin; fibronectin type III; NMR {	98.57
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.56
1wk0_A	137	KIAA0970 protein; fibronectin type III domain, str	98.55
2ic2_A	115	CG9211-PA, GH03927P; IHOG, hedgehog, fibronectin t	98.54
2dmk_A	127	Midline 2 isoform 2; midline defect 2, tripartite	98.53
1x5x_A	109	Fibronectin type-III domain containing protein 3A;	98.52
1x3d_A	118	Fibronectin type-III domain containing protein 3A;	98.52
2crm_A	120	Fibronectin type-III domain containing protein 3A;	98.48
1x4z_A	121	Biregional cell adhesion molecule-related/DOWN- re	98.48
1x4x_A	106	Fibronectin type-III domain containing protein 3A;	98.44
2dju_A	106	Receptor-type tyrosine-protein phosphatase F; LAR	98.42
2yuw_A	110	Myosin binding protein C, SLOW type; fibronectin I	98.41
1x5y_A	111	Myosin binding protein C, fast-type; fast MYBP-C,	98.4
1wis_A	124	KIAA1514 protein; FNIII domain, sidekick-2, struct	98.39
2e7h_A	109	Ephrin type-B receptor 4; FN3 domain, tyrosine- pr	98.37
1v5j_A	108	KIAA1355 protein, RSGI RUH-008; FN3 domain, human	98.34
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.32
1x5j_A	113	Neogenin; RGM binding, fibronectin type III domain	98.32
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.3
2haz_A	105	N-CAM 1, neural cell adhesion molecule 1; fibronec	98.28
2djs_A	108	Ephrin type-B receptor 1; tyrosine-protein kinase	98.25
2ed9_A	124	Netrin receptor DCC; tumor suppressor protein DCC,	98.25
1uem_A	117	KIAA1568 protein; immunoglobulin-like beta-sandwic	98.22
1wf5_A	121	Sidekick 2 protein; FNIII domain, structural genom	98.22
2yux_A	120	Myosin-binding protein C, SLOW-type; fibronectin I	98.21
2edd_A	123	Netrin receptor DCC; tumor suppressor protein DCC,	98.2
2ede_A	114	Netrin receptor DCC; tumor suppressor protein DCC,	98.2
1x5a_A	107	Ephrin type-A receptor 1; tyrosine-protein kinase	98.19
2dbj_A	124	Proto-oncogene tyrosine-protein kinase MER precurs	98.17
2dlh_A	121	Receptor-type tyrosine-protein phosphatase delta;	98.16
2dm4_A	108	Sortilin-related receptor; beta-sandwich, sorting	98.16
1x5l_A	111	Ephrin type-A receptor 8; FN3 domain, structural g	98.14
1x5z_A	115	Receptor-type tyrosine-protein phosphatase delta;	98.13
1x5g_A	116	Neogenin; RGM binding, fibronectin type III domain	98.12
1ujt_A	120	KIAA1568 protein; fibronectin type III domain, str	98.12
2edy_A	103	Receptor-type tyrosine-protein phosphatase F; LAR	98.11
2kbg_A	114	N-CAM 2, neural cell adhesion molecule 2; fibronec	98.1
3b83_A	100	Ten-D3; beta sheet, computational redesigned prote	98.1
2ed7_A	119	Netrin receptor DCC; tumor suppressor protein DCC,	98.08
1x4y_A	114	Biregional cell adhesion molecule-related/DOWN- re	98.08
2ed8_A	106	Netrin receptor DCC; tumor suppressor protein DCC,	98.06
3n1f_C	102	Cell adhesion molecule-related/DOWN-regulated BY;	98.04
2e3v_A	122	Neural cell adhesion molecule 1, 140 kDa isoform;	98.04
2ee2_A	119	Contactin-1; neural cell surface protein F3, glyco	98.04
1uey_A	127	KIAA0343 protein; immunoglobulin-like beta-sandwic	98.03
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.0
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.99
1x5f_A	120	Neogenin; RGM binding, fibronectin type III domain	97.97
1k85_A	88	Chitinase A1; fibronectin type III domain, chitin	97.96
1uc6_A	109	CNTF receptor, ciliary neurotrophic factor recepto	97.95
2edx_A	134	Protein tyrosine phosphatase, receptor type, F; LA	97.92
1va9_A	122	DOWN syndrome cell adhesion molecule like- protein	97.91
1uen_A	125	KIAA0343 protein; immunoglobulin-like beta-sandwic	97.88
2dn7_A	107	Receptor-type tyrosine-protein phosphatase F; LAR	97.87
1j8k_A	94	Fibronectin; EDA, TYPEIII domain, protein binding;	97.86
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.85
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.82
2edb_A	116	Netrin receptor DCC; tumor suppressor protein DCC,	97.81
2yrz_A	118	Integrin beta-4; GP150, CD104 antigen, structural	97.8
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.79
1x5i_A	126	Neogenin; RGM binding, fibronectin type III domain	97.78
1wfo_A	130	Sidekick 2; FN3, cell adhesion, structural genomic	97.78
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.78
1bqu_A	215	Protein (GP130); cytokine receptor, glycoprotein 1	97.76
1x5h_A	132	Neogenin; RGM binding, fibronectin type III domain	97.75
3teu_A	98	Fibcon; FN3 domain, fibronectin TPYE III domain, c	97.75
2rb8_A	104	Tenascin; beta sheet,loop design, alternative spli	97.74
3tes_A	98	Tencon; fibronectin type III domain, FN3, consensu	97.73
4go6_B	232	HCF C-terminal chain 1; tandem fibronectin repeat,	97.68
1wfn_A	119	Sidekick 2; FN3, cell adhesion, structural genomic	97.66
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.64
2dkm_A	104	Collagen alpha-1(XX) chain; FN3 domain, KIAA1510,	97.64
3t04_D	103	Monobody 7C12; engineered binding protein, antibod	97.64
2cum_A	105	Tenascin-X; hexabrachion-like, fibronectin type II	97.63
3qht_C	97	Monobody YSMB-1; fibronectin type III, yeast small	97.59
1wj3_A	117	KIAA1496 protein; beta sandwich, PANG, structural	97.56
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.55
3k2m_C	101	Monobody HA4; engineered binding protein, antibody	97.55
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.54
1n26_A	325	IL-6 receptor alpha chain; transmembrane, glycopro	97.49
3mpc_A	103	FN3-like protein; fibronectin, FN(III), unknown fu	97.48
2vkw_A	209	Neural cell adhesion molecule 1,140 kDa isoform; a	97.41
2d9q_B	313	Granulocyte colony-stimulating factor receptor; cy	97.4
2ocf_D	121	Fibronectin; estrogen receptor, LBD, monobody, est	97.37
2dle_A	104	Receptor-type tyrosine-protein phosphatase ETA; pr	97.34
2nzi_A	305	Titin; IG-domain, FNIII-domain, transferase; 2.90A	97.34
2ibg_A	214	CG9211-PA, GH03927P; IHOG, fibronectin type III, p	97.34
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.33
2ekj_A	105	Collagen alpha-1(XX) chain; KIAA1510, structural g	97.32
3p4l_A	211	Neogenin; iron homeostasis, hemojuvelin receptor,	97.32
1oww_A	98	FN, fibronectin first type III module, CIG; fibron	97.3
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.3
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.29
3lpw_A	197	A77-A78 domain from titin; intracellular FNIII-tan	97.29
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.28
2cuh_A	115	Tenascin-X; fibronectin type III domain, extracell	97.22
3f7q_A	234	Integrin beta-4, GP150; hemidesmosome, cell adhesi	97.15
2ee3_A	108	Collagen alpha-1(XX) chain; KIAA1510, structural g	97.14
1cfb_A	205	Drosophila neuroglian; neural adhesion molecule; H	97.12
3f7q_A	234	Integrin beta-4, GP150; hemidesmosome, cell adhesi	97.03
2cui_A	112	Tenascin-X; fibronectin type III domain, extracell	97.02
1zlg_A	680	Anosmin 1; insulin-like growth factor receptor Cys	96.97
3qwq_B	114	Adnectin; cell surface receptor, tyrosine kinase,	96.95
2ha1_A	201	Fibronectin; beta sandwich, protein-protein comple	96.82
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.82
3up1_A	223	Interleukin-7 receptor subunit alpha; cytokine rec	96.78
2h41_A	95	Fibronectin; beta sandwich, cell adhesion, structu	96.54
2erj_C	247	Cytokine receptor common gamma chain; immune syste	96.52
1q38_A	89	Fibronectin; amyloid fibril, anastellin, extracell	96.51
3l5h_A	589	Interleukin-6 receptor subunit beta; IG-like, FNII	96.42
3s98_A	306	Interferon alpha/beta receptor 1; human, type I in	96.42
3l5i_A	290	Interleukin-6 receptor subunit beta; cytokine rece	96.41
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.33
1qr4_A	186	Protein (tenascin); fibronectin type-III, heparin,	96.3
2gee_A	203	Hypothetical protein; fibronectin, EIIIB, cancer,	96.27
1zlg_A	680	Anosmin 1; insulin-like growth factor receptor Cys	96.25
2b5i_C	199	Cytokine receptor common gamma chain; four-helix b	96.16
3tgx_A	219	Interleukin-21 receptor; class I cytokine, class I	96.14
4go6_B	232	HCF C-terminal chain 1; tandem fibronectin repeat,	96.13
3r8q_A	290	Fibronectin; heparin, FNIII, heparin binding, cell	96.12
2b5i_B	214	Interleukin-2 receptor beta chain; four-helix bund	96.07
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.88
1fnf_A	368	Fibronectin; RGD, extracellular matrix, cell adhes	95.83
3r8q_A	290	Fibronectin; heparin, FNIII, heparin binding, cell	95.83
2jll_A	389	NCAM2, neural cell adhesion molecule 2; immunoglob	95.82
2v5y_A	731	Receptor-type tyrosine-protein phosphatase MU; mem	95.75
1tdq_A	283	Tenascin-R; extracellular matrix, lecticans, tenas	95.65
3t1w_A	375	Four-domain fibronectin fragment; human fibronecti	95.63
1tdq_A	283	Tenascin-R; extracellular matrix, lecticans, tenas	95.36
3fl7_A	536	Ephrin receptor; ATP-binding, kinase, nucleotide-b	95.26
3t1w_A	375	Four-domain fibronectin fragment; human fibronecti	95.23
2dtg_E	897	Insulin receptor; IR ectodomain, X-RAY crystallogr	95.21
3se4_A	414	Interferon alpha/beta receptor 1; type I interfero	95.1
3bpo_C	314	Interleukin-13 receptor alpha-1 chain; IL4, IL13,	94.92
1fnf_A	368	Fibronectin; RGD, extracellular matrix, cell adhes	94.88
1i1r_A	303	GP130, interleukin-6 receptor beta chain; cytokine	94.8
1bqu_A	215	Protein (GP130); cytokine receptor, glycoprotein 1	94.8
1eer_B	227	Epobp, erythropoietin receptor; signal transductio	94.65
2v5y_A	731	Receptor-type tyrosine-protein phosphatase MU; mem	94.61
3s98_A	306	Interferon alpha/beta receptor 1; human, type I in	93.86
3l5i_A	290	Interleukin-6 receptor subunit beta; cytokine rece	93.77
3l5h_A	589	Interleukin-6 receptor subunit beta; IG-like, FNII	93.72
2dtg_E	897	Insulin receptor; IR ectodomain, X-RAY crystallogr	93.71
2gys_A	419	Cytokine receptor common beta chain; dimer of inte	93.3
3lb6_C	380	IL-13, interleukin-13 receptor subunit alpha-2; cy	92.92
3lqm_A	201	Interleukin-10 receptor subunit beta; IL-10R2, com	92.74
3se4_A	414	Interferon alpha/beta receptor 1; type I interfero	92.52
1iar_B	207	Protein (interleukin-4 receptor alpha chain); cyto	92.15
3g9v_A	211	Interleukin 22 receptor, alpha 2; cytokine, cytoki	92.07
4doh_B	206	Interleukin-20 receptor subunit beta; IL10 family	92.05
1cd9_B	215	G-CSF-R, protein (G-CSF receptor); class1 cytokine	91.33
3lb6_C	380	IL-13, interleukin-13 receptor subunit alpha-2; cy	90.96
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	90.46
4doh_R	221	Interleukin-20 receptor subunit alpha; IL10 family	89.72
2d9q_B	313	Granulocyte colony-stimulating factor receptor; cy	89.47
3n06_B	210	PRL-R, prolactin receptor; PH dependence, hematopo	89.38
1wft_A	123	1700129L13RIK protein; FN3 domain, similar to HOST	86.3
4a2l_A	795	BT_4663, two-component system sensor histidine kin	85.67
3ott_A	758	Two-component system sensor histidine kinase; beta	83.22
4doh_R	221	Interleukin-20 receptor subunit alpha; IL10 family	82.68
3cxe_C	120	Granulocyte-macrophage colony-stimulating factor s	80.89

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.8e-70  Score=539.12  Aligned_cols=347  Identities=57%  Similarity=0.984  Sum_probs=292.3

Q ss_pred             CCceEeeeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceechhhhhHHHhhhhcccccccccccCCCCcccC
Q psy12427          2 SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDTFKKQIKKRQYDFDETGKKIRGKADEKVS   81 (356)
Q Consensus         2 ~~w~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (356)
                      ..|..+.++..|+++|+||.||+.|+|||+|.|.+|.|+||++++..+.++.....  .+.............. .....
T Consensus        54 ~~W~~v~~~~~t~~~V~~L~~g~~Y~FRV~A~N~~G~s~PS~~s~~v~~~~~~~~~--~~~~~~~~~~~~~~~~-~~~~~  130 (573)
T 3uto_A           54 GSWSPCAKSRYTYTTIEGLRAGKQYEFRIIAENKHGQSKPCEPTAPVLIPGDERKR--RRGYDVDEQGKIVRGK-GTVSS  130 (573)
T ss_dssp             CCCEEEEEESSSEEEECCCCTTCEEEEEEEEEETTEECCCCCCCCCEECC---------CCCEECSSSCEECCC-CCCCS
T ss_pred             CceEEeccccCCEEEeCCCCCCCcEeEEEEEEcCceEcCCcCCCCCEEcCCCCccc--cccccccccccccccc-ccccc
Confidence            47999999999999999999999999999999999999999999988876533211  1111111111111111 11112


Q ss_pred             CCCceeEeeecccCCCCCCCCCCCcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHh
Q psy12427         82 DYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQ  161 (356)
Q Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~  161 (356)
                      .......+......+.+...+...+.++|++++.||+|+||+||+|+++.+|+.||+|++......+.+.+.+|+.+|+.
T Consensus       131 ~~~~~~~~~~~~~~~~~~~~~~~~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~  210 (573)
T 3uto_A          131 NYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSV  210 (573)
T ss_dssp             CGGGGCCCHHHHCCCCCCCCBSSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccCCcccccCCCcCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHh
Confidence            22233333344455566677777788999999999999999999999999999999999988777778889999999999


Q ss_pred             cCCCCceeeeeeEEeCCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCC
Q psy12427        162 LHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPEN  241 (356)
Q Consensus       162 l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~N  241 (356)
                      ++|||||+++++|.+...++||||||+||+|.+++......+++     ..+..+++||+.||+|||++||+||||||+|
T Consensus       211 l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e-----~~~~~~~~qi~~al~ylH~~~iiHRDlKp~N  285 (573)
T 3uto_A          211 LRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE-----DEAVEYMRQVCKGLCHMHENNYVHLDLKPEN  285 (573)
T ss_dssp             TCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEH-----HHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             CCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCH-----HHHHHHHHHHHHHHHHHHHCCeeeccCChhh
Confidence            99999999999999999999999999999999999755444444     4455699999999999999999999999999


Q ss_pred             EEEeecCCCcEEEEeeeceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHH
Q psy12427        242 IMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETL  321 (356)
Q Consensus       242 Ilv~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~  321 (356)
                      ||++.+..+.+||+|||+|+.+.........+||+.|||||++.+..|+.++|||||||+||+|++|.+||.+.+..+++
T Consensus       286 ill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~  365 (573)
T 3uto_A          286 IMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL  365 (573)
T ss_dssp             EEESSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH
T ss_pred             ccccCCCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH
Confidence            99987655689999999999998877778889999999999999999999999999999999999999999999999999


Q ss_pred             HHhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        322 KNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       322 ~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+|....+.++...+..+|+++++||++||++||+
T Consensus       366 ~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~  400 (573)
T 3uto_A          366 RNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPN  400 (573)
T ss_dssp             HHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGG
T ss_pred             HHHHhCCCCCCcccccCCCHHHHHHHHHHccCChh
Confidence            99999999999999999999999999999999985

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.4e-61  Score=438.30  Aligned_cols=238  Identities=27%  Similarity=0.519  Sum_probs=212.2

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++....   ....+.+.+|+++|++++|||||+++++|++++.+|+|
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv  110 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG  110 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            367999999999999999999999999999999997542   23456788999999999999999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      |||++||+|.+++.... .+++     ..++.++.||+.||+|||++||+||||||+|||++.++  ++||+|||+|+.+
T Consensus       111 mEy~~gG~L~~~i~~~~-~l~e-----~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g--~vKl~DFGla~~~  182 (311)
T 4aw0_A          111 LSYAKNGELLKYIRKIG-SFDE-----TCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM--HIQITDFGTAKVL  182 (311)
T ss_dssp             ECCCTTEEHHHHHHHHS-SCCH-----HHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS--CEEECCCTTCEEC
T ss_pred             EecCCCCCHHHHHHHcC-CCCH-----HHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCC--CEEEEEcCCceec
Confidence            99999999999997532 3444     44556999999999999999999999999999997654  7999999999987


Q ss_pred             CCC---CceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCC
Q psy12427        264 DPN---EVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVS  340 (356)
Q Consensus       264 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  340 (356)
                      ...   ......+||+.|||||++.+..++.++||||+||++|+|++|++||.+.+..+++.+|....+.+|.    .+|
T Consensus       183 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~----~~s  258 (311)
T 4aw0_A          183 SPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE----KFF  258 (311)
T ss_dssp             CTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----TCC
T ss_pred             CCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc----ccC
Confidence            533   2344568999999999999999999999999999999999999999999999999999998887764    789


Q ss_pred             HHHHHHHHHhhhcCCC
Q psy12427        341 EEGKDFIRRLLLRNKE  356 (356)
Q Consensus       341 ~~~~~lI~~ll~~dP~  356 (356)
                      +++++||++||++||+
T Consensus       259 ~~~~dli~~lL~~dp~  274 (311)
T 4aw0_A          259 PKARDLVEKLLVLDAT  274 (311)
T ss_dssp             HHHHHHHHHHSCSSGG
T ss_pred             HHHHHHHHHHccCCHh
Confidence            9999999999999995

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.5e-60  Score=437.77  Aligned_cols=239  Identities=26%  Similarity=0.485  Sum_probs=211.7

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEec
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFL  187 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~  187 (356)
                      +.|++.++||+|+||+||+|+++.+|+.||+|++........+.+.+|+.+|++++|||||+++++|.+++.+|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            46999999999999999999999999999999998766556677889999999999999999999999999999999999


Q ss_pred             cccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC-
Q psy12427        188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN-  266 (356)
Q Consensus       188 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~-  266 (356)
                      +||+|.+++...  .+++     ..++.++.||+.||+|||++|||||||||+|||++.++  .+||+|||+|+.+... 
T Consensus       154 ~gg~L~~~l~~~--~l~e-----~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g--~vKl~DFGla~~~~~~~  224 (346)
T 4fih_A          154 EGGALTDIVTHT--RMNE-----EQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG--RVKLSDFGFCAQVSKEV  224 (346)
T ss_dssp             TTEEHHHHHHHS--CCCH-----HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCCTTCEECCSSS
T ss_pred             CCCcHHHHHHcC--CCCH-----HHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCC--CEEEecCcCceecCCCC
Confidence            999999998743  2333     44556999999999999999999999999999998654  7999999999987543 


Q ss_pred             CceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHH
Q psy12427        267 EVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDF  346 (356)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  346 (356)
                      ......+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+.+..+..... +..+.+..+|+++++|
T Consensus       225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~~dl  303 (346)
T 4fih_A          225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPSLKGF  303 (346)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CCCSCGGGSCHHHHHH
T ss_pred             CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCCccccCCHHHHHH
Confidence            344567899999999999999999999999999999999999999999999999888876432 3334456899999999


Q ss_pred             HHHhhhcCCC
Q psy12427        347 IRRLLLRNKE  356 (356)
Q Consensus       347 I~~ll~~dP~  356 (356)
                      |++||++||+
T Consensus       304 i~~~L~~dP~  313 (346)
T 4fih_A          304 LDRLLVRDPA  313 (346)
T ss_dssp             HHHHSCSSTT
T ss_pred             HHHHcCCChh
Confidence            9999999995

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=8.4e-61  Score=440.04  Aligned_cols=239  Identities=26%  Similarity=0.503  Sum_probs=204.3

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++....  ....+.+.+|+.+|++++|||||+++++|++++.+|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            68999999999999999999999999999999997653  4456788999999999999999999999999999999999


Q ss_pred             eccccchhhhhhCCCC-CCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        186 FLSGGELFERITAPDY-KMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      ||+||+|.+++..... .+++.     .+..|+.||+.||+|||++|||||||||+|||++.++  .+||+|||+|+...
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~-----~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g--~vKl~DFGla~~~~  176 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQED-----QILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG--TVQLGDFGIARVLN  176 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHH-----HHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTC--CEEECSTTEESCCC
T ss_pred             CCCCCcHHHHHHHcCCCCCCHH-----HHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC--CEEEcccccceeec
Confidence            9999999999964432 23333     3455999999999999999999999999999998654  79999999998765


Q ss_pred             CCC-ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHH
Q psy12427        265 PNE-VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG  343 (356)
Q Consensus       265 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  343 (356)
                      ... .....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+++.++....++..   +..+|+++
T Consensus       177 ~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~---~~~~s~~~  253 (350)
T 4b9d_A          177 STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPV---SLHYSYDL  253 (350)
T ss_dssp             HHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC---CTTSCHHH
T ss_pred             CCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC---CccCCHHH
Confidence            332 22345799999999999999999999999999999999999999999999999999988775432   35799999


Q ss_pred             HHHHHHhhhcCCC
Q psy12427        344 KDFIRRLLLRNKE  356 (356)
Q Consensus       344 ~~lI~~ll~~dP~  356 (356)
                      ++||++||++||+
T Consensus       254 ~~li~~~L~~dP~  266 (350)
T 4b9d_A          254 RSLVSQLFKRNPR  266 (350)
T ss_dssp             HHHHHHHTCSSGG
T ss_pred             HHHHHHHccCChh
Confidence            9999999999995

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=7.9e-60  Score=420.99  Aligned_cols=239  Identities=32%  Similarity=0.546  Sum_probs=194.1

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEE
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMV  181 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  181 (356)
                      ...++|++.+.||+|+||+||+|+++.+|+.||+|++....   ......+.+|+++|++++||||+++++++.+++.++
T Consensus        10 ~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~   89 (275)
T 3hyh_A           10 AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEII   89 (275)
T ss_dssp             ----CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            34578999999999999999999999999999999997543   233567889999999999999999999999999999


Q ss_pred             EEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeecee
Q psy12427        182 LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT  261 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~  261 (356)
                      +||||+ +|+|.+++.... .+++     ..++.++.||+.||+|||++||+||||||+|||++.++  ++||+|||+|+
T Consensus        90 ivmEy~-~g~L~~~l~~~~-~l~e-----~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~--~vkl~DFGla~  160 (275)
T 3hyh_A           90 MVIEYA-GNELFDYIVQRD-KMSE-----QEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHL--NVKIADFGLSN  160 (275)
T ss_dssp             EEEECC-CEEHHHHHHHSC-SCCH-----HHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTC--CEEECCSSCC-
T ss_pred             EEEeCC-CCCHHHHHHHcC-CCCH-----HHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCC--CEEEeecCCCe
Confidence            999999 689999887543 3444     44556999999999999999999999999999997654  79999999998


Q ss_pred             eeCCCCceeecCCCcCccccccccCCCC-CccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCC
Q psy12427        262 KLDPNEVVKISTGTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVS  340 (356)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  340 (356)
                      ...........+||+.|||||++.+..+ +.++||||+||++|+|++|+.||.+.+..+.++++....+.+|.    .+|
T Consensus       161 ~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~----~~s  236 (275)
T 3hyh_A          161 IMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK----FLS  236 (275)
T ss_dssp             --------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----TSC
T ss_pred             ecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC----CCC
Confidence            8766666667789999999999998886 57999999999999999999999999999999999988877663    789


Q ss_pred             HHHHHHHHHhhhcCCC
Q psy12427        341 EEGKDFIRRLLLRNKE  356 (356)
Q Consensus       341 ~~~~~lI~~ll~~dP~  356 (356)
                      +++++||++||++||+
T Consensus       237 ~~~~~li~~~L~~dP~  252 (275)
T 3hyh_A          237 PGAAGLIKRMLIVNPL  252 (275)
T ss_dssp             HHHHHHHHHHSCSSGG
T ss_pred             HHHHHHHHHHccCChh
Confidence            9999999999999995

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.9e-59  Score=439.37  Aligned_cols=240  Identities=26%  Similarity=0.480  Sum_probs=212.4

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      .+.|+++++||+|+||.||+|+++.+|+.||+|++........+.+.+|+.+|++++|||||+++++|..++.+||||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            46799999999999999999999999999999999877666667788999999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      |+||+|.+++...  .+++     ..+..++.||+.||+|||++|||||||||+|||++.++  .+||+|||+|+.+...
T Consensus       230 ~~gG~L~~~i~~~--~l~e-----~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g--~vKl~DFGla~~~~~~  300 (423)
T 4fie_A          230 LEGGALTDIVTHT--RMNE-----EQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG--RVKLSDFGFCAQVSKE  300 (423)
T ss_dssp             CTTEEHHHHHHHS--CCCH-----HHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTC--CEEECCCTTCEECCSS
T ss_pred             CCCCcHHHHHhcc--CCCH-----HHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC--CEEEecCccceECCCC
Confidence            9999999998643  2343     34556999999999999999999999999999998655  7999999999987543


Q ss_pred             -CceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHH
Q psy12427        267 -EVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD  345 (356)
Q Consensus       267 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  345 (356)
                       ......+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+.+..+..... +....+..+|+++++
T Consensus       301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~~d  379 (423)
T 4fie_A          301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPSLKG  379 (423)
T ss_dssp             CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCCSCTTSSCHHHHH
T ss_pred             CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCcccccCCHHHHH
Confidence             344566899999999999999999999999999999999999999999999999988876432 233445689999999


Q ss_pred             HHHHhhhcCCC
Q psy12427        346 FIRRLLLRNKE  356 (356)
Q Consensus       346 lI~~ll~~dP~  356 (356)
                      ||++||++||+
T Consensus       380 li~~~L~~dP~  390 (423)
T 4fie_A          380 FLDRLLVRDPA  390 (423)
T ss_dssp             HHHHHSCSSTT
T ss_pred             HHHHHcCCChh
Confidence            99999999995

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=6.1e-60  Score=427.33  Aligned_cols=237  Identities=29%  Similarity=0.555  Sum_probs=201.1

Q ss_pred             cceeeeccccccCceEEEEEEEc---cCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRER---KTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~---~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      ++|++++.||+|+||+||+|++.   .+++.||+|+++...  ..+...+.+|+++|++++|||||++++++++++.+|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999984   467899999997543  2233467789999999999999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      |||||+||+|.+++.... .+++     ..+..++.||+.||+|||++||+||||||+|||++.++  ++||+|||+|+.
T Consensus       104 vmEy~~gg~L~~~l~~~~-~l~e-----~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g--~vKl~DFGla~~  175 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV-MFTE-----EDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG--HIKLTDFGLSKE  175 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC-CCCH-----HHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTS--CEEEESSEEEEC
T ss_pred             EEEcCCCCCHHHHHHhcC-CCCH-----HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCC--CEEeccccccee
Confidence            999999999999997533 3333     44556999999999999999999999999999997655  799999999987


Q ss_pred             eCC-CCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCH
Q psy12427        263 LDP-NEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSE  341 (356)
Q Consensus       263 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  341 (356)
                      ... .......+||+.|||||++.+..++.++||||+||++|||++|+.||.+.+..+++.++....+.+|.    .+|+
T Consensus       176 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~  251 (304)
T 3ubd_A          176 SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSP  251 (304)
T ss_dssp             -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCH
T ss_pred             ccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC----cCCH
Confidence            543 33345568999999999999999999999999999999999999999999999999999988877664    7999


Q ss_pred             HHHHHHHHhhhcCCC
Q psy12427        342 EGKDFIRRLLLRNKE  356 (356)
Q Consensus       342 ~~~~lI~~ll~~dP~  356 (356)
                      ++++||++||++||+
T Consensus       252 ~~~~li~~~L~~dP~  266 (304)
T 3ubd_A          252 EAQSLLRMLFKRNPA  266 (304)
T ss_dssp             HHHHHHHHHTCSSGG
T ss_pred             HHHHHHHHHcccCHH
Confidence            999999999999995

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=8.4e-59  Score=424.84  Aligned_cols=237  Identities=22%  Similarity=0.318  Sum_probs=203.0

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      .+.|++.++||+|+||+||+|+++.+|+.||+|+++....     ..+|+.+|++++|||||+++++|.+++.+||||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            4579999999999999999999999999999999976432     23699999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      |+||+|.+++.... .+++     ..+..++.||+.||+|||++|||||||||+|||++.++. ++||+|||+|+.+...
T Consensus       132 ~~gg~L~~~l~~~~-~l~e-----~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~-~vKl~DFGla~~~~~~  204 (336)
T 4g3f_A          132 LEGGSLGQLIKQMG-CLPE-----DRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGS-RAALCDFGHALCLQPD  204 (336)
T ss_dssp             CTTCBHHHHHHHHS-SCCH-----HHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSC-CEEECCCTTCEEC---
T ss_pred             cCCCcHHHHHHHcC-CCCH-----HHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCC-EEEEeeCCCCeEccCC
Confidence            99999999997532 3444     445569999999999999999999999999999986543 6999999999987543


Q ss_pred             Cce------eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCC
Q psy12427        267 EVV------KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVS  340 (356)
Q Consensus       267 ~~~------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  340 (356)
                      ...      ...+||+.|||||++.+..++.++|||||||+||||++|+.||.+.+..+++.++.....++ .+.+.++|
T Consensus       205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~s  283 (336)
T 4g3f_A          205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPI-REIPPSCA  283 (336)
T ss_dssp             ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGG-GGSCTTSC
T ss_pred             CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCc-hhcCccCC
Confidence            221      22469999999999999999999999999999999999999999998888888887765433 34556899


Q ss_pred             HHHHHHHHHhhhcCCC
Q psy12427        341 EEGKDFIRRLLLRNKE  356 (356)
Q Consensus       341 ~~~~~lI~~ll~~dP~  356 (356)
                      +++++||++||++||+
T Consensus       284 ~~~~~li~~~L~~dP~  299 (336)
T 4g3f_A          284 PLTAQAIQEGLRKEPV  299 (336)
T ss_dssp             HHHHHHHHHHTCSSGG
T ss_pred             HHHHHHHHHHccCCHh
Confidence            9999999999999995

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.3e-58  Score=419.24  Aligned_cols=244  Identities=16%  Similarity=0.309  Sum_probs=207.1

Q ss_pred             cceeeeccccccCceEEEEEEEc-----cCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRER-----KTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~-----~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      ++|.+.++||+|+||+||+|++.     .++..||+|+++.......+.|.+|+++|++++|||||+++|+|.+++.+++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            57999999999999999999875     3578999999987777777889999999999999999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCC-------CCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEE
Q psy12427        183 IFEFLSGGELFERITAPDY-------KMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMI  255 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~  255 (356)
                      |||||++|+|.+++.....       ......+....+..++.||+.||+|||+++||||||||+|||++.++  .+||+
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~--~~Ki~  170 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL--LVKIG  170 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEEEC
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC--cEEEC
Confidence            9999999999999965321       11122344455666999999999999999999999999999998655  79999


Q ss_pred             eeeceeeeCCCCceee---cCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccc
Q psy12427        256 DFGLATKLDPNEVVKI---STGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEF  331 (356)
Q Consensus       256 Dfg~a~~~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~  331 (356)
                      |||+|+..........   ..||+.|||||++.+..++.++|||||||+||||+| |+.||.+.+..+++..+..+....
T Consensus       171 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~  250 (299)
T 4asz_A          171 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQ  250 (299)
T ss_dssp             CCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCCC
T ss_pred             CcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            9999987654433332   248999999999999999999999999999999999 999999999999999998866432


Q ss_pred             ChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        332 DEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       332 ~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .   +..+|+++.+||.+||+.||+
T Consensus       251 ~---p~~~~~~~~~li~~cl~~dP~  272 (299)
T 4asz_A          251 R---PRTCPQEVYELMLGCWQREPH  272 (299)
T ss_dssp             C---CTTCCHHHHHHHHHHTCSSGG
T ss_pred             C---CccchHHHHHHHHHHcCCChh
Confidence            2   247999999999999999995

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.9e-57  Score=415.69  Aligned_cols=244  Identities=16%  Similarity=0.280  Sum_probs=201.9

Q ss_pred             cceeeeccccccCceEEEEEEEc-----cCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRER-----KTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~-----~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      +++.+.++||+|+||+||+|+++     .++..||+|+++.......+.|.+|+++|++++|||||+++|+|.+...+++
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            56889999999999999999875     3578999999987777777889999999999999999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCC---------CCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEE
Q psy12427        183 IFEFLSGGELFERITAPDYK---------MSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVK  253 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~---------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vk  253 (356)
                      |||||++|+|.+++......         .....+....+..++.||+.||+|||+++||||||||+|||++.+.  .+|
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~--~~K  198 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL--VVK  198 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT--EEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC--cEE
Confidence            99999999999999764321         1122344455667999999999999999999999999999998654  799


Q ss_pred             EEeeeceeeeCCCCc---eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccc
Q psy12427        254 MIDFGLATKLDPNEV---VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDW  329 (356)
Q Consensus       254 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~  329 (356)
                      |+|||+|+.......   .....||+.|||||++.+..++.++|||||||+||||+| |+.||.+.+..+.+..+..+..
T Consensus       199 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~  278 (329)
T 4aoj_A          199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRE  278 (329)
T ss_dssp             ECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCC
T ss_pred             EcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC
Confidence            999999987643322   233568999999999999999999999999999999999 9999999999999998877542


Q ss_pred             ccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        330 EFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       330 ~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .   +.+..+|+++.+||.+||++||+
T Consensus       279 ~---~~p~~~~~~~~~li~~cl~~dP~  302 (329)
T 4aoj_A          279 L---ERPRACPPEVYAIMRGCWQREPQ  302 (329)
T ss_dssp             C---CCCTTCCHHHHHHHHHHCCSSTT
T ss_pred             C---CCcccccHHHHHHHHHHcCcChh
Confidence            2   22347999999999999999996

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.3e-57  Score=407.44  Aligned_cols=236  Identities=25%  Similarity=0.331  Sum_probs=196.7

Q ss_pred             eeeeccccccCceEEEEEEEccCCCEEEEEEcccC--ChhhHHHHHHHHHHHHhcCCCCceeeeeeEEe----CCeEEEE
Q psy12427        110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS--HNLEKELIRKEIDIMNQLHHPKLINLHDAFED----DDEMVLI  183 (356)
Q Consensus       110 y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~~~lv  183 (356)
                      |++.++||+|+||+||+|.++.++..||+|.+...  .....+.+.+|+++|++++|||||+++++|..    +..++||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            47788999999999999999999999999998654  34456778999999999999999999999875    3568999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEEeecCCCcEEEEeeecee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN--IIHLDVKPENIMCQTRNSTNVKMIDFGLAT  261 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~  261 (356)
                      ||||+||+|.+++.... .+++     ..+..++.||+.||+|||++|  ||||||||+|||++.. ++.+||+|||+|+
T Consensus       108 mEy~~gg~L~~~l~~~~-~l~~-----~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~-~g~vKl~DFGla~  180 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRFK-VMKI-----KVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP-TGSVKIGDLGLAT  180 (290)
T ss_dssp             EECCCSCBHHHHHHHHS-SCCH-----HHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESST-TSCEEECCTTGGG
T ss_pred             EeCCCCCCHHHHHHhcC-CCCH-----HHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECC-CCCEEEEeCcCCE
Confidence            99999999999997532 2333     344569999999999999998  9999999999999642 2479999999997


Q ss_pred             eeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHhhccccccChhhhccCC
Q psy12427        262 KLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDV-ETLKNVKACDWEFDEEAFKNVS  340 (356)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s  340 (356)
                      ... .......+||+.|||||++.+ .++.++|||||||+||||++|+.||.+.+.. .++..+....  .|......+|
T Consensus       181 ~~~-~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~--~~~~~~~~~~  256 (290)
T 3fpq_A          181 LKR-ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV--KPASFDKVAI  256 (290)
T ss_dssp             GCC-TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC--CCGGGGGCCC
T ss_pred             eCC-CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCC--CCCCCCccCC
Confidence            644 344566789999999999875 6999999999999999999999999876554 4455554443  2344456789


Q ss_pred             HHHHHHHHHhhhcCCC
Q psy12427        341 EEGKDFIRRLLLRNKE  356 (356)
Q Consensus       341 ~~~~~lI~~ll~~dP~  356 (356)
                      +++++||.+||++||+
T Consensus       257 ~~~~~li~~~L~~dP~  272 (290)
T 3fpq_A          257 PEVKEIIEGCIRQNKD  272 (290)
T ss_dssp             HHHHHHHHHHSCSSGG
T ss_pred             HHHHHHHHHHccCChh
Confidence            9999999999999995

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.6e-57  Score=410.11  Aligned_cols=239  Identities=24%  Similarity=0.414  Sum_probs=194.6

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      .+++++.++||+|+||+||+|+++   ..||+|+++...  ....+.|.+|+.+|++++|||||+++|++.. +.++|||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm  110 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT  110 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence            357889999999999999999865   359999997543  3455789999999999999999999998865 5689999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      |||+||+|.+++......+++..     +..++.||+.||+|||+++||||||||+|||++.++  .+||+|||+|+...
T Consensus       111 Ey~~gGsL~~~l~~~~~~l~~~~-----~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~--~~Ki~DFGla~~~~  183 (307)
T 3omv_A          111 QWCEGSSLYKHLHVQETKFQMFQ-----LIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGL--TVKIGDFGLATVKS  183 (307)
T ss_dssp             ECCSSCBHHHHHHTSCCCCCHHH-----HHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTE--EEEECCCSSCBC--
T ss_pred             EcCCCCCHHHHHhhcCCCCCHHH-----HHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCC--cEEEeeccCceecc
Confidence            99999999999976554454444     455999999999999999999999999999998654  79999999998764


Q ss_pred             CC---CceeecCCCcCccccccccC---CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC--hhhh
Q psy12427        265 PN---EVVKISTGTAEFAAPEIVER---EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD--EEAF  336 (356)
Q Consensus       265 ~~---~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~  336 (356)
                      ..   ......+||+.|||||++.+   .+++.++|||||||+||||+||+.||.+.+..+.+..+.......|  +..+
T Consensus       184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~  263 (307)
T 3omv_A          184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLY  263 (307)
T ss_dssp             ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSC
T ss_pred             cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccccc
Confidence            32   22345679999999999964   4689999999999999999999999998877666655544433322  3455


Q ss_pred             ccCCHHHHHHHHHhhhcCCC
Q psy12427        337 KNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       337 ~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .++|+++.+||.+||++||+
T Consensus       264 ~~~~~~l~~li~~cl~~dP~  283 (307)
T 3omv_A          264 KNCPKAMKRLVADCVKKVKE  283 (307)
T ss_dssp             TTSCHHHHHHHHHHTCSSST
T ss_pred             ccchHHHHHHHHHHcCCCHh
Confidence            68999999999999999995

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=7.6e-57  Score=409.29  Aligned_cols=244  Identities=19%  Similarity=0.318  Sum_probs=205.1

Q ss_pred             cceeeeccccccCceEEEEEEEc-----cCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRER-----KTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMV  181 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~-----~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  181 (356)
                      +.+++.++||+|+||+||+|.+.     .+++.||+|+++... ....+.|.+|+.+|++++|||||+++|+|..++.++
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            46889999999999999999864     357899999997543 334678999999999999999999999999999999


Q ss_pred             EEEEeccccchhhhhhCCCCCC----------CccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCc
Q psy12427        182 LIFEFLSGGELFERITAPDYKM----------SEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTN  251 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~  251 (356)
                      +|||||++|+|.++|.......          ....+....+..++.||+.||+|||+++||||||||+|||++.++  .
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~--~  183 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL--N  183 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--C
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCC--C
Confidence            9999999999999997543211          112344445667999999999999999999999999999998655  7


Q ss_pred             EEEEeeeceeeeCCCC---ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcc
Q psy12427        252 VKMIDFGLATKLDPNE---VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKAC  327 (356)
Q Consensus       252 vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~  327 (356)
                      +||+|||+|+......   ......||+.|||||++.++.++.++|||||||+||||+| |..||.+.+..+++..+..+
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~  263 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNR  263 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTT
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            9999999998764332   2234568999999999999999999999999999999998 89999999999999998876


Q ss_pred             ccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        328 DWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       328 ~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ....   .+.++|+++.+||.+||+.||+
T Consensus       264 ~~~~---~p~~~~~~~~~li~~C~~~dP~  289 (308)
T 4gt4_A          264 QVLP---CPDDCPAWVYALMIECWNEFPS  289 (308)
T ss_dssp             CCCC---CCTTCCHHHHHHHHHHTCSSGG
T ss_pred             CCCC---CcccchHHHHHHHHHHcCCChh
Confidence            5432   2358999999999999999995

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.6e-55  Score=397.96  Aligned_cols=239  Identities=23%  Similarity=0.419  Sum_probs=186.2

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCC-------
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDD-------  178 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-------  178 (356)
                      .++|++++.||+|+||+||+|+++.+|+.||+|+++... ....+.+.+|+.+|++++|||||+++++|...+       
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            357999999999999999999999999999999997654 334567889999999999999999999987544       


Q ss_pred             -----eEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEE
Q psy12427        179 -----EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVK  253 (356)
Q Consensus       179 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vk  253 (356)
                           .+|+||||++||+|.+++..... ..  ......+..++.||+.||+|||++||+||||||+|||++.++  .+|
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~--~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~--~vK  158 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCT-IE--ERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD--VVK  158 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCS-GG--GSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--CEE
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCC-CC--hhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCC--cEE
Confidence                 37999999999999999975432 11  122223456899999999999999999999999999998655  799


Q ss_pred             EEeeeceeeeCCCCc-------------eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCh-HH
Q psy12427        254 MIDFGLATKLDPNEV-------------VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEND-VE  319 (356)
Q Consensus       254 l~Dfg~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~-~~  319 (356)
                      |+|||+|+.+.....             ....+||+.|||||++.+..|+.++|||||||++|||++   ||.+..+ ..
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~  235 (299)
T 4g31_A          159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR  235 (299)
T ss_dssp             ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHH
Confidence            999999987754321             123469999999999999999999999999999999996   8865432 23


Q ss_pred             HHHHhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        320 TLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       320 ~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+..+....  +| +.+...++++++||++||++||+
T Consensus       236 ~~~~~~~~~--~p-~~~~~~~~~~~~li~~~L~~dP~  269 (299)
T 4g31_A          236 TLTDVRNLK--FP-PLFTQKYPCEYVMVQDMLSPSPM  269 (299)
T ss_dssp             HHHHHHTTC--CC-HHHHHHCHHHHHHHHHHTCSSGG
T ss_pred             HHHHHhcCC--CC-CCCcccCHHHHHHHHHHcCCChh
Confidence            344444333  33 34557788999999999999995

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-54  Score=408.39  Aligned_cols=242  Identities=24%  Similarity=0.401  Sum_probs=202.9

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEe------C
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFED------D  177 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~  177 (356)
                      +.++|++++.||+|+||+||+|+++.+|+.||+|+++...  ......+.+|+.+|+.++|||||++++++..      .
T Consensus        52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~  131 (398)
T 4b99_A           52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF  131 (398)
T ss_dssp             CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred             CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence            4568999999999999999999999999999999997543  3345677899999999999999999998763      4


Q ss_pred             CeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEee
Q psy12427        178 DEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDF  257 (356)
Q Consensus       178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Df  257 (356)
                      +.+|||||||+ |+|.+++.... .++     ...++.+++||+.||+|||++|||||||||+|||++.++  .+||+||
T Consensus       132 ~~~~ivmE~~~-g~L~~~i~~~~-~l~-----~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~--~~Ki~DF  202 (398)
T 4b99_A          132 KSVYVVLDLME-SDLHQIIHSSQ-PLT-----LEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENC--ELKIGDF  202 (398)
T ss_dssp             CCEEEEEECCS-EEHHHHHTSSS-CCC-----HHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC--CEEECCC
T ss_pred             CEEEEEEeCCC-CCHHHHHHhcC-CCC-----HHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCC--CEEEeec
Confidence            67899999995 67999886533 333     344566999999999999999999999999999997654  7999999


Q ss_pred             eceeeeCCC-----CceeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc
Q psy12427        258 GLATKLDPN-----EVVKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEF  331 (356)
Q Consensus       258 g~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~  331 (356)
                      |+|+.+...     ......+||+.|+|||++.+. .++.++||||+||++|||++|++||.+.+..+.+..|....+.+
T Consensus       203 Gla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p  282 (398)
T 4b99_A          203 GMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTP  282 (398)
T ss_dssp             TTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             ceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            999876322     223456899999999998875 56999999999999999999999999999999999987655544


Q ss_pred             Chh---------------------------hhccCCHHHHHHHHHhhhcCCC
Q psy12427        332 DEE---------------------------AFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       332 ~~~---------------------------~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +..                           .++++|++++|||++||++||+
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~  334 (398)
T 4b99_A          283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPS  334 (398)
T ss_dssp             CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTT
T ss_pred             ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChh
Confidence            432                           2346799999999999999995

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.7e-54  Score=399.21  Aligned_cols=245  Identities=22%  Similarity=0.299  Sum_probs=198.9

Q ss_pred             ccceeeeccccccCceEEEEEEEccCC-----CEEEEEEcccCC-hhhHHHHHHHHHHHHhcCC-CCceeeeeeEEeC-C
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTG-----NIFAAKFIPVSH-NLEKELIRKEIDIMNQLHH-PKLINLHDAFEDD-D  178 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~-----~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~-~  178 (356)
                      .++|++.++||+|+||+||+|.+..++     +.||+|.++... ..+.+.+.+|+.+|.+++| ||||+++|+|... .
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~  142 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  142 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence            468999999999999999999987643     589999987654 3445778899999999965 8999999999764 6


Q ss_pred             eEEEEEEeccccchhhhhhCCCCCC----------CccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecC
Q psy12427        179 EMVLIFEFLSGGELFERITAPDYKM----------SEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN  248 (356)
Q Consensus       179 ~~~lv~e~~~~g~L~~~l~~~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~  248 (356)
                      .+++|||||++|+|.++|.......          ....+....+..++.||+.||+|||+++||||||||+|||++.++
T Consensus       143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~  222 (353)
T 4ase_A          143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN  222 (353)
T ss_dssp             CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred             EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCC
Confidence            7899999999999999996532211          112244445666999999999999999999999999999998665


Q ss_pred             CCcEEEEeeeceeeeCCCCce---eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCh-HHHHHH
Q psy12427        249 STNVKMIDFGLATKLDPNEVV---KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGEND-VETLKN  323 (356)
Q Consensus       249 ~~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~-~~~~~~  323 (356)
                        .+||+|||+|+........   ...+||+.|||||++.+..++.++|||||||+||||+| |+.||.+.+. ......
T Consensus       223 --~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~  300 (353)
T 4ase_A          223 --VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR  300 (353)
T ss_dssp             --CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH
T ss_pred             --CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence              7999999999876543321   22458999999999999999999999999999999998 9999998764 445555


Q ss_pred             hhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        324 VKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       324 i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +..+.. +  +.+..+|+++.+||.+||+.||+
T Consensus       301 i~~g~~-~--~~p~~~~~~~~~li~~c~~~dP~  330 (353)
T 4ase_A          301 LKEGTR-M--RAPDYTTPEMYQTMLDCWHGEPS  330 (353)
T ss_dssp             HHHTCC-C--CCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             HHcCCC-C--CCCccCCHHHHHHHHHHcCcChh
Confidence            554332 1  12247899999999999999995

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=5.2e-53  Score=392.78  Aligned_cols=239  Identities=25%  Similarity=0.409  Sum_probs=192.8

Q ss_pred             cccceeeeccccccCceEEEEEEEc---cCCCEEEEEEcccCChhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRER---KTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMV  181 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~---~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~  181 (356)
                      +.++|++.++||+|+||+||+|+++   .+++.||+|.+.....  ...+.+|+++|+.+ +||||++++++|...++++
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~   96 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV   96 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence            4568999999999999999999986   3578999998865433  45677899999998 6999999999999999999


Q ss_pred             EEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeecee
Q psy12427        182 LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT  261 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~  261 (356)
                      +||||++||+|.+++.    .+++     ..++.++.||+.||+|||++||+||||||+|||++.+. +.+||+|||+|+
T Consensus        97 lvmE~~~g~~L~~~~~----~l~~-----~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~-~~~kl~DFGla~  166 (361)
T 4f9c_A           97 IAMPYLEHESFLDILN----SLSF-----QEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRL-KKYALVDFGLAQ  166 (361)
T ss_dssp             EEEECCCCCCHHHHHT----TCCH-----HHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT-TEEEECCCTTCE
T ss_pred             EEEeCCCcccHHHHHc----CCCH-----HHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCC-CeEEECcCCCCc
Confidence            9999999999999984    2333     34566999999999999999999999999999997642 479999999998


Q ss_pred             eeCCCC-----------------------------ceeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCC
Q psy12427        262 KLDPNE-----------------------------VVKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSP  311 (356)
Q Consensus       262 ~~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~P  311 (356)
                      ......                             .....+||+.|+|||++.+. .++.++||||+||++|||++|+.|
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P  246 (361)
T 4f9c_A          167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP  246 (361)
T ss_dssp             ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred             ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence            654321                             12334799999999999876 489999999999999999999999


Q ss_pred             CC-CCChHHHHHHhhccccc--------------------------------------------------cChhhhccCC
Q psy12427        312 FA-GENDVETLKNVKACDWE--------------------------------------------------FDEEAFKNVS  340 (356)
Q Consensus       312 f~-~~~~~~~~~~i~~~~~~--------------------------------------------------~~~~~~~~~s  340 (356)
                      |. +.++.+.+..|......                                                  ...+.+..+|
T Consensus       247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is  326 (361)
T 4f9c_A          247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP  326 (361)
T ss_dssp             SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred             CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence            95 44566666555331110                                                  1123345789


Q ss_pred             HHHHHHHHHhhhcCCC
Q psy12427        341 EEGKDFIRRLLLRNKE  356 (356)
Q Consensus       341 ~~~~~lI~~ll~~dP~  356 (356)
                      ++++|||++||+.||+
T Consensus       327 ~~a~DLl~~lL~~dP~  342 (361)
T 4f9c_A          327 DEAYDLLDKLLDLNPA  342 (361)
T ss_dssp             HHHHHHHHHHTCSCTT
T ss_pred             HHHHHHHHHHCcCChh
Confidence            9999999999999995

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3e-53  Score=415.93  Aligned_cols=237  Identities=24%  Similarity=0.458  Sum_probs=198.6

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh---hhHHHHHH---HHHHHHhcCCCCceeeeeeEEeCCeE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN---LEKELIRK---EIDIMNQLHHPKLINLHDAFEDDDEM  180 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~---E~~il~~l~hpnIv~l~~~~~~~~~~  180 (356)
                      .++|+++++||+|+||+||+|+++.+|+.||+|++.....   .....+.+   ++.+++.++|||||+++++|++...+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            4789999999999999999999999999999999964321   12223333   45666777999999999999999999


Q ss_pred             EEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeece
Q psy12427        181 VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA  260 (356)
Q Consensus       181 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a  260 (356)
                      ||||||++||+|.+++.... .+++     ..++.|+.||+.||+|||++|||||||||+|||++.++  ++||+|||+|
T Consensus       268 ylVmEy~~GGdL~~~l~~~~-~l~E-----~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G--~vKL~DFGlA  339 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHG-VFSE-----ADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG--HVRISDLGLA  339 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHC-CCCH-----HHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTS--CEEECCCTTC
T ss_pred             EEEEecCCCCcHHHHHHhcC-CCCH-----HHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCC--CEEeccccee
Confidence            99999999999999997532 3343     44566999999999999999999999999999998655  7999999999


Q ss_pred             eeeCCCCceeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCC---ChHHHHHHhhccccccChhhh
Q psy12427        261 TKLDPNEVVKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGE---NDVETLKNVKACDWEFDEEAF  336 (356)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~---~~~~~~~~i~~~~~~~~~~~~  336 (356)
                      +.+.... ..+.+||+.|||||++.. ..|+.++|+|||||+||||++|.+||.+.   +..++...+......+|    
T Consensus       340 ~~~~~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p----  414 (689)
T 3v5w_A          340 CDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----  414 (689)
T ss_dssp             EECSSCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCC----
T ss_pred             eecCCCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCC----
Confidence            8876433 345689999999999974 57999999999999999999999999764   33455666666665555    


Q ss_pred             ccCCHHHHHHHHHhhhcCCC
Q psy12427        337 KNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       337 ~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ..+|+++++||++||++||+
T Consensus       415 ~~~S~~a~dLI~~lL~~dP~  434 (689)
T 3v5w_A          415 DSFSPELRSLLEGLLQRDVN  434 (689)
T ss_dssp             TTSCHHHHHHHHHHTCSCGG
T ss_pred             ccCCHHHHHHHHHHccCCHh
Confidence            47999999999999999995

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-52  Score=393.60  Aligned_cols=267  Identities=69%  Similarity=1.149  Sum_probs=239.7

Q ss_pred             ceeEeeecccCCCCCCCCCCCcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCC
Q psy12427         85 QYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHH  164 (356)
Q Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~h  164 (356)
                      ....+++..+.+.+...+.+.+.++|++.+.||+|+||.||+|.++.+|+.+|+|++......+...+.+|+.+|++++|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~h  107 (387)
T 1kob_A           28 KFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH  107 (387)
T ss_dssp             GGCCCHHHHCCCCCCCCBCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCS
T ss_pred             HHHHHHHHHhCCCcccccCCccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCC
Confidence            33334556667778888888899999999999999999999999999999999999987766667788999999999999


Q ss_pred             CCceeeeeeEEeCCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEE
Q psy12427        165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMC  244 (356)
Q Consensus       165 pnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv  244 (356)
                      |||+++++++......++||||+.||+|.+++......+++.     .+..++.||+.||+|||++||+||||||+|||+
T Consensus       108 pnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~-----~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll  182 (387)
T 1kob_A          108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEA-----EVINYMRQACEGLKHMHEHSIVHLDIKPENIMC  182 (387)
T ss_dssp             TTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHH-----HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             cCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHH-----HHHHHHHHHHHHHHHHHhCCeeecccchHHeEE
Confidence            999999999999999999999999999999987654444443     445599999999999999999999999999999


Q ss_pred             eecCCCcEEEEeeeceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHh
Q psy12427        245 QTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV  324 (356)
Q Consensus       245 ~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i  324 (356)
                      +.++.+.+||+|||+++............||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+.++
T Consensus       183 ~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i  262 (387)
T 1kob_A          183 ETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV  262 (387)
T ss_dssp             SSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH
T ss_pred             ecCCCCceEEEecccceecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            86655689999999999887766667778999999999999999999999999999999999999999999999999999


Q ss_pred             hccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        325 KACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       325 ~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ....+.++...+..+|+++++||++||+.||+
T Consensus       263 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~  294 (387)
T 1kob_A          263 KRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPR  294 (387)
T ss_dssp             HHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGG
T ss_pred             HhCCCCCCccccccCCHHHHHHHHHHcCCChh
Confidence            99988888888889999999999999999985

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-51  Score=376.28  Aligned_cols=245  Identities=40%  Similarity=0.792  Sum_probs=222.3

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      +.++|++.+.||+|+||+||+|.++.++..+|+|++.... .+...+.+|+.+|+.++||||+++++++......++|||
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            4578999999999999999999999999999999987654 345678899999999999999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |++||+|.+++......+++.     .+..++.||+.||+|||++||+||||||+|||++.++++.+||+|||++.....
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~-----~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~  156 (321)
T 1tki_A           82 FISGLDIFERINTSAFELNER-----EIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHH-----HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             eCCCCCHHHHHHhcCCCCCHH-----HHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence            999999999997654444444     445599999999999999999999999999999875456899999999998877


Q ss_pred             CCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHH
Q psy12427        266 NEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD  345 (356)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  345 (356)
                      ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+.++....+.++...+..+|+++++
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  236 (321)
T 1tki_A          157 GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD  236 (321)
T ss_dssp             TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred             CCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHH
Confidence            66667778999999999999998999999999999999999999999999999999999999999999889999999999


Q ss_pred             HHHHhhhcCCC
Q psy12427        346 FIRRLLLRNKE  356 (356)
Q Consensus       346 lI~~ll~~dP~  356 (356)
                      ||++||+.||+
T Consensus       237 li~~~L~~dp~  247 (321)
T 1tki_A          237 FVDRLLVKERK  247 (321)
T ss_dssp             HHHTTSCSSGG
T ss_pred             HHHHHcCCChh
Confidence            99999999985

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=6.1e-51  Score=379.84  Aligned_cols=248  Identities=44%  Similarity=0.782  Sum_probs=221.7

Q ss_pred             CCCcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh------hHHHHHHHHHHHHhcCCCCceeeeeeEEe
Q psy12427        103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL------EKELIRKEIDIMNQLHHPKLINLHDAFED  176 (356)
Q Consensus       103 ~~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~------~~~~~~~E~~il~~l~hpnIv~l~~~~~~  176 (356)
                      ...+.++|++.+.||+|+||.||+|+++.+|..||+|++......      ..+.+.+|+.+|++++||||+++++++..
T Consensus         7 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~   86 (361)
T 2yab_A            7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN   86 (361)
T ss_dssp             CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             CCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe
Confidence            345667899999999999999999999999999999999764322      35778899999999999999999999999


Q ss_pred             CCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCC--CcEEE
Q psy12427        177 DDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNS--TNVKM  254 (356)
Q Consensus       177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~--~~vkl  254 (356)
                      ....++||||++||+|.+++.... .     +....+..++.||+.||+|||++||+||||||+|||++.++.  ..+||
T Consensus        87 ~~~~~lv~e~~~gg~L~~~l~~~~-~-----l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl  160 (361)
T 2yab_A           87 RTDVVLILELVSGGELFDFLAQKE-S-----LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKL  160 (361)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTTCS-C-----CBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcC-C-----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEE
Confidence            999999999999999999996532 2     334445669999999999999999999999999999976542  26999


Q ss_pred             EeeeceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChh
Q psy12427        255 IDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEE  334 (356)
Q Consensus       255 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  334 (356)
                      +|||++............+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+.++....+.++++
T Consensus       161 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  240 (361)
T 2yab_A          161 IDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEE  240 (361)
T ss_dssp             CCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHH
T ss_pred             EecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCch
Confidence            99999998876555566789999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhccCCHHHHHHHHHhhhcCCC
Q psy12427        335 AFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       335 ~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+..+|+++++||++||++||+
T Consensus       241 ~~~~~s~~~~~li~~~L~~dP~  262 (361)
T 2yab_A          241 FFSQTSELAKDFIRKLLVKETR  262 (361)
T ss_dssp             HHTTSCHHHHHHHHHHSCSSTT
T ss_pred             hccCCCHHHHHHHHHHCCCChh
Confidence            9999999999999999999995

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=8.7e-51  Score=369.66  Aligned_cols=237  Identities=22%  Similarity=0.275  Sum_probs=178.9

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCC----eEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDD----EMVLI  183 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----~~~lv  183 (356)
                      .+|.+.++||+|+||+||+|+++  |+.||+|++...... ......|+..+.+++|||||++++++..++    .++||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            46899999999999999999874  889999998654322 222334666677899999999999998653    58999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHC--------CceeccCCCCCEEEeecCCCcEEEE
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEK--------NIIHLDVKPENIMCQTRNSTNVKMI  255 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--------~ivH~Dlkp~NIlv~~~~~~~vkl~  255 (356)
                      ||||+||+|.+++....  +++     ..+..++.|++.||+|||++        +||||||||+|||++.++  .+||+
T Consensus        80 ~Ey~~~gsL~~~l~~~~--l~~-----~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~--~~Ki~  150 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNRYT--VTV-----EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG--TCCIA  150 (303)
T ss_dssp             EECCTTCBHHHHHHHCC--BCH-----HHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTS--CEEEC
T ss_pred             ecCCCCCcHHHHHHhCC--CCH-----HHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCC--CEEEE
Confidence            99999999999997532  333     33445999999999999987        999999999999998654  79999


Q ss_pred             eeeceeeeCCCCce-----eecCCCcCccccccccCC------CCCccccHHHHHHHHHHHHcCCCCCCCC---------
Q psy12427        256 DFGLATKLDPNEVV-----KISTGTAEFAAPEIVERE------PVGFYTDMWAVGVLAYVLLSGLSPFAGE---------  315 (356)
Q Consensus       256 Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlG~il~ell~g~~Pf~~~---------  315 (356)
                      |||+|+........     ...+||+.|||||++.+.      .++.++|||||||+||||+||.+||...         
T Consensus       151 DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~  230 (303)
T 3hmm_A          151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD  230 (303)
T ss_dssp             CCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred             eCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchh
Confidence            99999887543322     234699999999999764      4678999999999999999997765422         


Q ss_pred             ------ChHHHHHHhhccccc--cChhhh-ccCCHHHHHHHHHhhhcCCC
Q psy12427        316 ------NDVETLKNVKACDWE--FDEEAF-KNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       316 ------~~~~~~~~i~~~~~~--~~~~~~-~~~s~~~~~lI~~ll~~dP~  356 (356)
                            ...+....+......  +|.... ...++.+.+||.+||+.||+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~  280 (303)
T 3hmm_A          231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGA  280 (303)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGG
T ss_pred             cccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHh
Confidence                  123333444333332  222111 12456789999999999995

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=6.2e-50  Score=373.51  Aligned_cols=246  Identities=33%  Similarity=0.613  Sum_probs=219.1

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      .+.++|++.+.||+|+||.||+|.++.+|..||+|++....  ..+.+.+.+|+.+|+.++||||+++++++......++
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            34578999999999999999999999999999999997543  3445678899999999999999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecC-CCcEEEEeeecee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN-STNVKMIDFGLAT  261 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~-~~~vkl~Dfg~a~  261 (356)
                      ||||+.||+|.+++.... .++     ...+..++.||+.||+|||++||+||||||+|||++.++ ...+||+|||++.
T Consensus       106 v~e~~~gg~L~~~l~~~~-~~~-----~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~  179 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVARE-FYS-----EADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI  179 (362)
T ss_dssp             EECCCCSCBHHHHHTTCS-CCC-----HHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred             EEecCCCCCHHHHHHHcC-CCC-----HHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence            999999999999886543 233     334456999999999999999999999999999997654 2469999999998


Q ss_pred             eeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCH
Q psy12427        262 KLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSE  341 (356)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  341 (356)
                      ............||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+..+.+.++...+..+|+
T Consensus       180 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  259 (362)
T 2bdw_A          180 EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP  259 (362)
T ss_dssp             CCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCH
T ss_pred             EecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence            87655555556899999999999999999999999999999999999999999999999999999998888888889999


Q ss_pred             HHHHHHHHhhhcCCC
Q psy12427        342 EGKDFIRRLLLRNKE  356 (356)
Q Consensus       342 ~~~~lI~~ll~~dP~  356 (356)
                      ++++||.+||+.||+
T Consensus       260 ~~~~li~~~L~~dP~  274 (362)
T 2bdw_A          260 EAKSLIDSMLTVNPK  274 (362)
T ss_dssp             HHHHHHHHHSCSSGG
T ss_pred             HHHHHHHHHcCCChh
Confidence            999999999999985

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=9.4e-50  Score=373.69  Aligned_cols=246  Identities=48%  Similarity=0.903  Sum_probs=215.2

Q ss_pred             cccceee--eccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        106 VYDHYDI--LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       106 ~~~~y~~--~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      ..+.|.+  .+.||+|+||.||+|.+..+|..||+|+++.......+.+.+|+.+|++++||||+++++++......++|
T Consensus        85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  164 (373)
T 2x4f_A           85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV  164 (373)
T ss_dssp             GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            3445555  67899999999999999999999999999887766778899999999999999999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      |||+++++|.+++......+++     ..+..++.||+.||+|||+.||+||||||+|||+..++.+.+||+|||+++..
T Consensus       165 ~E~~~~~~L~~~l~~~~~~l~~-----~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~  239 (373)
T 2x4f_A          165 MEYVDGGELFDRIIDESYNLTE-----LDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY  239 (373)
T ss_dssp             EECCTTCEEHHHHHHTGGGCCH-----HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred             EeCCCCCcHHHHHHhcCCCCCH-----HHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence            9999999999988654333333     34455899999999999999999999999999997666668999999999988


Q ss_pred             CCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHH
Q psy12427        264 DPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG  343 (356)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  343 (356)
                      ..........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+.++....+.++...+..+|+++
T Consensus       240 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  319 (373)
T 2x4f_A          240 KPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEA  319 (373)
T ss_dssp             CTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHH
T ss_pred             CCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHH
Confidence            76665566679999999999999999999999999999999999999999999999999999998888888888999999


Q ss_pred             HHHHHHhhhcCCC
Q psy12427        344 KDFIRRLLLRNKE  356 (356)
Q Consensus       344 ~~lI~~ll~~dP~  356 (356)
                      ++||++||+.||+
T Consensus       320 ~~li~~~L~~dp~  332 (373)
T 2x4f_A          320 KEFISKLLIKEKS  332 (373)
T ss_dssp             HHHHHTTSCSSGG
T ss_pred             HHHHHHHcCCChh
Confidence            9999999999985

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.9e-49  Score=365.14  Aligned_cols=247  Identities=44%  Similarity=0.783  Sum_probs=219.6

Q ss_pred             CCcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh------hHHHHHHHHHHHHhcCCCCceeeeeeEEeC
Q psy12427        104 SSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL------EKELIRKEIDIMNQLHHPKLINLHDAFEDD  177 (356)
Q Consensus       104 ~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~------~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  177 (356)
                      ..+.++|.+.+.||+|+||.||+|.++.+|..||+|++......      ..+.+.+|+.+|+.++||||+++++++...
T Consensus         7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   86 (326)
T 2y0a_A            7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK   86 (326)
T ss_dssp             SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            34567899999999999999999999999999999998754321      357788999999999999999999999999


Q ss_pred             CeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecC--CCcEEEE
Q psy12427        178 DEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN--STNVKMI  255 (356)
Q Consensus       178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~--~~~vkl~  255 (356)
                      ...++||||+++++|.+++.... .     +....+..++.||+.||+|||++||+||||||+|||++.++  ...+||+
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~-~-----~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~  160 (326)
T 2y0a_A           87 TDVILILELVAGGELFDFLAEKE-S-----LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKII  160 (326)
T ss_dssp             SEEEEEEECCCSCBHHHHHTTSS-C-----CBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEEC
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcC-C-----cCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEE
Confidence            99999999999999999986432 2     33444566999999999999999999999999999997654  2369999


Q ss_pred             eeeceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhh
Q psy12427        256 DFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEA  335 (356)
Q Consensus       256 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  335 (356)
                      |||++.............||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+......++...
T Consensus       161 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  240 (326)
T 2y0a_A          161 DFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY  240 (326)
T ss_dssp             CCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred             ECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccc
Confidence            99999987655555566799999999999999999999999999999999999999999999999999999888888888


Q ss_pred             hccCCHHHHHHHHHhhhcCCC
Q psy12427        336 FKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       336 ~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +..+|.++++||++||+.||+
T Consensus       241 ~~~~~~~~~~li~~~L~~dP~  261 (326)
T 2y0a_A          241 FSNTSALAKDFIRRLLVKDPK  261 (326)
T ss_dssp             HTTSCHHHHHHHHHHSCSSGG
T ss_pred             cccCCHHHHHHHHHHccCChh
Confidence            899999999999999999985

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.5e-49  Score=367.16  Aligned_cols=238  Identities=26%  Similarity=0.476  Sum_probs=208.1

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|+++...   ......+.+|+.+|+.++||||+++++++.....+++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            367999999999999999999999999999999997542   23456678899999999999999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      |||++||+|.+++.... .     +....+..++.||+.||+|||++||+||||||+|||++.++  ++||+|||++...
T Consensus        84 ~E~~~gg~L~~~l~~~~-~-----~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--~vkL~DFG~a~~~  155 (337)
T 1o6l_A           84 MEYANGGELFFHLSRER-V-----FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG--HIKITDFGLCKEG  155 (337)
T ss_dssp             EECCTTCBHHHHHHHHS-C-----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCS
T ss_pred             EeCCCCCcHHHHHHhcC-C-----CCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCC--CEEEeeccchhhc
Confidence            99999999998886432 2     33344556999999999999999999999999999997654  7999999999864


Q ss_pred             C-CCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHH
Q psy12427        264 D-PNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEE  342 (356)
Q Consensus       264 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  342 (356)
                      . ........+||+.|+|||++.+..++.++|+|||||++|||++|..||.+.+..+....+......+|.    .+|++
T Consensus       156 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~  231 (337)
T 1o6l_A          156 ISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPE  231 (337)
T ss_dssp             CCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHH
T ss_pred             ccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHH
Confidence            3 233345567999999999999999999999999999999999999999999999999988887776664    78999


Q ss_pred             HHHHHHHhhhcCCC
Q psy12427        343 GKDFIRRLLLRNKE  356 (356)
Q Consensus       343 ~~~lI~~ll~~dP~  356 (356)
                      +++||++||++||+
T Consensus       232 ~~~li~~lL~~dP~  245 (337)
T 1o6l_A          232 AKSLLAGLLKKDPK  245 (337)
T ss_dssp             HHHHHHHHTCSSTT
T ss_pred             HHHHHHHHhhcCHH
Confidence            99999999999995

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.6e-49  Score=379.63  Aligned_cols=246  Identities=33%  Similarity=0.627  Sum_probs=216.5

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      .+.++|++.+.||+|+||+||+|.++.+|+.+|+|++....  ..+...+.+|+.+|+.++||||+++++++...+..++
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            45678999999999999999999999999999999987654  3345678899999999999999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeec-CCCcEEEEeeecee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTR-NSTNVKMIDFGLAT  261 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~-~~~~vkl~Dfg~a~  261 (356)
                      ||||+.||+|.+.+.... .+++     ..+..++.||+.||+|||++||+||||||+|||++.+ .++.+||+|||++.
T Consensus        88 v~E~~~gg~L~~~i~~~~-~~~e-----~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           88 IFDLVTGGELFEDIVARE-YYSE-----ADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             EECCCBCCBHHHHHHHCS-CCCH-----HHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             EEEeCCCCCHHHHHHHcC-CCCH-----HHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence            999999999999887543 2333     3445599999999999999999999999999999864 33579999999998


Q ss_pred             eeCCCCc-eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCC
Q psy12427        262 KLDPNEV-VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVS  340 (356)
Q Consensus       262 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  340 (356)
                      ....... .....||+.|+|||++.+..++.++||||+||++|+|++|.+||.+.+..+.+..+..+.+.++.+.+..+|
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  241 (444)
T 3soa_A          162 EVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVT  241 (444)
T ss_dssp             CCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred             EecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCC
Confidence            7754332 244579999999999999999999999999999999999999999999999999999999999988889999


Q ss_pred             HHHHHHHHHhhhcCCC
Q psy12427        341 EEGKDFIRRLLLRNKE  356 (356)
Q Consensus       341 ~~~~~lI~~ll~~dP~  356 (356)
                      +++++||++||+.||+
T Consensus       242 ~~~~~li~~~L~~dP~  257 (444)
T 3soa_A          242 PEAKDLINKMLTINPS  257 (444)
T ss_dssp             HHHHHHHHHHSCSSTT
T ss_pred             HHHHHHHHHHcCCChh
Confidence            9999999999999995

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.2e-49  Score=366.52  Aligned_cols=239  Identities=30%  Similarity=0.516  Sum_probs=210.9

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccC--ChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS--HNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++...  .......+.+|+.+|+.++||||+++++++...+..++|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            346899999999999999999999999999999998654  334456788999999999999999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      |||++||+|.+++.... .+++     ..+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||++...
T Consensus        93 ~e~~~~~~L~~~l~~~~-~l~~-----~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~--~~kl~DFG~a~~~  164 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAHG-RMKE-----KEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADM--NIKIADFGFSNEF  164 (328)
T ss_dssp             ECCCTTCBHHHHHHHHC-CCCH-----HHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--CEEECSTTCCGGG
T ss_pred             EECCCCCcHHHHHHHcC-CCCH-----HHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCC--CEEEeeccCceec
Confidence            99999999999986432 2333     34456999999999999999999999999999997654  7999999999877


Q ss_pred             CCCCceeecCCCcCccccccccCCCCC-ccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHH
Q psy12427        264 DPNEVVKISTGTAEFAAPEIVEREPVG-FYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEE  342 (356)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  342 (356)
                      .........+||+.|+|||++.+..+. .++||||+||++|+|++|+.||.+.+..+....+..+.+.+|.    .+|++
T Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~~  240 (328)
T 3fe3_A          165 TVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMSTD  240 (328)
T ss_dssp             SSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHH
T ss_pred             CCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHH
Confidence            665555667899999999999888765 7899999999999999999999999999999999888877664    68999


Q ss_pred             HHHHHHHhhhcCCC
Q psy12427        343 GKDFIRRLLLRNKE  356 (356)
Q Consensus       343 ~~~lI~~ll~~dP~  356 (356)
                      +.+||++||+.||+
T Consensus       241 ~~~li~~~L~~dP~  254 (328)
T 3fe3_A          241 CENLLKRFLVLNPI  254 (328)
T ss_dssp             HHHHHHHHCCSSTT
T ss_pred             HHHHHHHHCCCChh
Confidence            99999999999995

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.3e-49  Score=369.92  Aligned_cols=238  Identities=25%  Similarity=0.478  Sum_probs=204.3

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l  182 (356)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|+++...   ......+.+|..+|..+ +||||+++++++.....+++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            467999999999999999999999999999999997542   23446677899999998 79999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ||||++||+|.+++.... .+     ....++.++.||+.||+|||++||+||||||+|||++.++  ++||+|||+|+.
T Consensus       102 v~E~~~gg~L~~~l~~~~-~~-----~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g--~ikL~DFG~a~~  173 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKSR-RF-----DEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEG--HCKLADFGMCKE  173 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS-SC-----CHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBC
T ss_pred             EEeCCCCCcHHHHHHHcC-CC-----CHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCC--CEEEccccceee
Confidence            999999999999886432 23     3344566999999999999999999999999999997654  799999999986


Q ss_pred             eCC-CCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCH
Q psy12427        263 LDP-NEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSE  341 (356)
Q Consensus       263 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  341 (356)
                      ... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+++.++......+|.    .+++
T Consensus       174 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~  249 (353)
T 3txo_A          174 GICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLHE  249 (353)
T ss_dssp             SCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCH
T ss_pred             cccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCH
Confidence            432 23334567999999999999999999999999999999999999999999999999999988877764    6899


Q ss_pred             HHHHHHHHhhhcCCC
Q psy12427        342 EGKDFIRRLLLRNKE  356 (356)
Q Consensus       342 ~~~~lI~~ll~~dP~  356 (356)
                      ++++||++||++||+
T Consensus       250 ~~~~li~~lL~~dP~  264 (353)
T 3txo_A          250 DATGILKSFMTKNPT  264 (353)
T ss_dssp             HHHHHHHHHTCSSGG
T ss_pred             HHHHHHHHHhhhCHH
Confidence            999999999999995

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=6e-49  Score=365.45  Aligned_cols=249  Identities=33%  Similarity=0.596  Sum_probs=212.0

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC-----hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCe
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-----NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDE  179 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  179 (356)
                      .+.++|++.+.||+|+||+||+|.++.+|+.||+|++....     ....+.+.+|+.+|+.++||||+++++++...+.
T Consensus        21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  100 (351)
T 3c0i_A           21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM  100 (351)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            34578999999999999999999999999999999986432     1245778899999999999999999999999999


Q ss_pred             EEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecC-CCcEEEEeee
Q psy12427        180 MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN-STNVKMIDFG  258 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~-~~~vkl~Dfg  258 (356)
                      +++||||++|++|.+.+.....  ....+....+..++.||+.||+|||++||+||||||+|||++.++ ...+||+|||
T Consensus       101 ~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          101 LYMVFEFMDGADLCFEIVKRAD--AGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             EEEEEECCSSCBHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             EEEEEeCCCCCCHHHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence            9999999999999887753211  011123334556999999999999999999999999999997654 2459999999


Q ss_pred             ceeeeCCCCc-eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhc
Q psy12427        259 LATKLDPNEV-VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK  337 (356)
Q Consensus       259 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  337 (356)
                      ++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+. ..+.+..+....+.+++..+.
T Consensus       179 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~  257 (351)
T 3c0i_A          179 VAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWS  257 (351)
T ss_dssp             TCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHT
T ss_pred             ceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccccc
Confidence            9988765433 33457999999999999999999999999999999999999999885 456778888888888888888


Q ss_pred             cCCHHHHHHHHHhhhcCCC
Q psy12427        338 NVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       338 ~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+|+++++||++||+.||+
T Consensus       258 ~~s~~~~~li~~~L~~dP~  276 (351)
T 3c0i_A          258 HISESAKDLVRRMLMLDPA  276 (351)
T ss_dssp             TSCHHHHHHHHHHTCSSTT
T ss_pred             cCCHHHHHHHHHHCCCChh
Confidence            9999999999999999995

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-48  Score=358.24  Aligned_cols=236  Identities=29%  Similarity=0.568  Sum_probs=208.1

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      .++|++.+.||+|+||.||+|+++.+|+.||+|+++...   ....+.+.+|+.+|+.++||||+++++++.+...+++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            367999999999999999999999999999999987542   22356678899999999999999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      |||++||+|.+++.... .++     ...+..++.||+.||+|||++||+||||||+|||++.++  ++||+|||++...
T Consensus        85 ~e~~~gg~L~~~l~~~~-~~~-----~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--~~kL~Dfg~a~~~  156 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQ-RFP-----NPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG--HIKITDFGFAKYV  156 (318)
T ss_dssp             ECCCCSCBHHHHHHHTS-SCC-----HHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS--CEEECCCSSCEEC
T ss_pred             EeCCCCCCHHHHHHHcC-CCC-----HHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCC--CEEEeecCcceec
Confidence            99999999999987532 233     334556999999999999999999999999999997554  7999999999876


Q ss_pred             CCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHH
Q psy12427        264 DPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG  343 (356)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  343 (356)
                      ..  .....+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+..+.+.++......+|+    .+|+++
T Consensus       157 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~  230 (318)
T 1fot_A          157 PD--VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP----FFNEDV  230 (318)
T ss_dssp             SS--CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT----TSCHHH
T ss_pred             CC--ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHH
Confidence            43  234567999999999999999999999999999999999999999999999999999888777664    789999


Q ss_pred             HHHHHHhhhcCCC
Q psy12427        344 KDFIRRLLLRNKE  356 (356)
Q Consensus       344 ~~lI~~ll~~dP~  356 (356)
                      ++||++||+.||+
T Consensus       231 ~~li~~lL~~dp~  243 (318)
T 1fot_A          231 KDLLSRLITRDLS  243 (318)
T ss_dssp             HHHHHHHTCSCTT
T ss_pred             HHHHHHHhccCHH
Confidence            9999999999995

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=6.5e-49  Score=365.04  Aligned_cols=238  Identities=25%  Similarity=0.475  Sum_probs=208.4

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l  182 (356)
                      .++|++.+.||+|+||.||+|+++.+++.||+|+++...   ....+.+.+|..+|..+ +||||+++++++.....+++
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            467999999999999999999999999999999987542   23446677899999988 79999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ||||++||+|.+++.... .++     ...+..++.||+.||+|||++||+||||||+|||++.++  ++||+|||+|..
T Consensus        99 v~E~~~gg~L~~~l~~~~-~~~-----~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g--~vkL~DFG~a~~  170 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQVG-RFK-----EPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKE  170 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCC-----HHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBC
T ss_pred             EEeCCCCCcHHHHHHhcC-CCC-----HHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCC--cEEEEeCCcccc
Confidence            999999999999986432 233     344556999999999999999999999999999997654  799999999986


Q ss_pred             eC-CCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCH
Q psy12427        263 LD-PNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSE  341 (356)
Q Consensus       263 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  341 (356)
                      .. ........+||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.+..+++.++......+|.    .+|.
T Consensus       171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~  246 (353)
T 2i0e_A          171 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSK  246 (353)
T ss_dssp             CCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCH
T ss_pred             cccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCH
Confidence            43 233345567999999999999999999999999999999999999999999999999999988877764    7899


Q ss_pred             HHHHHHHHhhhcCCC
Q psy12427        342 EGKDFIRRLLLRNKE  356 (356)
Q Consensus       342 ~~~~lI~~ll~~dP~  356 (356)
                      ++++||++||++||+
T Consensus       247 ~~~~li~~lL~~dP~  261 (353)
T 2i0e_A          247 EAVAICKGLMTKHPG  261 (353)
T ss_dssp             HHHHHHHHHTCSCTT
T ss_pred             HHHHHHHHHhhcCHH
Confidence            999999999999995

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=8.1e-49  Score=363.30  Aligned_cols=238  Identities=25%  Similarity=0.463  Sum_probs=207.2

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l  182 (356)
                      .++|.+.+.||+|+||.||+|+++.+|+.||+|+++...   ......+..|..+|..+ +||||+++++++.....+++
T Consensus        16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l   95 (345)
T 1xjd_A           16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   95 (345)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence            468999999999999999999999999999999997542   23345677899999987 89999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ||||++||+|.+++.... .++     ...+..++.||+.||+|||++||+||||||+|||++.++  ++||+|||+++.
T Consensus        96 v~E~~~gg~L~~~l~~~~-~~~-----~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--~vkL~DFG~a~~  167 (345)
T 1xjd_A           96 VMEYLNGGDLMYHIQSCH-KFD-----LSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG--HIKIADFGMCKE  167 (345)
T ss_dssp             EEECCTTCBHHHHHHHHS-SCC-----HHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBC
T ss_pred             EEeCCCCCcHHHHHHHcC-CCC-----HHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCC--CEEEeEChhhhh
Confidence            999999999999986432 233     334456999999999999999999999999999997654  799999999986


Q ss_pred             eCC-CCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCH
Q psy12427        263 LDP-NEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSE  341 (356)
Q Consensus       263 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  341 (356)
                      ... .......+||+.|+|||++.+..++.++|+|||||++|||++|..||.+.+..+++.++......++.    .+|+
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~  243 (345)
T 1xjd_A          168 NMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEK  243 (345)
T ss_dssp             CCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCH
T ss_pred             cccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc----ccCH
Confidence            532 23345567999999999999999999999999999999999999999999999999999887766653    6899


Q ss_pred             HHHHHHHHhhhcCCC
Q psy12427        342 EGKDFIRRLLLRNKE  356 (356)
Q Consensus       342 ~~~~lI~~ll~~dP~  356 (356)
                      ++++||++||+.||+
T Consensus       244 ~~~~li~~lL~~dp~  258 (345)
T 1xjd_A          244 EAKDLLVKLFVREPE  258 (345)
T ss_dssp             HHHHHHHHHSCSSGG
T ss_pred             HHHHHHHHHhcCCHh
Confidence            999999999999985

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2e-48  Score=353.76  Aligned_cols=242  Identities=28%  Similarity=0.486  Sum_probs=208.2

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      ...++|++.+.||+|+||+||+|.+..+++.||+|++........+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   96 (297)
T 3fxz_A           17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (297)
T ss_dssp             CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence            34568999999999999999999999999999999998766666778889999999999999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      ||++||+|.+++....  ++     ...+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||++....
T Consensus        97 e~~~~~~L~~~~~~~~--~~-----~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~--~~kl~Dfg~~~~~~  167 (297)
T 3fxz_A           97 EYLAGGSLTDVVTETC--MD-----EGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG--SVKLTDFGFCAQIT  167 (297)
T ss_dssp             ECCTTCBHHHHHHHSC--CC-----HHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCCTTCEECC
T ss_pred             ECCCCCCHHHHHhhcC--CC-----HHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCC--CEEEeeCCCceecC
Confidence            9999999999987532  23     334556999999999999999999999999999997655  79999999998775


Q ss_pred             CCCc-eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHH
Q psy12427        265 PNEV-VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG  343 (356)
Q Consensus       265 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  343 (356)
                      .... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+...... .......+|+++
T Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  246 (297)
T 3fxz_A          168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAIF  246 (297)
T ss_dssp             STTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-CCSCGGGSCHHH
T ss_pred             CcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCCCccccCHHH
Confidence            4332 34457999999999999999999999999999999999999999999887777666543322 122235799999


Q ss_pred             HHHHHHhhhcCCC
Q psy12427        344 KDFIRRLLLRNKE  356 (356)
Q Consensus       344 ~~lI~~ll~~dP~  356 (356)
                      ++||.+||+.||+
T Consensus       247 ~~li~~~l~~dp~  259 (297)
T 3fxz_A          247 RDFLNRCLEMDVE  259 (297)
T ss_dssp             HHHHHHHSCSSTT
T ss_pred             HHHHHHHccCChh
Confidence            9999999999995

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4.2e-49  Score=372.91  Aligned_cols=240  Identities=26%  Similarity=0.497  Sum_probs=204.4

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh---hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN---LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      .++|++.++||+|+||+||+|+++.+++.||+|+++....   .....+.+|+.+|..++||||++++++|.+...+++|
T Consensus        68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV  147 (410)
T 3v8s_A           68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV  147 (410)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            3679999999999999999999999999999999865321   1224577899999999999999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      |||++||+|.+++...  .++     ...++.++.||+.||+|||++||+||||||+|||++.++  ++||+|||+|...
T Consensus       148 ~E~~~gg~L~~~l~~~--~~~-----e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g--~ikL~DFG~a~~~  218 (410)
T 3v8s_A          148 MEYMPGGDLVNLMSNY--DVP-----EKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG--HLKLADFGTCMKM  218 (410)
T ss_dssp             ECCCTTEEHHHHHHHC--CCC-----HHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEEC
T ss_pred             EeCCCCCcHHHHHHcC--CCC-----HHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCC--CEEEeccceeEee
Confidence            9999999999998643  233     334556999999999999999999999999999997654  7999999999887


Q ss_pred             CCCCce--eecCCCcCccccccccCCC----CCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhc
Q psy12427        264 DPNEVV--KISTGTAEFAAPEIVEREP----VGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK  337 (356)
Q Consensus       264 ~~~~~~--~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  337 (356)
                      ......  ...+||+.|+|||++.+..    ++.++|||||||++|||++|+.||.+.+..+.+.++......+..+...
T Consensus       219 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  298 (410)
T 3v8s_A          219 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN  298 (410)
T ss_dssp             CTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTC
T ss_pred             ccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcc
Confidence            654432  3457999999999998765    7889999999999999999999999999999999987754333333345


Q ss_pred             cCCHHHHHHHHHhhhcCC
Q psy12427        338 NVSEEGKDFIRRLLLRNK  355 (356)
Q Consensus       338 ~~s~~~~~lI~~ll~~dP  355 (356)
                      .+|+++++||++||+.+|
T Consensus       299 ~~s~~~~~li~~lL~~~~  316 (410)
T 3v8s_A          299 DISKEAKNLICAFLTDRE  316 (410)
T ss_dssp             CCCHHHHHHHHHHSSCGG
T ss_pred             cccHHHHHHHHHHccChh
Confidence            799999999999999766

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.1e-48  Score=368.20  Aligned_cols=238  Identities=24%  Similarity=0.499  Sum_probs=201.8

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l  182 (356)
                      .++|++.++||+|+||+||+|+++.+++.||+|+++...   ......+.+|..+|.++ +||||++++++|.....+++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            468999999999999999999999999999999997543   22234577899999887 89999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ||||++||+|..++.... .     +....++.++.||+.||+|||++||+||||||+|||++.++  ++||+|||+|+.
T Consensus       131 V~E~~~gg~L~~~l~~~~-~-----l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g--~ikL~DFGla~~  202 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQR-K-----LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG--HIKLTDYGMCKE  202 (396)
T ss_dssp             EEECCTTCBHHHHHHHHS-S-----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBC
T ss_pred             EEEcCCCCcHHHHHHHcC-C-----CCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCC--CEEEeecceeee
Confidence            999999999998886432 2     33344566999999999999999999999999999998654  799999999986


Q ss_pred             e-CCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC---------ChHHHHHHhhccccccC
Q psy12427        263 L-DPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGE---------NDVETLKNVKACDWEFD  332 (356)
Q Consensus       263 ~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~---------~~~~~~~~i~~~~~~~~  332 (356)
                      . .........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.         ......+.+......+|
T Consensus       203 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p  282 (396)
T 4dc2_A          203 GLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP  282 (396)
T ss_dssp             CCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCC
T ss_pred             cccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCC
Confidence            3 3444455678999999999999999999999999999999999999999643         23345666666666665


Q ss_pred             hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 ~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .    .+|.++++||++||++||+
T Consensus       283 ~----~~s~~~~~li~~lL~~dP~  302 (396)
T 4dc2_A          283 R----SLSVKAASVLKSFLNKDPK  302 (396)
T ss_dssp             T----TSCHHHHHHHHHHTCSCTT
T ss_pred             C----cCCHHHHHHHHHHhcCCHh
Confidence            4    7899999999999999995

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4.2e-48  Score=362.99  Aligned_cols=240  Identities=28%  Similarity=0.526  Sum_probs=205.9

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEE
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMV  181 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  181 (356)
                      ...++|++.+.||+|+||.||+|.++.+++.||+|++....   ......+.+|+.+|+.++||||++++++|......+
T Consensus        12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   91 (384)
T 4fr4_A           12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMF   91 (384)
T ss_dssp             CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            34578999999999999999999999999999999986532   223467889999999999999999999999999999


Q ss_pred             EEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeecee
Q psy12427        182 LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT  261 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~  261 (356)
                      +||||+.||+|.+++.... .++     ...+..++.||+.||+|||++||+||||||+|||++.++  ++||+|||++.
T Consensus        92 lv~e~~~gg~L~~~l~~~~-~l~-----~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g--~vkL~DFG~a~  163 (384)
T 4fr4_A           92 MVVDLLLGGDLRYHLQQNV-HFK-----EETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHG--HVHITDFNIAA  163 (384)
T ss_dssp             EEECCCTTEEHHHHHHTTC-CCC-----HHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCE
T ss_pred             EEEecCCCCcHHHHHHhcC-CCC-----HHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCC--CEEEeccceee
Confidence            9999999999999987532 233     344556999999999999999999999999999997654  79999999999


Q ss_pred             eeCCCCceeecCCCcCccccccccC---CCCCccccHHHHHHHHHHHHcCCCCCCCC---ChHHHHHHhhccccccChhh
Q psy12427        262 KLDPNEVVKISTGTAEFAAPEIVER---EPVGFYTDMWAVGVLAYVLLSGLSPFAGE---NDVETLKNVKACDWEFDEEA  335 (356)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~ell~g~~Pf~~~---~~~~~~~~i~~~~~~~~~~~  335 (356)
                      ...........+||+.|+|||++..   ..++.++|||||||++|+|++|+.||.+.   ...+....+......++.  
T Consensus       164 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~--  241 (384)
T 4fr4_A          164 MLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS--  241 (384)
T ss_dssp             ECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCT--
T ss_pred             eccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCC--
Confidence            8876666667789999999999974   45899999999999999999999999754   445566666666655553  


Q ss_pred             hccCCHHHHHHHHHhhhcCCC
Q psy12427        336 FKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       336 ~~~~s~~~~~lI~~ll~~dP~  356 (356)
                        .+|.++.+||++||+.||+
T Consensus       242 --~~s~~~~~li~~lL~~dP~  260 (384)
T 4fr4_A          242 --AWSQEMVSLLKKLLEPNPD  260 (384)
T ss_dssp             --TSCHHHHHHHHHHSCSSGG
T ss_pred             --cCCHHHHHHHHHHhcCCHh
Confidence              7899999999999999995

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=7.6e-49  Score=373.89  Aligned_cols=242  Identities=29%  Similarity=0.550  Sum_probs=204.9

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh---hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN---LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      .++|++.++||+|+||+||+|+++.+++.||+|++.....   .....+.+|+.+|..++||||++++++|.+...+++|
T Consensus        73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV  152 (437)
T 4aw2_A           73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV  152 (437)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEE
Confidence            4689999999999999999999999999999999865322   1223477899999999999999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      |||++||+|.+++......+++     ..++.++.||+.||+|||++||+||||||+|||++.++  ++||+|||+|+..
T Consensus       153 ~Ey~~gg~L~~~l~~~~~~l~e-----~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g--~vkL~DFGla~~~  225 (437)
T 4aw2_A          153 MDYYVGGDLLTLLSKFEDRLPE-----EMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG--HIRLADFGSCLKL  225 (437)
T ss_dssp             ECCCTTCBHHHHHHTTTTCCCH-----HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEEC
T ss_pred             EecCCCCcHHHHHHHccCCCCH-----HHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCC--CEEEcchhhhhhc
Confidence            9999999999999764334444     34456999999999999999999999999999998654  7999999999877


Q ss_pred             CCCCce--eecCCCcCcccccccc-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc--cccChh
Q psy12427        264 DPNEVV--KISTGTAEFAAPEIVE-----REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACD--WEFDEE  334 (356)
Q Consensus       264 ~~~~~~--~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~~~~  334 (356)
                      ......  ...+||+.|+|||++.     ...++.++|||||||++|||++|+.||.+.+..+.+.++....  ..+|. 
T Consensus       226 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-  304 (437)
T 4aw2_A          226 MEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPT-  304 (437)
T ss_dssp             CTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCS-
T ss_pred             ccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCc-
Confidence            544433  2357999999999997     5678999999999999999999999999999999998887643  33332 


Q ss_pred             hhccCCHHHHHHHHHhhhcCCC
Q psy12427        335 AFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       335 ~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+..+|+++++||++||+.+|+
T Consensus       305 ~~~~~s~~~~dLi~~lL~~~~~  326 (437)
T 4aw2_A          305 QVTDVSENAKDLIRRLICSREH  326 (437)
T ss_dssp             SCCCSCHHHHHHHHTTSSCGGG
T ss_pred             ccccCCHHHHHHHHHHhccccc
Confidence            2357999999999999987663

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4.2e-48  Score=358.77  Aligned_cols=238  Identities=25%  Similarity=0.498  Sum_probs=202.8

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l  182 (356)
                      .++|++.+.||+|+||.||+|+++.+++.||+|++....   ......+.+|+.++.++ +||||+++++++.....+++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            467999999999999999999999999999999997542   33456678899999998 89999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ||||++||+|.+++.... .     +....+..++.||+.||+|||++||+||||||+|||++.++  ++||+|||+++.
T Consensus        88 v~e~~~gg~L~~~l~~~~-~-----l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--~~kL~DFG~a~~  159 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQR-K-----LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG--HIKLTDYGMCKE  159 (345)
T ss_dssp             EECCCCSCBHHHHHHHHS-S-----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCGGGCBC
T ss_pred             EEeCCCCCcHHHHHHHcC-C-----CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC--CEEEEecccccc
Confidence            999999999999886432 2     33344566999999999999999999999999999997654  799999999986


Q ss_pred             eC-CCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCC---------CChHHHHHHhhccccccC
Q psy12427        263 LD-PNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAG---------ENDVETLKNVKACDWEFD  332 (356)
Q Consensus       263 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~---------~~~~~~~~~i~~~~~~~~  332 (356)
                      .. ........+||+.|+|||++.+..++.++|+|||||++|||++|+.||..         .......+.+......+|
T Consensus       160 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p  239 (345)
T 3a8x_A          160 GLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP  239 (345)
T ss_dssp             SCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC
T ss_pred             ccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC
Confidence            43 33344556899999999999999999999999999999999999999975         234455666666666665


Q ss_pred             hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 ~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .    .+|.++++||++||++||+
T Consensus       240 ~----~~s~~~~~li~~lL~~dP~  259 (345)
T 3a8x_A          240 R----SLSVKAASVLKSFLNKDPK  259 (345)
T ss_dssp             T----TSCHHHHHHHHHHTCSSTT
T ss_pred             C----CCCHHHHHHHHHHhcCCHh
Confidence            3    7899999999999999995

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=4.9e-48  Score=347.14  Aligned_cols=246  Identities=33%  Similarity=0.595  Sum_probs=218.5

Q ss_pred             CCcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        104 SSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       104 ~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      +.+.++|++.+.||+|+||+||+|.++.++..+|+|.+........+.+.+|+.++++++||||+++++++......++|
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (277)
T 3f3z_A            5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV   84 (277)
T ss_dssp             -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence            34567899999999999999999999999999999999876656677889999999999999999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEee-cCCCcEEEEeeeceee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQT-RNSTNVKMIDFGLATK  262 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~-~~~~~vkl~Dfg~a~~  262 (356)
                      |||+++++|.+++.... .+     ....+..++.|++.||+|||++||+||||||+|||+.. +.++.+||+|||++..
T Consensus        85 ~e~~~~~~L~~~~~~~~-~~-----~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~  158 (277)
T 3f3z_A           85 MELCTGGELFERVVHKR-VF-----RESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR  158 (277)
T ss_dssp             EECCCSCBHHHHHHHHC-SC-----CHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EeccCCCcHHHHHHHcC-CC-----CHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence            99999999998886432 23     33345569999999999999999999999999999932 1334799999999998


Q ss_pred             eCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHH
Q psy12427        263 LDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEE  342 (356)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  342 (356)
                      ...........||+.|+|||++.+. ++.++||||||+++|+|++|..||.+.+..+....+......++...+..+|++
T Consensus       159 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (277)
T 3f3z_A          159 FKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQ  237 (277)
T ss_dssp             CCTTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHH
T ss_pred             ccCccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHH
Confidence            8766666667899999999998765 899999999999999999999999999999999999999999998888899999


Q ss_pred             HHHHHHHhhhcCCC
Q psy12427        343 GKDFIRRLLLRNKE  356 (356)
Q Consensus       343 ~~~lI~~ll~~dP~  356 (356)
                      +++||++||+.||+
T Consensus       238 ~~~li~~~l~~dp~  251 (277)
T 3f3z_A          238 AESLIRRLLTKSPK  251 (277)
T ss_dssp             HHHHHHHHTCSSTT
T ss_pred             HHHHHHHHccCChh
Confidence            99999999999995

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=5.9e-48  Score=354.29  Aligned_cols=247  Identities=44%  Similarity=0.775  Sum_probs=219.5

Q ss_pred             CCcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh------hHHHHHHHHHHHHhcCCCCceeeeeeEEeC
Q psy12427        104 SSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL------EKELIRKEIDIMNQLHHPKLINLHDAFEDD  177 (356)
Q Consensus       104 ~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~------~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  177 (356)
                      ..+.++|++.+.||+|+||.||+|+++.+|..||+|++......      ..+.+.+|+.+|++++||||+++++++...
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   87 (321)
T 2a2a_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR   87 (321)
T ss_dssp             SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            34567899999999999999999999999999999998754321      357788999999999999999999999999


Q ss_pred             CeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCC--CcEEEE
Q psy12427        178 DEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNS--TNVKMI  255 (356)
Q Consensus       178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~--~~vkl~  255 (356)
                      ...++||||+++++|.+++....      .+....+..++.|++.||+|||++||+||||||+|||++.++.  ..+||+
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~  161 (321)
T 2a2a_A           88 TDVVLILELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLI  161 (321)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTCS------CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEc
Confidence            99999999999999999997532      2344455669999999999999999999999999999976542  169999


Q ss_pred             eeeceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhh
Q psy12427        256 DFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEA  335 (356)
Q Consensus       256 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  335 (356)
                      |||++.............||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+......+++..
T Consensus       162 Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  241 (321)
T 2a2a_A          162 DFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEF  241 (321)
T ss_dssp             CCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHH
T ss_pred             cCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhh
Confidence            99999887665555556799999999999999999999999999999999999999999999999999999888888888


Q ss_pred             hccCCHHHHHHHHHhhhcCCC
Q psy12427        336 FKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       336 ~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +..+|+++++||++||+.||+
T Consensus       242 ~~~~~~~~~~li~~~l~~dp~  262 (321)
T 2a2a_A          242 FSHTSELAKDFIRKLLVKETR  262 (321)
T ss_dssp             HTTCCHHHHHHHHTTSCSSTT
T ss_pred             hcccCHHHHHHHHHHcCCChh
Confidence            889999999999999999995

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.8e-48  Score=360.58  Aligned_cols=236  Identities=26%  Similarity=0.490  Sum_probs=208.4

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      .++|++.+.||+|+||.||+|+++.+|+.||+|++....   ....+.+.+|+.+|+.++||||+++++++.....+++|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            468999999999999999999999999999999986543   22346778899999999999999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      |||++||+|.+++.... .     +....+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+++..
T Consensus       120 ~e~~~gg~L~~~l~~~~-~-----~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--~~kL~DFg~a~~~  191 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIG-R-----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG--YIQVTDFGFAKRV  191 (350)
T ss_dssp             EECCTTCBHHHHHHHHC-C-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEEC
T ss_pred             EcCCCCCcHHHHHHHcC-C-----CCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCC--CEEEcccccceec
Confidence            99999999999987432 2     33344566999999999999999999999999999997654  7999999999876


Q ss_pred             CCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHH
Q psy12427        264 DPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG  343 (356)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  343 (356)
                      ...  ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+.++......+|.    .+|.++
T Consensus       192 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~  265 (350)
T 1rdq_E          192 KGR--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDL  265 (350)
T ss_dssp             SSC--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TCCHHH
T ss_pred             cCC--cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHH
Confidence            543  23457899999999999999999999999999999999999999999999999999888777664    789999


Q ss_pred             HHHHHHhhhcCCC
Q psy12427        344 KDFIRRLLLRNKE  356 (356)
Q Consensus       344 ~~lI~~ll~~dP~  356 (356)
                      ++||++||+.||+
T Consensus       266 ~~li~~lL~~dp~  278 (350)
T 1rdq_E          266 KDLLRNLLQVDLT  278 (350)
T ss_dssp             HHHHHHHSCSCTT
T ss_pred             HHHHHHHhhcCHH
Confidence            9999999999995

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.3e-47  Score=345.57  Aligned_cols=246  Identities=32%  Similarity=0.607  Sum_probs=218.0

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      .+.++|++.+.||+|+||.||+|.++.++..||+|++....  ....+.+.+|+.++++++||||+++++++......++
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   82 (284)
T 3kk8_A            3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   82 (284)
T ss_dssp             TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence            45678999999999999999999999999999999986543  3345678899999999999999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCC-CcEEEEeeecee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNS-TNVKMIDFGLAT  261 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~-~~vkl~Dfg~a~  261 (356)
                      ||||+.+++|.+.+.... .+     ....+..++.|++.||+|||++||+||||||+|||++.++. ..+||+|||++.
T Consensus        83 v~e~~~~~~l~~~~~~~~-~~-----~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~  156 (284)
T 3kk8_A           83 VFDLVTGGELFEDIVARE-FY-----SEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI  156 (284)
T ss_dssp             EECCCCSCBHHHHHHHHS-SC-----CHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEecCCCCCHHHHHHhcC-CC-----CHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence            999999999988876432 23     33345569999999999999999999999999999976542 459999999998


Q ss_pred             eeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCH
Q psy12427        262 KLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSE  341 (356)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  341 (356)
                      ............||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+......++.+.+..+++
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T 3kk8_A          157 EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP  236 (284)
T ss_dssp             ECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred             EcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCH
Confidence            87665555556799999999999999999999999999999999999999999999999999999888888888889999


Q ss_pred             HHHHHHHHhhhcCCC
Q psy12427        342 EGKDFIRRLLLRNKE  356 (356)
Q Consensus       342 ~~~~lI~~ll~~dP~  356 (356)
                      ++++||++||+.||+
T Consensus       237 ~~~~li~~~l~~dp~  251 (284)
T 3kk8_A          237 EAKSLIDSMLTVNPK  251 (284)
T ss_dssp             HHHHHHHHHSCSSTT
T ss_pred             HHHHHHHHHcccChh
Confidence            999999999999995

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.8e-48  Score=376.14  Aligned_cols=249  Identities=33%  Similarity=0.638  Sum_probs=217.2

Q ss_pred             CCCCCcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCC
Q psy12427        101 IKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDD  178 (356)
Q Consensus       101 ~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  178 (356)
                      ...+.+.++|++.+.||+|+||+||+|.++.+++.||+|++....  ......+.+|+.+|++++||||+++++++....
T Consensus        15 ~~~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   94 (486)
T 3mwu_A           15 YFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS   94 (486)
T ss_dssp             TTCCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             cccCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCC
Confidence            345667889999999999999999999999999999999986432  234567889999999999999999999999999


Q ss_pred             eEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeec-CCCcEEEEee
Q psy12427        179 EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTR-NSTNVKMIDF  257 (356)
Q Consensus       179 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~-~~~~vkl~Df  257 (356)
                      .+++||||+.+|+|.+.+.... .++     ...+..++.||+.||+|||++||+||||||+|||++.. ..+.+||+||
T Consensus        95 ~~~lv~e~~~~~~L~~~~~~~~-~~~-----~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  168 (486)
T 3mwu_A           95 SFYIVGELYTGGELFDEIIKRK-RFS-----EHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDF  168 (486)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS-SCC-----HHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSC
T ss_pred             EEEEEEEcCCCCcHHHHHHhcC-CCC-----HHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEEC
Confidence            9999999999999998886432 233     34455699999999999999999999999999999653 2357999999


Q ss_pred             eceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhc
Q psy12427        258 GLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK  337 (356)
Q Consensus       258 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  337 (356)
                      |++.............||+.|+|||++.+ .++.++||||+||++|+|++|.+||.+.+..+.+..+....+.++.+.+.
T Consensus       169 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  247 (486)
T 3mwu_A          169 GLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWR  247 (486)
T ss_dssp             SCTTTBCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGG
T ss_pred             CcCeECCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccC
Confidence            99987766555566789999999999976 58999999999999999999999999999999999999999888888889


Q ss_pred             cCCHHHHHHHHHhhhcCCC
Q psy12427        338 NVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       338 ~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+|+++++||++||+.||+
T Consensus       248 ~~s~~~~~li~~~L~~dp~  266 (486)
T 3mwu_A          248 TISDDAKDLIRKMLTFHPS  266 (486)
T ss_dssp             GSCHHHHHHHHHHTCSSTT
T ss_pred             CCCHHHHHHHHHHcCCChh
Confidence            9999999999999999995

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=5.3e-48  Score=374.96  Aligned_cols=247  Identities=32%  Similarity=0.622  Sum_probs=214.2

Q ss_pred             CCCcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeE
Q psy12427        103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM  180 (356)
Q Consensus       103 ~~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  180 (356)
                      .+.+.++|++.+.||+|+||+||+|+++.++..+|+|++....  ......+.+|+.+|+.++||||+++++++......
T Consensus        32 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  111 (494)
T 3lij_A           32 KGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNY  111 (494)
T ss_dssp             BCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            3456678999999999999999999999999999999987543  22356788999999999999999999999999999


Q ss_pred             EEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecC-CCcEEEEeeec
Q psy12427        181 VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN-STNVKMIDFGL  259 (356)
Q Consensus       181 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~-~~~vkl~Dfg~  259 (356)
                      ++||||+.+|+|.+.+.... .++     ...+..++.||+.||+|||++||+||||||+|||++..+ ...+||+|||+
T Consensus       112 ~lv~e~~~~g~L~~~~~~~~-~~~-----~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~  185 (494)
T 3lij_A          112 YLVMECYKGGELFDEIIHRM-KFN-----EVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGL  185 (494)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCC-----HHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEecCCCCcHHHHHHHcC-CCC-----HHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCC
Confidence            99999999999998886432 233     334456999999999999999999999999999997643 34699999999


Q ss_pred             eeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccC
Q psy12427        260 ATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNV  339 (356)
Q Consensus       260 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  339 (356)
                      +.............||+.|+|||++. ..++.++||||+||++|+|++|.+||.+.+..+.+..+..+.+.++.+.+..+
T Consensus       186 a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  264 (494)
T 3lij_A          186 SAVFENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNV  264 (494)
T ss_dssp             CEECBTTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTS
T ss_pred             CeECCCCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccC
Confidence            99887666566678999999999986 46899999999999999999999999999999999999999999988889999


Q ss_pred             CHHHHHHHHHhhhcCCC
Q psy12427        340 SEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       340 s~~~~~lI~~ll~~dP~  356 (356)
                      |+++++||++||+.||+
T Consensus       265 s~~~~~li~~~L~~dp~  281 (494)
T 3lij_A          265 SEGAKDLIKQMLQFDSQ  281 (494)
T ss_dssp             CHHHHHHHHHHTCSSTT
T ss_pred             CHHHHHHHHHHCCCChh
Confidence            99999999999999995

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4.8e-48  Score=359.09  Aligned_cols=244  Identities=32%  Similarity=0.626  Sum_probs=195.3

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      .+.++|++.+.||+|+||.||+|+++.+++.||+|+++...  ..+.+.+|+.+|++++||||+++++++......++||
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  127 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL  127 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence            34578999999999999999999999999999999987543  3456788999999999999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEee-cCCCcEEEEeeeceeee
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQT-RNSTNVKMIDFGLATKL  263 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~-~~~~~vkl~Dfg~a~~~  263 (356)
                      ||+++|+|.+++.... .+     ....+..++.||+.||+|||+.||+||||||+|||++. +.++.+||+|||+++..
T Consensus       128 e~~~~~~L~~~l~~~~-~~-----~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~  201 (349)
T 2w4o_A          128 ELVTGGELFDRIVEKG-YY-----SERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV  201 (349)
T ss_dssp             CCCCSCBHHHHHTTCS-SC-----CHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred             EeCCCCCHHHHHHhcC-CC-----CHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence            9999999999986543 23     33445569999999999999999999999999999975 23457999999999877


Q ss_pred             CCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHH-HHHHhhccccccChhhhccCCHH
Q psy12427        264 DPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVE-TLKNVKACDWEFDEEAFKNVSEE  342 (356)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~  342 (356)
                      ..........||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+ .+..+......++.+.+..+|.+
T Consensus       202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  281 (349)
T 2w4o_A          202 EHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLN  281 (349)
T ss_dssp             -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred             CcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHH
Confidence            65544555679999999999999999999999999999999999999998776544 67778888877777778899999


Q ss_pred             HHHHHHHhhhcCCC
Q psy12427        343 GKDFIRRLLLRNKE  356 (356)
Q Consensus       343 ~~~lI~~ll~~dP~  356 (356)
                      +++||++||+.||+
T Consensus       282 ~~~li~~~L~~dP~  295 (349)
T 2w4o_A          282 AKDLVRKLIVLDPK  295 (349)
T ss_dssp             HHHHHHTTSCSSGG
T ss_pred             HHHHHHHHccCChh
Confidence            99999999999995

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.3e-47  Score=373.07  Aligned_cols=247  Identities=35%  Similarity=0.613  Sum_probs=216.0

Q ss_pred             CCCcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh-------------hhHHHHHHHHHHHHhcCCCCcee
Q psy12427        103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN-------------LEKELIRKEIDIMNQLHHPKLIN  169 (356)
Q Consensus       103 ~~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~-------------~~~~~~~~E~~il~~l~hpnIv~  169 (356)
                      .+.+.++|++.++||+|+||+||+|.++.++..+|+|++.....             ...+.+.+|+.+|++++||||++
T Consensus        31 ~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  110 (504)
T 3q5i_A           31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIK  110 (504)
T ss_dssp             CSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCC
T ss_pred             CCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCe
Confidence            34567889999999999999999999999999999999875431             23467889999999999999999


Q ss_pred             eeeeEEeCCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCC
Q psy12427        170 LHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNS  249 (356)
Q Consensus       170 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~  249 (356)
                      +++++......++||||++||+|.+++.... .+     ....+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus       111 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~-----~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~  184 (504)
T 3q5i_A          111 LFDVFEDKKYFYLVTEFYEGGELFEQIINRH-KF-----DECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNS  184 (504)
T ss_dssp             EEEEEECSSEEEEEEECCTTCBHHHHHHHHS-CC-----CHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTC
T ss_pred             EEEEEEcCCEEEEEEecCCCCcHHHHHHHcC-CC-----CHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCC
Confidence            9999999999999999999999999886432 23     33445569999999999999999999999999999986543


Q ss_pred             -CcEEEEeeeceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc
Q psy12427        250 -TNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACD  328 (356)
Q Consensus       250 -~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~  328 (356)
                       ..+||+|||++.............||+.|+|||++.+ .++.++||||+||++|+|++|.+||.+.+..+.+..+..+.
T Consensus       185 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~  263 (504)
T 3q5i_A          185 LLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGK  263 (504)
T ss_dssp             CSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred             CccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence             3699999999998876666666789999999999874 68999999999999999999999999999999999999999


Q ss_pred             cccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        329 WEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       329 ~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +.++.+.+..+|+++++||++||+.||+
T Consensus       264 ~~~~~~~~~~~s~~~~~li~~~L~~dp~  291 (504)
T 3q5i_A          264 YYFDFNDWKNISDEAKELIKLMLTYDYN  291 (504)
T ss_dssp             CCCCHHHHTTSCHHHHHHHHHHTCSSTT
T ss_pred             CCCCccccCCCCHHHHHHHHHHcCCChh
Confidence            9999888999999999999999999995

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.4e-48  Score=363.78  Aligned_cols=238  Identities=26%  Similarity=0.515  Sum_probs=199.1

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh---hhHHHHHHHHHH-HHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN---LEKELIRKEIDI-MNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~i-l~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      .++|++.+.||+|+||.||+|+++.++..||+|++.....   .....+.+|..+ ++.++||||+++++++.....+++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            4689999999999999999999999999999999975432   233445567776 567899999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ||||++||+|.+++.... .+.     ...++.++.||+.||+|||++||+||||||+|||++.++  ++||+|||+++.
T Consensus       117 v~E~~~gg~L~~~l~~~~-~~~-----~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g--~ikL~DFG~a~~  188 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRER-CFL-----EPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG--HIVLTDFGLCKE  188 (373)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCC-----HHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCCCBCGG
T ss_pred             EEeCCCCCcHHHHHHhcC-CCC-----HHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC--CEEEeeCccccc
Confidence            999999999999886432 233     334556999999999999999999999999999998654  799999999986


Q ss_pred             eC-CCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCH
Q psy12427        263 LD-PNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSE  341 (356)
Q Consensus       263 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  341 (356)
                      .. ........+||+.|+|||++.+..++.++|+|||||++|||++|..||.+.+..+++.++......+++    .++.
T Consensus       189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~  264 (373)
T 2r5t_A          189 NIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP----NITN  264 (373)
T ss_dssp             GBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCS----SSCH
T ss_pred             cccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCC----CCCH
Confidence            42 333445568999999999999999999999999999999999999999999999999999887766653    7899


Q ss_pred             HHHHHHHHhhhcCCC
Q psy12427        342 EGKDFIRRLLLRNKE  356 (356)
Q Consensus       342 ~~~~lI~~ll~~dP~  356 (356)
                      ++++||++||++||+
T Consensus       265 ~~~~li~~lL~~dp~  279 (373)
T 2r5t_A          265 SARHLLEGLLQKDRT  279 (373)
T ss_dssp             HHHHHHHHHTCSSGG
T ss_pred             HHHHHHHHHcccCHH
Confidence            999999999999984

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.2e-47  Score=353.08  Aligned_cols=243  Identities=36%  Similarity=0.681  Sum_probs=191.1

Q ss_pred             Ccccceeee---ccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCeE
Q psy12427        105 SVYDHYDIL---EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLH-HPKLINLHDAFEDDDEM  180 (356)
Q Consensus       105 ~~~~~y~~~---~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~  180 (356)
                      .+.++|++.   +.||+|+||+||+|.++.+++.||+|++...   ....+.+|+.+++.+. ||||+++++++......
T Consensus         5 ~f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~   81 (325)
T 3kn6_A            5 PFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHT   81 (325)
T ss_dssp             HHHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             cchhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE
Confidence            445677775   7899999999999999999999999998643   3456678999999997 99999999999999999


Q ss_pred             EEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecC-CCcEEEEeeec
Q psy12427        181 VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN-STNVKMIDFGL  259 (356)
Q Consensus       181 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~-~~~vkl~Dfg~  259 (356)
                      ++||||++||+|.+++.... .++     ...+..++.||+.||+|||++||+||||||+|||++.++ ...+||+|||+
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~-~~~-----~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~  155 (325)
T 3kn6_A           82 FLVMELLNGGELFERIKKKK-HFS-----ETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGF  155 (325)
T ss_dssp             EEEECCCCSCBHHHHHHHCS-CCC-----HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTT
T ss_pred             EEEEEccCCCcHHHHHHhcC-CCC-----HHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecccc
Confidence            99999999999999987542 233     344556999999999999999999999999999997643 23699999999


Q ss_pred             eeeeCCCC-ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC-------hHHHHHHhhcccccc
Q psy12427        260 ATKLDPNE-VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN-------DVETLKNVKACDWEF  331 (356)
Q Consensus       260 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~-------~~~~~~~i~~~~~~~  331 (356)
                      ++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+       ..+.+..+..+.+.+
T Consensus       156 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~  235 (325)
T 3kn6_A          156 ARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF  235 (325)
T ss_dssp             CEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC
T ss_pred             ceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC
Confidence            98765432 2345578999999999999999999999999999999999999998754       357888888899888


Q ss_pred             ChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        332 DEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       332 ~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +.+.+..+|+++++||++||+.||+
T Consensus       236 ~~~~~~~~s~~~~~li~~~L~~dP~  260 (325)
T 3kn6_A          236 EGEAWKNVSQEAKDLIQGLLTVDPN  260 (325)
T ss_dssp             CSHHHHTSCHHHHHHHHHHHCCCTT
T ss_pred             CcccccCCCHHHHHHHHHHCCCChh
Confidence            9888899999999999999999995

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.4e-48  Score=358.93  Aligned_cols=242  Identities=29%  Similarity=0.576  Sum_probs=209.7

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEEEE
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      .+.++|++.+.||+|+||.||+|.++.+|+.||+|++.....    ...+|+++|.++ +||||+++++++.+....++|
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   94 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV   94 (342)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred             CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence            456789999999999999999999999999999999976533    234688889888 799999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCC--CcEEEEeeecee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNS--TNVKMIDFGLAT  261 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~--~~vkl~Dfg~a~  261 (356)
                      |||++||+|.+++.... .++     ...+..++.||+.||+|||++||+||||||+|||+..++.  ..+||+|||++.
T Consensus        95 ~E~~~gg~L~~~i~~~~-~~~-----~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~  168 (342)
T 2qr7_A           95 TELMKGGELLDKILRQK-FFS-----EREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK  168 (342)
T ss_dssp             ECCCCSCBHHHHHHTCT-TCC-----HHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred             EeCCCCCcHHHHHHHcC-CCC-----HHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence            99999999999987543 233     3445569999999999999999999999999999854332  359999999998


Q ss_pred             eeCCC-CceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCC---CChHHHHHHhhccccccChhhhc
Q psy12427        262 KLDPN-EVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAG---ENDVETLKNVKACDWEFDEEAFK  337 (356)
Q Consensus       262 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~---~~~~~~~~~i~~~~~~~~~~~~~  337 (356)
                      ..... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+   .+..+++..+..+.+.++...+.
T Consensus       169 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~  248 (342)
T 2qr7_A          169 QLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWN  248 (342)
T ss_dssp             ECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTT
T ss_pred             cCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccc
Confidence            76543 334456789999999999988899999999999999999999999986   46778888999888888888888


Q ss_pred             cCCHHHHHHHHHhhhcCCC
Q psy12427        338 NVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       338 ~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+|+++++||++||+.||+
T Consensus       249 ~~s~~~~~li~~~L~~dP~  267 (342)
T 2qr7_A          249 SVSDTAKDLVSKMLHVDPH  267 (342)
T ss_dssp             TSCHHHHHHHHHHTCSSTT
T ss_pred             cCCHHHHHHHHHHCCCChh
Confidence            9999999999999999995

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-48  Score=368.26  Aligned_cols=241  Identities=29%  Similarity=0.522  Sum_probs=202.3

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh---hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN---LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|++.....   .....+.+|..+|..++||||++++++|.+...+++|
T Consensus        60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV  139 (412)
T 2vd5_A           60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLV  139 (412)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred             hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence            3689999999999999999999999999999999865322   2234577899999999999999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      |||++||+|.+++......+++     ..++.++.||+.||+|||++||+||||||+|||++.++  ++||+|||+|...
T Consensus       140 mE~~~gg~L~~~l~~~~~~l~~-----~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g--~vkL~DFGla~~~  212 (412)
T 2vd5_A          140 MEYYVGGDLLTLLSKFGERIPA-----EMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCG--HIRLADFGSCLKL  212 (412)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCCH-----HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEEC
T ss_pred             EcCCCCCcHHHHHHhcCCCCCH-----HHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCC--CEEEeechhheec
Confidence            9999999999999753323333     34455999999999999999999999999999997654  7999999999887


Q ss_pred             CCCCcee--ecCCCcCcccccccc-------CCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc--cccC
Q psy12427        264 DPNEVVK--ISTGTAEFAAPEIVE-------REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACD--WEFD  332 (356)
Q Consensus       264 ~~~~~~~--~~~gt~~y~aPE~~~-------~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~~  332 (356)
                      .......  ..+||+.|+|||++.       ...++.++|||||||++|||++|+.||.+.+..+++.++....  ..+|
T Consensus       213 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p  292 (412)
T 2vd5_A          213 RADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLP  292 (412)
T ss_dssp             CTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC
T ss_pred             cCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCC
Confidence            6544332  357999999999997       4568999999999999999999999999999999988887643  2233


Q ss_pred             hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 ~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                       .....+|+++++||++||+ +|+
T Consensus       293 -~~~~~~s~~~~dli~~lL~-~p~  314 (412)
T 2vd5_A          293 -LVDEGVPEEARDFIQRLLC-PPE  314 (412)
T ss_dssp             -----CCCHHHHHHHHTTSS-CGG
T ss_pred             -ccccCCCHHHHHHHHHHcC-Chh
Confidence             2235799999999999998 774

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=4.4e-48  Score=374.62  Aligned_cols=246  Identities=34%  Similarity=0.630  Sum_probs=218.4

Q ss_pred             CCcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeE
Q psy12427        104 SSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM  180 (356)
Q Consensus       104 ~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  180 (356)
                      ..+.++|++.+.||+|+||.||+|.++.+|+.||+|++....   ......+.+|+.+|++++||||+++++++...+..
T Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  101 (484)
T 3nyv_A           22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYF  101 (484)
T ss_dssp             CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            345678999999999999999999999999999999986542   33567888999999999999999999999999999


Q ss_pred             EEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeec-CCCcEEEEeeec
Q psy12427        181 VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTR-NSTNVKMIDFGL  259 (356)
Q Consensus       181 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~-~~~~vkl~Dfg~  259 (356)
                      ++||||+.+|+|.+++.... .     +....+..++.||+.||+|||++||+||||||+|||++.. .++.+||+|||+
T Consensus       102 ~lv~e~~~~~~L~~~~~~~~-~-----~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~  175 (484)
T 3nyv_A          102 YLVGEVYTGGELFDEIISRK-R-----FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGL  175 (484)
T ss_dssp             EEEECCCCSCBHHHHHHTCS-C-----CBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred             EEEEecCCCCCHHHHHHhcC-C-----CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence            99999999999999887543 2     3334456699999999999999999999999999999642 345799999999


Q ss_pred             eeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccC
Q psy12427        260 ATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNV  339 (356)
Q Consensus       260 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  339 (356)
                      +.............||+.|+|||++.+ .++.++||||+||++|+|++|.+||.+.+..+.+..+..+.+.++.+.+..+
T Consensus       176 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  254 (484)
T 3nyv_A          176 STHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKV  254 (484)
T ss_dssp             HHHBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGS
T ss_pred             eEEcccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccC
Confidence            988766655556689999999999876 6899999999999999999999999999999999999999988888888999


Q ss_pred             CHHHHHHHHHhhhcCCC
Q psy12427        340 SEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       340 s~~~~~lI~~ll~~dP~  356 (356)
                      |+++++||++||+.||+
T Consensus       255 s~~~~~li~~~L~~dp~  271 (484)
T 3nyv_A          255 SESAKDLIRKMLTYVPS  271 (484)
T ss_dssp             CHHHHHHHHHHTCSSGG
T ss_pred             CHHHHHHHHHHCCCChh
Confidence            99999999999999995

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.9e-47  Score=361.29  Aligned_cols=246  Identities=28%  Similarity=0.515  Sum_probs=199.5

Q ss_pred             CCCCcccceeee-ccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHh-cCCCCceeeeeeEEe---
Q psy12427        102 KTSSVYDHYDIL-EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQ-LHHPKLINLHDAFED---  176 (356)
Q Consensus       102 ~~~~~~~~y~~~-~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~---  176 (356)
                      ..+.+.++|.+. +.||+|+||+||+|.++.+|+.||+|++...     ..+.+|+.++.+ .+||||+++++++..   
T Consensus        55 ~~~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~  129 (400)
T 1nxk_A           55 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYA  129 (400)
T ss_dssp             BCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             CCCcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence            344567788887 7899999999999999999999999998632     345678888754 589999999999875   


Q ss_pred             -CCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecC-CCcEEE
Q psy12427        177 -DDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN-STNVKM  254 (356)
Q Consensus       177 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~-~~~vkl  254 (356)
                       ...+++||||++||+|.+++.....    ..+....+..++.||+.||+|||+.||+||||||+|||++.++ ++.+||
T Consensus       130 ~~~~~~lv~E~~~gg~L~~~l~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl  205 (400)
T 1nxk_A          130 GRKCLLIVMECLDGGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKL  205 (400)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHCC-------CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEE
T ss_pred             CCcEEEEEEEeCCCCcHHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEE
Confidence             6678999999999999999976431    2234445566999999999999999999999999999998632 457999


Q ss_pred             EeeeceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHH----HHHHhhccccc
Q psy12427        255 IDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVE----TLKNVKACDWE  330 (356)
Q Consensus       255 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~----~~~~i~~~~~~  330 (356)
                      +|||+++...........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+    ....+....+.
T Consensus       206 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~  285 (400)
T 1nxk_A          206 TDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE  285 (400)
T ss_dssp             CCCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCC
T ss_pred             EecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCccc
Confidence            99999988765555566789999999999999999999999999999999999999998765432    45667777777


Q ss_pred             cChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        331 FDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       331 ~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ++...+..+|+++++||++||+.||+
T Consensus       286 ~~~~~~~~~s~~~~~li~~~L~~dP~  311 (400)
T 1nxk_A          286 FPNPEWSEVSEEVKMLIRNLLKTEPT  311 (400)
T ss_dssp             CCTTTTTTSCHHHHHHHHTTSCSSGG
T ss_pred             CCCcccccCCHHHHHHHHHHCCCChh
Confidence            88777789999999999999999985

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.6e-47  Score=352.46  Aligned_cols=238  Identities=33%  Similarity=0.609  Sum_probs=196.8

Q ss_pred             ccceeeeccccccCceEEEEEEEc---cCCCEEEEEEcccCC----hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCe
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRER---KTGNIFAAKFIPVSH----NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDE  179 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~---~~~~~~a~K~~~~~~----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  179 (356)
                      .++|++.+.||+|+||.||+|++.   .+++.||+|+++...    ......+.+|+.+|+.++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            468999999999999999999985   678999999997643    2234567789999999999999999999999999


Q ss_pred             EEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeec
Q psy12427        180 MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGL  259 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~  259 (356)
                      .++||||++|++|.+++.... .+     ....+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~-~~-----~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~--~~kl~Dfg~  167 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG-IF-----MEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG--HVKLTDFGL  167 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS-SC-----CHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTS--CEEECCCSC
T ss_pred             EEEEEeCCCCCcHHHHHHhCC-CC-----CHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCC--cEEEEeCCc
Confidence            999999999999999886432 22     3334556999999999999999999999999999997654  799999999


Q ss_pred             eeeeCCC-CceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhcc
Q psy12427        260 ATKLDPN-EVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKN  338 (356)
Q Consensus       260 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  338 (356)
                      ++..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+......+++    .
T Consensus       168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~----~  243 (327)
T 3a62_A          168 CKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPP----Y  243 (327)
T ss_dssp             C----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCT----T
T ss_pred             ccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC----C
Confidence            9764322 2233457999999999999999999999999999999999999999999999999999887776664    7


Q ss_pred             CCHHHHHHHHHhhhcCCC
Q psy12427        339 VSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       339 ~s~~~~~lI~~ll~~dP~  356 (356)
                      ++.++++||++||+.||+
T Consensus       244 ~~~~~~~li~~~L~~dp~  261 (327)
T 3a62_A          244 LTQEARDLLKKLLKRNAA  261 (327)
T ss_dssp             SCHHHHHHHHHHSCSCGG
T ss_pred             CCHHHHHHHHHHHhcCHh
Confidence            899999999999999984

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.2e-47  Score=356.22  Aligned_cols=243  Identities=27%  Similarity=0.485  Sum_probs=193.9

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      ...++|++.+.||+|+||+||+|+++.+++.||+|++..... ....+.+|+.+++.++||||+++++++......++||
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   95 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM   95 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence            345789999999999999999999999999999999975443 2356779999999999999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      ||+.+|+|.+++.... .     +....+..++.|++.||+|||++||+||||||+|||++.++..++||+|||+++...
T Consensus        96 e~~~~~~L~~~l~~~~-~-----~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~  169 (361)
T 3uc3_A           96 EYASGGELYERICNAG-R-----FSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  169 (361)
T ss_dssp             ECCCSCBHHHHHHHHS-S-----CCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred             EeCCCCCHHHHHHhcC-C-----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence            9999999999886432 2     333445669999999999999999999999999999987665679999999998654


Q ss_pred             CCCceeecCCCcCccccccccCCCCCcc-ccHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHhhccccccChhhhccC
Q psy12427        265 PNEVVKISTGTAEFAAPEIVEREPVGFY-TDMWAVGVLAYVLLSGLSPFAGEND----VETLKNVKACDWEFDEEAFKNV  339 (356)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwSlG~il~ell~g~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~  339 (356)
                      .........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+...    ...++.+....+.++..  ..+
T Consensus       170 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  247 (361)
T 3uc3_A          170 LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDD--IRI  247 (361)
T ss_dssp             -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTT--SCC
T ss_pred             ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCc--CCC
Confidence            4444455679999999999988887655 8999999999999999999987543    45566666666555542  368


Q ss_pred             CHHHHHHHHHhhhcCCC
Q psy12427        340 SEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       340 s~~~~~lI~~ll~~dP~  356 (356)
                      |+++++||++||+.||+
T Consensus       248 s~~~~~li~~~L~~dP~  264 (361)
T 3uc3_A          248 SPECCHLISRIFVADPA  264 (361)
T ss_dssp             CHHHHHHHHHHSCSCTT
T ss_pred             CHHHHHHHHHHccCChh
Confidence            99999999999999995

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.7e-47  Score=354.40  Aligned_cols=251  Identities=30%  Similarity=0.522  Sum_probs=210.8

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccC-----ChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS-----HNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM  180 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  180 (356)
                      +.++|++.+.||+|+||+||+|.++.++..||+|++...     .....+.+.+|+.+|++++||||+++++++......
T Consensus        24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  103 (345)
T 3hko_A           24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYI  103 (345)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeE
Confidence            346899999999999999999999999999999998643     233457788999999999999999999999999999


Q ss_pred             EEEEEeccccchhhhhhCCCCCC----------------------------------CccccccccHHHHHHHHHHHHHH
Q psy12427        181 VLIFEFLSGGELFERITAPDYKM----------------------------------SEAEVIPVTLPILMTQTSPAVKH  226 (356)
Q Consensus       181 ~lv~e~~~~g~L~~~l~~~~~~~----------------------------------~~~~~~~~~~~~~~~~i~~~l~~  226 (356)
                      ++||||++||+|.+++.......                                  .........+..++.||+.||+|
T Consensus       104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~  183 (345)
T 3hko_A          104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY  183 (345)
T ss_dssp             EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence            99999999999999885211000                                  01112233456699999999999


Q ss_pred             HHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCC-----ceeecCCCcCccccccccC--CCCCccccHHHHH
Q psy12427        227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE-----VVKISTGTAEFAAPEIVER--EPVGFYTDMWAVG  299 (356)
Q Consensus       227 lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG  299 (356)
                      ||++||+||||||+|||++.++...+||+|||++..+....     ......||+.|+|||++.+  ..++.++||||||
T Consensus       184 LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG  263 (345)
T 3hko_A          184 LHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG  263 (345)
T ss_dssp             HHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHH
T ss_pred             HHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHH
Confidence            99999999999999999987665679999999998763211     1234568999999999975  6788999999999


Q ss_pred             HHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        300 VLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       300 ~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      |++|+|++|+.||.+.+..+.+..+......++.+.+..+|+++++||++||+.||+
T Consensus       264 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  320 (345)
T 3hko_A          264 VLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVD  320 (345)
T ss_dssp             HHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTT
T ss_pred             HHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChh
Confidence            999999999999999999999999988888888777788999999999999999995

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.8e-47  Score=346.89  Aligned_cols=244  Identities=25%  Similarity=0.407  Sum_probs=201.7

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEE
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMV  181 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  181 (356)
                      .+.++|++.+.||+|+||.||+|.+..++..||+|.+....   ......+.+|+.++++++||||+++++++...+..+
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   87 (294)
T 4eqm_A            8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY   87 (294)
T ss_dssp             CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred             HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence            35578999999999999999999999999999999986533   334467889999999999999999999999999999


Q ss_pred             EEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeecee
Q psy12427        182 LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT  261 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~  261 (356)
                      +||||++|++|.+++.... .     +....+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||++.
T Consensus        88 lv~e~~~g~~L~~~l~~~~-~-----~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~--~~kl~Dfg~~~  159 (294)
T 4eqm_A           88 LVMEYIEGPTLSEYIESHG-P-----LSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNK--TLKIFDFGIAK  159 (294)
T ss_dssp             EEEECCCSCBHHHHHHHHC-S-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCCSSST
T ss_pred             EEEeCCCCCCHHHHHHhcC-C-----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEEeCCCcc
Confidence            9999999999999986432 2     33344556999999999999999999999999999997654  79999999997


Q ss_pred             eeCCCCc--eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc-cChhhhcc
Q psy12427        262 KLDPNEV--VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWE-FDEEAFKN  338 (356)
Q Consensus       262 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~  338 (356)
                      .......  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+........... .+.....+
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (294)
T 4eqm_A          160 ALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKD  239 (294)
T ss_dssp             TC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTT
T ss_pred             ccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccC
Confidence            6643322  23346899999999999999999999999999999999999999999887766555544333 33445567


Q ss_pred             CCHHHHHHHHHhhhcCCC
Q psy12427        339 VSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       339 ~s~~~~~lI~~ll~~dP~  356 (356)
                      +|+.+.++|.+||++||+
T Consensus       240 ~~~~l~~li~~~l~~dp~  257 (294)
T 4eqm_A          240 IPQSLSNVILRATEKDKA  257 (294)
T ss_dssp             SCHHHHHHHHHHSCSSGG
T ss_pred             CCHHHHHHHHHHhcCCHh
Confidence            999999999999999984

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=6.5e-48  Score=352.46  Aligned_cols=244  Identities=25%  Similarity=0.393  Sum_probs=201.8

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh---hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCC---
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN---LEKELIRKEIDIMNQLHHPKLINLHDAFEDDD---  178 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~---  178 (356)
                      .+.++|++.+.||+|+||.||+|++..+++.||+|++.....   .....+.+|+.++.+++||||+++++++....   
T Consensus         9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   88 (311)
T 3ork_A            9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG   88 (311)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred             eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence            456789999999999999999999999999999999976532   23456789999999999999999999987654   


Q ss_pred             -eEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEee
Q psy12427        179 -EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDF  257 (356)
Q Consensus       179 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Df  257 (356)
                       ..++||||++|++|.+++.... .+     ....+..++.|++.||+|||++||+||||||+|||++.++  .+||+||
T Consensus        89 ~~~~lv~e~~~g~~L~~~l~~~~-~~-----~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~kl~Df  160 (311)
T 3ork_A           89 PLPYIVMEYVDGVTLRDIVHTEG-PM-----TPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN--AVKVMDF  160 (311)
T ss_dssp             EEEEEEEECCCEEEHHHHHHHHC-SC-----CHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTS--CEEECCC
T ss_pred             cccEEEEecCCCCCHHHHHHhcC-CC-----CHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCC--CEEEeec
Confidence             3499999999999999986432 23     3334556999999999999999999999999999998655  7999999


Q ss_pred             eceeeeCCCC----ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCh
Q psy12427        258 GLATKLDPNE----VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE  333 (356)
Q Consensus       258 g~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~  333 (356)
                      |++.......    ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+...++......++.
T Consensus       161 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (311)
T 3ork_A          161 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS  240 (311)
T ss_dssp             SCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHH
T ss_pred             cCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcc
Confidence            9998764322    122345899999999999999999999999999999999999999999988888877777766666


Q ss_pred             hhhccCCHHHHHHHHHhhhcCCC
Q psy12427        334 EAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       334 ~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .....+|+++.+||.+||+.||+
T Consensus       241 ~~~~~~~~~l~~li~~~l~~dP~  263 (311)
T 3ork_A          241 ARHEGLSADLDAVVLKALAKNPE  263 (311)
T ss_dssp             HHSTTCCHHHHHHHHHHTCSSGG
T ss_pred             cccCCCCHHHHHHHHHHHhcCHh
Confidence            66678999999999999999985

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.8e-48  Score=358.41  Aligned_cols=238  Identities=31%  Similarity=0.529  Sum_probs=203.9

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh---hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN---LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|++.....   .....+.+|+.+|+.++||||+++++++......++
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l   86 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM   86 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            45689999999999999999999999999999999864321   123568899999999999999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ||||+ +|+|.+++.... .++     ...+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||++..
T Consensus        87 v~E~~-~g~l~~~l~~~~-~l~-----~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~--~~kl~DFG~s~~  157 (336)
T 3h4j_B           87 VIEYA-GGELFDYIVEKK-RMT-----EDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNL--NVKIADFGLSNI  157 (336)
T ss_dssp             EECCC-CEEHHHHHHHHC-SCC-----HHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTC--CEEECCSSCTBT
T ss_pred             EEECC-CCcHHHHHHHcC-CCC-----HHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCC--CEEEEEecccee
Confidence            99999 788988886432 233     334556999999999999999999999999999997554  799999999987


Q ss_pred             eCCCCceeecCCCcCccccccccCCCC-CccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCH
Q psy12427        263 LDPNEVVKISTGTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSE  341 (356)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  341 (356)
                      ..........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+....+....+....+.+|.    .+|+
T Consensus       158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~  233 (336)
T 3h4j_B          158 MTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPD----FLSP  233 (336)
T ss_dssp             TTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCT----TSCH
T ss_pred             ccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcc----cCCH
Confidence            766665666789999999999998876 68999999999999999999999988777666666665555543    6899


Q ss_pred             HHHHHHHHhhhcCCC
Q psy12427        342 EGKDFIRRLLLRNKE  356 (356)
Q Consensus       342 ~~~~lI~~ll~~dP~  356 (356)
                      ++++||++||+.||+
T Consensus       234 ~~~~li~~~L~~dP~  248 (336)
T 3h4j_B          234 GAQSLIRRMIVADPM  248 (336)
T ss_dssp             HHHHHHHTTSCSSGG
T ss_pred             HHHHHHHHHcCCChh
Confidence            999999999999995

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=5.2e-47  Score=346.61  Aligned_cols=243  Identities=24%  Similarity=0.461  Sum_probs=197.2

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh--hHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL--EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      .+.++|++.+.||+|+||+||+|++. +|+.||+|++......  ....+.+|+.+|++++||||+++++++..+...++
T Consensus        18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   96 (311)
T 3niz_A           18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL   96 (311)
T ss_dssp             CSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred             chHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence            45678999999999999999999985 4899999998754322  24667899999999999999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ||||+++ +|.+.+......+++.     .+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||+++.
T Consensus        97 v~e~~~~-~l~~~~~~~~~~~~~~-----~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~--~~kl~Dfg~a~~  168 (311)
T 3niz_A           97 VFEFMEK-DLKKVLDENKTGLQDS-----QIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDG--ALKLADFGLARA  168 (311)
T ss_dssp             EEECCSE-EHHHHHHTCTTCCCHH-----HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEE
T ss_pred             EEcCCCC-CHHHHHHhccCCCCHH-----HHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCC--CEEEccCcCcee
Confidence            9999975 7888877654444443     4455999999999999999999999999999997654  799999999987


Q ss_pred             eCCC-CceeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCh-------
Q psy12427        263 LDPN-EVVKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE-------  333 (356)
Q Consensus       263 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~-------  333 (356)
                      .... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+......+++       
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  248 (311)
T 3niz_A          169 FGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ  248 (311)
T ss_dssp             TTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGT
T ss_pred             cCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhh
Confidence            6532 23344578999999999876 56899999999999999999999999998877777766542222111       


Q ss_pred             -------------------hhhccCCHHHHHHHHHhhhcCCC
Q psy12427        334 -------------------EAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       334 -------------------~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                         .....+++++++||++||+.||+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  290 (311)
T 3niz_A          249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPN  290 (311)
T ss_dssp             TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTT
T ss_pred             ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChh
Confidence                               12235789999999999999995

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=4.9e-47  Score=341.55  Aligned_cols=245  Identities=45%  Similarity=0.829  Sum_probs=212.0

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh------hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCe
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN------LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDE  179 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~------~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  179 (356)
                      +.++|++.+.||+|+||.||+|.++.+++.+|+|+++....      ...+.+.+|+.++++++||||+++++++.....
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   82 (283)
T 3bhy_A            3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD   82 (283)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence            34679999999999999999999999999999999875432      135778899999999999999999999999999


Q ss_pred             EEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecC--CCcEEEEee
Q psy12427        180 MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN--STNVKMIDF  257 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~--~~~vkl~Df  257 (356)
                      .++||||+++++|.+++.... .     +....+..++.|++.||+|||++|++||||||+||+++.++  ...+||+||
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~-~-----~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~df  156 (283)
T 3bhy_A           83 VVLILELVSGGELFDFLAEKE-S-----LTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDF  156 (283)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS-S-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEeecCCCcHHHHHHhcC-C-----CCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEec
Confidence            999999999999999986422 2     33344566999999999999999999999999999997654  236999999


Q ss_pred             eceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhc
Q psy12427        258 GLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK  337 (356)
Q Consensus       258 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  337 (356)
                      |++.............|++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+.+..+......++...+.
T Consensus       157 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T 3bhy_A          157 GIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFS  236 (283)
T ss_dssp             TTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred             ccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcc
Confidence            99988765554555679999999999999999999999999999999999999999999999999998888888888888


Q ss_pred             cCCHHHHHHHHHhhhcCCC
Q psy12427        338 NVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       338 ~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+++++++||++||+.||+
T Consensus       237 ~~~~~~~~li~~~l~~dp~  255 (283)
T 3bhy_A          237 NTSELAKDFIRRLLVKDPK  255 (283)
T ss_dssp             TCCHHHHHHHHTTSCSSGG
T ss_pred             cCCHHHHHHHHHHccCCHh
Confidence            9999999999999999985

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.9e-47  Score=349.24  Aligned_cols=247  Identities=23%  Similarity=0.376  Sum_probs=189.2

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh-hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN-LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      .++|++.+.||+|+||+||+|.++.+|+.||+|+++.... .....+.+|+.+|++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            3579999999999999999999999999999999976543 234667889999999999999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |++ |+|.+++...........+....+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||++.....
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~--~~kl~Dfg~~~~~~~  160 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRG--QLKLGDFGLARAFGI  160 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCSSCEETTS
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCC--CEEECcCccceecCC
Confidence            997 58988886433222222344455667999999999999999999999999999997654  799999999987653


Q ss_pred             C-CceeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC-----------
Q psy12427        266 N-EVVKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD-----------  332 (356)
Q Consensus       266 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-----------  332 (356)
                      . .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+......++           
T Consensus       161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  240 (317)
T 2pmi_A          161 PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP  240 (317)
T ss_dssp             CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCT
T ss_pred             CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhh
Confidence            2 23344578999999999976 4689999999999999999999999999998888877754221111           


Q ss_pred             -------------------hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 -------------------EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 -------------------~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                         +.....++.++++||++||+.||+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~  283 (317)
T 2pmi_A          241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPD  283 (317)
T ss_dssp             TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGG
T ss_pred             hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcc
Confidence                               111225789999999999999995

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=5e-47  Score=364.92  Aligned_cols=239  Identities=26%  Similarity=0.478  Sum_probs=210.2

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh---hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN---LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      ..++|.+.+.||+|+||.||+|+++.+|+.||+|++.....   .....+.+|+.+|+.++||||+++++++......++
T Consensus        14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l   93 (476)
T 2y94_A           14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM   93 (476)
T ss_dssp             EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            34689999999999999999999999999999999865422   234678899999999999999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ||||++||+|.+++.... .++     ...+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||++..
T Consensus        94 v~E~~~gg~L~~~l~~~~-~l~-----~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~--~vkL~DFG~a~~  165 (476)
T 2y94_A           94 VMEYVSGGELFDYICKNG-RLD-----EKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHM--NAKIADFGLSNM  165 (476)
T ss_dssp             EEECCSSEEHHHHTTSSS-SCC-----HHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTC--CEEECCCSSCEE
T ss_pred             EEeCCCCCcHHHHHHhcC-CCC-----HHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCC--CeEEEeccchhh
Confidence            999999999999986432 233     344556999999999999999999999999999997654  799999999998


Q ss_pred             eCCCCceeecCCCcCccccccccCCCC-CccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCH
Q psy12427        263 LDPNEVVKISTGTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSE  341 (356)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  341 (356)
                      ..........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+.+.++..+.+..+.    .+++
T Consensus       166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~  241 (476)
T 2y94_A          166 MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQ----YLNP  241 (476)
T ss_dssp             CCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCT----TCCH
T ss_pred             ccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCc----cCCH
Confidence            876666666789999999999998775 68999999999999999999999999999999999887766553    6899


Q ss_pred             HHHHHHHHhhhcCCC
Q psy12427        342 EGKDFIRRLLLRNKE  356 (356)
Q Consensus       342 ~~~~lI~~ll~~dP~  356 (356)
                      ++++||++||+.||+
T Consensus       242 ~~~~Li~~~L~~dP~  256 (476)
T 2y94_A          242 SVISLLKHMLQVDPM  256 (476)
T ss_dssp             HHHHHHHHHTCSSTT
T ss_pred             HHHHHHHHHcCCCch
Confidence            999999999999995

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=4.6e-47  Score=365.04  Aligned_cols=240  Identities=23%  Similarity=0.379  Sum_probs=194.4

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccC--ChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeC------
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS--HNLEKELIRKEIDIMNQLHHPKLINLHDAFEDD------  177 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------  177 (356)
                      +.++|++.+.||+|+||+||+|.++.+++.||+|++...  .......+.+|+.+|+.++||||+++++++...      
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            457899999999999999999999999999999999754  334456778999999999999999999999654      


Q ss_pred             CeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEee
Q psy12427        178 DEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDF  257 (356)
Q Consensus       178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Df  257 (356)
                      ..+++||||++++ |.+.+..   .++     ...+..++.||+.||+|||++||+||||||+|||++.++  .+||+||
T Consensus       140 ~~~~lv~E~~~~~-l~~~~~~---~l~-----~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~--~~kl~DF  208 (464)
T 3ttj_A          140 QDVYLVMELMDAN-LCQVIQM---ELD-----HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDF  208 (464)
T ss_dssp             CEEEEEEECCSEE-HHHHHTS---CCC-----HHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCC
T ss_pred             CeEEEEEeCCCCC-HHHHHhh---cCC-----HHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCC--CEEEEEE
Confidence            4679999999764 6666542   233     334556999999999999999999999999999998654  7999999


Q ss_pred             eceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhc
Q psy12427        258 GLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK  337 (356)
Q Consensus       258 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  337 (356)
                      |+|+...........+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+..+......+.++.+.
T Consensus       209 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~  288 (464)
T 3ttj_A          209 GLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  288 (464)
T ss_dssp             CCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred             EeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            99988766555566789999999999999999999999999999999999999999999988888876644333332221


Q ss_pred             c--------------------------------------CCHHHHHHHHHhhhcCCC
Q psy12427        338 N--------------------------------------VSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       338 ~--------------------------------------~s~~~~~lI~~ll~~dP~  356 (356)
                      .                                      .++++++||++||+.||+
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~  345 (464)
T 3ttj_A          289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA  345 (464)
T ss_dssp             TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTT
T ss_pred             HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChh
Confidence            1                                      157899999999999995

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=7.3e-47  Score=369.19  Aligned_cols=240  Identities=25%  Similarity=0.474  Sum_probs=206.1

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      .++|++.+.||+|+||.||+|+++.+|+.||+|++....   ......+.+|+.+|..++||||+++++++.....+++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999999999999999986532   22345678899999999999999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      |||++||+|.+++.....    ..+....+..++.||+.||+|||++||+||||||+|||++.++  ++||+|||+|...
T Consensus       263 mEy~~gg~L~~~l~~~~~----~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g--~vKL~DFGla~~~  336 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQ----AGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG--HIRISDLGLAVHV  336 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSS----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS--CEEECCCTTCEEC
T ss_pred             EEcCCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCC--CeEEEecccceec
Confidence            999999999999875431    1233445566999999999999999999999999999997554  7999999999988


Q ss_pred             CCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC----hHHHHHHhhccccccChhhhccC
Q psy12427        264 DPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN----DVETLKNVKACDWEFDEEAFKNV  339 (356)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~  339 (356)
                      .........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+    ..++...+......++    ..+
T Consensus       337 ~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p----~~~  412 (576)
T 2acx_A          337 PEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS----ERF  412 (576)
T ss_dssp             CTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC----TTS
T ss_pred             ccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC----ccC
Confidence            76666666789999999999999999999999999999999999999998764    3455555655444444    478


Q ss_pred             CHHHHHHHHHhhhcCCC
Q psy12427        340 SEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       340 s~~~~~lI~~ll~~dP~  356 (356)
                      |+++++||++||++||+
T Consensus       413 s~~~~dLI~~lL~~dP~  429 (576)
T 2acx_A          413 SPQARSLCSQLLCKDPA  429 (576)
T ss_dssp             CHHHHHHHHHHTCSSGG
T ss_pred             CHHHHHHHHHhccCCHH
Confidence            99999999999999995

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=6.4e-47  Score=346.27  Aligned_cols=247  Identities=29%  Similarity=0.569  Sum_probs=205.5

Q ss_pred             CCcccceeee-ccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEE
Q psy12427        104 SSVYDHYDIL-EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMV  181 (356)
Q Consensus       104 ~~~~~~y~~~-~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~  181 (356)
                      +.+.+.|++. +.||+|+||+||+|.++.+++.||+|++..........+.+|+.+|.++ +||||+++++++...+..+
T Consensus         8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~   87 (316)
T 2ac3_A            8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY   87 (316)
T ss_dssp             CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence            3456789995 7899999999999999999999999999876655677888999999995 7999999999999999999


Q ss_pred             EEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCC-CcEEEEeeece
Q psy12427        182 LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNS-TNVKMIDFGLA  260 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~-~~vkl~Dfg~a  260 (356)
                      +||||+++++|.+++.... .     +....+..++.||+.||+|||++||+||||||+|||++.++. ..+||+|||++
T Consensus        88 lv~e~~~~~~L~~~l~~~~-~-----~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~  161 (316)
T 2ac3_A           88 LVFEKMRGGSILSHIHKRR-H-----FNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLG  161 (316)
T ss_dssp             EEEECCTTCBHHHHHHHHS-S-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred             EEEEcCCCCcHHHHHhccC-C-----CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence            9999999999999986532 2     333445569999999999999999999999999999986543 34999999998


Q ss_pred             eeeCCCC--------ceeecCCCcCccccccccC-----CCCCccccHHHHHHHHHHHHcCCCCCCCCC-----------
Q psy12427        261 TKLDPNE--------VVKISTGTAEFAAPEIVER-----EPVGFYTDMWAVGVLAYVLLSGLSPFAGEN-----------  316 (356)
Q Consensus       261 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~ell~g~~Pf~~~~-----------  316 (356)
                      .......        ......||+.|+|||++..     ..++.++|||||||++|+|++|+.||.+.+           
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~  241 (316)
T 2ac3_A          162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA  241 (316)
T ss_dssp             C-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----C
T ss_pred             cccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccccc
Confidence            7653211        1123458999999999975     568899999999999999999999998765           


Q ss_pred             ----hHHHHHHhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        317 ----DVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       317 ----~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                          .......+......++...+..+|.++++||++||+.||+
T Consensus       242 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  285 (316)
T 2ac3_A          242 CPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAK  285 (316)
T ss_dssp             CHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTT
T ss_pred             chhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChh
Confidence                2456777788888888887888999999999999999995

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.6e-46  Score=341.09  Aligned_cols=239  Identities=27%  Similarity=0.531  Sum_probs=198.7

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh--------------------------hHHHHHHHHHHHH
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL--------------------------EKELIRKEIDIMN  160 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~--------------------------~~~~~~~E~~il~  160 (356)
                      .++|++.+.||+|+||.||+|.++.+++.||+|++......                          ..+.+.+|+.+|+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            46899999999999999999999999999999998654321                          1245788999999


Q ss_pred             hcCCCCceeeeeeEEe--CCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCC
Q psy12427        161 QLHHPKLINLHDAFED--DDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVK  238 (356)
Q Consensus       161 ~l~hpnIv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlk  238 (356)
                      +++||||+++++++..  ....++||||+++++|.+++..       ..+....+..++.||+.||+|||++||+|||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk  164 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-------KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIK  164 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence            9999999999999986  6789999999999999876532       123344556699999999999999999999999


Q ss_pred             CCCEEEeecCCCcEEEEeeeceeeeCCCCc-eeecCCCcCccccccccCCC---CCccccHHHHHHHHHHHHcCCCCCCC
Q psy12427        239 PENIMCQTRNSTNVKMIDFGLATKLDPNEV-VKISTGTAEFAAPEIVEREP---VGFYTDMWAVGVLAYVLLSGLSPFAG  314 (356)
Q Consensus       239 p~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlG~il~ell~g~~Pf~~  314 (356)
                      |+|||++.++  .+||+|||++........ .....||+.|+|||++.+..   ++.++|||||||++|+|++|..||.+
T Consensus       165 p~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          165 PSNLLVGEDG--HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             GGGEEECTTS--CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             HHHEEECCCC--CEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            9999997654  799999999988754332 34457999999999998765   37789999999999999999999999


Q ss_pred             CChHHHHHHhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        315 ENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       315 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+.......+......++.  ...+++++++||.+||+.||+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~  282 (298)
T 2zv2_A          243 ERIMCLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPE  282 (298)
T ss_dssp             SSHHHHHHHHHHCCCCCCS--SSCCCHHHHHHHHHHTCSCTT
T ss_pred             ccHHHHHHHHhcccCCCCC--ccccCHHHHHHHHHHhhcChh
Confidence            9888888877776655543  247999999999999999995

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.4e-47  Score=367.48  Aligned_cols=239  Identities=26%  Similarity=0.463  Sum_probs=198.5

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccC---ChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS---HNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      ..++|++.+.||+|+||.||+|.++.+|+.||+|++...   .......+.+|+.+|+.++||||+++++++...+.+++
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            347899999999999999999999999999999998753   22334566789999999999999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEeecCCCcEEEEeeecee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE-KNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT  261 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~  261 (356)
                      ||||+++|+|.+++.... .     +....+..++.||+.||+|||+ .||+||||||+|||++.++  .+||+|||+|+
T Consensus       226 v~e~~~~~~L~~~l~~~~-~-----~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~--~~kl~DFG~a~  297 (446)
T 4ejn_A          226 VMEYANGGELFFHLSRER-V-----FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG--HIKITDFGLCK  297 (446)
T ss_dssp             EECCCSSCBHHHHHHHHS-C-----CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSS--CEEECCCCCCC
T ss_pred             EEeeCCCCcHHHHHHhcC-C-----CCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCC--CEEEccCCCce
Confidence            999999999998886432 2     3334455699999999999998 9999999999999998654  79999999997


Q ss_pred             eeCC-CCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCC
Q psy12427        262 KLDP-NEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVS  340 (356)
Q Consensus       262 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  340 (356)
                      .... .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+......+|.    .++
T Consensus       298 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~  373 (446)
T 4ejn_A          298 EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLG  373 (446)
T ss_dssp             TTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSC
T ss_pred             eccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCC
Confidence            6432 23334567999999999999999999999999999999999999999999999999998887777664    789


Q ss_pred             HHHHHHHHHhhhcCCC
Q psy12427        341 EEGKDFIRRLLLRNKE  356 (356)
Q Consensus       341 ~~~~~lI~~ll~~dP~  356 (356)
                      +++++||++||++||+
T Consensus       374 ~~~~~li~~~L~~dP~  389 (446)
T 4ejn_A          374 PEAKSLLSGLLKKDPK  389 (446)
T ss_dssp             HHHHHHHHHHTCSSTT
T ss_pred             HHHHHHHHHHcccCHH
Confidence            9999999999999995

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=5.6e-47  Score=345.03  Aligned_cols=245  Identities=31%  Similarity=0.614  Sum_probs=211.0

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      .+.++|.+.+.||+|+||+||+|+++.+|+.||+|++..........+.+|+.++++++||||+++++++......++||
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (304)
T 2jam_A            6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM   85 (304)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence            45678999999999999999999999999999999998765555567889999999999999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEee-cCCCcEEEEeeeceeee
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQT-RNSTNVKMIDFGLATKL  263 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~-~~~~~vkl~Dfg~a~~~  263 (356)
                      ||+++++|.+++.... .     +....+..++.|++.||+|||+.||+||||||+|||+.. ++++.+||+|||++...
T Consensus        86 e~~~~~~L~~~l~~~~-~-----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~  159 (304)
T 2jam_A           86 QLVSGGELFDRILERG-V-----YTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME  159 (304)
T ss_dssp             CCCCSCBHHHHHHHHS-C-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred             EcCCCccHHHHHHHcC-C-----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence            9999999999886432 2     333445569999999999999999999999999999942 23457999999998764


Q ss_pred             CCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHH
Q psy12427        264 DPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG  343 (356)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  343 (356)
                      ... ......|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+......++.+.+..+|+++
T Consensus       160 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  238 (304)
T 2jam_A          160 QNG-IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESA  238 (304)
T ss_dssp             CCB-TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHH
T ss_pred             CCC-ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHH
Confidence            332 2233468999999999999999999999999999999999999999999999999998888888877778999999


Q ss_pred             HHHHHHhhhcCCC
Q psy12427        344 KDFIRRLLLRNKE  356 (356)
Q Consensus       344 ~~lI~~ll~~dP~  356 (356)
                      ++||.+||+.||+
T Consensus       239 ~~li~~~l~~dp~  251 (304)
T 2jam_A          239 KDFICHLLEKDPN  251 (304)
T ss_dssp             HHHHHHHHCSSTT
T ss_pred             HHHHHHHcCCChh
Confidence            9999999999995

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=8.7e-47  Score=367.56  Aligned_cols=243  Identities=27%  Similarity=0.445  Sum_probs=206.8

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh---hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN---LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      ..++|.+.+.||+|+||.||+|+++.+|+.||+|++.....   .....+.+|+.+|++++||||+++++++.....+++
T Consensus       183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  262 (543)
T 3c4z_A          183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL  262 (543)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence            34789999999999999999999999999999999865432   234667889999999999999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ||||++||+|.+++.....  ....+....+..++.||+.||+|||++||+||||||+|||++.++  ++||+|||+++.
T Consensus       263 VmE~~~gg~L~~~l~~~~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g--~vkL~DFGla~~  338 (543)
T 3c4z_A          263 VMTIMNGGDIRYHIYNVDE--DNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDG--NVRISDLGLAVE  338 (543)
T ss_dssp             EECCCTTCBHHHHHHTSST--TSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS--CEEECCCTTCEE
T ss_pred             EEEeccCCCHHHHHHHhhc--ccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCC--CEEEeecceeee
Confidence            9999999999999875321  122344445566999999999999999999999999999998654  799999999988


Q ss_pred             eCCCCc-eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC----ChHHHHHHhhccccccChhhhc
Q psy12427        263 LDPNEV-VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGE----NDVETLKNVKACDWEFDEEAFK  337 (356)
Q Consensus       263 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~----~~~~~~~~i~~~~~~~~~~~~~  337 (356)
                      ...... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.    ...++...+......+|    .
T Consensus       339 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p----~  414 (543)
T 3c4z_A          339 LKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP----D  414 (543)
T ss_dssp             CCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC----T
T ss_pred             ccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC----c
Confidence            765433 23458999999999999999999999999999999999999999876    34667777776665555    3


Q ss_pred             cCCHHHHHHHHHhhhcCCC
Q psy12427        338 NVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       338 ~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+|.++++||++||++||+
T Consensus       415 ~~s~~~~~li~~lL~~dP~  433 (543)
T 3c4z_A          415 KFSPASKDFCEALLQKDPE  433 (543)
T ss_dssp             TSCHHHHHHHHHHSCSSGG
T ss_pred             ccCHHHHHHHHHhccCCHh
Confidence            7899999999999999995

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=7.1e-47  Score=378.77  Aligned_cols=238  Identities=25%  Similarity=0.475  Sum_probs=209.3

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l  182 (356)
                      .++|++++.||+|+||.||+|+++.+++.||+|+++...   ....+.+..|..+|..+ +||+|+++++++.....+++
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            468999999999999999999999999999999987532   22345677899999988 79999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ||||++||+|.+++.... .++     ...+..++.||+.||+|||++||+||||||+|||++.++  ++||+|||+|+.
T Consensus       420 V~E~~~gg~L~~~l~~~~-~~~-----~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g--~ikL~DFGla~~  491 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQVG-RFK-----EPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKE  491 (674)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCC-----HHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSS--CEEECCCTTCEE
T ss_pred             EEeCcCCCcHHHHHHhcC-CCC-----HHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCC--cEEEeecceeec
Confidence            999999999999987532 233     344556999999999999999999999999999998655  799999999986


Q ss_pred             eC-CCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCH
Q psy12427        263 LD-PNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSE  341 (356)
Q Consensus       263 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  341 (356)
                      .. ........+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+++..|......+|.    .+|+
T Consensus       492 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~  567 (674)
T 3pfq_A          492 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSK  567 (674)
T ss_dssp             CCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCT----TSCH
T ss_pred             cccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCH
Confidence            43 333445568999999999999999999999999999999999999999999999999999998877774    7899


Q ss_pred             HHHHHHHHhhhcCCC
Q psy12427        342 EGKDFIRRLLLRNKE  356 (356)
Q Consensus       342 ~~~~lI~~ll~~dP~  356 (356)
                      ++++||++||++||+
T Consensus       568 ~~~~li~~lL~~dP~  582 (674)
T 3pfq_A          568 EAVAICKGLMTKHPG  582 (674)
T ss_dssp             HHHHHHHHHSCSSST
T ss_pred             HHHHHHHHHccCCHH
Confidence            999999999999995

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=8.8e-47  Score=346.93  Aligned_cols=241  Identities=27%  Similarity=0.470  Sum_probs=196.8

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh-hHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL-EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      +.++|++.+.||+|+||+||+|+++.+++.||+|++...... ..+.+.+|+.+++.++||||+++++++......++||
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   84 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            457899999999999999999999999999999998755432 3456789999999999999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      ||+++|+|.+++.... .     +....+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||++..+.
T Consensus        85 e~~~~~~L~~~l~~~~-~-----~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~  156 (323)
T 3tki_A           85 EYCSGGELFDRIEPDI-G-----MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFR  156 (323)
T ss_dssp             ECCTTEEGGGGSBTTT-B-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCTTCEECE
T ss_pred             EcCCCCcHHHHHhhcC-C-----CCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCC--CEEEEEeeccceec
Confidence            9999999999886432 2     33344566999999999999999999999999999997654  79999999998764


Q ss_pred             CCC---ceeecCCCcCccccccccCCCC-CccccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHhhccccccChhhhccC
Q psy12427        265 PNE---VVKISTGTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDV-ETLKNVKACDWEFDEEAFKNV  339 (356)
Q Consensus       265 ~~~---~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~ell~g~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~  339 (356)
                      ...   ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.. .............  ..+..+
T Consensus       157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~  234 (323)
T 3tki_A          157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL--NPWKKI  234 (323)
T ss_dssp             ETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTS--TTGGGS
T ss_pred             cCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccC--CccccC
Confidence            222   2234578999999999988775 77899999999999999999999876553 2233333322222  224689


Q ss_pred             CHHHHHHHHHhhhcCCC
Q psy12427        340 SEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       340 s~~~~~lI~~ll~~dP~  356 (356)
                      ++++.+||++||+.||+
T Consensus       235 ~~~~~~li~~~L~~dP~  251 (323)
T 3tki_A          235 DSAPLALLHKILVENPS  251 (323)
T ss_dssp             CHHHHHHHHHHSCSSTT
T ss_pred             CHHHHHHHHHHccCChh
Confidence            99999999999999995

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.5e-46  Score=340.19  Aligned_cols=241  Identities=24%  Similarity=0.428  Sum_probs=196.8

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh--hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN--LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      ++|++.+.||+|+||+||+|.++.+++.||+|++.....  .....+.+|+.++++++||||+++++++..+...++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            579999999999999999999999999999999975542  234677899999999999999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |+.+ +|.+.+......+++     ..+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||++.....
T Consensus        82 ~~~~-~l~~~~~~~~~~l~~-----~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~--~~kl~Dfg~~~~~~~  153 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNGDLDP-----EIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG--ELKLANFGLARAFGI  153 (292)
T ss_dssp             CCSE-EHHHHHHHTTTCCCH-----HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECCS
T ss_pred             cCCC-CHHHHHHhCCCCCCH-----HHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEeecccceecCC
Confidence            9976 555555443333433     34556999999999999999999999999999998654  799999999987653


Q ss_pred             C-CceeecCCCcCccccccccCCC-CCccccHHHHHHHHHHHHcCCCC-CCCCChHHHHHHhhccccccChh--------
Q psy12427        266 N-EVVKISTGTAEFAAPEIVEREP-VGFYTDMWAVGVLAYVLLSGLSP-FAGENDVETLKNVKACDWEFDEE--------  334 (356)
Q Consensus       266 ~-~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~ell~g~~P-f~~~~~~~~~~~i~~~~~~~~~~--------  334 (356)
                      . .......||+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+..+.+..+......++..        
T Consensus       154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  233 (292)
T 3o0g_A          154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             ccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccc
Confidence            2 2334457899999999998766 79999999999999999987666 67777777777765432222211        


Q ss_pred             -----------------hhccCCHHHHHHHHHhhhcCCC
Q psy12427        335 -----------------AFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       335 -----------------~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                       ....+++++++||++||+.||+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  272 (292)
T 3o0g_A          234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPV  272 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGG
T ss_pred             ccccccccccCCcchhhcccccChHHHHHHHHHhccChh
Confidence                             1235789999999999999995

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.2e-46  Score=346.40  Aligned_cols=242  Identities=19%  Similarity=0.290  Sum_probs=202.8

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCC---EEEEEEcccC-ChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeE
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGN---IFAAKFIPVS-HNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM  180 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~---~~a~K~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  180 (356)
                      ...++|++.+.||+|+||+||+|.++.++.   .||+|+++.. .......+.+|+.+|++++||||+++++++...+..
T Consensus        46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  125 (325)
T 3kul_A           46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA  125 (325)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred             cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence            345789999999999999999999986655   5999999765 344567788999999999999999999999999999


Q ss_pred             EEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeece
Q psy12427        181 VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA  260 (356)
Q Consensus       181 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a  260 (356)
                      ++||||+++|+|.+++......+++     ..+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||++
T Consensus       126 ~lv~e~~~~~~L~~~l~~~~~~~~~-----~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~a  198 (325)
T 3kul_A          126 MIVTEYMENGSLDTFLRTHDGQFTI-----MQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL--VCKVSDFGLS  198 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCSCH-----HHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCSSC
T ss_pred             EEEeeCCCCCcHHHHHHhcccCCCH-----HHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCC--CEEECCCCcc
Confidence            9999999999999999765444443     34455999999999999999999999999999997544  7999999999


Q ss_pred             eeeCCCCce----eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhh
Q psy12427        261 TKLDPNEVV----KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEA  335 (356)
Q Consensus       261 ~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  335 (356)
                      +........    ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+.......   .
T Consensus       199 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---~  275 (325)
T 3kul_A          199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP---A  275 (325)
T ss_dssp             EECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC---C
T ss_pred             cccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC---C
Confidence            877533211    12235788999999999999999999999999999999 999999999999888887653222   2


Q ss_pred             hccCCHHHHHHHHHhhhcCCC
Q psy12427        336 FKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       336 ~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ...+|+++.+||.+||+.||+
T Consensus       276 ~~~~~~~l~~li~~~l~~dp~  296 (325)
T 3kul_A          276 PMGCPHALHQLMLDCWHKDRA  296 (325)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGG
T ss_pred             CCCcCHHHHHHHHHHccCChh
Confidence            247899999999999999985

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.3e-46  Score=350.42  Aligned_cols=246  Identities=22%  Similarity=0.319  Sum_probs=204.8

Q ss_pred             cccceeeeccccccCceEEEEEEEcc-------CCCEEEEEEcccCC-hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEe
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERK-------TGNIFAAKFIPVSH-NLEKELIRKEIDIMNQL-HHPKLINLHDAFED  176 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~-------~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~  176 (356)
                      ..++|++.+.||+|+||.||+|++..       ++..||+|+++... ......+.+|+.+|+.+ +||||+++++++..
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  158 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  158 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence            45789999999999999999999752       35679999997653 33456788999999999 89999999999999


Q ss_pred             CCeEEEEEEeccccchhhhhhCCCC----------CCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEee
Q psy12427        177 DDEMVLIFEFLSGGELFERITAPDY----------KMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQT  246 (356)
Q Consensus       177 ~~~~~lv~e~~~~g~L~~~l~~~~~----------~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~  246 (356)
                      .+.+++||||+++|+|.+++.....          ...+..+....+..++.||+.||+|||++||+||||||+|||++.
T Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~  238 (370)
T 2psq_A          159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE  238 (370)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT
T ss_pred             CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECC
Confidence            9999999999999999999975432          122334455556779999999999999999999999999999976


Q ss_pred             cCCCcEEEEeeeceeeeCCCCc---eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q psy12427        247 RNSTNVKMIDFGLATKLDPNEV---VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLK  322 (356)
Q Consensus       247 ~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~  322 (356)
                      ++  .+||+|||+++.......   .....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....+...
T Consensus       239 ~~--~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~  316 (370)
T 2psq_A          239 NN--VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK  316 (370)
T ss_dssp             TC--CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred             CC--CEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            54  799999999987654322   122346889999999999999999999999999999999 999999998888887


Q ss_pred             HhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        323 NVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       323 ~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+......   .....++.++.+||++||+.||+
T Consensus       317 ~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~  347 (370)
T 2psq_A          317 LLKEGHRM---DKPANCTNELYMMMRDCWHAVPS  347 (370)
T ss_dssp             HHHTTCCC---CCCTTSCHHHHHHHHHHTCSSGG
T ss_pred             HHhcCCCC---CCCCCCCHHHHHHHHHHcCCChh
Confidence            77665422   22247899999999999999985

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.2e-46  Score=340.22  Aligned_cols=240  Identities=25%  Similarity=0.434  Sum_probs=194.9

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh--hHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL--EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      ++|++.+.||+|+||+||+|++ .+|+.+|+|.+......  ....+.+|+.++++++||||+++++++...+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence            5799999999999999999998 67899999998765432  23667899999999999999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |+.+ +|.+++......+++     ..+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||++.....
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~-----~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~  152 (288)
T 1ob3_A           81 HLDQ-DLKKLLDVCEGGLES-----VTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG--ELKIADFGLARAFGI  152 (288)
T ss_dssp             CCSE-EHHHHHHTSTTCCCH-----HHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--CEEECCTTHHHHHCC
T ss_pred             ecCC-CHHHHHHhcccCCCH-----HHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC--CEEEeECccccccCc
Confidence            9975 898888754433333     34456999999999999999999999999999997654  799999999987643


Q ss_pred             C-CceeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC-----------
Q psy12427        266 N-EVVKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD-----------  332 (356)
Q Consensus       266 ~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-----------  332 (356)
                      . .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.......+           
T Consensus       153 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T 1ob3_A          153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP  232 (288)
T ss_dssp             ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             cccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccc
Confidence            2 223345689999999999764 589999999999999999999999999988887776644211110           


Q ss_pred             --------------hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 --------------EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 --------------~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                    ......+++++++||++||+.||+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  270 (288)
T 1ob3_A          233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPN  270 (288)
T ss_dssp             TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTT
T ss_pred             ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcc
Confidence                          122346899999999999999995

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=5.5e-47  Score=346.03  Aligned_cols=242  Identities=19%  Similarity=0.258  Sum_probs=197.8

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      .++|.+.+.||+|+||+||+|.++.++..+|+|.+..........+.+|+.+|++++||||+++++++......++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            36899999999999999999999999999999998777777778899999999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +++|+|.+++......+++.     .+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||++......
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~-----~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~  161 (310)
T 3s95_A           89 IKGGTLRGIIKSMDSQYPWS-----QRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENK--NVVVADFGLARLMVDE  161 (310)
T ss_dssp             CTTCBHHHHHHHCCTTSCHH-----HHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTS--CEEECCCTTCEECC--
T ss_pred             cCCCcHHHHHHhccCCCCHH-----HHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCC--CEEEeecccceecccc
Confidence            99999999997644444443     4455999999999999999999999999999997554  7999999999876433


Q ss_pred             Ccee---------------ecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc
Q psy12427        267 EVVK---------------ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEF  331 (356)
Q Consensus       267 ~~~~---------------~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~  331 (356)
                      ....               ...||+.|+|||++.+..++.++|||||||++|+|++|..||.............. ....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~-~~~~  240 (310)
T 3s95_A          162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV-RGFL  240 (310)
T ss_dssp             ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH-HHHH
T ss_pred             cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh-hccc
Confidence            2211               34689999999999999999999999999999999999999976532211000000 0001


Q ss_pred             ChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        332 DEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       332 ~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .......+|+++.++|.+||+.||+
T Consensus       241 ~~~~~~~~~~~l~~li~~~l~~dP~  265 (310)
T 3s95_A          241 DRYCPPNCPPSFFPITVRCCDLDPE  265 (310)
T ss_dssp             HHTCCTTCCTTHHHHHHHHTCSSGG
T ss_pred             cccCCCCCCHHHHHHHHHHccCChh
Confidence            1112347899999999999999995

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.9e-46  Score=343.97  Aligned_cols=247  Identities=35%  Similarity=0.646  Sum_probs=210.5

Q ss_pred             cccceeee-ccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCeEE
Q psy12427        106 VYDHYDIL-EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLH-HPKLINLHDAFEDDDEMV  181 (356)
Q Consensus       106 ~~~~y~~~-~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~  181 (356)
                      +.++|.+. +.||+|+||.||+|.++.+++.||+|++....  ......+.+|+.++..+. ||||+++++++......+
T Consensus        26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~  105 (327)
T 3lm5_A           26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII  105 (327)
T ss_dssp             HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence            45678887 89999999999999999999999999987543  233577889999999995 699999999999999999


Q ss_pred             EEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecC-CCcEEEEeeece
Q psy12427        182 LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN-STNVKMIDFGLA  260 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~-~~~vkl~Dfg~a  260 (356)
                      +||||+.+|+|.+++....    ...+....+..++.|++.||+|||++||+||||||+|||++... .+.+||+|||++
T Consensus       106 lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a  181 (327)
T 3lm5_A          106 LILEYAAGGEIFSLCLPEL----AEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS  181 (327)
T ss_dssp             EEEECCTTEEGGGGGSSCC-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGC
T ss_pred             EEEEecCCCcHHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccc
Confidence            9999999999999885432    12233445566999999999999999999999999999997622 347999999999


Q ss_pred             eeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCC
Q psy12427        261 TKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVS  340 (356)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  340 (356)
                      .............||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......++.+.+..++
T Consensus       182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  261 (327)
T 3lm5_A          182 RKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVS  261 (327)
T ss_dssp             EEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred             cccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccC
Confidence            98765555555679999999999999999999999999999999999999999999999999998888888888888999


Q ss_pred             HHHHHHHHHhhhcCCC
Q psy12427        341 EEGKDFIRRLLLRNKE  356 (356)
Q Consensus       341 ~~~~~lI~~ll~~dP~  356 (356)
                      +++++||++||+.||+
T Consensus       262 ~~~~~li~~~L~~dP~  277 (327)
T 3lm5_A          262 QLATDFIQSLLVKNPE  277 (327)
T ss_dssp             HHHHHHHHHHSCSSGG
T ss_pred             HHHHHHHHHHcCCChh
Confidence            9999999999999985

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=5.4e-46  Score=341.38  Aligned_cols=238  Identities=24%  Similarity=0.468  Sum_probs=205.7

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEecc
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLS  188 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  188 (356)
                      .|...+.||+|+||.||+|+++.+|+.||+|++........+.+.+|+.+|+.++||||+++++++......++||||++
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  125 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ  125 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence            47788899999999999999999999999999987766667788899999999999999999999999999999999999


Q ss_pred             ccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCC-
Q psy12427        189 GGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE-  267 (356)
Q Consensus       189 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~-  267 (356)
                      +++|.+++...  .+     ....+..++.|++.||+|||+.||+||||||+|||++.++  .+||+|||++....... 
T Consensus       126 ~~~L~~~l~~~--~l-----~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~~~~~~~~~~  196 (321)
T 2c30_A          126 GGALTDIVSQV--RL-----NEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDG--RVKLSDFGFCAQISKDVP  196 (321)
T ss_dssp             SCBHHHHHTTC--CC-----CHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCCTTCEECCSSSC
T ss_pred             CCCHHHHHHhc--CC-----CHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC--cEEEeeeeeeeecccCcc
Confidence            99999988643  23     3344556999999999999999999999999999997654  79999999998775432 


Q ss_pred             ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHH
Q psy12427        268 VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFI  347 (356)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI  347 (356)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+........ .....+|+++++||
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li  275 (321)
T 2c30_A          197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL-KNSHKVSPVLRDFL  275 (321)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC-TTGGGSCHHHHHHH
T ss_pred             ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCc-CccccCCHHHHHHH
Confidence            23445799999999999999999999999999999999999999999988888877766443221 22347899999999


Q ss_pred             HHhhhcCCC
Q psy12427        348 RRLLLRNKE  356 (356)
Q Consensus       348 ~~ll~~dP~  356 (356)
                      .+||+.||+
T Consensus       276 ~~~l~~dp~  284 (321)
T 2c30_A          276 ERMLVRDPQ  284 (321)
T ss_dssp             HHHSCSSTT
T ss_pred             HHHccCChh
Confidence            999999995

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.1e-46  Score=352.92  Aligned_cols=241  Identities=27%  Similarity=0.459  Sum_probs=189.3

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccC--ChhhHHHHHHHHHHHHhcC-CCCceeeeeeEEeCC--eE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS--HNLEKELIRKEIDIMNQLH-HPKLINLHDAFEDDD--EM  180 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~--~~  180 (356)
                      +.++|++.+.||+|+||.||+|.++.+|+.||+|++...  .......+.+|+.+|..+. ||||+++++++...+  .+
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            456899999999999999999999999999999998543  3445566778999999997 999999999997544  78


Q ss_pred             EEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeece
Q psy12427        181 VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA  260 (356)
Q Consensus       181 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a  260 (356)
                      ++||||+. ++|.+++...  .     +....+..++.||+.||+|||+.||+||||||+|||++.++  .+||+|||+|
T Consensus        87 ~lv~e~~~-~~L~~~~~~~--~-----~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~--~~kl~DFG~a  156 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRAN--I-----LEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAEC--HVKVADFGLS  156 (388)
T ss_dssp             EEEEECCS-EEHHHHHHHT--C-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTC
T ss_pred             EEEecccC-cCHHHHHHcC--C-----CCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCC--CEEecCCccc
Confidence            99999997 5898888642  2     23334455899999999999999999999999999997654  7999999999


Q ss_pred             eeeCC----------------------CCceeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCCh
Q psy12427        261 TKLDP----------------------NEVVKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGEND  317 (356)
Q Consensus       261 ~~~~~----------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~  317 (356)
                      +.+..                      .......+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  236 (388)
T 3oz6_A          157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST  236 (388)
T ss_dssp             EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            87532                      111233478999999999976 6789999999999999999999999999999


Q ss_pred             HHHHHHhhccccccChhh-------------------------------------------hccCCHHHHHHHHHhhhcC
Q psy12427        318 VETLKNVKACDWEFDEEA-------------------------------------------FKNVSEEGKDFIRRLLLRN  354 (356)
Q Consensus       318 ~~~~~~i~~~~~~~~~~~-------------------------------------------~~~~s~~~~~lI~~ll~~d  354 (356)
                      .+.+..+......++.+.                                           ...+++++++||++||+.|
T Consensus       237 ~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d  316 (388)
T 3oz6_A          237 MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN  316 (388)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred             HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccC
Confidence            888888764322222111                                           1267999999999999999


Q ss_pred             CC
Q psy12427        355 KE  356 (356)
Q Consensus       355 P~  356 (356)
                      |+
T Consensus       317 P~  318 (388)
T 3oz6_A          317 PN  318 (388)
T ss_dssp             GG
T ss_pred             cc
Confidence            95

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.5e-46  Score=349.62  Aligned_cols=243  Identities=34%  Similarity=0.599  Sum_probs=213.2

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh--------hhHHHHHHHHHHHHhc-CCCCceeeeeeEEe
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN--------LEKELIRKEIDIMNQL-HHPKLINLHDAFED  176 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~--------~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~  176 (356)
                      +.++|++.+.||.|+||.||+|.++.+|+.||+|++.....        ...+.+.+|+.+++++ +||||+++++++..
T Consensus        92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  171 (365)
T 2y7j_A           92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES  171 (365)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred             hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence            44679999999999999999999999999999999875431        1135677899999999 79999999999999


Q ss_pred             CCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEe
Q psy12427        177 DDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMID  256 (356)
Q Consensus       177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~D  256 (356)
                      ....++||||++|++|.+++....      .+....+..++.||+.||.|||+.||+|+||||+|||++.++  .+||+|
T Consensus       172 ~~~~~lv~e~~~g~~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~--~ikl~D  243 (365)
T 2y7j_A          172 SSFMFLVFDLMRKGELFDYLTEKV------ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNM--QIRLSD  243 (365)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECC
T ss_pred             CCEEEEEEEeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC--CEEEEe
Confidence            999999999999999999986422      233344566999999999999999999999999999997654  799999


Q ss_pred             eeceeeeCCCCceeecCCCcCccccccccC------CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc
Q psy12427        257 FGLATKLDPNEVVKISTGTAEFAAPEIVER------EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWE  330 (356)
Q Consensus       257 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~  330 (356)
                      ||++.............||+.|+|||++.+      ..++.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus       244 fG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  323 (365)
T 2y7j_A          244 FGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQ  323 (365)
T ss_dssp             CTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred             cCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC
Confidence            999998876665666789999999999863      35888999999999999999999999999999999999888888


Q ss_pred             cChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        331 FDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       331 ~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ++.+.+..+|.++.+||++||+.||+
T Consensus       324 ~~~~~~~~~~~~~~~li~~~L~~dP~  349 (365)
T 2y7j_A          324 FSSPEWDDRSSTVKDLISRLLQVDPE  349 (365)
T ss_dssp             CCHHHHSSSCHHHHHHHHHHSCSSTT
T ss_pred             CCCcccccCCHHHHHHHHHHcCCChh
Confidence            88888889999999999999999995

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.5e-46  Score=339.22  Aligned_cols=250  Identities=31%  Similarity=0.548  Sum_probs=203.6

Q ss_pred             CCCcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEE
Q psy12427        103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMV  181 (356)
Q Consensus       103 ~~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  181 (356)
                      .+.+.++|.+.+.||+|+||+||+|.++.++..+|+|++.... ....+.+.+|+++|++++||||+++++++......+
T Consensus        17 ~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   96 (285)
T 3is5_A           17 QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMY   96 (285)
T ss_dssp             SSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             CCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEE
Confidence            5567789999999999999999999999999999999987643 334677889999999999999999999999999999


Q ss_pred             EEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeec-CCCcEEEEeeece
Q psy12427        182 LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTR-NSTNVKMIDFGLA  260 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~-~~~~vkl~Dfg~a  260 (356)
                      +||||+++|+|.+++.....  ....+....+..++.|++.||+|||++||+||||||+|||++.+ ..+.+||+|||++
T Consensus        97 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a  174 (285)
T 3is5_A           97 IVMETCEGGELLERIVSAQA--RGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA  174 (285)
T ss_dssp             EEECCCSCCBHHHHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred             EEEEeCCCCcHHHHHHhhhh--cccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence            99999999999988853210  01123334455699999999999999999999999999999653 2357999999999


Q ss_pred             eeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCC
Q psy12427        261 TKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVS  340 (356)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  340 (356)
                      .............||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+..+....+......++.. ...++
T Consensus       175 ~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~  252 (285)
T 3is5_A          175 ELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE-CRPLT  252 (285)
T ss_dssp             CC----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC---CCCC
T ss_pred             eecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccc-cCcCC
Confidence            8776555555667999999999986 468899999999999999999999999999888877776655544432 23589


Q ss_pred             HHHHHHHHHhhhcCCC
Q psy12427        341 EEGKDFIRRLLLRNKE  356 (356)
Q Consensus       341 ~~~~~lI~~ll~~dP~  356 (356)
                      +++.+||++||+.||+
T Consensus       253 ~~~~~li~~~L~~dP~  268 (285)
T 3is5_A          253 PQAVDLLKQMLTKDPE  268 (285)
T ss_dssp             HHHHHHHHHHTCSCTT
T ss_pred             HHHHHHHHHHccCChh
Confidence            9999999999999995

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.8e-46  Score=342.28  Aligned_cols=244  Identities=25%  Similarity=0.392  Sum_probs=199.8

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh-----hhHHHHHHHHHHHHhcC---CCCceeeeeeEEeC
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN-----LEKELIRKEIDIMNQLH---HPKLINLHDAFEDD  177 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~-----~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~  177 (356)
                      ..++|++.+.||+|+||+||+|+++.+++.||+|++.....     .....+.+|+.+++.++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            35689999999999999999999999999999999874321     11245567888777764   99999999999876


Q ss_pred             C-----eEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcE
Q psy12427        178 D-----EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNV  252 (356)
Q Consensus       178 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~v  252 (356)
                      .     ..+++|||+. ++|.+++......    .+....+..++.|++.||+|||++||+||||||+|||++.++  .+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~--~~  159 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPP----GLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG--TV  159 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTT----CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTS--CE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC--CE
Confidence            5     5899999996 5999998754321    234445566999999999999999999999999999997654  79


Q ss_pred             EEEeeeceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC
Q psy12427        253 KMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD  332 (356)
Q Consensus       253 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~  332 (356)
                      ||+|||+++............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+.++......++
T Consensus       160 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  239 (308)
T 3g33_A          160 KLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP  239 (308)
T ss_dssp             EECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             EEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99999999877655555556799999999999999999999999999999999999999999999888888765322222


Q ss_pred             h-----------------------hhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 E-----------------------EAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 ~-----------------------~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .                       .....+++++.+||.+||+.||+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  286 (308)
T 3g33_A          240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPH  286 (308)
T ss_dssp             TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTT
T ss_pred             hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCc
Confidence            1                       22346899999999999999995

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2e-46  Score=345.39  Aligned_cols=242  Identities=22%  Similarity=0.242  Sum_probs=200.3

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEEEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      +.++|++.+.||+|+||+||+|.+..+++.||+|++.....  ...+.+|+.+++++ +||||+++++++......++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~   84 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL   84 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence            34689999999999999999999999999999999875533  23577899999999 9999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCC---CcEEEEeeecee
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNS---TNVKMIDFGLAT  261 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~---~~vkl~Dfg~a~  261 (356)
                      ||+ +++|.+++......+++     ..+..++.|++.||+|||+.||+||||||+|||++.++.   ..+||+|||+++
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~-----~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~  158 (330)
T 2izr_A           85 ELL-GPSLEDLFDLCDRTFSL-----KTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK  158 (330)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCH-----HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred             EeC-CCCHHHHHHHcCCCCCH-----HHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence            999 99999998754333443     445559999999999999999999999999999986542   129999999998


Q ss_pred             eeCCCCc--------eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC---ChHHHHHHhhccccc
Q psy12427        262 KLDPNEV--------VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGE---NDVETLKNVKACDWE  330 (356)
Q Consensus       262 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~---~~~~~~~~i~~~~~~  330 (356)
                      .......        .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.   ...+.+..+......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~  238 (330)
T 2izr_A          159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA  238 (330)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred             eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence            7643322        23457999999999999999999999999999999999999999884   445556666555555


Q ss_pred             cChhhhcc-CCHHHHHHHHHhhhcCCC
Q psy12427        331 FDEEAFKN-VSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       331 ~~~~~~~~-~s~~~~~lI~~ll~~dP~  356 (356)
                      .+.+.... +| ++.++|+.||+.||+
T Consensus       239 ~~~~~~~~~~p-~~~~li~~~l~~~p~  264 (330)
T 2izr_A          239 TPIEVLCENFP-EMATYLRYVRRLDFF  264 (330)
T ss_dssp             SCHHHHTTTCH-HHHHHHHHHHHCCTT
T ss_pred             CCHHHHhccCh-HHHHHHHHHHhCCCC
Confidence            55443333 55 999999999999985

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=5.5e-46  Score=337.18  Aligned_cols=245  Identities=32%  Similarity=0.595  Sum_probs=213.4

Q ss_pred             CCcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---------hhhHHHHHHHHHHHHhcC-CCCceeeeee
Q psy12427        104 SSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---------NLEKELIRKEIDIMNQLH-HPKLINLHDA  173 (356)
Q Consensus       104 ~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---------~~~~~~~~~E~~il~~l~-hpnIv~l~~~  173 (356)
                      ..+.++|++.+.||+|+||.||+|.++.+|+.||+|++....         ....+.+.+|+.+++++. ||||++++++
T Consensus        13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (298)
T 1phk_A           13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT   92 (298)
T ss_dssp             --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence            346688999999999999999999999999999999997543         122456778999999995 9999999999


Q ss_pred             EEeCCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEE
Q psy12427        174 FEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVK  253 (356)
Q Consensus       174 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vk  253 (356)
                      +......++||||+++++|.+++.... .     +....+..++.||+.||+|||++|++|+||+|+||+++.++  .+|
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~-----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~k  164 (298)
T 1phk_A           93 YETNTFFFLVFDLMKKGELFDYLTEKV-T-----LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM--NIK  164 (298)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHS-S-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEE
T ss_pred             eccCCeEEEEEeccCCCcHHHHHhccC-C-----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCC--cEE
Confidence            999999999999999999999986432 2     33344566999999999999999999999999999997554  799


Q ss_pred             EEeeeceeeeCCCCceeecCCCcCcccccccc------CCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc
Q psy12427        254 MIDFGLATKLDPNEVVKISTGTAEFAAPEIVE------REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKAC  327 (356)
Q Consensus       254 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~  327 (356)
                      |+|||++.............|++.|+|||++.      ...++.++||||||+++|+|++|..||.+.+..+....+...
T Consensus       165 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  244 (298)
T 1phk_A          165 LTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG  244 (298)
T ss_dssp             ECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred             EecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC
Confidence            99999998877665556667999999999985      456889999999999999999999999999999999999888


Q ss_pred             ccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        328 DWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       328 ~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ...++.+.+..+|+++++||++||+.||+
T Consensus       245 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~  273 (298)
T 1phk_A          245 NYQFGSPEWDDYSDTVKDLVSRFLVVQPQ  273 (298)
T ss_dssp             CCCCCTTTGGGSCHHHHHHHHHHCCSSGG
T ss_pred             CcccCcccccccCHHHHHHHHHHccCCcc
Confidence            88888777789999999999999999985

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-46  Score=350.30  Aligned_cols=248  Identities=18%  Similarity=0.250  Sum_probs=205.2

Q ss_pred             cccceeeeccccccCceEEEEEEE-----ccCCCEEEEEEcccC-ChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCe
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRE-----RKTGNIFAAKFIPVS-HNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDE  179 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~-----~~~~~~~a~K~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  179 (356)
                      ..++|++.+.||+|+||+||+|.+     ..++..||+|+++.. .......+.+|+.+|++++||||+++++++.....
T Consensus        69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  148 (367)
T 3l9p_A           69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  148 (367)
T ss_dssp             CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            346899999999999999999994     456789999999754 34445678899999999999999999999999999


Q ss_pred             EEEEEEeccccchhhhhhCCCCC-CCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecC-CCcEEEEee
Q psy12427        180 MVLIFEFLSGGELFERITAPDYK-MSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN-STNVKMIDF  257 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~-~~~vkl~Df  257 (356)
                      .++||||+++|+|.+++...... .....+....+..++.||+.||+|||++||+||||||+|||++.++ +..+||+||
T Consensus       149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DF  228 (367)
T 3l9p_A          149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF  228 (367)
T ss_dssp             CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred             CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCC
Confidence            99999999999999999754322 1122344445667999999999999999999999999999998543 235999999


Q ss_pred             eceeeeCC---CCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCh
Q psy12427        258 GLATKLDP---NEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDE  333 (356)
Q Consensus       258 g~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~  333 (356)
                      |+++....   ........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+.+..+.......++
T Consensus       229 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~~  308 (367)
T 3l9p_A          229 GMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP  308 (367)
T ss_dssp             HHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred             ccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            99975421   122234567999999999999999999999999999999998 99999999999998888776533322


Q ss_pred             hhhccCCHHHHHHHHHhhhcCCC
Q psy12427        334 EAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       334 ~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                         ..++.++.+||++||+.||+
T Consensus       309 ---~~~~~~l~~li~~~l~~dP~  328 (367)
T 3l9p_A          309 ---KNCPGPVYRIMTQCWQHQPE  328 (367)
T ss_dssp             ---TTCCHHHHHHHHHHTCSSGG
T ss_pred             ---ccCCHHHHHHHHHHcCCCHh
Confidence               47899999999999999985

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.4e-46  Score=357.43  Aligned_cols=245  Identities=28%  Similarity=0.538  Sum_probs=197.7

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh--------hhHHHHHHHHHHHHhcCCCCceeeeeeEEe
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN--------LEKELIRKEIDIMNQLHHPKLINLHDAFED  176 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~--------~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  176 (356)
                      .+.++|.+.+.||+|+||+||+|.++.+++.||+|++.....        .....+.+|+.+|++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            345789999999999999999999999999999999865321        112347789999999999999999999864


Q ss_pred             CCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecC-CCcEEEE
Q psy12427        177 DDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN-STNVKMI  255 (356)
Q Consensus       177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~-~~~vkl~  255 (356)
                       ...++||||+++|+|.+++.... .     +....+..++.|++.||+|||++||+||||||+|||++.++ ...+||+
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~~~-~-----~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVGNK-R-----LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSSSC-C-----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             -CceEEEEEcCCCCcHHHHHhccC-C-----CCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEe
Confidence             55899999999999999886432 2     33344556999999999999999999999999999997543 3469999


Q ss_pred             eeeceeeeCCCCceeecCCCcCccccccccC---CCCCccccHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHhhcccccc
Q psy12427        256 DFGLATKLDPNEVVKISTGTAEFAAPEIVER---EPVGFYTDMWAVGVLAYVLLSGLSPFAGEND-VETLKNVKACDWEF  331 (356)
Q Consensus       256 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~-~~~~~~i~~~~~~~  331 (356)
                      |||+++............||+.|+|||++.+   ..++.++|||||||++|+|++|..||.+... ......+......+
T Consensus       285 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~  364 (419)
T 3i6u_A          285 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF  364 (419)
T ss_dssp             CSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCC
T ss_pred             ecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCC
Confidence            9999988765555566789999999999863   5688899999999999999999999987643 34556677777788


Q ss_pred             ChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        332 DEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       332 ~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +++.+..+|+++++||++||+.||+
T Consensus       365 ~~~~~~~~~~~~~~li~~~L~~dP~  389 (419)
T 3i6u_A          365 IPEVWAEVSEKALDLVKKLLVVDPK  389 (419)
T ss_dssp             CHHHHTTSCHHHHHHHHHHSCSSTT
T ss_pred             CchhhcccCHHHHHHHHHHccCChh
Confidence            8888889999999999999999995

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4.8e-46  Score=350.54  Aligned_cols=244  Identities=18%  Similarity=0.298  Sum_probs=196.3

Q ss_pred             ccceeeecccccc--CceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        107 YDHYDILEEIGTG--AFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       107 ~~~y~~~~~lg~G--~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      .++|++.+.||+|  +||+||+|+++.+|+.||+|++....  ......+.+|+.+|+.++||||+++++++...+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4689999999999  99999999999999999999997543  3345678889999999999999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ||||+++|+|.+++.....    ..+....+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||.+..
T Consensus       104 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~--~~kl~dfg~~~~  177 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFM----DGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG--KVYLSGLRSNLS  177 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCGGGCEE
T ss_pred             EEEccCCCCHHHHHhhhcc----cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEccccccee
Confidence            9999999999999875421    1233444566999999999999999999999999999997554  799999999865


Q ss_pred             eCCCC--------ceeecCCCcCccccccccC--CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc--
Q psy12427        263 LDPNE--------VVKISTGTAEFAAPEIVER--EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWE--  330 (356)
Q Consensus       263 ~~~~~--------~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~--  330 (356)
                      .....        ......||+.|+|||++.+  ..++.++|||||||++|+|++|+.||.+.+..+.+..+......  
T Consensus       178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  257 (389)
T 3gni_B          178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL  257 (389)
T ss_dssp             CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred             eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence            42211        1122368999999999987  67899999999999999999999999988766665554432211  


Q ss_pred             ----------------------------------------cChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        331 ----------------------------------------FDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       331 ----------------------------------------~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                                              ...+.+..+|+++++||++||+.||+
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~  323 (389)
T 3gni_B          258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPD  323 (389)
T ss_dssp             ------------------------------------------------CCHHHHHHHHHHTCSCTT
T ss_pred             ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcc
Confidence                                                    11123456899999999999999995

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=4.7e-46  Score=340.00  Aligned_cols=241  Identities=23%  Similarity=0.381  Sum_probs=194.0

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      .++|++.+.||+|+||+||+|++.  |..||+|++....  ......+.+|+.+|++++||||+++++++......++||
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT  113 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred             hhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence            468999999999999999999874  7899999987654  334467889999999999999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN--IIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ||+++|+|.+++.....   ...+....+..++.|++.||+|||++|  |+||||||+|||++.++  .+||+|||+++.
T Consensus       114 e~~~~~~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~--~~kL~Dfg~a~~  188 (309)
T 3p86_A          114 EYLSRGSLYRLLHKSGA---REQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKY--TVKVCDFGLSRL  188 (309)
T ss_dssp             ECCTTCBHHHHHHSTTH---HHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTC--CEEECCCC----
T ss_pred             ecCCCCcHHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCC--cEEECCCCCCcc
Confidence            99999999999975431   112344455669999999999999999  99999999999997554  799999999976


Q ss_pred             eCCCC-ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCH
Q psy12427        263 LDPNE-VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSE  341 (356)
Q Consensus       263 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  341 (356)
                      ..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.......  .....+|+
T Consensus       189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~  266 (309)
T 3p86_A          189 KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL--EIPRNLNP  266 (309)
T ss_dssp             -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC--CCCTTSCH
T ss_pred             ccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCccCCH
Confidence            54332 2234568999999999999999999999999999999999999999999888877775433222  22347999


Q ss_pred             HHHHHHHHhhhcCCC
Q psy12427        342 EGKDFIRRLLLRNKE  356 (356)
Q Consensus       342 ~~~~lI~~ll~~dP~  356 (356)
                      ++.+||++||+.||+
T Consensus       267 ~l~~li~~~l~~dP~  281 (309)
T 3p86_A          267 QVAAIIEGCWTNEPW  281 (309)
T ss_dssp             HHHHHHHHHTCSSGG
T ss_pred             HHHHHHHHHccCChh
Confidence            999999999999985

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.4e-46  Score=335.34  Aligned_cols=240  Identities=30%  Similarity=0.463  Sum_probs=180.8

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh---hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN---LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++.....   .....+.+|+.++++++||||+++++++......++
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL   88 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence            45689999999999999999999999999999999865432   224678899999999999999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ||||+++++|.+++......+++     ..+..++.|++.||+|||++|++||||||+||+++.++  .+||+|||++..
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~-----~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~--~~kl~dfg~~~~  161 (278)
T 3cok_A           89 VLEMCHNGEMNRYLKNRVKPFSE-----NEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNM--NIKIADFGLATQ  161 (278)
T ss_dssp             EEECCTTEEHHHHHHTCSSCCCH-----HHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTC--CEEECCCTTCEE
T ss_pred             EEecCCCCcHHHHHhhccCCCCH-----HHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC--CEEEEeecceee
Confidence            99999999999999765433443     34456999999999999999999999999999997554  799999999987


Q ss_pred             eCCCC-ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCH
Q psy12427        263 LDPNE-VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSE  341 (356)
Q Consensus       263 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  341 (356)
                      ..... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+.+..+.......+    ..+|.
T Consensus       162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~  237 (278)
T 3cok_A          162 LKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMP----SFLSI  237 (278)
T ss_dssp             CC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCC----TTSCH
T ss_pred             ccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCc----cccCH
Confidence            65322 22345689999999999999999999999999999999999999998877777777665554444    36899


Q ss_pred             HHHHHHHHhhhcCCC
Q psy12427        342 EGKDFIRRLLLRNKE  356 (356)
Q Consensus       342 ~~~~lI~~ll~~dP~  356 (356)
                      ++++||++||+.||+
T Consensus       238 ~~~~li~~~l~~dp~  252 (278)
T 3cok_A          238 EAKDLIHQLLRRNPA  252 (278)
T ss_dssp             HHHHHHHHHSCSSGG
T ss_pred             HHHHHHHHHcccCHh
Confidence            999999999999985

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-46  Score=343.60  Aligned_cols=248  Identities=24%  Similarity=0.394  Sum_probs=200.5

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCC--eEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDD--EMVL  182 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--~~~l  182 (356)
                      ..++|++.+.||+|+||+||+|.++.+++.||+|++.... ....+.+.+|+++|++++||||+++++++....  ..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence            4578999999999999999999999999999999987543 234567789999999999999999999998655  7899


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeec--CCCcEEEEeeece
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTR--NSTNVKMIDFGLA  260 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~--~~~~vkl~Dfg~a  260 (356)
                      ||||+++++|.+++......   ..+....+..++.||+.||+|||++||+||||||+|||+..+  +...+||+|||++
T Consensus        87 v~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           87 IMEFCPCGSLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EEECCTTCBHHHHHHSGGGT---TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            99999999999999754321   113444556699999999999999999999999999998332  3346899999999


Q ss_pred             eeeCCCCceeecCCCcCcccccccc--------CCCCCccccHHHHHHHHHHHHcCCCCCCCCC----hHHHHHHhhccc
Q psy12427        261 TKLDPNEVVKISTGTAEFAAPEIVE--------REPVGFYTDMWAVGVLAYVLLSGLSPFAGEN----DVETLKNVKACD  328 (356)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~----~~~~~~~i~~~~  328 (356)
                      +............||+.|+|||++.        +..++.++|||||||++|+|++|..||....    ..+.+..+....
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  243 (319)
T 4euu_A          164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK  243 (319)
T ss_dssp             EECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred             eecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence            9887666556667999999999986        5778999999999999999999999997543    345555554332


Q ss_pred             c---------------------ccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        329 W---------------------EFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       329 ~---------------------~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .                     +.+......++..+.+||++||+.||+
T Consensus       244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~  292 (319)
T 4euu_A          244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE  292 (319)
T ss_dssp             CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTT
T ss_pred             CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChh
Confidence            1                     111122235677899999999999996

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=8.9e-47  Score=354.15  Aligned_cols=240  Identities=19%  Similarity=0.304  Sum_probs=201.6

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      .++|.+.+.||+|+||+||+|.++.++..||+|+++... ......+.+|+.+|++++||||+++++++......++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            468999999999999999999999999999999987543 2334567889999999999999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |+++|+|.+++......++     ...+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||+++....
T Consensus       193 ~~~~g~L~~~l~~~~~~~~-----~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~--~~kl~DfG~s~~~~~  265 (377)
T 3cbl_A          193 LVQGGDFLTFLRTEGARLR-----VKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKN--VLKISDFGMSREEAD  265 (377)
T ss_dssp             CCTTCBHHHHHHHHGGGCC-----HHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCGGGCEECTT
T ss_pred             cCCCCCHHHHHHhcCCCCC-----HHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCC--cEEECcCCCceecCC
Confidence            9999999999875332333     344556999999999999999999999999999997554  799999999987543


Q ss_pred             CCceee---cCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCH
Q psy12427        266 NEVVKI---STGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSE  341 (356)
Q Consensus       266 ~~~~~~---~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  341 (356)
                      ......   ..+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+.......   ....+|+
T Consensus       266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~  342 (377)
T 3cbl_A          266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLP---CPELCPD  342 (377)
T ss_dssp             SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCC---CCTTCCH
T ss_pred             CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCH
Confidence            221111   124678999999999899999999999999999998 999999999888877776643222   2247899


Q ss_pred             HHHHHHHHhhhcCCC
Q psy12427        342 EGKDFIRRLLLRNKE  356 (356)
Q Consensus       342 ~~~~lI~~ll~~dP~  356 (356)
                      ++.+||.+||+.||+
T Consensus       343 ~l~~li~~cl~~dP~  357 (377)
T 3cbl_A          343 AVFRLMEQCWAYEPG  357 (377)
T ss_dssp             HHHHHHHHHTCSSGG
T ss_pred             HHHHHHHHHcCCCch
Confidence            999999999999985

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=7.8e-46  Score=344.29  Aligned_cols=243  Identities=23%  Similarity=0.355  Sum_probs=201.1

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh--hHHHHHHHHHHHHhcCCCCceeeeeeEEe-------
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL--EKELIRKEIDIMNQLHHPKLINLHDAFED-------  176 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~-------  176 (356)
                      ..++|++.+.||+|+||+||+|+++.+|+.||+|++......  ....+.+|+.+|+.++||||+++++++..       
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            346899999999999999999999999999999998655432  23567789999999999999999999986       


Q ss_pred             -CCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEE
Q psy12427        177 -DDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMI  255 (356)
Q Consensus       177 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~  255 (356)
                       .+..++||||+.+ +|.+.+......+++     ..+..++.||+.||+|||++||+||||||+|||++.++  .+||+
T Consensus        95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~-----~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~--~~kl~  166 (351)
T 3mi9_A           95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTL-----SEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG--VLKLA  166 (351)
T ss_dssp             --CEEEEEEECCSE-EHHHHHHCTTSCCCH-----HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEEC
T ss_pred             CCceEEEEEeccCC-CHHHHHhhccCCCCH-----HHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC--CEEEc
Confidence             4568999999975 777777654444443     34556999999999999999999999999999997654  79999


Q ss_pred             eeeceeeeCCC-----CceeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc
Q psy12427        256 DFGLATKLDPN-----EVVKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDW  329 (356)
Q Consensus       256 Dfg~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~  329 (356)
                      |||+++.....     .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.....
T Consensus       167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  246 (351)
T 3mi9_A          167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG  246 (351)
T ss_dssp             CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             cchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            99999876421     22233468999999999876 4589999999999999999999999999999988888877655


Q ss_pred             ccChhhhccC----------------------------CHHHHHHHHHhhhcCCC
Q psy12427        330 EFDEEAFKNV----------------------------SEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       330 ~~~~~~~~~~----------------------------s~~~~~lI~~ll~~dP~  356 (356)
                      .+++..+..+                            ++++++||++||+.||+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  301 (351)
T 3mi9_A          247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA  301 (351)
T ss_dssp             CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGG
T ss_pred             CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChh
Confidence            5555444332                            78899999999999995

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.1e-46  Score=344.99  Aligned_cols=244  Identities=28%  Similarity=0.449  Sum_probs=195.7

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhh-----HHHHHHHHHHHHhcCCCCceeeeeeEEeCCe
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE-----KELIRKEIDIMNQLHHPKLINLHDAFEDDDE  179 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~-----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  179 (356)
                      ...++|++.+.||+|+||.||+|.++.+|+.||+|++.......     ...+.+|+.+++.++||||+++++++.....
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34568999999999999999999999999999999997543221     2357789999999999999999999999999


Q ss_pred             EEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeec
Q psy12427        180 MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGL  259 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~  259 (356)
                      .++||||+++ +|.+++......+++     ..+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||+
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~~~~~~-----~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~--~~kl~Dfg~  158 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNSLVLTP-----SHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG--VLKLADFGL  158 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCCSSCCS-----SHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--CEEECCCGG
T ss_pred             eEEEEEcCCC-CHHHHHHhcCcCCCH-----HHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCC--CEEEEeccc
Confidence            9999999975 888888765444444     34456999999999999999999999999999997654  799999999


Q ss_pred             eeeeCCC-CceeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCh----
Q psy12427        260 ATKLDPN-EVVKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE----  333 (356)
Q Consensus       260 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~----  333 (356)
                      ++..... .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+......++.    
T Consensus       159 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  238 (346)
T 1ua2_A          159 AKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP  238 (346)
T ss_dssp             GSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred             ceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Confidence            9876432 233445789999999999754 5889999999999999999999999999988888877653222211    


Q ss_pred             --------------------hhhccCCHHHHHHHHHhhhcCCC
Q psy12427        334 --------------------EAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       334 --------------------~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                          ..+..+++++++||++||+.||+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  281 (346)
T 1ua2_A          239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPC  281 (346)
T ss_dssp             STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTT
T ss_pred             hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChh
Confidence                                22356789999999999999995

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.5e-46  Score=345.39  Aligned_cols=241  Identities=23%  Similarity=0.408  Sum_probs=192.8

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhH-HHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK-ELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~-~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      ++|++.+.||+|+||+||+|.++.+++.||+|++........ ..+.+|+.+|+.++||||+++++++......++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            579999999999999999999999999999999875543221 2345799999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +. |+|.+++......+++     ..+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||++......
T Consensus        82 ~~-~~l~~~~~~~~~~~~~-----~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~--~~kl~Dfg~a~~~~~~  153 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGNIINM-----HNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERG--ELKLADFGLARAKSIP  153 (324)
T ss_dssp             CS-EEHHHHHHHTTTCCCH-----HHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTC--CEEECSSSEEECC---
T ss_pred             cc-cCHHHHHHhcCCCCCH-----HHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCC--CEEEccCcccccccCC
Confidence            97 5888888754433333     34455999999999999999999999999999997654  7999999999865432


Q ss_pred             -CceeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChh----------
Q psy12427        267 -EVVKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEE----------  334 (356)
Q Consensus       267 -~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~----------  334 (356)
                       .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+......+++.          
T Consensus       154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (324)
T 3mtl_A          154 TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE  233 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred             ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence             22334568999999999876 568999999999999999999999999999988888776543332222          


Q ss_pred             ----------------hhccCCHHHHHHHHHhhhcCCC
Q psy12427        335 ----------------AFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       335 ----------------~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                      ....+++++++||++||+.||+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  271 (324)
T 3mtl_A          234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGR  271 (324)
T ss_dssp             HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGG
T ss_pred             hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcc
Confidence                            2235789999999999999995

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.1e-45  Score=344.29  Aligned_cols=244  Identities=25%  Similarity=0.376  Sum_probs=203.3

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcC-----CCCceeeeeeEEeCCe
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLH-----HPKLINLHDAFEDDDE  179 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~-----hpnIv~l~~~~~~~~~  179 (356)
                      .+.++|++.++||+|+||+||+|++..+++.||+|++... ......+..|+.+++.+.     ||||+++++++.....
T Consensus        32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~  110 (360)
T 3llt_A           32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDH  110 (360)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTE
T ss_pred             EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCe
Confidence            3457899999999999999999999999999999998743 334456678999999996     9999999999999999


Q ss_pred             EEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEee-------------
Q psy12427        180 MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQT-------------  246 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~-------------  246 (356)
                      .++||||+ +++|.+++.....    ..+....+..++.||+.||+|||++||+||||||+|||++.             
T Consensus       111 ~~lv~e~~-~~~L~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~  185 (360)
T 3llt_A          111 MCLIFEPL-GPSLYEIITRNNY----NGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRV  185 (360)
T ss_dssp             EEEEECCC-CCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred             eEEEEcCC-CCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcc
Confidence            99999999 8999999875432    12333445669999999999999999999999999999974             


Q ss_pred             ----------cCCCcEEEEeeeceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q psy12427        247 ----------RNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN  316 (356)
Q Consensus       247 ----------~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~  316 (356)
                                ...+.+||+|||++......  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+
T Consensus       186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  263 (360)
T 3llt_A          186 TDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHE  263 (360)
T ss_dssp             TTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence                      22457999999999875432  234578999999999999999999999999999999999999999999


Q ss_pred             hHHHHHHhhccccccChhhh------------------------------------------ccCCHHHHHHHHHhhhcC
Q psy12427        317 DVETLKNVKACDWEFDEEAF------------------------------------------KNVSEEGKDFIRRLLLRN  354 (356)
Q Consensus       317 ~~~~~~~i~~~~~~~~~~~~------------------------------------------~~~s~~~~~lI~~ll~~d  354 (356)
                      ..+.+..+......++....                                          ...++++.+||++||+.|
T Consensus       264 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  343 (360)
T 3llt_A          264 HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQID  343 (360)
T ss_dssp             HHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSS
T ss_pred             HHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCC
Confidence            88888877665444443221                                          123478889999999999


Q ss_pred             CC
Q psy12427        355 KE  356 (356)
Q Consensus       355 P~  356 (356)
                      |+
T Consensus       344 P~  345 (360)
T 3llt_A          344 PT  345 (360)
T ss_dssp             GG
T ss_pred             hh
Confidence            95

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.1e-46  Score=346.37  Aligned_cols=239  Identities=25%  Similarity=0.441  Sum_probs=195.2

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccC--ChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeC------
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS--HNLEKELIRKEIDIMNQLHHPKLINLHDAFEDD------  177 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------  177 (356)
                      +.++|++.+.||+|+||.||+|.++.+|+.||+|.+...  .......+.+|+.+|+.++||||+++++++...      
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            456899999999999999999999999999999998653  233456788999999999999999999999765      


Q ss_pred             CeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEee
Q psy12427        178 DEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDF  257 (356)
Q Consensus       178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Df  257 (356)
                      ..+++||||+ +++|.+++...  .++     ...+..++.||+.||+|||++||+||||||+|||++.++  .+||+||
T Consensus       103 ~~~~lv~e~~-~~~L~~~~~~~--~l~-----~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~--~~kl~Df  172 (367)
T 1cm8_A          103 TDFYLVMPFM-GTDLGKLMKHE--KLG-----EDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC--ELKILDF  172 (367)
T ss_dssp             CCCEEEEECC-SEEHHHHHHHC--CCC-----HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCC
T ss_pred             ceEEEEEecC-CCCHHHHHhcC--CCC-----HHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCC--CEEEEee
Confidence            3469999999 88999988642  233     334556999999999999999999999999999997654  7999999


Q ss_pred             eceeeeCCCCceeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChh--
Q psy12427        258 GLATKLDPNEVVKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEE--  334 (356)
Q Consensus       258 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--  334 (356)
                      |+++.....  .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+.+..+......++.+  
T Consensus       173 g~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~  250 (367)
T 1cm8_A          173 GLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  250 (367)
T ss_dssp             TTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ecccccccc--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            999876532  334578999999999877 679999999999999999999999999999888888776544433322  


Q ss_pred             -------------------------hhccCCHHHHHHHHHhhhcCCC
Q psy12427        335 -------------------------AFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       335 -------------------------~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                               .+..+++++.+||++||+.||+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~  297 (367)
T 1cm8_A          251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAE  297 (367)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTT
T ss_pred             HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChh
Confidence                                     2346799999999999999995

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2e-45  Score=335.64  Aligned_cols=242  Identities=31%  Similarity=0.483  Sum_probs=195.6

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh--hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN--LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      .++|++.+.||+|+||+||+|.++.+|+.||+|++.....  .....+.+|+.++++++||||+++++++...+..++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            4679999999999999999999999999999998865543  23466778999999999999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      ||+++++|.+++.... .+     ....+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||++....
T Consensus        82 e~~~~~~l~~~~~~~~-~~-----~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~  153 (311)
T 4agu_A           82 EYCDHTVLHELDRYQR-GV-----PEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHS--VIKLCDFGFARLLT  153 (311)
T ss_dssp             ECCSEEHHHHHHHTSS-CC-----CHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECC
T ss_pred             EeCCCchHHHHHhhhc-CC-----CHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCC--CEEEeeCCCchhcc
Confidence            9999999988876432 23     3334556999999999999999999999999999997554  79999999998765


Q ss_pred             CC-CceeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC----------
Q psy12427        265 PN-EVVKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD----------  332 (356)
Q Consensus       265 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~----------  332 (356)
                      .. .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+........          
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (311)
T 4agu_A          154 GPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN  233 (311)
T ss_dssp             ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred             CcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence            32 23344578999999999976 6689999999999999999999999999988877766543211111          


Q ss_pred             -----------------hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 -----------------EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 -----------------~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                       ...+.++|.++.+||++||+.||+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  274 (311)
T 4agu_A          234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPT  274 (311)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTT
T ss_pred             cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChh
Confidence                             122357899999999999999995

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.6e-45  Score=344.97  Aligned_cols=240  Identities=23%  Similarity=0.385  Sum_probs=189.1

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccC--ChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCC-----
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS--HNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDD-----  178 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----  178 (356)
                      +.++|++.+.||+|+||.||+|.++.+++.||+|++...  .......+.+|+.+++.++||||+++++++....     
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence            346899999999999999999999999999999998753  2334567789999999999999999999997654     


Q ss_pred             -eEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEee
Q psy12427        179 -EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDF  257 (356)
Q Consensus       179 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Df  257 (356)
                       ..++||||+.+ +|.+.+..   .++     ...+..++.||+.||+|||++||+||||||+|||++.++  .+||+||
T Consensus       103 ~~~~lv~e~~~~-~l~~~~~~---~~~-----~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~--~~kl~Df  171 (371)
T 2xrw_A          103 QDVYIVMELMDA-NLCQVIQM---ELD-----HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDF  171 (371)
T ss_dssp             CEEEEEEECCSE-EHHHHHHS---CCC-----HHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--CEEECCC
T ss_pred             cceEEEEEcCCC-CHHHHHhh---ccC-----HHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC--CEEEEEe
Confidence             78999999974 78877753   223     334456999999999999999999999999999997654  7999999


Q ss_pred             eceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhc
Q psy12427        258 GLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFK  337 (356)
Q Consensus       258 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  337 (356)
                      |+++............||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+......+.++.+.
T Consensus       172 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  251 (371)
T 2xrw_A          172 GLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK  251 (371)
T ss_dssp             CC----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred             ecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            99987765444455679999999999999999999999999999999999999999999888888776643333222211


Q ss_pred             --------------------------------------cCCHHHHHHHHHhhhcCCC
Q psy12427        338 --------------------------------------NVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       338 --------------------------------------~~s~~~~~lI~~ll~~dP~  356 (356)
                                                            ..+.++++||++||+.||+
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~  308 (371)
T 2xrw_A          252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS  308 (371)
T ss_dssp             TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGG
T ss_pred             HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChh
Confidence                                                  1267899999999999995

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=337.71  Aligned_cols=237  Identities=22%  Similarity=0.375  Sum_probs=191.1

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l  182 (356)
                      +.++|++.++||+|+||+||+|+++.+|+.||+|++....  .........|+..+..+ +||||+++++++...+..++
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l  134 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL  134 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence            4478999999999999999999999999999999886543  23334445566666555 89999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ||||+ +++|.+++......+++     ..+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||++..
T Consensus       135 v~e~~-~~~L~~~~~~~~~~l~~-----~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~--~~kl~DFG~a~~  206 (311)
T 3p1a_A          135 QTELC-GPSLQQHCEAWGASLPE-----AQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRG--RCKLGDFGLLVE  206 (311)
T ss_dssp             EEECC-CCBHHHHHHHHCSCCCH-----HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGG--CEEECCCTTCEE
T ss_pred             EEecc-CCCHHHHHHhcCCCCCH-----HHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC--CEEEccceeeee
Confidence            99999 67898888654433443     34455999999999999999999999999999998665  799999999988


Q ss_pred             eCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHH
Q psy12427        263 LDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEE  342 (356)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  342 (356)
                      ...........||+.|+|||++.+ .++.++|||||||++|||++|..||.+...   ...+....  .+++....++++
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~--~~~~~~~~~~~~  280 (311)
T 3p1a_A          207 LGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGY--LPPEFTAGLSSE  280 (311)
T ss_dssp             CC------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTC--CCHHHHTTSCHH
T ss_pred             cccCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccC--CCcccccCCCHH
Confidence            766555556679999999999886 789999999999999999999777755433   33333332  455666789999


Q ss_pred             HHHHHHHhhhcCCC
Q psy12427        343 GKDFIRRLLLRNKE  356 (356)
Q Consensus       343 ~~~lI~~ll~~dP~  356 (356)
                      +.+||++||+.||+
T Consensus       281 l~~li~~~L~~dP~  294 (311)
T 3p1a_A          281 LRSVLVMMLEPDPK  294 (311)
T ss_dssp             HHHHHHHHSCSSTT
T ss_pred             HHHHHHHHcCCChh
Confidence            99999999999995

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=5.5e-46  Score=342.44  Aligned_cols=245  Identities=21%  Similarity=0.349  Sum_probs=193.9

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh--hHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL--EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      ...++|++.+.||+|+||+||+|.+..+++.||+|+++.....  ....+.+|+.+|++++||||+++++++......++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            4467899999999999999999999999999999999765432  23566789999999999999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecC---CCcEEEEeeec
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN---STNVKMIDFGL  259 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~---~~~vkl~Dfg~  259 (356)
                      ||||+. |+|.+++.... .     +....+..++.||+.||+|||++||+||||||+|||++.++   ...+||+|||+
T Consensus       111 v~e~~~-~~L~~~~~~~~-~-----~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~  183 (329)
T 3gbz_A          111 IFEYAE-NDLKKYMDKNP-D-----VSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL  183 (329)
T ss_dssp             EEECCS-EEHHHHHHHCT-T-----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred             EEecCC-CCHHHHHhhcC-C-----CCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence            999997 59999886543 2     33344566999999999999999999999999999996432   34699999999


Q ss_pred             eeeeCCC-CceeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhh--
Q psy12427        260 ATKLDPN-EVVKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEA--  335 (356)
Q Consensus       260 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~--  335 (356)
                      ++..... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+......++...  
T Consensus       184 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  263 (329)
T 3gbz_A          184 ARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP  263 (329)
T ss_dssp             HHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             ccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhh
Confidence            9876432 223445689999999999874 489999999999999999999999999998888877755322222111  


Q ss_pred             ------------------------hccCCHHHHHHHHHhhhcCCC
Q psy12427        336 ------------------------FKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       336 ------------------------~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                              ...+++++++||++||+.||+
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  308 (329)
T 3gbz_A          264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPV  308 (329)
T ss_dssp             TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGG
T ss_pred             hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChh
Confidence                                    122789999999999999995

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.5e-45  Score=342.00  Aligned_cols=237  Identities=24%  Similarity=0.358  Sum_probs=199.2

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      .+.|++.+.||+|+||+||+|++..+++.||+|++....   ......+.+|+.+|++++||||+++++++......++|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            356999999999999999999999999999999987543   22346788999999999999999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      |||+. |+|.+++......+++     ..+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||++...
T Consensus       133 ~e~~~-g~l~~~l~~~~~~l~~-----~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~DfG~a~~~  204 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVHKKPLQE-----VEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG--LVKLGDFGSASIM  204 (348)
T ss_dssp             EECCS-EEHHHHHHHHTSCCCH-----HHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT--EEEECCCTTCBSS
T ss_pred             EecCC-CCHHHHHHHhcCCCCH-----HHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC--CEEEeeccCceec
Confidence            99997 5787777543333333     34455999999999999999999999999999998554  7999999999876


Q ss_pred             CCCCceeecCCCcCcccccccc---CCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCC
Q psy12427        264 DPNEVVKISTGTAEFAAPEIVE---REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVS  340 (356)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  340 (356)
                      ...   ....||+.|+|||++.   ...++.++|||||||++|+|++|+.||.+.+..+.+..+.......  .....+|
T Consensus       205 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~  279 (348)
T 1u5q_A          205 APA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA--LQSGHWS  279 (348)
T ss_dssp             SSB---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC--CCCTTSC
T ss_pred             CCC---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--CCCCCCC
Confidence            432   3457999999999984   5678999999999999999999999999998888777776654322  2234789


Q ss_pred             HHHHHHHHHhhhcCCC
Q psy12427        341 EEGKDFIRRLLLRNKE  356 (356)
Q Consensus       341 ~~~~~lI~~ll~~dP~  356 (356)
                      +++++||.+||+.||+
T Consensus       280 ~~l~~li~~~l~~dP~  295 (348)
T 1u5q_A          280 EYFRNFVDSCLQKIPQ  295 (348)
T ss_dssp             HHHHHHHHHHTCSSGG
T ss_pred             HHHHHHHHHHcccChh
Confidence            9999999999999985

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=9.3e-46  Score=340.31  Aligned_cols=241  Identities=21%  Similarity=0.378  Sum_probs=193.3

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh-hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCC------
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN-LEKELIRKEIDIMNQLHHPKLINLHDAFEDDD------  178 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~------  178 (356)
                      +.++|++.+.||+|+||.||+|+++.+|+.||+|++..... ...+.+.+|+.+|++++||||++++++|....      
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            45689999999999999999999999999999999976543 35577889999999999999999999986543      


Q ss_pred             ---------------------------------------------------eEEEEEEeccccchhhhhhCCCCCCCccc
Q psy12427        179 ---------------------------------------------------EMVLIFEFLSGGELFERITAPDYKMSEAE  207 (356)
Q Consensus       179 ---------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~  207 (356)
                                                                         ..++||||+++++|.+++.....   ...
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~  160 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS---LED  160 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS---GGG
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC---ccc
Confidence                                                               38999999999999999976432   122


Q ss_pred             cccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCC-------------ceeecCC
Q psy12427        208 VIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE-------------VVKISTG  274 (356)
Q Consensus       208 ~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~-------------~~~~~~g  274 (356)
                      .....+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+++......             ......|
T Consensus       161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g  238 (332)
T 3qd2_B          161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD--VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG  238 (332)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred             hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCC--CEEEeecCcccccccchhhccccccccccccccccCC
Confidence            22223566999999999999999999999999999997554  79999999998875432             1123468


Q ss_pred             CcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHHHhhhcC
Q psy12427        275 TAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRN  354 (356)
Q Consensus       275 t~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~d  354 (356)
                      |+.|+|||++.+..++.++|||||||++|+|++|..|+..  .......+....  + +..+...++++++||++||+.|
T Consensus       239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~--~-~~~~~~~~~~~~~li~~~l~~~  313 (332)
T 3qd2_B          239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLK--F-PLLFTQKYPQEHMMVQDMLSPS  313 (332)
T ss_dssp             CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTC--C-CHHHHHHCHHHHHHHHHHHCSS
T ss_pred             CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccC--C-CcccccCChhHHHHHHHHccCC
Confidence            9999999999999999999999999999999998777522  223333333333  2 2334567899999999999999


Q ss_pred             CC
Q psy12427        355 KE  356 (356)
Q Consensus       355 P~  356 (356)
                      |+
T Consensus       314 p~  315 (332)
T 3qd2_B          314 PT  315 (332)
T ss_dssp             GG
T ss_pred             CC
Confidence            95

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=9.1e-46  Score=331.07  Aligned_cols=238  Identities=21%  Similarity=0.338  Sum_probs=201.9

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      .++|++.+.||+|+||.||+|.+.. +..||+|++..... ..+.+.+|+.++++++||||+++++++......++||||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   86 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hhhceeeheecCCCccEEEEEEecC-CCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence            3679999999999999999999874 67899999976543 346788999999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +++++|.+++......+++.     .+..++.|++.||+|||+.||+||||||+|||++.++  .+||+|||++......
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~-----~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~~~~~~~~  159 (269)
T 4hcu_A           87 MEHGCLSDYLRTQRGLFAAE-----TLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ--VIKVSDFGMTRFVLDD  159 (269)
T ss_dssp             CTTCBHHHHHHTTTTCCCHH-----HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG--CEEECCTTGGGGBCCH
T ss_pred             CCCCcHHHHHHhcCcccCHH-----HHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCC--CEEecccccccccccc
Confidence            99999999997654444443     4455999999999999999999999999999997654  7999999999865432


Q ss_pred             Cc--eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHH
Q psy12427        267 EV--VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG  343 (356)
Q Consensus       267 ~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  343 (356)
                      ..  .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+........+   ..+++++
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  236 (269)
T 4hcu_A          160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---RLASTHV  236 (269)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC---TTSCHHH
T ss_pred             ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCC---CcCCHHH
Confidence            21  122346788999999999999999999999999999999 99999999999988888775433222   4689999


Q ss_pred             HHHHHHhhhcCCC
Q psy12427        344 KDFIRRLLLRNKE  356 (356)
Q Consensus       344 ~~lI~~ll~~dP~  356 (356)
                      .++|++||+.||+
T Consensus       237 ~~li~~~l~~~p~  249 (269)
T 4hcu_A          237 YQIMNHCWRERPE  249 (269)
T ss_dssp             HHHHHHHTCSSGG
T ss_pred             HHHHHHHccCCcc
Confidence            9999999999995

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=4.2e-45  Score=330.97  Aligned_cols=239  Identities=26%  Similarity=0.453  Sum_probs=207.4

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccC---ChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS---HNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      ..++|.+.+.||+|+||.||+|.++.+++.+|+|++...   .....+.+.+|+.+++.++||||+++++++...+..++
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV   92 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence            456899999999999999999999999999999998654   23455778899999999999999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ||||+++++|.+++.... .+     ....+..++.|++.||+|||++|++||||||+|||++.++  .+||+|||++..
T Consensus        93 v~e~~~~~~L~~~~~~~~-~~-----~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~kl~dfg~~~~  164 (294)
T 2rku_A           93 VLELCRRRSLLELHKRRK-AL-----TEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL--EVKIGDFGLATK  164 (294)
T ss_dssp             EEECCTTCBHHHHHHHHC-SC-----CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEE
T ss_pred             EEecCCCCCHHHHHHhcC-CC-----CHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCC--CEEEEeccCcee
Confidence            999999999999876432 23     3344556999999999999999999999999999997554  799999999987


Q ss_pred             eCCC-CceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCH
Q psy12427        263 LDPN-EVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSE  341 (356)
Q Consensus       263 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  341 (356)
                      .... .......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+..+....+......++.    .++.
T Consensus       165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~  240 (294)
T 2rku_A          165 VEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINP  240 (294)
T ss_dssp             CCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT----TSCH
T ss_pred             cccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCcc----ccCH
Confidence            6532 2334456899999999999999999999999999999999999999999988888888777665553    7899


Q ss_pred             HHHHHHHHhhhcCCC
Q psy12427        342 EGKDFIRRLLLRNKE  356 (356)
Q Consensus       342 ~~~~lI~~ll~~dP~  356 (356)
                      ++.++|++||+.||+
T Consensus       241 ~~~~li~~~l~~~p~  255 (294)
T 2rku_A          241 VAASLIQKMLQTDPT  255 (294)
T ss_dssp             HHHHHHHHHTCSSGG
T ss_pred             HHHHHHHHHcccChh
Confidence            999999999999985

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=6.6e-46  Score=347.65  Aligned_cols=241  Identities=19%  Similarity=0.306  Sum_probs=192.0

Q ss_pred             cccceeeeccccccCceEEEEEEEc---cCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRER---KTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMV  181 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~---~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  181 (356)
                      ..++|++.+.||+|+||.||+|+++   .++..||+|.++... ......+.+|+.+|++++||||+++++++......+
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  122 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM  122 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence            3468999999999999999999987   457789999997653 445677889999999999999999999999999999


Q ss_pred             EEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeecee
Q psy12427        182 LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT  261 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~  261 (356)
                      +||||+++|+|.+++......+++     ..+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+++
T Consensus       123 lv~e~~~~~sL~~~l~~~~~~~~~-----~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~a~  195 (373)
T 2qol_A          123 IVTEYMENGSLDSFLRKHDAQFTV-----IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL--VCKVSDFGLGR  195 (373)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCSCH-----HHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECCC----
T ss_pred             EEEeCCCCCcHHHHHHhCCCCCCH-----HHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCC--CEEECcCcccc
Confidence            999999999999999765434443     34455999999999999999999999999999997554  79999999998


Q ss_pred             eeCCCCce----eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhh
Q psy12427        262 KLDPNEVV----KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAF  336 (356)
Q Consensus       262 ~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  336 (356)
                      ........    ....+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+.......+   .
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~---~  272 (373)
T 2qol_A          196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP---P  272 (373)
T ss_dssp             ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCC---C
T ss_pred             ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---C
Confidence            76533211    12235788999999999999999999999999999998 9999999999888887766432222   2


Q ss_pred             ccCCHHHHHHHHHhhhcCCC
Q psy12427        337 KNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       337 ~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ..++.++.++|.+||+.||+
T Consensus       273 ~~~~~~l~~li~~cl~~dp~  292 (373)
T 2qol_A          273 MDCPAALYQLMLDCWQKDRN  292 (373)
T ss_dssp             TTCBHHHHHHHHHHTCSSGG
T ss_pred             ccccHHHHHHHHHHhCcChh
Confidence            47899999999999999985

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.7e-45  Score=331.11  Aligned_cols=238  Identities=28%  Similarity=0.504  Sum_probs=203.3

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh---hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN---LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      ..++|++.+.||+|+||+||+|.++.++..||+|++.....   .....+.+|+.++++++||||+++++++......++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            34689999999999999999999999999999999865332   224668899999999999999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ||||+++++|.+++.... .     +....+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||++..
T Consensus        87 v~e~~~~~~l~~~l~~~~-~-----~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~--~~~l~Dfg~~~~  158 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKLS-K-----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG--ELKIADFGWSVH  158 (279)
T ss_dssp             EECCCTTEEHHHHHHHHS-S-----CCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTS--CEEECSCCEESC
T ss_pred             EEecCCCCcHHHHHHhcC-C-----CCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCC--CEEEEecccccc
Confidence            999999999999886432 2     33344556999999999999999999999999999997654  799999999865


Q ss_pred             eCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHH
Q psy12427        263 LDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEE  342 (356)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  342 (356)
                      .... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+....+......++.    .++++
T Consensus       159 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~  233 (279)
T 3fdn_A          159 APSS-RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEG  233 (279)
T ss_dssp             C---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT----TSCHH
T ss_pred             CCcc-cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCC----cCCHH
Confidence            5432 233457899999999999999999999999999999999999999999999999988887766654    68999


Q ss_pred             HHHHHHHhhhcCCC
Q psy12427        343 GKDFIRRLLLRNKE  356 (356)
Q Consensus       343 ~~~lI~~ll~~dP~  356 (356)
                      +++||++||+.||+
T Consensus       234 ~~~li~~~l~~~p~  247 (279)
T 3fdn_A          234 ARDLISRLLKHNPS  247 (279)
T ss_dssp             HHHHHHHHCCSSGG
T ss_pred             HHHHHHHHhccChh
Confidence            99999999999985

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.6e-45  Score=331.65  Aligned_cols=239  Identities=21%  Similarity=0.325  Sum_probs=190.4

Q ss_pred             ccceeeeccccccCceEEEEEEEccC---CCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKT---GNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~---~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      .++|++.+.||+|+||.||+|.+..+   +..+|+|.+.... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            46899999999999999999998754   4579999987643 344567889999999999999999999984 567899


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ||||+++++|.+++......+++.     .+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||+++.
T Consensus        93 v~e~~~~~~L~~~l~~~~~~~~~~-----~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~  165 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVRKYSLDLA-----SLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND--CVKLGDFGLSRY  165 (281)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHH-----HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECC------
T ss_pred             EEecCCCCCHHHHHHhcCCCCCHH-----HHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCC--CEEECccccccc
Confidence            999999999999997554344433     3455999999999999999999999999999998765  799999999987


Q ss_pred             eCCCCce--eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccC
Q psy12427        263 LDPNEVV--KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNV  339 (356)
Q Consensus       263 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  339 (356)
                      .......  ....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+.+..+.......   ....+
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~---~~~~~  242 (281)
T 1mp8_A          166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP---MPPNC  242 (281)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---CCTTC
T ss_pred             cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCC---CCCCC
Confidence            6543322  23346789999999999999999999999999999997 999999998888888877654322   23478


Q ss_pred             CHHHHHHHHHhhhcCCC
Q psy12427        340 SEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       340 s~~~~~lI~~ll~~dP~  356 (356)
                      |+++.++|++||+.||+
T Consensus       243 ~~~l~~li~~~l~~~p~  259 (281)
T 1mp8_A          243 PPTLYSLMTKCWAYDPS  259 (281)
T ss_dssp             CHHHHHHHHHHTCSSGG
T ss_pred             CHHHHHHHHHHccCChh
Confidence            99999999999999985

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.6e-45  Score=338.77  Aligned_cols=239  Identities=26%  Similarity=0.453  Sum_probs=207.6

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccC---ChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS---HNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      ..++|.+.+.||+|+||.||+|.+..+++.+|+|++...   .....+.+.+|+.+++.++||||+++++++...+..++
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  118 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV  118 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            346899999999999999999999999999999998654   23456778899999999999999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ||||+.+++|.+++.... .+     ....+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||++..
T Consensus       119 v~e~~~~~~L~~~~~~~~-~l-----~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~--~~kl~Dfg~~~~  190 (335)
T 2owb_A          119 VLELCRRRSLLELHKRRK-AL-----TEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL--EVKIGDFGLATK  190 (335)
T ss_dssp             EECCCTTCBHHHHHHHHC-SC-----CHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC--CEEECCCTTCEE
T ss_pred             EEecCCCCCHHHHHhccC-CC-----CHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCC--CEEEeeccCcee
Confidence            999999999999886432 23     3344556999999999999999999999999999997654  799999999987


Q ss_pred             eCCC-CceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCH
Q psy12427        263 LDPN-EVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSE  341 (356)
Q Consensus       263 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  341 (356)
                      .... .......|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..+.+..+......++.    .++.
T Consensus       191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~  266 (335)
T 2owb_A          191 VEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINP  266 (335)
T ss_dssp             CCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT----TSCH
T ss_pred             cccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCc----cCCH
Confidence            6532 2334457899999999999999999999999999999999999999999988888888777766553    7899


Q ss_pred             HHHHHHHHhhhcCCC
Q psy12427        342 EGKDFIRRLLLRNKE  356 (356)
Q Consensus       342 ~~~~lI~~ll~~dP~  356 (356)
                      ++.+||++||+.||+
T Consensus       267 ~~~~li~~~l~~dp~  281 (335)
T 2owb_A          267 VAASLIQKMLQTDPT  281 (335)
T ss_dssp             HHHHHHHHHTCSSGG
T ss_pred             HHHHHHHHHccCChh
Confidence            999999999999985

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=9.3e-46  Score=339.73  Aligned_cols=244  Identities=29%  Similarity=0.536  Sum_probs=202.0

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh--------hhHHHHHHHHHHHHhcCCCCceeeeeeEEeC
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN--------LEKELIRKEIDIMNQLHHPKLINLHDAFEDD  177 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~--------~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  177 (356)
                      +.++|++.+.||+|+||.||+|.++.+++.||+|++.....        .....+.+|+.+|++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            45789999999999999999999999999999999865421        1234577899999999999999999998766


Q ss_pred             CeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecC-CCcEEEEe
Q psy12427        178 DEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN-STNVKMID  256 (356)
Q Consensus       178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~-~~~vkl~D  256 (356)
                      . .++||||+++++|.+++.... .+     ....+..++.||+.||+|||++||+||||||+|||++.++ ...+||+|
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~~-~~-----~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGNK-RL-----KEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTTC-CC-----CHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             c-eEEEEecCCCCcHHHHHhccC-CC-----CHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEcc
Confidence            5 899999999999999886432 23     3344556999999999999999999999999999997654 23599999


Q ss_pred             eeceeeeCCCCceeecCCCcCcccccccc---CCCCCccccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHhhccccccC
Q psy12427        257 FGLATKLDPNEVVKISTGTAEFAAPEIVE---REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDV-ETLKNVKACDWEFD  332 (356)
Q Consensus       257 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~-~~~~~i~~~~~~~~  332 (356)
                      ||++.............||+.|+|||++.   ...++.++|||||||++|+|++|..||...... .....+......+.
T Consensus       161 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (322)
T 2ycf_A          161 FGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI  240 (322)
T ss_dssp             CTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCC
T ss_pred             CccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccC
Confidence            99998876544444456899999999974   567889999999999999999999999876543 44556666777777


Q ss_pred             hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 ~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +..+..+++++.+||++||+.||+
T Consensus       241 ~~~~~~~~~~~~~li~~~l~~dP~  264 (322)
T 2ycf_A          241 PEVWAEVSEKALDLVKKLLVVDPK  264 (322)
T ss_dssp             HHHHTTSCHHHHHHHHHHSCSSTT
T ss_pred             chhhhhcCHHHHHHHHHHcccCHh
Confidence            777889999999999999999995

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=6e-46  Score=335.46  Aligned_cols=247  Identities=32%  Similarity=0.641  Sum_probs=214.1

Q ss_pred             CCCcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeE
Q psy12427        103 TSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM  180 (356)
Q Consensus       103 ~~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  180 (356)
                      .+.+.++|++.+.||+|+||.||+|.++.+++.||+|++....  ......+.+|+.++++++||||+++++++......
T Consensus        17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   96 (287)
T 2wei_A           17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF   96 (287)
T ss_dssp             THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence            3456678999999999999999999999999999999986543  33467788999999999999999999999999999


Q ss_pred             EEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecC-CCcEEEEeeec
Q psy12427        181 VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN-STNVKMIDFGL  259 (356)
Q Consensus       181 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~-~~~vkl~Dfg~  259 (356)
                      ++||||+.+++|.+++.... .     +....+..++.||+.||+|||++|++|+||||+||+++.++ ...+||+|||+
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~-~-----~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~  170 (287)
T 2wei_A           97 YIVGELYTGGELFDEIIKRK-R-----FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGL  170 (287)
T ss_dssp             EEEECCCCSCBHHHHHHHHS-S-----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred             EEEEEccCCCCHHHHHHhcC-C-----CCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCc
Confidence            99999999999988876432 2     33344566999999999999999999999999999997643 34699999999


Q ss_pred             eeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccC
Q psy12427        260 ATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNV  339 (356)
Q Consensus       260 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  339 (356)
                      +.............|++.|+|||++.+. ++.++||||||+++|+|++|..||.+.+..+.+..+......++.+.+..+
T Consensus       171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (287)
T 2wei_A          171 STCFQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTI  249 (287)
T ss_dssp             GGTBCCCSSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTS
T ss_pred             ceeecCCCccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhc
Confidence            9876554444445689999999998764 889999999999999999999999999999999999888887777777889


Q ss_pred             CHHHHHHHHHhhhcCCC
Q psy12427        340 SEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       340 s~~~~~lI~~ll~~dP~  356 (356)
                      |+++.+||++||+.||+
T Consensus       250 ~~~~~~li~~~l~~dp~  266 (287)
T 2wei_A          250 SDDAKDLIRKMLTFHPS  266 (287)
T ss_dssp             CHHHHHHHHHHTCSSGG
T ss_pred             CHHHHHHHHHHcccChh
Confidence            99999999999999985

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.4e-45  Score=353.10  Aligned_cols=243  Identities=26%  Similarity=0.369  Sum_probs=179.7

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccC--ChhhHHHHHHHHHHHHhcCCCCceeeeeeEEe-----C
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS--HNLEKELIRKEIDIMNQLHHPKLINLHDAFED-----D  177 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-----~  177 (356)
                      .+.++|++.+.||+|+||+||+|+++.+++.||+|++...  .......+.+|+.+|+.++||||+++++++..     .
T Consensus        50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  129 (458)
T 3rp9_A           50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF  129 (458)
T ss_dssp             CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred             ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence            3457899999999999999999999999999999998653  33455678899999999999999999999843     3


Q ss_pred             CeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEee
Q psy12427        178 DEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDF  257 (356)
Q Consensus       178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Df  257 (356)
                      ..+++||||+ +++|.+++.... .     +....++.++.||+.||+|||++||+||||||+|||++.++  .+||+||
T Consensus       130 ~~~~lv~e~~-~~~L~~~~~~~~-~-----l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~--~~kl~DF  200 (458)
T 3rp9_A          130 DELYVVLEIA-DSDFKKLFRTPV-Y-----LTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDC--SVKVCDF  200 (458)
T ss_dssp             CCEEEEECCC-SEEHHHHHHSSC-C-----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC--CEEECCC
T ss_pred             ceEEEEEecc-ccchhhhcccCC-C-----CCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCC--CEeeccc
Confidence            6799999998 578998886532 2     33344566999999999999999999999999999997654  7999999


Q ss_pred             eceeeeCCCC----------------------------ceeecCCCcCccccccc-cCCCCCccccHHHHHHHHHHHHc-
Q psy12427        258 GLATKLDPNE----------------------------VVKISTGTAEFAAPEIV-EREPVGFYTDMWAVGVLAYVLLS-  307 (356)
Q Consensus       258 g~a~~~~~~~----------------------------~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlG~il~ell~-  307 (356)
                      |+|+......                            .....+||+.|+|||++ ....++.++|||||||+||||++ 
T Consensus       201 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          201 GLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             TTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             ccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            9998764211                            12334689999999986 56679999999999999999998 


Q ss_pred             ----------CCCCCCCCCh--------------------HHHHHHhhcccccc--------------------------
Q psy12427        308 ----------GLSPFAGEND--------------------VETLKNVKACDWEF--------------------------  331 (356)
Q Consensus       308 ----------g~~Pf~~~~~--------------------~~~~~~i~~~~~~~--------------------------  331 (356)
                                |++||.+.+.                    .+.+..+......+                          
T Consensus       281 ~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (458)
T 3rp9_A          281 IKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGT  360 (458)
T ss_dssp             STTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCC
T ss_pred             ccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCC
Confidence                      7888877652                    23333332211111                          


Q ss_pred             -ChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        332 -DEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       332 -~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                       ..+.+..+++++.+||++||+.||+
T Consensus       361 ~~~~~~~~~s~~~~dLl~~mL~~dP~  386 (458)
T 3rp9_A          361 DLAERFPASSADAIHLLKRMLVFNPN  386 (458)
T ss_dssp             CGGGGSTTSCHHHHHHHHHHSCSSTT
T ss_pred             CHHHHCCCCCHHHHHHHHHHhccCcc
Confidence             1233456799999999999999995

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-45  Score=341.73  Aligned_cols=246  Identities=20%  Similarity=0.311  Sum_probs=205.0

Q ss_pred             cccceeeeccccccCceEEEEEEEc-----cCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCe
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRER-----KTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDE  179 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~-----~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  179 (356)
                      ..++|++.+.||+|+||.||+|+++     .++..||+|+++... ......+.+|+.+|++++||||+++++++.....
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  124 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP  124 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence            3468999999999999999999997     345899999997654 3345678899999999999999999999999999


Q ss_pred             EEEEEEeccccchhhhhhCCCCCC------------------CccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCC
Q psy12427        180 MVLIFEFLSGGELFERITAPDYKM------------------SEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPEN  241 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~~~------------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~N  241 (356)
                      .++||||+++|+|.+++.......                  ....+....+..++.||+.||+|||++||+||||||+|
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~N  204 (343)
T 1luf_A          125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN  204 (343)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcce
Confidence            999999999999999987532110                  01234445566799999999999999999999999999


Q ss_pred             EEEeecCCCcEEEEeeeceeeeCCCC---ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCh
Q psy12427        242 IMCQTRNSTNVKMIDFGLATKLDPNE---VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGEND  317 (356)
Q Consensus       242 Ilv~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~  317 (356)
                      ||++.++  .+||+|||++.......   ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.
T Consensus       205 Il~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  282 (343)
T 1luf_A          205 CLVGENM--VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH  282 (343)
T ss_dssp             EEECGGG--CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             EEECCCC--eEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh
Confidence            9998655  79999999997654322   2233457899999999999999999999999999999999 9999999999


Q ss_pred             HHHHHHhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        318 VETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       318 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+....+........   ...+|.++.++|++||+.||+
T Consensus       283 ~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~  318 (343)
T 1luf_A          283 EEVIYYVRDGNILAC---PENCPLELYNLMRLCWSKLPA  318 (343)
T ss_dssp             HHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGG
T ss_pred             HHHHHHHhCCCcCCC---CCCCCHHHHHHHHHHcccCcc
Confidence            998888877654332   247899999999999999985

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=8.2e-46  Score=340.08  Aligned_cols=245  Identities=20%  Similarity=0.304  Sum_probs=186.7

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCC---EEEEEEcccC--ChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeE-
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGN---IFAAKFIPVS--HNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM-  180 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~---~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~-  180 (356)
                      .++|++.+.||+|+||.||+|.++.++.   .||+|+++..  .....+.+.+|+.++++++||||+++++++...... 
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG  101 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence            3579999999999999999999887765   8999999765  334567788999999999999999999999877655 


Q ss_pred             -----EEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEE
Q psy12427        181 -----VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMI  255 (356)
Q Consensus       181 -----~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~  255 (356)
                           ++||||+.+|+|.+++...........+....+..++.|++.||+|||++||+||||||+|||++.++  .+||+
T Consensus       102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~--~~kl~  179 (323)
T 3qup_A          102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM--TVCVA  179 (323)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS--CEEEC
T ss_pred             CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC--CEEEe
Confidence                 99999999999999886432211122344445666999999999999999999999999999997554  79999


Q ss_pred             eeeceeeeCCCCce---eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccc
Q psy12427        256 DFGLATKLDPNEVV---KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEF  331 (356)
Q Consensus       256 Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~  331 (356)
                      |||+++........   ....+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+....+.......
T Consensus       180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~  259 (323)
T 3qup_A          180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLK  259 (323)
T ss_dssp             CCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC
T ss_pred             eccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCC
Confidence            99999876543322   22346789999999999999999999999999999999 999999999888888877654322


Q ss_pred             ChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        332 DEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       332 ~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .   ...+++++.+||++||+.||+
T Consensus       260 ~---~~~~~~~l~~li~~~l~~dp~  281 (323)
T 3qup_A          260 Q---PPECMEEVYDLMYQCWSADPK  281 (323)
T ss_dssp             C---CTTCCHHHHHHHHHTTCSSGG
T ss_pred             C---CCccCHHHHHHHHHHccCChh
Confidence            2   247899999999999999985

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.8e-45  Score=330.81  Aligned_cols=240  Identities=22%  Similarity=0.364  Sum_probs=195.1

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhh-------HHHHHHHHHHHHhcCCCCceeeeeeEEeCC
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE-------KELIRKEIDIMNQLHHPKLINLHDAFEDDD  178 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~-------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  178 (356)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++.......       .+.+.+|+.++++++||||+++++++....
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   96 (287)
T 4f0f_A           17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP   96 (287)
T ss_dssp             CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred             hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence            3468999999999999999999999999999999986543221       156889999999999999999999987655


Q ss_pred             eEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEEeecCC---CcEE
Q psy12427        179 EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN--IIHLDVKPENIMCQTRNS---TNVK  253 (356)
Q Consensus       179 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~Dlkp~NIlv~~~~~---~~vk  253 (356)
                        ++||||+++|+|.+.+......+++.     .+..++.|++.||+|||+.|  |+||||||+|||++.++.   ..+|
T Consensus        97 --~lv~e~~~~~~L~~~l~~~~~~~~~~-----~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~k  169 (287)
T 4f0f_A           97 --RMVMEFVPCGDLYHRLLDKAHPIKWS-----VKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAK  169 (287)
T ss_dssp             --EEEEECCTTCBHHHHHHCTTSCCCHH-----HHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred             --eEEEEecCCCCHHHHHhcccCCccHH-----HHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEE
Confidence              69999999999999887654444443     34559999999999999999  999999999999976442   2389


Q ss_pred             EEeeeceeeeCCCCceeecCCCcCccccccc--cCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHH--HHHhhcccc
Q psy12427        254 MIDFGLATKLDPNEVVKISTGTAEFAAPEIV--EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVET--LKNVKACDW  329 (356)
Q Consensus       254 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~--~~~i~~~~~  329 (356)
                      |+|||+++....  ......||+.|+|||++  ....++.++|||||||++|+|++|+.||...+..+.  ...+.....
T Consensus       170 l~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  247 (287)
T 4f0f_A          170 VADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL  247 (287)
T ss_dssp             ECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC
T ss_pred             eCCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC
Confidence            999999975432  34456799999999999  455678899999999999999999999987754433  444443332


Q ss_pred             ccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        330 EFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       330 ~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                        .+.....+|+++.+||++||+.||+
T Consensus       248 --~~~~~~~~~~~l~~li~~~l~~dp~  272 (287)
T 4f0f_A          248 --RPTIPEDCPPRLRNVIELCWSGDPK  272 (287)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred             --CCCCCcccCHHHHHHHHHHhcCChh
Confidence              2233458899999999999999985

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.4e-45  Score=328.05  Aligned_cols=238  Identities=21%  Similarity=0.324  Sum_probs=202.1

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      .++|++.+.||+|+||.||+|.++ ++..||+|+++.... ....+.+|+.++.+++||||+++++++......++||||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY   84 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence            468999999999999999999876 467899999976543 346688999999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +++++|.+++......+     ....+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||++......
T Consensus        85 ~~~~~L~~~l~~~~~~~-----~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~~l~Dfg~~~~~~~~  157 (268)
T 3sxs_A           85 ISNGCLLNYLRSHGKGL-----EPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDL--CVKVSDFGMTRYVLDD  157 (268)
T ss_dssp             CTTCBHHHHHHHHGGGC-----CHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTC--CEEECCTTCEEECCTT
T ss_pred             cCCCcHHHHHHHcCCCC-----CHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCC--CEEEccCccceecchh
Confidence            99999999987543223     3344556999999999999999999999999999997654  7999999999877544


Q ss_pred             Cceee--cCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHH
Q psy12427        267 EVVKI--STGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG  343 (356)
Q Consensus       267 ~~~~~--~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  343 (356)
                      .....  ..+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+........+   ..+|+++
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l  234 (268)
T 3sxs_A          158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP---HLASDTI  234 (268)
T ss_dssp             CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTSCHHH
T ss_pred             hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCC---CcChHHH
Confidence            33222  235678999999999899999999999999999999 99999999998888888776544433   3679999


Q ss_pred             HHHHHHhhhcCCC
Q psy12427        344 KDFIRRLLLRNKE  356 (356)
Q Consensus       344 ~~lI~~ll~~dP~  356 (356)
                      .++|++||+.||+
T Consensus       235 ~~li~~~l~~~p~  247 (268)
T 3sxs_A          235 YQIMYSCWHELPE  247 (268)
T ss_dssp             HHHHHHTTCSSGG
T ss_pred             HHHHHHHcCCChh
Confidence            9999999999985

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1e-45  Score=335.22  Aligned_cols=241  Identities=22%  Similarity=0.359  Sum_probs=192.5

Q ss_pred             cccceeeeccccccCceEEEEEE----EccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEe--CCe
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCR----ERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFED--DDE  179 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~----~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~  179 (356)
                      ..++|++.+.||+|+||+||+|+    +..+++.||+|++........+.+.+|+.+|++++||||+++++++..  ...
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   87 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   87 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence            34689999999999999999999    566789999999987777777889999999999999999999999854  456


Q ss_pred             EEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeec
Q psy12427        180 MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGL  259 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~  259 (356)
                      .++||||+++|+|.+++......++     ...+..++.|++.||+|||+.||+||||||+|||++.++  .+||+|||+
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~~~~~-----~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~--~~kl~Dfg~  160 (295)
T 3ugc_A           88 LKLIMEYLPYGSLRDYLQKHKERID-----HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN--RVKIGDFGL  160 (295)
T ss_dssp             CEEEEECCTTCBHHHHHHHCGGGCC-----HHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECCCCS
T ss_pred             eEEEEEeCCCCCHHHHHHhcccccC-----HHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCC--eEEEccCcc
Confidence            8999999999999999976543333     334556999999999999999999999999999998765  799999999


Q ss_pred             eeeeCCCCc----eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChH----------------H
Q psy12427        260 ATKLDPNEV----VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDV----------------E  319 (356)
Q Consensus       260 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~----------------~  319 (356)
                      +........    .....+++.|+|||++.+..++.++||||||+++|+|++|..||......                .
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T 3ugc_A          161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  240 (295)
T ss_dssp             CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence            987643321    22234677899999999999999999999999999999999998654221                1


Q ss_pred             HHHHhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        320 TLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       320 ~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ....+.... ..  +....+|+++.+||++||+.||+
T Consensus       241 ~~~~~~~~~-~~--~~~~~~~~~l~~li~~~l~~dp~  274 (295)
T 3ugc_A          241 LIELLKNNG-RL--PRPDGCPDEIYMIMTECWNNNVN  274 (295)
T ss_dssp             HHHHHHTTC-CC--CCCTTCCHHHHHHHHHHSCSSGG
T ss_pred             HHHHHhccC-cC--CCCcCcCHHHHHHHHHHcCCChh
Confidence            122222221 11  22347899999999999999985

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.1e-45  Score=334.50  Aligned_cols=244  Identities=20%  Similarity=0.338  Sum_probs=192.5

Q ss_pred             CCcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh---hHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeE
Q psy12427        104 SSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL---EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM  180 (356)
Q Consensus       104 ~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  180 (356)
                      +...++|++.+.||+|+||.||+|.++.+++.||+|++......   ....+.+|+.++++++||||+++++++...+..
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~  109 (309)
T 2h34_A           30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL  109 (309)
T ss_dssp             ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence            34567899999999999999999999999999999999765322   346788999999999999999999999999999


Q ss_pred             EEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeece
Q psy12427        181 VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA  260 (356)
Q Consensus       181 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a  260 (356)
                      ++||||+++++|.+++.... .     +....+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||++
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~-~-----~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~--~~kl~Dfg~~  181 (309)
T 2h34_A          110 YVDMRLINGVDLAAMLRRQG-P-----LAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADD--FAYLVDFGIA  181 (309)
T ss_dssp             EEEEECCCCEEHHHHHHHHC-S-----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--CEEECSCCC-
T ss_pred             EEEEEecCCCCHHHHHHhcC-C-----CCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCC--CEEEecCccC
Confidence            99999999999999986432 2     33344556999999999999999999999999999997654  7999999999


Q ss_pred             eeeCCCCc--eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhcc
Q psy12427        261 TKLDPNEV--VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKN  338 (356)
Q Consensus       261 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  338 (356)
                      ........  .....|++.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.......+ ......+......
T Consensus       182 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~  260 (309)
T 2h34_A          182 SATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-NQAIPRPSTVRPG  260 (309)
T ss_dssp             ---------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH-HSCCCCGGGTSTT
T ss_pred             ccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh-ccCCCCccccCCC
Confidence            77654322  23446899999999999999999999999999999999999999988765443333 3344444455668


Q ss_pred             CCHHHHHHHHHhhhcCCC
Q psy12427        339 VSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       339 ~s~~~~~lI~~ll~~dP~  356 (356)
                      +|.++.++|.+||+.||+
T Consensus       261 ~~~~l~~li~~~l~~dP~  278 (309)
T 2h34_A          261 IPVAFDAVIARGMAKNPE  278 (309)
T ss_dssp             CCTHHHHHHHHHTCSSGG
T ss_pred             CCHHHHHHHHHhccCCHH
Confidence            999999999999999985

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.9e-45  Score=332.30  Aligned_cols=243  Identities=22%  Similarity=0.269  Sum_probs=201.7

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEEEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      +.++|++.+.||+|+||.||+|.+..+++.||+|++.....  ...+.+|+.++..+ +|+|++++++++......++||
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   85 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   85 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence            45689999999999999999999999999999999865432  34577899999999 7999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCC---CcEEEEeeecee
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNS---TNVKMIDFGLAT  261 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~---~~vkl~Dfg~a~  261 (356)
                      ||+ +++|.+++......+++     ..+..++.||+.||+|||++||+||||||+|||++.++.   ..+||+|||+++
T Consensus        86 e~~-~~~L~~~l~~~~~~~~~-----~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           86 DLL-GPSLEDLLDLCGRKFSV-----KTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCH-----HHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             Eec-CCCHHHHHHHhccCCCH-----HHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            999 99999999754433433     445569999999999999999999999999999976442   349999999998


Q ss_pred             eeCCCCc--------eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC---ChHHHHHHhhccccc
Q psy12427        262 KLDPNEV--------VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGE---NDVETLKNVKACDWE  330 (356)
Q Consensus       262 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~---~~~~~~~~i~~~~~~  330 (356)
                      .......        .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.   ...+.+..+......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (298)
T 1csn_A          160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  239 (298)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence            7754322        23446899999999999999999999999999999999999999884   344555555443333


Q ss_pred             cC-hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        331 FD-EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       331 ~~-~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+ +.....+|+++.++|.+||+.||+
T Consensus       240 ~~~~~~~~~~~~~l~~li~~~l~~dp~  266 (298)
T 1csn_A          240 TPLRELCAGFPEEFYKYMHYARNLAFD  266 (298)
T ss_dssp             SCHHHHTTTSCHHHHHHHHHHHHCCTT
T ss_pred             ccHHHHHhhCcHHHHHHHHHHhcCCcc
Confidence            22 344457999999999999999995

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=4.3e-45  Score=329.22  Aligned_cols=238  Identities=29%  Similarity=0.532  Sum_probs=206.3

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      ..++|++.+.||+|+||.||+|.+..++..||+|++....   ......+.+|+++++.++||||+++++++......++
T Consensus        12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   91 (284)
T 2vgo_A           12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL   91 (284)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence            3468999999999999999999999999999999986532   1224678899999999999999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ||||+++++|.+++.... .     +....+..++.|++.||+|||++|++||||||+||+++.++  .+||+|||++..
T Consensus        92 v~e~~~~~~L~~~l~~~~-~-----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~kl~Dfg~~~~  163 (284)
T 2vgo_A           92 MLEFAPRGELYKELQKHG-R-----FDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKG--ELKIADFGWSVH  163 (284)
T ss_dssp             EECCCTTEEHHHHHHHHS-S-----CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTC--CEEECCCTTCEE
T ss_pred             EEEeCCCCcHHHHHHhcC-C-----CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCC--CEEEeccccccc
Confidence            999999999999886432 2     33344556999999999999999999999999999997554  799999999976


Q ss_pred             eCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHH
Q psy12427        263 LDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEE  342 (356)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  342 (356)
                      .... ......|++.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+......+++    .+|.+
T Consensus       164 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~  238 (284)
T 2vgo_A          164 APSL-RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP----FLSDG  238 (284)
T ss_dssp             CSSS-CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT----TSCHH
T ss_pred             Cccc-ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCC----cCCHH
Confidence            6432 233457899999999999999999999999999999999999999999998888888877766553    78999


Q ss_pred             HHHHHHHhhhcCCC
Q psy12427        343 GKDFIRRLLLRNKE  356 (356)
Q Consensus       343 ~~~lI~~ll~~dP~  356 (356)
                      +++||++||+.||+
T Consensus       239 ~~~li~~~l~~~p~  252 (284)
T 2vgo_A          239 SKDLISKLLRYHPP  252 (284)
T ss_dssp             HHHHHHHHSCSSGG
T ss_pred             HHHHHHHHhhcCHh
Confidence            99999999999984

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=4e-45  Score=327.84  Aligned_cols=239  Identities=27%  Similarity=0.489  Sum_probs=197.1

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh---hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN---LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      ..++|++.+.||+|+||.||+|.++.+|+.||+|++.....   .....+.+|+.+++.++||||+++++++......++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM   88 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence            34689999999999999999999999999999999865422   234678899999999999999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ||||+++++|.+++.... .     +....+..++.|++.||+|||++|++|+||||+|||++.++  .+||+|||++..
T Consensus        89 v~e~~~~~~L~~~l~~~~-~-----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~~l~dfg~~~~  160 (276)
T 2h6d_A           89 VMEYVSGGELFDYICKHG-R-----VEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHM--NAKIADFGLSNM  160 (276)
T ss_dssp             EEECCCSCBHHHHHHHHC-S-----CCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTS--CEEECCCCGGGC
T ss_pred             EEeccCCCcHHHHHhccC-C-----CCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCC--CEEEeecccccc
Confidence            999999999999986432 2     23344556999999999999999999999999999997554  799999999987


Q ss_pred             eCCCCceeecCCCcCccccccccCCCC-CccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCH
Q psy12427        263 LDPNEVVKISTGTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSE  341 (356)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  341 (356)
                      ...........|++.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+..+....+......++    ..++.
T Consensus       161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~  236 (276)
T 2h6d_A          161 MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP----EYLNR  236 (276)
T ss_dssp             CCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCH
T ss_pred             cCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCc----hhcCH
Confidence            765554555678999999999988765 6899999999999999999999999988888888877665554    36899


Q ss_pred             HHHHHHHHhhhcCCC
Q psy12427        342 EGKDFIRRLLLRNKE  356 (356)
Q Consensus       342 ~~~~lI~~ll~~dP~  356 (356)
                      ++.++|.+||+.||+
T Consensus       237 ~l~~li~~~l~~~p~  251 (276)
T 2h6d_A          237 SVATLLMHMLQVDPL  251 (276)
T ss_dssp             HHHHHHHHHTCSSGG
T ss_pred             HHHHHHHHHccCChh
Confidence            999999999999984

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=6.9e-45  Score=335.29  Aligned_cols=242  Identities=29%  Similarity=0.497  Sum_probs=196.6

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh--hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN--LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      .++|++.+.||+|+||.||+|+++.+|+.||+|++.....  .....+.+|+.++++++||||+++++++......++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            4689999999999999999999999999999999865432  23456778999999999999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      ||+++++|.+++.... .     +....+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||++....
T Consensus       104 e~~~~~~l~~~~~~~~-~-----~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~  175 (331)
T 4aaa_A          104 EFVDHTILDDLELFPN-G-----LDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSG--VVKLCDFGFARTLA  175 (331)
T ss_dssp             ECCSEEHHHHHHHSTT-C-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCCTTC----
T ss_pred             ecCCcchHHHHHhhcc-C-----CCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCC--cEEEEeCCCceeec
Confidence            9999999988765432 2     33344556999999999999999999999999999997654  79999999998764


Q ss_pred             CC-CceeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC----------
Q psy12427        265 PN-EVVKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD----------  332 (356)
Q Consensus       265 ~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~----------  332 (356)
                      .. .......|++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.......+          
T Consensus       176 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (331)
T 4aaa_A          176 APGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN  255 (331)
T ss_dssp             --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred             CCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence            32 233445789999999999875 689999999999999999999999999988877766643222211          


Q ss_pred             -----------------hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 -----------------EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 -----------------~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                       ...+..+|+++.+||++||+.||+
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~  296 (331)
T 4aaa_A          256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPD  296 (331)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGG
T ss_pred             cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcc
Confidence                             122346899999999999999995

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=9.7e-45  Score=346.22  Aligned_cols=243  Identities=25%  Similarity=0.381  Sum_probs=190.9

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccC--ChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeC-----
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS--HNLEKELIRKEIDIMNQLHHPKLINLHDAFEDD-----  177 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----  177 (356)
                      .+.++|++.+.||+|+||.||+|+++.+++.||+|++...  .......+.+|+.+|+.++||||+++++++...     
T Consensus        23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  102 (432)
T 3n9x_A           23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF  102 (432)
T ss_dssp             CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred             eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence            4567899999999999999999999999999999999753  334456788999999999999999999999766     


Q ss_pred             CeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEee
Q psy12427        178 DEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDF  257 (356)
Q Consensus       178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Df  257 (356)
                      ...++||||+. ++|.+++.... .     +....+..++.||+.||+|||+.||+||||||+|||++.++  .+||+||
T Consensus       103 ~~~~lv~e~~~-~~L~~~~~~~~-~-----l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~--~~kL~DF  173 (432)
T 3n9x_A          103 DELYIVLEIAD-SDLKKLFKTPI-F-----LTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDC--SVKVCDF  173 (432)
T ss_dssp             CCEEEEEECCS-EEHHHHHHSSC-C-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCC
T ss_pred             CeEEEEEecCC-cCHHHHHhccC-C-----CCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCC--CEEEccC
Confidence            67999999985 69999987532 2     33344566999999999999999999999999999997554  7999999


Q ss_pred             eceeeeCCCC-----------------------ceeecCCCcCccccccc-cCCCCCccccHHHHHHHHHHHHc------
Q psy12427        258 GLATKLDPNE-----------------------VVKISTGTAEFAAPEIV-EREPVGFYTDMWAVGVLAYVLLS------  307 (356)
Q Consensus       258 g~a~~~~~~~-----------------------~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlG~il~ell~------  307 (356)
                      |+|+......                       .....+||+.|+|||++ ....++.++|||||||++|||++      
T Consensus       174 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             TTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             CCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            9998765332                       12456789999999986 56679999999999999999997      


Q ss_pred             -----CCCCCCCCC-----------------hHHHHHHhhccccccC---------------------------hhhhcc
Q psy12427        308 -----GLSPFAGEN-----------------DVETLKNVKACDWEFD---------------------------EEAFKN  338 (356)
Q Consensus       308 -----g~~Pf~~~~-----------------~~~~~~~i~~~~~~~~---------------------------~~~~~~  338 (356)
                           |.++|.+.+                 ..+.+..+......++                           ...+..
T Consensus       254 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (432)
T 3n9x_A          254 NDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPS  333 (432)
T ss_dssp             SSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTT
T ss_pred             cccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCC
Confidence                 555565543                 1233333322211111                           123356


Q ss_pred             CCHHHHHHHHHhhhcCCC
Q psy12427        339 VSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       339 ~s~~~~~lI~~ll~~dP~  356 (356)
                      +|+++.+||++||+.||+
T Consensus       334 ~s~~~~dLl~~mL~~dP~  351 (432)
T 3n9x_A          334 ISDDGINLLESMLKFNPN  351 (432)
T ss_dssp             SCHHHHHHHHHHSCSSTT
T ss_pred             CCHHHHHHHHHHhcCCcc
Confidence            899999999999999995

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.3e-45  Score=342.15  Aligned_cols=239  Identities=25%  Similarity=0.429  Sum_probs=182.0

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccC--ChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeC------
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS--HNLEKELIRKEIDIMNQLHHPKLINLHDAFEDD------  177 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------  177 (356)
                      +.++|++.+.||+|+||.||+|.+..+|+.||+|++...  .......+.+|+.+|+.++||||+++++++...      
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            346899999999999999999999999999999998653  334456778999999999999999999998654      


Q ss_pred             CeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEee
Q psy12427        178 DEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDF  257 (356)
Q Consensus       178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Df  257 (356)
                      ...++++|++ +++|.+++...  .     +....+..++.||+.||+|||+.||+||||||+|||++.++  .+||+||
T Consensus       107 ~~~~lv~e~~-~~~L~~~~~~~--~-----l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~--~~kL~DF  176 (367)
T 2fst_X          107 NDVYLVTHLM-GADLNNIVKCQ--K-----LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC--ELKILDF  176 (367)
T ss_dssp             CCCEEEEECC-CEECC-----C--C-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--CEEECC-
T ss_pred             CeEEEEeccc-CCCHHHHHhcC--C-----CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCC--CEEEeec
Confidence            6689999999 78998887642  2     33344566999999999999999999999999999997554  7999999


Q ss_pred             eceeeeCCCCceeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCh---
Q psy12427        258 GLATKLDPNEVVKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE---  333 (356)
Q Consensus       258 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~---  333 (356)
                      |+++.....  .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+......++.   
T Consensus       177 G~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~  254 (367)
T 2fst_X          177 GLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL  254 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             ccccccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            999875432  334578999999999887 67899999999999999999999999999988888777553322221   


Q ss_pred             ------------------------hhhccCCHHHHHHHHHhhhcCCC
Q psy12427        334 ------------------------EAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       334 ------------------------~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                              ..+..+++++++||++||+.||+
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~  301 (367)
T 2fst_X          255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSD  301 (367)
T ss_dssp             TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGG
T ss_pred             HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcc
Confidence                                    22345789999999999999995

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=340.49  Aligned_cols=247  Identities=23%  Similarity=0.301  Sum_probs=205.9

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCC-------CEEEEEEcccCC-hhhHHHHHHHHHHHHhc-CCCCceeeeeeEE
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTG-------NIFAAKFIPVSH-NLEKELIRKEIDIMNQL-HHPKLINLHDAFE  175 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~-------~~~a~K~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~  175 (356)
                      ...++|.+.+.||+|+||+||+|.+..++       ..||+|+++... ......+.+|+++++++ +||||+++++++.
T Consensus        66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  145 (382)
T 3tt0_A           66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT  145 (382)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence            34578999999999999999999986433       579999987653 33457788999999999 8999999999999


Q ss_pred             eCCeEEEEEEeccccchhhhhhCCCCC----------CCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEe
Q psy12427        176 DDDEMVLIFEFLSGGELFERITAPDYK----------MSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQ  245 (356)
Q Consensus       176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~----------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~  245 (356)
                      ..+..++||||+++|+|.+++......          .....+....+..++.||+.||+|||++||+||||||+|||++
T Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~  225 (382)
T 3tt0_A          146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT  225 (382)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEc
Confidence            999999999999999999999754321          1123345556677999999999999999999999999999997


Q ss_pred             ecCCCcEEEEeeeceeeeCCCCc---eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q psy12427        246 TRNSTNVKMIDFGLATKLDPNEV---VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETL  321 (356)
Q Consensus       246 ~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~  321 (356)
                      .++  .+||+|||+++.......   .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+..
T Consensus       226 ~~~--~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~  303 (382)
T 3tt0_A          226 EDN--VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF  303 (382)
T ss_dssp             TTC--CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             CCC--cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            654  799999999987654322   222346889999999999999999999999999999999 99999999988888


Q ss_pred             HHhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        322 KNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       322 ~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ..+........   ...+++++.+||++||+.||+
T Consensus       304 ~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~  335 (382)
T 3tt0_A          304 KLLKEGHRMDK---PSNCTNELYMMMRDCWHAVPS  335 (382)
T ss_dssp             HHHHTTCCCCC---CSSCCHHHHHHHHHHTCSSGG
T ss_pred             HHHHcCCCCCC---CccCCHHHHHHHHHHcCCChh
Confidence            88776543222   247899999999999999985

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.1e-45  Score=343.17  Aligned_cols=244  Identities=19%  Similarity=0.235  Sum_probs=187.9

Q ss_pred             ccceeeeccccccCceEEEEEEEccC-----CCEEEEEEcccCChhhH-----------HHHHHHHHHHHhcCCCCceee
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKT-----GNIFAAKFIPVSHNLEK-----------ELIRKEIDIMNQLHHPKLINL  170 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~-----~~~~a~K~~~~~~~~~~-----------~~~~~E~~il~~l~hpnIv~l  170 (356)
                      .++|++.+.||+|+||.||+|.++.+     ++.||+|++........           ..+..|+..+..++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            35899999999999999999999765     58899999876543211           123346667777889999999


Q ss_pred             eeeEEeC----CeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEee
Q psy12427        171 HDAFEDD----DEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQT  246 (356)
Q Consensus       171 ~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~  246 (356)
                      ++++...    ...++||||+ |++|.+++......+++.     .+..++.||+.||+|||++||+||||||+|||++.
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~-----~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~  187 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRK-----TVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY  187 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHH-----HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHH-----HHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec
Confidence            9998764    5589999999 999999997654344444     44559999999999999999999999999999985


Q ss_pred             cCCCcEEEEeeeceeeeCCCCce--------eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC-h
Q psy12427        247 RNSTNVKMIDFGLATKLDPNEVV--------KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN-D  317 (356)
Q Consensus       247 ~~~~~vkl~Dfg~a~~~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~-~  317 (356)
                      +.++.+||+|||+++.+......        ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.. .
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence            45568999999999876432211        23349999999999999999999999999999999999999998643 3


Q ss_pred             HHHHHHhhccccc----cChhhh--ccCCHHHHHHHHHhhhcCCC
Q psy12427        318 VETLKNVKACDWE----FDEEAF--KNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       318 ~~~~~~i~~~~~~----~~~~~~--~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .............    .....+  .++|+++.+||..||+.||+
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~  312 (364)
T 3op5_A          268 PKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYT  312 (364)
T ss_dssp             HHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTT
T ss_pred             HHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCC
Confidence            2222222111100    111111  47899999999999999995

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=9.3e-46  Score=341.78  Aligned_cols=234  Identities=28%  Similarity=0.442  Sum_probs=196.8

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh--------hHHHHHHHHHHHHhcCCCCceeeeeeEEe
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL--------EKELIRKEIDIMNQLHHPKLINLHDAFED  176 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~--------~~~~~~~E~~il~~l~hpnIv~l~~~~~~  176 (356)
                      .+.++|++.+.||+|+||+||+|+++.+++.||+|++......        ....+.+|+.+|++++||||+++++++..
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~  100 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN  100 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            4567899999999999999999999999999999998765321        23356679999999999999999999999


Q ss_pred             CCeEEEEEEecccc-chhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEE
Q psy12427        177 DDEMVLIFEFLSGG-ELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMI  255 (356)
Q Consensus       177 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~  255 (356)
                      .+..++||||+.+| +|.+++.... .++     ...+..++.||+.||+|||++||+||||||+|||++.++  .+||+
T Consensus       101 ~~~~~lv~e~~~~g~~l~~~~~~~~-~l~-----~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~  172 (335)
T 3dls_A          101 QGFFQLVMEKHGSGLDLFAFIDRHP-RLD-----EPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDF--TIKLI  172 (335)
T ss_dssp             SSEEEEEEECCTTSCBHHHHHHTCC-CCC-----HHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS--CEEEC
T ss_pred             CCEEEEEEEeCCCCccHHHHHHhcC-CCC-----HHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCC--cEEEe
Confidence            99999999999766 9999887543 233     334556999999999999999999999999999997654  79999


Q ss_pred             eeeceeeeCCCCceeecCCCcCccccccccCCCC-CccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChh
Q psy12427        256 DFGLATKLDPNEVVKISTGTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEE  334 (356)
Q Consensus       256 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  334 (356)
                      |||++.............||+.|+|||++.+..+ +.++|||||||++|+|++|..||.....      ........+  
T Consensus       173 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~~~--  244 (335)
T 3dls_A          173 DFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAIHPP--  244 (335)
T ss_dssp             CCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCCCCS--
T ss_pred             ecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhccCCC--
Confidence            9999998876666666789999999999998877 7899999999999999999999976322      222222222  


Q ss_pred             hhccCCHHHHHHHHHhhhcCCC
Q psy12427        335 AFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       335 ~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                        ..+|+++++||++||+.||+
T Consensus       245 --~~~~~~l~~li~~~L~~dP~  264 (335)
T 3dls_A          245 --YLVSKELMSLVSGLLQPVPE  264 (335)
T ss_dssp             --SCCCHHHHHHHHHHTCSSGG
T ss_pred             --cccCHHHHHHHHHHccCChh
Confidence              36899999999999999985

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3e-45  Score=337.21  Aligned_cols=239  Identities=18%  Similarity=0.267  Sum_probs=192.6

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCE----EEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNI----FAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMV  181 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~----~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  181 (356)
                      .++|++.+.||+|+||+||+|++..++..    ||+|.+.... ......+.+|+.++++++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            36799999999999999999999888765    4777775433 334567889999999999999999999998754 78


Q ss_pred             EEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeecee
Q psy12427        182 LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT  261 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~  261 (356)
                      +++||+.+|+|.+++......+++.     .+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+++
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~-----~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~--~~kl~Dfg~a~  165 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHKDNIGSQ-----YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ--HVKITDFGLAK  165 (327)
T ss_dssp             EEEECCTTCBHHHHHHHSTTSCCHH-----HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT--EEEECCTTHHH
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHH-----HHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCC--CEEEccCccee
Confidence            8999999999999997654444443     3455999999999999999999999999999998765  79999999998


Q ss_pred             eeCCCCce---eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhc
Q psy12427        262 KLDPNEVV---KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFK  337 (356)
Q Consensus       262 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  337 (356)
                      ........   ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+........   ..
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~---~~  242 (327)
T 3poz_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---PP  242 (327)
T ss_dssp             HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC---CT
T ss_pred             EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCC---Cc
Confidence            76543322   22346889999999999999999999999999999999 9999999988777777665543222   24


Q ss_pred             cCCHHHHHHHHHhhhcCCC
Q psy12427        338 NVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       338 ~~s~~~~~lI~~ll~~dP~  356 (356)
                      .++.++.++|.+||+.||+
T Consensus       243 ~~~~~~~~li~~~l~~~p~  261 (327)
T 3poz_A          243 ICTIDVYMIMVKCWMIDAD  261 (327)
T ss_dssp             TBCHHHHHHHHHHTCSCGG
T ss_pred             cCCHHHHHHHHHHcCCChh
Confidence            6899999999999999985

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.8e-45  Score=343.06  Aligned_cols=242  Identities=24%  Similarity=0.378  Sum_probs=194.5

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEe----------
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFED----------  176 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----------  176 (356)
                      .++|++.+.||+|+||+||+|.+..+|+.||+|++.....    ...+|+.+|+.++||||+++++++..          
T Consensus         6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~   81 (383)
T 3eb0_A            6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ   81 (383)
T ss_dssp             CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred             cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence            4689999999999999999999999999999999865432    22369999999999999999999843          


Q ss_pred             ----------------------------CCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHH
Q psy12427        177 ----------------------------DDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH  228 (356)
Q Consensus       177 ----------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH  228 (356)
                                                  ....++||||++ |+|.+.+....  .....+....++.++.||+.||+|||
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH  158 (383)
T 3eb0_A           82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFI--RSGRSIPMNLISIYIYQLFRAVGFIH  158 (383)
T ss_dssp             ----------------------------CCEEEEEECCCS-EEHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence                                        344889999997 57766654210  01122333445669999999999999


Q ss_pred             HCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCceeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHc
Q psy12427        229 EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLS  307 (356)
Q Consensus       229 ~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~  307 (356)
                      ++||+||||||+|||++.++ +.+||+|||+|+............||+.|+|||++.+. .++.++||||+||++|+|++
T Consensus       159 ~~gi~H~Dikp~Nil~~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~  237 (383)
T 3eb0_A          159 SLGICHRDIKPQNLLVNSKD-NTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL  237 (383)
T ss_dssp             TTTEECSCCCGGGEEEETTT-TEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred             HCcCccCccCHHHEEEcCCC-CcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence            99999999999999997433 47999999999987666666667789999999998765 48999999999999999999


Q ss_pred             CCCCCCCCChHHHHHHhhccccccC-------------------------hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        308 GLSPFAGENDVETLKNVKACDWEFD-------------------------EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       308 g~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      |+.||.+.+..+.+..+......++                         ......+|+++.+||++||+.||+
T Consensus       238 g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  311 (383)
T 3eb0_A          238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD  311 (383)
T ss_dssp             SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence            9999999998888877754322211                         112235899999999999999995

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.5e-45  Score=336.98  Aligned_cols=247  Identities=22%  Similarity=0.329  Sum_probs=199.3

Q ss_pred             cccceeeeccccccCceEEEEEEEc-----cCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCC
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRER-----KTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDD  178 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~-----~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  178 (356)
                      ..++|.+.+.||+|+||.||+|.+.     .++..||+|++.... ......+.+|+.+|.++ +||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            4578999999999999999999983     346689999997543 23446788999999999 8999999999999999


Q ss_pred             eEEEEEEeccccchhhhhhCCCCCCCc-----------------cccccccHHHHHHHHHHHHHHHHHCCceeccCCCCC
Q psy12427        179 EMVLIFEFLSGGELFERITAPDYKMSE-----------------AEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPEN  241 (356)
Q Consensus       179 ~~~lv~e~~~~g~L~~~l~~~~~~~~~-----------------~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~N  241 (356)
                      ..++||||+++|+|.+++......+.+                 ..+....+..++.||+.||+|||++||+||||||+|
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~N  202 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN  202 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhh
Confidence            999999999999999999865433221                 123445566799999999999999999999999999


Q ss_pred             EEEeecCCCcEEEEeeeceeeeCCCCce---eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCCh
Q psy12427        242 IMCQTRNSTNVKMIDFGLATKLDPNEVV---KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGEND  317 (356)
Q Consensus       242 Ilv~~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~  317 (356)
                      ||++.++  .+||+|||++.........   ....||+.|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus       203 Ill~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  280 (344)
T 1rjb_A          203 VLVTHGK--VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  280 (344)
T ss_dssp             EEEETTT--EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             EEEcCCC--cEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence            9998554  7999999999876433221   22346889999999999999999999999999999998 9999998876


Q ss_pred             HHHHHHhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        318 VETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       318 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+.+..+......++  ....+++++.+||.+||+.||+
T Consensus       281 ~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~  317 (344)
T 1rjb_A          281 DANFYKLIQNGFKMD--QPFYATEEIYIIMQSCWAFDSR  317 (344)
T ss_dssp             SHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGG
T ss_pred             HHHHHHHHhcCCCCC--CCCCCCHHHHHHHHHHcCCCch
Confidence            555555544433322  2247899999999999999984

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=9.7e-45  Score=331.23  Aligned_cols=245  Identities=21%  Similarity=0.288  Sum_probs=204.3

Q ss_pred             ccceeeeccccccCceEEEEEEEc-----cCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRER-----KTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM  180 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~-----~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  180 (356)
                      .++|.+.+.||+|+||.||+|.+.     .++..||+|++.... ......+.+|+.+|++++||||+++++++...+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            468999999999999999999984     445899999997643 34457788999999999999999999999999999


Q ss_pred             EEEEEeccccchhhhhhCCCCCC------------------CccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCE
Q psy12427        181 VLIFEFLSGGELFERITAPDYKM------------------SEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENI  242 (356)
Q Consensus       181 ~lv~e~~~~g~L~~~l~~~~~~~------------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NI  242 (356)
                      ++||||+++++|.+++.......                  ....+....+..++.||+.||+|||++||+||||||+||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NI  181 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNI  181 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheE
Confidence            99999999999999997543210                  112344556677999999999999999999999999999


Q ss_pred             EEeecCCCcEEEEeeeceeeeCCCCce---eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChH
Q psy12427        243 MCQTRNSTNVKMIDFGLATKLDPNEVV---KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDV  318 (356)
Q Consensus       243 lv~~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~  318 (356)
                      |++.++  .+||+|||+++........   ....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..
T Consensus       182 li~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~  259 (314)
T 2ivs_A          182 LVAEGR--KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE  259 (314)
T ss_dssp             EEETTT--EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             EEcCCC--CEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            998554  7999999999877543322   22346889999999999999999999999999999999 99999999888


Q ss_pred             HHHHHhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        319 ETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       319 ~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +....+......   .....+|+++.++|.+||+.||+
T Consensus       260 ~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~  294 (314)
T 2ivs_A          260 RLFNLLKTGHRM---ERPDNCSEEMYRLMLQCWKQEPD  294 (314)
T ss_dssp             GHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             HHHHHhhcCCcC---CCCccCCHHHHHHHHHHccCChh
Confidence            877777664422   22357899999999999999985

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.8e-45  Score=332.33  Aligned_cols=237  Identities=19%  Similarity=0.277  Sum_probs=195.7

Q ss_pred             ccceeeeccccccCceEEEEEEEccCC-------CEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCe
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTG-------NIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDE  179 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~-------~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  179 (356)
                      .++|++.+.||+|+||+||+|.++.++       ..||+|++........+.+.+|+.+|++++||||+++++++...+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            468999999999999999999999877       4799999977766677889999999999999999999999999999


Q ss_pred             EEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCC------cEE
Q psy12427        180 MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNST------NVK  253 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~------~vk  253 (356)
                      .++||||+++|+|.+++......++     ...+..++.|++.||+|||++||+||||||+|||++.++..      .+|
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~~~~~-----~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNKNCIN-----ILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGCC-----HHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             CEEEEECCCCCCHHHHHHhCCCCCC-----HHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence            9999999999999999975433233     33445699999999999999999999999999999876531      299


Q ss_pred             EEeeeceeeeCCCCceeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccc
Q psy12427        254 MIDFGLATKLDPNEVVKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEF  331 (356)
Q Consensus       254 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~  331 (356)
                      |+|||++......   ....|++.|+|||++.+ ..++.++|||||||++|+|++ |.+||............. .....
T Consensus       162 l~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~-~~~~~  237 (289)
T 4fvq_A          162 LSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE-DRHQL  237 (289)
T ss_dssp             ECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCC
T ss_pred             eccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh-ccCCC
Confidence            9999998654322   23457899999999987 778999999999999999999 555666655555444333 33333


Q ss_pred             ChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        332 DEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       332 ~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +    ..+++++.+||++||+.||+
T Consensus       238 ~----~~~~~~l~~li~~~l~~dp~  258 (289)
T 4fvq_A          238 P----APKAAELANLINNCMDYEPD  258 (289)
T ss_dssp             C----CCSSCTTHHHHHHHSCSSGG
T ss_pred             C----CCCCHHHHHHHHHHcCCChh
Confidence            3    35688999999999999985

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=4.4e-45  Score=354.26  Aligned_cols=240  Identities=24%  Similarity=0.355  Sum_probs=203.0

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      .++|++.+.||+|+||.||+|.++.++..||+|.++.... ..+.+.+|+.+|++++||||+++++++......++||||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            4679999999999999999999999999999999976543 467788999999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +++|+|.+++.....    ..+....+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+++.....
T Consensus       298 ~~~g~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~--~~kl~DFG~a~~~~~~  371 (495)
T 1opk_A          298 MTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENH--LVKVADFGLSRLMTGD  371 (495)
T ss_dssp             CTTCBHHHHHHHSCT----TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG--CEEECCTTCEECCTTC
T ss_pred             cCCCCHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCC--cEEEeecccceeccCC
Confidence            999999999975321    1233344556999999999999999999999999999997654  7999999999876543


Q ss_pred             Ccee--ecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHH
Q psy12427        267 EVVK--ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG  343 (356)
Q Consensus       267 ~~~~--~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  343 (356)
                      ....  ...+++.|+|||++.+..++.++|||||||+||||++ |..||.+.+..+....+......   +.+..+|+++
T Consensus       372 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l  448 (495)
T 1opk_A          372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---ERPEGCPEKV  448 (495)
T ss_dssp             CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC---CCCTTCCHHH
T ss_pred             ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHH
Confidence            3221  1235788999999999999999999999999999999 99999999888777776553221   2234789999


Q ss_pred             HHHHHHhhhcCCC
Q psy12427        344 KDFIRRLLLRNKE  356 (356)
Q Consensus       344 ~~lI~~ll~~dP~  356 (356)
                      .+||.+||+.||+
T Consensus       449 ~~li~~cl~~dP~  461 (495)
T 1opk_A          449 YELMRACWQWNPS  461 (495)
T ss_dssp             HHHHHHHTCSSGG
T ss_pred             HHHHHHHcCcChh
Confidence            9999999999985

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=3.2e-45  Score=340.91  Aligned_cols=246  Identities=22%  Similarity=0.296  Sum_probs=196.8

Q ss_pred             ccceeeeccccccCceEEEEEEE-----ccCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCC-
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRE-----RKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDD-  178 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~-----~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~-  178 (356)
                      .++|++.+.||+|+||.||+|.+     ..+++.||+|+++... ......+.+|+.+|.++ +||||+++++++...+ 
T Consensus        21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~  100 (359)
T 3vhe_A           21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  100 (359)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCC
Confidence            46899999999999999999994     4566899999997643 33456788999999999 7899999999998754 


Q ss_pred             eEEEEEEeccccchhhhhhCCCCCC-------------------------------------------------------
Q psy12427        179 EMVLIFEFLSGGELFERITAPDYKM-------------------------------------------------------  203 (356)
Q Consensus       179 ~~~lv~e~~~~g~L~~~l~~~~~~~-------------------------------------------------------  203 (356)
                      ..++||||+++|+|.+++.......                                                       
T Consensus       101 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (359)
T 3vhe_A          101 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  180 (359)
T ss_dssp             CCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------------
T ss_pred             ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcc
Confidence            4899999999999999997653210                                                       


Q ss_pred             -----CccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCc---eeecCCC
Q psy12427        204 -----SEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEV---VKISTGT  275 (356)
Q Consensus       204 -----~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt  275 (356)
                           ....+....+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||++........   .....||
T Consensus       181 ~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~t  258 (359)
T 3vhe_A          181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN--VVKICDFGLARDIYKDPDYVRKGDARLP  258 (359)
T ss_dssp             ---CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEEECCCGGGSCTTSCTTCEEC--CEEC
T ss_pred             cccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC--cEEEEeccceeeecccccchhccccCCC
Confidence                 011144455677999999999999999999999999999998655  799999999986643222   2234578


Q ss_pred             cCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHHHhhhcC
Q psy12427        276 AEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRN  354 (356)
Q Consensus       276 ~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~d  354 (356)
                      +.|+|||++.+..++.++|||||||++|+|++ |..||.+....+.+..........  .....+++++.++|.+||+.|
T Consensus       259 ~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~d  336 (359)
T 3vhe_A          259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--RAPDYTTPEMYQTMLDCWHGE  336 (359)
T ss_dssp             GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC--CCCTTCCHHHHHHHHHHTCSS
T ss_pred             ceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHHccCC
Confidence            99999999999999999999999999999998 999999887544443333322221  122478999999999999999


Q ss_pred             CC
Q psy12427        355 KE  356 (356)
Q Consensus       355 P~  356 (356)
                      |+
T Consensus       337 P~  338 (359)
T 3vhe_A          337 PS  338 (359)
T ss_dssp             GG
T ss_pred             hh
Confidence            85

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.7e-45  Score=329.39  Aligned_cols=238  Identities=22%  Similarity=0.330  Sum_probs=198.8

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      .++|++.+.||+|+||.||+|.++ ++..||+|+++.... ....+.+|+.++.+++||||+++++++......++||||
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            468999999999999999999887 567899999976543 346688999999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +++++|.+++......+++     ..+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||++......
T Consensus       101 ~~~~~L~~~l~~~~~~~~~-----~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~--~~kl~Dfg~~~~~~~~  173 (283)
T 3gen_A          101 MANGCLLNYLREMRHRFQT-----QQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG--VVKVSDFGLSRYVLDD  173 (283)
T ss_dssp             CTTCBHHHHHHCGGGCCCH-----HHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTS--CEEECSTTGGGGBCCH
T ss_pred             cCCCcHHHHHHHhccCCCH-----HHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCC--CEEEcccccccccccc
Confidence            9999999999764333333     34556999999999999999999999999999997554  7999999999866432


Q ss_pred             Cce--eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHH
Q psy12427        267 EVV--KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG  343 (356)
Q Consensus       267 ~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  343 (356)
                      ...  ....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+........+   ..+++++
T Consensus       174 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l  250 (283)
T 3gen_A          174 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---HLASEKV  250 (283)
T ss_dssp             HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTCCHHH
T ss_pred             ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCC---CcCCHHH
Confidence            211  12346788999999999999999999999999999998 99999999998888888776443332   4679999


Q ss_pred             HHHHHHhhhcCCC
Q psy12427        344 KDFIRRLLLRNKE  356 (356)
Q Consensus       344 ~~lI~~ll~~dP~  356 (356)
                      .++|.+||+.||+
T Consensus       251 ~~li~~~l~~~p~  263 (283)
T 3gen_A          251 YTIMYSCWHEKAD  263 (283)
T ss_dssp             HHHHHHTTCSSGG
T ss_pred             HHHHHHHccCChh
Confidence            9999999999985

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.8e-45  Score=338.31  Aligned_cols=239  Identities=18%  Similarity=0.297  Sum_probs=195.6

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCE----EEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNI----FAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMV  181 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~----~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  181 (356)
                      .++|++.+.||+|+||+||+|.+..++..    +|+|.+.... ......+.+|+.++++++||||+++++++. ....+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            35799999999999999999999988876    6777764432 222345668999999999999999999886 46689


Q ss_pred             EEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeecee
Q psy12427        182 LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT  261 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~  261 (356)
                      +||||+.+|+|.+++......+     ....+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||+++
T Consensus        91 ~v~e~~~~~~L~~~l~~~~~~~-----~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~--~~kl~Dfg~a~  163 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQHRGAL-----GPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPS--QVQVADFGVAD  163 (325)
T ss_dssp             EEEECCTTCBSHHHHHSSGGGS-----CTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSS--CEEECSCSGGG
T ss_pred             EEEEeCCCCCHHHHHHHccccC-----CHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCC--eEEECCCCccc
Confidence            9999999999999997653333     3344566999999999999999999999999999997654  79999999998


Q ss_pred             eeCCCC---ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhc
Q psy12427        262 KLDPNE---VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFK  337 (356)
Q Consensus       262 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  337 (356)
                      ......   ......|++.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+........+   .
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~  240 (325)
T 3kex_A          164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQP---Q  240 (325)
T ss_dssp             GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCC---T
T ss_pred             ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCC---C
Confidence            764332   2233457889999999999999999999999999999999 99999999888887777765433222   3


Q ss_pred             cCCHHHHHHHHHhhhcCCC
Q psy12427        338 NVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       338 ~~s~~~~~lI~~ll~~dP~  356 (356)
                      .++.++.++|.+||+.||+
T Consensus       241 ~~~~~~~~li~~~l~~dp~  259 (325)
T 3kex_A          241 ICTIDVYMVMVKCWMIDEN  259 (325)
T ss_dssp             TBCTTTTHHHHHHTCSCTT
T ss_pred             cCcHHHHHHHHHHcCCChh
Confidence            6889999999999999995

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=5e-45  Score=331.46  Aligned_cols=243  Identities=27%  Similarity=0.421  Sum_probs=199.1

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      ..++|++.+.||+|+||.||+|.++.++..+|+|++..........+.+|+.+++.++||||+++++++...+..++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            45689999999999999999999999999999999987766667888899999999999999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |+++++|.+++......+++     ..+..++.|++.||+|||+.|++||||||+|||++.++  .+||+|||++.....
T Consensus        97 ~~~~~~l~~~~~~~~~~~~~-----~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~  169 (302)
T 2j7t_A           97 FCPGGAVDAIMLELDRGLTE-----PQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEG--DIRLADFGVSAKNLK  169 (302)
T ss_dssp             CCTTEEHHHHHHHHTSCCCH-----HHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTS--CEEECCCHHHHHHHH
T ss_pred             eCCCCcHHHHHHhhccCCCH-----HHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCC--CEEEEECCCCccccc
Confidence            99999999988653333333     34455999999999999999999999999999997554  799999998754321


Q ss_pred             -CCceeecCCCcCccccccc-----cCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccC
Q psy12427        266 -NEVVKISTGTAEFAAPEIV-----EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNV  339 (356)
Q Consensus       266 -~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  339 (356)
                       ........|++.|+|||++     ....++.++||||||+++|+|++|..||...+..+.+..+........ .....+
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~  248 (302)
T 2j7t_A          170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL-LTPSKW  248 (302)
T ss_dssp             HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-SSGGGS
T ss_pred             cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc-CCcccc
Confidence             1112334689999999998     467789999999999999999999999999988887777766543221 223478


Q ss_pred             CHHHHHHHHHhhhcCCC
Q psy12427        340 SEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       340 s~~~~~lI~~ll~~dP~  356 (356)
                      |.++.+||++||+.||+
T Consensus       249 ~~~l~~li~~~l~~dp~  265 (302)
T 2j7t_A          249 SVEFRDFLKIALDKNPE  265 (302)
T ss_dssp             CHHHHHHHHHHSCSCTT
T ss_pred             CHHHHHHHHHHcccChh
Confidence            99999999999999995

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=6.4e-45  Score=346.18  Aligned_cols=241  Identities=22%  Similarity=0.332  Sum_probs=190.9

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeC------CeEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDD------DEMV  181 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------~~~~  181 (356)
                      .+|++.+.||+|+||.||+|+++.+|+.||+|.+.....    ...+|+++|+.++||||++++++|...      ..++
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            469999999999999999999999999999999865422    234699999999999999999988532      2367


Q ss_pred             EEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeecee
Q psy12427        182 LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT  261 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~  261 (356)
                      +||||+.+ +|.+.+....  .....+....+..++.||+.||+|||++||+||||||+|||++.++ ..+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~--~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~-~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYS--RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT-AVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTT-TEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCC-CeEEeccchhhh
Confidence            99999975 5555543110  0112233344566999999999999999999999999999998543 368999999999


Q ss_pred             eeCCCCceeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc----------
Q psy12427        262 KLDPNEVVKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWE----------  330 (356)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~----------  330 (356)
                      ............||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+.++......          
T Consensus       206 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~  285 (420)
T 1j1b_A          206 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN  285 (420)
T ss_dssp             ECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHC
T ss_pred             hcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence            87655545556789999999999764 7899999999999999999999999999888877766542111          


Q ss_pred             -------cCh--------hhhccCCHHHHHHHHHhhhcCCC
Q psy12427        331 -------FDE--------EAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       331 -------~~~--------~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                             ++.        .....+++++++||++||+.||+
T Consensus       286 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~  326 (420)
T 1j1b_A          286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT  326 (420)
T ss_dssp             SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGG
T ss_pred             hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChh
Confidence                   110        11235789999999999999985

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2e-44  Score=343.63  Aligned_cols=216  Identities=25%  Similarity=0.432  Sum_probs=183.3

Q ss_pred             CCcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhc------CCCCceeeeeeEEeC
Q psy12427        104 SSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL------HHPKLINLHDAFEDD  177 (356)
Q Consensus       104 ~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l------~hpnIv~l~~~~~~~  177 (356)
                      ..+..+|++.+.||+|+||+||+|.+..+++.||+|++.... .....+.+|+.+++.+      .|+||+++++++...
T Consensus        93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~  171 (429)
T 3kvw_A           93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR  171 (429)
T ss_dssp             CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred             CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence            345678999999999999999999999999999999997543 3345677899998887      567999999999999


Q ss_pred             CeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEee
Q psy12427        178 DEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDF  257 (356)
Q Consensus       178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Df  257 (356)
                      ...++||||+. ++|.+++......    .+....+..++.||+.||+|||++||+||||||+|||++.++...+||+||
T Consensus       172 ~~~~lv~e~~~-~~L~~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DF  246 (429)
T 3kvw_A          172 NHICMTFELLS-MNLYELIKKNKFQ----GFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF  246 (429)
T ss_dssp             TEEEEEECCCC-CBHHHHHHHTTTC----CCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred             CeEEEEEeccC-CCHHHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeec
Confidence            99999999995 6898888754321    233344566999999999999999999999999999998766445999999


Q ss_pred             eceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcc
Q psy12427        258 GLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKAC  327 (356)
Q Consensus       258 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~  327 (356)
                      |+++....  ......||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+...
T Consensus       247 G~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~  314 (429)
T 3kvw_A          247 GSSCYEHQ--RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIEL  314 (429)
T ss_dssp             TTCEETTC--CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             ccceecCC--cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            99977543  233457899999999999999999999999999999999999999999988888776653

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=7.9e-45  Score=348.55  Aligned_cols=235  Identities=20%  Similarity=0.334  Sum_probs=196.8

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCC-eEEEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDD-EMVLIFE  185 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-~~~lv~e  185 (356)
                      .++|++.+.||+|+||.||+|.++  |+.||+|+++...  ..+.+.+|+.+|++++||||+++++++.... ..++|||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            468999999999999999999886  7799999997654  4567889999999999999999999987665 7999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |+++|+|.+++......    .+....+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+++....
T Consensus       268 ~~~~g~L~~~l~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~--~~kl~DfG~a~~~~~  341 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGRS----VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN--VAKVSDFGLTKEASS  341 (450)
T ss_dssp             CCTTCBHHHHHHHHCTT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTS--CEEECCCTTCEECC-
T ss_pred             ecCCCcHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCC--CEEEeeCCCcccccc
Confidence            99999999999754321    123334556999999999999999999999999999997654  799999999986543


Q ss_pred             CCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHHH
Q psy12427        266 NEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK  344 (356)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  344 (356)
                      .  .....+++.|+|||++.+..++.++|||||||+||||++ |..||.+.+..+....+..+...   +....+|+++.
T Consensus       342 ~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---~~p~~~~~~l~  416 (450)
T 1k9a_A          342 T--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM---DAPDGCPPAVY  416 (450)
T ss_dssp             -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCC---CCCTTCCHHHH
T ss_pred             c--ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCcCCHHHH
Confidence            2  223467899999999999999999999999999999998 99999999888888877665322   22347999999


Q ss_pred             HHHHHhhhcCCC
Q psy12427        345 DFIRRLLLRNKE  356 (356)
Q Consensus       345 ~lI~~ll~~dP~  356 (356)
                      ++|++||+.||+
T Consensus       417 ~li~~cl~~dp~  428 (450)
T 1k9a_A          417 DVMKNCWHLDAA  428 (450)
T ss_dssp             HHHHHHTCSSGG
T ss_pred             HHHHHHcCCChh
Confidence            999999999985

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.7e-44  Score=325.82  Aligned_cols=241  Identities=24%  Similarity=0.357  Sum_probs=204.1

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      ..++|++.+.||+|+||.||+|.++.++..||+|.+..... ..+.+.+|+.++++++||||+++++++......++|||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST-HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            34689999999999999999999999999999999875443 45678899999999999999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |+.+++|.+++.....    ..+....+..++.|++.||+|||++||+||||||+||+++.++  .+||+|||++.....
T Consensus        90 ~~~~~~L~~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~~l~Dfg~~~~~~~  163 (288)
T 3kfa_A           90 FMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSRLMTG  163 (288)
T ss_dssp             CCTTEEHHHHHHHCCT----TTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGG--CEEECCCCGGGTSCS
T ss_pred             cCCCCcHHHHHHhccc----CCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCC--CEEEccCccceeccC
Confidence            9999999999975321    2233344566999999999999999999999999999997655  799999999987654


Q ss_pred             CCceee--cCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHH
Q psy12427        266 NEVVKI--STGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEE  342 (356)
Q Consensus       266 ~~~~~~--~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  342 (356)
                      ......  ..+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+......   .....+|++
T Consensus       164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  240 (288)
T 3kfa_A          164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---ERPEGCPEK  240 (288)
T ss_dssp             SSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC---CCCTTCCHH
T ss_pred             CccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCC---CCCCCCCHH
Confidence            433222  236889999999999999999999999999999999 99999998887777766654322   222478999


Q ss_pred             HHHHHHHhhhcCCC
Q psy12427        343 GKDFIRRLLLRNKE  356 (356)
Q Consensus       343 ~~~lI~~ll~~dP~  356 (356)
                      +.+||++||+.||+
T Consensus       241 l~~li~~~l~~dp~  254 (288)
T 3kfa_A          241 VYELMRACWQWNPS  254 (288)
T ss_dssp             HHHHHHHHTCSSGG
T ss_pred             HHHHHHHHhCCChh
Confidence            99999999999985

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.4e-44  Score=331.08  Aligned_cols=246  Identities=23%  Similarity=0.312  Sum_probs=203.3

Q ss_pred             cccceeeeccccccCceEEEEEEEc-------cCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEe
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRER-------KTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQL-HHPKLINLHDAFED  176 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~-------~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~  176 (356)
                      ..++|++.+.||+|+||.||+|.+.       .++..||+|++.... ......+.+|+.+|+++ +||||+++++++..
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            3478999999999999999999986       456789999997653 33456788999999999 89999999999999


Q ss_pred             CCeEEEEEEeccccchhhhhhCCCCC----------CCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEee
Q psy12427        177 DDEMVLIFEFLSGGELFERITAPDYK----------MSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQT  246 (356)
Q Consensus       177 ~~~~~lv~e~~~~g~L~~~l~~~~~~----------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~  246 (356)
                      .+..++||||+++|+|.+++......          .....+....+..++.||+.||+|||++||+||||||+|||++.
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~  192 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE  192 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcC
Confidence            99999999999999999999764321          11223444556779999999999999999999999999999975


Q ss_pred             cCCCcEEEEeeeceeeeCCCCce---eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q psy12427        247 RNSTNVKMIDFGLATKLDPNEVV---KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLK  322 (356)
Q Consensus       247 ~~~~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~  322 (356)
                      ++  .+||+|||++.........   ....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+...
T Consensus       193 ~~--~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~  270 (334)
T 2pvf_A          193 NN--VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK  270 (334)
T ss_dssp             TC--CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred             CC--CEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHH
Confidence            54  7999999999887644332   22346889999999998889999999999999999999 999999999888887


Q ss_pred             HhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        323 NVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       323 ~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+.......   ....++.++.++|++||+.||+
T Consensus       271 ~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~  301 (334)
T 2pvf_A          271 LLKEGHRMD---KPANCTNELYMMMRDCWHAVPS  301 (334)
T ss_dssp             HHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGG
T ss_pred             HHhcCCCCC---CCccCCHHHHHHHHHHccCChh
Confidence            776654222   2247899999999999999984

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.7e-44  Score=330.80  Aligned_cols=237  Identities=24%  Similarity=0.460  Sum_probs=195.2

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcC-CCCceeeeeeEEe--CCeEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLH-HPKLINLHDAFED--DDEMVLI  183 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~--~~~~~lv  183 (356)
                      .++|++.+.||+|+||+||+|++..+++.||+|+++...   ...+.+|+.+|++++ ||||+++++++..  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            468999999999999999999999999999999987543   456889999999997 9999999999987  6789999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      |||+.+++|.+++..    +     ....+..++.||+.||+|||++||+||||||+|||++.++ ..+||+|||+++..
T Consensus       112 ~e~~~~~~l~~~~~~----~-----~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~-~~~kl~Dfg~a~~~  181 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQT----L-----TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH-RKLRLIDWGLAEFY  181 (330)
T ss_dssp             EECCCCCCHHHHGGG----C-----CHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT-TEEEECCCTTCEEC
T ss_pred             EeccCchhHHHHHHh----C-----CHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCC-CEEEEEeCCCceEc
Confidence            999999999888752    2     2334556999999999999999999999999999997554 37999999999987


Q ss_pred             CCCCceeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCC-ChHHHHHHhhc-------------cc
Q psy12427        264 DPNEVVKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGE-NDVETLKNVKA-------------CD  328 (356)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~-~~~~~~~~i~~-------------~~  328 (356)
                      ..........|++.|+|||++.+ ..++.++|||||||++|+|++|..||... +..+.+..+..             ..
T Consensus       182 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  261 (330)
T 3nsz_A          182 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  261 (330)
T ss_dssp             CTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             CCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence            76665666789999999999977 67899999999999999999999999543 44444433322             11


Q ss_pred             cccC--------------------hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        329 WEFD--------------------EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       329 ~~~~--------------------~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ...+                    ......+|+++++||++||+.||+
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  309 (330)
T 3nsz_A          262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ  309 (330)
T ss_dssp             CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGG
T ss_pred             cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcc
Confidence            1111                    112234899999999999999995

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4.4e-44  Score=325.65  Aligned_cols=238  Identities=24%  Similarity=0.411  Sum_probs=204.9

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      .+.|++.+.||+|+||.||+|.++.+++.||+|++.... ....+.+.+|+.+++.++||||+++++++......++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            457999999999999999999999999999999987554 3346778899999999999999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |+++++|.+++...  .     +....+..++.|++.||+|||+.|++|+||||+|||++.++  .+||+|||++.....
T Consensus       101 ~~~~~~L~~~~~~~--~-----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~kl~Dfg~~~~~~~  171 (303)
T 3a7i_A          101 YLGGGSALDLLEPG--P-----LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG--EVKLADFGVAGQLTD  171 (303)
T ss_dssp             CCTTEEHHHHHTTS--C-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECBT
T ss_pred             eCCCCcHHHHHhcC--C-----CCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCC--CEEEeecccceecCc
Confidence            99999999998642  2     33344556999999999999999999999999999997554  799999999987754


Q ss_pred             CC-ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHH
Q psy12427        266 NE-VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK  344 (356)
Q Consensus       266 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  344 (356)
                      .. ......|++.|+|||++.+..++.++||||||+++|+|++|..||......+....+......   .....++.++.
T Consensus       172 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~  248 (303)
T 3a7i_A          172 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPP---TLEGNYSKPLK  248 (303)
T ss_dssp             TBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC---CCCSSCCHHHH
T ss_pred             cccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCC---CCccccCHHHH
Confidence            33 223456899999999999999999999999999999999999999998888877776654422   23357899999


Q ss_pred             HHHHHhhhcCCC
Q psy12427        345 DFIRRLLLRNKE  356 (356)
Q Consensus       345 ~lI~~ll~~dP~  356 (356)
                      +||.+||+.||+
T Consensus       249 ~li~~~l~~dp~  260 (303)
T 3a7i_A          249 EFVEACLNKEPS  260 (303)
T ss_dssp             HHHHHHCCSSGG
T ss_pred             HHHHHHcCCChh
Confidence            999999999985

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.6e-44  Score=323.04  Aligned_cols=238  Identities=25%  Similarity=0.395  Sum_probs=190.2

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh----hHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL----EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~----~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      .++|++.+.||+|+||.||+|.+.  +..+|+|+++.....    ..+.+.+|+.+++.++||||+++++++...+..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL   83 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence            467999999999999999999986  789999998764332    24678899999999999999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCC---ceeccCCCCCEEEeec------CCCcEE
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN---IIHLDVKPENIMCQTR------NSTNVK  253 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~Dlkp~NIlv~~~------~~~~vk  253 (356)
                      ||||+++++|.+++...  .+     ....+..++.|++.||+|||++|   |+||||||+|||++.+      ..+.+|
T Consensus        84 v~e~~~~~~L~~~~~~~--~~-----~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k  156 (271)
T 3dtc_A           84 VMEFARGGPLNRVLSGK--RI-----PPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILK  156 (271)
T ss_dssp             EEECCTTEEHHHHHTSS--CC-----CHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred             EEEcCCCCCHHHHhhcC--CC-----CHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceE
Confidence            99999999999988533  23     33445569999999999999999   9999999999999752      134799


Q ss_pred             EEeeeceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCh
Q psy12427        254 MIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE  333 (356)
Q Consensus       254 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~  333 (356)
                      |+|||++........ ....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.......+.......+ 
T Consensus       157 l~Dfg~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-  234 (271)
T 3dtc_A          157 ITDFGLAREWHRTTK-MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP-  234 (271)
T ss_dssp             ECCCCC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCC-
T ss_pred             EccCCcccccccccc-cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCC-
Confidence            999999987654322 345689999999999999999999999999999999999999999988888777766554433 


Q ss_pred             hhhccCCHHHHHHHHHhhhcCCC
Q psy12427        334 EAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       334 ~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                       ....+|+++.++|.+||+.||+
T Consensus       235 -~~~~~~~~~~~li~~~l~~~p~  256 (271)
T 3dtc_A          235 -IPSTCPEPFAKLMEDCWNPDPH  256 (271)
T ss_dssp             -CCTTCCHHHHHHHHHHTCSSGG
T ss_pred             -CCcccCHHHHHHHHHHhcCCcc
Confidence             2357899999999999999985

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=6.5e-45  Score=334.81  Aligned_cols=245  Identities=22%  Similarity=0.334  Sum_probs=200.1

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEE--EEEEcccCC-hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIF--AAKFIPVSH-NLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~--a~K~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l  182 (356)
                      .++|++.+.||+|+||.||+|+++.++..+  |+|.++... ......+.+|+.+|+++ +||||+++++++...+..++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  103 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL  103 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence            368999999999999999999999988765  889886532 33456688999999999 89999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCC----------CCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcE
Q psy12427        183 IFEFLSGGELFERITAPDYK----------MSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNV  252 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~----------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~v  252 (356)
                      ||||+++++|.+++......          .....+....+..++.||+.||+|||++||+||||||+|||++.++  .+
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~--~~  181 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY--VA  181 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG--CE
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC--eE
Confidence            99999999999999764310          1112344455667999999999999999999999999999997655  79


Q ss_pred             EEEeeeceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccc
Q psy12427        253 KMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEF  331 (356)
Q Consensus       253 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~  331 (356)
                      ||+|||+++............+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+...... 
T Consensus       182 kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~-  260 (327)
T 1fvr_A          182 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL-  260 (327)
T ss_dssp             EECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCC-
T ss_pred             EEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCC-
Confidence            9999999975433223334457889999999998889999999999999999998 99999999998888887664321 


Q ss_pred             ChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        332 DEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       332 ~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                        .....+++++.+||++||+.||+
T Consensus       261 --~~~~~~~~~l~~li~~~l~~dp~  283 (327)
T 1fvr_A          261 --EKPLNCDDEVYDLMRQCWREKPY  283 (327)
T ss_dssp             --CCCTTBCHHHHHHHHHHTCSSGG
T ss_pred             --CCCCCCCHHHHHHHHHHccCChh
Confidence              12247899999999999999984

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.5e-44  Score=322.55  Aligned_cols=241  Identities=27%  Similarity=0.460  Sum_probs=198.5

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      +.++|++.+.||+|+||.||+|.++.+++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            3468999999999999999999999999999999987543 334567889999999999999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      ||+++++|.+++....      .+....+..++.|++.||+|||++|++|+||||+||+++.++  .+||+|||++....
T Consensus        85 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~kl~dfg~~~~~~  156 (276)
T 2yex_A           85 EYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFR  156 (276)
T ss_dssp             ECCTTEEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCTTCEECE
T ss_pred             EecCCCcHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCC--CEEEeeCCCccccC
Confidence            9999999999886432      233344566999999999999999999999999999997554  79999999998654


Q ss_pred             CCC---ceeecCCCcCccccccccCCCC-CccccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHhhccccccChhhhccC
Q psy12427        265 PNE---VVKISTGTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDV-ETLKNVKACDWEFDEEAFKNV  339 (356)
Q Consensus       265 ~~~---~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~ell~g~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~  339 (356)
                      ...   ......|++.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.. ..+..+.......  ..+..+
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~  234 (276)
T 2yex_A          157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL--NPWKKI  234 (276)
T ss_dssp             ETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTS--TTGGGS
T ss_pred             CCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccccc--Cchhhc
Confidence            322   2234568999999999988775 77899999999999999999999876543 2333333322222  224579


Q ss_pred             CHHHHHHHHHhhhcCCC
Q psy12427        340 SEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       340 s~~~~~lI~~ll~~dP~  356 (356)
                      ++++++||++||+.||+
T Consensus       235 ~~~~~~li~~~l~~~p~  251 (276)
T 2yex_A          235 DSAPLALLHKILVENPS  251 (276)
T ss_dssp             CHHHHHHHHHHSCSSTT
T ss_pred             CHHHHHHHHHHCCCCch
Confidence            99999999999999995

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.2e-45  Score=346.92  Aligned_cols=248  Identities=24%  Similarity=0.400  Sum_probs=199.3

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCC--eEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDD--EMVL  182 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--~~~l  182 (356)
                      ..++|++.+.||+|+||+||+|+++.+|+.||+|++.... ....+.+.+|+++|++++||||+++++++....  ..++
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l   86 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence            4568999999999999999999999999999999987543 234567789999999999999999999998655  7899


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEee--cCCCcEEEEeeece
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQT--RNSTNVKMIDFGLA  260 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~--~~~~~vkl~Dfg~a  260 (356)
                      ||||+++|+|.+++......   ..+....+..++.||+.||+|||++||+||||||+|||+..  ++...+||+|||++
T Consensus        87 v~e~~~~g~L~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           87 IMEFCPCGSLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             EECCCTTEEHHHHTTSGGGT---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             EEecCCCCCHHHHHHhhhcc---cCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            99999999999998753321   11344455669999999999999999999999999999833  23346899999999


Q ss_pred             eeeCCCCceeecCCCcCccccccccC--------CCCCccccHHHHHHHHHHHHcCCCCCCCC----ChHHHHHHhhccc
Q psy12427        261 TKLDPNEVVKISTGTAEFAAPEIVER--------EPVGFYTDMWAVGVLAYVLLSGLSPFAGE----NDVETLKNVKACD  328 (356)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwSlG~il~ell~g~~Pf~~~----~~~~~~~~i~~~~  328 (356)
                      +............||+.|+|||++.+        ..++.++|||||||++|+|++|+.||...    ...+.+..+....
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  243 (396)
T 4eut_A          164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK  243 (396)
T ss_dssp             EECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC
T ss_pred             eEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC
Confidence            98766555556679999999999865        56788999999999999999999999743    3445555554432


Q ss_pred             cc---------------------cChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        329 WE---------------------FDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       329 ~~---------------------~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ..                     .+......++..++++|++||+.||+
T Consensus       244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~  292 (396)
T 4eut_A          244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE  292 (396)
T ss_dssp             CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTT
T ss_pred             CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChh
Confidence            11                     11112234667899999999999996

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=6.5e-45  Score=337.45  Aligned_cols=243  Identities=18%  Similarity=0.163  Sum_probs=187.9

Q ss_pred             ccceeeeccccccCceEEEEEEEcc---CCCEEEEEEcccCChh-----------hHHHHHHHHHHHHhcCCCCceeeee
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERK---TGNIFAAKFIPVSHNL-----------EKELIRKEIDIMNQLHHPKLINLHD  172 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~---~~~~~a~K~~~~~~~~-----------~~~~~~~E~~il~~l~hpnIv~l~~  172 (356)
                      .++|++.+.||+|+||.||+|.++.   ++..+|+|++......           ....+.+|+.+++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            4689999999999999999999987   7889999998765321           1123557889999999999999999


Q ss_pred             eEEe----CCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecC
Q psy12427        173 AFED----DDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN  248 (356)
Q Consensus       173 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~  248 (356)
                      ++..    ....++||||+ +++|.+++....      .+....+..++.||+.||+|||++||+||||||+|||++.++
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG------TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG------BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCC
Confidence            9987    78899999999 999999986533      333444566999999999999999999999999999998776


Q ss_pred             CCcEEEEeeeceeeeCCCCc--------eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC--ChH
Q psy12427        249 STNVKMIDFGLATKLDPNEV--------VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGE--NDV  318 (356)
Q Consensus       249 ~~~vkl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~--~~~  318 (356)
                      ...+||+|||+++.+.....        .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.  +..
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  268 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV  268 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence            56899999999987643211        13346899999999999999999999999999999999999999653  332


Q ss_pred             HHHHHhhccccccChhhhc-----cCCHHHHHHHHHhhhcCCC
Q psy12427        319 ETLKNVKACDWEFDEEAFK-----NVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       319 ~~~~~i~~~~~~~~~~~~~-----~~s~~~~~lI~~ll~~dP~  356 (356)
                      ............++.....     .+|+++++||.+||+.||+
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~  311 (345)
T 2v62_A          269 AVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYD  311 (345)
T ss_dssp             HHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTT
T ss_pred             HHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcc
Confidence            2222222222222222111     7899999999999999995

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.5e-44  Score=322.11  Aligned_cols=239  Identities=24%  Similarity=0.369  Sum_probs=199.7

Q ss_pred             ccceeeec-cccccCceEEEEEEEc--cCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        107 YDHYDILE-EIGTGAFGVVHRCRER--KTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       107 ~~~y~~~~-~lg~G~fg~V~~~~~~--~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      .++|.+.+ .||+|+||.||+|.++  .++..||+|+++... ....+.+.+|+.++++++||||+++++++ .....++
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l   86 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML   86 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence            35677777 9999999999999864  457889999997653 34567788999999999999999999999 4567999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ||||+.+++|.+++......+++     ..+..++.|++.||+|||+.||+||||||+|||++.++  .+||+|||++..
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~-----~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~kl~Dfg~~~~  159 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVGKREEIPV-----SNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH--YAKISDFGLSKA  159 (287)
T ss_dssp             EEECCTTEEHHHHHTTCTTTSCH-----HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT--EEEECCCTTCEE
T ss_pred             EEEeCCCCCHHHHHHhCCccCCH-----HHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCC--CEEECcccceee
Confidence            99999999999999754433443     34455999999999999999999999999999998655  799999999988


Q ss_pred             eCCCCcee----ecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhc
Q psy12427        263 LDPNEVVK----ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFK  337 (356)
Q Consensus       263 ~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  337 (356)
                      ........    ...+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..+....+......   ....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~---~~~~  236 (287)
T 1u59_A          160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---ECPP  236 (287)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC---CCCT
T ss_pred             eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcC---CCCC
Confidence            75433322    2346889999999998889999999999999999998 99999999988888877765422   2234


Q ss_pred             cCCHHHHHHHHHhhhcCCC
Q psy12427        338 NVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       338 ~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+|+++.++|++||+.||+
T Consensus       237 ~~~~~l~~li~~~l~~~p~  255 (287)
T 1u59_A          237 ECPPELYALMSDCWIYKWE  255 (287)
T ss_dssp             TCCHHHHHHHHHTTCSSGG
T ss_pred             CcCHHHHHHHHHHcCCChh
Confidence            7899999999999999985

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=8.9e-45  Score=331.36  Aligned_cols=247  Identities=21%  Similarity=0.304  Sum_probs=201.5

Q ss_pred             cccceeeeccccccCceEEEEEEE-----ccCCCEEEEEEcccCCh-hhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCC
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRE-----RKTGNIFAAKFIPVSHN-LEKELIRKEIDIMNQL-HHPKLINLHDAFEDDD  178 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~-----~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  178 (356)
                      ..++|++.+.||+|+||.||+|.+     ..++..||+|++..... ...+.+.+|+.++.++ +||||+++++++...+
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            346899999999999999999986     34678999999976543 4557788999999999 9999999999999999


Q ss_pred             eEEEEEEeccccchhhhhhCCCCCC------------CccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEee
Q psy12427        179 EMVLIFEFLSGGELFERITAPDYKM------------SEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQT  246 (356)
Q Consensus       179 ~~~lv~e~~~~g~L~~~l~~~~~~~------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~  246 (356)
                      ..++||||+++|+|.+++.......            ....+....+..++.|++.||+|||++||+||||||+|||++.
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~  180 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH  180 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcC
Confidence            9999999999999999987543211            1112444556679999999999999999999999999999986


Q ss_pred             cCCCcEEEEeeeceeeeCCCCcee---ecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q psy12427        247 RNSTNVKMIDFGLATKLDPNEVVK---ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLK  322 (356)
Q Consensus       247 ~~~~~vkl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~  322 (356)
                      ++  .+||+|||++..........   ...+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+.+.
T Consensus       181 ~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~  258 (313)
T 1t46_A          181 GR--ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY  258 (313)
T ss_dssp             TT--EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred             CC--CEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHH
Confidence            54  79999999998765433221   2346789999999999999999999999999999999 999999887655555


Q ss_pred             HhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        323 NVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       323 ~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .........+  ....+|+++.++|.+||+.||+
T Consensus       259 ~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~  290 (313)
T 1t46_A          259 KMIKEGFRML--SPEHAPAEMYDIMKTCWDADPL  290 (313)
T ss_dssp             HHHHHTCCCC--CCTTSCHHHHHHHHHHTCSSGG
T ss_pred             HHhccCCCCC--CcccCCHHHHHHHHHHcCCCch
Confidence            4444333222  2247899999999999999984

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-44  Score=331.21  Aligned_cols=240  Identities=19%  Similarity=0.275  Sum_probs=195.0

Q ss_pred             ccceeeeccccccCceEEEEEEEccCC----CEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTG----NIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMV  181 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~----~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  181 (356)
                      .++|++.+.||+|+||+||+|.++.++    ..||+|.++... ......+.+|+.++++++||||+++++++......+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            467999999999999999999987653    359999987653 334567889999999999999999999999999999


Q ss_pred             EEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeecee
Q psy12427        182 LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT  261 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~  261 (356)
                      +||||+++++|.+++......+++     ..+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||++.
T Consensus       123 lv~e~~~~~~L~~~l~~~~~~~~~-----~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~--~~kl~Dfg~~~  195 (333)
T 1mqb_A          123 IITEYMENGALDKFLREKDGEFSV-----LQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL--VCKVSDFGLSR  195 (333)
T ss_dssp             EEEECCTTEEHHHHHHHTTTCSCH-----HHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECCCCC--
T ss_pred             EEEeCCCCCcHHHHHHhCCCCCCH-----HHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCC--cEEECCCCcch
Confidence            999999999999999754433443     34455999999999999999999999999999997544  79999999998


Q ss_pred             eeCCCCc----eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhh
Q psy12427        262 KLDPNEV----VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAF  336 (356)
Q Consensus       262 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  336 (356)
                      .......    .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+.......   ..
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~---~~  272 (333)
T 1mqb_A          196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP---TP  272 (333)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC---CC
T ss_pred             hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCC---Cc
Confidence            7643221    122345789999999999999999999999999999999 999999999888888877653221   12


Q ss_pred             ccCCHHHHHHHHHhhhcCCC
Q psy12427        337 KNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       337 ~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ..+++++.++|++||+.||+
T Consensus       273 ~~~~~~l~~li~~~l~~~p~  292 (333)
T 1mqb_A          273 MDCPSAIYQLMMQCWQQERA  292 (333)
T ss_dssp             TTCBHHHHHHHHHHTCSSTT
T ss_pred             ccCCHHHHHHHHHHcCCChh
Confidence            47899999999999999995

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.4e-44  Score=329.17  Aligned_cols=243  Identities=22%  Similarity=0.365  Sum_probs=194.7

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEE---------
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFE---------  175 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~---------  175 (356)
                      .+.++|++.+.||+|+||.||+|.++.+++.||+|.+..........+.+|+.++++++||||+++++++.         
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   87 (320)
T 2i6l_A            8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD   87 (320)
T ss_dssp             EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred             ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence            45678999999999999999999999999999999998777666778889999999999999999999873         


Q ss_pred             -----eCCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCC
Q psy12427        176 -----DDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNST  250 (356)
Q Consensus       176 -----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~  250 (356)
                           .....++||||+. |+|.+++...  .+     ....+..++.|++.||+|||++||+||||||+|||++.++ .
T Consensus        88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~-----~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~  158 (320)
T 2i6l_A           88 VGSLTELNSVYIVQEYME-TDLANVLEQG--PL-----LEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED-L  158 (320)
T ss_dssp             ---CCSCSEEEEEEECCS-EEHHHHHTTC--CC-----CHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-T
T ss_pred             cccccccCceeEEeeccC-CCHHHHhhcC--Cc-----cHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-C
Confidence                 4478899999997 6999988642  22     3334556999999999999999999999999999997543 4


Q ss_pred             cEEEEeeeceeeeCCCC----ceeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhh
Q psy12427        251 NVKMIDFGLATKLDPNE----VVKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVK  325 (356)
Q Consensus       251 ~vkl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~  325 (356)
                      .+||+|||+++......    ......+++.|+|||.+.. ..++.++|||||||++|+|++|+.||.+.+..+.+..+.
T Consensus       159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  238 (320)
T 2i6l_A          159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL  238 (320)
T ss_dssp             EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            79999999998764321    1223457999999998865 678999999999999999999999999999888777665


Q ss_pred             cccccc--------------------------ChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        326 ACDWEF--------------------------DEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       326 ~~~~~~--------------------------~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ......                          ....+..+|.++++||++||+.||+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  295 (320)
T 2i6l_A          239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPM  295 (320)
T ss_dssp             HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGG
T ss_pred             HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCcc
Confidence            432211                          1223356899999999999999985

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.6e-44  Score=335.75  Aligned_cols=241  Identities=23%  Similarity=0.377  Sum_probs=198.3

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeC-----Ce
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDD-----DE  179 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~  179 (356)
                      +.++|++.+.||+|+||.||+|.+..++..||+|++.... ......+.+|+.+|++++||||+++++++...     ..
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            3468999999999999999999999999999999987543 33446788999999999999999999999754     47


Q ss_pred             EEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeec
Q psy12427        180 MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGL  259 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~  259 (356)
                      .++||||+. |+|.+++....       +....+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+
T Consensus       105 ~~iv~e~~~-~~L~~~l~~~~-------~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~--~~kl~Dfg~  174 (364)
T 3qyz_A          105 VYIVQDLME-TDLYKLLKTQH-------LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC--DLKICDFGL  174 (364)
T ss_dssp             EEEEEECCS-EEHHHHHHHCC-------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTT
T ss_pred             EEEEEcccC-cCHHHHHHhCC-------CCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCC--CEEEEeCcc
Confidence            899999996 58988886432       33344556999999999999999999999999999997654  799999999


Q ss_pred             eeeeCCCCc----eeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC--
Q psy12427        260 ATKLDPNEV----VKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD--  332 (356)
Q Consensus       260 a~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~--  332 (356)
                      +........    .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+......++  
T Consensus       175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  254 (364)
T 3qyz_A          175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE  254 (364)
T ss_dssp             CEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHH
T ss_pred             eEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            987653322    233478999999998754 4589999999999999999999999999988887777654322222  


Q ss_pred             -------------------------hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 -------------------------EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 -------------------------~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                               ...+..++.++.+||++||+.||+
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  303 (364)
T 3qyz_A          255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPH  303 (364)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTT
T ss_pred             HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChh
Confidence                                     222356899999999999999995

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.5e-44  Score=330.94  Aligned_cols=248  Identities=18%  Similarity=0.251  Sum_probs=200.8

Q ss_pred             cccceeeeccccccCceEEEEEE-----EccCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCe
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCR-----ERKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDE  179 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~-----~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  179 (356)
                      ..++|++.+.||+|+||.||+|+     ...++..||+|.+.... ......+.+|+.++++++||||+++++++.....
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  107 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence            34689999999999999999999     55678899999997543 3445678899999999999999999999999999


Q ss_pred             EEEEEEeccccchhhhhhCCCCCCC-ccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecC-CCcEEEEee
Q psy12427        180 MVLIFEFLSGGELFERITAPDYKMS-EAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN-STNVKMIDF  257 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~-~~~vkl~Df  257 (356)
                      .++||||+++++|.+++........ ...+....+..++.|++.||+|||++||+||||||+|||++.++ ...+||+||
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Df  187 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF  187 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcc
Confidence            9999999999999999976542211 12344445667999999999999999999999999999998543 346999999


Q ss_pred             eceeeeCCCCc---eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccCh
Q psy12427        258 GLATKLDPNEV---VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDE  333 (356)
Q Consensus       258 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~  333 (356)
                      |++........   .....|++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+.......+ 
T Consensus       188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-  266 (327)
T 2yfx_A          188 GMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP-  266 (327)
T ss_dssp             HHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC-
T ss_pred             ccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCCC-
Confidence            99975532221   123457899999999999999999999999999999998 9999999998888888776543322 


Q ss_pred             hhhccCCHHHHHHHHHhhhcCCC
Q psy12427        334 EAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       334 ~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                        ...++.++.++|.+||+.||+
T Consensus       267 --~~~~~~~l~~li~~~l~~dp~  287 (327)
T 2yfx_A          267 --PKNCPGPVYRIMTQCWQHQPE  287 (327)
T ss_dssp             --CTTCCHHHHHHHHHHTCSSGG
T ss_pred             --CCCCCHHHHHHHHHHhcCChh
Confidence              247899999999999999984

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=7.2e-46  Score=347.96  Aligned_cols=235  Identities=16%  Similarity=0.222  Sum_probs=185.1

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccC---ChhhHHHHHHHHH---HHHhcCCCCceeee-------ee
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS---HNLEKELIRKEID---IMNQLHHPKLINLH-------DA  173 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~~E~~---il~~l~hpnIv~l~-------~~  173 (356)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|++...   .....+.+.+|+.   +|++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46899999999999999999999999999999999743   3345577889994   55555899999998       66


Q ss_pred             EEeCC-----------------eEEEEEEeccccchhhhhhCCCCCCCc--cccccccHHHHHHHHHHHHHHHHHCCcee
Q psy12427        174 FEDDD-----------------EMVLIFEFLSGGELFERITAPDYKMSE--AEVIPVTLPILMTQTSPAVKHMHEKNIIH  234 (356)
Q Consensus       174 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH  234 (356)
                      +...+                 ..+++|||+ +|+|.+++.... .+.+  ..+....+..++.||+.||+|||++||+|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~-~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH  229 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLL-SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH  229 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHH-HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcc-ccccccccccHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            66553                 388999999 689999987432 1222  22333455569999999999999999999


Q ss_pred             ccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCceeecCCCcCccccccccCC-----------CCCccccHHHHHHHHH
Q psy12427        235 LDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVERE-----------PVGFYTDMWAVGVLAY  303 (356)
Q Consensus       235 ~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwSlG~il~  303 (356)
                      |||||+|||++.++  .+||+|||+|+...  .......| +.|+|||++.+.           .++.++|||||||++|
T Consensus       230 rDikp~NIll~~~~--~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~  304 (377)
T 3byv_A          230 TYLRPVDIVLDQRG--GVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY  304 (377)
T ss_dssp             SCCCGGGEEECTTC--CEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred             CCCCHHHEEEcCCC--CEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence            99999999998654  79999999998643  23445567 999999999887           8999999999999999


Q ss_pred             HHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        304 VLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       304 ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +|++|+.||.+.+..+....+..        .+..+|+++++||.+||+.||+
T Consensus       305 elltg~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~L~~dp~  349 (377)
T 3byv_A          305 WIWCADLPITKDAALGGSEWIFR--------SCKNIPQPVRALLEGFLRYPKE  349 (377)
T ss_dssp             HHHHSSCCC------CCSGGGGS--------SCCCCCHHHHHHHHHHTCSSGG
T ss_pred             HHHHCCCCCcccccccchhhhhh--------hccCCCHHHHHHHHHHcCCCch
Confidence            99999999987765544443322        1247899999999999999985

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.8e-44  Score=326.35  Aligned_cols=241  Identities=24%  Similarity=0.432  Sum_probs=197.4

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      ..++|++.+.||+|+||.||+|.++.+|+.||+|.+....  ....+.+|+.++..++||||+++++++......++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            3467999999999999999999999999999999987643  34567889999999999999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |+.+++|.+++......+++     ..+..++.|++.||.|||+.|++|+||+|+||+++.++  .+||+|||++.....
T Consensus       105 ~~~~~~L~~~~~~~~~~~~~-----~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~kl~dfg~~~~~~~  177 (314)
T 3com_A          105 YCGAGSVSDIIRLRNKTLTE-----DEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEG--HAKLADFGVAGQLTD  177 (314)
T ss_dssp             CCTTEEHHHHHHHHTCCCCH-----HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCCTTCEECBT
T ss_pred             cCCCCCHHHHHHhcCCCCCH-----HHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCC--CEEEeecccchhhhh
Confidence            99999999998643333333     34455999999999999999999999999999997654  799999999987654


Q ss_pred             CC-ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHH
Q psy12427        266 NE-VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK  344 (356)
Q Consensus       266 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  344 (356)
                      .. ......|++.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+...... .......+|.++.
T Consensus       178 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~  256 (314)
T 3com_A          178 TMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPP-TFRKPELWSDNFT  256 (314)
T ss_dssp             TBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-CCSSGGGSCHHHH
T ss_pred             hccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCc-ccCCcccCCHHHH
Confidence            32 223456899999999999999999999999999999999999999988877766655443221 1122346899999


Q ss_pred             HHHHHhhhcCCC
Q psy12427        345 DFIRRLLLRNKE  356 (356)
Q Consensus       345 ~lI~~ll~~dP~  356 (356)
                      +||++||+.||+
T Consensus       257 ~li~~~l~~dp~  268 (314)
T 3com_A          257 DFVKQCLVKSPE  268 (314)
T ss_dssp             HHHHHHTCSCTT
T ss_pred             HHHHHHccCChh
Confidence            999999999995

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.1e-44  Score=326.73  Aligned_cols=240  Identities=24%  Similarity=0.446  Sum_probs=197.9

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC----hhhHHHHHHHHHHHHhcCCCCceeeeeeE--EeCCe
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH----NLEKELIRKEIDIMNQLHHPKLINLHDAF--EDDDE  179 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~~E~~il~~l~hpnIv~l~~~~--~~~~~  179 (356)
                      +.++|++.+.||+|+||.||+|.++.++..+|+|++....    ......+.+|+.++++++||||+++++++  .....
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            4568999999999999999999999999999999987543    23456788999999999999999999998  45568


Q ss_pred             EEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeec
Q psy12427        180 MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGL  259 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~  259 (356)
                      .++||||+.++ |.+++....    ...+....+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~--~~kl~dfg~  155 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSVP----EKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGG--TLKISALGV  155 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHST----TCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCTT
T ss_pred             EEEEehhccCC-HHHHHHhCc----ccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCC--cEEeecccc
Confidence            99999999876 666654321    12333445566999999999999999999999999999997654  799999999


Q ss_pred             eeeeCCC---CceeecCCCcCccccccccCCC--CCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChh
Q psy12427        260 ATKLDPN---EVVKISTGTAEFAAPEIVEREP--VGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEE  334 (356)
Q Consensus       260 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  334 (356)
                      +......   .......|++.|+|||++.+..  ++.++||||||+++|+|++|..||.+.+..+....+......++. 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~-  234 (305)
T 2wtk_C          156 AEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPG-  234 (305)
T ss_dssp             CEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCS-
T ss_pred             ccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCC-
Confidence            9876532   2223456899999999998654  377999999999999999999999999998988888887766553 


Q ss_pred             hhccCCHHHHHHHHHhhhcCCC
Q psy12427        335 AFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       335 ~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                         .+++++.+||++||+.||+
T Consensus       235 ---~~~~~l~~li~~~l~~dp~  253 (305)
T 2wtk_C          235 ---DCGPPLSDLLKGMLEYEPA  253 (305)
T ss_dssp             ---SSCHHHHHHHHHHTCSSTT
T ss_pred             ---ccCHHHHHHHHHHccCChh
Confidence               7899999999999999995

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=4.2e-45  Score=335.24  Aligned_cols=246  Identities=21%  Similarity=0.284  Sum_probs=197.2

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      ..++|++.+.||+|+||.||+|.++ ++..||+|.+........+.+.+|+.+|+.++||||+++++++...+..++|||
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  115 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYK  115 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEE
T ss_pred             HHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEE
Confidence            4568999999999999999999965 689999999887766667788999999999999999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |+++|+|.+++.....  ....+....+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||++.....
T Consensus       116 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~  191 (321)
T 2qkw_B          116 YMENGNLKRHLYGSDL--PTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENF--VPKITDFGISKKGTE  191 (321)
T ss_dssp             CCTTCBTGGGSSSSCC--CSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTC--CEEECCCTTCEECSS
T ss_pred             cCCCCcHHHHHhccCC--CccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCC--CEEEeeccccccccc
Confidence            9999999999865432  222344455666999999999999999999999999999997544  799999999987543


Q ss_pred             CC---ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHH-------hhccc------c
Q psy12427        266 NE---VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKN-------VKACD------W  329 (356)
Q Consensus       266 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~-------i~~~~------~  329 (356)
                      ..   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+....       .....      .
T Consensus       192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (321)
T 2qkw_B          192 LDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDP  271 (321)
T ss_dssp             SSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSS
T ss_pred             ccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcCh
Confidence            22   22334589999999999999999999999999999999999999987643321110       00110      0


Q ss_pred             ccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        330 EFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       330 ~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .........++.++.++|.+||+.||+
T Consensus       272 ~~~~~~~~~~~~~l~~li~~~l~~dP~  298 (321)
T 2qkw_B          272 NLADKIRPESLRKFGDTAVKCLALSSE  298 (321)
T ss_dssp             SCTTCSCHHHHHHHHHHHHHHTCSSGG
T ss_pred             hhccccCHHHHHHHHHHHHHHcCCCcc
Confidence            111122234678899999999999995

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=7e-45  Score=326.79  Aligned_cols=243  Identities=26%  Similarity=0.461  Sum_probs=201.5

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEE--eCCeEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFE--DDDEMVL  182 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~~~~l  182 (356)
                      .++|++.+.||+|+||.||+|.++.+++.||+|.+....  ....+.+.+|+.++++++||||+++++++.  .....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            468999999999999999999999999999999997543  345677889999999999999999999885  4678999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCC-----ceeccCCCCCEEEeecCCCcEEEEee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN-----IIHLDVKPENIMCQTRNSTNVKMIDF  257 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-----ivH~Dlkp~NIlv~~~~~~~vkl~Df  257 (356)
                      ||||+++++|.+++.....  ....+....+..++.|++.||+|||+.|     |+||||||+|||++.++  .+||+||
T Consensus        85 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~--~~kl~df  160 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTK--ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDF  160 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSS--CEEECCC
T ss_pred             EEeCCCCCCHHHHHHhhcc--cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCC--CEEEecC
Confidence            9999999999999864221  1112334455669999999999999999     99999999999997554  7999999


Q ss_pred             eceeeeCCCCc-eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhh
Q psy12427        258 GLATKLDPNEV-VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAF  336 (356)
Q Consensus       258 g~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  336 (356)
                      |++........ .....|++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+........   .
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~---~  237 (279)
T 2w5a_A          161 GLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI---P  237 (279)
T ss_dssp             CHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC---C
T ss_pred             chheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccC---C
Confidence            99987643322 2234689999999999999999999999999999999999999999998888888877664322   2


Q ss_pred             ccCCHHHHHHHHHhhhcCCC
Q psy12427        337 KNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       337 ~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ..+|+++.++|++||+.||+
T Consensus       238 ~~~~~~l~~li~~~l~~~p~  257 (279)
T 2w5a_A          238 YRYSDELNEIITRMLNLKDY  257 (279)
T ss_dssp             TTSCHHHHHHHHHHTCSSGG
T ss_pred             cccCHHHHHHHHHHcCCCcc
Confidence            47899999999999999985

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-45  Score=343.14  Aligned_cols=238  Identities=30%  Similarity=0.571  Sum_probs=193.2

Q ss_pred             ccceeeeccccccCceEEEEEEEc---cCCCEEEEEEcccCC----hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCC
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRER---KTGNIFAAKFIPVSH----NLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDD  178 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~---~~~~~~a~K~~~~~~----~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  178 (356)
                      .++|++.+.||+|+||+||+|++.   .+++.||+|+++...    ......+.+|+.+|..+ +||||+++++++....
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            368999999999999999999984   578999999986532    12334566799999999 6999999999999999


Q ss_pred             eEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeee
Q psy12427        179 EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFG  258 (356)
Q Consensus       179 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg  258 (356)
                      ..++||||+++|+|.+++.... .     +....+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~-~-----~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kl~DfG  204 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE-R-----FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG--HVVLTDFG  204 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS-C-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEESCSS
T ss_pred             eEEEEeecCCCCCHHHHHHHcC-C-----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--cEEEeeCC
Confidence            9999999999999999986432 2     33344556999999999999999999999999999997654  79999999


Q ss_pred             ceeeeCCCC--ceeecCCCcCccccccccC--CCCCccccHHHHHHHHHHHHcCCCCCCCCC----hHHHHHHhhccccc
Q psy12427        259 LATKLDPNE--VVKISTGTAEFAAPEIVER--EPVGFYTDMWAVGVLAYVLLSGLSPFAGEN----DVETLKNVKACDWE  330 (356)
Q Consensus       259 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~ell~g~~Pf~~~~----~~~~~~~i~~~~~~  330 (356)
                      +++......  ......||+.|+|||++.+  ..++.++|||||||++|+|++|+.||....    ..+....+......
T Consensus       205 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  284 (355)
T 1vzo_A          205 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP  284 (355)
T ss_dssp             EEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC
T ss_pred             CCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCC
Confidence            998764322  2233469999999999985  347889999999999999999999997543    34445555444433


Q ss_pred             cChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        331 FDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       331 ~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ++    ..++..+++||++||+.||+
T Consensus       285 ~~----~~~~~~~~~li~~~L~~dP~  306 (355)
T 1vzo_A          285 YP----QEMSALAKDLIQRLLMKDPK  306 (355)
T ss_dssp             CC----TTSCHHHHHHHHHHTCSSGG
T ss_pred             CC----cccCHHHHHHHHHHhhhCHH
Confidence            33    47899999999999999985

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.2e-44  Score=322.98  Aligned_cols=238  Identities=21%  Similarity=0.317  Sum_probs=201.0

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      .++|++.+.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.++++++||||+++++++...+..++||||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF   84 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence            357999999999999999999987 577899999976543 346788999999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +++++|.+++......+++     ..+..++.|++.||+|||++|++||||||+||+++.++  .+||+|||++......
T Consensus        85 ~~~~~L~~~~~~~~~~~~~-----~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~--~~kl~dfg~~~~~~~~  157 (267)
T 3t9t_A           85 MEHGCLSDYLRTQRGLFAA-----ETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ--VIKVSDFGMTRFVLDD  157 (267)
T ss_dssp             CTTCBHHHHHHHTTTCCCH-----HHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGG--CEEECCTTGGGGBCCH
T ss_pred             CCCCcHHHHHhhCcccCCH-----HHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCC--CEEEcccccccccccc
Confidence            9999999999754433333     34455999999999999999999999999999997655  6999999999765432


Q ss_pred             Cc--eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHH
Q psy12427        267 EV--VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG  343 (356)
Q Consensus       267 ~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  343 (356)
                      ..  .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+........   ...+++++
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~~l  234 (267)
T 3t9t_A          158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTHV  234 (267)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CTTSCHHH
T ss_pred             cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCC---CccCcHHH
Confidence            11  112346789999999998899999999999999999999 9999999999888888876543222   23689999


Q ss_pred             HHHHHHhhhcCCC
Q psy12427        344 KDFIRRLLLRNKE  356 (356)
Q Consensus       344 ~~lI~~ll~~dP~  356 (356)
                      .++|++||+.||+
T Consensus       235 ~~li~~~l~~~p~  247 (267)
T 3t9t_A          235 YQIMNHCWRERPE  247 (267)
T ss_dssp             HHHHHHHTCSSGG
T ss_pred             HHHHHHHccCChh
Confidence            9999999999985

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-44  Score=332.84  Aligned_cols=239  Identities=19%  Similarity=0.277  Sum_probs=192.8

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEE----EEEEcccC-ChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIF----AAKFIPVS-HNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMV  181 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~----a~K~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  181 (356)
                      .++|++.+.||+|+||+||+|.+..++..+    |+|.+... .......+.+|+.++++++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            357999999999999999999999888765    66665433 2335677889999999999999999999998765 78


Q ss_pred             EEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeecee
Q psy12427        182 LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT  261 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~  261 (356)
                      +++|++.+|+|.+++......+++.     .+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||+++
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~~~~~~-----~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~--~~kL~DfG~a~  165 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKDNIGSQ-----YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ--HVKITDFGLAK  165 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTTCCCHH-----HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT--EEEECCTTC--
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHH-----HHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCC--CEEEccCccee
Confidence            8999999999999997654444443     3455999999999999999999999999999998765  79999999998


Q ss_pred             eeCCCCce---eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhc
Q psy12427        262 KLDPNEVV---KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFK  337 (356)
Q Consensus       262 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  337 (356)
                      ........   ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+........   ..
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~  242 (327)
T 3lzb_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---PP  242 (327)
T ss_dssp             --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC---CT
T ss_pred             EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---Cc
Confidence            76433222   22346889999999999999999999999999999999 9999999988887777766543222   24


Q ss_pred             cCCHHHHHHHHHhhhcCCC
Q psy12427        338 NVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       338 ~~s~~~~~lI~~ll~~dP~  356 (356)
                      .++.++.+||++||+.||+
T Consensus       243 ~~~~~l~~li~~~l~~dp~  261 (327)
T 3lzb_A          243 ICTIDVYMIMRKCWMIDAD  261 (327)
T ss_dssp             TBCHHHHHHHHHHTCSSGG
T ss_pred             cCCHHHHHHHHHHcCCChh
Confidence            6899999999999999985

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.2e-44  Score=328.07  Aligned_cols=245  Identities=19%  Similarity=0.276  Sum_probs=192.9

Q ss_pred             ccceeeeccccccCceEEEEEEEcc---CCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCC---
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERK---TGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDD---  178 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~---~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~---  178 (356)
                      .++|.+.+.||+|+||.||+|.+..   ++..||+|.++...  ......+.+|+.++++++||||+++++++....   
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  112 (313)
T 3brb_A           33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG  112 (313)
T ss_dssp             GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred             HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence            3679999999999999999998875   45589999997653  334567889999999999999999999997654   


Q ss_pred             --eEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEe
Q psy12427        179 --EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMID  256 (356)
Q Consensus       179 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~D  256 (356)
                        ..++||||+++++|.+++...........+....+..++.||+.||.|||++||+||||||+|||++.++  .+||+|
T Consensus       113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~--~~kl~D  190 (313)
T 3brb_A          113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM--TVCVAD  190 (313)
T ss_dssp             --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS--CEEECS
T ss_pred             CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC--cEEEee
Confidence              4599999999999999985433222333455556677999999999999999999999999999997654  799999


Q ss_pred             eeceeeeCCCCc---eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccC
Q psy12427        257 FGLATKLDPNEV---VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFD  332 (356)
Q Consensus       257 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~  332 (356)
                      ||++........   .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+....... 
T Consensus       191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-  269 (313)
T 3brb_A          191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLK-  269 (313)
T ss_dssp             CSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC-
T ss_pred             cCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCC-
Confidence            999987643321   123356889999999999999999999999999999999 999999998888877776654322 


Q ss_pred             hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 ~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                        ....+++++.++|.+||+.||+
T Consensus       270 --~~~~~~~~l~~li~~~l~~dp~  291 (313)
T 3brb_A          270 --QPEDCLDELYEIMYSCWRTDPL  291 (313)
T ss_dssp             --CBTTCCHHHHHHHHHTTCSSGG
T ss_pred             --CCccccHHHHHHHHHHcCCChh
Confidence              2347899999999999999985

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1e-44  Score=348.25  Aligned_cols=239  Identities=23%  Similarity=0.367  Sum_probs=199.3

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      ..++|++.+.||+|+||+||+|.++. +..||+|.++... ...+.+.+|+.+|++++||||+++++++. ....++|||
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e  262 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE  262 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred             chHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence            34689999999999999999999864 6789999997654 34678889999999999999999999986 567899999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |+.+|+|.+++.....    .......+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+++....
T Consensus       263 ~~~~g~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~--~~kl~DFG~a~~~~~  336 (454)
T 1qcf_A          263 FMAKGSLLDFLKSDEG----SKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL--VCKIADFGLARVIED  336 (454)
T ss_dssp             CCTTCBHHHHHHSHHH----HTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTC--CEEECSTTGGGGBCC
T ss_pred             ecCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCC--cEEEeeCCCceEcCC
Confidence            9999999999974321    1222334455999999999999999999999999999997654  799999999987643


Q ss_pred             CCc--eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHH
Q psy12427        266 NEV--VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEE  342 (356)
Q Consensus       266 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  342 (356)
                      ...  .....+++.|+|||++....++.++|||||||+||||++ |+.||.+.+..+.+..+.......   ....+|++
T Consensus       337 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~---~~~~~~~~  413 (454)
T 1qcf_A          337 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP---RPENCPEE  413 (454)
T ss_dssp             HHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC---CCTTSCHH
T ss_pred             CceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCHH
Confidence            221  122346789999999999999999999999999999999 999999999999888887653222   22478999


Q ss_pred             HHHHHHHhhhcCCC
Q psy12427        343 GKDFIRRLLLRNKE  356 (356)
Q Consensus       343 ~~~lI~~ll~~dP~  356 (356)
                      +.+||.+||+.||+
T Consensus       414 l~~li~~cl~~dp~  427 (454)
T 1qcf_A          414 LYNIMMRCWKNRPE  427 (454)
T ss_dssp             HHHHHHHHTCSSGG
T ss_pred             HHHHHHHHccCChh
Confidence            99999999999985

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3.9e-44  Score=323.96  Aligned_cols=240  Identities=23%  Similarity=0.406  Sum_probs=184.5

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      ..++|++.+.||+|+||+||+|.++.   .+|+|+++...  ....+.+.+|+.+|++++||||++++++. .....++|
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv   97 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV   97 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence            34689999999999999999997653   59999987553  34457788999999999999999999954 56678999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      |||+.+++|.+++......+++.     .+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||++...
T Consensus        98 ~e~~~~~~L~~~l~~~~~~~~~~-----~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~--~~kl~Dfg~~~~~  170 (289)
T 3og7_A           98 TQWCEGSSLYHHLHASETKFEMK-----KLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN--TVKIGDFGLATEK  170 (289)
T ss_dssp             EECCCEEEHHHHHTTC---CCHH-----HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT--EEEECCCC-----
T ss_pred             EEecCCCcHHHHHhhccCCCCHH-----HHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC--CEEEccceecccc
Confidence            99999999999997554444433     4455999999999999999999999999999998654  7999999999765


Q ss_pred             CCC---CceeecCCCcCcccccccc---CCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHH-HhhccccccC-hhh
Q psy12427        264 DPN---EVVKISTGTAEFAAPEIVE---REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLK-NVKACDWEFD-EEA  335 (356)
Q Consensus       264 ~~~---~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~-~i~~~~~~~~-~~~  335 (356)
                      ...   .......||+.|+|||++.   +..++.++||||||+++|+|++|+.||.+....+.+. .+.......+ ...
T Consensus       171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (289)
T 3og7_A          171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKV  250 (289)
T ss_dssp             -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSS
T ss_pred             ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhc
Confidence            421   2223346899999999987   6678889999999999999999999998876555444 4434333322 233


Q ss_pred             hccCCHHHHHHHHHhhhcCCC
Q psy12427        336 FKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       336 ~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ...+|+++.+||.+||+.||+
T Consensus       251 ~~~~~~~l~~li~~~l~~~p~  271 (289)
T 3og7_A          251 RSNCPKRMKRLMAECLKKKRD  271 (289)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGG
T ss_pred             cccCCHHHHHHHHHHccCChh
Confidence            457899999999999999985

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=3.4e-44  Score=324.95  Aligned_cols=243  Identities=23%  Similarity=0.259  Sum_probs=196.2

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeE-EeCCeEEEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF-EDDDEMVLIF  184 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-~~~~~~~lv~  184 (356)
                      +.++|++.+.||+|+||.||+|++..+++.||+|++......  ..+.+|+.+++.++|++++..+..+ ......++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            456899999999999999999999999999999998765432  3577899999999988866655554 6778889999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEee-cCCCcEEEEeeeceeee
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQT-RNSTNVKMIDFGLATKL  263 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~-~~~~~vkl~Dfg~a~~~  263 (356)
                      ||+ +++|.+++......+++     ..+..++.|++.||+|||++||+||||||+|||++. +.++.+||+|||++...
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~-----~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFCSRKFSL-----KTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCH-----HHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             Eec-CCCHHHHHHhhccCCCH-----HHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence            999 99999999744333333     445559999999999999999999999999999951 12347999999999877


Q ss_pred             CCCCc--------eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC---hHHHHHHhhccccccC
Q psy12427        264 DPNEV--------VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN---DVETLKNVKACDWEFD  332 (356)
Q Consensus       264 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~---~~~~~~~i~~~~~~~~  332 (356)
                      .....        .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+   ..+.+..+......++
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence            54332        234468999999999999999999999999999999999999998743   3344555544443333


Q ss_pred             -hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 -EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 -~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                       +.....+|+++.+||++||+.||+
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~dp~  263 (296)
T 3uzp_A          239 IEVLCKGYPSEFATYLNFCRSLRFD  263 (296)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHTSCTT
T ss_pred             hHHHHhhCCHHHHHHHHHHHhcCcC
Confidence             333457899999999999999995

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.8e-44  Score=340.32  Aligned_cols=242  Identities=22%  Similarity=0.323  Sum_probs=188.9

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCC------e
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDD------E  179 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~------~  179 (356)
                      ...+|++.+.||+|+||+||+|++..++. +|+|.+.....    ...+|+++|+.++||||+++++++....      .
T Consensus        38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~  112 (394)
T 4e7w_A           38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF  112 (394)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred             ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence            34579999999999999999999987766 77777654322    1236999999999999999999996443      3


Q ss_pred             EEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeec
Q psy12427        180 MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGL  259 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~  259 (356)
                      +++||||+.++.+........   ....+....++.++.||+.||+|||++||+||||||+|||++.. ++.+||+|||+
T Consensus       113 ~~lv~e~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~-~~~~kL~DFG~  188 (394)
T 4e7w_A          113 LNLVLEYVPETVYRASRHYAK---LKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPP-SGVLKLIDFGS  188 (394)
T ss_dssp             EEEEEECCSEEHHHHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETT-TTEEEECCCTT
T ss_pred             EEEEeeccCccHHHHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCC-CCcEEEeeCCC
Confidence            889999998754433221100   01123334456699999999999999999999999999999732 24799999999


Q ss_pred             eeeeCCCCceeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC------
Q psy12427        260 ATKLDPNEVVKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD------  332 (356)
Q Consensus       260 a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~------  332 (356)
                      |+............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+......++      
T Consensus       189 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~  268 (394)
T 4e7w_A          189 AKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT  268 (394)
T ss_dssp             CEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             cccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            9987665555566789999999998765 589999999999999999999999999998888777655322111      


Q ss_pred             -------------------hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 -------------------EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 -------------------~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                         ......+|+++.+||++||+.||+
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  311 (394)
T 4e7w_A          269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPS  311 (394)
T ss_dssp             HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred             hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChh
Confidence                               112234899999999999999995

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=6.6e-44  Score=333.94  Aligned_cols=238  Identities=21%  Similarity=0.394  Sum_probs=194.9

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeE---
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM---  180 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~---  180 (356)
                      +.++|.+.+.||+|+||+||+|.++.+|+.||+|++....  ......+.+|+.+++.++||||+++++++......   
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            4568999999999999999999999999999999997643  33356778999999999999999999999877655   


Q ss_pred             ---EEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEee
Q psy12427        181 ---VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDF  257 (356)
Q Consensus       181 ---~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Df  257 (356)
                         ++||||+. ++|.+.+..   .     +....+..++.|++.||+|||++||+||||||+|||++.++  .+||+||
T Consensus       120 ~~~~lv~e~~~-~~l~~~~~~---~-----~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~--~~kL~Df  188 (371)
T 4exu_A          120 YDFYLVMPFMQ-TDLQKIMGM---E-----FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC--ELKILDF  188 (371)
T ss_dssp             CCCEEEEECCC-EEHHHHTTS---C-----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECST
T ss_pred             eeEEEEEcccc-ccHHHHhhc---C-----CCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCC--CEEEEec
Confidence               99999997 688777642   2     33344566999999999999999999999999999997554  7999999


Q ss_pred             eceeeeCCCCceeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCh---
Q psy12427        258 GLATKLDPNEVVKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE---  333 (356)
Q Consensus       258 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~---  333 (356)
                      |+++....  ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+.++......++.   
T Consensus       189 g~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  266 (371)
T 4exu_A          189 GLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV  266 (371)
T ss_dssp             TCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             Cccccccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHH
Confidence            99986543  2344578999999999987 67899999999999999999999999999988888777553322222   


Q ss_pred             ------------------------hhhccCCHHHHHHHHHhhhcCCC
Q psy12427        334 ------------------------EAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       334 ------------------------~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                              ..+..+++++++||++||+.||+
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  313 (371)
T 4exu_A          267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVD  313 (371)
T ss_dssp             TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTT
T ss_pred             HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChh
Confidence                                    22346799999999999999995

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4.9e-44  Score=321.84  Aligned_cols=240  Identities=20%  Similarity=0.252  Sum_probs=196.1

Q ss_pred             cccceeeeccccccCceEEEEEEEccC---CCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKT---GNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMV  181 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~---~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  181 (356)
                      ..++|.+.+.||+|+||+||+|.+...   +..||+|.+.... ....+.+.+|+.+++.++||||+++++++.. ...+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence            346899999999999999999997643   3469999987653 3456778899999999999999999999875 4568


Q ss_pred             EEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeecee
Q psy12427        182 LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT  261 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~  261 (356)
                      +||||+.+++|.+++......+++     ..+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||++.
T Consensus        89 ~v~e~~~~~~L~~~l~~~~~~~~~-----~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~  161 (281)
T 3cc6_A           89 IIMELYPYGELGHYLERNKNSLKV-----LTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE--CVKLGDFGLSR  161 (281)
T ss_dssp             EEEECCTTCBHHHHHHHHTTTCCH-----HHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETT--EEEECCCCGGG
T ss_pred             EEEecCCCCCHHHHHHhccccCCH-----HHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCC--cEEeCccCCCc
Confidence            999999999999999754333333     34455999999999999999999999999999998765  79999999998


Q ss_pred             eeCCCCc--eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhcc
Q psy12427        262 KLDPNEV--VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKN  338 (356)
Q Consensus       262 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  338 (356)
                      .......  .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+........   ...
T Consensus       162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~  238 (281)
T 3cc6_A          162 YIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK---PDL  238 (281)
T ss_dssp             CC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCC---CTT
T ss_pred             ccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCC---CCC
Confidence            7654322  223356889999999998999999999999999999998 9999998887777777665443222   246


Q ss_pred             CCHHHHHHHHHhhhcCCC
Q psy12427        339 VSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       339 ~s~~~~~lI~~ll~~dP~  356 (356)
                      +++++.++|++||+.||+
T Consensus       239 ~~~~l~~li~~~l~~~p~  256 (281)
T 3cc6_A          239 CPPVLYTLMTRCWDYDPS  256 (281)
T ss_dssp             CCHHHHHHHHHHTCSSGG
T ss_pred             CCHHHHHHHHHHccCCch
Confidence            899999999999999985

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=7.2e-44  Score=325.25  Aligned_cols=245  Identities=26%  Similarity=0.432  Sum_probs=189.0

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccC---ChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS---HNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++...   .......+.+|+.++++++||||+++++++...+..++
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  109 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI  109 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence            456899999999999999999999999999999998753   23455678899999999999999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ||||+.+++|.+++.....  ....+....+..++.|++.||.|||+.|++|+||||+|||++.++  .+||+|||++..
T Consensus       110 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~--~~kl~Dfg~~~~  185 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKK--QKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG--VVKLGDLGLGRF  185 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCC-----
T ss_pred             EEecCCCCCHHHHHHHhcc--cccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCC--CEEEEeccceee
Confidence            9999999999998863110  011233344556999999999999999999999999999997554  799999999987


Q ss_pred             eCCCCc-eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC--ChHHHHHHhhccccccChhhhccC
Q psy12427        263 LDPNEV-VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGE--NDVETLKNVKACDWEFDEEAFKNV  339 (356)
Q Consensus       263 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~  339 (356)
                      ...... .....|++.|+|||++.+..++.++||||||+++|+|++|..||.+.  +..+....+......  +.....+
T Consensus       186 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  263 (310)
T 2wqm_A          186 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP--PLPSDHY  263 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSC--CCCTTTS
T ss_pred             ecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCC--CCccccc
Confidence            643322 23346899999999999999999999999999999999999999765  344555556554433  2223578


Q ss_pred             CHHHHHHHHHhhhcCCC
Q psy12427        340 SEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       340 s~~~~~lI~~ll~~dP~  356 (356)
                      ++++.+||++||+.||+
T Consensus       264 ~~~l~~li~~~l~~dp~  280 (310)
T 2wqm_A          264 SEELRQLVNMCINPDPE  280 (310)
T ss_dssp             CHHHHHHHHHHTCSSGG
T ss_pred             CHHHHHHHHHHcCCChh
Confidence            99999999999999984

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=4.6e-44  Score=323.13  Aligned_cols=243  Identities=25%  Similarity=0.340  Sum_probs=179.3

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh--hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN--LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      .++|++.+.||+|+||+||+|.+..+|+.||+|++.....  .....+.++...++.++||||+++++++...+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            4689999999999999999999999999999999876532  22334445566688889999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEK-NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      ||++ |+|.+++....  .....+....+..++.|++.||+|||++ ||+||||||+|||++.++  .+||+|||++...
T Consensus        86 e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~  160 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVI--DKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG--QVKMCDFGISGYL  160 (290)
T ss_dssp             ECCS-EEHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC--CEEBCCC------
T ss_pred             ehhc-cchHHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC--CEEEeecCCcccc
Confidence            9997 48777664310  0111233344556999999999999998 999999999999997544  7999999999877


Q ss_pred             CCCCceeecCCCcCccccccc----cCCCCCccccHHHHHHHHHHHHcCCCCCCCC-ChHHHHHHhhccccccChhhhcc
Q psy12427        264 DPNEVVKISTGTAEFAAPEIV----EREPVGFYTDMWAVGVLAYVLLSGLSPFAGE-NDVETLKNVKACDWEFDEEAFKN  338 (356)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~  338 (356)
                      ..........||+.|+|||++    ....++.++|||||||++|+|++|..||... .....+...........  ....
T Consensus       161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~  238 (290)
T 3fme_A          161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL--PADK  238 (290)
T ss_dssp             ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCC--CTTT
T ss_pred             cccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCc--cccc
Confidence            655555556799999999996    5667899999999999999999999999863 44444444443332211  1247


Q ss_pred             CCHHHHHHHHHhhhcCCC
Q psy12427        339 VSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       339 ~s~~~~~lI~~ll~~dP~  356 (356)
                      +|+++.+||.+||+.||+
T Consensus       239 ~~~~~~~li~~~l~~~p~  256 (290)
T 3fme_A          239 FSAEFVDFTSQCLKKNSK  256 (290)
T ss_dssp             SCHHHHHHHHHHTCSSGG
T ss_pred             CCHHHHHHHHHHhhcChh
Confidence            899999999999999985

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.8e-44  Score=326.53  Aligned_cols=240  Identities=21%  Similarity=0.334  Sum_probs=191.1

Q ss_pred             ccceeeeccccccCceEEEEEE----EccCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeC--Ce
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCR----ERKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDD--DE  179 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~----~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~  179 (356)
                      .++|++.+.||+|+||.||+|+    +..+++.||+|++.... ......+.+|+.+|+.++||||+++++++...  ..
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            3569999999999999999999    46678999999987543 33457788999999999999999999999876  77


Q ss_pred             EEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeec
Q psy12427        180 MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGL  259 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~  259 (356)
                      .++||||+++++|.+++......+++     ..+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||+
T Consensus       100 ~~lv~e~~~~~~L~~~l~~~~~~~~~-----~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~  172 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPKNKNKINL-----KQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH--QVKIGDFGL  172 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHHHTTTCCH-----HHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT--EEEECCCTT
T ss_pred             EEEEEEeCCCCcHHHHHHhccccCCH-----HHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCC--CEEECcccc
Confidence            89999999999999998654333333     34455999999999999999999999999999998765  799999999


Q ss_pred             eeeeCCCCce----eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC--------------ChH-HH
Q psy12427        260 ATKLDPNEVV----KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGE--------------NDV-ET  320 (356)
Q Consensus       260 a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~--------------~~~-~~  320 (356)
                      +.........    ....||..|+|||++.+..++.++|||||||++|+|++|..|+...              ... ..
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  252 (302)
T 4e5w_A          173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL  252 (302)
T ss_dssp             CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred             cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence            9887654332    2345788899999999999999999999999999999999876422              111 22


Q ss_pred             HHHhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        321 LKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       321 ~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ...+.... .  .+....+|+++.+||++||+.||+
T Consensus       253 ~~~~~~~~-~--~~~~~~~~~~l~~li~~~l~~dp~  285 (302)
T 4e5w_A          253 VNTLKEGK-R--LPCPPNCPDEVYQLMRKCWEFQPS  285 (302)
T ss_dssp             HHHHHTTC-C--CCCCTTCCHHHHHHHHHTTCSSGG
T ss_pred             HHHHhccC-C--CCCCCCCCHHHHHHHHHHcCCCCC
Confidence            22222222 1  122347899999999999999985

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=8.4e-44  Score=322.01  Aligned_cols=238  Identities=22%  Similarity=0.344  Sum_probs=197.2

Q ss_pred             ccceeeec-cccccCceEEEEEEE--ccCCCEEEEEEcccCCh--hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEE
Q psy12427        107 YDHYDILE-EIGTGAFGVVHRCRE--RKTGNIFAAKFIPVSHN--LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMV  181 (356)
Q Consensus       107 ~~~y~~~~-~lg~G~fg~V~~~~~--~~~~~~~a~K~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  181 (356)
                      .++|.+.+ .||+|+||+||+|.+  +.+++.||+|+++....  ...+.+.+|+.+++.++||||+++++++ .....+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            35799988 999999999999955  55678999999976532  2356788999999999999999999999 567789


Q ss_pred             EEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeecee
Q psy12427        182 LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT  261 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~  261 (356)
                      +||||+++++|.+++.... .++     ...+..++.|++.||+|||+.||+||||||+|||++.++  .+||+|||++.
T Consensus        94 lv~e~~~~~~L~~~l~~~~-~~~-----~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~~~  165 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQNR-HVK-----DKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH--YAKISDFGLSK  165 (291)
T ss_dssp             EEEECCTTEEHHHHHHHCT-TCC-----HHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT--EEEECCCTTCE
T ss_pred             EEEEeCCCCCHHHHHHhCc-CCC-----HHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCC--cEEEccCCcce
Confidence            9999999999999997532 233     334556999999999999999999999999999998765  79999999998


Q ss_pred             eeCCCCcee----ecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhh
Q psy12427        262 KLDPNEVVK----ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAF  336 (356)
Q Consensus       262 ~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  336 (356)
                      .........    ...+++.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..+....+......   ...
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~  242 (291)
T 1xbb_A          166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---GCP  242 (291)
T ss_dssp             ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCC
T ss_pred             eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCC
Confidence            875443322    2346789999999998889999999999999999999 99999999988888877665432   223


Q ss_pred             ccCCHHHHHHHHHhhhcCCC
Q psy12427        337 KNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       337 ~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ..+|+++.++|++||+.||+
T Consensus       243 ~~~~~~l~~li~~~l~~dp~  262 (291)
T 1xbb_A          243 AGCPREMYDLMNLCWTYDVE  262 (291)
T ss_dssp             TTCCHHHHHHHHHHTCSSTT
T ss_pred             CCCCHHHHHHHHHHcCCChh
Confidence            47899999999999999995

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=3.2e-44  Score=323.31  Aligned_cols=241  Identities=20%  Similarity=0.357  Sum_probs=194.8

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEE
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMV  181 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~  181 (356)
                      .+.++|++.+.||+|+||+||+|.++.+++.||+|++....  ......+.+|+.++..+ +||||+++++++...+..+
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~   87 (289)
T 1x8b_A            8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML   87 (289)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred             cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence            34578999999999999999999999999999999987643  33456677899999999 9999999999999999999


Q ss_pred             EEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecC-------------
Q psy12427        182 LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN-------------  248 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~-------------  248 (356)
                      +||||+++++|.+++.....  ....+....+..++.||+.||+|||++||+||||||+|||++.++             
T Consensus        88 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           88 IQNEYCNGGSLADAISENYR--IMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEEECCTTCBHHHHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------------
T ss_pred             EEEEecCCCcHHHHHHhhcc--cccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            99999999999999864311  001233344566999999999999999999999999999997542             


Q ss_pred             ----CCcEEEEeeeceeeeCCCCceeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q psy12427        249 ----STNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKN  323 (356)
Q Consensus       249 ----~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~  323 (356)
                          ...+||+|||++.......   ...||+.|+|||++.+. .++.++|||||||++|+|++|.+|+.....   ...
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~  239 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHE  239 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHH
T ss_pred             ccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHH
Confidence                3468999999998765432   24589999999999876 567899999999999999999988765533   333


Q ss_pred             hhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        324 VKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       324 i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +......   .....+|+++.+||++||+.||+
T Consensus       240 ~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~  269 (289)
T 1x8b_A          240 IRQGRLP---RIPQVLSQEFTELLKVMIHPDPE  269 (289)
T ss_dssp             HHTTCCC---CCSSCCCHHHHHHHHHHTCSSGG
T ss_pred             HHcCCCC---CCCcccCHHHHHHHHHHhCCCcc
Confidence            4433322   22347899999999999999985

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.3e-44  Score=334.63  Aligned_cols=242  Identities=21%  Similarity=0.336  Sum_probs=188.4

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh-----------hhHHHHHHHHHHHHhcCCCCceeeeeeE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN-----------LEKELIRKEIDIMNQLHHPKLINLHDAF  174 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~-----------~~~~~~~~E~~il~~l~hpnIv~l~~~~  174 (356)
                      +.++|++.+.||+|+||.||+|.+.. |..||+|++.....           .....+.+|+.+|++++||||+++++++
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   98 (362)
T 3pg1_A           20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF   98 (362)
T ss_dssp             TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence            34689999999999999999999865 89999998854321           1236788999999999999999999998


Q ss_pred             Ee-----CCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCC
Q psy12427        175 ED-----DDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNS  249 (356)
Q Consensus       175 ~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~  249 (356)
                      ..     ....++||||+. |+|.+.+......+++     ..+..++.||+.||+|||++||+||||||+|||++.++ 
T Consensus        99 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~-----~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~-  171 (362)
T 3pg1_A           99 VHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISP-----QHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN-  171 (362)
T ss_dssp             EECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCH-----HHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-
T ss_pred             EeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCH-----HHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCC-
Confidence            53     346899999997 6888888755434443     34455999999999999999999999999999997554 


Q ss_pred             CcEEEEeeeceeeeCCCCceeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc
Q psy12427        250 TNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACD  328 (356)
Q Consensus       250 ~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~  328 (356)
                       .+||+|||++.............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus       172 -~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~  250 (362)
T 3pg1_A          172 -DITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVV  250 (362)
T ss_dssp             -CEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             -CEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence             799999999987655555555678999999999877 678999999999999999999999999999888877765432


Q ss_pred             cccC----------------------------hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        329 WEFD----------------------------EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       329 ~~~~----------------------------~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ..++                            ......+++++.+||++||+.||+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  306 (362)
T 3pg1_A          251 GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQ  306 (362)
T ss_dssp             CCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGG
T ss_pred             CCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChh
Confidence            2211                            122345789999999999999995

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.3e-44  Score=332.68  Aligned_cols=242  Identities=23%  Similarity=0.421  Sum_probs=202.7

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhh-----------------HHHHHHHHHHHHhcCCCCce
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE-----------------KELIRKEIDIMNQLHHPKLI  168 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~-----------------~~~~~~E~~il~~l~hpnIv  168 (356)
                      ..++|++.+.||+|+||.||+|.+  +++.||+|++.......                 ...+.+|+.++++++||||+
T Consensus        29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~  106 (348)
T 2pml_X           29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL  106 (348)
T ss_dssp             EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred             ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence            346899999999999999999999  79999999986543211                 17788999999999999999


Q ss_pred             eeeeeEEeCCeEEEEEEeccccchhhh------hhCCCCCCCccccccccHHHHHHHHHHHHHHHHH-CCceeccCCCCC
Q psy12427        169 NLHDAFEDDDEMVLIFEFLSGGELFER------ITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE-KNIIHLDVKPEN  241 (356)
Q Consensus       169 ~l~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~Dlkp~N  241 (356)
                      ++++++...+..++||||+++++|.++      +...    ....+....+..++.|++.||+|||+ .|++||||||+|
T Consensus       107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N  182 (348)
T 2pml_X          107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN----YTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN  182 (348)
T ss_dssp             CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS----SCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred             eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc----cccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence            999999999999999999999999988      4321    12334445566699999999999999 999999999999


Q ss_pred             EEEeecCCCcEEEEeeeceeeeCCCCceeecCCCcCccccccccCC-CCCc-cccHHHHHHHHHHHHcCCCCCCCCCh-H
Q psy12427        242 IMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVERE-PVGF-YTDMWAVGVLAYVLLSGLSPFAGEND-V  318 (356)
Q Consensus       242 Ilv~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDvwSlG~il~ell~g~~Pf~~~~~-~  318 (356)
                      ||++.++  .+||+|||++...... ......|++.|+|||++.+. .++. ++|||||||++|+|++|..||.+.+. .
T Consensus       183 il~~~~~--~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  259 (348)
T 2pml_X          183 ILMDKNG--RVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV  259 (348)
T ss_dssp             EEECTTS--CEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred             EEEcCCC--cEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence            9997654  7999999999876543 33445789999999999887 6666 99999999999999999999998877 7


Q ss_pred             HHHHHhhccccccChh---------------hhccCCHHHHHHHHHhhhcCCC
Q psy12427        319 ETLKNVKACDWEFDEE---------------AFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       319 ~~~~~i~~~~~~~~~~---------------~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +....+......++..               ....+|.++.+||++||+.||+
T Consensus       260 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~  312 (348)
T 2pml_X          260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPA  312 (348)
T ss_dssp             HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChh
Confidence            8888887776665521               1147899999999999999985

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.5e-44  Score=330.96  Aligned_cols=239  Identities=21%  Similarity=0.335  Sum_probs=196.7

Q ss_pred             cceeeeccccccCceEEEEEE----EccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEE--eCCeEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCR----ERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFE--DDDEMV  181 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~----~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~~~~  181 (356)
                      ++|++.+.||+|+||.||+|+    +..++..||+|++........+.+.+|+.++++++||||+++++++.  .....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            589999999999999999999    46678999999998877777788999999999999999999999886  556789


Q ss_pred             EEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeecee
Q psy12427        182 LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT  261 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~  261 (356)
                      +||||+++++|.+++......     +....+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||++.
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~--~~kl~Dfg~~~  175 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHRAR-----LDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEA--HVKIADFGLAK  175 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT--EEEECCGGGCE
T ss_pred             EEEeecCCCCHHHHHHhcccC-----CCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCC--CEEEcccccce
Confidence            999999999999998753323     33344556999999999999999999999999999998765  79999999998


Q ss_pred             eeCCCCce----eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChH---------------HHHH
Q psy12427        262 KLDPNEVV----KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDV---------------ETLK  322 (356)
Q Consensus       262 ~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~---------------~~~~  322 (356)
                      ........    ....||+.|+|||++.+..++.++|||||||++|+|++|..||......               ....
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (327)
T 3lxl_A          176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE  255 (327)
T ss_dssp             ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred             ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence            87543322    2234788899999999999999999999999999999999999765432               1222


Q ss_pred             HhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        323 NVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       323 ~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+.... .  ......+|+++.+||++||+.||+
T Consensus       256 ~~~~~~-~--~~~~~~~~~~l~~li~~~l~~dP~  286 (327)
T 3lxl_A          256 LLEEGQ-R--LPAPPACPAEVHELMKLCWAPSPQ  286 (327)
T ss_dssp             HHHTTC-C--CCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             Hhhccc-C--CCCCCcccHHHHHHHHHHcCCChh
Confidence            222221 1  122347899999999999999985

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=8.5e-44  Score=335.28  Aligned_cols=236  Identities=24%  Similarity=0.431  Sum_probs=190.2

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcC--CCCceeeeeeEEeCCeEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLH--HPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~--hpnIv~l~~~~~~~~~~~lv  183 (356)
                      ++|++.+.||+|+||.||+|.+.. +..||+|++....  ......+.+|+.+|++++  ||||+++++++.....+++|
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            469999999999999999999875 8999999987543  344577889999999996  59999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      || +.+++|.+++.... .++     ...+..++.||+.||+|||++||+||||||+|||++.   +.+||+|||+++.+
T Consensus       135 ~E-~~~~~L~~~l~~~~-~~~-----~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~---~~~kl~DFG~a~~~  204 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKKK-SID-----PWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD---GMLKLIDFGIANQM  204 (390)
T ss_dssp             EE-CCSEEHHHHHHHCS-SCC-----HHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS---SCEEECCCSSSCCC
T ss_pred             Ee-cCCCCHHHHHHhcC-CCC-----HHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC---CeEEEEecCccccc
Confidence            99 56889999987543 222     2334569999999999999999999999999999942   47999999999876


Q ss_pred             CCCCc---eeecCCCcCccccccccC-----------CCCCccccHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHhhccc
Q psy12427        264 DPNEV---VKISTGTAEFAAPEIVER-----------EPVGFYTDMWAVGVLAYVLLSGLSPFAGEN-DVETLKNVKACD  328 (356)
Q Consensus       264 ~~~~~---~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlG~il~ell~g~~Pf~~~~-~~~~~~~i~~~~  328 (356)
                      .....   ....+||+.|+|||++.+           ..++.++|||||||++|+|++|+.||.+.. ....+..+....
T Consensus       205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~  284 (390)
T 2zmd_A          205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN  284 (390)
T ss_dssp             ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTT
T ss_pred             cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcc
Confidence            53322   234579999999999865           468899999999999999999999998764 345566665544


Q ss_pred             cccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        329 WEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       329 ~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ..++  .....+.++++||++||+.||+
T Consensus       285 ~~~~--~~~~~~~~~~~li~~~L~~dP~  310 (390)
T 2zmd_A          285 HEIE--FPDIPEKDLQDVLKCCLKRDPK  310 (390)
T ss_dssp             SCCC--CCCCSCHHHHHHHHHHTCSSTT
T ss_pred             ccCC--CCccchHHHHHHHHHHcccChh
Confidence            3322  2235689999999999999995

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=5.8e-45  Score=341.06  Aligned_cols=244  Identities=16%  Similarity=0.165  Sum_probs=178.5

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh---hhHHHHHHHHHHHHhc--CCCCceeee-------eeEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN---LEKELIRKEIDIMNQL--HHPKLINLH-------DAFE  175 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l--~hpnIv~l~-------~~~~  175 (356)
                      ..|++.+.||+|+||+||+|.++.+|+.||+|++.....   ...+.+.+|+.+++.+  +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            459999999999999999999999999999999987543   3456677886655555  699988755       4554


Q ss_pred             eC-----------------CeEEEEEEeccccchhhhhhCCCCCCCccccccccH-HHHHHHHHHHHHHHHHCCceeccC
Q psy12427        176 DD-----------------DEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTL-PILMTQTSPAVKHMHEKNIIHLDV  237 (356)
Q Consensus       176 ~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~-~~~~~~i~~~l~~lH~~~ivH~Dl  237 (356)
                      ..                 ..+++||||++ |+|.+++................+ ..++.||+.||+|||++||+||||
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi  220 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF  220 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence            33                 33899999998 899999975422222221100011 346699999999999999999999


Q ss_pred             CCCCEEEeecCCCcEEEEeeeceeeeCCCCceeecCCCcCccccccccC--CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q psy12427        238 KPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVER--EPVGFYTDMWAVGVLAYVLLSGLSPFAGE  315 (356)
Q Consensus       238 kp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~ell~g~~Pf~~~  315 (356)
                      ||+|||++.++  .+||+|||+|+....  ......+|+.|+|||++.+  ..++.++|||||||++|+|++|+.||.+.
T Consensus       221 kp~NIll~~~~--~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~  296 (371)
T 3q60_A          221 TPDNLFIMPDG--RLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV  296 (371)
T ss_dssp             SGGGEEECTTS--CEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred             CHHHEEECCCC--CEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence            99999998654  799999999987642  2224567899999999987  78999999999999999999999999887


Q ss_pred             ChHHH--HHH---hhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        316 NDVET--LKN---VKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       316 ~~~~~--~~~---i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .....  +..   .......+..+.+..+|+++++||.+||+.||+
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  342 (371)
T 3q60_A          297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRR  342 (371)
T ss_dssp             CTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTT
T ss_pred             CcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChh
Confidence            54211  111   111122233333458999999999999999995

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=7.1e-44  Score=329.34  Aligned_cols=244  Identities=28%  Similarity=0.505  Sum_probs=172.1

Q ss_pred             CCcccceeeec-cccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEe----CC
Q psy12427        104 SSVYDHYDILE-EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFED----DD  178 (356)
Q Consensus       104 ~~~~~~y~~~~-~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~  178 (356)
                      ..+.++|.+.+ .||+|+||+||+|.++.+|+.||+|++.....    ...+....++.++||||+++++++..    ..
T Consensus        24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~   99 (336)
T 3fhr_A           24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----ARQEVDHHWQASGGPHIVCILDVYENMHHGKR   99 (336)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH----HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH----HHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence            35667899965 69999999999999999999999999865322    22223344667799999999999976    45


Q ss_pred             eEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecC-CCcEEEEee
Q psy12427        179 EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN-STNVKMIDF  257 (356)
Q Consensus       179 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~-~~~vkl~Df  257 (356)
                      ..++||||++||+|.+++.....    ..+....+..++.||+.||+|||++||+||||||+|||++.++ .+.+||+||
T Consensus       100 ~~~lv~e~~~gg~L~~~l~~~~~----~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Df  175 (336)
T 3fhr_A          100 CLLIIMECMEGGELFSRIQERGD----QAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDF  175 (336)
T ss_dssp             EEEEEEECCTTEEHHHHHHTC-C----CCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred             eEEEEEeccCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecc
Confidence            68999999999999999975432    2234445566999999999999999999999999999997643 346999999


Q ss_pred             eceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHH----HHHhhccccccCh
Q psy12427        258 GLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVET----LKNVKACDWEFDE  333 (356)
Q Consensus       258 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~----~~~i~~~~~~~~~  333 (356)
                      |++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+......    ...+......++.
T Consensus       176 g~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  254 (336)
T 3fhr_A          176 GFAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPN  254 (336)
T ss_dssp             TTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCT
T ss_pred             ccceecccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCc
Confidence            999876532 33445789999999999998999999999999999999999999987765544    3444455566666


Q ss_pred             hhhccCCHHHHHHHHHhhhcCCC
Q psy12427        334 EAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       334 ~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +.+..+|+++++||++||+.||+
T Consensus       255 ~~~~~~~~~~~~li~~~L~~dP~  277 (336)
T 3fhr_A          255 PEWSEVSEDAKQLIRLLLKTDPT  277 (336)
T ss_dssp             TTSTTCCHHHHHHHHHHSCSSGG
T ss_pred             hhhccCCHHHHHHHHHHCCCChh
Confidence            67778999999999999999985

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.3e-44  Score=330.22  Aligned_cols=246  Identities=16%  Similarity=0.263  Sum_probs=203.1

Q ss_pred             cccceeeeccccccCceEEEEEEEc-----cCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCe
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRER-----KTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDE  179 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~-----~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  179 (356)
                      ..++|++.+.||+|+||.||+|.++     .++..||+|.+.... ......+.+|+.+|+.++||||+++++++.....
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~  102 (322)
T 1p4o_A           23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP  102 (322)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred             hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCc
Confidence            3468999999999999999999987     457899999997543 3345678899999999999999999999999999


Q ss_pred             EEEEEEeccccchhhhhhCCCCC----CCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEE
Q psy12427        180 MVLIFEFLSGGELFERITAPDYK----MSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMI  255 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~~----~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~  255 (356)
                      .++||||+++|+|.+++......    ..........+..++.||+.||+|||++||+||||||+|||++.++  .+||+
T Consensus       103 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~--~~kl~  180 (322)
T 1p4o_A          103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF--TVKIG  180 (322)
T ss_dssp             CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC--CEEEC
T ss_pred             cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC--eEEEC
Confidence            99999999999999988642210    0011223344566999999999999999999999999999998654  79999


Q ss_pred             eeeceeeeCCCCcee---ecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhcccccc
Q psy12427        256 DFGLATKLDPNEVVK---ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEF  331 (356)
Q Consensus       256 Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~  331 (356)
                      |||++..........   ...+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+.......
T Consensus       181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  260 (322)
T 1p4o_A          181 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD  260 (322)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred             cCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcCC
Confidence            999998654332221   2246889999999999999999999999999999999 899999999988888887755432


Q ss_pred             ChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        332 DEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       332 ~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .   ...+|+++.+||++||+.||+
T Consensus       261 ~---~~~~~~~l~~li~~~l~~dp~  282 (322)
T 1p4o_A          261 K---PDNCPDMLFELMRMCWQYNPK  282 (322)
T ss_dssp             C---CTTCCHHHHHHHHHHTCSSGG
T ss_pred             C---CCCCCHHHHHHHHHHcCCCcc
Confidence            2   247899999999999999985

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=4e-44  Score=324.27  Aligned_cols=243  Identities=23%  Similarity=0.264  Sum_probs=191.2

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeE-EeCCeEEEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAF-EDDDEMVLIF  184 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-~~~~~~~lv~  184 (356)
                      +.++|++.+.||+|+||+||+|++..+++.||+|++.....  ...+.+|+.+++.++|++++..+..+ ......++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            45789999999999999999999999999999998765433  23467899999999988877665554 6788899999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEee-cCCCcEEEEeeeceeee
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQT-RNSTNVKMIDFGLATKL  263 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~-~~~~~vkl~Dfg~a~~~  263 (356)
                      ||+ +++|.+++......+++     ..+..++.||+.||+|||++||+||||||+|||++. +.++.+||+|||+++..
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~-----~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSRKFSL-----KTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             ECC-CCBHHHHHHHTTSCCCH-----HHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             Ecc-CCCHHHHHHHhcCCCCH-----HHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            999 99999998754434443     344569999999999999999999999999999931 12347999999999877


Q ss_pred             CCCCc--------eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChH---HHHHHhhccccccC
Q psy12427        264 DPNEV--------VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDV---ETLKNVKACDWEFD  332 (356)
Q Consensus       264 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~---~~~~~i~~~~~~~~  332 (356)
                      .....        .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..   +.+..+.......+
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence            54322        22446899999999999999999999999999999999999999875432   33444444333333


Q ss_pred             -hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 -EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 -~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                       +.....+|+++.+||++||+.||+
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~~p~  263 (296)
T 4hgt_A          239 IEVLCKGYPSEFATYLNFCRSLRFD  263 (296)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHTSCTT
T ss_pred             hhhhhccCCHHHHHHHHHHHhcCCC
Confidence             333357899999999999999995

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-43  Score=325.44  Aligned_cols=242  Identities=25%  Similarity=0.467  Sum_probs=194.3

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhc-CCCCceeeeeeEEe------CC
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL-HHPKLINLHDAFED------DD  178 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~------~~  178 (356)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++..... ....+.+|+.+++++ +||||+++++++..      ..
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~  100 (326)
T 2x7f_A           22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD  100 (326)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence            35689999999999999999999999999999999876543 346788999999999 79999999999986      56


Q ss_pred             eEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeee
Q psy12427        179 EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFG  258 (356)
Q Consensus       179 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg  258 (356)
                      ..++||||+++++|.+++....    ...+....+..++.||+.||+|||+.||+|+||||+|||++.++  .+||+|||
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~--~~kl~Dfg  174 (326)
T 2x7f_A          101 QLWLVMEFCGAGSVTDLIKNTK----GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA--EVKLVDFG  174 (326)
T ss_dssp             EEEEEEECCTTEEHHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC--CEEECCCT
T ss_pred             eEEEEEEcCCCCcHHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCC--CEEEeeCc
Confidence            8999999999999999987532    12233444566999999999999999999999999999997544  79999999


Q ss_pred             ceeeeCCCC-ceeecCCCcCcccccccc-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC
Q psy12427        259 LATKLDPNE-VVKISTGTAEFAAPEIVE-----REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD  332 (356)
Q Consensus       259 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~  332 (356)
                      ++....... ......|++.|+|||++.     ...++.++|||||||++|+|++|..||.+.+..+.+..+......  
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--  252 (326)
T 2x7f_A          175 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP--  252 (326)
T ss_dssp             TTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC--
T ss_pred             CceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc--
Confidence            998764322 223456899999999997     567889999999999999999999999998887777666554322  


Q ss_pred             hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 ~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ......+|.++++||++||+.||+
T Consensus       253 ~~~~~~~~~~l~~li~~~l~~dp~  276 (326)
T 2x7f_A          253 RLKSKKWSKKFQSFIESCLVKNHS  276 (326)
T ss_dssp             CCSCSCSCHHHHHHHHHHCCSSGG
T ss_pred             cCCccccCHHHHHHHHHHhccChh
Confidence            222347899999999999999984

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=4.1e-44  Score=319.98  Aligned_cols=237  Identities=15%  Similarity=0.222  Sum_probs=197.8

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeC--CeEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDD--DEMV  181 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~  181 (356)
                      ..++|++.+.||+|+||.||+|.++  +..+|+|++....  ......+.+|+.++++++||||+++++++...  ...+
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   85 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT   85 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence            4568999999999999999999986  8899999997653  34456788999999999999999999999877  7889


Q ss_pred             EEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEEeecCCCcEEEEeeec
Q psy12427        182 LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN--IIHLDVKPENIMCQTRNSTNVKMIDFGL  259 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~  259 (356)
                      +||||+++|+|.+++.....    ..+....+..++.|++.||+|||++|  ++||||||+|||++.++  .++|+|||+
T Consensus        86 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~--~~~l~~~~~  159 (271)
T 3kmu_A           86 LITHWMPYGSLYNVLHEGTN----FVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM--TARISMADV  159 (271)
T ss_dssp             EEEECCTTCBHHHHHHSCSS----CCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTS--CEEEEGGGS
T ss_pred             eeecccCCCcHHHHHhhccc----CCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCc--ceeEEeccc
Confidence            99999999999999976432    12333445669999999999999999  99999999999997554  689998887


Q ss_pred             eeeeCCCCceeecCCCcCccccccccCCCCCc---cccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhh
Q psy12427        260 ATKLDPNEVVKISTGTAEFAAPEIVEREPVGF---YTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAF  336 (356)
Q Consensus       260 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  336 (356)
                      +.....    ....||+.|+|||++.+..++.   ++|||||||++|+|++|+.||.+.+..+....+......+  ...
T Consensus       160 ~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~  233 (271)
T 3kmu_A          160 KFSFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP--TIP  233 (271)
T ss_dssp             CCTTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC--CCC
T ss_pred             eeeecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC--CCC
Confidence            654332    2346899999999998765544   7999999999999999999999999888877776554332  233


Q ss_pred             ccCCHHHHHHHHHhhhcCCC
Q psy12427        337 KNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       337 ~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ..+|+++.++|++||+.||+
T Consensus       234 ~~~~~~~~~li~~~l~~~p~  253 (271)
T 3kmu_A          234 PGISPHVSKLMKICMNEDPA  253 (271)
T ss_dssp             TTCCHHHHHHHHHHTCSSGG
T ss_pred             CCCCHHHHHHHHHHcCCChh
Confidence            57999999999999999985

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=8.1e-44  Score=334.61  Aligned_cols=216  Identities=25%  Similarity=0.429  Sum_probs=182.5

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcC-CC-----CceeeeeeEEeCC
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLH-HP-----KLINLHDAFEDDD  178 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~-hp-----nIv~l~~~~~~~~  178 (356)
                      .+.++|++.+.||+|+||+||+|.++.+++.||+|+++... .....+.+|+.++..++ |+     +|+++++++....
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            35678999999999999999999999999999999997543 33456778999999885 55     4999999999999


Q ss_pred             eEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHH--HCCceeccCCCCCEEEeecCCCcEEEEe
Q psy12427        179 EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH--EKNIIHLDVKPENIMCQTRNSTNVKMID  256 (356)
Q Consensus       179 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~ivH~Dlkp~NIlv~~~~~~~vkl~D  256 (356)
                      ..++||||+. ++|.+++.....    ..+....+..++.|++.||.|||  +.||+||||||+|||++.++.+.+||+|
T Consensus       130 ~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D  204 (382)
T 2vx3_A          130 HLCLVFEMLS-YNLYDLLRNTNF----RGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD  204 (382)
T ss_dssp             EEEEEEECCC-CBHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred             ceEEEEecCC-CCHHHHHhhcCc----CCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence            9999999996 599998875432    12333445669999999999999  5799999999999999765556899999


Q ss_pred             eeceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccc
Q psy12427        257 FGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACD  328 (356)
Q Consensus       257 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~  328 (356)
                      ||+++.....  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus       205 FG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~  274 (382)
T 2vx3_A          205 FGSSCQLGQR--IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVL  274 (382)
T ss_dssp             CTTCEETTCC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             ccCceecccc--cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            9999876432  334578999999999999999999999999999999999999999999988888876543

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.9e-44  Score=330.31  Aligned_cols=247  Identities=21%  Similarity=0.314  Sum_probs=200.2

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCC-----EEEEEEcccCC-hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCC
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGN-----IFAAKFIPVSH-NLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDD  178 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~-----~~a~K~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~  178 (356)
                      ..++|++.+.||+|+||.||+|.+..++.     .||+|.+.... ......+.+|+.+|+++ +||||+++++++...+
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  123 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG  123 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence            34689999999999999999999987664     79999987654 34557788999999999 8999999999999999


Q ss_pred             eEEEEEEeccccchhhhhhCCCC--------CCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCC
Q psy12427        179 EMVLIFEFLSGGELFERITAPDY--------KMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNST  250 (356)
Q Consensus       179 ~~~lv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~  250 (356)
                      ..++||||+++|+|.+++.....        ......+....+..++.|++.||+|||++||+||||||+|||++.++  
T Consensus       124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~--  201 (333)
T 2i1m_A          124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH--  201 (333)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGG--
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCC--
Confidence            99999999999999998864221        01122334455667999999999999999999999999999998655  


Q ss_pred             cEEEEeeeceeeeCCCCce---eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhc
Q psy12427        251 NVKMIDFGLATKLDPNEVV---KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKA  326 (356)
Q Consensus       251 ~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~  326 (356)
                      .+||+|||++.........   ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+.+..+..
T Consensus       202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~  281 (333)
T 2i1m_A          202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK  281 (333)
T ss_dssp             EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHH
T ss_pred             eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHh
Confidence            7999999999866433221   12346789999999999999999999999999999998 9999998876555555544


Q ss_pred             cccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        327 CDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       327 ~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .....+  ....+|+++.++|.+||+.||+
T Consensus       282 ~~~~~~--~~~~~~~~l~~li~~~l~~~p~  309 (333)
T 2i1m_A          282 DGYQMA--QPAFAPKNIYSIMQACWALEPT  309 (333)
T ss_dssp             HTCCCC--CCTTCCHHHHHHHHHHTCSSGG
T ss_pred             cCCCCC--CCCCCCHHHHHHHHHHhccChh
Confidence            433322  2246799999999999999984

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.6e-44  Score=345.16  Aligned_cols=239  Identities=21%  Similarity=0.302  Sum_probs=194.6

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      ..++|++.+.||+|+||.||+|.++. +..||+|+++.... ..+.+.+|+.+|++++||||+++++++.. ...++|||
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e  258 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  258 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence            34689999999999999999999875 46799999976543 35678899999999999999999999876 67899999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |+++|+|.+++.....    ..+....+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+++....
T Consensus       259 ~~~~gsL~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~--~~kl~DfG~a~~~~~  332 (452)
T 1fmk_A          259 YMSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL--VCKVADFGLARLIED  332 (452)
T ss_dssp             CCTTCBHHHHHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEEECCCCTTC----
T ss_pred             hhcCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCC--CEEECCCccceecCC
Confidence            9999999999863211    1123334556999999999999999999999999999997654  799999999987643


Q ss_pred             CCce--eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHH
Q psy12427        266 NEVV--KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEE  342 (356)
Q Consensus       266 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  342 (356)
                      ....  ....+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+.+..+..+....   ....+|++
T Consensus       333 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~---~~~~~~~~  409 (452)
T 1fmk_A          333 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP---CPPECPES  409 (452)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTSCHH
T ss_pred             CceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCHH
Confidence            3221  22346789999999999999999999999999999999 999999999999888887653222   22478999


Q ss_pred             HHHHHHHhhhcCCC
Q psy12427        343 GKDFIRRLLLRNKE  356 (356)
Q Consensus       343 ~~~lI~~ll~~dP~  356 (356)
                      +.+||.+||+.||+
T Consensus       410 l~~li~~cl~~dP~  423 (452)
T 1fmk_A          410 LHDLMCQCWRKEPE  423 (452)
T ss_dssp             HHHHHHHHTCSSGG
T ss_pred             HHHHHHHHccCChh
Confidence            99999999999985

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3e-44  Score=334.68  Aligned_cols=239  Identities=23%  Similarity=0.400  Sum_probs=196.3

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      .++|++.+.||+|+||+||+|.++.++..||+|++.... ......+.+|+.+|++++||||+++++++...+..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            468999999999999999999999999999999997653 3445778899999999999999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEK-NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      |+++++|.+++.... .     +....+..++.|++.||+|||++ ||+||||||+|||++.++  .+||+|||++....
T Consensus       112 ~~~~~~L~~~l~~~~-~-----~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~  183 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAG-R-----IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG--EIKLCDFGVSGQLI  183 (360)
T ss_dssp             CCTTCBHHHHHHHHS-S-----CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC--CEEECCCCCCHHHH
T ss_pred             CCCCCCHHHHHHHcC-C-----CCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCC--CEEEEECCCCcccc
Confidence            999999999986432 2     33344556999999999999996 999999999999998654  79999999987553


Q ss_pred             CCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHh--------------------
Q psy12427        265 PNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV--------------------  324 (356)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i--------------------  324 (356)
                      .. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+                    
T Consensus       184 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (360)
T 3eqc_A          184 DS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR  262 (360)
T ss_dssp             HH-C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred             cc-cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence            21 223457899999999999999999999999999999999999999887765442221                    


Q ss_pred             ----------------------hccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        325 ----------------------KACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       325 ----------------------~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                            ....  .+......+|.++++||++||+.||+
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~  314 (360)
T 3eqc_A          263 PLNKFGMDSRPPMAIFELLDYIVNEP--PPKLPSGVFSLEFQDFVNKCLIKNPA  314 (360)
T ss_dssp             -----------CCCHHHHHHHHHHSC--CCCCCTTTSCHHHHHHHHHHHCSSTT
T ss_pred             cccccccCCCCcccchhhhhHHhccC--CCCCCcccccHHHHHHHHHHhhcChh
Confidence                                  1111  11111235799999999999999995

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3.4e-44  Score=337.99  Aligned_cols=244  Identities=20%  Similarity=0.334  Sum_probs=191.9

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcC--------CCCceeeeeeEE-
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLH--------HPKLINLHDAFE-  175 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~--------hpnIv~l~~~~~-  175 (356)
                      .+.++|++.++||+|+||+||+|++..+++.||+|++... ......+.+|+.+|+.++        ||||+++++++. 
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~  112 (397)
T 1wak_A           34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI  112 (397)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred             hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence            3457899999999999999999999999999999999754 334567789999999995        788999999997 


Q ss_pred             ---eCCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEeecC---
Q psy12427        176 ---DDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEK-NIIHLDVKPENIMCQTRN---  248 (356)
Q Consensus       176 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~ivH~Dlkp~NIlv~~~~---  248 (356)
                         .....++||||+ +++|.+.+.....    ..+....+..++.||+.||+|||++ ||+||||||+|||++.++   
T Consensus       113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~  187 (397)
T 1wak_A          113 SGVNGTHICMVFEVL-GHHLLKWIIKSNY----QGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYI  187 (397)
T ss_dssp             EETTEEEEEEEECCC-CCBHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHH
T ss_pred             cCCCCceEEEEEecc-CccHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhh
Confidence               566899999999 5566665543321    1233344566999999999999998 999999999999997543   


Q ss_pred             --------------------------------------------CCcEEEEeeeceeeeCCCCceeecCCCcCccccccc
Q psy12427        249 --------------------------------------------STNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV  284 (356)
Q Consensus       249 --------------------------------------------~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~  284 (356)
                                                                  ...+||+|||+++.....  .....||+.|+|||++
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHH
T ss_pred             hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhh
Confidence                                                        126999999999876532  3345789999999999


Q ss_pred             cCCCCCccccHHHHHHHHHHHHcCCCCCCCCC------hHHHHHHhhccccccChhh-----------------------
Q psy12427        285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN------DVETLKNVKACDWEFDEEA-----------------------  335 (356)
Q Consensus       285 ~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~------~~~~~~~i~~~~~~~~~~~-----------------------  335 (356)
                      .+..++.++|||||||++|+|++|+.||.+.+      ..+.+..+......++...                       
T Consensus       266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (397)
T 1wak_A          266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL  345 (397)
T ss_dssp             HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred             cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence            99999999999999999999999999998765      3344444433222222111                       


Q ss_pred             ---------------hccCCHHHHHHHHHhhhcCCC
Q psy12427        336 ---------------FKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       336 ---------------~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                     ....+.++++||++||+.||+
T Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  381 (397)
T 1wak_A          346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPE  381 (397)
T ss_dssp             CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGG
T ss_pred             CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChh
Confidence                           123457899999999999995

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3e-43  Score=318.18  Aligned_cols=239  Identities=24%  Similarity=0.313  Sum_probs=195.8

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccC--ChhhHHHHHHHHHHHHhcCCCCceeeeeeEEe----CCeE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS--HNLEKELIRKEIDIMNQLHHPKLINLHDAFED----DDEM  180 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~~  180 (356)
                      ...|.+.+.||+|+||+||+|.+..++..||+|.+...  .......+.+|+.+|++++||||+++++++..    ...+
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence            34689999999999999999999999999999998754  34456778899999999999999999999875    4668


Q ss_pred             EEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEEeecCCCcEEEEeee
Q psy12427        181 VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN--IIHLDVKPENIMCQTRNSTNVKMIDFG  258 (356)
Q Consensus       181 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~Dlkp~NIlv~~~~~~~vkl~Dfg  258 (356)
                      ++||||+++++|.+++.... .     +....+..++.|++.||+|||+.|  |+||||||+|||++.+ ++.+||+|||
T Consensus       105 ~lv~e~~~~~~L~~~l~~~~-~-----~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~-~~~~kl~Dfg  177 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKRFK-V-----MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP-TGSVKIGDLG  177 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-S-----CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESST-TSCEEECCTT
T ss_pred             EEEEEecCCCCHHHHHHHcc-C-----CCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECC-CCCEEEeeCC
Confidence            99999999999999986432 2     233445569999999999999999  9999999999999632 2379999999


Q ss_pred             ceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHH-HHHHhhccccccChhhhc
Q psy12427        259 LATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVE-TLKNVKACDWEFDEEAFK  337 (356)
Q Consensus       259 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~  337 (356)
                      ++..... .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+..... ....+....  .+.....
T Consensus       178 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~  253 (290)
T 1t4h_A          178 LATLKRA-SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV--KPASFDK  253 (290)
T ss_dssp             GGGGCCT-TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC--CCGGGGG
T ss_pred             Ccccccc-cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccC--CccccCC
Confidence            9975543 33445679999999998874 58999999999999999999999998865544 444444332  2334445


Q ss_pred             cCCHHHHHHHHHhhhcCCC
Q psy12427        338 NVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       338 ~~s~~~~~lI~~ll~~dP~  356 (356)
                      ..++++.+||++||+.||+
T Consensus       254 ~~~~~l~~li~~~l~~dp~  272 (290)
T 1t4h_A          254 VAIPEVKEIIEGCIRQNKD  272 (290)
T ss_dssp             CCCHHHHHHHHHHSCSSGG
T ss_pred             CCCHHHHHHHHHHccCChh
Confidence            7889999999999999985

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=7.6e-44  Score=327.17  Aligned_cols=244  Identities=25%  Similarity=0.402  Sum_probs=198.3

Q ss_pred             cccceeeeccccccCceEEEEEEEc-cCCCEEEEEEcccCChh--hHHHHHHHHHHHHhc---CCCCceeeeeeEE----
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRER-KTGNIFAAKFIPVSHNL--EKELIRKEIDIMNQL---HHPKLINLHDAFE----  175 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~-~~~~~~a~K~~~~~~~~--~~~~~~~E~~il~~l---~hpnIv~l~~~~~----  175 (356)
                      ..++|++.+.||+|+||.||+|++. .+|+.||+|++......  ....+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            3468999999999999999999995 67889999998654321  223456788777776   8999999999987    


Q ss_pred             -eCCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEE
Q psy12427        176 -DDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKM  254 (356)
Q Consensus       176 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl  254 (356)
                       .....++||||+. |+|.+++.....    ..+....+..++.|++.||+|||++||+||||||+|||++.++  .+||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~--~~kl  161 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG--QIKL  161 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCT----TCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--CEEE
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCC--CEEE
Confidence             5678899999997 599998865321    1233445566999999999999999999999999999997654  7999


Q ss_pred             EeeeceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc---
Q psy12427        255 IDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEF---  331 (356)
Q Consensus       255 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~---  331 (356)
                      +|||++.............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+......+   
T Consensus       162 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (326)
T 1blx_A          162 ADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  241 (326)
T ss_dssp             CSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             ecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc
Confidence            99999987654444445678999999999999999999999999999999999999999999888877765421111   


Q ss_pred             --------------------ChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        332 --------------------DEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       332 --------------------~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                          .......++.++++||.+||+.||+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  286 (326)
T 1blx_A          242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPA  286 (326)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTT
T ss_pred             cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcc
Confidence                                1223357899999999999999995

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.2e-44  Score=353.00  Aligned_cols=238  Identities=23%  Similarity=0.360  Sum_probs=195.5

Q ss_pred             cceeeec-cccccCceEEEEEEEcc--CCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        108 DHYDILE-EIGTGAFGVVHRCRERK--TGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       108 ~~y~~~~-~lg~G~fg~V~~~~~~~--~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      +++.+.+ +||+|+||.||+|.++.  ++..||+|+++... ....+.+.+|+++|++++||||+++++++.. ...++|
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv  413 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV  413 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence            3455555 89999999999998864  45679999997653 3356788999999999999999999999976 569999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      |||+.+|+|.+++......+++.     .+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+++..
T Consensus       414 ~E~~~~g~L~~~l~~~~~~l~~~-----~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~--~vkL~DFGla~~~  486 (613)
T 2ozo_A          414 MEMAGGGPLHKFLVGKREEIPVS-----NVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH--YAKISDFGLSKAL  486 (613)
T ss_dssp             EECCTTCBHHHHHTTCTTTSCHH-----HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECCCSTTTTC
T ss_pred             EEeCCCCcHHHHHhhccCCCCHH-----HHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCC--cEEEeeccCcccc
Confidence            99999999999997554334443     4455999999999999999999999999999998665  7999999999876


Q ss_pred             CCCCce----eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhcc
Q psy12427        264 DPNEVV----KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKN  338 (356)
Q Consensus       264 ~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  338 (356)
                      ......    ....+++.|+|||++.+..++.++|||||||+||||++ |+.||.+.+..+....+..+....   ....
T Consensus       487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~---~p~~  563 (613)
T 2ozo_A          487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME---CPPE  563 (613)
T ss_dssp             C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCC---CCTT
T ss_pred             cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC---CCCc
Confidence            432211    12335789999999999999999999999999999998 999999999999888887754322   2247


Q ss_pred             CCHHHHHHHHHhhhcCCC
Q psy12427        339 VSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       339 ~s~~~~~lI~~ll~~dP~  356 (356)
                      +|+++.++|.+||+.||+
T Consensus       564 ~~~~l~~li~~cl~~dP~  581 (613)
T 2ozo_A          564 CPPELYALMSDCWIYKWE  581 (613)
T ss_dssp             CCHHHHHHHHHTTCSSTT
T ss_pred             CCHHHHHHHHHHcCCChh
Confidence            999999999999999995

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.3e-43  Score=326.73  Aligned_cols=244  Identities=23%  Similarity=0.404  Sum_probs=199.2

Q ss_pred             CcccceeeeccccccCceEEEEEEE-ccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCC------CceeeeeeEEeC
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRE-RKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHP------KLINLHDAFEDD  177 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~-~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hp------nIv~l~~~~~~~  177 (356)
                      .+.++|++.+.||+|+||+||+|.+ +.+++.||+|+++.. ......+.+|+.+++.++|+      +++++++++...
T Consensus        11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~   89 (339)
T 1z57_A           11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH   89 (339)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred             CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence            3457899999999999999999998 567899999998754 33456778899999998765      499999999999


Q ss_pred             CeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecC---------
Q psy12427        178 DEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN---------  248 (356)
Q Consensus       178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~---------  248 (356)
                      +..++||||+ +++|.+++.....    ..+....+..++.||+.||+|||++||+||||||+|||++.++         
T Consensus        90 ~~~~lv~e~~-~~~l~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~  164 (339)
T 1z57_A           90 GHICIVFELL-GLSTYDFIKENGF----LPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKI  164 (339)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC---
T ss_pred             CcEEEEEcCC-CCCHHHHHHhcCC----CCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcc
Confidence            9999999999 8899998875432    1233344566999999999999999999999999999997643         


Q ss_pred             --------CCcEEEEeeeceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHH
Q psy12427        249 --------STNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVET  320 (356)
Q Consensus       249 --------~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~  320 (356)
                              ++.+||+|||++......  .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.
T Consensus       165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  242 (339)
T 1z57_A          165 KRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH  242 (339)
T ss_dssp             -CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred             ccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence                    457999999999875432  3345789999999999999999999999999999999999999999988877


Q ss_pred             HHHhhccccccChhhh----------------------------------------ccCCHHHHHHHHHhhhcCCC
Q psy12427        321 LKNVKACDWEFDEEAF----------------------------------------KNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       321 ~~~i~~~~~~~~~~~~----------------------------------------~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +..+......+|...+                                        ...++++.+||++||+.||+
T Consensus       243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~  318 (339)
T 1z57_A          243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA  318 (339)
T ss_dssp             HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred             HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence            7666544333332211                                        12357899999999999995

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=9.7e-44  Score=321.77  Aligned_cols=242  Identities=23%  Similarity=0.383  Sum_probs=192.6

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEecc
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLS  188 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  188 (356)
                      +|.....||+|+||.||+|.+..++..||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            45555689999999999999999999999999987766666788899999999999999999999999999999999999


Q ss_pred             ccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCc
Q psy12427        189 GGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEV  268 (356)
Q Consensus       189 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~  268 (356)
                      +++|.+++.......   ......+..++.|++.||+|||++|++|+||||+|||++.. ++.+||+|||++........
T Consensus       103 ~~~L~~~l~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~~kl~Dfg~~~~~~~~~~  178 (295)
T 2clq_A          103 GGSLSALLRSKWGPL---KDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTY-SGVLKISDFGTSKRLAGINP  178 (295)
T ss_dssp             EEEHHHHHHHTTCCC---TTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT-TCCEEECCTTTCEESCC---
T ss_pred             CCCHHHHHHhhccCC---CccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECC-CCCEEEeecccccccCCCCC
Confidence            999999987542211   12233455689999999999999999999999999999762 24799999999987653322


Q ss_pred             -eeecCCCcCccccccccCCC--CCccccHHHHHHHHHHHHcCCCCCCCCChHHH-HHHhhccccccChhhhccCCHHHH
Q psy12427        269 -VKISTGTAEFAAPEIVEREP--VGFYTDMWAVGVLAYVLLSGLSPFAGENDVET-LKNVKACDWEFDEEAFKNVSEEGK  344 (356)
Q Consensus       269 -~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~~~~  344 (356)
                       .....|++.|+|||++.+..  ++.++||||||+++|+|++|+.||........ .......  ...+.....+++++.
T Consensus       179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~  256 (295)
T 2clq_A          179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF--KVHPEIPESMSAEAK  256 (295)
T ss_dssp             --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH--CCCCCCCTTSCHHHH
T ss_pred             cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc--cccccccccCCHHHH
Confidence             23456899999999997654  78999999999999999999999976543322 2222111  122233357899999


Q ss_pred             HHHHHhhhcCCC
Q psy12427        345 DFIRRLLLRNKE  356 (356)
Q Consensus       345 ~lI~~ll~~dP~  356 (356)
                      +||.+||+.||+
T Consensus       257 ~li~~~l~~dp~  268 (295)
T 2clq_A          257 AFILKCFEPDPD  268 (295)
T ss_dssp             HHHHHTTCSSTT
T ss_pred             HHHHHHccCChh
Confidence            999999999995

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=4.4e-44  Score=324.76  Aligned_cols=240  Identities=25%  Similarity=0.411  Sum_probs=194.6

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEe---------
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFED---------  176 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---------  176 (356)
                      +.++|++.+.||+|+||.||+|++..+++.||+|++... ......+.+|+.++++++||||+++++++..         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            346899999999999999999999999999999998643 3345678899999999999999999998865         


Q ss_pred             ----CCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcE
Q psy12427        177 ----DDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNV  252 (356)
Q Consensus       177 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~v  252 (356)
                          ....++||||+++++|.+++.......+     ...+..++.|++.||+|||++|++||||||+|||++.++  .+
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~-----~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~--~~  155 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQ-----RDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR--NV  155 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSCGGGC-----HHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--CE
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccccccc-----hHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCC--CE
Confidence                4578999999999999999975433233     234455999999999999999999999999999997554  79


Q ss_pred             EEEeeeceeeeCCC---------------CceeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCC-C
Q psy12427        253 KMIDFGLATKLDPN---------------EVVKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAG-E  315 (356)
Q Consensus       253 kl~Dfg~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~-~  315 (356)
                      ||+|||++......               .......|++.|+|||++.+. .++.++|||||||++|+|++   ||.. .
T Consensus       156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~  232 (303)
T 1zy4_A          156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM  232 (303)
T ss_dssp             EECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred             EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch
Confidence            99999999765421               122334689999999999865 68999999999999999998   6643 3


Q ss_pred             ChHHHHHHhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        316 NDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       316 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +..+.+..+......+++.....++.++++||++||+.||+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  273 (303)
T 1zy4_A          233 ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPN  273 (303)
T ss_dssp             HHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGG
T ss_pred             hHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcc
Confidence            45566777777777777777778899999999999999985

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=327.88  Aligned_cols=237  Identities=24%  Similarity=0.426  Sum_probs=187.9

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCC--CCceeeeeeEEeCCeEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHH--PKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~~~~~l  182 (356)
                      .++|++.+.||+|+||.||+|.+. ++..||+|++....  ......+.+|+.+|..++|  |||+++++++......++
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            457999999999999999999885 58899999987543  3344678899999999986  999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ||| +.+++|.+++.... .++     ...+..++.||+.||+|||++||+||||||+|||++ +  +.+||+|||+++.
T Consensus        87 v~e-~~~~~L~~~l~~~~-~~~-----~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~--~~~kl~DFG~a~~  156 (343)
T 3dbq_A           87 VME-CGNIDLNSWLKKKK-SID-----PWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-D--GMLKLIDFGIANQ  156 (343)
T ss_dssp             EEC-CCSEEHHHHHHHSC-CCC-----HHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-T--TEEEECCCSSSCC
T ss_pred             EEe-CCCCCHHHHHHhcC-CCC-----HHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-C--CcEEEeecccccc
Confidence            999 56889999987543 233     334556999999999999999999999999999996 2  3799999999987


Q ss_pred             eCCCCc---eeecCCCcCccccccccC-----------CCCCccccHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHhhcc
Q psy12427        263 LDPNEV---VKISTGTAEFAAPEIVER-----------EPVGFYTDMWAVGVLAYVLLSGLSPFAGEND-VETLKNVKAC  327 (356)
Q Consensus       263 ~~~~~~---~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~-~~~~~~i~~~  327 (356)
                      ......   .....||+.|+|||++.+           ..++.++|||||||++|+|++|+.||.+... ...+..+...
T Consensus       157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  236 (343)
T 3dbq_A          157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP  236 (343)
T ss_dssp             C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT
T ss_pred             cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcC
Confidence            653322   234579999999999864           6788999999999999999999999987543 3444554443


Q ss_pred             ccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        328 DWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       328 ~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ....  ......+.++.+||.+||+.||+
T Consensus       237 ~~~~--~~~~~~~~~l~~li~~~L~~dp~  263 (343)
T 3dbq_A          237 NHEI--EFPDIPEKDLQDVLKCCLKRDPK  263 (343)
T ss_dssp             TSCC--CCCCCSCHHHHHHHHHHTCSSTT
T ss_pred             Cccc--CCcccCCHHHHHHHHHHcCCChh
Confidence            3222  22246788999999999999995

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.9e-43  Score=328.24  Aligned_cols=242  Identities=26%  Similarity=0.393  Sum_probs=195.6

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeC-----C
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDD-----D  178 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~  178 (356)
                      .+.++|++.+.||+|+||.||+|.++.+|+.||+|++.... ......+.+|+.+++.++||||+++++++...     .
T Consensus         8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   87 (353)
T 2b9h_A            8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN   87 (353)
T ss_dssp             CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred             ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence            45678999999999999999999999999999999987543 33456678999999999999999999987654     7


Q ss_pred             eEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeee
Q psy12427        179 EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFG  258 (356)
Q Consensus       179 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg  258 (356)
                      ..++||||+. ++|.+++...  .     +....+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||
T Consensus        88 ~~~lv~e~~~-~~L~~~~~~~--~-----~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~--~~kl~Dfg  157 (353)
T 2b9h_A           88 EVYIIQELMQ-TDLHRVISTQ--M-----LSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC--DLKVCDFG  157 (353)
T ss_dssp             CEEEEECCCS-EEHHHHHHHC--C-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC--CEEECCCT
T ss_pred             eEEEEEeccC-ccHHHHHhhc--C-----CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCC--cEEEEecc
Confidence            8899999996 6898888642  2     33344556999999999999999999999999999997554  79999999


Q ss_pred             ceeeeCCCCc-----------eeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhc
Q psy12427        259 LATKLDPNEV-----------VKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKA  326 (356)
Q Consensus       259 ~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~  326 (356)
                      ++........           .....||+.|+|||++.. ..++.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  237 (353)
T 2b9h_A          158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG  237 (353)
T ss_dssp             TCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             cccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence            9987643211           112368999999998764 6789999999999999999999999999987776655432


Q ss_pred             cccc----------------------------cChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        327 CDWE----------------------------FDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       327 ~~~~----------------------------~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ....                            .....+..+|+++++||++||+.||+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  295 (353)
T 2b9h_A          238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPA  295 (353)
T ss_dssp             HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGG
T ss_pred             HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcc
Confidence            1111                            11223457899999999999999995

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=6.3e-44  Score=322.38  Aligned_cols=240  Identities=23%  Similarity=0.356  Sum_probs=191.9

Q ss_pred             ccceeeeccccccCceEEEEEEEcc-CCC--EEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERK-TGN--IFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM  180 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~-~~~--~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  180 (356)
                      .++|++.+.||+|+||+||+|.+.. ++.  .||+|+++...   ....+.+.+|+.++++++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            3589999999999999999999754 333  68999887542   334567889999999999999999999998765 8


Q ss_pred             EEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeece
Q psy12427        181 VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA  260 (356)
Q Consensus       181 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a  260 (356)
                      ++||||+.+++|.+++......+     ....+..++.|++.||+|||++|++|+||||+|||++.++  .+||+|||++
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~~~~-----~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~--~~kl~Dfg~~  168 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQGHF-----LLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD--LVKIGDFGLM  168 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGS-----CHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT--EEEECCCTTC
T ss_pred             eeeEecccCCCHHHHHHhccCCc-----CHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCC--CEEEcccccc
Confidence            89999999999999987543223     3344556999999999999999999999999999998765  7999999999


Q ss_pred             eeeCCCCce----eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhh
Q psy12427        261 TKLDPNEVV----KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEA  335 (356)
Q Consensus       261 ~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  335 (356)
                      .........    ....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+.+..+......++.  
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--  246 (291)
T 1u46_A          169 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--  246 (291)
T ss_dssp             EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC--
T ss_pred             ccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCC--
Confidence            887544322    22346889999999998889999999999999999999 99999999999888888766544332  


Q ss_pred             hccCCHHHHHHHHHhhhcCCC
Q psy12427        336 FKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       336 ~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ...+|+++.++|.+||+.||+
T Consensus       247 ~~~~~~~l~~li~~~l~~~p~  267 (291)
T 1u46_A          247 PEDCPQDIYNVMVQCWAHKPE  267 (291)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGG
T ss_pred             CcCcCHHHHHHHHHHccCCcc
Confidence            347999999999999999985

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=8.5e-44  Score=322.87  Aligned_cols=239  Identities=20%  Similarity=0.246  Sum_probs=195.1

Q ss_pred             cceeeeccccccCceEEEEEEEccCC---CEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeE-EeCCeEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTG---NIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAF-EDDDEMVL  182 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~---~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~-~~~~~~~l  182 (356)
                      .+|++.+.||+|+||+||+|.+..++   ..+|+|.+.... ......+.+|+.++++++||||+++++++ ..++..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            46999999999999999999976443   468999887543 34457788999999999999999999985 45678899


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ||||+++|+|.+++......++..     .+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||++..
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~-----~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~a~~  177 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKF--TVKVADFGLARD  177 (298)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCCHH-----HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC--CEEECSCGGGCC
T ss_pred             EEeCCCCCCHHHHHHhcccCCCHH-----HHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCC--CEEECccccccc
Confidence            999999999999997644334333     3455999999999999999999999999999997544  799999999987


Q ss_pred             eCCCCc-----eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhh
Q psy12427        263 LDPNEV-----VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAF  336 (356)
Q Consensus       263 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  336 (356)
                      ......     .....+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||.+.+..+....+........+   
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  254 (298)
T 3f66_A          178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP---  254 (298)
T ss_dssp             CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCC---
T ss_pred             ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCC---
Confidence            643221     223356889999999999999999999999999999999 78888888887777777665544333   


Q ss_pred             ccCCHHHHHHHHHhhhcCCC
Q psy12427        337 KNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       337 ~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ..+|+++.++|++||+.||+
T Consensus       255 ~~~~~~l~~li~~~l~~~p~  274 (298)
T 3f66_A          255 EYCPDPLYEVMLKCWHPKAE  274 (298)
T ss_dssp             TTCCHHHHHHHHHHTCSSGG
T ss_pred             ccCCHHHHHHHHHHcCCChh
Confidence            46899999999999999985

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.8e-43  Score=317.78  Aligned_cols=238  Identities=23%  Similarity=0.379  Sum_probs=197.8

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      .++|++.+.||+|+||.||+|.++ ++..||+|.+..... ..+.+.+|+++|++++||||+++++++.. +..++||||
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~   88 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence            468999999999999999999976 467899999875432 45678899999999999999999998864 568999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +++++|.+++....    ...+....+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||++......
T Consensus        89 ~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~~~~~~~~  162 (279)
T 1qpc_A           89 MENGSLVDFLKTPS----GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL--SCKIADFGLARLIEDN  162 (279)
T ss_dssp             CTTCBHHHHTTSHH----HHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS--CEEECCCTTCEECSSS
T ss_pred             CCCCCHHHHHhcCC----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCC--CEEECCCcccccccCc
Confidence            99999999986421    11233344566999999999999999999999999999997544  7999999999887543


Q ss_pred             Ccee--ecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHH
Q psy12427        267 EVVK--ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG  343 (356)
Q Consensus       267 ~~~~--~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  343 (356)
                      ....  ...+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+.......   ....+|+++
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l  239 (279)
T 1qpc_A          163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV---RPDNCPEEL  239 (279)
T ss_dssp             CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTCCHHH
T ss_pred             ccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCC---CcccccHHH
Confidence            3222  2346789999999998889999999999999999999 999999999888888876653222   224789999


Q ss_pred             HHHHHHhhhcCCC
Q psy12427        344 KDFIRRLLLRNKE  356 (356)
Q Consensus       344 ~~lI~~ll~~dP~  356 (356)
                      .++|++||+.||+
T Consensus       240 ~~li~~~l~~~p~  252 (279)
T 1qpc_A          240 YQLMRLCWKERPE  252 (279)
T ss_dssp             HHHHHHHTCSSGG
T ss_pred             HHHHHHHhccChh
Confidence            9999999999985

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-44  Score=335.49  Aligned_cols=239  Identities=20%  Similarity=0.244  Sum_probs=188.2

Q ss_pred             cceeeeccccccCceEEEEEEEccCC---CEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEE-eCCeEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTG---NIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFE-DDDEMVL  182 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~---~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~~l  182 (356)
                      ..|++.+.||+|+||+||+|.+..++   ..+|+|.+.... ......+.+|+.+|++++||||+++++++. ..+..++
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            35889999999999999999986543   468999986543 345678889999999999999999999865 4568899


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ||||+++|+|.+++......++.     ..+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+++.
T Consensus       169 v~e~~~~g~L~~~l~~~~~~~~~-----~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~--~~kL~DFG~a~~  241 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRNETHNPTV-----KDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF--TVKVADFGLARD  241 (373)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCBH-----HHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECCC-----
T ss_pred             EEECCCCCCHHHHHhhcccCCCH-----HHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCC--CEEEeecccccc
Confidence            99999999999999765433333     33455899999999999999999999999999997544  799999999986


Q ss_pred             eCCCCc-----eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhh
Q psy12427        263 LDPNEV-----VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAF  336 (356)
Q Consensus       263 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  336 (356)
                      ......     .....+|+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+....+........+   
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p---  318 (373)
T 3c1x_A          242 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP---  318 (373)
T ss_dssp             ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCC---
T ss_pred             ccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCC---
Confidence            643221     122346889999999999999999999999999999999 88899988877777777665433322   


Q ss_pred             ccCCHHHHHHHHHhhhcCCC
Q psy12427        337 KNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       337 ~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ..+|+++.++|.+||+.||+
T Consensus       319 ~~~~~~l~~li~~cl~~dp~  338 (373)
T 3c1x_A          319 EYCPDPLYEVMLKCWHPKAE  338 (373)
T ss_dssp             TTCCHHHHHHHHHHTCSSGG
T ss_pred             CCCCHHHHHHHHHHcCCChh
Confidence            47899999999999999985

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=9e-44  Score=331.23  Aligned_cols=245  Identities=23%  Similarity=0.360  Sum_probs=182.9

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCe-------
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDE-------  179 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-------  179 (356)
                      .++|++.+.||+|+||+||+|.++.+|..||+|++..... ......+|+..+..++||||+++++++.....       
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  100 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY  100 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccccee
Confidence            4689999999999999999999999999999998865432 23345578888999999999999999965433       


Q ss_pred             EEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHH--HCCceeccCCCCCEEEeecCCCcEEEEee
Q psy12427        180 MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH--EKNIIHLDVKPENIMCQTRNSTNVKMIDF  257 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~ivH~Dlkp~NIlv~~~~~~~vkl~Df  257 (356)
                      .++||||+.++ |.+.+...  ...........+..++.|++.||.|||  ++||+||||||+|||++.. ++.+||+||
T Consensus       101 ~~lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~-~~~~kl~Df  176 (360)
T 3e3p_A          101 LNVVMEYVPDT-LHRCCRNY--YRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEA-DGTLKLCDF  176 (360)
T ss_dssp             EEEEEECCSCB-HHHHHHHH--HTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETT-TTEEEECCC
T ss_pred             EEEEeeccccc-HHHHHHHH--hhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCC-CCcEEEeeC
Confidence            88999999864 43333210  001112233345569999999999999  9999999999999999752 248999999


Q ss_pred             eceeeeCCCCceeecCCCcCccccccccCCC-CCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhh
Q psy12427        258 GLATKLDPNEVVKISTGTAEFAAPEIVEREP-VGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAF  336 (356)
Q Consensus       258 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  336 (356)
                      |+++............||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+......++.+.+
T Consensus       177 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  256 (360)
T 3e3p_A          177 GSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL  256 (360)
T ss_dssp             TTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             CCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHH
Confidence            9998877665555667899999999986654 899999999999999999999999999988888777653322222111


Q ss_pred             ----------------------------ccCCHHHHHHHHHhhhcCCC
Q psy12427        337 ----------------------------KNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       337 ----------------------------~~~s~~~~~lI~~ll~~dP~  356 (356)
                                                  ...++++++||.+||+.||+
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  304 (360)
T 3e3p_A          257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPE  304 (360)
T ss_dssp             HHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGG
T ss_pred             HhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCcc
Confidence                                        12578999999999999995

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.4e-44  Score=339.75  Aligned_cols=249  Identities=20%  Similarity=0.325  Sum_probs=178.4

Q ss_pred             Ccccceee-eccccccCceEEEEEEEc--cCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEE--eCCe
Q psy12427        105 SVYDHYDI-LEEIGTGAFGVVHRCRER--KTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFE--DDDE  179 (356)
Q Consensus       105 ~~~~~y~~-~~~lg~G~fg~V~~~~~~--~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~~  179 (356)
                      .+.+.|.+ .++||+|+||+||+|+++  .++..||+|++.....  ...+.+|+.+|++++||||+++++++.  ....
T Consensus        17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   94 (405)
T 3rgf_A           17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRK   94 (405)
T ss_dssp             CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred             hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence            34456777 458999999999999977  4688999999975533  245778999999999999999999995  4778


Q ss_pred             EEEEEEeccccchhhhhhCCCC---CCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeec--CCCcEEE
Q psy12427        180 MVLIFEFLSGGELFERITAPDY---KMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTR--NSTNVKM  254 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~--~~~~vkl  254 (356)
                      .++||||+. ++|.+++.....   ......+....++.++.||+.||+|||++||+||||||+|||+..+  ..+.+||
T Consensus        95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence            999999996 577777642211   0111124444566799999999999999999999999999999532  3357999


Q ss_pred             EeeeceeeeCCC----CceeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCCh---------HHH
Q psy12427        255 IDFGLATKLDPN----EVVKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGEND---------VET  320 (356)
Q Consensus       255 ~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~~---------~~~  320 (356)
                      +|||+|+.....    .......||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+.         .+.
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  253 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ  253 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence            999999876432    222345789999999999874 589999999999999999999999987654         244


Q ss_pred             HHHhhccccccChhhhc----------------------------------cCCHHHHHHHHHhhhcCCC
Q psy12427        321 LKNVKACDWEFDEEAFK----------------------------------NVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       321 ~~~i~~~~~~~~~~~~~----------------------------------~~s~~~~~lI~~ll~~dP~  356 (356)
                      +..+......++...|.                                  ..++++.+||++||+.||+
T Consensus       254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~  323 (405)
T 3rgf_A          254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPI  323 (405)
T ss_dssp             HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGG
T ss_pred             HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcc
Confidence            55544332222222221                                  1278999999999999995

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3.1e-43  Score=327.06  Aligned_cols=238  Identities=22%  Similarity=0.399  Sum_probs=193.1

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCe----
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDE----  179 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~----  179 (356)
                      +.++|.+.+.||+|+||.||+|.++.+|+.||+|++....  ......+.+|+.+++.++||||+++++++.....    
T Consensus        22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  101 (353)
T 3coi_A           22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  101 (353)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence            3467999999999999999999999999999999986543  3335677899999999999999999999987654    


Q ss_pred             --EEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEee
Q psy12427        180 --MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDF  257 (356)
Q Consensus       180 --~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Df  257 (356)
                        .++||||+. ++|.+++..   .     +....+..++.||+.||+|||++||+||||||+|||++.++  .+||+||
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~~---~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~--~~kl~Df  170 (353)
T 3coi_A          102 YDFYLVMPFMQ-TDLQKIMGL---K-----FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC--ELKILDF  170 (353)
T ss_dssp             CCCEEEEECCS-EEGGGTTTS---C-----CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTC--CEEECST
T ss_pred             eeEEEEecccc-CCHHHHhcC---C-----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCC--cEEEeec
Confidence              499999997 688777642   2     33344566999999999999999999999999999997554  7999999


Q ss_pred             eceeeeCCCCceeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC----
Q psy12427        258 GLATKLDPNEVVKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD----  332 (356)
Q Consensus       258 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~----  332 (356)
                      |+++.....  .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+......++    
T Consensus       171 g~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  248 (353)
T 3coi_A          171 GLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV  248 (353)
T ss_dssp             TCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHH
T ss_pred             ccccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            999765432  334578999999999887 6789999999999999999999999999988877776654322111    


Q ss_pred             -----------------------hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 -----------------------EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 -----------------------~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                             ...+..+++++++||++||+.||+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~  295 (353)
T 3coi_A          249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVD  295 (353)
T ss_dssp             TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTT
T ss_pred             HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcc
Confidence                                   122346799999999999999995

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.9e-44  Score=326.26  Aligned_cols=248  Identities=27%  Similarity=0.408  Sum_probs=180.7

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      .++|++.+.||+|+||.||+|.+..++..||+|.+.... ......+.+|+.++++++||||+++++++...+..++|||
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   93 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK   93 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence            468999999999999999999999999999999987543 2334667889999999999999999999999999999999


Q ss_pred             eccccchhhhhhCCC--CCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        186 FLSGGELFERITAPD--YKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      |+++++|.+++....  .......+....+..++.||+.||+|||++|++||||||+|||++.++  .+||+|||++...
T Consensus        94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~kl~dfg~~~~~  171 (303)
T 2vwi_A           94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG--SVQIADFGVSAFL  171 (303)
T ss_dssp             CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC--CEEECCCHHHHHC
T ss_pred             hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCC--CEEEEeccchhee
Confidence            999999999886310  001122234445566999999999999999999999999999997654  7999999998765


Q ss_pred             CCCC------ceeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc-----
Q psy12427        264 DPNE------VVKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEF-----  331 (356)
Q Consensus       264 ~~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-----  331 (356)
                      ....      ......||+.|+|||++.. ..++.++|||||||++|+|++|..||.+....+.+..........     
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  251 (303)
T 2vwi_A          172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGV  251 (303)
T ss_dssp             C---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC--
T ss_pred             ccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccccc
Confidence            4221      1233468999999999976 568999999999999999999999999887766655544332221     


Q ss_pred             -ChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        332 -DEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       332 -~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                       .......++.++++||.+||+.||+
T Consensus       252 ~~~~~~~~~~~~~~~li~~~l~~dp~  277 (303)
T 2vwi_A          252 QDKEMLKKYGKSFRKMISLCLQKDPE  277 (303)
T ss_dssp             ---CCCCCCCHHHHHHHHHHCCSSGG
T ss_pred             ccchhhhhhhHHHHHHHHHHccCChh
Confidence             1223357899999999999999985

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.4e-43  Score=318.79  Aligned_cols=233  Identities=23%  Similarity=0.383  Sum_probs=193.8

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEe---------
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFED---------  176 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---------  176 (356)
                      +.++|++.+.||+|+||.||+|.++.+++.||+|.+.....    .+.+|+.++++++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSG----GGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccH----HHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            45689999999999999999999999999999999976542    45689999999999999999998864         


Q ss_pred             -------CCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCC
Q psy12427        177 -------DDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNS  249 (356)
Q Consensus       177 -------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~  249 (356)
                             ....++||||+++++|.+++....    ...+....+..++.|++.||.|||++||+|+||||+|||++.++ 
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-  159 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR----GEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK-  159 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGG----GSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCC-
Confidence                   456899999999999999986432    11233344566999999999999999999999999999998655 


Q ss_pred             CcEEEEeeeceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc
Q psy12427        250 TNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDW  329 (356)
Q Consensus       250 ~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~  329 (356)
                       .+||+|||++.............|++.|+|||++.+..++.++||||||+++|+|++|..||...  ......+.... 
T Consensus       160 -~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~~-  235 (284)
T 2a19_B          160 -QVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDGI-  235 (284)
T ss_dssp             -EEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTTC-
T ss_pred             -CEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhccc-
Confidence             79999999998876655555567999999999999999999999999999999999999998532  23333333322 


Q ss_pred             ccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        330 EFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       330 ~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                       ++    ..++.+++++|++||+.||+
T Consensus       236 -~~----~~~~~~~~~li~~~l~~dp~  257 (284)
T 2a19_B          236 -IS----DIFDKKEKTLLQKLLSKKPE  257 (284)
T ss_dssp             -CC----TTSCHHHHHHHHHHTCSSGG
T ss_pred             -cc----ccCCHHHHHHHHHHccCChh
Confidence             12    36899999999999999985

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4.4e-44  Score=328.75  Aligned_cols=237  Identities=21%  Similarity=0.266  Sum_probs=185.5

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCC----eEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDD----EMVLI  183 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----~~~lv  183 (356)
                      ++|++.+.||+|+||+||+|++.  ++.||+|++..... ......+|+.+|++++||||+++++++....    .+++|
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhchhhheecccCceEEEEEEEC--CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            57999999999999999999876  78999999875533 3445566999999999999999999998744    47999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHC----------CceeccCCCCCEEEeecCCCcEE
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEK----------NIIHLDVKPENIMCQTRNSTNVK  253 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----------~ivH~Dlkp~NIlv~~~~~~~vk  253 (356)
                      |||+++|+|.+++....       +....+..++.|++.||+|||+.          ||+||||||+|||++.++  .+|
T Consensus       101 ~e~~~~g~L~~~l~~~~-------~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~--~~k  171 (322)
T 3soc_A          101 TAFHEKGSLSDFLKANV-------VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL--TAC  171 (322)
T ss_dssp             EECCTTCBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC--CEE
T ss_pred             EecCCCCCHHHHHHhcC-------CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC--eEE
Confidence            99999999999997532       33344566999999999999999          999999999999997554  799


Q ss_pred             EEeeeceeeeCCCCce---eecCCCcCccccccccC-----CCCCccccHHHHHHHHHHHHcCCCCCCCCCh--------
Q psy12427        254 MIDFGLATKLDPNEVV---KISTGTAEFAAPEIVER-----EPVGFYTDMWAVGVLAYVLLSGLSPFAGEND--------  317 (356)
Q Consensus       254 l~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~--------  317 (356)
                      |+|||+++........   ....||+.|+|||++.+     ..++.++|||||||++|+|++|+.||.+..+        
T Consensus       172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~  251 (322)
T 3soc_A          172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE  251 (322)
T ss_dssp             ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred             EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence            9999999887543322   22468999999999986     3566789999999999999999999976532        


Q ss_pred             --------HHHHHHhhcccccc-Chhhhc--cCCHHHHHHHHHhhhcCCC
Q psy12427        318 --------VETLKNVKACDWEF-DEEAFK--NVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       318 --------~~~~~~i~~~~~~~-~~~~~~--~~s~~~~~lI~~ll~~dP~  356 (356)
                              .+....+......+ .+..+.  ..++++.+||++||+.||+
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~  301 (322)
T 3soc_A          252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAE  301 (322)
T ss_dssp             HHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGG
T ss_pred             hhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChh
Confidence                    22222222222111 111111  2356799999999999995

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.2e-43  Score=324.18  Aligned_cols=245  Identities=22%  Similarity=0.304  Sum_probs=196.6

Q ss_pred             ccceeeeccccccCceEEEEEEEc-----cCCCEEEEEEcccCCh-hhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCC-
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRER-----KTGNIFAAKFIPVSHN-LEKELIRKEIDIMNQL-HHPKLINLHDAFEDDD-  178 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~-----~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~-  178 (356)
                      .++|++.+.||+|+||+||+|.+.     .+++.||+|++..... .....+.+|+.++.++ +||||+++++++...+ 
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  105 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  105 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence            468999999999999999999863     4568999999976543 3456788999999999 7999999999987654 


Q ss_pred             eEEEEEEeccccchhhhhhCCCCCC----------CccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecC
Q psy12427        179 EMVLIFEFLSGGELFERITAPDYKM----------SEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN  248 (356)
Q Consensus       179 ~~~lv~e~~~~g~L~~~l~~~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~  248 (356)
                      ..++||||+++++|.+++.......          ....+....+..++.|++.||+|||+.||+||||||+|||++.++
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~  185 (316)
T 2xir_A          106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN  185 (316)
T ss_dssp             CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred             ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC
Confidence            5899999999999999997654221          011144455677999999999999999999999999999997654


Q ss_pred             CCcEEEEeeeceeeeCCCCce---eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChH-HHHHH
Q psy12427        249 STNVKMIDFGLATKLDPNEVV---KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDV-ETLKN  323 (356)
Q Consensus       249 ~~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~-~~~~~  323 (356)
                        .+||+|||+++........   ....||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.... .....
T Consensus       186 --~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~  263 (316)
T 2xir_A          186 --VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR  263 (316)
T ss_dssp             --CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred             --CEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHH
Confidence              7999999999876433221   12346889999999999999999999999999999998 99999887644 34444


Q ss_pred             hhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        324 VKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       324 i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +......   .....+++++.++|.+||+.||+
T Consensus       264 ~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~  293 (316)
T 2xir_A          264 LKEGTRM---RAPDYTTPEMYQTMLDCWHGEPS  293 (316)
T ss_dssp             HHHTCCC---CCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             hccCccC---CCCCCCCHHHHHHHHHHcCCChh
Confidence            4433221   12246899999999999999984

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.7e-44  Score=333.21  Aligned_cols=240  Identities=15%  Similarity=0.195  Sum_probs=189.1

Q ss_pred             ccceeeeccccccCceEEEEEEEccC--------CCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCcee---------
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKT--------GNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLIN---------  169 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~--------~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~---------  169 (356)
                      .++|++.+.||+|+||.||+|+++.+        ++.||+|++...     ..+.+|++++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            36899999999999999999999874        889999998754     35678999999999999987         


Q ss_pred             ------eeeeEEe-CCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCE
Q psy12427        170 ------LHDAFED-DDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENI  242 (356)
Q Consensus       170 ------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NI  242 (356)
                            +++++.. ....++||||+ +++|.+++....    ...+....+..++.||+.||+|||++||+||||||+||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI  190 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP----KHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI  190 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC----cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence                  5667765 78899999999 999999997531    12334445566999999999999999999999999999


Q ss_pred             EEeecCCCcEEEEeeeceeeeCCCCc--------eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q psy12427        243 MCQTRNSTNVKMIDFGLATKLDPNEV--------VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAG  314 (356)
Q Consensus       243 lv~~~~~~~vkl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~  314 (356)
                      |++.++...+||+|||+++.+.....        .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            99865433799999999987643221        1233689999999999999999999999999999999999999987


Q ss_pred             CC--hHHHHHHhh---ccccccC--hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        315 EN--DVETLKNVK---ACDWEFD--EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       315 ~~--~~~~~~~i~---~~~~~~~--~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ..  .........   .....++  ...+..+|+++.+||++||+.||+
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~  319 (352)
T 2jii_A          271 CLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYE  319 (352)
T ss_dssp             GTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTT
T ss_pred             CCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChh
Confidence            64  333332222   1111111  112246799999999999999995

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-43  Score=319.84  Aligned_cols=238  Identities=19%  Similarity=0.258  Sum_probs=195.1

Q ss_pred             ceeeeccccccCceEEEEEEEccCCC---EEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeE-EEE
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGN---IFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM-VLI  183 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~---~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~-~lv  183 (356)
                      .|.+.+.||+|+||+||+|.+..++.   .+|+|.+.... ....+.+.+|+.++++++||||+++++++...... +++
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            47788999999999999999876654   79999987543 34557788999999999999999999999866555 999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      |||+.+|+|.+++......+++     ..+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||+++..
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~-----~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~--~~kl~Dfg~~~~~  174 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTV-----KDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESF--TVKVADFGLARDI  174 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBH-----HHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC--CEEECCTTSSCTT
T ss_pred             EecccCCCHHHHHhccccCCCH-----HHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC--cEEeCcCCCcccc
Confidence            9999999999999764433333     33455999999999999999999999999999997554  7999999999765


Q ss_pred             CCCC-----ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhc
Q psy12427        264 DPNE-----VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFK  337 (356)
Q Consensus       264 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  337 (356)
                      ....     ......+++.|+|||.+.+..++.++|||||||++|+|++ |.+||...+..+....+........   ..
T Consensus       175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---~~  251 (298)
T 3pls_A          175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ---PE  251 (298)
T ss_dssp             TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCC---CT
T ss_pred             cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCC---Cc
Confidence            3321     1223457889999999999999999999999999999999 6666777777777777666543222   24


Q ss_pred             cCCHHHHHHHHHhhhcCCC
Q psy12427        338 NVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       338 ~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+|+++.+||++||+.||+
T Consensus       252 ~~~~~l~~li~~~l~~~p~  270 (298)
T 3pls_A          252 YCPDSLYQVMQQCWEADPA  270 (298)
T ss_dssp             TCCHHHHHHHHHHTCSSGG
T ss_pred             cchHHHHHHHHHHccCChh
Confidence            7899999999999999985

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=8.1e-44  Score=325.84  Aligned_cols=242  Identities=19%  Similarity=0.323  Sum_probs=189.1

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEE----eCCeEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFE----DDDEMVLI  183 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~----~~~~~~lv  183 (356)
                      ++|++.+.||+|+||.||+|.++.+++.||+|++........+.+.+|+.+++.++||||+++++++.    .....++|
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  108 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL  108 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence            57999999999999999999999999999999998777767788899999999999999999999987    34578999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      |||+.+|+|.+++.....  ....+....+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||++...
T Consensus       109 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~--~~kl~dfg~~~~~  184 (317)
T 2buj_A          109 LPFFKRGTLWNEIERLKD--KGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEG--QPVLMDLGSMNQA  184 (317)
T ss_dssp             EECCTTCBHHHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS--CEEECCCSSCEES
T ss_pred             EEeCCCCcHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC--CEEEEecCcchhc
Confidence            999999999998864210  112233444566999999999999999999999999999997554  7999999998765


Q ss_pred             CCCCc----------eeecCCCcCccccccccCCC---CCccccHHHHHHHHHHHHcCCCCCCCCC--hHHHHHHhhccc
Q psy12427        264 DPNEV----------VKISTGTAEFAAPEIVEREP---VGFYTDMWAVGVLAYVLLSGLSPFAGEN--DVETLKNVKACD  328 (356)
Q Consensus       264 ~~~~~----------~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlG~il~ell~g~~Pf~~~~--~~~~~~~i~~~~  328 (356)
                      .....          .....||+.|+|||++....   ++.++|||||||++|+|++|+.||....  .......+.. .
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~  263 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN-Q  263 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC-C
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc-c
Confidence            32110          01234799999999997654   6889999999999999999999995421  1111122222 2


Q ss_pred             cccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        329 WEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       329 ~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ..++.  ...+|.++.++|++||+.||+
T Consensus       264 ~~~~~--~~~~~~~l~~li~~~l~~dp~  289 (317)
T 2buj_A          264 LSIPQ--SPRHSSALWQLLNSMMTVDPH  289 (317)
T ss_dssp             --CCC--CTTSCHHHHHHHHHHTCSSGG
T ss_pred             CCCCc--cccCCHHHHHHHHHHhhcChh
Confidence            22222  247899999999999999984

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=8.6e-43  Score=318.02  Aligned_cols=235  Identities=23%  Similarity=0.401  Sum_probs=184.7

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      .++|++.+.||+|+||+||+|.+.  ++.||+|.+...  .....+.+|+.+|++++||||+++++++.+  ..++||||
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~   80 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY   80 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence            467999999999999999999886  788999998643  345678899999999999999999998874  47999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHH---CCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE---KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      +++|+|.+++.....   ........+..++.|++.||+|||+   +||+||||||+|||++.++ ..+||+|||++...
T Consensus        81 ~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~-~~~kl~Dfg~~~~~  156 (307)
T 2eva_A           81 AEGGSLYNVLHGAEP---LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGG-TVLKICDFGTACDI  156 (307)
T ss_dssp             CTTCBHHHHHHCSSS---EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTT-TEEEECCCCC----
T ss_pred             CCCCCHHHHHhccCC---CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCC-CEEEEccccccccc
Confidence            999999999975431   1123333455688999999999999   8999999999999998654 24899999999765


Q ss_pred             CCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC--hHHHHHHhhccccccChhhhccCCH
Q psy12427        264 DPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN--DVETLKNVKACDWEFDEEAFKNVSE  341 (356)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~  341 (356)
                      ...  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||....  .......+....   .+.....+|.
T Consensus       157 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  231 (307)
T 2eva_A          157 QTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT---RPPLIKNLPK  231 (307)
T ss_dssp             ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC---CCCCBTTCCH
T ss_pred             ccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC---CCCcccccCH
Confidence            432  233468999999999999999999999999999999999999998653  233333333322   1233457999


Q ss_pred             HHHHHHHHhhhcCCC
Q psy12427        342 EGKDFIRRLLLRNKE  356 (356)
Q Consensus       342 ~~~~lI~~ll~~dP~  356 (356)
                      ++.++|.+||+.||+
T Consensus       232 ~l~~li~~~l~~dp~  246 (307)
T 2eva_A          232 PIESLMTRCWSKDPS  246 (307)
T ss_dssp             HHHHHHHHHTCSSGG
T ss_pred             HHHHHHHHHhcCChh
Confidence            999999999999984

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2e-43  Score=330.29  Aligned_cols=243  Identities=23%  Similarity=0.383  Sum_probs=191.2

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcC-----------CCCceeeeeeE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLH-----------HPKLINLHDAF  174 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~-----------hpnIv~l~~~~  174 (356)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++... ......+.+|+.++++++           ||||+++++++
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~   95 (373)
T 1q8y_A           17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   95 (373)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence            346899999999999999999999999999999998754 334566788999999886           89999999999


Q ss_pred             EeCC----eEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEeecC-
Q psy12427        175 EDDD----EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEK-NIIHLDVKPENIMCQTRN-  248 (356)
Q Consensus       175 ~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~ivH~Dlkp~NIlv~~~~-  248 (356)
                      ....    ..+++||++ +++|.+++.....    ..+....+..++.||+.||+|||++ ||+||||||+|||++.++ 
T Consensus        96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEH----RGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             EEEETTEEEEEEEECCC-CEEHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred             hccCCCCceEEEEEecC-CCCHHHHHHHhhc----cCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence            8654    789999999 8999999875321    1233344566999999999999998 999999999999997543 


Q ss_pred             ---CCcEEEEeeeceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC------hHH
Q psy12427        249 ---STNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN------DVE  319 (356)
Q Consensus       249 ---~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~------~~~  319 (356)
                         ...+||+|||++......  .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+      ..+
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  248 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  248 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             CcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence               236899999999876532  234578999999999999999999999999999999999999998765      333


Q ss_pred             HHHHhhccccccChh--------------------------------------hhccCCHHHHHHHHHhhhcCCC
Q psy12427        320 TLKNVKACDWEFDEE--------------------------------------AFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       320 ~~~~i~~~~~~~~~~--------------------------------------~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+..+......+|..                                      ....+++++++||++||+.||+
T Consensus       249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  323 (373)
T 1q8y_A          249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR  323 (373)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred             HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcc
Confidence            344433322222211                                      1124578899999999999995

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2e-43  Score=325.45  Aligned_cols=237  Identities=25%  Similarity=0.412  Sum_probs=173.8

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcC-CCCceeeeeeEE--------eCC
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLH-HPKLINLHDAFE--------DDD  178 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~--------~~~  178 (356)
                      .+|++.+.||+|+||.||+|.++.+++.||+|++..........+.+|+.++.++. ||||+++++++.        ...
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~  107 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA  107 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence            47999999999999999999999999999999987776666778889999999996 999999999984        345


Q ss_pred             eEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEEeecCCCcEEEEe
Q psy12427        179 EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN--IIHLDVKPENIMCQTRNSTNVKMID  256 (356)
Q Consensus       179 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~Dlkp~NIlv~~~~~~~vkl~D  256 (356)
                      .++++|||+. |+|.+++....   ....+....+..++.||+.||+|||+.|  |+||||||+|||++.++  .+||+|
T Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~--~~kl~D  181 (337)
T 3ll6_A          108 EFLLLTELCK-GQLVEFLKKME---SRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG--TIKLCD  181 (337)
T ss_dssp             EEEEEEECCS-EEHHHHHHHHH---TTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTS--CEEBCC
T ss_pred             eEEEEEEecC-CCHHHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCC--CEEEec
Confidence            5899999995 78888875311   0112333445669999999999999999  99999999999997654  799999


Q ss_pred             eeceeeeCCCCce-------------eecCCCcCccccccc---cCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHH
Q psy12427        257 FGLATKLDPNEVV-------------KISTGTAEFAAPEIV---EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVET  320 (356)
Q Consensus       257 fg~a~~~~~~~~~-------------~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~  320 (356)
                      ||++.........             ....||+.|+|||++   .+..++.++|||||||++|+|++|..||.+......
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~  261 (337)
T 3ll6_A          182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI  261 (337)
T ss_dssp             CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh
Confidence            9999876533221             134589999999998   567789999999999999999999999987665544


Q ss_pred             HHHhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        321 LKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       321 ~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +...    ...+.  ...++.++.+||++||+.||+
T Consensus       262 ~~~~----~~~~~--~~~~~~~~~~li~~~l~~~p~  291 (337)
T 3ll6_A          262 VNGK----YSIPP--HDTQYTVFHSLIRAMLQVNPE  291 (337)
T ss_dssp             --------CCCCT--TCCSSGGGHHHHHHHSCSSGG
T ss_pred             hcCc----ccCCc--ccccchHHHHHHHHHccCChh
Confidence            3332    22222  246788999999999999985

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=7.8e-44  Score=332.66  Aligned_cols=238  Identities=18%  Similarity=0.227  Sum_probs=185.7

Q ss_pred             ccceeeeccccccCceEEEEE-----EEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcC---CCCceeeeeeEEeCC
Q psy12427        107 YDHYDILEEIGTGAFGVVHRC-----RERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLH---HPKLINLHDAFEDDD  178 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~-----~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~  178 (356)
                      .++|.+.+.||+|+||+||+|     .+..+++.||+|++....   ...+.+|+.++..++   |+||+++++++...+
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~  140 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN  140 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence            367999999999999999999     467789999999987653   345677888888887   899999999999999


Q ss_pred             eEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeec---------CC
Q psy12427        179 EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTR---------NS  249 (356)
Q Consensus       179 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~---------~~  249 (356)
                      ..++||||+++|+|.+++.... ......+....+..++.||+.||+|||++||+||||||+|||++.+         ..
T Consensus       141 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~  219 (365)
T 3e7e_A          141 GSVLVGELYSYGTLLNAINLYK-NTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLS  219 (365)
T ss_dssp             CEEEEECCCCSCBHHHHHHHHH-TSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------C
T ss_pred             CcEEEEeccCCCcHHHHHHHhh-cccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccccc
Confidence            9999999999999999996421 1112234444556699999999999999999999999999999761         13


Q ss_pred             CcEEEEeeeceeeeC---CCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhc
Q psy12427        250 TNVKMIDFGLATKLD---PNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKA  326 (356)
Q Consensus       250 ~~vkl~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~  326 (356)
                      +.+||+|||+|+.+.   ........+||+.|+|||++.+..++.++|||||||++|||++|+.||.......     ..
T Consensus       220 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-----~~  294 (365)
T 3e7e_A          220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-----CK  294 (365)
T ss_dssp             TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-----EE
T ss_pred             CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-----ee
Confidence            579999999997653   2333345679999999999999999999999999999999999999996553311     00


Q ss_pred             cccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        327 CDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       327 ~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ....+..   ...++.+.+++..||+.+|.
T Consensus       295 ~~~~~~~---~~~~~~~~~~~~~~l~~~p~  321 (365)
T 3e7e_A          295 PEGLFRR---LPHLDMWNEFFHVMLNIPDC  321 (365)
T ss_dssp             ECSCCTT---CSSHHHHHHHHHHHHCCCCT
T ss_pred             echhccc---cCcHHHHHHHHHHHcCCCCC
Confidence            0000111   02367788888888888873

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.2e-43  Score=350.10  Aligned_cols=231  Identities=23%  Similarity=0.351  Sum_probs=191.0

Q ss_pred             ccccccCceEEEEEEEc--cCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEeccc
Q psy12427        114 EEIGTGAFGVVHRCRER--KTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSG  189 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~--~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  189 (356)
                      ++||+|+||.||+|.+.  .+++.||+|+++...  ....+.+.+|+.+|++++||||+++++++.. ...++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999654  556899999997643  2345788999999999999999999999975 568899999999


Q ss_pred             cchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCc-
Q psy12427        190 GELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEV-  268 (356)
Q Consensus       190 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~-  268 (356)
                      |+|.+++.... .+++     ..+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+++.+..... 
T Consensus       454 g~L~~~l~~~~-~l~~-----~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~--~~kL~DFGla~~~~~~~~~  525 (635)
T 4fl3_A          454 GPLNKYLQQNR-HVKD-----KNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH--YAKISDFGLSKALRADENY  525 (635)
T ss_dssp             EEHHHHHHHCT-TCCH-----HHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECCTTHHHHTTC----
T ss_pred             CCHHHHHhhCC-CCCH-----HHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCC--CEEEEEcCCccccccCccc
Confidence            99999996432 2333     34456999999999999999999999999999998765  799999999987643321 


Q ss_pred             ---eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHHH
Q psy12427        269 ---VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK  344 (356)
Q Consensus       269 ---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  344 (356)
                         .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+.......   ....+|+++.
T Consensus       526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~---~p~~~~~~l~  602 (635)
T 4fl3_A          526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG---CPAGCPREMY  602 (635)
T ss_dssp             ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTCCHHHH
T ss_pred             cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCHHHH
Confidence               122346789999999999999999999999999999998 999999999999888887765332   2247999999


Q ss_pred             HHHHHhhhcCCC
Q psy12427        345 DFIRRLLLRNKE  356 (356)
Q Consensus       345 ~lI~~ll~~dP~  356 (356)
                      +||++||+.||+
T Consensus       603 ~li~~cl~~dP~  614 (635)
T 4fl3_A          603 DLMNLCWTYDVE  614 (635)
T ss_dssp             HHHHHHTCSSTT
T ss_pred             HHHHHHcCCCHh
Confidence            999999999995

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=7.6e-43  Score=323.82  Aligned_cols=244  Identities=23%  Similarity=0.384  Sum_probs=196.2

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCC-CEEEEEEcccCChhhHHHHHHHHHHHHhcCCCC------ceeeeeeEEeC
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTG-NIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPK------LINLHDAFEDD  177 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~-~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpn------Iv~l~~~~~~~  177 (356)
                      .+.++|++.+.||+|+||+||+|.++.++ ..||+|+++.. ....+.+.+|+.+++.++|++      ++.+++++...
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~   94 (355)
T 2eu9_A           16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH   94 (355)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred             eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence            34578999999999999999999998877 68999998754 334567788999999997765      89999999999


Q ss_pred             CeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEee-----------
Q psy12427        178 DEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQT-----------  246 (356)
Q Consensus       178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~-----------  246 (356)
                      +..++||||+ +++|.+.+.....    ..+....+..++.||+.||+|||++||+||||||+|||++.           
T Consensus        95 ~~~~lv~e~~-~~~l~~~l~~~~~----~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~  169 (355)
T 2eu9_A           95 GHMCIAFELL-GKNTFEFLKENNF----QPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHK  169 (355)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred             CeEEEEEecc-CCChHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccc
Confidence            9999999999 5667666654321    12333445669999999999999999999999999999943           


Q ss_pred             ------cCCCcEEEEeeeceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHH
Q psy12427        247 ------RNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVET  320 (356)
Q Consensus       247 ------~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~  320 (356)
                            +..+.+||+|||++......  .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.
T Consensus       170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  247 (355)
T 2eu9_A          170 SCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH  247 (355)
T ss_dssp             CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             cccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence                  13457999999999875432  2345789999999999999999999999999999999999999999988877


Q ss_pred             HHHhhccccccChhhhc----------------------------------------cCCHHHHHHHHHhhhcCCC
Q psy12427        321 LKNVKACDWEFDEEAFK----------------------------------------NVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       321 ~~~i~~~~~~~~~~~~~----------------------------------------~~s~~~~~lI~~ll~~dP~  356 (356)
                      +..+......+|...+.                                        ..+.++.+||++||+.||+
T Consensus       248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~  323 (355)
T 2eu9_A          248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA  323 (355)
T ss_dssp             HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred             HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence            76665544333332111                                        1245899999999999995

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.3e-43  Score=347.04  Aligned_cols=239  Identities=21%  Similarity=0.299  Sum_probs=198.3

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      ..++|++.++||+|+||.||+|.++. +..||+|+++.... ..+.+.+|+.+|++++||||+++++++.. ...++|||
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e  341 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  341 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence            34689999999999999999999875 46799999976543 35678899999999999999999999876 67899999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |+.+|+|.+++.....    ..+....+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+++....
T Consensus       342 ~~~~gsL~~~l~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~--~~kl~DFG~a~~~~~  415 (535)
T 2h8h_A          342 YMSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL--VCKVADFGLARLIED  415 (535)
T ss_dssp             CCTTEEHHHHHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEEECCTTSTTTCCC
T ss_pred             hhcCCcHHHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCC--cEEEcccccceecCC
Confidence            9999999999863211    1123334556999999999999999999999999999997654  799999999986543


Q ss_pred             CCc--eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHH
Q psy12427        266 NEV--VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEE  342 (356)
Q Consensus       266 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  342 (356)
                      ...  .....++..|+|||++.+..++.++|||||||+||||++ |+.||.+....+.+..+..+....   ....++++
T Consensus       416 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~---~~~~~~~~  492 (535)
T 2h8h_A          416 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP---CPPECPES  492 (535)
T ss_dssp             HHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTCCHH
T ss_pred             CceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCHH
Confidence            211  122346789999999999999999999999999999999 999999999999888887653221   22478999


Q ss_pred             HHHHHHHhhhcCCC
Q psy12427        343 GKDFIRRLLLRNKE  356 (356)
Q Consensus       343 ~~~lI~~ll~~dP~  356 (356)
                      +.+||.+||+.||+
T Consensus       493 l~~li~~cl~~dP~  506 (535)
T 2h8h_A          493 LHDLMCQCWRKEPE  506 (535)
T ss_dssp             HHHHHHHHTCSSGG
T ss_pred             HHHHHHHHcCCChh
Confidence            99999999999985

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=9.1e-43  Score=335.82  Aligned_cols=243  Identities=23%  Similarity=0.267  Sum_probs=196.3

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCC-CCceeeeeeEEeCCeEEEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHH-PKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~~~lv~  184 (356)
                      +.++|++.++||+|+||.||+|.+..++..||+|++......  ..+.+|+++++.++| ++|..+..++......++||
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm   82 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM   82 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence            457899999999999999999999999999999987654432  346789999999987 55666666777888999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEee-cCCCcEEEEeeeceeee
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQT-RNSTNVKMIDFGLATKL  263 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~-~~~~~vkl~Dfg~a~~~  263 (356)
                      ||+ +++|.+++......+++     ..+..++.||+.||+|||++||+||||||+|||++. +..+.+||+|||+++.+
T Consensus        83 e~~-g~sL~~ll~~~~~~l~~-----~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~  156 (483)
T 3sv0_A           83 DLL-GPSLEDLFNFCSRKLSL-----KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY  156 (483)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCH-----HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             ECC-CCCHHHHHHhhcCCCCH-----HHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence            999 99999999754434444     344559999999999999999999999999999942 12347999999999887


Q ss_pred             CCCCce--------eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHhhccccc-c
Q psy12427        264 DPNEVV--------KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEND---VETLKNVKACDWE-F  331 (356)
Q Consensus       264 ~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~---~~~~~~i~~~~~~-~  331 (356)
                      ......        ....||+.|+|||++.+..++.++|||||||+||+|++|+.||.+...   .+.+..+...... .
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (483)
T 3sv0_A          157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS  236 (483)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred             cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence            543221        245689999999999999999999999999999999999999987643   4444444433322 2


Q ss_pred             ChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        332 DEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       332 ~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .......+++++.+||..||+.||+
T Consensus       237 ~~~l~~~~p~~l~~li~~cl~~dP~  261 (483)
T 3sv0_A          237 IEALCRGYPTEFASYFHYCRSLRFD  261 (483)
T ss_dssp             HHHHHTTSCHHHHHHHHHHHTCCTT
T ss_pred             HHHHhcCCcHHHHHHHHHHhcCChh
Confidence            2344468999999999999999985

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.8e-43  Score=316.43  Aligned_cols=235  Identities=20%  Similarity=0.329  Sum_probs=188.7

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEe-CCeEEEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFED-DDEMVLIFE  185 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~lv~e  185 (356)
                      .++|++.+.||+|+||+||+|.++  |..||+|+++...  ..+.+.+|+.++++++||||+++++++.. .+..++|||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   95 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   95 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence            468999999999999999999875  8899999987543  45678899999999999999999998754 457899999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |+++++|.+++.....    ..+....+..++.|++.||+|||++|++||||||+||+++.++  .+||+|||++.....
T Consensus        96 ~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           96 YMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN--VAKVSDFGLTKEASS  169 (278)
T ss_dssp             CCTTEEHHHHHHHHHH----HHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS--CEEECCCCC------
T ss_pred             cCCCCCHHHHHHhccc----ccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCC--cEEEeeccccccccc
Confidence            9999999999864321    1133344566999999999999999999999999999997554  799999999976543


Q ss_pred             CCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHHH
Q psy12427        266 NEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK  344 (356)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  344 (356)
                      .  .....+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+.....   ......+|+++.
T Consensus       170 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~  244 (278)
T 1byg_A          170 T--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPPAVY  244 (278)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC---CCCCTTCCHHHH
T ss_pred             c--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---CCCcccCCHHHH
Confidence            2  223457899999999999999999999999999999998 9999999888777777765432   222357899999


Q ss_pred             HHHHHhhhcCCC
Q psy12427        345 DFIRRLLLRNKE  356 (356)
Q Consensus       345 ~lI~~ll~~dP~  356 (356)
                      ++|++||+.||+
T Consensus       245 ~li~~~l~~~p~  256 (278)
T 1byg_A          245 EVMKNCWHLDAA  256 (278)
T ss_dssp             HHHHHHTCSSGG
T ss_pred             HHHHHHhcCChh
Confidence            999999999985

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=4.3e-43  Score=318.40  Aligned_cols=238  Identities=19%  Similarity=0.322  Sum_probs=184.5

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHh--cCCCCceeeeeeEEe----CC
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQ--LHHPKLINLHDAFED----DD  178 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~~~----~~  178 (356)
                      .+.++|++.+.||+|+||+||+|++  +++.||+|++...   ....+.+|.+++..  ++||||+++++++..    ..
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~   79 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST   79 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence            4567899999999999999999987  5889999998654   23455567777777  799999999998654    35


Q ss_pred             eEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHH--------HCCceeccCCCCCEEEeecCCC
Q psy12427        179 EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH--------EKNIIHLDVKPENIMCQTRNST  250 (356)
Q Consensus       179 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--------~~~ivH~Dlkp~NIlv~~~~~~  250 (356)
                      ..++||||+++|+|.+++...  .     +....+..++.|++.||+|||        +.||+||||||+|||++.++  
T Consensus        80 ~~~lv~e~~~~g~L~~~l~~~--~-----~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~--  150 (301)
T 3q4u_A           80 QLWLITHYHEMGSLYDYLQLT--T-----LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG--  150 (301)
T ss_dssp             EEEEEECCCTTCBHHHHHTTC--C-----BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS--
T ss_pred             eeEEehhhccCCCHHHHHhhc--c-----cCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC--
Confidence            689999999999999999543  2     333445569999999999999        99999999999999998554  


Q ss_pred             cEEEEeeeceeeeCCCCcee-----ecCCCcCccccccccCC------CCCccccHHHHHHHHHHHHcC----------C
Q psy12427        251 NVKMIDFGLATKLDPNEVVK-----ISTGTAEFAAPEIVERE------PVGFYTDMWAVGVLAYVLLSG----------L  309 (356)
Q Consensus       251 ~vkl~Dfg~a~~~~~~~~~~-----~~~gt~~y~aPE~~~~~------~~~~~sDvwSlG~il~ell~g----------~  309 (356)
                      .+||+|||+++.........     ...||+.|+|||++.+.      .++.++|||||||++|||++|          .
T Consensus       151 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~  230 (301)
T 3q4u_A          151 QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK  230 (301)
T ss_dssp             CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence            79999999998765433322     23689999999999876      455789999999999999999          8


Q ss_pred             CCCCCCC----hHHHHHHhhcc---ccccChhh-hccCCHHHHHHHHHhhhcCCC
Q psy12427        310 SPFAGEN----DVETLKNVKAC---DWEFDEEA-FKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       310 ~Pf~~~~----~~~~~~~i~~~---~~~~~~~~-~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .||....    ..+.+......   ...++... ...+++++.+||++||+.||+
T Consensus       231 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~  285 (301)
T 3q4u_A          231 PPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPS  285 (301)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGG
T ss_pred             ccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChh
Confidence            9996542    22333332221   11222221 123678899999999999995

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.8e-43  Score=322.93  Aligned_cols=240  Identities=22%  Similarity=0.360  Sum_probs=193.6

Q ss_pred             ccceeeeccccccCceEEEEEEE----ccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeC--CeE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRE----RKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDD--DEM  180 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~----~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~  180 (356)
                      .++|++.+.||+|+||.||+|+.    ..++..||+|++........+.+.+|+.++++++||||+++++++...  ...
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            46799999999999999999984    567899999999877666677899999999999999999999998654  378


Q ss_pred             EEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeece
Q psy12427        181 VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA  260 (356)
Q Consensus       181 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a  260 (356)
                      ++||||+++++|.+++......+++     ..+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||++
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~~~~~-----~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~--~~kL~Dfg~~  192 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKERIDH-----IKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN--RVKIGDFGLT  192 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTTSSCH-----HHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT--EEEECCCTTC
T ss_pred             EEEEECCCCCCHHHHHHhcccCCCH-----HHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCC--cEEEecCcch
Confidence            9999999999999999765433333     34455999999999999999999999999999998765  7999999999


Q ss_pred             eeeCCCCce----eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChH----------------HH
Q psy12427        261 TKLDPNEVV----KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDV----------------ET  320 (356)
Q Consensus       261 ~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~----------------~~  320 (356)
                      .........    ....++..|+|||++.+..++.++|||||||++|+|++|..||......                ..
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (326)
T 2w1i_A          193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  272 (326)
T ss_dssp             EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence            887544332    1234678899999999888999999999999999999999998643110                11


Q ss_pred             HHHhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        321 LKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       321 ~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ...+.... .+  +....+|+++.++|++||+.||+
T Consensus       273 ~~~~~~~~-~~--~~~~~~~~~l~~li~~cl~~dP~  305 (326)
T 2w1i_A          273 IELLKNNG-RL--PRPDGCPDEIYMIMTECWNNNVN  305 (326)
T ss_dssp             HHHHHTTC-CC--CCCTTCCHHHHHHHHHHSCSSGG
T ss_pred             HHHhhcCC-CC--CCCCcccHHHHHHHHHHcCCChh
Confidence            12222211 11  12347899999999999999985

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=318.23  Aligned_cols=241  Identities=24%  Similarity=0.388  Sum_probs=177.5

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh--hHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL--EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      .++|++.+.||+|+||.||+|.++.+|+.||+|++......  ....+.++..+++.++||||+++++++......++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            46799999999999999999999999999999999765432  2334445666788889999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEK-NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      ||+ ++.+..+.......++     ...+..++.|++.||+|||++ |++|+||||+|||++.++  .+||+|||++...
T Consensus       104 e~~-~~~~~~l~~~~~~~~~-----~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~--~~kl~dfg~~~~~  175 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQGPIP-----ERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG--QIKLCDFGISGRL  175 (318)
T ss_dssp             CCC-SEEHHHHHHHHTSCCC-----HHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTS--CEEECCCTTC---
T ss_pred             ecc-CCcHHHHHHHhccCCC-----HHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCC--CEEEEECCCchhc
Confidence            999 5555555443222333     334456999999999999996 999999999999997654  7999999999877


Q ss_pred             CCCCceeecCCCcCcccccccc-----CCCCCccccHHHHHHHHHHHHcCCCCCCCC-ChHHHHHHhhccccccChhhhc
Q psy12427        264 DPNEVVKISTGTAEFAAPEIVE-----REPVGFYTDMWAVGVLAYVLLSGLSPFAGE-NDVETLKNVKACDWEFDEEAFK  337 (356)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~ell~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~  337 (356)
                      ..........|++.|+|||++.     ...++.++|||||||++|+|++|+.||... ...+.+..+........+ ...
T Consensus       176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~  254 (318)
T 2dyl_A          176 VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLP-GHM  254 (318)
T ss_dssp             -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCC-SSS
T ss_pred             cCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCC-ccC
Confidence            5554445567899999999994     556889999999999999999999999874 556666666655433222 224


Q ss_pred             cCCHHHHHHHHHhhhcCCC
Q psy12427        338 NVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       338 ~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+|.++.+||.+||+.||+
T Consensus       255 ~~~~~l~~li~~~l~~dp~  273 (318)
T 2dyl_A          255 GFSGDFQSFVKDCLTKDHR  273 (318)
T ss_dssp             CCCHHHHHHHHHHTCSCTT
T ss_pred             CCCHHHHHHHHHHccCChh
Confidence            6899999999999999995

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.4e-42  Score=346.62  Aligned_cols=240  Identities=20%  Similarity=0.319  Sum_probs=198.4

Q ss_pred             cccceeeeccccccCceEEEEEEEccC---CCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKT---GNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMV  181 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~---~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  181 (356)
                      ..++|++.+.||+|+||.||+|.+..+   +..+|+|.++... ....+.+.+|+.+|++++||||+++++++. .+..+
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~  466 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW  466 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence            346899999999999999999998754   4579999987543 334577889999999999999999999985 46789


Q ss_pred             EEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeecee
Q psy12427        182 LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT  261 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~  261 (356)
                      +||||+++|+|.+++......+++.     .+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||+++
T Consensus       467 lv~E~~~~g~L~~~l~~~~~~l~~~-----~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~--~vkL~DFG~a~  539 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQVRKFSLDLA-----SLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND--CVKLGDFGLSR  539 (656)
T ss_dssp             EEEECCTTCBHHHHHHHTTTTCCHH-----HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECCCCCCC
T ss_pred             EEEEcCCCCcHHHHHHhccCCCCHH-----HHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCC--CEEEEecCCCe
Confidence            9999999999999997554444433     3445899999999999999999999999999998765  79999999998


Q ss_pred             eeCCCCce--eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhcc
Q psy12427        262 KLDPNEVV--KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKN  338 (356)
Q Consensus       262 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  338 (356)
                      ........  ....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+.+..+.......   ....
T Consensus       540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~---~~~~  616 (656)
T 2j0j_A          540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP---MPPN  616 (656)
T ss_dssp             SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC---CCTT
T ss_pred             ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC---CCcc
Confidence            76543322  22346789999999999999999999999999999997 999999999999888887654322   2247


Q ss_pred             CCHHHHHHHHHhhhcCCC
Q psy12427        339 VSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       339 ~s~~~~~lI~~ll~~dP~  356 (356)
                      +|+++.+||.+||+.||+
T Consensus       617 ~~~~l~~li~~~l~~dP~  634 (656)
T 2j0j_A          617 CPPTLYSLMTKCWAYDPS  634 (656)
T ss_dssp             CCHHHHHHHHHHTCSSGG
T ss_pred             ccHHHHHHHHHHcCCChh
Confidence            899999999999999995

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=5.4e-43  Score=320.91  Aligned_cols=239  Identities=20%  Similarity=0.311  Sum_probs=191.0

Q ss_pred             cccce-eeeccccccCceEEEEEEE----ccCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEe--C
Q psy12427        106 VYDHY-DILEEIGTGAFGVVHRCRE----RKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFED--D  177 (356)
Q Consensus       106 ~~~~y-~~~~~lg~G~fg~V~~~~~----~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~  177 (356)
                      +.++| ++.+.||+|+||+||++..    ..+++.||+|++.... ......+.+|+.+|++++||||+++++++..  .
T Consensus        28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (318)
T 3lxp_A           28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA  107 (318)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred             ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence            34455 9999999999999988764    3568899999997654 3445778899999999999999999999987  4


Q ss_pred             CeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEee
Q psy12427        178 DEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDF  257 (356)
Q Consensus       178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Df  257 (356)
                      ..+++||||+++|+|.+++....       +....+..++.|++.||+|||++||+||||||+|||++.++  .+||+||
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~--~~kl~Df  178 (318)
T 3lxp_A          108 ASLQLVMEYVPLGSLRDYLPRHS-------IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDR--LVKIGDF  178 (318)
T ss_dssp             TEEEEEECCCTTCBHHHHGGGSC-------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCG
T ss_pred             ceEEEEEecccCCcHHHHHhhCC-------CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCC--CEEECCc
Confidence            67899999999999999987543       33344556999999999999999999999999999997554  7999999


Q ss_pred             eceeeeCCCCce----eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChH---------------
Q psy12427        258 GLATKLDPNEVV----KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDV---------------  318 (356)
Q Consensus       258 g~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~---------------  318 (356)
                      |++.........    ....+|+.|+|||++.+..++.++|||||||++|+|++|..||......               
T Consensus       179 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~  258 (318)
T 3lxp_A          179 GLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL  258 (318)
T ss_dssp             GGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHH
T ss_pred             cccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHH
Confidence            999887654322    2345788899999999989999999999999999999999999764321               


Q ss_pred             HHHHHhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        319 ETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       319 ~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +....+....   .......+|.++.+||++||+.||+
T Consensus       259 ~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~  293 (318)
T 3lxp_A          259 RLTELLERGE---RLPRPDKCPAEVYHLMKNCWETEAS  293 (318)
T ss_dssp             HHHHHHHTTC---CCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             HHHHHHhccc---CCCCCccccHHHHHHHHHHcCCCcc
Confidence            1112222221   1222347899999999999999985

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=7.3e-43  Score=321.07  Aligned_cols=246  Identities=24%  Similarity=0.393  Sum_probs=170.7

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC-hhhHHHHHHHHH-HHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-NLEKELIRKEID-IMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      .++|++.+.||+|+||.||+|.++.+|+.||+|++.... ......+..|+. +++.++||||+++++++...+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            367999999999999999999999999999999997653 233344555655 677789999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEK-NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      ||+.+ +|.+++.... ......+....+..++.|++.||.|||+. ||+||||||+|||++.++  .+||+|||+++..
T Consensus       101 e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~--~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVY-SVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSG--NIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHH-HTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTT--EEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHH-hhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCC--CEEEccCCCceec
Confidence            99975 7776664210 00112233344556999999999999999 999999999999998554  7999999999877


Q ss_pred             CCCCceeecCCCcCccccccc----cCCCCCccccHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHhhcccc-ccChhhhc
Q psy12427        264 DPNEVVKISTGTAEFAAPEIV----EREPVGFYTDMWAVGVLAYVLLSGLSPFAGEND-VETLKNVKACDW-EFDEEAFK  337 (356)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~-~~~~~~i~~~~~-~~~~~~~~  337 (356)
                      ..........||+.|+|||++    .+..++.++|||||||++|+|++|..||.+... .+.+..+..... .++.....
T Consensus       177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (327)
T 3aln_A          177 VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEER  256 (327)
T ss_dssp             -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSC
T ss_pred             ccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccc
Confidence            554444445799999999999    466789999999999999999999999987543 233333333322 23333345


Q ss_pred             cCCHHHHHHHHHhhhcCCC
Q psy12427        338 NVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       338 ~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+++++.+||++||+.||+
T Consensus       257 ~~~~~l~~li~~~l~~dp~  275 (327)
T 3aln_A          257 EFSPSFINFVNLCLTKDES  275 (327)
T ss_dssp             CCCHHHHHHHHHHTCSSGG
T ss_pred             cCCHHHHHHHHHHhhCChh
Confidence            7899999999999999984

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=5.6e-43  Score=321.60  Aligned_cols=245  Identities=20%  Similarity=0.281  Sum_probs=190.2

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh-hHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL-EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      .++|++.+.||+|+||.||+|.++ +++.||+|++...... ....+.+|+.+++.++||||+++++++......++|||
T Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  107 (326)
T 3uim_A           29 SDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP  107 (326)
T ss_dssp             TTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEE
T ss_pred             hhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEE
Confidence            467999999999999999999854 6899999999765422 22367899999999999999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHC---CceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEK---NIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      |+.+|+|.+++.....  ....+....+..++.|++.||+|||+.   ||+||||||+|||++.++  .+||+|||++..
T Consensus       108 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~--~~kl~Dfg~~~~  183 (326)
T 3uim_A          108 YMANGSVASCLRERPE--SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF--EAVVGDFGLAKL  183 (326)
T ss_dssp             CCTTCBHHHHHHCCST--TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC--CEEECCCSSCEE
T ss_pred             eccCCCHHHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC--CEEeccCccccc
Confidence            9999999999976432  122344445566999999999999999   999999999999997554  799999999987


Q ss_pred             eCCCCc--eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCC-----Ch---HHHHHHhhcc-----
Q psy12427        263 LDPNEV--VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGE-----ND---VETLKNVKAC-----  327 (356)
Q Consensus       263 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~-----~~---~~~~~~i~~~-----  327 (356)
                      ......  .....||+.|+|||++.+..++.++|||||||++|+|++|..||...     ..   .+.+......     
T Consensus       184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (326)
T 3uim_A          184 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEA  263 (326)
T ss_dssp             CCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTT
T ss_pred             cCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhh
Confidence            753332  23345899999999999889999999999999999999999999521     11   1111111110     


Q ss_pred             --ccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        328 --DWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       328 --~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                        ............+.++.++|.+||+.||+
T Consensus       264 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~  294 (326)
T 3uim_A          264 LVDVDLQGNYKDEEVEQLIQVALLCTQSSPM  294 (326)
T ss_dssp             SSCTTCTTSCCHHHHHHHHHHHHHHTCSCGG
T ss_pred             hcChhhccccCHHHHHHHHHHHHHHhCcCCc
Confidence              00011112223458899999999999995

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=5.4e-43  Score=320.51  Aligned_cols=237  Identities=20%  Similarity=0.285  Sum_probs=193.3

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh--hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN--LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      .++|++.+.||+|+||.||+|.++.   .+|+|++.....  .....+.+|+.++++++||||+++++++......++||
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  108 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT  108 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence            4679999999999999999998864   499999875432  22345678999999999999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      ||+++++|.+++......+++     ..+..++.|++.||+|||++|++||||||+|||++ +  +.+||+|||++....
T Consensus       109 e~~~~~~L~~~l~~~~~~~~~-----~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~--~~~~l~Dfg~~~~~~  180 (319)
T 2y4i_B          109 SLCKGRTLYSVVRDAKIVLDV-----NKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-N--GKVVITDFGLFSISG  180 (319)
T ss_dssp             BCCCSEEHHHHTTSSCCCCCS-----HHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC-----CCEECCCSCCC---
T ss_pred             ecccCCcHHHHHHhcCCCCCH-----HHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-C--CCEEEeecCCccccc
Confidence            999999999999765433433     44555999999999999999999999999999996 2  369999999987543


Q ss_pred             C------CCceeecCCCcCccccccccC---------CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc
Q psy12427        265 P------NEVVKISTGTAEFAAPEIVER---------EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDW  329 (356)
Q Consensus       265 ~------~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~  329 (356)
                      .      ........|++.|+|||++..         ..++.++|||||||++|+|++|..||.+....+....+.....
T Consensus       181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~  260 (319)
T 2y4i_B          181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK  260 (319)
T ss_dssp             -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCC
T ss_pred             cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCC
Confidence            1      122233458999999999874         4578899999999999999999999999998888877766543


Q ss_pred             ccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        330 EFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       330 ~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ...  ....+|.++.++|.+||+.||+
T Consensus       261 ~~~--~~~~~~~~l~~li~~~l~~~p~  285 (319)
T 2y4i_B          261 PNL--SQIGMGKEISDILLFCWAFEQE  285 (319)
T ss_dssp             CCC--CCSSCCTTHHHHHHHHHCSSTT
T ss_pred             CCC--CcCCCCHHHHHHHHHHhcCChh
Confidence            322  2236899999999999999995

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=9.7e-42  Score=325.61  Aligned_cols=244  Identities=23%  Similarity=0.353  Sum_probs=183.5

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEEEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      +.+.|.+.+.||+|+||+||.+ ...+|+.||+|++....   .+.+.+|+.+|.++ +||||+++++++......++||
T Consensus        13 l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~   88 (434)
T 2rio_A           13 LKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL   88 (434)
T ss_dssp             CSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             hhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEE
Confidence            3456778899999999999875 55679999999986532   34567899999986 8999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCc-cccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeec-----------CCCcE
Q psy12427        185 EFLSGGELFERITAPDYKMSE-AEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTR-----------NSTNV  252 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~-----------~~~~v  252 (356)
                      ||+. |+|.+++......... .......+..++.||+.||+|||++||+||||||+|||++.+           +...+
T Consensus        89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence            9995 6999999765422111 111223455699999999999999999999999999999753           24579


Q ss_pred             EEEeeeceeeeCCCCc-----eeecCCCcCccccccccC-------CCCCccccHHHHHHHHHHHHc-CCCCCCCCChHH
Q psy12427        253 KMIDFGLATKLDPNEV-----VKISTGTAEFAAPEIVER-------EPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVE  319 (356)
Q Consensus       253 kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~  319 (356)
                      ||+|||++........     .....||+.|+|||++.+       ..++.++|||||||++|||++ |..||.+....+
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            9999999988754322     223469999999999976       678999999999999999999 999998765543


Q ss_pred             HHHHhhccccccChh---hhccCCHHHHHHHHHhhhcCCC
Q psy12427        320 TLKNVKACDWEFDEE---AFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       320 ~~~~i~~~~~~~~~~---~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                        .++.......+..   ....+++++++||++||+.||+
T Consensus       248 --~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  285 (434)
T 2rio_A          248 --SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPL  285 (434)
T ss_dssp             --HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGG
T ss_pred             --HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChh
Confidence              2333333222211   1124678999999999999985

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.3e-42  Score=325.95  Aligned_cols=237  Identities=22%  Similarity=0.350  Sum_probs=182.3

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEEEEEEec
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMVLIFEFL  187 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~e~~  187 (356)
                      +|.+.+.||+|+||+|+. ....+++.||+|++......   .+.+|+.+|+.+ +||||+++++++......++||||+
T Consensus        25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~  100 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC  100 (432)
T ss_dssp             EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence            599999999999999764 45567999999998654322   245799999999 7999999999999999999999999


Q ss_pred             cccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEee---cCCCcEEEEeeeceeeeC
Q psy12427        188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQT---RNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       188 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~---~~~~~vkl~Dfg~a~~~~  264 (356)
                      . |+|.+++........+.     .+..++.||+.||+|||++||+||||||+|||++.   ++...+||+|||+|....
T Consensus       101 ~-g~L~~~l~~~~~~~~~~-----~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~  174 (432)
T 3p23_A          101 A-ATLQEYVEQKDFAHLGL-----EPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA  174 (432)
T ss_dssp             S-EEHHHHHHSSSCCCCSS-----CHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred             C-CCHHHHHHhcCCCccch-----hHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence            6 69999998655433332     33459999999999999999999999999999953   233468999999998765


Q ss_pred             CCC----ceeecCCCcCcccccccc---CCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhh
Q psy12427        265 PNE----VVKISTGTAEFAAPEIVE---REPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAF  336 (356)
Q Consensus       265 ~~~----~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  336 (356)
                      ...    ......||+.|+|||++.   ...++.++|||||||++|+|++ |..||...........+......... ..
T Consensus       175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~  253 (432)
T 3p23_A          175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLH-PE  253 (432)
T ss_dssp             -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSC-TT
T ss_pred             CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccC-cc
Confidence            332    223456999999999997   4567889999999999999999 99999776655544333332222111 11


Q ss_pred             ccCCHHHHHHHHHhhhcCCC
Q psy12427        337 KNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       337 ~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ...+..+++||++||+.||+
T Consensus       254 ~~~~~~~~~li~~~L~~dP~  273 (432)
T 3p23_A          254 KHEDVIARELIEKMIAMDPQ  273 (432)
T ss_dssp             CHHHHHHHHHHHHHSCSSGG
T ss_pred             ccccHHHHHHHHHHHhCCHh
Confidence            24567799999999999985

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.3e-42  Score=341.05  Aligned_cols=249  Identities=26%  Similarity=0.412  Sum_probs=198.6

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccC-ChhhHHHHHHHHHHHHhcCCCCceeeeeeEEe------C
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS-HNLEKELIRKEIDIMNQLHHPKLINLHDAFED------D  177 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~  177 (356)
                      ...++|++.+.||+|+||+||+|.++.+|..||+|++... .......+.+|+.+|++++||||+++++++..      .
T Consensus        11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~   90 (676)
T 3qa8_A           11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN   90 (676)
T ss_dssp             ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred             CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence            3457899999999999999999999999999999998764 34456778899999999999999999998765      6


Q ss_pred             CeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCC-CcEEEEe
Q psy12427        178 DEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNS-TNVKMID  256 (356)
Q Consensus       178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~-~~vkl~D  256 (356)
                      +..++||||++||+|.+++.....   ...+....+..++.|++.||+|||+.||+||||||+|||++.++. ..+||+|
T Consensus        91 ~~~~LVmEy~~ggsL~~~L~~~~~---~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~D  167 (676)
T 3qa8_A           91 DLPLLAMEYCEGGDLRKYLNQFEN---CCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIID  167 (676)
T ss_dssp             SSCCCEEECCSSCBHHHHHHSSSC---TTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred             CeEEEEEEeCCCCCHHHHHHhccc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcc
Confidence            778999999999999999976432   122444556669999999999999999999999999999986543 3489999


Q ss_pred             eeceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHH-------------
Q psy12427        257 FGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKN-------------  323 (356)
Q Consensus       257 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~-------------  323 (356)
                      ||++.............||+.|+|||++.+..++.++|||||||++|+|++|..||.+......+..             
T Consensus       168 FG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~  247 (676)
T 3qa8_A          168 LGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY  247 (676)
T ss_dssp             CCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred             cccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence            9999887665555566799999999999999999999999999999999999999987643322110             


Q ss_pred             -hhcccc------ccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        324 -VKACDW------EFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       324 -i~~~~~------~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                       ...+..      +.+......+++++.+||++||+.||+
T Consensus       248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~  287 (676)
T 3qa8_A          248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQR  287 (676)
T ss_dssp             CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC
T ss_pred             hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHh
Confidence             011111      122233345789999999999999996

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-42  Score=315.58  Aligned_cols=235  Identities=27%  Similarity=0.445  Sum_probs=184.0

Q ss_pred             CCcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh------hHHHHHHHHHHHHhc----CCCCceeeeee
Q psy12427        104 SSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL------EKELIRKEIDIMNQL----HHPKLINLHDA  173 (356)
Q Consensus       104 ~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~------~~~~~~~E~~il~~l----~hpnIv~l~~~  173 (356)
                      ..+.++|++.+.||+|+||.||+|.++.+++.||+|++......      ....+.+|+.++.++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            34567899999999999999999999999999999999765322      223355799999999    89999999999


Q ss_pred             EEeCCeEEEEEEe-ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcE
Q psy12427        174 FEDDDEMVLIFEF-LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNV  252 (356)
Q Consensus       174 ~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~v  252 (356)
                      +...+..++|||+ +.+++|.+++.... .     +....+..++.||+.||+|||+.||+||||||+|||++.++ +.+
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~-----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~  179 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEKG-P-----LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRR-GCA  179 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHHC-S-----CCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTT-TEE
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhcC-C-----CCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCC-CeE
Confidence            9999999999999 78999999987532 2     33344566999999999999999999999999999997332 379


Q ss_pred             EEEeeeceeeeCCCCceeecCCCcCccccccccCCCCC-ccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc
Q psy12427        253 KMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVG-FYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEF  331 (356)
Q Consensus       253 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~  331 (356)
                      ||+|||++....... .....|++.|+|||++.+..+. .++|||||||++|+|++|+.||....  +    +......+
T Consensus       180 kl~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~----~~~~~~~~  252 (312)
T 2iwi_A          180 KLIDFGSGALLHDEP-YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--E----ILEAELHF  252 (312)
T ss_dssp             EECCCSSCEECCSSC-BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H----HHHTCCCC
T ss_pred             EEEEcchhhhcccCc-ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--H----HhhhccCC
Confidence            999999998775432 3445689999999999877664 58999999999999999999997542  2    22233333


Q ss_pred             ChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        332 DEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       332 ~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +    ..++.++++||++||+.||+
T Consensus       253 ~----~~~~~~~~~li~~~l~~~p~  273 (312)
T 2iwi_A          253 P----AHVSPDCCALIRRCLAPKPS  273 (312)
T ss_dssp             C----TTSCHHHHHHHHHHTCSSTT
T ss_pred             c----ccCCHHHHHHHHHHccCChh
Confidence            3    37899999999999999995

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.6e-42  Score=316.70  Aligned_cols=234  Identities=26%  Similarity=0.382  Sum_probs=191.2

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh------hHHHHHHHHHHHHhcC--CCCceeeeeeEEe
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL------EKELIRKEIDIMNQLH--HPKLINLHDAFED  176 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~------~~~~~~~E~~il~~l~--hpnIv~l~~~~~~  176 (356)
                      .+.++|++.+.||+|+||.||+|.++.+++.||+|++......      ....+.+|+.++++++  ||||+++++++..
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~  119 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER  119 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence            3557899999999999999999999999999999998654321      1244567999999996  5999999999999


Q ss_pred             CCeEEEEEEeccc-cchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEE
Q psy12427        177 DDEMVLIFEFLSG-GELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMI  255 (356)
Q Consensus       177 ~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~  255 (356)
                      ....++|||++.+ ++|.+++.... .     +....+..++.||+.||+|||++||+||||||+|||++.++ +.+||+
T Consensus       120 ~~~~~lv~e~~~~~~~L~~~l~~~~-~-----l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~~kL~  192 (320)
T 3a99_A          120 PDSFVLILERPEPVQDLFDFITERG-A-----LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-GELKLI  192 (320)
T ss_dssp             SSEEEEEEECCSSEEEHHHHHHHHC-S-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT-TEEEEC
T ss_pred             CCcEEEEEEcCCCCccHHHHHhccC-C-----CCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCC-CCEEEe
Confidence            9999999999976 89999886432 2     23344556999999999999999999999999999997332 379999


Q ss_pred             eeeceeeeCCCCceeecCCCcCccccccccCCCC-CccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChh
Q psy12427        256 DFGLATKLDPNEVVKISTGTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEE  334 (356)
Q Consensus       256 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  334 (356)
                      |||++...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....  +    +......++  
T Consensus       193 Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--~----~~~~~~~~~--  263 (320)
T 3a99_A          193 DFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--E----IIRGQVFFR--  263 (320)
T ss_dssp             CCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H----HHHCCCCCS--
T ss_pred             eCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--h----hhccccccc--
Confidence            99999877543 2334568999999999987765 688999999999999999999997542  2    222222232  


Q ss_pred             hhccCCHHHHHHHHHhhhcCCC
Q psy12427        335 AFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       335 ~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                        ..+++++.+||++||+.||+
T Consensus       264 --~~~~~~~~~li~~~l~~dp~  283 (320)
T 3a99_A          264 --QRVSSECQHLIRWCLALRPS  283 (320)
T ss_dssp             --SCCCHHHHHHHHHHTCSSGG
T ss_pred             --ccCCHHHHHHHHHHccCChh
Confidence              47899999999999999985

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.2e-41  Score=307.33  Aligned_cols=215  Identities=13%  Similarity=0.087  Sum_probs=178.0

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh---hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN---LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      +.++|++.+.||+|+||.||+|.+..+++.||+|++.....   .....+.+|+.++.+++||||+++++++...+..++
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  108 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV  108 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence            45789999999999999999999999999999999976532   334678899999999999999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ||||++|++|.+++...   ..     ...+..++.|++.||+|||++||+||||||+|||++.++  .+||+++|    
T Consensus       109 v~e~~~g~~L~~~l~~~---~~-----~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g--~~kl~~~~----  174 (286)
T 3uqc_A          109 VAEWIRGGSLQEVADTS---PS-----PVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDG--DVVLAYPA----  174 (286)
T ss_dssp             EEECCCEEEHHHHHTTC---CC-----HHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTS--CEEECSCC----
T ss_pred             EEEecCCCCHHHHHhcC---CC-----hHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCC--CEEEEecc----
Confidence            99999999999998542   11     123455899999999999999999999999999998655  68887443    


Q ss_pred             eCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHH---HhhccccccChhhhccC
Q psy12427        263 LDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLK---NVKACDWEFDEEAFKNV  339 (356)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~  339 (356)
                                     |++       +++.++|||||||++|+|++|+.||.+.+..+.+.   .........+.....++
T Consensus       175 ---------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T 3uqc_A          175 ---------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDI  232 (286)
T ss_dssp             ---------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTS
T ss_pred             ---------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCC
Confidence                           333       36889999999999999999999999887654331   22233333344555689


Q ss_pred             CHHHHHHHHHhhhcCCC
Q psy12427        340 SEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       340 s~~~~~lI~~ll~~dP~  356 (356)
                      |+++++||.+||++||+
T Consensus       233 ~~~l~~li~~~l~~dP~  249 (286)
T 3uqc_A          233 PFQISAVAARSVQGDGG  249 (286)
T ss_dssp             CHHHHHHHHHHHCTTSS
T ss_pred             CHHHHHHHHHHcccCCc
Confidence            99999999999999995

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=3e-43  Score=324.96  Aligned_cols=234  Identities=18%  Similarity=0.214  Sum_probs=182.3

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh--------hhHHHHHHHHHHHHhcC---------CCCcee
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN--------LEKELIRKEIDIMNQLH---------HPKLIN  169 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~--------~~~~~~~~E~~il~~l~---------hpnIv~  169 (356)
                      .++|++.+.||+|+||+||+|++  +|+.||+|++.....        .....+.+|+.+|+.++         ||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            46799999999999999999998  589999999976532        23367889999999986         666666


Q ss_pred             eeeeE-----------------Ee-------------CCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHH
Q psy12427        170 LHDAF-----------------ED-------------DDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQ  219 (356)
Q Consensus       170 l~~~~-----------------~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~  219 (356)
                      +.+++                 ..             ....++||||+++|++.+.+...  .     +....+..++.|
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~--~-----~~~~~~~~i~~q  169 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK--L-----SSLATAKSILHQ  169 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT--C-----CCHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc--C-----CCHHHHHHHHHH
Confidence            66654                 32             78899999999999877776431  2     234455669999


Q ss_pred             HHHHHHHHH-HCCceeccCCCCCEEEeecCC------------------CcEEEEeeeceeeeCCCCceeecCCCcCccc
Q psy12427        220 TSPAVKHMH-EKNIIHLDVKPENIMCQTRNS------------------TNVKMIDFGLATKLDPNEVVKISTGTAEFAA  280 (356)
Q Consensus       220 i~~~l~~lH-~~~ivH~Dlkp~NIlv~~~~~------------------~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~a  280 (356)
                      |+.||+||| ++||+||||||+|||++.++.                  ..+||+|||+|+.....    ..+||+.|+|
T Consensus       170 i~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~a  245 (336)
T 2vuw_A          170 LTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMD  245 (336)
T ss_dssp             HHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTC
T ss_pred             HHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccC
Confidence            999999999 999999999999999987641                  27999999999877543    3479999999


Q ss_pred             cccccCCCCCccccHHHHHHH-HHHHHcCCCCCCCCCh-HHHHHHhh---ccccccChhhhccCCHHHHHHHHHhhhcC
Q psy12427        281 PEIVEREPVGFYTDMWAVGVL-AYVLLSGLSPFAGEND-VETLKNVK---ACDWEFDEEAFKNVSEEGKDFIRRLLLRN  354 (356)
Q Consensus       281 PE~~~~~~~~~~sDvwSlG~i-l~ell~g~~Pf~~~~~-~~~~~~i~---~~~~~~~~~~~~~~s~~~~~lI~~ll~~d  354 (356)
                      ||++.+.. +.++||||++++ .+++++|..||.+... ......+.   ......+...+..+|+++++||++||++|
T Consensus       246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d  323 (336)
T 2vuw_A          246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS  323 (336)
T ss_dssp             SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS
T ss_pred             hhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC
Confidence            99998776 899999998777 7788889999954321 11222222   22223344556689999999999999986

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=8.3e-42  Score=311.07  Aligned_cols=239  Identities=21%  Similarity=0.334  Sum_probs=186.8

Q ss_pred             eeeeccccccCceEEEEEEEccCCCEEEEEEcccCC----hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH----NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       110 y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      |...+.||+|+||.||+|.+  ++..+|+|.+....    ....+.+.+|+.++++++||||+++++++......++|||
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  110 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV  110 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence            45568999999999999986  48899999986532    3345778899999999999999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |+++++|.+++.....   ...+....+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||++.....
T Consensus       111 ~~~~~~L~~~l~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~kl~Dfg~~~~~~~  185 (307)
T 2nru_A          111 YMPNGSLLDRLSCLDG---TPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAF--TAKISDFGLARASEK  185 (307)
T ss_dssp             CCTTCBHHHHHHTGGG---CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC--CEEECCCTTCEECCS
T ss_pred             ecCCCcHHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCC--cEEEeeccccccccc
Confidence            9999999999864321   11233444566999999999999999999999999999997544  799999999987654


Q ss_pred             CCce---eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHH----HHhhccccccC------
Q psy12427        266 NEVV---KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETL----KNVKACDWEFD------  332 (356)
Q Consensus       266 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~----~~i~~~~~~~~------  332 (356)
                      ....   ....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+....+.+    ..+......++      
T Consensus       186 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (307)
T 2nru_A          186 FAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKK  264 (307)
T ss_dssp             CSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSS
T ss_pred             ccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccc
Confidence            3222   22468999999998875 4788999999999999999999999876543222    22221111110      


Q ss_pred             -hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 -EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 -~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                       ......+++++.++|.+||+.||+
T Consensus       265 ~~~~~~~~~~~l~~li~~cl~~~p~  289 (307)
T 2nru_A          265 MNDADSTSVEAMYSVASQCLHEKKN  289 (307)
T ss_dssp             CSCCCHHHHHHHHHHHHHHTCSSTT
T ss_pred             ccccchHHHHHHHHHHHHHcCCCcc
Confidence             111224567899999999999995

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3.5e-41  Score=307.93  Aligned_cols=237  Identities=24%  Similarity=0.417  Sum_probs=187.3

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcC--CCCceeeeeeEEeCCeEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLH--HPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~--hpnIv~l~~~~~~~~~~~l  182 (356)
                      .++|++.+.||+|+||.||+|.++ ++..||+|++....  ......+.+|+.++.+++  ||||+++++++......++
T Consensus        27 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l  105 (313)
T 3cek_A           27 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  105 (313)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred             cceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence            357999999999999999999886 48899999987543  344577889999999997  5999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ||| +.+++|.+++.... .+     ....+..++.|++.||+|||++||+||||||+|||++.   +.+||+|||++..
T Consensus       106 v~e-~~~~~L~~~l~~~~-~~-----~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~---~~~kL~Dfg~~~~  175 (313)
T 3cek_A          106 VME-CGNIDLNSWLKKKK-SI-----DPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD---GMLKLIDFGIANQ  175 (313)
T ss_dssp             EEC-CCSEEHHHHHHHCS-SC-----CHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET---TEEEECCCSSSCC
T ss_pred             EEe-cCCCcHHHHHHhcC-CC-----CHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC---CeEEEeecccccc
Confidence            999 56889999987543 22     33345569999999999999999999999999999953   4799999999987


Q ss_pred             eCCCCc---eeecCCCcCccccccccC-----------CCCCccccHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHhhcc
Q psy12427        263 LDPNEV---VKISTGTAEFAAPEIVER-----------EPVGFYTDMWAVGVLAYVLLSGLSPFAGEN-DVETLKNVKAC  327 (356)
Q Consensus       263 ~~~~~~---~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlG~il~ell~g~~Pf~~~~-~~~~~~~i~~~  327 (356)
                      ......   .....|++.|+|||++.+           ..++.++|||||||++|+|++|..||.... ....+..+...
T Consensus       176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  255 (313)
T 3cek_A          176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP  255 (313)
T ss_dssp             --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT
T ss_pred             ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhc
Confidence            643322   233468999999999875           468889999999999999999999998764 33444554443


Q ss_pred             ccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        328 DWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       328 ~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ....  ......+.++.+||++||+.||+
T Consensus       256 ~~~~--~~~~~~~~~l~~li~~~l~~dp~  282 (313)
T 3cek_A          256 NHEI--EFPDIPEKDLQDVLKCCLKRDPK  282 (313)
T ss_dssp             TSCC--CCCCCSCHHHHHHHHHHTCSSTT
T ss_pred             cccc--CCcccchHHHHHHHHHHccCCcc
Confidence            3222  22236789999999999999995

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=5.1e-41  Score=305.03  Aligned_cols=227  Identities=29%  Similarity=0.536  Sum_probs=182.5

Q ss_pred             CCCCCCcccceeee-ccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHH-HhcCCCCceeeeeeEEe-
Q psy12427        100 DIKTSSVYDHYDIL-EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIM-NQLHHPKLINLHDAFED-  176 (356)
Q Consensus       100 ~~~~~~~~~~y~~~-~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il-~~l~hpnIv~l~~~~~~-  176 (356)
                      .++.+.+.++|.+. +.||+|+||.||+|.++.+++.||+|++...     ..+.+|+.++ +.++||||+++++++.. 
T Consensus         9 ~~~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~   83 (299)
T 3m2w_A            9 QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL   83 (299)
T ss_dssp             CCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             cCcccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence            34456677889988 7899999999999999999999999998643     3456788888 55689999999999987 


Q ss_pred             ---CCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecC-CCcE
Q psy12427        177 ---DDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN-STNV  252 (356)
Q Consensus       177 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~-~~~v  252 (356)
                         ....++||||+++|+|.+++.....    ..+....+..++.|++.||+|||++||+||||||+|||++.++ ++.+
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~  159 (299)
T 3m2w_A           84 YAGRKCLLIVMECLDGGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAIL  159 (299)
T ss_dssp             ETTEEEEEEEECCCCSCBHHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCE
T ss_pred             cCCCceEEEEEeecCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcE
Confidence               7789999999999999999975431    2234445566999999999999999999999999999998642 3579


Q ss_pred             EEEeeeceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHH----Hhhccc
Q psy12427        253 KMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLK----NVKACD  328 (356)
Q Consensus       253 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~----~i~~~~  328 (356)
                      ||+|||++....                     +..++.++|||||||++|+|++|..||.+.+..+...    .+....
T Consensus       160 kl~Dfg~a~~~~---------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  218 (299)
T 3m2w_A          160 KLTDFGFAKETT---------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ  218 (299)
T ss_dssp             EECCCTTCEECT---------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTC
T ss_pred             EEeccccccccc---------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhcc
Confidence            999999986543                     2346789999999999999999999998876655432    233445


Q ss_pred             cccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        329 WEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       329 ~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ..++...+..+|+++++||++||+.||+
T Consensus       219 ~~~~~~~~~~~~~~~~~li~~~l~~dP~  246 (299)
T 3m2w_A          219 YEFPNPEWSEVSEEVKMLIRNLLKTEPT  246 (299)
T ss_dssp             CSSCHHHHTTSCHHHHHHHHHHTCSSTT
T ss_pred             ccCCchhcccCCHHHHHHHHHHcccChh
Confidence            5566666678999999999999999995

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-41  Score=312.13  Aligned_cols=238  Identities=18%  Similarity=0.317  Sum_probs=181.9

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhc--CCCCceeeeeeEEeC----C
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL--HHPKLINLHDAFEDD----D  178 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l--~hpnIv~l~~~~~~~----~  178 (356)
                      .+.++|++.+.||+|+||.||+|.++  +..||+|++....   .....+|.+++..+  +||||+++++++...    .
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~  108 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT  108 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred             ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence            34578999999999999999999886  8899999986432   23344566666554  899999999999877    7


Q ss_pred             eEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHC--------CceeccCCCCCEEEeecCCC
Q psy12427        179 EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEK--------NIIHLDVKPENIMCQTRNST  250 (356)
Q Consensus       179 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--------~ivH~Dlkp~NIlv~~~~~~  250 (356)
                      ..++||||+++|+|.+++....       +....+..++.|++.||+|||+.        ||+||||||+|||++.++  
T Consensus       109 ~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~--  179 (337)
T 3mdy_A          109 QLYLITDYHENGSLYDYLKSTT-------LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG--  179 (337)
T ss_dssp             EEEEEECCCTTCBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS--
T ss_pred             ceEEEEeccCCCcHHHHhhccC-------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC--
Confidence            8999999999999999996432       33344556999999999999999        999999999999997554  


Q ss_pred             cEEEEeeeceeeeCCCCce-----eecCCCcCccccccccCCCCCcc------ccHHHHHHHHHHHHcC----------C
Q psy12427        251 NVKMIDFGLATKLDPNEVV-----KISTGTAEFAAPEIVEREPVGFY------TDMWAVGVLAYVLLSG----------L  309 (356)
Q Consensus       251 ~vkl~Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~------sDvwSlG~il~ell~g----------~  309 (356)
                      .+||+|||++.........     ....||+.|+|||++.+...+..      +|||||||++|||++|          .
T Consensus       180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~  259 (337)
T 3mdy_A          180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ  259 (337)
T ss_dssp             CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence            7999999999876433222     23468999999999988766655      9999999999999999          7


Q ss_pred             CCCCCCC----hHHHHHH-hhcc--ccccChhh-hccCCHHHHHHHHHhhhcCCC
Q psy12427        310 SPFAGEN----DVETLKN-VKAC--DWEFDEEA-FKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       310 ~Pf~~~~----~~~~~~~-i~~~--~~~~~~~~-~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .||....    ..+.+.. +...  ...++... ...+++++.+||++||+.||+
T Consensus       260 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~  314 (337)
T 3mdy_A          260 LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPA  314 (337)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGG
T ss_pred             ccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChh
Confidence            7876542    1222222 2221  22222211 125778899999999999995

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.8e-41  Score=311.19  Aligned_cols=237  Identities=22%  Similarity=0.318  Sum_probs=187.7

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHh--cCCCCceeeeeeEEeCC----e
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQ--LHHPKLINLHDAFEDDD----E  179 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~~~~~----~  179 (356)
                      +.++|++.+.||+|+||.||+|.+.  |+.||+|++...   ....+.+|++++..  ++||||+++++++....    .
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~  114 (342)
T 1b6c_B           40 IARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ  114 (342)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred             ccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence            3468999999999999999999884  889999998643   34566789999988  78999999999998776    8


Q ss_pred             EEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHH--------HCCceeccCCCCCEEEeecCCCc
Q psy12427        180 MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH--------EKNIIHLDVKPENIMCQTRNSTN  251 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--------~~~ivH~Dlkp~NIlv~~~~~~~  251 (356)
                      .++||||+++|+|.+++...  .     +....+..++.|++.||+|||        +.||+||||||+|||++.++  .
T Consensus       115 ~~lv~e~~~~g~L~~~l~~~--~-----~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~--~  185 (342)
T 1b6c_B          115 LWLVSDYHEHGSLFDYLNRY--T-----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG--T  185 (342)
T ss_dssp             EEEEECCCTTCBHHHHHHHC--C-----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS--C
T ss_pred             eEEEEeecCCCcHHHHHhcc--C-----ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC--C
Confidence            99999999999999999643  2     333445569999999999999        89999999999999997654  7


Q ss_pred             EEEEeeeceeeeCCCCce-----eecCCCcCccccccccCC------CCCccccHHHHHHHHHHHHcC----------CC
Q psy12427        252 VKMIDFGLATKLDPNEVV-----KISTGTAEFAAPEIVERE------PVGFYTDMWAVGVLAYVLLSG----------LS  310 (356)
Q Consensus       252 vkl~Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlG~il~ell~g----------~~  310 (356)
                      +||+|||++.........     ....||+.|+|||++.+.      .++.++|||||||++|+|++|          ..
T Consensus       186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~  265 (342)
T 1b6c_B          186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL  265 (342)
T ss_dssp             EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence            999999999877544322     334689999999999876      334689999999999999999          78


Q ss_pred             CCCCCC-----hHHHHHHhhccccc--cChhh-hccCCHHHHHHHHHhhhcCCC
Q psy12427        311 PFAGEN-----DVETLKNVKACDWE--FDEEA-FKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       311 Pf~~~~-----~~~~~~~i~~~~~~--~~~~~-~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ||....     ..+....+......  ++... ...+++.+.++|.+||+.||+
T Consensus       266 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~  319 (342)
T 1b6c_B          266 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGA  319 (342)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGG
T ss_pred             CccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChh
Confidence            997652     33444444333222  22111 124567899999999999995

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.7e-42  Score=317.31  Aligned_cols=237  Identities=22%  Similarity=0.296  Sum_probs=174.5

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHH--HHhcCCCCceeeeeeEE-----eCC
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDI--MNQLHHPKLINLHDAFE-----DDD  178 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~i--l~~l~hpnIv~l~~~~~-----~~~  178 (356)
                      ..++|++.+.||+|+||.||+|++  +++.||+|++.....   ..+..|.++  +..++||||+++++.+.     ...
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   85 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM   85 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred             ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence            346899999999999999999976  588999999865432   333344444  45589999999998654     234


Q ss_pred             eEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHC---------CceeccCCCCCEEEeecCC
Q psy12427        179 EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEK---------NIIHLDVKPENIMCQTRNS  249 (356)
Q Consensus       179 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---------~ivH~Dlkp~NIlv~~~~~  249 (356)
                      .+++||||+++|+|.+++.....       ....+..++.||+.||+|||+.         ||+||||||+|||++.++ 
T Consensus        86 ~~~lv~e~~~~g~L~~~l~~~~~-------~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~-  157 (336)
T 3g2f_A           86 EYLLVMEYYPNGSLXKYLSLHTS-------DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG-  157 (336)
T ss_dssp             EEEEEECCCTTCBHHHHHHHCCB-------CHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS-
T ss_pred             eEEEEEecCCCCcHHHHHhhccc-------chhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC-
Confidence            67899999999999999965432       2233455899999999999999         999999999999997554 


Q ss_pred             CcEEEEeeeceeeeCCCCc---------eeecCCCcCccccccccC-------CCCCccccHHHHHHHHHHHHcCCCCCC
Q psy12427        250 TNVKMIDFGLATKLDPNEV---------VKISTGTAEFAAPEIVER-------EPVGFYTDMWAVGVLAYVLLSGLSPFA  313 (356)
Q Consensus       250 ~~vkl~Dfg~a~~~~~~~~---------~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlG~il~ell~g~~Pf~  313 (356)
                       .+||+|||++........         .....||+.|+|||++.+       ..++.++|||||||++|||++|..||.
T Consensus       158 -~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~  236 (336)
T 3g2f_A          158 -TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF  236 (336)
T ss_dssp             -CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred             -cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence             799999999987643221         123468999999999987       456778999999999999999977653


Q ss_pred             C-CChH----------------HHHHH-hhc--cccccChhh--hccCCHHHHHHHHHhhhcCCC
Q psy12427        314 G-ENDV----------------ETLKN-VKA--CDWEFDEEA--FKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       314 ~-~~~~----------------~~~~~-i~~--~~~~~~~~~--~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      . ....                +.... +..  ....++...  ...+++++.+||.+||+.||+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~  301 (336)
T 3g2f_A          237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAE  301 (336)
T ss_dssp             TTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGG
T ss_pred             CccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChh
Confidence            3 2211                11111 111  111122111  112456899999999999995

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.3e-41  Score=337.07  Aligned_cols=226  Identities=22%  Similarity=0.347  Sum_probs=183.3

Q ss_pred             cccceeeeccccccCceEEEEEEEcc-CCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCe----
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERK-TGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDE----  179 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~-~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~----  179 (356)
                      +.++|++.+.||+|+||+||+|.++. +|+.||+|++.... ......+.+|+.+|.+++||||+++++++.....    
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~  157 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP  157 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence            45789999999999999999999986 78999999986543 3345678899999999999999999999987655    


Q ss_pred             -EEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeee
Q psy12427        180 -MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFG  258 (356)
Q Consensus       180 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg  258 (356)
                       .++||||++|++|.+++..   .     +....+..++.||+.||.|||++||+||||||+|||++.+   .+||+|||
T Consensus       158 ~~~lv~E~~~g~~L~~~~~~---~-----l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~---~~kl~DFG  226 (681)
T 2pzi_A          158 VGYIVMEYVGGQSLKRSKGQ---K-----LPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE---QLKLIDLG  226 (681)
T ss_dssp             EEEEEEECCCCEECC----C---C-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS---CEEECCCT
T ss_pred             eeEEEEEeCCCCcHHHHHhC---C-----CCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC---cEEEEecc
Confidence             7999999999999877643   2     3334455699999999999999999999999999999753   69999999


Q ss_pred             ceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhcc
Q psy12427        259 LATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKN  338 (356)
Q Consensus       259 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  338 (356)
                      ++......   ....||+.|+|||++.+.. +.++|||||||++|+|++|.+||.+....         ... .......
T Consensus       227 ~a~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------~~~-~~~~~~~  292 (681)
T 2pzi_A          227 AVSRINSF---GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD---------GLP-EDDPVLK  292 (681)
T ss_dssp             TCEETTCC---SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS---------SCC-TTCHHHH
T ss_pred             cchhcccC---CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc---------ccc-ccccccc
Confidence            99876543   3456999999999987654 88999999999999999999998763211         000 1111224


Q ss_pred             CCHHHHHHHHHhhhcCCC
Q psy12427        339 VSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       339 ~s~~~~~lI~~ll~~dP~  356 (356)
                      +++++.+||.+||++||+
T Consensus       293 ~~~~l~~li~~~l~~dP~  310 (681)
T 2pzi_A          293 TYDSYGRLLRRAIDPDPR  310 (681)
T ss_dssp             HCHHHHHHHHHHTCSSGG
T ss_pred             cCHHHHHHHhhhccCChh
Confidence            678999999999999995

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.4e-40  Score=315.56  Aligned_cols=235  Identities=14%  Similarity=0.151  Sum_probs=177.3

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh---hHHHHHHHHHHHHhcCC-CCce---------eee---
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL---EKELIRKEIDIMNQLHH-PKLI---------NLH---  171 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~---~~~~~~~E~~il~~l~h-pnIv---------~l~---  171 (356)
                      ..|.+.+.||+|+||+||+|.+..+|+.||+|++......   ..+.+.+|+.+++.++| +|..         ...   
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            4688999999999999999999999999999998744332   24678899999999987 3211         111   


Q ss_pred             ---------eeEEe-----CCeEEEEEEeccccchhhhhhCCCC-CCCccccccccHHHHHHHHHHHHHHHHHCCceecc
Q psy12427        172 ---------DAFED-----DDEMVLIFEFLSGGELFERITAPDY-KMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLD  236 (356)
Q Consensus       172 ---------~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~D  236 (356)
                               .++..     ....+++|+.+ +++|.+++..... ......+....+..++.||+.||+|||++||+|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD  236 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY  236 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence                     11111     23467777765 6899888742100 01123344445566889999999999999999999


Q ss_pred             CCCCCEEEeecCCCcEEEEeeeceeeeCCCCceeecCCCcCccccccc----------cCCCCCccccHHHHHHHHHHHH
Q psy12427        237 VKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV----------EREPVGFYTDMWAVGVLAYVLL  306 (356)
Q Consensus       237 lkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDvwSlG~il~ell  306 (356)
                      |||+|||++.++  .+||+|||+++.....  ....+| +.|+|||++          ....++.++|||||||++|+|+
T Consensus       237 iKp~NILl~~~~--~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell  311 (413)
T 3dzo_A          237 LRPVDIVLDQRG--GVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW  311 (413)
T ss_dssp             CCGGGEEECTTC--CEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred             cccceEEEecCC--eEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence            999999998665  6999999999875432  444567 999999999          6666889999999999999999


Q ss_pred             cCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        307 SGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       307 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +|+.||.+.+..+....+..        ....+|+++++||.+||+.||+
T Consensus       312 tg~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~dP~  353 (413)
T 3dzo_A          312 CADLPNTDDAALGGSEWIFR--------SCKNIPQPVRALLEGFLRYPKE  353 (413)
T ss_dssp             HSSCCCCTTGGGSCSGGGGS--------SCCCCCHHHHHHHHHHTCSSGG
T ss_pred             HCCCCCCCcchhhhHHHHHh--------hcccCCHHHHHHHHHHccCChh
Confidence            99999988765544333322        1237899999999999999995

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=1.2e-34  Score=284.70  Aligned_cols=187  Identities=18%  Similarity=0.168  Sum_probs=132.5

Q ss_pred             eccccccCceEEEEEEEccCCCEEEEEEcccCC----------hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEE
Q psy12427        113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH----------NLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMV  181 (356)
Q Consensus       113 ~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~----------~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~  181 (356)
                      ...++.|++|.+..++....|..+|+|++....          ....+.+.+|+++|+++ .|+||+++++++++++.+|
T Consensus       239 ~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~y  318 (569)
T 4azs_A          239 QNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGW  318 (569)
T ss_dssp             ECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEE
T ss_pred             hhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEE
Confidence            346788999999998988899999999997542          22346688999999999 6999999999999999999


Q ss_pred             EEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeecee
Q psy12427        182 LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT  261 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~  261 (356)
                      |||||++|++|.+++.... .+..        ..|+.||+.||+|+|++|||||||||+|||++.++  ++||+|||+|+
T Consensus       319 LVMEyv~G~~L~d~i~~~~-~l~~--------~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg--~vKL~DFGlAr  387 (569)
T 4azs_A          319 LVMEKLPGRLLSDMLAAGE-EIDR--------EKILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQ--HARLIDFGSIV  387 (569)
T ss_dssp             EEEECCCSEEHHHHHHTTC-CCCH--------HHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTS--CEEECCCTTEE
T ss_pred             EEEecCCCCcHHHHHHhCC-CCCH--------HHHHHHHHHHHHHHHHCCceeccCchHhEEECCCC--CEEEeecccCe
Confidence            9999999999999997643 2221        23889999999999999999999999999997654  79999999998


Q ss_pred             eeCCC-CceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCC
Q psy12427        262 KLDPN-EVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSP  311 (356)
Q Consensus       262 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~P  311 (356)
                      ..... ......+||+.|+|||++.+. +..++|+||+|++++++.++..|
T Consensus       388 ~~~~~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          388 TTPQDCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             SCC---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             eCCCCCccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence            76533 223445799999999999864 56789999999998877665443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=1.5e-30  Score=254.06  Aligned_cols=183  Identities=18%  Similarity=0.131  Sum_probs=143.3

Q ss_pred             eeeccccccCceEEEEEEEccCCCEEEEEEcccCCh--------hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        111 DILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN--------LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       111 ~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~--------~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      ...+.||+|+||+||+|.  ..+..+++|.......        ...+.+.+|+++|++++||||+++..++......++
T Consensus       339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            345689999999999994  4478899997643221        113457899999999999999966666667778899


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ||||++|++|.+++..              ...++.|++.||+|||++||+||||||+|||++.    .+||+|||+|+.
T Consensus       417 VmE~~~ggsL~~~l~~--------------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~----~~kL~DFGla~~  478 (540)
T 3en9_A          417 MMSYINGKLAKDVIED--------------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK----DLYIIDFGLGKI  478 (540)
T ss_dssp             EEECCCSEEHHHHSTT--------------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS----SEEECCCTTCEE
T ss_pred             EEECCCCCCHHHHHHH--------------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC----eEEEEECccCEE
Confidence            9999999999999874              1249999999999999999999999999999975    699999999998


Q ss_pred             eCCCCce--------eecCCCcCccccccccC--CCCCccccHHHHHHHHHHHHcCCCCCC
Q psy12427        263 LDPNEVV--------KISTGTAEFAAPEIVER--EPVGFYTDMWAVGVLAYVLLSGLSPFA  313 (356)
Q Consensus       263 ~~~~~~~--------~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlG~il~ell~g~~Pf~  313 (356)
                      .......        ....||+.|+|||++..  ..|+..+|+||..+-..+-+.++.+|.
T Consensus       479 ~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          479 SNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             CCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            7643221        24568999999999987  667888999999999888888887774

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.94  E-value=5.9e-27  Score=210.48  Aligned_cols=156  Identities=19%  Similarity=0.285  Sum_probs=121.7

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh------------------hhHHHHHHHHHHHHhcCCCCceee
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN------------------LEKELIRKEIDIMNQLHHPKLINL  170 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~------------------~~~~~~~~E~~il~~l~hpnIv~l  170 (356)
                      .|.+.+.||+|+||.||+|.+ .+|..||+|+++....                  .....+.+|+.+|++++  | +++
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v  166 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV  166 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred             EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence            355669999999999999999 7899999999965321                  13456889999999999  4 666


Q ss_pred             eeeEEeCCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCC
Q psy12427        171 HDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNST  250 (356)
Q Consensus       171 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~  250 (356)
                      .+++.. +..++||||++|++|.+ +..            .....++.|++.||.|||+.||+||||||+|||++ +  +
T Consensus       167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~~------------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~--~  229 (282)
T 1zar_A          167 PKVYAW-EGNAVLMELIDAKELYR-VRV------------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-E--E  229 (282)
T ss_dssp             CCEEEE-ETTEEEEECCCCEEGGG-CCC------------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-T--T
T ss_pred             CeEEec-cceEEEEEecCCCcHHH-cch------------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-C--C
Confidence            665544 55699999999999987 421            11234999999999999999999999999999998 4  4


Q ss_pred             cEEEEeeeceeeeCCCCceeecCCCcCccccccccC----------CCCCccccHHH
Q psy12427        251 NVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVER----------EPVGFYTDMWA  297 (356)
Q Consensus       251 ~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~sDvwS  297 (356)
                      .+||+|||+|+.            +..++|||++..          ..++..+|+|.
T Consensus       230 ~vkl~DFG~a~~------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~  274 (282)
T 1zar_A          230 GIWIIDFPQSVE------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS  274 (282)
T ss_dssp             EEEECCCTTCEE------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred             cEEEEECCCCeE------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence            799999999964            345788998753          34455556654

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.88  E-value=3.7e-23  Score=183.43  Aligned_cols=137  Identities=21%  Similarity=0.211  Sum_probs=105.2

Q ss_pred             eeeeccccccCceEEEEEEEccCCCE--EEEEEcccCChh------------------------hHHHHHHHHHHHHhcC
Q psy12427        110 YDILEEIGTGAFGVVHRCRERKTGNI--FAAKFIPVSHNL------------------------EKELIRKEIDIMNQLH  163 (356)
Q Consensus       110 y~~~~~lg~G~fg~V~~~~~~~~~~~--~a~K~~~~~~~~------------------------~~~~~~~E~~il~~l~  163 (356)
                      |.+.+.||+|+||.||+|.+..+|..  ||+|+++.....                        ....+.+|+.+|..+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            78899999999999999999778988  999987543211                        1235778999999998


Q ss_pred             CCCc--eeeeeeEEeCCeEEEEEEeccc-c----chhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHH-HCCceec
Q psy12427        164 HPKL--INLHDAFEDDDEMVLIFEFLSG-G----ELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMH-EKNIIHL  235 (356)
Q Consensus       164 hpnI--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~ivH~  235 (356)
                      |+++  +.+++.    ...++||||+.+ |    +|.+....         .....+..++.|++.||.||| +.||+||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~givHr  195 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---------LKELDVEGIFNDVVENVKRLYQEAELVHA  195 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---------GGGSCHHHHHHHHHHHHHHHHHTSCEECS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---------cChHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence            8764  344432    356899999942 3    55544321         112344569999999999999 9999999


Q ss_pred             cCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        236 DVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       236 Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      ||||+|||++.    .++|+|||+|...
T Consensus       196 Dlkp~NILl~~----~~~liDFG~a~~~  219 (258)
T 1zth_A          196 DLSEYNIMYID----KVYFIDMGQAVTL  219 (258)
T ss_dssp             SCSTTSEEESS----SEEECCCTTCEET
T ss_pred             CCCHHHEEEcC----cEEEEECcccccC
Confidence            99999999964    6999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.79  E-value=7e-20  Score=169.38  Aligned_cols=138  Identities=14%  Similarity=0.170  Sum_probs=100.1

Q ss_pred             eeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh--------------hhH--------HHHHHHHHHHHhcCCCCc
Q psy12427        110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN--------------LEK--------ELIRKEIDIMNQLHHPKL  167 (356)
Q Consensus       110 y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~--------------~~~--------~~~~~E~~il~~l~hpnI  167 (356)
                      |.+...||.|+||.||+|.+. +|+.||+|+++....              ...        -...+|...|.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            899999999999999999885 599999998753210              001        112356777777754443


Q ss_pred             e--eeeeeEEeCCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEe
Q psy12427        168 I--NLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQ  245 (356)
Q Consensus       168 v--~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~  245 (356)
                      .  ..++.  .  ..++||||++|++|.++...     .       ....++.|++.+|.+||+.|||||||||.|||++
T Consensus       176 ~vp~p~~~--~--~~~LVME~i~G~~L~~l~~~-----~-------~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~  239 (397)
T 4gyi_A          176 PVPEPIAQ--S--RHTIVMSLVDALPMRQVSSV-----P-------DPASLYADLIALILRLAKHGLIHGDFNEFNILIR  239 (397)
T ss_dssp             SCCCEEEE--E--TTEEEEECCSCEEGGGCCCC-----S-------CHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE
T ss_pred             CCCeeeec--c--CceEEEEecCCccHhhhccc-----H-------HHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEe
Confidence            2  22222  2  23799999999988654321     1       1234889999999999999999999999999998


Q ss_pred             ecCCC--------cEEEEeeeceeeeC
Q psy12427        246 TRNST--------NVKMIDFGLATKLD  264 (356)
Q Consensus       246 ~~~~~--------~vkl~Dfg~a~~~~  264 (356)
                      .++..        .+.|+||+-+....
T Consensus       240 ~dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          240 EEKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             EEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             CCCCcccccccccceEEEEeCCcccCC
Confidence            76532        38999999876543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.50  E-value=1.1e-13  Score=122.37  Aligned_cols=140  Identities=14%  Similarity=0.104  Sum_probs=110.2

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCeEEEEEEe
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLH-HPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      +.|++...++.|+.+.||++...  +..+++|+...........+.+|+.+|+.+. +..+.++++++...+..++||||
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~   91 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence            46888999999999999998754  6899999986532223346888999999995 67788999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHH-------------------------------------
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE-------------------------------------  229 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-------------------------------------  229 (356)
                      ++|.+|.+.+..      .     .....++.+++.+|+.||+                                     
T Consensus        92 i~G~~l~~~~~~------~-----~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T 3tm0_A           92 ADGVLCSEEYED------E-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             CSSEEHHHHCCT------T-----TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred             cCCeehhhccCC------c-----ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence            999999765321      0     1112378899999999998                                     


Q ss_pred             ----------------------CCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        230 ----------------------KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       230 ----------------------~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                                            ..++|+|++|.|||++.+  ..+.|+||+.+..
T Consensus       161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~--~~~~lIDwe~a~~  213 (263)
T 3tm0_A          161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG--KVSGFIDLGRSGR  213 (263)
T ss_dssp             TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETT--EEEEECCCTTCEE
T ss_pred             cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECC--cEEEEEEchhccc
Confidence                                  458999999999999642  2457999998754

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.38  E-value=2.6e-12  Score=112.94  Aligned_cols=135  Identities=16%  Similarity=0.139  Sum_probs=98.6

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCC--ceeeeeeEEeCCeEEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPK--LINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~~~~~~~~~~lv~e  185 (356)
                      ..+.+....+.|..+.||++.. .+|..+++|+....   ....+.+|+.+|+.+.+.+  +.+++++...++..++|||
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e   95 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG   95 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred             CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence            3566655555777799999854 45778999987543   2245678999999996544  5568888888888999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCC----------------------------------
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN----------------------------------  231 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~----------------------------------  231 (356)
                      |++|.+|.  ...    .        ....++.+++..|..||+..                                  
T Consensus        96 ~i~G~~l~--~~~----~--------~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (264)
T 1nd4_A           96 EVPGQDLL--SSH----L--------APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE  161 (264)
T ss_dssp             CCSSEETT--TSC----C--------CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred             ecCCcccC--cCc----C--------CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence            99998883  211    0        01136677777777777643                                  


Q ss_pred             ------------------------ceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        232 ------------------------IIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       232 ------------------------ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                                              ++|+|++|.|||++.+  ..+.|+|||.+..
T Consensus       162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~--~~~~liD~~~a~~  214 (264)
T 1nd4_A          162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENG--RFSGFIDCGRLGV  214 (264)
T ss_dssp             GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETT--EEEEECCCTTCEE
T ss_pred             ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECC--cEEEEEcchhccc
Confidence                                    9999999999999643  2457999998764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.24  E-value=2.4e-11  Score=112.32  Aligned_cols=142  Identities=20%  Similarity=0.328  Sum_probs=101.2

Q ss_pred             eeccccccCceEEEEEEEccCCCEEEEEEcc--cCC-hhhHHHHHHHHHHHHhcCC--CCceeeeeeEEeC---CeEEEE
Q psy12427        112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIP--VSH-NLEKELIRKEIDIMNQLHH--PKLINLHDAFEDD---DEMVLI  183 (356)
Q Consensus       112 ~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~--~~~-~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~---~~~~lv  183 (356)
                      ..+.|+.|.++.||++...  +..+++|+..  ... ......+.+|+.+|+.+..  ..+++++.++...   +..++|
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            3467899999999998764  4688888775  322 1224567889999999974  5578888888766   458999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHH----------------------------------
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE----------------------------------  229 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~----------------------------------  229 (356)
                      |||++|..+.+...        ..+.......++.+++.+|..||+                                  
T Consensus       120 me~v~G~~l~~~~~--------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (359)
T 3dxp_A          120 MEFVSGRVLWDQSL--------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET  191 (359)
T ss_dssp             EECCCCBCCCCTTC--------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred             EEecCCeecCCCcc--------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence            99999887743211        111222334478899999999997                                  


Q ss_pred             ------------------------CCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        230 ------------------------KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       230 ------------------------~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                                              ..++|+|++|.|||++.++...+.|+||+.+..-
T Consensus       192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                    3699999999999998655334699999998754

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.10  E-value=5.4e-11  Score=107.39  Aligned_cols=184  Identities=17%  Similarity=0.194  Sum_probs=112.9

Q ss_pred             ccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcC-CCC--ceeeeeeEEeCC---eEEEEEEec
Q psy12427        114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLH-HPK--LINLHDAFEDDD---EMVLIFEFL  187 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~-hpn--Iv~l~~~~~~~~---~~~lv~e~~  187 (356)
                      +.++.|.+..||++.     ..+++|+...  ......+.+|+.+|+.+. +..  +.+++.......   ..++||+++
T Consensus        26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN-----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CEEEECSSEEEEEST-----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             EecCCCCcceEEEEC-----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            458999999999863     4688888542  234567889999999884 333  344544433332   348899999


Q ss_pred             cccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHH--------------------------------------
Q psy12427        188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE--------------------------------------  229 (356)
Q Consensus       188 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--------------------------------------  229 (356)
                      +|.+|.+....   .++.     .....++.+++..|+.||+                                      
T Consensus        99 ~G~~l~~~~~~---~l~~-----~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (304)
T 3sg8_A           99 KGVPLTPLLLN---NLPK-----QSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM  170 (304)
T ss_dssp             CCEECCHHHHH---TSCH-----HHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred             CCeECCccccc---cCCH-----HHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence            99888643211   1111     1122355666666666664                                      


Q ss_pred             --------------------CCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCceeecCCCcCcccccccc----
Q psy12427        230 --------------------KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE----  285 (356)
Q Consensus       230 --------------------~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~----  285 (356)
                                          ..++|+|++|.||+++.+....+.|+||+.+..-++..-.........-.+|+...    
T Consensus       171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~  250 (304)
T 3sg8_A          171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILN  250 (304)
T ss_dssp             HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHH
Confidence                                24799999999999986423357899999987654321110000000001222111    


Q ss_pred             C-CC---------CCccccHHHHHHHHHHHHcCCCCC
Q psy12427        286 R-EP---------VGFYTDMWAVGVLAYVLLSGLSPF  312 (356)
Q Consensus       286 ~-~~---------~~~~sDvwSlG~il~ell~g~~Pf  312 (356)
                      . ..         .....+.|+++.++|.+.+|..+|
T Consensus       251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            0 01         112368999999999999998876

>1wfu_A Unnamed protein product; FN3 domain, similar to 1700007B22RIK protein, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Mus musculus} SCOP: b.1.2.1

Probab=98.84  E-value=1.7e-09  Score=83.34  Aligned_cols=51  Identities=24%  Similarity=0.322  Sum_probs=45.8

Q ss_pred             CCceEeeeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceechh
Q psy12427          2 SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD   52 (356)
Q Consensus         2 ~~w~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~~   52 (356)
                      ..|..+.....|+++|++|+|++.|.|||+|.|..|.|.+|..+.+.|.++
T Consensus        64 ~~~~~v~~~~~t~~~v~gL~p~t~Y~frV~A~n~~G~s~~S~~~~~~T~~~  114 (120)
T 1wfu_A           64 HSYGVIYTGYATRHVVEGLEPRTLYKFRLKVTSPSGEYEYSPVVSVATTRE  114 (120)
T ss_dssp             CCEEEEEEESCSEEEEESCCTTCEEEEEEEEECSSSCEEECCCEEEECCCC
T ss_pred             CceEEEecCCccEEEECCCCCCCEEEEEEEEECCCCCCCCCccEeeEcCCC
Confidence            468887777788999999999999999999999999999999998888754

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.71  E-value=1.3e-07  Score=85.33  Aligned_cols=74  Identities=16%  Similarity=0.140  Sum_probs=55.1

Q ss_pred             ccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCC---CceeeeeeEE-eCCeEEEEEEeccc
Q psy12427        114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHP---KLINLHDAFE-DDDEMVLIFEFLSG  189 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hp---nIv~l~~~~~-~~~~~~lv~e~~~~  189 (356)
                      +.++.|....||++     |..+++|+-  ........+.+|+.+|+.+.+.   .+.+++.+.. ..+..+++||+++|
T Consensus        25 ~~l~~G~~n~v~~v-----g~~~VlR~~--~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           25 ESLGEGFRNYAILV-----NGDWVFRFP--KSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEECSSEEEEEE-----TTTEEEEEE--SSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eecCCCcceeEEEE-----CCEEEEEec--CCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            45789999999998     567888874  2233456788999999999752   3556666664 45567899999999


Q ss_pred             cchhh
Q psy12427        190 GELFE  194 (356)
Q Consensus       190 g~L~~  194 (356)
                      ..+.+
T Consensus        98 ~~l~~  102 (306)
T 3tdw_A           98 QILGE  102 (306)
T ss_dssp             EECHH
T ss_pred             eECch
Confidence            88865

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.68  E-value=2.9e-07  Score=81.11  Aligned_cols=78  Identities=17%  Similarity=0.146  Sum_probs=59.4

Q ss_pred             ccccCce-EEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCeEEEEEEeccccchh
Q psy12427        116 IGTGAFG-VVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLH-HPKLINLHDAFEDDDEMVLIFEFLSGGELF  193 (356)
Q Consensus       116 lg~G~fg-~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~  193 (356)
                      +..|..| .||+......+..+++|+-...   ....+.+|+.+|+.+. +--+.++++++...+..++|||+++|.++.
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~  108 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF  108 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence            4445554 6999888777888999986432   3456788999999885 333677888899999999999999998775


Q ss_pred             hhh
Q psy12427        194 ERI  196 (356)
Q Consensus       194 ~~l  196 (356)
                      +..
T Consensus       109 ~~~  111 (272)
T 4gkh_A          109 QVL  111 (272)
T ss_dssp             HHH
T ss_pred             ccc
Confidence            543

>2db8_A Tripartite motif protein 9, isoform 2; ring finger protein 91, TRIM9, KIAA0282, RNF91, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=98.58  E-value=5e-08  Score=73.88  Aligned_cols=50  Identities=30%  Similarity=0.200  Sum_probs=43.9

Q ss_pred             CCceEeeeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceech
Q psy12427          2 SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK   51 (356)
Q Consensus         2 ~~w~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~   51 (356)
                      ..|..+.....++++|+||+|++.|.|||+|.|..|.|.+|....+.|..
T Consensus        54 ~~~~~~~~~~~~~~~v~~L~p~t~Y~frV~A~n~~G~s~~S~~~~~~T~~  103 (110)
T 2db8_A           54 GQFREVYVGKETMCTVDGLHFNSTYNARVKAFNKTGVSPYSKTLVLQTSE  103 (110)
T ss_dssp             SCCEEEEEESCSCEEEECCCSSSCCEEEEEEECSSCBCCCCSCEECCCCC
T ss_pred             CceEEEEeCCcCEEEECCCCCCCEEEEEEEEEeCCcCCCCCCCEEEEcCC
Confidence            36887776788999999999999999999999999999999988776653

>2crz_A Fibronectin type-III domain containing protein 3A; structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: b.1.2.1

Probab=98.58  E-value=4.1e-08  Score=74.20  Aligned_cols=50  Identities=26%  Similarity=0.301  Sum_probs=45.0

Q ss_pred             CCceEeeeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceech
Q psy12427          2 SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK   51 (356)
Q Consensus         2 ~~w~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~   51 (356)
                      ..|..+.....++++|++|.|++.|.|||+|.|..|.|.+|..+.+.|..
T Consensus        54 ~~~~~~~~~~~~~~~v~~L~p~t~Y~frV~A~n~~G~g~~S~~~~~~T~~  103 (110)
T 2crz_A           54 DEPREVYQGSEVECTVSSLLPGKTYSFRLRAANKMGFGPFSEKCDITTAP  103 (110)
T ss_dssp             CCCEEEEEESCSEEEEESCCTTCEEEECCEEECSSCBCCCCCCEEEECCC
T ss_pred             CceEEEEeCCcEEEEECCcCCCCEEEEEEEEEcCCccCCCCCccccccCC
Confidence            35888888889999999999999999999999999999999988877653

>1bpv_A Titin, A71, connectin; fibronectin type III; NMR {Homo sapiens} SCOP: b.1.2.1

Probab=98.57  E-value=1.5e-08  Score=77.14  Aligned_cols=52  Identities=38%  Similarity=0.660  Sum_probs=45.0

Q ss_pred             CCceEee--eeeecceeeecCccCceEEEEEEEEecCCC-CCCCCCccceechhh
Q psy12427          2 SSWIRVG--NTRFTTMAITGLSPGHQYEFRVYAENVYGR-SDPSTTSDLITTKDT   53 (356)
Q Consensus         2 ~~w~~~~--~~~~~~~~v~~L~p~~~y~frv~a~n~~g~-s~~s~~s~~~t~~~~   53 (356)
                      ..|..+.  ....++++|+||+|++.|.|||+|.|..|. |.+|..++..+.++.
T Consensus        55 ~~w~~~~~~~~~~~~~~v~~L~p~t~Y~frV~A~N~~G~~s~~S~~~~~~t~~~~  109 (112)
T 1bpv_A           55 GRWLKANFSNILENEFTVSGLTEDAAYEFRVIAKNAAGAISPPSEPSDAITCRDD  109 (112)
T ss_dssp             CCCEECCCSCCCSSEEEECSCCSSCCEEEEEEEECTTSCEEEEEEEEEEECSCHH
T ss_pred             CceEEeecccCccCEEEECCCCCCCEEEEEEEEEECCCCCCCCCCCCCCEEeCCC
Confidence            3588764  367889999999999999999999999997 999999998887653

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.56  E-value=1.7e-07  Score=87.60  Aligned_cols=76  Identities=21%  Similarity=0.211  Sum_probs=49.6

Q ss_pred             eccccccCceEEEEEEEccCCCEEEEEEcccCCh-------hhHHHHHHHHHHHHhcCC--CCc-eeeeeeEEeCCeEEE
Q psy12427        113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN-------LEKELIRKEIDIMNQLHH--PKL-INLHDAFEDDDEMVL  182 (356)
Q Consensus       113 ~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~-------~~~~~~~~E~~il~~l~h--pnI-v~l~~~~~~~~~~~l  182 (356)
                      .+.||.|.++.||++....+++.+++|.......       .....+..|+++|+.+..  |.. .+++.+  +....++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            4579999999999997766678999997643211       123456679999988742  443 345543  3445689


Q ss_pred             EEEecccc
Q psy12427        183 IFEFLSGG  190 (356)
Q Consensus       183 v~e~~~~g  190 (356)
                      |||+++|.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999874

>1wk0_A KIAA0970 protein; fibronectin type III domain, structural genomics, riken structural genomics/proteomics initiative, RSGI, unknown function; NMR {Homo sapiens} SCOP: b.1.2.1

Probab=98.55  E-value=6.6e-08  Score=76.04  Aligned_cols=49  Identities=22%  Similarity=0.215  Sum_probs=44.0

Q ss_pred             ceEeeeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceechh
Q psy12427          4 WIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD   52 (356)
Q Consensus         4 w~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~~   52 (356)
                      |..+..+..++++|+||+|+|.|.|||+|.|..|.|.+|.+.++.|...
T Consensus        73 ~~~~~~g~~ts~~v~~L~P~T~Y~~rV~A~n~~G~G~~S~~~~f~T~~~  121 (137)
T 1wk0_A           73 YKSVYVGEETNITLNDLKPAMDYHAKVQAEYNSIKGTPSEAEIFTTLSC  121 (137)
T ss_dssp             CEEEEEESCSEEEECSCCTTCEECEEEEEEETTEECCCCCCCCEECCCS
T ss_pred             eEEEEecCccEEEEcCCCCCCEEEEEEEEEeCCCcCCCCCCEEEECCCC
Confidence            4455568899999999999999999999999999999999999988754

>2ic2_A CG9211-PA, GH03927P; IHOG, hedgehog, fibronectin type III, protein binding; HET: MSE; 1.30A {Drosophila melanogaster} SCOP: b.1.2.1

Probab=98.54  E-value=7.1e-08  Score=73.73  Aligned_cols=40  Identities=30%  Similarity=0.389  Sum_probs=35.8

Q ss_pred             eecceeeecCccCceEEEEEEEEecCCCCCCCCCccceec
Q psy12427         11 RFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT   50 (356)
Q Consensus        11 ~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~   50 (356)
                      ..++++|++|.|++.|.|||+|.|..|.|.+|..|+..+.
T Consensus        69 ~~~~~~v~~L~p~t~Y~FRV~A~N~~G~~~pS~~S~~~~~  108 (115)
T 2ic2_A           69 KSFTASVTDLKPQHTYRFRILAVYSNNDNKESNTSAKFYL  108 (115)
T ss_dssp             EEEEEEECSCCSSEEEEEEEEEEETTSCEEECCCCCCEEE
T ss_pred             ceeEEEeCCCCCCCEEEEEEEEEeCCCCCCCCCCCCCEEe
Confidence            4578999999999999999999999999999998886554

>2dmk_A Midline 2 isoform 2; midline defect 2, tripartite motif protein 1, midin-2, ring finger protein 60, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=98.53  E-value=4.9e-08  Score=76.01  Aligned_cols=47  Identities=34%  Similarity=0.485  Sum_probs=40.7

Q ss_pred             CceEeeeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceec
Q psy12427          3 SWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT   50 (356)
Q Consensus         3 ~w~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~   50 (356)
                      .|..+.....++++|+||+|++.|.|||+|.|..|. .+|.+..+.|.
T Consensus        70 ~w~~~~~~~~~~~~v~gL~p~t~Y~frV~A~N~~G~-~~S~~v~~~T~  116 (127)
T 2dmk_A           70 SWMIVPNIKQNHYTVHGLQSGTRYIFIVKAINQAGS-RNSEPTRLKTN  116 (127)
T ss_dssp             GSEEEEEECSSEEEEESCCSSCEEEEEEEEEESSCE-EECCCEEEECC
T ss_pred             CcEEeecccCCeEEECCCCCCCEEEEEEEEEeCCCC-CCCcCeEeEeC
Confidence            588777788999999999999999999999999999 56666666654

>1x5x_A Fibronectin type-III domain containing protein 3A; structural genomics, KIAA0970, NPPSFA; NMR {Homo sapiens} SCOP: b.1.2.1

Probab=98.52  E-value=5.3e-08  Score=73.45  Aligned_cols=49  Identities=22%  Similarity=0.336  Sum_probs=42.8

Q ss_pred             CceEeeeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceech
Q psy12427          3 SWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK   51 (356)
Q Consensus         3 ~w~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~   51 (356)
                      .|..+.....++++|++|+|++.|.|||+|.|..|.|.+|..+.+.|..
T Consensus        54 ~~~~~~~~~~~~~~v~~L~p~t~Y~frV~A~n~~G~s~~S~~~~~~T~~  102 (109)
T 1x5x_A           54 GFKPKYDGEDLAYTVKNLRRSTKYKFKVIAYNSEGKSNPSEVVEFTTCP  102 (109)
T ss_dssp             CCEEEEEESCSEEEEESCCSSCEEEEEEEEECSSCEEEECCCEEEECCC
T ss_pred             ceEEeEeCCccEEEECCCCCCCEEEEEEEEEeCCCCcCCccCEEeEeCC
Confidence            4666666778999999999999999999999999999999888777654

>1x3d_A Fibronectin type-III domain containing protein 3A; structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: b.1.2.1

Probab=98.52  E-value=7.7e-08  Score=73.59  Aligned_cols=50  Identities=28%  Similarity=0.276  Sum_probs=44.6

Q ss_pred             CCceEeeeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceech
Q psy12427          2 SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK   51 (356)
Q Consensus         2 ~~w~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~   51 (356)
                      ..|..+.....++++|++|+|++.|.|||+|.|..|.|.+|..+.+.|..
T Consensus        62 ~~~~~~~~~~~~~~~v~~L~p~t~Y~frV~A~n~~G~s~~S~~~~~~T~~  111 (118)
T 1x3d_A           62 GEFCQCYMGSQKQFKITKLSPAMGCKFRLSARNDYGTSGFSEEVLYYTSG  111 (118)
T ss_dssp             SCCEEEEEESCSEEEEESCCTTCEEEEECCEEESSCBCCCCCCEEEECSC
T ss_pred             CCeEEeeccCCcEEEeCCCCCCCEEEEEEEEEECCCCCCCccCEEEEcCC
Confidence            36888877788999999999999999999999999999999988877653

>2crm_A Fibronectin type-III domain containing protein 3A; structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: b.1.2.1

Probab=98.48  E-value=1.1e-07  Score=73.02  Aligned_cols=49  Identities=24%  Similarity=0.296  Sum_probs=44.0

Q ss_pred             CCceEeeeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceec
Q psy12427          2 SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT   50 (356)
Q Consensus         2 ~~w~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~   50 (356)
                      ..|..+.....++++|++|+|++.|.|||+|.|..|.|.+|....+.|.
T Consensus        64 ~~~~~~~~~~~~~~~v~~L~p~t~Y~frV~A~n~~G~s~~S~~~~~~T~  112 (120)
T 2crm_A           64 NKWEMIYSGATREHLCDRLNPGCFYRLRVYCISDGGQSAVSESLLVQTP  112 (120)
T ss_dssp             CCCEEEECSSCSEEEECSCCTTSCEEEEEEEEETTEECCCCCCCCCCCC
T ss_pred             cCCEEEEeccccEEEECCCCCCCEEEEEEEEEcCCccCCCcccEEEEcC
Confidence            3688887778899999999999999999999999999999998877664

>1x4z_A Biregional cell adhesion molecule-related/DOWN- regulated oncogenes (CDON)binding...; fibronectin type III, FN3; NMR {Mus musculus} SCOP: b.1.2.1

Probab=98.48  E-value=1.7e-07  Score=72.08  Aligned_cols=50  Identities=36%  Similarity=0.569  Sum_probs=42.7

Q ss_pred             CCceEeee---eeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceech
Q psy12427          2 SSWIRVGN---TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK   51 (356)
Q Consensus         2 ~~w~~~~~---~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~   51 (356)
                      ..|..+..   ...++++|++|.|++.|.|||+|.|..|.|.+|..++..+..
T Consensus        62 ~~w~~~~~~~~~~~~~~~v~~L~p~t~Y~frV~A~n~~G~s~~S~~~~~v~~~  114 (121)
T 1x4z_A           62 GDWILATSAIPPSRLSVEITGLEKGISYKFRVRALNMLGESEPSAPSRPYVVS  114 (121)
T ss_dssp             CCCEEEEEEECTTCCEEEEESCCTTCEEEEEEEEEETTEECCCCCCCCCEECC
T ss_pred             CceEEeecccCCCcCEEEECCCCCCCEEEEEEEEEcCCCcCCCcCCCCCEEcC
Confidence            46876653   367899999999999999999999999999999999866653

>1x4x_A Fibronectin type-III domain containing protein 3A; FN3, immunoglobulin-like beta- sandwich fold, KIAA0970, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.1.2.1

Probab=98.44  E-value=2.1e-07  Score=69.80  Aligned_cols=49  Identities=29%  Similarity=0.195  Sum_probs=41.6

Q ss_pred             CceEeeeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceech
Q psy12427          3 SWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK   51 (356)
Q Consensus         3 ~w~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~   51 (356)
                      .|..+.....++++|+||+|++.|.|||+|.|..|.|.+|....+.|..
T Consensus        51 ~~~~~~~~~~~~~~v~~L~p~t~Y~frV~A~n~~G~g~~S~~v~~~T~~   99 (106)
T 1x4x_A           51 SMQICYCGPGLSYEIKGLSPATTYYCRVQALSVVGAGPFSEVVACVTPP   99 (106)
T ss_dssp             SCCEEEEESCSEEEEESCCSSCEEEEEEEEECSSCCCCBCCCEEEECCC
T ss_pred             ceEEEEeCCcceEEEcCCCCCCEEEEEEEEEcCCcCCCCcCCEEEECCC
Confidence            3555556777899999999999999999999999999999887776653

>2dju_A Receptor-type tyrosine-protein phosphatase F; LAR protein, leukocyte antigen related, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=98.42  E-value=1.8e-07  Score=69.89  Aligned_cols=49  Identities=37%  Similarity=0.483  Sum_probs=42.8

Q ss_pred             CceEeeeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceech
Q psy12427          3 SWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK   51 (356)
Q Consensus         3 ~w~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~   51 (356)
                      .|..+.....++++|++|+|++.|.|||+|.|..|.|.+|....+.|..
T Consensus        51 ~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~A~n~~G~~~~S~~~~~~T~~   99 (106)
T 2dju_A           51 PFQEVDGVATTRYSIGGLSPFSEYAFRVLAVNSIGRGPPSEAVRARTGE   99 (106)
T ss_dssp             CCCCBCCCCSSEEEEESCCTTCEEEEEEEEECSSCBCCCCCCEEEECCC
T ss_pred             CeEEccCCCccEEEEeCCCCCcEEEEEEEEEeCCccCCCcccEEeEcCC
Confidence            4776666778899999999999999999999999999999988776653

>2yuw_A Myosin binding protein C, SLOW type; fibronectin III domain, SLOW- type protein, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=98.41  E-value=1.4e-07  Score=71.19  Aligned_cols=50  Identities=34%  Similarity=0.434  Sum_probs=43.0

Q ss_pred             CceEeee--eeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceechh
Q psy12427          3 SWIRVGN--TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD   52 (356)
Q Consensus         3 ~w~~~~~--~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~~   52 (356)
                      .|..+..  ...++++|++|.|++.|.|||+|.|..|.|.+|..++.++.++
T Consensus        53 ~w~~~~~~~~~~~~~~v~~L~p~t~Y~frV~A~n~~G~s~~S~~~~~v~~~~  104 (110)
T 2yuw_A           53 DWIVANKDLIDKTKFTITGLPTDAKIFVRVKAVNAAGASEPKYYSQPILVKE  104 (110)
T ss_dssp             SEEECCSSCCCSSEEEECSCCTTCEEEEEEEEEETTEECCCEECSSCEECCC
T ss_pred             cceEeccccCccCEEEECCCCCCCEEEEEEEEEcCCcCCCCcCCCCCEEecC
Confidence            5776643  5788999999999999999999999999999999888776543

>1x5y_A Myosin binding protein C, fast-type; fast MYBP-C, fibronectin type III domain containing protein, cytoskeleton, muscle contraction; NMR {Mus musculus} SCOP: b.1.2.1

Probab=98.40  E-value=2e-07  Score=70.45  Aligned_cols=49  Identities=27%  Similarity=0.510  Sum_probs=42.2

Q ss_pred             CceEeee--eeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceech
Q psy12427          3 SWIRVGN--TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK   51 (356)
Q Consensus         3 ~w~~~~~--~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~   51 (356)
                      .|..+..  ...++++|++|.|++.|.|||+|.|..|.|.+|..++..+..
T Consensus        54 ~w~~~~~~~~~~~~~~v~~L~p~t~Y~frV~A~n~~G~s~~S~~~~~v~~~  104 (111)
T 1x5y_A           54 EWVPANKEPVERCGFTVKDLPTGARILFRVVGVNIAGRSEPATLLQPVTIR  104 (111)
T ss_dssp             CCEESSSSCBSSSEEEEECCCTTCCEEEEEEEEETTEECCCCCCSSCBCCC
T ss_pred             ceEEccccCCcccEEEECCCCCCCEEEEEEEEEcCCcCCCCccCCCCEEec
Confidence            5776643  568899999999999999999999999999999998776654

>1wis_A KIAA1514 protein; FNIII domain, sidekick-2, structural genomics, riken structural genomics/proteomics initiative, RSGI, unknown function; NMR {Homo sapiens} SCOP: b.1.2.1

Probab=98.39  E-value=1.8e-07  Score=72.39  Aligned_cols=48  Identities=29%  Similarity=0.510  Sum_probs=41.1

Q ss_pred             CCceEeee----eeecceeeecCccCceEEEEEEEEecCCCCCCCCCcccee
Q psy12427          2 SSWIRVGN----TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLIT   49 (356)
Q Consensus         2 ~~w~~~~~----~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t   49 (356)
                      +.|..+..    ...++++|++|+|++.|.|||+|.|..|.|.+|..+...+
T Consensus        64 ~~w~~~~~~~~~~~~~~~~v~~L~p~t~Y~frV~A~N~~G~s~~S~~~~~~~  115 (124)
T 1wis_A           64 EEWLLIHQLSNEPDARSMEVPDLNPFTCYSFRMRQVNIVGTSPPSQPSRKIQ  115 (124)
T ss_dssp             SCCEEEEEEESCTTCSEEEECSCCTTSEECCCCEEECSSCBCCCCCCCCCEE
T ss_pred             CCCeEeeeEccCCCceEEEeCCCCCCCEEEEEEEEEECCccCCCcCCccceE
Confidence            36876653    4788999999999999999999999999999999876544

>2e7h_A Ephrin type-B receptor 4; FN3 domain, tyrosine- protein kinase receptor HTK, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=98.37  E-value=3.2e-07  Score=69.07  Aligned_cols=46  Identities=22%  Similarity=0.169  Sum_probs=40.8

Q ss_pred             eeeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceechh
Q psy12427          7 VGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD   52 (356)
Q Consensus         7 ~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~~   52 (356)
                      +..+..++++|++|+|++.|.|||+|.|..|.|.+|....+.|.++
T Consensus        58 ~~~~~~~~~~i~~L~p~t~Y~~~V~A~n~~G~g~~S~~~~~~T~~~  103 (109)
T 2e7h_A           58 FLKTSENRAELRGLKRGASYLVQVRARSEAGYGPFGQEHHSQTQLD  103 (109)
T ss_dssp             EEEESSSEEEEESCCTTSCEEEEEEEECSSCBCCCCSCEECCCCCC
T ss_pred             EEccCCCEEEECCCCCCCeEEEEEEEEeCCccCCCCCCEEEEcCCC
Confidence            4466778999999999999999999999999999999888877643

>1v5j_A KIAA1355 protein, RSGI RUH-008; FN3 domain, human cDNA, structural genomics, riken structural genomics/proteomics initiative, cell adhesion; NMR {Homo sapiens} SCOP: b.1.2.1

Probab=98.34  E-value=1.1e-07  Score=71.73  Aligned_cols=49  Identities=31%  Similarity=0.363  Sum_probs=43.0

Q ss_pred             CceEeee---eeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceech
Q psy12427          3 SWIRVGN---TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK   51 (356)
Q Consensus         3 ~w~~~~~---~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~   51 (356)
                      .|..+..   ...|+++|.+|.|++.|.|||+|.|..|.|.||....+.|..
T Consensus        50 ~W~~~~~~~~~~~t~~~v~~L~pg~~Y~FRV~A~n~~G~s~pS~~~~v~T~~  101 (108)
T 1v5j_A           50 GWEVLDPAVAGTETELLVPGLIKDVLYEFRLVAFAGSFVSDPSNTANVSTSG  101 (108)
T ss_dssp             CCEEEEEEECSSCCEEECCCCCTTSCEECCBEEEETTEEEEECSCCCCCCSS
T ss_pred             CcEEeeeecCCCcCEEEeCCCCCCCEEEEEEEEEcCCCCcCCCCCEEEEeCC
Confidence            5886653   467999999999999999999999999999999988887754

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.32  E-value=5.8e-07  Score=82.58  Aligned_cols=82  Identities=7%  Similarity=0.102  Sum_probs=56.7

Q ss_pred             eeccc-cccCceEEEEEEEc--c----CCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcC-C--CCceeeeeeEEeC-
Q psy12427        112 ILEEI-GTGAFGVVHRCRER--K----TGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLH-H--PKLINLHDAFEDD-  177 (356)
Q Consensus       112 ~~~~l-g~G~fg~V~~~~~~--~----~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~-h--pnIv~l~~~~~~~-  177 (356)
                      ..+.| +.|....+|++...  .    ++..+++|+.....   ......+.+|+.+|+.+. +  -.+.+++.++... 
T Consensus        24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~  103 (357)
T 3ats_A           24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD  103 (357)
T ss_dssp             EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred             EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence            44678 89999999998754  1    15678888865432   101245678999998884 3  3467788777654 


Q ss_pred             --CeEEEEEEeccccchh
Q psy12427        178 --DEMVLIFEFLSGGELF  193 (356)
Q Consensus       178 --~~~~lv~e~~~~g~L~  193 (356)
                        +..++||||++|..+.
T Consensus       104 ~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          104 VLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TTSSCEEEEECCCCBCCC
T ss_pred             ccCCceEEEEecCCCChh
Confidence              3568999999987664

>1x5j_A Neogenin; RGM binding, fibronectin type III domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: b.1.2.1

Probab=98.32  E-value=3.8e-07  Score=69.34  Aligned_cols=45  Identities=29%  Similarity=0.260  Sum_probs=40.1

Q ss_pred             eeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceechh
Q psy12427          8 GNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD   52 (356)
Q Consensus         8 ~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~~   52 (356)
                      .++..++++|+||+|+|.|.|+|+|.|..|.|.+|.+..+.|.++
T Consensus        63 ~~~~~~~~~i~gL~P~T~Y~f~V~A~~~~G~g~~S~~v~~~T~~~  107 (113)
T 1x5j_A           63 ANATTLSYLVTGLKPNTLYEFSVMVTKGRRSSTWSMTAHGTTFEL  107 (113)
T ss_dssp             CCBCSSEEEEESCCTTCEECCEEEEECSSCBCCCCCCCCEECCCS
T ss_pred             EecCcCEEEeCCCCCCcEEEEEEEEecCCccCCCcccEEeeccCC
Confidence            346778999999999999999999999999999999998887643

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.30  E-value=8.5e-06  Score=74.00  Aligned_cols=73  Identities=10%  Similarity=0.139  Sum_probs=42.7

Q ss_pred             ccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCC--CCceeeee------eEEeCCeEEEEEE
Q psy12427        114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHH--PKLINLHD------AFEDDDEMVLIFE  185 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~------~~~~~~~~~lv~e  185 (356)
                      +.|+.|..+.||++...  +..+++|+....    ...+..|+.+++.|..  -.+.+++.      +....+..+++|+
T Consensus        38 ~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTD--SGAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EECC----CEEEEEEET--TEEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeccccccCcEEEEEeC--CCCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            45677789999998764  335889988652    2334456666665531  12333332      1235677899999


Q ss_pred             eccccch
Q psy12427        186 FLSGGEL  192 (356)
Q Consensus       186 ~~~~g~L  192 (356)
                      |++|..+
T Consensus       112 ~i~G~~~  118 (346)
T 2q83_A          112 WIEGRPF  118 (346)
T ss_dssp             CCCCBCC
T ss_pred             eecCccC
Confidence            9998654

>2haz_A N-CAM 1, neural cell adhesion molecule 1; fibronectin type III repeat, FN1, beta sandwich; 1.70A {Homo sapiens} SCOP: b.1.2.1

Probab=98.28  E-value=4.7e-07  Score=67.73  Aligned_cols=40  Identities=30%  Similarity=0.351  Sum_probs=37.3

Q ss_pred             eecceeeecCccCceEEEEEEEEecCCCCCCCCCccceec
Q psy12427         11 RFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT   50 (356)
Q Consensus        11 ~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~   50 (356)
                      ..++++|++|+|++.|.|||+|.|..|.|.+|..+.+.|.
T Consensus        64 ~~~~~~i~~L~p~t~Y~~rV~A~n~~G~g~~S~~~~~~T~  103 (105)
T 2haz_A           64 MEGIVTIVGLKPETTYAVRLAALNGKGLGEISAASEFKTQ  103 (105)
T ss_dssp             HHSEEEECSCCTTCEEEEEEEEEETTEECCCCCCEEEECC
T ss_pred             CccEEEECCCCCCCEEEEEEEEEcCCccCCCcCCEeeEEe
Confidence            5688999999999999999999999999999999988775

>2djs_A Ephrin type-B receptor 1; tyrosine-protein kinase receptor EPH-2, NET, HEK6, ELK, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.1.2.1

Probab=98.25  E-value=5.7e-07  Score=67.45  Aligned_cols=46  Identities=30%  Similarity=0.356  Sum_probs=41.0

Q ss_pred             eeeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceechh
Q psy12427          7 VGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD   52 (356)
Q Consensus         7 ~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~~   52 (356)
                      +.....++++|++|+|++.|.|||+|.|..|.|.+|....+.|..+
T Consensus        57 ~~~~~~~~~~l~~L~p~t~Y~~~V~A~n~~G~g~~S~~~~~~T~~~  102 (108)
T 2djs_A           57 MARSQTNTARIDGLRPGMVYVVQVRARTVAGYGKFSGKMCFQTLTD  102 (108)
T ss_dssp             EEEESSSEEEEESCCTTCEEEEEEEEEESSCEEEECCCEEEECCCS
T ss_pred             EEecCccEEEEcCCCCCCEEEEEEEEEeCCEECCCCCCEEEEeCCC
Confidence            4457789999999999999999999999999999999988887654

>2ed9_A Netrin receptor DCC; tumor suppressor protein DCC, colorectal cancer suppressor, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=98.25  E-value=7.8e-07  Score=68.44  Aligned_cols=49  Identities=29%  Similarity=0.282  Sum_probs=42.8

Q ss_pred             CceEeeeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceech
Q psy12427          3 SWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK   51 (356)
Q Consensus         3 ~w~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~   51 (356)
                      .|..+.....++++|++|+|++.|.|||+|.|..|.|.+|....+.|.+
T Consensus        75 ~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~A~n~~G~g~~S~~~~~~T~e  123 (124)
T 2ed9_A           75 GEMETLEPNNLWYLFTGLEKGSQYSFQVSAMTVNGTGPPSNWYTAETPE  123 (124)
T ss_dssp             CCEEEECSSCSEEEEECCCSSCEEEECEEEECSSCBCCCCCCEEEECCC
T ss_pred             cceEEecCCcCEEEEcCCCCCCEEEEEEEEEcCCccCCCCCCEEEECCC
Confidence            3655566778899999999999999999999999999999988887754

>1uem_A KIAA1568 protein; immunoglobulin-like beta-sandwich fold, fibronectin type III, structural genomics; NMR {Homo sapiens} SCOP: b.1.2.1

Probab=98.22  E-value=6.9e-07  Score=67.96  Aligned_cols=47  Identities=40%  Similarity=0.572  Sum_probs=40.6

Q ss_pred             CceEee-eeeecceeeecCccCceEEEEEEEEecCCCCCCCCCcccee
Q psy12427          3 SWIRVG-NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLIT   49 (356)
Q Consensus         3 ~w~~~~-~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t   49 (356)
                      .|..+. ....++++|++|+|++.|.|||+|.|..|.|.+|..+...+
T Consensus        61 ~~~~~~~~~~~~~~~i~~L~p~t~Y~frV~A~n~~G~s~~S~~~~~v~  108 (117)
T 1uem_A           61 SWQTVANHVKTTLYTVRGLRPNTIYLFMVRAINPQGLSDPSPMSDPVR  108 (117)
T ss_dssp             EEEEEEEEECSSEEEECSCCTTCEEEEEEEEEETTEEEEECCCCCCEE
T ss_pred             ceeEcccccCcCEEEECCCCCCCEEEEEEEEECCCccCCCcCCCccEE
Confidence            477664 46889999999999999999999999999999999888433

>1wf5_A Sidekick 2 protein; FNIII domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: b.1.2.1

Probab=98.22  E-value=7.3e-07  Score=68.27  Aligned_cols=48  Identities=25%  Similarity=0.544  Sum_probs=40.2

Q ss_pred             CceEe---eeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceec
Q psy12427          3 SWIRV---GNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT   50 (356)
Q Consensus         3 ~w~~~---~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~   50 (356)
                      .|..+   .....++++|++|+|++.|.|||+|.|..|.|.+|..+...+.
T Consensus        63 ~~~~~~~~~~~~~~~~~v~~L~p~t~Y~frV~A~n~~G~s~~S~~~~~~~t  113 (121)
T 1wf5_A           63 PWTVLLASVDPKATSVTVKGLVPARSYQFRLCAVNDVGKGQFSKDTERVSL  113 (121)
T ss_dssp             CCEEEESSCCTTCCEEEEESCCTTCEEEEEEEEEESSCEEEECCCCSCEEC
T ss_pred             CceEeEcccCCCccEEEECCcCCCCEEEEEEEEEcCCccCCCcCCcceeEc
Confidence            57755   2357789999999999999999999999999999998864443

>2yux_A Myosin-binding protein C, SLOW-type; fibronectin III domain, structural genomics., NPPSFA; NMR {Homo sapiens}

Probab=98.21  E-value=5.7e-07  Score=69.01  Aligned_cols=47  Identities=34%  Similarity=0.517  Sum_probs=40.5

Q ss_pred             CCceEee-eeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccce
Q psy12427          2 SSWIRVG-NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLI   48 (356)
Q Consensus         2 ~~w~~~~-~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~   48 (356)
                      ..|..+. ....++++|++|.|++.|.|||+|.|..|.|.+|..+...
T Consensus        62 ~~w~~~~~~~~~~~~~v~~L~p~t~Y~frV~A~n~~G~s~~S~~s~~~  109 (120)
T 2yux_A           62 MEWFTVIEHYHRTSATITELVIGNEYYFRVFSENMCGLSEDATMTKES  109 (120)
T ss_dssp             CCCEEEESSCCSSCCEECCCCSSEEEEEEECCCSSSCSCSSCEECSSC
T ss_pred             CceEEeeecCCcCEEEECCCCCCCEEEEEEEEeeCCcCCCCccCcCCc
Confidence            3588764 4778999999999999999999999999999999976543

>2edd_A Netrin receptor DCC; tumor suppressor protein DCC, colorectal cancer suppressor, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=98.20  E-value=9.7e-07  Score=68.15  Aligned_cols=44  Identities=30%  Similarity=0.311  Sum_probs=39.1

Q ss_pred             eeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceechh
Q psy12427          9 NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD   52 (356)
Q Consensus         9 ~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~~   52 (356)
                      .+..++++|+||+|+|.|.|+|+|.|..|.|.+|....+.|.++
T Consensus        74 ~~~~~~~~v~gL~P~T~Y~f~V~A~n~~g~g~~S~~v~~~T~~~  117 (123)
T 2edd_A           74 DTTSLSYTATGLKPNTMYEFSVMVTKNRRSSTWSMTAHATTYEA  117 (123)
T ss_dssp             EESSSEEEEESCCTTCEEEEEEEECCSSSCCCCCCCEEEECCCS
T ss_pred             eCCceEEEecCCCCCCEEEEEEEEeCCCcccCCCCCEEEEccCC
Confidence            35578999999999999999999999999999999888877643

>2ede_A Netrin receptor DCC; tumor suppressor protein DCC, colorectal cancer suppressor, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=98.20  E-value=1.4e-06  Score=65.87  Aligned_cols=49  Identities=29%  Similarity=0.268  Sum_probs=41.9

Q ss_pred             CceEee-eeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceech
Q psy12427          3 SWIRVG-NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK   51 (356)
Q Consensus         3 ~w~~~~-~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~   51 (356)
                      .|.... ....++++|++|+|++.|.|||+|.|..|.|.+|....+.|..
T Consensus        58 ~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~A~n~~G~g~~S~~~~~~T~~  107 (114)
T 2ede_A           58 DWIMETISGDRLTHQIMDLNLDTMYYFRIQARNSKGVGPLSDPILFRTLK  107 (114)
T ss_dssp             TSEEEEEETTCCEEEECSCCSSCEEEEEEEEECSSCBCCCCCCEEEECCC
T ss_pred             ceEEEEECCCceEEEEcCCCCCCEEEEEEEEEeCCcCcCCcccEEEEecC
Confidence            465443 4778899999999999999999999999999999988877754

>1x5a_A Ephrin type-A receptor 1; tyrosine-protein kinase receptor, ESK, fibronectin type III (FN3) domain, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: b.1.2.1

Probab=98.19  E-value=1.3e-06  Score=65.70  Aligned_cols=40  Identities=23%  Similarity=0.275  Sum_probs=36.0

Q ss_pred             cceeeecCccCceEEEEEEEEecCCCCCCCCCccceechh
Q psy12427         13 TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD   52 (356)
Q Consensus        13 ~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~~   52 (356)
                      ++++|+||+|++.|.|||||.|..|.|.+|....+.|.++
T Consensus        62 ~~~~i~~L~p~t~Y~f~V~A~~~~G~g~~S~~~~~~T~~~  101 (107)
T 1x5a_A           62 PRVLLTKLQPDTTYIVRVRTLTPLGPGPFSPDHEFRTSPP  101 (107)
T ss_dssp             SEEEEESCCSSCEEEEEEEEECSSSCCCCCCCEEEECCCC
T ss_pred             ceEEECCCCCCCEEEEEEEEECCCccCCCCCCEEEEECCC
Confidence            3499999999999999999999999999999988877654

>2dbj_A Proto-oncogene tyrosine-protein kinase MER precursor; C-MER, receptor tyrosine kinase mertk, FN3 domain, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=98.17  E-value=1.3e-06  Score=67.34  Aligned_cols=49  Identities=10%  Similarity=-0.020  Sum_probs=41.7

Q ss_pred             ceEeeeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceechh
Q psy12427          4 WIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD   52 (356)
Q Consensus         4 w~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~~   52 (356)
                      |........++++|++|.|++.|.|||+|.|..|.|.+|....+.|.++
T Consensus        70 ~~~~~~~~~~~~~l~~L~p~t~Y~~~V~A~n~~G~Gp~S~~~~~~T~~~  118 (124)
T 2dbj_A           70 LLEEVGQNGSRARISVQVHNATCTVRIAAVTRGGVGPFSDPVKIFIPAH  118 (124)
T ss_dssp             EEEEEESTTSCEEEECCCSSSEEEECEEEEESSCBCCCCCCEEEECCCS
T ss_pred             eEEEeCCCcceEEecCCCCCCEEEEEEEEECCCccCCCCCCEEEEcCCC
Confidence            4433446678999999999999999999999999999999988887654

>2dlh_A Receptor-type tyrosine-protein phosphatase delta; protein-tyrosine phosphatase delta, R-PTP-delta, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=98.16  E-value=1.2e-06  Score=66.95  Aligned_cols=49  Identities=22%  Similarity=0.364  Sum_probs=41.4

Q ss_pred             CceEeeeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceech
Q psy12427          3 SWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK   51 (356)
Q Consensus         3 ~w~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~   51 (356)
                      .|..+.....++++|++|+|++.|.|||+|.|..|.|.+|....+.|..
T Consensus        66 ~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~A~n~~G~g~~S~~~~~~T~~  114 (121)
T 2dlh_A           66 NWMKHNVADSQITTIGNLVPQKTYSVKVLAFTSIGDGPLSSDIQVITQT  114 (121)
T ss_dssp             TSCCCCCSSCSEECCBSCCSSCEEEEEEEEEESSCBCCCCCCEEEECCC
T ss_pred             ccEEEecCCceEEEecCCCCCCEEEEEEEEEeCCccCCCCCCEEEECCC
Confidence            4554445677899999999999999999999999999999888777654

>2dm4_A Sortilin-related receptor; beta-sandwich, sorting protein-related receptor containing LDLR class A repeats, sorla; NMR {Homo sapiens}

Probab=98.16  E-value=1.2e-06  Score=65.70  Aligned_cols=48  Identities=23%  Similarity=0.237  Sum_probs=40.8

Q ss_pred             CceEeeeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceech
Q psy12427          3 SWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK   51 (356)
Q Consensus         3 ~w~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~   51 (356)
                      .|..+ .+..++++|++|+|++.|.|||+|.|..|.|.+|....+.|..
T Consensus        54 ~~~~~-~~~~~~~~l~~L~p~t~Y~~~V~A~n~~G~g~~S~~~~~~T~~  101 (108)
T 2dm4_A           54 MWASQ-RAASNFTEIKNLLVNTLYTVRVAAVTSRGIGNWSDSKSITTIK  101 (108)
T ss_dssp             CCEEE-EESSSEEEECSCCSSCEEEEEEEEEESSCEEEECCCEEEECCS
T ss_pred             CeEEe-cCCccEEEeCCCCCCCEEEEEEEEECCCceeCCCCCEEEECCC
Confidence            46644 4567899999999999999999999999999999988877653

>1x5l_A Ephrin type-A receptor 8; FN3 domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: b.1.2.1

Probab=98.14  E-value=1.4e-06  Score=65.51  Aligned_cols=45  Identities=29%  Similarity=0.369  Sum_probs=40.1

Q ss_pred             eeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceechh
Q psy12427          8 GNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD   52 (356)
Q Consensus         8 ~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~~   52 (356)
                      .....++++|++|.|++.|.|||+|.|..|.|.+|....+.|..+
T Consensus        61 ~~~~~~~~~i~~L~p~t~Y~~~V~A~n~~G~g~~S~~~~~~T~~~  105 (111)
T 1x5l_A           61 LKAVTTRATVSGLKPGTRYVFQVRARTSAGCGRFSQAMEVETGKP  105 (111)
T ss_dssp             EEESSSEEEECSCCTTCEEEECEEEEETTEECCCCCCEEEECCCT
T ss_pred             ecCCCCEEEEcCCCCCCEEEEEEEEEeCCcCCCCcccEEEEcCCC
Confidence            356788999999999999999999999999999999988877654

>1x5z_A Receptor-type tyrosine-protein phosphatase delta; fibronectin type III domain containing protein, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.1.2.1

Probab=98.13  E-value=7.4e-07  Score=67.52  Aligned_cols=48  Identities=23%  Similarity=0.254  Sum_probs=40.9

Q ss_pred             ceEeeeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceech
Q psy12427          4 WIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK   51 (356)
Q Consensus         4 w~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~   51 (356)
                      |..+.....++++|+||+|++.|.|||+|.|..|.|.+|....+.|..
T Consensus        61 ~~~~~~~~~~~~~i~~L~p~t~Y~~~V~A~n~~G~g~~S~~~~~~T~~  108 (115)
T 1x5z_A           61 EQRITIEPGTSYRLQGLKPNSLYYFRLAARSPQGLGASTAEISARTMQ  108 (115)
T ss_dssp             CBCCEECSSSEEEEECCCTTCEEEECEEEECSSCEEEECCCEEEECCC
T ss_pred             ceEEecCCCcEEEECCCCCCCeEEEEEEEECCCcccCCCcCEEEecCC
Confidence            544445567999999999999999999999999999999988877654

>1x5g_A Neogenin; RGM binding, fibronectin type III domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: b.1.2.1

Probab=98.12  E-value=2.5e-06  Score=64.69  Aligned_cols=45  Identities=27%  Similarity=0.301  Sum_probs=39.7

Q ss_pred             eeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceechh
Q psy12427          8 GNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD   52 (356)
Q Consensus         8 ~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~~   52 (356)
                      ..+..++++|++|+|++.|.|||+|.|..|.|.+|....+.|..+
T Consensus        66 ~~~~~~~~~i~~L~p~t~Y~~~V~A~n~~G~g~~S~~~~~~T~~~  110 (116)
T 1x5g_A           66 VDVSSHSYTINGLKKYTEYSFRVVAYNKHGPGVSTPDVAVRTLSD  110 (116)
T ss_dssp             EEECSSEEEECSCCTTCEEEEEEEEECSSCCCCBCCCCCEECCCS
T ss_pred             EecCCceEEEcCCCCCCEEEEEEEEEcCCCcCCCCCCEEEECCCC
Confidence            346788999999999999999999999999999999888877543

>1ujt_A KIAA1568 protein; fibronectin type III domain, structural genomics, riken structural genomics/proteomics initiative, RSGI, unknown function; NMR {Homo sapiens} SCOP: b.1.2.1

Probab=98.12  E-value=2.1e-06  Score=65.88  Aligned_cols=50  Identities=20%  Similarity=0.219  Sum_probs=42.3

Q ss_pred             CceEe--eeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceechh
Q psy12427          3 SWIRV--GNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD   52 (356)
Q Consensus         3 ~w~~~--~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~~   52 (356)
                      .|...  .....++++|+||+|+|.|.|+|+|.|..|.|.+|.+..+.|.++
T Consensus        63 ~~~~~~v~~~~~~~~~l~~L~p~T~Y~~~V~A~n~~G~Gp~S~~v~~~T~e~  114 (120)
T 1ujt_A           63 SWQNLDAKVPTERSAVLVNLKKGVTYEIKVRPYFNEFQGMDSESKTVRTTEE  114 (120)
T ss_dssp             CCEEEECCCTTCCEEEEESCCSSEEEEEEEEEESSSCCCCCCCCEEEEECSS
T ss_pred             ccEEEEecCCCcCEEEECCCCCCCEEEEEEEEECCCccCCCCCCEEEECCCC
Confidence            46533  235578999999999999999999999999999999988888654

>2edy_A Receptor-type tyrosine-protein phosphatase F; LAR protein, leukocyte antigen related, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=98.11  E-value=1.9e-06  Score=63.76  Aligned_cols=42  Identities=29%  Similarity=0.306  Sum_probs=38.1

Q ss_pred             eeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceec
Q psy12427          9 NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT   50 (356)
Q Consensus         9 ~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~   50 (356)
                      ....++++|+||+|++.|.|||+|.|..|.|.+|....+.|.
T Consensus        60 ~~~~~~~~i~~L~p~t~Y~~~V~A~n~~G~g~~S~~~~~~T~  101 (103)
T 2edy_A           60 ITTDTRFTLTGLKPDTTYDIKVRAWTSKGSGPLSPSIQSRTM  101 (103)
T ss_dssp             EESSSCCEECSCCTTCCEEEECCEECSSCBCCCCCCCCCCCC
T ss_pred             cCCcceEEEcCCCCCCEEEEEEEEECCCCCCCCCCCEEEEec
Confidence            466789999999999999999999999999999998887764

>2kbg_A N-CAM 2, neural cell adhesion molecule 2; fibronectin type III module, beta-sheet sandwich, cell membrane, glycoprotein, immunoglobulin domain; NMR {Homo sapiens}

Probab=98.10  E-value=1e-06  Score=67.02  Aligned_cols=47  Identities=17%  Similarity=0.169  Sum_probs=37.6

Q ss_pred             CceEee--eeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceec
Q psy12427          3 SWIRVG--NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT   50 (356)
Q Consensus         3 ~w~~~~--~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~   50 (356)
                      .|..+.  ....++++|.+|+|++.|.|||.|.|..|.|.||.. .+.|.
T Consensus        52 ~w~~~~~~~~~~~~~~l~~L~p~t~Y~frV~A~N~~G~s~pS~~-~~~T~  100 (114)
T 2kbg_A           52 DQWLEKKVQGNKDHIILEHLQWTMGYEVQITAANRLGYSEPTVY-EFSMP  100 (114)
T ss_dssp             SCCEEEEEETTTCCEEECCCCTTCCEEEEEEEECTTSCEEEEEE-EECCC
T ss_pred             CcEEeEEcCCCcCEEEEcCCCCCCEEEEEEEEEeCCcCcCCcCC-EEEcC
Confidence            465443  356788999999999999999999999999998874 34443

>3b83_A Ten-D3; beta sheet, computational redesigned protein, alternative splicing, cell adhesion, coiled coil, EGF-like domain, extracellular matrix; 2.40A {Homo sapiens}

Probab=98.10  E-value=1.2e-06  Score=64.95  Aligned_cols=42  Identities=29%  Similarity=0.377  Sum_probs=36.4

Q ss_pred             eeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCcccee
Q psy12427          8 GNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLIT   49 (356)
Q Consensus         8 ~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t   49 (356)
                      .....++++|+||+|++.|.|||+|.|..|.|.|+.......
T Consensus        50 ~~~~~t~~~i~~L~p~t~Y~~~V~A~n~~g~s~p~~~~~~~~   91 (100)
T 3b83_A           50 LTSSITSLTLTNLEPNTTYEIRIVARNGQQYSPPVSTTFTTG   91 (100)
T ss_dssp             ECTTEEEEEECSCCTTCEEEEEEEEEETTEECCCEEEEEECC
T ss_pred             ECCcceEEEECCCCCCCEEEEEEEEEeCCCCCCCEEEEEEEE
Confidence            347788999999999999999999999999999887665443

>2ed7_A Netrin receptor DCC; tumor suppressor protein DCC, colorectal cancer suppressor, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=98.08  E-value=1.4e-06  Score=66.40  Aligned_cols=42  Identities=26%  Similarity=0.401  Sum_probs=38.2

Q ss_pred             eeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceech
Q psy12427         10 TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK   51 (356)
Q Consensus        10 ~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~   51 (356)
                      ...++++|++|+|++.|.|||+|.|..|.|.+|....+.|..
T Consensus        71 ~~~~~~~i~~L~p~t~Y~~~V~A~n~~G~g~~S~~~~~~T~~  112 (119)
T 2ed7_A           71 PGSLQLTVGNLKPEAMYTFRVVAYNEWGPGESSQPIKVATQP  112 (119)
T ss_dssp             TTCCEEEECSCCSSSEEEECCEEEESSCBCSCCCCEEEECCC
T ss_pred             CCceEEEeCCCCCCCEEEEEEEEEcCCccCCCcCCEEEEeCC
Confidence            557899999999999999999999999999999988887754

>1x4y_A Biregional cell adhesion molecule-related/DOWN- regulated oncogenes (CDON)binding...; fibronectin type III, FN3; NMR {Mus musculus} SCOP: b.1.2.1

Probab=98.08  E-value=2.9e-06  Score=64.32  Aligned_cols=45  Identities=20%  Similarity=0.108  Sum_probs=39.0

Q ss_pred             eeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceechh
Q psy12427          8 GNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD   52 (356)
Q Consensus         8 ~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~~   52 (356)
                      .....++++|++|+|++.|.|||+|.|..|.|.+|....+.|..+
T Consensus        64 ~~~~~~~~~i~~L~p~t~Y~~~V~A~n~~G~g~~S~~v~~~T~~~  108 (114)
T 1x4y_A           64 VEGDRYWHSISHLQPETSYDIKMQCFNEGGESEFSNVMICETKAR  108 (114)
T ss_dssp             EETTCCEEEECSCCTTCEEEEEEEEECTTCCCCCCCCEEEECCCC
T ss_pred             cCCcEeEEEcCCCCCCCEEEEEEEEEcCCccCCCcCCEEEEeCCC
Confidence            344567899999999999999999999999999999888877643

>2ed8_A Netrin receptor DCC; tumor suppressor protein DCC, colorectal cancer suppressor, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=98.06  E-value=2.2e-06  Score=63.90  Aligned_cols=44  Identities=23%  Similarity=0.322  Sum_probs=38.7

Q ss_pred             eeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceechh
Q psy12427          9 NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD   52 (356)
Q Consensus         9 ~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~~   52 (356)
                      .+..++++|++|+|++.|.|||+|.|..|.|.+|....+.|..+
T Consensus        57 ~~~~~~~~i~~L~p~t~Y~~~V~A~n~~G~g~~S~~~~~~T~~~  100 (106)
T 2ed8_A           57 EVDGLSYKLEGLKKFTEYSLRFLAYNRYGPGVSTDDITVVTLSD  100 (106)
T ss_dssp             EECSSCEEEESCCTTCEEEEEEEEECSSCEEEECCCEEEECCCC
T ss_pred             eCCccEEEECCCCCCCEEEEEEEEEeCCccCCCcCCEEEEcCCC
Confidence            45689999999999999999999999999999998887776543

>3n1f_C Cell adhesion molecule-related/DOWN-regulated BY; binding sites, calcium, cell adhesion molecules, cell cycle cell LINE, conserved sequence; 1.60A {Homo sapiens} SCOP: b.1.2.1 PDB: 3d1m_C 3n1q_C 3n1m_C 3n1g_C 3n1p_C

Probab=98.04  E-value=3.6e-06  Score=62.54  Aligned_cols=47  Identities=21%  Similarity=0.121  Sum_probs=38.9

Q ss_pred             CceEee-eeeecceeeecCccCceEEEEEEEEecCCCCCCCCCcccee
Q psy12427          3 SWIRVG-NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLIT   49 (356)
Q Consensus         3 ~w~~~~-~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t   49 (356)
                      .|..+. ....++++|++|+|++.|.|+|+|.|..|.|.+|....+.|
T Consensus        54 ~~~~~~v~~~~~~~~l~~L~p~t~Y~v~V~A~n~~G~G~~S~~~~~~T  101 (102)
T 3n1f_C           54 DYKRDVVEGSKQWHMIGHLQPETSYDIKMQCFNEGGESEFSNVMICET  101 (102)
T ss_dssp             GCEEEEEETTCSEEEECSCCTTCEEEEEEEEEETTEECCCCCCEEEEC
T ss_pred             ceEEEEEcCCceEEECCCCCCCCEEEEEEEEECCCcCCCCCCCEEeec
Confidence            465433 34567899999999999999999999999999999876654

>2e3v_A Neural cell adhesion molecule 1, 140 kDa isoform; NCAM, N-CAM 1, NCAM-120, CD56 antigen, membra protein, glycoprotein, structural genomics, NPPSFA; HET: PGE BTB; 1.95A {Homo sapiens}

Probab=98.04  E-value=2.4e-06  Score=65.69  Aligned_cols=41  Identities=29%  Similarity=0.354  Sum_probs=36.7

Q ss_pred             eeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceec
Q psy12427         10 TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT   50 (356)
Q Consensus        10 ~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~   50 (356)
                      ...++++|++|+|++.|.|||+|.|..|.|.+|....+.+.
T Consensus        64 ~~~~~~~i~~L~p~t~Y~~rV~A~n~~G~g~~S~~~~~~t~  104 (122)
T 2e3v_A           64 SMEGIVTIVGLKPETTYAVRLAALNGKGLGEISAASEFKTQ  104 (122)
T ss_dssp             HTTTEEEECSCCTTCEEEEEEEEEETTEECCCCCCEEEECC
T ss_pred             CccceEEeCCCCCCCEEEEEEEEEeCCccCCCccccccccc
Confidence            45789999999999999999999999999999998887443

>2ee2_A Contactin-1; neural cell surface protein F3, glycoprotein GP135, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=98.04  E-value=5.1e-06  Score=63.38  Aligned_cols=42  Identities=29%  Similarity=0.295  Sum_probs=37.2

Q ss_pred             eeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceech
Q psy12427         10 TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK   51 (356)
Q Consensus        10 ~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~   51 (356)
                      ...++++|+||+|++.|.|||+|.|..|.|.+|....+.|..
T Consensus        71 ~~~~~~~i~~L~p~t~Y~~~V~A~n~~G~g~~S~~~~~~T~~  112 (119)
T 2ee2_A           71 SQEYSARLENLLPDTQYFIEVGACNSAGCGPPSDMIEAFTKK  112 (119)
T ss_dssp             TTCSEEEECSCCTTCEEEEEEEEECSSSCCCCCCCEEEECCC
T ss_pred             CCEeEEEECCCCCCCEEEEEEEEEcCCccCCCCCCEEEECCC
Confidence            345699999999999999999999999999999988877653

>1uey_A KIAA0343 protein; immunoglobulin-like beta-sandwich fold, NG-CAM related cell adhesion molecule, fibronectin type III domain, structural genomics; NMR {Homo sapiens} SCOP: b.1.2.1

Probab=98.03  E-value=5.1e-06  Score=64.15  Aligned_cols=48  Identities=38%  Similarity=0.484  Sum_probs=37.2

Q ss_pred             CCceEeeee-eecceeeecCccCceEEEEEEEEecCCCCCCCCCcc-cee
Q psy12427          2 SSWIRVGNT-RFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSD-LIT   49 (356)
Q Consensus         2 ~~w~~~~~~-~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~-~~t   49 (356)
                      ..|..+... ...+..|.+|+|++.|.|||+|.|..|.|.+|..+. +.|
T Consensus        62 ~~w~~~~~~~~~~~~~i~~L~p~t~Y~frV~A~n~~G~s~~S~~~~~~~T  111 (127)
T 1uey_A           62 GLWHHQTEVSGTQTTAQLNLSPYVNYSFRVMAVNSIGKSLPSEASEQYLT  111 (127)
T ss_dssp             TCEEEEEEEESSCCEEEECCCTTCEECCEEEEEESSCBCCCCSCCCCEEC
T ss_pred             CccEEEeeeCCCceEEEecCCCCCEEEEEEEEEeCCccCCccccccceEc
Confidence            358766542 233336889999999999999999999999999864 444

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.00  E-value=2.1e-05  Score=73.91  Aligned_cols=78  Identities=13%  Similarity=0.093  Sum_probs=46.3

Q ss_pred             HHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCceeecCC--CcCccccccccCCC---CCccccHHHHHHHH
Q psy12427        228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTG--TAEFAAPEIVEREP---VGFYTDMWAVGVLA  302 (356)
Q Consensus       228 H~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g--t~~y~aPE~~~~~~---~~~~sDvwSlG~il  302 (356)
                      +...++|+|++|.|||++.++   +.|+||+.+..-++..-......  ...|++|+......   .....++.+....+
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~---~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS---TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT  306 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC---EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred             CCCeEEecCCCCCcEEEeCCC---CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence            356799999999999996543   99999998876432111100010  23456666553211   11234455677777


Q ss_pred             HHHHcC
Q psy12427        303 YVLLSG  308 (356)
Q Consensus       303 ~ell~g  308 (356)
                      |+.+.+
T Consensus       307 ~~~y~~  312 (420)
T 2pyw_A          307 WNLFNK  312 (420)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            776654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.99  E-value=8.3e-05  Score=66.88  Aligned_cols=75  Identities=15%  Similarity=0.124  Sum_probs=60.1

Q ss_pred             eccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcC---CCCceeeeeeEEeCCeEEEEEEeccc
Q psy12427        113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLH---HPKLINLHDAFEDDDEMVLIFEFLSG  189 (356)
Q Consensus       113 ~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~lv~e~~~~  189 (356)
                      .+.|+.|....+|++..  ++..+++|+....   ....+..|+..|+.|.   ...+++++++....+..++||||++|
T Consensus        41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eEEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            46789999999999874  4678889986532   3567888999999884   25678888888888899999999998


Q ss_pred             cch
Q psy12427        190 GEL  192 (356)
Q Consensus       190 g~L  192 (356)
                      ..+
T Consensus       116 ~~~  118 (312)
T 3jr1_A          116 SKN  118 (312)
T ss_dssp             CCC
T ss_pred             CCC
Confidence            764

>1x5f_A Neogenin; RGM binding, fibronectin type III domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: b.1.2.1

Probab=97.97  E-value=3.5e-06  Score=64.30  Aligned_cols=42  Identities=29%  Similarity=0.362  Sum_probs=37.8

Q ss_pred             eeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceech
Q psy12427         10 TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK   51 (356)
Q Consensus        10 ~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~   51 (356)
                      ...++++|++|+|++.|.|||+|.|..|.|.+|....+.|..
T Consensus        72 ~~~~~~~i~~L~p~t~Y~~~V~A~n~~G~g~~S~~~~~~T~~  113 (120)
T 1x5f_A           72 PGEMQVTIQNLMPATVYIFRVMAQNKHGSGESSAPLRVETQP  113 (120)
T ss_dssp             TTCSEEEECSCCTTCEEEEEEEEECSSCEEEECCCEEEECCC
T ss_pred             CCccEEEeCCCCCCCEEEEEEEEECCCccCCCCCCEEEEeCC
Confidence            558899999999999999999999999999999888877654

>1k85_A Chitinase A1; fibronectin type III domain, chitin binding domain, carbohydrase, horizontal gene transfer, hydrolase; NMR {Bacillus circulans} SCOP: b.1.2.1

Probab=97.96  E-value=8.4e-06  Score=58.60  Aligned_cols=40  Identities=30%  Similarity=0.414  Sum_probs=33.8

Q ss_pred             eeeeecceeeecCccCceEEEEEEEEecCCC-CCCCCCccc
Q psy12427          8 GNTRFTTMAITGLSPGHQYEFRVYAENVYGR-SDPSTTSDL   47 (356)
Q Consensus         8 ~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~-s~~s~~s~~   47 (356)
                      ..+..+++++++|.|++.|.|||+|.|..|. |.+|....+
T Consensus        46 ~~~~~~~~~~~~L~~~t~Y~~~V~A~n~~G~~s~~S~~v~v   86 (88)
T 1k85_A           46 TTVTGTTATISGLAADTSYTFTVKAKDAAGNVSAASNAVSV   86 (88)
T ss_dssp             EEESSSEEEECCCCSSCEEEEEEEEEETTTEECCCCCCEEE
T ss_pred             eecCCCEEEeCCCCCCCEEEEEEEEEeCCCCcCCCCCCEEE
Confidence            3456789999999999999999999999998 667766544

>1uc6_A CNTF receptor, ciliary neurotrophic factor receptor alpha; cytokine, leukemia inhibitory factor, cytokine receptor; NMR {Homo sapiens} SCOP: b.1.2.1

Probab=97.95  E-value=5.3e-06  Score=62.39  Aligned_cols=46  Identities=24%  Similarity=0.181  Sum_probs=37.7

Q ss_pred             CceEeeeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCcccee
Q psy12427          3 SWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLIT   49 (356)
Q Consensus         3 ~w~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t   49 (356)
                      .|..+.....++++|.+|+||+.|.|||||.+. |.|.+|+=|+..+
T Consensus        57 ~w~~~~~~~~~~~~l~~L~p~t~Y~~~VRa~~~-g~g~wS~WS~~~~  102 (109)
T 1uc6_A           57 QWQHVELSNGTAHTITDAYAGKEYIIQVAAKDN-EIGTWSDWSVAAH  102 (109)
T ss_dssp             CCCCEEESSCSEEEETTCCSSSCEEEEEECCBS-SSCCCCCCCEEEE
T ss_pred             CcEEEecccCCEEEEeCCCCCCEEEEEEEEEeC-CCCCcCcCCCCee
Confidence            477666667799999999999999999999986 8877777666543

>2edx_A Protein tyrosine phosphatase, receptor type, F; LAR protein, leukocyte antigen related, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=97.92  E-value=9.8e-06  Score=62.95  Aligned_cols=42  Identities=19%  Similarity=0.213  Sum_probs=37.4

Q ss_pred             eeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceech
Q psy12427         10 TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK   51 (356)
Q Consensus        10 ~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~   51 (356)
                      ...++++|+||+|++.|.|||+|.|..|.|.+|....+.|..
T Consensus        76 ~~~~~~~i~~L~p~t~Y~~~V~A~n~~G~g~~S~~~~~~T~~  117 (134)
T 2edx_A           76 REHSSWDLVGLEKWTEYRVWVRAHTDVGPGPESSPVLVRTDE  117 (134)
T ss_dssp             TTCSEEEEESCCTTCEEEEEEEEEETTBCCCCCCCEEEECCC
T ss_pred             CCccEEEeCCCCCCCEEEEEEEEEcCCCcCCCCCCEEeecCC
Confidence            567899999999999999999999999999999887776653

>1va9_A DOWN syndrome cell adhesion molecule like- protein 1B; FNIII domain, dscaml1 protein, structural genomics; NMR {Homo sapiens} SCOP: b.1.2.1

Probab=97.91  E-value=6.1e-06  Score=63.02  Aligned_cols=41  Identities=22%  Similarity=0.137  Sum_probs=36.9

Q ss_pred             eecceeeecCccCceEEEEEEEEecCCCCCCCCCccceech
Q psy12427         11 RFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK   51 (356)
Q Consensus        11 ~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~   51 (356)
                      ..++++|++|+|++.|.|||+|.|..|.|.+|....+.|..
T Consensus        76 ~~~~~~i~~L~p~t~Y~~~V~A~n~~G~g~~S~~~~~~T~~  116 (122)
T 1va9_A           76 DSEVYTLDNLKKFAQYGVVVQAFNRAGTGPSSSEINATTLE  116 (122)
T ss_dssp             SEEEEEEESCCSSCCEEEEEEEEETTEECCCCCCEECCCCS
T ss_pred             ceeEEEeCCCCCCCEEEEEEEEEcCCCCCCCccCEEEEeCC
Confidence            45899999999999999999999999999999988877654

>1uen_A KIAA0343 protein; immunoglobulin-like beta-sandwich fold, fibronectin type III, NG-CAM related cell adhesion molecule, structural genomics; NMR {Homo sapiens} SCOP: b.1.2.1

Probab=97.88  E-value=6e-06  Score=63.41  Aligned_cols=43  Identities=23%  Similarity=0.223  Sum_probs=38.2

Q ss_pred             eeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceech
Q psy12427          9 NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK   51 (356)
Q Consensus         9 ~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~   51 (356)
                      ....++++|++|+|++.|.|||+|.|..|.|.+|....+.|..
T Consensus        76 ~~~~~~~~i~~L~p~t~Y~~~V~A~n~~G~g~~S~~~~~~T~~  118 (125)
T 1uen_A           76 QGSKTHGMLPGLEPFSHYTLNVRVVNGKGEGPASPDRVFNTPE  118 (125)
T ss_dssp             ESSCSEEEEESCCSSCEEEEEEEEEESSCEEEECCCEEEECCC
T ss_pred             cCCccEEEeCCCCCCCEEEEEEEEecCCCCCCCCCCEEEECCC
Confidence            4667899999999999999999999999999999888777654

>2dn7_A Receptor-type tyrosine-protein phosphatase F; LAR protein, leukocyte antigen related, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.1.2.1

Probab=97.87  E-value=4e-06  Score=62.52  Aligned_cols=46  Identities=24%  Similarity=0.318  Sum_probs=37.1

Q ss_pred             CceEee-eeeecceeeecCccCceEEEEEEEEecCCCCCCCCCcccee
Q psy12427          3 SWIRVG-NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLIT   49 (356)
Q Consensus         3 ~w~~~~-~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t   49 (356)
                      .|..+. ....++++|++|+|++.|.|||+|.|..|.|.+|. ..+.|
T Consensus        51 ~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~A~n~~G~g~~s~-~~~~T   97 (107)
T 2dn7_A           51 RPNTIDFGKDDQHFTVTGLHKGTTYIFRLAAKNRAGLGEEFE-KEIRT   97 (107)
T ss_dssp             SCEEEEEETTCCEEEEECCCTTCEEEEEEEEEETTEEEEEEE-EEEEC
T ss_pred             CCEEEEeCCCccEEEeCCCCCCCEEEEEEEEEcCCcccCCee-eEEeC
Confidence            466543 35678999999999999999999999999998887 33444

>1j8k_A Fibronectin; EDA, TYPEIII domain, protein binding; NMR {Homo sapiens} SCOP: b.1.2.1

Probab=97.86  E-value=6.4e-06  Score=59.96  Aligned_cols=36  Identities=28%  Similarity=0.345  Sum_probs=31.6

Q ss_pred             eeeecceeeecCccCceEEEEEEEEecCCCCCCCCC
Q psy12427          9 NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTT   44 (356)
Q Consensus         9 ~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~   44 (356)
                      ....++++++||+||+.|.|+|+|.|..|.|.++..
T Consensus        51 ~~~~~~~~l~~L~p~t~Y~~~V~A~~~~g~s~p~~~   86 (94)
T 1j8k_A           51 DGEEDTAELQGLRPGSEYTVSVVALHDDMESQPLIG   86 (94)
T ss_dssp             CSSCCEEEECSCCCCSEEEEEEEECSSSCCCCCEEE
T ss_pred             CCCccEEEeCCCCCCCEEEEEEEEEcCCCcCCCEEe
Confidence            456789999999999999999999999998887654

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.85  E-value=2.6e-05  Score=69.75  Aligned_cols=71  Identities=8%  Similarity=-0.016  Sum_probs=44.7

Q ss_pred             eccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCc-eeeeeeEEeCCeEEEEEEec-ccc
Q psy12427        113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKL-INLHDAFEDDDEMVLIFEFL-SGG  190 (356)
Q Consensus       113 ~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~lv~e~~-~~g  190 (356)
                      .+.|+.|....+|++      ..+++|+....... .....+|+.+++.+...++ .++++..  ...-++++||+ +|.
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~   93 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ   93 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence            567899999999998      45788877543211 1122468888887743223 4555543  33447899999 665


Q ss_pred             ch
Q psy12427        191 EL  192 (356)
Q Consensus       191 ~L  192 (356)
                      ++
T Consensus        94 ~l   95 (301)
T 3dxq_A           94 TM   95 (301)
T ss_dssp             EC
T ss_pred             cC
Confidence            55

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.82  E-value=0.00013  Score=64.60  Aligned_cols=78  Identities=15%  Similarity=0.081  Sum_probs=56.1

Q ss_pred             eeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCC---CceeeeeeEEeCCeEEEEEEe
Q psy12427        110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHP---KLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       110 y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hp---nIv~l~~~~~~~~~~~lv~e~  186 (356)
                      ..-.+.+|.|..+.||++... +|+.+++|+...........+..|+..|+.|.-.   -+.+++++.    ..++||||
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~   91 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW   91 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred             eEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence            455678999999999999764 6889999987654444445688899999998421   244555432    23789999


Q ss_pred             ccccch
Q psy12427        187 LSGGEL  192 (356)
Q Consensus       187 ~~~g~L  192 (356)
                      +.++..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            987643

>2edb_A Netrin receptor DCC; tumor suppressor protein DCC, colorectal cancer suppressor, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=97.81  E-value=1.1e-05  Score=61.38  Aligned_cols=37  Identities=19%  Similarity=0.170  Sum_probs=32.6

Q ss_pred             eeeeeecceeeecCccCceEEEEEEEEecCCCCCCCC
Q psy12427          7 VGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPST   43 (356)
Q Consensus         7 ~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~   43 (356)
                      ......++++|++|+|++.|.|||+|.|..|.|.++.
T Consensus        65 ~~~~~~~~~~l~~L~p~t~Y~~~V~A~n~~G~g~~~~  101 (116)
T 2edb_A           65 RVDSKQRYYSIERLESSSHYVISLKAFNNAGEGVPLY  101 (116)
T ss_dssp             EEETTCCEEEECSCCSSSBEEEEEEEEETTEECSCEE
T ss_pred             EeCCCeeEEEeCCCCCCCEEEEEEEEEeCCccCCCCc
Confidence            3446678999999999999999999999999998764

>2yrz_A Integrin beta-4; GP150, CD104 antigen, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens}

Probab=97.80  E-value=7e-06  Score=62.41  Aligned_cols=42  Identities=29%  Similarity=0.422  Sum_probs=34.9

Q ss_pred             CceEee--eeeecceeeecCccCceEEEEEEEEecCCCCCCCCC
Q psy12427          3 SWIRVG--NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTT   44 (356)
Q Consensus         3 ~w~~~~--~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~   44 (356)
                      .|..+.  ....++++|++|+|++.|.|||+|.|..|.|.+|..
T Consensus        61 ~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~A~n~~G~g~~S~~  104 (118)
T 2yrz_A           61 ELHRLNIPNPAQTSVVVEDLLPNHSYVFRVRAQSQEGWGREREG  104 (118)
T ss_dssp             CEEEEEESCTTCCEEEEESCCTTCEEEEEEEEEESSCEEEEEEE
T ss_pred             ceEEEEcCCCCcCEEEeCCCCCCCEEEEEEEEEcCCcCCCCcCC
Confidence            354443  355889999999999999999999999999988863

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.79  E-value=7.1e-05  Score=69.18  Aligned_cols=144  Identities=12%  Similarity=0.158  Sum_probs=81.1

Q ss_pred             ccccccCceEEEEEEEcc-------CCCEEEEEEcccCChhhHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCeEEEEEE
Q psy12427        114 EEIGTGAFGVVHRCRERK-------TGNIFAAKFIPVSHNLEKELIRKEIDIMNQLH-HPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~-------~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      +.|..|-...+|++....       ++..+++|+.... ......+.+|..+++.|. +.-..++++.+.+    .+|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            467788899999987642       3578999986321 223455668999998884 3223566766543    28999


Q ss_pred             eccccchhh-----------------hhhCCCCCCCcccc-ccccHHHHHHHHHH-------------------HHHHH-
Q psy12427        186 FLSGGELFE-----------------RITAPDYKMSEAEV-IPVTLPILMTQTSP-------------------AVKHM-  227 (356)
Q Consensus       186 ~~~~g~L~~-----------------~l~~~~~~~~~~~~-~~~~~~~~~~~i~~-------------------~l~~l-  227 (356)
                      |++|..|..                 .++.....+..... ....+..++.++..                   .+..| 
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            999876531                 11222111111111 11233334433321                   22333 


Q ss_pred             ---HH----CCceeccCCCCCEEEeec--CCCcEEEEeeeceee
Q psy12427        228 ---HE----KNIIHLDVKPENIMCQTR--NSTNVKMIDFGLATK  262 (356)
Q Consensus       228 ---H~----~~ivH~Dlkp~NIlv~~~--~~~~vkl~Dfg~a~~  262 (356)
                         ..    ..++|+|+.+.|||++.+  ....+.|+||..|..
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence               22    249999999999999765  123689999998865

>1x5i_A Neogenin; RGM binding, fibronectin type III domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: b.1.2.1

Probab=97.78  E-value=1.2e-05  Score=62.15  Aligned_cols=36  Identities=22%  Similarity=0.270  Sum_probs=32.8

Q ss_pred             eeeecceeeecCccCceEEEEEEEEecCCCCCCCCC
Q psy12427          9 NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTT   44 (356)
Q Consensus         9 ~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~   44 (356)
                      ....++++|++|+|++.|.|||+|.|..|.|.++..
T Consensus        77 ~~~~~~~~i~~L~p~t~Y~~~V~A~n~~G~g~~s~~  112 (126)
T 1x5i_A           77 DYKQRYYTIENLDPSSHYVITLKAFNNVGEGIPLYE  112 (126)
T ss_dssp             CTTCCEEEECSCCSSCEECCEEEEECSSCBCCCCCC
T ss_pred             CCCeeEEEEeCCCCCCEEEEEEEEEeCCccCcceee
Confidence            466789999999999999999999999999998864

>1wfo_A Sidekick 2; FN3, cell adhesion, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: b.1.2.1

Probab=97.78  E-value=5.4e-06  Score=64.23  Aligned_cols=44  Identities=25%  Similarity=0.311  Sum_probs=38.3

Q ss_pred             eeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceech
Q psy12427          8 GNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK   51 (356)
Q Consensus         8 ~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~   51 (356)
                      .....++++|++|+|++.|.|||+|.|..|.|.+|....+.|..
T Consensus        80 ~~~~~~~~~i~~L~p~t~Y~~~V~A~n~~G~g~~S~~~~~~T~~  123 (130)
T 1wfo_A           80 LAPSARQYTATGLKPESVYLFRITAQTRKGWGEAAEALVVTTEK  123 (130)
T ss_dssp             ECTTCCEEEEESCCSSSEEEEEEEEECSSCEEEEEEEEEECCSS
T ss_pred             eCCCceEEEEcCCCCCCEEEEEEEEEeCCcCCCCcccEEEecCC
Confidence            34678899999999999999999999999999998877766653

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.78  E-value=7.1e-05  Score=70.52  Aligned_cols=74  Identities=18%  Similarity=0.206  Sum_probs=50.8

Q ss_pred             eccccccCceEEEEEEEcc-------CCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCc-eeeeeeEEeCCeEEEEE
Q psy12427        113 LEEIGTGAFGVVHRCRERK-------TGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKL-INLHDAFEDDDEMVLIF  184 (356)
Q Consensus       113 ~~~lg~G~fg~V~~~~~~~-------~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~lv~  184 (356)
                      .+.|+.|....||++....       ++..+++|+......  ...+.+|+.+++.+...++ .++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            4578899999999998653       257899998743211  1344579999998853334 566766542    2899


Q ss_pred             Eeccccch
Q psy12427        185 EFLSGGEL  192 (356)
Q Consensus       185 e~~~~g~L  192 (356)
                      ||++|.+|
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99987554

>1bqu_A Protein (GP130); cytokine receptor, glycoprotein 130, interleukine 6 R beta subunit, signaling protein; 2.00A {Homo sapiens} SCOP: b.1.2.1 b.1.2.1 PDB: 1pvh_A 1bj8_A

Probab=97.76  E-value=2.8e-05  Score=65.50  Aligned_cols=45  Identities=20%  Similarity=0.351  Sum_probs=36.8

Q ss_pred             CceEee----eeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccc
Q psy12427          3 SWIRVG----NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDL   47 (356)
Q Consensus         3 ~w~~~~----~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~   47 (356)
                      .|..+.    ....++++|++|+|++.|.|||||.|..|.|.+|..|+.
T Consensus       150 ~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~A~n~~g~g~~S~~S~~  198 (215)
T 1bqu_A          150 TWSQIPPEDTASTRSSFTVQDLKPFTEYVFRIRCMKEDGKGYWSDWSEE  198 (215)
T ss_dssp             SCEECCGGGGCSCCSEEEECSCCSSEEEEEEEEEEETTSCSCCCCCCCC
T ss_pred             CceEeccccccCccceEEeCCCCCCCEEEEEEEEccCCCCCccCCCCCc
Confidence            576653    466789999999999999999999999998776665543

>1x5h_A Neogenin; RGM binding, fibronectin type III domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: b.1.2.1

Probab=97.75  E-value=7e-06  Score=63.73  Aligned_cols=43  Identities=26%  Similarity=0.319  Sum_probs=38.6

Q ss_pred             eeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceech
Q psy12427          9 NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK   51 (356)
Q Consensus         9 ~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~   51 (356)
                      ....++++|++|+|++.|.|||+|.|..|.|.+|....+.|..
T Consensus        73 ~~~~~~~~i~~L~p~t~Y~~~V~A~n~~G~g~~S~~~~~~T~~  115 (132)
T 1x5h_A           73 SGTQLSQLIEGLDRGTEYNFRVAALTINGTGPATDWLSAETFE  115 (132)
T ss_dssp             CTTCCEEEEECCCSSCEEEEECEEEETTEEEEECCCEEEECCS
T ss_pred             CCCccEEEeCCCCCCCEEEEEEEEEcCCccCCCCcCEEeEcCc
Confidence            4567899999999999999999999999999999988877754

>3teu_A Fibcon; FN3 domain, fibronectin TPYE III domain, consensus design, S de novo protein; HET: DIO; 1.00A {Synthetic}

Probab=97.75  E-value=2.3e-05  Score=57.48  Aligned_cols=34  Identities=38%  Similarity=0.543  Sum_probs=30.8

Q ss_pred             eeecceeeecCccCceEEEEEEEEecCCCCCCCC
Q psy12427         10 TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPST   43 (356)
Q Consensus        10 ~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~   43 (356)
                      ...++++|+||.|++.|.|||+|.|..|.|.|..
T Consensus        52 ~~~~~~~i~~L~p~t~Y~~~V~A~n~~G~s~p~~   85 (98)
T 3teu_A           52 PSSTSVTITGLTPGVEYVVSVYALKDNQESPPLV   85 (98)
T ss_dssp             TTCSEEEECSCCTTCEEEEEEEEEETTEECCCEE
T ss_pred             CCcCEEEecCCCCCCEEEEEEEEEeCCCCCCCeE
Confidence            5678999999999999999999999999887654

>2rb8_A Tenascin; beta sheet,loop design, alternative splicing, cell adhesion, coiled coil, EGF-like domain, extracellular matrix, glycoprotein; 1.45A {Homo sapiens} PDB: 2rbl_A 1ten_A

Probab=97.74  E-value=2e-05  Score=58.60  Aligned_cols=41  Identities=20%  Similarity=0.281  Sum_probs=33.6

Q ss_pred             eeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceec
Q psy12427          9 NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT   50 (356)
Q Consensus         9 ~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~   50 (356)
                      ....++++|+||+||+.|.|+|+|.|..|.|.++.. .+.|.
T Consensus        52 ~~~~~~~~l~~L~p~t~Y~~~V~A~~~~g~s~p~~~-~~~T~   92 (104)
T 2rb8_A           52 TEDENQYSIGNLKPDTEYEVSLISRRGDMSSNPAKE-TFTTG   92 (104)
T ss_dssp             ETTCCEEEECSCCTTCEEEEEEEEEETTEECCCEEE-EEECC
T ss_pred             CCCcCEEEeCCCCCCCEEEEEEEEEeCCccCCCEEE-EEECC
Confidence            456789999999999999999999999999877543 24443

>3tes_A Tencon; fibronectin type III domain, FN3, consensus design, de novo; 2.50A {Synthetic}

Probab=97.73  E-value=2.2e-05  Score=57.77  Aligned_cols=35  Identities=29%  Similarity=0.492  Sum_probs=31.1

Q ss_pred             eeeecceeeecCccCceEEEEEEEEecCCCCCCCC
Q psy12427          9 NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPST   43 (356)
Q Consensus         9 ~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~   43 (356)
                      ....++++|+||+|++.|.|+|+|.|..|.|.|..
T Consensus        51 ~~~~t~~~l~gL~P~t~Y~~~V~A~~~~g~S~p~~   85 (98)
T 3tes_A           51 PGSERSYDLTGLKPGTEYTVSIYGVKGGHRSNPLS   85 (98)
T ss_dssp             ETTCSEEEECSCCTTCEEEEEEEEEETTEEBCCEE
T ss_pred             CCCcCEEEECCCCCCCEEEEEEEEEeCCcccCCEE
Confidence            45678999999999999999999999998888754

>4go6_B HCF C-terminal chain 1; tandem fibronectin repeat, protein interaction, transcriptio protein binding; 2.70A {Homo sapiens}

Probab=97.68  E-value=1.1e-05  Score=69.36  Aligned_cols=41  Identities=32%  Similarity=0.476  Sum_probs=32.1

Q ss_pred             eeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceec
Q psy12427         10 TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT   50 (356)
Q Consensus        10 ~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~   50 (356)
                      ...+++++++|.|++.|.|||+|.|..|.|.+|....+.+.
T Consensus        43 ~~~t~~~~~~L~p~t~Y~frV~A~n~~G~g~~s~~~~~~t~   83 (232)
T 4go6_B           43 PDYNQLKKQELQPGTAYKFRVAGINACGRGPFSEISAFKTC   83 (232)
T ss_dssp             ------CEEECCTTCEEEEEEEEEETTEEEEECCCEEEECC
T ss_pred             CCccEEEeCCCCCCCEEEEEEEEEeCCCccccccceeeeec
Confidence            55678999999999999999999999999999988776654

>1wfn_A Sidekick 2; FN3, cell adhesion, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: b.1.2.1

Probab=97.66  E-value=1.2e-05  Score=61.12  Aligned_cols=38  Identities=21%  Similarity=0.209  Sum_probs=34.1

Q ss_pred             eeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCc
Q psy12427          8 GNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTS   45 (356)
Q Consensus         8 ~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s   45 (356)
                      .....++++|++|+|++.|.|||+|.|..|.|.+|...
T Consensus        69 ~~~~~~~~~i~~L~p~t~Y~~~V~A~n~~G~g~~S~~~  106 (119)
T 1wfn_A           69 LPNVTLEYRVTGLTALTTYTIEVAAMTSKGQGQVSAST  106 (119)
T ss_dssp             ECSSCCEEEEESCCTTCEEEEEEEEECSSCEEEEEEEE
T ss_pred             eCCCceEEEEcCCCCCCEEEEEEEEEcCCccCCCCCCE
Confidence            34678899999999999999999999999999888765

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.64  E-value=0.00015  Score=65.28  Aligned_cols=145  Identities=16%  Similarity=0.132  Sum_probs=77.9

Q ss_pred             eeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCC--ceeeeee------EEeCCeEEEE
Q psy12427        112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPK--LINLHDA------FEDDDEMVLI  183 (356)
Q Consensus       112 ~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~~------~~~~~~~~lv  183 (356)
                      -.+.|+.|....+|++...  +..+++|+.....  ..+.+..|+.++..+...+  +.+++..      ....+..+++
T Consensus        26 ~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l  101 (322)
T 2ppq_A           26 SYKGIAEGVENSNFLLHTT--KDPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL  101 (322)
T ss_dssp             EEEEECC---EEEEEEEES--SCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred             EeeccCCCcccceEEEEeC--CccEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEE
Confidence            3456888999999998754  3368889876521  2234556888887774212  2333321      2234677899


Q ss_pred             EEeccccchhh--------------hhhC--CCCCCCccc---cc--cc----------c-HHHHHHHHHHHHHHHHH--
Q psy12427        184 FEFLSGGELFE--------------RITA--PDYKMSEAE---VI--PV----------T-LPILMTQTSPAVKHMHE--  229 (356)
Q Consensus       184 ~e~~~~g~L~~--------------~l~~--~~~~~~~~~---~~--~~----------~-~~~~~~~i~~~l~~lH~--  229 (356)
                      ++|++|..+..              .++.  ..+......   ..  ..          . ...+-..+...++.+++  
T Consensus       102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~  181 (322)
T 2ppq_A          102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW  181 (322)
T ss_dssp             EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred             EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence            99998865421              1111  111111000   00  00          0 00011123444555553  


Q ss_pred             -----CCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        230 -----KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       230 -----~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                           .+++|+|+.+.|||++.+  ..+.|+||+.+..
T Consensus       182 ~~~~~~~liHgDl~~~Nil~~~~--~~~~lIDf~~a~~  217 (322)
T 2ppq_A          182 PKDLPAGVIHADLFQDNVFFLGD--ELSGLIDFYFACN  217 (322)
T ss_dssp             CCSSCEEEECSCCCGGGEEEETT--EEEEECCCTTCEE
T ss_pred             cccCCcccCCCCCCccCEEEeCC--ceEEEecchhccC
Confidence                 369999999999999743  2347999998764

>2dkm_A Collagen alpha-1(XX) chain; FN3 domain, KIAA1510, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens}

Probab=97.64  E-value=5.4e-05  Score=56.21  Aligned_cols=34  Identities=24%  Similarity=0.323  Sum_probs=29.3

Q ss_pred             eeecceeeecCccCceEEEEEEEEecCCCCCCCC
Q psy12427         10 TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPST   43 (356)
Q Consensus        10 ~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~   43 (356)
                      +..++++|+||+|++.|.|+|+|.|..|.|.+..
T Consensus        58 ~~~~~~~l~~L~p~t~Y~~~V~A~~~~~~s~p~~   91 (104)
T 2dkm_A           58 VGRPEVLLDGLEPGRDYEVSVQSLRGPEGSEARG   91 (104)
T ss_dssp             ESSSEEEEESCCTTCCEEEEEEEECSSSBCCCEE
T ss_pred             cCCCEEEECCCCCCCEEEEEEEEECCCCCCCCEE
Confidence            3445999999999999999999999988887754

>3t04_D Monobody 7C12; engineered binding protein, antibody mimic, protein-protein SH2 domain, ATP-binding, phosphoprotein; 2.10A {Homo sapiens}

Probab=97.64  E-value=3.9e-05  Score=56.94  Aligned_cols=35  Identities=31%  Similarity=0.570  Sum_probs=30.4

Q ss_pred             eeeecceeeecCccCceEEEEEEEEec--CCCCCCCCC
Q psy12427          9 NTRFTTMAITGLSPGHQYEFRVYAENV--YGRSDPSTT   44 (356)
Q Consensus         9 ~~~~~~~~v~~L~p~~~y~frv~a~n~--~g~s~~s~~   44 (356)
                      ....++++|+||+|++.|.|+|+|.|.  .|.+. |.+
T Consensus        60 ~~~~ts~~l~~L~p~t~Y~~~V~A~~~~~~G~~~-S~p   96 (103)
T 3t04_D           60 PGYYSTATISGLKPGVDYTITVYAYDTFFPGYEP-NSP   96 (103)
T ss_dssp             ETTCCEEEECSCCTTCCEEEEEEEESCCCTTCCC-SCC
T ss_pred             CCCcCEEEeCCCCCCCEEEEEEEEEeCCCCCCCC-CCC
Confidence            356789999999999999999999999  88887 443

>2cum_A Tenascin-X; hexabrachion-like, fibronectin type III domain, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.1.2.1

Probab=97.63  E-value=5.4e-05  Score=56.32  Aligned_cols=39  Identities=21%  Similarity=0.142  Sum_probs=32.4

Q ss_pred             ceEee-eeeecceeeecCccCceEEEEEEEEecCCCCCCC
Q psy12427          4 WIRVG-NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPS   42 (356)
Q Consensus         4 w~~~~-~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s   42 (356)
                      |..+. ....++++|+||+|++.|.|+|+|.|..|.|.+.
T Consensus        49 ~~~~~~~~~~ts~~l~~L~p~t~Y~~~V~A~~~~g~s~~~   88 (105)
T 2cum_A           49 TQEILLPGGITSHQLLGLFPSTSYNARLQAMWGQSLLPPV   88 (105)
T ss_dssp             EEEEEECSSCSEEEECSCCTTCEEEEEEEEEBTTBCCCCE
T ss_pred             eEEEEECCCccEEEECCCCCCCEEEEEEEEEeCCcccCCE
Confidence            54442 3577899999999999999999999998888763

>3qht_C Monobody YSMB-1; fibronectin type III, yeast small ubiquitin-like modifier, S NOVO protein; 2.40A {Artificial gene}

Probab=97.59  E-value=3e-05  Score=56.76  Aligned_cols=35  Identities=37%  Similarity=0.412  Sum_probs=30.7

Q ss_pred             eeeecceeeecCccCceEEEEEEEEecCCCCCCCC
Q psy12427          9 NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPST   43 (356)
Q Consensus         9 ~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~   43 (356)
                      ....++++|+||+|++.|.|+|+|.|..|.|.++.
T Consensus        54 ~~~~t~~~l~~L~p~t~Y~v~V~A~~~~G~gp~ss   88 (97)
T 3qht_C           54 PGSSSTATISGLSPGVDYTITVYAYYSYYDLYYSY   88 (97)
T ss_dssp             ETTCCEEEECSCCTTCEEEEEEEEEEEETTEEEEC
T ss_pred             CCCcCEEEeCCCCCCCEEEEEEEEEeCCccCCCCC
Confidence            35678999999999999999999999999986543

>1wj3_A KIAA1496 protein; beta sandwich, PANG, structural genomics, riken structural genomics/proteomics initiative, RSGI, neuropeptide; NMR {Homo sapiens} SCOP: b.1.2.1

Probab=97.56  E-value=6.9e-05  Score=56.97  Aligned_cols=44  Identities=23%  Similarity=0.159  Sum_probs=37.3

Q ss_pred             eeeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceech
Q psy12427          7 VGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK   51 (356)
Q Consensus         7 ~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~   51 (356)
                      +..+..+++.+. |.|++.|.|||+|.|..|.|.+|....+.|..
T Consensus        67 ~~~~~~~~~~~~-L~~~t~Y~~~V~A~n~~G~Gp~S~~v~~~T~~  110 (117)
T 1wj3_A           67 VLNTNKTSAELV-LPIKEDYIIEVKATTDGGDGTSSEQIRIPRIT  110 (117)
T ss_dssp             EEEESSSEEEEE-CCCSSCEEEEEEEEESSCCCCBCCCEEECCCC
T ss_pred             EEeCCCcEEEEE-CCCCCEEEEEEEEECCCccCCCCCCEEEEcCC
Confidence            334556778888 99999999999999999999999888877754

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.55  E-value=0.00019  Score=66.11  Aligned_cols=75  Identities=15%  Similarity=0.115  Sum_probs=45.4

Q ss_pred             eccccccCceEEEEEEEcc--------CCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCC-ceeeeeeEEeCCeEEEE
Q psy12427        113 LEEIGTGAFGVVHRCRERK--------TGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPK-LINLHDAFEDDDEMVLI  183 (356)
Q Consensus       113 ~~~lg~G~fg~V~~~~~~~--------~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~~~lv  183 (356)
                      .+.|+.|....+|++....        .+..+++|+....... ......|..+++.+...+ ..++++.+  .  -++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence            3467889899999998653        1368888987543221 112356888888885333 34666554  2  2689


Q ss_pred             EEeccccch
Q psy12427        184 FEFLSGGEL  192 (356)
Q Consensus       184 ~e~~~~g~L  192 (356)
                      |||++|..+
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999988654

>3k2m_C Monobody HA4; engineered binding protein, antibody mimic, protein-protein SH2 domain, ATP-binding, phosphoprotein; 1.75A {Homo sapiens} PDB: 3uyo_D 1ttf_A 1ttg_A 3rzw_A 1fna_A

Probab=97.55  E-value=8.1e-05  Score=54.93  Aligned_cols=29  Identities=38%  Similarity=0.503  Sum_probs=26.9

Q ss_pred             eeecceeeecCccCceEEEEEEEEecCCC
Q psy12427         10 TRFTTMAITGLSPGHQYEFRVYAENVYGR   38 (356)
Q Consensus        10 ~~~~~~~v~~L~p~~~y~frv~a~n~~g~   38 (356)
                      ...++++|+||+|++.|.|+|+|.|..|.
T Consensus        57 ~~~t~~~l~~L~p~t~Y~~~V~A~~~~~~   85 (101)
T 3k2m_C           57 YSSSTATISGLSPGVDYTITVYAWGEDSA   85 (101)
T ss_dssp             TTCCEEEECSCCTTCEEEEEEEEEEECTT
T ss_pred             CCccEEEECCCCCCCEEEEEEEEEeCCcc
Confidence            56789999999999999999999999887

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.54  E-value=0.00037  Score=66.06  Aligned_cols=75  Identities=15%  Similarity=0.158  Sum_probs=49.4

Q ss_pred             eccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCc-eeeeeeEEeCCeEEEEEEeccccc
Q psy12427        113 LEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKL-INLHDAFEDDDEMVLIFEFLSGGE  191 (356)
Q Consensus       113 ~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~lv~e~~~~g~  191 (356)
                      .+.|+.|....+|++.....+..+++|+....... .-.-.+|+.++..|...++ .++++.+.  +  .+|+||++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            45788999999999987654578889987432211 1112479999999975555 46777663  2  25999998865


Q ss_pred             h
Q psy12427        192 L  192 (356)
Q Consensus       192 L  192 (356)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            5

>1n26_A IL-6 receptor alpha chain; transmembrane, glycoprotein, immunoglobulin domain, cytokine; HET: NAG BMA MAN NDG; 2.40A {Homo sapiens} SCOP: b.1.1.4 b.1.2.1 b.1.2.1 PDB: 1p9m_C 2arw_A

Probab=97.49  E-value=9.7e-05  Score=66.69  Aligned_cols=48  Identities=13%  Similarity=0.048  Sum_probs=40.1

Q ss_pred             CCceEee-eeeecceeeecCccCceEEEEEEEEecCCCCCCCCCcccee
Q psy12427          2 SSWIRVG-NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLIT   49 (356)
Q Consensus         2 ~~w~~~~-~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t   49 (356)
                      ..|..+. ....++++|.+|.|++.|.|||||.|..|.|.+|.-|+...
T Consensus       244 ~~W~~~~~~~~~~~~~l~~L~p~t~Y~~rVrA~n~~g~G~~S~wS~~~~  292 (325)
T 1n26_A          244 KTFTTWMVKDLQHHCVIHDAWSGLRHVVQLRAQEEFGQGEWSEWSPEAM  292 (325)
T ss_dssp             SCCEEEECGGGCSEEEESSCCTTCCEEEEEEEEETTTBSCCCCCCCCEE
T ss_pred             CCCEEEcccCCceEEEEeCCCCCCeEEEEEEEecCCCCCCCcCCCCccc
Confidence            3687654 35678899999999999999999999999998888777554

>3mpc_A FN3-like protein; fibronectin, FN(III), unknown function; 1.60A {Clostridium thermocellum}

Probab=97.48  E-value=9.9e-05  Score=54.77  Aligned_cols=48  Identities=19%  Similarity=0.159  Sum_probs=40.3

Q ss_pred             CceEeee-eeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceec
Q psy12427          3 SWIRVGN-TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT   50 (356)
Q Consensus         3 ~w~~~~~-~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~   50 (356)
                      .|..++. ...|+++.++|.||+.|.|+|+|.|..|.|.+|......+.
T Consensus        46 ~~~~i~~~~~~tsy~d~~l~~g~~Y~Y~V~Avn~~geS~~S~~vs~~~~   94 (103)
T 3mpc_A           46 PYTTIATNITSTNYTDTGVATGTKYYYVVSAVSNGVETLNSAEAILQYP   94 (103)
T ss_dssp             CCEEEEEEECSSEEEETTCCTTCCCEEEEEEEETTEECCCCCCEECBCC
T ss_pred             CcEEEeecCCCCEEEECCCCCCCEEEEEEEEEeCcCCcCCCccEEEECC
Confidence            4776765 67899999999999999999999998888888887765543

>2vkw_A Neural cell adhesion molecule 1,140 kDa isoform; adhesion receptor; 2.3A {Homo sapiens} SCOP: b.1.2.1 b.1.2.1 PDB: 2vkx_A 1lwr_A

Probab=97.41  E-value=0.00012  Score=61.32  Aligned_cols=48  Identities=27%  Similarity=0.318  Sum_probs=39.5

Q ss_pred             CceEeeee-----eecceeeecCccCceEEEEEEEEecCCCCCCCCCccceec
Q psy12427          3 SWIRVGNT-----RFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT   50 (356)
Q Consensus         3 ~w~~~~~~-----~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~   50 (356)
                      .|..+...     ..+++++++|.|++.|.|||+|.|..|.|.+|..+.+.|.
T Consensus        53 ~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~A~n~~G~~~~s~~~~~~T~  105 (209)
T 2vkw_A           53 VWHSKWYDAKEASMEGIVTIVGLKPETTYAVRLAALNGKGLGEISAASEFKTQ  105 (209)
T ss_dssp             CCEEEEEEHHHHHHHSEEEECCCCTTCEEEEEEEEEETTEECCCCCCEEEECC
T ss_pred             CceEeEeeccCCCccceEEeCCCCCCCeEEEEEEEEcCCcccCCccccccccc
Confidence            56655432     3568999999999999999999999999999988876654

>2d9q_B Granulocyte colony-stimulating factor receptor; cytokine, ligand-receptor complex, signaling protein-cytokin; HET: NAG; 2.80A {Homo sapiens} SCOP: b.1.1.3 b.1.2.1 b.1.2.1

Probab=97.40  E-value=0.00019  Score=64.25  Aligned_cols=48  Identities=21%  Similarity=0.234  Sum_probs=39.1

Q ss_pred             CCceEee--eeeecceeeecCccCceEEEEEEEEecCCCCCCCCCcccee
Q psy12427          2 SSWIRVG--NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLIT   49 (356)
Q Consensus         2 ~~w~~~~--~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t   49 (356)
                      ..|..+.  ....++++|.+|.|++.|.|||||.|..|.|.+|.-|+...
T Consensus       253 ~~w~~~~~~~~~~~~~~l~~L~p~t~Y~~rVra~~~~g~G~wS~wS~~~~  302 (313)
T 2d9q_B          253 ASWALVGPLPLEALQYELCGLLPATAYTLQIRCIRWPLPGHWSDWSPSLE  302 (313)
T ss_dssp             CCCEEEEEECSCEEEEEECSCCSCCCEEEEEEEEECSSCCCCCCCCCCEE
T ss_pred             CCcEEcccccCcceEEEEeCCCCCCeEEEEEEeeECCCCCccCCCCCccc
Confidence            3587653  24567899999999999999999999999988887776544

>2ocf_D Fibronectin; estrogen receptor, LBD, monobody, estradiol, hormone-growth complex; HET: CME EST; 2.95A {Homo sapiens}

Probab=97.37  E-value=4e-05  Score=58.78  Aligned_cols=35  Identities=29%  Similarity=0.370  Sum_probs=30.8

Q ss_pred             eeeecceeeecCccCceEEEEEEEEecCCCCCCCC
Q psy12427          9 NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPST   43 (356)
Q Consensus         9 ~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~   43 (356)
                      ....++++|+||+|++.|.|+|+|.|..|.|.+|.
T Consensus        78 ~~~~t~~~l~gL~P~t~Y~~~V~A~~~~G~g~~Ss  112 (121)
T 2ocf_D           78 PGSKSTATISGLKPGVDYTITVYAVTGLRLMLAGS  112 (121)
T ss_dssp             ETTCCEEEECCCCTTCEEEEEEEEECCHHHHHHSC
T ss_pred             CCCcCEEEeCCCCCCCEEEEEEEEEeCCCccCCCC
Confidence            35678999999999999999999999999887654

>2dle_A Receptor-type tyrosine-protein phosphatase ETA; protein-tyrosine phosphatase ETA, R-PTP-ETA, HPTP ETA, protein-tyrosine phosphatase receptor type J; NMR {Homo sapiens}

Probab=97.34  E-value=0.0002  Score=53.23  Aligned_cols=27  Identities=22%  Similarity=0.185  Sum_probs=24.2

Q ss_pred             eeeeecceeeecCccCceEEEEEEEEe
Q psy12427          8 GNTRFTTMAITGLSPGHQYEFRVYAEN   34 (356)
Q Consensus         8 ~~~~~~~~~v~~L~p~~~y~frv~a~n   34 (356)
                      ..+..|+++|+||+|||.|.|+|+|..
T Consensus        54 ~~~~~t~~~i~gL~PgT~Y~~~V~A~~   80 (104)
T 2dle_A           54 LNVSEPRAVIPGLRSSTFYNITVCPVL   80 (104)
T ss_dssp             EEESSSEEECCSCCSSCEEEEEEEEES
T ss_pred             EcCCCCEEEECCCCCCCEEEEEEEEEE
Confidence            456788999999999999999999994

>2nzi_A Titin; IG-domain, FNIII-domain, transferase; 2.90A {Homo sapiens}

Probab=97.34  E-value=0.0002  Score=63.43  Aligned_cols=52  Identities=40%  Similarity=0.652  Sum_probs=46.0

Q ss_pred             CCceEeeeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceechhh
Q psy12427          2 SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDT   53 (356)
Q Consensus         2 ~~w~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~~~   53 (356)
                      ..|........++++|.+|.|++.|.|||+|.|..|.|.+|..++..+.++.
T Consensus       243 ~~w~~~~~~~~~~~~i~~l~~~~~y~~~~~A~N~~G~~~~S~~~~~~~t~~~  294 (305)
T 2nzi_A          243 ERWLRVGQARETRYTVINLFGKTSYQFRVIAENKFGLSKPSEPSEPTITKED  294 (305)
T ss_dssp             CCEEEEEEESSSEEEECSCCSSCEEEEEEEEEETTEECCCCCCCCCEECCC-
T ss_pred             CccEECccccCceEEecCCCCCCeEEEEEEEEeCCcccCCcCCCCCEEcCCc
Confidence            3688887777889999999999999999999999999999999998876653

>2ibg_A CG9211-PA, GH03927P; IHOG, fibronectin type III, protein binding; 2.20A {Drosophila melanogaster} SCOP: b.1.2.1 b.1.2.1 PDB: 2ibb_A

Probab=97.34  E-value=0.00018  Score=60.43  Aligned_cols=39  Identities=31%  Similarity=0.416  Sum_probs=34.1

Q ss_pred             eeecceeeecCccCceEEEEEEEEecCCCCCCCCCccce
Q psy12427         10 TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLI   48 (356)
Q Consensus        10 ~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~   48 (356)
                      ...+++++++|.|++.|.|||+|.|..|.+.+|..+...
T Consensus        67 ~~~~~~~i~~L~p~t~Y~~~V~A~n~~g~~~~s~~s~~~  105 (214)
T 2ibg_A           67 GKSFTASVTDLKPQHTYRFRILAVYSNNDNKESNTSAKF  105 (214)
T ss_dssp             EEEEEEEECSCCTTCEEEEEEEEEETTSCEEECCCCCCE
T ss_pred             CcceeEEecCCcCCCEEEEEEEEEecCCCCCCCCCcccE
Confidence            567889999999999999999999999998888766543

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.33  E-value=0.0015  Score=58.67  Aligned_cols=75  Identities=13%  Similarity=0.144  Sum_probs=48.2

Q ss_pred             cccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCC--Cceeeeee-----EEeCCeEEEEEEec
Q psy12427        115 EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHP--KLINLHDA-----FEDDDEMVLIFEFL  187 (356)
Q Consensus       115 ~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hp--nIv~l~~~-----~~~~~~~~lv~e~~  187 (356)
                      .|+ |....||++... +|..+++|+..... .....+..|..++..+...  .+++++..     ....+..+++|+|+
T Consensus        33 ~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEC-CSSSEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             eec-CcccceEEEEcC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            456 888899987543 46678999886332 1345667788888887421  23444432     23356678899999


Q ss_pred             cccch
Q psy12427        188 SGGEL  192 (356)
Q Consensus       188 ~~g~L  192 (356)
                      +|..+
T Consensus       110 ~G~~~  114 (328)
T 1zyl_A          110 GGRQF  114 (328)
T ss_dssp             CCEEC
T ss_pred             CCCCC
Confidence            88654

>2ekj_A Collagen alpha-1(XX) chain; KIAA1510, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens}

Probab=97.32  E-value=3.8e-05  Score=57.11  Aligned_cols=37  Identities=19%  Similarity=0.269  Sum_probs=33.0

Q ss_pred             eeeecceeeecCccCceEEEEEEEEecCCCCCCCCCc
Q psy12427          9 NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTS   45 (356)
Q Consensus         9 ~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s   45 (356)
                      ....++++|+||+|++.|.|+|+|.|..|.|.++...
T Consensus        57 ~~~~~~~~l~~L~p~t~Y~~~V~A~~~~g~g~~s~~~   93 (105)
T 2ekj_A           57 PGARSHVTLPDLQAATKYRVLVSAIYAAGRSEAVSAT   93 (105)
T ss_dssp             BTTSSEEEECSCCSSCCCBCBBCBBCSSCBCCCBCCB
T ss_pred             CCCcCEEEeCCCCCCCEEEEEEEEEeCCccCCccccE
Confidence            3567899999999999999999999999999987654

>3p4l_A Neogenin; iron homeostasis, hemojuvelin receptor, FNIII domain, fibron type III, cell adhesion; 1.80A {Homo sapiens} PDB: 1x5k_A

Probab=97.32  E-value=0.00018  Score=60.32  Aligned_cols=44  Identities=30%  Similarity=0.296  Sum_probs=38.1

Q ss_pred             eeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceech
Q psy12427          8 GNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK   51 (356)
Q Consensus         8 ~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~   51 (356)
                      .....+++++++|+|++.|.|||+|.|..|.|.+|....+.|..
T Consensus        59 ~~~~~~~~~i~~L~p~t~Y~~~V~A~n~~g~~~~S~~~~~~t~~  102 (211)
T 3p4l_A           59 ANATTLSYLVTGLKPNTLYEFSVMVTKGRRSSTWSMTAHGTTFE  102 (211)
T ss_dssp             EEESSSEEEECSCCTTCEEEEEEEEEETTEECCCCCCEEEECCC
T ss_pred             eCCCceEEEecCcCCCCEEEEEEEEEcCCCCCccceeEeeeccc
Confidence            35677899999999999999999999999999988877766643

>1oww_A FN, fibronectin first type III module, CIG; fibronectin type III module, structural protein; NMR {Homo sapiens} SCOP: b.1.2.1

Probab=97.30  E-value=0.00015  Score=51.13  Aligned_cols=47  Identities=26%  Similarity=0.482  Sum_probs=40.1

Q ss_pred             CCceEeee-eeecceeeecCccCceEEEEEEEEecCCCCCCCCCcccee
Q psy12427          2 SSWIRVGN-TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLIT   49 (356)
Q Consensus         2 ~~w~~~~~-~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t   49 (356)
                      ..|..+.- .--.+|+|+||+||..|-.+|.+.|.+|.++.+ ..++.|
T Consensus        49 g~Wke~~Ip~h~nSYtI~GL~P~~~YE~qv~S~~ryG~~Evs-~f~FtT   96 (98)
T 1oww_A           49 GRWKEATIPGHLNSYTIKGLKPGVVYEGQLISIQQYGHQEVT-RFDFTT   96 (98)
T ss_dssp             SCCEEEEECSSCCEEEECSCCSSEEEEEEEEEEESSSCEEEE-EEEEEE
T ss_pred             CceeEEEecCccceEEEecCCCCcEEEEEEEEeeccCcccce-EEEEEe
Confidence            36887764 677899999999999999999999999999988 556554

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.30  E-value=0.00087  Score=60.92  Aligned_cols=69  Identities=12%  Similarity=0.130  Sum_probs=44.5

Q ss_pred             ccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcC---CCCceeeeee------EEeCCeEEEEEEe
Q psy12427        116 IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLH---HPKLINLHDA------FEDDDEMVLIFEF  186 (356)
Q Consensus       116 lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~------~~~~~~~~lv~e~  186 (356)
                      .|.|....||++... +| .+++|+......      ..|+.+++.|.   -|++++++..      ....+..+++|+|
T Consensus        31 ~G~g~~N~vy~v~~~-~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~  102 (339)
T 3i1a_A           31 GGADTNAFAYQADSE-SK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPF  102 (339)
T ss_dssp             TTSCSSCEEEEEECS-SC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEEC
T ss_pred             ccCccccceEEEEeC-CC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEec
Confidence            345557899998654 34 899998765432      35666666663   2334454432      2345778999999


Q ss_pred             ccccch
Q psy12427        187 LSGGEL  192 (356)
Q Consensus       187 ~~~g~L  192 (356)
                      ++|..+
T Consensus       103 i~G~~~  108 (339)
T 3i1a_A          103 IHAPNG  108 (339)
T ss_dssp             CCCCBT
T ss_pred             cCCCcC
Confidence            998765

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.29  E-value=0.00046  Score=62.40  Aligned_cols=35  Identities=23%  Similarity=0.279  Sum_probs=27.7

Q ss_pred             CCceeccCCCCCEEEeecC--CCcEEEEeeeceeeeC
Q psy12427        230 KNIIHLDVKPENIMCQTRN--STNVKMIDFGLATKLD  264 (356)
Q Consensus       230 ~~ivH~Dlkp~NIlv~~~~--~~~vkl~Dfg~a~~~~  264 (356)
                      ..++|+|+.+.|||++.+.  ...+.|+||+.+..-+
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence            4699999999999997531  1368999999887654

>3lpw_A A77-A78 domain from titin; intracellular FNIII-tandem, structural protein; 1.65A {Homo sapiens}

Probab=97.29  E-value=0.00022  Score=58.70  Aligned_cols=48  Identities=33%  Similarity=0.520  Sum_probs=40.7

Q ss_pred             CceEee-eeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceec
Q psy12427          3 SWIRVG-NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT   50 (356)
Q Consensus         3 ~w~~~~-~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~   50 (356)
                      .|..+. ....+++++++|.|++.|.|||+|.|..|.|.++......+.
T Consensus        51 ~~~~~~~~~~~~~~~~~~L~p~t~Y~~~V~a~~~~g~~~~s~~~~~~t~   99 (197)
T 3lpw_A           51 AYSTVATNCHKTSWKVDQLQEGCSYYFRVLAENEYGIGLPAETAESVKA   99 (197)
T ss_dssp             SCEEEEEEECSSEEEECCCCTTCEEEEEEEEEETTEECCCEECSSCEES
T ss_pred             ccEEeecCCCccEEEEcCCCCCCEEEEEEEEEcCccccCCCCCccceec
Confidence            566665 478899999999999999999999999999998877666554

>2cuh_A Tenascin-X; fibronectin type III domain, extracellular matrix, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.1.2.1

Probab=97.22  E-value=0.00025  Score=53.54  Aligned_cols=34  Identities=12%  Similarity=0.053  Sum_probs=29.3

Q ss_pred             eeeecceeeecCccCceEEEEEEEEecCCCCCCC
Q psy12427          9 NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPS   42 (356)
Q Consensus         9 ~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s   42 (356)
                      ....++++|+||+|++.|.|+|+|.|..|.+.+.
T Consensus        55 ~~~~t~~~l~~L~P~t~Y~~~V~A~~~~~~s~~~   88 (115)
T 2cuh_A           55 PGSAVDYPLHDLVLHTNYTATVRGLRGPNLTSPA   88 (115)
T ss_dssp             ETTCSEEEECSCCSSSEEEEEEEEEETTEECCCE
T ss_pred             CCCccEEEEeCCCCCCEEEEEEEEEeCCCcCCCE
Confidence            3567899999999999999999999988766654

>3f7q_A Integrin beta-4, GP150; hemidesmosome, cell adhesion, carcinoma, epidermolysis bullosa, alternative splicing, disease mutation, glycoprotein; HET: 1PE PG4; 1.75A {Homo sapiens} PDB: 3f7r_A 3f7p_C 1qg3_A

Probab=97.15  E-value=0.0003  Score=60.06  Aligned_cols=44  Identities=23%  Similarity=0.297  Sum_probs=38.1

Q ss_pred             eeeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceec
Q psy12427          7 VGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT   50 (356)
Q Consensus         7 ~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~   50 (356)
                      ......++++|++|.|++.|.|||+|.|..|.|.+|....+.|.
T Consensus        52 ~~~~~~~~~~i~~L~p~t~Y~~~V~A~n~~G~g~~s~~~~~~T~   95 (234)
T 3f7q_A           52 LLDSKVPSVELTNLYPYCDYEMKVCAYGAQGEGPYSSLVSCRTH   95 (234)
T ss_dssp             EEEESSSEEEECSCCTTCEEEEEEEEEETTEECCCCCCEEEECC
T ss_pred             EEcCCccEEEECCCCCCCEEEEEEEEEeCCCcCCCCCeEEEEcC
Confidence            34577889999999999999999999999999998877766654

>2ee3_A Collagen alpha-1(XX) chain; KIAA1510, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens}

Probab=97.14  E-value=0.00018  Score=53.86  Aligned_cols=35  Identities=26%  Similarity=0.178  Sum_probs=31.4

Q ss_pred             eeecceeeecCccCceEEEEEEEEecCCCCCCCCC
Q psy12427         10 TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTT   44 (356)
Q Consensus        10 ~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~   44 (356)
                      ...+++++++|+|++.|.|+|+|.|..|.|.++..
T Consensus        57 ~~~t~~~l~~L~p~T~Y~v~V~A~~~~g~s~p~~~   91 (108)
T 2ee3_A           57 GNATSAMLGPLSSSTTYTVRVTCLYPGGGSSTLTG   91 (108)
T ss_dssp             TTCCEEEECSCCSSCEEEEEEEEECTTSCEEEEEE
T ss_pred             CCcCEEEcCCCCCCCEEEEEEEEEeCCCcCCCccC
Confidence            45689999999999999999999999999888754

>1cfb_A Drosophila neuroglian; neural adhesion molecule; HET: NAG; 2.00A {Drosophila melanogaster} SCOP: b.1.2.1 b.1.2.1

Probab=97.12  E-value=0.00039  Score=57.92  Aligned_cols=48  Identities=31%  Similarity=0.445  Sum_probs=36.0

Q ss_pred             CCceEeee---eeecceeeecCccCceEEEEEEEEecCCCCCCCC-Cccceec
Q psy12427          2 SSWIRVGN---TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPST-TSDLITT   50 (356)
Q Consensus         2 ~~w~~~~~---~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~-~s~~~t~   50 (356)
                      ..|..+..   ...+++.+ +|.|++.|.|||+|.|..|.|.+|. ...+.|.
T Consensus        49 ~~w~~~~~~~~~~~~~~~~-~L~p~t~Y~~~V~A~n~~G~~~~s~~~~~~~T~  100 (205)
T 1cfb_A           49 ASWDAAYEKVPNTDSSFVV-QMSPWANYTFRVIAFNKIGASPPSAHSDSCTTQ  100 (205)
T ss_dssp             TCCEEEEEEEETTCSEEEE-ECCSSEEEEEEEEEEETTEECCCCCCCCCEEEC
T ss_pred             CCceeeeeccCCCceEEEE-eCCCCCEEEEEEEEEECCccCCCCCCceeEEcC
Confidence            35754432   34566776 9999999999999999999999994 4555554

>3f7q_A Integrin beta-4, GP150; hemidesmosome, cell adhesion, carcinoma, epidermolysis bullosa, alternative splicing, disease mutation, glycoprotein; HET: 1PE PG4; 1.75A {Homo sapiens} PDB: 3f7r_A 3f7p_C 1qg3_A

Probab=97.03  E-value=0.00024  Score=60.73  Aligned_cols=40  Identities=23%  Similarity=0.298  Sum_probs=34.0

Q ss_pred             eeecceeeecCccCceEEEEEEEEecCCCCCCCCC-cccee
Q psy12427         10 TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTT-SDLIT   49 (356)
Q Consensus        10 ~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~-s~~~t   49 (356)
                      ...++++|+||+|++.|.|||+|.|..|.|.+|.+ ..+.|
T Consensus       157 ~~~~~~~i~~L~p~t~Y~~~V~A~n~~G~g~~S~~~~~~~T  197 (234)
T 3f7q_A          157 PKNRMLLIENLRESQPYRYTVKARNGAGWGPEREAIINLAT  197 (234)
T ss_dssp             TTCCEEEEECCCTTCCEEEEEEEEETTEECCCEEEEECGGG
T ss_pred             CcceEEEeCCCCCCCeEEEEEEEECCCccCCCcCceeEeec
Confidence            45578999999999999999999999999998874 44444

>2cui_A Tenascin-X; fibronectin type III domain, extracellular matirx, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.1.2.1

Probab=97.02  E-value=0.00031  Score=52.91  Aligned_cols=34  Identities=15%  Similarity=0.217  Sum_probs=28.0

Q ss_pred             eeeeecceeeecCccCceEEEEEEEEecCCCCCC
Q psy12427          8 GNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDP   41 (356)
Q Consensus         8 ~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~   41 (356)
                      .....++++|+||+|++.|.|+|+|.+..+.|.+
T Consensus        65 v~~~~t~~~l~gL~PgT~Y~~~V~A~~~~~~s~p   98 (112)
T 2cui_A           65 VPGTRHSAVLRDLRSGTLYSLTLYGLRGPHKADS   98 (112)
T ss_dssp             EETTCCEEEECSCCTTCEEEEEEEEECSSSEEEE
T ss_pred             cCCCcCEEEeCCCCCCCEEEEEEEEEECCcccCC
Confidence            3466789999999999999999999987655443

>1zlg_A Anosmin 1; insulin-like growth factor receptor Cys-rich fold, WHEY acidic protein fold, fibronectin type III fold, hormone- growth factor complex; NMR {Homo sapiens}

Probab=96.97  E-value=0.00069  Score=67.64  Aligned_cols=44  Identities=32%  Similarity=0.498  Sum_probs=37.1

Q ss_pred             CCceEeeeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCc
Q psy12427          2 SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTS   45 (356)
Q Consensus         2 ~~w~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s   45 (356)
                      ..|..+..+..++++|++|.|++.|.|||+|.|..|.+.++..+
T Consensus       212 ~~w~~v~~~~~~~~~i~~L~P~t~Y~frV~A~n~~G~~~~ss~s  255 (680)
T 1zlg_A          212 THWQTVAQTTDERVQLTDIRPSRWYQFRVAAVNVHGTRGFTAPS  255 (680)
T ss_pred             CceEEEEecCCCeEEeCCCCCCCEEEEEEEEEeCCCCCCCCCCc
Confidence            46988887788899999999999999999999999955544444

>3qwq_B Adnectin; cell surface receptor, tyrosine kinase, glycoprotein, adnect antitumor, drug, engineered binding protein; HET: NAG BMA MAN FUC; 2.75A {Homo sapiens} PDB: 3qwr_D*

Probab=96.95  E-value=0.0005  Score=51.91  Aligned_cols=29  Identities=34%  Similarity=0.496  Sum_probs=26.8

Q ss_pred             eeeecceeeecCccCceEEEEEEEEecCC
Q psy12427          9 NTRFTTMAITGLSPGHQYEFRVYAENVYG   37 (356)
Q Consensus         9 ~~~~~~~~v~~L~p~~~y~frv~a~n~~g   37 (356)
                      ....++++|+||+|++.|.|+|+|.|..|
T Consensus        53 ~~~~ts~~l~gL~P~T~Y~v~V~A~~~~G   81 (114)
T 3qwq_B           53 PGPVHTATISGLKPGVDYTITVYAVTDHK   81 (114)
T ss_dssp             ETTCCEEEECSCCTTCEEEEEEEEEEEEE
T ss_pred             CCCcCEEEeCCCCCCCEEEEEEEEEECCc
Confidence            35678999999999999999999999999

>2ha1_A Fibronectin; beta sandwich, protein-protein complex, rigid BODY docking, cell adhesion, structural protein; NMR {Homo sapiens}

Probab=96.82  E-value=0.00052  Score=56.98  Aligned_cols=40  Identities=25%  Similarity=0.517  Sum_probs=33.0

Q ss_pred             CceEeee-eeecceeeecCccCceEEEEEEEEecCCCCCCC
Q psy12427          3 SWIRVGN-TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPS   42 (356)
Q Consensus         3 ~w~~~~~-~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s   42 (356)
                      .|..+.. ...++++|+||+|++.|.|||+|.|..|.+.++
T Consensus        45 ~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~a~n~~G~~~~~   85 (201)
T 2ha1_A           45 RWKEATIPGHLNSYTIKGLKPGVVYEGQLISIQQYGHQEVT   85 (201)
T ss_dssp             CCEEEEECTTCCEEEECSCCTTEEEEEEEEEECTTSCEEEE
T ss_pred             ceEEEecCCCccEEEecCCCCCCEEEEEEEEEecccccCce
Confidence            3555432 457899999999999999999999999998764

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.82  E-value=0.0029  Score=59.18  Aligned_cols=75  Identities=16%  Similarity=0.106  Sum_probs=48.9

Q ss_pred             eccccccCceEEEEEEEccC-------CCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCC-ceeeeeeEEeCCeEEEEE
Q psy12427        113 LEEIGTGAFGVVHRCRERKT-------GNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPK-LINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       113 ~~~lg~G~fg~V~~~~~~~~-------~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~~~lv~  184 (356)
                      .+.|..|-...+|++.....       +..+++++...... ..-+..+|..+++.+.-.+ ..++++.+  .  -++|+
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence            45678899999999987531       57899998644321 1112346888888884322 34556543  2  27899


Q ss_pred             Eeccccch
Q psy12427        185 EFLSGGEL  192 (356)
Q Consensus       185 e~~~~g~L  192 (356)
                      ||++|..|
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998765

>3up1_A Interleukin-7 receptor subunit alpha; cytokine receptor, fibronectin type 3 fold, membrane and SOL glycosylation, immune system; HET: NAG FUC NGA; 2.15A {Homo sapiens} PDB: 3di3_B* 3di2_B*

Probab=96.78  E-value=0.0017  Score=55.13  Aligned_cols=49  Identities=24%  Similarity=0.235  Sum_probs=35.2

Q ss_pred             CCceEeeeeeeccee--eecCccCceEEEEEEEEec----CCCCCCCCCccceech
Q psy12427          2 SSWIRVGNTRFTTMA--ITGLSPGHQYEFRVYAENV----YGRSDPSTTSDLITTK   51 (356)
Q Consensus         2 ~~w~~~~~~~~~~~~--v~~L~p~~~y~frv~a~n~----~g~s~~s~~s~~~t~~   51 (356)
                      ..|..+ ....++.+  +.+|.|++.|.|||||...    .+.|++|.+..+.|..
T Consensus       160 ~~W~~v-~~~~t~~~i~l~~L~Pgt~Y~vqVR~r~~~~~~G~WSeWS~~~~~~T~~  214 (223)
T 3up1_A          160 NKWTHV-NLSSTKLTLLQRKLQPAAMYEIKVRSIPDHYFKGFWSEWSPSYYFRTPE  214 (223)
T ss_dssp             SCCEEE-EESSSEEEEEGGGSCTTCEEEEEEEEEECSSCCBCCCCCCCCEEEECCC
T ss_pred             CceEEE-EecCceeEEeccccCCCcEEEEEEEEeeCCCCCCCCCCCCCCeEEECCC
Confidence            357654 44455544  4699999999999999986    2467888877776643

>2h41_A Fibronectin; beta sandwich, cell adhesion, structural protein; NMR {Homo sapiens} PDB: 2h45_A

Probab=96.54  E-value=0.0015  Score=47.50  Aligned_cols=33  Identities=27%  Similarity=0.417  Sum_probs=27.8

Q ss_pred             eeeecceeeecCccCceEEEEEEEEecCCCCCC
Q psy12427          9 NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDP   41 (356)
Q Consensus         9 ~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~   41 (356)
                      ....++++++||.||+.|.+.|+|.+..+.|.|
T Consensus        55 ~g~~~s~~l~~L~PgT~Y~V~v~a~~~~~~S~p   87 (95)
T 2h41_A           55 PSTATSVNIPDLLPGRKYIVNVYQISEDGEQSL   87 (95)
T ss_dssp             ETTCCEEEECSCCTTCEEEEEEEEEETTSCEEE
T ss_pred             CCCccEEEECCCCCCCEEEEEEEEEcCCCcccC
Confidence            356789999999999999999999987666553

>2erj_C Cytokine receptor common gamma chain; immune system-cytok complex; HET: NAG FUC BMA; 3.00A {Homo sapiens} SCOP: b.1.2.1 b.1.2.1

Probab=96.52  E-value=0.0026  Score=54.97  Aligned_cols=47  Identities=17%  Similarity=0.147  Sum_probs=35.4

Q ss_pred             CceEeeeeeecceeeecCccCceEEEEEEEEecCC------CCCCCCCcccee
Q psy12427          3 SWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYG------RSDPSTTSDLIT   49 (356)
Q Consensus         3 ~w~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g------~s~~s~~s~~~t   49 (356)
                      .|..+.....+++.+.+|.|++.|.|||||....|      .|++|++..+.+
T Consensus       179 ~W~~~~~~~~~~~~l~~L~p~~~Y~vqVR~k~~~~~~~~g~WSeWS~~~~~~t  231 (247)
T 2erj_C          179 SWTEQSVDYRHKFSLPSVDGQKRYTFRVRSRFNPLCGSAQHWSEWSHPIHWGS  231 (247)
T ss_dssp             SCEEEEECSSCEEEESCCCTTSCEEEEEEEEECSSSCCCCCCCCCCCCEEECC
T ss_pred             CCEEEecCCceEEEecCCCCCCEEEEEEEEEeCCCCCCCCccCCCCcCEEEEC
Confidence            68766555678899999999999999999998653      355555554444

>1q38_A Fibronectin; amyloid fibril, anastellin, extracellular matrix, dynamic fluctuations, conformational exchange, chaps, cell adhesion; NMR {Homo sapiens} SCOP: b.1.2.1

Probab=96.51  E-value=0.0024  Score=43.59  Aligned_cols=40  Identities=25%  Similarity=0.507  Sum_probs=34.1

Q ss_pred             CCceEeee-eeecceeeecCccCceEEEEEEEEecCCCCCC
Q psy12427          2 SSWIRVGN-TRFTTMAITGLSPGHQYEFRVYAENVYGRSDP   41 (356)
Q Consensus         2 ~~w~~~~~-~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~   41 (356)
                      ..|..+.- ....||+|.||+||+.|--++++.-.+|.+++
T Consensus        26 ~~wKev~IPgh~nSYtIsGLkPGvtYegQLisV~r~g~~Ev   66 (89)
T 1q38_A           26 GRWKEATIPGHLNSYTIKGLKPGVVYEGQLISIQQYGHQEV   66 (89)
T ss_dssp             CCCEEEEECSSSSCCCCCCCCTTCCEEEEEEEECTTSCCCE
T ss_pred             CccEEEEcCCccceEEEeccCCCcEEEEEEEeeeecccCCc
Confidence            35777765 56889999999999999999999988888774

>3l5h_A Interleukin-6 receptor subunit beta; IG-like, FNIII, cell membrane, disulfide bond, glycoprotein, immunoglobulin domain, membrane, phosphoprotein; HET: NAG NDG BMA FUC; 3.60A {Homo sapiens}

Probab=96.42  E-value=0.0023  Score=62.32  Aligned_cols=45  Identities=20%  Similarity=0.351  Sum_probs=35.8

Q ss_pred             CceEee----eeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccc
Q psy12427          3 SWIRVG----NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDL   47 (356)
Q Consensus         3 ~w~~~~----~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~   47 (356)
                      .|..+.    ....+++++.+|.|++.|.|||+|.|..|.|.+|..|+.
T Consensus       245 ~w~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~a~~~~g~g~~S~~S~~  293 (589)
T 3l5h_A          245 TWSQIPPEDTASTRSSFTVQDLKPFTEYVFRIRCMKEDGKGYWSDWSEE  293 (589)
T ss_dssp             CCBCCCTTSSCSCCSEEEECSCCSSCCEEEEEEEEESSSCSCCCCCCCC
T ss_pred             CcEEEccccCcCceeEEEECCCCCCCEEEEEEEEEeCCCCCccCCCCCc
Confidence            466552    245689999999999999999999999998777655543

>3s98_A Interferon alpha/beta receptor 1; human, type I interferons, receptor chain, ifnar1, fibronect III, type I interferon receptor chain; HET: NAG; 1.90A {Homo sapiens}

Probab=96.42  E-value=0.0026  Score=56.78  Aligned_cols=44  Identities=23%  Similarity=0.208  Sum_probs=38.0

Q ss_pred             eeeecceeeecCccCceEEEEEEEEe--cCCCCCCCCCccceechh
Q psy12427          9 NTRFTTMAITGLSPGHQYEFRVYAEN--VYGRSDPSTTSDLITTKD   52 (356)
Q Consensus         9 ~~~~~~~~v~~L~p~~~y~frv~a~n--~~g~s~~s~~s~~~t~~~   52 (356)
                      .+..++++|.+|+|++.|.|+|+|.|  ..|.|.+|.+....|..+
T Consensus       155 ~~~~~~~~l~~L~p~t~Y~~~V~A~~~~~~g~g~~S~~~~~~T~~~  200 (306)
T 3s98_A          155 ENIYSRHKIYKLSPETTYCLKVKAALLTSWKIGVYSPVHCIKTTVE  200 (306)
T ss_dssp             EEECTEEEECSCCTTCEEEEEEEEEEGGGTEECCCCCCEEEECCSC
T ss_pred             ecccceEEEccCCCCCeEEEEEEEEEccCCCCCCCCCcEeeEecCC
Confidence            35678999999999999999999999  679999999888777543

>3l5i_A Interleukin-6 receptor subunit beta; cytokine receptor, fibronectin type III domain, alternative cell membrane, disulfide bond; 1.90A {Homo sapiens} PDB: 3l5j_A

Probab=96.41  E-value=0.0015  Score=57.30  Aligned_cols=39  Identities=21%  Similarity=0.259  Sum_probs=33.9

Q ss_pred             CceEeeeeeecceeeecCccCceEEEEEEEEecCCCCCC
Q psy12427          3 SWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDP   41 (356)
Q Consensus         3 ~w~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~   41 (356)
                      .|..+.....+++++++|.|++.|.|||+|.|..|.|.+
T Consensus       147 ~~~~~~~~~~~~~~~~~L~p~t~Y~~~V~A~n~~g~g~~  185 (290)
T 3l5i_A          147 DWQQEDGTVHRTYLRGNLAESKCYLITVTPVYADGPGSP  185 (290)
T ss_dssp             EEEEEETTCSEEECCSCCCTTCEEEEEEEEEETTEECCC
T ss_pred             CeEEccCCCcceEEecCcCCccEEEEEEEEEeCCccccc
Confidence            377776667778899999999999999999999998874

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.33  E-value=0.011  Score=49.65  Aligned_cols=124  Identities=12%  Similarity=0.097  Sum_probs=75.8

Q ss_pred             ccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCC
Q psy12427        189 GGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE-KNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE  267 (356)
Q Consensus       189 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~  267 (356)
                      .-+|.++|...+..+++.+++.     ++.|.+.+|+-+-. ..-..+=+.|..|++..+|  .|-+.+ +.+.      
T Consensus        32 ~vSL~eIL~~~~~PlsEEqaWA-----Lc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG--~V~f~~-~~s~------   97 (229)
T 2yle_A           32 ALSLEEILRLYNQPINEEQAWA-----VCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDG--AVTLAP-AADD------   97 (229)
T ss_dssp             EEEHHHHHHHHTSCCCHHHHHH-----HHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTS--CEEECC-C---------
T ss_pred             cccHHHHHHHcCCCcCHHHHHH-----HHHHHHHHHHhhhhcccCCceecCCcceEEecCC--ceeccc-cccc------
Confidence            3478888887777777777755     99999998877622 2222344456888887665  344332 1110      


Q ss_pred             ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHHH
Q psy12427        268 VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFI  347 (356)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI  347 (356)
                           .....+.|||... ...+.+.=|||||+++|..+-                     |..++.....+|+++.+||
T Consensus        98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD---------------------ygL~e~eE~eLS~~LE~LL  150 (229)
T 2yle_A           98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD---------------------YGLKENEERELSPPLEQLI  150 (229)
T ss_dssp             --------------CCSS-SSSCHHHHHHHHHHHHHHHHT---------------------TTCCTTEEECCCHHHHHHH
T ss_pred             -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh---------------------cCCCcccchhhCHHHHHHH
Confidence                 1233566888763 345677889999999998764                     2233333357899999999


Q ss_pred             HHhhhc
Q psy12427        348 RRLLLR  353 (356)
Q Consensus       348 ~~ll~~  353 (356)
                      ..|..-
T Consensus       151 ~~Mt~~  156 (229)
T 2yle_A          151 DHMANT  156 (229)
T ss_dssp             HHHTTC
T ss_pred             HHHHhc
Confidence            888654

>1qr4_A Protein (tenascin); fibronectin type-III, heparin, extracellular matrix, adhesion, fusion protein, structural protein; 2.55A {Gallus gallus} SCOP: b.1.2.1 b.1.2.1

Probab=96.30  E-value=0.0037  Score=50.91  Aligned_cols=32  Identities=28%  Similarity=0.482  Sum_probs=27.0

Q ss_pred             eeecceeeecCccCceEEEEEEEEecCCCCCC
Q psy12427         10 TRFTTMAITGLSPGHQYEFRVYAENVYGRSDP   41 (356)
Q Consensus        10 ~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~   41 (356)
                      ...+++++++|.|++.|.|||+|.|..|.|.+
T Consensus        55 ~~~~~~~i~~L~p~t~Y~~~V~a~~~~~~s~~   86 (186)
T 1qr4_A           55 VDSTSFILRGLDAGTEYTISLVAEKGRHKSKP   86 (186)
T ss_dssp             TTCSEEEEESCCSSCEEEEEEEEESSSCBCCC
T ss_pred             CCCCEEEECCCCCCCEEEEEEEEEcCCccCCC
Confidence            45688999999999999999999997665544

>2gee_A Hypothetical protein; fibronectin, EIIIB, cancer, neovascularization, cell adhesion, protein binding, oncoprotein; 2.01A {Homo sapiens} PDB: 2fnb_A

Probab=96.27  E-value=0.003  Score=52.47  Aligned_cols=33  Identities=33%  Similarity=0.629  Sum_probs=29.0

Q ss_pred             eeecceeeecCccCceEEEEEEEEecCCCCCCC
Q psy12427         10 TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPS   42 (356)
Q Consensus        10 ~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s   42 (356)
                      ...+++++++|.|++.|.|+|+|.|..|.|.+.
T Consensus        74 ~~~~~~~i~~L~p~t~Y~~~V~a~~~~g~s~~~  106 (203)
T 2gee_A           74 SSVGYYTVTGLEPGIDYDISVYTVKNGGESTPT  106 (203)
T ss_dssp             TTCCEEEECSCCTTCEEEEEEEEESSSCBCCCE
T ss_pred             CCccEEEeCCCCCCCEEEEEEEEEeCCCccccE
Confidence            567899999999999999999999988876554

>1zlg_A Anosmin 1; insulin-like growth factor receptor Cys-rich fold, WHEY acidic protein fold, fibronectin type III fold, hormone- growth factor complex; NMR {Homo sapiens}

Probab=96.25  E-value=0.0035  Score=62.50  Aligned_cols=42  Identities=14%  Similarity=0.210  Sum_probs=35.2

Q ss_pred             CceEee-eeeecceeeecCccCceEEEEEEEEecCCCCCCCCC
Q psy12427          3 SWIRVG-NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTT   44 (356)
Q Consensus         3 ~w~~~~-~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~   44 (356)
                      .|.... ....++++|++|.|++.|.|||+|.|..|.|.+|..
T Consensus       323 ~~~~~~v~~~~~~~~l~~L~p~t~Y~~~V~A~n~~G~g~~S~~  365 (680)
T 1zlg_A          323 KKRRKTTDGFQNSVILEKLQPDCDYVVELQAITYWGQTRLKSA  365 (680)
T ss_pred             ceEEEEEcCCeeEEEeCCCCCCCEEEEEEEEEECCCcCCCCCC
Confidence            455443 245589999999999999999999999999988877

>2b5i_C Cytokine receptor common gamma chain; four-helix bundle, fibronectin domain, cytokine-cytokine REC complex; HET: NAG; 2.30A {Homo sapiens} SCOP: b.1.2.1 b.1.2.1 PDB: 3bpl_C* 3qb7_C* 3qaz_C*

Probab=96.16  E-value=0.0067  Score=50.35  Aligned_cols=44  Identities=16%  Similarity=0.195  Sum_probs=33.3

Q ss_pred             CceEeeeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCcc
Q psy12427          3 SWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSD   46 (356)
Q Consensus         3 ~w~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~   46 (356)
                      .|..+.....+++.+.+|.|++.|.|||||....|.+..+.=|+
T Consensus       141 ~w~~~~~~~~~~~~l~~l~p~~~Y~vqVR~~~~~~~~~~g~WSe  184 (199)
T 2b5i_C          141 SWTEQSVDYRHKFSLPSVDGQKRYTFRVRSRFNPLCGSAQHWSE  184 (199)
T ss_dssp             SCEEEEECSSCEEEECSCCTTSCEEEEEEEECCSSSCCCCCCCC
T ss_pred             ccEEEeccCceEEEecCCCCCcEEEEEEEEeccCCcCcCCeECC
Confidence            58766555568899999999999999999998765444444333

>3tgx_A Interleukin-21 receptor; class I cytokine, class I cytokine receptor, sugarbridge, fibronectine domain, signaling, cytokine-cytokine receptor; HET: MAN FUL NAG BMA FUC; 2.80A {Homo sapiens}

Probab=96.14  E-value=0.0043  Score=52.50  Aligned_cols=43  Identities=19%  Similarity=0.175  Sum_probs=32.7

Q ss_pred             ecceeeecCccCceEEEEEEEEecCC------CCCCCCCccceechhhh
Q psy12427         12 FTTMAITGLSPGHQYEFRVYAENVYG------RSDPSTTSDLITTKDTF   54 (356)
Q Consensus        12 ~~~~~v~~L~p~~~y~frv~a~n~~g------~s~~s~~s~~~t~~~~~   54 (356)
                      .+++.+.+|.||+.|.|||||....|      .|++|++..+.|.....
T Consensus       163 ~~~~~~~~L~p~t~Y~vqVRa~~~~g~~~~G~WSeWS~~~~~~T~~~~~  211 (219)
T 3tgx_A          163 SVSLLPLEFRKDSSYELQVRAGPMPGSSYQGTWSEWSDPVIFQTQSEEL  211 (219)
T ss_dssp             EEEECTTSSCSSCEEEEEEEEEECTTSSCCBCCCCCCCCEEEECCC---
T ss_pred             EEEEEeccCCCCCEEEEEEEEeeCCCCCCCCcCcCCCCCeEEECCchhh
Confidence            45667889999999999999998854      36778888888765543

>4go6_B HCF C-terminal chain 1; tandem fibronectin repeat, protein interaction, transcriptio protein binding; 2.70A {Homo sapiens}

Probab=96.13  E-value=0.0028  Score=54.07  Aligned_cols=31  Identities=19%  Similarity=0.177  Sum_probs=26.3

Q ss_pred             ceeeecCccCceEEEEEEEEecCCCCCCCCC
Q psy12427         14 TMAITGLSPGHQYEFRVYAENVYGRSDPSTT   44 (356)
Q Consensus        14 ~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~   44 (356)
                      ++.+.+|.|++.|.|||+|.|..|.|.+|+.
T Consensus       164 ~~~~~~L~~~t~Y~frV~A~N~~G~Gp~S~v  194 (232)
T 4go6_B          164 SNAHIDYTTKPAIIFRIAARNEKGYGPATQV  194 (232)
T ss_dssp             TTBCBEESSSEEEEEEEEEECSSCBCCCEEE
T ss_pred             EEeeecCccCCceEEEEEEECCCcCCCCccc
Confidence            3455689999999999999999999887753

>3r8q_A Fibronectin; heparin, FNIII, heparin binding, cell adhesion; 2.40A {Homo sapiens} PDB: 1fnh_A

Probab=96.12  E-value=0.0035  Score=55.02  Aligned_cols=41  Identities=22%  Similarity=0.308  Sum_probs=33.7

Q ss_pred             CceEeee-eeecceeeecCccCceEEEEEEEEecCCCCCCCC
Q psy12427          3 SWIRVGN-TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPST   43 (356)
Q Consensus         3 ~w~~~~~-~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~   43 (356)
                      .|..+.. ...++++|++|.|++.|.|||+|.|..|.|.++.
T Consensus        63 ~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~a~~~~g~s~~s~  104 (290)
T 3r8q_A           63 PMKEINLAPDSSSVVVSGLMVATKYEVSVYALKDTLTSRPAQ  104 (290)
T ss_dssp             CCEEEEECTTCCEEEECSCCSSCEEEEEEEEEETTEECCCEE
T ss_pred             ceEEEEcCCCccEEEeCCCCCCCEEEEEEEEEeCCCCCCCcc
Confidence            3554432 4578999999999999999999999999988873

>2b5i_B Interleukin-2 receptor beta chain; four-helix bundle, fibronectin domain, cytokine-cytokine REC complex; HET: NAG; 2.30A {Homo sapiens} SCOP: b.1.2.1 b.1.2.1 PDB: 3qaz_B* 2erj_B*

Probab=96.07  E-value=0.008  Score=50.64  Aligned_cols=30  Identities=27%  Similarity=0.517  Sum_probs=26.0

Q ss_pred             eeeecceeeecCccCceEEEEEEEEecCCC
Q psy12427          9 NTRFTTMAITGLSPGHQYEFRVYAENVYGR   38 (356)
Q Consensus         9 ~~~~~~~~v~~L~p~~~y~frv~a~n~~g~   38 (356)
                      .+..+++.+.+|.||+.|.|||||....|+
T Consensus       161 ~~~~~~~~l~~L~p~t~Y~vqVRa~~~~~~  190 (214)
T 2b5i_B          161 KQKQEWICLETLTPDTQYEFQVRVKPLQGE  190 (214)
T ss_dssp             CSCCCEEEECSCCTTCEEEEEEEEEESCCS
T ss_pred             cccceEEEeccCCCCCEEEEEEEEeeCCCC
Confidence            356789999999999999999999987653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.88  E-value=0.033  Score=51.62  Aligned_cols=32  Identities=22%  Similarity=0.339  Sum_probs=25.4

Q ss_pred             ceeccCCCCCEEEee----cCCCcEEEEeeeceeee
Q psy12427        232 IIHLDVKPENIMCQT----RNSTNVKMIDFGLATKL  263 (356)
Q Consensus       232 ivH~Dlkp~NIlv~~----~~~~~vkl~Dfg~a~~~  263 (356)
                      ++|+|+.+.|||+..    +....+.++||..|..-
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n  281 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN  281 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence            689999999999953    22346999999988753

>1fnf_A Fibronectin; RGD, extracellular matrix, cell adhesion protein; 2.00A {Homo sapiens} SCOP: b.1.2.1 b.1.2.1 b.1.2.1 b.1.2.1 PDB: 1mfn_A 2mfn_A 2ck2_A

Probab=95.83  E-value=0.0042  Score=56.47  Aligned_cols=39  Identities=26%  Similarity=0.329  Sum_probs=33.3

Q ss_pred             ceEeeeeeecceeeecCccCceEEEEEEEEecCCCCCCC
Q psy12427          4 WIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPS   42 (356)
Q Consensus         4 w~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s   42 (356)
                      |........+++++++|.|++.|.|||+|.|..|.|.++
T Consensus        49 ~~~~~~~~~~~~~i~~L~p~t~Y~~~V~a~~~~g~s~~~   87 (368)
T 1fnf_A           49 LEEVVHADQSSCTFDNLSPGLEYNVSVYTVKDDKESVPI   87 (368)
T ss_dssp             EEEEECTTCCEEECCCCCTTSCEEEEEEEEETTEECCCE
T ss_pred             eEEEecCCcCEEEECCCCCCCEEEEEEEEEcCCCccCce
Confidence            555555678899999999999999999999999987764

>3r8q_A Fibronectin; heparin, FNIII, heparin binding, cell adhesion; 2.40A {Homo sapiens} PDB: 1fnh_A

Probab=95.83  E-value=0.0057  Score=53.64  Aligned_cols=35  Identities=34%  Similarity=0.568  Sum_probs=30.4

Q ss_pred             eeeeecceeeecCccCceEEEEEEEEecCCCCCCC
Q psy12427          8 GNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPS   42 (356)
Q Consensus         8 ~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s   42 (356)
                      .....++++++||.|++.|.|+|+|.|..|.|.+.
T Consensus       160 ~~~~~~~~~i~~L~p~t~Y~~~V~A~n~~g~s~~~  194 (290)
T 3r8q_A          160 IKPDVRSYTITGLQPGTDYKIYLYTLNDNARSSPV  194 (290)
T ss_dssp             ECTTCSEEEECSCCTTCEEEEEEEEEETTEECCCE
T ss_pred             cCCCccEEEECCCCCCCEEEEEEEEEeCCcccCCE
Confidence            34667899999999999999999999998887653

>2jll_A NCAM2, neural cell adhesion molecule 2; immunoglobulin domain, immunoglobulin superfamily, transmembrane, phosphoprotein, membrane, glycoprotein; HET: NAG; 2.30A {Homo sapiens} PDB: 2xyc_A* 2jlk_A* 2doc_A

Probab=95.82  E-value=0.0082  Score=54.79  Aligned_cols=48  Identities=31%  Similarity=0.358  Sum_probs=39.0

Q ss_pred             CceEeee-eeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceec
Q psy12427          3 SWIRVGN-TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT   50 (356)
Q Consensus         3 ~w~~~~~-~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~   50 (356)
                      .|..+.. ...++++|.+|.|++.|.|||+|.|..|.|.+|....+.+.
T Consensus       241 ~~~~~~~~~~~~~~~i~~l~~~~~y~~~v~A~N~~G~~~~s~~~~~~t~  289 (389)
T 2jll_A          241 IWKIVRSHGVQTMVVLNNLEPNTTYEIRVAAVNGKGQGDYSKIEIFQTL  289 (389)
T ss_dssp             CCEEEECSTTCSEEEECSCCTTCEEEEEEEEEESSCBCCCCCCEEEECC
T ss_pred             ccEEeeccCCcceEEECCccCCCEEEEEEEEEcCCccCCCCcceEEEec
Confidence            4554433 34578999999999999999999999999999988776654

>2v5y_A Receptor-type tyrosine-protein phosphatase MU; membrane, hydrolase, glycoprotein, receptor protei tyrosine phosphatase, cell adhesion; HET: NAG; 3.10A {Homo sapiens}

Probab=95.75  E-value=0.0082  Score=60.24  Aligned_cols=48  Identities=25%  Similarity=0.322  Sum_probs=41.4

Q ss_pred             CceEeeeeeecceeeecCccCceEEEEEEEE--ecCCCCCCCCCccceec
Q psy12427          3 SWIRVGNTRFTTMAITGLSPGHQYEFRVYAE--NVYGRSDPSTTSDLITT   50 (356)
Q Consensus         3 ~w~~~~~~~~~~~~v~~L~p~~~y~frv~a~--n~~g~s~~s~~s~~~t~   50 (356)
                      .|..+.....++++|.+|.|++.|.|||+|.  |..|.|.+|....+.+.
T Consensus       306 ~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~A~~~N~~G~s~~S~~~~~~t~  355 (731)
T 2v5y_A          306 SWNDRQPVDSTSYKIGHLDPDTEYEISVLLTRPGEGGTGSPGPALRTRTK  355 (731)
T ss_dssp             SCEEEEECCSSEEEECSCCTTCEEEEEEEEECSSTTCSCCBCCCEEEECC
T ss_pred             CceEEeccCcceEEEeCCCCCCEEEEEEEEEecCCCccccCCCcEEeeec
Confidence            5777766777999999999999999999999  99999999887665554

>1tdq_A Tenascin-R; extracellular matrix, lecticans, tenascins, protein-protein interactions, C-type lectin domain; 2.60A {Rattus norvegicus} SCOP: b.1.2.1 b.1.2.1 b.1.2.1

Probab=95.65  E-value=0.011  Score=51.43  Aligned_cols=31  Identities=29%  Similarity=0.360  Sum_probs=27.7

Q ss_pred             ecceeeecCccCceEEEEEEEEecCCCCCCC
Q psy12427         12 FTTMAITGLSPGHQYEFRVYAENVYGRSDPS   42 (356)
Q Consensus        12 ~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s   42 (356)
                      .+++++++|.|++.|.|+|+|.|..|.|.+.
T Consensus       159 ~~~~~i~~L~p~t~Y~~~V~A~n~~g~s~~~  189 (283)
T 1tdq_A          159 TTKTTLTDLVPGTEYGVGISAVMNSKQSIPA  189 (283)
T ss_dssp             EEEEEECSCCTTCEEEEEEEEEETTEECCCE
T ss_pred             cceEEEecCCCCCEEEEEEEEEeCCCCCcce
Confidence            7899999999999999999999988876543

>3t1w_A Four-domain fibronectin fragment; human fibronectin, FN type-III domain, oncofetal splice VARI extra-domain B, EIIIB, ED-B, angiogenesis, integrin; 2.40A {Homo sapiens} PDB: 4gh7_B

Probab=95.63  E-value=0.007  Score=55.15  Aligned_cols=40  Identities=25%  Similarity=0.333  Sum_probs=32.2

Q ss_pred             ceEeeeeeecceeeecCccCceEEEEEEEEecCCCCCCCC
Q psy12427          4 WIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPST   43 (356)
Q Consensus         4 w~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~   43 (356)
                      |........+++++++|.|++.|.|+|+|.|..|.|.+..
T Consensus        50 ~~~~~~~~~~~~~i~~L~p~t~Y~~~V~a~~~~g~s~~~~   89 (375)
T 3t1w_A           50 LEEVVHADQSSCTFDNLSPGLEYNVSVYTVKDDKESVPIS   89 (375)
T ss_dssp             EEEEEETTCCEEEECCCCTTCCEEEEEEEEETTEECCCEE
T ss_pred             eeEEcCCCccEEEEcCCcCCCEEEEEEEEEcCCCCCCcEE
Confidence            3334456779999999999999999999999888766543

>1tdq_A Tenascin-R; extracellular matrix, lecticans, tenascins, protein-protein interactions, C-type lectin domain; 2.60A {Rattus norvegicus} SCOP: b.1.2.1 b.1.2.1 b.1.2.1

Probab=95.36  E-value=0.012  Score=51.16  Aligned_cols=32  Identities=25%  Similarity=0.445  Sum_probs=28.5

Q ss_pred             eeecceeeecCccCceEEEEEEEEecCCCCCC
Q psy12427         10 TRFTTMAITGLSPGHQYEFRVYAENVYGRSDP   41 (356)
Q Consensus        10 ~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~   41 (356)
                      ...+++++++|.|++.|.|+|+|.|..|.|.+
T Consensus        65 ~~~~~~~i~~L~p~t~Y~~~V~a~~~~g~s~~   96 (283)
T 1tdq_A           65 PPLSQYSVQALRPGSRYEVSISAVRGTNESDA   96 (283)
T ss_dssp             TTCSEEEECSCCTTCEEEEEEEEEETTEECCC
T ss_pred             CCCCEEEecCCCCCCEEEEEEEEECCCCCCCC
Confidence            56789999999999999999999998887654

>3fl7_A Ephrin receptor; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase, glycoprotein; HET: NAG; 2.50A {Homo sapiens} PDB: 2x10_A* 2x11_A 3mx0_A* 3mbw_A*

Probab=95.26  E-value=0.011  Score=56.87  Aligned_cols=35  Identities=26%  Similarity=0.301  Sum_probs=29.9

Q ss_pred             eeecceeeecCccCceEEEEEEEEecCCCCCCCCC
Q psy12427         10 TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTT   44 (356)
Q Consensus        10 ~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~   44 (356)
                      ...++++|++|.|++.|.|||+|.|..|.+.++..
T Consensus       397 ~~~ts~tI~gL~P~T~Y~frV~A~N~~G~~sps~~  431 (536)
T 3fl7_A          397 LTRTSVTVSDLEPHMNYTFTVEARNGVSGLVTSRS  431 (536)
T ss_dssp             BCSSEEEEECCCTTCEEEEEEEEECTTGGGCSCCC
T ss_pred             CccceeEeCCCCCCCEEEEEEEEEecCCCCCCCCc
Confidence            46789999999999999999999999998655333

>3t1w_A Four-domain fibronectin fragment; human fibronectin, FN type-III domain, oncofetal splice VARI extra-domain B, EIIIB, ED-B, angiogenesis, integrin; 2.40A {Homo sapiens} PDB: 4gh7_B

Probab=95.23  E-value=0.011  Score=53.77  Aligned_cols=37  Identities=30%  Similarity=0.442  Sum_probs=32.3

Q ss_pred             eeeeecceeeecCccCceEEEEEEEEecCCCCCCCCC
Q psy12427          8 GNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTT   44 (356)
Q Consensus         8 ~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~   44 (356)
                      .....+++++++|.|++.|.|||+|.|..|.|.++..
T Consensus       145 ~~~~~~~~~i~~L~p~t~Y~~~V~a~~~~g~s~~s~~  181 (375)
T 3t1w_A          145 VDSSVGYYTVTGLEPGIDYDISVITLINGGESAPTTL  181 (375)
T ss_dssp             ECTTCCEEEEECCCTTCEEEEEEEEEETTEECCCEEE
T ss_pred             cCCCcceEEEeCCCCCCEEEEEEEEEeCCcccCCeee
Confidence            3466789999999999999999999999998877663

>2dtg_E Insulin receptor; IR ectodomain, X-RAY crystallography, hormone receptor/immune system complex; 3.80A {Homo sapiens} SCOP: b.1.2.1 b.1.2.1 b.1.2.1 c.10.2.5 c.10.2.5 g.3.9.1 PDB: 3loh_E

Probab=95.21  E-value=0.0073  Score=62.18  Aligned_cols=40  Identities=20%  Similarity=0.160  Sum_probs=32.9

Q ss_pred             ecceeeecCccCceEEEEEEE-EecCCC----CCCCCCccceech
Q psy12427         12 FTTMAITGLSPGHQYEFRVYA-ENVYGR----SDPSTTSDLITTK   51 (356)
Q Consensus        12 ~~~~~v~~L~p~~~y~frv~a-~n~~g~----s~~s~~s~~~t~~   51 (356)
                      .++++|++|+|+|.|.|||+| .|..|.    |.+|....+.|..
T Consensus       548 ~~~~~l~~L~P~T~Y~~~V~A~~n~~G~~~~~~~~S~~v~~~T~~  592 (897)
T 2dtg_E          548 HPGWLMRGLKPWTQYAIFVKTLVTFSDERRTYGAKSDIIYVQTDA  592 (897)
T ss_dssp             CCEEEECSCCSSCBCCBEEEECCCCCSSCCCCCCBCCCBCCBCCC
T ss_pred             ccceEeCCCCCCcEEEEEEEEEEeccCCccccCCccceEEEECCC
Confidence            588999999999999999999 999997    5666666555543

>3se4_A Interferon alpha/beta receptor 1; type I interferon signaling complex, extracellular space, IM system receptor; HET: NAG; 3.50A {Homo sapiens} PDB: 3se3_A*

Probab=95.10  E-value=0.01  Score=55.30  Aligned_cols=43  Identities=23%  Similarity=0.213  Sum_probs=35.8

Q ss_pred             eeeecceeeecCccCceEEEEEEEEec--CCCCCCCCCccceech
Q psy12427          9 NTRFTTMAITGLSPGHQYEFRVYAENV--YGRSDPSTTSDLITTK   51 (356)
Q Consensus         9 ~~~~~~~~v~~L~p~~~y~frv~a~n~--~g~s~~s~~s~~~t~~   51 (356)
                      .+..++++|.+|.|++.|.|||+|.|.  .|.|.+|.+..+.+..
T Consensus       159 ~~~~~~~~i~~L~p~t~Y~~~V~A~n~~~~g~g~~S~~~~~~t~~  203 (414)
T 3se4_A          159 ENIYSRHKIYKLSPETTYCLKVKAALLTSWKIGVYSPVHCIKTTV  203 (414)
T ss_dssp             EEECSEEEECCCCTTCEEEEEEEEECTTTCCEEEECCCEEEECCS
T ss_pred             ecCCcEEEEcCCCCCCeEEEEEEEEeccCCCCCccCccccccccc
Confidence            356788999999999999999999994  6788888877666653

>3bpo_C Interleukin-13 receptor alpha-1 chain; IL4, IL13, IL4R, IL13R, cytokine, glycoprotein, IM response, membrane, phosphoprotein, secreted; HET: NAG; 3.00A {Homo sapiens} PDB: 3bpn_C*

Probab=94.92  E-value=0.023  Score=50.55  Aligned_cols=28  Identities=11%  Similarity=0.156  Sum_probs=24.4

Q ss_pred             eeecceeeecCccCceEEEEEEEEecCC
Q psy12427         10 TRFTTMAITGLSPGHQYEFRVYAENVYG   37 (356)
Q Consensus        10 ~~~~~~~v~~L~p~~~y~frv~a~n~~g   37 (356)
                      ...++++|.+|+|++.|.|||||.+..+
T Consensus       264 ~~~~~~~l~~L~p~t~Y~~qVra~~~~~  291 (314)
T 3bpo_C          264 ENTSCFMVPGVLPDTLNTVRIRVKTNKL  291 (314)
T ss_dssp             SSEEEEEEESCCTTSCEEEEEEEEECTT
T ss_pred             CCceEEEEccCCCCCEEEEEEEeeeccc
Confidence            4678899999999999999999997543

>1fnf_A Fibronectin; RGD, extracellular matrix, cell adhesion protein; 2.00A {Homo sapiens} SCOP: b.1.2.1 b.1.2.1 b.1.2.1 b.1.2.1 PDB: 1mfn_A 2mfn_A 2ck2_A

Probab=94.88  E-value=0.02  Score=51.90  Aligned_cols=40  Identities=20%  Similarity=0.253  Sum_probs=32.3

Q ss_pred             CceEee-eeeecceeeecCccCceEEEEEEEEecCCCCCCC
Q psy12427          3 SWIRVG-NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPS   42 (356)
Q Consensus         3 ~w~~~~-~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s   42 (356)
                      .|..+. ....+++++++|.|++.|.|+|+|.|..|.|.+.
T Consensus       138 ~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~a~~~~g~s~~~  178 (368)
T 1fnf_A          138 DVAELSISPSDNAVVLTNLLPGTEYVVSVSSVYEQHESTPL  178 (368)
T ss_dssp             CCEEEEECTTCCEEEECSCCTTCEEEEEEEEEETTEECCCE
T ss_pred             ccEEEEcCCCcceEEecCCCCCCEEEEEEEEEeCCCCCCCe
Confidence            355443 3567899999999999999999999999877653

>1i1r_A GP130, interleukin-6 receptor beta chain; cytokine/receptor complex, GP130; 2.40A {Homo sapiens} SCOP: b.1.2.1 b.1.2.1 b.1.2.1 PDB: 1p9m_A

Probab=94.80  E-value=0.01  Score=52.41  Aligned_cols=34  Identities=21%  Similarity=0.071  Sum_probs=29.5

Q ss_pred             eeecceeeecC-ccCceEEEEEEEEecCCCCCCCC
Q psy12427         10 TRFTTMAITGL-SPGHQYEFRVYAENVYGRSDPST   43 (356)
Q Consensus        10 ~~~~~~~v~~L-~p~~~y~frv~a~n~~g~s~~s~   43 (356)
                      ...++++|++| .|++.|.|||+|.|..|.+.++.
T Consensus       155 ~~~~~~~i~~L~~p~t~Y~f~V~A~N~~G~~~s~~  189 (303)
T 1i1r_A          155 DTPTSCTVDYSTVYFVNIEVWVEAENALGKVTSDH  189 (303)
T ss_dssp             SCTTEEECSSCCCTTSCEEEEEEEEETTEEEECCC
T ss_pred             CCceEEEECCcCcccccEEEEEEEEcCCCCcccCC
Confidence            34588999999 99999999999999999986543

>1bqu_A Protein (GP130); cytokine receptor, glycoprotein 130, interleukine 6 R beta subunit, signaling protein; 2.00A {Homo sapiens} SCOP: b.1.2.1 b.1.2.1 PDB: 1pvh_A 1bj8_A

Probab=94.80  E-value=0.011  Score=49.25  Aligned_cols=30  Identities=23%  Similarity=0.073  Sum_probs=27.6

Q ss_pred             eecceeeecC-ccCceEEEEEEEEecCCCCC
Q psy12427         11 RFTTMAITGL-SPGHQYEFRVYAENVYGRSD   40 (356)
Q Consensus        11 ~~~~~~v~~L-~p~~~y~frv~a~n~~g~s~   40 (356)
                      ..++++|++| .|++.|.|||+|.|..|.+.
T Consensus        60 ~~~~~~i~~L~~~~t~Y~~~V~A~n~~G~~~   90 (215)
T 1bqu_A           60 TPTSCTVDYSTVYFVNIEVWVEAENALGKVT   90 (215)
T ss_dssp             CTTEEECSSCCCTTSCEEEEEEEEETTEEEE
T ss_pred             CcceEEEcCCccccccEEEEEEEEecccCcc
Confidence            4588999999 99999999999999999876

>1eer_B Epobp, erythropoietin receptor; signal transduction, hematopoietic cytokine, cytokine receptor class 1, complex (cytokine/receptor); 1.90A {Homo sapiens} SCOP: b.1.2.1 b.1.2.1 PDB: 1cn4_A 2jix_B 1eba_A* 1ern_A 1ebp_A

Probab=94.65  E-value=0.021  Score=48.38  Aligned_cols=27  Identities=22%  Similarity=0.221  Sum_probs=23.9

Q ss_pred             eeeecceeeecCccCceEEEEEEEEec
Q psy12427          9 NTRFTTMAITGLSPGHQYEFRVYAENV   35 (356)
Q Consensus         9 ~~~~~~~~v~~L~p~~~y~frv~a~n~   35 (356)
                      ....+++.|.+|+||+.|.|||||...
T Consensus       176 ~~~~~~~~l~~L~p~t~Y~vqVRa~~~  202 (227)
T 1eer_B          176 LEGRTECVLSNLRGRTRYTFAVRARMA  202 (227)
T ss_dssp             CTTCCEEEECCCCSSCEEEEEEEEEEC
T ss_pred             ecCceEEEEcccCCCCeEEEEEEEeEC
Confidence            356789999999999999999999964

>2v5y_A Receptor-type tyrosine-protein phosphatase MU; membrane, hydrolase, glycoprotein, receptor protei tyrosine phosphatase, cell adhesion; HET: NAG; 3.10A {Homo sapiens}

Probab=94.61  E-value=0.012  Score=58.98  Aligned_cols=40  Identities=25%  Similarity=0.239  Sum_probs=33.3

Q ss_pred             eeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceec
Q psy12427         10 TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT   50 (356)
Q Consensus        10 ~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~   50 (356)
                      ...++++|++|+|++.|.|||+|.|..|.|. |....+.|.
T Consensus       419 ~~~~~~~i~~L~p~t~Y~~~V~A~n~~G~s~-S~~~~~~T~  458 (731)
T 2v5y_A          419 NSHPQHTITNLSPYTNVSVKLILMNPEGRKE-SQELIVQTD  458 (731)
T ss_dssp             CSSCEEEECSCCSSCEEEEEEEEECSSCEEE-CCCEEEECC
T ss_pred             CCcceEEECCCCCCCEEEEEEEEEcCCCCCC-CceEEEEcc
Confidence            5678899999999999999999999999974 655555554

>3s98_A Interferon alpha/beta receptor 1; human, type I interferons, receptor chain, ifnar1, fibronect III, type I interferon receptor chain; HET: NAG; 1.90A {Homo sapiens}

Probab=93.86  E-value=0.017  Score=51.35  Aligned_cols=47  Identities=19%  Similarity=0.263  Sum_probs=30.6

Q ss_pred             CCceEee---eeeecceee--ecCccCceEEEEEEEEecCCCCCCCCCcccee
Q psy12427          2 SSWIRVG---NTRFTTMAI--TGLSPGHQYEFRVYAENVYGRSDPSTTSDLIT   49 (356)
Q Consensus         2 ~~w~~~~---~~~~~~~~v--~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t   49 (356)
                      ..|..+.   ++..+...+  .+|.|++.|.|||+|.| .|.|.++.+..+.+
T Consensus        45 ~~W~~~~~c~~~~~~~c~lt~~~l~~~~~Y~~rV~A~n-~~~S~~s~~~~f~~   96 (306)
T 3s98_A           45 DNWIKLSGCQNITSTKCNFSSLKLNVYEEIKLRIRAEK-ENTSSWYEVDSFTP   96 (306)
T ss_dssp             SSCEECTTCSSBSSSEEECCC---CTTSCEEEEEEEEC-SSCEEEEECCCBCH
T ss_pred             CCcEECCCccCCCCCEEEccccccCCCCcEEEEEEEEe-CCcCCCEeeeeEec
Confidence            4687653   234444444  46789999999999999 77777665555543

>3l5i_A Interleukin-6 receptor subunit beta; cytokine receptor, fibronectin type III domain, alternative cell membrane, disulfide bond; 1.90A {Homo sapiens} PDB: 3l5j_A

Probab=93.77  E-value=0.036  Score=48.35  Aligned_cols=32  Identities=19%  Similarity=0.255  Sum_probs=27.7

Q ss_pred             eecceeeecCccCceEEEEEEEEecCCCCCCC
Q psy12427         11 RFTTMAITGLSPGHQYEFRVYAENVYGRSDPS   42 (356)
Q Consensus        11 ~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s   42 (356)
                      ..++.++++|.|++.|.|||+|.|..|.|.++
T Consensus        59 ~~~~~~~~~l~p~t~Y~~~V~A~n~~G~s~~s   90 (290)
T 3l5i_A           59 TVNATKLTVNLTNDRYLATLTVRNLVGKSDAA   90 (290)
T ss_dssp             EESSSEEEEEECSSCEEEEEEEEESSCBCCCE
T ss_pred             ecCCcEEEEEcCCceEEEEEEEEcCCCCCCCc
Confidence            34566789999999999999999999988666

>3l5h_A Interleukin-6 receptor subunit beta; IG-like, FNIII, cell membrane, disulfide bond, glycoprotein, immunoglobulin domain, membrane, phosphoprotein; HET: NAG NDG BMA FUC; 3.60A {Homo sapiens}

Probab=93.72  E-value=0.017  Score=56.16  Aligned_cols=39  Identities=21%  Similarity=0.256  Sum_probs=32.1

Q ss_pred             ceEeeeeeecceeeecCccCceEEEEEEEEecCCCCCCC
Q psy12427          4 WIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPS   42 (356)
Q Consensus         4 w~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s   42 (356)
                      |..+.....+++.+++|.|++.|.|+|+|.|..|.+.++
T Consensus       447 ~~~~~~~~~~~~~~~~L~p~t~Y~~~V~A~~~~g~g~~~  485 (589)
T 3l5h_A          447 WQQEDGTVHRTYLRGNLAESKCYLITVTPVYADGPGSPE  485 (589)
T ss_dssp             ECCBCSSCCEEECCSCCCSSSEEEEEECBEETTEECCCE
T ss_pred             cEEeeCCcceEEehhccccCcEEEEEEEEEeCCcccCCE
Confidence            555544556677789999999999999999999988774

>2dtg_E Insulin receptor; IR ectodomain, X-RAY crystallography, hormone receptor/immune system complex; 3.80A {Homo sapiens} SCOP: b.1.2.1 b.1.2.1 b.1.2.1 c.10.2.5 c.10.2.5 g.3.9.1 PDB: 3loh_E

Probab=93.71  E-value=0.032  Score=57.43  Aligned_cols=31  Identities=19%  Similarity=0.198  Sum_probs=28.3

Q ss_pred             eecceeeecCccCceEEEEEEEEecCCCCCC
Q psy12427         11 RFTTMAITGLSPGHQYEFRVYAENVYGRSDP   41 (356)
Q Consensus        11 ~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~   41 (356)
                      ..++++|+||.|++.|.|||+|.|..|.+.+
T Consensus       745 ~~t~~~i~gL~p~t~Y~~~V~A~n~~G~g~~  775 (897)
T 2dtg_E          745 NKESLVISGLRHFTGYRIELQACNQDTPEER  775 (897)
T ss_dssp             SCSEEEECSSCSSCEEEECCEEESCSSSSCC
T ss_pred             CceEEEECCCCCCcEEEEEEEEEeCCCCCCC
Confidence            4489999999999999999999999998775

>2gys_A Cytokine receptor common beta chain; dimer of interlocking chains of fibronectin-III domains, FOU fibronectin-III domains PER chain; HET: NAG FUC BMA NDG; 2.70A {Homo sapiens} SCOP: b.1.2.1 b.1.2.1 b.1.2.1 b.1.2.1 PDB: 1gh7_A* 3cxe_A* 1egj_A* 1c8p_A

Probab=93.30  E-value=0.078  Score=49.23  Aligned_cols=44  Identities=25%  Similarity=0.321  Sum_probs=29.1

Q ss_pred             CceEeee--eeecceeee--cCccCceEEEEEEEEecCC---CCCCCCCcc
Q psy12427          3 SWIRVGN--TRFTTMAIT--GLSPGHQYEFRVYAENVYG---RSDPSTTSD   46 (356)
Q Consensus         3 ~w~~~~~--~~~~~~~v~--~L~p~~~y~frv~a~n~~g---~s~~s~~s~   46 (356)
                      .|..+..  ...+++.+.  +|.|++.|.|||||.+..|   .|.+|.-|+
T Consensus       157 ~w~~~~~~~~~~~~~~~~~~~L~p~~~Y~~rVra~~~~g~~~~G~wS~WS~  207 (419)
T 2gys_A          157 SWEDAAILLSNTSQATLGPEHLMPSSTYVARVRTRLAPGSRLSGRPSKWSP  207 (419)
T ss_dssp             CSTTCEEEEESSSEEEECTTTCCTTCEEEEEEEEEECTTSSCCBCCCCCCC
T ss_pred             ChhheeeecccceEEEechhhcCCCCeEEEEEEEecCCCCCCCcccCCCCC
Confidence            4553332  244556666  9999999999999999753   345544333

>3lb6_C IL-13, interleukin-13 receptor subunit alpha-2; cytokine, decoy, decoy receptor, glycoprotein; HET: MLY NAG; 3.05A {Homo sapiens} PDB: 3lb6_D*

Probab=92.92  E-value=0.029  Score=51.61  Aligned_cols=38  Identities=16%  Similarity=-0.030  Sum_probs=14.8

Q ss_pred             cceeeec-CccCceEEEEEEEEecC-----C-CCCCCCCccceec
Q psy12427         13 TTMAITG-LSPGHQYEFRVYAENVY-----G-RSDPSTTSDLITT   50 (356)
Q Consensus        13 ~~~~v~~-L~p~~~y~frv~a~n~~-----g-~s~~s~~s~~~t~   50 (356)
                      +++++.+ |+|++.|.|||||....     | .|++|++..+.|.
T Consensus       290 ~~~~l~~~L~p~t~Y~~qVRa~~~~~~~~~g~WSeWS~~~~~~t~  334 (380)
T 3lb6_C          290 NETYTLKTTNETRQLCFVVRSKVNIYCSDDGIWSEWSDKQCWEGE  334 (380)
T ss_dssp             SSCC------------CCEEEEECTTTCSSCCCCCCCCC------
T ss_pred             ceEEEeCccCCCcEEEEEEEEEEcccCCCCCCCCCCCCCEEEeCC
Confidence            4688999 99999999999999542     2 2677777666654

>3lqm_A Interleukin-10 receptor subunit beta; IL-10R2, common chain, cytokine, IL-10, IL-22, IL- 28, IL-29, disulfide bond, glycoprotein, membrane; 2.14A {Homo sapiens}

Probab=92.74  E-value=0.072  Score=44.10  Aligned_cols=41  Identities=24%  Similarity=0.096  Sum_probs=33.4

Q ss_pred             CceEe-eeeeecceeeecCccCceEEEEEEEEecCCCCCCCC
Q psy12427          3 SWIRV-GNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPST   43 (356)
Q Consensus         3 ~w~~~-~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~   43 (356)
                      .|..- .++..+...|++|.|.+.|.|||+|.|..|.|.++.
T Consensus        42 ~w~~~c~~~~~~~c~lt~l~~~~~Y~~rV~A~~~~~~S~~s~   83 (201)
T 3lqm_A           42 IFQDKCMQTTLTECDFSSLSKYGDHTLRVRAEFADEHSDWVQ   83 (201)
T ss_dssp             EEEEEEEEESSSEEECTTSCSSSCEEEEEEEEETTEECCCEE
T ss_pred             CcccCcCccCCCEEECCCCccCCCEEEEEEEecCCCcCccee
Confidence            46532 246778899999999999999999999888788764

>3se4_A Interferon alpha/beta receptor 1; type I interferon signaling complex, extracellular space, IM system receptor; HET: NAG; 3.50A {Homo sapiens} PDB: 3se3_A*

Probab=92.52  E-value=0.045  Score=50.81  Aligned_cols=49  Identities=20%  Similarity=0.156  Sum_probs=37.8

Q ss_pred             CceEee---eeeecceeee-cCccCceEEEEEEEEecCCCCCCCCCccceech
Q psy12427          3 SWIRVG---NTRFTTMAIT-GLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK   51 (356)
Q Consensus         3 ~w~~~~---~~~~~~~~v~-~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~   51 (356)
                      .|..+.   +...+.+.++ +|.|++.|.|||+|.|..|.|.+|....+.+..
T Consensus       254 ~w~~~~~~~~~~~~~~~~t~~l~~~~~Y~~rV~A~n~~g~s~~s~~~~~~t~~  306 (414)
T 3se4_A          254 KWKQIPDCENVKTTQCVFPQNVFQKGIYLLRVQASDGNNTSFWSEEIKFDTEI  306 (414)
T ss_dssp             CCCBCSTTTTBSSSEEEEEGGGSCSSEEEEEEEEECSSSEEEECCCEEEETTC
T ss_pred             CceECCCccCCCCCEEcCCcccccCccEEEEEEEecCCCcccccccccccchh
Confidence            466543   2445666776 699999999999999999999998877766543

>1iar_B Protein (interleukin-4 receptor alpha chain); cytokine receptor,interleukin-4, cytokine/receptor complex; 2.30A {Homo sapiens} SCOP: b.1.2.1 b.1.2.1 PDB: 3bpl_B* 3bpn_B* 3bpo_B*

Probab=92.15  E-value=0.11  Score=43.08  Aligned_cols=33  Identities=24%  Similarity=0.099  Sum_probs=19.1

Q ss_pred             eecceeeecCccCceEEEEEEEEecCCCCCCCC
Q psy12427         11 RFTTMAITGLSPGHQYEFRVYAENVYGRSDPST   43 (356)
Q Consensus        11 ~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~   43 (356)
                      ..++..+.+|.||+.|.|||||.-..+.|.+|+
T Consensus       157 ~~~~~~~~~L~p~~~Y~vqVR~k~~~~~G~WSe  189 (207)
T 1iar_B          157 PSLRIAASTLKSGISYRARVRAWAQAYNTTWSE  189 (207)
T ss_dssp             CEEEECC-----CCCEEEEEEEECGGGTCCCCC
T ss_pred             cEEEEEHHHCCCCCEEEEEEEEecCCCCCCCCC
Confidence            344566679999999999999997643333333

>3g9v_A Interleukin 22 receptor, alpha 2; cytokine, cytokine receptor, receptor, glycoprotein, polymorphism, secreted, cytokine/cytokine receptor complex; 2.76A {Homo sapiens}

Probab=92.07  E-value=0.11  Score=43.49  Aligned_cols=48  Identities=21%  Similarity=0.130  Sum_probs=36.5

Q ss_pred             CCceEee---eeeecceeee--cCccCceEEEEEEEEecCCCCCCCCCcccee
Q psy12427          2 SSWIRVG---NTRFTTMAIT--GLSPGHQYEFRVYAENVYGRSDPSTTSDLIT   49 (356)
Q Consensus         2 ~~w~~~~---~~~~~~~~v~--~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t   49 (356)
                      +.|..+.   ++..++..++  .|.|...|.+||+|.+..+.|.++....+..
T Consensus        50 ~~W~~~~~C~~i~~~~Cdlt~~~~~~~~~Y~~RV~A~~~~~~S~ws~~~~f~~  102 (211)
T 3g9v_A           50 RQWKNKEDCWGTQELSCDLTSETSDIQEPYYGRVRAASAGSYSEWSMTPRFTP  102 (211)
T ss_dssp             SSCEEEEEEEEECCSEEECTGGGCSTTSCEEEEEEEEETTEECCCEECCCBCH
T ss_pred             CceEECccCCCCCCCEECCCCcccccCccEEEEEEEECCCCcCCCEecCcccc
Confidence            4798765   4555666676  4589999999999999888888876665544

>4doh_B Interleukin-20 receptor subunit beta; IL10 family cytokine receptor complex, alpha helical cytokin beta sandwhich receptor fold, signaling complex; HET: NAG; 2.80A {Homo sapiens}

Probab=92.05  E-value=0.14  Score=42.48  Aligned_cols=48  Identities=21%  Similarity=0.151  Sum_probs=38.2

Q ss_pred             CCceEeee---eeecceeeec-CccCceEEEEEEEEecCCCCCCCCCcccee
Q psy12427          2 SSWIRVGN---TRFTTMAITG-LSPGHQYEFRVYAENVYGRSDPSTTSDLIT   49 (356)
Q Consensus         2 ~~w~~~~~---~~~~~~~v~~-L~p~~~y~frv~a~n~~g~s~~s~~s~~~t   49 (356)
                      +.|..+..   +..+...++. |.++..|.|||+|.+..+.|.++....+..
T Consensus        53 ~~W~~~~~C~~i~~~~Cdlt~~~~~~~~Y~~RVrA~~~~~~S~w~~~~~f~~  104 (206)
T 4doh_B           53 HIWIPSSWCSLTEGPECDVTDDITATVPYNLRVRATLGSQTSAWSILKHPFN  104 (206)
T ss_dssp             TCCEEEEEEEEESSSEEECTTTCCSSSCEEEEEEEEETTEECCCEECSSCBC
T ss_pred             ccceecccccCCCCCEEcCCccccCCCCEEEEEEEEcCCCccCccccccccc
Confidence            57988754   5677778884 778999999999999999888887666543

>1cd9_B G-CSF-R, protein (G-CSF receptor); class1 cytokine, hematopoietic receptor, signal transduction cytokine; HET: NAG; 2.80A {Mus musculus} SCOP: b.1.2.1 b.1.2.1 PDB: 1pgr_B 1cto_A 1gcf_A

Probab=91.33  E-value=0.084  Score=43.77  Aligned_cols=30  Identities=23%  Similarity=0.200  Sum_probs=26.3

Q ss_pred             eecceeeecCccCceEEEEEEEEecCCCCC
Q psy12427         11 RFTTMAITGLSPGHQYEFRVYAENVYGRSD   40 (356)
Q Consensus        11 ~~~~~~v~~L~p~~~y~frv~a~n~~g~s~   40 (356)
                      ..+++++.+|.|++.|.|+|+|.|..|.+.
T Consensus        66 ~~~~~~~~~L~~~~~Y~~~V~A~N~~G~~~   95 (215)
T 1cd9_B           66 NNCSIPRKNLLLYQYMAIWVQAENMLGSSE   95 (215)
T ss_dssp             CEEEEEGGGCCTTSCEEEEEEEEETTEEEE
T ss_pred             cEEEECCcccccceEEEEEEEEECCCCCcc
Confidence            456788889999999999999999999763

>3lb6_C IL-13, interleukin-13 receptor subunit alpha-2; cytokine, decoy, decoy receptor, glycoprotein; HET: MLY NAG; 3.05A {Homo sapiens} PDB: 3lb6_D*

Probab=90.96  E-value=0.25  Score=45.23  Aligned_cols=46  Identities=11%  Similarity=0.071  Sum_probs=34.5

Q ss_pred             CCceEeeeeeecceeeecCccCceEEEEEEEEec----CCCCCCCCCcccee
Q psy12427          2 SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENV----YGRSDPSTTSDLIT   49 (356)
Q Consensus         2 ~~w~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~----~g~s~~s~~s~~~t   49 (356)
                      +.|..+....  +..+.++.+++.|.|||+|.|.    .|.|.+|+.++..+
T Consensus        79 ~~w~~~~~~~--~~~~~~~~l~~~y~~rV~a~~~~~~~~g~g~~S~~s~~~~  128 (380)
T 3lb6_C           79 ETWKTIITKN--LHYKDGFDLNKGIEAXIHTLLPWQCTNGSEVQSSWAETTY  128 (380)
T ss_dssp             SSCEEEEESS--SEEEEECCTTSCEEEEEEEECCHHHHSSSCCBCCCEEEEE
T ss_pred             CcceEEEecc--EEEEEeecCCCceEEEEEeecCCcccCCccCccccchhhc
Confidence            4688765542  3445678889999999999976    78888888776655

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=90.46  E-value=0.025  Score=53.58  Aligned_cols=62  Identities=13%  Similarity=0.117  Sum_probs=18.2

Q ss_pred             eeeccccccCceEEEEEEEccCCCEEEE------EEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEE
Q psy12427        111 DILEEIGTGAFGVVHRCRERKTGNIFAA------KFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFE  175 (356)
Q Consensus       111 ~~~~~lg~G~fg~V~~~~~~~~~~~~a~------K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  175 (356)
                      .+.+.||   ||.||++..+....+||+      |..+...  ......+.+|+.++..++|||+++.+++..
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            3456676   999999999865567888      6554322  223356778999999999999999988654

>4doh_R Interleukin-20 receptor subunit alpha; IL10 family cytokine receptor complex, alpha helical cytokin beta sandwhich receptor fold, signaling complex; HET: NAG; 2.80A {Homo sapiens}

Probab=89.72  E-value=0.35  Score=40.61  Aligned_cols=26  Identities=23%  Similarity=0.166  Sum_probs=22.7

Q ss_pred             eeecceeeecCccCceEEEEEEEEec
Q psy12427         10 TRFTTMAITGLSPGHQYEFRVYAENV   35 (356)
Q Consensus        10 ~~~~~~~v~~L~p~~~y~frv~a~n~   35 (356)
                      .+.++++|.+|+|++.|.|+|+|...
T Consensus       170 ~~~~~~~l~~L~p~t~Ycv~V~a~~~  195 (221)
T 4doh_R          170 VTNHTLVLTWLEPNTLYCVHVESFVP  195 (221)
T ss_dssp             ECSSEEEECSCCTTCEEEEEEEEECS
T ss_pred             ecCcEEEEecCCCCCcEEEEEEEEEc
Confidence            45567889999999999999999865

>2d9q_B Granulocyte colony-stimulating factor receptor; cytokine, ligand-receptor complex, signaling protein-cytokin; HET: NAG; 2.80A {Homo sapiens} SCOP: b.1.1.3 b.1.2.1 b.1.2.1

Probab=89.47  E-value=0.14  Score=45.21  Aligned_cols=29  Identities=24%  Similarity=0.158  Sum_probs=23.6

Q ss_pred             cceeeecCccCceEEEEEEEEecCCCCCC
Q psy12427         13 TTMAITGLSPGHQYEFRVYAENVYGRSDP   41 (356)
Q Consensus        13 ~~~~v~~L~p~~~y~frv~a~n~~g~s~~   41 (356)
                      +++.+++|.|.+.|.|||+|.|..|.+.+
T Consensus       162 ~~~~~~~L~~~~~Y~f~V~A~N~~G~~~s  190 (313)
T 2d9q_B          162 CSIPRKHLLLYQNMGIWVQAENALGTSMS  190 (313)
T ss_dssp             EEEEGGGCCSSSCEEEEEEEEETTEEEEC
T ss_pred             EEECccccccceeEEEEEEEECCCCCccC
Confidence            34444569999999999999999998643

>3n06_B PRL-R, prolactin receptor; PH dependence, hematopoietic cytokine, hormone-hormone recep complex; 2.00A {Homo sapiens} PDB: 3mzg_B 3n0p_B 3ncb_B 1bp3_B 3d48_R 3nce_B 3ncc_B 3ncf_B 3ew3_B 3npz_B 1f6f_B 2lfg_A

Probab=89.38  E-value=0.15  Score=42.06  Aligned_cols=30  Identities=23%  Similarity=0.040  Sum_probs=25.0

Q ss_pred             ecceeeecCccCceEEEEEEEEecCCCCCC
Q psy12427         12 FTTMAITGLSPGHQYEFRVYAENVYGRSDP   41 (356)
Q Consensus        12 ~~~~~v~~L~p~~~y~frv~a~n~~g~s~~   41 (356)
                      .+.+.+.+|.|.+.|.|||+|.|..|.+.+
T Consensus        61 ~c~~~~~~l~~~~~Y~~~V~A~N~~G~~~s   90 (210)
T 3n06_B           61 SCHFGKQYTSMWRTYIMMVNATNQMGSSFS   90 (210)
T ss_dssp             EEEECGGGCCSSSCEEEEEEEEETTEEEEC
T ss_pred             EEEeCCCCcccceeEEEEEEEEcCCCCeeC
Confidence            445556789999999999999999998743

>1wft_A 1700129L13RIK protein; FN3 domain, similar to HOST cell factor 2, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Mus musculus} SCOP: b.1.2.1

Probab=86.30  E-value=0.47  Score=34.73  Aligned_cols=38  Identities=21%  Similarity=0.181  Sum_probs=29.2

Q ss_pred             eeecceeee---------cCccCceEEEEEEEEecCCCCCCCCCccc
Q psy12427         10 TRFTTMAIT---------GLSPGHQYEFRVYAENVYGRSDPSTTSDL   47 (356)
Q Consensus        10 ~~~~~~~v~---------~L~p~~~y~frv~a~n~~g~s~~s~~s~~   47 (356)
                      ...++.+|.         ++.+-..|.|||.|+|.-|++..++...+
T Consensus        66 G~~~~C~V~~~~L~~ahid~t~kpAiiFRIaArNeKGYGPaTqVrwl  112 (123)
T 1wft_A           66 GLKTSCTVTAGQLANAHIDYTSRPAIVFRISAKNEKGYGPATQIRWL  112 (123)
T ss_dssp             ESCSEEEEEHHHHTTCCCBCSSSCEEEEEEEEBSSSSBCCCEEEEEE
T ss_pred             cCCcceEecccchhhhhhccCCCceEEEEEEeecCCCCCCcccceeh
Confidence            355666677         56666799999999999999987765544

>4a2l_A BT_4663, two-component system sensor histidine kinase/RESP; transcription, beta-propeller; HET: PGE PG4 MES 2PE; 2.60A {Bacteroides thetaiotaomicron} PDB: 4a2m_A*

Probab=85.67  E-value=0.51  Score=47.53  Aligned_cols=35  Identities=29%  Similarity=0.483  Sum_probs=28.4

Q ss_pred             CCceEeeeeeecceeeecCccCceEEEEEEEEecCCCC
Q psy12427          2 SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRS   39 (356)
Q Consensus         2 ~~w~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s   39 (356)
                      +.|..+.  ...+++-++|.|| .|.|+|+|.|..|.-
T Consensus       735 ~~W~~~~--~~~~~~ytnL~pG-~Y~f~V~a~n~~g~w  769 (795)
T 4a2l_A          735 KEWYYLT--DSRTVSYSNLPQG-TYQFLVKAANSDGKW  769 (795)
T ss_dssp             SSCEEES--SCCEEEEECCCSE-EEEEEEEEECTTSCB
T ss_pred             CCccCCC--CcCeEEecccCCC-eEEEEEEEECCCCcc
Confidence            4688774  3456889999999 999999999987753

>3ott_A Two-component system sensor histidine kinase; beta-propeller, beta-sandwich, transcription; HET: TBR; 2.30A {Bacteroides thetaiotaomicron} PDB: 3va6_A

Probab=83.22  E-value=0.62  Score=46.63  Aligned_cols=35  Identities=17%  Similarity=0.360  Sum_probs=27.2

Q ss_pred             CCceEeeeeeecceeeecCccCceEEEEEEEEecCCC
Q psy12427          2 SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGR   38 (356)
Q Consensus         2 ~~w~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~   38 (356)
                      +.|..+.. ...+++.++|.|| .|.|+|+|.|..|.
T Consensus       700 ~~W~~~~~-~~~~~~ytnL~pG-~Y~f~V~a~~~~g~  734 (758)
T 3ott_A          700 KEWNFLKS-NINRITYSNLSYG-NYQLIISKLERDGQ  734 (758)
T ss_dssp             SSCEECCT-TCCEEEECSCCSE-EEEEEEEEBCTTSC
T ss_pred             CCccCCCC-CcceEEecCCCCc-cEEEEEEEeCCCCC
Confidence            36876532 2345788999999 99999999998876

>4doh_R Interleukin-20 receptor subunit alpha; IL10 family cytokine receptor complex, alpha helical cytokin beta sandwhich receptor fold, signaling complex; HET: NAG; 2.80A {Homo sapiens}

Probab=82.68  E-value=0.85  Score=38.20  Aligned_cols=47  Identities=19%  Similarity=0.134  Sum_probs=34.9

Q ss_pred             CCceEeee---eeecceeeecC--ccCceEEEEEEEEecCCCCCCCCCccce
Q psy12427          2 SSWIRVGN---TRFTTMAITGL--SPGHQYEFRVYAENVYGRSDPSTTSDLI   48 (356)
Q Consensus         2 ~~w~~~~~---~~~~~~~v~~L--~p~~~y~frv~a~n~~g~s~~s~~s~~~   48 (356)
                      +.|..+..   +..+...++++  .+...|.+||+|.+..+.|.++....+.
T Consensus        51 ~~W~~~~~C~~~~~~~Cdlt~~~~~~~~~Y~~RV~A~~g~~~S~w~~~~~F~  102 (221)
T 4doh_R           51 KKWLNKSECRNINRTYCDLSAETSDYEHQYYARVRAIWGTKCSKWAESGRFY  102 (221)
T ss_dssp             CCCEECGGGSSBSSSEEECTTTTCCSSCCEEEEEEEESSSCBCCCEECCCBC
T ss_pred             CCceecccccCCCCCEEeCCCccccCCCCEEEEEEEEcCCcccCCEecCcee
Confidence            46887654   66677788876  4778899999999887777776655554

>3cxe_C Granulocyte-macrophage colony-stimulating factor subunit alpha; GM-CSF, receptor complex, dodecamer, disease mutation, glyco membrane; HET: NAG BMA; 3.30A {Homo sapiens}

Probab=80.89  E-value=0.92  Score=33.97  Aligned_cols=38  Identities=13%  Similarity=0.092  Sum_probs=30.7

Q ss_pred             ecceeeecCccCceEEEEEEEEecC--CCCCCCCCcccee
Q psy12427         12 FTTMAITGLSPGHQYEFRVYAENVY--GRSDPSTTSDLIT   49 (356)
Q Consensus        12 ~~~~~v~~L~p~~~y~frv~a~n~~--g~s~~s~~s~~~t   49 (356)
                      .+.+.+-+..|...|++||||....  ..|++|++..+..
T Consensus        78 ~~~~~~~~~~~~~~ytVrVRa~~~~~~~WS~WSqp~~ig~  117 (120)
T 3cxe_C           78 ENRYNFPSSEPRAKHSVKIRAADVRILNWSSWSEAIEFGS  117 (120)
T ss_dssp             CCCCCCBCCSTTCBCCCEEEEEESSSCCCBCCCCCCCBC-
T ss_pred             cceeEeeecCCCccEEEEEEeCCCCCCccCCCCCceEccc
Confidence            5788889999999999999998544  4678888887753

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	356
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-98
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-93
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-75
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	5e-65
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-64
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-62
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-62
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-62
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-62
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	7e-61
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-57
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	5e-57
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-56
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	7e-55
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	8e-55
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-54
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	8e-54
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-52
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-51
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-51
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	5e-51
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-50
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	7e-49
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	6e-48
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-47
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	8e-47
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-46
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	7e-46
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	8e-46
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-45
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-45
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-45
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	9e-45
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-44
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-44
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-44
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-44
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	8e-44
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-43
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	5e-43
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	6e-43
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	7e-43
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	7e-43
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	7e-43
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-42
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-41
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-41
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-41
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	5e-41
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-40
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-40
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-40
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-40
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-40
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	8e-40
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-37
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-37
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-36
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-36
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	6e-35
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-33
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-26
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	5e-14
d1x4za1	108	b.1.2.1 (A:8-115) Brother of CDO precursor (BOC) {	2e-11
d1wisa1	111	b.1.2.1 (A:8-118) Sidekick 2 {Human (Homo sapiens)	4e-11
d1uema_	117	b.1.2.1 (A:) KIAA1568 protein {Human (Homo sapiens	6e-11
d2ic2a1	107	b.1.2.1 (A:466-572) Hedgehog receptor iHog {Fruit	1e-10
d1ueya_	127	b.1.2.1 (A:) KIAA0343 protein {Human (Homo sapiens	3e-10
d1wf5a1	108	b.1.2.1 (A:8-115) Sidekick 2 {Human (Homo sapiens)	4e-10
d1x5ya1	98	b.1.2.1 (A:8-105) Myosin binding protein C, fast-t	5e-10
d1cfba1	100	b.1.2.1 (A:610-709) Neuroglian, two amino proximal	8e-10
d1bpva_	104	b.1.2.1 (A:) Type I titin module {Human (Homo sapi	4e-09
d1x5xa1	96	b.1.2.1 (A:8-103) Fibronectin type-III domain cont	4e-09
d1x3da1	105	b.1.2.1 (A:8-112) Fibronectin type-III domain cont	9e-09
d1fyhb1	98	b.1.2.1 (B:12-109) Interferon-gamma receptor alpha	1e-08
d2cuma1	93	b.1.2.1 (A:7-99) Tenascin-X {Human (Homo sapiens)	2e-08
d1fnaa_	91	b.1.2.1 (A:) Fibronectin, different Fn3 modules {H	3e-08
d1tdqa2	92	b.1.2.1 (A:94-185) Tenascin {Rat (Rattus norvegicu	3e-08
d1qr4a1	87	b.1.2.1 (A:1-87) Tenascin {Chicken (Gallus gallus)	4e-08
d1x5za1	102	b.1.2.1 (A:8-109) Receptor-type tyrosine-protein p	5e-08
d1wfoa1	117	b.1.2.1 (A:8-124) Sidekick 2 {Human (Homo sapiens)	5e-08
d1uena_	125	b.1.2.1 (A:) KIAA0343 protein {Human (Homo sapiens	7e-08
d1x5fa1	107	b.1.2.1 (A:8-114) Neogenin {Human (Homo sapiens) [	7e-08
d1tdqa3	86	b.1.2.1 (A:186-271) Tenascin {Rat (Rattus norvegic	8e-08
d1j8ka_	94	b.1.2.1 (A:) Fibronectin, different Fn3 modules {H	8e-08
d2crza1	97	b.1.2.1 (A:8-104) Fibronectin type-III domain cont	1e-07
d1x5la1	98	b.1.2.1 (A:8-105) Ephrin type-A receptor 8 {Human	2e-07
d1x5ka1	111	b.1.2.1 (A:8-118) Neogenin {Human (Homo sapiens) [	2e-07
d1qr4a2	88	b.1.2.1 (A:88-175) Tenascin {Chicken (Gallus gallu	2e-07
d2dtge2	196	b.1.2.1 (E:593-807) Insulin receptor {Human (Homo	2e-07
d1wfta_	123	b.1.2.1 (A:) Host cell factor 2, HCF-2 {Mouse (Mus	2e-07
d1x5ga1	103	b.1.2.1 (A:8-110) Neogenin {Human (Homo sapiens) [	2e-07
d2cuia1	101	b.1.2.1 (A:6-106) Tenascin-X {Human (Homo sapiens)	2e-07
d1wfua_	120	b.1.2.1 (A:) Fibronectin type 3 and ankyrin repeat	4e-07
d1fnfa1	94	b.1.2.1 (A:1142-1235) Fibronectin, different Fn3 m	6e-07
d1wk0a_	137	b.1.2.1 (A:) Fibronectin type-III domain containin	8e-07
d1fnha1	90	b.1.2.1 (A:3-92) Fibronectin, different Fn3 module	1e-06
d1fnha3	89	b.1.2.1 (A:183-271) Fibronectin, different Fn3 mod	1e-06
d1x5ja1	100	b.1.2.1 (A:8-107) Neogenin {Human (Homo sapiens) [	1e-06
d2crma1	107	b.1.2.1 (A:8-114) Fibronectin type-III domain cont	1e-06
d1k85a_	88	b.1.2.1 (A:) Fibronectin type III domain from chit	1e-06
d1fnfa3	89	b.1.2.1 (A:1327-1415) Fibronectin, different Fn3 m	2e-06
d1bqua2	115	b.1.2.1 (A:100-214) Cytokine receptor gp130 cytoki	2e-06
d1tdqa1	93	b.1.2.1 (A:1-93) Tenascin {Rat (Rattus norvegicus)	2e-06
d1n26a3	104	b.1.2.1 (A:196-299) Interleukin-6 receptor alpha c	2e-06
d1x5ha1	119	b.1.2.1 (A:8-126) Neogenin {Human (Homo sapiens) [	3e-06
d1x4ya1	101	b.1.2.1 (A:8-108) Brother of CDO precursor (BOC) {	3e-06
d1ujta_	120	b.1.2.1 (A:) KIAA1568 protein {Human (Homo sapiens	4e-06
d1cfba2	105	b.1.2.1 (A:710-814) Neuroglian, two amino proximal	4e-06
d1fnha2	90	b.1.2.1 (A:93-182) Fibronectin, different Fn3 modu	5e-06
d1iarb2	101	b.1.2.1 (B:97-197) Interleukin-4 receptor alpha ch	5e-06
d1owwa_	93	b.1.2.1 (A:) Fibronectin, different Fn3 modules {H	6e-06
d1wfna1	106	b.1.2.1 (A:8-113) Sidekick 2 {Human (Homo sapiens)	7e-06
d1fnfa2	91	b.1.2.1 (A:1236-1326) Fibronectin, different Fn3 m	1e-05
d1va9a1	109	b.1.2.1 (A:8-116) Down syndrome cell adhesion mole	1e-05
d1qg3a2	103	b.1.2.1 (A:1218-1320) Integrin beta-4 subunit {Hum	1e-05
d1tena_	90	b.1.2.1 (A:) Tenascin {Human (Homo sapiens) [TaxId	1e-05
d2djsa1	95	b.1.2.1 (A:8-102) Ephrin type-B receptor 1 {Human	2e-05
d1x5aa1	94	b.1.2.1 (A:8-101) Ephrin type-A receptor 1 {Mouse	3e-05
d2ibga1	95	b.1.2.1 (A:573-667) Hedgehog receptor iHog {Fruit	3e-05
d2dn7a1	94	b.1.2.1 (A:8-101) Receptor-type tyrosine-protein p	4e-05
d2vkwa2	93	b.1.2.1 (A:601-693) Neural cell adhesion molecule	4e-05
d1cd9b1	107	b.1.2.1 (B:1-107) Granulocyte colony-stimulating f	7e-05
d1qg3a1	92	b.1.2.1 (A:1126-1217) Integrin beta-4 subunit {Hum	8e-05
d1x4xa1	93	b.1.2.1 (A:8-100) Fibronectin type-III domain cont	8e-05
d1uc6a_	109	b.1.2.1 (A:) Ciliary neurotrophic factor receptor	9e-05
d1cd9b2	106	b.1.2.1 (B:108-213) Granulocyte colony-stimulating	1e-04
d1y6kr1	99	b.1.2.1 (R:2-100) Interleukin-10 receptor 1, IL-10	2e-04
d1x5ia1	113	b.1.2.1 (A:8-120) Neogenin {Human (Homo sapiens) [	2e-04
d2haza1	101	b.1.2.1 (A:489-589) Neural cell adhesion molecule	2e-04
d2fnba_	95	b.1.2.1 (A:) Fibronectin, different Fn3 modules {H	2e-04
d2cuha1	102	b.1.2.1 (A:8-109) Tenascin-X {Human (Homo sapiens)	5e-04
d1v5ja_	108	b.1.2.1 (A:) KIAA1355 {Human (Homo sapiens) [TaxId	7e-04
d2b5ib2	104	b.1.2.1 (B:104-207) Interleukin-2 receptor beta ch	7e-04
d1axib2	106	b.1.2.1 (B:131-236) Growth hormone receptor {Human	7e-04
d2dtge3	125	b.1.2.1 (E:468-592) Insulin receptor {Human (Homo	8e-04
d2b5ic1	95	b.1.2.1 (C:130-224) Cytokine receptor common gamma	0.001
d1f6fb2	103	b.1.2.1 (B:101-203) Prolactin receptor {Rat (Rattu	0.001
d3d48r2	104	b.1.2.1 (R:101-204) Prolactin receptor {Human (Hom	0.001
d2gysa4	100	b.1.2.1 (A:317-416) Common beta-chain in the GM-CS	0.002
d2dtge1	102	b.1.2.1 (E:808-909) Insulin receptor {Human (Homo	0.002
d1bqua1	95	b.1.2.1 (A:5-99) Cytokine receptor gp130 cytokine-	0.003

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  293 bits (751), Expect = 2e-98
 Identities = 187/275 (68%), Positives = 228/275 (82%), Gaps = 5/275 (1%)

Query: 80  VSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAK 139
           ++DYD++  DI+ KYVPQPV++K  SVYD+YDILEE+G+GAFGVVHRC E+ TG +F AK
Sbjct: 1   INDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAK 60

Query: 140 FIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAP 199
           FI   + L+K  ++ EI IMNQLHHPKLINLHDAFED  EMVLI EFLSGGELF+RI A 
Sbjct: 61  FINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE 120

Query: 200 DYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGL 259
           DYKMSEAEVI              +KHMHE +I+HLD+KPENIMC+T+ +++VK+IDFGL
Sbjct: 121 DYKMSEAEVINYMRQACE-----GLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGL 175

Query: 260 ATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVE 319
           ATKL+P+E+VK++T TAEFAAPEIV+REPVGFYTDMWA+GVL YVLLSGLSPFAGE+D+E
Sbjct: 176 ATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE 235

Query: 320 TLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
           TL+NVK CDWEFDE+AF +VS E KDFI+ LL + 
Sbjct: 236 TLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKE 270

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  280 bits (718), Expect = 2e-93
 Identities = 169/272 (62%), Positives = 207/272 (76%), Gaps = 5/272 (1%)

Query: 83  YDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP 142
           YD YVFDI+ +Y PQPV+IK   V DHYDI EE+GTGAFGVVHR  ER TGN FAAKF+ 
Sbjct: 1   YDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM 60

Query: 143 VSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK 202
             H  +KE +RKEI  M+ L HP L+NLHDAFEDD+EMV+I+EF+SGGELFE++     K
Sbjct: 61  TPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK 120

Query: 203 MSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK 262
           MSE E +       M Q    + HMHE N +HLD+KPENIM  T+ S  +K+IDFGL   
Sbjct: 121 MSEDEAV-----EYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175

Query: 263 LDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLK 322
           LDP + VK++TGTAEFAAPE+ E +PVG+YTDMW+VGVL+Y+LLSGLSPF GEND ETL+
Sbjct: 176 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR 235

Query: 323 NVKACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
           NVK+CDW  D+ AF  +SE+GKDFIR+LLL +
Sbjct: 236 NVKSCDWNMDDSAFSGISEDGKDFIRKLLLAD 267

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  233 bits (595), Expect = 3e-75
 Identities = 98/251 (39%), Positives = 164/251 (65%), Gaps = 6/251 (2%)

Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHP 165
           +Y+ Y I E++G G FG+VHRC E  +   + AKF+ V    ++ L++KEI I+N   H 
Sbjct: 3   LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHR 61

Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            +++LH++FE  +E+V+IFEF+SG ++FERI    ++++E E++     +       A++
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE-----ALQ 116

Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
            +H  NI H D++PENI+ QTR S+ +K+I+FG A +L P +  ++     E+ APE+ +
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ 176

Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD 345
            + V   TDMW++G L YVLLSG++PF  E + + ++N+   ++ FDEEAFK +S E  D
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236

Query: 346 FIRRLLLRNKE 356
           F+ RLL++ ++
Sbjct: 237 FVDRLLVKERK 247

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (524), Expect = 5e-65
 Identities = 112/261 (42%), Positives = 160/261 (61%), Gaps = 14/261 (5%)

Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH------NLEKELIRKE 155
           +  +V D+YD  EE+G+G F VV +CRE+ TG  +AAKFI           + +E I +E
Sbjct: 4   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 63

Query: 156 IDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI 215
           + I+ ++ HP +I LH+ +E+  +++LI E ++GGELF+ +   +  ++E E       I
Sbjct: 64  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQI 122

Query: 216 LMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN--STNVKMIDFGLATKLDPNEVVKIST 273
           L       V ++H   I H D+KPENIM   RN     +K+IDFGLA K+D     K   
Sbjct: 123 L-----NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 177

Query: 274 GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE 333
           GT EF APEIV  EP+G   DMW++GV+ Y+LLSG SPF G+   ETL NV A ++EF++
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 237

Query: 334 EAFKNVSEEGKDFIRRLLLRN 354
           E F N S   KDFIRRLL+++
Sbjct: 238 EYFSNTSALAKDFIRRLLVKD 258

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  204 bits (519), Expect = 4e-64
 Identities = 83/255 (32%), Positives = 142/255 (55%), Gaps = 8/255 (3%)

Query: 102 KTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKE-LIRKEIDIMN 160
           +   + D YD  + +GTGAF  V    +++T  + A K I       KE  +  EI +++
Sbjct: 3   QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLH 62

Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
           ++ HP ++ L D +E    + LI + +SGGELF+RI       +E +        L+ Q 
Sbjct: 63  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDAS-----RLIFQV 116

Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNST-NVKMIDFGLATKLDPNEVVKISTGTAEFA 279
             AVK++H+  I+H D+KPEN++  + +    + + DFGL+   DP  V+  + GT  + 
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYV 176

Query: 280 APEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNV 339
           APE++ ++P     D W++GV+AY+LL G  PF  END +  + +   ++EFD   + ++
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI 236

Query: 340 SEEGKDFIRRLLLRN 354
           S+  KDFIR L+ ++
Sbjct: 237 SDSAKDFIRHLMEKD 251

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (508), Expect = 1e-62
 Identities = 69/250 (27%), Positives = 125/250 (50%), Gaps = 11/250 (4%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKL 167
             Y   E+IG GA G V+   +  TG   A + + +    +KELI  EI +M +  +P +
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79

Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
           +N  D++   DE+ ++ E+L+GG L + +   +  M E ++  V    L      A++ +
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQ-----ALEFL 132

Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEFAAPEIVER 286
           H   +IH D+K +NI+       +VK+ DFG   ++           GT  + APE+V R
Sbjct: 133 HSNQVIHRDIKSDNILLGMDG--SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190

Query: 287 EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDF 346
           +  G   D+W++G++A  ++ G  P+  EN +  L  + A +   + +  + +S   +DF
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-ATNGTPELQNPEKLSAIFRDF 249

Query: 347 IRRLLLRNKE 356
           + R L  + E
Sbjct: 250 LNRCLDMDVE 259

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (506), Expect = 2e-62
 Identities = 67/270 (24%), Positives = 130/270 (48%), Gaps = 19/270 (7%)

Query: 93  KYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELI 152
           ++V + ++ +     D ++I+ E+G GAFG V++ + ++T  + AAK I      E E  
Sbjct: 2   EHVTRDLNPE-----DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY 56

Query: 153 RKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVT 212
             EIDI+    HP ++ L DAF  ++ + ++ EF +GG +   +   +  ++E+++  V 
Sbjct: 57  MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVC 116

Query: 213 LPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL-DPNEVVKI 271
              L      A+ ++H+  IIH D+K  NI+       ++K+ DFG++ K     +    
Sbjct: 117 KQTLD-----ALNYLHDNKIIHRDLKAGNILFTLDG--DIKLADFGVSAKNTRTIQRRDS 169

Query: 272 STGTAEFAAPEIV-----EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKA 326
             GT  + APE+V     +  P  +  D+W++G+    +     P    N +  L  +  
Sbjct: 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK 229

Query: 327 CDWEFDEEAFKNVSEEGKDFIRRLLLRNKE 356
            +     +     S   KDF+++ L +N +
Sbjct: 230 SEPPTLAQ-PSRWSSNFKDFLKKCLEKNVD 258

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  198 bits (504), Expect = 3e-62
 Identities = 81/264 (30%), Positives = 133/264 (50%), Gaps = 24/264 (9%)

Query: 107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE---------KELIRKEID 157
           Y++Y+  E +G G   VV RC  + T   +A K I V+             +E   KE+D
Sbjct: 2   YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61

Query: 158 IMNQLH-HPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPIL 216
           I+ ++  HP +I L D +E +    L+F+ +  GELF+ +T     +SE E        +
Sbjct: 62  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETR-----KI 115

Query: 217 MTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA 276
           M      +  +H+ NI+H D+KPENI+    +  N+K+ DFG + +LDP E ++   GT 
Sbjct: 116 MRALLEVICALHKLNIVHRDLKPENILL--DDDMNIKLTDFGFSCQLDPGEKLREVCGTP 173

Query: 277 EFAAPEIVE------REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWE 330
            + APEI+E          G   DMW+ GV+ Y LL+G  PF     +  L+ + + +++
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233

Query: 331 FDEEAFKNVSEEGKDFIRRLLLRN 354
           F    + + S+  KD + R L+  
Sbjct: 234 FGSPEWDDYSDTVKDLVSRFLVVQ 257

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 4e-62
 Identities = 69/252 (27%), Positives = 122/252 (48%), Gaps = 16/252 (6%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL---IRKEIDIMNQLHH 164
           + ++I   +G G FG V+  RE+++  I A K +  +   +  +   +R+E++I + L H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P ++ L+  F D   + LI E+   G ++  +     K  E           +T+ + A+
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTA-----TYITELANAL 119

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
            + H K +IH D+KPEN++    ++  +K+ DFG +    P+       GT ++  PE++
Sbjct: 120 SYCHSKRVIHRDIKPENLLL--GSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMI 176

Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
           E        D+W++GVL Y  L G  PF      ET K +   ++ F +     V+E  +
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGAR 232

Query: 345 DFIRRLLLRNKE 356
           D I RLL  N  
Sbjct: 233 DLISRLLKHNPS 244

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 7e-61
 Identities = 66/253 (26%), Positives = 125/253 (49%), Gaps = 18/253 (7%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK---ELIRKEIDIMNQLHH 164
           + +   + +G G+F  V   RE  T   +A K +   H +++     + +E D+M++L H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P  + L+  F+DD+++     +   GEL + I        E      T  I+      A+
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVS-----AL 121

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST---GTAEFAAP 281
           +++H K IIH D+KPENI+       ++++ DFG A  L P      +    GTA++ +P
Sbjct: 122 EYLHGKGIIHRDLKPENILL--NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179

Query: 282 EIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSE 341
           E++  +     +D+WA+G + Y L++GL PF   N+    + +   +++F E        
Sbjct: 180 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE----KFFP 235

Query: 342 EGKDFIRRLLLRN 354
           + +D + +LL+ +
Sbjct: 236 KARDLVEKLLVLD 248

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  186 bits (473), Expect = 3e-57
 Identities = 59/253 (23%), Positives = 101/253 (39%), Gaps = 19/253 (7%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL---IRKEIDIMNQLHH 164
             +  L EIG G+FG V+  R+ +   + A K +  S     E    I KE+  + +L H
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74

Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P  I     +  +    L+ E+  G             + E E+       +       +
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH-KKPLQEVEIA-----AVTHGALQGL 128

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
            ++H  N+IH DVK  NI+        VK+ DFG A+ + P        GT  + APE++
Sbjct: 129 AYLHSHNMIHRDVKAGNILLSEPG--LVKLGDFGSASIMAPANSF---VGTPYWMAPEVI 183

Query: 285 EREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSE 341
                G Y    D+W++G+    L     P    N +  L ++   +    +    + SE
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS--GHWSE 241

Query: 342 EGKDFIRRLLLRN 354
             ++F+   L + 
Sbjct: 242 YFRNFVDSCLQKI 254

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 5e-57
 Identities = 68/252 (26%), Positives = 119/252 (47%), Gaps = 14/252 (5%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE-KELIRKEIDIMNQLHHPK 166
           + +D+++ +G GA+G V     R T    A K + +   ++  E I+KEI I   L+H  
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKH 226
           ++  +    + +   L  E+ SGGELF+RI  PD  M E +           Q    V +
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQ-----RFFHQLMAGVVY 118

Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST---GTAEFAAPEI 283
           +H   I H D+KPEN++   R+  N+K+ DFGLAT    N   ++     GT  + APE+
Sbjct: 119 LHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176

Query: 284 VEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEE 342
           ++R        D+W+ G++   +L+G  P+   +D     +       +    +K +   
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP-WKKIDSA 235

Query: 343 GKDFIRRLLLRN 354
               + ++L+ N
Sbjct: 236 PLALLHKILVEN 247

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 2e-56
 Identities = 65/262 (24%), Positives = 121/262 (46%), Gaps = 23/262 (8%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE--KELIRKEIDIMNQLHHP 165
           + Y++L  IGTG++G   + R +  G I   K +      E  K+++  E++++ +L HP
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 166 KLINLHDAFED--DDEMVLIFEFLSGGELFERI---TAPDYKMSEAEVIPVTLPILMTQT 220
            ++  +D   D  +  + ++ E+  GG+L   I   T     + E  V+ V   + +   
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL--- 120

Query: 221 SPAVKHMHEKN-----IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE-VVKISTG 274
             A+K  H ++     ++H D+KP N+    +   NVK+ DFGLA  L+ +    K   G
Sbjct: 121 --ALKECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGLARILNHDTSFAKAFVG 176

Query: 275 TAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEE 334
           T  + +PE + R      +D+W++G L Y L + + PF   +  E    ++   +     
Sbjct: 177 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY 236

Query: 335 AFKNVSEEGKDFIRRLLLRNKE 356
                S+E  + I R+L     
Sbjct: 237 ---RYSDELNEIITRMLNLKDY 255

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 7e-55
 Identities = 74/268 (27%), Positives = 127/268 (47%), Gaps = 22/268 (8%)

Query: 99  VDIKTSSVYDHYDILEE-IGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEID 157
           + IK +++ D Y +  + +G G  G V +   ++T   FA K +      +    R+E++
Sbjct: 2   LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVE 56

Query: 158 IMNQL-HHPKLINLHDAFED----DDEMVLIFEFLSGGELFERITA-PDYKMSEAEVIPV 211
           +  +    P ++ + D +E+       ++++ E L GGELF RI    D   +E E   +
Sbjct: 57  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 116

Query: 212 TLPILMTQTSPAVKHMHEKNIIHLDVKPENIM-CQTRNSTNVKMIDFGLATKLDPNEVVK 270
              I       A++++H  NI H DVKPEN++    R +  +K+ DFG A +   +  + 
Sbjct: 117 MKSIGE-----AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 171

Query: 271 ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETL----KNVKA 326
               T  + APE++  E      DMW++GV+ Y+LL G  PF   + +         ++ 
Sbjct: 172 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 231

Query: 327 CDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
             +EF    +  VSEE K  IR LL   
Sbjct: 232 GQYEFPNPEWSEVSEEVKMLIRNLLKTE 259

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  179 bits (454), Expect = 8e-55
 Identities = 60/258 (23%), Positives = 106/258 (41%), Gaps = 15/258 (5%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL---IRKEIDIMNQLHH 164
           D Y++ E +G G    VH  R+ +     A K +      +       R+E      L+H
Sbjct: 7   DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66

Query: 165 PKLINLHDAFEDDDE----MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQT 220
           P ++ ++D  E +        ++ E++ G  L + +      M+    I V         
Sbjct: 67  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQ--- 122

Query: 221 SPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEF 278
             A+   H+  IIH DVKP NIM    N+  V       A     N V + +   GTA++
Sbjct: 123 --ALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180

Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKN 338
            +PE    + V   +D++++G + Y +L+G  PF G++ V         D        + 
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 240

Query: 339 VSEEGKDFIRRLLLRNKE 356
           +S +    + + L +N E
Sbjct: 241 LSADLDAVVLKALAKNPE 258

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 2e-54
 Identities = 50/214 (23%), Positives = 107/214 (50%), Gaps = 11/214 (5%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE-KELIRKEIDIMNQLHHPK 166
           D ++ + E+G G  GVV +   + +G + A K I +      +  I +E+ ++++ + P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65

Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKH 226
           ++  + AF  D E+ +  E + GG L + +     ++ E  +  V++ ++       + +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIK-----GLTY 119

Query: 227 MHEKN-IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           + EK+ I+H DVKP NI+  +R    +K+ DFG++ +L  + +     GT  + +PE ++
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRG--EIKLCDFGVSGQL-IDSMANSFVGTRSYMSPERLQ 176

Query: 286 REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVE 319
                  +D+W++G+    +  G  P    +  E
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 8e-54
 Identities = 60/254 (23%), Positives = 118/254 (46%), Gaps = 17/254 (6%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIP---VSHNLEKELIRKEIDIMN-QLH 163
           + + + + +G G+FG V     +KT   FA K +    V  + + E    E  +++    
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 164 HPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPA 223
           HP L ++   F+  + +  + E+L+GG+L   I +   K   +            +    
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRAT-----FYAAEIILG 115

Query: 224 VKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL-DPNEVVKISTGTAEFAAPE 282
           ++ +H K I++ D+K +NI+       ++K+ DFG+  +    +       GT ++ APE
Sbjct: 116 LQFLHSKGIVYRDLKLDNILLDKDG--HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPE 173

Query: 283 IVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEE 342
           I+  +      D W+ GVL Y +L G SPF G+++ E   +++  +  +       + +E
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKE 229

Query: 343 GKDFIRRLLLRNKE 356
            KD + +L +R  E
Sbjct: 230 AKDLLVKLFVREPE 243

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 2e-52
 Identities = 51/260 (19%), Positives = 115/260 (44%), Gaps = 21/260 (8%)

Query: 107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL--IRKEIDIMNQLHH 164
                + + IG+G+FG V++ +        A K + V+    ++L   + E+ ++ +  H
Sbjct: 7   DGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 63

Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
             ++     +    ++ ++ ++  G  L+  +   + K    ++I      +  QT+  +
Sbjct: 64  VNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-----DIARQTAQGM 117

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST---GTAEFAAP 281
            ++H K+IIH D+K  NI         VK+ DFGLAT               G+  + AP
Sbjct: 118 DYLHAKSIIHRDLKSNNIFL--HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175

Query: 282 EIVEREPVGFYT---DMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE--EAF 336
           E++  +    Y+   D++A G++ Y L++G  P++  N+ + +  +    +   +  +  
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 235

Query: 337 KNVSEEGKDFIRRLLLRNKE 356
            N  +  K  +   L + ++
Sbjct: 236 SNCPKAMKRLMAECLKKKRD 255

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  171 bits (434), Expect = 2e-51
 Identities = 69/252 (27%), Positives = 123/252 (48%), Gaps = 17/252 (6%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK---ELIRKEIDIMNQLHH 164
             + IL  +GTG+FG VH  R R  G  +A K +     +     E    E  +++ + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P +I +   F+D  ++ +I +++ GGELF  +     +                +   A+
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFS-LLRKSQRFPNPVAK-----FYAAEVCLAL 117

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIV 284
           +++H K+II+ D+KPENI+       ++K+ DFG A  +   +V     GT ++ APE+V
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNG--HIKITDFGFAKYVP--DVTYTLCGTPDYIAPEVV 173

Query: 285 EREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
             +P     D W+ G+L Y +L+G +PF   N ++T + +   +  F        +E+ K
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP----FFNEDVK 229

Query: 345 DFIRRLLLRNKE 356
           D + RL+ R+  
Sbjct: 230 DLLSRLITRDLS 241

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 4e-51
 Identities = 57/255 (22%), Positives = 105/255 (41%), Gaps = 18/255 (7%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL--EKELIRKEIDIMNQLHHPKL 167
                EIG G+F  V++  + +T    A   +        E++  ++E +++  L HP +
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 168 INLHDAFED----DDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPA 223
           +  +D++E        +VL+ E ++ G L   +      M    +          Q    
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLR-----SWCRQILKG 124

Query: 224 VKHMHEKN--IIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAP 281
           ++ +H +   IIH D+K +NI   T  + +VK+ D GLA  L      K   GT EF AP
Sbjct: 125 LQFLHTRTPPIIHRDLKCDNIFI-TGPTGSVKIGDLGLA-TLKRASFAKAVIGTPEFMAP 182

Query: 282 EIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSE 341
           E+   E      D++A G+    + +   P++   +   +   +           K    
Sbjct: 183 EMY-EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR-RVTSGVKPASFDKVAIP 240

Query: 342 EGKDFIRRLLLRNKE 356
           E K+ I   + +NK+
Sbjct: 241 EVKEIIEGCIRQNKD 255

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  171 bits (435), Expect = 5e-51
 Identities = 53/253 (20%), Positives = 107/253 (42%), Gaps = 15/253 (5%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL------IRKEIDIMNQ 161
           + + +   IG G FG V+ CR+  TG ++A K +       K+        R  + +++ 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 162 LHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTS 221
              P ++ +  AF   D++  I + ++GG+L   ++       EA++      I++    
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-EADMRFYAAEIIL---- 118

Query: 222 PAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAP 281
             ++HMH + +++ D+KP NI+       +V++ D GLA      +           A  
Sbjct: 119 -GLEHMHNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFSKKKPHASVGTHGYMAPE 175

Query: 282 EIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSE 341
            + +        D +++G + + LL G SPF      +  +  +        E   + S 
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTMAVELPDSFSP 234

Query: 342 EGKDFIRRLLLRN 354
           E +  +  LL R+
Sbjct: 235 ELRSLLEGLLQRD 247

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 2e-50
 Identities = 65/251 (25%), Positives = 120/251 (47%), Gaps = 16/251 (6%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELI---RKEIDIMNQLHH 164
           + +D L+ +G G FG V   RE+ TG  +A K +     + K+ +     E  ++    H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 165 PKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           P L  L  AF+  D +  + E+ +GGELF  ++  +   +E         I+      A+
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLS-RERVFTEERARFYGAEIVS-----AL 118

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL-DPNEVVKISTGTAEFAAPEI 283
           +++H +++++ D+K EN+M       ++K+ DFGL  +       +K   GT E+ APE+
Sbjct: 119 EYLHSRDVVYRDIKLENLML--DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 176

Query: 284 VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG 343
           +E    G   D W +GV+ Y ++ G  PF  ++     + +   +  F     + +S E 
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEA 232

Query: 344 KDFIRRLLLRN 354
           K  +  LL ++
Sbjct: 233 KSLLAGLLKKD 243

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 7e-49
 Identities = 58/256 (22%), Positives = 95/256 (37%), Gaps = 26/256 (10%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK------ELIRKEIDIMNQ 161
             Y +   +G+G FG V+           A K +      +         +  E+ ++ +
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 162 LH--HPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQ 219
           +      +I L D FE  D  VLI E     +           + E         +L   
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE-- 121

Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFA 279
              AV+H H   ++H D+K ENI+    N   +K+IDFG    L  + V     GT  ++
Sbjct: 122 ---AVRHCHNCGVLHRDIKDENILI-DLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYS 176

Query: 280 APEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKN 338
            PE +      G    +W++G+L Y ++ G  PF  +        +      F +     
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQ----R 226

Query: 339 VSEEGKDFIRRLLLRN 354
           VS E +  IR  L   
Sbjct: 227 VSSECQHLIRWCLALR 242

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 6e-48
 Identities = 54/252 (21%), Positives = 102/252 (40%), Gaps = 15/252 (5%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKL 167
                L+E+GTG FGVV   + R      A K I      E E I  E  +M  L H KL
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIE-EAKVMMNLSHEKL 61

Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
           + L+        + +I E+++ G L   +    ++    +++ +   +       A++++
Sbjct: 62  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE-----AMEYL 116

Query: 228 HEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFAAPEIVE 285
             K  +H D+   N +    +   VK+ DFGL+  +  +E            ++ PE++ 
Sbjct: 117 ESKQFLHRDLAARNCLV--NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM 174

Query: 286 REPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
                  +D+WA GVL + + S G  P+    + ET +++      +        SE+  
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH---LASEKVY 231

Query: 345 DFIRRLLLRNKE 356
             +        +
Sbjct: 232 TIMYSCWHEKAD 243

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 1e-47
 Identities = 51/253 (20%), Positives = 106/253 (41%), Gaps = 15/253 (5%)

Query: 107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPK 166
                 ++EIG+G FG+VH        +  A K I      E++ I  E ++M +L HPK
Sbjct: 4   PSELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIE-EAEVMMKLSHPK 61

Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKH 226
           L+ L+    +   + L+FEF+  G L + +       +   ++ + L +        + +
Sbjct: 62  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE-----GMAY 116

Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFAAPEIV 284
           + E  +IH D+   N +     +  +K+ DFG+   +  ++    +      ++A+PE+ 
Sbjct: 117 LEEACVIHRDLAARNCLV--GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 174

Query: 285 EREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG 343
                   +D+W+ GVL + + S G  P+   ++ E ++++      +        S   
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPR---LASTHV 231

Query: 344 KDFIRRLLLRNKE 356
              +        E
Sbjct: 232 YQIMNHCWKERPE 244

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (399), Expect = 8e-47
 Identities = 48/252 (19%), Positives = 101/252 (40%), Gaps = 19/252 (7%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKL 167
               +L+ IG G FG V     R  GN  A K I   ++   +    E  +M QL H  L
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNL 62

Query: 168 INLHDAF-EDDDEMVLIFEFLSGGELFERITAPDYK-MSEAEVIPVTLPILMTQTSPAVK 225
           + L     E+   + ++ E+++ G L + + +     +    ++  +L +       A++
Sbjct: 63  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE-----AME 117

Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVE 285
           ++   N +H D+   N++    N    K+ DFGL  +    +         ++ APE + 
Sbjct: 118 YLEGNNFVHRDLAARNVLVSEDN--VAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALR 173

Query: 286 REPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK 344
            +     +D+W+ G+L + + S G  P+      + +  V+     +  +A         
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK---GYKMDAPDGCPPAVY 230

Query: 345 DFIRRLLLRNKE 356
           + ++     +  
Sbjct: 231 EVMKNCWHLDAA 242

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 1e-46
 Identities = 57/295 (19%), Positives = 114/295 (38%), Gaps = 32/295 (10%)

Query: 90  IYSKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV------ 143
            Y  +     D+K     ++ +  + +G+GAFG V             +  + V      
Sbjct: 19  FYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK 78

Query: 144 SHNLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK 202
           + + E+E +  E+ +M QL  H  ++NL  A      + LIFE+   G+L   + +   K
Sbjct: 79  ADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREK 138

Query: 203 MSEAEVIPVTLPIL-----------------MTQTSPAVKHMHEKNIIHLDVKPENIMCQ 245
            SE E+       L                   Q +  ++ +  K+ +H D+   N++  
Sbjct: 139 FSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT 198

Query: 246 TRNSTNVKMIDFGLATKLDPNEVVKIST---GTAEFAAPEIVEREPVGFYTDMWAVGVLA 302
                 VK+ DFGLA  +  +    +        ++ APE +        +D+W+ G+L 
Sbjct: 199 HGK--VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 256

Query: 303 YVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE 356
           + + S G++P+ G         +    ++ D+      +EE    ++     +  
Sbjct: 257 WEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQP--FYATEEIYIIMQSCWAFDSR 309

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 7e-46
 Identities = 53/260 (20%), Positives = 97/260 (37%), Gaps = 21/260 (8%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGN---IFAAKFIPVSHNLEKEL---IRKEIDIMNQ 161
               +LE++G G+FGVV R             A K +      + E      +E++ M+ 
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 162 LHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTS 221
           L H  LI L+        M ++ E    G L +R+           +          Q +
Sbjct: 68  LDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVA 121

Query: 222 PAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST----GTAE 277
             + ++  K  IH D+   N++  TR+   VK+ DFGL   L  N+   +          
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRD--LVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179

Query: 278 FAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAF 336
           + APE ++       +D W  GV  + + + G  P+ G N  + L  +            
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP-- 237

Query: 337 KNVSEEGKDFIRRLLLRNKE 356
           ++  ++  + + +      E
Sbjct: 238 EDCPQDIYNVMVQCWAHKPE 257

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 8e-46
 Identities = 68/274 (24%), Positives = 113/274 (41%), Gaps = 39/274 (14%)

Query: 112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK-----ELIRKEIDIMNQLHHPK 166
            L+ +G G F  V++ R++ T  I A K I + H  E          +EI ++ +L HP 
Sbjct: 2   KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 61

Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKH 226
           +I L DAF     + L+F+F+        I      ++ + +    L  L       +++
Sbjct: 62  IIGLLDAFGHKSNISLVFDFMETDLEVI-IKDNSLVLTPSHIKAYMLMTLQ-----GLEY 115

Query: 227 MHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL-DPNEVVKISTGTAEFAAPEIVE 285
           +H+  I+H D+KP N++     +  +K+ DFGLA     PN        T  + APE++ 
Sbjct: 116 LHQHWILHRDLKPNNLLL--DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF 173

Query: 286 R-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEE---------- 334
                G   DMWAVG +   LL  +    G++D++ L  +        EE          
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233

Query: 335 --------------AFKNVSEEGKDFIRRLLLRN 354
                          F    ++  D I+ L L N
Sbjct: 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFN 267

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 1e-45
 Identities = 76/259 (29%), Positives = 139/259 (53%), Gaps = 20/259 (7%)

Query: 108 DHYDILEEIGTGAFGVVHRCRE---RKTGNIFAAKFIPVSHNLEK----ELIRKEIDIMN 160
           +++++L+ +GTGA+G V   R+     TG ++A K +  +  ++K    E  R E  ++ 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 161 QL-HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQ 219
            +   P L+ LH AF+ + ++ LI ++++GGELF  + +   + +E EV      I + +
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL-SQRERFTEHEV-----QIYVGE 137

Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP--NEVVKISTGTAE 277
              A++H+H+  II+ D+K ENI+    ++ +V + DFGL+ +      E      GT E
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILL--DSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 195

Query: 278 FAAPEIVEREPVGFY--TDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEA 335
           + AP+IV     G     D W++GVL Y LL+G SPF  + +  +   +     + +   
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 255

Query: 336 FKNVSEEGKDFIRRLLLRN 354
            + +S   KD I+RLL+++
Sbjct: 256 PQEMSALAKDLIQRLLMKD 274

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 2e-45
 Identities = 53/252 (21%), Positives = 105/252 (41%), Gaps = 17/252 (6%)

Query: 107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPK 166
            +   ++E +G G FG V            A K +          +  E ++M QL H +
Sbjct: 12  RETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLA-EANLMKQLQHQR 69

Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPD-YKMSEAEVIPVTLPILMTQTSPAVK 225
           L+ L+     +  + +I E++  G L + +  P   K++  +++ +   I        + 
Sbjct: 70  LVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE-----GMA 123

Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFAAPEI 283
            + E+N IH D++  NI+       + K+ DFGLA  ++ NE           ++ APE 
Sbjct: 124 FIEERNYIHRDLRAANILVSDTL--SCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181

Query: 284 VEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEE 342
           +        +D+W+ G+L   +++ G  P+ G  + E ++N++        +   N  EE
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD---NCPEE 238

Query: 343 GKDFIRRLLLRN 354
               +R      
Sbjct: 239 LYQLMRLCWKER 250

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 3e-45
 Identities = 54/254 (21%), Positives = 103/254 (40%), Gaps = 18/254 (7%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL----EKELIRKEIDIMNQLH 163
           +  ++   IG G FG VH+       N   A  I    N      +E   +E   M Q  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 164 HPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPA 223
           HP ++ L     ++  + +I E  + GEL   +    Y +  A +I     +   Q S A
Sbjct: 67  HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLI-----LYAYQLSTA 120

Query: 224 VKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFAAP 281
           + ++  K  +H D+   N++  + +   VK+ DFGL+  ++ +   K S      ++ AP
Sbjct: 121 LAYLESKRFVHRDIAARNVLVSSND--CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178

Query: 282 EIVEREPVGFYTDMWAVGVLAY-VLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVS 340
           E +        +D+W  GV  + +L+ G+ PF G  + + +  ++  +         N  
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE---RLPMPPNCP 235

Query: 341 EEGKDFIRRLLLRN 354
                 + +    +
Sbjct: 236 PTLYSLMTKCWAYD 249

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 9e-45
 Identities = 57/258 (22%), Positives = 107/258 (41%), Gaps = 20/258 (7%)

Query: 108 DHYDILE-EIGTGAFGVVHRC--RERKTGNIFAAKFI-PVSHNLEKELIRKEIDIMNQLH 163
           D+  I + E+G G FG V +   R RK     A K +   +   + E + +E  IM+QL 
Sbjct: 8   DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD 67

Query: 164 HPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPA 223
           +P ++ L    + +  ++L+ E   GG L + +     ++  + V  +   + M      
Sbjct: 68  NPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM-----G 121

Query: 224 VKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST----GTAEFA 279
           +K++ EKN +H D+   N++    N    K+ DFGL+  L  ++    +        ++ 
Sbjct: 122 MKYLEEKNFVHRDLAARNVLLV--NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179

Query: 280 APEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKN 338
           APE +        +D+W+ GV  +  LS G  P+      E +  ++        E    
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK---RMECPPE 236

Query: 339 VSEEGKDFIRRLLLRNKE 356
              E    +    +   E
Sbjct: 237 CPPELYALMSDCWIYKWE 254

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  153 bits (387), Expect = 1e-44
 Identities = 53/262 (20%), Positives = 91/262 (34%), Gaps = 20/262 (7%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKL 167
           + Y +  +IG+G+FG ++   +   G   A K   V     +  +  E  I   +     
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVG 64

Query: 168 INLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHM 227
           I        + +  ++   L G  L +       K S   V+     +L  Q    ++++
Sbjct: 65  IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVL-----LLADQMISRIEYI 119

Query: 228 HEKNIIHLDVKPENIMCQTRNSTN-VKMIDFGLATKLDPNEVVKIS--------TGTAEF 278
           H KN IH DVKP+N +       N V +IDFGLA K       +          TGTA +
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179

Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACD----WEFDEE 334
           A+             D+ ++G +      G  P+ G       +  +           E 
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239

Query: 335 AFKNVSEEGKDFIRRLLLRNKE 356
             K    E   ++        +
Sbjct: 240 LCKGYPSEFATYLNFCRSLRFD 261

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 2e-44
 Identities = 55/279 (19%), Positives = 103/279 (36%), Gaps = 44/279 (15%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLIN 169
           Y   + IG G+FGVV++ +   +G + A K +      +K    +E+ IM +L H  ++ 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVR 77

Query: 170 LHDAFEDDDE------MVLIFEFLSGG--ELFERITAPDYKMSEAEVIPVTLPILMTQTS 221
           L   F    E      + L+ +++      +    +     +    V      + M Q  
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK-----LYMYQLF 132

Query: 222 PAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAP 281
            ++ ++H   I H D+KP+N++    ++  +K+ DFG A +L   E       +  + AP
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 191

Query: 282 -EIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV---------------- 324
             I          D+W+ G +   LL G   F G++ V+ L  +                
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251

Query: 325 ---------KACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
                    +     + +        E      RLL   
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT 290

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (386), Expect = 2e-44
 Identities = 63/281 (22%), Positives = 113/281 (40%), Gaps = 41/281 (14%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGN-IFAAKFIPVSHNLEKELIR--KEIDIMNQL-- 162
             Y+ + EIG GA+G V + R+ K G    A K + V    E   +   +E+ ++  L  
Sbjct: 7   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66

Query: 163 -HHPKLINLHDAF-----EDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPIL 216
             HP ++ L D       + + ++ L+FE +           P+  +    +       +
Sbjct: 67  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK-----DM 121

Query: 217 MTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTA 276
           M Q    +  +H   ++H D+KP+NI+  +     +K+ DFGLA        +     T 
Sbjct: 122 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG--QIKLADFGLARIYSFQMALTSVVVTL 179

Query: 277 EFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKAC-------DW 329
            + APE++ +       D+W+VG +   +      F G +DV+ L  +          DW
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239

Query: 330 EFD----------------EEAFKNVSEEGKDFIRRLLLRN 354
             D                E+   ++ E GKD + + L  N
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFN 280

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 3e-44
 Identities = 57/276 (20%), Positives = 117/276 (42%), Gaps = 36/276 (13%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK--ELIRKEIDIMNQLHHP 165
           +++  +E+IG G +GVV++ R + TG + A K I +    E       +EI ++ +L+HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++ L D    ++++ L+FEFL          +    +    +        + Q    + 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK-----SYLFQLLQGLA 116

Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEFAAPEIV 284
             H   ++H D+KP+N++  T     +K+ DFGLA     P         T  + APEI+
Sbjct: 117 FCHSHRVLHRDLKPQNLLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174

Query: 285 EREP-VGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE---------- 333
                     D+W++G +   +++  + F G+++++ L  +       DE          
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234

Query: 334 ---------------EAFKNVSEEGKDFIRRLLLRN 354
                          +    + E+G+  + ++L  +
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYD 270

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  152 bits (385), Expect = 8e-44
 Identities = 68/285 (23%), Positives = 138/285 (48%), Gaps = 19/285 (6%)

Query: 73  RGKADEKVSDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKT 132
           +G   E V ++     + + K    P   + ++  D +D ++ +GTG+FG V   + +++
Sbjct: 8   KGSEQESVKEFLAKAKEDFLKKWETPS--QNTAQLDQFDRIKTLGTGSFGRVMLVKHKES 65

Query: 133 GNIFAAKFIPVSHNLEKELI---RKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSG 189
           GN +A K +     ++ + I     E  I+  ++ P L+ L  +F+D+  + ++ E+++G
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125

Query: 190 GELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNS 249
           GE+F  +     + SE         I++       +++H  ++I+ D+KPEN++   +  
Sbjct: 126 GEMFSHLRRIG-RFSEPHARFYAAQIVL-----TFEYLHSLDLIYRDLKPENLLIDQQG- 178

Query: 250 TNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGL 309
             +++ DFG A ++          GT E  APEI+  +      D WA+GVL Y + +G 
Sbjct: 179 -YIQVTDFGFAKRVKGRT--WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235

Query: 310 SPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
            PF  +  ++  + + +    F      + S + KD +R LL  +
Sbjct: 236 PPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVD 276

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 2e-43
 Identities = 57/263 (21%), Positives = 108/263 (41%), Gaps = 20/263 (7%)

Query: 107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR---KEIDIMNQL- 162
           ++     + IG G FG V + R +K G    A    +     K+  R    E++++ +L 
Sbjct: 9   WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG 68

Query: 163 HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERI-------TAPDYKMSEAEVIPVTLPI 215
           HHP +INL  A E    + L  E+   G L + +       T P + ++ +    ++   
Sbjct: 69  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128

Query: 216 L---MTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIS 272
           L       +  + ++ +K  IH D+   NI+     +   K+ DFGL+   +      + 
Sbjct: 129 LLHFAADVARGMDYLSQKQFIHRDLAARNILVG--ENYVAKIADFGLSRGQEVYVKKTMG 186

Query: 273 TGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEF 331
                + A E +        +D+W+ GVL + ++S G +P+ G    E  + +      +
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---Y 243

Query: 332 DEEAFKNVSEEGKDFIRRLLLRN 354
             E   N  +E  D +R+     
Sbjct: 244 RLEKPLNCDDEVYDLMRQCWREK 266

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  148 bits (374), Expect = 5e-43
 Identities = 55/276 (19%), Positives = 105/276 (38%), Gaps = 38/276 (13%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK--ELIRKEIDIMNQLHHP 165
           + Y  LE+IG G +GVV++ +    G  FA K I +    E       +EI I+ +L H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60

Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++ L+D       +VL+FE L            +  +         L +L       + 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV-CEGGLESVTAKSFLLQLLN-----GIA 114

Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFAAPEI 283
           + H++ ++H D+KP+N++        +K+ DFGLA                    A   +
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREG--ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172

Query: 284 VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEA-------- 335
           +  +      D+W+VG +   +++G   F G ++ + L  +       + +         
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232

Query: 336 -----------------FKNVSEEGKDFIRRLLLRN 354
                             K + E G D + ++L  +
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLD 268

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  148 bits (375), Expect = 6e-43
 Identities = 50/251 (19%), Positives = 106/251 (42%), Gaps = 13/251 (5%)

Query: 107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPK 166
                +  ++G G +G V+    +K     A K +       +E ++ E  +M ++ HP 
Sbjct: 16  RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPN 74

Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERIT-APDYKMSEAEVIPVTLPILMTQTSPAVK 225
           L+ L      +    +I EF++ G L + +      ++S   ++      + TQ S A++
Sbjct: 75  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL-----YMATQISSAME 129

Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFAAPEI 283
           ++ +KN IH D+   N +     +  VK+ DFGL+  +  +     +      ++ APE 
Sbjct: 130 YLEKKNFIHRDLAARNCLV--GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 187

Query: 284 VEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG 343
           +        +D+WA GVL + + +         D+  +   +  + ++  E  +   E+ 
Sbjct: 188 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--YELLEKDYRMERPEGCPEKV 245

Query: 344 KDFIRRLLLRN 354
            + +R     N
Sbjct: 246 YELMRACWQWN 256

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  148 bits (375), Expect = 7e-43
 Identities = 52/277 (18%), Positives = 110/277 (39%), Gaps = 33/277 (11%)

Query: 108 DHYDILEEIGTGAFGVVHRCRER-----KTGNIFAAKFIPVSHNLE-KELIRKEIDIMNQ 161
           ++ + + +IG GAFG V + R       +   + A K +    + + +   ++E  +M +
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 162 LHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERI---------------TAPDYKMSEA 206
             +P ++ L         M L+FE+++ G+L E +                +   ++S  
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 207 EVIPVTLP---ILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL 263
              P++      +  Q +  + ++ E+  +H D+   N +        VK+ DFGL+  +
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM--VVKIADFGLSRNI 190

Query: 264 DPNEVVKIST---GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVE 319
              +  K          +  PE +        +D+WA GV+ + + S GL P+ G    E
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250

Query: 320 TLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE 356
            +  V+  +        +N   E  + +R    +   
Sbjct: 251 VIYYVRDGNI---LACPENCPLELYNLMRLCWSKLPA 284

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (378), Expect = 7e-43
 Identities = 62/284 (21%), Positives = 109/284 (38%), Gaps = 46/284 (16%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI-PVSHNLEKELIRKEIDIMNQLHHPK 166
             Y  L  IG GA+G+V    +       A K I P  H    +   +EI I+ +  H  
Sbjct: 8   PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 67

Query: 167 LINLHDAFEDDD----EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSP 222
           +I ++D          + V +   L G +L++ +      +S   +      IL      
Sbjct: 68  IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK--TQHLSNDHICYFLYQILR----- 120

Query: 223 AVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGT----AEF 278
            +K++H  N++H D+KP N++  T    ++K+ DFGLA   DP+               +
Sbjct: 121 GLKYIHSANVLHRDLKPSNLLLNTTC--DLKICDFGLARVADPDHDHTGFLTEYVATRWY 178

Query: 279 AAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEE--- 334
            APEI+          D+W+VG +   +LS    F G++ ++ L ++        +E   
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238

Query: 335 ------------------------AFKNVSEEGKDFIRRLLLRN 354
                                    F N   +  D + ++L  N
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFN 282

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  148 bits (374), Expect = 7e-43
 Identities = 50/265 (18%), Positives = 95/265 (35%), Gaps = 24/265 (9%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKL 167
            HY +   IG G+FGV+            A KF P   +  +  +R E      L     
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ--LRDEYRTYKLLAGCTG 62

Query: 168 IN-LHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKH 226
           I  ++   ++    VL+ + L G  L + +     K S   V      +   Q    V+ 
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVA-----MAAKQMLARVQS 116

Query: 227 MHEKNIIHLDVKPENIMC---QTRNSTNVKMIDFGLATKLDPNEVVKIS--------TGT 275
           +HEK++++ D+KP+N +     ++N+  + ++DFG+          +          +GT
Sbjct: 117 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176

Query: 276 AEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD--- 332
           A + +             D+ A+G +    L G  P+ G       +  +    +     
Sbjct: 177 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236

Query: 333 -EEAFKNVSEEGKDFIRRLLLRNKE 356
             E      EE   ++        +
Sbjct: 237 LRELCAGFPEEFYKYMHYARNLAFD 261

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  146 bits (370), Expect = 3e-42
 Identities = 46/260 (17%), Positives = 103/260 (39%), Gaps = 21/260 (8%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGN---IFAAKFIPVSHNL-EKELIRKEIDIMNQLH 163
               I + IG G FG V     +  G      A K +   +   ++     E  IM Q  
Sbjct: 26  SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85

Query: 164 HPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPA 223
           HP +I+L         +++I EF+  G L   +   D + +  +++      ++   +  
Sbjct: 86  HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLV-----GMLRGIAAG 140

Query: 224 VKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST------GTAE 277
           +K++ + N +H D+   NI+  +      K+ DFGL+  L+ +      T          
Sbjct: 141 MKYLADMNYVHRDLAARNILVNSNL--VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIR 198

Query: 278 FAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAF 336
           + APE ++       +D+W+ G++ + ++S G  P+    + + +  +   + ++     
Sbjct: 199 WTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI---EQDYRLPPP 255

Query: 337 KNVSEEGKDFIRRLLLRNKE 356
            +        +     +++ 
Sbjct: 256 MDCPSALHQLMLDCWQKDRN 275

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 1e-41
 Identities = 60/291 (20%), Positives = 103/291 (35%), Gaps = 52/291 (17%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIR--KEIDIMNQLHHP 165
             Y+ L +IG G FG V + R RKTG   A K + + +  E   I   +EI I+  L H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 166 KLINLHDAFEDDDE--------MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILM 217
            ++NL +               + L+F+F               K + +E+  V   +L 
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-KFTLSEIKRVMQMLLN 128

Query: 218 TQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST---- 273
                 + ++H   I+H D+K  N++        +K+ DFGLA      +  + +     
Sbjct: 129 -----GLYYIHRNKILHRDMKAANVLIT--RDGVLKLADFGLARAFSLAKNSQPNRYTNR 181

Query: 274 -GTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEF 331
             T  +  PE++  E   G   D+W  G +   + +      G  +   L  +       
Sbjct: 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241

Query: 332 DEEAFKNV----------------------------SEEGKDFIRRLLLRN 354
             E + NV                                 D I +LL+ +
Sbjct: 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLD 292

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 3e-41
 Identities = 60/277 (21%), Positives = 110/277 (39%), Gaps = 38/277 (13%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK--ELIRKEIDIMNQLHHP 165
             Y+ LE+IG G +G V + + R+T  I A K + +  + E       +EI ++ +L H 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 166 KLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVK 225
            ++ LHD    D ++ L+FEF              +     ++ P  +   + Q    + 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKK------YFDSCNGDLDPEIVKSFLFQLLKGLG 115

Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD-PNEVVKISTGTAEFAAPEIV 284
             H +N++H D+KP+N++        +K+ +FGLA     P         T  +  P+++
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNG--ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173

Query: 285 EREPV-GFYTDMWAVGVLAYVLLSGLSP-FAGENDVETLKNVKACDWEFDEE-------- 334
               +     DMW+ G +   L +   P F G +  + LK +        EE        
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233

Query: 335 -----------------AFKNVSEEGKDFIRRLLLRN 354
                                ++  G+D ++ LL  N
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCN 270

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 4e-41
 Identities = 50/271 (18%), Positives = 98/271 (36%), Gaps = 27/271 (9%)

Query: 107 YDHYDILEEIGTGAFGVVHRCR-----ERKTGNIFAAKFIPVSHNL-EKELIRKEIDIMN 160
            +     + +G GAFG V         +       A K +  S +L E+E +  E+ +++
Sbjct: 22  RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLS 81

Query: 161 QL-HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI---- 215
            L +H  ++NL  A       ++I E+   G+L   +         ++  P  +      
Sbjct: 82  YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141

Query: 216 --------LMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE 267
                      Q +  +  +  KN IH D+   NI+         K+ DFGLA  +  + 
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR--ITKICDFGLARDIKNDS 199

Query: 268 VVKIST---GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSP-FAGENDVETLKN 323
              +        ++ APE +      F +D+W+ G+  + L S  S  + G         
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259

Query: 324 VKACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
           +    +       ++   E  D ++     +
Sbjct: 260 MIKEGFRMLSP--EHAPAEMYDIMKTCWDAD 288

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 5e-41
 Identities = 51/254 (20%), Positives = 102/254 (40%), Gaps = 17/254 (6%)

Query: 107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPK 166
            +   +  ++G G FG V       T  + A K +       +  ++ E  +M +L H K
Sbjct: 16  RESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAFLQ-EAQVMKKLRHEK 73

Query: 167 LINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYK-MSEAEVIPVTLPILMTQTSPAVK 225
           L+ L+     ++ + ++ E++S G L + +     K +   +++ +   I        + 
Sbjct: 74  LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG-----MA 127

Query: 226 HMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--GTAEFAAPEI 283
           ++   N +H D++  NI+         K+ DFGLA  ++ NE           ++ APE 
Sbjct: 128 YVERMNYVHRDLRAANILVGENL--VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 185

Query: 284 VEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEE 342
                    +D+W+ G+L   L + G  P+ G  + E L  V+     +         E 
Sbjct: 186 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPES 242

Query: 343 GKDFIRRLLLRNKE 356
             D + +   +  E
Sbjct: 243 LHDLMCQCWRKEPE 256

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 1e-40
 Identities = 54/251 (21%), Positives = 104/251 (41%), Gaps = 21/251 (8%)

Query: 115 EIGTGAFGVVHRC--RERKTGNIFAAKFIPVSHNLE--KELIRKEIDIMNQLHHPKLINL 170
           E+G+G FG V +   + +K     A K +    N    K+ +  E ++M QL +P ++ +
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73

Query: 171 HDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEK 230
               E +  M L+ E    G L + +   +  + +  +I +   + M      +K++ E 
Sbjct: 74  IGICEAESWM-LVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSM-----GMKYLEES 126

Query: 231 NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST----GTAEFAAPEIVER 286
           N +H D+   N++  T++    K+ DFGL+  L  +E    +        ++ APE +  
Sbjct: 127 NFVHRDLAARNVLLVTQH--YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184

Query: 287 EPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD 345
                 +D+W+ GVL +   S G  P+ G    E    ++  +             E  D
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE---RMGCPAGCPREMYD 241

Query: 346 FIRRLLLRNKE 356
            +      + E
Sbjct: 242 LMNLCWTYDVE 252

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  143 bits (360), Expect = 2e-40
 Identities = 58/285 (20%), Positives = 112/285 (39%), Gaps = 51/285 (17%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL-HHPK 166
           D Y ++ ++G G +  V              K +     ++K+ I++EI I+  L   P 
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPN 91

Query: 167 LINLHDAFEDDDE--MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAV 224
           +I L D  +D       L+FE ++  +  +        +++ ++        M +   A+
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIR-----FYMYEILKAL 142

Query: 225 KHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEI- 283
            + H   I+H DVKP N+M    +   +++ID+GLA    P +   +   +  F  PE+ 
Sbjct: 143 DYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 201

Query: 284 VEREPVGFYTDMWAVGVLAYVLLSGLSPF-AGENDVETLKNV------------------ 324
           V+ +   +  DMW++G +   ++    PF  G ++ + L  +                  
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261

Query: 325 ---------------KACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
                          K  +     E    VS E  DF+ +LL  +
Sbjct: 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD 306

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 4e-40
 Identities = 58/283 (20%), Positives = 107/283 (37%), Gaps = 44/283 (15%)

Query: 106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI--PVSHNLEKELIRKEIDIMNQLH 163
           V + Y  L  +G+GA+G V    + KTG   A K +  P    +  +   +E+ ++  + 
Sbjct: 16  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 75

Query: 164 HPKLINLHDAFED-----DDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMT 218
           H  +I L D F       +   V +   L G +L   +          + +       + 
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-------IY 128

Query: 219 QTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEF 278
           Q    +K++H  +IIH D+KP N+         +K++DFGLA   D      ++T     
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNLAVNEDC--ELKILDFGLARHTDDEMTGYVAT-RWYR 185

Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEE---- 334
           A   ++         D+W+VG +   LL+G + F G + ++ LK +         E    
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245

Query: 335 -----------------------AFKNVSEEGKDFIRRLLLRN 354
                                   F   +    D + ++L+ +
Sbjct: 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 288

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 4e-40
 Identities = 54/267 (20%), Positives = 109/267 (40%), Gaps = 19/267 (7%)

Query: 92  SKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL 151
           +++    V   T +V   Y  L+ IG+GA G+V    +       A K +      +   
Sbjct: 1   NQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA 60

Query: 152 --IRKEIDIMNQLHHPKLINLHDAF------EDDDEMVLIFEFLSGGELFERITAPDYKM 203
               +E+ +M  ++H  +I+L + F      E+  ++ L+ E +              ++
Sbjct: 61  KRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ----MEL 116

Query: 204 SEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL 263
               +       L+ Q    +KH+H   IIH D+KP NI+ ++     +K++DFGLA   
Sbjct: 117 DHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTA 169

Query: 264 DPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKN 323
             + ++     T  + APE++         D+W+VG +   ++     F G + ++    
Sbjct: 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 229

Query: 324 VKACDWEFDEEAFKNVSEEGKDFIRRL 350
           V         E  K +    ++++   
Sbjct: 230 VIEQLGTPCPEFMKKLQPTVRNYVENR 256

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 4e-40
 Identities = 41/256 (16%), Positives = 95/256 (37%), Gaps = 20/256 (7%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFI-----PVSHNLEKELIRKEIDIMNQL 162
             +  ++ +G+GAFG V++      G               +     + I  E  +M  +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68

Query: 163 HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSP 222
            +P +  L           LI + +  G L + +      +    ++   + I       
Sbjct: 69  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK----- 122

Query: 223 AVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST---GTAEFA 279
            + ++ ++ ++H D+   N++ +T    +VK+ DFGLA  L   E    +       ++ 
Sbjct: 123 GMNYLEDRRLVHRDLAARNVLVKTPQ--HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180

Query: 280 APEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKN 338
           A E +        +D+W+ GV  + L++ G  P+ G    E    ++  +          
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE---RLPQPPI 237

Query: 339 VSEEGKDFIRRLLLRN 354
            + +    + +  + +
Sbjct: 238 CTIDVYMIMVKCWMID 253

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 8e-40
 Identities = 58/293 (19%), Positives = 109/293 (37%), Gaps = 40/293 (13%)

Query: 94  YVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEK--EL 151
           +  Q V      V   Y  L+ +G+GA+G V    + +TG   A K +      E   + 
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 152 IRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITA---PDYKMSEAEV 208
             +E+ ++  + H  +I L D F  D+ +    +F                  K+ E  +
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123

Query: 209 IPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEV 268
                  L+ Q    ++++H   IIH D+KP N+         +K++DFGLA + D +E+
Sbjct: 124 Q-----FLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN--EDCELKILDFGLARQAD-SEM 175

Query: 269 VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACD 328
                     A   I+         D+W+VG +   +++G + F G + ++ LK +    
Sbjct: 176 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 235

Query: 329 WEFDEE---------------------------AFKNVSEEGKDFIRRLLLRN 354
                E                              N S    + + ++L+ +
Sbjct: 236 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLD 288

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 2e-37
 Identities = 45/258 (17%), Positives = 99/258 (38%), Gaps = 18/258 (6%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGN----IFAAKFIPVSHNL-EKELIRKEIDIMNQL 162
                 + IG G FG V++   + +        A K +   +   ++     E  IM Q 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 163 HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSP 222
            H  +I L         M++I E++  G L + +   D + S  +++      ++   + 
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLV-----GMLRGIAA 121

Query: 223 AVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST----GTAEF 278
            +K++   N +H D+   NI+  +      K+ DFGL+  L+ +     +T        +
Sbjct: 122 GMKYLANMNYVHRDLAARNILVNSNL--VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179

Query: 279 AAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKN 338
            APE +        +D+W+ G++ + +++       E     +  +KA +  F      +
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV--MKAINDGFRLPTPMD 237

Query: 339 VSEEGKDFIRRLLLRNKE 356
                   + +   + + 
Sbjct: 238 CPSAIYQLMMQCWQQERA 255

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 2e-37
 Identities = 41/264 (15%), Positives = 104/264 (39%), Gaps = 19/264 (7%)

Query: 107 YDHYDILEEIGTGAFGVVHRCRER-----KTGNIFAAKFIPVSHNL-EKELIRKEIDIMN 160
            +   +  E+G G+FG+V+    +     +     A K +  + ++ E+     E  +M 
Sbjct: 19  REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMK 78

Query: 161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPV----TLPIL 216
           + +   ++ L          ++I E ++ G+L   + +    M+   V+       +  +
Sbjct: 79  EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138

Query: 217 MTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKIST--- 273
             + +  + +++    +H D+   N M        VK+ DFG+   +   +  +      
Sbjct: 139 AGEIADGMAYLNANKFVHRDLAARNCMV--AEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 274 GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGL-SPFAGENDVETLKNVKACDWEFD 332
               + +PE ++      Y+D+W+ GV+ + + +    P+ G ++ + L+ V        
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL--- 253

Query: 333 EEAFKNVSEEGKDFIRRLLLRNKE 356
            +   N  +   + +R     N +
Sbjct: 254 LDKPDNCPDMLFELMRMCWQYNPK 277

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 1e-36
 Identities = 54/271 (19%), Positives = 101/271 (37%), Gaps = 23/271 (8%)

Query: 97  QPVDIKTSSVYDHYDILEEIGTGAFGVVHRCR---ERKTGNIFAAKFI-PVSHNLEKELI 152
           Q V I  SS+  H++  E IG G FG V+              A K +  ++   E    
Sbjct: 18  QHVVIGPSSLIVHFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF 75

Query: 153 RKEIDIMNQLHHPKLINLHDA-FEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPV 211
             E  IM    HP +++L       +   +++  ++  G+L   I    +  +  ++I  
Sbjct: 76  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-- 133

Query: 212 TLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVVKI 271
                  Q +  +K +  K  +H D+   N M        VK+ DFGLA  +   E   +
Sbjct: 134 ---GFGLQVAKGMKFLASKKFVHRDLAARNCML--DEKFTVKVADFGLARDMYDKEFDSV 188

Query: 272 ST-----GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVK 325
                     ++ A E ++ +     +D+W+ GVL + L++ G  P+   N  +    + 
Sbjct: 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 248

Query: 326 ACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE 356
                   E      +   + + +      E
Sbjct: 249 QGRRLLQPE---YCPDPLYEVMLKCWHPKAE 276

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 3e-36
 Identities = 52/268 (19%), Positives = 93/268 (34%), Gaps = 24/268 (8%)

Query: 108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV--------SHNLEKELIRKEIDIM 159
           D   + + +G GAFG V              +   V        +   +   +  E+++M
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 160 NQL-HHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLP---- 214
             +  H  +INL  A   D  + +I E+ S G L E + A      E    P   P    
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 215 ------ILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMI-DFGLATKLDPNE 267
                     Q +  ++++  K  IH D+   N++    N   +           +D  +
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192

Query: 268 VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKA 326
                    ++ APE +        +D+W+ GVL + + + G SP+ G    E  K +K 
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 252

Query: 327 CDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
                  +   N + E    +R      
Sbjct: 253 G---HRMDKPSNCTNELYMMMRDCWHAV 277

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 6e-35
 Identities = 53/254 (20%), Positives = 89/254 (35%), Gaps = 25/254 (9%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLIN 169
             + E IG G FG V R +    G   A K    S          EI     L H  ++ 
Sbjct: 5   IVLQESIGKGRFGEVWRGKW--RGEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILG 61

Query: 170 LHDAFEDDD----EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPI---LMTQTSP 222
              A   D+    ++ L+ ++   G LF+ +    Y ++   +I + L     L      
Sbjct: 62  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHME 119

Query: 223 AVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE-----VVKISTGTAE 277
            V    +  I H D+K +NI+ +        + D GLA + D              GT  
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNG--TCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177

Query: 278 FAAPEIVERE------PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEF 331
           + APE+++              D++A+G++ + +    S      D +            
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237

Query: 332 DEEAFKNVSEEGKD 345
            EE  K V E+   
Sbjct: 238 VEEMRKVVCEQKLR 251

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 4e-33
 Identities = 52/272 (19%), Positives = 97/272 (35%), Gaps = 26/272 (9%)

Query: 107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPV-------SHNLEKELIRKEIDIM 159
            D   + + +G GAFG V              + + V       +H+  + L+ +   ++
Sbjct: 12  RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI 71

Query: 160 NQLHHPKLINLHDA-FEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLP---- 214
           +  HH  ++NL  A  +    +++I EF   G L   + +   +    +V P  L     
Sbjct: 72  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131

Query: 215 ------ILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEV 268
                     Q +  ++ +  +  IH D+   NI+   +N   VK+ DFGLA  +  +  
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN--VVKICDFGLARDIYKDPD 189

Query: 269 VKIST---GTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGL-SPFAGENDVETLKNV 324
                      ++ APE +        +D+W+ GVL + + S   SP+ G    E     
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249

Query: 325 KACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE 356
                     A    + E    +         
Sbjct: 250 LKEGTRM--RAPDYTTPEMYQTMLDCWHGEPS 279

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  106 bits (265), Expect = 1e-26
 Identities = 55/271 (20%), Positives = 101/271 (37%), Gaps = 34/271 (12%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLIN 169
           Y ++ ++G G F  V   ++       A K +     +  E    EI ++ +++      
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTK 73

Query: 170 L---------------HDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLP 214
                           +    +   +V++FE L    L          +    V  ++  
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 215 ILMTQTSPAVKHMHEK-NIIHLDVKPENIM----CQTRNSTNVKMIDFGLATKLDPNEVV 269
           +L+      + +MH +  IIH D+KPEN++        N   +K+ D G A   D +   
Sbjct: 134 LLL-----GLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-- 186

Query: 270 KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGE------NDVETLKN 323
             S  T E+ +PE++   P G   D+W+   L + L++G   F  +       D + +  
Sbjct: 187 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246

Query: 324 VKACDWEFDEEAFKNVSEEGKDFIRRLLLRN 354
           +     E      +N       F  R LLRN
Sbjct: 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRN 277

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 67.5 bits (164), Expect = 5e-14
 Identities = 25/168 (14%), Positives = 49/168 (29%), Gaps = 23/168 (13%)

Query: 110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKEL----------IRKEIDIM 159
             I + +G G    V  C   +       KF  V H   K++                  
Sbjct: 2   DAIGKLMGEGKESAVFNCY-SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60

Query: 160 NQLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQ 219
            +     L  L         +  ++ +     L E I A +       V       ++  
Sbjct: 61  ARNEFRALQKLQGLA-----VPKVYAWEGNAVLMELIDAKELYR----VRVENPDEVLDM 111

Query: 220 TSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE 267
               V   + + I+H D+   N++        + +IDF  + ++    
Sbjct: 112 ILEEVAKFYHRGIVHGDLSQYNVLVS---EEGIWIIDFPQSVEVGEEG 156

>d1x4za1 b.1.2.1 (A:8-115) Brother of CDO precursor (BOC) {Mouse (Mus musculus) [TaxId: 10090]} Length = 108

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Brother of CDO precursor (BOC)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 57.8 bits (139), Expect = 2e-11
 Identities = 18/53 (33%), Positives = 24/53 (45%), Gaps = 3/53 (5%)

Query: 2   SSWIRVGNTRF---TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK 51
             WI   +       ++ ITGL  G  Y+FRV A N+ G S+PS  S      
Sbjct: 55  GDWILATSAIPPSRLSVEITGLEKGISYKFRVRALNMLGESEPSAPSRPYVVS 107

>d1wisa1 b.1.2.1 (A:8-118) Sidekick 2 {Human (Homo sapiens) [TaxId: 9606]} Length = 111

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Sidekick 2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.3 bits (137), Expect = 4e-11
 Identities = 14/38 (36%), Positives = 19/38 (50%)

Query: 13  TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT 50
            +M +  L+P   Y FR+   N+ G S PS  S  I T
Sbjct: 72  RSMEVPDLNPFTCYSFRMRQVNIVGTSPPSQPSRKIQT 109

>d1uema_ b.1.2.1 (A:) KIAA1568 protein {Human (Homo sapiens) [TaxId: 9606]} Length = 117

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: KIAA1568 protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.2 bits (137), Expect = 6e-11
 Identities = 22/51 (43%), Positives = 27/51 (52%), Gaps = 1/51 (1%)

Query: 4   WIRVGNTRFTTM-AITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDT 53
           W  V N   TT+  + GL P   Y F V A N  G SDPS  SD + T+D+
Sbjct: 62  WQTVANHVKTTLYTVRGLRPNTIYLFMVRAINPQGLSDPSPMSDPVRTQDS 112

>d2ic2a1 b.1.2.1 (A:466-572) Hedgehog receptor iHog {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 107

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Hedgehog receptor iHog
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 55.8 bits (133), Expect = 1e-10
 Identities = 12/49 (24%), Positives = 18/49 (36%)

Query: 3   SWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK 51
                   +  T ++T L P H Y FR+ A      +  S TS     +
Sbjct: 58  PKWNSELGKSFTASVTDLKPQHTYRFRILAVYSNNDNKESNTSAKFYLQ 106

>d1ueya_ b.1.2.1 (A:) KIAA0343 protein {Human (Homo sapiens) [TaxId: 9606]} Length = 127

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: KIAA0343 protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.4 bits (132), Expect = 3e-10
 Identities = 18/41 (43%), Positives = 21/41 (51%)

Query: 13  TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDT 53
            T A   LSP   Y FRV A N  G+S PS  S+   TK +
Sbjct: 74  QTTAQLNLSPYVNYSFRVMAVNSIGKSLPSEASEQYLTKAS 114

>d1wf5a1 b.1.2.1 (A:8-115) Sidekick 2 {Human (Homo sapiens) [TaxId: 9606]} Length = 108

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Sidekick 2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.4 bits (130), Expect = 4e-10
 Identities = 11/52 (21%), Positives = 26/52 (50%)

Query: 1   MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD 52
            +  +   + + T++ + GL P   Y+FR+ A N  G+   S  ++ ++  +
Sbjct: 57  WTVLLASVDPKATSVTVKGLVPARSYQFRLCAVNDVGKGQFSKDTERVSLPE 108

>d1x5ya1 b.1.2.1 (A:8-105) Myosin binding protein C, fast-type {Mouse (Mus musculus) [TaxId: 10090]} Length = 98

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Myosin binding protein C, fast-type
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 53.7 bits (128), Expect = 5e-10
 Identities = 12/45 (26%), Positives = 20/45 (44%)

Query: 8  GNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD 52
                   +  L  G +  FRV   N+ GRS+P+T    +T ++
Sbjct: 54 EPVERCGFTVKDLPTGARILFRVVGVNIAGRSEPATLLQPVTIRE 98

>d1cfba1 b.1.2.1 (A:610-709) Neuroglian, two amino proximal Fn3 repeats {Drosophila melanogaster [TaxId: 7227]} Length = 100

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Neuroglian, two amino proximal Fn3 repeats
species: Drosophila melanogaster [TaxId: 7227]

 Score = 53.5 bits (127), Expect = 8e-10
 Identities = 16/39 (41%), Positives = 20/39 (51%)

Query: 13  TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK 51
            +  +  +SP   Y FRV A N  G S PS  SD  TT+
Sbjct: 62  DSSFVVQMSPWANYTFRVIAFNKIGASPPSAHSDSCTTQ 100

>d1bpva_ b.1.2.1 (A:) Type I titin module {Human (Homo sapiens) [TaxId: 9606]} Length = 104

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Type I titin module
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.5 bits (122), Expect = 4e-09
 Identities = 19/53 (35%), Positives = 25/53 (47%), Gaps = 1/53 (1%)

Query: 4   WIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGR-SDPSTTSDLITTKDTFK 55
                N       ++GL+    YEFRV A+N  G  S PS  SD IT +D  +
Sbjct: 51  KANFSNILENEFTVSGLTEDAAYEFRVIAKNAAGAISPPSEPSDAITCRDDVE 103

>d1x5xa1 b.1.2.1 (A:8-103) Fibronectin type-III domain containing protein 3a, FNDC3A (KIAA0970) {Human (Homo sapiens) [TaxId: 9606]} Length = 96

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Fibronectin type-III domain containing protein 3a, FNDC3A (KIAA0970)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.2 bits (121), Expect = 4e-09
 Identities = 12/40 (30%), Positives = 19/40 (47%)

Query: 13 TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD 52
              +  L    +Y+F+V A N  G+S+PS   +  T  D
Sbjct: 57 LAYTVKNLRRSTKYKFKVIAYNSEGKSNPSEVVEFTTCPD 96

>d1x3da1 b.1.2.1 (A:8-112) Fibronectin type-III domain containing protein 3a, FNDC3A (KIAA0970) {Human (Homo sapiens) [TaxId: 9606]} Length = 105

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Fibronectin type-III domain containing protein 3a, FNDC3A (KIAA0970)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.3 bits (119), Expect = 9e-09
 Identities = 14/50 (28%), Positives = 19/50 (38%)

Query: 1   MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT 50
              + +          IT LSP    +FR+ A N YG S  S      T+
Sbjct: 54  NGEFCQCYMGSQKQFKITKLSPAMGCKFRLSARNDYGTSGFSEEVLYYTS 103

>d1fyhb1 b.1.2.1 (B:12-109) Interferon-gamma receptor alpha chain {Human (Homo sapiens) [TaxId: 9606]} Length = 98

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Interferon-gamma receptor alpha chain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.0 bits (118), Expect = 1e-08
 Identities = 6/53 (11%), Positives = 15/53 (28%)

Query: 1  MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDT 53
                  +  +  ++     P +    RV A      S  + + +    +D 
Sbjct: 45 WIDACINISHHYCNISDHVGDPSNSLWVRVKARVGQKESAYAKSEEFAVCRDG 97

>d2cuma1 b.1.2.1 (A:7-99) Tenascin-X {Human (Homo sapiens) [TaxId: 9606]} Length = 93

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Tenascin-X
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.1 bits (116), Expect = 2e-08
 Identities = 12/50 (24%), Positives = 18/50 (36%), Gaps = 2/50 (4%)

Query: 1  MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT 50
            +   +     T+  + GL P   Y  R+ A        P +TS   TT
Sbjct: 41 GQTQEILLPGGITSHQLLGLFPSTSYNARLQAMWGQSLLPPVSTS--FTT 88

>d1fnaa_ b.1.2.1 (A:) Fibronectin, different Fn3 modules {Human (Homo sapiens) [TaxId: 9606]} Length = 91

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Fibronectin, different Fn3 modules
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.7 bits (115), Expect = 3e-08
 Identities = 15/48 (31%), Positives = 21/48 (43%), Gaps = 1/48 (2%)

Query: 4  WIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK 51
             V  ++ +T  I+GL PG  Y   VYA    G S  S+    I  +
Sbjct: 42 EFTVPGSK-STATISGLKPGVDYTITVYAVTGRGDSPASSKPISINYR 88

>d1tdqa2 b.1.2.1 (A:94-185) Tenascin {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 92

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Tenascin
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 48.7 bits (115), Expect = 3e-08
 Identities = 11/42 (26%), Positives = 18/42 (42%)

Query: 4  WIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTS 45
           +  G    T   +T L PG +Y   + A     +S P+T +
Sbjct: 47 LVPKGIGPTTKTTLTDLVPGTEYGVGISAVMNSKQSIPATMN 88

>d1qr4a1 b.1.2.1 (A:1-87) Tenascin {Chicken (Gallus gallus) [TaxId: 9031]} Length = 87

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Tenascin
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 48.3 bits (114), Expect = 4e-08
 Identities = 10/45 (22%), Positives = 16/45 (35%)

Query: 1  MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTS 45
                      T+  + GL  G +Y   + AE    +S P+T  
Sbjct: 39 GKKNEMEIPVDSTSFILRGLDAGTEYTISLVAEKGRHKSKPTTIK 83

>d1x5za1 b.1.2.1 (A:8-109) Receptor-type tyrosine-protein phosphatase delta, PTPRD {Human (Homo sapiens) [TaxId: 9606]} Length = 102

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Receptor-type tyrosine-protein phosphatase delta, PTPRD
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.2 bits (114), Expect = 5e-08
 Identities = 11/46 (23%), Positives = 17/46 (36%)

Query: 4  WIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLIT 49
            R+     T+  + GL P   Y FR+ A +  G    +      T
Sbjct: 54 EQRITIEPGTSYRLQGLKPNSLYYFRLAARSPQGLGASTAEISART 99

>d1wfoa1 b.1.2.1 (A:8-124) Sidekick 2 {Human (Homo sapiens) [TaxId: 9606]} Length = 117

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Sidekick 2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.7 bits (115), Expect = 5e-08
 Identities = 12/51 (23%), Positives = 20/51 (39%)

Query: 1   MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK 51
            ++ + V          TGL P   Y FR+ A+   G  + +    + T K
Sbjct: 66  NTATVEVLAPSARQYTATGLKPESVYLFRITAQTRKGWGEAAEALVVTTEK 116

>d1uena_ b.1.2.1 (A:) KIAA0343 protein {Human (Homo sapiens) [TaxId: 9606]} Length = 125

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: KIAA0343 protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.7 bits (115), Expect = 7e-08
 Identities = 11/52 (21%), Positives = 14/52 (26%)

Query: 2   SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDT 53
              I       T   + GL P   Y   V   N  G    S      T + +
Sbjct: 69  EKKILTFQGSKTHGMLPGLEPFSHYTLNVRVVNGKGEGPASPDRVFNTPEGS 120

>d1x5fa1 b.1.2.1 (A:8-114) Neogenin {Human (Homo sapiens) [TaxId: 9606]} Length = 107

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Neogenin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.0 bits (113), Expect = 7e-08
 Identities = 12/52 (23%), Positives = 19/52 (36%)

Query: 1   MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD 52
                   +     + I  L P   Y FRV A+N +G  + S    + T  +
Sbjct: 56  RERVENTSHPGEMQVTIQNLMPATVYIFRVMAQNKHGSGESSAPLRVETQPE 107

>d1tdqa3 b.1.2.1 (A:186-271) Tenascin {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 86

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Tenascin
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 47.2 bits (111), Expect = 8e-08
 Identities = 12/45 (26%), Positives = 17/45 (37%)

Query: 1  MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTS 45
            S         T+  +T L PG +Y   + AE    +S  ST  
Sbjct: 40 GISSEVTVPRDRTSYTLTDLEPGAEYIISITAERGRQQSLESTVD 84

>d1j8ka_ b.1.2.1 (A:) Fibronectin, different Fn3 modules {Human (Homo sapiens) [TaxId: 9606]} Length = 94

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Fibronectin, different Fn3 modules
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.5 bits (112), Expect = 8e-08
 Identities = 10/43 (23%), Positives = 15/43 (34%)

Query: 3  SWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTS 45
                +    T  + GL PG +Y   V A +    S P   +
Sbjct: 45 ELFPAPDGEEDTAELQGLRPGSEYTVSVVALHDDMESQPLIGT 87

>d2crza1 b.1.2.1 (A:8-104) Fibronectin type-III domain containing protein 3a, FNDC3A (KIAA0970) {Human (Homo sapiens) [TaxId: 9606]} Length = 97

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Fibronectin type-III domain containing protein 3a, FNDC3A (KIAA0970)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.1 bits (111), Expect = 1e-07
 Identities = 13/47 (27%), Positives = 17/47 (36%)

Query: 4  WIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT 50
             V         ++ L PG  Y FR+ A N  G    S   D+ T 
Sbjct: 49 PREVYQGSEVECTVSSLLPGKTYSFRLRAANKMGFGPFSEKCDITTA 95

>d1x5la1 b.1.2.1 (A:8-105) Ephrin type-A receptor 8 {Human (Homo sapiens) [TaxId: 9606]} Length = 98

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Ephrin type-A receptor 8
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.7 bits (110), Expect = 2e-07
 Identities = 13/48 (27%), Positives = 19/48 (39%)

Query: 4  WIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK 51
                   T   ++GL PG +Y F+V A    G    S   ++ T K
Sbjct: 50 SYSTLKAVTTRATVSGLKPGTRYVFQVRARTSAGCGRFSQAMEVETGK 97

>d1x5ka1 b.1.2.1 (A:8-118) Neogenin {Human (Homo sapiens) [TaxId: 9606]} Length = 111

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Neogenin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.2 bits (111), Expect = 2e-07
 Identities = 11/39 (28%), Positives = 14/39 (35%)

Query: 13  TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK 51
            T  I  L+    Y F++ A N  G    S      T K
Sbjct: 72  LTHQIQELTLDTPYYFKIQARNSKGMGPMSEAVQFRTPK 110

>d1qr4a2 b.1.2.1 (A:88-175) Tenascin {Chicken (Gallus gallus) [TaxId: 9031]} Length = 88

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Tenascin
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 46.4 bits (109), Expect = 2e-07
 Identities = 8/38 (21%), Positives = 15/38 (39%), Gaps = 2/38 (5%)

Query: 13 TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT 50
          T   +  L PG  Y   + +   +  S+P +    + T
Sbjct: 53 TRTKLVKLVPGVDYNVNIISVKGFEESEPISGI--LKT 88

>d2dtge2 b.1.2.1 (E:593-807) Insulin receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 196

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Insulin receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.7 bits (114), Expect = 2e-07
 Identities = 6/50 (12%), Positives = 16/50 (32%)

Query: 2   SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK 51
                       ++ I+GL     Y   + A N     +  + +  ++ +
Sbjct: 144 EHRPFEKVVNKESLVISGLRHFTGYRIELQACNQDTPEERCSVAAYVSAR 193

>d1wfta_ b.1.2.1 (A:) Host cell factor 2, HCF-2 {Mouse (Mus musculus) [TaxId: 10090]} Length = 123

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Host cell factor 2, HCF-2
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 46.9 bits (110), Expect = 2e-07
 Identities = 7/52 (13%), Positives = 12/52 (23%)

Query: 2   SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDT 53
                         A    +      FR+ A+N  G    +    L     +
Sbjct: 67  LKTSCTVTAGQLANAHIDYTSRPAIVFRISAKNEKGYGPATQIRWLQGNSKS 118

>d1x5ga1 b.1.2.1 (A:8-110) Neogenin {Human (Homo sapiens) [TaxId: 9606]} Length = 103

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Neogenin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.3 bits (109), Expect = 2e-07
 Identities = 12/52 (23%), Positives = 20/52 (38%)

Query: 1   MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD 52
            +   +  +    +  I GL    +Y FRV A N +G    +    + T  D
Sbjct: 52  GTDKEQDVDVSSHSYTINGLKKYTEYSFRVVAYNKHGPGVSTPDVAVRTLSD 103

>d2cuia1 b.1.2.1 (A:6-106) Tenascin-X {Human (Homo sapiens) [TaxId: 9606]} Length = 101

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Tenascin-X
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.2 bits (108), Expect = 2e-07
 Identities = 6/38 (15%), Positives = 12/38 (31%), Gaps = 2/38 (5%)

Query: 13  TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT 50
            +  +  L  G  Y   +Y      ++D    +    T
Sbjct: 65  HSAVLRDLRSGTLYSLTLYGLRGPHKADSIQGT--ART 100

>d1wfua_ b.1.2.1 (A:) Fibronectin type 3 and ankyrin repeat domains 1 protein, FANK1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 120

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Fibronectin type 3 and ankyrin repeat domains 1 protein, FANK1
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 46.2 bits (108), Expect = 4e-07
 Identities = 13/52 (25%), Positives = 23/52 (44%)

Query: 1   MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD 52
           M S+  +     T   + GL P   Y+FR+   +  G  + S    + TT++
Sbjct: 63  MHSYGVIYTGYATRHVVEGLEPRTLYKFRLKVTSPSGEYEYSPVVSVATTRE 114

>d1fnfa1 b.1.2.1 (A:1142-1235) Fibronectin, different Fn3 modules {Human (Homo sapiens) [TaxId: 9606]} Length = 94

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Fibronectin, different Fn3 modules
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.2 bits (106), Expect = 6e-07
 Identities = 9/29 (31%), Positives = 12/29 (41%)

Query: 17 ITGLSPGHQYEFRVYAENVYGRSDPSTTS 45
             LSPG +Y   VY       S P + +
Sbjct: 62 FDNLSPGLEYNVSVYTVKDDKESVPISDT 90

>d1wk0a_ b.1.2.1 (A:) Fibronectin type-III domain containing protein 3a, FNDC3A (KIAA0970) {Human (Homo sapiens) [TaxId: 9606]} Length = 137

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Fibronectin type-III domain containing protein 3a, FNDC3A (KIAA0970)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.6 bits (107), Expect = 8e-07
 Identities = 11/49 (22%), Positives = 16/49 (32%)

Query: 4   WIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD 52
           +  V     T + +  L P   Y  +V AE    +  PS      T   
Sbjct: 73  YKSVYVGEETNITLNDLKPAMDYHAKVQAEYNSIKGTPSEAEIFTTLSC 121

>d1fnha1 b.1.2.1 (A:3-92) Fibronectin, different Fn3 modules {Human (Homo sapiens) [TaxId: 9606]} Length = 90

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Fibronectin, different Fn3 modules
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.1 bits (103), Expect = 1e-06
 Identities = 11/40 (27%), Positives = 20/40 (50%), Gaps = 2/40 (5%)

Query: 13 TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD 52
          +++ ++GL    +YE  VYA      S P+     +TT +
Sbjct: 53 SSVVVSGLMVATKYEVSVYALKDTLTSRPAQGV--VTTLE 90

>d1fnha3 b.1.2.1 (A:183-271) Fibronectin, different Fn3 modules {Human (Homo sapiens) [TaxId: 9606]} Length = 89

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Fibronectin, different Fn3 modules
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.1 bits (103), Expect = 1e-06
 Identities = 12/43 (27%), Positives = 16/43 (37%)

Query: 3  SWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTS 45
            +       T   ITGL PG +Y   V A     +S+P    
Sbjct: 44 EVVPRPRPGVTEATITGLEPGTEYTIYVIALKNNQKSEPLIGR 86

>d1x5ja1 b.1.2.1 (A:8-107) Neogenin {Human (Homo sapiens) [TaxId: 9606]} Length = 100

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Neogenin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.3 bits (103), Expect = 1e-06
 Identities = 13/49 (26%), Positives = 19/49 (38%)

Query: 1  MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLIT 49
           ++  +  N    +  +TGL P   YEF V        S  S T+   T
Sbjct: 49 ANTKYKNANATTLSYLVTGLKPNTLYEFSVMVTKGRRSSTWSMTAHGTT 97

>d2crma1 b.1.2.1 (A:8-114) Fibronectin type-III domain containing protein 3a, FNDC3A (KIAA0970) {Human (Homo sapiens) [TaxId: 9606]} Length = 107

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Fibronectin type-III domain containing protein 3a, FNDC3A (KIAA0970)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (103), Expect = 1e-06
 Identities = 12/46 (26%), Positives = 19/46 (41%)

Query: 4   WIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLIT 49
           W  + +          L+PG  Y  RVY  +  G+S  S +  + T
Sbjct: 59  WEMIYSGATREHLCDRLNPGCFYRLRVYCISDGGQSAVSESLLVQT 104

>d1k85a_ b.1.2.1 (A:) Fibronectin type III domain from chitinase A1. {Bacillus circulans [TaxId: 1397]} Length = 88

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Fibronectin type III domain from chitinase A1.
species: Bacillus circulans [TaxId: 1397]

 Score = 43.6 bits (102), Expect = 1e-06
 Identities = 11/50 (22%), Positives = 20/50 (40%)

Query: 1  MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT 50
           +          TT  I+GL+    Y F V A++  G    ++ +  + T
Sbjct: 39 YNGTALATTVTGTTATISGLAADTSYTFTVKAKDAAGNVSAASNAVSVKT 88

>d1fnfa3 b.1.2.1 (A:1327-1415) Fibronectin, different Fn3 modules {Human (Homo sapiens) [TaxId: 9606]} Length = 89

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Fibronectin, different Fn3 modules
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.7 bits (102), Expect = 2e-06
 Identities = 9/38 (23%), Positives = 16/38 (42%), Gaps = 2/38 (5%)

Query: 13 TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT 50
           ++ +T L+PG +Y   + A N    S         +T
Sbjct: 54 NSITLTNLTPGTEYVVSIVALNGREESPLLIGQ--QST 89

>d1bqua2 b.1.2.1 (A:100-214) Cytokine receptor gp130 cytokine-binding domains {Human (Homo sapiens) [TaxId: 9606]} Length = 115

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Cytokine receptor gp130 cytokine-binding domains
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.3 bits (103), Expect = 2e-06
 Identities = 8/52 (15%), Positives = 17/52 (32%)

Query: 1   MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD 52
                    +  ++  +  L P  +Y FR+      G+   S  S+  +   
Sbjct: 53  SQIPPEDTASTRSSFTVQDLKPFTEYVFRIRCMKEDGKGYWSDWSEEASGIT 104

>d1tdqa1 b.1.2.1 (A:1-93) Tenascin {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 93

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Tenascin
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 43.4 bits (101), Expect = 2e-06
 Identities = 12/50 (24%), Positives = 18/50 (36%), Gaps = 2/50 (4%)

Query: 1  MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT 50
                      +  ++  L PG +YE  + A      SD S+T    TT
Sbjct: 45 GGKTTFRLQPPLSQYSVQALRPGSRYEVSISAVRGTNESDASSTQ--FTT 92

>d1n26a3 b.1.2.1 (A:196-299) Interleukin-6 receptor alpha chain, domains 2 and 3 {Human (Homo sapiens) [TaxId: 9606]} Length = 104

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Interleukin-6 receptor alpha chain, domains 2 and 3
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.9 bits (102), Expect = 2e-06
 Identities = 6/39 (15%), Positives = 14/39 (35%)

Query: 13 TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK 51
              I     G ++  ++ A+  +G+ + S  S      
Sbjct: 61 HHCVIHDAWSGLRHVVQLRAQEEFGQGEWSEWSPEAMGT 99

>d1x5ha1 b.1.2.1 (A:8-126) Neogenin {Human (Homo sapiens) [TaxId: 9606]} Length = 119

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Neogenin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.3 bits (101), Expect = 3e-06
 Identities = 11/52 (21%), Positives = 18/52 (34%)

Query: 1   MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD 52
                 + +    +  I GL  G +Y FRV A  + G    +      T + 
Sbjct: 58  SDVTETLVSGTQLSQLIEGLDRGTEYNFRVAALTINGTGPATDWLSAETFES 109

>d1x4ya1 b.1.2.1 (A:8-108) Brother of CDO precursor (BOC) {Mouse (Mus musculus) [TaxId: 10090]} Length = 101

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Brother of CDO precursor (BOC)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 43.1 bits (100), Expect = 3e-06
 Identities = 10/51 (19%), Positives = 18/51 (35%), Gaps = 1/51 (1%)

Query: 1  MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK 51
                +        +I+ L P   Y+ ++   N  G S+ S    +  TK
Sbjct: 50 SDYKKDMVEGDRYWHSISHLQPETSYDIKMQCFNEGGESEFSNVM-ICETK 99

>d1ujta_ b.1.2.1 (A:) KIAA1568 protein {Human (Homo sapiens) [TaxId: 9606]} Length = 120

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: KIAA1568 protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.3 bits (101), Expect = 4e-06
 Identities = 8/52 (15%), Positives = 17/52 (32%)

Query: 1   MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD 52
               +        +  +  L  G  YE +V       +   S +  + TT++
Sbjct: 63  SWQNLDAKVPTERSAVLVNLKKGVTYEIKVRPYFNEFQGMDSESKTVRTTEE 114

>d1cfba2 b.1.2.1 (A:710-814) Neuroglian, two amino proximal Fn3 repeats {Drosophila melanogaster [TaxId: 7227]} Length = 105

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Neuroglian, two amino proximal Fn3 repeats
species: Drosophila melanogaster [TaxId: 7227]

 Score = 43.0 bits (100), Expect = 4e-06
 Identities = 8/50 (16%), Positives = 17/50 (34%)

Query: 1   MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT 50
                 + + R   + I       +Y  +V A N  G S+ +    +  +
Sbjct: 52  AWENNNIFDWRQNNIVIADQPTFVKYLIKVVAINDRGESNVAAEEVVGYS 101

>d1fnha2 b.1.2.1 (A:93-182) Fibronectin, different Fn3 modules {Human (Homo sapiens) [TaxId: 9606]} Length = 90

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Fibronectin, different Fn3 modules
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.2 bits (98), Expect = 5e-06
 Identities = 12/33 (36%), Positives = 15/33 (45%)

Query: 13 TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTS 45
           +  ITGL PG  Y+  +Y  N   RS P    
Sbjct: 54 RSYTITGLQPGTDYKIYLYTLNDNARSSPVVID 86

>d1iarb2 b.1.2.1 (B:97-197) Interleukin-4 receptor alpha chain {Human (Homo sapiens) [TaxId: 9606]} Length = 101

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Interleukin-4 receptor alpha chain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.7 bits (99), Expect = 5e-06
 Identities = 9/49 (18%), Positives = 13/49 (26%)

Query: 1  MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLIT 49
             +          +A + L  G  Y  RV A      +  S  S    
Sbjct: 51 FRIYNVTYLEPSLRIAASTLKSGISYRARVRAWAQAYNTTWSEWSPSTK 99

>d1owwa_ b.1.2.1 (A:) Fibronectin, different Fn3 modules {Human (Homo sapiens) [TaxId: 9606]} Length = 93

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Fibronectin, different Fn3 modules
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.2 bits (98), Expect = 6e-06
 Identities = 12/50 (24%), Positives = 19/50 (38%), Gaps = 4/50 (8%)

Query: 1  MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT 50
                 G+    T+   GL PG  YE ++ +   YG  + +      TT
Sbjct: 46 WKEATIPGHLNSYTI--KGLKPGVVYEGQLISIQQYGHQEVTRFD--FTT 91

>d1wfna1 b.1.2.1 (A:8-113) Sidekick 2 {Human (Homo sapiens) [TaxId: 9606]} Length = 106

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Sidekick 2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.1 bits (98), Expect = 7e-06
 Identities = 9/50 (18%), Positives = 17/50 (34%), Gaps = 2/50 (4%)

Query: 1   MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT 50
            +              +TGL+    Y   V A    G+   S ++  I++
Sbjct: 55  NTRVTHYLPNVTLEYRVTGLTALTTYTIEVAAMTSKGQGQVSAST--ISS 102

>d1fnfa2 b.1.2.1 (A:1236-1326) Fibronectin, different Fn3 modules {Human (Homo sapiens) [TaxId: 9606]} Length = 91

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Fibronectin, different Fn3 modules
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.4 bits (96), Expect = 1e-05
 Identities = 8/37 (21%), Positives = 13/37 (35%)

Query: 9  NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTS 45
          +     + +T L PG +Y   V +      S P    
Sbjct: 51 SPSDNAVVLTNLLPGTEYVVSVSSVYEQHESTPLRGR 87

>d1va9a1 b.1.2.1 (A:8-116) Down syndrome cell adhesion molecule-like protein 1, DSCAML1 {Human (Homo sapiens) [TaxId: 9606]} Length = 109

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Down syndrome cell adhesion molecule-like protein 1, DSCAML1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.8 bits (97), Expect = 1e-05
 Identities = 9/37 (24%), Positives = 12/37 (32%)

Query: 13  TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLIT 49
               +  L    QY   V A N  G    S+  +  T
Sbjct: 71  EVYTLDNLKKFAQYGVVVQAFNRAGTGPSSSEINATT 107

>d1qg3a2 b.1.2.1 (A:1218-1320) Integrin beta-4 subunit {Human (Homo sapiens) [TaxId: 9606]} Length = 103

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Integrin beta-4 subunit
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.6 bits (96), Expect = 1e-05
 Identities = 10/48 (20%), Positives = 16/48 (33%)

Query: 4   WIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK 51
            + V N +   + I  L     Y + V A N  G          + T+
Sbjct: 55  KVLVDNPKNRMLLIENLRESQPYRYTVKARNGAGWGPEREAIINLATQ 102

>d1tena_ b.1.2.1 (A:) Tenascin {Human (Homo sapiens) [TaxId: 9606]} Length = 90

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Tenascin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.1 bits (95), Expect = 1e-05
 Identities = 9/50 (18%), Positives = 16/50 (32%), Gaps = 2/50 (4%)

Query: 1  MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT 50
                         +I  L P  +YE  + +      S+P+  +   TT
Sbjct: 43 GDRTTIDLTEDENQYSIGNLKPDTEYEVSLISRRGDMSSNPAKET--FTT 90

>d2djsa1 b.1.2.1 (A:8-102) Ephrin type-B receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 95

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Ephrin type-B receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.8 bits (94), Expect = 2e-05
 Identities = 14/49 (28%), Positives = 18/49 (36%)

Query: 4  WIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD 52
             +  ++  T  I GL PG  Y  +V A  V G    S      T  D
Sbjct: 47 NSSMARSQTNTARIDGLRPGMVYVVQVRARTVAGYGKFSGKMCFQTLTD 95

>d1x5aa1 b.1.2.1 (A:8-101) Ephrin type-A receptor 1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 94

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Ephrin type-A receptor 1
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 40.3 bits (93), Expect = 3e-05
 Identities = 9/48 (18%), Positives = 12/48 (25%)

Query: 2  SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLIT 49
                       + +T L P   Y  RV      G    S   +  T
Sbjct: 44 QDEEWHQMVLEPRVLLTKLQPDTTYIVRVRTLTPLGPGPFSPDHEFRT 91

>d2ibga1 b.1.2.1 (A:573-667) Hedgehog receptor iHog {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 95

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Hedgehog receptor iHog
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 40.1 bits (92), Expect = 3e-05
 Identities = 7/43 (16%), Positives = 14/43 (32%)

Query: 1  MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPST 43
                +      +  I  L     YEF++ + +    S+ S 
Sbjct: 53 EYFKATIEGAHARSFKIAPLETATMYEFKLQSFSAASASEFSA 95

>d2dn7a1 b.1.2.1 (A:8-101) Receptor-type tyrosine-protein phosphatase F, PTPRF {Human (Homo sapiens) [TaxId: 9606]} Length = 94

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Receptor-type tyrosine-protein phosphatase F, PTPRF
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.8 bits (92), Expect = 4e-05
 Identities = 12/40 (30%), Positives = 18/40 (45%), Gaps = 1/40 (2%)

Query: 13 TTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD 52
              +TGL  G  Y FR+ A+N  G  +      + T +D
Sbjct: 55 QHFTVTGLHKGTTYIFRLAAKNRAGLGEEFEKE-IRTPED 93

>d2vkwa2 b.1.2.1 (A:601-693) Neural cell adhesion molecule 1, NCAM {Human (Homo sapiens) [TaxId: 9606]} Length = 93

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Neural cell adhesion molecule 1, NCAM
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.1 bits (92), Expect = 4e-05
 Identities = 9/45 (20%), Positives = 15/45 (33%)

Query: 1  MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTS 45
                   +    + +  L    +YE  V AEN  G+S  +   
Sbjct: 44 EWKPEIRLPSGSDHVMLKSLDWNAEYEVYVVAENQQGKSKAAHFV 88

>d1cd9b1 b.1.2.1 (B:1-107) Granulocyte colony-stimulating factor (GC-SF) receptor {Mouse (Mus musculus) [TaxId: 10090]} Length = 107

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Granulocyte colony-stimulating factor (GC-SF) receptor
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 39.6 bits (91), Expect = 7e-05
 Identities = 7/35 (20%), Positives = 11/35 (31%)

Query: 9  NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPST 43
               ++    L         V AEN+ G S+   
Sbjct: 64 RQNNCSIPRKNLLLYQYMAIWVQAENMLGSSESPK 98

>d1qg3a1 b.1.2.1 (A:1126-1217) Integrin beta-4 subunit {Human (Homo sapiens) [TaxId: 9606]} Length = 92

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Integrin beta-4 subunit
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.2 bits (90), Expect = 8e-05
 Identities = 11/49 (22%), Positives = 20/49 (40%)

Query: 1  MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLIT 49
            S   + +++  ++ +T L P   YE +V A    G    S+     T
Sbjct: 42 SESEAHLLDSKVPSVELTNLYPYCDYEMKVCAYGAQGEGPYSSLVSCRT 90

>d1x4xa1 b.1.2.1 (A:8-100) Fibronectin type-III domain containing protein 3a, FNDC3A (KIAA0970) {Human (Homo sapiens) [TaxId: 9606]} Length = 93

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Fibronectin type-III domain containing protein 3a, FNDC3A (KIAA0970)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.9 bits (89), Expect = 8e-05
 Identities = 14/47 (29%), Positives = 17/47 (36%)

Query: 3  SWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLIT 49
          S          +  I GLSP   Y  RV A +V G    S     +T
Sbjct: 44 SMQICYCGPGLSYEIKGLSPATTYYCRVQALSVVGAGPFSEVVACVT 90

>d1uc6a_ b.1.2.1 (A:) Ciliary neurotrophic factor receptor alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 109

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Ciliary neurotrophic factor receptor alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.2 bits (90), Expect = 9e-05
 Identities = 11/51 (21%), Positives = 17/51 (33%), Gaps = 1/51 (1%)

Query: 1   MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK 51
           +  W  V  +  T   IT    G +Y  +V A++       S  S      
Sbjct: 55  LDQWQHVELSNGTAHTITDAYAGKEYIIQVAAKDNEI-GTWSDWSVAAHAT 104

>d1cd9b2 b.1.2.1 (B:108-213) Granulocyte colony-stimulating factor (GC-SF) receptor {Mouse (Mus musculus) [TaxId: 10090]} Length = 106

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Granulocyte colony-stimulating factor (GC-SF) receptor
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 39.2 bits (90), Expect = 1e-04
 Identities = 6/53 (11%), Positives = 14/53 (26%)

Query: 1   MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKDT 53
             + +    +      + GL     Y  ++           S  S  +  + T
Sbjct: 53  NWTLVFHLPSSKDQFELCGLHQAPVYTLQMRCIRSSLPGFWSPWSPGLQLRPT 105

>d1y6kr1 b.1.2.1 (R:2-100) Interleukin-10 receptor 1, IL-10R1 {Human (Homo sapiens) [TaxId: 9606]} Length = 99

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Interleukin-10 receptor 1, IL-10R1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.3 bits (88), Expect = 2e-04
 Identities = 7/35 (20%), Positives = 12/35 (34%)

Query: 15 MAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLIT 49
               L   + Y  RV A +    S  + T+   +
Sbjct: 63 AVTLDLYHSNGYRARVRAVDGSRHSQWTVTNTRFS 97

>d1x5ia1 b.1.2.1 (A:8-120) Neogenin {Human (Homo sapiens) [TaxId: 9606]} Length = 113

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Neogenin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.2 bits (87), Expect = 2e-04
 Identities = 10/48 (20%), Positives = 14/48 (29%), Gaps = 2/48 (4%)

Query: 4   WIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK 51
                + +     I  L P   Y   + A N  G   P   S    T+
Sbjct: 65  QTIKVDYKQRYYTIENLDPSSHYVITLKAFNNVGEGIPLYES--AVTR 110

>d2haza1 b.1.2.1 (A:489-589) Neural cell adhesion molecule 1, NCAM {Human (Homo sapiens) [TaxId: 9606]} Length = 101

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Neural cell adhesion molecule 1, NCAM
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.9 bits (86), Expect = 2e-04
 Identities = 12/50 (24%), Positives = 18/50 (36%)

Query: 1  MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT 50
             +     +    + I GL P   Y  R+ A N  G  + S  S+  T 
Sbjct: 50 SKWYDAKEASMEGIVTIVGLKPETTYAVRLAALNGKGLGEISAASEFKTQ 99

>d2fnba_ b.1.2.1 (A:) Fibronectin, different Fn3 modules {Human (Homo sapiens) [TaxId: 9606]} Length = 95

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Fibronectin, different Fn3 modules
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.7 bits (86), Expect = 2e-04
 Identities = 11/45 (24%), Positives = 19/45 (42%)

Query: 1  MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTS 45
          +  +    ++      +TGL PG  Y+  V      G S P+T +
Sbjct: 48 IPIFEDFVDSSVGYYTVTGLEPGIDYDISVITLINGGESAPTTLT 92

>d2cuha1 b.1.2.1 (A:8-109) Tenascin-X {Human (Homo sapiens) [TaxId: 9606]} Length = 102

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Tenascin-X
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.9 bits (84), Expect = 5e-04
 Identities = 6/50 (12%), Positives = 11/50 (22%), Gaps = 2/50 (4%)

Query: 1  MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT 50
                          +  L     Y   V        + P++ +   TT
Sbjct: 40 APPLQAETPGSAVDYPLHDLVLHTNYTATVRGLRGPNLTSPASIT--FTT 87

>d1v5ja_ b.1.2.1 (A:) KIAA1355 {Human (Homo sapiens) [TaxId: 9606]} Length = 108

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: KIAA1355
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.6 bits (83), Expect = 7e-04
 Identities = 14/50 (28%), Positives = 21/50 (42%)

Query: 1   MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT 50
                       T + + GL     YEFR+ A      SDPS T+++ T+
Sbjct: 51  WEVLDPAVAGTETELLVPGLIKDVLYEFRLVAFAGSFVSDPSNTANVSTS 100

>d2b5ib2 b.1.2.1 (B:104-207) Interleukin-2 receptor beta chain {Human (Homo sapiens) [TaxId: 9606]} Length = 104

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Interleukin-2 receptor beta chain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.5 bits (83), Expect = 7e-04
 Identities = 10/52 (19%), Positives = 22/52 (42%), Gaps = 1/52 (1%)

Query: 1   MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGR-SDPSTTSDLITTK 51
             + +     +   + +  L+P  QYEF+V  + + G  +  S  S  +  +
Sbjct: 50  EEAPLLTLKQKQEWICLETLTPDTQYEFQVRVKPLQGEFTTWSPWSQPLAFR 101

>d1axib2 b.1.2.1 (B:131-236) Growth hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 106

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Growth hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.4 bits (83), Expect = 7e-04
 Identities = 8/49 (16%), Positives = 19/49 (38%), Gaps = 1/49 (2%)

Query: 4   WIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD 52
           W  +     T++ +  L    +YE RV ++      +    S+++    
Sbjct: 56  WKMMDPILTTSVPVYSLKVDKEYEVRVRSKQRNS-GNYGEFSEVLYVTL 103

>d2dtge3 b.1.2.1 (E:468-592) Insulin receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 125

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Insulin receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.9 bits (84), Expect = 8e-04
 Identities = 9/52 (17%), Positives = 15/52 (28%), Gaps = 2/52 (3%)

Query: 2   SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPST--TSDLITTK 51
                  +       + GL P  QY   V     +     +    SD+I  +
Sbjct: 71  LRSNDPKSQNHPGWLMRGLKPWTQYAIFVKTLVTFSDERRTYGAKSDIIYVQ 122

>d2b5ic1 b.1.2.1 (C:130-224) Cytokine receptor common gamma chain {Human (Homo sapiens) [TaxId: 9606]} Length = 95

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Cytokine receptor common gamma chain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.1 bits (82), Expect = 0.001
 Identities = 7/46 (15%), Positives = 13/46 (28%)

Query: 1  MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSD 46
            SW           ++  +    +Y FRV +            S+
Sbjct: 43 DHSWTEQSVDYRHKFSLPSVDGQKRYTFRVRSRFNPLCGSAQHWSE 88

>d1f6fb2 b.1.2.1 (B:101-203) Prolactin receptor {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 103

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Prolactin receptor
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 36.1 bits (82), Expect = 0.001
 Identities = 10/47 (21%), Positives = 16/47 (34%), Gaps = 1/47 (2%)

Query: 4   WIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGR-SDPSTTSDLIT 49
           W        T   +  L PG +Y  +   +  +G  S  S  S +  
Sbjct: 56  WEIHFTGHQTQFKVFDLYPGQKYLVQTRCKPDHGYWSRWSQESSVEM 102

>d3d48r2 b.1.2.1 (R:101-204) Prolactin receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 104

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Prolactin receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 35.8 bits (81), Expect = 0.001
 Identities = 11/50 (22%), Positives = 19/50 (38%), Gaps = 1/50 (2%)

Query: 1   MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGR-SDPSTTSDLIT 49
            + W      + T   I  L PG +Y  +V  +  +G  S  S  + +  
Sbjct: 53  AAEWEIHFAGQQTEFKILSLHPGQKYLVQVRCKPDHGYWSAWSPATFIQI 102

>d2gysa4 b.1.2.1 (A:317-416) Common beta-chain in the GM-CSF, IL-3 and IL-5 receptors {Human (Homo sapiens) [TaxId: 9606]} Length = 100

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Common beta-chain in the GM-CSF, IL-3 and IL-5 receptors
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 35.0 bits (79), Expect = 0.002
 Identities = 9/47 (19%), Positives = 13/47 (27%), Gaps = 5/47 (10%)

Query: 1  MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGR-----SDPS 42
                       +MA+  L P  +Y  RV             S+ S
Sbjct: 49 WKDSKTETLQNAHSMALPALEPSTRYWARVRVRTSRTGYNGIWSEWS 95

>d2dtge1 b.1.2.1 (E:808-909) Insulin receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 102

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Insulin receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 34.9 bits (79), Expect = 0.002
 Identities = 5/50 (10%), Positives = 12/50 (24%)

Query: 1  MSSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT 50
          +       +                Y  R+ A ++ G    +  +    T
Sbjct: 50 LHLCDTRKHFALERGCRLRGLSPGNYSVRIRATSLAGNGSWTEPTYFYVT 99

>d1bqua1 b.1.2.1 (A:5-99) Cytokine receptor gp130 cytokine-binding domains {Human (Homo sapiens) [TaxId: 9606]} Length = 95

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Cytokine receptor gp130 cytokine-binding domains
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 34.2 bits (77), Expect = 0.003
 Identities = 7/42 (16%), Positives = 11/42 (26%)

Query: 4  WIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTS 45
               +T  +             E  V AEN  G+      +
Sbjct: 50 CKAKRDTPTSCTVDYSTVYFVNIEVWVEAENALGKVTSDHIN 91

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	356
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.94
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.72
d2crza1	97	Fibronectin type-III domain containing protein 3a,	98.71
d1x5ya1	98	Myosin binding protein C, fast-type {Mouse (Mus mu	98.68
d1wfua_	120	Fibronectin type 3 and ankyrin repeat domains 1 pr	98.54
d1x5xa1	96	Fibronectin type-III domain containing protein 3a,	98.51
d2djsa1	95	Ephrin type-B receptor 1 {Human (Homo sapiens) [Ta	98.5
d1uema_	117	KIAA1568 protein {Human (Homo sapiens) [TaxId: 960	98.49
d1x4za1	108	Brother of CDO precursor (BOC) {Mouse (Mus musculu	98.48
d1cfba1	100	Neuroglian, two amino proximal Fn3 repeats {Drosop	98.47
d2ic2a1	107	Hedgehog receptor iHog {Fruit fly (Drosophila mela	98.46
d1wf5a1	108	Sidekick 2 {Human (Homo sapiens) [TaxId: 9606]}	98.46
d1f6fb2	103	Prolactin receptor {Rat (Rattus norvegicus) [TaxId	98.46
d3d48r2	104	Prolactin receptor {Human (Homo sapiens) [TaxId: 9	98.45
d1x4xa1	93	Fibronectin type-III domain containing protein 3a,	98.45
d2crma1	107	Fibronectin type-III domain containing protein 3a,	98.43
d1bpva_	104	Type I titin module {Human (Homo sapiens) [TaxId:	98.42
d1x5aa1	94	Ephrin type-A receptor 1 {Mouse (Mus musculus) [Ta	98.37
d1x3da1	105	Fibronectin type-III domain containing protein 3a,	98.36
d2d9qb2	105	Granulocyte colony-stimulating factor (GC-SF) rece	98.34
d2haza1	101	Neural cell adhesion molecule 1, NCAM {Human (Homo	98.33
d1x5ga1	103	Neogenin {Human (Homo sapiens) [TaxId: 9606]}	98.33
d1qg3a1	92	Integrin beta-4 subunit {Human (Homo sapiens) [Tax	98.33
d1k85a_	88	Fibronectin type III domain from chitinase A1. {Ba	98.32
d1wk0a_	137	Fibronectin type-III domain containing protein 3a,	98.31
d1x5la1	98	Ephrin type-A receptor 8 {Human (Homo sapiens) [Ta	98.28
d1wisa1	111	Sidekick 2 {Human (Homo sapiens) [TaxId: 9606]}	98.28
d1x5ka1	111	Neogenin {Human (Homo sapiens) [TaxId: 9606]}	98.27
d1axib2	106	Growth hormone receptor {Human (Homo sapiens) [Tax	98.25
d1x5ja1	100	Neogenin {Human (Homo sapiens) [TaxId: 9606]}	98.24
d1iarb2	101	Interleukin-4 receptor alpha chain {Human (Homo sa	98.23
d1cd9b2	106	Granulocyte colony-stimulating factor (GC-SF) rece	98.21
d1x5fa1	107	Neogenin {Human (Homo sapiens) [TaxId: 9606]}	98.2
d2b5ib2	104	Interleukin-2 receptor beta chain {Human (Homo sap	98.2
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.2
d1x5za1	102	Receptor-type tyrosine-protein phosphatase delta,	98.18
d1ujta_	120	KIAA1568 protein {Human (Homo sapiens) [TaxId: 960	98.16
d1n26a3	104	Interleukin-6 receptor alpha chain, domains 2 and	98.16
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.14
d2b5ic1	95	Cytokine receptor common gamma chain {Human (Homo	98.13
d1uc6a_	109	Ciliary neurotrophic factor receptor alpha {Human	98.12
d2ibga1	95	Hedgehog receptor iHog {Fruit fly (Drosophila mela	98.03
d2vkwa2	93	Neural cell adhesion molecule 1, NCAM {Human (Homo	98.03
d2gysa2	114	Common beta-chain in the GM-CSF, IL-3 and IL-5 rec	98.01
d1ueya_	127	KIAA0343 protein {Human (Homo sapiens) [TaxId: 960	98.01
d1fnha1	90	Fibronectin, different Fn3 modules {Human (Homo sa	98.0
d1cfba2	105	Neuroglian, two amino proximal Fn3 repeats {Drosop	98.0
d1wfta_	123	Host cell factor 2, HCF-2 {Mouse (Mus musculus) [T	98.0
d1fyhb1	98	Interferon-gamma receptor alpha chain {Human (Homo	97.98
d1v5ja_	108	KIAA1355 {Human (Homo sapiens) [TaxId: 9606]}	97.98
d1uena_	125	KIAA0343 protein {Human (Homo sapiens) [TaxId: 960	97.98
d1va9a1	109	Down syndrome cell adhesion molecule-like protein	97.97
d1wfoa1	117	Sidekick 2 {Human (Homo sapiens) [TaxId: 9606]}	97.96
d2fnba_	95	Fibronectin, different Fn3 modules {Human (Homo sa	97.94
d2dn7a1	94	Receptor-type tyrosine-protein phosphatase F, PTPR	97.91
d1x4ya1	101	Brother of CDO precursor (BOC) {Mouse (Mus musculu	97.91
d1qg3a2	103	Integrin beta-4 subunit {Human (Homo sapiens) [Tax	97.9
d1bqua2	115	Cytokine receptor gp130 cytokine-binding domains {	97.84
d1x5ha1	119	Neogenin {Human (Homo sapiens) [TaxId: 9606]}	97.84
d1tdqa2	92	Tenascin {Rat (Rattus norvegicus) [TaxId: 10116]}	97.79
d2cuma1	93	Tenascin-X {Human (Homo sapiens) [TaxId: 9606]}	97.77
d1erna2	105	Erythropoietin (EPO) receptor {Human (Homo sapiens	97.77
d1j8ka_	94	Fibronectin, different Fn3 modules {Human (Homo sa	97.76
d1tdqa3	86	Tenascin {Rat (Rattus norvegicus) [TaxId: 10116]}	97.75
d1qr4a2	88	Tenascin {Chicken (Gallus gallus) [TaxId: 9031]}	97.75
d1wfna1	106	Sidekick 2 {Human (Homo sapiens) [TaxId: 9606]}	97.75
d1x5ia1	113	Neogenin {Human (Homo sapiens) [TaxId: 9606]}	97.74
d2gysa4	100	Common beta-chain in the GM-CSF, IL-3 and IL-5 rec	97.74
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.74
d2cspa1	117	Rim binding protein 2 {Human (Homo sapiens) [TaxId	97.72
d1fnfa3	89	Fibronectin, different Fn3 modules {Human (Homo sa	97.7
d1fnaa_	91	Fibronectin, different Fn3 modules {Human (Homo sa	97.7
d1fnha2	90	Fibronectin, different Fn3 modules {Human (Homo sa	97.67
d1qr4a1	87	Tenascin {Chicken (Gallus gallus) [TaxId: 9031]}	97.65
d1tdqa1	93	Tenascin {Rat (Rattus norvegicus) [TaxId: 10116]}	97.63
d1fnha3	89	Fibronectin, different Fn3 modules {Human (Homo sa	97.63
d1tena_	90	Tenascin {Human (Homo sapiens) [TaxId: 9606]}	97.62
d2cuha1	102	Tenascin-X {Human (Homo sapiens) [TaxId: 9606]}	97.61
d1wj3a_	117	Contactin 3 (KIAA1496) {Human (Homo sapiens) [TaxI	97.6
d2cuia1	101	Tenascin-X {Human (Homo sapiens) [TaxId: 9606]}	97.59
d1owwa_	93	Fibronectin, different Fn3 modules {Human (Homo sa	97.58
d2dtge1	102	Insulin receptor {Human (Homo sapiens) [TaxId: 960	97.56
d1fnfa2	91	Fibronectin, different Fn3 modules {Human (Homo sa	97.55
d1cd9b1	107	Granulocyte colony-stimulating factor (GC-SF) rece	97.42
d2dtge3	125	Insulin receptor {Human (Homo sapiens) [TaxId: 960	97.42
d1fnfa1	94	Fibronectin, different Fn3 modules {Human (Homo sa	97.29
d1y6kr1	99	Interleukin-10 receptor 1, IL-10R1 {Human (Homo sa	97.29
d1bqua1	95	Cytokine receptor gp130 cytokine-binding domains {	97.23
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.92
d3d85d3	94	The p40 domain of interleukin-12 (IL-12 beta chain	96.7
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.3
d2qfra1	112	Purple acid phosphatase, N-terminal domain {Kidney	94.13
d1xzwa1	119	Purple acid phosphatase, N-terminal domain {Sweet	92.9
d2c4fu1	116	Extracellular region of human tissue factor {Human	91.96

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=4.6e-62  Score=449.62  Aligned_cols=268  Identities=63%  Similarity=1.074  Sum_probs=247.0

Q ss_pred             CceeEeeecccCCCCCCCCCCCcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcC
Q psy12427         84 DQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLH  163 (356)
Q Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~  163 (356)
                      |.+++++++++.|+|.+++...+.++|++.+.||+|+||+||+|+++.+|+.||+|++......+.+.+.+|+.+|++++
T Consensus         2 ~~~~~~~~~~~~p~p~~l~~~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~   81 (350)
T d1koaa2           2 DNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR   81 (350)
T ss_dssp             GGGCCCHHHHCCCCCCCCBCSCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTC
T ss_pred             ccHHHHHHHhcCCCCCcCCCCCCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCC
Confidence            45677889999999999988888999999999999999999999999999999999998877777788999999999999


Q ss_pred             CCCceeeeeeEEeCCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEE
Q psy12427        164 HPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIM  243 (356)
Q Consensus       164 hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIl  243 (356)
                      ||||+++++++.+++.+++||||++||+|.+++......+++..     +..++.||+.||+|||++||+||||||+|||
T Consensus        82 HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~-----~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIl  156 (350)
T d1koaa2          82 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDE-----AVEYMRQVCKGLCHMHENNYVHLDLKPENIM  156 (350)
T ss_dssp             CTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHH-----HHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             CCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHH-----HHHHHHHHHHHHHHHHhcCCeeeeechhHee
Confidence            99999999999999999999999999999999975544454444     4559999999999999999999999999999


Q ss_pred             EeecCCCcEEEEeeeceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q psy12427        244 CQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKN  323 (356)
Q Consensus       244 v~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~  323 (356)
                      ++.+.++.+||+|||+|+.+..........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+.+
T Consensus       157 l~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~  236 (350)
T d1koaa2         157 FTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN  236 (350)
T ss_dssp             ESSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             eccCCCCeEEEeecchheecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            97665668999999999998877777788999999999999999999999999999999999999999999999999999


Q ss_pred             hhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        324 VKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       324 i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +....+.++...+..+|+++++||++||++||+
T Consensus       237 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~  269 (350)
T d1koaa2         237 VKSCDWNMDDSAFSGISEDGKDFIRKLLLADPN  269 (350)
T ss_dssp             HHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGG
T ss_pred             HHhCCCCCCcccccCCCHHHHHHHHHHccCChh
Confidence            999999988888889999999999999999995

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=4.9e-62  Score=449.82  Aligned_cols=271  Identities=69%  Similarity=1.161  Sum_probs=249.3

Q ss_pred             CCCCceeEeeecccCCCCCCCCCCCcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHH
Q psy12427         81 SDYDQYVFDIYSKYVPQPVDIKTSSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMN  160 (356)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~  160 (356)
                      ++++++..+.+.++.|+|...+.+.+.++|++++.||+|+||+||+|+++.+|+.||+|++......+...+.+|+.+|+
T Consensus         2 ~~~d~~~~~~~~~~~p~p~~~~~~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~   81 (352)
T d1koba_           2 NDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMN   81 (352)
T ss_dssp             CCSGGGCCCHHHHCCCCCCCCBCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHT
T ss_pred             CchHHHHHHHHHhcCCCCccCCCCCcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHH
Confidence            45667777888899999999999999999999999999999999999999999999999998877777788899999999


Q ss_pred             hcCCCCceeeeeeEEeCCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCC
Q psy12427        161 QLHHPKLINLHDAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPE  240 (356)
Q Consensus       161 ~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~  240 (356)
                      +++||||++++++|.++..+++||||++||+|.+++......+++..+     ..++.||+.||+|||++||+||||||+
T Consensus        82 ~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~-----~~i~~qi~~aL~ylH~~~iiHRDiKp~  156 (352)
T d1koba_          82 QLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEV-----INYMRQACEGLKHMHEHSIVHLDIKPE  156 (352)
T ss_dssp             TCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHH-----HHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred             hCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHH-----HHHHHHHHHHHHHHHHCCeeecccccc
Confidence            999999999999999999999999999999999988765544555444     559999999999999999999999999


Q ss_pred             CEEEeecCCCcEEEEeeeceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHH
Q psy12427        241 NIMCQTRNSTNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVET  320 (356)
Q Consensus       241 NIlv~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~  320 (356)
                      |||++....+.+||+|||+|..+..........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.
T Consensus       157 NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~  236 (352)
T d1koba_         157 NIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET  236 (352)
T ss_dssp             GEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred             cccccccCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            99998655668999999999999887777888999999999999999999999999999999999999999999999999


Q ss_pred             HHHhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        321 LKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       321 ~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +.++....+.++...+.++|+++++||++||++||+
T Consensus       237 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~  272 (352)
T d1koba_         237 LQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPR  272 (352)
T ss_dssp             HHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGG
T ss_pred             HHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChh
Confidence            999999999999888889999999999999999995

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.1e-59  Score=420.48  Aligned_cols=246  Identities=33%  Similarity=0.642  Sum_probs=201.4

Q ss_pred             CcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh-hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        105 SVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN-LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       105 ~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      .+.+.|++.+.||+|+||+||+|+++.+|+.||+|++..... .....+.+|+.+|++++||||+++++++.+++.+++|
T Consensus         6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   85 (307)
T d1a06a_           6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI   85 (307)
T ss_dssp             CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            355679999999999999999999999999999999976543 2345677899999999999999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEee-cCCCcEEEEeeeceee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQT-RNSTNVKMIDFGLATK  262 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~-~~~~~vkl~Dfg~a~~  262 (356)
                      |||++||+|.+++.... .+++     ..+..++.||+.||+|||++||+||||||+|||+.. +.++.+||+|||+|+.
T Consensus        86 mE~~~gg~L~~~l~~~~-~l~e-----~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~  159 (307)
T d1a06a_          86 MQLVSGGELFDRIVEKG-FYTE-----RDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM  159 (307)
T ss_dssp             ECCCCSCBHHHHHHTCS-CCCH-----HHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred             EeccCCCcHHHhhhccc-CCCH-----HHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEE
Confidence            99999999999997543 3444     445569999999999999999999999999999964 2345899999999988


Q ss_pred             eCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHH
Q psy12427        263 LDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEE  342 (356)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  342 (356)
                      ..........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+...++......++.+.+.++|++
T Consensus       160 ~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  239 (307)
T d1a06a_         160 EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS  239 (307)
T ss_dssp             -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred             ccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHH
Confidence            77666666678999999999999999999999999999999999999999999999999999999988888888899999


Q ss_pred             HHHHHHHhhhcCCC
Q psy12427        343 GKDFIRRLLLRNKE  356 (356)
Q Consensus       343 ~~~lI~~ll~~dP~  356 (356)
                      +++||++||++||+
T Consensus       240 ~~~li~~~L~~dP~  253 (307)
T d1a06a_         240 AKDFIRHLMEKDPE  253 (307)
T ss_dssp             HHHHHHHHSCSSGG
T ss_pred             HHHHHHHHccCCHh
Confidence            99999999999995

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-58  Score=411.41  Aligned_cols=239  Identities=28%  Similarity=0.495  Sum_probs=209.4

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEec
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFL  187 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~  187 (356)
                      ++|++.++||+|+||+||+|+++.+|+.||+|++........+.+.+|+.+|++++||||+++++++..++.+++||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            47999999999999999999999999999999998766666788999999999999999999999999999999999999


Q ss_pred             cccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCC
Q psy12427        188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE  267 (356)
Q Consensus       188 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~  267 (356)
                      +||+|.+++...  .++     ...+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+|+.+....
T Consensus       100 ~gg~L~~~~~~~--~l~-----~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~--~vkl~DFG~a~~~~~~~  170 (293)
T d1yhwa1         100 AGGSLTDVVTET--CMD-----EGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG--SVKLTDFGFCAQITPEQ  170 (293)
T ss_dssp             TTCBHHHHHHHS--CCC-----HHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCCTTCEECCSTT
T ss_pred             CCCcHHHHhhcc--CCC-----HHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCC--cEeeccchhheeecccc
Confidence            999999987643  233     344556999999999999999999999999999997654  79999999999875433


Q ss_pred             -ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHHH
Q psy12427        268 -VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKDF  346 (356)
Q Consensus       268 -~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  346 (356)
                       .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+...... +...+..+|+++++|
T Consensus       171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~l  249 (293)
T d1yhwa1         171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAIFRDF  249 (293)
T ss_dssp             CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-CCSSGGGSCHHHHHH
T ss_pred             ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC-CCCCcccCCHHHHHH
Confidence             345567999999999999999999999999999999999999999999988887777654332 223346899999999


Q ss_pred             HHHhhhcCCC
Q psy12427        347 IRRLLLRNKE  356 (356)
Q Consensus       347 I~~ll~~dP~  356 (356)
                      |++||++||+
T Consensus       250 i~~~L~~dP~  259 (293)
T d1yhwa1         250 LNRCLDMDVE  259 (293)
T ss_dssp             HHHHTCSSTT
T ss_pred             HHHHccCChh
Confidence            9999999995

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-58  Score=418.34  Aligned_cols=245  Identities=40%  Similarity=0.800  Sum_probs=225.2

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      ++++|++.+.||+|+||+||+|.++.+|+.||+|+++.... +...+.+|+++|++++||||++++++|.+++.+++|||
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE   81 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            56889999999999999999999999999999999987643 34668899999999999999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |++||+|.+++......+++..+     +.++.||+.||+|||++||+||||||+|||++.++...+||+|||+++....
T Consensus        82 ~~~gg~L~~~i~~~~~~l~e~~~-----~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~  156 (321)
T d1tkia_          82 FISGLDIFERINTSAFELNEREI-----VSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHH-----HHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHH-----HHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence            99999999999766545555444     5599999999999999999999999999999877667899999999998877


Q ss_pred             CCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHHH
Q psy12427        266 NEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGKD  345 (356)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  345 (356)
                      ........||+.|+|||.+.+..++.++||||+||++|+|++|..||.+.+..+.+.++....+.++...+..+|+++++
T Consensus       157 ~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  236 (321)
T d1tkia_         157 GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD  236 (321)
T ss_dssp             TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred             CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHH
Confidence            77777788999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCC
Q psy12427        346 FIRRLLLRNKE  356 (356)
Q Consensus       346 lI~~ll~~dP~  356 (356)
                      ||++||++||+
T Consensus       237 li~~~L~~dp~  247 (321)
T d1tkia_         237 FVDRLLVKERK  247 (321)
T ss_dssp             HHHTTSCSSGG
T ss_pred             HHHHHccCChh
Confidence            99999999995

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-58  Score=407.90  Aligned_cols=237  Identities=28%  Similarity=0.522  Sum_probs=209.9

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      .++|++.+.||+|+||+||+|+++.+++.||+|++....   ......+.+|+++|++++||||+++++++.+++.+++|
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence            367999999999999999999999999999999986432   22356788999999999999999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      |||+++|+|.+++.... .++     ...+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+|...
T Consensus        85 mEy~~~g~L~~~l~~~~-~l~-----e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~--~~kl~DFG~a~~~  156 (263)
T d2j4za1          85 LEYAPLGTVYRELQKLS-KFD-----EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG--ELKIADFGWSVHA  156 (263)
T ss_dssp             EECCTTCBHHHHHHHHS-SCC-----HHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCCCSCSCC
T ss_pred             EeecCCCcHHHHHhhcC-CCC-----HHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCC--CEeecccceeeec
Confidence            99999999999986432 233     344556999999999999999999999999999998654  7999999999876


Q ss_pred             CCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHH
Q psy12427        264 DPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG  343 (356)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  343 (356)
                      ... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+.++....+.+|+    .+|+++
T Consensus       157 ~~~-~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~  231 (263)
T d2j4za1         157 PSS-RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGA  231 (263)
T ss_dssp             CCC-CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT----TSCHHH
T ss_pred             CCC-cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCc----cCCHHH
Confidence            543 345567999999999999999999999999999999999999999999999999999988877664    789999


Q ss_pred             HHHHHHhhhcCCC
Q psy12427        344 KDFIRRLLLRNKE  356 (356)
Q Consensus       344 ~~lI~~ll~~dP~  356 (356)
                      ++||++||++||+
T Consensus       232 ~~li~~~L~~dp~  244 (263)
T d2j4za1         232 RDLISRLLKHNPS  244 (263)
T ss_dssp             HHHHHHHTCSSGG
T ss_pred             HHHHHHHccCCHh
Confidence            9999999999995

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-57  Score=411.58  Aligned_cols=247  Identities=44%  Similarity=0.786  Sum_probs=221.5

Q ss_pred             CCcccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC------hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeC
Q psy12427        104 SSVYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH------NLEKELIRKEIDIMNQLHHPKLINLHDAFEDD  177 (356)
Q Consensus       104 ~~~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~------~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  177 (356)
                      ..+.++|++.+.||+|+||+||+|+++.+|+.||+|+++...      ....+.+.+|+.+|++++|||||+++++|.+.
T Consensus         6 ~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~   85 (293)
T d1jksa_           6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK   85 (293)
T ss_dssp             SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            345678999999999999999999999999999999986432      12357889999999999999999999999999


Q ss_pred             CeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCC--CcEEEE
Q psy12427        178 DEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNS--TNVKMI  255 (356)
Q Consensus       178 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~--~~vkl~  255 (356)
                      +.+++||||++||+|.+++.... .     +....+..++.|++.||+|||++||+||||||+|||++.++.  ..+||+
T Consensus        86 ~~~~iv~E~~~gg~L~~~i~~~~-~-----l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~  159 (293)
T d1jksa_          86 TDVILILELVAGGELFDFLAEKE-S-----LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKII  159 (293)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHS-S-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred             CEEEEEEEcCCCccccchhcccc-c-----cchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEec
Confidence            99999999999999999986532 2     334445669999999999999999999999999999986653  359999


Q ss_pred             eeeceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhh
Q psy12427        256 DFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEA  335 (356)
Q Consensus       256 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  335 (356)
                      |||+|.............||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+.+.++......++...
T Consensus       160 DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  239 (293)
T d1jksa_         160 DFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY  239 (293)
T ss_dssp             CCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHH
T ss_pred             chhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchh
Confidence            99999988766666667899999999999999999999999999999999999999999999999999999999999988


Q ss_pred             hccCCHHHHHHHHHhhhcCCC
Q psy12427        336 FKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       336 ~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +.++|+++++||++||+.||+
T Consensus       240 ~~~~s~~~~~li~~~L~~dP~  260 (293)
T d1jksa_         240 FSNTSALAKDFIRRLLVKDPK  260 (293)
T ss_dssp             HTTSCHHHHHHHHTTSCSSGG
T ss_pred             cCCCCHHHHHHHHHHccCChh
Confidence            899999999999999999995

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-58  Score=410.74  Aligned_cols=238  Identities=26%  Similarity=0.520  Sum_probs=207.7

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|++....   ......+.+|+++|++++||||+++++++.+++.+++|
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv   86 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG   86 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence            367999999999999999999999999999999986532   23456788999999999999999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      |||++||+|.+++.... .++     ...+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||+|+.+
T Consensus        87 mEy~~gg~L~~~~~~~~-~l~-----e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~--~vkl~DFG~a~~~  158 (288)
T d1uu3a_          87 LSYAKNGELLKYIRKIG-SFD-----ETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM--HIQITDFGTAKVL  158 (288)
T ss_dssp             ECCCTTEEHHHHHHHHS-SCC-----HHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS--CEEECCCTTCEEC
T ss_pred             EEccCCCCHHHhhhccC-CCC-----HHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCc--eEEecccccceec
Confidence            99999999999886432 333     344556999999999999999999999999999998654  7999999999887


Q ss_pred             CCCC---ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCC
Q psy12427        264 DPNE---VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVS  340 (356)
Q Consensus       264 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  340 (356)
                      ....   .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++++++....+.+|.    .+|
T Consensus       159 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s  234 (288)
T d1uu3a_         159 SPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE----KFF  234 (288)
T ss_dssp             C----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCT----TCC
T ss_pred             ccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCc----cCC
Confidence            5322   233457999999999999999999999999999999999999999999999999999988877764    789


Q ss_pred             HHHHHHHHHhhhcCCC
Q psy12427        341 EEGKDFIRRLLLRNKE  356 (356)
Q Consensus       341 ~~~~~lI~~ll~~dP~  356 (356)
                      +++++||++||++||+
T Consensus       235 ~~~~~li~~~L~~dP~  250 (288)
T d1uu3a_         235 PKARDLVEKLLVLDAT  250 (288)
T ss_dssp             HHHHHHHHTTSCSSGG
T ss_pred             HHHHHHHHHHccCCHh
Confidence            9999999999999995

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-57  Score=405.14  Aligned_cols=240  Identities=28%  Similarity=0.474  Sum_probs=197.8

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh-hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN-LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|++..... ...+.+.+|+.+|++++||||+++++++.+++.+++|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            4689999999999999999999999999999999976543 234568899999999999999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |++||+|.+++.... .++     ...+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+|+....
T Consensus        84 y~~gg~L~~~l~~~~-~l~-----e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~--~~KL~DFG~a~~~~~  155 (271)
T d1nvra_          84 YCSGGELFDRIEPDI-GMP-----EPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRY  155 (271)
T ss_dssp             CCTTEEGGGGSBTTT-BCC-----HHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC--CEEECCCTTCEECEE
T ss_pred             ccCCCcHHHHHhcCC-CCC-----HHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCC--CEEEccchhheeecc
Confidence            999999999986432 333     344556999999999999999999999999999998654  799999999987643


Q ss_pred             CC---ceeecCCCcCccccccccCCCC-CccccHHHHHHHHHHHHcCCCCCCCCChHHH-HHHhhccccccChhhhccCC
Q psy12427        266 NE---VVKISTGTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDVET-LKNVKACDWEFDEEAFKNVS  340 (356)
Q Consensus       266 ~~---~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~s  340 (356)
                      ..   .....+||+.|+|||++.+..+ +.++||||+||++|||++|+.||...++... +..+.... .+ ...+..+|
T Consensus       156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~-~~-~~~~~~~s  233 (271)
T d1nvra_         156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK-TY-LNPWKKID  233 (271)
T ss_dssp             TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTC-TT-STTGGGSC
T ss_pred             CCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CC-CCccccCC
Confidence            32   2334579999999999988876 5789999999999999999999987654433 33333322 22 23346899


Q ss_pred             HHHHHHHHHhhhcCCC
Q psy12427        341 EEGKDFIRRLLLRNKE  356 (356)
Q Consensus       341 ~~~~~lI~~ll~~dP~  356 (356)
                      +++++||++||+.||+
T Consensus       234 ~~~~~li~~~L~~dP~  249 (271)
T d1nvra_         234 SAPLALLHKILVENPS  249 (271)
T ss_dssp             HHHHHHHHHHSCSSTT
T ss_pred             HHHHHHHHHHcCCChh
Confidence            9999999999999995

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-58  Score=410.43  Aligned_cols=241  Identities=27%  Similarity=0.452  Sum_probs=208.4

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEec
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFL  187 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~  187 (356)
                      +.|++++.||+|+||+||+|+++.+|..||+|++........+.+.+|+++|++++||||+++++++.+++.+++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            46999999999999999999999999999999998776666778889999999999999999999999999999999999


Q ss_pred             cccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC-
Q psy12427        188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN-  266 (356)
Q Consensus       188 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~-  266 (356)
                      +||+|.+++......+++.     .+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+|+..... 
T Consensus        92 ~~g~L~~~~~~~~~~l~e~-----~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~--~~Kl~DFG~a~~~~~~~  164 (288)
T d2jfla1          92 AGGAVDAVMLELERPLTES-----QIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDG--DIKLADFGVSAKNTRTI  164 (288)
T ss_dssp             TTEEHHHHHHHHTSCCCHH-----HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECHHHH
T ss_pred             CCCcHHHHHHhcCCCCCHH-----HHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCC--CEEEEechhhhccCCCc
Confidence            9999999876543334444     3455999999999999999999999999999998655  7999999999875422 


Q ss_pred             CceeecCCCcCcccccccc-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCH
Q psy12427        267 EVVKISTGTAEFAAPEIVE-----REPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSE  341 (356)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  341 (356)
                      .......||+.|+|||++.     ...++.++|||||||++|+|++|+.||.+.+..+.+.++.....+.. ..+..+|+
T Consensus       165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~s~  243 (288)
T d2jfla1         165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL-AQPSRWSS  243 (288)
T ss_dssp             HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCC-SSGGGSCH
T ss_pred             ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC-CccccCCH
Confidence            1223457999999999984     45688999999999999999999999999999999988887654332 23358999


Q ss_pred             HHHHHHHHhhhcCCC
Q psy12427        342 EGKDFIRRLLLRNKE  356 (356)
Q Consensus       342 ~~~~lI~~ll~~dP~  356 (356)
                      ++++||++||++||+
T Consensus       244 ~~~~li~~~L~~dp~  258 (288)
T d2jfla1         244 NFKDFLKKCLEKNVD  258 (288)
T ss_dssp             HHHHHHHHHSCSSTT
T ss_pred             HHHHHHHHHccCChh
Confidence            999999999999995

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-57  Score=413.25  Aligned_cols=237  Identities=27%  Similarity=0.491  Sum_probs=211.0

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      ++|++++.||+|+||.||+|+++.+|+.||+|+++...   ......+.+|+.+|++++||||++++++|.+...+++||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            57999999999999999999999999999999997542   234567889999999999999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      ||++||+|.+++.... .+++     ..++.++.||+.||+|||++||+||||||+|||++.++  ++||+|||+|+...
T Consensus        85 ey~~gg~L~~~~~~~~-~~~e-----~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g--~vkl~DFG~a~~~~  156 (337)
T d1o6la_          85 EYANGGELFFHLSRER-VFTE-----ERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGI  156 (337)
T ss_dssp             ECCTTCBHHHHHHHHS-CCCH-----HHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCSC
T ss_pred             eccCCCchhhhhhccc-CCcH-----HHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCC--CEEEeecccccccc
Confidence            9999999999887533 3333     34456999999999999999999999999999998654  79999999998764


Q ss_pred             C-CCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHH
Q psy12427        265 P-NEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG  343 (356)
Q Consensus       265 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  343 (356)
                      . .......+||+.|+|||++.+..++.++||||+||++|||++|++||.+.+..++++++....+.+|.    .+|+++
T Consensus       157 ~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~  232 (337)
T d1o6la_         157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEA  232 (337)
T ss_dssp             CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHH
T ss_pred             cCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCc----cCCHHH
Confidence            3 33445568999999999999999999999999999999999999999999999999999998877764    799999


Q ss_pred             HHHHHHhhhcCCC
Q psy12427        344 KDFIRRLLLRNKE  356 (356)
Q Consensus       344 ~~lI~~ll~~dP~  356 (356)
                      ++||++||++||+
T Consensus       233 ~dli~~~L~~dP~  245 (337)
T d1o6la_         233 KSLLAGLLKKDPK  245 (337)
T ss_dssp             HHHHHHHTCSSTT
T ss_pred             HHHHHhhccCCch
Confidence            9999999999995

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-57  Score=401.48  Aligned_cols=243  Identities=27%  Similarity=0.468  Sum_probs=196.5

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEe--CCeEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFED--DDEMVL  182 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~l  182 (356)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|++....  ..+.+.+.+|+++|++++||||+++++++.+  .+.+++
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            468999999999999999999999999999999987653  3456778899999999999999999999864  567899


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCC-----ceeccCCCCCEEEeecCCCcEEEEee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN-----IIHLDVKPENIMCQTRNSTNVKMIDF  257 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-----ivH~Dlkp~NIlv~~~~~~~vkl~Df  257 (356)
                      ||||++||+|.+++.....  ....+....++.++.||+.||+|||++|     |+||||||+|||++.++  .+||+||
T Consensus        83 vmEy~~~g~L~~~i~~~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~--~vkl~DF  158 (269)
T d2java1          83 VMEYCEGGDLASVITKGTK--ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDF  158 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTS--CEEECCH
T ss_pred             EEecCCCCcHHHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCC--cEEEeec
Confidence            9999999999998853210  1112333445669999999999999976     99999999999998654  7999999


Q ss_pred             eceeeeCCCC-ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhh
Q psy12427        258 GLATKLDPNE-VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAF  336 (356)
Q Consensus       258 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  336 (356)
                      |+|+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++..++........   +
T Consensus       159 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~---~  235 (269)
T d2java1         159 GLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI---P  235 (269)
T ss_dssp             HHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC---C
T ss_pred             cceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC---C
Confidence            9998775433 33456799999999999999999999999999999999999999999999999999888765433   2


Q ss_pred             ccCCHHHHHHHHHhhhcCCC
Q psy12427        337 KNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       337 ~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ..+|+++++||++||+.||+
T Consensus       236 ~~~s~~l~~li~~~L~~dp~  255 (269)
T d2java1         236 YRYSDELNEIITRMLNLKDY  255 (269)
T ss_dssp             TTSCHHHHHHHHHHTCSSGG
T ss_pred             cccCHHHHHHHHHHcCCChh
Confidence            47999999999999999995

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7.9e-56  Score=402.72  Aligned_cols=235  Identities=29%  Similarity=0.565  Sum_probs=208.7

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      ++|++++.||+|+||+||+|+++.+|+.||+|+++...   ....+.+.+|+.+|++++||||+++++++...+.+++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            57999999999999999999999999999999986532   234567889999999999999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      ||+.||+|..++.... ...+     ..++.++.||+.||+|||++||+||||||+|||++.++  .+||+|||+|+...
T Consensus        84 E~~~gg~l~~~~~~~~-~~~~-----~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g--~vkL~DFG~a~~~~  155 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ-RFPN-----PVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG--HIKITDFGFAKYVP  155 (316)
T ss_dssp             CCCCSCBHHHHHHHTS-SCCH-----HHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS--CEEECCCSSCEECS
T ss_pred             eecCCccccccccccc-cccc-----cHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCC--CEEEecCccceEec
Confidence            9999999998887543 2333     23455899999999999999999999999999998654  79999999998875


Q ss_pred             CCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHHH
Q psy12427        265 PNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK  344 (356)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  344 (356)
                      ..  ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+.++......+|+    .+|++++
T Consensus       156 ~~--~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~  229 (316)
T d1fota_         156 DV--TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP----FFNEDVK  229 (316)
T ss_dssp             SC--BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT----TSCHHHH
T ss_pred             cc--cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC----CCCHHHH
Confidence            43  34567999999999999999999999999999999999999999999999999999988877664    7899999


Q ss_pred             HHHHHhhhcCCC
Q psy12427        345 DFIRRLLLRNKE  356 (356)
Q Consensus       345 ~lI~~ll~~dP~  356 (356)
                      ++|++||++||+
T Consensus       230 ~li~~~L~~dp~  241 (316)
T d1fota_         230 DLLSRLITRDLS  241 (316)
T ss_dssp             HHHHHHTCSCTT
T ss_pred             HHHHHHhhhCHH
Confidence            999999999995

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.8e-55  Score=393.11  Aligned_cols=243  Identities=32%  Similarity=0.593  Sum_probs=214.6

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh---------hHHHHHHHHHHHHhcC-CCCceeeeeeEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL---------EKELIRKEIDIMNQLH-HPKLINLHDAFE  175 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~---------~~~~~~~E~~il~~l~-hpnIv~l~~~~~  175 (356)
                      +.++|++.+.||+|+||+||+|+++.+|+.||+|+++.....         ..+.+.+|+.+|++++ ||||+++++++.
T Consensus         1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~   80 (277)
T d1phka_           1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   80 (277)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence            357899999999999999999999999999999998754311         2345778999999997 999999999999


Q ss_pred             eCCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEE
Q psy12427        176 DDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMI  255 (356)
Q Consensus       176 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~  255 (356)
                      +++.+++||||++||+|.+++.... .     +....++.++.||+.||+|||++||+||||||+|||++.++  .+||+
T Consensus        81 ~~~~~~ivmE~~~~g~L~~~l~~~~-~-----l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~--~~kl~  152 (277)
T d1phka_          81 TNTFFFLVFDLMKKGELFDYLTEKV-T-----LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM--NIKLT  152 (277)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS-S-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEEC
T ss_pred             cCcceEEEEEcCCCchHHHHHHhcC-C-----CCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCC--CeEEc
Confidence            9999999999999999999996432 3     34445566999999999999999999999999999997554  79999


Q ss_pred             eeeceeeeCCCCceeecCCCcCccccccccC------CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccc
Q psy12427        256 DFGLATKLDPNEVVKISTGTAEFAAPEIVER------EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDW  329 (356)
Q Consensus       256 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~  329 (356)
                      |||+++............||+.|+|||++.+      ..++.++||||+||++|+|++|+.||.+.+..+.+.++.....
T Consensus       153 DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~  232 (277)
T d1phka_         153 DFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY  232 (277)
T ss_dssp             CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred             cchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCC
Confidence            9999998877666666789999999999853      3568899999999999999999999999999999999999888


Q ss_pred             ccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        330 EFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       330 ~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .++.+.+.++|+++++||++||++||+
T Consensus       233 ~~~~~~~~~~s~~~~~li~~~L~~~p~  259 (277)
T d1phka_         233 QFGSPEWDDYSDTVKDLVSRFLVVQPQ  259 (277)
T ss_dssp             CCCTTTGGGSCHHHHHHHHHHCCSSGG
T ss_pred             CCCCcccccCCHHHHHHHHHHccCChh
Confidence            888888889999999999999999985

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-55  Score=402.09  Aligned_cols=248  Identities=28%  Similarity=0.517  Sum_probs=209.6

Q ss_pred             CCCCCCcccceeeec-cccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhc-CCCCceeeeeeEEe-
Q psy12427        100 DIKTSSVYDHYDILE-EIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQL-HHPKLINLHDAFED-  176 (356)
Q Consensus       100 ~~~~~~~~~~y~~~~-~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~-  176 (356)
                      .++...+.++|.+.. .||+|+||+||+|+++.+++.||+|+++..     ..+.+|+.++.++ +||||++++++|.+ 
T Consensus         3 ~~~~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~   77 (335)
T d2ozaa1           3 QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL   77 (335)
T ss_dssp             CCBCSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             cCCCCCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence            344556778999875 599999999999999999999999998643     3566899987655 89999999999975 


Q ss_pred             ---CCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecC-CCcE
Q psy12427        177 ---DDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRN-STNV  252 (356)
Q Consensus       177 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~-~~~v  252 (356)
                         ...+++|||||+||+|.+++.....    ..+....++.++.||+.||+|||++||+||||||+|||++.++ .+.+
T Consensus        78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~----~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~  153 (335)
T d2ozaa1          78 YAGRKCLLIVMECLDGGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAIL  153 (335)
T ss_dssp             ETTEEEEEEEEECCCSEEHHHHHHSCSC----CCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCE
T ss_pred             ccCCCEEEEEEECCCCCcHHHHHHhcCC----CCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccc
Confidence               4678999999999999999975431    2344455566999999999999999999999999999998643 4579


Q ss_pred             EEEeeeceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHH----HHHhhccc
Q psy12427        253 KMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVET----LKNVKACD  328 (356)
Q Consensus       253 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~----~~~i~~~~  328 (356)
                      ||+|||+|+............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.    ..++....
T Consensus       154 Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~  233 (335)
T d2ozaa1         154 KLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ  233 (335)
T ss_dssp             EECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCS
T ss_pred             cccccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCC
Confidence            99999999988776666777899999999999999999999999999999999999999988765443    44566677


Q ss_pred             cccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        329 WEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       329 ~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +.+|.+.+..+|+++++||++||++||+
T Consensus       234 ~~~~~~~~~~~s~~~~~li~~~L~~dP~  261 (335)
T d2ozaa1         234 YEFPNPEWSEVSEEVKMLIRNLLKTEPT  261 (335)
T ss_dssp             SSCCTTHHHHSCHHHHHHHHHHSCSSTT
T ss_pred             CCCCCcccccCCHHHHHHHHHHccCChh
Confidence            7788778889999999999999999995

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3e-55  Score=397.45  Aligned_cols=236  Identities=24%  Similarity=0.343  Sum_probs=202.2

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh---hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN---LEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      +.|+++++||+|+||+||+|+++.+|+.||+|++.....   .....+.+|+.+|++++|||||++++++.+++.+++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            359999999999999999999999999999999876542   23456889999999999999999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      ||+.+|+|..++.... .+++     ..+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+|....
T Consensus        95 E~~~~g~l~~~~~~~~-~l~e-----~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~--~~Kl~DFG~a~~~~  166 (309)
T d1u5ra_          95 EYCLGSASDLLEVHKK-PLQE-----VEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG--LVKLGDFGSASIMA  166 (309)
T ss_dssp             ECCSEEHHHHHHHHTS-CCCH-----HHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT--EEEECCCTTCBSSS
T ss_pred             EecCCCchHHHHHhCC-CCCH-----HHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCC--CEEEeecccccccC
Confidence            9999999976665332 3343     34456999999999999999999999999999998654  79999999998764


Q ss_pred             CCCceeecCCCcCccccccccC---CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCH
Q psy12427        265 PNEVVKISTGTAEFAAPEIVER---EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSE  341 (356)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  341 (356)
                      .   .....||+.|+|||++.+   ..++.++|||||||++|||++|..||.+.+..+.+.++.......+.  ...+|+
T Consensus       167 ~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~s~  241 (309)
T d1u5ra_         167 P---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ--SGHWSE  241 (309)
T ss_dssp             S---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS--CTTSCH
T ss_pred             C---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCCCH
Confidence            3   234579999999999864   45889999999999999999999999999998888888776544332  247899


Q ss_pred             HHHHHHHHhhhcCCC
Q psy12427        342 EGKDFIRRLLLRNKE  356 (356)
Q Consensus       342 ~~~~lI~~ll~~dP~  356 (356)
                      ++++||++||+.||+
T Consensus       242 ~~~~li~~~L~~dP~  256 (309)
T d1u5ra_         242 YFRNFVDSCLQKIPQ  256 (309)
T ss_dssp             HHHHHHHHHTCSSGG
T ss_pred             HHHHHHHHHCcCChh
Confidence            999999999999995

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-55  Score=387.25  Aligned_cols=236  Identities=25%  Similarity=0.332  Sum_probs=196.1

Q ss_pred             eeeeccccccCceEEEEEEEccCCCEEEEEEcccC--ChhhHHHHHHHHHHHHhcCCCCceeeeeeEEe----CCeEEEE
Q psy12427        110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVS--HNLEKELIRKEIDIMNQLHHPKLINLHDAFED----DDEMVLI  183 (356)
Q Consensus       110 y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~~~lv  183 (356)
                      |++.++||+|+||+||+|+++.++..||+|.+...  ...+.+.+.+|+++|++++||||+++++++..    ...+++|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            47788999999999999999999999999998654  34456778899999999999999999999865    4568999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEEeecCCCcEEEEeeecee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKN--IIHLDVKPENIMCQTRNSTNVKMIDFGLAT  261 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~  261 (356)
                      |||+++|+|.+++.... .++     ...+..++.||+.||+|||+++  |+||||||+|||++.+ ++.+||+|||+|+
T Consensus        91 mE~~~~g~L~~~l~~~~-~~~-----~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~-~~~~Kl~DFGla~  163 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRFK-VMK-----IKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP-TGSVKIGDLGLAT  163 (270)
T ss_dssp             EECCCSCBHHHHHHHHS-SCC-----HHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESST-TSCEEECCTTGGG
T ss_pred             EeCCCCCcHHHHHhccc-ccc-----HHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCC-CCCEEEeecCcce
Confidence            99999999999986432 233     3344569999999999999998  9999999999999643 3479999999997


Q ss_pred             eeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHhhccccccChhhhccCC
Q psy12427        262 KLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDV-ETLKNVKACDWEFDEEAFKNVS  340 (356)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s  340 (356)
                      .... ......+||+.|+|||++.+ .++.++|||||||++|||++|+.||.+..+. ++.+.+....  .+......++
T Consensus       164 ~~~~-~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~--~~~~~~~~~~  239 (270)
T d1t4ha_         164 LKRA-SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV--KPASFDKVAI  239 (270)
T ss_dssp             GCCT-TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC--CCGGGGGCCC
T ss_pred             eccC-CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCC--CCcccCccCC
Confidence            6543 34456789999999999875 5999999999999999999999999876544 4555555433  2344556799


Q ss_pred             HHHHHHHHHhhhcCCC
Q psy12427        341 EEGKDFIRRLLLRNKE  356 (356)
Q Consensus       341 ~~~~~lI~~ll~~dP~  356 (356)
                      +++++||++||++||+
T Consensus       240 ~~~~~li~~~l~~dp~  255 (270)
T d1t4ha_         240 PEVKEIIEGCIRQNKD  255 (270)
T ss_dssp             HHHHHHHHHHSCSSGG
T ss_pred             HHHHHHHHHHccCCHh
Confidence            9999999999999995

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.2e-55  Score=403.19  Aligned_cols=236  Identities=26%  Similarity=0.497  Sum_probs=209.4

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++....   ....+.+.+|+.+|+.++||||+++++++......++|
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v  119 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence            368999999999999999999999999999999986432   23346788999999999999999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      |||+.||+|.+++.... .++     ...++.++.||+.||+|||++|||||||||+|||++.++  ++||+|||+|+..
T Consensus       120 ~e~~~~g~l~~~l~~~~-~l~-----e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g--~ikL~DFG~a~~~  191 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRIG-RFS-----EPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG--YIQVTDFGFAKRV  191 (350)
T ss_dssp             EECCTTCBHHHHHHHHC-CCC-----HHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEEC
T ss_pred             cccccccchhhhHhhcC-CCC-----HHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCC--CEEeeeceeeeec
Confidence            99999999999886543 233     344566999999999999999999999999999997654  7999999999987


Q ss_pred             CCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHHH
Q psy12427        264 DPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG  343 (356)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  343 (356)
                      ...  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+.++......++.    .+|+++
T Consensus       192 ~~~--~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~  265 (350)
T d1rdqe_         192 KGR--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDL  265 (350)
T ss_dssp             SSC--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TCCHHH
T ss_pred             ccc--cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCc----cCCHHH
Confidence            543  33457999999999999999999999999999999999999999999999999999888776654    799999


Q ss_pred             HHHHHHhhhcCCC
Q psy12427        344 KDFIRRLLLRNKE  356 (356)
Q Consensus       344 ~~lI~~ll~~dP~  356 (356)
                      ++||++||++||+
T Consensus       266 ~~li~~~L~~dP~  278 (350)
T d1rdqe_         266 KDLLRNLLQVDLT  278 (350)
T ss_dssp             HHHHHHHSCSCTT
T ss_pred             HHHHHHHhhhCHH
Confidence            9999999999995

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-54  Score=392.52  Aligned_cols=240  Identities=19%  Similarity=0.316  Sum_probs=193.4

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCC---EEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGN---IFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~---~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      .++|++.++||+|+||+||+|+++.+++   .||+|.+.... ....+.+.+|+.+|++++|||||+++|++..++.+++
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i  104 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI  104 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            3579999999999999999999987764   58888886543 4455778999999999999999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ||||+++|+|.+++......+++..     +..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+|+.
T Consensus       105 v~Ey~~~g~L~~~~~~~~~~l~~~~-----~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~--~~Kl~DFGla~~  177 (299)
T d1jpaa_         105 ITEFMENGSLDSFLRQNDGQFTVIQ-----LVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNL--VCKVSDFGLSRF  177 (299)
T ss_dssp             EEECCTTEEHHHHHHTTTTCSCHHH-----HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECCC-----
T ss_pred             EEEecCCCcceeeeccccCCCCHHH-----HHHHHHHHHHHHHHHhhCCCccCccccceEEECCCC--cEEECCcccceE
Confidence            9999999999998876544444443     455999999999999999999999999999998654  799999999987


Q ss_pred             eCCCCcee------ecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhh
Q psy12427        263 LDPNEVVK------ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEA  335 (356)
Q Consensus       263 ~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  335 (356)
                      ........      ...||+.|+|||++.+..++.++|||||||+||||+| |+.||.+.+..+.+..+.......+   
T Consensus       178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~---  254 (299)
T d1jpaa_         178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP---  254 (299)
T ss_dssp             ------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---
T ss_pred             ccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---
Confidence            65432211      1347899999999999999999999999999999998 8999999999999888876543222   


Q ss_pred             hccCCHHHHHHHHHhhhcCCC
Q psy12427        336 FKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       336 ~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +.++|+++.+||.+||+.||+
T Consensus       255 ~~~~~~~l~~li~~cl~~~P~  275 (299)
T d1jpaa_         255 PMDCPSALHQLMLDCWQKDRN  275 (299)
T ss_dssp             CTTCCHHHHHHHHHHTCSSTT
T ss_pred             CccchHHHHHHHHHHcCCCHh
Confidence            247999999999999999995

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.2e-54  Score=388.59  Aligned_cols=243  Identities=25%  Similarity=0.384  Sum_probs=204.2

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh---hhHHHHHHHHHHHHhcCCCCceeeeeeEEeCC----
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN---LEKELIRKEIDIMNQLHHPKLINLHDAFEDDD----  178 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----  178 (356)
                      +.++|++.+.||+|+||+||+|+++.+|+.||+|+++....   .....+.+|+.+|+.++||||+++++++....    
T Consensus         5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~   84 (277)
T d1o6ya_           5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   84 (277)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred             ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence            45789999999999999999999999999999999975432   33457889999999999999999999997644    


Q ss_pred             eEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeee
Q psy12427        179 EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFG  258 (356)
Q Consensus       179 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg  258 (356)
                      .+++||||++|++|.+++.... .+++     ..+..++.||+.||+|||++||+||||||+|||++.++  .++|+|||
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~~~-~l~~-----~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~--~~~l~d~~  156 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHTEG-PMTP-----KRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN--AVKVMDFG  156 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHC-SCCH-----HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTS--CEEECCCT
T ss_pred             eEEEEEECCCCCEehhhhcccC-CCCH-----HHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccc--cceeehhh
Confidence            3899999999999998886543 3333     34455999999999999999999999999999998655  69999999


Q ss_pred             ceeeeCCCC----ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChh
Q psy12427        259 LATKLDPNE----VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEE  334 (356)
Q Consensus       259 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  334 (356)
                      .+.......    .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+.++......++..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  236 (277)
T d1o6ya_         157 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA  236 (277)
T ss_dssp             TCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGG
T ss_pred             hhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCch
Confidence            987654322    2334569999999999999999999999999999999999999999999999998888887777777


Q ss_pred             hhccCCHHHHHHHHHhhhcCCC
Q psy12427        335 AFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       335 ~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+.++|+++++||++||++||+
T Consensus       237 ~~~~~s~~l~~li~~~L~~dp~  258 (277)
T d1o6ya_         237 RHEGLSADLDAVVLKALAKNPE  258 (277)
T ss_dssp             TSSSCCHHHHHHHHHHTCSSGG
T ss_pred             hccCCCHHHHHHHHHHccCCHh
Confidence            7789999999999999999995

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-54  Score=389.28  Aligned_cols=240  Identities=23%  Similarity=0.334  Sum_probs=200.0

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      .++|++.++||+|+||+||+|+++.+++.||+|+++.... +.+.+.+|+++|++++||||++++++|.+++..++||||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence            4679999999999999999999999999999999875543 456789999999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +++|+|.+++.....    ..+....+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+|+.....
T Consensus        95 ~~~g~l~~~l~~~~~----~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~--~~Kl~DFG~a~~~~~~  168 (287)
T d1opja_          95 MTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSRLMTGD  168 (287)
T ss_dssp             CTTCBHHHHHHHSCT----TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEEECCCCCTTTCCSS
T ss_pred             ccCcchHHHhhhccc----cchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCC--cEEEccccceeecCCC
Confidence            999999999864321    1233334456999999999999999999999999999998665  7999999999876544


Q ss_pred             Cceee--cCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCC-CCCCChHHHHHHhhccccccChhhhccCCHHH
Q psy12427        267 EVVKI--STGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSP-FAGENDVETLKNVKACDWEFDEEAFKNVSEEG  343 (356)
Q Consensus       267 ~~~~~--~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~P-f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  343 (356)
                      .....  ..|++.|+|||++.+..++.++|||||||++|||++|..| |.+.+..+..+.+... ..  ++.+..+|+++
T Consensus       169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~-~~--~~~~~~~~~~l  245 (287)
T d1opja_         169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YR--MERPEGCPEKV  245 (287)
T ss_dssp             SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CC--CCCCTTCCHHH
T ss_pred             CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC-CC--CCCCccchHHH
Confidence            33322  2478999999999999999999999999999999996555 5566666665555443 22  23345899999


Q ss_pred             HHHHHHhhhcCCC
Q psy12427        344 KDFIRRLLLRNKE  356 (356)
Q Consensus       344 ~~lI~~ll~~dP~  356 (356)
                      ++||++||+.||+
T Consensus       246 ~~li~~cl~~dP~  258 (287)
T d1opja_         246 YELMRACWQWNPS  258 (287)
T ss_dssp             HHHHHHHTCSSGG
T ss_pred             HHHHHHHcCCCHh
Confidence            9999999999995

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-55  Score=388.45  Aligned_cols=239  Identities=21%  Similarity=0.382  Sum_probs=192.5

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~  184 (356)
                      .++|++.+.||+|+||+||+|+.+   ..||+|+++...  ....+.+.+|+.+|++++||||+++++++.. ..+++||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~   82 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT   82 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence            357999999999999999999754   369999997543  4456788999999999999999999998754 5689999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      ||++||+|.+++......+++..     +..++.||+.||+|||++|||||||||+|||++.++  .+||+|||+|+...
T Consensus        83 Ey~~~g~L~~~l~~~~~~~~~~~-----~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~--~~Kl~DFGla~~~~  155 (276)
T d1uwha_          83 QWCEGSSLYHHLHIIETKFEMIK-----LIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL--TVKIGDFGLATVKS  155 (276)
T ss_dssp             ECCCEEEHHHHHHTSCCCCCHHH-----HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTS--SEEECCCCCSCC--
T ss_pred             ecCCCCCHHHHHhhccCCCCHHH-----HHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCC--CEEEccccceeecc
Confidence            99999999999976554444443     455999999999999999999999999999998654  79999999998764


Q ss_pred             CCC---ceeecCCCcCccccccccC---CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC--hhhh
Q psy12427        265 PNE---VVKISTGTAEFAAPEIVER---EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD--EEAF  336 (356)
Q Consensus       265 ~~~---~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~  336 (356)
                      ...   ......||+.|+|||++.+   ..++.++|||||||+||||++|+.||.+.+..+.+..+.......|  ....
T Consensus       156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~  235 (276)
T d1uwha_         156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR  235 (276)
T ss_dssp             ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSC
T ss_pred             ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcc
Confidence            322   2234578999999999964   3578999999999999999999999998877666555444333222  3445


Q ss_pred             ccCCHHHHHHHHHhhhcCCC
Q psy12427        337 KNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       337 ~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .++|+++++||.+||+.||+
T Consensus       236 ~~~~~~l~~li~~cl~~dp~  255 (276)
T d1uwha_         236 SNCPKAMKRLMAECLKKKRD  255 (276)
T ss_dssp             TTCCHHHHHHHHHHTCSSGG
T ss_pred             ccchHHHHHHHHHHcCCCHh
Confidence            67999999999999999985

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-54  Score=395.34  Aligned_cols=237  Identities=25%  Similarity=0.468  Sum_probs=205.6

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC---hhhHHHHHHHHHHHH-hcCCCCceeeeeeEEeCCeEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH---NLEKELIRKEIDIMN-QLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~-~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      ++|.+.++||+|+||+||+|+++.+|+.||+|+++...   ....+.+..|..++. .++||||+++++++.+++.+++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57999999999999999999999999999999997532   223455666777665 68999999999999999999999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      |||++||+|.+++.... .+++     ..+..++.||+.||+|||++||+||||||+|||++.++  ++||+|||+|+..
T Consensus        82 mEy~~~g~L~~~i~~~~-~~~e-----~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~--~~kl~DFG~a~~~  153 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH-KFDL-----SRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG--HIKIADFGMCKEN  153 (320)
T ss_dssp             EECCTTCBHHHHHHHHS-SCCH-----HHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCC
T ss_pred             EeecCCCcHHHHhhccC-CCCH-----HHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCC--ceeccccchhhhc
Confidence            99999999999986433 3333     34556999999999999999999999999999998554  7999999999876


Q ss_pred             CCC-CceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhhccCCHH
Q psy12427        264 DPN-EVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEE  342 (356)
Q Consensus       264 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  342 (356)
                      ... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+++.++....+.+|    +.+|++
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~  229 (320)
T d1xjda_         154 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP----RWLEKE  229 (320)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHH
T ss_pred             ccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----ccCCHH
Confidence            533 333446799999999999999999999999999999999999999999999999999988776665    378999


Q ss_pred             HHHHHHHhhhcCCC
Q psy12427        343 GKDFIRRLLLRNKE  356 (356)
Q Consensus       343 ~~~lI~~ll~~dP~  356 (356)
                      +++||++||++||+
T Consensus       230 ~~dli~~~L~~dP~  243 (320)
T d1xjda_         230 AKDLLVKLFVREPE  243 (320)
T ss_dssp             HHHHHHHHSCSSGG
T ss_pred             HHHHHHHhcccCCC
Confidence            99999999999995

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-54  Score=385.11  Aligned_cols=238  Identities=24%  Similarity=0.370  Sum_probs=200.4

Q ss_pred             cceeeec-cccccCceEEEEEEEccC--CCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEE
Q psy12427        108 DHYDILE-EIGTGAFGVVHRCRERKT--GNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       108 ~~y~~~~-~lg~G~fg~V~~~~~~~~--~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv  183 (356)
                      ++|.+.+ +||+|+||+||+|.++.+  +..||+|+++... ....+.+.+|+++|++++|||||+++|++.. +.+++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            4678888 499999999999987644  4579999987553 4456788999999999999999999999875 468999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      |||+++|+|.+++......+++.     .+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+|+..
T Consensus        87 mE~~~~g~L~~~l~~~~~~l~~~-----~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~--~~Kl~DFGla~~~  159 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKREEIPVS-----NVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH--YAKISDFGLSKAL  159 (285)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHH-----HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT--EEEECCCTTCEEC
T ss_pred             EEeCCCCcHHHHhhccccCCCHH-----HHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCC--ceeeccchhhhcc
Confidence            99999999999986654444444     3455999999999999999999999999999998765  7999999999987


Q ss_pred             CCCCcee----ecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhcc
Q psy12427        264 DPNEVVK----ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKN  338 (356)
Q Consensus       264 ~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  338 (356)
                      .......    ...||+.|+|||++....++.++|||||||++|||+| |+.||.+.+..+++..+..+...   +.+.+
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~---~~p~~  236 (285)
T d1u59a_         160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---ECPPE  236 (285)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC---CCCTT
T ss_pred             cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCc
Confidence            6543322    2357999999999999999999999999999999998 99999999999998888775532   22358


Q ss_pred             CCHHHHHHHHHhhhcCCC
Q psy12427        339 VSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       339 ~s~~~~~lI~~ll~~dP~  356 (356)
                      +|+++.+||++||+.||+
T Consensus       237 ~~~~l~~li~~cl~~~p~  254 (285)
T d1u59a_         237 CPPELYALMSDCWIYKWE  254 (285)
T ss_dssp             CCHHHHHHHHHTTCSSGG
T ss_pred             CCHHHHHHHHHHcCCCHh
Confidence            999999999999999995

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-54  Score=383.02  Aligned_cols=237  Identities=21%  Similarity=0.341  Sum_probs=194.0

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEec
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFL  187 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~  187 (356)
                      ++|++.+.||+|+||+||+|+++ ++..||+|+++.... ..+.+.+|+++|++++||||++++|++..++..++||||+
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~   82 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   82 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC-cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence            47999999999999999999986 467899999976443 4567889999999999999999999999999999999999


Q ss_pred             cccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCC
Q psy12427        188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE  267 (356)
Q Consensus       188 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~  267 (356)
                      ++|+|.+++......+++..     +..++.||+.||+|||+++|+||||||+|||++.++  .+||+|||+|+......
T Consensus        83 ~~g~L~~~l~~~~~~~~~~~-----~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~--~~Kl~DFGla~~~~~~~  155 (263)
T d1sm2a_          83 EHGCLSDYLRTQRGLFAAET-----LLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ--VIKVSDFGMTRFVLDDQ  155 (263)
T ss_dssp             TTCBHHHHHHTTTTCCCHHH-----HHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGG--CEEECSCC---------
T ss_pred             CCCcHHHHhhccccCCCHHH-----HHHHHHHHHHHHHhhhccceeecccchhheeecCCC--CeEecccchheeccCCC
Confidence            99999999876554444433     345999999999999999999999999999998665  79999999998765433


Q ss_pred             ce--eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHHH
Q psy12427        268 VV--KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK  344 (356)
Q Consensus       268 ~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  344 (356)
                      ..  ....||+.|+|||++.+..++.++|||||||++|||++ |.+||...+..+.+..+..+.....+   ..+|+++.
T Consensus       156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p---~~~~~~l~  232 (263)
T d1sm2a_         156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---RLASTHVY  232 (263)
T ss_dssp             ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCC---TTSCHHHH
T ss_pred             ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCc---cccCHHHH
Confidence            22  23568999999999999999999999999999999999 68888888888888888775433322   47899999


Q ss_pred             HHHHHhhhcCCC
Q psy12427        345 DFIRRLLLRNKE  356 (356)
Q Consensus       345 ~lI~~ll~~dP~  356 (356)
                      +||++||+.||+
T Consensus       233 ~li~~cl~~~p~  244 (263)
T d1sm2a_         233 QIMNHCWKERPE  244 (263)
T ss_dssp             HHHHHHTCSSGG
T ss_pred             HHHHHHccCCHh
Confidence            999999999995

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-55  Score=399.93  Aligned_cols=202  Identities=24%  Similarity=0.465  Sum_probs=175.6

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      .++|+++++||+|+||+||+|+++.+|..||+|+++... ......+.+|+.+|++++|||||+++++|.++..+++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            468999999999999999999999999999999997653 3345678899999999999999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEEeecCCCcEEEEeeeceeeeC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEK-NIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLD  264 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~  264 (356)
                      |++||+|.+++.... .+     ....++.++.|++.||+|||++ ||+||||||+|||++.++  .+||+|||+|+...
T Consensus        85 y~~gg~L~~~l~~~~-~l-----~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~--~vkl~DFGla~~~~  156 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAG-RI-----PEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG--EIKLCDFGVSGQLI  156 (322)
T ss_dssp             CCTTEEHHHHHHHHS-SC-----CHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC--CEEECCCCCCHHHH
T ss_pred             cCCCCcHHHHHhhcC-CC-----CHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCC--CEEEeeCCCccccC
Confidence            999999999987432 23     3344566999999999999975 999999999999997654  79999999998764


Q ss_pred             CCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCCh
Q psy12427        265 PNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEND  317 (356)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~  317 (356)
                      .. .....+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+.
T Consensus       157 ~~-~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~  208 (322)
T d1s9ja_         157 DS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA  208 (322)
T ss_dssp             HH-TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred             CC-ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence            32 23446899999999999999999999999999999999999999987654

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-54  Score=378.90  Aligned_cols=237  Identities=22%  Similarity=0.337  Sum_probs=205.0

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEec
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFL  187 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~  187 (356)
                      ++|++.++||+|+||+||+|+++ +++.||+|+++.... ..+.+.+|+.++++++||||++++|++.+++.+++||||+
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            47899999999999999999985 678999999986544 4567899999999999999999999999999999999999


Q ss_pred             cccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCC
Q psy12427        188 SGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNE  267 (356)
Q Consensus       188 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~  267 (356)
                      ++|+|.+++......+.+.     .+..++.|+++||+|||++||+||||||+|||++.++  .+||+|||+|+......
T Consensus        82 ~~g~l~~~~~~~~~~~~~~-----~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~--~~kl~DfG~a~~~~~~~  154 (258)
T d1k2pa_          82 ANGCLLNYLREMRHRFQTQ-----QLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG--VVKVSDFGLSRYVLDDE  154 (258)
T ss_dssp             TTEEHHHHHHSGGGCCCHH-----HHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTC--CEEECCCSSCCBCSSSS
T ss_pred             CCCcHHHhhhccccCCcHH-----HHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCC--cEEECcchhheeccCCC
Confidence            9999999987654444443     3455999999999999999999999999999998644  79999999998765433


Q ss_pred             ce--eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHHH
Q psy12427        268 VV--KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK  344 (356)
Q Consensus       268 ~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  344 (356)
                      ..  ....||+.|+|||.+....++.++|||||||++|||+| |+.||.+.+..++..++..+...+.+   ..+|+++.
T Consensus       155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p---~~~~~~l~  231 (258)
T d1k2pa_         155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---HLASEKVY  231 (258)
T ss_dssp             CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCC---TTCCHHHH
T ss_pred             ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc---ccccHHHH
Confidence            32  23468999999999999999999999999999999998 89999999999999988875433332   47899999


Q ss_pred             HHHHHhhhcCCC
Q psy12427        345 DFIRRLLLRNKE  356 (356)
Q Consensus       345 ~lI~~ll~~dP~  356 (356)
                      +||++||+.||+
T Consensus       232 ~li~~cl~~dP~  243 (258)
T d1k2pa_         232 TIMYSCWHEKAD  243 (258)
T ss_dssp             HHHHHTTCSSGG
T ss_pred             HHHHHHccCCHh
Confidence            999999999995

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-53  Score=390.08  Aligned_cols=246  Identities=22%  Similarity=0.336  Sum_probs=202.0

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCC-----EEEEEEcccCC-hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCe
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGN-----IFAAKFIPVSH-NLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDE  179 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~-----~~a~K~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  179 (356)
                      .++|++.++||+|+||+||+|+++.+++     .||+|.+.... ......+.+|+.+|.++ +|||||++++++...+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            4689999999999999999999986554     68999886543 33456788999999998 89999999999999999


Q ss_pred             EEEEEEeccccchhhhhhCCCCCCCc-----------------cccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCE
Q psy12427        180 MVLIFEFLSGGELFERITAPDYKMSE-----------------AEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENI  242 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~~~~~-----------------~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NI  242 (356)
                      +++||||+++|+|.+++........+                 ..+....+..++.||+.||+|||++||+||||||+||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Ni  195 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV  195 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhcc
Confidence            99999999999999999765433222                 2234445677999999999999999999999999999


Q ss_pred             EEeecCCCcEEEEeeeceeeeCCCCce---eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChH
Q psy12427        243 MCQTRNSTNVKMIDFGLATKLDPNEVV---KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDV  318 (356)
Q Consensus       243 lv~~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~  318 (356)
                      |++.++  .+||+|||+|+........   ....||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..
T Consensus       196 ll~~~~--~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~  273 (325)
T d1rjba_         196 LVTHGK--VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  273 (325)
T ss_dssp             EEETTT--EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             ccccCC--eEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence            998654  8999999999876543322   23357999999999999999999999999999999998 89999998776


Q ss_pred             HHHHHhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        319 ETLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       319 ~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +.+.++......++  .+..+|+++++||.+||+.||+
T Consensus       274 ~~~~~~~~~~~~~~--~p~~~~~~l~~li~~cl~~dP~  309 (325)
T d1rjba_         274 ANFYKLIQNGFKMD--QPFYATEEIYIIMQSCWAFDSR  309 (325)
T ss_dssp             HHHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGG
T ss_pred             HHHHHHHhcCCCCC--CCCcCCHHHHHHHHHHcCCChh
Confidence            66666666554433  2357999999999999999995

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-53  Score=376.53  Aligned_cols=231  Identities=23%  Similarity=0.348  Sum_probs=192.6

Q ss_pred             ccccccCceEEEEEEEcc--CCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEeccc
Q psy12427        114 EEIGTGAFGVVHRCRERK--TGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEFLSG  189 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~--~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  189 (356)
                      ++||+|+||+||+|.++.  +++.||+|+++...  ....+.+.+|+++|++++||||+++++++.. ...++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            469999999999998754  45789999986543  2345678999999999999999999999965 457899999999


Q ss_pred             cchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCCCce
Q psy12427        190 GELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPNEVV  269 (356)
Q Consensus       190 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~~~~  269 (356)
                      |+|.+++.... .+++     ..+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+|+........
T Consensus        92 g~L~~~l~~~~-~l~~-----~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~--~~kl~DFGla~~~~~~~~~  163 (277)
T d1xbba_          92 GPLNKYLQQNR-HVKD-----KNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH--YAKISDFGLSKALRADENY  163 (277)
T ss_dssp             EEHHHHHHHCT-TCCH-----HHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT--EEEECCCTTCEECCTTCSE
T ss_pred             CcHHHHHhhcc-CCCH-----HHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccC--cccccchhhhhhccccccc
Confidence            99999987543 2333     34455999999999999999999999999999998765  7999999999987544332


Q ss_pred             e----ecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHHH
Q psy12427        270 K----ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK  344 (356)
Q Consensus       270 ~----~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  344 (356)
                      .    ...||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+..+...   +.+..+|++++
T Consensus       164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~---~~p~~~~~~~~  240 (277)
T d1xbba_         164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---GCPAGCPREMY  240 (277)
T ss_dssp             EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTCCHHHH
T ss_pred             cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCC---CCCcccCHHHH
Confidence            2    2358999999999999999999999999999999998 99999999999888888775432   22357999999


Q ss_pred             HHHHHhhhcCCC
Q psy12427        345 DFIRRLLLRNKE  356 (356)
Q Consensus       345 ~lI~~ll~~dP~  356 (356)
                      +||.+||+.||+
T Consensus       241 ~li~~cl~~dp~  252 (277)
T d1xbba_         241 DLMNLCWTYDVE  252 (277)
T ss_dssp             HHHHHHTCSSTT
T ss_pred             HHHHHHcCCCHh
Confidence            999999999995

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.4e-53  Score=394.94  Aligned_cols=236  Identities=23%  Similarity=0.444  Sum_probs=193.3

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh---hhHHHHHH---HHHHHHhcCCCCceeeeeeEEeCCeEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN---LEKELIRK---EIDIMNQLHHPKLINLHDAFEDDDEMV  181 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~---E~~il~~l~hpnIv~l~~~~~~~~~~~  181 (356)
                      ++|++.++||+|+||+||+|+++.+|+.||+|++.....   .....+.+   |+.+++.++||||++++++|...+.++
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            579999999999999999999999999999999864321   12233334   466677778999999999999999999


Q ss_pred             EEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeecee
Q psy12427        182 LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT  261 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~  261 (356)
                      +||||++||+|.+++.... .++     ...++.++.||+.||+|||++||+||||||+|||++.++  .+||+|||+|+
T Consensus        84 ivmE~~~gg~L~~~l~~~~-~~~-----e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g--~iKl~DFGla~  155 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHG-VFS-----EADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG--HVRISDLGLAC  155 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHC-SCC-----HHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSS--CEEECCCTTCE
T ss_pred             EEEEecCCCcHHHHHHhcc-ccc-----HHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCC--cEEEeeeceee
Confidence            9999999999999986532 233     334556999999999999999999999999999997655  79999999999


Q ss_pred             eeCCCCceeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCChHH---HHHHhhccccccChhhhc
Q psy12427        262 KLDPNEVVKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVE---TLKNVKACDWEFDEEAFK  337 (356)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~---~~~~i~~~~~~~~~~~~~  337 (356)
                      .+.... ....+||+.|+|||++.. ..++.++|||||||++|||++|+.||.+.+..+   ....+....    ...+.
T Consensus       156 ~~~~~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~----~~~~~  230 (364)
T d1omwa3         156 DFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA----VELPD  230 (364)
T ss_dssp             ECSSSC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCC----CCCCS
T ss_pred             ecCCCc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC----CCCCC
Confidence            876433 345679999999999974 568999999999999999999999998765432   333333333    33345


Q ss_pred             cCCHHHHHHHHHhhhcCCC
Q psy12427        338 NVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       338 ~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+|+++++||++||++||+
T Consensus       231 ~~s~~~~~li~~~L~~dP~  249 (364)
T d1omwa3         231 SFSPELRSLLEGLLQRDVN  249 (364)
T ss_dssp             SSCHHHHHHHHHHTCSSTT
T ss_pred             CCCHHHHHHHHHHcccCHH
Confidence            8999999999999999995

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-53  Score=376.16  Aligned_cols=238  Identities=23%  Similarity=0.382  Sum_probs=198.4

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      .++|++.+.||+|+||+||+|+++ ++..||+|+++.... ..+.+.+|+++|++++|||||+++|++.. +..++||||
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey   88 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence            468999999999999999999986 467899999975443 45678999999999999999999998754 567999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +++|+|.+++....    ...+....+..++.||+.||+|||+++|+||||||+|||++.++  .+||+|||+|+.....
T Consensus        89 ~~~g~L~~~~~~~~----~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~--~~Kl~DFGla~~~~~~  162 (272)
T d1qpca_          89 MENGSLVDFLKTPS----GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL--SCKIADFGLARLIEDN  162 (272)
T ss_dssp             CTTCBHHHHTTSHH----HHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS--CEEECCCTTCEECSSS
T ss_pred             CCCCcHHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeeccc--ceeeccccceEEccCC
Confidence            99999998775332    11233444556999999999999999999999999999998554  7999999999987654


Q ss_pred             Cce--eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHH
Q psy12427        267 EVV--KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG  343 (356)
Q Consensus       267 ~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  343 (356)
                      ...  ....||+.|+|||++.+..++.++|||||||++|||+| |.+||...+..+.+..+..+.....   +..+|+++
T Consensus       163 ~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~---p~~~~~~l  239 (272)
T d1qpca_         163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR---PDNCPEEL  239 (272)
T ss_dssp             CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---CTTCCHHH
T ss_pred             ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC---cccChHHH
Confidence            332  22458999999999999999999999999999999999 5677788888888888876543322   24799999


Q ss_pred             HHHHHHhhhcCCC
Q psy12427        344 KDFIRRLLLRNKE  356 (356)
Q Consensus       344 ~~lI~~ll~~dP~  356 (356)
                      ++||++||+.||+
T Consensus       240 ~~li~~cl~~~P~  252 (272)
T d1qpca_         240 YQLMRLCWKERPE  252 (272)
T ss_dssp             HHHHHHHTCSSGG
T ss_pred             HHHHHHHcCCCHh
Confidence            9999999999985

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=379.64  Aligned_cols=237  Identities=27%  Similarity=0.425  Sum_probs=193.4

Q ss_pred             eeccccccCceEEEEEEEccCCCEEEEEEcccCChhh-----HHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        112 ILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLE-----KELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       112 ~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~-----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      .+++||+|+||+||+|+++.+|+.||+|+++......     ...+.+|+.+|++++||||+++++++..++.+++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            4678999999999999999999999999997553321     24578999999999999999999999999999999999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +.++++..+... ...+++     ..+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+|+.....
T Consensus        82 ~~~~~~~~~~~~-~~~l~~-----~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~--~~KL~DFG~a~~~~~~  153 (299)
T d1ua2a_          82 METDLEVIIKDN-SLVLTP-----SHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG--VLKLADFGLAKSFGSP  153 (299)
T ss_dssp             CSEEHHHHHTTC-CSSCCS-----SHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--CEEECCCGGGSTTTSC
T ss_pred             hcchHHhhhhhc-ccCCCH-----HHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCC--ccccccCccccccCCC
Confidence            998877665542 223333     44566999999999999999999999999999997554  7999999999876543


Q ss_pred             C-ceeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC------------
Q psy12427        267 E-VVKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD------------  332 (356)
Q Consensus       267 ~-~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~------------  332 (356)
                      . .....+||+.|+|||++... .++.++||||+||++|||++|.+||.+.++.+.+.++.+....++            
T Consensus       154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~  233 (299)
T d1ua2a_         154 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD  233 (299)
T ss_dssp             CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred             cccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccch
Confidence            3 33445799999999998754 579999999999999999999999999999998888765322211            


Q ss_pred             ------------hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 ------------EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 ------------~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                  ...++.+|+++++||++||+.||+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~  269 (299)
T d1ua2a_         234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPC  269 (299)
T ss_dssp             CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTT
T ss_pred             hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChh
Confidence                        122346799999999999999995

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-52  Score=374.23  Aligned_cols=239  Identities=19%  Similarity=0.283  Sum_probs=192.8

Q ss_pred             cceeeeccccccCceEEEEEEEccCC----CEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTG----NIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~----~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      ++|++.++||+|+||+||+|.++.++    ..||+|.+.... ......+.+|+++|++++|||||+++|++......++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            57999999999999999999988665    479999986543 3445678899999999999999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ||||+.++++.+.+......+++..     +..++.||+.||+|||+++|+||||||+|||++.++  .+||+|||+|+.
T Consensus        87 v~e~~~~~~l~~~~~~~~~~~~~~~-----~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~--~~Kl~DFGla~~  159 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDGEFSVLQ-----LVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL--VCKVSDFGLSRV  159 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHH-----HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECCCCC---
T ss_pred             EEEecccCcchhhhhcccccccHHH-----HHHHHHHHHHhhhhccccccccCccccceEEECCCC--eEEEcccchhhc
Confidence            9999999999988875544444443     445999999999999999999999999999998654  799999999987


Q ss_pred             eCCCCc----eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhc
Q psy12427        263 LDPNEV----VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFK  337 (356)
Q Consensus       263 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  337 (356)
                      ......    .....||+.|+|||++.++.++.++|||||||++|||++ |.+||.+.+..+++..+..+...   +...
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~---~~~~  236 (283)
T d1mqba_         160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL---PTPM  236 (283)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---CCCT
T ss_pred             ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCC---CCch
Confidence            643321    123457999999999999999999999999999999999 56667777788888777665322   2234


Q ss_pred             cCCHHHHHHHHHhhhcCCC
Q psy12427        338 NVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       338 ~~s~~~~~lI~~ll~~dP~  356 (356)
                      ++|.++.+||++||+.||+
T Consensus       237 ~~~~~l~~li~~cl~~~p~  255 (283)
T d1mqba_         237 DCPSAIYQLMMQCWQQERA  255 (283)
T ss_dssp             TCBHHHHHHHHHHTCSSTT
T ss_pred             hhHHHHHHHHHHHCcCCHh
Confidence            7999999999999999995

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-52  Score=374.15  Aligned_cols=239  Identities=21%  Similarity=0.328  Sum_probs=192.3

Q ss_pred             ccceeeeccccccCceEEEEEEEccCC---CEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTG---NIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~---~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      .++|++.+.||+|+||+||+|++..++   ..||+|.++... ....+.+.+|+.+|++++||||+++++++. .+.+++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            368999999999999999999987653   468889886543 344577889999999999999999999986 467899


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ||||+++|+|.+++......+++..     +..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+|+.
T Consensus        85 v~E~~~~g~l~~~~~~~~~~l~~~~-----~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~--~~Kl~DfG~a~~  157 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRKYSLDLAS-----LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND--CVKLGDFGLSRY  157 (273)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHH-----HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECC------
T ss_pred             EEEeccCCcHHhhhhccCCCCCHHH-----HHHHHHHHHHHhhhhcccCeeccccchhheeecCCC--cEEEccchhhee
Confidence            9999999999998765554444443     455999999999999999999999999999998765  799999999987


Q ss_pred             eCCCCc--eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccC
Q psy12427        263 LDPNEV--VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNV  339 (356)
Q Consensus       263 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  339 (356)
                      ......  .....||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+++.++..+...   +.++++
T Consensus       158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~~  234 (273)
T d1mp8a_         158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMPPNC  234 (273)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCCTTC
T ss_pred             ccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCCC
Confidence            654332  233457999999999999999999999999999999998 99999999999999888776532   233589


Q ss_pred             CHHHHHHHHHhhhcCCC
Q psy12427        340 SEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       340 s~~~~~lI~~ll~~dP~  356 (356)
                      |+++++||++||+.||+
T Consensus       235 ~~~~~~li~~cl~~dp~  251 (273)
T d1mp8a_         235 PPTLYSLMTKCWAYDPS  251 (273)
T ss_dssp             CHHHHHHHHHHTCSSGG
T ss_pred             CHHHHHHHHHHcCCCHh
Confidence            99999999999999995

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-52  Score=378.77  Aligned_cols=242  Identities=22%  Similarity=0.406  Sum_probs=197.0

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh--hHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL--EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      ++|++++.||+|+||+||+|+++.+|+.||+|+++.....  ....+.+|+++|++++||||+++++++..+..+++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5799999999999999999999999999999999765432  34678899999999999999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |+.++.+..........+++     ..+..++.||+.||+|||++|||||||||+|||++.++  .+||+|||+|+....
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e-----~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~--~~kl~DFG~a~~~~~  154 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPL-----PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG--AIKLADFGLARAFGV  154 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCH-----HHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--CEEECSTTHHHHHCC
T ss_pred             ecCCchhhhhhhhcccCCCH-----HHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccC--cceeccCCcceeccC
Confidence            99765554443433333444     44556999999999999999999999999999997654  799999999987653


Q ss_pred             C-CceeecCCCcCccccccccCCC-CCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC-----------
Q psy12427        266 N-EVVKISTGTAEFAAPEIVEREP-VGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD-----------  332 (356)
Q Consensus       266 ~-~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-----------  332 (356)
                      . .......||+.|+|||.+.... ++.++||||+||++|+|++|+.||.+.+..+.+.++......++           
T Consensus       155 ~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  234 (298)
T d1gz8a_         155 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP  234 (298)
T ss_dssp             CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             CcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence            3 2334457999999999887765 57899999999999999999999999998888777654322211           


Q ss_pred             --------------hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 --------------EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 --------------~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                    ......+|+++++||++||+.||+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~  272 (298)
T d1gz8a_         235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPN  272 (298)
T ss_dssp             TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTT
T ss_pred             ccccccccccccchhhhccCCCHHHHHHHHHHccCChh
Confidence                          122346789999999999999995

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-52  Score=370.34  Aligned_cols=239  Identities=23%  Similarity=0.341  Sum_probs=193.7

Q ss_pred             cceeeeccccccCceEEEEEEEccC-C--CEEEEEEcccCC---hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKT-G--NIFAAKFIPVSH---NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMV  181 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~-~--~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  181 (356)
                      ++|++.+.||+|+||+||+|+.+.+ +  ..||+|+++...   ....+.+.+|+.+|++++||||++++|++.+ ...+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            5799999999999999999987644 3  368999886542   2334678899999999999999999999976 4678


Q ss_pred             EEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeecee
Q psy12427        182 LIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLAT  261 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~  261 (356)
                      +||||+++|+|.+++......+++     ..+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+++
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~-----~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~--~vkl~DfGl~~  159 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLL-----GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD--LVKIGDFGLMR  159 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCH-----HHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT--EEEECCCTTCE
T ss_pred             eeeeeecCcchhhhhhcccCCCCH-----HHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccccc--ceeeccchhhh
Confidence            999999999999887654333443     34456999999999999999999999999999998765  79999999999


Q ss_pred             eeCCCCcee----ecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhh
Q psy12427        262 KLDPNEVVK----ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAF  336 (356)
Q Consensus       262 ~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  336 (356)
                      .........    ...|+..|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+.+.++......++  ..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~--~~  237 (273)
T d1u46a_         160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP--RP  237 (273)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC--CC
T ss_pred             hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCC--Cc
Confidence            875443322    2347889999999999999999999999999999998 8999999999999999987765543  23


Q ss_pred             ccCCHHHHHHHHHhhhcCCC
Q psy12427        337 KNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       337 ~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .++|+++++||.+||+.||+
T Consensus       238 ~~~~~~l~~li~~cl~~dp~  257 (273)
T d1u46a_         238 EDCPQDIYNVMVQCWAHKPE  257 (273)
T ss_dssp             TTCCHHHHHHHHHHTCSSGG
T ss_pred             ccccHHHHHHHHHHcCCChh
Confidence            58999999999999999995

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-52  Score=376.55  Aligned_cols=243  Identities=25%  Similarity=0.394  Sum_probs=198.5

Q ss_pred             ccceeeeccccccCceEEEEEEEccC-CCEEEEEEcccCCh--hhHHHHHHHHHHHHhc---CCCCceeeeeeEEe----
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKT-GNIFAAKFIPVSHN--LEKELIRKEIDIMNQL---HHPKLINLHDAFED----  176 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~-~~~~a~K~~~~~~~--~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~----  176 (356)
                      .++|+++++||+|+||+||+|++..+ ++.||+|+++....  .....+.+|+.+|+.|   +||||++++++|..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            46899999999999999999999766 56799999865432  2233455788887766   79999999999853    


Q ss_pred             -CCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEE
Q psy12427        177 -DDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMI  255 (356)
Q Consensus       177 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~  255 (356)
                       ....+++|||+.++.+..........+++     ..++.++.|++.||+|||++||+||||||+|||++.++  .+||+
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~--~~kl~  158 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPT-----ETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG--QIKLA  158 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCH-----HHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--CEEEC
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCH-----HHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCC--Ceeec
Confidence             35789999999988776555444333433     34456999999999999999999999999999997654  79999


Q ss_pred             eeeceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc-----
Q psy12427        256 DFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWE-----  330 (356)
Q Consensus       256 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~-----  330 (356)
                      |||++.............||+.|+|||++.+.+++.++||||+||++|||++|+.||.+.++.+.+.++......     
T Consensus       159 dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  238 (305)
T d1blxa_         159 DFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  238 (305)
T ss_dssp             SCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             chhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhc
Confidence            999998776555566678999999999999999999999999999999999999999999999888877542211     


Q ss_pred             ------------------cChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        331 ------------------FDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       331 ------------------~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                        .....+..+|+++++||++||++||+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~  282 (305)
T d1blxa_         239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPA  282 (305)
T ss_dssp             SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTT
T ss_pred             ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChh
Confidence                              11233456899999999999999996

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-51  Score=376.30  Aligned_cols=238  Identities=18%  Similarity=0.269  Sum_probs=194.8

Q ss_pred             cceeeeccccccCceEEEEEEEccCCC----EEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGN----IFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~----~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l  182 (356)
                      ++|+++++||+|+||+||+|.+..+|+    .||+|.++... ....+.+.+|+.+|++++|||||+++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            369999999999999999999988876    57888776433 33457789999999999999999999999865 5678


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ++|++.+|+|.+.+......+++..     +..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+|+.
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~-----~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~--~~kl~DFGla~~  160 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQY-----LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ--HVKITDFGLAKL  160 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHH-----HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT--EEEECCCSHHHH
T ss_pred             EEEeccCCcccccccccccCCCHHH-----HHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCC--CeEeecccccee
Confidence            8899999999998876554454443     455999999999999999999999999999998765  799999999987


Q ss_pred             eCCCCce---eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhcc
Q psy12427        263 LDPNEVV---KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKN  338 (356)
Q Consensus       263 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  338 (356)
                      .......   ....||+.|+|||++.++.++.++|||||||++|||+| |.+||.+.+..++...+..+....   .+..
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~---~p~~  237 (317)
T d1xkka_         161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP---QPPI  237 (317)
T ss_dssp             TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCC---CCTT
T ss_pred             cccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC---CCcc
Confidence            7543322   23358999999999999999999999999999999998 899999998888877776654322   2247


Q ss_pred             CCHHHHHHHHHhhhcCCC
Q psy12427        339 VSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       339 ~s~~~~~lI~~ll~~dP~  356 (356)
                      +|+++.+||++||+.||+
T Consensus       238 ~~~~~~~li~~cl~~dP~  255 (317)
T d1xkka_         238 CTIDVYMIMVKCWMIDAD  255 (317)
T ss_dssp             BCHHHHHHHHHHTCSSGG
T ss_pred             cCHHHHHHHHHhCCCChh
Confidence            899999999999999995

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-51  Score=368.68  Aligned_cols=238  Identities=22%  Similarity=0.317  Sum_probs=192.4

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEEe
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFEF  186 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~  186 (356)
                      .++|++.+.||+|+||+||+|+++.+ ..||+|+++.... ..+.+.+|+.+|++++|||||++++++.+ +..++||||
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey   92 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY   92 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence            36899999999999999999999765 5799999975543 45678999999999999999999999854 568899999


Q ss_pred             ccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCCC
Q psy12427        187 LSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDPN  266 (356)
Q Consensus       187 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~~  266 (356)
                      +++|+|..++....    ...+....+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+|+.....
T Consensus        93 ~~~g~l~~~~~~~~----~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~--~~kl~DfGla~~~~~~  166 (285)
T d1fmka3          93 MSKGSLLDFLKGET----GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL--VCKVADFGLARLIEDN  166 (285)
T ss_dssp             CTTCBHHHHHSHHH----HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEEECCCCTTC-----
T ss_pred             cCCCchhhhhhhcc----cccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCC--cEEEcccchhhhccCC
Confidence            99999988875321    11233344556999999999999999999999999999998665  7999999999876433


Q ss_pred             Cc--eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHH
Q psy12427        267 EV--VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEG  343 (356)
Q Consensus       267 ~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  343 (356)
                      ..  .....||+.|+|||++....++.++|||||||++|||++ |.+||.+....+++..+......   +....+|+++
T Consensus       167 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~---~~~~~~~~~l  243 (285)
T d1fmka3         167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---PCPPECPESL  243 (285)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTSCHHH
T ss_pred             CceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC---CCCcccCHHH
Confidence            32  233568999999999999999999999999999999999 56667777888888887764322   2335899999


Q ss_pred             HHHHHHhhhcCCC
Q psy12427        344 KDFIRRLLLRNKE  356 (356)
Q Consensus       344 ~~lI~~ll~~dP~  356 (356)
                      ++||.+||+.||+
T Consensus       244 ~~li~~cl~~dP~  256 (285)
T d1fmka3         244 HDLMCQCWRKEPE  256 (285)
T ss_dssp             HHHHHHHTCSSGG
T ss_pred             HHHHHHHcccCHh
Confidence            9999999999995

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.5e-51  Score=371.12  Aligned_cols=244  Identities=20%  Similarity=0.311  Sum_probs=203.7

Q ss_pred             cceeeeccccccCceEEEEEEEcc-----CCCEEEEEEcccCChh-hHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERK-----TGNIFAAKFIPVSHNL-EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMV  181 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~-----~~~~~a~K~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~  181 (356)
                      ++|++.+.||+|+||+||+|+++.     ++..||+|+++..... ....+.+|+++|++++||||+++++++......+
T Consensus        13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~   92 (301)
T d1lufa_          13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC   92 (301)
T ss_dssp             GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceE
Confidence            579999999999999999999863     4578999999765433 4567899999999999999999999999999999


Q ss_pred             EEEEeccccchhhhhhCCCCCC------------------CccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEE
Q psy12427        182 LIFEFLSGGELFERITAPDYKM------------------SEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIM  243 (356)
Q Consensus       182 lv~e~~~~g~L~~~l~~~~~~~------------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIl  243 (356)
                      ++|||+.+|+|.+++.......                  ....+....+..++.|++.||+|||++++|||||||+|||
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NIL  172 (301)
T d1lufa_          93 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL  172 (301)
T ss_dssp             EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             EEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceE
Confidence            9999999999999986433210                  0112333456669999999999999999999999999999


Q ss_pred             EeecCCCcEEEEeeeceeeeCCCC---ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcC-CCCCCCCChHH
Q psy12427        244 CQTRNSTNVKMIDFGLATKLDPNE---VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSG-LSPFAGENDVE  319 (356)
Q Consensus       244 v~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g-~~Pf~~~~~~~  319 (356)
                      ++.++  .+||+|||+|+......   ......|++.|+|||.+.+..++.++|||||||++|||++| .+||.+.+..+
T Consensus       173 ld~~~--~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e  250 (301)
T d1lufa_         173 VGENM--VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE  250 (301)
T ss_dssp             ECGGG--CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred             ECCCC--cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHH
Confidence            98654  79999999998664332   22345689999999999999999999999999999999997 57899999999


Q ss_pred             HHHHhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        320 TLKNVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       320 ~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+..+..+....   .+.++|+++.+||.+||+.||+
T Consensus       251 ~~~~v~~~~~~~---~p~~~~~~~~~li~~cl~~~P~  284 (301)
T d1lufa_         251 VIYYVRDGNILA---CPENCPLELYNLMRLCWSKLPA  284 (301)
T ss_dssp             HHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGG
T ss_pred             HHHHHHcCCCCC---CCccchHHHHHHHHHHcCCChh
Confidence            999988876432   2358999999999999999995

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-52  Score=369.70  Aligned_cols=232  Identities=26%  Similarity=0.389  Sum_probs=191.0

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh------hHHHHHHHHHHHHhcC--CCCceeeeeeEEeCC
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL------EKELIRKEIDIMNQLH--HPKLINLHDAFEDDD  178 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~------~~~~~~~E~~il~~l~--hpnIv~l~~~~~~~~  178 (356)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|++......      ....+.+|+.+|++++  ||||+++++++..++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            45899999999999999999999999999999998643211      1233568999999996  899999999999999


Q ss_pred             eEEEEEEeccc-cchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEee
Q psy12427        179 EMVLIFEFLSG-GELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDF  257 (356)
Q Consensus       179 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Df  257 (356)
                      ..++||||+.+ +++.+++.... .+++     ..++.++.||+.||+|||++||+||||||+|||++.++ +.+||+||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~-~l~e-----~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~-~~vkl~DF  155 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERG-ALQE-----ELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-GELKLIDF  155 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHC-SCCH-----HHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT-TEEEECCC
T ss_pred             eEEEEEEeccCcchHHHHHhccC-CCCH-----HHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCC-CeEEECcc
Confidence            99999999976 56777765432 3333     44556999999999999999999999999999997543 47999999


Q ss_pred             eceeeeCCCCceeecCCCcCccccccccCCCC-CccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChhhh
Q psy12427        258 GLATKLDPNEVVKISTGTAEFAAPEIVEREPV-GFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEEAF  336 (356)
Q Consensus       258 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  336 (356)
                      |+|+..... ......||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+.+      .+......++    
T Consensus       156 G~a~~~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~----  224 (273)
T d1xwsa_         156 GSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR----  224 (273)
T ss_dssp             TTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCS----
T ss_pred             ccceecccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCC----
Confidence            999876433 3445679999999999987765 577899999999999999999997642      2344444444    


Q ss_pred             ccCCHHHHHHHHHhhhcCCC
Q psy12427        337 KNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       337 ~~~s~~~~~lI~~ll~~dP~  356 (356)
                      ..+|+++++||++||++||+
T Consensus       225 ~~~s~~~~~li~~~L~~dp~  244 (273)
T d1xwsa_         225 QRVSSECQHLIRWCLALRPS  244 (273)
T ss_dssp             SCCCHHHHHHHHHHTCSSGG
T ss_pred             CCCCHHHHHHHHHHccCCHh
Confidence            37999999999999999995

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-51  Score=371.56  Aligned_cols=245  Identities=22%  Similarity=0.317  Sum_probs=200.2

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCC--EEEEEEcccC-ChhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCeEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGN--IFAAKFIPVS-HNLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDEMVL  182 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~--~~a~K~~~~~-~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~l  182 (356)
                      +++|++.++||+|+||+||+|+++.+|.  .||+|.++.. .....+.+.+|+++|.++ +||||+++++++...+..++
T Consensus         9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i   88 (309)
T d1fvra_           9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   88 (309)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence            4689999999999999999999998886  4667776543 333456789999999999 79999999999999999999


Q ss_pred             EEEeccccchhhhhhCCCC----------CCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcE
Q psy12427        183 IFEFLSGGELFERITAPDY----------KMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNV  252 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~----------~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~v  252 (356)
                      ||||++||+|.+++.....          ......+....+..++.||+.||+|||+++|+||||||+|||++.++  .+
T Consensus        89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~--~~  166 (309)
T d1fvra_          89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY--VA  166 (309)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG--CE
T ss_pred             EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC--ce
Confidence            9999999999999975421          01112334445566999999999999999999999999999998665  79


Q ss_pred             EEEeeeceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcC-CCCCCCCChHHHHHHhhcccccc
Q psy12427        253 KMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSG-LSPFAGENDVETLKNVKACDWEF  331 (356)
Q Consensus       253 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g-~~Pf~~~~~~~~~~~i~~~~~~~  331 (356)
                      ||+|||+|+............||..|+|||.+.+..++.++|||||||++|||++| .+||.+.+..+++..+..+..  
T Consensus       167 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~--  244 (309)
T d1fvra_         167 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR--  244 (309)
T ss_dssp             EECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC--
T ss_pred             EEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC--
Confidence            99999999876544444455689999999999999999999999999999999995 568999999999998876532  


Q ss_pred             ChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        332 DEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       332 ~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                       ++.+.++|+++++||++||+.||+
T Consensus       245 -~~~~~~~~~~~~~li~~cl~~dP~  268 (309)
T d1fvra_         245 -LEKPLNCDDEVYDLMRQCWREKPY  268 (309)
T ss_dssp             -CCCCTTBCHHHHHHHHHHTCSSGG
T ss_pred             -CCCCccCCHHHHHHHHHHcCCChh
Confidence             222357999999999999999995

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1e-50  Score=364.77  Aligned_cols=240  Identities=24%  Similarity=0.389  Sum_probs=195.4

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChh--hHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNL--EKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      ++|+++++||+|+||+||+|+++ +|+.||+|++......  ....+.+|+.+|++++||||+++++++..++..+++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e   80 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence            58999999999999999999986 7899999999765432  34678899999999999999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      ++.++.+..+... ...+++.     .+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||.|.....
T Consensus        81 ~~~~~~~~~~~~~-~~~l~~~-----~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~--~~kl~DfG~a~~~~~  152 (286)
T d1ob3a_          81 HLDQDLKKLLDVC-EGGLESV-----TAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG--ELKIADFGLARAFGI  152 (286)
T ss_dssp             CCSEEHHHHHHTS-TTCCCHH-----HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--CEEECCTTHHHHHCC
T ss_pred             eehhhhHHHHHhh-cCCcchh-----hhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCC--CEEecccccceeccc
Confidence            9987766666543 3334444     4455999999999999999999999999999998654  799999999987653


Q ss_pred             CCc-eeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc------------
Q psy12427        266 NEV-VKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEF------------  331 (356)
Q Consensus       266 ~~~-~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~------------  331 (356)
                      ... .....|++.|+|||.+.+. .++.++||||+||++|||++|+.||.+.+..+.+.++......+            
T Consensus       153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  232 (286)
T d1ob3a_         153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP  232 (286)
T ss_dssp             ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             CccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhh
Confidence            322 3444689999999998754 56899999999999999999999999999888887764322211            


Q ss_pred             -------------ChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        332 -------------DEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       332 -------------~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                   .......+|++++|||++||++||+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~  270 (286)
T d1ob3a_         233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPN  270 (286)
T ss_dssp             TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTT
T ss_pred             hcccccccccCcchhhhcccCCHHHHHHHHHHccCChh
Confidence                         1233456899999999999999996

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-50  Score=365.08  Aligned_cols=246  Identities=23%  Similarity=0.313  Sum_probs=200.5

Q ss_pred             cccceeeeccccccCceEEEEEEEccCC-------CEEEEEEcccCCh-hhHHHHHHHHHHHHhc-CCCCceeeeeeEEe
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTG-------NIFAAKFIPVSHN-LEKELIRKEIDIMNQL-HHPKLINLHDAFED  176 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~-------~~~a~K~~~~~~~-~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~  176 (356)
                      ..++|.+.+.||+|+||.||+|+...++       ..||+|+++.... .....+.+|...+.++ +||||++++++|.+
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            3578999999999999999999987654       3799999976543 3456788899999888 79999999999999


Q ss_pred             CCeEEEEEEeccccchhhhhhCCCCC----------CCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEee
Q psy12427        177 DDEMVLIFEFLSGGELFERITAPDYK----------MSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQT  246 (356)
Q Consensus       177 ~~~~~lv~e~~~~g~L~~~l~~~~~~----------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~  246 (356)
                      +...++||||+++|+|.+++......          .....+....+..++.||+.||+|||+.+||||||||+|||++.
T Consensus        91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~  170 (299)
T d1fgka_          91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE  170 (299)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred             CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecC
Confidence            99999999999999999999765421          12234555667779999999999999999999999999999986


Q ss_pred             cCCCcEEEEeeeceeeeCCCCc---eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q psy12427        247 RNSTNVKMIDFGLATKLDPNEV---VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLK  322 (356)
Q Consensus       247 ~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~  322 (356)
                      ++  .+||+|||+++.......   .....|++.|+|||.+.++.++.++|||||||++|||++ |.+||.+.+..+...
T Consensus       171 ~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~  248 (299)
T d1fgka_         171 DN--VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK  248 (299)
T ss_dssp             TC--CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred             CC--CeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHH
Confidence            55  799999999987753322   223468999999999999999999999999999999998 799999999888888


Q ss_pred             HhhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        323 NVKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       323 ~i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+..+...   +....+|+++++||++||+.||+
T Consensus       249 ~i~~~~~~---~~p~~~~~~l~~li~~cl~~dP~  279 (299)
T d1fgka_         249 LLKEGHRM---DKPSNCTNELYMMMRDCWHAVPS  279 (299)
T ss_dssp             HHHTTCCC---CCCSSCCHHHHHHHHHHTCSSGG
T ss_pred             HHHcCCCC---CCCccchHHHHHHHHHHccCCHh
Confidence            77664322   22358999999999999999995

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-51  Score=359.98  Aligned_cols=235  Identities=20%  Similarity=0.332  Sum_probs=190.6

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEe-CCeEEEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFED-DDEMVLIFE  185 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~lv~e  185 (356)
                      .++|++.+.||+|+||.||+|+++  |..||+|+++.+.  ..+.+.+|+++|++++||||++++|++.+ .+.+++|||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e   81 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   81 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence            357999999999999999999986  7799999997543  35678899999999999999999999854 567899999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |+++|+|.+++....    ...+....+..++.||+.||+|||+.+|+||||||+|||++.++  .+||+|||+++....
T Consensus        82 y~~~g~L~~~l~~~~----~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~--~~kl~dfg~s~~~~~  155 (262)
T d1byga_          82 YMAKGSLVDYLRSRG----RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN--VAKVSDFGLTKEASS  155 (262)
T ss_dssp             CCTTEEHHHHHHHHH----HHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS--CEEECCCCC------
T ss_pred             ccCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCC--CEeecccccceecCC
Confidence            999999999986432    11234445566999999999999999999999999999998655  799999999987653


Q ss_pred             CCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHhhccccccChhhhccCCHHHH
Q psy12427        266 NEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKNVKACDWEFDEEAFKNVSEEGK  344 (356)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  344 (356)
                      .  .....+++.|+|||++.+..++.++|||||||++|||++ |++||...+..++..++.....   ++....+|++++
T Consensus       156 ~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~  230 (262)
T d1byga_         156 T--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPPAVY  230 (262)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC---CCCCTTCCHHHH
T ss_pred             C--CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC---CCCCccCCHHHH
Confidence            3  334568999999999999999999999999999999998 8999999998888888866432   223347899999


Q ss_pred             HHHHHhhhcCCC
Q psy12427        345 DFIRRLLLRNKE  356 (356)
Q Consensus       345 ~lI~~ll~~dP~  356 (356)
                      +||++||+.||+
T Consensus       231 ~li~~cl~~dP~  242 (262)
T d1byga_         231 EVMKNCWHLDAA  242 (262)
T ss_dssp             HHHHHHTCSSGG
T ss_pred             HHHHHHcccCHh
Confidence            999999999995

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-50  Score=369.90  Aligned_cols=240  Identities=22%  Similarity=0.306  Sum_probs=193.4

Q ss_pred             ceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEe------CCeEEE
Q psy12427        109 HYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFED------DDEMVL  182 (356)
Q Consensus       109 ~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~~~~l  182 (356)
                      +|+..++||+|+||+||+|+++.+|+.||+|++.....    ...+|+++|++++||||++++++|..      ..++++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            59999999999999999999999999999999976532    23479999999999999999999853      345799


Q ss_pred             EEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        183 IFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       183 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      ||||++++.+..+....   .....+....++.++.||+.||+|||++||+||||||+|||++.++ ..+||+|||++..
T Consensus        97 v~Ey~~~~~~~~l~~~~---~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~-~~~kl~DFG~a~~  172 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYS---RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT-AVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEECCSEEHHHHHHHHH---HTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTT-CCEEECCCTTCEE
T ss_pred             EEeccCCccHHHHHhhh---hccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCC-CceeEecccchhh
Confidence            99999876443332210   0112233344566999999999999999999999999999997654 3699999999998


Q ss_pred             eCCCCceeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccC---------
Q psy12427        263 LDPNEVVKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFD---------  332 (356)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~---------  332 (356)
                      ...........||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.+.+..+.+.++.......+         
T Consensus       173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  252 (350)
T d1q5ka_         173 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP  252 (350)
T ss_dssp             CCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC
T ss_pred             ccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhcc
Confidence            876666667789999999998765 5689999999999999999999999999998888777654221111         


Q ss_pred             ----------------hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 ----------------EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 ----------------~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                      ......+|+++.+||++||+.||+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~  292 (350)
T d1q5ka_         253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT  292 (350)
T ss_dssp             ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGG
T ss_pred             chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChh
Confidence                            112235799999999999999995

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-49  Score=365.79  Aligned_cols=239  Identities=25%  Similarity=0.426  Sum_probs=193.1

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCC-----
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDD-----  178 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----  178 (356)
                      +.++|+++++||+|+||+||+|.++.+|+.||+|+++...  ......+.+|+++|++++|||||+++++|...+     
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            5678999999999999999999999999999999997543  334567889999999999999999999997654     


Q ss_pred             -eEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEee
Q psy12427        179 -EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDF  257 (356)
Q Consensus       179 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Df  257 (356)
                       .+++||||+ +.+|..++...  .+     ....++.++.||+.||+|||++||+||||||+|||++.++  .+||+||
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~~~--~l-----~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~--~~kl~Df  165 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMKHE--KL-----GEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC--ELKILDF  165 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHHHC--CC-----CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCC
T ss_pred             ceEEEEEecc-cccHHHHHHhc--cc-----cHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccc--ccccccc
Confidence             579999999 66777776532  23     3344566999999999999999999999999999998654  7999999


Q ss_pred             eceeeeCCCCceeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccCh---
Q psy12427        258 GLATKLDPNEVVKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDE---  333 (356)
Q Consensus       258 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~---  333 (356)
                      |+|+....  ......||+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+..+.+..+......++.   
T Consensus       166 g~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (346)
T d1cm8a_         166 GLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  243 (346)
T ss_dssp             TTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             cceeccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence            99988653  23456799999999998764 5689999999999999999999999999888877666543333222   


Q ss_pred             ------------------------hhhccCCHHHHHHHHHhhhcCCC
Q psy12427        334 ------------------------EAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       334 ------------------------~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                              ..+.++|+++++||++||+.||+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~  290 (346)
T d1cm8a_         244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAE  290 (346)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTT
T ss_pred             hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChh
Confidence                                    22346799999999999999995

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-50  Score=361.47  Aligned_cols=245  Identities=21%  Similarity=0.278  Sum_probs=185.4

Q ss_pred             cceeeeccccccCceEEEEEEEccC-----CCEEEEEEcccCC-hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEe-CCe
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKT-----GNIFAAKFIPVSH-NLEKELIRKEIDIMNQL-HHPKLINLHDAFED-DDE  179 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~-----~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~-~~~  179 (356)
                      ++|++.++||+|+||.||+|.+...     ++.||+|+++... ..+.+.+.+|..++.++ +||||+.+++++.. ...
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   92 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   92 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence            6799999999999999999998653     4689999987543 33456677788888877 68999999998765 456


Q ss_pred             EEEEEEeccccchhhhhhCCCCC----------CCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCC
Q psy12427        180 MVLIFEFLSGGELFERITAPDYK----------MSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNS  249 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~~----------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~  249 (356)
                      +++||||+++|+|.+++......          .....+....+..++.||+.||+|||++||+||||||+|||++.++ 
T Consensus        93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~-  171 (299)
T d1ywna1          93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN-  171 (299)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG-
T ss_pred             EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCC-
Confidence            89999999999999998644321          1122344455677999999999999999999999999999998655 


Q ss_pred             CcEEEEeeeceeeeCCCCc---eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcC-CCCCCCCChHHHHHHhh
Q psy12427        250 TNVKMIDFGLATKLDPNEV---VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSG-LSPFAGENDVETLKNVK  325 (356)
Q Consensus       250 ~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g-~~Pf~~~~~~~~~~~i~  325 (356)
                       .+||+|||+|+.......   .....||+.|+|||++.+..++.++|||||||++|||++| .+||.+.+..+.+..+.
T Consensus       172 -~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~  250 (299)
T d1ywna1         172 -VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL  250 (299)
T ss_dssp             -CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHH
T ss_pred             -cEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence             799999999987643322   2234689999999999999999999999999999999986 67898776544444433


Q ss_pred             ccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        326 ACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       326 ~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .....+  +.+..+|+++++||.+||+.||+
T Consensus       251 ~~~~~~--~~~~~~~~~l~~li~~cl~~dP~  279 (299)
T d1ywna1         251 KEGTRM--RAPDYTTPEMYQTMLDCWHGEPS  279 (299)
T ss_dssp             HHTCCC--CCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             hcCCCC--CCCccCCHHHHHHHHHHcCCChh
Confidence            322222  22347899999999999999995

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-49  Score=360.70  Aligned_cols=242  Identities=23%  Similarity=0.325  Sum_probs=194.4

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh--hhHHHHHHHHHHHHhcCCCCceeeeeeEEe--------
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN--LEKELIRKEIDIMNQLHHPKLINLHDAFED--------  176 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--------  176 (356)
                      .++|+++++||+|+||+||+|+++.+|+.||+|++.....  .....+.+|+.+|++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            4689999999999999999999999999999999865432  334677899999999999999999999854        


Q ss_pred             CCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEe
Q psy12427        177 DDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMID  256 (356)
Q Consensus       177 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~D  256 (356)
                      ...+++||||+.++.+..... ....+.+     ..++.++.||+.||+|||++||+||||||+|||++.++  .+||+|
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~-~~~~~~~-----~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~--~~kl~d  160 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSN-VLVKFTL-----SEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG--VLKLAD  160 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTC-TTCCCCH-----HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS--CEEECC
T ss_pred             CceEEEEEeccCCCccchhhh-ccccccc-----HHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCC--cEEeee
Confidence            456899999998776654433 2223333     34566999999999999999999999999999998655  799999


Q ss_pred             eeceeeeCCCC-----ceeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccc
Q psy12427        257 FGLATKLDPNE-----VVKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWE  330 (356)
Q Consensus       257 fg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~  330 (356)
                      ||++.......     .....+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.++.+.+..+......
T Consensus       161 fg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~  240 (318)
T d3blha1         161 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS  240 (318)
T ss_dssp             CTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             cceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99998765322     22334689999999998765 6899999999999999999999999999999988887665544


Q ss_pred             cChhhhcc----------------------------CCHHHHHHHHHhhhcCCC
Q psy12427        331 FDEEAFKN----------------------------VSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       331 ~~~~~~~~----------------------------~s~~~~~lI~~ll~~dP~  356 (356)
                      ++++.+..                            .+++++|||.+||+.||+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~  294 (318)
T d3blha1         241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA  294 (318)
T ss_dssp             CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTT
T ss_pred             CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChh
Confidence            44333222                            378899999999999996

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-49  Score=359.97  Aligned_cols=246  Identities=21%  Similarity=0.300  Sum_probs=202.0

Q ss_pred             ccceeeeccccccCceEEEEEEEc-----cCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCe
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRER-----KTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQL-HHPKLINLHDAFEDDDE  179 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~-----~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~  179 (356)
                      .++|++.+.||+|+||.||+|+++     .+++.||+|+++... ..+...+.+|+.++..+ +||||+++++++.....
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            468999999999999999999874     356799999997644 44566788999999999 69999999999999999


Q ss_pred             EEEEEEeccccchhhhhhCCCCCC------------CccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeec
Q psy12427        180 MVLIFEFLSGGELFERITAPDYKM------------SEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTR  247 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~~~------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~  247 (356)
                      .+++|||+++|+|.+++.......            ....+....+..++.||+.||+|||+++++||||||+|||++.+
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~  181 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG  181 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETT
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccccc
Confidence            999999999999999986543211            11234444566799999999999999999999999999999865


Q ss_pred             CCCcEEEEeeeceeeeCCCCcee---ecCCCcCccccccccCCCCCccccHHHHHHHHHHHHc-CCCCCCCCChHHHHHH
Q psy12427        248 NSTNVKMIDFGLATKLDPNEVVK---ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLS-GLSPFAGENDVETLKN  323 (356)
Q Consensus       248 ~~~~vkl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~-g~~Pf~~~~~~~~~~~  323 (356)
                      +  .+||+|||+++.........   ...||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+.+.+
T Consensus       182 ~--~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~  259 (311)
T d1t46a_         182 R--ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK  259 (311)
T ss_dssp             T--EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred             C--cccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            4  79999999998775433222   2357999999999999999999999999999999998 7777878777666666


Q ss_pred             hhccccccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        324 VKACDWEFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       324 i~~~~~~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      +......++  ....+|+++++||.+||+.||+
T Consensus       260 ~i~~~~~~~--~~~~~~~~l~~Li~~cl~~dP~  290 (311)
T d1t46a_         260 MIKEGFRML--SPEHAPAEMYDIMKTCWDADPL  290 (311)
T ss_dssp             HHHHTCCCC--CCTTSCHHHHHHHHHHTCSSGG
T ss_pred             HHhcCCCCC--CcccccHHHHHHHHHHcCCChh
Confidence            655443332  2357899999999999999995

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-49  Score=363.48  Aligned_cols=242  Identities=24%  Similarity=0.370  Sum_probs=192.4

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCC----eE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDD----EM  180 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----~~  180 (356)
                      +.++|+++++||+|+||+||+|.++.+|+.||+|++.... ......+.+|+.+|++++||||+++++++....    ..
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence            3467999999999999999999999999999999997544 344567889999999999999999999987543    23


Q ss_pred             EEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeece
Q psy12427        181 VLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLA  260 (356)
Q Consensus       181 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a  260 (356)
                      +++++++.+|+|.+++...  .+     ....++.++.|++.||+|||++||+||||||+|||++.++  .+||+|||+|
T Consensus        86 ~~l~~~~~~g~L~~~l~~~--~l-----~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~--~~kl~DfG~a  156 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLKTQ--HL-----SNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC--DLKICDFGLA  156 (345)
T ss_dssp             EEEEEECCCEEHHHHHHHC--CC-----CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTC
T ss_pred             EEEEEeecCCchhhhhhcC--CC-----CHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCC--CEEEcccCce
Confidence            4445567799999998643  23     3444566999999999999999999999999999997544  7999999999


Q ss_pred             eeeCCCCc----eeecCCCcCccccccccC-CCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhcccccc----
Q psy12427        261 TKLDPNEV----VKISTGTAEFAAPEIVER-EPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEF----  331 (356)
Q Consensus       261 ~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~----  331 (356)
                      ........    ....+||+.|+|||++.. ..++.++||||+||++|+|++|+.||.+.+..+...........+    
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (345)
T d1pmea_         157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED  236 (345)
T ss_dssp             EECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             eeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhh
Confidence            87643322    234568999999999854 467899999999999999999999999988776665543321111    


Q ss_pred             -----------------------ChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        332 -----------------------DEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       332 -----------------------~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                             ....+.++|.++++||.+||+.||+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~  284 (345)
T d1pmea_         237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPH  284 (345)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTT
T ss_pred             hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChh
Confidence                                   1233457899999999999999995

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=7e-49  Score=359.46  Aligned_cols=237  Identities=24%  Similarity=0.440  Sum_probs=193.9

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcC-CCCceeeeeeEEe--CCeEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLH-HPKLINLHDAFED--DDEMVLI  183 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~--~~~~~lv  183 (356)
                      .++|+++++||+|+||+||+|+++.+|+.||+|+++...   ...+.+|+++|+.++ ||||++++++|..  ...+++|
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            468999999999999999999999999999999987543   456789999999995 9999999999984  4679999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeee
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKL  263 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~  263 (356)
                      |||+.+++|.....    .++     ...++.++.||+.||+|||++||+||||||+|||++.++ ..+||+|||+|+..
T Consensus       111 ~e~~~~~~L~~~~~----~l~-----e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~-~~vkl~DFG~a~~~  180 (328)
T d3bqca1         111 FEHVNNTDFKQLYQ----TLT-----DYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH-RKLRLIDWGLAEFY  180 (328)
T ss_dssp             EECCCSCBGGGTTT----SCC-----HHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT-TEEEECCGGGCEEC
T ss_pred             EeecCCCcHHHHhc----CCC-----HHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCC-Ceeeecccccceec
Confidence            99999999976542    233     344566999999999999999999999999999998654 36999999999988


Q ss_pred             CCCCceeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHhhcc-------------c
Q psy12427        264 DPNEVVKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGEND-VETLKNVKAC-------------D  328 (356)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~~-~~~~~~i~~~-------------~  328 (356)
                      ..........+|+.|+|||.+.+. .++.++||||+||++|+|++|+.||....+ .+....+...             .
T Consensus       181 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  260 (328)
T d3bqca1         181 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  260 (328)
T ss_dssp             CTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             cCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence            776666677899999999998765 479999999999999999999999976643 3322222110             0


Q ss_pred             c--------------------ccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        329 W--------------------EFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       329 ~--------------------~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .                    .++......+|++++|||++||+.||+
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~  308 (328)
T d3bqca1         261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ  308 (328)
T ss_dssp             CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGG
T ss_pred             cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChh
Confidence            0                    012223345899999999999999995

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.7e-49  Score=356.04  Aligned_cols=243  Identities=23%  Similarity=0.247  Sum_probs=190.2

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCce-eeeeeEEeCCeEEEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLI-NLHDAFEDDDEMVLIF  184 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv-~l~~~~~~~~~~~lv~  184 (356)
                      +.++|++.+.||+|+||.||+|+++.+|+.||+|++......  ..+..|+++++.++|+|++ .+.+++......++||
T Consensus         5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm   82 (299)
T d1ckia_           5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   82 (299)
T ss_dssp             ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence            346899999999999999999999999999999998765432  3467899999999877654 5566678888999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeec-CCCcEEEEeeeceeee
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTR-NSTNVKMIDFGLATKL  263 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~-~~~~vkl~Dfg~a~~~  263 (356)
                      ||+ +++|.+.+......+++.     .+..++.|++.||+|||++||+||||||+|||++.. .+..+||+|||+|+.+
T Consensus        83 e~~-~~~l~~~~~~~~~~~~~~-----~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~  156 (299)
T d1ckia_          83 ELL-GPSLEDLFNFCSRKFSLK-----TVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  156 (299)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHH-----HHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred             EEc-CCchhhhhhhccCCCcHH-----HHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence            999 556666665444344444     445599999999999999999999999999998653 3457999999999987


Q ss_pred             CCCCc--------eeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHh---hcccccc-
Q psy12427        264 DPNEV--------VKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNV---KACDWEF-  331 (356)
Q Consensus       264 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i---~~~~~~~-  331 (356)
                      .....        .....||+.|+|||++.+..++.++|||||||++|||++|..||.+....+....+   ......+ 
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~  236 (299)
T d1ckia_         157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  236 (299)
T ss_dssp             BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred             cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC
Confidence            54321        22346999999999999999999999999999999999999999887655443333   2222222 


Q ss_pred             ChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        332 DEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       332 ~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+....++|+++.+||..||+.||+
T Consensus       237 ~~~~~~~~p~~~~~li~~cl~~~p~  261 (299)
T d1ckia_         237 IEVLCKGYPSEFATYLNFCRSLRFD  261 (299)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHHSCTT
T ss_pred             hhHhccCCCHHHHHHHHHHccCChh
Confidence            2344568999999999999999995

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-50  Score=367.73  Aligned_cols=242  Identities=30%  Similarity=0.551  Sum_probs=199.6

Q ss_pred             ccceeeeccccccCceEEEEEEEc---cCCCEEEEEEcccCC----hhhHHHHHHHHHHHHhcCC-CCceeeeeeEEeCC
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRER---KTGNIFAAKFIPVSH----NLEKELIRKEIDIMNQLHH-PKLINLHDAFEDDD  178 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~---~~~~~~a~K~~~~~~----~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~  178 (356)
                      .++|+++++||+|+||+||+|.+.   .+|+.||+|+++...    ....+.+.+|+++|++++| |||+++++++....
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            367999999999999999999874   468999999986432    2234567789999999976 89999999999999


Q ss_pred             eEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeee
Q psy12427        179 EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFG  258 (356)
Q Consensus       179 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg  258 (356)
                      ..+++|||+.+|+|.+++.... ...+     ..+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~~~-~~~e-----~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~--~vkL~DFG  174 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQRE-RFTE-----HEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG--HVVLTDFG  174 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS-CCCH-----HHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEESCSS
T ss_pred             ceeeeeecccccHHHHHHHhcc-cccH-----HHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCC--CEEEeecc
Confidence            9999999999999999986543 2222     33455899999999999999999999999999998654  79999999


Q ss_pred             ceeeeCCCC--ceeecCCCcCccccccccCC--CCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChh
Q psy12427        259 LATKLDPNE--VVKISTGTAEFAAPEIVERE--PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEE  334 (356)
Q Consensus       259 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  334 (356)
                      +|+.+....  ......|++.|+|||.+.+.  .++.++|||||||+||+|++|+.||.+.+..+....+........++
T Consensus       175 ~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~  254 (322)
T d1vzoa_         175 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP  254 (322)
T ss_dssp             EEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC
T ss_pred             chhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCC
Confidence            998764322  23445799999999999765  46789999999999999999999999887666666665555444555


Q ss_pred             hhccCCHHHHHHHHHhhhcCCC
Q psy12427        335 AFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       335 ~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .+..+|+++++||++||++||+
T Consensus       255 ~~~~~s~~~~~li~~~l~~dP~  276 (322)
T d1vzoa_         255 YPQEMSALAKDLIQRLLMKDPK  276 (322)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGG
T ss_pred             CcccCCHHHHHHHHHHcccCHH
Confidence            5568999999999999999995

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-49  Score=355.93  Aligned_cols=236  Identities=19%  Similarity=0.223  Sum_probs=187.7

Q ss_pred             eeeccccccCceEEEEEEEccCC---CEEEEEEcccC-ChhhHHHHHHHHHHHHhcCCCCceeeeeeEEe-CCeEEEEEE
Q psy12427        111 DILEEIGTGAFGVVHRCRERKTG---NIFAAKFIPVS-HNLEKELIRKEIDIMNQLHHPKLINLHDAFED-DDEMVLIFE  185 (356)
Q Consensus       111 ~~~~~lg~G~fg~V~~~~~~~~~---~~~a~K~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~lv~e  185 (356)
                      .+.++||+|+||+||+|++..++   ..||+|.++.. .......+.+|+++|++++||||++++|++.. ++..++|||
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E  109 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  109 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence            34678999999999999987653   36899998743 45556789999999999999999999999765 568999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      |+++|+|.+++..........     .+..++.|++.||.|||+.+|+||||||+|||++.++  .+||+|||+++....
T Consensus       110 ~~~~g~l~~~~~~~~~~~~~~-----~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~--~~kL~DFG~~~~~~~  182 (311)
T d1r0pa_         110 YMKHGDLRNFIRNETHNPTVK-----DLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF--TVKVADFGLARDMYD  182 (311)
T ss_dssp             CCTTCBHHHHHHCTTCCCBHH-----HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC--CEEECSSGGGCCTTT
T ss_pred             EeecCchhhhhccccccchHH-----HHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCC--CEEEecccchhhccc
Confidence            999999999987654433333     3345999999999999999999999999999997544  799999999987643


Q ss_pred             CCce-----eecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCC-CCChHHHHHHhhccccccChhhhccC
Q psy12427        266 NEVV-----KISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFA-GENDVETLKNVKACDWEFDEEAFKNV  339 (356)
Q Consensus       266 ~~~~-----~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~  339 (356)
                      ....     ....||+.|+|||.+....++.++||||||+++|||++|..||. ..+..+....+..+.....   ...+
T Consensus       183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~---p~~~  259 (311)
T d1r0pa_         183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ---PEYC  259 (311)
T ss_dssp             TTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCC---CTTC
T ss_pred             cccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---cccC
Confidence            3221     22358999999999999999999999999999999999666665 4455566666666543322   2478


Q ss_pred             CHHHHHHHHHhhhcCCC
Q psy12427        340 SEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       340 s~~~~~lI~~ll~~dP~  356 (356)
                      ++++.+||.+||+.||+
T Consensus       260 ~~~l~~li~~cl~~dP~  276 (311)
T d1r0pa_         260 PDPLYEVMLKCWHPKAE  276 (311)
T ss_dssp             CHHHHHHHHHHTCSSGG
T ss_pred             cHHHHHHHHHHcCCCHh
Confidence            99999999999999995

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-49  Score=359.92  Aligned_cols=245  Identities=16%  Similarity=0.254  Sum_probs=203.2

Q ss_pred             ccceeeeccccccCceEEEEEEEcc-----CCCEEEEEEcccCC-hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERK-----TGNIFAAKFIPVSH-NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEM  180 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~-----~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  180 (356)
                      .++|++.+.||+|+||+||+|.++.     ++..||+|+++... ..+...+.+|++++++++||||+++++++..+...
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            4789999999999999999999863     35789999997543 34456788999999999999999999999999999


Q ss_pred             EEEEEeccccchhhhhhCCCCC----CCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEe
Q psy12427        181 VLIFEFLSGGELFERITAPDYK----MSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMID  256 (356)
Q Consensus       181 ~lv~e~~~~g~L~~~l~~~~~~----~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~D  256 (356)
                      ++||||+++|+|.+++......    ..........+..++.|++.||+|||+++|+||||||+|||++.+.  ++||+|
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~--~~Kl~D  176 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF--TVKIGD  176 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC--CEEECC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCc--eEEEee
Confidence            9999999999999987532110    0111123334566999999999999999999999999999997544  799999


Q ss_pred             eeceeeeCCCCcee---ecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcC-CCCCCCCChHHHHHHhhccccccC
Q psy12427        257 FGLATKLDPNEVVK---ISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSG-LSPFAGENDVETLKNVKACDWEFD  332 (356)
Q Consensus       257 fg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g-~~Pf~~~~~~~~~~~i~~~~~~~~  332 (356)
                      ||+|+.........   ...||+.|+|||.+.+..++.++|||||||++|||++| .+||.+.+..+.+..+..+.....
T Consensus       177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~~  256 (308)
T d1p4oa_         177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK  256 (308)
T ss_dssp             TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCC
T ss_pred             cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence            99998764333222   23579999999999999999999999999999999997 689999999999998887664332


Q ss_pred             hhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        333 EEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       333 ~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                         ...+|+++.++|.+||+.||+
T Consensus       257 ---p~~~~~~l~~li~~cl~~~P~  277 (308)
T d1p4oa_         257 ---PDNCPDMLFELMRMCWQYNPK  277 (308)
T ss_dssp             ---CTTCCHHHHHHHHHHTCSSGG
T ss_pred             ---cccchHHHHHHHHHHcCCChh
Confidence               247899999999999999995

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=6.3e-49  Score=353.93  Aligned_cols=243  Identities=21%  Similarity=0.260  Sum_probs=198.3

Q ss_pred             cccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCC-CCceeeeeeEEeCCeEEEEE
Q psy12427        106 VYDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHH-PKLINLHDAFEDDDEMVLIF  184 (356)
Q Consensus       106 ~~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~~~lv~  184 (356)
                      +.++|++.++||+|+||+||+|+++.+|+.||+|++.....  ...+.+|++++..++| +|++.+++++......++||
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm   80 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   80 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence            34689999999999999999999999999999999865432  2356789999999975 89999999999999999999


Q ss_pred             EeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeec---CCCcEEEEeeecee
Q psy12427        185 EFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTR---NSTNVKMIDFGLAT  261 (356)
Q Consensus       185 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~---~~~~vkl~Dfg~a~  261 (356)
                      ||+ +++|.+++......++..     .+..++.|++.||+|||++||+||||||+|||++.+   ..+.+||+|||+|+
T Consensus        81 e~~-~~~l~~~~~~~~~~~~~~-----~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~  154 (293)
T d1csna_          81 DLL-GPSLEDLLDLCGRKFSVK-----TVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  154 (293)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHH-----HHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             Eec-CCCHHHHHHhhccchhhH-----HHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeE
Confidence            999 789988887554444443     345599999999999999999999999999999753   23579999999998


Q ss_pred             eeCCCC--------ceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC---hHHHHHHhhccc-c
Q psy12427        262 KLDPNE--------VVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN---DVETLKNVKACD-W  329 (356)
Q Consensus       262 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~---~~~~~~~i~~~~-~  329 (356)
                      .+....        .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+..   ..+....+.... .
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (293)
T d1csna_         155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  234 (293)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence            764221        1233469999999999999999999999999999999999999998654   333444443322 2


Q ss_pred             ccChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        330 EFDEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       330 ~~~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                      .++++..+++|+++.++|..|++.+|+
T Consensus       235 ~~~~~l~~~~p~~l~~ii~~~~~~~~~  261 (293)
T d1csna_         235 TPLRELCAGFPEEFYKYMHYARNLAFD  261 (293)
T ss_dssp             SCHHHHTTTSCHHHHHHHHHHHHCCTT
T ss_pred             CChHHhcCCCCHHHHHHHHHHhcCCcc
Confidence            234555678999999999999998874

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-48  Score=359.19  Aligned_cols=239  Identities=22%  Similarity=0.347  Sum_probs=185.6

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEe------CC
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFED------DD  178 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~  178 (356)
                      .++|+++++||+|+||+||+|+++.+|+.||+|++....  ......+.+|+.+|++++||||++++++|..      ..
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            378999999999999999999999999999999997543  3445678899999999999999999999963      47


Q ss_pred             eEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeee
Q psy12427        179 EMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFG  258 (356)
Q Consensus       179 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg  258 (356)
                      .+|+||||+.++.+ +.+..   .++     ...++.++.||+.||+|||++||+||||||+|||++.++  .+|++|||
T Consensus        96 ~~~iv~Ey~~~~l~-~~~~~---~~~-----~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~--~~kl~df~  164 (355)
T d2b1pa1          96 DVYLVMELMDANLC-QVIQM---ELD-----HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFG  164 (355)
T ss_dssp             EEEEEEECCSEEHH-HHHTS---CCC-----HHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECCCC
T ss_pred             eeEEEEeccchHHH-Hhhhc---CCC-----HHHHHHHHHHHHHHHHHhhhcccccccCCcccccccccc--ceeeechh
Confidence            88999999976555 44432   233     344566999999999999999999999999999998654  69999999


Q ss_pred             ceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChh----
Q psy12427        259 LATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEE----  334 (356)
Q Consensus       259 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~----  334 (356)
                      +++............||+.|+|||++.+..++.++||||+||++|+|++|++||.+.+....+.++......+.++    
T Consensus       165 ~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (355)
T d2b1pa1         165 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_dssp             C---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             hhhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence            9988766665666679999999999999999999999999999999999999999998887777664332221111    


Q ss_pred             ----------------------------------hhccCCHHHHHHHHHhhhcCCC
Q psy12427        335 ----------------------------------AFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       335 ----------------------------------~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                                        ....+|+++++||++||+.||+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~  300 (355)
T d2b1pa1         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA  300 (355)
T ss_dssp             SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTT
T ss_pred             hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChh
Confidence                                              1123578899999999999996

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-48  Score=347.54  Aligned_cols=241  Identities=23%  Similarity=0.387  Sum_probs=198.6

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCCeEEEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      ++|+++++||+|+||+||+|+++.+|+.||+|+++...  ......+.+|+.+|+.++||||+++++++......+++++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            57999999999999999999999999999999987554  3345788899999999999999999999999999999999


Q ss_pred             eccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeeceeeeCC
Q psy12427        186 FLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATKLDP  265 (356)
Q Consensus       186 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~~~~  265 (356)
                      ++.+++|..++.... .+.     ...+..++.|++.||+|||++||+||||||+|||++.++  .+||+|||.|+....
T Consensus        82 ~~~~~~l~~~~~~~~-~~~-----~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~--~~kl~DFG~a~~~~~  153 (292)
T d1unla_          82 FCDQDLKKYFDSCNG-DLD-----PEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG--ELKLANFGLARAFGI  153 (292)
T ss_dssp             CCSEEHHHHHHHTTT-CCC-----HHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCCTTCEECCS
T ss_pred             ecccccccccccccc-ccc-----hhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCC--ceeeeecchhhcccC
Confidence            999999888776432 333     334566999999999999999999999999999998654  799999999988754


Q ss_pred             CC-ceeecCCCcCccccccccCCC-CCccccHHHHHHHHHHHHcCCCCC-CCCChHHHHHHhhcccccc-----------
Q psy12427        266 NE-VVKISTGTAEFAAPEIVEREP-VGFYTDMWAVGVLAYVLLSGLSPF-AGENDVETLKNVKACDWEF-----------  331 (356)
Q Consensus       266 ~~-~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlG~il~ell~g~~Pf-~~~~~~~~~~~i~~~~~~~-----------  331 (356)
                      .. ......+++.|+|||++.... ++.++||||+||++|||++|+.|| .+.+..+.+.++......+           
T Consensus       154 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (292)
T d1unla_         154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             CCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence            33 333345789999999987665 689999999999999999999885 5666666666654322211           


Q ss_pred             --------------ChhhhccCCHHHHHHHHHhhhcCCC
Q psy12427        332 --------------DEEAFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       332 --------------~~~~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                    .......+|+++++||++||+.||+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~  272 (292)
T d1unla_         234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPV  272 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGG
T ss_pred             ccccccccccccchhhhccccCCHHHHHHHHHHccCChh
Confidence                          1223346789999999999999995

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-48  Score=358.06  Aligned_cols=239  Identities=26%  Similarity=0.410  Sum_probs=194.3

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCC--hhhHHHHHHHHHHHHhcCCCCceeeeeeEEeC-----Ce
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSH--NLEKELIRKEIDIMNQLHHPKLINLHDAFEDD-----DE  179 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~  179 (356)
                      .++|+++++||+|+||+||+|+++.+|+.||+|+++...  ......+.+|+++|++++||||+++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            468999999999999999999999999999999997543  33456788999999999999999999998643     33


Q ss_pred             EEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCcEEEEeeec
Q psy12427        180 MVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTNVKMIDFGL  259 (356)
Q Consensus       180 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~  259 (356)
                      .+++++++.||+|.+++...  .+     ....++.++.||+.||+|||++||+||||||+|||++.++  .+|++|||+
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~--~l-----~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~--~~kl~dfg~  167 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ--KL-----TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC--ELKILDFGL  167 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC--CC-----CHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--CEEECCC--
T ss_pred             eEEEEEeecCCchhhhcccc--cc-----cHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccc--cccccccch
Confidence            46667778899999998643  23     3344566999999999999999999999999999998654  799999999


Q ss_pred             eeeeCCCCceeecCCCcCccccccccCC-CCCccccHHHHHHHHHHHHcCCCCCCCCChHHHHHHhhccccccChh----
Q psy12427        260 ATKLDPNEVVKISTGTAEFAAPEIVERE-PVGFYTDMWAVGVLAYVLLSGLSPFAGENDVETLKNVKACDWEFDEE----  334 (356)
Q Consensus       260 a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~----  334 (356)
                      |.....  ......|++.|+|||.+.+. .++.++||||+||++|+|++|++||.+.+.......+......++.+    
T Consensus       168 a~~~~~--~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  245 (348)
T d2gfsa1         168 ARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  245 (348)
T ss_dssp             --CCTG--GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             hcccCc--ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence            976542  33445689999999987665 46889999999999999999999999999888887776544433322    


Q ss_pred             -----------------------hhccCCHHHHHHHHHhhhcCCC
Q psy12427        335 -----------------------AFKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       335 -----------------------~~~~~s~~~~~lI~~ll~~dP~  356 (356)
                                             .+.++|++++|||++||+.||+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~  290 (348)
T d2gfsa1         246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSD  290 (348)
T ss_dssp             CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGG
T ss_pred             ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChh
Confidence                                   2346899999999999999995

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=340.71  Aligned_cols=237  Identities=21%  Similarity=0.263  Sum_probs=177.2

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCceeeeeeEEeCC----eEEEE
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKLINLHDAFEDDD----EMVLI  183 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----~~~lv  183 (356)
                      ++|.+.+.||+|+||+||+|++  +|+.||+|+++.... .......|+..+.+++||||+++++++....    .+++|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence            4689999999999999999986  488999999865432 2222334555666789999999999997543    68999


Q ss_pred             EEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHH--------CCceeccCCCCCEEEeecCCCcEEEE
Q psy12427        184 FEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE--------KNIIHLDVKPENIMCQTRNSTNVKMI  255 (356)
Q Consensus       184 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--------~~ivH~Dlkp~NIlv~~~~~~~vkl~  255 (356)
                      |||+++|+|.+++....  +++     ..+..++.|++.||+|||+        +||+||||||+|||++.++  .+||+
T Consensus        80 ~Ey~~~g~L~~~l~~~~--l~~-----~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~--~~Kl~  150 (303)
T d1vjya_          80 SDYHEHGSLFDYLNRYT--VTV-----EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG--TCCIA  150 (303)
T ss_dssp             EECCTTCBHHHHHHHCC--BCH-----HHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS--CEEEC
T ss_pred             EecccCCCHHHHHhcCC--CCH-----HHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC--CeEEE
Confidence            99999999999997532  333     3334599999999999996        5999999999999997554  79999


Q ss_pred             eeeceeeeCCCCc-----eeecCCCcCccccccccCCC------CCccccHHHHHHHHHHHHcCCCCCCCCC--------
Q psy12427        256 DFGLATKLDPNEV-----VKISTGTAEFAAPEIVEREP------VGFYTDMWAVGVLAYVLLSGLSPFAGEN--------  316 (356)
Q Consensus       256 Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlG~il~ell~g~~Pf~~~~--------  316 (356)
                      |||+++.......     .....||+.|+|||++.+..      ++.++|||||||+||||++|..||....        
T Consensus       151 DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~  230 (303)
T d1vjya_         151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD  230 (303)
T ss_dssp             CCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred             ecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh
Confidence            9999988754332     23356999999999987643      5678999999999999999988874322        


Q ss_pred             -------hHHHHHHhhccccc--cChhh-hccCCHHHHHHHHHhhhcCCC
Q psy12427        317 -------DVETLKNVKACDWE--FDEEA-FKNVSEEGKDFIRRLLLRNKE  356 (356)
Q Consensus       317 -------~~~~~~~i~~~~~~--~~~~~-~~~~s~~~~~lI~~ll~~dP~  356 (356)
                             ..+....+......  ++... ....+.++.+||.+||+.||+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~  280 (303)
T d1vjya_         231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGA  280 (303)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGG
T ss_pred             cccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHh
Confidence                   12222223222221  12111 112446799999999999995

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.6e-41  Score=314.47  Aligned_cols=203  Identities=23%  Similarity=0.375  Sum_probs=158.8

Q ss_pred             cceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcC-----------CCCceeeeeeEEe
Q psy12427        108 DHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLH-----------HPKLINLHDAFED  176 (356)
Q Consensus       108 ~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~-----------hpnIv~l~~~~~~  176 (356)
                      ++|+++++||+|+||+||+|+++.+|+.||+|+++.... ..+.+.+|+.+|+.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            469999999999999999999999999999999976543 3456778999998875           4789999988764


Q ss_pred             --CCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEEeecCC----
Q psy12427        177 --DDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHE-KNIIHLDVKPENIMCQTRNS----  249 (356)
Q Consensus       177 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~Dlkp~NIlv~~~~~----  249 (356)
                        ....+++++++..+.........   ..........++.++.||+.||+|||+ .||+||||||+|||++.++.    
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKK---YEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHH---TTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred             ccccceeeeeeeccccccccccccc---ccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence              45667777776554432222111   111222334456799999999999998 89999999999999987653    


Q ss_pred             CcEEEEeeeceeeeCCCCceeecCCCcCccccccccCCCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q psy12427        250 TNVKMIDFGLATKLDPNEVVKISTGTAEFAAPEIVEREPVGFYTDMWAVGVLAYVLLSGLSPFAGEN  316 (356)
Q Consensus       250 ~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG~il~ell~g~~Pf~~~~  316 (356)
                      ..++++|||.|.....  .....+||+.|+|||++....++.++|+||+||++++|++|+.||....
T Consensus       169 ~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~  233 (362)
T d1q8ya_         169 IQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE  233 (362)
T ss_dssp             EEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             ceeeEeeccccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence            2489999999987543  3345679999999999999999999999999999999999999997653

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.94  E-value=1.5e-26  Score=193.90  Aligned_cols=163  Identities=16%  Similarity=0.170  Sum_probs=118.9

Q ss_pred             eeeeccccccCceEEEEEEEccCCCEEEEEEcccCCh------------------hhHHHHHHHHHHHHhcCCCCceeee
Q psy12427        110 YDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHN------------------LEKELIRKEIDIMNQLHHPKLINLH  171 (356)
Q Consensus       110 y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~------------------~~~~~~~~E~~il~~l~hpnIv~l~  171 (356)
                      +.+.++||+|+||+||+|++. +|+.||+|+++....                  .......+|...|.++.|++++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            457889999999999999885 689999998753211                  0123345689999999999999988


Q ss_pred             eeEEeCCeEEEEEEeccccchhhhhhCCCCCCCccccccccHHHHHHHHHHHHHHHHHCCceeccCCCCCEEEeecCCCc
Q psy12427        172 DAFEDDDEMVLIFEFLSGGELFERITAPDYKMSEAEVIPVTLPILMTQTSPAVKHMHEKNIIHLDVKPENIMCQTRNSTN  251 (356)
Q Consensus       172 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~Dlkp~NIlv~~~~~~~  251 (356)
                      ++..    .+++|||+++..+.++             .......++.|++.||+|||++||+||||||+|||++.+   .
T Consensus        81 ~~~~----~~lvme~~~~~~~~~l-------------~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~---~  140 (191)
T d1zara2          81 AWEG----NAVLMELIDAKELYRV-------------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE---G  140 (191)
T ss_dssp             EEET----TEEEEECCCCEEGGGC-------------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT---E
T ss_pred             EecC----CEEEEEeeccccccch-------------hhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC---C
Confidence            6532    3799999988765331             122234589999999999999999999999999999743   4


Q ss_pred             EEEEeeeceeeeCCCCceeecCCCcCcccc------ccccCCCCCccccHHHHHHH
Q psy12427        252 VKMIDFGLATKLDPNEVVKISTGTAEFAAP------EIVEREPVGFYTDMWAVGVL  301 (356)
Q Consensus       252 vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~sDvwSlG~i  301 (356)
                      ++|+|||+|.........       .|...      +.+ .+.|+.++|+||+.--
T Consensus       141 ~~liDFG~a~~~~~~~~~-------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         141 IWIIDFPQSVEVGEEGWR-------EILERDVRNIITYF-SRTYRTEKDINSAIDR  188 (191)
T ss_dssp             EEECCCTTCEETTSTTHH-------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHH
T ss_pred             EEEEECCCcccCCCCCcH-------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHH
Confidence            999999999776433211       11111      111 3567889999997543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.72  E-value=4.5e-08  Score=83.82  Aligned_cols=87  Identities=13%  Similarity=0.012  Sum_probs=63.8

Q ss_pred             ccceeeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCeEEEEEE
Q psy12427        107 YDHYDILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLH-HPKLINLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       107 ~~~y~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lv~e  185 (356)
                      .+.|++.+..+.++.+.||++.  .++..+++|+...........+.+|...+..+. +--+.+++.+...++..++||+
T Consensus        13 ~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~   90 (263)
T d1j7la_          13 IEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS   90 (263)
T ss_dssp             HTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred             hhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEE
Confidence            3457777776666678999875  346678888876554444455678999988874 3336778888888899999999


Q ss_pred             eccccchhhh
Q psy12427        186 FLSGGELFER  195 (356)
Q Consensus       186 ~~~~g~L~~~  195 (356)
                      +++|.++.+.
T Consensus        91 ~l~G~~~~~~  100 (263)
T d1j7la_          91 EADGVLCSEE  100 (263)
T ss_dssp             CCSSEEHHHH
T ss_pred             eccccccccc
Confidence            9999877543

>d2crza1 b.1.2.1 (A:8-104) Fibronectin type-III domain containing protein 3a, FNDC3A (KIAA0970) {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Fibronectin type-III domain containing protein 3a, FNDC3A (KIAA0970)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.71  E-value=5e-09  Score=75.83  Aligned_cols=49  Identities=27%  Similarity=0.311  Sum_probs=44.2

Q ss_pred             CCceEeeeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceec
Q psy12427          2 SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT   50 (356)
Q Consensus         2 ~~w~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~   50 (356)
                      ..|..+..+..++++|++|+|++.|.|||+|.|..|.|.+|..+.+.|.
T Consensus        47 ~~~~~~~~~~~~~~~v~~L~p~t~Y~frV~A~N~~G~s~~S~~~~~~T~   95 (97)
T d2crza1          47 DEPREVYQGSEVECTVSSLLPGKTYSFRLRAANKMGFGPFSEKCDITTA   95 (97)
T ss_dssp             CCCEEEEEESCSEEEEESCCTTCEEEECCEEECSSCBCCCCCCEEEECC
T ss_pred             CceeEeecCCceEEEEcCCCCCEEEEEEEEEecCCeEcCCcCCCeEEeC
Confidence            3577777888899999999999999999999999999999998887764

>d1x5ya1 b.1.2.1 (A:8-105) Myosin binding protein C, fast-type {Mouse (Mus musculus) [TaxId: 10090]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Myosin binding protein C, fast-type
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=98.68  E-value=6.1e-09  Score=75.50  Aligned_cols=50  Identities=26%  Similarity=0.502  Sum_probs=43.3

Q ss_pred             CCceEeee--eeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceech
Q psy12427          2 SSWIRVGN--TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK   51 (356)
Q Consensus         2 ~~w~~~~~--~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~   51 (356)
                      ..|..+..  ...++++|+||.||+.|.|||+|.|..|.|.+|..++.++.+
T Consensus        46 ~~~~~~~~~~~~~~~~~v~~L~~~~~Y~frV~A~n~~G~s~~s~~~~~vtv~   97 (98)
T d1x5ya1          46 EEWVPANKEPVERCGFTVKDLPTGARILFRVVGVNIAGRSEPATLLQPVTIR   97 (98)
T ss_dssp             CCCEESSSSCBSSSEEEEECCCTTCCEEEEEEEEETTEECCCCCCSSCBCCC
T ss_pred             ceeEEeeeecCceeEEEECCCcCCeEEEEEEEEECCCcCCCCcCCCCCEEee
Confidence            46887654  577899999999999999999999999999999988877654

>d1wfua_ b.1.2.1 (A:) Fibronectin type 3 and ankyrin repeat domains 1 protein, FANK1 {Mouse (Mus musculus) [TaxId: 10090]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Fibronectin type 3 and ankyrin repeat domains 1 protein, FANK1
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=98.54  E-value=2.3e-08  Score=75.21  Aligned_cols=50  Identities=24%  Similarity=0.330  Sum_probs=44.6

Q ss_pred             CceEeeeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceechh
Q psy12427          3 SWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD   52 (356)
Q Consensus         3 ~w~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~~   52 (356)
                      .|..+.+...++++|++|+|++.|.|||+|.|..|.|.+|+...+.|.++
T Consensus        65 ~~~~~~~~~~~~~~v~~L~p~t~Y~frV~A~n~~G~s~~S~~~~~~T~~~  114 (120)
T d1wfua_          65 SYGVIYTGYATRHVVEGLEPRTLYKFRLKVTSPSGEYEYSPVVSVATTRE  114 (120)
T ss_dssp             CEEEEEEESCSEEEEESCCTTCEEEEEEEEECSSSCEEECCCEEEECCCC
T ss_pred             ceeeeccccccEEeCCCCCCCcEeeEEEEEEeCCcEeCCCCCEEEEeCCC
Confidence            57777788889999999999999999999999999999999888877543

>d1x5xa1 b.1.2.1 (A:8-103) Fibronectin type-III domain containing protein 3a, FNDC3A (KIAA0970) {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Fibronectin type-III domain containing protein 3a, FNDC3A (KIAA0970)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.51  E-value=2.7e-08  Score=71.32  Aligned_cols=45  Identities=27%  Similarity=0.406  Sum_probs=40.3

Q ss_pred             eeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceechh
Q psy12427          8 GNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD   52 (356)
Q Consensus         8 ~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~~   52 (356)
                      .....++++|+||+|++.|.|||+|.|..|.|.+|....+.|.+|
T Consensus        52 ~~~~~~~~~v~~L~p~t~Y~~rV~A~n~~G~s~~S~~~~~~T~pd   96 (96)
T d1x5xa1          52 YDGEDLAYTVKNLRRSTKYKFKVIAYNSEGKSNPSEVVEFTTCPD   96 (96)
T ss_dssp             EEESCSEEEEESCCSSCEEEEEEEEECSSCEEEECCCEEEECCCC
T ss_pred             ecCCCCEEEECCCCCCCEEEEEEEEEcCCcEeCCCCCEEEEeCcC
Confidence            357788999999999999999999999999999999888877653

>d2djsa1 b.1.2.1 (A:8-102) Ephrin type-B receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Ephrin type-B receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.50  E-value=3.1e-08  Score=70.97  Aligned_cols=47  Identities=30%  Similarity=0.347  Sum_probs=41.5

Q ss_pred             EeeeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceechh
Q psy12427          6 RVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD   52 (356)
Q Consensus         6 ~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~~   52 (356)
                      .......+++++++|+|++.|.|||+|.|..|.|.+|....+.|+.|
T Consensus        49 ~~~~~~~~~~~i~~L~p~t~Y~~~V~A~n~~G~g~~S~~~~~~T~~d   95 (95)
T d2djsa1          49 SMARSQTNTARIDGLRPGMVYVVQVRARTVAGYGKFSGKMCFQTLTD   95 (95)
T ss_dssp             EEEEESSSEEEEESCCTTCEEEEEEEEEESSCEEEECCCEEEECCCS
T ss_pred             EeecCCccEEEEeecCCccEEEEEEEEEcCCCCCCCCCCEEEEeCCC
Confidence            34457888999999999999999999999999999999998887653

>d1uema_ b.1.2.1 (A:) KIAA1568 protein {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: KIAA1568 protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.49  E-value=3.2e-08  Score=74.04  Aligned_cols=48  Identities=44%  Similarity=0.596  Sum_probs=41.3

Q ss_pred             CceEeee-eeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceec
Q psy12427          3 SWIRVGN-TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT   50 (356)
Q Consensus         3 ~w~~~~~-~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~   50 (356)
                      .|..+.. ...++++|+||+|++.|.|||+|.|..|.|.+|..++.++.
T Consensus        61 ~~~~~~~~~~~~~~~v~~L~p~t~Y~frV~A~N~~G~s~~S~~s~~v~t  109 (117)
T d1uema_          61 SWQTVANHVKTTLYTVRGLRPNTIYLFMVRAINPQGLSDPSPMSDPVRT  109 (117)
T ss_dssp             EEEEEEEEECSSEEEECSCCTTCEEEEEEEEEETTEEEEECCCCCCEEC
T ss_pred             eeEEeccccccccceECCCCCCCEEEEEEEEEeCCcCCCCcCCCcCEEe
Confidence            4776654 67789999999999999999999999999999998875544

>d1x4za1 b.1.2.1 (A:8-115) Brother of CDO precursor (BOC) {Mouse (Mus musculus) [TaxId: 10090]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Brother of CDO precursor (BOC)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=98.48  E-value=8e-08  Score=70.70  Aligned_cols=48  Identities=38%  Similarity=0.589  Sum_probs=39.9

Q ss_pred             CceEeee---eeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceec
Q psy12427          3 SWIRVGN---TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT   50 (356)
Q Consensus         3 ~w~~~~~---~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~   50 (356)
                      .|..+..   ...++++|+||.|++.|.|||+|.|..|.|++|.+++..+.
T Consensus        56 ~~~~~~~~~~~~~~~~~v~~L~p~t~Y~frV~A~N~~G~s~~S~pS~p~~~  106 (108)
T d1x4za1          56 DWILATSAIPPSRLSVEITGLEKGISYKFRVRALNMLGESEPSAPSRPYVV  106 (108)
T ss_dssp             CCEEEEEEECTTCCEEEEESCCTTCEEEEEEEEEETTEECCCCCCCCCEEC
T ss_pred             ceEEEEEeecCCccEEEECCCCCCCEEEEEEEEECCCcCCCCCCCCCCEEe
Confidence            4554443   35678999999999999999999999999999999876553

>d1cfba1 b.1.2.1 (A:610-709) Neuroglian, two amino proximal Fn3 repeats {Drosophila melanogaster [TaxId: 7227]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Neuroglian, two amino proximal Fn3 repeats
species: Drosophila melanogaster [TaxId: 7227]

Probab=98.47  E-value=8.1e-08  Score=69.51  Aligned_cols=41  Identities=39%  Similarity=0.447  Sum_probs=37.0

Q ss_pred             eeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceec
Q psy12427         10 TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT   50 (356)
Q Consensus        10 ~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~   50 (356)
                      ...+++++.+|+|++.|.|||+|.|..|.|.+|.+++..+.
T Consensus        59 ~~~~~~~~~~L~p~t~Y~frV~A~n~~G~g~~S~~s~~vtT   99 (100)
T d1cfba1          59 PNTDSSFVVQMSPWANYTFRVIAFNKIGASPPSAHSDSCTT   99 (100)
T ss_dssp             ETTCSEEEEECCSSEEEEEEEEEEETTEECCCCCCCCCEEE
T ss_pred             CCceEEEEecCCCCCEEEEEEEEEeCCcCCCCcCCCcCEEe
Confidence            45678999999999999999999999999999999887654

>d2ic2a1 b.1.2.1 (A:466-572) Hedgehog receptor iHog {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Hedgehog receptor iHog
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=98.46  E-value=4e-08  Score=72.23  Aligned_cols=42  Identities=29%  Similarity=0.338  Sum_probs=37.4

Q ss_pred             eeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceec
Q psy12427          9 NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT   50 (356)
Q Consensus         9 ~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~   50 (356)
                      ....++++|+||+|++.|.|||+|.|.+|.|.+|.++....+
T Consensus        64 ~~~~~~~~i~~L~p~t~Y~frV~A~N~~G~s~~S~~s~~~~~  105 (107)
T d2ic2a1          64 LGKSFTASVTDLKPQHTYRFRILAVYSNNDNKESNTSAKFYL  105 (107)
T ss_dssp             SEEEEEEEECSCCSSEEEEEEEEEEETTSCEEECCCCCCEEE
T ss_pred             ccceeEEEECCCcCCcEEEEEEEEEcCCCCCCCCCCCCCEEc
Confidence            466789999999999999999999999999999998876543

>d1wf5a1 b.1.2.1 (A:8-115) Sidekick 2 {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Sidekick 2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.46  E-value=4.3e-08  Score=72.17  Aligned_cols=43  Identities=26%  Similarity=0.526  Sum_probs=38.8

Q ss_pred             eeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceechh
Q psy12427         10 TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD   52 (356)
Q Consensus        10 ~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~~   52 (356)
                      ...++++|+||.|++.|.|||+|.|..|.|.+|..++..+.+|
T Consensus        66 ~~~~~~~i~~L~p~t~Y~frV~A~N~~G~s~~S~~~~~~t~PE  108 (108)
T d1wf5a1          66 PKATSVTVKGLVPARSYQFRLCAVNDVGKGQFSKDTERVSLPE  108 (108)
T ss_dssp             TTCCEEEEESCCTTCEEEEEEEEEESSCEEEECCCCSCEECCC
T ss_pred             CCccEEEECCCCCCCEEEEEEEEEcCCcCCCCcCCcCCEECCC
Confidence            4567899999999999999999999999999999998887653

>d1f6fb2 b.1.2.1 (B:101-203) Prolactin receptor {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Prolactin receptor
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=98.46  E-value=1.1e-07  Score=69.11  Aligned_cols=47  Identities=21%  Similarity=0.211  Sum_probs=40.8

Q ss_pred             CCceEeeeeeecceeeecCccCceEEEEEEEEecCCC-CCCCCCccce
Q psy12427          2 SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGR-SDPSTTSDLI   48 (356)
Q Consensus         2 ~~w~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~-s~~s~~s~~~   48 (356)
                      ..|........++++|.||.||+.|.|||||.|..|. |++|++..+.
T Consensus        54 ~~~~~~~~~~~~~~~i~~L~p~t~Y~~rVra~~~~G~wS~wS~~~~~~  101 (103)
T d1f6fb2          54 EEWEIHFTGHQTQFKVFDLYPGQKYLVQTRCKPDHGYWSRWSQESSVE  101 (103)
T ss_dssp             SCCEEEEEETCSEEEECCCCTTCEEEEEEEEEESSSCCCCCCCCEEEE
T ss_pred             cceeeecccceeEEEeCCCCcceEEEEEEEEEeCCCCCCCCcCceeeE
Confidence            4677777788899999999999999999999999996 8888877654

>d3d48r2 b.1.2.1 (R:101-204) Prolactin receptor {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Prolactin receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.45  E-value=1.1e-07  Score=69.14  Aligned_cols=47  Identities=23%  Similarity=0.234  Sum_probs=38.5

Q ss_pred             CceEeeeeeecceeeecCccCceEEEEEEEEecCCC-CCCCCCcccee
Q psy12427          3 SWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGR-SDPSTTSDLIT   49 (356)
Q Consensus         3 ~w~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~-s~~s~~s~~~t   49 (356)
                      .|........++++|.||+|++.|.|||||.|..|. |++|++..+.+
T Consensus        55 ~~~~~~~~~~~~~~i~~L~p~t~Y~~rVrA~n~~G~ws~wS~~~~v~t  102 (104)
T d3d48r2          55 EWEIHFAGQQTEFKILSLHPGQKYLVQVRCKPDHGYWSAWSPATFIQI  102 (104)
T ss_dssp             SCEEEEEETCSEEEECC--CCCEEEEEEEEEESSSCCCCCCCCEEEEC
T ss_pred             ceeeeccccccEEEECCCCCCCEEEEEEEEEeCCCCCCCCcCCEEEEC
Confidence            466666688899999999999999999999999997 99998876654

>d1x4xa1 b.1.2.1 (A:8-100) Fibronectin type-III domain containing protein 3a, FNDC3A (KIAA0970) {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Fibronectin type-III domain containing protein 3a, FNDC3A (KIAA0970)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.45  E-value=1e-07  Score=67.94  Aligned_cols=47  Identities=28%  Similarity=0.192  Sum_probs=40.8

Q ss_pred             ceEeeeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceec
Q psy12427          4 WIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT   50 (356)
Q Consensus         4 w~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~   50 (356)
                      |..+.....++++|++|.|++.|.|||+|.|..|.|.+|+...+.|.
T Consensus        45 ~~~~~~~~~~~~~i~~L~p~t~Y~~~V~A~n~~G~s~~S~~~~~~Tp   91 (93)
T d1x4xa1          45 MQICYCGPGLSYEIKGLSPATTYYCRVQALSVVGAGPFSEVVACVTP   91 (93)
T ss_dssp             CCEEEEESCSEEEEESCCSSCEEEEEEEEECSSCCCCBCCCEEEECC
T ss_pred             ceEeecCCccEEEEcccceeeEEEEEEEEEECCcCcCCCCcEEEEeC
Confidence            44566788899999999999999999999999999999987776553

>d2crma1 b.1.2.1 (A:8-114) Fibronectin type-III domain containing protein 3a, FNDC3A (KIAA0970) {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Fibronectin type-III domain containing protein 3a, FNDC3A (KIAA0970)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.43  E-value=8.3e-08  Score=70.35  Aligned_cols=47  Identities=26%  Similarity=0.302  Sum_probs=40.8

Q ss_pred             CceEeeeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCcccee
Q psy12427          3 SWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLIT   49 (356)
Q Consensus         3 ~w~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t   49 (356)
                      .|........+++.++||+||+.|.|||+|.|..|.|.+|+...+.|
T Consensus        58 ~~~~~~~~~~~~~~i~~L~p~t~Y~~rV~A~n~~G~s~~S~~v~v~T  104 (107)
T d2crma1          58 KWEMIYSGATREHLCDRLNPGCFYRLRVYCISDGGQSAVSESLLVQT  104 (107)
T ss_dssp             CCEEEECSSCSEEEECSCCTTSCEEEEEEEEETTEECCCCCCCCCCC
T ss_pred             cEEEeecCCccEEEEeccCCCCEEEEEEEEECCCcCcCCCCcEEEEC
Confidence            45555568889999999999999999999999999999998877654

>d1bpva_ b.1.2.1 (A:) Type I titin module {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Type I titin module
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.42  E-value=3.3e-08  Score=72.14  Aligned_cols=51  Identities=39%  Similarity=0.670  Sum_probs=42.0

Q ss_pred             CceEee--eeeecceeeecCccCceEEEEEEEEecCCC-CCCCCCccceechhh
Q psy12427          3 SWIRVG--NTRFTTMAITGLSPGHQYEFRVYAENVYGR-SDPSTTSDLITTKDT   53 (356)
Q Consensus         3 ~w~~~~--~~~~~~~~v~~L~p~~~y~frv~a~n~~g~-s~~s~~s~~~t~~~~   53 (356)
                      .|..+.  ....++++++||+|++.|.|||+|.|..|. |.+|..++.++.++.
T Consensus        48 ~~~~~~~~~~~~~~~~i~~L~p~t~Y~frV~A~n~~G~~s~~S~~s~~vt~~d~  101 (104)
T d1bpva_          48 RWLKANFSNILENEFTVSGLTEDAAYEFRVIAKNAAGAISPPSEPSDAITCRDD  101 (104)
T ss_dssp             CCEECCCSCCCSSEEEECSCCSSCCEEEEEEEECTTSCEEEEEEEEEEECSCHH
T ss_pred             ceeEEEeeccceeEEEEcCCCCCCEEEEEEEEEECCCCCCCCcCCCCCEEeCCC
Confidence            355443  367788999999999999999999999996 788888888877654

>d1x5aa1 b.1.2.1 (A:8-101) Ephrin type-A receptor 1 {Mouse (Mus musculus) [TaxId: 10090]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Ephrin type-A receptor 1
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=98.37  E-value=1.4e-07  Score=67.44  Aligned_cols=41  Identities=22%  Similarity=0.229  Sum_probs=37.6

Q ss_pred             eeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceec
Q psy12427         10 TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT   50 (356)
Q Consensus        10 ~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~   50 (356)
                      ...++++|+||+|++.|.|||+|.|..|.|.+|....+.|.
T Consensus        52 ~~~t~~~i~~L~p~t~Y~~rV~A~n~~G~g~~S~~~~~~T~   92 (94)
T d1x5aa1          52 VLEPRVLLTKLQPDTTYIVRVRTLTPLGPGPFSPDHEFRTS   92 (94)
T ss_dssp             ESSSEEEEESCCSSCEEEEEEEEECSSSCCCCCCCEEEECC
T ss_pred             eccCEEEECCCCCCCEEEEEEEEEcCCcCcCCCCCEEEEeC
Confidence            45789999999999999999999999999999998888775

>d1x3da1 b.1.2.1 (A:8-112) Fibronectin type-III domain containing protein 3a, FNDC3A (KIAA0970) {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Fibronectin type-III domain containing protein 3a, FNDC3A (KIAA0970)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.36  E-value=1.7e-07  Score=68.43  Aligned_cols=48  Identities=29%  Similarity=0.292  Sum_probs=42.2

Q ss_pred             CceEeeeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceec
Q psy12427          3 SWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT   50 (356)
Q Consensus         3 ~w~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~   50 (356)
                      .|..+.....+++++.+|+|++.|.|||+|.|..|.|.+|+.+.+.|.
T Consensus        56 ~~~~~~~~~~~~~~~~~L~p~t~Y~frV~A~N~~G~s~~S~~~~~~T~  103 (105)
T d1x3da1          56 EFCQCYMGSQKQFKITKLSPAMGCKFRLSARNDYGTSGFSEEVLYYTS  103 (105)
T ss_dssp             CCEEEEEESCSEEEEESCCTTCEEEEECCEEESSCBCCCCCCEEEECS
T ss_pred             eeEEEecCCccEEEecCCcCCcEEEEEEEEECCCeEcCCCCcEEEECC
Confidence            355566788899999999999999999999999999999998877664

>d2d9qb2 b.1.2.1 (B:204-308) Granulocyte colony-stimulating factor (GC-SF) receptor {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Granulocyte colony-stimulating factor (GC-SF) receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.34  E-value=3.7e-07  Score=66.55  Aligned_cols=47  Identities=21%  Similarity=0.232  Sum_probs=38.1

Q ss_pred             CceEee--eeeecceeeecCccCceEEEEEEEEecCCCCCCCCCcccee
Q psy12427          3 SWIRVG--NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLIT   49 (356)
Q Consensus         3 ~w~~~~--~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t   49 (356)
                      .|..+.  ....++++|++|+|++.|.|||||.|..|.|.+|.-|...+
T Consensus        52 ~~~~~~~~~~~~~~~~i~~L~p~t~Y~frVra~n~~g~G~~S~wS~~~~  100 (105)
T d2d9qb2          52 SWALVGPLPLEALQYELCGLLPATAYTLQIRCIRWPLPGHWSDWSPSLE  100 (105)
T ss_dssp             CCEEEEEECSCEEEEEECSCCSCCCEEEEEEEEECSSCCCCCCCCCCEE
T ss_pred             ceeeeecccCCcceeEEecccCCeEEEEEEEEEeCCCCCCCcCCCCCEE
Confidence            466553  35677899999999999999999999999987777666543

>d2haza1 b.1.2.1 (A:489-589) Neural cell adhesion molecule 1, NCAM {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Neural cell adhesion molecule 1, NCAM
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.33  E-value=1.4e-07  Score=68.37  Aligned_cols=41  Identities=29%  Similarity=0.354  Sum_probs=37.1

Q ss_pred             eeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceec
Q psy12427         10 TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT   50 (356)
Q Consensus        10 ~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~   50 (356)
                      ...++++|+||.|++.|.|||+|.|..|.|++|..+.+.|.
T Consensus        59 ~~~~~~~i~~L~p~t~Y~frV~A~N~~G~g~~S~~~~~~T~   99 (101)
T d2haza1          59 SMEGIVTIVGLKPETTYAVRLAALNGKGLGEISAASEFKTQ   99 (101)
T ss_dssp             HHHSEEEECSCCTTCEEEEEEEEEETTEECCCCCCEEEECC
T ss_pred             cceeEEEecCCCCCeEEEEEEEEEeCCcCcCCCCceeEEeC
Confidence            34578999999999999999999999999999999888765

>d1x5ga1 b.1.2.1 (A:8-110) Neogenin {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Neogenin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.33  E-value=2.4e-07  Score=67.31  Aligned_cols=43  Identities=26%  Similarity=0.304  Sum_probs=38.7

Q ss_pred             eeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceech
Q psy12427          9 NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK   51 (356)
Q Consensus         9 ~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~   51 (356)
                      .+..++++|+||+|++.|.|||+|.|..|.|.+|....+.|..
T Consensus        60 ~~~~~~~~i~~L~p~t~Y~~~V~A~n~~G~g~~S~~v~v~T~e  102 (103)
T d1x5ga1          60 DVSSHSYTINGLKKYTEYSFRVVAYNKHGPGVSTPDVAVRTLS  102 (103)
T ss_dssp             EECSSEEEECSCCTTCEEEEEEEEECSSCCCCBCCCCCEECCC
T ss_pred             eccccEEecCCCCCCCEEEEEEEEEcCCcCcCCCCCEEEEcCC
Confidence            4677899999999999999999999999999999888877764

>d1qg3a1 b.1.2.1 (A:1126-1217) Integrin beta-4 subunit {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Integrin beta-4 subunit
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.33  E-value=2.5e-07  Score=65.60  Aligned_cols=44  Identities=23%  Similarity=0.297  Sum_probs=38.7

Q ss_pred             eeeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceec
Q psy12427          7 VGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT   50 (356)
Q Consensus         7 ~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~   50 (356)
                      ......++++|++|+|++.|.|||+|.|..|.|.+|.+..+.|.
T Consensus        48 ~~~~~~~~~~i~~L~p~t~Y~~~V~A~n~~G~g~~S~~~~~~T~   91 (92)
T d1qg3a1          48 LLDSKVPSVELTNLYPYCDYEMKVCAYGAQGEGPYSSLVSCRTH   91 (92)
T ss_dssp             EEEESSSEEEECSCCTTCEEEEEEEEECSSCBCCCCCCEEEECC
T ss_pred             EecCCccEEEECCCCCCcEEEEEEEEEeCCcCcCCCCCEEEEcC
Confidence            34577889999999999999999999999999999998876653

>d1k85a_ b.1.2.1 (A:) Fibronectin type III domain from chitinase A1. {Bacillus circulans [TaxId: 1397]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Fibronectin type III domain from chitinase A1.
species: Bacillus circulans [TaxId: 1397]

Probab=98.32  E-value=2.9e-07  Score=64.82  Aligned_cols=44  Identities=27%  Similarity=0.322  Sum_probs=37.1

Q ss_pred             eEeeeeeecceeeecCccCceEEEEEEEEecCC-CCCCCCCccce
Q psy12427          5 IRVGNTRFTTMAITGLSPGHQYEFRVYAENVYG-RSDPSTTSDLI   48 (356)
Q Consensus         5 ~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g-~s~~s~~s~~~   48 (356)
                      ..+..+..++++++||+|++.|.|||+|.|..| .|.+|.+..+.
T Consensus        43 ~~~~~~~~t~~~~~~L~p~t~Y~~~V~A~n~~G~~s~~S~~v~vt   87 (88)
T d1k85a_          43 ALATTVTGTTATISGLAADTSYTFTVKAKDAAGNVSAASNAVSVK   87 (88)
T ss_dssp             SEEEEESSSEEEECCCCSSCEEEEEEEEEETTTEECCCCCCEEEE
T ss_pred             eEEEecCCCEEEECCCCCCCEEEEEEEEEECCCCcCCCCcCEEEE
Confidence            345567889999999999999999999999999 68888766543

>d1wk0a_ b.1.2.1 (A:) Fibronectin type-III domain containing protein 3a, FNDC3A (KIAA0970) {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Fibronectin type-III domain containing protein 3a, FNDC3A (KIAA0970)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.31  E-value=2.6e-07  Score=70.91  Aligned_cols=49  Identities=22%  Similarity=0.237  Sum_probs=43.6

Q ss_pred             CceEeeeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceech
Q psy12427          3 SWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK   51 (356)
Q Consensus         3 ~w~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~   51 (356)
                      .|..+.....++++|+||+|++.|.|||+|.|..|.|.+|....+.|..
T Consensus        72 ~~~~~~~~~~~~~~i~~L~P~t~Y~f~V~A~n~~G~g~~S~~~~~~T~~  120 (137)
T d1wk0a_          72 KYKSVYVGEETNITLNDLKPAMDYHAKVQAEYNSIKGTPSEAEIFTTLS  120 (137)
T ss_dssp             CCEEEEEESCSEEEECSCCTTCEECEEEEEEETTEECCCCCCCCEECCC
T ss_pred             cEEEEEecCccEEEECCCCCCcEEEEEEEEEcCCcccCCCCCEEEECCC
Confidence            4566667888999999999999999999999999999999988888754

>d1x5la1 b.1.2.1 (A:8-105) Ephrin type-A receptor 8 {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Ephrin type-A receptor 8
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.28  E-value=2.7e-07  Score=66.42  Aligned_cols=43  Identities=28%  Similarity=0.366  Sum_probs=38.7

Q ss_pred             eeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceec
Q psy12427          8 GNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT   50 (356)
Q Consensus         8 ~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~   50 (356)
                      ..+..++++|+||.|++.|.|||+|.|..|.|.+|....+.|.
T Consensus        54 ~~~~~~~~~i~~L~p~t~Y~~~V~a~n~~G~g~~S~~v~~~T~   96 (98)
T d1x5la1          54 LKAVTTRATVSGLKPGTRYVFQVRARTSAGCGRFSQAMEVETG   96 (98)
T ss_dssp             EEESSSEEEECSCCTTCEEEECEEEEETTEECCCCCCEEEECC
T ss_pred             ecCCceEEEECCCCCCCEEEEEEEEEcCCCCcCCCCCEEEEcC
Confidence            3467789999999999999999999999999999998887764

>d1wisa1 b.1.2.1 (A:8-118) Sidekick 2 {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Sidekick 2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.28  E-value=1.5e-07  Score=69.33  Aligned_cols=39  Identities=33%  Similarity=0.478  Sum_probs=35.3

Q ss_pred             eeecceeeecCccCceEEEEEEEEecCCCCCCCCCccce
Q psy12427         10 TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLI   48 (356)
Q Consensus        10 ~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~   48 (356)
                      ...+++.|.||+|++.|.|||+|.|..|.|.+|++++..
T Consensus        69 ~~~~~~~v~~L~p~t~Y~frV~A~N~~G~s~~S~~s~~~  107 (111)
T d1wisa1          69 PDARSMEVPDLNPFTCYSFRMRQVNIVGTSPPSQPSRKI  107 (111)
T ss_dssp             TTCSEEEECSCCTTSEECCCCEEECSSCBCCCCCCCCCE
T ss_pred             cceeEEEeCCCCCCCEEEEEEEEEcCCcCCCCcCCCCCE
Confidence            567789999999999999999999999999999988643

>d1x5ka1 b.1.2.1 (A:8-118) Neogenin {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Neogenin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.27  E-value=3.9e-07  Score=66.86  Aligned_cols=48  Identities=23%  Similarity=0.266  Sum_probs=40.4

Q ss_pred             CceEee-eeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceec
Q psy12427          3 SWIRVG-NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT   50 (356)
Q Consensus         3 ~w~~~~-~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~   50 (356)
                      .|.... ....++++|++|+|++.|.|||+|.|..|.|.+|....+.|.
T Consensus        61 ~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~A~n~~G~g~~S~~v~~~T~  109 (111)
T d1x5ka1          61 DWVIEPVVGNRLTHQIQELTLDTPYYFKIQARNSKGMGPMSEAVQFRTP  109 (111)
T ss_dssp             TSEEEEESTTCSEEEECSCCSSSEEEEEEEEECSSCBCCCCCCEEEECC
T ss_pred             eeEEEEeCCCeeEEEECCCCCCCEEEEEEEEEcCCCCcCCCCCEEEECC
Confidence            355443 367778999999999999999999999999999988777664

>d1axib2 b.1.2.1 (B:131-236) Growth hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Growth hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.25  E-value=3.3e-07  Score=67.03  Aligned_cols=47  Identities=17%  Similarity=0.246  Sum_probs=38.4

Q ss_pred             CCceEeeeeeecceeeecCccCceEEEEEEEEecCCC--CCCCCCccce
Q psy12427          2 SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGR--SDPSTTSDLI   48 (356)
Q Consensus         2 ~~w~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~--s~~s~~s~~~   48 (356)
                      +.|..+.....++++|++|+||+.|.|||||.+..|.  |++|++..+.
T Consensus        54 ~~w~~~~~~~~~~~~i~~L~~~t~Y~frVRa~~~~~g~ws~wS~~v~v~  102 (106)
T d1axib2          54 TKWKMMDPILTTSVPVYSLKVDKEYEVRVRSKQRNSGNYGEFSEVLYVT  102 (106)
T ss_dssp             SSCEECCCBSSSEEEEEEEETTSCEEEEEEEEETTSSCCCCCCCCEEEC
T ss_pred             ccceeeeecccceEEECCCCCCCEEEEEEEEEECCCCCCCCCCCCEEEE
Confidence            4688777788899999999999999999999987653  6777665443

>d1x5ja1 b.1.2.1 (A:8-107) Neogenin {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Neogenin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.24  E-value=4.3e-07  Score=65.40  Aligned_cols=44  Identities=30%  Similarity=0.271  Sum_probs=39.3

Q ss_pred             eeeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceec
Q psy12427          7 VGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT   50 (356)
Q Consensus         7 ~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~   50 (356)
                      ...+..++++|+||+|++.|.|||+|.|..|.|.+|.+....|.
T Consensus        55 ~~~~~~~~~~i~~L~p~t~Y~~~V~a~n~~g~s~~S~~~~~~T~   98 (100)
T d1x5ja1          55 NANATTLSYLVTGLKPNTLYEFSVMVTKGRRSSTWSMTAHGTTF   98 (100)
T ss_dssp             ECCBCSSEEEEESCCTTCEECCEEEEECSSCBCCCCCCCCEECC
T ss_pred             ecCCCccEEEECCCCCCCEEEEEEEEEeCCcCcCCCCeEEEEec
Confidence            44567789999999999999999999999999999998887764

>d1iarb2 b.1.2.1 (B:97-197) Interleukin-4 receptor alpha chain {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Interleukin-4 receptor alpha chain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.23  E-value=3.5e-07  Score=66.04  Aligned_cols=39  Identities=23%  Similarity=0.044  Sum_probs=29.3

Q ss_pred             eeecceeeecCccCceEEEEEEEEecCCCCCCCCCccce
Q psy12427         10 TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLI   48 (356)
Q Consensus        10 ~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~   48 (356)
                      ...+++++.+|.|++.|.|||||.|..|.|.+|+-|+..
T Consensus        60 ~~~~~~~i~~L~p~t~Y~~rVrA~~~~g~g~wSewS~~v   98 (101)
T d1iarb2          60 EPSLRIAASTLKSGISYRARVRAWAQAYNTTWSEWSPST   98 (101)
T ss_dssp             CCEEEECC-----CCCEEEEEEEECGGGTCCCCCCCCCE
T ss_pred             ccceEEEECCCCCCCEEEEEEEEEcCCCCCCCcCCCCCE
Confidence            455788999999999999999999999999888877654

>d1cd9b2 b.1.2.1 (B:108-213) Granulocyte colony-stimulating factor (GC-SF) receptor {Mouse (Mus musculus) [TaxId: 10090]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Granulocyte colony-stimulating factor (GC-SF) receptor
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=98.21  E-value=1.1e-06  Score=64.14  Aligned_cols=47  Identities=15%  Similarity=0.089  Sum_probs=39.2

Q ss_pred             CceEeee--eeecceeeecCccCceEEEEEEEEecCCCCCCCCCcccee
Q psy12427          3 SWIRVGN--TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLIT   49 (356)
Q Consensus         3 ~w~~~~~--~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t   49 (356)
                      .|..+..  ...++++|++|.|++.|.|||||.|..|.|.+|+-|...+
T Consensus        53 ~w~~v~~~~~~~~~~~l~~L~p~t~Y~frVra~~~~g~g~wS~wS~~~~  101 (106)
T d1cd9b2          53 NWTLVFHLPSSKDQFELCGLHQAPVYTLQMRCIRSSLPGFWSPWSPGLQ  101 (106)
T ss_dssp             CCEEEEEEESCEEEEEECCCCSCSCEEEEEEEEESSSCCCCCCCCCCEE
T ss_pred             cceeeecccCCceEEEEeccCCCeEEEEEEEEEeCCCCCCCcCCCCCeE
Confidence            5777654  5678999999999999999999999999988777666543

>d1x5fa1 b.1.2.1 (A:8-114) Neogenin {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Neogenin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.20  E-value=1.9e-07  Score=68.51  Aligned_cols=45  Identities=27%  Similarity=0.350  Sum_probs=39.2

Q ss_pred             eeeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceech
Q psy12427          7 VGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK   51 (356)
Q Consensus         7 ~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~   51 (356)
                      ......++++|++|.|++.|.|||+|.|..|.|.+|....+.|.+
T Consensus        62 ~~~~~~~~~~~~~L~p~t~Y~~rV~A~n~~G~g~~S~~i~v~T~~  106 (107)
T d1x5fa1          62 TSHPGEMQVTIQNLMPATVYIFRVMAQNKHGSGESSAPLRVETQP  106 (107)
T ss_dssp             CSSTTCSEEEECSCCTTCEEEEEEEEECSSCEEEECCCEEEECCC
T ss_pred             EeCCCccEEEecCCCCCCEEEEEEEEEeCCCCcCCCCCEEEECCC
Confidence            345778899999999999999999999999999999887776643

>d2b5ib2 b.1.2.1 (B:104-207) Interleukin-2 receptor beta chain {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Interleukin-2 receptor beta chain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.20  E-value=7.1e-07  Score=64.59  Aligned_cols=41  Identities=27%  Similarity=0.367  Sum_probs=33.1

Q ss_pred             eeeecceeeecCccCceEEEEEEEEecCCC----CCCCCCcccee
Q psy12427          9 NTRFTTMAITGLSPGHQYEFRVYAENVYGR----SDPSTTSDLIT   49 (356)
Q Consensus         9 ~~~~~~~~v~~L~p~~~y~frv~a~n~~g~----s~~s~~s~~~t   49 (356)
                      .+..++++|+||+|++.|.|||||.|..|.    |++|.+..+.|
T Consensus        58 ~~~~~~~~i~~L~p~t~Y~~rVra~~~~g~~g~wS~wS~~v~~~T  102 (104)
T d2b5ib2          58 KQKQEWICLETLTPDTQYEFQVRVKPLQGEFTTWSPWSQPLAFRT  102 (104)
T ss_dssp             CSCCCEEEECSCCTTCEEEEEEEEEESCCSSCCCCCCCCCEEEEC
T ss_pred             CCCcEEEEECCCCCCCEEEEEEEEEECCCCCCCCCCCcCCEEEEC
Confidence            356788999999999999999999999886    45555555554

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.20  E-value=2.7e-06  Score=77.11  Aligned_cols=76  Identities=21%  Similarity=0.220  Sum_probs=48.0

Q ss_pred             ccccccCceEEEEEEEccCCCEEEEEEccc----CC---hhhHHHHHHHHHHHHhcC-C-C-CceeeeeeEEeCCeEEEE
Q psy12427        114 EEIGTGAFGVVHRCRERKTGNIFAAKFIPV----SH---NLEKELIRKEIDIMNQLH-H-P-KLINLHDAFEDDDEMVLI  183 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~----~~---~~~~~~~~~E~~il~~l~-h-p-nIv~l~~~~~~~~~~~lv  183 (356)
                      +.||.|....||++.+..+++.+++|.-..    ..   .........|++.|+.+. + | .+++++.+  ++...++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            468999999999999887788999996432    11   112234556888888773 3 3 34555543  34556789


Q ss_pred             EEeccccc
Q psy12427        184 FEFLSGGE  191 (356)
Q Consensus       184 ~e~~~~g~  191 (356)
                      ||++.+..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997654

>d1x5za1 b.1.2.1 (A:8-109) Receptor-type tyrosine-protein phosphatase delta, PTPRD {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Receptor-type tyrosine-protein phosphatase delta, PTPRD
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.18  E-value=2.6e-07  Score=67.00  Aligned_cols=47  Identities=23%  Similarity=0.249  Sum_probs=39.5

Q ss_pred             ceEeeeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceec
Q psy12427          4 WIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT   50 (356)
Q Consensus         4 w~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~   50 (356)
                      |..+.....++++|+||+|++.|.|||+|.|..|.|.+|....+.|.
T Consensus        54 ~~~~~~~~~~~~~i~~L~p~t~Y~~~V~A~n~~G~g~~S~~v~~~T~  100 (102)
T d1x5za1          54 EQRITIEPGTSYRLQGLKPNSLYYFRLAARSPQGLGASTAEISARTM  100 (102)
T ss_dssp             CBCCEECSSSEEEEECCCTTCEEEECEEEECSSCEEEECCCEEEECC
T ss_pred             eEEEEcCCcCEEEECCCCCCCEEEEEEEEEcCCCEeCCCCCEEEEcC
Confidence            33344456789999999999999999999999999999988777664

>d1ujta_ b.1.2.1 (A:) KIAA1568 protein {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: KIAA1568 protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.16  E-value=8.6e-07  Score=66.29  Aligned_cols=50  Identities=20%  Similarity=0.240  Sum_probs=42.1

Q ss_pred             CceEeee--eeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceechh
Q psy12427          3 SWIRVGN--TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTKD   52 (356)
Q Consensus         3 ~w~~~~~--~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~~   52 (356)
                      .|..+..  ...++++|.||+|++.|.|||+|.|..|.|.+|....+.|.++
T Consensus        63 ~~~~~~v~~~~~~s~~i~~L~p~t~Y~f~V~A~n~~G~G~~S~~~~~~T~e~  114 (120)
T d1ujta_          63 SWQNLDAKVPTERSAVLVNLKKGVTYEIKVRPYFNEFQGMDSESKTVRTTEE  114 (120)
T ss_dssp             CCEEEECCCTTCCEEEEESCCSSEEEEEEEEEESSSCCCCCCCCEEEEECSS
T ss_pred             ceEEEEeccCceeEEEECCCCCCCEEEEEEEEEeCCcCcCCCCCEEEEeCCC
Confidence            4665532  5677899999999999999999999999999999888777654

>d1n26a3 b.1.2.1 (A:196-299) Interleukin-6 receptor alpha chain, domains 2 and 3 {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Interleukin-6 receptor alpha chain, domains 2 and 3
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.16  E-value=1.2e-06  Score=63.57  Aligned_cols=45  Identities=13%  Similarity=0.061  Sum_probs=37.5

Q ss_pred             CceEee-eeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccc
Q psy12427          3 SWIRVG-NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDL   47 (356)
Q Consensus         3 ~w~~~~-~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~   47 (356)
                      .|..+. ....++++|.+|.|++.|.|||||.|..|.|.+|.-|..
T Consensus        50 ~~~~~~~~~~~~~~~i~~L~p~t~Y~~rVra~n~~g~g~wSewS~~   95 (104)
T d1n26a3          50 TFTTWMVKDLQHHCVIHDAWSGLRHVVQLRAQEEFGQGEWSEWSPE   95 (104)
T ss_dssp             CCEEEECGGGCSEEEESSCCTTCCEEEEEEEEETTTBSCCCCCCCC
T ss_pred             ceeeeccccceEEEEECCCCCCCEEEEEEEEEeCCCccCCcCCcCC
Confidence            566654 366688999999999999999999999999888876543

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.14  E-value=1.3e-05  Score=67.46  Aligned_cols=74  Identities=14%  Similarity=0.103  Sum_probs=52.3

Q ss_pred             ccccC-ceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCC--CCceeeeeeEEeCCeEEEEEEeccccch
Q psy12427        116 IGTGA-FGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHH--PKLINLHDAFEDDDEMVLIFEFLSGGEL  192 (356)
Q Consensus       116 lg~G~-fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~~~~~lv~e~~~~g~L  192 (356)
                      +..|. .+.||++... .+..+++|.......   ..+..|+..|+.+..  -.+.+++.+...++..++||++++|.++
T Consensus        18 ~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             CSCTTSSCEEEEEECT-TSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             cCCcccCCeEEEEEeC-CCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            34444 4789988654 466788887654432   346678888887743  2356788888888899999999988765


Q ss_pred             h
Q psy12427        193 F  193 (356)
Q Consensus       193 ~  193 (356)
                      .
T Consensus        94 ~   94 (255)
T d1nd4a_          94 L   94 (255)
T ss_dssp             T
T ss_pred             c
Confidence            3

>d2b5ic1 b.1.2.1 (C:130-224) Cytokine receptor common gamma chain {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Cytokine receptor common gamma chain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.13  E-value=1.7e-06  Score=61.73  Aligned_cols=41  Identities=15%  Similarity=0.199  Sum_probs=33.6

Q ss_pred             CCceEeeeeeecceeeecCccCceEEEEEEEEecCCCCCCC
Q psy12427          2 SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPS   42 (356)
Q Consensus         2 ~~w~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s   42 (356)
                      ..|.....+..+++++.+|.|++.|.|||||.+..+.+..+
T Consensus        44 ~~~~~~~~~~~~~~~~~~L~p~t~Y~frVRa~~~~~~~~~g   84 (95)
T d2b5ic1          44 HSWTEQSVDYRHKFSLPSVDGQKRYTFRVRSRFNPLCGSAQ   84 (95)
T ss_dssp             SSCEEEEECSSCEEEECSCCTTSCEEEEEEEECCSSSCCCC
T ss_pred             ceeeEeeecccceeEcCCCCCCCEEEEEEEEeeCCCCCCCC
Confidence            45777666788999999999999999999999877654433

>d1uc6a_ b.1.2.1 (A:) Ciliary neurotrophic factor receptor alpha {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Ciliary neurotrophic factor receptor alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.12  E-value=4.1e-07  Score=66.70  Aligned_cols=46  Identities=26%  Similarity=0.249  Sum_probs=35.2

Q ss_pred             CCceEeeeeeecceeeecCccCceEEEEEEEEecCCC--CCCCCCccc
Q psy12427          2 SSWIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGR--SDPSTTSDL   47 (356)
Q Consensus         2 ~~w~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~--s~~s~~s~~   47 (356)
                      ..|..+.....++++|.+|.|++.|.|||||.|..+.  |++|++...
T Consensus        56 ~~~~~~~~~~~~~~~i~~L~~~t~Y~~rVrA~~~~~g~wS~WS~~~~~  103 (109)
T d1uc6a_          56 DQWQHVELSNGTAHTITDAYAGKEYIIQVAAKDNEIGTWSDWSVAAHA  103 (109)
T ss_dssp             CCCCCEEESSCSEEEETTCCSSSCEEEEEECCBSSSCCCCCCCEEEEE
T ss_pred             CceEEeccCCceeEEeCCCCCCCEEEEEEEEEECCCCCcCCCCCCEEe
Confidence            3577777788899999999999999999999886432  444544443

>d2ibga1 b.1.2.1 (A:573-667) Hedgehog receptor iHog {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Hedgehog receptor iHog
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=98.03  E-value=2e-06  Score=61.20  Aligned_cols=35  Identities=20%  Similarity=0.280  Sum_probs=31.6

Q ss_pred             eeeecceeeecCccCceEEEEEEEEecCCCCCCCC
Q psy12427          9 NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPST   43 (356)
Q Consensus         9 ~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~   43 (356)
                      ....++++|+||+|++.|.|||+|.|..|.|++|.
T Consensus        61 ~~~~~~~~i~~L~p~t~Y~~~V~A~n~~G~s~~Ss   95 (95)
T d2ibga1          61 GAHARSFKIAPLETATMYEFKLQSFSAASASEFSA   95 (95)
T ss_dssp             CTTCCEEEECSCCTTCEEEEEEEEECSSCBCCCCC
T ss_pred             CCceeEEEEeeccCCeEEEEEEEEEeCCccCCCCC
Confidence            35678899999999999999999999999999873

>d2vkwa2 b.1.2.1 (A:601-693) Neural cell adhesion molecule 1, NCAM {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Neural cell adhesion molecule 1, NCAM
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.03  E-value=1.1e-06  Score=62.34  Aligned_cols=34  Identities=26%  Similarity=0.336  Sum_probs=31.8

Q ss_pred             eeecceeeecCccCceEEEEEEEEecCCCCCCCC
Q psy12427         10 TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPST   43 (356)
Q Consensus        10 ~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~   43 (356)
                      ...++++|+||+|++.|.|||+|.|..|.|+|+.
T Consensus        53 ~~~~~~~i~~L~p~t~Y~~~V~A~N~~G~s~ps~   86 (93)
T d2vkwa2          53 SGSDHVMLKSLDWNAEYEVYVVAENQQGKSKAAH   86 (93)
T ss_dssp             TTCCEEEECSCCTTCEEEEEEEEEETTEECCCEE
T ss_pred             CCceEEEEeccccceEEEEEEEEEcCCCCcCCEe
Confidence            6778999999999999999999999999999985

>d2gysa2 b.1.2.1 (A:104-217) Common beta-chain in the GM-CSF, IL-3 and IL-5 receptors {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Common beta-chain in the GM-CSF, IL-3 and IL-5 receptors
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.01  E-value=2.3e-06  Score=63.07  Aligned_cols=40  Identities=25%  Similarity=0.139  Sum_probs=32.6

Q ss_pred             eeecceeeecCccCceEEEEEEEEecCCC------CCCCCCcccee
Q psy12427         10 TRFTTMAITGLSPGHQYEFRVYAENVYGR------SDPSTTSDLIT   49 (356)
Q Consensus        10 ~~~~~~~v~~L~p~~~y~frv~a~n~~g~------s~~s~~s~~~t   49 (356)
                      +..+++.+.+|.|++.|.|||||.|..|.      |++|++..+.|
T Consensus        65 ~~~~~~~~~~L~p~t~Y~~rVRa~~~~g~~~~g~wS~WS~~v~~~t  110 (114)
T d2gysa2          65 TSQATLGPEHLMPSSTYVARVRTRLAPGSRLSGRPSKWSPEVCWDS  110 (114)
T ss_dssp             SSEEEECTTTCCTTCEEEEEEEEEECTTSSCCBCCCCCCCCEEEEC
T ss_pred             CceEEEEeCCCCCCcEEEEEEEEEeCCCCCCCCCccCCcCCEeeeC
Confidence            67778999999999999999999999886      45555555544

>d1ueya_ b.1.2.1 (A:) KIAA0343 protein {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: KIAA0343 protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.01  E-value=2.8e-06  Score=63.83  Aligned_cols=47  Identities=38%  Similarity=0.449  Sum_probs=39.3

Q ss_pred             ceEee-eeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceec
Q psy12427          4 WIRVG-NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT   50 (356)
Q Consensus         4 w~~~~-~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~   50 (356)
                      |.... ....++++|.+|+|++.|.|||+|.|..|.|.+|..+...+.
T Consensus        64 ~~~~~~~~~~~~~~i~~L~p~t~Y~frV~A~n~~G~s~~S~~s~~~~t  111 (127)
T d1ueya_          64 WHHQTEVSGTQTTAQLNLSPYVNYSFRVMAVNSIGKSLPSEASEQYLT  111 (127)
T ss_dssp             EEEEEEEESSCCEEEECCCTTCEECCEEEEEESSCBCCCCSCCCCEEC
T ss_pred             EEEEeecCCceEEEECCCccCCEEEEEEEEEcCCcCcCCcCCcccEEc
Confidence            44343 467788999999999999999999999999999988776543

>d1fnha1 b.1.2.1 (A:3-92) Fibronectin, different Fn3 modules {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Fibronectin, different Fn3 modules
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.00  E-value=1.5e-06  Score=61.18  Aligned_cols=37  Identities=24%  Similarity=0.305  Sum_probs=33.1

Q ss_pred             eeeeecceeeecCccCceEEEEEEEEecCCCCCCCCC
Q psy12427          8 GNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTT   44 (356)
Q Consensus         8 ~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~   44 (356)
                      .....++++++||.|++.|.|||+|.|..|.|.++..
T Consensus        48 ~~~~~~~~~i~~L~p~t~Y~~~V~a~n~~g~s~~~~~   84 (90)
T d1fnha1          48 LAPDSSSVVVSGLMVATKYEVSVYALKDTLTSRPAQG   84 (90)
T ss_dssp             ECTTCCEEEECSCCTTCEEEEEEEEEETTEECCCEEE
T ss_pred             eCCCCeEEEEecccCceEEEEEEEEEeCCCCcCCEeE
Confidence            3477889999999999999999999999999998754

>d1cfba2 b.1.2.1 (A:710-814) Neuroglian, two amino proximal Fn3 repeats {Drosophila melanogaster [TaxId: 7227]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Neuroglian, two amino proximal Fn3 repeats
species: Drosophila melanogaster [TaxId: 7227]

Probab=98.00  E-value=2.5e-06  Score=61.95  Aligned_cols=47  Identities=19%  Similarity=0.194  Sum_probs=38.5

Q ss_pred             CceEee--eeeecceeeecCccCceEEEEEEEEecCCCCCCCCCcccee
Q psy12427          3 SWIRVG--NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLIT   49 (356)
Q Consensus         3 ~w~~~~--~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t   49 (356)
                      .|....  ....++++|++|.|++.|.|||+|.|..|.|.+|..+-+.+
T Consensus        52 ~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~A~N~~G~gp~S~~~v~~~  100 (105)
T d1cfba2          52 AWENNNIFDWRQNNIVIADQPTFVKYLIKVVAINDRGESNVAAEEVVGY  100 (105)
T ss_dssp             CCEEEEECCTTCCEEEECSCCSSCEEEEEEEEEETTEECSSCCCCEEEE
T ss_pred             ceeEEEecCCCccEEEECCCCCCCEEEEEEEEEeCCcCCCCCCCcEeEc
Confidence            354333  46678999999999999999999999999999998765543

>d1wfta_ b.1.2.1 (A:) Host cell factor 2, HCF-2 {Mouse (Mus musculus) [TaxId: 10090]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Host cell factor 2, HCF-2
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=98.00  E-value=8.1e-07  Score=66.68  Aligned_cols=43  Identities=16%  Similarity=0.076  Sum_probs=36.9

Q ss_pred             eeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceech
Q psy12427          9 NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK   51 (356)
Q Consensus         9 ~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~   51 (356)
                      ....++++|.+|+|++.|.|||+|.|..|.|.+|+...+.+..
T Consensus        74 ~~~~~~~~i~~L~p~t~Y~frV~A~N~~G~Gp~S~~~~~~t~~  116 (123)
T d1wfta_          74 TAGQLANAHIDYTSRPAIVFRISAKNEKGYGPATQIRWLQGNS  116 (123)
T ss_dssp             EHHHHTTCCCBCSSSCEEEEEEEEBSSSSBCCCEEEEEECCSC
T ss_pred             cCCccEEEEcCCCCCCEEEEEEEEecCCcCCCCCCcEEEEecC
Confidence            3455788999999999999999999999999998877776643

>d1fyhb1 b.1.2.1 (B:12-109) Interferon-gamma receptor alpha chain {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Interferon-gamma receptor alpha chain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.98  E-value=1.4e-06  Score=62.44  Aligned_cols=42  Identities=12%  Similarity=0.094  Sum_probs=37.4

Q ss_pred             eeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceech
Q psy12427         10 TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK   51 (356)
Q Consensus        10 ~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~   51 (356)
                      ...+.+++.+|.|++.|.|||+|.|..|.|.++++.+++..+
T Consensus        54 ~~~~~~~~~~l~~~~~Y~fRV~A~n~~g~S~ws~s~~f~~~~   95 (98)
T d1fyhb1          54 HHYCNISDHVGDPSNSLWVRVKARVGQKESAYAKSEEFAVCR   95 (98)
T ss_dssp             SSEEECGGGCCSTTSCEEEEEEEEETTEECCCEECCCBCHHH
T ss_pred             cceeeeEecccCCCCEEEEEEEEEcCCcccCCccCCCcEEee
Confidence            455678899999999999999999999999999999987653

>d1v5ja_ b.1.2.1 (A:) KIAA1355 {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: KIAA1355
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.98  E-value=8e-07  Score=65.07  Aligned_cols=48  Identities=31%  Similarity=0.378  Sum_probs=40.2

Q ss_pred             CceEeee---eeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceec
Q psy12427          3 SWIRVGN---TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT   50 (356)
Q Consensus         3 ~w~~~~~---~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~   50 (356)
                      .|..+..   ...++++|++|.|++.|.|||+|.|..|.|++|....+.|.
T Consensus        50 ~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~rV~A~n~~g~s~~S~~~~~~T~  100 (108)
T d1v5ja_          50 GWEVLDPAVAGTETELLVPGLIKDVLYEFRLVAFAGSFVSDPSNTANVSTS  100 (108)
T ss_dssp             CCEEEEEEECSSCCEEECCCCCTTSCEECCBEEEETTEEEEECSCCCCCCS
T ss_pred             eeeeccccccceeeeEEEEeccCCcEEEEEEEEEeCCCEeCCcCceEEECC
Confidence            4665543   46788999999999999999999999999999987776653

>d1uena_ b.1.2.1 (A:) KIAA0343 protein {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: KIAA0343 protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.98  E-value=1.6e-06  Score=64.92  Aligned_cols=44  Identities=23%  Similarity=0.179  Sum_probs=38.4

Q ss_pred             eeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceech
Q psy12427          8 GNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK   51 (356)
Q Consensus         8 ~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~   51 (356)
                      .....++++|.+|.|++.|.|||+|.|..|.|.+|....+.|.+
T Consensus        75 ~~~~~~~~~i~~L~p~t~Y~~~V~A~n~~G~g~~S~~~~~~T~~  118 (125)
T d1uena_          75 FQGSKTHGMLPGLEPFSHYTLNVRVVNGKGEGPASPDRVFNTPE  118 (125)
T ss_dssp             EESSCSEEEEESCCSSCEEEEEEEEEESSCEEEECCCEEEECCC
T ss_pred             eCCCccEEEECCCCCCCEEEEEEEEEeCCcccCCCCCEEEECCC
Confidence            34566789999999999999999999999999999888777754

>d1va9a1 b.1.2.1 (A:8-116) Down syndrome cell adhesion molecule-like protein 1, DSCAML1 {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Down syndrome cell adhesion molecule-like protein 1, DSCAML1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.97  E-value=1.9e-06  Score=62.85  Aligned_cols=41  Identities=22%  Similarity=0.118  Sum_probs=37.2

Q ss_pred             eeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceec
Q psy12427         10 TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT   50 (356)
Q Consensus        10 ~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~   50 (356)
                      ...++++|.+|+|++.|.|||+|.|..|.|.+|....+.|+
T Consensus        68 ~~~~~~~i~~L~p~t~Y~~~V~a~n~~G~g~~S~~v~~~T~  108 (109)
T d1va9a1          68 GDSEVYTLDNLKKFAQYGVVVQAFNRAGTGPSSSEINATTL  108 (109)
T ss_dssp             SSEEEEEEESCCSSCCEEEEEEEEETTEECCCCCCEECCCC
T ss_pred             CCeeEEEECCCCcceEEEEEEEEEcCCcCCCCCCCEEEEcC
Confidence            56789999999999999999999999999999988877664

>d1wfoa1 b.1.2.1 (A:8-124) Sidekick 2 {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Sidekick 2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.96  E-value=9.5e-07  Score=65.60  Aligned_cols=44  Identities=25%  Similarity=0.316  Sum_probs=36.6

Q ss_pred             EeeeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCcccee
Q psy12427          6 RVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLIT   49 (356)
Q Consensus         6 ~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t   49 (356)
                      .+.....++++|+||+|++.|.|||+|.|..|.|.+|....+.|
T Consensus        71 ~~~~~~~~~~~i~~L~p~t~Y~~~V~A~n~~G~g~~S~~~~~tT  114 (117)
T d1wfoa1          71 EVLAPSARQYTATGLKPESVYLFRITAQTRKGWGEAAEALVVTT  114 (117)
T ss_dssp             EEECTTCCEEEEESCCSSSEEEEEEEEECSSCEEEEEEEEEECC
T ss_pred             EecCCceEEEEECCCCCCCEEEEEEEEECCCcCCCCcCCEEEEC
Confidence            33456778999999999999999999999999999887655443

>d2fnba_ b.1.2.1 (A:) Fibronectin, different Fn3 modules {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Fibronectin, different Fn3 modules
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.94  E-value=3.8e-06  Score=59.64  Aligned_cols=35  Identities=31%  Similarity=0.511  Sum_probs=31.6

Q ss_pred             eeeecceeeecCccCceEEEEEEEEecCCCCCCCC
Q psy12427          9 NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPST   43 (356)
Q Consensus         9 ~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~   43 (356)
                      ....++++|+||.||+.|.|||+|.|..|.|.|+.
T Consensus        56 ~~~~t~~~i~~L~p~t~Y~~~V~a~~~~g~s~p~~   90 (95)
T d2fnba_          56 DSSVGYYTVTGLEPGIDYDISVITLINGGESAPTT   90 (95)
T ss_dssp             CSSCSEEEECCCCTTSEEEEEEEEEETTEECCCCE
T ss_pred             CCCCeEEEEecccCCEEEEEEEEEEeCCcEeCCEE
Confidence            46778999999999999999999999999888774

>d2dn7a1 b.1.2.1 (A:8-101) Receptor-type tyrosine-protein phosphatase F, PTPRF {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Receptor-type tyrosine-protein phosphatase F, PTPRF
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.91  E-value=1.5e-06  Score=61.67  Aligned_cols=41  Identities=24%  Similarity=0.310  Sum_probs=34.8

Q ss_pred             CceEee-eeeecceeeecCccCceEEEEEEEEecCCCCCCCC
Q psy12427          3 SWIRVG-NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPST   43 (356)
Q Consensus         3 ~w~~~~-~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~   43 (356)
                      .|..+. ....++++|++|.|++.|.|||+|.|..|.|+++.
T Consensus        44 ~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~A~n~~G~g~~s~   85 (94)
T d2dn7a1          44 RPNTIDFGKDDQHFTVTGLHKGTTYIFRLAAKNRAGLGEEFE   85 (94)
T ss_dssp             SCEEEEEETTCCEEEEECCCTTCEEEEEEEEEETTEEEEEEE
T ss_pred             CcEEEEcCCCccEEEEEccCCeeEEEEEEEEEcCCcCCCCcc
Confidence            455443 46778999999999999999999999999998775

>d1x4ya1 b.1.2.1 (A:8-108) Brother of CDO precursor (BOC) {Mouse (Mus musculus) [TaxId: 10090]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Brother of CDO precursor (BOC)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=97.91  E-value=4.9e-06  Score=59.74  Aligned_cols=42  Identities=21%  Similarity=0.147  Sum_probs=37.4

Q ss_pred             eeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceec
Q psy12427          9 NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT   50 (356)
Q Consensus         9 ~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~   50 (356)
                      ....++++|++|+|++.|.|||+|.|..|.|.+|......|.
T Consensus        58 ~~~~~~~~i~~L~p~t~Y~~~v~a~n~~G~s~~S~~~~~~T~   99 (101)
T d1x4ya1          58 EGDRYWHSISHLQPETSYDIKMQCFNEGGESEFSNVMICETK   99 (101)
T ss_dssp             ETTCCEEEECSCCTTCEEEEEEEEECTTCCCCCCCCEEEECC
T ss_pred             cCCeeEEEEcCCCCCCEEEEEEEEEcCCCCCCCCCcEEEEcc
Confidence            456788999999999999999999999999999988777653

>d1qg3a2 b.1.2.1 (A:1218-1320) Integrin beta-4 subunit {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Integrin beta-4 subunit
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.90  E-value=2.3e-06  Score=61.77  Aligned_cols=37  Identities=22%  Similarity=0.285  Sum_probs=32.5

Q ss_pred             eeeecceeeecCccCceEEEEEEEEecCCCCCCCCCc
Q psy12427          9 NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTS   45 (356)
Q Consensus         9 ~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s   45 (356)
                      ....++++|+||+|++.|.|||+|.|..|.|.++...
T Consensus        60 ~~~~~~~~i~~L~p~t~Y~~~V~A~n~~G~g~~s~~~   96 (103)
T d1qg3a2          60 NPKNRMLLIENLRESQPYRYTVKARNGAGWGPEREAI   96 (103)
T ss_dssp             CTTCCEEEECCCCTTCCEEEEEEEEETTEECCCEEEE
T ss_pred             CCCceEEEEeecCCCCEEEEEEEEEcCCccCCCcccc
Confidence            3666789999999999999999999999999877644

>d1bqua2 b.1.2.1 (A:100-214) Cytokine receptor gp130 cytokine-binding domains {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Cytokine receptor gp130 cytokine-binding domains
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.84  E-value=4.7e-06  Score=61.36  Aligned_cols=39  Identities=21%  Similarity=0.261  Sum_probs=33.8

Q ss_pred             eeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccc
Q psy12427          9 NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDL   47 (356)
Q Consensus         9 ~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~   47 (356)
                      ....++++|++|.|++.|.|||+|.|..|.|.+|..++.
T Consensus        61 ~~~~~~~~i~~L~~~t~Y~~~V~a~~~~G~g~~S~~S~~   99 (115)
T d1bqua2          61 ASTRSSFTVQDLKPFTEYVFRIRCMKEDGKGYWSDWSEE   99 (115)
T ss_dssp             CSCCSEEEECSCCSSEEEEEEEEEEETTSCSCCCCCCCC
T ss_pred             cccccEEeeCCCccCcEEEEEEEEEeCCCccCCcCCcCC
Confidence            356689999999999999999999999999887776653

>d1x5ha1 b.1.2.1 (A:8-126) Neogenin {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Neogenin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.84  E-value=1.6e-06  Score=64.51  Aligned_cols=43  Identities=26%  Similarity=0.319  Sum_probs=37.9

Q ss_pred             eeeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceech
Q psy12427          9 NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITTK   51 (356)
Q Consensus         9 ~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~~   51 (356)
                      ....++++++||+|++.|.|||+|.|..|.|.+|....+.|.+
T Consensus        66 ~~~~~~~~i~~L~p~t~Y~~~V~A~n~~G~G~~S~~~~~~T~~  108 (119)
T d1x5ha1          66 SGTQLSQLIEGLDRGTEYNFRVAALTINGTGPATDWLSAETFE  108 (119)
T ss_dssp             CTTCCEEEEECCCSSCEEEEECEEEETTEEEEECCCEEEECCS
T ss_pred             CCCccEEEeCCCCCCCEEEEEEEEEcCCcCCCCCCCEEEEeCC
Confidence            3567889999999999999999999999999999888777754

>d1tdqa2 b.1.2.1 (A:94-185) Tenascin {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Tenascin
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=97.79  E-value=5.7e-06  Score=58.13  Aligned_cols=35  Identities=29%  Similarity=0.298  Sum_probs=31.1

Q ss_pred             eeeecceeeecCccCceEEEEEEEEecCCCCCCCC
Q psy12427          9 NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPST   43 (356)
Q Consensus         9 ~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~   43 (356)
                      ....++++|+||.|++.|.|||+|.|..|.|.|+.
T Consensus        52 ~~~~~~~~i~~L~p~t~Y~~~V~a~~~~g~s~p~~   86 (92)
T d1tdqa2          52 IGPTTKTTLTDLVPGTEYGVGISAVMNSKQSIPAT   86 (92)
T ss_dssp             SSSEEEEEECSCCTTCEEEEEEEEEETTEECCCEE
T ss_pred             CCCeeEEEECCccCCCEEEEEEEEEeCCCEecCEE
Confidence            35668899999999999999999999999988763

>d2cuma1 b.1.2.1 (A:7-99) Tenascin-X {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Tenascin-X
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.77  E-value=8.7e-06  Score=57.41  Aligned_cols=36  Identities=22%  Similarity=0.185  Sum_probs=31.9

Q ss_pred             eeeeecceeeecCccCceEEEEEEEEecCCCCCCCC
Q psy12427          8 GNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPST   43 (356)
Q Consensus         8 ~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~   43 (356)
                      .....++++++||.||+.|.|+|+|.|..|.|.++.
T Consensus        48 ~~~~~~~~~i~~L~p~t~Y~~~V~a~~~~g~s~~~~   83 (93)
T d2cuma1          48 LPGGITSHQLLGLFPSTSYNARLQAMWGQSLLPPVS   83 (93)
T ss_dssp             ECSSCSEEEECSCCTTCEEEEEEEEEBTTBCCCCEE
T ss_pred             ECCCccEEEEeCccCCCEEEEEEEEEeCCCCCCCEE
Confidence            356778999999999999999999999999888754

>d1erna2 b.1.2.1 (A:117-221) Erythropoietin (EPO) receptor {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Erythropoietin (EPO) receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.77  E-value=1.2e-05  Score=58.13  Aligned_cols=40  Identities=23%  Similarity=0.121  Sum_probs=30.2

Q ss_pred             eeeecceeeecCccCceEEEEEEEEecC--CC---CCCCCCccce
Q psy12427          9 NTRFTTMAITGLSPGHQYEFRVYAENVY--GR---SDPSTTSDLI   48 (356)
Q Consensus         9 ~~~~~~~~v~~L~p~~~y~frv~a~n~~--g~---s~~s~~s~~~   48 (356)
                      ....|++.|.+|.|++.|.|||||.+..  +.   |++|++..+.
T Consensus        59 ~~~~t~~~i~~L~p~t~Y~~rVRar~~~~~~~G~WSeWS~~v~~~  103 (105)
T d1erna2          59 LEGRTECVLSNLRGRTRYTFAVRARMAEPSFGGFWSAWSEPVSLL  103 (105)
T ss_dssp             CTTCCEEEECSCCSSCEEEEEEEEEECSSSCCBCCCCCCCCEEEE
T ss_pred             cCCccEEEEeCCCCCcEEEEEEEEEECCCCCCCCCCCCCCCEEee
Confidence            3566889999999999999999999653  22   5566655444

>d1j8ka_ b.1.2.1 (A:) Fibronectin, different Fn3 modules {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Fibronectin, different Fn3 modules
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.76  E-value=6.5e-06  Score=58.17  Aligned_cols=36  Identities=28%  Similarity=0.340  Sum_probs=31.4

Q ss_pred             eeeeecceeeecCccCceEEEEEEEEecCCCCCCCC
Q psy12427          8 GNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPST   43 (356)
Q Consensus         8 ~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~   43 (356)
                      .....++++|+||.||+.|.|||+|.|..|.|.|..
T Consensus        50 ~~~~~~~~~i~~L~p~t~Y~~~V~a~~~~g~S~p~~   85 (94)
T d1j8ka_          50 PDGEEDTAELQGLRPGSEYTVSVVALHDDMESQPLI   85 (94)
T ss_dssp             CCSSCCEEEECSCCCCSEEEEEEEECSSSCCCCCEE
T ss_pred             cCCCccEEEECCCCCCCEEEEEEEEEeCCCCcCCEE
Confidence            346788999999999999999999999999877653

>d1tdqa3 b.1.2.1 (A:186-271) Tenascin {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Tenascin
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=97.75  E-value=6.3e-06  Score=57.33  Aligned_cols=39  Identities=28%  Similarity=0.283  Sum_probs=33.8

Q ss_pred             eeeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCc
Q psy12427          7 VGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTS   45 (356)
Q Consensus         7 ~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s   45 (356)
                      ......++++++||.||+.|.|+|+|.|..|.|.|+..+
T Consensus        46 ~~~~~~~~~~~~~L~p~t~Y~v~V~a~~~~~~s~p~~~~   84 (86)
T d1tdqa3          46 TVPRDRTSYTLTDLEPGAEYIISITAERGRQQSLESTVD   84 (86)
T ss_dssp             EEESSCSEEEECCCCTTCCEEEEEEEEETTEECCCEEEE
T ss_pred             EeCCCccEEEECCCccccEEEEEEEEEcCCCEECCEEee
Confidence            345778899999999999999999999999988887543

>d1qr4a2 b.1.2.1 (A:88-175) Tenascin {Chicken (Gallus gallus) [TaxId: 9031]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Tenascin
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.75  E-value=9.9e-06  Score=56.52  Aligned_cols=40  Identities=20%  Similarity=0.287  Sum_probs=33.4

Q ss_pred             ceEee-eeeecceeeecCccCceEEEEEEEEecCCCCCCCC
Q psy12427          4 WIRVG-NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPST   43 (356)
Q Consensus         4 w~~~~-~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~   43 (356)
                      |.... ....++++++||.|++.|.|+|+|.|..|.|+|..
T Consensus        43 ~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~a~~~~g~s~p~~   83 (88)
T d1qr4a2          43 PNVVTVDGSKTRTKLVKLVPGVDYNVNIISVKGFEESEPIS   83 (88)
T ss_dssp             CEEEEEETTCCEEEECSCCSSCEEEEEEEEEETTEECCCEE
T ss_pred             eEEEEecCCccEEEECCCCCCCEEEEEEEEEeCCCCcCCEE
Confidence            44333 46778999999999999999999999999888743

>d1wfna1 b.1.2.1 (A:8-113) Sidekick 2 {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Sidekick 2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.75  E-value=3.5e-06  Score=61.18  Aligned_cols=38  Identities=21%  Similarity=0.209  Sum_probs=32.8

Q ss_pred             eeeeecceeeecCccCceEEEEEEEEecCCCCCCCCCc
Q psy12427          8 GNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTS   45 (356)
Q Consensus         8 ~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s   45 (356)
                      .....++++|+||+|++.|.|||+|.|..|.|.+|...
T Consensus        62 ~~~~~~~~~i~~L~p~t~Y~~~V~A~n~~G~g~~s~~~   99 (106)
T d1wfna1          62 LPNVTLEYRVTGLTALTTYTIEVAAMTSKGQGQVSAST   99 (106)
T ss_dssp             ECSSCCEEEEESCCTTCEEEEEEEEECSSCEEEEEEEE
T ss_pred             cCCCeeEEEEccCCCCCEEEEEEEEECCCCCcCCcCCE
Confidence            34666789999999999999999999999998877643

>d1x5ia1 b.1.2.1 (A:8-120) Neogenin {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Neogenin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.74  E-value=8.2e-06  Score=59.92  Aligned_cols=41  Identities=20%  Similarity=0.151  Sum_probs=34.6

Q ss_pred             ceEeeeeeecceeeecCccCceEEEEEEEEecCCCCCCCCC
Q psy12427          4 WIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTT   44 (356)
Q Consensus         4 w~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~   44 (356)
                      |........+++++.+|+|++.|.|||+|.|..|.|.+...
T Consensus        65 ~~~~~~~~~~~~~i~~L~p~t~Y~~~V~A~n~~G~g~~~~~  105 (113)
T d1x5ia1          65 QTIKVDYKQRYYTIENLDPSSHYVITLKAFNNVGEGIPLYE  105 (113)
T ss_dssp             EEEECCTTCCEEEECSCCSSCEECCEEEEECSSCBCCCCCC
T ss_pred             eeeeeeCCccEEEEeccccCcEEEEEEEEECCCcCCCCeee
Confidence            34444567889999999999999999999999999987653

>d2gysa4 b.1.2.1 (A:317-416) Common beta-chain in the GM-CSF, IL-3 and IL-5 receptors {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Common beta-chain in the GM-CSF, IL-3 and IL-5 receptors
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.74  E-value=1.8e-05  Score=56.60  Aligned_cols=30  Identities=23%  Similarity=0.261  Sum_probs=27.2

Q ss_pred             eeeecceeeecCccCceEEEEEEEEecCCC
Q psy12427          9 NTRFTTMAITGLSPGHQYEFRVYAENVYGR   38 (356)
Q Consensus         9 ~~~~~~~~v~~L~p~~~y~frv~a~n~~g~   38 (356)
                      ....++++|.+|+||+.|.|||||.+..|.
T Consensus        57 ~~~~~~~~l~~L~p~t~Y~~rVRa~~~~g~   86 (100)
T d2gysa4          57 LQNAHSMALPALEPSTRYWARVRVRTSRTG   86 (100)
T ss_dssp             EESCSEEECCCCCSSCCCEEEEEEEECCTT
T ss_pred             cCCceEEEeCCCCCCCeEEEEEEEEECCCC
Confidence            467899999999999999999999998875

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.74  E-value=6.3e-05  Score=67.79  Aligned_cols=73  Identities=18%  Similarity=0.193  Sum_probs=50.7

Q ss_pred             ccccccCceEEEEEEEcc-------CCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCc-eeeeeeEEeCCeEEEEEE
Q psy12427        114 EEIGTGAFGVVHRCRERK-------TGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKL-INLHDAFEDDDEMVLIFE  185 (356)
Q Consensus       114 ~~lg~G~fg~V~~~~~~~-------~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~~~lv~e  185 (356)
                      +.|+.|-.-.+|++....       .+..+.+++.-...  ......+|..+++.+.-.++ .++++++.+    .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            578999999999998753       24567777764222  22345579999998853344 467777643    68899


Q ss_pred             eccccch
Q psy12427        186 FLSGGEL  192 (356)
Q Consensus       186 ~~~~g~L  192 (356)
                      |++|..|
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9988655

>d2cspa1 b.1.2.1 (A:8-124) Rim binding protein 2 {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Rim binding protein 2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.72  E-value=2.9e-06  Score=62.94  Aligned_cols=41  Identities=15%  Similarity=0.068  Sum_probs=36.2

Q ss_pred             eeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceec
Q psy12427         10 TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT   50 (356)
Q Consensus        10 ~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~   50 (356)
                      ...++++|+||+|++.|.|||+|.|..|.|.+|.+..+.+.
T Consensus        68 ~~~~~~~i~~L~~~t~Y~v~V~A~n~~G~s~~S~~v~i~t~  108 (117)
T d2cspa1          68 ADSTAVELVRLRSLEAKGVTVRTLSAQGESVDSAVAAVPPE  108 (117)
T ss_dssp             CSEEEEESHHHHHHTCSCBEEEEEESSCCCCCCSCBCCCHH
T ss_pred             cceeeeeccCCCCCcEEEEEEEEEcCCCcCCCCCCEEeeCC
Confidence            55678889999999999999999999999999988776654

>d1fnfa3 b.1.2.1 (A:1327-1415) Fibronectin, different Fn3 modules {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Fibronectin, different Fn3 modules
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.70  E-value=1.5e-05  Score=55.68  Aligned_cols=35  Identities=23%  Similarity=0.282  Sum_probs=30.8

Q ss_pred             eeeecceeeecCccCceEEEEEEEEecCCCCCCCC
Q psy12427          9 NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPST   43 (356)
Q Consensus         9 ~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~   43 (356)
                      ....++++|++|+|++.|.|||+|.|..|.|.|..
T Consensus        50 ~~~~~~~~i~~L~p~t~Y~~~V~a~~~~g~s~p~~   84 (89)
T d1fnfa3          50 PHSRNSITLTNLTPGTEYVVSIVALNGREESPLLI   84 (89)
T ss_dssp             ETTCCEEEEESCCTTCEEEEEEEEEETTEECCCEE
T ss_pred             CCCccEEEECCCcccCEEEEEEEEEcCCcCcCCEE
Confidence            46788999999999999999999999999877643

>d1fnaa_ b.1.2.1 (A:) Fibronectin, different Fn3 modules {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Fibronectin, different Fn3 modules
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.70  E-value=1.7e-05  Score=55.56  Aligned_cols=36  Identities=36%  Similarity=0.512  Sum_probs=32.1

Q ss_pred             eeeecceeeecCccCceEEEEEEEEecCCCCCCCCC
Q psy12427          9 NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTT   44 (356)
Q Consensus         9 ~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~   44 (356)
                      ....++++|+||.||+.|.|+|+|.|..|.|.++..
T Consensus        46 ~~~~t~~~l~~L~p~t~Y~~~V~a~~~~g~s~~~s~   81 (91)
T d1fnaa_          46 PGSKSTATISGLKPGVDYTITVYAVTGRGDSPASSK   81 (91)
T ss_dssp             ETTCCEEEECSCCTTCEEEEEEEEECTTCCSSCSCC
T ss_pred             CCCccEEEeCCCCCCCEEEEEEEEEeCCccCCCcCC
Confidence            467789999999999999999999999999887653

>d1fnha2 b.1.2.1 (A:93-182) Fibronectin, different Fn3 modules {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Fibronectin, different Fn3 modules
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.67  E-value=1.5e-05  Score=55.76  Aligned_cols=40  Identities=33%  Similarity=0.513  Sum_probs=33.3

Q ss_pred             ceEee-eeeecceeeecCccCceEEEEEEEEecCCCCCCCC
Q psy12427          4 WIRVG-NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPST   43 (356)
Q Consensus         4 w~~~~-~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~   43 (356)
                      |.... ....+.+++++|+||+.|.|+|+|.|..|.|.|..
T Consensus        44 ~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~a~~~~g~s~p~~   84 (90)
T d1fnha2          44 PIQRTIKPDVRSYTITGLQPGTDYKIYLYTLNDNARSSPVV   84 (90)
T ss_dssp             CEEEECCTTCSEEEEESCCTTCEEEEEEEEEETTEECCCEE
T ss_pred             eEEEecCCCccEEEeCCCCCCcEEEEEEEEEeCCCCcCCEE
Confidence            44333 47789999999999999999999999999887543

>d1qr4a1 b.1.2.1 (A:1-87) Tenascin {Chicken (Gallus gallus) [TaxId: 9031]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Tenascin
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.65  E-value=1.6e-05  Score=55.24  Aligned_cols=35  Identities=29%  Similarity=0.470  Sum_probs=31.3

Q ss_pred             eeeecceeeecCccCceEEEEEEEEecCCCCCCCC
Q psy12427          9 NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPST   43 (356)
Q Consensus         9 ~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~   43 (356)
                      ....++++++||.||+.|.|+|+|.+..|.|.|+.
T Consensus        47 ~~~~~~~~~~~L~p~t~Y~v~V~a~~~~~~s~~~~   81 (87)
T d1qr4a1          47 PVDSTSFILRGLDAGTEYTISLVAEKGRHKSKPTT   81 (87)
T ss_dssp             CTTCSEEEEESCCSSCEEEEEEEEESSSCBCCCEE
T ss_pred             CCCcCEEEECCCCcCCEEEEEEEEEcCCCCccCEE
Confidence            46778999999999999999999999999887754

>d1tdqa1 b.1.2.1 (A:1-93) Tenascin {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Tenascin
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=97.63  E-value=1.2e-05  Score=56.69  Aligned_cols=36  Identities=25%  Similarity=0.396  Sum_probs=32.0

Q ss_pred             eeeeecceeeecCccCceEEEEEEEEecCCCCCCCC
Q psy12427          8 GNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPST   43 (356)
Q Consensus         8 ~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~   43 (356)
                      .....++++++||+||+.|.|+|+|.|..|.|.++.
T Consensus        52 ~~~~~~~~~i~~L~p~t~Y~v~V~a~~~~g~s~~~~   87 (93)
T d1tdqa1          52 LQPPLSQYSVQALRPGSRYEVSISAVRGTNESDASS   87 (93)
T ss_dssp             ECTTCSEEEECSCCTTCEEEEEEEEEETTEECCCEE
T ss_pred             eCCCceEEEEeCcccceEEEEEEEEEeCCCCcCCEE
Confidence            346678999999999999999999999999988764

>d1fnha3 b.1.2.1 (A:183-271) Fibronectin, different Fn3 modules {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Fibronectin, different Fn3 modules
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.63  E-value=8.3e-06  Score=56.97  Aligned_cols=32  Identities=38%  Similarity=0.573  Sum_probs=28.6

Q ss_pred             eeecceeeecCccCceEEEEEEEEecCCCCCC
Q psy12427         10 TRFTTMAITGLSPGHQYEFRVYAENVYGRSDP   41 (356)
Q Consensus        10 ~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~   41 (356)
                      ...++++|+||.||+.|.|||+|.|..|.|.|
T Consensus        51 ~~~~~~~~~~L~p~t~Y~~~V~a~n~~g~S~p   82 (89)
T d1fnha3          51 PGVTEATITGLEPGTEYTIYVIALKNNQKSEP   82 (89)
T ss_dssp             TTCCEEEEESCCTTCEEEEEEEEESSSCEEEE
T ss_pred             CCccEEEEEeeeCCCEEEEEEEEEcCCCEeCC
Confidence            56778999999999999999999999887654

>d1tena_ b.1.2.1 (A:) Tenascin {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Tenascin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.62  E-value=1.9e-05  Score=55.19  Aligned_cols=35  Identities=20%  Similarity=0.303  Sum_probs=31.5

Q ss_pred             eeeecceeeecCccCceEEEEEEEEecCCCCCCCC
Q psy12427          9 NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPST   43 (356)
Q Consensus         9 ~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~   43 (356)
                      ....++++|.||+||+.|.|+|+|.|..|.|.++.
T Consensus        51 ~~~~~~~~i~~L~p~t~Y~~~V~a~~~~g~s~~~~   85 (90)
T d1tena_          51 TEDENQYSIGNLKPDTEYEVSLISRRGDMSSNPAK   85 (90)
T ss_dssp             ETTCCEEEECSCCTTCEEEEEEEEEETTEECCCEE
T ss_pred             cCCcceeeEeeecCCCEEEEEEEEEeCCCEeCCEE
Confidence            46788999999999999999999999999888753

>d2cuha1 b.1.2.1 (A:8-109) Tenascin-X {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Tenascin-X
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.61  E-value=1.8e-05  Score=56.74  Aligned_cols=40  Identities=10%  Similarity=0.007  Sum_probs=33.8

Q ss_pred             ceEeeeeeecceeeecCccCceEEEEEEEEecCCCCCCCC
Q psy12427          4 WIRVGNTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPST   43 (356)
Q Consensus         4 w~~~~~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~   43 (356)
                      |........++++++||+||+.|.|+|+|.|..|.|.++.
T Consensus        43 ~~~~~~~~~~~~~l~~L~p~t~Y~~~V~a~~~~~~s~~~~   82 (102)
T d2cuha1          43 LQAETPGSAVDYPLHDLVLHTNYTATVRGLRGPNLTSPAS   82 (102)
T ss_dssp             EEEEEETTCSEEEECSCCSSSEEEEEEEEEETTEECCCEE
T ss_pred             eeeeeeeeeeeEEEccEEeeEEEEEEEEEEeCCCCcCCEE
Confidence            4444567788999999999999999999999988887654

>d1wj3a_ b.1.2.1 (A:) Contactin 3 (KIAA1496) {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Contactin 3 (KIAA1496)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.60  E-value=3e-05  Score=57.11  Aligned_cols=40  Identities=20%  Similarity=0.046  Sum_probs=34.0

Q ss_pred             eecceeeecCccCceEEEEEEEEecCCCCCCCCCccceec
Q psy12427         11 RFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT   50 (356)
Q Consensus        11 ~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~   50 (356)
                      ..+++++.+|.|++.|.|||+|.|..|.|.+|++..+.+.
T Consensus        70 ~~~~~~~~~L~p~t~Y~~~V~A~n~~G~G~~S~~v~v~~~  109 (117)
T d1wj3a_          70 TNKTSAELVLPIKEDYIIEVKATTDGGDGTSSEQIRIPRI  109 (117)
T ss_dssp             ESSSEEEEECCCSSCEEEEEEEEESSCCCCBCCCEEECCC
T ss_pred             ceeeEEEeeccCCcEEEEEEEEEcCCccCCCCCCEEEecc
Confidence            4567888999999999999999999999999987665443

>d2cuia1 b.1.2.1 (A:6-106) Tenascin-X {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Tenascin-X
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.59  E-value=8.8e-06  Score=58.27  Aligned_cols=34  Identities=15%  Similarity=0.241  Sum_probs=30.4

Q ss_pred             eeecceeeecCccCceEEEEEEEEecCCCCCCCC
Q psy12427         10 TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPST   43 (356)
Q Consensus        10 ~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~   43 (356)
                      ...++++|+||+|++.|.|+|+|.|..|.|.++.
T Consensus        62 ~~~~~~~v~~L~p~t~Y~~~V~a~~~~g~g~~~~   95 (101)
T d2cuia1          62 GTRHSAVLRDLRSGTLYSLTLYGLRGPHKADSIQ   95 (101)
T ss_dssp             TTCCEEEECSCCTTCEEEEEEEEECSSSEEEEEE
T ss_pred             cceeEEEeCCCCcCCEEEEEEEEEeCCcEeCCeE
Confidence            5678899999999999999999999999887654

>d1owwa_ b.1.2.1 (A:) Fibronectin, different Fn3 modules {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Fibronectin, different Fn3 modules
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.58  E-value=1.8e-05  Score=55.87  Aligned_cols=41  Identities=24%  Similarity=0.518  Sum_probs=34.0

Q ss_pred             CceEee-eeeecceeeecCccCceEEEEEEEEecCCCCCCCC
Q psy12427          3 SWIRVG-NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPST   43 (356)
Q Consensus         3 ~w~~~~-~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~   43 (356)
                      .|..+. ....++++|+||+||+.|.|+|.|.|..|.|+++.
T Consensus        45 ~~~~~~v~~~~~~~~l~gL~P~t~Y~v~v~av~~~G~s~~~~   86 (93)
T d1owwa_          45 RWKEATIPGHLNSYTIKGLKPGVVYEGQLISIQQYGHQEVTR   86 (93)
T ss_dssp             CCEEEEECSSCCEEEECSCCSSEEEEEEEEEEESSSCEEEEE
T ss_pred             eeeeeccCCCccEEEECCcccCcEEEEEEEEEeCCCccCcEE
Confidence            355443 46778899999999999999999999999887664

>d2dtge1 b.1.2.1 (E:808-909) Insulin receptor {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Insulin receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.56  E-value=6.1e-06  Score=59.47  Aligned_cols=40  Identities=25%  Similarity=0.386  Sum_probs=35.5

Q ss_pred             eeecceeeecCccCceEEEEEEEEecCCCCCCCCCccceec
Q psy12427         10 TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTSDLITT   50 (356)
Q Consensus        10 ~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s~~~t~   50 (356)
                      ...+++.+.+|+|++ |.|||+|.|..|.|.+|.+..+.+.
T Consensus        60 ~~~~~~~~~~L~~~t-Y~~rV~A~n~~G~g~~S~~v~f~~~   99 (102)
T d2dtge1          60 ALERGCRLRGLSPGN-YSVRIRATSLAGNGSWTEPTYFYVT   99 (102)
T ss_dssp             CCTTCCCCCSCCSSE-ECCCCCEEETTBCCCCCCCCEECCC
T ss_pred             cceEEEEEeccceee-EEEEEEEEcCCccCCCCCCEEEEcc
Confidence            566779999999985 9999999999999999998887763

>d1fnfa2 b.1.2.1 (A:1236-1326) Fibronectin, different Fn3 modules {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Fibronectin, different Fn3 modules
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.55  E-value=2.7e-05  Score=54.42  Aligned_cols=34  Identities=24%  Similarity=0.300  Sum_probs=30.0

Q ss_pred             eeeecceeeecCccCceEEEEEEEEecCCCCCCC
Q psy12427          9 NTRFTTMAITGLSPGHQYEFRVYAENVYGRSDPS   42 (356)
Q Consensus         9 ~~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s   42 (356)
                      ....++++|+||+|++.|.|+|+|.|..|.|.|.
T Consensus        51 ~~~~~~~~i~~L~p~t~Y~~~V~a~~~~g~S~p~   84 (91)
T d1fnfa2          51 SPSDNAVVLTNLLPGTEYVVSVSSVYEQHESTPL   84 (91)
T ss_dssp             CTTCCEEEECSCCTTCEEEEEEEEEETTEECCCE
T ss_pred             CCCceEEEEeceeCCCEEEEEEEEEcCCCCCCCE
Confidence            3567899999999999999999999999987754

>d1cd9b1 b.1.2.1 (B:1-107) Granulocyte colony-stimulating factor (GC-SF) receptor {Mouse (Mus musculus) [TaxId: 10090]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Granulocyte colony-stimulating factor (GC-SF) receptor
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=97.42  E-value=2.4e-05  Score=56.57  Aligned_cols=32  Identities=22%  Similarity=0.192  Sum_probs=28.8

Q ss_pred             eeecceeeecCccCceEEEEEEEEecCCCCCC
Q psy12427         10 TRFTTMAITGLSPGHQYEFRVYAENVYGRSDP   41 (356)
Q Consensus        10 ~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~   41 (356)
                      ...+++++.+|.|++.|.|||+|.|..|.|.+
T Consensus        65 ~~~~~~~~~~L~~~t~Y~frV~A~N~~G~s~S   96 (107)
T d1cd9b1          65 QNNCSIPRKNLLLYQYMAIWVQAENMLGSSES   96 (107)
T ss_dssp             CCEEEEEGGGCCTTSCEEEEEEEEETTEEEEC
T ss_pred             ccccEEEcCCCCcCceEEEEEEEEeCCccccC
Confidence            45688999999999999999999999999863

>d2dtge3 b.1.2.1 (E:468-592) Insulin receptor {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Insulin receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.42  E-value=2.3e-05  Score=58.46  Aligned_cols=38  Identities=21%  Similarity=0.276  Sum_probs=30.6

Q ss_pred             eeecceeeecCccCceEEEEEEEEecCCCCC--CCCCccc
Q psy12427         10 TRFTTMAITGLSPGHQYEFRVYAENVYGRSD--PSTTSDL   47 (356)
Q Consensus        10 ~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~--~s~~s~~   47 (356)
                      ...++++|+||+|++.|.|||+|.|..|.+.  ++..|+.
T Consensus        79 ~~~~~~~l~~L~p~T~Y~~~V~A~n~~G~~~~~~g~~S~~  118 (125)
T d2dtge3          79 QNHPGWLMRGLKPWTQYAIFVKTLVTFSDERRTYGAKSDI  118 (125)
T ss_dssp             SSCCEEEECSCCSSCBCCBEEEECCCCCSSCCCCCCBCCC
T ss_pred             CccCEEEECCCccCCEEEEEEEEEeCCCccCCCCCCCccc
Confidence            4678899999999999999999999999643  2444443

>d1fnfa1 b.1.2.1 (A:1142-1235) Fibronectin, different Fn3 modules {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Fibronectin, different Fn3 modules
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.29  E-value=6.8e-05  Score=52.82  Aligned_cols=33  Identities=27%  Similarity=0.405  Sum_probs=29.1

Q ss_pred             eeecceeeecCccCceEEEEEEEEecCCCCCCC
Q psy12427         10 TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPS   42 (356)
Q Consensus        10 ~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s   42 (356)
                      ...++++|+||+||+.|.|+|+|.|..|.|.|.
T Consensus        55 ~~~~~~~i~~L~p~t~Y~v~V~a~~~~g~s~p~   87 (94)
T d1fnfa1          55 ADQSSCTFDNLSPGLEYNVSVYTVKDDKESVPI   87 (94)
T ss_dssp             TTCCEEECCCCCTTSCEEEEEEEEETTEECCCE
T ss_pred             CCccEEEECCCCCCCEEEEEEEEEcCCCEeCCE
Confidence            467899999999999999999999998877653

>d1y6kr1 b.1.2.1 (R:2-100) Interleukin-10 receptor 1, IL-10R1 {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Interleukin-10 receptor 1, IL-10R1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.29  E-value=6.4e-05  Score=53.56  Aligned_cols=44  Identities=23%  Similarity=0.194  Sum_probs=35.8

Q ss_pred             CCceEeeeee-----ecceeeecCccCceEEEEEEEEecCCCCCCCCCc
Q psy12427          2 SSWIRVGNTR-----FTTMAITGLSPGHQYEFRVYAENVYGRSDPSTTS   45 (356)
Q Consensus         2 ~~w~~~~~~~-----~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s   45 (356)
                      ..|..+..+.     .+++.+.+|.++..|.|||||.|..|.|.++.+.
T Consensus        45 ~~W~~v~~c~~~t~~~~~~~~~~l~~~~~Y~fRVrA~n~~g~S~Ws~t~   93 (99)
T d1y6kr1          45 ESWNSISQCSQTLSYDLTAVTLDLYHSNGYRARVRAVDGSRHSQWTVTN   93 (99)
T ss_dssp             CCCEEEEEEESSSEEECGGGGTTGGGSSCEEEEEEEEETTEECCCEECS
T ss_pred             cceEEEEeeccccccceeeeeeecCCCCEEEEEEEEEcCCCcCCCcccC
Confidence            4688875433     3456788999999999999999999999988755

>d1bqua1 b.1.2.1 (A:5-99) Cytokine receptor gp130 cytokine-binding domains {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Cytokine receptor gp130 cytokine-binding domains
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.23  E-value=4.8e-05  Score=53.67  Aligned_cols=33  Identities=21%  Similarity=0.042  Sum_probs=28.7

Q ss_pred             eeecceeeecCccCceEEEEEEEEecCCCCCCC
Q psy12427         10 TRFTTMAITGLSPGHQYEFRVYAENVYGRSDPS   42 (356)
Q Consensus        10 ~~~~~~~v~~L~p~~~y~frv~a~n~~g~s~~s   42 (356)
                      ...+++.+.+|.|++.|.|||+|.|..|.|.++
T Consensus        56 ~~~~~~~~~~L~~~~~Y~f~V~A~N~~G~s~S~   88 (95)
T d1bqua1          56 TPTSCTVDYSTVYFVNIEVWVEAENALGKVTSD   88 (95)
T ss_dssp             CTTEEECSSCCCTTSCEEEEEEEEETTEEEECC
T ss_pred             cceeeeeeeecCCCcEEEEEEEEEeCCccccCC
Confidence            555678888999999999999999999988643

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.92  E-value=0.0029  Score=54.87  Aligned_cols=70  Identities=14%  Similarity=0.151  Sum_probs=46.3

Q ss_pred             ceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCCCCc--eeee-----eeEEeCCeEEEEEEeccccch
Q psy12427        121 FGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHHPKL--INLH-----DAFEDDDEMVLIFEFLSGGEL  192 (356)
Q Consensus       121 fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnI--v~l~-----~~~~~~~~~~lv~e~~~~g~L  192 (356)
                      --.||++... +|..+++|+.+.... ..+.+..|...|..|...++  +..+     ..+...+..+.+++++.|..+
T Consensus        35 EN~vy~v~~~-dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~  111 (325)
T d1zyla1          35 ENRVYQFQDE-DRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF  111 (325)
T ss_dssp             SSEEEEECCT-TCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred             cceeEEEEcC-CCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence            4689998764 588899999865432 34667789998888742221  1111     133456778899999987543

>d3d85d3 b.1.2.1 (D:212-305) The p40 domain of interleukin-12 (IL-12 beta chain), domains 2 and 3 {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: The p40 domain of interleukin-12 (IL-12 beta chain), domains 2 and 3
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.70  E-value=0.00052  Score=48.03  Aligned_cols=32  Identities=16%  Similarity=0.000  Sum_probs=26.2

Q ss_pred             ceeeecCccCceEEEEEEEEecCCCCCCCCCc
Q psy12427         14 TMAITGLSPGHQYEFRVYAENVYGRSDPSTTS   45 (356)
Q Consensus        14 ~~~v~~L~p~~~y~frv~a~n~~g~s~~s~~s   45 (356)
                      ..+...|.||+.|.|||||.+..+.|.+|+=|
T Consensus        59 ~~t~~~L~p~~~Y~v~VRa~~~~~~g~WSeWS   90 (94)
T d3d85d3          59 DKTSATVICRKNASISVRAQDRYYSSSWSEWA   90 (94)
T ss_dssp             SSSEEEECCCSSCEEEEEEEESSSCCCCCCCE
T ss_pred             cceEEEecCCCCEEEEEEEecCCCCCCCccCc
Confidence            34456799999999999999998888777644

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.30  E-value=0.0061  Score=52.30  Aligned_cols=146  Identities=15%  Similarity=0.145  Sum_probs=73.3

Q ss_pred             eeeccccccCceEEEEEEEccCCCEEEEEEcccCChhhHHHHHHHHHHHHhcCC-----CCceee-ee--eEEeCCeEEE
Q psy12427        111 DILEEIGTGAFGVVHRCRERKTGNIFAAKFIPVSHNLEKELIRKEIDIMNQLHH-----PKLINL-HD--AFEDDDEMVL  182 (356)
Q Consensus       111 ~~~~~lg~G~fg~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~h-----pnIv~l-~~--~~~~~~~~~l  182 (356)
                      .-.+.|..|---+.|++...  +..+++|+.....  +...+..|+++|..|..     |..+.. -|  ..........
T Consensus        21 ~~~~~i~~G~~N~ny~v~t~--~g~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~   96 (316)
T d2ppqa1          21 TSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAA   96 (316)
T ss_dssp             EEEEEECC---EEEEEEEES--SCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEE
T ss_pred             eEeecCCCCcccCeEEEEEC--CCcEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccce
Confidence            33456778888999998765  3358999875432  23445567777777742     222211 11  1233455667


Q ss_pred             EEEeccccchhh--------------hhh--CCCCCCCc-------------------cccccccHHHHHHHHHHHHHHH
Q psy12427        183 IFEFLSGGELFE--------------RIT--APDYKMSE-------------------AEVIPVTLPILMTQTSPAVKHM  227 (356)
Q Consensus       183 v~e~~~~g~L~~--------------~l~--~~~~~~~~-------------------~~~~~~~~~~~~~~i~~~l~~l  227 (356)
                      ++.++.|.....              .+.  ........                   .......+...+..+...+...
T Consensus        97 ~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  176 (316)
T d2ppqa1          97 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH  176 (316)
T ss_dssp             EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred             eeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhcc
Confidence            777776643311              000  00000000                   0000011111222222223322


Q ss_pred             H----HCCceeccCCCCCEEEeecCCCcEEEEeeeceee
Q psy12427        228 H----EKNIIHLDVKPENIMCQTRNSTNVKMIDFGLATK  262 (356)
Q Consensus       228 H----~~~ivH~Dlkp~NIlv~~~~~~~vkl~Dfg~a~~  262 (356)
                      +    ..|+||+|+.++||+++.+.  ..-|+||+.|..
T Consensus       177 ~~~~L~~giIHgDl~~dNvl~~~~~--v~gvIDF~~~~~  213 (316)
T d2ppqa1         177 WPKDLPAGVIHADLFQDNVFFLGDE--LSGLIDFYFACN  213 (316)
T ss_dssp             CCCSSCEEEECSCCCGGGEEEETTE--EEEECCCTTCEE
T ss_pred             CccccccccccCCcchhhhhccccc--ceeEeccccccc
Confidence            2    23699999999999997432  458999998864

>d2qfra1 b.1.12.1 (A:9-120) Purple acid phosphatase, N-terminal domain {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Purple acid phosphatase, N-terminal domain
family: Purple acid phosphatase, N-terminal domain
domain: Purple acid phosphatase, N-terminal domain
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=94.13  E-value=0.012  Score=42.28  Aligned_cols=17  Identities=24%  Similarity=0.374  Sum_probs=16.0

Q ss_pred             ceeeecCccCceEEEEE
Q psy12427         14 TMAITGLSPGHQYEFRV   30 (356)
Q Consensus        14 ~~~v~~L~p~~~y~frv   30 (356)
                      .++++||+|+|.|.|||
T Consensus        81 ~v~Lt~L~P~T~Y~YrV   97 (112)
T d2qfra1          81 HTTIRKLKYNTKYYYEV   97 (112)
T ss_dssp             EEEECSCCTTCEEEEEE
T ss_pred             EEEECCCCCCCEEEEEE
Confidence            57899999999999999

>d1xzwa1 b.1.12.1 (A:1-119) Purple acid phosphatase, N-terminal domain {Sweet potato (Ipomoea batatas) [TaxId: 4120]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Purple acid phosphatase, N-terminal domain
family: Purple acid phosphatase, N-terminal domain
domain: Purple acid phosphatase, N-terminal domain
species: Sweet potato (Ipomoea batatas) [TaxId: 4120]

Probab=92.90  E-value=0.017  Score=41.82  Aligned_cols=18  Identities=22%  Similarity=0.347  Sum_probs=16.3

Q ss_pred             ceeeecCccCceEEEEEE
Q psy12427         14 TMAITGLSPGHQYEFRVY   31 (356)
Q Consensus        14 ~~~v~~L~p~~~y~frv~   31 (356)
                      .++++||+|+|.|.|||-
T Consensus        88 ~v~LtgL~P~T~Y~YrVG  105 (119)
T d1xzwa1          88 HCTIKDLEYDTKYYYRLG  105 (119)
T ss_dssp             EEEECCCCTTCEEEEEEC
T ss_pred             EEEECCCCCCCEEEEEEC
Confidence            588999999999999993

>d2c4fu1 b.1.2.1 (U:91-210) Extracellular region of human tissue factor {Human (Homo sapiens) [TaxId: 9606]}

class: All beta proteins
fold: Immunoglobulin-like beta-sandwich
superfamily: Fibronectin type III
family: Fibronectin type III
domain: Extracellular region of human tissue factor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=91.96  E-value=0.073  Score=38.12  Aligned_cols=24  Identities=25%  Similarity=0.293  Sum_probs=21.9

Q ss_pred             eeecceeeecCccCceEEEEEEEE
Q psy12427         10 TRFTTMAITGLSPGHQYEFRVYAE   33 (356)
Q Consensus        10 ~~~~~~~v~~L~p~~~y~frv~a~   33 (356)
                      .+.++..+.+|+|++.|.|.|+|.
T Consensus        75 ~~~~~~~l~~L~p~t~YCv~Vqa~   98 (116)
T d2c4fu1          75 KTNTNEFLIDVDKGENYCFSVQAV   98 (116)
T ss_dssp             EESSSEEEEECCTTCCCEEEEEEE
T ss_pred             EEeeeEEEeCCCCCCcEEEEEEEE
Confidence            566788999999999999999997